id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
156977603|NCT02906683|566673512|FG000|Overall Study|Adverse Event|0|||
156977604|NCT02906683|566673513|FG001|Overall Study|Adverse Event|1|||
156977605|NCT02906683|566673514|FG002|Overall Study|Adverse Event|0|||
156977606|NCT02906683|566673512|FG000|Overall Study|Physician Decision|0|||
156977607|NCT02906683|566673513|FG001|Overall Study|Physician Decision|1|||
156977608|NCT02906683|566673514|FG002|Overall Study|Physician Decision|1|||
156977609|NCT02906683|566673512|FG000|Overall Study|Withdrawal by Subject|0|||
156977610|NCT02906683|566673513|FG001|Overall Study|Withdrawal by Subject|2|||
156977611|NCT02906683|566673514|FG002|Overall Study|Withdrawal by Subject|1|||
156977612|NCT02906683|566673512|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
156977613|NCT02906683|566673513|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
156977614|NCT02906683|566673514|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
156977615|NCT02906683|566673512|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
156977616|NCT02906683|566673513|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
156977617|NCT02906683|566673514|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
156977618|NCT01167179|566673515|FG000|Overall Study|disease recurrence|4|||
156977619|NCT01167179|566673516|FG001|Overall Study|disease recurrence|4|||
156977620|NCT01167179|566673515|FG000|Overall Study|Death|4|||
156977621|NCT01167179|566673516|FG001|Overall Study|Death|10|||
156977622|NCT01167179|566673515|FG000|Overall Study|Withdrawal by Subject|1|||
156977623|NCT01167179|566673516|FG001|Overall Study|Withdrawal by Subject|2|||
156977624|NCT01167179|566673515|FG000|Overall Study|diverse|6|||
156977625|NCT01167179|566673516|FG001|Overall Study|diverse|5|||
157091668|NCT05195489|567091416|FG000|Overall Study|Lost to Follow-up|1|||
157091669|NCT05195489|567091417|FG001|Overall Study|Lost to Follow-up|0|||
156977626|NCT01158378|566673517|FG000|Overall Study|Death|4|||
156977627|NCT01158378|566673518|FG001|Overall Study|Death|5|||
156977628|NCT01158378|566673517|FG000|Overall Study|Lost to Follow-up|2|||
156977629|NCT01158378|566673518|FG001|Overall Study|Lost to Follow-up|4|||
156977630|NCT01158378|566673517|FG000|Overall Study|Withdrawal by Subject|4|||
156977631|NCT01158378|566673518|FG001|Overall Study|Withdrawal by Subject|0|||
156977632|NCT02769065|566673519|FG000|Overall Study|Voluntary Withdrawal|1|||
156977633|NCT02769065|566673520|FG001|Overall Study|Voluntary Withdrawal|0|||
156977634|NCT02769065|566673521|FG002|Overall Study|Voluntary Withdrawal|0|||
156977635|NCT02769065|566673522|FG003|Overall Study|Voluntary Withdrawal|0|||
156977636|NCT02769065|566673523|FG004|Overall Study|Voluntary Withdrawal|0|||
156977637|NCT02769065|566673524|FG005|Overall Study|Voluntary Withdrawal|0|||
156977638|NCT02769065|566673525|FG006|Overall Study|Voluntary Withdrawal|0|||
156977639|NCT02769065|566673526|FG007|Overall Study|Voluntary Withdrawal|0|||
156977640|NCT02769065|566673527|FG008|Overall Study|Voluntary Withdrawal|0|||
156977641|NCT02769065|566673528|FG009|Overall Study|Voluntary Withdrawal|0|||
156977642|NCT02769065|566673529|FG010|Overall Study|Voluntary Withdrawal|0|||
156977643|NCT02769065|566673530|FG011|Overall Study|Voluntary Withdrawal|0|||
156977644|NCT02769065|566673531|FG012|Overall Study|Voluntary Withdrawal|0|||
156977645|NCT02769065|566673532|FG013|Overall Study|Voluntary Withdrawal|0|||
156977646|NCT02769065|566673533|FG014|Overall Study|Voluntary Withdrawal|0|||
156977647|NCT02769065|566673534|FG015|Overall Study|Voluntary Withdrawal|0|||
156977648|NCT02769065|566673535|FG016|Overall Study|Voluntary Withdrawal|0|||
156977649|NCT02769065|566673536|FG017|Overall Study|Voluntary Withdrawal|0|||
156977650|NCT02769065|566673537|FG018|Overall Study|Voluntary Withdrawal|0|||
156977651|NCT02769065|566673538|FG019|Overall Study|Voluntary Withdrawal|0|||
156977652|NCT02769065|566673539|FG020|Overall Study|Voluntary Withdrawal|0|||
156977653|NCT02769065|566673540|FG021|Overall Study|Voluntary Withdrawal|0|||
156977654|NCT02769065|566673541|FG022|Overall Study|Voluntary Withdrawal|0|||
156977655|NCT02769065|566673542|FG023|Overall Study|Voluntary Withdrawal|0|||
156977656|NCT02769065|566673543|FG024|Overall Study|Voluntary Withdrawal|0|||
156977657|NCT02769065|566673544|FG025|Overall Study|Voluntary Withdrawal|0|||
156977658|NCT02769065|566673545|FG026|Overall Study|Voluntary Withdrawal|0|||
156977659|NCT02769065|566673546|FG027|Overall Study|Voluntary Withdrawal|0|||
156977660|NCT02769065|566673547|FG028|Overall Study|Voluntary Withdrawal|0|||
156977661|NCT02769065|566673548|FG029|Overall Study|Voluntary Withdrawal|0|||
156977662|NCT02769065|566673519|FG000|Overall Study|Reason Not Specified|0|||
156977663|NCT02769065|566673520|FG001|Overall Study|Reason Not Specified|0|||
156977664|NCT02769065|566673521|FG002|Overall Study|Reason Not Specified|0|||
156977665|NCT02769065|566673522|FG003|Overall Study|Reason Not Specified|0|||
156977666|NCT02769065|566673523|FG004|Overall Study|Reason Not Specified|0|||
156977667|NCT02769065|566673524|FG005|Overall Study|Reason Not Specified|0|||
156977668|NCT02769065|566673525|FG006|Overall Study|Reason Not Specified|1|||
156977669|NCT02769065|566673526|FG007|Overall Study|Reason Not Specified|0|||
156977670|NCT02769065|566673527|FG008|Overall Study|Reason Not Specified|0|||
156977671|NCT02769065|566673528|FG009|Overall Study|Reason Not Specified|0|||
156977672|NCT02769065|566673529|FG010|Overall Study|Reason Not Specified|0|||
156977673|NCT02769065|566673530|FG011|Overall Study|Reason Not Specified|0|||
156977674|NCT02769065|566673531|FG012|Overall Study|Reason Not Specified|0|||
157221623|NCT01644890|567558453|FG000|Overall Study|Adverse Event|7|||
156977675|NCT02769065|566673532|FG013|Overall Study|Reason Not Specified|0|||
156977676|NCT02769065|566673533|FG014|Overall Study|Reason Not Specified|0|||
156977677|NCT02769065|566673534|FG015|Overall Study|Reason Not Specified|0|||
156977678|NCT02769065|566673535|FG016|Overall Study|Reason Not Specified|0|||
156977679|NCT02769065|566673536|FG017|Overall Study|Reason Not Specified|0|||
156977680|NCT02769065|566673537|FG018|Overall Study|Reason Not Specified|0|||
156977681|NCT02769065|566673538|FG019|Overall Study|Reason Not Specified|0|||
156977682|NCT02769065|566673539|FG020|Overall Study|Reason Not Specified|0|||
156977683|NCT02769065|566673540|FG021|Overall Study|Reason Not Specified|0|||
156977684|NCT02769065|566673541|FG022|Overall Study|Reason Not Specified|0|||
156977685|NCT02769065|566673542|FG023|Overall Study|Reason Not Specified|0|||
156977686|NCT02769065|566673543|FG024|Overall Study|Reason Not Specified|0|||
156977687|NCT02769065|566673544|FG025|Overall Study|Reason Not Specified|0|||
156977688|NCT02769065|566673545|FG026|Overall Study|Reason Not Specified|0|||
156977689|NCT02769065|566673546|FG027|Overall Study|Reason Not Specified|0|||
156977690|NCT02769065|566673547|FG028|Overall Study|Reason Not Specified|0|||
156977691|NCT02769065|566673548|FG029|Overall Study|Reason Not Specified|0|||
156977692|NCT02769065|566673519|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977693|NCT02769065|566673520|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977694|NCT02769065|566673521|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977695|NCT02769065|566673522|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977696|NCT02769065|566673523|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977697|NCT02769065|566673524|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977698|NCT02769065|566673525|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977699|NCT02769065|566673526|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977700|NCT02769065|566673527|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977701|NCT02769065|566673528|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977702|NCT02769065|566673529|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
156977703|NCT02769065|566673530|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977704|NCT02769065|566673531|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977705|NCT02769065|566673532|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977706|NCT02769065|566673533|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977707|NCT02769065|566673534|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977708|NCT02769065|566673535|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977709|NCT02769065|566673536|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977710|NCT02769065|566673537|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977711|NCT02769065|566673538|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977712|NCT02769065|566673539|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977713|NCT02769065|566673540|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977714|NCT02769065|566673541|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977715|NCT02769065|566673542|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977716|NCT02769065|566673543|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977717|NCT02769065|566673544|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977718|NCT02769065|566673545|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
156863836|NCT00303069|566260781|FG000|Overall Study|Lost to Follow-up|1|||
156863837|NCT00303069|566260782|FG001|Overall Study|Lost to Follow-up|0|||
156863838|NCT00303069|566260783|FG002|Overall Study|Lost to Follow-up|0|||
156863839|NCT00303069|566260784|FG003|Overall Study|Lost to Follow-up|2|||
156863840|NCT00303069|566260781|FG000|Overall Study|subject moved|1|||
156863841|NCT00303069|566260782|FG001|Overall Study|subject moved|0|||
156863842|NCT00303069|566260783|FG002|Overall Study|subject moved|0|||
156977719|NCT02769065|566673546|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977720|NCT02769065|566673547|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977721|NCT02769065|566673548|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
156977722|NCT02531295|566673549|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
156977723|NCT02531295|566673550|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
156977724|NCT02531295|566673551|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
156977725|NCT02531295|566673552|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
156977726|NCT02531295|566673553|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
157205619|NCT03514121|567497988|FG000|Overall Study|Withdrawal by Subject|0|||
157205620|NCT03514121|567497989|FG001|Overall Study|Withdrawal by Subject|0|||
157205621|NCT03514121|567497990|FG002|Overall Study|Withdrawal by Subject|0|||
157205622|NCT03514121|567497991|FG003|Overall Study|Withdrawal by Subject|0|||
156977727|NCT02531295|566673554|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
156977728|NCT04666922|566673555|FG000|Overall Study|Withdrawal by Subject|1|||
156977729|NCT04666922|566673556|FG001|Overall Study|Withdrawal by Subject|0|||
157205623|NCT03514121|567497992|FG004|Overall Study|Withdrawal by Subject|1|||
156863843|NCT00303069|566260784|FG003|Overall Study|subject moved|0|||
156863844|NCT00303069|566260781|FG000|Overall Study|Recruitment into Army Reserves|0|||
156863845|NCT00303069|566260782|FG001|Overall Study|Recruitment into Army Reserves|0|||
156863846|NCT00303069|566260783|FG002|Overall Study|Recruitment into Army Reserves|1|||
156863847|NCT00303069|566260784|FG003|Overall Study|Recruitment into Army Reserves|0|||
156977730|NCT04666922|566673557|FG002|Overall Study|Withdrawal by Subject|0|||
156977731|NCT04666922|566673558|FG003|Overall Study|Withdrawal by Subject|0|||
156977732|NCT04666922|566673559|FG004|Overall Study|Withdrawal by Subject|0|||
156977733|NCT04666922|566673560|FG005|Overall Study|Withdrawal by Subject|0|||
156977734|NCT04666922|566673561|FG006|Overall Study|Withdrawal by Subject|0|||
156977735|NCT02105636|566673563|FG000|Pre-Treatment|Disease Progression|1|||
156977736|NCT02105636|566673564|FG001|Pre-Treatment|Disease Progression|0|||
156977737|NCT02105636|566673563|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
156863848|NCT00092417|566260785|FG000|Overall Study|Lost to Follow-up|2|||
156863849|NCT00092417|566260786|FG001|Overall Study|Lost to Follow-up|0|||
156863850|NCT00092417|566260785|FG000|Overall Study|Withdrawal by Subject|2|||
156863851|NCT00092417|566260786|FG001|Overall Study|Withdrawal by Subject|1|||
156863852|NCT00092417|566260785|FG000|Overall Study|Other|1|||
156863853|NCT00092417|566260786|FG001|Overall Study|Other|0|||
156863854|NCT01520506|566260787|FG000|Overall Study|Missed Visit|4|||
156863855|NCT01520506|566260787|FG000|Overall Study|Lost to Follow-up|1|||
156863856|NCT01520506|566260787|FG000|Overall Study|Withdrawal by Subject|1|||
156863857|NCT00425269|566260788|FG000|Overall Study|Pregnancy|5|||
156863858|NCT00425269|566260789|FG001|Overall Study|Pregnancy|7|||
156863859|NCT00425269|566260788|FG000|Overall Study|Lost to Follow-up|9|||
156863860|NCT00425269|566260789|FG001|Overall Study|Lost to Follow-up|9|||
156863861|NCT00425269|566260788|FG000|Overall Study|moved or medical reason|5|||
156863862|NCT00425269|566260789|FG001|Overall Study|moved or medical reason|4|||
156863863|NCT01084655|566260794|FG000|Overall Study|Radiographic disease progression|3|||
156863864|NCT01084655|566260795|FG001|Overall Study|Radiographic disease progression|2|||
156863865|NCT01084655|566260796|FG002|Overall Study|Radiographic disease progression|8|||
156863866|NCT01084655|566260794|FG000|Overall Study|Withdrawal by Subject|1|||
156863867|NCT01084655|566260795|FG001|Overall Study|Withdrawal by Subject|0|||
156863868|NCT01084655|566260796|FG002|Overall Study|Withdrawal by Subject|4|||
156863869|NCT01084655|566260794|FG000|Overall Study|Adverse Event|2|||
156863870|NCT01084655|566260795|FG001|Overall Study|Adverse Event|1|||
156863871|NCT01084655|566260796|FG002|Overall Study|Adverse Event|2|||
156863872|NCT01084655|566260794|FG000|Overall Study|Other|0|||
156863873|NCT01084655|566260795|FG001|Overall Study|Other|3|||
156863874|NCT01084655|566260796|FG002|Overall Study|Other|2|||
156863875|NCT01084655|566260794|FG000|Overall Study|Symptomatic deterioration|0|||
156863876|NCT01084655|566260795|FG001|Overall Study|Symptomatic deterioration|0|||
156863877|NCT01084655|566260796|FG002|Overall Study|Symptomatic deterioration|2|||
156863878|NCT01084655|566260794|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
156863879|NCT01084655|566260795|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
156863880|NCT01084655|566260796|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
156863881|NCT01256788|566260797|FG000|Overall Study|Lost to Follow-up|5|||
156863882|NCT01256788|566260798|FG001|Overall Study|Lost to Follow-up|8|||
156863883|NCT01256788|566260799|FG002|Overall Study|Lost to Follow-up|3|||
156863884|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863885|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
156863886|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863887|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
156863888|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
156863889|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
156863890|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
156863891|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
156863892|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863893|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
156863894|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863895|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
156863896|NCT01972217|566260800|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
156863897|NCT01972217|566260801|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
156863898|NCT01972217|566260802|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
156863899|NCT01972217|566260803|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
156863900|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Death|0|||
156863901|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Death|0|||
156977738|NCT02105636|566673564|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
156977739|NCT02105636|566673563|FG000|Pre-Treatment|Participant withdrew consent|0|||
156977740|NCT02105636|566673564|FG001|Pre-Treatment|Participant withdrew consent|6|||
156863902|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Death|43|||
156863903|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Death|44|||
156863904|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863905|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863906|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
156977741|NCT02105636|566673563|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
157091670|NCT05195489|567091416|FG000|Overall Study|Protocol Violation|0|||
156863907|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
156863908|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
156977742|NCT02105636|566673564|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
156977743|NCT02105636|566673563|FG000|Treatment|Study Drug Toxicity|14|||
156863909|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
156863910|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
156863911|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
156863912|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
156863913|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
156863914|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
156863915|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
156863916|NCT01972217|566260800|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863917|NCT01972217|566260801|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863918|NCT01972217|566260802|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
156863919|NCT01972217|566260803|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
156863920|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
156863921|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
156863922|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
156863923|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
156863924|NCT00906204|566260804|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
156863925|NCT00906204|566260805|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
156863926|NCT00906204|566260804|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
156863927|NCT00906204|566260805|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
156863928|NCT00906204|566260804|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
156863929|NCT00906204|566260805|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
156863930|NCT00696072|566260806|FG000|Overall Study|continuing active treatment|10|||
156863931|NCT00696072|566260807|FG001|Overall Study|continuing active treatment|13|||
156863932|NCT00696072|566260806|FG000|Overall Study|Adverse Event|10|||
156863933|NCT00696072|566260807|FG001|Overall Study|Adverse Event|6|||
156863934|NCT00696072|566260806|FG000|Overall Study|Patient Request|3|||
156863935|NCT00696072|566260807|FG001|Overall Study|Patient Request|7|||
156863936|NCT00696072|566260806|FG000|Overall Study|Investigator Request|1|||
156863937|NCT00696072|566260807|FG001|Overall Study|Investigator Request|4|||
156863938|NCT00696072|566260806|FG000|Overall Study|Sponsor Request|0|||
156863939|NCT00696072|566260807|FG001|Overall Study|Sponsor Request|1|||
156863940|NCT00696072|566260806|FG000|Overall Study|Disease Progression|32|||
156863941|NCT00696072|566260807|FG001|Overall Study|Disease Progression|30|||
156863942|NCT00696072|566260806|FG000|Overall Study|Non-specified|1|||
156863943|NCT00696072|566260807|FG001|Overall Study|Non-specified|2|||
156863944|NCT01597596|566260808|FG000|Overall Study|Study terminated by sponsor|1|||
156863945|NCT01597596|566260809|FG001|Overall Study|Study terminated by sponsor|0|||
156863946|NCT01597596|566260808|FG000|Overall Study|Physician Decision|0|||
156977744|NCT02105636|566673564|FG001|Treatment|Study Drug Toxicity|10|||
156977745|NCT02105636|566673563|FG000|Treatment|Adverse event unrelated to study drug|19|||
156977746|NCT02105636|566673564|FG001|Treatment|Adverse event unrelated to study drug|3|||
156977747|NCT02105636|566673563|FG000|Treatment|Participant request to discontinue study treatment|8|||
156977748|NCT02105636|566673564|FG001|Treatment|Participant request to discontinue study treatment|6|||
156977749|NCT02105636|566673563|FG000|Treatment|Participant withdrew consent|5|||
156977750|NCT02105636|566673564|FG001|Treatment|Participant withdrew consent|1|||
156977751|NCT02105636|566673563|FG000|Treatment|Lost to Follow-up|1|||
156977752|NCT02105636|566673564|FG001|Treatment|Lost to Follow-up|0|||
156977753|NCT02105636|566673563|FG000|Treatment|Maximum Clinical Benefit|1|||
156977754|NCT02105636|566673564|FG001|Treatment|Maximum Clinical Benefit|3|||
156977755|NCT02105636|566673563|FG000|Treatment|Poor/Non-compliance|0|||
156977756|NCT02105636|566673564|FG001|Treatment|Poor/Non-compliance|1|||
156977757|NCT02105636|566673563|FG000|Treatment|Participant no longer meets study criteria|1|||
156977758|NCT02105636|566673564|FG001|Treatment|Participant no longer meets study criteria|0|||
156977759|NCT02105636|566673563|FG000|Treatment|Other reasons|1|||
156977760|NCT02105636|566673564|FG001|Treatment|Other reasons|0|||
156749958|NCT00385827|565836900|FG000|Part 1|Adverse Event|1|||
156749959|NCT00385827|565836901|FG001|Part 1|Adverse Event|0|||
156749960|NCT00385827|565836902|FG002|Part 1|Adverse Event|0|||
156749961|NCT00385827|565836900|FG000|Part 1|Death|2|||
156749962|NCT00385827|565836901|FG001|Part 1|Death|0|||
156749963|NCT00385827|565836902|FG002|Part 1|Death|0|||
156749964|NCT00385827|565836900|FG000|Part 1|Lack of Efficacy|5|||
156863947|NCT01597596|566260809|FG001|Overall Study|Physician Decision|1|||
156863948|NCT00992108|566260816|FG000|Overall Study|Lost to Follow-up|0|||
156863949|NCT00992108|566260817|FG001|Overall Study|Lost to Follow-up|1|||
156863950|NCT04639245|566260818|FG000|Overall Study|Death|1|||
156863951|NCT02419001|566260821|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
156883063|NCT00715910|566330921|FG002|Booster and ESFU Phase|Other|0|||
156749965|NCT00385827|565836901|FG001|Part 1|Lack of Efficacy|0|||
156863952|NCT02419001|566260822|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
156863953|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863954|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863955|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
156863956|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
156863957|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863958|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
156863959|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
156863960|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863961|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863962|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156863963|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
156863964|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
156863965|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863966|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
156863967|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863968|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863969|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
156863970|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
156863971|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156863972|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156863973|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156863974|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
156863975|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
156863976|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
156863977|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
156863978|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863979|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863980|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
156863981|NCT03175367|566260826|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863982|NCT03175367|566260827|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863983|NCT03175367|566260828|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
156863984|NCT03175367|566260829|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863985|NCT03175367|566260830|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
156863986|NCT03175367|566260831|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863987|NCT03175367|566260832|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156863988|NCT03175367|566260826|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863989|NCT03175367|566260827|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863990|NCT03175367|566260828|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863991|NCT03175367|566260829|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863992|NCT03175367|566260830|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863993|NCT03175367|566260831|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
156863994|NCT03175367|566260832|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
156863995|NCT03175367|566260826|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863996|NCT03175367|566260827|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863997|NCT03175367|566260828|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863998|NCT03175367|566260829|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156977761|NCT02105636|566673563|FG000|Treatment|Disease Progression|185|||
156977762|NCT02105636|566673564|FG001|Treatment|Disease Progression|87|||
156749966|NCT00385827|565836902|FG002|Part 1|Lack of Efficacy|0|||
156977763|NCT00720902|566673565|FG000|Overall Study|Withdrawal by Subject|1|||
156977764|NCT00720902|566673566|FG001|Overall Study|Withdrawal by Subject|0|||
156977765|NCT00720902|566673565|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
156977766|NCT00720902|566673566|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
156977767|NCT03462706|566673568|FG000|Overall Study|Polyp was pedunculated|1|||
156977768|NCT03462706|566673569|FG001|Overall Study|Polyp was pedunculated|0|||
156977769|NCT03462706|566673570|FG002|Overall Study|Polyp was pedunculated|1|||
156977770|NCT03462706|566673571|FG003|Overall Study|Polyp was pedunculated|0|||
156977771|NCT03462706|566673568|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
156977772|NCT03462706|566673569|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
156977773|NCT03462706|566673570|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
156977774|NCT03462706|566673571|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
156977775|NCT01923896|566673577|FG000|Overall Study|Adverse Event|1|||
156977776|NCT01923896|566673578|FG001|Overall Study|Adverse Event|0|||
156749967|NCT00385827|565836900|FG000|Part 1|Other|1|||
156749968|NCT00385827|565836901|FG001|Part 1|Other|0|||
156977777|NCT03545113|566673581|FG000|Overall Study|Surgery Cancelled|1|||
156863999|NCT03175367|566260830|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156864000|NCT03175367|566260831|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
156864001|NCT03175367|566260832|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156864002|NCT02851615|566260833|FG000|Overall Study|Cognitive Issue|1|||
156864003|NCT02851615|566260834|FG001|Overall Study|Cognitive Issue|0|||
156864004|NCT02851615|566260833|FG000|Overall Study|Lost to Follow-up|0|||
156864005|NCT02851615|566260834|FG001|Overall Study|Lost to Follow-up|4|||
156864006|NCT00371150|566260836|FG000|Overall Study|Lost to Follow-up|3|||
156864007|NCT00371150|566260837|FG001|Overall Study|Lost to Follow-up|2|||
156864008|NCT02151058|566260839|FG000|Overall Study|Withdrawal by Subject|1|||
156977778|NCT03545113|566673582|FG001|Overall Study|Surgery Cancelled|0|||
156977779|NCT03545113|566673581|FG000|Overall Study|Death|1|||
156977780|NCT03545113|566673582|FG001|Overall Study|Death|0|||
156977781|NCT03545113|566673581|FG000|Overall Study|Adverse Event|2|||
156977782|NCT03545113|566673582|FG001|Overall Study|Adverse Event|0|||
156977783|NCT03545113|566673581|FG000|Overall Study|Received different surgery|1|||
156977784|NCT03545113|566673582|FG001|Overall Study|Received different surgery|0|||
156977785|NCT00474929|566673586|FG000|Overall Study|Withdrawal by Subject|0|||
156977786|NCT00474929|566673587|FG001|Overall Study|Withdrawal by Subject|1|||
156977787|NCT00474929|566673588|FG002|Overall Study|Withdrawal by Subject|0|||
156977788|NCT00474929|566673589|FG003|Overall Study|Withdrawal by Subject|0|||
156977789|NCT00474929|566673590|FG004|Overall Study|Withdrawal by Subject|0|||
156977790|NCT00474929|566673586|FG000|Overall Study|Unrelated medical condition|0|||
156977791|NCT00474929|566673587|FG001|Overall Study|Unrelated medical condition|0|||
156977792|NCT00474929|566673588|FG002|Overall Study|Unrelated medical condition|1|||
156977793|NCT00474929|566673589|FG003|Overall Study|Unrelated medical condition|0|||
156977794|NCT00474929|566673590|FG004|Overall Study|Unrelated medical condition|0|||
156864009|NCT02151058|566260840|FG001|Overall Study|Withdrawal by Subject|1|||
156864010|NCT02151058|566260841|FG002|Overall Study|Withdrawal by Subject|3|||
156864011|NCT02151058|566260839|FG000|Overall Study|Lost to Follow-up|1|||
156864012|NCT02151058|566260840|FG001|Overall Study|Lost to Follow-up|0|||
156864013|NCT02151058|566260841|FG002|Overall Study|Lost to Follow-up|2|||
156864014|NCT03337477|566260842|FG000|Overall Study|not categorized into the listed ones|11|||
156864015|NCT03337477|566260843|FG001|Overall Study|not categorized into the listed ones|9|||
156864016|NCT03337477|566260842|FG000|Overall Study|Withdrawal by Subject|0|||
156864017|NCT03337477|566260843|FG001|Overall Study|Withdrawal by Subject|1|||
156864018|NCT03337477|566260842|FG000|Overall Study|Death|0|||
156864019|NCT03337477|566260843|FG001|Overall Study|Death|1|||
156864020|NCT03337477|566260842|FG000|Overall Study|Lost to Follow-up|0|||
156864021|NCT03337477|566260843|FG001|Overall Study|Lost to Follow-up|2|||
156864022|NCT03304626|566260844|FG000|Overall Study|Adverse Event|1|||
156977795|NCT00474929|566673586|FG000|Overall Study|Physician Decision|0|||
156864023|NCT03304626|566260845|FG001|Overall Study|Adverse Event|0|||
156864024|NCT03304626|566260844|FG000|Overall Study|Lack of Efficacy|1|||
156864025|NCT03304626|566260845|FG001|Overall Study|Lack of Efficacy|1|||
156864026|NCT00744497|566260846|FG000|Overall Study|Withdrawal by Subject|21|||
156864027|NCT00744497|566260847|FG001|Overall Study|Withdrawal by Subject|18|||
156864028|NCT00744497|566260846|FG000|Overall Study|Death|11|||
156864029|NCT00744497|566260847|FG001|Overall Study|Death|9|||
156864030|NCT00744497|566260846|FG000|Overall Study|Lost to Follow-up|4|||
156864031|NCT00744497|566260847|FG001|Overall Study|Lost to Follow-up|2|||
156864032|NCT00744497|566260846|FG000|Overall Study|Poor compliance/noncompliance|9|||
156864033|NCT00744497|566260847|FG001|Overall Study|Poor compliance/noncompliance|5|||
156864034|NCT00744497|566260846|FG000|Overall Study|No longer meets study criteria|7|||
156864035|NCT00744497|566260847|FG001|Overall Study|No longer meets study criteria|3|||
156864036|NCT00744497|566260846|FG000|Overall Study|Administrative Reason By Sponsor|25|||
156864037|NCT00744497|566260847|FG001|Overall Study|Administrative Reason By Sponsor|8|||
156864038|NCT00744497|566260846|FG000|Overall Study|Disease progression|312|||
156864039|NCT00744497|566260847|FG001|Overall Study|Disease progression|219|||
156864040|NCT00744497|566260846|FG000|Overall Study|Study drug toxicity|68|||
156864041|NCT00744497|566260847|FG001|Overall Study|Study drug toxicity|141|||
156864042|NCT00744497|566260846|FG000|Overall Study|Adverse event unrelated to study drug|78|||
156864043|NCT00744497|566260847|FG001|Overall Study|Adverse event unrelated to study drug|122|||
156864044|NCT00744497|566260846|FG000|Overall Study|Patient requested to stop study drug|65|||
156977796|NCT00474929|566673587|FG001|Overall Study|Physician Decision|0|||
156977797|NCT00474929|566673588|FG002|Overall Study|Physician Decision|1|||
156977798|NCT00474929|566673589|FG003|Overall Study|Physician Decision|2|||
156977799|NCT00474929|566673590|FG004|Overall Study|Physician Decision|0|||
156864045|NCT00744497|566260847|FG001|Overall Study|Patient requested to stop study drug|80|||
156864046|NCT00744497|566260846|FG000|Overall Study|Maximum clinical benefit|141|||
156864047|NCT00744497|566260847|FG001|Overall Study|Maximum clinical benefit|142|||
156864048|NCT00744497|566260846|FG000|Overall Study|Not defined|19|||
156864049|NCT00744497|566260847|FG001|Overall Study|Not defined|13|||
156864050|NCT03182374|566260850|FG000|Overall Study|Lost to Follow-up|3|||
156864051|NCT03182374|566260851|FG001|Overall Study|Lost to Follow-up|2|||
156977800|NCT03661996|566673593|FG000|Overall Study|Adverse Event|0|||
156864052|NCT03182374|566260850|FG000|Overall Study|Lack of Efficacy|8|||
156864053|NCT03182374|566260851|FG001|Overall Study|Lack of Efficacy|14|||
156864054|NCT03182374|566260850|FG000|Overall Study|Withdrawal by Subject|1|||
156864055|NCT03182374|566260851|FG001|Overall Study|Withdrawal by Subject|1|||
156864056|NCT03182374|566260850|FG000|Overall Study|exit for non-compliance|1|||
156864057|NCT03182374|566260851|FG001|Overall Study|exit for non-compliance|1|||
156864058|NCT03182374|566260850|FG000|Overall Study|one subject was randomized but not treated|1|||
156864059|NCT03182374|566260851|FG001|Overall Study|one subject was randomized but not treated|0|||
156864060|NCT03182374|566260850|FG000|Overall Study|Other reasons|0|||
156864061|NCT03182374|566260851|FG001|Overall Study|Other reasons|3|||
156864062|NCT06271993|566260856|FG000|Overall Study|Not reactive to histamine|5|||
156864063|NCT06271993|566260857|FG001|Overall Study|Not reactive to histamine|5|||
156864064|NCT06271993|566260858|FG002|Overall Study|Not reactive to histamine|5|||
156864065|NCT04613362|566260859|FG000|3 Month Follow-up|Lost to Follow-up|1|||
156864066|NCT04613362|566260860|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156864067|NCT04613362|566260859|FG000|6 Month Follow-up|Lost to Follow-up|0|||
156864068|NCT04613362|566260860|FG001|6 Month Follow-up|Lost to Follow-up|1|||
156864069|NCT03331315|566260862|FG000|Overall Study|Physician Decision|18|||
156864070|NCT03331315|566260863|FG001|Overall Study|Physician Decision|14|||
156864071|NCT00481832|566260864|FG000|Enrollment|Physician Decision|8|||
156864072|NCT00481832|566260864|FG000|Enrollment|Unable to collect enough stem cells|2|||
156864073|NCT00481832|566260864|FG000|Inter-transplant Period|Adverse Event|4|||
156864074|NCT00481832|566260864|FG000|Inter-transplant Period|Death|3|||
156864075|NCT00481832|566260864|FG000|Inter-transplant Period|Physician Decision|4|||
156864076|NCT00481832|566260864|FG000|Inter-transplant Period|Disease relapse|11|||
156864077|NCT00481832|566260864|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
156864078|NCT00581308|566260865|FG000|Pre Discharge|Lost to Follow-up|1|||
156864079|NCT00581308|566260865|FG000|Pre Discharge|Device Removed|1|||
156864080|NCT00581308|566260865|FG000|Month 1|Lost to Follow-up|3|||
156864081|NCT00581308|566260865|FG000|Month 1|Withdrawal by Subject|2|||
156864082|NCT00581308|566260865|FG000|Month 1|Device Removed|2|||
156864083|NCT00581308|566260865|FG000|Month 1|Uknown|1|||
156864084|NCT00581308|566260865|FG000|Month 6|Lost to Follow-up|1|||
156864085|NCT00581308|566260865|FG000|Month 6|Withdrawal by Subject|2|||
156864086|NCT00581308|566260865|FG000|Month 12|Death|1|||
156864087|NCT00581308|566260865|FG000|Month 12|Lost to Follow-up|14|||
156864088|NCT00581308|566260865|FG000|Month 12|Withdrawal by Subject|3|||
156864089|NCT00581308|566260865|FG000|Month 12|Device Removed|1|||
156864090|NCT00581308|566260865|FG000|Month 12|Other|1|||
156864091|NCT00456846|566260866|FG000|Overall Study|Adverse Event|2|||
156864092|NCT00456846|566260867|FG001|Overall Study|Adverse Event|15|||
156864093|NCT00456846|566260866|FG000|Overall Study|Physician Decision|11|||
156864094|NCT00456846|566260867|FG001|Overall Study|Physician Decision|6|||
156864095|NCT00456846|566260866|FG000|Overall Study|Protocol Deviation|2|||
156864096|NCT00456846|566260867|FG001|Overall Study|Protocol Deviation|0|||
156864097|NCT00456846|566260866|FG000|Overall Study|Participant Discretion|1|||
156864098|NCT00456846|566260867|FG001|Overall Study|Participant Discretion|5|||
156864099|NCT00456846|566260866|FG000|Overall Study|Other|0|||
156864100|NCT00456846|566260867|FG001|Overall Study|Other|2|||
156864101|NCT03253796|566260870|FG000|Period 1: Run-In|Adverse Event|4|||
156864102|NCT03253796|566260871|FG001|Period 1: Run-In|Adverse Event|0|||
156864103|NCT03253796|566260872|FG002|Period 1: Run-In|Adverse Event|0|||
156864104|NCT03253796|566260873|FG003|Period 1: Run-In|Adverse Event|0|||
156864105|NCT03253796|566260874|FG004|Period 1: Run-In|Adverse Event|0|||
156864106|NCT03253796|566260870|FG000|Period 1: Run-In|Lack of Efficacy|1|||
156864107|NCT03253796|566260871|FG001|Period 1: Run-In|Lack of Efficacy|0|||
156864108|NCT03253796|566260872|FG002|Period 1: Run-In|Lack of Efficacy|0|||
156864109|NCT03253796|566260873|FG003|Period 1: Run-In|Lack of Efficacy|0|||
156864110|NCT03253796|566260874|FG004|Period 1: Run-In|Lack of Efficacy|0|||
156864111|NCT03253796|566260870|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
156864112|NCT03253796|566260871|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
156864113|NCT03253796|566260872|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
156864114|NCT03253796|566260873|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
156864115|NCT03253796|566260874|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
156864116|NCT03253796|566260870|FG000|Period 1: Run-In|Protocol Violation|5|||
156864117|NCT03253796|566260871|FG001|Period 1: Run-In|Protocol Violation|0|||
156864118|NCT03253796|566260872|FG002|Period 1: Run-In|Protocol Violation|0|||
156864119|NCT03253796|566260873|FG003|Period 1: Run-In|Protocol Violation|0|||
156864120|NCT03253796|566260874|FG004|Period 1: Run-In|Protocol Violation|0|||
156864121|NCT03253796|566260870|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
156864122|NCT03253796|566260871|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
156864123|NCT03253796|566260872|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
156864124|NCT03253796|566260873|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
156864125|NCT03253796|566260874|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
156864126|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864127|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864128|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
156864129|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864130|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
156864131|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864132|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864133|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
156864134|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864135|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
156864136|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
156977801|NCT03661996|566673594|FG001|Overall Study|Adverse Event|0|||
156977802|NCT03661996|566673595|FG002|Overall Study|Adverse Event|1|||
156977803|NCT03661996|566673596|FG003|Overall Study|Adverse Event|1|||
156977804|NCT03661996|566673597|FG004|Overall Study|Adverse Event|0|||
156977805|NCT03661996|566673593|FG000|Overall Study|Lost to Follow-up|5|||
156977806|NCT03661996|566673594|FG001|Overall Study|Lost to Follow-up|1|||
156977807|NCT03661996|566673595|FG002|Overall Study|Lost to Follow-up|2|||
156977808|NCT03661996|566673596|FG003|Overall Study|Lost to Follow-up|2|||
156977809|NCT03661996|566673597|FG004|Overall Study|Lost to Follow-up|6|||
156977810|NCT03661996|566673593|FG000|Overall Study|Physician Decision|1|||
156977811|NCT03661996|566673594|FG001|Overall Study|Physician Decision|1|||
156977812|NCT03661996|566673595|FG002|Overall Study|Physician Decision|1|||
156977813|NCT03661996|566673596|FG003|Overall Study|Physician Decision|2|||
156977814|NCT03661996|566673597|FG004|Overall Study|Physician Decision|0|||
156977815|NCT03661996|566673593|FG000|Overall Study|Protocol Violation|0|||
156977816|NCT03661996|566673594|FG001|Overall Study|Protocol Violation|0|||
156977817|NCT03661996|566673595|FG002|Overall Study|Protocol Violation|0|||
156977818|NCT03661996|566673596|FG003|Overall Study|Protocol Violation|0|||
156977819|NCT03661996|566673597|FG004|Overall Study|Protocol Violation|1|||
156977820|NCT03661996|566673593|FG000|Overall Study|Withdrawal by Subject|3|||
156977821|NCT03661996|566673594|FG001|Overall Study|Withdrawal by Subject|5|||
156977822|NCT03661996|566673595|FG002|Overall Study|Withdrawal by Subject|1|||
156977823|NCT03661996|566673596|FG003|Overall Study|Withdrawal by Subject|7|||
156977824|NCT03661996|566673597|FG004|Overall Study|Withdrawal by Subject|7|||
156977825|NCT03661996|566673593|FG000|Overall Study|Sponsors Decision|2|||
156977826|NCT03661996|566673594|FG001|Overall Study|Sponsors Decision|0|||
156977827|NCT03661996|566673595|FG002|Overall Study|Sponsors Decision|0|||
156977828|NCT03661996|566673596|FG003|Overall Study|Sponsors Decision|0|||
156977829|NCT03661996|566673597|FG004|Overall Study|Sponsors Decision|0|||
156977830|NCT03661996|566673593|FG000|Overall Study|Other|1|||
156977831|NCT03661996|566673594|FG001|Overall Study|Other|1|||
156977832|NCT03661996|566673595|FG002|Overall Study|Other|1|||
156977833|NCT03661996|566673596|FG003|Overall Study|Other|1|||
156977834|NCT03661996|566673597|FG004|Overall Study|Other|0|||
156977835|NCT03321513|566673598|FG000|Overall Study|Death|11|||
156977836|NCT03321513|566673599|FG001|Overall Study|Death|5|||
156977837|NCT03321513|566673598|FG000|Overall Study|Withdrawal by Subject|5|||
156977838|NCT03321513|566673599|FG001|Overall Study|Withdrawal by Subject|10|||
156977839|NCT03321513|566673598|FG000|Overall Study|Lost to Follow-up|10|||
156977840|NCT03321513|566673599|FG001|Overall Study|Lost to Follow-up|11|||
156977841|NCT03029247|566673600|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
156977842|NCT03029247|566673601|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
156977843|NCT03029247|566673600|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
156977844|NCT03029247|566673601|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
156977845|NCT03029247|566673600|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
156977846|NCT03029247|566673601|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
157091671|NCT05195489|567091417|FG001|Overall Study|Protocol Violation|2|||
157091672|NCT05195489|567091416|FG000|Overall Study|Withdrawal by Subject|1|||
157091673|NCT05195489|567091417|FG001|Overall Study|Withdrawal by Subject|1|||
157091674|NCT05195489|567091416|FG000|Overall Study|Removed|0|||
157091675|NCT05195489|567091417|FG001|Overall Study|Removed|1|||
157091676|NCT01328717|567091426|FG000|Overall Study|Adverse Event|1|||
157091677|NCT00346268|567091427|FG000|Overall Study|Adverse Event|1|||
157091678|NCT00346268|567091428|FG001|Overall Study|Adverse Event|0|||
157091679|NCT00346268|567091427|FG000|Overall Study|Protocol Violation|1|||
157091680|NCT00346268|567091428|FG001|Overall Study|Protocol Violation|0|||
157091681|NCT00346268|567091427|FG000|Overall Study|Participant refused|0|||
157091682|NCT00346268|567091428|FG001|Overall Study|Participant refused|3|||
157091683|NCT00031551|567091429|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
157091684|NCT00031551|567091430|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
157091685|NCT01177722|567091435|FG000|Overall Study|Serious Adverse Event|0|||
157091686|NCT01177722|567091436|FG001|Overall Study|Serious Adverse Event|0|||
157091687|NCT01177722|567091437|FG002|Overall Study|Serious Adverse Event|1|||
157091688|NCT01177722|567091438|FG003|Overall Study|Serious Adverse Event|0|||
157091689|NCT01177722|567091435|FG000|Overall Study|Protocol Violation|0|||
156977847|NCT03029247|566673600|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
156977848|NCT03029247|566673601|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
157091690|NCT01177722|567091436|FG001|Overall Study|Protocol Violation|0|||
157091691|NCT01177722|567091437|FG002|Overall Study|Protocol Violation|1|||
157091692|NCT01177722|567091438|FG003|Overall Study|Protocol Violation|0|||
157091693|NCT01177722|567091435|FG000|Overall Study|Lost to Follow-up|3|||
157091694|NCT01177722|567091436|FG001|Overall Study|Lost to Follow-up|4|||
157091695|NCT01177722|567091437|FG002|Overall Study|Lost to Follow-up|3|||
157091696|NCT01177722|567091438|FG003|Overall Study|Lost to Follow-up|1|||
157091697|NCT01177722|567091435|FG000|Overall Study|Withdrawal by Subject|10|||
157091698|NCT01177722|567091436|FG001|Overall Study|Withdrawal by Subject|6|||
157091699|NCT01177722|567091437|FG002|Overall Study|Withdrawal by Subject|4|||
157091700|NCT01177722|567091438|FG003|Overall Study|Withdrawal by Subject|6|||
157091701|NCT02831387|567091439|FG000|Overall Study|Withdrawal by Subject|1|||
157091702|NCT02831387|567091440|FG001|Overall Study|Withdrawal by Subject|1|||
157091703|NCT02831387|567091439|FG000|Overall Study|Discontinued due to stock recovery|0|||
157091704|NCT02831387|567091440|FG001|Overall Study|Discontinued due to stock recovery|1|||
157091705|NCT00192647|567091441|FG000|Overall Study|Death|1|||
157091706|NCT00192647|567091442|FG001|Overall Study|Death|1|||
157091707|NCT00192647|567091441|FG000|Overall Study|Adverse Event|35|||
157091708|NCT00192647|567091442|FG001|Overall Study|Adverse Event|29|||
157091709|NCT00192647|567091441|FG000|Overall Study|Laboratory Test Abnormality|4|||
157091710|NCT00192647|567091442|FG001|Overall Study|Laboratory Test Abnormality|2|||
157091711|NCT00192647|567091441|FG000|Overall Study|Insufficient Therapeutic Response|53|||
157091712|NCT00192647|567091442|FG001|Overall Study|Insufficient Therapeutic Response|83|||
157091713|NCT00192647|567091441|FG000|Overall Study|Entry Criteria Violation|6|||
157091714|NCT00192647|567091442|FG001|Overall Study|Entry Criteria Violation|6|||
157091715|NCT00192647|567091441|FG000|Overall Study|Protocol Violation|3|||
157091716|NCT00192647|567091442|FG001|Overall Study|Protocol Violation|1|||
157091717|NCT00192647|567091441|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
157091718|NCT00192647|567091442|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
157091719|NCT00192647|567091441|FG000|Overall Study|Failure to Return|11|||
157091720|NCT00192647|567091442|FG001|Overall Study|Failure to Return|13|||
157091721|NCT00192647|567091441|FG000|Overall Study|Other/Administrative|5|||
156977849|NCT02593305|566673602|FG000|Post 1|Comparison only group. No intervention.|0|||
156977850|NCT02593305|566673603|FG001|Post 1|Comparison only group. No intervention.|0|||
156977851|NCT02593305|566673604|FG002|Post 1|Comparison only group. No intervention.|10|||
156977852|NCT01993017|566673605|FG000|Overall Study|Death|23|||
156977853|NCT01993017|566673606|FG001|Overall Study|Death|26|||
156977854|NCT01993017|566673607|FG002|Overall Study|Death|18|||
156977855|NCT01993017|566673605|FG000|Overall Study|Could not be contacted|43|||
156977856|NCT01993017|566673606|FG001|Overall Study|Could not be contacted|42|||
156977857|NCT01993017|566673607|FG002|Overall Study|Could not be contacted|38|||
156977858|NCT01993017|566673605|FG000|Overall Study|Dropped out|19|||
156977859|NCT01993017|566673606|FG001|Overall Study|Dropped out|6|||
156977860|NCT01993017|566673607|FG002|Overall Study|Dropped out|11|||
156977861|NCT01993017|566673605|FG000|Overall Study|Other reasons|17|||
156977862|NCT01993017|566673606|FG001|Overall Study|Other reasons|11|||
156977863|NCT01993017|566673607|FG002|Overall Study|Other reasons|7|||
156977864|NCT01993017|566673605|FG000|Overall Study|Ineligible after randomization|4|||
156977865|NCT01993017|566673606|FG001|Overall Study|Ineligible after randomization|5|||
156977866|NCT01993017|566673607|FG002|Overall Study|Ineligible after randomization|5|||
156977867|NCT00068380|566673608|FG000|Overall Study|Withdrawal by Subject|3|||
156977868|NCT00068380|566673608|FG000|Overall Study|Adverse Event|2|||
156977869|NCT01976364|566673609|FG000|Main Study (36 Months)|Adverse Event|63|||
156977870|NCT01976364|566673610|FG001|Main Study (36 Months)|Adverse Event|0|||
156977871|NCT01976364|566673611|FG002|Main Study (36 Months)|Adverse Event|0|||
156977872|NCT01976364|566673609|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
156977873|NCT01976364|566673610|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
156977874|NCT01976364|566673611|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
156977875|NCT01976364|566673609|FG000|Main Study (36 Months)|Other|13|||
156977876|NCT01976364|566673610|FG001|Main Study (36 Months)|Other|0|||
156977877|NCT01976364|566673611|FG002|Main Study (36 Months)|Other|0|||
156977878|NCT01976364|566673609|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
156977879|NCT01976364|566673610|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
156977880|NCT01976364|566673611|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
156977881|NCT01976364|566673609|FG000|Main Study (36 Months)|Medication error|1|||
156977882|NCT01976364|566673610|FG001|Main Study (36 Months)|Medication error|0|||
156977883|NCT01976364|566673611|FG002|Main Study (36 Months)|Medication error|0|||
156977884|NCT01976364|566673609|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
156977885|NCT01976364|566673610|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
156977886|NCT01976364|566673611|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
156977887|NCT01976364|566673609|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
156977888|NCT01976364|566673610|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
156977889|NCT01976364|566673611|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
156977890|NCT01976364|566673609|FG000|Main Study (36 Months)|Protocol Violation|13|||
156977891|NCT01976364|566673610|FG001|Main Study (36 Months)|Protocol Violation|0|||
156977892|NCT01976364|566673611|FG002|Main Study (36 Months)|Protocol Violation|0|||
157091722|NCT00192647|567091442|FG001|Overall Study|Other/Administrative|3|||
157091723|NCT01828073|567091443|FG000|Overall Study|Lost to Follow-up|1|||
157091724|NCT01828073|567091444|FG001|Overall Study|Lost to Follow-up|2|||
156977893|NCT01976364|566673609|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
156977894|NCT01976364|566673610|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
156977895|NCT01976364|566673611|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
156977896|NCT01976364|566673609|FG000|Main Study (36 Months)|Death|5|||
156977897|NCT01976364|566673610|FG001|Main Study (36 Months)|Death|0|||
156977898|NCT01976364|566673611|FG002|Main Study (36 Months)|Death|0|||
156977899|NCT01976364|566673609|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
156977900|NCT01976364|566673610|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
156977901|NCT01976364|566673611|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
156977902|NCT01976364|566673609|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
157091725|NCT03057977|567091452|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
157091726|NCT03057977|567091453|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
157091727|NCT03057977|567091452|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
157091728|NCT03057977|567091453|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
157091729|NCT03057977|567091452|FG000|Discontinuation From Treatment|Protocol Violation|6|||
157091730|NCT03057977|567091453|FG001|Discontinuation From Treatment|Protocol Violation|5|||
157091731|NCT03057977|567091452|FG000|Discontinuation From Treatment|Not treated|4|||
157091732|NCT03057977|567091453|FG001|Discontinuation From Treatment|Not treated|0|||
157091733|NCT03057977|567091452|FG000|Discontinuation From Treatment|Adverse Event|343|||
157091734|NCT03057977|567091453|FG001|Discontinuation From Treatment|Adverse Event|337|||
157091735|NCT03057977|567091452|FG000|Discontinuation From Treatment|Reason Unknown|0|||
157091736|NCT03057977|567091453|FG001|Discontinuation From Treatment|Reason Unknown|1|||
157091737|NCT03057977|567091452|FG000|Discontinuation From Treatment|Personal Reasons|1|||
157091738|NCT03057977|567091453|FG001|Discontinuation From Treatment|Personal Reasons|1|||
157091739|NCT03057977|567091452|FG000|Discontinuation From Treatment|Unblinded medication|1|||
157091740|NCT03057977|567091453|FG001|Discontinuation From Treatment|Unblinded medication|0|||
157091741|NCT03057977|567091452|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
157091742|NCT03057977|567091453|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
157091743|NCT03057977|567091452|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
157091744|NCT03057977|567091453|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
157091745|NCT03057977|567091452|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
157091746|NCT03057977|567091453|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
157091747|NCT03057977|567091452|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
157091748|NCT03057977|567091453|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
157091749|NCT03057977|567091452|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
157091750|NCT03057977|567091453|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
157091751|NCT03057977|567091452|FG000|Discontinuation From Treatment|Not attending study visit|3|||
157091752|NCT03057977|567091453|FG001|Discontinuation From Treatment|Not attending study visit|10|||
157091753|NCT03057977|567091452|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
157091754|NCT03057977|567091453|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
157091755|NCT03057977|567091452|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
157091756|NCT03057977|567091453|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
157091757|NCT03057977|567091452|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
157091758|NCT03057977|567091453|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
157091759|NCT03057977|567091452|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
157091760|NCT03057977|567091453|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
157091761|NCT03057977|567091452|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
157091762|NCT03057977|567091453|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
157091763|NCT01201317|567091454|FG000|Overall Study|Withdrawal by Subject|5|||
157091764|NCT01201317|567091455|FG001|Overall Study|Withdrawal by Subject|0|||
156977903|NCT01976364|566673610|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
156977904|NCT01976364|566673611|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
156977905|NCT01976364|566673609|FG000|Sub-study (12 Months)|Protocol Violation|0|||
156977906|NCT01976364|566673610|FG001|Sub-study (12 Months)|Protocol Violation|1|||
156977907|NCT01976364|566673611|FG002|Sub-study (12 Months)|Protocol Violation|1|||
156977908|NCT01976364|566673609|FG000|Sub-study (12 Months)|Adverse Event|0|||
156977909|NCT01976364|566673610|FG001|Sub-study (12 Months)|Adverse Event|4|||
156977910|NCT01976364|566673611|FG002|Sub-study (12 Months)|Adverse Event|3|||
156977911|NCT02757521|566673612|FG000|Overall Study|Adverse Event|1|||
156977912|NCT02757521|566673613|FG001|Overall Study|Adverse Event|0|||
156977913|NCT01190215|566673614|FG000|Up to Month 6|Lost to Follow-up|2|||
156977914|NCT01190215|566673615|FG001|Up to Month 6|Lost to Follow-up|0|||
156977915|NCT01161472|566673616|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
156977916|NCT01161472|566673617|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156977917|NCT01161472|566673618|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156977918|NCT01161472|566673619|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
156977919|NCT00003511|566673620|FG000|Overall Study|Not evaluable|4|||
157091765|NCT01201317|567091456|FG002|Overall Study|Withdrawal by Subject|3|||
157091766|NCT01201317|567091454|FG000|Overall Study|Adverse Event|2|||
157091767|NCT01201317|567091455|FG001|Overall Study|Adverse Event|2|||
157091768|NCT01201317|567091456|FG002|Overall Study|Adverse Event|2|||
157091769|NCT01201317|567091454|FG000|Overall Study|Screen failure|1|||
157091770|NCT01201317|567091455|FG001|Overall Study|Screen failure|1|||
157091771|NCT01201317|567091456|FG002|Overall Study|Screen failure|0|||
157091772|NCT01201317|567091454|FG000|Overall Study|Protocol Violation|0|||
156977920|NCT02914184|566673621|FG000|Overall Study|Lost to Follow-up|7|||
156977921|NCT02914184|566673622|FG001|Overall Study|Lost to Follow-up|10|||
156977922|NCT02914184|566673623|FG002|Overall Study|Lost to Follow-up|8|||
156977923|NCT02914184|566673624|FG003|Overall Study|Lost to Follow-up|7|||
157091773|NCT01201317|567091455|FG001|Overall Study|Protocol Violation|1|||
157091774|NCT01201317|567091456|FG002|Overall Study|Protocol Violation|1|||
157091775|NCT01201317|567091454|FG000|Overall Study|Death|0|||
157091776|NCT01201317|567091455|FG001|Overall Study|Death|1|||
157091777|NCT01201317|567091456|FG002|Overall Study|Death|0|||
157091778|NCT01201317|567091454|FG000|Overall Study|Study-specific withdrawal criteria|0|||
157091779|NCT01201317|567091455|FG001|Overall Study|Study-specific withdrawal criteria|0|||
157091780|NCT01201317|567091456|FG002|Overall Study|Study-specific withdrawal criteria|1|||
157091781|NCT01201317|567091454|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
157091782|NCT01201317|567091455|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
157091783|NCT01201317|567091456|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
157091784|NCT01201317|567091454|FG000|Overall Study|Decrease in renal function|0|||
157091785|NCT01201317|567091455|FG001|Overall Study|Decrease in renal function|1|||
157091786|NCT01201317|567091456|FG002|Overall Study|Decrease in renal function|0|||
157091787|NCT01201317|567091454|FG000|Overall Study|Lack of Efficacy|1|||
157091788|NCT01201317|567091455|FG001|Overall Study|Lack of Efficacy|0|||
157091789|NCT01201317|567091456|FG002|Overall Study|Lack of Efficacy|0|||
157091790|NCT01201317|567091454|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
157091791|NCT01201317|567091455|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
157091792|NCT01201317|567091456|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
157091793|NCT01350336|567091457|FG000|Overall Study|Lost to Follow-up|31|||
157091794|NCT01350336|567091457|FG000|Overall Study|Withdrawal by Subject|14|||
157091795|NCT01350336|567091457|FG000|Overall Study|Physician Decision|8|||
157091796|NCT01350336|567091457|FG000|Overall Study|Death|4|||
157091797|NCT00876928|567091459|FG000|Overall Study|Lost to Follow-up|2|||
157091798|NCT00876928|567091460|FG001|Overall Study|Lost to Follow-up|5|||
157091799|NCT00876928|567091459|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
157091800|NCT00876928|567091460|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
157091801|NCT02795429|567091461|FG000|Overall Study|Adverse Event|1|||
157091802|NCT02795429|567091462|FG001|Overall Study|Adverse Event|2|||
157091803|NCT02795429|567091463|FG002|Overall Study|Adverse Event|1|||
157091804|NCT02795429|567091464|FG003|Overall Study|Adverse Event|2|||
157091805|NCT02795429|567091465|FG004|Overall Study|Adverse Event|1|||
157091806|NCT02795429|567091461|FG000|Overall Study|Death|1|||
157091807|NCT02795429|567091462|FG001|Overall Study|Death|0|||
157091808|NCT02795429|567091463|FG002|Overall Study|Death|1|||
157091809|NCT02795429|567091464|FG003|Overall Study|Death|2|||
157091810|NCT02795429|567091465|FG004|Overall Study|Death|1|||
157091811|NCT02795429|567091461|FG000|Overall Study|Physician Decision|0|||
157091812|NCT02795429|567091462|FG001|Overall Study|Physician Decision|0|||
157091813|NCT02795429|567091463|FG002|Overall Study|Physician Decision|2|||
157091814|NCT02795429|567091464|FG003|Overall Study|Physician Decision|1|||
157091815|NCT02795429|567091465|FG004|Overall Study|Physician Decision|5|||
157091816|NCT02795429|567091461|FG000|Overall Study|Progressive disease|3|||
157091817|NCT02795429|567091462|FG001|Overall Study|Progressive disease|7|||
157091818|NCT02795429|567091463|FG002|Overall Study|Progressive disease|6|||
157091819|NCT02795429|567091464|FG003|Overall Study|Progressive disease|26|||
157091820|NCT02795429|567091465|FG004|Overall Study|Progressive disease|20|||
157091821|NCT02795429|567091461|FG000|Overall Study|Subject/guardian decision|1|||
157091822|NCT02795429|567091462|FG001|Overall Study|Subject/guardian decision|1|||
157091823|NCT02795429|567091463|FG002|Overall Study|Subject/guardian decision|1|||
157091824|NCT02795429|567091464|FG003|Overall Study|Subject/guardian decision|1|||
157091825|NCT02795429|567091465|FG004|Overall Study|Subject/guardian decision|3|||
157091826|NCT05220254|567091466|FG000|Overall Study|Withdrawal by Subject|4|||
157091827|NCT05220254|567091466|FG000|Overall Study|Removed due to ineligibility|1|||
157091828|NCT05220254|567091466|FG000|Overall Study|Lost to Follow-up|7|||
157091829|NCT01016977|567091474|FG000|Overall Study|Lost to Follow-up|1|||
157091830|NCT01016977|567091475|FG001|Overall Study|Lost to Follow-up|0|||
157091831|NCT01016977|567091474|FG000|Overall Study|Withdrawal by Subject|2|||
157091832|NCT01016977|567091475|FG001|Overall Study|Withdrawal by Subject|2|||
157091833|NCT02080221|567091476|FG000|Overall Study|Withdrawal by Subject|1|||
157091834|NCT02080221|567091476|FG000|Overall Study|Clinical Progression of Disease|1|||
157091835|NCT03184870|567091482|FG000|Initial Treatment|Death|6|||
157091836|NCT03184870|567091483|FG001|Initial Treatment|Death|6|||
157091837|NCT03184870|567091484|FG002|Initial Treatment|Death|8|||
157091838|NCT03184870|567091485|FG003|Initial Treatment|Death|8|||
156977924|NCT02914184|566673621|FG000|Overall Study|Withdrawal by Subject|4|||
156977925|NCT02914184|566673622|FG001|Overall Study|Withdrawal by Subject|2|||
156977926|NCT02914184|566673623|FG002|Overall Study|Withdrawal by Subject|7|||
156977927|NCT02914184|566673624|FG003|Overall Study|Withdrawal by Subject|3|||
156977928|NCT02914184|566673621|FG000|Overall Study|Other|1|||
156977929|NCT02914184|566673622|FG001|Overall Study|Other|0|||
156977930|NCT02914184|566673623|FG002|Overall Study|Other|0|||
156977931|NCT02914184|566673624|FG003|Overall Study|Other|0|||
156977932|NCT02914184|566673621|FG000|Overall Study|Migrated/moved from the study area|2|||
156977933|NCT02914184|566673622|FG001|Overall Study|Migrated/moved from the study area|1|||
156977934|NCT02914184|566673623|FG002|Overall Study|Migrated/moved from the study area|2|||
156977935|NCT02914184|566673624|FG003|Overall Study|Migrated/moved from the study area|1|||
156977936|NCT00798174|566673630|FG000|Overall Study|inability to implant azygos coil|3|||
156977937|NCT00798174|566673631|FG001|Overall Study|inability to implant azygos coil|3|||
156977938|NCT00798174|566673630|FG000|Overall Study|Inability to sedate for DFT testing|1|||
156977939|NCT00798174|566673631|FG001|Overall Study|Inability to sedate for DFT testing|0|||
156977940|NCT01683994|566673650|FG000|Overall Study|Withdrawal by Subject|1|||
156977941|NCT01683994|566673651|FG001|Overall Study|Withdrawal by Subject|0|||
156977942|NCT01683994|566673652|FG002|Overall Study|Withdrawal by Subject|0|||
156977943|NCT01683994|566673653|FG003|Overall Study|Withdrawal by Subject|1|||
156977944|NCT01683994|566673654|FG004|Overall Study|Withdrawal by Subject|0|||
156977945|NCT01683994|566673650|FG000|Overall Study|Intercurrent illness|0|||
156977946|NCT01683994|566673651|FG001|Overall Study|Intercurrent illness|0|||
156977947|NCT01683994|566673652|FG002|Overall Study|Intercurrent illness|0|||
156977948|NCT01683994|566673653|FG003|Overall Study|Intercurrent illness|2|||
156977949|NCT01683994|566673654|FG004|Overall Study|Intercurrent illness|1|||
156977950|NCT00999661|566673655|FG000|Overall Study|Lost to Follow-up|59|||
156977951|NCT00999661|566673655|FG000|Overall Study|Adverse Event|1|||
156977952|NCT00999661|566673655|FG000|Overall Study|Withdrawal by Subject|1|||
156977953|NCT00999661|566673655|FG000|Overall Study|Not meeting eligibility criteria|9|||
156977954|NCT00312858|566673656|FG000|Overall Study|Adverse Event|0|||
156977955|NCT00312858|566673657|FG001|Overall Study|Adverse Event|1|||
156977956|NCT00312858|566673656|FG000|Overall Study|Lost to Follow-up|25|||
156977957|NCT00312858|566673657|FG001|Overall Study|Lost to Follow-up|42|||
156977958|NCT00312858|566673656|FG000|Overall Study|Protocol Violation|3|||
156977959|NCT00312858|566673657|FG001|Overall Study|Protocol Violation|8|||
156977960|NCT00312858|566673656|FG000|Overall Study|Withdraw by Participant|20|||
156977961|NCT00312858|566673657|FG001|Overall Study|Withdraw by Participant|20|||
156977962|NCT00312858|566673656|FG000|Overall Study|Participant Moved|11|||
156977963|NCT00312858|566673657|FG001|Overall Study|Participant Moved|10|||
156977964|NCT00312858|566673656|FG000|Overall Study|Other|9|||
156977965|NCT00312858|566673657|FG001|Overall Study|Other|12|||
156977966|NCT03638635|566673658|FG000|Initial Hospitalization|Study terminated prematurely|0|||
156977967|NCT03638635|566673659|FG001|Initial Hospitalization|Study terminated prematurely|1|||
156977968|NCT03638635|566673658|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
156977969|NCT03638635|566673659|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
156977970|NCT03638635|566673658|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
156977971|NCT03638635|566673659|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
156977972|NCT02176421|566673662|FG000|Overall Study|Lost to Follow-up|4|||
156977973|NCT02176421|566673662|FG000|Overall Study|Adverse Event|1|||
156977974|NCT01987596|566673665|FG000|Overall Study|Physician Decision|1|||
156977975|NCT01987596|566673666|FG001|Overall Study|Physician Decision|0|||
156977976|NCT01987596|566673665|FG000|Overall Study|Progressive Disease; missing all period|0|||
156977977|NCT01987596|566673666|FG001|Overall Study|Progressive Disease; missing all period|1|||
156977978|NCT00422799|566673672|FG000|Overall Study|Withdrawal by Subject|6|||
156977979|NCT00422799|566673672|FG000|Overall Study|Adverse Event|7|||
156977980|NCT01965158|566673673|FG000|Overall Study|Adverse Event|14|||
156977981|NCT01965158|566673674|FG001|Overall Study|Adverse Event|5|||
156977982|NCT01965158|566673673|FG000|Overall Study|Withdrawal by Subject|16|||
156977983|NCT01965158|566673674|FG001|Overall Study|Withdrawal by Subject|24|||
156977984|NCT01965158|566673673|FG000|Overall Study|Lost to Follow-up|7|||
156977985|NCT01965158|566673674|FG001|Overall Study|Lost to Follow-up|5|||
157221624|NCT01644890|567558454|FG001|Overall Study|Adverse Event|20|||
156977986|NCT01965158|566673673|FG000|Overall Study|Protocol Violation|1|||
156977987|NCT01965158|566673674|FG001|Overall Study|Protocol Violation|1|||
156977988|NCT01965158|566673673|FG000|Overall Study|Other - Miscellaneous|3|||
156977989|NCT01965158|566673674|FG001|Overall Study|Other - Miscellaneous|0|||
156977990|NCT02912468|566673675|FG000|Overall Study|Adverse Event|3|||
156977991|NCT02912468|566673676|FG001|Overall Study|Adverse Event|2|||
156977992|NCT02912468|566673675|FG000|Overall Study|Withdrawal by Subject|6|||
156977993|NCT02912468|566673676|FG001|Overall Study|Withdrawal by Subject|2|||
156977994|NCT02912468|566673675|FG000|Overall Study|Randomized and not treated|0|||
156977995|NCT02912468|566673676|FG001|Overall Study|Randomized and not treated|1|||
156977996|NCT01617005|566673679|FG000|Overall Study|Pregnancy|1|||
156977997|NCT01617005|566673679|FG000|Overall Study|Lack of motivation for treatment|1|||
156977998|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
156977999|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
156978000|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
157091839|NCT03184870|567091486|FG004|Initial Treatment|Death|6|||
157091840|NCT03184870|567091487|FG005|Initial Treatment|Death|6|||
157091841|NCT03184870|567091488|FG006|Initial Treatment|Death|6|||
157091842|NCT03184870|567091489|FG007|Initial Treatment|Death|7|||
157091843|NCT03184870|567091490|FG008|Initial Treatment|Death|1|||
157091844|NCT03184870|567091491|FG009|Initial Treatment|Death|2|||
157091845|NCT03184870|567091492|FG010|Initial Treatment|Death|26|||
157091846|NCT03184870|567091493|FG011|Initial Treatment|Death|28|||
157091847|NCT03184870|567091494|FG012|Initial Treatment|Death|10|||
157091848|NCT03184870|567091495|FG013|Initial Treatment|Death|33|||
157091849|NCT03184870|567091496|FG014|Initial Treatment|Death|34|||
157091850|NCT03184870|567091497|FG015|Initial Treatment|Death|26|||
157091851|NCT03184870|567091498|FG016|Initial Treatment|Death|20|||
157091852|NCT03184870|567091499|FG017|Initial Treatment|Death|18|||
157091853|NCT03184870|567091482|FG000|Initial Treatment|Other Reasons|2|||
157091854|NCT03184870|567091483|FG001|Initial Treatment|Other Reasons|2|||
157091855|NCT03184870|567091484|FG002|Initial Treatment|Other Reasons|0|||
157091856|NCT03184870|567091485|FG003|Initial Treatment|Other Reasons|1|||
157091857|NCT03184870|567091486|FG004|Initial Treatment|Other Reasons|0|||
157091858|NCT03184870|567091487|FG005|Initial Treatment|Other Reasons|0|||
157091859|NCT03184870|567091488|FG006|Initial Treatment|Other Reasons|0|||
157091860|NCT03184870|567091489|FG007|Initial Treatment|Other Reasons|2|||
157091861|NCT03184870|567091490|FG008|Initial Treatment|Other Reasons|0|||
157091862|NCT03184870|567091491|FG009|Initial Treatment|Other Reasons|0|||
157091863|NCT03184870|567091492|FG010|Initial Treatment|Other Reasons|4|||
157091864|NCT03184870|567091493|FG011|Initial Treatment|Other Reasons|2|||
157091865|NCT03184870|567091494|FG012|Initial Treatment|Other Reasons|2|||
157091866|NCT03184870|567091495|FG013|Initial Treatment|Other Reasons|0|||
157091867|NCT03184870|567091496|FG014|Initial Treatment|Other Reasons|0|||
157091868|NCT03184870|567091497|FG015|Initial Treatment|Other Reasons|1|||
157091869|NCT03184870|567091498|FG016|Initial Treatment|Other Reasons|0|||
157091870|NCT03184870|567091499|FG017|Initial Treatment|Other Reasons|2|||
157091871|NCT03184870|567091482|FG000|Initial Treatment|Lost to Follow-up|2|||
157091872|NCT03184870|567091483|FG001|Initial Treatment|Lost to Follow-up|0|||
157091873|NCT03184870|567091484|FG002|Initial Treatment|Lost to Follow-up|0|||
157091874|NCT03184870|567091485|FG003|Initial Treatment|Lost to Follow-up|1|||
157091875|NCT03184870|567091486|FG004|Initial Treatment|Lost to Follow-up|1|||
157091876|NCT03184870|567091487|FG005|Initial Treatment|Lost to Follow-up|1|||
157091877|NCT03184870|567091488|FG006|Initial Treatment|Lost to Follow-up|0|||
157091878|NCT03184870|567091489|FG007|Initial Treatment|Lost to Follow-up|2|||
157091879|NCT03184870|567091490|FG008|Initial Treatment|Lost to Follow-up|0|||
157091880|NCT03184870|567091491|FG009|Initial Treatment|Lost to Follow-up|0|||
157091881|NCT03184870|567091492|FG010|Initial Treatment|Lost to Follow-up|2|||
157091882|NCT03184870|567091493|FG011|Initial Treatment|Lost to Follow-up|0|||
157091883|NCT03184870|567091494|FG012|Initial Treatment|Lost to Follow-up|2|||
157091884|NCT03184870|567091495|FG013|Initial Treatment|Lost to Follow-up|2|||
157091885|NCT03184870|567091496|FG014|Initial Treatment|Lost to Follow-up|0|||
157091886|NCT03184870|567091497|FG015|Initial Treatment|Lost to Follow-up|0|||
157091887|NCT03184870|567091498|FG016|Initial Treatment|Lost to Follow-up|2|||
157091888|NCT03184870|567091499|FG017|Initial Treatment|Lost to Follow-up|2|||
157091889|NCT03184870|567091482|FG000|Initial Treatment|Withdrawal by Subject|0|||
157091890|NCT03184870|567091483|FG001|Initial Treatment|Withdrawal by Subject|0|||
157091891|NCT03184870|567091484|FG002|Initial Treatment|Withdrawal by Subject|2|||
157091892|NCT03184870|567091485|FG003|Initial Treatment|Withdrawal by Subject|1|||
157091893|NCT03184870|567091486|FG004|Initial Treatment|Withdrawal by Subject|1|||
157091894|NCT03184870|567091487|FG005|Initial Treatment|Withdrawal by Subject|0|||
157091895|NCT03184870|567091488|FG006|Initial Treatment|Withdrawal by Subject|1|||
157091896|NCT03184870|567091489|FG007|Initial Treatment|Withdrawal by Subject|0|||
157091897|NCT03184870|567091490|FG008|Initial Treatment|Withdrawal by Subject|0|||
157091898|NCT03184870|567091491|FG009|Initial Treatment|Withdrawal by Subject|0|||
157091899|NCT03184870|567091492|FG010|Initial Treatment|Withdrawal by Subject|0|||
157091900|NCT03184870|567091493|FG011|Initial Treatment|Withdrawal by Subject|2|||
157091901|NCT03184870|567091494|FG012|Initial Treatment|Withdrawal by Subject|3|||
157091902|NCT03184870|567091495|FG013|Initial Treatment|Withdrawal by Subject|0|||
157091903|NCT03184870|567091496|FG014|Initial Treatment|Withdrawal by Subject|1|||
157091904|NCT03184870|567091497|FG015|Initial Treatment|Withdrawal by Subject|5|||
157091905|NCT03184870|567091498|FG016|Initial Treatment|Withdrawal by Subject|2|||
157091906|NCT03184870|567091499|FG017|Initial Treatment|Withdrawal by Subject|2|||
157091907|NCT03184870|567091482|FG000|Initial Treatment|Moved to crossover treatment|0|||
157091908|NCT03184870|567091483|FG001|Initial Treatment|Moved to crossover treatment|0|||
157091909|NCT03184870|567091484|FG002|Initial Treatment|Moved to crossover treatment|0|||
157091910|NCT03184870|567091485|FG003|Initial Treatment|Moved to crossover treatment|0|||
157091911|NCT03184870|567091486|FG004|Initial Treatment|Moved to crossover treatment|0|||
157091912|NCT03184870|567091487|FG005|Initial Treatment|Moved to crossover treatment|0|||
157091913|NCT03184870|567091488|FG006|Initial Treatment|Moved to crossover treatment|0|||
157091914|NCT03184870|567091489|FG007|Initial Treatment|Moved to crossover treatment|0|||
157091915|NCT03184870|567091490|FG008|Initial Treatment|Moved to crossover treatment|0|||
157091916|NCT03184870|567091491|FG009|Initial Treatment|Moved to crossover treatment|0|||
157091917|NCT03184870|567091492|FG010|Initial Treatment|Moved to crossover treatment|0|||
157091918|NCT03184870|567091493|FG011|Initial Treatment|Moved to crossover treatment|0|||
157091919|NCT03184870|567091494|FG012|Initial Treatment|Moved to crossover treatment|9|||
157091920|NCT03184870|567091495|FG013|Initial Treatment|Moved to crossover treatment|0|||
157091921|NCT03184870|567091496|FG014|Initial Treatment|Moved to crossover treatment|0|||
157091922|NCT03184870|567091497|FG015|Initial Treatment|Moved to crossover treatment|0|||
157091923|NCT03184870|567091498|FG016|Initial Treatment|Moved to crossover treatment|0|||
157091924|NCT03184870|567091499|FG017|Initial Treatment|Moved to crossover treatment|0|||
157091925|NCT03184870|567091482|FG000|Crossover Treatment|Other reasons|0|||
157091926|NCT03184870|567091483|FG001|Crossover Treatment|Other reasons|0|||
157091927|NCT03184870|567091484|FG002|Crossover Treatment|Other reasons|0|||
157091928|NCT03184870|567091485|FG003|Crossover Treatment|Other reasons|0|||
157091929|NCT03184870|567091486|FG004|Crossover Treatment|Other reasons|0|||
157091930|NCT03184870|567091487|FG005|Crossover Treatment|Other reasons|0|||
157091931|NCT03184870|567091488|FG006|Crossover Treatment|Other reasons|0|||
157091932|NCT03184870|567091489|FG007|Crossover Treatment|Other reasons|0|||
157091933|NCT03184870|567091490|FG008|Crossover Treatment|Other reasons|0|||
157091934|NCT03184870|567091491|FG009|Crossover Treatment|Other reasons|0|||
157091935|NCT03184870|567091492|FG010|Crossover Treatment|Other reasons|0|||
157091936|NCT03184870|567091493|FG011|Crossover Treatment|Other reasons|0|||
157091937|NCT03184870|567091494|FG012|Crossover Treatment|Other reasons|0|||
157091938|NCT03184870|567091495|FG013|Crossover Treatment|Other reasons|0|||
157091939|NCT03184870|567091496|FG014|Crossover Treatment|Other reasons|0|||
157091940|NCT03184870|567091497|FG015|Crossover Treatment|Other reasons|0|||
157091941|NCT03184870|567091498|FG016|Crossover Treatment|Other reasons|0|||
157091942|NCT03184870|567091499|FG017|Crossover Treatment|Other reasons|2|||
157091943|NCT03184870|567091482|FG000|Crossover Treatment|Death|0|||
157091944|NCT03184870|567091483|FG001|Crossover Treatment|Death|0|||
157091945|NCT03184870|567091484|FG002|Crossover Treatment|Death|0|||
157091946|NCT03184870|567091485|FG003|Crossover Treatment|Death|0|||
157091947|NCT03184870|567091486|FG004|Crossover Treatment|Death|0|||
157091948|NCT03184870|567091487|FG005|Crossover Treatment|Death|0|||
157091949|NCT03184870|567091488|FG006|Crossover Treatment|Death|0|||
157091950|NCT03184870|567091489|FG007|Crossover Treatment|Death|0|||
157091951|NCT03184870|567091490|FG008|Crossover Treatment|Death|0|||
157091952|NCT03184870|567091491|FG009|Crossover Treatment|Death|0|||
157091953|NCT03184870|567091492|FG010|Crossover Treatment|Death|0|||
157091954|NCT03184870|567091493|FG011|Crossover Treatment|Death|0|||
157091955|NCT03184870|567091494|FG012|Crossover Treatment|Death|0|||
157091956|NCT03184870|567091495|FG013|Crossover Treatment|Death|0|||
157091957|NCT03184870|567091496|FG014|Crossover Treatment|Death|0|||
157091958|NCT03184870|567091497|FG015|Crossover Treatment|Death|0|||
157091959|NCT03184870|567091498|FG016|Crossover Treatment|Death|0|||
157091960|NCT03184870|567091499|FG017|Crossover Treatment|Death|7|||
157091961|NCT05081388|567091500|FG000|Overall Study|Adverse Event|1|||
157091962|NCT05081388|567091501|FG001|Overall Study|Adverse Event|0|||
157091963|NCT05081388|567091502|FG002|Overall Study|Adverse Event|0|||
157091964|NCT05081388|567091503|FG003|Overall Study|Adverse Event|0|||
157091965|NCT05081388|567091504|FG004|Overall Study|Adverse Event|0|||
157091966|NCT05081388|567091500|FG000|Overall Study|Lost to Follow-up|0|||
157091967|NCT05081388|567091501|FG001|Overall Study|Lost to Follow-up|1|||
157091968|NCT05081388|567091502|FG002|Overall Study|Lost to Follow-up|0|||
157091969|NCT05081388|567091503|FG003|Overall Study|Lost to Follow-up|0|||
157091970|NCT05081388|567091504|FG004|Overall Study|Lost to Follow-up|0|||
157091971|NCT05081388|567091500|FG000|Overall Study|Subject decision|0|||
157091972|NCT05081388|567091501|FG001|Overall Study|Subject decision|0|||
157091973|NCT05081388|567091502|FG002|Overall Study|Subject decision|0|||
157091974|NCT05081388|567091503|FG003|Overall Study|Subject decision|1|||
157091975|NCT05081388|567091504|FG004|Overall Study|Subject decision|0|||
157091976|NCT03786783|567091505|FG000|Overall Study|Death|1|||
157091977|NCT03786783|567091505|FG000|Overall Study|Physician Decision|6|||
157091978|NCT03786783|567091505|FG000|Overall Study|Withdrawal by Subject|2|||
157091979|NCT03786783|567091505|FG000|Overall Study|Disease Progression|7|||
157091980|NCT03786783|567091505|FG000|Overall Study|Patient/Parent Refusal|4|||
157091981|NCT01776541|567091506|FG000|Overall Study|Administrative Reason|6|||
157091982|NCT01776541|567091507|FG001|Overall Study|Administrative Reason|2|||
157091983|NCT01776541|567091506|FG000|Overall Study|Death|4|||
157091984|NCT01776541|567091507|FG001|Overall Study|Death|0|||
157091985|NCT01776541|567091506|FG000|Overall Study|Lost to Follow-up|27|||
157091986|NCT01776541|567091507|FG001|Overall Study|Lost to Follow-up|48|||
157091987|NCT01776541|567091506|FG000|Overall Study|Unclassified|5|||
156749969|NCT00385827|565836902|FG002|Part 1|Other|0|||
156749970|NCT00385827|565836900|FG000|Part 2|Adverse Event|0|||
157091988|NCT01776541|567091507|FG001|Overall Study|Unclassified|4|||
157091989|NCT01776541|567091506|FG000|Overall Study|Protocol Violation|2|||
157091990|NCT01776541|567091507|FG001|Overall Study|Protocol Violation|1|||
157091991|NCT01776541|567091506|FG000|Overall Study|Withdrawal by Subject|12|||
157091992|NCT01776541|567091507|FG001|Overall Study|Withdrawal by Subject|20|||
157091993|NCT04279392|567091510|FG000|Overall Study|Physician Decision|1|||
157091994|NCT04279392|567091511|FG001|Overall Study|Physician Decision|0|||
157091995|NCT04964388|567091512|FG000|Overall Study|Lost to Follow-up|3|||
157091996|NCT04964388|567091513|FG001|Overall Study|Lost to Follow-up|2|||
157091997|NCT01347762|567091514|FG000|Overall Study|Lost to Follow-up|0|||
157091998|NCT01347762|567091515|FG001|Overall Study|Lost to Follow-up|1|||
157091999|NCT01347762|567091516|FG002|Overall Study|Lost to Follow-up|6|||
157092000|NCT01347762|567091517|FG003|Overall Study|Lost to Follow-up|5|||
157092001|NCT01347762|567091514|FG000|Overall Study|Withdrawal by Subject|4|||
157092002|NCT01347762|567091515|FG001|Overall Study|Withdrawal by Subject|1|||
157092003|NCT01347762|567091516|FG002|Overall Study|Withdrawal by Subject|3|||
157092004|NCT01347762|567091517|FG003|Overall Study|Withdrawal by Subject|3|||
157092005|NCT02476279|567091518|FG000|Overall Study|Lost to Follow-up|1|||
157092006|NCT02476279|567091519|FG001|Overall Study|Lost to Follow-up|1|||
157092007|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
157092008|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
157092009|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
157092010|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
157092011|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
157092012|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
157092013|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
157092014|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092015|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092016|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092017|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092018|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
157092019|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092020|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
157092021|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
157092022|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
157092023|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
157205624|NCT03514121|567497993|FG005|Overall Study|Withdrawal by Subject|2|||
157205625|NCT03514121|567497994|FG006|Overall Study|Withdrawal by Subject|1|||
157205626|NCT03514121|567497995|FG007|Overall Study|Withdrawal by Subject|1|||
157205627|NCT03514121|567497996|FG008|Overall Study|Withdrawal by Subject|7|||
157205628|NCT03514121|567497997|FG009|Overall Study|Withdrawal by Subject|2|||
157205629|NCT03514121|567497988|FG000|Overall Study|Death|0|||
157205630|NCT03514121|567497989|FG001|Overall Study|Death|0|||
157205631|NCT03514121|567497990|FG002|Overall Study|Death|0|||
157205632|NCT03514121|567497991|FG003|Overall Study|Death|0|||
157205633|NCT03514121|567497992|FG004|Overall Study|Death|0|||
157205634|NCT03514121|567497993|FG005|Overall Study|Death|3|||
157205635|NCT03514121|567497994|FG006|Overall Study|Death|2|||
157205636|NCT03514121|567497995|FG007|Overall Study|Death|1|||
157205637|NCT03514121|567497996|FG008|Overall Study|Death|26|||
157205638|NCT03514121|567497997|FG009|Overall Study|Death|3|||
157205639|NCT03514121|567497988|FG000|Overall Study|Lost to Follow-up|0|||
157205640|NCT03514121|567497989|FG001|Overall Study|Lost to Follow-up|0|||
157205641|NCT03514121|567497990|FG002|Overall Study|Lost to Follow-up|1|||
157205642|NCT03514121|567497991|FG003|Overall Study|Lost to Follow-up|0|||
157205643|NCT03514121|567497992|FG004|Overall Study|Lost to Follow-up|0|||
157205644|NCT03514121|567497993|FG005|Overall Study|Lost to Follow-up|0|||
157205645|NCT03514121|567497994|FG006|Overall Study|Lost to Follow-up|0|||
157205646|NCT03514121|567497995|FG007|Overall Study|Lost to Follow-up|0|||
157205647|NCT03514121|567497996|FG008|Overall Study|Lost to Follow-up|1|||
157205648|NCT03514121|567497997|FG009|Overall Study|Lost to Follow-up|0|||
157205649|NCT03514121|567497988|FG000|Overall Study|Adverse Event|0|||
157205650|NCT03514121|567497989|FG001|Overall Study|Adverse Event|0|||
157205651|NCT03514121|567497990|FG002|Overall Study|Adverse Event|0|||
157205652|NCT03514121|567497991|FG003|Overall Study|Adverse Event|0|||
157205653|NCT03514121|567497992|FG004|Overall Study|Adverse Event|0|||
157205654|NCT03514121|567497993|FG005|Overall Study|Adverse Event|0|||
157205655|NCT03514121|567497994|FG006|Overall Study|Adverse Event|1|||
157205656|NCT03514121|567497995|FG007|Overall Study|Adverse Event|0|||
157205657|NCT03514121|567497996|FG008|Overall Study|Adverse Event|0|||
157205658|NCT03514121|567497997|FG009|Overall Study|Adverse Event|0|||
157205659|NCT03514121|567497988|FG000|Overall Study|Other|0|||
157205660|NCT03514121|567497989|FG001|Overall Study|Other|1|||
157205661|NCT03514121|567497990|FG002|Overall Study|Other|1|||
157205662|NCT03514121|567497991|FG003|Overall Study|Other|0|||
156749971|NCT00385827|565836901|FG001|Part 2|Adverse Event|6|||
156749972|NCT00385827|565836902|FG002|Part 2|Adverse Event|10|||
156749973|NCT00385827|565836900|FG000|Part 2|Death|0|||
156749974|NCT00385827|565836901|FG001|Part 2|Death|0|||
157205663|NCT03514121|567497992|FG004|Overall Study|Other|1|||
157205664|NCT03514121|567497993|FG005|Overall Study|Other|2|||
157205665|NCT03514121|567497994|FG006|Overall Study|Other|3|||
157205666|NCT03514121|567497995|FG007|Overall Study|Other|2|||
157205667|NCT03514121|567497996|FG008|Overall Study|Other|7|||
156749975|NCT00385827|565836902|FG002|Part 2|Death|2|||
157205668|NCT03514121|567497997|FG009|Overall Study|Other|3|||
157205669|NCT03514121|567497988|FG000|Overall Study|Study termination by Sponsor|0|||
157092024|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
157092025|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
157092026|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
157092027|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
157092028|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092029|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092030|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092031|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
157205670|NCT03514121|567497989|FG001|Overall Study|Study termination by Sponsor|0|||
157205671|NCT03514121|567497990|FG002|Overall Study|Study termination by Sponsor|0|||
157205672|NCT03514121|567497991|FG003|Overall Study|Study termination by Sponsor|0|||
157205673|NCT03514121|567497992|FG004|Overall Study|Study termination by Sponsor|0|||
157205674|NCT03514121|567497993|FG005|Overall Study|Study termination by Sponsor|0|||
157205675|NCT03514121|567497994|FG006|Overall Study|Study termination by Sponsor|0|||
157205676|NCT03514121|567497995|FG007|Overall Study|Study termination by Sponsor|0|||
157205677|NCT03514121|567497996|FG008|Overall Study|Study termination by Sponsor|11|||
157205678|NCT03514121|567497997|FG009|Overall Study|Study termination by Sponsor|3|||
157205679|NCT03514121|567497988|FG000|Overall Study|Investigator decision|0|||
157205680|NCT03514121|567497989|FG001|Overall Study|Investigator decision|0|||
157205681|NCT03514121|567497990|FG002|Overall Study|Investigator decision|0|||
157205682|NCT03514121|567497991|FG003|Overall Study|Investigator decision|0|||
157205683|NCT03514121|567497992|FG004|Overall Study|Investigator decision|0|||
157205684|NCT03514121|567497993|FG005|Overall Study|Investigator decision|0|||
157205685|NCT03514121|567497994|FG006|Overall Study|Investigator decision|0|||
157205686|NCT03514121|567497995|FG007|Overall Study|Investigator decision|0|||
157205687|NCT03514121|567497996|FG008|Overall Study|Investigator decision|1|||
157205688|NCT03514121|567497997|FG009|Overall Study|Investigator decision|0|||
157205689|NCT00388674|567497998|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
157092032|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
157092033|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092034|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092035|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
157092036|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
157092037|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
157092038|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
157092039|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
157092040|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
157092041|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
157092042|NCT04494256|567091520|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092043|NCT04494256|567091521|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092044|NCT04494256|567091522|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092045|NCT04494256|567091523|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092046|NCT04494256|567091524|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
157092047|NCT04494256|567091525|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092048|NCT04494256|567091526|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
157092049|NCT04494256|567091520|FG000|Part 2: Open Label Period|Death|0|||
157092050|NCT04494256|567091521|FG001|Part 2: Open Label Period|Death|0|||
157092051|NCT04494256|567091522|FG002|Part 2: Open Label Period|Death|0|||
157092052|NCT04494256|567091523|FG003|Part 2: Open Label Period|Death|0|||
157092053|NCT04494256|567091524|FG004|Part 2: Open Label Period|Death|0|||
157092054|NCT04494256|567091525|FG005|Part 2: Open Label Period|Death|4|||
157092055|NCT04494256|567091526|FG006|Part 2: Open Label Period|Death|2|||
157092056|NCT04494256|567091520|FG000|Part 2: Open Label Period|Adverse Event|0|||
157092057|NCT04494256|567091521|FG001|Part 2: Open Label Period|Adverse Event|0|||
157092058|NCT04494256|567091522|FG002|Part 2: Open Label Period|Adverse Event|0|||
157205690|NCT00388674|567497999|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
157205691|NCT00388674|567497998|FG000|Initial Treatment|Adverse Event|22|||
157205692|NCT00388674|567497999|FG001|Initial Treatment|Adverse Event|87|||
157205693|NCT00388674|567497998|FG000|Initial Treatment|Death|215|||
156749976|NCT00385827|565836900|FG000|Part 2|Lack of Efficacy|0|||
157092059|NCT04494256|567091523|FG003|Part 2: Open Label Period|Adverse Event|0|||
157205694|NCT00388674|567497999|FG001|Initial Treatment|Death|216|||
157205695|NCT00388674|567497998|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
157205696|NCT00388674|567497999|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
157205697|NCT00388674|567497998|FG000|Initial Treatment|HCC|12|||
157205698|NCT00388674|567497999|FG001|Initial Treatment|HCC|20|||
157205699|NCT00388674|567497998|FG000|Initial Treatment|Lost to Follow-up|526|||
157205700|NCT00388674|567497999|FG001|Initial Treatment|Lost to Follow-up|624|||
157205701|NCT00388674|567497998|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
157092060|NCT04494256|567091524|FG004|Part 2: Open Label Period|Adverse Event|0|||
157092061|NCT04494256|567091525|FG005|Part 2: Open Label Period|Adverse Event|0|||
157092062|NCT04494256|567091526|FG006|Part 2: Open Label Period|Adverse Event|2|||
157205702|NCT00388674|567497999|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
157205703|NCT00388674|567497998|FG000|Initial Treatment|Never Treated with Study Medication|1|||
157205704|NCT00388674|567497999|FG001|Initial Treatment|Never Treated with Study Medication|7|||
157205705|NCT00388674|567497998|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
157205706|NCT00388674|567497999|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
157205707|NCT00388674|567497998|FG000|Initial Treatment|Not Defined|125|||
157092063|NCT04494256|567091520|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
157205708|NCT00388674|567497999|FG001|Initial Treatment|Not Defined|172|||
157205709|NCT00388674|567497998|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
157205710|NCT00388674|567497999|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
157205711|NCT00388674|567497998|FG000|Initial Treatment|Pregnancy|26|||
157205712|NCT00388674|567497999|FG001|Initial Treatment|Pregnancy|16|||
157205713|NCT00388674|567497998|FG000|Initial Treatment|Study Drug Toxicity|5|||
157205714|NCT00388674|567497999|FG001|Initial Treatment|Study Drug Toxicity|92|||
157205715|NCT00388674|567497998|FG000|Initial Treatment|Participant Request|501|||
157205716|NCT00388674|567497999|FG001|Initial Treatment|Participant Request|673|||
157205717|NCT00388674|567497998|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
157205718|NCT00388674|567497999|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
157205719|NCT00388674|567497998|FG000|Initial Treatment|Not Reported|10|||
157205720|NCT00388674|567497999|FG001|Initial Treatment|Not Reported|12|||
157205721|NCT00388674|567497998|FG000|End of Study|Administrative Reason By Sponsor|299|||
157205722|NCT00388674|567497999|FG001|End of Study|Administrative Reason By Sponsor|253|||
157205723|NCT00388674|567497998|FG000|End of Study|Death|239|||
157205724|NCT00388674|567497999|FG001|End of Study|Death|262|||
157205725|NCT00388674|567497998|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
157205726|NCT00388674|567497999|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
157205727|NCT00388674|567497998|FG000|End of Study|HCC|8|||
157205728|NCT00388674|567497999|FG001|End of Study|HCC|7|||
157205729|NCT00388674|567497998|FG000|End of Study|Lost to Follow-up|587|||
157205730|NCT00388674|567497999|FG001|End of Study|Lost to Follow-up|715|||
157205731|NCT00388674|567497998|FG000|End of Study|Malignancy (Non-HCC)|1|||
157205732|NCT00388674|567497999|FG001|End of Study|Malignancy (Non-HCC)|1|||
157205733|NCT00388674|567497998|FG000|End of Study|Non-Study Related Comorbidities|3|||
157205734|NCT00388674|567497999|FG001|End of Study|Non-Study Related Comorbidities|4|||
157205735|NCT00388674|567497998|FG000|End of Study|Not Defined|135|||
157205736|NCT00388674|567497999|FG001|End of Study|Not Defined|214|||
157205737|NCT00388674|567497998|FG000|End of Study|Participant Withdrew Consent|437|||
157205738|NCT00388674|567497999|FG001|End of Study|Participant Withdrew Consent|673|||
157205739|NCT00388674|567497998|FG000|End of Study|No Off-Treatment Status Data|22|||
157205740|NCT00388674|567497999|FG001|End of Study|No Off-Treatment Status Data|30|||
157205741|NCT00388674|567497998|FG000|End of Study|Not Reported|0|||
157205742|NCT00388674|567497999|FG001|End of Study|Not Reported|1|||
157205743|NCT00568776|567498000|FG000|Overall Study|Adverse Event|8|||
157205744|NCT00568776|567498001|FG001|Overall Study|Adverse Event|8|||
157205745|NCT00568776|567498002|FG002|Overall Study|Adverse Event|10|||
157205746|NCT00568776|567498003|FG003|Overall Study|Adverse Event|8|||
157205747|NCT00568776|567498000|FG000|Overall Study|Death|0|||
157205748|NCT00568776|567498001|FG001|Overall Study|Death|1|||
157205749|NCT00568776|567498002|FG002|Overall Study|Death|4|||
157205750|NCT00568776|567498003|FG003|Overall Study|Death|3|||
156749977|NCT00385827|565836901|FG001|Part 2|Lack of Efficacy|14|||
156864137|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
157092064|NCT04494256|567091521|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
157092065|NCT04494256|567091522|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
157092066|NCT04494256|567091523|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
157092067|NCT04494256|567091524|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
157145062|NCT00923091|567277981|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
157205751|NCT00568776|567498000|FG000|Overall Study|Physician Decision|0|||
157205752|NCT00568776|567498001|FG001|Overall Study|Physician Decision|2|||
157205753|NCT00568776|567498002|FG002|Overall Study|Physician Decision|0|||
157205754|NCT00568776|567498003|FG003|Overall Study|Physician Decision|0|||
157205755|NCT00568776|567498000|FG000|Overall Study|Lack of Efficacy|2|||
157205756|NCT00568776|567498001|FG001|Overall Study|Lack of Efficacy|2|||
157205757|NCT00568776|567498002|FG002|Overall Study|Lack of Efficacy|2|||
157205758|NCT00568776|567498003|FG003|Overall Study|Lack of Efficacy|4|||
157205759|NCT00568776|567498000|FG000|Overall Study|Lost to Follow-up|1|||
157205760|NCT00568776|567498001|FG001|Overall Study|Lost to Follow-up|1|||
157205761|NCT00568776|567498002|FG002|Overall Study|Lost to Follow-up|1|||
157205762|NCT00568776|567498003|FG003|Overall Study|Lost to Follow-up|1|||
157205763|NCT00568776|567498000|FG000|Overall Study|Protocol Violation|1|||
157205764|NCT00568776|567498001|FG001|Overall Study|Protocol Violation|0|||
157205765|NCT00568776|567498002|FG002|Overall Study|Protocol Violation|1|||
156749978|NCT00385827|565836902|FG002|Part 2|Lack of Efficacy|13|||
156749979|NCT00385827|565836900|FG000|Part 2|Randomized but not treated|0|||
156749980|NCT00385827|565836901|FG001|Part 2|Randomized but not treated|2|||
156749981|NCT00385827|565836902|FG002|Part 2|Randomized but not treated|2|||
156749982|NCT00385827|565836900|FG000|Part 2|Other|0|||
156749983|NCT00385827|565836901|FG001|Part 2|Other|11|||
156749984|NCT00385827|565836902|FG002|Part 2|Other|21|||
156749985|NCT01421147|565836903|FG000|Treatment Period|Adverse Event|2|||
156749986|NCT01421147|565836904|FG001|Treatment Period|Adverse Event|3|||
156749987|NCT01421147|565836903|FG000|Treatment Period|Lost to Follow-up|2|||
156749988|NCT01421147|565836904|FG001|Treatment Period|Lost to Follow-up|1|||
156749989|NCT01421147|565836903|FG000|Treatment Period|Physician Decision|2|||
156749990|NCT01421147|565836904|FG001|Treatment Period|Physician Decision|2|||
156749991|NCT01421147|565836903|FG000|Treatment Period|Withdrawal by Subject|10|||
156749992|NCT01421147|565836904|FG001|Treatment Period|Withdrawal by Subject|5|||
156749993|NCT01421147|565836903|FG000|Extension Period|Adverse Event|0|||
156749994|NCT01421147|565836904|FG001|Extension Period|Adverse Event|2|||
156749995|NCT01421147|565836903|FG000|Extension Period|Death|0|||
156749996|NCT01421147|565836904|FG001|Extension Period|Death|1|||
156749997|NCT01421147|565836903|FG000|Extension Period|Lost to Follow-up|2|||
156749998|NCT01421147|565836904|FG001|Extension Period|Lost to Follow-up|5|||
156749999|NCT01421147|565836903|FG000|Extension Period|Physician Decision|1|||
156750000|NCT01421147|565836904|FG001|Extension Period|Physician Decision|0|||
156750001|NCT01421147|565836903|FG000|Extension Period|Withdrawal by Subject|5|||
156750002|NCT01421147|565836904|FG001|Extension Period|Withdrawal by Subject|3|||
156750003|NCT01212159|565836905|FG000|Overall Study|Withdrawal by Subject|12|||
156750004|NCT01212159|565836906|FG001|Overall Study|Withdrawal by Subject|12|||
156750005|NCT00582426|565836917|FG000|Overall Study|Lost to Follow-up|0|||
156750006|NCT00582426|565836918|FG001|Overall Study|Lost to Follow-up|2|||
156750007|NCT00582426|565836917|FG000|Overall Study|Adverse Event|4|||
156750008|NCT00582426|565836918|FG001|Overall Study|Adverse Event|2|||
156750009|NCT00582426|565836917|FG000|Overall Study|Protocol Violation|6|||
156750010|NCT00582426|565836918|FG001|Overall Study|Protocol Violation|2|||
157205766|NCT00568776|567498003|FG003|Overall Study|Protocol Violation|1|||
157205767|NCT00568776|567498000|FG000|Overall Study|Withdrawal by Subject|13|||
156750011|NCT00582426|565836917|FG000|Overall Study|Death|4|||
157205768|NCT00568776|567498001|FG001|Overall Study|Withdrawal by Subject|15|||
157205769|NCT00568776|567498002|FG002|Overall Study|Withdrawal by Subject|13|||
157205770|NCT00568776|567498003|FG003|Overall Study|Withdrawal by Subject|7|||
157205771|NCT00568776|567498000|FG000|Overall Study|Loss of Caregiver|0|||
157205772|NCT00568776|567498001|FG001|Overall Study|Loss of Caregiver|2|||
157205773|NCT00568776|567498002|FG002|Overall Study|Loss of Caregiver|1|||
157205774|NCT00568776|567498003|FG003|Overall Study|Loss of Caregiver|2|||
157205775|NCT00568776|567498000|FG000|Overall Study|Sponsor Decision|2|||
157205776|NCT00568776|567498001|FG001|Overall Study|Sponsor Decision|2|||
157205777|NCT00568776|567498002|FG002|Overall Study|Sponsor Decision|41|||
157205778|NCT00568776|567498003|FG003|Overall Study|Sponsor Decision|42|||
157205779|NCT00568776|567498000|FG000|Overall Study|Miscellaeneous|3|||
157205780|NCT00568776|567498001|FG001|Overall Study|Miscellaeneous|3|||
157205781|NCT00568776|567498002|FG002|Overall Study|Miscellaeneous|1|||
157205782|NCT00568776|567498003|FG003|Overall Study|Miscellaeneous|4|||
157205783|NCT03576131|567498004|FG000|Overall Study|Investigator decision|0|||
157205784|NCT03576131|567498005|FG001|Overall Study|Investigator decision|0|||
157205785|NCT03576131|567498006|FG002|Overall Study|Investigator decision|0|||
157205786|NCT03576131|567498007|FG003|Overall Study|Investigator decision|1|||
157205787|NCT03576131|567498008|FG004|Overall Study|Investigator decision|0|||
157205788|NCT03576131|567498009|FG005|Overall Study|Investigator decision|1|||
157205789|NCT03576131|567498010|FG006|Overall Study|Investigator decision|0|||
157205790|NCT03576131|567498011|FG007|Overall Study|Investigator decision|0|||
157205791|NCT03576131|567498004|FG000|Overall Study|Withdrawal by Subject|1|||
157205792|NCT03576131|567498005|FG001|Overall Study|Withdrawal by Subject|1|||
156750012|NCT00582426|565836918|FG001|Overall Study|Death|3|||
156750013|NCT00582426|565836917|FG000|Overall Study|Withdrawal by Subject|3|||
157205793|NCT03576131|567498006|FG002|Overall Study|Withdrawal by Subject|0|||
157205794|NCT03576131|567498007|FG003|Overall Study|Withdrawal by Subject|1|||
157205795|NCT03576131|567498008|FG004|Overall Study|Withdrawal by Subject|2|||
157205796|NCT03576131|567498009|FG005|Overall Study|Withdrawal by Subject|3|||
157205797|NCT03576131|567498010|FG006|Overall Study|Withdrawal by Subject|1|||
157205798|NCT03576131|567498011|FG007|Overall Study|Withdrawal by Subject|0|||
157205799|NCT03576131|567498004|FG000|Overall Study|Death|3|||
156750014|NCT00582426|565836918|FG001|Overall Study|Withdrawal by Subject|2|||
157205800|NCT03576131|567498005|FG001|Overall Study|Death|3|||
157205801|NCT03576131|567498006|FG002|Overall Study|Death|1|||
157205802|NCT03576131|567498007|FG003|Overall Study|Death|5|||
157205803|NCT03576131|567498008|FG004|Overall Study|Death|4|||
157205804|NCT03576131|567498009|FG005|Overall Study|Death|1|||
157205805|NCT03576131|567498010|FG006|Overall Study|Death|0|||
157205806|NCT03576131|567498011|FG007|Overall Study|Death|1|||
157205807|NCT03576131|567498004|FG000|Overall Study|New anti-cancer treatment|5|||
157205808|NCT03576131|567498005|FG001|Overall Study|New anti-cancer treatment|1|||
157205809|NCT03576131|567498006|FG002|Overall Study|New anti-cancer treatment|2|||
157205810|NCT03576131|567498007|FG003|Overall Study|New anti-cancer treatment|3|||
157205811|NCT03576131|567498008|FG004|Overall Study|New anti-cancer treatment|0|||
157205812|NCT03576131|567498009|FG005|Overall Study|New anti-cancer treatment|0|||
157205813|NCT03576131|567498010|FG006|Overall Study|New anti-cancer treatment|0|||
157205814|NCT03576131|567498011|FG007|Overall Study|New anti-cancer treatment|0|||
157205815|NCT03576131|567498004|FG000|Overall Study|Unspecified reason|0|||
157205816|NCT03576131|567498005|FG001|Overall Study|Unspecified reason|0|||
157205817|NCT03576131|567498006|FG002|Overall Study|Unspecified reason|1|||
157205818|NCT03576131|567498007|FG003|Overall Study|Unspecified reason|1|||
157205819|NCT03576131|567498008|FG004|Overall Study|Unspecified reason|1|||
157205820|NCT03576131|567498009|FG005|Overall Study|Unspecified reason|1|||
157205821|NCT03576131|567498010|FG006|Overall Study|Unspecified reason|0|||
157205822|NCT03576131|567498011|FG007|Overall Study|Unspecified reason|0|||
157205823|NCT03576131|567498004|FG000|Overall Study|Subject non-compliance|0|||
157205824|NCT03576131|567498005|FG001|Overall Study|Subject non-compliance|0|||
157205825|NCT03576131|567498006|FG002|Overall Study|Subject non-compliance|0|||
157205826|NCT03576131|567498007|FG003|Overall Study|Subject non-compliance|0|||
157205827|NCT03576131|567498008|FG004|Overall Study|Subject non-compliance|0|||
157205828|NCT03576131|567498009|FG005|Overall Study|Subject non-compliance|1|||
157205829|NCT03576131|567498010|FG006|Overall Study|Subject non-compliance|0|||
157205830|NCT03576131|567498011|FG007|Overall Study|Subject non-compliance|0|||
157205831|NCT02118896|567498014|FG000|Overall Study|Death|4|||
157205832|NCT02118896|567498015|FG001|Overall Study|Death|0|||
157205833|NCT02118896|567498016|FG002|Overall Study|Death|4|||
157205834|NCT02118896|567498017|FG003|Overall Study|Death|6|||
157205835|NCT02118896|567498018|FG004|Overall Study|Death|3|||
157205836|NCT02118896|567498019|FG005|Overall Study|Death|1|||
157205837|NCT02118896|567498020|FG006|Overall Study|Death|0|||
157205838|NCT02118896|567498021|FG007|Overall Study|Death|0|||
157205839|NCT02118896|567498022|FG008|Overall Study|Death|0|||
157205840|NCT02118896|567498023|FG009|Overall Study|Death|0|||
157205841|NCT02118896|567498014|FG000|Overall Study|Adverse Event|5|||
157205842|NCT02118896|567498015|FG001|Overall Study|Adverse Event|4|||
157205843|NCT02118896|567498016|FG002|Overall Study|Adverse Event|4|||
157205844|NCT02118896|567498017|FG003|Overall Study|Adverse Event|5|||
157205845|NCT02118896|567498018|FG004|Overall Study|Adverse Event|5|||
157205846|NCT02118896|567498019|FG005|Overall Study|Adverse Event|9|||
157205847|NCT02118896|567498020|FG006|Overall Study|Adverse Event|1|||
157205848|NCT02118896|567498021|FG007|Overall Study|Adverse Event|1|||
157205849|NCT02118896|567498022|FG008|Overall Study|Adverse Event|4|||
157205850|NCT02118896|567498023|FG009|Overall Study|Adverse Event|0|||
157205851|NCT02118896|567498014|FG000|Overall Study|Consent withdrawn|2|||
157205852|NCT02118896|567498015|FG001|Overall Study|Consent withdrawn|0|||
157205853|NCT02118896|567498016|FG002|Overall Study|Consent withdrawn|3|||
157205854|NCT02118896|567498017|FG003|Overall Study|Consent withdrawn|4|||
157205855|NCT02118896|567498018|FG004|Overall Study|Consent withdrawn|1|||
157205856|NCT02118896|567498019|FG005|Overall Study|Consent withdrawn|4|||
157205857|NCT02118896|567498020|FG006|Overall Study|Consent withdrawn|0|||
156750015|NCT00582426|565836917|FG000|Overall Study|Disease Progression|2|||
156750016|NCT00582426|565836918|FG001|Overall Study|Disease Progression|2|||
157205858|NCT02118896|567498021|FG007|Overall Study|Consent withdrawn|0|||
157205859|NCT02118896|567498022|FG008|Overall Study|Consent withdrawn|0|||
157205860|NCT02118896|567498023|FG009|Overall Study|Consent withdrawn|0|||
157205861|NCT02118896|567498014|FG000|Overall Study|Non-compliance|2|||
156750017|NCT00582426|565836917|FG000|Overall Study|Use of illicit drugs|1|||
156750018|NCT00582426|565836918|FG001|Overall Study|Use of illicit drugs|0|||
157205862|NCT02118896|567498015|FG001|Overall Study|Non-compliance|1|||
157205863|NCT02118896|567498016|FG002|Overall Study|Non-compliance|1|||
157205864|NCT02118896|567498017|FG003|Overall Study|Non-compliance|5|||
157205865|NCT02118896|567498018|FG004|Overall Study|Non-compliance|0|||
157205866|NCT02118896|567498019|FG005|Overall Study|Non-compliance|1|||
157205867|NCT02118896|567498020|FG006|Overall Study|Non-compliance|0|||
157205868|NCT02118896|567498021|FG007|Overall Study|Non-compliance|1|||
157205869|NCT02118896|567498022|FG008|Overall Study|Non-compliance|0|||
157205870|NCT02118896|567498023|FG009|Overall Study|Non-compliance|0|||
157205871|NCT02118896|567498014|FG000|Overall Study|Pregnancy|1|||
157205872|NCT02118896|567498015|FG001|Overall Study|Pregnancy|1|||
157205873|NCT02118896|567498016|FG002|Overall Study|Pregnancy|0|||
157205874|NCT02118896|567498017|FG003|Overall Study|Pregnancy|0|||
157205875|NCT02118896|567498018|FG004|Overall Study|Pregnancy|1|||
156750019|NCT00199849|565836919|FG000|Overall Study|Unrelated illness or complication|0|||
157205876|NCT02118896|567498019|FG005|Overall Study|Pregnancy|3|||
157205877|NCT02118896|567498020|FG006|Overall Study|Pregnancy|1|||
157205878|NCT02118896|567498021|FG007|Overall Study|Pregnancy|0|||
157205879|NCT02118896|567498022|FG008|Overall Study|Pregnancy|0|||
157205880|NCT02118896|567498023|FG009|Overall Study|Pregnancy|0|||
157205881|NCT02118896|567498014|FG000|Overall Study|Lost to Follow-up|1|||
157205882|NCT02118896|567498015|FG001|Overall Study|Lost to Follow-up|2|||
157205883|NCT02118896|567498016|FG002|Overall Study|Lost to Follow-up|1|||
157205884|NCT02118896|567498017|FG003|Overall Study|Lost to Follow-up|0|||
157205885|NCT02118896|567498018|FG004|Overall Study|Lost to Follow-up|2|||
157205886|NCT02118896|567498019|FG005|Overall Study|Lost to Follow-up|1|||
157205887|NCT02118896|567498020|FG006|Overall Study|Lost to Follow-up|0|||
157205888|NCT02118896|567498021|FG007|Overall Study|Lost to Follow-up|0|||
157205889|NCT02118896|567498022|FG008|Overall Study|Lost to Follow-up|0|||
157205890|NCT02118896|567498023|FG009|Overall Study|Lost to Follow-up|0|||
157205891|NCT02118896|567498014|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
157205892|NCT02118896|567498015|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
157205893|NCT02118896|567498016|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
157205894|NCT02118896|567498017|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
157205895|NCT02118896|567498018|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
157205896|NCT02118896|567498019|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
157205897|NCT02118896|567498020|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
157205898|NCT02118896|567498021|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
157205899|NCT02118896|567498022|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
157205900|NCT02118896|567498023|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
157205901|NCT02118896|567498014|FG000|Overall Study|Prohibited medication|0|||
157205902|NCT02118896|567498015|FG001|Overall Study|Prohibited medication|0|||
157205903|NCT02118896|567498016|FG002|Overall Study|Prohibited medication|0|||
157205904|NCT02118896|567498017|FG003|Overall Study|Prohibited medication|0|||
157205905|NCT02118896|567498018|FG004|Overall Study|Prohibited medication|1|||
157205906|NCT02118896|567498019|FG005|Overall Study|Prohibited medication|3|||
157205907|NCT02118896|567498020|FG006|Overall Study|Prohibited medication|0|||
157205908|NCT02118896|567498021|FG007|Overall Study|Prohibited medication|0|||
157205909|NCT02118896|567498022|FG008|Overall Study|Prohibited medication|0|||
157205910|NCT02118896|567498023|FG009|Overall Study|Prohibited medication|0|||
157205911|NCT02118896|567498014|FG000|Overall Study|Miscellaneous|1|||
157205912|NCT02118896|567498015|FG001|Overall Study|Miscellaneous|2|||
157205913|NCT02118896|567498016|FG002|Overall Study|Miscellaneous|0|||
157205914|NCT02118896|567498017|FG003|Overall Study|Miscellaneous|2|||
157205915|NCT02118896|567498018|FG004|Overall Study|Miscellaneous|0|||
157205916|NCT02118896|567498019|FG005|Overall Study|Miscellaneous|4|||
157205917|NCT02118896|567498020|FG006|Overall Study|Miscellaneous|0|||
157205918|NCT02118896|567498021|FG007|Overall Study|Miscellaneous|0|||
157205919|NCT02118896|567498022|FG008|Overall Study|Miscellaneous|0|||
157205920|NCT02118896|567498023|FG009|Overall Study|Miscellaneous|0|||
157205921|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
157205922|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
157205923|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
157205924|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
157205925|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
157205926|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
157205927|NCT00566631|567498024|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
157205928|NCT00566631|567498024|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
157205929|NCT00566631|567498024|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
157205930|NCT00566631|567498024|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
157205931|NCT00566631|567498024|FG000|Part 2: Extension Phase|Adverse Event|11|||
157205932|NCT00566631|567498024|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
157205933|NCT00566631|567498024|FG000|Part 2: Extension Phase|Death|1|||
157205934|NCT00566631|567498024|FG000|Part 2: Extension Phase|Other|5|||
157205935|NCT00877799|567498025|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
157205936|NCT00877799|567498026|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
157205937|NCT00877799|567498027|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
157205938|NCT00877799|567498028|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
157205939|NCT00877799|567498029|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
157205940|NCT00877799|567498025|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
157205941|NCT00877799|567498026|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
157205942|NCT00877799|567498027|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
157205943|NCT00877799|567498028|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
157205944|NCT00877799|567498029|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
157205945|NCT00877799|567498025|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
157205946|NCT00877799|567498026|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
157205947|NCT00877799|567498027|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
156864138|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
156883064|NCT00715910|566330922|FG003|Booster and ESFU Phase|Other|5|||
157205948|NCT00877799|567498028|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
157205949|NCT00877799|567498029|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
157205950|NCT00877799|567498025|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
157205951|NCT00877799|567498026|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
157205952|NCT00877799|567498027|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
157205953|NCT00877799|567498028|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
157205954|NCT00877799|567498029|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
157205955|NCT00877799|567498025|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
157205956|NCT00877799|567498026|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
157205957|NCT00877799|567498027|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
157205958|NCT00877799|567498028|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
157205959|NCT00877799|567498029|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
157205960|NCT04054011|567498030|FG000|Overall Study|COVID|3|||
157205961|NCT00592007|567498031|FG000|Overall Study|Withdrawal by Subject|1|||
157205962|NCT00592007|567498031|FG000|Overall Study|patient ineligible (out of lab range)|1|||
157205963|NCT00595127|567498032|FG000|Overall Study|Death|6|||
157205964|NCT00595127|567498032|FG000|Overall Study|Relapsed|3|||
157205965|NCT00595127|567498032|FG000|Overall Study|joined another trial|1|||
157205966|NCT00557830|567498034|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
157205967|NCT00557830|567498035|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
157205968|NCT00557830|567498036|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
157205969|NCT00557830|567498034|FG000|Screening Treatment Phase|Adverse Event|2|||
157205970|NCT00557830|567498035|FG001|Screening Treatment Phase|Adverse Event|0|||
157205971|NCT00557830|567498036|FG002|Screening Treatment Phase|Adverse Event|0|||
157205972|NCT00557830|567498034|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
157205973|NCT00557830|567498035|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
157205974|NCT00557830|567498036|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
157205975|NCT00538473|567498037|FG000|Overall Study|Adverse Event|1|||
157205976|NCT00538473|567498038|FG001|Overall Study|Adverse Event|0|||
157205977|NCT01569074|567498039|FG000|Overall Study|Study stopped|6|||
157205978|NCT01569074|567498040|FG001|Overall Study|Study stopped|6|||
157205979|NCT01569074|567498041|FG002|Overall Study|Study stopped|8|||
157205980|NCT01569074|567498042|FG003|Overall Study|Study stopped|7|||
157205981|NCT01569074|567498043|FG004|Overall Study|Study stopped|7|||
157205982|NCT01569074|567498039|FG000|Overall Study|Study-specific discontinuation criteria|0|||
157205983|NCT01569074|567498040|FG001|Overall Study|Study-specific discontinuation criteria|1|||
157205984|NCT01569074|567498041|FG002|Overall Study|Study-specific discontinuation criteria|0|||
157205985|NCT01569074|567498042|FG003|Overall Study|Study-specific discontinuation criteria|0|||
157205986|NCT01569074|567498043|FG004|Overall Study|Study-specific discontinuation criteria|0|||
157205987|NCT01569074|567498039|FG000|Overall Study|Severe non-compliance to protocol|0|||
157205988|NCT01569074|567498040|FG001|Overall Study|Severe non-compliance to protocol|0|||
157205989|NCT01569074|567498041|FG002|Overall Study|Severe non-compliance to protocol|1|||
157205990|NCT01569074|567498042|FG003|Overall Study|Severe non-compliance to protocol|0|||
157205991|NCT01569074|567498043|FG004|Overall Study|Severe non-compliance to protocol|0|||
157205992|NCT01569074|567498039|FG000|Overall Study|eg change in circumstances|0|||
157205993|NCT01569074|567498040|FG001|Overall Study|eg change in circumstances|2|||
157205994|NCT01569074|567498041|FG002|Overall Study|eg change in circumstances|0|||
157205995|NCT01569074|567498042|FG003|Overall Study|eg change in circumstances|1|||
157205996|NCT01569074|567498043|FG004|Overall Study|eg change in circumstances|1|||
157205997|NCT01569074|567498039|FG000|Overall Study|Adverse Event|1|||
157205998|NCT01569074|567498040|FG001|Overall Study|Adverse Event|0|||
157205999|NCT01569074|567498041|FG002|Overall Study|Adverse Event|3|||
157206000|NCT01569074|567498042|FG003|Overall Study|Adverse Event|0|||
157206001|NCT01569074|567498043|FG004|Overall Study|Adverse Event|0|||
157206002|NCT02860039|567498049|FG000|Overall Study|Death|4|||
157206003|NCT02860039|567498050|FG001|Overall Study|Death|0|||
157206004|NCT02860039|567498049|FG000|Overall Study|Lost to Follow-up|2|||
157206005|NCT02860039|567498050|FG001|Overall Study|Lost to Follow-up|2|||
157206006|NCT02860039|567498049|FG000|Overall Study|Protocol Violation|3|||
157206007|NCT02860039|567498050|FG001|Overall Study|Protocol Violation|1|||
157206008|NCT02860039|567498049|FG000|Overall Study|Withdrawal by Subject|1|||
157206009|NCT02860039|567498050|FG001|Overall Study|Withdrawal by Subject|0|||
157206010|NCT02860039|567498049|FG000|Overall Study|Not otherwise eligible|1|||
157206011|NCT02860039|567498050|FG001|Overall Study|Not otherwise eligible|1|||
157206012|NCT02723786|567498053|FG000|Overall Study|Lost to Follow-up|1|||
157206013|NCT03170271|567498057|FG000|Overall Study|Adverse Event|7|||
157206014|NCT03170271|567498058|FG001|Overall Study|Adverse Event|2|||
157206015|NCT03170271|567498057|FG000|Overall Study|Lost to Follow-up|0|||
157206016|NCT03170271|567498058|FG001|Overall Study|Lost to Follow-up|1|||
157206017|NCT03170271|567498057|FG000|Overall Study|Physician Decision|1|||
157206018|NCT03170271|567498058|FG001|Overall Study|Physician Decision|0|||
156750020|NCT00199849|565836920|FG001|Overall Study|Unrelated illness or complication|1|||
157206019|NCT03170271|567498057|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
157206020|NCT03170271|567498058|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
157206021|NCT03170271|567498057|FG000|Overall Study|Withdrawal by Subject|17|||
157206022|NCT03170271|567498058|FG001|Overall Study|Withdrawal by Subject|5|||
157206023|NCT03170271|567498057|FG000|Overall Study|Other|2|||
157206024|NCT03170271|567498058|FG001|Overall Study|Other|2|||
157206025|NCT03170271|567498057|FG000|Overall Study|Randomized in error|4|||
157206026|NCT03170271|567498058|FG001|Overall Study|Randomized in error|0|||
157206027|NCT03466060|567498062|FG000|Period 1|Test Lens Damage|0|||
157206028|NCT03466060|567498063|FG001|Period 1|Test Lens Damage|2|||
157206029|NCT03466060|567498064|FG002|Period 1|Test Lens Damage|0|||
157206030|NCT03466060|567498065|FG003|Period 1|Test Lens Damage|0|||
157206031|NCT03466060|567498066|FG004|Period 1|Test Lens Damage|0|||
157206032|NCT03466060|567498067|FG005|Period 1|Test Lens Damage|0|||
157206033|NCT03466060|567498062|FG000|Period 1|Withdrawal by Subject|0|||
157206034|NCT03466060|567498063|FG001|Period 1|Withdrawal by Subject|0|||
157206035|NCT03466060|567498064|FG002|Period 1|Withdrawal by Subject|2|||
157206036|NCT03466060|567498065|FG003|Period 1|Withdrawal by Subject|0|||
157206037|NCT03466060|567498066|FG004|Period 1|Withdrawal by Subject|0|||
157206038|NCT03466060|567498067|FG005|Period 1|Withdrawal by Subject|0|||
157206039|NCT03466060|567498062|FG000|Period 1|Lost to Follow-up|0|||
157206040|NCT03466060|567498063|FG001|Period 1|Lost to Follow-up|0|||
157206041|NCT03466060|567498064|FG002|Period 1|Lost to Follow-up|0|||
157206042|NCT03466060|567498065|FG003|Period 1|Lost to Follow-up|1|||
157206043|NCT03466060|567498066|FG004|Period 1|Lost to Follow-up|0|||
157206044|NCT03466060|567498067|FG005|Period 1|Lost to Follow-up|0|||
157206045|NCT03466060|567498062|FG000|Period 1|Grade 2 Conjunctivitis|0|||
156750021|NCT00199849|565836921|FG002|Overall Study|Unrelated illness or complication|0|||
156750022|NCT00199849|565836919|FG000|Overall Study|Progressive disease requiring intervention|0|||
156750023|NCT00199849|565836920|FG001|Overall Study|Progressive disease requiring intervention|0|||
156750024|NCT00199849|565836921|FG002|Overall Study|Progressive disease requiring intervention|1|||
156750025|NCT00199849|565836919|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
156750026|NCT00199849|565836920|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
156750027|NCT00199849|565836921|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
157206046|NCT03466060|567498063|FG001|Period 1|Grade 2 Conjunctivitis|0|||
157206047|NCT03466060|567498064|FG002|Period 1|Grade 2 Conjunctivitis|1|||
157206048|NCT03466060|567498065|FG003|Period 1|Grade 2 Conjunctivitis|0|||
157206049|NCT03466060|567498066|FG004|Period 1|Grade 2 Conjunctivitis|0|||
157206050|NCT03466060|567498067|FG005|Period 1|Grade 2 Conjunctivitis|0|||
157206051|NCT03466060|567498062|FG000|Period 2|Lens Handling Difficulties|0|||
157206052|NCT03466060|567498063|FG001|Period 2|Lens Handling Difficulties|0|||
157206053|NCT03466060|567498064|FG002|Period 2|Lens Handling Difficulties|1|||
157206054|NCT03466060|567498065|FG003|Period 2|Lens Handling Difficulties|0|||
157206055|NCT03466060|567498066|FG004|Period 2|Lens Handling Difficulties|0|||
157206056|NCT03466060|567498067|FG005|Period 2|Lens Handling Difficulties|0|||
157206057|NCT00244881|567498070|FG000|Overall Study|Withdrawal by Subject|3|||
157206058|NCT03345485|567498071|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
157206059|NCT03345485|567498072|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
157206060|NCT03345485|567498073|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
157206061|NCT03345485|567498074|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
157206062|NCT03345485|567498075|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
157206063|NCT03345485|567498076|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
157206064|NCT03345485|567498077|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
157206065|NCT03345485|567498078|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
157206066|NCT03345485|567498079|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
157206067|NCT03345485|567498080|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
157206068|NCT03345485|567498081|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
156750028|NCT02164318|565836922|FG000|Overall Study|Withdrawal by Subject|0|||
156750029|NCT02164318|565836923|FG001|Overall Study|Withdrawal by Subject|1|||
156750030|NCT02164318|565836924|FG002|Overall Study|Withdrawal by Subject|0|||
156750031|NCT02164318|565836925|FG003|Overall Study|Withdrawal by Subject|1|||
156750032|NCT00662311|565836926|FG000|Overall Study|Respiratory Infection|1|||
156750033|NCT00662311|565836927|FG001|Overall Study|Respiratory Infection|0|||
156750034|NCT00662311|565836928|FG002|Overall Study|Respiratory Infection|0|||
156750035|NCT04727528|565836929|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
157206069|NCT03345485|567498082|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
157206070|NCT03345485|567498083|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
156750036|NCT04727528|565836930|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
156750037|NCT04727528|565836929|FG000|Open-label Period|Randomized who did not receive treatment|1|||
156750038|NCT04727528|565836930|FG001|Open-label Period|Randomized who did not receive treatment|0|||
157206071|NCT01610284|567498084|FG000|Randomization Phase|Adverse Event|1|||
157206072|NCT01610284|567498085|FG001|Randomization Phase|Adverse Event|0|||
156750039|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Adverse Event|0|||
157206073|NCT01610284|567498084|FG000|Randomization Phase|Physician Decision|1|||
157206074|NCT01610284|567498085|FG001|Randomization Phase|Physician Decision|1|||
157206075|NCT01610284|567498084|FG000|Randomization Phase|Death|0|||
157206076|NCT01610284|567498085|FG001|Randomization Phase|Death|1|||
157206077|NCT01610284|567498084|FG000|Treatment Phase|Adverse Event|80|||
157206078|NCT01610284|567498085|FG001|Treatment Phase|Adverse Event|12|||
157206079|NCT01610284|567498084|FG000|Treatment Phase|Lost to Follow-up|1|||
157206080|NCT01610284|567498085|FG001|Treatment Phase|Lost to Follow-up|0|||
157206081|NCT01610284|567498084|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
157206082|NCT01610284|567498085|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
157206083|NCT01610284|567498084|FG000|Treatment Phase|Physician Decision|27|||
156750040|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Adverse Event|1|||
156750041|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Death|0|||
156750042|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Death|1|||
156750043|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
156750044|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
156750045|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
156750046|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
156750047|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Physician Decision|0|||
156750048|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Physician Decision|1|||
156750049|NCT04727528|565836929|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
156750050|NCT04727528|565836930|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156750051|NCT01467271|565836934|FG000|Overall Study|Death|84|||
156750052|NCT01467271|565836934|FG000|Overall Study|Lost to Follow-up|83|||
156750053|NCT01467271|565836934|FG000|Overall Study|Retraction of patient's consent|21|||
156750054|NCT01467271|565836934|FG000|Overall Study|Other reason|14|||
156750055|NCT01964989|565836936|FG000|Overall Study|Protocol Violation|3|||
156750056|NCT01964989|565836937|FG001|Overall Study|Protocol Violation|4|||
156750057|NCT01964989|565836936|FG000|Overall Study|Administrative Reason|103|||
156750058|NCT01964989|565836937|FG001|Overall Study|Administrative Reason|95|||
156750059|NCT01964989|565836936|FG000|Overall Study|Adverse Event|0|||
156750060|NCT01964989|565836937|FG001|Overall Study|Adverse Event|1|||
156750061|NCT01964989|565836936|FG000|Overall Study|Death|1|||
156750062|NCT01964989|565836937|FG001|Overall Study|Death|3|||
156750063|NCT01964989|565836936|FG000|Overall Study|Withdrawal by Subject|156|||
156750064|NCT01964989|565836937|FG001|Overall Study|Withdrawal by Subject|160|||
156750065|NCT01964989|565836936|FG000|Overall Study|Lost to Follow-up|254|||
156750066|NCT01964989|565836937|FG001|Overall Study|Lost to Follow-up|232|||
156750067|NCT01964989|565836936|FG000|Overall Study|Other|267|||
156750068|NCT01964989|565836937|FG001|Overall Study|Other|252|||
156750069|NCT02815267|565836938|FG000|Double-Blind Phase|Adverse Event|0|||
156750070|NCT02815267|565836939|FG001|Double-Blind Phase|Adverse Event|3|||
156750071|NCT02815267|565836938|FG000|Double-Blind Phase|Lost to Follow-up|17|||
156750072|NCT02815267|565836939|FG001|Double-Blind Phase|Lost to Follow-up|9|||
156750073|NCT02815267|565836938|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
156750074|NCT02815267|565836939|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
156750075|NCT02815267|565836938|FG000|Double-Blind Phase|Protocol Violation|3|||
156750076|NCT02815267|565836939|FG001|Double-Blind Phase|Protocol Violation|2|||
156750077|NCT02815267|565836938|FG000|Double-Blind Phase|Site withdrawal|1|||
156750078|NCT02815267|565836939|FG001|Double-Blind Phase|Site withdrawal|6|||
156750079|NCT02815267|565836938|FG000|Double-Blind Phase|Received a disallowed medication|1|||
156750080|NCT02815267|565836939|FG001|Double-Blind Phase|Received a disallowed medication|1|||
156750081|NCT02815267|565836938|FG000|Open-Label Phase|Adverse Event|1|||
156750082|NCT02815267|565836939|FG001|Open-Label Phase|Adverse Event|1|||
156750083|NCT02815267|565836938|FG000|Open-Label Phase|Lost to Follow-up|23|||
156750084|NCT02815267|565836939|FG001|Open-Label Phase|Lost to Follow-up|9|||
156750085|NCT02815267|565836938|FG000|Open-Label Phase|Withdrawal by Subject|24|||
156750086|NCT02815267|565836939|FG001|Open-Label Phase|Withdrawal by Subject|13|||
156750087|NCT02815267|565836938|FG000|Open-Label Phase|Protocol Violation|0|||
156750088|NCT02815267|565836939|FG001|Open-Label Phase|Protocol Violation|1|||
156750089|NCT02815267|565836938|FG000|Open-Label Phase|Administrative|21|||
156750090|NCT02815267|565836939|FG001|Open-Label Phase|Administrative|12|||
156750091|NCT02815267|565836938|FG000|Open-Label Phase|Other|2|||
156750092|NCT02815267|565836939|FG001|Open-Label Phase|Other|5|||
156750093|NCT02769312|565836940|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
156750094|NCT02769312|565836941|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
156750095|NCT02769312|565836940|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
156750096|NCT02769312|565836941|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
156750097|NCT02769312|565836940|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
156750098|NCT02769312|565836941|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
156750099|NCT02769312|565836940|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
156750100|NCT02769312|565836941|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
156750101|NCT02769312|565836940|FG000|Follow-up|Lost to Follow-up|1|||
156750102|NCT02769312|565836941|FG001|Follow-up|Lost to Follow-up|1|||
156750103|NCT04126317|565836942|FG000|Overall Study|Adverse Event|0|||
156750104|NCT04126317|565836943|FG001|Overall Study|Adverse Event|1|||
156750105|NCT04126317|565836942|FG000|Overall Study|Withdrawal by Subject|4|||
156750106|NCT04126317|565836943|FG001|Overall Study|Withdrawal by Subject|1|||
156750107|NCT00948922|565836946|FG000|Overall Study|Did not start study treatment|2|||
156750108|NCT00948922|565836947|FG001|Overall Study|Did not start study treatment|5|||
157206084|NCT01610284|567498085|FG001|Treatment Phase|Physician Decision|24|||
156750109|NCT00948922|565836948|FG002|Overall Study|Did not start study treatment|0|||
156750110|NCT00948922|565836946|FG000|Overall Study|Withdrawal by Subject|0|||
156750111|NCT00948922|565836947|FG001|Overall Study|Withdrawal by Subject|2|||
156750112|NCT00948922|565836948|FG002|Overall Study|Withdrawal by Subject|1|||
156750113|NCT00948922|565836946|FG000|Overall Study|Death|3|||
156750114|NCT00948922|565836947|FG001|Overall Study|Death|0|||
156750115|NCT00948922|565836948|FG002|Overall Study|Death|0|||
156750116|NCT00948922|565836946|FG000|Overall Study|Disease progression|0|||
156750117|NCT00948922|565836947|FG001|Overall Study|Disease progression|1|||
156750118|NCT00948922|565836948|FG002|Overall Study|Disease progression|0|||
156750119|NCT00948922|565836946|FG000|Overall Study|Insurance issues|1|||
156750120|NCT00948922|565836947|FG001|Overall Study|Insurance issues|0|||
156750121|NCT00948922|565836948|FG002|Overall Study|Insurance issues|0|||
156750122|NCT00948922|565836946|FG000|Overall Study|Transplant eligibility issues|2|||
156750123|NCT00948922|565836947|FG001|Overall Study|Transplant eligibility issues|3|||
156750124|NCT00948922|565836948|FG002|Overall Study|Transplant eligibility issues|0|||
156750125|NCT00948922|565836946|FG000|Overall Study|Not evaluable at time of analysis|0|||
156750126|NCT00948922|565836947|FG001|Overall Study|Not evaluable at time of analysis|3|||
156750127|NCT00948922|565836948|FG002|Overall Study|Not evaluable at time of analysis|0|||
156750128|NCT04854057|565836949|FG000|Overall Study|Adverse Event|0|||
156750129|NCT04854057|565836950|FG001|Overall Study|Adverse Event|1|||
156750130|NCT02131233|565836951|FG000|Overall Study|Not Treated|2|||
156750131|NCT02131233|565836952|FG001|Overall Study|Not Treated|3|||
156750132|NCT02131233|565836951|FG000|Overall Study|Adverse Event|7|||
156750133|NCT02131233|565836952|FG001|Overall Study|Adverse Event|6|||
156750134|NCT02131233|565836951|FG000|Overall Study|Death|0|||
156750135|NCT02131233|565836952|FG001|Overall Study|Death|1|||
156750136|NCT02131233|565836951|FG000|Overall Study|Lack of Efficacy|6|||
156750137|NCT02131233|565836952|FG001|Overall Study|Lack of Efficacy|3|||
156750138|NCT02131233|565836951|FG000|Overall Study|Lost to Follow-up|14|||
156750139|NCT02131233|565836952|FG001|Overall Study|Lost to Follow-up|13|||
156750140|NCT02131233|565836951|FG000|Overall Study|Non-Compliance With Study Drug|8|||
156750141|NCT02131233|565836952|FG001|Overall Study|Non-Compliance With Study Drug|5|||
156750142|NCT02131233|565836951|FG000|Overall Study|Physician Decision|7|||
156750143|NCT02131233|565836952|FG001|Overall Study|Physician Decision|0|||
156750144|NCT02131233|565836951|FG000|Overall Study|Pregnancy|4|||
156750145|NCT02131233|565836952|FG001|Overall Study|Pregnancy|0|||
156750146|NCT02131233|565836951|FG000|Overall Study|Withdrawal by Subject|18|||
156750147|NCT02131233|565836952|FG001|Overall Study|Withdrawal by Subject|11|||
156750148|NCT05114564|565836954|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
156750149|NCT05114564|565836955|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
156750150|NCT05114564|565836954|FG000|First Intervention|Adverse Event|0|||
156750151|NCT05114564|565836955|FG001|First Intervention|Adverse Event|1|||
156750152|NCT00339833|565836964|FG000|Overall Study|Withdrawal by Subject|1|||
156750153|NCT00339833|565836965|FG001|Overall Study|Withdrawal by Subject|2|||
156750154|NCT00339833|565836964|FG000|Overall Study|toothache|0|||
156750155|NCT00339833|565836965|FG001|Overall Study|toothache|1|||
156750156|NCT00339833|565836964|FG000|Overall Study|indigestion|0|||
156750157|NCT00339833|565836965|FG001|Overall Study|indigestion|1|||
156750158|NCT00339833|565836964|FG000|Overall Study|Chest pain|0|||
156750159|NCT00339833|565836965|FG001|Overall Study|Chest pain|1|||
156750160|NCT00339833|565836964|FG000|Overall Study|minor infection|0|||
156750161|NCT00339833|565836965|FG001|Overall Study|minor infection|1|||
156750162|NCT00339833|565836964|FG000|Overall Study|Poor venous access|2|||
156750163|NCT00339833|565836965|FG001|Overall Study|Poor venous access|2|||
156750164|NCT00339833|565836964|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
156750165|NCT00339833|565836965|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
156750166|NCT00339833|565836964|FG000|Overall Study|Error in data records|1|||
156750167|NCT00339833|565836965|FG001|Overall Study|Error in data records|0|||
156750168|NCT00217581|565836966|FG000|Overall Study|Withdrawal by Subject|1|||
156750169|NCT02829047|565836967|FG000|Overall Study|Withdrawal by Subject|1|||
156750170|NCT01597492|565836987|FG000|Overall Study|Withdrawal by Subject|1|||
156750171|NCT01597492|565836988|FG001|Overall Study|Withdrawal by Subject|2|||
156750172|NCT01597492|565836987|FG000|Overall Study|Adverse Event|3|||
156750173|NCT01597492|565836988|FG001|Overall Study|Adverse Event|0|||
156750174|NCT01597492|565836987|FG000|Overall Study|Lost to Follow-up|0|||
157092068|NCT04494256|567091525|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
156750175|NCT01597492|565836988|FG001|Overall Study|Lost to Follow-up|2|||
156750176|NCT01597492|565836987|FG000|Overall Study|Other Reason|2|||
156750177|NCT01597492|565836988|FG001|Overall Study|Other Reason|0|||
156750178|NCT02570750|565836989|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
157092069|NCT04494256|567091526|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
156750179|NCT02570750|565836990|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
156750180|NCT02570750|565836989|FG000|Overall Study|Protocol deviation|4|||
156750181|NCT02570750|565836990|FG001|Overall Study|Protocol deviation|2|||
156750182|NCT02570750|565836989|FG000|Overall Study|Withdrawal by Subject|5|||
156750183|NCT02570750|565836990|FG001|Overall Study|Withdrawal by Subject|0|||
156750184|NCT02570750|565836989|FG000|Overall Study|Lost to Follow-up|2|||
156750185|NCT02570750|565836990|FG001|Overall Study|Lost to Follow-up|2|||
156750186|NCT02570750|565836989|FG000|Overall Study|Adverse Event|2|||
156750187|NCT02570750|565836990|FG001|Overall Study|Adverse Event|1|||
156750188|NCT01410240|565836991|FG000|Overall Study|Physician Decision|0|||
157206085|NCT01610284|567498084|FG000|Treatment Phase|Progressive Disease|377|||
157206086|NCT01610284|567498085|FG001|Treatment Phase|Progressive Disease|486|||
156750189|NCT01410240|565836992|FG001|Overall Study|Physician Decision|0|||
156750190|NCT01410240|565836993|FG002|Overall Study|Physician Decision|1|||
156750191|NCT01410240|565836991|FG000|Overall Study|Missed week 6 assessments|1|||
156750192|NCT01410240|565836992|FG001|Overall Study|Missed week 6 assessments|1|||
156750193|NCT01410240|565836993|FG002|Overall Study|Missed week 6 assessments|1|||
156750194|NCT00496587|565836994|FG000|Overall Study|Adverse Event|2|||
156750195|NCT00496587|565836994|FG000|Overall Study|Progressive Disease|24|||
156750196|NCT00496587|565836994|FG000|Overall Study|Withdrawal by Subject|2|||
156750197|NCT00496587|565836994|FG000|Overall Study|Death|1|||
156750198|NCT00496587|565836994|FG000|Overall Study|Complications unrelated|2|||
156750199|NCT00482170|565836995|FG000|Overall Study|Adverse Event|5|||
156750200|NCT00482170|565836996|FG001|Overall Study|Adverse Event|14|||
156750201|NCT00482170|565836995|FG000|Overall Study|Withdrawal by Subject|6|||
156750202|NCT00482170|565836996|FG001|Overall Study|Withdrawal by Subject|1|||
156750203|NCT00482170|565836995|FG000|Overall Study|Protocol Violation|2|||
156750204|NCT00482170|565836996|FG001|Overall Study|Protocol Violation|3|||
156750205|NCT00482170|565836995|FG000|Overall Study|Lost to Follow-up|2|||
156750206|NCT00482170|565836996|FG001|Overall Study|Lost to Follow-up|0|||
156750207|NCT00482170|565836995|FG000|Overall Study|Unspecified reason|0|||
156750208|NCT00482170|565836996|FG001|Overall Study|Unspecified reason|2|||
156750209|NCT01134263|565836997|FG000|Overall Study|Serious adverse event|2|||
156750210|NCT01134263|565836998|FG001|Overall Study|Serious adverse event|1|||
156750211|NCT01134263|565836999|FG002|Overall Study|Serious adverse event|1|||
156750212|NCT01134263|565837000|FG003|Overall Study|Serious adverse event|1|||
156750213|NCT01134263|565837001|FG004|Overall Study|Serious adverse event|1|||
156750214|NCT01134263|565836997|FG000|Overall Study|Other adverse event|1|||
156750215|NCT01134263|565836998|FG001|Overall Study|Other adverse event|2|||
156750216|NCT01134263|565836999|FG002|Overall Study|Other adverse event|5|||
156750217|NCT01134263|565837000|FG003|Overall Study|Other adverse event|3|||
156750218|NCT01134263|565837001|FG004|Overall Study|Other adverse event|0|||
156750219|NCT01134263|565836997|FG000|Overall Study|Protocol Violation|8|||
156750220|NCT01134263|565836998|FG001|Overall Study|Protocol Violation|7|||
156750221|NCT01134263|565836999|FG002|Overall Study|Protocol Violation|2|||
156750222|NCT01134263|565837000|FG003|Overall Study|Protocol Violation|4|||
156750223|NCT01134263|565837001|FG004|Overall Study|Protocol Violation|2|||
156750224|NCT01134263|565836997|FG000|Overall Study|Lost to Follow-up|4|||
156750225|NCT01134263|565836998|FG001|Overall Study|Lost to Follow-up|3|||
156750226|NCT01134263|565836999|FG002|Overall Study|Lost to Follow-up|5|||
156750227|NCT01134263|565837000|FG003|Overall Study|Lost to Follow-up|3|||
156750228|NCT01134263|565837001|FG004|Overall Study|Lost to Follow-up|1|||
156750229|NCT01134263|565836997|FG000|Overall Study|Withdrawal by Subject|8|||
156750230|NCT01134263|565836998|FG001|Overall Study|Withdrawal by Subject|6|||
156750231|NCT01134263|565836999|FG002|Overall Study|Withdrawal by Subject|16|||
156750232|NCT01134263|565837000|FG003|Overall Study|Withdrawal by Subject|7|||
156750233|NCT01134263|565837001|FG004|Overall Study|Withdrawal by Subject|5|||
156750234|NCT01134263|565836997|FG000|Overall Study|Enrolled, but not treated|1|||
156750235|NCT01134263|565836998|FG001|Overall Study|Enrolled, but not treated|1|||
156750236|NCT01134263|565836999|FG002|Overall Study|Enrolled, but not treated|0|||
156750237|NCT01134263|565837000|FG003|Overall Study|Enrolled, but not treated|1|||
156750238|NCT01134263|565837001|FG004|Overall Study|Enrolled, but not treated|0|||
156750239|NCT01557517|565837002|FG000|Overall Study|Death|1|||
156750240|NCT01557517|565837003|FG001|Overall Study|Death|0|||
156750241|NCT01557517|565837002|FG000|Overall Study|Refused further treatment|0|||
156750242|NCT01557517|565837003|FG001|Overall Study|Refused further treatment|2|||
156750243|NCT01557517|565837002|FG000|Overall Study|Adverse Event|0|||
156750244|NCT01557517|565837003|FG001|Overall Study|Adverse Event|2|||
156750245|NCT01557517|565837002|FG000|Overall Study|Pt declined before treatment started|1|||
156750246|NCT01557517|565837003|FG001|Overall Study|Pt declined before treatment started|0|||
156750247|NCT00162097|565837004|FG000|Overall Study|Participant no longer met study criteria|0|||
156750248|NCT00162097|565837005|FG001|Overall Study|Participant no longer met study criteria|0|||
156750249|NCT00162097|565837006|FG002|Overall Study|Participant no longer met study criteria|0|||
156750250|NCT00162097|565837007|FG003|Overall Study|Participant no longer met study criteria|1|||
156750251|NCT01204918|565837008|FG000|Overall Study|Withdrawal by Subject|4|||
156864139|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
157206087|NCT01610284|567498084|FG000|Treatment Phase|Protocol Deviation|2|||
156750252|NCT01204918|565837009|FG001|Overall Study|Withdrawal by Subject|10|||
156750253|NCT01204918|565837010|FG002|Overall Study|Withdrawal by Subject|5|||
156750254|NCT03585712|565837013|FG000|Treatment Period 1|Protocol Violation|1|||
156750255|NCT03585712|565837014|FG001|Treatment Period 1|Protocol Violation|0|||
156750256|NCT03585712|565837015|FG002|Treatment Period 1|Protocol Violation|0|||
156750257|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
156750258|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
156750259|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
156750260|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
156750261|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
156750262|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
156750263|NCT03585712|565837013|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
156750264|NCT03585712|565837014|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
156750265|NCT03585712|565837015|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
156750266|NCT03517449|565837018|FG000|Overall Study|Death|184|||
156750267|NCT03517449|565837019|FG001|Overall Study|Death|236|||
156750268|NCT03517449|565837018|FG000|Overall Study|Lost to Follow-up|0|||
156750269|NCT03517449|565837019|FG001|Overall Study|Lost to Follow-up|2|||
156750270|NCT03517449|565837018|FG000|Overall Study|Withdrawal by Subject|7|||
156750271|NCT03517449|565837019|FG001|Overall Study|Withdrawal by Subject|26|||
156750272|NCT03517449|565837018|FG000|Overall Study|Participants Ongoing|220|||
156750273|NCT03517449|565837019|FG001|Overall Study|Participants Ongoing|152|||
156750274|NCT01280682|565837028|FG000|Overall Study|Lost to Follow-up|0|||
156750275|NCT01280682|565837029|FG001|Overall Study|Lost to Follow-up|6|||
156750276|NCT01280682|565837028|FG000|Overall Study|Withdrawal by Subject|0|||
156750277|NCT01280682|565837029|FG001|Overall Study|Withdrawal by Subject|7|||
156750278|NCT00269477|565837035|FG000|Overall Study|Protocol Violation|5|||
156750279|NCT00269477|565837036|FG001|Overall Study|Protocol Violation|5|||
156750280|NCT00269477|565837037|FG002|Overall Study|Protocol Violation|1|||
156750281|NCT00269477|565837038|FG003|Overall Study|Protocol Violation|0|||
156750282|NCT00269477|565837035|FG000|Overall Study|Missed post-vaccination blood draw|0|||
156750283|NCT00269477|565837036|FG001|Overall Study|Missed post-vaccination blood draw|1|||
156750284|NCT00269477|565837037|FG002|Overall Study|Missed post-vaccination blood draw|0|||
156750285|NCT00269477|565837038|FG003|Overall Study|Missed post-vaccination blood draw|0|||
156750286|NCT00431067|565837039|FG000|Overall Study|Other Adverse Event|9|||
156750287|NCT00431067|565837039|FG000|Overall Study|Progressive disease|30|||
156750288|NCT00431067|565837039|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
156750289|NCT00548249|565837040|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
156750290|NCT00548249|565837041|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750291|NCT00548249|565837042|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750292|NCT00548249|565837043|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
156750293|NCT00548249|565837044|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
156750294|NCT00548249|565837040|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
156750295|NCT00548249|565837041|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
156750296|NCT00548249|565837042|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
156750297|NCT00548249|565837043|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
156750298|NCT00548249|565837044|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
156750299|NCT00548249|565837040|FG000|Overall Study|Protocol Violation|1|||
156750300|NCT00548249|565837041|FG001|Overall Study|Protocol Violation|1|||
156750301|NCT00548249|565837042|FG002|Overall Study|Protocol Violation|4|||
156750302|NCT00548249|565837043|FG003|Overall Study|Protocol Violation|0|||
156750303|NCT00548249|565837044|FG004|Overall Study|Protocol Violation|3|||
156750304|NCT00548249|565837040|FG000|Overall Study|Miscellaneous|2|||
156750305|NCT00548249|565837041|FG001|Overall Study|Miscellaneous|3|||
156750306|NCT00548249|565837042|FG002|Overall Study|Miscellaneous|2|||
156750307|NCT00548249|565837043|FG003|Overall Study|Miscellaneous|0|||
156750308|NCT00548249|565837044|FG004|Overall Study|Miscellaneous|2|||
156750309|NCT00548249|565837040|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
156750310|NCT00548249|565837041|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
156750311|NCT00548249|565837042|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
156750312|NCT00548249|565837043|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
156750313|NCT00548249|565837044|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
156750314|NCT00548249|565837040|FG000|Overall Study|Adverse Event|2|||
156750315|NCT00548249|565837041|FG001|Overall Study|Adverse Event|2|||
156750316|NCT00548249|565837042|FG002|Overall Study|Adverse Event|0|||
156750317|NCT00548249|565837043|FG003|Overall Study|Adverse Event|1|||
156750318|NCT00548249|565837044|FG004|Overall Study|Adverse Event|1|||
156750319|NCT00548249|565837040|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
156750320|NCT00548249|565837041|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
156750321|NCT00548249|565837042|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
156750322|NCT00548249|565837043|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
156750323|NCT00548249|565837044|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
156864140|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
156864141|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864142|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864143|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
156864144|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864145|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
156864146|NCT03253796|566260870|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
156750324|NCT00548249|565837040|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
156750325|NCT00548249|565837041|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
156750326|NCT00548249|565837042|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
156750327|NCT00548249|565837043|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
156750328|NCT00548249|565837044|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
156750329|NCT00548249|565837040|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750330|NCT00548249|565837041|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750331|NCT00548249|565837042|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156864147|NCT03253796|566260871|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
156864148|NCT03253796|566260872|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
156864149|NCT03253796|566260873|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
156864150|NCT03253796|566260874|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
156864151|NCT03253796|566260870|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864152|NCT03253796|566260871|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864153|NCT03253796|566260872|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864154|NCT03253796|566260873|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
156864155|NCT03253796|566260874|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
156864156|NCT00231816|566260875|FG000|Overall Study|Adverse Event|1|||
156864157|NCT00231816|566260876|FG001|Overall Study|Adverse Event|0|||
156864158|NCT00231816|566260875|FG000|Overall Study|Lost to Follow-up|8|||
156864159|NCT00231816|566260876|FG001|Overall Study|Lost to Follow-up|5|||
156864160|NCT00231816|566260875|FG000|Overall Study|Protocol Violation|2|||
156864161|NCT00231816|566260876|FG001|Overall Study|Protocol Violation|3|||
156864162|NCT00231816|566260875|FG000|Overall Study|Withdrawal by Subject|3|||
156864163|NCT00231816|566260876|FG001|Overall Study|Withdrawal by Subject|3|||
156864164|NCT00231816|566260875|FG000|Overall Study|Other|2|||
156864165|NCT00231816|566260876|FG001|Overall Study|Other|1|||
156864166|NCT01075243|566260877|FG000|Overall Study|Lost to Follow-up|5|||
156864167|NCT01075243|566260878|FG001|Overall Study|Lost to Follow-up|2|||
156864168|NCT01075243|566260879|FG002|Overall Study|Lost to Follow-up|0|||
156864169|NCT01075243|566260877|FG000|Overall Study|Withdrawal by Subject|1|||
156864170|NCT01075243|566260878|FG001|Overall Study|Withdrawal by Subject|1|||
156864171|NCT01075243|566260879|FG002|Overall Study|Withdrawal by Subject|0|||
156864172|NCT00551642|566260880|FG000|Treatment Period|Protocol Deviation|6|||
156864173|NCT00551642|566260881|FG001|Treatment Period|Protocol Deviation|11|||
156864174|NCT00551642|566260880|FG000|Treatment Period|Delivery device failure|1|||
156864175|NCT00551642|566260881|FG001|Treatment Period|Delivery device failure|3|||
156864176|NCT00551642|566260880|FG000|Treatment Period|Physician Decision|0|||
156864177|NCT00551642|566260881|FG001|Treatment Period|Physician Decision|1|||
156864178|NCT00551642|566260880|FG000|Treatment Period|Death|33|||
156864179|NCT00551642|566260881|FG001|Treatment Period|Death|31|||
157092070|NCT04494256|567091520|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156864180|NCT00551642|566260880|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
156864181|NCT00551642|566260881|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
156864182|NCT00551642|566260880|FG000|Treatment Period|Adverse Event|15|||
156864183|NCT00551642|566260881|FG001|Treatment Period|Adverse Event|12|||
156864184|NCT00551642|566260880|FG000|Treatment Period|Withdrawal by Subject|2|||
156864185|NCT00551642|566260881|FG001|Treatment Period|Withdrawal by Subject|1|||
156864186|NCT03337308|566260882|FG000|Overall Study|Adverse Event|2|||
156864187|NCT03337308|566260883|FG001|Overall Study|Adverse Event|3|||
156864188|NCT03337308|566260884|FG002|Overall Study|Adverse Event|3|||
156864189|NCT03337308|566260885|FG003|Overall Study|Adverse Event|1|||
156864190|NCT03337308|566260882|FG000|Overall Study|Lost to Follow-up|1|||
156864191|NCT03337308|566260883|FG001|Overall Study|Lost to Follow-up|2|||
156864192|NCT03337308|566260884|FG002|Overall Study|Lost to Follow-up|0|||
156864193|NCT03337308|566260885|FG003|Overall Study|Lost to Follow-up|0|||
156864194|NCT03337308|566260882|FG000|Overall Study|Withdrawal by Subject|2|||
156864195|NCT03337308|566260883|FG001|Overall Study|Withdrawal by Subject|1|||
156864196|NCT03337308|566260884|FG002|Overall Study|Withdrawal by Subject|2|||
156864197|NCT03337308|566260885|FG003|Overall Study|Withdrawal by Subject|1|||
156864198|NCT03337308|566260882|FG000|Overall Study|Protocol Violation|0|||
156864199|NCT03337308|566260883|FG001|Overall Study|Protocol Violation|1|||
156864200|NCT03337308|566260884|FG002|Overall Study|Protocol Violation|0|||
156864201|NCT03337308|566260885|FG003|Overall Study|Protocol Violation|0|||
156864202|NCT03558737|566260886|FG000|Overall Study|Death|1|||
156864203|NCT03558737|566260887|FG001|Overall Study|Death|1|||
156864204|NCT00005780|566260890|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
156864205|NCT04973449|566260891|FG000|Overall Study|Withdrawal by Subject|3|||
156864206|NCT04973449|566260892|FG001|Overall Study|Withdrawal by Subject|3|||
156864207|NCT04973449|566260893|FG002|Overall Study|Withdrawal by Subject|2|||
156864208|NCT04973449|566260894|FG003|Overall Study|Withdrawal by Subject|5|||
157092071|NCT04494256|567091521|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
156864209|NCT04973449|566260895|FG004|Overall Study|Withdrawal by Subject|5|||
156864210|NCT04973449|566260896|FG005|Overall Study|Withdrawal by Subject|4|||
156864211|NCT04973449|566260897|FG006|Overall Study|Withdrawal by Subject|7|||
156864212|NCT04973449|566260898|FG007|Overall Study|Withdrawal by Subject|5|||
156864213|NCT04973449|566260891|FG000|Overall Study|Lost to Follow-up|15|||
156864214|NCT04973449|566260892|FG001|Overall Study|Lost to Follow-up|16|||
156864215|NCT04973449|566260893|FG002|Overall Study|Lost to Follow-up|16|||
156864216|NCT04973449|566260894|FG003|Overall Study|Lost to Follow-up|13|||
156864217|NCT04973449|566260895|FG004|Overall Study|Lost to Follow-up|5|||
156864218|NCT04973449|566260896|FG005|Overall Study|Lost to Follow-up|6|||
156864219|NCT04973449|566260897|FG006|Overall Study|Lost to Follow-up|10|||
156864220|NCT04973449|566260898|FG007|Overall Study|Lost to Follow-up|6|||
156864221|NCT04973449|566260891|FG000|Overall Study|Death|1|||
156864222|NCT04973449|566260892|FG001|Overall Study|Death|0|||
156864223|NCT04973449|566260893|FG002|Overall Study|Death|0|||
156864224|NCT04973449|566260894|FG003|Overall Study|Death|0|||
156864225|NCT04973449|566260895|FG004|Overall Study|Death|0|||
156864226|NCT04973449|566260896|FG005|Overall Study|Death|1|||
156864227|NCT04973449|566260897|FG006|Overall Study|Death|0|||
156864228|NCT04973449|566260898|FG007|Overall Study|Death|0|||
156864229|NCT04973449|566260891|FG000|Overall Study|Other|1|||
156864230|NCT04973449|566260892|FG001|Overall Study|Other|1|||
156978001|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
156978002|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
156978003|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
156978004|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
156978005|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
156978006|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
156978007|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
156978008|NCT02307513|566673680|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
156978009|NCT02307513|566673681|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
156978010|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
156978011|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
156978012|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
156750332|NCT00548249|565837043|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
156750333|NCT00548249|565837044|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
156750334|NCT00548249|565837040|FG000|Overall Study|Prolonged hospitalization|0|||
156750335|NCT00548249|565837041|FG001|Overall Study|Prolonged hospitalization|0|||
156750336|NCT00548249|565837042|FG002|Overall Study|Prolonged hospitalization|2|||
156750337|NCT00548249|565837043|FG003|Overall Study|Prolonged hospitalization|1|||
156750338|NCT00548249|565837044|FG004|Overall Study|Prolonged hospitalization|0|||
156750339|NCT00548249|565837040|FG000|Overall Study|Withdrawal by Subject|2|||
156750340|NCT00548249|565837041|FG001|Overall Study|Withdrawal by Subject|0|||
156750341|NCT00548249|565837042|FG002|Overall Study|Withdrawal by Subject|0|||
156750342|NCT00548249|565837043|FG003|Overall Study|Withdrawal by Subject|0|||
156750343|NCT00548249|565837044|FG004|Overall Study|Withdrawal by Subject|0|||
156750344|NCT00548249|565837040|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750345|NCT00548249|565837041|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
156750346|NCT00548249|565837042|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750347|NCT00548249|565837043|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
156750348|NCT00548249|565837044|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
156750349|NCT00548249|565837040|FG000|Overall Study|Sponsor's request|0|||
156750350|NCT00548249|565837041|FG001|Overall Study|Sponsor's request|0|||
156750351|NCT00548249|565837042|FG002|Overall Study|Sponsor's request|0|||
156750352|NCT00548249|565837043|FG003|Overall Study|Sponsor's request|1|||
156750353|NCT00548249|565837044|FG004|Overall Study|Sponsor's request|0|||
156750354|NCT03760458|565837046|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
156750355|NCT03760458|565837047|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
156750356|NCT03760458|565837048|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750357|NCT03760458|565837049|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750358|NCT03760458|565837050|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
156750359|NCT00750919|565837051|FG000|Overall Study|Adverse Event|9|||
156750360|NCT00750919|565837051|FG000|Overall Study|Withdrawal by Subject|1|||
156750361|NCT00750919|565837051|FG000|Overall Study|Lack of Efficacy|8|||
156750362|NCT00750919|565837051|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
156750363|NCT00750919|565837051|FG000|Overall Study|Other|36|||
156750364|NCT02886884|565837066|FG000|Follow-up|Withdrawal by Subject|0|||
156750365|NCT02886884|565837067|FG001|Follow-up|Withdrawal by Subject|0|||
156750366|NCT02886884|565837068|FG002|Follow-up|Withdrawal by Subject|0|||
156750367|NCT02886884|565837069|FG003|Follow-up|Withdrawal by Subject|1|||
156750368|NCT01573754|565837070|FG000|Overall Study|Noncompliance or remission not achieved|3|||
156750369|NCT01573754|565837071|FG001|Overall Study|Noncompliance or remission not achieved|15|||
156808566|NCT01070979|566052715|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
156864231|NCT04973449|566260893|FG002|Overall Study|Other|2|||
156978013|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
156750370|NCT04227405|565838802|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
156750371|NCT04227405|565838803|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
156750372|NCT04227405|565838802|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
156750373|NCT04227405|565838803|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
156750374|NCT04227405|565838802|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
156750375|NCT04227405|565838803|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
156750376|NCT03396822|565838806|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
156750377|NCT03396822|565838806|FG000|Overall Study|Physician Decision|1|||
156750378|NCT04985942|565838807|FG000|Overall Study|Adverse Event|14|||
156750379|NCT04985942|565838808|FG001|Overall Study|Adverse Event|2|||
156750380|NCT04985942|565838807|FG000|Overall Study|Lack of Efficacy|0|||
156750381|NCT04985942|565838808|FG001|Overall Study|Lack of Efficacy|3|||
156750382|NCT04985942|565838807|FG000|Overall Study|Lost to Follow-up|1|||
156750383|NCT04985942|565838808|FG001|Overall Study|Lost to Follow-up|1|||
156864232|NCT04973449|566260894|FG003|Overall Study|Other|1|||
156864233|NCT04973449|566260895|FG004|Overall Study|Other|4|||
156864234|NCT04973449|566260896|FG005|Overall Study|Other|0|||
156864235|NCT04973449|566260897|FG006|Overall Study|Other|2|||
156864236|NCT04973449|566260898|FG007|Overall Study|Other|2|||
156864237|NCT01488890|566260899|FG000|Overall Study|Serious adverse event|2|||
156864238|NCT01488890|566260900|FG001|Overall Study|Serious adverse event|0|||
156864239|NCT01488890|566260901|FG002|Overall Study|Serious adverse event|0|||
156750384|NCT04985942|565838807|FG000|Overall Study|Protocol Violation|1|||
156750385|NCT04985942|565838808|FG001|Overall Study|Protocol Violation|1|||
156750386|NCT04985942|565838807|FG000|Overall Study|Withdrawal by Subject|5|||
156750387|NCT04985942|565838808|FG001|Overall Study|Withdrawal by Subject|4|||
156750388|NCT00171158|565838809|FG000|Core Study|Death|27|||
156750389|NCT00171158|565838809|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
156750390|NCT00171158|565838809|FG000|Core Study|Protocol Violation|4|||
156750391|NCT00171158|565838809|FG000|Core Study|Administrative problems|1|||
156750392|NCT00171158|565838809|FG000|Core Study|Adverse event, non-fatal|21|||
156750393|NCT00171158|565838809|FG000|Core Study|Consent withdrawn by subject|6|||
156864240|NCT01488890|566260902|FG003|Overall Study|Serious adverse event|0|||
156864241|NCT01488890|566260899|FG000|Overall Study|Protocol Violation|3|||
156864242|NCT01488890|566260900|FG001|Overall Study|Protocol Violation|0|||
156864243|NCT01488890|566260901|FG002|Overall Study|Protocol Violation|4|||
156864244|NCT01488890|566260902|FG003|Overall Study|Protocol Violation|0|||
156864245|NCT01488890|566260899|FG000|Overall Study|Lost to Follow-up|13|||
156864246|NCT01488890|566260900|FG001|Overall Study|Lost to Follow-up|10|||
156864247|NCT01488890|566260901|FG002|Overall Study|Lost to Follow-up|20|||
156864248|NCT01488890|566260902|FG003|Overall Study|Lost to Follow-up|3|||
156864249|NCT01488890|566260899|FG000|Overall Study|Withdrawal by Subject|14|||
156864250|NCT01488890|566260900|FG001|Overall Study|Withdrawal by Subject|10|||
156864251|NCT01488890|566260901|FG002|Overall Study|Withdrawal by Subject|11|||
156864252|NCT01488890|566260902|FG003|Overall Study|Withdrawal by Subject|2|||
156864253|NCT05712460|566260903|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864254|NCT05712460|566260904|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864255|NCT05712460|566260905|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864256|NCT05712460|566260906|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864257|NCT05712460|566260907|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864258|NCT05712460|566260908|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864259|NCT05712460|566260909|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864260|NCT05712460|566260910|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
156864261|NCT05712460|566260911|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864262|NCT05712460|566260912|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864263|NCT05712460|566260913|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864264|NCT05712460|566260914|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
156864265|NCT05135767|566260918|FG000|Baseline|Lost to Follow-up|1|||
156864266|NCT05135767|566260919|FG001|Baseline|Lost to Follow-up|1|||
156864267|NCT05135767|566260918|FG000|Baseline|Withdrawal by Subject|0|||
156750394|NCT00171158|565838809|FG000|Core Study|No longer required drug (BMT)|14|||
156750395|NCT00171158|565838809|FG000|Core Study|Abnormal Laboratory Values|2|||
156750396|NCT00171158|565838809|FG000|Core Study|Lost to Follow-up|1|||
156750397|NCT00171158|565838809|FG000|E2 Extension|Other|7|||
156750398|NCT03630705|565838814|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
156750399|NCT03630705|565838815|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
156750400|NCT03630705|565838816|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156750401|NCT03630705|565838817|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156750402|NCT03630705|565838814|FG000|Overall Study|Lost to Follow-up|1|||
156750403|NCT03630705|565838815|FG001|Overall Study|Lost to Follow-up|2|||
156750404|NCT03630705|565838816|FG002|Overall Study|Lost to Follow-up|0|||
156750405|NCT03630705|565838817|FG003|Overall Study|Lost to Follow-up|0|||
156750406|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
156750407|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750408|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
156750409|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750410|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156864268|NCT05135767|566260919|FG001|Baseline|Withdrawal by Subject|2|||
156864269|NCT05135767|566260918|FG000|Active Study Phase|Lost to Follow-up|2|||
156864270|NCT05135767|566260919|FG001|Active Study Phase|Lost to Follow-up|0|||
156864271|NCT02694185|566260920|FG000|Overall Study|Withdrawal by Subject|45|||
156864272|NCT02694185|566260921|FG001|Overall Study|Withdrawal by Subject|0|||
156864273|NCT05082857|566260922|FG000|Overall Study|participants relocated and could not continue|2|||
156864274|NCT05082857|566260923|FG001|Overall Study|participants relocated and could not continue|1|||
156864275|NCT05082857|566260922|FG000|Overall Study|Lost to Follow-up|1|||
156864276|NCT05082857|566260923|FG001|Overall Study|Lost to Follow-up|3|||
156864277|NCT04363320|566260924|FG000|Overall Study|Lost to Follow-up|43|||
156864278|NCT04363320|566260925|FG001|Overall Study|Lost to Follow-up|42|||
156864279|NCT04363320|566260926|FG002|Overall Study|Lost to Follow-up|24|||
156864280|NCT04363320|566260927|FG003|Overall Study|Lost to Follow-up|29|||
156864281|NCT04363320|566260924|FG000|Overall Study|Death|0|||
156864282|NCT04363320|566260925|FG001|Overall Study|Death|0|||
156864283|NCT04363320|566260926|FG002|Overall Study|Death|1|||
156864284|NCT04363320|566260927|FG003|Overall Study|Death|0|||
156864285|NCT00604565|566260931|FG000|Overall Study|Study terminated|0|||
156864286|NCT00604565|566260932|FG001|Overall Study|Study terminated|3|||
156864287|NCT02260934|566260940|FG000|Overall Study|Lost to Follow-up|2|||
156864288|NCT02260934|566260941|FG001|Overall Study|Lost to Follow-up|1|||
156864289|NCT02260934|566260940|FG000|Overall Study|Withdrawal by Subject|0|||
156864290|NCT02260934|566260941|FG001|Overall Study|Withdrawal by Subject|2|||
156864291|NCT02260934|566260940|FG000|Overall Study|Participant Relocated|1|||
156864292|NCT02260934|566260941|FG001|Overall Study|Participant Relocated|0|||
156864293|NCT02260934|566260940|FG000|Overall Study|Site error|0|||
156864294|NCT02260934|566260941|FG001|Overall Study|Site error|1|||
156864295|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
156864296|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
156864297|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
156864298|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
156864299|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
156864300|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
156864301|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
156864302|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
156864303|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
156864304|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
156864305|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
156864306|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
156864307|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
156864308|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
156864309|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
156864310|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
156864311|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
156864312|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
156864313|NCT03605667|566260944|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
156864314|NCT03605667|566260945|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
156864315|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
156864316|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
156864317|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Other|6|||
156864318|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Other|8|||
156864319|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
156864320|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
156864321|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
156864322|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
156864323|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
156864324|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
156864325|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
156864326|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
156864327|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
156864328|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
156864329|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
156864330|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
156864331|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Death|0|||
156864332|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Death|2|||
156864333|NCT03605667|566260944|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
156864334|NCT03605667|566260945|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
156864335|NCT05632211|566260946|FG000|Overall Study|Withdrawal by Subject|2|||
156864336|NCT05632211|566260947|FG001|Overall Study|Withdrawal by Subject|0|||
156864337|NCT05632211|566260948|FG002|Overall Study|Withdrawal by Subject|2|||
156864338|NCT05632211|566260946|FG000|Overall Study|Other reasons|1|||
156864339|NCT05632211|566260947|FG001|Overall Study|Other reasons|1|||
156864340|NCT05632211|566260948|FG002|Overall Study|Other reasons|1|||
157221625|NCT01644890|567558453|FG000|Overall Study|Death|1|||
156750411|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750412|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750413|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750414|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750415|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
156750416|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750417|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750418|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
156750419|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750420|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750421|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750422|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750423|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750424|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750425|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
156750426|NCT02757352|565838818|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
156750427|NCT02757352|565838819|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
156750428|NCT02757352|565838820|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
156750429|NCT02757352|565838821|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750430|NCT02757352|565838822|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750431|NCT02757352|565838823|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750432|NCT02757352|565838824|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750433|NCT02757352|565838825|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750434|NCT02757352|565838826|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750435|NCT02757352|565838827|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
156750436|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750437|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
156750438|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750439|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750440|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750441|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750442|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750443|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750444|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750445|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
156750446|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750447|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156750448|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750449|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750450|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750451|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750452|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750453|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750454|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750455|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750456|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750457|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750458|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
156750459|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750460|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750461|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750462|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750463|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750464|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750465|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750466|NCT02757352|565838818|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
156750467|NCT02757352|565838819|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
156750468|NCT02757352|565838820|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
156864341|NCT02532517|566260949|FG000|Overall Study|Did not complete 24-Month visit|4|||
156864342|NCT02532517|566260949|FG000|Overall Study|Failed Angiographic eligibility|1|||
156864343|NCT02532517|566260949|FG000|Overall Study|Lost to Follow-up|4|||
156864344|NCT02532517|566260949|FG000|Overall Study|Withdrawal by Subject|4|||
156864345|NCT02532517|566260949|FG000|Overall Study|Death|4|||
156864346|NCT03312231|566260950|FG000|Overall Study|Lost to Follow-up|2|||
156864347|NCT03312231|566260951|FG001|Overall Study|Lost to Follow-up|6|||
156864348|NCT03312231|566260952|FG002|Overall Study|Lost to Follow-up|1|||
156864349|NCT03312231|566260953|FG003|Overall Study|Lost to Follow-up|3|||
156864350|NCT03312231|566260954|FG004|Overall Study|Lost to Follow-up|1|||
156864351|NCT03312231|566260950|FG000|Overall Study|Withdrawal by Subject|0|||
156864352|NCT03312231|566260951|FG001|Overall Study|Withdrawal by Subject|3|||
156864353|NCT03312231|566260952|FG002|Overall Study|Withdrawal by Subject|1|||
156864354|NCT03312231|566260953|FG003|Overall Study|Withdrawal by Subject|0|||
156864355|NCT03312231|566260954|FG004|Overall Study|Withdrawal by Subject|0|||
156864356|NCT03312231|566260950|FG000|Overall Study|Death|0|||
156864357|NCT03312231|566260951|FG001|Overall Study|Death|1|||
156864358|NCT03312231|566260952|FG002|Overall Study|Death|1|||
156864359|NCT03312231|566260953|FG003|Overall Study|Death|0|||
156864360|NCT03312231|566260954|FG004|Overall Study|Death|0|||
156864361|NCT03312231|566260950|FG000|Overall Study|Study Vaccination not Received|1|||
156864362|NCT03312231|566260951|FG001|Overall Study|Study Vaccination not Received|1|||
156864363|NCT03312231|566260952|FG002|Overall Study|Study Vaccination not Received|1|||
156864364|NCT03312231|566260953|FG003|Overall Study|Study Vaccination not Received|0|||
156864365|NCT03312231|566260954|FG004|Overall Study|Study Vaccination not Received|0|||
156864366|NCT03157830|566260955|FG000|Overall Study|Lost to Follow-up|1|||
156864367|NCT03157830|566260955|FG000|Overall Study|Withdrawal by Subject|1|||
156864368|NCT03472885|566260956|FG000|24-Week Treatment Period|Adverse Event|1|||
156883065|NCT00715910|566330923|FG004|Booster and ESFU Phase|Other|1|||
156883066|NCT00715910|566330924|FG005|Booster and ESFU Phase|Other|0|||
156883067|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156883068|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156883069|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156883070|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
156883071|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
156883072|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156883073|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156883074|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156883075|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156883076|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
156883077|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883078|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883079|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883080|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883081|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
156883082|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883083|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883084|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883085|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883086|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
156883087|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
156883088|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883089|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883090|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883091|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
156883092|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883093|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883094|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883095|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883096|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
156883097|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
157092072|NCT04494256|567091522|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
157092073|NCT04494256|567091523|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
157092074|NCT04494256|567091524|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
157092075|NCT04494256|567091525|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
157092076|NCT04494256|567091526|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
157092077|NCT04494256|567091520|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
157092078|NCT04494256|567091521|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156883098|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156883099|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
156883100|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156883101|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
156883102|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156883103|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156864369|NCT01083771|566263098|FG000|Overall Study|non-compliant|2|||
156864370|NCT01083771|566263098|FG000|Overall Study|Withdrawal by Subject|3|||
156864371|NCT01462370|566263103|FG000|Overall Study|Lack of Qualifying Event|1|||
156864372|NCT01462370|566263104|FG001|Overall Study|Lack of Qualifying Event|1|||
156864373|NCT01462370|566263103|FG000|Overall Study|Physician Decision|0|||
156864374|NCT01462370|566263104|FG001|Overall Study|Physician Decision|1|||
156864375|NCT01462370|566263103|FG000|Overall Study|Withdrawal by Subject|0|||
156864376|NCT01462370|566263104|FG001|Overall Study|Withdrawal by Subject|3|||
156864377|NCT01747876|566263105|FG000|Overall Study|Adverse Event|1|||
156864378|NCT01747876|566263106|FG001|Overall Study|Adverse Event|0|||
156864379|NCT01747876|566263107|FG002|Overall Study|Adverse Event|2|||
156864380|NCT01747876|566263105|FG000|Overall Study|Withdrawal by Subject|0|||
156864381|NCT01747876|566263106|FG001|Overall Study|Withdrawal by Subject|1|||
156864382|NCT01747876|566263107|FG002|Overall Study|Withdrawal by Subject|1|||
156864383|NCT01747876|566263105|FG000|Overall Study|Disease progression|4|||
156864384|NCT01747876|566263106|FG001|Overall Study|Disease progression|13|||
156864385|NCT01747876|566263107|FG002|Overall Study|Disease progression|8|||
156864386|NCT01747876|566263105|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
156864387|NCT01747876|566263106|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
156864388|NCT01747876|566263107|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
156864389|NCT03198715|566263110|FG000|Overall Study|Death|0|||
156864390|NCT03198715|566263111|FG001|Overall Study|Death|0|||
156864391|NCT03198715|566263112|FG002|Overall Study|Death|1|||
156864392|NCT03198715|566263113|FG003|Overall Study|Death|0|||
156864393|NCT03198715|566263114|FG004|Overall Study|Death|2|||
156864394|NCT03198715|566263110|FG000|Overall Study|Other|0|||
156864395|NCT03198715|566263111|FG001|Overall Study|Other|1|||
156864396|NCT03198715|566263112|FG002|Overall Study|Other|1|||
156864397|NCT03198715|566263113|FG003|Overall Study|Other|0|||
156864398|NCT03198715|566263114|FG004|Overall Study|Other|0|||
156864399|NCT00853307|566263115|FG000|Overall Study|Adverse Event|1|||
156864400|NCT00853307|566263116|FG001|Overall Study|Adverse Event|2|||
156864401|NCT00853307|566263115|FG000|Overall Study|Withdrawal by Subject|1|||
156864402|NCT00853307|566263116|FG001|Overall Study|Withdrawal by Subject|2|||
157092079|NCT04494256|567091522|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156864403|NCT00853307|566263115|FG000|Overall Study|Reason Not Specified|0|||
156864404|NCT00853307|566263116|FG001|Overall Study|Reason Not Specified|1|||
156864405|NCT00473564|566263117|FG000|Overall Study|robot surgery aborted in OR|23|||
156864406|NCT00914316|566263120|FG000|Phase 1|Physician Decision|4|||
156864407|NCT00914316|566263121|FG001|Phase 1|Physician Decision|0|||
156864408|NCT00914316|566263122|FG002|Phase 1|Physician Decision|1|||
156864409|NCT00914316|566263123|FG003|Phase 1|Physician Decision|2|||
156864410|NCT00914316|566263120|FG000|Phase 1|Withdrawal by Subject|0|||
156864411|NCT00914316|566263121|FG001|Phase 1|Withdrawal by Subject|2|||
156864412|NCT00914316|566263122|FG002|Phase 1|Withdrawal by Subject|4|||
156864413|NCT00914316|566263123|FG003|Phase 1|Withdrawal by Subject|0|||
156864414|NCT00914316|566263120|FG000|Phase 1|Adverse Event|1|||
156864415|NCT00914316|566263121|FG001|Phase 1|Adverse Event|0|||
156864416|NCT00914316|566263122|FG002|Phase 1|Adverse Event|0|||
156864417|NCT00914316|566263123|FG003|Phase 1|Adverse Event|0|||
156864418|NCT00914316|566263120|FG000|Phase 2|Withdrawal by Subject|1|||
156864419|NCT00914316|566263121|FG001|Phase 2|Withdrawal by Subject|0|||
156864420|NCT00914316|566263122|FG002|Phase 2|Withdrawal by Subject|1|||
156864421|NCT00914316|566263123|FG003|Phase 2|Withdrawal by Subject|0|||
156864422|NCT03131219|566263124|FG000|Initial Evaluation Period|Adverse Event|2|||
156864423|NCT03131219|566263125|FG001|Initial Evaluation Period|Adverse Event|0|||
156864424|NCT03131219|566263124|FG000|Initial Evaluation Period|Protocol Violation|1|||
156864425|NCT03131219|566263125|FG001|Initial Evaluation Period|Protocol Violation|0|||
156864426|NCT03131219|566263124|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
156864427|NCT03131219|566263125|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
156864428|NCT03131219|566263124|FG000|Initial Evaluation Period|Physician Decision|1|||
156864429|NCT03131219|566263125|FG001|Initial Evaluation Period|Physician Decision|0|||
156864430|NCT03131219|566263124|FG000|Extension Period|Physician Decision|1|||
156864431|NCT03131219|566263125|FG001|Extension Period|Physician Decision|0|||
156864432|NCT00616759|566263127|FG000|Overall Study|Physician Decision|2|||
156864433|NCT00616759|566263128|FG001|Overall Study|Physician Decision|0|||
156864434|NCT00616759|566263127|FG000|Overall Study|Withdrawal by Subject|1|||
156864435|NCT00616759|566263128|FG001|Overall Study|Withdrawal by Subject|2|||
156864436|NCT02399163|566263131|FG000|Overall Study|Adverse Event|2|||
156864437|NCT02399163|566263131|FG000|Overall Study|Protocol Deviation|2|||
157092080|NCT04494256|567091523|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
157206088|NCT01610284|567498085|FG001|Treatment Phase|Protocol Deviation|3|||
157206089|NCT01610284|567498084|FG000|Treatment Phase|Study terminated by Sponsor|18|||
156864438|NCT02399163|566263131|FG000|Overall Study|Withdrawal by Participant|5|||
156864439|NCT01391546|566263137|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
156864440|NCT01391546|566263138|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
156864441|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864442|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
156864443|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864444|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864445|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864446|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864447|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864448|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864449|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864450|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864451|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864452|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
156864453|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864454|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864455|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
156864456|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864457|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864458|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864459|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864460|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864461|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864462|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864463|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864464|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
156864465|NCT04225897|566263139|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864466|NCT04225897|566263140|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864467|NCT04225897|566263141|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
156864468|NCT04225897|566263142|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864469|NCT04225897|566263143|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864470|NCT04225897|566263144|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864471|NCT04225897|566263145|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864472|NCT04225897|566263146|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864473|NCT04225897|566263147|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864474|NCT04225897|566263148|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864475|NCT04225897|566263149|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864476|NCT04225897|566263150|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
156864477|NCT04225897|566263139|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864478|NCT04225897|566263140|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864479|NCT04225897|566263141|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864480|NCT04225897|566263142|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864481|NCT04225897|566263143|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864482|NCT04225897|566263144|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864483|NCT04225897|566263145|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864484|NCT04225897|566263146|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
156864485|NCT04225897|566263147|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864486|NCT04225897|566263148|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864487|NCT04225897|566263149|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864488|NCT04225897|566263150|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
156864489|NCT00074711|566263151|FG000|Overall Study|Withdrawal by Subject|1|||
156864490|NCT00074711|566263152|FG001|Overall Study|Withdrawal by Subject|1|||
156864491|NCT00074711|566263151|FG000|Overall Study|Lost to Follow-up|10|||
156864492|NCT00074711|566263152|FG001|Overall Study|Lost to Follow-up|8|||
156864493|NCT00074711|566263151|FG000|Overall Study|Participant stopped study drug|4|||
156864494|NCT00074711|566263152|FG001|Overall Study|Participant stopped study drug|6|||
156864495|NCT03466658|566263153|FG000|Overall Study|Withdrawal by Subject|3|||
156864496|NCT00360230|566263158|FG000|Overall Study|Withdrawal by Subject|1|||
156864497|NCT00360230|566263159|FG001|Overall Study|Withdrawal by Subject|1|||
156864498|NCT00360230|566263160|FG002|Overall Study|Withdrawal by Subject|0|||
156864499|NCT00360230|566263161|FG003|Overall Study|Withdrawal by Subject|1|||
156864500|NCT00360230|566263162|FG004|Overall Study|Withdrawal by Subject|1|||
156864501|NCT00360230|566263163|FG005|Overall Study|Withdrawal by Subject|1|||
156864502|NCT00360230|566263164|FG006|Overall Study|Withdrawal by Subject|0|||
156864503|NCT00360230|566263158|FG000|Overall Study|Migrated|4|||
156864504|NCT00360230|566263159|FG001|Overall Study|Migrated|1|||
156864505|NCT00360230|566263160|FG002|Overall Study|Migrated|3|||
156864506|NCT00360230|566263161|FG003|Overall Study|Migrated|1|||
156864507|NCT00360230|566263162|FG004|Overall Study|Migrated|4|||
156864508|NCT00360230|566263163|FG005|Overall Study|Migrated|1|||
156864509|NCT00360230|566263164|FG006|Overall Study|Migrated|1|||
156864510|NCT00360230|566263158|FG000|Overall Study|Other|1|||
156864511|NCT00360230|566263159|FG001|Overall Study|Other|0|||
156864512|NCT00360230|566263160|FG002|Overall Study|Other|0|||
156864513|NCT00360230|566263161|FG003|Overall Study|Other|0|||
156864514|NCT00360230|566263162|FG004|Overall Study|Other|0|||
156864515|NCT00360230|566263163|FG005|Overall Study|Other|0|||
156864516|NCT00360230|566263164|FG006|Overall Study|Other|0|||
156864517|NCT00360230|566263158|FG000|Overall Study|Protocol Violation|0|||
156864518|NCT00360230|566263159|FG001|Overall Study|Protocol Violation|0|||
156864519|NCT00360230|566263160|FG002|Overall Study|Protocol Violation|0|||
156864520|NCT00360230|566263161|FG003|Overall Study|Protocol Violation|0|||
156864521|NCT00360230|566263162|FG004|Overall Study|Protocol Violation|0|||
156864522|NCT00360230|566263163|FG005|Overall Study|Protocol Violation|1|||
156864523|NCT00360230|566263164|FG006|Overall Study|Protocol Violation|0|||
156864524|NCT00360230|566263158|FG000|Overall Study|Death|0|||
156864525|NCT00360230|566263159|FG001|Overall Study|Death|1|||
156864526|NCT00360230|566263160|FG002|Overall Study|Death|0|||
156864527|NCT00360230|566263161|FG003|Overall Study|Death|0|||
156864528|NCT00360230|566263162|FG004|Overall Study|Death|0|||
156864529|NCT00360230|566263163|FG005|Overall Study|Death|1|||
156864530|NCT00360230|566263164|FG006|Overall Study|Death|1|||
156864531|NCT02703597|566263165|FG000|Assignment to Baseline|Lost to Follow-up|17|||
156864532|NCT02703597|566263166|FG001|Assignment to Baseline|Lost to Follow-up|16|||
156864533|NCT02703597|566263165|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
156864534|NCT02703597|566263166|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
156864535|NCT02703597|566263165|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
156864536|NCT02703597|566263166|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
156864537|NCT02703597|566263165|FG000|First Post-test to First Follow-up|Site drop out|0|||
156864538|NCT02703597|566263166|FG001|First Post-test to First Follow-up|Site drop out|58|||
156864539|NCT02703597|566263165|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
156864540|NCT02703597|566263166|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
156864541|NCT02703597|566263165|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
156864542|NCT02703597|566263166|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
156864543|NCT02703597|566263165|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
156864544|NCT02703597|566263166|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
156864545|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
156864546|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
156864547|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
156864548|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
156864549|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
156864550|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864551|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864552|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
156864553|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864554|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
156864555|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
156864556|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
156864557|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
156864558|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
156864559|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
156864560|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Other|1|||
156864561|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Other|5|||
156864562|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Other|0|||
156864563|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Other|2|||
156864564|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Other|3|||
156864565|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
156864566|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
156864567|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
156864568|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
156864569|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
156864570|NCT02006472|566263167|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864571|NCT02006472|566263168|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
157092081|NCT04494256|567091524|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
156864572|NCT02006472|566263169|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864573|NCT02006472|566263170|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
156864574|NCT02006472|566263171|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
156864575|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864576|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
156864577|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
156864578|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864579|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
156864580|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
156864581|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
156864582|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
156864583|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
156864584|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
156864585|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
156864586|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
156864587|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
156864588|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
156864589|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
157092082|NCT04494256|567091525|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
157092083|NCT04494256|567091526|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
156864590|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Other|0|||
156864591|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Other|1|||
156864592|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Other|0|||
156864593|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Other|1|||
156864594|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Other|0|||
156864595|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Not treated|0|||
156864596|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Not treated|0|||
156864597|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Not treated|2|||
156864598|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Not treated|0|||
156864599|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Not treated|0|||
156864600|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
156864601|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
156864602|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
156864603|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
156864604|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
156864605|NCT02006472|566263167|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
156864606|NCT02006472|566263168|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
156864607|NCT02006472|566263169|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
156864608|NCT02006472|566263170|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
156864609|NCT02006472|566263171|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
156864610|NCT00886379|566263172|FG000|Overall Study|Transferred Schools|0|||
156864611|NCT00886379|566263173|FG001|Overall Study|Transferred Schools|0|||
156864612|NCT00886379|566263174|FG002|Overall Study|Transferred Schools|2|||
156864613|NCT00886379|566263175|FG003|Overall Study|Transferred Schools|1|||
156864614|NCT00886379|566263176|FG004|Overall Study|Transferred Schools|1|||
156864615|NCT00886379|566263172|FG000|Overall Study|Final blood draw not obtained|3|||
156864616|NCT00886379|566263173|FG001|Overall Study|Final blood draw not obtained|3|||
156864617|NCT00886379|566263174|FG002|Overall Study|Final blood draw not obtained|4|||
156864618|NCT00886379|566263175|FG003|Overall Study|Final blood draw not obtained|2|||
156864619|NCT00886379|566263176|FG004|Overall Study|Final blood draw not obtained|2|||
156864620|NCT03219723|566263177|FG000|Overall Study|Case Report Forms Uncollected|6|||
156864621|NCT03219723|566263177|FG000|Overall Study|Protocol Deviation|4|||
156864622|NCT00459316|566263182|FG000|Steps 1 & 2|Other eligibility failure|1|||
156864623|NCT00459316|566263183|FG001|Steps 1 & 2|Other eligibility failure|1|||
156864624|NCT00459316|566263184|FG002|Steps 1 & 2|Other eligibility failure|0|||
156864625|NCT00459316|566263182|FG000|Steps 1 & 2|Death|1|||
156864626|NCT00459316|566263183|FG001|Steps 1 & 2|Death|1|||
156864627|NCT00459316|566263184|FG002|Steps 1 & 2|Death|0|||
156864628|NCT00459316|566263182|FG000|Steps 1 & 2|Not able to get to clinic|7|||
156864629|NCT00459316|566263183|FG001|Steps 1 & 2|Not able to get to clinic|4|||
156864630|NCT00459316|566263184|FG002|Steps 1 & 2|Not able to get to clinic|0|||
156864631|NCT00459316|566263182|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
156864632|NCT00459316|566263183|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
156864633|NCT00459316|566263184|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
156864634|NCT00459316|566263182|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
156864635|NCT00459316|566263183|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
156864636|NCT00459316|566263184|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
156864637|NCT00459316|566263182|FG000|Steps 1 & 2|Lost to Follow-up|5|||
156864638|NCT00459316|566263183|FG001|Steps 1 & 2|Lost to Follow-up|0|||
156864639|NCT00459316|566263184|FG002|Steps 1 & 2|Lost to Follow-up|2|||
156864640|NCT00459316|566263182|FG000|Step 3|Withdrawal by Subject|3|||
156864641|NCT00459316|566263183|FG001|Step 3|Withdrawal by Subject|0|||
156864642|NCT00459316|566263184|FG002|Step 3|Withdrawal by Subject|1|||
156864643|NCT01614886|566263185|FG000|Overall Study|Adverse Event|15|||
157092084|NCT04494256|567091520|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157206090|NCT01610284|567498085|FG001|Treatment Phase|Study terminated by Sponsor|15|||
156864644|NCT01614886|566263186|FG001|Overall Study|Adverse Event|20|||
156864645|NCT01614886|566263185|FG000|Overall Study|Withdrawal by Subject|4|||
156864646|NCT01614886|566263186|FG001|Overall Study|Withdrawal by Subject|4|||
156864647|NCT01614886|566263185|FG000|Overall Study|Death|1|||
156864648|NCT01614886|566263186|FG001|Overall Study|Death|0|||
156864649|NCT01614886|566263185|FG000|Overall Study|Protocol deviation|0|||
156864650|NCT01614886|566263186|FG001|Overall Study|Protocol deviation|2|||
156864651|NCT01207414|566263187|FG000|Overall Study|Adverse Event|25|||
156864652|NCT01207414|566263188|FG001|Overall Study|Adverse Event|39|||
156864653|NCT01207414|566263187|FG000|Overall Study|Abnormal test procedure results|0|||
156864654|NCT01207414|566263188|FG001|Overall Study|Abnormal test procedure results|1|||
156864655|NCT01207414|566263187|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156864656|NCT01207414|566263188|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156864657|NCT01207414|566263187|FG000|Overall Study|Patient withdrew consent|14|||
156864658|NCT01207414|566263188|FG001|Overall Study|Patient withdrew consent|11|||
156864659|NCT01207414|566263187|FG000|Overall Study|Lost to Follow-up|15|||
156864660|NCT01207414|566263188|FG001|Overall Study|Lost to Follow-up|17|||
156864661|NCT01207414|566263187|FG000|Overall Study|Administrative problems|1|||
156864662|NCT01207414|566263188|FG001|Overall Study|Administrative problems|1|||
156864663|NCT01207414|566263187|FG000|Overall Study|Protocol deviation|12|||
156864664|NCT01207414|566263188|FG001|Overall Study|Protocol deviation|9|||
156864665|NCT01207414|566263187|FG000|Overall Study|Randomized in error|1|||
156864666|NCT01207414|566263188|FG001|Overall Study|Randomized in error|0|||
156864667|NCT01435382|566263191|FG000|Overall Study|Lost to Follow-up|1|||
156864668|NCT01435382|566263192|FG001|Overall Study|Lost to Follow-up|0|||
156864669|NCT01435382|566263193|FG002|Overall Study|Lost to Follow-up|1|||
156864670|NCT01435382|566263194|FG003|Overall Study|Lost to Follow-up|0|||
156864671|NCT01435382|566263191|FG000|Overall Study|Withdrawal by Subject|0|||
156864672|NCT01435382|566263192|FG001|Overall Study|Withdrawal by Subject|2|||
156864673|NCT01435382|566263193|FG002|Overall Study|Withdrawal by Subject|0|||
156864674|NCT01435382|566263194|FG003|Overall Study|Withdrawal by Subject|1|||
156864675|NCT00910650|566263195|FG000|Overall Study|Death|2|||
156864676|NCT00423579|566263196|FG000|Overall Study|Lost to Follow-up|3|||
156864677|NCT00423579|566263197|FG001|Overall Study|Lost to Follow-up|0|||
156864678|NCT00423579|566263196|FG000|Overall Study|Protocol Violation|1|||
156864679|NCT00423579|566263197|FG001|Overall Study|Protocol Violation|3|||
156864680|NCT00423579|566263196|FG000|Overall Study|Diagnosis of diabetes|0|||
156864681|NCT00423579|566263197|FG001|Overall Study|Diagnosis of diabetes|1|||
156864682|NCT04004988|566263199|FG000|Period 1|Physician Decision|2|||
156864683|NCT04004988|566263200|FG001|Period 1|Physician Decision|0|||
156864684|NCT04004988|566263199|FG000|Period 1|Withdrawal by Subject|0|||
156864685|NCT04004988|566263200|FG001|Period 1|Withdrawal by Subject|1|||
156864686|NCT04004988|566263199|FG000|Period 1|Adverse Event|1|||
156864687|NCT04004988|566263200|FG001|Period 1|Adverse Event|2|||
156864688|NCT03873116|566263201|FG000|Part 1|Study drug discontinuation due to rash|0|||
156864689|NCT03873116|566263202|FG001|Part 1|Study drug discontinuation due to rash|0|||
156864690|NCT03873116|566263203|FG002|Part 1|Study drug discontinuation due to rash|0|||
156864691|NCT03873116|566263204|FG003|Part 1|Study drug discontinuation due to rash|0|||
156864692|NCT03873116|566263205|FG004|Part 1|Study drug discontinuation due to rash|0|||
156864693|NCT03873116|566263206|FG005|Part 1|Study drug discontinuation due to rash|1|||
156864694|NCT03873116|566263201|FG000|Part 2|Withdrawal by Subject|0|||
156864695|NCT03873116|566263202|FG001|Part 2|Withdrawal by Subject|0|||
156864696|NCT03873116|566263203|FG002|Part 2|Withdrawal by Subject|1|||
156864697|NCT03873116|566263204|FG003|Part 2|Withdrawal by Subject|0|||
156864698|NCT03873116|566263205|FG004|Part 2|Withdrawal by Subject|0|||
156864699|NCT03873116|566263206|FG005|Part 2|Withdrawal by Subject|0|||
156864700|NCT03873116|566263201|FG000|Part 2|Lab abnormality or AE|0|||
156864701|NCT03873116|566263202|FG001|Part 2|Lab abnormality or AE|0|||
156864702|NCT03873116|566263203|FG002|Part 2|Lab abnormality or AE|0|||
156864703|NCT03873116|566263204|FG003|Part 2|Lab abnormality or AE|0|||
156864704|NCT03873116|566263205|FG004|Part 2|Lab abnormality or AE|1|||
156864705|NCT03873116|566263206|FG005|Part 2|Lab abnormality or AE|0|||
156864706|NCT03873116|566263201|FG000|Part 3|Withdrawal by Subject|0|||
156864707|NCT03873116|566263202|FG001|Part 3|Withdrawal by Subject|0|||
156864708|NCT03873116|566263203|FG002|Part 3|Withdrawal by Subject|0|||
156864709|NCT03873116|566263204|FG003|Part 3|Withdrawal by Subject|0|||
156864710|NCT03873116|566263205|FG004|Part 3|Withdrawal by Subject|1|||
156864711|NCT03873116|566263206|FG005|Part 3|Withdrawal by Subject|0|||
156864712|NCT04682366|566263207|FG000|Overall Study|Lost to Follow-up|1|||
156864713|NCT04682366|566263208|FG001|Overall Study|Lost to Follow-up|1|||
156864714|NCT02461758|566263210|FG000|Overall Study|Lost to Follow-up|0|||
156864715|NCT02461758|566263211|FG001|Overall Study|Lost to Follow-up|1|||
156864716|NCT02461758|566263212|FG002|Overall Study|Lost to Follow-up|1|||
156864717|NCT02461758|566263213|FG003|Overall Study|Lost to Follow-up|0|||
156864718|NCT00929695|566263214|FG000|Overall Study|Death|2|||
156864719|NCT00929695|566263215|FG001|Overall Study|Death|1|||
156864720|NCT00929695|566263214|FG000|Overall Study|Withdrawal by Subject|0|||
156864721|NCT00929695|566263215|FG001|Overall Study|Withdrawal by Subject|2|||
156864722|NCT00929695|566263214|FG000|Overall Study|discharge home|4|||
156864723|NCT00929695|566263215|FG001|Overall Study|discharge home|3|||
156864724|NCT00929695|566263214|FG000|Overall Study|incorrect stratification|2|||
156864725|NCT00929695|566263215|FG001|Overall Study|incorrect stratification|0|||
156864726|NCT04030143|566263216|FG000|Overall Study|Adverse Event|5|||
156864727|NCT04030143|566263217|FG001|Overall Study|Adverse Event|10|||
156864728|NCT04030143|566263216|FG000|Overall Study|Lost to Follow-up|3|||
156864729|NCT04030143|566263217|FG001|Overall Study|Lost to Follow-up|7|||
156864730|NCT04030143|566263216|FG000|Overall Study|Protocol Deviation|2|||
156864731|NCT04030143|566263217|FG001|Overall Study|Protocol Deviation|2|||
156864732|NCT04030143|566263216|FG000|Overall Study|Withdrawal by Subject|16|||
156864733|NCT04030143|566263217|FG001|Overall Study|Withdrawal by Subject|18|||
156750469|NCT02757352|565838821|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750470|NCT02757352|565838822|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750471|NCT02757352|565838823|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750472|NCT02757352|565838824|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750473|NCT02757352|565838825|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750474|NCT02757352|565838826|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750475|NCT02757352|565838827|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
156750476|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750477|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750478|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750479|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
156750480|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750481|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
156750482|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750483|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750484|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750485|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
156750486|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750487|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750488|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750489|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
156750490|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156750491|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
156750492|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750493|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750494|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750495|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156750496|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750497|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750498|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750499|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750500|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
156750501|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750502|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750503|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750504|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750505|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
156750506|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750507|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750508|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750509|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750510|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750511|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
156750512|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750513|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750514|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750515|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
156750516|NCT02757352|565838818|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750517|NCT02757352|565838819|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750518|NCT02757352|565838820|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750519|NCT02757352|565838821|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
156750520|NCT02757352|565838822|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750521|NCT02757352|565838823|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
156750522|NCT02757352|565838824|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750523|NCT02757352|565838825|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750524|NCT02757352|565838826|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750525|NCT02757352|565838827|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156750526|NCT02757352|565838818|FG000|Follow-Up Period|Adverse Event|0|||
156750527|NCT02757352|565838819|FG001|Follow-Up Period|Adverse Event|0|||
156750528|NCT02757352|565838820|FG002|Follow-Up Period|Adverse Event|0|||
156750529|NCT02757352|565838821|FG003|Follow-Up Period|Adverse Event|0|||
156750530|NCT02757352|565838822|FG004|Follow-Up Period|Adverse Event|0|||
156750531|NCT02757352|565838823|FG005|Follow-Up Period|Adverse Event|0|||
156750532|NCT02757352|565838824|FG006|Follow-Up Period|Adverse Event|1|||
156864734|NCT04030143|566263216|FG000|Overall Study|Physician Decision|1|||
156864735|NCT04030143|566263217|FG001|Overall Study|Physician Decision|1|||
156864736|NCT04030143|566263216|FG000|Overall Study|Due to Covid-19|2|||
156864737|NCT04030143|566263217|FG001|Overall Study|Due to Covid-19|3|||
156864738|NCT04030143|566263216|FG000|Overall Study|Not Due to Covid-19|1|||
156864739|NCT04030143|566263217|FG001|Overall Study|Not Due to Covid-19|1|||
156864740|NCT01352715|566263218|FG000|Overall Study|Death|3|||
156864741|NCT01352715|566263219|FG001|Overall Study|Death|3|||
156864742|NCT01352715|566263218|FG000|Overall Study|Lost to Follow-up|5|||
156864743|NCT01352715|566263219|FG001|Overall Study|Lost to Follow-up|7|||
156864744|NCT01352715|566263218|FG000|Overall Study|Withdrawal by Subject|4|||
156864745|NCT01352715|566263219|FG001|Overall Study|Withdrawal by Subject|8|||
156864746|NCT01352715|566263218|FG000|Overall Study|site closure|16|||
156864747|NCT01352715|566263219|FG001|Overall Study|site closure|15|||
156864748|NCT01352715|566263218|FG000|Overall Study|no final visit in closeout period|15|||
156864749|NCT01352715|566263219|FG001|Overall Study|no final visit in closeout period|12|||
156864750|NCT01352715|566263218|FG000|Overall Study|major ineligibility|2|||
156864751|NCT01352715|566263219|FG001|Overall Study|major ineligibility|1|||
156864752|NCT02000440|566263221|FG000|Overall Study|Adverse Event|3|||
156864753|NCT02000440|566263221|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
156864754|NCT02383576|566263222|FG000|Overall Study|Death|53|||
156864755|NCT02383576|566263223|FG001|Overall Study|Death|33|||
156864756|NCT02383576|566263222|FG000|Overall Study|Lost to Follow-up|7|||
156864757|NCT02383576|566263223|FG001|Overall Study|Lost to Follow-up|1|||
156864758|NCT02383576|566263222|FG000|Overall Study|Withdrew Consent|1|||
156864759|NCT02383576|566263223|FG001|Overall Study|Withdrew Consent|6|||
156864760|NCT02383576|566263222|FG000|Overall Study|Investigator's Decision|0|||
156864761|NCT02383576|566263223|FG001|Overall Study|Investigator's Decision|1|||
156864762|NCT02383576|566263222|FG000|Overall Study|Administrative/Other|2|||
156864763|NCT02383576|566263223|FG001|Overall Study|Administrative/Other|4|||
156864764|NCT00528112|566263224|FG000|Treatment up to 3 Years|Adverse Event|313|||
156864765|NCT00528112|566263225|FG001|Treatment up to 3 Years|Adverse Event|278|||
156864766|NCT00528112|566263224|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
156864767|NCT00528112|566263225|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
156864768|NCT00528112|566263224|FG000|Treatment up to 3 Years|Protocol Violation|16|||
156864769|NCT00528112|566263225|FG001|Treatment up to 3 Years|Protocol Violation|16|||
157092085|NCT04494256|567091521|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092086|NCT04494256|567091522|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092087|NCT04494256|567091523|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092088|NCT04494256|567091524|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
157092089|NCT04494256|567091525|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
157092090|NCT04494256|567091526|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
157092091|NCT04494256|567091520|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
157092092|NCT04494256|567091521|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
157092093|NCT04494256|567091522|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
157092094|NCT04494256|567091523|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
157092095|NCT04494256|567091524|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
157092096|NCT04494256|567091525|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
157092097|NCT04494256|567091526|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
157092098|NCT00903630|567091527|FG000|Phase 2|Adverse Event|0|||
157092099|NCT00903630|567091528|FG001|Phase 2|Adverse Event|0|||
157092100|NCT00903630|567091529|FG002|Phase 2|Adverse Event|1|||
157092101|NCT01249274|567091533|FG000|Overall Study|Lost to Follow-up|3|||
157092102|NCT01249274|567091534|FG001|Overall Study|Lost to Follow-up|4|||
157092103|NCT01249274|567091533|FG000|Overall Study|Received inpatient substance treatment|1|||
157092104|NCT01249274|567091534|FG001|Overall Study|Received inpatient substance treatment|2|||
157092105|NCT04634825|567091535|FG000|Overall Study|Death|10|||
157092106|NCT04634825|567091536|FG001|Overall Study|Death|3|||
157092107|NCT04634825|567091535|FG000|Overall Study|Lost to Follow-up|1|||
157092108|NCT04634825|567091536|FG001|Overall Study|Lost to Follow-up|0|||
157092109|NCT04634825|567091535|FG000|Overall Study|Study terminated by sponsor|35|||
157092110|NCT04634825|567091536|FG001|Overall Study|Study terminated by sponsor|11|||
157092111|NCT04634825|567091535|FG000|Overall Study|Withdrawal by Subject|2|||
157092112|NCT04634825|567091536|FG001|Overall Study|Withdrawal by Subject|0|||
157092113|NCT01100034|567091539|FG000|Overall Study|Lost to Follow-up|11|||
157092114|NCT01100034|567091539|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
157092115|NCT01100034|567091539|FG000|Overall Study|Withdrawal by Subject|4|||
157092116|NCT01100034|567091539|FG000|Overall Study|Sponsor decision|21|||
157092117|NCT01100034|567091539|FG000|Overall Study|Participated in another clinical trial|1|||
156864770|NCT00528112|566263224|FG000|Treatment up to 3 Years|Death|0|||
157092118|NCT01100034|567091539|FG000|Overall Study|Participants moved to another hospital|4|||
156864771|NCT00528112|566263225|FG001|Treatment up to 3 Years|Death|1|||
156864772|NCT00528112|566263224|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
156864773|NCT00528112|566263225|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
157092119|NCT01100034|567091539|FG000|Overall Study|Site closed due to non-responsiveness|1|||
157092120|NCT00402597|567091540|FG000|Overall Study|Death|15|||
157092121|NCT00402597|567091541|FG001|Overall Study|Death|7|||
157092122|NCT00402597|567091542|FG002|Overall Study|Death|6|||
157092123|NCT00402597|567091543|FG003|Overall Study|Death|4|||
157092124|NCT00402597|567091544|FG004|Overall Study|Death|6|||
157092125|NCT00402597|567091540|FG000|Overall Study|Adverse Event|81|||
157092126|NCT00402597|567091541|FG001|Overall Study|Adverse Event|18|||
157092127|NCT00402597|567091542|FG002|Overall Study|Adverse Event|106|||
157092128|NCT00402597|567091543|FG003|Overall Study|Adverse Event|39|||
157092129|NCT00402597|567091544|FG004|Overall Study|Adverse Event|71|||
157092130|NCT00402597|567091540|FG000|Overall Study|Lost to Follow-up|8|||
157092131|NCT00402597|567091541|FG001|Overall Study|Lost to Follow-up|1|||
157092132|NCT00402597|567091542|FG002|Overall Study|Lost to Follow-up|8|||
157092133|NCT00402597|567091543|FG003|Overall Study|Lost to Follow-up|2|||
157092134|NCT00402597|567091544|FG004|Overall Study|Lost to Follow-up|3|||
157092135|NCT00402597|567091540|FG000|Overall Study|Withdrawal by Subject|57|||
157092136|NCT00402597|567091541|FG001|Overall Study|Withdrawal by Subject|16|||
157092137|NCT00402597|567091542|FG002|Overall Study|Withdrawal by Subject|65|||
157092138|NCT00402597|567091543|FG003|Overall Study|Withdrawal by Subject|15|||
157092139|NCT00402597|567091544|FG004|Overall Study|Withdrawal by Subject|24|||
157092140|NCT00402597|567091540|FG000|Overall Study|reason not specified|30|||
157092141|NCT00402597|567091541|FG001|Overall Study|reason not specified|4|||
157092142|NCT00402597|567091542|FG002|Overall Study|reason not specified|27|||
157092143|NCT00402597|567091543|FG003|Overall Study|reason not specified|14|||
157092144|NCT00402597|567091544|FG004|Overall Study|reason not specified|20|||
157092145|NCT01831856|567091545|FG000|Overall Study|Adverse Event|5|||
157092146|NCT01831856|567091546|FG001|Overall Study|Adverse Event|8|||
157092147|NCT01831856|567091545|FG000|Overall Study|Lack of Efficacy|13|||
157092148|NCT01831856|567091546|FG001|Overall Study|Lack of Efficacy|11|||
157092149|NCT01831856|567091545|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
157092150|NCT01831856|567091546|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
157092151|NCT00836095|567091547|FG000|Overall Study|Physician Decision|0|||
157092152|NCT00836095|567091548|FG001|Overall Study|Physician Decision|3|||
157092153|NCT01602562|567091549|FG000|Overall Study|Adverse Event|3|||
157092154|NCT01602562|567091550|FG001|Overall Study|Adverse Event|1|||
157092155|NCT01602562|567091549|FG000|Overall Study|Physician Decision|1|||
157092156|NCT01602562|567091550|FG001|Overall Study|Physician Decision|1|||
157092157|NCT01602562|567091549|FG000|Overall Study|Withdrawal by Subject|1|||
157092158|NCT01602562|567091550|FG001|Overall Study|Withdrawal by Subject|1|||
157092159|NCT00609765|567091554|FG000|Overall Study|Study ended prior to 12 months|1|||
157092160|NCT01920854|567091560|FG000|Overall Study|Withdrawal by Subject|1|||
157092161|NCT01920854|567091561|FG001|Overall Study|Withdrawal by Subject|0|||
157092162|NCT01920854|567091562|FG002|Overall Study|Withdrawal by Subject|0|||
157092163|NCT01920854|567091563|FG003|Overall Study|Withdrawal by Subject|0|||
157092164|NCT01920854|567091564|FG004|Overall Study|Withdrawal by Subject|1|||
157092165|NCT01920854|567091565|FG005|Overall Study|Withdrawal by Subject|0|||
157092166|NCT01920854|567091566|FG006|Overall Study|Withdrawal by Subject|1|||
157092167|NCT01272804|567091567|FG000|Overall Study|Adverse Event|1|||
157092168|NCT01272804|567091568|FG001|Overall Study|Adverse Event|0|||
157092169|NCT01272804|567091569|FG002|Overall Study|Adverse Event|0|||
157092170|NCT01272804|567091570|FG003|Overall Study|Adverse Event|0|||
157092171|NCT01272804|567091571|FG004|Overall Study|Adverse Event|2|||
157092172|NCT01272804|567091572|FG005|Overall Study|Adverse Event|1|||
156864774|NCT00528112|566263224|FG000|Treatment up to 3 Years|Pregnancy|9|||
156864775|NCT00528112|566263225|FG001|Treatment up to 3 Years|Pregnancy|10|||
156864776|NCT00528112|566263224|FG000|Treatment up to 3 Years|Other reasons|186|||
156864777|NCT00528112|566263225|FG001|Treatment up to 3 Years|Other reasons|186|||
156864778|NCT00528112|566263224|FG000|Extension Phase|Withdrawal by Subject|0|||
156864779|NCT00528112|566263225|FG001|Extension Phase|Withdrawal by Subject|3|||
156864780|NCT00528112|566263224|FG000|Extension Phase|Other reasons|0|||
156864781|NCT00528112|566263225|FG001|Extension Phase|Other reasons|100|||
156864782|NCT00528112|566263224|FG000|Extension Phase|Pregnancy|0|||
156864783|NCT00528112|566263225|FG001|Extension Phase|Pregnancy|3|||
156864784|NCT00528112|566263224|FG000|Extension Phase|Lost to Follow-up|0|||
156864785|NCT00528112|566263225|FG001|Extension Phase|Lost to Follow-up|12|||
156864786|NCT00528112|566263224|FG000|Extension Phase|Death|0|||
157092173|NCT02003573|567091576|FG000|Overall Study|Progressive disease|2|||
157092174|NCT02003573|567091577|FG001|Overall Study|Progressive disease|0|||
157092175|NCT02003573|567091578|FG002|Overall Study|Progressive disease|1|||
157092176|NCT02003573|567091576|FG000|Overall Study|Other Adverse event|0|||
157092177|NCT02003573|567091577|FG001|Overall Study|Other Adverse event|1|||
157092178|NCT02003573|567091578|FG002|Overall Study|Other Adverse event|1|||
157092179|NCT02003573|567091576|FG000|Overall Study|Refuse to take trial medication|0|||
157092180|NCT02003573|567091577|FG001|Overall Study|Refuse to take trial medication|1|||
156750533|NCT02757352|565838825|FG007|Follow-Up Period|Adverse Event|0|||
156864787|NCT00528112|566263225|FG001|Extension Phase|Death|1|||
156864788|NCT00528112|566263224|FG000|Extension Phase|Adverse Event|0|||
156864789|NCT00528112|566263225|FG001|Extension Phase|Adverse Event|36|||
156864790|NCT00528112|566263224|FG000|Extension Phase|Protocol Violation|0|||
156864791|NCT00528112|566263225|FG001|Extension Phase|Protocol Violation|2|||
156864792|NCT02559622|566263227|FG000|Overall Study|Progressive disease|0|||
156864793|NCT02559622|566263228|FG001|Overall Study|Progressive disease|1|||
156864794|NCT02559622|566263229|FG002|Overall Study|Progressive disease|0|||
156864795|NCT02559622|566263230|FG003|Overall Study|Progressive disease|0|||
156864796|NCT02559622|566263227|FG000|Overall Study|Adverse Event|0|||
156864797|NCT02559622|566263228|FG001|Overall Study|Adverse Event|2|||
156864798|NCT02559622|566263229|FG002|Overall Study|Adverse Event|2|||
156864799|NCT02559622|566263230|FG003|Overall Study|Adverse Event|2|||
156864800|NCT02559622|566263227|FG000|Overall Study|Patient/guardian decision|1|||
156864801|NCT02559622|566263228|FG001|Overall Study|Patient/guardian decision|2|||
156864802|NCT02559622|566263229|FG002|Overall Study|Patient/guardian decision|0|||
156864803|NCT02559622|566263230|FG003|Overall Study|Patient/guardian decision|1|||
156864804|NCT00894803|566263231|FG000|Overall Study|Death|20|||
156864805|NCT00894803|566263232|FG001|Overall Study|Death|4|||
156864806|NCT00894803|566263231|FG000|Overall Study|Lost to Follow-up|0|||
156864807|NCT00894803|566263232|FG001|Overall Study|Lost to Follow-up|1|||
156864808|NCT00449696|566263233|FG000|Overall Study|Other Treatment Required|6|||
156864809|NCT00449696|566263234|FG001|Overall Study|Other Treatment Required|1|||
156864810|NCT00449696|566263233|FG000|Overall Study|Withdrawal by Subject|5|||
156864811|NCT00449696|566263234|FG001|Overall Study|Withdrawal by Subject|5|||
156864812|NCT00449696|566263233|FG000|Overall Study|Lost to Follow-up|2|||
156864813|NCT00449696|566263234|FG001|Overall Study|Lost to Follow-up|3|||
156864814|NCT00449696|566263233|FG000|Overall Study|Others|7|||
156864815|NCT00449696|566263234|FG001|Overall Study|Others|0|||
156864816|NCT01033019|566263237|FG000|Overall Study|Withdrawal by Subject|1|||
156864817|NCT01033019|566263238|FG001|Overall Study|Withdrawal by Subject|0|||
156864818|NCT01052493|566263241|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
156864819|NCT01052493|566263242|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
156864820|NCT01052493|566263243|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
156864821|NCT00307801|566263246|FG000|Overall Study|Adverse Event|12|||
156864822|NCT00307801|566263247|FG001|Overall Study|Adverse Event|4|||
156864823|NCT00307801|566263246|FG000|Overall Study|Withdrawal by Subject|9|||
156864824|NCT00307801|566263247|FG001|Overall Study|Withdrawal by Subject|4|||
156864825|NCT00307801|566263246|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
156864826|NCT00307801|566263247|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
156864827|NCT00307801|566263246|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
156864828|NCT00307801|566263247|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
156864829|NCT00307801|566263246|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
156864830|NCT00307801|566263247|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
156864831|NCT00307801|566263246|FG000|Overall Study|Wrong Randomization|1|||
156864832|NCT00307801|566263247|FG001|Overall Study|Wrong Randomization|0|||
156864833|NCT00307801|566263246|FG000|Overall Study|Lack of Efficacy|0|||
156864834|NCT00307801|566263247|FG001|Overall Study|Lack of Efficacy|2|||
156864835|NCT00307801|566263246|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
156864836|NCT00307801|566263247|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
156864837|NCT00307801|566263246|FG000|Overall Study|Frustration with e-diary|1|||
156864838|NCT00307801|566263247|FG001|Overall Study|Frustration with e-diary|0|||
156864839|NCT00307801|566263246|FG000|Overall Study|Protocol Violation|3|||
156864840|NCT00307801|566263247|FG001|Overall Study|Protocol Violation|2|||
156864841|NCT00307801|566263246|FG000|Overall Study|No reason specified|2|||
156864842|NCT00307801|566263247|FG001|Overall Study|No reason specified|0|||
156864843|NCT00307801|566263246|FG000|Overall Study|Pregnancy|0|||
156864844|NCT00307801|566263247|FG001|Overall Study|Pregnancy|1|||
156864845|NCT03944577|566263251|FG000|Overall Study|Adverse Event|3|||
156864846|NCT03011099|566263252|FG000|Overall Study|Withdrawal by Subject|0|||
156864847|NCT03011099|566263253|FG001|Overall Study|Withdrawal by Subject|2|||
156864848|NCT00283296|566263258|FG000|Overall Study|in-home trial not completed|5|||
156864849|NCT05417438|566263261|FG000|Overall Study|Withdrawal by Subject|3|||
156864850|NCT02681523|566263266|FG000|Overall Study|Adverse Event|1|||
156864851|NCT02681523|566263266|FG000|Overall Study|Patient Non-compliance|1|||
156864852|NCT03253393|566263270|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
156864853|NCT03253393|566263271|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
156864854|NCT03253393|566263272|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
156864855|NCT01350999|566263274|FG000|Overall Study|Adverse Event|4|||
156864856|NCT01350999|566263275|FG001|Overall Study|Adverse Event|9|||
156864857|NCT01350999|566263276|FG002|Overall Study|Adverse Event|10|||
156864858|NCT01350999|566263274|FG000|Overall Study|Voluntary withdrawal|3|||
156864859|NCT01350999|566263275|FG001|Overall Study|Voluntary withdrawal|4|||
156864860|NCT01350999|566263276|FG002|Overall Study|Voluntary withdrawal|6|||
156864861|NCT01350999|566263274|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
156864862|NCT01350999|566263275|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
156864863|NCT01350999|566263276|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
156864864|NCT00124943|566265356|FG000|Phase II|Adverse Event|0|||
156864865|NCT00124943|566265357|FG001|Phase II|Adverse Event|2|||
156864866|NCT00124943|566265358|FG002|Phase II|Adverse Event|0|||
156864867|NCT00124943|566265359|FG003|Phase II|Adverse Event|1|||
156864868|NCT00124943|566265356|FG000|Phase II|Protocol Violation|0|||
156864869|NCT00124943|566265357|FG001|Phase II|Protocol Violation|0|||
156864870|NCT00124943|566265358|FG002|Phase II|Protocol Violation|0|||
156864871|NCT00124943|566265359|FG003|Phase II|Protocol Violation|1|||
156750534|NCT02757352|565838826|FG008|Follow-Up Period|Adverse Event|2|||
156864872|NCT00124943|566265356|FG000|Phase II|Lost to Follow-up|0|||
156864873|NCT00124943|566265357|FG001|Phase II|Lost to Follow-up|0|||
156864874|NCT00124943|566265358|FG002|Phase II|Lost to Follow-up|0|||
156864875|NCT00124943|566265359|FG003|Phase II|Lost to Follow-up|1|||
156864876|NCT00124943|566265356|FG000|Phase II|Withdrawal by Subject|0|||
156864877|NCT00124943|566265357|FG001|Phase II|Withdrawal by Subject|0|||
156864878|NCT00124943|566265358|FG002|Phase II|Withdrawal by Subject|0|||
156864879|NCT00124943|566265359|FG003|Phase II|Withdrawal by Subject|2|||
156864880|NCT00321620|566265360|FG000|Overall Study|Death|269|||
156864881|NCT00321620|566265361|FG001|Overall Study|Death|294|||
156864882|NCT00321620|566265360|FG000|Overall Study|Withdrawal by Subject|164|||
156864883|NCT00321620|566265361|FG001|Overall Study|Withdrawal by Subject|147|||
156864884|NCT00321620|566265360|FG000|Overall Study|Disease progression|113|||
156864885|NCT00321620|566265361|FG001|Overall Study|Disease progression|117|||
156864886|NCT00321620|566265360|FG000|Overall Study|Adverse Event|43|||
156864887|NCT00321620|566265361|FG001|Overall Study|Adverse Event|56|||
156864888|NCT00321620|566265360|FG000|Overall Study|Lost to Follow-up|13|||
156864889|NCT00321620|566265361|FG001|Overall Study|Lost to Follow-up|9|||
156864890|NCT00321620|566265360|FG000|Overall Study|Physician Decision|4|||
156864891|NCT00321620|566265361|FG001|Overall Study|Physician Decision|1|||
156864892|NCT00321620|566265360|FG000|Overall Study|Noncompliance|14|||
156864893|NCT00321620|566265361|FG001|Overall Study|Noncompliance|7|||
156864894|NCT00321620|566265360|FG000|Overall Study|Protocol deviation|4|||
156864895|NCT00321620|566265361|FG001|Overall Study|Protocol deviation|3|||
156864896|NCT00321620|566265360|FG000|Overall Study|Ineligibility determined|2|||
156864897|NCT00321620|566265361|FG001|Overall Study|Ineligibility determined|3|||
156864898|NCT00321620|566265360|FG000|Overall Study|Participant request|75|||
156864899|NCT00321620|566265361|FG001|Overall Study|Participant request|52|||
156864900|NCT00321620|566265360|FG000|Overall Study|Other|42|||
156864901|NCT00321620|566265361|FG001|Overall Study|Other|33|||
156864902|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
156864903|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
156864904|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
156864905|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
156864906|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
156864907|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
156864908|NCT03181932|566265362|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
156864909|NCT03181932|566265363|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
156864910|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
156864911|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
156864912|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
156864913|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
156864914|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
156864915|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
156864916|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
156864917|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
156864918|NCT03181932|566265362|FG000|Period 2 (Open-label Period)|Reason missing|2|||
156864919|NCT03181932|566265363|FG001|Period 2 (Open-label Period)|Reason missing|0|||
156864920|NCT00408317|566265368|FG000|First Intervention Period|Adverse Event|0|||
156864921|NCT00408317|566265369|FG001|First Intervention Period|Adverse Event|1|||
156864922|NCT00408317|566265368|FG000|Second Intervention Period|Adverse Event|2|||
156864923|NCT00408317|566265369|FG001|Second Intervention Period|Adverse Event|0|||
156864924|NCT00408317|566265368|FG000|Second Intervention Period|Protocol Violation|0|||
156864925|NCT00408317|566265369|FG001|Second Intervention Period|Protocol Violation|1|||
156864926|NCT00408317|566265368|FG000|Second Intervention Period|Withdrawal of consent|0|||
156864927|NCT00408317|566265369|FG001|Second Intervention Period|Withdrawal of consent|1|||
156864928|NCT02177123|566265370|FG000|Overall Study|Lost to Follow-up|6|||
156864929|NCT02177123|566265370|FG000|Overall Study|Withdrawal by Subject|4|||
156864930|NCT02177123|566265370|FG000|Overall Study|Adverse Event|4|||
156864931|NCT02177123|566265370|FG000|Overall Study|Physician Decision|3|||
156864932|NCT02177123|566265370|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
156864933|NCT02177123|566265370|FG000|Overall Study|Excluded for medical reasons|2|||
156864934|NCT02177123|566265370|FG000|Overall Study|Death|1|||
156864935|NCT02177123|566265370|FG000|Overall Study|Other|1|||
156864936|NCT02177123|566265370|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
156864937|NCT01921205|566265376|FG000|Overall Study|Adverse Event|12|||
156864938|NCT01921205|566265377|FG001|Overall Study|Adverse Event|7|||
156864939|NCT01921205|566265376|FG000|Overall Study|Lack of Efficacy|1|||
156864940|NCT01921205|566265377|FG001|Overall Study|Lack of Efficacy|0|||
156864941|NCT01921205|566265376|FG000|Overall Study|Protocol Violation|1|||
156864942|NCT01921205|566265377|FG001|Overall Study|Protocol Violation|3|||
156864943|NCT01921205|566265376|FG000|Overall Study|Lost to Follow-up|1|||
156864944|NCT01921205|566265377|FG001|Overall Study|Lost to Follow-up|1|||
156864945|NCT01921205|566265376|FG000|Overall Study|Withdrawal by Subject|6|||
156864946|NCT01921205|566265377|FG001|Overall Study|Withdrawal by Subject|5|||
156864947|NCT01921205|566265376|FG000|Overall Study|Use Of Prohibited Medication|0|||
156864948|NCT01921205|566265377|FG001|Overall Study|Use Of Prohibited Medication|1|||
156864949|NCT01921205|566265376|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
156864950|NCT01921205|566265377|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
156864951|NCT01921205|566265376|FG000|Overall Study|Non Compliance Of The Parent|0|||
156864952|NCT01921205|566265377|FG001|Overall Study|Non Compliance Of The Parent|1|||
156864953|NCT01921205|566265376|FG000|Overall Study|Non Compliance Of Child|0|||
156864954|NCT01921205|566265377|FG001|Overall Study|Non Compliance Of Child|1|||
156864955|NCT05966142|566265384|FG000|Overall Study|Death|3|||
156864956|NCT05966142|566265385|FG001|Overall Study|Death|3|||
156864957|NCT05966142|566265384|FG000|Overall Study|Lost to Follow-up|55|||
157092181|NCT02003573|567091578|FG002|Overall Study|Refuse to take trial medication|1|||
157092182|NCT02003573|567091576|FG000|Overall Study|Other than specified|1|||
157092183|NCT02003573|567091577|FG001|Overall Study|Other than specified|2|||
157092184|NCT02003573|567091578|FG002|Overall Study|Other than specified|3|||
157092185|NCT05026710|567091579|FG000|Overall Study|No longer met eligibility criteria|3|||
157092186|NCT05026710|567091580|FG001|Overall Study|No longer met eligibility criteria|1|||
157092187|NCT03218397|567091581|FG000|Overall Study|Prior positive blood culture|8|||
157092188|NCT03218397|567091582|FG001|Overall Study|Prior positive blood culture|13|||
157092189|NCT03218397|567091581|FG000|Overall Study|Comfort care|8|||
157092190|NCT03218397|567091582|FG001|Overall Study|Comfort care|5|||
157092191|NCT03218397|567091581|FG000|Overall Study|Comfort care and positive blood culture|1|||
157092192|NCT03218397|567091582|FG001|Overall Study|Comfort care and positive blood culture|0|||
157092193|NCT03218397|567091581|FG000|Overall Study|Comfort care and mixed culture|0|||
157092194|NCT03218397|567091582|FG001|Overall Study|Comfort care and mixed culture|1|||
157092195|NCT03218397|567091581|FG000|Overall Study|Mixed culture|2|||
157092196|NCT03218397|567091582|FG001|Overall Study|Mixed culture|2|||
157092197|NCT03218397|567091581|FG000|Overall Study|Inaccessible hospital records|2|||
157092198|NCT03218397|567091582|FG001|Overall Study|Inaccessible hospital records|5|||
157092199|NCT03218397|567091581|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
157092200|NCT03218397|567091582|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
157092201|NCT03218397|567091581|FG000|Overall Study|Randomized during laboratory off hours|2|||
157092202|NCT03218397|567091582|FG001|Overall Study|Randomized during laboratory off hours|1|||
157092203|NCT01796548|567091583|FG000|Overall Study|Lost to Follow-up|1|||
157092204|NCT01796548|567091583|FG000|Overall Study|Other|2|||
157092205|NCT00126503|567091586|FG000|Overall Study|disease progression|23|||
157092206|NCT00126503|567091587|FG001|Overall Study|disease progression|14|||
157092207|NCT00126503|567091586|FG000|Overall Study|Withdrawal by Subject|0|||
157092208|NCT00126503|567091587|FG001|Overall Study|Withdrawal by Subject|1|||
157092209|NCT00126503|567091586|FG000|Overall Study|alternative therapy|1|||
157092210|NCT00126503|567091587|FG001|Overall Study|alternative therapy|1|||
157092211|NCT00126503|567091586|FG000|Overall Study|other complicating disease|4|||
157092212|NCT00126503|567091587|FG001|Overall Study|other complicating disease|1|||
157092213|NCT00126503|567091586|FG000|Overall Study|Death|3|||
157092214|NCT00126503|567091587|FG001|Overall Study|Death|0|||
157092215|NCT00126503|567091586|FG000|Overall Study|Adverse Event|13|||
157092216|NCT00126503|567091587|FG001|Overall Study|Adverse Event|3|||
157092217|NCT00126503|567091586|FG000|Overall Study|non-compliant|1|||
157092218|NCT00126503|567091587|FG001|Overall Study|non-compliant|0|||
157092219|NCT00126503|567091586|FG000|Overall Study|Physician Decision|2|||
157092220|NCT00126503|567091587|FG001|Overall Study|Physician Decision|1|||
157092221|NCT02495792|567091588|FG000|Overall Study|Lost to Follow-up|5|||
157092222|NCT02495792|567091589|FG001|Overall Study|Lost to Follow-up|9|||
157092223|NCT02495792|567091588|FG000|Overall Study|Protocol Violation|32|||
157092224|NCT02495792|567091589|FG001|Overall Study|Protocol Violation|31|||
157092225|NCT04134845|567091594|FG000|Overall Study|withdrawl by PI|12|||
157092226|NCT04134845|567091595|FG001|Overall Study|withdrawl by PI|5|||
157092227|NCT03992846|567091596|FG000|Overall Study|Adverse Event|8|||
157092228|NCT03992846|567091597|FG001|Overall Study|Adverse Event|6|||
157092229|NCT03992846|567091598|FG002|Overall Study|Adverse Event|3|||
157092230|NCT03992846|567091596|FG000|Overall Study|Lost to Follow-up|0|||
157092231|NCT03992846|567091597|FG001|Overall Study|Lost to Follow-up|1|||
157092232|NCT03992846|567091598|FG002|Overall Study|Lost to Follow-up|1|||
157092233|NCT03992846|567091596|FG000|Overall Study|Pregnancy|2|||
157092234|NCT03992846|567091597|FG001|Overall Study|Pregnancy|0|||
156864958|NCT05966142|566265385|FG001|Overall Study|Lost to Follow-up|52|||
156864959|NCT05966142|566265384|FG000|Overall Study|Physician Decision|1|||
156864960|NCT05966142|566265385|FG001|Overall Study|Physician Decision|0|||
156864961|NCT05966142|566265384|FG000|Overall Study|Withdrawal by Subject|9|||
157092235|NCT03992846|567091598|FG002|Overall Study|Pregnancy|1|||
157092236|NCT03992846|567091596|FG000|Overall Study|Protocol Violation|1|||
157092237|NCT03992846|567091597|FG001|Overall Study|Protocol Violation|2|||
157092238|NCT03992846|567091598|FG002|Overall Study|Protocol Violation|0|||
157092239|NCT03992846|567091596|FG000|Overall Study|Withdrawal by Subject|8|||
157092240|NCT03992846|567091597|FG001|Overall Study|Withdrawal by Subject|10|||
157092241|NCT03992846|567091598|FG002|Overall Study|Withdrawal by Subject|20|||
157092242|NCT03992846|567091596|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
157092243|NCT03992846|567091597|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
157092244|NCT03992846|567091598|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
157145063|NCT00923091|567277982|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
157145064|NCT00923091|567277983|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145065|NCT00923091|567277984|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
157145066|NCT00923091|567277985|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145067|NCT00923091|567277986|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145068|NCT00923091|567277987|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145069|NCT00923091|567277988|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145070|NCT00923091|567277989|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145071|NCT00923091|567277990|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145072|NCT00923091|567277991|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145073|NCT00923091|567277992|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
157145074|NCT00923091|567277980|FG000|Period VI (Open-Label)|Protocol Violation|6|||
157145075|NCT00923091|567277981|FG001|Period VI (Open-Label)|Protocol Violation|1|||
157145076|NCT00923091|567277982|FG002|Period VI (Open-Label)|Protocol Violation|3|||
157145077|NCT00923091|567277983|FG003|Period VI (Open-Label)|Protocol Violation|1|||
157145078|NCT00923091|567277984|FG004|Period VI (Open-Label)|Protocol Violation|4|||
157145079|NCT00923091|567277985|FG005|Period VI (Open-Label)|Protocol Violation|0|||
157145080|NCT00923091|567277986|FG006|Period VI (Open-Label)|Protocol Violation|0|||
157145081|NCT00923091|567277987|FG007|Period VI (Open-Label)|Protocol Violation|0|||
157145082|NCT00923091|567277988|FG008|Period VI (Open-Label)|Protocol Violation|0|||
157145083|NCT00923091|567277989|FG009|Period VI (Open-Label)|Protocol Violation|0|||
157145084|NCT00923091|567277990|FG010|Period VI (Open-Label)|Protocol Violation|0|||
157145085|NCT00923091|567277991|FG011|Period VI (Open-Label)|Protocol Violation|0|||
157145086|NCT00923091|567277992|FG012|Period VI (Open-Label)|Protocol Violation|0|||
157145087|NCT00923091|567277980|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
157145088|NCT00923091|567277981|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
157145089|NCT00923091|567277982|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
157145090|NCT00923091|567277983|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
157145091|NCT00923091|567277984|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
157145092|NCT00923091|567277985|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
157145093|NCT00923091|567277986|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
157145094|NCT00923091|567277987|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
157145095|NCT00923091|567277988|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
157145096|NCT00923091|567277989|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
157145097|NCT00923091|567277990|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
157145098|NCT00923091|567277991|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
157145099|NCT00923091|567277992|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
157145100|NCT00923091|567277980|FG000|Period VI (Open-Label)|Other Reason|0|||
157145101|NCT00923091|567277981|FG001|Period VI (Open-Label)|Other Reason|0|||
157145102|NCT00923091|567277982|FG002|Period VI (Open-Label)|Other Reason|0|||
157145103|NCT00923091|567277983|FG003|Period VI (Open-Label)|Other Reason|1|||
157145104|NCT00923091|567277984|FG004|Period VI (Open-Label)|Other Reason|1|||
157145105|NCT00923091|567277985|FG005|Period VI (Open-Label)|Other Reason|0|||
157145106|NCT00923091|567277986|FG006|Period VI (Open-Label)|Other Reason|0|||
157145107|NCT00923091|567277987|FG007|Period VI (Open-Label)|Other Reason|0|||
157145108|NCT00923091|567277988|FG008|Period VI (Open-Label)|Other Reason|0|||
157145109|NCT00923091|567277989|FG009|Period VI (Open-Label)|Other Reason|0|||
157145110|NCT00923091|567277990|FG010|Period VI (Open-Label)|Other Reason|0|||
157145111|NCT00923091|567277991|FG011|Period VI (Open-Label)|Other Reason|0|||
157145112|NCT00923091|567277992|FG012|Period VI (Open-Label)|Other Reason|0|||
157145113|NCT03237845|567277996|FG000|Overall Study|Adverse Event|0|||
157145114|NCT03237845|567277997|FG001|Overall Study|Adverse Event|1|||
157145115|NCT03237845|567277996|FG000|Overall Study|Lost to Follow-up|13|||
157145116|NCT03237845|567277997|FG001|Overall Study|Lost to Follow-up|10|||
157145117|NCT03237845|567277996|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
157145118|NCT03237845|567277997|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
157145119|NCT03237845|567277996|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
157145120|NCT03237845|567277997|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
157145121|NCT03237845|567277996|FG000|Overall Study|Physician Decision|1|||
157145122|NCT03237845|567277997|FG001|Overall Study|Physician Decision|2|||
157145123|NCT03237845|567277996|FG000|Overall Study|Pregnancy|1|||
157145124|NCT03237845|567277997|FG001|Overall Study|Pregnancy|0|||
157145125|NCT03237845|567277996|FG000|Overall Study|Protocol Deviation|0|||
157145126|NCT03237845|567277997|FG001|Overall Study|Protocol Deviation|1|||
157206091|NCT01610284|567498084|FG000|Treatment Phase|Subject/Guardian Decision|55|||
157206092|NCT01610284|567498085|FG001|Treatment Phase|Subject/Guardian Decision|23|||
157092245|NCT00409773|567093309|FG000|Overall Study|Adverse Event|3|||
157092246|NCT00409773|567093310|FG001|Overall Study|Adverse Event|4|||
157092247|NCT00409773|567093311|FG002|Overall Study|Adverse Event|4|||
157092248|NCT00409773|567093312|FG003|Overall Study|Adverse Event|2|||
157092249|NCT00409773|567093313|FG004|Overall Study|Adverse Event|6|||
157092250|NCT00409773|567093309|FG000|Overall Study|Lost to Follow-up|6|||
157092251|NCT00409773|567093310|FG001|Overall Study|Lost to Follow-up|1|||
157092252|NCT00409773|567093311|FG002|Overall Study|Lost to Follow-up|2|||
157092253|NCT00409773|567093312|FG003|Overall Study|Lost to Follow-up|3|||
157092254|NCT00409773|567093313|FG004|Overall Study|Lost to Follow-up|1|||
157092255|NCT00409773|567093309|FG000|Overall Study|Physician Decision|0|||
157092256|NCT00409773|567093310|FG001|Overall Study|Physician Decision|0|||
157092257|NCT00409773|567093311|FG002|Overall Study|Physician Decision|0|||
157092258|NCT00409773|567093312|FG003|Overall Study|Physician Decision|2|||
157092259|NCT00409773|567093313|FG004|Overall Study|Physician Decision|0|||
157092260|NCT00409773|567093309|FG000|Overall Study|Protocol Violation|0|||
157092261|NCT00409773|567093310|FG001|Overall Study|Protocol Violation|2|||
157092262|NCT00409773|567093311|FG002|Overall Study|Protocol Violation|3|||
157092263|NCT00409773|567093312|FG003|Overall Study|Protocol Violation|3|||
157092264|NCT00409773|567093313|FG004|Overall Study|Protocol Violation|1|||
157092265|NCT00409773|567093309|FG000|Overall Study|Withdrawal by Subject|0|||
157092266|NCT00409773|567093310|FG001|Overall Study|Withdrawal by Subject|0|||
157092267|NCT00409773|567093311|FG002|Overall Study|Withdrawal by Subject|0|||
157092268|NCT00409773|567093312|FG003|Overall Study|Withdrawal by Subject|2|||
157092269|NCT00409773|567093313|FG004|Overall Study|Withdrawal by Subject|1|||
157092270|NCT00409773|567093309|FG000|Overall Study|Lack of Eligibility|0|||
157092271|NCT00409773|567093310|FG001|Overall Study|Lack of Eligibility|0|||
157092272|NCT00409773|567093311|FG002|Overall Study|Lack of Eligibility|0|||
157092273|NCT00409773|567093312|FG003|Overall Study|Lack of Eligibility|0|||
157092274|NCT00409773|567093313|FG004|Overall Study|Lack of Eligibility|1|||
157092275|NCT01201343|567093314|FG000|Overall Study|Adverse Event|6|||
157092276|NCT01201343|567093314|FG000|Overall Study|Withdrawal by Subject|5|||
157092277|NCT01201343|567093314|FG000|Overall Study|Lost to Follow-up|2|||
157092278|NCT01201343|567093314|FG000|Overall Study|Lack of Efficacy|2|||
157092279|NCT01201343|567093314|FG000|Overall Study|Participant wrongly included in trial|1|||
157092280|NCT01201343|567093314|FG000|Overall Study|Randomized, not treated|3|||
157092281|NCT01919814|567093315|FG000|Overall Study|Adverse Event|1|||
157092282|NCT01919814|567093316|FG001|Overall Study|Adverse Event|0|||
157092283|NCT01919814|567093315|FG000|Overall Study|Protocol Violation|1|||
157092284|NCT01919814|567093316|FG001|Overall Study|Protocol Violation|0|||
157092285|NCT01919814|567093315|FG000|Overall Study|Withdrawal by Subject|1|||
157092286|NCT01919814|567093316|FG001|Overall Study|Withdrawal by Subject|0|||
157092287|NCT01440374|567093317|FG000|Part 1: Open-label Phase|Adverse Event|5|||
157092288|NCT01440374|567093318|FG001|Part 1: Open-label Phase|Adverse Event|0|||
157092289|NCT01440374|567093319|FG002|Part 1: Open-label Phase|Adverse Event|0|||
157092290|NCT01440374|567093320|FG003|Part 1: Open-label Phase|Adverse Event|0|||
157092291|NCT01440374|567093317|FG000|Part 1: Open-label Phase|Physician Decision|1|||
157092292|NCT01440374|567093318|FG001|Part 1: Open-label Phase|Physician Decision|0|||
157092293|NCT01440374|567093319|FG002|Part 1: Open-label Phase|Physician Decision|0|||
157092294|NCT01440374|567093320|FG003|Part 1: Open-label Phase|Physician Decision|0|||
157092295|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
157092296|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
157092297|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
157092298|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
157092299|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
157092300|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
157092301|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
157092302|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
157092303|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
157092304|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
157092305|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
157092306|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
157092307|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
157092308|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
157206093|NCT01610284|567498084|FG000|Treatment Phase|Death|6|||
157092309|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
157092310|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
157092311|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
157092312|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
157092313|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
157092314|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
157092315|NCT01440374|567093317|FG000|Part 2; Double-blind Phase|Not treated|0|||
157092316|NCT01440374|567093318|FG001|Part 2; Double-blind Phase|Not treated|0|||
157092317|NCT01440374|567093319|FG002|Part 2; Double-blind Phase|Not treated|1|||
157092318|NCT01440374|567093320|FG003|Part 2; Double-blind Phase|Not treated|0|||
157092319|NCT01440374|567093317|FG000|Part 3: Extension|Withdrawal by Subject|0|||
157092320|NCT01440374|567093318|FG001|Part 3: Extension|Withdrawal by Subject|0|||
157092321|NCT01440374|567093319|FG002|Part 3: Extension|Withdrawal by Subject|0|||
157092322|NCT01440374|567093320|FG003|Part 3: Extension|Withdrawal by Subject|5|||
157092323|NCT01440374|567093317|FG000|Part 3: Extension|Adverse Event|0|||
157092324|NCT01440374|567093318|FG001|Part 3: Extension|Adverse Event|0|||
157092325|NCT01440374|567093319|FG002|Part 3: Extension|Adverse Event|0|||
157092326|NCT01440374|567093320|FG003|Part 3: Extension|Adverse Event|13|||
157092327|NCT01440374|567093317|FG000|Part 3: Extension|Physician Decision|0|||
157092328|NCT01440374|567093318|FG001|Part 3: Extension|Physician Decision|0|||
157092329|NCT01440374|567093319|FG002|Part 3: Extension|Physician Decision|0|||
157092330|NCT01440374|567093320|FG003|Part 3: Extension|Physician Decision|14|||
157092331|NCT04812548|567093322|FG000|Overall Study|Adverse Event|2|||
157092332|NCT04812548|567093323|FG001|Overall Study|Adverse Event|7|||
157092333|NCT04812548|567093322|FG000|Overall Study|HSCT Planned|2|||
157092334|NCT04812548|567093323|FG001|Overall Study|HSCT Planned|3|||
157092335|NCT04812548|567093322|FG000|Overall Study|Progressive Disease|0|||
157092336|NCT04812548|567093323|FG001|Overall Study|Progressive Disease|2|||
157092337|NCT04812548|567093322|FG000|Overall Study|Death|0|||
157092338|NCT04812548|567093323|FG001|Overall Study|Death|1|||
157092339|NCT04812548|567093322|FG000|Overall Study|Post Study Access to Treatment|0|||
157092340|NCT04812548|567093323|FG001|Overall Study|Post Study Access to Treatment|1|||
157092341|NCT04812548|567093322|FG000|Overall Study|Withdrawal by Subject|0|||
157092342|NCT04812548|567093323|FG001|Overall Study|Withdrawal by Subject|1|||
157092343|NCT04812548|567093322|FG000|Overall Study|Physician Decision|1|||
157092344|NCT04812548|567093323|FG001|Overall Study|Physician Decision|0|||
157092345|NCT02141984|567093325|FG000|Overall Study|Lack of Efficacy|2|||
157092346|NCT02079610|567093326|FG000|Overall Study|Withdrawal by Subject|1|||
157092347|NCT02079610|567093327|FG001|Overall Study|Withdrawal by Subject|1|||
157092348|NCT01557283|567093330|FG000|Overall Study|Lost to Follow-up|7|||
157092349|NCT01557283|567093330|FG000|Overall Study|Non-responder|19|||
157092350|NCT01557283|567093330|FG000|Overall Study|Adverse Event|7|||
157092351|NCT01557283|567093330|FG000|Overall Study|Lack of Efficacy|1|||
157092352|NCT01557283|567093330|FG000|Overall Study|Non-compliance|1|||
157092353|NCT01557283|567093330|FG000|Overall Study|Withdrawal by Subject|1|||
157092354|NCT01557283|567093330|FG000|Overall Study|Participant's weight too high for dose|1|||
157092355|NCT01557283|567093330|FG000|Overall Study|Worsening of psoriasis|1|||
157092356|NCT01557283|567093330|FG000|Overall Study|Other|6|||
157092357|NCT01716117|567093331|FG000|Overall Study|Death|5|||
157092358|NCT01716117|567093332|FG001|Overall Study|Death|2|||
157092359|NCT01716117|567093331|FG000|Overall Study|Withdrawal by Subject|2|||
157092360|NCT01716117|567093332|FG001|Overall Study|Withdrawal by Subject|0|||
157092361|NCT01765192|567093333|FG000|Treatment Period 1|Adverse Event|0|||
157092362|NCT01765192|567093334|FG001|Treatment Period 1|Adverse Event|1|||
157092363|NCT01765192|567093333|FG000|Washout Period|Voluntary Withdrawal|1|||
157092364|NCT01765192|567093334|FG001|Washout Period|Voluntary Withdrawal|1|||
157092365|NCT01765192|567093333|FG000|Washout Period|Reason not specified|1|||
157092366|NCT01765192|567093334|FG001|Washout Period|Reason not specified|0|||
157092367|NCT01765192|567093333|FG000|Treatment Period 2|Reason not specified|0|||
157092368|NCT01765192|567093334|FG001|Treatment Period 2|Reason not specified|2|||
157092369|NCT01765192|567093333|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
157092370|NCT01765192|567093334|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
157092371|NCT03645057|567093338|FG000|Randomization to Baseline|Lost to Follow-up|1|||
157092372|NCT03645057|567093339|FG001|Randomization to Baseline|Lost to Follow-up|0|||
157092373|NCT03645057|567093340|FG002|Randomization to Baseline|Lost to Follow-up|1|||
157092374|NCT03645057|567093341|FG003|Randomization to Baseline|Lost to Follow-up|0|||
157092375|NCT03645057|567093338|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
157092376|NCT03645057|567093339|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
157092377|NCT03645057|567093340|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
157092378|NCT03645057|567093341|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
157092379|NCT03645057|567093338|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
157092380|NCT03645057|567093339|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
157092381|NCT03645057|567093340|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
157092382|NCT03645057|567093341|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
157092383|NCT03645057|567093338|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
157092384|NCT03645057|567093339|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
157092385|NCT03645057|567093340|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
157092386|NCT03645057|567093341|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
157092387|NCT01171807|567093342|FG000|Overall Study|Treatment failure|2|||
157092388|NCT01171807|567093343|FG001|Overall Study|Treatment failure|4|||
157092389|NCT01171807|567093342|FG000|Overall Study|Non compliance|1|||
157092390|NCT01171807|567093343|FG001|Overall Study|Non compliance|0|||
157092391|NCT01171807|567093342|FG000|Overall Study|Lost to Follow-up|3|||
157092392|NCT01171807|567093343|FG001|Overall Study|Lost to Follow-up|0|||
157092393|NCT01901341|567093344|FG000|Overall Study|Adverse Event|4|||
157092394|NCT01901341|567093345|FG001|Overall Study|Adverse Event|2|||
157092395|NCT01901341|567093344|FG000|Overall Study|Lack of Efficacy|0|||
157092396|NCT01901341|567093345|FG001|Overall Study|Lack of Efficacy|2|||
157092397|NCT01901341|567093344|FG000|Overall Study|Lost to Follow-up|0|||
157092398|NCT01901341|567093345|FG001|Overall Study|Lost to Follow-up|1|||
157092399|NCT01901341|567093344|FG000|Overall Study|Protocol Violation|2|||
157092400|NCT01901341|567093345|FG001|Overall Study|Protocol Violation|0|||
157092401|NCT01901341|567093344|FG000|Overall Study|Study Terminated by Sponsor|13|||
157092402|NCT01901341|567093345|FG001|Overall Study|Study Terminated by Sponsor|15|||
157092403|NCT01901341|567093344|FG000|Overall Study|Withdrawal by Subject|1|||
157092404|NCT01901341|567093345|FG001|Overall Study|Withdrawal by Subject|1|||
157092405|NCT00250679|567093346|FG000|Overall Study|Adverse Event|12|||
157092406|NCT00250679|567093347|FG001|Overall Study|Adverse Event|15|||
157092407|NCT00250679|567093348|FG002|Overall Study|Adverse Event|16|||
157092408|NCT00250679|567093346|FG000|Overall Study|Protocol Violation|2|||
157092409|NCT00250679|567093347|FG001|Overall Study|Protocol Violation|4|||
157092410|NCT00250679|567093348|FG002|Overall Study|Protocol Violation|3|||
157092411|NCT00250679|567093346|FG000|Overall Study|Withdrawal by Subject|15|||
157092412|NCT00250679|567093347|FG001|Overall Study|Withdrawal by Subject|18|||
157092413|NCT00250679|567093348|FG002|Overall Study|Withdrawal by Subject|15|||
157092414|NCT00250679|567093346|FG000|Overall Study|Lost to Follow-up|3|||
157092415|NCT00250679|567093347|FG001|Overall Study|Lost to Follow-up|4|||
157092416|NCT00250679|567093348|FG002|Overall Study|Lost to Follow-up|2|||
157092417|NCT00250679|567093346|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
157092418|NCT00250679|567093347|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
157092419|NCT00250679|567093348|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
157092420|NCT00250679|567093346|FG000|Overall Study|Lack of Efficacy|0|||
157092421|NCT00250679|567093347|FG001|Overall Study|Lack of Efficacy|1|||
157092422|NCT00250679|567093348|FG002|Overall Study|Lack of Efficacy|3|||
157092423|NCT00250679|567093346|FG000|Overall Study|Technical Holter issues|1|||
157092424|NCT00250679|567093347|FG001|Overall Study|Technical Holter issues|0|||
157092425|NCT00250679|567093348|FG002|Overall Study|Technical Holter issues|2|||
157092426|NCT00250679|567093346|FG000|Overall Study|Moved|1|||
157092427|NCT00250679|567093347|FG001|Overall Study|Moved|1|||
157092428|NCT00250679|567093348|FG002|Overall Study|Moved|0|||
157092429|NCT00250679|567093346|FG000|Overall Study|Non-compliance|1|||
157092430|NCT00250679|567093347|FG001|Overall Study|Non-compliance|1|||
157092431|NCT00250679|567093348|FG002|Overall Study|Non-compliance|0|||
157092432|NCT00250679|567093346|FG000|Overall Study|various single events: hip surgery,diary|3|||
157092433|NCT00250679|567093347|FG001|Overall Study|various single events: hip surgery,diary|1|||
157092434|NCT00250679|567093348|FG002|Overall Study|various single events: hip surgery,diary|1|||
157092435|NCT00448279|567093350|FG000|Overall Study|Lost to Follow-up|2|||
157092436|NCT00448279|567093351|FG001|Overall Study|Lost to Follow-up|2|||
157092437|NCT00448279|567093350|FG000|Overall Study|Adverse Event|1|||
157092438|NCT00448279|567093351|FG001|Overall Study|Adverse Event|1|||
157092439|NCT00448279|567093350|FG000|Overall Study|Disease progression|16|||
157092440|NCT00448279|567093351|FG001|Overall Study|Disease progression|18|||
157092441|NCT00448279|567093350|FG000|Overall Study|Withdrawal by Subject|4|||
157092442|NCT00448279|567093351|FG001|Overall Study|Withdrawal by Subject|3|||
157092443|NCT00448279|567093350|FG000|Overall Study|Other|6|||
157092444|NCT00448279|567093351|FG001|Overall Study|Other|4|||
157092445|NCT00448279|567093350|FG000|Overall Study|Protocol Violation|0|||
157092446|NCT00448279|567093351|FG001|Overall Study|Protocol Violation|1|||
157092447|NCT03907410|567093352|FG000|Overall Study|Lost to Follow-up|4|||
157092448|NCT03907410|567093353|FG001|Overall Study|Lost to Follow-up|1|||
157092449|NCT03907410|567093354|FG002|Overall Study|Lost to Follow-up|1|||
157092450|NCT03907410|567093352|FG000|Overall Study|Lost to follow-up and research burden|0|||
157092451|NCT03907410|567093353|FG001|Overall Study|Lost to follow-up and research burden|0|||
157206094|NCT01610284|567498085|FG001|Treatment Phase|Death|5|||
157206095|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
157206096|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
157206097|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
157206098|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
157206099|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
157206100|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
157206101|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
157206102|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
157206103|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
157206104|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
157206105|NCT01610284|567498084|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
157206106|NCT01610284|567498085|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
157206107|NCT03020966|567498086|FG000|Overall Study|Withdrawal by Subject|2|||
157206108|NCT03020966|567498087|FG001|Overall Study|Withdrawal by Subject|0|||
157206109|NCT01856257|567498088|FG000|Overall Study|Death|2|||
157206110|NCT01856257|567498089|FG001|Overall Study|Death|0|||
157092452|NCT03907410|567093354|FG002|Overall Study|Lost to follow-up and research burden|1|||
157092453|NCT01981473|567093355|FG000|Overall Study|Incorrect diagnosis of RA|0|||
157092454|NCT01981473|567093356|FG001|Overall Study|Incorrect diagnosis of RA|0|||
157092455|NCT01981473|567093357|FG002|Overall Study|Incorrect diagnosis of RA|1|||
157092456|NCT01981473|567093355|FG000|Overall Study|Received treatment for < 6 months|0|||
157092457|NCT01981473|567093356|FG001|Overall Study|Received treatment for < 6 months|0|||
157092458|NCT01981473|567093357|FG002|Overall Study|Received treatment for < 6 months|1|||
157092459|NCT01981473|567093355|FG000|Overall Study|Received treatment for >24 months|2|||
157092460|NCT01981473|567093356|FG001|Overall Study|Received treatment for >24 months|0|||
157092461|NCT01981473|567093357|FG002|Overall Study|Received treatment for >24 months|6|||
157092462|NCT04776148|567093358|FG000|Overall Study|Death|249|||
157092463|NCT04776148|567093359|FG001|Overall Study|Death|260|||
157092464|NCT04776148|567093358|FG000|Overall Study|Lost to Follow-up|0|||
157092465|NCT04776148|567093359|FG001|Overall Study|Lost to Follow-up|1|||
157092466|NCT04776148|567093358|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157092467|NCT04776148|567093359|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
157092468|NCT04776148|567093358|FG000|Overall Study|Withdrawal by Subject|3|||
157092469|NCT04776148|567093359|FG001|Overall Study|Withdrawal by Subject|4|||
157092470|NCT04776148|567093358|FG000|Overall Study|Sponsor Decision|30|||
157092471|NCT04776148|567093359|FG001|Overall Study|Sponsor Decision|15|||
157092472|NCT00738582|567093360|FG000|Combination Therapy|Completed Combination Therapy|1|||
157092473|NCT00738582|567093361|FG001|Combination Therapy|Completed Combination Therapy|0|||
157092474|NCT00738582|567093360|FG000|Combination Therapy|Physician Decision|1|||
157092475|NCT00738582|567093361|FG001|Combination Therapy|Physician Decision|0|||
157092476|NCT00738582|567093360|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
157092477|NCT00738582|567093361|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
157092478|NCT00738582|567093360|FG000|Combination Therapy|Other|5|||
157092479|NCT00738582|567093361|FG001|Combination Therapy|Other|0|||
157092480|NCT00738582|567093360|FG000|Combination Therapy|Adverse Event|16|||
157092481|NCT00738582|567093361|FG001|Combination Therapy|Adverse Event|0|||
157092482|NCT00738582|567093360|FG000|Combination Therapy|Progressive Disease|9|||
157092483|NCT00738582|567093361|FG001|Combination Therapy|Progressive Disease|0|||
157092484|NCT00738582|567093360|FG000|Maintenance Therapy|Other|0|||
157092485|NCT00738582|567093361|FG001|Maintenance Therapy|Other|2|||
157092486|NCT00738582|567093360|FG000|Maintenance Therapy|Adverse Event|0|||
157092487|NCT00738582|567093361|FG001|Maintenance Therapy|Adverse Event|6|||
157092488|NCT00738582|567093360|FG000|Maintenance Therapy|Progressive Disease|0|||
157092489|NCT00738582|567093361|FG001|Maintenance Therapy|Progressive Disease|47|||
157092490|NCT00738582|567093360|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
157092491|NCT00738582|567093361|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
157092492|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
157092493|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
157092494|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
157092495|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
157092496|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
157092497|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
157145127|NCT03237845|567277996|FG000|Overall Study|Technical Problems|8|||
157206111|NCT01856257|567498090|FG002|Overall Study|Death|0|||
157206112|NCT01856257|567498091|FG003|Overall Study|Death|0|||
157206113|NCT01856257|567498088|FG000|Overall Study|Physician Decision|0|||
157206114|NCT01856257|567498089|FG001|Overall Study|Physician Decision|0|||
157206115|NCT01856257|567498090|FG002|Overall Study|Physician Decision|0|||
157206116|NCT01856257|567498091|FG003|Overall Study|Physician Decision|1|||
157206117|NCT01856257|567498088|FG000|Overall Study|Withdrawal by Subject|1|||
157206118|NCT01856257|567498089|FG001|Overall Study|Withdrawal by Subject|1|||
157206119|NCT01856257|567498090|FG002|Overall Study|Withdrawal by Subject|0|||
157206120|NCT01856257|567498091|FG003|Overall Study|Withdrawal by Subject|0|||
157206121|NCT01856257|567498088|FG000|Overall Study|Donor complication|0|||
157206122|NCT01856257|567498089|FG001|Overall Study|Donor complication|0|||
157206123|NCT01856257|567498090|FG002|Overall Study|Donor complication|0|||
157206124|NCT01856257|567498091|FG003|Overall Study|Donor complication|1|||
157206125|NCT01125358|567498095|FG000|Overall Study|Adverse Event|3|||
157206126|NCT01125358|567498096|FG001|Overall Study|Adverse Event|0|||
157206127|NCT01125358|567498097|FG002|Overall Study|Adverse Event|0|||
157206128|NCT01125358|567498098|FG003|Overall Study|Adverse Event|2|||
157206129|NCT01125358|567498095|FG000|Overall Study|Perceived Lack of Efficacy|6|||
157206130|NCT01125358|567498096|FG001|Overall Study|Perceived Lack of Efficacy|3|||
157206131|NCT01125358|567498097|FG002|Overall Study|Perceived Lack of Efficacy|7|||
157206132|NCT01125358|567498098|FG003|Overall Study|Perceived Lack of Efficacy|4|||
157206133|NCT01125358|567498095|FG000|Overall Study|Protocol Violation|1|||
157206134|NCT01125358|567498096|FG001|Overall Study|Protocol Violation|0|||
157206135|NCT01125358|567498097|FG002|Overall Study|Protocol Violation|0|||
157206136|NCT01125358|567498098|FG003|Overall Study|Protocol Violation|0|||
157206137|NCT01125358|567498095|FG000|Overall Study|Sponsor Decision|0|||
157206138|NCT01125358|567498096|FG001|Overall Study|Sponsor Decision|0|||
157206139|NCT01125358|567498097|FG002|Overall Study|Sponsor Decision|1|||
157206140|NCT01125358|567498098|FG003|Overall Study|Sponsor Decision|1|||
157206141|NCT01125358|567498095|FG000|Overall Study|Withdrawal by Subject|2|||
157206142|NCT01125358|567498096|FG001|Overall Study|Withdrawal by Subject|1|||
157206143|NCT01125358|567498097|FG002|Overall Study|Withdrawal by Subject|1|||
157092498|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
157092499|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
157092500|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
157092501|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
157092502|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
157092503|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
157092504|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
157092505|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
157092506|NCT00757588|567093362|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
157092507|NCT00757588|567093363|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
157092508|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
157092509|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
157092510|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
157092511|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
157092512|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
157092513|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
157092514|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
157092515|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
157092516|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
157092517|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
157092518|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
157092519|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
157092520|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
157092521|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
157092522|NCT00757588|567093362|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
157092523|NCT00757588|567093363|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
157092524|NCT02563522|567093364|FG000|Overall Study|Adverse Event|2|||
157092525|NCT02563522|567093365|FG001|Overall Study|Adverse Event|3|||
157092526|NCT02563522|567093364|FG000|Overall Study|Lost to Follow-up|1|||
157092527|NCT02563522|567093365|FG001|Overall Study|Lost to Follow-up|0|||
157092528|NCT02563522|567093364|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
157092529|NCT02563522|567093365|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
157092530|NCT01052103|567093366|FG000|Overall Study|Adverse Event|10|||
157092531|NCT01052103|567093367|FG001|Overall Study|Adverse Event|6|||
157092532|NCT01052103|567093366|FG000|Overall Study|Entry Criteria Not Met|3|||
157092533|NCT01052103|567093367|FG001|Overall Study|Entry Criteria Not Met|1|||
157092534|NCT01052103|567093366|FG000|Overall Study|Lost to Follow-up|3|||
157092535|NCT01052103|567093367|FG001|Overall Study|Lost to Follow-up|5|||
157092536|NCT01052103|567093366|FG000|Overall Study|Protocol Violation|10|||
157092537|NCT01052103|567093367|FG001|Overall Study|Protocol Violation|4|||
157092538|NCT01052103|567093366|FG000|Overall Study|Scheduling conflict|2|||
157092539|NCT01052103|567093367|FG001|Overall Study|Scheduling conflict|1|||
157092540|NCT01052103|567093366|FG000|Overall Study|Sponsor Decision|2|||
157092541|NCT01052103|567093367|FG001|Overall Study|Sponsor Decision|0|||
157092542|NCT01052103|567093366|FG000|Overall Study|Withdrawal by Subject|3|||
157092543|NCT01052103|567093367|FG001|Overall Study|Withdrawal by Subject|6|||
157092544|NCT01052103|567093366|FG000|Overall Study|Perceived Lack of Efficacy|1|||
157092545|NCT01052103|567093367|FG001|Overall Study|Perceived Lack of Efficacy|0|||
157092546|NCT00799513|567093370|FG000|Overall Study|Physician Decision|1|||
157092547|NCT00799513|567093370|FG000|Overall Study|Adverse Event|1|||
157092548|NCT00666679|567093374|FG000|First Intervention|Lost to Follow-up|1|||
157092549|NCT00666679|567093375|FG001|First Intervention|Lost to Follow-up|0|||
157092550|NCT00666679|567093374|FG000|First Intervention|Protocol Violation|1|||
157092551|NCT00666679|567093375|FG001|First Intervention|Protocol Violation|0|||
157092552|NCT00666679|567093374|FG000|First Intervention|Withdrawal by Subject|1|||
157092553|NCT00666679|567093375|FG001|First Intervention|Withdrawal by Subject|0|||
157092554|NCT00666679|567093374|FG000|First Intervention|Randomized did not start treatment|1|||
157092555|NCT00666679|567093375|FG001|First Intervention|Randomized did not start treatment|1|||
157092556|NCT00666679|567093374|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
157092557|NCT00666679|567093375|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
157092558|NCT00666679|567093374|FG000|Washout Period of 1 Week|Protocol Violation|0|||
157092559|NCT00666679|567093375|FG001|Washout Period of 1 Week|Protocol Violation|1|||
157092560|NCT00666679|567093374|FG000|Second Intervention|Adverse Event|1|||
157092561|NCT00666679|567093375|FG001|Second Intervention|Adverse Event|0|||
157092562|NCT00666679|567093374|FG000|Second Intervention|Death|0|||
157092563|NCT00666679|567093375|FG001|Second Intervention|Death|1|||
157092564|NCT00903006|567093376|FG000|Overall Study|Withdrawal by Subject|2|||
157092565|NCT00903006|567093377|FG001|Overall Study|Withdrawal by Subject|0|||
157092566|NCT00903006|567093378|FG002|Overall Study|Withdrawal by Subject|0|||
157206144|NCT01125358|567498098|FG003|Overall Study|Withdrawal by Subject|1|||
157206145|NCT05168657|567498101|FG000|Overall Study|Adverse Event|0|||
157206146|NCT05168657|567498102|FG001|Overall Study|Adverse Event|0|||
157092567|NCT00903006|567093379|FG003|Overall Study|Withdrawal by Subject|0|||
157092568|NCT00903006|567093376|FG000|Overall Study|Progressive Disease|0|||
157092569|NCT00903006|567093377|FG001|Overall Study|Progressive Disease|3|||
157092570|NCT00903006|567093378|FG002|Overall Study|Progressive Disease|1|||
157092571|NCT00903006|567093379|FG003|Overall Study|Progressive Disease|0|||
157092572|NCT03405792|567093380|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
157092573|NCT03405792|567093381|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
157092574|NCT03405792|567093380|FG000|Overall Study|o Did not receive pembrolizumab|1|||
157092575|NCT03405792|567093381|FG001|Overall Study|o Did not receive pembrolizumab|0|||
157092576|NCT00918580|567093382|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
157092577|NCT00918580|567093382|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
157092578|NCT00918580|567093382|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
157092579|NCT00918580|567093382|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
157092580|NCT00918580|567093382|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
157092581|NCT00918580|567093382|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
157092582|NCT00918580|567093382|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
157092583|NCT04882995|567093383|FG000|Overall Study|Withdrawal by Subject|1|||
157092584|NCT04882995|567093384|FG001|Overall Study|Withdrawal by Subject|2|||
157092585|NCT04882995|567093383|FG000|Overall Study|Protocol Violation|4|||
157092586|NCT04882995|567093384|FG001|Overall Study|Protocol Violation|4|||
157092587|NCT04882995|567093383|FG000|Overall Study|Surgery postponed due to COVID|1|||
157092588|NCT04882995|567093384|FG001|Overall Study|Surgery postponed due to COVID|1|||
157092589|NCT04371198|567093385|FG000|Overall Study|inadequate sample|4|||
157092590|NCT00372229|567093386|FG000|Study Phase|Graft loss|0|||
157092591|NCT00372229|567093387|FG001|Study Phase|Graft loss|3|||
157092592|NCT00372229|567093386|FG000|Study Phase|Protocol Violation|3|||
157092593|NCT00372229|567093387|FG001|Study Phase|Protocol Violation|4|||
157092594|NCT00372229|567093386|FG000|Study Phase|Consent withdrawn|16|||
157092595|NCT00372229|567093387|FG001|Study Phase|Consent withdrawn|14|||
157092596|NCT00372229|567093386|FG000|Study Phase|Refused treatment/did not cooperate|3|||
157092597|NCT00372229|567093387|FG001|Study Phase|Refused treatment/did not cooperate|1|||
157092598|NCT00372229|567093386|FG000|Study Phase|Death|3|||
157092599|NCT00372229|567093387|FG001|Study Phase|Death|2|||
157092600|NCT00372229|567093386|FG000|Study Phase|Reason not specified|3|||
157092601|NCT00372229|567093387|FG001|Study Phase|Reason not specified|2|||
157092602|NCT00372229|567093386|FG000|Study Phase|Lost to Follow-up|3|||
157092603|NCT00372229|567093387|FG001|Study Phase|Lost to Follow-up|3|||
157092604|NCT00372229|567093386|FG000|Follow-Up Phase|Graft loss|8|||
157092605|NCT00372229|567093387|FG001|Follow-Up Phase|Graft loss|7|||
157092606|NCT00372229|567093386|FG000|Follow-Up Phase|Consent withdrawn|13|||
157092607|NCT00372229|567093387|FG001|Follow-Up Phase|Consent withdrawn|19|||
157092608|NCT00372229|567093386|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
157092609|NCT00372229|567093387|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
157092610|NCT00372229|567093386|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
157092611|NCT00372229|567093387|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
157092612|NCT00372229|567093386|FG000|Follow-Up Phase|Death|9|||
157092613|NCT00372229|567093387|FG001|Follow-Up Phase|Death|12|||
157092614|NCT00372229|567093386|FG000|Follow-Up Phase|Administrative|1|||
157092615|NCT00372229|567093387|FG001|Follow-Up Phase|Administrative|0|||
157092616|NCT00372229|567093386|FG000|Follow-Up Phase|Reason not specified|2|||
157092617|NCT00372229|567093387|FG001|Follow-Up Phase|Reason not specified|3|||
157092618|NCT00372229|567093386|FG000|Follow-Up Phase|Lost to Follow-up|12|||
157092619|NCT00372229|567093387|FG001|Follow-Up Phase|Lost to Follow-up|10|||
157092620|NCT00701220|567093388|FG000|Overall Study|Withdrawal by Subject|0|||
157092621|NCT00701220|567093389|FG001|Overall Study|Withdrawal by Subject|2|||
157092622|NCT00701220|567093388|FG000|Overall Study|Protocol Violation|2|||
157092623|NCT00701220|567093389|FG001|Overall Study|Protocol Violation|0|||
157092624|NCT03235284|567093390|FG000|Overall Study|Adverse Event|1|||
157092625|NCT03235284|567093391|FG001|Overall Study|Adverse Event|2|||
157092626|NCT03235284|567093392|FG002|Overall Study|Adverse Event|1|||
157092627|NCT05478499|567093393|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
157092628|NCT05478499|567093394|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
157092629|NCT05478499|567093393|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
157092630|NCT05478499|567093394|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
157092631|NCT05478499|567093393|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
157092632|NCT05478499|567093394|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
157092633|NCT05478499|567093393|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
157092634|NCT05478499|567093394|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
157092635|NCT05478499|567093393|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
157092636|NCT05478499|567093394|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
157092637|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
157092638|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
157092639|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
157092640|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
157092641|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
157092642|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
157092643|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
157092644|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
157092645|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
157092646|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
157092647|NCT05478499|567093393|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
157092648|NCT05478499|567093394|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
157092649|NCT00211185|567093395|FG000|Overall Study|Death|2|||
157092650|NCT00211185|567093395|FG000|Overall Study|Disease progression|7|||
157092651|NCT00211185|567093395|FG000|Overall Study|Withdrawal by Subject|6|||
157092652|NCT00211185|567093395|FG000|Overall Study|Physician Decision|5|||
157092653|NCT00249002|567093396|FG000|Overall Study|Adverse Event|2|||
157092654|NCT00249002|567093396|FG000|Overall Study|Study cancellation|3|||
157092655|NCT00249002|567093396|FG000|Overall Study|Other|2|||
157092656|NCT00069108|567093397|FG000|Overall Study|Withdrawal by Subject|5|||
157092657|NCT00069108|567093398|FG001|Overall Study|Withdrawal by Subject|9|||
157092658|NCT00069108|567093397|FG000|Overall Study|Adverse Event|64|||
157092659|NCT00069108|567093398|FG001|Overall Study|Adverse Event|42|||
157092660|NCT00069108|567093397|FG000|Overall Study|Death|6|||
157092661|NCT00069108|567093398|FG001|Overall Study|Death|6|||
157092662|NCT00069108|567093397|FG000|Overall Study|Administration|15|||
157092663|NCT00069108|567093398|FG001|Overall Study|Administration|4|||
157092664|NCT00069108|567093397|FG000|Overall Study|Insufficient therapy|117|||
157092665|NCT00069108|567093398|FG001|Overall Study|Insufficient therapy|144|||
157092666|NCT00069108|567093397|FG000|Overall Study|Violation criteria|1|||
157092667|NCT00069108|567093398|FG001|Overall Study|Violation criteria|4|||
157092668|NCT00069108|567093397|FG000|Overall Study|Refused treatment|5|||
157092669|NCT00069108|567093398|FG001|Overall Study|Refused treatment|10|||
157092670|NCT02208999|567093399|FG000|Overall Study|Lost to Follow-up|1|||
157092671|NCT00319839|567093400|FG000|Overall Study|Adverse Event|5|||
157092672|NCT00319839|567093400|FG000|Overall Study|Withdrawal by Subject|1|||
157092673|NCT00986674|567093401|FG000|Overall Study|Lack of Efficacy|28|||
157092674|NCT00986674|567093402|FG001|Overall Study|Lack of Efficacy|25|||
157092675|NCT00986674|567093403|FG002|Overall Study|Lack of Efficacy|23|||
157092676|NCT00986674|567093401|FG000|Overall Study|Adverse Event|4|||
157092677|NCT00986674|567093402|FG001|Overall Study|Adverse Event|8|||
157092678|NCT00986674|567093403|FG002|Overall Study|Adverse Event|9|||
157092679|NCT00986674|567093401|FG000|Overall Study|Death|5|||
157092680|NCT00986674|567093402|FG001|Overall Study|Death|0|||
157092681|NCT00986674|567093403|FG002|Overall Study|Death|4|||
157092682|NCT00986674|567093401|FG000|Overall Study|Withdrawal by Subject|6|||
157092683|NCT00986674|567093402|FG001|Overall Study|Withdrawal by Subject|2|||
157092684|NCT00986674|567093403|FG002|Overall Study|Withdrawal by Subject|1|||
157092685|NCT00986674|567093401|FG000|Overall Study|alternative therapy|0|||
157092686|NCT00986674|567093402|FG001|Overall Study|alternative therapy|0|||
157092687|NCT00986674|567093403|FG002|Overall Study|alternative therapy|1|||
157092688|NCT00986674|567093401|FG000|Overall Study|not start protocol therapy|4|||
157092689|NCT00986674|567093402|FG001|Overall Study|not start protocol therapy|3|||
157092690|NCT00986674|567093403|FG002|Overall Study|not start protocol therapy|1|||
157092691|NCT00986674|567093401|FG000|Overall Study|unknown/not specify|0|||
157092692|NCT00986674|567093402|FG001|Overall Study|unknown/not specify|7|||
157092693|NCT00986674|567093403|FG002|Overall Study|unknown/not specify|9|||
157092694|NCT00690820|567093404|FG000|Period 1|Withdrawal by Subject|0|||
157092695|NCT00690820|567093405|FG001|Period 1|Withdrawal by Subject|1|||
157092696|NCT01411215|567093406|FG000|Overall Study|Adverse Event|1|||
157092697|NCT01411215|567093407|FG001|Overall Study|Adverse Event|2|||
157092698|NCT01411215|567093406|FG000|Overall Study|Lack of Efficacy|2|||
157092699|NCT01411215|567093407|FG001|Overall Study|Lack of Efficacy|4|||
157092700|NCT01411215|567093406|FG000|Overall Study|Lost to Follow-up|12|||
157092701|NCT01411215|567093407|FG001|Overall Study|Lost to Follow-up|18|||
157092702|NCT01411215|567093406|FG000|Overall Study|Did not meet entrance criteria|0|||
157092703|NCT01411215|567093407|FG001|Overall Study|Did not meet entrance criteria|1|||
157092704|NCT01411215|567093406|FG000|Overall Study|Study terminated by sponsor|2|||
157092705|NCT01411215|567093407|FG001|Overall Study|Study terminated by sponsor|15|||
157092706|NCT01411215|567093406|FG000|Overall Study|Protocol Violation|3|||
157092707|NCT01411215|567093407|FG001|Overall Study|Protocol Violation|5|||
157092708|NCT01411215|567093406|FG000|Overall Study|Withdrawal by Subject|34|||
157092709|NCT01411215|567093407|FG001|Overall Study|Withdrawal by Subject|21|||
157092710|NCT01411215|567093406|FG000|Overall Study|Other|12|||
157092711|NCT01411215|567093407|FG001|Overall Study|Other|17|||
157092712|NCT01411215|567093406|FG000|Overall Study|Screen failure|0|||
157092713|NCT01411215|567093407|FG001|Overall Study|Screen failure|1|||
157092714|NCT04025580|567093408|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
157092715|NCT04025580|567093409|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
157092716|NCT04025580|567093410|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
157092717|NCT03451162|567093412|FG000|Overall Study|Lost to Follow-up|1|||
157092718|NCT03451162|567093413|FG001|Overall Study|Lost to Follow-up|0|||
157092719|NCT03451162|567093414|FG002|Overall Study|Lost to Follow-up|0|||
157092720|NCT03451162|567093415|FG003|Overall Study|Lost to Follow-up|0|||
157092721|NCT03451162|567093416|FG004|Overall Study|Lost to Follow-up|0|||
157092722|NCT03451162|567093412|FG000|Overall Study|Physician Decision|0|||
157092723|NCT03451162|567093413|FG001|Overall Study|Physician Decision|1|||
157092724|NCT03451162|567093414|FG002|Overall Study|Physician Decision|0|||
157092725|NCT03451162|567093415|FG003|Overall Study|Physician Decision|0|||
157092726|NCT03451162|567093416|FG004|Overall Study|Physician Decision|0|||
157092727|NCT03451162|567093412|FG000|Overall Study|Withdrawal by Subject|1|||
157092728|NCT03451162|567093413|FG001|Overall Study|Withdrawal by Subject|1|||
157092729|NCT03451162|567093414|FG002|Overall Study|Withdrawal by Subject|0|||
157092730|NCT03451162|567093415|FG003|Overall Study|Withdrawal by Subject|0|||
157092731|NCT03451162|567093416|FG004|Overall Study|Withdrawal by Subject|0|||
157092732|NCT03658668|567093417|FG000|Overall Study|Time Commitment|1|||
157092733|NCT03658668|567093418|FG001|Overall Study|Time Commitment|1|||
157092734|NCT03305731|567093419|FG000|Overall Study|Protocol Violation|1|||
157092735|NCT01952054|567093420|FG000|Overall Study|Physician Decision|1|||
157092736|NCT05208866|567093422|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
157092737|NCT04964414|567093425|FG000|Overall Study|Lost to Follow-up|10|||
157092738|NCT04964414|567093426|FG001|Overall Study|Lost to Follow-up|8|||
157092739|NCT04964414|567093425|FG000|Overall Study|Withdrawal by Subject|1|||
157092740|NCT04964414|567093426|FG001|Overall Study|Withdrawal by Subject|1|||
157092741|NCT03881553|567093427|FG000|Overall Study|Discharged prior to participation|1|||
157092742|NCT03881553|567093428|FG001|Overall Study|Discharged prior to participation|1|||
157092743|NCT03881553|567093429|FG002|Overall Study|Discharged prior to participation|0|||
157092744|NCT03881553|567093427|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
157092745|NCT03881553|567093428|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
157092746|NCT03881553|567093429|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
157092747|NCT01718353|567093430|FG000|Overall Study|Lost to Follow-up|0|||
157092748|NCT01718353|567093431|FG001|Overall Study|Lost to Follow-up|1|||
157092749|NCT01718353|567093430|FG000|Overall Study|Principal Investigator's Decision|10|||
157092750|NCT01718353|567093431|FG001|Overall Study|Principal Investigator's Decision|4|||
157092751|NCT01718353|567093430|FG000|Overall Study|Randomized but not treated|2|||
157092752|NCT01718353|567093431|FG001|Overall Study|Randomized but not treated|0|||
157092753|NCT01959516|567093432|FG000|Epoch 1|Adverse Event|4|||
157092754|NCT01959516|567093433|FG001|Epoch 1|Adverse Event|1|||
157092755|NCT01959516|567093432|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
157092756|NCT01959516|567093433|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
157092757|NCT01959516|567093432|FG000|Epoch 1|Subject withdrew consent|3|||
157092758|NCT01959516|567093433|FG001|Epoch 1|Subject withdrew consent|2|||
157092759|NCT01959516|567093432|FG000|Epoch 1|Administrative problems|1|||
157092760|NCT01959516|567093433|FG001|Epoch 1|Administrative problems|0|||
157092761|NCT01959516|567093432|FG000|Epoch 1|Use of prohibited treatment|1|||
157092762|NCT01959516|567093433|FG001|Epoch 1|Use of prohibited treatment|0|||
157092763|NCT01959516|567093432|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
157092764|NCT01959516|567093433|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
157092765|NCT01959516|567093432|FG000|Epoch 1|Protocol deviation|0|||
157092766|NCT01959516|567093433|FG001|Epoch 1|Protocol deviation|1|||
157092767|NCT01959516|567093432|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
157092768|NCT01959516|567093433|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
157092769|NCT01959516|567093432|FG000|Epoch 2|Subject withdrew consent|1|||
157092770|NCT01959516|567093433|FG001|Epoch 2|Subject withdrew consent|0|||
157092771|NCT01959516|567093432|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
157092772|NCT01959516|567093433|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
157092773|NCT00455325|567093434|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
157092774|NCT00455325|567093435|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
157092775|NCT00455325|567093436|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
157092776|NCT00455325|567093437|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
157092777|NCT00455325|567093434|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
157092778|NCT00455325|567093435|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
157092779|NCT00455325|567093436|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
157092780|NCT00455325|567093437|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
157092781|NCT00455325|567093434|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
157092782|NCT00455325|567093435|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
157092783|NCT00455325|567093436|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
157092784|NCT00455325|567093437|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
157092785|NCT00455325|567093434|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
157092786|NCT00455325|567093435|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
157092787|NCT00455325|567093436|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
157092788|NCT00455325|567093437|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
157092789|NCT00455325|567093434|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
157092790|NCT00455325|567093435|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
157092791|NCT00455325|567093436|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
157092792|NCT00455325|567093437|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
157092793|NCT00455325|567093434|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
157092794|NCT00455325|567093435|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
157092795|NCT00455325|567093436|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
157092796|NCT00455325|567093437|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
157092797|NCT00455325|567093434|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
157092798|NCT00455325|567093435|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
157092799|NCT00455325|567093436|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
157092800|NCT00455325|567093437|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
157092801|NCT01759368|567093444|FG000|Overall Study|Lost to Follow-up|1|||
157092802|NCT01759368|567093445|FG001|Overall Study|Lost to Follow-up|0|||
157092803|NCT02951767|567093446|FG000|Overall Study|Study Terminated By Sponsor|9|||
157092804|NCT02951767|567093446|FG000|Overall Study|Withdrawal by Subject|11|||
157092805|NCT02951767|567093446|FG000|Overall Study|Death|96|||
157092806|NCT02951767|567093446|FG000|Overall Study|Lost to Follow-up|2|||
157092807|NCT02951767|567093446|FG000|Overall Study|Physician Decision|1|||
157092808|NCT02457559|567093447|FG000|Overall Study|Progressive Disease|1|||
157092809|NCT02457559|567093448|FG001|Overall Study|Progressive Disease|2|||
157092810|NCT02457559|567093449|FG002|Overall Study|Progressive Disease|3|||
157092811|NCT02457559|567093450|FG003|Overall Study|Progressive Disease|0|||
157092812|NCT02457559|567093451|FG004|Overall Study|Progressive Disease|0|||
157092813|NCT02457559|567093452|FG005|Overall Study|Progressive Disease|2|||
157092814|NCT02457559|567093453|FG006|Overall Study|Progressive Disease|1|||
157092815|NCT02457559|567093454|FG007|Overall Study|Progressive Disease|0|||
157092816|NCT02457559|567093455|FG008|Overall Study|Progressive Disease|1|||
157092817|NCT02457559|567093456|FG009|Overall Study|Progressive Disease|1|||
157092818|NCT02457559|567093457|FG010|Overall Study|Progressive Disease|1|||
157092819|NCT02457559|567093447|FG000|Overall Study|Investigator's Discretion|0|||
157092820|NCT02457559|567093448|FG001|Overall Study|Investigator's Discretion|0|||
157092821|NCT02457559|567093449|FG002|Overall Study|Investigator's Discretion|2|||
157092822|NCT02457559|567093450|FG003|Overall Study|Investigator's Discretion|0|||
157092823|NCT02457559|567093451|FG004|Overall Study|Investigator's Discretion|1|||
157092824|NCT02457559|567093452|FG005|Overall Study|Investigator's Discretion|0|||
157092825|NCT02457559|567093453|FG006|Overall Study|Investigator's Discretion|1|||
157092826|NCT02457559|567093454|FG007|Overall Study|Investigator's Discretion|0|||
157092827|NCT02457559|567093455|FG008|Overall Study|Investigator's Discretion|1|||
157092828|NCT02457559|567093456|FG009|Overall Study|Investigator's Discretion|0|||
157092829|NCT02457559|567093457|FG010|Overall Study|Investigator's Discretion|1|||
157092830|NCT02457559|567093447|FG000|Overall Study|Adverse Event|0|||
157092831|NCT02457559|567093448|FG001|Overall Study|Adverse Event|1|||
157092832|NCT02457559|567093449|FG002|Overall Study|Adverse Event|2|||
157092833|NCT02457559|567093450|FG003|Overall Study|Adverse Event|0|||
157092834|NCT02457559|567093451|FG004|Overall Study|Adverse Event|0|||
157092835|NCT02457559|567093452|FG005|Overall Study|Adverse Event|0|||
157092836|NCT02457559|567093453|FG006|Overall Study|Adverse Event|0|||
157092837|NCT02457559|567093454|FG007|Overall Study|Adverse Event|0|||
157092838|NCT02457559|567093455|FG008|Overall Study|Adverse Event|0|||
157092839|NCT02457559|567093456|FG009|Overall Study|Adverse Event|0|||
157092840|NCT02457559|567093457|FG010|Overall Study|Adverse Event|0|||
157092841|NCT02457559|567093447|FG000|Overall Study|Reason not Specified|1|||
157092842|NCT02457559|567093448|FG001|Overall Study|Reason not Specified|0|||
157092843|NCT02457559|567093449|FG002|Overall Study|Reason not Specified|0|||
157092844|NCT02457559|567093450|FG003|Overall Study|Reason not Specified|0|||
157092845|NCT02457559|567093451|FG004|Overall Study|Reason not Specified|0|||
157092846|NCT02457559|567093452|FG005|Overall Study|Reason not Specified|0|||
157092847|NCT02457559|567093453|FG006|Overall Study|Reason not Specified|0|||
157092848|NCT02457559|567093454|FG007|Overall Study|Reason not Specified|0|||
157092849|NCT02457559|567093455|FG008|Overall Study|Reason not Specified|0|||
157092850|NCT02457559|567093456|FG009|Overall Study|Reason not Specified|2|||
157092851|NCT02457559|567093457|FG010|Overall Study|Reason not Specified|0|||
157092852|NCT02457559|567093447|FG000|Overall Study|Death|0|||
157092853|NCT02457559|567093448|FG001|Overall Study|Death|0|||
157092854|NCT02457559|567093449|FG002|Overall Study|Death|0|||
157092855|NCT02457559|567093450|FG003|Overall Study|Death|0|||
157092856|NCT02457559|567093451|FG004|Overall Study|Death|0|||
157092857|NCT02457559|567093452|FG005|Overall Study|Death|0|||
157092858|NCT02457559|567093453|FG006|Overall Study|Death|0|||
157092859|NCT02457559|567093454|FG007|Overall Study|Death|0|||
157092860|NCT02457559|567093455|FG008|Overall Study|Death|1|||
157092861|NCT02457559|567093456|FG009|Overall Study|Death|1|||
157092862|NCT02457559|567093457|FG010|Overall Study|Death|0|||
157092863|NCT03110224|567093463|FG000|Overall Study|Death|3|||
157092864|NCT03110224|567093463|FG000|Overall Study|Lost to Follow-up|132|||
157092865|NCT03110224|567093463|FG000|Overall Study|Physician Decision|2|||
157092866|NCT03110224|567093463|FG000|Overall Study|Site Closed by Physician|35|||
157092867|NCT03110224|567093463|FG000|Overall Study|Site Closed by Sponsor|202|||
157092868|NCT03110224|567093463|FG000|Overall Study|Withdrawal by Subject|9|||
157092869|NCT01873495|567095743|FG000|Overall Study|Withdrawal by Subject|1|||
157092870|NCT01873495|567095743|FG000|Overall Study|Physician Decision|3|||
157092871|NCT01873495|567095743|FG000|Overall Study|Adverse Event|1|||
157092872|NCT01873495|567095743|FG000|Overall Study|Removed for Transplantation|1|||
157092873|NCT01873495|567095743|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
157092874|NCT04874415|567095747|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092875|NCT04874415|567095748|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092876|NCT04874415|567095749|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092877|NCT04874415|567095750|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092878|NCT04874415|567095751|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092879|NCT04874415|567095752|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092880|NCT04874415|567095753|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
157092881|NCT04874415|567095754|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092882|NCT04874415|567095755|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
157092883|NCT04874415|567095756|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
157092884|NCT04874415|567095757|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092885|NCT04874415|567095758|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
157092886|NCT04874415|567095759|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
157092887|NCT04874415|567095760|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
157092888|NCT04874415|567095761|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
157092889|NCT04874415|567095762|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
157092890|NCT04874415|567095747|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092891|NCT04874415|567095748|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092892|NCT04874415|567095749|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092893|NCT04874415|567095750|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092894|NCT04874415|567095751|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092895|NCT04874415|567095752|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092896|NCT04874415|567095753|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092897|NCT04874415|567095754|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092898|NCT04874415|567095755|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092899|NCT04874415|567095756|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
157092900|NCT04874415|567095757|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092901|NCT04874415|567095758|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092902|NCT04874415|567095759|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092903|NCT04874415|567095760|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092904|NCT04874415|567095761|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
157092905|NCT04874415|567095762|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
157092906|NCT04874415|567095747|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092907|NCT04874415|567095748|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092908|NCT04874415|567095749|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092909|NCT04874415|567095750|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092910|NCT04874415|567095751|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
157092911|NCT04874415|567095752|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092912|NCT04874415|567095753|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092913|NCT04874415|567095754|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092914|NCT04874415|567095755|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092915|NCT04874415|567095756|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092916|NCT04874415|567095757|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092917|NCT04874415|567095758|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092918|NCT04874415|567095759|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092919|NCT04874415|567095760|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092920|NCT04874415|567095761|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092921|NCT04874415|567095762|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
157092922|NCT05062759|567095765|FG000|Overall Study|Death|0|||
157092923|NCT05062759|567095766|FG001|Overall Study|Death|1|||
157092924|NCT05062759|567095765|FG000|Overall Study|Lost to Follow-up|1|||
157092925|NCT05062759|567095766|FG001|Overall Study|Lost to Follow-up|0|||
157092926|NCT04981366|567095767|FG000|Overall Study|Withdrawal by Subject|5|||
157092927|NCT04981366|567095768|FG001|Overall Study|Withdrawal by Subject|4|||
157092928|NCT04981366|567095769|FG002|Overall Study|Withdrawal by Subject|8|||
157092929|NCT04981366|567095767|FG000|Overall Study|Health issues unrelated to the trial|1|||
157092930|NCT04981366|567095768|FG001|Overall Study|Health issues unrelated to the trial|2|||
157092931|NCT04981366|567095769|FG002|Overall Study|Health issues unrelated to the trial|0|||
157092932|NCT03214094|567095770|FG000|Overall Study|Case Report Forms Uncollected|14|||
157092933|NCT03214094|567095770|FG000|Overall Study|Protocol Deviation|46|||
157206147|NCT05168657|567498103|FG002|Overall Study|Adverse Event|1|||
157206148|NCT05168657|567498104|FG003|Overall Study|Adverse Event|0|||
157092934|NCT00310037|567095771|FG000|Overall Study|Adverse Event|7|||
157092935|NCT00310037|567095772|FG001|Overall Study|Adverse Event|14|||
157092936|NCT00310037|567095771|FG000|Overall Study|Withdrawal by Subject|4|||
157092937|NCT00310037|567095772|FG001|Overall Study|Withdrawal by Subject|3|||
157092938|NCT00310037|567095771|FG000|Overall Study|Progression|6|||
157092939|NCT00310037|567095772|FG001|Overall Study|Progression|0|||
157092940|NCT00310037|567095771|FG000|Overall Study|Non-protocol treatment|1|||
157092941|NCT00310037|567095772|FG001|Overall Study|Non-protocol treatment|0|||
157092942|NCT00440999|567095783|FG000|Overall Study|Adverse Event|0|||
157092943|NCT00440999|567095784|FG001|Overall Study|Adverse Event|2|||
157092944|NCT00440999|567095783|FG000|Overall Study|Lack of Efficacy|6|||
157092945|NCT00440999|567095784|FG001|Overall Study|Lack of Efficacy|7|||
157092946|NCT00440999|567095783|FG000|Overall Study|Lost to Follow-up|19|||
157092947|NCT00440999|567095784|FG001|Overall Study|Lost to Follow-up|12|||
157092948|NCT00440999|567095783|FG000|Overall Study|Protocol Violation|1|||
157092949|NCT00440999|567095784|FG001|Overall Study|Protocol Violation|0|||
157092950|NCT00440999|567095783|FG000|Overall Study|Withdrawal by Subject|2|||
157092951|NCT00440999|567095784|FG001|Overall Study|Withdrawal by Subject|5|||
157092952|NCT00440999|567095783|FG000|Overall Study|Subjets missed the visit|1|||
157092953|NCT00440999|567095784|FG001|Overall Study|Subjets missed the visit|0|||
157092954|NCT00440999|567095783|FG000|Overall Study|Mixed infection at entry|1|||
157092955|NCT00440999|567095784|FG001|Overall Study|Mixed infection at entry|0|||
157092956|NCT00440999|567095783|FG000|Overall Study|P. falciparum malaria|5|||
157092957|NCT00440999|567095784|FG001|Overall Study|P. falciparum malaria|14|||
157092958|NCT00440999|567095783|FG000|Overall Study|Subj left hosp without inform staff|0|||
157092959|NCT00440999|567095784|FG001|Overall Study|Subj left hosp without inform staff|1|||
157092960|NCT05559099|567095787|FG000|Overall Study|Death|5|||
157092961|NCT05559099|567095788|FG001|Overall Study|Death|4|||
157092962|NCT05559099|567095787|FG000|Overall Study|Lost to Follow-up|0|||
157092963|NCT05559099|567095788|FG001|Overall Study|Lost to Follow-up|2|||
157092964|NCT05559099|567095787|FG000|Overall Study|Adverse Event|1|||
157092965|NCT05559099|567095788|FG001|Overall Study|Adverse Event|1|||
157092966|NCT04018092|567095789|FG000|Overall Study|Withdrawal by Subject|1|||
157092967|NCT04018092|567095790|FG001|Overall Study|Withdrawal by Subject|1|||
157092968|NCT04018092|567095789|FG000|Overall Study|Withdrawal by Subject|1|||
157206149|NCT05168657|567498105|FG004|Overall Study|Adverse Event|0|||
157206150|NCT05168657|567498106|FG005|Overall Study|Adverse Event|0|||
157206151|NCT05168657|567498107|FG006|Overall Study|Adverse Event|0|||
157206152|NCT05168657|567498108|FG007|Overall Study|Adverse Event|0|||
157206153|NCT04935931|567498109|FG000|Overall Study|Withdrawal by Subject|1|||
157206154|NCT00962013|567498110|FG000|Overall Study|Did not have surgery|1|||
156750535|NCT02757352|565838827|FG009|Follow-Up Period|Adverse Event|0|||
157092969|NCT04018092|567095790|FG001|Overall Study|Withdrawal by Subject|1|||
157092970|NCT06469242|567095791|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
157092971|NCT06469242|567095792|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
157092972|NCT06469242|567095791|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
157092973|NCT06469242|567095792|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
157092974|NCT05041101|567095793|FG000|Overall Study|Adverse Event|1|||
157092975|NCT05041101|567095794|FG001|Overall Study|Adverse Event|0|||
157092976|NCT05041101|567095795|FG002|Overall Study|Adverse Event|0|||
157092977|NCT05041101|567095793|FG000|Overall Study|Diease Progression|5|||
157092978|NCT05041101|567095794|FG001|Overall Study|Diease Progression|0|||
157092979|NCT05041101|567095795|FG002|Overall Study|Diease Progression|0|||
157092980|NCT01205152|567095796|FG000|Overall Study|Death|1|||
157092981|NCT00842985|567095797|FG000|Screening|Did not meet entrance requirements|27|||
157092982|NCT00842985|567095797|FG000|First Intervention|Withdrawal by Subject|3|||
157092983|NCT00842985|567095797|FG000|First Intervention|Protocol Violation|3|||
157092984|NCT00842985|567095797|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
157092985|NCT00842985|567095797|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
157092986|NCT01037244|567095798|FG000|Overall Study|Adverse Event|3|||
157206155|NCT00962013|567498110|FG000|Overall Study|Death|8|||
157206156|NCT00962013|567498110|FG000|Overall Study|Lost to Follow-up|12|||
157206157|NCT00962013|567498110|FG000|Overall Study|Unable/Unwilling to return|6|||
157206158|NCT00962013|567498110|FG000|Overall Study|Withdrawal by Subject|8|||
157206159|NCT00962013|567498110|FG000|Overall Study|Removal of study device|3|||
157206160|NCT00962013|567498110|FG000|Overall Study|Site Termination|24|||
157206161|NCT00962013|567498110|FG000|Overall Study|No 5 year evaluation|6|||
157206162|NCT02057549|567498120|FG000|Overall Study|Lost to Follow-up|1|||
157206163|NCT02057549|567498121|FG001|Overall Study|Lost to Follow-up|0|||
157206164|NCT02057549|567498120|FG000|Overall Study|Physician Decision|1|||
157206165|NCT02057549|567498121|FG001|Overall Study|Physician Decision|0|||
157206166|NCT02057549|567498120|FG000|Overall Study|Withdrawal by Subject|1|||
157206167|NCT02057549|567498121|FG001|Overall Study|Withdrawal by Subject|0|||
157206168|NCT01418365|567498122|FG000|First Intervention|Withdrawal by Subject|0|||
157206169|NCT01418365|567498123|FG001|First Intervention|Withdrawal by Subject|1|||
157206170|NCT01418365|567498122|FG000|First Intervention|Non-compliance|1|||
157206171|NCT01418365|567498123|FG001|First Intervention|Non-compliance|0|||
157221626|NCT01644890|567558454|FG001|Overall Study|Death|3|||
157092987|NCT01037244|567095799|FG001|Overall Study|Adverse Event|2|||
157092988|NCT01037244|567095800|FG002|Overall Study|Adverse Event|6|||
157092989|NCT01037244|567095801|FG003|Overall Study|Adverse Event|3|||
157092990|NCT01037244|567095798|FG000|Overall Study|Lack of Efficacy|1|||
157092991|NCT01037244|567095799|FG001|Overall Study|Lack of Efficacy|1|||
157092992|NCT01037244|567095800|FG002|Overall Study|Lack of Efficacy|0|||
157092993|NCT01037244|567095801|FG003|Overall Study|Lack of Efficacy|1|||
157092994|NCT01037244|567095798|FG000|Overall Study|Lost to Follow-up|3|||
157092995|NCT01037244|567095799|FG001|Overall Study|Lost to Follow-up|3|||
157092996|NCT01037244|567095800|FG002|Overall Study|Lost to Follow-up|4|||
157092997|NCT01037244|567095801|FG003|Overall Study|Lost to Follow-up|4|||
157092998|NCT01037244|567095798|FG000|Overall Study|Withdrawal by Subject|1|||
157092999|NCT01037244|567095799|FG001|Overall Study|Withdrawal by Subject|5|||
157093000|NCT01037244|567095800|FG002|Overall Study|Withdrawal by Subject|3|||
157093001|NCT01037244|567095801|FG003|Overall Study|Withdrawal by Subject|5|||
157093002|NCT01037244|567095798|FG000|Overall Study|Partner Withdrew Consent|2|||
157093003|NCT01037244|567095799|FG001|Overall Study|Partner Withdrew Consent|1|||
157093004|NCT01037244|567095800|FG002|Overall Study|Partner Withdrew Consent|0|||
157093005|NCT01037244|567095801|FG003|Overall Study|Partner Withdrew Consent|0|||
157093006|NCT01037244|567095798|FG000|Overall Study|Various|3|||
157093007|NCT01037244|567095799|FG001|Overall Study|Various|2|||
157093008|NCT01037244|567095800|FG002|Overall Study|Various|1|||
157093009|NCT01037244|567095801|FG003|Overall Study|Various|1|||
157093010|NCT01127139|567095802|FG000|Overall Study|Adverse Event|40|||
157093011|NCT01127139|567095802|FG000|Overall Study|Incompliance|12|||
157093012|NCT01127139|567095802|FG000|Overall Study|Lack of Efficacy|4|||
157093013|NCT01127139|567095802|FG000|Overall Study|Reason not specified|1|||
157093014|NCT01136772|567095803|FG000|Overall Study|Adverse Event|15|||
157093015|NCT01136772|567095804|FG001|Overall Study|Adverse Event|14|||
157093016|NCT01136772|567095803|FG000|Overall Study|Lack of Efficacy|42|||
157093017|NCT01136772|567095804|FG001|Overall Study|Lack of Efficacy|39|||
157093018|NCT01136772|567095803|FG000|Overall Study|Administrative|14|||
157093019|NCT01136772|567095804|FG001|Overall Study|Administrative|12|||
157093020|NCT01136772|567095803|FG000|Overall Study|Withdrawal by Subject|33|||
157093021|NCT01136772|567095804|FG001|Overall Study|Withdrawal by Subject|36|||
157093022|NCT01136772|567095803|FG000|Overall Study|Did not receive injection|10|||
157093023|NCT01136772|567095804|FG001|Overall Study|Did not receive injection|7|||
157093024|NCT01136772|567095803|FG000|Overall Study|Did not follow up after first injection|2|||
157093025|NCT01136772|567095804|FG001|Overall Study|Did not follow up after first injection|2|||
157093026|NCT01498653|567095805|FG000|Overall Study|Adverse Event|2|||
157093027|NCT01498653|567095806|FG001|Overall Study|Adverse Event|2|||
157093028|NCT01498653|567095805|FG000|Overall Study|Lack of Efficacy|12|||
157093029|NCT01498653|567095806|FG001|Overall Study|Lack of Efficacy|26|||
157093030|NCT01498653|567095805|FG000|Overall Study|Protocol Violation|0|||
157093031|NCT01498653|567095806|FG001|Overall Study|Protocol Violation|4|||
157093032|NCT01498653|567095805|FG000|Overall Study|Lost to Follow-up|1|||
157093033|NCT01498653|567095806|FG001|Overall Study|Lost to Follow-up|0|||
157093034|NCT01498653|567095805|FG000|Overall Study|Physician Decision|2|||
157093035|NCT01498653|567095806|FG001|Overall Study|Physician Decision|0|||
157093036|NCT01498653|567095805|FG000|Overall Study|Withdrawal by Subject|2|||
157093037|NCT01498653|567095806|FG001|Overall Study|Withdrawal by Subject|3|||
157093038|NCT03421431|567095812|FG000|Overall Study|Adverse Event|2|||
157093039|NCT03421431|567095813|FG001|Overall Study|Adverse Event|1|||
157093040|NCT03421431|567095814|FG002|Overall Study|Adverse Event|12|||
157093041|NCT03421431|567095812|FG000|Overall Study|Lost to Follow-up|1|||
157093042|NCT03421431|567095813|FG001|Overall Study|Lost to Follow-up|1|||
157093043|NCT03421431|567095814|FG002|Overall Study|Lost to Follow-up|1|||
157093044|NCT03421431|567095812|FG000|Overall Study|Withdrawal by Subject|3|||
157093045|NCT03421431|567095813|FG001|Overall Study|Withdrawal by Subject|2|||
157093046|NCT03421431|567095814|FG002|Overall Study|Withdrawal by Subject|1|||
157093047|NCT03421431|567095812|FG000|Overall Study|Protocol Violation|0|||
157093048|NCT03421431|567095813|FG001|Overall Study|Protocol Violation|1|||
157093049|NCT03421431|567095814|FG002|Overall Study|Protocol Violation|0|||
157093050|NCT03421431|567095812|FG000|Overall Study|Participant met Stopping Rules|0|||
157093051|NCT03421431|567095813|FG001|Overall Study|Participant met Stopping Rules|1|||
157093052|NCT03421431|567095814|FG002|Overall Study|Participant met Stopping Rules|0|||
157093053|NCT02216357|567095818|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
157093054|NCT02216357|567095819|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
157093055|NCT00141726|567095821|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
157093056|NCT00235326|567095826|FG000|Overall Study|Lost to Follow-up|746|||
157206172|NCT01418365|567498122|FG000|Second Intervention|Withdrawal by Subject|0|||
157093057|NCT00235326|567095827|FG001|Overall Study|Lost to Follow-up|1400|||
157093058|NCT01477333|567095830|FG000|Overall Study|Adverse Event|1|||
157093059|NCT01477333|567095830|FG000|Overall Study|Withdrawal by Subject|1|||
157093060|NCT01477333|567095830|FG000|Overall Study|Clinical Deterioration|1|||
157093061|NCT01178671|567095831|FG000|Overall Study|Adverse Event|4|||
157093062|NCT01178671|567095832|FG001|Overall Study|Adverse Event|6|||
157093063|NCT01178671|567095831|FG000|Overall Study|Protocol Violation|1|||
157093064|NCT01178671|567095832|FG001|Overall Study|Protocol Violation|1|||
157093065|NCT01178671|567095831|FG000|Overall Study|Lack of Efficacy|0|||
157093066|NCT01178671|567095832|FG001|Overall Study|Lack of Efficacy|1|||
157093067|NCT01178671|567095831|FG000|Overall Study|Lost to Follow-up|3|||
157093068|NCT01178671|567095832|FG001|Overall Study|Lost to Follow-up|1|||
157093069|NCT01178671|567095831|FG000|Overall Study|Physician Decision|4|||
157093070|NCT01178671|567095832|FG001|Overall Study|Physician Decision|6|||
157093071|NCT02435966|567095833|FG000|Overall Study|Withdrawal by Subject|0|||
157093072|NCT02435966|567095834|FG001|Overall Study|Withdrawal by Subject|1|||
157093073|NCT02435966|567095835|FG002|Overall Study|Withdrawal by Subject|0|||
157206173|NCT01418365|567498123|FG001|Second Intervention|Withdrawal by Subject|1|||
157206174|NCT03319368|567498124|FG000|Overall Study|Discharge swabs not collected from resident|57|||
157206175|NCT03319368|567498125|FG001|Overall Study|Discharge swabs not collected from resident|46|||
157206176|NCT00824993|567498132|FG000|Overall Study|Withdrawal by Subject|1|||
157206177|NCT00824993|567498133|FG001|Overall Study|Withdrawal by Subject|1|||
157206178|NCT00824993|567498132|FG000|Overall Study|Malignancy Relapse|9|||
157206179|NCT00824993|567498133|FG001|Overall Study|Malignancy Relapse|10|||
157206180|NCT00824993|567498132|FG000|Overall Study|Rapid Bone Loss|0|||
157206181|NCT00824993|567498133|FG001|Overall Study|Rapid Bone Loss|1|||
157206182|NCT00824993|567498132|FG000|Overall Study|Non-Compliant|2|||
157206183|NCT00824993|567498133|FG001|Overall Study|Non-Compliant|1|||
157206184|NCT00824993|567498132|FG000|Overall Study|Insurance Issue|2|||
157206185|NCT00824993|567498133|FG001|Overall Study|Insurance Issue|1|||
157206186|NCT00824993|567498132|FG000|Overall Study|Death|0|||
157206187|NCT00824993|567498133|FG001|Overall Study|Death|3|||
157206188|NCT02380248|567498134|FG000|Overall Study|Lost to Follow-up|11|||
157206189|NCT02380248|567498134|FG000|Overall Study|Withdrawal by Subject|3|||
157206190|NCT01275170|567498137|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
157206191|NCT01275170|567498138|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206192|NCT01275170|567498139|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206193|NCT01275170|567498140|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206194|NCT01275170|567498141|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206195|NCT01275170|567498142|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206196|NCT01275170|567498143|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206197|NCT01275170|567498144|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
157206198|NCT02864953|567498145|FG000|Overall Study|Adverse Event|22|||
156750536|NCT02757352|565838818|FG000|Follow-Up Period|Lost to Follow-up|0|||
156750537|NCT02757352|565838819|FG001|Follow-Up Period|Lost to Follow-up|0|||
156750538|NCT02757352|565838820|FG002|Follow-Up Period|Lost to Follow-up|0|||
156750539|NCT02757352|565838821|FG003|Follow-Up Period|Lost to Follow-up|0|||
156750540|NCT02757352|565838822|FG004|Follow-Up Period|Lost to Follow-up|0|||
156750541|NCT02757352|565838823|FG005|Follow-Up Period|Lost to Follow-up|0|||
156750542|NCT02757352|565838824|FG006|Follow-Up Period|Lost to Follow-up|0|||
156750543|NCT02757352|565838825|FG007|Follow-Up Period|Lost to Follow-up|0|||
156750544|NCT02757352|565838826|FG008|Follow-Up Period|Lost to Follow-up|1|||
156750545|NCT02757352|565838827|FG009|Follow-Up Period|Lost to Follow-up|0|||
156750546|NCT02757352|565838818|FG000|Follow-Up Period|Lack of Efficacy|0|||
156750547|NCT02757352|565838819|FG001|Follow-Up Period|Lack of Efficacy|0|||
156750548|NCT02757352|565838820|FG002|Follow-Up Period|Lack of Efficacy|0|||
156750549|NCT02757352|565838821|FG003|Follow-Up Period|Lack of Efficacy|0|||
156750550|NCT02757352|565838822|FG004|Follow-Up Period|Lack of Efficacy|0|||
156750551|NCT02757352|565838823|FG005|Follow-Up Period|Lack of Efficacy|0|||
157093074|NCT01078675|567095836|FG000|Overall Study|Withdrawal by Subject|7|||
157093075|NCT01078675|567095837|FG001|Overall Study|Withdrawal by Subject|3|||
157093076|NCT01078675|567095836|FG000|Overall Study|Protocol Violation|56|||
157093077|NCT01078675|567095837|FG001|Overall Study|Protocol Violation|0|||
157093078|NCT01078675|567095836|FG000|Overall Study|Provided in CRF for specific reasons|2|||
157093079|NCT01078675|567095837|FG001|Overall Study|Provided in CRF for specific reasons|3|||
157093080|NCT01078675|567095836|FG000|Overall Study|Adverse Event|3|||
157093081|NCT01078675|567095837|FG001|Overall Study|Adverse Event|0|||
157093082|NCT00928746|567095840|FG000|Overall Study|Adverse Event|2|||
157093083|NCT00928746|567095840|FG000|Overall Study|Protocol Violation|1|||
157093084|NCT00928746|567095840|FG000|Overall Study|Withdrawal by Subject|1|||
157093085|NCT00928746|567095840|FG000|Overall Study|Other|2|||
157206199|NCT02864953|567498146|FG001|Overall Study|Adverse Event|19|||
156750552|NCT02757352|565838824|FG006|Follow-Up Period|Lack of Efficacy|0|||
156750553|NCT02757352|565838825|FG007|Follow-Up Period|Lack of Efficacy|0|||
156750554|NCT02757352|565838826|FG008|Follow-Up Period|Lack of Efficacy|1|||
156750555|NCT02757352|565838827|FG009|Follow-Up Period|Lack of Efficacy|1|||
156750556|NCT02757352|565838818|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156750557|NCT02757352|565838819|FG001|Follow-Up Period|Withdrawal by Subject|0|||
157206200|NCT02864953|567498145|FG000|Overall Study|Withdrawal by Subject|1|||
156750558|NCT02757352|565838820|FG002|Follow-Up Period|Withdrawal by Subject|0|||
157206201|NCT02864953|567498146|FG001|Overall Study|Withdrawal by Subject|0|||
157206202|NCT02864953|567498145|FG000|Overall Study|Physician Decision|4|||
157093086|NCT02745392|567095842|FG000|Overall Study|Lost to Follow-up|0|||
157093087|NCT02745392|567095843|FG001|Overall Study|Lost to Follow-up|1|||
157093088|NCT02745392|567095844|FG002|Overall Study|Lost to Follow-up|0|||
157093089|NCT02745392|567095845|FG003|Overall Study|Lost to Follow-up|0|||
157093090|NCT02513303|567095846|FG000|Overall Study|Withdrawal by Subject|9|||
157093091|NCT02513303|567095847|FG001|Overall Study|Withdrawal by Subject|7|||
157093092|NCT02513303|567095848|FG002|Overall Study|Withdrawal by Subject|2|||
157093093|NCT02513303|567095846|FG000|Overall Study|Lost to Follow-up|2|||
157093094|NCT02513303|567095847|FG001|Overall Study|Lost to Follow-up|4|||
157093095|NCT02513303|567095848|FG002|Overall Study|Lost to Follow-up|0|||
157093096|NCT02513303|567095846|FG000|Overall Study|Adverse Event|0|||
157093097|NCT02513303|567095847|FG001|Overall Study|Adverse Event|1|||
157093098|NCT02513303|567095848|FG002|Overall Study|Adverse Event|0|||
157093099|NCT02513303|567095846|FG000|Overall Study|Physician Decision|1|||
157093100|NCT02513303|567095847|FG001|Overall Study|Physician Decision|1|||
157093101|NCT02513303|567095848|FG002|Overall Study|Physician Decision|0|||
157093102|NCT02513303|567095846|FG000|Overall Study|Death|8|||
157093103|NCT02513303|567095847|FG001|Overall Study|Death|4|||
157093104|NCT02513303|567095848|FG002|Overall Study|Death|2|||
157093105|NCT02004353|567095853|FG000|Overall Study|Voluntary participation|1334|||
157093106|NCT01691768|567095854|FG000|Overall Study|Death|0|||
157093107|NCT01691768|567095855|FG001|Overall Study|Death|2|||
157093108|NCT01691768|567095854|FG000|Overall Study|Lost to Follow-up|4|||
157093109|NCT01691768|567095855|FG001|Overall Study|Lost to Follow-up|3|||
157093110|NCT01691768|567095854|FG000|Overall Study|Withdrawal by Subject|10|||
157093111|NCT01691768|567095855|FG001|Overall Study|Withdrawal by Subject|9|||
157093112|NCT01691768|567095854|FG000|Overall Study|Relocated|0|||
157093113|NCT01691768|567095855|FG001|Overall Study|Relocated|1|||
157093114|NCT01691768|567095854|FG000|Overall Study|Investigator decision|1|||
157093115|NCT01691768|567095855|FG001|Overall Study|Investigator decision|1|||
157093116|NCT02581631|567095856|FG000|Overall Study|Disease progression|29|||
157093117|NCT02581631|567095857|FG001|Overall Study|Disease progression|19|||
157093118|NCT02581631|567095858|FG002|Overall Study|Disease progression|13|||
157093119|NCT02581631|567095859|FG003|Overall Study|Disease progression|5|||
157093120|NCT02581631|567095860|FG004|Overall Study|Disease progression|8|||
156750559|NCT02757352|565838821|FG003|Follow-Up Period|Withdrawal by Subject|0|||
156750560|NCT02757352|565838822|FG004|Follow-Up Period|Withdrawal by Subject|0|||
157093121|NCT02581631|567095856|FG000|Overall Study|Study drug toxicity|4|||
157093122|NCT02581631|567095857|FG001|Overall Study|Study drug toxicity|6|||
157093123|NCT02581631|567095858|FG002|Overall Study|Study drug toxicity|7|||
157093124|NCT02581631|567095859|FG003|Overall Study|Study drug toxicity|0|||
157093125|NCT02581631|567095860|FG004|Overall Study|Study drug toxicity|3|||
157093126|NCT02581631|567095856|FG000|Overall Study|AE unrelated to study drug|3|||
157093127|NCT02581631|567095857|FG001|Overall Study|AE unrelated to study drug|1|||
157093128|NCT02581631|567095858|FG002|Overall Study|AE unrelated to study drug|1|||
157093129|NCT02581631|567095859|FG003|Overall Study|AE unrelated to study drug|0|||
157093130|NCT02581631|567095860|FG004|Overall Study|AE unrelated to study drug|2|||
157093131|NCT02581631|567095856|FG000|Overall Study|Request to discontinue|1|||
157093132|NCT02581631|567095857|FG001|Overall Study|Request to discontinue|0|||
157093133|NCT02581631|567095858|FG002|Overall Study|Request to discontinue|3|||
157093134|NCT02581631|567095859|FG003|Overall Study|Request to discontinue|0|||
157093135|NCT02581631|567095860|FG004|Overall Study|Request to discontinue|1|||
157093136|NCT02581631|567095856|FG000|Overall Study|participant withdrew consent|3|||
157093137|NCT02581631|567095857|FG001|Overall Study|participant withdrew consent|0|||
157093138|NCT02581631|567095858|FG002|Overall Study|participant withdrew consent|1|||
157093139|NCT02581631|567095859|FG003|Overall Study|participant withdrew consent|0|||
157093140|NCT02581631|567095860|FG004|Overall Study|participant withdrew consent|0|||
157093141|NCT02581631|567095856|FG000|Overall Study|Maximum clinical benefit|1|||
157093142|NCT02581631|567095857|FG001|Overall Study|Maximum clinical benefit|7|||
157093143|NCT02581631|567095858|FG002|Overall Study|Maximum clinical benefit|1|||
157093144|NCT02581631|567095859|FG003|Overall Study|Maximum clinical benefit|3|||
157093145|NCT02581631|567095860|FG004|Overall Study|Maximum clinical benefit|13|||
157093146|NCT02581631|567095856|FG000|Overall Study|Other Reasons|1|||
157093147|NCT02581631|567095857|FG001|Overall Study|Other Reasons|0|||
157093148|NCT02581631|567095858|FG002|Overall Study|Other Reasons|2|||
157093149|NCT02581631|567095859|FG003|Overall Study|Other Reasons|2|||
157093150|NCT02581631|567095860|FG004|Overall Study|Other Reasons|3|||
157093151|NCT02581631|567095856|FG000|Overall Study|Poor/Non-Compliance|0|||
157093152|NCT02581631|567095857|FG001|Overall Study|Poor/Non-Compliance|0|||
157093153|NCT02581631|567095858|FG002|Overall Study|Poor/Non-Compliance|1|||
157093154|NCT02581631|567095859|FG003|Overall Study|Poor/Non-Compliance|0|||
157093155|NCT02581631|567095860|FG004|Overall Study|Poor/Non-Compliance|0|||
156750561|NCT02757352|565838823|FG005|Follow-Up Period|Withdrawal by Subject|0|||
157093156|NCT01191268|567095870|FG000|Overall Study|Withdrawal by Subject|19|||
157093157|NCT01191268|567095871|FG001|Overall Study|Withdrawal by Subject|25|||
157093158|NCT01191268|567095872|FG002|Overall Study|Withdrawal by Subject|21|||
157093159|NCT01191268|567095870|FG000|Overall Study|Adverse Event|21|||
157093160|NCT01191268|567095871|FG001|Overall Study|Adverse Event|13|||
157093161|NCT01191268|567095872|FG002|Overall Study|Adverse Event|8|||
157093162|NCT01191268|567095870|FG000|Overall Study|Physician Decision|6|||
157093163|NCT01191268|567095871|FG001|Overall Study|Physician Decision|8|||
156750562|NCT02757352|565838824|FG006|Follow-Up Period|Withdrawal by Subject|0|||
156750563|NCT02757352|565838825|FG007|Follow-Up Period|Withdrawal by Subject|1|||
156750564|NCT02757352|565838826|FG008|Follow-Up Period|Withdrawal by Subject|6|||
156750565|NCT02757352|565838827|FG009|Follow-Up Period|Withdrawal by Subject|2|||
156750566|NCT03536663|565838828|FG000|Endexo|Protocol Violation|1|||
156750567|NCT01128400|565838829|FG000|Overall Study|Lost to Follow-up|1|||
156750568|NCT01128400|565838830|FG001|Overall Study|Lost to Follow-up|0|||
156750569|NCT01128400|565838831|FG002|Overall Study|Lost to Follow-up|1|||
157093164|NCT01191268|567095872|FG002|Overall Study|Physician Decision|9|||
157093165|NCT01191268|567095870|FG000|Overall Study|Lost to Follow-up|8|||
157093166|NCT01191268|567095871|FG001|Overall Study|Lost to Follow-up|5|||
157093167|NCT01191268|567095872|FG002|Overall Study|Lost to Follow-up|9|||
157093168|NCT01191268|567095870|FG000|Overall Study|Entry Criteria Not Met|3|||
157093169|NCT01191268|567095871|FG001|Overall Study|Entry Criteria Not Met|1|||
157093170|NCT01191268|567095872|FG002|Overall Study|Entry Criteria Not Met|1|||
157093171|NCT01191268|567095870|FG000|Overall Study|Death|0|||
157093172|NCT01191268|567095871|FG001|Overall Study|Death|1|||
157093173|NCT01191268|567095872|FG002|Overall Study|Death|3|||
157093174|NCT01191268|567095870|FG000|Overall Study|Protocol Violation|1|||
157093175|NCT01191268|567095871|FG001|Overall Study|Protocol Violation|0|||
157093176|NCT01191268|567095872|FG002|Overall Study|Protocol Violation|1|||
157093177|NCT01191268|567095870|FG000|Overall Study|Sponsor Decision|0|||
157093178|NCT01191268|567095871|FG001|Overall Study|Sponsor Decision|2|||
157093179|NCT01191268|567095872|FG002|Overall Study|Sponsor Decision|0|||
157093180|NCT00336895|567095873|FG000|Overall Study|diarrhea|1|||
157093181|NCT00336895|567095873|FG000|Overall Study|nausea and upset stomach|1|||
156750570|NCT01128400|565838829|FG000|Overall Study|Screening failure|1|||
156750571|NCT01128400|565838830|FG001|Overall Study|Screening failure|0|||
156750572|NCT01128400|565838831|FG002|Overall Study|Screening failure|0|||
156750573|NCT01128400|565838829|FG000|Overall Study|were not invited to participate on taste|0|||
156750574|NCT01128400|565838830|FG001|Overall Study|were not invited to participate on taste|0|||
156750575|NCT01128400|565838831|FG002|Overall Study|were not invited to participate on taste|15|||
156750576|NCT01128400|565838829|FG000|Overall Study|Excluded due to sinus problems|0|||
156750577|NCT01128400|565838830|FG001|Overall Study|Excluded due to sinus problems|1|||
156750578|NCT01128400|565838831|FG002|Overall Study|Excluded due to sinus problems|0|||
156750579|NCT04750278|565838832|FG000|Overall Study|Death|9|||
156750580|NCT04750278|565838833|FG001|Overall Study|Death|10|||
156750581|NCT04750278|565838834|FG002|Overall Study|Death|10|||
156750582|NCT04750278|565838832|FG000|Overall Study|Withdrawal by Subject|4|||
156750583|NCT04750278|565838833|FG001|Overall Study|Withdrawal by Subject|1|||
156750584|NCT04750278|565838834|FG002|Overall Study|Withdrawal by Subject|2|||
156750585|NCT04750278|565838832|FG000|Overall Study|Lost to Follow-up|1|||
156750586|NCT04750278|565838833|FG001|Overall Study|Lost to Follow-up|1|||
157093182|NCT00336895|567095873|FG000|Overall Study|Physician Decision|1|||
156750587|NCT04750278|565838834|FG002|Overall Study|Lost to Follow-up|1|||
156750588|NCT04750278|565838832|FG000|Overall Study|Pregnancy|1|||
156750589|NCT04750278|565838833|FG001|Overall Study|Pregnancy|0|||
156750590|NCT04750278|565838834|FG002|Overall Study|Pregnancy|0|||
156750591|NCT04750278|565838832|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
156750592|NCT04750278|565838833|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
156750593|NCT04750278|565838834|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
156750594|NCT04750278|565838832|FG000|Overall Study|Non-compliance|0|||
156750595|NCT04750278|565838833|FG001|Overall Study|Non-compliance|0|||
156750596|NCT04750278|565838834|FG002|Overall Study|Non-compliance|1|||
156750597|NCT04750278|565838832|FG000|Overall Study|Transfer to Outside Facility|0|||
156750598|NCT04750278|565838833|FG001|Overall Study|Transfer to Outside Facility|2|||
156750599|NCT04750278|565838834|FG002|Overall Study|Transfer to Outside Facility|1|||
157093183|NCT00336895|567095873|FG000|Overall Study|screen failed|1|||
157093184|NCT01959334|567095874|FG000|Second Dose|Adverse Event|1|||
157093185|NCT01959334|567095875|FG001|Second Dose|Adverse Event|0|||
157093186|NCT01959334|567095874|FG000|Third Dose|Adverse Event|0|||
157093187|NCT01959334|567095875|FG001|Third Dose|Adverse Event|1|||
157093188|NCT01313689|567095876|FG000|24-Week Randomization 1|Adverse Event|10|||
157093189|NCT01313689|567095877|FG001|24-Week Randomization 1|Adverse Event|5|||
157093190|NCT01313689|567095878|FG002|24-Week Randomization 1|Adverse Event|0|||
157093191|NCT01313689|567095879|FG003|24-Week Randomization 1|Adverse Event|0|||
157093192|NCT01313689|567095880|FG004|24-Week Randomization 1|Adverse Event|0|||
157093193|NCT01313689|567095876|FG000|24-Week Randomization 1|Physician Decision|4|||
157093194|NCT01313689|567095877|FG001|24-Week Randomization 1|Physician Decision|5|||
157093195|NCT01313689|567095878|FG002|24-Week Randomization 1|Physician Decision|0|||
157093196|NCT01313689|567095879|FG003|24-Week Randomization 1|Physician Decision|0|||
157093197|NCT01313689|567095880|FG004|24-Week Randomization 1|Physician Decision|0|||
157093198|NCT01313689|567095876|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
156750600|NCT04750278|565838832|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
157093199|NCT01313689|567095877|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
157093200|NCT01313689|567095878|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
157093201|NCT01313689|567095879|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
157093202|NCT01313689|567095880|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
157093203|NCT01313689|567095876|FG000|24-Week Randomization 2|Adverse Event|0|||
157093204|NCT01313689|567095877|FG001|24-Week Randomization 2|Adverse Event|0|||
157093205|NCT01313689|567095878|FG002|24-Week Randomization 2|Adverse Event|2|||
157093206|NCT01313689|567095879|FG003|24-Week Randomization 2|Adverse Event|0|||
157093207|NCT01313689|567095880|FG004|24-Week Randomization 2|Adverse Event|8|||
157093208|NCT01313689|567095876|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
157093209|NCT01313689|567095877|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
157093210|NCT01313689|567095878|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
157093211|NCT01313689|567095879|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
157093212|NCT01313689|567095880|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
157206203|NCT02864953|567498146|FG001|Overall Study|Physician Decision|2|||
157206204|NCT02864953|567498145|FG000|Overall Study|Death|3|||
157206205|NCT02864953|567498146|FG001|Overall Study|Death|13|||
157206206|NCT02864953|567498145|FG000|Overall Study|Reason not specified|14|||
157206207|NCT02864953|567498146|FG001|Overall Study|Reason not specified|12|||
157206208|NCT02864953|567498145|FG000|Overall Study|Withdrew Prior to Dosing|9|||
157206209|NCT02864953|567498146|FG001|Overall Study|Withdrew Prior to Dosing|8|||
157206210|NCT04636437|567498150|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
157206211|NCT04636437|567498151|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
157206212|NCT04636437|567498152|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
157206213|NCT04636437|567498150|FG000|Overall Study|Started weight loss drug/program|2|||
157206214|NCT04636437|567498151|FG001|Overall Study|Started weight loss drug/program|1|||
157206215|NCT04636437|567498152|FG002|Overall Study|Started weight loss drug/program|1|||
157206216|NCT04636437|567498150|FG000|Overall Study|Lost to Follow-up|3|||
157206217|NCT04636437|567498151|FG001|Overall Study|Lost to Follow-up|1|||
157206218|NCT04636437|567498152|FG002|Overall Study|Lost to Follow-up|4|||
157206219|NCT04636437|567498150|FG000|Overall Study|Participant or physician decision|3|||
157206220|NCT04636437|567498151|FG001|Overall Study|Participant or physician decision|1|||
157206221|NCT04636437|567498152|FG002|Overall Study|Participant or physician decision|1|||
157206222|NCT00816166|567498153|FG000|Overall Study|Lost to Follow-up|6|||
157206223|NCT00816166|567498154|FG001|Overall Study|Lost to Follow-up|10|||
157206224|NCT00816166|567498153|FG000|Overall Study|Death|4|||
157206225|NCT00816166|567498154|FG001|Overall Study|Death|2|||
157206226|NCT01071278|567498155|FG000|Overall Study|Premature Discontinuation|254|||
157206227|NCT01071278|567498155|FG000|Overall Study|Completion Status Unknown|459|||
157206228|NCT00352664|567498156|FG000|Overall Study|Withdrawal by Subject|7|||
157206229|NCT00352664|567498157|FG001|Overall Study|Withdrawal by Subject|0|||
157206230|NCT03539952|567498158|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
157206231|NCT03539952|567498159|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
157206232|NCT03539952|567498158|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
157206233|NCT03539952|567498159|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
157206234|NCT03539952|567498158|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
157206235|NCT03539952|567498159|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
157206236|NCT03539952|567498158|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
157206237|NCT03539952|567498159|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
157206238|NCT03539952|567498158|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
157206239|NCT03539952|567498159|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
157206240|NCT03539952|567498158|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
157206241|NCT03539952|567498159|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
157206242|NCT03539952|567498158|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
157206243|NCT03539952|567498159|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
157206244|NCT02184988|567498160|FG000|Overall Study|Pregnancy|2|||
157206245|NCT02184988|567498160|FG000|Overall Study|Adverse Event|2|||
157206246|NCT02184988|567498160|FG000|Overall Study|moving away/travelling/unable to complet|6|||
157206247|NCT02184988|567498160|FG000|Overall Study|work scheduling issues|4|||
157206248|NCT02184988|567498160|FG000|Overall Study|various other reasons|9|||
157206249|NCT02184988|567498160|FG000|Overall Study|Lost to Follow-up|32|||
157206250|NCT03075215|567498161|FG000|12-Month Primary Endpoint|Death|152|||
157206251|NCT03075215|567498161|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
157206252|NCT03075215|567498161|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
156750601|NCT04750278|565838833|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
157206253|NCT03075215|567498161|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
157206254|NCT01821391|567498162|FG000|Overall Study|Adverse Event|1|||
157206255|NCT01821391|567498163|FG001|Overall Study|Adverse Event|0|||
157206256|NCT02146365|567498164|FG000|Overall Study|Lost to Follow-up|2|||
157206257|NCT02146365|567498165|FG001|Overall Study|Lost to Follow-up|1|||
157206258|NCT02146365|567498166|FG002|Overall Study|Lost to Follow-up|3|||
157206259|NCT02146365|567498167|FG003|Overall Study|Lost to Follow-up|3|||
157206260|NCT02146365|567498168|FG004|Overall Study|Lost to Follow-up|1|||
156750602|NCT04750278|565838834|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
157206261|NCT02146365|567498169|FG005|Overall Study|Lost to Follow-up|1|||
157206262|NCT02146365|567498170|FG006|Overall Study|Lost to Follow-up|0|||
157206263|NCT02146365|567498171|FG007|Overall Study|Lost to Follow-up|1|||
157206264|NCT02146365|567498164|FG000|Overall Study|Withdrawal by Subject|1|||
157206265|NCT02146365|567498165|FG001|Overall Study|Withdrawal by Subject|2|||
157206266|NCT02146365|567498166|FG002|Overall Study|Withdrawal by Subject|1|||
157206267|NCT02146365|567498167|FG003|Overall Study|Withdrawal by Subject|5|||
157206268|NCT02146365|567498168|FG004|Overall Study|Withdrawal by Subject|1|||
157206269|NCT02146365|567498169|FG005|Overall Study|Withdrawal by Subject|0|||
157206270|NCT02146365|567498170|FG006|Overall Study|Withdrawal by Subject|0|||
157206271|NCT02146365|567498171|FG007|Overall Study|Withdrawal by Subject|0|||
157206272|NCT02146365|567498164|FG000|Overall Study|Unable to Comply with Protocol|0|||
157206273|NCT02146365|567498165|FG001|Overall Study|Unable to Comply with Protocol|1|||
157206274|NCT02146365|567498166|FG002|Overall Study|Unable to Comply with Protocol|1|||
157206275|NCT02146365|567498167|FG003|Overall Study|Unable to Comply with Protocol|0|||
157206276|NCT02146365|567498168|FG004|Overall Study|Unable to Comply with Protocol|0|||
157206277|NCT02146365|567498169|FG005|Overall Study|Unable to Comply with Protocol|0|||
156750603|NCT04750278|565838832|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
156750604|NCT04750278|565838833|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
156750605|NCT04750278|565838834|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
156750606|NCT01616758|565838838|FG000|Overall Study|Adverse Event|1|||
156750607|NCT01616758|565838838|FG000|Overall Study|Withdrawal by Subject|2|||
156750608|NCT01616758|565838838|FG000|Overall Study|Disease progression|18|||
156750609|NCT01616758|565838838|FG000|Overall Study|Study termination by Sponsor|1|||
156750610|NCT01054222|565838843|FG000|Overall Study|Lack of Efficacy|1|||
156750611|NCT01054222|565838843|FG000|Overall Study|Lost to Follow-up|4|||
156750612|NCT01054222|565838843|FG000|Overall Study|Withdrawal by Subject|6|||
156750613|NCT03782571|565838844|FG000|Period 1|Withdrawal by Subject|1|||
156750614|NCT03782571|565838845|FG001|Period 1|Withdrawal by Subject|0|||
156750615|NCT03782571|565838846|FG002|Period 1|Withdrawal by Subject|0|||
156750616|NCT03782571|565838847|FG003|Period 1|Withdrawal by Subject|0|||
156750617|NCT03782571|565838844|FG000|Period 3|Subject Unable to Attend V5|1|||
156750618|NCT03782571|565838845|FG001|Period 3|Subject Unable to Attend V5|0|||
156750619|NCT03782571|565838846|FG002|Period 3|Subject Unable to Attend V5|0|||
156750620|NCT03782571|565838847|FG003|Period 3|Subject Unable to Attend V5|0|||
156750621|NCT03782571|565838844|FG000|Period 3|Adverse Event|1|||
156750622|NCT03782571|565838845|FG001|Period 3|Adverse Event|0|||
156750623|NCT03782571|565838846|FG002|Period 3|Adverse Event|0|||
156750624|NCT03782571|565838847|FG003|Period 3|Adverse Event|0|||
156750625|NCT03504189|565838848|FG000|Overall Study|Withdrawal by Subject|1|||
156750626|NCT03504189|565838848|FG000|Overall Study|Screening Failure|1|||
156750627|NCT03504189|565838848|FG000|Overall Study|Device Failure|2|||
156750628|NCT03488563|565838849|FG000|Overall Study|Lost to Follow-up|7|||
156750629|NCT03488563|565838850|FG001|Overall Study|Lost to Follow-up|6|||
156750630|NCT03488563|565838851|FG002|Overall Study|Lost to Follow-up|7|||
156750631|NCT03488563|565838849|FG000|Overall Study|Withdrawal by Subject|8|||
156750632|NCT03488563|565838850|FG001|Overall Study|Withdrawal by Subject|7|||
156750633|NCT03488563|565838851|FG002|Overall Study|Withdrawal by Subject|7|||
156750634|NCT03488563|565838849|FG000|Overall Study|Physician Decision|0|||
156750635|NCT03488563|565838850|FG001|Overall Study|Physician Decision|0|||
156750636|NCT03488563|565838851|FG002|Overall Study|Physician Decision|1|||
156750637|NCT03488563|565838849|FG000|Overall Study|Protocol Violation|3|||
156750638|NCT03488563|565838850|FG001|Overall Study|Protocol Violation|2|||
156750639|NCT03488563|565838851|FG002|Overall Study|Protocol Violation|6|||
156750640|NCT03488563|565838849|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
156750641|NCT03488563|565838850|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
156750642|NCT03488563|565838851|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
156750643|NCT03488563|565838849|FG000|Overall Study|Use of prohibited medication|2|||
156750644|NCT03488563|565838850|FG001|Overall Study|Use of prohibited medication|0|||
156750645|NCT03488563|565838851|FG002|Overall Study|Use of prohibited medication|0|||
156750646|NCT03488563|565838849|FG000|Overall Study|Adverse Event|1|||
156750647|NCT03488563|565838850|FG001|Overall Study|Adverse Event|0|||
156750648|NCT03488563|565838851|FG002|Overall Study|Adverse Event|1|||
156750649|NCT03488563|565838849|FG000|Overall Study|Subject returned for ET visit|0|||
156750650|NCT03488563|565838850|FG001|Overall Study|Subject returned for ET visit|1|||
156978014|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
157206278|NCT02146365|567498170|FG006|Overall Study|Unable to Comply with Protocol|0|||
157206279|NCT02146365|567498171|FG007|Overall Study|Unable to Comply with Protocol|0|||
157206280|NCT02146365|567498164|FG000|Overall Study|Other|1|||
157206281|NCT02146365|567498165|FG001|Overall Study|Other|0|||
157206282|NCT02146365|567498166|FG002|Overall Study|Other|2|||
157206283|NCT02146365|567498167|FG003|Overall Study|Other|1|||
157206284|NCT02146365|567498168|FG004|Overall Study|Other|0|||
157206285|NCT02146365|567498169|FG005|Overall Study|Other|0|||
157206286|NCT02146365|567498170|FG006|Overall Study|Other|0|||
157206287|NCT02146365|567498171|FG007|Overall Study|Other|0|||
157206288|NCT01608321|567498172|FG000|Overall Study|Withdrawal by Subject|1|||
157206289|NCT01608321|567498173|FG001|Overall Study|Withdrawal by Subject|0|||
157206290|NCT03222856|567498176|FG000|Overall Study|Adverse Event|6|||
157206291|NCT03222856|567498176|FG000|Overall Study|Death|1|||
157206292|NCT02545868|567499642|FG000|Overall Study|Lack of Efficacy|1|||
157206293|NCT02545868|567499643|FG001|Overall Study|Lack of Efficacy|1|||
157206294|NCT02545868|567499644|FG002|Overall Study|Lack of Efficacy|0|||
157206295|NCT02545868|567499642|FG000|Overall Study|Lost to Follow-up|1|||
157206296|NCT02545868|567499643|FG001|Overall Study|Lost to Follow-up|5|||
157206297|NCT02545868|567499644|FG002|Overall Study|Lost to Follow-up|1|||
156750651|NCT03488563|565838851|FG002|Overall Study|Subject returned for ET visit|0|||
156750652|NCT03488563|565838849|FG000|Overall Study|Sponsor's decision|0|||
157206298|NCT02545868|567499642|FG000|Overall Study|Non-compliance|1|||
157206299|NCT02545868|567499643|FG001|Overall Study|Non-compliance|1|||
156750653|NCT03488563|565838850|FG001|Overall Study|Sponsor's decision|0|||
156750654|NCT03488563|565838851|FG002|Overall Study|Sponsor's decision|1|||
156750655|NCT02007278|565838870|FG000|Overall Study|Failure to comply with an eligibility|0|||
156750656|NCT02007278|565838871|FG001|Overall Study|Failure to comply with an eligibility|1|||
156750657|NCT02007278|565838870|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
156750658|NCT02007278|565838871|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
156750659|NCT02007278|565838870|FG000|Overall Study|Incorrect medication administration|1|||
156750660|NCT02007278|565838871|FG001|Overall Study|Incorrect medication administration|0|||
156750661|NCT02007278|565838870|FG000|Overall Study|Mis-randomization|1|||
156750662|NCT02007278|565838871|FG001|Overall Study|Mis-randomization|1|||
156750663|NCT01429441|565838875|FG000|Overall Study|Adverse Event|5|||
156750664|NCT01429441|565838876|FG001|Overall Study|Adverse Event|1|||
156750665|NCT01429441|565838875|FG000|Overall Study|Death|0|||
156750666|NCT01429441|565838876|FG001|Overall Study|Death|2|||
156750667|NCT01429441|565838875|FG000|Overall Study|Lost to Follow-up|5|||
156750668|NCT01429441|565838876|FG001|Overall Study|Lost to Follow-up|2|||
156750669|NCT01429441|565838875|FG000|Overall Study|Physician Decision|1|||
156750670|NCT01429441|565838876|FG001|Overall Study|Physician Decision|0|||
156750671|NCT01429441|565838875|FG000|Overall Study|Withdrawal by Subject|27|||
156750672|NCT01429441|565838876|FG001|Overall Study|Withdrawal by Subject|18|||
156750673|NCT02670382|565838880|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
156750674|NCT02670382|565838881|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
156750675|NCT03244618|565838882|FG000|Overall Study|Lost to Follow-up|3|||
156750676|NCT03244618|565838883|FG001|Overall Study|Lost to Follow-up|4|||
156750677|NCT03244618|565838882|FG000|Overall Study|Protocol Violation|4|||
156750678|NCT03244618|565838883|FG001|Overall Study|Protocol Violation|3|||
156750679|NCT03244618|565838882|FG000|Overall Study|Withdrawal by Subject|0|||
156750680|NCT03244618|565838883|FG001|Overall Study|Withdrawal by Subject|2|||
156750681|NCT03469999|565838886|FG000|Overall Study|Lost to Follow-up|2|||
156750682|NCT03383692|565838889|FG000|Overall Study|Progressive disease as per RECIST|3|||
156750683|NCT03383692|565838890|FG001|Overall Study|Progressive disease as per RECIST|3|||
156750684|NCT03383692|565838889|FG000|Overall Study|Clinical progression|0|||
156750685|NCT03383692|565838890|FG001|Overall Study|Clinical progression|1|||
156750686|NCT03383692|565838889|FG000|Overall Study|Adverse Event|3|||
156750687|NCT03383692|565838890|FG001|Overall Study|Adverse Event|0|||
156750688|NCT03816007|565838891|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
156750689|NCT03816007|565838892|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
156750690|NCT03816007|565838891|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
156750691|NCT03816007|565838892|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
156750692|NCT03816007|565838891|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
156750693|NCT03816007|565838892|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
156750694|NCT02179749|565838893|FG000|Overall Study|Adverse Event|0|||
156750695|NCT02179749|565838894|FG001|Overall Study|Adverse Event|0|||
156750696|NCT02179749|565838895|FG002|Overall Study|Adverse Event|1|||
156750697|NCT02179749|565838893|FG000|Overall Study|Withdrawal by Subject|0|||
156750698|NCT02179749|565838894|FG001|Overall Study|Withdrawal by Subject|0|||
156750699|NCT02179749|565838895|FG002|Overall Study|Withdrawal by Subject|1|||
156750700|NCT01810783|565838897|FG000|Overall Study|Adverse Event|32|||
156750701|NCT01810783|565838897|FG000|Overall Study|Withdrawal by Subject|22|||
156750702|NCT01810783|565838897|FG000|Overall Study|Lack of Efficacy|12|||
156750703|NCT01810783|565838897|FG000|Overall Study|Lost to Follow-up|10|||
156750704|NCT01810783|565838897|FG000|Overall Study|Protocol Violation|5|||
156750705|NCT01810783|565838897|FG000|Overall Study|Non-compliance with IMP|4|||
156750706|NCT01810783|565838897|FG000|Overall Study|Adminstrative or other reason(s)|23|||
156750707|NCT01810783|565838897|FG000|Overall Study|Enrolled, not treated|1|||
156750708|NCT00793546|565838898|FG000|Overall Study|Death|3|||
156750709|NCT00793546|565838899|FG001|Overall Study|Death|0|||
156750710|NCT00793546|565838898|FG000|Overall Study|Lost to Follow-up|1|||
156750711|NCT00793546|565838899|FG001|Overall Study|Lost to Follow-up|0|||
156750712|NCT00793546|565838898|FG000|Overall Study|Withdrawal by Subject|1|||
156750713|NCT00793546|565838899|FG001|Overall Study|Withdrawal by Subject|1|||
156750714|NCT00793546|565838898|FG000|Overall Study|Study Terminated by Sponsor|8|||
156750715|NCT00793546|565838899|FG001|Overall Study|Study Terminated by Sponsor|27|||
156750716|NCT00793546|565838898|FG000|Overall Study|Other|1|||
156750717|NCT00793546|565838899|FG001|Overall Study|Other|0|||
156750718|NCT02620384|565838900|FG000|Overall Study|Adverse Event|2|||
156750719|NCT02620384|565838901|FG001|Overall Study|Adverse Event|1|||
156750720|NCT02620384|565838900|FG000|Overall Study|Discharged prior to 2nd dose|2|||
156750721|NCT02620384|565838901|FG001|Overall Study|Discharged prior to 2nd dose|5|||
156750722|NCT02620384|565838900|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
156750723|NCT02620384|565838901|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
156750724|NCT00094536|565838902|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
156750725|NCT00094536|565838902|FG000|Treatment and Follow-up|Adverse Event|4|||
156750726|NCT00094536|565838902|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
156750727|NCT00094536|565838902|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
156750728|NCT00094536|565838902|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
156750729|NCT00094536|565838902|FG000|Treatment and Follow-up|Subject non-compliance|9|||
156750730|NCT00094536|565838902|FG000|Treatment and Follow-up|Unable to attend visits|1|||
156750731|NCT02071082|565838903|FG000|Overall Study|Enrolled and Never Treated|1|||
156750732|NCT02071082|565838904|FG001|Overall Study|Enrolled and Never Treated|1|||
156750733|NCT02071082|565838903|FG000|Overall Study|Adverse Event|0|||
156750734|NCT02071082|565838904|FG001|Overall Study|Adverse Event|1|||
156750735|NCT02071082|565838903|FG000|Overall Study|Withdrew Consent|0|||
156750736|NCT02071082|565838904|FG001|Overall Study|Withdrew Consent|4|||
156750737|NCT02071082|565838903|FG000|Overall Study|Lost to Follow-up|1|||
156750738|NCT02071082|565838904|FG001|Overall Study|Lost to Follow-up|1|||
156750739|NCT02101359|565838905|FG000|Overall Study|Not included|23|||
156750740|NCT02101359|565838906|FG001|Overall Study|Not included|13|||
156750741|NCT02101359|565838905|FG000|Overall Study|Withdrawal by Subject|5|||
156750742|NCT02101359|565838906|FG001|Overall Study|Withdrawal by Subject|4|||
156750743|NCT02101359|565838905|FG000|Overall Study|Lost to Follow-up|1|||
156750744|NCT02101359|565838906|FG001|Overall Study|Lost to Follow-up|0|||
156750745|NCT02101359|565838905|FG000|Overall Study|Protocol Violation|0|||
156750746|NCT02101359|565838906|FG001|Overall Study|Protocol Violation|2|||
156750747|NCT00494221|565838907|FG000|Overall Study|Death|15|||
156750748|NCT00494221|565838908|FG001|Overall Study|Death|9|||
156750749|NCT00494221|565838909|FG002|Overall Study|Death|14|||
156750750|NCT00494221|565838907|FG000|Overall Study|Withdrawal by Subject|1|||
156750751|NCT00494221|565838908|FG001|Overall Study|Withdrawal by Subject|2|||
156750752|NCT00494221|565838909|FG002|Overall Study|Withdrawal by Subject|0|||
156750753|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
156750754|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
156750755|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
156750756|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
156750757|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
156750758|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
156750759|NCT01900431|565838914|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
156750760|NCT01900431|565838915|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
156750761|NCT01900431|565838916|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
156750762|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
156750763|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
156750764|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
156750765|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
156750766|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
156750767|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
156750768|NCT01900431|565838914|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
156750769|NCT01900431|565838915|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
156750770|NCT01900431|565838916|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
156750771|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
156750772|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
156750773|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
156750774|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
156750775|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
157206300|NCT02545868|567499644|FG002|Overall Study|Non-compliance|1|||
157206301|NCT02545868|567499642|FG000|Overall Study|Treatment change|21|||
157206302|NCT02545868|567499643|FG001|Overall Study|Treatment change|19|||
157206303|NCT02545868|567499644|FG002|Overall Study|Treatment change|22|||
157206304|NCT02545868|567499642|FG000|Overall Study|Physician Decision|1|||
157206305|NCT02545868|567499643|FG001|Overall Study|Physician Decision|1|||
157206306|NCT02545868|567499644|FG002|Overall Study|Physician Decision|1|||
157206307|NCT02545868|567499642|FG000|Overall Study|Withdrawal by Subject|6|||
157206308|NCT02545868|567499643|FG001|Overall Study|Withdrawal by Subject|7|||
157206309|NCT02545868|567499644|FG002|Overall Study|Withdrawal by Subject|9|||
157206310|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
157206311|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
157206312|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
157206313|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
157206314|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
157206315|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
156750776|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
156750777|NCT01900431|565838914|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
156750778|NCT01900431|565838915|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
156750779|NCT01900431|565838916|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
156750780|NCT01841567|565838917|FG000|Overall Study|Adverse Event|3|||
156750781|NCT00630747|565838918|FG000|Overall Study|Death|1|||
156750782|NCT00630747|565838918|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
156750783|NCT00630747|565838918|FG000|Overall Study|Returned to country of origin|1|||
156750784|NCT02732327|565838921|FG000|Overall Study|Protocol Violation|0|||
156750785|NCT02732327|565838922|FG001|Overall Study|Protocol Violation|1|||
156750786|NCT00435019|565838923|FG000|Overall Study|Adverse Event|1|||
156750787|NCT00435019|565838924|FG001|Overall Study|Adverse Event|0|||
156750788|NCT00435019|565838923|FG000|Overall Study|Lack of Efficacy|1|||
156750789|NCT00435019|565838924|FG001|Overall Study|Lack of Efficacy|2|||
156750790|NCT00435019|565838923|FG000|Overall Study|Protocol Violation|3|||
156750791|NCT00435019|565838924|FG001|Overall Study|Protocol Violation|1|||
156750792|NCT00435019|565838923|FG000|Overall Study|Personal reasons for withdrawal|8|||
156750793|NCT00435019|565838924|FG001|Overall Study|Personal reasons for withdrawal|7|||
156750794|NCT04503668|565838925|FG000|Overall Study|Incomplete data|4|||
156750795|NCT04503668|565838926|FG001|Overall Study|Incomplete data|3|||
156750796|NCT04503668|565838925|FG000|Overall Study|Withdrawal by Subject|1|||
156750797|NCT04503668|565838926|FG001|Overall Study|Withdrawal by Subject|1|||
156750798|NCT04503668|565838925|FG000|Overall Study|Adverse Event|2|||
156750799|NCT04503668|565838926|FG001|Overall Study|Adverse Event|0|||
156750800|NCT02306694|565838927|FG000|Overall Study|Withdrawal by Subject|3|||
156750801|NCT02306694|565838927|FG000|Overall Study|Lost to Follow-up|1|||
156750802|NCT00603382|565838928|FG000|Overall Study|Adverse Event|0|||
156750803|NCT00603382|565838929|FG001|Overall Study|Adverse Event|1|||
156750804|NCT00603382|565838930|FG002|Overall Study|Adverse Event|1|||
156750805|NCT00603382|565838931|FG003|Overall Study|Adverse Event|2|||
156750806|NCT00603382|565838932|FG004|Overall Study|Adverse Event|1|||
156750807|NCT00603382|565838933|FG005|Overall Study|Adverse Event|2|||
156750808|NCT00603382|565838928|FG000|Overall Study|Lack of Efficacy|14|||
156750809|NCT00603382|565838929|FG001|Overall Study|Lack of Efficacy|9|||
156750810|NCT00603382|565838930|FG002|Overall Study|Lack of Efficacy|3|||
156750811|NCT00603382|565838931|FG003|Overall Study|Lack of Efficacy|6|||
156750812|NCT00603382|565838932|FG004|Overall Study|Lack of Efficacy|6|||
156750813|NCT00603382|565838933|FG005|Overall Study|Lack of Efficacy|11|||
156750814|NCT00603382|565838928|FG000|Overall Study|Protocol Violation|1|||
156750815|NCT00603382|565838929|FG001|Overall Study|Protocol Violation|0|||
156750816|NCT00603382|565838930|FG002|Overall Study|Protocol Violation|1|||
156750817|NCT00603382|565838931|FG003|Overall Study|Protocol Violation|2|||
156750818|NCT00603382|565838932|FG004|Overall Study|Protocol Violation|1|||
156750819|NCT00603382|565838933|FG005|Overall Study|Protocol Violation|0|||
156750820|NCT00603382|565838928|FG000|Overall Study|Lost to Follow-up|0|||
156750821|NCT00603382|565838929|FG001|Overall Study|Lost to Follow-up|1|||
156750822|NCT00603382|565838930|FG002|Overall Study|Lost to Follow-up|1|||
156750823|NCT00603382|565838931|FG003|Overall Study|Lost to Follow-up|1|||
156750824|NCT00603382|565838932|FG004|Overall Study|Lost to Follow-up|0|||
157206316|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
157206317|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
157206318|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
157206319|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
157206320|NCT01777191|567499645|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
157206321|NCT01777191|567499646|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
157206322|NCT01777191|567499645|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
157206323|NCT01777191|567499646|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
157206324|NCT01777191|567499645|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
157206325|NCT01777191|567499646|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
157206326|NCT01777191|567499645|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
157206327|NCT01777191|567499646|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
157206328|NCT01777191|567499645|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
157206329|NCT01777191|567499646|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
157206330|NCT01777191|567499645|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
156750825|NCT00603382|565838933|FG005|Overall Study|Lost to Follow-up|1|||
156750826|NCT00603382|565838928|FG000|Overall Study|Physician Decision|0|||
156750827|NCT00603382|565838929|FG001|Overall Study|Physician Decision|0|||
156750828|NCT00603382|565838930|FG002|Overall Study|Physician Decision|2|||
156750829|NCT00603382|565838931|FG003|Overall Study|Physician Decision|0|||
156750830|NCT00603382|565838932|FG004|Overall Study|Physician Decision|1|||
157206331|NCT01777191|567499646|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
157206332|NCT03286400|567499651|FG000|Overall Study|Death|10|||
157206333|NCT03286400|567499651|FG000|Overall Study|Lost to Follow-up|10|||
157206334|NCT03286400|567499651|FG000|Overall Study|Physician Decision|1|||
157206335|NCT03286400|567499651|FG000|Overall Study|Scheduling difficulty|4|||
157206336|NCT01856686|567499652|FG000|Overall Study|Lost to Follow-up|5|||
157206337|NCT01856686|567499653|FG001|Overall Study|Lost to Follow-up|11|||
157206338|NCT01461369|567499654|FG000|Overall Study|Lack of Efficacy|2|||
157206339|NCT01461369|567499655|FG001|Overall Study|Lack of Efficacy|0|||
157206340|NCT01461369|567499656|FG002|Overall Study|Lack of Efficacy|6|||
157206341|NCT01461369|567499654|FG000|Overall Study|Lost to Follow-up|0|||
157206342|NCT01461369|567499655|FG001|Overall Study|Lost to Follow-up|0|||
157206343|NCT01461369|567499656|FG002|Overall Study|Lost to Follow-up|3|||
157206344|NCT01461369|567499654|FG000|Overall Study|Adverse Event|9|||
157206345|NCT01461369|567499655|FG001|Overall Study|Adverse Event|12|||
157206346|NCT01461369|567499656|FG002|Overall Study|Adverse Event|4|||
156750831|NCT00603382|565838933|FG005|Overall Study|Physician Decision|3|||
156750832|NCT00603382|565838928|FG000|Overall Study|Withdrawal by Subject|3|||
156750833|NCT00603382|565838929|FG001|Overall Study|Withdrawal by Subject|3|||
156750834|NCT00603382|565838930|FG002|Overall Study|Withdrawal by Subject|1|||
156750835|NCT00603382|565838931|FG003|Overall Study|Withdrawal by Subject|1|||
156750836|NCT00603382|565838932|FG004|Overall Study|Withdrawal by Subject|0|||
156750837|NCT00603382|565838933|FG005|Overall Study|Withdrawal by Subject|1|||
156750838|NCT00395642|565838934|FG000|Overall Study|Death|4|||
156750839|NCT00395642|565838934|FG000|Overall Study|Lost to Follow-up|1|||
156750840|NCT00395642|565838934|FG000|Overall Study|Physician Decision|7|||
156750841|NCT00395642|565838934|FG000|Overall Study|Withdrawal by Subject|1|||
156750842|NCT01078298|565838942|FG000|Overall Study|Lost to Follow-up|12|||
156750843|NCT01078298|565838943|FG001|Overall Study|Lost to Follow-up|13|||
156750844|NCT01078298|565838942|FG000|Overall Study|Withdrawal by Subject|31|||
156750845|NCT01078298|565838943|FG001|Overall Study|Withdrawal by Subject|33|||
156750846|NCT01078298|565838942|FG000|Overall Study|Protocol Violation|6|||
156750847|NCT01078298|565838943|FG001|Overall Study|Protocol Violation|6|||
156750848|NCT01078298|565838942|FG000|Overall Study|Adverse Event|6|||
156750849|NCT01078298|565838943|FG001|Overall Study|Adverse Event|5|||
156750850|NCT01078298|565838942|FG000|Overall Study|Death|2|||
156750851|NCT01078298|565838943|FG001|Overall Study|Death|0|||
156750852|NCT01078298|565838942|FG000|Overall Study|Did not meet entrance criteria|0|||
156750853|NCT01078298|565838943|FG001|Overall Study|Did not meet entrance criteria|1|||
156750854|NCT01078298|565838942|FG000|Overall Study|Other|24|||
156750855|NCT01078298|565838943|FG001|Overall Study|Other|32|||
156750856|NCT00659776|565838947|FG000|Overall Study|Withdrawal by Subject|12|||
156750857|NCT00659776|565838948|FG001|Overall Study|Withdrawal by Subject|2|||
156750858|NCT00659776|565838949|FG002|Overall Study|Withdrawal by Subject|0|||
156750859|NCT00742027|565838950|FG000|Overall Study|Disease Progression|76|||
156750860|NCT00742027|565838950|FG000|Overall Study|New Cancer Therapy|19|||
156750861|NCT00742027|565838950|FG000|Overall Study|Withdrawal by Subject|18|||
156750862|NCT00742027|565838950|FG000|Overall Study|Death|7|||
156750863|NCT00742027|565838950|FG000|Overall Study|Lost to Follow-up|4|||
156750864|NCT00742027|565838950|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
156750865|NCT00742027|565838950|FG000|Overall Study|Missing|2|||
156750866|NCT00742027|565838950|FG000|Overall Study|Administrative Problems|1|||
156750867|NCT01180049|565838951|FG000|Overall Study|Other|9|||
156750868|NCT01180049|565838952|FG001|Overall Study|Other|7|||
156750869|NCT01180049|565838951|FG000|Overall Study|Lost to Follow-up|8|||
156750870|NCT01180049|565838952|FG001|Overall Study|Lost to Follow-up|6|||
156750871|NCT01180049|565838951|FG000|Overall Study|Death|36|||
156750872|NCT01180049|565838952|FG001|Overall Study|Death|35|||
156750873|NCT00628927|565838953|FG000|Overall Study|Problems performing blood draw|6|||
156750874|NCT00628927|565838954|FG001|Overall Study|Problems performing blood draw|0|||
156750875|NCT00628927|565838953|FG000|Overall Study|Lost to Follow-up|1|||
156750876|NCT00628927|565838954|FG001|Overall Study|Lost to Follow-up|0|||
156750877|NCT00628927|565838953|FG000|Overall Study|Equipment failure|1|||
156750878|NCT00628927|565838954|FG001|Overall Study|Equipment failure|0|||
156750879|NCT01298141|565838958|FG000|Overall Study|Adverse Event|3|||
156750880|NCT01298141|565838958|FG000|Overall Study|Refusal of Required Study Procedures|1|||
157206347|NCT01461369|567499654|FG000|Overall Study|Protocol Violation|1|||
157206348|NCT01461369|567499655|FG001|Overall Study|Protocol Violation|2|||
157206349|NCT01461369|567499656|FG002|Overall Study|Protocol Violation|2|||
157206350|NCT01461369|567499654|FG000|Overall Study|Withdrawal by Subject|1|||
156750881|NCT01298141|565838958|FG000|Overall Study|Withdrawal by Subject|6|||
156750882|NCT01298141|565838958|FG000|Overall Study|Termination of Study by the Investigator|5|||
156750883|NCT01298141|565838958|FG000|Overall Study|Other|5|||
156750884|NCT01298141|565838958|FG000|Overall Study|Lost to Follow-up|1|||
156750885|NCT01298141|565838958|FG000|Overall Study|Death|6|||
156750886|NCT01298141|565838958|FG000|Overall Study|Not treated|4|||
156750887|NCT02552888|565838959|FG000|Overall Study|Lost to Follow-up|1|||
157206351|NCT01461369|567499655|FG001|Overall Study|Withdrawal by Subject|3|||
156750888|NCT02552888|565838960|FG001|Overall Study|Lost to Follow-up|1|||
157206352|NCT01461369|567499656|FG002|Overall Study|Withdrawal by Subject|2|||
157206353|NCT01563029|567499663|FG000|Overall Study|Adverse Event|1|||
157206354|NCT01563029|567499664|FG001|Overall Study|Adverse Event|0|||
157206355|NCT01563029|567499665|FG002|Overall Study|Adverse Event|1|||
157206356|NCT01563029|567499666|FG003|Overall Study|Adverse Event|2|||
157206357|NCT01563029|567499667|FG004|Overall Study|Adverse Event|1|||
157206358|NCT01563029|567499663|FG000|Overall Study|Lack of Efficacy|42|||
157206359|NCT01563029|567499664|FG001|Overall Study|Lack of Efficacy|16|||
157206360|NCT01563029|567499665|FG002|Overall Study|Lack of Efficacy|23|||
157206361|NCT01563029|567499666|FG003|Overall Study|Lack of Efficacy|21|||
157206362|NCT01563029|567499667|FG004|Overall Study|Lack of Efficacy|19|||
157206363|NCT01563029|567499663|FG000|Overall Study|Protocol Violation|1|||
157206364|NCT01563029|567499664|FG001|Overall Study|Protocol Violation|2|||
157206365|NCT01563029|567499665|FG002|Overall Study|Protocol Violation|3|||
157206366|NCT01563029|567499666|FG003|Overall Study|Protocol Violation|1|||
157206367|NCT01563029|567499667|FG004|Overall Study|Protocol Violation|3|||
157206368|NCT01563029|567499663|FG000|Overall Study|Protocol defined stopping criteria|1|||
157206369|NCT01563029|567499664|FG001|Overall Study|Protocol defined stopping criteria|0|||
157206370|NCT01563029|567499665|FG002|Overall Study|Protocol defined stopping criteria|0|||
157206371|NCT01563029|567499666|FG003|Overall Study|Protocol defined stopping criteria|0|||
157206372|NCT01563029|567499667|FG004|Overall Study|Protocol defined stopping criteria|0|||
157206373|NCT01563029|567499663|FG000|Overall Study|Lost to Follow-up|1|||
157206374|NCT01563029|567499664|FG001|Overall Study|Lost to Follow-up|0|||
157206375|NCT01563029|567499665|FG002|Overall Study|Lost to Follow-up|1|||
157206376|NCT01563029|567499666|FG003|Overall Study|Lost to Follow-up|1|||
157206377|NCT01563029|567499667|FG004|Overall Study|Lost to Follow-up|1|||
157206378|NCT01563029|567499663|FG000|Overall Study|Physician Decision|3|||
157206379|NCT01563029|567499664|FG001|Overall Study|Physician Decision|5|||
157206380|NCT01563029|567499665|FG002|Overall Study|Physician Decision|2|||
157206381|NCT01563029|567499666|FG003|Overall Study|Physician Decision|4|||
157206382|NCT01563029|567499667|FG004|Overall Study|Physician Decision|2|||
157206383|NCT01563029|567499663|FG000|Overall Study|Withdrawal by Subject|4|||
157206384|NCT01563029|567499664|FG001|Overall Study|Withdrawal by Subject|1|||
157206385|NCT01563029|567499665|FG002|Overall Study|Withdrawal by Subject|3|||
157206386|NCT01563029|567499666|FG003|Overall Study|Withdrawal by Subject|4|||
157206387|NCT01563029|567499667|FG004|Overall Study|Withdrawal by Subject|3|||
157206388|NCT01569594|567499668|FG000|Overall Study|Physician Decision|4|||
157206389|NCT01569594|567499668|FG000|Overall Study|Death|13|||
157206390|NCT01569594|567499668|FG000|Overall Study|Lost to Follow-up|22|||
157206391|NCT01569594|567499668|FG000|Overall Study|Adverse Event|2|||
157206392|NCT01569594|567499668|FG000|Overall Study|Withdrawal by Subject|13|||
157206393|NCT01569594|567499668|FG000|Overall Study|Other|4|||
157206394|NCT01569594|567499668|FG000|Overall Study|No ECM used|9|||
157206395|NCT03069365|567499669|FG000|Overall Study|Adverse Event|1|||
157206396|NCT02861534|567499670|FG000|Overall Study|Death|541|||
157206397|NCT02861534|567499671|FG001|Overall Study|Death|552|||
157206398|NCT02861534|567499670|FG000|Overall Study|Lost to Follow-up|14|||
157206399|NCT02861534|567499671|FG001|Overall Study|Lost to Follow-up|14|||
157206400|NCT02861534|567499670|FG000|Overall Study|Site Terminated by Sponsor|4|||
157206401|NCT02861534|567499671|FG001|Overall Study|Site Terminated by Sponsor|3|||
157206402|NCT02861534|567499670|FG000|Overall Study|Withdrawal by Subject|15|||
157206403|NCT02861534|567499671|FG001|Overall Study|Withdrawal by Subject|18|||
157206404|NCT02886494|567499672|FG000|Overall Study|Adverse Event|1|||
157206405|NCT02886494|567499673|FG001|Overall Study|Adverse Event|0|||
157206406|NCT02886494|567499672|FG000|Overall Study|Withdrawal by Subject|12|||
157206407|NCT02886494|567499673|FG001|Overall Study|Withdrawal by Subject|3|||
157206408|NCT02886494|567499672|FG000|Overall Study|Protocol Violation|4|||
157206409|NCT02886494|567499673|FG001|Overall Study|Protocol Violation|1|||
157206410|NCT02780115|567499674|FG000|Overall Study|Withdrawal by Subject|0|||
157206411|NCT02780115|567499675|FG001|Overall Study|Withdrawal by Subject|1|||
157206412|NCT02780115|567499676|FG002|Overall Study|Withdrawal by Subject|1|||
157206413|NCT02780115|567499677|FG003|Overall Study|Withdrawal by Subject|0|||
157206414|NCT02780115|567499678|FG004|Overall Study|Withdrawal by Subject|0|||
157206415|NCT02780115|567499674|FG000|Overall Study|Adverse Event|0|||
157206416|NCT02780115|567499675|FG001|Overall Study|Adverse Event|0|||
157206417|NCT02780115|567499676|FG002|Overall Study|Adverse Event|0|||
157206418|NCT02780115|567499677|FG003|Overall Study|Adverse Event|1|||
157206419|NCT02780115|567499678|FG004|Overall Study|Adverse Event|1|||
157206420|NCT00769132|567499681|FG000|Period 1|Adverse Event|1|||
157206421|NCT00769132|567499682|FG001|Period 1|Adverse Event|0|||
157206422|NCT00769132|567499683|FG002|Period 1|Adverse Event|0|||
157206423|NCT00769132|567499684|FG003|Period 1|Adverse Event|1|||
157206424|NCT00769132|567499681|FG000|Period 2|Withdrawal by Subject|0|||
157206425|NCT00769132|567499682|FG001|Period 2|Withdrawal by Subject|0|||
157206426|NCT00769132|567499683|FG002|Period 2|Withdrawal by Subject|0|||
157206427|NCT00769132|567499684|FG003|Period 2|Withdrawal by Subject|1|||
157206428|NCT00769132|567499681|FG000|Period 3|Withdrawal by Subject|1|||
157206429|NCT00769132|567499682|FG001|Period 3|Withdrawal by Subject|0|||
157206430|NCT00769132|567499683|FG002|Period 3|Withdrawal by Subject|0|||
157206431|NCT00769132|567499684|FG003|Period 3|Withdrawal by Subject|0|||
157206432|NCT00769132|567499681|FG000|Period 4|Withdrawal by Subject|0|||
157206433|NCT00769132|567499682|FG001|Period 4|Withdrawal by Subject|1|||
157206434|NCT00769132|567499683|FG002|Period 4|Withdrawal by Subject|0|||
157206435|NCT00769132|567499684|FG003|Period 4|Withdrawal by Subject|0|||
157206436|NCT00499252|567499685|FG000|Overall Study|Adverse Event|3|||
157206437|NCT00499252|567499685|FG000|Overall Study|Refused further treatment|2|||
157206438|NCT00499252|567499685|FG000|Overall Study|Ineligible|4|||
157206439|NCT00499252|567499685|FG000|Overall Study|<no further label>|3|||
157206440|NCT02230332|567499686|FG000|Overall Study|Adverse Event|2|||
157206441|NCT02230332|567499687|FG001|Overall Study|Adverse Event|1|||
157206442|NCT02230332|567499686|FG000|Overall Study|Lost to Follow-up|1|||
157206443|NCT02230332|567499687|FG001|Overall Study|Lost to Follow-up|0|||
157206444|NCT02230332|567499686|FG000|Overall Study|Protocol Violation|1|||
157206445|NCT02230332|567499687|FG001|Overall Study|Protocol Violation|0|||
157206446|NCT01260194|567499689|FG000|Overall Study|Withdrawal of Consent|1|||
157206447|NCT01785472|567499690|FG000|Overall Study|Adverse Event|5|||
157206448|NCT01785472|567499691|FG001|Overall Study|Adverse Event|4|||
157206449|NCT01785472|567499692|FG002|Overall Study|Adverse Event|6|||
157206450|NCT01785472|567499690|FG000|Overall Study|Lack of Efficacy|2|||
157206451|NCT01785472|567499691|FG001|Overall Study|Lack of Efficacy|0|||
157206452|NCT01785472|567499692|FG002|Overall Study|Lack of Efficacy|1|||
157206453|NCT01785472|567499690|FG000|Overall Study|Lost to Follow-up|1|||
157206454|NCT01785472|567499691|FG001|Overall Study|Lost to Follow-up|2|||
157206455|NCT01785472|567499692|FG002|Overall Study|Lost to Follow-up|0|||
157206456|NCT01785472|567499690|FG000|Overall Study|Physician Decision|1|||
157206457|NCT01785472|567499691|FG001|Overall Study|Physician Decision|1|||
157206458|NCT01785472|567499692|FG002|Overall Study|Physician Decision|1|||
157206459|NCT01785472|567499690|FG000|Overall Study|Protocol deviation|0|||
157206460|NCT01785472|567499691|FG001|Overall Study|Protocol deviation|2|||
157206461|NCT01785472|567499692|FG002|Overall Study|Protocol deviation|2|||
157206462|NCT01785472|567499690|FG000|Overall Study|Subject/guardian decision|15|||
157206463|NCT01785472|567499691|FG001|Overall Study|Subject/guardian decision|10|||
157206464|NCT01785472|567499692|FG002|Overall Study|Subject/guardian decision|11|||
157206465|NCT01785472|567499690|FG000|Overall Study|Technical problems|0|||
157206466|NCT01785472|567499691|FG001|Overall Study|Technical problems|0|||
157206467|NCT01785472|567499692|FG002|Overall Study|Technical problems|1|||
157206468|NCT00127192|567499694|FG000|Overall Study|Adverse Event|0|||
157206469|NCT00127192|567499695|FG001|Overall Study|Adverse Event|1|||
157206470|NCT00127192|567499696|FG002|Overall Study|Adverse Event|1|||
157206471|NCT00127192|567499697|FG003|Overall Study|Adverse Event|1|||
157206472|NCT00127192|567499698|FG004|Overall Study|Adverse Event|0|||
157206473|NCT00127192|567499694|FG000|Overall Study|Lack of Efficacy|2|||
157206474|NCT00127192|567499695|FG001|Overall Study|Lack of Efficacy|0|||
157206475|NCT00127192|567499696|FG002|Overall Study|Lack of Efficacy|0|||
157206476|NCT00127192|567499697|FG003|Overall Study|Lack of Efficacy|0|||
157206477|NCT00127192|567499698|FG004|Overall Study|Lack of Efficacy|2|||
157206478|NCT00127192|567499694|FG000|Overall Study|Withdrawal by Subject|0|||
157206479|NCT00127192|567499695|FG001|Overall Study|Withdrawal by Subject|0|||
157206480|NCT00127192|567499696|FG002|Overall Study|Withdrawal by Subject|1|||
157206481|NCT00127192|567499697|FG003|Overall Study|Withdrawal by Subject|0|||
157206482|NCT00127192|567499698|FG004|Overall Study|Withdrawal by Subject|3|||
157206483|NCT00127192|567499694|FG000|Overall Study|Adverse event in pre-treatment period|1|||
157206484|NCT00127192|567499695|FG001|Overall Study|Adverse event in pre-treatment period|0|||
157206485|NCT00127192|567499696|FG002|Overall Study|Adverse event in pre-treatment period|0|||
157206486|NCT00127192|567499697|FG003|Overall Study|Adverse event in pre-treatment period|0|||
157206487|NCT00127192|567499698|FG004|Overall Study|Adverse event in pre-treatment period|0|||
157206488|NCT01036594|567499712|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
157206489|NCT01036594|567499713|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
157206490|NCT01036594|567499712|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
157206491|NCT01036594|567499713|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
157206492|NCT01036594|567499712|FG000|Week 12 Evaluation|Adverse Event|5|||
157206493|NCT01036594|567499713|FG001|Week 12 Evaluation|Adverse Event|0|||
157206494|NCT01036594|567499712|FG000|Week 12 Evaluation|Physician Decision|1|||
157206495|NCT01036594|567499713|FG001|Week 12 Evaluation|Physician Decision|0|||
157206496|NCT01036594|567499712|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
157206497|NCT01036594|567499713|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
157206498|NCT01036594|567499712|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
157206499|NCT01036594|567499713|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
157206500|NCT01036594|567499712|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
157206501|NCT01036594|567499713|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
157206502|NCT01036594|567499712|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
157206503|NCT01036594|567499713|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
157206504|NCT01036594|567499712|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
157206505|NCT01036594|567499713|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
157206506|NCT01612780|567499716|FG000|Overall Study|Treatment not completed|1|||
157206507|NCT01612780|567499716|FG000|Overall Study|Withdrawal by Subject|5|||
157206508|NCT02628418|567499720|FG000|Overall Study|Lost to Follow-up|1|||
157206509|NCT02628418|567499721|FG001|Overall Study|Lost to Follow-up|2|||
157206510|NCT00424632|567499722|FG000|Overall Study|Death|0|||
157206511|NCT00424632|567499723|FG001|Overall Study|Death|0|||
157206512|NCT00424632|567499724|FG002|Overall Study|Death|0|||
157206513|NCT00424632|567499725|FG003|Overall Study|Death|0|||
157206514|NCT00424632|567499726|FG004|Overall Study|Death|0|||
157206515|NCT00424632|567499727|FG005|Overall Study|Death|2|||
157206516|NCT00424632|567499728|FG006|Overall Study|Death|0|||
157206517|NCT00424632|567499729|FG007|Overall Study|Death|0|||
157206518|NCT00424632|567499730|FG008|Overall Study|Death|0|||
157206519|NCT00424632|567499731|FG009|Overall Study|Death|0|||
157206520|NCT00424632|567499722|FG000|Overall Study|Adverse Event|0|||
157206521|NCT00424632|567499723|FG001|Overall Study|Adverse Event|0|||
157206522|NCT00424632|567499724|FG002|Overall Study|Adverse Event|0|||
157206523|NCT00424632|567499725|FG003|Overall Study|Adverse Event|0|||
157206524|NCT00424632|567499726|FG004|Overall Study|Adverse Event|0|||
157206525|NCT00424632|567499727|FG005|Overall Study|Adverse Event|0|||
157206526|NCT00424632|567499728|FG006|Overall Study|Adverse Event|0|||
157206527|NCT00424632|567499729|FG007|Overall Study|Adverse Event|0|||
157206528|NCT00424632|567499730|FG008|Overall Study|Adverse Event|3|||
157206529|NCT00424632|567499731|FG009|Overall Study|Adverse Event|2|||
157206530|NCT00424632|567499722|FG000|Overall Study|Global deterioration of health status|0|||
157206531|NCT00424632|567499723|FG001|Overall Study|Global deterioration of health status|0|||
157206532|NCT00424632|567499724|FG002|Overall Study|Global deterioration of health status|0|||
157206533|NCT00424632|567499725|FG003|Overall Study|Global deterioration of health status|1|||
157206534|NCT00424632|567499726|FG004|Overall Study|Global deterioration of health status|1|||
157206535|NCT00424632|567499727|FG005|Overall Study|Global deterioration of health status|0|||
157206536|NCT00424632|567499728|FG006|Overall Study|Global deterioration of health status|0|||
157206537|NCT00424632|567499729|FG007|Overall Study|Global deterioration of health status|0|||
157206538|NCT00424632|567499730|FG008|Overall Study|Global deterioration of health status|0|||
157206539|NCT00424632|567499731|FG009|Overall Study|Global deterioration of health status|0|||
157206540|NCT00424632|567499722|FG000|Overall Study|Objective progression or relapse|1|||
157206541|NCT00424632|567499723|FG001|Overall Study|Objective progression or relapse|1|||
157206542|NCT00424632|567499724|FG002|Overall Study|Objective progression or relapse|1|||
157206543|NCT00424632|567499725|FG003|Overall Study|Objective progression or relapse|2|||
157206544|NCT00424632|567499726|FG004|Overall Study|Objective progression or relapse|2|||
157206545|NCT00424632|567499727|FG005|Overall Study|Objective progression or relapse|13|||
157206546|NCT00424632|567499728|FG006|Overall Study|Objective progression or relapse|7|||
157206547|NCT00424632|567499729|FG007|Overall Study|Objective progression or relapse|3|||
157206548|NCT00424632|567499730|FG008|Overall Study|Objective progression or relapse|12|||
157206549|NCT00424632|567499731|FG009|Overall Study|Objective progression or relapse|4|||
157206550|NCT00424632|567499722|FG000|Overall Study|Other|0|||
157206551|NCT00424632|567499723|FG001|Overall Study|Other|0|||
157206552|NCT00424632|567499724|FG002|Overall Study|Other|0|||
157206553|NCT00424632|567499725|FG003|Overall Study|Other|1|||
157206554|NCT00424632|567499726|FG004|Overall Study|Other|0|||
157206555|NCT00424632|567499727|FG005|Overall Study|Other|0|||
157206556|NCT00424632|567499728|FG006|Overall Study|Other|0|||
157206557|NCT00424632|567499729|FG007|Overall Study|Other|0|||
157206558|NCT00424632|567499730|FG008|Overall Study|Other|1|||
157206559|NCT00424632|567499731|FG009|Overall Study|Other|0|||
157206560|NCT03159611|567499732|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
157206561|NCT03159611|567499733|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
157206562|NCT03159611|567499732|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
157206563|NCT03159611|567499733|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
157206564|NCT03159611|567499732|FG000|Overall Study|Protocol Violation|7|||
157206565|NCT03159611|567499733|FG001|Overall Study|Protocol Violation|4|||
157206566|NCT03159611|567499732|FG000|Overall Study|Adverse Event|1|||
157206567|NCT03159611|567499733|FG001|Overall Study|Adverse Event|0|||
157206568|NCT03159611|567499732|FG000|Overall Study|Withdrawal by Subject|1|||
157206569|NCT03159611|567499733|FG001|Overall Study|Withdrawal by Subject|1|||
157206570|NCT03159611|567499732|FG000|Overall Study|Non-compliance with protocol requirement|3|||
157206571|NCT03159611|567499733|FG001|Overall Study|Non-compliance with protocol requirement|2|||
157206572|NCT03159611|567499732|FG000|Overall Study|Inability to perform procedures|1|||
157206573|NCT03159611|567499733|FG001|Overall Study|Inability to perform procedures|0|||
157206574|NCT01984229|567499734|FG000|Safety Follow-up Period|Adverse Event|1|||
157206575|NCT01984229|567499735|FG001|Safety Follow-up Period|Adverse Event|1|||
157093213|NCT01313689|567095876|FG000|24-Week Randomization 2|Physician Decision|0|||
157206576|NCT01984229|567499734|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
157206577|NCT01984229|567499735|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
157206578|NCT05674721|567499737|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
157206579|NCT05674721|567499738|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
157206580|NCT05674721|567499737|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
157206581|NCT05674721|567499738|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
157206582|NCT03506425|567499748|FG000|Overall Study|Adverse Event|1|||
156750889|NCT01299896|565840470|FG000|Overall Study|Withdrawal by Subject|1|||
156750890|NCT01299896|565840471|FG001|Overall Study|Withdrawal by Subject|7|||
156750891|NCT01299896|565840470|FG000|Overall Study|Lost to Follow-up|0|||
156750892|NCT01299896|565840471|FG001|Overall Study|Lost to Follow-up|11|||
156750893|NCT01502956|565840474|FG000|Overall Study|Death|0|||
156750894|NCT01502956|565840475|FG001|Overall Study|Death|2|||
156750895|NCT01502956|565840474|FG000|Overall Study|Lost to Follow-up|14|||
156750896|NCT01502956|565840475|FG001|Overall Study|Lost to Follow-up|11|||
156750897|NCT01502956|565840474|FG000|Overall Study|Physician Decision|2|||
156750898|NCT01502956|565840475|FG001|Overall Study|Physician Decision|3|||
156750899|NCT01502956|565840474|FG000|Overall Study|Withdrawal by Subject|8|||
156750900|NCT01502956|565840475|FG001|Overall Study|Withdrawal by Subject|10|||
156750901|NCT04076319|565840476|FG000|Overall Study|Withdrawal by Subject|2|||
156750902|NCT04076319|565840477|FG001|Overall Study|Withdrawal by Subject|0|||
156750903|NCT04076319|565840476|FG000|Overall Study|Death|1|||
156750904|NCT04076319|565840477|FG001|Overall Study|Death|0|||
156750905|NCT02626000|565840478|FG000|Overall Study|Decision by Sponsor|1|||
156750906|NCT02626000|565840478|FG000|Overall Study|Death|29|||
156750907|NCT01411319|565840483|FG000|Overall Study|Lost to Follow-up|1|||
156750908|NCT01796301|565840502|FG000|Overall Study|Withdrawal by Subject|15|||
156750909|NCT01796301|565840503|FG001|Overall Study|Withdrawal by Subject|15|||
156750910|NCT01796301|565840502|FG000|Overall Study|Lost to Follow-up|3|||
156750911|NCT01796301|565840503|FG001|Overall Study|Lost to Follow-up|3|||
156750912|NCT01796301|565840502|FG000|Overall Study|Death|0|||
156750913|NCT01796301|565840503|FG001|Overall Study|Death|1|||
156750914|NCT01796301|565840502|FG000|Overall Study|Decision by Sponsor|0|||
156750915|NCT01796301|565840503|FG001|Overall Study|Decision by Sponsor|1|||
156750916|NCT02187029|565840504|FG000|Overall Study|Adverse Event|0|||
156750917|NCT02187029|565840505|FG001|Overall Study|Adverse Event|1|||
156750918|NCT02187029|565840506|FG002|Overall Study|Adverse Event|1|||
156750919|NCT02187029|565840507|FG003|Overall Study|Adverse Event|0|||
156750920|NCT02187029|565840504|FG000|Overall Study|Study Terminated by Sponsor|0|||
156750921|NCT02187029|565840505|FG001|Overall Study|Study Terminated by Sponsor|0|||
156750922|NCT02187029|565840506|FG002|Overall Study|Study Terminated by Sponsor|10|||
156750923|NCT02187029|565840507|FG003|Overall Study|Study Terminated by Sponsor|3|||
156750924|NCT02187029|565840504|FG000|Overall Study|Withdrawal by Subject|1|||
156750925|NCT02187029|565840505|FG001|Overall Study|Withdrawal by Subject|0|||
156750926|NCT02187029|565840506|FG002|Overall Study|Withdrawal by Subject|0|||
156750927|NCT02187029|565840507|FG003|Overall Study|Withdrawal by Subject|0|||
156750928|NCT04105842|565840508|FG000|Overall Study|Withdrawal by Subject|2|||
156750929|NCT04399889|565840510|FG000|Overall Study|Death|5|||
156750930|NCT04399889|565840511|FG001|Overall Study|Death|1|||
156750931|NCT04399889|565840512|FG002|Overall Study|Death|1|||
156750932|NCT00707980|565840513|FG000|Overall Study|Adverse Event|49|||
156750933|NCT00707980|565840513|FG000|Overall Study|Lack of Efficacy|35|||
156750934|NCT00707980|565840513|FG000|Overall Study|Non-Compliance with Study Drug|28|||
156750935|NCT00707980|565840513|FG000|Overall Study|Protocol Deviations|19|||
156750936|NCT00707980|565840513|FG000|Overall Study|Withdrawal of Consent|81|||
156750937|NCT00707980|565840513|FG000|Overall Study|Lost to Follow-up|59|||
156750938|NCT00707980|565840513|FG000|Overall Study|Other|39|||
156750939|NCT01152996|565840517|FG000|Overall Study|Withdrawal by Subject|142|||
156750940|NCT01152996|565840517|FG000|Overall Study|Adverse Event|115|||
156750941|NCT01152996|565840517|FG000|Overall Study|Lost to Follow-up|112|||
156750942|NCT01152996|565840517|FG000|Overall Study|Lack of Efficacy|68|||
156750943|NCT01152996|565840517|FG000|Overall Study|Noncompliance|41|||
156750944|NCT01152996|565840517|FG000|Overall Study|Other|36|||
156750945|NCT01152996|565840517|FG000|Overall Study|Protocol Violation|22|||
156750946|NCT01152996|565840517|FG000|Overall Study|Elevated liver enzymes|1|||
156750947|NCT00460239|565840519|FG000|Overall Study|Physician Decision|0|||
156750948|NCT00460239|565840520|FG001|Overall Study|Physician Decision|1|||
156750949|NCT00460239|565840521|FG002|Overall Study|Physician Decision|0|||
156750950|NCT00460239|565840522|FG003|Overall Study|Physician Decision|0|||
156750951|NCT00460239|565840523|FG004|Overall Study|Physician Decision|0|||
156750952|NCT00460239|565840524|FG005|Overall Study|Physician Decision|2|||
156750953|NCT00460239|565840525|FG006|Overall Study|Physician Decision|0|||
156750954|NCT00460239|565840526|FG007|Overall Study|Physician Decision|0|||
156750955|NCT00460239|565840527|FG008|Overall Study|Physician Decision|0|||
156750956|NCT00460239|565840519|FG000|Overall Study|Withdrawal by Subject|0|||
156750957|NCT00460239|565840520|FG001|Overall Study|Withdrawal by Subject|0|||
156750958|NCT00460239|565840521|FG002|Overall Study|Withdrawal by Subject|0|||
156750959|NCT00460239|565840522|FG003|Overall Study|Withdrawal by Subject|0|||
156750960|NCT00460239|565840523|FG004|Overall Study|Withdrawal by Subject|0|||
156750961|NCT00460239|565840524|FG005|Overall Study|Withdrawal by Subject|1|||
156750962|NCT00460239|565840525|FG006|Overall Study|Withdrawal by Subject|0|||
156750963|NCT00460239|565840526|FG007|Overall Study|Withdrawal by Subject|0|||
156750964|NCT00460239|565840527|FG008|Overall Study|Withdrawal by Subject|0|||
156750965|NCT01535443|565840529|FG000|Overall Study|Physician Decision|3|||
156750966|NCT00760487|565840531|FG000|Overall Study|Unilateral implantation|3|||
156750967|NCT02260817|565840534|FG000|Overall Study|Lost to Follow-up|0|||
156750968|NCT02260817|565840535|FG001|Overall Study|Lost to Follow-up|14|||
156750969|NCT02260817|565840534|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
156750970|NCT02260817|565840535|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
156750971|NCT02260817|565840534|FG000|Overall Study|Observation, no biopsy|0|||
156750972|NCT02260817|565840535|FG001|Overall Study|Observation, no biopsy|1|||
156750973|NCT02260817|565840534|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
156750974|NCT02260817|565840535|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
156750975|NCT02260817|565840534|FG000|Overall Study|Protocol Violation|0|||
156750976|NCT02260817|565840535|FG001|Overall Study|Protocol Violation|14|||
156750977|NCT00592592|565840540|FG000|Overall Study|Patient found ineligible upon chart review|1|||
156750978|NCT03230838|565840545|FG000|Overall Study|Withdrawal by Subject|3|||
156750979|NCT03230838|565840546|FG001|Overall Study|Withdrawal by Subject|0|||
156750980|NCT03230838|565840545|FG000|Overall Study|Temperature excursion|1|||
156750981|NCT03230838|565840546|FG001|Overall Study|Temperature excursion|0|||
156750982|NCT00435188|565840547|FG000|Overall Study|Death|1|||
156750983|NCT00435188|565840548|FG001|Overall Study|Death|6|||
156750984|NCT00435188|565840547|FG000|Overall Study|Withdrawal by Subject|16|||
156750985|NCT00435188|565840548|FG001|Overall Study|Withdrawal by Subject|11|||
156750986|NCT00435188|565840547|FG000|Overall Study|Lost to Follow-up|5|||
156750987|NCT00435188|565840548|FG001|Overall Study|Lost to Follow-up|6|||
156750988|NCT01915771|565840549|FG000|Day 1|Withdrawal by Subject|1|||
156750989|NCT01915771|565840549|FG000|Day 15|Withdrawal by Subject|1|||
156750990|NCT00575510|565840552|FG000|Overall Study|Lost to Follow-up|4|||
156750991|NCT00575510|565840553|FG001|Overall Study|Lost to Follow-up|6|||
157206583|NCT03506425|567499749|FG001|Overall Study|Adverse Event|3|||
157206584|NCT03506425|567499750|FG002|Overall Study|Adverse Event|0|||
157206585|NCT03506425|567499748|FG000|Overall Study|Death|1|||
157206586|NCT03506425|567499749|FG001|Overall Study|Death|0|||
157206587|NCT03506425|567499750|FG002|Overall Study|Death|0|||
157206588|NCT03506425|567499748|FG000|Overall Study|Withdrawal by Subject|0|||
157206589|NCT03506425|567499749|FG001|Overall Study|Withdrawal by Subject|0|||
157206590|NCT03506425|567499750|FG002|Overall Study|Withdrawal by Subject|1|||
157206591|NCT00077766|567499751|FG000|Overall Study|Adverse Event|1|||
157206592|NCT00077766|567499752|FG001|Overall Study|Adverse Event|1|||
157206593|NCT00077766|567499751|FG000|Overall Study|Withdrawal by Subject|4|||
157206594|NCT00077766|567499752|FG001|Overall Study|Withdrawal by Subject|3|||
157206595|NCT00077766|567499751|FG000|Overall Study|Death|12|||
157206596|NCT00077766|567499752|FG001|Overall Study|Death|10|||
157206597|NCT00077766|567499751|FG000|Overall Study|Lost to Follow-up|2|||
157206598|NCT00077766|567499752|FG001|Overall Study|Lost to Follow-up|0|||
157206599|NCT00077766|567499751|FG000|Overall Study|Protocol Violation|1|||
157206600|NCT00077766|567499752|FG001|Overall Study|Protocol Violation|0|||
157206601|NCT00077766|567499751|FG000|Overall Study|Kidney Transplantation|9|||
157206602|NCT00077766|567499752|FG001|Overall Study|Kidney Transplantation|5|||
157206603|NCT00077766|567499751|FG000|Overall Study|Transplantation|5|||
157206604|NCT00077766|567499752|FG001|Overall Study|Transplantation|1|||
157206605|NCT00077766|567499751|FG000|Overall Study|Investigators Discretion|1|||
157206606|NCT00077766|567499752|FG001|Overall Study|Investigators Discretion|0|||
157206607|NCT00077766|567499751|FG000|Overall Study|Participant's decision|1|||
157206608|NCT00077766|567499752|FG001|Overall Study|Participant's decision|0|||
157206609|NCT00077766|567499751|FG000|Overall Study|Dialysis Discontinued|1|||
157206610|NCT00077766|567499752|FG001|Overall Study|Dialysis Discontinued|0|||
157206611|NCT00077766|567499751|FG000|Overall Study|Dialysis|0|||
157206612|NCT00077766|567499752|FG001|Overall Study|Dialysis|1|||
157206613|NCT00077766|567499751|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
157206614|NCT00077766|567499752|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
157206615|NCT00077766|567499751|FG000|Overall Study|Started Nocturnal Dialysis|0|||
157206616|NCT00077766|567499752|FG001|Overall Study|Started Nocturnal Dialysis|1|||
157206617|NCT00077766|567499751|FG000|Overall Study|Stop Dialysis|0|||
156750992|NCT00575510|565840554|FG002|Overall Study|Lost to Follow-up|9|||
156750993|NCT00575510|565840552|FG000|Overall Study|Withdrawal by Subject|1|||
156750994|NCT00575510|565840553|FG001|Overall Study|Withdrawal by Subject|0|||
156750995|NCT00575510|565840554|FG002|Overall Study|Withdrawal by Subject|0|||
156750996|NCT00575510|565840552|FG000|Overall Study|Clinic Called Patient|7|||
156750997|NCT00575510|565840553|FG001|Overall Study|Clinic Called Patient|7|||
156750998|NCT00575510|565840554|FG002|Overall Study|Clinic Called Patient|7|||
156750999|NCT00575510|565840552|FG000|Overall Study|Pregnancy|0|||
156751000|NCT00575510|565840553|FG001|Overall Study|Pregnancy|0|||
156751001|NCT00575510|565840554|FG002|Overall Study|Pregnancy|1|||
156751002|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
157206618|NCT00077766|567499752|FG001|Overall Study|Stop Dialysis|1|||
157206619|NCT00077766|567499751|FG000|Overall Study|Participants Vacation|2|||
157206620|NCT00077766|567499752|FG001|Overall Study|Participants Vacation|1|||
157206621|NCT04150107|567499760|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
157206622|NCT04150107|567499761|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
156751003|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
156751004|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Adverse Event|1|||
156751005|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Adverse Event|2|||
156751006|NCT02697734|565840555|FG000|Core Phase - up to Week 48|Physician Decision|1|||
156751007|NCT02697734|565840556|FG001|Core Phase - up to Week 48|Physician Decision|0|||
156751008|NCT02697734|565840555|FG000|Optional Extension Phase|Adverse Event|5|||
156751009|NCT02697734|565840556|FG001|Optional Extension Phase|Adverse Event|1|||
156751010|NCT02697734|565840555|FG000|Optional Extension Phase|Physician Decision|0|||
156751011|NCT02697734|565840556|FG001|Optional Extension Phase|Physician Decision|1|||
156751012|NCT03970200|565840557|FG000|Overall Study|Death|2|||
156751013|NCT03970200|565840558|FG001|Overall Study|Death|2|||
156751014|NCT03970200|565840559|FG002|Overall Study|Death|1|||
156751015|NCT03970200|565840557|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
156751016|NCT03970200|565840558|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
156751017|NCT03970200|565840559|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
156751018|NCT01607346|565840560|FG000|Overall Study|Adverse Event|3|||
156751019|NCT01098162|565840561|FG000|Overall Study|Adverse Event|37|||
156751020|NCT01098162|565840561|FG000|Overall Study|Lack of Efficacy|4|||
156751021|NCT01098162|565840561|FG000|Overall Study|Wish of Patient|7|||
156751022|NCT01098162|565840561|FG000|Overall Study|Lost to Follow-up|9|||
156751023|NCT01098162|565840561|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
156751024|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
156751025|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
156751026|NCT01098162|565840561|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
156751027|NCT01098162|565840561|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
156751028|NCT01098162|565840561|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
156751029|NCT01098162|565840561|FG000|Overall Study|Other Reason|1|||
156751030|NCT01098162|565840561|FG000|Overall Study|Reason Unknown|26|||
156751031|NCT01605825|565840562|FG000|Overall Study|Adverse Event|4|||
156751032|NCT01605825|565840563|FG001|Overall Study|Adverse Event|2|||
156751033|NCT01605825|565840562|FG000|Overall Study|Withdrawal by Subject|0|||
156751034|NCT01605825|565840563|FG001|Overall Study|Withdrawal by Subject|1|||
156751035|NCT01605825|565840562|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
156751036|NCT01605825|565840563|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
156751037|NCT01605825|565840562|FG000|Overall Study|Non-Compliance with Protocol|3|||
156751038|NCT01605825|565840563|FG001|Overall Study|Non-Compliance with Protocol|0|||
156751039|NCT02279745|565840564|FG000|Overall Study|Adverse Event|7|||
156751040|NCT02279745|565840564|FG000|Overall Study|Death|6|||
156751041|NCT02279745|565840564|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
156751042|NCT02279745|565840564|FG000|Overall Study|Withdrawal by Subject|2|||
156751043|NCT02279745|565840564|FG000|Overall Study|Pregnancy|1|||
156751044|NCT02279745|565840564|FG000|Overall Study|Study Non-compliance|1|||
156751045|NCT02279745|565840564|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
156751046|NCT00380718|565840565|FG000|Overall Study|Adverse Event|1|||
156751047|NCT00380718|565840565|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
156751048|NCT01706575|565840567|FG000|Overall Study|Participant Withdrew Consent|4|||
156751049|NCT01706575|565840567|FG000|Overall Study|Lost to Follow-up|2|||
156751050|NCT01706575|565840567|FG000|Overall Study|Started but not Treated|6|||
156751051|NCT02155322|565840576|FG000|Overall Study|Adverse Event|1|||
156751052|NCT02155322|565840576|FG000|Overall Study|Physician Decision|1|||
156751053|NCT02155322|565840576|FG000|Overall Study|Relapse/Recurrence|8|||
156751054|NCT02155322|565840576|FG000|Overall Study|Withdrawal by Subject|4|||
156751055|NCT00840034|565840582|FG000|Acute Treatment Phase|Adverse Event|6|||
156751056|NCT00840034|565840583|FG001|Acute Treatment Phase|Adverse Event|8|||
156751057|NCT00840034|565840582|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
156751058|NCT00840034|565840583|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
156751059|NCT00840034|565840582|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
156751060|NCT00840034|565840583|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
156751061|NCT00840034|565840582|FG000|Acute Treatment Phase|Physician Decision|0|||
156751062|NCT00840034|565840583|FG001|Acute Treatment Phase|Physician Decision|1|||
156751063|NCT00840034|565840582|FG000|Acute Treatment Phase|Protocol Violation|2|||
156751064|NCT00840034|565840583|FG001|Acute Treatment Phase|Protocol Violation|4|||
156751065|NCT00840034|565840582|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
156751066|NCT00840034|565840583|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
156751067|NCT00840034|565840582|FG000|Taper Phase|Adverse Event|1|||
156751068|NCT00840034|565840583|FG001|Taper Phase|Adverse Event|0|||
156751069|NCT00840034|565840582|FG000|Taper Phase|Lost to Follow-up|1|||
156751070|NCT00840034|565840583|FG001|Taper Phase|Lost to Follow-up|1|||
156751071|NCT00840034|565840582|FG000|Taper Phase|Withdrawal by Subject|1|||
156751072|NCT00840034|565840583|FG001|Taper Phase|Withdrawal by Subject|1|||
156751073|NCT01215435|565840584|FG000|Overall Study|Adverse Event|1|||
156751074|NCT01215435|565840585|FG001|Overall Study|Adverse Event|0|||
156751075|NCT01215435|565840584|FG000|Overall Study|Protocol Violation|2|||
156751076|NCT01215435|565840585|FG001|Overall Study|Protocol Violation|0|||
156751077|NCT01215435|565840584|FG000|Overall Study|Withdrawal Criteria|8|||
156864962|NCT05966142|566265385|FG001|Overall Study|Withdrawal by Subject|8|||
156751078|NCT01215435|565840585|FG001|Overall Study|Withdrawal Criteria|11|||
156751079|NCT01215435|565840584|FG000|Overall Study|Lost to Follow-up|3|||
156751080|NCT01215435|565840585|FG001|Overall Study|Lost to Follow-up|0|||
156751081|NCT01215435|565840584|FG000|Overall Study|Unclassified|5|||
156751082|NCT01215435|565840585|FG001|Overall Study|Unclassified|5|||
156751083|NCT02839876|565840590|FG000|Overall Study|Protocol Violation|10|||
156751084|NCT02839876|565840591|FG001|Overall Study|Protocol Violation|11|||
156751085|NCT01428115|565840594|FG000|Overall Study|Lack of Efficacy|3|||
156751086|NCT01428115|565840594|FG000|Overall Study|Lost to Follow-up|10|||
156751087|NCT01428115|565840594|FG000|Overall Study|Pregnancy|1|||
156751088|NCT01428115|565840594|FG000|Overall Study|Protocol Violation|3|||
156751089|NCT01428115|565840594|FG000|Overall Study|Withdrawal by Subject|4|||
156751090|NCT01738191|565840595|FG000|Overall Study|Withdrawal by Subject|4|||
156751091|NCT01738191|565840596|FG001|Overall Study|Withdrawal by Subject|1|||
156751092|NCT02483572|565840597|FG000|Overall Study|Withdrawal by Subject|1|||
156751093|NCT02483572|565840598|FG001|Overall Study|Withdrawal by Subject|0|||
156751094|NCT02483572|565840597|FG000|Overall Study|Lost to Follow-up|1|||
156751095|NCT02483572|565840598|FG001|Overall Study|Lost to Follow-up|0|||
156751096|NCT02483572|565840597|FG000|Overall Study|Physician Decision|0|||
156751097|NCT02483572|565840598|FG001|Overall Study|Physician Decision|1|||
156751098|NCT00350779|565840599|FG000|Overall Study|Adverse Event|4|||
156751099|NCT00350779|565840600|FG001|Overall Study|Adverse Event|2|||
156751100|NCT00350779|565840599|FG000|Overall Study|Lack of Efficacy|0|||
156751101|NCT00350779|565840600|FG001|Overall Study|Lack of Efficacy|4|||
156751102|NCT00350779|565840599|FG000|Overall Study|Lost to Follow-up|2|||
156751103|NCT00350779|565840600|FG001|Overall Study|Lost to Follow-up|0|||
156751104|NCT00350779|565840599|FG000|Overall Study|Physician Decision|2|||
156751105|NCT00350779|565840600|FG001|Overall Study|Physician Decision|4|||
156751106|NCT00350779|565840599|FG000|Overall Study|Protocol Violation|3|||
156751107|NCT00350779|565840600|FG001|Overall Study|Protocol Violation|1|||
156751108|NCT00350779|565840599|FG000|Overall Study|Withdrawal by Subject|9|||
156751109|NCT00350779|565840600|FG001|Overall Study|Withdrawal by Subject|8|||
156751110|NCT00350779|565840599|FG000|Overall Study|Patient Moved|2|||
156751111|NCT00350779|565840600|FG001|Overall Study|Patient Moved|1|||
156751112|NCT00350779|565840599|FG000|Overall Study|Non-compliance with study procedures|0|||
156751113|NCT00350779|565840600|FG001|Overall Study|Non-compliance with study procedures|1|||
156751114|NCT00262002|565840603|FG000|Overall Study|Adverse Event|2|||
156751115|NCT00262002|565840604|FG001|Overall Study|Adverse Event|1|||
156751116|NCT00262002|565840605|FG002|Overall Study|Adverse Event|0|||
156751117|NCT00262002|565840606|FG003|Overall Study|Adverse Event|0|||
156751118|NCT00262002|565840607|FG004|Overall Study|Adverse Event|0|||
156751119|NCT00262002|565840608|FG005|Overall Study|Adverse Event|1|||
156751120|NCT00262002|565840609|FG006|Overall Study|Adverse Event|0|||
156751121|NCT00262002|565840603|FG000|Overall Study|Withdrawal by Subject|4|||
156751122|NCT00262002|565840604|FG001|Overall Study|Withdrawal by Subject|2|||
156751123|NCT00262002|565840605|FG002|Overall Study|Withdrawal by Subject|0|||
156751124|NCT00262002|565840606|FG003|Overall Study|Withdrawal by Subject|1|||
156751125|NCT00262002|565840607|FG004|Overall Study|Withdrawal by Subject|2|||
156751126|NCT00262002|565840608|FG005|Overall Study|Withdrawal by Subject|2|||
156751127|NCT00262002|565840609|FG006|Overall Study|Withdrawal by Subject|2|||
156751128|NCT00262002|565840603|FG000|Overall Study|Lost to Follow-up|2|||
156751129|NCT00262002|565840604|FG001|Overall Study|Lost to Follow-up|0|||
156751130|NCT00262002|565840605|FG002|Overall Study|Lost to Follow-up|0|||
156751131|NCT00262002|565840606|FG003|Overall Study|Lost to Follow-up|2|||
156751132|NCT00262002|565840607|FG004|Overall Study|Lost to Follow-up|0|||
156751133|NCT00262002|565840608|FG005|Overall Study|Lost to Follow-up|1|||
156751134|NCT00262002|565840609|FG006|Overall Study|Lost to Follow-up|0|||
156751135|NCT00262002|565840603|FG000|Overall Study|Inapropriate enrollment|0|||
156751136|NCT00262002|565840604|FG001|Overall Study|Inapropriate enrollment|1|||
156751137|NCT00262002|565840605|FG002|Overall Study|Inapropriate enrollment|0|||
156751138|NCT00262002|565840606|FG003|Overall Study|Inapropriate enrollment|0|||
156751139|NCT00262002|565840607|FG004|Overall Study|Inapropriate enrollment|0|||
156751140|NCT00262002|565840608|FG005|Overall Study|Inapropriate enrollment|0|||
156751141|NCT00262002|565840609|FG006|Overall Study|Inapropriate enrollment|0|||
156751142|NCT00262002|565840603|FG000|Overall Study|Protocol Violation|3|||
156751143|NCT00262002|565840604|FG001|Overall Study|Protocol Violation|2|||
156751144|NCT00262002|565840605|FG002|Overall Study|Protocol Violation|0|||
156751145|NCT00262002|565840606|FG003|Overall Study|Protocol Violation|2|||
156751146|NCT00262002|565840607|FG004|Overall Study|Protocol Violation|5|||
156751147|NCT00262002|565840608|FG005|Overall Study|Protocol Violation|3|||
156751148|NCT00262002|565840609|FG006|Overall Study|Protocol Violation|2|||
156751149|NCT00262002|565840603|FG000|Overall Study|Unable to classify|0|||
156751150|NCT00262002|565840604|FG001|Overall Study|Unable to classify|0|||
156751151|NCT00262002|565840605|FG002|Overall Study|Unable to classify|0|||
156751152|NCT00262002|565840606|FG003|Overall Study|Unable to classify|0|||
156751153|NCT00262002|565840607|FG004|Overall Study|Unable to classify|0|||
156751154|NCT00262002|565840608|FG005|Overall Study|Unable to classify|0|||
156751155|NCT00262002|565840609|FG006|Overall Study|Unable to classify|2|||
156751156|NCT03951753|565840610|FG000|Overall Study|Adverse Event|1|||
156751157|NCT03951753|565840611|FG001|Overall Study|Adverse Event|0|||
156751158|NCT03951753|565840612|FG002|Overall Study|Adverse Event|3|||
156751159|NCT03951753|565840610|FG000|Overall Study|Withdrawal by Subject|3|||
156751160|NCT03951753|565840611|FG001|Overall Study|Withdrawal by Subject|1|||
156751161|NCT03951753|565840612|FG002|Overall Study|Withdrawal by Subject|0|||
156751162|NCT03951753|565840610|FG000|Overall Study|Lost to Follow-up|0|||
156751163|NCT03951753|565840611|FG001|Overall Study|Lost to Follow-up|0|||
156751164|NCT03951753|565840612|FG002|Overall Study|Lost to Follow-up|1|||
156751165|NCT01905592|565840615|FG000|Overall Study|Disease Progression|51|||
156751166|NCT01905592|565840616|FG001|Overall Study|Disease Progression|110|||
156751167|NCT01905592|565840615|FG000|Overall Study|Toxicity|1|||
156751168|NCT01905592|565840616|FG001|Overall Study|Toxicity|16|||
156751169|NCT01905592|565840615|FG000|Overall Study|Physician Decision|0|||
156751170|NCT01905592|565840616|FG001|Overall Study|Physician Decision|2|||
156751171|NCT01905592|565840615|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
156751172|NCT01905592|565840616|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
156751173|NCT01905592|565840615|FG000|Overall Study|Protocol Violation|0|||
156751174|NCT01905592|565840616|FG001|Overall Study|Protocol Violation|1|||
156751175|NCT01905592|565840615|FG000|Overall Study|Sponsor's decision|1|||
156751176|NCT01905592|565840616|FG001|Overall Study|Sponsor's decision|1|||
156751177|NCT01905592|565840615|FG000|Overall Study|Not treated|7|||
156751178|NCT01905592|565840616|FG001|Overall Study|Not treated|3|||
157206623|NCT04150107|567499760|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
157206624|NCT04150107|567499761|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
157206625|NCT03409328|567499764|FG000|Overall Study|Lost to Follow-up|6|||
157206626|NCT03409328|567499765|FG001|Overall Study|Lost to Follow-up|3|||
157206627|NCT02998645|567499766|FG000|Treatment Period 1|Adverse Event|6|||
157206628|NCT02998645|567499766|FG000|Treatment Period 1|Death|5|||
157206629|NCT02998645|567499766|FG000|Treatment Period 1|Technical Problems|4|||
157206630|NCT02998645|567499766|FG000|Treatment Period 1|Lack of Efficacy|2|||
157206631|NCT02998645|567499766|FG000|Treatment Period 1|Progressive disease|1|||
157206632|NCT02998645|567499766|FG000|Treatment Period 1|Subject/guardian decision|1|||
157206633|NCT02998645|567499766|FG000|Treatment Period 2|Lack of Efficacy|5|||
157206634|NCT02998645|567499766|FG000|Treatment Period 2|Adverse Event|2|||
157206635|NCT02998645|567499766|FG000|Treatment Period 2|Progressive disease|2|||
157206636|NCT02998645|567499766|FG000|Treatment Period 2|Physician Decision|1|||
157206637|NCT00478673|567499767|FG000|30-Days Post-Procedure|Death|2|||
157206638|NCT00478673|567499767|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
157206639|NCT00478673|567499767|FG000|30-Days Post-Procedure|Missed Visit|7|||
157206640|NCT00478673|567499767|FG000|12-Months Post-Procedure|Death|23|||
157206641|NCT00478673|567499767|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
157206642|NCT00478673|567499767|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
157206643|NCT00478673|567499767|FG000|12-Months Post-Procedure|Missed Visit|25|||
157206644|NCT00478673|567499767|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
157206645|NCT03701516|567499768|FG000|Period 1|Lost to Follow-up|0|||
157206646|NCT03701516|567499769|FG001|Period 1|Lost to Follow-up|1|||
157206647|NCT03701516|567499768|FG000|Period 1|Adverse Event|0|||
156751179|NCT01905592|565840615|FG000|Overall Study|Withdrawal by Subject|10|||
156751180|NCT01905592|565840616|FG001|Overall Study|Withdrawal by Subject|2|||
156751181|NCT02109445|565840617|FG000|Overall Study|Symptomatic deterioration|2|||
156751182|NCT02109445|565840617|FG000|Overall Study|Adverse Event|1|||
156751183|NCT00966355|565840622|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
156751184|NCT00966355|565840623|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
156751185|NCT00966355|565840624|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
157206648|NCT03701516|567499769|FG001|Period 1|Adverse Event|2|||
157206649|NCT03701516|567499768|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
157206650|NCT03701516|567499769|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
157206651|NCT03701516|567499768|FG000|Period 1|Non Compliance to Protocol|2|||
156751186|NCT00966355|565840622|FG000|Overall Study|newly diagnosed advanced HCC|11|||
156751187|NCT00966355|565840623|FG001|Overall Study|newly diagnosed advanced HCC|12|||
156751188|NCT00966355|565840624|FG002|Overall Study|newly diagnosed advanced HCC|10|||
156751189|NCT00966355|565840622|FG000|Overall Study|Lost to Follow-up|5|||
156751190|NCT00966355|565840623|FG001|Overall Study|Lost to Follow-up|4|||
156751191|NCT00966355|565840624|FG002|Overall Study|Lost to Follow-up|3|||
156751192|NCT00958412|565840625|FG000|Overall Study|Study prematurely terminated|18|||
156751193|NCT02526160|565841941|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
156751194|NCT02526160|565841942|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
156751195|NCT02526160|565841941|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
156751196|NCT02526160|565841942|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
156751197|NCT02526160|565841941|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
156751198|NCT02526160|565841942|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
156751199|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Death|0|||
156751200|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Death|1|||
156751201|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
156751202|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
156751203|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
156751204|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
156751205|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
156751206|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
156751207|NCT02526160|565841941|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
156751208|NCT02526160|565841942|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
156751209|NCT00398216|565841943|FG000|Overall Study|Adverse Event|4|||
157206652|NCT03701516|567499769|FG001|Period 1|Non Compliance to Protocol|1|||
157206653|NCT03701516|567499768|FG000|Period 1|Withdrawal by Subject|0|||
157206654|NCT03701516|567499769|FG001|Period 1|Withdrawal by Subject|1|||
157206655|NCT03701516|567499768|FG000|Period 2|failed to meet all eligibility creiteria|1|||
157206656|NCT03701516|567499769|FG001|Period 2|failed to meet all eligibility creiteria|0|||
157206657|NCT03701516|567499768|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
157206658|NCT03701516|567499769|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
157206659|NCT03930615|567499772|FG000|Overall Study|Death|9|||
157206660|NCT03930615|567499773|FG001|Overall Study|Death|3|||
157206661|NCT03930615|567499772|FG000|Overall Study|Lost to Follow-up|1|||
157206662|NCT03930615|567499773|FG001|Overall Study|Lost to Follow-up|2|||
157206663|NCT03930615|567499772|FG000|Overall Study|Physician Decision|3|||
157206664|NCT03930615|567499773|FG001|Overall Study|Physician Decision|4|||
157206665|NCT03930615|567499772|FG000|Overall Study|Withdrawal by Subject|13|||
157206666|NCT03930615|567499773|FG001|Overall Study|Withdrawal by Subject|2|||
157206667|NCT03930615|567499772|FG000|Overall Study|Not treated|1|||
157206668|NCT03930615|567499773|FG001|Overall Study|Not treated|1|||
157206669|NCT03644927|567499776|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
157206670|NCT03644927|567499777|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
157206671|NCT00956813|567499778|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
157206672|NCT00956813|567499779|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
157206673|NCT00956813|567499778|FG000|Flaxseed and Placebo|Ineligible|3|||
157206674|NCT00956813|567499779|FG001|Flaxseed and Placebo|Ineligible|1|||
157206675|NCT00358670|567499780|FG000|Overall Study|Adverse Event|26|||
157206676|NCT00358670|567499781|FG001|Overall Study|Adverse Event|29|||
157206677|NCT00358670|567499780|FG000|Overall Study|Lack of Efficacy|20|||
157206678|NCT00358670|567499781|FG001|Overall Study|Lack of Efficacy|23|||
157206679|NCT00358670|567499780|FG000|Overall Study|Protocol Violation|6|||
157206680|NCT00358670|567499781|FG001|Overall Study|Protocol Violation|9|||
157206681|NCT00358670|567499780|FG000|Overall Study|Lost to Follow-up|4|||
157206682|NCT00358670|567499781|FG001|Overall Study|Lost to Follow-up|5|||
157206683|NCT00358670|567499780|FG000|Overall Study|Withdrawal by Subject|13|||
157206684|NCT00358670|567499781|FG001|Overall Study|Withdrawal by Subject|24|||
157206685|NCT00358670|567499780|FG000|Overall Study|Protocol Defined Clinical Event|0|||
157206686|NCT00358670|567499781|FG001|Overall Study|Protocol Defined Clinical Event|1|||
157206687|NCT00358670|567499780|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
157206688|NCT00358670|567499781|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
157206689|NCT00358670|567499780|FG000|Overall Study|Administrative|153|||
157206690|NCT00358670|567499781|FG001|Overall Study|Administrative|125|||
157206691|NCT00981019|567499782|FG000|Overall Study|Did not respond|65|||
157206692|NCT00981019|567499782|FG000|Overall Study|Did not match target population|94|||
157206693|NCT00981019|567499782|FG000|Overall Study|Inadvertent exclusion|239|||
157206694|NCT00981019|567499782|FG000|Overall Study|Hit the survey after closure|79|||
157206695|NCT00865306|567499783|FG000|Controlled Trial|Lost to Follow-up|1|||
156751210|NCT00398216|565841944|FG001|Overall Study|Adverse Event|2|||
156751211|NCT00398216|565841945|FG002|Overall Study|Adverse Event|5|||
156751212|NCT00398216|565841946|FG003|Overall Study|Adverse Event|7|||
156751213|NCT00398216|565841947|FG004|Overall Study|Adverse Event|2|||
157206696|NCT00865306|567499784|FG001|Controlled Trial|Lost to Follow-up|1|||
157206697|NCT00865306|567499783|FG000|Controlled Trial|Difficulty commuting|2|||
157206698|NCT00865306|567499784|FG001|Controlled Trial|Difficulty commuting|0|||
157206699|NCT00865306|567499783|FG000|Controlled Trial|Improved btw baseline and first session|1|||
157206700|NCT00865306|567499784|FG001|Controlled Trial|Improved btw baseline and first session|0|||
157206701|NCT00865306|567499783|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
157206702|NCT00865306|567499784|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
157206703|NCT00865306|567499783|FG000|Controlled Trial|Withdrawal by Subject|0|||
157206704|NCT00865306|567499784|FG001|Controlled Trial|Withdrawal by Subject|1|||
157206705|NCT05083559|567499785|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
157206706|NCT05083559|567499786|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
157206707|NCT05083559|567499785|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
156751214|NCT00398216|565841943|FG000|Overall Study|Protocol Violation|2|||
156751215|NCT00398216|565841944|FG001|Overall Study|Protocol Violation|4|||
156751216|NCT00398216|565841945|FG002|Overall Study|Protocol Violation|5|||
156751217|NCT00398216|565841946|FG003|Overall Study|Protocol Violation|7|||
156751218|NCT00398216|565841947|FG004|Overall Study|Protocol Violation|5|||
156751219|NCT00398216|565841943|FG000|Overall Study|Lost to Follow-up|1|||
156751220|NCT00398216|565841944|FG001|Overall Study|Lost to Follow-up|6|||
156751221|NCT00398216|565841945|FG002|Overall Study|Lost to Follow-up|4|||
156751222|NCT00398216|565841946|FG003|Overall Study|Lost to Follow-up|4|||
156751223|NCT00398216|565841947|FG004|Overall Study|Lost to Follow-up|1|||
156751224|NCT00398216|565841943|FG000|Overall Study|Death|0|||
156751225|NCT00398216|565841944|FG001|Overall Study|Death|3|||
156751226|NCT00398216|565841945|FG002|Overall Study|Death|0|||
156751227|NCT00398216|565841946|FG003|Overall Study|Death|0|||
156751228|NCT00398216|565841947|FG004|Overall Study|Death|0|||
156751229|NCT00398216|565841943|FG000|Overall Study|Withdrawal by Subject|1|||
156751230|NCT00398216|565841944|FG001|Overall Study|Withdrawal by Subject|0|||
156751231|NCT00398216|565841945|FG002|Overall Study|Withdrawal by Subject|3|||
157206708|NCT05083559|567499786|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
157206709|NCT05083559|567499785|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
157206710|NCT05083559|567499786|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
157206711|NCT02704130|567499788|FG000|Overall Study|Physician Decision|5|||
157206712|NCT02704130|567499789|FG001|Overall Study|Physician Decision|3|||
157206713|NCT01819467|567501171|FG000|Overall Study|Physician Decision|20|||
157206714|NCT01819467|567501172|FG001|Overall Study|Physician Decision|9|||
157206715|NCT00734617|567501177|FG000|Overall Study|Adverse Event|4|||
157206716|NCT00734617|567501178|FG001|Overall Study|Adverse Event|7|||
157206717|NCT00734617|567501177|FG000|Overall Study|Withdrawal by Subject|103|||
157206718|NCT00734617|567501178|FG001|Overall Study|Withdrawal by Subject|95|||
157206719|NCT03692078|567501181|FG000|Overall Study|Adverse Event|0|||
156751232|NCT00398216|565841946|FG003|Overall Study|Withdrawal by Subject|1|||
156751233|NCT00398216|565841947|FG004|Overall Study|Withdrawal by Subject|2|||
156751234|NCT00398216|565841943|FG000|Overall Study|administrative reasons|3|||
156751235|NCT00398216|565841944|FG001|Overall Study|administrative reasons|4|||
156751236|NCT00398216|565841945|FG002|Overall Study|administrative reasons|4|||
157206720|NCT03692078|567501182|FG001|Overall Study|Adverse Event|0|||
157206721|NCT03692078|567501183|FG002|Overall Study|Adverse Event|0|||
157206722|NCT03692078|567501184|FG003|Overall Study|Adverse Event|0|||
157206723|NCT03692078|567501185|FG004|Overall Study|Adverse Event|0|||
157206724|NCT03692078|567501186|FG005|Overall Study|Adverse Event|1|||
157206725|NCT03692078|567501187|FG006|Overall Study|Adverse Event|0|||
157206726|NCT03692078|567501181|FG000|Overall Study|Enrollment Closed|5|||
157206727|NCT03692078|567501182|FG001|Overall Study|Enrollment Closed|0|||
157206728|NCT03692078|567501183|FG002|Overall Study|Enrollment Closed|0|||
157206729|NCT03692078|567501184|FG003|Overall Study|Enrollment Closed|0|||
157206730|NCT03692078|567501185|FG004|Overall Study|Enrollment Closed|0|||
157206731|NCT03692078|567501186|FG005|Overall Study|Enrollment Closed|0|||
157206732|NCT03692078|567501187|FG006|Overall Study|Enrollment Closed|0|||
157206733|NCT03692078|567501181|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
157206734|NCT03692078|567501182|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
157206735|NCT03692078|567501183|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
157206736|NCT03692078|567501184|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
157206737|NCT03692078|567501185|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
157206738|NCT03692078|567501186|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
157206739|NCT03692078|567501187|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
157206740|NCT03692078|567501181|FG000|Overall Study|Withdrawal by Subject|0|||
157206741|NCT03692078|567501182|FG001|Overall Study|Withdrawal by Subject|2|||
156751237|NCT00398216|565841946|FG003|Overall Study|administrative reasons|3|||
156751238|NCT00398216|565841947|FG004|Overall Study|administrative reasons|3|||
156751239|NCT00398216|565841943|FG000|Overall Study|entrance criteria|0|||
156751240|NCT00398216|565841944|FG001|Overall Study|entrance criteria|0|||
156751241|NCT00398216|565841945|FG002|Overall Study|entrance criteria|0|||
156751242|NCT00398216|565841946|FG003|Overall Study|entrance criteria|0|||
156751243|NCT00398216|565841947|FG004|Overall Study|entrance criteria|2|||
156751244|NCT02985021|565841948|FG000|Overall Study|Inability to comply with study procedures|1|||
156751245|NCT03299101|565841953|FG000|Overall Study|Lost to Follow-up|1|||
156751246|NCT03299101|565841953|FG000|Overall Study|Withdrawal by Subject|5|||
156751247|NCT03299101|565841953|FG000|Overall Study|Surgery was changed|3|||
156751248|NCT03299101|565841953|FG000|Overall Study|Not enough time to complete prehab|1|||
156751249|NCT01884545|565841956|FG000|Overall Study|Lost to Follow-up|6|||
156751250|NCT01884545|565841957|FG001|Overall Study|Lost to Follow-up|4|||
156751251|NCT01884545|565841958|FG002|Overall Study|Lost to Follow-up|9|||
156751252|NCT01884545|565841959|FG003|Overall Study|Lost to Follow-up|4|||
156751253|NCT01884545|565841956|FG000|Overall Study|Patient withdrawn|7|||
156751254|NCT01884545|565841957|FG001|Overall Study|Patient withdrawn|12|||
156751255|NCT01884545|565841958|FG002|Overall Study|Patient withdrawn|5|||
156751256|NCT01884545|565841959|FG003|Overall Study|Patient withdrawn|5|||
156751257|NCT01884545|565841956|FG000|Overall Study|Non-adherence|0|||
156751258|NCT01884545|565841957|FG001|Overall Study|Non-adherence|2|||
156751259|NCT01884545|565841958|FG002|Overall Study|Non-adherence|0|||
156751260|NCT01884545|565841959|FG003|Overall Study|Non-adherence|0|||
156751261|NCT01424241|565841960|FG000|Overall Study|Withdrawal by Subject|1|||
156751262|NCT01424241|565841960|FG000|Overall Study|Time constraints|2|||
156751263|NCT00551525|565841961|FG000|Overall Study|Protocol Violation|5|||
156751264|NCT05259917|565841963|FG000|Overall Study|Protocol Violation|0|||
156751265|NCT05259917|565841964|FG001|Overall Study|Protocol Violation|0|||
156751266|NCT05259917|565841965|FG002|Overall Study|Protocol Violation|1|||
156751267|NCT05259917|565841966|FG003|Overall Study|Protocol Violation|0|||
156751268|NCT05259917|565841967|FG004|Overall Study|Protocol Violation|0|||
156751269|NCT05259917|565841968|FG005|Overall Study|Protocol Violation|0|||
156751270|NCT05259917|565841963|FG000|Overall Study|Lost to Follow-up|0|||
156751271|NCT05259917|565841964|FG001|Overall Study|Lost to Follow-up|0|||
156751272|NCT05259917|565841965|FG002|Overall Study|Lost to Follow-up|1|||
156751273|NCT05259917|565841966|FG003|Overall Study|Lost to Follow-up|0|||
156751274|NCT05259917|565841967|FG004|Overall Study|Lost to Follow-up|0|||
156751275|NCT05259917|565841968|FG005|Overall Study|Lost to Follow-up|1|||
156751276|NCT05259917|565841963|FG000|Overall Study|Physician Decision|0|||
157206742|NCT03692078|567501183|FG002|Overall Study|Withdrawal by Subject|0|||
157206743|NCT03692078|567501184|FG003|Overall Study|Withdrawal by Subject|1|||
157206744|NCT03692078|567501185|FG004|Overall Study|Withdrawal by Subject|5|||
157206745|NCT03692078|567501186|FG005|Overall Study|Withdrawal by Subject|3|||
157206746|NCT03692078|567501187|FG006|Overall Study|Withdrawal by Subject|3|||
157206747|NCT00996632|567501190|FG000|Overall Study|Physician Decision|0|||
157206748|NCT00996632|567501191|FG001|Overall Study|Physician Decision|0|||
157206749|NCT00916617|567501195|FG000|Overall Study|Adverse Event|3|||
157206750|NCT00916617|567501196|FG001|Overall Study|Adverse Event|2|||
157206751|NCT00916617|567501197|FG002|Overall Study|Adverse Event|6|||
157206752|NCT00916617|567501198|FG003|Overall Study|Adverse Event|3|||
157206753|NCT00916617|567501195|FG000|Overall Study|Withdrawal by Subject|3|||
157206754|NCT00916617|567501196|FG001|Overall Study|Withdrawal by Subject|2|||
157206755|NCT00916617|567501197|FG002|Overall Study|Withdrawal by Subject|0|||
157206756|NCT00916617|567501198|FG003|Overall Study|Withdrawal by Subject|1|||
157206757|NCT00916617|567501195|FG000|Overall Study|Caregiver Request|3|||
157206758|NCT00916617|567501196|FG001|Overall Study|Caregiver Request|2|||
157206759|NCT00916617|567501197|FG002|Overall Study|Caregiver Request|1|||
157206760|NCT00916617|567501198|FG003|Overall Study|Caregiver Request|0|||
157206761|NCT00916617|567501195|FG000|Overall Study|Physician Decision|1|||
157206762|NCT00916617|567501196|FG001|Overall Study|Physician Decision|1|||
157206763|NCT00916617|567501197|FG002|Overall Study|Physician Decision|0|||
157206764|NCT00916617|567501198|FG003|Overall Study|Physician Decision|0|||
157206765|NCT00916617|567501195|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
157206766|NCT00916617|567501196|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
157206767|NCT00916617|567501197|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
157206768|NCT00916617|567501198|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
157206769|NCT00916617|567501195|FG000|Overall Study|Lost to Follow-up|2|||
157206770|NCT00916617|567501196|FG001|Overall Study|Lost to Follow-up|1|||
157206771|NCT00916617|567501197|FG002|Overall Study|Lost to Follow-up|0|||
157206772|NCT00916617|567501198|FG003|Overall Study|Lost to Follow-up|0|||
157206773|NCT00916617|567501195|FG000|Overall Study|Lack of Efficacy|1|||
157206774|NCT00916617|567501196|FG001|Overall Study|Lack of Efficacy|0|||
157206775|NCT00916617|567501197|FG002|Overall Study|Lack of Efficacy|0|||
157206776|NCT00916617|567501198|FG003|Overall Study|Lack of Efficacy|0|||
157206777|NCT00916617|567501195|FG000|Overall Study|Other|2|||
157206778|NCT00916617|567501196|FG001|Overall Study|Other|0|||
157206779|NCT00916617|567501197|FG002|Overall Study|Other|0|||
157206780|NCT00916617|567501198|FG003|Overall Study|Other|2|||
157206781|NCT02086968|567501202|FG000|Overall Study|Adverse Event|1|||
157206782|NCT02086968|567501203|FG001|Overall Study|Adverse Event|5|||
157206783|NCT02086968|567501202|FG000|Overall Study|Lost to Follow-up|2|||
157206784|NCT02086968|567501203|FG001|Overall Study|Lost to Follow-up|3|||
157206785|NCT02086968|567501202|FG000|Overall Study|Study drug received outside protocol|0|||
157206786|NCT02086968|567501203|FG001|Overall Study|Study drug received outside protocol|1|||
157206787|NCT02086968|567501202|FG000|Overall Study|Physician Decision|4|||
157206788|NCT02086968|567501203|FG001|Overall Study|Physician Decision|0|||
157206789|NCT02086968|567501202|FG000|Overall Study|Withdrawal by Subject|1|||
157206790|NCT02086968|567501203|FG001|Overall Study|Withdrawal by Subject|4|||
157206791|NCT00537056|567501207|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
157206792|NCT01257737|567501208|FG000|Overall Study|Lost to Follow-up|1|||
157206793|NCT01257737|567501209|FG001|Overall Study|Lost to Follow-up|2|||
157206794|NCT01257737|567501208|FG000|Overall Study|Liver transplant|1|||
157206795|NCT01257737|567501209|FG001|Overall Study|Liver transplant|0|||
157206796|NCT01257737|567501208|FG000|Overall Study|Relocation out of the country|0|||
157206797|NCT01257737|567501209|FG001|Overall Study|Relocation out of the country|1|||
157206798|NCT01257737|567501208|FG000|Overall Study|Withdrew from study|0|||
157206799|NCT01257737|567501209|FG001|Overall Study|Withdrew from study|1|||
157206800|NCT00203892|567501216|FG000|Overall Study|Physician Decision|1|||
157206801|NCT00203892|567501217|FG001|Overall Study|Physician Decision|2|||
157206802|NCT00203892|567501218|FG002|Overall Study|Physician Decision|0|||
157206803|NCT00203892|567501216|FG000|Overall Study|Death|1|||
157206804|NCT00203892|567501217|FG001|Overall Study|Death|0|||
157206805|NCT00203892|567501218|FG002|Overall Study|Death|0|||
157206806|NCT00556166|567501219|FG000|Overall Study|Withdrawal by Subject|1|||
157206807|NCT02985515|567501220|FG000|Olfaction Testing|Lost to Follow-up|0|||
157206808|NCT02985515|567501221|FG001|Olfaction Testing|Lost to Follow-up|5|||
157206809|NCT02985515|567501220|FG000|Olfaction Testing|Protocol Violation|0|||
157206810|NCT02985515|567501221|FG001|Olfaction Testing|Protocol Violation|3|||
157206811|NCT01060007|567501224|FG000|Overall Study|Withdrawal by Subject|1|||
157206812|NCT01060007|567501224|FG000|Overall Study|Inevaluable for response at surgery|3|||
157206813|NCT00445458|567501225|FG000|Overall Study|Disease Progression|3|||
157206814|NCT00445458|567501226|FG001|Overall Study|Disease Progression|4|||
157206815|NCT00445458|567501227|FG002|Overall Study|Disease Progression|54|||
157206816|NCT00445458|567501228|FG003|Overall Study|Disease Progression|27|||
157206817|NCT00445458|567501225|FG000|Overall Study|Withdrawal by Subject|0|||
157206818|NCT00445458|567501226|FG001|Overall Study|Withdrawal by Subject|0|||
157206819|NCT00445458|567501227|FG002|Overall Study|Withdrawal by Subject|7|||
157206820|NCT00445458|567501228|FG003|Overall Study|Withdrawal by Subject|0|||
157206821|NCT00445458|567501225|FG000|Overall Study|Adverse Event|0|||
157206822|NCT00445458|567501226|FG001|Overall Study|Adverse Event|0|||
157206823|NCT00445458|567501227|FG002|Overall Study|Adverse Event|3|||
157206824|NCT00445458|567501228|FG003|Overall Study|Adverse Event|0|||
157206825|NCT00445458|567501225|FG000|Overall Study|Death|0|||
157206826|NCT00445458|567501226|FG001|Overall Study|Death|1|||
157206827|NCT00445458|567501227|FG002|Overall Study|Death|2|||
157206828|NCT00445458|567501228|FG003|Overall Study|Death|0|||
157206829|NCT00445458|567501225|FG000|Overall Study|Physician Decision|0|||
157206830|NCT00445458|567501226|FG001|Overall Study|Physician Decision|0|||
157206831|NCT00445458|567501227|FG002|Overall Study|Physician Decision|1|||
157206832|NCT00445458|567501228|FG003|Overall Study|Physician Decision|1|||
157206833|NCT00445458|567501225|FG000|Overall Study|Surgery|0|||
157206834|NCT00445458|567501226|FG001|Overall Study|Surgery|0|||
157206835|NCT00445458|567501227|FG002|Overall Study|Surgery|1|||
157206836|NCT00445458|567501228|FG003|Overall Study|Surgery|0|||
157206837|NCT02072174|567501232|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
156751277|NCT05259917|565841964|FG001|Overall Study|Physician Decision|1|||
156751278|NCT05259917|565841965|FG002|Overall Study|Physician Decision|0|||
156751279|NCT05259917|565841966|FG003|Overall Study|Physician Decision|0|||
156751280|NCT05259917|565841967|FG004|Overall Study|Physician Decision|0|||
156751281|NCT05259917|565841968|FG005|Overall Study|Physician Decision|0|||
156751282|NCT05259917|565841963|FG000|Overall Study|Withdrawal by Subject|0|||
156751283|NCT05259917|565841964|FG001|Overall Study|Withdrawal by Subject|1|||
156751284|NCT05259917|565841965|FG002|Overall Study|Withdrawal by Subject|0|||
156751285|NCT05259917|565841966|FG003|Overall Study|Withdrawal by Subject|0|||
156751286|NCT05259917|565841967|FG004|Overall Study|Withdrawal by Subject|1|||
156751287|NCT05259917|565841968|FG005|Overall Study|Withdrawal by Subject|1|||
156751288|NCT05259917|565841963|FG000|Overall Study|Trial Termination by Sponsor|7|||
156751289|NCT05259917|565841964|FG001|Overall Study|Trial Termination by Sponsor|2|||
156751290|NCT05259917|565841965|FG002|Overall Study|Trial Termination by Sponsor|3|||
156751291|NCT05259917|565841966|FG003|Overall Study|Trial Termination by Sponsor|5|||
156751292|NCT05259917|565841967|FG004|Overall Study|Trial Termination by Sponsor|11|||
156751293|NCT05259917|565841968|FG005|Overall Study|Trial Termination by Sponsor|4|||
156751294|NCT05259917|565841963|FG000|Overall Study|Other|1|||
156751295|NCT05259917|565841964|FG001|Overall Study|Other|0|||
156751296|NCT05259917|565841965|FG002|Overall Study|Other|2|||
156751297|NCT05259917|565841966|FG003|Overall Study|Other|0|||
156751298|NCT05259917|565841967|FG004|Overall Study|Other|0|||
156751299|NCT05259917|565841968|FG005|Overall Study|Other|0|||
156751300|NCT00303472|565841973|FG000|Treatment Period|Adverse Event|0|||
156751301|NCT00303472|565841974|FG001|Treatment Period|Adverse Event|0|||
156751302|NCT00303472|565841975|FG002|Treatment Period|Adverse Event|0|||
156751303|NCT00303472|565841976|FG003|Treatment Period|Adverse Event|0|||
156751304|NCT00303472|565841977|FG004|Treatment Period|Adverse Event|1|||
156751305|NCT00303472|565841978|FG005|Treatment Period|Adverse Event|0|||
156751306|NCT00303472|565841979|FG006|Treatment Period|Adverse Event|0|||
156751307|NCT00303472|565841973|FG000|Treatment Period|Death|0|||
156751308|NCT00303472|565841974|FG001|Treatment Period|Death|0|||
156751309|NCT00303472|565841975|FG002|Treatment Period|Death|0|||
156751310|NCT00303472|565841976|FG003|Treatment Period|Death|1|||
156751311|NCT00303472|565841977|FG004|Treatment Period|Death|0|||
156751312|NCT00303472|565841978|FG005|Treatment Period|Death|0|||
156751313|NCT00303472|565841979|FG006|Treatment Period|Death|1|||
156751314|NCT00303472|565841973|FG000|Treatment Period|Withdrawal by Subject|0|||
156751315|NCT00303472|565841974|FG001|Treatment Period|Withdrawal by Subject|0|||
156751316|NCT00303472|565841975|FG002|Treatment Period|Withdrawal by Subject|0|||
156751317|NCT00303472|565841976|FG003|Treatment Period|Withdrawal by Subject|1|||
156751318|NCT00303472|565841977|FG004|Treatment Period|Withdrawal by Subject|0|||
156751319|NCT00303472|565841978|FG005|Treatment Period|Withdrawal by Subject|1|||
156751320|NCT00303472|565841979|FG006|Treatment Period|Withdrawal by Subject|0|||
156751321|NCT00303472|565841973|FG000|Treatment Period|Other|0|||
156751322|NCT00303472|565841974|FG001|Treatment Period|Other|0|||
156751323|NCT00303472|565841975|FG002|Treatment Period|Other|0|||
156751324|NCT00303472|565841976|FG003|Treatment Period|Other|0|||
156751325|NCT00303472|565841977|FG004|Treatment Period|Other|1|||
156751326|NCT00303472|565841978|FG005|Treatment Period|Other|0|||
156751327|NCT00303472|565841979|FG006|Treatment Period|Other|1|||
156751328|NCT00303472|565841973|FG000|Treatment Period|Disease Progression (to AML)|0|||
156751329|NCT00303472|565841974|FG001|Treatment Period|Disease Progression (to AML)|0|||
156751330|NCT00303472|565841975|FG002|Treatment Period|Disease Progression (to AML)|0|||
156751331|NCT00303472|565841976|FG003|Treatment Period|Disease Progression (to AML)|0|||
156751332|NCT00303472|565841977|FG004|Treatment Period|Disease Progression (to AML)|1|||
156751333|NCT00303472|565841978|FG005|Treatment Period|Disease Progression (to AML)|0|||
156751334|NCT00303472|565841979|FG006|Treatment Period|Disease Progression (to AML)|0|||
156751335|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Adverse Event|1|||
156751336|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Adverse Event|0|||
156751337|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Adverse Event|1|||
156751338|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Adverse Event|0|||
156751339|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Adverse Event|0|||
156751340|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Adverse Event|0|||
156751341|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Adverse Event|0|||
156751342|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Death|2|||
156751343|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Death|0|||
156751344|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Death|1|||
156751345|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Death|0|||
156751346|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Death|0|||
156751347|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Death|0|||
156751348|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Death|0|||
156751349|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751350|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751351|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751352|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
156751353|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751354|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751355|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
156751356|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Physician Decision|0|||
156751357|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Physician Decision|4|||
156751358|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Physician Decision|2|||
156751359|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Physician Decision|3|||
156751360|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Physician Decision|2|||
156751361|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Physician Decision|0|||
156751362|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Physician Decision|0|||
156751363|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751364|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751365|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751366|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
156751367|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
156751368|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751369|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
156751370|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Other|0|||
156751371|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Other|2|||
156751372|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Other|4|||
156751373|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Other|2|||
156751374|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Other|1|||
156751375|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Other|0|||
156751376|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Other|0|||
156751377|NCT00303472|565841973|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
156751378|NCT00303472|565841974|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751379|NCT00303472|565841975|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751380|NCT00303472|565841976|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751381|NCT00303472|565841977|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751382|NCT00303472|565841978|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
156751383|NCT00303472|565841979|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
156751384|NCT02937636|565841988|FG000|Overall Study|Other (Not specified)|3|||
156751385|NCT02937636|565841989|FG001|Overall Study|Other (Not specified)|2|||
156751386|NCT00770913|565841990|FG000|Overall Study|Adverse Event|1|||
156751387|NCT00770913|565841991|FG001|Overall Study|Adverse Event|3|||
156751388|NCT00770913|565841992|FG002|Overall Study|Adverse Event|6|||
156751389|NCT00770913|565841990|FG000|Overall Study|Refusal to continue participation|6|||
156751390|NCT00770913|565841991|FG001|Overall Study|Refusal to continue participation|4|||
156751391|NCT00770913|565841992|FG002|Overall Study|Refusal to continue participation|5|||
156751392|NCT00770913|565841990|FG000|Overall Study|Physician Decision|0|||
156751393|NCT00770913|565841991|FG001|Overall Study|Physician Decision|1|||
156751394|NCT00770913|565841992|FG002|Overall Study|Physician Decision|1|||
156751395|NCT00770913|565841990|FG000|Overall Study|Protocol Violation|3|||
156751396|NCT00770913|565841991|FG001|Overall Study|Protocol Violation|0|||
156751397|NCT00770913|565841992|FG002|Overall Study|Protocol Violation|1|||
156751398|NCT00770913|565841990|FG000|Overall Study|Incorrect drug was allocated|1|||
156751399|NCT00770913|565841991|FG001|Overall Study|Incorrect drug was allocated|0|||
156751400|NCT00770913|565841992|FG002|Overall Study|Incorrect drug was allocated|0|||
156751401|NCT02347072|565841996|FG000|Overall Study|Adverse Event|2|||
156751402|NCT02347072|565841996|FG000|Overall Study|Withdrawal by Subject|6|||
156751403|NCT02347072|565841996|FG000|Overall Study|Physician Decision|1|||
156751404|NCT02347072|565841996|FG000|Overall Study|Lost to Follow-up|2|||
156751405|NCT02347072|565841996|FG000|Overall Study|Protocol Violation|1|||
156751406|NCT02347072|565841996|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
156751407|NCT01134393|565842001|FG000|Overall Study|Adverse Event|18|||
156751408|NCT01134393|565842001|FG000|Overall Study|Lack of Efficacy|2|||
156751409|NCT01134393|565842001|FG000|Overall Study|Protocol Violation|12|||
156751410|NCT01134393|565842001|FG000|Overall Study|Lost to Follow-up|3|||
156751411|NCT01134393|565842001|FG000|Overall Study|Withdrawal by Subject|11|||
156751412|NCT01134393|565842001|FG000|Overall Study|Other|6|||
156751413|NCT01808222|565842004|FG000|Overall Study|mpMR scan was not performed|1|||
156751414|NCT02324699|565842007|FG000|Overall Study|study terminated|1|||
156751415|NCT02912455|565842010|FG000|Overall Study|Withdrawal by Subject|0|||
156751416|NCT02912455|565842011|FG001|Overall Study|Withdrawal by Subject|1|||
156751417|NCT02912455|565842010|FG000|Overall Study|Lack of Efficacy|0|||
156751418|NCT02912455|565842011|FG001|Overall Study|Lack of Efficacy|1|||
156751419|NCT02912455|565842010|FG000|Overall Study|Lost to Follow-up|2|||
156751420|NCT02912455|565842011|FG001|Overall Study|Lost to Follow-up|1|||
156751421|NCT00621517|565842012|FG000|Overall Study|Lost to Follow-up|3|||
156751422|NCT00621517|565842013|FG001|Overall Study|Lost to Follow-up|3|||
157206838|NCT02072174|567501233|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
156751423|NCT00621517|565842012|FG000|Overall Study|Withdrawal by Subject|3|||
156751424|NCT00621517|565842013|FG001|Overall Study|Withdrawal by Subject|4|||
156751425|NCT00621517|565842012|FG000|Overall Study|Adverse Event|1|||
157206839|NCT02072174|567501232|FG000|Overall Study|Protocol Violation|16|||
157206840|NCT02072174|567501233|FG001|Overall Study|Protocol Violation|23|||
157206841|NCT02072174|567501232|FG000|Overall Study|Physician Decision|0|||
157206842|NCT02072174|567501233|FG001|Overall Study|Physician Decision|1|||
157206843|NCT02072174|567501232|FG000|Overall Study|Non-compliance with protocol requirement|2|||
157206844|NCT02072174|567501233|FG001|Overall Study|Non-compliance with protocol requirement|0|||
157206845|NCT00440193|567501234|FG000|Treatment Period|Adverse Event|74|||
157206846|NCT00440193|567501235|FG001|Treatment Period|Adverse Event|67|||
157206847|NCT00440193|567501234|FG000|Treatment Period|Death|19|||
157206848|NCT00440193|567501235|FG001|Treatment Period|Death|22|||
157206849|NCT00440193|567501234|FG000|Treatment Period|Lack of Efficacy|0|||
157206850|NCT00440193|567501235|FG001|Treatment Period|Lack of Efficacy|1|||
157206851|NCT00440193|567501234|FG000|Treatment Period|Lost to Follow-up|12|||
157206852|NCT00440193|567501235|FG001|Treatment Period|Lost to Follow-up|18|||
157206853|NCT00440193|567501234|FG000|Treatment Period|Physician Decision|3|||
157206854|NCT00440193|567501235|FG001|Treatment Period|Physician Decision|6|||
157206855|NCT00440193|567501234|FG000|Treatment Period|Protocol Violation|16|||
157206856|NCT00440193|567501235|FG001|Treatment Period|Protocol Violation|19|||
157206857|NCT00440193|567501234|FG000|Treatment Period|Withdrawal by Subject|36|||
157206858|NCT00440193|567501235|FG001|Treatment Period|Withdrawal by Subject|77|||
157206859|NCT00440193|567501234|FG000|Treatment Period|Clinical endpoint reached|28|||
157206860|NCT00440193|567501235|FG001|Treatment Period|Clinical endpoint reached|25|||
157206861|NCT00440193|567501234|FG000|Treatment Period|Study terminated by sponsor|102|||
157206862|NCT00440193|567501235|FG001|Treatment Period|Study terminated by sponsor|94|||
157206863|NCT00440193|567501234|FG000|Treatment Period|Protocol driven decision point|2|||
156751426|NCT00621517|565842013|FG001|Overall Study|Adverse Event|0|||
156751427|NCT00073008|565842015|FG000|Overall Study|Missing|6|||
156751428|NCT00073008|565842016|FG001|Overall Study|Missing|6|||
156751429|NCT00073008|565842015|FG000|Overall Study|Withdrawal by Subject|2|||
156751430|NCT00073008|565842016|FG001|Overall Study|Withdrawal by Subject|2|||
156751431|NCT00073008|565842015|FG000|Overall Study|Lost to Follow-up|1|||
156751432|NCT00073008|565842016|FG001|Overall Study|Lost to Follow-up|3|||
156751433|NCT00073008|565842015|FG000|Overall Study|Death|46|||
156751434|NCT00073008|565842016|FG001|Overall Study|Death|47|||
156751435|NCT00073008|565842015|FG000|Overall Study|"Other selected on Case Report Form"|7|||
156751436|NCT00073008|565842016|FG001|Overall Study|"Other selected on Case Report Form"|5|||
156751437|NCT01778751|565842026|FG000|Overall Study|Lost to Follow-up|1|||
156751438|NCT01778751|565842027|FG001|Overall Study|Lost to Follow-up|0|||
156751439|NCT01778751|565842026|FG000|Overall Study|Withdrawal by Subject|0|||
156751440|NCT01778751|565842027|FG001|Overall Study|Withdrawal by Subject|2|||
156751441|NCT01778751|565842026|FG000|Overall Study|Transfered care|1|||
156751442|NCT01778751|565842027|FG001|Overall Study|Transfered care|0|||
156751443|NCT02669667|565842028|FG000|Overall Study|Lost to Follow-up|0|||
156751444|NCT02669667|565842029|FG001|Overall Study|Lost to Follow-up|0|||
156751445|NCT02669667|565842030|FG002|Overall Study|Lost to Follow-up|0|||
156751446|NCT02669667|565842031|FG003|Overall Study|Lost to Follow-up|0|||
156751447|NCT02669667|565842032|FG004|Overall Study|Lost to Follow-up|0|||
156751448|NCT02669667|565842033|FG005|Overall Study|Lost to Follow-up|1|||
156751449|NCT02669667|565842034|FG006|Overall Study|Lost to Follow-up|0|||
156751450|NCT00636961|565842046|FG000|Period 1|Administrative problems|1|||
156751451|NCT00636961|565842047|FG001|Period 1|Administrative problems|1|||
156751452|NCT00636961|565842046|FG000|Period 2|Adverse Event|1|||
156751453|NCT00636961|565842047|FG001|Period 2|Adverse Event|0|||
156751454|NCT01156051|565842051|FG000|Overall Study|Lost to Follow-up|1|||
156751455|NCT01156051|565842052|FG001|Overall Study|Lost to Follow-up|0|||
156751456|NCT01156051|565842051|FG000|Overall Study|patient not compliant with protocol|0|||
156751457|NCT01156051|565842052|FG001|Overall Study|patient not compliant with protocol|1|||
156751458|NCT03628716|565842053|FG000|Overall Study|Adverse Event|1|||
156751459|NCT03628716|565842054|FG001|Overall Study|Adverse Event|1|||
156751460|NCT03628716|565842053|FG000|Overall Study|Death|1|||
156751461|NCT03628716|565842054|FG001|Overall Study|Death|0|||
156751462|NCT03628716|565842053|FG000|Overall Study|Lack of Efficacy|15|||
156751463|NCT03628716|565842054|FG001|Overall Study|Lack of Efficacy|20|||
156751464|NCT03628716|565842053|FG000|Overall Study|Withdrawal by Subject|1|||
156751465|NCT03628716|565842054|FG001|Overall Study|Withdrawal by Subject|2|||
156751466|NCT03628716|565842053|FG000|Overall Study|Study Terminated by Sponsor|1|||
156751467|NCT03628716|565842054|FG001|Overall Study|Study Terminated by Sponsor|0|||
156751468|NCT00856843|565842055|FG000|Overall Study|Withdrawal by Subject|1|||
156751469|NCT00856843|565842056|FG001|Overall Study|Withdrawal by Subject|5|||
156751470|NCT00856843|565842055|FG000|Overall Study|Lack of Efficacy|1|||
156751471|NCT00856843|565842056|FG001|Overall Study|Lack of Efficacy|0|||
156751472|NCT03172364|565842057|FG000|Overall Study|Adverse Event|1|||
156751473|NCT03172364|565842058|FG001|Overall Study|Adverse Event|1|||
156751474|NCT03172364|565842057|FG000|Overall Study|Protocol Violation|1|||
157206864|NCT00440193|567501235|FG001|Treatment Period|Protocol driven decision point|2|||
156751475|NCT03172364|565842058|FG001|Overall Study|Protocol Violation|0|||
156751476|NCT03755518|565842059|FG000|Overall Study|Lack of Efficacy|10|||
156751477|NCT03755518|565842059|FG000|Overall Study|Adverse Event|7|||
156751478|NCT03755518|565842059|FG000|Overall Study|Study Terminated by Sponsor|5|||
156751479|NCT03755518|565842059|FG000|Overall Study|Death|1|||
156751480|NCT03755518|565842059|FG000|Overall Study|Withdrawal by Subject|3|||
156751481|NCT03755518|565842059|FG000|Overall Study|Progressive Disease|4|||
156751482|NCT03755518|565842059|FG000|Overall Study|Bone Marrow Transplant|4|||
156751483|NCT03755518|565842059|FG000|Overall Study|Physicians Decision|1|||
156751484|NCT03755518|565842059|FG000|Overall Study|Relapse|1|||
156751485|NCT03755518|565842059|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
156751486|NCT03755518|565842059|FG000|Overall Study|Withdrawal by PI|1|||
156751487|NCT01714609|565842060|FG000|Overall Study|Protocol Violation|1|||
156751488|NCT01714609|565842061|FG001|Overall Study|Protocol Violation|0|||
156751489|NCT00583102|565842062|FG000|Overall Study|Adverse Event|3|||
156751490|NCT03403621|565842063|FG000|Overall Study|Withdrawal by Subject|2|||
156751491|NCT03403621|565842064|FG001|Overall Study|Withdrawal by Subject|2|||
156751492|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
156751493|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751494|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751495|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751496|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751497|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751498|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156864963|NCT05966142|566265384|FG000|Overall Study|Duplicate Enrollment|1|||
156864964|NCT05966142|566265385|FG001|Overall Study|Duplicate Enrollment|0|||
156864965|NCT05966142|566265384|FG000|Overall Study|Study Logistical Reason|1|||
156864966|NCT05966142|566265385|FG001|Overall Study|Study Logistical Reason|0|||
156864967|NCT05966142|566265384|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
156864968|NCT05966142|566265385|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
156864969|NCT04849364|566265386|FG000|Overall Study|Eligibility criteria not meet|0|||
156864970|NCT04849364|566265387|FG001|Overall Study|Eligibility criteria not meet|1|||
156864971|NCT04849364|566265388|FG002|Overall Study|Eligibility criteria not meet|0|||
156864972|NCT01643668|566265389|FG000|Overall Study|Death|1|||
156864973|NCT01294553|566265392|FG000|Overall Study|Duplicated Participants|1|||
156864974|NCT01294553|566265392|FG000|Overall Study|Protocol Violation|268|||
156864975|NCT01217229|566265393|FG000|Overall Study|Adverse Event|1|||
156864976|NCT01217229|566265393|FG000|Overall Study|Disease progression, deterioration|2|||
156864977|NCT01217229|566265393|FG000|Overall Study|Disease progression, Cheson criteria|14|||
156864978|NCT01217229|566265393|FG000|Overall Study|Protocol Violation|1|||
156864979|NCT01217229|566265393|FG000|Overall Study|Disease progression not confirmed|2|||
156864980|NCT00453206|566265395|FG000|Overall Study|Death|1|||
156864981|NCT03058146|566265396|FG000|Overall Study|Withdrawal by Subject|4|||
156864982|NCT03058146|566265397|FG001|Overall Study|Withdrawal by Subject|1|||
156864983|NCT03058146|566265396|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
156864984|NCT03058146|566265397|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
156864985|NCT00632229|566265398|FG000|Overall Study|Adverse Event|6|||
156864986|NCT00632229|566265399|FG001|Overall Study|Adverse Event|0|||
156864987|NCT00632229|566265398|FG000|Overall Study|Lost to Follow-up|0|||
156864988|NCT00632229|566265399|FG001|Overall Study|Lost to Follow-up|3|||
156864989|NCT00632229|566265398|FG000|Overall Study|Lack of Efficacy|0|||
156864990|NCT00632229|566265399|FG001|Overall Study|Lack of Efficacy|2|||
156864991|NCT00632229|566265398|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
156864992|NCT00632229|566265399|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
156864993|NCT00577889|566265402|FG000|Overall Study|Withdrawal by Subject|1|||
156864994|NCT00577889|566265403|FG001|Overall Study|Withdrawal by Subject|0|||
156864995|NCT00577889|566265404|FG002|Overall Study|Withdrawal by Subject|0|||
156864996|NCT03041181|566265406|FG000|Overall Study|Disease Progression|1|||
156864997|NCT03041181|566265407|FG001|Overall Study|Disease Progression|2|||
156864998|NCT03224819|566265408|FG000|Overall Study|Withdrawal by Subject|0|||
156864999|NCT03224819|566265409|FG001|Overall Study|Withdrawal by Subject|0|||
156865000|NCT03224819|566265410|FG002|Overall Study|Withdrawal by Subject|0|||
156865001|NCT03224819|566265411|FG003|Overall Study|Withdrawal by Subject|0|||
156865002|NCT03224819|566265412|FG004|Overall Study|Withdrawal by Subject|0|||
156865003|NCT03224819|566265413|FG005|Overall Study|Withdrawal by Subject|0|||
156751499|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751500|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
156751501|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156865004|NCT03224819|566265414|FG006|Overall Study|Withdrawal by Subject|0|||
156865005|NCT03224819|566265415|FG007|Overall Study|Withdrawal by Subject|0|||
156865006|NCT03224819|566265416|FG008|Overall Study|Withdrawal by Subject|0|||
156865007|NCT03224819|566265417|FG009|Overall Study|Withdrawal by Subject|0|||
156865008|NCT03224819|566265418|FG010|Overall Study|Withdrawal by Subject|0|||
156865009|NCT03224819|566265419|FG011|Overall Study|Withdrawal by Subject|0|||
156865010|NCT03224819|566265420|FG012|Overall Study|Withdrawal by Subject|1|||
156865011|NCT03224819|566265421|FG013|Overall Study|Withdrawal by Subject|0|||
156865012|NCT03224819|566265408|FG000|Overall Study|Sponsor Decision|0|||
156751502|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
156751503|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
156751504|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
156751505|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751506|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
156751507|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
156751508|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751509|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
156751510|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
156751511|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
156751512|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
156751513|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
156751514|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
156751515|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
156751516|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
156751517|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
156751518|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
156751519|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
156751520|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
156751521|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751522|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751523|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751524|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751525|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
156751526|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
156751527|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
156751528|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751529|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751530|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751531|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
156751532|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751533|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
156751534|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751535|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156751536|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
156865013|NCT03224819|566265409|FG001|Overall Study|Sponsor Decision|0|||
156865014|NCT03224819|566265410|FG002|Overall Study|Sponsor Decision|0|||
156865015|NCT03224819|566265411|FG003|Overall Study|Sponsor Decision|1|||
156865016|NCT03224819|566265412|FG004|Overall Study|Sponsor Decision|1|||
156865017|NCT03224819|566265413|FG005|Overall Study|Sponsor Decision|2|||
156865018|NCT03224819|566265414|FG006|Overall Study|Sponsor Decision|1|||
156865019|NCT03224819|566265415|FG007|Overall Study|Sponsor Decision|1|||
156865020|NCT03224819|566265416|FG008|Overall Study|Sponsor Decision|1|||
156865021|NCT03224819|566265417|FG009|Overall Study|Sponsor Decision|2|||
156865022|NCT03224819|566265418|FG010|Overall Study|Sponsor Decision|1|||
156865023|NCT03224819|566265419|FG011|Overall Study|Sponsor Decision|1|||
156865024|NCT03224819|566265420|FG012|Overall Study|Sponsor Decision|1|||
156865025|NCT03224819|566265421|FG013|Overall Study|Sponsor Decision|0|||
156865026|NCT03224819|566265408|FG000|Overall Study|Lost to Follow-up|0|||
156865027|NCT03224819|566265409|FG001|Overall Study|Lost to Follow-up|0|||
156865028|NCT03224819|566265410|FG002|Overall Study|Lost to Follow-up|0|||
156865029|NCT03224819|566265411|FG003|Overall Study|Lost to Follow-up|0|||
156865030|NCT03224819|566265412|FG004|Overall Study|Lost to Follow-up|0|||
156865031|NCT03224819|566265413|FG005|Overall Study|Lost to Follow-up|0|||
156865032|NCT03224819|566265414|FG006|Overall Study|Lost to Follow-up|0|||
156865033|NCT03224819|566265415|FG007|Overall Study|Lost to Follow-up|0|||
156865034|NCT03224819|566265416|FG008|Overall Study|Lost to Follow-up|1|||
156865035|NCT03224819|566265417|FG009|Overall Study|Lost to Follow-up|0|||
156865036|NCT03224819|566265418|FG010|Overall Study|Lost to Follow-up|0|||
156865037|NCT03224819|566265419|FG011|Overall Study|Lost to Follow-up|0|||
156865038|NCT03224819|566265420|FG012|Overall Study|Lost to Follow-up|0|||
156865039|NCT03224819|566265421|FG013|Overall Study|Lost to Follow-up|0|||
156865040|NCT03224819|566265408|FG000|Overall Study|Death|0|||
156865041|NCT03224819|566265409|FG001|Overall Study|Death|1|||
156865042|NCT03224819|566265410|FG002|Overall Study|Death|0|||
156865043|NCT03224819|566265411|FG003|Overall Study|Death|0|||
156865044|NCT03224819|566265412|FG004|Overall Study|Death|0|||
156865045|NCT03224819|566265413|FG005|Overall Study|Death|0|||
156865046|NCT03224819|566265414|FG006|Overall Study|Death|0|||
156865047|NCT03224819|566265415|FG007|Overall Study|Death|1|||
156865048|NCT03224819|566265416|FG008|Overall Study|Death|0|||
156865049|NCT03224819|566265417|FG009|Overall Study|Death|0|||
156865050|NCT03224819|566265418|FG010|Overall Study|Death|0|||
156865051|NCT03224819|566265419|FG011|Overall Study|Death|1|||
156865052|NCT03224819|566265420|FG012|Overall Study|Death|0|||
156865053|NCT03224819|566265421|FG013|Overall Study|Death|0|||
156865054|NCT01903460|566265424|FG000|Overall Study|Adverse Event|0|||
156865055|NCT01903460|566265425|FG001|Overall Study|Adverse Event|0|||
156865056|NCT01903460|566265426|FG002|Overall Study|Adverse Event|0|||
156865057|NCT01903460|566265427|FG003|Overall Study|Adverse Event|1|||
156865058|NCT03104868|566265428|FG000|6 Week Follow up|Lost to Follow-up|5|||
156865059|NCT03104868|566265429|FG001|6 Week Follow up|Lost to Follow-up|8|||
156865060|NCT03104868|566265428|FG000|6 Week Follow up|Death|1|||
156865061|NCT03104868|566265429|FG001|6 Week Follow up|Death|1|||
156865062|NCT03104868|566265428|FG000|6 Week Follow up|Withdrawal by Subject|7|||
156865063|NCT03104868|566265429|FG001|6 Week Follow up|Withdrawal by Subject|6|||
156865064|NCT03104868|566265428|FG000|6 Week Follow up|Completed Later Timepoint|24|||
156865065|NCT03104868|566265429|FG001|6 Week Follow up|Completed Later Timepoint|22|||
156865066|NCT03104868|566265428|FG000|6 Month Follow up|Lost to Follow-up|2|||
156865067|NCT03104868|566265429|FG001|6 Month Follow up|Lost to Follow-up|2|||
156865068|NCT03104868|566265428|FG000|6 Month Follow up|Death|0|||
156865069|NCT03104868|566265429|FG001|6 Month Follow up|Death|1|||
156865070|NCT03104868|566265428|FG000|6 Month Follow up|Completed Later Timepoint|22|||
156865071|NCT03104868|566265429|FG001|6 Month Follow up|Completed Later Timepoint|32|||
156865072|NCT03104868|566265428|FG000|12 Month Follow up|Lost to Follow-up|1|||
156865073|NCT03104868|566265429|FG001|12 Month Follow up|Lost to Follow-up|2|||
156865074|NCT03104868|566265428|FG000|12 Month Follow up|Death|0|||
156865075|NCT03104868|566265429|FG001|12 Month Follow up|Death|1|||
156865076|NCT03104868|566265428|FG000|12 Month Follow up|Withdrawal by Subject|0|||
156865077|NCT03104868|566265429|FG001|12 Month Follow up|Withdrawal by Subject|3|||
156865078|NCT03104868|566265428|FG000|12 Month Follow up|Completed Later Timepoint|32|||
156865079|NCT03104868|566265429|FG001|12 Month Follow up|Completed Later Timepoint|29|||
156865080|NCT03104868|566265428|FG000|18 Month Follow up|Lost to Follow-up|7|||
156865081|NCT03104868|566265429|FG001|18 Month Follow up|Lost to Follow-up|11|||
156865082|NCT03104868|566265428|FG000|18 Month Follow up|Death|2|||
156865083|NCT03104868|566265429|FG001|18 Month Follow up|Death|1|||
156865084|NCT03104868|566265428|FG000|18 Month Follow up|Withdrawal by Subject|1|||
156865085|NCT03104868|566265429|FG001|18 Month Follow up|Withdrawal by Subject|2|||
156865086|NCT03104868|566265428|FG000|18 Month Follow up|Graft Loss|1|||
156865087|NCT03104868|566265429|FG001|18 Month Follow up|Graft Loss|1|||
156865088|NCT03104868|566265428|FG000|18 Month Follow up|Completed Later Timepoint|19|||
156865089|NCT03104868|566265429|FG001|18 Month Follow up|Completed Later Timepoint|20|||
156865090|NCT03104868|566265428|FG000|24 Month Follow up|Lost to Follow-up|15|||
156865091|NCT03104868|566265429|FG001|24 Month Follow up|Lost to Follow-up|16|||
156865092|NCT03104868|566265428|FG000|24 Month Follow up|Death|3|||
156865093|NCT03104868|566265429|FG001|24 Month Follow up|Death|2|||
156865094|NCT03104868|566265428|FG000|24 Month Follow up|Withdrawal by Subject|1|||
156865095|NCT03104868|566265429|FG001|24 Month Follow up|Withdrawal by Subject|0|||
156865096|NCT03104868|566265428|FG000|24 Month Follow up|Graft Loss|2|||
156865097|NCT03104868|566265429|FG001|24 Month Follow up|Graft Loss|0|||
156865098|NCT00521079|566265430|FG000|Overall Study|Adverse Event|7|||
156865099|NCT00521079|566265431|FG001|Overall Study|Adverse Event|1|||
156865100|NCT00521079|566265430|FG000|Overall Study|Lost to Follow-up|2|||
156865101|NCT00521079|566265431|FG001|Overall Study|Lost to Follow-up|1|||
156865102|NCT00521079|566265430|FG000|Overall Study|Withdrawal by Subject|5|||
156865103|NCT00521079|566265431|FG001|Overall Study|Withdrawal by Subject|3|||
156865104|NCT02059278|566265432|FG000|Overall Study|Adverse Event|1|||
156865105|NCT02059278|566265433|FG001|Overall Study|Adverse Event|1|||
156865106|NCT02059278|566265432|FG000|Overall Study|Lost to Follow-up|1|||
156865107|NCT02059278|566265433|FG001|Overall Study|Lost to Follow-up|0|||
156865108|NCT02059278|566265432|FG000|Overall Study|Withdrawal by Subject|0|||
156865109|NCT02059278|566265433|FG001|Overall Study|Withdrawal by Subject|3|||
156865110|NCT02059278|566265432|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
156865111|NCT02059278|566265433|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
156865112|NCT00888173|566265434|FG000|Overall Study|Wrong Primary|1|||
156865113|NCT00888173|566265434|FG000|Overall Study|Ineligible: required test not done|1|||
156865114|NCT00737672|566265441|FG000|Overall Study|Graft Abandonment|48|||
156865115|NCT00737672|566265442|FG001|Overall Study|Graft Abandonment|56|||
156865116|NCT00737672|566265441|FG000|Overall Study|Death|23|||
156865117|NCT00737672|566265442|FG001|Overall Study|Death|22|||
156865118|NCT00737672|566265441|FG000|Overall Study|Withdrawal by Subject|1|||
156865119|NCT00737672|566265442|FG001|Overall Study|Withdrawal by Subject|2|||
156865120|NCT00737672|566265441|FG000|Overall Study|Lost to Follow-up|1|||
156865121|NCT00737672|566265442|FG001|Overall Study|Lost to Follow-up|0|||
156865122|NCT00737672|566265441|FG000|Overall Study|Miscellaneous|7|||
156865123|NCT00737672|566265442|FG001|Overall Study|Miscellaneous|1|||
156865124|NCT00737672|566265441|FG000|Overall Study|Physician Decision|0|||
156865125|NCT00737672|566265442|FG001|Overall Study|Physician Decision|2|||
156865126|NCT00829426|566265447|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
157093214|NCT01313689|567095877|FG001|24-Week Randomization 2|Physician Decision|0|||
156865127|NCT00829426|566265448|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156865128|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
156865129|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
156865130|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
156865131|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
156865132|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Adverse Event|2|||
156865133|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Adverse Event|5|||
156865134|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Adverse Event|1|||
156865135|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Adverse Event|2|||
156865136|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Death|13|||
156865137|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Death|17|||
156865138|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Death|1|||
156865139|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Death|0|||
156865140|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
156865141|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
156865142|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
156865143|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
156865144|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Disease Progression|2|||
156865145|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Disease Progression|0|||
156865146|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Disease Progression|0|||
156865147|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Disease Progression|0|||
156865148|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
156865149|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
156865150|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
156865151|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
156865152|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
156865153|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
156865154|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
156865155|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
156865156|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
156865157|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
156865158|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
156865159|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
156865160|NCT03955146|566265449|FG000|DB Period (48 Weeks)|Participant Decision|9|||
156865161|NCT03955146|566265450|FG001|DB Period (48 Weeks)|Participant Decision|12|||
156865162|NCT03955146|566265451|FG002|DB Period (48 Weeks)|Participant Decision|1|||
156865163|NCT03955146|566265452|FG003|DB Period (48 Weeks)|Participant Decision|1|||
156865164|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
156865165|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
156865166|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
156865167|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
156865168|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
156865169|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
156865170|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
156865171|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
156865172|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865173|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
156865174|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865175|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
156865176|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
156865177|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
156865178|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
156865179|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
156865180|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
156865181|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
156865182|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
156865183|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
156865184|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
156865185|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865186|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865187|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
156865188|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
156865189|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
156865190|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
156865191|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
156865192|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
156865193|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
156865194|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
156865195|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
156865196|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
156865197|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865198|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865199|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
156865200|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
156865201|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
156865202|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
156865203|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
156865204|NCT03955146|566265449|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
156865205|NCT03955146|566265450|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865206|NCT03955146|566265451|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865207|NCT03955146|566265452|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
156865208|NCT04408989|566265453|FG000|Overall Study|Lost to Follow-up|0|||
156865209|NCT04408989|566265454|FG001|Overall Study|Lost to Follow-up|0|||
156865210|NCT04408989|566265455|FG002|Overall Study|Lost to Follow-up|1|||
156865211|NCT04408989|566265453|FG000|Overall Study|Withdrawal by Subject|0|||
156865212|NCT04408989|566265454|FG001|Overall Study|Withdrawal by Subject|0|||
156865213|NCT04408989|566265455|FG002|Overall Study|Withdrawal by Subject|2|||
156865214|NCT02002598|566265460|FG000|Dose Level 1|Withdrawal by Subject|1|||
156865215|NCT02002598|566265461|FG001|Dose Level 1|Withdrawal by Subject|0|||
156865216|NCT02002598|566265462|FG002|Dose Level 1|Withdrawal by Subject|0|||
156865217|NCT02002598|566265463|FG003|Dose Level 1|Withdrawal by Subject|0|||
156865218|NCT02002598|566265464|FG004|Dose Level 1|Withdrawal by Subject|0|||
156865219|NCT02628873|566265465|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
156865220|NCT02628873|566265466|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
156865221|NCT02628873|566265465|FG000|Second Test (1 Hour)|Physician Decision|1|||
156865222|NCT02628873|566265466|FG001|Second Test (1 Hour)|Physician Decision|0|||
156865223|NCT04672239|566265467|FG000|Week 2 Survey|Failed survey check items|1|||
156865224|NCT04672239|566265468|FG001|Week 2 Survey|Failed survey check items|2|||
156865225|NCT04672239|566265469|FG002|Week 2 Survey|Failed survey check items|3|||
156865226|NCT04672239|566265467|FG000|Week 2 Survey|Partially completed survey|7|||
156865227|NCT04672239|566265468|FG001|Week 2 Survey|Partially completed survey|1|||
156865228|NCT04672239|566265469|FG002|Week 2 Survey|Partially completed survey|4|||
156865229|NCT04672239|566265467|FG000|Week 2 Survey|Withdrawal by Subject|0|||
156865230|NCT04672239|566265468|FG001|Week 2 Survey|Withdrawal by Subject|1|||
156865231|NCT04672239|566265469|FG002|Week 2 Survey|Withdrawal by Subject|0|||
156865232|NCT04672239|566265467|FG000|Week 2 Survey|Lost to Follow-up|3|||
156865233|NCT04672239|566265468|FG001|Week 2 Survey|Lost to Follow-up|2|||
156865234|NCT04672239|566265469|FG002|Week 2 Survey|Lost to Follow-up|5|||
156865235|NCT04672239|566265467|FG000|Week 6 Survey|Failed survey check items|2|||
156865236|NCT04672239|566265468|FG001|Week 6 Survey|Failed survey check items|2|||
156865237|NCT04672239|566265469|FG002|Week 6 Survey|Failed survey check items|2|||
156865238|NCT04672239|566265467|FG000|Week 6 Survey|Partially completed survey|3|||
156865239|NCT04672239|566265468|FG001|Week 6 Survey|Partially completed survey|3|||
156865240|NCT04672239|566265469|FG002|Week 6 Survey|Partially completed survey|2|||
156865241|NCT04672239|566265467|FG000|Week 6 Survey|Withdrawal by Subject|1|||
156865242|NCT04672239|566265468|FG001|Week 6 Survey|Withdrawal by Subject|1|||
156865243|NCT04672239|566265469|FG002|Week 6 Survey|Withdrawal by Subject|1|||
156865244|NCT04672239|566265467|FG000|Week 6 Survey|Withdrawn by PI|0|||
156865245|NCT04672239|566265468|FG001|Week 6 Survey|Withdrawn by PI|1|||
156865246|NCT04672239|566265469|FG002|Week 6 Survey|Withdrawn by PI|0|||
156865247|NCT04672239|566265467|FG000|Week 6 Survey|Lost to Follow-up|12|||
156865248|NCT04672239|566265468|FG001|Week 6 Survey|Lost to Follow-up|2|||
156865249|NCT04672239|566265469|FG002|Week 6 Survey|Lost to Follow-up|5|||
156865250|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
156865251|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
156865252|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
156865253|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
156865254|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
156865255|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
156865256|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
156865257|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
156865258|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
156865259|NCT04672239|566265467|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
156865260|NCT04672239|566265468|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
156865261|NCT04672239|566265469|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
156865262|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
156865263|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
156865264|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
156865265|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
156865266|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
156865267|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
156865268|NCT04672239|566265467|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
156865269|NCT04672239|566265468|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
156865270|NCT04672239|566265469|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
156865271|NCT03597347|566265473|FG000|Overall Study|Withdrawal by Subject|1|||
156865272|NCT03597347|566265474|FG001|Overall Study|Withdrawal by Subject|1|||
156865273|NCT03597347|566265475|FG002|Overall Study|Withdrawal by Subject|0|||
156865274|NCT03597347|566265473|FG000|Overall Study|Withdrawal due to Covid-19|3|||
156865275|NCT03597347|566265474|FG001|Overall Study|Withdrawal due to Covid-19|0|||
156865276|NCT03597347|566265475|FG002|Overall Study|Withdrawal due to Covid-19|0|||
156865277|NCT03597347|566265473|FG000|Overall Study|Sponsor decision to terminate study|3|||
156865278|NCT03597347|566265474|FG001|Overall Study|Sponsor decision to terminate study|2|||
156865279|NCT03597347|566265475|FG002|Overall Study|Sponsor decision to terminate study|4|||
156865280|NCT04606134|566265476|FG000|Overall Study|Adverse Event|0|||
156865281|NCT04606134|566265477|FG001|Overall Study|Adverse Event|1|||
156865282|NCT00107653|566265478|FG000|Overall Study|Adverse Event|24|||
156865283|NCT00107653|566265479|FG001|Overall Study|Adverse Event|43|||
156865284|NCT00107653|566265478|FG000|Overall Study|Insufficient Therapeutic Response|25|||
156865285|NCT00107653|566265479|FG001|Overall Study|Insufficient Therapeutic Response|11|||
156865286|NCT00107653|566265478|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156865287|NCT00107653|566265479|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156865288|NCT00107653|566265478|FG000|Overall Study|Protocol Violation|1|||
156865289|NCT00107653|566265479|FG001|Overall Study|Protocol Violation|0|||
156865290|NCT00107653|566265478|FG000|Overall Study|Withdrawal by Subject|12|||
156865291|NCT00107653|566265479|FG001|Overall Study|Withdrawal by Subject|13|||
156865292|NCT00107653|566265478|FG000|Overall Study|Lost to Follow-up|13|||
156865293|NCT00107653|566265479|FG001|Overall Study|Lost to Follow-up|5|||
156865294|NCT00107653|566265478|FG000|Overall Study|Administrative Reasons|3|||
156865295|NCT00107653|566265479|FG001|Overall Study|Administrative Reasons|3|||
156865296|NCT00541658|566265481|FG000|Overall Study|Adverse Event|28|||
156865297|NCT00541658|566265482|FG001|Overall Study|Adverse Event|37|||
156865298|NCT00541658|566265483|FG002|Overall Study|Adverse Event|25|||
156865299|NCT00541658|566265481|FG000|Overall Study|Physician Decision|0|||
156865300|NCT00541658|566265482|FG001|Overall Study|Physician Decision|0|||
156865301|NCT00541658|566265483|FG002|Overall Study|Physician Decision|4|||
156865302|NCT00541658|566265481|FG000|Overall Study|Lost to Follow-up|3|||
156865303|NCT00541658|566265482|FG001|Overall Study|Lost to Follow-up|3|||
156865304|NCT00541658|566265483|FG002|Overall Study|Lost to Follow-up|6|||
156865305|NCT00541658|566265481|FG000|Overall Study|Protocol Violation|0|||
156865306|NCT00541658|566265482|FG001|Overall Study|Protocol Violation|1|||
156865307|NCT00541658|566265483|FG002|Overall Study|Protocol Violation|1|||
156865308|NCT00541658|566265481|FG000|Overall Study|Withdrawal by Subject|28|||
156865309|NCT00541658|566265482|FG001|Overall Study|Withdrawal by Subject|32|||
156865310|NCT00541658|566265483|FG002|Overall Study|Withdrawal by Subject|32|||
156865311|NCT00541658|566265481|FG000|Overall Study|Took No Study Drug|1|||
156865312|NCT00541658|566265482|FG001|Overall Study|Took No Study Drug|0|||
156865313|NCT00541658|566265483|FG002|Overall Study|Took No Study Drug|0|||
156865314|NCT01099267|566265484|FG000|MDS-003 Study|Adverse Event|37|||
156865315|NCT01099267|566265484|FG000|MDS-003 Study|Lack of Efficacy|52|||
156865316|NCT01099267|566265484|FG000|MDS-003 Study|Withdrawal by Subject|8|||
156865317|NCT01099267|566265484|FG000|MDS-003 Study|Lost to Follow-up|1|||
156865318|NCT01099267|566265484|FG000|MDS-003 Study|Death|11|||
156865319|NCT01099267|566265484|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
156865320|NCT01099267|566265484|FG000|MDS-003 Study|Disease Progression|7|||
156865321|NCT01099267|566265484|FG000|MDS-003 Study|Investigator Decision|2|||
156865322|NCT01099267|566265484|FG000|MDS-003 Study|Non-Compliance|2|||
156865323|NCT01099267|566265484|FG000|MDS-003 Study|Loss of Response|1|||
156865324|NCT01099267|566265484|FG000|MDS-003 Study|Secondary Malign Disease|1|||
156865325|NCT04986904|566265485|FG000|Overall Study|Lost to Follow-up|11|||
156865326|NCT04986904|566265485|FG000|Overall Study|Withdrawal by Subject|1|||
156865327|NCT04123470|566265492|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
156865328|NCT04123470|566265493|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156865329|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
156865330|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
156865331|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
156865332|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
157221627|NCT01644890|567558453|FG000|Overall Study|Physician Decision|3|||
156865333|NCT04123470|566265492|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
156865334|NCT04123470|566265493|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
156865335|NCT02018562|566265494|FG000|Overall Study|Withdrawal by Subject|2|||
156865336|NCT02018562|566265495|FG001|Overall Study|Withdrawal by Subject|0|||
156865337|NCT02018562|566265494|FG000|Overall Study|Discharged prior to study completion|1|||
156865338|NCT02018562|566265495|FG001|Overall Study|Discharged prior to study completion|0|||
156865339|NCT05408429|566265500|FG000|Overall Study|Lost to Follow-up|1|||
156865340|NCT05408429|566265501|FG001|Overall Study|Lost to Follow-up|1|||
156865341|NCT05408429|566265502|FG002|Overall Study|Lost to Follow-up|0|||
156865342|NCT05408429|566265500|FG000|Overall Study|Withdrawal by Subject|5|||
156865343|NCT05408429|566265501|FG001|Overall Study|Withdrawal by Subject|0|||
156865344|NCT05408429|566265502|FG002|Overall Study|Withdrawal by Subject|1|||
156865345|NCT03435211|566265503|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
156865346|NCT01253291|566265505|FG000|Overall Study|Withdrawal by Subject|1|||
156865347|NCT01253291|566265506|FG001|Overall Study|Withdrawal by Subject|1|||
156865348|NCT01253291|566265507|FG002|Overall Study|Withdrawal by Subject|0|||
156865349|NCT01253291|566265508|FG003|Overall Study|Withdrawal by Subject|0|||
156865350|NCT01253291|566265509|FG004|Overall Study|Withdrawal by Subject|0|||
156865351|NCT01253291|566265505|FG000|Overall Study|Adverse Event|0|||
156865352|NCT01253291|566265506|FG001|Overall Study|Adverse Event|1|||
156865353|NCT01253291|566265507|FG002|Overall Study|Adverse Event|0|||
156865354|NCT01253291|566265508|FG003|Overall Study|Adverse Event|0|||
156865355|NCT01253291|566265509|FG004|Overall Study|Adverse Event|0|||
156865356|NCT01253291|566265505|FG000|Overall Study|Lack of Efficacy|1|||
156865357|NCT01253291|566265506|FG001|Overall Study|Lack of Efficacy|0|||
156865358|NCT01253291|566265507|FG002|Overall Study|Lack of Efficacy|0|||
156865359|NCT01253291|566265508|FG003|Overall Study|Lack of Efficacy|0|||
156865360|NCT01253291|566265509|FG004|Overall Study|Lack of Efficacy|0|||
156865361|NCT01253291|566265505|FG000|Overall Study|Physician Decision|2|||
156865362|NCT01253291|566265506|FG001|Overall Study|Physician Decision|0|||
156865363|NCT01253291|566265507|FG002|Overall Study|Physician Decision|0|||
156865364|NCT01253291|566265508|FG003|Overall Study|Physician Decision|0|||
156865365|NCT01253291|566265509|FG004|Overall Study|Physician Decision|2|||
156865366|NCT01838395|566265513|FG000|Overall Study|Withdrawal by Subject|0|||
156865367|NCT01838395|566265514|FG001|Overall Study|Withdrawal by Subject|0|||
156865368|NCT01838395|566265515|FG002|Overall Study|Withdrawal by Subject|0|||
156865369|NCT01838395|566265516|FG003|Overall Study|Withdrawal by Subject|0|||
156865370|NCT01838395|566265517|FG004|Overall Study|Withdrawal by Subject|1|||
156865371|NCT01838395|566265518|FG005|Overall Study|Withdrawal by Subject|0|||
156865372|NCT01838395|566265513|FG000|Overall Study|Death|0|||
156865373|NCT01838395|566265514|FG001|Overall Study|Death|0|||
156865374|NCT01838395|566265515|FG002|Overall Study|Death|1|||
156865375|NCT01838395|566265516|FG003|Overall Study|Death|0|||
156865376|NCT01838395|566265517|FG004|Overall Study|Death|0|||
156865377|NCT01838395|566265518|FG005|Overall Study|Death|0|||
156865378|NCT01838395|566265513|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865379|NCT01838395|566265514|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
156865380|NCT01838395|566265515|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865381|NCT01838395|566265516|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865382|NCT01838395|566265517|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865383|NCT01838395|566265518|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
156865384|NCT05972993|566265519|FG000|Overall Study|Lost to Follow-up|2|||
156865385|NCT05972993|566265520|FG001|Overall Study|Lost to Follow-up|0|||
156865386|NCT05972993|566265521|FG002|Overall Study|Lost to Follow-up|1|||
156865387|NCT05972993|566265522|FG003|Overall Study|Lost to Follow-up|0|||
156865388|NCT05972993|566265523|FG004|Overall Study|Lost to Follow-up|0|||
156865389|NCT05972993|566265524|FG005|Overall Study|Lost to Follow-up|0|||
156865390|NCT05972993|566265525|FG006|Overall Study|Lost to Follow-up|0|||
156865391|NCT05972993|566265526|FG007|Overall Study|Lost to Follow-up|2|||
156865392|NCT05972993|566265527|FG008|Overall Study|Lost to Follow-up|0|||
156865393|NCT03866577|566265528|FG000|Overall Study|Protocol Violation|0|||
156865394|NCT03866577|566265529|FG001|Overall Study|Protocol Violation|0|||
156865395|NCT03866577|566265530|FG002|Overall Study|Protocol Violation|0|||
156865396|NCT03866577|566265531|FG003|Overall Study|Protocol Violation|0|||
156865397|NCT03866577|566265532|FG004|Overall Study|Protocol Violation|0|||
156865398|NCT03866577|566265533|FG005|Overall Study|Protocol Violation|0|||
156865399|NCT03866577|566265534|FG006|Overall Study|Protocol Violation|0|||
156865400|NCT03866577|566265535|FG007|Overall Study|Protocol Violation|0|||
156865401|NCT03866577|566265536|FG008|Overall Study|Protocol Violation|0|||
156865402|NCT03866577|566265537|FG009|Overall Study|Protocol Violation|0|||
156865403|NCT03866577|566265538|FG010|Overall Study|Protocol Violation|0|||
156865404|NCT03866577|566265539|FG011|Overall Study|Protocol Violation|1|||
156865405|NCT03866577|566265540|FG012|Overall Study|Protocol Violation|0|||
156865406|NCT03866577|566265528|FG000|Overall Study|Withdrawal by Subject|0|||
156865407|NCT03866577|566265529|FG001|Overall Study|Withdrawal by Subject|0|||
157093215|NCT01313689|567095878|FG002|24-Week Randomization 2|Physician Decision|0|||
156865408|NCT03866577|566265530|FG002|Overall Study|Withdrawal by Subject|0|||
156865409|NCT03866577|566265531|FG003|Overall Study|Withdrawal by Subject|0|||
156865410|NCT03866577|566265532|FG004|Overall Study|Withdrawal by Subject|0|||
156865411|NCT03866577|566265533|FG005|Overall Study|Withdrawal by Subject|0|||
156865412|NCT03866577|566265534|FG006|Overall Study|Withdrawal by Subject|0|||
156865413|NCT03866577|566265535|FG007|Overall Study|Withdrawal by Subject|0|||
156865414|NCT03866577|566265536|FG008|Overall Study|Withdrawal by Subject|1|||
156865415|NCT03866577|566265537|FG009|Overall Study|Withdrawal by Subject|1|||
156865416|NCT03866577|566265538|FG010|Overall Study|Withdrawal by Subject|0|||
156865417|NCT03866577|566265539|FG011|Overall Study|Withdrawal by Subject|0|||
156865418|NCT03866577|566265540|FG012|Overall Study|Withdrawal by Subject|0|||
157206865|NCT00440193|567501234|FG000|Treatment Period|Switch to commercial drug|0|||
157206866|NCT00440193|567501235|FG001|Treatment Period|Switch to commercial drug|2|||
157206867|NCT00440193|567501234|FG000|Treatment Period|Technical problems|1|||
157206868|NCT00440193|567501235|FG001|Treatment Period|Technical problems|1|||
157206869|NCT00440193|567501234|FG000|Treatment Period|Participant convenience|5|||
157206870|NCT00440193|567501235|FG001|Treatment Period|Participant convenience|2|||
157206871|NCT00440193|567501234|FG000|Treatment Period|Participant did not receive treatment|7|||
157206872|NCT00440193|567501235|FG001|Treatment Period|Participant did not receive treatment|13|||
156751537|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
157206873|NCT00440193|567501234|FG000|Treatment Period|Site closed by investigator|0|||
157206874|NCT00440193|567501235|FG001|Treatment Period|Site closed by investigator|2|||
157206875|NCT00440193|567501234|FG000|Observational Period|Adverse Event|2|||
157206876|NCT00440193|567501235|FG001|Observational Period|Adverse Event|2|||
157206877|NCT00440193|567501234|FG000|Observational Period|Death|15|||
157206878|NCT00440193|567501235|FG001|Observational Period|Death|20|||
157206879|NCT00440193|567501234|FG000|Observational Period|Lost to Follow-up|12|||
157206880|NCT00440193|567501235|FG001|Observational Period|Lost to Follow-up|8|||
157206881|NCT00440193|567501234|FG000|Observational Period|Protocol Violation|1|||
157206882|NCT00440193|567501235|FG001|Observational Period|Protocol Violation|0|||
157206883|NCT00440193|567501234|FG000|Observational Period|Withdrawal by Subject|11|||
156751538|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751539|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
156751540|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751541|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751542|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
156751543|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751544|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751545|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
156751546|NCT00528372|565842067|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
156751547|NCT00528372|565842068|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751548|NCT00528372|565842069|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751549|NCT00528372|565842070|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
156751550|NCT00528372|565842071|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751551|NCT00528372|565842072|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751552|NCT00528372|565842073|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751553|NCT00528372|565842074|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
156751554|NCT00528372|565842075|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
156751555|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
156751556|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
156751557|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
156751558|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751559|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751560|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
156751561|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
156751562|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
156751563|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
156751564|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
156751565|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
156751566|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
156751567|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751568|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
156751569|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
156751570|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
156751571|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751572|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
156751573|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
156751574|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
156751575|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
156751576|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
156751577|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
156751578|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
156751579|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
156751580|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
156751581|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
156751582|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
156751583|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
156865419|NCT03866577|566265528|FG000|Overall Study|Not qualified for IVIg infusion|0|||
156865420|NCT03866577|566265529|FG001|Overall Study|Not qualified for IVIg infusion|0|||
156865421|NCT03866577|566265530|FG002|Overall Study|Not qualified for IVIg infusion|0|||
156865422|NCT03866577|566265531|FG003|Overall Study|Not qualified for IVIg infusion|0|||
156865423|NCT03866577|566265532|FG004|Overall Study|Not qualified for IVIg infusion|0|||
156865424|NCT03866577|566265533|FG005|Overall Study|Not qualified for IVIg infusion|0|||
156865425|NCT03866577|566265534|FG006|Overall Study|Not qualified for IVIg infusion|0|||
156865426|NCT03866577|566265535|FG007|Overall Study|Not qualified for IVIg infusion|0|||
156865427|NCT03866577|566265536|FG008|Overall Study|Not qualified for IVIg infusion|0|||
156865428|NCT03866577|566265537|FG009|Overall Study|Not qualified for IVIg infusion|1|||
156865429|NCT03866577|566265538|FG010|Overall Study|Not qualified for IVIg infusion|0|||
156865430|NCT03866577|566265539|FG011|Overall Study|Not qualified for IVIg infusion|0|||
156865431|NCT03866577|566265540|FG012|Overall Study|Not qualified for IVIg infusion|0|||
156865432|NCT04825678|566265543|FG000|Overall Study|Decision by Sponsor|2|||
156865433|NCT04825678|566265544|FG001|Overall Study|Decision by Sponsor|3|||
156865434|NCT04825678|566265543|FG000|Overall Study|Withdrawal of Consent From Study|7|||
156865435|NCT04825678|566265544|FG001|Overall Study|Withdrawal of Consent From Study|9|||
156865436|NCT04825678|566265543|FG000|Overall Study|Lost to Follow-up|3|||
156865437|NCT04825678|566265544|FG001|Overall Study|Lost to Follow-up|4|||
156865438|NCT04825678|566265543|FG000|Overall Study|Never Received Investigational Product|1|||
156865439|NCT04825678|566265544|FG001|Overall Study|Never Received Investigational Product|1|||
156865440|NCT02195518|566265545|FG000|Overall Study|Adverse Event|1|||
156865441|NCT02195518|566265545|FG000|Overall Study|Protocol Violation|4|||
156865442|NCT02195518|566265545|FG000|Overall Study|Pregnancy|2|||
156865443|NCT02195518|566265545|FG000|Overall Study|Withdrawal by Subject|1|||
156865444|NCT02195518|566265545|FG000|Overall Study|Lost to Follow-up|1|||
156865445|NCT03818256|566265546|FG000|Overall Study|Withdrawal by Subject|2|||
156865446|NCT03818256|566265547|FG001|Overall Study|Withdrawal by Subject|2|||
156865447|NCT03818256|566265546|FG000|Overall Study|Adverse Event|3|||
156865448|NCT03818256|566265547|FG001|Overall Study|Adverse Event|1|||
156865449|NCT03818256|566265546|FG000|Overall Study|Lost to Follow-up|0|||
156865450|NCT03818256|566265547|FG001|Overall Study|Lost to Follow-up|5|||
156865451|NCT03818256|566265546|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
156865452|NCT03818256|566265547|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
156865453|NCT03818256|566265546|FG000|Overall Study|Not reporting for scheduled visits|1|||
156865454|NCT03818256|566265547|FG001|Overall Study|Not reporting for scheduled visits|0|||
156865455|NCT03818256|566265546|FG000|Overall Study|Non-compliant with investigational product|1|||
156865456|NCT03818256|566265547|FG001|Overall Study|Non-compliant with investigational product|0|||
156865457|NCT00400179|566265554|FG000|Overall Study|Adverse Event|2|||
156865458|NCT00400179|566265555|FG001|Overall Study|Adverse Event|2|||
156865459|NCT00400179|566265554|FG000|Overall Study|Death|1|||
156865460|NCT00400179|566265555|FG001|Overall Study|Death|2|||
156865461|NCT00400179|566265554|FG000|Overall Study|Withdrew Consent|1|||
156865462|NCT00400179|566265555|FG001|Overall Study|Withdrew Consent|5|||
156865463|NCT00400179|566265554|FG000|Overall Study|Disease progression|1|||
156865464|NCT00400179|566265555|FG001|Overall Study|Disease progression|1|||
156865465|NCT00400179|566265554|FG000|Overall Study|Intercurrent illness|0|||
156865466|NCT00400179|566265555|FG001|Overall Study|Intercurrent illness|1|||
156865467|NCT00400179|566265554|FG000|Overall Study|Investigator judgment|0|||
156865468|NCT00400179|566265555|FG001|Overall Study|Investigator judgment|1|||
156865469|NCT00400179|566265554|FG000|Overall Study|Randomization error/patient ineligible|1|||
156865470|NCT00400179|566265555|FG001|Overall Study|Randomization error/patient ineligible|6|||
156865471|NCT04780061|566265556|FG000|Overall Study|Withdrawal by Subject|5|||
156865472|NCT04780061|566265557|FG001|Overall Study|Withdrawal by Subject|8|||
156865473|NCT04780061|566265556|FG000|Overall Study|Adverse Event|2|||
156865474|NCT04780061|566265557|FG001|Overall Study|Adverse Event|2|||
156865475|NCT04780061|566265556|FG000|Overall Study|Lost to Follow-up|1|||
156865476|NCT04780061|566265557|FG001|Overall Study|Lost to Follow-up|5|||
156865477|NCT02023086|566265560|FG000|Overall Study|Withdrawal by Subject|2|||
156865478|NCT02023086|566265561|FG001|Overall Study|Withdrawal by Subject|0|||
156865479|NCT03589859|566265564|FG000|Overall Study|Withdrawal by Subject|0|||
156865480|NCT03589859|566265565|FG001|Overall Study|Withdrawal by Subject|6|||
156865481|NCT05530252|566265567|FG000|Overall Study|Lost to Follow-up|1|||
156865482|NCT05530252|566265568|FG001|Overall Study|Lost to Follow-up|1|||
156865483|NCT05530252|566265569|FG002|Overall Study|Lost to Follow-up|1|||
156865484|NCT03125395|566267261|FG000|Overall Study|Adverse Event|2|||
156865485|NCT03125395|566267261|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156865486|NCT03125395|566267261|FG000|Overall Study|Physician Decision|2|||
156865487|NCT03125395|566267261|FG000|Overall Study|Commercial drug is available|5|||
156865488|NCT02531802|566267262|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
156865489|NCT02531802|566267263|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
156865490|NCT02531802|566267264|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
156865491|NCT02531802|566267265|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
157145128|NCT03237845|567277997|FG001|Overall Study|Technical Problems|1|||
156865492|NCT02531802|566267266|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
156865493|NCT02531802|566267267|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
156865494|NCT02531802|566267268|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
156865495|NCT02531802|566267269|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
156865496|NCT02531802|566267270|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
156865497|NCT02531802|566267271|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
156865498|NCT02531802|566267272|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
156865499|NCT02531802|566267273|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
156865500|NCT02531802|566267274|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
156865501|NCT02531802|566267275|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
156865502|NCT02531802|566267276|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
156865503|NCT02531802|566267277|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
156865504|NCT02531802|566267278|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
156865505|NCT02531802|566267279|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
156865506|NCT02531802|566267280|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
156865507|NCT02531802|566267281|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
156865508|NCT02531802|566267282|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
156865509|NCT02531802|566267262|FG000|Received Vaccination 2|Physician Decision|0|||
156865510|NCT02531802|566267263|FG001|Received Vaccination 2|Physician Decision|0|||
156865511|NCT02531802|566267264|FG002|Received Vaccination 2|Physician Decision|0|||
156865512|NCT02531802|566267265|FG003|Received Vaccination 2|Physician Decision|0|||
156865513|NCT02531802|566267266|FG004|Received Vaccination 2|Physician Decision|0|||
156865514|NCT02531802|566267267|FG005|Received Vaccination 2|Physician Decision|1|||
156865515|NCT02531802|566267268|FG006|Received Vaccination 2|Physician Decision|0|||
156865516|NCT02531802|566267269|FG007|Received Vaccination 2|Physician Decision|0|||
156865517|NCT02531802|566267270|FG008|Received Vaccination 2|Physician Decision|0|||
156865518|NCT02531802|566267271|FG009|Received Vaccination 2|Physician Decision|2|||
156865519|NCT02531802|566267272|FG010|Received Vaccination 2|Physician Decision|0|||
156865520|NCT02531802|566267273|FG011|Received Vaccination 2|Physician Decision|0|||
156865521|NCT02531802|566267274|FG012|Received Vaccination 2|Physician Decision|0|||
156865522|NCT02531802|566267275|FG013|Received Vaccination 2|Physician Decision|1|||
156865523|NCT02531802|566267276|FG014|Received Vaccination 2|Physician Decision|0|||
156865524|NCT02531802|566267277|FG015|Received Vaccination 2|Physician Decision|0|||
156865525|NCT02531802|566267278|FG016|Received Vaccination 2|Physician Decision|0|||
156865526|NCT02531802|566267279|FG017|Received Vaccination 2|Physician Decision|1|||
156865527|NCT02531802|566267280|FG018|Received Vaccination 2|Physician Decision|0|||
156865528|NCT02531802|566267281|FG019|Received Vaccination 2|Physician Decision|0|||
156865529|NCT02531802|566267282|FG020|Received Vaccination 2|Physician Decision|0|||
156865530|NCT02531802|566267262|FG000|Received Vaccination 2|Adverse Event|0|||
156865531|NCT02531802|566267263|FG001|Received Vaccination 2|Adverse Event|0|||
156865532|NCT02531802|566267264|FG002|Received Vaccination 2|Adverse Event|0|||
156865533|NCT02531802|566267265|FG003|Received Vaccination 2|Adverse Event|0|||
156865534|NCT02531802|566267266|FG004|Received Vaccination 2|Adverse Event|0|||
156865535|NCT02531802|566267267|FG005|Received Vaccination 2|Adverse Event|2|||
156865536|NCT02531802|566267268|FG006|Received Vaccination 2|Adverse Event|0|||
156865537|NCT02531802|566267269|FG007|Received Vaccination 2|Adverse Event|0|||
156865538|NCT02531802|566267270|FG008|Received Vaccination 2|Adverse Event|0|||
156865539|NCT02531802|566267271|FG009|Received Vaccination 2|Adverse Event|0|||
156865540|NCT02531802|566267272|FG010|Received Vaccination 2|Adverse Event|0|||
156865541|NCT02531802|566267273|FG011|Received Vaccination 2|Adverse Event|0|||
156865542|NCT02531802|566267274|FG012|Received Vaccination 2|Adverse Event|0|||
156865543|NCT02531802|566267275|FG013|Received Vaccination 2|Adverse Event|0|||
156865544|NCT02531802|566267276|FG014|Received Vaccination 2|Adverse Event|0|||
156865545|NCT02531802|566267277|FG015|Received Vaccination 2|Adverse Event|0|||
156865546|NCT02531802|566267278|FG016|Received Vaccination 2|Adverse Event|0|||
156865547|NCT02531802|566267279|FG017|Received Vaccination 2|Adverse Event|2|||
156865548|NCT02531802|566267280|FG018|Received Vaccination 2|Adverse Event|1|||
156865549|NCT02531802|566267281|FG019|Received Vaccination 2|Adverse Event|0|||
156865550|NCT02531802|566267282|FG020|Received Vaccination 2|Adverse Event|1|||
156865551|NCT02531802|566267262|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156865552|NCT02531802|566267263|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156865553|NCT02531802|566267264|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
156865554|NCT02531802|566267265|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156865555|NCT02531802|566267266|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
157221628|NCT01644890|567558454|FG001|Overall Study|Physician Decision|9|||
156865556|NCT02531802|566267267|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
156865557|NCT02531802|566267268|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
156865558|NCT02531802|566267269|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
156865559|NCT02531802|566267270|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
156865560|NCT02531802|566267271|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
156865561|NCT02531802|566267272|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
156865562|NCT02531802|566267273|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
156865563|NCT02531802|566267274|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
156865564|NCT02531802|566267275|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
156865565|NCT02531802|566267276|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
156865566|NCT02531802|566267277|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
156865567|NCT02531802|566267278|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
156865568|NCT02531802|566267279|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
156865569|NCT02531802|566267280|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
156865570|NCT02531802|566267281|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
156865571|NCT02531802|566267282|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
156865572|NCT00482053|566267283|FG000|Inter-treatment Period|Disease progression|1|||
156865573|NCT02224560|566267286|FG000|Overall Study|Protocol Deviation|1|||
156865574|NCT02224560|566267287|FG001|Overall Study|Protocol Deviation|0|||
156865575|NCT02224560|566267288|FG002|Overall Study|Protocol Deviation|0|||
156865576|NCT02224560|566267286|FG000|Overall Study|Withdrawal by Subject|2|||
156865577|NCT02224560|566267287|FG001|Overall Study|Withdrawal by Subject|0|||
156865578|NCT02224560|566267288|FG002|Overall Study|Withdrawal by Subject|1|||
156865579|NCT02224560|566267286|FG000|Overall Study|Met Withdrawal Criteria|1|||
156865580|NCT02224560|566267287|FG001|Overall Study|Met Withdrawal Criteria|0|||
156865581|NCT02224560|566267288|FG002|Overall Study|Met Withdrawal Criteria|0|||
156865582|NCT02224560|566267286|FG000|Overall Study|Adverse Event|4|||
156865583|NCT02224560|566267287|FG001|Overall Study|Adverse Event|1|||
156865584|NCT02224560|566267288|FG002|Overall Study|Adverse Event|1|||
156865585|NCT02224560|566267286|FG000|Overall Study|Withdrawn by Investigator|1|||
156865586|NCT02224560|566267287|FG001|Overall Study|Withdrawn by Investigator|1|||
156865587|NCT02224560|566267288|FG002|Overall Study|Withdrawn by Investigator|0|||
156865588|NCT00728689|566267289|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
156865589|NCT00728689|566267290|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
156865590|NCT01523366|566267291|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156865591|NCT01523366|566267292|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156865592|NCT01523366|566267291|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
156865593|NCT01523366|566267292|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
156865594|NCT04543279|566267294|FG000|Overall Study|Withdrawal by Subject|1|||
156865595|NCT04543279|566267295|FG001|Overall Study|Withdrawal by Subject|0|||
156865596|NCT04543279|566267294|FG000|Overall Study|Adverse Event|1|||
156865597|NCT04543279|566267295|FG001|Overall Study|Adverse Event|0|||
156865598|NCT04543279|566267294|FG000|Overall Study|Physician Decision|1|||
156865599|NCT04543279|566267295|FG001|Overall Study|Physician Decision|0|||
156865600|NCT03216226|566267298|FG000|Overall Study|Adverse Event|3|||
156865601|NCT03216226|566267299|FG001|Overall Study|Adverse Event|0|||
156865602|NCT03216226|566267298|FG000|Overall Study|Protocol Violation|1|||
156865603|NCT03216226|566267299|FG001|Overall Study|Protocol Violation|3|||
156865604|NCT03216226|566267298|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
156865605|NCT03216226|566267299|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
156865606|NCT03216226|566267298|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
156865607|NCT03216226|566267299|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
156865608|NCT03216226|566267298|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
156865609|NCT03216226|566267299|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
156865610|NCT00871975|566267301|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
156865611|NCT00871975|566267301|FG000|Overall Study|Catheters could not be inserted|1|||
156865612|NCT00871975|566267301|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
156865613|NCT00871975|566267301|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
156865614|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
156865615|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
156865616|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
156865617|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
156865618|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
156865619|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
156865620|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
156865621|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156865622|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156865623|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
156865624|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156865625|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156865626|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
156865627|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156865628|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156865629|NCT01436149|566267305|FG000|Antidepressant Lead-in Phase|Other|119|||
157093216|NCT01313689|567095879|FG003|24-Week Randomization 2|Physician Decision|0|||
157221629|NCT01644890|567558453|FG000|Overall Study|Protocol Violation|6|||
156865630|NCT01436149|566267306|FG001|Antidepressant Lead-in Phase|Other|0|||
156865631|NCT01436149|566267307|FG002|Antidepressant Lead-in Phase|Other|0|||
156865632|NCT01436149|566267305|FG000|Randomized Phase|Adverse Event|9|||
156865633|NCT01436149|566267306|FG001|Randomized Phase|Adverse Event|10|||
156865634|NCT01436149|566267307|FG002|Randomized Phase|Adverse Event|11|||
156865635|NCT01436149|566267305|FG000|Randomized Phase|Protocol Violation|4|||
156865636|NCT01436149|566267306|FG001|Randomized Phase|Protocol Violation|5|||
156865637|NCT01436149|566267307|FG002|Randomized Phase|Protocol Violation|0|||
156865638|NCT01436149|566267305|FG000|Randomized Phase|Withdrawal by Subject|16|||
156865639|NCT01436149|566267306|FG001|Randomized Phase|Withdrawal by Subject|10|||
156865640|NCT01436149|566267307|FG002|Randomized Phase|Withdrawal by Subject|10|||
156865641|NCT01436149|566267305|FG000|Randomized Phase|Lost to Follow-up|34|||
156865642|NCT01436149|566267306|FG001|Randomized Phase|Lost to Follow-up|5|||
156865643|NCT01436149|566267307|FG002|Randomized Phase|Lost to Follow-up|6|||
156865644|NCT01436149|566267305|FG000|Randomized Phase|Lack of Efficacy|0|||
156865645|NCT01436149|566267306|FG001|Randomized Phase|Lack of Efficacy|0|||
156865646|NCT01436149|566267307|FG002|Randomized Phase|Lack of Efficacy|1|||
156865647|NCT01436149|566267305|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
156865648|NCT01436149|566267306|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
156865649|NCT01436149|566267307|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
156865650|NCT01436149|566267305|FG000|Randomized Phase|Other|12|||
156865651|NCT01436149|566267306|FG001|Randomized Phase|Other|5|||
156865652|NCT01436149|566267307|FG002|Randomized Phase|Other|11|||
156865653|NCT01690143|566267308|FG000|Overall Study|Withdrawal by Subject|1|||
156865654|NCT01710345|566267324|FG000|Overall Study|Adverse Event|0|||
156865655|NCT01710345|566267325|FG001|Overall Study|Adverse Event|2|||
156865656|NCT01710345|566267326|FG002|Overall Study|Adverse Event|0|||
156865657|NCT01710345|566267324|FG000|Overall Study|Lack of Efficacy|2|||
156865658|NCT01710345|566267325|FG001|Overall Study|Lack of Efficacy|3|||
156865659|NCT01710345|566267326|FG002|Overall Study|Lack of Efficacy|1|||
156865660|NCT01710345|566267324|FG000|Overall Study|Drug Dosing Error|1|||
156865661|NCT01710345|566267325|FG001|Overall Study|Drug Dosing Error|0|||
156865662|NCT01710345|566267326|FG002|Overall Study|Drug Dosing Error|0|||
156865663|NCT01502293|566267328|FG000|Overall Study|Progressive Disease|20|||
156865664|NCT01502293|566267329|FG001|Overall Study|Progressive Disease|12|||
156865665|NCT01502293|566267330|FG002|Overall Study|Progressive Disease|2|||
156865666|NCT01502293|566267328|FG000|Overall Study|Withdrawal by Subject|3|||
156865667|NCT01502293|566267329|FG001|Overall Study|Withdrawal by Subject|3|||
156865668|NCT01502293|566267330|FG002|Overall Study|Withdrawal by Subject|1|||
156865669|NCT01502293|566267328|FG000|Overall Study|Adverse Event|0|||
156865670|NCT01502293|566267329|FG001|Overall Study|Adverse Event|2|||
156865671|NCT01502293|566267330|FG002|Overall Study|Adverse Event|0|||
156865672|NCT01502293|566267328|FG000|Overall Study|Reason Not Specified|2|||
156865673|NCT01502293|566267329|FG001|Overall Study|Reason Not Specified|0|||
156865674|NCT01502293|566267330|FG002|Overall Study|Reason Not Specified|0|||
156865675|NCT01502293|566267328|FG000|Overall Study|Physician Decision|0|||
156865676|NCT01502293|566267329|FG001|Overall Study|Physician Decision|0|||
156865677|NCT01502293|566267330|FG002|Overall Study|Physician Decision|1|||
156865678|NCT00391586|566267332|FG000|Overall Study|Progressive disease|13|||
156865679|NCT00391586|566267332|FG000|Overall Study|Adverse Event|5|||
156865680|NCT00391586|566267332|FG000|Overall Study|Physician Decision|2|||
156865681|NCT00391586|566267332|FG000|Overall Study|Death|4|||
156865682|NCT00198822|566267333|FG000|Overall Study|Lost to Follow-up|14|||
156865683|NCT00198822|566267334|FG001|Overall Study|Lost to Follow-up|20|||
156865684|NCT00198822|566267335|FG002|Overall Study|Lost to Follow-up|21|||
156865685|NCT01409707|566267336|FG000|Overall Study|Withdrawal by Subject|5|||
156865686|NCT01409707|566267337|FG001|Overall Study|Withdrawal by Subject|17|||
156865687|NCT01409707|566267338|FG002|Overall Study|Withdrawal by Subject|16|||
156865688|NCT01716234|566267339|FG000|Overall Study|Protocol Violation|0|||
156865689|NCT01716234|566267340|FG001|Overall Study|Protocol Violation|0|||
156865690|NCT01716234|566267341|FG002|Overall Study|Protocol Violation|0|||
156865691|NCT01716234|566267342|FG003|Overall Study|Protocol Violation|1|||
156865692|NCT01716234|566267343|FG004|Overall Study|Protocol Violation|1|||
156865693|NCT01716234|566267344|FG005|Overall Study|Protocol Violation|1|||
156865694|NCT01716234|566267345|FG006|Overall Study|Protocol Violation|0|||
156865695|NCT01716234|566267339|FG000|Overall Study|Lack of Efficacy|0|||
156865696|NCT01716234|566267340|FG001|Overall Study|Lack of Efficacy|0|||
156865697|NCT01716234|566267341|FG002|Overall Study|Lack of Efficacy|0|||
156865698|NCT01716234|566267342|FG003|Overall Study|Lack of Efficacy|1|||
156865699|NCT01716234|566267343|FG004|Overall Study|Lack of Efficacy|0|||
156865700|NCT01716234|566267344|FG005|Overall Study|Lack of Efficacy|0|||
156865701|NCT01716234|566267345|FG006|Overall Study|Lack of Efficacy|0|||
156865702|NCT01716234|566267339|FG000|Overall Study|Did not meet protocol eligibility|0|||
156865703|NCT01716234|566267340|FG001|Overall Study|Did not meet protocol eligibility|0|||
156865704|NCT01716234|566267341|FG002|Overall Study|Did not meet protocol eligibility|1|||
156865705|NCT01716234|566267342|FG003|Overall Study|Did not meet protocol eligibility|0|||
156865706|NCT01716234|566267343|FG004|Overall Study|Did not meet protocol eligibility|0|||
156865707|NCT01716234|566267344|FG005|Overall Study|Did not meet protocol eligibility|4|||
156865708|NCT01716234|566267345|FG006|Overall Study|Did not meet protocol eligibility|0|||
156865709|NCT01716234|566267339|FG000|Overall Study|Adverse Event|7|||
156865710|NCT01716234|566267340|FG001|Overall Study|Adverse Event|10|||
156865711|NCT01716234|566267341|FG002|Overall Study|Adverse Event|2|||
156865712|NCT01716234|566267342|FG003|Overall Study|Adverse Event|8|||
156865713|NCT01716234|566267343|FG004|Overall Study|Adverse Event|3|||
156865714|NCT01716234|566267344|FG005|Overall Study|Adverse Event|6|||
156865715|NCT01716234|566267345|FG006|Overall Study|Adverse Event|0|||
156865716|NCT01716234|566267339|FG000|Overall Study|Withdrawal by Subject|3|||
156865717|NCT01716234|566267340|FG001|Overall Study|Withdrawal by Subject|0|||
156865718|NCT01716234|566267341|FG002|Overall Study|Withdrawal by Subject|2|||
156865719|NCT01716234|566267342|FG003|Overall Study|Withdrawal by Subject|2|||
156865720|NCT01716234|566267343|FG004|Overall Study|Withdrawal by Subject|1|||
156865721|NCT01716234|566267344|FG005|Overall Study|Withdrawal by Subject|3|||
156865722|NCT01716234|566267345|FG006|Overall Study|Withdrawal by Subject|0|||
156865723|NCT02667119|566267346|FG000|Overall Study|Lost to Follow-up|3|||
156865724|NCT02667119|566267347|FG001|Overall Study|Lost to Follow-up|0|||
156865725|NCT01523756|566267348|FG000|Baseline Period|Adverse Event|0|||
156865726|NCT01523756|566267349|FG001|Baseline Period|Adverse Event|1|||
156865727|NCT01523756|566267348|FG000|Test Period 1|Adverse Event|1|||
156865728|NCT01523756|566267349|FG001|Test Period 1|Adverse Event|0|||
156865729|NCT01523756|566267348|FG000|Test Period 2|Withdrawal by Subject|0|||
156865730|NCT01523756|566267349|FG001|Test Period 2|Withdrawal by Subject|1|||
156865731|NCT03783078|566267352|FG000|Overall Study|Death|31|||
156865732|NCT03783078|566267352|FG000|Overall Study|Sponsor Decision|23|||
156865733|NCT03783078|566267352|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156865734|NCT01467960|566267354|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865735|NCT01467960|566267355|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865736|NCT01467960|566267356|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
156865737|NCT01467960|566267357|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865738|NCT01467960|566267358|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865739|NCT01467960|566267359|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
156865740|NCT00474812|566267362|FG000|Overall Study|Withdrawal by Subject|5|||
156865741|NCT00474812|566267362|FG000|Overall Study|No Initiation of treatment|2|||
156865742|NCT00651742|566267375|FG000|Overall Study|Objective Disease Progression|22|||
156865743|NCT00651742|566267375|FG000|Overall Study|Toxicity|3|||
156865744|NCT00651742|566267375|FG000|Overall Study|Investigator Judgment|1|||
156865745|NCT00651742|566267375|FG000|Overall Study|Withdrawal of Consent|1|||
156865746|NCT00651742|566267375|FG000|Overall Study|Enrolled but not treated|1|||
156865747|NCT05720897|566267378|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
156865748|NCT05720897|566267379|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
156865749|NCT04050553|566267381|FG000|Period 1|Physician Decision|2|||
156865750|NCT04050553|566267382|FG001|Period 1|Physician Decision|2|||
156865751|NCT04050553|566267381|FG000|Period 1|Adverse Event|1|||
156865752|NCT04050553|566267382|FG001|Period 1|Adverse Event|1|||
156865753|NCT04050553|566267381|FG000|Period 1|Withdrawal by Subject|0|||
156865754|NCT04050553|566267382|FG001|Period 1|Withdrawal by Subject|1|||
156865755|NCT04050553|566267381|FG000|Wash-out|Adverse Event|0|||
156865756|NCT04050553|566267382|FG001|Wash-out|Adverse Event|1|||
156865757|NCT04050553|566267381|FG000|Wash-out|Withdrawal by Subject|0|||
156865758|NCT04050553|566267382|FG001|Wash-out|Withdrawal by Subject|1|||
156865759|NCT01535040|566267383|FG000|Overall Study|Physician Decision|0|||
156865760|NCT01535040|566267384|FG001|Overall Study|Physician Decision|1|||
156865761|NCT01535040|566267383|FG000|Overall Study|Withdrawal by Subject|13|||
156865762|NCT01535040|566267384|FG001|Overall Study|Withdrawal by Subject|10|||
156865763|NCT01535040|566267383|FG000|Overall Study|Never Started|9|||
156865764|NCT01535040|566267384|FG001|Overall Study|Never Started|4|||
156865765|NCT01535040|566267383|FG000|Overall Study|Toxicity|7|||
156865766|NCT01535040|566267384|FG001|Overall Study|Toxicity|5|||
156865767|NCT01535040|566267383|FG000|Overall Study|Multiple Reasons|1|||
156865768|NCT01535040|566267384|FG001|Overall Study|Multiple Reasons|1|||
156865769|NCT01074970|566267385|FG000|Overall Study|Never Treated|0|||
156865770|NCT01074970|566267386|FG001|Overall Study|Never Treated|0|||
156865771|NCT01074970|566267387|FG002|Overall Study|Never Treated|8|||
156865772|NCT01074970|566267388|FG003|Overall Study|Never Treated|1|||
156865773|NCT01074970|566267385|FG000|Overall Study|Adverse Event|1|||
156865774|NCT01074970|566267386|FG001|Overall Study|Adverse Event|0|||
156865775|NCT01074970|566267387|FG002|Overall Study|Adverse Event|4|||
156865776|NCT01074970|566267388|FG003|Overall Study|Adverse Event|3|||
156865777|NCT01074970|566267385|FG000|Overall Study|Disease progression during treatment|3|||
156865778|NCT01074970|566267386|FG001|Overall Study|Disease progression during treatment|1|||
156865779|NCT01074970|566267387|FG002|Overall Study|Disease progression during treatment|2|||
156865780|NCT01074970|566267388|FG003|Overall Study|Disease progression during treatment|9|||
156865781|NCT01074970|566267385|FG000|Overall Study|Lost to Follow-up|0|||
156865782|NCT01074970|566267386|FG001|Overall Study|Lost to Follow-up|0|||
156865783|NCT01074970|566267387|FG002|Overall Study|Lost to Follow-up|1|||
156865784|NCT01074970|566267388|FG003|Overall Study|Lost to Follow-up|0|||
156865785|NCT01074970|566267385|FG000|Overall Study|Withdrawal by Subject|0|||
156865786|NCT01074970|566267386|FG001|Overall Study|Withdrawal by Subject|0|||
156865787|NCT01074970|566267387|FG002|Overall Study|Withdrawal by Subject|6|||
156865788|NCT01074970|566267388|FG003|Overall Study|Withdrawal by Subject|4|||
156865789|NCT00734149|566267390|FG000|Overall Study|Withdrawal by Subject|1|||
156865790|NCT05430854|566267391|FG000|Overall Study|Trial terminated by Sponsor|39|||
156865791|NCT05430854|566267392|FG001|Overall Study|Trial terminated by Sponsor|50|||
156865792|NCT05430854|566267393|FG002|Overall Study|Trial terminated by Sponsor|46|||
156865793|NCT05430854|566267391|FG000|Overall Study|Withdrawal by Subject|0|||
156865794|NCT05430854|566267392|FG001|Overall Study|Withdrawal by Subject|3|||
156865795|NCT05430854|566267393|FG002|Overall Study|Withdrawal by Subject|0|||
156865796|NCT04314284|566267394|FG000|Overall Study|Withdrawal by Subject|4|||
157206884|NCT00440193|567501235|FG001|Observational Period|Withdrawal by Subject|8|||
157206885|NCT00440193|567501234|FG000|Observational Period|Physician Decision|1|||
157206886|NCT00440193|567501235|FG001|Observational Period|Physician Decision|0|||
157206887|NCT00440193|567501234|FG000|Observational Period|Clinical endpoint reached|1|||
156751584|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751585|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751586|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
156751587|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
156751588|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
156751589|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
156751590|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
156751591|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751592|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751593|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751594|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751595|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751596|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751597|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
156751598|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751599|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
156751600|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751601|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751602|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751603|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751604|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
156751605|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
156751606|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751607|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751608|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
156751609|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751610|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156751611|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751612|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751613|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751614|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751615|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156865797|NCT04314284|566267395|FG001|Overall Study|Withdrawal by Subject|7|||
156865798|NCT04314284|566267394|FG000|Overall Study|Consented but did not complete survey|0|||
156865799|NCT04314284|566267395|FG001|Overall Study|Consented but did not complete survey|6|||
156865800|NCT01652235|566267399|FG000|Overall Study|Death|9|||
156865801|NCT01652235|566267399|FG000|Overall Study|Lost to Follow-up|5|||
156865802|NCT01652235|566267399|FG000|Overall Study|Withdrawal by Subject|2|||
156865803|NCT03043794|566267404|FG000|Overall Study|Lost to Follow-up|1|||
156751616|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
156751617|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
156751618|NCT00528372|565842067|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751619|NCT00528372|565842068|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751620|NCT00528372|565842069|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
156751621|NCT00528372|565842070|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
156751622|NCT00528372|565842071|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
156751623|NCT00528372|565842072|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
156751624|NCT00528372|565842073|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
156865804|NCT00626106|566267405|FG000|Overall Study|Withdrawal by Subject|2|||
156865805|NCT00626106|566267406|FG001|Overall Study|Withdrawal by Subject|1|||
156865806|NCT00626106|566267405|FG000|Overall Study|Lost to Follow-up|1|||
156865807|NCT00626106|566267406|FG001|Overall Study|Lost to Follow-up|4|||
156865808|NCT00626106|566267405|FG000|Overall Study|Death|64|||
156865809|NCT00626106|566267406|FG001|Overall Study|Death|19|||
156865810|NCT02201953|566267407|FG000|Overall Study|Randomized but Never Treated|1|||
156865811|NCT02201953|566267408|FG001|Overall Study|Randomized but Never Treated|5|||
156865812|NCT02201953|566267407|FG000|Overall Study|Lack of Efficacy|9|||
156865813|NCT02201953|566267408|FG001|Overall Study|Lack of Efficacy|30|||
156865814|NCT02201953|566267407|FG000|Overall Study|Lost to Follow-up|8|||
156865815|NCT02201953|566267408|FG001|Overall Study|Lost to Follow-up|8|||
156865816|NCT02201953|566267407|FG000|Overall Study|Withdrew Consent|2|||
156865817|NCT02201953|566267408|FG001|Overall Study|Withdrew Consent|5|||
156865818|NCT02201953|566267407|FG000|Overall Study|Adverse Event|0|||
156865819|NCT02201953|566267408|FG001|Overall Study|Adverse Event|5|||
156865820|NCT02201953|566267407|FG000|Overall Study|Death|0|||
156865821|NCT02201953|566267408|FG001|Overall Study|Death|3|||
156865822|NCT00911170|566267409|FG000|Treatment Period|Randomized in error|1|||
156865823|NCT00911170|566267410|FG001|Treatment Period|Randomized in error|1|||
156865824|NCT00911170|566267409|FG000|Treatment Period|Ineligibility determined|1|||
156865825|NCT00911170|566267410|FG001|Treatment Period|Ineligibility determined|3|||
156865826|NCT00911170|566267409|FG000|Treatment Period|Protocol deviation|1|||
156865827|NCT00911170|566267410|FG001|Treatment Period|Protocol deviation|2|||
156865828|NCT00911170|566267409|FG000|Treatment Period|Adverse Event|9|||
156865829|NCT00911170|566267410|FG001|Treatment Period|Adverse Event|10|||
156865830|NCT00911170|566267409|FG000|Treatment Period|Withdrawal by Subject|4|||
156865831|NCT00911170|566267410|FG001|Treatment Period|Withdrawal by Subject|4|||
156865832|NCT00911170|566267409|FG000|Treatment Period|Disease progression|0|||
156865833|NCT00911170|566267410|FG001|Treatment Period|Disease progression|2|||
156865834|NCT00911170|566267409|FG000|Treatment Period|Physician Decision|5|||
156865835|NCT00911170|566267410|FG001|Treatment Period|Physician Decision|5|||
156865836|NCT00911170|566267409|FG000|Treatment Period|Lost to Follow-up|0|||
156865837|NCT00911170|566267410|FG001|Treatment Period|Lost to Follow-up|1|||
156865838|NCT00911170|566267409|FG000|Treatment Period|Death|6|||
156865839|NCT00911170|566267410|FG001|Treatment Period|Death|9|||
156865840|NCT00911170|566267409|FG000|Long Term Follow-Up|Continuing in study|274|||
156865841|NCT00911170|566267410|FG001|Long Term Follow-Up|Continuing in study|269|||
156865842|NCT00911170|566267409|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
156865843|NCT00911170|566267410|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
156865844|NCT00911170|566267409|FG000|Long Term Follow-Up|Physician Decision|5|||
156865845|NCT00911170|566267410|FG001|Long Term Follow-Up|Physician Decision|4|||
156865846|NCT00911170|566267409|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
156865847|NCT00911170|566267410|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
156865848|NCT00911170|566267409|FG000|Long Term Follow-Up|Death|116|||
156865849|NCT00911170|566267410|FG001|Long Term Follow-Up|Death|121|||
156865850|NCT02079246|566269053|FG000|OLEX|Withdrawal before treatment|1|||
156865851|NCT02079246|566269054|FG001|OLEX|Withdrawal before treatment|0|||
156865852|NCT02079246|566269053|FG000|OLEX|Death|11|||
156865853|NCT02079246|566269054|FG001|OLEX|Death|0|||
156865854|NCT02079246|566269053|FG000|OLEX|Adverse Event|66|||
156865855|NCT02079246|566269054|FG001|OLEX|Adverse Event|0|||
156865856|NCT02079246|566269053|FG000|OLEX|Withdrawal by Subject|60|||
156865857|NCT02079246|566269054|FG001|OLEX|Withdrawal by Subject|0|||
156865858|NCT02079246|566269053|FG000|OLEX|Lost to Follow-up|6|||
156865859|NCT02079246|566269054|FG001|OLEX|Lost to Follow-up|0|||
156865860|NCT02079246|566269053|FG000|OLEX|Protocol Violation|6|||
156865861|NCT02079246|566269054|FG001|OLEX|Protocol Violation|0|||
156865862|NCT02079246|566269053|FG000|OLEX|Lack of Efficacy|3|||
156865863|NCT02079246|566269054|FG001|OLEX|Lack of Efficacy|0|||
156865864|NCT02079246|566269053|FG000|OLEX|Results of the lead-in studies|58|||
156865865|NCT02079246|566269054|FG001|OLEX|Results of the lead-in studies|0|||
156865866|NCT02079246|566269053|FG000|OLEX|Other: Disallowed medication|8|||
156865867|NCT02079246|566269054|FG001|OLEX|Other: Disallowed medication|0|||
156865868|NCT02079246|566269053|FG000|OLEX|Other: Insufficient compliance|2|||
156865869|NCT02079246|566269054|FG001|OLEX|Other: Insufficient compliance|0|||
156865870|NCT02079246|566269053|FG000|OLEX|Other: Caregiver unavailable|3|||
156865871|NCT02079246|566269054|FG001|OLEX|Other: Caregiver unavailable|0|||
156865872|NCT02079246|566269053|FG000|OLEX|Other: Coordinator decision|1|||
156865873|NCT02079246|566269054|FG001|OLEX|Other: Coordinator decision|0|||
156865874|NCT02079246|566269053|FG000|OLEX|Other: Worsening of condition|1|||
156865875|NCT02079246|566269054|FG001|OLEX|Other: Worsening of condition|0|||
156865876|NCT02079246|566269053|FG000|OLEX|Other: Moved to nursing home|1|||
156865877|NCT02079246|566269054|FG001|OLEX|Other: Moved to nursing home|0|||
156865878|NCT02079246|566269053|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
156865879|NCT02079246|566269054|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
156865880|NCT02079246|566269053|FG000|OLEX-MEM|Adverse Event|0|||
156865881|NCT02079246|566269054|FG001|OLEX-MEM|Adverse Event|6|||
156865882|NCT02079246|566269053|FG000|OLEX-MEM|Withdrawal by Subject|0|||
156865883|NCT02079246|566269054|FG001|OLEX-MEM|Withdrawal by Subject|7|||
156865884|NCT02079246|566269053|FG000|OLEX-MEM|Protocol Violation|0|||
156865885|NCT02079246|566269054|FG001|OLEX-MEM|Protocol Violation|2|||
156865886|NCT02079246|566269053|FG000|OLEX-MEM|Lost to Follow-up|0|||
156865887|NCT02079246|566269054|FG001|OLEX-MEM|Lost to Follow-up|1|||
156865888|NCT02079246|566269053|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
156865889|NCT02079246|566269054|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
156865890|NCT03591406|566269059|FG000|Overall Study|Adverse Event|5|||
156865891|NCT03591406|566269060|FG001|Overall Study|Adverse Event|3|||
156865892|NCT03591406|566269059|FG000|Overall Study|Protocol Violation|2|||
156865893|NCT03591406|566269060|FG001|Overall Study|Protocol Violation|1|||
156865894|NCT03591406|566269059|FG000|Overall Study|Withdrawal by Subject|0|||
156865895|NCT03591406|566269060|FG001|Overall Study|Withdrawal by Subject|5|||
156865896|NCT02144610|566269061|FG000|Overall Study|Physician Decision|1|||
156865897|NCT02144610|566269062|FG001|Overall Study|Physician Decision|0|||
156865898|NCT02144610|566269061|FG000|Overall Study|Withdrawal by Subject|1|||
156865899|NCT02144610|566269062|FG001|Overall Study|Withdrawal by Subject|5|||
156865900|NCT02144610|566269061|FG000|Overall Study|Death|2|||
156865901|NCT02144610|566269062|FG001|Overall Study|Death|2|||
156865902|NCT02144610|566269061|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
156865903|NCT02144610|566269062|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
156865904|NCT02144610|566269061|FG000|Overall Study|Other|0|||
156865905|NCT02144610|566269062|FG001|Overall Study|Other|1|||
156865906|NCT02796170|566269069|FG000|Overall Study|Lost to Follow-up|3|||
156865907|NCT02796170|566269070|FG001|Overall Study|Lost to Follow-up|0|||
156865908|NCT01527370|566269073|FG000|Overall Study|Withdrawal by Subject|4|||
156865909|NCT01527370|566269073|FG000|Overall Study|Physician Decision|1|||
156865910|NCT01527370|566269073|FG000|Overall Study|Death|1|||
156865911|NCT00907335|566269078|FG000|Overall Study|Withdrawal by Subject|2|||
156865912|NCT00907335|566269079|FG001|Overall Study|Withdrawal by Subject|0|||
156865913|NCT00907335|566269078|FG000|Overall Study|Adverse Event|4|||
156865914|NCT00907335|566269079|FG001|Overall Study|Adverse Event|1|||
156865915|NCT00907335|566269078|FG000|Overall Study|Lost to Follow-up|2|||
156865916|NCT00907335|566269079|FG001|Overall Study|Lost to Follow-up|0|||
156865917|NCT03879772|566269080|FG000|Overall Study|Adverse Event|2|||
156865918|NCT03879772|566269081|FG001|Overall Study|Adverse Event|2|||
156865919|NCT03879772|566269082|FG002|Overall Study|Adverse Event|3|||
156865920|NCT03879772|566269083|FG003|Overall Study|Adverse Event|4|||
156865921|NCT03879772|566269084|FG004|Overall Study|Adverse Event|3|||
156865922|NCT03879772|566269080|FG000|Overall Study|Treatment Failure|1|||
156865923|NCT03879772|566269081|FG001|Overall Study|Treatment Failure|0|||
156865924|NCT03879772|566269082|FG002|Overall Study|Treatment Failure|0|||
156865925|NCT03879772|566269083|FG003|Overall Study|Treatment Failure|2|||
156865926|NCT03879772|566269084|FG004|Overall Study|Treatment Failure|1|||
156865927|NCT03879772|566269080|FG000|Overall Study|Lost to Follow-up|0|||
156865928|NCT03879772|566269081|FG001|Overall Study|Lost to Follow-up|0|||
156865929|NCT03879772|566269082|FG002|Overall Study|Lost to Follow-up|0|||
156865930|NCT03879772|566269083|FG003|Overall Study|Lost to Follow-up|0|||
156865931|NCT03879772|566269084|FG004|Overall Study|Lost to Follow-up|1|||
156865932|NCT03879772|566269080|FG000|Overall Study|Withdrawal by Subject|0|||
156865933|NCT03879772|566269081|FG001|Overall Study|Withdrawal by Subject|1|||
156865934|NCT03879772|566269082|FG002|Overall Study|Withdrawal by Subject|3|||
156865935|NCT03879772|566269083|FG003|Overall Study|Withdrawal by Subject|1|||
156865936|NCT03879772|566269084|FG004|Overall Study|Withdrawal by Subject|1|||
156865937|NCT03879772|566269080|FG000|Overall Study|Protocol Violation|0|||
156865938|NCT03879772|566269081|FG001|Overall Study|Protocol Violation|0|||
156865939|NCT03879772|566269082|FG002|Overall Study|Protocol Violation|3|||
156865940|NCT03879772|566269083|FG003|Overall Study|Protocol Violation|1|||
156865941|NCT03879772|566269084|FG004|Overall Study|Protocol Violation|2|||
156865942|NCT03879772|566269080|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
156865943|NCT03879772|566269081|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
156865944|NCT03879772|566269082|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
156865945|NCT03879772|566269083|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
156865946|NCT03879772|566269084|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
156865947|NCT00887809|566269092|FG000|Overall Study|Patient Not Treated|3|||
156865948|NCT00887809|566269093|FG001|Overall Study|Patient Not Treated|0|||
156865949|NCT00887809|566269092|FG000|Overall Study|Death|1|||
156865950|NCT00887809|566269093|FG001|Overall Study|Death|0|||
156865951|NCT03131570|566269094|FG000|Overall Study|Adverse Event|1|||
156865952|NCT03131570|566269095|FG001|Overall Study|Adverse Event|0|||
156865953|NCT04596267|566269096|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
156865954|NCT04596267|566269097|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
156865955|NCT04596267|566269096|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
156865956|NCT04596267|566269097|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
156865957|NCT00071058|566269098|FG000|Overall Study|brain tumor-removed from study|1|||
156865958|NCT01210313|566269106|FG000|Overall Study|Withdrawal by Subject|3|||
156865959|NCT01210313|566269106|FG000|Overall Study|Adverse Event|2|||
156865960|NCT01210313|566269106|FG000|Overall Study|Distant recurrence|4|||
156865961|NCT01210313|566269106|FG000|Overall Study|Non-compliance|7|||
156865962|NCT03113487|566269111|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
156865963|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
156865964|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
156865965|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
156865966|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
156865967|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
156865968|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
156865969|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
156865970|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
156865971|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
156865972|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
156865973|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
156865974|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
156865975|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
156865976|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
156865977|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
156865978|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
156865979|NCT03773978|566269112|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
156865980|NCT03773978|566269113|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
156865981|NCT03773978|566269112|FG000|DBW Period|Adverse Event|2|||
156865982|NCT03773978|566269113|FG001|DBW Period|Adverse Event|2|||
156865983|NCT03773978|566269112|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
156978015|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
156978016|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
156978017|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
156978018|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
156978019|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
156978020|NCT02307513|566673680|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
156978021|NCT02307513|566673681|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
156978022|NCT02307513|566673680|FG000|Long-term Extension|Physician Decision|1|||
156978023|NCT02307513|566673681|FG001|Long-term Extension|Physician Decision|0|||
156978024|NCT01913639|566673684|FG000|Overall Study|Not Eligible|3|||
156978025|NCT02541383|566673685|FG000|Overall Study|Death|50|||
156978026|NCT02541383|566673686|FG001|Overall Study|Death|37|||
156978027|NCT02541383|566673687|FG002|Overall Study|Death|48|||
156978028|NCT02541383|566673688|FG003|Overall Study|Death|41|||
156978029|NCT02541383|566673689|FG004|Overall Study|Death|21|||
156978030|NCT02541383|566673690|FG005|Overall Study|Death|25|||
156978031|NCT02541383|566673685|FG000|Overall Study|Lost to Follow-up|5|||
156978032|NCT02541383|566673686|FG001|Overall Study|Lost to Follow-up|3|||
156978033|NCT02541383|566673687|FG002|Overall Study|Lost to Follow-up|1|||
156978034|NCT02541383|566673688|FG003|Overall Study|Lost to Follow-up|1|||
156978035|NCT02541383|566673689|FG004|Overall Study|Lost to Follow-up|3|||
156978036|NCT02541383|566673690|FG005|Overall Study|Lost to Follow-up|0|||
156978037|NCT02541383|566673685|FG000|Overall Study|Consent withdrawn|5|||
156978038|NCT02541383|566673686|FG001|Overall Study|Consent withdrawn|6|||
156978039|NCT02541383|566673687|FG002|Overall Study|Consent withdrawn|1|||
156978040|NCT02541383|566673688|FG003|Overall Study|Consent withdrawn|1|||
156978041|NCT02541383|566673689|FG004|Overall Study|Consent withdrawn|0|||
156978042|NCT02541383|566673690|FG005|Overall Study|Consent withdrawn|0|||
156978043|NCT02541383|566673685|FG000|Overall Study|Sponsor's decision|1|||
156978044|NCT02541383|566673686|FG001|Overall Study|Sponsor's decision|1|||
156978045|NCT02541383|566673687|FG002|Overall Study|Sponsor's decision|0|||
156978046|NCT02541383|566673688|FG003|Overall Study|Sponsor's decision|0|||
156978047|NCT02541383|566673689|FG004|Overall Study|Sponsor's decision|0|||
156978048|NCT02541383|566673690|FG005|Overall Study|Sponsor's decision|0|||
156978049|NCT01036022|566673691|FG000|Overall Study|Adverse Event|1|||
156978050|NCT01036022|566673692|FG001|Overall Study|Adverse Event|3|||
156978051|NCT01036022|566673693|FG002|Overall Study|Adverse Event|2|||
156978052|NCT01036022|566673694|FG003|Overall Study|Adverse Event|1|||
156978053|NCT01036022|566673695|FG004|Overall Study|Adverse Event|0|||
156978054|NCT01036022|566673696|FG005|Overall Study|Adverse Event|2|||
156978055|NCT01036022|566673691|FG000|Overall Study|Lack of Efficacy|1|||
156978056|NCT01036022|566673692|FG001|Overall Study|Lack of Efficacy|1|||
156978057|NCT01036022|566673693|FG002|Overall Study|Lack of Efficacy|1|||
156978058|NCT01036022|566673694|FG003|Overall Study|Lack of Efficacy|0|||
156978059|NCT01036022|566673695|FG004|Overall Study|Lack of Efficacy|1|||
156978060|NCT01036022|566673696|FG005|Overall Study|Lack of Efficacy|1|||
156978061|NCT01036022|566673691|FG000|Overall Study|Physician Decision|0|||
156978062|NCT01036022|566673692|FG001|Overall Study|Physician Decision|0|||
156978063|NCT01036022|566673693|FG002|Overall Study|Physician Decision|1|||
156978064|NCT01036022|566673694|FG003|Overall Study|Physician Decision|0|||
156978065|NCT01036022|566673695|FG004|Overall Study|Physician Decision|0|||
156978066|NCT01036022|566673696|FG005|Overall Study|Physician Decision|0|||
156978067|NCT01036022|566673691|FG000|Overall Study|Withdrawal by Subject|0|||
156978068|NCT01036022|566673692|FG001|Overall Study|Withdrawal by Subject|0|||
156978069|NCT01036022|566673693|FG002|Overall Study|Withdrawal by Subject|0|||
156978070|NCT01036022|566673694|FG003|Overall Study|Withdrawal by Subject|1|||
156978071|NCT01036022|566673695|FG004|Overall Study|Withdrawal by Subject|2|||
156978072|NCT01036022|566673696|FG005|Overall Study|Withdrawal by Subject|0|||
156978073|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
156978074|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
156978075|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
156978076|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
156978077|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
156978078|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
156978079|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
156978080|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
156978081|NCT01336621|566673700|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
156978082|NCT01336621|566673700|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
156978083|NCT01336621|566673700|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
156978084|NCT01336621|566673700|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
156978085|NCT01336621|566673700|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
156978086|NCT01336621|566673700|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
156978087|NCT02487095|566673701|FG000|Dose Expansion|Unable to scan/restage participant|0|||
156978088|NCT02487095|566673702|FG001|Dose Expansion|Unable to scan/restage participant|0|||
156978089|NCT02487095|566673703|FG002|Dose Expansion|Unable to scan/restage participant|0|||
156978090|NCT02487095|566673704|FG003|Dose Expansion|Unable to scan/restage participant|0|||
156978091|NCT02487095|566673705|FG004|Dose Expansion|Unable to scan/restage participant|1|||
156978092|NCT03108157|566673712|FG000|Overall Study|Protocol Violation|15|||
156978093|NCT03108157|566673713|FG001|Overall Study|Protocol Violation|4|||
156978094|NCT02759185|566673714|FG000|Stage 1|Adverse Event|0|||
156978095|NCT02759185|566673715|FG001|Stage 1|Adverse Event|1|||
156978096|NCT02759185|566673716|FG002|Stage 1|Adverse Event|3|||
156978097|NCT02759185|566673717|FG003|Stage 1|Adverse Event|0|||
156978098|NCT02759185|566673718|FG004|Stage 1|Adverse Event|0|||
156978099|NCT02759185|566673719|FG005|Stage 1|Adverse Event|0|||
156978100|NCT02759185|566673720|FG006|Stage 1|Adverse Event|0|||
156978101|NCT02759185|566673714|FG000|Stage 1|Withdrawal by Subject|1|||
156978102|NCT02759185|566673715|FG001|Stage 1|Withdrawal by Subject|0|||
156978103|NCT02759185|566673716|FG002|Stage 1|Withdrawal by Subject|0|||
156978104|NCT02759185|566673717|FG003|Stage 1|Withdrawal by Subject|0|||
156978105|NCT02759185|566673718|FG004|Stage 1|Withdrawal by Subject|0|||
156978106|NCT02759185|566673719|FG005|Stage 1|Withdrawal by Subject|0|||
156978107|NCT02759185|566673720|FG006|Stage 1|Withdrawal by Subject|0|||
156978108|NCT02759185|566673714|FG000|Stage 2|Adverse Event|0|||
156978109|NCT02759185|566673715|FG001|Stage 2|Adverse Event|0|||
156978110|NCT02759185|566673716|FG002|Stage 2|Adverse Event|0|||
156978111|NCT02759185|566673717|FG003|Stage 2|Adverse Event|0|||
156978112|NCT02759185|566673718|FG004|Stage 2|Adverse Event|1|||
156978113|NCT02759185|566673719|FG005|Stage 2|Adverse Event|2|||
156978114|NCT02759185|566673720|FG006|Stage 2|Adverse Event|0|||
156978115|NCT02759185|566673714|FG000|Stage 2|Withdrawal by Subject|0|||
156978116|NCT02759185|566673715|FG001|Stage 2|Withdrawal by Subject|0|||
156978117|NCT02759185|566673716|FG002|Stage 2|Withdrawal by Subject|0|||
156978118|NCT02759185|566673717|FG003|Stage 2|Withdrawal by Subject|0|||
156978119|NCT02759185|566673718|FG004|Stage 2|Withdrawal by Subject|1|||
156978120|NCT02759185|566673719|FG005|Stage 2|Withdrawal by Subject|1|||
156978121|NCT02759185|566673720|FG006|Stage 2|Withdrawal by Subject|1|||
156978122|NCT04395183|566673721|FG000|Overall Study|Withdrawal by Subject|1|||
156978123|NCT04395183|566673722|FG001|Overall Study|Withdrawal by Subject|0|||
156978124|NCT04395183|566673723|FG002|Overall Study|Withdrawal by Subject|2|||
156978125|NCT04395183|566673724|FG003|Overall Study|Withdrawal by Subject|2|||
156978126|NCT00962247|566673732|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
156978127|NCT00962247|566673732|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
156978128|NCT03203694|566673738|FG000|Overall Study|Withdrawal by Subject|2|||
156978129|NCT03203694|566673739|FG001|Overall Study|Withdrawal by Subject|0|||
156978130|NCT03203694|566673740|FG002|Overall Study|Withdrawal by Subject|0|||
156978131|NCT03203694|566673741|FG003|Overall Study|Withdrawal by Subject|0|||
156978132|NCT03203694|566673742|FG004|Overall Study|Withdrawal by Subject|0|||
156978133|NCT03203694|566673743|FG005|Overall Study|Withdrawal by Subject|0|||
156978134|NCT01709305|566673746|FG000|Phase 1|Clinical Adverse Event|80|||
156978135|NCT01709305|566673747|FG001|Phase 1|Clinical Adverse Event|0|||
156978136|NCT01709305|566673748|FG002|Phase 1|Clinical Adverse Event|0|||
156978137|NCT01709305|566673749|FG003|Phase 1|Clinical Adverse Event|0|||
156978138|NCT01709305|566673750|FG004|Phase 1|Clinical Adverse Event|0|||
156978139|NCT01709305|566673746|FG000|Phase 1|Death|2|||
156978140|NCT01709305|566673747|FG001|Phase 1|Death|0|||
156978141|NCT01709305|566673748|FG002|Phase 1|Death|0|||
156978142|NCT01709305|566673749|FG003|Phase 1|Death|0|||
156978143|NCT01709305|566673750|FG004|Phase 1|Death|0|||
156978144|NCT01709305|566673746|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
156978145|NCT01709305|566673747|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156978146|NCT01709305|566673748|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156978147|NCT01709305|566673749|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156978148|NCT01709305|566673750|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
156978149|NCT01709305|566673746|FG000|Phase 1|Laboratory Adverse Event|16|||
156978150|NCT01709305|566673747|FG001|Phase 1|Laboratory Adverse Event|0|||
156978151|NCT01709305|566673748|FG002|Phase 1|Laboratory Adverse Event|0|||
156978152|NCT01709305|566673749|FG003|Phase 1|Laboratory Adverse Event|0|||
156978153|NCT01709305|566673750|FG004|Phase 1|Laboratory Adverse Event|0|||
156978154|NCT01709305|566673746|FG000|Phase 1|Lost to Follow-up|147|||
156978155|NCT01709305|566673747|FG001|Phase 1|Lost to Follow-up|0|||
156978156|NCT01709305|566673748|FG002|Phase 1|Lost to Follow-up|0|||
156978157|NCT01709305|566673749|FG003|Phase 1|Lost to Follow-up|0|||
156978158|NCT01709305|566673750|FG004|Phase 1|Lost to Follow-up|0|||
156978159|NCT01709305|566673746|FG000|Phase 1|Travel, moving, etc.|30|||
156978160|NCT01709305|566673747|FG001|Phase 1|Travel, moving, etc.|0|||
156978161|NCT01709305|566673748|FG002|Phase 1|Travel, moving, etc.|0|||
156978162|NCT01709305|566673749|FG003|Phase 1|Travel, moving, etc.|0|||
156978163|NCT01709305|566673750|FG004|Phase 1|Travel, moving, etc.|0|||
156978164|NCT01709305|566673746|FG000|Phase 1|Physician Decision|13|||
156978165|NCT01709305|566673747|FG001|Phase 1|Physician Decision|0|||
156978166|NCT01709305|566673748|FG002|Phase 1|Physician Decision|0|||
156978167|NCT01709305|566673749|FG003|Phase 1|Physician Decision|0|||
156978168|NCT01709305|566673750|FG004|Phase 1|Physician Decision|0|||
156978169|NCT01709305|566673746|FG000|Phase 1|Protocol Violation|118|||
156978170|NCT01709305|566673747|FG001|Phase 1|Protocol Violation|0|||
156978171|NCT01709305|566673748|FG002|Phase 1|Protocol Violation|0|||
156978172|NCT01709305|566673749|FG003|Phase 1|Protocol Violation|0|||
156978173|NCT01709305|566673750|FG004|Phase 1|Protocol Violation|0|||
156978174|NCT01709305|566673746|FG000|Phase 1|Withdrawal by Subject|218|||
156978175|NCT01709305|566673747|FG001|Phase 1|Withdrawal by Subject|0|||
156978176|NCT01709305|566673748|FG002|Phase 1|Withdrawal by Subject|0|||
156978177|NCT01709305|566673749|FG003|Phase 1|Withdrawal by Subject|0|||
156978178|NCT01709305|566673750|FG004|Phase 1|Withdrawal by Subject|0|||
156978179|NCT01709305|566673746|FG000|Phase 2|Clinical Adverse Event|0|||
156978180|NCT01709305|566673747|FG001|Phase 2|Clinical Adverse Event|10|||
156978181|NCT01709305|566673748|FG002|Phase 2|Clinical Adverse Event|10|||
156978182|NCT01709305|566673749|FG003|Phase 2|Clinical Adverse Event|6|||
156978183|NCT01709305|566673750|FG004|Phase 2|Clinical Adverse Event|11|||
156978184|NCT01709305|566673746|FG000|Phase 2|Death|0|||
156978185|NCT01709305|566673747|FG001|Phase 2|Death|0|||
156978186|NCT01709305|566673748|FG002|Phase 2|Death|1|||
156978187|NCT01709305|566673749|FG003|Phase 2|Death|0|||
156978188|NCT01709305|566673750|FG004|Phase 2|Death|0|||
156978189|NCT01709305|566673746|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156978190|NCT01709305|566673747|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156978191|NCT01709305|566673748|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156978192|NCT01709305|566673749|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
156978193|NCT01709305|566673750|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
156978194|NCT01709305|566673746|FG000|Phase 2|Laboratory Adverse Event|0|||
156978195|NCT01709305|566673747|FG001|Phase 2|Laboratory Adverse Event|1|||
156978196|NCT01709305|566673748|FG002|Phase 2|Laboratory Adverse Event|0|||
156978197|NCT01709305|566673749|FG003|Phase 2|Laboratory Adverse Event|1|||
156978198|NCT01709305|566673750|FG004|Phase 2|Laboratory Adverse Event|1|||
156978199|NCT01709305|566673746|FG000|Phase 2|Lost to Follow-up|0|||
156978200|NCT01709305|566673747|FG001|Phase 2|Lost to Follow-up|10|||
156978201|NCT01709305|566673748|FG002|Phase 2|Lost to Follow-up|6|||
156978202|NCT01709305|566673749|FG003|Phase 2|Lost to Follow-up|9|||
156978203|NCT01709305|566673750|FG004|Phase 2|Lost to Follow-up|5|||
156978204|NCT01709305|566673746|FG000|Phase 2|Travel, moving, etc.|0|||
156978205|NCT01709305|566673747|FG001|Phase 2|Travel, moving, etc.|2|||
156978206|NCT01709305|566673748|FG002|Phase 2|Travel, moving, etc.|3|||
156978207|NCT01709305|566673749|FG003|Phase 2|Travel, moving, etc.|3|||
156978208|NCT01709305|566673750|FG004|Phase 2|Travel, moving, etc.|5|||
156978209|NCT01709305|566673746|FG000|Phase 2|Physician Decision|0|||
156978210|NCT01709305|566673747|FG001|Phase 2|Physician Decision|2|||
156978211|NCT01709305|566673748|FG002|Phase 2|Physician Decision|0|||
156978212|NCT01709305|566673749|FG003|Phase 2|Physician Decision|1|||
156978213|NCT01709305|566673750|FG004|Phase 2|Physician Decision|2|||
156978214|NCT01709305|566673746|FG000|Phase 2|Protocol Violation|0|||
156978215|NCT01709305|566673747|FG001|Phase 2|Protocol Violation|19|||
156978216|NCT01709305|566673748|FG002|Phase 2|Protocol Violation|19|||
156978217|NCT01709305|566673749|FG003|Phase 2|Protocol Violation|13|||
156978218|NCT01709305|566673750|FG004|Phase 2|Protocol Violation|9|||
156978219|NCT01709305|566673746|FG000|Phase 2|Withdrawal by Subject|0|||
157093217|NCT01313689|567095880|FG004|24-Week Randomization 2|Physician Decision|4|||
156978220|NCT01709305|566673747|FG001|Phase 2|Withdrawal by Subject|8|||
156978221|NCT01709305|566673748|FG002|Phase 2|Withdrawal by Subject|6|||
156978222|NCT01709305|566673749|FG003|Phase 2|Withdrawal by Subject|15|||
156978223|NCT01709305|566673750|FG004|Phase 2|Withdrawal by Subject|12|||
156978224|NCT03443713|566673751|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
156978225|NCT03443713|566673752|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
157093218|NCT01768637|567095882|FG000|Overall Study|Lost to Follow-up|2|||
156978226|NCT03443713|566673753|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
156978227|NCT01672853|566673758|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
156978228|NCT01672853|566673759|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
156978229|NCT01672853|566673760|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
156978230|NCT01672853|566673758|FG000|Overall Study|Pregnancy|0|||
156978231|NCT01672853|566673759|FG001|Overall Study|Pregnancy|1|||
156978232|NCT01672853|566673760|FG002|Overall Study|Pregnancy|0|||
156978233|NCT01672853|566673758|FG000|Overall Study|Investigator's Discretion|1|||
156978234|NCT01672853|566673759|FG001|Overall Study|Investigator's Discretion|0|||
156978235|NCT01672853|566673760|FG002|Overall Study|Investigator's Discretion|0|||
156978236|NCT01672853|566673758|FG000|Overall Study|Withdrew Consent|5|||
156978237|NCT01672853|566673759|FG001|Overall Study|Withdrew Consent|5|||
156978238|NCT01672853|566673760|FG002|Overall Study|Withdrew Consent|5|||
156978239|NCT01672853|566673758|FG000|Overall Study|Adverse Event|4|||
156978240|NCT01672853|566673759|FG001|Overall Study|Adverse Event|6|||
156978241|NCT01672853|566673760|FG002|Overall Study|Adverse Event|8|||
156978242|NCT01672853|566673758|FG000|Overall Study|Lost to Follow-up|0|||
156978243|NCT01672853|566673759|FG001|Overall Study|Lost to Follow-up|1|||
156978244|NCT01672853|566673760|FG002|Overall Study|Lost to Follow-up|0|||
156978245|NCT01672853|566673758|FG000|Overall Study|Randomized but Never Treated|0|||
156978246|NCT01672853|566673759|FG001|Overall Study|Randomized but Never Treated|0|||
156978247|NCT01672853|566673760|FG002|Overall Study|Randomized but Never Treated|1|||
156978248|NCT02969525|566673761|FG000|Double-Blind Period|Adverse Event|0|||
156978249|NCT02969525|566673762|FG001|Double-Blind Period|Adverse Event|0|||
156978250|NCT02969525|566673763|FG002|Double-Blind Period|Adverse Event|1|||
156978251|NCT02969525|566673764|FG003|Double-Blind Period|Adverse Event|1|||
156978252|NCT02969525|566673765|FG004|Double-Blind Period|Adverse Event|0|||
156978253|NCT02969525|566673766|FG005|Double-Blind Period|Adverse Event|0|||
156978254|NCT02969525|566673767|FG006|Double-Blind Period|Adverse Event|0|||
156978255|NCT02969525|566673768|FG007|Double-Blind Period|Adverse Event|0|||
156978256|NCT02969525|566673769|FG008|Double-Blind Period|Adverse Event|0|||
156978257|NCT02969525|566673770|FG009|Double-Blind Period|Adverse Event|0|||
156978258|NCT02969525|566673771|FG010|Double-Blind Period|Adverse Event|0|||
156978259|NCT02969525|566673772|FG011|Double-Blind Period|Adverse Event|0|||
156978260|NCT02969525|566673761|FG000|Double-Blind Period|LOW EGFR|0|||
156978261|NCT02969525|566673762|FG001|Double-Blind Period|LOW EGFR|0|||
156978262|NCT02969525|566673763|FG002|Double-Blind Period|LOW EGFR|0|||
156978263|NCT02969525|566673764|FG003|Double-Blind Period|LOW EGFR|1|||
156978264|NCT02969525|566673765|FG004|Double-Blind Period|LOW EGFR|0|||
156978265|NCT02969525|566673766|FG005|Double-Blind Period|LOW EGFR|0|||
156978266|NCT02969525|566673767|FG006|Double-Blind Period|LOW EGFR|0|||
156978267|NCT02969525|566673768|FG007|Double-Blind Period|LOW EGFR|0|||
156978268|NCT02969525|566673769|FG008|Double-Blind Period|LOW EGFR|0|||
156978269|NCT02969525|566673770|FG009|Double-Blind Period|LOW EGFR|0|||
156978270|NCT02969525|566673771|FG010|Double-Blind Period|LOW EGFR|0|||
156978271|NCT02969525|566673772|FG011|Double-Blind Period|LOW EGFR|0|||
156978272|NCT02969525|566673761|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
156978273|NCT02969525|566673762|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978274|NCT02969525|566673763|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978275|NCT02969525|566673764|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
156978276|NCT02969525|566673765|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978277|NCT02969525|566673766|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978278|NCT02969525|566673767|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978279|NCT02969525|566673768|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978280|NCT02969525|566673769|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978281|NCT02969525|566673770|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978282|NCT02969525|566673771|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978283|NCT02969525|566673772|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
156978284|NCT02969525|566673761|FG000|Dose-Blind Period|Adverse Event|0|||
156978285|NCT02969525|566673762|FG001|Dose-Blind Period|Adverse Event|0|||
156978286|NCT02969525|566673763|FG002|Dose-Blind Period|Adverse Event|0|||
156978287|NCT02969525|566673764|FG003|Dose-Blind Period|Adverse Event|0|||
156978288|NCT02969525|566673765|FG004|Dose-Blind Period|Adverse Event|0|||
156978289|NCT02969525|566673766|FG005|Dose-Blind Period|Adverse Event|0|||
156978290|NCT02969525|566673767|FG006|Dose-Blind Period|Adverse Event|0|||
156978291|NCT02969525|566673768|FG007|Dose-Blind Period|Adverse Event|0|||
156978292|NCT02969525|566673769|FG008|Dose-Blind Period|Adverse Event|0|||
156978293|NCT02969525|566673770|FG009|Dose-Blind Period|Adverse Event|1|||
156978294|NCT02969525|566673771|FG010|Dose-Blind Period|Adverse Event|1|||
156978295|NCT02969525|566673772|FG011|Dose-Blind Period|Adverse Event|1|||
156978296|NCT02969525|566673761|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
156978297|NCT02969525|566673762|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
156978298|NCT02969525|566673763|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
156978299|NCT02969525|566673764|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
156978300|NCT02969525|566673765|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
156978301|NCT02969525|566673766|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
156978302|NCT02969525|566673767|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
156978303|NCT02969525|566673768|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
156978304|NCT02969525|566673769|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
156978305|NCT02969525|566673770|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
156978306|NCT02969525|566673771|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
156978307|NCT02969525|566673772|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
156978308|NCT02969525|566673761|FG000|Dose-Blind Period|Non-cooperating patient|0|||
156978309|NCT02969525|566673762|FG001|Dose-Blind Period|Non-cooperating patient|0|||
156978310|NCT02969525|566673763|FG002|Dose-Blind Period|Non-cooperating patient|0|||
156978311|NCT02969525|566673764|FG003|Dose-Blind Period|Non-cooperating patient|0|||
156978312|NCT02969525|566673765|FG004|Dose-Blind Period|Non-cooperating patient|0|||
156978313|NCT02969525|566673766|FG005|Dose-Blind Period|Non-cooperating patient|0|||
156978314|NCT02969525|566673767|FG006|Dose-Blind Period|Non-cooperating patient|0|||
156978315|NCT02969525|566673768|FG007|Dose-Blind Period|Non-cooperating patient|0|||
156978316|NCT02969525|566673769|FG008|Dose-Blind Period|Non-cooperating patient|0|||
156978317|NCT02969525|566673770|FG009|Dose-Blind Period|Non-cooperating patient|0|||
156978318|NCT02969525|566673771|FG010|Dose-Blind Period|Non-cooperating patient|0|||
156978319|NCT02969525|566673772|FG011|Dose-Blind Period|Non-cooperating patient|1|||
156978320|NCT02969525|566673761|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156865984|NCT03773978|566269113|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
156865985|NCT03773978|566269112|FG000|DBW Period|Withdrawal by Subject|2|||
156865986|NCT03773978|566269113|FG001|DBW Period|Withdrawal by Subject|1|||
156865987|NCT03773978|566269112|FG000|DBW Period|Due to epidemic or pandemic|5|||
156865988|NCT03773978|566269113|FG001|DBW Period|Due to epidemic or pandemic|6|||
156865989|NCT03773978|566269112|FG000|DBW Period|Study team decision|1|||
156865990|NCT03773978|566269113|FG001|DBW Period|Study team decision|0|||
156865991|NCT03777982|566269114|FG000|Overall Study|Physician Decision|0|||
156865992|NCT03777982|566269115|FG001|Overall Study|Physician Decision|1|||
156865993|NCT04189952|566269118|FG000|Follow-up Period|Death|1|||
156865994|NCT04189952|566269118|FG000|Follow-up Period|Withdrawal by Subject|1|||
156865995|NCT00870740|566269119|FG000|Overall Study|Adverse Event|2|||
156865996|NCT00870740|566269120|FG001|Overall Study|Adverse Event|1|||
156865997|NCT00870740|566269121|FG002|Overall Study|Adverse Event|3|||
156865998|NCT00870740|566269122|FG003|Overall Study|Adverse Event|2|||
156865999|NCT00870740|566269123|FG004|Overall Study|Adverse Event|1|||
156866000|NCT00870740|566269124|FG005|Overall Study|Adverse Event|6|||
156866001|NCT00870740|566269119|FG000|Overall Study|Consent Withdrawn|6|||
156866002|NCT00870740|566269120|FG001|Overall Study|Consent Withdrawn|3|||
156866003|NCT00870740|566269121|FG002|Overall Study|Consent Withdrawn|4|||
156866004|NCT00870740|566269122|FG003|Overall Study|Consent Withdrawn|6|||
156866005|NCT00870740|566269123|FG004|Overall Study|Consent Withdrawn|6|||
156866006|NCT00870740|566269124|FG005|Overall Study|Consent Withdrawn|5|||
156866007|NCT00870740|566269119|FG000|Overall Study|Investigator Decision|2|||
156866008|NCT00870740|566269120|FG001|Overall Study|Investigator Decision|0|||
156866009|NCT00870740|566269121|FG002|Overall Study|Investigator Decision|1|||
156866010|NCT00870740|566269122|FG003|Overall Study|Investigator Decision|0|||
156866011|NCT00870740|566269123|FG004|Overall Study|Investigator Decision|0|||
156866012|NCT00870740|566269124|FG005|Overall Study|Investigator Decision|0|||
156866013|NCT00870740|566269119|FG000|Overall Study|Subject Non-compliance|0|||
156866014|NCT00870740|566269120|FG001|Overall Study|Subject Non-compliance|0|||
156866015|NCT00870740|566269121|FG002|Overall Study|Subject Non-compliance|0|||
156866016|NCT00870740|566269122|FG003|Overall Study|Subject Non-compliance|0|||
156866017|NCT00870740|566269123|FG004|Overall Study|Subject Non-compliance|0|||
156866018|NCT00870740|566269124|FG005|Overall Study|Subject Non-compliance|1|||
156866019|NCT00870740|566269119|FG000|Overall Study|Death|0|||
156866020|NCT00870740|566269120|FG001|Overall Study|Death|0|||
156866021|NCT00870740|566269121|FG002|Overall Study|Death|0|||
156866022|NCT00870740|566269122|FG003|Overall Study|Death|0|||
156866023|NCT00870740|566269123|FG004|Overall Study|Death|1|||
156866024|NCT00870740|566269124|FG005|Overall Study|Death|0|||
156866025|NCT00870740|566269119|FG000|Overall Study|Other|2|||
156866026|NCT00870740|566269120|FG001|Overall Study|Other|5|||
156866027|NCT00870740|566269121|FG002|Overall Study|Other|2|||
156866028|NCT00870740|566269122|FG003|Overall Study|Other|4|||
156866029|NCT00870740|566269123|FG004|Overall Study|Other|3|||
156866030|NCT00870740|566269124|FG005|Overall Study|Other|5|||
156866031|NCT03995368|566269132|FG000|Overall Study|Lost to Follow-up|1|||
156866032|NCT03995368|566269133|FG001|Overall Study|Lost to Follow-up|4|||
156866033|NCT03995368|566269134|FG002|Overall Study|Lost to Follow-up|1|||
156866034|NCT03995368|566269132|FG000|Overall Study|Did not meet inclusion criteria|1|||
156866035|NCT03995368|566269133|FG001|Overall Study|Did not meet inclusion criteria|6|||
156866036|NCT03995368|566269134|FG002|Overall Study|Did not meet inclusion criteria|3|||
156866037|NCT03995368|566269132|FG000|Overall Study|Withdrawal by Subject|0|||
156866038|NCT03995368|566269133|FG001|Overall Study|Withdrawal by Subject|1|||
156866039|NCT03995368|566269134|FG002|Overall Study|Withdrawal by Subject|1|||
156866040|NCT03592186|566269135|FG000|Overall Study|Withdrawal by Subject|1|||
156866041|NCT03592186|566269136|FG001|Overall Study|Withdrawal by Subject|0|||
156866042|NCT03592186|566269135|FG000|Overall Study|Lost to Follow-up|16|||
156866043|NCT03592186|566269136|FG001|Overall Study|Lost to Follow-up|11|||
156866044|NCT03755934|566269137|FG000|Overall Study|Adverse Event|4|||
156866045|NCT03755934|566269138|FG001|Overall Study|Adverse Event|1|||
156866046|NCT03755934|566269139|FG002|Overall Study|Adverse Event|1|||
156866047|NCT03755934|566269140|FG003|Overall Study|Adverse Event|3|||
156978321|NCT02969525|566673762|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978322|NCT02969525|566673763|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978323|NCT02969525|566673764|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978324|NCT02969525|566673765|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978325|NCT02969525|566673766|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978326|NCT02969525|566673767|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978327|NCT02969525|566673768|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978328|NCT02969525|566673769|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978329|NCT02969525|566673770|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978330|NCT02969525|566673771|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
156978331|NCT02969525|566673772|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
156978332|NCT03445065|566673773|FG000|Overall Study|Withdrawal by Subject|3|||
156978333|NCT03445065|566673774|FG001|Overall Study|Withdrawal by Subject|6|||
156978334|NCT03445065|566673775|FG002|Overall Study|Withdrawal by Subject|2|||
156978335|NCT03445065|566673776|FG003|Overall Study|Withdrawal by Subject|2|||
156978336|NCT03445065|566673773|FG000|Overall Study|Other|4|||
156978337|NCT03445065|566673774|FG001|Overall Study|Other|3|||
156978338|NCT03445065|566673775|FG002|Overall Study|Other|3|||
156978339|NCT03445065|566673776|FG003|Overall Study|Other|1|||
157021563|NCT04169373|566830900|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
157021564|NCT04169373|566830901|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
157021565|NCT04169373|566830902|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
157021566|NCT04169373|566830899|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
157021567|NCT04169373|566830900|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
157021568|NCT04169373|566830901|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
157021569|NCT04169373|566830902|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
157021570|NCT04169373|566830899|FG000|Week 14 to Week 52|Other|4|||
157021571|NCT04169373|566830900|FG001|Week 14 to Week 52|Other|5|||
157021572|NCT04169373|566830901|FG002|Week 14 to Week 52|Other|4|||
157021573|NCT04169373|566830902|FG003|Week 14 to Week 52|Other|5|||
157021574|NCT04169373|566830899|FG000|Week 14 to Week 52|Ongoing|0|||
157021575|NCT04169373|566830900|FG001|Week 14 to Week 52|Ongoing|1|||
157021576|NCT04169373|566830901|FG002|Week 14 to Week 52|Ongoing|0|||
157021577|NCT04169373|566830902|FG003|Week 14 to Week 52|Ongoing|0|||
157021578|NCT04610892|566830903|FG000|Overall Study|Adverse Event|1|||
157021579|NCT04610892|566830904|FG001|Overall Study|Adverse Event|0|||
157021580|NCT04610892|566830905|FG002|Overall Study|Adverse Event|0|||
157021581|NCT04610892|566830906|FG003|Overall Study|Adverse Event|1|||
156866048|NCT03755934|566269137|FG000|Overall Study|Physician Decision|2|||
156866049|NCT03755934|566269138|FG001|Overall Study|Physician Decision|0|||
156866050|NCT03755934|566269139|FG002|Overall Study|Physician Decision|0|||
156866051|NCT03755934|566269140|FG003|Overall Study|Physician Decision|1|||
156866052|NCT03755934|566269137|FG000|Overall Study|Withdrawal by Subject|5|||
156866053|NCT03755934|566269138|FG001|Overall Study|Withdrawal by Subject|0|||
156866054|NCT03755934|566269139|FG002|Overall Study|Withdrawal by Subject|0|||
156866055|NCT03755934|566269140|FG003|Overall Study|Withdrawal by Subject|1|||
156866056|NCT03755934|566269137|FG000|Overall Study|Other|3|||
156866057|NCT03755934|566269138|FG001|Overall Study|Other|1|||
156866058|NCT03755934|566269139|FG002|Overall Study|Other|3|||
156866059|NCT03755934|566269140|FG003|Overall Study|Other|1|||
156866060|NCT01498068|566269141|FG000|Overall Study|Withdrawal by Subject|1|||
156866061|NCT01498068|566269142|FG001|Overall Study|Withdrawal by Subject|1|||
156866062|NCT00361296|566269145|FG000|Overall Study|Physician Decision|1|||
156866063|NCT00361296|566269145|FG000|Overall Study|Lack of Efficacy|2|||
156866064|NCT01353898|566269148|FG000|Overall Study|Study site terminated|0|||
156866065|NCT01353898|566269149|FG001|Overall Study|Study site terminated|0|||
156866066|NCT01353898|566269150|FG002|Overall Study|Study site terminated|0|||
156866067|NCT01353898|566269151|FG003|Overall Study|Study site terminated|0|||
156866068|NCT01353898|566269152|FG004|Overall Study|Study site terminated|0|||
156866069|NCT01353898|566269153|FG005|Overall Study|Study site terminated|1|||
156866070|NCT02072668|566269154|FG000|Second Intervention|Lost to Follow-up|1|||
156866071|NCT02072668|566269155|FG001|Second Intervention|Lost to Follow-up|0|||
156866072|NCT02668653|566269156|FG000|Overall Study|Refractory disease|41|||
156866073|NCT02668653|566269157|FG001|Overall Study|Refractory disease|70|||
156866074|NCT02668653|566269156|FG000|Overall Study|Relapse|44|||
156866075|NCT02668653|566269157|FG001|Overall Study|Relapse|65|||
156866076|NCT02668653|566269156|FG000|Overall Study|Adverse Event|58|||
156866077|NCT02668653|566269157|FG001|Overall Study|Adverse Event|23|||
156866078|NCT02668653|566269156|FG000|Overall Study|Subject decision to stop study drug|25|||
156866079|NCT02668653|566269157|FG001|Overall Study|Subject decision to stop study drug|23|||
156866080|NCT02668653|566269156|FG000|Overall Study|Other reasons not specified|16|||
156866081|NCT02668653|566269157|FG001|Overall Study|Other reasons not specified|11|||
156866082|NCT02668653|566269156|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
156866083|NCT02668653|566269157|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
156866084|NCT02668653|566269156|FG000|Overall Study|Investigator decision|10|||
156866085|NCT02668653|566269157|FG001|Overall Study|Investigator decision|7|||
156866086|NCT02668653|566269156|FG000|Overall Study|Failure to meet continuation criteria|5|||
156866087|NCT02668653|566269157|FG001|Overall Study|Failure to meet continuation criteria|12|||
156866088|NCT02668653|566269156|FG000|Overall Study|Lost to Follow-up|1|||
156866089|NCT02668653|566269157|FG001|Overall Study|Lost to Follow-up|0|||
156866090|NCT02668653|566269156|FG000|Overall Study|Pregnancy|0|||
156866091|NCT02668653|566269157|FG001|Overall Study|Pregnancy|1|||
156866092|NCT02668653|566269156|FG000|Overall Study|Death|0|||
156866093|NCT02668653|566269157|FG001|Overall Study|Death|1|||
156866094|NCT01352793|566269163|FG000|Overall Study|Lost to Follow-up|289|||
156866095|NCT01352793|566269164|FG001|Overall Study|Lost to Follow-up|125|||
156866096|NCT01352793|566269163|FG000|Overall Study|Withdrawal by Subject|120|||
156866097|NCT01352793|566269164|FG001|Overall Study|Withdrawal by Subject|55|||
156866098|NCT01352793|566269163|FG000|Overall Study|Protocol Violation|44|||
156866099|NCT01352793|566269164|FG001|Overall Study|Protocol Violation|23|||
156866100|NCT01352793|566269163|FG000|Overall Study|Adverse Event|44|||
156866101|NCT01352793|566269164|FG001|Overall Study|Adverse Event|10|||
156866102|NCT01352793|566269163|FG000|Overall Study|Physician Decision|1|||
156866103|NCT01352793|566269164|FG001|Overall Study|Physician Decision|0|||
156866104|NCT01352793|566269163|FG000|Overall Study|Pregnancy|26|||
156866105|NCT01352793|566269164|FG001|Overall Study|Pregnancy|8|||
156866106|NCT01352793|566269163|FG000|Overall Study|Other|25|||
156866107|NCT01352793|566269164|FG001|Overall Study|Other|7|||
156866108|NCT01352793|566269163|FG000|Overall Study|Medication error|2|||
156866109|NCT01352793|566269164|FG001|Overall Study|Medication error|2|||
156866110|NCT01352793|566269163|FG000|Overall Study|Death|1|||
156866111|NCT01352793|566269164|FG001|Overall Study|Death|0|||
156866112|NCT01352793|566269163|FG000|Overall Study|Randomized but not vaccinated|8|||
156866113|NCT01352793|566269164|FG001|Overall Study|Randomized but not vaccinated|0|||
156866114|NCT01352793|566269163|FG000|Overall Study|No longer meets eligibility criteria|25|||
156866115|NCT01352793|566269164|FG001|Overall Study|No longer meets eligibility criteria|15|||
156866116|NCT04322526|566269167|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
156866117|NCT04322526|566269168|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156866118|NCT04322526|566269167|FG000|Washout (1 Week)|Lost to Follow-up|1|||
156866119|NCT04322526|566269168|FG001|Washout (1 Week)|Lost to Follow-up|2|||
156866120|NCT00993967|566269172|FG000|Overall Study|Adverse Event|8|||
156866121|NCT00993967|566269172|FG000|Overall Study|Death|1|||
156866122|NCT00993967|566269172|FG000|Overall Study|Lost to Follow-up|14|||
156866123|NCT00993967|566269172|FG000|Overall Study|Withdrawal by Subject|36|||
156866124|NCT00993967|566269172|FG000|Overall Study|Protocol Violation|2|||
156866125|NCT01342211|566269175|FG000|Overall Study|Lost to Follow-up|0|||
156866126|NCT01342211|566269176|FG001|Overall Study|Lost to Follow-up|0|||
156866127|NCT01342211|566269177|FG002|Overall Study|Lost to Follow-up|0|||
156866128|NCT01342211|566269178|FG003|Overall Study|Lost to Follow-up|1|||
156866129|NCT01342211|566269179|FG004|Overall Study|Lost to Follow-up|0|||
156866130|NCT01342211|566269175|FG000|Overall Study|Adverse Event|0|||
156866131|NCT01342211|566269176|FG001|Overall Study|Adverse Event|0|||
156866132|NCT01342211|566269177|FG002|Overall Study|Adverse Event|0|||
156866133|NCT01342211|566269178|FG003|Overall Study|Adverse Event|0|||
156866134|NCT01342211|566269179|FG004|Overall Study|Adverse Event|1|||
156866135|NCT01342211|566269175|FG000|Overall Study|Withdrawal by Subject|0|||
156866136|NCT01342211|566269176|FG001|Overall Study|Withdrawal by Subject|0|||
156978340|NCT00663117|566675646|FG000|Overall Study|Lack of Efficacy|1|||
156978341|NCT00663117|566675647|FG001|Overall Study|Lack of Efficacy|0|||
156978342|NCT02248961|566675648|FG000|Overall Study|Adverse Event|1|||
156978343|NCT02248961|566675649|FG001|Overall Study|Adverse Event|0|||
156978344|NCT02248961|566675648|FG000|Overall Study|Withdrawal by Subject|1|||
156978345|NCT02248961|566675649|FG001|Overall Study|Withdrawal by Subject|2|||
156978346|NCT02248961|566675648|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
156978347|NCT02248961|566675649|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
156978348|NCT02802319|566675651|FG000|Overall Study|Physician Decision|2|||
156978349|NCT02802319|566675652|FG001|Overall Study|Physician Decision|1|||
156978350|NCT02802319|566675651|FG000|Overall Study|Lost to Follow-up|0|||
156978351|NCT02802319|566675652|FG001|Overall Study|Lost to Follow-up|4|||
156978352|NCT02960763|566675653|FG000|Step 1|Withdrawal by Subject|10|||
156978353|NCT02960763|566675654|FG001|Step 1|Withdrawal by Subject|8|||
156978354|NCT02960763|566675655|FG002|Step 1|Withdrawal by Subject|13|||
156978355|NCT02960763|566675656|FG003|Step 1|Withdrawal by Subject|0|||
156978356|NCT02960763|566675657|FG004|Step 1|Withdrawal by Subject|0|||
156978357|NCT02960763|566675653|FG000|Step 1|Lost to Follow-up|7|||
156978358|NCT02960763|566675654|FG001|Step 1|Lost to Follow-up|9|||
156978359|NCT02960763|566675655|FG002|Step 1|Lost to Follow-up|12|||
156978360|NCT02960763|566675656|FG003|Step 1|Lost to Follow-up|0|||
156978361|NCT02960763|566675657|FG004|Step 1|Lost to Follow-up|0|||
156978362|NCT02960763|566675653|FG000|Step 1|Death|1|||
156978363|NCT02960763|566675654|FG001|Step 1|Death|1|||
156978364|NCT02960763|566675655|FG002|Step 1|Death|1|||
156978365|NCT02960763|566675656|FG003|Step 1|Death|0|||
156978366|NCT02960763|566675657|FG004|Step 1|Death|0|||
156978367|NCT02960763|566675653|FG000|Step 1|Investigator discretion|1|||
156978368|NCT02960763|566675654|FG001|Step 1|Investigator discretion|0|||
156978369|NCT02960763|566675655|FG002|Step 1|Investigator discretion|1|||
156978370|NCT02960763|566675656|FG003|Step 1|Investigator discretion|0|||
156978371|NCT02960763|566675657|FG004|Step 1|Investigator discretion|0|||
156978372|NCT02960763|566675653|FG000|Step 1|Other|0|||
156978373|NCT02960763|566675654|FG001|Step 1|Other|0|||
156978374|NCT02960763|566675655|FG002|Step 1|Other|1|||
156978375|NCT02960763|566675656|FG003|Step 1|Other|0|||
156978376|NCT02960763|566675657|FG004|Step 1|Other|0|||
156978377|NCT02960763|566675653|FG000|Step 2|Withdrawal by Subject|0|||
156978378|NCT02960763|566675654|FG001|Step 2|Withdrawal by Subject|0|||
156978379|NCT02960763|566675655|FG002|Step 2|Withdrawal by Subject|0|||
156978380|NCT02960763|566675656|FG003|Step 2|Withdrawal by Subject|7|||
156978381|NCT02960763|566675657|FG004|Step 2|Withdrawal by Subject|3|||
156978382|NCT02960763|566675653|FG000|Step 2|Lost to Follow-up|0|||
156978383|NCT02960763|566675654|FG001|Step 2|Lost to Follow-up|0|||
156978384|NCT02960763|566675655|FG002|Step 2|Lost to Follow-up|0|||
156978385|NCT02960763|566675656|FG003|Step 2|Lost to Follow-up|4|||
156978386|NCT02960763|566675657|FG004|Step 2|Lost to Follow-up|1|||
156978387|NCT02960763|566675653|FG000|Step 2|Investigator discretion|0|||
156978388|NCT02960763|566675654|FG001|Step 2|Investigator discretion|0|||
156978389|NCT02960763|566675655|FG002|Step 2|Investigator discretion|0|||
156978390|NCT02960763|566675656|FG003|Step 2|Investigator discretion|0|||
156978391|NCT02960763|566675657|FG004|Step 2|Investigator discretion|1|||
156978392|NCT01336634|566675673|FG000|Overall Study|Study closed/terminated|5|||
156978393|NCT01336634|566675674|FG001|Overall Study|Study closed/terminated|6|||
156978394|NCT01336634|566675675|FG002|Overall Study|Study closed/terminated|6|||
156978395|NCT01336634|566675673|FG000|Overall Study|Lost to Follow-up|2|||
156978396|NCT01336634|566675674|FG001|Overall Study|Lost to Follow-up|1|||
156978397|NCT01336634|566675675|FG002|Overall Study|Lost to Follow-up|1|||
156978398|NCT01336634|566675673|FG000|Overall Study|Physician Decision|1|||
156978399|NCT01336634|566675674|FG001|Overall Study|Physician Decision|1|||
156978400|NCT01336634|566675675|FG002|Overall Study|Physician Decision|0|||
156978401|NCT01336634|566675673|FG000|Overall Study|Withdrawal by Subject|6|||
156978402|NCT01336634|566675674|FG001|Overall Study|Withdrawal by Subject|0|||
156978403|NCT01336634|566675675|FG002|Overall Study|Withdrawal by Subject|2|||
156978404|NCT01863043|566675676|FG000|Overall Study|Death|6|||
156978405|NCT01863043|566675677|FG001|Overall Study|Death|1|||
156978406|NCT01863043|566675676|FG000|Overall Study|Withdrawal by Subject|0|||
156978407|NCT01863043|566675677|FG001|Overall Study|Withdrawal by Subject|2|||
156978408|NCT01863043|566675676|FG000|Overall Study|Adverse Event|7|||
156978409|NCT01863043|566675677|FG001|Overall Study|Adverse Event|8|||
156978410|NCT01863043|566675676|FG000|Overall Study|exclusion criteria found after enrollment|0|||
156978411|NCT01863043|566675677|FG001|Overall Study|exclusion criteria found after enrollment|1|||
156978412|NCT00854295|566675680|FG000|Overall Study|Death|7|||
156978413|NCT00854295|566675681|FG001|Overall Study|Death|0|||
156978414|NCT00854295|566675682|FG002|Overall Study|Death|1|||
156978415|NCT00854295|566675683|FG003|Overall Study|Death|1|||
156978416|NCT00854295|566675680|FG000|Overall Study|Adverse Event|6|||
156978417|NCT00854295|566675681|FG001|Overall Study|Adverse Event|1|||
156978418|NCT00854295|566675682|FG002|Overall Study|Adverse Event|1|||
156978419|NCT00854295|566675683|FG003|Overall Study|Adverse Event|3|||
156978420|NCT00854295|566675680|FG000|Overall Study|Lost to Follow-up|18|||
156978421|NCT00854295|566675681|FG001|Overall Study|Lost to Follow-up|5|||
156978422|NCT00854295|566675682|FG002|Overall Study|Lost to Follow-up|21|||
156978423|NCT00854295|566675683|FG003|Overall Study|Lost to Follow-up|21|||
156978424|NCT00854295|566675680|FG000|Overall Study|Physician Decision|10|||
156978425|NCT00854295|566675681|FG001|Overall Study|Physician Decision|0|||
156978426|NCT00854295|566675682|FG002|Overall Study|Physician Decision|0|||
156978427|NCT00854295|566675683|FG003|Overall Study|Physician Decision|0|||
156978428|NCT02440594|566675687|FG000|Overall Study|Lost to Follow-up|34|||
156978429|NCT02440594|566675688|FG001|Overall Study|Lost to Follow-up|33|||
156978430|NCT02440594|566675689|FG002|Overall Study|Lost to Follow-up|54|||
156978431|NCT02440594|566675690|FG003|Overall Study|Lost to Follow-up|47|||
156978432|NCT02440594|566675691|FG004|Overall Study|Lost to Follow-up|5|||
156978433|NCT02440594|566675692|FG005|Overall Study|Lost to Follow-up|4|||
156978434|NCT02440594|566675693|FG006|Overall Study|Lost to Follow-up|28|||
156978435|NCT02440594|566675694|FG007|Overall Study|Lost to Follow-up|48|||
156978436|NCT02440594|566675687|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
156978437|NCT02440594|566675688|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
156978438|NCT02440594|566675689|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
156978439|NCT02440594|566675690|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
156978440|NCT02440594|566675691|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
156978441|NCT02440594|566675692|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
156978442|NCT02440594|566675693|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
156978443|NCT02440594|566675694|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
156978444|NCT02440594|566675687|FG000|Overall Study|Withdrawal by Subject|81|||
156978445|NCT02440594|566675688|FG001|Overall Study|Withdrawal by Subject|67|||
156978446|NCT02440594|566675689|FG002|Overall Study|Withdrawal by Subject|59|||
156978447|NCT02440594|566675690|FG003|Overall Study|Withdrawal by Subject|38|||
156978448|NCT02440594|566675691|FG004|Overall Study|Withdrawal by Subject|2|||
156978449|NCT02440594|566675692|FG005|Overall Study|Withdrawal by Subject|2|||
156978450|NCT02440594|566675693|FG006|Overall Study|Withdrawal by Subject|7|||
156978451|NCT02440594|566675694|FG007|Overall Study|Withdrawal by Subject|7|||
156978452|NCT02440594|566675687|FG000|Overall Study|Administratively w/drawn|3|||
156978453|NCT02440594|566675688|FG001|Overall Study|Administratively w/drawn|2|||
156978454|NCT02440594|566675689|FG002|Overall Study|Administratively w/drawn|0|||
156978455|NCT02440594|566675690|FG003|Overall Study|Administratively w/drawn|0|||
156978456|NCT02440594|566675691|FG004|Overall Study|Administratively w/drawn|0|||
156978457|NCT02440594|566675692|FG005|Overall Study|Administratively w/drawn|0|||
156978458|NCT02440594|566675693|FG006|Overall Study|Administratively w/drawn|2|||
156978459|NCT02440594|566675694|FG007|Overall Study|Administratively w/drawn|1|||
156978460|NCT04250337|566675695|FG000|Overall Study|Adverse Event|0|||
156978461|NCT04250337|566675696|FG001|Overall Study|Adverse Event|3|||
156978462|NCT04250337|566675695|FG000|Overall Study|Lack of Efficacy|1|||
156978463|NCT04250337|566675696|FG001|Overall Study|Lack of Efficacy|3|||
156978464|NCT04250337|566675695|FG000|Overall Study|Physician Decision|1|||
156978465|NCT04250337|566675696|FG001|Overall Study|Physician Decision|0|||
156978466|NCT04250337|566675695|FG000|Overall Study|Protocol Deviation|2|||
156978467|NCT04250337|566675696|FG001|Overall Study|Protocol Deviation|2|||
156978468|NCT04250337|566675695|FG000|Overall Study|Withdrawal by Subject|4|||
156978469|NCT04250337|566675696|FG001|Overall Study|Withdrawal by Subject|3|||
156978470|NCT01129336|566675697|FG000|Overall Study|Protocol Violation|1|||
156978471|NCT01129336|566675698|FG001|Overall Study|Protocol Violation|0|||
156978472|NCT01129336|566675697|FG000|Overall Study|Disease Progression|1|||
156978473|NCT01129336|566675698|FG001|Overall Study|Disease Progression|4|||
156978474|NCT01129336|566675697|FG000|Overall Study|Lost to Follow-up|1|||
156978475|NCT01129336|566675698|FG001|Overall Study|Lost to Follow-up|0|||
156978476|NCT01129336|566675697|FG000|Overall Study|Withdrawal by Subject|7|||
156978477|NCT01129336|566675698|FG001|Overall Study|Withdrawal by Subject|4|||
156978478|NCT01129336|566675697|FG000|Overall Study|Adverse Event|0|||
156978479|NCT01129336|566675698|FG001|Overall Study|Adverse Event|1|||
156978480|NCT01129336|566675697|FG000|Overall Study|Missing Study Completion Status|2|||
156978481|NCT01129336|566675698|FG001|Overall Study|Missing Study Completion Status|3|||
156978482|NCT01129336|566675697|FG000|Overall Study|Death|0|||
156978483|NCT01129336|566675698|FG001|Overall Study|Death|4|||
156978484|NCT00152763|566675699|FG000|Overall Study|Death|4|||
156978485|NCT00152763|566675700|FG001|Overall Study|Death|1|||
156978486|NCT00152763|566675701|FG002|Overall Study|Death|2|||
156978487|NCT00152763|566675702|FG003|Overall Study|Death|1|||
156978488|NCT00152763|566675699|FG000|Overall Study|Lost to Follow-up|6|||
156978489|NCT00152763|566675700|FG001|Overall Study|Lost to Follow-up|4|||
156978490|NCT00152763|566675701|FG002|Overall Study|Lost to Follow-up|2|||
156978491|NCT00152763|566675702|FG003|Overall Study|Lost to Follow-up|13|||
156978492|NCT04668989|566675705|FG000|First Intervention|Covid-19 related self-isolation|0|||
156978493|NCT04668989|566675706|FG001|First Intervention|Covid-19 related self-isolation|1|||
156978494|NCT04668989|566675705|FG000|Second Intervention|Adverse Event|0|||
156978495|NCT04668989|566675706|FG001|Second Intervention|Adverse Event|1|||
156978496|NCT01993823|566675707|FG000|Overall Study|Requested by the patient|6|||
156978497|NCT01993823|566675708|FG001|Overall Study|Requested by the patient|11|||
156978498|NCT01993823|566675707|FG000|Overall Study|Protocol Violation|0|||
156978499|NCT01993823|566675708|FG001|Overall Study|Protocol Violation|1|||
156978500|NCT01993823|566675707|FG000|Overall Study|Lost to Follow-up|1|||
156978501|NCT01993823|566675708|FG001|Overall Study|Lost to Follow-up|4|||
156978502|NCT01622348|566675710|FG000|Overall Study|Withdrawal by Subject|1|||
156978503|NCT01622348|566675711|FG001|Overall Study|Withdrawal by Subject|0|||
156978504|NCT01622348|566675712|FG002|Overall Study|Withdrawal by Subject|1|||
156978505|NCT00791921|566675713|FG000|Overall Study|Protocol planed|24|||
156978506|NCT00791921|566675714|FG001|Overall Study|Protocol planed|88|||
156978507|NCT00791921|566675713|FG000|Overall Study|Withdrawal by Subject|1|||
156978508|NCT00791921|566675714|FG001|Overall Study|Withdrawal by Subject|2|||
156978509|NCT00791921|566675713|FG000|Overall Study|Adverse Event|8|||
156978510|NCT00791921|566675714|FG001|Overall Study|Adverse Event|2|||
156978511|NCT00791921|566675713|FG000|Overall Study|Lack of Efficacy|0|||
156978512|NCT00791921|566675714|FG001|Overall Study|Lack of Efficacy|2|||
156978513|NCT00791921|566675713|FG000|Overall Study|Lack of study drug administration|1|||
156978514|NCT00791921|566675714|FG001|Overall Study|Lack of study drug administration|1|||
156978515|NCT00791921|566675713|FG000|Overall Study|Reason other than those above|0|||
156978516|NCT00791921|566675714|FG001|Overall Study|Reason other than those above|1|||
156978517|NCT00474175|566675717|FG000|Overall Study|Lack of Efficacy|0|||
156978518|NCT00474175|566675718|FG001|Overall Study|Lack of Efficacy|0|||
156978519|NCT00474175|566675719|FG002|Overall Study|Lack of Efficacy|1|||
156978520|NCT00474175|566675717|FG000|Overall Study|Withdrawal by Subject|0|||
156978521|NCT00474175|566675718|FG001|Overall Study|Withdrawal by Subject|1|||
156978522|NCT00474175|566675719|FG002|Overall Study|Withdrawal by Subject|1|||
156978523|NCT00474175|566675717|FG000|Overall Study|Ineligible|1|||
156978524|NCT00474175|566675718|FG001|Overall Study|Ineligible|3|||
156978525|NCT00474175|566675719|FG002|Overall Study|Ineligible|1|||
156978526|NCT00474175|566675717|FG000|Overall Study|Protocol Violation|0|||
156978527|NCT00474175|566675718|FG001|Overall Study|Protocol Violation|2|||
156978528|NCT00474175|566675719|FG002|Overall Study|Protocol Violation|1|||
156978529|NCT00474175|566675717|FG000|Overall Study|Administrative|0|||
156978530|NCT00474175|566675718|FG001|Overall Study|Administrative|1|||
156978531|NCT00474175|566675719|FG002|Overall Study|Administrative|0|||
156978532|NCT00467142|566675720|FG000|Overall Study|Withdrawal by Subject|1|||
156978533|NCT00467142|566675720|FG000|Overall Study|Adverse Event|1|||
156978534|NCT00467142|566675720|FG000|Overall Study|Protocol Violation|1|||
156978535|NCT01619787|566675721|FG000|Overall Study|Lost to Follow-up|5|||
156978536|NCT04537897|566675722|FG000|Overall Study|Other than listed|0|||
156978537|NCT04537897|566675723|FG001|Overall Study|Other than listed|0|||
156978538|NCT04537897|566675724|FG002|Overall Study|Other than listed|0|||
156978539|NCT04537897|566675725|FG003|Overall Study|Other than listed|0|||
156978540|NCT04537897|566675726|FG004|Overall Study|Other than listed|0|||
156978541|NCT04537897|566675727|FG005|Overall Study|Other than listed|0|||
156978542|NCT04537897|566675728|FG006|Overall Study|Other than listed|1|||
156978543|NCT04537897|566675729|FG007|Overall Study|Other than listed|0|||
156978544|NCT04537897|566675730|FG008|Overall Study|Other than listed|0|||
156978545|NCT04537897|566675722|FG000|Overall Study|Adverse Event|0|||
156978546|NCT04537897|566675723|FG001|Overall Study|Adverse Event|0|||
156978547|NCT04537897|566675724|FG002|Overall Study|Adverse Event|0|||
156978548|NCT04537897|566675725|FG003|Overall Study|Adverse Event|1|||
156978549|NCT04537897|566675726|FG004|Overall Study|Adverse Event|0|||
156978550|NCT04537897|566675727|FG005|Overall Study|Adverse Event|0|||
156978551|NCT04537897|566675728|FG006|Overall Study|Adverse Event|0|||
156978552|NCT04537897|566675729|FG007|Overall Study|Adverse Event|0|||
156978553|NCT04537897|566675730|FG008|Overall Study|Adverse Event|0|||
156978554|NCT04537897|566675722|FG000|Overall Study|Withdrawal by Subject|0|||
156978555|NCT04537897|566675723|FG001|Overall Study|Withdrawal by Subject|1|||
156978556|NCT04537897|566675724|FG002|Overall Study|Withdrawal by Subject|0|||
156978557|NCT04537897|566675725|FG003|Overall Study|Withdrawal by Subject|0|||
156978558|NCT04537897|566675726|FG004|Overall Study|Withdrawal by Subject|0|||
156978559|NCT04537897|566675727|FG005|Overall Study|Withdrawal by Subject|0|||
156978560|NCT04537897|566675728|FG006|Overall Study|Withdrawal by Subject|0|||
156978561|NCT04537897|566675729|FG007|Overall Study|Withdrawal by Subject|0|||
156978562|NCT04537897|566675730|FG008|Overall Study|Withdrawal by Subject|0|||
156978563|NCT00197028|566675737|FG000|Overall Study|Adverse Event|2|||
156978564|NCT00197028|566675738|FG001|Overall Study|Adverse Event|2|||
156978565|NCT00197028|566675737|FG000|Overall Study|Protocol Violation|2|||
156978566|NCT00197028|566675738|FG001|Overall Study|Protocol Violation|1|||
156978567|NCT00197028|566675737|FG000|Overall Study|Withdrawal by Subject|8|||
156978568|NCT00197028|566675738|FG001|Overall Study|Withdrawal by Subject|12|||
156978569|NCT00197028|566675737|FG000|Overall Study|Lost to Follow-up|1|||
156978570|NCT00197028|566675738|FG001|Overall Study|Lost to Follow-up|0|||
156978571|NCT00197028|566675737|FG000|Overall Study|Other|3|||
156978572|NCT00197028|566675738|FG001|Overall Study|Other|6|||
156978573|NCT00178256|566675739|FG000|Overall Study|Adverse Event|2|||
156978574|NCT00178256|566675740|FG001|Overall Study|Adverse Event|0|||
156978575|NCT00178256|566675741|FG002|Overall Study|Adverse Event|0|||
156978576|NCT00178256|566675742|FG003|Overall Study|Adverse Event|0|||
156978577|NCT00178256|566675739|FG000|Overall Study|Death|0|||
156978578|NCT00178256|566675740|FG001|Overall Study|Death|1|||
156978579|NCT00178256|566675741|FG002|Overall Study|Death|0|||
156978580|NCT00178256|566675742|FG003|Overall Study|Death|1|||
156978581|NCT00178256|566675739|FG000|Overall Study|Cancer progression|2|||
156978582|NCT00178256|566675740|FG001|Overall Study|Cancer progression|0|||
156978583|NCT00178256|566675741|FG002|Overall Study|Cancer progression|0|||
156978584|NCT00178256|566675742|FG003|Overall Study|Cancer progression|1|||
156978585|NCT01763788|566675743|FG000|Overall Study|Lost to Follow-up|0|||
156978586|NCT01763788|566675744|FG001|Overall Study|Lost to Follow-up|0|||
156978587|NCT01763788|566675745|FG002|Overall Study|Lost to Follow-up|1|||
156978588|NCT01763788|566675746|FG003|Overall Study|Lost to Follow-up|0|||
156978589|NCT03303469|566675747|FG000|Overall Study|Lost to Follow-up|2|||
156978590|NCT04488003|566675753|FG000|Assessed for Eligibility|Screen Failure|24|||
156978591|NCT04488003|566675754|FG001|Assessed for Eligibility|Screen Failure|0|||
156978592|NCT04488003|566675755|FG002|Assessed for Eligibility|Screen Failure|0|||
156978593|NCT04488003|566675753|FG000|Assessed for Eligibility|Adverse Event|1|||
156978594|NCT04488003|566675754|FG001|Assessed for Eligibility|Adverse Event|0|||
156978595|NCT04488003|566675755|FG002|Assessed for Eligibility|Adverse Event|0|||
157093219|NCT01768637|567095883|FG001|Overall Study|Lost to Follow-up|7|||
156978596|NCT04488003|566675753|FG000|Assessed for Eligibility|Death|1|||
156978597|NCT04488003|566675754|FG001|Assessed for Eligibility|Death|0|||
156978598|NCT04488003|566675755|FG002|Assessed for Eligibility|Death|0|||
156978599|NCT04488003|566675753|FG000|Assessed for Eligibility|Physician Decision|1|||
156978600|NCT04488003|566675754|FG001|Assessed for Eligibility|Physician Decision|0|||
156978601|NCT04488003|566675755|FG002|Assessed for Eligibility|Physician Decision|0|||
156978602|NCT04488003|566675753|FG000|Allocated to Treatment|Progressive Disease|51|||
156978603|NCT04488003|566675754|FG001|Allocated to Treatment|Progressive Disease|0|||
156978604|NCT04488003|566675755|FG002|Allocated to Treatment|Progressive Disease|0|||
156978605|NCT04488003|566675753|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
156978606|NCT04488003|566675754|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
156978607|NCT04488003|566675755|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
156978608|NCT04488003|566675753|FG000|Allocated to Treatment|Adverse Event|6|||
156978609|NCT04488003|566675754|FG001|Allocated to Treatment|Adverse Event|0|||
156978610|NCT04488003|566675755|FG002|Allocated to Treatment|Adverse Event|0|||
156978611|NCT04488003|566675753|FG000|Allocated to Treatment|Other|5|||
156978612|NCT04488003|566675754|FG001|Allocated to Treatment|Other|0|||
156978613|NCT04488003|566675755|FG002|Allocated to Treatment|Other|0|||
156978614|NCT04488003|566675753|FG000|Allocated to Treatment|Physician Decision|4|||
156978615|NCT04488003|566675754|FG001|Allocated to Treatment|Physician Decision|0|||
156978616|NCT04488003|566675755|FG002|Allocated to Treatment|Physician Decision|0|||
156978617|NCT04488003|566675753|FG000|Allocated to Treatment|Death|4|||
156978618|NCT04488003|566675754|FG001|Allocated to Treatment|Death|0|||
156978619|NCT04488003|566675755|FG002|Allocated to Treatment|Death|0|||
156978620|NCT01737996|566675756|FG000|Overall Study|Adverse Event|0|||
156978621|NCT01737996|566675757|FG001|Overall Study|Adverse Event|1|||
156978622|NCT01737996|566675758|FG002|Overall Study|Adverse Event|1|||
156978623|NCT01737996|566675756|FG000|Overall Study|Withdrawal by Subject|0|||
156978624|NCT01737996|566675757|FG001|Overall Study|Withdrawal by Subject|0|||
156978625|NCT01737996|566675758|FG002|Overall Study|Withdrawal by Subject|1|||
156978626|NCT01248962|566675761|FG000|Overall Study|Withdrawal by Subject|1|||
156978627|NCT01248962|566675762|FG001|Overall Study|Withdrawal by Subject|1|||
156978628|NCT01248962|566675761|FG000|Overall Study|Adverse Event|2|||
156978629|NCT01248962|566675762|FG001|Overall Study|Adverse Event|1|||
156978630|NCT01248962|566675761|FG000|Overall Study|Complete Response after 4 Cycles|1|||
156978631|NCT01248962|566675762|FG001|Overall Study|Complete Response after 4 Cycles|0|||
156978632|NCT01248962|566675761|FG000|Overall Study|Complete Response after 3 Cycles|0|||
156978633|NCT01248962|566675762|FG001|Overall Study|Complete Response after 3 Cycles|1|||
156978634|NCT01248962|566675761|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
156978635|NCT01248962|566675762|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
156978636|NCT00245856|566675764|FG000|Period Two|Withdrawal by Subject|0|||
156978637|NCT00245856|566675765|FG001|Period Two|Withdrawal by Subject|1|||
156978638|NCT01003184|566675766|FG000|Overall Study|Adverse Event|12|||
156978639|NCT01003184|566675767|FG001|Overall Study|Adverse Event|5|||
156978640|NCT01003184|566675766|FG000|Overall Study|Lost to Follow-up|1|||
156978641|NCT01003184|566675767|FG001|Overall Study|Lost to Follow-up|0|||
156978642|NCT01003184|566675766|FG000|Overall Study|Loss of glucose control|1|||
156978643|NCT01003184|566675767|FG001|Overall Study|Loss of glucose control|1|||
156978644|NCT01003184|566675766|FG000|Overall Study|Protocol Violation|3|||
156978645|NCT01003184|566675767|FG001|Overall Study|Protocol Violation|0|||
156978646|NCT01003184|566675766|FG000|Overall Study|Withdrawal by Subject|1|||
156978647|NCT01003184|566675767|FG001|Overall Study|Withdrawal by Subject|6|||
156978648|NCT01003184|566675766|FG000|Overall Study|Physician Decision|1|||
156978649|NCT01003184|566675767|FG001|Overall Study|Physician Decision|0|||
156978650|NCT00557622|566675768|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
156978651|NCT00557622|566675769|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
156978652|NCT00557622|566675768|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
156978653|NCT00557622|566675769|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
156978654|NCT00557622|566675768|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
156978655|NCT00557622|566675769|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
156978656|NCT01468922|566675770|FG000|Overall Study|Screening failure|0|||
156978657|NCT01468922|566675771|FG001|Overall Study|Screening failure|0|||
156978658|NCT01468922|566675772|FG002|Overall Study|Screening failure|0|||
156978659|NCT01468922|566675773|FG003|Overall Study|Screening failure|0|||
156978660|NCT01468922|566675774|FG004|Overall Study|Screening failure|0|||
156978661|NCT01468922|566675775|FG005|Overall Study|Screening failure|0|||
156978662|NCT01468922|566675776|FG006|Overall Study|Screening failure|0|||
156978663|NCT01468922|566675777|FG007|Overall Study|Screening failure|0|||
156978664|NCT01468922|566675778|FG008|Overall Study|Screening failure|1|||
156978665|NCT01468922|566675770|FG000|Overall Study|Per patient choice|1|||
156978666|NCT01468922|566675771|FG001|Overall Study|Per patient choice|0|||
156978667|NCT01468922|566675772|FG002|Overall Study|Per patient choice|0|||
156978668|NCT01468922|566675773|FG003|Overall Study|Per patient choice|0|||
156978669|NCT01468922|566675774|FG004|Overall Study|Per patient choice|0|||
156978670|NCT01468922|566675775|FG005|Overall Study|Per patient choice|0|||
156978671|NCT01468922|566675776|FG006|Overall Study|Per patient choice|0|||
156978672|NCT01468922|566675777|FG007|Overall Study|Per patient choice|0|||
156978673|NCT01468922|566675778|FG008|Overall Study|Per patient choice|0|||
156978674|NCT01468922|566675770|FG000|Overall Study|Switched to alternative treatment|1|||
156978675|NCT01468922|566675771|FG001|Overall Study|Switched to alternative treatment|0|||
156978676|NCT01468922|566675772|FG002|Overall Study|Switched to alternative treatment|0|||
156978677|NCT01468922|566675773|FG003|Overall Study|Switched to alternative treatment|0|||
156978678|NCT01468922|566675774|FG004|Overall Study|Switched to alternative treatment|1|||
156978679|NCT01468922|566675775|FG005|Overall Study|Switched to alternative treatment|0|||
156978680|NCT01468922|566675776|FG006|Overall Study|Switched to alternative treatment|0|||
156978681|NCT01468922|566675777|FG007|Overall Study|Switched to alternative treatment|0|||
156978682|NCT01468922|566675778|FG008|Overall Study|Switched to alternative treatment|0|||
156978683|NCT01468922|566675770|FG000|Overall Study|Enrolled on new protocol|0|||
156978684|NCT01468922|566675771|FG001|Overall Study|Enrolled on new protocol|0|||
156978685|NCT01468922|566675772|FG002|Overall Study|Enrolled on new protocol|0|||
156978686|NCT01468922|566675773|FG003|Overall Study|Enrolled on new protocol|0|||
156978687|NCT01468922|566675774|FG004|Overall Study|Enrolled on new protocol|1|||
156978688|NCT01468922|566675775|FG005|Overall Study|Enrolled on new protocol|0|||
156978689|NCT01468922|566675776|FG006|Overall Study|Enrolled on new protocol|0|||
156978690|NCT01468922|566675777|FG007|Overall Study|Enrolled on new protocol|0|||
156978691|NCT01468922|566675778|FG008|Overall Study|Enrolled on new protocol|0|||
156978692|NCT01468922|566675770|FG000|Overall Study|Adverse Event|0|||
156978693|NCT01468922|566675771|FG001|Overall Study|Adverse Event|0|||
156978694|NCT01468922|566675772|FG002|Overall Study|Adverse Event|0|||
156978695|NCT01468922|566675773|FG003|Overall Study|Adverse Event|0|||
156978696|NCT01468922|566675774|FG004|Overall Study|Adverse Event|0|||
156978697|NCT01468922|566675775|FG005|Overall Study|Adverse Event|0|||
156978698|NCT01468922|566675776|FG006|Overall Study|Adverse Event|0|||
156978699|NCT01468922|566675777|FG007|Overall Study|Adverse Event|1|||
156978700|NCT01468922|566675778|FG008|Overall Study|Adverse Event|0|||
156978701|NCT01468922|566675770|FG000|Overall Study|Infection of blood|0|||
156978702|NCT01468922|566675771|FG001|Overall Study|Infection of blood|0|||
156978703|NCT01468922|566675772|FG002|Overall Study|Infection of blood|0|||
156978704|NCT01468922|566675773|FG003|Overall Study|Infection of blood|0|||
156978705|NCT01468922|566675774|FG004|Overall Study|Infection of blood|0|||
156978706|NCT01468922|566675775|FG005|Overall Study|Infection of blood|0|||
156978707|NCT01468922|566675776|FG006|Overall Study|Infection of blood|0|||
156978708|NCT01468922|566675777|FG007|Overall Study|Infection of blood|1|||
156978709|NCT01468922|566675778|FG008|Overall Study|Infection of blood|0|||
156978710|NCT01468922|566675770|FG000|Overall Study|Patient choice - surgery|0|||
156978711|NCT01468922|566675771|FG001|Overall Study|Patient choice - surgery|0|||
156978712|NCT01468922|566675772|FG002|Overall Study|Patient choice - surgery|0|||
156978713|NCT01468922|566675773|FG003|Overall Study|Patient choice - surgery|0|||
156978714|NCT01468922|566675774|FG004|Overall Study|Patient choice - surgery|0|||
156978715|NCT01468922|566675775|FG005|Overall Study|Patient choice - surgery|0|||
156978716|NCT01468922|566675776|FG006|Overall Study|Patient choice - surgery|0|||
156978717|NCT01468922|566675777|FG007|Overall Study|Patient choice - surgery|1|||
156978718|NCT01468922|566675778|FG008|Overall Study|Patient choice - surgery|0|||
156978719|NCT01468922|566675770|FG000|Overall Study|Refused further treatment|0|||
156978720|NCT01468922|566675771|FG001|Overall Study|Refused further treatment|0|||
156978721|NCT01468922|566675772|FG002|Overall Study|Refused further treatment|0|||
156978722|NCT01468922|566675773|FG003|Overall Study|Refused further treatment|0|||
156978723|NCT01468922|566675774|FG004|Overall Study|Refused further treatment|0|||
156978724|NCT01468922|566675775|FG005|Overall Study|Refused further treatment|0|||
156978725|NCT01468922|566675776|FG006|Overall Study|Refused further treatment|0|||
156978726|NCT01468922|566675777|FG007|Overall Study|Refused further treatment|1|||
156978727|NCT01468922|566675778|FG008|Overall Study|Refused further treatment|0|||
156978728|NCT01923389|566675779|FG000|Overall Study|Protocol Violation|1|||
156978729|NCT01923389|566675780|FG001|Overall Study|Protocol Violation|0|||
156978730|NCT04848662|566675781|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
156978731|NCT04848662|566675782|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
156978732|NCT00007475|566675785|FG000|Overall Study|Withdrawal by Subject|1|||
156978733|NCT00007475|566675786|FG001|Overall Study|Withdrawal by Subject|0|||
156978734|NCT00007475|566675787|FG002|Overall Study|Withdrawal by Subject|0|||
156978735|NCT00007475|566675788|FG003|Overall Study|Withdrawal by Subject|0|||
156978736|NCT00007475|566675785|FG000|Overall Study|Adverse Event|3|||
156978737|NCT00007475|566675786|FG001|Overall Study|Adverse Event|0|||
156978738|NCT00007475|566675787|FG002|Overall Study|Adverse Event|0|||
156978739|NCT00007475|566675788|FG003|Overall Study|Adverse Event|0|||
156978740|NCT01719224|566675789|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
156978741|NCT01719224|566675790|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
156978742|NCT00258440|566675791|FG000|Overall Study|Withdrawal by Subject|0|||
156978743|NCT00258440|566675792|FG001|Overall Study|Withdrawal by Subject|0|||
156978744|NCT00258440|566675793|FG002|Overall Study|Withdrawal by Subject|1|||
156978745|NCT00737061|566675794|FG000|Waiting Period|Lost to Follow-up|6|||
156978746|NCT00737061|566675794|FG000|Waiting Period|Withdrawal by Subject|1|||
156978747|NCT00737061|566675794|FG000|Waiting Period|Bilateral placement failure|34|||
156978748|NCT00737061|566675794|FG000|Waiting Period|Deemed patent following HSG|26|||
156978749|NCT00737061|566675794|FG000|Waiting Period|Alternative contraception failure|3|||
156978750|NCT00737061|566675794|FG000|Waiting Period|Elected surgical tubal ligation|5|||
156978751|NCT00737061|566675794|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
157021582|NCT04610892|566830907|FG004|Overall Study|Adverse Event|3|||
156978752|NCT00737061|566675794|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
156978753|NCT00737061|566675794|FG000|1 Year Wearing Period|Discontinued reilance|3|||
156978754|NCT00737061|566675794|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
156978755|NCT05266963|566675795|FG000|Drug Period A|Withdrawal by Subject|0|||
156978756|NCT05266963|566675796|FG001|Drug Period A|Withdrawal by Subject|1|||
156978757|NCT04091360|566675797|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978758|NCT04091360|566675798|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978759|NCT04091360|566675799|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978760|NCT04091360|566675800|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978761|NCT04091360|566675801|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978762|NCT04091360|566675802|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978763|NCT04091360|566675803|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978764|NCT04091360|566675804|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
156978765|NCT04091360|566675805|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
156978766|NCT04091360|566675806|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
156978767|NCT04091360|566675797|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978768|NCT04091360|566675798|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978769|NCT04091360|566675799|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978770|NCT04091360|566675800|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978771|NCT04091360|566675801|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978772|NCT04091360|566675802|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978773|NCT04091360|566675803|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
156978774|NCT04091360|566675804|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
156978775|NCT04091360|566675805|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978776|NCT04091360|566675806|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
156978777|NCT04091360|566675797|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978778|NCT04091360|566675798|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978779|NCT04091360|566675799|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978780|NCT04091360|566675800|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978781|NCT04091360|566675801|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978782|NCT04091360|566675802|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978783|NCT04091360|566675803|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
156978784|NCT04091360|566675804|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978785|NCT04091360|566675805|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
156978786|NCT04091360|566675806|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
156978787|NCT00692406|566675807|FG000|Overall Study|PI dropped, bad data|57|||
156978788|NCT02597933|566675808|FG000|Overall Study|Withdrawal by Subject|7|||
156978789|NCT02597933|566675809|FG001|Overall Study|Withdrawal by Subject|5|||
156978790|NCT02597933|566675808|FG000|Overall Study|Protocol Violation|2|||
156978791|NCT02597933|566675809|FG001|Overall Study|Protocol Violation|2|||
156978792|NCT02597933|566675808|FG000|Overall Study|Adverse Event|20|||
156978793|NCT02597933|566675809|FG001|Overall Study|Adverse Event|28|||
156978794|NCT02597933|566675808|FG000|Overall Study|Not treated|2|||
156978795|NCT02597933|566675809|FG001|Overall Study|Not treated|2|||
156978796|NCT02597933|566675808|FG000|Overall Study|Other than stated above|7|||
156978797|NCT02597933|566675809|FG001|Overall Study|Other than stated above|14|||
156978798|NCT01320735|566675813|FG000|Overall Study|Adverse Event|3|||
156978799|NCT01320735|566675813|FG000|Overall Study|Withdrawal by Subject|3|||
156978800|NCT01320735|566675813|FG000|Overall Study|Lost to Follow-up|13|||
156978801|NCT01320735|566675813|FG000|Overall Study|Administrative Reason|6|||
156978802|NCT01320735|566675813|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
156978803|NCT01320735|566675813|FG000|Overall Study|Protocol Violation|1|||
156978804|NCT01320735|566675813|FG000|Overall Study|Other|1|||
156978805|NCT01320735|566675813|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
156978806|NCT01320735|566675813|FG000|Overall Study|Investigator Unable to be Contacted|17|||
156978807|NCT04599101|566675814|FG000|Overall Study|Lost to Follow-up|5|||
156978808|NCT04599101|566675815|FG001|Overall Study|Lost to Follow-up|5|||
156978809|NCT02234063|566675819|FG000|Overall Study|Lost to Follow-up|235|||
156978810|NCT02234063|566675820|FG001|Overall Study|Lost to Follow-up|42|||
156978811|NCT02234063|566675819|FG000|Overall Study|Withdrawal by Subject|20|||
156978812|NCT02234063|566675820|FG001|Overall Study|Withdrawal by Subject|1|||
156978813|NCT00886639|566675821|FG000|Overall Study|acute exacerbation|14|||
156978814|NCT00886639|566675821|FG000|Overall Study|non-compliance|2|||
156978815|NCT01871558|566675822|FG000|Overall Study|Other reason|0|||
156978816|NCT01871558|566675823|FG001|Overall Study|Other reason|1|||
156978817|NCT01871558|566675822|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
156978818|NCT01871558|566675823|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
156978819|NCT01871558|566675822|FG000|Overall Study|Withdrawal by Subject|2|||
156978820|NCT01871558|566675823|FG001|Overall Study|Withdrawal by Subject|0|||
156978821|NCT00118898|566675824|FG000|Overall Study|Death|6|||
156978822|NCT00118898|566675825|FG001|Overall Study|Death|11|||
156978823|NCT00118898|566675826|FG002|Overall Study|Death|6|||
156978824|NCT00118898|566675827|FG003|Overall Study|Death|8|||
156978825|NCT00118898|566675824|FG000|Overall Study|Lost to Follow-up|26|||
156978826|NCT00118898|566675825|FG001|Overall Study|Lost to Follow-up|34|||
156978827|NCT00118898|566675826|FG002|Overall Study|Lost to Follow-up|33|||
156978828|NCT00118898|566675827|FG003|Overall Study|Lost to Follow-up|33|||
156978829|NCT00118898|566675824|FG000|Overall Study|Withdrawal by Subject|10|||
156978830|NCT00118898|566675825|FG001|Overall Study|Withdrawal by Subject|5|||
156978831|NCT00118898|566675826|FG002|Overall Study|Withdrawal by Subject|8|||
156978832|NCT00118898|566675827|FG003|Overall Study|Withdrawal by Subject|8|||
156978833|NCT00118898|566675824|FG000|Overall Study|Site Closure|33|||
156978834|NCT00118898|566675825|FG001|Overall Study|Site Closure|31|||
156978835|NCT00118898|566675826|FG002|Overall Study|Site Closure|28|||
156978836|NCT00118898|566675827|FG003|Overall Study|Site Closure|37|||
156978837|NCT00118898|566675824|FG000|Overall Study|Severe debilitation|1|||
156978838|NCT00118898|566675825|FG001|Overall Study|Severe debilitation|4|||
156978839|NCT00118898|566675826|FG002|Overall Study|Severe debilitation|6|||
156978840|NCT00118898|566675827|FG003|Overall Study|Severe debilitation|4|||
156978841|NCT00118898|566675824|FG000|Overall Study|Not compliant with requirements|11|||
156978842|NCT00118898|566675825|FG001|Overall Study|Not compliant with requirements|13|||
156978843|NCT00118898|566675826|FG002|Overall Study|Not compliant with requirements|11|||
156978844|NCT00118898|566675827|FG003|Overall Study|Not compliant with requirements|11|||
156978845|NCT00118898|566675824|FG000|Overall Study|Not able to get to clinic|34|||
156978846|NCT00118898|566675825|FG001|Overall Study|Not able to get to clinic|43|||
156978847|NCT00118898|566675826|FG002|Overall Study|Not able to get to clinic|31|||
156978848|NCT00118898|566675827|FG003|Overall Study|Not able to get to clinic|40|||
156978849|NCT01338012|566675830|FG000|Overall Study|Death|4|||
156978850|NCT01338012|566675830|FG000|Overall Study|Study terminated|4|||
156978851|NCT02714205|566675831|FG000|Overall Study|Cannot tolerate medication|1|||
156978852|NCT02714205|566675832|FG001|Overall Study|Cannot tolerate medication|0|||
156978853|NCT02714205|566675831|FG000|Overall Study|Adverse Event|2|||
156978854|NCT02714205|566675832|FG001|Overall Study|Adverse Event|0|||
156978855|NCT02714205|566675831|FG000|Overall Study|Too busy|1|||
156978856|NCT02714205|566675832|FG001|Overall Study|Too busy|0|||
156978857|NCT02714205|566675831|FG000|Overall Study|Incomplete outcome data|0|||
156978858|NCT02714205|566675832|FG001|Overall Study|Incomplete outcome data|1|||
156978859|NCT02089230|566675833|FG000|Overall Study|Death|0|||
156978860|NCT02089230|566675834|FG001|Overall Study|Death|0|||
156978861|NCT02089230|566675835|FG002|Overall Study|Death|2|||
156978862|NCT02089230|566675833|FG000|Overall Study|Seeking Alternative Therapy|0|||
156978863|NCT02089230|566675834|FG001|Overall Study|Seeking Alternative Therapy|0|||
156978864|NCT02089230|566675835|FG002|Overall Study|Seeking Alternative Therapy|4|||
156978865|NCT03813147|566675836|FG000|Overall Study|Lack of Efficacy|4|||
156978866|NCT03813147|566675837|FG001|Overall Study|Lack of Efficacy|4|||
156978867|NCT03813147|566675836|FG000|Overall Study|Physician Decision|2|||
156978868|NCT03813147|566675837|FG001|Overall Study|Physician Decision|1|||
156978869|NCT02781506|566677183|FG000|Overall Study|Adverse Event|5|||
156978870|NCT00437125|566677184|FG000|Overall Study|Adverse Event|12|||
156978871|NCT00437125|566677184|FG000|Overall Study|Death|1|||
156978872|NCT00437125|566677184|FG000|Overall Study|Clinical Relapse|1|||
156978873|NCT00437125|566677184|FG000|Overall Study|Lack of Efficacy|1|||
156978874|NCT00437125|566677184|FG000|Overall Study|Lost to Follow-up|1|||
156978875|NCT00437125|566677184|FG000|Overall Study|Withdrawal by Subject|13|||
156978876|NCT00437125|566677184|FG000|Overall Study|Withdrawal by Caregiver|2|||
156978877|NCT00437125|566677184|FG000|Overall Study|Physician Decision|1|||
156978878|NCT04651114|566677189|FG000|Overall Study|Withdrawal by Subject|8|||
156978879|NCT00235443|566677194|FG000|Overall Study|Adverse Event|4|||
156978880|NCT00235443|566677195|FG001|Overall Study|Adverse Event|12|||
156978881|NCT00235443|566677196|FG002|Overall Study|Adverse Event|17|||
156978882|NCT00235443|566677197|FG003|Overall Study|Adverse Event|44|||
156978883|NCT00235443|566677198|FG004|Overall Study|Adverse Event|10|||
156978884|NCT00235443|566677199|FG005|Overall Study|Adverse Event|15|||
156978885|NCT00235443|566677194|FG000|Overall Study|Lack of Efficacy|0|||
156978886|NCT00235443|566677195|FG001|Overall Study|Lack of Efficacy|1|||
156978887|NCT00235443|566677196|FG002|Overall Study|Lack of Efficacy|5|||
156978888|NCT00235443|566677197|FG003|Overall Study|Lack of Efficacy|12|||
156978889|NCT00235443|566677198|FG004|Overall Study|Lack of Efficacy|2|||
156978890|NCT00235443|566677199|FG005|Overall Study|Lack of Efficacy|9|||
156978891|NCT00235443|566677194|FG000|Overall Study|Withdrawal by Subject|3|||
156978892|NCT00235443|566677195|FG001|Overall Study|Withdrawal by Subject|9|||
156978893|NCT00235443|566677196|FG002|Overall Study|Withdrawal by Subject|25|||
156978894|NCT00235443|566677197|FG003|Overall Study|Withdrawal by Subject|24|||
156978895|NCT00235443|566677198|FG004|Overall Study|Withdrawal by Subject|10|||
156978896|NCT00235443|566677199|FG005|Overall Study|Withdrawal by Subject|12|||
156978897|NCT00235443|566677194|FG000|Overall Study|Lost to Follow-up|0|||
156978898|NCT00235443|566677195|FG001|Overall Study|Lost to Follow-up|8|||
156978899|NCT00235443|566677196|FG002|Overall Study|Lost to Follow-up|6|||
156978900|NCT00235443|566677197|FG003|Overall Study|Lost to Follow-up|6|||
156978901|NCT00235443|566677198|FG004|Overall Study|Lost to Follow-up|4|||
156978902|NCT00235443|566677199|FG005|Overall Study|Lost to Follow-up|3|||
156978903|NCT00235443|566677194|FG000|Overall Study|Unsatisfactory compliance|0|||
156978904|NCT00235443|566677195|FG001|Overall Study|Unsatisfactory compliance|2|||
156978905|NCT00235443|566677196|FG002|Overall Study|Unsatisfactory compliance|3|||
156978906|NCT00235443|566677197|FG003|Overall Study|Unsatisfactory compliance|4|||
156978907|NCT00235443|566677198|FG004|Overall Study|Unsatisfactory compliance|1|||
156978908|NCT00235443|566677199|FG005|Overall Study|Unsatisfactory compliance|0|||
156978909|NCT00235443|566677194|FG000|Overall Study|Other reasons for premature termination|1|||
156978910|NCT00235443|566677195|FG001|Overall Study|Other reasons for premature termination|6|||
156978911|NCT00235443|566677196|FG002|Overall Study|Other reasons for premature termination|6|||
156978912|NCT00235443|566677197|FG003|Overall Study|Other reasons for premature termination|7|||
156978913|NCT00235443|566677198|FG004|Overall Study|Other reasons for premature termination|3|||
156978914|NCT00235443|566677199|FG005|Overall Study|Other reasons for premature termination|6|||
156978915|NCT02318719|566677202|FG000|Double-blind Phase|Adverse Event|7|||
156978916|NCT02318719|566677203|FG001|Double-blind Phase|Adverse Event|6|||
156978917|NCT02318719|566677204|FG002|Double-blind Phase|Adverse Event|12|||
156978918|NCT02318719|566677205|FG003|Double-blind Phase|Adverse Event|4|||
156978919|NCT02318719|566677206|FG004|Double-blind Phase|Adverse Event|0|||
156978920|NCT02318719|566677202|FG000|Double-blind Phase|Lack of Efficacy|5|||
156978921|NCT02318719|566677203|FG001|Double-blind Phase|Lack of Efficacy|0|||
156978922|NCT02318719|566677204|FG002|Double-blind Phase|Lack of Efficacy|1|||
156978923|NCT02318719|566677205|FG003|Double-blind Phase|Lack of Efficacy|1|||
156978924|NCT02318719|566677206|FG004|Double-blind Phase|Lack of Efficacy|0|||
156978925|NCT02318719|566677202|FG000|Double-blind Phase|Protocol Violation|0|||
156978926|NCT02318719|566677203|FG001|Double-blind Phase|Protocol Violation|1|||
156978927|NCT02318719|566677204|FG002|Double-blind Phase|Protocol Violation|3|||
156978928|NCT02318719|566677205|FG003|Double-blind Phase|Protocol Violation|0|||
156978929|NCT02318719|566677206|FG004|Double-blind Phase|Protocol Violation|0|||
156978930|NCT02318719|566677202|FG000|Double-blind Phase|Withdrawal by Subject|25|||
156978931|NCT02318719|566677203|FG001|Double-blind Phase|Withdrawal by Subject|7|||
156978932|NCT02318719|566677204|FG002|Double-blind Phase|Withdrawal by Subject|9|||
156978933|NCT02318719|566677205|FG003|Double-blind Phase|Withdrawal by Subject|10|||
156978934|NCT02318719|566677206|FG004|Double-blind Phase|Withdrawal by Subject|0|||
156978935|NCT02318719|566677202|FG000|Double-blind Phase|Other|1|||
156978936|NCT02318719|566677203|FG001|Double-blind Phase|Other|2|||
156978937|NCT02318719|566677204|FG002|Double-blind Phase|Other|0|||
156978938|NCT02318719|566677205|FG003|Double-blind Phase|Other|0|||
156978939|NCT02318719|566677206|FG004|Double-blind Phase|Other|0|||
156978940|NCT02318719|566677202|FG000|Open-label Extension Phase|Adverse Event|0|||
156978941|NCT02318719|566677203|FG001|Open-label Extension Phase|Adverse Event|0|||
156978942|NCT02318719|566677204|FG002|Open-label Extension Phase|Adverse Event|0|||
156978943|NCT02318719|566677205|FG003|Open-label Extension Phase|Adverse Event|0|||
156978944|NCT02318719|566677206|FG004|Open-label Extension Phase|Adverse Event|15|||
156978945|NCT02318719|566677202|FG000|Open-label Extension Phase|Death|0|||
156978946|NCT02318719|566677203|FG001|Open-label Extension Phase|Death|0|||
156978947|NCT02318719|566677204|FG002|Open-label Extension Phase|Death|0|||
156978948|NCT02318719|566677205|FG003|Open-label Extension Phase|Death|0|||
156978949|NCT02318719|566677206|FG004|Open-label Extension Phase|Death|1|||
156978950|NCT02318719|566677202|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
156978951|NCT02318719|566677203|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156978952|NCT02318719|566677204|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
156978953|NCT02318719|566677205|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
156978954|NCT02318719|566677206|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
156978955|NCT02318719|566677202|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
156978956|NCT02318719|566677203|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
156978957|NCT02318719|566677204|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
156978958|NCT02318719|566677205|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
156978959|NCT02318719|566677206|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
156978960|NCT02318719|566677202|FG000|Open-label Extension Phase|Other|0|||
156978961|NCT02318719|566677203|FG001|Open-label Extension Phase|Other|0|||
156978962|NCT02318719|566677204|FG002|Open-label Extension Phase|Other|0|||
156978963|NCT02318719|566677205|FG003|Open-label Extension Phase|Other|0|||
156978964|NCT02318719|566677206|FG004|Open-label Extension Phase|Other|7|||
156978965|NCT00806624|566677207|FG000|Overall Study|Adverse Event|2|||
156978966|NCT00806624|566677208|FG001|Overall Study|Adverse Event|8|||
156978967|NCT00806624|566677209|FG002|Overall Study|Adverse Event|0|||
156978968|NCT00806624|566677207|FG000|Overall Study|Death|0|||
156978969|NCT00806624|566677208|FG001|Overall Study|Death|1|||
156978970|NCT00806624|566677209|FG002|Overall Study|Death|1|||
156978971|NCT00806624|566677207|FG000|Overall Study|Lost to Follow-up|1|||
156978972|NCT00806624|566677208|FG001|Overall Study|Lost to Follow-up|0|||
156978973|NCT00806624|566677209|FG002|Overall Study|Lost to Follow-up|1|||
156978974|NCT00806624|566677207|FG000|Overall Study|Withdrawal by Subject|6|||
156978975|NCT00806624|566677208|FG001|Overall Study|Withdrawal by Subject|3|||
156978976|NCT00806624|566677209|FG002|Overall Study|Withdrawal by Subject|3|||
156978977|NCT00806624|566677207|FG000|Overall Study|discontinued before start of treatment|0|||
156978978|NCT00806624|566677208|FG001|Overall Study|discontinued before start of treatment|0|||
156978979|NCT00806624|566677209|FG002|Overall Study|discontinued before start of treatment|1|||
156978980|NCT03093428|566677210|FG000|Overall Study|Not eligible for treatment|2|||
156978981|NCT03093428|566677211|FG001|Overall Study|Not eligible for treatment|1|||
156978982|NCT03093428|566677210|FG000|Overall Study|Progression|14|||
156978983|NCT03093428|566677211|FG001|Overall Study|Progression|4|||
156978984|NCT03093428|566677210|FG000|Overall Study|Death|1|||
156978985|NCT03093428|566677211|FG001|Overall Study|Death|0|||
156978986|NCT03093428|566677210|FG000|Overall Study|Adverse Event|1|||
156978987|NCT03093428|566677211|FG001|Overall Study|Adverse Event|0|||
156978988|NCT03093428|566677210|FG000|Overall Study|Withdrawal by Subject|1|||
156978989|NCT03093428|566677211|FG001|Overall Study|Withdrawal by Subject|1|||
156978990|NCT05340751|566677213|FG000|Overall Study|Physician Decision|3|||
156978991|NCT01014975|566677214|FG000|Overall Study|Withdrawal by Subject|1|||
156978992|NCT01014975|566677215|FG001|Overall Study|Withdrawal by Subject|0|||
156978993|NCT01014975|566677216|FG002|Overall Study|Withdrawal by Subject|1|||
156978994|NCT01014975|566677214|FG000|Overall Study|Death|3|||
156978995|NCT01014975|566677215|FG001|Overall Study|Death|3|||
156978996|NCT01014975|566677216|FG002|Overall Study|Death|4|||
156978997|NCT01014975|566677214|FG000|Overall Study|Lost to Follow-up|0|||
156978998|NCT01014975|566677215|FG001|Overall Study|Lost to Follow-up|0|||
156978999|NCT01014975|566677216|FG002|Overall Study|Lost to Follow-up|1|||
156979000|NCT01973491|566677219|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
156979001|NCT01973491|566677219|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
156979002|NCT01973491|566677219|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
156979003|NCT02632786|566677220|FG000|Overall Study|Adverse Event|2|||
156979004|NCT02632786|566677221|FG001|Overall Study|Adverse Event|1|||
156979005|NCT02632786|566677220|FG000|Overall Study|Death|3|||
156979006|NCT02632786|566677221|FG001|Overall Study|Death|2|||
156979007|NCT02632786|566677220|FG000|Overall Study|Physician Decision|5|||
156979008|NCT02632786|566677221|FG001|Overall Study|Physician Decision|4|||
156979009|NCT02632786|566677220|FG000|Overall Study|Withdrawal by Subject|1|||
156979010|NCT02632786|566677221|FG001|Overall Study|Withdrawal by Subject|0|||
156979011|NCT00709592|566677222|FG000|Overall Study|Unable to proceed to transplant|0|||
156979012|NCT00709592|566677223|FG001|Overall Study|Unable to proceed to transplant|1|||
156979013|NCT01460160|566677224|FG000|Treatment Phase|Lack of Efficacy|3|||
156979014|NCT01460160|566677224|FG000|Treatment Phase|Study Drug Toxicity|2|||
156979015|NCT01460160|566677224|FG000|Treatment Phase|Adverse Event|8|||
156979016|NCT01460160|566677224|FG000|Treatment Phase|Withdrawal by Subject|4|||
156979017|NCT01460160|566677224|FG000|Treatment Phase|Death|2|||
156979018|NCT01460160|566677224|FG000|Treatment Phase|Other reasons|9|||
156979019|NCT01460160|566677224|FG000|Follow-up Phase|Withdrawal by Subject|4|||
156979020|NCT01460160|566677224|FG000|Follow-up Phase|Death|14|||
156979021|NCT01460160|566677224|FG000|Follow-up Phase|Lost to Follow-up|7|||
156979022|NCT01460160|566677224|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
156979023|NCT01460160|566677224|FG000|Follow-up Phase|Other and not reported reasons|5|||
156979024|NCT03893825|566677225|FG000|Overall Study|Death|2|||
156979025|NCT03893825|566677226|FG001|Overall Study|Death|1|||
156979026|NCT03893825|566677225|FG000|Overall Study|Adverse Event|0|||
156979027|NCT03893825|566677226|FG001|Overall Study|Adverse Event|2|||
156979028|NCT03893825|566677225|FG000|Overall Study|Withdrawal by Subject|19|||
156979029|NCT03893825|566677226|FG001|Overall Study|Withdrawal by Subject|21|||
156979030|NCT03893825|566677225|FG000|Overall Study|Protocol deviation|1|||
156979031|NCT03893825|566677226|FG001|Overall Study|Protocol deviation|0|||
156979032|NCT03893825|566677225|FG000|Overall Study|Lost to Follow-up|10|||
156979033|NCT03893825|566677226|FG001|Overall Study|Lost to Follow-up|10|||
156979034|NCT03893825|566677225|FG000|Overall Study|Other than specified|7|||
156979035|NCT03893825|566677226|FG001|Overall Study|Other than specified|6|||
156979036|NCT02006121|566677227|FG000|Double Blind Phase|Adverse Event|6|||
156979037|NCT02006121|566677228|FG001|Double Blind Phase|Adverse Event|0|||
156979038|NCT02006121|566677227|FG000|Double Blind Phase|Lack of Efficacy|1|||
156979039|NCT02006121|566677228|FG001|Double Blind Phase|Lack of Efficacy|16|||
156979040|NCT02006121|566677227|FG000|Double Blind Phase|Withdrawal by Subject|3|||
156979041|NCT02006121|566677228|FG001|Double Blind Phase|Withdrawal by Subject|4|||
156979042|NCT02006121|566677227|FG000|Double Blind Phase|Non-compliance with study drug|1|||
156979043|NCT02006121|566677228|FG001|Double Blind Phase|Non-compliance with study drug|3|||
156979044|NCT02006121|566677227|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
156979045|NCT02006121|566677228|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
156979046|NCT02006121|566677227|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
156979047|NCT02006121|566677228|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
156979048|NCT02006121|566677227|FG000|Open Label Phase|Adverse Event|15|||
156979049|NCT02006121|566677228|FG001|Open Label Phase|Adverse Event|0|||
156979050|NCT02006121|566677227|FG000|Open Label Phase|Lack of Efficacy|2|||
156979051|NCT02006121|566677228|FG001|Open Label Phase|Lack of Efficacy|0|||
156979052|NCT02006121|566677227|FG000|Open Label Phase|Protocol Violation|2|||
156979053|NCT02006121|566677228|FG001|Open Label Phase|Protocol Violation|0|||
156979054|NCT02006121|566677227|FG000|Open Label Phase|Withdrawal by Subject|3|||
156979055|NCT02006121|566677228|FG001|Open Label Phase|Withdrawal by Subject|0|||
156979056|NCT02006121|566677227|FG000|Open Label Phase|Non-compliance with study drug|3|||
156979057|NCT02006121|566677228|FG001|Open Label Phase|Non-compliance with study drug|0|||
156979058|NCT03101241|566677231|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
156979059|NCT03101241|566677232|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
156979060|NCT03101241|566677231|FG000|Overall Study|Participant withdrew consent|3|||
156979061|NCT03101241|566677232|FG001|Overall Study|Participant withdrew consent|1|||
156979062|NCT03101241|566677231|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
156979063|NCT03101241|566677232|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
156979064|NCT03101241|566677231|FG000|Overall Study|Lost to Follow-up|2|||
156979065|NCT03101241|566677232|FG001|Overall Study|Lost to Follow-up|0|||
156979066|NCT03101241|566677231|FG000|Overall Study|Lack of Efficacy|0|||
156979067|NCT03101241|566677232|FG001|Overall Study|Lack of Efficacy|1|||
156979068|NCT03101241|566677231|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
156979069|NCT03101241|566677232|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
156979070|NCT00669903|566677233|FG000|Overall Study|Adverse Event|0|||
156979071|NCT00669903|566677234|FG001|Overall Study|Adverse Event|1|||
156979072|NCT00669903|566677235|FG002|Overall Study|Adverse Event|3|||
156979073|NCT00669903|566677236|FG003|Overall Study|Adverse Event|1|||
156979074|NCT00669903|566677233|FG000|Overall Study|Withdrawal by Subject|0|||
156979075|NCT00669903|566677234|FG001|Overall Study|Withdrawal by Subject|2|||
156979076|NCT00669903|566677235|FG002|Overall Study|Withdrawal by Subject|2|||
156979077|NCT00669903|566677236|FG003|Overall Study|Withdrawal by Subject|2|||
156979078|NCT00669903|566677233|FG000|Overall Study|Lost to Follow-up|1|||
156979079|NCT00669903|566677234|FG001|Overall Study|Lost to Follow-up|1|||
156979080|NCT00669903|566677235|FG002|Overall Study|Lost to Follow-up|0|||
156979081|NCT00669903|566677236|FG003|Overall Study|Lost to Follow-up|1|||
156979082|NCT00669903|566677233|FG000|Overall Study|Protocol Violation|0|||
156979083|NCT00669903|566677234|FG001|Overall Study|Protocol Violation|1|||
156979084|NCT00669903|566677235|FG002|Overall Study|Protocol Violation|0|||
156979085|NCT00669903|566677236|FG003|Overall Study|Protocol Violation|0|||
156979086|NCT02765490|566677237|FG000|Overall Study|Lost to Follow-up|1|||
156979087|NCT02765490|566677238|FG001|Overall Study|Lost to Follow-up|1|||
156979088|NCT02765490|566677237|FG000|Overall Study|Other|0|||
156979089|NCT02765490|566677238|FG001|Overall Study|Other|1|||
156979090|NCT02765490|566677237|FG000|Overall Study|Death|0|||
156979091|NCT02765490|566677238|FG001|Overall Study|Death|1|||
156979092|NCT03237013|566677244|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
156979093|NCT03237013|566677245|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
156979094|NCT03237013|566677246|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
156979095|NCT03000673|566677249|FG000|Overall Study|Withdrawal by Subject|1|||
156979096|NCT03000673|566677250|FG001|Overall Study|Withdrawal by Subject|0|||
156979097|NCT03000673|566677251|FG002|Overall Study|Withdrawal by Subject|0|||
156979098|NCT03000673|566677252|FG003|Overall Study|Withdrawal by Subject|0|||
156979099|NCT02357810|566677254|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
156979100|NCT02357810|566677254|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
156979101|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Adverse Event|5|||
156979102|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
156979103|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
156979104|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
156979105|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Death|1|||
156979106|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Physician Decision|1|||
156979107|NCT02357810|566677254|FG000|Reached 12 Weeks Response|Other|1|||
156979108|NCT02357810|566677254|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
156979109|NCT02357810|566677254|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
156979110|NCT02357810|566677254|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
156979111|NCT02357810|566677254|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
156979112|NCT02357810|566677254|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
156979113|NCT02357810|566677254|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
156979114|NCT00562978|566677255|FG000|Overall Study|Patient had imaging dose only|1|||
156979115|NCT00562978|566677256|FG001|Overall Study|Patient had imaging dose only|11|||
156979116|NCT00152971|566677258|FG000|Overall Study|Adverse Event|12|||
156979117|NCT00152971|566677259|FG001|Overall Study|Adverse Event|10|||
156979118|NCT00152971|566677260|FG002|Overall Study|Adverse Event|9|||
156979119|NCT00152971|566677258|FG000|Overall Study|Protocol Violation|10|||
156979120|NCT00152971|566677259|FG001|Overall Study|Protocol Violation|11|||
156979121|NCT00152971|566677260|FG002|Overall Study|Protocol Violation|8|||
156979122|NCT00152971|566677258|FG000|Overall Study|Lost to Follow-up|17|||
156979123|NCT00152971|566677259|FG001|Overall Study|Lost to Follow-up|14|||
156979124|NCT00152971|566677260|FG002|Overall Study|Lost to Follow-up|13|||
156979125|NCT00152971|566677258|FG000|Overall Study|Withdrawal by Subject|9|||
156979126|NCT00152971|566677259|FG001|Overall Study|Withdrawal by Subject|8|||
156979127|NCT00152971|566677260|FG002|Overall Study|Withdrawal by Subject|14|||
156979128|NCT00152971|566677258|FG000|Overall Study|Other|3|||
156979129|NCT00152971|566677259|FG001|Overall Study|Other|5|||
156979130|NCT00152971|566677260|FG002|Overall Study|Other|5|||
156979131|NCT00152971|566677258|FG000|Treatment|Adverse Event|49|||
156979132|NCT00152971|566677259|FG001|Treatment|Adverse Event|40|||
156979133|NCT00152971|566677260|FG002|Treatment|Adverse Event|54|||
156979134|NCT00152971|566677258|FG000|Treatment|Protocol Violation|8|||
156979135|NCT00152971|566677259|FG001|Treatment|Protocol Violation|6|||
156979136|NCT00152971|566677260|FG002|Treatment|Protocol Violation|10|||
156979137|NCT00152971|566677258|FG000|Treatment|Lost to Follow-up|1|||
156979138|NCT00152971|566677259|FG001|Treatment|Lost to Follow-up|2|||
156979139|NCT00152971|566677260|FG002|Treatment|Lost to Follow-up|1|||
156979140|NCT00152971|566677258|FG000|Treatment|Withdrawal by Subject|4|||
156979141|NCT00152971|566677259|FG001|Treatment|Withdrawal by Subject|4|||
156979142|NCT00152971|566677260|FG002|Treatment|Withdrawal by Subject|5|||
156979143|NCT00152971|566677258|FG000|Treatment|Other|9|||
156979144|NCT00152971|566677259|FG001|Treatment|Other|11|||
156979145|NCT00152971|566677260|FG002|Treatment|Other|10|||
156979146|NCT00675506|566677261|FG000|Overall Study|Lost to Follow-up|1|||
156979147|NCT00675506|566677262|FG001|Overall Study|Lost to Follow-up|5|||
156979148|NCT00675506|566677261|FG000|Overall Study|Lost interest|3|||
156979149|NCT00675506|566677262|FG001|Overall Study|Lost interest|5|||
156979150|NCT00675506|566677261|FG000|Overall Study|Elevated fasting glucose|2|||
156979151|NCT00675506|566677262|FG001|Overall Study|Elevated fasting glucose|1|||
156979152|NCT00675506|566677261|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
156979153|NCT00675506|566677262|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
156979154|NCT00675506|566677261|FG000|Overall Study|Elevated IGF-1|2|||
156979155|NCT00675506|566677262|FG001|Overall Study|Elevated IGF-1|0|||
156979156|NCT00675506|566677261|FG000|Overall Study|Hypersensitivity Reaction|1|||
156979157|NCT00675506|566677262|FG001|Overall Study|Hypersensitivity Reaction|0|||
156979158|NCT00675506|566677261|FG000|Overall Study|Disclosed history of cancer|1|||
156979159|NCT00675506|566677262|FG001|Overall Study|Disclosed history of cancer|0|||
156979160|NCT00675506|566677261|FG000|Overall Study|Declined participation|1|||
156979161|NCT00675506|566677262|FG001|Overall Study|Declined participation|0|||
156979162|NCT00675506|566677261|FG000|Overall Study|Schedule conflict|0|||
156979163|NCT00675506|566677262|FG001|Overall Study|Schedule conflict|1|||
156979164|NCT00936221|566677263|FG000|Overall Study|Withdrawal by Subject|1|||
156979165|NCT00936221|566677264|FG001|Overall Study|Withdrawal by Subject|1|||
156979166|NCT06173570|566677265|FG000|Overall Study|Adverse Event|1|||
156979167|NCT06173570|566677266|FG001|Overall Study|Adverse Event|0|||
156979168|NCT06173570|566677267|FG002|Overall Study|Adverse Event|0|||
156979169|NCT06173570|566677268|FG003|Overall Study|Adverse Event|2|||
156979170|NCT06173570|566677269|FG004|Overall Study|Adverse Event|0|||
156979171|NCT06173570|566677265|FG000|Overall Study|Lost to Follow-up|1|||
156979172|NCT06173570|566677266|FG001|Overall Study|Lost to Follow-up|0|||
156979173|NCT06173570|566677267|FG002|Overall Study|Lost to Follow-up|0|||
156979174|NCT06173570|566677268|FG003|Overall Study|Lost to Follow-up|0|||
156979175|NCT06173570|566677269|FG004|Overall Study|Lost to Follow-up|2|||
156979176|NCT06173570|566677265|FG000|Overall Study|Protocol Violation|0|||
156979177|NCT06173570|566677266|FG001|Overall Study|Protocol Violation|2|||
156979178|NCT06173570|566677267|FG002|Overall Study|Protocol Violation|0|||
156979179|NCT06173570|566677268|FG003|Overall Study|Protocol Violation|0|||
157093220|NCT01768637|567095882|FG000|Overall Study|Difficult blood draw|1|||
157093221|NCT01768637|567095883|FG001|Overall Study|Difficult blood draw|0|||
157093222|NCT01007448|567095884|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
157093223|NCT01007448|567095885|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
157093224|NCT01007448|567095884|FG000|Overall Study|Staph Skin Infection Flare|1|||
157093225|NCT01007448|567095885|FG001|Overall Study|Staph Skin Infection Flare|0|||
157093226|NCT01007448|567095884|FG000|Overall Study|Participant Leaving the Country|1|||
157093227|NCT01007448|567095885|FG001|Overall Study|Participant Leaving the Country|0|||
157093228|NCT01007448|567095884|FG000|Overall Study|Participant Given Prohibited Medication|1|||
157093229|NCT01007448|567095885|FG001|Overall Study|Participant Given Prohibited Medication|0|||
157093230|NCT01007448|567095884|FG000|Overall Study|Progressive Disease|1|||
157093231|NCT01007448|567095885|FG001|Overall Study|Progressive Disease|2|||
157093232|NCT01007448|567095884|FG000|Overall Study|Lack of Efficacy|2|||
157093233|NCT01007448|567095885|FG001|Overall Study|Lack of Efficacy|0|||
157093234|NCT01007448|567095884|FG000|Overall Study|Withdrawal by Subject|2|||
157093235|NCT01007448|567095885|FG001|Overall Study|Withdrawal by Subject|3|||
156979180|NCT06173570|566677269|FG004|Overall Study|Protocol Violation|1|||
156979181|NCT06173570|566677265|FG000|Overall Study|Withdrawal by Subject|0|||
156979182|NCT06173570|566677266|FG001|Overall Study|Withdrawal by Subject|1|||
156979183|NCT06173570|566677267|FG002|Overall Study|Withdrawal by Subject|1|||
156979184|NCT06173570|566677268|FG003|Overall Study|Withdrawal by Subject|1|||
156979185|NCT06173570|566677269|FG004|Overall Study|Withdrawal by Subject|1|||
156979186|NCT06173570|566677265|FG000|Overall Study|Non-compliance with Study Drug|1|||
156979187|NCT06173570|566677266|FG001|Overall Study|Non-compliance with Study Drug|0|||
156979188|NCT06173570|566677267|FG002|Overall Study|Non-compliance with Study Drug|0|||
157093236|NCT01007448|567095884|FG000|Overall Study|Adverse Event|1|||
157093237|NCT01007448|567095885|FG001|Overall Study|Adverse Event|4|||
157093238|NCT01054170|567095886|FG000|Overall Study|Protocol Violation|1|||
157093239|NCT01054170|567095887|FG001|Overall Study|Protocol Violation|0|||
157093240|NCT01054170|567095886|FG000|Overall Study|Withdrawal by Subject|3|||
157093241|NCT01054170|567095887|FG001|Overall Study|Withdrawal by Subject|2|||
157093242|NCT01054170|567095886|FG000|Overall Study|Adverse Event|0|||
157093243|NCT01054170|567095887|FG001|Overall Study|Adverse Event|4|||
157093244|NCT02751320|567095888|FG000|Overall Study|Adverse Event|2|||
157093245|NCT02751320|567095888|FG000|Overall Study|Withdrawal by Subject|1|||
157093246|NCT03426605|567095889|FG000|Overall Study|AML relapse or progression|2|||
157093247|NCT03426605|567095890|FG001|Overall Study|AML relapse or progression|1|||
157093248|NCT03426605|567095891|FG002|Overall Study|AML relapse or progression|2|||
157093249|NCT03426605|567095892|FG003|Overall Study|AML relapse or progression|2|||
157093250|NCT03426605|567095889|FG000|Overall Study|Treatment failure|3|||
157093251|NCT03426605|567095890|FG001|Overall Study|Treatment failure|2|||
157093252|NCT03426605|567095891|FG002|Overall Study|Treatment failure|0|||
157093253|NCT03426605|567095892|FG003|Overall Study|Treatment failure|0|||
157093254|NCT03426605|567095889|FG000|Overall Study|Adverse Event|1|||
157093255|NCT03426605|567095890|FG001|Overall Study|Adverse Event|0|||
157093256|NCT03426605|567095891|FG002|Overall Study|Adverse Event|1|||
157093257|NCT03426605|567095892|FG003|Overall Study|Adverse Event|1|||
157093258|NCT03426605|567095889|FG000|Overall Study|Withdrawal by Subject|0|||
157093259|NCT03426605|567095890|FG001|Overall Study|Withdrawal by Subject|0|||
157093260|NCT03426605|567095891|FG002|Overall Study|Withdrawal by Subject|1|||
157093261|NCT03426605|567095892|FG003|Overall Study|Withdrawal by Subject|1|||
157093262|NCT01337115|567095893|FG000|Overall Study|Protocol Violation|2|||
157093263|NCT01337115|567095894|FG001|Overall Study|Protocol Violation|0|||
157093264|NCT03426267|567095902|FG000|Overall Study|Physician Decision|1|||
157093265|NCT03426267|567095903|FG001|Overall Study|Physician Decision|4|||
157093266|NCT03426267|567095902|FG000|Overall Study|Lost to Follow-up|1|||
157093267|NCT03426267|567095903|FG001|Overall Study|Lost to Follow-up|0|||
157093268|NCT03426267|567095902|FG000|Overall Study|Withdrawal by Subject|4|||
157093269|NCT03426267|567095903|FG001|Overall Study|Withdrawal by Subject|10|||
157093270|NCT03426267|567095902|FG000|Overall Study|Protocol Violation|1|||
157093271|NCT03426267|567095903|FG001|Overall Study|Protocol Violation|3|||
157093272|NCT03426267|567095902|FG000|Overall Study|Adverse Event|9|||
157093273|NCT03426267|567095903|FG001|Overall Study|Adverse Event|27|||
157093274|NCT03426267|567095902|FG000|Overall Study|Prohibited Treatment Intake|2|||
157093275|NCT03426267|567095903|FG001|Overall Study|Prohibited Treatment Intake|3|||
157093276|NCT03426267|567095902|FG000|Overall Study|Lack of Efficacy|0|||
157093277|NCT03426267|567095903|FG001|Overall Study|Lack of Efficacy|25|||
157093278|NCT03426267|567095902|FG000|Overall Study|other|3|||
157093279|NCT03426267|567095903|FG001|Overall Study|other|0|||
157093280|NCT02054520|567095911|FG000|Overall Study|Adverse Event|1|||
157093281|NCT02054520|567095912|FG001|Overall Study|Adverse Event|4|||
157093282|NCT02054520|567095913|FG002|Overall Study|Adverse Event|2|||
157093283|NCT02054520|567095914|FG003|Overall Study|Adverse Event|1|||
157093284|NCT02054520|567095915|FG004|Overall Study|Adverse Event|1|||
157093285|NCT02054520|567095916|FG005|Overall Study|Adverse Event|0|||
157093286|NCT02054520|567095911|FG000|Overall Study|Lack of Efficacy|7|||
157093287|NCT02054520|567095912|FG001|Overall Study|Lack of Efficacy|0|||
157093288|NCT02054520|567095913|FG002|Overall Study|Lack of Efficacy|2|||
157093289|NCT02054520|567095914|FG003|Overall Study|Lack of Efficacy|1|||
157093290|NCT02054520|567095915|FG004|Overall Study|Lack of Efficacy|3|||
157093291|NCT02054520|567095916|FG005|Overall Study|Lack of Efficacy|2|||
157093292|NCT02054520|567095911|FG000|Overall Study|Withdrawal by Subject|1|||
157093293|NCT02054520|567095912|FG001|Overall Study|Withdrawal by Subject|0|||
157093294|NCT02054520|567095913|FG002|Overall Study|Withdrawal by Subject|0|||
157093295|NCT02054520|567095914|FG003|Overall Study|Withdrawal by Subject|2|||
157093296|NCT02054520|567095915|FG004|Overall Study|Withdrawal by Subject|1|||
157093297|NCT02054520|567095916|FG005|Overall Study|Withdrawal by Subject|0|||
157093298|NCT02054520|567095911|FG000|Overall Study|Physician Decision|0|||
157093299|NCT02054520|567095912|FG001|Overall Study|Physician Decision|1|||
157093300|NCT02054520|567095913|FG002|Overall Study|Physician Decision|0|||
157093301|NCT02054520|567095914|FG003|Overall Study|Physician Decision|1|||
157093302|NCT02054520|567095915|FG004|Overall Study|Physician Decision|0|||
157093303|NCT02054520|567095916|FG005|Overall Study|Physician Decision|1|||
156979189|NCT06173570|566677268|FG003|Overall Study|Non-compliance with Study Drug|0|||
156979190|NCT06173570|566677269|FG004|Overall Study|Non-compliance with Study Drug|0|||
156979191|NCT06173570|566677265|FG000|Overall Study|Screen Failure|0|||
156979192|NCT06173570|566677266|FG001|Overall Study|Screen Failure|0|||
156979193|NCT06173570|566677267|FG002|Overall Study|Screen Failure|0|||
156979194|NCT06173570|566677268|FG003|Overall Study|Screen Failure|0|||
156979195|NCT06173570|566677269|FG004|Overall Study|Screen Failure|1|||
156979196|NCT06173570|566677265|FG000|Overall Study|Other|2|||
156979197|NCT06173570|566677266|FG001|Overall Study|Other|1|||
157093304|NCT02054520|567095911|FG000|Overall Study|Study terminated by Sponsor|0|||
156979198|NCT06173570|566677267|FG002|Overall Study|Other|0|||
156979199|NCT06173570|566677268|FG003|Overall Study|Other|2|||
156979200|NCT06173570|566677269|FG004|Overall Study|Other|0|||
156979201|NCT03820323|566677270|FG000|Overall Study|Lost to Follow-up|2|||
156979202|NCT03820323|566677271|FG001|Overall Study|Lost to Follow-up|1|||
156979203|NCT03820323|566677270|FG000|Overall Study|Missed 12-month visit|22|||
156979204|NCT03820323|566677271|FG001|Overall Study|Missed 12-month visit|14|||
156979205|NCT03820323|566677270|FG000|Overall Study|Death|2|||
156979206|NCT03820323|566677271|FG001|Overall Study|Death|1|||
156979207|NCT03820323|566677270|FG000|Overall Study|Transferred out|13|||
156979208|NCT03820323|566677271|FG001|Overall Study|Transferred out|11|||
156979209|NCT03820323|566677270|FG000|Overall Study|Terminated|0|||
156979210|NCT03820323|566677271|FG001|Overall Study|Terminated|3|||
156979211|NCT03820323|566677270|FG000|Overall Study|Withdrawal by Subject|1|||
156979212|NCT03820323|566677271|FG001|Overall Study|Withdrawal by Subject|6|||
156979213|NCT03151395|566677272|FG000|Overall Study|Adverse Event|2|||
156979214|NCT03151395|566677272|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
156979215|NCT03151395|566677272|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
156979216|NCT03151395|566677272|FG000|Overall Study|Unspecified reason|4|||
156979217|NCT00366301|566677273|FG000|Overall Study|Lost to Follow-up|4|||
156979218|NCT00366301|566677274|FG001|Overall Study|Lost to Follow-up|4|||
156979219|NCT00366301|566677275|FG002|Overall Study|Lost to Follow-up|3|||
156979220|NCT00366301|566677276|FG003|Overall Study|Lost to Follow-up|7|||
156979221|NCT00366301|566677273|FG000|Overall Study|Withdrawal by Subject|4|||
156979222|NCT00366301|566677274|FG001|Overall Study|Withdrawal by Subject|2|||
156979223|NCT00366301|566677275|FG002|Overall Study|Withdrawal by Subject|1|||
156979224|NCT00366301|566677276|FG003|Overall Study|Withdrawal by Subject|1|||
156979225|NCT05952297|566677277|FG000|Overall Study|Withdrawal by Subject|1|||
156979226|NCT05952297|566677278|FG001|Overall Study|Withdrawal by Subject|0|||
156979227|NCT00284089|566677281|FG000|Multiple Dose Phase|Adverse Event|1|||
156979228|NCT00284089|566677282|FG001|Multiple Dose Phase|Adverse Event|0|||
156979229|NCT00284089|566677283|FG002|Multiple Dose Phase|Adverse Event|1|||
156979230|NCT00284089|566677284|FG003|Multiple Dose Phase|Adverse Event|1|||
156979231|NCT00284089|566677281|FG000|Multiple Dose Phase|Protocol Violation|0|||
156979232|NCT00284089|566677282|FG001|Multiple Dose Phase|Protocol Violation|0|||
156979233|NCT00284089|566677283|FG002|Multiple Dose Phase|Protocol Violation|1|||
156979234|NCT00284089|566677284|FG003|Multiple Dose Phase|Protocol Violation|0|||
156979235|NCT00284089|566677281|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
156979236|NCT00284089|566677282|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
156979237|NCT00284089|566677283|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
156979238|NCT00284089|566677284|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
156979239|NCT00284089|566677281|FG000|Multiple Dose Phase|Death|0|||
156979240|NCT00284089|566677282|FG001|Multiple Dose Phase|Death|0|||
156979241|NCT00284089|566677283|FG002|Multiple Dose Phase|Death|1|||
156979242|NCT00284089|566677284|FG003|Multiple Dose Phase|Death|1|||
156979243|NCT00284089|566677281|FG000|Extension Phase|Adverse Event|0|||
156979244|NCT00284089|566677282|FG001|Extension Phase|Adverse Event|0|||
156979245|NCT00284089|566677283|FG002|Extension Phase|Adverse Event|2|||
156979246|NCT00284089|566677284|FG003|Extension Phase|Adverse Event|2|||
156979247|NCT00284089|566677281|FG000|Extension Phase|condition no longer requires study drug|2|||
156979248|NCT00284089|566677282|FG001|Extension Phase|condition no longer requires study drug|0|||
156979249|NCT00284089|566677283|FG002|Extension Phase|condition no longer requires study drug|2|||
156979250|NCT00284089|566677284|FG003|Extension Phase|condition no longer requires study drug|7|||
156979251|NCT00284089|566677281|FG000|Extension Phase|Protocol Violation|0|||
156979252|NCT00284089|566677282|FG001|Extension Phase|Protocol Violation|0|||
156979253|NCT00284089|566677283|FG002|Extension Phase|Protocol Violation|1|||
156979254|NCT00284089|566677284|FG003|Extension Phase|Protocol Violation|0|||
156979255|NCT00284089|566677281|FG000|Extension Phase|Withdrawal by Subject|0|||
156979256|NCT00284089|566677282|FG001|Extension Phase|Withdrawal by Subject|0|||
156979257|NCT00284089|566677283|FG002|Extension Phase|Withdrawal by Subject|1|||
156979258|NCT00284089|566677284|FG003|Extension Phase|Withdrawal by Subject|3|||
156979259|NCT00089895|566677285|FG000|Overall Study|Consent Withdrawn|11|||
156979260|NCT00089895|566677286|FG001|Overall Study|Consent Withdrawn|14|||
156979261|NCT00089895|566677285|FG000|Overall Study|Technical reason|7|||
156979262|NCT00089895|566677286|FG001|Overall Study|Technical reason|2|||
156979263|NCT00089895|566677285|FG000|Overall Study|Surgery|0|||
156979264|NCT00089895|566677286|FG001|Overall Study|Surgery|1|||
156979265|NCT00089895|566677285|FG000|Overall Study|Bleeding|0|||
156979266|NCT00089895|566677286|FG001|Overall Study|Bleeding|2|||
156979267|NCT00089895|566677285|FG000|Overall Study|Physician Decision|3|||
156979268|NCT00089895|566677286|FG001|Overall Study|Physician Decision|7|||
156979269|NCT00089895|566677285|FG000|Overall Study|Exclusion criteria met|6|||
156979270|NCT00089895|566677286|FG001|Overall Study|Exclusion criteria met|6|||
156979271|NCT00089895|566677285|FG000|Overall Study|Not otherwise specified|4|||
156979272|NCT00089895|566677286|FG001|Overall Study|Not otherwise specified|8|||
156979273|NCT00089895|566677285|FG000|Overall Study|Missing|4|||
156979274|NCT00089895|566677286|FG001|Overall Study|Missing|2|||
156979275|NCT03679767|566677287|FG000|Overall Study|Death|16|||
157093305|NCT02054520|567095912|FG001|Overall Study|Study terminated by Sponsor|0|||
157093306|NCT02054520|567095913|FG002|Overall Study|Study terminated by Sponsor|2|||
157093307|NCT02054520|567095914|FG003|Overall Study|Study terminated by Sponsor|1|||
157093308|NCT02054520|567095915|FG004|Overall Study|Study terminated by Sponsor|0|||
157093309|NCT02054520|567095916|FG005|Overall Study|Study terminated by Sponsor|0|||
157093310|NCT03801915|567095917|FG000|Overall Study|Screen failure|0|||
157093311|NCT03801915|567095918|FG001|Overall Study|Screen failure|0|||
157093312|NCT03801915|567095919|FG002|Overall Study|Screen failure|1|||
157093313|NCT03801915|567095917|FG000|Overall Study|Ineligible|1|||
157093314|NCT03801915|567095918|FG001|Overall Study|Ineligible|0|||
157093315|NCT03801915|567095919|FG002|Overall Study|Ineligible|0|||
157093316|NCT03801915|567095917|FG000|Overall Study|Physician Decision|2|||
157093317|NCT03801915|567095918|FG001|Overall Study|Physician Decision|1|||
157093318|NCT03801915|567095919|FG002|Overall Study|Physician Decision|0|||
157093319|NCT02308020|567095920|FG000|Overall Study|Lost to Follow-up|1|||
157093320|NCT02308020|567095921|FG001|Overall Study|Lost to Follow-up|7|||
157093321|NCT02308020|567095922|FG002|Overall Study|Lost to Follow-up|0|||
157093322|NCT02308020|567095923|FG003|Overall Study|Lost to Follow-up|0|||
157093323|NCT02308020|567095924|FG004|Overall Study|Lost to Follow-up|1|||
157093324|NCT02308020|567095925|FG005|Overall Study|Lost to Follow-up|2|||
157093325|NCT02308020|567095920|FG000|Overall Study|Sponsor Decision|0|||
157093326|NCT02308020|567095921|FG001|Overall Study|Sponsor Decision|8|||
157093327|NCT02308020|567095922|FG002|Overall Study|Sponsor Decision|0|||
157093328|NCT02308020|567095923|FG003|Overall Study|Sponsor Decision|2|||
157093329|NCT02308020|567095924|FG004|Overall Study|Sponsor Decision|2|||
157093330|NCT02308020|567095925|FG005|Overall Study|Sponsor Decision|1|||
157093331|NCT02308020|567095920|FG000|Overall Study|Withdrawal by Subject|3|||
157093332|NCT02308020|567095921|FG001|Overall Study|Withdrawal by Subject|5|||
157093333|NCT02308020|567095922|FG002|Overall Study|Withdrawal by Subject|3|||
157093334|NCT02308020|567095923|FG003|Overall Study|Withdrawal by Subject|2|||
157093335|NCT02308020|567095924|FG004|Overall Study|Withdrawal by Subject|1|||
157093336|NCT02308020|567095925|FG005|Overall Study|Withdrawal by Subject|2|||
157093337|NCT01211288|567095926|FG000|Overall Study|Lost to Follow-up|1|||
157093338|NCT01211288|567095927|FG001|Overall Study|Lost to Follow-up|1|||
157093339|NCT01270971|567095928|FG000|Overall Study|Withdrawal by Subject|24|||
157093340|NCT01270971|567095929|FG001|Overall Study|Withdrawal by Subject|11|||
157093341|NCT01270971|567095928|FG000|Overall Study|Lost to Follow-up|18|||
157093342|NCT01270971|567095929|FG001|Overall Study|Lost to Follow-up|5|||
157093343|NCT01270971|567095928|FG000|Overall Study|Adverse Event|1|||
157093344|NCT01270971|567095929|FG001|Overall Study|Adverse Event|2|||
157093345|NCT01270971|567095928|FG000|Overall Study|Non compliance|2|||
157093346|NCT01270971|567095929|FG001|Overall Study|Non compliance|2|||
157093347|NCT01270971|567095928|FG000|Overall Study|Non-specific|7|||
157093348|NCT01270971|567095929|FG001|Overall Study|Non-specific|3|||
157093349|NCT03333837|567095931|FG000|Overall Study|Adverse Event|2|||
157093350|NCT03333837|567095932|FG001|Overall Study|Adverse Event|1|||
157093351|NCT03333837|567095933|FG002|Overall Study|Adverse Event|1|||
157093352|NCT03333837|567095934|FG003|Overall Study|Adverse Event|1|||
157093353|NCT03333837|567095935|FG004|Overall Study|Adverse Event|0|||
157093354|NCT03333837|567095931|FG000|Overall Study|Caregiver withdrew|0|||
157093355|NCT03333837|567095932|FG001|Overall Study|Caregiver withdrew|2|||
157093356|NCT03333837|567095933|FG002|Overall Study|Caregiver withdrew|1|||
157093357|NCT03333837|567095934|FG003|Overall Study|Caregiver withdrew|0|||
157093358|NCT03333837|567095935|FG004|Overall Study|Caregiver withdrew|0|||
157093359|NCT03333837|567095931|FG000|Overall Study|Withdrawal by Subject|0|||
157093360|NCT03333837|567095932|FG001|Overall Study|Withdrawal by Subject|0|||
157093361|NCT03333837|567095933|FG002|Overall Study|Withdrawal by Subject|1|||
157093362|NCT03333837|567095934|FG003|Overall Study|Withdrawal by Subject|1|||
157093363|NCT03333837|567095935|FG004|Overall Study|Withdrawal by Subject|3|||
157093364|NCT03333837|567095931|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
157093365|NCT03333837|567095932|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
157093366|NCT03333837|567095933|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
157093367|NCT03333837|567095934|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
157093368|NCT03333837|567095935|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
157093369|NCT01551212|567095936|FG000|Overall Study|Graft loss/Retransplantation|0|||
157093370|NCT01551212|567095937|FG001|Overall Study|Graft loss/Retransplantation|1|||
157093371|NCT01551212|567095936|FG000|Overall Study|Administrative problems|1|||
157093372|NCT01551212|567095937|FG001|Overall Study|Administrative problems|2|||
157093373|NCT01551212|567095936|FG000|Overall Study|Lost to Follow-up|0|||
157093374|NCT01551212|567095937|FG001|Overall Study|Lost to Follow-up|1|||
157093375|NCT01551212|567095936|FG000|Overall Study|Protocol Violation|0|||
157093376|NCT01551212|567095937|FG001|Overall Study|Protocol Violation|1|||
157093377|NCT01551212|567095936|FG000|Overall Study|Withdrawal by Subject|0|||
157093378|NCT01551212|567095937|FG001|Overall Study|Withdrawal by Subject|7|||
157093379|NCT01551212|567095936|FG000|Overall Study|Death|2|||
157093380|NCT01551212|567095937|FG001|Overall Study|Death|4|||
157093381|NCT01551212|567095936|FG000|Overall Study|Never Received Study Treatment|2|||
157093382|NCT01551212|567095937|FG001|Overall Study|Never Received Study Treatment|4|||
157093383|NCT04217590|567095938|FG000|Overall Study|Other|1|||
157093384|NCT04217590|567095939|FG001|Overall Study|Other|1|||
157093385|NCT04217590|567095938|FG000|Overall Study|Withdrawal by Subject|3|||
157093386|NCT04217590|567095939|FG001|Overall Study|Withdrawal by Subject|1|||
157093387|NCT04217590|567095938|FG000|Overall Study|Death|0|||
157093388|NCT04217590|567095939|FG001|Overall Study|Death|1|||
157093389|NCT01013285|567095940|FG000|Overall Study|Death|48|||
157093390|NCT01013285|567095941|FG001|Overall Study|Death|89|||
157093391|NCT02232243|567095942|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
157093392|NCT02232243|567095943|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
157093393|NCT02232243|567095944|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
157093394|NCT00490724|567095945|FG000|Period I|Physician Decision|0|||
157093395|NCT00490724|567095946|FG001|Period I|Physician Decision|0|||
157093396|NCT00490724|567095947|FG002|Period I|Physician Decision|1|||
157093397|NCT00490724|567095945|FG000|Period II|Treatment Discontinuation|3|||
157093398|NCT00490724|567095946|FG001|Period II|Treatment Discontinuation|1|||
157093399|NCT00490724|567095947|FG002|Period II|Treatment Discontinuation|3|||
157093400|NCT00704405|567095948|FG000|Overall Study (NC Population)|Adverse Event|1|||
157093401|NCT00704405|567095949|FG001|Overall Study (NC Population)|Adverse Event|0|||
157093402|NCT00704405|567095950|FG002|Overall Study (NC Population)|Adverse Event|0|||
157093403|NCT00704405|567095951|FG003|Overall Study (NC Population)|Adverse Event|0|||
157093404|NCT00704405|567095952|FG004|Overall Study (NC Population)|Adverse Event|0|||
157093405|NCT00704405|567095948|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
157093406|NCT00704405|567095949|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
157093407|NCT00704405|567095950|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
157093408|NCT00704405|567095951|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
157093409|NCT00704405|567095952|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
157093410|NCT00704405|567095948|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
157093411|NCT00704405|567095949|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
157093412|NCT00704405|567095950|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
157093413|NCT00704405|567095951|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
157093414|NCT00704405|567095952|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
157093415|NCT00704405|567095948|FG000|Overall Study (NC Population)|Other|0|||
157093416|NCT00704405|567095949|FG001|Overall Study (NC Population)|Other|0|||
157093417|NCT00704405|567095950|FG002|Overall Study (NC Population)|Other|0|||
157093418|NCT00704405|567095951|FG003|Overall Study (NC Population)|Other|0|||
157093419|NCT00704405|567095952|FG004|Overall Study (NC Population)|Other|1|||
157093420|NCT00704405|567095948|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
157093421|NCT00704405|567095949|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
157093422|NCT00704405|567095950|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
157093423|NCT00704405|567095951|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
157093424|NCT00704405|567095952|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
157093425|NCT00704405|567095948|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
157093426|NCT00704405|567095949|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
156979276|NCT03679767|566677288|FG001|Overall Study|Death|11|||
156979277|NCT03679767|566677289|FG002|Overall Study|Death|17|||
156979278|NCT03679767|566677290|FG003|Overall Study|Death|10|||
156979279|NCT03679767|566677287|FG000|Overall Study|Lost to Follow-up|1|||
156979280|NCT03679767|566677288|FG001|Overall Study|Lost to Follow-up|1|||
156979281|NCT03679767|566677289|FG002|Overall Study|Lost to Follow-up|1|||
156979282|NCT03679767|566677290|FG003|Overall Study|Lost to Follow-up|1|||
156979283|NCT03679767|566677287|FG000|Overall Study|Withdrawal by Subject|0|||
156979284|NCT03679767|566677288|FG001|Overall Study|Withdrawal by Subject|0|||
156979285|NCT03679767|566677289|FG002|Overall Study|Withdrawal by Subject|0|||
156979286|NCT03679767|566677290|FG003|Overall Study|Withdrawal by Subject|1|||
156979287|NCT03679767|566677287|FG000|Overall Study|Follow-up Completed|18|||
156979288|NCT03679767|566677288|FG001|Overall Study|Follow-up Completed|11|||
156979289|NCT03679767|566677289|FG002|Overall Study|Follow-up Completed|11|||
156979290|NCT03679767|566677290|FG003|Overall Study|Follow-up Completed|20|||
156979291|NCT03679767|566677287|FG000|Overall Study|Entered Hospice Care|0|||
156979292|NCT03679767|566677288|FG001|Overall Study|Entered Hospice Care|0|||
156979293|NCT03679767|566677289|FG002|Overall Study|Entered Hospice Care|0|||
156979294|NCT03679767|566677290|FG003|Overall Study|Entered Hospice Care|1|||
156979295|NCT03679767|566677287|FG000|Overall Study|Progressive Disease|0|||
156979296|NCT03679767|566677288|FG001|Overall Study|Progressive Disease|0|||
156979297|NCT03679767|566677289|FG002|Overall Study|Progressive Disease|0|||
156979298|NCT03679767|566677290|FG003|Overall Study|Progressive Disease|1|||
156979299|NCT03915951|566677291|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
156979300|NCT03915951|566677292|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
156979301|NCT03915951|566677291|FG000|Overall Study|Adverse Event|12|||
156979302|NCT03915951|566677292|FG001|Overall Study|Adverse Event|6|||
156979303|NCT03915951|566677291|FG000|Overall Study|Disease progression (radiological)|17|||
156979304|NCT03915951|566677292|FG001|Overall Study|Disease progression (radiological)|15|||
156979305|NCT03915951|566677291|FG000|Overall Study|Disease progression (clinical)|4|||
156979306|NCT03915951|566677292|FG001|Overall Study|Disease progression (clinical)|1|||
156979307|NCT03915951|566677291|FG000|Overall Study|Patient decision|0|||
156979308|NCT03915951|566677292|FG001|Overall Study|Patient decision|4|||
156979309|NCT03915951|566677291|FG000|Overall Study|Investigator decision|0|||
156979310|NCT03915951|566677292|FG001|Overall Study|Investigator decision|1|||
156979311|NCT03915951|566677291|FG000|Overall Study|Consent withdrawn|1|||
156979312|NCT03915951|566677292|FG001|Overall Study|Consent withdrawn|1|||
156979313|NCT03915951|566677291|FG000|Overall Study|Death|0|||
156979314|NCT03915951|566677292|FG001|Overall Study|Death|3|||
156979315|NCT05408468|566677293|FG000|Overall Study|Lost to Follow-up|3|||
156979316|NCT05408468|566677294|FG001|Overall Study|Lost to Follow-up|1|||
156979317|NCT05408468|566677293|FG000|Overall Study|Physician Decision|1|||
156979318|NCT05408468|566677294|FG001|Overall Study|Physician Decision|0|||
156979319|NCT05408468|566677293|FG000|Overall Study|Overwhelmed by clinical situation|3|||
156979320|NCT05408468|566677294|FG001|Overall Study|Overwhelmed by clinical situation|0|||
156979321|NCT05408468|566677293|FG000|Overall Study|Personal illness precluding participation|1|||
156979322|NCT05408468|566677294|FG001|Overall Study|Personal illness precluding participation|0|||
156979323|NCT05408468|566677293|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
156979324|NCT05408468|566677294|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
156979325|NCT03916744|566677297|FG000|Overall Study|Withdrawal by Subject|0|||
156979326|NCT03916744|566677298|FG001|Overall Study|Withdrawal by Subject|1|||
156979327|NCT03916744|566677299|FG002|Overall Study|Withdrawal by Subject|2|||
156979328|NCT03556358|566677304|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
156979329|NCT03556358|566677305|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
156979330|NCT03556358|566677304|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
156979331|NCT03556358|566677305|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
156979332|NCT03556358|566677304|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
156979333|NCT03556358|566677305|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
156979334|NCT03556358|566677304|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
156979335|NCT03556358|566677305|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
156979336|NCT03556358|566677304|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
156979337|NCT03556358|566677305|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
156979338|NCT03556358|566677304|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
156979339|NCT03556358|566677305|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
156979340|NCT03556358|566677304|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
156979341|NCT03556358|566677305|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
156979342|NCT01103960|566677311|FG000|Overall Study|Adverse Event|2|||
156979343|NCT01103960|566677312|FG001|Overall Study|Adverse Event|1|||
156979344|NCT01103960|566677311|FG000|Overall Study|Withdrawal by Subject|2|||
156979345|NCT01103960|566677312|FG001|Overall Study|Withdrawal by Subject|1|||
156979346|NCT01103960|566677311|FG000|Overall Study|Other|1|||
156979347|NCT01103960|566677312|FG001|Overall Study|Other|0|||
156979348|NCT02875834|566677313|FG000|Open-label Phase|Withdrawal by Subject|3|||
156979349|NCT02875834|566677314|FG001|Open-label Phase|Withdrawal by Subject|0|||
156979350|NCT02875834|566677315|FG002|Open-label Phase|Withdrawal by Subject|0|||
156979351|NCT02875834|566677316|FG003|Open-label Phase|Withdrawal by Subject|0|||
156979352|NCT02875834|566677313|FG000|Open-label Phase|(Not collected)|4|||
156979353|NCT02875834|566677314|FG001|Open-label Phase|(Not collected)|0|||
156979354|NCT02875834|566677315|FG002|Open-label Phase|(Not collected)|0|||
156979355|NCT02875834|566677316|FG003|Open-label Phase|(Not collected)|0|||
156979356|NCT02875834|566677313|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
156979357|NCT02875834|566677314|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
156979358|NCT02875834|566677315|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
156979359|NCT02875834|566677316|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
156979360|NCT02875834|566677313|FG000|Randomized Treatment Phase|Protocol Violation|0|||
156979361|NCT02875834|566677314|FG001|Randomized Treatment Phase|Protocol Violation|2|||
156979362|NCT02875834|566677315|FG002|Randomized Treatment Phase|Protocol Violation|0|||
156979363|NCT02875834|566677316|FG003|Randomized Treatment Phase|Protocol Violation|0|||
156979364|NCT02875834|566677313|FG000|Randomized Treatment Phase|(Not collected)|0|||
156979365|NCT02875834|566677314|FG001|Randomized Treatment Phase|(Not collected)|9|||
156979366|NCT02875834|566677315|FG002|Randomized Treatment Phase|(Not collected)|10|||
156979367|NCT02875834|566677316|FG003|Randomized Treatment Phase|(Not collected)|9|||
156979368|NCT02593539|566678903|FG000|Overall Study|Adverse Event|1|||
156979369|NCT01811563|566678910|FG000|Overall Study|Lost to Follow-up|5|||
156979370|NCT01811563|566678911|FG001|Overall Study|Lost to Follow-up|2|||
156979371|NCT01811563|566678910|FG000|Overall Study|Incorrect Randomization procedure|0|||
156979372|NCT01811563|566678911|FG001|Overall Study|Incorrect Randomization procedure|1|||
156979373|NCT04424290|566678913|FG000|Overall Study|Not treated|0|||
156979374|NCT04424290|566678914|FG001|Overall Study|Not treated|0|||
157093427|NCT00704405|567095950|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
157093428|NCT00704405|567095951|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
157093429|NCT00704405|567095952|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
157093430|NCT01395888|567095953|FG000|2-week Run-in Period|Adverse Event|2|||
157093431|NCT01395888|567095954|FG001|2-week Run-in Period|Adverse Event|0|||
157093432|NCT01395888|567095955|FG002|2-week Run-in Period|Adverse Event|0|||
157093433|NCT01395888|567095953|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
157093434|NCT01395888|567095954|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
157093435|NCT01395888|567095955|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
157093436|NCT01395888|567095953|FG000|2-week Run-in Period|Lost to Follow-up|1|||
157093437|NCT01395888|567095954|FG001|2-week Run-in Period|Lost to Follow-up|0|||
157093438|NCT01395888|567095955|FG002|2-week Run-in Period|Lost to Follow-up|0|||
157093439|NCT01395888|567095953|FG000|2-week Run-in Period|Protocol Violation|2|||
157093440|NCT01395888|567095954|FG001|2-week Run-in Period|Protocol Violation|0|||
157093441|NCT01395888|567095955|FG002|2-week Run-in Period|Protocol Violation|0|||
157093442|NCT01395888|567095953|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
157093443|NCT01395888|567095954|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
157093444|NCT01395888|567095955|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
157093445|NCT01395888|567095953|FG000|Treatment Period (TP)|Adverse Event|0|||
157093446|NCT01395888|567095954|FG001|Treatment Period (TP)|Adverse Event|7|||
157093447|NCT01395888|567095955|FG002|Treatment Period (TP)|Adverse Event|6|||
157093448|NCT01395888|567095953|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
157093449|NCT01395888|567095954|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
157093450|NCT01395888|567095955|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
157093451|NCT01395888|567095953|FG000|Treatment Period (TP)|Protocol Violation|0|||
157093452|NCT01395888|567095954|FG001|Treatment Period (TP)|Protocol Violation|1|||
157093453|NCT01395888|567095955|FG002|Treatment Period (TP)|Protocol Violation|5|||
157093454|NCT01395888|567095953|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
157093455|NCT01395888|567095954|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
157093456|NCT01395888|567095955|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
157093457|NCT01395888|567095953|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
157093458|NCT01395888|567095954|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
157093459|NCT01395888|567095955|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
157093460|NCT03866473|567095958|FG000|Phase 1|Death|1|||
157093461|NCT03866473|567095959|FG001|Phase 1|Death|0|||
157093462|NCT03866473|567095958|FG000|Phase 2|Death|0|||
157093463|NCT03866473|567095959|FG001|Phase 2|Death|2|||
157093464|NCT03866473|567095958|FG000|Phase 2|Dropped|1|||
157093465|NCT03866473|567095959|FG001|Phase 2|Dropped|1|||
157093466|NCT03866473|567095958|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
157093467|NCT03866473|567095959|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
157093468|NCT05590884|567095960|FG000|Overall Study|Withdrawal by Subject|1|||
157093469|NCT05590884|567095961|FG001|Overall Study|Withdrawal by Subject|0|||
157093470|NCT05590884|567095962|FG002|Overall Study|Withdrawal by Subject|0|||
157093471|NCT04443153|567095966|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
157093472|NCT04443153|567095967|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
157093473|NCT04443153|567095966|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
157093474|NCT04443153|567095967|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
157093475|NCT04443153|567095966|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
157093476|NCT04443153|567095967|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
157093477|NCT04443153|567095966|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
157093478|NCT04443153|567095967|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
157093479|NCT05328167|567095969|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
157093480|NCT05328167|567095969|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
157093481|NCT03440320|567097542|FG000|Overall Study|Withdrawal by Subject|0|||
157093482|NCT03440320|567097543|FG001|Overall Study|Withdrawal by Subject|1|||
157093483|NCT01912456|567097544|FG000|Period 1|Physician Decision|0|||
157093484|NCT01912456|567097545|FG001|Period 1|Physician Decision|0|||
157093485|NCT01912456|567097546|FG002|Period 1|Physician Decision|1|||
157093486|NCT01912456|567097547|FG003|Period 1|Physician Decision|0|||
157093487|NCT01912456|567097544|FG000|Period 1|non-compliance|1|||
157093488|NCT01912456|567097545|FG001|Period 1|non-compliance|0|||
157093489|NCT01912456|567097546|FG002|Period 1|non-compliance|0|||
157093490|NCT01912456|567097547|FG003|Period 1|non-compliance|1|||
157093491|NCT01912456|567097544|FG000|Period 1|Adverse Event|1|||
157093492|NCT01912456|567097545|FG001|Period 1|Adverse Event|0|||
157093493|NCT01912456|567097546|FG002|Period 1|Adverse Event|0|||
157093494|NCT01912456|567097547|FG003|Period 1|Adverse Event|1|||
157093495|NCT01912456|567097544|FG000|Period 1|Withdrawal by Subject|0|||
157093496|NCT01912456|567097545|FG001|Period 1|Withdrawal by Subject|1|||
157093497|NCT01912456|567097546|FG002|Period 1|Withdrawal by Subject|1|||
156979375|NCT04424290|566678915|FG002|Overall Study|Not treated|1|||
156979376|NCT04424290|566678916|FG003|Overall Study|Not treated|0|||
156979377|NCT04424290|566678917|FG004|Overall Study|Not treated|1|||
156979378|NCT04424290|566678913|FG000|Overall Study|Adverse Event|0|||
156979379|NCT04424290|566678914|FG001|Overall Study|Adverse Event|0|||
156979380|NCT04424290|566678915|FG002|Overall Study|Adverse Event|0|||
156979381|NCT04424290|566678916|FG003|Overall Study|Adverse Event|2|||
156979382|NCT04424290|566678917|FG004|Overall Study|Adverse Event|0|||
156979383|NCT04424290|566678913|FG000|Overall Study|Withdrawal by Subject|0|||
156979384|NCT04424290|566678914|FG001|Overall Study|Withdrawal by Subject|0|||
156979385|NCT04424290|566678915|FG002|Overall Study|Withdrawal by Subject|0|||
156979386|NCT04424290|566678916|FG003|Overall Study|Withdrawal by Subject|0|||
156979387|NCT04424290|566678917|FG004|Overall Study|Withdrawal by Subject|1|||
156979388|NCT04424290|566678913|FG000|Overall Study|Other than listed|0|||
156979389|NCT04424290|566678914|FG001|Overall Study|Other than listed|0|||
156979390|NCT04424290|566678915|FG002|Overall Study|Other than listed|0|||
156979391|NCT04424290|566678916|FG003|Overall Study|Other than listed|1|||
156979392|NCT04424290|566678917|FG004|Overall Study|Other than listed|0|||
156979393|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
156979394|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
156979395|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
156979396|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
156979397|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
156979398|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
156979399|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Death|0|||
156979400|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Death|1|||
156979401|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Adverse Event|11|||
156979402|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Adverse Event|11|||
156979403|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
156979404|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
156979405|NCT02936037|566678918|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156979406|NCT02936037|566678919|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156979407|NCT02936037|566678918|FG000|Open Label Extension|Adverse Event|0|||
156979408|NCT02936037|566678919|FG001|Open Label Extension|Adverse Event|3|||
156979409|NCT02936037|566678918|FG000|Open Label Extension|Other|0|||
156979410|NCT02936037|566678919|FG001|Open Label Extension|Other|3|||
156979411|NCT02936037|566678918|FG000|Open Label Extension|Withdrawal by Subject|0|||
156979412|NCT02936037|566678919|FG001|Open Label Extension|Withdrawal by Subject|4|||
156979413|NCT01267825|566678920|FG000|Overall Study|study terminated. no data collected.|1|||
156979414|NCT01267825|566678921|FG001|Overall Study|study terminated. no data collected.|0|||
156979415|NCT04249336|566678922|FG000|Overall Study|Lost to Follow-up|3|||
156979416|NCT04249336|566678923|FG001|Overall Study|Lost to Follow-up|3|||
156979417|NCT04249336|566678924|FG002|Overall Study|Lost to Follow-up|3|||
156979418|NCT04249336|566678925|FG003|Overall Study|Lost to Follow-up|3|||
156979419|NCT01242176|566678926|FG000|Washout Period of 7 Days|Adverse Event|0|||
156979420|NCT01242176|566678927|FG001|Washout Period of 7 Days|Adverse Event|2|||
156979421|NCT01242176|566678926|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
156979422|NCT01242176|566678927|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
156979423|NCT00871351|566678928|FG000|Overall Study|Withdrawal by Subject|1|||
156979424|NCT00871351|566678929|FG001|Overall Study|Withdrawal by Subject|0|||
156979425|NCT00871351|566678930|FG002|Overall Study|Withdrawal by Subject|0|||
156979426|NCT00871351|566678928|FG000|Overall Study|Adverse Event|3|||
156979427|NCT00871351|566678929|FG001|Overall Study|Adverse Event|1|||
156979428|NCT00871351|566678930|FG002|Overall Study|Adverse Event|0|||
156979429|NCT02791490|566678931|FG000|Overall Study|Lost to Follow-up|1|||
156979430|NCT02791490|566678932|FG001|Overall Study|Lost to Follow-up|2|||
156979431|NCT02791490|566678931|FG000|Overall Study|Withdrawal by Subject|2|||
156979432|NCT02791490|566678932|FG001|Overall Study|Withdrawal by Subject|6|||
156979433|NCT01189890|566678933|FG000|Overall Study|Adverse Event|3|||
156979434|NCT01189890|566678934|FG001|Overall Study|Adverse Event|4|||
156979435|NCT01189890|566678933|FG000|Overall Study|Lack of Efficacy|7|||
156979436|NCT01189890|566678934|FG001|Overall Study|Lack of Efficacy|2|||
156979437|NCT01189890|566678933|FG000|Overall Study|Lost to Follow-up|1|||
156979438|NCT01189890|566678934|FG001|Overall Study|Lost to Follow-up|7|||
156979439|NCT01189890|566678933|FG000|Overall Study|Protocol Violation|1|||
156979440|NCT01189890|566678934|FG001|Overall Study|Protocol Violation|5|||
156979441|NCT01189890|566678933|FG000|Overall Study|Withdrawal by Subject|15|||
156979442|NCT01189890|566678934|FG001|Overall Study|Withdrawal by Subject|11|||
156979443|NCT01189890|566678933|FG000|Overall Study|Non Compliance|0|||
156979444|NCT01189890|566678934|FG001|Overall Study|Non Compliance|1|||
156979445|NCT01189890|566678933|FG000|Overall Study|Physician Decision|5|||
156979446|NCT01189890|566678934|FG001|Overall Study|Physician Decision|4|||
156979447|NCT01189890|566678933|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
156979448|NCT01189890|566678934|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
156979449|NCT00077636|566678935|FG000|Overall Study|Refused Treatment|9|||
156979450|NCT00077636|566678936|FG001|Overall Study|Refused Treatment|31|||
157093498|NCT01912456|567097547|FG003|Period 1|Withdrawal by Subject|1|||
157093499|NCT01912456|567097544|FG000|Period 2|Lack of Efficacy|0|||
157093500|NCT01912456|567097545|FG001|Period 2|Lack of Efficacy|2|||
157093501|NCT01912456|567097546|FG002|Period 2|Lack of Efficacy|0|||
157093502|NCT01912456|567097547|FG003|Period 2|Lack of Efficacy|0|||
157093503|NCT01912456|567097544|FG000|Period 2|Adverse Event|0|||
157093504|NCT01912456|567097545|FG001|Period 2|Adverse Event|0|||
157093505|NCT01912456|567097546|FG002|Period 2|Adverse Event|0|||
157093506|NCT01912456|567097547|FG003|Period 2|Adverse Event|1|||
157093507|NCT00001962|567097553|FG000|Overall Study|Lack of Efficacy|18|||
157093508|NCT00001962|567097553|FG000|Overall Study|Lack of Accrual|6|||
157093509|NCT00001962|567097553|FG000|Overall Study|Death|1|||
157093510|NCT00001962|567097553|FG000|Overall Study|Lost to Follow-up|2|||
157093511|NCT00001962|567097553|FG000|Overall Study|Adverse Event|1|||
157093512|NCT00171704|567097554|FG000|Overall Study|Adverse Event|24|||
157093513|NCT00171704|567097555|FG001|Overall Study|Adverse Event|33|||
157093514|NCT00171704|567097554|FG000|Overall Study|Disease Progression|14|||
157093515|NCT00171704|567097555|FG001|Overall Study|Disease Progression|9|||
157093516|NCT00171704|567097554|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
157093517|NCT00171704|567097555|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
157093518|NCT00171704|567097554|FG000|Overall Study|Administrative Problems|2|||
157093519|NCT00171704|567097555|FG001|Overall Study|Administrative Problems|1|||
157093520|NCT00171704|567097554|FG000|Overall Study|Death|2|||
157093521|NCT00171704|567097555|FG001|Overall Study|Death|2|||
157093522|NCT00171704|567097554|FG000|Overall Study|Withdrawal by Subject|1|||
157093523|NCT00171704|567097555|FG001|Overall Study|Withdrawal by Subject|3|||
157093524|NCT00171704|567097554|FG000|Overall Study|Protocol Violation|0|||
157093525|NCT00171704|567097555|FG001|Overall Study|Protocol Violation|1|||
157093526|NCT00320541|567097558|FG000|Overall Study|Adverse Event|21|||
157093527|NCT00320541|567097559|FG001|Overall Study|Adverse Event|19|||
157093528|NCT00320541|567097558|FG000|Overall Study|Protocol Violation|0|||
157093529|NCT00320541|567097559|FG001|Overall Study|Protocol Violation|1|||
157093530|NCT00320541|567097558|FG000|Overall Study|Withdrawal by Subject|12|||
157093531|NCT00320541|567097559|FG001|Overall Study|Withdrawal by Subject|16|||
157093532|NCT00320541|567097558|FG000|Overall Study|Physician Decision|9|||
157093533|NCT00320541|567097559|FG001|Overall Study|Physician Decision|13|||
157093534|NCT00320541|567097558|FG000|Overall Study|Other|3|||
157093535|NCT00320541|567097559|FG001|Overall Study|Other|4|||
157093536|NCT00320541|567097558|FG000|Overall Study|Sponsor Decision|2|||
157093537|NCT00320541|567097559|FG001|Overall Study|Sponsor Decision|1|||
157093538|NCT00320541|567097558|FG000|Overall Study|Death due to Study Disease|1|||
157093539|NCT00320541|567097559|FG001|Overall Study|Death due to Study Disease|3|||
157093540|NCT00320541|567097558|FG000|Overall Study|Death due to Adverse Event(s)|1|||
157093541|NCT00320541|567097559|FG001|Overall Study|Death due to Adverse Event(s)|0|||
157093542|NCT00320541|567097558|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
157093543|NCT00320541|567097559|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
157093544|NCT04363801|567097560|FG000|Overall Study|Death|18|||
157093545|NCT04363801|567097561|FG001|Overall Study|Death|14|||
157093546|NCT04363801|567097562|FG002|Overall Study|Death|16|||
157093547|NCT04363801|567097563|FG003|Overall Study|Death|48|||
157093548|NCT04363801|567097564|FG004|Overall Study|Death|38|||
157093549|NCT04363801|567097560|FG000|Overall Study|Withdrawal by Subject|1|||
157093550|NCT04363801|567097561|FG001|Overall Study|Withdrawal by Subject|6|||
157093551|NCT04363801|567097562|FG002|Overall Study|Withdrawal by Subject|1|||
157093552|NCT04363801|567097563|FG003|Overall Study|Withdrawal by Subject|4|||
157093553|NCT04363801|567097564|FG004|Overall Study|Withdrawal by Subject|14|||
157093554|NCT04363801|567097560|FG000|Overall Study|Sponsor Decision|6|||
157093555|NCT04363801|567097561|FG001|Overall Study|Sponsor Decision|4|||
157093556|NCT04363801|567097562|FG002|Overall Study|Sponsor Decision|10|||
157093557|NCT04363801|567097563|FG003|Overall Study|Sponsor Decision|33|||
157093558|NCT04363801|567097564|FG004|Overall Study|Sponsor Decision|32|||
157093559|NCT04363801|567097560|FG000|Overall Study|Lost to Follow-up|0|||
157093560|NCT04363801|567097561|FG001|Overall Study|Lost to Follow-up|0|||
157093561|NCT04363801|567097562|FG002|Overall Study|Lost to Follow-up|1|||
157093562|NCT04363801|567097563|FG003|Overall Study|Lost to Follow-up|0|||
157093563|NCT04363801|567097564|FG004|Overall Study|Lost to Follow-up|1|||
157093564|NCT01146054|567097565|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
157093565|NCT01146054|567097565|FG000|Overall Study|Rapid tumor progression|2|||
157093566|NCT01146054|567097565|FG000|Overall Study|Other illness precluded treatment|2|||
157093567|NCT01146054|567097565|FG000|Overall Study|Lost to Follow-up|1|||
157093568|NCT01155375|567097566|FG000|Overall Study|Adverse Event|1|||
157093569|NCT01155375|567097567|FG001|Overall Study|Adverse Event|0|||
157093570|NCT04335812|567097568|FG000|Overall Study|Withdrawal by Subject|1|||
157093571|NCT04335812|567097569|FG001|Overall Study|Withdrawal by Subject|3|||
157093572|NCT04335812|567097568|FG000|Overall Study|Lost to Follow-up|12|||
157093573|NCT04335812|567097569|FG001|Overall Study|Lost to Follow-up|12|||
157093574|NCT04335812|567097568|FG000|Overall Study|Did not engage in the intervention|22|||
157093575|NCT04335812|567097569|FG001|Overall Study|Did not engage in the intervention|18|||
157093576|NCT02901041|567097570|FG000|Overall Study|Withdrawal by PI|4|||
157093577|NCT02901041|567097571|FG001|Overall Study|Withdrawal by PI|8|||
157093578|NCT02901041|567097570|FG000|Overall Study|Withdrawal by Subject|7|||
157093579|NCT02901041|567097571|FG001|Overall Study|Withdrawal by Subject|3|||
157093580|NCT03818204|567097575|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093581|NCT03818204|567097576|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093582|NCT03818204|567097577|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093583|NCT03818204|567097578|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093584|NCT03818204|567097579|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
157093585|NCT03818204|567097580|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093586|NCT03818204|567097581|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093587|NCT03818204|567097582|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093588|NCT03818204|567097583|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093589|NCT03818204|567097584|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093590|NCT03818204|567097585|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093591|NCT03818204|567097586|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093592|NCT03818204|567097587|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093593|NCT03818204|567097588|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
157093594|NCT03818204|567097589|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093595|NCT03818204|567097590|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093596|NCT03818204|567097591|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093597|NCT03818204|567097592|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093598|NCT03818204|567097593|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
157093599|NCT03818204|567097575|FG000|Overall Study|Physician Decision|0|||
157093600|NCT03818204|567097576|FG001|Overall Study|Physician Decision|0|||
157093601|NCT03818204|567097577|FG002|Overall Study|Physician Decision|0|||
157093602|NCT03818204|567097578|FG003|Overall Study|Physician Decision|0|||
157093603|NCT03818204|567097579|FG004|Overall Study|Physician Decision|0|||
157093604|NCT03818204|567097580|FG005|Overall Study|Physician Decision|0|||
157093605|NCT03818204|567097581|FG006|Overall Study|Physician Decision|0|||
157093606|NCT03818204|567097582|FG007|Overall Study|Physician Decision|0|||
157093607|NCT03818204|567097583|FG008|Overall Study|Physician Decision|0|||
157093608|NCT03818204|567097584|FG009|Overall Study|Physician Decision|0|||
157093609|NCT03818204|567097585|FG010|Overall Study|Physician Decision|0|||
157093610|NCT03818204|567097586|FG011|Overall Study|Physician Decision|0|||
157093611|NCT03818204|567097587|FG012|Overall Study|Physician Decision|0|||
157093612|NCT03818204|567097588|FG013|Overall Study|Physician Decision|0|||
157093613|NCT03818204|567097589|FG014|Overall Study|Physician Decision|1|||
157093614|NCT03818204|567097590|FG015|Overall Study|Physician Decision|0|||
157093615|NCT03818204|567097591|FG016|Overall Study|Physician Decision|0|||
157093616|NCT03818204|567097592|FG017|Overall Study|Physician Decision|0|||
157093617|NCT03818204|567097593|FG018|Overall Study|Physician Decision|0|||
157093618|NCT00887250|567097594|FG000|Overall Study|Adverse Event|3|||
157093619|NCT00887250|567097595|FG001|Overall Study|Adverse Event|0|||
157093620|NCT00887250|567097596|FG002|Overall Study|Adverse Event|7|||
157093621|NCT00887250|567097594|FG000|Overall Study|Lack of Efficacy|9|||
157093622|NCT00887250|567097595|FG001|Overall Study|Lack of Efficacy|6|||
157093623|NCT00887250|567097596|FG002|Overall Study|Lack of Efficacy|1|||
157093624|NCT00887250|567097594|FG000|Overall Study|Lost to Follow-up|2|||
157093625|NCT00887250|567097595|FG001|Overall Study|Lost to Follow-up|3|||
157093626|NCT00887250|567097596|FG002|Overall Study|Lost to Follow-up|1|||
157093627|NCT00887250|567097594|FG000|Overall Study|Protocol Violation|2|||
157093628|NCT00887250|567097595|FG001|Overall Study|Protocol Violation|2|||
157093629|NCT00887250|567097596|FG002|Overall Study|Protocol Violation|1|||
157093630|NCT00887250|567097594|FG000|Overall Study|Withdrawal by Subject|2|||
157093631|NCT00887250|567097595|FG001|Overall Study|Withdrawal by Subject|1|||
157093632|NCT00887250|567097596|FG002|Overall Study|Withdrawal by Subject|2|||
157093633|NCT00887250|567097594|FG000|Overall Study|Patient uncooperative|0|||
157093634|NCT00887250|567097595|FG001|Overall Study|Patient uncooperative|0|||
157093635|NCT00887250|567097596|FG002|Overall Study|Patient uncooperative|1|||
157093636|NCT05754333|567097597|FG000|Overall Study|Miscellaneous|3|||
157093637|NCT05754333|567097598|FG001|Overall Study|Miscellaneous|0|||
157093638|NCT05754333|567097599|FG002|Overall Study|Miscellaneous|0|||
157093639|NCT05754333|567097600|FG003|Overall Study|Miscellaneous|0|||
157093640|NCT05754333|567097597|FG000|Overall Study|Lost to Follow-up|2|||
157093641|NCT05754333|567097598|FG001|Overall Study|Lost to Follow-up|1|||
157093642|NCT05754333|567097599|FG002|Overall Study|Lost to Follow-up|0|||
157093643|NCT05754333|567097600|FG003|Overall Study|Lost to Follow-up|1|||
157093644|NCT03864146|567097601|FG000|Overall Study|Lost to Follow-up|14|||
157093645|NCT03864146|567097602|FG001|Overall Study|Lost to Follow-up|23|||
157093646|NCT03864146|567097601|FG000|Overall Study|Withdrawal by Subject|3|||
157093647|NCT03864146|567097602|FG001|Overall Study|Withdrawal by Subject|2|||
157093648|NCT01112306|567097608|FG000|Overall Study|Death|175|||
157093649|NCT01112306|567097608|FG000|Overall Study|Lost to Follow-up|9|||
157093650|NCT01112306|567097608|FG000|Overall Study|Withdrawal by Subject|31|||
157093651|NCT01112306|567097608|FG000|Overall Study|Other|70|||
157093652|NCT00881608|567097609|FG000|Overall Study|Study prematurely terminated|11|||
157093653|NCT00655486|567097615|FG000|Overall Study|Adverse Event|10|||
157093654|NCT00655486|567097615|FG000|Overall Study|Lack of Efficacy|8|||
157093655|NCT00655486|567097615|FG000|Overall Study|Withdrawal by Subject|4|||
157093656|NCT00655486|567097615|FG000|Overall Study|Protocol Violation|1|||
157093657|NCT00655486|567097615|FG000|Overall Study|Unsatisfactory compliance|2|||
157093658|NCT00655486|567097615|FG000|Overall Study|Other: Pregnancy|1|||
157093659|NCT00655486|567097615|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
157093660|NCT00655486|567097615|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
157093661|NCT04218084|567097616|FG000|Overall Study|Adverse Event|7|||
157093662|NCT04218084|567097617|FG001|Overall Study|Adverse Event|2|||
157093663|NCT04218084|567097616|FG000|Overall Study|Withdrawal of Consent|4|||
157093664|NCT04218084|567097617|FG001|Overall Study|Withdrawal of Consent|5|||
157093665|NCT04218084|567097616|FG000|Overall Study|Physician Decision|1|||
157093666|NCT04218084|567097617|FG001|Overall Study|Physician Decision|1|||
157093667|NCT04218084|567097616|FG000|Overall Study|Lost to Follow-up|1|||
157093668|NCT04218084|567097617|FG001|Overall Study|Lost to Follow-up|1|||
157093669|NCT04218084|567097616|FG000|Overall Study|Non-compliance with study drug|1|||
157093670|NCT04218084|567097617|FG001|Overall Study|Non-compliance with study drug|1|||
157093671|NCT04218084|567097616|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
157093672|NCT04218084|567097617|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
157093673|NCT04218084|567097616|FG000|Overall Study|Other|0|||
157093674|NCT04218084|567097617|FG001|Overall Study|Other|1|||
157093675|NCT04218084|567097616|FG000|Overall Study|Ongoing at data cut-off date|62|||
157093676|NCT04218084|567097617|FG001|Overall Study|Ongoing at data cut-off date|58|||
157093677|NCT02783768|567097618|FG000|Overall Study|Lost to Follow-up|1|||
157093678|NCT02783768|567097619|FG001|Overall Study|Lost to Follow-up|0|||
157093679|NCT01853137|567097620|FG000|Overall Study|Lost to Follow-up|4|||
157093680|NCT01853137|567097621|FG001|Overall Study|Lost to Follow-up|1|||
157093681|NCT03401229|567097622|FG000|Overall Study|Lost to Follow-up|2|||
157093682|NCT03401229|567097623|FG001|Overall Study|Lost to Follow-up|1|||
157093683|NCT03401229|567097622|FG000|Overall Study|Other|1|||
157093684|NCT03401229|567097623|FG001|Overall Study|Other|3|||
157093685|NCT03401229|567097622|FG000|Overall Study|Adverse Event|8|||
157093686|NCT03401229|567097623|FG001|Overall Study|Adverse Event|6|||
157093687|NCT03401229|567097622|FG000|Overall Study|Withdrawal by Subject|29|||
157093688|NCT03401229|567097623|FG001|Overall Study|Withdrawal by Subject|26|||
157093689|NCT03401229|567097622|FG000|Overall Study|COVID-19|0|||
157093690|NCT03401229|567097623|FG001|Overall Study|COVID-19|1|||
157093691|NCT05333224|567097624|FG000|Overall Study - Infants|Lost to Follow-up|1|||
157093692|NCT05333224|567097625|FG001|Overall Study - Infants|Lost to Follow-up|1|||
157093693|NCT00848926|567097627|FG000|Treatment Period|Progressive disease|45|||
157093694|NCT00848926|567097627|FG000|Treatment Period|Adverse Event|20|||
157093695|NCT00848926|567097627|FG000|Treatment Period|Physician Decision|12|||
157093696|NCT00848926|567097627|FG000|Treatment Period|Withdrawal by Subject|7|||
157093697|NCT00848926|567097627|FG000|Follow-up Period|Lost to Follow-up|7|||
157093698|NCT00848926|567097627|FG000|Follow-up Period|Withdrawal by Subject|3|||
157093699|NCT00848926|567097627|FG000|Follow-up Period|Other|2|||
157093700|NCT00966277|567097629|FG000|Overall Study|Withdrawal by Subject|3|||
157093701|NCT00966277|567097630|FG001|Overall Study|Withdrawal by Subject|0|||
157093702|NCT00966277|567097629|FG000|Overall Study|Ineligible|1|||
157093703|NCT00966277|567097630|FG001|Overall Study|Ineligible|3|||
157093704|NCT00966277|567097629|FG000|Overall Study|Treatment Plan Changed|0|||
157093705|NCT00966277|567097630|FG001|Overall Study|Treatment Plan Changed|1|||
157093706|NCT04620811|567097632|FG000|Overall Study|Withdrawal by Subject|18|||
157093707|NCT04620811|567097633|FG001|Overall Study|Withdrawal by Subject|15|||
157093708|NCT04620811|567097632|FG000|Overall Study|Adverse Event|6|||
157093709|NCT04620811|567097633|FG001|Overall Study|Adverse Event|11|||
157093710|NCT04620811|567097632|FG000|Overall Study|Lost to Follow-up|4|||
157093711|NCT04620811|567097633|FG001|Overall Study|Lost to Follow-up|8|||
157093712|NCT04620811|567097632|FG000|Overall Study|Physician Decision|1|||
157093713|NCT04620811|567097633|FG001|Overall Study|Physician Decision|4|||
157093714|NCT04620811|567097632|FG000|Overall Study|Sponsor Decision|0|||
157093715|NCT04620811|567097633|FG001|Overall Study|Sponsor Decision|1|||
157093716|NCT04620811|567097632|FG000|Overall Study|Elevation of ALT or AST|1|||
157093717|NCT04620811|567097633|FG001|Overall Study|Elevation of ALT or AST|0|||
157093718|NCT04620811|567097632|FG000|Overall Study|Other|3|||
157093719|NCT04620811|567097633|FG001|Overall Study|Other|5|||
157093720|NCT02481947|567097638|FG000|Overall Study|Withdrawal by Subject|24|||
157093721|NCT02481947|567097639|FG001|Overall Study|Withdrawal by Subject|10|||
157093722|NCT02481947|567097638|FG000|Overall Study|Lost to Follow-up|11|||
157093723|NCT02481947|567097639|FG001|Overall Study|Lost to Follow-up|5|||
157093724|NCT02481947|567097638|FG000|Overall Study|Adverse Event|6|||
157093725|NCT02481947|567097639|FG001|Overall Study|Adverse Event|11|||
157093726|NCT02481947|567097638|FG000|Overall Study|Physician Decision|4|||
157093727|NCT02481947|567097639|FG001|Overall Study|Physician Decision|5|||
157093728|NCT02481947|567097638|FG000|Overall Study|Protocol Violation|1|||
157093729|NCT02481947|567097639|FG001|Overall Study|Protocol Violation|5|||
157093730|NCT02027623|567097640|FG000|Overall Study|Lost to Follow-up|3|||
157093731|NCT02027623|567097641|FG001|Overall Study|Lost to Follow-up|3|||
157093732|NCT02027623|567097640|FG000|Overall Study|Withdrawal by Subject|6|||
157093733|NCT02027623|567097641|FG001|Overall Study|Withdrawal by Subject|9|||
157093734|NCT01886378|567097642|FG000|Overall Study|Adverse Event|1|||
157093735|NCT01886378|567097642|FG000|Overall Study|Withdrawal by Subject|4|||
157093736|NCT02374671|567097651|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
157093737|NCT02374671|567097652|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
157093738|NCT02374671|567097653|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
157093739|NCT02374671|567097651|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
157093740|NCT02374671|567097652|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
157093741|NCT02374671|567097653|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
157093742|NCT02374671|567097651|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
157093743|NCT02374671|567097652|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
157093744|NCT02374671|567097653|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
157093745|NCT02374671|567097651|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
157093746|NCT02374671|567097652|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
157093747|NCT02374671|567097653|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
157093748|NCT02374671|567097651|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
157093749|NCT02374671|567097652|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
157093750|NCT02374671|567097653|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
157093751|NCT03169101|567097654|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
157093752|NCT03169101|567097655|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
157093753|NCT03169101|567097656|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
157093754|NCT03169101|567097657|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
157093755|NCT02641496|567097658|FG000|Overall Study|Lost to Follow-up|13|||
157093756|NCT02641496|567097659|FG001|Overall Study|Lost to Follow-up|12|||
157093757|NCT02641496|567097658|FG000|Overall Study|Withdrawal by Subject|1|||
157093758|NCT02641496|567097659|FG001|Overall Study|Withdrawal by Subject|0|||
157093759|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
157093760|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
157093761|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
157093762|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
157093763|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
157093764|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
157093765|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
157093766|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
157093767|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
157093768|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
157093769|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
157093770|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
157093771|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
157093772|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
157093773|NCT00600886|567097662|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
157093774|NCT00600886|567097663|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
157093775|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
157093776|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
157093777|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
157093778|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
157093779|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
157093780|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
157093781|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
157093782|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
157093783|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
157093784|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
157093785|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
157093786|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
157093787|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Death|1|||
157093788|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Death|1|||
157093789|NCT00600886|567097662|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
157093790|NCT00600886|567097663|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
157093791|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
157093792|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
157093793|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
157093794|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
157093795|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
157093796|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
157093797|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
157093798|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
157093799|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
157093800|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
157093801|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
157093802|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
157093803|NCT00600886|567097662|FG000|Extension - After Crossover (CAS)|Death|1|||
157093804|NCT00600886|567097663|FG001|Extension - After Crossover (CAS)|Death|0|||
157093805|NCT01028027|567097664|FG000|Overall Study|Lost to Follow-up|4|||
157093806|NCT01028027|567097665|FG001|Overall Study|Lost to Follow-up|1|||
157093807|NCT01028027|567097664|FG000|Overall Study|Withdrawal by Subject|5|||
157093808|NCT01028027|567097665|FG001|Overall Study|Withdrawal by Subject|3|||
157093809|NCT01028027|567097664|FG000|Overall Study|Adverse Event|4|||
157093810|NCT01028027|567097665|FG001|Overall Study|Adverse Event|7|||
157093811|NCT01028027|567097664|FG000|Overall Study|Protocol Violation|3|||
157093812|NCT01028027|567097665|FG001|Overall Study|Protocol Violation|1|||
157093813|NCT01028027|567097664|FG000|Overall Study|Lack of Efficacy|0|||
157093814|NCT01028027|567097665|FG001|Overall Study|Lack of Efficacy|1|||
157093815|NCT03035201|567097675|FG000|Overall Study|Death|9|||
157093816|NCT03035201|567097676|FG001|Overall Study|Death|12|||
157093817|NCT03035201|567097677|FG002|Overall Study|Death|9|||
157093818|NCT03035201|567097678|FG003|Overall Study|Death|10|||
157093819|NCT03035201|567097675|FG000|Overall Study|Withdrawal by Subject|51|||
157093820|NCT03035201|567097676|FG001|Overall Study|Withdrawal by Subject|49|||
157093821|NCT03035201|567097677|FG002|Overall Study|Withdrawal by Subject|37|||
157093822|NCT03035201|567097678|FG003|Overall Study|Withdrawal by Subject|46|||
157093823|NCT03035201|567097675|FG000|Overall Study|Lost to Follow-up|67|||
157093824|NCT03035201|567097676|FG001|Overall Study|Lost to Follow-up|51|||
157093825|NCT03035201|567097677|FG002|Overall Study|Lost to Follow-up|64|||
157093826|NCT03035201|567097678|FG003|Overall Study|Lost to Follow-up|69|||
157093827|NCT03727438|567097685|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
157093828|NCT03727438|567097686|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
157093829|NCT03727438|567097685|FG000|Intervention Period|Excluded (health)|1|||
157093830|NCT03727438|567097686|FG001|Intervention Period|Excluded (health)|0|||
157093831|NCT03727438|567097685|FG000|Intervention Period|Withdrawal by Subject|3|||
157093832|NCT03727438|567097686|FG001|Intervention Period|Withdrawal by Subject|1|||
157093833|NCT03727438|567097685|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
157093834|NCT03727438|567097686|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
157093835|NCT03727438|567097685|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
157093836|NCT03727438|567097686|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
157093837|NCT03727438|567097685|FG000|8 Week Assessment|Withdrawal by Subject|6|||
157093838|NCT03727438|567097686|FG001|8 Week Assessment|Withdrawal by Subject|1|||
157093839|NCT03727438|567097685|FG000|6 mo Assessment|did not complete assessment|10|||
157093840|NCT03727438|567097686|FG001|6 mo Assessment|did not complete assessment|11|||
157093841|NCT06729606|567097687|FG000|Overall Study|Adverse Event|0|||
157093842|NCT06729606|567097688|FG001|Overall Study|Adverse Event|2|||
157093843|NCT06729606|567097687|FG000|Overall Study|Death|1|||
157093844|NCT06729606|567097688|FG001|Overall Study|Death|0|||
157093845|NCT06729606|567097687|FG000|Overall Study|Physician Decision|0|||
157093846|NCT06729606|567097688|FG001|Overall Study|Physician Decision|1|||
157093847|NCT06729606|567097687|FG000|Overall Study|Withdrawal by Subject|2|||
157093848|NCT06729606|567097688|FG001|Overall Study|Withdrawal by Subject|4|||
157093849|NCT03170349|567097695|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
157093850|NCT03170349|567097695|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
157093851|NCT03170349|567097695|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
157093852|NCT03170349|567097695|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
157093853|NCT03170349|567097695|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
157093854|NCT03170349|567097695|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
157093855|NCT03170349|567097695|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
157093856|NCT03170349|567097695|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
157093857|NCT03170349|567097695|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
157093858|NCT03170349|567097695|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
157093859|NCT03170349|567097695|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
157093860|NCT03170349|567097695|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
157093861|NCT03170349|567097695|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
157093862|NCT03170349|567097695|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
157093863|NCT03170349|567097695|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
157093864|NCT03170349|567097695|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
157093865|NCT04281004|567099618|FG000|Overall Study|Physician Decision|1|||
157093866|NCT04281004|567099619|FG001|Overall Study|Physician Decision|0|||
157093867|NCT00701779|567099620|FG000|Overall Study|Adverse Event|6|||
157093868|NCT00701779|567099620|FG000|Overall Study|Lost to Follow-up|1|||
157093869|NCT00701779|567099620|FG000|Overall Study|Withdrawal by Subject|2|||
157093870|NCT02245672|567099621|FG000|Overall Study|Adverse Event|4|||
157093871|NCT02245672|567099622|FG001|Overall Study|Adverse Event|4|||
157093872|NCT02245672|567099623|FG002|Overall Study|Adverse Event|4|||
157093873|NCT02245672|567099621|FG000|Overall Study|Lost to Follow-up|3|||
157093874|NCT02245672|567099622|FG001|Overall Study|Lost to Follow-up|5|||
157093875|NCT02245672|567099623|FG002|Overall Study|Lost to Follow-up|1|||
157093876|NCT02245672|567099621|FG000|Overall Study|Withdrawal by Subject|6|||
157093877|NCT02245672|567099622|FG001|Overall Study|Withdrawal by Subject|3|||
157093878|NCT02245672|567099623|FG002|Overall Study|Withdrawal by Subject|0|||
157093879|NCT02245672|567099621|FG000|Overall Study|Randomized in error (not treated)|0|||
157093880|NCT02245672|567099622|FG001|Overall Study|Randomized in error (not treated)|1|||
157093881|NCT02245672|567099623|FG002|Overall Study|Randomized in error (not treated)|0|||
157093882|NCT01217957|567099626|FG000|Phase 1|Withdrawal by Patient|1|||
157093883|NCT01217957|567099627|FG001|Phase 1|Withdrawal by Patient|0|||
157093884|NCT01217957|567099628|FG002|Phase 1|Withdrawal by Patient|1|||
157093885|NCT01217957|567099629|FG003|Phase 1|Withdrawal by Patient|1|||
157093886|NCT01217957|567099630|FG004|Phase 1|Withdrawal by Patient|0|||
157093887|NCT01217957|567099626|FG000|Phase 2|Withdrawal by Patient|0|||
157093888|NCT01217957|567099627|FG001|Phase 2|Withdrawal by Patient|0|||
157093889|NCT01217957|567099628|FG002|Phase 2|Withdrawal by Patient|0|||
157093890|NCT01217957|567099629|FG003|Phase 2|Withdrawal by Patient|0|||
157093891|NCT01217957|567099630|FG004|Phase 2|Withdrawal by Patient|1|||
157093892|NCT00971932|567099631|FG000|Overall Study|Withdrawal by Subject|1|||
157093893|NCT00971932|567099631|FG000|Overall Study|Investigator's decision|2|||
157093894|NCT00971932|567099631|FG000|Overall Study|Ongoing|4|||
157093895|NCT01640054|567099632|FG000|Overall Study|Study-specific disc criteria|1|||
157093896|NCT01640054|567099632|FG000|Overall Study|Lack of Efficacy|3|||
157093897|NCT01640054|567099632|FG000|Overall Study|Adverse Event|2|||
157093898|NCT01620255|567099636|FG000|Overall Study|Withdrawal by Subject|4|||
157093899|NCT01620255|567099637|FG001|Overall Study|Withdrawal by Subject|1|||
157093900|NCT01620255|567099638|FG002|Overall Study|Withdrawal by Subject|1|||
157093901|NCT01620255|567099639|FG003|Overall Study|Withdrawal by Subject|2|||
157093902|NCT01620255|567099640|FG004|Overall Study|Withdrawal by Subject|4|||
157093903|NCT01620255|567099636|FG000|Overall Study|Participant underwent fecal transplant|0|||
157093904|NCT01620255|567099637|FG001|Overall Study|Participant underwent fecal transplant|0|||
157093905|NCT01620255|567099638|FG002|Overall Study|Participant underwent fecal transplant|1|||
157093906|NCT01620255|567099639|FG003|Overall Study|Participant underwent fecal transplant|0|||
157093907|NCT01620255|567099640|FG004|Overall Study|Participant underwent fecal transplant|0|||
157093908|NCT01620255|567099636|FG000|Overall Study|Non-compliance|0|||
157093909|NCT01620255|567099637|FG001|Overall Study|Non-compliance|1|||
157093910|NCT01620255|567099638|FG002|Overall Study|Non-compliance|0|||
157093911|NCT01620255|567099639|FG003|Overall Study|Non-compliance|0|||
157093912|NCT01620255|567099640|FG004|Overall Study|Non-compliance|0|||
157093913|NCT01620255|567099636|FG000|Overall Study|Adverse Event|0|||
157093914|NCT01620255|567099637|FG001|Overall Study|Adverse Event|4|||
157093915|NCT01620255|567099638|FG002|Overall Study|Adverse Event|0|||
157093916|NCT01620255|567099639|FG003|Overall Study|Adverse Event|1|||
157093917|NCT01620255|567099640|FG004|Overall Study|Adverse Event|1|||
157093918|NCT01620255|567099636|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
157093919|NCT01620255|567099637|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
157093920|NCT01620255|567099638|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
157093921|NCT01620255|567099639|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
157093922|NCT01620255|567099640|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
157093923|NCT01206777|567099646|FG000|Overall Study|Death|1|||
157093924|NCT01206777|567099646|FG000|Overall Study|Adverse Event|1|||
157093925|NCT01122862|567099649|FG000|Period 1|Protocol Violation|0|||
157093926|NCT01122862|567099650|FG001|Period 1|Protocol Violation|1|||
157093927|NCT01122862|567099651|FG002|Period 1|Protocol Violation|0|||
157093928|NCT01122862|567099649|FG000|Period 2|Adverse Event|0|||
157093929|NCT01122862|567099650|FG001|Period 2|Adverse Event|0|||
157093930|NCT01122862|567099651|FG002|Period 2|Adverse Event|1|||
157093931|NCT02070588|567099657|FG000|Overall Study|Withdrawal by Subject|29|||
157093932|NCT02070588|567099658|FG001|Overall Study|Withdrawal by Subject|1|||
157093933|NCT02070588|567099659|FG002|Overall Study|Withdrawal by Subject|0|||
157093934|NCT02070588|567099657|FG000|Overall Study|Writhdrawal due to early termination|9|||
157093935|NCT02070588|567099658|FG001|Overall Study|Writhdrawal due to early termination|0|||
157093936|NCT02070588|567099659|FG002|Overall Study|Writhdrawal due to early termination|0|||
157093937|NCT02070588|567099657|FG000|Overall Study|Adverse Event|1|||
157093938|NCT02070588|567099658|FG001|Overall Study|Adverse Event|0|||
157093939|NCT02070588|567099659|FG002|Overall Study|Adverse Event|0|||
157093940|NCT01790126|567099660|FG000|Overall Study|PSA Progression|12|||
157093941|NCT01790126|567099661|FG001|Overall Study|PSA Progression|16|||
157093942|NCT01790126|567099662|FG002|Overall Study|PSA Progression|16|||
157093943|NCT01790126|567099660|FG000|Overall Study|Other|5|||
157093944|NCT01790126|567099661|FG001|Overall Study|Other|4|||
157093945|NCT01790126|567099662|FG002|Overall Study|Other|8|||
157093946|NCT01790126|567099660|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
157093947|NCT01790126|567099661|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
157093948|NCT01790126|567099662|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
157093949|NCT01790126|567099660|FG000|Overall Study|Withdrawal by Physician|1|||
157093950|NCT01790126|567099661|FG001|Overall Study|Withdrawal by Physician|1|||
157093951|NCT01790126|567099662|FG002|Overall Study|Withdrawal by Physician|2|||
157093952|NCT01790126|567099660|FG000|Overall Study|Withdrawal by Subject|3|||
157093953|NCT01790126|567099661|FG001|Overall Study|Withdrawal by Subject|1|||
157093954|NCT01790126|567099662|FG002|Overall Study|Withdrawal by Subject|2|||
157093955|NCT01790126|567099660|FG000|Overall Study|Lost to Follow-up|1|||
157093956|NCT01790126|567099661|FG001|Overall Study|Lost to Follow-up|0|||
157093957|NCT01790126|567099662|FG002|Overall Study|Lost to Follow-up|1|||
157093958|NCT01790126|567099660|FG000|Overall Study|Adverse Event|0|||
157093959|NCT01790126|567099661|FG001|Overall Study|Adverse Event|2|||
157093960|NCT01790126|567099662|FG002|Overall Study|Adverse Event|0|||
157093961|NCT01790126|567099660|FG000|Overall Study|Death|2|||
157093962|NCT01790126|567099661|FG001|Overall Study|Death|0|||
157093963|NCT01790126|567099662|FG002|Overall Study|Death|0|||
157093964|NCT01790126|567099660|FG000|Overall Study|Radiographic Progression|3|||
157093965|NCT01790126|567099661|FG001|Overall Study|Radiographic Progression|1|||
157093966|NCT01790126|567099662|FG002|Overall Study|Radiographic Progression|0|||
157093967|NCT00819390|567099664|FG000|Overall Study|Lost to Follow-up|1|||
157093968|NCT00819390|567099665|FG001|Overall Study|Lost to Follow-up|1|||
157093969|NCT00819390|567099666|FG002|Overall Study|Lost to Follow-up|0|||
157093970|NCT00819390|567099667|FG003|Overall Study|Lost to Follow-up|0|||
157093971|NCT00819390|567099664|FG000|Overall Study|Withdrawal by Subject|2|||
157093972|NCT00819390|567099665|FG001|Overall Study|Withdrawal by Subject|0|||
157093973|NCT00819390|567099666|FG002|Overall Study|Withdrawal by Subject|0|||
157093974|NCT00819390|567099667|FG003|Overall Study|Withdrawal by Subject|0|||
157093975|NCT00819390|567099664|FG000|Overall Study|Adverse Event|0|||
157093976|NCT00819390|567099665|FG001|Overall Study|Adverse Event|0|||
157093977|NCT00819390|567099666|FG002|Overall Study|Adverse Event|1|||
157093978|NCT00819390|567099667|FG003|Overall Study|Adverse Event|0|||
157093979|NCT00551460|567099668|FG000|Overall Study|Adverse Event|1|||
157093980|NCT00551460|567099668|FG000|Overall Study|Withdrawal by Subject|1|||
157093981|NCT00551460|567099668|FG000|Overall Study|Physician Decision|1|||
157093982|NCT00551460|567099668|FG000|Overall Study|Death|7|||
157093983|NCT00551460|567099668|FG000|Overall Study|Ineligible|4|||
157093984|NCT00551460|567099668|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
157093985|NCT01209780|567099669|FG000|Overall Study|Adverse Event|0|||
157093986|NCT01209780|567099670|FG001|Overall Study|Adverse Event|1|||
157093987|NCT01209780|567099671|FG002|Overall Study|Adverse Event|0|||
157093988|NCT01209780|567099672|FG003|Overall Study|Adverse Event|0|||
157093989|NCT01209780|567099673|FG004|Overall Study|Adverse Event|0|||
157093990|NCT01209780|567099669|FG000|Overall Study|Withdrawal by Subject|9|||
157093991|NCT01209780|567099670|FG001|Overall Study|Withdrawal by Subject|2|||
157093992|NCT01209780|567099671|FG002|Overall Study|Withdrawal by Subject|1|||
157093993|NCT01209780|567099672|FG003|Overall Study|Withdrawal by Subject|1|||
157093994|NCT01209780|567099673|FG004|Overall Study|Withdrawal by Subject|0|||
157093995|NCT01209780|567099669|FG000|Overall Study|Lost to Follow-up|17|||
157093996|NCT01209780|567099670|FG001|Overall Study|Lost to Follow-up|12|||
157093997|NCT01209780|567099671|FG002|Overall Study|Lost to Follow-up|3|||
157093998|NCT01209780|567099672|FG003|Overall Study|Lost to Follow-up|9|||
157093999|NCT01209780|567099673|FG004|Overall Study|Lost to Follow-up|4|||
157094000|NCT01209780|567099669|FG000|Overall Study|Protocol Violation|0|||
157094001|NCT01209780|567099670|FG001|Overall Study|Protocol Violation|1|||
157094002|NCT01209780|567099671|FG002|Overall Study|Protocol Violation|0|||
157094003|NCT01209780|567099672|FG003|Overall Study|Protocol Violation|0|||
157094004|NCT01209780|567099673|FG004|Overall Study|Protocol Violation|0|||
157094005|NCT01209780|567099669|FG000|Overall Study|Inappropriate enrollment|0|||
157094006|NCT01209780|567099670|FG001|Overall Study|Inappropriate enrollment|2|||
157094007|NCT01209780|567099671|FG002|Overall Study|Inappropriate enrollment|0|||
157094008|NCT01209780|567099672|FG003|Overall Study|Inappropriate enrollment|0|||
157094009|NCT01209780|567099673|FG004|Overall Study|Inappropriate enrollment|1|||
157094010|NCT02709096|567099677|FG000|Overall Study|non-compliance|1|||
157094011|NCT02709096|567099678|FG001|Overall Study|non-compliance|1|||
157094012|NCT00818649|567099679|FG000|Overall Study|Declining performance status|2|||
157094013|NCT00818649|567099679|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
157094014|NCT00818649|567099679|FG000|Overall Study|Adverse Event|1|||
157094015|NCT00505284|567099680|FG000|Overall Study|Adverse Event|3|||
157094016|NCT00505284|567099681|FG001|Overall Study|Adverse Event|7|||
157094017|NCT00505284|567099682|FG002|Overall Study|Adverse Event|9|||
157094018|NCT00505284|567099683|FG003|Overall Study|Adverse Event|14|||
157094019|NCT00505284|567099684|FG004|Overall Study|Adverse Event|22|||
157094020|NCT00505284|567099680|FG000|Overall Study|Protocol Violation|0|||
157094021|NCT00505284|567099681|FG001|Overall Study|Protocol Violation|1|||
157094022|NCT00505284|567099682|FG002|Overall Study|Protocol Violation|1|||
157094023|NCT00505284|567099683|FG003|Overall Study|Protocol Violation|0|||
157094024|NCT00505284|567099684|FG004|Overall Study|Protocol Violation|0|||
157094025|NCT00505284|567099680|FG000|Overall Study|Withdrawal by Subject|2|||
157094026|NCT00505284|567099681|FG001|Overall Study|Withdrawal by Subject|6|||
157094027|NCT00505284|567099682|FG002|Overall Study|Withdrawal by Subject|1|||
157094028|NCT00505284|567099683|FG003|Overall Study|Withdrawal by Subject|0|||
157094029|NCT00505284|567099684|FG004|Overall Study|Withdrawal by Subject|6|||
157094030|NCT00505284|567099680|FG000|Overall Study|Lack of Efficacy|0|||
157094031|NCT00505284|567099681|FG001|Overall Study|Lack of Efficacy|1|||
157094032|NCT00505284|567099682|FG002|Overall Study|Lack of Efficacy|1|||
157094033|NCT00505284|567099683|FG003|Overall Study|Lack of Efficacy|1|||
157094034|NCT00505284|567099684|FG004|Overall Study|Lack of Efficacy|1|||
157094035|NCT00505284|567099680|FG000|Overall Study|Physician Decision|0|||
157094036|NCT00505284|567099681|FG001|Overall Study|Physician Decision|1|||
157094037|NCT00505284|567099682|FG002|Overall Study|Physician Decision|0|||
157094038|NCT00505284|567099683|FG003|Overall Study|Physician Decision|0|||
157094039|NCT00505284|567099684|FG004|Overall Study|Physician Decision|0|||
157094040|NCT00505284|567099680|FG000|Overall Study|Other|5|||
157094041|NCT00505284|567099681|FG001|Overall Study|Other|0|||
157094042|NCT00505284|567099682|FG002|Overall Study|Other|0|||
157094043|NCT00505284|567099683|FG003|Overall Study|Other|4|||
157094044|NCT00505284|567099684|FG004|Overall Study|Other|4|||
157094045|NCT03513588|567099685|FG000|Overall Study|Lost to Follow-up|0|||
157094046|NCT03513588|567099686|FG001|Overall Study|Lost to Follow-up|1|||
157094047|NCT03513588|567099687|FG002|Overall Study|Lost to Follow-up|1|||
157094048|NCT03513588|567099685|FG000|Overall Study|Study dosing paused by sponsor|1|||
157094049|NCT03513588|567099686|FG001|Overall Study|Study dosing paused by sponsor|1|||
157094050|NCT03513588|567099687|FG002|Overall Study|Study dosing paused by sponsor|0|||
157094051|NCT03513588|567099685|FG000|Overall Study|Death|0|||
157094052|NCT03513588|567099686|FG001|Overall Study|Death|0|||
157094053|NCT03513588|567099687|FG002|Overall Study|Death|1|||
157094054|NCT01275131|567099688|FG000|Period 1|Withdrawal by Subject|1|||
157094055|NCT01275131|567099689|FG001|Period 1|Withdrawal by Subject|0|||
157094056|NCT01275131|567099690|FG002|Period 1|Withdrawal by Subject|3|||
157094057|NCT01275131|567099691|FG003|Period 1|Withdrawal by Subject|2|||
157094058|NCT01275131|567099688|FG000|Period 1|Physician Decision|1|||
157094059|NCT01275131|567099689|FG001|Period 1|Physician Decision|0|||
157094060|NCT01275131|567099690|FG002|Period 1|Physician Decision|0|||
157094061|NCT01275131|567099691|FG003|Period 1|Physician Decision|0|||
157094062|NCT01275131|567099688|FG000|Period 2 (Crossover)|Adverse Event|0|||
157094063|NCT01275131|567099689|FG001|Period 2 (Crossover)|Adverse Event|1|||
157094064|NCT01275131|567099690|FG002|Period 2 (Crossover)|Adverse Event|0|||
157094065|NCT01275131|567099691|FG003|Period 2 (Crossover)|Adverse Event|0|||
157094066|NCT01275131|567099688|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
157094067|NCT01275131|567099689|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
157094068|NCT01275131|567099690|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
157094069|NCT01275131|567099691|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
157094070|NCT01740323|567099692|FG000|Overall Study|Adverse Event|1|||
157094071|NCT01740323|567099693|FG001|Overall Study|Adverse Event|0|||
157094072|NCT01740323|567099692|FG000|Overall Study|Randomized but did not take study drug|1|||
157094073|NCT01740323|567099693|FG001|Overall Study|Randomized but did not take study drug|0|||
157094074|NCT02112708|567099698|FG000|Baseline|Physician Decision|16|||
157094075|NCT02112708|567099699|FG001|Baseline|Physician Decision|11|||
157094076|NCT02112708|567099698|FG000|Baseline|Lost to Follow-up|12|||
157094077|NCT02112708|567099699|FG001|Baseline|Lost to Follow-up|0|||
157094078|NCT02112708|567099698|FG000|4 Month|Death|0|||
157094079|NCT02112708|567099699|FG001|4 Month|Death|1|||
157094080|NCT02112708|567099698|FG000|4 Month|Withdrawal by Subject|12|||
157094081|NCT02112708|567099699|FG001|4 Month|Withdrawal by Subject|0|||
157094082|NCT00953745|567099700|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
157094083|NCT00953745|567099701|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
157094084|NCT00953745|567099700|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
157094085|NCT00953745|567099701|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
157094086|NCT00953745|567099700|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
157094087|NCT00953745|567099701|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
157094088|NCT00953745|567099700|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
157094089|NCT00953745|567099701|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
157094090|NCT00953745|567099700|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
156979451|NCT00077636|566678935|FG000|Overall Study|Admin|3|||
156979452|NCT00077636|566678936|FG001|Overall Study|Admin|3|||
156979453|NCT00077636|566678935|FG000|Overall Study|Withdrawal by Subject|2|||
156979454|NCT00077636|566678936|FG001|Overall Study|Withdrawal by Subject|2|||
156979455|NCT00077636|566678935|FG000|Overall Study|Adverse Event|17|||
156979456|NCT00077636|566678936|FG001|Overall Study|Adverse Event|34|||
156979457|NCT00077636|566678935|FG000|Overall Study|Protocol Violation|0|||
156979458|NCT00077636|566678936|FG001|Overall Study|Protocol Violation|2|||
156979459|NCT00077636|566678935|FG000|Overall Study|Lost to Follow-up|10|||
156979460|NCT00077636|566678936|FG001|Overall Study|Lost to Follow-up|18|||
156979461|NCT00077636|566678935|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
156979462|NCT00077636|566678936|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
156979463|NCT00603265|566678937|FG000|Overall Study|Adverse Event|2|||
156979464|NCT00603265|566678938|FG001|Overall Study|Adverse Event|11|||
156979465|NCT00603265|566678939|FG002|Overall Study|Adverse Event|1|||
157094091|NCT00953745|567099701|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
157094092|NCT00953745|567099700|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
157094093|NCT00953745|567099701|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
157094094|NCT00903682|567099704|FG000|Overall Study|Adverse Event|6|||
157094095|NCT00903682|567099705|FG001|Overall Study|Adverse Event|13|||
157094096|NCT00903682|567099704|FG000|Overall Study|Lost to Follow-up|1|||
157094097|NCT00903682|567099705|FG001|Overall Study|Lost to Follow-up|0|||
157094098|NCT00903682|567099704|FG000|Overall Study|Withdrawal by Subject|5|||
157094099|NCT00903682|567099705|FG001|Overall Study|Withdrawal by Subject|0|||
157094100|NCT00903682|567099704|FG000|Overall Study|Pregnancy|0|||
157094101|NCT00903682|567099705|FG001|Overall Study|Pregnancy|1|||
157094102|NCT00903682|567099704|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
157094103|NCT00903682|567099705|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
157094104|NCT00903682|567099704|FG000|Overall Study|Subject Non-Compliant|1|||
157094105|NCT00903682|567099705|FG001|Overall Study|Subject Non-Compliant|0|||
157094106|NCT00903682|567099704|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
157094107|NCT00903682|567099705|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
157094108|NCT00903682|567099704|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
157094109|NCT00903682|567099705|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
157094110|NCT03110185|567099707|FG000|Overall Study|Death|0|||
157094111|NCT03110185|567099708|FG001|Overall Study|Death|1|||
157094112|NCT03110185|567099707|FG000|Overall Study|Withdrawal by Subject|2|||
157094113|NCT03110185|567099708|FG001|Overall Study|Withdrawal by Subject|7|||
157094114|NCT03110185|567099707|FG000|Overall Study|Time Constraints|0|||
157094115|NCT03110185|567099708|FG001|Overall Study|Time Constraints|6|||
157094116|NCT03110185|567099707|FG000|Overall Study|Conflict with care|5|||
157094117|NCT03110185|567099708|FG001|Overall Study|Conflict with care|12|||
157094118|NCT03110185|567099707|FG000|Overall Study|Protocol Violation|1|||
157094119|NCT03110185|567099708|FG001|Overall Study|Protocol Violation|4|||
157094120|NCT03110185|567099707|FG000|Overall Study|MRI Incompatible|2|||
157094121|NCT03110185|567099708|FG001|Overall Study|MRI Incompatible|0|||
157094122|NCT03110185|567099707|FG000|Overall Study|Patient Refusal|0|||
157094123|NCT03110185|567099708|FG001|Overall Study|Patient Refusal|1|||
157094124|NCT02053792|567099709|FG000|Overall Study|Physician Decision|0|||
157094125|NCT02053792|567099710|FG001|Overall Study|Physician Decision|1|||
157094126|NCT02053792|567099709|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
157094127|NCT02053792|567099710|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
157094128|NCT02053792|567099709|FG000|Overall Study|Lack of Efficacy|1|||
157094129|NCT02053792|567099710|FG001|Overall Study|Lack of Efficacy|0|||
157094130|NCT02053792|567099709|FG000|Overall Study|Adverse Event|1|||
157094131|NCT02053792|567099710|FG001|Overall Study|Adverse Event|0|||
157094132|NCT02053792|567099709|FG000|Overall Study|Withdrawal by Subject|2|||
157094133|NCT02053792|567099710|FG001|Overall Study|Withdrawal by Subject|2|||
157094134|NCT02053792|567099709|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
157094135|NCT02053792|567099710|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
157094136|NCT02053792|567099709|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
157094137|NCT02053792|567099710|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
157094138|NCT03075410|567099711|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
157094139|NCT03075410|567099712|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
157094140|NCT03075410|567099713|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
157094141|NCT03075410|567099714|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
156979466|NCT00603265|566678937|FG000|Overall Study|Withdrawal by Subject|1|||
157094142|NCT03075410|567099715|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
157094143|NCT03075410|567099716|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
157094144|NCT03075410|567099717|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
157094145|NCT03075410|567099718|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
157221630|NCT01644890|567558454|FG001|Overall Study|Protocol Violation|7|||
156979467|NCT00603265|566678938|FG001|Overall Study|Withdrawal by Subject|2|||
156979468|NCT00603265|566678939|FG002|Overall Study|Withdrawal by Subject|1|||
156979469|NCT00603265|566678937|FG000|Overall Study|Lack of Efficacy|3|||
156979470|NCT00603265|566678938|FG001|Overall Study|Lack of Efficacy|0|||
156979471|NCT00603265|566678939|FG002|Overall Study|Lack of Efficacy|3|||
156979472|NCT00603265|566678937|FG000|Overall Study|Lost to Follow-up|0|||
156979473|NCT00603265|566678938|FG001|Overall Study|Lost to Follow-up|1|||
156979474|NCT00603265|566678939|FG002|Overall Study|Lost to Follow-up|0|||
156979475|NCT00603265|566678937|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
156979476|NCT00603265|566678938|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
156979477|NCT00603265|566678939|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
156979478|NCT00603265|566678937|FG000|Overall Study|Participant Left Country, No Responses|0|||
156979479|NCT00603265|566678938|FG001|Overall Study|Participant Left Country, No Responses|1|||
156979480|NCT00603265|566678939|FG002|Overall Study|Participant Left Country, No Responses|0|||
156979481|NCT00603265|566678937|FG000|Overall Study|Protocol Violation|1|||
156979482|NCT00603265|566678938|FG001|Overall Study|Protocol Violation|0|||
156979483|NCT00603265|566678939|FG002|Overall Study|Protocol Violation|0|||
156979484|NCT02961881|566678940|FG000|Overall Study|Adverse Event|1|||
156979485|NCT02961881|566678941|FG001|Overall Study|Adverse Event|2|||
156979486|NCT02961881|566678942|FG002|Overall Study|Adverse Event|2|||
156979487|NCT02961881|566678943|FG003|Overall Study|Adverse Event|0|||
156979488|NCT02961881|566678944|FG004|Overall Study|Adverse Event|1|||
156979489|NCT02961881|566678940|FG000|Overall Study|Participant request|0|||
156979490|NCT02961881|566678941|FG001|Overall Study|Participant request|2|||
156979491|NCT02961881|566678942|FG002|Overall Study|Participant request|0|||
156979492|NCT02961881|566678943|FG003|Overall Study|Participant request|0|||
156979493|NCT02961881|566678944|FG004|Overall Study|Participant request|0|||
156979494|NCT02961881|566678940|FG000|Overall Study|Disease progression|1|||
156979495|NCT02961881|566678941|FG001|Overall Study|Disease progression|0|||
156979496|NCT02961881|566678942|FG002|Overall Study|Disease progression|1|||
156979497|NCT02961881|566678943|FG003|Overall Study|Disease progression|0|||
156979498|NCT02961881|566678944|FG004|Overall Study|Disease progression|0|||
156979499|NCT00451217|566678949|FG000|Overall Study|Lost to Follow-up|0|||
156979500|NCT00451217|566678950|FG001|Overall Study|Lost to Follow-up|1|||
156979501|NCT00451217|566678951|FG002|Overall Study|Lost to Follow-up|1|||
156979502|NCT00451217|566678952|FG003|Overall Study|Lost to Follow-up|1|||
156979503|NCT00451217|566678949|FG000|Overall Study|Withdrawal by Subject|1|||
156979504|NCT00451217|566678950|FG001|Overall Study|Withdrawal by Subject|0|||
156979505|NCT00451217|566678951|FG002|Overall Study|Withdrawal by Subject|0|||
156979506|NCT00451217|566678952|FG003|Overall Study|Withdrawal by Subject|0|||
156979507|NCT00451217|566678949|FG000|Overall Study|Not Treated|1|||
156979508|NCT00451217|566678950|FG001|Overall Study|Not Treated|1|||
156979509|NCT00451217|566678951|FG002|Overall Study|Not Treated|3|||
156979510|NCT00451217|566678952|FG003|Overall Study|Not Treated|4|||
156979511|NCT03154359|566678953|FG000|Overall Study|Adverse Event|1|||
156979512|NCT03154359|566678953|FG000|Overall Study|Lack of Efficacy|2|||
156979513|NCT03154359|566678953|FG000|Overall Study|Lost to Follow-up|3|||
156979514|NCT03154359|566678953|FG000|Overall Study|Physician Decision|3|||
156979515|NCT03154359|566678953|FG000|Overall Study|Protocol Violation|4|||
156979516|NCT03154359|566678953|FG000|Overall Study|Withdrawal by Subject|5|||
156979517|NCT03154359|566678953|FG000|Overall Study|Disruption of study due to COVID-19|4|||
156979518|NCT00569803|566678959|FG000|Overall Study|Lost to Follow-up|1|||
156979519|NCT00569803|566678960|FG001|Overall Study|Lost to Follow-up|0|||
156979520|NCT00569803|566678961|FG002|Overall Study|Lost to Follow-up|0|||
156979521|NCT00569803|566678962|FG003|Overall Study|Lost to Follow-up|0|||
156979522|NCT00569803|566678963|FG004|Overall Study|Lost to Follow-up|0|||
156979523|NCT00569803|566678964|FG005|Overall Study|Lost to Follow-up|0|||
156979524|NCT00569803|566678965|FG006|Overall Study|Lost to Follow-up|0|||
156979525|NCT00569803|566678966|FG007|Overall Study|Lost to Follow-up|0|||
156979526|NCT00569803|566678959|FG000|Overall Study|injection syringe leaked during dosing|0|||
156979527|NCT00569803|566678960|FG001|Overall Study|injection syringe leaked during dosing|0|||
156979528|NCT00569803|566678961|FG002|Overall Study|injection syringe leaked during dosing|0|||
156979529|NCT00569803|566678962|FG003|Overall Study|injection syringe leaked during dosing|1|||
156979530|NCT00569803|566678963|FG004|Overall Study|injection syringe leaked during dosing|0|||
156979531|NCT00569803|566678964|FG005|Overall Study|injection syringe leaked during dosing|0|||
156979532|NCT00569803|566678965|FG006|Overall Study|injection syringe leaked during dosing|0|||
156979533|NCT00569803|566678966|FG007|Overall Study|injection syringe leaked during dosing|0|||
156979534|NCT00569803|566678959|FG000|Overall Study|Withdrawal by Subject|0|||
156979535|NCT00569803|566678960|FG001|Overall Study|Withdrawal by Subject|0|||
156979536|NCT00569803|566678961|FG002|Overall Study|Withdrawal by Subject|0|||
156979537|NCT00569803|566678962|FG003|Overall Study|Withdrawal by Subject|0|||
156979538|NCT00569803|566678963|FG004|Overall Study|Withdrawal by Subject|0|||
156979539|NCT00569803|566678964|FG005|Overall Study|Withdrawal by Subject|0|||
156979540|NCT00569803|566678965|FG006|Overall Study|Withdrawal by Subject|0|||
156979541|NCT00569803|566678966|FG007|Overall Study|Withdrawal by Subject|1|||
156979542|NCT01592695|566678969|FG000|Overall Study|Lost to Follow-up|8|||
156979543|NCT01592695|566678970|FG001|Overall Study|Lost to Follow-up|4|||
156979544|NCT03029780|566678971|FG000|Overall Study|Disease Progression|20|||
156979545|NCT03029780|566678972|FG001|Overall Study|Disease Progression|22|||
156979546|NCT03029780|566678971|FG000|Overall Study|Study Drug Toxicity|15|||
157094146|NCT03075410|567099719|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
157094147|NCT03075410|567099711|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
157094148|NCT03075410|567099712|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094149|NCT03075410|567099713|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094150|NCT03075410|567099714|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094151|NCT03075410|567099715|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094152|NCT03075410|567099716|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094153|NCT03075410|567099717|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094154|NCT03075410|567099718|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094155|NCT03075410|567099719|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
157094156|NCT01427751|567099720|FG000|Overall Study|Adverse Event|18|||
157094157|NCT01427751|567099721|FG001|Overall Study|Adverse Event|2|||
157094158|NCT01427751|567099720|FG000|Overall Study|No further treatment benefit expected|5|||
157094159|NCT01427751|567099721|FG001|Overall Study|No further treatment benefit expected|1|||
157094160|NCT01427751|567099720|FG000|Overall Study|Lost to Follow-up|3|||
157094161|NCT01427751|567099721|FG001|Overall Study|Lost to Follow-up|1|||
157094162|NCT01427751|567099720|FG000|Overall Study|Withdrawal of consent|2|||
157094163|NCT01427751|567099721|FG001|Overall Study|Withdrawal of consent|2|||
157094164|NCT01427751|567099720|FG000|Overall Study|Protocol Violation|6|||
157094165|NCT01427751|567099721|FG001|Overall Study|Protocol Violation|4|||
157094166|NCT01427751|567099720|FG000|Overall Study|Death|2|||
157094167|NCT01427751|567099721|FG001|Overall Study|Death|0|||
157094168|NCT01427751|567099720|FG000|Overall Study|Other miscellaneous reasons|6|||
157094169|NCT01427751|567099721|FG001|Overall Study|Other miscellaneous reasons|4|||
157094170|NCT00368992|567099728|FG000|Overall Study|Ineligible|5|||
157094171|NCT00368992|567099728|FG000|Overall Study|Refused treatment|3|||
157094172|NCT00368992|567099728|FG000|Overall Study|Lack of Efficacy|63|||
157094173|NCT00368992|567099728|FG000|Overall Study|Adverse Event|26|||
157094174|NCT00368992|567099728|FG000|Overall Study|Death|4|||
157094175|NCT00368992|567099728|FG000|Overall Study|Other|9|||
156979547|NCT03029780|566678972|FG001|Overall Study|Study Drug Toxicity|11|||
156979548|NCT03029780|566678971|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156979549|NCT03029780|566678972|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156979550|NCT03029780|566678971|FG000|Overall Study|Participant request to discontinue study treatment|4|||
156979551|NCT03029780|566678972|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156979552|NCT03029780|566678971|FG000|Overall Study|Maximum clinical benefit|1|||
156979553|NCT03029780|566678972|FG001|Overall Study|Maximum clinical benefit|0|||
156979554|NCT03029780|566678971|FG000|Overall Study|Participant no longer meets study criteria|0|||
156979555|NCT03029780|566678972|FG001|Overall Study|Participant no longer meets study criteria|1|||
156979556|NCT03029780|566678971|FG000|Overall Study|Other reasons|6|||
156979557|NCT03029780|566678972|FG001|Overall Study|Other reasons|6|||
156979558|NCT03029780|566678971|FG000|Overall Study|Not reported|1|||
156979559|NCT03029780|566678972|FG001|Overall Study|Not reported|1|||
156979560|NCT03029780|566678971|FG000|Overall Study|Death|2|||
156979561|NCT03029780|566678972|FG001|Overall Study|Death|6|||
156979562|NCT03066622|566678973|FG000|Overall Study|Lost to Follow-up|24|||
156979563|NCT03066622|566678974|FG001|Overall Study|Lost to Follow-up|25|||
156979564|NCT03066622|566678973|FG000|Overall Study|Withdrawal by Subject|2|||
156979565|NCT03066622|566678974|FG001|Overall Study|Withdrawal by Subject|1|||
156979566|NCT00641719|566678975|FG000|Overall Study|Lack of Efficacy|1|||
156979567|NCT00641719|566678976|FG001|Overall Study|Lack of Efficacy|2|||
156979568|NCT00641719|566678975|FG000|Overall Study|Adverse Event|24|||
156979569|NCT00641719|566678976|FG001|Overall Study|Adverse Event|29|||
156979570|NCT00641719|566678975|FG000|Overall Study|Withdrawal by Subject|4|||
156979571|NCT00641719|566678976|FG001|Overall Study|Withdrawal by Subject|4|||
156979572|NCT00641719|566678975|FG000|Overall Study|Reason Not Specified|1|||
156979573|NCT00641719|566678976|FG001|Overall Study|Reason Not Specified|2|||
156979574|NCT03321006|566678977|FG000|Overall Study|Death|1|||
156979575|NCT03321006|566678978|FG001|Overall Study|Death|0|||
156979576|NCT03321006|566678977|FG000|Overall Study|Lack of Efficacy|1|||
156979577|NCT03321006|566678978|FG001|Overall Study|Lack of Efficacy|0|||
156979578|NCT00885352|566678981|FG000|Overall Study|Adverse Event|2|||
156979579|NCT00885352|566678982|FG001|Overall Study|Adverse Event|3|||
156979580|NCT00885352|566678981|FG000|Overall Study|Lost to Follow-up|2|||
156979581|NCT00885352|566678982|FG001|Overall Study|Lost to Follow-up|2|||
156979582|NCT00885352|566678981|FG000|Overall Study|Physician Decision|0|||
156979583|NCT00885352|566678982|FG001|Overall Study|Physician Decision|3|||
156979584|NCT00885352|566678981|FG000|Overall Study|Protocol Violation|0|||
156979585|NCT00885352|566678982|FG001|Overall Study|Protocol Violation|2|||
156979586|NCT00885352|566678981|FG000|Overall Study|Withdrawal by Subject|1|||
156979587|NCT00885352|566678982|FG001|Overall Study|Withdrawal by Subject|5|||
156979588|NCT00885352|566678981|FG000|Overall Study|Contradiction to study medication|0|||
156979589|NCT00885352|566678982|FG001|Overall Study|Contradiction to study medication|2|||
156979590|NCT00885352|566678981|FG000|Overall Study|Excluded medication|2|||
156979591|NCT00885352|566678982|FG001|Overall Study|Excluded medication|2|||
156979592|NCT00885352|566678981|FG000|Overall Study|Lab abnormalities|1|||
156979593|NCT00885352|566678982|FG001|Overall Study|Lab abnormalities|1|||
156979594|NCT04741802|566678983|FG000|Overall Study|Death|1|||
156979595|NCT04741802|566678983|FG000|Overall Study|Lost to Follow-up|11|||
156979596|NCT03560258|566678984|FG000|Overall Study|Lost to Follow-up|3|||
156979597|NCT03560258|566678985|FG001|Overall Study|Lost to Follow-up|0|||
156979598|NCT03560258|566678986|FG002|Overall Study|Lost to Follow-up|0|||
156979599|NCT03560258|566678984|FG000|Overall Study|Protocol Violation|0|||
156979600|NCT03560258|566678985|FG001|Overall Study|Protocol Violation|1|||
156979601|NCT03560258|566678986|FG002|Overall Study|Protocol Violation|0|||
156979602|NCT03560258|566678984|FG000|Overall Study|Withdrawal by Subject|0|||
156979603|NCT03560258|566678985|FG001|Overall Study|Withdrawal by Subject|0|||
156979604|NCT03560258|566678986|FG002|Overall Study|Withdrawal by Subject|1|||
156979605|NCT04498247|566678991|FG000|Overall Study|Lost to Follow-up|0|||
156979606|NCT04498247|566678992|FG001|Overall Study|Lost to Follow-up|0|||
156979607|NCT04498247|566678993|FG002|Overall Study|Lost to Follow-up|0|||
157094176|NCT00790751|567099735|FG000|Overall Study|Protocol non-compliance|16|||
156979608|NCT04498247|566678994|FG003|Overall Study|Lost to Follow-up|1|||
156979609|NCT04498247|566678995|FG004|Overall Study|Lost to Follow-up|0|||
156979610|NCT04498247|566678996|FG005|Overall Study|Lost to Follow-up|0|||
156979611|NCT04498247|566678997|FG006|Overall Study|Lost to Follow-up|0|||
156979612|NCT04498247|566678998|FG007|Overall Study|Lost to Follow-up|0|||
156979613|NCT04498247|566678991|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
156979614|NCT04498247|566678992|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979615|NCT04498247|566678993|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979616|NCT04498247|566678994|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979617|NCT04498247|566678995|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979618|NCT04498247|566678996|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979619|NCT04498247|566678997|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979620|NCT04498247|566678998|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
156979621|NCT04498247|566678991|FG000|Overall Study|Withdrawal by Subject|0|||
157094177|NCT00790751|567099736|FG001|Overall Study|Protocol non-compliance|16|||
157094178|NCT00790751|567099737|FG002|Overall Study|Protocol non-compliance|10|||
157094179|NCT00790751|567099738|FG003|Overall Study|Protocol non-compliance|11|||
157094180|NCT00790751|567099735|FG000|Overall Study|Lost to Follow-up|4|||
157094181|NCT00790751|567099736|FG001|Overall Study|Lost to Follow-up|9|||
157094182|NCT00790751|567099737|FG002|Overall Study|Lost to Follow-up|4|||
157094183|NCT00790751|567099738|FG003|Overall Study|Lost to Follow-up|5|||
157094184|NCT00790751|567099735|FG000|Overall Study|Adverse Event|5|||
157094185|NCT00790751|567099736|FG001|Overall Study|Adverse Event|3|||
157094186|NCT00790751|567099737|FG002|Overall Study|Adverse Event|5|||
157094187|NCT00790751|567099738|FG003|Overall Study|Adverse Event|4|||
157094188|NCT00790751|567099735|FG000|Overall Study|Requirement for restricted medication|0|||
157094189|NCT00790751|567099736|FG001|Overall Study|Requirement for restricted medication|2|||
157094190|NCT00790751|567099737|FG002|Overall Study|Requirement for restricted medication|0|||
157094191|NCT00790751|567099738|FG003|Overall Study|Requirement for restricted medication|0|||
157094192|NCT00790751|567099735|FG000|Overall Study|Death|0|||
157094193|NCT00790751|567099736|FG001|Overall Study|Death|0|||
157094194|NCT00790751|567099737|FG002|Overall Study|Death|1|||
157094195|NCT00790751|567099738|FG003|Overall Study|Death|0|||
157094196|NCT00790751|567099735|FG000|Overall Study|Physician Decision|0|||
157094197|NCT00790751|567099736|FG001|Overall Study|Physician Decision|0|||
157094198|NCT00790751|567099737|FG002|Overall Study|Physician Decision|0|||
157094199|NCT00790751|567099738|FG003|Overall Study|Physician Decision|1|||
157094200|NCT02427464|567099741|FG000|Overall Study|Adverse Event|6|||
157094201|NCT02427464|567099742|FG001|Overall Study|Adverse Event|1|||
157094202|NCT02427464|567099741|FG000|Overall Study|Lost to Follow-up|16|||
157094203|NCT02427464|567099742|FG001|Overall Study|Lost to Follow-up|5|||
157094204|NCT02427464|567099741|FG000|Overall Study|Physician Decision|2|||
157094205|NCT02427464|567099742|FG001|Overall Study|Physician Decision|0|||
157094206|NCT02427464|567099741|FG000|Overall Study|Withdrawal by Subject|10|||
157094207|NCT02427464|567099742|FG001|Overall Study|Withdrawal by Subject|8|||
157094208|NCT02427464|567099741|FG000|Overall Study|Noncompliance|16|||
157094209|NCT02427464|567099742|FG001|Overall Study|Noncompliance|10|||
157094210|NCT02572843|567099746|FG000|Accrual|Brain metastasis retrospectively detected|1|||
157094211|NCT02572843|567099746|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
157094212|NCT02572843|567099746|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
157094213|NCT02572843|567099746|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
157094214|NCT02572843|567099746|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
157094215|NCT02572843|567099746|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
157094216|NCT02572843|567099746|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
157094217|NCT02572843|567099746|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
157094218|NCT02572843|567099746|FG000|Surgery|lost to follow up|7|||
157094219|NCT02572843|567099746|FG000|Surgery|Death|1|||
157094220|NCT01078454|567099747|FG000|Overall Study|Adverse Event|1|||
157094221|NCT01078454|567099748|FG001|Overall Study|Adverse Event|1|||
157094222|NCT01078454|567099747|FG000|Overall Study|Death|0|||
157094223|NCT01078454|567099748|FG001|Overall Study|Death|1|||
157094224|NCT04737187|567099749|FG000|Overall Study|Switched to marketed drug|32|||
157094225|NCT04737187|567099750|FG001|Overall Study|Switched to marketed drug|4|||
157094226|NCT04737187|567099749|FG000|Overall Study|Radiological Progressive Disease|145|||
157094227|NCT04737187|567099750|FG001|Overall Study|Radiological Progressive Disease|146|||
157094228|NCT04737187|567099749|FG000|Overall Study|Clinical Progressive Disease|20|||
157094229|NCT04737187|567099750|FG001|Overall Study|Clinical Progressive Disease|20|||
157094230|NCT04737187|567099749|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
157094231|NCT04737187|567099750|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
157094232|NCT04737187|567099749|FG000|Overall Study|Adverse Event|16|||
157094233|NCT04737187|567099750|FG001|Overall Study|Adverse Event|16|||
157094234|NCT04737187|567099749|FG000|Overall Study|Physician Decision|2|||
157094235|NCT04737187|567099750|FG001|Overall Study|Physician Decision|0|||
157094236|NCT04737187|567099749|FG000|Overall Study|Withdrawal by Subject|5|||
157094237|NCT04737187|567099750|FG001|Overall Study|Withdrawal by Subject|8|||
157094238|NCT05227703|567099751|FG000|Overall Study|Adverse Event|2|||
157094239|NCT05227703|567099752|FG001|Overall Study|Adverse Event|6|||
157094240|NCT05227703|567099753|FG002|Overall Study|Adverse Event|4|||
157094241|NCT05227703|567099751|FG000|Overall Study|Lack of Efficacy|4|||
157094242|NCT05227703|567099752|FG001|Overall Study|Lack of Efficacy|0|||
157094243|NCT05227703|567099753|FG002|Overall Study|Lack of Efficacy|1|||
157094244|NCT05227703|567099751|FG000|Overall Study|Physician Decision|2|||
157094245|NCT05227703|567099752|FG001|Overall Study|Physician Decision|2|||
157094246|NCT05227703|567099753|FG002|Overall Study|Physician Decision|1|||
157094247|NCT05227703|567099751|FG000|Overall Study|Protocol Violation|2|||
157094248|NCT05227703|567099752|FG001|Overall Study|Protocol Violation|1|||
157094249|NCT05227703|567099753|FG002|Overall Study|Protocol Violation|0|||
157094250|NCT05227703|567099751|FG000|Overall Study|Withdrawal by Subject|17|||
157094251|NCT05227703|567099752|FG001|Overall Study|Withdrawal by Subject|26|||
157094252|NCT05227703|567099753|FG002|Overall Study|Withdrawal by Subject|32|||
157094253|NCT05227703|567099751|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
157094254|NCT05227703|567099752|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
157094255|NCT05227703|567099753|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
157094256|NCT05227703|567099751|FG000|Overall Study|Other|1|||
157094257|NCT05227703|567099752|FG001|Overall Study|Other|1|||
157094258|NCT05227703|567099753|FG002|Overall Study|Other|0|||
157094259|NCT03756129|567099758|FG000|Overall Study|Adverse Event|1|||
157094260|NCT03756129|567099759|FG001|Overall Study|Adverse Event|1|||
157094261|NCT03756129|567099760|FG002|Overall Study|Adverse Event|0|||
157094262|NCT03756129|567099761|FG003|Overall Study|Adverse Event|2|||
157094263|NCT03756129|567099762|FG004|Overall Study|Adverse Event|0|||
157094264|NCT03756129|567099763|FG005|Overall Study|Adverse Event|0|||
157094265|NCT03756129|567099758|FG000|Overall Study|Withdrawal by Subject|2|||
157094266|NCT03756129|567099759|FG001|Overall Study|Withdrawal by Subject|1|||
157094267|NCT03756129|567099760|FG002|Overall Study|Withdrawal by Subject|3|||
156979622|NCT04498247|566678992|FG001|Overall Study|Withdrawal by Subject|8|||
156979623|NCT04498247|566678993|FG002|Overall Study|Withdrawal by Subject|0|||
156979624|NCT04498247|566678994|FG003|Overall Study|Withdrawal by Subject|7|||
156979625|NCT04498247|566678995|FG004|Overall Study|Withdrawal by Subject|0|||
156979626|NCT04498247|566678996|FG005|Overall Study|Withdrawal by Subject|0|||
156979627|NCT04498247|566678997|FG006|Overall Study|Withdrawal by Subject|1|||
156979628|NCT04498247|566678998|FG007|Overall Study|Withdrawal by Subject|0|||
156979629|NCT04498247|566678991|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156979630|NCT04498247|566678992|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
156979631|NCT04498247|566678993|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156979632|NCT04498247|566678994|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
156979633|NCT04498247|566678995|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156979634|NCT04498247|566678996|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156979635|NCT04498247|566678997|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
156979636|NCT04498247|566678998|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
156979637|NCT03662997|566678999|FG000|Overall Study|Adverse Event|0|||
156979638|NCT03662997|566679000|FG001|Overall Study|Adverse Event|2|||
156979639|NCT03662997|566679001|FG002|Overall Study|Adverse Event|0|||
156979640|NCT03662997|566679002|FG003|Overall Study|Adverse Event|0|||
156979641|NCT01512745|566679003|FG000|Overall Study|Adverse Event|22|||
156979642|NCT01512745|566679004|FG001|Overall Study|Adverse Event|3|||
156979643|NCT01512745|566679003|FG000|Overall Study|Death|9|||
156979644|NCT01512745|566679004|FG001|Overall Study|Death|13|||
156979645|NCT01512745|566679003|FG000|Overall Study|Withdrawal by Subject|2|||
156979646|NCT01512745|566679004|FG001|Overall Study|Withdrawal by Subject|2|||
156979647|NCT01512745|566679003|FG000|Overall Study|Lost to Follow-up|4|||
156979648|NCT01512745|566679004|FG001|Overall Study|Lost to Follow-up|0|||
156979649|NCT01512745|566679003|FG000|Overall Study|Lack of Efficacy|2|||
156979650|NCT01512745|566679004|FG001|Overall Study|Lack of Efficacy|2|||
156979651|NCT01512745|566679003|FG000|Overall Study|Protocol Violation|1|||
156979652|NCT01512745|566679004|FG001|Overall Study|Protocol Violation|0|||
156979653|NCT01348776|566679005|FG000|Overall Study|Lost to Follow-up|3|||
156979654|NCT01372605|566679009|FG000|Overall Study|Death|1|||
156979655|NCT01372605|566679010|FG001|Overall Study|Death|2|||
157094268|NCT03756129|567099761|FG003|Overall Study|Withdrawal by Subject|1|||
157094269|NCT03756129|567099762|FG004|Overall Study|Withdrawal by Subject|1|||
157094270|NCT03756129|567099763|FG005|Overall Study|Withdrawal by Subject|3|||
157094271|NCT03756129|567099758|FG000|Overall Study|Lost to Follow-up|0|||
157094272|NCT03756129|567099759|FG001|Overall Study|Lost to Follow-up|0|||
157094273|NCT03756129|567099760|FG002|Overall Study|Lost to Follow-up|0|||
156979656|NCT01372605|566679009|FG000|Overall Study|Lost to Follow-up|2|||
156979657|NCT01372605|566679010|FG001|Overall Study|Lost to Follow-up|1|||
156979658|NCT01372605|566679009|FG000|Overall Study|Withdrawal by Subject|4|||
157094274|NCT03756129|567099761|FG003|Overall Study|Lost to Follow-up|0|||
157094275|NCT03756129|567099762|FG004|Overall Study|Lost to Follow-up|0|||
156979659|NCT01372605|566679010|FG001|Overall Study|Withdrawal by Subject|7|||
156979660|NCT01372605|566679009|FG000|Overall Study|Moved|3|||
156979661|NCT01372605|566679010|FG001|Overall Study|Moved|0|||
156979662|NCT01372605|566679009|FG000|Overall Study|Changed medical home|2|||
156979663|NCT01372605|566679010|FG001|Overall Study|Changed medical home|0|||
156979664|NCT01108510|566679011|FG000|Overall Study|Randomized but Not Treated|5|||
156979665|NCT01108510|566679012|FG001|Overall Study|Randomized but Not Treated|1|||
156979666|NCT01108510|566679011|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
157094276|NCT03756129|567099763|FG005|Overall Study|Lost to Follow-up|1|||
157094277|NCT03756129|567099758|FG000|Overall Study|Physician Decision|0|||
157094278|NCT03756129|567099759|FG001|Overall Study|Physician Decision|0|||
156979667|NCT01108510|566679012|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
157094279|NCT03756129|567099760|FG002|Overall Study|Physician Decision|0|||
157094280|NCT03756129|567099761|FG003|Overall Study|Physician Decision|0|||
157094281|NCT03756129|567099762|FG004|Overall Study|Physician Decision|0|||
157094282|NCT03756129|567099763|FG005|Overall Study|Physician Decision|1|||
157094283|NCT03464097|567099764|FG000|Overall Study|Withdrawal by Subject|15|||
157094284|NCT03464097|567099765|FG001|Overall Study|Withdrawal by Subject|13|||
157094285|NCT03464097|567099766|FG002|Overall Study|Withdrawal by Subject|11|||
157094286|NCT03464097|567099764|FG000|Overall Study|Study terminated by sponsor|47|||
157094287|NCT03464097|567099765|FG001|Overall Study|Study terminated by sponsor|44|||
157094288|NCT03464097|567099766|FG002|Overall Study|Study terminated by sponsor|40|||
157094289|NCT03464097|567099764|FG000|Overall Study|Pregnancy|0|||
157094290|NCT03464097|567099765|FG001|Overall Study|Pregnancy|1|||
157094291|NCT03464097|567099766|FG002|Overall Study|Pregnancy|0|||
157094292|NCT03464097|567099764|FG000|Overall Study|Other reasons|5|||
157094293|NCT03464097|567099765|FG001|Overall Study|Other reasons|12|||
157094294|NCT03464097|567099766|FG002|Overall Study|Other reasons|14|||
157094295|NCT03464097|567099764|FG000|Overall Study|Lost to Follow-up|0|||
157094296|NCT03464097|567099765|FG001|Overall Study|Lost to Follow-up|1|||
157094297|NCT03464097|567099766|FG002|Overall Study|Lost to Follow-up|1|||
157094298|NCT03464097|567099764|FG000|Overall Study|Lack of Efficacy|11|||
157094299|NCT03464097|567099765|FG001|Overall Study|Lack of Efficacy|18|||
157094300|NCT03464097|567099766|FG002|Overall Study|Lack of Efficacy|30|||
157094301|NCT03464097|567099764|FG000|Overall Study|Death|1|||
157094302|NCT03464097|567099765|FG001|Overall Study|Death|0|||
157094303|NCT03464097|567099766|FG002|Overall Study|Death|0|||
157094304|NCT03464097|567099764|FG000|Overall Study|Adverse Event|13|||
157094305|NCT03464097|567099765|FG001|Overall Study|Adverse Event|6|||
157094306|NCT03464097|567099766|FG002|Overall Study|Adverse Event|8|||
157094307|NCT03432260|567099767|FG000|Overall Study|Lost to Follow-up|1|||
157094308|NCT03432260|567099768|FG001|Overall Study|Lost to Follow-up|1|||
157094309|NCT03432260|567099769|FG002|Overall Study|Lost to Follow-up|0|||
157094310|NCT03432260|567099770|FG003|Overall Study|Lost to Follow-up|0|||
157094311|NCT03432260|567099771|FG004|Overall Study|Lost to Follow-up|1|||
157094312|NCT02186847|567099772|FG000|Overall Study|Protocol Violation|3|||
157094313|NCT02186847|567099773|FG001|Overall Study|Protocol Violation|0|||
157094314|NCT03319849|567099774|FG000|Overall Study|Adverse Event|1|||
157094315|NCT03319849|567099775|FG001|Overall Study|Adverse Event|0|||
157094316|NCT03319849|567099774|FG000|Overall Study|Physician Decision|0|||
157094317|NCT03319849|567099775|FG001|Overall Study|Physician Decision|1|||
157094318|NCT03319849|567099774|FG000|Overall Study|Withdrawal by Subject|0|||
157094319|NCT03319849|567099775|FG001|Overall Study|Withdrawal by Subject|1|||
157094320|NCT03319849|567099774|FG000|Overall Study|COVID-19|0|||
157094321|NCT03319849|567099775|FG001|Overall Study|COVID-19|1|||
157094322|NCT03319849|567099774|FG000|Overall Study|Other|1|||
157094323|NCT03319849|567099775|FG001|Overall Study|Other|2|||
157094324|NCT03319849|567099774|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
157094325|NCT03319849|567099775|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
157094326|NCT03319849|567099774|FG000|Overall Study|Lost to Follow-up|0|||
157094327|NCT03319849|567099775|FG001|Overall Study|Lost to Follow-up|2|||
157094328|NCT00112047|567099776|FG000|Randomized Phase|Lost to Follow-up|26|||
157094329|NCT00112047|567099777|FG001|Randomized Phase|Lost to Follow-up|33|||
157094330|NCT00112047|567099776|FG000|Randomized Phase|Adverse Event|10|||
157094331|NCT00112047|567099777|FG001|Randomized Phase|Adverse Event|10|||
157094332|NCT00112047|567099776|FG000|Randomized Phase|Withrawal of consent|10|||
157094333|NCT00112047|567099777|FG001|Randomized Phase|Withrawal of consent|18|||
157094334|NCT00112047|567099776|FG000|Randomized Phase|Sub-optimal virological response|3|||
157094335|NCT00112047|567099777|FG001|Randomized Phase|Sub-optimal virological response|13|||
157094336|NCT00112047|567099776|FG000|Randomized Phase|Noncompliance|8|||
157094337|NCT00112047|567099777|FG001|Randomized Phase|Noncompliance|4|||
157094338|NCT00112047|567099776|FG000|Randomized Phase|Protocol Violation|2|||
157094339|NCT00112047|567099777|FG001|Randomized Phase|Protocol Violation|0|||
157094340|NCT00112047|567099776|FG000|Randomized Phase|Pregnancy|3|||
157094341|NCT00112047|567099777|FG001|Randomized Phase|Pregnancy|1|||
157094342|NCT00112047|567099776|FG000|Randomized Phase|Death|1|||
157094343|NCT00112047|567099777|FG001|Randomized Phase|Death|3|||
157094344|NCT00112047|567099776|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
157094345|NCT00112047|567099777|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
157094346|NCT00112047|567099776|FG000|Randomized Phase|Inability to swallow pills|0|||
157094347|NCT00112047|567099777|FG001|Randomized Phase|Inability to swallow pills|1|||
157094348|NCT00112047|567099776|FG000|Randomized Phase|Incarceration|3|||
157094349|NCT00112047|567099777|FG001|Randomized Phase|Incarceration|2|||
157094350|NCT00112047|567099776|FG000|Randomized Phase|Moved out of State|0|||
157094351|NCT00112047|567099777|FG001|Randomized Phase|Moved out of State|1|||
157094352|NCT00112047|567099776|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
157094353|NCT00112047|567099777|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
157094354|NCT00112047|567099776|FG000|Randomized Phase|High Hepatitis B DNA|0|||
157094355|NCT00112047|567099777|FG001|Randomized Phase|High Hepatitis B DNA|1|||
157094356|NCT00112047|567099776|FG000|Atripla Phase|Adverse Event|2|||
157094357|NCT00112047|567099777|FG001|Atripla Phase|Adverse Event|1|||
157094358|NCT00112047|567099776|FG000|Atripla Phase|Lost to Follow-up|5|||
157094359|NCT00112047|567099777|FG001|Atripla Phase|Lost to Follow-up|7|||
157094360|NCT00112047|567099776|FG000|Atripla Phase|Pregnancy|0|||
157094361|NCT00112047|567099777|FG001|Atripla Phase|Pregnancy|1|||
157094362|NCT00112047|567099776|FG000|Atripla Phase|Death|0|||
157094363|NCT00112047|567099777|FG001|Atripla Phase|Death|2|||
157094364|NCT00112047|567099776|FG000|Atripla Phase|Withdrew consent|7|||
157094365|NCT00112047|567099777|FG001|Atripla Phase|Withdrew consent|7|||
157094366|NCT00112047|567099776|FG000|Atripla Phase|Sub-optimal virological response|0|||
157094367|NCT00112047|567099777|FG001|Atripla Phase|Sub-optimal virological response|1|||
157094368|NCT00112047|567099776|FG000|Atripla Phase|Non-compliance|1|||
157094369|NCT00112047|567099777|FG001|Atripla Phase|Non-compliance|0|||
157094370|NCT00112047|567099776|FG000|Atripla Phase|Other|3|||
157094371|NCT00112047|567099777|FG001|Atripla Phase|Other|1|||
157094372|NCT01307579|567099778|FG000|Overall Study|Death|3|||
157094373|NCT01307579|567099779|FG001|Overall Study|Death|6|||
157094374|NCT01307579|567099778|FG000|Overall Study|Physician Decision|26|||
157094375|NCT01307579|567099779|FG001|Overall Study|Physician Decision|29|||
157094376|NCT01307579|567099778|FG000|Overall Study|Withdrawal by Subject|7|||
157094377|NCT01307579|567099779|FG001|Overall Study|Withdrawal by Subject|3|||
157094378|NCT01307579|567099778|FG000|Overall Study|Institutional diagnosis of IFD|21|||
157094379|NCT01307579|567099779|FG001|Overall Study|Institutional diagnosis of IFD|36|||
157094380|NCT01307579|567099778|FG000|Overall Study|Begin conditioning for HSCT|42|||
157094381|NCT01307579|567099779|FG001|Overall Study|Begin conditioning for HSCT|44|||
157094382|NCT01307579|567099778|FG000|Overall Study|Refractory or relapsed AML|38|||
157094383|NCT01307579|567099779|FG001|Overall Study|Refractory or relapsed AML|23|||
157094384|NCT01307579|567099778|FG000|Overall Study|Ineligible|3|||
157094385|NCT01307579|567099779|FG001|Overall Study|Ineligible|4|||
157094386|NCT01340196|567101004|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
157094387|NCT00604279|567101009|FG000|Overall Study|Lack of Efficacy|22|||
157094388|NCT00604279|567101010|FG001|Overall Study|Lack of Efficacy|9|||
157094389|NCT00604279|567101009|FG000|Overall Study|Lost to Follow-up|9|||
157094390|NCT00604279|567101010|FG001|Overall Study|Lost to Follow-up|14|||
157094391|NCT00604279|567101009|FG000|Overall Study|Pregnancy|2|||
157094392|NCT00604279|567101010|FG001|Overall Study|Pregnancy|0|||
157094393|NCT00604279|567101009|FG000|Overall Study|Protocol Violation|3|||
157094394|NCT00604279|567101010|FG001|Overall Study|Protocol Violation|1|||
157094395|NCT00604279|567101009|FG000|Overall Study|Withdrawal by Subject|16|||
157094396|NCT00604279|567101010|FG001|Overall Study|Withdrawal by Subject|5|||
157094397|NCT00604279|567101009|FG000|Overall Study|Adverse Event|4|||
157094398|NCT00604279|567101010|FG001|Overall Study|Adverse Event|5|||
156979668|NCT01108510|566679011|FG000|Overall Study|Adverse Event|26|||
156979669|NCT01108510|566679012|FG001|Overall Study|Adverse Event|19|||
156979670|NCT01108510|566679011|FG000|Overall Study|Lost to Follow-up|20|||
156979671|NCT01108510|566679012|FG001|Overall Study|Lost to Follow-up|17|||
156979672|NCT01108510|566679011|FG000|Overall Study|Withdrew Consent|21|||
156979673|NCT01108510|566679012|FG001|Overall Study|Withdrew Consent|15|||
156979674|NCT01108510|566679011|FG000|Overall Study|Investigator's Discretion|12|||
157094399|NCT00604279|567101009|FG000|Overall Study|Other|8|||
157094400|NCT00604279|567101010|FG001|Overall Study|Other|4|||
157094401|NCT03938545|567101011|FG000|Overall Study|Lost to Follow-up|0|||
157094402|NCT03938545|567101012|FG001|Overall Study|Lost to Follow-up|0|||
157094403|NCT03938545|567101013|FG002|Overall Study|Lost to Follow-up|0|||
157094404|NCT03938545|567101014|FG003|Overall Study|Lost to Follow-up|1|||
157094405|NCT03938545|567101011|FG000|Overall Study|Non-compliance with study drug|0|||
157094406|NCT03938545|567101012|FG001|Overall Study|Non-compliance with study drug|0|||
157094407|NCT03938545|567101013|FG002|Overall Study|Non-compliance with study drug|1|||
157094408|NCT03938545|567101014|FG003|Overall Study|Non-compliance with study drug|0|||
157094409|NCT03938545|567101011|FG000|Overall Study|Pregnancy|1|||
157094410|NCT03938545|567101012|FG001|Overall Study|Pregnancy|0|||
157094411|NCT03938545|567101013|FG002|Overall Study|Pregnancy|0|||
157094412|NCT03938545|567101014|FG003|Overall Study|Pregnancy|0|||
157094413|NCT03938545|567101011|FG000|Overall Study|Study terminated by sponsor|6|||
157094414|NCT03938545|567101012|FG001|Overall Study|Study terminated by sponsor|4|||
157094415|NCT03938545|567101013|FG002|Overall Study|Study terminated by sponsor|2|||
157094416|NCT03938545|567101014|FG003|Overall Study|Study terminated by sponsor|4|||
157094417|NCT03938545|567101011|FG000|Overall Study|Withdrawal by Subject|0|||
157094418|NCT03938545|567101012|FG001|Overall Study|Withdrawal by Subject|1|||
157094419|NCT03938545|567101013|FG002|Overall Study|Withdrawal by Subject|0|||
157094420|NCT03938545|567101014|FG003|Overall Study|Withdrawal by Subject|0|||
157094421|NCT03938545|567101011|FG000|Overall Study|Adverse Event|1|||
157094422|NCT03938545|567101012|FG001|Overall Study|Adverse Event|0|||
157094423|NCT03938545|567101013|FG002|Overall Study|Adverse Event|0|||
157094424|NCT03938545|567101014|FG003|Overall Study|Adverse Event|0|||
157094425|NCT00355056|567101015|FG000|Randomization Period|Early Termination|4|||
157094426|NCT00355056|567101016|FG001|Randomization Period|Early Termination|6|||
157094427|NCT01060540|567101017|FG000|Overall Study|Withdrawal by Subject|10|||
157094428|NCT01060540|567101018|FG001|Overall Study|Withdrawal by Subject|20|||
157094429|NCT01060540|567101017|FG000|Overall Study|Lost to Follow-up|52|||
157094430|NCT01060540|567101018|FG001|Overall Study|Lost to Follow-up|43|||
157094431|NCT01060540|567101017|FG000|Overall Study|Death|2|||
157094432|NCT01060540|567101018|FG001|Overall Study|Death|1|||
157094433|NCT01060540|567101017|FG000|Overall Study|Physician Decision|0|||
157094434|NCT01060540|567101018|FG001|Overall Study|Physician Decision|1|||
157094435|NCT00816400|567101022|FG000|Overall Study|Death|2|||
157094436|NCT00816400|567101023|FG001|Overall Study|Death|3|||
157094437|NCT00816400|567101024|FG002|Overall Study|Death|3|||
157094438|NCT00816400|567101025|FG003|Overall Study|Death|3|||
157094439|NCT00816400|567101026|FG004|Overall Study|Death|2|||
157094440|NCT00816400|567101027|FG005|Overall Study|Death|3|||
157094441|NCT00816400|567101028|FG006|Overall Study|Death|2|||
157094442|NCT00816400|567101029|FG007|Overall Study|Death|5|||
157094443|NCT00816400|567101030|FG008|Overall Study|Death|6|||
157094444|NCT00816400|567101022|FG000|Overall Study|In hospice care at the end of the study|0|||
157094445|NCT00816400|567101023|FG001|Overall Study|In hospice care at the end of the study|0|||
157094446|NCT00816400|567101024|FG002|Overall Study|In hospice care at the end of the study|2|||
157094447|NCT00816400|567101025|FG003|Overall Study|In hospice care at the end of the study|0|||
157094448|NCT00816400|567101026|FG004|Overall Study|In hospice care at the end of the study|0|||
156979675|NCT01108510|566679012|FG001|Overall Study|Investigator's Discretion|10|||
156979676|NCT01108510|566679011|FG000|Overall Study|Participant Noncompliance|5|||
157094449|NCT00816400|567101027|FG005|Overall Study|In hospice care at the end of the study|0|||
157094450|NCT00816400|567101028|FG006|Overall Study|In hospice care at the end of the study|0|||
157094451|NCT00816400|567101029|FG007|Overall Study|In hospice care at the end of the study|0|||
157094452|NCT00816400|567101030|FG008|Overall Study|In hospice care at the end of the study|0|||
157094453|NCT01222507|567101034|FG000|Overall Study|Physician Decision|1|||
157094454|NCT01222507|567101034|FG000|Overall Study|Withdrawal by Subject|1|||
157094455|NCT02647320|567101035|FG000|Overall Study|Adverse Event|0|||
157094456|NCT02647320|567101036|FG001|Overall Study|Adverse Event|1|||
157094457|NCT02647320|567101037|FG002|Overall Study|Adverse Event|3|||
157094458|NCT02647320|567101038|FG003|Overall Study|Adverse Event|2|||
157094459|NCT02647320|567101039|FG004|Overall Study|Adverse Event|1|||
157094460|NCT02647320|567101035|FG000|Overall Study|Protocol Violation|0|||
157094461|NCT02647320|567101036|FG001|Overall Study|Protocol Violation|0|||
157094462|NCT02647320|567101037|FG002|Overall Study|Protocol Violation|3|||
157094463|NCT02647320|567101038|FG003|Overall Study|Protocol Violation|0|||
157094464|NCT02647320|567101039|FG004|Overall Study|Protocol Violation|0|||
157094465|NCT02647320|567101035|FG000|Overall Study|Withdrawal by Subject|7|||
157094466|NCT02647320|567101036|FG001|Overall Study|Withdrawal by Subject|4|||
157094467|NCT02647320|567101037|FG002|Overall Study|Withdrawal by Subject|2|||
157094468|NCT02647320|567101038|FG003|Overall Study|Withdrawal by Subject|2|||
157094469|NCT02647320|567101039|FG004|Overall Study|Withdrawal by Subject|7|||
157094470|NCT02647320|567101035|FG000|Overall Study|Persistent hyperglycemia|0|||
157094471|NCT02647320|567101036|FG001|Overall Study|Persistent hyperglycemia|1|||
157094472|NCT02647320|567101037|FG002|Overall Study|Persistent hyperglycemia|1|||
157094473|NCT02647320|567101038|FG003|Overall Study|Persistent hyperglycemia|1|||
157094474|NCT02647320|567101039|FG004|Overall Study|Persistent hyperglycemia|1|||
157094475|NCT02647320|567101035|FG000|Overall Study|Study terminated by sponsor|1|||
157094476|NCT02647320|567101036|FG001|Overall Study|Study terminated by sponsor|1|||
157094477|NCT02647320|567101037|FG002|Overall Study|Study terminated by sponsor|1|||
157094478|NCT02647320|567101038|FG003|Overall Study|Study terminated by sponsor|1|||
157094479|NCT02647320|567101039|FG004|Overall Study|Study terminated by sponsor|2|||
157094480|NCT02647320|567101035|FG000|Overall Study|Reason not provided|0|||
157094481|NCT02647320|567101036|FG001|Overall Study|Reason not provided|0|||
157094482|NCT02647320|567101037|FG002|Overall Study|Reason not provided|1|||
157094483|NCT02647320|567101038|FG003|Overall Study|Reason not provided|0|||
157094484|NCT02647320|567101039|FG004|Overall Study|Reason not provided|2|||
157094485|NCT02647320|567101035|FG000|Overall Study|Lost to Follow-up|1|||
157094486|NCT02647320|567101036|FG001|Overall Study|Lost to Follow-up|1|||
157094487|NCT02647320|567101037|FG002|Overall Study|Lost to Follow-up|0|||
157094488|NCT02647320|567101038|FG003|Overall Study|Lost to Follow-up|0|||
157094489|NCT02647320|567101039|FG004|Overall Study|Lost to Follow-up|0|||
157094490|NCT02647320|567101035|FG000|Overall Study|Develop anemia|1|||
157094491|NCT02647320|567101036|FG001|Overall Study|Develop anemia|0|||
157094492|NCT02647320|567101037|FG002|Overall Study|Develop anemia|0|||
157094493|NCT02647320|567101038|FG003|Overall Study|Develop anemia|0|||
157094494|NCT02647320|567101039|FG004|Overall Study|Develop anemia|0|||
157094495|NCT02647320|567101035|FG000|Overall Study|Lack of Efficacy|0|||
157094496|NCT02647320|567101036|FG001|Overall Study|Lack of Efficacy|0|||
157094497|NCT02647320|567101037|FG002|Overall Study|Lack of Efficacy|0|||
157094498|NCT02647320|567101038|FG003|Overall Study|Lack of Efficacy|1|||
157094499|NCT02647320|567101039|FG004|Overall Study|Lack of Efficacy|0|||
156979677|NCT01108510|566679012|FG001|Overall Study|Participant Noncompliance|7|||
156979678|NCT01108510|566679011|FG000|Overall Study|Lack of Efficacy|3|||
156979679|NCT01108510|566679012|FG001|Overall Study|Lack of Efficacy|0|||
156979680|NCT01108510|566679011|FG000|Overall Study|Pregnancy|0|||
156979681|NCT01108510|566679012|FG001|Overall Study|Pregnancy|3|||
156979682|NCT01108510|566679011|FG000|Overall Study|Death|1|||
156979683|NCT01108510|566679012|FG001|Overall Study|Death|1|||
156979684|NCT00210119|566679013|FG000|Overall Study|Protocol Violation|1|||
156979685|NCT00210119|566679013|FG000|Overall Study|Withdrawal by Subject|1|||
156979686|NCT00951509|566679014|FG000|Overall Study|Withdrawal by Subject|2|||
156979687|NCT03125941|566679019|FG000|Overall Study|did not receive intervention|1|||
156979688|NCT03125941|566679020|FG001|Overall Study|did not receive intervention|2|||
156979689|NCT00734214|566679021|FG000|Overall Study|Withdrawal by Subject|3|||
156979690|NCT00734214|566679022|FG001|Overall Study|Withdrawal by Subject|4|||
156979691|NCT00734214|566679021|FG000|Overall Study|MD withdrawal|1|||
156979692|NCT00734214|566679022|FG001|Overall Study|MD withdrawal|0|||
156979693|NCT02204579|566679026|FG000|Overall Study|Screen failures|2|||
156979694|NCT01396395|566679027|FG000|Overall Study|Withdrawal by Subject|10|||
156979695|NCT01396395|566679028|FG001|Overall Study|Withdrawal by Subject|12|||
156979696|NCT01396395|566679027|FG000|Overall Study|Protocol Violation|3|||
156979697|NCT01396395|566679028|FG001|Overall Study|Protocol Violation|1|||
157094500|NCT02647320|567101035|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
156979698|NCT01396395|566679027|FG000|Overall Study|Adverse Event|10|||
157094501|NCT02647320|567101036|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
156979699|NCT01396395|566679028|FG001|Overall Study|Adverse Event|2|||
156979700|NCT01396395|566679027|FG000|Overall Study|Lost to Follow-up|17|||
156979701|NCT01396395|566679028|FG001|Overall Study|Lost to Follow-up|11|||
156979702|NCT01396395|566679027|FG000|Overall Study|Other|0|||
156979703|NCT01396395|566679028|FG001|Overall Study|Other|1|||
157094502|NCT02647320|567101037|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
157094503|NCT02647320|567101038|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
157094504|NCT02647320|567101039|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
157094505|NCT00596427|567101040|FG000|Overall Study|Withdrawal by Subject|2|||
157094506|NCT00596427|567101041|FG001|Overall Study|Withdrawal by Subject|2|||
156979704|NCT01370005|566679029|FG000|Overall Study|Not treated|1|||
156979705|NCT01370005|566679030|FG001|Overall Study|Not treated|0|||
156979706|NCT01370005|566679031|FG002|Overall Study|Not treated|0|||
156979707|NCT01370005|566679029|FG000|Overall Study|Adverse Event|5|||
156979708|NCT01370005|566679030|FG001|Overall Study|Adverse Event|5|||
156979709|NCT01370005|566679031|FG002|Overall Study|Adverse Event|6|||
156979710|NCT01370005|566679029|FG000|Overall Study|Lack of Efficacy|1|||
156979711|NCT01370005|566679030|FG001|Overall Study|Lack of Efficacy|0|||
156979712|NCT01370005|566679031|FG002|Overall Study|Lack of Efficacy|0|||
156979713|NCT01370005|566679029|FG000|Overall Study|Non compliant with protocol|0|||
156979714|NCT01370005|566679030|FG001|Overall Study|Non compliant with protocol|1|||
156979715|NCT01370005|566679031|FG002|Overall Study|Non compliant with protocol|2|||
156979716|NCT01370005|566679029|FG000|Overall Study|Lost to Follow-up|1|||
156979717|NCT01370005|566679030|FG001|Overall Study|Lost to Follow-up|1|||
156979718|NCT01370005|566679031|FG002|Overall Study|Lost to Follow-up|1|||
156979719|NCT01370005|566679029|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
156979720|NCT01370005|566679030|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
156979721|NCT01370005|566679031|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
156979722|NCT01370005|566679029|FG000|Overall Study|Other reason not defined above|3|||
156979723|NCT01370005|566679030|FG001|Overall Study|Other reason not defined above|0|||
156979724|NCT01370005|566679031|FG002|Overall Study|Other reason not defined above|2|||
156979725|NCT03691948|566679032|FG000|Overall Study|Lost to Follow-up|1|||
156979726|NCT03691948|566679033|FG001|Overall Study|Lost to Follow-up|3|||
156979727|NCT05067933|566679038|FG000|Overall Study|Withdrawal by Subject|2|||
156979728|NCT05067933|566679039|FG001|Overall Study|Withdrawal by Subject|0|||
156979729|NCT05067933|566679040|FG002|Overall Study|Withdrawal by Subject|0|||
156979730|NCT05067933|566679041|FG003|Overall Study|Withdrawal by Subject|0|||
156979731|NCT05067933|566679042|FG004|Overall Study|Withdrawal by Subject|0|||
156979732|NCT05067933|566679043|FG005|Overall Study|Withdrawal by Subject|0|||
156979733|NCT05067933|566679038|FG000|Overall Study|Lost to Follow-up|1|||
156979734|NCT05067933|566679039|FG001|Overall Study|Lost to Follow-up|1|||
156979735|NCT05067933|566679040|FG002|Overall Study|Lost to Follow-up|1|||
156979736|NCT05067933|566679041|FG003|Overall Study|Lost to Follow-up|2|||
156979737|NCT05067933|566679042|FG004|Overall Study|Lost to Follow-up|1|||
156979738|NCT05067933|566679043|FG005|Overall Study|Lost to Follow-up|0|||
156979739|NCT05067933|566679038|FG000|Overall Study|Miscellaneous|1|||
156979740|NCT05067933|566679039|FG001|Overall Study|Miscellaneous|0|||
156979741|NCT05067933|566679040|FG002|Overall Study|Miscellaneous|0|||
156979742|NCT05067933|566679041|FG003|Overall Study|Miscellaneous|0|||
156979743|NCT05067933|566679042|FG004|Overall Study|Miscellaneous|0|||
156979744|NCT05067933|566679043|FG005|Overall Study|Miscellaneous|0|||
156979745|NCT05067933|566679038|FG000|Overall Study|Death|0|||
156979746|NCT05067933|566679039|FG001|Overall Study|Death|0|||
156979747|NCT05067933|566679040|FG002|Overall Study|Death|0|||
156979748|NCT05067933|566679041|FG003|Overall Study|Death|1|||
156979749|NCT05067933|566679042|FG004|Overall Study|Death|0|||
156979750|NCT05067933|566679043|FG005|Overall Study|Death|0|||
156979751|NCT02716038|566679050|FG000|Overall Study|Not evaluable|1|||
156979752|NCT02716038|566679050|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
156979753|NCT02716038|566679050|FG000|Overall Study|Unresectable|3|||
156979754|NCT00550550|566679051|FG000|Overall Study|Adverse Event|13|||
156979755|NCT00550550|566679052|FG001|Overall Study|Adverse Event|5|||
156979756|NCT00550550|566679051|FG000|Overall Study|Treatment Failure|0|||
156979757|NCT00550550|566679052|FG001|Overall Study|Treatment Failure|1|||
156979758|NCT00550550|566679051|FG000|Overall Study|Lost to Follow-up|4|||
156979759|NCT00550550|566679052|FG001|Overall Study|Lost to Follow-up|0|||
156979760|NCT00550550|566679051|FG000|Overall Study|Withdrawal by Subject|10|||
156979761|NCT00550550|566679052|FG001|Overall Study|Withdrawal by Subject|8|||
156979762|NCT00550550|566679051|FG000|Overall Study|Protocol Violation|5|||
156979763|NCT00550550|566679052|FG001|Overall Study|Protocol Violation|14|||
156979764|NCT00550550|566679051|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156979765|NCT00550550|566679052|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
156979766|NCT00550550|566679051|FG000|Overall Study|Randomized But Not Treated|1|||
156979767|NCT00550550|566679052|FG001|Overall Study|Randomized But Not Treated|0|||
156979768|NCT00118092|566679053|FG000|Overall Study|Withdrawal by Subject|1|||
156979769|NCT00118092|566679053|FG000|Overall Study|Protocol Violation|1|||
156979770|NCT02459093|566679054|FG000|Overall Study|Protocol Violation|6|||
156979771|NCT02459093|566679055|FG001|Overall Study|Protocol Violation|11|||
156979772|NCT02459093|566679054|FG000|Overall Study|Lost to Follow-up|6|||
156979773|NCT02459093|566679055|FG001|Overall Study|Lost to Follow-up|7|||
156979774|NCT00591864|566679056|FG000|Overall Study|Incomplete Imaging|5|||
156979775|NCT00539279|566679061|FG000|Treatment|Withdrawal by Subject|10|||
156979776|NCT00539279|566679062|FG001|Treatment|Withdrawal by Subject|8|||
156979777|NCT00539279|566679061|FG000|Treatment|Death|1|||
156979778|NCT00539279|566679062|FG001|Treatment|Death|0|||
156979779|NCT00539279|566679061|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
156979780|NCT00539279|566679062|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
156979781|NCT00539279|566679061|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
156979782|NCT00539279|566679062|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
156979783|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156979784|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
156979785|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
156979786|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156979787|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156979788|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156979789|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
156979790|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
156979791|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979792|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979793|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979794|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979795|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979796|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156979797|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
156979798|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156979799|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156979800|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156979801|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156979802|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156979803|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156979804|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156979805|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
156979806|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
156979807|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156979808|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156979809|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156979810|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
156979811|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979812|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979813|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
156979814|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979815|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979816|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979817|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
156979818|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
156979819|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
156979820|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
156979821|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156979822|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156979823|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156979824|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156979825|NCT04921969|566679068|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
156979826|NCT04921969|566679069|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
156979827|NCT04921969|566679070|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156979828|NCT04921969|566679071|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156979829|NCT04921969|566679072|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156979830|NCT04921969|566679073|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156979831|NCT04921969|566679074|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
156979832|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979833|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979834|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979835|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979836|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979837|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
156979838|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
156979839|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156979840|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156979841|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156979842|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
156979843|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156979844|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
156979845|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156979846|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156979847|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156979848|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156979849|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
156979850|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
156979851|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
157021583|NCT04610892|566830903|FG000|Overall Study|Death|0|||
157094507|NCT00596427|567101040|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
157094508|NCT00596427|567101041|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
157094509|NCT00596427|567101040|FG000|Overall Study|Protocol Violation|1|||
157094510|NCT00596427|567101041|FG001|Overall Study|Protocol Violation|0|||
157094511|NCT02401867|567101046|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
157094512|NCT02401867|567101046|FG000|Analysis|Cervical assay could not be conducted|9|||
157094513|NCT01650246|567101047|FG000|Overall Study|Adverse Event|23|||
157094514|NCT01650246|567101047|FG000|Overall Study|Protocol Violation|5|||
157094515|NCT01650246|567101047|FG000|Overall Study|Sponsor terminated study|53|||
157094516|NCT01650246|567101047|FG000|Overall Study|Lost to Follow-up|5|||
157094517|NCT01650246|567101047|FG000|Overall Study|Withdrawal by Subject|26|||
157094518|NCT01650246|567101047|FG000|Overall Study|Death|1|||
157094519|NCT01650246|567101047|FG000|Overall Study|Lack of Efficacy|30|||
157094520|NCT00081770|567101048|FG000|Overall Study|Adverse Event|130|||
157094521|NCT00081770|567101049|FG001|Overall Study|Adverse Event|98|||
157094522|NCT00081770|567101050|FG002|Overall Study|Adverse Event|136|||
157094523|NCT00081770|567101048|FG000|Overall Study|Lack of Efficacy|262|||
157094524|NCT00081770|567101049|FG001|Overall Study|Lack of Efficacy|357|||
157094525|NCT00081770|567101050|FG002|Overall Study|Lack of Efficacy|211|||
157094526|NCT00081770|567101048|FG000|Overall Study|Lost to Follow-up|45|||
157094527|NCT00081770|567101049|FG001|Overall Study|Lost to Follow-up|34|||
157094528|NCT00081770|567101050|FG002|Overall Study|Lost to Follow-up|45|||
157094529|NCT00081770|567101048|FG000|Overall Study|Protocol Violation|15|||
157094530|NCT00081770|567101049|FG001|Overall Study|Protocol Violation|10|||
157094531|NCT00081770|567101050|FG002|Overall Study|Protocol Violation|10|||
157094532|NCT00081770|567101048|FG000|Overall Study|Withdrawal by Subject|45|||
157094533|NCT00081770|567101049|FG001|Overall Study|Withdrawal by Subject|40|||
156979852|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
156979853|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156979854|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156979855|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156979856|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156979857|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
156979858|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156979859|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
156979860|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156979861|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156979862|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156979863|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
156979864|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
156979865|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
156979866|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
156979867|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156979868|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156979869|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156979870|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
156979871|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
156979872|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
156979873|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
156979874|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156979875|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156979876|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156979877|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
156979878|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156979879|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
156979880|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
156979881|NCT04921969|566679068|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156979882|NCT04921969|566679069|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
157094534|NCT00081770|567101050|FG002|Overall Study|Withdrawal by Subject|42|||
157094535|NCT00081770|567101048|FG000|Overall Study|Did not meet protocol eligibility|2|||
157094536|NCT00081770|567101049|FG001|Overall Study|Did not meet protocol eligibility|0|||
157094537|NCT00081770|567101050|FG002|Overall Study|Did not meet protocol eligibility|3|||
157094538|NCT00081770|567101048|FG000|Overall Study|Administrative|1|||
157094539|NCT00081770|567101049|FG001|Overall Study|Administrative|0|||
156979883|NCT04921969|566679070|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156979884|NCT04921969|566679071|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
157094540|NCT00081770|567101050|FG002|Overall Study|Administrative|1|||
157094541|NCT00081770|567101048|FG000|Overall Study|Other|2|||
157094542|NCT00081770|567101049|FG001|Overall Study|Other|7|||
157094543|NCT00081770|567101050|FG002|Overall Study|Other|8|||
157094544|NCT03435497|567101052|FG000|Overall Study|Lost to Follow-up|1|||
157094545|NCT03435497|567101053|FG001|Overall Study|Lost to Follow-up|0|||
157094546|NCT03435497|567101052|FG000|Overall Study|Death|1|||
157094547|NCT03435497|567101053|FG001|Overall Study|Death|0|||
157094548|NCT03435497|567101052|FG000|Overall Study|Withdrawal by Subject|0|||
157094549|NCT03435497|567101053|FG001|Overall Study|Withdrawal by Subject|4|||
157094550|NCT03435497|567101052|FG000|Overall Study|Wrong survey administered|0|||
157094551|NCT03435497|567101053|FG001|Overall Study|Wrong survey administered|2|||
157094552|NCT01072877|567101054|FG000|Overall Study|Lost to Follow-up|1|||
157094553|NCT01072877|567101055|FG001|Overall Study|Lost to Follow-up|1|||
157094554|NCT01072877|567101056|FG002|Overall Study|Lost to Follow-up|0|||
157094555|NCT01072877|567101057|FG003|Overall Study|Lost to Follow-up|2|||
157094556|NCT01072877|567101058|FG004|Overall Study|Lost to Follow-up|0|||
157094557|NCT01614197|567101067|FG000|Overall Study|Withdrawal by Subject|0|||
157094558|NCT01614197|567101068|FG001|Overall Study|Withdrawal by Subject|1|||
157094559|NCT01614197|567101069|FG002|Overall Study|Withdrawal by Subject|0|||
157094560|NCT01614197|567101070|FG003|Overall Study|Withdrawal by Subject|0|||
157094561|NCT03628898|567101072|FG000|Overall Study|Device deficiency|1|||
157094562|NCT03442985|567101073|FG000|Overall Study|Sponsor Request|55|||
157094563|NCT03442985|567101074|FG001|Overall Study|Sponsor Request|60|||
157094564|NCT03442985|567101075|FG002|Overall Study|Sponsor Request|54|||
157094565|NCT03442985|567101073|FG000|Overall Study|Lost to Follow-up|5|||
157094566|NCT03442985|567101074|FG001|Overall Study|Lost to Follow-up|2|||
157094567|NCT03442985|567101075|FG002|Overall Study|Lost to Follow-up|7|||
157094568|NCT03442985|567101073|FG000|Overall Study|Withdrawal by Subject|2|||
157094569|NCT03442985|567101074|FG001|Overall Study|Withdrawal by Subject|3|||
157094570|NCT03442985|567101075|FG002|Overall Study|Withdrawal by Subject|4|||
157094571|NCT03442985|567101073|FG000|Overall Study|Adverse Event|0|||
157094572|NCT03442985|567101074|FG001|Overall Study|Adverse Event|1|||
157094573|NCT03442985|567101075|FG002|Overall Study|Adverse Event|0|||
157094574|NCT00975507|567101082|FG000|Overall Study|Adverse Event|1|||
157094575|NCT00975507|567101083|FG001|Overall Study|Adverse Event|0|||
157094576|NCT00975507|567101082|FG000|Overall Study|Lost to Follow-up|7|||
157094577|NCT00975507|567101083|FG001|Overall Study|Lost to Follow-up|1|||
157094578|NCT00975507|567101082|FG000|Overall Study|Protocol Violation|2|||
157094579|NCT00975507|567101083|FG001|Overall Study|Protocol Violation|0|||
157094580|NCT00975507|567101082|FG000|Overall Study|Withdrawal by Subject|10|||
157094581|NCT00975507|567101083|FG001|Overall Study|Withdrawal by Subject|3|||
157094582|NCT00824161|567101084|FG000|Overall Study|Withdrawal by Subject|1|||
157094583|NCT00824161|567101084|FG000|Overall Study|Screen Failure|1|||
157094584|NCT04754477|567101085|FG000|Overall Study|Withdrawal by Subject|1|||
157094585|NCT00655863|567101086|FG000|Overall Study|Lost to Follow-up|0|||
157094586|NCT00655863|567101087|FG001|Overall Study|Lost to Follow-up|0|||
157094587|NCT00655863|567101088|FG002|Overall Study|Lost to Follow-up|1|||
157094588|NCT01774110|567101093|FG000|Overall Study|Lost to Follow-up|7|||
157094589|NCT02203695|567101094|FG000|Overall Study|Patient withdrew consent|1|||
157094590|NCT02203695|567101095|FG001|Overall Study|Patient withdrew consent|1|||
157094591|NCT02203695|567101094|FG000|Overall Study|Started non-study treatment|1|||
157094592|NCT02203695|567101095|FG001|Overall Study|Started non-study treatment|0|||
157094593|NCT00846391|567101096|FG000|Overall Study|Physician Decision|0|||
157094594|NCT00846391|567101097|FG001|Overall Study|Physician Decision|0|||
157094595|NCT00846391|567101098|FG002|Overall Study|Physician Decision|1|||
157094596|NCT00846391|567101096|FG000|Overall Study|Study Terminated by Sponsor|1|||
157094597|NCT00846391|567101097|FG001|Overall Study|Study Terminated by Sponsor|2|||
157094598|NCT00846391|567101098|FG002|Overall Study|Study Terminated by Sponsor|2|||
157094599|NCT03575143|567101099|FG000|Overall Study|Lost to Follow-up|0|||
157094600|NCT03575143|567101100|FG001|Overall Study|Lost to Follow-up|0|||
157094601|NCT03575143|567101101|FG002|Overall Study|Lost to Follow-up|4|||
157094602|NCT03575143|567101099|FG000|Overall Study|Withdrawal by Subject|0|||
157094603|NCT03575143|567101100|FG001|Overall Study|Withdrawal by Subject|0|||
157094604|NCT03575143|567101101|FG002|Overall Study|Withdrawal by Subject|5|||
157094605|NCT03575143|567101099|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
157094606|NCT03575143|567101100|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
157094607|NCT03575143|567101101|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
157094608|NCT00899548|567101108|FG000|Overall Study|Physician Decision|3|||
157094609|NCT04781387|567101109|FG000|Overall Study|Withdrawal by Subject|1|||
157094610|NCT04781387|567101110|FG001|Overall Study|Withdrawal by Subject|0|||
157094611|NCT04781387|567101111|FG002|Overall Study|Withdrawal by Subject|1|||
157094612|NCT04781387|567101109|FG000|Overall Study|Lost to Follow-up|1|||
157094613|NCT04781387|567101110|FG001|Overall Study|Lost to Follow-up|0|||
157094614|NCT04781387|567101111|FG002|Overall Study|Lost to Follow-up|0|||
157094615|NCT01636960|567101112|FG000|Induction Phase|Adverse Event|2|||
157094616|NCT01636960|567101112|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
157094617|NCT01636960|567101112|FG000|Maintenance Phase|Adverse Event|3|||
157094618|NCT01636960|567101112|FG000|Maintenance Phase|Progressive disease|1|||
157094619|NCT00679627|567101113|FG000|Overall Study|Death|41|||
157094620|NCT00679627|567101114|FG001|Overall Study|Death|29|||
157094621|NCT00679627|567101113|FG000|Overall Study|Adverse Event|43|||
157094622|NCT00679627|567101114|FG001|Overall Study|Adverse Event|53|||
157094623|NCT00679627|567101113|FG000|Overall Study|Withdrawal by Subject|168|||
157094624|NCT00679627|567101114|FG001|Overall Study|Withdrawal by Subject|172|||
157094625|NCT00679627|567101113|FG000|Overall Study|Lost to Follow-up|22|||
157094626|NCT00679627|567101114|FG001|Overall Study|Lost to Follow-up|26|||
157094627|NCT00679627|567101113|FG000|Overall Study|Early Study Closure|425|||
157094628|NCT00679627|567101114|FG001|Overall Study|Early Study Closure|405|||
157094629|NCT06338462|567101117|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
157094630|NCT03581825|567101123|FG000|Period 1|Lens Discomfort|1|||
157094631|NCT03581825|567101124|FG001|Period 1|Lens Discomfort|0|||
157094632|NCT03581825|567101123|FG000|Period 2|Unsatisfactory Vision to Test|0|||
157094633|NCT03581825|567101124|FG001|Period 2|Unsatisfactory Vision to Test|1|||
157094634|NCT05330312|567101126|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
157094635|NCT05330312|567101127|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
157094636|NCT05330312|567101128|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
157094637|NCT05330312|567101126|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
157094638|NCT05330312|567101127|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
157094639|NCT05330312|567101128|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
157094640|NCT05330312|567101126|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
157094641|NCT05330312|567101127|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
157094642|NCT05330312|567101128|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
157094643|NCT05330312|567101126|FG000|Pivotal Investigation - Part 2|Death|1|||
157094644|NCT05330312|567101127|FG001|Pivotal Investigation - Part 2|Death|4|||
157094645|NCT05330312|567101128|FG002|Pivotal Investigation - Part 2|Death|0|||
157094646|NCT05572021|567101129|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
157094647|NCT05572021|567101130|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
157094648|NCT00345293|567101131|FG000|Overall Study|Unable to access line for sample|1|||
157094649|NCT00345293|567101132|FG001|Overall Study|Unable to access line for sample|0|||
157094650|NCT00345293|567101131|FG000|Overall Study|Withdrawal by Subject|1|||
157094651|NCT00345293|567101132|FG001|Overall Study|Withdrawal by Subject|0|||
157094652|NCT04873232|567101133|FG000|Overall Study|Lost to Follow-up|1|||
157094653|NCT04873232|567101134|FG001|Overall Study|Lost to Follow-up|4|||
157094654|NCT04873232|567101133|FG000|Overall Study|Withdrawal by Subject|1|||
157094655|NCT04873232|567101134|FG001|Overall Study|Withdrawal by Subject|0|||
157094656|NCT00601419|567103042|FG000|Overall Study|Lost to Follow-up|3|||
157094657|NCT00601419|567103042|FG000|Overall Study|Missed Visits|1|||
157094658|NCT01786174|567103043|FG000|Overall Study|Discontinued Study Drug|2|||
157094659|NCT01786174|567103044|FG001|Overall Study|Discontinued Study Drug|0|||
157094660|NCT00995020|567103045|FG000|Overall Study|margin analysis not performed|2|||
157094661|NCT00995020|567103046|FG001|Overall Study|margin analysis not performed|5|||
157094662|NCT00995020|567103045|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
157094663|NCT00995020|567103046|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
157094664|NCT00876694|567103049|FG000|Overall Study|Adverse Event|10|||
157094665|NCT00876694|567103050|FG001|Overall Study|Adverse Event|7|||
157094666|NCT00876694|567103049|FG000|Overall Study|Subject withdrew consent|6|||
157094667|NCT00876694|567103050|FG001|Overall Study|Subject withdrew consent|4|||
157094668|NCT00876694|567103049|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
157094669|NCT00876694|567103050|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157094670|NCT00876694|567103049|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157094671|NCT00876694|567103050|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157094672|NCT00876694|567103049|FG000|Overall Study|Administrative problems|1|||
157094673|NCT00876694|567103050|FG001|Overall Study|Administrative problems|1|||
157094674|NCT00876694|567103049|FG000|Overall Study|Death|1|||
157094675|NCT00876694|567103050|FG001|Overall Study|Death|0|||
157094676|NCT00288509|567103051|FG000|Treatment Cycle 1|Adverse Event|1|||
157094677|NCT00288509|567103051|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
157094678|NCT00288509|567103051|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
157094679|NCT00288509|567103051|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
157094680|NCT00288509|567103051|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
157094681|NCT00288509|567103051|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
157094682|NCT00288509|567103051|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
157094683|NCT00288509|567103051|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
157094684|NCT00288509|567103051|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
157094685|NCT00288509|567103051|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
156751625|NCT00528372|565842074|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
157094686|NCT00288509|567103051|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
157094687|NCT00288509|567103051|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
157094688|NCT00288509|567103051|FG000|Treatment Cycle 4|Physician Decision|4|||
157094689|NCT00288509|567103051|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
157094690|NCT02382016|567103052|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
157094691|NCT02382016|567103053|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
157094692|NCT02382016|567103052|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
157094693|NCT02382016|567103053|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
157094694|NCT02382016|567103052|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
157094695|NCT02382016|567103053|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
157094696|NCT02382016|567103052|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
157094697|NCT02382016|567103053|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
157094698|NCT02382016|567103052|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
157094699|NCT02382016|567103053|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
157094700|NCT02382016|567103052|FG000|Open-label (OL) Treatment Period|Death|4|||
157094701|NCT02382016|567103053|FG001|Open-label (OL) Treatment Period|Death|0|||
157094702|NCT02382016|567103052|FG000|OL Extension Period|Physician Decision|3|||
157094703|NCT02382016|567103053|FG001|OL Extension Period|Physician Decision|0|||
157094704|NCT02382016|567103052|FG000|OL Extension Period|Death|2|||
157094705|NCT02382016|567103053|FG001|OL Extension Period|Death|0|||
157094706|NCT02382016|567103052|FG000|OL Extension Period|Withdrawal by Subject|1|||
157094707|NCT02382016|567103053|FG001|OL Extension Period|Withdrawal by Subject|0|||
157094708|NCT00084266|567103054|FG000|Overall Study|Death|42|||
157094709|NCT00084266|567103055|FG001|Overall Study|Death|39|||
157094710|NCT00084266|567103054|FG000|Overall Study|Adverse Event|8|||
157094711|NCT00084266|567103055|FG001|Overall Study|Adverse Event|5|||
157094712|NCT00084266|567103054|FG000|Overall Study|Lack of Efficacy|2|||
157094713|NCT00084266|567103055|FG001|Overall Study|Lack of Efficacy|4|||
157094714|NCT00084266|567103054|FG000|Overall Study|Lost to Follow-up|5|||
157094715|NCT00084266|567103055|FG001|Overall Study|Lost to Follow-up|3|||
157094716|NCT00084266|567103054|FG000|Overall Study|Participant not willing to participate|3|||
157094717|NCT00084266|567103055|FG001|Overall Study|Participant not willing to participate|8|||
157094718|NCT00084266|567103054|FG000|Overall Study|Other|360|||
157094719|NCT00084266|567103055|FG001|Overall Study|Other|344|||
157094720|NCT00084266|567103054|FG000|Overall Study|Randomized not treated|21|||
157094721|NCT00084266|567103055|FG001|Overall Study|Randomized not treated|20|||
157094722|NCT00730171|567103056|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
157094723|NCT00730171|567103056|FG000|Overall Study|Adverse Event|193|||
157094724|NCT00730171|567103056|FG000|Overall Study|Protocol Violation|48|||
157094725|NCT00730171|567103056|FG000|Overall Study|Withdrawal by Subject|202|||
157094726|NCT00730171|567103056|FG000|Overall Study|Lost to Follow-up|121|||
157094727|NCT00730171|567103056|FG000|Overall Study|Insufficient Therapeutic Response|141|||
157094728|NCT00730171|567103056|FG000|Overall Study|Other|61|||
157094729|NCT01729156|567103057|FG000|Overall Study|Withdrawal by Subject|1|||
157094730|NCT01729156|567103058|FG001|Overall Study|Withdrawal by Subject|0|||
157094731|NCT01729156|567103059|FG002|Overall Study|Withdrawal by Subject|0|||
157094732|NCT01215422|567103060|FG000|Overall Study|Relocation|1|||
157094733|NCT01215422|567103061|FG001|Overall Study|Relocation|0|||
157094734|NCT01215422|567103062|FG002|Overall Study|Relocation|0|||
157094735|NCT01215422|567103063|FG003|Overall Study|Relocation|0|||
157094736|NCT01215422|567103060|FG000|Overall Study|Failed intubations|0|||
157094737|NCT01215422|567103061|FG001|Overall Study|Failed intubations|0|||
157094738|NCT01215422|567103062|FG002|Overall Study|Failed intubations|3|||
157094739|NCT01215422|567103063|FG003|Overall Study|Failed intubations|8|||
157094740|NCT01215422|567103060|FG000|Overall Study|Did not complete all intubations|7|||
157094741|NCT01215422|567103061|FG001|Overall Study|Did not complete all intubations|0|||
157094742|NCT01215422|567103062|FG002|Overall Study|Did not complete all intubations|0|||
157094743|NCT01215422|567103063|FG003|Overall Study|Did not complete all intubations|0|||
157094744|NCT01256658|567103066|FG000|Period 1|Lost to Follow-up|837|||
157094745|NCT01256658|567103067|FG001|Period 1|Lost to Follow-up|661|||
157094746|NCT01256658|567103066|FG000|Period 1|Withdrawal by Subject|35|||
157094747|NCT01256658|567103067|FG001|Period 1|Withdrawal by Subject|43|||
157094748|NCT01256658|567103066|FG000|Period 1|Death|48|||
157094749|NCT01256658|567103067|FG001|Period 1|Death|44|||
157094750|NCT00719563|567103072|FG000|Overall Study|Adverse Event|16|||
157094751|NCT00719563|567103073|FG001|Overall Study|Adverse Event|13|||
157094752|NCT00719563|567103072|FG000|Overall Study|Medical condition changed|3|||
157094753|NCT00719563|567103073|FG001|Overall Study|Medical condition changed|5|||
157094754|NCT00719563|567103072|FG000|Overall Study|Lack of Efficacy|3|||
157094755|NCT00719563|567103073|FG001|Overall Study|Lack of Efficacy|7|||
157094756|NCT00719563|567103072|FG000|Overall Study|Personal reasons|6|||
157094757|NCT00719563|567103073|FG001|Overall Study|Personal reasons|7|||
157094758|NCT00719563|567103072|FG000|Overall Study|Unknown reasons|4|||
157094759|NCT00719563|567103073|FG001|Overall Study|Unknown reasons|6|||
157094760|NCT00719563|567103072|FG000|Overall Study|Noncompliant|1|||
157094761|NCT00719563|567103073|FG001|Overall Study|Noncompliant|1|||
157094762|NCT00719563|567103072|FG000|Overall Study|Lost to Follow-up|5|||
157094763|NCT00719563|567103073|FG001|Overall Study|Lost to Follow-up|3|||
157094764|NCT01386788|567103076|FG000|Overall Study|Lost to Follow-up|2|||
157094765|NCT00462865|567103079|FG000|Overall Study|Adverse Event|1|||
157094766|NCT02120625|567103081|FG000|Overall Study|Physician Decision|2|||
157094767|NCT04142450|567103082|FG000|Overall Study|Screen Failure|1|||
157094768|NCT04142450|567103082|FG000|Overall Study|Lost to Follow-up|1|||
157094769|NCT00120406|567103083|FG000|Overall Study|Death|9|||
157094770|NCT00120406|567103084|FG001|Overall Study|Death|4|||
157094771|NCT00120406|567103083|FG000|Overall Study|Withdrawal by Subject|5|||
157094772|NCT00120406|567103084|FG001|Overall Study|Withdrawal by Subject|7|||
157094773|NCT00120406|567103083|FG000|Overall Study|Lost to Follow-up|5|||
157094774|NCT00120406|567103084|FG001|Overall Study|Lost to Follow-up|2|||
157094775|NCT00120406|567103083|FG000|Overall Study|received non-study stent|0|||
157094776|NCT00120406|567103084|FG001|Overall Study|received non-study stent|2|||
157094777|NCT00120406|567103083|FG000|Overall Study|patient moved but has not withdrawn|0|||
157094778|NCT00120406|567103084|FG001|Overall Study|patient moved but has not withdrawn|1|||
157094779|NCT06336603|567103085|FG000|Overall Study|Withdrawal by Subject|1|||
157094780|NCT06336603|567103085|FG000|Overall Study|Lost to Follow-up|2|||
157094781|NCT00762970|567103091|FG000|Overall Study|Withdrawal by Subject|7|||
157094782|NCT00762970|567103092|FG001|Overall Study|Withdrawal by Subject|4|||
157094783|NCT00762970|567103093|FG002|Overall Study|Withdrawal by Subject|0|||
157094784|NCT00762970|567103091|FG000|Overall Study|Protocol Violation|3|||
157094785|NCT00762970|567103092|FG001|Overall Study|Protocol Violation|1|||
157094786|NCT00762970|567103093|FG002|Overall Study|Protocol Violation|1|||
157094787|NCT00762970|567103091|FG000|Overall Study|Lost to Follow-up|1|||
157094788|NCT00762970|567103092|FG001|Overall Study|Lost to Follow-up|2|||
157094789|NCT00762970|567103093|FG002|Overall Study|Lost to Follow-up|0|||
157094790|NCT00762970|567103091|FG000|Overall Study|Difficulty of handling lens|1|||
157094791|NCT00762970|567103092|FG001|Overall Study|Difficulty of handling lens|2|||
157094792|NCT00762970|567103093|FG002|Overall Study|Difficulty of handling lens|0|||
157094793|NCT01480674|567103094|FG000|Overall Study|Death|23|||
157094794|NCT01480674|567103094|FG000|Overall Study|Lost to Follow-up|2|||
157094795|NCT01480674|567103094|FG000|Overall Study|visit not done|10|||
157094796|NCT01295034|567103095|FG000|Overall Study|Lost to Follow-up|5|||
157094797|NCT01295034|567103096|FG001|Overall Study|Lost to Follow-up|5|||
157094798|NCT03249714|567103097|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
157094799|NCT03249714|567103098|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
157094800|NCT03249714|567103097|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
157094801|NCT03249714|567103098|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
157094802|NCT03249714|567103097|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
157094803|NCT03249714|567103098|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
157094804|NCT03249714|567103097|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
157094805|NCT03249714|567103098|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
157094806|NCT00879762|567103101|FG000|Overall Study|Lost to Follow-up|3|||
157094807|NCT00879762|567103102|FG001|Overall Study|Lost to Follow-up|1|||
157094808|NCT01313637|567103107|FG000|Overall Study|Adverse Event|17|||
157094809|NCT01313637|567103108|FG001|Overall Study|Adverse Event|24|||
157094810|NCT01313637|567103109|FG002|Overall Study|Adverse Event|25|||
157094811|NCT01313637|567103110|FG003|Overall Study|Adverse Event|18|||
157094812|NCT01313637|567103107|FG000|Overall Study|Lack of Efficacy|44|||
157094813|NCT01313637|567103108|FG001|Overall Study|Lack of Efficacy|38|||
157094814|NCT01313637|567103109|FG002|Overall Study|Lack of Efficacy|37|||
157094815|NCT01313637|567103110|FG003|Overall Study|Lack of Efficacy|24|||
157094816|NCT01313637|567103107|FG000|Overall Study|Protocol Violation|4|||
157094817|NCT01313637|567103108|FG001|Overall Study|Protocol Violation|3|||
157094818|NCT01313637|567103109|FG002|Overall Study|Protocol Violation|11|||
157094819|NCT01313637|567103110|FG003|Overall Study|Protocol Violation|5|||
157094820|NCT01313637|567103107|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
157094821|NCT01313637|567103108|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
157094822|NCT01313637|567103109|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
157094823|NCT01313637|567103110|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
157094824|NCT01313637|567103107|FG000|Overall Study|Lost to Follow-up|0|||
157094825|NCT01313637|567103108|FG001|Overall Study|Lost to Follow-up|2|||
157094826|NCT01313637|567103109|FG002|Overall Study|Lost to Follow-up|1|||
157094827|NCT01313637|567103110|FG003|Overall Study|Lost to Follow-up|3|||
157094828|NCT01313637|567103107|FG000|Overall Study|Withdrawal by Subject|11|||
157094829|NCT01313637|567103108|FG001|Overall Study|Withdrawal by Subject|13|||
157094830|NCT01313637|567103109|FG002|Overall Study|Withdrawal by Subject|18|||
157094831|NCT01313637|567103110|FG003|Overall Study|Withdrawal by Subject|15|||
157094832|NCT00795951|567103116|FG000|Overall Study|Lost to Follow-up|1|||
157094833|NCT00795951|567103116|FG000|Overall Study|Withdrawal by Subject|1|||
157094834|NCT04572841|567103118|FG000|Overall Study|Adverse Event|1|||
157094835|NCT04572841|567103119|FG001|Overall Study|Adverse Event|1|||
157094836|NCT04572841|567103118|FG000|Overall Study|Withdrawal by Subject|2|||
157094837|NCT04572841|567103119|FG001|Overall Study|Withdrawal by Subject|1|||
157094838|NCT04661878|567103120|FG000|Overall Study|Lost to Follow-up|6|||
157094839|NCT04661878|567103121|FG001|Overall Study|Lost to Follow-up|5|||
157094840|NCT00712673|567103124|FG000|Overall Study|Adverse Event|3|||
157094841|NCT00712673|567103125|FG001|Overall Study|Adverse Event|3|||
157094842|NCT00712673|567103126|FG002|Overall Study|Adverse Event|21|||
157094843|NCT00712673|567103127|FG003|Overall Study|Adverse Event|26|||
157094844|NCT00712673|567103124|FG000|Overall Study|Lack of Efficacy|2|||
157094845|NCT00712673|567103125|FG001|Overall Study|Lack of Efficacy|8|||
157094846|NCT00712673|567103126|FG002|Overall Study|Lack of Efficacy|8|||
157094847|NCT00712673|567103127|FG003|Overall Study|Lack of Efficacy|6|||
157094848|NCT00712673|567103124|FG000|Overall Study|Poor Compliance to Protocol|3|||
157094849|NCT00712673|567103125|FG001|Overall Study|Poor Compliance to Protocol|3|||
157094850|NCT00712673|567103126|FG002|Overall Study|Poor Compliance to Protocol|4|||
157094851|NCT00712673|567103127|FG003|Overall Study|Poor Compliance to Protocol|16|||
157094852|NCT00712673|567103124|FG000|Overall Study|Lost to Follow-up|1|||
157094853|NCT00712673|567103125|FG001|Overall Study|Lost to Follow-up|0|||
157094854|NCT00712673|567103126|FG002|Overall Study|Lost to Follow-up|2|||
157094855|NCT00712673|567103127|FG003|Overall Study|Lost to Follow-up|0|||
157094856|NCT00712673|567103124|FG000|Overall Study|Withdrawal by Subject|6|||
157094857|NCT00712673|567103125|FG001|Overall Study|Withdrawal by Subject|7|||
157094858|NCT00712673|567103126|FG002|Overall Study|Withdrawal by Subject|15|||
157094859|NCT00712673|567103127|FG003|Overall Study|Withdrawal by Subject|20|||
157094860|NCT00712673|567103124|FG000|Overall Study|Familial and Personal Reasons|5|||
157094861|NCT00712673|567103125|FG001|Overall Study|Familial and Personal Reasons|0|||
157094862|NCT00712673|567103126|FG002|Overall Study|Familial and Personal Reasons|5|||
157094863|NCT00712673|567103127|FG003|Overall Study|Familial and Personal Reasons|2|||
157094864|NCT00712673|567103124|FG000|Overall Study|Investigator's Decision|1|||
157094865|NCT00712673|567103125|FG001|Overall Study|Investigator's Decision|0|||
157094866|NCT00712673|567103126|FG002|Overall Study|Investigator's Decision|0|||
157094867|NCT00712673|567103127|FG003|Overall Study|Investigator's Decision|0|||
157094868|NCT00712673|567103124|FG000|Overall Study|Protocol Violation|0|||
157094869|NCT00712673|567103125|FG001|Overall Study|Protocol Violation|0|||
157094870|NCT00712673|567103126|FG002|Overall Study|Protocol Violation|2|||
157094871|NCT00712673|567103127|FG003|Overall Study|Protocol Violation|0|||
157094872|NCT01323647|567103128|FG000|Overall Study|Migrated/moved from study area|2|||
156979885|NCT04921969|566679072|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
156979886|NCT04921969|566679073|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
156979887|NCT04921969|566679074|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
156979888|NCT04287868|566679075|FG000|Overall Study|Screening fail|1|||
156979889|NCT04287868|566679076|FG001|Overall Study|Screening fail|0|||
156979890|NCT01340482|566680519|FG000|Overall Study|Adverse Event|2|||
156979891|NCT01340482|566680520|FG001|Overall Study|Adverse Event|0|||
156979892|NCT01340482|566680521|FG002|Overall Study|Adverse Event|0|||
156979893|NCT01282476|566680522|FG000|Overall Study|Death|11|||
156979894|NCT01087723|566680523|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
156979895|NCT01087723|566680524|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
156979896|NCT01087723|566680523|FG000|Overall Study|Withdrawal by Subject|10|||
156979897|NCT01087723|566680524|FG001|Overall Study|Withdrawal by Subject|13|||
156979898|NCT01087723|566680523|FG000|Overall Study|Physician Decision|2|||
156979899|NCT01087723|566680524|FG001|Overall Study|Physician Decision|0|||
156979900|NCT01087723|566680523|FG000|Overall Study|Lost to Follow-up|1|||
156979901|NCT01087723|566680524|FG001|Overall Study|Lost to Follow-up|4|||
156979902|NCT01087723|566680523|FG000|Overall Study|Reason Not Specified|1|||
156979903|NCT01087723|566680524|FG001|Overall Study|Reason Not Specified|2|||
156979904|NCT04399551|566680525|FG000|Overall Study|Adverse Event|15|||
156979905|NCT04399551|566680525|FG000|Overall Study|Withdrawal by Subject|6|||
156979906|NCT04399551|566680525|FG000|Overall Study|Physician Decision|3|||
156979907|NCT04399551|566680525|FG000|Overall Study|Lost to Follow-up|2|||
156979908|NCT04399551|566680525|FG000|Overall Study|Protocol Deviation|2|||
156979909|NCT01642602|566680529|FG000|Overall Study|Adverse Event|2|||
156979910|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
156979911|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
156979912|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156979913|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
156979914|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
156979915|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
156979916|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
156979917|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
156979918|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
156979919|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
156979920|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
156979921|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
156979922|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
156979923|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
156979924|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
156979925|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
156979926|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
156979927|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
156979928|NCT00365378|566680538|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
156979929|NCT00365378|566680539|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
156979930|NCT00365378|566680540|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
156979931|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
156979932|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
156979933|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
156979934|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
156979935|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
157021584|NCT04610892|566830904|FG001|Overall Study|Death|1|||
157021585|NCT04610892|566830905|FG002|Overall Study|Death|0|||
157021586|NCT04610892|566830906|FG003|Overall Study|Death|1|||
157021587|NCT04610892|566830907|FG004|Overall Study|Death|0|||
157021588|NCT04610892|566830903|FG000|Overall Study|Withdrawal by Subject|3|||
157021589|NCT04610892|566830904|FG001|Overall Study|Withdrawal by Subject|2|||
157021590|NCT04610892|566830905|FG002|Overall Study|Withdrawal by Subject|0|||
157021591|NCT04610892|566830906|FG003|Overall Study|Withdrawal by Subject|6|||
157021592|NCT04610892|566830907|FG004|Overall Study|Withdrawal by Subject|6|||
157021593|NCT04610892|566830903|FG000|Overall Study|Subjects who did not receive treatment|1|||
157021594|NCT04610892|566830904|FG001|Overall Study|Subjects who did not receive treatment|0|||
157021595|NCT04610892|566830905|FG002|Overall Study|Subjects who did not receive treatment|0|||
157021596|NCT04610892|566830906|FG003|Overall Study|Subjects who did not receive treatment|0|||
157021597|NCT04610892|566830907|FG004|Overall Study|Subjects who did not receive treatment|2|||
157021598|NCT03699709|566830910|FG000|Overall Study|Death|1|||
157021599|NCT03699709|566830911|FG001|Overall Study|Death|2|||
157021600|NCT03699709|566830910|FG000|Overall Study|Lost to Follow-up|10|||
157021601|NCT03699709|566830911|FG001|Overall Study|Lost to Follow-up|3|||
157021602|NCT03699709|566830910|FG000|Overall Study|Withdrawal by Subject|5|||
157021603|NCT03699709|566830911|FG001|Overall Study|Withdrawal by Subject|0|||
157021604|NCT03699709|566830910|FG000|Overall Study|incarcerated|1|||
157021605|NCT03699709|566830911|FG001|Overall Study|incarcerated|0|||
157094873|NCT01323647|567103129|FG001|Overall Study|Migrated/moved from study area|0|||
157094874|NCT01323647|567103128|FG000|Overall Study|Withdrawal by Subject|5|||
157094875|NCT01323647|567103129|FG001|Overall Study|Withdrawal by Subject|0|||
157094876|NCT01323647|567103128|FG000|Overall Study|Lost to Follow-up|2|||
157094877|NCT01323647|567103129|FG001|Overall Study|Lost to Follow-up|0|||
157094878|NCT03603028|567103130|FG000|Overall Study|Withdrawal by Subject|1|||
157094879|NCT02768870|567103133|FG000|Overall Study|Death|1|||
157094880|NCT02768870|567103133|FG000|Overall Study|Reoperation|6|||
157094881|NCT02768870|567103133|FG000|Overall Study|Lost to Follow-up|1|||
157094882|NCT02768870|567103133|FG000|Overall Study|Exit|4|||
157094883|NCT02963610|567103134|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
157094884|NCT00063154|567103135|FG000|Overall Study|Disease progression|27|||
157094885|NCT00063154|567103135|FG000|Overall Study|Adverse Event|2|||
157094886|NCT00063154|567103135|FG000|Overall Study|Physician Decision|10|||
157094887|NCT00063154|567103135|FG000|Overall Study|Death|3|||
157094888|NCT00063154|567103135|FG000|Overall Study|Reason unspecified|1|||
157094889|NCT00063154|567103135|FG000|Overall Study|Did not receive treatment|8|||
157094890|NCT00640016|567103136|FG000|Overall Study|Withdrawal by Subject|0|||
157094891|NCT00640016|567103137|FG001|Overall Study|Withdrawal by Subject|1|||
157094892|NCT00640016|567103138|FG002|Overall Study|Withdrawal by Subject|0|||
157094893|NCT00640016|567103139|FG003|Overall Study|Withdrawal by Subject|0|||
157094894|NCT00640016|567103136|FG000|Overall Study|Study termination|2|||
157094895|NCT00640016|567103137|FG001|Overall Study|Study termination|1|||
157094896|NCT00640016|567103138|FG002|Overall Study|Study termination|3|||
157094897|NCT00640016|567103139|FG003|Overall Study|Study termination|2|||
157094898|NCT00640016|567103136|FG000|Overall Study|Adverse Event|0|||
157094899|NCT00640016|567103137|FG001|Overall Study|Adverse Event|0|||
157094900|NCT00640016|567103138|FG002|Overall Study|Adverse Event|0|||
157094901|NCT00640016|567103139|FG003|Overall Study|Adverse Event|1|||
157094902|NCT02924064|567103141|FG000|Overall Study|Adverse Event|2|||
157094903|NCT02924064|567103142|FG001|Overall Study|Adverse Event|2|||
157094904|NCT02924064|567103141|FG000|Overall Study|Lost to Follow-up|0|||
157094905|NCT02924064|567103142|FG001|Overall Study|Lost to Follow-up|2|||
157094906|NCT02924064|567103141|FG000|Overall Study|Physician Decision|0|||
157094907|NCT02924064|567103142|FG001|Overall Study|Physician Decision|2|||
157094908|NCT02924064|567103141|FG000|Overall Study|Protocol Violation|1|||
157094909|NCT02924064|567103142|FG001|Overall Study|Protocol Violation|3|||
157094910|NCT02924064|567103141|FG000|Overall Study|Withdrawal by Subject|4|||
157094911|NCT02924064|567103142|FG001|Overall Study|Withdrawal by Subject|5|||
157094912|NCT02924064|567103141|FG000|Overall Study|Other|17|||
157094913|NCT02924064|567103142|FG001|Overall Study|Other|29|||
157094914|NCT02699983|567103143|FG000|Overall Study|Withdrawal by Subject|1|||
157094915|NCT02699983|567103144|FG001|Overall Study|Withdrawal by Subject|0|||
157094916|NCT01287065|567103145|FG000|Treatment Period 1|Adverse Event|0|||
157094917|NCT01287065|567103146|FG001|Treatment Period 1|Adverse Event|0|||
157094918|NCT01287065|567103147|FG002|Treatment Period 1|Adverse Event|0|||
157094919|NCT01287065|567103148|FG003|Treatment Period 1|Adverse Event|0|||
157094920|NCT01287065|567103149|FG004|Treatment Period 1|Adverse Event|1|||
157094921|NCT01287065|567103150|FG005|Treatment Period 1|Adverse Event|0|||
157094922|NCT01287065|567103145|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157094923|NCT01287065|567103146|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157094924|NCT01287065|567103147|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157094925|NCT01287065|567103148|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157094926|NCT01287065|567103149|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157094927|NCT01287065|567103150|FG005|Treatment Period 1|Withdrawal by Subject|1|||
157094928|NCT01259726|567103151|FG000|Overall Study|Death|1|||
157094929|NCT01259726|567103152|FG001|Overall Study|Death|0|||
157094930|NCT01259726|567103153|FG002|Overall Study|Death|0|||
157094931|NCT01259726|567103154|FG003|Overall Study|Death|0|||
157094932|NCT01259726|567103151|FG000|Overall Study|Physician Decision|2|||
157094933|NCT01259726|567103152|FG001|Overall Study|Physician Decision|0|||
157094934|NCT01259726|567103153|FG002|Overall Study|Physician Decision|1|||
157094935|NCT01259726|567103154|FG003|Overall Study|Physician Decision|1|||
157094936|NCT01259726|567103151|FG000|Overall Study|Withdrawal by Subject|1|||
157094937|NCT01259726|567103152|FG001|Overall Study|Withdrawal by Subject|3|||
157094938|NCT01259726|567103153|FG002|Overall Study|Withdrawal by Subject|2|||
157094939|NCT01259726|567103154|FG003|Overall Study|Withdrawal by Subject|1|||
157094940|NCT01259726|567103151|FG000|Overall Study|Lost to Follow-up|1|||
157094941|NCT01259726|567103152|FG001|Overall Study|Lost to Follow-up|1|||
157094942|NCT01259726|567103153|FG002|Overall Study|Lost to Follow-up|1|||
157094943|NCT01259726|567103154|FG003|Overall Study|Lost to Follow-up|3|||
157094944|NCT01211197|567103156|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157094945|NCT01211197|567103157|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157094946|NCT01211197|567103158|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
157094947|NCT01211197|567103159|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157094948|NCT01211197|567103160|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157094949|NCT01211197|567103161|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157094950|NCT01211197|567103156|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
157094951|NCT01211197|567103157|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
157094952|NCT01211197|567103158|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
157094953|NCT01211197|567103159|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
157094954|NCT01211197|567103160|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
157094955|NCT01211197|567103161|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
157094956|NCT00261846|567103162|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
157094957|NCT00261846|567103163|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
157094958|NCT00261846|567103164|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
157094959|NCT00261846|567103165|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094960|NCT00261846|567103166|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094961|NCT00261846|567103167|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094962|NCT00261846|567103168|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094963|NCT00261846|567103169|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094964|NCT00261846|567103170|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094965|NCT00261846|567103171|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094966|NCT00261846|567103172|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094967|NCT00261846|567103173|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
157094968|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094969|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094970|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094971|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
157094972|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094973|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094974|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094975|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094976|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
157094977|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094978|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094979|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
157094980|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094981|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094982|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094983|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
157094984|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
157094985|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
157094986|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
157094987|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
157094988|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094989|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
157094990|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094991|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
157094992|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157094993|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157094994|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157094995|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
157094996|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
157094997|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157094998|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
157094999|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157095000|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
157095001|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
157095002|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
157095003|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
157095004|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
157095005|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
157095006|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
157095007|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
157095008|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
157095009|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
157095010|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
157095011|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
157095012|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
157095013|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
157095014|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
157095015|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
157095016|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
157095017|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
157095018|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
157095019|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
157095020|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
156979936|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
156979937|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
156979938|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
156979939|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
156979940|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
156979941|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
156979942|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
156979943|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
156979944|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
157095021|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
156979945|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
156979946|NCT00365378|566680538|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
156979947|NCT00365378|566680539|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
156979948|NCT00365378|566680540|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
156979949|NCT00365378|566680538|FG000|Extension|Adverse Event|0|||
156979950|NCT00365378|566680539|FG001|Extension|Adverse Event|0|||
156979951|NCT00365378|566680540|FG002|Extension|Adverse Event|1|||
156979952|NCT00365378|566680538|FG000|Extension|Moved|0|||
156979953|NCT00365378|566680539|FG001|Extension|Moved|0|||
156979954|NCT00365378|566680540|FG002|Extension|Moved|8|||
156979955|NCT00365378|566680538|FG000|Extension|Lost to Follow-up|0|||
156979956|NCT00365378|566680539|FG001|Extension|Lost to Follow-up|0|||
156979957|NCT00365378|566680540|FG002|Extension|Lost to Follow-up|57|||
156979958|NCT00365378|566680538|FG000|Extension|Protocol Violation|0|||
156979959|NCT00365378|566680539|FG001|Extension|Protocol Violation|0|||
157095022|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
157095023|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
157095024|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
157095025|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
157095026|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
157095027|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
157095028|NCT00261846|567103162|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
157095029|NCT00261846|567103163|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
157095030|NCT00261846|567103164|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
157095031|NCT00261846|567103165|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
157095032|NCT00261846|567103166|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
157095033|NCT00261846|567103167|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
157095034|NCT00261846|567103168|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
156979960|NCT00365378|566680540|FG002|Extension|Protocol Violation|2|||
156979961|NCT00365378|566680538|FG000|Extension|Withdrawal by Subject|0|||
156979962|NCT00365378|566680539|FG001|Extension|Withdrawal by Subject|0|||
157095035|NCT00261846|567103169|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
157095036|NCT00261846|567103170|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
157095037|NCT00261846|567103171|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
157095038|NCT00261846|567103172|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
157095039|NCT00261846|567103173|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
157095040|NCT01776424|567103174|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
157095041|NCT01776424|567103175|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
157095042|NCT01776424|567103176|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
157095043|NCT01776424|567103174|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
157095044|NCT01776424|567103175|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
157095045|NCT01776424|567103176|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
157095046|NCT01776424|567103174|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
157095047|NCT01776424|567103175|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
157095048|NCT01776424|567103176|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
157095049|NCT01776424|567103174|FG000|LTOLE Part (Open Label)|Refused|5|||
157095050|NCT01776424|567103175|FG001|LTOLE Part (Open Label)|Refused|2|||
157095051|NCT01776424|567103176|FG002|LTOLE Part (Open Label)|Refused|11|||
157095052|NCT01776424|567103174|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
157095053|NCT01776424|567103175|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
157095054|NCT01776424|567103176|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
157095055|NCT02294227|567103179|FG000|Overall Study|Death|0|||
157095056|NCT02294227|567103180|FG001|Overall Study|Death|0|||
157095057|NCT02294227|567103181|FG002|Overall Study|Death|1|||
156979963|NCT00365378|566680540|FG002|Extension|Withdrawal by Subject|98|||
156979964|NCT00365378|566680538|FG000|Extension|Other|0|||
156979965|NCT00365378|566680539|FG001|Extension|Other|0|||
156979966|NCT00365378|566680540|FG002|Extension|Other|31|||
156979967|NCT00251927|566680554|FG000|Overall Study|Adverse Event|3|||
156979968|NCT00251927|566680555|FG001|Overall Study|Adverse Event|15|||
156979969|NCT00251927|566680554|FG000|Overall Study|Lack of Efficacy|22|||
156979970|NCT00251927|566680555|FG001|Overall Study|Lack of Efficacy|16|||
157095058|NCT02294227|567103179|FG000|Overall Study|Subject/Guardian Decision|6|||
156979971|NCT00251927|566680554|FG000|Overall Study|Lost to Follow-up|22|||
157095059|NCT02294227|567103180|FG001|Overall Study|Subject/Guardian Decision|3|||
157095060|NCT02294227|567103181|FG002|Overall Study|Subject/Guardian Decision|7|||
157095061|NCT02294227|567103179|FG000|Overall Study|Physician Decision|1|||
157095062|NCT02294227|567103180|FG001|Overall Study|Physician Decision|2|||
157095063|NCT02294227|567103181|FG002|Overall Study|Physician Decision|1|||
157095064|NCT02294227|567103179|FG000|Overall Study|Lost to Follow-up|1|||
157095065|NCT02294227|567103180|FG001|Overall Study|Lost to Follow-up|0|||
157095066|NCT02294227|567103181|FG002|Overall Study|Lost to Follow-up|0|||
157095067|NCT02294227|567103179|FG000|Overall Study|Lack of Efficacy|11|||
157095068|NCT02294227|567103180|FG001|Overall Study|Lack of Efficacy|12|||
157095069|NCT02294227|567103181|FG002|Overall Study|Lack of Efficacy|8|||
157095070|NCT02294227|567103179|FG000|Overall Study|Adverse Event|6|||
157095071|NCT02294227|567103180|FG001|Overall Study|Adverse Event|8|||
157095072|NCT02294227|567103181|FG002|Overall Study|Adverse Event|2|||
157095073|NCT00887432|567103182|FG000|Overall Study|Start Excluded Therapy|3|||
157095074|NCT00887432|567103183|FG001|Overall Study|Start Excluded Therapy|0|||
157095075|NCT00887432|567103182|FG000|Overall Study|Did not complete treatment|6|||
157095076|NCT00887432|567103183|FG001|Overall Study|Did not complete treatment|8|||
157095077|NCT00887432|567103182|FG000|Overall Study|Protocol Violation|2|||
157095078|NCT00887432|567103183|FG001|Overall Study|Protocol Violation|3|||
157095079|NCT00887432|567103182|FG000|Overall Study|Withdrawal by Subject|3|||
157095080|NCT00887432|567103183|FG001|Overall Study|Withdrawal by Subject|2|||
157095081|NCT00887432|567103182|FG000|Overall Study|Lost to Follow-up|1|||
157095082|NCT00887432|567103183|FG001|Overall Study|Lost to Follow-up|0|||
157095083|NCT00887432|567103182|FG000|Overall Study|No reason provided|0|||
157095084|NCT00887432|567103183|FG001|Overall Study|No reason provided|1|||
157095085|NCT01580969|567103188|FG000|Overall Study|Physician Decision|3|||
157095086|NCT01580969|567103189|FG001|Overall Study|Physician Decision|0|||
157095087|NCT01580969|567103190|FG002|Overall Study|Physician Decision|0|||
157095088|NCT01745848|567103191|FG000|Overall Study|Adverse Event|6|||
157095089|NCT00448123|567103193|FG000|Overall Study|Lost to Follow-up|9|||
157095090|NCT00448123|567103194|FG001|Overall Study|Lost to Follow-up|6|||
157095091|NCT00448123|567103193|FG000|Overall Study|Physician Decision|6|||
157095092|NCT00448123|567103194|FG001|Overall Study|Physician Decision|6|||
157095093|NCT02318797|567103195|FG000|Overall Study|Death|3|||
157095094|NCT02318797|567103196|FG001|Overall Study|Death|6|||
157095095|NCT02318797|567103195|FG000|Overall Study|Lost to Follow-up|85|||
157095096|NCT02318797|567103196|FG001|Overall Study|Lost to Follow-up|96|||
157095097|NCT01079741|567103202|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
157095098|NCT01079741|567103203|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
157095099|NCT01079741|567103204|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
157095100|NCT01079741|567103205|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
157095101|NCT01079741|567103206|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
157095102|NCT01079741|567103202|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
157095103|NCT01079741|567103203|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
157095104|NCT01079741|567103204|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
157095105|NCT01079741|567103205|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
157095106|NCT01079741|567103206|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
157095107|NCT00511472|567103207|FG000|Overall Study|Clinical Adverse Event|1|||
157095108|NCT00511472|567103208|FG001|Overall Study|Clinical Adverse Event|2|||
157095109|NCT00511472|567103207|FG000|Overall Study|Laboratory Adverse Event|0|||
157095110|NCT00511472|567103208|FG001|Overall Study|Laboratory Adverse Event|2|||
157095111|NCT00511472|567103207|FG000|Overall Study|Not reported|2|||
157095112|NCT00511472|567103208|FG001|Overall Study|Not reported|2|||
157095113|NCT00446992|567103209|FG000|Overall Study|Adverse Event|11|||
157095114|NCT00446992|567103209|FG000|Overall Study|Lost to Follow-up|5|||
157095115|NCT00406653|567103210|FG000|Induction Period|Adverse Event|1|||
157095116|NCT00406653|567103211|FG001|Induction Period|Adverse Event|10|||
157095117|NCT00406653|567103212|FG002|Induction Period|Adverse Event|4|||
157095118|NCT00406653|567103213|FG003|Induction Period|Adverse Event|11|||
157095119|NCT00406653|567103214|FG004|Induction Period|Adverse Event|0|||
157095120|NCT00406653|567103215|FG005|Induction Period|Adverse Event|0|||
157095121|NCT00406653|567103216|FG006|Induction Period|Adverse Event|0|||
157095122|NCT00406653|567103210|FG000|Induction Period|Lack of Efficacy|11|||
157095123|NCT00406653|567103211|FG001|Induction Period|Lack of Efficacy|14|||
157095124|NCT00406653|567103212|FG002|Induction Period|Lack of Efficacy|8|||
157095125|NCT00406653|567103213|FG003|Induction Period|Lack of Efficacy|10|||
157095126|NCT00406653|567103214|FG004|Induction Period|Lack of Efficacy|0|||
157095127|NCT00406653|567103215|FG005|Induction Period|Lack of Efficacy|0|||
157095128|NCT00406653|567103216|FG006|Induction Period|Lack of Efficacy|0|||
157095129|NCT00406653|567103210|FG000|Induction Period|Lost to Follow-up|0|||
157095130|NCT00406653|567103211|FG001|Induction Period|Lost to Follow-up|2|||
157095131|NCT00406653|567103212|FG002|Induction Period|Lost to Follow-up|0|||
157095132|NCT00406653|567103213|FG003|Induction Period|Lost to Follow-up|0|||
157095133|NCT00406653|567103214|FG004|Induction Period|Lost to Follow-up|0|||
157095134|NCT00406653|567103215|FG005|Induction Period|Lost to Follow-up|0|||
157095135|NCT00406653|567103216|FG006|Induction Period|Lost to Follow-up|0|||
156979972|NCT00251927|566680555|FG001|Overall Study|Lost to Follow-up|8|||
156979973|NCT00251927|566680554|FG000|Overall Study|Protocol Violation|1|||
156979974|NCT00251927|566680555|FG001|Overall Study|Protocol Violation|2|||
156979975|NCT00251927|566680554|FG000|Overall Study|Pregnancy|2|||
156979976|NCT00251927|566680555|FG001|Overall Study|Pregnancy|0|||
156979977|NCT00251927|566680554|FG000|Overall Study|Withdrawal by Subject|40|||
156979978|NCT00251927|566680555|FG001|Overall Study|Withdrawal by Subject|25|||
156979979|NCT00251927|566680554|FG000|Overall Study|Study-specific discont. achieved|13|||
156979980|NCT00251927|566680555|FG001|Overall Study|Study-specific discont. achieved|2|||
156979981|NCT00251927|566680554|FG000|Overall Study|Study procedure non-compliance|5|||
156979982|NCT00251927|566680555|FG001|Overall Study|Study procedure non-compliance|6|||
156979983|NCT01678820|566680556|FG000|Overall Study|Study Terminated by Sponsor|45|||
156979984|NCT01678820|566680557|FG001|Overall Study|Study Terminated by Sponsor|43|||
156979985|NCT01678820|566680558|FG002|Overall Study|Study Terminated by Sponsor|43|||
156979986|NCT01678820|566680556|FG000|Overall Study|Withdrawal by Subject|2|||
156979987|NCT01678820|566680557|FG001|Overall Study|Withdrawal by Subject|5|||
156979988|NCT01678820|566680558|FG002|Overall Study|Withdrawal by Subject|2|||
156979989|NCT01678820|566680556|FG000|Overall Study|Protocol Specified Criteria|2|||
156979990|NCT01678820|566680557|FG001|Overall Study|Protocol Specified Criteria|3|||
156979991|NCT01678820|566680558|FG002|Overall Study|Protocol Specified Criteria|1|||
156979992|NCT01678820|566680556|FG000|Overall Study|Adverse Event|2|||
156979993|NCT01678820|566680557|FG001|Overall Study|Adverse Event|2|||
156979994|NCT01678820|566680558|FG002|Overall Study|Adverse Event|2|||
156979995|NCT01678820|566680556|FG000|Overall Study|Lost to Follow-up|7|||
156979996|NCT01678820|566680557|FG001|Overall Study|Lost to Follow-up|2|||
156979997|NCT01678820|566680558|FG002|Overall Study|Lost to Follow-up|2|||
156979998|NCT01678820|566680556|FG000|Overall Study|Non-compliance with study drug|0|||
156979999|NCT01678820|566680557|FG001|Overall Study|Non-compliance with study drug|1|||
156980000|NCT01678820|566680558|FG002|Overall Study|Non-compliance with study drug|0|||
156980001|NCT01678820|566680556|FG000|Overall Study|Physician Decision|0|||
156980002|NCT01678820|566680557|FG001|Overall Study|Physician Decision|0|||
156980003|NCT01678820|566680558|FG002|Overall Study|Physician Decision|1|||
156980004|NCT01678820|566680556|FG000|Overall Study|Protocol Violation|4|||
156980005|NCT01678820|566680557|FG001|Overall Study|Protocol Violation|5|||
156980006|NCT01678820|566680558|FG002|Overall Study|Protocol Violation|4|||
156980007|NCT01678820|566680556|FG000|Overall Study|Not treated with double-blind study drug|0|||
156980008|NCT01678820|566680557|FG001|Overall Study|Not treated with double-blind study drug|2|||
156980009|NCT01678820|566680558|FG002|Overall Study|Not treated with double-blind study drug|2|||
156980010|NCT01381874|566680560|FG000|Overall Study|Lost to Follow-up|1|||
156980011|NCT01381874|566680561|FG001|Overall Study|Lost to Follow-up|1|||
156980012|NCT01381874|566680562|FG002|Overall Study|Lost to Follow-up|0|||
156980013|NCT01381874|566680560|FG000|Overall Study|Withdrawal by Subject|9|||
156980014|NCT01381874|566680561|FG001|Overall Study|Withdrawal by Subject|10|||
156980015|NCT01381874|566680562|FG002|Overall Study|Withdrawal by Subject|9|||
156980016|NCT01381874|566680560|FG000|Overall Study|Other|67|||
156980017|NCT01381874|566680561|FG001|Overall Study|Other|52|||
156980018|NCT01381874|566680562|FG002|Overall Study|Other|67|||
156980019|NCT00452413|566680565|FG000|Overall Study|Progressive Disease|4|||
156980020|NCT00452413|566680566|FG001|Overall Study|Progressive Disease|11|||
156980021|NCT00452413|566680567|FG002|Overall Study|Progressive Disease|30|||
156980022|NCT00452413|566680565|FG000|Overall Study|Withdrawal by Subject|0|||
156980023|NCT00452413|566680566|FG001|Overall Study|Withdrawal by Subject|1|||
156980024|NCT00452413|566680567|FG002|Overall Study|Withdrawal by Subject|4|||
157095136|NCT00406653|567103210|FG000|Induction Period|Withdrawal of Consent|2|||
157095137|NCT00406653|567103211|FG001|Induction Period|Withdrawal of Consent|5|||
157095138|NCT00406653|567103212|FG002|Induction Period|Withdrawal of Consent|1|||
157095139|NCT00406653|567103213|FG003|Induction Period|Withdrawal of Consent|2|||
157095140|NCT00406653|567103214|FG004|Induction Period|Withdrawal of Consent|0|||
157095141|NCT00406653|567103215|FG005|Induction Period|Withdrawal of Consent|0|||
157095142|NCT00406653|567103216|FG006|Induction Period|Withdrawal of Consent|0|||
157095143|NCT00406653|567103210|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
157095144|NCT00406653|567103211|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
157095145|NCT00406653|567103212|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
157095146|NCT00406653|567103213|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
157095147|NCT00406653|567103214|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
156980025|NCT00452413|566680565|FG000|Overall Study|Adverse Event|0|||
156980026|NCT00452413|566680566|FG001|Overall Study|Adverse Event|0|||
156980027|NCT00452413|566680567|FG002|Overall Study|Adverse Event|5|||
156980028|NCT00452413|566680565|FG000|Overall Study|Physician Decision|0|||
157095148|NCT00406653|567103215|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
156980029|NCT00452413|566680566|FG001|Overall Study|Physician Decision|0|||
156980030|NCT00452413|566680567|FG002|Overall Study|Physician Decision|4|||
156980031|NCT00452413|566680565|FG000|Overall Study|Death due to study disease|0|||
156980032|NCT00452413|566680566|FG001|Overall Study|Death due to study disease|0|||
156980033|NCT00452413|566680567|FG002|Overall Study|Death due to study disease|2|||
156980034|NCT00452413|566680565|FG000|Overall Study|Death due to adverse event (AE)|0|||
157095149|NCT00406653|567103216|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
157095150|NCT00406653|567103210|FG000|Induction Period|Pregnancy|1|||
157095151|NCT00406653|567103211|FG001|Induction Period|Pregnancy|0|||
157095152|NCT00406653|567103212|FG002|Induction Period|Pregnancy|0|||
157095153|NCT00406653|567103213|FG003|Induction Period|Pregnancy|0|||
157095154|NCT00406653|567103214|FG004|Induction Period|Pregnancy|0|||
157095155|NCT00406653|567103215|FG005|Induction Period|Pregnancy|0|||
157095156|NCT00406653|567103216|FG006|Induction Period|Pregnancy|0|||
157095157|NCT00406653|567103210|FG000|Induction Period|Declined participation but followup done|0|||
157095158|NCT00406653|567103211|FG001|Induction Period|Declined participation but followup done|2|||
157095159|NCT00406653|567103212|FG002|Induction Period|Declined participation but followup done|1|||
157095160|NCT00406653|567103213|FG003|Induction Period|Declined participation but followup done|1|||
157095161|NCT00406653|567103214|FG004|Induction Period|Declined participation but followup done|0|||
157095162|NCT00406653|567103215|FG005|Induction Period|Declined participation but followup done|0|||
157095163|NCT00406653|567103216|FG006|Induction Period|Declined participation but followup done|0|||
157095164|NCT00406653|567103210|FG000|Induction Period|Given prohibited drug|0|||
157095165|NCT00406653|567103211|FG001|Induction Period|Given prohibited drug|1|||
157095166|NCT00406653|567103212|FG002|Induction Period|Given prohibited drug|2|||
157095167|NCT00406653|567103213|FG003|Induction Period|Given prohibited drug|0|||
157095168|NCT00406653|567103214|FG004|Induction Period|Given prohibited drug|0|||
157095169|NCT00406653|567103215|FG005|Induction Period|Given prohibited drug|0|||
157095170|NCT00406653|567103216|FG006|Induction Period|Given prohibited drug|0|||
157095171|NCT00406653|567103210|FG000|Induction Period|Incarcerated|0|||
157095172|NCT00406653|567103211|FG001|Induction Period|Incarcerated|0|||
157095173|NCT00406653|567103212|FG002|Induction Period|Incarcerated|1|||
157095174|NCT00406653|567103213|FG003|Induction Period|Incarcerated|0|||
157095175|NCT00406653|567103214|FG004|Induction Period|Incarcerated|0|||
157095176|NCT00406653|567103215|FG005|Induction Period|Incarcerated|0|||
157095177|NCT00406653|567103216|FG006|Induction Period|Incarcerated|0|||
157095178|NCT00406653|567103210|FG000|Induction Period|Patient relocated|0|||
157095179|NCT00406653|567103211|FG001|Induction Period|Patient relocated|0|||
157095180|NCT00406653|567103212|FG002|Induction Period|Patient relocated|1|||
157095181|NCT00406653|567103213|FG003|Induction Period|Patient relocated|0|||
157095182|NCT00406653|567103214|FG004|Induction Period|Patient relocated|0|||
157095183|NCT00406653|567103215|FG005|Induction Period|Patient relocated|0|||
157095184|NCT00406653|567103216|FG006|Induction Period|Patient relocated|0|||
157095185|NCT00406653|567103210|FG000|Maintenance Period|Adverse Event|0|||
157095186|NCT00406653|567103211|FG001|Maintenance Period|Adverse Event|0|||
157095187|NCT00406653|567103212|FG002|Maintenance Period|Adverse Event|0|||
157095188|NCT00406653|567103213|FG003|Maintenance Period|Adverse Event|0|||
157095189|NCT00406653|567103214|FG004|Maintenance Period|Adverse Event|1|||
157095190|NCT00406653|567103215|FG005|Maintenance Period|Adverse Event|1|||
157095191|NCT00406653|567103216|FG006|Maintenance Period|Adverse Event|0|||
157095192|NCT00406653|567103210|FG000|Maintenance Period|Lack of Efficacy|0|||
157095193|NCT00406653|567103211|FG001|Maintenance Period|Lack of Efficacy|0|||
157095194|NCT00406653|567103212|FG002|Maintenance Period|Lack of Efficacy|0|||
157095195|NCT00406653|567103213|FG003|Maintenance Period|Lack of Efficacy|0|||
157095196|NCT00406653|567103214|FG004|Maintenance Period|Lack of Efficacy|20|||
157095197|NCT00406653|567103215|FG005|Maintenance Period|Lack of Efficacy|26|||
157095198|NCT00406653|567103216|FG006|Maintenance Period|Lack of Efficacy|0|||
157095199|NCT00406653|567103210|FG000|Maintenance Period|Lost to Follow-up|0|||
157095200|NCT00406653|567103211|FG001|Maintenance Period|Lost to Follow-up|0|||
157095201|NCT00406653|567103212|FG002|Maintenance Period|Lost to Follow-up|0|||
157095202|NCT00406653|567103213|FG003|Maintenance Period|Lost to Follow-up|0|||
157095203|NCT00406653|567103214|FG004|Maintenance Period|Lost to Follow-up|2|||
157095204|NCT00406653|567103215|FG005|Maintenance Period|Lost to Follow-up|1|||
157095205|NCT00406653|567103216|FG006|Maintenance Period|Lost to Follow-up|0|||
157095206|NCT00406653|567103210|FG000|Maintenance Period|Withdrawal of Consent|0|||
157095207|NCT00406653|567103211|FG001|Maintenance Period|Withdrawal of Consent|0|||
157095208|NCT00406653|567103212|FG002|Maintenance Period|Withdrawal of Consent|0|||
157095209|NCT00406653|567103213|FG003|Maintenance Period|Withdrawal of Consent|0|||
157095210|NCT00406653|567103214|FG004|Maintenance Period|Withdrawal of Consent|2|||
157095211|NCT00406653|567103215|FG005|Maintenance Period|Withdrawal of Consent|0|||
157095212|NCT00406653|567103216|FG006|Maintenance Period|Withdrawal of Consent|0|||
157095213|NCT00406653|567103210|FG000|Maintenance Period|Pregnancy|0|||
157095214|NCT00406653|567103211|FG001|Maintenance Period|Pregnancy|0|||
157095215|NCT00406653|567103212|FG002|Maintenance Period|Pregnancy|0|||
157095216|NCT00406653|567103213|FG003|Maintenance Period|Pregnancy|0|||
157095217|NCT00406653|567103214|FG004|Maintenance Period|Pregnancy|0|||
157095218|NCT00406653|567103215|FG005|Maintenance Period|Pregnancy|1|||
157095219|NCT00406653|567103216|FG006|Maintenance Period|Pregnancy|0|||
157095220|NCT00406653|567103210|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
157095221|NCT00406653|567103211|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
157095222|NCT00406653|567103212|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
157095223|NCT00406653|567103213|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
156980035|NCT00452413|566680566|FG001|Overall Study|Death due to adverse event (AE)|0|||
156980036|NCT00452413|566680567|FG002|Overall Study|Death due to adverse event (AE)|1|||
157095224|NCT00406653|567103214|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
157095225|NCT00406653|567103215|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
157095226|NCT00406653|567103216|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
157095227|NCT00406653|567103210|FG000|Maintenance Period|Error in disease score evaluation|0|||
157095228|NCT00406653|567103211|FG001|Maintenance Period|Error in disease score evaluation|0|||
157095229|NCT00406653|567103212|FG002|Maintenance Period|Error in disease score evaluation|0|||
157095230|NCT00406653|567103213|FG003|Maintenance Period|Error in disease score evaluation|0|||
157095231|NCT00406653|567103214|FG004|Maintenance Period|Error in disease score evaluation|1|||
157095232|NCT00406653|567103215|FG005|Maintenance Period|Error in disease score evaluation|0|||
157095233|NCT00406653|567103216|FG006|Maintenance Period|Error in disease score evaluation|0|||
157095234|NCT00406653|567103210|FG000|Open-Label Period|Death|0|||
157095235|NCT00406653|567103211|FG001|Open-Label Period|Death|0|||
157095236|NCT00406653|567103212|FG002|Open-Label Period|Death|0|||
157095237|NCT00406653|567103213|FG003|Open-Label Period|Death|0|||
157095238|NCT00406653|567103214|FG004|Open-Label Period|Death|0|||
157095239|NCT00406653|567103215|FG005|Open-Label Period|Death|0|||
157095240|NCT00406653|567103216|FG006|Open-Label Period|Death|1|||
157095241|NCT00406653|567103210|FG000|Open-Label Period|Adverse Event|0|||
157095242|NCT00406653|567103211|FG001|Open-Label Period|Adverse Event|0|||
157095243|NCT00406653|567103212|FG002|Open-Label Period|Adverse Event|0|||
156980037|NCT00452413|566680565|FG000|Overall Study|On treatment|0|||
156980038|NCT00452413|566680566|FG001|Overall Study|On treatment|0|||
156980039|NCT00452413|566680567|FG002|Overall Study|On treatment|3|||
156980040|NCT03119610|566680569|FG000|Overall Study|Adverse Event|1|||
156980041|NCT03119610|566680570|FG001|Overall Study|Adverse Event|0|||
156980042|NCT03119610|566680569|FG000|Overall Study|Lost to Follow-up|0|||
156980043|NCT03119610|566680570|FG001|Overall Study|Lost to Follow-up|1|||
156980044|NCT00114634|566680595|FG000|Overall Study|failure to return forms|3|||
156980045|NCT03283696|566680596|FG000|Overall Study|Physician Decision|5|||
156980046|NCT03283696|566680597|FG001|Overall Study|Physician Decision|6|||
156980047|NCT03283696|566680596|FG000|Overall Study|Withdrawal by Subject|2|||
156980048|NCT03283696|566680597|FG001|Overall Study|Withdrawal by Subject|0|||
156980049|NCT00684762|566680600|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
156980050|NCT00684762|566680601|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
156980051|NCT01539863|566680615|FG000|Overall Study|Lost to Follow-up|5|||
156980052|NCT01539863|566680616|FG001|Overall Study|Lost to Follow-up|4|||
156980053|NCT02693834|566680617|FG000|Baseline Measurement|Withdrawal by Subject|1|||
156980054|NCT02693834|566680618|FG001|Baseline Measurement|Withdrawal by Subject|0|||
156980055|NCT02693834|566680617|FG000|Baseline Measurement|Adverse Event|1|||
156980056|NCT02693834|566680618|FG001|Baseline Measurement|Adverse Event|0|||
156980057|NCT02693834|566680617|FG000|Week 2 Practice|Adverse Event|0|||
156980058|NCT02693834|566680618|FG001|Week 2 Practice|Adverse Event|1|||
156980059|NCT01844115|566680621|FG000|Overall Study|Adverse Event|4|||
156980060|NCT01844115|566680622|FG001|Overall Study|Adverse Event|22|||
156980061|NCT01844115|566680621|FG000|Overall Study|Lack of Efficacy|1|||
156980062|NCT01844115|566680622|FG001|Overall Study|Lack of Efficacy|4|||
156980063|NCT01844115|566680621|FG000|Overall Study|Protocol Violation|12|||
156980064|NCT01844115|566680622|FG001|Overall Study|Protocol Violation|10|||
156980065|NCT01844115|566680621|FG000|Overall Study|Withdrawal by Subject|11|||
156980066|NCT01844115|566680622|FG001|Overall Study|Withdrawal by Subject|11|||
156980067|NCT01844115|566680621|FG000|Overall Study|Lost to Follow-up|11|||
156980068|NCT01844115|566680622|FG001|Overall Study|Lost to Follow-up|10|||
157095244|NCT00406653|567103213|FG003|Open-Label Period|Adverse Event|0|||
157095245|NCT00406653|567103214|FG004|Open-Label Period|Adverse Event|0|||
157095246|NCT00406653|567103215|FG005|Open-Label Period|Adverse Event|0|||
157095247|NCT00406653|567103216|FG006|Open-Label Period|Adverse Event|18|||
157095248|NCT00406653|567103210|FG000|Open-Label Period|Lack of Efficacy|0|||
157095249|NCT00406653|567103211|FG001|Open-Label Period|Lack of Efficacy|0|||
157095250|NCT00406653|567103212|FG002|Open-Label Period|Lack of Efficacy|0|||
157095251|NCT00406653|567103213|FG003|Open-Label Period|Lack of Efficacy|0|||
157095252|NCT00406653|567103214|FG004|Open-Label Period|Lack of Efficacy|0|||
156980069|NCT01844115|566680621|FG000|Overall Study|Pregnancy|0|||
157095253|NCT00406653|567103215|FG005|Open-Label Period|Lack of Efficacy|0|||
157095254|NCT00406653|567103216|FG006|Open-Label Period|Lack of Efficacy|160|||
157095255|NCT00406653|567103210|FG000|Open-Label Period|Lost to Follow-up|0|||
157095256|NCT00406653|567103211|FG001|Open-Label Period|Lost to Follow-up|0|||
156980070|NCT01844115|566680622|FG001|Overall Study|Pregnancy|1|||
156980071|NCT01830881|566680623|FG000|Overall Study|Changed decision to have an abortion|0|||
156980072|NCT01830881|566680624|FG001|Overall Study|Changed decision to have an abortion|1|||
156980073|NCT01425632|566680625|FG000|Overall Study|Adverse Event|0|||
156980074|NCT01425632|566680626|FG001|Overall Study|Adverse Event|1|||
156980075|NCT01425632|566680627|FG002|Overall Study|Adverse Event|1|||
156980076|NCT01425632|566680625|FG000|Overall Study|Physician Decision|1|||
156980077|NCT01425632|566680626|FG001|Overall Study|Physician Decision|0|||
156980078|NCT01425632|566680627|FG002|Overall Study|Physician Decision|0|||
157095257|NCT00406653|567103212|FG002|Open-Label Period|Lost to Follow-up|0|||
157095258|NCT00406653|567103213|FG003|Open-Label Period|Lost to Follow-up|0|||
157095259|NCT00406653|567103214|FG004|Open-Label Period|Lost to Follow-up|0|||
157095260|NCT00406653|567103215|FG005|Open-Label Period|Lost to Follow-up|0|||
157095261|NCT00406653|567103216|FG006|Open-Label Period|Lost to Follow-up|6|||
157095262|NCT00406653|567103210|FG000|Open-Label Period|Withdrawal of Consent|0|||
157095263|NCT00406653|567103211|FG001|Open-Label Period|Withdrawal of Consent|0|||
157095264|NCT00406653|567103212|FG002|Open-Label Period|Withdrawal of Consent|0|||
157095265|NCT00406653|567103213|FG003|Open-Label Period|Withdrawal of Consent|0|||
157095266|NCT00406653|567103214|FG004|Open-Label Period|Withdrawal of Consent|0|||
157095267|NCT00406653|567103215|FG005|Open-Label Period|Withdrawal of Consent|0|||
157095268|NCT00406653|567103216|FG006|Open-Label Period|Withdrawal of Consent|11|||
157095269|NCT00406653|567103210|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095270|NCT00406653|567103211|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095271|NCT00406653|567103212|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095272|NCT00406653|567103213|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095273|NCT00406653|567103214|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095274|NCT00406653|567103215|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
157095275|NCT00406653|567103216|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
157095276|NCT00406653|567103210|FG000|Open-Label Period|Pregnancy|0|||
157095277|NCT00406653|567103211|FG001|Open-Label Period|Pregnancy|0|||
157095278|NCT00406653|567103212|FG002|Open-Label Period|Pregnancy|0|||
157095279|NCT00406653|567103213|FG003|Open-Label Period|Pregnancy|0|||
157095280|NCT00406653|567103214|FG004|Open-Label Period|Pregnancy|0|||
157095281|NCT00406653|567103215|FG005|Open-Label Period|Pregnancy|0|||
157095282|NCT00406653|567103216|FG006|Open-Label Period|Pregnancy|2|||
157095283|NCT00406653|567103210|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
157095284|NCT00406653|567103211|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
157095285|NCT00406653|567103212|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
157095286|NCT00406653|567103213|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
156980079|NCT01425632|566680625|FG000|Overall Study|Protocol Violation|0|||
156980080|NCT01425632|566680626|FG001|Overall Study|Protocol Violation|0|||
157095287|NCT00406653|567103214|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
157095288|NCT00406653|567103215|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
157095289|NCT00406653|567103216|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
157095290|NCT00406653|567103210|FG000|Open-Label Period|Declined participation but followup done|0|||
157095291|NCT00406653|567103211|FG001|Open-Label Period|Declined participation but followup done|0|||
157095292|NCT00406653|567103212|FG002|Open-Label Period|Declined participation but followup done|0|||
157095293|NCT00406653|567103213|FG003|Open-Label Period|Declined participation but followup done|0|||
156980081|NCT01425632|566680627|FG002|Overall Study|Protocol Violation|2|||
156980082|NCT01425632|566680625|FG000|Overall Study|Withdrawal by Subject|0|||
156980083|NCT01425632|566680626|FG001|Overall Study|Withdrawal by Subject|0|||
156980084|NCT01425632|566680627|FG002|Overall Study|Withdrawal by Subject|1|||
156980085|NCT00406419|566680634|FG000|Overall Study|Death|3|||
156980086|NCT00406419|566680635|FG001|Overall Study|Death|1|||
156980087|NCT00406419|566680636|FG002|Overall Study|Death|4|||
156980088|NCT00406419|566680634|FG000|Overall Study|Protocol Violation|6|||
156980089|NCT00406419|566680635|FG001|Overall Study|Protocol Violation|2|||
156980090|NCT00406419|566680636|FG002|Overall Study|Protocol Violation|5|||
156980091|NCT00406419|566680634|FG000|Overall Study|Study Terminated by Sponsor|260|||
156980092|NCT00406419|566680635|FG001|Overall Study|Study Terminated by Sponsor|288|||
156980093|NCT00406419|566680636|FG002|Overall Study|Study Terminated by Sponsor|282|||
156980094|NCT00406419|566680634|FG000|Overall Study|Withdrawal by Subject|17|||
156980095|NCT00406419|566680635|FG001|Overall Study|Withdrawal by Subject|24|||
156980096|NCT00406419|566680636|FG002|Overall Study|Withdrawal by Subject|26|||
156980097|NCT00406419|566680634|FG000|Overall Study|Lack of Efficacy|12|||
156980098|NCT00406419|566680635|FG001|Overall Study|Lack of Efficacy|1|||
156980099|NCT00406419|566680636|FG002|Overall Study|Lack of Efficacy|6|||
156980100|NCT00406419|566680634|FG000|Overall Study|Non-Compliance with Study Drug|5|||
156980101|NCT00406419|566680635|FG001|Overall Study|Non-Compliance with Study Drug|6|||
156980102|NCT00406419|566680636|FG002|Overall Study|Non-Compliance with Study Drug|3|||
156980103|NCT00406419|566680634|FG000|Overall Study|Adverse Event|10|||
156980104|NCT00406419|566680635|FG001|Overall Study|Adverse Event|12|||
156980105|NCT00406419|566680636|FG002|Overall Study|Adverse Event|16|||
156980106|NCT00406419|566680634|FG000|Overall Study|Lost to Follow-up|11|||
156980107|NCT00406419|566680635|FG001|Overall Study|Lost to Follow-up|10|||
156980108|NCT00406419|566680636|FG002|Overall Study|Lost to Follow-up|5|||
156980109|NCT01115491|566680639|FG000|Overall Study|Death|22|||
156980110|NCT01115491|566680639|FG000|Overall Study|Adverse Event|3|||
156980111|NCT01115491|566680639|FG000|Overall Study|Lost to Follow-up|3|||
156980112|NCT01115491|566680639|FG000|Overall Study|Withdrawal by Subject|1|||
156980113|NCT01115491|566680639|FG000|Overall Study|Physician Decision|1|||
156980114|NCT04362137|566680640|FG000|Overall Study|Death|9|||
156980115|NCT04362137|566680641|FG001|Overall Study|Death|3|||
156980116|NCT04362137|566680640|FG000|Overall Study|Patient decision|6|||
156980117|NCT04362137|566680641|FG001|Overall Study|Patient decision|3|||
156980118|NCT04362137|566680640|FG000|Overall Study|Adverse Event|1|||
156980119|NCT04362137|566680641|FG001|Overall Study|Adverse Event|0|||
156980120|NCT04362137|566680640|FG000|Overall Study|Lost to Follow-up|1|||
156980121|NCT04362137|566680641|FG001|Overall Study|Lost to Follow-up|0|||
156980122|NCT04362137|566680640|FG000|Overall Study|Protocol deviation|1|||
156980123|NCT04362137|566680641|FG001|Overall Study|Protocol deviation|0|||
156980124|NCT02494206|566680645|FG000|Overall Study|Adverse Event|1|||
156980125|NCT02494206|566680645|FG000|Overall Study|Disease Progression|1|||
156980126|NCT01013792|566680646|FG000|Overall Study|Study suspended|2|||
156980127|NCT01013792|566680647|FG001|Overall Study|Study suspended|1|||
156980128|NCT01013792|566680646|FG000|Overall Study|Adverse Event|0|||
156980129|NCT01013792|566680647|FG001|Overall Study|Adverse Event|3|||
156980130|NCT01013792|566680646|FG000|Overall Study|Lost to Follow-up|0|||
156980131|NCT01013792|566680647|FG001|Overall Study|Lost to Follow-up|1|||
156980132|NCT00896454|566680648|FG000|Overall Study|Death|10|||
156980133|NCT00896454|566680648|FG000|Overall Study|Adverse Event|8|||
156980134|NCT00896454|566680648|FG000|Overall Study|Disease Progression|5|||
156980135|NCT00896454|566680648|FG000|Overall Study|Other|4|||
156980136|NCT00896454|566680648|FG000|Overall Study|Requirement for alternative therapy|3|||
156980137|NCT00896454|566680648|FG000|Overall Study|Ongoing in study|2|||
156980138|NCT00896454|566680648|FG000|Overall Study|Withdrawal by Subject|1|||
156980139|NCT01461993|566680649|FG000|Overall Study|Withdrawal by Subject|60|||
156980140|NCT01461993|566680650|FG001|Overall Study|Withdrawal by Subject|53|||
156980141|NCT01461993|566680651|FG002|Overall Study|Withdrawal by Subject|16|||
156980142|NCT01461993|566680649|FG000|Overall Study|Lost to Follow-up|44|||
156980143|NCT01461993|566680650|FG001|Overall Study|Lost to Follow-up|48|||
156980144|NCT01461993|566680651|FG002|Overall Study|Lost to Follow-up|22|||
156980145|NCT01461993|566680649|FG000|Overall Study|Protocol Violation|10|||
156980146|NCT01461993|566680650|FG001|Overall Study|Protocol Violation|9|||
156980147|NCT01461993|566680651|FG002|Overall Study|Protocol Violation|7|||
156980148|NCT01461993|566680649|FG000|Overall Study|Adverse Event|9|||
156980149|NCT01461993|566680650|FG001|Overall Study|Adverse Event|11|||
156980150|NCT01461993|566680651|FG002|Overall Study|Adverse Event|3|||
156980151|NCT01461993|566680649|FG000|Overall Study|No longer met eligibility criteria|13|||
156980152|NCT01461993|566680650|FG001|Overall Study|No longer met eligibility criteria|18|||
156980153|NCT01461993|566680651|FG002|Overall Study|No longer met eligibility criteria|10|||
156980154|NCT01461993|566680649|FG000|Overall Study|Did not meet entrance criteria|2|||
156980155|NCT01461993|566680650|FG001|Overall Study|Did not meet entrance criteria|3|||
156980156|NCT01461993|566680651|FG002|Overall Study|Did not meet entrance criteria|0|||
156980157|NCT01461993|566680649|FG000|Overall Study|Other|13|||
156980158|NCT01461993|566680650|FG001|Overall Study|Other|15|||
156980159|NCT01461993|566680651|FG002|Overall Study|Other|6|||
157095294|NCT00406653|567103214|FG004|Open-Label Period|Declined participation but followup done|0|||
157095295|NCT00406653|567103215|FG005|Open-Label Period|Declined participation but followup done|0|||
157095296|NCT00406653|567103216|FG006|Open-Label Period|Declined participation but followup done|8|||
157095297|NCT00406653|567103210|FG000|Open-Label Period|Discontinued by Sponsor|0|||
157095298|NCT00406653|567103211|FG001|Open-Label Period|Discontinued by Sponsor|0|||
157095299|NCT00406653|567103212|FG002|Open-Label Period|Discontinued by Sponsor|0|||
157095300|NCT00406653|567103213|FG003|Open-Label Period|Discontinued by Sponsor|0|||
157095301|NCT00406653|567103214|FG004|Open-Label Period|Discontinued by Sponsor|0|||
157095302|NCT00406653|567103215|FG005|Open-Label Period|Discontinued by Sponsor|0|||
157095303|NCT00406653|567103216|FG006|Open-Label Period|Discontinued by Sponsor|1|||
157095304|NCT00406653|567103210|FG000|Open-Label Period|Refused followup|0|||
157095305|NCT00406653|567103211|FG001|Open-Label Period|Refused followup|0|||
157095306|NCT00406653|567103212|FG002|Open-Label Period|Refused followup|0|||
157095307|NCT00406653|567103213|FG003|Open-Label Period|Refused followup|0|||
157095308|NCT00406653|567103214|FG004|Open-Label Period|Refused followup|0|||
157095309|NCT00406653|567103215|FG005|Open-Label Period|Refused followup|0|||
157095310|NCT00406653|567103216|FG006|Open-Label Period|Refused followup|1|||
157095311|NCT00940108|567103217|FG000|Overall Study|Adverse Event|2|||
157095312|NCT00940108|567103218|FG001|Overall Study|Adverse Event|4|||
157095313|NCT00940108|567103219|FG002|Overall Study|Adverse Event|0|||
157095314|NCT00940108|567103220|FG003|Overall Study|Adverse Event|2|||
157095315|NCT00940108|567103217|FG000|Overall Study|Withdrew Consent|2|||
156980160|NCT01121484|566680653|FG000|Overall Study|Adverse Event|12|||
156980161|NCT01121484|566680654|FG001|Overall Study|Adverse Event|5|||
157095316|NCT00940108|567103218|FG001|Overall Study|Withdrew Consent|1|||
157095317|NCT00940108|567103219|FG002|Overall Study|Withdrew Consent|0|||
157095318|NCT00940108|567103220|FG003|Overall Study|Withdrew Consent|1|||
157095319|NCT00940108|567103217|FG000|Overall Study|Dose 2 contraindicated|1|||
156980162|NCT01121484|566680653|FG000|Overall Study|Lack of Efficacy|3|||
156980163|NCT01121484|566680654|FG001|Overall Study|Lack of Efficacy|11|||
156980164|NCT01121484|566680653|FG000|Overall Study|Lost to Follow-up|5|||
156980165|NCT01121484|566680654|FG001|Overall Study|Lost to Follow-up|9|||
156980166|NCT01121484|566680653|FG000|Overall Study|Physician Decision|0|||
157095320|NCT00940108|567103218|FG001|Overall Study|Dose 2 contraindicated|1|||
157095321|NCT00940108|567103219|FG002|Overall Study|Dose 2 contraindicated|0|||
157095322|NCT00940108|567103220|FG003|Overall Study|Dose 2 contraindicated|1|||
157095323|NCT00940108|567103217|FG000|Overall Study|Declined further vaccination|0|||
157095324|NCT00940108|567103218|FG001|Overall Study|Declined further vaccination|1|||
157095325|NCT00940108|567103219|FG002|Overall Study|Declined further vaccination|3|||
157095326|NCT00940108|567103220|FG003|Overall Study|Declined further vaccination|0|||
157095327|NCT00940108|567103217|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
157095328|NCT00940108|567103218|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
157095329|NCT00940108|567103219|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
157095330|NCT00940108|567103220|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
157095331|NCT00940108|567103217|FG000|Overall Study|Viral illness after Dose 1|0|||
157095332|NCT00940108|567103218|FG001|Overall Study|Viral illness after Dose 1|1|||
157095333|NCT00940108|567103219|FG002|Overall Study|Viral illness after Dose 1|0|||
157095334|NCT00940108|567103220|FG003|Overall Study|Viral illness after Dose 1|0|||
157095335|NCT00940108|567103217|FG000|Overall Study|Diagnosed with H1N1|0|||
157095336|NCT00940108|567103218|FG001|Overall Study|Diagnosed with H1N1|0|||
157095337|NCT00940108|567103219|FG002|Overall Study|Diagnosed with H1N1|0|||
157095338|NCT00940108|567103220|FG003|Overall Study|Diagnosed with H1N1|1|||
157095339|NCT01001832|567103221|FG000|Short-term Period|Adverse Event|2|||
157095340|NCT01001832|567103222|FG001|Short-term Period|Adverse Event|3|||
157095341|NCT01001832|567103221|FG000|Long-term Period|Adverse Event|2|||
157095342|NCT01001832|567103222|FG001|Long-term Period|Adverse Event|1|||
157095343|NCT01001832|567103221|FG000|Long-term Period|Withdrawal by Subject|1|||
157095344|NCT01001832|567103222|FG001|Long-term Period|Withdrawal by Subject|0|||
157095345|NCT01001832|567103221|FG000|Long-term Period|Lack of Efficacy|0|||
157095346|NCT01001832|567103222|FG001|Long-term Period|Lack of Efficacy|2|||
157095347|NCT01001832|567103221|FG000|Long-term Period|Other|1|||
157095348|NCT01001832|567103222|FG001|Long-term Period|Other|2|||
157095349|NCT01001832|567103221|FG000|Follow-up Period|Withdrawal by Subject|1|||
157095350|NCT01001832|567103222|FG001|Follow-up Period|Withdrawal by Subject|0|||
157095351|NCT01001832|567103221|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
157095352|NCT01001832|567103222|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
157095353|NCT01001832|567103221|FG000|Follow-up Period|Other|2|||
157095354|NCT01001832|567103222|FG001|Follow-up Period|Other|1|||
157095355|NCT05677893|567105327|FG000|Overall Study|Withdrawal by Subject|0|||
157095356|NCT05677893|567105328|FG001|Overall Study|Withdrawal by Subject|0|||
157095357|NCT05677893|567105329|FG002|Overall Study|Withdrawal by Subject|0|||
157095358|NCT05677893|567105330|FG003|Overall Study|Withdrawal by Subject|0|||
157095359|NCT05677893|567105331|FG004|Overall Study|Withdrawal by Subject|1|||
157095360|NCT05677893|567105332|FG005|Overall Study|Withdrawal by Subject|1|||
157095361|NCT05677893|567105333|FG006|Overall Study|Withdrawal by Subject|0|||
157095362|NCT05677893|567105327|FG000|Overall Study|Others|1|||
157095363|NCT05677893|567105328|FG001|Overall Study|Others|0|||
157095364|NCT05677893|567105329|FG002|Overall Study|Others|0|||
157095365|NCT05677893|567105330|FG003|Overall Study|Others|0|||
157095366|NCT05677893|567105331|FG004|Overall Study|Others|0|||
156980167|NCT01121484|566680654|FG001|Overall Study|Physician Decision|3|||
156980168|NCT01121484|566680653|FG000|Overall Study|Protocol Violation|1|||
156980169|NCT01121484|566680654|FG001|Overall Study|Protocol Violation|0|||
156980170|NCT01121484|566680653|FG000|Overall Study|Withdrawal by Subject|8|||
156980171|NCT01121484|566680654|FG001|Overall Study|Withdrawal by Subject|7|||
156980172|NCT01121484|566680653|FG000|Overall Study|Discontinuation of study by sponsor|0|||
156980173|NCT01121484|566680654|FG001|Overall Study|Discontinuation of study by sponsor|1|||
156980174|NCT01121484|566680653|FG000|Overall Study|Other|3|||
156980175|NCT01121484|566680654|FG001|Overall Study|Other|3|||
156980176|NCT01121484|566680653|FG000|Overall Study|Randomized, not treated|1|||
156980177|NCT01121484|566680654|FG001|Overall Study|Randomized, not treated|4|||
156980178|NCT00180713|566680657|FG000|Overall Study|Withdrawal by Subject|2|||
156980179|NCT00180713|566680658|FG001|Overall Study|Withdrawal by Subject|0|||
156980180|NCT00180713|566680657|FG000|Overall Study|Adverse Event|3|||
156980181|NCT00180713|566680658|FG001|Overall Study|Adverse Event|3|||
156980182|NCT05295732|566680659|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
156980183|NCT05295732|566680660|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
156980184|NCT05295732|566680661|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
156980185|NCT05295732|566680662|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
156980186|NCT05295732|566680663|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
156980187|NCT05295732|566680659|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
156980188|NCT05295732|566680660|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
157095367|NCT05677893|567105332|FG005|Overall Study|Others|0|||
157095368|NCT05677893|567105333|FG006|Overall Study|Others|0|||
157095369|NCT03217266|567105334|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
157095370|NCT03217266|567105335|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
157095371|NCT03217266|567105336|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
157095372|NCT03217266|567105337|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
157095373|NCT03217266|567105334|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
156980189|NCT05295732|566680661|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
156980190|NCT05295732|566680662|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
156980191|NCT05295732|566680663|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
156980192|NCT01065350|566680665|FG000|Overall Study|Received incorrect drug allocation|0|||
156980193|NCT01065350|566680666|FG001|Overall Study|Received incorrect drug allocation|1|||
156980194|NCT03311230|566680673|FG000|Overall Study|Withdrawal by Subject|1|||
156980195|NCT03311230|566680674|FG001|Overall Study|Withdrawal by Subject|4|||
156980196|NCT03311230|566680675|FG002|Overall Study|Withdrawal by Subject|2|||
156980197|NCT03311230|566680676|FG003|Overall Study|Withdrawal by Subject|7|||
156980198|NCT03311230|566680673|FG000|Overall Study|Unrelated injury|0|||
156980199|NCT03311230|566680674|FG001|Overall Study|Unrelated injury|1|||
156980200|NCT03311230|566680675|FG002|Overall Study|Unrelated injury|0|||
156980201|NCT03311230|566680676|FG003|Overall Study|Unrelated injury|0|||
156980202|NCT03342053|566680677|FG000|Overall Study|Adverse Event|2|||
156980203|NCT03342053|566680678|FG001|Overall Study|Adverse Event|0|||
157095374|NCT03217266|567105335|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
157095375|NCT03217266|567105336|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
157095376|NCT03217266|567105337|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
157095377|NCT03217266|567105334|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
157095378|NCT03217266|567105335|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
157095379|NCT03217266|567105336|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
157095380|NCT03217266|567105337|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
157095381|NCT02101034|567105338|FG000|Overall Study|Enrolled but did not start treatment|0|||
157095382|NCT02101034|567105339|FG001|Overall Study|Enrolled but did not start treatment|0|||
157095383|NCT02101034|567105340|FG002|Overall Study|Enrolled but did not start treatment|1|||
157095384|NCT02101034|567105341|FG003|Overall Study|Enrolled but did not start treatment|0|||
157095385|NCT02101034|567105342|FG004|Overall Study|Enrolled but did not start treatment|0|||
157095386|NCT01390181|567105343|FG000|Overall Study|Lost to Follow-up|1|||
157095387|NCT01390181|567105343|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
157095388|NCT01101477|567105348|FG000|Overall Study|Protocol Violation|5|||
157095389|NCT01101477|567105349|FG001|Overall Study|Protocol Violation|3|||
157095390|NCT01101477|567105350|FG002|Overall Study|Protocol Violation|1|||
157095391|NCT00720941|567105351|FG000|Overall Study|Protocol Violation|1|||
157095392|NCT00720941|567105352|FG001|Overall Study|Protocol Violation|2|||
157095393|NCT00720941|567105351|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
157095394|NCT00720941|567105352|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
157095395|NCT00720941|567105351|FG000|Overall Study|Lost to Follow-up|20|||
157095396|NCT00720941|567105352|FG001|Overall Study|Lost to Follow-up|15|||
157095397|NCT00720941|567105351|FG000|Overall Study|Physician Decision|14|||
157095398|NCT00720941|567105352|FG001|Overall Study|Physician Decision|12|||
157095399|NCT00720941|567105351|FG000|Overall Study|Withdrawal by Subject|29|||
157095400|NCT00720941|567105352|FG001|Overall Study|Withdrawal by Subject|36|||
157095401|NCT00294554|567105357|FG000|Overall Study|Lack of Efficacy|0|||
157095402|NCT00294554|567105358|FG001|Overall Study|Lack of Efficacy|1|||
157095403|NCT00294554|567105357|FG000|Overall Study|Physician Decision|0|||
157095404|NCT00294554|567105358|FG001|Overall Study|Physician Decision|1|||
157095405|NCT01717989|567105359|FG000|Overall Study|Ineligibility determined|6|||
157095406|NCT01717989|567105359|FG000|Overall Study|Protocol deviation|6|||
157095407|NCT01717989|567105359|FG000|Overall Study|Withdrawal by Subject|11|||
157095408|NCT01717989|567105359|FG000|Overall Study|Physician Decision|2|||
156980204|NCT03342053|566680677|FG000|Overall Study|Withdrawal by Subject|0|||
156980205|NCT03342053|566680678|FG001|Overall Study|Withdrawal by Subject|1|||
156980206|NCT01302938|566680679|FG000|Overall Study|Withdrawal by Subject|1|||
157095409|NCT01717989|567105359|FG000|Overall Study|Lost to Follow-up|11|||
157095410|NCT01717989|567105359|FG000|Overall Study|Death|439|||
157095411|NCT01717989|567105359|FG000|Overall Study|Protocol-specified criteria|551|||
157095412|NCT01717989|567105359|FG000|Overall Study|Other|40|||
157095413|NCT03224325|567105360|FG000|Overall Study|Adverse Event|1|||
157095414|NCT03224325|567105361|FG001|Overall Study|Adverse Event|0|||
157095415|NCT03224325|567105362|FG002|Overall Study|Adverse Event|0|||
157095416|NCT03224325|567105363|FG003|Overall Study|Adverse Event|0|||
157095417|NCT03224325|567105364|FG004|Overall Study|Adverse Event|0|||
157095418|NCT03224325|567105365|FG005|Overall Study|Adverse Event|0|||
157095419|NCT03224325|567105366|FG006|Overall Study|Adverse Event|1|||
157095420|NCT03224325|567105360|FG000|Overall Study|Withdrawal by Subject|0|||
157095421|NCT03224325|567105361|FG001|Overall Study|Withdrawal by Subject|0|||
157095422|NCT03224325|567105362|FG002|Overall Study|Withdrawal by Subject|0|||
157095423|NCT03224325|567105363|FG003|Overall Study|Withdrawal by Subject|1|||
157095424|NCT03224325|567105364|FG004|Overall Study|Withdrawal by Subject|0|||
157095425|NCT03224325|567105365|FG005|Overall Study|Withdrawal by Subject|0|||
157095426|NCT03224325|567105366|FG006|Overall Study|Withdrawal by Subject|0|||
157095427|NCT02598557|567105367|FG000|Overall Study|Withdrawal by Subject|1|||
157095428|NCT02598557|567105368|FG001|Overall Study|Withdrawal by Subject|0|||
157095429|NCT02598557|567105369|FG002|Overall Study|Withdrawal by Subject|1|||
157095430|NCT02598557|567105367|FG000|Overall Study|Participant did not start treatment|2|||
157095431|NCT02598557|567105368|FG001|Overall Study|Participant did not start treatment|1|||
157095432|NCT02598557|567105369|FG002|Overall Study|Participant did not start treatment|1|||
157095433|NCT02598557|567105367|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
157095434|NCT02598557|567105368|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
157095435|NCT02598557|567105369|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
157095436|NCT02598557|567105367|FG000|Overall Study|Adverse Event|1|||
157095437|NCT02598557|567105368|FG001|Overall Study|Adverse Event|1|||
157095438|NCT02598557|567105369|FG002|Overall Study|Adverse Event|0|||
157095439|NCT02864381|567105370|FG000|Overall Study|Death|58|||
157095440|NCT02864381|567105371|FG001|Overall Study|Death|61|||
157095441|NCT02864381|567105370|FG000|Overall Study|Withdrew Consent|5|||
157095442|NCT02864381|567105371|FG001|Overall Study|Withdrew Consent|6|||
157095443|NCT02864381|567105370|FG000|Overall Study|Reason Unknown|7|||
157095444|NCT02864381|567105371|FG001|Overall Study|Reason Unknown|3|||
157095445|NCT02864381|567105370|FG000|Overall Study|Lost to Follow-up|1|||
157095446|NCT02864381|567105371|FG001|Overall Study|Lost to Follow-up|1|||
157095447|NCT02864381|567105370|FG000|Overall Study|Investigator's Discretion|1|||
157095448|NCT02864381|567105371|FG001|Overall Study|Investigator's Discretion|0|||
157095449|NCT02864381|567105370|FG000|Overall Study|Protocol Violation|0|||
157095450|NCT02864381|567105371|FG001|Overall Study|Protocol Violation|1|||
157095451|NCT02986334|567105372|FG000|Overall Study|Withdrawal by Subject|0|||
157095452|NCT02986334|567105373|FG001|Overall Study|Withdrawal by Subject|1|||
157095453|NCT02986334|567105374|FG002|Overall Study|Withdrawal by Subject|2|||
157095454|NCT02986334|567105372|FG000|Overall Study|Lost to Follow-up|1|||
157095455|NCT02986334|567105373|FG001|Overall Study|Lost to Follow-up|2|||
157095456|NCT02986334|567105374|FG002|Overall Study|Lost to Follow-up|1|||
157095457|NCT02986334|567105372|FG000|Overall Study|Adverse Event|0|||
157095458|NCT02986334|567105373|FG001|Overall Study|Adverse Event|2|||
157095459|NCT02986334|567105374|FG002|Overall Study|Adverse Event|1|||
157095460|NCT02986334|567105372|FG000|Overall Study|non compliance in phone ratings|2|||
157095461|NCT02986334|567105373|FG001|Overall Study|non compliance in phone ratings|1|||
157095462|NCT02986334|567105374|FG002|Overall Study|non compliance in phone ratings|2|||
157095463|NCT02986334|567105372|FG000|Overall Study|undisclosed comorbidities|0|||
157095464|NCT02986334|567105373|FG001|Overall Study|undisclosed comorbidities|1|||
157095465|NCT02986334|567105374|FG002|Overall Study|undisclosed comorbidities|1|||
157095466|NCT01138007|567105375|FG000|Overall Study|Adverse Event|4|||
157095467|NCT01138007|567105376|FG001|Overall Study|Adverse Event|12|||
157095468|NCT01138007|567105377|FG002|Overall Study|Adverse Event|9|||
157095469|NCT01138007|567105375|FG000|Overall Study|Lack of Efficacy|2|||
157095470|NCT01138007|567105376|FG001|Overall Study|Lack of Efficacy|0|||
157095471|NCT01138007|567105377|FG002|Overall Study|Lack of Efficacy|6|||
157095472|NCT01138007|567105375|FG000|Overall Study|Protocol Violation|2|||
157095473|NCT01138007|567105376|FG001|Overall Study|Protocol Violation|3|||
157095474|NCT01138007|567105377|FG002|Overall Study|Protocol Violation|2|||
157095475|NCT01138007|567105375|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
157095476|NCT01138007|567105376|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
157095477|NCT01138007|567105377|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
157095478|NCT01138007|567105375|FG000|Overall Study|Lost to Follow-up|3|||
157095479|NCT01138007|567105376|FG001|Overall Study|Lost to Follow-up|3|||
157095480|NCT01138007|567105377|FG002|Overall Study|Lost to Follow-up|5|||
157095481|NCT01138007|567105375|FG000|Overall Study|Physician Decision|0|||
157095482|NCT01138007|567105376|FG001|Overall Study|Physician Decision|5|||
157095483|NCT01138007|567105377|FG002|Overall Study|Physician Decision|3|||
157095484|NCT01138007|567105375|FG000|Overall Study|Withdrawal by Subject|5|||
157095485|NCT01138007|567105376|FG001|Overall Study|Withdrawal by Subject|6|||
157095486|NCT01138007|567105377|FG002|Overall Study|Withdrawal by Subject|15|||
157095487|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
157095488|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
157095489|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
156980207|NCT01302938|566680680|FG001|Overall Study|Withdrawal by Subject|0|||
156980208|NCT01302938|566680679|FG000|Overall Study|Adverse Event|1|||
156980209|NCT01302938|566680680|FG001|Overall Study|Adverse Event|0|||
156980210|NCT02294474|566680681|FG000|Overall Study|Adverse Event|7|||
156980211|NCT02294474|566680682|FG001|Overall Study|Adverse Event|7|||
156980212|NCT02294474|566680681|FG000|Overall Study|Lack of Efficacy|2|||
156980213|NCT02294474|566680682|FG001|Overall Study|Lack of Efficacy|1|||
156980214|NCT02294474|566680681|FG000|Overall Study|Protocol Violation|4|||
156980215|NCT02294474|566680682|FG001|Overall Study|Protocol Violation|2|||
156980216|NCT02294474|566680681|FG000|Overall Study|Other than specified above|12|||
156980217|NCT02294474|566680682|FG001|Overall Study|Other than specified above|12|||
156980218|NCT05200936|566680686|FG000|Overall Study|Withdrawal by Subject|2|||
156980219|NCT05200936|566680687|FG001|Overall Study|Withdrawal by Subject|2|||
156980220|NCT05200936|566680686|FG000|Overall Study|Lost to Follow-up|2|||
156980221|NCT05200936|566680687|FG001|Overall Study|Lost to Follow-up|0|||
156980222|NCT05200936|566680686|FG000|Overall Study|Pregnancy|0|||
156980223|NCT05200936|566680687|FG001|Overall Study|Pregnancy|1|||
156980224|NCT00592319|566682134|FG000|Overall Study|Lost to Follow-up|0|||
156980225|NCT00592319|566682135|FG001|Overall Study|Lost to Follow-up|3|||
156980226|NCT02032173|566682138|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
156980227|NCT02291289|566682142|FG000|Induction Treatment|Withdrawal by Subject|0|||
156980228|NCT02291289|566682143|FG001|Induction Treatment|Withdrawal by Subject|0|||
156980229|NCT02291289|566682144|FG002|Induction Treatment|Withdrawal by Subject|0|||
156980230|NCT02291289|566682145|FG003|Induction Treatment|Withdrawal by Subject|24|||
156980231|NCT02291289|566682146|FG004|Induction Treatment|Withdrawal by Subject|0|||
156980232|NCT02291289|566682147|FG005|Induction Treatment|Withdrawal by Subject|0|||
156980233|NCT02291289|566682148|FG006|Induction Treatment|Withdrawal by Subject|0|||
156980234|NCT02291289|566682149|FG007|Induction Treatment|Withdrawal by Subject|0|||
156980235|NCT02291289|566682150|FG008|Induction Treatment|Withdrawal by Subject|0|||
156980236|NCT02291289|566682151|FG009|Induction Treatment|Withdrawal by Subject|18|||
156980237|NCT02291289|566682152|FG010|Induction Treatment|Withdrawal by Subject|0|||
156980238|NCT02291289|566682153|FG011|Induction Treatment|Withdrawal by Subject|0|||
156980239|NCT02291289|566682154|FG012|Induction Treatment|Withdrawal by Subject|0|||
156980240|NCT02291289|566682142|FG000|Induction Treatment|Adverse Event|0|||
156980241|NCT02291289|566682143|FG001|Induction Treatment|Adverse Event|0|||
156980242|NCT02291289|566682144|FG002|Induction Treatment|Adverse Event|0|||
156980243|NCT02291289|566682145|FG003|Induction Treatment|Adverse Event|3|||
156980244|NCT02291289|566682146|FG004|Induction Treatment|Adverse Event|0|||
156980245|NCT02291289|566682147|FG005|Induction Treatment|Adverse Event|0|||
156980246|NCT02291289|566682148|FG006|Induction Treatment|Adverse Event|0|||
156980247|NCT02291289|566682149|FG007|Induction Treatment|Adverse Event|0|||
156980248|NCT02291289|566682150|FG008|Induction Treatment|Adverse Event|0|||
156980249|NCT02291289|566682151|FG009|Induction Treatment|Adverse Event|1|||
156980250|NCT02291289|566682152|FG010|Induction Treatment|Adverse Event|0|||
156980251|NCT02291289|566682153|FG011|Induction Treatment|Adverse Event|0|||
156980252|NCT02291289|566682154|FG012|Induction Treatment|Adverse Event|0|||
156980253|NCT02291289|566682142|FG000|Induction Treatment|Death|25|||
156980254|NCT02291289|566682143|FG001|Induction Treatment|Death|0|||
156980255|NCT02291289|566682144|FG002|Induction Treatment|Death|0|||
156980256|NCT02291289|566682145|FG003|Induction Treatment|Death|111|||
156980257|NCT02291289|566682146|FG004|Induction Treatment|Death|0|||
156980258|NCT02291289|566682147|FG005|Induction Treatment|Death|0|||
156980259|NCT02291289|566682148|FG006|Induction Treatment|Death|1|||
156980260|NCT02291289|566682149|FG007|Induction Treatment|Death|0|||
156980261|NCT02291289|566682150|FG008|Induction Treatment|Death|0|||
156980262|NCT02291289|566682151|FG009|Induction Treatment|Death|82|||
156980263|NCT02291289|566682152|FG010|Induction Treatment|Death|0|||
156980264|NCT02291289|566682153|FG011|Induction Treatment|Death|0|||
156980265|NCT02291289|566682154|FG012|Induction Treatment|Death|0|||
156980266|NCT02291289|566682142|FG000|Induction Treatment|Lost to Follow-up|1|||
156980267|NCT02291289|566682143|FG001|Induction Treatment|Lost to Follow-up|0|||
156980268|NCT02291289|566682144|FG002|Induction Treatment|Lost to Follow-up|0|||
156980269|NCT02291289|566682145|FG003|Induction Treatment|Lost to Follow-up|12|||
156980270|NCT02291289|566682146|FG004|Induction Treatment|Lost to Follow-up|0|||
156980271|NCT02291289|566682147|FG005|Induction Treatment|Lost to Follow-up|0|||
156980272|NCT02291289|566682148|FG006|Induction Treatment|Lost to Follow-up|0|||
156980273|NCT02291289|566682149|FG007|Induction Treatment|Lost to Follow-up|0|||
156980274|NCT02291289|566682150|FG008|Induction Treatment|Lost to Follow-up|0|||
156980275|NCT02291289|566682151|FG009|Induction Treatment|Lost to Follow-up|9|||
156980276|NCT02291289|566682152|FG010|Induction Treatment|Lost to Follow-up|0|||
156980277|NCT02291289|566682153|FG011|Induction Treatment|Lost to Follow-up|0|||
156980278|NCT02291289|566682154|FG012|Induction Treatment|Lost to Follow-up|0|||
156980279|NCT02291289|566682142|FG000|Induction Treatment|Non-Compliance|0|||
156980280|NCT02291289|566682143|FG001|Induction Treatment|Non-Compliance|0|||
156980281|NCT02291289|566682144|FG002|Induction Treatment|Non-Compliance|0|||
156980282|NCT02291289|566682145|FG003|Induction Treatment|Non-Compliance|1|||
156980283|NCT02291289|566682146|FG004|Induction Treatment|Non-Compliance|0|||
156980284|NCT02291289|566682147|FG005|Induction Treatment|Non-Compliance|0|||
156980285|NCT02291289|566682148|FG006|Induction Treatment|Non-Compliance|0|||
156980286|NCT02291289|566682149|FG007|Induction Treatment|Non-Compliance|0|||
156980287|NCT02291289|566682150|FG008|Induction Treatment|Non-Compliance|0|||
156980288|NCT02291289|566682151|FG009|Induction Treatment|Non-Compliance|1|||
156980289|NCT02291289|566682152|FG010|Induction Treatment|Non-Compliance|0|||
156980290|NCT02291289|566682153|FG011|Induction Treatment|Non-Compliance|0|||
156980291|NCT02291289|566682154|FG012|Induction Treatment|Non-Compliance|0|||
156980292|NCT02291289|566682142|FG000|Induction Treatment|Reason Not Specified|0|||
156980293|NCT02291289|566682143|FG001|Induction Treatment|Reason Not Specified|0|||
156980294|NCT02291289|566682144|FG002|Induction Treatment|Reason Not Specified|0|||
156980295|NCT02291289|566682145|FG003|Induction Treatment|Reason Not Specified|4|||
156980296|NCT02291289|566682146|FG004|Induction Treatment|Reason Not Specified|0|||
156980297|NCT02291289|566682147|FG005|Induction Treatment|Reason Not Specified|0|||
156980298|NCT02291289|566682148|FG006|Induction Treatment|Reason Not Specified|0|||
156980299|NCT02291289|566682149|FG007|Induction Treatment|Reason Not Specified|0|||
156980300|NCT02291289|566682150|FG008|Induction Treatment|Reason Not Specified|0|||
156980301|NCT02291289|566682151|FG009|Induction Treatment|Reason Not Specified|7|||
156980302|NCT02291289|566682152|FG010|Induction Treatment|Reason Not Specified|0|||
156980303|NCT02291289|566682153|FG011|Induction Treatment|Reason Not Specified|0|||
156980304|NCT02291289|566682154|FG012|Induction Treatment|Reason Not Specified|0|||
156980305|NCT02291289|566682142|FG000|Induction Treatment|Physician Decision|0|||
156980306|NCT02291289|566682143|FG001|Induction Treatment|Physician Decision|0|||
156980307|NCT02291289|566682144|FG002|Induction Treatment|Physician Decision|0|||
156980308|NCT02291289|566682145|FG003|Induction Treatment|Physician Decision|3|||
156980309|NCT02291289|566682146|FG004|Induction Treatment|Physician Decision|0|||
156980310|NCT02291289|566682147|FG005|Induction Treatment|Physician Decision|0|||
156980311|NCT02291289|566682148|FG006|Induction Treatment|Physician Decision|0|||
156980312|NCT02291289|566682149|FG007|Induction Treatment|Physician Decision|0|||
156980313|NCT02291289|566682150|FG008|Induction Treatment|Physician Decision|0|||
156980314|NCT02291289|566682151|FG009|Induction Treatment|Physician Decision|1|||
156980315|NCT02291289|566682152|FG010|Induction Treatment|Physician Decision|0|||
156980316|NCT02291289|566682153|FG011|Induction Treatment|Physician Decision|0|||
156980317|NCT02291289|566682154|FG012|Induction Treatment|Physician Decision|0|||
156980318|NCT02291289|566682142|FG000|Induction Treatment|Protocol Violation|0|||
156980319|NCT02291289|566682143|FG001|Induction Treatment|Protocol Violation|0|||
156980320|NCT02291289|566682144|FG002|Induction Treatment|Protocol Violation|0|||
156980321|NCT02291289|566682145|FG003|Induction Treatment|Protocol Violation|3|||
156980322|NCT02291289|566682146|FG004|Induction Treatment|Protocol Violation|0|||
156980323|NCT02291289|566682147|FG005|Induction Treatment|Protocol Violation|0|||
156980324|NCT02291289|566682148|FG006|Induction Treatment|Protocol Violation|0|||
156980325|NCT02291289|566682149|FG007|Induction Treatment|Protocol Violation|0|||
156980326|NCT02291289|566682150|FG008|Induction Treatment|Protocol Violation|0|||
156980327|NCT02291289|566682151|FG009|Induction Treatment|Protocol Violation|2|||
156980328|NCT02291289|566682152|FG010|Induction Treatment|Protocol Violation|0|||
156980329|NCT02291289|566682153|FG011|Induction Treatment|Protocol Violation|0|||
156980330|NCT02291289|566682154|FG012|Induction Treatment|Protocol Violation|0|||
156980331|NCT02291289|566682142|FG000|Induction Treatment|Missing|4|||
156980332|NCT02291289|566682143|FG001|Induction Treatment|Missing|0|||
156980333|NCT02291289|566682144|FG002|Induction Treatment|Missing|0|||
156980334|NCT02291289|566682145|FG003|Induction Treatment|Missing|14|||
156980335|NCT02291289|566682146|FG004|Induction Treatment|Missing|0|||
156980336|NCT02291289|566682147|FG005|Induction Treatment|Missing|0|||
156980337|NCT02291289|566682148|FG006|Induction Treatment|Missing|0|||
156980338|NCT02291289|566682149|FG007|Induction Treatment|Missing|0|||
156980339|NCT02291289|566682150|FG008|Induction Treatment|Missing|0|||
156980340|NCT02291289|566682151|FG009|Induction Treatment|Missing|54|||
156980341|NCT02291289|566682152|FG010|Induction Treatment|Missing|0|||
156980342|NCT02291289|566682153|FG011|Induction Treatment|Missing|0|||
156980343|NCT02291289|566682154|FG012|Induction Treatment|Missing|0|||
156980344|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980345|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980346|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980347|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980348|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
156980349|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
156980350|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980351|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980352|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980353|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980354|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
156980355|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
156980356|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156980357|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Death|0|||
156980358|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Death|29|||
156980359|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Death|16|||
156980360|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Death|0|||
156980361|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Death|188|||
157095490|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
157095491|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
157095492|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
157095493|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
157095494|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
157095495|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
157095496|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
157095497|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
157095498|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
157095499|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
157095500|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
157095501|NCT03548987|567105378|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
157095502|NCT03548987|567105379|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
157095503|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
157095504|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
157095505|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
157095506|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
157095507|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
157095508|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
157095509|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
157095510|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
157095511|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
157095512|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
157095513|NCT03548987|567105378|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
157095514|NCT03548987|567105379|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
157095515|NCT05580588|567105380|FG000|Overall Study|Lack of Efficacy|12|||
157095516|NCT02875977|567105383|FG000|Overall Study|Lost to Follow-up|42|||
157095517|NCT02875977|567105384|FG001|Overall Study|Lost to Follow-up|29|||
157095518|NCT02019927|567105385|FG000|Overall Study|Lost to Follow-up|2|||
157095519|NCT02019927|567105386|FG001|Overall Study|Lost to Follow-up|4|||
157095520|NCT02019927|567105387|FG002|Overall Study|Lost to Follow-up|1|||
157095521|NCT02019927|567105388|FG003|Overall Study|Lost to Follow-up|2|||
157095522|NCT02019927|567105389|FG004|Overall Study|Lost to Follow-up|3|||
157095523|NCT02019927|567105390|FG005|Overall Study|Lost to Follow-up|1|||
157095524|NCT00928447|567105399|FG000|Overall Study|Withdrawal by Subject|1|||
157095525|NCT00928447|567105399|FG000|Overall Study|Investigator's decision|1|||
157095526|NCT00069238|567105400|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
157095527|NCT00069238|567105401|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
157095528|NCT00069238|567105402|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
157095529|NCT00069238|567105400|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
157095530|NCT00069238|567105401|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
157095531|NCT00069238|567105402|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
157095532|NCT00069238|567105400|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
157095533|NCT00069238|567105401|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
157095534|NCT00069238|567105402|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
157095535|NCT04508023|567105404|FG000|Overall Study|Withdrawal by Subject|1|||
157095536|NCT04508023|567105405|FG001|Overall Study|Withdrawal by Subject|2|||
157095537|NCT01668667|567105413|FG000|Overall Study|Adverse Event|3|||
157095538|NCT01668667|567105414|FG001|Overall Study|Adverse Event|6|||
157095539|NCT01668667|567105415|FG002|Overall Study|Adverse Event|4|||
157095540|NCT01668667|567105416|FG003|Overall Study|Adverse Event|4|||
157095541|NCT01668667|567105413|FG000|Overall Study|Lack of Efficacy|3|||
156980362|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Death|107|||
156980363|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Death|0|||
156980364|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Death|1|||
156980365|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Death|1|||
156980366|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Death|0|||
156980367|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Death|46|||
156980368|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Death|19|||
156980369|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Death|0|||
156980370|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Adverse Event|0|||
156980371|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Adverse Event|0|||
156980372|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Adverse Event|0|||
156980373|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Adverse Event|0|||
156980374|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Adverse Event|1|||
156980375|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Adverse Event|1|||
156980376|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Adverse Event|0|||
156980377|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Adverse Event|0|||
156980378|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Adverse Event|0|||
156980379|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Adverse Event|0|||
156980380|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Adverse Event|0|||
156980381|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Adverse Event|0|||
156980382|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Adverse Event|0|||
156980383|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980384|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
156980385|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980386|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980387|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
156980388|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
156980389|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980390|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
156980391|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980392|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980393|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
156980394|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
156980395|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
156980396|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
156980397|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
156980398|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
156980399|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
156980400|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
156980401|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
156980402|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
156980403|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
156980404|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
156980405|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
156980406|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
156980407|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
156980408|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
156980409|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Physician Decision|0|||
156980410|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Physician Decision|2|||
156980411|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Physician Decision|0|||
156980412|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Physician Decision|0|||
156980413|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Physician Decision|3|||
156980414|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Physician Decision|0|||
156980415|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Physician Decision|0|||
156980416|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Physician Decision|0|||
156980417|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Physician Decision|0|||
156980418|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Physician Decision|0|||
156980419|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Physician Decision|1|||
156980420|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Physician Decision|3|||
156980421|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Physician Decision|0|||
156980422|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Not Treated|0|||
156980423|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Not Treated|0|||
156980424|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Not Treated|2|||
156980425|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Not Treated|0|||
156980426|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Not Treated|0|||
156980427|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Not Treated|0|||
156980428|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Not Treated|0|||
156980429|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Not Treated|0|||
156980430|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Not Treated|0|||
156980431|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Not Treated|0|||
156980432|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Not Treated|0|||
156980433|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Not Treated|0|||
156980434|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Not Treated|0|||
156980435|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980436|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
156980437|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980438|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980439|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980440|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980441|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980442|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980443|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980444|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980445|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980446|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980447|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
156980448|NCT02291289|566682142|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
156980449|NCT02291289|566682143|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
156980450|NCT02291289|566682144|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
157095542|NCT01668667|567105414|FG001|Overall Study|Lack of Efficacy|2|||
157095543|NCT01668667|567105415|FG002|Overall Study|Lack of Efficacy|2|||
157095544|NCT01668667|567105416|FG003|Overall Study|Lack of Efficacy|3|||
157095545|NCT01668667|567105413|FG000|Overall Study|Protocol Violation|6|||
157095546|NCT01668667|567105414|FG001|Overall Study|Protocol Violation|10|||
157095547|NCT01668667|567105415|FG002|Overall Study|Protocol Violation|12|||
156980451|NCT02291289|566682145|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
156980452|NCT02291289|566682146|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
156980453|NCT02291289|566682147|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
156980454|NCT02291289|566682148|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
156980455|NCT02291289|566682149|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
156980456|NCT02291289|566682150|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
156980457|NCT02291289|566682151|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
156980458|NCT02291289|566682152|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
156980459|NCT02291289|566682153|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
156980460|NCT02291289|566682154|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
156980461|NCT02291289|566682142|FG000|Early Disease Progression|Death|0|||
156980462|NCT02291289|566682143|FG001|Early Disease Progression|Death|0|||
156980463|NCT02291289|566682144|FG002|Early Disease Progression|Death|0|||
156980464|NCT02291289|566682145|FG003|Early Disease Progression|Death|0|||
156980465|NCT02291289|566682146|FG004|Early Disease Progression|Death|0|||
156980466|NCT02291289|566682147|FG005|Early Disease Progression|Death|0|||
156980467|NCT02291289|566682148|FG006|Early Disease Progression|Death|0|||
156980468|NCT02291289|566682149|FG007|Early Disease Progression|Death|0|||
156980469|NCT02291289|566682150|FG008|Early Disease Progression|Death|0|||
156980470|NCT02291289|566682151|FG009|Early Disease Progression|Death|0|||
156980471|NCT02291289|566682152|FG010|Early Disease Progression|Death|0|||
156980472|NCT02291289|566682153|FG011|Early Disease Progression|Death|0|||
156980473|NCT02291289|566682154|FG012|Early Disease Progression|Death|10|||
156980474|NCT02291289|566682142|FG000|Early Disease Progression|Lost to Follow-up|0|||
156980475|NCT02291289|566682143|FG001|Early Disease Progression|Lost to Follow-up|0|||
156980476|NCT02291289|566682144|FG002|Early Disease Progression|Lost to Follow-up|0|||
156980477|NCT02291289|566682145|FG003|Early Disease Progression|Lost to Follow-up|0|||
156980478|NCT02291289|566682146|FG004|Early Disease Progression|Lost to Follow-up|0|||
156980479|NCT02291289|566682147|FG005|Early Disease Progression|Lost to Follow-up|0|||
156980480|NCT02291289|566682148|FG006|Early Disease Progression|Lost to Follow-up|0|||
156980481|NCT02291289|566682149|FG007|Early Disease Progression|Lost to Follow-up|0|||
156980482|NCT02291289|566682150|FG008|Early Disease Progression|Lost to Follow-up|0|||
157095548|NCT01668667|567105416|FG003|Overall Study|Protocol Violation|5|||
157095549|NCT01668667|567105413|FG000|Overall Study|Lost to Follow-up|9|||
157095550|NCT01668667|567105414|FG001|Overall Study|Lost to Follow-up|4|||
157095551|NCT01668667|567105415|FG002|Overall Study|Lost to Follow-up|7|||
157095552|NCT01668667|567105416|FG003|Overall Study|Lost to Follow-up|6|||
157095553|NCT01668667|567105413|FG000|Overall Study|Physician Decision|3|||
157095554|NCT01668667|567105414|FG001|Overall Study|Physician Decision|0|||
157095555|NCT01668667|567105415|FG002|Overall Study|Physician Decision|1|||
157095556|NCT01668667|567105416|FG003|Overall Study|Physician Decision|0|||
157095557|NCT01668667|567105413|FG000|Overall Study|Withdrawal by Subject|7|||
157095558|NCT01668667|567105414|FG001|Overall Study|Withdrawal by Subject|4|||
157095559|NCT01668667|567105415|FG002|Overall Study|Withdrawal by Subject|5|||
157095560|NCT01668667|567105416|FG003|Overall Study|Withdrawal by Subject|5|||
157095561|NCT01204398|567105420|FG000|Overall Study|Adverse Event|1|||
157095562|NCT01281969|567105421|FG000|Overall Study|not randomized didn't meet criteria|0|||
157095563|NCT01281969|567105422|FG001|Overall Study|not randomized didn't meet criteria|0|||
157095564|NCT01281969|567105423|FG002|Overall Study|not randomized didn't meet criteria|7|||
157095565|NCT01281969|567105421|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
157095566|NCT01281969|567105422|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
157095567|NCT01281969|567105423|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
157095568|NCT01281969|567105421|FG000|Overall Study|not randomized, child consent not given|0|||
157095569|NCT01281969|567105422|FG001|Overall Study|not randomized, child consent not given|0|||
157095570|NCT01281969|567105423|FG002|Overall Study|not randomized, child consent not given|2|||
157095571|NCT01723254|567105425|FG000|Overall Study|Conflict with work schedule|0|||
157095572|NCT01723254|567105426|FG001|Overall Study|Conflict with work schedule|0|||
157095573|NCT01723254|567105427|FG002|Overall Study|Conflict with work schedule|0|||
157095574|NCT01723254|567105428|FG003|Overall Study|Conflict with work schedule|0|||
157095575|NCT01723254|567105429|FG004|Overall Study|Conflict with work schedule|0|||
157095576|NCT01723254|567105430|FG005|Overall Study|Conflict with work schedule|0|||
157095577|NCT01723254|567105431|FG006|Overall Study|Conflict with work schedule|0|||
156980483|NCT02291289|566682151|FG009|Early Disease Progression|Lost to Follow-up|0|||
156980484|NCT02291289|566682152|FG010|Early Disease Progression|Lost to Follow-up|0|||
156980485|NCT02291289|566682153|FG011|Early Disease Progression|Lost to Follow-up|0|||
156980486|NCT02291289|566682154|FG012|Early Disease Progression|Lost to Follow-up|1|||
156980487|NCT01017120|566682158|FG000|Overall Study|Adverse Event|9|||
157095578|NCT01723254|567105432|FG007|Overall Study|Conflict with work schedule|1|||
157095579|NCT01723254|567105425|FG000|Overall Study|Personal issues|0|||
157095580|NCT01723254|567105426|FG001|Overall Study|Personal issues|0|||
157095581|NCT01723254|567105427|FG002|Overall Study|Personal issues|0|||
157095582|NCT01723254|567105428|FG003|Overall Study|Personal issues|0|||
157095583|NCT01723254|567105429|FG004|Overall Study|Personal issues|0|||
157095584|NCT01723254|567105430|FG005|Overall Study|Personal issues|1|||
157095585|NCT01723254|567105431|FG006|Overall Study|Personal issues|0|||
157095586|NCT01723254|567105432|FG007|Overall Study|Personal issues|0|||
157095587|NCT01723254|567105425|FG000|Overall Study|No longer have time to participate|0|||
157095588|NCT01723254|567105426|FG001|Overall Study|No longer have time to participate|0|||
157095589|NCT01723254|567105427|FG002|Overall Study|No longer have time to participate|0|||
157095590|NCT01723254|567105428|FG003|Overall Study|No longer have time to participate|1|||
157095591|NCT01723254|567105429|FG004|Overall Study|No longer have time to participate|0|||
156980488|NCT01017120|566682159|FG001|Overall Study|Adverse Event|0|||
156980489|NCT01017120|566682158|FG000|Overall Study|Lost to Follow-up|13|||
156980490|NCT01017120|566682159|FG001|Overall Study|Lost to Follow-up|11|||
156980491|NCT01017120|566682158|FG000|Overall Study|Lack of Efficacy|1|||
156980492|NCT01017120|566682159|FG001|Overall Study|Lack of Efficacy|0|||
156980493|NCT01017120|566682158|FG000|Overall Study|Withdrawal by Subject|39|||
156980494|NCT01017120|566682159|FG001|Overall Study|Withdrawal by Subject|21|||
156980495|NCT01017120|566682158|FG000|Overall Study|Pregnancy|1|||
156980496|NCT01017120|566682159|FG001|Overall Study|Pregnancy|1|||
156980497|NCT01017120|566682158|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156980498|NCT01017120|566682159|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156980499|NCT01017120|566682158|FG000|Overall Study|Relocated Out of Town|0|||
156980500|NCT01017120|566682159|FG001|Overall Study|Relocated Out of Town|2|||
156980501|NCT01017120|566682158|FG000|Overall Study|Protocol Violation|1|||
156980502|NCT01017120|566682159|FG001|Overall Study|Protocol Violation|0|||
156980503|NCT01017120|566682158|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
156980504|NCT01017120|566682159|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
156980505|NCT01912222|566682160|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
156980506|NCT01912222|566682161|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
156980507|NCT01912222|566682162|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
156980508|NCT01912222|566682160|FG000|Part B: Treatment Period|Progressive disease|10|||
156980509|NCT01912222|566682161|FG001|Part B: Treatment Period|Progressive disease|12|||
156980510|NCT01912222|566682162|FG002|Part B: Treatment Period|Progressive disease|15|||
156980511|NCT01912222|566682160|FG000|Part B: Treatment Period|Adverse Event|1|||
156980512|NCT01912222|566682161|FG001|Part B: Treatment Period|Adverse Event|2|||
156980513|NCT01912222|566682162|FG002|Part B: Treatment Period|Adverse Event|3|||
156980514|NCT01912222|566682160|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
156980515|NCT01912222|566682161|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
156980516|NCT01912222|566682162|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
156980517|NCT01804673|566682163|FG000|Overall Study|Adverse Event|4|||
156980518|NCT01804673|566682163|FG000|Overall Study|Withdrawal by Subject|1|||
156980519|NCT01804673|566682163|FG000|Overall Study|Lack of Efficacy|9|||
156980520|NCT01804673|566682163|FG000|Overall Study|Change to Oral Therapy|37|||
156980521|NCT01804673|566682163|FG000|Overall Study|No Further Therapy Required|84|||
156980522|NCT01804673|566682163|FG000|Overall Study|Use of Prohibited Medication|1|||
156980523|NCT01804673|566682163|FG000|Overall Study|Other|4|||
156980524|NCT01857934|566682171|FG000|Overall Study|Relapse or progression|2|||
156980525|NCT01857934|566682171|FG000|Overall Study|Unacceptable toxicity|3|||
156980526|NCT01857934|566682171|FG000|Overall Study|Unwillingness or inability to comply|2|||
156980527|NCT01857934|566682171|FG000|Overall Study|Physician Decision|3|||
156980528|NCT01112514|566682172|FG000|Overall Study|Lost to Follow-up|1|||
156980529|NCT01024959|566682173|FG000|Overall Study|ineligible|12|||
156980530|NCT01024959|566682173|FG000|Overall Study|results not evaluable|12|||
156980531|NCT01024959|566682173|FG000|Overall Study|missing results required for analysis|17|||
156980532|NCT01118455|566682174|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
156980533|NCT01118455|566682175|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
156980534|NCT00313911|566682183|FG000|Overall Study|Serious adverse event|6|||
156980535|NCT00313911|566682184|FG001|Overall Study|Serious adverse event|1|||
156980536|NCT00313911|566682183|FG000|Overall Study|Adverse Event|2|||
156980537|NCT00313911|566682184|FG001|Overall Study|Adverse Event|3|||
156980538|NCT00313911|566682183|FG000|Overall Study|Protocol Violation|19|||
156980539|NCT00313911|566682184|FG001|Overall Study|Protocol Violation|10|||
156980540|NCT00313911|566682183|FG000|Overall Study|Lost to Follow-up|27|||
156980541|NCT00313911|566682184|FG001|Overall Study|Lost to Follow-up|14|||
156980542|NCT00313911|566682183|FG000|Overall Study|Withdrawal by Subject|39|||
157095592|NCT01723254|567105430|FG005|Overall Study|No longer have time to participate|0|||
157095593|NCT01723254|567105431|FG006|Overall Study|No longer have time to participate|0|||
156980543|NCT00313911|566682184|FG001|Overall Study|Withdrawal by Subject|12|||
156980544|NCT00313911|566682183|FG000|Overall Study|Did not meet age criteria|1|||
156980545|NCT00313911|566682184|FG001|Overall Study|Did not meet age criteria|1|||
156980546|NCT00636792|566682187|FG000|Overall Study|Adverse Event|16|||
156980547|NCT00636792|566682187|FG000|Overall Study|Physician Decision|7|||
156980548|NCT00636792|566682187|FG000|Overall Study|Progressive Disease|4|||
157095594|NCT01723254|567105432|FG007|Overall Study|No longer have time to participate|0|||
157095595|NCT01723254|567105425|FG000|Overall Study|Move/Left to another country/city|0|||
157095596|NCT01723254|567105426|FG001|Overall Study|Move/Left to another country/city|0|||
157095597|NCT01723254|567105427|FG002|Overall Study|Move/Left to another country/city|2|||
157095598|NCT01723254|567105428|FG003|Overall Study|Move/Left to another country/city|1|||
157095599|NCT01723254|567105429|FG004|Overall Study|Move/Left to another country/city|1|||
157095600|NCT01723254|567105430|FG005|Overall Study|Move/Left to another country/city|0|||
157095601|NCT01723254|567105431|FG006|Overall Study|Move/Left to another country/city|0|||
156980549|NCT00636792|566682187|FG000|Overall Study|Withdrawal by Subject|3|||
156980550|NCT00636792|566682187|FG000|Overall Study|Other|3|||
156980551|NCT01912781|566682188|FG000|Overall Study|Withdrawal by Subject|2|||
156980552|NCT01912781|566682189|FG001|Overall Study|Withdrawal by Subject|0|||
157095602|NCT01723254|567105432|FG007|Overall Study|Move/Left to another country/city|0|||
157095603|NCT01723254|567105425|FG000|Overall Study|Protocol Violation|0|||
157095604|NCT01723254|567105426|FG001|Overall Study|Protocol Violation|1|||
157095605|NCT01723254|567105427|FG002|Overall Study|Protocol Violation|0|||
157095606|NCT01723254|567105428|FG003|Overall Study|Protocol Violation|0|||
157095607|NCT01723254|567105429|FG004|Overall Study|Protocol Violation|0|||
157095608|NCT01723254|567105430|FG005|Overall Study|Protocol Violation|0|||
157095609|NCT01723254|567105431|FG006|Overall Study|Protocol Violation|0|||
157095610|NCT01723254|567105432|FG007|Overall Study|Protocol Violation|0|||
157095611|NCT01723254|567105425|FG000|Overall Study|Withdrawal by Subject|1|||
157095612|NCT01723254|567105426|FG001|Overall Study|Withdrawal by Subject|2|||
157095613|NCT01723254|567105427|FG002|Overall Study|Withdrawal by Subject|1|||
157095614|NCT01723254|567105428|FG003|Overall Study|Withdrawal by Subject|0|||
157095615|NCT01723254|567105429|FG004|Overall Study|Withdrawal by Subject|1|||
157095616|NCT01723254|567105430|FG005|Overall Study|Withdrawal by Subject|1|||
157095617|NCT01723254|567105431|FG006|Overall Study|Withdrawal by Subject|1|||
157095618|NCT01723254|567105432|FG007|Overall Study|Withdrawal by Subject|2|||
157095619|NCT01257425|567105433|FG000|Overall Study|Lack of Efficacy|3|||
157095620|NCT01257425|567105434|FG001|Overall Study|Lack of Efficacy|3|||
157095621|NCT01257425|567105433|FG000|Overall Study|Adverse Event|1|||
157095622|NCT01257425|567105434|FG001|Overall Study|Adverse Event|1|||
156980553|NCT03377790|566682190|FG000|Overall Study|Withdrawal by Subject|1|||
156980554|NCT03377790|566682191|FG001|Overall Study|Withdrawal by Subject|0|||
157095623|NCT01257425|567105433|FG000|Overall Study|Protocol Violation|1|||
157095624|NCT01257425|567105434|FG001|Overall Study|Protocol Violation|1|||
157095625|NCT01257425|567105433|FG000|Overall Study|Withdrawal by Subject|0|||
157095626|NCT01257425|567105434|FG001|Overall Study|Withdrawal by Subject|1|||
157095627|NCT01257425|567105433|FG000|Overall Study|Death|1|||
157095628|NCT01257425|567105434|FG001|Overall Study|Death|0|||
157095629|NCT02240693|567105436|FG000|Overall Study|Adverse Event|0|||
157095630|NCT02240693|567105437|FG001|Overall Study|Adverse Event|0|||
157095631|NCT02240693|567105438|FG002|Overall Study|Adverse Event|0|||
157095632|NCT02240693|567105439|FG003|Overall Study|Adverse Event|0|||
157095633|NCT02240693|567105440|FG004|Overall Study|Adverse Event|1|||
157095634|NCT02240693|567105436|FG000|Overall Study|Withdrawal by Subject|0|||
157095635|NCT02240693|567105437|FG001|Overall Study|Withdrawal by Subject|0|||
157095636|NCT02240693|567105438|FG002|Overall Study|Withdrawal by Subject|2|||
157095637|NCT02240693|567105439|FG003|Overall Study|Withdrawal by Subject|1|||
157095638|NCT02240693|567105440|FG004|Overall Study|Withdrawal by Subject|0|||
157095639|NCT02240693|567105436|FG000|Overall Study|Other than specified|0|||
157095640|NCT02240693|567105437|FG001|Overall Study|Other than specified|0|||
157095641|NCT02240693|567105438|FG002|Overall Study|Other than specified|2|||
157095642|NCT02240693|567105439|FG003|Overall Study|Other than specified|0|||
157095643|NCT02240693|567105440|FG004|Overall Study|Other than specified|0|||
157095644|NCT03343301|567105441|FG000|Overall Study|Withdrawal by Subject|1|||
157095645|NCT03343301|567105442|FG001|Overall Study|Withdrawal by Subject|1|||
157095646|NCT03343301|567105441|FG000|Overall Study|Death|0|||
157095647|NCT03343301|567105442|FG001|Overall Study|Death|2|||
157095648|NCT03343301|567105441|FG000|Overall Study|Other|0|||
157095649|NCT03343301|567105442|FG001|Overall Study|Other|6|||
157095650|NCT03343301|567105441|FG000|Overall Study|Missing|2|||
157095651|NCT03343301|567105442|FG001|Overall Study|Missing|0|||
157095652|NCT02668185|567105445|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
157095653|NCT02668185|567105446|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
156980555|NCT03377790|566682190|FG000|Overall Study|Adverse Event|1|||
156980556|NCT03377790|566682191|FG001|Overall Study|Adverse Event|0|||
157095654|NCT02668185|567105445|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
157095655|NCT02668185|567105446|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
157095656|NCT02668185|567105445|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
157095657|NCT02668185|567105446|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
156980557|NCT03377790|566682190|FG000|Overall Study|Lost to Follow-up|0|||
157095658|NCT02668185|567105445|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
157095659|NCT02668185|567105446|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
157095660|NCT01013597|567105447|FG000|Overall Study|Withdrawal by Subject|1|||
156980558|NCT03377790|566682191|FG001|Overall Study|Lost to Follow-up|2|||
156980559|NCT03377790|566682190|FG000|Overall Study|Randomized but not treated|1|||
156980560|NCT03377790|566682191|FG001|Overall Study|Randomized but not treated|0|||
156980561|NCT03377790|566682190|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
156980562|NCT03377790|566682191|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
156980563|NCT01928225|566682192|FG000|Overall Study|Pregnancy|1|||
156980564|NCT01928225|566682193|FG001|Overall Study|Pregnancy|0|||
156980565|NCT01928225|566682192|FG000|Overall Study|basaloid cervical cancer|1|||
156980566|NCT01928225|566682193|FG001|Overall Study|basaloid cervical cancer|0|||
156980567|NCT01928225|566682192|FG000|Overall Study|Lost to Follow-up|1|||
156980568|NCT01928225|566682193|FG001|Overall Study|Lost to Follow-up|3|||
156980569|NCT01235975|566682195|FG000|Overall Study|Serious Adverse Event|0|||
156980570|NCT01235975|566682196|FG001|Overall Study|Serious Adverse Event|1|||
156980571|NCT01235975|566682195|FG000|Overall Study|Withdrawal by Subject|8|||
156980572|NCT01235975|566682196|FG001|Overall Study|Withdrawal by Subject|2|||
156980573|NCT01235975|566682195|FG000|Overall Study|Migrated/moved from study area|2|||
156980574|NCT01235975|566682196|FG001|Overall Study|Migrated/moved from study area|1|||
156980575|NCT01235975|566682195|FG000|Overall Study|Lost to Follow-up|7|||
156980576|NCT01235975|566682196|FG001|Overall Study|Lost to Follow-up|3|||
156980577|NCT05033743|566682197|FG000|Overall Study|Lost to Follow-up|1|||
156980578|NCT05033743|566682197|FG000|Overall Study|Protocol Violation|2|||
156980579|NCT05033743|566682197|FG000|Overall Study|Withdrawal by Subject|1|||
156980580|NCT00919893|566682199|FG000|Overall Study|Protocol Violation|19|||
156980581|NCT00919893|566682200|FG001|Overall Study|Protocol Violation|9|||
156980582|NCT04161807|566682204|FG000|Overall Study|Withdrawal by Subject|2|||
156980583|NCT04161807|566682204|FG000|Overall Study|Performed only 1 treatment|2|||
156980584|NCT00708305|566682209|FG000|Period 1|Protocol Violation|1|||
156980585|NCT00708305|566682210|FG001|Period 1|Protocol Violation|0|||
156980586|NCT00708305|566682211|FG002|Period 1|Protocol Violation|1|||
156980587|NCT00708305|566682212|FG003|Period 1|Protocol Violation|0|||
156980588|NCT00708305|566682209|FG000|Period 1|Other Reason|0|||
156980589|NCT00708305|566682210|FG001|Period 1|Other Reason|0|||
156980590|NCT00708305|566682211|FG002|Period 1|Other Reason|0|||
156980591|NCT00708305|566682212|FG003|Period 1|Other Reason|2|||
156980592|NCT00708305|566682209|FG000|Period 2|Lost to Follow-up|0|||
156980593|NCT00708305|566682210|FG001|Period 2|Lost to Follow-up|1|||
156980594|NCT00708305|566682211|FG002|Period 2|Lost to Follow-up|0|||
156980595|NCT00708305|566682212|FG003|Period 2|Lost to Follow-up|0|||
156980596|NCT00708305|566682209|FG000|Period 2|Protocol Violation|0|||
156980597|NCT00708305|566682210|FG001|Period 2|Protocol Violation|1|||
156980598|NCT00708305|566682211|FG002|Period 2|Protocol Violation|0|||
156980599|NCT00708305|566682212|FG003|Period 2|Protocol Violation|0|||
156980600|NCT00708305|566682209|FG000|Period 2|Other Reason|1|||
156980601|NCT00708305|566682210|FG001|Period 2|Other Reason|0|||
156980602|NCT00708305|566682211|FG002|Period 2|Other Reason|0|||
156980603|NCT00708305|566682212|FG003|Period 2|Other Reason|1|||
156980604|NCT00708305|566682209|FG000|Period 3|Protocol Violation|0|||
156980605|NCT00708305|566682210|FG001|Period 3|Protocol Violation|2|||
156980606|NCT00708305|566682211|FG002|Period 3|Protocol Violation|0|||
157095661|NCT00427895|567105448|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095662|NCT00427895|567105449|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095663|NCT00427895|567105450|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095664|NCT00427895|567105451|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
157095665|NCT00427895|567105452|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095666|NCT00427895|567105453|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095667|NCT00427895|567105454|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095668|NCT00427895|567105455|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
157095669|NCT00427895|567105448|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156980607|NCT00708305|566682212|FG003|Period 3|Protocol Violation|0|||
156980608|NCT00708305|566682209|FG000|Period 3|Other Reason|1|||
156980609|NCT00708305|566682210|FG001|Period 3|Other Reason|0|||
156980610|NCT00708305|566682211|FG002|Period 3|Other Reason|0|||
156980611|NCT00708305|566682212|FG003|Period 3|Other Reason|0|||
156980612|NCT00192023|566682213|FG000|Period III - Double-Blind|Adverse Event|3|||
156980613|NCT00192023|566682214|FG001|Period III - Double-Blind|Adverse Event|0|||
157095670|NCT00427895|567105449|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
157095671|NCT00427895|567105450|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
156980614|NCT00192023|566682213|FG000|Period III - Double-Blind|Physician Decision|2|||
156980615|NCT00192023|566682214|FG001|Period III - Double-Blind|Physician Decision|0|||
156980616|NCT00192023|566682213|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
156980617|NCT00192023|566682214|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
156980618|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
156980619|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
156980620|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
156980621|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
157095672|NCT00427895|567105451|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
157095673|NCT00427895|567105452|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
157095674|NCT00427895|567105453|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
157095675|NCT00427895|567105454|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
157095676|NCT00427895|567105455|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
157095677|NCT00427895|567105448|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095678|NCT00427895|567105449|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095679|NCT00427895|567105450|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095680|NCT00427895|567105451|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095681|NCT00427895|567105452|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095682|NCT00427895|567105453|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095683|NCT00427895|567105454|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
157095684|NCT00427895|567105455|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
157095685|NCT00427895|567105448|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
157095686|NCT00427895|567105449|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
157095687|NCT00427895|567105450|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
157095688|NCT00427895|567105451|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
157095689|NCT00427895|567105452|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
157095690|NCT00427895|567105453|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
157095691|NCT00427895|567105454|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
157095692|NCT00427895|567105455|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
157095693|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
157095694|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
157095695|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
157095696|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
157095697|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
157095698|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
157095699|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
157095700|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
157095701|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
157095702|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
157095703|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
157095704|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
157095705|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
157095706|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
157095707|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
157095708|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
157095709|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
157095710|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
157095711|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095712|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095713|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095714|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095715|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095716|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
157095717|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
157095718|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
156980622|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
156980623|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
156980624|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
156980625|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
156980626|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
156980627|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
156980628|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
156980629|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
156980630|NCT00192023|566682213|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
156980631|NCT00192023|566682214|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
156980632|NCT02111213|566682218|FG000|Overall Study|Withdrawal by Subject|3|||
156980633|NCT02111213|566682219|FG001|Overall Study|Withdrawal by Subject|2|||
156980634|NCT02111213|566682218|FG000|Overall Study|Lost to Follow-up|3|||
156980635|NCT02111213|566682219|FG001|Overall Study|Lost to Follow-up|4|||
156980636|NCT02761629|566682224|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
156980637|NCT02761629|566682225|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
156980638|NCT02761629|566682224|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156980639|NCT02761629|566682225|FG001|Overall Study|Insufficient Therapeutic Response|7|||
156980640|NCT02761629|566682224|FG000|Overall Study|Failure to Return|2|||
156980641|NCT02761629|566682225|FG001|Overall Study|Failure to Return|4|||
156980642|NCT02761629|566682224|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
156980643|NCT02761629|566682225|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
156980644|NCT02761629|566682224|FG000|Overall Study|Protocol Violation|2|||
156980645|NCT02761629|566682225|FG001|Overall Study|Protocol Violation|2|||
156980646|NCT02761629|566682224|FG000|Overall Study|Withdrawal by Subject|0|||
156980647|NCT02761629|566682225|FG001|Overall Study|Withdrawal by Subject|3|||
156980648|NCT02761629|566682224|FG000|Overall Study|Other|0|||
156980649|NCT02761629|566682225|FG001|Overall Study|Other|2|||
156980650|NCT02761629|566682224|FG000|Overall Study|Lost to Follow-up|4|||
156980651|NCT02761629|566682225|FG001|Overall Study|Lost to Follow-up|1|||
156980652|NCT02761629|566682224|FG000|Overall Study|Randomized But Not Treated|8|||
156980653|NCT02761629|566682225|FG001|Overall Study|Randomized But Not Treated|4|||
156980654|NCT01258660|566682226|FG000|Overall Study|Adverse Event|2|||
156980655|NCT01258660|566682227|FG001|Overall Study|Adverse Event|4|||
156980656|NCT01258660|566682226|FG000|Overall Study|Withdrawal by Subject|3|||
156980657|NCT01258660|566682227|FG001|Overall Study|Withdrawal by Subject|0|||
156980658|NCT01258660|566682226|FG000|Overall Study|due to relocation|2|||
156980659|NCT01258660|566682227|FG001|Overall Study|due to relocation|0|||
156980660|NCT01258660|566682226|FG000|Overall Study|Protocol Violation|0|||
156980661|NCT01258660|566682227|FG001|Overall Study|Protocol Violation|1|||
156980662|NCT01258660|566682226|FG000|Overall Study|Invalid for primary analysis data set|4|||
156980663|NCT01258660|566682227|FG001|Overall Study|Invalid for primary analysis data set|6|||
156980664|NCT02340520|566682232|FG000|Overall Study|Lost to Follow-up|1|||
156980665|NCT02340520|566682232|FG000|Overall Study|Patient did not take drug as specified|1|||
156980666|NCT02340520|566682232|FG000|Overall Study|Withdrawal by Subject|1|||
156980667|NCT03306043|566682236|FG000|Overall Study|Adverse Event|1|||
156980668|NCT03306043|566682236|FG000|Overall Study|Lost to Follow-up|1|||
156980669|NCT03306043|566682236|FG000|Overall Study|Withdrawal by Subject|2|||
156980670|NCT01544491|566682237|FG000|Overall Study|Withdrawal by Subject|3|||
156980671|NCT01544491|566682238|FG001|Overall Study|Withdrawal by Subject|2|||
156980672|NCT01544491|566682237|FG000|Overall Study|Lost to Follow-up|0|||
156980673|NCT01544491|566682238|FG001|Overall Study|Lost to Follow-up|1|||
156980674|NCT01544491|566682237|FG000|Overall Study|administrative problems|2|||
156980675|NCT01544491|566682238|FG001|Overall Study|administrative problems|0|||
156980676|NCT01821898|566682252|FG000|Overall Study|Withdrawal by Subject|2|||
156980677|NCT01821898|566682253|FG001|Overall Study|Withdrawal by Subject|1|||
156980678|NCT04654468|566682256|FG000|Overall Study|Death|1|||
156980679|NCT04654468|566682256|FG000|Overall Study|Ongoing in the Study|50|||
156980680|NCT06390826|566682257|FG000|Overall Study|Never Start Protocol Therapy|1|||
156980681|NCT06390826|566682257|FG000|Overall Study|Adverse Event|1|||
156980682|NCT06390826|566682257|FG000|Overall Study|Disease Progression|8|||
156980683|NCT05229653|566682258|FG000|Overall Study|Lost to Follow-up|1|||
156980684|NCT05229653|566682259|FG001|Overall Study|Lost to Follow-up|0|||
156980685|NCT02009696|566682261|FG000|Overall Study|Withdrawal by Subject|2|||
156980686|NCT01018563|566682262|FG000|Overall Study|Termination of the study by Sponsor|2|||
156980687|NCT01018563|566682263|FG001|Overall Study|Termination of the study by Sponsor|1|||
156980688|NCT02344537|566682264|FG000|Overall Study|Protocol Violation|1|||
156980689|NCT02344537|566682265|FG001|Overall Study|Protocol Violation|1|||
156980690|NCT02344537|566682264|FG000|Overall Study|Subject started another treatment after wk 6|1|||
156980691|NCT02344537|566682265|FG001|Overall Study|Subject started another treatment after wk 6|0|||
156980692|NCT02344537|566682264|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
156980693|NCT02344537|566682265|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
156980694|NCT05490329|566682268|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
156980695|NCT05490329|566682269|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
156980696|NCT05490329|566682268|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
156980697|NCT05490329|566682269|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
156980698|NCT05490329|566682268|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
156980699|NCT05490329|566682269|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
156980700|NCT00856661|566682270|FG000|Overall Study|Death|15|||
156980701|NCT00856661|566682271|FG001|Overall Study|Death|18|||
156980702|NCT00856661|566682270|FG000|Overall Study|Protocol Violation|2|||
156980703|NCT00856661|566682271|FG001|Overall Study|Protocol Violation|1|||
156980704|NCT00856661|566682270|FG000|Overall Study|Withdrawal by Subject|1|||
156980705|NCT00856661|566682271|FG001|Overall Study|Withdrawal by Subject|2|||
156980706|NCT00856661|566682270|FG000|Overall Study|Lost to Follow-up|1|||
156980707|NCT00856661|566682271|FG001|Overall Study|Lost to Follow-up|3|||
156980708|NCT00856661|566682270|FG000|Overall Study|Physician Judgement|8|||
156980709|NCT00856661|566682271|FG001|Overall Study|Physician Judgement|5|||
156980710|NCT02120664|566682272|FG000|Overall Study|Withdrawal by Subject|0|||
156980711|NCT02120664|566682273|FG001|Overall Study|Withdrawal by Subject|0|||
156980712|NCT02120664|566682274|FG002|Overall Study|Withdrawal by Subject|0|||
156980713|NCT02120664|566682275|FG003|Overall Study|Withdrawal by Subject|1|||
156980714|NCT02120664|566682276|FG004|Overall Study|Withdrawal by Subject|0|||
156980715|NCT03176238|566682277|FG000|Overall Study|Unacceptable AEs|15|||
156980716|NCT03176238|566682278|FG001|Overall Study|Unacceptable AEs|8|||
156980717|NCT03176238|566682277|FG000|Overall Study|Abnormal lab value(s)|2|||
156980718|NCT03176238|566682278|FG001|Overall Study|Abnormal lab value(s)|0|||
156980719|NCT03176238|566682277|FG000|Overall Study|Inter-current illness|0|||
157095719|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
157095720|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
157095721|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
157095722|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
157095723|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
157095724|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
157095725|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095726|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095727|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095728|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
157095729|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095730|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095731|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095732|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
157095733|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
157095734|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
157095735|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
157095736|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
157095737|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
157095738|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
157095739|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
157095740|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
157095741|NCT00427895|567105448|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095742|NCT00427895|567105449|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095743|NCT00427895|567105450|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
157095744|NCT00427895|567105451|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
157095745|NCT00427895|567105452|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095746|NCT00427895|567105453|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095747|NCT00427895|567105454|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095748|NCT00427895|567105455|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
157095749|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
157095750|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
157095751|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
157095752|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
157095753|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
157095754|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
157095755|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
157095756|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
157095757|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
157095758|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
157095759|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
157095760|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
157095761|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
157095762|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
157095763|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
157095764|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
157095765|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
157095766|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
157095767|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
157095768|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
157095769|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
157095770|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
157095771|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
157095772|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
157095773|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095774|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
157095775|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095776|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095777|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095778|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095779|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095780|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
157095781|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Death|1|||
157095782|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Death|0|||
157095783|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Death|0|||
157095784|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Death|0|||
157095785|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Death|0|||
157095786|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Death|0|||
157095787|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Death|0|||
157095788|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Death|0|||
157095789|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
156980720|NCT03176238|566682278|FG001|Overall Study|Inter-current illness|1|||
156980721|NCT03176238|566682277|FG000|Overall Study|Consent withdrawal|14|||
156980722|NCT03176238|566682278|FG001|Overall Study|Consent withdrawal|2|||
156980723|NCT03176238|566682277|FG000|Overall Study|Lost to Follow-up|3|||
156980724|NCT03176238|566682278|FG001|Overall Study|Lost to Follow-up|0|||
156980725|NCT03176238|566682277|FG000|Overall Study|Administrative problems|1|||
156980726|NCT03176238|566682278|FG001|Overall Study|Administrative problems|0|||
156980727|NCT03176238|566682277|FG000|Overall Study|Death|3|||
156980728|NCT03176238|566682278|FG001|Overall Study|Death|0|||
156980729|NCT03176238|566682277|FG000|Overall Study|Disease Progression|133|||
156980730|NCT03176238|566682278|FG001|Overall Study|Disease Progression|22|||
156980731|NCT03176238|566682277|FG000|Overall Study|Tx duration completed per EAP|0|||
156980732|NCT03176238|566682278|FG001|Overall Study|Tx duration completed per EAP|1|||
156980733|NCT03176238|566682277|FG000|Overall Study|Patient is switched to commercial drug|16|||
156980734|NCT03176238|566682278|FG001|Overall Study|Patient is switched to commercial drug|1|||
156980735|NCT03176238|566682277|FG000|Overall Study|Protocol Violation|1|||
156980736|NCT03176238|566682278|FG001|Overall Study|Protocol Violation|0|||
156980737|NCT03176238|566682277|FG000|Overall Study|Changes in the patient's condition|2|||
156980738|NCT03176238|566682278|FG001|Overall Study|Changes in the patient's condition|1|||
156980739|NCT03176238|566682277|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
156980740|NCT03176238|566682278|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
156980741|NCT04524598|566682279|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
156980742|NCT04524598|566682280|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
156980743|NCT04524598|566682281|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
156980744|NCT04524598|566682282|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
156980745|NCT04524598|566682283|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
156980746|NCT04524598|566682279|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
156980747|NCT04524598|566682280|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
156980748|NCT04524598|566682281|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980749|NCT04524598|566682282|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980750|NCT04524598|566682283|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980751|NCT04524598|566682279|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
156980752|NCT04524598|566682280|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
156980753|NCT04524598|566682281|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
156980754|NCT04524598|566682282|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
156980755|NCT04524598|566682283|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
156980756|NCT04524598|566682279|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
156980757|NCT04524598|566682280|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
156980758|NCT04524598|566682281|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
156980759|NCT04524598|566682282|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
156980760|NCT04524598|566682283|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
156980761|NCT04524598|566682279|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980762|NCT04524598|566682280|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980763|NCT04524598|566682281|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
156980764|NCT04524598|566682282|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
156980765|NCT04524598|566682283|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980766|NCT04524598|566682279|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
156980767|NCT04524598|566682280|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
156980768|NCT04524598|566682281|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
156980769|NCT04524598|566682282|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
156980770|NCT04524598|566682283|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
156980771|NCT04524598|566682279|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980772|NCT04524598|566682280|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980773|NCT04524598|566682281|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980774|NCT04524598|566682282|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
156980775|NCT04524598|566682283|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
156980776|NCT02306122|566682284|FG000|Initial Physician Randomization|Physician Decision|0|||
156980777|NCT02306122|566682285|FG001|Initial Physician Randomization|Physician Decision|0|||
156980778|NCT02306122|566682286|FG002|Initial Physician Randomization|Physician Decision|0|||
156980779|NCT02306122|566682287|FG003|Initial Physician Randomization|Physician Decision|0|||
156980780|NCT02306122|566682288|FG004|Initial Physician Randomization|Physician Decision|0|||
156980781|NCT02306122|566682289|FG005|Initial Physician Randomization|Physician Decision|0|||
156980782|NCT02306122|566682290|FG006|Initial Physician Randomization|Physician Decision|0|||
156980783|NCT02306122|566682291|FG007|Initial Physician Randomization|Physician Decision|0|||
156980784|NCT02306122|566682292|FG008|Initial Physician Randomization|Physician Decision|1|||
156980785|NCT02306122|566682293|FG009|Initial Physician Randomization|Physician Decision|0|||
156980786|NCT02306122|566682294|FG010|Initial Physician Randomization|Physician Decision|0|||
156980787|NCT01351025|566682296|FG000|Week 0 - 20|Lost to Follow-up|2|||
156980788|NCT01351025|566682297|FG001|Week 0 - 20|Lost to Follow-up|1|||
156980789|NCT01351025|566682296|FG000|Week 0 - 20|Withdrawal by Subject|1|||
156980790|NCT01351025|566682297|FG001|Week 0 - 20|Withdrawal by Subject|0|||
156980791|NCT01351025|566682296|FG000|Week 24 - 44|Lost to Follow-up|0|||
156980792|NCT01351025|566682297|FG001|Week 24 - 44|Lost to Follow-up|2|||
156980793|NCT01351025|566682296|FG000|Week 24 - 44|Site closed|0|||
156980794|NCT01351025|566682297|FG001|Week 24 - 44|Site closed|1|||
156980795|NCT01351025|566682296|FG000|Week 24 - 44|unable to get to clinic|1|||
156980796|NCT01351025|566682297|FG001|Week 24 - 44|unable to get to clinic|1|||
156980797|NCT02736968|566682298|FG000|Overall Study|Lost to Follow-up|0|||
156980798|NCT02736968|566682299|FG001|Overall Study|Lost to Follow-up|0|||
156980799|NCT02736968|566682300|FG002|Overall Study|Lost to Follow-up|0|||
156980800|NCT02736968|566682301|FG003|Overall Study|Lost to Follow-up|0|||
156980801|NCT02736968|566682302|FG004|Overall Study|Lost to Follow-up|0|||
156980802|NCT02736968|566682303|FG005|Overall Study|Lost to Follow-up|0|||
156980803|NCT02736968|566682304|FG006|Overall Study|Lost to Follow-up|5|||
156980804|NCT02736968|566682305|FG007|Overall Study|Lost to Follow-up|2|||
156980805|NCT02736968|566682298|FG000|Overall Study|COVID-19 Pandemic|0|||
156980806|NCT02736968|566682299|FG001|Overall Study|COVID-19 Pandemic|0|||
156980807|NCT02736968|566682300|FG002|Overall Study|COVID-19 Pandemic|0|||
156980808|NCT02736968|566682301|FG003|Overall Study|COVID-19 Pandemic|0|||
156980809|NCT02736968|566682302|FG004|Overall Study|COVID-19 Pandemic|0|||
156980810|NCT02736968|566682303|FG005|Overall Study|COVID-19 Pandemic|0|||
156980811|NCT02736968|566682304|FG006|Overall Study|COVID-19 Pandemic|2|||
156980812|NCT02736968|566682305|FG007|Overall Study|COVID-19 Pandemic|0|||
156980813|NCT02736968|566682298|FG000|Overall Study|Withdrawal by Subject|0|||
156980814|NCT02736968|566682299|FG001|Overall Study|Withdrawal by Subject|0|||
156980815|NCT02736968|566682300|FG002|Overall Study|Withdrawal by Subject|0|||
156980816|NCT02736968|566682301|FG003|Overall Study|Withdrawal by Subject|0|||
156980817|NCT02736968|566682302|FG004|Overall Study|Withdrawal by Subject|0|||
156980818|NCT02736968|566682303|FG005|Overall Study|Withdrawal by Subject|0|||
156980819|NCT02736968|566682304|FG006|Overall Study|Withdrawal by Subject|1|||
156980820|NCT02736968|566682305|FG007|Overall Study|Withdrawal by Subject|0|||
156980821|NCT03864926|566684371|FG000|Overall Study|Death|0|||
156980822|NCT03864926|566684372|FG001|Overall Study|Death|2|||
156980823|NCT01091428|566684373|FG000|Phase 1|Progressive Disease|24|||
156980824|NCT01091428|566684374|FG001|Phase 1|Progressive Disease|8|||
156980825|NCT01091428|566684375|FG002|Phase 1|Progressive Disease|0|||
156980826|NCT01091428|566684376|FG003|Phase 1|Progressive Disease|0|||
156980827|NCT01091428|566684373|FG000|Phase 1|Symptomatic Deterioration|3|||
156980828|NCT01091428|566684374|FG001|Phase 1|Symptomatic Deterioration|2|||
156980829|NCT01091428|566684375|FG002|Phase 1|Symptomatic Deterioration|0|||
156980830|NCT01091428|566684376|FG003|Phase 1|Symptomatic Deterioration|0|||
156980831|NCT01091428|566684373|FG000|Phase 1|Adverse Event|2|||
156980832|NCT01091428|566684374|FG001|Phase 1|Adverse Event|0|||
156980833|NCT01091428|566684375|FG002|Phase 1|Adverse Event|0|||
156980834|NCT01091428|566684376|FG003|Phase 1|Adverse Event|0|||
156980835|NCT01091428|566684373|FG000|Phase 1|Withdrawal by Subject|7|||
156980836|NCT01091428|566684374|FG001|Phase 1|Withdrawal by Subject|0|||
156980837|NCT01091428|566684375|FG002|Phase 1|Withdrawal by Subject|0|||
156980838|NCT01091428|566684376|FG003|Phase 1|Withdrawal by Subject|0|||
156980839|NCT01091428|566684373|FG000|Phase 1|Reason not specified|0|||
156980840|NCT01091428|566684374|FG001|Phase 1|Reason not specified|1|||
156980841|NCT01091428|566684375|FG002|Phase 1|Reason not specified|0|||
156980842|NCT01091428|566684376|FG003|Phase 1|Reason not specified|0|||
156980843|NCT01091428|566684373|FG000|Phase 1|Single-Patient IND|2|||
156980844|NCT01091428|566684374|FG001|Phase 1|Single-Patient IND|0|||
156980845|NCT01091428|566684375|FG002|Phase 1|Single-Patient IND|0|||
156980846|NCT01091428|566684376|FG003|Phase 1|Single-Patient IND|0|||
156980847|NCT01091428|566684373|FG000|Phase 2|Progressive Disease|0|||
156980848|NCT01091428|566684374|FG001|Phase 2|Progressive Disease|0|||
156980849|NCT01091428|566684375|FG002|Phase 2|Progressive Disease|44|||
156980850|NCT01091428|566684376|FG003|Phase 2|Progressive Disease|46|||
156980851|NCT01091428|566684373|FG000|Phase 2|Symptomatic Deterioration|0|||
156980852|NCT01091428|566684374|FG001|Phase 2|Symptomatic Deterioration|0|||
156980853|NCT01091428|566684375|FG002|Phase 2|Symptomatic Deterioration|1|||
156980854|NCT01091428|566684376|FG003|Phase 2|Symptomatic Deterioration|6|||
156980855|NCT01091428|566684373|FG000|Phase 2|Adverse Event|0|||
156980856|NCT01091428|566684374|FG001|Phase 2|Adverse Event|0|||
156980857|NCT01091428|566684375|FG002|Phase 2|Adverse Event|12|||
156980858|NCT01091428|566684376|FG003|Phase 2|Adverse Event|5|||
157095790|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
157095791|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
156980859|NCT01091428|566684373|FG000|Phase 2|Withdrawal by Subject|0|||
156980860|NCT01091428|566684374|FG001|Phase 2|Withdrawal by Subject|0|||
156980861|NCT01091428|566684375|FG002|Phase 2|Withdrawal by Subject|9|||
156980862|NCT01091428|566684376|FG003|Phase 2|Withdrawal by Subject|8|||
156980863|NCT01091428|566684373|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
156980864|NCT01091428|566684374|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
156980865|NCT01091428|566684375|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
156980866|NCT01091428|566684376|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
156980867|NCT01091428|566684373|FG000|Phase 2|Reason not specified|0|||
157095792|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
157095793|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
157095794|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
157095795|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
157095796|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
157095797|NCT00427895|567105448|FG000|Vax 1/Year 1 Follow-up|Other|0|||
157095798|NCT00427895|567105449|FG001|Vax 1/Year 1 Follow-up|Other|0|||
157095799|NCT00427895|567105450|FG002|Vax 1/Year 1 Follow-up|Other|0|||
157095800|NCT00427895|567105451|FG003|Vax 1/Year 1 Follow-up|Other|2|||
157095801|NCT00427895|567105452|FG004|Vax 1/Year 1 Follow-up|Other|0|||
157095802|NCT00427895|567105453|FG005|Vax 1/Year 1 Follow-up|Other|0|||
157095803|NCT00427895|567105454|FG006|Vax 1/Year 1 Follow-up|Other|0|||
157095804|NCT00427895|567105455|FG007|Vax 1/Year 1 Follow-up|Other|0|||
157095805|NCT00427895|567105448|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
157095806|NCT00427895|567105449|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
157095807|NCT00427895|567105450|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
157095808|NCT00427895|567105451|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
157095809|NCT00427895|567105452|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
157095810|NCT00427895|567105453|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
157095811|NCT00427895|567105454|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
157095812|NCT00427895|567105455|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
157095813|NCT00585195|567105457|FG000|Overall Study|Adverse Event|0|||
157095814|NCT00585195|567105458|FG001|Overall Study|Adverse Event|0|||
156980868|NCT01091428|566684374|FG001|Phase 2|Reason not specified|0|||
156980869|NCT01091428|566684375|FG002|Phase 2|Reason not specified|4|||
156980870|NCT01091428|566684376|FG003|Phase 2|Reason not specified|3|||
156980871|NCT01091428|566684373|FG000|Phase 2|Physician Decision|0|||
156980872|NCT01091428|566684374|FG001|Phase 2|Physician Decision|0|||
156980873|NCT01091428|566684375|FG002|Phase 2|Physician Decision|2|||
156980874|NCT01091428|566684376|FG003|Phase 2|Physician Decision|0|||
156980875|NCT00358215|566684383|FG000|Overall Study|Ineligibility determined|4|||
156980876|NCT00358215|566684384|FG001|Overall Study|Ineligibility determined|3|||
156980877|NCT00358215|566684383|FG000|Overall Study|Adverse Event|83|||
156980878|NCT00358215|566684384|FG001|Overall Study|Adverse Event|65|||
156980879|NCT00358215|566684383|FG000|Overall Study|Withdrawal by Subject|111|||
156980880|NCT00358215|566684384|FG001|Overall Study|Withdrawal by Subject|102|||
156980881|NCT00358215|566684383|FG000|Overall Study|Participant request|65|||
156980882|NCT00358215|566684384|FG001|Overall Study|Participant request|64|||
156980883|NCT00358215|566684383|FG000|Overall Study|Physician Decision|47|||
156980884|NCT00358215|566684384|FG001|Overall Study|Physician Decision|39|||
156980885|NCT00358215|566684383|FG000|Overall Study|Lost to Follow-up|16|||
156980886|NCT00358215|566684384|FG001|Overall Study|Lost to Follow-up|22|||
156980887|NCT00358215|566684383|FG000|Overall Study|Death|265|||
156980888|NCT00358215|566684384|FG001|Overall Study|Death|281|||
156980889|NCT00358215|566684383|FG000|Overall Study|Protocol Violation|64|||
156980890|NCT00358215|566684384|FG001|Overall Study|Protocol Violation|59|||
156980891|NCT00358215|566684383|FG000|Overall Study|Pregnancy|1|||
156980892|NCT00358215|566684384|FG001|Overall Study|Pregnancy|0|||
156980893|NCT00358215|566684383|FG000|Overall Study|Other|21|||
156980894|NCT00358215|566684384|FG001|Overall Study|Other|14|||
156980895|NCT00358215|566684383|FG000|Overall Study|Did not receive investigational product|2|||
156980896|NCT00358215|566684384|FG001|Overall Study|Did not receive investigational product|3|||
156980897|NCT00744237|566684385|FG000|Overall Study|Lack of Efficacy|1|||
156980898|NCT00744237|566684386|FG001|Overall Study|Lack of Efficacy|1|||
156980899|NCT00744237|566684387|FG002|Overall Study|Lack of Efficacy|0|||
156980900|NCT00744237|566684385|FG000|Overall Study|Withdrawal by Subject|9|||
156980901|NCT00744237|566684386|FG001|Overall Study|Withdrawal by Subject|5|||
156980902|NCT00744237|566684387|FG002|Overall Study|Withdrawal by Subject|3|||
156980903|NCT00744237|566684385|FG000|Overall Study|Lost to Follow-up|1|||
156980904|NCT00744237|566684386|FG001|Overall Study|Lost to Follow-up|1|||
156980905|NCT00744237|566684387|FG002|Overall Study|Lost to Follow-up|1|||
156980906|NCT00744237|566684385|FG000|Overall Study|Protocol Violation|3|||
156980907|NCT00744237|566684386|FG001|Overall Study|Protocol Violation|4|||
156980908|NCT00744237|566684387|FG002|Overall Study|Protocol Violation|3|||
156980909|NCT00744237|566684385|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
156980910|NCT00744237|566684386|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
156980911|NCT00744237|566684387|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
156980912|NCT00744237|566684385|FG000|Overall Study|Dosing Error|1|||
156980913|NCT00744237|566684386|FG001|Overall Study|Dosing Error|0|||
156980914|NCT00744237|566684387|FG002|Overall Study|Dosing Error|1|||
156980915|NCT00744237|566684385|FG000|Overall Study|Study Drug Error|1|||
156980916|NCT00744237|566684386|FG001|Overall Study|Study Drug Error|0|||
156980917|NCT00744237|566684387|FG002|Overall Study|Study Drug Error|0|||
156980918|NCT00744237|566684385|FG000|Overall Study|Prohibited Concomitant Medication|0|||
156980919|NCT00744237|566684386|FG001|Overall Study|Prohibited Concomitant Medication|0|||
156980920|NCT00744237|566684387|FG002|Overall Study|Prohibited Concomitant Medication|1|||
156980921|NCT00744237|566684385|FG000|Overall Study|Poor Compliance|0|||
156980922|NCT00744237|566684386|FG001|Overall Study|Poor Compliance|2|||
156980923|NCT00744237|566684387|FG002|Overall Study|Poor Compliance|0|||
156980924|NCT00744237|566684385|FG000|Overall Study|Administrative. Site Closed|1|||
156980925|NCT00744237|566684386|FG001|Overall Study|Administrative. Site Closed|1|||
156980926|NCT00744237|566684387|FG002|Overall Study|Administrative. Site Closed|1|||
156980927|NCT00744237|566684385|FG000|Overall Study|Adverse Event|9|||
156980928|NCT00744237|566684386|FG001|Overall Study|Adverse Event|13|||
156980929|NCT00744237|566684387|FG002|Overall Study|Adverse Event|5|||
156980930|NCT01868035|566684389|FG000|Overall Study|Lost to Follow-up|3|||
156980931|NCT01868035|566684389|FG000|Overall Study|Withdrawal by Subject|1|||
156980932|NCT01868035|566684389|FG000|Overall Study|Progressive Disease|2|||
156980933|NCT01868035|566684389|FG000|Overall Study|Non-compliance|1|||
156980934|NCT01757665|566684394|FG000|Overall Study|Still on Study - Visit Completed|240|||
156980935|NCT01757665|566684395|FG001|Overall Study|Still on Study - Visit Completed|30|||
156980936|NCT01757665|566684394|FG000|Overall Study|Still on Study - Visit Pending|398|||
156980937|NCT01757665|566684395|FG001|Overall Study|Still on Study - Visit Pending|40|||
156980938|NCT01757665|566684394|FG000|Overall Study|Still on Study - Missed Visit|14|||
156980939|NCT01757665|566684395|FG001|Overall Study|Still on Study - Missed Visit|1|||
156980940|NCT01757665|566684394|FG000|Overall Study|Death|25|||
156980941|NCT01757665|566684395|FG001|Overall Study|Death|8|||
156980942|NCT01757665|566684394|FG000|Overall Study|Explant|1|||
156980943|NCT01757665|566684395|FG001|Overall Study|Explant|2|||
156980944|NCT01757665|566684394|FG000|Overall Study|Withdrawal by Subject|10|||
156980945|NCT01757665|566684395|FG001|Overall Study|Withdrawal by Subject|0|||
156980946|NCT01757665|566684394|FG000|Overall Study|Lost to Follow-up|1|||
156980947|NCT01757665|566684395|FG001|Overall Study|Lost to Follow-up|1|||
156980948|NCT01757665|566684394|FG000|Overall Study|Not Implanted with Device|5|||
156980949|NCT01757665|566684395|FG001|Overall Study|Not Implanted with Device|1|||
156980950|NCT00154063|566684398|FG000|Overall Study|Adverse Event|4|||
156980951|NCT00154063|566684399|FG001|Overall Study|Adverse Event|8|||
156980952|NCT00154063|566684398|FG000|Overall Study|Protocol Violation|1|||
156980953|NCT00154063|566684399|FG001|Overall Study|Protocol Violation|1|||
156980954|NCT00154063|566684398|FG000|Overall Study|Investigator or Sponsor Request|0|||
156980955|NCT00154063|566684399|FG001|Overall Study|Investigator or Sponsor Request|1|||
156980956|NCT00154063|566684398|FG000|Overall Study|Withdrawal by Subject|4|||
156980957|NCT00154063|566684399|FG001|Overall Study|Withdrawal by Subject|9|||
156980958|NCT00154063|566684398|FG000|Overall Study|Other|3|||
156980959|NCT00154063|566684399|FG001|Overall Study|Other|3|||
156980960|NCT01533714|566684400|FG000|Overall Study|Adverse Event|0|||
156980961|NCT01533714|566684401|FG001|Overall Study|Adverse Event|1|||
156980962|NCT01533714|566684402|FG002|Overall Study|Adverse Event|2|||
156980963|NCT01533714|566684403|FG003|Overall Study|Adverse Event|2|||
156980964|NCT01533714|566684404|FG004|Overall Study|Adverse Event|2|||
156980965|NCT01533714|566684405|FG005|Overall Study|Adverse Event|1|||
156980966|NCT01533714|566684400|FG000|Overall Study|Lack of Efficacy|0|||
156980967|NCT01533714|566684401|FG001|Overall Study|Lack of Efficacy|0|||
156980968|NCT01533714|566684402|FG002|Overall Study|Lack of Efficacy|0|||
156980969|NCT01533714|566684403|FG003|Overall Study|Lack of Efficacy|0|||
156980970|NCT01533714|566684404|FG004|Overall Study|Lack of Efficacy|0|||
156980971|NCT01533714|566684405|FG005|Overall Study|Lack of Efficacy|1|||
156980972|NCT01533714|566684400|FG000|Overall Study|Withdrawal by Subject|0|||
156980973|NCT01533714|566684401|FG001|Overall Study|Withdrawal by Subject|1|||
156980974|NCT01533714|566684402|FG002|Overall Study|Withdrawal by Subject|0|||
156980975|NCT01533714|566684403|FG003|Overall Study|Withdrawal by Subject|1|||
156980976|NCT01533714|566684404|FG004|Overall Study|Withdrawal by Subject|1|||
156980977|NCT01533714|566684405|FG005|Overall Study|Withdrawal by Subject|0|||
156980978|NCT01533714|566684400|FG000|Overall Study|Exclusion criteria|0|||
156980979|NCT01533714|566684401|FG001|Overall Study|Exclusion criteria|1|||
156980980|NCT01533714|566684402|FG002|Overall Study|Exclusion criteria|0|||
156980981|NCT01533714|566684403|FG003|Overall Study|Exclusion criteria|0|||
156980982|NCT01533714|566684404|FG004|Overall Study|Exclusion criteria|0|||
156980983|NCT01533714|566684405|FG005|Overall Study|Exclusion criteria|0|||
156980984|NCT01533714|566684400|FG000|Overall Study|Positive for purified protein derivative|0|||
156980985|NCT01533714|566684401|FG001|Overall Study|Positive for purified protein derivative|0|||
156980986|NCT01533714|566684402|FG002|Overall Study|Positive for purified protein derivative|1|||
156980987|NCT01533714|566684403|FG003|Overall Study|Positive for purified protein derivative|0|||
156980988|NCT01533714|566684404|FG004|Overall Study|Positive for purified protein derivative|1|||
156980989|NCT01533714|566684405|FG005|Overall Study|Positive for purified protein derivative|0|||
156980990|NCT01533714|566684400|FG000|Overall Study|Withdrawal criteria|0|||
156980991|NCT01533714|566684401|FG001|Overall Study|Withdrawal criteria|0|||
156980992|NCT01533714|566684402|FG002|Overall Study|Withdrawal criteria|1|||
156980993|NCT01533714|566684403|FG003|Overall Study|Withdrawal criteria|0|||
156980994|NCT01533714|566684404|FG004|Overall Study|Withdrawal criteria|3|||
156980995|NCT01533714|566684405|FG005|Overall Study|Withdrawal criteria|1|||
156980996|NCT01533714|566684400|FG000|Overall Study|Ineligibility reason|0|||
156980997|NCT01533714|566684401|FG001|Overall Study|Ineligibility reason|0|||
156980998|NCT01533714|566684402|FG002|Overall Study|Ineligibility reason|0|||
156980999|NCT01533714|566684403|FG003|Overall Study|Ineligibility reason|1|||
156981000|NCT01533714|566684404|FG004|Overall Study|Ineligibility reason|0|||
156981001|NCT01533714|566684405|FG005|Overall Study|Ineligibility reason|0|||
156981002|NCT02564055|566684406|FG000|Overall Study|Adverse Event|1|||
156981003|NCT02564055|566684407|FG001|Overall Study|Adverse Event|0|||
156981004|NCT02564055|566684408|FG002|Overall Study|Adverse Event|4|||
156981005|NCT02564055|566684409|FG003|Overall Study|Adverse Event|1|||
156981006|NCT02564055|566684410|FG004|Overall Study|Adverse Event|4|||
156981007|NCT02564055|566684411|FG005|Overall Study|Adverse Event|1|||
156981008|NCT02564055|566684406|FG000|Overall Study|Protocol Violation|1|||
156981009|NCT02564055|566684407|FG001|Overall Study|Protocol Violation|0|||
156981010|NCT02564055|566684408|FG002|Overall Study|Protocol Violation|0|||
156981011|NCT02564055|566684409|FG003|Overall Study|Protocol Violation|0|||
156981012|NCT02564055|566684410|FG004|Overall Study|Protocol Violation|0|||
156981013|NCT02564055|566684411|FG005|Overall Study|Protocol Violation|0|||
156981014|NCT02564055|566684406|FG000|Overall Study|Reached stopping criteria|0|||
156981015|NCT02564055|566684407|FG001|Overall Study|Reached stopping criteria|0|||
156981016|NCT02564055|566684408|FG002|Overall Study|Reached stopping criteria|0|||
156981017|NCT02564055|566684409|FG003|Overall Study|Reached stopping criteria|0|||
156981018|NCT02564055|566684410|FG004|Overall Study|Reached stopping criteria|0|||
156981019|NCT02564055|566684411|FG005|Overall Study|Reached stopping criteria|1|||
156981020|NCT02564055|566684406|FG000|Overall Study|Lost to Follow-up|0|||
156981021|NCT02564055|566684407|FG001|Overall Study|Lost to Follow-up|1|||
156981022|NCT02564055|566684408|FG002|Overall Study|Lost to Follow-up|4|||
156981023|NCT02564055|566684409|FG003|Overall Study|Lost to Follow-up|2|||
156981024|NCT02564055|566684410|FG004|Overall Study|Lost to Follow-up|1|||
156981025|NCT02564055|566684411|FG005|Overall Study|Lost to Follow-up|0|||
156981026|NCT02564055|566684406|FG000|Overall Study|Physician Decision|0|||
156981027|NCT02564055|566684407|FG001|Overall Study|Physician Decision|0|||
156981028|NCT02564055|566684408|FG002|Overall Study|Physician Decision|1|||
156981029|NCT02564055|566684409|FG003|Overall Study|Physician Decision|0|||
156981030|NCT02564055|566684410|FG004|Overall Study|Physician Decision|0|||
156981031|NCT02564055|566684411|FG005|Overall Study|Physician Decision|0|||
156981032|NCT02564055|566684406|FG000|Overall Study|Withdrawal by Subject|4|||
156981033|NCT02564055|566684407|FG001|Overall Study|Withdrawal by Subject|4|||
156981034|NCT02564055|566684408|FG002|Overall Study|Withdrawal by Subject|3|||
156981035|NCT02564055|566684409|FG003|Overall Study|Withdrawal by Subject|3|||
156981036|NCT02564055|566684410|FG004|Overall Study|Withdrawal by Subject|10|||
156981037|NCT02564055|566684411|FG005|Overall Study|Withdrawal by Subject|10|||
156981038|NCT04012814|566684415|FG000|Overall Study|Lost to Follow-up|4|||
156981039|NCT04012814|566684415|FG000|Overall Study|Withdrawal by Subject|2|||
156981040|NCT04012814|566684415|FG000|Overall Study|Protocol Violation|1|||
156981041|NCT04012814|566684415|FG000|Overall Study|Adverse Event|1|||
156981042|NCT02572817|566684416|FG000|Overall Study|Death|6|||
156981043|NCT02572817|566684417|FG001|Overall Study|Death|3|||
156981044|NCT02572817|566684416|FG000|Overall Study|Lost to Follow-up|3|||
156981045|NCT02572817|566684417|FG001|Overall Study|Lost to Follow-up|3|||
157095815|NCT00585195|567105459|FG002|Overall Study|Adverse Event|0|||
156981046|NCT02310126|566684419|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
156981047|NCT02310126|566684420|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
156981048|NCT02310126|566684419|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
156981049|NCT02310126|566684420|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
156981050|NCT02441946|566684421|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
156981051|NCT02441946|566684422|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
156981052|NCT02441946|566684423|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
156981053|NCT02441946|566684421|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
156981054|NCT02441946|566684422|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
156981055|NCT02441946|566684423|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
156981056|NCT02441946|566684421|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156981057|NCT02441946|566684422|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
156981058|NCT02441946|566684423|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156981059|NCT02441946|566684421|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
156981060|NCT02441946|566684422|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
156981061|NCT02441946|566684423|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
156981062|NCT02441946|566684421|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
156981063|NCT02441946|566684422|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
156981064|NCT02441946|566684423|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
156981065|NCT02441946|566684421|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
156981066|NCT02441946|566684422|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
156981067|NCT02441946|566684423|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
156981068|NCT02441946|566684421|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
156981069|NCT02441946|566684422|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
156981070|NCT02441946|566684423|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
156981071|NCT02441946|566684421|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
156981072|NCT02441946|566684422|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
156981073|NCT02441946|566684423|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
156981074|NCT02441946|566684421|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
156981075|NCT02441946|566684422|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
156981076|NCT02441946|566684423|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
156981077|NCT02441946|566684421|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
156981078|NCT02441946|566684422|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
156981079|NCT02441946|566684423|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
156981080|NCT02441946|566684421|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
156981081|NCT02441946|566684422|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156981082|NCT02441946|566684423|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156981083|NCT02226172|566684424|FG000|Overall Study|Participant refused further follow-up|4|||
156981084|NCT02226172|566684424|FG000|Overall Study|Other|5|||
156981085|NCT02226172|566684424|FG000|Overall Study|Death|1|||
156981086|NCT02226172|566684424|FG000|Overall Study|Study terminated by sponsor|1|||
156981087|NCT02226172|566684424|FG000|Overall Study|Adverse Event|6|||
156981088|NCT00439179|566684427|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156981089|NCT00439179|566684428|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
156981090|NCT00439179|566684429|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156981091|NCT00439179|566684430|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
156981092|NCT00758160|566684442|FG000|Overall Study|No Longer Requires Study Medication|4|||
156981093|NCT00758160|566684442|FG000|Overall Study|Administration Problems|3|||
156981094|NCT00758160|566684442|FG000|Overall Study|Adverse Event|15|||
156981095|NCT00758160|566684442|FG000|Overall Study|Lack of Efficacy|10|||
156981096|NCT00758160|566684442|FG000|Overall Study|Lost to Follow-up|14|||
156981097|NCT00758160|566684442|FG000|Overall Study|Protocol Violation|12|||
156981098|NCT00758160|566684442|FG000|Overall Study|Withdrawal by Subject|8|||
156981099|NCT00545363|566684443|FG000|Overall Study|Adverse Event|6|||
156981100|NCT00545363|566684444|FG001|Overall Study|Adverse Event|7|||
156981101|NCT00545363|566684443|FG000|Overall Study|Withdrawal by Subject|6|||
156981102|NCT00545363|566684444|FG001|Overall Study|Withdrawal by Subject|5|||
156981103|NCT00545363|566684443|FG000|Overall Study|Non-compliance|3|||
156981104|NCT00545363|566684444|FG001|Overall Study|Non-compliance|1|||
156981105|NCT00545363|566684443|FG000|Overall Study|Did not meet entry criteria|1|||
156981106|NCT00545363|566684444|FG001|Overall Study|Did not meet entry criteria|1|||
156981107|NCT00545363|566684443|FG000|Overall Study|Lost to Follow-up|2|||
156981108|NCT00545363|566684444|FG001|Overall Study|Lost to Follow-up|0|||
156981109|NCT00545363|566684443|FG000|Overall Study|Other|1|||
156981110|NCT00545363|566684444|FG001|Overall Study|Other|1|||
156981111|NCT02153359|566684445|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
157095816|NCT00585195|567105460|FG003|Overall Study|Adverse Event|0|||
157095817|NCT00585195|567105461|FG004|Overall Study|Adverse Event|2|||
157095818|NCT00585195|567105462|FG005|Overall Study|Adverse Event|1|||
157095819|NCT00585195|567105463|FG006|Overall Study|Adverse Event|0|||
157095820|NCT00585195|567105464|FG007|Overall Study|Adverse Event|1|||
157095821|NCT00585195|567105465|FG008|Overall Study|Adverse Event|0|||
157095822|NCT00585195|567105466|FG009|Overall Study|Adverse Event|0|||
157095823|NCT00585195|567105467|FG010|Overall Study|Adverse Event|3|||
157095824|NCT00585195|567105468|FG011|Overall Study|Adverse Event|0|||
157095825|NCT00585195|567105469|FG012|Overall Study|Adverse Event|8|||
157095826|NCT00585195|567105470|FG013|Overall Study|Adverse Event|6|||
157095827|NCT00585195|567105471|FG014|Overall Study|Adverse Event|4|||
157095828|NCT00585195|567105472|FG015|Overall Study|Adverse Event|1|||
157095829|NCT00585195|567105473|FG016|Overall Study|Adverse Event|14|||
157095830|NCT00585195|567105474|FG017|Overall Study|Adverse Event|9|||
157095831|NCT00585195|567105475|FG018|Overall Study|Adverse Event|2|||
157095832|NCT00585195|567105476|FG019|Overall Study|Adverse Event|3|||
157095833|NCT00585195|567105477|FG020|Overall Study|Adverse Event|1|||
157095834|NCT00585195|567105457|FG000|Overall Study|Progressive Disease|2|||
156981112|NCT02153359|566684446|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
156981113|NCT00582491|566684447|FG000|Overall Study|Withdrawal by Subject|1|||
156981114|NCT00582491|566684448|FG001|Overall Study|Withdrawal by Subject|0|||
156981115|NCT04192630|566684449|FG000|Overall Study|Discontinued before surgery|2|||
156981116|NCT04192630|566684450|FG001|Overall Study|Discontinued before surgery|0|||
157095835|NCT00585195|567105458|FG001|Overall Study|Progressive Disease|2|||
157095836|NCT00585195|567105459|FG002|Overall Study|Progressive Disease|5|||
157095837|NCT00585195|567105460|FG003|Overall Study|Progressive Disease|4|||
157095838|NCT00585195|567105461|FG004|Overall Study|Progressive Disease|6|||
157095839|NCT00585195|567105462|FG005|Overall Study|Progressive Disease|4|||
157095840|NCT00585195|567105463|FG006|Overall Study|Progressive Disease|6|||
157095841|NCT00585195|567105464|FG007|Overall Study|Progressive Disease|3|||
157095842|NCT00585195|567105465|FG008|Overall Study|Progressive Disease|0|||
157095843|NCT00585195|567105466|FG009|Overall Study|Progressive Disease|5|||
157095844|NCT00585195|567105467|FG010|Overall Study|Progressive Disease|2|||
157095845|NCT00585195|567105468|FG011|Overall Study|Progressive Disease|25|||
157095846|NCT00585195|567105469|FG012|Overall Study|Progressive Disease|29|||
157095847|NCT00585195|567105470|FG013|Overall Study|Progressive Disease|26|||
157095848|NCT00585195|567105471|FG014|Overall Study|Progressive Disease|21|||
157095849|NCT00585195|567105472|FG015|Overall Study|Progressive Disease|12|||
157095850|NCT00585195|567105473|FG016|Overall Study|Progressive Disease|94|||
157095851|NCT00585195|567105474|FG017|Overall Study|Progressive Disease|42|||
157095852|NCT00585195|567105475|FG018|Overall Study|Progressive Disease|4|||
157095853|NCT00585195|567105476|FG019|Overall Study|Progressive Disease|9|||
157095854|NCT00585195|567105477|FG020|Overall Study|Progressive Disease|8|||
157095855|NCT00585195|567105457|FG000|Overall Study|Withdrawal by Subject|1|||
157095856|NCT00585195|567105458|FG001|Overall Study|Withdrawal by Subject|1|||
157095857|NCT00585195|567105459|FG002|Overall Study|Withdrawal by Subject|2|||
157095858|NCT00585195|567105460|FG003|Overall Study|Withdrawal by Subject|2|||
157095859|NCT00585195|567105461|FG004|Overall Study|Withdrawal by Subject|0|||
157095860|NCT00585195|567105462|FG005|Overall Study|Withdrawal by Subject|0|||
157095861|NCT00585195|567105463|FG006|Overall Study|Withdrawal by Subject|0|||
157095862|NCT00585195|567105464|FG007|Overall Study|Withdrawal by Subject|1|||
157095863|NCT00585195|567105465|FG008|Overall Study|Withdrawal by Subject|0|||
156981117|NCT04192630|566684449|FG000|Overall Study|Discontinued after surgery|5|||
156981118|NCT04192630|566684450|FG001|Overall Study|Discontinued after surgery|3|||
156981119|NCT01193582|566684451|FG000|Vaccination Series|Withdrawal by Subject|11|||
156981120|NCT01193582|566684452|FG001|Vaccination Series|Withdrawal by Subject|13|||
156981121|NCT01193582|566684453|FG002|Vaccination Series|Withdrawal by Subject|8|||
156981122|NCT01193582|566684454|FG003|Vaccination Series|Withdrawal by Subject|3|||
156981123|NCT01193582|566684451|FG000|12 Month Follow-up|Death|0|||
156981124|NCT01193582|566684452|FG001|12 Month Follow-up|Death|0|||
156981125|NCT01193582|566684453|FG002|12 Month Follow-up|Death|1|||
156981126|NCT01193582|566684454|FG003|12 Month Follow-up|Death|0|||
156981127|NCT01193582|566684451|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
156981128|NCT01193582|566684452|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
156981129|NCT01193582|566684453|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
156981130|NCT01193582|566684454|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
156981131|NCT00779584|566684455|FG000|Overall Study|Protocol Violation|0|||
156981132|NCT00779584|566684456|FG001|Overall Study|Protocol Violation|0|||
156981133|NCT00779584|566684457|FG002|Overall Study|Protocol Violation|0|||
156981134|NCT00779584|566684458|FG003|Overall Study|Protocol Violation|0|||
156981135|NCT00779584|566684459|FG004|Overall Study|Protocol Violation|0|||
156981136|NCT00779584|566684460|FG005|Overall Study|Protocol Violation|1|||
156981137|NCT00779584|566684461|FG006|Overall Study|Protocol Violation|0|||
156981138|NCT00779584|566684462|FG007|Overall Study|Protocol Violation|0|||
156981139|NCT00779584|566684463|FG008|Overall Study|Protocol Violation|0|||
156981140|NCT00779584|566684455|FG000|Overall Study|Withdrawal by Subject|1|||
156981141|NCT00779584|566684456|FG001|Overall Study|Withdrawal by Subject|1|||
156981142|NCT00779584|566684457|FG002|Overall Study|Withdrawal by Subject|2|||
156981143|NCT00779584|566684458|FG003|Overall Study|Withdrawal by Subject|0|||
156981144|NCT00779584|566684459|FG004|Overall Study|Withdrawal by Subject|0|||
156981145|NCT00779584|566684460|FG005|Overall Study|Withdrawal by Subject|2|||
156981146|NCT00779584|566684461|FG006|Overall Study|Withdrawal by Subject|1|||
156981147|NCT00779584|566684462|FG007|Overall Study|Withdrawal by Subject|0|||
157095864|NCT00585195|567105466|FG009|Overall Study|Withdrawal by Subject|0|||
157095865|NCT00585195|567105467|FG010|Overall Study|Withdrawal by Subject|3|||
157095866|NCT00585195|567105468|FG011|Overall Study|Withdrawal by Subject|8|||
157095867|NCT00585195|567105469|FG012|Overall Study|Withdrawal by Subject|15|||
157095868|NCT00585195|567105470|FG013|Overall Study|Withdrawal by Subject|0|||
156981148|NCT00779584|566684463|FG008|Overall Study|Withdrawal by Subject|0|||
156981149|NCT00779584|566684455|FG000|Overall Study|Lost to Follow-up|0|||
156981150|NCT00779584|566684456|FG001|Overall Study|Lost to Follow-up|0|||
156981151|NCT00779584|566684457|FG002|Overall Study|Lost to Follow-up|0|||
156981152|NCT00779584|566684458|FG003|Overall Study|Lost to Follow-up|0|||
156981153|NCT00779584|566684459|FG004|Overall Study|Lost to Follow-up|1|||
157095869|NCT00585195|567105471|FG014|Overall Study|Withdrawal by Subject|3|||
157095870|NCT00585195|567105472|FG015|Overall Study|Withdrawal by Subject|0|||
157095871|NCT00585195|567105473|FG016|Overall Study|Withdrawal by Subject|7|||
157095872|NCT00585195|567105474|FG017|Overall Study|Withdrawal by Subject|1|||
157095873|NCT00585195|567105475|FG018|Overall Study|Withdrawal by Subject|2|||
156981154|NCT00779584|566684460|FG005|Overall Study|Lost to Follow-up|0|||
157095874|NCT00585195|567105476|FG019|Overall Study|Withdrawal by Subject|2|||
157095875|NCT00585195|567105477|FG020|Overall Study|Withdrawal by Subject|0|||
157095876|NCT00585195|567105457|FG000|Overall Study|Other|0|||
157095877|NCT00585195|567105458|FG001|Overall Study|Other|1|||
157095878|NCT00585195|567105459|FG002|Overall Study|Other|1|||
157095879|NCT00585195|567105460|FG003|Overall Study|Other|1|||
157095880|NCT00585195|567105461|FG004|Overall Study|Other|0|||
157095881|NCT00585195|567105462|FG005|Overall Study|Other|1|||
157095882|NCT00585195|567105463|FG006|Overall Study|Other|0|||
157095883|NCT00585195|567105464|FG007|Overall Study|Other|0|||
156981155|NCT00779584|566684461|FG006|Overall Study|Lost to Follow-up|0|||
156981156|NCT00779584|566684462|FG007|Overall Study|Lost to Follow-up|0|||
156981157|NCT00779584|566684463|FG008|Overall Study|Lost to Follow-up|0|||
156981158|NCT00779584|566684455|FG000|Overall Study|Progression of Disease|0|||
156981159|NCT00779584|566684456|FG001|Overall Study|Progression of Disease|1|||
156981160|NCT00779584|566684457|FG002|Overall Study|Progression of Disease|2|||
156981161|NCT00779584|566684458|FG003|Overall Study|Progression of Disease|6|||
156981162|NCT00779584|566684459|FG004|Overall Study|Progression of Disease|5|||
156981163|NCT00779584|566684460|FG005|Overall Study|Progression of Disease|1|||
156981164|NCT00779584|566684461|FG006|Overall Study|Progression of Disease|4|||
156981165|NCT00779584|566684462|FG007|Overall Study|Progression of Disease|2|||
156981166|NCT00779584|566684463|FG008|Overall Study|Progression of Disease|1|||
156981167|NCT00779584|566684455|FG000|Overall Study|Adverse Event|1|||
156981168|NCT00779584|566684456|FG001|Overall Study|Adverse Event|0|||
156981169|NCT00779584|566684457|FG002|Overall Study|Adverse Event|2|||
156981170|NCT00779584|566684458|FG003|Overall Study|Adverse Event|0|||
156981171|NCT00779584|566684459|FG004|Overall Study|Adverse Event|0|||
156981172|NCT00779584|566684460|FG005|Overall Study|Adverse Event|0|||
156981173|NCT00779584|566684461|FG006|Overall Study|Adverse Event|2|||
156981174|NCT00779584|566684462|FG007|Overall Study|Adverse Event|1|||
156981175|NCT00779584|566684463|FG008|Overall Study|Adverse Event|1|||
156981176|NCT00779584|566684455|FG000|Overall Study|Symptomatic Deterioration|1|||
156981177|NCT00779584|566684456|FG001|Overall Study|Symptomatic Deterioration|1|||
156981178|NCT00779584|566684457|FG002|Overall Study|Symptomatic Deterioration|1|||
157095884|NCT00585195|567105465|FG008|Overall Study|Other|2|||
156981179|NCT00779584|566684458|FG003|Overall Study|Symptomatic Deterioration|0|||
156981180|NCT00779584|566684459|FG004|Overall Study|Symptomatic Deterioration|0|||
156981181|NCT00779584|566684460|FG005|Overall Study|Symptomatic Deterioration|1|||
156981182|NCT00779584|566684461|FG006|Overall Study|Symptomatic Deterioration|1|||
156981183|NCT00779584|566684462|FG007|Overall Study|Symptomatic Deterioration|0|||
156981184|NCT00779584|566684463|FG008|Overall Study|Symptomatic Deterioration|0|||
156981185|NCT00779584|566684455|FG000|Overall Study|Ongoing in Study|0|||
156981186|NCT00779584|566684456|FG001|Overall Study|Ongoing in Study|0|||
156981187|NCT00779584|566684457|FG002|Overall Study|Ongoing in Study|0|||
156981188|NCT00779584|566684458|FG003|Overall Study|Ongoing in Study|0|||
156981189|NCT00779584|566684459|FG004|Overall Study|Ongoing in Study|1|||
156981190|NCT00779584|566684460|FG005|Overall Study|Ongoing in Study|1|||
156981191|NCT00779584|566684461|FG006|Overall Study|Ongoing in Study|0|||
156981192|NCT00779584|566684462|FG007|Overall Study|Ongoing in Study|0|||
156981193|NCT00779584|566684463|FG008|Overall Study|Ongoing in Study|0|||
156981194|NCT01775930|566684467|FG000|Overall Study|Futility stopping boundary met|1|||
156981195|NCT01208415|566684468|FG000|Overall Study|Death|1|||
156981196|NCT01208415|566684468|FG000|Overall Study|Lost to Follow-up|2|||
156981197|NCT01208415|566684468|FG000|Overall Study|Withdrawal by Subject|3|||
156981198|NCT01208415|566684468|FG000|Overall Study|Device not placed|1|||
156981199|NCT01208415|566684468|FG000|Overall Study|Still be eligible for follow-up|33|||
156981200|NCT03856996|566684469|FG000|Overall Study|Withdrawal by Subject|1|||
156981201|NCT03856996|566684470|FG001|Overall Study|Withdrawal by Subject|0|||
156981202|NCT03856996|566684469|FG000|Overall Study|Lost to Follow-up|0|||
156981203|NCT03856996|566684470|FG001|Overall Study|Lost to Follow-up|1|||
156981204|NCT03856996|566684469|FG000|Overall Study|Adverse Event|1|||
156981205|NCT03856996|566684470|FG001|Overall Study|Adverse Event|1|||
156981206|NCT03856996|566684469|FG000|Overall Study|Other|1|||
156981207|NCT03856996|566684470|FG001|Overall Study|Other|0|||
156981208|NCT01586338|566684471|FG000|Overall Study|Adverse Event|3|||
156981209|NCT01586338|566684471|FG000|Overall Study|Lost to Follow-up|1|||
156981210|NCT01586338|566684471|FG000|Overall Study|Withdrawal by participant|3|||
156981211|NCT01586338|566684471|FG000|Overall Study|Other|1|||
156981212|NCT01868074|566684474|FG000|Overall Study|Lost to Follow-up|3|||
156981213|NCT01868074|566684475|FG001|Overall Study|Lost to Follow-up|2|||
156981214|NCT01868074|566684474|FG000|Overall Study|Withdrawal by Subject|4|||
156981215|NCT01868074|566684475|FG001|Overall Study|Withdrawal by Subject|2|||
156981216|NCT01234649|566684476|FG000|Overall Study|Withdrawal by Subject|32|||
156981217|NCT01234649|566684477|FG001|Overall Study|Withdrawal by Subject|26|||
156981218|NCT01234649|566684476|FG000|Overall Study|Pregnancy|6|||
156981219|NCT01234649|566684477|FG001|Overall Study|Pregnancy|6|||
156981220|NCT01234649|566684476|FG000|Overall Study|intolerant to side effects|4|||
156981221|NCT01234649|566684477|FG001|Overall Study|intolerant to side effects|3|||
156981222|NCT01234649|566684476|FG000|Overall Study|Allergic reaction|1|||
156981223|NCT01234649|566684477|FG001|Overall Study|Allergic reaction|0|||
156981224|NCT01234649|566684476|FG000|Overall Study|Lack of Efficacy|0|||
156981225|NCT01234649|566684477|FG001|Overall Study|Lack of Efficacy|3|||
156981226|NCT00680056|566684480|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
156981227|NCT00680056|566684481|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
156981228|NCT00680056|566684480|FG000|Second Intervention|Protocol Violation|3|||
156981229|NCT00680056|566684481|FG001|Second Intervention|Protocol Violation|1|||
156981230|NCT04175912|566684487|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
156981231|NCT04175912|566684488|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
156981232|NCT04175912|566684487|FG000|Overall Study|Adverse Event|0|||
156981233|NCT04175912|566684488|FG001|Overall Study|Adverse Event|3|||
156981234|NCT04175912|566684487|FG000|Overall Study|Never started treatment|3|||
156981235|NCT04175912|566684488|FG001|Overall Study|Never started treatment|3|||
156981236|NCT04175912|566684487|FG000|Overall Study|Death|0|||
156981237|NCT04175912|566684488|FG001|Overall Study|Death|1|||
156981238|NCT01155661|566684489|FG000|Overall Study|Adverse Event|101|||
156981239|NCT01155661|566684489|FG000|Overall Study|Death|1|||
156981240|NCT01155661|566684489|FG000|Overall Study|Lack of Efficacy|32|||
156981241|NCT01155661|566684489|FG000|Overall Study|Lost to Follow-up|22|||
156981242|NCT01155661|566684489|FG000|Overall Study|Physician Decision|3|||
156981243|NCT01155661|566684489|FG000|Overall Study|Protocol Violation|35|||
156981244|NCT01155661|566684489|FG000|Overall Study|Withdrawal by Subject|73|||
156981245|NCT01155661|566684489|FG000|Overall Study|Sponsor Decision|13|||
156981246|NCT05064735|566684490|FG000|Overall Study|Withdrawal by Subject|7|||
156981247|NCT05064735|566684491|FG001|Overall Study|Withdrawal by Subject|8|||
156981248|NCT05064735|566684490|FG000|Overall Study|Lost to Follow-up|7|||
156981249|NCT05064735|566684491|FG001|Overall Study|Lost to Follow-up|2|||
156981250|NCT05064735|566684490|FG000|Overall Study|Physician Decision|2|||
156981251|NCT05064735|566684491|FG001|Overall Study|Physician Decision|1|||
156981252|NCT05064735|566684490|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
156981253|NCT05064735|566684491|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
156981254|NCT05064735|566684490|FG000|Overall Study|Site Closure|7|||
156981255|NCT05064735|566684491|FG001|Overall Study|Site Closure|2|||
156981256|NCT04844970|566684492|FG000|Overall Study|Adverse Event|0|||
156981257|NCT04844970|566684493|FG001|Overall Study|Adverse Event|1|||
156981258|NCT04844970|566684492|FG000|Overall Study|Withdrawal by Subject|2|||
156981259|NCT04844970|566684493|FG001|Overall Study|Withdrawal by Subject|0|||
156981260|NCT00447954|566684494|FG000|Overall Study|Adverse Event|0|||
156981261|NCT00447954|566684495|FG001|Overall Study|Adverse Event|2|||
156981262|NCT00447954|566684496|FG002|Overall Study|Adverse Event|0|||
156981263|NCT00447954|566684494|FG000|Overall Study|Withdrawal by Subject|0|||
156981264|NCT00447954|566684495|FG001|Overall Study|Withdrawal by Subject|1|||
156981265|NCT00447954|566684496|FG002|Overall Study|Withdrawal by Subject|1|||
156981266|NCT00447954|566684494|FG000|Overall Study|Lost to Follow-up|0|||
156981267|NCT00447954|566684495|FG001|Overall Study|Lost to Follow-up|1|||
156981268|NCT00447954|566684496|FG002|Overall Study|Lost to Follow-up|0|||
156981269|NCT00447954|566684494|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
156981270|NCT00447954|566684495|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
156981271|NCT00447954|566684496|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
156981272|NCT02460263|566684497|FG000|Transition Period|Withdrawal by Subject|1|||
156981273|NCT02460263|566684497|FG000|Transition Period|Death|1|||
156981274|NCT03797326|566684503|FG000|Overall Study|Lost to Follow-up|1|||
156981275|NCT03797326|566684504|FG001|Overall Study|Lost to Follow-up|0|||
156981276|NCT03797326|566684505|FG002|Overall Study|Lost to Follow-up|0|||
156981277|NCT03797326|566684506|FG003|Overall Study|Lost to Follow-up|1|||
156981278|NCT03797326|566684507|FG004|Overall Study|Lost to Follow-up|0|||
156981279|NCT03797326|566684508|FG005|Overall Study|Lost to Follow-up|0|||
156981280|NCT03797326|566684509|FG006|Overall Study|Lost to Follow-up|0|||
156981281|NCT03797326|566684510|FG007|Overall Study|Lost to Follow-up|0|||
156981282|NCT03797326|566684503|FG000|Overall Study|Withdrawal by Subject|0|||
156981283|NCT03797326|566684504|FG001|Overall Study|Withdrawal by Subject|0|||
156981284|NCT03797326|566684505|FG002|Overall Study|Withdrawal by Subject|1|||
156981285|NCT03797326|566684506|FG003|Overall Study|Withdrawal by Subject|3|||
156981286|NCT03797326|566684507|FG004|Overall Study|Withdrawal by Subject|0|||
156981287|NCT03797326|566684508|FG005|Overall Study|Withdrawal by Subject|2|||
156981288|NCT03797326|566684509|FG006|Overall Study|Withdrawal by Subject|2|||
156981289|NCT03797326|566684510|FG007|Overall Study|Withdrawal by Subject|3|||
156981290|NCT03797326|566684503|FG000|Overall Study|Sponsor Decision|3|||
156981291|NCT03797326|566684504|FG001|Overall Study|Sponsor Decision|3|||
156981292|NCT03797326|566684505|FG002|Overall Study|Sponsor Decision|3|||
156981293|NCT03797326|566684506|FG003|Overall Study|Sponsor Decision|6|||
156981294|NCT03797326|566684507|FG004|Overall Study|Sponsor Decision|0|||
156981295|NCT03797326|566684508|FG005|Overall Study|Sponsor Decision|3|||
156981296|NCT03797326|566684509|FG006|Overall Study|Sponsor Decision|3|||
156981297|NCT03797326|566684510|FG007|Overall Study|Sponsor Decision|2|||
156981298|NCT03797326|566684503|FG000|Overall Study|Death|27|||
156981299|NCT03797326|566684504|FG001|Overall Study|Death|28|||
156981300|NCT03797326|566684505|FG002|Overall Study|Death|95|||
156981301|NCT03797326|566684506|FG003|Overall Study|Death|95|||
156981302|NCT03797326|566684507|FG004|Overall Study|Death|30|||
156981303|NCT03797326|566684508|FG005|Overall Study|Death|96|||
156981304|NCT03797326|566684509|FG006|Overall Study|Death|97|||
156981305|NCT03797326|566684510|FG007|Overall Study|Death|98|||
156981306|NCT03797326|566684503|FG000|Overall Study|Enrolled in error|0|||
156981307|NCT03797326|566684504|FG001|Overall Study|Enrolled in error|0|||
156981308|NCT03797326|566684505|FG002|Overall Study|Enrolled in error|3|||
156981309|NCT03797326|566684506|FG003|Overall Study|Enrolled in error|2|||
156981310|NCT03797326|566684507|FG004|Overall Study|Enrolled in error|2|||
156981311|NCT03797326|566684508|FG005|Overall Study|Enrolled in error|1|||
156981312|NCT03797326|566684509|FG006|Overall Study|Enrolled in error|1|||
156981313|NCT03797326|566684510|FG007|Overall Study|Enrolled in error|0|||
156981314|NCT03757234|566684515|FG000|Overall Study|Adverse Event|0|||
156981315|NCT03757234|566684516|FG001|Overall Study|Adverse Event|0|||
156981316|NCT03757234|566684517|FG002|Overall Study|Adverse Event|0|||
156981317|NCT03757234|566684518|FG003|Overall Study|Adverse Event|0|||
156981318|NCT03757234|566684519|FG004|Overall Study|Adverse Event|1|||
156981319|NCT03757234|566684515|FG000|Overall Study|Lost to Follow-up|1|||
156981320|NCT03757234|566684516|FG001|Overall Study|Lost to Follow-up|0|||
156981321|NCT03757234|566684517|FG002|Overall Study|Lost to Follow-up|0|||
156981322|NCT03757234|566684518|FG003|Overall Study|Lost to Follow-up|0|||
156981323|NCT03757234|566684519|FG004|Overall Study|Lost to Follow-up|1|||
156981324|NCT03757234|566684515|FG000|Overall Study|Withdrawal by Subject|1|||
156981325|NCT03757234|566684516|FG001|Overall Study|Withdrawal by Subject|1|||
156981326|NCT03757234|566684517|FG002|Overall Study|Withdrawal by Subject|0|||
156981327|NCT03757234|566684518|FG003|Overall Study|Withdrawal by Subject|1|||
156981328|NCT03757234|566684519|FG004|Overall Study|Withdrawal by Subject|2|||
156981329|NCT03757234|566684515|FG000|Overall Study|Other|1|||
156981330|NCT03757234|566684516|FG001|Overall Study|Other|1|||
156981331|NCT03757234|566684517|FG002|Overall Study|Other|0|||
156981332|NCT03757234|566684518|FG003|Overall Study|Other|0|||
156981333|NCT03757234|566684519|FG004|Overall Study|Other|0|||
156981334|NCT02998021|566684523|FG000|Overall Study|Withdrawal by Subject|3|||
156981335|NCT02998021|566684524|FG001|Overall Study|Withdrawal by Subject|1|||
156981336|NCT02998021|566684523|FG000|Overall Study|unsafe home|0|||
156981337|NCT02998021|566684524|FG001|Overall Study|unsafe home|1|||
156981338|NCT02961374|566684525|FG000|Overall Study|Adverse Event|4|||
156981339|NCT02041923|566684526|FG000|Overall Study|Lost to Follow-up|26|||
156981340|NCT02041923|566684527|FG001|Overall Study|Lost to Follow-up|30|||
156981341|NCT00309608|566684532|FG000|Overall Study|Adverse Event|1|||
156981342|NCT00309608|566684533|FG001|Overall Study|Adverse Event|5|||
156981343|NCT00309608|566684534|FG002|Overall Study|Adverse Event|3|||
156981344|NCT00309608|566684535|FG003|Overall Study|Adverse Event|2|||
156981345|NCT00309608|566684536|FG004|Overall Study|Adverse Event|3|||
156981346|NCT00309608|566684532|FG000|Overall Study|Protocol Violation|2|||
156981347|NCT00309608|566684533|FG001|Overall Study|Protocol Violation|0|||
156981348|NCT00309608|566684534|FG002|Overall Study|Protocol Violation|0|||
156981349|NCT00309608|566684535|FG003|Overall Study|Protocol Violation|0|||
156981350|NCT00309608|566684536|FG004|Overall Study|Protocol Violation|0|||
156981351|NCT00309608|566684532|FG000|Overall Study|Lost to Follow-up|0|||
156981352|NCT00309608|566684533|FG001|Overall Study|Lost to Follow-up|0|||
156981353|NCT00309608|566684534|FG002|Overall Study|Lost to Follow-up|2|||
156981354|NCT00309608|566684535|FG003|Overall Study|Lost to Follow-up|0|||
156981355|NCT00309608|566684536|FG004|Overall Study|Lost to Follow-up|1|||
156981356|NCT00309608|566684532|FG000|Overall Study|Withdrawal by Subject|1|||
156981357|NCT00309608|566684533|FG001|Overall Study|Withdrawal by Subject|4|||
156981358|NCT00309608|566684534|FG002|Overall Study|Withdrawal by Subject|2|||
156981359|NCT00309608|566684535|FG003|Overall Study|Withdrawal by Subject|0|||
156981360|NCT00309608|566684536|FG004|Overall Study|Withdrawal by Subject|0|||
156981361|NCT00309608|566684532|FG000|Overall Study|Other incl. Lack of efficacy|10|||
156981362|NCT00309608|566684533|FG001|Overall Study|Other incl. Lack of efficacy|4|||
156981363|NCT00309608|566684534|FG002|Overall Study|Other incl. Lack of efficacy|3|||
156981364|NCT00309608|566684535|FG003|Overall Study|Other incl. Lack of efficacy|4|||
156981365|NCT00309608|566684536|FG004|Overall Study|Other incl. Lack of efficacy|0|||
157095885|NCT00585195|567105466|FG009|Overall Study|Other|1|||
157095886|NCT00585195|567105467|FG010|Overall Study|Other|0|||
157095887|NCT00585195|567105468|FG011|Overall Study|Other|19|||
157095888|NCT00585195|567105469|FG012|Overall Study|Other|24|||
157095889|NCT00585195|567105470|FG013|Overall Study|Other|7|||
157095890|NCT00585195|567105471|FG014|Overall Study|Other|11|||
157095891|NCT00585195|567105472|FG015|Overall Study|Other|3|||
157095892|NCT00585195|567105473|FG016|Overall Study|Other|28|||
157095893|NCT00585195|567105474|FG017|Overall Study|Other|12|||
157095894|NCT00585195|567105475|FG018|Overall Study|Other|10|||
157095895|NCT00585195|567105476|FG019|Overall Study|Other|4|||
157095896|NCT00585195|567105477|FG020|Overall Study|Other|2|||
157095897|NCT00585195|567105457|FG000|Overall Study|Randomized not treated|0|||
157095898|NCT00585195|567105458|FG001|Overall Study|Randomized not treated|0|||
157095899|NCT00585195|567105459|FG002|Overall Study|Randomized not treated|1|||
157095900|NCT00585195|567105460|FG003|Overall Study|Randomized not treated|0|||
157095901|NCT00585195|567105461|FG004|Overall Study|Randomized not treated|1|||
157095902|NCT00585195|567105462|FG005|Overall Study|Randomized not treated|0|||
157095903|NCT00585195|567105463|FG006|Overall Study|Randomized not treated|1|||
157095904|NCT00585195|567105464|FG007|Overall Study|Randomized not treated|0|||
157095905|NCT00585195|567105465|FG008|Overall Study|Randomized not treated|0|||
157095906|NCT00585195|567105466|FG009|Overall Study|Randomized not treated|0|||
157095907|NCT00585195|567105467|FG010|Overall Study|Randomized not treated|2|||
157095908|NCT00585195|567105468|FG011|Overall Study|Randomized not treated|0|||
157095909|NCT00585195|567105469|FG012|Overall Study|Randomized not treated|0|||
157095910|NCT00585195|567105470|FG013|Overall Study|Randomized not treated|0|||
157095911|NCT00585195|567105471|FG014|Overall Study|Randomized not treated|0|||
157095912|NCT00585195|567105472|FG015|Overall Study|Randomized not treated|1|||
157095913|NCT00585195|567105473|FG016|Overall Study|Randomized not treated|0|||
157095914|NCT00585195|567105474|FG017|Overall Study|Randomized not treated|1|||
157095915|NCT00585195|567105475|FG018|Overall Study|Randomized not treated|3|||
157095916|NCT00585195|567105476|FG019|Overall Study|Randomized not treated|0|||
156981366|NCT00621296|566684543|FG000|Overall Study|Adverse Event|2|||
156981367|NCT00621296|566684543|FG000|Overall Study|Lack of Efficacy|1|||
157095917|NCT00585195|567105477|FG020|Overall Study|Randomized not treated|2|||
157095918|NCT00585195|567105457|FG000|Overall Study|Death|0|||
157095919|NCT00585195|567105458|FG001|Overall Study|Death|0|||
157095920|NCT00585195|567105459|FG002|Overall Study|Death|0|||
157095921|NCT00585195|567105460|FG003|Overall Study|Death|0|||
157095922|NCT00585195|567105461|FG004|Overall Study|Death|0|||
157095923|NCT00585195|567105462|FG005|Overall Study|Death|0|||
157095924|NCT00585195|567105463|FG006|Overall Study|Death|0|||
157095925|NCT00585195|567105464|FG007|Overall Study|Death|0|||
157095926|NCT00585195|567105465|FG008|Overall Study|Death|1|||
156981368|NCT00621296|566684543|FG000|Overall Study|Physician Decision|7|||
156981369|NCT00621296|566684543|FG000|Overall Study|Unmatch Criteria|1|||
156981370|NCT00621296|566684543|FG000|Overall Study|Stopping Criteria|3|||
157095927|NCT00585195|567105466|FG009|Overall Study|Death|0|||
157095928|NCT00585195|567105467|FG010|Overall Study|Death|1|||
156981371|NCT00127413|566684544|FG000|Overall Study|Lost to Follow-up|6|||
156981372|NCT00127413|566684545|FG001|Overall Study|Lost to Follow-up|4|||
156981373|NCT00127413|566684546|FG002|Overall Study|Lost to Follow-up|8|||
156981374|NCT00127413|566684547|FG003|Overall Study|Lost to Follow-up|2|||
156981375|NCT01051063|566684548|FG000|Overall Study|Death|2|||
156981376|NCT01051063|566684549|FG001|Overall Study|Death|2|||
156981377|NCT01051063|566684548|FG000|Overall Study|Withdrawal by Subject|1|||
156981378|NCT01051063|566684549|FG001|Overall Study|Withdrawal by Subject|1|||
156981379|NCT01051063|566684548|FG000|Overall Study|Termination of the study|5|||
156981380|NCT01051063|566684549|FG001|Overall Study|Termination of the study|0|||
156981381|NCT01051063|566684548|FG000|Overall Study|Moved from the study site area|1|||
156981382|NCT01051063|566684549|FG001|Overall Study|Moved from the study site area|0|||
156981383|NCT01051063|566684548|FG000|Overall Study|Other|1|||
156981384|NCT01051063|566684549|FG001|Overall Study|Other|0|||
156981385|NCT01051063|566684548|FG000|Overall Study|Lost to Follow-up|0|||
156981386|NCT01051063|566684549|FG001|Overall Study|Lost to Follow-up|1|||
156981387|NCT00874432|566684552|FG000|Overall Study|Withdrawal by Subject|1|||
156981388|NCT00874432|566684553|FG001|Overall Study|Withdrawal by Subject|0|||
156981389|NCT00874432|566684554|FG002|Overall Study|Withdrawal by Subject|0|||
156981390|NCT00874432|566684555|FG003|Overall Study|Withdrawal by Subject|0|||
156981391|NCT00874432|566684552|FG000|Overall Study|Physician Decision|1|||
156981392|NCT00874432|566684553|FG001|Overall Study|Physician Decision|0|||
156981393|NCT00874432|566684554|FG002|Overall Study|Physician Decision|0|||
156981394|NCT00874432|566684555|FG003|Overall Study|Physician Decision|0|||
156981395|NCT00874432|566684552|FG000|Overall Study|Other|1|||
156981396|NCT00874432|566684553|FG001|Overall Study|Other|2|||
156981397|NCT00874432|566684554|FG002|Overall Study|Other|8|||
156981398|NCT00874432|566684555|FG003|Overall Study|Other|3|||
156981399|NCT00445601|566686309|FG000|Overall Study|Withdrawal by Subject|11|||
156981400|NCT00445601|566686310|FG001|Overall Study|Withdrawal by Subject|11|||
156981401|NCT00445601|566686309|FG000|Overall Study|TURBT Complication|12|||
156981402|NCT00445601|566686310|FG001|Overall Study|TURBT Complication|8|||
156981403|NCT00445601|566686309|FG000|Overall Study|Incorrect Disease Status|6|||
156981404|NCT00445601|566686310|FG001|Overall Study|Incorrect Disease Status|6|||
156981405|NCT00445601|566686309|FG000|Overall Study|Drug Delivery Issue|2|||
156981406|NCT00445601|566686310|FG001|Overall Study|Drug Delivery Issue|2|||
156981407|NCT00445601|566686309|FG000|Overall Study|Adverse Event|2|||
156981408|NCT00445601|566686310|FG001|Overall Study|Adverse Event|0|||
156981409|NCT00445601|566686309|FG000|Overall Study|Death prior to TURBT|0|||
156981410|NCT00445601|566686310|FG001|Overall Study|Death prior to TURBT|1|||
156981411|NCT03918239|566686311|FG000|Overall Study|Lost to Follow-up|3|||
156981412|NCT03918239|566686312|FG001|Overall Study|Lost to Follow-up|1|||
156981413|NCT03918239|566686311|FG000|Overall Study|Pregnancy|0|||
156981414|NCT03918239|566686312|FG001|Overall Study|Pregnancy|2|||
156981415|NCT03918239|566686311|FG000|Overall Study|Withdrawal by Subject|3|||
156981416|NCT03918239|566686312|FG001|Overall Study|Withdrawal by Subject|3|||
156981417|NCT03918239|566686311|FG000|Overall Study|positive urine drug screening results|4|||
156981418|NCT03918239|566686312|FG001|Overall Study|positive urine drug screening results|1|||
156981419|NCT01984424|566686315|FG000|Overall Study|Withdrawal by Subject|3|||
156981420|NCT01984424|566686316|FG001|Overall Study|Withdrawal by Subject|5|||
156981421|NCT01984424|566686315|FG000|Overall Study|Sponsor Decision|0|||
156981422|NCT01984424|566686316|FG001|Overall Study|Sponsor Decision|1|||
156981423|NCT01984424|566686315|FG000|Overall Study|Lost to Follow-up|0|||
156981424|NCT01984424|566686316|FG001|Overall Study|Lost to Follow-up|1|||
156981425|NCT06017999|566686317|FG000|Overall Study|Withdrawal by Subject|0|||
156981426|NCT06017999|566686318|FG001|Overall Study|Withdrawal by Subject|4|||
156981427|NCT06017999|566686319|FG002|Overall Study|Withdrawal by Subject|3|||
156981428|NCT06017999|566686317|FG000|Overall Study|Adverse Event|2|||
156981429|NCT06017999|566686318|FG001|Overall Study|Adverse Event|1|||
156981430|NCT06017999|566686319|FG002|Overall Study|Adverse Event|1|||
156981431|NCT06017999|566686317|FG000|Overall Study|Lost to Follow-up|0|||
156981432|NCT06017999|566686318|FG001|Overall Study|Lost to Follow-up|0|||
156981433|NCT06017999|566686319|FG002|Overall Study|Lost to Follow-up|1|||
156981434|NCT06017999|566686317|FG000|Overall Study|Physician Decision|1|||
157095929|NCT00585195|567105468|FG011|Overall Study|Death|1|||
157095930|NCT00585195|567105469|FG012|Overall Study|Death|7|||
156981435|NCT06017999|566686318|FG001|Overall Study|Physician Decision|1|||
156981436|NCT06017999|566686319|FG002|Overall Study|Physician Decision|0|||
156981437|NCT06017999|566686317|FG000|Overall Study|Non-Compliance|0|||
156981438|NCT06017999|566686318|FG001|Overall Study|Non-Compliance|0|||
156981439|NCT06017999|566686319|FG002|Overall Study|Non-Compliance|1|||
156981440|NCT06017999|566686317|FG000|Overall Study|Lack of Efficacy|1|||
156981441|NCT06017999|566686318|FG001|Overall Study|Lack of Efficacy|0|||
156981442|NCT06017999|566686319|FG002|Overall Study|Lack of Efficacy|7|||
157095931|NCT00585195|567105470|FG013|Overall Study|Death|2|||
156981443|NCT06017999|566686317|FG000|Overall Study|COVID Positive|0|||
156981444|NCT06017999|566686318|FG001|Overall Study|COVID Positive|1|||
156981445|NCT06017999|566686319|FG002|Overall Study|COVID Positive|0|||
156981446|NCT06017999|566686317|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
156981447|NCT06017999|566686318|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
156981448|NCT06017999|566686319|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
156981449|NCT00373295|566686320|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156981450|NCT00373295|566686321|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
156981451|NCT00373295|566686322|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156981452|NCT00373295|566686323|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156981453|NCT00373295|566686324|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
156981454|NCT00373295|566686325|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
156981455|NCT01702428|566686333|FG000|Overall Study|Adverse Event|2|||
156981456|NCT01702428|566686334|FG001|Overall Study|Adverse Event|0|||
156981457|NCT01702428|566686335|FG002|Overall Study|Adverse Event|0|||
156981458|NCT01702428|566686336|FG003|Overall Study|Adverse Event|0|||
156981459|NCT01702428|566686333|FG000|Overall Study|Lost to Follow-up|33|||
156981460|NCT01702428|566686334|FG001|Overall Study|Lost to Follow-up|41|||
156981461|NCT01702428|566686335|FG002|Overall Study|Lost to Follow-up|37|||
156981462|NCT01702428|566686336|FG003|Overall Study|Lost to Follow-up|44|||
156981463|NCT01702428|566686333|FG000|Overall Study|Parents cannot assist to site|1|||
156981464|NCT01702428|566686334|FG001|Overall Study|Parents cannot assist to site|0|||
156981465|NCT01702428|566686335|FG002|Overall Study|Parents cannot assist to site|1|||
156981466|NCT01702428|566686336|FG003|Overall Study|Parents cannot assist to site|0|||
156981467|NCT01702428|566686333|FG000|Overall Study|Lost Coverage|0|||
156981468|NCT01702428|566686334|FG001|Overall Study|Lost Coverage|0|||
156981469|NCT01702428|566686335|FG002|Overall Study|Lost Coverage|0|||
156981470|NCT01702428|566686336|FG003|Overall Study|Lost Coverage|1|||
156981471|NCT01702428|566686333|FG000|Overall Study|Lost Health Plan|3|||
156981472|NCT01702428|566686334|FG001|Overall Study|Lost Health Plan|5|||
156981473|NCT01702428|566686335|FG002|Overall Study|Lost Health Plan|0|||
156981474|NCT01702428|566686336|FG003|Overall Study|Lost Health Plan|2|||
156981475|NCT01702428|566686333|FG000|Overall Study|Mother transferred care|0|||
156981476|NCT01702428|566686334|FG001|Overall Study|Mother transferred care|1|||
156981477|NCT01702428|566686335|FG002|Overall Study|Mother transferred care|0|||
156981478|NCT01702428|566686336|FG003|Overall Study|Mother transferred care|0|||
156981479|NCT01702428|566686333|FG000|Overall Study|Parents too busy|1|||
156981480|NCT01702428|566686334|FG001|Overall Study|Parents too busy|0|||
157095932|NCT00585195|567105471|FG014|Overall Study|Death|8|||
157095933|NCT00585195|567105472|FG015|Overall Study|Death|2|||
157095934|NCT00585195|567105473|FG016|Overall Study|Death|11|||
157095935|NCT00585195|567105474|FG017|Overall Study|Death|0|||
157095936|NCT00585195|567105475|FG018|Overall Study|Death|0|||
157095937|NCT00585195|567105476|FG019|Overall Study|Death|0|||
157095938|NCT00585195|567105477|FG020|Overall Study|Death|1|||
157095939|NCT00585195|567105457|FG000|Overall Study|Lost to Follow-up|0|||
157095940|NCT00585195|567105458|FG001|Overall Study|Lost to Follow-up|0|||
157095941|NCT00585195|567105459|FG002|Overall Study|Lost to Follow-up|0|||
157095942|NCT00585195|567105460|FG003|Overall Study|Lost to Follow-up|0|||
157095943|NCT00585195|567105461|FG004|Overall Study|Lost to Follow-up|0|||
157095944|NCT00585195|567105462|FG005|Overall Study|Lost to Follow-up|0|||
157095945|NCT00585195|567105463|FG006|Overall Study|Lost to Follow-up|0|||
157095946|NCT00585195|567105464|FG007|Overall Study|Lost to Follow-up|0|||
157095947|NCT00585195|567105465|FG008|Overall Study|Lost to Follow-up|0|||
157095948|NCT00585195|567105466|FG009|Overall Study|Lost to Follow-up|0|||
157095949|NCT00585195|567105467|FG010|Overall Study|Lost to Follow-up|0|||
157095950|NCT00585195|567105468|FG011|Overall Study|Lost to Follow-up|0|||
157095951|NCT00585195|567105469|FG012|Overall Study|Lost to Follow-up|1|||
157095952|NCT00585195|567105470|FG013|Overall Study|Lost to Follow-up|0|||
157095953|NCT00585195|567105471|FG014|Overall Study|Lost to Follow-up|0|||
157095954|NCT00585195|567105472|FG015|Overall Study|Lost to Follow-up|0|||
157095955|NCT00585195|567105473|FG016|Overall Study|Lost to Follow-up|0|||
157095956|NCT00585195|567105474|FG017|Overall Study|Lost to Follow-up|2|||
157095957|NCT00585195|567105475|FG018|Overall Study|Lost to Follow-up|0|||
157095958|NCT00585195|567105476|FG019|Overall Study|Lost to Follow-up|0|||
157095959|NCT00585195|567105477|FG020|Overall Study|Lost to Follow-up|0|||
157095960|NCT00585195|567105457|FG000|Overall Study|Site Terminated by Sponsor|0|||
157095961|NCT00585195|567105458|FG001|Overall Study|Site Terminated by Sponsor|0|||
157095962|NCT00585195|567105459|FG002|Overall Study|Site Terminated by Sponsor|0|||
156981481|NCT01702428|566686335|FG002|Overall Study|Parents too busy|0|||
156981482|NCT01702428|566686336|FG003|Overall Study|Parents too busy|0|||
156981483|NCT01702428|566686333|FG000|Overall Study|Protocol Violation|3|||
156981484|NCT01702428|566686334|FG001|Overall Study|Protocol Violation|0|||
156981485|NCT01702428|566686335|FG002|Overall Study|Protocol Violation|1|||
156981486|NCT01702428|566686336|FG003|Overall Study|Protocol Violation|0|||
156981487|NCT01702428|566686333|FG000|Overall Study|Withdrawal by Subject|21|||
157095963|NCT00585195|567105460|FG003|Overall Study|Site Terminated by Sponsor|0|||
157095964|NCT00585195|567105461|FG004|Overall Study|Site Terminated by Sponsor|0|||
157095965|NCT00585195|567105462|FG005|Overall Study|Site Terminated by Sponsor|0|||
157095966|NCT00585195|567105463|FG006|Overall Study|Site Terminated by Sponsor|0|||
157095967|NCT00585195|567105464|FG007|Overall Study|Site Terminated by Sponsor|0|||
157095968|NCT00585195|567105465|FG008|Overall Study|Site Terminated by Sponsor|0|||
156981488|NCT01702428|566686334|FG001|Overall Study|Withdrawal by Subject|23|||
156981489|NCT01702428|566686335|FG002|Overall Study|Withdrawal by Subject|14|||
157095969|NCT00585195|567105466|FG009|Overall Study|Site Terminated by Sponsor|0|||
156981490|NCT01702428|566686336|FG003|Overall Study|Withdrawal by Subject|10|||
156981491|NCT02091869|566686337|FG000|Overall Study|Withdrawal by Subject|0|||
156981492|NCT02091869|566686338|FG001|Overall Study|Withdrawal by Subject|3|||
156981493|NCT01375959|566686340|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
156981494|NCT01375959|566686341|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
156981495|NCT01375959|566686340|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156981496|NCT01375959|566686341|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
156981497|NCT01375959|566686340|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156981498|NCT01375959|566686341|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
156981499|NCT04789577|566686342|FG000|Overall Study|Withdrawal by Subject|1|||
156981500|NCT04789577|566686343|FG001|Overall Study|Withdrawal by Subject|1|||
156981501|NCT04789577|566686344|FG002|Overall Study|Withdrawal by Subject|1|||
156981502|NCT04789577|566686345|FG003|Overall Study|Withdrawal by Subject|3|||
156981503|NCT04789577|566686346|FG004|Overall Study|Withdrawal by Subject|1|||
156981504|NCT04789577|566686347|FG005|Overall Study|Withdrawal by Subject|7|||
156981505|NCT04789577|566686348|FG006|Overall Study|Withdrawal by Subject|1|||
156981506|NCT04789577|566686342|FG000|Overall Study|Lost to Follow-up|7|||
156981507|NCT04789577|566686343|FG001|Overall Study|Lost to Follow-up|12|||
156981508|NCT04789577|566686344|FG002|Overall Study|Lost to Follow-up|7|||
156981509|NCT04789577|566686345|FG003|Overall Study|Lost to Follow-up|10|||
156981510|NCT04789577|566686346|FG004|Overall Study|Lost to Follow-up|8|||
156981511|NCT04789577|566686347|FG005|Overall Study|Lost to Follow-up|6|||
156981512|NCT04789577|566686348|FG006|Overall Study|Lost to Follow-up|10|||
156981513|NCT04789577|566686342|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
156981514|NCT04789577|566686343|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
156981515|NCT04789577|566686344|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
156981516|NCT04789577|566686345|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
156981517|NCT04789577|566686346|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
156981518|NCT04789577|566686347|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
156981519|NCT04789577|566686348|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
156981520|NCT04789577|566686342|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
156981521|NCT04789577|566686343|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
156981522|NCT04789577|566686344|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
156981523|NCT04789577|566686345|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
156981524|NCT04789577|566686346|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
156981525|NCT04789577|566686347|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
156981526|NCT04789577|566686348|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
156981527|NCT01027364|566686349|FG000|Overall Study|Adverse Event|1|||
156981528|NCT01027364|566686350|FG001|Overall Study|Adverse Event|0|||
156981529|NCT01027364|566686351|FG002|Overall Study|Adverse Event|1|||
156981530|NCT01027364|566686352|FG003|Overall Study|Adverse Event|0|||
156981531|NCT01027364|566686349|FG000|Overall Study|Lost to Follow-up|1|||
156981532|NCT01027364|566686350|FG001|Overall Study|Lost to Follow-up|0|||
156981533|NCT01027364|566686351|FG002|Overall Study|Lost to Follow-up|0|||
156981534|NCT01027364|566686352|FG003|Overall Study|Lost to Follow-up|0|||
156981535|NCT01027364|566686349|FG000|Overall Study|Protocol Violation|1|||
156981536|NCT01027364|566686350|FG001|Overall Study|Protocol Violation|0|||
156981537|NCT01027364|566686351|FG002|Overall Study|Protocol Violation|0|||
156981538|NCT01027364|566686352|FG003|Overall Study|Protocol Violation|1|||
156981539|NCT01027364|566686349|FG000|Overall Study|Withdrawal by Subject|1|||
156981540|NCT01027364|566686350|FG001|Overall Study|Withdrawal by Subject|2|||
156981541|NCT01027364|566686351|FG002|Overall Study|Withdrawal by Subject|0|||
156981542|NCT01027364|566686352|FG003|Overall Study|Withdrawal by Subject|0|||
156981543|NCT01394250|566686353|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
156981544|NCT01394250|566686354|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
156981545|NCT01394250|566686353|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
156981546|NCT01394250|566686354|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
156981547|NCT03632434|566686357|FG000|Overall Study|Withdrawal by Subject|2|||
156981548|NCT04297241|566686361|FG000|Overall Study|Withdrawal by Subject|1|||
156981549|NCT04297241|566686361|FG000|Overall Study|Adverse Event|1|||
156981550|NCT04297241|566686361|FG000|Overall Study|Physician Decision|3|||
156981551|NCT00786474|566686370|FG000|Overall Study|Death|5|||
156981552|NCT00786474|566686371|FG001|Overall Study|Death|4|||
156981553|NCT00786474|566686370|FG000|Overall Study|Withdrawal by Subject|23|||
156981554|NCT00786474|566686371|FG001|Overall Study|Withdrawal by Subject|31|||
156981555|NCT00786474|566686370|FG000|Overall Study|Lost to Follow-up|3|||
156981556|NCT00786474|566686371|FG001|Overall Study|Lost to Follow-up|3|||
156981557|NCT00786474|566686370|FG000|Overall Study|Physician Decision|2|||
156981558|NCT00786474|566686371|FG001|Overall Study|Physician Decision|1|||
156981559|NCT00786474|566686370|FG000|Overall Study|Other|4|||
156981560|NCT00786474|566686371|FG001|Overall Study|Other|4|||
156981561|NCT02733042|566686376|FG000|Overall Study|Adverse Event|1|||
156981562|NCT02733042|566686377|FG001|Overall Study|Adverse Event|0|||
156981563|NCT02733042|566686378|FG002|Overall Study|Adverse Event|1|||
156981564|NCT02733042|566686379|FG003|Overall Study|Adverse Event|1|||
157095970|NCT00585195|567105467|FG010|Overall Study|Site Terminated by Sponsor|0|||
157095971|NCT00585195|567105468|FG011|Overall Study|Site Terminated by Sponsor|0|||
157095972|NCT00585195|567105469|FG012|Overall Study|Site Terminated by Sponsor|1|||
157095973|NCT00585195|567105470|FG013|Overall Study|Site Terminated by Sponsor|0|||
157095974|NCT00585195|567105471|FG014|Overall Study|Site Terminated by Sponsor|0|||
157095975|NCT00585195|567105472|FG015|Overall Study|Site Terminated by Sponsor|0|||
157095976|NCT00585195|567105473|FG016|Overall Study|Site Terminated by Sponsor|0|||
157095977|NCT00585195|567105474|FG017|Overall Study|Site Terminated by Sponsor|0|||
157095978|NCT00585195|567105475|FG018|Overall Study|Site Terminated by Sponsor|0|||
157095979|NCT00585195|567105476|FG019|Overall Study|Site Terminated by Sponsor|0|||
157095980|NCT00585195|567105477|FG020|Overall Study|Site Terminated by Sponsor|0|||
157095981|NCT00585195|567105457|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
157095982|NCT00585195|567105458|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
157095983|NCT00585195|567105459|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
157095984|NCT00585195|567105460|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
157095985|NCT00585195|567105461|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
157095986|NCT00585195|567105462|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
157095987|NCT00585195|567105463|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
157095988|NCT00585195|567105464|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
157095989|NCT00585195|567105465|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
157095990|NCT00585195|567105466|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
157095991|NCT00585195|567105467|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
157095992|NCT00585195|567105468|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
157095993|NCT00585195|567105469|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
156981565|NCT02733042|566686380|FG004|Overall Study|Adverse Event|0|||
156981566|NCT02733042|566686381|FG005|Overall Study|Adverse Event|0|||
156981567|NCT02733042|566686382|FG006|Overall Study|Adverse Event|0|||
156981568|NCT02733042|566686383|FG007|Overall Study|Adverse Event|0|||
156981569|NCT02733042|566686384|FG008|Overall Study|Adverse Event|0|||
156981570|NCT02733042|566686385|FG009|Overall Study|Adverse Event|0|||
156981571|NCT02733042|566686386|FG010|Overall Study|Adverse Event|2|||
156981572|NCT02733042|566686387|FG011|Overall Study|Adverse Event|2|||
156981573|NCT02733042|566686388|FG012|Overall Study|Adverse Event|0|||
156981574|NCT02733042|566686389|FG013|Overall Study|Adverse Event|2|||
156981575|NCT02733042|566686390|FG014|Overall Study|Adverse Event|0|||
156981576|NCT02733042|566686391|FG015|Overall Study|Adverse Event|0|||
156981577|NCT02733042|566686392|FG016|Overall Study|Adverse Event|0|||
156981578|NCT02733042|566686393|FG017|Overall Study|Adverse Event|1|||
156981579|NCT02733042|566686394|FG018|Overall Study|Adverse Event|0|||
156981580|NCT02733042|566686376|FG000|Overall Study|Progressive Disease|2|||
156981581|NCT02733042|566686377|FG001|Overall Study|Progressive Disease|1|||
156981582|NCT02733042|566686378|FG002|Overall Study|Progressive Disease|3|||
156981583|NCT02733042|566686379|FG003|Overall Study|Progressive Disease|1|||
156981584|NCT02733042|566686380|FG004|Overall Study|Progressive Disease|2|||
156981585|NCT02733042|566686381|FG005|Overall Study|Progressive Disease|3|||
156981586|NCT02733042|566686382|FG006|Overall Study|Progressive Disease|0|||
156981587|NCT02733042|566686383|FG007|Overall Study|Progressive Disease|3|||
156981588|NCT02733042|566686384|FG008|Overall Study|Progressive Disease|3|||
156981589|NCT02733042|566686385|FG009|Overall Study|Progressive Disease|2|||
156981590|NCT02733042|566686386|FG010|Overall Study|Progressive Disease|2|||
156981591|NCT02733042|566686387|FG011|Overall Study|Progressive Disease|2|||
156981592|NCT02733042|566686388|FG012|Overall Study|Progressive Disease|8|||
156981593|NCT02733042|566686389|FG013|Overall Study|Progressive Disease|1|||
156981594|NCT02733042|566686390|FG014|Overall Study|Progressive Disease|4|||
156981595|NCT02733042|566686391|FG015|Overall Study|Progressive Disease|7|||
156981596|NCT02733042|566686392|FG016|Overall Study|Progressive Disease|2|||
156981597|NCT02733042|566686393|FG017|Overall Study|Progressive Disease|3|||
156981598|NCT02733042|566686394|FG018|Overall Study|Progressive Disease|4|||
156981599|NCT02733042|566686376|FG000|Overall Study|Withdrawal by Subject|0|||
156981600|NCT02733042|566686377|FG001|Overall Study|Withdrawal by Subject|1|||
156981601|NCT02733042|566686378|FG002|Overall Study|Withdrawal by Subject|2|||
156981602|NCT02733042|566686379|FG003|Overall Study|Withdrawal by Subject|1|||
156981603|NCT02733042|566686380|FG004|Overall Study|Withdrawal by Subject|1|||
156981604|NCT02733042|566686381|FG005|Overall Study|Withdrawal by Subject|0|||
156981605|NCT02733042|566686382|FG006|Overall Study|Withdrawal by Subject|0|||
156981606|NCT02733042|566686383|FG007|Overall Study|Withdrawal by Subject|0|||
156981607|NCT02733042|566686384|FG008|Overall Study|Withdrawal by Subject|1|||
156981608|NCT02733042|566686385|FG009|Overall Study|Withdrawal by Subject|1|||
156981609|NCT02733042|566686386|FG010|Overall Study|Withdrawal by Subject|0|||
156981610|NCT02733042|566686387|FG011|Overall Study|Withdrawal by Subject|2|||
156981611|NCT02733042|566686388|FG012|Overall Study|Withdrawal by Subject|1|||
156981612|NCT02733042|566686389|FG013|Overall Study|Withdrawal by Subject|1|||
156981613|NCT02733042|566686390|FG014|Overall Study|Withdrawal by Subject|0|||
156981614|NCT02733042|566686391|FG015|Overall Study|Withdrawal by Subject|0|||
156981615|NCT02733042|566686392|FG016|Overall Study|Withdrawal by Subject|0|||
156981616|NCT02733042|566686393|FG017|Overall Study|Withdrawal by Subject|0|||
156981617|NCT02733042|566686394|FG018|Overall Study|Withdrawal by Subject|0|||
156981618|NCT02733042|566686376|FG000|Overall Study|Other Reasons|0|||
156981619|NCT02733042|566686377|FG001|Overall Study|Other Reasons|0|||
156981620|NCT02733042|566686378|FG002|Overall Study|Other Reasons|1|||
156981621|NCT02733042|566686379|FG003|Overall Study|Other Reasons|0|||
156981622|NCT02733042|566686380|FG004|Overall Study|Other Reasons|0|||
156981623|NCT02733042|566686381|FG005|Overall Study|Other Reasons|0|||
156981624|NCT02733042|566686382|FG006|Overall Study|Other Reasons|0|||
156981625|NCT02733042|566686383|FG007|Overall Study|Other Reasons|0|||
156981626|NCT02733042|566686384|FG008|Overall Study|Other Reasons|0|||
156981627|NCT02733042|566686385|FG009|Overall Study|Other Reasons|1|||
156981628|NCT02733042|566686386|FG010|Overall Study|Other Reasons|1|||
156981629|NCT02733042|566686387|FG011|Overall Study|Other Reasons|0|||
156981630|NCT02733042|566686388|FG012|Overall Study|Other Reasons|0|||
156981631|NCT02733042|566686389|FG013|Overall Study|Other Reasons|0|||
156981632|NCT02733042|566686390|FG014|Overall Study|Other Reasons|0|||
156981633|NCT02733042|566686391|FG015|Overall Study|Other Reasons|1|||
156981634|NCT02733042|566686392|FG016|Overall Study|Other Reasons|0|||
156981635|NCT02733042|566686393|FG017|Overall Study|Other Reasons|1|||
156981636|NCT02733042|566686394|FG018|Overall Study|Other Reasons|0|||
156981637|NCT02733042|566686376|FG000|Overall Study|Death|0|||
156981638|NCT02733042|566686377|FG001|Overall Study|Death|0|||
156981639|NCT02733042|566686378|FG002|Overall Study|Death|0|||
156981640|NCT02733042|566686379|FG003|Overall Study|Death|0|||
156981641|NCT02733042|566686380|FG004|Overall Study|Death|0|||
156981642|NCT02733042|566686381|FG005|Overall Study|Death|0|||
156981643|NCT02733042|566686382|FG006|Overall Study|Death|1|||
156981644|NCT02733042|566686383|FG007|Overall Study|Death|0|||
156981645|NCT02733042|566686384|FG008|Overall Study|Death|1|||
156981646|NCT02733042|566686385|FG009|Overall Study|Death|0|||
156981647|NCT02733042|566686386|FG010|Overall Study|Death|1|||
156981648|NCT02733042|566686387|FG011|Overall Study|Death|0|||
156981649|NCT02733042|566686388|FG012|Overall Study|Death|0|||
156981650|NCT02733042|566686389|FG013|Overall Study|Death|0|||
156981651|NCT02733042|566686390|FG014|Overall Study|Death|1|||
156981652|NCT02733042|566686391|FG015|Overall Study|Death|2|||
156981653|NCT02733042|566686392|FG016|Overall Study|Death|0|||
156981654|NCT02733042|566686393|FG017|Overall Study|Death|0|||
156981655|NCT02733042|566686394|FG018|Overall Study|Death|0|||
156981656|NCT03688711|566686395|FG000|Overall Study|Withdrawal by Subject|0|||
156981657|NCT03688711|566686396|FG001|Overall Study|Withdrawal by Subject|1|||
156981658|NCT01088529|566686397|FG000|Overall Study|Did not receive study treatment|0|||
156981659|NCT01088529|566686398|FG001|Overall Study|Did not receive study treatment|1|||
156981660|NCT02838628|566686399|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
156981661|NCT02838628|566686400|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
156981662|NCT02838628|566686399|FG000|Recurrence Follow-up Period|Adverse Event|1|||
156981663|NCT02838628|566686400|FG001|Recurrence Follow-up Period|Adverse Event|0|||
156981664|NCT02838628|566686399|FG000|Recurrence Follow-up Period|Non-compliance|0|||
156981665|NCT02838628|566686400|FG001|Recurrence Follow-up Period|Non-compliance|1|||
156981666|NCT02838628|566686399|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
156981667|NCT02838628|566686400|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
156981668|NCT02838628|566686399|FG000|Recurrence Follow-up Period|Other un-specified|1|||
156981669|NCT02838628|566686400|FG001|Recurrence Follow-up Period|Other un-specified|1|||
156981670|NCT05407311|566686403|FG000|Overall Study|Withdrawal by Subject|5|||
156981671|NCT05407311|566686403|FG000|Overall Study|Protocol Violation|3|||
156981672|NCT05407311|566686403|FG000|Overall Study|Physician Decision|1|||
156981673|NCT05407311|566686403|FG000|Overall Study|Non-compliance|1|||
156981674|NCT01263106|566686404|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
156981675|NCT01263106|566686405|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
156981676|NCT03169881|566686411|FG000|Overall Study|Incomplete Follow-up|10|||
156981677|NCT03169881|566686412|FG001|Overall Study|Incomplete Follow-up|15|||
156981678|NCT03169881|566686411|FG000|Overall Study|Lost to Follow-up|18|||
156981679|NCT03169881|566686412|FG001|Overall Study|Lost to Follow-up|20|||
156981680|NCT03169881|566686411|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
156981681|NCT03169881|566686412|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
156981682|NCT03936777|566686413|FG000|Overall Study|Adverse Event|3|||
156981683|NCT03936777|566686413|FG000|Overall Study|Death|3|||
156981684|NCT03936777|566686413|FG000|Overall Study|Lack of Efficacy|24|||
156981685|NCT03936777|566686413|FG000|Overall Study|Lost to Follow-up|3|||
156981686|NCT03936777|566686413|FG000|Overall Study|Physician Decision|1|||
156981687|NCT03936777|566686413|FG000|Overall Study|Withdrawal by Subject|11|||
156981688|NCT03936777|566686413|FG000|Overall Study|Subjected Weaned of ZX008|1|||
156981689|NCT03936777|566686413|FG000|Overall Study|Missing|6|||
156981690|NCT02301156|566686414|FG000|Overall Study|Adverse Event|13|||
156981691|NCT02301156|566686415|FG001|Overall Study|Adverse Event|14|||
156981692|NCT02301156|566686414|FG000|Overall Study|Death|1|||
156981693|NCT02301156|566686415|FG001|Overall Study|Death|5|||
156981694|NCT02301156|566686414|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
157021606|NCT03699709|566830910|FG000|Overall Study|scheduled, but no show|0|||
156981695|NCT02301156|566686415|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
156981696|NCT02301156|566686414|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
156981697|NCT02301156|566686415|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
156981698|NCT02301156|566686414|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
156981699|NCT02301156|566686415|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
156981700|NCT02301156|566686414|FG000|Overall Study|Reason not Specified|6|||
156981701|NCT02301156|566686415|FG001|Overall Study|Reason not Specified|3|||
156981702|NCT03734991|566686418|FG000|Overall Study|Adverse Event|4|||
156981703|NCT03734991|566686419|FG001|Overall Study|Adverse Event|0|||
156981704|NCT03734991|566686418|FG000|Overall Study|Lost to Follow-up|4|||
156981705|NCT03734991|566686419|FG001|Overall Study|Lost to Follow-up|0|||
156981706|NCT03734991|566686418|FG000|Overall Study|Physician Decision|0|||
156981707|NCT03734991|566686419|FG001|Overall Study|Physician Decision|1|||
156981708|NCT03734991|566686418|FG000|Overall Study|Pregnancy|1|||
156981709|NCT03734991|566686419|FG001|Overall Study|Pregnancy|0|||
156981710|NCT03734991|566686418|FG000|Overall Study|Withdrawal by Subject|6|||
156981711|NCT03734991|566686419|FG001|Overall Study|Withdrawal by Subject|3|||
156981712|NCT03734991|566686418|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
156981713|NCT03734991|566686419|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
156981714|NCT03734991|566686418|FG000|Overall Study|Other|2|||
156981715|NCT03734991|566686419|FG001|Overall Study|Other|2|||
156981716|NCT02638623|566686420|FG000|Overall Study|Surgery timing|5|||
156981717|NCT02638623|566686421|FG001|Overall Study|Surgery timing|6|||
156981718|NCT02638623|566686420|FG000|Overall Study|Not given intervention|2|||
156981719|NCT02638623|566686421|FG001|Overall Study|Not given intervention|0|||
156981720|NCT02322814|566686424|FG000|Overall Study|Death|7|||
156981721|NCT02322814|566686425|FG001|Overall Study|Death|29|||
157095994|NCT00585195|567105470|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
157095995|NCT00585195|567105471|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
157095996|NCT00585195|567105472|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
157095997|NCT00585195|567105473|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
157095998|NCT00585195|567105474|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
157095999|NCT00585195|567105475|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
157096000|NCT00585195|567105476|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
157096001|NCT00585195|567105477|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
157096002|NCT00770341|567105478|FG000|Overall Study|Did not meet eligibility criteria|1|||
157096003|NCT00770341|567105479|FG001|Overall Study|Did not meet eligibility criteria|0|||
157096004|NCT00770341|567105480|FG002|Overall Study|Did not meet eligibility criteria|0|||
157096005|NCT00770341|567105478|FG000|Overall Study|Withdrawal by Subject|0|||
157096006|NCT00770341|567105479|FG001|Overall Study|Withdrawal by Subject|1|||
157096007|NCT00770341|567105480|FG002|Overall Study|Withdrawal by Subject|0|||
157096008|NCT00770341|567105478|FG000|Overall Study|Clinical Adverse Event|3|||
157096009|NCT00770341|567105479|FG001|Overall Study|Clinical Adverse Event|1|||
157096010|NCT00770341|567105480|FG002|Overall Study|Clinical Adverse Event|2|||
157096011|NCT00770341|567105478|FG000|Overall Study|Laboratory adverse event|3|||
157096012|NCT00770341|567105479|FG001|Overall Study|Laboratory adverse event|3|||
157096013|NCT00770341|567105480|FG002|Overall Study|Laboratory adverse event|0|||
157096014|NCT00770341|567105478|FG000|Overall Study|Lack of Efficacy|3|||
157096015|NCT00770341|567105479|FG001|Overall Study|Lack of Efficacy|0|||
157096016|NCT00770341|567105480|FG002|Overall Study|Lack of Efficacy|1|||
157096017|NCT00770341|567105478|FG000|Overall Study|Other|1|||
157096018|NCT00770341|567105479|FG001|Overall Study|Other|0|||
157096019|NCT00770341|567105480|FG002|Overall Study|Other|0|||
157096020|NCT00770341|567105478|FG000|Overall Study|Not treated|1|||
157096021|NCT00770341|567105479|FG001|Overall Study|Not treated|0|||
157096022|NCT00770341|567105480|FG002|Overall Study|Not treated|0|||
157096023|NCT02796560|567105486|FG000|Overall Study|Adverse Event|2|||
157096024|NCT02796560|567105487|FG001|Overall Study|Adverse Event|0|||
157096025|NCT02796560|567105486|FG000|Overall Study|Withdrawal by Subject|2|||
157096026|NCT02796560|567105487|FG001|Overall Study|Withdrawal by Subject|2|||
157096027|NCT02533570|567105489|FG000|Overall Study|Adverse Event|0|||
157096028|NCT02533570|567105490|FG001|Overall Study|Adverse Event|1|||
157096029|NCT02533570|567105491|FG002|Overall Study|Adverse Event|1|||
157096030|NCT01163916|567105492|FG000|Overall Study|Withdrawal by Subject|2|||
157096031|NCT01163916|567105493|FG001|Overall Study|Withdrawal by Subject|0|||
157096032|NCT01163916|567105494|FG002|Overall Study|Withdrawal by Subject|2|||
156981722|NCT02322814|566686426|FG002|Overall Study|Death|32|||
156981723|NCT02322814|566686427|FG003|Overall Study|Death|23|||
156981724|NCT02322814|566686428|FG004|Overall Study|Death|14|||
156981725|NCT02322814|566686424|FG000|Overall Study|Lost to Follow-up|1|||
156981726|NCT02322814|566686425|FG001|Overall Study|Lost to Follow-up|3|||
157096033|NCT01163916|567105492|FG000|Overall Study|Adverse Event|2|||
157096034|NCT01163916|567105493|FG001|Overall Study|Adverse Event|0|||
157096035|NCT01163916|567105494|FG002|Overall Study|Adverse Event|1|||
157096036|NCT01163916|567105492|FG000|Overall Study|Lack of Efficacy|2|||
157096037|NCT01163916|567105493|FG001|Overall Study|Lack of Efficacy|0|||
157096038|NCT01163916|567105494|FG002|Overall Study|Lack of Efficacy|1|||
157096039|NCT01163916|567105492|FG000|Overall Study|Other|24|||
157096040|NCT01163916|567105493|FG001|Overall Study|Other|4|||
157096041|NCT01163916|567105494|FG002|Overall Study|Other|16|||
157096042|NCT00529958|567105495|FG000|2-Year Follow-up|Lost to Follow-up|1|||
157096043|NCT00529958|567105496|FG001|2-Year Follow-up|Lost to Follow-up|2|||
157096044|NCT00529958|567105497|FG002|2-Year Follow-up|Lost to Follow-up|2|||
157096045|NCT00529958|567105495|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
157096046|NCT00529958|567105496|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
157096047|NCT00529958|567105497|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
157096048|NCT00529958|567105495|FG000|5-Year Follow-up|Lost to Follow-up|2|||
157096049|NCT00529958|567105496|FG001|5-Year Follow-up|Lost to Follow-up|3|||
157096050|NCT00529958|567105497|FG002|5-Year Follow-up|Lost to Follow-up|1|||
157096051|NCT00529958|567105495|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
157096052|NCT00529958|567105496|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
157096053|NCT00529958|567105497|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
157096054|NCT03816332|567105498|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
157096055|NCT03816332|567105498|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
157096056|NCT03534284|567105501|FG000|Overall Study|Death|2|||
157096057|NCT03534284|567105502|FG001|Overall Study|Death|3|||
157096058|NCT03534284|567105503|FG002|Overall Study|Death|3|||
157096059|NCT03534284|567105501|FG000|Overall Study|Withdrawal by Subject|5|||
157096060|NCT03534284|567105502|FG001|Overall Study|Withdrawal by Subject|0|||
157096061|NCT03534284|567105503|FG002|Overall Study|Withdrawal by Subject|0|||
157096062|NCT03316300|567105504|FG000|Overall Study|Withdrawal by Subject|3|||
157096063|NCT03316300|567105505|FG001|Overall Study|Withdrawal by Subject|2|||
157096064|NCT03316300|567105504|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
157096065|NCT03316300|567105505|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
157096066|NCT03316300|567105504|FG000|Overall Study|Adverse Event|1|||
157096067|NCT03316300|567105505|FG001|Overall Study|Adverse Event|0|||
157096068|NCT03316300|567105504|FG000|Overall Study|COVID-19|0|||
157096069|NCT03316300|567105505|FG001|Overall Study|COVID-19|1|||
157096070|NCT03164564|567105506|FG000|Overall Study|Death|3|||
157096071|NCT03164564|567105507|FG001|Overall Study|Death|0|||
157096072|NCT03164564|567105506|FG000|Overall Study|Withdrawal by Subject|20|||
157096073|NCT03164564|567105507|FG001|Overall Study|Withdrawal by Subject|15|||
157096074|NCT03164564|567105506|FG000|Overall Study|Lost to Follow-up|2|||
157096075|NCT03164564|567105507|FG001|Overall Study|Lost to Follow-up|0|||
157096076|NCT03164564|567105506|FG000|Overall Study|Physician Decision|0|||
157096077|NCT03164564|567105507|FG001|Overall Study|Physician Decision|1|||
157096078|NCT03164564|567105506|FG000|Overall Study|Adverse Event|0|||
157096079|NCT03164564|567105507|FG001|Overall Study|Adverse Event|1|||
157096080|NCT03164564|567105506|FG000|Overall Study|Ongoing|1586|||
157096081|NCT03164564|567105507|FG001|Overall Study|Ongoing|1586|||
157096082|NCT04002401|567105508|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
157096083|NCT04002401|567105508|FG000|Overall Study|Death|10|||
157096084|NCT04002401|567105508|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
157096085|NCT04002401|567105508|FG000|Overall Study|Enrolled but Never Treated|1|||
157096086|NCT04002401|567105508|FG000|Overall Study|Lost to Follow-up|1|||
157096087|NCT00423930|567105509|FG000|Overall Study|Withdrawal by Subject|2|||
157096088|NCT02337751|567105510|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
157096089|NCT02337751|567105511|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
157096090|NCT02337751|567105510|FG000|Overall Study|Voluntary Withdrawal|6|||
157096091|NCT02337751|567105511|FG001|Overall Study|Voluntary Withdrawal|8|||
157096092|NCT02337751|567105510|FG000|Overall Study|Lack of Efficacy|2|||
157096093|NCT02337751|567105511|FG001|Overall Study|Lack of Efficacy|5|||
157096094|NCT02337751|567105510|FG000|Overall Study|Investigator's Judgement|1|||
157096095|NCT02337751|567105511|FG001|Overall Study|Investigator's Judgement|0|||
157096096|NCT01340651|567105512|FG000|Overall Study|Adverse Event|3|||
157096097|NCT01340651|567105512|FG000|Overall Study|Consent Withdrawn|2|||
157096098|NCT01340651|567105512|FG000|Overall Study|Commercial Supply per Sponsor|12|||
157096099|NCT01315353|567105513|FG000|Overall Study|Death|2|||
157096100|NCT01315353|567105514|FG001|Overall Study|Death|1|||
157096101|NCT01315353|567105515|FG002|Overall Study|Death|0|||
157096102|NCT01315353|567105513|FG000|Overall Study|Withdrawal by Subject|2|||
157096103|NCT01315353|567105514|FG001|Overall Study|Withdrawal by Subject|6|||
157096104|NCT01315353|567105515|FG002|Overall Study|Withdrawal by Subject|1|||
157096105|NCT01315353|567105513|FG000|Overall Study|Lost to Follow-up|13|||
157096106|NCT01315353|567105514|FG001|Overall Study|Lost to Follow-up|6|||
157096107|NCT01315353|567105515|FG002|Overall Study|Lost to Follow-up|6|||
157096108|NCT01315353|567105513|FG000|Overall Study|Unwilling to adhere to requirements|5|||
157096109|NCT01315353|567105514|FG001|Overall Study|Unwilling to adhere to requirements|5|||
157096110|NCT01315353|567105515|FG002|Overall Study|Unwilling to adhere to requirements|4|||
157096111|NCT01315353|567105513|FG000|Overall Study|Site closing|7|||
157096112|NCT01315353|567105514|FG001|Overall Study|Site closing|4|||
157096113|NCT01315353|567105515|FG002|Overall Study|Site closing|0|||
157096114|NCT01315353|567105513|FG000|Overall Study|Taken off study by site in error|0|||
156981727|NCT02322814|566686426|FG002|Overall Study|Lost to Follow-up|3|||
156981728|NCT02322814|566686427|FG003|Overall Study|Lost to Follow-up|1|||
156981729|NCT02322814|566686428|FG004|Overall Study|Lost to Follow-up|0|||
156981730|NCT02322814|566686424|FG000|Overall Study|Various Reasons|2|||
156981731|NCT02322814|566686425|FG001|Overall Study|Various Reasons|0|||
156981732|NCT02322814|566686426|FG002|Overall Study|Various Reasons|1|||
156981733|NCT02322814|566686427|FG003|Overall Study|Various Reasons|1|||
156981734|NCT02322814|566686428|FG004|Overall Study|Various Reasons|0|||
156981735|NCT02322814|566686424|FG000|Overall Study|Progressive Disease|0|||
156981736|NCT02322814|566686425|FG001|Overall Study|Progressive Disease|0|||
156981737|NCT02322814|566686426|FG002|Overall Study|Progressive Disease|0|||
156981738|NCT02322814|566686427|FG003|Overall Study|Progressive Disease|1|||
156981739|NCT02322814|566686428|FG004|Overall Study|Progressive Disease|1|||
156981740|NCT02322814|566686424|FG000|Overall Study|Protocol Violation|1|||
156981741|NCT02322814|566686425|FG001|Overall Study|Protocol Violation|0|||
156981742|NCT02322814|566686426|FG002|Overall Study|Protocol Violation|0|||
156981743|NCT02322814|566686427|FG003|Overall Study|Protocol Violation|0|||
156981744|NCT02322814|566686428|FG004|Overall Study|Protocol Violation|0|||
156981745|NCT02322814|566686424|FG000|Overall Study|Study Terminated by Sponsor|0|||
156981746|NCT02322814|566686425|FG001|Overall Study|Study Terminated by Sponsor|7|||
156981747|NCT02322814|566686426|FG002|Overall Study|Study Terminated by Sponsor|9|||
156981748|NCT02322814|566686427|FG003|Overall Study|Study Terminated by Sponsor|5|||
156981749|NCT02322814|566686428|FG004|Overall Study|Study Terminated by Sponsor|13|||
156981750|NCT02322814|566686424|FG000|Overall Study|Withdrawal by Subject|5|||
156981751|NCT02322814|566686425|FG001|Overall Study|Withdrawal by Subject|4|||
156981752|NCT02322814|566686426|FG002|Overall Study|Withdrawal by Subject|2|||
156981753|NCT02322814|566686427|FG003|Overall Study|Withdrawal by Subject|1|||
156981754|NCT02322814|566686428|FG004|Overall Study|Withdrawal by Subject|3|||
156981755|NCT03012061|566686429|FG000|Overall Study|Withdrawal by Subject|1|||
156981756|NCT03012061|566686430|FG001|Overall Study|Withdrawal by Subject|5|||
156981757|NCT03012061|566686431|FG002|Overall Study|Withdrawal by Subject|4|||
156981758|NCT03012061|566686429|FG000|Overall Study|Investigator Site Closed|1|||
156981759|NCT03012061|566686430|FG001|Overall Study|Investigator Site Closed|2|||
156981760|NCT03012061|566686431|FG002|Overall Study|Investigator Site Closed|0|||
156981761|NCT03012061|566686429|FG000|Overall Study|Lost to Follow-up|2|||
156981762|NCT03012061|566686430|FG001|Overall Study|Lost to Follow-up|1|||
156981763|NCT03012061|566686431|FG002|Overall Study|Lost to Follow-up|0|||
156981764|NCT03012061|566686429|FG000|Overall Study|Study closed/ Terminated|0|||
156981765|NCT03012061|566686430|FG001|Overall Study|Study closed/ Terminated|0|||
156981766|NCT03012061|566686431|FG002|Overall Study|Study closed/ Terminated|1|||
156981767|NCT03012061|566686429|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
156981768|NCT03012061|566686430|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
156981769|NCT03012061|566686431|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
156981770|NCT03012061|566686429|FG000|Overall Study|Protocol Violation|0|||
156981771|NCT03012061|566686430|FG001|Overall Study|Protocol Violation|0|||
156981772|NCT03012061|566686431|FG002|Overall Study|Protocol Violation|2|||
156981773|NCT03012061|566686429|FG000|Overall Study|Lack of Efficacy|0|||
156981774|NCT03012061|566686430|FG001|Overall Study|Lack of Efficacy|1|||
156981775|NCT03012061|566686431|FG002|Overall Study|Lack of Efficacy|0|||
156981776|NCT03012061|566686429|FG000|Overall Study|Adverse Event|2|||
156981777|NCT03012061|566686430|FG001|Overall Study|Adverse Event|0|||
156981778|NCT03012061|566686431|FG002|Overall Study|Adverse Event|0|||
156981779|NCT04152343|566686432|FG000|Overall Study|Transplanted|5|||
156981780|NCT04152343|566686432|FG000|Overall Study|Death|20|||
156981781|NCT04152343|566686432|FG000|Overall Study|Lost to Follow-up|3|||
156981782|NCT01965938|566686433|FG000|Overall Study|Withdrawal by Subject|1|||
156981783|NCT01965938|566686434|FG001|Overall Study|Withdrawal by Subject|0|||
156981784|NCT02090634|566686435|FG000|Overall Study|Lost to Follow-up|0|||
156981785|NCT02090634|566686436|FG001|Overall Study|Lost to Follow-up|1|||
156981786|NCT02090634|566686435|FG000|Overall Study|Death|0|||
156981787|NCT02090634|566686436|FG001|Overall Study|Death|1|||
156981788|NCT02090634|566686435|FG000|Overall Study|Protocol Violation|3|||
156981789|NCT02090634|566686436|FG001|Overall Study|Protocol Violation|1|||
156981790|NCT02090634|566686435|FG000|Overall Study|Adverse Event|2|||
156981791|NCT02090634|566686436|FG001|Overall Study|Adverse Event|0|||
156981792|NCT01164228|566686437|FG000|Overall Study|Progression|24|||
156981793|NCT01164228|566686438|FG001|Overall Study|Progression|25|||
156981794|NCT01164228|566686437|FG000|Overall Study|Adverse Event|13|||
156981795|NCT01164228|566686438|FG001|Overall Study|Adverse Event|7|||
156981796|NCT01164228|566686437|FG000|Overall Study|Death|1|||
156981797|NCT01164228|566686438|FG001|Overall Study|Death|1|||
156981798|NCT01164228|566686437|FG000|Overall Study|Withdrawal by Subject|2|||
156981799|NCT01164228|566686438|FG001|Overall Study|Withdrawal by Subject|0|||
156981800|NCT01164228|566686437|FG000|Overall Study|Physician Decision|1|||
156981801|NCT01164228|566686438|FG001|Overall Study|Physician Decision|2|||
156981802|NCT01164228|566686437|FG000|Overall Study|Symptomatic deterioration|1|||
156981803|NCT01164228|566686438|FG001|Overall Study|Symptomatic deterioration|0|||
156981804|NCT01164228|566686437|FG000|Overall Study|Never started treatment|1|||
156981805|NCT01164228|566686438|FG001|Overall Study|Never started treatment|3|||
156981806|NCT01164228|566686437|FG000|Overall Study|Ineligible|1|||
156981807|NCT01164228|566686438|FG001|Overall Study|Ineligible|0|||
156981808|NCT04908449|566686443|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
156981809|NCT04908449|566686444|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
156981810|NCT04908449|566686443|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
156981811|NCT04908449|566686444|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
156981812|NCT02401308|566686446|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
156981813|NCT02401308|566686447|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
156981814|NCT00147225|566686448|FG000|Overall Study|Withdrawal by Subject|1|||
157096115|NCT01315353|567105514|FG001|Overall Study|Taken off study by site in error|1|||
157096116|NCT01315353|567105515|FG002|Overall Study|Taken off study by site in error|0|||
157096117|NCT01315353|567105513|FG000|Overall Study|Inadvertent randomization/assignment|0|||
157096118|NCT01315353|567105514|FG001|Overall Study|Inadvertent randomization/assignment|0|||
157096119|NCT01315353|567105515|FG002|Overall Study|Inadvertent randomization/assignment|2|||
157096120|NCT01009580|567105516|FG000|Overall Study|Adverse Event|4|||
157096121|NCT01009580|567105517|FG001|Overall Study|Adverse Event|4|||
157096122|NCT01009580|567105516|FG000|Overall Study|Lack of Efficacy|0|||
157096123|NCT01009580|567105517|FG001|Overall Study|Lack of Efficacy|1|||
157096124|NCT01009580|567105516|FG000|Overall Study|Protocol Violation|2|||
157096125|NCT01009580|567105517|FG001|Overall Study|Protocol Violation|3|||
157096126|NCT01009580|567105516|FG000|Overall Study|Withdrawal Criteria|4|||
157096127|NCT01009580|567105517|FG001|Overall Study|Withdrawal Criteria|6|||
157096128|NCT01009580|567105516|FG000|Overall Study|Unclassified|17|||
157096129|NCT01009580|567105517|FG001|Overall Study|Unclassified|21|||
157096130|NCT04576455|567105518|FG000|Overall Study|Ongoing in the Study|48|||
157096131|NCT04576455|567105519|FG001|Overall Study|Ongoing in the Study|58|||
157096132|NCT04576455|567105518|FG000|Overall Study|Death|83|||
157096133|NCT04576455|567105519|FG001|Overall Study|Death|77|||
157096134|NCT04576455|567105518|FG000|Overall Study|Lost to Follow-up|4|||
157096135|NCT04576455|567105519|FG001|Overall Study|Lost to Follow-up|5|||
157096136|NCT04576455|567105518|FG000|Overall Study|Withdrawal by Subject|16|||
157096137|NCT04576455|567105519|FG001|Overall Study|Withdrawal by Subject|12|||
157096138|NCT02544217|567107624|FG000|Overall Study|Withdrawal by Subject|1|||
157096139|NCT02544217|567107625|FG001|Overall Study|Withdrawal by Subject|1|||
157096140|NCT02544217|567107626|FG002|Overall Study|Withdrawal by Subject|0|||
157096141|NCT02544217|567107627|FG003|Overall Study|Withdrawal by Subject|0|||
157096142|NCT02544217|567107628|FG004|Overall Study|Withdrawal by Subject|0|||
157096143|NCT02544217|567107629|FG005|Overall Study|Withdrawal by Subject|0|||
157096144|NCT00667355|567107630|FG000|Overall Study|Adverse Event|5|||
157096145|NCT00667355|567107630|FG000|Overall Study|Lost to Follow-up|1|||
157096146|NCT00667355|567107630|FG000|Overall Study|Other reason was not specified|5|||
157096147|NCT00887679|567107631|FG000|Overall Study|Withdrawal by Subject|1|||
157096148|NCT00887679|567107631|FG000|Overall Study|Lost to Follow-up|4|||
157096149|NCT00887679|567107631|FG000|Overall Study|Physician Decision|5|||
157096150|NCT02683941|567107632|FG000|Double-blind Phase|Adverse Event|0|||
157096151|NCT02683941|567107633|FG001|Double-blind Phase|Adverse Event|1|||
157096152|NCT02683941|567107632|FG000|Double-blind Phase|Withdrawal by Subject|4|||
157096153|NCT02683941|567107633|FG001|Double-blind Phase|Withdrawal by Subject|2|||
157096154|NCT02683941|567107632|FG000|Double-blind Phase|Lost to Follow-up|1|||
157096155|NCT02683941|567107633|FG001|Double-blind Phase|Lost to Follow-up|0|||
157096156|NCT02683941|567107632|FG000|Double-blind Phase|Disease Progression|5|||
157096157|NCT02683941|567107633|FG001|Double-blind Phase|Disease Progression|2|||
157096158|NCT02683941|567107632|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
157096159|NCT02683941|567107633|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
157096160|NCT02683941|567107632|FG000|Open-label Treatment Phase|Disease Progression|1|||
157096161|NCT02683941|567107633|FG001|Open-label Treatment Phase|Disease Progression|2|||
157096162|NCT02683941|567107632|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
157096163|NCT02683941|567107633|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
156981815|NCT00147225|566686449|FG001|Overall Study|Withdrawal by Subject|0|||
157096164|NCT02683941|567107632|FG000|Open-label Treatment Phase|Other|1|||
157096165|NCT02683941|567107633|FG001|Open-label Treatment Phase|Other|0|||
157096166|NCT02683941|567107632|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
157096167|NCT02683941|567107633|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
157096168|NCT02683941|567107632|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
157096169|NCT02683941|567107633|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
157096170|NCT02683941|567107632|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
157096171|NCT02683941|567107633|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
157096172|NCT02683941|567107632|FG000|Open-label Follow-up Phase|Other|8|||
157096173|NCT02683941|567107633|FG001|Open-label Follow-up Phase|Other|1|||
157096174|NCT02075541|567107635|FG000|Overall Study|Serious Adverse Event|1|||
157096175|NCT02075541|567107636|FG001|Overall Study|Serious Adverse Event|4|||
157096176|NCT02075541|567107635|FG000|Overall Study|Protocol Violation|1|||
157096177|NCT02075541|567107636|FG001|Overall Study|Protocol Violation|0|||
157096178|NCT02075541|567107635|FG000|Overall Study|Withdrawal by Subject|1|||
157096179|NCT02075541|567107636|FG001|Overall Study|Withdrawal by Subject|3|||
157096180|NCT02075541|567107635|FG000|Overall Study|Sponsor study termination|0|||
157096181|NCT02075541|567107636|FG001|Overall Study|Sponsor study termination|1|||
157096182|NCT02075541|567107635|FG000|Overall Study|Other- unable to perform study procedure|1|||
157096183|NCT02075541|567107636|FG001|Overall Study|Other- unable to perform study procedure|0|||
157096184|NCT00731120|567107637|FG000|Overall Study|Adverse Event|7|||
157096185|NCT00731120|567107638|FG001|Overall Study|Adverse Event|6|||
157096186|NCT00731120|567107639|FG002|Overall Study|Adverse Event|8|||
157096187|NCT00731120|567107637|FG000|Overall Study|Lack of Efficacy|4|||
157096188|NCT00731120|567107638|FG001|Overall Study|Lack of Efficacy|5|||
157096189|NCT00731120|567107639|FG002|Overall Study|Lack of Efficacy|4|||
157096190|NCT00731120|567107637|FG000|Overall Study|Noncompliance with Study Drug|3|||
157096191|NCT00731120|567107638|FG001|Overall Study|Noncompliance with Study Drug|3|||
157096192|NCT00731120|567107639|FG002|Overall Study|Noncompliance with Study Drug|1|||
157096193|NCT00731120|567107637|FG000|Overall Study|Protocol Deviations|1|||
157096194|NCT00731120|567107638|FG001|Overall Study|Protocol Deviations|6|||
157096195|NCT00731120|567107639|FG002|Overall Study|Protocol Deviations|1|||
157096196|NCT00731120|567107637|FG000|Overall Study|Withdrawal of Consent|13|||
157096197|NCT00731120|567107638|FG001|Overall Study|Withdrawal of Consent|8|||
157096198|NCT00731120|567107639|FG002|Overall Study|Withdrawal of Consent|4|||
157096199|NCT00731120|567107637|FG000|Overall Study|Lost to Follow-up|10|||
157096200|NCT00731120|567107638|FG001|Overall Study|Lost to Follow-up|15|||
157096201|NCT00731120|567107639|FG002|Overall Study|Lost to Follow-up|17|||
157096202|NCT00731120|567107637|FG000|Overall Study|Other|4|||
157096203|NCT00731120|567107638|FG001|Overall Study|Other|0|||
157096204|NCT00731120|567107639|FG002|Overall Study|Other|1|||
157096205|NCT02434939|567107640|FG000|Overall Study|Lack of Efficacy|34|||
157096206|NCT02434939|567107641|FG001|Overall Study|Lack of Efficacy|48|||
157096207|NCT02434939|567107640|FG000|Overall Study|Withdrawal by Subject|3|||
157096208|NCT02434939|567107641|FG001|Overall Study|Withdrawal by Subject|0|||
157096209|NCT02434939|567107640|FG000|Overall Study|Adverse Event|0|||
157096210|NCT02434939|567107641|FG001|Overall Study|Adverse Event|1|||
157096211|NCT03181451|567107642|FG000|Overall Study|Adverse Event|0|||
157096212|NCT03181451|567107643|FG001|Overall Study|Adverse Event|1|||
157096213|NCT03181451|567107644|FG002|Overall Study|Adverse Event|0|||
157096214|NCT03181451|567107642|FG000|Overall Study|Withdrawal by Subject|0|||
157096215|NCT03181451|567107643|FG001|Overall Study|Withdrawal by Subject|1|||
157096216|NCT03181451|567107644|FG002|Overall Study|Withdrawal by Subject|0|||
157096217|NCT01259284|567107645|FG000|Overall Study|Study Termination|2|||
157096218|NCT01259284|567107646|FG001|Overall Study|Study Termination|0|||
157096219|NCT01259284|567107647|FG002|Overall Study|Study Termination|0|||
157096220|NCT01326533|567107648|FG000|Overall Study|Lost to Follow-up|2|||
157096221|NCT01326533|567107649|FG001|Overall Study|Lost to Follow-up|0|||
157096222|NCT01326533|567107648|FG000|Overall Study|Withdrawal by Subject|1|||
157096223|NCT01326533|567107649|FG001|Overall Study|Withdrawal by Subject|0|||
157096224|NCT01326533|567107648|FG000|Overall Study|Adverse Event|1|||
157096225|NCT01326533|567107649|FG001|Overall Study|Adverse Event|0|||
157096226|NCT04079803|567107650|FG000|Overall Study|Withdrawal by Subject|0|||
157096227|NCT04079803|567107651|FG001|Overall Study|Withdrawal by Subject|0|||
157096228|NCT04079803|567107652|FG002|Overall Study|Withdrawal by Subject|1|||
157096229|NCT00926211|567107654|FG000|Overall Study|Lost to Follow-up|1|||
157096230|NCT01032382|567107655|FG000|Overall Study|Disease dissemination|1|||
157096231|NCT01032382|567107656|FG001|Overall Study|Disease dissemination|1|||
157096232|NCT01032382|567107655|FG000|Overall Study|Treatment failure|3|||
157096233|NCT01032382|567107656|FG001|Overall Study|Treatment failure|1|||
157096234|NCT01032382|567107655|FG000|Overall Study|Index lesion relapse|1|||
157096235|NCT01032382|567107656|FG001|Overall Study|Index lesion relapse|3|||
157096236|NCT01012713|567107657|FG000|Overall Study|Lack of Efficacy|3|||
157096237|NCT01242800|567107658|FG000|Overall Study|Patient refusal|0|||
157096238|NCT01242800|567107659|FG001|Overall Study|Patient refusal|10|||
157096239|NCT01242800|567107658|FG000|Overall Study|Physician Decision|0|||
157096240|NCT01242800|567107659|FG001|Overall Study|Physician Decision|1|||
157096241|NCT01242800|567107658|FG000|Overall Study|Disease progression|0|||
157096242|NCT01242800|567107659|FG001|Overall Study|Disease progression|3|||
157096243|NCT01242800|567107658|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
157096244|NCT01242800|567107659|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
157096245|NCT01242800|567107658|FG000|Overall Study|Reasons not reported|0|||
157096246|NCT01242800|567107659|FG001|Overall Study|Reasons not reported|4|||
157096247|NCT00511901|567107661|FG000|Overall Study|Withdrawal by Subject|1|||
157096248|NCT00511901|567107662|FG001|Overall Study|Withdrawal by Subject|3|||
157096249|NCT02988622|567107663|FG000|Overall Study|Lost to Follow-up|17|||
157096250|NCT02447172|567107664|FG000|Overall Study|Adverse Event|11|||
157096251|NCT02447172|567107665|FG001|Overall Study|Adverse Event|8|||
157096252|NCT02447172|567107666|FG002|Overall Study|Adverse Event|7|||
157096253|NCT02447172|567107664|FG000|Overall Study|Death|3|||
157096254|NCT02447172|567107665|FG001|Overall Study|Death|1|||
157096255|NCT02447172|567107666|FG002|Overall Study|Death|0|||
157096256|NCT02447172|567107664|FG000|Overall Study|Protocol Violation|2|||
156981816|NCT00147225|566686450|FG002|Overall Study|Withdrawal by Subject|1|||
156981817|NCT00147225|566686451|FG003|Overall Study|Withdrawal by Subject|0|||
156981818|NCT00147225|566686452|FG004|Overall Study|Withdrawal by Subject|0|||
156981819|NCT00147225|566686453|FG005|Overall Study|Withdrawal by Subject|1|||
156981820|NCT00147225|566686448|FG000|Overall Study|Adverse Event|0|||
156981821|NCT00147225|566686449|FG001|Overall Study|Adverse Event|0|||
156981822|NCT00147225|566686450|FG002|Overall Study|Adverse Event|1|||
156981823|NCT00147225|566686451|FG003|Overall Study|Adverse Event|1|||
156981824|NCT00147225|566686452|FG004|Overall Study|Adverse Event|0|||
156981825|NCT00147225|566686453|FG005|Overall Study|Adverse Event|0|||
156981826|NCT00147225|566686448|FG000|Overall Study|Screen Failure|0|||
156981827|NCT00147225|566686449|FG001|Overall Study|Screen Failure|0|||
156981828|NCT00147225|566686450|FG002|Overall Study|Screen Failure|0|||
156981829|NCT00147225|566686451|FG003|Overall Study|Screen Failure|0|||
156981830|NCT00147225|566686452|FG004|Overall Study|Screen Failure|1|||
156981831|NCT00147225|566686453|FG005|Overall Study|Screen Failure|0|||
156981832|NCT00147225|566686448|FG000|Overall Study|Chemotherapy Changed|0|||
156981833|NCT00147225|566686449|FG001|Overall Study|Chemotherapy Changed|0|||
156981834|NCT00147225|566686450|FG002|Overall Study|Chemotherapy Changed|0|||
156981835|NCT00147225|566686451|FG003|Overall Study|Chemotherapy Changed|0|||
156981836|NCT00147225|566686452|FG004|Overall Study|Chemotherapy Changed|0|||
156981837|NCT00147225|566686453|FG005|Overall Study|Chemotherapy Changed|1|||
156981838|NCT01032044|566686454|FG000|Overall Study|Protocol Violation|14|||
156981839|NCT01032044|566686455|FG001|Overall Study|Protocol Violation|8|||
156981840|NCT01032044|566686454|FG000|Overall Study|Adverse Event|0|||
156981841|NCT01032044|566686455|FG001|Overall Study|Adverse Event|1|||
156981842|NCT01032044|566686454|FG000|Overall Study|Lost to Follow-up|11|||
156981843|NCT01032044|566686455|FG001|Overall Study|Lost to Follow-up|11|||
156981844|NCT00171873|566686456|FG000|Overall Study|Withdrawal by Subject|4|||
156981845|NCT00171873|566686457|FG001|Overall Study|Withdrawal by Subject|2|||
156981846|NCT00171873|566686456|FG000|Overall Study|Adverse Event|5|||
156981847|NCT00171873|566686457|FG001|Overall Study|Adverse Event|0|||
156981848|NCT00171873|566686456|FG000|Overall Study|Switched to Octreotide|0|||
156981849|NCT00171873|566686457|FG001|Overall Study|Switched to Octreotide|1|||
156981850|NCT01567865|566686460|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
156981851|NCT01567865|566686461|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
156981852|NCT01567865|566686462|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
156981853|NCT01567865|566686463|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
156981854|NCT01567865|566686460|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
156981855|NCT01567865|566686461|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
156981856|NCT01567865|566686462|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
156981857|NCT01567865|566686463|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
156981858|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
156981859|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
156981860|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
156981861|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
156981862|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
156981863|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
156981864|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
156981865|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
156981866|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
156981867|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
156981868|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
156981869|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
156981870|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
156981871|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
156981872|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
156981873|NCT02023879|566686467|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
156981874|NCT02023879|566686468|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
156981875|NCT02023879|566686469|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
156981876|NCT02023879|566686467|FG000|Extension Open Label Treatment|Adverse Event|1|||
156981877|NCT02023879|566686468|FG001|Extension Open Label Treatment|Adverse Event|7|||
156981878|NCT02023879|566686469|FG002|Extension Open Label Treatment|Adverse Event|3|||
156981879|NCT02023879|566686467|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
156981880|NCT02023879|566686468|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
156981881|NCT02023879|566686469|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
156981882|NCT02023879|566686467|FG000|Extension Open Label Treatment|Participant moved|1|||
156981883|NCT02023879|566686468|FG001|Extension Open Label Treatment|Participant moved|2|||
156981884|NCT02023879|566686469|FG002|Extension Open Label Treatment|Participant moved|0|||
156981885|NCT02023879|566686467|FG000|Extension Open Label Treatment|Other than specified above|2|||
156981886|NCT02023879|566686468|FG001|Extension Open Label Treatment|Other than specified above|7|||
156981887|NCT02023879|566686469|FG002|Extension Open Label Treatment|Other than specified above|2|||
156981888|NCT03713021|566686470|FG000|Overall Study|Did not have CT sim scan available|6|||
156981889|NCT03713021|566686470|FG000|Overall Study|Not eligible|4|||
156981890|NCT03713021|566686470|FG000|Overall Study|Issues with TraceIT markers|5|||
156981891|NCT00384059|566686471|FG000|Infant Series|Not consented|2|||
156981892|NCT00384059|566686472|FG001|Infant Series|Not consented|6|||
156981893|NCT00384059|566686471|FG000|Infant Series|Withdrawal by Subject|2|||
156981894|NCT00384059|566686472|FG001|Infant Series|Withdrawal by Subject|2|||
156981895|NCT00384059|566686471|FG000|Infant Series|Adverse Event|1|||
156981896|NCT00384059|566686472|FG001|Infant Series|Adverse Event|2|||
156981897|NCT00384059|566686471|FG000|Infant Series|Protocol Violation|1|||
156981898|NCT00384059|566686472|FG001|Infant Series|Protocol Violation|2|||
156981899|NCT00384059|566686471|FG000|Infant Series|Lost to Follow-up|0|||
156981900|NCT00384059|566686472|FG001|Infant Series|Lost to Follow-up|1|||
156981901|NCT00384059|566686471|FG000|After Infant Series|Protocol Violation|2|||
156981902|NCT00384059|566686472|FG001|After Infant Series|Protocol Violation|3|||
156981903|NCT00384059|566686471|FG000|After Infant Series|Withdrawal by Subject|2|||
156981904|NCT00384059|566686472|FG001|After Infant Series|Withdrawal by Subject|2|||
156981905|NCT00384059|566686471|FG000|After Infant Series|Failed to Return|0|||
156981906|NCT00384059|566686472|FG001|After Infant Series|Failed to Return|2|||
156981907|NCT00384059|566686471|FG000|After Infant Series|Adverse Event|0|||
156981908|NCT00384059|566686472|FG001|After Infant Series|Adverse Event|1|||
156981909|NCT00384059|566686471|FG000|After Infant Series|Physician Decision|0|||
156981910|NCT00384059|566686472|FG001|After Infant Series|Physician Decision|1|||
156981911|NCT00384059|566686471|FG000|After Infant Series|Lost to Follow-up|0|||
156981912|NCT00384059|566686472|FG001|After Infant Series|Lost to Follow-up|1|||
156981913|NCT00384059|566686471|FG000|Toddler Dose|Lost to Follow-up|1|||
156981914|NCT00384059|566686472|FG001|Toddler Dose|Lost to Follow-up|1|||
156981915|NCT00384059|566686471|FG000|Toddler Dose|Failed to return|0|||
156981916|NCT00384059|566686472|FG001|Toddler Dose|Failed to return|1|||
156981917|NCT03390036|566687847|FG000|Overall Study|Lost to Follow-up|1|||
156981918|NCT03390036|566687848|FG001|Overall Study|Lost to Follow-up|0|||
156981919|NCT03390036|566687849|FG002|Overall Study|Lost to Follow-up|0|||
156981920|NCT03390036|566687847|FG000|Overall Study|Lack of Efficacy|1|||
156981921|NCT03390036|566687848|FG001|Overall Study|Lack of Efficacy|0|||
156981922|NCT03390036|566687849|FG002|Overall Study|Lack of Efficacy|0|||
156981923|NCT00594906|566687850|FG000|Overall Study|Physician Decision|1|||
156981924|NCT00594906|566687851|FG001|Overall Study|Physician Decision|0|||
156981925|NCT00594906|566687850|FG000|Overall Study|Physician Decision|0|||
156981926|NCT00594906|566687851|FG001|Overall Study|Physician Decision|1|||
156981927|NCT00594906|566687850|FG000|Overall Study|Death|0|||
156981928|NCT00594906|566687851|FG001|Overall Study|Death|1|||
156981929|NCT02222896|566687858|FG000|Abdomen|Did not qualify|34|||
156981930|NCT02222896|566687859|FG001|Abdomen|Did not qualify|10|||
156981931|NCT02222896|566687860|FG002|Abdomen|Did not qualify|32|||
156981932|NCT02222896|566687858|FG000|Groin|Did not qualify|43|||
156981933|NCT02222896|566687859|FG001|Groin|Did not qualify|9|||
156981934|NCT02222896|566687860|FG002|Groin|Did not qualify|40|||
156981935|NCT01865617|566687863|FG000|Overall Study|Death|27|||
156981936|NCT01865617|566687864|FG001|Overall Study|Death|3|||
156981937|NCT01865617|566687865|FG002|Overall Study|Death|1|||
156981938|NCT01865617|566687866|FG003|Overall Study|Death|1|||
156981939|NCT01865617|566687867|FG004|Overall Study|Death|5|||
156981940|NCT01865617|566687868|FG005|Overall Study|Death|1|||
156981941|NCT01865617|566687869|FG006|Overall Study|Death|11|||
156981942|NCT01865617|566687870|FG007|Overall Study|Death|1|||
156981943|NCT01865617|566687871|FG008|Overall Study|Death|11|||
156981944|NCT01865617|566687872|FG009|Overall Study|Death|3|||
156981945|NCT01865617|566687873|FG010|Overall Study|Death|32|||
156981946|NCT01865617|566687874|FG011|Overall Study|Death|6|||
156981947|NCT01865617|566687875|FG012|Overall Study|Death|13|||
156981948|NCT01865617|566687863|FG000|Overall Study|Lost to Follow-up|2|||
156981949|NCT01865617|566687864|FG001|Overall Study|Lost to Follow-up|0|||
157096257|NCT02447172|567107665|FG001|Overall Study|Protocol Violation|1|||
157096258|NCT02447172|567107666|FG002|Overall Study|Protocol Violation|2|||
157096259|NCT02447172|567107664|FG000|Overall Study|Lost to Follow-up|7|||
157096260|NCT02447172|567107665|FG001|Overall Study|Lost to Follow-up|4|||
157096261|NCT02447172|567107666|FG002|Overall Study|Lost to Follow-up|4|||
157096262|NCT02447172|567107664|FG000|Overall Study|Withdrawal by Subject|5|||
157096263|NCT02447172|567107665|FG001|Overall Study|Withdrawal by Subject|1|||
157096264|NCT02447172|567107666|FG002|Overall Study|Withdrawal by Subject|3|||
157096265|NCT02447172|567107664|FG000|Overall Study|protocol specific treatment unrelated|3|||
157096266|NCT02447172|567107665|FG001|Overall Study|protocol specific treatment unrelated|0|||
157096267|NCT02447172|567107666|FG002|Overall Study|protocol specific treatment unrelated|2|||
156981950|NCT01865617|566687865|FG002|Overall Study|Lost to Follow-up|0|||
156981951|NCT01865617|566687866|FG003|Overall Study|Lost to Follow-up|0|||
156981952|NCT01865617|566687867|FG004|Overall Study|Lost to Follow-up|0|||
156981953|NCT01865617|566687868|FG005|Overall Study|Lost to Follow-up|0|||
156981954|NCT01865617|566687869|FG006|Overall Study|Lost to Follow-up|0|||
156981955|NCT01865617|566687870|FG007|Overall Study|Lost to Follow-up|0|||
156981956|NCT01865617|566687871|FG008|Overall Study|Lost to Follow-up|0|||
156981957|NCT01865617|566687872|FG009|Overall Study|Lost to Follow-up|0|||
156981958|NCT01865617|566687873|FG010|Overall Study|Lost to Follow-up|0|||
156981959|NCT01865617|566687874|FG011|Overall Study|Lost to Follow-up|0|||
156981960|NCT01865617|566687875|FG012|Overall Study|Lost to Follow-up|0|||
156981961|NCT01865617|566687863|FG000|Overall Study|Withdrawal by Subject|1|||
156981962|NCT01865617|566687864|FG001|Overall Study|Withdrawal by Subject|0|||
156981963|NCT01865617|566687865|FG002|Overall Study|Withdrawal by Subject|0|||
156981964|NCT01865617|566687866|FG003|Overall Study|Withdrawal by Subject|0|||
156981965|NCT01865617|566687867|FG004|Overall Study|Withdrawal by Subject|0|||
156981966|NCT01865617|566687868|FG005|Overall Study|Withdrawal by Subject|0|||
156981967|NCT01865617|566687869|FG006|Overall Study|Withdrawal by Subject|0|||
156981968|NCT01865617|566687870|FG007|Overall Study|Withdrawal by Subject|0|||
156981969|NCT01865617|566687871|FG008|Overall Study|Withdrawal by Subject|0|||
156981970|NCT01865617|566687872|FG009|Overall Study|Withdrawal by Subject|0|||
156981971|NCT01865617|566687873|FG010|Overall Study|Withdrawal by Subject|0|||
156981972|NCT01865617|566687874|FG011|Overall Study|Withdrawal by Subject|0|||
156981973|NCT01865617|566687875|FG012|Overall Study|Withdrawal by Subject|0|||
156981974|NCT01865617|566687863|FG000|Overall Study|Patient proceeded to new therapy|0|||
156981975|NCT01865617|566687864|FG001|Overall Study|Patient proceeded to new therapy|0|||
156981976|NCT01865617|566687865|FG002|Overall Study|Patient proceeded to new therapy|0|||
156981977|NCT01865617|566687866|FG003|Overall Study|Patient proceeded to new therapy|0|||
156981978|NCT01865617|566687867|FG004|Overall Study|Patient proceeded to new therapy|2|||
156981979|NCT01865617|566687868|FG005|Overall Study|Patient proceeded to new therapy|0|||
156981980|NCT01865617|566687869|FG006|Overall Study|Patient proceeded to new therapy|0|||
156981981|NCT01865617|566687870|FG007|Overall Study|Patient proceeded to new therapy|0|||
156981982|NCT01865617|566687871|FG008|Overall Study|Patient proceeded to new therapy|0|||
156981983|NCT01865617|566687872|FG009|Overall Study|Patient proceeded to new therapy|0|||
156981984|NCT01865617|566687873|FG010|Overall Study|Patient proceeded to new therapy|0|||
156981985|NCT01865617|566687874|FG011|Overall Study|Patient proceeded to new therapy|0|||
156981986|NCT01865617|566687875|FG012|Overall Study|Patient proceeded to new therapy|0|||
156981987|NCT01865617|566687863|FG000|Overall Study|Other|0|||
156981988|NCT01865617|566687864|FG001|Overall Study|Other|0|||
156981989|NCT01865617|566687865|FG002|Overall Study|Other|0|||
156981990|NCT01865617|566687866|FG003|Overall Study|Other|0|||
156981991|NCT01865617|566687867|FG004|Overall Study|Other|0|||
156981992|NCT01865617|566687868|FG005|Overall Study|Other|0|||
156981993|NCT01865617|566687869|FG006|Overall Study|Other|1|||
156981994|NCT01865617|566687870|FG007|Overall Study|Other|0|||
156981995|NCT01865617|566687871|FG008|Overall Study|Other|0|||
156981996|NCT01865617|566687872|FG009|Overall Study|Other|0|||
156981997|NCT01865617|566687873|FG010|Overall Study|Other|0|||
156981998|NCT01865617|566687874|FG011|Overall Study|Other|0|||
156981999|NCT01865617|566687875|FG012|Overall Study|Other|0|||
156982000|NCT02500979|566687880|FG000|Period 1|Hyperglycemia|1|||
156982001|NCT02500979|566687881|FG001|Period 1|Hyperglycemia|0|||
156982002|NCT02500979|566687880|FG000|Period 1|Severe non-compliance to protocol|0|||
156982003|NCT02500979|566687881|FG001|Period 1|Severe non-compliance to protocol|1|||
156982004|NCT02500979|566687880|FG000|Period 1|Adverse Event|1|||
156982005|NCT02500979|566687881|FG001|Period 1|Adverse Event|0|||
156982006|NCT02500979|566687880|FG000|Period 1|Subject decision|2|||
156982007|NCT02500979|566687881|FG001|Period 1|Subject decision|0|||
156982008|NCT02500979|566687880|FG000|Period 2|Change in risk|1|||
156982009|NCT02500979|566687881|FG001|Period 2|Change in risk|0|||
156982010|NCT03772314|566687882|FG000|Overall Study|Adverse Event|7|||
156982011|NCT03772314|566687883|FG001|Overall Study|Adverse Event|2|||
156982012|NCT01613027|566687884|FG000|Overall Study|Lost to Follow-up|5|||
156982013|NCT01613027|566687884|FG000|Overall Study|Switched Physician|1|||
156982014|NCT01613027|566687884|FG000|Overall Study|Lack of Efficacy|1|||
156982015|NCT01613027|566687884|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
157096268|NCT03562247|567107667|FG000|Overall Study|Lost to Follow-up|3|||
156982016|NCT04267614|566687887|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
156982017|NCT04267614|566687887|FG000|Overall Study|Lost to Follow-up|115|||
156982018|NCT00988351|566687892|FG000|Overall Study|Withdrawal by Subject|8|||
156982019|NCT00988351|566687893|FG001|Overall Study|Withdrawal by Subject|0|||
156982020|NCT00988351|566687892|FG000|Overall Study|Lost to Follow-up|6|||
156982021|NCT00988351|566687893|FG001|Overall Study|Lost to Follow-up|9|||
156982022|NCT00988351|566687892|FG000|Overall Study|not using CPAP|5|||
156982023|NCT00988351|566687893|FG001|Overall Study|not using CPAP|3|||
156982024|NCT00119262|566687894|FG000|Overall Study|Lack of Efficacy|0|||
156982025|NCT00119262|566687895|FG001|Overall Study|Lack of Efficacy|3|||
156982026|NCT00119262|566687894|FG000|Overall Study|Withdrawal by Subject|12|||
156982027|NCT00119262|566687895|FG001|Overall Study|Withdrawal by Subject|11|||
156982028|NCT00119262|566687894|FG000|Overall Study|Adverse Event|33|||
156982029|NCT00119262|566687895|FG001|Overall Study|Adverse Event|35|||
156982030|NCT00119262|566687894|FG000|Overall Study|other disease|0|||
156982031|NCT00119262|566687895|FG001|Overall Study|other disease|2|||
156982032|NCT00119262|566687894|FG000|Overall Study|ineligble|1|||
156982033|NCT00119262|566687895|FG001|Overall Study|ineligble|2|||
156982034|NCT00119262|566687894|FG000|Overall Study|others|0|||
156982035|NCT00119262|566687895|FG001|Overall Study|others|5|||
156982036|NCT01799720|566687896|FG000|Overall Study|Withdrawal by Subject|3|||
156982037|NCT01799720|566687897|FG001|Overall Study|Withdrawal by Subject|0|||
156982038|NCT01799720|566687898|FG002|Overall Study|Withdrawal by Subject|0|||
156982039|NCT01799720|566687896|FG000|Overall Study|Protocol Violation|0|||
156982040|NCT01799720|566687897|FG001|Overall Study|Protocol Violation|1|||
156982041|NCT01799720|566687898|FG002|Overall Study|Protocol Violation|0|||
156982042|NCT01799720|566687896|FG000|Overall Study|Pregnancy|0|||
156982043|NCT01799720|566687897|FG001|Overall Study|Pregnancy|0|||
156982044|NCT01799720|566687898|FG002|Overall Study|Pregnancy|1|||
156982045|NCT05832437|566687910|FG000|Overall Study|time off work|1|||
156982046|NCT05832437|566687911|FG001|Overall Study|time off work|0|||
156982047|NCT05832437|566687912|FG002|Overall Study|time off work|0|||
156982048|NCT05832437|566687913|FG003|Overall Study|time off work|0|||
156982049|NCT05376371|566687914|FG000|Overall Study|change in release date|10|||
156982050|NCT00337662|566687915|FG000|Study Period II|Lost to Follow-up|0|||
156982051|NCT00337662|566687916|FG001|Study Period II|Lost to Follow-up|0|||
156982052|NCT00337662|566687917|FG002|Study Period II|Lost to Follow-up|0|||
156982053|NCT00337662|566687918|FG003|Study Period II|Lost to Follow-up|35|||
156982054|NCT00337662|566687915|FG000|Study Period II|Withdrawal by Subject|0|||
156982055|NCT00337662|566687916|FG001|Study Period II|Withdrawal by Subject|0|||
156982056|NCT00337662|566687917|FG002|Study Period II|Withdrawal by Subject|0|||
156982057|NCT00337662|566687918|FG003|Study Period II|Withdrawal by Subject|20|||
156982058|NCT00337662|566687915|FG000|Study Period II|Adverse Event|0|||
156982059|NCT00337662|566687916|FG001|Study Period II|Adverse Event|0|||
156982060|NCT00337662|566687917|FG002|Study Period II|Adverse Event|0|||
156982061|NCT00337662|566687918|FG003|Study Period II|Adverse Event|16|||
156982062|NCT00337662|566687915|FG000|Study Period II|Physician Decision|0|||
156982063|NCT00337662|566687916|FG001|Study Period II|Physician Decision|0|||
156982064|NCT00337662|566687917|FG002|Study Period II|Physician Decision|0|||
156982065|NCT00337662|566687918|FG003|Study Period II|Physician Decision|13|||
156982066|NCT00337662|566687915|FG000|Study Period II|Entry Criteria Not Met|0|||
156982067|NCT00337662|566687916|FG001|Study Period II|Entry Criteria Not Met|0|||
156982068|NCT00337662|566687917|FG002|Study Period II|Entry Criteria Not Met|0|||
156982069|NCT00337662|566687918|FG003|Study Period II|Entry Criteria Not Met|6|||
156982070|NCT00337662|566687915|FG000|Study Period II|Protocol Violation|0|||
156982071|NCT00337662|566687916|FG001|Study Period II|Protocol Violation|0|||
156982072|NCT00337662|566687917|FG002|Study Period II|Protocol Violation|0|||
156982073|NCT00337662|566687918|FG003|Study Period II|Protocol Violation|6|||
156982074|NCT00337662|566687915|FG000|Study Period II|Lack of Efficacy|0|||
156982075|NCT00337662|566687916|FG001|Study Period II|Lack of Efficacy|0|||
156982076|NCT00337662|566687917|FG002|Study Period II|Lack of Efficacy|0|||
156982077|NCT00337662|566687918|FG003|Study Period II|Lack of Efficacy|7|||
156982078|NCT00337662|566687915|FG000|Study Period II|Sponsor Decision|0|||
156982079|NCT00337662|566687916|FG001|Study Period II|Sponsor Decision|0|||
156982080|NCT00337662|566687917|FG002|Study Period II|Sponsor Decision|0|||
156982081|NCT00337662|566687918|FG003|Study Period II|Sponsor Decision|2|||
156982082|NCT00337662|566687915|FG000|Study Period II|Parent/Caregiver Decision|0|||
156982083|NCT00337662|566687916|FG001|Study Period II|Parent/Caregiver Decision|0|||
156982084|NCT00337662|566687917|FG002|Study Period II|Parent/Caregiver Decision|0|||
156982085|NCT00337662|566687918|FG003|Study Period II|Parent/Caregiver Decision|1|||
156982086|NCT00337662|566687915|FG000|Study Period III|Lost to Follow-up|14|||
156982087|NCT00337662|566687916|FG001|Study Period III|Lost to Follow-up|16|||
156982088|NCT00337662|566687917|FG002|Study Period III|Lost to Follow-up|14|||
156982089|NCT00337662|566687918|FG003|Study Period III|Lost to Follow-up|0|||
156982090|NCT00337662|566687915|FG000|Study Period III|Withdrawal by Subject|18|||
156982091|NCT00337662|566687916|FG001|Study Period III|Withdrawal by Subject|14|||
156982092|NCT00337662|566687917|FG002|Study Period III|Withdrawal by Subject|12|||
156982093|NCT00337662|566687918|FG003|Study Period III|Withdrawal by Subject|0|||
156982094|NCT00337662|566687915|FG000|Study Period III|Adverse Event|9|||
156982095|NCT00337662|566687916|FG001|Study Period III|Adverse Event|10|||
156982096|NCT00337662|566687917|FG002|Study Period III|Adverse Event|8|||
156982097|NCT00337662|566687918|FG003|Study Period III|Adverse Event|0|||
156982098|NCT00337662|566687915|FG000|Study Period III|Protocol Violation|3|||
156982099|NCT00337662|566687916|FG001|Study Period III|Protocol Violation|8|||
156982100|NCT00337662|566687917|FG002|Study Period III|Protocol Violation|2|||
156982101|NCT00337662|566687918|FG003|Study Period III|Protocol Violation|0|||
156982102|NCT00337662|566687915|FG000|Study Period III|Physician Decision|6|||
156982103|NCT00337662|566687916|FG001|Study Period III|Physician Decision|5|||
156982104|NCT00337662|566687917|FG002|Study Period III|Physician Decision|0|||
156982105|NCT00337662|566687918|FG003|Study Period III|Physician Decision|0|||
156982106|NCT00337662|566687915|FG000|Study Period III|Entry Criteria Not Met|4|||
156982107|NCT00337662|566687916|FG001|Study Period III|Entry Criteria Not Met|1|||
156982108|NCT00337662|566687917|FG002|Study Period III|Entry Criteria Not Met|3|||
156982109|NCT00337662|566687918|FG003|Study Period III|Entry Criteria Not Met|0|||
156982110|NCT00337662|566687915|FG000|Study Period III|Lack of Efficacy|4|||
156982111|NCT00337662|566687916|FG001|Study Period III|Lack of Efficacy|4|||
156982112|NCT00337662|566687917|FG002|Study Period III|Lack of Efficacy|2|||
156982113|NCT00337662|566687918|FG003|Study Period III|Lack of Efficacy|0|||
156982114|NCT00337662|566687915|FG000|Study Period III|Parent/Caregiver Decision|0|||
156982115|NCT00337662|566687916|FG001|Study Period III|Parent/Caregiver Decision|0|||
156982116|NCT00337662|566687917|FG002|Study Period III|Parent/Caregiver Decision|2|||
156982117|NCT00337662|566687918|FG003|Study Period III|Parent/Caregiver Decision|0|||
156982118|NCT00337662|566687915|FG000|Study Period III|Sponsor Decision|1|||
156982119|NCT00337662|566687916|FG001|Study Period III|Sponsor Decision|0|||
156982120|NCT00337662|566687917|FG002|Study Period III|Sponsor Decision|1|||
156982121|NCT00337662|566687918|FG003|Study Period III|Sponsor Decision|0|||
156982122|NCT00337662|566687915|FG000|Study Period III|Clinical Relapse|1|||
156982123|NCT00337662|566687916|FG001|Study Period III|Clinical Relapse|0|||
156982124|NCT00337662|566687917|FG002|Study Period III|Clinical Relapse|0|||
156982125|NCT00337662|566687918|FG003|Study Period III|Clinical Relapse|0|||
156982126|NCT01265823|566687922|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
156982127|NCT01265823|566687922|FG000|Overall Study|Failure to Return|4|||
156982128|NCT01265823|566687922|FG000|Overall Study|Protocol Violation|1|||
156982129|NCT01265823|566687922|FG000|Overall Study|Participant Request|1|||
156982130|NCT00882921|566687923|FG000|Overall Study|Death|2|||
156982131|NCT00882921|566687923|FG000|Overall Study|Other|3|||
156982132|NCT00882921|566687923|FG000|Overall Study|Lost to Follow-up|2|||
156982133|NCT00882921|566687923|FG000|Overall Study|Termination By Investigator|3|||
156982134|NCT00882921|566687923|FG000|Overall Study|Withdrawal Of Consent|1|||
156982135|NCT05027074|566687940|FG000|Overall Study|Death|47|||
156982136|NCT05027074|566687941|FG001|Overall Study|Death|42|||
156982137|NCT05027074|566687942|FG002|Overall Study|Death|39|||
156982138|NCT05027074|566687940|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156982139|NCT05027074|566687941|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156982140|NCT05027074|566687942|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156982141|NCT05027074|566687940|FG000|Overall Study|Site Terminated By Sponsor|3|||
156982142|NCT05027074|566687941|FG001|Overall Study|Site Terminated By Sponsor|0|||
156982143|NCT05027074|566687942|FG002|Overall Study|Site Terminated By Sponsor|2|||
156982144|NCT05027074|566687940|FG000|Overall Study|Withdrawal by Subject|13|||
156982145|NCT05027074|566687941|FG001|Overall Study|Withdrawal by Subject|8|||
156982146|NCT05027074|566687942|FG002|Overall Study|Withdrawal by Subject|10|||
156982147|NCT05027074|566687940|FG000|Overall Study|Lost to Follow-up|2|||
156982148|NCT05027074|566687941|FG001|Overall Study|Lost to Follow-up|4|||
156982149|NCT05027074|566687942|FG002|Overall Study|Lost to Follow-up|3|||
156982150|NCT05027074|566687940|FG000|Overall Study|Status Not Recorded|0|||
156982151|NCT05027074|566687941|FG001|Overall Study|Status Not Recorded|0|||
156982152|NCT05027074|566687942|FG002|Overall Study|Status Not Recorded|1|||
156982153|NCT05256381|566687945|FG000|Overall Study|Withdrawal by Subject|4|||
156982154|NCT05256381|566687946|FG001|Overall Study|Withdrawal by Subject|0|||
156982155|NCT05256381|566687947|FG002|Overall Study|Withdrawal by Subject|2|||
156982156|NCT05256381|566687948|FG003|Overall Study|Withdrawal by Subject|2|||
156982157|NCT05256381|566687949|FG004|Overall Study|Withdrawal by Subject|8|||
156982158|NCT05256381|566687950|FG005|Overall Study|Withdrawal by Subject|6|||
156982159|NCT05256381|566687945|FG000|Overall Study|Physician Decision|0|||
156982160|NCT05256381|566687946|FG001|Overall Study|Physician Decision|0|||
156982161|NCT05256381|566687947|FG002|Overall Study|Physician Decision|1|||
156982162|NCT05256381|566687948|FG003|Overall Study|Physician Decision|0|||
156982163|NCT05256381|566687949|FG004|Overall Study|Physician Decision|2|||
156982164|NCT05256381|566687950|FG005|Overall Study|Physician Decision|0|||
156982165|NCT05256381|566687945|FG000|Overall Study|Death|17|||
156982166|NCT05256381|566687946|FG001|Overall Study|Death|3|||
156982167|NCT05256381|566687947|FG002|Overall Study|Death|4|||
156982168|NCT05256381|566687948|FG003|Overall Study|Death|5|||
156982169|NCT05256381|566687949|FG004|Overall Study|Death|24|||
156982170|NCT05256381|566687950|FG005|Overall Study|Death|21|||
156982171|NCT05256381|566687945|FG000|Overall Study|Other, not specified|0|||
156982172|NCT05256381|566687946|FG001|Overall Study|Other, not specified|0|||
156982173|NCT05256381|566687947|FG002|Overall Study|Other, not specified|0|||
156982174|NCT05256381|566687948|FG003|Overall Study|Other, not specified|0|||
156982175|NCT05256381|566687949|FG004|Overall Study|Other, not specified|2|||
156982176|NCT05256381|566687950|FG005|Overall Study|Other, not specified|1|||
156982177|NCT05256381|566687945|FG000|Overall Study|Study terminated by sponsor|18|||
156982178|NCT05256381|566687946|FG001|Overall Study|Study terminated by sponsor|5|||
156982179|NCT05256381|566687947|FG002|Overall Study|Study terminated by sponsor|5|||
156982180|NCT05256381|566687948|FG003|Overall Study|Study terminated by sponsor|5|||
156982181|NCT05256381|566687949|FG004|Overall Study|Study terminated by sponsor|18|||
156982182|NCT05256381|566687950|FG005|Overall Study|Study terminated by sponsor|11|||
156982183|NCT05256381|566687945|FG000|Overall Study|Lost to Follow-up|1|||
156982184|NCT05256381|566687946|FG001|Overall Study|Lost to Follow-up|0|||
156982185|NCT05256381|566687947|FG002|Overall Study|Lost to Follow-up|0|||
156982186|NCT05256381|566687948|FG003|Overall Study|Lost to Follow-up|0|||
156982187|NCT05256381|566687949|FG004|Overall Study|Lost to Follow-up|1|||
156982188|NCT05256381|566687950|FG005|Overall Study|Lost to Follow-up|0|||
156982189|NCT05569954|566687953|FG000|Overall Study|Lost to Follow-up|3|||
156982190|NCT05569954|566687954|FG001|Overall Study|Lost to Follow-up|4|||
156982191|NCT05569954|566687953|FG000|Overall Study|Protocol Violation|1|||
156982192|NCT05569954|566687954|FG001|Overall Study|Protocol Violation|2|||
156982193|NCT05569954|566687953|FG000|Overall Study|Withdrawal by Subject|4|||
156982194|NCT05569954|566687954|FG001|Overall Study|Withdrawal by Subject|2|||
156982195|NCT01518946|566687964|FG000|Open-label Phase|Other|4|||
156982196|NCT01518946|566687965|FG001|Open-label Phase|Other|0|||
156982197|NCT01518946|566687966|FG002|Open-label Phase|Other|0|||
156982198|NCT01518946|566687964|FG000|Randomized Phase (First Intervention)|Other|0|||
156982199|NCT01518946|566687965|FG001|Randomized Phase (First Intervention)|Other|1|||
156982200|NCT01518946|566687966|FG002|Randomized Phase (First Intervention)|Other|0|||
156982201|NCT03857841|566687967|FG000|Overall Study|Death|1|||
156982202|NCT03857841|566687968|FG001|Overall Study|Death|0|||
156982203|NCT03857841|566687969|FG002|Overall Study|Death|0|||
156982204|NCT03857841|566687970|FG003|Overall Study|Death|0|||
156982205|NCT03857841|566687967|FG000|Overall Study|Study Terminated by Sponsor|1|||
156982206|NCT03857841|566687968|FG001|Overall Study|Study Terminated by Sponsor|0|||
156982207|NCT03857841|566687969|FG002|Overall Study|Study Terminated by Sponsor|0|||
156982208|NCT03857841|566687970|FG003|Overall Study|Study Terminated by Sponsor|0|||
156982209|NCT00381641|566687973|FG000|Overall Study|Withdrawal by Subject|0|||
156982210|NCT00381641|566687974|FG001|Overall Study|Withdrawal by Subject|2|||
156982211|NCT01625910|566689293|FG000|Overall Study|Lost to Follow-up|3|||
156982212|NCT01625910|566689294|FG001|Overall Study|Lost to Follow-up|4|||
156982213|NCT02959138|566689295|FG000|Overall Study|Enrolled but Never Treated|0|||
156982214|NCT02959138|566689296|FG001|Overall Study|Enrolled but Never Treated|1|||
156982215|NCT02959138|566689297|FG002|Overall Study|Enrolled but Never Treated|0|||
156982216|NCT04213989|566689298|FG000|Overall Study|Withdrawal by Subject|3|||
156982217|NCT04213989|566689299|FG001|Overall Study|Withdrawal by Subject|2|||
156982218|NCT04213989|566689298|FG000|Overall Study|Physician Decision|1|||
156982219|NCT04213989|566689299|FG001|Overall Study|Physician Decision|0|||
156982220|NCT04213989|566689298|FG000|Overall Study|Lost to Follow-up|0|||
156982221|NCT04213989|566689299|FG001|Overall Study|Lost to Follow-up|4|||
156982222|NCT01681368|566689304|FG000|Overall Study|Refused further treatment|1|||
156982223|NCT01681368|566689304|FG000|Overall Study|Refused further follow up|1|||
156982224|NCT01807221|566689307|FG000|Overall Study|Progressive disease|1|||
156982225|NCT01807221|566689308|FG001|Overall Study|Progressive disease|0|||
156982226|NCT01807221|566689309|FG002|Overall Study|Progressive disease|1|||
156982227|NCT01807221|566689310|FG003|Overall Study|Progressive disease|0|||
156982228|NCT01807221|566689311|FG004|Overall Study|Progressive disease|0|||
156982229|NCT01807221|566689312|FG005|Overall Study|Progressive disease|0|||
156982230|NCT01807221|566689307|FG000|Overall Study|Death|7|||
156982231|NCT01807221|566689308|FG001|Overall Study|Death|9|||
156982232|NCT01807221|566689309|FG002|Overall Study|Death|4|||
156982233|NCT01807221|566689310|FG003|Overall Study|Death|2|||
156982234|NCT01807221|566689311|FG004|Overall Study|Death|1|||
156982235|NCT01807221|566689312|FG005|Overall Study|Death|6|||
156982236|NCT01807221|566689307|FG000|Overall Study|Physician Decision|2|||
156982237|NCT01807221|566689308|FG001|Overall Study|Physician Decision|1|||
156982238|NCT01807221|566689309|FG002|Overall Study|Physician Decision|0|||
156982239|NCT01807221|566689310|FG003|Overall Study|Physician Decision|0|||
156982240|NCT01807221|566689311|FG004|Overall Study|Physician Decision|0|||
156982241|NCT01807221|566689312|FG005|Overall Study|Physician Decision|0|||
156982242|NCT01807221|566689307|FG000|Overall Study|Adverse Event|33|||
156982243|NCT01807221|566689308|FG001|Overall Study|Adverse Event|22|||
156982244|NCT01807221|566689309|FG002|Overall Study|Adverse Event|26|||
156982245|NCT01807221|566689310|FG003|Overall Study|Adverse Event|25|||
156982246|NCT01807221|566689311|FG004|Overall Study|Adverse Event|18|||
157096269|NCT03562247|567107668|FG001|Overall Study|Lost to Follow-up|1|||
156982247|NCT01807221|566689312|FG005|Overall Study|Adverse Event|21|||
156982248|NCT01807221|566689307|FG000|Overall Study|Protocol Violation|0|||
156982249|NCT01807221|566689308|FG001|Overall Study|Protocol Violation|2|||
156982250|NCT01807221|566689309|FG002|Overall Study|Protocol Violation|1|||
156982251|NCT01807221|566689310|FG003|Overall Study|Protocol Violation|2|||
156982252|NCT01807221|566689311|FG004|Overall Study|Protocol Violation|0|||
156982253|NCT01807221|566689312|FG005|Overall Study|Protocol Violation|1|||
156982254|NCT01807221|566689307|FG000|Overall Study|Non-compliance|1|||
156982255|NCT01807221|566689308|FG001|Overall Study|Non-compliance|2|||
156982256|NCT01807221|566689309|FG002|Overall Study|Non-compliance|0|||
156982257|NCT01807221|566689310|FG003|Overall Study|Non-compliance|1|||
156982258|NCT01807221|566689311|FG004|Overall Study|Non-compliance|0|||
156982259|NCT01807221|566689312|FG005|Overall Study|Non-compliance|0|||
156982260|NCT01807221|566689307|FG000|Overall Study|Logistical difficulties|0|||
156982261|NCT01807221|566689308|FG001|Overall Study|Logistical difficulties|1|||
156982262|NCT01807221|566689309|FG002|Overall Study|Logistical difficulties|0|||
156982263|NCT01807221|566689310|FG003|Overall Study|Logistical difficulties|0|||
156982264|NCT01807221|566689311|FG004|Overall Study|Logistical difficulties|1|||
156982265|NCT01807221|566689312|FG005|Overall Study|Logistical difficulties|0|||
156982266|NCT01807221|566689307|FG000|Overall Study|Withdrawal by Subject|33|||
156982267|NCT01807221|566689308|FG001|Overall Study|Withdrawal by Subject|15|||
156982268|NCT01807221|566689309|FG002|Overall Study|Withdrawal by Subject|8|||
156982269|NCT01807221|566689310|FG003|Overall Study|Withdrawal by Subject|14|||
156982270|NCT01807221|566689311|FG004|Overall Study|Withdrawal by Subject|16|||
156982271|NCT01807221|566689312|FG005|Overall Study|Withdrawal by Subject|13|||
156982272|NCT01807221|566689307|FG000|Overall Study|Sponsor decision|2|||
156982273|NCT01807221|566689308|FG001|Overall Study|Sponsor decision|0|||
156982274|NCT01807221|566689309|FG002|Overall Study|Sponsor decision|1|||
156982275|NCT01807221|566689310|FG003|Overall Study|Sponsor decision|1|||
156982276|NCT01807221|566689311|FG004|Overall Study|Sponsor decision|0|||
156982277|NCT01807221|566689312|FG005|Overall Study|Sponsor decision|0|||
156982278|NCT01807221|566689307|FG000|Overall Study|Lost to Follow-up|1|||
156982279|NCT01807221|566689308|FG001|Overall Study|Lost to Follow-up|0|||
156982280|NCT01807221|566689309|FG002|Overall Study|Lost to Follow-up|2|||
156982281|NCT01807221|566689310|FG003|Overall Study|Lost to Follow-up|1|||
156982282|NCT01807221|566689311|FG004|Overall Study|Lost to Follow-up|0|||
156982283|NCT01807221|566689312|FG005|Overall Study|Lost to Follow-up|0|||
156982284|NCT00900627|566689313|FG000|Overall Study|Condition under investigation worsened|4|||
156982285|NCT00900627|566689314|FG001|Overall Study|Condition under investigation worsened|0|||
156982286|NCT00900627|566689315|FG002|Overall Study|Condition under investigation worsened|5|||
156982287|NCT00900627|566689316|FG003|Overall Study|Condition under investigation worsened|3|||
156982288|NCT00900627|566689317|FG004|Overall Study|Condition under investigation worsened|0|||
156982289|NCT00900627|566689318|FG005|Overall Study|Condition under investigation worsened|0|||
156982290|NCT00900627|566689313|FG000|Overall Study|Withdrawal by Subject|1|||
156982291|NCT00900627|566689314|FG001|Overall Study|Withdrawal by Subject|0|||
156982292|NCT00900627|566689315|FG002|Overall Study|Withdrawal by Subject|1|||
156982293|NCT00900627|566689316|FG003|Overall Study|Withdrawal by Subject|0|||
156982294|NCT00900627|566689317|FG004|Overall Study|Withdrawal by Subject|1|||
156982295|NCT00900627|566689318|FG005|Overall Study|Withdrawal by Subject|2|||
156982296|NCT00900627|566689313|FG000|Overall Study|Adverse Event|1|||
156982297|NCT00900627|566689314|FG001|Overall Study|Adverse Event|2|||
156982298|NCT00900627|566689315|FG002|Overall Study|Adverse Event|0|||
156982299|NCT00900627|566689316|FG003|Overall Study|Adverse Event|3|||
156982300|NCT00900627|566689317|FG004|Overall Study|Adverse Event|0|||
156982301|NCT00900627|566689318|FG005|Overall Study|Adverse Event|0|||
156982302|NCT00900627|566689313|FG000|Overall Study|Death|0|||
156982303|NCT00900627|566689314|FG001|Overall Study|Death|0|||
156982304|NCT00900627|566689315|FG002|Overall Study|Death|0|||
156982305|NCT00900627|566689316|FG003|Overall Study|Death|0|||
156982306|NCT00900627|566689317|FG004|Overall Study|Death|28|||
156982307|NCT00900627|566689318|FG005|Overall Study|Death|24|||
156982308|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
156982309|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
156982310|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
156982311|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
156982312|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
156982313|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
156982314|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
156982315|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
156982316|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156982317|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156982318|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156982319|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
156982320|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
156982321|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
156982322|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156982323|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156982324|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156982325|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
156982326|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
157096270|NCT03562247|567107669|FG002|Overall Study|Lost to Follow-up|1|||
156982327|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
156982328|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156982329|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156982330|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156982331|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
156982332|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
156982333|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
156982334|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
156982335|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
156982336|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
156982337|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
156982338|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
156982339|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
156982340|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156982341|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156982342|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156982343|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
156982344|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
156982345|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
156982346|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156982347|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156982348|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156982349|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
156982350|NCT01089556|566689319|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
156982351|NCT01089556|566689320|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
156982352|NCT01089556|566689321|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156982353|NCT01089556|566689322|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156982354|NCT01089556|566689323|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156982355|NCT01089556|566689324|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
156982356|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
156982357|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
156982358|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
156982359|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
156982360|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
156982361|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
156982362|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
156982363|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
156982364|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156982365|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156982366|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156982367|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
156982368|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156982369|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156982370|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156982371|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
156982372|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
156982373|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
156982374|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156982375|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156982376|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
156982377|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156982378|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156982379|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
156982380|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156982381|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156982382|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156982383|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156982384|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
156982385|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
156982386|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
156982387|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
156982388|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
156982389|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
156982390|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
156982391|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
156982392|NCT01089556|566689319|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156982393|NCT01089556|566689320|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156982394|NCT01089556|566689321|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
156982395|NCT01089556|566689322|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
156982396|NCT01089556|566689323|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
156982397|NCT01089556|566689324|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
156982398|NCT03685708|566689330|FG000|Overall Study|Withdrawal by Subject|0|||
156982399|NCT03685708|566689331|FG001|Overall Study|Withdrawal by Subject|0|||
156982400|NCT03685708|566689332|FG002|Overall Study|Withdrawal by Subject|1|||
156982401|NCT03685708|566689330|FG000|Overall Study|Screen Fail|0|||
156982402|NCT03685708|566689331|FG001|Overall Study|Screen Fail|1|||
156982403|NCT03685708|566689332|FG002|Overall Study|Screen Fail|1|||
156982404|NCT03685708|566689330|FG000|Overall Study|COVID 19 Pandemic|1|||
156982405|NCT03685708|566689331|FG001|Overall Study|COVID 19 Pandemic|1|||
156982406|NCT03685708|566689332|FG002|Overall Study|COVID 19 Pandemic|6|||
156982407|NCT03685708|566689330|FG000|Overall Study|Disease Progression|0|||
156982408|NCT03685708|566689331|FG001|Overall Study|Disease Progression|0|||
156982409|NCT03685708|566689332|FG002|Overall Study|Disease Progression|1|||
156982410|NCT02771210|566689333|FG000|Period 1|Adverse Event|5|||
156982411|NCT02771210|566689334|FG001|Period 1|Adverse Event|3|||
156982412|NCT02771210|566689333|FG000|Period 1|Lack of Efficacy|3|||
156982413|NCT02771210|566689334|FG001|Period 1|Lack of Efficacy|6|||
156982414|NCT02771210|566689333|FG000|Period 1|Lost to Follow-up|2|||
156982415|NCT02771210|566689334|FG001|Period 1|Lost to Follow-up|0|||
156982416|NCT02771210|566689333|FG000|Period 1|Physician Decision|0|||
156982417|NCT02771210|566689334|FG001|Period 1|Physician Decision|1|||
156982418|NCT02771210|566689333|FG000|Period 1|Withdrawal by Subject|0|||
156982419|NCT02771210|566689334|FG001|Period 1|Withdrawal by Subject|3|||
156982420|NCT02771210|566689333|FG000|Period 1|Withdrawal of informed consent|1|||
156982421|NCT02771210|566689334|FG001|Period 1|Withdrawal of informed consent|5|||
156982422|NCT02771210|566689333|FG000|Period 2|Adverse Event|1|||
156982423|NCT02771210|566689334|FG001|Period 2|Adverse Event|0|||
156982424|NCT02771210|566689333|FG000|Period 2|Lack of Efficacy|0|||
156982425|NCT02771210|566689334|FG001|Period 2|Lack of Efficacy|1|||
156982426|NCT02771210|566689333|FG000|Period 2|Withdrawal by Subject|1|||
156982427|NCT02771210|566689334|FG001|Period 2|Withdrawal by Subject|0|||
156982428|NCT02771210|566689333|FG000|Period 2|Withdrawal of informed consent|0|||
156982429|NCT02771210|566689334|FG001|Period 2|Withdrawal of informed consent|2|||
156982430|NCT04397523|566689337|FG000|Overall Study|Lost to Follow-up|3|||
156982431|NCT04397523|566689337|FG000|Overall Study|Transfer from/to other hospital|8|||
156982432|NCT01275196|566689338|FG000|Overall Study|Adverse Event|3|||
156982433|NCT01275196|566689339|FG001|Overall Study|Adverse Event|5|||
156982434|NCT01275196|566689338|FG000|Overall Study|Withdrawal by Subject|4|||
156982435|NCT01275196|566689339|FG001|Overall Study|Withdrawal by Subject|5|||
156982436|NCT01275196|566689338|FG000|Overall Study|Lost to Follow-up|1|||
156982437|NCT01275196|566689339|FG001|Overall Study|Lost to Follow-up|0|||
156982438|NCT01275196|566689338|FG000|Overall Study|Disease Progression|6|||
156982439|NCT01275196|566689339|FG001|Overall Study|Disease Progression|5|||
156982440|NCT01275196|566689338|FG000|Overall Study|Protocol Violation|1|||
156982441|NCT01275196|566689339|FG001|Overall Study|Protocol Violation|0|||
156982442|NCT01275196|566689338|FG000|Overall Study|Suboptimal response/treatment failure|5|||
156982443|NCT01275196|566689339|FG001|Overall Study|Suboptimal response/treatment failure|6|||
156982444|NCT01744496|566689344|FG000|Titration Period|Adverse Event|2|||
156982445|NCT01744496|566689345|FG001|Titration Period|Adverse Event|1|||
156982446|NCT01744496|566689344|FG000|Titration Period|Personal reasons|0|||
156982447|NCT01744496|566689345|FG001|Titration Period|Personal reasons|1|||
156982448|NCT01744496|566689344|FG000|Maintenance Period|Adverse Event|1|||
156982449|NCT01744496|566689345|FG001|Maintenance Period|Adverse Event|3|||
156982450|NCT01744496|566689344|FG000|Maintenance Period|Protocol Violation|1|||
156982451|NCT01744496|566689345|FG001|Maintenance Period|Protocol Violation|0|||
156982452|NCT01744496|566689344|FG000|Maintenance Period|Withdrawal by Subject|1|||
156982453|NCT01744496|566689345|FG001|Maintenance Period|Withdrawal by Subject|1|||
156982454|NCT01744496|566689344|FG000|Maintenance Period|Subject left town|1|||
156982455|NCT01744496|566689345|FG001|Maintenance Period|Subject left town|0|||
156982456|NCT00579982|566689347|FG000|Overall Study|Adverse Event|4|||
156982457|NCT00579982|566689347|FG000|Overall Study|Protocol Violation|4|||
156982458|NCT00305864|566689357|FG000|Overall Study|Ineligible / No protocol treatment|0|||
156982459|NCT00305864|566689358|FG001|Overall Study|Ineligible / No protocol treatment|1|||
156982460|NCT00305864|566689359|FG002|Overall Study|Ineligible / No protocol treatment|1|||
156982461|NCT00305864|566689360|FG003|Overall Study|Ineligible / No protocol treatment|13|||
156982462|NCT02836613|566689363|FG000|Overall Study|Accidental drowning|1|||
156982463|NCT02836613|566689364|FG001|Overall Study|Accidental drowning|0|||
156982464|NCT02836613|566689363|FG000|Overall Study|Lost to Follow-up|0|||
156982465|NCT02836613|566689364|FG001|Overall Study|Lost to Follow-up|1|||
156982466|NCT02836613|566689363|FG000|Overall Study|Withdrawal by Subject|0|||
156982467|NCT02836613|566689364|FG001|Overall Study|Withdrawal by Subject|2|||
156982468|NCT01464255|566689365|FG000|Overall Study|unresolve corneal staining|0|||
156982469|NCT01464255|566689366|FG001|Overall Study|unresolve corneal staining|1|||
156982470|NCT03881059|566689367|FG000|Treatment Period - Part A|Adverse Event|1|||
156982471|NCT03881059|566689368|FG001|Treatment Period - Part A|Adverse Event|3|||
156982472|NCT03881059|566689369|FG002|Treatment Period - Part A|Adverse Event|4|||
156982473|NCT03881059|566689367|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
157096271|NCT03261700|567107670|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
157096272|NCT03261700|567107671|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
156982474|NCT03881059|566689368|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
156982475|NCT03881059|566689369|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
156982476|NCT03881059|566689367|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
156982477|NCT03881059|566689368|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
156982478|NCT03881059|566689369|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
156982479|NCT03881059|566689367|FG000|Treatment Period - Part A|Other reasons|2|||
156982480|NCT03881059|566689368|FG001|Treatment Period - Part A|Other reasons|1|||
156982481|NCT03881059|566689369|FG002|Treatment Period - Part A|Other reasons|0|||
156982482|NCT03881059|566689367|FG000|Treatment Period - Part B|Adverse Event|0|||
156982483|NCT03881059|566689368|FG001|Treatment Period - Part B|Adverse Event|0|||
156982484|NCT03881059|566689369|FG002|Treatment Period - Part B|Adverse Event|3|||
156982485|NCT03881059|566689367|FG000|Treatment Period - Part B|Death|0|||
156982486|NCT03881059|566689368|FG001|Treatment Period - Part B|Death|1|||
156982487|NCT03881059|566689369|FG002|Treatment Period - Part B|Death|1|||
156982488|NCT03881059|566689367|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
156982489|NCT03881059|566689368|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
156982490|NCT03881059|566689369|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
156982491|NCT03881059|566689367|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
156982492|NCT03881059|566689368|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
156982493|NCT03881059|566689369|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
156982494|NCT03881059|566689367|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
156982495|NCT03881059|566689368|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
156982496|NCT03881059|566689369|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
156982497|NCT03881059|566689367|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
156982498|NCT03881059|566689368|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
156982499|NCT03881059|566689369|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
156982500|NCT03881059|566689367|FG000|Treatment Period - Part B|Other reasons|4|||
156982501|NCT03881059|566689368|FG001|Treatment Period - Part B|Other reasons|3|||
156982502|NCT03881059|566689369|FG002|Treatment Period - Part B|Other reasons|3|||
156982503|NCT02065570|566689370|FG000|Induction Study|Adverse Event|5|||
156982504|NCT02065570|566689371|FG001|Induction Study|Adverse Event|12|||
156982505|NCT02065570|566689372|FG002|Induction Study|Adverse Event|0|||
156982506|NCT02065570|566689373|FG003|Induction Study|Adverse Event|0|||
156982507|NCT02065570|566689370|FG000|Induction Study|Withdrawal by Subject|2|||
156982508|NCT02065570|566689371|FG001|Induction Study|Withdrawal by Subject|3|||
156982509|NCT02065570|566689372|FG002|Induction Study|Withdrawal by Subject|0|||
156982510|NCT02065570|566689373|FG003|Induction Study|Withdrawal by Subject|0|||
156982511|NCT02065570|566689370|FG000|Induction Study|Lost to Follow-up|1|||
156982512|NCT02065570|566689371|FG001|Induction Study|Lost to Follow-up|1|||
156982513|NCT02065570|566689372|FG002|Induction Study|Lost to Follow-up|0|||
156982514|NCT02065570|566689373|FG003|Induction Study|Lost to Follow-up|0|||
156982515|NCT02065570|566689370|FG000|Induction Study|Other, Not Specified|6|||
156982516|NCT02065570|566689371|FG001|Induction Study|Other, Not Specified|5|||
156982517|NCT02065570|566689372|FG002|Induction Study|Other, Not Specified|0|||
156982518|NCT02065570|566689373|FG003|Induction Study|Other, Not Specified|0|||
156982519|NCT02065570|566689370|FG000|Maintenance Study|Adverse Event|0|||
156982520|NCT02065570|566689371|FG001|Maintenance Study|Adverse Event|0|||
156982521|NCT02065570|566689372|FG002|Maintenance Study|Adverse Event|8|||
156982522|NCT02065570|566689373|FG003|Maintenance Study|Adverse Event|8|||
156982523|NCT02065570|566689370|FG000|Maintenance Study|Withdrawal by Subject|0|||
156982524|NCT02065570|566689371|FG001|Maintenance Study|Withdrawal by Subject|0|||
156982525|NCT02065570|566689372|FG002|Maintenance Study|Withdrawal by Subject|1|||
156982526|NCT02065570|566689373|FG003|Maintenance Study|Withdrawal by Subject|4|||
156982527|NCT02065570|566689370|FG000|Maintenance Study|Lost to Follow-up|0|||
156982528|NCT02065570|566689371|FG001|Maintenance Study|Lost to Follow-up|0|||
156982529|NCT02065570|566689372|FG002|Maintenance Study|Lost to Follow-up|2|||
156982530|NCT02065570|566689373|FG003|Maintenance Study|Lost to Follow-up|2|||
156982531|NCT02065570|566689370|FG000|Maintenance Study|Other, Not Specified|0|||
156982532|NCT02065570|566689371|FG001|Maintenance Study|Other, Not Specified|0|||
156982533|NCT02065570|566689372|FG002|Maintenance Study|Other, Not Specified|11|||
156982534|NCT02065570|566689373|FG003|Maintenance Study|Other, Not Specified|5|||
156982535|NCT02743793|566689374|FG000|Overall Study|Death|1|||
156982536|NCT02743793|566689375|FG001|Overall Study|Death|1|||
156982537|NCT02743793|566689374|FG000|Overall Study|Withdrawal by Subject|0|||
156982538|NCT02743793|566689375|FG001|Overall Study|Withdrawal by Subject|1|||
156982539|NCT02743793|566689374|FG000|Overall Study|Screen Failure|4|||
156982540|NCT02743793|566689375|FG001|Overall Study|Screen Failure|0|||
156982541|NCT02743793|566689374|FG000|Overall Study|No Primary Care Physician|0|||
156982542|NCT02743793|566689375|FG001|Overall Study|No Primary Care Physician|1|||
156982543|NCT02743793|566689374|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
156982544|NCT02743793|566689375|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
156982545|NCT02743793|566689374|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
156982546|NCT02743793|566689375|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
156982547|NCT04276090|566689378|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
156982548|NCT04276090|566689379|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
156982549|NCT04642469|566689380|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
156982550|NCT04642469|566689381|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
156982551|NCT04642469|566689380|FG000|Overall Study|Death|1|||
156982552|NCT04642469|566689381|FG001|Overall Study|Death|2|||
156751626|NCT00528372|565842075|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
156751627|NCT02432144|565842076|FG000|Overall Study|Participant Non-Compliance|1|||
156751628|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
156751629|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751630|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751631|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
156751632|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
156751633|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
156751634|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
156751635|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751636|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751637|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751638|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751639|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751640|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751641|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
156751642|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751643|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751644|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751645|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751646|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751647|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751648|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
156751649|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751650|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751651|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751652|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751653|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751654|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751655|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
156751656|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
156751657|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751658|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751659|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751660|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751661|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751662|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751663|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751664|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751665|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751666|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751667|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751668|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751669|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
156751670|NCT01483599|565842077|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
156751671|NCT01483599|565842078|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
156751672|NCT01483599|565842079|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
156751673|NCT01483599|565842080|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
156751674|NCT01483599|565842081|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
156751675|NCT01483599|565842082|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
156751676|NCT01483599|565842083|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
156751677|NCT01483599|565842084|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
156751678|NCT01483599|565842085|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
156751679|NCT01483599|565842086|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
156751680|NCT01483599|565842087|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
156751681|NCT01483599|565842088|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
156751682|NCT01483599|565842089|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
156751683|NCT01483599|565842090|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
156751684|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
156751685|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
156751686|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
156751687|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
156751688|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
156751689|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
156751690|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
156751691|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
156751692|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
156982553|NCT04642469|566689380|FG000|Overall Study|Study/site closed following amendment 1|11|||
156982554|NCT04642469|566689381|FG001|Overall Study|Study/site closed following amendment 1|11|||
156982555|NCT04642469|566689380|FG000|Overall Study|Other|1|||
156982556|NCT04642469|566689381|FG001|Overall Study|Other|1|||
156982557|NCT04642469|566689380|FG000|Overall Study|Withdrawal by Subject|1|||
156982558|NCT04642469|566689381|FG001|Overall Study|Withdrawal by Subject|0|||
156982559|NCT00960752|566689392|FG000|Overall Study|Adverse Event|0|||
156982560|NCT00960752|566689393|FG001|Overall Study|Adverse Event|0|||
156982561|NCT00960752|566689394|FG002|Overall Study|Adverse Event|1|||
156982562|NCT00960752|566689392|FG000|Overall Study|Progression|0|||
156982563|NCT00960752|566689393|FG001|Overall Study|Progression|0|||
156982564|NCT00960752|566689394|FG002|Overall Study|Progression|1|||
156982565|NCT02180438|566689403|FG000|Overall Study|Lost to Follow-up|1|||
156982566|NCT02058290|566689404|FG000|Overall Study|Protocol Violation|2|||
156982567|NCT02058290|566689405|FG001|Overall Study|Protocol Violation|1|||
156982568|NCT02058290|566689404|FG000|Overall Study|Physician Decision|1|||
156982569|NCT02058290|566689405|FG001|Overall Study|Physician Decision|0|||
156982570|NCT02058290|566689404|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
156982571|NCT02058290|566689405|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
156982572|NCT02058290|566689404|FG000|Overall Study|Withdrawal by Subject|0|||
156982573|NCT02058290|566689405|FG001|Overall Study|Withdrawal by Subject|1|||
156982574|NCT00785707|566689407|FG000|Overall Study|Lost to Follow-up|7|||
156982575|NCT00105586|566689410|FG000|Overall Study|Adverse Event|4|||
156982576|NCT00105586|566689411|FG001|Overall Study|Adverse Event|3|||
156982577|NCT00105586|566689410|FG000|Overall Study|Physician Decision|13|||
156982578|NCT00105586|566689411|FG001|Overall Study|Physician Decision|13|||
156982579|NCT02262260|566689412|FG000|Overall Study|Adverse Event|4|||
156982580|NCT02262260|566689413|FG001|Overall Study|Adverse Event|1|||
156982581|NCT02262260|566689412|FG000|Overall Study|Withdrawal of consent|4|||
156982582|NCT02262260|566689413|FG001|Overall Study|Withdrawal of consent|2|||
156982583|NCT02262260|566689412|FG000|Overall Study|Lost to Follow-up|1|||
156982584|NCT02262260|566689413|FG001|Overall Study|Lost to Follow-up|2|||
156982585|NCT02262260|566689412|FG000|Overall Study|Protocol deviation|2|||
156982586|NCT02262260|566689413|FG001|Overall Study|Protocol deviation|5|||
156982587|NCT01794117|566689416|FG000|Overall Study|Adverse Event|1|||
156982588|NCT01794117|566689417|FG001|Overall Study|Adverse Event|0|||
156982589|NCT01794117|566689418|FG002|Overall Study|Adverse Event|0|||
156982590|NCT01794117|566689419|FG003|Overall Study|Adverse Event|0|||
156982591|NCT01794117|566689416|FG000|Overall Study|Participant noncompliance|0|||
156982592|NCT01794117|566689417|FG001|Overall Study|Participant noncompliance|1|||
156982593|NCT01794117|566689418|FG002|Overall Study|Participant noncompliance|0|||
156982594|NCT01794117|566689419|FG003|Overall Study|Participant noncompliance|0|||
156982595|NCT01794117|566689416|FG000|Overall Study|Refused further treatment|0|||
156982596|NCT01794117|566689417|FG001|Overall Study|Refused further treatment|2|||
156982597|NCT01794117|566689418|FG002|Overall Study|Refused further treatment|0|||
156982598|NCT01794117|566689419|FG003|Overall Study|Refused further treatment|0|||
156982599|NCT04150029|566689422|FG000|Overall Study|Disease Relapse|0|||
156982600|NCT04150029|566689423|FG001|Overall Study|Disease Relapse|18|||
156982601|NCT04150029|566689422|FG000|Overall Study|Progressive Disease|2|||
156982602|NCT04150029|566689423|FG001|Overall Study|Progressive Disease|16|||
156982603|NCT04150029|566689422|FG000|Overall Study|Adverse Event|1|||
156982604|NCT04150029|566689423|FG001|Overall Study|Adverse Event|11|||
156982605|NCT04150029|566689422|FG000|Overall Study|Physician Decision|0|||
156982606|NCT04150029|566689423|FG001|Overall Study|Physician Decision|10|||
156982607|NCT04150029|566689422|FG000|Overall Study|Study Terminated by Sponsor|1|||
156982608|NCT04150029|566689423|FG001|Overall Study|Study Terminated by Sponsor|10|||
156982609|NCT04150029|566689422|FG000|Overall Study|Death|0|||
156982610|NCT04150029|566689423|FG001|Overall Study|Death|8|||
156982611|NCT04150029|566689422|FG000|Overall Study|Participant Decision|0|||
156982612|NCT04150029|566689423|FG001|Overall Study|Participant Decision|7|||
156982613|NCT04150029|566689422|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
156982614|NCT04150029|566689423|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
156982615|NCT02696902|566689424|FG000|Overall Study|Lost to Follow-up|0|||
156982616|NCT02696902|566689425|FG001|Overall Study|Lost to Follow-up|1|||
156982617|NCT02696902|566689426|FG002|Overall Study|Lost to Follow-up|1|||
156982618|NCT02696902|566689424|FG000|Overall Study|Withdrawal by Subject|0|||
156982619|NCT02696902|566689425|FG001|Overall Study|Withdrawal by Subject|0|||
156982620|NCT02696902|566689426|FG002|Overall Study|Withdrawal by Subject|1|||
156982621|NCT02696902|566689424|FG000|Overall Study|Death|19|||
156982622|NCT02696902|566689425|FG001|Overall Study|Death|3|||
156982623|NCT02696902|566689426|FG002|Overall Study|Death|24|||
156982624|NCT02696902|566689424|FG000|Overall Study|Participant not fit post-randomization|0|||
156982625|NCT02696902|566689425|FG001|Overall Study|Participant not fit post-randomization|0|||
156982626|NCT02696902|566689426|FG002|Overall Study|Participant not fit post-randomization|1|||
156982627|NCT02696902|566689424|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
156982628|NCT02696902|566689425|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
156982629|NCT02696902|566689426|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
156982630|NCT02696902|566689424|FG000|Overall Study|Principal investigator's decision|1|||
156982631|NCT02696902|566689425|FG001|Overall Study|Principal investigator's decision|0|||
156982632|NCT02696902|566689426|FG002|Overall Study|Principal investigator's decision|0|||
156982633|NCT02696902|566689424|FG000|Overall Study|Sponsor's decision|1|||
156982634|NCT02696902|566689425|FG001|Overall Study|Sponsor's decision|0|||
156982635|NCT02696902|566689426|FG002|Overall Study|Sponsor's decision|0|||
156982636|NCT02696902|566689424|FG000|Overall Study|Transferred to other hospital|1|||
156982637|NCT02696902|566689425|FG001|Overall Study|Transferred to other hospital|0|||
156982638|NCT02696902|566689426|FG002|Overall Study|Transferred to other hospital|0|||
156982639|NCT01233609|566689430|FG000|Overall Study|Death|1|||
156982640|NCT01233609|566689431|FG001|Overall Study|Death|0|||
156982641|NCT01233609|566689430|FG000|Overall Study|Lost to Follow-up|3|||
156982642|NCT01233609|566689431|FG001|Overall Study|Lost to Follow-up|1|||
156982643|NCT01233609|566689430|FG000|Overall Study|Adverse Event|2|||
156982644|NCT01233609|566689431|FG001|Overall Study|Adverse Event|1|||
156982645|NCT01233609|566689430|FG000|Overall Study|Withdrawal by Subject|3|||
156982646|NCT01233609|566689431|FG001|Overall Study|Withdrawal by Subject|0|||
156982647|NCT00654940|566690855|FG000|Period 1|Adverse Event|0|||
156982648|NCT00654940|566690856|FG001|Period 1|Adverse Event|1|||
156982649|NCT00654940|566690855|FG000|Period 1|Intolerable Pain Level|1|||
156982650|NCT00654940|566690856|FG001|Period 1|Intolerable Pain Level|0|||
156982651|NCT00802737|566690857|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
156982652|NCT00802737|566690858|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
156982653|NCT00802737|566690859|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
156982654|NCT00802737|566690857|FG000|Overall Study|Death|6|||
156982655|NCT00802737|566690858|FG001|Overall Study|Death|5|||
156982656|NCT00802737|566690859|FG002|Overall Study|Death|1|||
156982657|NCT00802737|566690857|FG000|Overall Study|Adverse Event|1|||
156982658|NCT00802737|566690858|FG001|Overall Study|Adverse Event|0|||
156982659|NCT00802737|566690859|FG002|Overall Study|Adverse Event|0|||
156982660|NCT00802737|566690857|FG000|Overall Study|Received Prohibited Therapy|1|||
156982661|NCT00802737|566690858|FG001|Overall Study|Received Prohibited Therapy|0|||
156982662|NCT00802737|566690859|FG002|Overall Study|Received Prohibited Therapy|0|||
156982663|NCT00802737|566690857|FG000|Overall Study|Ongoing CLL-Treatment|0|||
156982664|NCT00802737|566690858|FG001|Overall Study|Ongoing CLL-Treatment|1|||
156982665|NCT00802737|566690859|FG002|Overall Study|Ongoing CLL-Treatment|0|||
156982666|NCT00802737|566690857|FG000|Overall Study|Participant too Unwell|0|||
156982667|NCT00802737|566690858|FG001|Overall Study|Participant too Unwell|2|||
156982668|NCT00802737|566690859|FG002|Overall Study|Participant too Unwell|0|||
156982669|NCT00619476|566690860|FG000|Overall Study|Adverse Event|12|||
156982670|NCT00619476|566690861|FG001|Overall Study|Adverse Event|6|||
156982671|NCT00619476|566690862|FG002|Overall Study|Adverse Event|12|||
156982672|NCT00619476|566690863|FG003|Overall Study|Adverse Event|16|||
156982673|NCT00619476|566690860|FG000|Overall Study|Lack of Efficacy|6|||
156982674|NCT00619476|566690861|FG001|Overall Study|Lack of Efficacy|1|||
156982675|NCT00619476|566690862|FG002|Overall Study|Lack of Efficacy|1|||
156982676|NCT00619476|566690863|FG003|Overall Study|Lack of Efficacy|4|||
156982677|NCT00619476|566690860|FG000|Overall Study|Protocol Violation|5|||
156982678|NCT00619476|566690861|FG001|Overall Study|Protocol Violation|4|||
156982679|NCT00619476|566690862|FG002|Overall Study|Protocol Violation|4|||
156982680|NCT00619476|566690863|FG003|Overall Study|Protocol Violation|9|||
156982681|NCT00619476|566690860|FG000|Overall Study|Lost to Follow-up|1|||
156982682|NCT00619476|566690861|FG001|Overall Study|Lost to Follow-up|2|||
156982683|NCT00619476|566690862|FG002|Overall Study|Lost to Follow-up|0|||
156982684|NCT00619476|566690863|FG003|Overall Study|Lost to Follow-up|1|||
156982685|NCT00619476|566690860|FG000|Overall Study|Investigator Discretion|2|||
156982686|NCT00619476|566690861|FG001|Overall Study|Investigator Discretion|2|||
156982687|NCT00619476|566690862|FG002|Overall Study|Investigator Discretion|2|||
156982688|NCT00619476|566690863|FG003|Overall Study|Investigator Discretion|0|||
156982689|NCT00619476|566690860|FG000|Overall Study|Withdrawal by Subject|5|||
156982690|NCT00619476|566690861|FG001|Overall Study|Withdrawal by Subject|7|||
156982691|NCT00619476|566690862|FG002|Overall Study|Withdrawal by Subject|5|||
156982692|NCT00619476|566690863|FG003|Overall Study|Withdrawal by Subject|4|||
156982693|NCT01155388|566690868|FG000|Overall Study|Adverse Event|1|||
156982694|NCT01155388|566690869|FG001|Overall Study|Adverse Event|0|||
156982695|NCT03884231|566690870|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
156982696|NCT03884231|566690870|FG000|Overall Study|Subject Withdrew Consent|1|||
156982697|NCT03884231|566690870|FG000|Overall Study|MRI Scan Not Performed|1|||
156982698|NCT00830947|566690871|FG000|Overall Study|Lost to Follow-up|4|||
156982699|NCT00830947|566690872|FG001|Overall Study|Lost to Follow-up|4|||
156982700|NCT04422639|566690883|FG000|Overall Study|Death|1|||
156982701|NCT04422639|566690884|FG001|Overall Study|Death|0|||
156982702|NCT04422639|566690883|FG000|Overall Study|study closed prior to completion of FU visits|0|||
156982703|NCT04422639|566690884|FG001|Overall Study|study closed prior to completion of FU visits|2|||
156982704|NCT01964521|566690885|FG000|Overall Study|Lost to Follow-up|4|||
156982705|NCT02374593|566690887|FG000|Overall Study|non-compliant|2|||
156982706|NCT02374593|566690888|FG001|Overall Study|non-compliant|0|||
156982707|NCT01463293|566690889|FG000|Overall Study|Lost to Follow-up|1|||
156982708|NCT01463293|566690890|FG001|Overall Study|Lost to Follow-up|4|||
156982709|NCT01463293|566690891|FG002|Overall Study|Lost to Follow-up|5|||
156982710|NCT01463293|566690889|FG000|Overall Study|Adverse Event|1|||
156982711|NCT01463293|566690890|FG001|Overall Study|Adverse Event|2|||
156982712|NCT01463293|566690891|FG002|Overall Study|Adverse Event|0|||
156982713|NCT01463293|566690889|FG000|Overall Study|Withdrawal by Subject|4|||
156982714|NCT01463293|566690890|FG001|Overall Study|Withdrawal by Subject|10|||
156982715|NCT01463293|566690891|FG002|Overall Study|Withdrawal by Subject|5|||
156982716|NCT01463293|566690889|FG000|Overall Study|Other|0|||
156982717|NCT01463293|566690890|FG001|Overall Study|Other|0|||
156982718|NCT01463293|566690891|FG002|Overall Study|Other|2|||
156982719|NCT01284140|566690892|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
156982720|NCT01284140|566690893|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
156982721|NCT01284140|566690892|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
156982722|NCT01284140|566690893|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
156982723|NCT02796963|566690894|FG000|Overall Study|Lost to Follow-up|89|||
156982724|NCT02796963|566690895|FG001|Overall Study|Lost to Follow-up|76|||
156982725|NCT02796963|566690896|FG002|Overall Study|Lost to Follow-up|69|||
156982726|NCT02796963|566690897|FG003|Overall Study|Lost to Follow-up|72|||
156982727|NCT03192215|566690898|FG000|Overall Study|Death|28|||
156982728|NCT03192215|566690899|FG001|Overall Study|Death|23|||
156982729|NCT03192215|566690898|FG000|Overall Study|Lost to Follow-up|10|||
156982730|NCT03192215|566690899|FG001|Overall Study|Lost to Follow-up|15|||
156982731|NCT03192215|566690898|FG000|Overall Study|Withdrawal by Subject|49|||
156982732|NCT03192215|566690899|FG001|Overall Study|Withdrawal by Subject|48|||
156982733|NCT03192215|566690898|FG000|Overall Study|Other as reported in analysis|4|||
156982734|NCT03192215|566690899|FG001|Overall Study|Other as reported in analysis|1|||
156982735|NCT02038764|566690902|FG000|Overall Study|Adverse Event|0|||
156982736|NCT02038764|566690903|FG001|Overall Study|Adverse Event|0|||
156982737|NCT02038764|566690904|FG002|Overall Study|Adverse Event|1|||
156982738|NCT02038764|566690905|FG003|Overall Study|Adverse Event|0|||
156982739|NCT02038764|566690906|FG004|Overall Study|Adverse Event|0|||
156982740|NCT02038764|566690902|FG000|Overall Study|Lost to Follow-up|0|||
156982741|NCT02038764|566690903|FG001|Overall Study|Lost to Follow-up|1|||
156982742|NCT02038764|566690904|FG002|Overall Study|Lost to Follow-up|0|||
156982743|NCT02038764|566690905|FG003|Overall Study|Lost to Follow-up|0|||
156982744|NCT02038764|566690906|FG004|Overall Study|Lost to Follow-up|0|||
156982745|NCT02038764|566690902|FG000|Overall Study|Withdrawal by Subject|0|||
156982746|NCT02038764|566690903|FG001|Overall Study|Withdrawal by Subject|0|||
156982747|NCT02038764|566690904|FG002|Overall Study|Withdrawal by Subject|0|||
156982748|NCT02038764|566690905|FG003|Overall Study|Withdrawal by Subject|0|||
156982749|NCT02038764|566690906|FG004|Overall Study|Withdrawal by Subject|1|||
156982750|NCT02038764|566690902|FG000|Overall Study|Other|1|||
156982751|NCT02038764|566690903|FG001|Overall Study|Other|0|||
156982752|NCT02038764|566690904|FG002|Overall Study|Other|1|||
156982753|NCT02038764|566690905|FG003|Overall Study|Other|0|||
156982754|NCT02038764|566690906|FG004|Overall Study|Other|0|||
156982755|NCT03853317|566690907|FG000|Overall Study|Progressive Disease|5|||
156982756|NCT03853317|566690907|FG000|Overall Study|Adverse Event|1|||
156982757|NCT03853317|566690907|FG000|Overall Study|Death|1|||
156982758|NCT03853317|566690907|FG000|Overall Study|other event|2|||
156982759|NCT01551303|566690922|FG000|Overall Study|failed awareness check on vision test|4|||
156982760|NCT01551303|566690923|FG001|Overall Study|failed awareness check on vision test|7|||
156982761|NCT02141659|566690927|FG000|Overall Study|Major Protocol Deviation|0|||
156982762|NCT02141659|566690928|FG001|Overall Study|Major Protocol Deviation|1|||
156982763|NCT02141659|566690929|FG002|Overall Study|Major Protocol Deviation|0|||
156982764|NCT02141659|566690930|FG003|Overall Study|Major Protocol Deviation|0|||
156982765|NCT02141659|566690931|FG004|Overall Study|Major Protocol Deviation|0|||
156982766|NCT02141659|566690932|FG005|Overall Study|Major Protocol Deviation|0|||
156982767|NCT02141659|566690927|FG000|Overall Study|Lack of Efficacy|0|||
156982768|NCT02141659|566690928|FG001|Overall Study|Lack of Efficacy|0|||
156982769|NCT02141659|566690929|FG002|Overall Study|Lack of Efficacy|0|||
156982770|NCT02141659|566690930|FG003|Overall Study|Lack of Efficacy|0|||
156982771|NCT02141659|566690931|FG004|Overall Study|Lack of Efficacy|0|||
156982772|NCT02141659|566690932|FG005|Overall Study|Lack of Efficacy|1|||
156982773|NCT02141659|566690927|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
156982774|NCT02141659|566690928|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
156982775|NCT02141659|566690929|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
156982776|NCT02141659|566690930|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
156982777|NCT02141659|566690931|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
156982778|NCT02141659|566690932|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
156982779|NCT02471404|566690935|FG000|Overall Study|Adverse Event|7|||
156982780|NCT02471404|566690936|FG001|Overall Study|Adverse Event|1|||
156982781|NCT02471404|566690937|FG002|Overall Study|Adverse Event|2|||
156982782|NCT02471404|566690935|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
156982783|NCT02471404|566690936|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
156982784|NCT02471404|566690937|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
156982785|NCT02471404|566690935|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
156982786|NCT02471404|566690936|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156982787|NCT02471404|566690937|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
156982788|NCT02471404|566690935|FG000|Overall Study|Lost to Follow-up|1|||
156982789|NCT02471404|566690936|FG001|Overall Study|Lost to Follow-up|1|||
156982790|NCT02471404|566690937|FG002|Overall Study|Lost to Follow-up|3|||
156982791|NCT02471404|566690935|FG000|Overall Study|Protocol Violation|1|||
156982792|NCT02471404|566690936|FG001|Overall Study|Protocol Violation|0|||
156982793|NCT02471404|566690937|FG002|Overall Study|Protocol Violation|0|||
156982794|NCT02471404|566690935|FG000|Overall Study|Withdrawal by Subject|8|||
156982795|NCT02471404|566690936|FG001|Overall Study|Withdrawal by Subject|4|||
156982796|NCT02471404|566690937|FG002|Overall Study|Withdrawal by Subject|5|||
156982797|NCT02471404|566690935|FG000|Overall Study|Other reasons not specified|10|||
156982798|NCT02471404|566690936|FG001|Overall Study|Other reasons not specified|7|||
156982799|NCT02471404|566690937|FG002|Overall Study|Other reasons not specified|12|||
156982800|NCT01927731|566690938|FG000|Overall Study|Graft Failure|1|||
156982801|NCT01927731|566690939|FG001|Overall Study|Graft Failure|2|||
156982802|NCT01927731|566690938|FG000|Overall Study|Physician Decision|2|||
156982803|NCT01927731|566690939|FG001|Overall Study|Physician Decision|3|||
156982804|NCT01927731|566690938|FG000|Overall Study|Withdrawal by Subject|0|||
156982805|NCT01927731|566690939|FG001|Overall Study|Withdrawal by Subject|2|||
156982806|NCT01927731|566690938|FG000|Overall Study|Death|0|||
156982807|NCT01927731|566690939|FG001|Overall Study|Death|3|||
156982808|NCT02066532|566690940|FG000|Phase II|Withdrawal by Subject|1|||
156982809|NCT02066532|566690941|FG001|Phase II|Withdrawal by Subject|0|||
156982810|NCT02066532|566690942|FG002|Phase II|Withdrawal by Subject|0|||
156982811|NCT02066532|566690943|FG003|Phase II|Withdrawal by Subject|0|||
156982812|NCT05033080|566690944|FG000|Overall Study|Adverse Event|4|||
156982813|NCT05033080|566690945|FG001|Overall Study|Adverse Event|4|||
156982814|NCT05033080|566690944|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
156982815|NCT05033080|566690945|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
156982816|NCT05033080|566690944|FG000|Overall Study|Lost to Follow-up|1|||
156982817|NCT05033080|566690945|FG001|Overall Study|Lost to Follow-up|0|||
156982818|NCT05033080|566690944|FG000|Overall Study|Other non-compliance|0|||
156982819|NCT05033080|566690945|FG001|Overall Study|Other non-compliance|1|||
156982820|NCT05033080|566690944|FG000|Overall Study|Physician Decision|0|||
156982821|NCT05033080|566690945|FG001|Overall Study|Physician Decision|1|||
156982822|NCT05033080|566690944|FG000|Overall Study|Other|1|||
156982823|NCT05033080|566690945|FG001|Overall Study|Other|1|||
156982824|NCT02303626|566690946|FG000|Overall Study|Lack of Efficacy|1|||
156982825|NCT02303626|566690947|FG001|Overall Study|Lack of Efficacy|0|||
156982826|NCT02303626|566690948|FG002|Overall Study|Lack of Efficacy|1|||
156982827|NCT02303626|566690946|FG000|Overall Study|Adverse Event|0|||
156982828|NCT02303626|566690947|FG001|Overall Study|Adverse Event|2|||
156982829|NCT02303626|566690948|FG002|Overall Study|Adverse Event|0|||
156982830|NCT02303626|566690946|FG000|Overall Study|Protocol Violation|0|||
156982831|NCT02303626|566690947|FG001|Overall Study|Protocol Violation|1|||
156982832|NCT02303626|566690948|FG002|Overall Study|Protocol Violation|0|||
156982833|NCT02303626|566690946|FG000|Overall Study|Pregnancy|0|||
156982834|NCT02303626|566690947|FG001|Overall Study|Pregnancy|0|||
156982835|NCT02303626|566690948|FG002|Overall Study|Pregnancy|1|||
156982836|NCT02303626|566690946|FG000|Overall Study|Subject Non-Compliance|0|||
156982837|NCT02303626|566690947|FG001|Overall Study|Subject Non-Compliance|0|||
156982838|NCT02303626|566690948|FG002|Overall Study|Subject Non-Compliance|1|||
156982839|NCT04159415|566690949|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982840|NCT04159415|566690950|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982841|NCT04159415|566690951|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982842|NCT04159415|566690952|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982843|NCT04159415|566690953|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982844|NCT04159415|566690954|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982845|NCT04159415|566690955|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
156982846|NCT04159415|566690956|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
156982847|NCT04159415|566690957|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982848|NCT04159415|566690958|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
156982849|NCT04159415|566690949|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982850|NCT04159415|566690950|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982851|NCT04159415|566690951|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
157096273|NCT00983931|567107672|FG000|14 Day Washout Period|Physician Decision|1|||
157096274|NCT04640077|567107678|FG000|Period 1|Withdrawal by Subject|4|||
156982852|NCT04159415|566690952|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982853|NCT04159415|566690953|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982854|NCT04159415|566690954|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982855|NCT04159415|566690955|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982856|NCT04159415|566690956|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
156982857|NCT04159415|566690957|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982858|NCT04159415|566690958|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
156982859|NCT04159415|566690949|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982860|NCT04159415|566690950|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982861|NCT04159415|566690951|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982862|NCT04159415|566690952|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982863|NCT04159415|566690953|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982864|NCT04159415|566690954|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982865|NCT04159415|566690955|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982866|NCT04159415|566690956|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
156982867|NCT04159415|566690957|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982868|NCT04159415|566690958|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
156982869|NCT04159415|566690949|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982870|NCT04159415|566690950|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982871|NCT04159415|566690951|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982872|NCT04159415|566690952|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982873|NCT04159415|566690953|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982874|NCT04159415|566690954|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982875|NCT04159415|566690955|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982876|NCT04159415|566690956|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982877|NCT04159415|566690957|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
156982878|NCT04159415|566690958|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
156982879|NCT02138747|566690960|FG000|Treatment Period 1|Adverse Event|10|||
156982880|NCT02138747|566690961|FG001|Treatment Period 1|Adverse Event|14|||
156982881|NCT02138747|566690962|FG002|Treatment Period 1|Adverse Event|2|||
156982882|NCT02138747|566690963|FG003|Treatment Period 1|Adverse Event|1|||
156982883|NCT02138747|566690960|FG000|Treatment Period 1|Lost to Follow-up|0|||
156982884|NCT02138747|566690961|FG001|Treatment Period 1|Lost to Follow-up|1|||
156982885|NCT02138747|566690962|FG002|Treatment Period 1|Lost to Follow-up|1|||
156982886|NCT02138747|566690963|FG003|Treatment Period 1|Lost to Follow-up|0|||
156982887|NCT02138747|566690960|FG000|Treatment Period 1|Protocol Violation|0|||
156982888|NCT02138747|566690961|FG001|Treatment Period 1|Protocol Violation|2|||
156982889|NCT02138747|566690962|FG002|Treatment Period 1|Protocol Violation|0|||
156982890|NCT02138747|566690963|FG003|Treatment Period 1|Protocol Violation|0|||
156982891|NCT02138747|566690960|FG000|Treatment Period 1|Withdrawal by Subject|8|||
156982892|NCT02138747|566690961|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156982893|NCT02138747|566690962|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156982894|NCT02138747|566690963|FG003|Treatment Period 1|Withdrawal by Subject|3|||
156982895|NCT02138747|566690960|FG000|Treatment Period 1|Other - Miscellaneous|2|||
156982896|NCT02138747|566690961|FG001|Treatment Period 1|Other - Miscellaneous|4|||
156982897|NCT02138747|566690962|FG002|Treatment Period 1|Other - Miscellaneous|0|||
156982898|NCT02138747|566690963|FG003|Treatment Period 1|Other - Miscellaneous|0|||
156982899|NCT02138747|566690960|FG000|Treatment Period 2|Adverse Event|6|||
156982900|NCT02138747|566690961|FG001|Treatment Period 2|Adverse Event|3|||
156982901|NCT02138747|566690962|FG002|Treatment Period 2|Adverse Event|1|||
156982902|NCT02138747|566690963|FG003|Treatment Period 2|Adverse Event|1|||
156982903|NCT02138747|566690960|FG000|Treatment Period 2|Lost to Follow-up|2|||
156982904|NCT02138747|566690961|FG001|Treatment Period 2|Lost to Follow-up|0|||
156982905|NCT02138747|566690962|FG002|Treatment Period 2|Lost to Follow-up|0|||
156982906|NCT02138747|566690963|FG003|Treatment Period 2|Lost to Follow-up|0|||
156982907|NCT02138747|566690960|FG000|Treatment Period 2|Protocol Violation|1|||
156982908|NCT02138747|566690961|FG001|Treatment Period 2|Protocol Violation|0|||
156982909|NCT02138747|566690962|FG002|Treatment Period 2|Protocol Violation|0|||
156982910|NCT02138747|566690963|FG003|Treatment Period 2|Protocol Violation|0|||
156982911|NCT02138747|566690960|FG000|Treatment Period 2|Withdrawal by Subject|5|||
156982912|NCT02138747|566690961|FG001|Treatment Period 2|Withdrawal by Subject|4|||
156982913|NCT02138747|566690962|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156982914|NCT02138747|566690963|FG003|Treatment Period 2|Withdrawal by Subject|2|||
156982915|NCT02138747|566690960|FG000|Treatment Period 2|Other - Miscellaneous|3|||
156982916|NCT02138747|566690961|FG001|Treatment Period 2|Other - Miscellaneous|0|||
156982917|NCT02138747|566690962|FG002|Treatment Period 2|Other - Miscellaneous|0|||
156982918|NCT02138747|566690963|FG003|Treatment Period 2|Other - Miscellaneous|0|||
156982919|NCT02302066|566690964|FG000|Overall Study|Adverse Event|1|||
156982920|NCT02302066|566690965|FG001|Overall Study|Adverse Event|1|||
156982921|NCT02302066|566690966|FG002|Overall Study|Adverse Event|3|||
156982922|NCT02302066|566690967|FG003|Overall Study|Adverse Event|0|||
156982923|NCT02302066|566690964|FG000|Overall Study|Lost to Follow-up|4|||
156982924|NCT02302066|566690965|FG001|Overall Study|Lost to Follow-up|5|||
156982925|NCT02302066|566690966|FG002|Overall Study|Lost to Follow-up|24|||
156982926|NCT02302066|566690967|FG003|Overall Study|Lost to Follow-up|7|||
156982927|NCT02302066|566690964|FG000|Overall Study|Withdrawal by Subject|25|||
156982928|NCT02302066|566690965|FG001|Overall Study|Withdrawal by Subject|58|||
156982929|NCT02302066|566690966|FG002|Overall Study|Withdrawal by Subject|124|||
156982930|NCT02302066|566690967|FG003|Overall Study|Withdrawal by Subject|33|||
156982931|NCT02302066|566690964|FG000|Overall Study|Pregnancy|2|||
156982932|NCT02302066|566690965|FG001|Overall Study|Pregnancy|10|||
156982933|NCT02302066|566690966|FG002|Overall Study|Pregnancy|12|||
156982934|NCT02302066|566690967|FG003|Overall Study|Pregnancy|0|||
156982935|NCT02302066|566690964|FG000|Overall Study|Reason Not Specified|1|||
156982936|NCT02302066|566690965|FG001|Overall Study|Reason Not Specified|1|||
156982937|NCT02302066|566690966|FG002|Overall Study|Reason Not Specified|9|||
156982938|NCT02302066|566690967|FG003|Overall Study|Reason Not Specified|1|||
156982939|NCT03406702|566690972|FG000|Overall Study|Missed Day 27 Dosing|1|||
156982940|NCT00735644|566690974|FG000|Overall Study|Did not receive study vaccine|0|||
156982941|NCT00735644|566690975|FG001|Overall Study|Did not receive study vaccine|1|||
156982942|NCT00735644|566690976|FG002|Overall Study|Did not receive study vaccine|0|||
156982943|NCT00735644|566690977|FG003|Overall Study|Did not receive study vaccine|0|||
156982944|NCT00735644|566690978|FG004|Overall Study|Did not receive study vaccine|0|||
156982945|NCT00735644|566690974|FG000|Overall Study|Withdrawal by Subject|0|||
156982946|NCT00735644|566690975|FG001|Overall Study|Withdrawal by Subject|1|||
156982947|NCT00735644|566690976|FG002|Overall Study|Withdrawal by Subject|1|||
156982948|NCT00735644|566690977|FG003|Overall Study|Withdrawal by Subject|1|||
156982949|NCT00735644|566690978|FG004|Overall Study|Withdrawal by Subject|0|||
156982950|NCT00655551|566690979|FG000|All Periods Combined|Adverse Event|0|||
156982951|NCT00655551|566690980|FG001|All Periods Combined|Adverse Event|3|||
156982952|NCT00655551|566690981|FG002|All Periods Combined|Adverse Event|4|||
156982953|NCT00655551|566690979|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
156982954|NCT00655551|566690980|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
156982955|NCT00655551|566690981|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
156982956|NCT00655551|566690979|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
156982957|NCT00655551|566690980|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
156982958|NCT00655551|566690981|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
156982959|NCT00655551|566690979|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
156982960|NCT00655551|566690980|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
156982961|NCT00655551|566690981|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
157096275|NCT04640077|567107679|FG001|Period 1|Withdrawal by Subject|5|||
157096276|NCT04640077|567107680|FG002|Period 1|Withdrawal by Subject|0|||
156982962|NCT00876460|566690982|FG000|Combination Therapy Phase|Progressive disease|2|||
156982963|NCT00876460|566690983|FG001|Combination Therapy Phase|Progressive disease|3|||
156982964|NCT00876460|566690984|FG002|Combination Therapy Phase|Progressive disease|3|||
156982965|NCT00876460|566690985|FG003|Combination Therapy Phase|Progressive disease|3|||
156982966|NCT00876460|566690986|FG004|Combination Therapy Phase|Progressive disease|3|||
156982967|NCT00876460|566690987|FG005|Combination Therapy Phase|Progressive disease|1|||
156982968|NCT00876460|566690988|FG006|Combination Therapy Phase|Progressive disease|1|||
156982969|NCT00876460|566690989|FG007|Combination Therapy Phase|Progressive disease|1|||
156982970|NCT00876460|566690982|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
156982971|NCT00876460|566690983|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
156982972|NCT00876460|566690984|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
156982973|NCT00876460|566690985|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
156982974|NCT00876460|566690986|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
156982975|NCT00876460|566690987|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
156982976|NCT00876460|566690988|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
156982977|NCT00876460|566690989|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
156982978|NCT00876460|566690982|FG000|Combination Therapy Phase|Adverse Event|0|||
156982979|NCT00876460|566690983|FG001|Combination Therapy Phase|Adverse Event|2|||
156982980|NCT00876460|566690984|FG002|Combination Therapy Phase|Adverse Event|0|||
156982981|NCT00876460|566690985|FG003|Combination Therapy Phase|Adverse Event|2|||
156982982|NCT00876460|566690986|FG004|Combination Therapy Phase|Adverse Event|2|||
156982983|NCT00876460|566690987|FG005|Combination Therapy Phase|Adverse Event|0|||
156982984|NCT00876460|566690988|FG006|Combination Therapy Phase|Adverse Event|3|||
156982985|NCT00876460|566690989|FG007|Combination Therapy Phase|Adverse Event|2|||
156982986|NCT00876460|566690982|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
156982987|NCT00876460|566690983|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
156982988|NCT00876460|566690984|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
157096277|NCT04640077|567107678|FG000|Period 1|Adverse Event|1|||
156982989|NCT00876460|566690985|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
156982990|NCT00876460|566690986|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
156982991|NCT00876460|566690987|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
156982992|NCT00876460|566690988|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
156982993|NCT00876460|566690989|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
156982994|NCT00876460|566690982|FG000|Combination Therapy Phase|Other reason not defined above|0|||
156982995|NCT00876460|566690983|FG001|Combination Therapy Phase|Other reason not defined above|0|||
156982996|NCT00876460|566690984|FG002|Combination Therapy Phase|Other reason not defined above|0|||
156982997|NCT00876460|566690985|FG003|Combination Therapy Phase|Other reason not defined above|0|||
157096278|NCT04640077|567107679|FG001|Period 1|Adverse Event|1|||
157096279|NCT04640077|567107680|FG002|Period 1|Adverse Event|0|||
157096280|NCT04640077|567107678|FG000|Period 1|Screen Failure|2|||
157096281|NCT04640077|567107679|FG001|Period 1|Screen Failure|0|||
157096282|NCT04640077|567107680|FG002|Period 1|Screen Failure|0|||
157096283|NCT04640077|567107678|FG000|Period 2|Withdrawal by Subject|0|||
157096284|NCT04640077|567107679|FG001|Period 2|Withdrawal by Subject|0|||
157096285|NCT04640077|567107680|FG002|Period 2|Withdrawal by Subject|18|||
157096286|NCT04640077|567107678|FG000|Period 2|Adverse Event|0|||
157096287|NCT04640077|567107679|FG001|Period 2|Adverse Event|0|||
157096288|NCT04640077|567107680|FG002|Period 2|Adverse Event|6|||
157096289|NCT04640077|567107678|FG000|Period 2|Lost to Follow-up|0|||
157096290|NCT04640077|567107679|FG001|Period 2|Lost to Follow-up|0|||
157096291|NCT04640077|567107680|FG002|Period 2|Lost to Follow-up|2|||
157096292|NCT04640077|567107678|FG000|Period 2|Death|0|||
157096293|NCT04640077|567107679|FG001|Period 2|Death|0|||
157096294|NCT04640077|567107680|FG002|Period 2|Death|2|||
157096295|NCT04640077|567107678|FG000|Period 2|Progressive Disease|0|||
157096296|NCT04640077|567107679|FG001|Period 2|Progressive Disease|0|||
157096297|NCT04640077|567107680|FG002|Period 2|Progressive Disease|1|||
157096298|NCT04640077|567107678|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
157096299|NCT04640077|567107679|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
156982998|NCT00876460|566690986|FG004|Combination Therapy Phase|Other reason not defined above|0|||
156982999|NCT00876460|566690987|FG005|Combination Therapy Phase|Other reason not defined above|0|||
156983000|NCT00876460|566690988|FG006|Combination Therapy Phase|Other reason not defined above|1|||
156983001|NCT00876460|566690989|FG007|Combination Therapy Phase|Other reason not defined above|2|||
156983002|NCT00876460|566690982|FG000|Combination Therapy Phase|Not treated|0|||
156983003|NCT00876460|566690983|FG001|Combination Therapy Phase|Not treated|0|||
156983004|NCT00876460|566690984|FG002|Combination Therapy Phase|Not treated|0|||
156983005|NCT00876460|566690985|FG003|Combination Therapy Phase|Not treated|0|||
156983006|NCT00876460|566690986|FG004|Combination Therapy Phase|Not treated|0|||
156983007|NCT00876460|566690987|FG005|Combination Therapy Phase|Not treated|0|||
156983008|NCT00876460|566690988|FG006|Combination Therapy Phase|Not treated|1|||
156983009|NCT00876460|566690989|FG007|Combination Therapy Phase|Not treated|0|||
156983010|NCT00876460|566690982|FG000|Mono Therapy Phase|Progressive disease|0|||
156983011|NCT00876460|566690983|FG001|Mono Therapy Phase|Progressive disease|0|||
156983012|NCT00876460|566690984|FG002|Mono Therapy Phase|Progressive disease|0|||
156983013|NCT00876460|566690985|FG003|Mono Therapy Phase|Progressive disease|0|||
156983014|NCT00876460|566690986|FG004|Mono Therapy Phase|Progressive disease|2|||
156983015|NCT00876460|566690987|FG005|Mono Therapy Phase|Progressive disease|0|||
156983016|NCT00876460|566690988|FG006|Mono Therapy Phase|Progressive disease|1|||
156983017|NCT00876460|566690989|FG007|Mono Therapy Phase|Progressive disease|3|||
156983018|NCT00876460|566690982|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
156983019|NCT00876460|566690983|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
156983020|NCT00876460|566690984|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
156983021|NCT00876460|566690985|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
156983022|NCT00876460|566690986|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
156983023|NCT00876460|566690987|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
156983024|NCT00876460|566690988|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
156983025|NCT00876460|566690989|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
156983026|NCT00876460|566690982|FG000|Mono Therapy Phase|Adverse Event|0|||
156983027|NCT00876460|566690983|FG001|Mono Therapy Phase|Adverse Event|0|||
156983028|NCT00876460|566690984|FG002|Mono Therapy Phase|Adverse Event|0|||
156983029|NCT00876460|566690985|FG003|Mono Therapy Phase|Adverse Event|1|||
156983030|NCT00876460|566690986|FG004|Mono Therapy Phase|Adverse Event|0|||
156983031|NCT00876460|566690987|FG005|Mono Therapy Phase|Adverse Event|0|||
156983032|NCT00876460|566690988|FG006|Mono Therapy Phase|Adverse Event|0|||
156983033|NCT00876460|566690989|FG007|Mono Therapy Phase|Adverse Event|0|||
156983034|NCT02049710|566690990|FG000|Overall Study|Lost to Follow-up|319|||
156983035|NCT02049710|566690991|FG001|Overall Study|Lost to Follow-up|324|||
156983036|NCT00003458|566690992|FG000|Overall Study|Not evaluable|4|||
156983037|NCT06385483|566690993|FG000|Overall Study|Withdrawal by Subject|2|||
156983038|NCT06385483|566690993|FG000|Overall Study|Never start protocol therapy|2|||
156983039|NCT06385483|566690993|FG000|Overall Study|Disease progression|15|||
156983040|NCT01216293|566690994|FG000|Main Study|Adverse Event|1|||
156983041|NCT01216293|566690995|FG001|Main Study|Adverse Event|4|||
156983042|NCT01216293|566690996|FG002|Main Study|Adverse Event|2|||
156983043|NCT01216293|566690994|FG000|Main Study|Major Protocol Deviation|1|||
156983044|NCT01216293|566690995|FG001|Main Study|Major Protocol Deviation|0|||
156983045|NCT01216293|566690996|FG002|Main Study|Major Protocol Deviation|1|||
156983046|NCT01216293|566690994|FG000|Main Study|Lost to Follow-up|3|||
156983047|NCT01216293|566690995|FG001|Main Study|Lost to Follow-up|1|||
156983048|NCT01216293|566690996|FG002|Main Study|Lost to Follow-up|0|||
156983049|NCT01216293|566690994|FG000|Main Study|Voluntary Withdrawal|2|||
156983050|NCT01216293|566690995|FG001|Main Study|Voluntary Withdrawal|2|||
156983051|NCT01216293|566690996|FG002|Main Study|Voluntary Withdrawal|2|||
156983052|NCT01216293|566690994|FG000|Main Study|Other Reason Not Specified|0|||
156983053|NCT01216293|566690995|FG001|Main Study|Other Reason Not Specified|1|||
156983054|NCT01216293|566690996|FG002|Main Study|Other Reason Not Specified|1|||
156983055|NCT01216293|566690994|FG000|Main Study|Randomized, Not Treated|1|||
156983056|NCT01216293|566690995|FG001|Main Study|Randomized, Not Treated|0|||
156983057|NCT01216293|566690996|FG002|Main Study|Randomized, Not Treated|0|||
156983058|NCT01216293|566690994|FG000|Calcium Absorption Substudy|Adverse Event|0|||
156983059|NCT01216293|566690995|FG001|Calcium Absorption Substudy|Adverse Event|2|||
156983060|NCT01216293|566690996|FG002|Calcium Absorption Substudy|Adverse Event|0|||
156983061|NCT01216293|566690994|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
156983062|NCT01216293|566690995|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
156983063|NCT01216293|566690996|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
156983064|NCT01216293|566690994|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
157096300|NCT04640077|567107680|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
156983065|NCT01216293|566690995|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
156983066|NCT01216293|566690996|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
156983067|NCT01040780|566692915|FG000|Overall Study|Protocol Violation|1|||
156983068|NCT01040780|566692916|FG001|Overall Study|Protocol Violation|3|||
156983069|NCT03681639|566692917|FG000|Overall Study|Death|4|||
156983070|NCT03681639|566692917|FG000|Overall Study|Lost to Follow-up|2|||
156983071|NCT03681639|566692917|FG000|Overall Study|Withdrawal by Subject|1|||
156983072|NCT03681639|566692917|FG000|Overall Study|Adverse Event|2|||
156983073|NCT01818141|566692923|FG000|Overall Study|Withdrawal by Subject|2|||
156983074|NCT01818141|566692924|FG001|Overall Study|Withdrawal by Subject|0|||
156983075|NCT01818141|566692923|FG000|Overall Study|No baseline C.diff colonies|1|||
156983076|NCT01818141|566692924|FG001|Overall Study|No baseline C.diff colonies|1|||
156983077|NCT01818141|566692923|FG000|Overall Study|Lost to Follow-up|0|||
156983078|NCT01818141|566692924|FG001|Overall Study|Lost to Follow-up|2|||
156983079|NCT03204695|566692927|FG000|Overall Study|Death|1|||
156983080|NCT03204695|566692927|FG000|Overall Study|Participant was treated with another device|1|||
156983081|NCT03204695|566692927|FG000|Overall Study|Physician Decision|2|||
156983082|NCT04834362|566692928|FG000|Overall Study|Death|1|||
156983083|NCT04834362|566692929|FG001|Overall Study|Death|2|||
156983084|NCT02391038|566692930|FG000|Overall Study|Progressive disease|3|||
156983085|NCT02391038|566692931|FG001|Overall Study|Progressive disease|3|||
156983086|NCT02391038|566692932|FG002|Overall Study|Progressive disease|6|||
156983087|NCT01327547|566692938|FG000|Overall Study|Adverse Event|4|||
156983088|NCT01327547|566692939|FG001|Overall Study|Adverse Event|1|||
156983089|NCT01327547|566692938|FG000|Overall Study|Death|1|||
156983090|NCT01327547|566692939|FG001|Overall Study|Death|2|||
156983091|NCT01327547|566692938|FG000|Overall Study|Lost to Follow-up|6|||
156983092|NCT01327547|566692939|FG001|Overall Study|Lost to Follow-up|6|||
156983093|NCT01327547|566692938|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
156983094|NCT01327547|566692939|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
156983095|NCT01327547|566692938|FG000|Overall Study|Withdrawal by Subject|3|||
156983096|NCT01327547|566692939|FG001|Overall Study|Withdrawal by Subject|7|||
156983097|NCT01327547|566692938|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
156983098|NCT01327547|566692939|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
156983099|NCT01327547|566692938|FG000|Overall Study|Protocol Violation|1|||
156983100|NCT01327547|566692939|FG001|Overall Study|Protocol Violation|0|||
156983101|NCT01327547|566692938|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
156983102|NCT01327547|566692939|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
156983103|NCT01327547|566692938|FG000|Overall Study|Required prohibited medication|2|||
156983104|NCT01327547|566692939|FG001|Overall Study|Required prohibited medication|0|||
156983105|NCT01327547|566692938|FG000|Overall Study|Non-compliance with study procedures|1|||
156983106|NCT01327547|566692939|FG001|Overall Study|Non-compliance with study procedures|0|||
156983107|NCT01327547|566692938|FG000|Overall Study|By investigator in subject's interest|0|||
156983108|NCT01327547|566692939|FG001|Overall Study|By investigator in subject's interest|1|||
156983109|NCT00329719|566692940|FG000|Overall Study|Lost to Follow-up|0|||
156983110|NCT00329719|566692941|FG001|Overall Study|Lost to Follow-up|0|||
156983111|NCT00329719|566692942|FG002|Overall Study|Lost to Follow-up|0|||
156983112|NCT00329719|566692943|FG003|Overall Study|Lost to Follow-up|1|||
156983113|NCT01004250|566692946|FG000|Induction Therapy Period|Adverse Event|10|||
156983114|NCT01004250|566692946|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
156983115|NCT01004250|566692946|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
156983116|NCT01004250|566692946|FG000|Induction Therapy Period|Physician Decision|2|||
156983117|NCT01004250|566692946|FG000|Maintenance Therapy Period|Adverse Event|15|||
156983118|NCT01004250|566692946|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
156983119|NCT01004250|566692946|FG000|Maintenance Therapy Period|Protocol Violation|1|||
156983120|NCT01004250|566692946|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
156983121|NCT01004250|566692946|FG000|Maintenance Therapy Period|Physician Decision|4|||
156983122|NCT01004250|566692946|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
156983123|NCT03943589|566692947|FG000|Overall Study|Death|1|||
156983124|NCT03943589|566692947|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
156983125|NCT04329104|566692948|FG000|Efficacy Study|Withdrawal by Subject|0|||
156983126|NCT04329104|566692949|FG001|Efficacy Study|Withdrawal by Subject|0|||
156983127|NCT04329104|566692950|FG002|Efficacy Study|Withdrawal by Subject|0|||
156983128|NCT04329104|566692951|FG003|Efficacy Study|Withdrawal by Subject|5|||
156983129|NCT04329104|566692952|FG004|Efficacy Study|Withdrawal by Subject|6|||
156983130|NCT04329104|566692953|FG005|Efficacy Study|Withdrawal by Subject|8|||
156983131|NCT04076020|566692960|FG000|Overall Study|Death|4|||
156983132|NCT04076020|566692961|FG001|Overall Study|Death|6|||
156983133|NCT04076020|566692960|FG000|Overall Study|Withdrawal by Subject|12|||
156983134|NCT04076020|566692961|FG001|Overall Study|Withdrawal by Subject|8|||
156983135|NCT00502996|566692966|FG000|Overall Study|Lost to Follow-up|9|||
156983136|NCT00502996|566692966|FG000|Overall Study|Protocol Violation|2|||
156983137|NCT00502996|566692966|FG000|Overall Study|Treatment failure|25|||
156983138|NCT00502996|566692966|FG000|Overall Study|Withdrawal Informed Consent|6|||
156983139|NCT00502996|566692966|FG000|Overall Study|Adverse Event|2|||
156983140|NCT01729728|566692967|FG000|Overall Study|Adverse Event|0|||
156983141|NCT01729728|566692968|FG001|Overall Study|Adverse Event|6|||
156983142|NCT01729728|566692969|FG002|Overall Study|Adverse Event|0|||
156983143|NCT01729728|566692967|FG000|Overall Study|Protocol Violation|1|||
156983144|NCT01729728|566692968|FG001|Overall Study|Protocol Violation|0|||
156983145|NCT01729728|566692969|FG002|Overall Study|Protocol Violation|1|||
156983146|NCT01316692|566692970|FG000|Overall Study|Adverse Event|5|||
156983147|NCT01316692|566692970|FG000|Overall Study|Disease Progression|7|||
156983148|NCT02001974|566692971|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
156983149|NCT02001974|566692972|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
156983150|NCT02001974|566692973|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
156983151|NCT02001974|566692971|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
156983152|NCT02001974|566692972|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
156983153|NCT02001974|566692973|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
156983154|NCT02001974|566692971|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
156983155|NCT02001974|566692972|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
156983156|NCT02001974|566692973|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
156983157|NCT02001974|566692971|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
156983158|NCT02001974|566692972|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
156983159|NCT02001974|566692973|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
156983160|NCT00993317|566692974|FG000|Overall Study|Adverse Event|2|||
156983161|NCT00993317|566692975|FG001|Overall Study|Adverse Event|4|||
156983162|NCT00993317|566692974|FG000|Overall Study|Lack of Efficacy|18|||
156983163|NCT00993317|566692975|FG001|Overall Study|Lack of Efficacy|18|||
156983164|NCT00993317|566692974|FG000|Overall Study|Withdrawal by Subject|0|||
156983165|NCT00993317|566692975|FG001|Overall Study|Withdrawal by Subject|2|||
156983166|NCT00993317|566692974|FG000|Overall Study|Investigator's opinion|0|||
156983167|NCT00993317|566692975|FG001|Overall Study|Investigator's opinion|1|||
156983168|NCT00993317|566692974|FG000|Overall Study|Early study termination at the site|1|||
156983169|NCT00993317|566692975|FG001|Overall Study|Early study termination at the site|0|||
156983170|NCT00672958|566692976|FG000|Overall Study|Adverse Event|11|||
156983171|NCT00672958|566692977|FG001|Overall Study|Adverse Event|9|||
156983172|NCT00672958|566692976|FG000|Overall Study|Lack of Efficacy|6|||
156983173|NCT00672958|566692977|FG001|Overall Study|Lack of Efficacy|11|||
156983174|NCT00672958|566692976|FG000|Overall Study|Non-compliance with study drug|2|||
156983175|NCT00672958|566692977|FG001|Overall Study|Non-compliance with study drug|3|||
156983176|NCT00672958|566692976|FG000|Overall Study|Protocol deviations|11|||
156983177|NCT00672958|566692977|FG001|Overall Study|Protocol deviations|5|||
156983178|NCT00672958|566692976|FG000|Overall Study|Voluntary withdrawal|12|||
156983179|NCT00672958|566692977|FG001|Overall Study|Voluntary withdrawal|8|||
156983180|NCT00672958|566692976|FG000|Overall Study|Lost to Follow-up|22|||
156983181|NCT00672958|566692977|FG001|Overall Study|Lost to Follow-up|17|||
156983182|NCT00672958|566692976|FG000|Overall Study|Reason not specified|0|||
156983183|NCT00672958|566692977|FG001|Overall Study|Reason not specified|3|||
156983184|NCT01380990|566692978|FG000|Overall Study|Treatment Failure|1|||
156983185|NCT01380990|566692979|FG001|Overall Study|Treatment Failure|0|||
156983186|NCT01380990|566692978|FG000|Overall Study|Death|0|||
156983187|NCT01380990|566692979|FG001|Overall Study|Death|1|||
156983188|NCT04844918|566692980|FG000|Overall Study|Adverse Event|7|||
156983189|NCT04844918|566692981|FG001|Overall Study|Adverse Event|8|||
156983190|NCT04844918|566692982|FG002|Overall Study|Adverse Event|5|||
156983191|NCT04844918|566692980|FG000|Overall Study|Physician Decision|0|||
156983192|NCT04844918|566692981|FG001|Overall Study|Physician Decision|1|||
156983193|NCT04844918|566692982|FG002|Overall Study|Physician Decision|0|||
156983194|NCT04844918|566692980|FG000|Overall Study|Withdrawal by Subject|6|||
156983195|NCT04844918|566692981|FG001|Overall Study|Withdrawal by Subject|3|||
156983196|NCT04844918|566692982|FG002|Overall Study|Withdrawal by Subject|3|||
157096301|NCT02409368|567107681|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
156983197|NCT04844918|566692980|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
156983198|NCT04844918|566692981|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
157096302|NCT02409368|567107682|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
157096303|NCT02409368|567107683|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
157096304|NCT02409368|567107684|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
157096305|NCT02409368|567107681|FG000|ECOG Reclassification|Death|1|||
157096306|NCT02409368|567107682|FG001|ECOG Reclassification|Death|5|||
157096307|NCT02409368|567107683|FG002|ECOG Reclassification|Death|0|||
156983199|NCT04844918|566692982|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
156983200|NCT01009047|566692986|FG000|Overall Study|Adverse Event|5|||
156983201|NCT01009047|566692987|FG001|Overall Study|Adverse Event|0|||
156983202|NCT01009047|566692986|FG000|Overall Study|Lost to Follow-up|0|||
156983203|NCT01009047|566692987|FG001|Overall Study|Lost to Follow-up|2|||
156983204|NCT01009047|566692986|FG000|Overall Study|Lack of Efficacy|4|||
156983205|NCT01009047|566692987|FG001|Overall Study|Lack of Efficacy|11|||
156983206|NCT01009047|566692986|FG000|Overall Study|Withdrawal by consent|16|||
156983207|NCT01009047|566692987|FG001|Overall Study|Withdrawal by consent|11|||
156983208|NCT01009047|566692986|FG000|Overall Study|Other|3|||
156983209|NCT01009047|566692987|FG001|Overall Study|Other|2|||
156983210|NCT04716881|566692988|FG000|Overall Study|Adverse Event|1|||
156983211|NCT04716881|566692988|FG000|Overall Study|Lost to Follow-up|1|||
156983212|NCT02878213|566692990|FG000|Overall Study|Withdrawal by Subject|2|||
156983213|NCT02878213|566692990|FG000|Overall Study|Adverse Event|1|||
156983214|NCT01558674|566692991|FG000|Part 1|Study Terminated by Sponsor|10|||
156983215|NCT01558674|566692992|FG001|Part 1|Study Terminated by Sponsor|0|||
156983216|NCT01558674|566692991|FG000|Part 1|Withdrawal by Subject|1|||
156983217|NCT01558674|566692992|FG001|Part 1|Withdrawal by Subject|0|||
156983218|NCT02589392|566692995|FG000|Overall Study|Adverse Event|1|||
156983219|NCT02589392|566692996|FG001|Overall Study|Adverse Event|1|||
156983220|NCT02589392|566692995|FG000|Overall Study|Withdrawal by Subject|1|||
156983221|NCT02589392|566692996|FG001|Overall Study|Withdrawal by Subject|2|||
156983222|NCT02589392|566692995|FG000|Overall Study|Protocol Violation|1|||
156983223|NCT02589392|566692996|FG001|Overall Study|Protocol Violation|1|||
156983224|NCT02589392|566692995|FG000|Overall Study|Lost to Follow-up|2|||
156983225|NCT02589392|566692996|FG001|Overall Study|Lost to Follow-up|2|||
156983226|NCT02589392|566692995|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
156983227|NCT02589392|566692996|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
156983228|NCT03051659|566692997|FG000|Treatment Period|Withdrawal by Subject|0|||
156983229|NCT03051659|566692998|FG001|Treatment Period|Withdrawal by Subject|2|||
156983230|NCT03051659|566692997|FG000|Survival Follow-up|Lost to Follow-up|23|||
156983231|NCT03051659|566692998|FG001|Survival Follow-up|Lost to Follow-up|22|||
156983232|NCT00849680|566693000|FG000|Overall Study|Adverse Event|0|||
156983233|NCT00849680|566693001|FG001|Overall Study|Adverse Event|0|||
156983234|NCT00849680|566693002|FG002|Overall Study|Adverse Event|0|||
156983235|NCT00849680|566693003|FG003|Overall Study|Adverse Event|0|||
156983236|NCT00849680|566693004|FG004|Overall Study|Adverse Event|0|||
156983237|NCT00849680|566693005|FG005|Overall Study|Adverse Event|0|||
156983238|NCT00849680|566693006|FG006|Overall Study|Adverse Event|2|||
156983239|NCT00849680|566693007|FG007|Overall Study|Adverse Event|0|||
156983240|NCT00849680|566693000|FG000|Overall Study|Lost to Follow-up|7|||
156983241|NCT00849680|566693001|FG001|Overall Study|Lost to Follow-up|3|||
156983242|NCT00849680|566693002|FG002|Overall Study|Lost to Follow-up|12|||
156983243|NCT00849680|566693003|FG003|Overall Study|Lost to Follow-up|11|||
156983244|NCT00849680|566693004|FG004|Overall Study|Lost to Follow-up|8|||
156983245|NCT00849680|566693005|FG005|Overall Study|Lost to Follow-up|11|||
156983246|NCT00849680|566693006|FG006|Overall Study|Lost to Follow-up|12|||
156983247|NCT00849680|566693007|FG007|Overall Study|Lost to Follow-up|5|||
156983248|NCT00849680|566693000|FG000|Overall Study|Subject moved|1|||
156983249|NCT00849680|566693001|FG001|Overall Study|Subject moved|0|||
156983250|NCT00849680|566693002|FG002|Overall Study|Subject moved|3|||
156983251|NCT00849680|566693003|FG003|Overall Study|Subject moved|1|||
156983252|NCT00849680|566693004|FG004|Overall Study|Subject moved|0|||
156983253|NCT00849680|566693005|FG005|Overall Study|Subject moved|2|||
156983254|NCT00849680|566693006|FG006|Overall Study|Subject moved|2|||
156983255|NCT00849680|566693007|FG007|Overall Study|Subject moved|2|||
156983256|NCT00849680|566693000|FG000|Overall Study|Withdrawal by Subject|2|||
156983257|NCT00849680|566693001|FG001|Overall Study|Withdrawal by Subject|0|||
156983258|NCT00849680|566693002|FG002|Overall Study|Withdrawal by Subject|0|||
157096308|NCT02409368|567107684|FG003|ECOG Reclassification|Death|0|||
157096309|NCT02409368|567107681|FG000|ECOG Reclassification|Disease Progression|113|||
156983259|NCT00849680|566693003|FG003|Overall Study|Withdrawal by Subject|2|||
156983260|NCT00849680|566693004|FG004|Overall Study|Withdrawal by Subject|2|||
156983261|NCT00849680|566693005|FG005|Overall Study|Withdrawal by Subject|2|||
156983262|NCT00849680|566693006|FG006|Overall Study|Withdrawal by Subject|1|||
156983263|NCT00849680|566693007|FG007|Overall Study|Withdrawal by Subject|1|||
156983264|NCT00849680|566693000|FG000|Overall Study|Subject unable to comply with protocol|1|||
156983265|NCT00849680|566693001|FG001|Overall Study|Subject unable to comply with protocol|0|||
156983266|NCT00849680|566693002|FG002|Overall Study|Subject unable to comply with protocol|0|||
156983267|NCT00849680|566693003|FG003|Overall Study|Subject unable to comply with protocol|0|||
156983268|NCT00849680|566693004|FG004|Overall Study|Subject unable to comply with protocol|0|||
156983269|NCT00849680|566693005|FG005|Overall Study|Subject unable to comply with protocol|0|||
156983270|NCT00849680|566693006|FG006|Overall Study|Subject unable to comply with protocol|0|||
156983271|NCT00849680|566693007|FG007|Overall Study|Subject unable to comply with protocol|0|||
156983272|NCT00785538|566693008|FG000|Treatment Period|Adverse Event|1|||
156983273|NCT00785538|566693009|FG001|Treatment Period|Adverse Event|2|||
156983274|NCT00785538|566693010|FG002|Treatment Period|Adverse Event|2|||
156983275|NCT00785538|566693011|FG003|Treatment Period|Adverse Event|0|||
156983276|NCT00785538|566693008|FG000|Treatment Period|Withdrawal by Subject|0|||
156983277|NCT00785538|566693009|FG001|Treatment Period|Withdrawal by Subject|0|||
156983278|NCT00785538|566693010|FG002|Treatment Period|Withdrawal by Subject|0|||
156983279|NCT00785538|566693011|FG003|Treatment Period|Withdrawal by Subject|1|||
156983280|NCT00322374|566693012|FG000|Starting Dose|Physician Decision|2|||
156983281|NCT00322374|566693013|FG001|Starting Dose|Physician Decision|0|||
156983282|NCT00322374|566693014|FG002|Starting Dose|Physician Decision|0|||
156983283|NCT00322374|566693015|FG003|Starting Dose|Physician Decision|0|||
156983284|NCT00322374|566693012|FG000|Starting Dose|Study Drug Toxicity|4|||
156983285|NCT00322374|566693013|FG001|Starting Dose|Study Drug Toxicity|0|||
156983286|NCT00322374|566693014|FG002|Starting Dose|Study Drug Toxicity|0|||
156983287|NCT00322374|566693015|FG003|Starting Dose|Study Drug Toxicity|0|||
156983288|NCT00322374|566693012|FG000|First Escalation|Documented Disease Progression|0|||
156983289|NCT00322374|566693013|FG001|First Escalation|Documented Disease Progression|6|||
156983290|NCT00322374|566693014|FG002|First Escalation|Documented Disease Progression|0|||
156983291|NCT00322374|566693015|FG003|First Escalation|Documented Disease Progression|0|||
156983292|NCT00322374|566693012|FG000|First Escalation|Physician Decision|0|||
156983293|NCT00322374|566693013|FG001|First Escalation|Physician Decision|12|||
156983294|NCT00322374|566693014|FG002|First Escalation|Physician Decision|0|||
156983295|NCT00322374|566693015|FG003|First Escalation|Physician Decision|0|||
156983296|NCT00322374|566693012|FG000|First Escalation|Study Drug Toxicity|0|||
156983297|NCT00322374|566693013|FG001|First Escalation|Study Drug Toxicity|11|||
156983298|NCT00322374|566693014|FG002|First Escalation|Study Drug Toxicity|0|||
156983299|NCT00322374|566693015|FG003|First Escalation|Study Drug Toxicity|0|||
156983300|NCT00322374|566693012|FG000|First Escalation|Participant Request|0|||
156983301|NCT00322374|566693013|FG001|First Escalation|Participant Request|1|||
156983302|NCT00322374|566693014|FG002|First Escalation|Participant Request|0|||
156983303|NCT00322374|566693015|FG003|First Escalation|Participant Request|0|||
156983304|NCT00322374|566693012|FG000|Second Escalation|Physician Decision|0|||
156983305|NCT00322374|566693013|FG001|Second Escalation|Physician Decision|0|||
156983306|NCT00322374|566693014|FG002|Second Escalation|Physician Decision|5|||
157096310|NCT02409368|567107682|FG001|ECOG Reclassification|Disease Progression|382|||
157096311|NCT02409368|567107683|FG002|ECOG Reclassification|Disease Progression|70|||
157096312|NCT02409368|567107684|FG003|ECOG Reclassification|Disease Progression|1|||
157096313|NCT02409368|567107681|FG000|ECOG Reclassification|Lost to Follow-up|1|||
157096314|NCT02409368|567107682|FG001|ECOG Reclassification|Lost to Follow-up|5|||
157096315|NCT02409368|567107683|FG002|ECOG Reclassification|Lost to Follow-up|0|||
156983307|NCT00322374|566693015|FG003|Second Escalation|Physician Decision|0|||
156983308|NCT00322374|566693012|FG000|Second Escalation|Study Drug Toxicity|0|||
156983309|NCT00322374|566693013|FG001|Second Escalation|Study Drug Toxicity|0|||
156983310|NCT00322374|566693014|FG002|Second Escalation|Study Drug Toxicity|1|||
156983311|NCT00322374|566693015|FG003|Second Escalation|Study Drug Toxicity|0|||
156983312|NCT03382600|566693016|FG000|Overall Study|Adverse Event|3|||
156983313|NCT03382600|566693017|FG001|Overall Study|Adverse Event|3|||
156983314|NCT03382600|566693016|FG000|Overall Study|Clinical Disease Progression|2|||
156983315|NCT03382600|566693017|FG001|Overall Study|Clinical Disease Progression|4|||
156983316|NCT03382600|566693016|FG000|Overall Study|Radiological Progression|40|||
156983317|NCT03382600|566693017|FG001|Overall Study|Radiological Progression|31|||
156983318|NCT03382600|566693016|FG000|Overall Study|Withdrawal by Subject|0|||
156983319|NCT03382600|566693017|FG001|Overall Study|Withdrawal by Subject|1|||
156983320|NCT03382600|566693016|FG000|Overall Study|Other|9|||
156983321|NCT03382600|566693017|FG001|Overall Study|Other|7|||
156983322|NCT02269943|566693018|FG000|Treatment Period|Death|0|||
156983323|NCT02269943|566693019|FG001|Treatment Period|Death|1|||
156983324|NCT02269943|566693018|FG000|Treatment Period|Adverse Event|1|||
156983325|NCT02269943|566693019|FG001|Treatment Period|Adverse Event|10|||
156983326|NCT02269943|566693018|FG000|Treatment Period|Progressive Disease|5|||
156983327|NCT02269943|566693019|FG001|Treatment Period|Progressive Disease|17|||
156983328|NCT02269943|566693018|FG000|Treatment Period|Symptomatic Deterioration|0|||
156983329|NCT02269943|566693019|FG001|Treatment Period|Symptomatic Deterioration|2|||
156983330|NCT02269943|566693018|FG000|Follow-Up Survival Period|Death|3|||
156983331|NCT02269943|566693019|FG001|Follow-Up Survival Period|Death|16|||
156983332|NCT02269943|566693018|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
156983333|NCT02269943|566693019|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
156983334|NCT02269943|566693018|FG000|Follow-Up Survival Period|Alive|2|||
157096316|NCT02409368|567107684|FG003|ECOG Reclassification|Lost to Follow-up|0|||
156983335|NCT02269943|566693019|FG001|Follow-Up Survival Period|Alive|8|||
156983336|NCT04285229|566693020|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
157096317|NCT02409368|567107681|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
156983337|NCT04285229|566693021|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156983338|NCT04285229|566693022|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156983339|NCT04285229|566693023|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156983340|NCT04285229|566693024|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156983341|NCT04285229|566693025|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156983342|NCT04285229|566693020|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
156983343|NCT04285229|566693021|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
156983344|NCT04285229|566693022|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
156983345|NCT04285229|566693023|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
156983346|NCT04285229|566693024|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
156983347|NCT04285229|566693025|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
156983348|NCT04285229|566693020|FG000|Extended Treatment Period|Adverse Event|0|||
156983349|NCT04285229|566693021|FG001|Extended Treatment Period|Adverse Event|0|||
156983350|NCT04285229|566693022|FG002|Extended Treatment Period|Adverse Event|0|||
156983351|NCT04285229|566693023|FG003|Extended Treatment Period|Adverse Event|1|||
156983352|NCT04285229|566693024|FG004|Extended Treatment Period|Adverse Event|0|||
156983353|NCT04285229|566693025|FG005|Extended Treatment Period|Adverse Event|0|||
156983354|NCT04285229|566693020|FG000|Extended Treatment Period|Physician Decision|0|||
156983355|NCT04285229|566693021|FG001|Extended Treatment Period|Physician Decision|0|||
156983356|NCT04285229|566693022|FG002|Extended Treatment Period|Physician Decision|1|||
156983357|NCT04285229|566693023|FG003|Extended Treatment Period|Physician Decision|0|||
156983358|NCT04285229|566693024|FG004|Extended Treatment Period|Physician Decision|0|||
156983359|NCT04285229|566693025|FG005|Extended Treatment Period|Physician Decision|0|||
156983360|NCT04285229|566693020|FG000|Follow-up Period|Adverse Event|0|||
156983361|NCT04285229|566693021|FG001|Follow-up Period|Adverse Event|0|||
156983362|NCT04285229|566693022|FG002|Follow-up Period|Adverse Event|0|||
156983363|NCT04285229|566693023|FG003|Follow-up Period|Adverse Event|0|||
156983364|NCT04285229|566693024|FG004|Follow-up Period|Adverse Event|1|||
156983365|NCT04285229|566693025|FG005|Follow-up Period|Adverse Event|4|||
156983366|NCT04285229|566693020|FG000|Follow-up Period|Withdrawal by Subject|0|||
156983367|NCT04285229|566693021|FG001|Follow-up Period|Withdrawal by Subject|0|||
156983368|NCT04285229|566693022|FG002|Follow-up Period|Withdrawal by Subject|0|||
156983369|NCT04285229|566693023|FG003|Follow-up Period|Withdrawal by Subject|0|||
156983370|NCT04285229|566693024|FG004|Follow-up Period|Withdrawal by Subject|0|||
156983371|NCT04285229|566693025|FG005|Follow-up Period|Withdrawal by Subject|5|||
156983372|NCT04285229|566693020|FG000|Follow-up Period|Covid-19|0|||
156983373|NCT04285229|566693021|FG001|Follow-up Period|Covid-19|0|||
156983374|NCT04285229|566693022|FG002|Follow-up Period|Covid-19|0|||
156983375|NCT04285229|566693023|FG003|Follow-up Period|Covid-19|0|||
156983376|NCT04285229|566693024|FG004|Follow-up Period|Covid-19|0|||
156983377|NCT04285229|566693025|FG005|Follow-up Period|Covid-19|2|||
156983378|NCT04285229|566693020|FG000|Follow-up Period|Physician Decision|0|||
156983379|NCT04285229|566693021|FG001|Follow-up Period|Physician Decision|0|||
156983380|NCT04285229|566693022|FG002|Follow-up Period|Physician Decision|0|||
156983381|NCT04285229|566693023|FG003|Follow-up Period|Physician Decision|0|||
156983382|NCT04285229|566693024|FG004|Follow-up Period|Physician Decision|0|||
156983383|NCT04285229|566693025|FG005|Follow-up Period|Physician Decision|1|||
156983384|NCT03560245|566693026|FG000|Overall Study|Withdrawal by Subject|3|||
156983385|NCT03560245|566693027|FG001|Overall Study|Withdrawal by Subject|2|||
157096318|NCT02409368|567107682|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
157096319|NCT02409368|567107683|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
157096320|NCT02409368|567107684|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
157096321|NCT02409368|567107681|FG000|ECOG Reclassification|Poor/non-compliance|0|||
156751693|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
156751694|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
156751695|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
156751696|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
156751697|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
156751698|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751699|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751700|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751701|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751702|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751703|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751704|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751705|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156751706|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156751707|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156751708|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156983386|NCT03560245|566693026|FG000|Overall Study|Adverse Event|1|||
156983387|NCT03560245|566693027|FG001|Overall Study|Adverse Event|1|||
156983388|NCT03560245|566693026|FG000|Overall Study|Protocol Violation|1|||
156983389|NCT03560245|566693027|FG001|Overall Study|Protocol Violation|0|||
156983390|NCT03560245|566693026|FG000|Overall Study|Death|0|||
156983391|NCT03560245|566693027|FG001|Overall Study|Death|1|||
156983392|NCT03560245|566693026|FG000|Overall Study|Lost to Follow-up|0|||
156983393|NCT03560245|566693027|FG001|Overall Study|Lost to Follow-up|1|||
156983394|NCT03560245|566693026|FG000|Overall Study|Physician Decision|0|||
156983395|NCT03560245|566693027|FG001|Overall Study|Physician Decision|1|||
156983396|NCT03560245|566693026|FG000|Overall Study|Other|0|||
156983397|NCT03560245|566693027|FG001|Overall Study|Other|1|||
156983398|NCT01680458|566693034|FG000|Overall Study|Protocol Violation|3|||
156983399|NCT04318093|566693036|FG000|Overall Study|Adverse Event|2|||
156983400|NCT04318093|566693037|FG001|Overall Study|Adverse Event|2|||
156983401|NCT04318093|566693036|FG000|Overall Study|Participant withdrew consent|1|||
156983402|NCT04318093|566693037|FG001|Overall Study|Participant withdrew consent|0|||
156983403|NCT04318093|566693036|FG000|Overall Study|Other reasons|0|||
156983404|NCT04318093|566693037|FG001|Overall Study|Other reasons|1|||
156983405|NCT00514046|566693042|FG000|Overall Study|transferred to another protocol|2|||
156983406|NCT00514046|566693043|FG001|Overall Study|transferred to another protocol|1|||
156983407|NCT00514046|566693044|FG002|Overall Study|transferred to another protocol|3|||
156983408|NCT00514046|566693045|FG003|Overall Study|transferred to another protocol|0|||
156983409|NCT00514046|566693046|FG004|Overall Study|transferred to another protocol|1|||
156983410|NCT00514046|566693047|FG005|Overall Study|transferred to another protocol|0|||
156983411|NCT00514046|566693048|FG006|Overall Study|transferred to another protocol|0|||
157096322|NCT02409368|567107682|FG001|ECOG Reclassification|Poor/non-compliance|3|||
157096323|NCT02409368|567107683|FG002|ECOG Reclassification|Poor/non-compliance|2|||
157096324|NCT02409368|567107684|FG003|ECOG Reclassification|Poor/non-compliance|0|||
157096325|NCT02409368|567107681|FG000|ECOG Reclassification|Study drug toxicity|17|||
157096326|NCT02409368|567107682|FG001|ECOG Reclassification|Study drug toxicity|42|||
157096327|NCT02409368|567107683|FG002|ECOG Reclassification|Study drug toxicity|7|||
157096328|NCT02409368|567107684|FG003|ECOG Reclassification|Study drug toxicity|0|||
157096329|NCT02409368|567107681|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
157096330|NCT02409368|567107682|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
157096331|NCT02409368|567107683|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
157096332|NCT02409368|567107684|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
157096333|NCT02409368|567107681|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
157096334|NCT02409368|567107682|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
157096335|NCT02409368|567107683|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
157096336|NCT02409368|567107684|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
157096337|NCT02409368|567107681|FG000|ECOG Reclassification|Participant withdrew consent|2|||
157096338|NCT02409368|567107682|FG001|ECOG Reclassification|Participant withdrew consent|3|||
157096339|NCT02409368|567107683|FG002|ECOG Reclassification|Participant withdrew consent|4|||
157096340|NCT02409368|567107684|FG003|ECOG Reclassification|Participant withdrew consent|0|||
157096341|NCT02409368|567107681|FG000|ECOG Reclassification|Other Reasons|5|||
157096342|NCT02409368|567107682|FG001|ECOG Reclassification|Other Reasons|26|||
157096343|NCT02409368|567107683|FG002|ECOG Reclassification|Other Reasons|2|||
157096344|NCT02409368|567107684|FG003|ECOG Reclassification|Other Reasons|0|||
157096345|NCT02409368|567107681|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
157096346|NCT02409368|567107682|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
157096347|NCT02409368|567107683|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
157096348|NCT02409368|567107684|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
157096349|NCT01296347|567107685|FG000|Allocation|Withdrawal by Subject|1|||
157096350|NCT01296347|567107686|FG001|Allocation|Withdrawal by Subject|2|||
157096351|NCT01296347|567107685|FG000|Allocation|Lack of Efficacy|1|||
157096352|NCT01296347|567107686|FG001|Allocation|Lack of Efficacy|2|||
157096353|NCT01296347|567107685|FG000|Allocation|not received infusion|1|||
157096354|NCT01296347|567107686|FG001|Allocation|not received infusion|0|||
157096355|NCT01296347|567107685|FG000|6 Week Follow up|Death|0|||
157096356|NCT01296347|567107686|FG001|6 Week Follow up|Death|1|||
157096357|NCT01296347|567107685|FG000|3 Month Follow up|Death|1|||
157096358|NCT01296347|567107686|FG001|3 Month Follow up|Death|0|||
157096359|NCT01296347|567107685|FG000|3 Month Follow up|Lost to Follow-up|0|||
156983412|NCT00514046|566693049|FG007|Overall Study|transferred to another protocol|0|||
156983413|NCT00514046|566693050|FG008|Overall Study|transferred to another protocol|0|||
156983414|NCT00514046|566693042|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
156983415|NCT00514046|566693043|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
156983416|NCT00514046|566693044|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
156983417|NCT00514046|566693045|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
157096360|NCT01296347|567107686|FG001|3 Month Follow up|Lost to Follow-up|1|||
157096361|NCT01296347|567107685|FG000|6 Month Follow up|Death|2|||
157096362|NCT01296347|567107686|FG001|6 Month Follow up|Death|1|||
157096363|NCT01296347|567107685|FG000|6 Month Follow up|Lost to Follow-up|0|||
157096364|NCT01296347|567107686|FG001|6 Month Follow up|Lost to Follow-up|1|||
157096365|NCT01296347|567107685|FG000|12 Month Follow up|Lost to Follow-up|3|||
157096366|NCT01296347|567107686|FG001|12 Month Follow up|Lost to Follow-up|1|||
157096367|NCT01296347|567107685|FG000|12 Month Follow up|Death|1|||
157096368|NCT01296347|567107686|FG001|12 Month Follow up|Death|1|||
157096369|NCT01296347|567107685|FG000|12 Month Follow up|Withdrawal by Subject|0|||
157096370|NCT01296347|567107686|FG001|12 Month Follow up|Withdrawal by Subject|1|||
157096371|NCT01910181|567107692|FG000|Overall Study|Death|37|||
157096372|NCT01910181|567107692|FG000|Overall Study|Lost to Follow-up|3|||
157096373|NCT01910181|567107692|FG000|Overall Study|Study Terminated by Sponsor|6|||
157096374|NCT02656823|567107693|FG000|Overall Study|Adverse Event|3|||
157096375|NCT02656823|567107693|FG000|Overall Study|Lost to Follow-up|2|||
157096376|NCT03567434|567107694|FG000|Overall Study|Lost to Follow-up|1|||
157096377|NCT03567434|567107695|FG001|Overall Study|Lost to Follow-up|3|||
157096378|NCT04469270|567107699|FG000|Overall Study|Adverse Event|2|||
157096379|NCT04469270|567107700|FG001|Overall Study|Adverse Event|0|||
157096380|NCT04469270|567107699|FG000|Overall Study|Lost to Follow-up|4|||
157096381|NCT04469270|567107700|FG001|Overall Study|Lost to Follow-up|3|||
157096382|NCT04469270|567107699|FG000|Overall Study|Withdrawal by Subject|7|||
157096383|NCT04469270|567107700|FG001|Overall Study|Withdrawal by Subject|3|||
157096384|NCT04469270|567107699|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
157096385|NCT04469270|567107700|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
157096386|NCT04469270|567107699|FG000|Overall Study|missing|1|||
157096387|NCT04469270|567107700|FG001|Overall Study|missing|0|||
157096388|NCT05269355|567107708|FG000|Overall Study|Progressive Disease|104|||
157096389|NCT05269355|567107709|FG001|Overall Study|Progressive Disease|68|||
157096390|NCT05269355|567107708|FG000|Overall Study|Study Terminated by Sponsor|87|||
157096391|NCT05269355|567107709|FG001|Overall Study|Study Terminated by Sponsor|29|||
157096392|NCT05269355|567107708|FG000|Overall Study|Adverse Event|15|||
157096393|NCT05269355|567107709|FG001|Overall Study|Adverse Event|8|||
157096394|NCT05269355|567107708|FG000|Overall Study|Withdrawal by Subject|18|||
157096395|NCT05269355|567107709|FG001|Overall Study|Withdrawal by Subject|5|||
157096396|NCT05269355|567107708|FG000|Overall Study|Physician Decision|6|||
157096397|NCT05269355|567107709|FG001|Overall Study|Physician Decision|4|||
157096398|NCT05269355|567107708|FG000|Overall Study|Death|3|||
157096399|NCT05269355|567107709|FG001|Overall Study|Death|5|||
157096400|NCT05269355|567107708|FG000|Overall Study|Other Than Specified|5|||
157096401|NCT05269355|567107709|FG001|Overall Study|Other Than Specified|1|||
157096402|NCT05269355|567107708|FG000|Overall Study|Randomized But Not Treated|1|||
157096403|NCT05269355|567107709|FG001|Overall Study|Randomized But Not Treated|0|||
157096404|NCT01050790|567107710|FG000|Overall Study|Adverse Event|1|||
157096405|NCT03705832|567107711|FG000|Overall Study|Physician Decision|0|||
157096406|NCT03705832|567107712|FG001|Overall Study|Physician Decision|1|||
157096407|NCT03705832|567107711|FG000|Overall Study|Withdrawal by Subject|1|||
157096408|NCT03705832|567107712|FG001|Overall Study|Withdrawal by Subject|0|||
157096409|NCT01880528|567107713|FG000|Overall Study|Other|1|||
157096410|NCT01880528|567107714|FG001|Overall Study|Other|1|||
157096411|NCT00081497|567107715|FG000|Overall Study|Adverse Event|2|||
157096412|NCT00081497|567107716|FG001|Overall Study|Adverse Event|0|||
157096413|NCT00081497|567107715|FG000|Overall Study|Death|0|||
157096414|NCT00081497|567107716|FG001|Overall Study|Death|1|||
157096415|NCT00081497|567107715|FG000|Overall Study|Withdrawal by Subject|1|||
157096416|NCT00081497|567107716|FG001|Overall Study|Withdrawal by Subject|0|||
157096417|NCT00081497|567107715|FG000|Overall Study|Non-compliance|0|||
157096418|NCT00081497|567107716|FG001|Overall Study|Non-compliance|1|||
157096419|NCT01439360|567107717|FG000|Overall Study|Adverse Event|4|||
157096420|NCT01439360|567107718|FG001|Overall Study|Adverse Event|16|||
157096421|NCT01439360|567107717|FG000|Overall Study|Lost to Follow-up|43|||
157096422|NCT01439360|567107718|FG001|Overall Study|Lost to Follow-up|58|||
157096423|NCT01439360|567107717|FG000|Overall Study|Others|10|||
157096424|NCT01439360|567107718|FG001|Overall Study|Others|5|||
157096425|NCT01439360|567107717|FG000|Overall Study|Protocol Violation|1|||
157096426|NCT01439360|567107718|FG001|Overall Study|Protocol Violation|0|||
157096427|NCT01439360|567107717|FG000|Overall Study|Withdrawal by Subject|140|||
157096428|NCT01439360|567107718|FG001|Overall Study|Withdrawal by Subject|129|||
157096429|NCT02390245|567107720|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
157096430|NCT02390245|567107721|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
157096431|NCT02390245|567107722|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
157096432|NCT02390245|567107720|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
157096433|NCT02390245|567107721|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
157096434|NCT02390245|567107722|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
157096435|NCT05437510|567107725|FG000|Overall Study|Adverse Event|2|||
157096436|NCT05437510|567107726|FG001|Overall Study|Adverse Event|1|||
157096437|NCT05437510|567107725|FG000|Overall Study|Protocol Deviation|1|||
157096438|NCT05437510|567107726|FG001|Overall Study|Protocol Deviation|6|||
157096439|NCT05437510|567107725|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
157096440|NCT05437510|567107726|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
157096441|NCT05437510|567107725|FG000|Overall Study|Lost to Follow-up|265|||
157096442|NCT05437510|567107726|FG001|Overall Study|Lost to Follow-up|358|||
157096443|NCT03573401|567107727|FG000|Overall Study|Withdrawal by Subject|2|||
157096444|NCT03573401|567107728|FG001|Overall Study|Withdrawal by Subject|0|||
157096445|NCT03573401|567107727|FG000|Overall Study|Subject non-compliance with study schedule|1|||
157096446|NCT03573401|567107728|FG001|Overall Study|Subject non-compliance with study schedule|0|||
157096447|NCT03573401|567107727|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
157096448|NCT03573401|567107728|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
157096449|NCT03573401|567107727|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
157096450|NCT03573401|567107728|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
157096451|NCT01195545|567109188|FG000|Overall Study|Protocol Violation|4|||
157096452|NCT00300781|567109190|FG000|Overall Study|Disease Progression|55|||
157096453|NCT00300781|567109191|FG001|Overall Study|Disease Progression|52|||
157096454|NCT00300781|567109190|FG000|Overall Study|Adverse Event|5|||
157096455|NCT00300781|567109191|FG001|Overall Study|Adverse Event|6|||
157096456|NCT00300781|567109190|FG000|Overall Study|Withdrawal by Subject|1|||
157096457|NCT00300781|567109191|FG001|Overall Study|Withdrawal by Subject|2|||
157096458|NCT00300781|567109190|FG000|Overall Study|Physician Decision|1|||
157096459|NCT00300781|567109191|FG001|Overall Study|Physician Decision|0|||
157096460|NCT00300781|567109190|FG000|Overall Study|Not Recorded|0|||
157096461|NCT00300781|567109191|FG001|Overall Study|Not Recorded|1|||
157096462|NCT00300781|567109190|FG000|Overall Study|Symptomatic Deterioration|1|||
157096463|NCT00300781|567109191|FG001|Overall Study|Symptomatic Deterioration|0|||
157096464|NCT00300781|567109190|FG000|Overall Study|Lost to Follow-up|0|||
157096465|NCT00300781|567109191|FG001|Overall Study|Lost to Follow-up|1|||
157096466|NCT00792805|567109192|FG000|Overall Study|Adverse Event|12|||
157096467|NCT00792805|567109193|FG001|Overall Study|Adverse Event|10|||
157096468|NCT00792805|567109194|FG002|Overall Study|Adverse Event|10|||
157096469|NCT00792805|567109192|FG000|Overall Study|Subject withdrew consent|5|||
157096470|NCT00792805|567109193|FG001|Overall Study|Subject withdrew consent|6|||
157096471|NCT00792805|567109194|FG002|Overall Study|Subject withdrew consent|5|||
157096472|NCT00792805|567109192|FG000|Overall Study|Administrative problems|2|||
157096473|NCT00792805|567109193|FG001|Overall Study|Administrative problems|0|||
157096474|NCT00792805|567109194|FG002|Overall Study|Administrative problems|4|||
157096475|NCT00792805|567109192|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157096476|NCT00792805|567109193|FG001|Overall Study|Abnormal test procedure result(s)|2|||
157096477|NCT00792805|567109194|FG002|Overall Study|Abnormal test procedure result(s)|0|||
157096478|NCT00792805|567109192|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157096479|NCT00792805|567109193|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
157096480|NCT00792805|567109194|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
157096481|NCT00792805|567109192|FG000|Overall Study|Lost to Follow-up|1|||
157096482|NCT00792805|567109193|FG001|Overall Study|Lost to Follow-up|1|||
157096483|NCT00792805|567109194|FG002|Overall Study|Lost to Follow-up|6|||
157096484|NCT00792805|567109192|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157096485|NCT00792805|567109193|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157096486|NCT00792805|567109194|FG002|Overall Study|Abnormal laboratory value(s)|1|||
157096487|NCT00792805|567109192|FG000|Overall Study|Protocol deviation|0|||
157096488|NCT00792805|567109193|FG001|Overall Study|Protocol deviation|1|||
157096489|NCT00792805|567109194|FG002|Overall Study|Protocol deviation|1|||
157096490|NCT02072434|567109198|FG000|Overall Study|Protocol Violation|10|||
157096491|NCT02072434|567109199|FG001|Overall Study|Protocol Violation|9|||
157096492|NCT02072434|567109198|FG000|Overall Study|Physician Decision|5|||
157096493|NCT02072434|567109199|FG001|Overall Study|Physician Decision|10|||
157096494|NCT02072434|567109198|FG000|Overall Study|Adverse event, serious fatal|1|||
157096495|NCT02072434|567109199|FG001|Overall Study|Adverse event, serious fatal|6|||
157096496|NCT02072434|567109198|FG000|Overall Study|Adverse Event|7|||
157096497|NCT02072434|567109199|FG001|Overall Study|Adverse Event|6|||
157096498|NCT02072434|567109198|FG000|Overall Study|Withdrawal by Subject|17|||
157096499|NCT02072434|567109199|FG001|Overall Study|Withdrawal by Subject|29|||
157096500|NCT02072434|567109198|FG000|Overall Study|Other|14|||
157096501|NCT02072434|567109199|FG001|Overall Study|Other|29|||
157096502|NCT02072434|567109198|FG000|Overall Study|Lost to Follow-up|0|||
157096503|NCT02072434|567109199|FG001|Overall Study|Lost to Follow-up|1|||
157096504|NCT02525861|567109202|FG000|Overall Study|Adverse Event|1|||
157096505|NCT02525861|567109203|FG001|Overall Study|Adverse Event|0|||
157096506|NCT02525861|567109202|FG000|Overall Study|Withdrawal by Subject|0|||
157096507|NCT02525861|567109203|FG001|Overall Study|Withdrawal by Subject|1|||
157096508|NCT02525861|567109202|FG000|Overall Study|Physician Decision|0|||
157096509|NCT02525861|567109203|FG001|Overall Study|Physician Decision|1|||
157096510|NCT00888433|567109204|FG000|Overall Study|Withdrawal by Subject|1|||
157096511|NCT00888433|567109205|FG001|Overall Study|Withdrawal by Subject|2|||
157096512|NCT00888433|567109204|FG000|Overall Study|Missed Visit|2|||
157096513|NCT00888433|567109205|FG001|Overall Study|Missed Visit|1|||
157096514|NCT00402363|567109206|FG000|Overall Study|Adverse Event|9|||
157096515|NCT00402363|567109207|FG001|Overall Study|Adverse Event|14|||
157096516|NCT00402363|567109208|FG002|Overall Study|Adverse Event|2|||
157096517|NCT00402363|567109209|FG003|Overall Study|Adverse Event|2|||
157096518|NCT00402363|567109206|FG000|Overall Study|Withdrew Consent|10|||
157096519|NCT00402363|567109207|FG001|Overall Study|Withdrew Consent|5|||
157096520|NCT00402363|567109208|FG002|Overall Study|Withdrew Consent|2|||
157096521|NCT00402363|567109209|FG003|Overall Study|Withdrew Consent|1|||
157096522|NCT00402363|567109206|FG000|Overall Study|Protocol Violation|3|||
157096523|NCT00402363|567109207|FG001|Overall Study|Protocol Violation|5|||
157096524|NCT00402363|567109208|FG002|Overall Study|Protocol Violation|0|||
157096525|NCT00402363|567109209|FG003|Overall Study|Protocol Violation|3|||
157096526|NCT00402363|567109206|FG000|Overall Study|Lost to Follow-up|5|||
157096527|NCT00402363|567109207|FG001|Overall Study|Lost to Follow-up|4|||
157096528|NCT00402363|567109208|FG002|Overall Study|Lost to Follow-up|0|||
157096529|NCT00402363|567109209|FG003|Overall Study|Lost to Follow-up|2|||
157096530|NCT00402363|567109206|FG000|Overall Study|"Captured as Other"|6|||
157096531|NCT00402363|567109207|FG001|Overall Study|"Captured as Other"|2|||
157096532|NCT00402363|567109208|FG002|Overall Study|"Captured as Other"|2|||
157096533|NCT00402363|567109209|FG003|Overall Study|"Captured as Other"|2|||
157096534|NCT01607554|567109220|FG000|Overall Study|Disease progression|2|||
157096535|NCT03952806|567109221|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
157096536|NCT03952806|567109222|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
157096537|NCT03952806|567109221|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
157096538|NCT03952806|567109222|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
157096539|NCT03952806|567109221|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
157096540|NCT03952806|567109222|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
157096541|NCT03952806|567109221|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
157096542|NCT03952806|567109222|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
156751709|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
156983418|NCT00514046|566693046|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
156983419|NCT00514046|566693047|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
156983420|NCT00514046|566693048|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
157096543|NCT03952806|567109221|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
156983421|NCT00514046|566693049|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
156983422|NCT00514046|566693050|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
156983423|NCT00514046|566693042|FG000|Overall Study|Disease progression on study|0|||
156983424|NCT00514046|566693043|FG001|Overall Study|Disease progression on study|0|||
156983425|NCT00514046|566693044|FG002|Overall Study|Disease progression on study|2|||
156983426|NCT00514046|566693045|FG003|Overall Study|Disease progression on study|0|||
156983427|NCT00514046|566693046|FG004|Overall Study|Disease progression on study|0|||
156983428|NCT00514046|566693047|FG005|Overall Study|Disease progression on study|1|||
156983429|NCT00514046|566693048|FG006|Overall Study|Disease progression on study|0|||
156983430|NCT00514046|566693049|FG007|Overall Study|Disease progression on study|0|||
156983431|NCT00514046|566693050|FG008|Overall Study|Disease progression on study|0|||
156983432|NCT01734434|566693051|FG000|Overall Study|Death Infant|3|||
156983433|NCT01734434|566693052|FG001|Overall Study|Death Infant|1|||
156983434|NCT01734434|566693053|FG002|Overall Study|Death Infant|17|||
156983435|NCT01734434|566693054|FG003|Overall Study|Death Infant|5|||
156983436|NCT01734434|566693051|FG000|Overall Study|Lost to Follow-up|2|||
156983437|NCT01734434|566693052|FG001|Overall Study|Lost to Follow-up|9|||
156983438|NCT01734434|566693053|FG002|Overall Study|Lost to Follow-up|67|||
156983439|NCT01734434|566693054|FG003|Overall Study|Lost to Follow-up|11|||
156983440|NCT01734434|566693051|FG000|Overall Study|No Live Birth|1|||
156983441|NCT01734434|566693052|FG001|Overall Study|No Live Birth|2|||
156983442|NCT01734434|566693053|FG002|Overall Study|No Live Birth|32|||
156983443|NCT01734434|566693054|FG003|Overall Study|No Live Birth|6|||
156983444|NCT01734434|566693051|FG000|Overall Study|Withdrawal by Subject|4|||
156983445|NCT01734434|566693052|FG001|Overall Study|Withdrawal by Subject|0|||
156983446|NCT01734434|566693053|FG002|Overall Study|Withdrawal by Subject|8|||
156983447|NCT01734434|566693054|FG003|Overall Study|Withdrawal by Subject|1|||
156983448|NCT01734434|566693051|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
156983449|NCT01734434|566693052|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
156983450|NCT01734434|566693053|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
156983451|NCT01734434|566693054|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
156983452|NCT01734434|566693051|FG000|Overall Study|Subject Not Reachable|0|||
156983453|NCT01734434|566693052|FG001|Overall Study|Subject Not Reachable|0|||
156983454|NCT01734434|566693053|FG002|Overall Study|Subject Not Reachable|1|||
156983455|NCT01734434|566693054|FG003|Overall Study|Subject Not Reachable|0|||
156983456|NCT01734434|566693051|FG000|Overall Study|Treatment Defaulter|0|||
156983457|NCT01734434|566693052|FG001|Overall Study|Treatment Defaulter|0|||
156983458|NCT01734434|566693053|FG002|Overall Study|Treatment Defaulter|1|||
156983459|NCT01734434|566693054|FG003|Overall Study|Treatment Defaulter|0|||
156983460|NCT01734434|566693051|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
156983461|NCT01734434|566693052|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
156983462|NCT01734434|566693053|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
156983463|NCT01734434|566693054|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
156983464|NCT01734434|566693051|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156983465|NCT01734434|566693052|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156983466|NCT01734434|566693053|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
156983467|NCT01734434|566693054|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
156983468|NCT02855164|566693056|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156983469|NCT02855164|566693057|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156983470|NCT02855164|566693058|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
156983471|NCT02855164|566693059|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
156983472|NCT02855164|566693060|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
156983473|NCT02855164|566693061|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156983474|NCT02855164|566693062|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156983475|NCT02855164|566693063|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
156983476|NCT02855164|566693056|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
156983477|NCT02855164|566693057|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
156983478|NCT02855164|566693058|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
156983479|NCT02855164|566693059|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
156983480|NCT02855164|566693060|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
156983481|NCT02855164|566693061|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
156983482|NCT02855164|566693062|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
156983483|NCT02855164|566693063|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
156983484|NCT02855164|566693056|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
156983485|NCT02855164|566693057|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
156983486|NCT02855164|566693058|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
156983487|NCT02855164|566693059|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
156983488|NCT02855164|566693060|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
156983489|NCT02855164|566693061|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
156983490|NCT02855164|566693062|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
156983491|NCT02855164|566693063|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
156983492|NCT02855164|566693056|FG000|Part C (Randomized Set)|Adverse Event|0|||
156983493|NCT02855164|566693057|FG001|Part C (Randomized Set)|Adverse Event|0|||
156983494|NCT02855164|566693058|FG002|Part C (Randomized Set)|Adverse Event|0|||
157096544|NCT03952806|567109222|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
156751710|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
157096545|NCT03952806|567109221|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
156983495|NCT02855164|566693059|FG003|Part C (Randomized Set)|Adverse Event|0|||
156983496|NCT02855164|566693060|FG004|Part C (Randomized Set)|Adverse Event|0|||
156983497|NCT02855164|566693061|FG005|Part C (Randomized Set)|Adverse Event|5|||
156983498|NCT02855164|566693062|FG006|Part C (Randomized Set)|Adverse Event|9|||
156983499|NCT02855164|566693063|FG007|Part C (Randomized Set)|Adverse Event|2|||
156983500|NCT02855164|566693056|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
156983501|NCT02855164|566693057|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
156983502|NCT02855164|566693058|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
156983503|NCT02855164|566693059|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
156983504|NCT02855164|566693060|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
156983505|NCT02855164|566693061|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
156983506|NCT02855164|566693062|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
156983507|NCT02855164|566693063|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
156983508|NCT02855164|566693056|FG000|Part C (Randomized Set)|Physician Decision|0|||
156983509|NCT02855164|566693057|FG001|Part C (Randomized Set)|Physician Decision|0|||
156983510|NCT02855164|566693058|FG002|Part C (Randomized Set)|Physician Decision|0|||
156983511|NCT02855164|566693059|FG003|Part C (Randomized Set)|Physician Decision|0|||
156983512|NCT02855164|566693060|FG004|Part C (Randomized Set)|Physician Decision|0|||
156983513|NCT02855164|566693061|FG005|Part C (Randomized Set)|Physician Decision|1|||
156983514|NCT02855164|566693062|FG006|Part C (Randomized Set)|Physician Decision|0|||
156983515|NCT02855164|566693063|FG007|Part C (Randomized Set)|Physician Decision|1|||
156983516|NCT02855164|566693056|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
156983517|NCT02855164|566693057|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
156983518|NCT02855164|566693058|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
156983519|NCT02855164|566693059|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
156983520|NCT02855164|566693060|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
156983521|NCT02855164|566693061|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
156983522|NCT02855164|566693062|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
156983523|NCT02855164|566693063|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
156983524|NCT03391960|566693068|FG000|Overall Study|Protocol Violation|0|||
156983525|NCT03391960|566693069|FG001|Overall Study|Protocol Violation|0|||
156983526|NCT02169830|566694985|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
156983527|NCT02169830|566694986|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
156983528|NCT02169830|566694987|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
156983529|NCT02169830|566694985|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
156983530|NCT02169830|566694986|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156983531|NCT02169830|566694987|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156983532|NCT02169830|566694985|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
157096546|NCT03952806|567109222|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
157096547|NCT03952806|567109221|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
157096548|NCT03952806|567109222|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
156751711|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
156983533|NCT02169830|566694986|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
156983534|NCT02169830|566694987|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156983535|NCT02169830|566694985|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
156983536|NCT02169830|566694986|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
156983537|NCT02169830|566694987|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
156983538|NCT02169830|566694985|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
156983539|NCT02169830|566694986|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
156983540|NCT02169830|566694987|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
156983541|NCT02555371|566694990|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
156983542|NCT02555371|566694991|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156983543|NCT02555371|566694992|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156983544|NCT02555371|566694993|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156983545|NCT02555371|566694994|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
156983546|NCT02555371|566694990|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
156983547|NCT02555371|566694991|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156983548|NCT02555371|566694992|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156983549|NCT02555371|566694993|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156983550|NCT02555371|566694994|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
156983551|NCT02555371|566694990|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
156983552|NCT02555371|566694991|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156983553|NCT02555371|566694992|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156983554|NCT02555371|566694993|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156983555|NCT02555371|566694994|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
156983556|NCT02555371|566694990|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
156983557|NCT02555371|566694991|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156983558|NCT02555371|566694992|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156983559|NCT02555371|566694993|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156983560|NCT02555371|566694994|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
156983561|NCT02555371|566694990|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
156983562|NCT02555371|566694991|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156983563|NCT02555371|566694992|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156983564|NCT02555371|566694993|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156983565|NCT02555371|566694994|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
156983566|NCT02555371|566694990|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156983567|NCT02555371|566694991|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
156983568|NCT02555371|566694992|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
156983569|NCT02555371|566694993|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156983570|NCT02555371|566694994|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
156983571|NCT02555371|566694990|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156983572|NCT02555371|566694991|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
156983573|NCT02555371|566694992|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
156983574|NCT02555371|566694993|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156983575|NCT02555371|566694994|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
156983576|NCT02555371|566694990|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156983577|NCT02555371|566694991|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
156983578|NCT02555371|566694992|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156983579|NCT02555371|566694993|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156983580|NCT02555371|566694994|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
156983581|NCT02555371|566694990|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156983582|NCT02555371|566694991|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
156983583|NCT02555371|566694992|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
156983584|NCT02555371|566694993|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156983585|NCT02555371|566694994|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
156983586|NCT02555371|566694990|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156983587|NCT02555371|566694991|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156983588|NCT02555371|566694992|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156983589|NCT02555371|566694993|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
156983590|NCT02555371|566694994|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
156983591|NCT02555371|566694990|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156983592|NCT02555371|566694991|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156983593|NCT02555371|566694992|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156983594|NCT02555371|566694993|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
156983595|NCT02555371|566694994|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
156983596|NCT02555371|566694990|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156983597|NCT02555371|566694991|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156983598|NCT02555371|566694992|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156983599|NCT02555371|566694993|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
156983600|NCT02555371|566694994|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
156983601|NCT02555371|566694990|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156983602|NCT02555371|566694991|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156983603|NCT02555371|566694992|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156983604|NCT02555371|566694993|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
156983605|NCT02555371|566694994|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
156983606|NCT02555371|566694990|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156983607|NCT02555371|566694991|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156983608|NCT02555371|566694992|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
157096549|NCT03952806|567109221|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
156983609|NCT02555371|566694993|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
156983610|NCT02555371|566694994|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
156983611|NCT03095599|566694995|FG000|Overall Study|Withdrawal by Subject|1|||
156983612|NCT03095599|566694996|FG001|Overall Study|Withdrawal by Subject|0|||
156983613|NCT03095599|566694995|FG000|Overall Study|Lost to Follow-up|1|||
156751712|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156983614|NCT03095599|566694996|FG001|Overall Study|Lost to Follow-up|0|||
156983615|NCT03095599|566694995|FG000|Overall Study|Withdrawal prior to vaccination|1|||
156983616|NCT03095599|566694996|FG001|Overall Study|Withdrawal prior to vaccination|0|||
156983617|NCT00742885|566694999|FG000|Overall Study|Lost to Follow-up|1|||
156983618|NCT00742885|566695000|FG001|Overall Study|Lost to Follow-up|0|||
156983619|NCT04781647|566695001|FG000|Overall Study|Study terminated by Sponsor|11|||
156983620|NCT04781647|566695002|FG001|Overall Study|Study terminated by Sponsor|9|||
156983621|NCT04781647|566695003|FG002|Overall Study|Study terminated by Sponsor|9|||
156983622|NCT04781647|566695001|FG000|Overall Study|Withdrawal by Subject|1|||
156983623|NCT04781647|566695002|FG001|Overall Study|Withdrawal by Subject|2|||
156983624|NCT04781647|566695003|FG002|Overall Study|Withdrawal by Subject|0|||
156983625|NCT04781647|566695001|FG000|Overall Study|Adverse Event|0|||
156983626|NCT04781647|566695002|FG001|Overall Study|Adverse Event|1|||
156983627|NCT04781647|566695003|FG002|Overall Study|Adverse Event|1|||
156983628|NCT04781647|566695001|FG000|Overall Study|Protocol Violation|1|||
156983629|NCT04781647|566695002|FG001|Overall Study|Protocol Violation|0|||
156983630|NCT04781647|566695003|FG002|Overall Study|Protocol Violation|0|||
156983631|NCT04781647|566695001|FG000|Overall Study|Pregnancy|0|||
156983632|NCT04781647|566695002|FG001|Overall Study|Pregnancy|0|||
156983633|NCT04781647|566695003|FG002|Overall Study|Pregnancy|1|||
156983634|NCT04781647|566695001|FG000|Overall Study|Virology rebounded|1|||
156983635|NCT04781647|566695002|FG001|Overall Study|Virology rebounded|0|||
156983636|NCT04781647|566695003|FG002|Overall Study|Virology rebounded|0|||
156983637|NCT00777803|566695004|FG000|Overall Study|Lost to Follow-up|12|||
156983638|NCT00777803|566695005|FG001|Overall Study|Lost to Follow-up|5|||
156983639|NCT00777803|566695004|FG000|Overall Study|Adverse Event|1|||
156983640|NCT00777803|566695005|FG001|Overall Study|Adverse Event|0|||
156983641|NCT00777803|566695004|FG000|Overall Study|Non-compliance|2|||
156983642|NCT00777803|566695005|FG001|Overall Study|Non-compliance|2|||
156983643|NCT01755689|566695006|FG000|Overall Study|Withdrawal by Subject|1|||
156983644|NCT01755689|566695007|FG001|Overall Study|Withdrawal by Subject|3|||
156983645|NCT01755689|566695008|FG002|Overall Study|Withdrawal by Subject|2|||
156983646|NCT01755689|566695009|FG003|Overall Study|Withdrawal by Subject|1|||
156983647|NCT01755689|566695010|FG004|Overall Study|Withdrawal by Subject|1|||
156983648|NCT01755689|566695006|FG000|Overall Study|Migrated/moved from study area|0|||
156983649|NCT01755689|566695007|FG001|Overall Study|Migrated/moved from study area|1|||
156983650|NCT01755689|566695008|FG002|Overall Study|Migrated/moved from study area|1|||
156983651|NCT01755689|566695009|FG003|Overall Study|Migrated/moved from study area|1|||
156983652|NCT01755689|566695010|FG004|Overall Study|Migrated/moved from study area|1|||
156983653|NCT01755689|566695006|FG000|Overall Study|Lost to Follow-up|1|||
156983654|NCT01755689|566695007|FG001|Overall Study|Lost to Follow-up|0|||
156983655|NCT01755689|566695008|FG002|Overall Study|Lost to Follow-up|1|||
156983656|NCT01755689|566695009|FG003|Overall Study|Lost to Follow-up|0|||
156983657|NCT01755689|566695010|FG004|Overall Study|Lost to Follow-up|2|||
156983658|NCT01755689|566695006|FG000|Overall Study|Pregnancy|1|||
156983659|NCT01755689|566695007|FG001|Overall Study|Pregnancy|1|||
156983660|NCT01755689|566695008|FG002|Overall Study|Pregnancy|2|||
156983661|NCT01755689|566695009|FG003|Overall Study|Pregnancy|4|||
156983662|NCT01755689|566695010|FG004|Overall Study|Pregnancy|2|||
156983663|NCT01642186|566695011|FG000|Overall Study|Death|0|||
156983664|NCT01642186|566695012|FG001|Overall Study|Death|2|||
156983665|NCT01642186|566695013|FG002|Overall Study|Death|2|||
156983666|NCT01642186|566695011|FG000|Overall Study|Lost to Follow-up|0|||
156983667|NCT01642186|566695012|FG001|Overall Study|Lost to Follow-up|0|||
156983668|NCT01642186|566695013|FG002|Overall Study|Lost to Follow-up|1|||
156983669|NCT00163215|566695014|FG000|Overall Study|Lack of Efficacy|3|||
156983670|NCT00163215|566695014|FG000|Overall Study|Withdrawal by Subject|5|||
156983671|NCT00163215|566695014|FG000|Overall Study|Other|7|||
156983672|NCT01668147|566695017|FG000|Overall Study|Withdrawal by Subject|6|||
156983673|NCT01809210|566695018|FG000|Overall Study|Withdrawal by Subject|0|||
156983674|NCT01809210|566695019|FG001|Overall Study|Withdrawal by Subject|0|||
156983675|NCT01809210|566695020|FG002|Overall Study|Withdrawal by Subject|1|||
156983676|NCT01809210|566695021|FG003|Overall Study|Withdrawal by Subject|1|||
156983677|NCT01809210|566695022|FG004|Overall Study|Withdrawal by Subject|1|||
156983678|NCT01809210|566695023|FG005|Overall Study|Withdrawal by Subject|0|||
156983679|NCT01809210|566695024|FG006|Overall Study|Withdrawal by Subject|4|||
156983680|NCT01809210|566695018|FG000|Overall Study|Death|1|||
156983681|NCT01809210|566695019|FG001|Overall Study|Death|1|||
156983682|NCT01809210|566695020|FG002|Overall Study|Death|2|||
156983683|NCT01809210|566695021|FG003|Overall Study|Death|0|||
156983684|NCT01809210|566695022|FG004|Overall Study|Death|1|||
156983685|NCT01809210|566695023|FG005|Overall Study|Death|3|||
156983686|NCT01809210|566695024|FG006|Overall Study|Death|1|||
156983687|NCT01115998|566695027|FG000|Overall Study|Lost to Follow-up|6|||
156983688|NCT01115998|566695028|FG001|Overall Study|Lost to Follow-up|6|||
156983689|NCT00224133|566695029|FG000|Overall Study|Adverse Event|93|||
156983690|NCT00224133|566695029|FG000|Overall Study|Protocol Violation|6|||
156983691|NCT00224133|566695029|FG000|Overall Study|Withdrawal by Subject|33|||
156983692|NCT00224133|566695029|FG000|Overall Study|Lack of Efficacy|58|||
156983693|NCT00224133|566695029|FG000|Overall Study|Lost to Follow-up|21|||
156983694|NCT00224133|566695029|FG000|Overall Study|Physician Decision|1|||
156983695|NCT00224133|566695029|FG000|Overall Study|Other|14|||
156983696|NCT01474512|566695033|FG000|Induction Period|Adverse Event|6|||
156983697|NCT01474512|566695034|FG001|Induction Period|Adverse Event|10|||
156983698|NCT01474512|566695035|FG002|Induction Period|Adverse Event|10|||
157096550|NCT03952806|567109222|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
156983699|NCT01474512|566695036|FG003|Induction Period|Adverse Event|0|||
157096551|NCT03952806|567109221|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
157096552|NCT03952806|567109222|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
156983700|NCT01474512|566695037|FG004|Induction Period|Adverse Event|0|||
156983701|NCT01474512|566695038|FG005|Induction Period|Adverse Event|0|||
156983702|NCT01474512|566695039|FG006|Induction Period|Adverse Event|0|||
156983703|NCT01474512|566695040|FG007|Induction Period|Adverse Event|0|||
156983704|NCT01474512|566695041|FG008|Induction Period|Adverse Event|0|||
156983705|NCT01474512|566695042|FG009|Induction Period|Adverse Event|0|||
156983706|NCT01474512|566695043|FG010|Induction Period|Adverse Event|0|||
156983707|NCT01474512|566695044|FG011|Induction Period|Adverse Event|0|||
156983708|NCT01474512|566695045|FG012|Induction Period|Adverse Event|0|||
156983709|NCT01474512|566695046|FG013|Induction Period|Adverse Event|0|||
156983710|NCT01474512|566695047|FG014|Induction Period|Adverse Event|0|||
156983711|NCT01474512|566695048|FG015|Induction Period|Adverse Event|0|||
156983712|NCT01474512|566695049|FG016|Induction Period|Adverse Event|0|||
156983713|NCT01474512|566695050|FG017|Induction Period|Adverse Event|0|||
156983714|NCT01474512|566695033|FG000|Induction Period|Lack of Efficacy|7|||
156983715|NCT01474512|566695034|FG001|Induction Period|Lack of Efficacy|1|||
156983716|NCT01474512|566695035|FG002|Induction Period|Lack of Efficacy|0|||
156983717|NCT01474512|566695036|FG003|Induction Period|Lack of Efficacy|0|||
156983718|NCT01474512|566695037|FG004|Induction Period|Lack of Efficacy|0|||
156983719|NCT01474512|566695038|FG005|Induction Period|Lack of Efficacy|0|||
156983720|NCT01474512|566695039|FG006|Induction Period|Lack of Efficacy|0|||
156983721|NCT01474512|566695040|FG007|Induction Period|Lack of Efficacy|0|||
156983722|NCT01474512|566695041|FG008|Induction Period|Lack of Efficacy|0|||
156983723|NCT01474512|566695042|FG009|Induction Period|Lack of Efficacy|0|||
156983724|NCT01474512|566695043|FG010|Induction Period|Lack of Efficacy|0|||
156983725|NCT01474512|566695044|FG011|Induction Period|Lack of Efficacy|0|||
156983726|NCT01474512|566695045|FG012|Induction Period|Lack of Efficacy|0|||
156983727|NCT01474512|566695046|FG013|Induction Period|Lack of Efficacy|0|||
156983728|NCT01474512|566695047|FG014|Induction Period|Lack of Efficacy|0|||
156983729|NCT01474512|566695048|FG015|Induction Period|Lack of Efficacy|0|||
157096553|NCT03952806|567109221|FG000|OLE Phase (48 Weeks)|Other|16|||
156983730|NCT01474512|566695049|FG016|Induction Period|Lack of Efficacy|0|||
156983731|NCT01474512|566695050|FG017|Induction Period|Lack of Efficacy|0|||
157096554|NCT03952806|567109222|FG001|OLE Phase (48 Weeks)|Other|13|||
157096555|NCT02027701|567109226|FG000|Overall Study|Adverse Event|3|||
157096556|NCT02027701|567109226|FG000|Overall Study|Lack of Efficacy|8|||
157096557|NCT02027701|567109226|FG000|Overall Study|Physician Decision|2|||
156983732|NCT01474512|566695033|FG000|Induction Period|Withdrawal by Subject|6|||
156983733|NCT01474512|566695034|FG001|Induction Period|Withdrawal by Subject|6|||
156983734|NCT01474512|566695035|FG002|Induction Period|Withdrawal by Subject|5|||
156983735|NCT01474512|566695036|FG003|Induction Period|Withdrawal by Subject|0|||
156983736|NCT01474512|566695037|FG004|Induction Period|Withdrawal by Subject|0|||
156983737|NCT01474512|566695038|FG005|Induction Period|Withdrawal by Subject|0|||
156983738|NCT01474512|566695039|FG006|Induction Period|Withdrawal by Subject|0|||
156983739|NCT01474512|566695040|FG007|Induction Period|Withdrawal by Subject|0|||
156983740|NCT01474512|566695041|FG008|Induction Period|Withdrawal by Subject|0|||
156983741|NCT01474512|566695042|FG009|Induction Period|Withdrawal by Subject|0|||
156983742|NCT01474512|566695043|FG010|Induction Period|Withdrawal by Subject|0|||
156983743|NCT01474512|566695044|FG011|Induction Period|Withdrawal by Subject|0|||
156983744|NCT01474512|566695045|FG012|Induction Period|Withdrawal by Subject|0|||
156983745|NCT01474512|566695046|FG013|Induction Period|Withdrawal by Subject|0|||
156983746|NCT01474512|566695047|FG014|Induction Period|Withdrawal by Subject|0|||
156983747|NCT01474512|566695048|FG015|Induction Period|Withdrawal by Subject|0|||
156983748|NCT01474512|566695049|FG016|Induction Period|Withdrawal by Subject|0|||
156983749|NCT01474512|566695050|FG017|Induction Period|Withdrawal by Subject|0|||
156983750|NCT01474512|566695033|FG000|Induction Period|Protocol Violation|3|||
156983751|NCT01474512|566695034|FG001|Induction Period|Protocol Violation|6|||
156983752|NCT01474512|566695035|FG002|Induction Period|Protocol Violation|0|||
156983753|NCT01474512|566695036|FG003|Induction Period|Protocol Violation|0|||
156983754|NCT01474512|566695037|FG004|Induction Period|Protocol Violation|0|||
156983755|NCT01474512|566695038|FG005|Induction Period|Protocol Violation|0|||
156983756|NCT01474512|566695039|FG006|Induction Period|Protocol Violation|0|||
156983757|NCT01474512|566695040|FG007|Induction Period|Protocol Violation|0|||
156983758|NCT01474512|566695041|FG008|Induction Period|Protocol Violation|0|||
156983759|NCT01474512|566695042|FG009|Induction Period|Protocol Violation|0|||
156983760|NCT01474512|566695043|FG010|Induction Period|Protocol Violation|0|||
156983761|NCT01474512|566695044|FG011|Induction Period|Protocol Violation|0|||
156983762|NCT01474512|566695045|FG012|Induction Period|Protocol Violation|0|||
156983763|NCT01474512|566695046|FG013|Induction Period|Protocol Violation|0|||
156983764|NCT01474512|566695047|FG014|Induction Period|Protocol Violation|0|||
156983765|NCT01474512|566695048|FG015|Induction Period|Protocol Violation|0|||
156983766|NCT01474512|566695049|FG016|Induction Period|Protocol Violation|0|||
156983767|NCT01474512|566695050|FG017|Induction Period|Protocol Violation|0|||
156983768|NCT01474512|566695033|FG000|Induction Period|Sponsor Decision|1|||
156983769|NCT01474512|566695034|FG001|Induction Period|Sponsor Decision|1|||
156983770|NCT01474512|566695035|FG002|Induction Period|Sponsor Decision|1|||
156983771|NCT01474512|566695036|FG003|Induction Period|Sponsor Decision|0|||
156983772|NCT01474512|566695037|FG004|Induction Period|Sponsor Decision|0|||
156983773|NCT01474512|566695038|FG005|Induction Period|Sponsor Decision|0|||
156983774|NCT01474512|566695039|FG006|Induction Period|Sponsor Decision|0|||
156983775|NCT01474512|566695040|FG007|Induction Period|Sponsor Decision|0|||
156983776|NCT01474512|566695041|FG008|Induction Period|Sponsor Decision|0|||
156983777|NCT01474512|566695042|FG009|Induction Period|Sponsor Decision|0|||
156983778|NCT01474512|566695043|FG010|Induction Period|Sponsor Decision|0|||
156983779|NCT01474512|566695044|FG011|Induction Period|Sponsor Decision|0|||
156983780|NCT01474512|566695045|FG012|Induction Period|Sponsor Decision|0|||
156983781|NCT01474512|566695046|FG013|Induction Period|Sponsor Decision|0|||
156983782|NCT01474512|566695047|FG014|Induction Period|Sponsor Decision|0|||
156983783|NCT01474512|566695048|FG015|Induction Period|Sponsor Decision|0|||
156983784|NCT01474512|566695049|FG016|Induction Period|Sponsor Decision|0|||
156983785|NCT01474512|566695050|FG017|Induction Period|Sponsor Decision|0|||
156983786|NCT01474512|566695033|FG000|Induction Period|Lost to Follow-up|1|||
156983787|NCT01474512|566695034|FG001|Induction Period|Lost to Follow-up|0|||
156983788|NCT01474512|566695035|FG002|Induction Period|Lost to Follow-up|2|||
156983789|NCT01474512|566695036|FG003|Induction Period|Lost to Follow-up|0|||
156983790|NCT01474512|566695037|FG004|Induction Period|Lost to Follow-up|0|||
156983791|NCT01474512|566695038|FG005|Induction Period|Lost to Follow-up|0|||
156983792|NCT01474512|566695039|FG006|Induction Period|Lost to Follow-up|0|||
156983793|NCT01474512|566695040|FG007|Induction Period|Lost to Follow-up|0|||
156983794|NCT01474512|566695041|FG008|Induction Period|Lost to Follow-up|0|||
156983795|NCT01474512|566695042|FG009|Induction Period|Lost to Follow-up|0|||
156983796|NCT01474512|566695043|FG010|Induction Period|Lost to Follow-up|0|||
156983797|NCT01474512|566695044|FG011|Induction Period|Lost to Follow-up|0|||
156983798|NCT01474512|566695045|FG012|Induction Period|Lost to Follow-up|0|||
156983799|NCT01474512|566695046|FG013|Induction Period|Lost to Follow-up|0|||
156983800|NCT01474512|566695047|FG014|Induction Period|Lost to Follow-up|0|||
156983801|NCT01474512|566695048|FG015|Induction Period|Lost to Follow-up|0|||
156983802|NCT01474512|566695049|FG016|Induction Period|Lost to Follow-up|0|||
156983803|NCT01474512|566695050|FG017|Induction Period|Lost to Follow-up|0|||
156983804|NCT01474512|566695033|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983805|NCT01474512|566695034|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983806|NCT01474512|566695035|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983807|NCT01474512|566695036|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
156983808|NCT01474512|566695037|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
156983809|NCT01474512|566695038|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
156983810|NCT01474512|566695039|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
156983811|NCT01474512|566695040|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983812|NCT01474512|566695041|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983813|NCT01474512|566695042|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983814|NCT01474512|566695043|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983815|NCT01474512|566695044|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
157096558|NCT02027701|567109226|FG000|Overall Study|Withdrawal by Subject|3|||
157096559|NCT00756470|567109227|FG000|Overall Study|Withdrawal by Subject|1|||
156983816|NCT01474512|566695045|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983817|NCT01474512|566695046|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983818|NCT01474512|566695047|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983819|NCT01474512|566695048|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983820|NCT01474512|566695049|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983821|NCT01474512|566695050|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
156983822|NCT01474512|566695033|FG000|Maintenance Period|Adverse Event|0|||
156983823|NCT01474512|566695034|FG001|Maintenance Period|Adverse Event|0|||
156983824|NCT01474512|566695035|FG002|Maintenance Period|Adverse Event|0|||
156983825|NCT01474512|566695036|FG003|Maintenance Period|Adverse Event|4|||
156983826|NCT01474512|566695037|FG004|Maintenance Period|Adverse Event|2|||
156983827|NCT01474512|566695038|FG005|Maintenance Period|Adverse Event|7|||
156983828|NCT01474512|566695039|FG006|Maintenance Period|Adverse Event|0|||
156983829|NCT01474512|566695040|FG007|Maintenance Period|Adverse Event|19|||
156983830|NCT01474512|566695041|FG008|Maintenance Period|Adverse Event|1|||
156983831|NCT01474512|566695042|FG009|Maintenance Period|Adverse Event|3|||
156983832|NCT01474512|566695043|FG010|Maintenance Period|Adverse Event|0|||
156983833|NCT01474512|566695044|FG011|Maintenance Period|Adverse Event|0|||
156983834|NCT01474512|566695045|FG012|Maintenance Period|Adverse Event|0|||
156983835|NCT01474512|566695046|FG013|Maintenance Period|Adverse Event|0|||
156983836|NCT01474512|566695047|FG014|Maintenance Period|Adverse Event|0|||
156983837|NCT01474512|566695048|FG015|Maintenance Period|Adverse Event|0|||
156983838|NCT01474512|566695049|FG016|Maintenance Period|Adverse Event|0|||
156983839|NCT01474512|566695050|FG017|Maintenance Period|Adverse Event|0|||
156983840|NCT01474512|566695033|FG000|Maintenance Period|Withdrawal by Subject|0|||
156983841|NCT01474512|566695034|FG001|Maintenance Period|Withdrawal by Subject|0|||
156983842|NCT01474512|566695035|FG002|Maintenance Period|Withdrawal by Subject|0|||
156983843|NCT01474512|566695036|FG003|Maintenance Period|Withdrawal by Subject|6|||
156983844|NCT01474512|566695037|FG004|Maintenance Period|Withdrawal by Subject|2|||
156983845|NCT01474512|566695038|FG005|Maintenance Period|Withdrawal by Subject|3|||
156983846|NCT01474512|566695039|FG006|Maintenance Period|Withdrawal by Subject|1|||
156983847|NCT01474512|566695040|FG007|Maintenance Period|Withdrawal by Subject|6|||
156983848|NCT01474512|566695041|FG008|Maintenance Period|Withdrawal by Subject|3|||
156983849|NCT01474512|566695042|FG009|Maintenance Period|Withdrawal by Subject|1|||
156983850|NCT01474512|566695043|FG010|Maintenance Period|Withdrawal by Subject|0|||
156983851|NCT01474512|566695044|FG011|Maintenance Period|Withdrawal by Subject|0|||
156983852|NCT01474512|566695045|FG012|Maintenance Period|Withdrawal by Subject|0|||
156983853|NCT01474512|566695046|FG013|Maintenance Period|Withdrawal by Subject|0|||
156983854|NCT01474512|566695047|FG014|Maintenance Period|Withdrawal by Subject|0|||
156983855|NCT01474512|566695048|FG015|Maintenance Period|Withdrawal by Subject|0|||
156983856|NCT01474512|566695049|FG016|Maintenance Period|Withdrawal by Subject|0|||
156983857|NCT01474512|566695050|FG017|Maintenance Period|Withdrawal by Subject|0|||
156983858|NCT01474512|566695033|FG000|Maintenance Period|Lost to Follow-up|0|||
156983859|NCT01474512|566695034|FG001|Maintenance Period|Lost to Follow-up|0|||
156983860|NCT01474512|566695035|FG002|Maintenance Period|Lost to Follow-up|0|||
156983861|NCT01474512|566695036|FG003|Maintenance Period|Lost to Follow-up|3|||
156983862|NCT01474512|566695037|FG004|Maintenance Period|Lost to Follow-up|3|||
156983863|NCT01474512|566695038|FG005|Maintenance Period|Lost to Follow-up|0|||
156983864|NCT01474512|566695039|FG006|Maintenance Period|Lost to Follow-up|0|||
156983865|NCT01474512|566695040|FG007|Maintenance Period|Lost to Follow-up|2|||
156983866|NCT01474512|566695041|FG008|Maintenance Period|Lost to Follow-up|1|||
156983867|NCT01474512|566695042|FG009|Maintenance Period|Lost to Follow-up|1|||
156983868|NCT01474512|566695043|FG010|Maintenance Period|Lost to Follow-up|0|||
156983869|NCT01474512|566695044|FG011|Maintenance Period|Lost to Follow-up|0|||
156983870|NCT01474512|566695045|FG012|Maintenance Period|Lost to Follow-up|0|||
156983871|NCT01474512|566695046|FG013|Maintenance Period|Lost to Follow-up|0|||
156983872|NCT01474512|566695047|FG014|Maintenance Period|Lost to Follow-up|0|||
156983873|NCT01474512|566695048|FG015|Maintenance Period|Lost to Follow-up|0|||
156983874|NCT01474512|566695049|FG016|Maintenance Period|Lost to Follow-up|0|||
156983875|NCT01474512|566695050|FG017|Maintenance Period|Lost to Follow-up|0|||
156983876|NCT01474512|566695033|FG000|Maintenance Period|Death|0|||
156983877|NCT01474512|566695034|FG001|Maintenance Period|Death|0|||
156983878|NCT01474512|566695035|FG002|Maintenance Period|Death|0|||
156983879|NCT01474512|566695036|FG003|Maintenance Period|Death|0|||
156983880|NCT01474512|566695037|FG004|Maintenance Period|Death|0|||
156983881|NCT01474512|566695038|FG005|Maintenance Period|Death|2|||
156983882|NCT01474512|566695039|FG006|Maintenance Period|Death|0|||
156983883|NCT01474512|566695040|FG007|Maintenance Period|Death|0|||
156983884|NCT01474512|566695041|FG008|Maintenance Period|Death|0|||
156983885|NCT01474512|566695042|FG009|Maintenance Period|Death|0|||
156983886|NCT01474512|566695043|FG010|Maintenance Period|Death|0|||
156983887|NCT01474512|566695044|FG011|Maintenance Period|Death|0|||
156983888|NCT01474512|566695045|FG012|Maintenance Period|Death|0|||
156983889|NCT01474512|566695046|FG013|Maintenance Period|Death|0|||
156983890|NCT01474512|566695047|FG014|Maintenance Period|Death|0|||
156983891|NCT01474512|566695048|FG015|Maintenance Period|Death|0|||
157096560|NCT00756470|567109227|FG000|Overall Study|Adverse Event|4|||
156983892|NCT01474512|566695049|FG016|Maintenance Period|Death|0|||
156983893|NCT01474512|566695050|FG017|Maintenance Period|Death|0|||
156983894|NCT01474512|566695033|FG000|Maintenance Period|Physician Decision|0|||
156983895|NCT01474512|566695034|FG001|Maintenance Period|Physician Decision|0|||
156983896|NCT01474512|566695035|FG002|Maintenance Period|Physician Decision|0|||
156983897|NCT01474512|566695036|FG003|Maintenance Period|Physician Decision|0|||
156983898|NCT01474512|566695037|FG004|Maintenance Period|Physician Decision|0|||
156983899|NCT01474512|566695038|FG005|Maintenance Period|Physician Decision|1|||
156983900|NCT01474512|566695039|FG006|Maintenance Period|Physician Decision|0|||
156983901|NCT01474512|566695040|FG007|Maintenance Period|Physician Decision|2|||
156983902|NCT01474512|566695041|FG008|Maintenance Period|Physician Decision|0|||
156983903|NCT01474512|566695042|FG009|Maintenance Period|Physician Decision|0|||
156983904|NCT01474512|566695043|FG010|Maintenance Period|Physician Decision|0|||
156983905|NCT01474512|566695044|FG011|Maintenance Period|Physician Decision|0|||
156983906|NCT01474512|566695045|FG012|Maintenance Period|Physician Decision|0|||
156983907|NCT01474512|566695046|FG013|Maintenance Period|Physician Decision|0|||
156983908|NCT01474512|566695047|FG014|Maintenance Period|Physician Decision|0|||
156983909|NCT01474512|566695048|FG015|Maintenance Period|Physician Decision|0|||
156983910|NCT01474512|566695049|FG016|Maintenance Period|Physician Decision|0|||
156983911|NCT01474512|566695050|FG017|Maintenance Period|Physician Decision|0|||
156983912|NCT01474512|566695033|FG000|Maintenance Period|Clinical Relapse|0|||
156983913|NCT01474512|566695034|FG001|Maintenance Period|Clinical Relapse|0|||
156983914|NCT01474512|566695035|FG002|Maintenance Period|Clinical Relapse|0|||
156983915|NCT01474512|566695036|FG003|Maintenance Period|Clinical Relapse|1|||
156983916|NCT01474512|566695037|FG004|Maintenance Period|Clinical Relapse|0|||
156983917|NCT01474512|566695038|FG005|Maintenance Period|Clinical Relapse|0|||
156983918|NCT01474512|566695039|FG006|Maintenance Period|Clinical Relapse|0|||
156983919|NCT01474512|566695040|FG007|Maintenance Period|Clinical Relapse|0|||
156983920|NCT01474512|566695041|FG008|Maintenance Period|Clinical Relapse|0|||
156983921|NCT01474512|566695042|FG009|Maintenance Period|Clinical Relapse|0|||
156983922|NCT01474512|566695043|FG010|Maintenance Period|Clinical Relapse|0|||
156983923|NCT01474512|566695044|FG011|Maintenance Period|Clinical Relapse|0|||
156983924|NCT01474512|566695045|FG012|Maintenance Period|Clinical Relapse|0|||
156983925|NCT01474512|566695046|FG013|Maintenance Period|Clinical Relapse|0|||
156983926|NCT01474512|566695047|FG014|Maintenance Period|Clinical Relapse|0|||
156983927|NCT01474512|566695048|FG015|Maintenance Period|Clinical Relapse|0|||
156983928|NCT01474512|566695049|FG016|Maintenance Period|Clinical Relapse|0|||
156983929|NCT01474512|566695050|FG017|Maintenance Period|Clinical Relapse|0|||
156983930|NCT01474512|566695033|FG000|Maintenance Period|Lack of Efficacy|0|||
156983931|NCT01474512|566695034|FG001|Maintenance Period|Lack of Efficacy|0|||
156983932|NCT01474512|566695035|FG002|Maintenance Period|Lack of Efficacy|0|||
156983933|NCT01474512|566695036|FG003|Maintenance Period|Lack of Efficacy|1|||
156983934|NCT01474512|566695037|FG004|Maintenance Period|Lack of Efficacy|0|||
156983935|NCT01474512|566695038|FG005|Maintenance Period|Lack of Efficacy|0|||
156983936|NCT01474512|566695039|FG006|Maintenance Period|Lack of Efficacy|0|||
156983937|NCT01474512|566695040|FG007|Maintenance Period|Lack of Efficacy|11|||
156983938|NCT01474512|566695041|FG008|Maintenance Period|Lack of Efficacy|11|||
156983939|NCT01474512|566695042|FG009|Maintenance Period|Lack of Efficacy|12|||
156983940|NCT01474512|566695043|FG010|Maintenance Period|Lack of Efficacy|0|||
156983941|NCT01474512|566695044|FG011|Maintenance Period|Lack of Efficacy|0|||
156983942|NCT01474512|566695045|FG012|Maintenance Period|Lack of Efficacy|0|||
156983943|NCT01474512|566695046|FG013|Maintenance Period|Lack of Efficacy|0|||
156983944|NCT01474512|566695047|FG014|Maintenance Period|Lack of Efficacy|0|||
156983945|NCT01474512|566695048|FG015|Maintenance Period|Lack of Efficacy|0|||
156983946|NCT01474512|566695049|FG016|Maintenance Period|Lack of Efficacy|0|||
156983947|NCT01474512|566695050|FG017|Maintenance Period|Lack of Efficacy|0|||
156983948|NCT01474512|566695033|FG000|Maintenance Period|Protocol Violation|0|||
156983949|NCT01474512|566695034|FG001|Maintenance Period|Protocol Violation|0|||
156983950|NCT01474512|566695035|FG002|Maintenance Period|Protocol Violation|0|||
156983951|NCT01474512|566695036|FG003|Maintenance Period|Protocol Violation|1|||
156983952|NCT01474512|566695037|FG004|Maintenance Period|Protocol Violation|0|||
156983953|NCT01474512|566695038|FG005|Maintenance Period|Protocol Violation|0|||
156983954|NCT01474512|566695039|FG006|Maintenance Period|Protocol Violation|0|||
156983955|NCT01474512|566695040|FG007|Maintenance Period|Protocol Violation|1|||
156983956|NCT01474512|566695041|FG008|Maintenance Period|Protocol Violation|0|||
156983957|NCT01474512|566695042|FG009|Maintenance Period|Protocol Violation|1|||
156983958|NCT01474512|566695043|FG010|Maintenance Period|Protocol Violation|0|||
156983959|NCT01474512|566695044|FG011|Maintenance Period|Protocol Violation|0|||
156983960|NCT01474512|566695045|FG012|Maintenance Period|Protocol Violation|0|||
156983961|NCT01474512|566695046|FG013|Maintenance Period|Protocol Violation|0|||
156983962|NCT01474512|566695047|FG014|Maintenance Period|Protocol Violation|0|||
156983963|NCT01474512|566695048|FG015|Maintenance Period|Protocol Violation|0|||
156983964|NCT01474512|566695049|FG016|Maintenance Period|Protocol Violation|0|||
156983965|NCT01474512|566695050|FG017|Maintenance Period|Protocol Violation|0|||
156983966|NCT01474512|566695033|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
156983967|NCT01474512|566695034|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
156983968|NCT01474512|566695035|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
157096561|NCT00820027|567109228|FG000|Overall Study|Adverse Event|15|||
156983969|NCT01474512|566695036|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
156983970|NCT01474512|566695037|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
156983971|NCT01474512|566695038|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
156983972|NCT01474512|566695039|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
156983973|NCT01474512|566695040|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
156983974|NCT01474512|566695041|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
156983975|NCT01474512|566695042|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
156983976|NCT01474512|566695043|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
156983977|NCT01474512|566695044|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
156983978|NCT01474512|566695045|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
156983979|NCT01474512|566695046|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
156983980|NCT01474512|566695047|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
156983981|NCT01474512|566695048|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
156983982|NCT01474512|566695049|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
156983983|NCT01474512|566695050|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
156983984|NCT01474512|566695033|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
156983985|NCT01474512|566695034|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
156983986|NCT01474512|566695035|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
156983987|NCT01474512|566695036|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
156983988|NCT01474512|566695037|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
156983989|NCT01474512|566695038|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
156983990|NCT01474512|566695039|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
156983991|NCT01474512|566695040|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
156983992|NCT01474512|566695041|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
156983993|NCT01474512|566695042|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
156983994|NCT01474512|566695043|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
156983995|NCT01474512|566695044|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
156983996|NCT01474512|566695045|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
156983997|NCT01474512|566695046|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
156983998|NCT01474512|566695047|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
156983999|NCT01474512|566695048|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
156984000|NCT01474512|566695049|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
156984001|NCT01474512|566695050|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
156984002|NCT01474512|566695033|FG000|Long-Term Extension Period|Adverse Event|0|||
156984003|NCT01474512|566695034|FG001|Long-Term Extension Period|Adverse Event|0|||
156984004|NCT01474512|566695035|FG002|Long-Term Extension Period|Adverse Event|0|||
156984005|NCT01474512|566695036|FG003|Long-Term Extension Period|Adverse Event|0|||
156984006|NCT01474512|566695037|FG004|Long-Term Extension Period|Adverse Event|0|||
156984007|NCT01474512|566695038|FG005|Long-Term Extension Period|Adverse Event|0|||
156984008|NCT01474512|566695039|FG006|Long-Term Extension Period|Adverse Event|0|||
156984009|NCT01474512|566695040|FG007|Long-Term Extension Period|Adverse Event|0|||
156984010|NCT01474512|566695041|FG008|Long-Term Extension Period|Adverse Event|0|||
156984011|NCT01474512|566695042|FG009|Long-Term Extension Period|Adverse Event|0|||
156984012|NCT01474512|566695043|FG010|Long-Term Extension Period|Adverse Event|0|||
156984013|NCT01474512|566695044|FG011|Long-Term Extension Period|Adverse Event|1|||
156984014|NCT01474512|566695045|FG012|Long-Term Extension Period|Adverse Event|57|||
156984015|NCT01474512|566695046|FG013|Long-Term Extension Period|Adverse Event|58|||
156984016|NCT01474512|566695047|FG014|Long-Term Extension Period|Adverse Event|0|||
156984017|NCT01474512|566695048|FG015|Long-Term Extension Period|Adverse Event|0|||
156984018|NCT01474512|566695049|FG016|Long-Term Extension Period|Adverse Event|0|||
156984019|NCT01474512|566695050|FG017|Long-Term Extension Period|Adverse Event|0|||
156984020|NCT01474512|566695033|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
156984021|NCT01474512|566695034|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
156984022|NCT01474512|566695035|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
156984023|NCT01474512|566695036|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
156984024|NCT01474512|566695037|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
156984025|NCT01474512|566695038|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
156984026|NCT01474512|566695039|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
156984027|NCT01474512|566695040|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
156984028|NCT01474512|566695041|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
156984029|NCT01474512|566695042|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
156984030|NCT01474512|566695043|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
156984031|NCT01474512|566695044|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
156984032|NCT01474512|566695045|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
156984033|NCT01474512|566695046|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
156984034|NCT01474512|566695047|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
156984035|NCT01474512|566695048|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
156984036|NCT01474512|566695049|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
156984037|NCT01474512|566695050|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
156984038|NCT01474512|566695033|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
156984039|NCT01474512|566695034|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
156984040|NCT01474512|566695035|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
156984041|NCT01474512|566695036|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
156984042|NCT01474512|566695037|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
156984043|NCT01474512|566695038|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
156984044|NCT01474512|566695039|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
156984045|NCT01474512|566695040|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
156984046|NCT01474512|566695041|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
156984047|NCT01474512|566695042|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
156984048|NCT01474512|566695043|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
156984049|NCT01474512|566695044|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
156984050|NCT01474512|566695045|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
156984051|NCT01474512|566695046|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
156984052|NCT01474512|566695047|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
156984053|NCT01474512|566695048|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
156984054|NCT01474512|566695049|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
156984055|NCT01474512|566695050|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
156984056|NCT01474512|566695033|FG000|Long-Term Extension Period|Physician Decision|0|||
156984057|NCT01474512|566695034|FG001|Long-Term Extension Period|Physician Decision|0|||
156984058|NCT01474512|566695035|FG002|Long-Term Extension Period|Physician Decision|0|||
156984059|NCT01474512|566695036|FG003|Long-Term Extension Period|Physician Decision|0|||
156984060|NCT01474512|566695037|FG004|Long-Term Extension Period|Physician Decision|0|||
156984061|NCT01474512|566695038|FG005|Long-Term Extension Period|Physician Decision|0|||
156984062|NCT01474512|566695039|FG006|Long-Term Extension Period|Physician Decision|0|||
156984063|NCT01474512|566695040|FG007|Long-Term Extension Period|Physician Decision|0|||
156984064|NCT01474512|566695041|FG008|Long-Term Extension Period|Physician Decision|0|||
156984065|NCT01474512|566695042|FG009|Long-Term Extension Period|Physician Decision|0|||
156984066|NCT01474512|566695043|FG010|Long-Term Extension Period|Physician Decision|0|||
156984067|NCT01474512|566695044|FG011|Long-Term Extension Period|Physician Decision|0|||
156984068|NCT01474512|566695045|FG012|Long-Term Extension Period|Physician Decision|21|||
156984069|NCT01474512|566695046|FG013|Long-Term Extension Period|Physician Decision|21|||
156984070|NCT01474512|566695047|FG014|Long-Term Extension Period|Physician Decision|0|||
156984071|NCT01474512|566695048|FG015|Long-Term Extension Period|Physician Decision|0|||
156984072|NCT01474512|566695049|FG016|Long-Term Extension Period|Physician Decision|0|||
156984073|NCT01474512|566695050|FG017|Long-Term Extension Period|Physician Decision|0|||
156984074|NCT01474512|566695033|FG000|Long-Term Extension Period|Clinical Relapse|0|||
156984075|NCT01474512|566695034|FG001|Long-Term Extension Period|Clinical Relapse|0|||
156984076|NCT01474512|566695035|FG002|Long-Term Extension Period|Clinical Relapse|0|||
156984077|NCT01474512|566695036|FG003|Long-Term Extension Period|Clinical Relapse|0|||
156984078|NCT01474512|566695037|FG004|Long-Term Extension Period|Clinical Relapse|0|||
156984079|NCT01474512|566695038|FG005|Long-Term Extension Period|Clinical Relapse|0|||
156984080|NCT01474512|566695039|FG006|Long-Term Extension Period|Clinical Relapse|0|||
156984081|NCT01474512|566695040|FG007|Long-Term Extension Period|Clinical Relapse|0|||
156984082|NCT01474512|566695041|FG008|Long-Term Extension Period|Clinical Relapse|0|||
156984083|NCT01474512|566695042|FG009|Long-Term Extension Period|Clinical Relapse|0|||
156984084|NCT01474512|566695043|FG010|Long-Term Extension Period|Clinical Relapse|0|||
156984085|NCT01474512|566695044|FG011|Long-Term Extension Period|Clinical Relapse|0|||
156984086|NCT01474512|566695045|FG012|Long-Term Extension Period|Clinical Relapse|9|||
156984087|NCT01474512|566695046|FG013|Long-Term Extension Period|Clinical Relapse|9|||
156984088|NCT01474512|566695047|FG014|Long-Term Extension Period|Clinical Relapse|0|||
156984089|NCT01474512|566695048|FG015|Long-Term Extension Period|Clinical Relapse|0|||
156984090|NCT01474512|566695049|FG016|Long-Term Extension Period|Clinical Relapse|0|||
156984091|NCT01474512|566695050|FG017|Long-Term Extension Period|Clinical Relapse|0|||
156984092|NCT01474512|566695033|FG000|Long-Term Extension Period|Death|0|||
156984093|NCT01474512|566695034|FG001|Long-Term Extension Period|Death|0|||
156984094|NCT01474512|566695035|FG002|Long-Term Extension Period|Death|0|||
156984095|NCT01474512|566695036|FG003|Long-Term Extension Period|Death|0|||
156984096|NCT01474512|566695037|FG004|Long-Term Extension Period|Death|0|||
156984097|NCT01474512|566695038|FG005|Long-Term Extension Period|Death|0|||
156984098|NCT01474512|566695039|FG006|Long-Term Extension Period|Death|0|||
156984099|NCT01474512|566695040|FG007|Long-Term Extension Period|Death|0|||
156984100|NCT01474512|566695041|FG008|Long-Term Extension Period|Death|0|||
156984101|NCT01474512|566695042|FG009|Long-Term Extension Period|Death|0|||
156984102|NCT01474512|566695043|FG010|Long-Term Extension Period|Death|0|||
156984103|NCT01474512|566695044|FG011|Long-Term Extension Period|Death|0|||
156984104|NCT01474512|566695045|FG012|Long-Term Extension Period|Death|9|||
156984105|NCT01474512|566695046|FG013|Long-Term Extension Period|Death|9|||
156984106|NCT01474512|566695047|FG014|Long-Term Extension Period|Death|0|||
156984107|NCT01474512|566695048|FG015|Long-Term Extension Period|Death|0|||
156984108|NCT01474512|566695049|FG016|Long-Term Extension Period|Death|0|||
156984109|NCT01474512|566695050|FG017|Long-Term Extension Period|Death|0|||
156984110|NCT01474512|566695033|FG000|Long-Term Extension Period|Sponsor Decision|0|||
156984111|NCT01474512|566695034|FG001|Long-Term Extension Period|Sponsor Decision|0|||
156984112|NCT01474512|566695035|FG002|Long-Term Extension Period|Sponsor Decision|0|||
157096562|NCT00820027|567109229|FG001|Overall Study|Adverse Event|8|||
156984113|NCT01474512|566695036|FG003|Long-Term Extension Period|Sponsor Decision|0|||
156984114|NCT01474512|566695037|FG004|Long-Term Extension Period|Sponsor Decision|0|||
156984115|NCT01474512|566695038|FG005|Long-Term Extension Period|Sponsor Decision|0|||
156984116|NCT01474512|566695039|FG006|Long-Term Extension Period|Sponsor Decision|0|||
156984117|NCT01474512|566695040|FG007|Long-Term Extension Period|Sponsor Decision|0|||
156984118|NCT01474512|566695041|FG008|Long-Term Extension Period|Sponsor Decision|0|||
156984119|NCT01474512|566695042|FG009|Long-Term Extension Period|Sponsor Decision|0|||
156984120|NCT01474512|566695043|FG010|Long-Term Extension Period|Sponsor Decision|0|||
156984121|NCT01474512|566695044|FG011|Long-Term Extension Period|Sponsor Decision|0|||
156984122|NCT01474512|566695045|FG012|Long-Term Extension Period|Sponsor Decision|6|||
156984123|NCT01474512|566695046|FG013|Long-Term Extension Period|Sponsor Decision|6|||
156984124|NCT01474512|566695047|FG014|Long-Term Extension Period|Sponsor Decision|0|||
156984125|NCT01474512|566695048|FG015|Long-Term Extension Period|Sponsor Decision|0|||
156984126|NCT01474512|566695049|FG016|Long-Term Extension Period|Sponsor Decision|0|||
156984127|NCT01474512|566695050|FG017|Long-Term Extension Period|Sponsor Decision|0|||
156984128|NCT01474512|566695033|FG000|Long-Term Extension Period|Protocol Violation|0|||
156984129|NCT01474512|566695034|FG001|Long-Term Extension Period|Protocol Violation|0|||
156984130|NCT01474512|566695035|FG002|Long-Term Extension Period|Protocol Violation|0|||
156984131|NCT01474512|566695036|FG003|Long-Term Extension Period|Protocol Violation|0|||
156984132|NCT01474512|566695037|FG004|Long-Term Extension Period|Protocol Violation|0|||
156984133|NCT01474512|566695038|FG005|Long-Term Extension Period|Protocol Violation|0|||
156984134|NCT01474512|566695039|FG006|Long-Term Extension Period|Protocol Violation|0|||
156984135|NCT01474512|566695040|FG007|Long-Term Extension Period|Protocol Violation|0|||
156984136|NCT01474512|566695041|FG008|Long-Term Extension Period|Protocol Violation|0|||
156984137|NCT01474512|566695042|FG009|Long-Term Extension Period|Protocol Violation|0|||
156984138|NCT01474512|566695043|FG010|Long-Term Extension Period|Protocol Violation|0|||
156984139|NCT01474512|566695044|FG011|Long-Term Extension Period|Protocol Violation|0|||
156984140|NCT01474512|566695045|FG012|Long-Term Extension Period|Protocol Violation|5|||
156984141|NCT01474512|566695046|FG013|Long-Term Extension Period|Protocol Violation|5|||
156984142|NCT01474512|566695047|FG014|Long-Term Extension Period|Protocol Violation|0|||
156984143|NCT01474512|566695048|FG015|Long-Term Extension Period|Protocol Violation|0|||
156984144|NCT01474512|566695049|FG016|Long-Term Extension Period|Protocol Violation|0|||
156984145|NCT01474512|566695050|FG017|Long-Term Extension Period|Protocol Violation|0|||
156984146|NCT01474512|566695033|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984147|NCT01474512|566695034|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984148|NCT01474512|566695035|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984149|NCT01474512|566695036|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984150|NCT01474512|566695037|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984151|NCT01474512|566695038|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984152|NCT01474512|566695039|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
157096563|NCT00820027|567109230|FG002|Overall Study|Adverse Event|10|||
156984153|NCT01474512|566695040|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156751713|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156984154|NCT01474512|566695041|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984155|NCT01474512|566695042|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984156|NCT01474512|566695043|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984157|NCT01474512|566695044|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984158|NCT01474512|566695045|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
156984159|NCT01474512|566695046|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
156984160|NCT01474512|566695047|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984161|NCT01474512|566695048|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984162|NCT01474512|566695049|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984163|NCT01474512|566695050|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
156984164|NCT01474512|566695033|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984165|NCT01474512|566695034|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984166|NCT01474512|566695035|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984167|NCT01474512|566695036|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984168|NCT01474512|566695037|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984169|NCT01474512|566695038|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984170|NCT01474512|566695039|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984171|NCT01474512|566695040|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984172|NCT01474512|566695041|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984173|NCT01474512|566695042|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984174|NCT01474512|566695043|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984175|NCT01474512|566695044|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
156984176|NCT01474512|566695045|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984177|NCT01474512|566695046|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984178|NCT01474512|566695047|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984179|NCT01474512|566695048|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984180|NCT01474512|566695049|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984181|NCT01474512|566695050|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
156984182|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
156984183|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
156984184|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
156984185|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
156984186|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
156984187|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
156984188|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
156984189|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
156984190|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
156984191|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
156984192|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
156984193|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
156984194|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
156984195|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
156984196|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
156984197|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
157096564|NCT00820027|567109231|FG003|Overall Study|Adverse Event|5|||
156984198|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
156984199|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
156984200|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984201|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984202|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984203|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984204|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
157096565|NCT00820027|567109228|FG000|Overall Study|Lack of Efficacy|2|||
157096566|NCT00820027|567109229|FG001|Overall Study|Lack of Efficacy|1|||
157096567|NCT00820027|567109230|FG002|Overall Study|Lack of Efficacy|2|||
157096568|NCT00820027|567109231|FG003|Overall Study|Lack of Efficacy|2|||
156984205|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984206|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984207|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984208|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984209|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984210|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984211|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984212|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984213|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
156984214|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
156984215|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
156984216|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
156984217|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
156984218|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984219|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984220|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984221|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984222|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984223|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984224|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984225|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984226|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984227|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984228|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984229|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984230|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984231|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
156984232|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
156984233|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
156984234|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
156984235|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
156984236|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984237|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984238|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984239|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984240|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984241|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984242|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984243|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
157096569|NCT00820027|567109228|FG000|Overall Study|Physician Decision|0|||
157096570|NCT00820027|567109229|FG001|Overall Study|Physician Decision|1|||
157096571|NCT00820027|567109230|FG002|Overall Study|Physician Decision|1|||
157096572|NCT00820027|567109231|FG003|Overall Study|Physician Decision|0|||
157096573|NCT00820027|567109228|FG000|Overall Study|Protocol Violation|3|||
157096574|NCT00820027|567109229|FG001|Overall Study|Protocol Violation|0|||
157096575|NCT00820027|567109230|FG002|Overall Study|Protocol Violation|4|||
157096576|NCT00820027|567109231|FG003|Overall Study|Protocol Violation|0|||
157096577|NCT00820027|567109228|FG000|Overall Study|Withdrawal by Subject|6|||
157096578|NCT00820027|567109229|FG001|Overall Study|Withdrawal by Subject|4|||
157096579|NCT00820027|567109230|FG002|Overall Study|Withdrawal by Subject|4|||
157096580|NCT00820027|567109231|FG003|Overall Study|Withdrawal by Subject|6|||
157096581|NCT02604433|567109232|FG000|Overall Study|Withdrawal by Subject|37|||
157096582|NCT02604433|567109233|FG001|Overall Study|Withdrawal by Subject|16|||
157096583|NCT02604433|567109232|FG000|Overall Study|Adverse Event|4|||
157096584|NCT02604433|567109233|FG001|Overall Study|Adverse Event|0|||
157096585|NCT02604433|567109232|FG000|Overall Study|Other reasons|3|||
157096586|NCT02604433|567109233|FG001|Overall Study|Other reasons|5|||
157096587|NCT02604433|567109232|FG000|Overall Study|Death|4|||
157096588|NCT02604433|567109233|FG001|Overall Study|Death|1|||
157096589|NCT02604433|567109232|FG000|Overall Study|Transition to Rollover Protocol|169|||
157096590|NCT02604433|567109233|FG001|Overall Study|Transition to Rollover Protocol|82|||
157096591|NCT02604433|567109232|FG000|Overall Study|Physician Decision|1|||
157096592|NCT02604433|567109233|FG001|Overall Study|Physician Decision|1|||
157096593|NCT02604433|567109232|FG000|Overall Study|Lack of Efficacy|0|||
157096594|NCT02604433|567109233|FG001|Overall Study|Lack of Efficacy|1|||
157096595|NCT01128738|567109234|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
157096596|NCT01128738|567109235|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
157096597|NCT01128738|567109234|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
157096598|NCT01128738|567109235|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
157096599|NCT01128738|567109234|FG000|Second TP|Lost to Follow-up|0|||
157096600|NCT01128738|567109235|FG001|Second TP|Lost to Follow-up|1|||
157096601|NCT01128738|567109234|FG000|Second TP|Withdrawal by Subject|0|||
157096602|NCT01128738|567109235|FG001|Second TP|Withdrawal by Subject|2|||
157096603|NCT03353350|567109245|FG000|30-week Core Treatment Period|Protocol Violation|1|||
157096604|NCT03353350|567109246|FG001|30-week Core Treatment Period|Protocol Violation|1|||
157096605|NCT03353350|567109247|FG002|30-week Core Treatment Period|Protocol Violation|1|||
157096606|NCT03353350|567109248|FG003|30-week Core Treatment Period|Protocol Violation|0|||
157096607|NCT03353350|567109245|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
157096608|NCT03353350|567109246|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
157096609|NCT03353350|567109247|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
157096610|NCT03353350|567109248|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
157096611|NCT03353350|567109245|FG000|30-week Core Treatment Period|Adverse Event|0|||
157096612|NCT03353350|567109246|FG001|30-week Core Treatment Period|Adverse Event|4|||
157096613|NCT03353350|567109247|FG002|30-week Core Treatment Period|Adverse Event|2|||
157096614|NCT03353350|567109248|FG003|30-week Core Treatment Period|Adverse Event|3|||
157096615|NCT03353350|567109245|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
157096616|NCT03353350|567109246|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
157096617|NCT03353350|567109247|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
157096618|NCT03353350|567109248|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
157096619|NCT03353350|567109245|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
157096620|NCT03353350|567109246|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
157096621|NCT03353350|567109247|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
157096622|NCT03353350|567109248|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
157096623|NCT03353350|567109245|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
157096624|NCT03353350|567109246|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
157096625|NCT03353350|567109247|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
157096626|NCT03353350|567109248|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
157096627|NCT03353350|567109245|FG000|26-week Treatment Extension Period|Adverse Event|1|||
157096628|NCT03353350|567109246|FG001|26-week Treatment Extension Period|Adverse Event|0|||
157096629|NCT03353350|567109247|FG002|26-week Treatment Extension Period|Adverse Event|0|||
157096630|NCT03353350|567109248|FG003|26-week Treatment Extension Period|Adverse Event|1|||
157096631|NCT03353350|567109245|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
156984244|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984245|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984246|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984247|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984248|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984249|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984250|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984251|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
156984252|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
156984253|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
156984254|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
156984255|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
156984256|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
156984257|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
156984258|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
156984259|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
156984260|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
157096632|NCT03353350|567109246|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
156984261|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
156984262|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
157096633|NCT03353350|567109247|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
156984263|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
156984264|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
156984265|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
156984266|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
156984267|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
156984268|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
156984269|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
156984270|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
156984271|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
156984272|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984273|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984274|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984275|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984276|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984277|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984278|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984279|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984280|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984281|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984282|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984283|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984284|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984285|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984286|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984287|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
156984288|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
156984289|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
156984290|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
156984291|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
156984292|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
156984293|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
156984294|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
157096634|NCT03353350|567109248|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
157096635|NCT00807235|567109255|FG000|Overall Study|Adverse Event|1|||
156984295|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
156984296|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
156984297|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
156984298|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
156984299|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
156984300|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
156984301|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
156984302|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
156984303|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
156984304|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
156984305|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
156984306|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
156984307|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
156984308|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984309|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984310|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984311|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984312|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984313|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984314|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984315|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984316|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984317|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984318|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984319|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984320|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984321|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984322|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
156984323|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
156984324|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
156984325|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
157096636|NCT00807235|567109256|FG001|Overall Study|Adverse Event|0|||
156984326|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984327|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984328|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984329|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984330|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
157096637|NCT00985153|567109259|FG000|Overall Study|Lost to Follow-up|16|||
157096638|NCT00985153|567109260|FG001|Overall Study|Lost to Follow-up|19|||
157096639|NCT00985153|567109261|FG002|Overall Study|Lost to Follow-up|17|||
157096640|NCT00985153|567109262|FG003|Overall Study|Lost to Follow-up|20|||
157096641|NCT00985153|567109259|FG000|Overall Study|Protocol Violation|3|||
157096642|NCT00985153|567109260|FG001|Overall Study|Protocol Violation|2|||
157096643|NCT00985153|567109261|FG002|Overall Study|Protocol Violation|4|||
157096644|NCT00985153|567109262|FG003|Overall Study|Protocol Violation|3|||
157096645|NCT00985153|567109259|FG000|Overall Study|Withdrawal by Subject|6|||
157096646|NCT00985153|567109260|FG001|Overall Study|Withdrawal by Subject|11|||
157096647|NCT00985153|567109261|FG002|Overall Study|Withdrawal by Subject|11|||
157096648|NCT00985153|567109262|FG003|Overall Study|Withdrawal by Subject|10|||
157096649|NCT00985153|567109259|FG000|Overall Study|Missed One or More Bleeds|7|||
157096650|NCT00985153|567109260|FG001|Overall Study|Missed One or More Bleeds|7|||
157096651|NCT00985153|567109261|FG002|Overall Study|Missed One or More Bleeds|8|||
157096652|NCT00985153|567109262|FG003|Overall Study|Missed One or More Bleeds|10|||
157096653|NCT00985153|567109259|FG000|Overall Study|Incomplete Safety Follow-up|3|||
157096654|NCT00985153|567109260|FG001|Overall Study|Incomplete Safety Follow-up|5|||
157096655|NCT00985153|567109261|FG002|Overall Study|Incomplete Safety Follow-up|4|||
157096656|NCT00985153|567109262|FG003|Overall Study|Incomplete Safety Follow-up|4|||
157096657|NCT00561951|567109264|FG000|Overall Study|Adverse Event|11|||
157096658|NCT00561951|567109265|FG001|Overall Study|Adverse Event|14|||
157096659|NCT00561951|567109266|FG002|Overall Study|Adverse Event|14|||
157096660|NCT00561951|567109264|FG000|Overall Study|Lack of Efficacy|5|||
157096661|NCT00561951|567109265|FG001|Overall Study|Lack of Efficacy|3|||
157096662|NCT00561951|567109266|FG002|Overall Study|Lack of Efficacy|2|||
157096663|NCT00561951|567109264|FG000|Overall Study|Lost to Follow-up|1|||
157096664|NCT00561951|567109265|FG001|Overall Study|Lost to Follow-up|1|||
157096665|NCT00561951|567109266|FG002|Overall Study|Lost to Follow-up|0|||
157096666|NCT00561951|567109264|FG000|Overall Study|Withdrawal by Subject|10|||
157096667|NCT00561951|567109265|FG001|Overall Study|Withdrawal by Subject|9|||
157096668|NCT00561951|567109266|FG002|Overall Study|Withdrawal by Subject|10|||
157096669|NCT00561951|567109264|FG000|Overall Study|Protocol Violation|4|||
157096670|NCT00561951|567109265|FG001|Overall Study|Protocol Violation|3|||
157096671|NCT00561951|567109266|FG002|Overall Study|Protocol Violation|4|||
157096672|NCT00561951|567109264|FG000|Overall Study|Physician Decision|1|||
157096673|NCT00561951|567109265|FG001|Overall Study|Physician Decision|0|||
157096674|NCT00561951|567109266|FG002|Overall Study|Physician Decision|0|||
157096675|NCT00561951|567109264|FG000|Overall Study|Pregnancy|0|||
157096676|NCT00561951|567109265|FG001|Overall Study|Pregnancy|1|||
157096677|NCT00561951|567109266|FG002|Overall Study|Pregnancy|0|||
157096678|NCT00561951|567109264|FG000|Overall Study|Meet Withdrawal Criterion|0|||
157096679|NCT00561951|567109265|FG001|Overall Study|Meet Withdrawal Criterion|1|||
157096680|NCT00561951|567109266|FG002|Overall Study|Meet Withdrawal Criterion|1|||
157096681|NCT00561951|567109264|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
157096682|NCT00561951|567109265|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
157096683|NCT00561951|567109266|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
157096684|NCT01765179|567109267|FG000|Overall Study|Adverse Event|3|||
157096685|NCT01765179|567109267|FG000|Overall Study|Lost to Follow-up|5|||
157096686|NCT01765179|567109267|FG000|Overall Study|Non-compliance with study drug|2|||
157096687|NCT01765179|567109267|FG000|Overall Study|Protocol Violation|1|||
157096688|NCT01765179|567109267|FG000|Overall Study|Withdrawal by Subject|8|||
157096689|NCT01765179|567109267|FG000|Overall Study|Hematocrit >54%|3|||
157096690|NCT01765179|567109267|FG000|Overall Study|prohibited med|1|||
157096691|NCT01765179|567109267|FG000|Overall Study|Out of country unable to finish study|1|||
157096692|NCT01765179|567109267|FG000|Overall Study|lack of venous access|1|||
157096693|NCT01765179|567109267|FG000|Overall Study|work conflict|1|||
157096694|NCT01765179|567109267|FG000|Overall Study|Ca elevated 10.6|1|||
157096695|NCT02640157|567109268|FG000|Overall Study|Adverse Event|2|||
157096696|NCT02640157|567109269|FG001|Overall Study|Adverse Event|2|||
157096697|NCT02640157|567109270|FG002|Overall Study|Adverse Event|1|||
157096698|NCT02640157|567109268|FG000|Overall Study|Withdrew consent|2|||
157096699|NCT02640157|567109269|FG001|Overall Study|Withdrew consent|0|||
157096700|NCT02640157|567109270|FG002|Overall Study|Withdrew consent|2|||
157096701|NCT02640157|567109268|FG000|Overall Study|Lost to Follow-up|9|||
157096702|NCT02640157|567109269|FG001|Overall Study|Lost to Follow-up|2|||
157096703|NCT02640157|567109270|FG002|Overall Study|Lost to Follow-up|7|||
157096704|NCT02640157|567109268|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
157096705|NCT02640157|567109269|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
157096706|NCT02640157|567109270|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
157096707|NCT01596621|567109271|FG000|Overall Study|Death|4|||
157096708|NCT01596621|567109271|FG000|Overall Study|Withdrawal by Subject|9|||
157096709|NCT01596621|567109271|FG000|Overall Study|Disease Progression|49|||
157096710|NCT01596621|567109271|FG000|Overall Study|Lost to Follow-up|3|||
157096711|NCT01596621|567109271|FG000|Overall Study|Other than specified|13|||
157096712|NCT00710021|567109272|FG000|Overall Study|Lost to Follow-up|1|||
157096713|NCT00710021|567109273|FG001|Overall Study|Lost to Follow-up|0|||
157096714|NCT00710021|567109274|FG002|Overall Study|Lost to Follow-up|0|||
156984331|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984332|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984333|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984334|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984335|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984336|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984337|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984338|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984339|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984340|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
156984341|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984342|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
156984343|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
156984344|NCT01474512|566695033|FG000|Post-Treatment Follow-Up|Death|0|||
156984345|NCT01474512|566695034|FG001|Post-Treatment Follow-Up|Death|0|||
156984346|NCT01474512|566695035|FG002|Post-Treatment Follow-Up|Death|0|||
156984347|NCT01474512|566695036|FG003|Post-Treatment Follow-Up|Death|0|||
156984348|NCT01474512|566695037|FG004|Post-Treatment Follow-Up|Death|0|||
157096715|NCT00710021|567109272|FG000|Overall Study|Subject's Decision|0|||
157096716|NCT00710021|567109273|FG001|Overall Study|Subject's Decision|1|||
157096717|NCT00710021|567109274|FG002|Overall Study|Subject's Decision|0|||
157096718|NCT00710021|567109272|FG000|Overall Study|Subject misrandomized|0|||
157096719|NCT00710021|567109273|FG001|Overall Study|Subject misrandomized|1|||
157096720|NCT00710021|567109274|FG002|Overall Study|Subject misrandomized|1|||
157096721|NCT00710021|567109272|FG000|Overall Study|Physician Decision|0|||
157096722|NCT00710021|567109273|FG001|Overall Study|Physician Decision|1|||
157096723|NCT00710021|567109274|FG002|Overall Study|Physician Decision|0|||
157096724|NCT01679405|567109275|FG000|Overall Study|Death|2|||
157096725|NCT01679405|567109276|FG001|Overall Study|Death|5|||
157096726|NCT04677179|567109277|FG000|Induction Treatment Period|Adverse Event|1|||
157096727|NCT04677179|567109278|FG001|Induction Treatment Period|Adverse Event|0|||
157096728|NCT04677179|567109279|FG002|Induction Treatment Period|Adverse Event|0|||
157096729|NCT04677179|567109280|FG003|Induction Treatment Period|Adverse Event|0|||
157096730|NCT04677179|567109281|FG004|Induction Treatment Period|Adverse Event|0|||
157096731|NCT04677179|567109282|FG005|Induction Treatment Period|Adverse Event|0|||
157096732|NCT04677179|567109283|FG006|Induction Treatment Period|Adverse Event|0|||
157096733|NCT04677179|567109284|FG007|Induction Treatment Period|Adverse Event|0|||
157096734|NCT04677179|567109285|FG008|Induction Treatment Period|Adverse Event|0|||
157096735|NCT04677179|567109286|FG009|Induction Treatment Period|Adverse Event|0|||
157096736|NCT04677179|567109277|FG000|Induction Treatment Period|Physician Decision|1|||
157096737|NCT04677179|567109278|FG001|Induction Treatment Period|Physician Decision|0|||
157096738|NCT04677179|567109279|FG002|Induction Treatment Period|Physician Decision|1|||
157096739|NCT04677179|567109280|FG003|Induction Treatment Period|Physician Decision|0|||
157096740|NCT04677179|567109281|FG004|Induction Treatment Period|Physician Decision|0|||
157096741|NCT04677179|567109282|FG005|Induction Treatment Period|Physician Decision|0|||
157096742|NCT04677179|567109283|FG006|Induction Treatment Period|Physician Decision|0|||
157096743|NCT04677179|567109284|FG007|Induction Treatment Period|Physician Decision|0|||
157096744|NCT04677179|567109285|FG008|Induction Treatment Period|Physician Decision|0|||
157096745|NCT04677179|567109286|FG009|Induction Treatment Period|Physician Decision|0|||
157096746|NCT04677179|567109277|FG000|Induction Treatment Period|Protocol Violation|0|||
157096747|NCT04677179|567109278|FG001|Induction Treatment Period|Protocol Violation|1|||
157096748|NCT04677179|567109279|FG002|Induction Treatment Period|Protocol Violation|0|||
157096749|NCT04677179|567109280|FG003|Induction Treatment Period|Protocol Violation|0|||
157096750|NCT04677179|567109281|FG004|Induction Treatment Period|Protocol Violation|0|||
157096751|NCT04677179|567109282|FG005|Induction Treatment Period|Protocol Violation|0|||
157096752|NCT04677179|567109283|FG006|Induction Treatment Period|Protocol Violation|0|||
157096753|NCT04677179|567109284|FG007|Induction Treatment Period|Protocol Violation|0|||
157096754|NCT04677179|567109285|FG008|Induction Treatment Period|Protocol Violation|0|||
157096755|NCT04677179|567109286|FG009|Induction Treatment Period|Protocol Violation|0|||
157096756|NCT04677179|567109277|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
157096757|NCT04677179|567109278|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
157096758|NCT04677179|567109279|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
157096759|NCT04677179|567109280|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
157096760|NCT04677179|567109281|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
157096761|NCT04677179|567109282|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
157096762|NCT04677179|567109283|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
157096763|NCT04677179|567109284|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
157096764|NCT04677179|567109285|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
157096765|NCT04677179|567109286|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
157096766|NCT04677179|567109277|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
157096767|NCT04677179|567109278|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
157096768|NCT04677179|567109279|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
157096769|NCT04677179|567109280|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
157096770|NCT04677179|567109281|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
157096771|NCT04677179|567109282|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
157096772|NCT04677179|567109283|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
157096773|NCT04677179|567109284|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
157096774|NCT04677179|567109285|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
157096775|NCT04677179|567109286|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
157096776|NCT04677179|567109277|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
157096777|NCT04677179|567109278|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
157096778|NCT04677179|567109279|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
157096779|NCT04677179|567109280|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
157096780|NCT04677179|567109281|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
157096781|NCT04677179|567109282|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
157096782|NCT04677179|567109283|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
157096783|NCT04677179|567109284|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
157096784|NCT04677179|567109285|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
157096785|NCT04677179|567109286|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
157096786|NCT04677179|567109277|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
156984349|NCT01474512|566695038|FG005|Post-Treatment Follow-Up|Death|0|||
156984350|NCT01474512|566695039|FG006|Post-Treatment Follow-Up|Death|0|||
156984351|NCT01474512|566695040|FG007|Post-Treatment Follow-Up|Death|0|||
156984352|NCT01474512|566695041|FG008|Post-Treatment Follow-Up|Death|0|||
156984353|NCT01474512|566695042|FG009|Post-Treatment Follow-Up|Death|0|||
156984354|NCT01474512|566695043|FG010|Post-Treatment Follow-Up|Death|0|||
156984355|NCT01474512|566695044|FG011|Post-Treatment Follow-Up|Death|0|||
156984356|NCT01474512|566695045|FG012|Post-Treatment Follow-Up|Death|0|||
156984357|NCT01474512|566695046|FG013|Post-Treatment Follow-Up|Death|0|||
156984358|NCT01474512|566695047|FG014|Post-Treatment Follow-Up|Death|0|||
156984359|NCT01474512|566695048|FG015|Post-Treatment Follow-Up|Death|0|||
156984360|NCT01474512|566695049|FG016|Post-Treatment Follow-Up|Death|1|||
156984361|NCT01474512|566695050|FG017|Post-Treatment Follow-Up|Death|0|||
156984362|NCT01118962|566695053|FG000|Overall Study|Adverse Event|2|||
156984363|NCT01118962|566695053|FG000|Overall Study|Lack of Efficacy|1|||
156984364|NCT01118962|566695053|FG000|Overall Study|Protocol Violation|1|||
156984365|NCT01118962|566695053|FG000|Overall Study|Withdrawal by Subject|4|||
156984366|NCT01118962|566695053|FG000|Overall Study|Pregnancy|1|||
156984367|NCT01118962|566695053|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
156984368|NCT01238575|566695056|FG000|Overall Study|Lack of Efficacy|2|||
156984369|NCT01238575|566695057|FG001|Overall Study|Lack of Efficacy|4|||
156984370|NCT01238575|566695056|FG000|Overall Study|Adverse Event|2|||
156984371|NCT01238575|566695057|FG001|Overall Study|Adverse Event|0|||
156984372|NCT00593554|566695059|FG000|Overall Study|Death|1|||
156984373|NCT00593554|566695060|FG001|Overall Study|Death|2|||
156984374|NCT00593554|566695059|FG000|Overall Study|Physician Decision|0|||
156984375|NCT00593554|566695060|FG001|Overall Study|Physician Decision|1|||
156984376|NCT00593554|566695059|FG000|Overall Study|Withdrawal by Subject|1|||
156984377|NCT00593554|566695060|FG001|Overall Study|Withdrawal by Subject|0|||
156984378|NCT00593554|566695059|FG000|Overall Study|Disease Progression|1|||
157096787|NCT04677179|567109278|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
156984379|NCT00593554|566695060|FG001|Overall Study|Disease Progression|2|||
156984380|NCT00795132|566695063|FG000|Overall Study|Death|1|||
156984381|NCT00795132|566695063|FG000|Overall Study|Relapse|2|||
156984382|NCT00962585|566695066|FG000|Overall Study|Adverse Event|0|||
156984383|NCT00962585|566695067|FG001|Overall Study|Adverse Event|2|||
156984384|NCT00962585|566695068|FG002|Overall Study|Adverse Event|1|||
156984385|NCT00962585|566695069|FG003|Overall Study|Adverse Event|0|||
156984386|NCT00962585|566695066|FG000|Overall Study|Lost to Follow-up|3|||
156984387|NCT00962585|566695067|FG001|Overall Study|Lost to Follow-up|0|||
156984388|NCT00962585|566695068|FG002|Overall Study|Lost to Follow-up|1|||
156984389|NCT00962585|566695069|FG003|Overall Study|Lost to Follow-up|0|||
156984390|NCT00962585|566695066|FG000|Overall Study|Protocol Violation|0|||
156984391|NCT00962585|566695067|FG001|Overall Study|Protocol Violation|0|||
156984392|NCT00962585|566695068|FG002|Overall Study|Protocol Violation|1|||
156984393|NCT00962585|566695069|FG003|Overall Study|Protocol Violation|0|||
156984394|NCT00962585|566695066|FG000|Overall Study|Withdrawal by Subject|1|||
156984395|NCT00962585|566695067|FG001|Overall Study|Withdrawal by Subject|0|||
156984396|NCT00962585|566695068|FG002|Overall Study|Withdrawal by Subject|0|||
156984397|NCT00962585|566695069|FG003|Overall Study|Withdrawal by Subject|0|||
156984398|NCT00962585|566695066|FG000|Overall Study|Withdrew Consent|2|||
156984399|NCT00962585|566695067|FG001|Overall Study|Withdrew Consent|0|||
156984400|NCT00962585|566695068|FG002|Overall Study|Withdrew Consent|0|||
156984401|NCT00962585|566695069|FG003|Overall Study|Withdrew Consent|0|||
156984402|NCT00262743|566695072|FG000|Overall Study|Adverse Event|0|||
156984403|NCT00262743|566695073|FG001|Overall Study|Adverse Event|9|||
156984404|NCT00262743|566695072|FG000|Overall Study|Disease progression|0|||
156984405|NCT00262743|566695073|FG001|Overall Study|Disease progression|3|||
156984406|NCT02254421|566695078|FG000|Overall Study|Randomized but Not Treated|1|||
156984407|NCT02254421|566695079|FG001|Overall Study|Randomized but Not Treated|0|||
156984408|NCT02254421|566695078|FG000|Overall Study|Death|0|||
156984409|NCT02254421|566695079|FG001|Overall Study|Death|2|||
156984410|NCT02254421|566695078|FG000|Overall Study|Withdrew Consent|1|||
156984411|NCT02254421|566695079|FG001|Overall Study|Withdrew Consent|1|||
157096788|NCT04677179|567109279|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
156984412|NCT00358150|566695082|FG000|Overall Study|Adverse Event|3|||
156984413|NCT00358150|566695082|FG000|Overall Study|Withdrawal by Subject|1|||
156984414|NCT00358150|566695082|FG000|Overall Study|Undefined|3|||
156984415|NCT00627042|566695083|FG000|Overall Study|Withdrawal by Subject|2|||
156984416|NCT04747275|566695084|FG000|Overall Study|Study terminated|0|||
156984417|NCT04747275|566695085|FG001|Overall Study|Study terminated|1|||
156984418|NCT03268590|566695088|FG000|Overall Study|Previously unknown exclusion criteria|1|||
157096789|NCT04677179|567109280|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
156984419|NCT00531011|566695089|FG000|Overall Study|Withdrawal by Subject|2|||
157096790|NCT04677179|567109281|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096791|NCT04677179|567109282|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096792|NCT04677179|567109283|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096793|NCT04677179|567109284|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096794|NCT04677179|567109285|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096795|NCT04677179|567109286|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
157096796|NCT04677179|567109277|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096797|NCT04677179|567109278|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096798|NCT04677179|567109279|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096799|NCT04677179|567109280|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
157096800|NCT04677179|567109281|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
157096801|NCT04677179|567109282|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
157096802|NCT04677179|567109283|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096803|NCT04677179|567109284|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096804|NCT04677179|567109285|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096805|NCT04677179|567109286|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
157096806|NCT04677179|567109277|FG000|Extension Treatment Period|Lack of Efficacy|0|||
157096807|NCT04677179|567109278|FG001|Extension Treatment Period|Lack of Efficacy|0|||
157096808|NCT04677179|567109279|FG002|Extension Treatment Period|Lack of Efficacy|0|||
157096809|NCT04677179|567109280|FG003|Extension Treatment Period|Lack of Efficacy|0|||
157096810|NCT04677179|567109281|FG004|Extension Treatment Period|Lack of Efficacy|0|||
157096811|NCT04677179|567109282|FG005|Extension Treatment Period|Lack of Efficacy|0|||
157096812|NCT04677179|567109283|FG006|Extension Treatment Period|Lack of Efficacy|6|||
157096813|NCT04677179|567109284|FG007|Extension Treatment Period|Lack of Efficacy|0|||
157096814|NCT04677179|567109285|FG008|Extension Treatment Period|Lack of Efficacy|0|||
157096815|NCT04677179|567109286|FG009|Extension Treatment Period|Lack of Efficacy|0|||
157096816|NCT04677179|567109277|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
157096817|NCT04677179|567109278|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
157096818|NCT04677179|567109279|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
157096819|NCT04677179|567109280|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
157096820|NCT04677179|567109281|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
157096821|NCT04677179|567109282|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
157096822|NCT04677179|567109283|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
157096823|NCT04677179|567109284|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
157096824|NCT04677179|567109285|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
157096825|NCT04677179|567109286|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
157096826|NCT04677179|567109277|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
157096827|NCT04677179|567109278|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
157096828|NCT04677179|567109279|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
157096829|NCT04677179|567109280|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
157096830|NCT04677179|567109281|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
157096831|NCT04677179|567109282|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
157096832|NCT04677179|567109283|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
157096833|NCT04677179|567109284|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
157096834|NCT04677179|567109285|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
157096835|NCT04677179|567109286|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
157096836|NCT04677179|567109277|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
157096837|NCT04677179|567109278|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
157096838|NCT04677179|567109279|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
157096839|NCT04677179|567109280|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
157096840|NCT04677179|567109281|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
157096841|NCT04677179|567109282|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
156984420|NCT00531011|566695090|FG001|Overall Study|Withdrawal by Subject|4|||
156984421|NCT00531011|566695089|FG000|Overall Study|Death|1|||
156984422|NCT00531011|566695090|FG001|Overall Study|Death|0|||
156984423|NCT00531011|566695089|FG000|Overall Study|Lost to Follow-up|1|||
156984424|NCT00531011|566695090|FG001|Overall Study|Lost to Follow-up|0|||
156984425|NCT00531011|566695089|FG000|Overall Study|Physician Decision|0|||
156984426|NCT00531011|566695090|FG001|Overall Study|Physician Decision|3|||
156984427|NCT04254679|566695111|FG000|Overall Study|Protocol Violation|1|||
156984428|NCT04254679|566695112|FG001|Overall Study|Protocol Violation|1|||
156984429|NCT04254679|566695111|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
156984430|NCT04254679|566695112|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
156984431|NCT03537261|566695125|FG000|Overall Study|Lost to Follow-up|4|||
156984432|NCT03537261|566695126|FG001|Overall Study|Lost to Follow-up|5|||
156984433|NCT03537261|566695125|FG000|Overall Study|Withdrawal by Subject|4|||
156984434|NCT03537261|566695126|FG001|Overall Study|Withdrawal by Subject|6|||
156984435|NCT03537261|566695125|FG000|Overall Study|Did not return study questionnaires|0|||
156984436|NCT03537261|566695126|FG001|Overall Study|Did not return study questionnaires|1|||
156984437|NCT01630590|566695130|FG000|Overall Study|Adverse Event|9|||
156984438|NCT01630590|566695130|FG000|Overall Study|Lack of Efficacy|37|||
156984439|NCT01630590|566695130|FG000|Overall Study|Withdrawal by Subject|4|||
156984440|NCT01630590|566695130|FG000|Overall Study|2nd primary tumor|2|||
156984441|NCT01630590|566695130|FG000|Overall Study|Automobile accident|1|||
156984442|NCT01630590|566695130|FG000|Overall Study|Maximum benefit|4|||
156984443|NCT02366936|566695131|FG000|Overall Study|Withdrawal by Subject|2|||
156984444|NCT02366936|566695131|FG000|Overall Study|Lost to Follow-up|4|||
156984445|NCT02366936|566695131|FG000|Overall Study|Physician Decision|2|||
156984446|NCT01751113|566695132|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156984447|NCT01751113|566695133|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156984448|NCT01751113|566695134|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156984449|NCT01751113|566695135|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156984450|NCT01751113|566695136|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156984451|NCT01751113|566695137|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156984452|NCT01751113|566695132|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156984453|NCT01751113|566695133|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156984454|NCT01751113|566695134|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156984455|NCT01751113|566695135|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156984456|NCT01751113|566695136|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
156984457|NCT01751113|566695137|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
156984458|NCT00363896|566695138|FG000|Overall Study|Withdrawal by Subject|29|||
156984459|NCT00363896|566695139|FG001|Overall Study|Withdrawal by Subject|16|||
156984460|NCT00363896|566695138|FG000|Overall Study|Adverse Event|24|||
156984461|NCT00363896|566695139|FG001|Overall Study|Adverse Event|13|||
156984462|NCT00363896|566695138|FG000|Overall Study|COPD exacerbation|13|||
156984463|NCT00363896|566695139|FG001|Overall Study|COPD exacerbation|7|||
156984464|NCT00363896|566695138|FG000|Overall Study|Lack of Efficacy|12|||
156984465|NCT00363896|566695139|FG001|Overall Study|Lack of Efficacy|8|||
156984466|NCT00363896|566695138|FG000|Overall Study|Protocol Violation|6|||
156984467|NCT00363896|566695139|FG001|Overall Study|Protocol Violation|1|||
156984468|NCT00363896|566695138|FG000|Overall Study|Lost to Follow-up|3|||
156984469|NCT00363896|566695139|FG001|Overall Study|Lost to Follow-up|0|||
156984470|NCT00363896|566695138|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
156984471|NCT00363896|566695139|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
156984472|NCT00363896|566695138|FG000|Overall Study|Other|1|||
156984473|NCT00363896|566695139|FG001|Overall Study|Other|2|||
156984474|NCT01555021|566695140|FG000|Overall Study|Lost to Follow-up|1|||
156984475|NCT01555021|566695141|FG001|Overall Study|Lost to Follow-up|2|||
156984476|NCT01388530|566695145|FG000|Overall Study|Lost to Follow-up|5|||
156984477|NCT02420327|566695146|FG000|Overall Study|Adverse Event|7|||
156984478|NCT02420327|566695146|FG000|Overall Study|Pregnancy|1|||
156984479|NCT02420327|566695146|FG000|Overall Study|Withdrawal by Subject|6|||
156984480|NCT02420327|566695146|FG000|Overall Study|Lost to Follow-up|1|||
156984481|NCT02420327|566695146|FG000|Overall Study|Protocol Violation|1|||
156984482|NCT02204293|566695147|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
156984483|NCT02204293|566695148|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
156984484|NCT02204293|566695149|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
157096842|NCT04677179|567109283|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
157096843|NCT04677179|567109284|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
157096844|NCT04677179|567109285|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
157096845|NCT04677179|567109286|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
157096846|NCT04677179|567109277|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156984485|NCT02204293|566695150|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
156984486|NCT02204293|566695151|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
156984487|NCT02204293|566695152|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
156984488|NCT02204293|566695147|FG000|Core Study Part I|Adverse Event|1|||
156984489|NCT02204293|566695148|FG001|Core Study Part I|Adverse Event|0|||
156984490|NCT02204293|566695149|FG002|Core Study Part I|Adverse Event|0|||
156984491|NCT02204293|566695150|FG003|Core Study Part I|Adverse Event|0|||
156984492|NCT02204293|566695151|FG004|Core Study Part I|Adverse Event|0|||
156984493|NCT02204293|566695152|FG005|Core Study Part I|Adverse Event|0|||
156984494|NCT02204293|566695147|FG000|Core Study Part I|Physician Decision|0|||
156984495|NCT02204293|566695148|FG001|Core Study Part I|Physician Decision|3|||
156984496|NCT02204293|566695149|FG002|Core Study Part I|Physician Decision|0|||
156984497|NCT02204293|566695150|FG003|Core Study Part I|Physician Decision|0|||
156984498|NCT02204293|566695151|FG004|Core Study Part I|Physician Decision|0|||
156984499|NCT02204293|566695152|FG005|Core Study Part I|Physician Decision|0|||
156984500|NCT02204293|566695147|FG000|LTE Phase|Study Suspended|0|||
156984501|NCT02204293|566695148|FG001|LTE Phase|Study Suspended|0|||
156984502|NCT02204293|566695149|FG002|LTE Phase|Study Suspended|0|||
156984503|NCT02204293|566695150|FG003|LTE Phase|Study Suspended|0|||
156984504|NCT02204293|566695151|FG004|LTE Phase|Study Suspended|0|||
156984505|NCT02204293|566695152|FG005|LTE Phase|Study Suspended|7|||
156984506|NCT01225835|566695155|FG000|Overall Study|Completed protocol|2|||
156984507|NCT01225835|566695156|FG001|Overall Study|Completed protocol|1|||
156984508|NCT01225835|566695155|FG000|Overall Study|Did not meet hCG criterion|2|||
156984509|NCT01225835|566695156|FG001|Overall Study|Did not meet hCG criterion|0|||
156984510|NCT01225835|566695155|FG000|Overall Study|Adverse Event|2|||
156984511|NCT01225835|566695156|FG001|Overall Study|Adverse Event|1|||
156984512|NCT01225835|566695155|FG000|Overall Study|Other|1|||
156984513|NCT01225835|566695156|FG001|Overall Study|Other|1|||
156984514|NCT01146574|566695157|FG000|Overall Study|Death|0|||
156984515|NCT01146574|566695158|FG001|Overall Study|Death|1|||
156984516|NCT01146574|566695159|FG002|Overall Study|Death|1|||
156984517|NCT01146574|566695160|FG003|Overall Study|Death|0|||
156984518|NCT01146574|566695161|FG004|Overall Study|Death|0|||
156984519|NCT01146574|566695162|FG005|Overall Study|Death|0|||
156984520|NCT01146574|566695163|FG006|Overall Study|Death|0|||
156984521|NCT01146574|566695157|FG000|Overall Study|Other reasons|0|||
156984522|NCT01146574|566695158|FG001|Overall Study|Other reasons|0|||
156984523|NCT01146574|566695159|FG002|Overall Study|Other reasons|3|||
156984524|NCT01146574|566695160|FG003|Overall Study|Other reasons|0|||
156984525|NCT01146574|566695161|FG004|Overall Study|Other reasons|0|||
156984526|NCT01146574|566695162|FG005|Overall Study|Other reasons|0|||
156984527|NCT01146574|566695163|FG006|Overall Study|Other reasons|0|||
156984528|NCT01146574|566695157|FG000|Overall Study|Kidney transplant|0|||
156984529|NCT01146574|566695158|FG001|Overall Study|Kidney transplant|0|||
156984530|NCT01146574|566695159|FG002|Overall Study|Kidney transplant|1|||
156984531|NCT01146574|566695160|FG003|Overall Study|Kidney transplant|1|||
156984532|NCT01146574|566695161|FG004|Overall Study|Kidney transplant|0|||
156984533|NCT01146574|566695162|FG005|Overall Study|Kidney transplant|0|||
156984534|NCT01146574|566695163|FG006|Overall Study|Kidney transplant|0|||
156984535|NCT01146574|566695157|FG000|Overall Study|Withdrew consent|0|||
156984536|NCT01146574|566695158|FG001|Overall Study|Withdrew consent|0|||
156984537|NCT01146574|566695159|FG002|Overall Study|Withdrew consent|1|||
156984538|NCT01146574|566695160|FG003|Overall Study|Withdrew consent|1|||
156984539|NCT01146574|566695161|FG004|Overall Study|Withdrew consent|2|||
156984540|NCT01146574|566695162|FG005|Overall Study|Withdrew consent|1|||
156984541|NCT01146574|566695163|FG006|Overall Study|Withdrew consent|1|||
156984542|NCT01266993|566695164|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
156984543|NCT01266993|566695165|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
156984544|NCT01266993|566695164|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
156984545|NCT01266993|566695165|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
156984546|NCT04779242|566695166|FG000|Overall Study|Adverse Event|1|||
156984547|NCT04779242|566695167|FG001|Overall Study|Adverse Event|1|||
156984548|NCT04779242|566695166|FG000|Overall Study|Lost to Follow-up|2|||
156984549|NCT04779242|566695167|FG001|Overall Study|Lost to Follow-up|4|||
156984550|NCT04779242|566695166|FG000|Overall Study|Withdrawal by Subject|7|||
156984551|NCT04779242|566695167|FG001|Overall Study|Withdrawal by Subject|9|||
156984552|NCT04779242|566695166|FG000|Overall Study|Death|6|||
156984553|NCT04779242|566695167|FG001|Overall Study|Death|6|||
156984554|NCT04779242|566695166|FG000|Overall Study|COVID-19 related reasons|2|||
156984555|NCT04779242|566695167|FG001|Overall Study|COVID-19 related reasons|1|||
156984556|NCT04779242|566695166|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
156984557|NCT04779242|566695167|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
156984558|NCT04779242|566695166|FG000|Overall Study|Martial Law in Ukraine|2|||
156984559|NCT04779242|566695167|FG001|Overall Study|Martial Law in Ukraine|3|||
156984560|NCT01076088|566695170|FG000|Overall Study|Adverse Event|1|||
156984561|NCT01076088|566695171|FG001|Overall Study|Adverse Event|6|||
156984562|NCT01076088|566695172|FG002|Overall Study|Adverse Event|3|||
156984563|NCT01076088|566695173|FG003|Overall Study|Adverse Event|2|||
156984564|NCT01076088|566695174|FG004|Overall Study|Adverse Event|3|||
156984565|NCT01076088|566695175|FG005|Overall Study|Adverse Event|3|||
156984566|NCT01076088|566695170|FG000|Overall Study|Lost to Follow-up|1|||
156984567|NCT01076088|566695171|FG001|Overall Study|Lost to Follow-up|1|||
156984568|NCT01076088|566695172|FG002|Overall Study|Lost to Follow-up|0|||
156984569|NCT01076088|566695173|FG003|Overall Study|Lost to Follow-up|1|||
156984570|NCT01076088|566695174|FG004|Overall Study|Lost to Follow-up|1|||
156984571|NCT01076088|566695175|FG005|Overall Study|Lost to Follow-up|2|||
156984572|NCT01076088|566695170|FG000|Overall Study|Non-compliance with study drug|0|||
156984573|NCT01076088|566695171|FG001|Overall Study|Non-compliance with study drug|0|||
156984574|NCT01076088|566695172|FG002|Overall Study|Non-compliance with study drug|0|||
156984575|NCT01076088|566695173|FG003|Overall Study|Non-compliance with study drug|1|||
156984576|NCT01076088|566695174|FG004|Overall Study|Non-compliance with study drug|0|||
156984577|NCT01076088|566695175|FG005|Overall Study|Non-compliance with study drug|0|||
156984578|NCT01076088|566695170|FG000|Overall Study|Physician Decision|1|||
156984579|NCT01076088|566695171|FG001|Overall Study|Physician Decision|3|||
156984580|NCT01076088|566695172|FG002|Overall Study|Physician Decision|0|||
156984581|NCT01076088|566695173|FG003|Overall Study|Physician Decision|1|||
156984582|NCT01076088|566695174|FG004|Overall Study|Physician Decision|1|||
156984583|NCT01076088|566695175|FG005|Overall Study|Physician Decision|0|||
156984584|NCT01076088|566695170|FG000|Overall Study|Withdrawal by Subject|8|||
156984585|NCT01076088|566695171|FG001|Overall Study|Withdrawal by Subject|8|||
156984586|NCT01076088|566695172|FG002|Overall Study|Withdrawal by Subject|14|||
156984587|NCT01076088|566695173|FG003|Overall Study|Withdrawal by Subject|10|||
156984588|NCT01076088|566695174|FG004|Overall Study|Withdrawal by Subject|11|||
156984589|NCT01076088|566695175|FG005|Overall Study|Withdrawal by Subject|17|||
156984590|NCT01076088|566695170|FG000|Overall Study|Other protocol specified criteria|0|||
156984591|NCT01076088|566695171|FG001|Overall Study|Other protocol specified criteria|0|||
156984592|NCT01076088|566695172|FG002|Overall Study|Other protocol specified criteria|0|||
156984593|NCT01076088|566695173|FG003|Overall Study|Other protocol specified criteria|0|||
156984594|NCT01076088|566695174|FG004|Overall Study|Other protocol specified criteria|0|||
156984595|NCT01076088|566695175|FG005|Overall Study|Other protocol specified criteria|1|||
156984596|NCT03053492|566695178|FG000|Overall Study|Adverse Event|1|||
156984597|NCT03053492|566695179|FG001|Overall Study|Adverse Event|1|||
156984598|NCT03053492|566695178|FG000|Overall Study|Withdrawal by Subject|7|||
156984599|NCT03053492|566695179|FG001|Overall Study|Withdrawal by Subject|5|||
156984600|NCT00683449|566695183|FG000|Overall Study|Lost to Follow-up|0|||
156984601|NCT00683449|566695184|FG001|Overall Study|Lost to Follow-up|1|||
156984602|NCT00683449|566695185|FG002|Overall Study|Lost to Follow-up|0|||
156984603|NCT00683449|566695186|FG003|Overall Study|Lost to Follow-up|0|||
156984604|NCT00683449|566695187|FG004|Overall Study|Lost to Follow-up|0|||
156984605|NCT01000376|566695191|FG000|Cycle 1 Day 1|Adverse Event|1|||
156984606|NCT01000376|566695192|FG001|Cycle 1 Day 1|Adverse Event|0|||
156984607|NCT01000376|566695191|FG000|Cycle 1 Day 1|Progressive Disease|1|||
156984608|NCT01000376|566695192|FG001|Cycle 1 Day 1|Progressive Disease|0|||
156984609|NCT04793464|566695194|FG000|Overall Study|Lost to Follow-up|458|||
156984610|NCT04793464|566695195|FG001|Overall Study|Lost to Follow-up|168|||
156984611|NCT04793464|566695196|FG002|Overall Study|Lost to Follow-up|5|||
156984612|NCT04793464|566695194|FG000|Overall Study|Withdrawal by Subject|43|||
156984613|NCT04793464|566695195|FG001|Overall Study|Withdrawal by Subject|15|||
156984614|NCT04793464|566695196|FG002|Overall Study|Withdrawal by Subject|0|||
156984615|NCT00845871|566695204|FG000|Assessment Period|Adverse Event|2|||
156984616|NCT00845871|566695204|FG000|Assessment Period|Abnormal laboratory values|1|||
156984617|NCT00845871|566695204|FG000|Assessment Period|Abnormal test procedure results|1|||
156984618|NCT00845871|566695204|FG000|Assessment Period|Patient withdrew consent|3|||
156984619|NCT01857622|566695205|FG000|Overall Study|Adverse Event|5|||
156984620|NCT01857622|566695206|FG001|Overall Study|Adverse Event|0|||
156984621|NCT01857622|566695207|FG002|Overall Study|Adverse Event|2|||
156984622|NCT01857622|566695205|FG000|Overall Study|Physician Decision|1|||
156984623|NCT01857622|566695206|FG001|Overall Study|Physician Decision|0|||
156984624|NCT01857622|566695207|FG002|Overall Study|Physician Decision|0|||
156984625|NCT01857622|566695205|FG000|Overall Study|Protocol Violation|4|||
156984626|NCT01857622|566695206|FG001|Overall Study|Protocol Violation|1|||
156984627|NCT01857622|566695207|FG002|Overall Study|Protocol Violation|0|||
156984628|NCT01857622|566695205|FG000|Overall Study|Withdrawal by Subject|1|||
156984629|NCT01857622|566695206|FG001|Overall Study|Withdrawal by Subject|0|||
156984630|NCT01857622|566695207|FG002|Overall Study|Withdrawal by Subject|0|||
156984631|NCT01291225|566695210|FG000|Overall Study|Lost to Follow-up|85|||
156984632|NCT01291225|566695211|FG001|Overall Study|Lost to Follow-up|39|||
156984633|NCT00581113|566697197|FG000|Overall Study|Withdrawal by Subject|0|||
156984634|NCT00581113|566697198|FG001|Overall Study|Withdrawal by Subject|1|||
156984635|NCT02930122|566697201|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
156984636|NCT02930122|566697202|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
156984637|NCT01995357|566697203|FG000|Period 5|Lack of Efficacy|1|||
156984638|NCT01995357|566697204|FG001|Period 5|Lack of Efficacy|0|||
156984639|NCT01995357|566697205|FG002|Period 5|Lack of Efficacy|0|||
156984640|NCT01995357|566697206|FG003|Period 5|Lack of Efficacy|0|||
156984641|NCT01995357|566697207|FG004|Period 5|Lack of Efficacy|0|||
156984642|NCT01995357|566697208|FG005|Period 5|Lack of Efficacy|0|||
156984643|NCT01995357|566697203|FG000|Period 5|Adverse Event|1|||
156984644|NCT01995357|566697204|FG001|Period 5|Adverse Event|0|||
156984645|NCT01995357|566697205|FG002|Period 5|Adverse Event|1|||
156984646|NCT01995357|566697206|FG003|Period 5|Adverse Event|0|||
156984647|NCT01995357|566697207|FG004|Period 5|Adverse Event|0|||
156984648|NCT01995357|566697208|FG005|Period 5|Adverse Event|0|||
156984649|NCT02609659|566697209|FG000|Overall Study|Adverse Event|1|||
156984650|NCT02609659|566697209|FG000|Overall Study|Lost to Follow-up|6|||
156984651|NCT02609659|566697209|FG000|Overall Study|Other|1|||
156984652|NCT01853254|566697212|FG000|Overall Study|Abnormal Laboratory Test|1|||
156984653|NCT01853254|566697212|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
156984654|NCT01853254|566697212|FG000|Overall Study|Death|1|||
156984655|NCT01853254|566697212|FG000|Overall Study|Failure to Return|43|||
156984656|NCT01853254|566697212|FG000|Overall Study|Insufficient Therapeutic Response|22|||
156984657|NCT01853254|566697212|FG000|Overall Study|Refusal of Treatment|1|||
156984658|NCT01853254|566697212|FG000|Overall Study|Other Protocol Violation|1|||
156984659|NCT01853254|566697212|FG000|Overall Study|Withdrawal of Consent|16|||
156984660|NCT01853254|566697212|FG000|Overall Study|Administrative/Other|16|||
156984661|NCT02462083|566697213|FG000|Overall Study|Sponsor request|39|||
156984662|NCT02462083|566697213|FG000|Overall Study|Withdrawal by Subject|87|||
156984663|NCT02462083|566697213|FG000|Overall Study|Lost to Follow-up|41|||
156984664|NCT02462083|566697213|FG000|Overall Study|Lack of Efficacy|151|||
156984665|NCT02462083|566697213|FG000|Overall Study|Pregnancy|1|||
156984666|NCT02462083|566697213|FG000|Overall Study|Protocol Violation|6|||
156984667|NCT02462083|566697213|FG000|Overall Study|Adverse Event|33|||
156984668|NCT02462083|566697213|FG000|Overall Study|Worsening condition|16|||
156984669|NCT02462083|566697213|FG000|Overall Study|Other than specified|45|||
156984670|NCT00867490|566697217|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
156984671|NCT00867490|566697217|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
156984672|NCT00867490|566697217|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
156984673|NCT00867490|566697217|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
156984674|NCT00867490|566697217|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
156984675|NCT04430335|566697220|FG000|Overall Study|Withdrawal by Subject|1|||
156984676|NCT00179010|566697223|FG000|Overall Study|Muscle probe defective|1|||
156984677|NCT00179010|566697224|FG001|Overall Study|Muscle probe defective|1|||
156984678|NCT00179010|566697223|FG000|Overall Study|Failure to place arterial line|0|||
156984679|NCT00179010|566697224|FG001|Overall Study|Failure to place arterial line|1|||
156984680|NCT03249376|566697242|FG000|Overall Study|Adverse Event|11|||
156984681|NCT03249376|566697243|FG001|Overall Study|Adverse Event|5|||
156984682|NCT03249376|566697242|FG000|Overall Study|Lack of Efficacy|2|||
156984683|NCT03249376|566697243|FG001|Overall Study|Lack of Efficacy|4|||
156984684|NCT03249376|566697242|FG000|Overall Study|Protocol Violation|3|||
156984685|NCT03249376|566697243|FG001|Overall Study|Protocol Violation|2|||
156984686|NCT03249376|566697242|FG000|Overall Study|Physician Decision|0|||
156984687|NCT03249376|566697243|FG001|Overall Study|Physician Decision|2|||
156984688|NCT03249376|566697242|FG000|Overall Study|Withdrawal by Subject|3|||
156984689|NCT03249376|566697243|FG001|Overall Study|Withdrawal by Subject|9|||
156984690|NCT03249376|566697242|FG000|Overall Study|LTFU|2|||
156984691|NCT03249376|566697243|FG001|Overall Study|LTFU|1|||
156984692|NCT02823964|566697244|FG000|Overall Study|Adverse Event|2|||
156984693|NCT02823964|566697244|FG000|Overall Study|Physician Decision|1|||
156984694|NCT02823964|566697244|FG000|Overall Study|Lack of Efficacy|1|||
156984695|NCT02823964|566697244|FG000|Overall Study|Withdrawal by Subject|1|||
156984696|NCT00794820|566697249|FG000|Overall Study|Adverse Event|11|||
156984697|NCT00794820|566697249|FG000|Overall Study|Secondary Malignancies|2|||
156984698|NCT00794820|566697249|FG000|Overall Study|Resistant Disease|2|||
156984699|NCT00794820|566697249|FG000|Overall Study|Ineligible/Screen Failure|1|||
156984700|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
156984701|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
156984702|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
156984703|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
156984704|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156984705|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
156984706|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156984707|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156984708|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
156984709|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
156984710|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
157096847|NCT04677179|567109278|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
156984711|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156984712|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
156984713|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
156984714|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156984715|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156984716|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
156984717|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
156984718|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
156984719|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
156984720|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
156984721|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
156984722|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
156984723|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
156984724|NCT03230864|566697252|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
156984725|NCT03230864|566697253|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156984726|NCT03230864|566697254|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156984727|NCT03230864|566697255|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
156984728|NCT03230864|566697252|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
156984729|NCT03230864|566697253|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
156984730|NCT03230864|566697254|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
156984731|NCT03230864|566697255|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
156984732|NCT03230864|566697252|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156984733|NCT03230864|566697253|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156984734|NCT03230864|566697254|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
156984735|NCT03230864|566697255|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
156984736|NCT03230864|566697252|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156984737|NCT03230864|566697253|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156984738|NCT03230864|566697254|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
156984739|NCT03230864|566697255|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
156984740|NCT00432679|566697258|FG000|Overall Study|Adverse Event|2|||
156984741|NCT00432679|566697259|FG001|Overall Study|Adverse Event|1|||
156984742|NCT00432679|566697258|FG000|Overall Study|Withdrawal by Subject|3|||
156984743|NCT00432679|566697259|FG001|Overall Study|Withdrawal by Subject|2|||
156984744|NCT04102540|566697260|FG000|Overall Study|Withdrawn by PI|2|||
156984745|NCT04102540|566697260|FG000|Overall Study|Lost to Follow-up|6|||
156984746|NCT00280293|566697261|FG000|Overall Study|Protocol Violation|3|||
156984747|NCT00280293|566697262|FG001|Overall Study|Protocol Violation|0|||
156984748|NCT00280293|566697261|FG000|Overall Study|Physician Decision|5|||
156984749|NCT00280293|566697262|FG001|Overall Study|Physician Decision|4|||
156984750|NCT00280293|566697261|FG000|Overall Study|Lost to Follow-up|14|||
156984751|NCT00280293|566697262|FG001|Overall Study|Lost to Follow-up|12|||
156984752|NCT00280293|566697261|FG000|Overall Study|Withdrawal by Subject|3|||
156984753|NCT00280293|566697262|FG001|Overall Study|Withdrawal by Subject|5|||
156984754|NCT00280293|566697261|FG000|Overall Study|Incarceration/Legal Reasons|1|||
156984755|NCT00280293|566697262|FG001|Overall Study|Incarceration/Legal Reasons|1|||
156984756|NCT00280293|566697261|FG000|Overall Study|Adverse Event|0|||
156984757|NCT00280293|566697262|FG001|Overall Study|Adverse Event|1|||
156984758|NCT01177813|566697263|FG000|Overall Study|Adverse Event|8|||
156984759|NCT01177813|566697264|FG001|Overall Study|Adverse Event|2|||
156984760|NCT01177813|566697265|FG002|Overall Study|Adverse Event|4|||
156984761|NCT01177813|566697266|FG003|Overall Study|Adverse Event|6|||
156984762|NCT01177813|566697267|FG004|Overall Study|Adverse Event|3|||
156984763|NCT01177813|566697263|FG000|Overall Study|Lack of Efficacy|1|||
156984764|NCT01177813|566697264|FG001|Overall Study|Lack of Efficacy|0|||
156984765|NCT01177813|566697265|FG002|Overall Study|Lack of Efficacy|0|||
156984766|NCT01177813|566697266|FG003|Overall Study|Lack of Efficacy|0|||
156984767|NCT01177813|566697267|FG004|Overall Study|Lack of Efficacy|0|||
156984768|NCT01177813|566697263|FG000|Overall Study|Protocol Violation|3|||
156984769|NCT01177813|566697264|FG001|Overall Study|Protocol Violation|2|||
156984770|NCT01177813|566697265|FG002|Overall Study|Protocol Violation|2|||
156984771|NCT01177813|566697266|FG003|Overall Study|Protocol Violation|0|||
156984772|NCT01177813|566697267|FG004|Overall Study|Protocol Violation|1|||
156984773|NCT01177813|566697263|FG000|Overall Study|Lost to Follow-up|12|||
156984774|NCT01177813|566697264|FG001|Overall Study|Lost to Follow-up|5|||
156984775|NCT01177813|566697265|FG002|Overall Study|Lost to Follow-up|6|||
156984776|NCT01177813|566697266|FG003|Overall Study|Lost to Follow-up|3|||
156984777|NCT01177813|566697267|FG004|Overall Study|Lost to Follow-up|0|||
156984778|NCT01177813|566697263|FG000|Overall Study|Withdrawal by Subject|12|||
156984779|NCT01177813|566697264|FG001|Overall Study|Withdrawal by Subject|7|||
156984780|NCT01177813|566697265|FG002|Overall Study|Withdrawal by Subject|6|||
156984781|NCT01177813|566697266|FG003|Overall Study|Withdrawal by Subject|5|||
156984782|NCT01177813|566697267|FG004|Overall Study|Withdrawal by Subject|3|||
156984783|NCT01177813|566697263|FG000|Overall Study|Other reason not defined above|5|||
156984784|NCT01177813|566697264|FG001|Overall Study|Other reason not defined above|2|||
156984785|NCT01177813|566697265|FG002|Overall Study|Other reason not defined above|2|||
156984786|NCT01177813|566697266|FG003|Overall Study|Other reason not defined above|3|||
156984787|NCT01177813|566697267|FG004|Overall Study|Other reason not defined above|2|||
156984788|NCT00610675|566697272|FG000|Overall Study|Untreated|4|||
156984789|NCT00610675|566697272|FG000|Overall Study|Adverse Event|67|||
156984790|NCT00610675|566697272|FG000|Overall Study|Insufficient Effect|31|||
156984791|NCT00610675|566697272|FG000|Overall Study|Withdrawal by Subject|28|||
156984792|NCT00610675|566697272|FG000|Overall Study|Reasons unrelated to trial|27|||
156984793|NCT00610675|566697272|FG000|Overall Study|Lack of Compliance|7|||
156984794|NCT00610675|566697272|FG000|Overall Study|Lost to Follow-up|31|||
156984795|NCT00610675|566697272|FG000|Overall Study|Other reason (not specified)|25|||
156984796|NCT01458249|566697273|FG000|Overall Study|Not treated|1|||
156984797|NCT01458249|566697273|FG000|Overall Study|Adverse Event|4|||
156984798|NCT01458249|566697273|FG000|Overall Study|Other|2|||
156984799|NCT01458249|566697273|FG000|Overall Study|Ongoing|1|||
156984800|NCT02056119|566697276|FG000|Overall Study|Death|1|||
156984801|NCT02056119|566697277|FG001|Overall Study|Death|2|||
156984802|NCT02056119|566697276|FG000|Overall Study|Intubated for less than 24 hrs|2|||
156984803|NCT02056119|566697277|FG001|Overall Study|Intubated for less than 24 hrs|7|||
156984804|NCT02056119|566697276|FG000|Overall Study|No aerosol treatments were given.|3|||
156984805|NCT02056119|566697277|FG001|Overall Study|No aerosol treatments were given.|2|||
156984806|NCT02056119|566697276|FG000|Overall Study|Received Metaneb treatment|0|||
156984807|NCT02056119|566697277|FG001|Overall Study|Received Metaneb treatment|2|||
156984808|NCT02056119|566697276|FG000|Overall Study|Protocol Violation|4|||
156984809|NCT02056119|566697277|FG001|Overall Study|Protocol Violation|7|||
156984810|NCT03220737|566697278|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156984811|NCT03220737|566697279|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
156984812|NCT03220737|566697280|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156984813|NCT03220737|566697281|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
156984814|NCT03220737|566697282|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
156984815|NCT03220737|566697283|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
156984816|NCT03220737|566697284|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
156984817|NCT03220737|566697278|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
156984818|NCT03220737|566697279|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156984819|NCT03220737|566697280|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
156984820|NCT03220737|566697281|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156984821|NCT03220737|566697282|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
156984822|NCT03220737|566697283|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
156984823|NCT03220737|566697284|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
156984824|NCT03220737|566697278|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
156984825|NCT03220737|566697279|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
156984826|NCT03220737|566697280|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
156984827|NCT03220737|566697281|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
156984828|NCT03220737|566697282|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
156984829|NCT03220737|566697283|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
156984830|NCT03220737|566697284|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
156984831|NCT03220737|566697278|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984832|NCT03220737|566697279|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984833|NCT03220737|566697280|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
156984834|NCT03220737|566697281|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984835|NCT03220737|566697282|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984836|NCT03220737|566697283|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984837|NCT03220737|566697284|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
156984838|NCT03220737|566697278|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984839|NCT03220737|566697279|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984840|NCT03220737|566697280|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984841|NCT03220737|566697281|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984842|NCT03220737|566697282|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
156984843|NCT03220737|566697283|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984844|NCT03220737|566697284|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
156984845|NCT03220737|566697278|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
156984846|NCT03220737|566697279|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984847|NCT03220737|566697280|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984848|NCT03220737|566697281|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984849|NCT03220737|566697282|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984850|NCT03220737|566697283|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984851|NCT03220737|566697284|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
156984852|NCT03220737|566697278|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
156984853|NCT03220737|566697279|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984854|NCT03220737|566697280|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984855|NCT03220737|566697281|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984856|NCT03220737|566697282|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984857|NCT03220737|566697283|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984858|NCT03220737|566697284|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
156984859|NCT03220737|566697278|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
156984860|NCT03220737|566697279|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984861|NCT03220737|566697280|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984862|NCT03220737|566697281|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984863|NCT03220737|566697282|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984864|NCT03220737|566697283|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984865|NCT03220737|566697284|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
156984866|NCT04011384|566697302|FG000|Overall Study|Withdrawal by Subject|2|||
156984867|NCT04011384|566697303|FG001|Overall Study|Withdrawal by Subject|0|||
156984868|NCT01686932|566697304|FG000|Period 1|Adverse Event|1|||
156984869|NCT01686932|566697305|FG001|Period 1|Adverse Event|1|||
156984870|NCT00924469|566697311|FG000|Overall Study|Adverse Event|2|||
156984871|NCT00924469|566697312|FG001|Overall Study|Adverse Event|0|||
156984872|NCT00924469|566697311|FG000|Overall Study|Withdrawal by Subject|0|||
156984873|NCT00924469|566697312|FG001|Overall Study|Withdrawal by Subject|1|||
156984874|NCT00924469|566697311|FG000|Overall Study|Lost to Follow-up|0|||
156984875|NCT00924469|566697312|FG001|Overall Study|Lost to Follow-up|1|||
156984876|NCT04147260|566697313|FG000|Overall Study|Adverse Event|1|||
156984877|NCT04147260|566697314|FG001|Overall Study|Adverse Event|0|||
156984878|NCT04147260|566697315|FG002|Overall Study|Adverse Event|1|||
156984879|NCT04147260|566697316|FG003|Overall Study|Adverse Event|2|||
156984880|NCT04147260|566697317|FG004|Overall Study|Adverse Event|0|||
156984881|NCT04147260|566697313|FG000|Overall Study|Withdrawal by Subject|0|||
156984882|NCT04147260|566697314|FG001|Overall Study|Withdrawal by Subject|0|||
156984883|NCT04147260|566697315|FG002|Overall Study|Withdrawal by Subject|1|||
156984884|NCT04147260|566697316|FG003|Overall Study|Withdrawal by Subject|1|||
156984885|NCT04147260|566697317|FG004|Overall Study|Withdrawal by Subject|0|||
156984886|NCT00630058|566697320|FG000|Overall Study|Adverse Event|1|||
156984887|NCT00630058|566697321|FG001|Overall Study|Adverse Event|1|||
156984888|NCT00630058|566697320|FG000|Overall Study|Withdrawal by Subject|0|||
156984889|NCT00630058|566697321|FG001|Overall Study|Withdrawal by Subject|1|||
156984890|NCT00630058|566697320|FG000|Overall Study|stopping criteria|3|||
156984891|NCT00630058|566697321|FG001|Overall Study|stopping criteria|2|||
156984892|NCT01651936|566697322|FG000|Base Study|Adverse Event|3|||
156984893|NCT01651936|566697323|FG001|Base Study|Adverse Event|0|||
156984894|NCT01651936|566697324|FG002|Base Study|Adverse Event|0|||
156984895|NCT01651936|566697322|FG000|Base Study|Withdrawal by Subject|1|||
156984896|NCT01651936|566697323|FG001|Base Study|Withdrawal by Subject|1|||
156984897|NCT01651936|566697324|FG002|Base Study|Withdrawal by Subject|0|||
156984898|NCT01651936|566697322|FG000|Base Study|Early Escape|2|||
156984899|NCT01651936|566697323|FG001|Base Study|Early Escape|8|||
156984900|NCT01651936|566697324|FG002|Base Study|Early Escape|0|||
156984901|NCT01651936|566697322|FG000|Base Study|Study terminated by sponsor|21|||
156984902|NCT01651936|566697323|FG001|Base Study|Study terminated by sponsor|16|||
156984903|NCT01651936|566697324|FG002|Base Study|Study terminated by sponsor|0|||
156984904|NCT01651936|566697322|FG000|Extension Study|Lack of Efficacy|0|||
156984905|NCT01651936|566697323|FG001|Extension Study|Lack of Efficacy|0|||
156984906|NCT01651936|566697324|FG002|Extension Study|Lack of Efficacy|1|||
156984907|NCT01651936|566697322|FG000|Extension Study|Study terminated by sponsor|0|||
156984908|NCT01651936|566697323|FG001|Extension Study|Study terminated by sponsor|0|||
156984909|NCT01651936|566697324|FG002|Extension Study|Study terminated by sponsor|13|||
156984910|NCT03044353|566697325|FG000|Overall Study|Adverse Event|0|||
156984911|NCT03044353|566697326|FG001|Overall Study|Adverse Event|1|||
156984912|NCT03044353|566697327|FG002|Overall Study|Adverse Event|0|||
156984913|NCT05284019|566697332|FG000|Overall Study|Study terminated|2|||
156984914|NCT05284019|566697333|FG001|Overall Study|Study terminated|2|||
156984915|NCT05284019|566697334|FG002|Overall Study|Study terminated|2|||
156984916|NCT05284019|566697335|FG003|Overall Study|Study terminated|5|||
156984917|NCT05284019|566697336|FG004|Overall Study|Study terminated|15|||
156984918|NCT05284019|566697332|FG000|Overall Study|Withdrawal by Subject|0|||
156984919|NCT05284019|566697333|FG001|Overall Study|Withdrawal by Subject|0|||
156984920|NCT05284019|566697334|FG002|Overall Study|Withdrawal by Subject|0|||
156984921|NCT05284019|566697335|FG003|Overall Study|Withdrawal by Subject|1|||
156984922|NCT05284019|566697336|FG004|Overall Study|Withdrawal by Subject|1|||
156984923|NCT05284019|566697332|FG000|Overall Study|Lost to Follow-up|1|||
156984924|NCT05284019|566697333|FG001|Overall Study|Lost to Follow-up|0|||
156984925|NCT05284019|566697334|FG002|Overall Study|Lost to Follow-up|0|||
156984926|NCT05284019|566697335|FG003|Overall Study|Lost to Follow-up|2|||
156984927|NCT05284019|566697336|FG004|Overall Study|Lost to Follow-up|1|||
156984928|NCT01990300|566697337|FG000|Overall Study|Case Report Forms Uncollected|89|||
156984929|NCT01990300|566697337|FG000|Overall Study|Protocol Deviation|53|||
156984930|NCT02293837|566697338|FG000|Overall Study|Lost to Follow-up|0|||
156984931|NCT02293837|566697339|FG001|Overall Study|Lost to Follow-up|2|||
156984932|NCT02293837|566697340|FG002|Overall Study|Lost to Follow-up|1|||
156984933|NCT02293837|566697341|FG003|Overall Study|Lost to Follow-up|0|||
156984934|NCT02293837|566697338|FG000|Overall Study|Withdrawal by Subject|2|||
156984935|NCT02293837|566697339|FG001|Overall Study|Withdrawal by Subject|1|||
156984936|NCT02293837|566697340|FG002|Overall Study|Withdrawal by Subject|2|||
156984937|NCT02293837|566697341|FG003|Overall Study|Withdrawal by Subject|1|||
156984938|NCT02293837|566697338|FG000|Overall Study|COVID-19 Related|1|||
156984939|NCT02293837|566697339|FG001|Overall Study|COVID-19 Related|1|||
156984940|NCT02293837|566697340|FG002|Overall Study|COVID-19 Related|0|||
156984941|NCT02293837|566697341|FG003|Overall Study|COVID-19 Related|0|||
156984942|NCT02293837|566697338|FG000|Overall Study|Participant ill and could not be infused|0|||
156984943|NCT02293837|566697339|FG001|Overall Study|Participant ill and could not be infused|0|||
156984944|NCT02293837|566697340|FG002|Overall Study|Participant ill and could not be infused|1|||
156984945|NCT02293837|566697341|FG003|Overall Study|Participant ill and could not be infused|0|||
156984946|NCT03285113|566697342|FG000|Overall Study|Unable to implant leads|2|||
156984947|NCT02087150|566697343|FG000|Overall Study|Death|0|||
156984948|NCT02087150|566697344|FG001|Overall Study|Death|1|||
156984949|NCT02087150|566697345|FG002|Overall Study|Death|0|||
156984950|NCT02087150|566697343|FG000|Overall Study|Lost to Follow-up|6|||
156984951|NCT02087150|566697344|FG001|Overall Study|Lost to Follow-up|13|||
156984952|NCT02087150|566697345|FG002|Overall Study|Lost to Follow-up|7|||
156984953|NCT02087150|566697343|FG000|Overall Study|Withdrawal by Subject|2|||
156984954|NCT02087150|566697344|FG001|Overall Study|Withdrawal by Subject|5|||
156984955|NCT02087150|566697345|FG002|Overall Study|Withdrawal by Subject|3|||
156984956|NCT02087150|566697343|FG000|Overall Study|Physician Decision|0|||
156984957|NCT02087150|566697344|FG001|Overall Study|Physician Decision|1|||
156984958|NCT02087150|566697345|FG002|Overall Study|Physician Decision|0|||
156984959|NCT02087150|566697343|FG000|Overall Study|Procedure not done|1|||
156984960|NCT02087150|566697344|FG001|Overall Study|Procedure not done|13|||
156984961|NCT02087150|566697345|FG002|Overall Study|Procedure not done|0|||
156984962|NCT02087150|566697343|FG000|Overall Study|F/U not completed w/in study window|0|||
156984963|NCT02087150|566697344|FG001|Overall Study|F/U not completed w/in study window|0|||
156984964|NCT02087150|566697345|FG002|Overall Study|F/U not completed w/in study window|1|||
156984965|NCT02087150|566697343|FG000|Overall Study|Other|1|||
156984966|NCT02087150|566697344|FG001|Overall Study|Other|0|||
156984967|NCT02087150|566697345|FG002|Overall Study|Other|0|||
156984968|NCT02087150|566697343|FG000|Overall Study|Pt moved out of town|0|||
156984969|NCT02087150|566697344|FG001|Overall Study|Pt moved out of town|1|||
156984970|NCT02087150|566697345|FG002|Overall Study|Pt moved out of town|0|||
156984971|NCT01448044|566697348|FG000|Treatment Period|Adverse Event|4|||
156984972|NCT01448044|566697349|FG001|Treatment Period|Adverse Event|3|||
156984973|NCT01448044|566697348|FG000|Treatment Period|Lack of Efficacy|5|||
156984974|NCT01448044|566697349|FG001|Treatment Period|Lack of Efficacy|12|||
156984975|NCT01448044|566697348|FG000|Treatment Period|Subject requested discontinue study drug|1|||
156984976|NCT01448044|566697349|FG001|Treatment Period|Subject requested discontinue study drug|0|||
156984977|NCT01448044|566697348|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
156984978|NCT01448044|566697349|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
156984979|NCT01448044|566697348|FG000|Treatment Period|Participant does not meet study criteria|1|||
156984980|NCT01448044|566697349|FG001|Treatment Period|Participant does not meet study criteria|0|||
156984981|NCT01448044|566697348|FG000|Treatment Period|Lost to Follow-up|2|||
156984982|NCT01448044|566697349|FG001|Treatment Period|Lost to Follow-up|1|||
156984983|NCT01448044|566697348|FG000|Treatment Period|Other reason|2|||
156984984|NCT01448044|566697349|FG001|Treatment Period|Other reason|0|||
156984985|NCT01448044|566697348|FG000|Follow Up Period|Withdrawal by Subject|1|||
156984986|NCT01448044|566697349|FG001|Follow Up Period|Withdrawal by Subject|1|||
156984987|NCT01448044|566697348|FG000|Follow Up Period|Lost to Follow-up|6|||
156984988|NCT01448044|566697349|FG001|Follow Up Period|Lost to Follow-up|2|||
156984989|NCT01448044|566697348|FG000|Follow Up Period|Other|5|||
156984990|NCT01448044|566697349|FG001|Follow Up Period|Other|11|||
156984991|NCT00507026|566697350|FG000|Overall Study|Lack of Efficacy|6|||
156984992|NCT00507026|566697351|FG001|Overall Study|Lack of Efficacy|4|||
156984993|NCT00507026|566697352|FG002|Overall Study|Lack of Efficacy|21|||
156984994|NCT00507026|566697350|FG000|Overall Study|Withdrawal by Subject|2|||
156984995|NCT00507026|566697351|FG001|Overall Study|Withdrawal by Subject|0|||
156984996|NCT00507026|566697352|FG002|Overall Study|Withdrawal by Subject|0|||
156984997|NCT00507026|566697350|FG000|Overall Study|Investigator Decision|1|||
156984998|NCT00507026|566697351|FG001|Overall Study|Investigator Decision|0|||
156984999|NCT00507026|566697352|FG002|Overall Study|Investigator Decision|0|||
156985000|NCT00507026|566697350|FG000|Overall Study|Adverse Event|2|||
156985001|NCT00507026|566697351|FG001|Overall Study|Adverse Event|0|||
156985002|NCT00507026|566697352|FG002|Overall Study|Adverse Event|0|||
156985003|NCT00507026|566697350|FG000|Overall Study|Protocol Violation|1|||
156985004|NCT00507026|566697351|FG001|Overall Study|Protocol Violation|0|||
156985005|NCT00507026|566697352|FG002|Overall Study|Protocol Violation|0|||
156985006|NCT00507026|566697350|FG000|Overall Study|Other|1|||
156985007|NCT00507026|566697351|FG001|Overall Study|Other|0|||
156985008|NCT00507026|566697352|FG002|Overall Study|Other|0|||
156985009|NCT04230980|566697355|FG000|Overall Study|Lost to Follow-up|1|||
156985010|NCT04230980|566697356|FG001|Overall Study|Lost to Follow-up|2|||
156985011|NCT04230980|566697355|FG000|Overall Study|Adverse Event|0|||
156985012|NCT04230980|566697356|FG001|Overall Study|Adverse Event|1|||
156985013|NCT00318149|566697357|FG000|Overall Study|Adverse Event|0|||
156985014|NCT00318149|566697358|FG001|Overall Study|Adverse Event|0|||
156985015|NCT00318149|566697359|FG002|Overall Study|Adverse Event|0|||
156985016|NCT00318149|566697360|FG003|Overall Study|Adverse Event|0|||
156985017|NCT00318149|566697361|FG004|Overall Study|Adverse Event|0|||
156985018|NCT00318149|566697362|FG005|Overall Study|Adverse Event|2|||
156985019|NCT03541642|566697363|FG000|Overall Study|Withdrawal by Subject|1|||
156985020|NCT03541642|566697364|FG001|Overall Study|Withdrawal by Subject|2|||
156985021|NCT03541642|566697363|FG000|Overall Study|Lost to Follow-up|16|||
156985022|NCT03541642|566697364|FG001|Overall Study|Lost to Follow-up|12|||
156985023|NCT03541642|566697363|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
156985024|NCT03541642|566697364|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
156985025|NCT03523871|566697365|FG000|Overall Study|Death|1|||
156985026|NCT00219141|566697366|FG000|Overall Study|Adverse Event|4|||
156985027|NCT00219141|566697367|FG001|Overall Study|Adverse Event|10|||
156985028|NCT00219141|566697368|FG002|Overall Study|Adverse Event|5|||
156985029|NCT00219141|566697366|FG000|Overall Study|Lack of Efficacy|3|||
156985030|NCT00219141|566697367|FG001|Overall Study|Lack of Efficacy|2|||
156985031|NCT00219141|566697368|FG002|Overall Study|Lack of Efficacy|0|||
156985032|NCT00219141|566697366|FG000|Overall Study|Administrative problems|0|||
156985033|NCT00219141|566697367|FG001|Overall Study|Administrative problems|1|||
156985034|NCT00219141|566697368|FG002|Overall Study|Administrative problems|0|||
156985035|NCT00219141|566697366|FG000|Overall Study|Lost to Follow-up|2|||
156985036|NCT00219141|566697367|FG001|Overall Study|Lost to Follow-up|4|||
156985037|NCT00219141|566697368|FG002|Overall Study|Lost to Follow-up|1|||
156985038|NCT00219141|566697366|FG000|Overall Study|Protocol Violation|3|||
156985039|NCT00219141|566697367|FG001|Overall Study|Protocol Violation|1|||
156985040|NCT00219141|566697368|FG002|Overall Study|Protocol Violation|1|||
156985041|NCT00219141|566697366|FG000|Overall Study|Withdrawal by Subject|1|||
156985042|NCT00219141|566697367|FG001|Overall Study|Withdrawal by Subject|3|||
156985043|NCT00219141|566697368|FG002|Overall Study|Withdrawal by Subject|5|||
156985044|NCT00219141|566697366|FG000|Overall Study|Condition no longer requires study drug|1|||
156985045|NCT00219141|566697367|FG001|Overall Study|Condition no longer requires study drug|0|||
156985046|NCT00219141|566697368|FG002|Overall Study|Condition no longer requires study drug|0|||
156985047|NCT01994720|566697369|FG000|Overall Study|Withdrawal by Subject|46|||
156985048|NCT01994720|566697370|FG001|Overall Study|Withdrawal by Subject|56|||
156985049|NCT02061761|566697372|FG000|Overall Study|Disease progression|2|||
156985050|NCT02061761|566697373|FG001|Overall Study|Disease progression|8|||
156985051|NCT02061761|566697374|FG002|Overall Study|Disease progression|4|||
156985052|NCT02061761|566697375|FG003|Overall Study|Disease progression|5|||
156985053|NCT02061761|566697376|FG004|Overall Study|Disease progression|9|||
156985054|NCT02061761|566697377|FG005|Overall Study|Disease progression|3|||
156985055|NCT02061761|566697378|FG006|Overall Study|Disease progression|1|||
156985056|NCT02061761|566697379|FG007|Overall Study|Disease progression|2|||
156985057|NCT02061761|566697380|FG008|Overall Study|Disease progression|28|||
156985058|NCT02061761|566697372|FG000|Overall Study|Study Drug toxicity|0|||
156985059|NCT02061761|566697373|FG001|Overall Study|Study Drug toxicity|0|||
156985060|NCT02061761|566697374|FG002|Overall Study|Study Drug toxicity|0|||
156985061|NCT02061761|566697375|FG003|Overall Study|Study Drug toxicity|0|||
156985062|NCT02061761|566697376|FG004|Overall Study|Study Drug toxicity|0|||
156985063|NCT02061761|566697377|FG005|Overall Study|Study Drug toxicity|1|||
156985064|NCT02061761|566697378|FG006|Overall Study|Study Drug toxicity|0|||
156985065|NCT02061761|566697379|FG007|Overall Study|Study Drug toxicity|2|||
156985066|NCT02061761|566697380|FG008|Overall Study|Study Drug toxicity|6|||
156985067|NCT02061761|566697372|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
156985068|NCT02061761|566697373|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
156985069|NCT02061761|566697374|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
156985070|NCT02061761|566697375|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
156985071|NCT02061761|566697376|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
156985072|NCT02061761|566697377|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
156985073|NCT02061761|566697378|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
156985074|NCT02061761|566697379|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
156985075|NCT02061761|566697380|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
156985076|NCT02061761|566697372|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156985077|NCT02061761|566697373|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156985078|NCT02061761|566697374|FG002|Overall Study|Participant request to discontinue study treatment|2|||
156985079|NCT02061761|566697375|FG003|Overall Study|Participant request to discontinue study treatment|2|||
156985080|NCT02061761|566697376|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156985081|NCT02061761|566697377|FG005|Overall Study|Participant request to discontinue study treatment|1|||
156985082|NCT02061761|566697378|FG006|Overall Study|Participant request to discontinue study treatment|0|||
156985083|NCT02061761|566697379|FG007|Overall Study|Participant request to discontinue study treatment|0|||
156985084|NCT02061761|566697380|FG008|Overall Study|Participant request to discontinue study treatment|2|||
156985085|NCT02061761|566697372|FG000|Overall Study|Withdrawal by Subject|0|||
156985086|NCT02061761|566697373|FG001|Overall Study|Withdrawal by Subject|0|||
156985087|NCT02061761|566697374|FG002|Overall Study|Withdrawal by Subject|0|||
156985088|NCT02061761|566697375|FG003|Overall Study|Withdrawal by Subject|0|||
156985089|NCT02061761|566697376|FG004|Overall Study|Withdrawal by Subject|0|||
156985090|NCT02061761|566697377|FG005|Overall Study|Withdrawal by Subject|0|||
156985091|NCT02061761|566697378|FG006|Overall Study|Withdrawal by Subject|0|||
156985092|NCT02061761|566697379|FG007|Overall Study|Withdrawal by Subject|0|||
156985093|NCT02061761|566697380|FG008|Overall Study|Withdrawal by Subject|2|||
156985094|NCT02061761|566697372|FG000|Overall Study|Maximum clinical benefit|0|||
157096848|NCT04677179|567109279|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096849|NCT04677179|567109280|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096850|NCT04677179|567109281|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096851|NCT04677179|567109282|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096852|NCT04677179|567109283|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096853|NCT04677179|567109284|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
157096854|NCT04677179|567109285|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
157096855|NCT04677179|567109286|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
157096856|NCT04677179|567109277|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096857|NCT04677179|567109278|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096858|NCT04677179|567109279|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096859|NCT04677179|567109280|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156985095|NCT02061761|566697373|FG001|Overall Study|Maximum clinical benefit|0|||
156985096|NCT02061761|566697374|FG002|Overall Study|Maximum clinical benefit|0|||
156985097|NCT02061761|566697375|FG003|Overall Study|Maximum clinical benefit|1|||
156985098|NCT02061761|566697376|FG004|Overall Study|Maximum clinical benefit|0|||
156985099|NCT02061761|566697377|FG005|Overall Study|Maximum clinical benefit|0|||
156985100|NCT02061761|566697378|FG006|Overall Study|Maximum clinical benefit|0|||
156985101|NCT02061761|566697379|FG007|Overall Study|Maximum clinical benefit|0|||
156985102|NCT02061761|566697380|FG008|Overall Study|Maximum clinical benefit|6|||
156985103|NCT02061761|566697372|FG000|Overall Study|Participant no longer meets study criteria|0|||
156985104|NCT02061761|566697373|FG001|Overall Study|Participant no longer meets study criteria|0|||
156985105|NCT02061761|566697374|FG002|Overall Study|Participant no longer meets study criteria|0|||
156985106|NCT02061761|566697375|FG003|Overall Study|Participant no longer meets study criteria|0|||
156985107|NCT02061761|566697376|FG004|Overall Study|Participant no longer meets study criteria|0|||
156985108|NCT02061761|566697377|FG005|Overall Study|Participant no longer meets study criteria|0|||
156985109|NCT02061761|566697378|FG006|Overall Study|Participant no longer meets study criteria|0|||
156985110|NCT02061761|566697379|FG007|Overall Study|Participant no longer meets study criteria|0|||
156985111|NCT02061761|566697380|FG008|Overall Study|Participant no longer meets study criteria|1|||
156985112|NCT02061761|566697372|FG000|Overall Study|Other reasons|0|||
156985113|NCT02061761|566697373|FG001|Overall Study|Other reasons|0|||
156985114|NCT02061761|566697374|FG002|Overall Study|Other reasons|0|||
156985115|NCT02061761|566697375|FG003|Overall Study|Other reasons|0|||
156985116|NCT02061761|566697376|FG004|Overall Study|Other reasons|2|||
156985117|NCT02061761|566697377|FG005|Overall Study|Other reasons|0|||
156985118|NCT02061761|566697378|FG006|Overall Study|Other reasons|0|||
156985119|NCT02061761|566697379|FG007|Overall Study|Other reasons|0|||
156985120|NCT02061761|566697380|FG008|Overall Study|Other reasons|6|||
156985121|NCT04170296|566697387|FG000|Overall Study|Adverse Event|1|||
156985122|NCT04170296|566697388|FG001|Overall Study|Adverse Event|0|||
157096860|NCT04677179|567109281|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096861|NCT04677179|567109282|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096862|NCT04677179|567109283|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
157096863|NCT04677179|567109284|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
156985123|NCT04170296|566697387|FG000|Overall Study|Withdrawal by Subject|3|||
156985124|NCT04170296|566697388|FG001|Overall Study|Withdrawal by Subject|2|||
156985125|NCT04170296|566697387|FG000|Overall Study|Lost to Follow-up|4|||
156985126|NCT04170296|566697388|FG001|Overall Study|Lost to Follow-up|2|||
156985127|NCT03567993|566697389|FG000|Overall Study|Lost to Follow-up|4|||
156985128|NCT03567993|566697390|FG001|Overall Study|Lost to Follow-up|2|||
156985129|NCT03567993|566697389|FG000|Overall Study|Death|1|||
156985130|NCT03567993|566697390|FG001|Overall Study|Death|1|||
156985131|NCT03567993|566697389|FG000|Overall Study|Withdrawal by Subject|1|||
156985132|NCT03567993|566697390|FG001|Overall Study|Withdrawal by Subject|0|||
156985133|NCT00383240|566697391|FG000|Overall Study|Adverse Event|4|||
156985134|NCT00383240|566697392|FG001|Overall Study|Adverse Event|6|||
156985135|NCT00383240|566697393|FG002|Overall Study|Adverse Event|9|||
156985136|NCT00383240|566697394|FG003|Overall Study|Adverse Event|7|||
156985137|NCT00383240|566697391|FG000|Overall Study|Treatment Failure|8|||
156985138|NCT00383240|566697392|FG001|Overall Study|Treatment Failure|13|||
156985139|NCT00383240|566697393|FG002|Overall Study|Treatment Failure|47|||
156985140|NCT00383240|566697394|FG003|Overall Study|Treatment Failure|46|||
156985141|NCT00383240|566697391|FG000|Overall Study|Lost to Follow-up|3|||
156985142|NCT00383240|566697392|FG001|Overall Study|Lost to Follow-up|0|||
156985143|NCT00383240|566697393|FG002|Overall Study|Lost to Follow-up|0|||
156985144|NCT00383240|566697394|FG003|Overall Study|Lost to Follow-up|2|||
156985145|NCT00383240|566697391|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
156985146|NCT00383240|566697392|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
156985147|NCT00383240|566697393|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
156985148|NCT00383240|566697394|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
156985149|NCT00383240|566697391|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
156985150|NCT00383240|566697392|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
156985151|NCT00383240|566697393|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
156985152|NCT00383240|566697394|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
156985153|NCT00383240|566697391|FG000|Overall Study|Protocol Violation|4|||
156985154|NCT00383240|566697392|FG001|Overall Study|Protocol Violation|5|||
156985155|NCT00383240|566697393|FG002|Overall Study|Protocol Violation|9|||
156985156|NCT00383240|566697394|FG003|Overall Study|Protocol Violation|6|||
156985157|NCT00383240|566697391|FG000|Overall Study|Did not meet protocol eligibility|9|||
156985158|NCT00383240|566697392|FG001|Overall Study|Did not meet protocol eligibility|4|||
156985159|NCT00383240|566697393|FG002|Overall Study|Did not meet protocol eligibility|9|||
156985160|NCT00383240|566697394|FG003|Overall Study|Did not meet protocol eligibility|3|||
156985161|NCT00383240|566697391|FG000|Overall Study|Administrative|1|||
156985162|NCT00383240|566697392|FG001|Overall Study|Administrative|1|||
156985163|NCT00383240|566697393|FG002|Overall Study|Administrative|0|||
156985164|NCT00383240|566697394|FG003|Overall Study|Administrative|0|||
156985165|NCT01370603|566697395|FG000|Period 1|Adverse Event|5|||
156985166|NCT01370603|566697396|FG001|Period 1|Adverse Event|3|||
156985167|NCT01370603|566697395|FG000|Period 1|Lost to Follow-up|2|||
156985168|NCT01370603|566697396|FG001|Period 1|Lost to Follow-up|0|||
156985169|NCT01370603|566697395|FG000|Period 1|Protocol Violation|2|||
156985170|NCT01370603|566697396|FG001|Period 1|Protocol Violation|2|||
156985171|NCT01370603|566697395|FG000|Period 1|Withdrawal by Subject|5|||
156985172|NCT01370603|566697396|FG001|Period 1|Withdrawal by Subject|5|||
156985173|NCT01370603|566697395|FG000|Crossover Washout|Adverse Event|2|||
156985174|NCT01370603|566697396|FG001|Crossover Washout|Adverse Event|1|||
156985175|NCT01370603|566697395|FG000|Crossover Washout|Lost to Follow-up|2|||
156985176|NCT01370603|566697396|FG001|Crossover Washout|Lost to Follow-up|0|||
156985177|NCT01370603|566697395|FG000|Crossover Washout|Protocol Violation|1|||
156985178|NCT01370603|566697396|FG001|Crossover Washout|Protocol Violation|0|||
156985179|NCT01370603|566697395|FG000|Crossover Washout|Withdrawal by Subject|4|||
156985180|NCT01370603|566697396|FG001|Crossover Washout|Withdrawal by Subject|1|||
156985181|NCT01370603|566697395|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
156985182|NCT01370603|566697396|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
156985183|NCT01370603|566697395|FG000|Period 2|Adverse Event|1|||
156985184|NCT01370603|566697396|FG001|Period 2|Adverse Event|4|||
156985185|NCT01370603|566697395|FG000|Period 2|Lost to Follow-up|1|||
156985186|NCT01370603|566697396|FG001|Period 2|Lost to Follow-up|0|||
156985187|NCT01370603|566697395|FG000|Period 2|Withdrawal by Subject|1|||
156985188|NCT01370603|566697396|FG001|Period 2|Withdrawal by Subject|0|||
156985189|NCT02133924|566697397|FG000|Overall Study|Death|38|||
156985190|NCT02133924|566697397|FG000|Overall Study|Physician Decision|1|||
156985191|NCT02133924|566697397|FG000|Overall Study|Withdrawal by Subject|3|||
156985192|NCT01644474|566697398|FG000|Overall Study|Poor compliance to protocol|1|||
156985193|NCT01644474|566697399|FG001|Overall Study|Poor compliance to protocol|0|||
156985194|NCT01644474|566697398|FG000|Overall Study|Consent withdrawn by participant|0|||
156985195|NCT01644474|566697399|FG001|Overall Study|Consent withdrawn by participant|1|||
156985196|NCT01644474|566697398|FG000|Overall Study|Participant moved|0|||
156985197|NCT01644474|566697399|FG001|Overall Study|Participant moved|1|||
156985198|NCT01644474|566697398|FG000|Overall Study|Adverse Event|4|||
156985199|NCT01644474|566697399|FG001|Overall Study|Adverse Event|5|||
156985200|NCT01644474|566697398|FG000|Overall Study|Site scheduling error|1|||
156985201|NCT01644474|566697399|FG001|Overall Study|Site scheduling error|1|||
156985202|NCT01644474|566697398|FG000|Overall Study|Protocol Violation|1|||
156985203|NCT01644474|566697399|FG001|Overall Study|Protocol Violation|0|||
156985204|NCT01163747|566697405|FG000|Overall Study|Adverse Event|0|||
156985205|NCT01163747|566697406|FG001|Overall Study|Adverse Event|5|||
156985206|NCT01163747|566697405|FG000|Overall Study|Insufficient Therapeutic Response|0|||
156985207|NCT01163747|566697406|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156985208|NCT01163747|566697405|FG000|Overall Study|Protocol Violation|0|||
156985209|NCT01163747|566697406|FG001|Overall Study|Protocol Violation|1|||
156985210|NCT01163747|566697405|FG000|Overall Study|Refused Treatment|6|||
156985211|NCT01163747|566697406|FG001|Overall Study|Refused Treatment|4|||
156985212|NCT02044458|566697407|FG000|Overall Study|Protocol Violation|3|||
156985213|NCT02044458|566697408|FG001|Overall Study|Protocol Violation|8|||
156985214|NCT04714216|566699477|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
156985215|NCT04714216|566699477|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
156985216|NCT01349829|566699478|FG000|Overall Study|Lost to Follow-up|4|||
156985217|NCT01349829|566699479|FG001|Overall Study|Lost to Follow-up|8|||
156985218|NCT01349829|566699478|FG000|Overall Study|Consent withdrawal|3|||
156985219|NCT01349829|566699479|FG001|Overall Study|Consent withdrawal|8|||
156985220|NCT01349829|566699478|FG000|Overall Study|Migrated/moved|2|||
156985221|NCT01349829|566699479|FG001|Overall Study|Migrated/moved|7|||
156985222|NCT02711995|566699484|FG000|Washout (90 Days)|Conflicting medication|1|||
156985223|NCT00322868|566699487|FG000|Overall Study|disease progression|1|||
156985224|NCT03615482|566699488|FG000|Overall Study|Death|1|||
156985225|NCT03615482|566699489|FG001|Overall Study|Death|0|||
156985226|NCT03615482|566699488|FG000|Overall Study|Lost to Follow-up|7|||
156985227|NCT03615482|566699489|FG001|Overall Study|Lost to Follow-up|7|||
156985228|NCT03615482|566699488|FG000|Overall Study|Physician Decision|2|||
156985229|NCT03615482|566699489|FG001|Overall Study|Physician Decision|3|||
156985230|NCT03615482|566699488|FG000|Overall Study|Withdrawal by Subject|7|||
156985231|NCT03615482|566699489|FG001|Overall Study|Withdrawal by Subject|7|||
156985232|NCT01852162|566699491|FG000|Overall Study|Adverse Event|1|||
156985233|NCT01852162|566699492|FG001|Overall Study|Adverse Event|0|||
156985234|NCT01852162|566699491|FG000|Overall Study|Withdrawal by Subject|3|||
156985235|NCT01852162|566699492|FG001|Overall Study|Withdrawal by Subject|1|||
156985236|NCT02955277|566699495|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
156985237|NCT02955277|566699496|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
156985238|NCT02955277|566699495|FG000|Post to Follow-up|Lost to Follow-up|8|||
156985239|NCT02955277|566699496|FG001|Post to Follow-up|Lost to Follow-up|11|||
156985240|NCT04212169|566699497|FG000|Overall Study|Adverse Event|0|||
156985241|NCT04212169|566699498|FG001|Overall Study|Adverse Event|0|||
156985242|NCT04212169|566699499|FG002|Overall Study|Adverse Event|0|||
156985243|NCT04212169|566699500|FG003|Overall Study|Adverse Event|2|||
156985244|NCT04212169|566699497|FG000|Overall Study|Lost to Follow-up|1|||
156985245|NCT04212169|566699498|FG001|Overall Study|Lost to Follow-up|0|||
156985246|NCT04212169|566699499|FG002|Overall Study|Lost to Follow-up|0|||
156985247|NCT04212169|566699500|FG003|Overall Study|Lost to Follow-up|2|||
156985248|NCT04212169|566699497|FG000|Overall Study|Withdrawal by Subject|10|||
156985249|NCT04212169|566699498|FG001|Overall Study|Withdrawal by Subject|2|||
156985250|NCT04212169|566699499|FG002|Overall Study|Withdrawal by Subject|5|||
156985251|NCT04212169|566699500|FG003|Overall Study|Withdrawal by Subject|7|||
156985252|NCT04212169|566699497|FG000|Overall Study|Other reason, unspecified|3|||
156985253|NCT04212169|566699498|FG001|Overall Study|Other reason, unspecified|1|||
156985254|NCT04212169|566699499|FG002|Overall Study|Other reason, unspecified|0|||
156985255|NCT04212169|566699500|FG003|Overall Study|Other reason, unspecified|2|||
156985256|NCT02176928|566699501|FG000|Overall Study|Lost to Follow-up|2|||
156985257|NCT02176928|566699502|FG001|Overall Study|Lost to Follow-up|4|||
156985258|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156985259|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
156985260|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
156985261|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
156985262|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
156985263|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
156985264|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156985265|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156985266|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156985267|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
156985268|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985269|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985270|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985271|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
156985272|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
156985273|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985274|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985275|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985276|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985277|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
156985278|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156985279|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156985280|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156985281|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
156985282|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
156985283|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
156985284|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156985285|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156985286|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156985287|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
156985288|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
156985289|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985290|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985291|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
156985292|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
156985293|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985294|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985295|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985296|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985297|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
156985298|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985299|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985300|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
156985301|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
156985302|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985303|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985304|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985305|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985306|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985307|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
156985308|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985309|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985310|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985311|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985312|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
156985313|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985314|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985315|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985316|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
157021607|NCT03699709|566830911|FG001|Overall Study|scheduled, but no show|1|||
156985317|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
156985318|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985319|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985320|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985321|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
156985322|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
156985323|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
156985324|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985325|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985326|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985327|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
156985328|NCT02018861|566699503|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985329|NCT02018861|566699504|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985330|NCT02018861|566699505|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985331|NCT02018861|566699506|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
156985332|NCT02018861|566699507|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
156985333|NCT02018861|566699508|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985334|NCT02018861|566699509|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985335|NCT02018861|566699510|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985336|NCT02018861|566699511|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985337|NCT02018861|566699512|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
156985338|NCT02018861|566699503|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985339|NCT02018861|566699504|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985340|NCT02018861|566699505|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985341|NCT02018861|566699506|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985342|NCT02018861|566699507|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985343|NCT02018861|566699508|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985344|NCT02018861|566699509|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
156985345|NCT02018861|566699510|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
156985346|NCT02018861|566699511|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985347|NCT02018861|566699512|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
156985348|NCT02018861|566699503|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985349|NCT02018861|566699504|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985350|NCT02018861|566699505|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985351|NCT02018861|566699506|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985352|NCT02018861|566699507|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985353|NCT02018861|566699508|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985354|NCT02018861|566699509|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
156985355|NCT02018861|566699510|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
156985356|NCT02018861|566699511|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985357|NCT02018861|566699512|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
156985358|NCT02018861|566699503|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985359|NCT02018861|566699504|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985360|NCT02018861|566699505|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985361|NCT02018861|566699506|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985362|NCT02018861|566699507|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985363|NCT02018861|566699508|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985364|NCT02018861|566699509|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985365|NCT02018861|566699510|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985366|NCT02018861|566699511|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
156985367|NCT02018861|566699512|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
156985368|NCT02018861|566699503|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985369|NCT02018861|566699504|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985370|NCT02018861|566699505|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985371|NCT02018861|566699506|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985372|NCT02018861|566699507|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985373|NCT02018861|566699508|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985374|NCT02018861|566699509|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985375|NCT02018861|566699510|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985376|NCT02018861|566699511|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
156985377|NCT02018861|566699512|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
156985378|NCT02018861|566699503|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985379|NCT02018861|566699504|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
157021608|NCT04831216|566830917|FG000|Overall Study|Lost to Follow-up|32|||
156985380|NCT02018861|566699505|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985381|NCT02018861|566699506|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985382|NCT02018861|566699507|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985383|NCT02018861|566699508|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985384|NCT02018861|566699509|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985385|NCT02018861|566699510|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985386|NCT02018861|566699511|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
156985387|NCT02018861|566699512|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
156985388|NCT00590980|566699513|FG000|Overall Study|Did not meet all inclusion criteria|10|||
156985389|NCT00506285|566699514|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
156985390|NCT00506285|566699515|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
156985391|NCT00506285|566699514|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
156985392|NCT00506285|566699515|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
156985393|NCT00506285|566699514|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
156985394|NCT00506285|566699515|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
156985395|NCT00506285|566699514|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
156985396|NCT00506285|566699515|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
156985397|NCT00506285|566699514|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
156985398|NCT00506285|566699515|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
156985399|NCT01023308|566699516|FG000|Overall Study|Abnormal test proceedure results|3|||
156985400|NCT01023308|566699517|FG001|Overall Study|Abnormal test proceedure results|8|||
156985401|NCT01023308|566699516|FG000|Overall Study|Administrative problems|2|||
156985402|NCT01023308|566699517|FG001|Overall Study|Administrative problems|1|||
156985403|NCT01023308|566699516|FG000|Overall Study|Adverse Event|130|||
156985404|NCT01023308|566699517|FG001|Overall Study|Adverse Event|66|||
156985405|NCT01023308|566699516|FG000|Overall Study|Death|21|||
156985406|NCT01023308|566699517|FG001|Overall Study|Death|17|||
156985407|NCT01023308|566699516|FG000|Overall Study|Disease progression|82|||
156985408|NCT01023308|566699517|FG001|Overall Study|Disease progression|153|||
156985409|NCT01023308|566699516|FG000|Overall Study|New Cancer therapy|4|||
156985410|NCT01023308|566699517|FG001|Overall Study|New Cancer therapy|7|||
156985411|NCT01023308|566699516|FG000|Overall Study|Protocol Violation|3|||
156985412|NCT01023308|566699517|FG001|Overall Study|Protocol Violation|4|||
156985413|NCT01023308|566699516|FG000|Overall Study|Untreated|5|||
156985414|NCT01023308|566699517|FG001|Overall Study|Untreated|5|||
156985415|NCT01023308|566699516|FG000|Overall Study|Lost to Follow-up|1|||
156985416|NCT01023308|566699517|FG001|Overall Study|Lost to Follow-up|0|||
156985417|NCT01023308|566699516|FG000|Overall Study|Withdrawal by Subject|34|||
156985418|NCT01023308|566699517|FG001|Overall Study|Withdrawal by Subject|18|||
156985419|NCT01890967|566699518|FG000|Overall Study|Adverse Event|3|||
156985420|NCT01890967|566699519|FG001|Overall Study|Adverse Event|3|||
156985421|NCT01890967|566699520|FG002|Overall Study|Adverse Event|3|||
156985422|NCT01890967|566699521|FG003|Overall Study|Adverse Event|2|||
156985423|NCT01890967|566699522|FG004|Overall Study|Adverse Event|1|||
156985424|NCT01890967|566699523|FG005|Overall Study|Adverse Event|7|||
156985425|NCT01890967|566699518|FG000|Overall Study|Death|1|||
156985426|NCT01890967|566699519|FG001|Overall Study|Death|0|||
156985427|NCT01890967|566699520|FG002|Overall Study|Death|0|||
156985428|NCT01890967|566699521|FG003|Overall Study|Death|0|||
156985429|NCT01890967|566699522|FG004|Overall Study|Death|0|||
156985430|NCT01890967|566699523|FG005|Overall Study|Death|0|||
156985431|NCT01890967|566699518|FG000|Overall Study|Lost to Follow-up|1|||
156985432|NCT01890967|566699519|FG001|Overall Study|Lost to Follow-up|1|||
156985433|NCT01890967|566699520|FG002|Overall Study|Lost to Follow-up|1|||
156985434|NCT01890967|566699521|FG003|Overall Study|Lost to Follow-up|1|||
156985435|NCT01890967|566699522|FG004|Overall Study|Lost to Follow-up|0|||
156985436|NCT01890967|566699523|FG005|Overall Study|Lost to Follow-up|1|||
156985437|NCT01890967|566699518|FG000|Overall Study|Protocol Violation|0|||
156985438|NCT01890967|566699519|FG001|Overall Study|Protocol Violation|3|||
156985439|NCT01890967|566699520|FG002|Overall Study|Protocol Violation|3|||
156985440|NCT01890967|566699521|FG003|Overall Study|Protocol Violation|2|||
156985441|NCT01890967|566699522|FG004|Overall Study|Protocol Violation|4|||
156985442|NCT01890967|566699523|FG005|Overall Study|Protocol Violation|1|||
156985443|NCT01890967|566699518|FG000|Overall Study|Sponsor Decision|2|||
156985444|NCT01890967|566699519|FG001|Overall Study|Sponsor Decision|0|||
156985445|NCT01890967|566699520|FG002|Overall Study|Sponsor Decision|1|||
156985446|NCT01890967|566699521|FG003|Overall Study|Sponsor Decision|3|||
156985447|NCT01890967|566699522|FG004|Overall Study|Sponsor Decision|2|||
156985448|NCT01890967|566699523|FG005|Overall Study|Sponsor Decision|3|||
156985449|NCT01890967|566699518|FG000|Overall Study|Withdrawal by Subject|3|||
156985450|NCT01890967|566699519|FG001|Overall Study|Withdrawal by Subject|4|||
156985451|NCT01890967|566699520|FG002|Overall Study|Withdrawal by Subject|2|||
156985452|NCT01890967|566699521|FG003|Overall Study|Withdrawal by Subject|3|||
156985453|NCT01890967|566699522|FG004|Overall Study|Withdrawal by Subject|3|||
156985454|NCT01890967|566699523|FG005|Overall Study|Withdrawal by Subject|1|||
156985455|NCT01383993|566699527|FG000|Overall Study|Adverse Event|1|||
156985456|NCT01383993|566699528|FG001|Overall Study|Adverse Event|1|||
156985457|NCT01383993|566699529|FG002|Overall Study|Adverse Event|0|||
156985458|NCT01383993|566699527|FG000|Overall Study|Withdrawal by Subject|0|||
156985459|NCT01383993|566699528|FG001|Overall Study|Withdrawal by Subject|0|||
156985460|NCT01383993|566699529|FG002|Overall Study|Withdrawal by Subject|1|||
156985461|NCT01383993|566699527|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
156985462|NCT01383993|566699528|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
156985463|NCT01383993|566699529|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
156985464|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
156985465|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
156985466|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
156985467|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
156985468|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
156985469|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
156985470|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
156985471|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
156985472|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156985473|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
156985474|NCT01646320|566699534|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
156985475|NCT01646320|566699535|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
156985476|NCT01646320|566699534|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
156985477|NCT01646320|566699535|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
156985478|NCT01646320|566699534|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
156985479|NCT01646320|566699535|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
156985480|NCT01646320|566699534|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
156985481|NCT01646320|566699535|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
156985482|NCT01646320|566699534|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
156985483|NCT01646320|566699535|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
156985484|NCT01646320|566699534|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
156985485|NCT01646320|566699535|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
156985486|NCT02892409|566699536|FG000|Overall Study|Adverse Event|1|||
156985487|NCT02892409|566699537|FG001|Overall Study|Adverse Event|0|||
156985488|NCT02892409|566699536|FG000|Overall Study|Withdrawal by Subject|2|||
156985489|NCT02892409|566699537|FG001|Overall Study|Withdrawal by Subject|1|||
156985490|NCT02451930|566699541|FG000|Overall Study|Death|0|||
156985491|NCT02451930|566699542|FG001|Overall Study|Death|15|||
156985492|NCT02451930|566699541|FG000|Overall Study|Lost to Follow-up|0|||
156985493|NCT02451930|566699542|FG001|Overall Study|Lost to Follow-up|3|||
156985494|NCT02451930|566699541|FG000|Overall Study|Sponsor Decision|2|||
156985495|NCT02451930|566699542|FG001|Overall Study|Sponsor Decision|10|||
156985496|NCT02451930|566699541|FG000|Overall Study|Withdrawal by Subject|0|||
156985497|NCT02451930|566699542|FG001|Overall Study|Withdrawal by Subject|1|||
156985498|NCT02451930|566699541|FG000|Overall Study|Other|0|||
156985499|NCT02451930|566699542|FG001|Overall Study|Other|1|||
156985500|NCT02485353|566699545|FG000|Overall Study|Death|1|||
156985501|NCT02485353|566699545|FG000|Overall Study|Disease Progression|1|||
156985502|NCT01154036|566699560|FG000|Phase I|Physician Decision|0|||
156985503|NCT01154036|566699561|FG001|Phase I|Physician Decision|1|||
156985504|NCT01154036|566699562|FG002|Phase I|Physician Decision|0|||
156985505|NCT01154036|566699563|FG003|Phase I|Physician Decision|0|||
156985506|NCT01154036|566699564|FG004|Phase I|Physician Decision|0|||
156985507|NCT01154036|566699565|FG005|Phase I|Physician Decision|0|||
156985508|NCT01154036|566699566|FG006|Phase I|Physician Decision|0|||
156985509|NCT01154036|566699567|FG007|Phase I|Physician Decision|0|||
156985510|NCT01154036|566699560|FG000|Phase I|Lost to Follow-up|0|||
156985511|NCT01154036|566699561|FG001|Phase I|Lost to Follow-up|3|||
156985512|NCT01154036|566699562|FG002|Phase I|Lost to Follow-up|6|||
156985513|NCT01154036|566699563|FG003|Phase I|Lost to Follow-up|0|||
156985514|NCT01154036|566699564|FG004|Phase I|Lost to Follow-up|0|||
156985515|NCT01154036|566699565|FG005|Phase I|Lost to Follow-up|0|||
156985516|NCT01154036|566699566|FG006|Phase I|Lost to Follow-up|0|||
156985517|NCT01154036|566699567|FG007|Phase I|Lost to Follow-up|0|||
156985518|NCT01154036|566699560|FG000|Phase I|Protocol Violation|0|||
156985519|NCT01154036|566699561|FG001|Phase I|Protocol Violation|3|||
156985520|NCT01154036|566699562|FG002|Phase I|Protocol Violation|9|||
156985521|NCT01154036|566699563|FG003|Phase I|Protocol Violation|0|||
156985522|NCT01154036|566699564|FG004|Phase I|Protocol Violation|0|||
156985523|NCT01154036|566699565|FG005|Phase I|Protocol Violation|0|||
156985524|NCT01154036|566699566|FG006|Phase I|Protocol Violation|0|||
156985525|NCT01154036|566699567|FG007|Phase I|Protocol Violation|0|||
156985526|NCT01154036|566699560|FG000|Phase I|Withdrawal by Subject|2|||
156985527|NCT01154036|566699561|FG001|Phase I|Withdrawal by Subject|10|||
156985528|NCT01154036|566699562|FG002|Phase I|Withdrawal by Subject|29|||
156985529|NCT01154036|566699563|FG003|Phase I|Withdrawal by Subject|0|||
156985530|NCT01154036|566699564|FG004|Phase I|Withdrawal by Subject|0|||
156985531|NCT01154036|566699565|FG005|Phase I|Withdrawal by Subject|0|||
156985532|NCT01154036|566699566|FG006|Phase I|Withdrawal by Subject|0|||
156985533|NCT01154036|566699567|FG007|Phase I|Withdrawal by Subject|0|||
156985534|NCT01154036|566699560|FG000|Phase I|Adverse Event|1|||
156985535|NCT01154036|566699561|FG001|Phase I|Adverse Event|11|||
156985536|NCT01154036|566699562|FG002|Phase I|Adverse Event|12|||
156985537|NCT01154036|566699563|FG003|Phase I|Adverse Event|0|||
156985538|NCT01154036|566699564|FG004|Phase I|Adverse Event|0|||
156985539|NCT01154036|566699565|FG005|Phase I|Adverse Event|0|||
156985540|NCT01154036|566699566|FG006|Phase I|Adverse Event|0|||
156985541|NCT01154036|566699567|FG007|Phase I|Adverse Event|0|||
156985542|NCT01154036|566699560|FG000|Phase II|Adverse Event|0|||
156985543|NCT01154036|566699561|FG001|Phase II|Adverse Event|0|||
156985544|NCT01154036|566699562|FG002|Phase II|Adverse Event|0|||
156985545|NCT01154036|566699563|FG003|Phase II|Adverse Event|0|||
156985546|NCT01154036|566699564|FG004|Phase II|Adverse Event|1|||
156985547|NCT01154036|566699565|FG005|Phase II|Adverse Event|1|||
156985548|NCT01154036|566699566|FG006|Phase II|Adverse Event|1|||
156985549|NCT01154036|566699567|FG007|Phase II|Adverse Event|1|||
156985550|NCT01154036|566699560|FG000|Phase II|Physician Decision|0|||
156985551|NCT01154036|566699561|FG001|Phase II|Physician Decision|0|||
156985552|NCT01154036|566699562|FG002|Phase II|Physician Decision|0|||
156985553|NCT01154036|566699563|FG003|Phase II|Physician Decision|0|||
156985554|NCT01154036|566699564|FG004|Phase II|Physician Decision|0|||
156985555|NCT01154036|566699565|FG005|Phase II|Physician Decision|0|||
156985556|NCT01154036|566699566|FG006|Phase II|Physician Decision|1|||
156985557|NCT01154036|566699567|FG007|Phase II|Physician Decision|0|||
156985558|NCT01154036|566699560|FG000|Phase II|Lost to Follow-up|0|||
156985559|NCT01154036|566699561|FG001|Phase II|Lost to Follow-up|0|||
156985560|NCT01154036|566699562|FG002|Phase II|Lost to Follow-up|0|||
156985561|NCT01154036|566699563|FG003|Phase II|Lost to Follow-up|1|||
156985562|NCT01154036|566699564|FG004|Phase II|Lost to Follow-up|2|||
156985563|NCT01154036|566699565|FG005|Phase II|Lost to Follow-up|0|||
156985564|NCT01154036|566699566|FG006|Phase II|Lost to Follow-up|2|||
156985565|NCT01154036|566699567|FG007|Phase II|Lost to Follow-up|1|||
156985566|NCT01154036|566699560|FG000|Phase II|Protocol Violation|0|||
156985567|NCT01154036|566699561|FG001|Phase II|Protocol Violation|0|||
156985568|NCT01154036|566699562|FG002|Phase II|Protocol Violation|0|||
156985569|NCT01154036|566699563|FG003|Phase II|Protocol Violation|0|||
156985570|NCT01154036|566699564|FG004|Phase II|Protocol Violation|1|||
156985571|NCT01154036|566699565|FG005|Phase II|Protocol Violation|2|||
156985572|NCT01154036|566699566|FG006|Phase II|Protocol Violation|0|||
156985573|NCT01154036|566699567|FG007|Phase II|Protocol Violation|0|||
156985574|NCT01154036|566699560|FG000|Phase II|Withdrawal by Subject|0|||
156985575|NCT01154036|566699561|FG001|Phase II|Withdrawal by Subject|0|||
156985576|NCT01154036|566699562|FG002|Phase II|Withdrawal by Subject|0|||
156985577|NCT01154036|566699563|FG003|Phase II|Withdrawal by Subject|0|||
156985578|NCT01154036|566699564|FG004|Phase II|Withdrawal by Subject|4|||
156985579|NCT01154036|566699565|FG005|Phase II|Withdrawal by Subject|2|||
156985580|NCT01154036|566699566|FG006|Phase II|Withdrawal by Subject|5|||
156985581|NCT01154036|566699567|FG007|Phase II|Withdrawal by Subject|4|||
156985582|NCT02264574|566699568|FG000|Overall Study|Death|21|||
156985583|NCT02264574|566699569|FG001|Overall Study|Death|21|||
156985584|NCT02264574|566699568|FG000|Overall Study|Withdrawal by Subject|8|||
156985585|NCT02264574|566699569|FG001|Overall Study|Withdrawal by Subject|6|||
156985586|NCT02264574|566699568|FG000|Overall Study|Other, Not Specified|0|||
156985587|NCT02264574|566699569|FG001|Overall Study|Other, Not Specified|3|||
156985588|NCT03405662|566699571|FG000|Overall Study|COVID-19 restriction|1|||
156985589|NCT03405662|566699572|FG001|Overall Study|COVID-19 restriction|0|||
156985590|NCT03405662|566699571|FG000|Overall Study|unblinding|0|||
156985591|NCT03405662|566699572|FG001|Overall Study|unblinding|1|||
156985592|NCT03405662|566699571|FG000|Overall Study|placement in memory care facility|0|||
156985593|NCT03405662|566699572|FG001|Overall Study|placement in memory care facility|2|||
156985594|NCT04827134|566699573|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156985595|NCT04827134|566699574|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156985596|NCT04827134|566699575|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
156985597|NCT04827134|566699576|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
156985598|NCT02443103|566699577|FG000|Overall Study|Adverse Event|2|||
156985599|NCT02443103|566699577|FG000|Overall Study|Noncompliance|1|||
156985600|NCT03358329|566699580|FG000|Overall Study|Lost to Follow-up|2|||
156985601|NCT03358329|566699580|FG000|Overall Study|Withdrawal by Subject|2|||
156985602|NCT01313923|566699581|FG000|Overall Study|Physician Decision|3|||
156985603|NCT02982720|566699582|FG000|Overall Study|Adverse Event|3|||
156985604|NCT02982720|566699582|FG000|Overall Study|Death|1|||
156985605|NCT03875911|566699585|FG000|Overall Study|Lost to Follow-up|3|||
156985606|NCT03875911|566699586|FG001|Overall Study|Lost to Follow-up|6|||
156985607|NCT03875911|566699587|FG002|Overall Study|Lost to Follow-up|2|||
156985608|NCT03875911|566699585|FG000|Overall Study|Surgery cancelled|1|||
156985609|NCT03875911|566699586|FG001|Overall Study|Surgery cancelled|0|||
156985610|NCT03875911|566699587|FG002|Overall Study|Surgery cancelled|1|||
156985611|NCT03875911|566699585|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
156985612|NCT03875911|566699586|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
156985613|NCT03875911|566699587|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
156985614|NCT01231503|566699590|FG000|Overall Study|Adverse Event|0|||
156985615|NCT01231503|566699591|FG001|Overall Study|Adverse Event|0|||
156985616|NCT01231503|566699592|FG002|Overall Study|Adverse Event|0|||
156985617|NCT01231503|566699593|FG003|Overall Study|Adverse Event|0|||
156985618|NCT01231503|566699594|FG004|Overall Study|Adverse Event|0|||
156985619|NCT01231503|566699595|FG005|Overall Study|Adverse Event|1|||
156985620|NCT01231503|566699596|FG006|Overall Study|Adverse Event|0|||
156985621|NCT01231503|566699597|FG007|Overall Study|Adverse Event|0|||
156985622|NCT01231503|566699590|FG000|Overall Study|Adverse event, serious fatal|0|||
156985623|NCT01231503|566699591|FG001|Overall Study|Adverse event, serious fatal|0|||
156985624|NCT01231503|566699592|FG002|Overall Study|Adverse event, serious fatal|1|||
156985625|NCT01231503|566699593|FG003|Overall Study|Adverse event, serious fatal|1|||
156985626|NCT01231503|566699594|FG004|Overall Study|Adverse event, serious fatal|0|||
156985627|NCT01231503|566699595|FG005|Overall Study|Adverse event, serious fatal|1|||
156985628|NCT01231503|566699596|FG006|Overall Study|Adverse event, serious fatal|0|||
156985629|NCT01231503|566699597|FG007|Overall Study|Adverse event, serious fatal|0|||
156985630|NCT01231503|566699590|FG000|Overall Study|Withdrawal by Subject|6|||
156985631|NCT01231503|566699591|FG001|Overall Study|Withdrawal by Subject|3|||
156985632|NCT01231503|566699592|FG002|Overall Study|Withdrawal by Subject|3|||
156985633|NCT01231503|566699593|FG003|Overall Study|Withdrawal by Subject|1|||
156985634|NCT01231503|566699594|FG004|Overall Study|Withdrawal by Subject|3|||
156985635|NCT01231503|566699595|FG005|Overall Study|Withdrawal by Subject|5|||
156985636|NCT01231503|566699596|FG006|Overall Study|Withdrawal by Subject|1|||
156985637|NCT01231503|566699597|FG007|Overall Study|Withdrawal by Subject|2|||
156985638|NCT01231503|566699590|FG000|Overall Study|Lost to Follow-up|8|||
156985639|NCT01231503|566699591|FG001|Overall Study|Lost to Follow-up|10|||
156985640|NCT01231503|566699592|FG002|Overall Study|Lost to Follow-up|8|||
156985641|NCT01231503|566699593|FG003|Overall Study|Lost to Follow-up|5|||
156985642|NCT01231503|566699594|FG004|Overall Study|Lost to Follow-up|7|||
156985643|NCT01231503|566699595|FG005|Overall Study|Lost to Follow-up|9|||
156985644|NCT01231503|566699596|FG006|Overall Study|Lost to Follow-up|6|||
156985645|NCT01231503|566699597|FG007|Overall Study|Lost to Follow-up|6|||
156985646|NCT01231503|566699590|FG000|Overall Study|Protocol Violation|0|||
156985647|NCT01231503|566699591|FG001|Overall Study|Protocol Violation|0|||
156985648|NCT01231503|566699592|FG002|Overall Study|Protocol Violation|0|||
156985649|NCT01231503|566699593|FG003|Overall Study|Protocol Violation|1|||
156985650|NCT01231503|566699594|FG004|Overall Study|Protocol Violation|0|||
156985651|NCT01231503|566699595|FG005|Overall Study|Protocol Violation|0|||
156985652|NCT01231503|566699596|FG006|Overall Study|Protocol Violation|0|||
156985653|NCT01231503|566699597|FG007|Overall Study|Protocol Violation|0|||
156985654|NCT00287469|566699598|FG000|Overall Study|serious adverse event|1|||
156985655|NCT00287469|566699599|FG001|Overall Study|serious adverse event|6|||
156985656|NCT00287469|566699598|FG000|Overall Study|Adverse Event|1|||
156985657|NCT00287469|566699599|FG001|Overall Study|Adverse Event|1|||
156985658|NCT00287469|566699598|FG000|Overall Study|moved from area|144|||
156985659|NCT00287469|566699599|FG001|Overall Study|moved from area|138|||
156985660|NCT00287469|566699598|FG000|Overall Study|Lost to Follow-up|74|||
156985661|NCT00287469|566699599|FG001|Overall Study|Lost to Follow-up|69|||
156985662|NCT02207374|566699603|FG000|Overall Study|Withdrawal by Subject|5|||
156985663|NCT02207374|566699604|FG001|Overall Study|Withdrawal by Subject|9|||
156985664|NCT02207374|566699605|FG002|Overall Study|Withdrawal by Subject|4|||
156985665|NCT02207374|566699603|FG000|Overall Study|Death|1|||
156985666|NCT02207374|566699604|FG001|Overall Study|Death|0|||
156985667|NCT02207374|566699605|FG002|Overall Study|Death|1|||
156985668|NCT02207374|566699603|FG000|Overall Study|Missing follow-up information|0|||
156985669|NCT02207374|566699604|FG001|Overall Study|Missing follow-up information|1|||
156985670|NCT02207374|566699605|FG002|Overall Study|Missing follow-up information|1|||
156985671|NCT00393094|566699609|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
156985672|NCT00393094|566699609|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
156985673|NCT02019602|566699610|FG000|Screening Period|Ineligibility|4|||
156985674|NCT02019602|566699611|FG001|Screening Period|Ineligibility|0|||
156985675|NCT02019602|566699610|FG000|Screening Period|Adverse Event|1|||
156985676|NCT02019602|566699611|FG001|Screening Period|Adverse Event|0|||
156985677|NCT02372058|566699612|FG000|Overall Study|Withdrawal by Subject|3|||
156985678|NCT03055832|566699613|FG000|Week 2|Withdrawal by Subject|1|||
156985679|NCT03055832|566699614|FG001|Week 2|Withdrawal by Subject|0|||
156985680|NCT03619174|566699615|FG000|Overall Study|Lost to Follow-up|3|||
156985681|NCT03619174|566699616|FG001|Overall Study|Lost to Follow-up|0|||
156985682|NCT03619174|566699615|FG000|Overall Study|Withdrawal by Subject|4|||
156985683|NCT03619174|566699616|FG001|Overall Study|Withdrawal by Subject|3|||
156985684|NCT03619174|566699615|FG000|Overall Study|Pregnancy|1|||
156985685|NCT03619174|566699616|FG001|Overall Study|Pregnancy|1|||
156985686|NCT03619174|566699615|FG000|Overall Study|Discomfort during treatment|1|||
156985687|NCT03619174|566699616|FG001|Overall Study|Discomfort during treatment|0|||
156985688|NCT01012973|566699619|FG000|Overall Study|Adverse Event|5|||
156985689|NCT01012973|566699620|FG001|Overall Study|Adverse Event|5|||
156985690|NCT01012973|566699619|FG000|Overall Study|Lack of Efficacy|0|||
156985691|NCT01012973|566699620|FG001|Overall Study|Lack of Efficacy|5|||
156985692|NCT01012973|566699619|FG000|Overall Study|Lost to Follow-up|1|||
156985693|NCT01012973|566699620|FG001|Overall Study|Lost to Follow-up|0|||
156985694|NCT01012973|566699619|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
156985695|NCT01012973|566699620|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
156985696|NCT01012973|566699619|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
156985697|NCT01012973|566699620|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
156985698|NCT01012973|566699619|FG000|Overall Study|Protocol Violation|5|||
156985699|NCT01012973|566699620|FG001|Overall Study|Protocol Violation|2|||
156985700|NCT01012973|566699619|FG000|Overall Study|Withdrawal by Subject|4|||
156985701|NCT01012973|566699620|FG001|Overall Study|Withdrawal by Subject|6|||
156985702|NCT00967018|566699621|FG000|Overall Study|Adverse Event|2|||
156985703|NCT00967018|566699621|FG000|Overall Study|Physician Decision|7|||
156985704|NCT00967018|566699621|FG000|Overall Study|Lost to Follow-up|2|||
156985705|NCT00967018|566699621|FG000|Overall Study|Withdrawal by Subject|1|||
156985706|NCT00967018|566699621|FG000|Overall Study|Miscellaneous Reasons|9|||
156985707|NCT00064025|566699631|FG000|Overall Study|Ineligible|4|||
156985708|NCT00064025|566699631|FG000|Overall Study|Inevaluable|3|||
156985709|NCT02468934|566699632|FG000|Overall Study|Withdrawal by Subject|4|||
156985710|NCT02468934|566699632|FG000|Overall Study|Screen Failure|3|||
156985711|NCT02924389|566699639|FG000|Overall Study|Lost to Follow-up|1|||
156985712|NCT02924389|566699640|FG001|Overall Study|Lost to Follow-up|0|||
156985713|NCT02924389|566699639|FG000|Overall Study|Physician Decision|2|||
156985714|NCT02924389|566699640|FG001|Overall Study|Physician Decision|0|||
156985715|NCT02924389|566699639|FG000|Overall Study|Withdrawal by Subject|3|||
156985716|NCT02924389|566699640|FG001|Overall Study|Withdrawal by Subject|0|||
156985717|NCT02924389|566699639|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
156985718|NCT02924389|566699640|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
156985719|NCT01500226|566701263|FG000|Overall Study|Adverse Event|31|||
156985720|NCT01500226|566701264|FG001|Overall Study|Adverse Event|38|||
156985721|NCT01500226|566701263|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
156985722|NCT01500226|566701264|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
156985723|NCT01500226|566701263|FG000|Overall Study|Withdrawal by Subject|93|||
156985724|NCT01500226|566701264|FG001|Overall Study|Withdrawal by Subject|96|||
156985725|NCT01500226|566701263|FG000|Overall Study|Death|12|||
156985726|NCT01500226|566701264|FG001|Overall Study|Death|4|||
156985727|NCT01500226|566701263|FG000|Overall Study|Disease Progression|16|||
156985728|NCT01500226|566701264|FG001|Overall Study|Disease Progression|14|||
156985729|NCT01500226|566701263|FG000|Overall Study|Protocol Violation|53|||
156985730|NCT01500226|566701264|FG001|Overall Study|Protocol Violation|39|||
156985731|NCT01500226|566701263|FG000|Overall Study|Physician Decision|17|||
156985732|NCT01500226|566701264|FG001|Overall Study|Physician Decision|15|||
156985733|NCT01500226|566701263|FG000|Overall Study|Lack of Efficacy|14|||
156985734|NCT01500226|566701264|FG001|Overall Study|Lack of Efficacy|30|||
156985735|NCT01500226|566701263|FG000|Overall Study|Lost to Follow-up|9|||
156985736|NCT01500226|566701264|FG001|Overall Study|Lost to Follow-up|5|||
157096864|NCT04677179|567109285|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156985737|NCT01500226|566701263|FG000|Overall Study|Other Reasons|19|||
156985738|NCT01500226|566701264|FG001|Overall Study|Other Reasons|16|||
156985739|NCT00504348|566701286|FG000|Overall Study|Adverse Event|3|||
156985740|NCT00504348|566701286|FG000|Overall Study|Lack of Efficacy|4|||
156985741|NCT00504348|566701286|FG000|Overall Study|Physician Decision|1|||
156985742|NCT02819479|566701287|FG000|Overall Study|Adverse Event|2|||
156985743|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
156985744|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
156985745|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
156985746|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
156985747|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
156985748|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
156985749|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
156985750|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
157096865|NCT04677179|567109286|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156985751|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
156985752|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
156985753|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
156985754|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
156985755|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
156985756|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
156985757|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
156985758|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
156985759|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
156985760|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
156985761|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
156985762|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
156985763|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
156985764|NCT02718417|566701290|FG000|Chemotherapy Phase (CP)|Other|2|||
156985765|NCT02718417|566701291|FG001|Chemotherapy Phase (CP)|Other|0|||
156985766|NCT02718417|566701292|FG002|Chemotherapy Phase (CP)|Other|1|||
156985767|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Adverse Event|21|||
156985768|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Adverse Event|26|||
156985769|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Adverse Event|0|||
156985770|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
156985771|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
156985772|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
156985773|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
156985774|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
156985775|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
156985776|NCT02718417|566701290|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
156985777|NCT02718417|566701291|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
156985778|NCT02718417|566701292|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
156985779|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Physician's decision|6|||
156985780|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Physician's decision|7|||
156985781|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Physician's decision|0|||
156985782|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Progressive disease|100|||
156985783|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Progressive disease|88|||
156985784|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Progressive disease|0|||
156985785|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Other|2|||
156985786|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Other|1|||
156985787|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Other|0|||
156985788|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
156985789|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
156985790|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
156985791|NCT02718417|566701290|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
156985792|NCT02718417|566701291|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
156985793|NCT02718417|566701292|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
156985794|NCT02718417|566701290|FG000|Observation Phase (OP)|Adverse Event|0|||
156985795|NCT02718417|566701291|FG001|Observation Phase (OP)|Adverse Event|0|||
156985796|NCT02718417|566701292|FG002|Observation Phase (OP)|Adverse Event|1|||
156985797|NCT02718417|566701290|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
156985798|NCT02718417|566701291|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
156985799|NCT02718417|566701292|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
156985800|NCT02718417|566701290|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
156985801|NCT02718417|566701291|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
157096866|NCT04677179|567109277|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156985802|NCT02718417|566701292|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
156985803|NCT02718417|566701290|FG000|Observation Phase (OP)|Physician Decision|0|||
156985804|NCT02718417|566701291|FG001|Observation Phase (OP)|Physician Decision|0|||
156985805|NCT02718417|566701292|FG002|Observation Phase (OP)|Physician Decision|9|||
156985806|NCT02718417|566701290|FG000|Observation Phase (OP)|Progressive disease|0|||
156985807|NCT02718417|566701291|FG001|Observation Phase (OP)|Progressive disease|0|||
156985808|NCT02718417|566701292|FG002|Observation Phase (OP)|Progressive disease|92|||
156985809|NCT02718417|566701290|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
156985810|NCT02718417|566701291|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
156985811|NCT02718417|566701292|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
156985812|NCT02718417|566701290|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
156985813|NCT02718417|566701291|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
156985814|NCT02718417|566701292|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
156985815|NCT02718417|566701290|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
156985816|NCT02718417|566701291|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
156985817|NCT02718417|566701292|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
156985818|NCT02718417|566701290|FG000|Observation Phase (OP)|Other|0|||
156985819|NCT02718417|566701291|FG001|Observation Phase (OP)|Other|0|||
156985820|NCT02718417|566701292|FG002|Observation Phase (OP)|Other|7|||
156985821|NCT02718417|566701290|FG000|Follow-up Phase|Adverse Event|3|||
156985822|NCT02718417|566701291|FG001|Follow-up Phase|Adverse Event|1|||
156985823|NCT02718417|566701292|FG002|Follow-up Phase|Adverse Event|1|||
156985824|NCT02718417|566701290|FG000|Follow-up Phase|Other|4|||
156985825|NCT02718417|566701291|FG001|Follow-up Phase|Other|6|||
156985826|NCT02718417|566701292|FG002|Follow-up Phase|Other|4|||
156985827|NCT02718417|566701290|FG000|Follow-up Phase|Withdrawal by Subject|19|||
156985828|NCT02718417|566701291|FG001|Follow-up Phase|Withdrawal by Subject|17|||
156985829|NCT02718417|566701292|FG002|Follow-up Phase|Withdrawal by Subject|5|||
156985830|NCT02718417|566701290|FG000|Follow-up Phase|Study terminated by sponsor|100|||
156985831|NCT02718417|566701291|FG001|Follow-up Phase|Study terminated by sponsor|138|||
156985832|NCT02718417|566701292|FG002|Follow-up Phase|Study terminated by sponsor|6|||
156985833|NCT02718417|566701290|FG000|Follow-up Phase|Lost to Follow-up|2|||
156985834|NCT02718417|566701291|FG001|Follow-up Phase|Lost to Follow-up|3|||
156985835|NCT02718417|566701292|FG002|Follow-up Phase|Lost to Follow-up|0|||
156985836|NCT02718417|566701290|FG000|Follow-up Phase|Death leading to discontinuation|7|||
156985837|NCT02718417|566701291|FG001|Follow-up Phase|Death leading to discontinuation|7|||
156985838|NCT02718417|566701292|FG002|Follow-up Phase|Death leading to discontinuation|3|||
156985839|NCT02718417|566701290|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
156985840|NCT02718417|566701291|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
156985841|NCT02718417|566701292|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
156985842|NCT02718417|566701290|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
156985843|NCT02718417|566701291|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
156985844|NCT02718417|566701292|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
156985845|NCT02718417|566701290|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
156985846|NCT02718417|566701291|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
156985847|NCT02718417|566701292|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
156985848|NCT02718417|566701290|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
156985849|NCT02718417|566701291|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
156985850|NCT02718417|566701292|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
156985851|NCT02718417|566701290|FG000|Long-term Follow-up Phase|Other|0|||
156985852|NCT02718417|566701291|FG001|Long-term Follow-up Phase|Other|2|||
156985853|NCT02718417|566701292|FG002|Long-term Follow-up Phase|Other|0|||
156985854|NCT00551213|566701295|FG000|Overall Study|Adverse Event|6|||
156985855|NCT00551213|566701296|FG001|Overall Study|Adverse Event|3|||
156985856|NCT00551213|566701295|FG000|Overall Study|Progressive Disease|41|||
156985857|NCT00551213|566701296|FG001|Overall Study|Progressive Disease|12|||
156985858|NCT00551213|566701295|FG000|Overall Study|Withdrawal by Subject|2|||
156985859|NCT00551213|566701296|FG001|Overall Study|Withdrawal by Subject|0|||
156985860|NCT00551213|566701295|FG000|Overall Study|Not Treated|1|||
156985861|NCT00551213|566701296|FG001|Overall Study|Not Treated|2|||
156985862|NCT01489020|566701297|FG000|Overall Study|Withdrawal by Subject|1|||
156985863|NCT01489020|566701298|FG001|Overall Study|Withdrawal by Subject|0|||
156985864|NCT01489020|566701299|FG002|Overall Study|Withdrawal by Subject|0|||
156985865|NCT01489020|566701300|FG003|Overall Study|Withdrawal by Subject|0|||
156985866|NCT01489020|566701301|FG004|Overall Study|Withdrawal by Subject|0|||
156985867|NCT01489020|566701302|FG005|Overall Study|Withdrawal by Subject|0|||
156985868|NCT01489020|566701297|FG000|Overall Study|Adverse Event|0|||
156985869|NCT01489020|566701298|FG001|Overall Study|Adverse Event|0|||
156985870|NCT01489020|566701299|FG002|Overall Study|Adverse Event|3|||
156985871|NCT01489020|566701300|FG003|Overall Study|Adverse Event|0|||
156985872|NCT01489020|566701301|FG004|Overall Study|Adverse Event|3|||
156985873|NCT01489020|566701302|FG005|Overall Study|Adverse Event|0|||
156985874|NCT01489020|566701297|FG000|Overall Study|Concomitant disease|0|||
156985875|NCT01489020|566701298|FG001|Overall Study|Concomitant disease|0|||
156985876|NCT01489020|566701299|FG002|Overall Study|Concomitant disease|0|||
156985877|NCT01489020|566701300|FG003|Overall Study|Concomitant disease|0|||
156985878|NCT01489020|566701301|FG004|Overall Study|Concomitant disease|3|||
156985879|NCT01489020|566701302|FG005|Overall Study|Concomitant disease|0|||
156985880|NCT01950273|566701303|FG000|Overall Study|Protocol Violation|1|||
156985881|NCT01950273|566701304|FG001|Overall Study|Protocol Violation|0|||
156985882|NCT01950273|566701303|FG000|Overall Study|Withdrawal by Subject|2|||
156985883|NCT01950273|566701304|FG001|Overall Study|Withdrawal by Subject|0|||
156985884|NCT01950273|566701303|FG000|Overall Study|Other not defined above|1|||
156985885|NCT01950273|566701304|FG001|Overall Study|Other not defined above|0|||
156985886|NCT01591460|566701305|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
156985887|NCT01591460|566701305|FG000|Overall Study|Futility Rule (Week 12)|7|||
156985888|NCT01591460|566701305|FG000|Overall Study|Futility Rule (Week 24)|3|||
156985889|NCT01591460|566701305|FG000|Overall Study|Rebound or Breakthrough|3|||
156985890|NCT01591460|566701305|FG000|Overall Study|Treatment Discontinued by Error|1|||
156985891|NCT01591460|566701305|FG000|Overall Study|Lost to Follow-up|1|||
156985892|NCT01591460|566701305|FG000|Overall Study|Noncompliance|1|||
156985893|NCT01591460|566701305|FG000|Overall Study|Participant Refusal|3|||
156985894|NCT01591460|566701305|FG000|Overall Study|Withdrawal by Subject|1|||
156985895|NCT01591460|566701305|FG000|Overall Study|Protocol Violation|1|||
156985896|NCT01567163|566701308|FG000|Overall Study|Progressive Disease|2|||
156985897|NCT01567163|566701308|FG000|Overall Study|Lost to Follow-up|2|||
156985898|NCT01348854|566701309|FG000|Overall Study|Lost to Follow-up|2|||
156985899|NCT01348854|566701310|FG001|Overall Study|Lost to Follow-up|1|||
156985900|NCT01348854|566701309|FG000|Overall Study|Withdrawal by Subject|1|||
156985901|NCT01348854|566701310|FG001|Overall Study|Withdrawal by Subject|0|||
156985902|NCT01720797|566701311|FG000|Overall Study|Withdrawal by Subject|3|||
156985903|NCT01720797|566701312|FG001|Overall Study|Withdrawal by Subject|0|||
156985904|NCT00983619|566701313|FG000|Overall Study|Lost to Follow-up|0|||
156985905|NCT00983619|566701314|FG001|Overall Study|Lost to Follow-up|1|||
156985906|NCT00983619|566701315|FG002|Overall Study|Lost to Follow-up|0|||
156985907|NCT00983619|566701316|FG003|Overall Study|Lost to Follow-up|0|||
156985908|NCT00983619|566701317|FG004|Overall Study|Lost to Follow-up|0|||
156985909|NCT00983619|566701318|FG005|Overall Study|Lost to Follow-up|2|||
156985910|NCT00983619|566701319|FG006|Overall Study|Lost to Follow-up|0|||
156985911|NCT00983619|566701320|FG007|Overall Study|Lost to Follow-up|0|||
156985912|NCT00983619|566701321|FG008|Overall Study|Lost to Follow-up|0|||
156985913|NCT00983619|566701322|FG009|Overall Study|Lost to Follow-up|0|||
156985914|NCT00983619|566701323|FG010|Overall Study|Lost to Follow-up|0|||
156985915|NCT00983619|566701324|FG011|Overall Study|Lost to Follow-up|2|||
156985916|NCT00983619|566701313|FG000|Overall Study|Withdrawal by Subject|2|||
156985917|NCT00983619|566701314|FG001|Overall Study|Withdrawal by Subject|1|||
156985918|NCT00983619|566701315|FG002|Overall Study|Withdrawal by Subject|1|||
156985919|NCT00983619|566701316|FG003|Overall Study|Withdrawal by Subject|3|||
156985920|NCT00983619|566701317|FG004|Overall Study|Withdrawal by Subject|1|||
156985921|NCT00983619|566701318|FG005|Overall Study|Withdrawal by Subject|23|||
156985922|NCT00983619|566701319|FG006|Overall Study|Withdrawal by Subject|0|||
156985923|NCT00983619|566701320|FG007|Overall Study|Withdrawal by Subject|0|||
156985924|NCT00983619|566701321|FG008|Overall Study|Withdrawal by Subject|0|||
156985925|NCT00983619|566701322|FG009|Overall Study|Withdrawal by Subject|0|||
156985926|NCT00983619|566701323|FG010|Overall Study|Withdrawal by Subject|1|||
156985927|NCT00983619|566701324|FG011|Overall Study|Withdrawal by Subject|1|||
156985928|NCT00983619|566701313|FG000|Overall Study|Death|0|||
156985929|NCT00983619|566701314|FG001|Overall Study|Death|2|||
156985930|NCT00983619|566701315|FG002|Overall Study|Death|2|||
156985931|NCT00983619|566701316|FG003|Overall Study|Death|1|||
156985932|NCT00983619|566701317|FG004|Overall Study|Death|2|||
156985933|NCT00983619|566701318|FG005|Overall Study|Death|30|||
156985934|NCT00983619|566701319|FG006|Overall Study|Death|1|||
156985935|NCT00983619|566701320|FG007|Overall Study|Death|0|||
156985936|NCT00983619|566701321|FG008|Overall Study|Death|1|||
156985937|NCT00983619|566701322|FG009|Overall Study|Death|2|||
156985938|NCT00983619|566701323|FG010|Overall Study|Death|9|||
156985939|NCT00983619|566701324|FG011|Overall Study|Death|8|||
156985940|NCT00983619|566701313|FG000|Overall Study|Other|1|||
156985941|NCT00983619|566701314|FG001|Overall Study|Other|0|||
156985942|NCT00983619|566701315|FG002|Overall Study|Other|0|||
156985943|NCT00983619|566701316|FG003|Overall Study|Other|1|||
156985944|NCT00983619|566701317|FG004|Overall Study|Other|0|||
156985945|NCT00983619|566701318|FG005|Overall Study|Other|12|||
156985946|NCT00983619|566701319|FG006|Overall Study|Other|2|||
156985947|NCT00983619|566701320|FG007|Overall Study|Other|2|||
156985948|NCT00983619|566701321|FG008|Overall Study|Other|0|||
156985949|NCT00983619|566701322|FG009|Overall Study|Other|1|||
156985950|NCT00983619|566701323|FG010|Overall Study|Other|1|||
156985951|NCT00983619|566701324|FG011|Overall Study|Other|0|||
156985952|NCT00724061|566701325|FG000|Dose Escalation Phase|Adverse Event|2|||
156985953|NCT00724061|566701325|FG000|Dose Escalation Phase|Disease Progression|3|||
156985954|NCT00688259|566701332|FG000|Overall Study|Lost to Follow-up|2|||
156985955|NCT00688259|566701333|FG001|Overall Study|Lost to Follow-up|4|||
156985956|NCT00688259|566701332|FG000|Overall Study|Physician Decision|1|||
156985957|NCT00688259|566701333|FG001|Overall Study|Physician Decision|0|||
156985958|NCT00688259|566701332|FG000|Overall Study|Withdrawal by Subject|2|||
156985959|NCT00688259|566701333|FG001|Overall Study|Withdrawal by Subject|0|||
156985960|NCT00688259|566701332|FG000|Overall Study|Declined Interview|2|||
156985961|NCT00688259|566701333|FG001|Overall Study|Declined Interview|3|||
156985962|NCT00688259|566701332|FG000|Overall Study|Hospitalized at Follow-up|0|||
156985963|NCT00688259|566701333|FG001|Overall Study|Hospitalized at Follow-up|1|||
156985964|NCT03653416|566701338|FG000|Overall Study|Protocol Violation|6|||
156985965|NCT03653416|566701339|FG001|Overall Study|Protocol Violation|1|||
156985966|NCT00681187|566701340|FG000|Overall Study|Withdrawal by Subject|1|||
156985967|NCT00681187|566701341|FG001|Overall Study|Withdrawal by Subject|0|||
156985968|NCT00681187|566701340|FG000|Overall Study|Death|0|||
156985969|NCT00681187|566701341|FG001|Overall Study|Death|1|||
156985970|NCT00681187|566701340|FG000|Overall Study|Adverse Event|0|||
156985971|NCT00681187|566701341|FG001|Overall Study|Adverse Event|1|||
156985972|NCT03207711|566701342|FG000|Overall Study|Withdrawal by Subject|1|||
156985973|NCT03207711|566701343|FG001|Overall Study|Withdrawal by Subject|2|||
156985974|NCT02788006|566701347|FG000|Overall Study|Patient not treated|1|||
156985975|NCT01083160|566701350|FG000|Overall Study|Adverse Event|1|||
156985976|NCT01951092|566701351|FG000|Overall Study|Lost to Follow-up|10|||
156985977|NCT01951092|566701351|FG000|Overall Study|Incarceration|1|||
156985978|NCT01951092|566701351|FG000|Overall Study|Transfer of Care|1|||
156985979|NCT00972179|566701352|FG000|Overall Study|Noncompliance|1|||
156985980|NCT00972179|566701353|FG001|Overall Study|Noncompliance|0|||
156985981|NCT00972179|566701354|FG002|Overall Study|Noncompliance|0|||
156985982|NCT00972179|566701355|FG003|Overall Study|Noncompliance|0|||
156985983|NCT00972179|566701356|FG004|Overall Study|Noncompliance|1|||
156985984|NCT00972179|566701357|FG005|Overall Study|Noncompliance|0|||
156985985|NCT00972179|566701358|FG006|Overall Study|Noncompliance|1|||
156985986|NCT00972179|566701352|FG000|Overall Study|Withdrawal by Subject|0|||
156985987|NCT00972179|566701353|FG001|Overall Study|Withdrawal by Subject|3|||
156985988|NCT00972179|566701354|FG002|Overall Study|Withdrawal by Subject|0|||
156985989|NCT00972179|566701355|FG003|Overall Study|Withdrawal by Subject|1|||
156985990|NCT00972179|566701356|FG004|Overall Study|Withdrawal by Subject|0|||
156985991|NCT00972179|566701357|FG005|Overall Study|Withdrawal by Subject|0|||
156985992|NCT00972179|566701358|FG006|Overall Study|Withdrawal by Subject|2|||
156985993|NCT00972179|566701352|FG000|Overall Study|Administrative Decision|0|||
156985994|NCT00972179|566701353|FG001|Overall Study|Administrative Decision|0|||
156985995|NCT00972179|566701354|FG002|Overall Study|Administrative Decision|0|||
156985996|NCT00972179|566701355|FG003|Overall Study|Administrative Decision|0|||
156985997|NCT00972179|566701356|FG004|Overall Study|Administrative Decision|1|||
156985998|NCT00972179|566701357|FG005|Overall Study|Administrative Decision|0|||
156985999|NCT00972179|566701358|FG006|Overall Study|Administrative Decision|0|||
156986000|NCT00972179|566701352|FG000|Overall Study|Lost to Follow-up|0|||
156986001|NCT00972179|566701353|FG001|Overall Study|Lost to Follow-up|0|||
156986002|NCT00972179|566701354|FG002|Overall Study|Lost to Follow-up|1|||
156986003|NCT00972179|566701355|FG003|Overall Study|Lost to Follow-up|0|||
156986004|NCT00972179|566701356|FG004|Overall Study|Lost to Follow-up|0|||
156986005|NCT00972179|566701357|FG005|Overall Study|Lost to Follow-up|3|||
156986006|NCT00972179|566701358|FG006|Overall Study|Lost to Follow-up|1|||
156986007|NCT00136916|566701359|FG000|Overall Study|Never received study treatment|3|||
156986008|NCT00136916|566701360|FG001|Overall Study|Never received study treatment|5|||
156986009|NCT00136916|566701359|FG000|Overall Study|Death|1|||
156986010|NCT00136916|566701360|FG001|Overall Study|Death|3|||
156986011|NCT00136916|566701359|FG000|Overall Study|Adverse Event|27|||
156986012|NCT00136916|566701360|FG001|Overall Study|Adverse Event|8|||
156986013|NCT00136916|566701359|FG000|Overall Study|Laboratory abnormality|0|||
156986014|NCT00136916|566701360|FG001|Overall Study|Laboratory abnormality|1|||
156986015|NCT00136916|566701359|FG000|Overall Study|Lack of Efficacy|13|||
156986016|NCT00136916|566701360|FG001|Overall Study|Lack of Efficacy|3|||
156986017|NCT00136916|566701359|FG000|Overall Study|Lost to Follow-up|12|||
156986018|NCT00136916|566701360|FG001|Overall Study|Lost to Follow-up|14|||
156986019|NCT00136916|566701359|FG000|Overall Study|Withdrawal by Subject|44|||
156986020|NCT00136916|566701360|FG001|Overall Study|Withdrawal by Subject|46|||
156986021|NCT00136916|566701359|FG000|Overall Study|Other|22|||
156986022|NCT00136916|566701360|FG001|Overall Study|Other|24|||
156986023|NCT00136916|566701359|FG000|Overall Study|Discontinued in follow up period|3|||
156986024|NCT00136916|566701360|FG001|Overall Study|Discontinued in follow up period|0|||
156986025|NCT01991197|566701361|FG000|Overall Study|Lost to Follow-up|1|||
156986026|NCT01991197|566701362|FG001|Overall Study|Lost to Follow-up|1|||
156986027|NCT01991197|566701361|FG000|Overall Study|Physician Decision|0|||
156986028|NCT01991197|566701362|FG001|Overall Study|Physician Decision|2|||
156986029|NCT01991197|566701361|FG000|Overall Study|Withdrawal by Subject|2|||
156986030|NCT01991197|566701362|FG001|Overall Study|Withdrawal by Subject|0|||
156986031|NCT05868954|566701368|FG000|Overall Study|Lost to Follow-up|0|||
156986032|NCT05868954|566701369|FG001|Overall Study|Lost to Follow-up|1|||
156986033|NCT05868954|566701368|FG000|Overall Study|Withdrawal by Subject|2|||
156986034|NCT05868954|566701369|FG001|Overall Study|Withdrawal by Subject|2|||
156986035|NCT05868954|566701368|FG000|Overall Study|Participant delivered|1|||
156986036|NCT05868954|566701369|FG001|Overall Study|Participant delivered|1|||
156986037|NCT05868954|566701368|FG000|Overall Study|Miscarriage|0|||
156986038|NCT05868954|566701369|FG001|Overall Study|Miscarriage|1|||
156986039|NCT01435798|566701372|FG000|Overall Study|Withdrawal by Subject|1|||
156986040|NCT01570868|566701376|FG000|Overall Study|Adverse Event|8|||
156986041|NCT01570868|566701377|FG001|Overall Study|Adverse Event|1|||
156986042|NCT01570868|566701376|FG000|Overall Study|FDA Recommendation|23|||
156986043|NCT01570868|566701377|FG001|Overall Study|FDA Recommendation|3|||
156986044|NCT01570868|566701376|FG000|Overall Study|Physician Decision|10|||
156986045|NCT01570868|566701377|FG001|Overall Study|Physician Decision|4|||
156986046|NCT01570868|566701376|FG000|Overall Study|Lost to Follow-up|1|||
156986047|NCT01570868|566701377|FG001|Overall Study|Lost to Follow-up|0|||
156986048|NCT01570868|566701376|FG000|Overall Study|Withdrawal by Subject|1|||
156986049|NCT01570868|566701377|FG001|Overall Study|Withdrawal by Subject|0|||
156986050|NCT04936308|566701378|FG000|Overall Study|Death|0|||
156986051|NCT04936308|566701379|FG001|Overall Study|Death|0|||
156986052|NCT04936308|566701380|FG002|Overall Study|Death|1|||
156986053|NCT04936308|566701378|FG000|Overall Study|Withdrawal by Subject|6|||
156986054|NCT04936308|566701379|FG001|Overall Study|Withdrawal by Subject|3|||
156986055|NCT04936308|566701380|FG002|Overall Study|Withdrawal by Subject|0|||
156986056|NCT04936308|566701378|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
156986057|NCT04936308|566701379|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
156986058|NCT04936308|566701380|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
156986059|NCT04936308|566701378|FG000|Overall Study|Completed protocol-required follow-up|1|||
156986060|NCT04936308|566701379|FG001|Overall Study|Completed protocol-required follow-up|2|||
156986061|NCT04936308|566701380|FG002|Overall Study|Completed protocol-required follow-up|2|||
156986062|NCT04936308|566701378|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
156986063|NCT04936308|566701379|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
156986064|NCT04936308|566701380|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
156986065|NCT04936308|566701378|FG000|Overall Study|Other|3|||
156986066|NCT04936308|566701379|FG001|Overall Study|Other|0|||
156986067|NCT04936308|566701380|FG002|Overall Study|Other|2|||
156986068|NCT01556763|566701381|FG000|Overall Study|Withdrawal by Subject|0|||
156986069|NCT01556763|566701382|FG001|Overall Study|Withdrawal by Subject|1|||
156986070|NCT01556763|566701383|FG002|Overall Study|Withdrawal by Subject|0|||
156986071|NCT02258464|566701384|FG000|Overall Study|Progressive disease (PD)|9|||
156986072|NCT02258464|566701385|FG001|Overall Study|Progressive disease (PD)|17|||
156986073|NCT02258464|566701384|FG000|Overall Study|Study drug never administered|1|||
156986074|NCT02258464|566701385|FG001|Overall Study|Study drug never administered|1|||
156986075|NCT02258464|566701384|FG000|Overall Study|AE not related to clinical PD|1|||
156986076|NCT02258464|566701385|FG001|Overall Study|AE not related to clinical PD|3|||
156986077|NCT02258464|566701384|FG000|Overall Study|Withdrawal by Subject|5|||
156986078|NCT02258464|566701385|FG001|Overall Study|Withdrawal by Subject|4|||
156986079|NCT02258464|566701384|FG000|Overall Study|AE related to clinical PD|1|||
156986080|NCT02258464|566701385|FG001|Overall Study|AE related to clinical PD|0|||
156986081|NCT00776100|566701386|FG000|Overall Study|Disease Progression|1|||
156986082|NCT00776100|566701387|FG001|Overall Study|Disease Progression|0|||
156986083|NCT00903786|566701388|FG000|Overall Study|Physician Decision|6|||
156986084|NCT00903786|566701388|FG000|Overall Study|Lack of Efficacy|5|||
156986085|NCT00903786|566701388|FG000|Overall Study|Reason other than lack of efficacy|4|||
156986086|NCT02285595|566701389|FG000|Overall Study|Lost to Follow-up|14|||
156986087|NCT02285595|566701389|FG000|Overall Study|Withdrawal by Subject|1|||
156986088|NCT01960790|566701390|FG000|Overall Study|Survey forms could not be recovered|3|||
156986089|NCT01960790|566701390|FG000|Overall Study|Treat with Humira outside survey period|3|||
156986090|NCT01960790|566701390|FG000|Overall Study|Transferred to another hospital|4|||
156986091|NCT01960790|566701390|FG000|Overall Study|Unevaluable for safety|1|||
156986092|NCT05822921|566701391|FG000|Overall Study|Lost to Follow-up|1|||
156986093|NCT05822921|566701392|FG001|Overall Study|Lost to Follow-up|1|||
156986094|NCT01267253|566701394|FG000|Overall Study|Ineligible - required test not done|1|||
156986095|NCT01267253|566701394|FG000|Overall Study|Inevaluable-never received study treatme|2|||
156986096|NCT00547911|566701400|FG000|Overall Study|Adverse Event|0|||
156986097|NCT00547911|566701401|FG001|Overall Study|Adverse Event|0|||
156986098|NCT00547911|566701402|FG002|Overall Study|Adverse Event|0|||
156986099|NCT00547911|566701403|FG003|Overall Study|Adverse Event|1|||
156986100|NCT00547911|566701404|FG004|Overall Study|Adverse Event|0|||
156986101|NCT00547911|566701405|FG005|Overall Study|Adverse Event|0|||
156986102|NCT04129580|566703038|FG000|Overall Study|Lost to Follow-up|14|||
156986103|NCT04129580|566703039|FG001|Overall Study|Lost to Follow-up|25|||
156986104|NCT03699124|566703040|FG000|Overall Study|Adverse Event|6|||
156986105|NCT03699124|566703041|FG001|Overall Study|Adverse Event|5|||
156986106|NCT03699124|566703042|FG002|Overall Study|Adverse Event|2|||
156986107|NCT03699124|566703040|FG000|Overall Study|Death|0|||
156986108|NCT03699124|566703041|FG001|Overall Study|Death|2|||
156986109|NCT03699124|566703042|FG002|Overall Study|Death|0|||
156986110|NCT03699124|566703040|FG000|Overall Study|Lost to Follow-up|20|||
156986111|NCT03699124|566703041|FG001|Overall Study|Lost to Follow-up|16|||
156986112|NCT03699124|566703042|FG002|Overall Study|Lost to Follow-up|15|||
156986113|NCT03699124|566703040|FG000|Overall Study|Protocol Violation|1|||
156986114|NCT03699124|566703041|FG001|Overall Study|Protocol Violation|0|||
156986115|NCT03699124|566703042|FG002|Overall Study|Protocol Violation|0|||
156986116|NCT03699124|566703040|FG000|Overall Study|Withdrawal by Subject|13|||
156986117|NCT03699124|566703041|FG001|Overall Study|Withdrawal by Subject|14|||
156986118|NCT03699124|566703042|FG002|Overall Study|Withdrawal by Subject|13|||
156986119|NCT03699124|566703040|FG000|Overall Study|Other reasons|5|||
156986120|NCT03699124|566703041|FG001|Overall Study|Other reasons|3|||
156986121|NCT03699124|566703042|FG002|Overall Study|Other reasons|10|||
156986122|NCT03595683|566703043|FG000|Overall Study|Adverse Event|1|||
156986123|NCT03595683|566703044|FG001|Overall Study|Adverse Event|0|||
156986124|NCT03595683|566703043|FG000|Overall Study|Pursue alternative therapy|1|||
156986125|NCT03595683|566703044|FG001|Overall Study|Pursue alternative therapy|1|||
156986126|NCT03595683|566703043|FG000|Overall Study|Progressive disease|1|||
156986127|NCT03595683|566703044|FG001|Overall Study|Progressive disease|3|||
156986128|NCT01254565|566703048|FG000|Overall Study|Non-compliance to Study Procedures|0|||
156986129|NCT01254565|566703049|FG001|Overall Study|Non-compliance to Study Procedures|0|||
156986130|NCT01254565|566703050|FG002|Overall Study|Non-compliance to Study Procedures|0|||
156986131|NCT01254565|566703051|FG003|Overall Study|Non-compliance to Study Procedures|0|||
156986132|NCT01254565|566703052|FG004|Overall Study|Non-compliance to Study Procedures|1|||
156986133|NCT01254565|566703053|FG005|Overall Study|Non-compliance to Study Procedures|0|||
156986134|NCT01254565|566703048|FG000|Overall Study|Did not Receive Treatment|1|||
156986135|NCT01254565|566703049|FG001|Overall Study|Did not Receive Treatment|1|||
156986136|NCT01254565|566703050|FG002|Overall Study|Did not Receive Treatment|0|||
156986137|NCT01254565|566703051|FG003|Overall Study|Did not Receive Treatment|0|||
156986138|NCT01254565|566703052|FG004|Overall Study|Did not Receive Treatment|3|||
156986139|NCT01254565|566703053|FG005|Overall Study|Did not Receive Treatment|4|||
156986140|NCT01254565|566703048|FG000|Overall Study|Other|0|||
156986141|NCT01254565|566703049|FG001|Overall Study|Other|0|||
156986142|NCT01254565|566703050|FG002|Overall Study|Other|0|||
156986143|NCT01254565|566703051|FG003|Overall Study|Other|1|||
156986144|NCT01254565|566703052|FG004|Overall Study|Other|0|||
156986145|NCT01254565|566703053|FG005|Overall Study|Other|0|||
156986146|NCT04006366|566703060|FG000|Overall Study|Withdrawal by Subject|1|||
156986147|NCT02086552|566703061|FG000|Overall Study|Withdrawal by Subject|1|||
156986148|NCT02206152|566703062|FG000|Pre-Randomization|Withdrawal by Subject|2|||
156986149|NCT00478608|566703063|FG000|Overall Study|Adverse Event|1|||
156986150|NCT00478608|566703063|FG000|Overall Study|Serious Adverse Event|14|||
156986151|NCT00478608|566703063|FG000|Overall Study|Withdrawal by Subject|2|||
156986152|NCT00478608|566703063|FG000|Overall Study|Protocol Violation|3|||
156986153|NCT02080520|566703064|FG000|Overall Study|Self-reported symptoms|5|||
156986154|NCT02080520|566703065|FG001|Overall Study|Self-reported symptoms|6|||
156986155|NCT02080520|566703064|FG000|Overall Study|Unable to contact|2|||
156986156|NCT02080520|566703065|FG001|Overall Study|Unable to contact|1|||
156986157|NCT02080520|566703064|FG000|Overall Study|Initiated aspirin|2|||
156986158|NCT02080520|566703065|FG001|Overall Study|Initiated aspirin|0|||
156986159|NCT02080520|566703064|FG000|Overall Study|Atrial fibrillation|1|||
156986160|NCT02080520|566703065|FG001|Overall Study|Atrial fibrillation|1|||
156986161|NCT02080520|566703064|FG000|Overall Study|Cancer|1|||
156986162|NCT02080520|566703065|FG001|Overall Study|Cancer|2|||
156986163|NCT02080520|566703064|FG000|Overall Study|Not interested in study|1|||
156986164|NCT02080520|566703065|FG001|Overall Study|Not interested in study|3|||
156986165|NCT02080520|566703064|FG000|Overall Study|Too busy|1|||
156986166|NCT02080520|566703065|FG001|Overall Study|Too busy|1|||
156986167|NCT02080520|566703064|FG000|Overall Study|Work-related injury|1|||
156986168|NCT02080520|566703065|FG001|Overall Study|Work-related injury|0|||
156986169|NCT02080520|566703064|FG000|Overall Study|Personal reasons|0|||
156986170|NCT02080520|566703065|FG001|Overall Study|Personal reasons|3|||
156986171|NCT00390455|566703066|FG000|Overall Study|Adverse Event|17|||
156986172|NCT00390455|566703067|FG001|Overall Study|Adverse Event|3|||
156986173|NCT00390455|566703066|FG000|Overall Study|Withdrawal by Subject|8|||
156986174|NCT00390455|566703067|FG001|Overall Study|Withdrawal by Subject|8|||
156986175|NCT00390455|566703066|FG000|Overall Study|Alternate Treatment|0|||
156986176|NCT00390455|566703067|FG001|Overall Study|Alternate Treatment|1|||
156986177|NCT00390455|566703066|FG000|Overall Study|Other Medical Reasons|7|||
156986178|NCT00390455|566703067|FG001|Overall Study|Other Medical Reasons|11|||
156986179|NCT02406261|566703070|FG000|Period 1|Lost to Follow-up|2|||
156986180|NCT02406261|566703071|FG001|Period 1|Lost to Follow-up|0|||
156986181|NCT02406261|566703070|FG000|Period 1|Adverse Event|1|||
156986182|NCT02406261|566703071|FG001|Period 1|Adverse Event|0|||
156986183|NCT02406261|566703070|FG000|Period 2|Physician Decision|0|||
156986184|NCT02406261|566703071|FG001|Period 2|Physician Decision|1|||
156986185|NCT02406261|566703070|FG000|Period 2|Protocol Violation|0|||
156986186|NCT02406261|566703071|FG001|Period 2|Protocol Violation|1|||
156986187|NCT02406261|566703070|FG000|Period 2|Withdrawal by Subject|0|||
156986188|NCT02406261|566703071|FG001|Period 2|Withdrawal by Subject|1|||
156986189|NCT00594932|566703079|FG000|First 3 Months|Withdrawal by Subject|1|||
156986190|NCT00594932|566703080|FG001|First 3 Months|Withdrawal by Subject|3|||
156986191|NCT00594932|566703079|FG000|Final 3 Months|Withdrawal by Subject|4|||
156986192|NCT00594932|566703080|FG001|Final 3 Months|Withdrawal by Subject|3|||
156986193|NCT01094171|566703081|FG000|Overall Study|Lost to Follow-up|2|||
156986194|NCT01094171|566703081|FG000|Overall Study|Informed consent withdrawal|4|||
156986195|NCT01094171|566703081|FG000|Overall Study|Migration from the study area|3|||
156986196|NCT01094171|566703081|FG000|Overall Study|Other|1|||
156986197|NCT01536145|566703082|FG000|Overall Study|Progressive disease|3|||
156986198|NCT01536145|566703083|FG001|Overall Study|Progressive disease|4|||
156986199|NCT01536145|566703084|FG002|Overall Study|Progressive disease|1|||
156986200|NCT01536145|566703085|FG003|Overall Study|Progressive disease|2|||
156986201|NCT01536145|566703086|FG004|Overall Study|Progressive disease|1|||
156986202|NCT01536145|566703087|FG005|Overall Study|Progressive disease|2|||
156986203|NCT01536145|566703088|FG006|Overall Study|Progressive disease|1|||
156986204|NCT01536145|566703089|FG007|Overall Study|Progressive disease|2|||
156986205|NCT01536145|566703090|FG008|Overall Study|Progressive disease|1|||
156986206|NCT01536145|566703091|FG009|Overall Study|Progressive disease|3|||
156986207|NCT01536145|566703092|FG010|Overall Study|Progressive disease|3|||
156986208|NCT01536145|566703082|FG000|Overall Study|Withdrawal by Subject|0|||
156986209|NCT01536145|566703083|FG001|Overall Study|Withdrawal by Subject|0|||
156986210|NCT01536145|566703084|FG002|Overall Study|Withdrawal by Subject|1|||
156986211|NCT01536145|566703085|FG003|Overall Study|Withdrawal by Subject|0|||
156986212|NCT01536145|566703086|FG004|Overall Study|Withdrawal by Subject|0|||
156986213|NCT01536145|566703087|FG005|Overall Study|Withdrawal by Subject|1|||
156986214|NCT01536145|566703088|FG006|Overall Study|Withdrawal by Subject|0|||
156986215|NCT01536145|566703089|FG007|Overall Study|Withdrawal by Subject|0|||
156986216|NCT01536145|566703090|FG008|Overall Study|Withdrawal by Subject|2|||
156986217|NCT01536145|566703091|FG009|Overall Study|Withdrawal by Subject|0|||
156986218|NCT01536145|566703092|FG010|Overall Study|Withdrawal by Subject|2|||
156986219|NCT01536145|566703082|FG000|Overall Study|Other|0|||
156986220|NCT01536145|566703083|FG001|Overall Study|Other|0|||
156986221|NCT01536145|566703084|FG002|Overall Study|Other|0|||
156986222|NCT01536145|566703085|FG003|Overall Study|Other|0|||
156986223|NCT01536145|566703086|FG004|Overall Study|Other|1|||
156986224|NCT01536145|566703087|FG005|Overall Study|Other|0|||
156986225|NCT01536145|566703088|FG006|Overall Study|Other|0|||
156986226|NCT01536145|566703089|FG007|Overall Study|Other|0|||
156986227|NCT01536145|566703090|FG008|Overall Study|Other|0|||
156986228|NCT01536145|566703091|FG009|Overall Study|Other|3|||
156986229|NCT01536145|566703092|FG010|Overall Study|Other|2|||
156986230|NCT01536145|566703082|FG000|Overall Study|Death|0|||
156986231|NCT01536145|566703083|FG001|Overall Study|Death|0|||
156986232|NCT01536145|566703084|FG002|Overall Study|Death|0|||
156986233|NCT01536145|566703085|FG003|Overall Study|Death|0|||
156986234|NCT01536145|566703086|FG004|Overall Study|Death|0|||
156986235|NCT01536145|566703087|FG005|Overall Study|Death|0|||
156986236|NCT01536145|566703088|FG006|Overall Study|Death|1|||
156986237|NCT01536145|566703089|FG007|Overall Study|Death|0|||
156986238|NCT01536145|566703090|FG008|Overall Study|Death|0|||
156986239|NCT01536145|566703091|FG009|Overall Study|Death|0|||
156986240|NCT01536145|566703092|FG010|Overall Study|Death|0|||
156986241|NCT01536145|566703082|FG000|Overall Study|Adverse Event|0|||
156986242|NCT01536145|566703083|FG001|Overall Study|Adverse Event|0|||
156986243|NCT01536145|566703084|FG002|Overall Study|Adverse Event|0|||
156986244|NCT01536145|566703085|FG003|Overall Study|Adverse Event|0|||
156986245|NCT01536145|566703086|FG004|Overall Study|Adverse Event|0|||
156986246|NCT01536145|566703087|FG005|Overall Study|Adverse Event|0|||
156986247|NCT01536145|566703088|FG006|Overall Study|Adverse Event|0|||
156986248|NCT01536145|566703089|FG007|Overall Study|Adverse Event|2|||
156986249|NCT01536145|566703090|FG008|Overall Study|Adverse Event|0|||
156986250|NCT01536145|566703091|FG009|Overall Study|Adverse Event|0|||
156986251|NCT01536145|566703092|FG010|Overall Study|Adverse Event|3|||
156986252|NCT00088205|566703097|FG000|Overall Study|Adverse Event|4|||
156986253|NCT00088205|566703097|FG000|Overall Study|Progressive Disease|51|||
156986254|NCT00088205|566703097|FG000|Overall Study|Physician Decision|1|||
156986255|NCT00088205|566703097|FG000|Overall Study|Death Due to Study Disease|4|||
156986256|NCT05199233|566703098|FG000|Overall Study|Lack of Efficacy|1|||
156986257|NCT02491892|566703101|FG000|Overall Study|Adverse Event|1|||
156986258|NCT02491892|566703102|FG001|Overall Study|Adverse Event|1|||
156986259|NCT02491892|566703101|FG000|Overall Study|Death|1|||
156986260|NCT02491892|566703102|FG001|Overall Study|Death|1|||
156986261|NCT02491892|566703101|FG000|Overall Study|Lack of Efficacy|37|||
156986262|NCT02491892|566703102|FG001|Overall Study|Lack of Efficacy|36|||
156986263|NCT02491892|566703101|FG000|Overall Study|Refused Treatment|1|||
156986264|NCT02491892|566703102|FG001|Overall Study|Refused Treatment|0|||
156986265|NCT02491892|566703101|FG000|Overall Study|Lost to Follow-up|1|||
156986266|NCT02491892|566703102|FG001|Overall Study|Lost to Follow-up|0|||
156986267|NCT01734850|566703103|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
156986268|NCT01734850|566703104|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
156986269|NCT01734850|566703105|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
156986270|NCT01734850|566703103|FG000|Overall Study|Not infused due to manufacturing failure|0|||
156986271|NCT01734850|566703104|FG001|Overall Study|Not infused due to manufacturing failure|0|||
156986272|NCT01734850|566703105|FG002|Overall Study|Not infused due to manufacturing failure|1|||
156986273|NCT03824938|566703106|FG000|Overall Study|Withdrawal by Subject|2|||
156986274|NCT03824938|566703107|FG001|Overall Study|Withdrawal by Subject|1|||
156986275|NCT03824938|566703108|FG002|Overall Study|Withdrawal by Subject|0|||
156986276|NCT03824938|566703109|FG003|Overall Study|Withdrawal by Subject|2|||
156986277|NCT03824938|566703110|FG004|Overall Study|Withdrawal by Subject|0|||
156986278|NCT03824938|566703111|FG005|Overall Study|Withdrawal by Subject|1|||
156986279|NCT03824938|566703106|FG000|Overall Study|Lost to Follow-up|0|||
156986280|NCT03824938|566703107|FG001|Overall Study|Lost to Follow-up|1|||
156986281|NCT03824938|566703108|FG002|Overall Study|Lost to Follow-up|0|||
156986282|NCT03824938|566703109|FG003|Overall Study|Lost to Follow-up|0|||
156986283|NCT03824938|566703110|FG004|Overall Study|Lost to Follow-up|1|||
156986284|NCT03824938|566703111|FG005|Overall Study|Lost to Follow-up|0|||
156986285|NCT04496167|566703115|FG000|Overall Study|Adverse Event|6|||
156986286|NCT04496167|566703116|FG001|Overall Study|Adverse Event|2|||
156986287|NCT04496167|566703115|FG000|Overall Study|Withdrawal by Subject|7|||
156986288|NCT04496167|566703116|FG001|Overall Study|Withdrawal by Subject|6|||
156986289|NCT04496167|566703115|FG000|Overall Study|Lost to Follow-up|3|||
156986290|NCT04496167|566703116|FG001|Overall Study|Lost to Follow-up|5|||
156986291|NCT04496167|566703115|FG000|Overall Study|Not Treated|1|||
156986292|NCT04496167|566703116|FG001|Overall Study|Not Treated|2|||
156986293|NCT04496167|566703115|FG000|Overall Study|Other Than Specified|1|||
156986294|NCT04496167|566703116|FG001|Overall Study|Other Than Specified|1|||
156986295|NCT01058863|566703117|FG000|Overall Study|Lost to Follow-up|1|||
156986296|NCT01058863|566703117|FG000|Overall Study|Withdrawal by Subject|1|||
156986297|NCT01058863|566703117|FG000|Overall Study|Sponsor requested withdrawal|1|||
156986298|NCT01058863|566703117|FG000|Overall Study|Randomized in error|1|||
156986299|NCT03050398|566703122|FG000|Overall Study|Study terminated by sponsor|8|||
156986300|NCT05108649|566703123|FG000|Overall Study|Lost to Follow-up|0|||
156986301|NCT05108649|566703124|FG001|Overall Study|Lost to Follow-up|4|||
156986302|NCT05108649|566703125|FG002|Overall Study|Lost to Follow-up|3|||
156986303|NCT05108649|566703126|FG003|Overall Study|Lost to Follow-up|6|||
156986304|NCT05108649|566703123|FG000|Overall Study|Not Interested|1|||
156986305|NCT05108649|566703124|FG001|Overall Study|Not Interested|1|||
156986306|NCT05108649|566703125|FG002|Overall Study|Not Interested|0|||
156986307|NCT05108649|566703126|FG003|Overall Study|Not Interested|1|||
156986308|NCT05108649|566703123|FG000|Overall Study|Out of area|0|||
156986309|NCT05108649|566703124|FG001|Overall Study|Out of area|0|||
156986310|NCT05108649|566703125|FG002|Overall Study|Out of area|0|||
156986311|NCT05108649|566703126|FG003|Overall Study|Out of area|1|||
156986312|NCT05108649|566703123|FG000|Overall Study|PI decision|1|||
156986313|NCT05108649|566703124|FG001|Overall Study|PI decision|0|||
156986314|NCT05108649|566703125|FG002|Overall Study|PI decision|0|||
156986315|NCT05108649|566703126|FG003|Overall Study|PI decision|0|||
156986316|NCT05108649|566703123|FG000|Overall Study|Significant Non-Compliance|0|||
156986317|NCT05108649|566703124|FG001|Overall Study|Significant Non-Compliance|1|||
156986318|NCT05108649|566703125|FG002|Overall Study|Significant Non-Compliance|0|||
156986319|NCT05108649|566703126|FG003|Overall Study|Significant Non-Compliance|0|||
156986320|NCT05108649|566703123|FG000|Overall Study|Unable to adhere to study protocol|0|||
156986321|NCT05108649|566703124|FG001|Overall Study|Unable to adhere to study protocol|2|||
156986322|NCT05108649|566703125|FG002|Overall Study|Unable to adhere to study protocol|0|||
156986323|NCT05108649|566703126|FG003|Overall Study|Unable to adhere to study protocol|0|||
156986324|NCT00918749|566703129|FG000|Overall Study|Adverse Event|1|||
156986325|NCT00918749|566703130|FG001|Overall Study|Adverse Event|0|||
156986326|NCT00918749|566703131|FG002|Overall Study|Adverse Event|1|||
156986327|NCT00918749|566703129|FG000|Overall Study|Lost to Follow-up|0|||
156986328|NCT00918749|566703130|FG001|Overall Study|Lost to Follow-up|0|||
156986329|NCT00918749|566703131|FG002|Overall Study|Lost to Follow-up|1|||
156986330|NCT00918749|566703129|FG000|Overall Study|Withdrawal by Subject|5|||
156986331|NCT00918749|566703130|FG001|Overall Study|Withdrawal by Subject|3|||
156986332|NCT00918749|566703131|FG002|Overall Study|Withdrawal by Subject|5|||
156986333|NCT00918749|566703129|FG000|Overall Study|No Study Medication Taken|1|||
156986334|NCT00918749|566703130|FG001|Overall Study|No Study Medication Taken|0|||
156986335|NCT00918749|566703131|FG002|Overall Study|No Study Medication Taken|0|||
156986336|NCT01712789|566703132|FG000|Overall Study|Lack of Efficacy|2|||
156986337|NCT01712789|566703132|FG000|Overall Study|Lost to Follow-up|1|||
156986338|NCT01712789|566703132|FG000|Overall Study|Progressive Disease|504|||
156986339|NCT01712789|566703132|FG000|Overall Study|Death|57|||
156986340|NCT01712789|566703132|FG000|Overall Study|Adverse Event|52|||
156986341|NCT01712789|566703132|FG000|Overall Study|Miscellaneous|31|||
156986342|NCT01712789|566703132|FG000|Overall Study|Withdrawal by Subject|21|||
156986343|NCT01712789|566703132|FG000|Overall Study|Transition to Commercial Treatment|8|||
156986344|NCT01712789|566703132|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
156986345|NCT03018106|566703133|FG000|Overall Study|Lost to Follow-up|0|||
156986346|NCT03018106|566703134|FG001|Overall Study|Lost to Follow-up|1|||
156986347|NCT01010217|566703135|FG000|Overall Study|Lost to Follow-up|4|||
156986348|NCT01010217|566703136|FG001|Overall Study|Lost to Follow-up|5|||
156986349|NCT01010217|566703137|FG002|Overall Study|Lost to Follow-up|1|||
156986350|NCT01010217|566703138|FG003|Overall Study|Lost to Follow-up|0|||
156986351|NCT01010217|566703139|FG004|Overall Study|Lost to Follow-up|0|||
156986352|NCT01010217|566703135|FG000|Overall Study|Withdrawal by Subject|1|||
156986353|NCT01010217|566703136|FG001|Overall Study|Withdrawal by Subject|0|||
156986354|NCT01010217|566703137|FG002|Overall Study|Withdrawal by Subject|0|||
156986355|NCT01010217|566703138|FG003|Overall Study|Withdrawal by Subject|0|||
156986356|NCT01010217|566703139|FG004|Overall Study|Withdrawal by Subject|0|||
156986357|NCT01010217|566703135|FG000|Overall Study|Physician Decision|0|||
156986358|NCT01010217|566703136|FG001|Overall Study|Physician Decision|0|||
157096867|NCT04677179|567109278|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
157096868|NCT04677179|567109279|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
157096869|NCT04677179|567109280|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
157096870|NCT04677179|567109281|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156986359|NCT01010217|566703137|FG002|Overall Study|Physician Decision|0|||
156986360|NCT01010217|566703138|FG003|Overall Study|Physician Decision|6|||
156986361|NCT01010217|566703139|FG004|Overall Study|Physician Decision|3|||
156986362|NCT02213055|566703142|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
156986363|NCT02213055|566703143|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
156986364|NCT02213055|566703142|FG000|Overall Study|Protocol was not Followed during Study|1|||
156986365|NCT02213055|566703143|FG001|Overall Study|Protocol was not Followed during Study|0|||
156986366|NCT02213055|566703142|FG000|Overall Study|Documentation Issue at Enrollment|1|||
156986367|NCT02213055|566703143|FG001|Overall Study|Documentation Issue at Enrollment|0|||
156986368|NCT02213055|566703142|FG000|Overall Study|Documentation Issue during Study|10|||
156986369|NCT02213055|566703143|FG001|Overall Study|Documentation Issue during Study|0|||
156986370|NCT02213055|566703142|FG000|Overall Study|Did not have Live Lice|8|||
156986371|NCT02213055|566703143|FG001|Overall Study|Did not have Live Lice|0|||
156986372|NCT02213055|566703142|FG000|Overall Study|Had another Treatment during the Study|3|||
156986373|NCT02213055|566703143|FG001|Overall Study|Had another Treatment during the Study|0|||
156986374|NCT02213055|566703142|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
156986375|NCT02213055|566703143|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
156986376|NCT02213055|566703142|FG000|Overall Study|Did not Return to School|5|||
156986377|NCT02213055|566703143|FG001|Overall Study|Did not Return to School|0|||
156986378|NCT01024751|566703145|FG000|Enrolled Participants|Ineligible at baseline|3|||
156986379|NCT01024751|566703146|FG001|Enrolled Participants|Ineligible at baseline|4|||
156986380|NCT01024751|566703145|FG000|Eligible Participants|Withdrawal by Subject|0|||
156986381|NCT01024751|566703146|FG001|Eligible Participants|Withdrawal by Subject|1|||
156986382|NCT01024751|566703145|FG000|Eligible Participants|Lost to Follow-up|0|||
156986383|NCT01024751|566703146|FG001|Eligible Participants|Lost to Follow-up|1|||
156986384|NCT01024751|566703145|FG000|Eligible Participants|Ineligible|0|||
156986385|NCT01024751|566703146|FG001|Eligible Participants|Ineligible|1|||
156986386|NCT00577720|566703152|FG000|Overall Study|Adverse Event|2|||
156986387|NCT00577720|566703153|FG001|Overall Study|Adverse Event|1|||
156986388|NCT00577720|566703154|FG002|Overall Study|Adverse Event|0|||
157096871|NCT04677179|567109282|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156986389|NCT00577720|566703155|FG003|Overall Study|Adverse Event|4|||
156986390|NCT00577720|566703152|FG000|Overall Study|Lost to Follow-up|0|||
156986391|NCT00577720|566703153|FG001|Overall Study|Lost to Follow-up|0|||
156986392|NCT00577720|566703154|FG002|Overall Study|Lost to Follow-up|1|||
156986393|NCT00577720|566703155|FG003|Overall Study|Lost to Follow-up|0|||
156986394|NCT00577720|566703152|FG000|Overall Study|Protocol Violation|0|||
156986395|NCT00577720|566703153|FG001|Overall Study|Protocol Violation|0|||
156986396|NCT00577720|566703154|FG002|Overall Study|Protocol Violation|0|||
156986397|NCT00577720|566703155|FG003|Overall Study|Protocol Violation|1|||
156986398|NCT00577720|566703152|FG000|Overall Study|Withdrawal by Subject|2|||
156986399|NCT00577720|566703153|FG001|Overall Study|Withdrawal by Subject|0|||
156986400|NCT00577720|566703154|FG002|Overall Study|Withdrawal by Subject|0|||
156986401|NCT00577720|566703155|FG003|Overall Study|Withdrawal by Subject|2|||
156986402|NCT03246672|566703158|FG000|Overall Study|Lost to Follow-up|2|||
156986403|NCT03260504|566703159|FG000|Overall Study|Adverse Event|0|||
156986404|NCT03260504|566703160|FG001|Overall Study|Adverse Event|1|||
156986405|NCT01932996|566703161|FG000|Overall Study|Protocol Violation|2|||
156986406|NCT01932996|566703162|FG001|Overall Study|Protocol Violation|0|||
156986407|NCT00846742|566703165|FG000|Overall Study|Withdrawal by Subject|1|||
156986408|NCT03257995|566703166|FG000|Overall Study|Adverse Event|0|||
156986409|NCT03257995|566703167|FG001|Overall Study|Adverse Event|1|||
156986410|NCT03257995|566703168|FG002|Overall Study|Adverse Event|0|||
156986411|NCT03257995|566703169|FG003|Overall Study|Adverse Event|0|||
156986412|NCT03257995|566703170|FG004|Overall Study|Adverse Event|0|||
156986413|NCT03257995|566703171|FG005|Overall Study|Adverse Event|0|||
156986414|NCT03257995|566703166|FG000|Overall Study|Protocol deviation|0|||
156986415|NCT03257995|566703167|FG001|Overall Study|Protocol deviation|0|||
156986416|NCT03257995|566703168|FG002|Overall Study|Protocol deviation|0|||
156986417|NCT03257995|566703169|FG003|Overall Study|Protocol deviation|0|||
156986418|NCT03257995|566703170|FG004|Overall Study|Protocol deviation|0|||
156986419|NCT03257995|566703171|FG005|Overall Study|Protocol deviation|2|||
156986420|NCT02275533|566703172|FG000|Overall Study|Protocol Violation|2|||
156986421|NCT02275533|566703173|FG001|Overall Study|Protocol Violation|0|||
156986422|NCT02275533|566703172|FG000|Overall Study|Never received study treatment|1|||
156986423|NCT02275533|566703173|FG001|Overall Study|Never received study treatment|0|||
156986424|NCT00195715|566703174|FG000|Overall Study|Adverse Event|122|||
156986425|NCT00195715|566703174|FG000|Overall Study|Withdrawal by Subject|58|||
156986426|NCT00195715|566703174|FG000|Overall Study|Lost to Follow-up|27|||
156986427|NCT00195715|566703174|FG000|Overall Study|Protocol Violation|13|||
156986428|NCT00195715|566703174|FG000|Overall Study|Lack of Efficacy|93|||
156986429|NCT00195715|566703174|FG000|Overall Study|Pregnancy|14|||
156986430|NCT00195715|566703174|FG000|Overall Study|Investigative site closure|8|||
156986431|NCT00195715|566703174|FG000|Overall Study|Subject moved/relocated|7|||
156986432|NCT00195715|566703174|FG000|Overall Study|Subject non-compliance|6|||
156986433|NCT00195715|566703174|FG000|Overall Study|Subject started commercial Humira|5|||
156986434|NCT00195715|566703174|FG000|Overall Study|Subject choice|3|||
156986435|NCT00195715|566703174|FG000|Overall Study|Loss of response/no improvement|3|||
156986436|NCT00195715|566703174|FG000|Overall Study|Sponsor stopped study|1|||
156986437|NCT00195715|566703174|FG000|Overall Study|Administrative reasons|2|||
156986438|NCT00195715|566703174|FG000|Overall Study|Investigator's decision|2|||
156986439|NCT00195715|566703174|FG000|Overall Study|Subject wants to get pregnant|4|||
156986440|NCT00195715|566703174|FG000|Overall Study|Use of prohibited medication|2|||
156986441|NCT00195715|566703174|FG000|Overall Study|Planned surgery|2|||
156986442|NCT00195715|566703174|FG000|Overall Study|Increased infection rate|1|||
156986443|NCT00195715|566703174|FG000|Overall Study|Ineligible|1|||
156986444|NCT00195715|566703174|FG000|Overall Study|Colonic stricture|1|||
156986445|NCT00195715|566703174|FG000|Overall Study|Sponsor discontinued trial|1|||
156986446|NCT00195715|566703174|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
156986447|NCT02036515|566703181|FG000|Overall Study|Adverse Event|1|||
156986448|NCT02036515|566703182|FG001|Overall Study|Adverse Event|1|||
156986449|NCT02036515|566703183|FG002|Overall Study|Adverse Event|2|||
156986450|NCT02036515|566703181|FG000|Overall Study|Lost to Follow-up|0|||
156986451|NCT02036515|566703182|FG001|Overall Study|Lost to Follow-up|2|||
156986452|NCT02036515|566703183|FG002|Overall Study|Lost to Follow-up|0|||
156986453|NCT02036515|566703181|FG000|Overall Study|Non-compliance with study drug|0|||
156986454|NCT02036515|566703182|FG001|Overall Study|Non-compliance with study drug|0|||
156986455|NCT02036515|566703183|FG002|Overall Study|Non-compliance with study drug|2|||
156986456|NCT02036515|566703181|FG000|Overall Study|Screen failure|0|||
156986457|NCT02036515|566703182|FG001|Overall Study|Screen failure|2|||
156986458|NCT02036515|566703183|FG002|Overall Study|Screen failure|0|||
156986459|NCT02036515|566703181|FG000|Overall Study|Withdrawal by Subject|4|||
156986460|NCT02036515|566703182|FG001|Overall Study|Withdrawal by Subject|7|||
156986461|NCT02036515|566703183|FG002|Overall Study|Withdrawal by Subject|9|||
156986462|NCT02036515|566703181|FG000|Overall Study|Hyperglycemia|0|||
156986463|NCT02036515|566703182|FG001|Overall Study|Hyperglycemia|0|||
156986464|NCT02036515|566703183|FG002|Overall Study|Hyperglycemia|1|||
156986465|NCT00513019|566704397|FG000|Overall Study|Adverse Event|1|||
156986466|NCT00513019|566704398|FG001|Overall Study|Adverse Event|0|||
156986467|NCT00513019|566704397|FG000|Overall Study|Withdrawal by Subject|4|||
156986468|NCT00513019|566704398|FG001|Overall Study|Withdrawal by Subject|5|||
156986469|NCT02561455|566704400|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
156986470|NCT02561455|566704401|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
156986471|NCT02561455|566704402|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
156986472|NCT02561455|566704403|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
156986473|NCT02561455|566704400|FG000|Overall Study|Withdrawal by Subject|1|||
156986474|NCT02561455|566704401|FG001|Overall Study|Withdrawal by Subject|0|||
156986475|NCT02561455|566704402|FG002|Overall Study|Withdrawal by Subject|1|||
156986476|NCT02561455|566704403|FG003|Overall Study|Withdrawal by Subject|0|||
156986477|NCT02561455|566704400|FG000|Overall Study|Disease Progression|0|||
156986478|NCT02561455|566704401|FG001|Overall Study|Disease Progression|1|||
156986479|NCT02561455|566704402|FG002|Overall Study|Disease Progression|0|||
156986480|NCT02561455|566704403|FG003|Overall Study|Disease Progression|0|||
156986481|NCT00472186|566704407|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
156986482|NCT00472186|566704408|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
156986483|NCT03354637|566704409|FG000|Double-blind Period|Protocol Violation|2|||
156986484|NCT03354637|566704410|FG001|Double-blind Period|Protocol Violation|0|||
156986485|NCT03354637|566704411|FG002|Double-blind Period|Protocol Violation|0|||
156986486|NCT03354637|566704409|FG000|Double-blind Period|Adverse Event|1|||
156986487|NCT03354637|566704410|FG001|Double-blind Period|Adverse Event|2|||
156986488|NCT03354637|566704411|FG002|Double-blind Period|Adverse Event|0|||
156986489|NCT03354637|566704409|FG000|Double-blind Period|Lost to Follow-up|3|||
156986490|NCT03354637|566704410|FG001|Double-blind Period|Lost to Follow-up|4|||
156986491|NCT03354637|566704411|FG002|Double-blind Period|Lost to Follow-up|3|||
156986492|NCT03354637|566704409|FG000|Double-blind Period|Withdrawal by Subject|10|||
156986493|NCT03354637|566704410|FG001|Double-blind Period|Withdrawal by Subject|6|||
156986494|NCT03354637|566704411|FG002|Double-blind Period|Withdrawal by Subject|4|||
156986495|NCT03354637|566704409|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
156986496|NCT03354637|566704410|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
156986497|NCT03354637|566704411|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
156986498|NCT03354637|566704409|FG000|Open Label Extension|Adverse Event|0|||
156986499|NCT03354637|566704410|FG001|Open Label Extension|Adverse Event|0|||
156986500|NCT03354637|566704411|FG002|Open Label Extension|Adverse Event|1|||
156986501|NCT03354637|566704409|FG000|Open Label Extension|Lost to Follow-up|0|||
156986502|NCT03354637|566704410|FG001|Open Label Extension|Lost to Follow-up|0|||
156986503|NCT03354637|566704411|FG002|Open Label Extension|Lost to Follow-up|2|||
156986504|NCT03354637|566704409|FG000|Open Label Extension|Withdrawal by Subject|0|||
156986505|NCT03354637|566704410|FG001|Open Label Extension|Withdrawal by Subject|0|||
156986506|NCT03354637|566704411|FG002|Open Label Extension|Withdrawal by Subject|5|||
156986507|NCT03354637|566704409|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
156986508|NCT03354637|566704410|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
156986509|NCT03354637|566704411|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
156986510|NCT03354637|566704409|FG000|Open Label Extension|Subject Noncompliance|0|||
156986511|NCT03354637|566704410|FG001|Open Label Extension|Subject Noncompliance|0|||
156986512|NCT03354637|566704411|FG002|Open Label Extension|Subject Noncompliance|1|||
156986513|NCT03354637|566704409|FG000|Open Label Extension|Lack of Efficacy|0|||
156986514|NCT03354637|566704410|FG001|Open Label Extension|Lack of Efficacy|0|||
156986515|NCT03354637|566704411|FG002|Open Label Extension|Lack of Efficacy|1|||
156986516|NCT03354637|566704409|FG000|Open Label Extension|Physician Decision|0|||
156986517|NCT03354637|566704410|FG001|Open Label Extension|Physician Decision|0|||
156986518|NCT03354637|566704411|FG002|Open Label Extension|Physician Decision|1|||
156986519|NCT02726399|566704412|FG000|Overall Study|Participant Non-Compliance|1|||
156986520|NCT02726399|566704412|FG000|Overall Study|Adverse Event|2|||
156986521|NCT02726399|566704412|FG000|Overall Study|Progression of disease|4|||
156986522|NCT00997243|566704419|FG000|Overall Study|Early termination of study by sponsor|7|||
156986523|NCT03415022|566704428|FG000|Overall Study|Withdrawal by Subject|1|||
156986524|NCT03415022|566704429|FG001|Overall Study|Withdrawal by Subject|2|||
156986525|NCT03415022|566704428|FG000|Overall Study|COVID-19 Suspension|2|||
156986526|NCT03415022|566704429|FG001|Overall Study|COVID-19 Suspension|3|||
156986527|NCT03415022|566704428|FG000|Overall Study|Lost to Follow-up|2|||
156986528|NCT03415022|566704429|FG001|Overall Study|Lost to Follow-up|0|||
156986529|NCT03583541|566704433|FG000|Overall Study|Lost to Follow-up|31|||
156986530|NCT03583541|566704434|FG001|Overall Study|Lost to Follow-up|65|||
156986531|NCT00884286|566704436|FG000|Overall Study|Progressive disease|21|||
156986532|NCT00884286|566704437|FG001|Overall Study|Progressive disease|28|||
156986533|NCT00884286|566704436|FG000|Overall Study|Toxicity|4|||
156986534|NCT00884286|566704437|FG001|Overall Study|Toxicity|1|||
156986535|NCT00884286|566704436|FG000|Overall Study|Death|2|||
156986536|NCT00884286|566704437|FG001|Overall Study|Death|2|||
156986537|NCT00884286|566704436|FG000|Overall Study|Physician Decision|1|||
156986538|NCT00884286|566704437|FG001|Overall Study|Physician Decision|0|||
156986539|NCT00884286|566704436|FG000|Overall Study|Septic shock|1|||
156986540|NCT00884286|566704437|FG001|Overall Study|Septic shock|0|||
156986541|NCT00884286|566704436|FG000|Overall Study|Thrombus in right auricle|1|||
156986542|NCT00884286|566704437|FG001|Overall Study|Thrombus in right auricle|0|||
156986543|NCT00884286|566704436|FG000|Overall Study|Not treated|2|||
156986544|NCT00884286|566704437|FG001|Overall Study|Not treated|1|||
156986545|NCT00884286|566704436|FG000|Overall Study|Comprised lung carcinoma|0|||
156986546|NCT00884286|566704437|FG001|Overall Study|Comprised lung carcinoma|1|||
156986547|NCT01196104|566704438|FG000|Overall Study|Lost to Follow-up|1|||
156986548|NCT01196104|566704439|FG001|Overall Study|Lost to Follow-up|0|||
156986549|NCT01196104|566704438|FG000|Overall Study|Physician Decision|0|||
156986550|NCT01196104|566704439|FG001|Overall Study|Physician Decision|1|||
156986551|NCT01196104|566704438|FG000|Overall Study|Withdrawal by Subject|3|||
156986552|NCT01196104|566704439|FG001|Overall Study|Withdrawal by Subject|3|||
156986553|NCT01196104|566704438|FG000|Overall Study|Various|0|||
156986554|NCT01196104|566704439|FG001|Overall Study|Various|1|||
156986555|NCT00065468|566704442|FG000|Overall Study|Death|172|||
156986556|NCT00065468|566704443|FG001|Overall Study|Death|169|||
156986557|NCT00065468|566704444|FG002|Overall Study|Death|171|||
156986558|NCT00065468|566704442|FG000|Overall Study|Withdrawal by Subject|3|||
156986559|NCT00065468|566704443|FG001|Overall Study|Withdrawal by Subject|4|||
156986560|NCT00065468|566704444|FG002|Overall Study|Withdrawal by Subject|5|||
156986561|NCT00065468|566704442|FG000|Overall Study|Lost to Follow-up|5|||
156986562|NCT00065468|566704443|FG001|Overall Study|Lost to Follow-up|3|||
156986563|NCT00065468|566704444|FG002|Overall Study|Lost to Follow-up|2|||
156986564|NCT00065468|566704442|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
156986565|NCT00065468|566704443|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
156986566|NCT00065468|566704444|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
156986567|NCT00065468|566704442|FG000|Overall Study|Disease progression|0|||
156986568|NCT00065468|566704443|FG001|Overall Study|Disease progression|0|||
156986569|NCT00065468|566704444|FG002|Overall Study|Disease progression|1|||
156986570|NCT00065468|566704442|FG000|Overall Study|Other|14|||
156986571|NCT00065468|566704443|FG001|Overall Study|Other|24|||
156986572|NCT00065468|566704444|FG002|Overall Study|Other|18|||
156986573|NCT02025205|566704445|FG000|Overall Study|Withdrawal by Subject|1|||
156986574|NCT02025205|566704446|FG001|Overall Study|Withdrawal by Subject|1|||
156986575|NCT02025205|566704445|FG000|Overall Study|Protocol Violation|2|||
156986576|NCT02025205|566704446|FG001|Overall Study|Protocol Violation|1|||
156986577|NCT02025205|566704445|FG000|Overall Study|Death|0|||
156986578|NCT02025205|566704446|FG001|Overall Study|Death|1|||
156986579|NCT02448719|566704449|FG000|Overall Study|Withdrawal by Subject|0|||
156986580|NCT02448719|566704450|FG001|Overall Study|Withdrawal by Subject|0|||
156986581|NCT02448719|566704451|FG002|Overall Study|Withdrawal by Subject|0|||
156986582|NCT02448719|566704452|FG003|Overall Study|Withdrawal by Subject|0|||
156986583|NCT02448719|566704453|FG004|Overall Study|Withdrawal by Subject|1|||
156986584|NCT02448719|566704454|FG005|Overall Study|Withdrawal by Subject|0|||
156986585|NCT02448719|566704455|FG006|Overall Study|Withdrawal by Subject|0|||
156986586|NCT02448719|566704456|FG007|Overall Study|Withdrawal by Subject|0|||
156986587|NCT02448719|566704457|FG008|Overall Study|Withdrawal by Subject|0|||
156986588|NCT02448719|566704458|FG009|Overall Study|Withdrawal by Subject|0|||
156986589|NCT02448719|566704459|FG010|Overall Study|Withdrawal by Subject|0|||
156986590|NCT00932646|566704462|FG000|Overall Study|Adverse Event|2|||
156986591|NCT00932646|566704463|FG001|Overall Study|Adverse Event|1|||
156986592|NCT00932646|566704464|FG002|Overall Study|Adverse Event|1|||
156986593|NCT00932646|566704465|FG003|Overall Study|Adverse Event|1|||
156986594|NCT00932646|566704462|FG000|Overall Study|Lost to Follow-up|2|||
156986595|NCT00932646|566704463|FG001|Overall Study|Lost to Follow-up|1|||
156986596|NCT00932646|566704464|FG002|Overall Study|Lost to Follow-up|0|||
156986597|NCT00932646|566704465|FG003|Overall Study|Lost to Follow-up|0|||
156986598|NCT00932646|566704462|FG000|Overall Study|Withdrawal by Subject|1|||
156986599|NCT00932646|566704463|FG001|Overall Study|Withdrawal by Subject|1|||
156986600|NCT00932646|566704464|FG002|Overall Study|Withdrawal by Subject|3|||
156986601|NCT00932646|566704465|FG003|Overall Study|Withdrawal by Subject|0|||
156986602|NCT00653263|566704466|FG000|Overall Study|Withdrawal by Subject|1|||
156986603|NCT00653263|566704466|FG000|Overall Study|Physician Decision|1|||
156986604|NCT03500172|566704469|FG000|Period 1: Baseline Randomization|Death|0|||
156986605|NCT03500172|566704470|FG001|Period 1: Baseline Randomization|Death|0|||
156986606|NCT03500172|566704471|FG002|Period 1: Baseline Randomization|Death|0|||
156986607|NCT03500172|566704472|FG003|Period 1: Baseline Randomization|Death|0|||
156986608|NCT03500172|566704473|FG004|Period 1: Baseline Randomization|Death|0|||
156986609|NCT03500172|566704474|FG005|Period 1: Baseline Randomization|Death|0|||
156986610|NCT03500172|566704475|FG006|Period 1: Baseline Randomization|Death|0|||
156986611|NCT03500172|566704476|FG007|Period 1: Baseline Randomization|Death|0|||
156986612|NCT03500172|566704477|FG008|Period 1: Baseline Randomization|Death|0|||
156986613|NCT03500172|566704478|FG009|Period 1: Baseline Randomization|Death|2|||
156986614|NCT03500172|566704479|FG010|Period 1: Baseline Randomization|Death|0|||
156986615|NCT03500172|566704469|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
156986616|NCT03500172|566704470|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
156986617|NCT03500172|566704471|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
156986618|NCT03500172|566704472|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
156986619|NCT03500172|566704473|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
156986620|NCT03500172|566704474|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
156986621|NCT03500172|566704475|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
156986622|NCT03500172|566704476|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
156986623|NCT03500172|566704477|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
156986624|NCT03500172|566704478|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
156986625|NCT03500172|566704479|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
156986626|NCT03500172|566704469|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
156986627|NCT03500172|566704470|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
156986628|NCT03500172|566704471|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
156986629|NCT03500172|566704472|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
156986630|NCT03500172|566704473|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
156986631|NCT03500172|566704474|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
156986632|NCT03500172|566704475|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
156986633|NCT03500172|566704476|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
156986634|NCT03500172|566704477|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
156986635|NCT03500172|566704478|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
156986636|NCT03500172|566704479|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
156986637|NCT03500172|566704469|FG000|Period 2: Re-Randomization|Death|0|||
156986638|NCT03500172|566704470|FG001|Period 2: Re-Randomization|Death|0|||
156986639|NCT03500172|566704471|FG002|Period 2: Re-Randomization|Death|0|||
156986640|NCT03500172|566704472|FG003|Period 2: Re-Randomization|Death|4|||
156986641|NCT03500172|566704473|FG004|Period 2: Re-Randomization|Death|2|||
156986642|NCT03500172|566704474|FG005|Period 2: Re-Randomization|Death|0|||
156986643|NCT03500172|566704475|FG006|Period 2: Re-Randomization|Death|5|||
156986644|NCT03500172|566704476|FG007|Period 2: Re-Randomization|Death|2|||
156986645|NCT03500172|566704477|FG008|Period 2: Re-Randomization|Death|0|||
156986646|NCT03500172|566704478|FG009|Period 2: Re-Randomization|Death|0|||
156986647|NCT03500172|566704479|FG010|Period 2: Re-Randomization|Death|0|||
156986648|NCT04759885|566704482|FG000|Overall Study|Other|1|||
156986649|NCT04759885|566704483|FG001|Overall Study|Other|0|||
156986650|NCT04759885|566704484|FG002|Overall Study|Other|2|||
156986651|NCT04759885|566704485|FG003|Overall Study|Other|0|||
156986652|NCT04759885|566704486|FG004|Overall Study|Other|0|||
156986653|NCT04759885|566704482|FG000|Overall Study|Withdrawal by Subject|0|||
156986654|NCT04759885|566704483|FG001|Overall Study|Withdrawal by Subject|0|||
156986655|NCT04759885|566704484|FG002|Overall Study|Withdrawal by Subject|1|||
156986656|NCT04759885|566704485|FG003|Overall Study|Withdrawal by Subject|9|||
156986657|NCT04759885|566704486|FG004|Overall Study|Withdrawal by Subject|6|||
156986658|NCT04759885|566704482|FG000|Overall Study|Adverse Event|0|||
156986659|NCT04759885|566704483|FG001|Overall Study|Adverse Event|0|||
156986660|NCT04759885|566704484|FG002|Overall Study|Adverse Event|0|||
156986661|NCT04759885|566704485|FG003|Overall Study|Adverse Event|3|||
156986662|NCT04759885|566704486|FG004|Overall Study|Adverse Event|0|||
156986663|NCT04759885|566704482|FG000|Overall Study|Physician Decision|0|||
156986664|NCT04759885|566704483|FG001|Overall Study|Physician Decision|0|||
156986665|NCT04759885|566704484|FG002|Overall Study|Physician Decision|0|||
156986666|NCT04759885|566704485|FG003|Overall Study|Physician Decision|2|||
156986667|NCT04759885|566704486|FG004|Overall Study|Physician Decision|0|||
156986668|NCT00544544|566704487|FG000|Overall Study|Withdrawal by Subject|1|||
156986669|NCT00544544|566704487|FG000|Overall Study|Adverse Event|1|||
156986670|NCT00544544|566704487|FG000|Overall Study|Lost to Follow-up|1|||
156986671|NCT00996580|566704488|FG000|Overall Study|Adverse Event|466|||
156986672|NCT00996580|566704488|FG000|Overall Study|Lost to Follow-up|480|||
156986673|NCT00996580|566704488|FG000|Overall Study|Noncompliance with the protocol|137|||
156986674|NCT00996580|566704488|FG000|Overall Study|Physician Decision|5|||
156986675|NCT00996580|566704488|FG000|Overall Study|Pregnancy|68|||
156986676|NCT00996580|566704488|FG000|Overall Study|Protocol Violation|16|||
156986677|NCT00996580|566704488|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
156986678|NCT00996580|566704488|FG000|Overall Study|Withdrawal by Subject|217|||
156986679|NCT00996580|566704488|FG000|Overall Study|Other|29|||
156986680|NCT02218489|566704489|FG000|Overall Study|Withdrawal by Subject|4|||
156986681|NCT02218489|566704490|FG001|Overall Study|Withdrawal by Subject|3|||
156986682|NCT02218489|566704489|FG000|Overall Study|Lost to Follow-up|1|||
156986683|NCT02218489|566704490|FG001|Overall Study|Lost to Follow-up|0|||
156986684|NCT01778062|566704491|FG000|Overall Study|Adverse Event|1|||
156986685|NCT01778062|566704492|FG001|Overall Study|Adverse Event|3|||
156986686|NCT01778062|566704491|FG000|Overall Study|Consent Withdrawal|1|||
156986687|NCT01778062|566704492|FG001|Overall Study|Consent Withdrawal|5|||
156986688|NCT01778062|566704491|FG000|Overall Study|major protocol deviation|4|||
156986689|NCT01778062|566704492|FG001|Overall Study|major protocol deviation|3|||
156986690|NCT03958630|566704493|FG000|Overall Study|Withdrawal by Subject|0|||
156986691|NCT03958630|566704494|FG001|Overall Study|Withdrawal by Subject|0|||
156986692|NCT03958630|566704495|FG002|Overall Study|Withdrawal by Subject|1|||
156986693|NCT03958630|566704493|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
156986694|NCT03958630|566704494|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
156986695|NCT03958630|566704495|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
156986696|NCT04039503|566704496|FG000|Overall Study|Adverse Event|3|||
156986697|NCT04039503|566704497|FG001|Overall Study|Adverse Event|0|||
156986698|NCT04039503|566704498|FG002|Overall Study|Adverse Event|2|||
156986699|NCT04039503|566704499|FG003|Overall Study|Adverse Event|0|||
156986700|NCT04039503|566704496|FG000|Overall Study|Lost to Follow-up|0|||
156986701|NCT04039503|566704497|FG001|Overall Study|Lost to Follow-up|0|||
156986702|NCT04039503|566704498|FG002|Overall Study|Lost to Follow-up|1|||
156986703|NCT04039503|566704499|FG003|Overall Study|Lost to Follow-up|0|||
156986704|NCT04039503|566704496|FG000|Overall Study|Protocol Violation|0|||
156986705|NCT04039503|566704497|FG001|Overall Study|Protocol Violation|1|||
156986706|NCT04039503|566704498|FG002|Overall Study|Protocol Violation|2|||
156986707|NCT04039503|566704499|FG003|Overall Study|Protocol Violation|1|||
156986708|NCT04039503|566704496|FG000|Overall Study|Withdrawal by Subject|4|||
156986709|NCT04039503|566704497|FG001|Overall Study|Withdrawal by Subject|3|||
156986710|NCT04039503|566704498|FG002|Overall Study|Withdrawal by Subject|5|||
156986711|NCT04039503|566704499|FG003|Overall Study|Withdrawal by Subject|2|||
156986712|NCT01671748|566704500|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
156986713|NCT01671748|566704501|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
156986714|NCT01671748|566704500|FG000|4 Week run-in Phase|Adverse Event|1|||
156986715|NCT01671748|566704501|FG001|4 Week run-in Phase|Adverse Event|0|||
156986716|NCT01671748|566704500|FG000|4 Week run-in Phase|Not eligible|9|||
156986717|NCT01671748|566704501|FG001|4 Week run-in Phase|Not eligible|0|||
156986718|NCT03872388|566704504|FG000|Overall Study|Disease Progression|0|||
156986719|NCT03872388|566704505|FG001|Overall Study|Disease Progression|0|||
156986720|NCT03872388|566704506|FG002|Overall Study|Disease Progression|0|||
156986721|NCT03872388|566704507|FG003|Overall Study|Disease Progression|0|||
156986722|NCT03872388|566704508|FG004|Overall Study|Disease Progression|0|||
156986723|NCT03872388|566704509|FG005|Overall Study|Disease Progression|0|||
156986724|NCT03872388|566704510|FG006|Overall Study|Disease Progression|1|||
156986725|NCT03872388|566704511|FG007|Overall Study|Disease Progression|1|||
156986726|NCT02601937|566704512|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986727|NCT02601937|566704513|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986728|NCT02601937|566704514|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986729|NCT02601937|566704515|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986730|NCT02601937|566704516|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986731|NCT02601937|566704517|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
156986732|NCT02601937|566704518|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986733|NCT02601937|566704519|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986734|NCT02601937|566704520|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986735|NCT02601937|566704521|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986736|NCT02601937|566704522|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
156986737|NCT02601937|566704512|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
156986738|NCT02601937|566704513|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986739|NCT02601937|566704514|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986740|NCT02601937|566704515|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986741|NCT02601937|566704516|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986742|NCT02601937|566704517|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986743|NCT02601937|566704518|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
156986744|NCT02601937|566704519|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986745|NCT02601937|566704520|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986746|NCT02601937|566704521|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986747|NCT02601937|566704522|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
156986748|NCT02601937|566704512|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986749|NCT02601937|566704513|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986750|NCT02601937|566704514|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
156986751|NCT02601937|566704515|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
157096872|NCT04677179|567109283|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156986752|NCT02601937|566704516|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986753|NCT02601937|566704517|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986754|NCT02601937|566704518|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986755|NCT02601937|566704519|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986756|NCT02601937|566704520|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986757|NCT02601937|566704521|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
156986758|NCT02601937|566704522|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
157096873|NCT04677179|567109284|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
156986759|NCT02601937|566704512|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
156986760|NCT02601937|566704513|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
156986761|NCT02601937|566704514|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
156986762|NCT02601937|566704515|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
156986763|NCT02601937|566704516|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
156986764|NCT02601937|566704517|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
156986765|NCT02601937|566704518|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
156986766|NCT02601937|566704519|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
156986767|NCT02601937|566704520|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
156986768|NCT02601937|566704521|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
156986769|NCT02601937|566704522|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
156986770|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986771|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986772|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986773|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986774|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986775|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986776|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986777|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986778|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986779|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
156986780|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
156986781|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986782|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986783|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986784|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986785|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986786|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986787|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986788|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
156986789|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986790|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986791|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
156986792|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986793|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986794|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986795|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986796|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986797|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986798|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986799|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986800|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
156986801|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
156986802|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
156986803|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986804|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986805|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986806|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986807|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986808|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986809|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
156986810|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
156986811|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
156986812|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
156986813|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
156986814|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Other|0|||
156986815|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Other|0|||
156986816|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Other|0|||
156986817|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Other|0|||
156986818|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Other|0|||
156986819|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Other|0|||
156986820|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Other|0|||
156986821|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Other|0|||
156986822|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Other|2|||
156986823|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Other|2|||
156986824|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Other|0|||
156986825|NCT02601937|566704512|FG000|Period 2: Dose Expansion Cohort|Death|0|||
156986826|NCT02601937|566704513|FG001|Period 2: Dose Expansion Cohort|Death|0|||
156986827|NCT02601937|566704514|FG002|Period 2: Dose Expansion Cohort|Death|0|||
156986828|NCT02601937|566704515|FG003|Period 2: Dose Expansion Cohort|Death|0|||
156986829|NCT02601937|566704516|FG004|Period 2: Dose Expansion Cohort|Death|0|||
156986830|NCT02601937|566704517|FG005|Period 2: Dose Expansion Cohort|Death|0|||
156986831|NCT02601937|566704518|FG006|Period 2: Dose Expansion Cohort|Death|0|||
156986832|NCT02601937|566704519|FG007|Period 2: Dose Expansion Cohort|Death|0|||
156986833|NCT02601937|566704520|FG008|Period 2: Dose Expansion Cohort|Death|1|||
156986834|NCT02601937|566704521|FG009|Period 2: Dose Expansion Cohort|Death|0|||
156986835|NCT02601937|566704522|FG010|Period 2: Dose Expansion Cohort|Death|0|||
156986836|NCT04191135|566704524|FG000|Induction Treatment|Not Treated|2|||
156986837|NCT04191135|566704525|FG001|Induction Treatment|Not Treated|0|||
156986838|NCT04191135|566704526|FG002|Induction Treatment|Not Treated|0|||
156986839|NCT04191135|566704524|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
156986840|NCT04191135|566704525|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
156986841|NCT04191135|566704526|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
156986842|NCT04191135|566704524|FG000|Induction Treatment|Adverse Event|25|||
156986843|NCT04191135|566704525|FG001|Induction Treatment|Adverse Event|0|||
156986844|NCT04191135|566704526|FG002|Induction Treatment|Adverse Event|0|||
156986845|NCT04191135|566704524|FG000|Induction Treatment|Clinical Progression|8|||
156986846|NCT04191135|566704525|FG001|Induction Treatment|Clinical Progression|0|||
156986847|NCT04191135|566704526|FG002|Induction Treatment|Clinical Progression|0|||
156986848|NCT04191135|566704524|FG000|Induction Treatment|Excluded Medication|1|||
156986849|NCT04191135|566704525|FG001|Induction Treatment|Excluded Medication|0|||
156986850|NCT04191135|566704526|FG002|Induction Treatment|Excluded Medication|0|||
156986851|NCT04191135|566704524|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
156986852|NCT04191135|566704525|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
156986853|NCT04191135|566704526|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
156986854|NCT04191135|566704524|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
156986855|NCT04191135|566704525|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
156986856|NCT04191135|566704526|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
156986857|NCT04191135|566704524|FG000|Induction Treatment|Physician Decision|2|||
156986858|NCT04191135|566704525|FG001|Induction Treatment|Physician Decision|0|||
156986859|NCT04191135|566704526|FG002|Induction Treatment|Physician Decision|0|||
156986860|NCT04191135|566704524|FG000|Induction Treatment|Progressive Disease|135|||
156986861|NCT04191135|566704525|FG001|Induction Treatment|Progressive Disease|0|||
156986862|NCT04191135|566704526|FG002|Induction Treatment|Progressive Disease|0|||
156986863|NCT04191135|566704524|FG000|Induction Treatment|Protocol Violation|10|||
156986864|NCT04191135|566704525|FG001|Induction Treatment|Protocol Violation|0|||
156986865|NCT04191135|566704526|FG002|Induction Treatment|Protocol Violation|0|||
156986866|NCT04191135|566704524|FG000|Induction Treatment|Withdrawal by Subject|4|||
156986867|NCT04191135|566704525|FG001|Induction Treatment|Withdrawal by Subject|0|||
156986868|NCT04191135|566704526|FG002|Induction Treatment|Withdrawal by Subject|0|||
156986869|NCT04191135|566704524|FG000|Randomized Treatment|Death|0|||
156986870|NCT04191135|566704525|FG001|Randomized Treatment|Death|50|||
156986871|NCT04191135|566704526|FG002|Randomized Treatment|Death|54|||
156986872|NCT04191135|566704524|FG000|Randomized Treatment|Lost to Follow-up|0|||
156986873|NCT04191135|566704525|FG001|Randomized Treatment|Lost to Follow-up|0|||
156986874|NCT04191135|566704526|FG002|Randomized Treatment|Lost to Follow-up|1|||
156986875|NCT04191135|566704524|FG000|Randomized Treatment|Withdrawal by Subject|0|||
156986876|NCT04191135|566704525|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156986877|NCT04191135|566704526|FG002|Randomized Treatment|Withdrawal by Subject|0|||
156986878|NCT04191135|566704524|FG000|Randomized Treatment|Ongoing in Trial|0|||
156986879|NCT04191135|566704525|FG001|Randomized Treatment|Ongoing in Trial|83|||
156986880|NCT04191135|566704526|FG002|Randomized Treatment|Ongoing in Trial|81|||
156986881|NCT04145349|566706135|FG000|Overall Study|Withdrawal by Subject|3|||
156986882|NCT04145349|566706136|FG001|Overall Study|Withdrawal by Subject|0|||
156986883|NCT04145349|566706135|FG000|Overall Study|Lost to Follow-up|0|||
156986884|NCT04145349|566706136|FG001|Overall Study|Lost to Follow-up|1|||
156986885|NCT04145349|566706135|FG000|Overall Study|On study treatment (Ongoing)|0|||
156986886|NCT04145349|566706136|FG001|Overall Study|On study treatment (Ongoing)|1|||
156986887|NCT03038672|566706137|FG000|Initial Treatment|Unacceptable chemistry|0|||
156986888|NCT03038672|566706138|FG001|Initial Treatment|Unacceptable chemistry|1|||
156986889|NCT03038672|566706137|FG000|Initial Treatment|Progression prior to treatment|1|||
156986890|NCT03038672|566706138|FG001|Initial Treatment|Progression prior to treatment|0|||
156986891|NCT03038672|566706137|FG000|Initial Treatment|No treatment per protocol|1|||
156986892|NCT03038672|566706138|FG001|Initial Treatment|No treatment per protocol|0|||
156986893|NCT04423393|566706139|FG000|Overall Study|Withdrawal by Subject|0|||
156986894|NCT04423393|566706140|FG001|Overall Study|Withdrawal by Subject|0|||
156986895|NCT04423393|566706141|FG002|Overall Study|Withdrawal by Subject|0|||
156986896|NCT04423393|566706142|FG003|Overall Study|Withdrawal by Subject|0|||
156986897|NCT04423393|566706143|FG004|Overall Study|Withdrawal by Subject|0|||
156986898|NCT04423393|566706144|FG005|Overall Study|Withdrawal by Subject|1|||
156986899|NCT04423393|566706145|FG006|Overall Study|Withdrawal by Subject|0|||
156986900|NCT04423393|566706146|FG007|Overall Study|Withdrawal by Subject|0|||
156986901|NCT04423393|566706147|FG008|Overall Study|Withdrawal by Subject|0|||
156986902|NCT04423393|566706148|FG009|Overall Study|Withdrawal by Subject|0|||
156986903|NCT04423393|566706149|FG010|Overall Study|Withdrawal by Subject|0|||
156986904|NCT04423393|566706150|FG011|Overall Study|Withdrawal by Subject|0|||
156986905|NCT04423393|566706151|FG012|Overall Study|Withdrawal by Subject|0|||
156986906|NCT04423393|566706152|FG013|Overall Study|Withdrawal by Subject|1|||
156986907|NCT04423393|566706153|FG014|Overall Study|Withdrawal by Subject|0|||
156986908|NCT04423393|566706154|FG015|Overall Study|Withdrawal by Subject|0|||
156986909|NCT04423393|566706155|FG016|Overall Study|Withdrawal by Subject|0|||
156986910|NCT04423393|566706156|FG017|Overall Study|Withdrawal by Subject|0|||
156986911|NCT04423393|566706139|FG000|Overall Study|Sponsor Decision|0|||
156986912|NCT04423393|566706140|FG001|Overall Study|Sponsor Decision|0|||
156986913|NCT04423393|566706141|FG002|Overall Study|Sponsor Decision|0|||
156986914|NCT04423393|566706142|FG003|Overall Study|Sponsor Decision|0|||
156986915|NCT04423393|566706143|FG004|Overall Study|Sponsor Decision|0|||
156986916|NCT04423393|566706144|FG005|Overall Study|Sponsor Decision|0|||
156986917|NCT04423393|566706145|FG006|Overall Study|Sponsor Decision|0|||
156986918|NCT04423393|566706146|FG007|Overall Study|Sponsor Decision|0|||
156986919|NCT04423393|566706147|FG008|Overall Study|Sponsor Decision|0|||
156986920|NCT04423393|566706148|FG009|Overall Study|Sponsor Decision|0|||
156986921|NCT04423393|566706149|FG010|Overall Study|Sponsor Decision|0|||
156986922|NCT04423393|566706150|FG011|Overall Study|Sponsor Decision|0|||
156986923|NCT04423393|566706151|FG012|Overall Study|Sponsor Decision|0|||
156986924|NCT04423393|566706152|FG013|Overall Study|Sponsor Decision|1|||
156986925|NCT04423393|566706153|FG014|Overall Study|Sponsor Decision|0|||
156986926|NCT04423393|566706154|FG015|Overall Study|Sponsor Decision|0|||
156986927|NCT04423393|566706155|FG016|Overall Study|Sponsor Decision|0|||
156986928|NCT04423393|566706156|FG017|Overall Study|Sponsor Decision|0|||
156986929|NCT01021878|566706157|FG000|Overall Study|Lost to Follow-up|4|||
156986930|NCT01021878|566706158|FG001|Overall Study|Lost to Follow-up|3|||
156986931|NCT01021878|566706157|FG000|Overall Study|Death|0|||
156986932|NCT01021878|566706158|FG001|Overall Study|Death|1|||
156986933|NCT01021878|566706157|FG000|Overall Study|Adverse Event|6|||
156986934|NCT01021878|566706158|FG001|Overall Study|Adverse Event|5|||
156986935|NCT01021878|566706157|FG000|Overall Study|Transplantation|6|||
156986936|NCT01021878|566706158|FG001|Overall Study|Transplantation|1|||
156986937|NCT01155726|566706159|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
156986938|NCT01155726|566706160|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
156986939|NCT01155726|566706161|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
156986940|NCT01155726|566706162|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
156986941|NCT05675709|566706165|FG000|Overall Study|incomplete outcome data|2|||
156986942|NCT05675709|566706166|FG001|Overall Study|incomplete outcome data|8|||
156986943|NCT05876351|566706167|FG000|Overall Study|Other than specified|2|||
156986944|NCT05876351|566706167|FG000|Overall Study|Study specific discontinuation criteria|1|||
156986945|NCT02268552|566706168|FG000|Part 1|Death|1|||
156986946|NCT02268552|566706169|FG001|Part 1|Death|1|||
156986947|NCT02268552|566706170|FG002|Part 1|Death|1|||
156986948|NCT02268552|566706171|FG003|Part 1|Death|2|||
156986949|NCT02268552|566706172|FG004|Part 1|Death|0|||
156986950|NCT02268552|566706173|FG005|Part 1|Death|0|||
156986951|NCT02268552|566706174|FG006|Part 1|Death|0|||
156986952|NCT02268552|566706168|FG000|Part 1|Subject/guardian decision|0|||
156986953|NCT02268552|566706169|FG001|Part 1|Subject/guardian decision|0|||
156986954|NCT02268552|566706170|FG002|Part 1|Subject/guardian decision|0|||
156986955|NCT02268552|566706171|FG003|Part 1|Subject/guardian decision|1|||
156986956|NCT02268552|566706172|FG004|Part 1|Subject/guardian decision|0|||
156986957|NCT02268552|566706173|FG005|Part 1|Subject/guardian decision|0|||
156986958|NCT02268552|566706174|FG006|Part 1|Subject/guardian decision|0|||
156986959|NCT02268552|566706168|FG000|Part 2|Death|0|||
156986960|NCT02268552|566706169|FG001|Part 2|Death|0|||
156986961|NCT02268552|566706170|FG002|Part 2|Death|0|||
156986962|NCT02268552|566706171|FG003|Part 2|Death|0|||
156986963|NCT02268552|566706172|FG004|Part 2|Death|0|||
156986964|NCT02268552|566706173|FG005|Part 2|Death|0|||
156986965|NCT02268552|566706174|FG006|Part 2|Death|2|||
156986966|NCT02268552|566706168|FG000|Part 2|Subject/guardian decision|0|||
156986967|NCT02268552|566706169|FG001|Part 2|Subject/guardian decision|0|||
156986968|NCT02268552|566706170|FG002|Part 2|Subject/guardian decision|0|||
156986969|NCT02268552|566706171|FG003|Part 2|Subject/guardian decision|0|||
156986970|NCT02268552|566706172|FG004|Part 2|Subject/guardian decision|0|||
156986971|NCT02268552|566706173|FG005|Part 2|Subject/guardian decision|0|||
156986972|NCT02268552|566706174|FG006|Part 2|Subject/guardian decision|1|||
156986973|NCT02268552|566706168|FG000|Part 3 Extension|Death|0|||
156986974|NCT02268552|566706169|FG001|Part 3 Extension|Death|1|||
156986975|NCT02268552|566706170|FG002|Part 3 Extension|Death|1|||
156986976|NCT02268552|566706171|FG003|Part 3 Extension|Death|1|||
156986977|NCT02268552|566706172|FG004|Part 3 Extension|Death|1|||
156986978|NCT02268552|566706173|FG005|Part 3 Extension|Death|1|||
156986979|NCT02268552|566706174|FG006|Part 3 Extension|Death|0|||
156986980|NCT02268552|566706168|FG000|Part 3 Extension|Early termination of trial|1|||
156986981|NCT02268552|566706169|FG001|Part 3 Extension|Early termination of trial|0|||
156986982|NCT02268552|566706170|FG002|Part 3 Extension|Early termination of trial|0|||
156986983|NCT02268552|566706171|FG003|Part 3 Extension|Early termination of trial|0|||
156986984|NCT02268552|566706172|FG004|Part 3 Extension|Early termination of trial|2|||
156986985|NCT02268552|566706173|FG005|Part 3 Extension|Early termination of trial|9|||
156986986|NCT02268552|566706174|FG006|Part 3 Extension|Early termination of trial|11|||
156986987|NCT02268552|566706168|FG000|Part 3 Extension|Subject/guardian decision|0|||
156986988|NCT02268552|566706169|FG001|Part 3 Extension|Subject/guardian decision|0|||
156986989|NCT02268552|566706170|FG002|Part 3 Extension|Subject/guardian decision|0|||
156986990|NCT02268552|566706171|FG003|Part 3 Extension|Subject/guardian decision|0|||
156986991|NCT02268552|566706172|FG004|Part 3 Extension|Subject/guardian decision|0|||
156986992|NCT02268552|566706173|FG005|Part 3 Extension|Subject/guardian decision|0|||
156986993|NCT02268552|566706174|FG006|Part 3 Extension|Subject/guardian decision|1|||
156986994|NCT02748512|566706175|FG000|Overall Study|Lost to Follow-up|1|||
156986995|NCT02748512|566706176|FG001|Overall Study|Lost to Follow-up|1|||
156986996|NCT02408549|566706184|FG000|Overall Study|Adverse Event|15|||
156986997|NCT02408549|566706184|FG000|Overall Study|Death|4|||
156986998|NCT02408549|566706184|FG000|Overall Study|Lack of Efficacy|17|||
156986999|NCT02408549|566706184|FG000|Overall Study|Protocol Violation|4|||
156987000|NCT02408549|566706184|FG000|Overall Study|Lost to Follow-up|6|||
156987001|NCT02408549|566706184|FG000|Overall Study|Consent withdrawn|30|||
156987002|NCT02408549|566706184|FG000|Overall Study|Neurology research program closing at site|1|||
156987003|NCT02408549|566706184|FG000|Overall Study|Site closure|1|||
156987004|NCT02408549|566706184|FG000|Overall Study|Pregnancy|1|||
156987005|NCT02408549|566706184|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
156987006|NCT02408549|566706184|FG000|Overall Study|Subject moved to another place, far from site|1|||
156987007|NCT02408549|566706184|FG000|Overall Study|Study terminated at site|1|||
156987008|NCT00231894|566706185|FG000|Overall Study|Withdrawal by Subject|1|||
156987009|NCT00231894|566706186|FG001|Overall Study|Withdrawal by Subject|1|||
156987010|NCT01232556|566706189|FG000|Overall Study|Withdrawal by Subject|21|||
156987011|NCT01232556|566706190|FG001|Overall Study|Withdrawal by Subject|17|||
156987012|NCT01232556|566706189|FG000|Overall Study|Death|97|||
156987013|NCT01232556|566706190|FG001|Overall Study|Death|97|||
156987014|NCT01232556|566706189|FG000|Overall Study|Lost to Follow-up|0|||
156987015|NCT01232556|566706190|FG001|Overall Study|Lost to Follow-up|2|||
156987016|NCT01232556|566706189|FG000|Overall Study|Terminated by Sponsor|35|||
156987017|NCT01232556|566706190|FG001|Overall Study|Terminated by Sponsor|51|||
156987018|NCT01232556|566706189|FG000|Overall Study|Other|6|||
156987019|NCT01232556|566706190|FG001|Overall Study|Other|4|||
156987020|NCT01628510|566706191|FG000|Overall Study|Withdrawal by Subject|0|||
156987021|NCT01628510|566706192|FG001|Overall Study|Withdrawal by Subject|4|||
156987022|NCT01628510|566706191|FG000|Overall Study|Death|3|||
156987023|NCT01628510|566706192|FG001|Overall Study|Death|1|||
156987024|NCT04707391|566706193|FG000|Overall Study|Adverse Event|5|||
156987025|NCT04707391|566706194|FG001|Overall Study|Adverse Event|8|||
156987026|NCT04707391|566706193|FG000|Overall Study|Lost to Follow-up|44|||
156987027|NCT04707391|566706194|FG001|Overall Study|Lost to Follow-up|31|||
156987028|NCT04707391|566706193|FG000|Overall Study|Protocol Violation|1|||
156987029|NCT04707391|566706194|FG001|Overall Study|Protocol Violation|5|||
156987030|NCT04707391|566706193|FG000|Overall Study|Withdrawal by Subject|27|||
156987031|NCT04707391|566706194|FG001|Overall Study|Withdrawal by Subject|25|||
156987032|NCT04707391|566706193|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
156987033|NCT04707391|566706194|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
156987034|NCT04707391|566706193|FG000|Overall Study|Other|0|||
156987035|NCT04707391|566706194|FG001|Overall Study|Other|2|||
156987036|NCT02500316|566706197|FG000|Overall Study|Adverse Event|3|||
156987037|NCT02500316|566706197|FG000|Overall Study|Lost to Follow-up|2|||
156987038|NCT02500316|566706197|FG000|Overall Study|Protocol Violation|1|||
156987039|NCT02500316|566706197|FG000|Overall Study|Withdrawal by Subject|15|||
156987040|NCT02500316|566706197|FG000|Overall Study|Final height achieved|5|||
156987041|NCT02500316|566706197|FG000|Overall Study|Due to war activity|1|||
156987042|NCT01406717|566706198|FG000|Overall Study|Subject non-compliance|4|||
156987043|NCT01406717|566706199|FG001|Overall Study|Subject non-compliance|3|||
156987044|NCT01406717|566706198|FG000|Overall Study|Protocol Violation|5|||
156987045|NCT01406717|566706199|FG001|Overall Study|Protocol Violation|1|||
156987046|NCT01406717|566706198|FG000|Overall Study|Lost to Follow-up|14|||
156987047|NCT01406717|566706199|FG001|Overall Study|Lost to Follow-up|8|||
156987048|NCT01406717|566706198|FG000|Overall Study|Withdrawal by Subject|19|||
156987049|NCT01406717|566706199|FG001|Overall Study|Withdrawal by Subject|15|||
156987050|NCT01406717|566706198|FG000|Overall Study|Adverse Event|1|||
156987051|NCT01406717|566706199|FG001|Overall Study|Adverse Event|2|||
156987052|NCT01406717|566706198|FG000|Overall Study|Lack of Efficacy|0|||
156987053|NCT01406717|566706199|FG001|Overall Study|Lack of Efficacy|1|||
156987054|NCT01406717|566706198|FG000|Overall Study|Non-completion of visit activity|0|||
156987055|NCT01406717|566706199|FG001|Overall Study|Non-completion of visit activity|1|||
156987056|NCT02040090|566706200|FG000|Overall Study|Adverse Event|2|||
156987057|NCT02040090|566706201|FG001|Overall Study|Adverse Event|0|||
156987058|NCT02040090|566706200|FG000|Overall Study|Physician Decision|1|||
156987059|NCT02040090|566706201|FG001|Overall Study|Physician Decision|0|||
156987060|NCT02040090|566706200|FG000|Overall Study|Withdrawal by Subject|0|||
156987061|NCT02040090|566706201|FG001|Overall Study|Withdrawal by Subject|1|||
156987062|NCT02040090|566706200|FG000|Overall Study|Lost to Follow-up|0|||
156987063|NCT02040090|566706201|FG001|Overall Study|Lost to Follow-up|1|||
156987064|NCT03370276|566706204|FG000|Overall Study|Death|0|||
156987065|NCT03370276|566706205|FG001|Overall Study|Death|2|||
156987066|NCT03370276|566706206|FG002|Overall Study|Death|5|||
156987067|NCT02584855|566706210|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
156987068|NCT02584855|566706211|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156987069|NCT02584855|566706212|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156987070|NCT02584855|566706213|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
156987071|NCT02584855|566706214|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
156987072|NCT02584855|566706215|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
156987073|NCT02584855|566706210|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
156987074|NCT02584855|566706211|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156987075|NCT02584855|566706212|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
156987076|NCT02584855|566706213|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
156987077|NCT02584855|566706214|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
156987078|NCT02584855|566706215|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
156987079|NCT02584855|566706210|FG000|Open-Label Treatment Period|Adverse Event|14|||
156987080|NCT02584855|566706211|FG001|Open-Label Treatment Period|Adverse Event|0|||
156987081|NCT02584855|566706212|FG002|Open-Label Treatment Period|Adverse Event|0|||
156987082|NCT02584855|566706213|FG003|Open-Label Treatment Period|Adverse Event|0|||
156987083|NCT02584855|566706214|FG004|Open-Label Treatment Period|Adverse Event|0|||
156987084|NCT02584855|566706215|FG005|Open-Label Treatment Period|Adverse Event|0|||
156987085|NCT02584855|566706210|FG000|Open-Label Treatment Period|Death|2|||
156987086|NCT02584855|566706211|FG001|Open-Label Treatment Period|Death|0|||
156987087|NCT02584855|566706212|FG002|Open-Label Treatment Period|Death|0|||
156987088|NCT02584855|566706213|FG003|Open-Label Treatment Period|Death|0|||
156987089|NCT02584855|566706214|FG004|Open-Label Treatment Period|Death|0|||
156987090|NCT02584855|566706215|FG005|Open-Label Treatment Period|Death|0|||
156987091|NCT02584855|566706210|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
156987092|NCT02584855|566706211|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
156987093|NCT02584855|566706212|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
156987094|NCT02584855|566706213|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
156987095|NCT02584855|566706214|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
156987096|NCT02584855|566706215|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
156987097|NCT02584855|566706210|FG000|Open-Label Treatment Period|Protocol Violation|1|||
156987098|NCT02584855|566706211|FG001|Open-Label Treatment Period|Protocol Violation|0|||
156987099|NCT02584855|566706212|FG002|Open-Label Treatment Period|Protocol Violation|0|||
156987100|NCT02584855|566706213|FG003|Open-Label Treatment Period|Protocol Violation|0|||
156987101|NCT02584855|566706214|FG004|Open-Label Treatment Period|Protocol Violation|0|||
156987102|NCT02584855|566706215|FG005|Open-Label Treatment Period|Protocol Violation|0|||
156987103|NCT02584855|566706210|FG000|Open-Label Treatment Period|No PI Available|2|||
156987104|NCT02584855|566706211|FG001|Open-Label Treatment Period|No PI Available|0|||
156987105|NCT02584855|566706212|FG002|Open-Label Treatment Period|No PI Available|0|||
156987106|NCT02584855|566706213|FG003|Open-Label Treatment Period|No PI Available|0|||
156987107|NCT02584855|566706214|FG004|Open-Label Treatment Period|No PI Available|0|||
156987108|NCT02584855|566706215|FG005|Open-Label Treatment Period|No PI Available|0|||
156987109|NCT02584855|566706210|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
156987110|NCT02584855|566706211|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
156987111|NCT02584855|566706212|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
156987112|NCT02584855|566706213|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
156987113|NCT02584855|566706214|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
156987114|NCT02584855|566706215|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
156987115|NCT02584855|566706210|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156987116|NCT02584855|566706211|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156987117|NCT02584855|566706212|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
156987118|NCT02584855|566706213|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156987119|NCT02584855|566706214|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156987120|NCT02584855|566706215|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
156987121|NCT02584855|566706210|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
156987122|NCT02584855|566706211|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
156987123|NCT02584855|566706212|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
156987124|NCT02584855|566706213|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
156987125|NCT02584855|566706214|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
156987126|NCT02584855|566706215|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
156987127|NCT02584855|566706210|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156987128|NCT02584855|566706211|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
156987129|NCT02584855|566706212|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156987130|NCT02584855|566706213|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156987131|NCT02584855|566706214|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156987132|NCT02584855|566706215|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
156987133|NCT02584855|566706210|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156987134|NCT02584855|566706211|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
156987135|NCT02584855|566706212|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156987136|NCT02584855|566706213|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156987137|NCT02584855|566706214|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156987138|NCT02584855|566706215|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
156987139|NCT02584855|566706210|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156987140|NCT02584855|566706211|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156987141|NCT02584855|566706212|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156987142|NCT02584855|566706213|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156987143|NCT02584855|566706214|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
156987144|NCT02584855|566706215|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156987145|NCT02584855|566706210|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
156987146|NCT02584855|566706211|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
156987147|NCT02584855|566706212|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
156987148|NCT02584855|566706213|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
156987149|NCT02584855|566706214|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
156987150|NCT02584855|566706215|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
156987151|NCT02337478|566706216|FG000|Overall Study|Lack of Efficacy|5|||
156987152|NCT00895843|566706217|FG000|Overall Study|Protocol Violation|12|||
156987153|NCT00895843|566706218|FG001|Overall Study|Protocol Violation|12|||
156987154|NCT02611830|566706219|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
156987155|NCT02611830|566706220|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156987156|NCT02611830|566706221|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156987157|NCT02611830|566706222|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
156987158|NCT02611830|566706219|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
156987159|NCT02611830|566706220|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
156987160|NCT02611830|566706221|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
156987161|NCT02611830|566706222|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
156987162|NCT02611830|566706219|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
156987163|NCT02611830|566706220|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
156987164|NCT02611830|566706221|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
156987165|NCT02611830|566706222|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
156987166|NCT02611830|566706219|FG000|OL Induction Phase|Lack of Efficacy|9|||
156987167|NCT02611830|566706220|FG001|OL Induction Phase|Lack of Efficacy|0|||
156987168|NCT02611830|566706221|FG002|OL Induction Phase|Lack of Efficacy|0|||
156987169|NCT02611830|566706222|FG003|OL Induction Phase|Lack of Efficacy|0|||
156987170|NCT02611830|566706219|FG000|OL Induction Phase|Reason not specified|3|||
156987171|NCT02611830|566706220|FG001|OL Induction Phase|Reason not specified|0|||
156987172|NCT02611830|566706221|FG002|OL Induction Phase|Reason not specified|0|||
156987173|NCT02611830|566706222|FG003|OL Induction Phase|Reason not specified|0|||
156987174|NCT02611830|566706219|FG000|Maintenance Phase|Lack of Efficacy|0|||
156987175|NCT02611830|566706220|FG001|Maintenance Phase|Lack of Efficacy|29|||
156987176|NCT02611830|566706221|FG002|Maintenance Phase|Lack of Efficacy|18|||
156987177|NCT02611830|566706222|FG003|Maintenance Phase|Lack of Efficacy|6|||
156987178|NCT02611830|566706219|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156987179|NCT02611830|566706220|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
156987180|NCT02611830|566706221|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
156987181|NCT02611830|566706222|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
156987182|NCT02611830|566706219|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
156987183|NCT02611830|566706220|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
156987184|NCT02611830|566706221|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
156987185|NCT02611830|566706222|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
156987186|NCT02611830|566706219|FG000|Maintenance Phase|Lost to Follow-up|0|||
156987187|NCT02611830|566706220|FG001|Maintenance Phase|Lost to Follow-up|0|||
156987188|NCT02611830|566706221|FG002|Maintenance Phase|Lost to Follow-up|0|||
156987189|NCT02611830|566706222|FG003|Maintenance Phase|Lost to Follow-up|1|||
156987190|NCT02611830|566706219|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
156987191|NCT02611830|566706220|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
156987192|NCT02611830|566706221|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
156987193|NCT02611830|566706222|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
156987194|NCT02611830|566706219|FG000|Maintenance Phase|Pregnancy|0|||
156987195|NCT02611830|566706220|FG001|Maintenance Phase|Pregnancy|0|||
156987196|NCT02611830|566706221|FG002|Maintenance Phase|Pregnancy|1|||
156987197|NCT02611830|566706222|FG003|Maintenance Phase|Pregnancy|0|||
156987198|NCT02611830|566706219|FG000|Maintenance Phase|Reason not specified|0|||
156987199|NCT02611830|566706220|FG001|Maintenance Phase|Reason not specified|1|||
156987200|NCT02611830|566706221|FG002|Maintenance Phase|Reason not specified|4|||
156987201|NCT02611830|566706222|FG003|Maintenance Phase|Reason not specified|0|||
156987202|NCT04963062|566706228|FG000|Overall Study|withdrew by the study team|4|||
156987203|NCT04963062|566706229|FG001|Overall Study|withdrew by the study team|2|||
156987204|NCT00057811|566706233|FG000|Overall Study|Lack of Efficacy|1|||
156987205|NCT00057811|566706234|FG001|Overall Study|Lack of Efficacy|4|||
156987206|NCT00057811|566706233|FG000|Overall Study|Physician Decision|1|||
156987207|NCT00057811|566706234|FG001|Overall Study|Physician Decision|0|||
156987208|NCT00057811|566706233|FG000|Overall Study|Withdrawal by Subject|3|||
156987209|NCT00057811|566706234|FG001|Overall Study|Withdrawal by Subject|4|||
156987210|NCT00057811|566706233|FG000|Overall Study|Ineligible|4|||
156987211|NCT00057811|566706234|FG001|Overall Study|Ineligible|2|||
156987212|NCT00057811|566706233|FG000|Overall Study|Inevaluable|1|||
156987213|NCT00057811|566706234|FG001|Overall Study|Inevaluable|2|||
156987214|NCT04140890|566706235|FG000|Overall Study|Withdrawal by Subject|0|||
156987215|NCT04140890|566706236|FG001|Overall Study|Withdrawal by Subject|1|||
156987216|NCT02404493|566706237|FG000|Overall Study|Adverse Event|1|||
156987217|NCT02404493|566706238|FG001|Overall Study|Adverse Event|1|||
156987218|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
156987219|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
156987220|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
156987221|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
156987222|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
156987223|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
156987224|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
156987225|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
156987226|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
156987227|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
156987228|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
156987229|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
156987230|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
156987231|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
156987232|NCT01815736|566706247|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
156987233|NCT01815736|566706248|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
156987234|NCT01815736|566706247|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
156987235|NCT01815736|566706248|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
156987236|NCT01815736|566706247|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
156987237|NCT01815736|566706248|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
156987238|NCT01815736|566706247|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
157096874|NCT04677179|567109285|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
156987239|NCT01815736|566706248|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
156987240|NCT01815736|566706247|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
156987241|NCT01815736|566706248|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
156987242|NCT01815736|566706247|FG000|Extension Treatment Phase- After Week 96|Death|1|||
156987243|NCT01815736|566706248|FG001|Extension Treatment Phase- After Week 96|Death|0|||
156987244|NCT03387514|566706252|FG000|Overall Study|Withdrawal by Subject|2|||
156987245|NCT03387514|566706252|FG000|Overall Study|Physician Decision|1|||
156987246|NCT03387514|566706252|FG000|Overall Study|Lost to Follow-up|2|||
156987247|NCT03040687|566706257|FG000|Overall Study|Withdrawal by Subject|1|||
156987248|NCT03040687|566706258|FG001|Overall Study|Withdrawal by Subject|0|||
156987249|NCT03040687|566706259|FG002|Overall Study|Withdrawal by Subject|0|||
156987250|NCT04157686|566706260|FG000|Overall Study|Adverse Event|1|||
156987251|NCT04157686|566706261|FG001|Overall Study|Adverse Event|0|||
156987252|NCT04157686|566706262|FG002|Overall Study|Adverse Event|1|||
156987253|NCT04157686|566706263|FG003|Overall Study|Adverse Event|0|||
156987254|NCT04157686|566706264|FG004|Overall Study|Adverse Event|1|||
156987255|NCT04157686|566706265|FG005|Overall Study|Adverse Event|0|||
156987256|NCT04157686|566706266|FG006|Overall Study|Adverse Event|0|||
156987257|NCT04157686|566706267|FG007|Overall Study|Adverse Event|0|||
156987258|NCT04157686|566706260|FG000|Overall Study|Pregnancy|0|||
156987259|NCT04157686|566706261|FG001|Overall Study|Pregnancy|1|||
156987260|NCT04157686|566706262|FG002|Overall Study|Pregnancy|3|||
156987261|NCT04157686|566706263|FG003|Overall Study|Pregnancy|0|||
156987262|NCT04157686|566706264|FG004|Overall Study|Pregnancy|0|||
156987263|NCT04157686|566706265|FG005|Overall Study|Pregnancy|0|||
156987264|NCT04157686|566706266|FG006|Overall Study|Pregnancy|3|||
156987265|NCT04157686|566706267|FG007|Overall Study|Pregnancy|0|||
156987266|NCT04157686|566706260|FG000|Overall Study|Lost to Follow-up|1|||
156987267|NCT04157686|566706261|FG001|Overall Study|Lost to Follow-up|2|||
156987268|NCT04157686|566706262|FG002|Overall Study|Lost to Follow-up|8|||
156987269|NCT04157686|566706263|FG003|Overall Study|Lost to Follow-up|6|||
156987270|NCT04157686|566706264|FG004|Overall Study|Lost to Follow-up|6|||
156987271|NCT04157686|566706265|FG005|Overall Study|Lost to Follow-up|3|||
156987272|NCT04157686|566706266|FG006|Overall Study|Lost to Follow-up|7|||
156987273|NCT04157686|566706267|FG007|Overall Study|Lost to Follow-up|9|||
156987274|NCT04157686|566706260|FG000|Overall Study|Lack of Efficacy|0|||
156987275|NCT04157686|566706261|FG001|Overall Study|Lack of Efficacy|0|||
156987276|NCT04157686|566706262|FG002|Overall Study|Lack of Efficacy|0|||
156987277|NCT04157686|566706263|FG003|Overall Study|Lack of Efficacy|0|||
156987278|NCT04157686|566706264|FG004|Overall Study|Lack of Efficacy|0|||
156987279|NCT04157686|566706265|FG005|Overall Study|Lack of Efficacy|2|||
156987280|NCT04157686|566706266|FG006|Overall Study|Lack of Efficacy|0|||
156987281|NCT04157686|566706267|FG007|Overall Study|Lack of Efficacy|1|||
156987282|NCT04157686|566706260|FG000|Overall Study|Withdrawal by Subject|10|||
156987283|NCT04157686|566706261|FG001|Overall Study|Withdrawal by Subject|10|||
156987284|NCT04157686|566706262|FG002|Overall Study|Withdrawal by Subject|12|||
156987285|NCT04157686|566706263|FG003|Overall Study|Withdrawal by Subject|20|||
156987286|NCT04157686|566706264|FG004|Overall Study|Withdrawal by Subject|12|||
156987287|NCT04157686|566706265|FG005|Overall Study|Withdrawal by Subject|11|||
156987288|NCT04157686|566706266|FG006|Overall Study|Withdrawal by Subject|18|||
156987289|NCT04157686|566706267|FG007|Overall Study|Withdrawal by Subject|24|||
156987290|NCT04157686|566706260|FG000|Overall Study|Physician Decision|0|||
156987291|NCT04157686|566706261|FG001|Overall Study|Physician Decision|0|||
156987292|NCT04157686|566706262|FG002|Overall Study|Physician Decision|1|||
156987293|NCT04157686|566706263|FG003|Overall Study|Physician Decision|0|||
156987294|NCT04157686|566706264|FG004|Overall Study|Physician Decision|1|||
156987295|NCT04157686|566706265|FG005|Overall Study|Physician Decision|0|||
156987296|NCT04157686|566706266|FG006|Overall Study|Physician Decision|3|||
156987297|NCT04157686|566706267|FG007|Overall Study|Physician Decision|0|||
156987298|NCT04157686|566706260|FG000|Overall Study|Death|0|||
156987299|NCT04157686|566706261|FG001|Overall Study|Death|0|||
156987300|NCT04157686|566706262|FG002|Overall Study|Death|0|||
156987301|NCT04157686|566706263|FG003|Overall Study|Death|2|||
156987302|NCT04157686|566706264|FG004|Overall Study|Death|0|||
156987303|NCT04157686|566706265|FG005|Overall Study|Death|0|||
156987304|NCT04157686|566706266|FG006|Overall Study|Death|0|||
156987305|NCT04157686|566706267|FG007|Overall Study|Death|0|||
156987306|NCT04157686|566706260|FG000|Overall Study|Protocol Violation|0|||
156987307|NCT04157686|566706261|FG001|Overall Study|Protocol Violation|0|||
156987308|NCT04157686|566706262|FG002|Overall Study|Protocol Violation|0|||
156987309|NCT04157686|566706263|FG003|Overall Study|Protocol Violation|0|||
156987310|NCT04157686|566706264|FG004|Overall Study|Protocol Violation|1|||
156987311|NCT04157686|566706265|FG005|Overall Study|Protocol Violation|0|||
156987312|NCT04157686|566706266|FG006|Overall Study|Protocol Violation|0|||
156987313|NCT04157686|566706267|FG007|Overall Study|Protocol Violation|0|||
156987314|NCT04157686|566706260|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
156987315|NCT04157686|566706261|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
156987316|NCT04157686|566706262|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
156987317|NCT04157686|566706263|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
156987318|NCT04157686|566706264|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
156987319|NCT04157686|566706265|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
156987320|NCT04157686|566706266|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
156987321|NCT04157686|566706267|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
156987322|NCT04445155|566706268|FG000|Overall Study|Lost to Follow-up|11|||
156987323|NCT04445155|566706269|FG001|Overall Study|Lost to Follow-up|2|||
156987324|NCT04445155|566706270|FG002|Overall Study|Lost to Follow-up|3|||
156987325|NCT04445155|566706271|FG003|Overall Study|Lost to Follow-up|0|||
156987326|NCT04445155|566706268|FG000|Overall Study|Withdrawal by Subject|8|||
156987327|NCT04445155|566706269|FG001|Overall Study|Withdrawal by Subject|0|||
156987328|NCT04445155|566706270|FG002|Overall Study|Withdrawal by Subject|0|||
156987329|NCT04445155|566706271|FG003|Overall Study|Withdrawal by Subject|0|||
156987330|NCT04445155|566706268|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
156987331|NCT04445155|566706269|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156987332|NCT04445155|566706270|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156987333|NCT04445155|566706271|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
156987334|NCT04445155|566706268|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
156987335|NCT04445155|566706269|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156987336|NCT04445155|566706270|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156987337|NCT04445155|566706271|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
156987338|NCT00810641|566706276|FG000|Overall Study|Withdrawal by Subject|0|||
156987339|NCT00810641|566706277|FG001|Overall Study|Withdrawal by Subject|1|||
156987340|NCT00810641|566706278|FG002|Overall Study|Withdrawal by Subject|2|||
156987341|NCT01556243|566706279|FG000|Overall Study|Ineligible|34|||
156987342|NCT01556243|566706279|FG000|Overall Study|Converted to mastectomy|14|||
156987343|NCT01556243|566706279|FG000|Overall Study|Unable to achieve negative margins|2|||
156987344|NCT01556243|566706279|FG000|Overall Study|Withdrawal by Subject|16|||
156987345|NCT01388543|566706280|FG000|Day 14|Adverse Event|1|||
156987346|NCT01388543|566706281|FG001|Day 14|Adverse Event|4|||
156987347|NCT02325713|566706284|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987348|NCT02325713|566706285|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987349|NCT02325713|566706286|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987350|NCT02325713|566706287|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987351|NCT02325713|566706288|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987352|NCT02325713|566706289|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987353|NCT02325713|566706290|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987354|NCT02325713|566706291|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987355|NCT02325713|566706292|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987356|NCT02325713|566706293|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987357|NCT02325713|566706294|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
156987358|NCT02325713|566706295|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987359|NCT02325713|566706296|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987360|NCT02325713|566706297|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987361|NCT02325713|566706298|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987362|NCT02325713|566706299|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
156987363|NCT02325713|566706284|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
156987364|NCT02325713|566706285|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987365|NCT02325713|566706286|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987366|NCT02325713|566706287|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987367|NCT02325713|566706288|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987368|NCT02325713|566706289|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987369|NCT02325713|566706290|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987370|NCT02325713|566706291|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987371|NCT02325713|566706292|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987372|NCT02325713|566706293|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987373|NCT02325713|566706294|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987374|NCT02325713|566706295|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987375|NCT02325713|566706296|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987376|NCT02325713|566706297|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987377|NCT02325713|566706298|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987378|NCT02325713|566706299|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
156987379|NCT02325713|566706284|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987380|NCT02325713|566706285|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987381|NCT02325713|566706286|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987382|NCT02325713|566706287|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987383|NCT02325713|566706288|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987384|NCT02325713|566706289|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987385|NCT02325713|566706290|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987386|NCT02325713|566706291|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987387|NCT02325713|566706292|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987388|NCT02325713|566706293|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
156987389|NCT02325713|566706294|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987390|NCT02325713|566706295|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987391|NCT02325713|566706296|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987392|NCT02325713|566706297|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987393|NCT02325713|566706298|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987394|NCT02325713|566706299|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
156987395|NCT04684914|566706300|FG000|Overall Study|Withdrawal by Subject|1|||
156987396|NCT04684914|566706301|FG001|Overall Study|Withdrawal by Subject|0|||
156987397|NCT04684914|566706300|FG000|Overall Study|Discontinued before receiving study treatment|1|||
156987398|NCT04684914|566706301|FG001|Overall Study|Discontinued before receiving study treatment|2|||
156987399|NCT03363659|566706302|FG000|Overall Study|Adverse Event|1|||
156987400|NCT03363659|566706302|FG000|Overall Study|Screen fail|1|||
156987401|NCT03363659|566706302|FG000|Overall Study|Withdrawal by Subject|1|||
156987402|NCT05089656|566706304|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
156987403|NCT05089656|566706305|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
156987404|NCT05089656|566706304|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
156987405|NCT05089656|566706305|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
156987406|NCT05089656|566706304|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
156987407|NCT05089656|566706305|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
156987408|NCT05089656|566706304|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
156987409|NCT05089656|566706305|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
156987410|NCT05220501|566708160|FG000|Overall Study|Withdrawal by Subject|11|||
156987411|NCT05220501|566708161|FG001|Overall Study|Withdrawal by Subject|21|||
156987412|NCT05220501|566708162|FG002|Overall Study|Withdrawal by Subject|32|||
156987413|NCT05220501|566708160|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
156987414|NCT05220501|566708161|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
156987415|NCT05220501|566708162|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
156987416|NCT02692235|566708163|FG000|Overall Study|Withdrawal by Subject|2|||
156987417|NCT02692235|566708164|FG001|Overall Study|Withdrawal by Subject|1|||
156987418|NCT02692235|566708163|FG000|Overall Study|Adverse Event|1|||
156987419|NCT02692235|566708164|FG001|Overall Study|Adverse Event|2|||
156987420|NCT01929993|566708166|FG000|Overall Study|Protocol Violation|4|||
156987421|NCT01929993|566708167|FG001|Overall Study|Protocol Violation|6|||
156987422|NCT01929993|566708166|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
156987423|NCT01929993|566708167|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
156987424|NCT03673098|566708168|FG000|Overall Study|Lost to Follow-up|2|||
156987425|NCT03673098|566708169|FG001|Overall Study|Lost to Follow-up|3|||
156987426|NCT03673098|566708168|FG000|Overall Study|Withdrawal by Subject|6|||
156987427|NCT03673098|566708169|FG001|Overall Study|Withdrawal by Subject|1|||
156987428|NCT03673098|566708168|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
156987429|NCT03673098|566708169|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
156987430|NCT01268059|566708170|FG000|Overall Study|Lost to Follow-up|0|||
156987431|NCT01268059|566708171|FG001|Overall Study|Lost to Follow-up|1|||
156987432|NCT01268059|566708172|FG002|Overall Study|Lost to Follow-up|0|||
156987433|NCT01268059|566708173|FG003|Overall Study|Lost to Follow-up|0|||
156987434|NCT01268059|566708170|FG000|Overall Study|Withdrawal by Subject|7|||
156987435|NCT01268059|566708171|FG001|Overall Study|Withdrawal by Subject|4|||
156987436|NCT01268059|566708172|FG002|Overall Study|Withdrawal by Subject|0|||
156987437|NCT01268059|566708173|FG003|Overall Study|Withdrawal by Subject|0|||
156987438|NCT01268059|566708170|FG000|Overall Study|Death|20|||
156987439|NCT01268059|566708171|FG001|Overall Study|Death|30|||
156987440|NCT01268059|566708172|FG002|Overall Study|Death|3|||
156987441|NCT01268059|566708173|FG003|Overall Study|Death|5|||
156987442|NCT01268059|566708170|FG000|Overall Study|Progression of disease|1|||
156987443|NCT01268059|566708171|FG001|Overall Study|Progression of disease|0|||
156987444|NCT01268059|566708172|FG002|Overall Study|Progression of disease|0|||
156987445|NCT01268059|566708173|FG003|Overall Study|Progression of disease|0|||
156987446|NCT03660943|566708174|FG000|Overall Study|Adverse Event|5|||
156987447|NCT03660943|566708175|FG001|Overall Study|Adverse Event|3|||
156987448|NCT03660943|566708174|FG000|Overall Study|Death|0|||
156987449|NCT03660943|566708175|FG001|Overall Study|Death|2|||
156987450|NCT03660943|566708174|FG000|Overall Study|Lost to Follow-up|7|||
156987451|NCT03660943|566708175|FG001|Overall Study|Lost to Follow-up|3|||
156987452|NCT03660943|566708174|FG000|Overall Study|Protocol Violation|3|||
156987453|NCT03660943|566708175|FG001|Overall Study|Protocol Violation|5|||
156987454|NCT03660943|566708174|FG000|Overall Study|Withdrawal by Subject|8|||
156987455|NCT03660943|566708175|FG001|Overall Study|Withdrawal by Subject|15|||
156987456|NCT03660943|566708174|FG000|Overall Study|Lack of Efficacy|9|||
156987457|NCT03660943|566708175|FG001|Overall Study|Lack of Efficacy|12|||
156987458|NCT03660943|566708174|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
156987459|NCT03660943|566708175|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
156987460|NCT03158948|566708177|FG000|Overall Study|Death|1|||
156987461|NCT03158948|566708178|FG001|Overall Study|Death|1|||
156987462|NCT03158948|566708179|FG002|Overall Study|Death|3|||
156987463|NCT03158948|566708180|FG003|Overall Study|Death|2|||
156987464|NCT03158948|566708177|FG000|Overall Study|Physician Decision|0|||
156987465|NCT03158948|566708178|FG001|Overall Study|Physician Decision|0|||
156987466|NCT03158948|566708179|FG002|Overall Study|Physician Decision|0|||
156987467|NCT03158948|566708180|FG003|Overall Study|Physician Decision|1|||
156987468|NCT02424344|566708181|FG000|Overall Study|Lack of Efficacy|0|||
156987469|NCT02424344|566708182|FG001|Overall Study|Lack of Efficacy|1|||
156987470|NCT02424344|566708181|FG000|Overall Study|Withdrawal by Subject|2|||
156987471|NCT02424344|566708182|FG001|Overall Study|Withdrawal by Subject|1|||
156987472|NCT02424344|566708181|FG000|Overall Study|Lost to Follow-up|1|||
156987473|NCT02424344|566708182|FG001|Overall Study|Lost to Follow-up|0|||
156987474|NCT02424344|566708181|FG000|Overall Study|Adverse Event|4|||
156987475|NCT02424344|566708182|FG001|Overall Study|Adverse Event|8|||
156987476|NCT04730947|566708183|FG000|Overall Study|Withdrawal by Subject|0|||
156987477|NCT04730947|566708184|FG001|Overall Study|Withdrawal by Subject|1|||
156987478|NCT02123966|566708185|FG000|Overall Study|Intercurrent Illness|1|||
156987479|NCT05257837|566708186|FG000|Overall Study|Excluded (did not find the guns)|4|||
156987480|NCT05257837|566708187|FG001|Overall Study|Excluded (did not find the guns)|2|||
156987481|NCT05257837|566708188|FG002|Overall Study|Excluded (did not find the guns)|4|||
156987482|NCT05257837|566708189|FG003|Overall Study|Excluded (did not find the guns)|0|||
156987483|NCT03639675|566708190|FG000|Overall Study|Withdrawal by Subject|1|||
156987484|NCT05343455|566708192|FG000|Overall Study|Withdrawal by Subject|4|||
156987485|NCT05343455|566708193|FG001|Overall Study|Withdrawal by Subject|9|||
156987486|NCT05343455|566708194|FG002|Overall Study|Withdrawal by Subject|7|||
156987487|NCT05343455|566708192|FG000|Overall Study|Adverse Event|2|||
156987488|NCT05343455|566708193|FG001|Overall Study|Adverse Event|1|||
156987489|NCT05343455|566708194|FG002|Overall Study|Adverse Event|2|||
156987490|NCT05343455|566708192|FG000|Overall Study|Lost to Follow-up|1|||
156987491|NCT05343455|566708193|FG001|Overall Study|Lost to Follow-up|1|||
156987492|NCT05343455|566708194|FG002|Overall Study|Lost to Follow-up|3|||
156987493|NCT05343455|566708192|FG000|Overall Study|Pregnancy|1|||
156987494|NCT05343455|566708193|FG001|Overall Study|Pregnancy|0|||
156987495|NCT05343455|566708194|FG002|Overall Study|Pregnancy|0|||
156987496|NCT05343455|566708192|FG000|Overall Study|Physician Decision|0|||
156987497|NCT05343455|566708193|FG001|Overall Study|Physician Decision|0|||
156987498|NCT05343455|566708194|FG002|Overall Study|Physician Decision|1|||
156987499|NCT05343455|566708192|FG000|Overall Study|Protocol Violation|0|||
156987500|NCT05343455|566708193|FG001|Overall Study|Protocol Violation|1|||
156987501|NCT05343455|566708194|FG002|Overall Study|Protocol Violation|1|||
156987502|NCT00839917|566708195|FG000|Overall Study|Lost to Follow-up|1|||
156987503|NCT00839917|566708196|FG001|Overall Study|Lost to Follow-up|0|||
156987504|NCT00839917|566708195|FG000|Overall Study|Did not receive vaccine|0|||
156987505|NCT00839917|566708196|FG001|Overall Study|Did not receive vaccine|1|||
156987506|NCT03468426|566708199|FG000|Overall Study|Progressive disease|3|||
156987507|NCT03468426|566708200|FG001|Overall Study|Progressive disease|0|||
156987508|NCT03468426|566708201|FG002|Overall Study|Progressive disease|4|||
156987509|NCT03468426|566708202|FG003|Overall Study|Progressive disease|20|||
156987510|NCT03468426|566708203|FG004|Overall Study|Progressive disease|23|||
156987511|NCT03468426|566708204|FG005|Overall Study|Progressive disease|15|||
156987512|NCT03468426|566708205|FG006|Overall Study|Progressive disease|24|||
156987513|NCT03468426|566708206|FG007|Overall Study|Progressive disease|27|||
156987514|NCT03468426|566708207|FG008|Overall Study|Progressive disease|13|||
156987515|NCT03468426|566708208|FG009|Overall Study|Progressive disease|13|||
156987516|NCT03468426|566708209|FG010|Overall Study|Progressive disease|0|||
156987517|NCT03468426|566708199|FG000|Overall Study|Other adverse event or clinical progression|0|||
156987518|NCT03468426|566708200|FG001|Overall Study|Other adverse event or clinical progression|1|||
156987519|NCT03468426|566708201|FG002|Overall Study|Other adverse event or clinical progression|3|||
156987520|NCT03468426|566708202|FG003|Overall Study|Other adverse event or clinical progression|14|||
156987521|NCT03468426|566708203|FG004|Overall Study|Other adverse event or clinical progression|10|||
156987522|NCT03468426|566708204|FG005|Overall Study|Other adverse event or clinical progression|8|||
156987523|NCT03468426|566708205|FG006|Overall Study|Other adverse event or clinical progression|5|||
156987524|NCT03468426|566708206|FG007|Overall Study|Other adverse event or clinical progression|4|||
156987525|NCT03468426|566708207|FG008|Overall Study|Other adverse event or clinical progression|6|||
156987526|NCT03468426|566708208|FG009|Overall Study|Other adverse event or clinical progression|11|||
156987527|NCT03468426|566708209|FG010|Overall Study|Other adverse event or clinical progression|0|||
156987528|NCT03468426|566708199|FG000|Overall Study|Refused to continue taking trial medication|0|||
156987529|NCT03468426|566708200|FG001|Overall Study|Refused to continue taking trial medication|0|||
156987530|NCT03468426|566708201|FG002|Overall Study|Refused to continue taking trial medication|0|||
156987531|NCT03468426|566708202|FG003|Overall Study|Refused to continue taking trial medication|2|||
156987532|NCT03468426|566708203|FG004|Overall Study|Refused to continue taking trial medication|0|||
156987533|NCT03468426|566708204|FG005|Overall Study|Refused to continue taking trial medication|3|||
156987534|NCT03468426|566708205|FG006|Overall Study|Refused to continue taking trial medication|0|||
157096875|NCT04677179|567109286|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156987535|NCT03468426|566708206|FG007|Overall Study|Refused to continue taking trial medication|0|||
156987536|NCT03468426|566708207|FG008|Overall Study|Refused to continue taking trial medication|1|||
156987537|NCT03468426|566708208|FG009|Overall Study|Refused to continue taking trial medication|0|||
156987538|NCT03468426|566708209|FG010|Overall Study|Refused to continue taking trial medication|0|||
156987539|NCT03468426|566708199|FG000|Overall Study|Other than listed|0|||
156987540|NCT03468426|566708200|FG001|Overall Study|Other than listed|1|||
156987541|NCT03468426|566708201|FG002|Overall Study|Other than listed|0|||
156987542|NCT03468426|566708202|FG003|Overall Study|Other than listed|0|||
156987543|NCT03468426|566708203|FG004|Overall Study|Other than listed|2|||
156987544|NCT03468426|566708204|FG005|Overall Study|Other than listed|2|||
156987545|NCT03468426|566708205|FG006|Overall Study|Other than listed|0|||
156987546|NCT03468426|566708206|FG007|Overall Study|Other than listed|0|||
156987547|NCT03468426|566708207|FG008|Overall Study|Other than listed|4|||
156987548|NCT03468426|566708208|FG009|Overall Study|Other than listed|4|||
156987549|NCT03468426|566708209|FG010|Overall Study|Other than listed|1|||
156987550|NCT03468426|566708199|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987551|NCT03468426|566708200|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987552|NCT03468426|566708201|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156987553|NCT03468426|566708202|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987554|NCT03468426|566708203|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987555|NCT03468426|566708204|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987556|NCT03468426|566708205|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987557|NCT03468426|566708206|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987558|NCT03468426|566708207|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987559|NCT03468426|566708208|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987560|NCT03468426|566708209|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156987561|NCT03468426|566708199|FG000|Overall Study|missing reason|0|||
156987562|NCT03468426|566708200|FG001|Overall Study|missing reason|0|||
156987563|NCT03468426|566708201|FG002|Overall Study|missing reason|0|||
156987564|NCT03468426|566708202|FG003|Overall Study|missing reason|0|||
156987565|NCT03468426|566708203|FG004|Overall Study|missing reason|0|||
156987566|NCT03468426|566708204|FG005|Overall Study|missing reason|0|||
156987567|NCT03468426|566708205|FG006|Overall Study|missing reason|0|||
156987568|NCT03468426|566708206|FG007|Overall Study|missing reason|0|||
156987569|NCT03468426|566708207|FG008|Overall Study|missing reason|0|||
156987570|NCT03468426|566708208|FG009|Overall Study|missing reason|1|||
156987571|NCT03468426|566708209|FG010|Overall Study|missing reason|0|||
156987572|NCT01440049|566708210|FG000|Overall Study|Adverse Event|5|||
156987573|NCT04168385|566708211|FG000|Overall Study|Withdrawal by Subject|1|||
156987574|NCT04168385|566708212|FG001|Overall Study|Withdrawal by Subject|0|||
156987575|NCT04168385|566708211|FG000|Overall Study|Adverse Event|2|||
156987576|NCT04168385|566708212|FG001|Overall Study|Adverse Event|1|||
156987577|NCT04168385|566708211|FG000|Overall Study|Liver transplant|3|||
156987578|NCT04168385|566708212|FG001|Overall Study|Liver transplant|1|||
156987579|NCT04168385|566708211|FG000|Overall Study|Listed for liver transplant|1|||
156987580|NCT04168385|566708212|FG001|Overall Study|Listed for liver transplant|0|||
156987581|NCT02139982|566708213|FG000|Overall Study|Lack of Efficacy|0|||
156987582|NCT02139982|566708214|FG001|Overall Study|Lack of Efficacy|1|||
156987583|NCT02139982|566708215|FG002|Overall Study|Lack of Efficacy|0|||
156987584|NCT02139982|566708216|FG003|Overall Study|Lack of Efficacy|1|||
156987585|NCT02139982|566708217|FG004|Overall Study|Lack of Efficacy|0|||
156987586|NCT02139982|566708218|FG005|Overall Study|Lack of Efficacy|0|||
156987587|NCT02139982|566708219|FG006|Overall Study|Lack of Efficacy|0|||
156987588|NCT02139982|566708220|FG007|Overall Study|Lack of Efficacy|0|||
156987589|NCT02139982|566708221|FG008|Overall Study|Lack of Efficacy|0|||
156987590|NCT02139982|566708222|FG009|Overall Study|Lack of Efficacy|0|||
156987591|NCT01349907|566708226|FG000|Overall Study|Adverse Event|37|||
156987592|NCT01349907|566708227|FG001|Overall Study|Adverse Event|11|||
156987593|NCT01349907|566708226|FG000|Overall Study|Treatment failure|13|||
156987594|NCT01349907|566708227|FG001|Overall Study|Treatment failure|4|||
156987595|NCT01349907|566708226|FG000|Overall Study|Lost to Follow-up|25|||
156987596|NCT01349907|566708227|FG001|Overall Study|Lost to Follow-up|6|||
156987597|NCT01349907|566708226|FG000|Overall Study|Withdrawal by Subject|30|||
156987598|NCT01349907|566708227|FG001|Overall Study|Withdrawal by Subject|8|||
156987599|NCT01349907|566708226|FG000|Overall Study|Protocol Violation|33|||
156987600|NCT01349907|566708227|FG001|Overall Study|Protocol Violation|13|||
156987601|NCT01349907|566708226|FG000|Overall Study|Administrative|1|||
156987602|NCT01349907|566708227|FG001|Overall Study|Administrative|1|||
156987603|NCT02800928|566708230|FG000|Overall Study|Withdrawal by Subject|1|||
156987604|NCT02800928|566708231|FG001|Overall Study|Withdrawal by Subject|1|||
156987605|NCT02800928|566708230|FG000|Overall Study|Protocol Violation|1|||
156987606|NCT02800928|566708231|FG001|Overall Study|Protocol Violation|1|||
156987607|NCT02886728|566708235|FG000|Overall Study|Withdrew Consent|31|||
156987608|NCT02886728|566708236|FG001|Overall Study|Withdrew Consent|13|||
156987609|NCT02886728|566708237|FG002|Overall Study|Withdrew Consent|11|||
156987610|NCT02886728|566708238|FG003|Overall Study|Withdrew Consent|47|||
156987611|NCT02886728|566708235|FG000|Overall Study|Lost to Follow-up|12|||
156987612|NCT02886728|566708236|FG001|Overall Study|Lost to Follow-up|6|||
156987613|NCT02886728|566708237|FG002|Overall Study|Lost to Follow-up|13|||
156987614|NCT02886728|566708238|FG003|Overall Study|Lost to Follow-up|12|||
156987615|NCT02886728|566708235|FG000|Overall Study|Adverse Event|13|||
156987616|NCT02886728|566708236|FG001|Overall Study|Adverse Event|5|||
156987617|NCT02886728|566708237|FG002|Overall Study|Adverse Event|5|||
156987618|NCT02886728|566708238|FG003|Overall Study|Adverse Event|11|||
156987619|NCT02886728|566708235|FG000|Overall Study|Investigator's Discretion|11|||
156987620|NCT02886728|566708236|FG001|Overall Study|Investigator's Discretion|7|||
156987621|NCT02886728|566708237|FG002|Overall Study|Investigator's Discretion|5|||
156987622|NCT02886728|566708238|FG003|Overall Study|Investigator's Discretion|11|||
156987623|NCT02886728|566708235|FG000|Overall Study|Death|3|||
156987624|NCT02886728|566708236|FG001|Overall Study|Death|1|||
156987625|NCT02886728|566708237|FG002|Overall Study|Death|0|||
156987626|NCT02886728|566708238|FG003|Overall Study|Death|0|||
156987627|NCT02886728|566708235|FG000|Overall Study|Protocol Violation|0|||
156987628|NCT02886728|566708236|FG001|Overall Study|Protocol Violation|0|||
156987629|NCT02886728|566708237|FG002|Overall Study|Protocol Violation|0|||
156987630|NCT02886728|566708238|FG003|Overall Study|Protocol Violation|4|||
156987631|NCT02886728|566708235|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156987632|NCT02886728|566708236|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156987633|NCT02886728|566708237|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156987634|NCT02886728|566708238|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156987635|NCT02886728|566708235|FG000|Overall Study|Pregnancy|0|||
156987636|NCT02886728|566708236|FG001|Overall Study|Pregnancy|0|||
156987637|NCT02886728|566708237|FG002|Overall Study|Pregnancy|1|||
156987638|NCT02886728|566708238|FG003|Overall Study|Pregnancy|0|||
156987639|NCT02886728|566708235|FG000|Overall Study|Randomized but Not Dosed|1|||
156987640|NCT02886728|566708236|FG001|Overall Study|Randomized but Not Dosed|0|||
156987641|NCT02886728|566708237|FG002|Overall Study|Randomized but Not Dosed|0|||
156987642|NCT02886728|566708238|FG003|Overall Study|Randomized but Not Dosed|2|||
156987643|NCT00109928|566708239|FG000|Overall Study|Adverse Event|2|||
156987644|NCT00109928|566708239|FG000|Overall Study|Progression|6|||
156987645|NCT00109928|566708239|FG000|Overall Study|Death|2|||
156987646|NCT00109928|566708239|FG000|Overall Study|not protocol specified|2|||
156987647|NCT00109928|566708239|FG000|Overall Study|not eligible|1|||
156987648|NCT00661258|566708248|FG000|Overall Study|Death|1|||
156987649|NCT00661258|566708249|FG001|Overall Study|Death|0|||
156987650|NCT00661258|566708248|FG000|Overall Study|caught by police and in detox center|2|||
156987651|NCT00661258|566708249|FG001|Overall Study|caught by police and in detox center|1|||
156987652|NCT00598481|566708250|FG000|Treatment|Physician Decision|1|||
156987653|NCT01708187|566708251|FG000|Overall Study|Lost to Follow-up|0|||
156987654|NCT01708187|566708252|FG001|Overall Study|Lost to Follow-up|1|||
156987655|NCT04179461|566708254|FG000|Overall Study|Lost to Follow-up|4|||
156987656|NCT03785340|566708255|FG000|Overall Study|Lost to Follow-up|2|||
156987657|NCT03785340|566708256|FG001|Overall Study|Lost to Follow-up|0|||
156987658|NCT03785340|566708255|FG000|Overall Study|Adverse Event|1|||
156987659|NCT03785340|566708256|FG001|Overall Study|Adverse Event|0|||
156987660|NCT01848834|566708257|FG000|Overall Study|Adverse Event|3|||
156987661|NCT01848834|566708258|FG001|Overall Study|Adverse Event|11|||
156987662|NCT01848834|566708259|FG002|Overall Study|Adverse Event|3|||
156987663|NCT01848834|566708260|FG003|Overall Study|Adverse Event|5|||
156987664|NCT01848834|566708261|FG004|Overall Study|Adverse Event|9|||
156987665|NCT01848834|566708257|FG000|Overall Study|Death|2|||
156987666|NCT01848834|566708258|FG001|Overall Study|Death|11|||
156987667|NCT01848834|566708259|FG002|Overall Study|Death|1|||
156987668|NCT01848834|566708260|FG003|Overall Study|Death|8|||
156987669|NCT01848834|566708261|FG004|Overall Study|Death|27|||
156987670|NCT01848834|566708257|FG000|Overall Study|Excluded Medication|5|||
156987671|NCT01848834|566708258|FG001|Overall Study|Excluded Medication|4|||
156987672|NCT01848834|566708259|FG002|Overall Study|Excluded Medication|3|||
156987673|NCT01848834|566708260|FG003|Overall Study|Excluded Medication|6|||
156987674|NCT01848834|566708261|FG004|Overall Study|Excluded Medication|6|||
156987675|NCT01848834|566708257|FG000|Overall Study|Lost to Follow-up|5|||
156987676|NCT01848834|566708258|FG001|Overall Study|Lost to Follow-up|5|||
156987677|NCT01848834|566708259|FG002|Overall Study|Lost to Follow-up|3|||
156987678|NCT01848834|566708260|FG003|Overall Study|Lost to Follow-up|0|||
156987679|NCT01848834|566708261|FG004|Overall Study|Lost to Follow-up|3|||
156987680|NCT01848834|566708257|FG000|Overall Study|Physician Decision|1|||
156987681|NCT01848834|566708258|FG001|Overall Study|Physician Decision|3|||
156987682|NCT01848834|566708259|FG002|Overall Study|Physician Decision|4|||
156987683|NCT01848834|566708260|FG003|Overall Study|Physician Decision|0|||
156987684|NCT01848834|566708261|FG004|Overall Study|Physician Decision|11|||
156987685|NCT01848834|566708257|FG000|Overall Study|Protocol Violation|0|||
156987686|NCT01848834|566708258|FG001|Overall Study|Protocol Violation|0|||
156987687|NCT01848834|566708259|FG002|Overall Study|Protocol Violation|0|||
156987688|NCT01848834|566708260|FG003|Overall Study|Protocol Violation|0|||
156987689|NCT01848834|566708261|FG004|Overall Study|Protocol Violation|1|||
156987690|NCT01848834|566708257|FG000|Overall Study|Sponsor Decision|1|||
156987691|NCT01848834|566708258|FG001|Overall Study|Sponsor Decision|1|||
156987692|NCT01848834|566708259|FG002|Overall Study|Sponsor Decision|0|||
156987693|NCT01848834|566708260|FG003|Overall Study|Sponsor Decision|1|||
156987694|NCT01848834|566708261|FG004|Overall Study|Sponsor Decision|1|||
156987695|NCT01848834|566708257|FG000|Overall Study|Withdrawal by Subject|2|||
156987696|NCT01848834|566708258|FG001|Overall Study|Withdrawal by Subject|13|||
156987697|NCT01848834|566708259|FG002|Overall Study|Withdrawal by Subject|10|||
156987698|NCT01848834|566708260|FG003|Overall Study|Withdrawal by Subject|6|||
156987699|NCT01848834|566708261|FG004|Overall Study|Withdrawal by Subject|36|||
156987700|NCT01987830|566708275|FG000|Overall Study|Never received baseline scan|1|||
156987701|NCT00556374|566708276|FG000|Overall Study|Withdrawal by Subject|235|||
156987702|NCT00556374|566708277|FG001|Overall Study|Withdrawal by Subject|205|||
156987703|NCT00556374|566708276|FG000|Overall Study|Death|158|||
156987704|NCT00556374|566708277|FG001|Overall Study|Death|127|||
156987705|NCT00556374|566708276|FG000|Overall Study|Lost to Follow-up|24|||
156987706|NCT00556374|566708277|FG001|Overall Study|Lost to Follow-up|17|||
156987707|NCT00556374|566708276|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
156987708|NCT00556374|566708277|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
156987709|NCT04131907|566708278|FG000|Overall Study|Adverse Event|2|||
156987710|NCT04131907|566708279|FG001|Overall Study|Adverse Event|0|||
156987711|NCT04131907|566708280|FG002|Overall Study|Adverse Event|0|||
156987712|NCT04131907|566708278|FG000|Overall Study|Physician Decision|4|||
156987713|NCT04131907|566708279|FG001|Overall Study|Physician Decision|22|||
156987714|NCT04131907|566708280|FG002|Overall Study|Physician Decision|0|||
156987715|NCT04131907|566708278|FG000|Overall Study|Withdrawal by Subject|2|||
156987716|NCT04131907|566708279|FG001|Overall Study|Withdrawal by Subject|0|||
156987717|NCT04131907|566708280|FG002|Overall Study|Withdrawal by Subject|1|||
156987718|NCT04131907|566708278|FG000|Overall Study|Treatment failure|2|||
156987719|NCT04131907|566708279|FG001|Overall Study|Treatment failure|0|||
156987720|NCT04131907|566708280|FG002|Overall Study|Treatment failure|1|||
156987721|NCT05294419|566708281|FG000|Overall Study|Protocol Violation|4|||
156987722|NCT05294419|566708282|FG001|Overall Study|Protocol Violation|0|||
156987723|NCT05294419|566708283|FG002|Overall Study|Protocol Violation|0|||
156987724|NCT05294419|566708281|FG000|Overall Study|Lost to Follow-up|6|||
156987725|NCT05294419|566708282|FG001|Overall Study|Lost to Follow-up|0|||
156987726|NCT05294419|566708283|FG002|Overall Study|Lost to Follow-up|0|||
156987727|NCT05294419|566708281|FG000|Overall Study|Results voided after publishing|2|||
156987728|NCT05294419|566708282|FG001|Overall Study|Results voided after publishing|0|||
156987729|NCT05294419|566708283|FG002|Overall Study|Results voided after publishing|0|||
156987730|NCT00847301|566708284|FG000|Overall Study|Adverse Event|35|||
156987731|NCT00847301|566708284|FG000|Overall Study|Switch to other anticoagulants|16|||
156987732|NCT00847301|566708284|FG000|Overall Study|Lost to Follow-up|1|||
156987733|NCT00847301|566708284|FG000|Overall Study|No prescription after hospital discharge|1|||
156987734|NCT00847301|566708284|FG000|Overall Study|Other reason not defined above|1|||
156987735|NCT05708846|566708285|FG000|Overall Study|Death|5|||
156987736|NCT05708846|566708285|FG000|Overall Study|Withdrawal by Subject|20|||
156987737|NCT03621982|566708286|FG000|Overall Study|Withdrawal by Subject|1|||
156987738|NCT03621982|566708287|FG001|Overall Study|Withdrawal by Subject|0|||
156987739|NCT03621982|566708288|FG002|Overall Study|Withdrawal by Subject|0|||
156987740|NCT03621982|566708289|FG003|Overall Study|Withdrawal by Subject|1|||
156987741|NCT03621982|566708290|FG004|Overall Study|Withdrawal by Subject|0|||
156987742|NCT03621982|566708291|FG005|Overall Study|Withdrawal by Subject|1|||
156987743|NCT03621982|566708292|FG006|Overall Study|Withdrawal by Subject|1|||
156987744|NCT03621982|566708293|FG007|Overall Study|Withdrawal by Subject|0|||
156987745|NCT03621982|566708294|FG008|Overall Study|Withdrawal by Subject|1|||
156987746|NCT03621982|566708295|FG009|Overall Study|Withdrawal by Subject|0|||
156987747|NCT03621982|566708296|FG010|Overall Study|Withdrawal by Subject|2|||
156987748|NCT03621982|566708297|FG011|Overall Study|Withdrawal by Subject|1|||
156987749|NCT03621982|566708298|FG012|Overall Study|Withdrawal by Subject|2|||
156987750|NCT03621982|566708299|FG013|Overall Study|Withdrawal by Subject|2|||
156987751|NCT03621982|566708286|FG000|Overall Study|Investigator/Sponsor decision|0|||
156987752|NCT03621982|566708287|FG001|Overall Study|Investigator/Sponsor decision|0|||
156987753|NCT03621982|566708288|FG002|Overall Study|Investigator/Sponsor decision|0|||
156987754|NCT03621982|566708289|FG003|Overall Study|Investigator/Sponsor decision|0|||
156987755|NCT03621982|566708290|FG004|Overall Study|Investigator/Sponsor decision|0|||
156987756|NCT03621982|566708291|FG005|Overall Study|Investigator/Sponsor decision|0|||
156987757|NCT03621982|566708292|FG006|Overall Study|Investigator/Sponsor decision|0|||
156987758|NCT03621982|566708293|FG007|Overall Study|Investigator/Sponsor decision|0|||
156987759|NCT03621982|566708294|FG008|Overall Study|Investigator/Sponsor decision|0|||
156987760|NCT03621982|566708295|FG009|Overall Study|Investigator/Sponsor decision|0|||
156987761|NCT03621982|566708296|FG010|Overall Study|Investigator/Sponsor decision|0|||
156987762|NCT03621982|566708297|FG011|Overall Study|Investigator/Sponsor decision|4|||
156987763|NCT03621982|566708298|FG012|Overall Study|Investigator/Sponsor decision|0|||
156987764|NCT03621982|566708299|FG013|Overall Study|Investigator/Sponsor decision|2|||
156987765|NCT03621982|566708286|FG000|Overall Study|Death|2|||
156987766|NCT03621982|566708287|FG001|Overall Study|Death|4|||
156987767|NCT03621982|566708288|FG002|Overall Study|Death|4|||
156987768|NCT03621982|566708289|FG003|Overall Study|Death|3|||
156987769|NCT03621982|566708290|FG004|Overall Study|Death|8|||
156987770|NCT03621982|566708291|FG005|Overall Study|Death|4|||
156987771|NCT03621982|566708292|FG006|Overall Study|Death|6|||
156987772|NCT03621982|566708293|FG007|Overall Study|Death|3|||
156987773|NCT03621982|566708294|FG008|Overall Study|Death|0|||
156987774|NCT03621982|566708295|FG009|Overall Study|Death|3|||
156987775|NCT03621982|566708296|FG010|Overall Study|Death|8|||
156987776|NCT03621982|566708297|FG011|Overall Study|Death|4|||
156987777|NCT03621982|566708298|FG012|Overall Study|Death|2|||
156987778|NCT03621982|566708299|FG013|Overall Study|Death|2|||
156987779|NCT03621982|566708286|FG000|Overall Study|Lost to Follow-up|0|||
156987780|NCT03621982|566708287|FG001|Overall Study|Lost to Follow-up|0|||
156987781|NCT03621982|566708288|FG002|Overall Study|Lost to Follow-up|1|||
156987782|NCT03621982|566708289|FG003|Overall Study|Lost to Follow-up|0|||
156987783|NCT03621982|566708290|FG004|Overall Study|Lost to Follow-up|0|||
156987784|NCT03621982|566708291|FG005|Overall Study|Lost to Follow-up|0|||
156987785|NCT03621982|566708292|FG006|Overall Study|Lost to Follow-up|1|||
156987786|NCT03621982|566708293|FG007|Overall Study|Lost to Follow-up|0|||
156987787|NCT03621982|566708294|FG008|Overall Study|Lost to Follow-up|0|||
156987788|NCT03621982|566708295|FG009|Overall Study|Lost to Follow-up|1|||
156987789|NCT03621982|566708296|FG010|Overall Study|Lost to Follow-up|0|||
156987790|NCT03621982|566708297|FG011|Overall Study|Lost to Follow-up|0|||
157096876|NCT04677179|567109277|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
157096877|NCT04677179|567109278|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156987791|NCT03621982|566708298|FG012|Overall Study|Lost to Follow-up|0|||
156987792|NCT03621982|566708299|FG013|Overall Study|Lost to Follow-up|0|||
156987793|NCT00238420|566708300|FG000|Overall Study|Protocol Violation|1|||
156987794|NCT00238420|566708301|FG001|Overall Study|Protocol Violation|1|||
156987795|NCT00641186|566708302|FG000|Overall Study|Adverse Event|3|||
156987796|NCT00442286|566708303|FG000|Overall Study|Death|2|||
156987797|NCT00442286|566708304|FG001|Overall Study|Death|2|||
156987798|NCT00442286|566708303|FG000|Overall Study|Lost to Follow-up|1|||
156987799|NCT00442286|566708304|FG001|Overall Study|Lost to Follow-up|0|||
156987800|NCT00442286|566708303|FG000|Overall Study|Withdrawal by Subject|2|||
156987801|NCT00442286|566708304|FG001|Overall Study|Withdrawal by Subject|0|||
156987802|NCT00442286|566708303|FG000|Overall Study|System explanted|1|||
156987803|NCT00442286|566708304|FG001|Overall Study|System explanted|0|||
156987804|NCT00442286|566708303|FG000|Overall Study|Patient Injury|1|||
156987805|NCT00442286|566708304|FG001|Overall Study|Patient Injury|0|||
156987806|NCT05221749|566708307|FG000|Overall Study|Lost to Follow-up|2|||
156987807|NCT05221749|566708308|FG001|Overall Study|Lost to Follow-up|3|||
156987808|NCT03428815|566708309|FG000|Overall Study|Lost to Follow-up|2|||
156987809|NCT03428815|566708310|FG001|Overall Study|Lost to Follow-up|2|||
156987810|NCT03428815|566708309|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
156987811|NCT03428815|566708310|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
156987812|NCT03428815|566708309|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
156987813|NCT03428815|566708310|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
156987814|NCT01700348|566708313|FG000|Overall Study|Withdrawal by Subject|22|||
156987815|NCT01700348|566708313|FG000|Overall Study|Lost to Follow-up|1|||
156987816|NCT02102464|566708314|FG000|Randomized Study|Withdrawal by Subject|0|||
156987817|NCT02102464|566708315|FG001|Randomized Study|Withdrawal by Subject|1|||
156987818|NCT02102464|566708316|FG002|Randomized Study|Withdrawal by Subject|0|||
156987819|NCT01824472|566708317|FG000|Overall Study|Lost to Follow-up|0|||
156987820|NCT01824472|566708318|FG001|Overall Study|Lost to Follow-up|0|||
156987821|NCT01824472|566708319|FG002|Overall Study|Lost to Follow-up|1|||
156987822|NCT01824472|566708317|FG000|Overall Study|Withdrawal by Subject|1|||
156987823|NCT01824472|566708318|FG001|Overall Study|Withdrawal by Subject|5|||
156987824|NCT01824472|566708319|FG002|Overall Study|Withdrawal by Subject|3|||
156987825|NCT01824472|566708317|FG000|Overall Study|Ineligible post randomization&screening|0|||
156987826|NCT01824472|566708318|FG001|Overall Study|Ineligible post randomization&screening|2|||
156987827|NCT01824472|566708319|FG002|Overall Study|Ineligible post randomization&screening|0|||
156987828|NCT03317379|566708320|FG000|Overall Study|Lost to Follow-up|0|||
156987829|NCT03317379|566708321|FG001|Overall Study|Lost to Follow-up|3|||
156987830|NCT03317379|566708322|FG002|Overall Study|Lost to Follow-up|2|||
156987831|NCT02846558|566708323|FG000|Overall Study|Adverse Event|1|||
156987832|NCT02846558|566708324|FG001|Overall Study|Adverse Event|0|||
156987833|NCT02846558|566708325|FG002|Overall Study|Adverse Event|0|||
156987834|NCT02846558|566708326|FG003|Overall Study|Adverse Event|0|||
156987835|NCT02846558|566708323|FG000|Overall Study|Withdrawal by Subject|5|||
156987836|NCT02846558|566708324|FG001|Overall Study|Withdrawal by Subject|4|||
156987837|NCT02846558|566708325|FG002|Overall Study|Withdrawal by Subject|2|||
156987838|NCT02846558|566708326|FG003|Overall Study|Withdrawal by Subject|2|||
156987839|NCT02846558|566708323|FG000|Overall Study|Lost to Follow-up|2|||
156987840|NCT02846558|566708324|FG001|Overall Study|Lost to Follow-up|0|||
156987841|NCT02846558|566708325|FG002|Overall Study|Lost to Follow-up|0|||
156987842|NCT02846558|566708326|FG003|Overall Study|Lost to Follow-up|0|||
156987843|NCT01213173|566708329|FG000|Overall Study|Protocol Violation|2|||
156987844|NCT01213173|566708330|FG001|Overall Study|Protocol Violation|0|||
156987845|NCT01213173|566708329|FG000|Overall Study|Adverse Event|4|||
156987846|NCT01213173|566708330|FG001|Overall Study|Adverse Event|8|||
156987847|NCT01213173|566708329|FG000|Overall Study|Withdrawal by Subject|5|||
156987848|NCT01213173|566708330|FG001|Overall Study|Withdrawal by Subject|5|||
156987849|NCT01213173|566708329|FG000|Overall Study|Incorrect Enrollment|1|||
156987850|NCT01213173|566708330|FG001|Overall Study|Incorrect Enrollment|3|||
156987851|NCT02253316|566708331|FG000|Consolidation|Progression|4|||
156987852|NCT02253316|566708332|FG001|Consolidation|Progression|0|||
156987853|NCT02253316|566708333|FG002|Consolidation|Progression|0|||
156987854|NCT02253316|566708331|FG000|Consolidation|Non-Compliance|1|||
156987855|NCT02253316|566708332|FG001|Consolidation|Non-Compliance|0|||
156987856|NCT02253316|566708333|FG002|Consolidation|Non-Compliance|0|||
156987857|NCT02253316|566708331|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
156987858|NCT02253316|566708332|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
156987859|NCT02253316|566708333|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
156987860|NCT02253316|566708331|FG000|Consolidation|Secondary Malignancy|2|||
156987861|NCT02253316|566708332|FG001|Consolidation|Secondary Malignancy|0|||
156987862|NCT02253316|566708333|FG002|Consolidation|Secondary Malignancy|0|||
156987863|NCT02253316|566708331|FG000|Consolidation|Adverse Event|7|||
156987864|NCT02253316|566708332|FG001|Consolidation|Adverse Event|0|||
156987865|NCT02253316|566708333|FG002|Consolidation|Adverse Event|0|||
156987866|NCT02253316|566708331|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
156987867|NCT02253316|566708332|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
156987868|NCT02253316|566708333|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
156987869|NCT02253316|566708331|FG000|Maintenance|Physician Decision|0|||
156987870|NCT02253316|566708332|FG001|Maintenance|Physician Decision|7|||
156987871|NCT02253316|566708333|FG002|Maintenance|Physician Decision|16|||
156987872|NCT02253316|566708331|FG000|Maintenance|Non-Compliance|0|||
156987873|NCT02253316|566708332|FG001|Maintenance|Non-Compliance|1|||
156987874|NCT02253316|566708333|FG002|Maintenance|Non-Compliance|1|||
156987875|NCT02253316|566708331|FG000|Maintenance|Secondary Malignancy|0|||
156987876|NCT02253316|566708332|FG001|Maintenance|Secondary Malignancy|2|||
156987877|NCT02253316|566708333|FG002|Maintenance|Secondary Malignancy|6|||
156987878|NCT02253316|566708331|FG000|Maintenance|Adverse Event|0|||
156987879|NCT02253316|566708332|FG001|Maintenance|Adverse Event|8|||
156987880|NCT02253316|566708333|FG002|Maintenance|Adverse Event|12|||
156987881|NCT02253316|566708331|FG000|Maintenance|Still receiving active treatment|0|||
156987882|NCT02253316|566708332|FG001|Maintenance|Still receiving active treatment|4|||
156987883|NCT02253316|566708333|FG002|Maintenance|Still receiving active treatment|0|||
156987884|NCT02353832|566708334|FG000|Overall Study|Ineligible after enrollment|1|||
156987885|NCT02353832|566708334|FG000|Overall Study|Lost to Follow-up|1|||
156987886|NCT00904150|566708335|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
156987887|NCT00904150|566708336|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
156987888|NCT00904150|566708335|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
156987889|NCT00904150|566708336|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
156987890|NCT05567952|566709738|FG000|Overall Study|Lost to Follow-up|3|||
156987891|NCT05567952|566709739|FG001|Overall Study|Lost to Follow-up|2|||
156987892|NCT05567952|566709738|FG000|Overall Study|Withdrawal by Subject|6|||
156987893|NCT05567952|566709739|FG001|Overall Study|Withdrawal by Subject|3|||
156987894|NCT05567952|566709738|FG000|Overall Study|Other|3|||
156987895|NCT05567952|566709739|FG001|Overall Study|Other|1|||
156987896|NCT03280563|566709741|FG000|Stage 1|Death|2|||
156987897|NCT03280563|566709742|FG001|Stage 1|Death|1|||
156987898|NCT03280563|566709743|FG002|Stage 1|Death|0|||
156987899|NCT03280563|566709744|FG003|Stage 1|Death|0|||
156987900|NCT03280563|566709745|FG004|Stage 1|Death|0|||
156987901|NCT03280563|566709746|FG005|Stage 1|Death|3|||
156987902|NCT03280563|566709747|FG006|Stage 1|Death|0|||
156987903|NCT03280563|566709748|FG007|Stage 1|Death|0|||
156987904|NCT03280563|566709749|FG008|Stage 1|Death|0|||
156987905|NCT03280563|566709741|FG000|Stage 1|Study Ended by Sponsor|0|||
156987906|NCT03280563|566709742|FG001|Stage 1|Study Ended by Sponsor|0|||
156987907|NCT03280563|566709743|FG002|Stage 1|Study Ended by Sponsor|1|||
156987908|NCT03280563|566709744|FG003|Stage 1|Study Ended by Sponsor|0|||
156987909|NCT03280563|566709745|FG004|Stage 1|Study Ended by Sponsor|0|||
156987910|NCT03280563|566709746|FG005|Stage 1|Study Ended by Sponsor|1|||
156987911|NCT03280563|566709747|FG006|Stage 1|Study Ended by Sponsor|0|||
156987912|NCT03280563|566709748|FG007|Stage 1|Study Ended by Sponsor|0|||
156987913|NCT03280563|566709749|FG008|Stage 1|Study Ended by Sponsor|0|||
156987914|NCT03280563|566709741|FG000|Stage 1|Withdrawal by Subject|5|||
156987915|NCT03280563|566709742|FG001|Stage 1|Withdrawal by Subject|1|||
156987916|NCT03280563|566709743|FG002|Stage 1|Withdrawal by Subject|2|||
156987917|NCT03280563|566709744|FG003|Stage 1|Withdrawal by Subject|0|||
156987918|NCT03280563|566709745|FG004|Stage 1|Withdrawal by Subject|0|||
156987919|NCT03280563|566709746|FG005|Stage 1|Withdrawal by Subject|2|||
156987920|NCT03280563|566709747|FG006|Stage 1|Withdrawal by Subject|0|||
156987921|NCT03280563|566709748|FG007|Stage 1|Withdrawal by Subject|0|||
156987922|NCT03280563|566709749|FG008|Stage 1|Withdrawal by Subject|0|||
156987923|NCT03280563|566709741|FG000|Stage 1|Reason Not Specified|0|||
156987924|NCT03280563|566709742|FG001|Stage 1|Reason Not Specified|0|||
156987925|NCT03280563|566709743|FG002|Stage 1|Reason Not Specified|0|||
156987926|NCT03280563|566709744|FG003|Stage 1|Reason Not Specified|0|||
156987927|NCT03280563|566709745|FG004|Stage 1|Reason Not Specified|0|||
156987928|NCT03280563|566709746|FG005|Stage 1|Reason Not Specified|1|||
156987929|NCT03280563|566709747|FG006|Stage 1|Reason Not Specified|0|||
156987930|NCT03280563|566709748|FG007|Stage 1|Reason Not Specified|0|||
156987931|NCT03280563|566709749|FG008|Stage 1|Reason Not Specified|0|||
156987932|NCT03280563|566709741|FG000|Stage 1|Physician Decision|0|||
156987933|NCT03280563|566709742|FG001|Stage 1|Physician Decision|1|||
156987934|NCT03280563|566709743|FG002|Stage 1|Physician Decision|0|||
156987935|NCT03280563|566709744|FG003|Stage 1|Physician Decision|0|||
156987936|NCT03280563|566709745|FG004|Stage 1|Physician Decision|0|||
156987937|NCT03280563|566709746|FG005|Stage 1|Physician Decision|0|||
156987938|NCT03280563|566709747|FG006|Stage 1|Physician Decision|0|||
156987939|NCT03280563|566709748|FG007|Stage 1|Physician Decision|0|||
157096878|NCT04677179|567109279|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
156987940|NCT03280563|566709749|FG008|Stage 1|Physician Decision|0|||
156987941|NCT03280563|566709741|FG000|Stage 2|Death|0|||
156987942|NCT03280563|566709742|FG001|Stage 2|Death|0|||
156987943|NCT03280563|566709743|FG002|Stage 2|Death|0|||
156987944|NCT03280563|566709744|FG003|Stage 2|Death|0|||
156987945|NCT03280563|566709745|FG004|Stage 2|Death|0|||
156987946|NCT03280563|566709746|FG005|Stage 2|Death|0|||
156987947|NCT03280563|566709747|FG006|Stage 2|Death|0|||
156987948|NCT03280563|566709748|FG007|Stage 2|Death|1|||
156987949|NCT03280563|566709749|FG008|Stage 2|Death|0|||
156987950|NCT03280563|566709741|FG000|Stage 2|Progressive Disease|0|||
156987951|NCT03280563|566709742|FG001|Stage 2|Progressive Disease|0|||
156987952|NCT03280563|566709743|FG002|Stage 2|Progressive Disease|0|||
156987953|NCT03280563|566709744|FG003|Stage 2|Progressive Disease|0|||
156987954|NCT03280563|566709745|FG004|Stage 2|Progressive Disease|0|||
156987955|NCT03280563|566709746|FG005|Stage 2|Progressive Disease|0|||
156987956|NCT03280563|566709747|FG006|Stage 2|Progressive Disease|2|||
156987957|NCT03280563|566709748|FG007|Stage 2|Progressive Disease|0|||
156987958|NCT03280563|566709749|FG008|Stage 2|Progressive Disease|0|||
156987959|NCT03280563|566709741|FG000|Long-term Survival Follow-up|Death|10|||
156987960|NCT03280563|566709742|FG001|Long-term Survival Follow-up|Death|14|||
156987961|NCT03280563|566709743|FG002|Long-term Survival Follow-up|Death|15|||
157096879|NCT04677179|567109280|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
157096880|NCT04677179|567109281|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
157096881|NCT04677179|567109282|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
157096882|NCT04677179|567109283|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
157096883|NCT04677179|567109284|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
157096884|NCT04677179|567109285|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
157096885|NCT04677179|567109286|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
157096886|NCT01536015|567109287|FG000|Overall Study|Adverse Event|1|||
157096887|NCT01536015|567109288|FG001|Overall Study|Adverse Event|4|||
157096888|NCT01536015|567109287|FG000|Overall Study|Lost to Follow-up|0|||
157096889|NCT01536015|567109288|FG001|Overall Study|Lost to Follow-up|1|||
157096890|NCT01536015|567109287|FG000|Overall Study|Inclusion Criterion not met|2|||
157096891|NCT01536015|567109288|FG001|Overall Study|Inclusion Criterion not met|0|||
157096892|NCT01536015|567109287|FG000|Overall Study|Study closure|5|||
157096893|NCT01536015|567109288|FG001|Overall Study|Study closure|5|||
157096894|NCT01201265|567109291|FG000|Overall Study|Death|14|||
157096895|NCT01201265|567109291|FG000|Overall Study|Insufficient Therapeutic Response|3|||
157096896|NCT01201265|567109291|FG000|Overall Study|Lost to Follow-up|10|||
157096897|NCT01201265|567109291|FG000|Overall Study|Withdrawal by Subject|7|||
157096898|NCT01201265|567109291|FG000|Overall Study|Disease Progression|4|||
157096899|NCT02041520|567109292|FG000|Overall Study|Adverse Event|2|||
157096900|NCT02041520|567109293|FG001|Overall Study|Adverse Event|1|||
157096901|NCT02041520|567109292|FG000|Overall Study|Withdrawal by Subject|3|||
157096902|NCT02041520|567109293|FG001|Overall Study|Withdrawal by Subject|4|||
157096903|NCT02041520|567109292|FG000|Overall Study|Protocol Violation|1|||
157096904|NCT02041520|567109293|FG001|Overall Study|Protocol Violation|0|||
157096905|NCT02041520|567109292|FG000|Overall Study|Lost to Follow-up|0|||
157096906|NCT02041520|567109293|FG001|Overall Study|Lost to Follow-up|1|||
157096907|NCT02041520|567109292|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
157096908|NCT02041520|567109293|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
157096909|NCT00413972|567109294|FG000|Overall Study|Adverse Event|2|||
157096910|NCT00413972|567109295|FG001|Overall Study|Adverse Event|1|||
157096911|NCT00413972|567109296|FG002|Overall Study|Adverse Event|0|||
157096912|NCT00413972|567109297|FG003|Overall Study|Adverse Event|0|||
157096913|NCT00413972|567109294|FG000|Overall Study|Lost to Follow-up|1|||
157096914|NCT00413972|567109295|FG001|Overall Study|Lost to Follow-up|2|||
157096915|NCT00413972|567109296|FG002|Overall Study|Lost to Follow-up|1|||
157096916|NCT00413972|567109297|FG003|Overall Study|Lost to Follow-up|0|||
157096917|NCT00413972|567109294|FG000|Overall Study|Withdrawal by Subject|4|||
157096918|NCT00413972|567109295|FG001|Overall Study|Withdrawal by Subject|5|||
157096919|NCT00413972|567109296|FG002|Overall Study|Withdrawal by Subject|7|||
157096920|NCT00413972|567109297|FG003|Overall Study|Withdrawal by Subject|2|||
157096921|NCT00413972|567109294|FG000|Overall Study|Protocol Violation|0|||
157096922|NCT00413972|567109295|FG001|Overall Study|Protocol Violation|0|||
157096923|NCT00413972|567109296|FG002|Overall Study|Protocol Violation|2|||
157096924|NCT00413972|567109297|FG003|Overall Study|Protocol Violation|0|||
157096925|NCT00413972|567109294|FG000|Overall Study|Other|0|||
157096926|NCT00413972|567109295|FG001|Overall Study|Other|0|||
157096927|NCT00413972|567109296|FG002|Overall Study|Other|0|||
157096928|NCT00413972|567109297|FG003|Overall Study|Other|1|||
157096929|NCT01898923|567109300|FG000|Overall Study|Lack of Efficacy|5|||
157096930|NCT01898923|567109301|FG001|Overall Study|Lack of Efficacy|6|||
157096931|NCT01898923|567109300|FG000|Overall Study|Adverse Event|3|||
157096932|NCT01898923|567109301|FG001|Overall Study|Adverse Event|1|||
157096933|NCT01898923|567109300|FG000|Overall Study|Lost to Follow-up|0|||
157096934|NCT01898923|567109301|FG001|Overall Study|Lost to Follow-up|1|||
157096935|NCT01898923|567109300|FG000|Overall Study|Withdrawal by Subject|4|||
157096936|NCT01898923|567109301|FG001|Overall Study|Withdrawal by Subject|7|||
157096937|NCT01898923|567109300|FG000|Overall Study|Physician Decision|3|||
157096938|NCT01898923|567109301|FG001|Overall Study|Physician Decision|4|||
157096939|NCT01898923|567109300|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
157096940|NCT01898923|567109301|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
157096941|NCT02678247|567109304|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
157096942|NCT02678247|567109305|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
157096943|NCT02678247|567109304|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
157096944|NCT02678247|567109305|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
157096945|NCT02678247|567109304|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
157096946|NCT02678247|567109305|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
157096947|NCT02678247|567109304|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
157096948|NCT02678247|567109305|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
157096949|NCT02678247|567109304|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
157096950|NCT02678247|567109305|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
157096951|NCT02678247|567109304|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
157096952|NCT02678247|567109305|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
156987962|NCT03280563|566709744|FG003|Long-term Survival Follow-up|Death|3|||
156987963|NCT03280563|566709745|FG004|Long-term Survival Follow-up|Death|6|||
156987964|NCT03280563|566709746|FG005|Long-term Survival Follow-up|Death|18|||
156987965|NCT03280563|566709747|FG006|Long-term Survival Follow-up|Death|11|||
156987966|NCT03280563|566709748|FG007|Long-term Survival Follow-up|Death|1|||
156987967|NCT03280563|566709749|FG008|Long-term Survival Follow-up|Death|3|||
156987968|NCT03280563|566709741|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
156987969|NCT03280563|566709742|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
156987970|NCT03280563|566709743|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
156987971|NCT03280563|566709744|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156987972|NCT03280563|566709745|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156987973|NCT03280563|566709746|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
156987974|NCT03280563|566709747|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156987975|NCT03280563|566709748|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
156987976|NCT03280563|566709749|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
156987977|NCT03280563|566709741|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156987978|NCT03280563|566709742|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156987979|NCT03280563|566709743|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156987980|NCT03280563|566709744|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156987981|NCT03280563|566709745|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
156987982|NCT03280563|566709746|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156987983|NCT03280563|566709747|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156987984|NCT03280563|566709748|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156987985|NCT03280563|566709749|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
156987986|NCT03280563|566709741|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
156987987|NCT03280563|566709742|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
156987988|NCT03280563|566709743|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
156987989|NCT03280563|566709744|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
156987990|NCT03280563|566709745|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
156987991|NCT03280563|566709746|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
156987992|NCT03280563|566709747|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
156987993|NCT03280563|566709748|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
156987994|NCT03280563|566709749|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
156987995|NCT00802841|566709750|FG000|Overall Study|Administrative problems|1|||
156987996|NCT00802841|566709751|FG001|Overall Study|Administrative problems|0|||
156987997|NCT00802841|566709750|FG000|Overall Study|Lost to Follow-up|2|||
156987998|NCT00802841|566709751|FG001|Overall Study|Lost to Follow-up|1|||
156987999|NCT00802841|566709750|FG000|Overall Study|Death|1|||
156988000|NCT00802841|566709751|FG001|Overall Study|Death|2|||
156988001|NCT00802841|566709750|FG000|Overall Study|Adverse Event|8|||
156988002|NCT00802841|566709751|FG001|Overall Study|Adverse Event|2|||
156988003|NCT00802841|566709750|FG000|Overall Study|Disease progression|7|||
156988004|NCT00802841|566709751|FG001|Overall Study|Disease progression|3|||
156988005|NCT00802841|566709750|FG000|Overall Study|Withdrawal by Subject|9|||
156988006|NCT00802841|566709751|FG001|Overall Study|Withdrawal by Subject|5|||
156988007|NCT00802841|566709750|FG000|Overall Study|Protocol deviation|2|||
156988008|NCT00802841|566709751|FG001|Overall Study|Protocol deviation|6|||
156988009|NCT00802841|566709750|FG000|Overall Study|Treatment duration completed|66|||
156988010|NCT00802841|566709751|FG001|Overall Study|Treatment duration completed|76|||
156988011|NCT00432159|566709752|FG000|Overall Study|Death|0|||
156988012|NCT00432159|566709753|FG001|Overall Study|Death|1|||
156988013|NCT00432159|566709754|FG002|Overall Study|Death|0|||
156988014|NCT00432159|566709755|FG003|Overall Study|Death|0|||
156988015|NCT00432159|566709756|FG004|Overall Study|Death|0|||
156988016|NCT00432159|566709752|FG000|Overall Study|Failure|9|||
156988017|NCT00432159|566709753|FG001|Overall Study|Failure|5|||
156988018|NCT00432159|566709754|FG002|Overall Study|Failure|3|||
156988019|NCT00432159|566709755|FG003|Overall Study|Failure|2|||
156988020|NCT00432159|566709756|FG004|Overall Study|Failure|3|||
156988021|NCT00432159|566709752|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
156988022|NCT00432159|566709753|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
156988023|NCT00432159|566709754|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
156988024|NCT00432159|566709755|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
156988025|NCT00432159|566709756|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
156988026|NCT00107380|566709757|FG000|Overall Study|Adverse Event|7|||
156988027|NCT00107380|566709757|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
156988028|NCT00107380|566709757|FG000|Overall Study|Progression/relapse|4|||
156988029|NCT00107380|566709757|FG000|Overall Study|Death|3|||
156988030|NCT00107380|566709757|FG000|Overall Study|Other - not protocol specified|7|||
156988031|NCT00107380|566709757|FG000|Overall Study|Ineligible|2|||
156988032|NCT03850444|566709758|FG000|Overall Study|Adverse Event|16|||
156988033|NCT03850444|566709759|FG001|Overall Study|Adverse Event|10|||
156988034|NCT03850444|566709758|FG000|Overall Study|Death|87|||
156988035|NCT03850444|566709759|FG001|Overall Study|Death|107|||
156988036|NCT03850444|566709758|FG000|Overall Study|Lost to Follow-up|1|||
156988037|NCT03850444|566709759|FG001|Overall Study|Lost to Follow-up|1|||
156988038|NCT03850444|566709758|FG000|Overall Study|Withdrawal by Subject|1|||
156988039|NCT03850444|566709759|FG001|Overall Study|Withdrawal by Subject|5|||
156988040|NCT03850444|566709758|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
156988041|NCT03850444|566709759|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
156988042|NCT01518257|566709762|FG000|Overall Study|Lost to Follow-up|1|||
156988043|NCT01518257|566709763|FG001|Overall Study|Lost to Follow-up|0|||
156988044|NCT01518257|566709762|FG000|Overall Study|Other Miscellaneous Reason|1|||
156988045|NCT01518257|566709763|FG001|Overall Study|Other Miscellaneous Reason|0|||
156988046|NCT02107274|566709764|FG000|Treatment vs. Placebo|Adverse Event|3|||
156988047|NCT02107274|566709765|FG001|Treatment vs. Placebo|Adverse Event|0|||
156988048|NCT02107274|566709764|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
156988049|NCT02107274|566709765|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
156988050|NCT02107274|566709764|FG000|Control Phase|Lost to Follow-up|1|||
156988051|NCT02107274|566709765|FG001|Control Phase|Lost to Follow-up|1|||
156988052|NCT02107274|566709764|FG000|Control Phase|Death|2|||
156988053|NCT02107274|566709765|FG001|Control Phase|Death|0|||
156988054|NCT02107274|566709764|FG000|Control Phase|Adverse Event|0|||
156988055|NCT02107274|566709765|FG001|Control Phase|Adverse Event|1|||
156988056|NCT01174550|566709769|FG000|Overall Study|Death|75|||
156988057|NCT01174550|566709770|FG001|Overall Study|Death|74|||
156988058|NCT01174550|566709769|FG000|Overall Study|Lost to Follow-up|652|||
156988059|NCT01174550|566709770|FG001|Overall Study|Lost to Follow-up|510|||
156988060|NCT01174550|566709769|FG000|Overall Study|Withdrawal by Subject|543|||
156988061|NCT01174550|566709770|FG001|Overall Study|Withdrawal by Subject|289|||
156988062|NCT01460381|566709771|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
156988063|NCT01460381|566709772|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
156988064|NCT01097655|566709773|FG000|Overall Study|Withdrawal by Subject|1|||
156988065|NCT01097655|566709773|FG000|Overall Study|Subject Documented Twice|1|||
156988066|NCT01097655|566709773|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
156988067|NCT02459587|566709774|FG000|3-Month Follow-up Assessment|Death|0|||
156988068|NCT02459587|566709775|FG001|3-Month Follow-up Assessment|Death|2|||
156988069|NCT02459587|566709774|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
156988070|NCT02459587|566709775|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
156988071|NCT02459587|566709774|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
156988072|NCT02459587|566709775|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
156988073|NCT02459587|566709774|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
156988074|NCT02459587|566709775|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
156988075|NCT02459587|566709774|FG000|6-month Follow-up Assessment|Death|2|||
156988076|NCT02459587|566709775|FG001|6-month Follow-up Assessment|Death|1|||
156988077|NCT02459587|566709774|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
156988078|NCT02459587|566709775|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
156988079|NCT02459587|566709774|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
156988080|NCT02459587|566709775|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
156988081|NCT02459587|566709774|FG000|12-month Follow-up Assessment|Death|2|||
156988082|NCT02459587|566709775|FG001|12-month Follow-up Assessment|Death|0|||
156988083|NCT02459587|566709774|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
156988084|NCT02459587|566709775|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
156988085|NCT02459587|566709774|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
156988086|NCT02459587|566709775|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
156988087|NCT02459587|566709774|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
156988088|NCT02459587|566709775|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
156988089|NCT01021332|566709776|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
156988090|NCT01021332|566709776|FG000|Overall Study|Adverse Event|43|||
156988091|NCT01021332|566709776|FG000|Overall Study|Lack of Efficacy|19|||
156988092|NCT01021332|566709776|FG000|Overall Study|Withdrawal of Consent|23|||
156988093|NCT01021332|566709776|FG000|Overall Study|Lost to Follow-up|4|||
156988094|NCT01021332|566709776|FG000|Overall Study|Protocol Violation|9|||
156988095|NCT01021332|566709776|FG000|Overall Study|Miscellaneous|3|||
156988096|NCT04466618|566709787|FG000|Overall Study|Withdrawal by Subject|0|||
156988097|NCT04466618|566709788|FG001|Overall Study|Withdrawal by Subject|1|||
156988098|NCT01676220|566709795|FG000|Overall Study|Randomized But Not Treated|4|||
156988099|NCT01676220|566709796|FG001|Overall Study|Randomized But Not Treated|1|||
156988100|NCT01676220|566709795|FG000|Overall Study|Adverse Event|10|||
156988101|NCT01676220|566709796|FG001|Overall Study|Adverse Event|8|||
156988102|NCT01676220|566709795|FG000|Overall Study|Lack of Efficacy|2|||
156988103|NCT01676220|566709796|FG001|Overall Study|Lack of Efficacy|5|||
156988104|NCT01676220|566709795|FG000|Overall Study|Protocol Violation|11|||
156988105|NCT01676220|566709796|FG001|Overall Study|Protocol Violation|12|||
156988106|NCT01676220|566709795|FG000|Overall Study|Received Rescue Therapy|14|||
156988107|NCT01676220|566709796|FG001|Overall Study|Received Rescue Therapy|22|||
156988108|NCT01676220|566709795|FG000|Overall Study|Personal Reason|34|||
156988109|NCT01676220|566709796|FG001|Overall Study|Personal Reason|45|||
156988110|NCT01676220|566709795|FG000|Overall Study|Lost to Follow-up|11|||
156988111|NCT01676220|566709796|FG001|Overall Study|Lost to Follow-up|18|||
156988112|NCT01676220|566709795|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
156988113|NCT01676220|566709796|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
156988114|NCT01676220|566709795|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
156988115|NCT01676220|566709796|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
156988116|NCT01676220|566709795|FG000|Overall Study|Perceived Lack of Efficacy|3|||
156988117|NCT01676220|566709796|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156988118|NCT01676220|566709795|FG000|Overall Study|Non Serious Hypoglycemia|2|||
156988119|NCT01676220|566709796|FG001|Overall Study|Non Serious Hypoglycemia|0|||
156988120|NCT01676220|566709795|FG000|Overall Study|No More Need of Insulin|1|||
156988121|NCT01676220|566709796|FG001|Overall Study|No More Need of Insulin|0|||
156988122|NCT01310868|566709797|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
156988123|NCT02411591|566709798|FG000|Overall Study|Adverse Event|0|||
156988124|NCT02411591|566709799|FG001|Overall Study|Adverse Event|4|||
156988125|NCT02411591|566709800|FG002|Overall Study|Adverse Event|2|||
156988126|NCT02411591|566709798|FG000|Overall Study|Withdrawal by Subject|0|||
156988127|NCT02411591|566709799|FG001|Overall Study|Withdrawal by Subject|3|||
156988128|NCT02411591|566709800|FG002|Overall Study|Withdrawal by Subject|0|||
156988129|NCT02411591|566709798|FG000|Overall Study|Physician Decision|0|||
156988130|NCT02411591|566709799|FG001|Overall Study|Physician Decision|3|||
156988131|NCT02411591|566709800|FG002|Overall Study|Physician Decision|1|||
156988132|NCT00750893|566709803|FG000|Overall Study|Adverse Event|5|||
156988133|NCT00750893|566709803|FG000|Overall Study|Withdrawal by Subject|10|||
156988134|NCT00750893|566709803|FG000|Overall Study|Lost to Follow-up|510|||
156988135|NCT00750893|566709803|FG000|Overall Study|Other|17|||
156988136|NCT01628874|566709804|FG000|Overall Study|Physician Decision|1|||
156988137|NCT01628874|566709805|FG001|Overall Study|Physician Decision|1|||
156988138|NCT01628874|566709804|FG000|Overall Study|Age >4 months|4|||
156988139|NCT01628874|566709805|FG001|Overall Study|Age >4 months|2|||
156988140|NCT00873093|566709806|FG000|Overall Study|Adverse Event|0|||
156988141|NCT00873093|566709807|FG001|Overall Study|Adverse Event|2|||
156988142|NCT00873093|566709808|FG002|Overall Study|Adverse Event|0|||
156988143|NCT00873093|566709809|FG003|Overall Study|Adverse Event|0|||
156988144|NCT00873093|566709810|FG004|Overall Study|Adverse Event|0|||
156988145|NCT00873093|566709806|FG000|Overall Study|Death|0|||
156988146|NCT00873093|566709807|FG001|Overall Study|Death|3|||
156988147|NCT00873093|566709808|FG002|Overall Study|Death|2|||
156988148|NCT00873093|566709809|FG003|Overall Study|Death|0|||
156988149|NCT00873093|566709810|FG004|Overall Study|Death|0|||
156988150|NCT00873093|566709806|FG000|Overall Study|Physician Decision|0|||
156988151|NCT00873093|566709807|FG001|Overall Study|Physician Decision|17|||
156988152|NCT00873093|566709808|FG002|Overall Study|Physician Decision|10|||
156988153|NCT00873093|566709809|FG003|Overall Study|Physician Decision|10|||
156988154|NCT00873093|566709810|FG004|Overall Study|Physician Decision|2|||
156988155|NCT00873093|566709806|FG000|Overall Study|Withdrawal by Subject|1|||
156988156|NCT00873093|566709807|FG001|Overall Study|Withdrawal by Subject|4|||
156988157|NCT00873093|566709808|FG002|Overall Study|Withdrawal by Subject|4|||
156988158|NCT00873093|566709809|FG003|Overall Study|Withdrawal by Subject|0|||
156988159|NCT00873093|566709810|FG004|Overall Study|Withdrawal by Subject|0|||
156988160|NCT00873093|566709806|FG000|Overall Study|Ineligible|0|||
156988161|NCT00873093|566709807|FG001|Overall Study|Ineligible|1|||
156988162|NCT00873093|566709808|FG002|Overall Study|Ineligible|0|||
156988163|NCT00873093|566709809|FG003|Overall Study|Ineligible|1|||
156988164|NCT00873093|566709810|FG004|Overall Study|Ineligible|0|||
156988165|NCT01152554|566709812|FG000|Overall Study|Withdrawal by Subject|73|||
156988166|NCT01152554|566709813|FG001|Overall Study|Withdrawal by Subject|28|||
156988167|NCT01152554|566709812|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
156988168|NCT01152554|566709813|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
156988169|NCT01152554|566709812|FG000|Overall Study|Adverse Event|67|||
156988170|NCT01152554|566709813|FG001|Overall Study|Adverse Event|14|||
156988171|NCT01152554|566709812|FG000|Overall Study|Severe non-compliance to protocol|36|||
156988172|NCT01152554|566709813|FG001|Overall Study|Severe non-compliance to protocol|14|||
156988173|NCT01152554|566709812|FG000|Overall Study|Condition under investigation worsened|5|||
156988174|NCT01152554|566709813|FG001|Overall Study|Condition under investigation worsened|2|||
156988175|NCT01152554|566709812|FG000|Overall Study|Lack of Efficacy|20|||
156988176|NCT01152554|566709813|FG001|Overall Study|Lack of Efficacy|3|||
156988177|NCT01152554|566709812|FG000|Overall Study|Study-specific withdrawal criteria|17|||
156988178|NCT01152554|566709813|FG001|Overall Study|Study-specific withdrawal criteria|8|||
156988179|NCT01152554|566709812|FG000|Overall Study|Lost to Follow-up|87|||
156988180|NCT01152554|566709813|FG001|Overall Study|Lost to Follow-up|32|||
156988181|NCT01152554|566709812|FG000|Overall Study|Other|28|||
156988182|NCT01152554|566709813|FG001|Overall Study|Other|8|||
156988183|NCT01152554|566709812|FG000|Overall Study|Death|1|||
156988184|NCT01152554|566709813|FG001|Overall Study|Death|1|||
156988185|NCT00146640|566709816|FG000|Overall Study|Adverse Event|12|||
156988186|NCT00146640|566709817|FG001|Overall Study|Adverse Event|10|||
156988187|NCT00146640|566709816|FG000|Overall Study|Medical Reasons|3|||
156988188|NCT00146640|566709817|FG001|Overall Study|Medical Reasons|0|||
156988189|NCT00146640|566709816|FG000|Overall Study|Non-Medical Reasons|8|||
156988190|NCT00146640|566709817|FG001|Overall Study|Non-Medical Reasons|4|||
156988191|NCT02117544|566709818|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
156988192|NCT02117544|566709819|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
156988193|NCT01439711|566709820|FG000|Overall Study|Ineligible|13|||
156988194|NCT01439711|566709820|FG000|Overall Study|Cancel|3|||
156988195|NCT01439711|566709820|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
156988196|NCT01439711|566709820|FG000|Overall Study|Adverse Event|5|||
156988197|NCT01439711|566709820|FG000|Overall Study|Withdrawal by Subject|3|||
156988198|NCT01439711|566709820|FG000|Overall Study|Progression During Active Tx|3|||
156988199|NCT01439711|566709820|FG000|Overall Study|Noncompliance|3|||
156988200|NCT01439711|566709820|FG000|Overall Study|No MRI|9|||
156988201|NCT04242875|566709821|FG000|Overall Study|Adverse Event|2|||
156988202|NCT02397460|566709822|FG000|Treatment Period 2|Adverse Event|0|||
156988203|NCT02397460|566709823|FG001|Treatment Period 2|Adverse Event|0|||
156988204|NCT02397460|566709824|FG002|Treatment Period 2|Adverse Event|0|||
156988205|NCT02397460|566709825|FG003|Treatment Period 2|Adverse Event|0|||
156988206|NCT02397460|566709826|FG004|Treatment Period 2|Adverse Event|0|||
156988207|NCT02397460|566709827|FG005|Treatment Period 2|Adverse Event|0|||
156988208|NCT02397460|566709828|FG006|Treatment Period 2|Adverse Event|0|||
156988209|NCT02397460|566709829|FG007|Treatment Period 2|Adverse Event|1|||
156988210|NCT02397460|566709822|FG000|Treatment Period 4|Adverse Event|0|||
156988211|NCT02397460|566709823|FG001|Treatment Period 4|Adverse Event|1|||
156988212|NCT02397460|566709824|FG002|Treatment Period 4|Adverse Event|0|||
156988213|NCT02397460|566709825|FG003|Treatment Period 4|Adverse Event|0|||
156988214|NCT02397460|566709826|FG004|Treatment Period 4|Adverse Event|0|||
156988215|NCT02397460|566709827|FG005|Treatment Period 4|Adverse Event|0|||
156988216|NCT02397460|566709828|FG006|Treatment Period 4|Adverse Event|0|||
156988217|NCT02397460|566709829|FG007|Treatment Period 4|Adverse Event|0|||
156988218|NCT02397460|566709822|FG000|Treatment Period 4|Physician Decision|0|||
156988219|NCT02397460|566709823|FG001|Treatment Period 4|Physician Decision|0|||
156988220|NCT02397460|566709824|FG002|Treatment Period 4|Physician Decision|0|||
156988221|NCT02397460|566709825|FG003|Treatment Period 4|Physician Decision|0|||
156988222|NCT02397460|566709826|FG004|Treatment Period 4|Physician Decision|1|||
156988223|NCT02397460|566709827|FG005|Treatment Period 4|Physician Decision|0|||
156988224|NCT02397460|566709828|FG006|Treatment Period 4|Physician Decision|0|||
156988225|NCT02397460|566709829|FG007|Treatment Period 4|Physician Decision|0|||
156988226|NCT01603121|566709834|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
156988227|NCT01603121|566709835|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
156988228|NCT00738530|566709836|FG000|Overall Study|Death|220|||
156988229|NCT00738530|566709837|FG001|Overall Study|Death|224|||
156988230|NCT00738530|566709836|FG000|Overall Study|Lost to Follow-up|8|||
156988231|NCT00738530|566709837|FG001|Overall Study|Lost to Follow-up|6|||
156988232|NCT00738530|566709836|FG000|Overall Study|Withdrawal by Subject|6|||
156988233|NCT00738530|566709837|FG001|Overall Study|Withdrawal by Subject|8|||
156988234|NCT01656759|566709838|FG000|Overall Study|Protocol Violation|2|||
156988235|NCT01656759|566709839|FG001|Overall Study|Protocol Violation|3|||
156988236|NCT03160079|566709848|FG000|Overall Study|Adverse Event|2|||
156988237|NCT03160079|566709849|FG001|Overall Study|Adverse Event|0|||
156988238|NCT03160079|566709848|FG000|Overall Study|Disease Progression|1|||
156988239|NCT03160079|566709849|FG001|Overall Study|Disease Progression|0|||
156988240|NCT03160079|566709848|FG000|Overall Study|Physician Decision|1|||
156988241|NCT03160079|566709849|FG001|Overall Study|Physician Decision|0|||
156988242|NCT01923428|566709859|FG000|Overall Study|Adverse Event|8|||
156988243|NCT01923428|566709860|FG001|Overall Study|Adverse Event|6|||
156988244|NCT01923428|566709861|FG002|Overall Study|Adverse Event|3|||
156988245|NCT01923428|566709862|FG003|Overall Study|Adverse Event|3|||
156988246|NCT01923428|566709859|FG000|Overall Study|Withdrawal by Subject|5|||
156988247|NCT01923428|566709860|FG001|Overall Study|Withdrawal by Subject|3|||
156988248|NCT01923428|566709861|FG002|Overall Study|Withdrawal by Subject|0|||
156988249|NCT01923428|566709862|FG003|Overall Study|Withdrawal by Subject|4|||
156988250|NCT01923428|566709859|FG000|Overall Study|Lost to Follow-up|2|||
156988251|NCT01923428|566709860|FG001|Overall Study|Lost to Follow-up|1|||
156988252|NCT01923428|566709861|FG002|Overall Study|Lost to Follow-up|5|||
156988253|NCT01923428|566709862|FG003|Overall Study|Lost to Follow-up|0|||
156988254|NCT01923428|566709859|FG000|Overall Study|Protocol Violation|3|||
156988255|NCT01923428|566709860|FG001|Overall Study|Protocol Violation|0|||
156988256|NCT01923428|566709861|FG002|Overall Study|Protocol Violation|2|||
156988257|NCT01923428|566709862|FG003|Overall Study|Protocol Violation|1|||
156988258|NCT01923428|566709859|FG000|Overall Study|Non Compliance to treatment|1|||
156988259|NCT01923428|566709860|FG001|Overall Study|Non Compliance to treatment|2|||
156988260|NCT01923428|566709861|FG002|Overall Study|Non Compliance to treatment|0|||
156988261|NCT01923428|566709862|FG003|Overall Study|Non Compliance to treatment|1|||
156988262|NCT01923428|566709859|FG000|Overall Study|Lack of Efficacy|0|||
156988263|NCT01923428|566709860|FG001|Overall Study|Lack of Efficacy|0|||
156988264|NCT01923428|566709861|FG002|Overall Study|Lack of Efficacy|1|||
156988265|NCT01923428|566709862|FG003|Overall Study|Lack of Efficacy|1|||
156988266|NCT01368211|566709866|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
156988267|NCT01368211|566709867|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
156988268|NCT01513967|566709871|FG000|Overall Study|Pregnancy|0|||
156988269|NCT01513967|566709872|FG001|Overall Study|Pregnancy|0|||
156988270|NCT01513967|566709873|FG002|Overall Study|Pregnancy|0|||
156988271|NCT01513967|566709874|FG003|Overall Study|Pregnancy|0|||
156988272|NCT01513967|566709875|FG004|Overall Study|Pregnancy|0|||
156988273|NCT01513967|566709876|FG005|Overall Study|Pregnancy|0|||
156988274|NCT01513967|566709877|FG006|Overall Study|Pregnancy|1|||
156988275|NCT01513967|566709878|FG007|Overall Study|Pregnancy|0|||
156988276|NCT01513967|566709871|FG000|Overall Study|missed a study visit|0|||
156988277|NCT01513967|566709872|FG001|Overall Study|missed a study visit|0|||
156988278|NCT01513967|566709873|FG002|Overall Study|missed a study visit|0|||
156988279|NCT01513967|566709874|FG003|Overall Study|missed a study visit|0|||
156988280|NCT01513967|566709875|FG004|Overall Study|missed a study visit|0|||
156988281|NCT01513967|566709876|FG005|Overall Study|missed a study visit|0|||
156988282|NCT01513967|566709877|FG006|Overall Study|missed a study visit|1|||
156988283|NCT01513967|566709878|FG007|Overall Study|missed a study visit|0|||
156988284|NCT01513967|566709871|FG000|Overall Study|excluded due to positive drug screen|0|||
156988285|NCT01513967|566709872|FG001|Overall Study|excluded due to positive drug screen|0|||
156988286|NCT01513967|566709873|FG002|Overall Study|excluded due to positive drug screen|0|||
156988287|NCT01513967|566709874|FG003|Overall Study|excluded due to positive drug screen|0|||
156988288|NCT01513967|566709875|FG004|Overall Study|excluded due to positive drug screen|0|||
156988289|NCT01513967|566709876|FG005|Overall Study|excluded due to positive drug screen|0|||
156988290|NCT01513967|566709877|FG006|Overall Study|excluded due to positive drug screen|0|||
156988291|NCT01513967|566709878|FG007|Overall Study|excluded due to positive drug screen|2|||
156988292|NCT01513967|566709871|FG000|Overall Study|Physician Decision|0|||
156988293|NCT01513967|566709872|FG001|Overall Study|Physician Decision|0|||
156988294|NCT01513967|566709873|FG002|Overall Study|Physician Decision|0|||
156988295|NCT01513967|566709874|FG003|Overall Study|Physician Decision|0|||
156988296|NCT01513967|566709875|FG004|Overall Study|Physician Decision|0|||
156988297|NCT01513967|566709876|FG005|Overall Study|Physician Decision|1|||
156988298|NCT01513967|566709877|FG006|Overall Study|Physician Decision|0|||
156988299|NCT01513967|566709878|FG007|Overall Study|Physician Decision|0|||
156988300|NCT02906202|566709879|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
156988301|NCT01563978|566709880|FG000|Overall Study|Physician Decision|1|||
156988302|NCT01563978|566709881|FG001|Overall Study|Physician Decision|0|||
156988303|NCT01563978|566709880|FG000|Overall Study|Lost to Follow-up|1|||
156988304|NCT01563978|566709881|FG001|Overall Study|Lost to Follow-up|0|||
156988305|NCT01563978|566709880|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
156988306|NCT01563978|566709881|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
156988307|NCT01563978|566709880|FG000|Overall Study|Adverse Event|1|||
156988308|NCT01563978|566709881|FG001|Overall Study|Adverse Event|2|||
156988309|NCT05764239|566709882|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
156988310|NCT05764239|566709882|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
156988311|NCT05764239|566709882|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
156988312|NCT05764239|566709882|FG000|DEP (Part 1)|Adverse Event|1|||
156988313|NCT05764239|566709882|FG000|DEP (Part 1)|Lost to Follow-up|1|||
156988314|NCT05764239|566709882|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
156988315|NCT05764239|566709882|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
156988316|NCT05764239|566709882|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
156988317|NCT05764239|566709882|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
156988318|NCT04630756|566709883|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
156988319|NCT04630756|566709884|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
156988320|NCT04630756|566709885|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
156988321|NCT02388074|566709888|FG000|Overall Study|Lost in Transit|2|||
156988322|NCT02388074|566709888|FG000|Overall Study|Sample Not Returned|1|||
156988323|NCT07083843|566709893|FG000|Intervention period.|Withdrawal by Subject|1|||
156988324|NCT07083843|566709894|FG001|Intervention period.|Withdrawal by Subject|0|||
156988325|NCT07083843|566709893|FG000|Intervention period.|Death|0|||
156988326|NCT07083843|566709894|FG001|Intervention period.|Death|1|||
156988327|NCT01939158|566711740|FG000|Overall Study|Adverse Event|1|||
156988328|NCT01939158|566711741|FG001|Overall Study|Adverse Event|0|||
156988329|NCT01939158|566711742|FG002|Overall Study|Adverse Event|0|||
156988330|NCT01939158|566711743|FG003|Overall Study|Adverse Event|0|||
156988331|NCT01939158|566711740|FG000|Overall Study|Withdrawal by Subject|22|||
156988332|NCT01939158|566711741|FG001|Overall Study|Withdrawal by Subject|25|||
156988333|NCT01939158|566711742|FG002|Overall Study|Withdrawal by Subject|15|||
156988334|NCT01939158|566711743|FG003|Overall Study|Withdrawal by Subject|17|||
156988335|NCT01939158|566711740|FG000|Overall Study|Migrated/moved from study area|5|||
156988336|NCT01939158|566711741|FG001|Overall Study|Migrated/moved from study area|7|||
156988337|NCT01939158|566711742|FG002|Overall Study|Migrated/moved from study area|3|||
156988338|NCT01939158|566711743|FG003|Overall Study|Migrated/moved from study area|6|||
156988339|NCT01939158|566711740|FG000|Overall Study|Lost to Follow-up|18|||
156988340|NCT01939158|566711741|FG001|Overall Study|Lost to Follow-up|17|||
156988341|NCT01939158|566711742|FG002|Overall Study|Lost to Follow-up|17|||
156988342|NCT01939158|566711743|FG003|Overall Study|Lost to Follow-up|17|||
156988343|NCT01939158|566711740|FG000|Overall Study|Death|0|||
156988344|NCT01939158|566711741|FG001|Overall Study|Death|0|||
156988345|NCT01939158|566711742|FG002|Overall Study|Death|1|||
156988346|NCT01939158|566711743|FG003|Overall Study|Death|1|||
156988347|NCT01939158|566711740|FG000|Overall Study|No longer meets eligibility criteria|0|||
156988348|NCT01939158|566711741|FG001|Overall Study|No longer meets eligibility criteria|0|||
156988349|NCT01939158|566711742|FG002|Overall Study|No longer meets eligibility criteria|1|||
156988350|NCT01939158|566711743|FG003|Overall Study|No longer meets eligibility criteria|0|||
156988351|NCT01939158|566711740|FG000|Overall Study|Other|1|||
156988352|NCT01939158|566711741|FG001|Overall Study|Other|3|||
156988353|NCT01939158|566711742|FG002|Overall Study|Other|4|||
156988354|NCT01939158|566711743|FG003|Overall Study|Other|3|||
156988355|NCT05310084|566711744|FG000|Overall Study|Withdrawal by Subject|2|||
156988356|NCT05310084|566711745|FG001|Overall Study|Withdrawal by Subject|3|||
156988357|NCT05310084|566711744|FG000|Overall Study|Participant availability|0|||
156988358|NCT05310084|566711745|FG001|Overall Study|Participant availability|4|||
156988359|NCT05310084|566711744|FG000|Overall Study|Lost to Follow-up|1|||
156988360|NCT05310084|566711745|FG001|Overall Study|Lost to Follow-up|1|||
156988361|NCT05310084|566711744|FG000|Overall Study|Adverse Event|1|||
156988362|NCT05310084|566711745|FG001|Overall Study|Adverse Event|1|||
156988363|NCT05310084|566711744|FG000|Overall Study|Randomized but not vaccinated|4|||
156988364|NCT05310084|566711745|FG001|Overall Study|Randomized but not vaccinated|2|||
156988365|NCT02065245|566711747|FG000|Infusion 1|Lost to Follow-up|0|||
156988366|NCT02065245|566711748|FG001|Infusion 1|Lost to Follow-up|0|||
156988367|NCT02065245|566711749|FG002|Infusion 1|Lost to Follow-up|0|||
156988368|NCT02065245|566711750|FG003|Infusion 1|Lost to Follow-up|0|||
156988369|NCT02065245|566711751|FG004|Infusion 1|Lost to Follow-up|0|||
156988370|NCT02065245|566711752|FG005|Infusion 1|Lost to Follow-up|0|||
156988371|NCT02065245|566711753|FG006|Infusion 1|Lost to Follow-up|1|||
156988372|NCT02065245|566711747|FG000|Infusion 1|Death|0|||
156988373|NCT02065245|566711748|FG001|Infusion 1|Death|0|||
156988374|NCT02065245|566711749|FG002|Infusion 1|Death|1|||
156988375|NCT02065245|566711750|FG003|Infusion 1|Death|0|||
156988376|NCT02065245|566711751|FG004|Infusion 1|Death|1|||
156988377|NCT02065245|566711752|FG005|Infusion 1|Death|0|||
156988378|NCT02065245|566711753|FG006|Infusion 1|Death|0|||
156988379|NCT02065245|566711747|FG000|Infusion 2|Death|0|||
156988380|NCT02065245|566711748|FG001|Infusion 2|Death|0|||
156988381|NCT02065245|566711749|FG002|Infusion 2|Death|0|||
156988382|NCT02065245|566711750|FG003|Infusion 2|Death|0|||
156988383|NCT02065245|566711751|FG004|Infusion 2|Death|0|||
156988384|NCT02065245|566711752|FG005|Infusion 2|Death|0|||
156988385|NCT02065245|566711753|FG006|Infusion 2|Death|1|||
156988386|NCT02065245|566711747|FG000|Infusion 3|Lost to Follow-up|1|||
156988387|NCT02065245|566711748|FG001|Infusion 3|Lost to Follow-up|1|||
156988388|NCT02065245|566711749|FG002|Infusion 3|Lost to Follow-up|0|||
156988389|NCT02065245|566711750|FG003|Infusion 3|Lost to Follow-up|0|||
156988390|NCT02065245|566711751|FG004|Infusion 3|Lost to Follow-up|0|||
156988391|NCT02065245|566711752|FG005|Infusion 3|Lost to Follow-up|0|||
156988392|NCT02065245|566711753|FG006|Infusion 3|Lost to Follow-up|0|||
156988393|NCT01598987|566711754|FG000|Baseline to Month 12|Administrative problems|2|||
156988394|NCT01598987|566711754|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
156988395|NCT01598987|566711754|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
156988396|NCT01598987|566711754|FG000|Baseline to 24 Month|Administrative problems|2|||
156988397|NCT01598987|566711754|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
156988398|NCT00924664|566711755|FG000|Overall Study|Adverse Event|23|||
156988399|NCT00924664|566711756|FG001|Overall Study|Adverse Event|39|||
156988400|NCT00924664|566711755|FG000|Overall Study|Lack of Efficacy|10|||
156988401|NCT00924664|566711756|FG001|Overall Study|Lack of Efficacy|15|||
156988402|NCT00924664|566711755|FG000|Overall Study|Lost to Follow-up|10|||
156988403|NCT00924664|566711756|FG001|Overall Study|Lost to Follow-up|12|||
156988404|NCT00924664|566711755|FG000|Overall Study|Withdrawal by Subject|47|||
156988405|NCT00924664|566711756|FG001|Overall Study|Withdrawal by Subject|71|||
156988406|NCT00924664|566711755|FG000|Overall Study|Protocol Violation|2|||
156988407|NCT00924664|566711756|FG001|Overall Study|Protocol Violation|5|||
156988408|NCT00924664|566711755|FG000|Overall Study|Pregnancy|1|||
156988409|NCT00924664|566711756|FG001|Overall Study|Pregnancy|1|||
156988410|NCT00924664|566711755|FG000|Overall Study|Death|0|||
156988411|NCT00924664|566711756|FG001|Overall Study|Death|2|||
156988412|NCT00924664|566711755|FG000|Overall Study|Study terminated by sponsor|199|||
156988413|NCT00924664|566711756|FG001|Overall Study|Study terminated by sponsor|330|||
156988414|NCT00924664|566711755|FG000|Overall Study|Other|29|||
156988415|NCT00924664|566711756|FG001|Overall Study|Other|52|||
156988416|NCT00924664|566711755|FG000|Overall Study|Randomized but not Treated|1|||
156988417|NCT00924664|566711756|FG001|Overall Study|Randomized but not Treated|0|||
156988418|NCT03531905|566711757|FG000|Overall Study|Withdrawal by Subject|3|||
156988419|NCT03531905|566711758|FG001|Overall Study|Withdrawal by Subject|3|||
156988420|NCT03531905|566711759|FG002|Overall Study|Withdrawal by Subject|2|||
156988421|NCT03531905|566711757|FG000|Overall Study|Lost to Follow-up|2|||
156988422|NCT03531905|566711758|FG001|Overall Study|Lost to Follow-up|2|||
156988423|NCT03531905|566711759|FG002|Overall Study|Lost to Follow-up|1|||
156988424|NCT03531905|566711757|FG000|Overall Study|Participant was out of town|1|||
156988425|NCT03531905|566711758|FG001|Overall Study|Participant was out of town|0|||
156988426|NCT03531905|566711759|FG002|Overall Study|Participant was out of town|0|||
156988427|NCT03531905|566711757|FG000|Overall Study|Could not speak with the participant|1|||
156988428|NCT03531905|566711758|FG001|Overall Study|Could not speak with the participant|0|||
156988429|NCT03531905|566711759|FG002|Overall Study|Could not speak with the participant|0|||
156988430|NCT05305040|566711762|FG000|Overall Study|Not Dosed|37|||
156988431|NCT05305040|566711763|FG001|Overall Study|Not Dosed|37|||
156988432|NCT05305040|566711762|FG000|Overall Study|Study Closure|34|||
156988433|NCT05305040|566711763|FG001|Overall Study|Study Closure|46|||
156988434|NCT05305040|566711762|FG000|Overall Study|Death|14|||
156988435|NCT05305040|566711763|FG001|Overall Study|Death|13|||
156988436|NCT05305040|566711762|FG000|Overall Study|Withdrawal by Subject|15|||
156988437|NCT05305040|566711763|FG001|Overall Study|Withdrawal by Subject|10|||
156988438|NCT05305040|566711762|FG000|Overall Study|Other|13|||
156988439|NCT05305040|566711763|FG001|Overall Study|Other|10|||
156988440|NCT05305040|566711762|FG000|Overall Study|Primary Malignancy Relapse|3|||
156988441|NCT05305040|566711763|FG001|Overall Study|Primary Malignancy Relapse|4|||
156988442|NCT05305040|566711762|FG000|Overall Study|Adverse Event|3|||
156988443|NCT05305040|566711763|FG001|Overall Study|Adverse Event|3|||
156988444|NCT05305040|566711762|FG000|Overall Study|Lost to Follow-up|2|||
156988445|NCT05305040|566711763|FG001|Overall Study|Lost to Follow-up|1|||
156988446|NCT05305040|566711762|FG000|Overall Study|Graft versus host disease|2|||
156988447|NCT05305040|566711763|FG001|Overall Study|Graft versus host disease|0|||
156988448|NCT05305040|566711762|FG000|Overall Study|Investigator's Decision|1|||
156988449|NCT05305040|566711763|FG001|Overall Study|Investigator's Decision|1|||
156988450|NCT05305040|566711762|FG000|Overall Study|COVID-19 Reasons|1|||
156988451|NCT05305040|566711763|FG001|Overall Study|COVID-19 Reasons|0|||
156988452|NCT01195675|566711764|FG000|Overall Study|Adverse Event|1|||
156988453|NCT01195675|566711764|FG000|Overall Study|Withdrawal by Subject|2|||
156988454|NCT01536262|566711765|FG000|Overall Study|Adverse Event|6|||
156988455|NCT01536262|566711766|FG001|Overall Study|Adverse Event|1|||
156988456|NCT01536262|566711767|FG002|Overall Study|Adverse Event|2|||
156988457|NCT01536262|566711765|FG000|Overall Study|Withdrawal by Subject|1|||
156988458|NCT01536262|566711766|FG001|Overall Study|Withdrawal by Subject|1|||
156988459|NCT01536262|566711767|FG002|Overall Study|Withdrawal by Subject|0|||
156988460|NCT01536262|566711765|FG000|Overall Study|Other than stated above|1|||
156988461|NCT01536262|566711766|FG001|Overall Study|Other than stated above|0|||
156988462|NCT01536262|566711767|FG002|Overall Study|Other than stated above|0|||
156988463|NCT01033643|566711771|FG000|Overall Study|Withdrew Consent|0|||
156988464|NCT01033643|566711772|FG001|Overall Study|Withdrew Consent|3|||
156988465|NCT01033643|566711773|FG002|Overall Study|Withdrew Consent|0|||
156988466|NCT01033643|566711774|FG003|Overall Study|Withdrew Consent|0|||
156988467|NCT01033643|566711775|FG004|Overall Study|Withdrew Consent|0|||
156988468|NCT01033643|566711776|FG005|Overall Study|Withdrew Consent|1|||
156988469|NCT03527277|566711777|FG000|Overall Study|Withdrawal by Subject|5|||
156988470|NCT03527277|566711778|FG001|Overall Study|Withdrawal by Subject|0|||
156988471|NCT03527277|566711777|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
156988472|NCT03527277|566711778|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
156988473|NCT03527277|566711777|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
156988474|NCT03527277|566711778|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
156988475|NCT01781611|566711779|FG000|Overall Study|Adverse Event|4|||
156988476|NCT01781611|566711780|FG001|Overall Study|Adverse Event|0|||
156988477|NCT01333943|566711781|FG000|Overall Study|Known neuropathy|1|||
156988478|NCT01333943|566711782|FG001|Overall Study|Known neuropathy|0|||
156988479|NCT02652130|566711789|FG000|Overall Study|Death|1|||
156988480|NCT02028884|566711792|FG000|Double-blind Period|Adverse Event|5|||
156988481|NCT02028884|566711793|FG001|Double-blind Period|Adverse Event|3|||
156988482|NCT02028884|566711794|FG002|Double-blind Period|Adverse Event|0|||
156988483|NCT02028884|566711792|FG000|Double-blind Period|Eligibility Violation|1|||
156988484|NCT02028884|566711793|FG001|Double-blind Period|Eligibility Violation|0|||
156988485|NCT02028884|566711794|FG002|Double-blind Period|Eligibility Violation|0|||
156988486|NCT02028884|566711792|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
156988487|NCT02028884|566711793|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
156988488|NCT02028884|566711794|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
156988489|NCT02028884|566711792|FG000|Double-blind Period|Withdrawal by Subject|2|||
156988490|NCT02028884|566711793|FG001|Double-blind Period|Withdrawal by Subject|0|||
156988491|NCT02028884|566711794|FG002|Double-blind Period|Withdrawal by Subject|0|||
156988492|NCT02028884|566711792|FG000|Open-label Extension Period|Adverse Event|3|||
156988493|NCT02028884|566711793|FG001|Open-label Extension Period|Adverse Event|1|||
156988494|NCT02028884|566711794|FG002|Open-label Extension Period|Adverse Event|0|||
156988495|NCT02028884|566711792|FG000|Open-label Extension Period|Lack of Efficacy|3|||
156988496|NCT02028884|566711793|FG001|Open-label Extension Period|Lack of Efficacy|0|||
156988497|NCT02028884|566711794|FG002|Open-label Extension Period|Lack of Efficacy|0|||
156988498|NCT02028884|566711792|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156988499|NCT02028884|566711793|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
156988500|NCT02028884|566711794|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156988501|NCT02028884|566711792|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156988502|NCT02028884|566711793|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
156988503|NCT02028884|566711794|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
156988504|NCT02028884|566711792|FG000|Open-label Extension Period|Switched to another treatment option|3|||
156988505|NCT02028884|566711793|FG001|Open-label Extension Period|Switched to another treatment option|0|||
156988506|NCT02028884|566711794|FG002|Open-label Extension Period|Switched to another treatment option|0|||
156988507|NCT00354029|566711795|FG000|Overall Study|Protocol Violation|4|||
156988508|NCT00354029|566711796|FG001|Overall Study|Protocol Violation|2|||
156988509|NCT00826280|566711797|FG000|Overall Study|Randomized but drug not received|1|||
156988510|NCT00826280|566711798|FG001|Overall Study|Randomized but drug not received|0|||
156988511|NCT00826280|566711799|FG002|Overall Study|Randomized but drug not received|1|||
156988512|NCT00826280|566711797|FG000|Overall Study|Adverse Event|1|||
156988513|NCT00826280|566711798|FG001|Overall Study|Adverse Event|3|||
156988514|NCT00826280|566711799|FG002|Overall Study|Adverse Event|0|||
156988515|NCT00826280|566711797|FG000|Overall Study|Lost to Follow-up|0|||
156988516|NCT00826280|566711798|FG001|Overall Study|Lost to Follow-up|1|||
156988517|NCT00826280|566711799|FG002|Overall Study|Lost to Follow-up|0|||
156988518|NCT00826280|566711797|FG000|Overall Study|Sponsor discontinued subject or study|1|||
156988519|NCT00826280|566711798|FG001|Overall Study|Sponsor discontinued subject or study|0|||
156988520|NCT00826280|566711799|FG002|Overall Study|Sponsor discontinued subject or study|0|||
156988521|NCT00826280|566711797|FG000|Overall Study|Reversible ischemic defect not present|43|||
156988522|NCT00826280|566711798|FG001|Overall Study|Reversible ischemic defect not present|40|||
156988523|NCT00826280|566711799|FG002|Overall Study|Reversible ischemic defect not present|44|||
156988524|NCT00826280|566711797|FG000|Overall Study|Interpretation Failure|1|||
156988525|NCT00826280|566711798|FG001|Overall Study|Interpretation Failure|0|||
157096953|NCT00723021|567109308|FG000|Intervention Period 4|Adverse Event|0|||
157096954|NCT00723021|567109309|FG001|Intervention Period 4|Adverse Event|0|||
157096955|NCT00723021|567109310|FG002|Intervention Period 4|Adverse Event|0|||
156988526|NCT00826280|566711799|FG002|Overall Study|Interpretation Failure|0|||
156988527|NCT00826280|566711797|FG000|Overall Study|Machine Failure|1|||
156988528|NCT00826280|566711798|FG001|Overall Study|Machine Failure|1|||
156988529|NCT00826280|566711799|FG002|Overall Study|Machine Failure|0|||
156988530|NCT00826280|566711797|FG000|Overall Study|One or more non-interpretable scan|0|||
156988531|NCT00826280|566711798|FG001|Overall Study|One or more non-interpretable scan|1|||
156988532|NCT00826280|566711799|FG002|Overall Study|One or more non-interpretable scan|1|||
156988533|NCT01364727|566711804|FG000|Overall Study|Not Eligible|2|||
156988534|NCT04227340|566711805|FG000|Overall Study|Withdrawal by Subject|3|||
156988535|NCT03486899|566711812|FG000|Overall Study|Lost to Follow-up|4|||
156988536|NCT03486899|566711813|FG001|Overall Study|Lost to Follow-up|1|||
156988537|NCT03486899|566711814|FG002|Overall Study|Lost to Follow-up|4|||
156988538|NCT03486899|566711815|FG003|Overall Study|Lost to Follow-up|3|||
156988539|NCT03486899|566711812|FG000|Overall Study|Death|1|||
156988540|NCT03486899|566711813|FG001|Overall Study|Death|0|||
156988541|NCT03486899|566711814|FG002|Overall Study|Death|0|||
156988542|NCT03486899|566711815|FG003|Overall Study|Death|1|||
156988543|NCT03486899|566711812|FG000|Overall Study|Adverse Event|0|||
156988544|NCT03486899|566711813|FG001|Overall Study|Adverse Event|2|||
156988545|NCT03486899|566711814|FG002|Overall Study|Adverse Event|0|||
156988546|NCT03486899|566711815|FG003|Overall Study|Adverse Event|2|||
156988547|NCT03486899|566711812|FG000|Overall Study|Withdrawal by Subject|3|||
156988548|NCT03486899|566711813|FG001|Overall Study|Withdrawal by Subject|7|||
156988549|NCT03486899|566711814|FG002|Overall Study|Withdrawal by Subject|4|||
156988550|NCT03486899|566711815|FG003|Overall Study|Withdrawal by Subject|3|||
156988551|NCT03486899|566711812|FG000|Overall Study|Other Reasons|0|||
156988552|NCT03486899|566711813|FG001|Overall Study|Other Reasons|1|||
156988553|NCT03486899|566711814|FG002|Overall Study|Other Reasons|0|||
156988554|NCT03486899|566711815|FG003|Overall Study|Other Reasons|1|||
156988555|NCT01723826|566711816|FG000|Overall Study|Adverse Event|4|||
156988556|NCT01723826|566711817|FG001|Overall Study|Adverse Event|1|||
156988557|NCT01723826|566711818|FG002|Overall Study|Adverse Event|4|||
156988558|NCT01723826|566711819|FG003|Overall Study|Adverse Event|5|||
156988559|NCT01723826|566711816|FG000|Overall Study|Death according to AE eCRF|2|||
156988560|NCT01723826|566711817|FG001|Overall Study|Death according to AE eCRF|3|||
156988561|NCT01723826|566711818|FG002|Overall Study|Death according to AE eCRF|3|||
156988562|NCT01723826|566711819|FG003|Overall Study|Death according to AE eCRF|7|||
156988563|NCT01723826|566711816|FG000|Overall Study|Lost to Follow-up|1|||
156988564|NCT01723826|566711817|FG001|Overall Study|Lost to Follow-up|3|||
156988565|NCT01723826|566711818|FG002|Overall Study|Lost to Follow-up|1|||
156988566|NCT01723826|566711819|FG003|Overall Study|Lost to Follow-up|1|||
156988567|NCT01723826|566711816|FG000|Overall Study|Non-compliance|0|||
156988568|NCT01723826|566711817|FG001|Overall Study|Non-compliance|1|||
156988569|NCT01723826|566711818|FG002|Overall Study|Non-compliance|3|||
156988570|NCT01723826|566711819|FG003|Overall Study|Non-compliance|3|||
156988571|NCT01723826|566711816|FG000|Overall Study|Non-compliance With Study Drug|0|||
156988572|NCT01723826|566711817|FG001|Overall Study|Non-compliance With Study Drug|1|||
156988573|NCT01723826|566711818|FG002|Overall Study|Non-compliance With Study Drug|0|||
156988574|NCT01723826|566711819|FG003|Overall Study|Non-compliance With Study Drug|0|||
156988575|NCT01723826|566711816|FG000|Overall Study|Other Reason|8|||
156988576|NCT01723826|566711817|FG001|Overall Study|Other Reason|6|||
156988577|NCT01723826|566711818|FG002|Overall Study|Other Reason|12|||
156988578|NCT01723826|566711819|FG003|Overall Study|Other Reason|14|||
156988579|NCT01723826|566711816|FG000|Overall Study|Physician Decision|1|||
156988580|NCT01723826|566711817|FG001|Overall Study|Physician Decision|3|||
156988581|NCT01723826|566711818|FG002|Overall Study|Physician Decision|4|||
156988582|NCT01723826|566711819|FG003|Overall Study|Physician Decision|11|||
156988583|NCT01723826|566711816|FG000|Overall Study|Protocol Violation|1|||
156988584|NCT01723826|566711817|FG001|Overall Study|Protocol Violation|1|||
156988585|NCT01723826|566711818|FG002|Overall Study|Protocol Violation|3|||
156988586|NCT01723826|566711819|FG003|Overall Study|Protocol Violation|1|||
156988587|NCT01723826|566711816|FG000|Overall Study|Withdrawal by Subject|10|||
157096956|NCT00723021|567109311|FG003|Intervention Period 4|Adverse Event|0|||
156988588|NCT01723826|566711817|FG001|Overall Study|Withdrawal by Subject|17|||
156988589|NCT01723826|566711818|FG002|Overall Study|Withdrawal by Subject|27|||
156988590|NCT01723826|566711819|FG003|Overall Study|Withdrawal by Subject|48|||
156988591|NCT01767129|566711820|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156988592|NCT01767129|566711821|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
157096957|NCT00723021|567109312|FG004|Intervention Period 4|Adverse Event|1|||
157096958|NCT02739360|567109314|FG000|Overall Study|Adverse Event|1|||
157096959|NCT02739360|567109314|FG000|Overall Study|Study terminated by Sponsor|2|||
157096960|NCT00026208|567109317|FG000|Overall Study|Complications of auto accident|1|||
157096961|NCT00026208|567109318|FG001|Overall Study|Complications of auto accident|0|||
157096962|NCT02881957|567109325|FG000|Overall Study|Comfort care|0|||
157096963|NCT02881957|567109326|FG001|Overall Study|Comfort care|1|||
157096964|NCT02881957|567109325|FG000|Overall Study|Concurrent trial enrollment|0|||
157096965|NCT02881957|567109326|FG001|Overall Study|Concurrent trial enrollment|1|||
157096966|NCT02881957|567109325|FG000|Overall Study|Discharged within 48 hours|0|||
157096967|NCT02881957|567109326|FG001|Overall Study|Discharged within 48 hours|1|||
157096968|NCT02881957|567109325|FG000|Overall Study|Withdrawal by Subject|2|||
157096969|NCT02881957|567109326|FG001|Overall Study|Withdrawal by Subject|1|||
157096970|NCT02881957|567109325|FG000|Overall Study|Protocol Violation|1|||
156988593|NCT01473420|566711824|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
156988594|NCT01473420|566711825|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
156988595|NCT01473420|566711824|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
156988596|NCT01473420|566711825|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
156988597|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
156988598|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
156988599|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
156988600|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
157096971|NCT02881957|567109326|FG001|Overall Study|Protocol Violation|0|||
156988601|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
156988602|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
156988603|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
156988604|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
156988605|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
156988606|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
156988607|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
156988608|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
156988609|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
156988610|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
156988611|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
156988612|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
156988613|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
156988614|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
156988615|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
156988616|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
156988617|NCT01473420|566711824|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
156988618|NCT01473420|566711825|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
156988619|NCT04172987|566711826|FG000|Lead In Period|Adverse Event|1|||
156988620|NCT04172987|566711826|FG000|Lead In Period|Protocol Violation|1|||
156988621|NCT04172987|566711826|FG000|Period 1|Physician Decision|1|||
156988622|NCT04172987|566711826|FG000|Period 2|Adverse Event|5|||
156988623|NCT04172987|566711826|FG000|Period 2|Dosing Termination by Sponsor|4|||
156988624|NCT04770220|566711829|FG000|Overall Study|Adverse Event|2|||
156988625|NCT04770220|566711830|FG001|Overall Study|Adverse Event|11|||
156988626|NCT04770220|566711829|FG000|Overall Study|Withdrawal by Subject|5|||
156988627|NCT04770220|566711830|FG001|Overall Study|Withdrawal by Subject|11|||
156988628|NCT04770220|566711829|FG000|Overall Study|Lost to Follow-up|4|||
156988629|NCT04770220|566711830|FG001|Overall Study|Lost to Follow-up|3|||
156988630|NCT04770220|566711829|FG000|Overall Study|not otherwise specified|2|||
156988631|NCT04770220|566711830|FG001|Overall Study|not otherwise specified|3|||
156988632|NCT04770220|566711829|FG000|Overall Study|Physician Decision|1|||
156988633|NCT04770220|566711830|FG001|Overall Study|Physician Decision|3|||
156988634|NCT04894903|566711832|FG000|Overall Study|Death|1|||
156988635|NCT04894903|566711833|FG001|Overall Study|Death|0|||
156988636|NCT04894903|566711832|FG000|Overall Study|Pregnancy|1|||
156988637|NCT04894903|566711833|FG001|Overall Study|Pregnancy|0|||
156988638|NCT04894903|566711832|FG000|Overall Study|Withdrawal by Subject|1|||
156988639|NCT04894903|566711833|FG001|Overall Study|Withdrawal by Subject|1|||
156988640|NCT04894903|566711832|FG000|Overall Study|moved or exited health system|1|||
156988641|NCT04894903|566711833|FG001|Overall Study|moved or exited health system|3|||
156988642|NCT04320615|566711835|FG000|Overall Study|Withdrawal by Subject|4|||
156988643|NCT04320615|566711836|FG001|Overall Study|Withdrawal by Subject|10|||
156988644|NCT04320615|566711835|FG000|Overall Study|Physician Decision|2|||
156988645|NCT04320615|566711836|FG001|Overall Study|Physician Decision|0|||
156988646|NCT04320615|566711835|FG000|Overall Study|Other|2|||
156988647|NCT04320615|566711836|FG001|Overall Study|Other|0|||
156988648|NCT04320615|566711835|FG000|Overall Study|Lost to Follow-up|5|||
156988649|NCT04320615|566711836|FG001|Overall Study|Lost to Follow-up|23|||
156988650|NCT04320615|566711835|FG000|Overall Study|Death|35|||
156988651|NCT04320615|566711836|FG001|Overall Study|Death|71|||
156988652|NCT01857323|566711838|FG000|Overall Study|Adverse Event|1|||
156988653|NCT01857323|566711838|FG000|Overall Study|Withdrawal by Subject|3|||
156988654|NCT01857323|566711838|FG000|Overall Study|Non-compliance|1|||
156988655|NCT01857323|566711838|FG000|Overall Study|Protocol Violation|6|||
156988656|NCT01857323|566711838|FG000|Overall Study|Lost to Follow-up|1|||
156988657|NCT01857323|566711838|FG000|Overall Study|Other|4|||
156988658|NCT01857323|566711838|FG000|Overall Study|Did not complete 180 doses|48|||
156988659|NCT03873246|566711839|FG000|Overall Study|Adverse Event|1|||
156988660|NCT03873246|566711840|FG001|Overall Study|Adverse Event|3|||
156988661|NCT03873246|566711841|FG002|Overall Study|Adverse Event|3|||
156988662|NCT03873246|566711839|FG000|Overall Study|Lost to Follow-up|4|||
156988663|NCT03873246|566711840|FG001|Overall Study|Lost to Follow-up|4|||
156988664|NCT03873246|566711841|FG002|Overall Study|Lost to Follow-up|5|||
156988665|NCT03873246|566711839|FG000|Overall Study|Protocol Violation|0|||
156988666|NCT03873246|566711840|FG001|Overall Study|Protocol Violation|1|||
156988667|NCT03873246|566711841|FG002|Overall Study|Protocol Violation|0|||
156988668|NCT03873246|566711839|FG000|Overall Study|Withdrawal by Subject|0|||
156988669|NCT03873246|566711840|FG001|Overall Study|Withdrawal by Subject|4|||
156988670|NCT03873246|566711841|FG002|Overall Study|Withdrawal by Subject|1|||
156988671|NCT02107443|566711842|FG000|Overall Study|Death|42|||
156988672|NCT02107443|566711843|FG001|Overall Study|Death|30|||
156988673|NCT02107443|566711842|FG000|Overall Study|Study Protocol Violation|3|||
156988674|NCT02107443|566711843|FG001|Overall Study|Study Protocol Violation|1|||
156988675|NCT02107443|566711842|FG000|Overall Study|Registered but Not Eligible|0|||
156988676|NCT02107443|566711843|FG001|Overall Study|Registered but Not Eligible|1|||
156988677|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
157096972|NCT02254278|567109327|FG000|Overall Study|Protocol Violation|1|||
156988678|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
156988679|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
157096973|NCT02254278|567109328|FG001|Overall Study|Protocol Violation|1|||
157096974|NCT00826111|567110909|FG000|Overall Study|Lost to Follow-up|0|||
157096975|NCT00826111|567110910|FG001|Overall Study|Lost to Follow-up|1|||
156988680|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
156988681|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Changed Mind|2|||
156988682|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Changed Mind|0|||
156988683|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
156988684|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
156988685|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
156988686|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
156988687|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
156988688|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
156988689|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
156988690|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
156988691|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Other Medical|9|||
156988692|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Other Medical|5|||
156988693|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Disease Progression|4|||
156988694|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Disease Progression|2|||
156988695|NCT02107443|566711842|FG000|Overall Study|Withdrawal: Personal Issues|0|||
156988696|NCT02107443|566711843|FG001|Overall Study|Withdrawal: Personal Issues|3|||
156988697|NCT00946647|566711844|FG000|Phase 1 Part|Adverse Event|2|||
156988698|NCT00946647|566711845|FG001|Phase 1 Part|Adverse Event|5|||
156988699|NCT00946647|566711846|FG002|Phase 1 Part|Adverse Event|3|||
156988700|NCT00946647|566711847|FG003|Phase 1 Part|Adverse Event|0|||
156988701|NCT00946647|566711848|FG004|Phase 1 Part|Adverse Event|0|||
156988702|NCT00946647|566711844|FG000|Phase 1 Part|Disease progression|3|||
156988703|NCT00946647|566711845|FG001|Phase 1 Part|Disease progression|6|||
156988704|NCT00946647|566711846|FG002|Phase 1 Part|Disease progression|1|||
156988705|NCT00946647|566711847|FG003|Phase 1 Part|Disease progression|0|||
156988706|NCT00946647|566711848|FG004|Phase 1 Part|Disease progression|0|||
156988707|NCT00946647|566711844|FG000|Phase 1 Part|Withdrawal by Subject|1|||
156988708|NCT00946647|566711845|FG001|Phase 1 Part|Withdrawal by Subject|4|||
156988709|NCT00946647|566711846|FG002|Phase 1 Part|Withdrawal by Subject|3|||
156988710|NCT00946647|566711847|FG003|Phase 1 Part|Withdrawal by Subject|0|||
156988711|NCT00946647|566711848|FG004|Phase 1 Part|Withdrawal by Subject|0|||
156988712|NCT00946647|566711844|FG000|Phase 1 Part|Abnormal values|0|||
156988713|NCT00946647|566711845|FG001|Phase 1 Part|Abnormal values|2|||
156988714|NCT00946647|566711846|FG002|Phase 1 Part|Abnormal values|0|||
156988715|NCT00946647|566711847|FG003|Phase 1 Part|Abnormal values|0|||
156988716|NCT00946647|566711848|FG004|Phase 1 Part|Abnormal values|0|||
156988717|NCT00946647|566711844|FG000|Phase 1 Part|Reason missing|0|||
156988718|NCT00946647|566711845|FG001|Phase 1 Part|Reason missing|1|||
156988719|NCT00946647|566711846|FG002|Phase 1 Part|Reason missing|0|||
156988720|NCT00946647|566711847|FG003|Phase 1 Part|Reason missing|0|||
156988721|NCT00946647|566711848|FG004|Phase 1 Part|Reason missing|0|||
156988722|NCT00946647|566711844|FG000|Phase ll Part|Untreated|0|||
156988723|NCT00946647|566711845|FG001|Phase ll Part|Untreated|0|||
156988724|NCT00946647|566711846|FG002|Phase ll Part|Untreated|0|||
156988725|NCT00946647|566711847|FG003|Phase ll Part|Untreated|0|||
156988726|NCT00946647|566711848|FG004|Phase ll Part|Untreated|2|||
156988727|NCT00946647|566711844|FG000|Phase ll Part|Adverse Event|0|||
156988728|NCT00946647|566711845|FG001|Phase ll Part|Adverse Event|0|||
156988729|NCT00946647|566711846|FG002|Phase ll Part|Adverse Event|0|||
156988730|NCT00946647|566711847|FG003|Phase ll Part|Adverse Event|10|||
156988731|NCT00946647|566711848|FG004|Phase ll Part|Adverse Event|6|||
156988732|NCT00946647|566711844|FG000|Phase ll Part|Withdrawal by Subject|0|||
156988733|NCT00946647|566711845|FG001|Phase ll Part|Withdrawal by Subject|0|||
156988734|NCT00946647|566711846|FG002|Phase ll Part|Withdrawal by Subject|0|||
156988735|NCT00946647|566711847|FG003|Phase ll Part|Withdrawal by Subject|8|||
156988736|NCT00946647|566711848|FG004|Phase ll Part|Withdrawal by Subject|6|||
156988737|NCT00946647|566711844|FG000|Phase ll Part|Administrative problems|0|||
156988738|NCT00946647|566711845|FG001|Phase ll Part|Administrative problems|0|||
156988739|NCT00946647|566711846|FG002|Phase ll Part|Administrative problems|0|||
156988740|NCT00946647|566711847|FG003|Phase ll Part|Administrative problems|3|||
156988741|NCT00946647|566711848|FG004|Phase ll Part|Administrative problems|8|||
156988742|NCT00946647|566711844|FG000|Phase ll Part|Death|0|||
156988743|NCT00946647|566711845|FG001|Phase ll Part|Death|0|||
156988744|NCT00946647|566711846|FG002|Phase ll Part|Death|0|||
156988745|NCT00946647|566711847|FG003|Phase ll Part|Death|7|||
156988746|NCT00946647|566711848|FG004|Phase ll Part|Death|4|||
156988747|NCT00946647|566711844|FG000|Phase ll Part|Disease progression|0|||
156988748|NCT00946647|566711845|FG001|Phase ll Part|Disease progression|0|||
156988749|NCT00946647|566711846|FG002|Phase ll Part|Disease progression|0|||
156988750|NCT00946647|566711847|FG003|Phase ll Part|Disease progression|6|||
156988751|NCT00946647|566711848|FG004|Phase ll Part|Disease progression|14|||
156988752|NCT00946647|566711844|FG000|Phase ll Part|Protocol Violation|0|||
156988753|NCT00946647|566711845|FG001|Phase ll Part|Protocol Violation|0|||
156988754|NCT00946647|566711846|FG002|Phase ll Part|Protocol Violation|0|||
156988755|NCT00946647|566711847|FG003|Phase ll Part|Protocol Violation|4|||
156988756|NCT00946647|566711848|FG004|Phase ll Part|Protocol Violation|2|||
156988757|NCT00946647|566711844|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
156988758|NCT00946647|566711845|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
156988759|NCT00946647|566711846|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
156988760|NCT00946647|566711847|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
156988761|NCT00946647|566711848|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
156988762|NCT03057834|566711851|FG000|Overall Study|Withdrawal by Subject|25|||
156988763|NCT03057834|566711852|FG001|Overall Study|Withdrawal by Subject|29|||
156988764|NCT03990363|566711854|FG000|Overall Study|Withdrawal by Subject|10|||
156988765|NCT03990363|566711855|FG001|Overall Study|Withdrawal by Subject|9|||
156988766|NCT03990363|566711856|FG002|Overall Study|Withdrawal by Subject|18|||
156988767|NCT03990363|566711857|FG003|Overall Study|Withdrawal by Subject|11|||
156988768|NCT03990363|566711858|FG004|Overall Study|Withdrawal by Subject|9|||
156988769|NCT03990363|566711854|FG000|Overall Study|Physician Decision|1|||
156988770|NCT03990363|566711855|FG001|Overall Study|Physician Decision|0|||
156988771|NCT03990363|566711856|FG002|Overall Study|Physician Decision|0|||
156988772|NCT03990363|566711857|FG003|Overall Study|Physician Decision|0|||
156988773|NCT03990363|566711858|FG004|Overall Study|Physician Decision|0|||
156988774|NCT03990363|566711854|FG000|Overall Study|Adverse Event|1|||
156988775|NCT03990363|566711855|FG001|Overall Study|Adverse Event|3|||
156988776|NCT03990363|566711856|FG002|Overall Study|Adverse Event|2|||
156988777|NCT03990363|566711857|FG003|Overall Study|Adverse Event|2|||
156988778|NCT03990363|566711858|FG004|Overall Study|Adverse Event|0|||
157096976|NCT00826111|567110909|FG000|Overall Study|Protocol Violation|1|||
157096977|NCT00826111|567110910|FG001|Overall Study|Protocol Violation|0|||
157096978|NCT00826111|567110909|FG000|Overall Study|Withdrawal by Subject|5|||
156988779|NCT03990363|566711854|FG000|Overall Study|Death|14|||
156988780|NCT03990363|566711855|FG001|Overall Study|Death|8|||
156988781|NCT03990363|566711856|FG002|Overall Study|Death|14|||
156988782|NCT03990363|566711857|FG003|Overall Study|Death|10|||
156988783|NCT03990363|566711858|FG004|Overall Study|Death|11|||
156988784|NCT03990363|566711854|FG000|Overall Study|Failure to meet randomization criteria|0|||
156988785|NCT03990363|566711855|FG001|Overall Study|Failure to meet randomization criteria|1|||
156988786|NCT03990363|566711856|FG002|Overall Study|Failure to meet randomization criteria|1|||
156988787|NCT03990363|566711857|FG003|Overall Study|Failure to meet randomization criteria|0|||
156988788|NCT03990363|566711858|FG004|Overall Study|Failure to meet randomization criteria|0|||
156988789|NCT03990363|566711854|FG000|Overall Study|Lost to Follow-up|0|||
156988790|NCT03990363|566711855|FG001|Overall Study|Lost to Follow-up|0|||
156988791|NCT03990363|566711856|FG002|Overall Study|Lost to Follow-up|0|||
156988792|NCT03990363|566711857|FG003|Overall Study|Lost to Follow-up|1|||
156988793|NCT03990363|566711858|FG004|Overall Study|Lost to Follow-up|2|||
156988794|NCT03990363|566711854|FG000|Overall Study|Non-compliance with study drug|2|||
156988795|NCT03990363|566711855|FG001|Overall Study|Non-compliance with study drug|1|||
156988796|NCT03990363|566711856|FG002|Overall Study|Non-compliance with study drug|2|||
156988797|NCT03990363|566711857|FG003|Overall Study|Non-compliance with study drug|0|||
156988798|NCT03990363|566711858|FG004|Overall Study|Non-compliance with study drug|0|||
157096979|NCT00826111|567110910|FG001|Overall Study|Withdrawal by Subject|0|||
157096980|NCT00826111|567110909|FG000|Overall Study|Physician Decision|1|||
156988799|NCT03990363|566711854|FG000|Overall Study|Study terminated by sponsor|0|||
156988800|NCT03990363|566711855|FG001|Overall Study|Study terminated by sponsor|1|||
156988801|NCT03990363|566711856|FG002|Overall Study|Study terminated by sponsor|0|||
156988802|NCT03990363|566711857|FG003|Overall Study|Study terminated by sponsor|0|||
156988803|NCT03990363|566711858|FG004|Overall Study|Study terminated by sponsor|0|||
156988804|NCT03990363|566711854|FG000|Overall Study|Site terminated by sponsor|2|||
156988805|NCT03990363|566711855|FG001|Overall Study|Site terminated by sponsor|1|||
156988806|NCT03990363|566711856|FG002|Overall Study|Site terminated by sponsor|2|||
156988807|NCT03990363|566711857|FG003|Overall Study|Site terminated by sponsor|0|||
156988808|NCT03990363|566711858|FG004|Overall Study|Site terminated by sponsor|2|||
156988809|NCT03990363|566711854|FG000|Overall Study|Not categorized|5|||
156988810|NCT03990363|566711855|FG001|Overall Study|Not categorized|5|||
156988811|NCT03990363|566711856|FG002|Overall Study|Not categorized|3|||
156988812|NCT03990363|566711857|FG003|Overall Study|Not categorized|2|||
156988813|NCT03990363|566711858|FG004|Overall Study|Not categorized|2|||
156988814|NCT01349660|566711864|FG000|Overall Study|Still Receiving Study Treatment|0|||
156988815|NCT01349660|566711865|FG001|Overall Study|Still Receiving Study Treatment|0|||
156988816|NCT01349660|566711866|FG002|Overall Study|Still Receiving Study Treatment|1|||
156988817|NCT01349660|566711864|FG000|Overall Study|Disease Progression|2|||
156988818|NCT01349660|566711865|FG001|Overall Study|Disease Progression|4|||
156988819|NCT01349660|566711866|FG002|Overall Study|Disease Progression|50|||
156988820|NCT01349660|566711864|FG000|Overall Study|Adverse Event|1|||
156988821|NCT01349660|566711865|FG001|Overall Study|Adverse Event|1|||
156988822|NCT01349660|566711866|FG002|Overall Study|Adverse Event|12|||
156988823|NCT01349660|566711864|FG000|Overall Study|Withdrawal by Subject|2|||
156988824|NCT01349660|566711865|FG001|Overall Study|Withdrawal by Subject|0|||
156988825|NCT01349660|566711866|FG002|Overall Study|Withdrawal by Subject|9|||
156988826|NCT01349660|566711864|FG000|Overall Study|Death|1|||
156988827|NCT01349660|566711865|FG001|Overall Study|Death|1|||
156988828|NCT01349660|566711866|FG002|Overall Study|Death|0|||
156988829|NCT01349660|566711864|FG000|Overall Study|Non-Permitted Interventions|0|||
156988830|NCT01349660|566711865|FG001|Overall Study|Non-Permitted Interventions|0|||
156988831|NCT01349660|566711866|FG002|Overall Study|Non-Permitted Interventions|2|||
156988832|NCT01349660|566711864|FG000|Overall Study|Study Compliance|0|||
156988833|NCT01349660|566711865|FG001|Overall Study|Study Compliance|0|||
156988834|NCT01349660|566711866|FG002|Overall Study|Study Compliance|1|||
156988835|NCT01349660|566711864|FG000|Overall Study|Declining Performance Status|0|||
156988836|NCT01349660|566711865|FG001|Overall Study|Declining Performance Status|0|||
156988837|NCT01349660|566711866|FG002|Overall Study|Declining Performance Status|1|||
156988838|NCT05593211|566711871|FG000|Overall Study|Withdrawal by Subject|1|||
156988839|NCT03225846|566711872|FG000|Overall Study|Adverse Event|0|||
156988840|NCT03225846|566711873|FG001|Overall Study|Adverse Event|0|||
156988841|NCT03225846|566711874|FG002|Overall Study|Adverse Event|0|||
156988842|NCT03225846|566711875|FG003|Overall Study|Adverse Event|0|||
156988843|NCT03225846|566711876|FG004|Overall Study|Adverse Event|0|||
156988844|NCT03225846|566711877|FG005|Overall Study|Adverse Event|0|||
156988845|NCT03225846|566711878|FG006|Overall Study|Adverse Event|6|||
156988846|NCT03225846|566711872|FG000|Overall Study|Withdrawal by Subject|0|||
156988847|NCT03225846|566711873|FG001|Overall Study|Withdrawal by Subject|1|||
156988848|NCT03225846|566711874|FG002|Overall Study|Withdrawal by Subject|0|||
156988849|NCT03225846|566711875|FG003|Overall Study|Withdrawal by Subject|0|||
156988850|NCT03225846|566711876|FG004|Overall Study|Withdrawal by Subject|0|||
156988851|NCT03225846|566711877|FG005|Overall Study|Withdrawal by Subject|0|||
156988852|NCT03225846|566711878|FG006|Overall Study|Withdrawal by Subject|0|||
156988853|NCT03225846|566711872|FG000|Overall Study|Death|0|||
156988854|NCT03225846|566711873|FG001|Overall Study|Death|1|||
156988855|NCT03225846|566711874|FG002|Overall Study|Death|0|||
156988856|NCT03225846|566711875|FG003|Overall Study|Death|0|||
156988857|NCT03225846|566711876|FG004|Overall Study|Death|0|||
156988858|NCT03225846|566711877|FG005|Overall Study|Death|0|||
156988859|NCT03225846|566711878|FG006|Overall Study|Death|0|||
156988860|NCT03225846|566711872|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988861|NCT03225846|566711873|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988862|NCT03225846|566711874|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
156988863|NCT03225846|566711875|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988864|NCT03225846|566711876|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988865|NCT03225846|566711877|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988866|NCT03225846|566711878|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
156988867|NCT03225846|566711872|FG000|Overall Study|Patient decision|0|||
156988868|NCT03225846|566711873|FG001|Overall Study|Patient decision|0|||
156988869|NCT03225846|566711874|FG002|Overall Study|Patient decision|0|||
156988870|NCT03225846|566711875|FG003|Overall Study|Patient decision|0|||
156988871|NCT03225846|566711876|FG004|Overall Study|Patient decision|0|||
156988872|NCT03225846|566711877|FG005|Overall Study|Patient decision|0|||
156988873|NCT03225846|566711878|FG006|Overall Study|Patient decision|1|||
156988874|NCT04248465|566711879|FG000|Randomized-Controlled Period|Death|12|||
156988875|NCT04248465|566711880|FG001|Randomized-Controlled Period|Death|5|||
156988876|NCT04248465|566711879|FG000|Randomized-Controlled Period|Adverse Event|2|||
156988877|NCT04248465|566711880|FG001|Randomized-Controlled Period|Adverse Event|0|||
156988878|NCT04248465|566711879|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
156988879|NCT04248465|566711880|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
156988880|NCT04248465|566711879|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
156988881|NCT04248465|566711880|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
156988882|NCT04248465|566711879|FG000|Randomized-Controlled Period|Physician Decision|1|||
156988883|NCT04248465|566711880|FG001|Randomized-Controlled Period|Physician Decision|1|||
156988884|NCT04248465|566711879|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
156988885|NCT04248465|566711880|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
156988886|NCT04248465|566711879|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
156988887|NCT04248465|566711880|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
156988888|NCT04248465|566711879|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
156988889|NCT04248465|566711880|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
156988890|NCT01254890|566711881|FG000|Overall Study|Ineligible|0|||
156988891|NCT01254890|566711882|FG001|Overall Study|Ineligible|3|||
156988892|NCT01254890|566711881|FG000|Overall Study|Withdrawal by Subject|1|||
156988893|NCT01254890|566711882|FG001|Overall Study|Withdrawal by Subject|2|||
156988894|NCT01254890|566711881|FG000|Overall Study|Disease Progression|0|||
156988895|NCT01254890|566711882|FG001|Overall Study|Disease Progression|5|||
156988896|NCT04988477|566711888|FG000|Overall Study|Death|1|||
156988897|NCT04988477|566711889|FG001|Overall Study|Death|0|||
156988898|NCT04988477|566711890|FG002|Overall Study|Death|0|||
156988899|NCT04988477|566711888|FG000|Overall Study|Lost to Follow-up|5|||
156988900|NCT04988477|566711889|FG001|Overall Study|Lost to Follow-up|2|||
156988901|NCT04988477|566711890|FG002|Overall Study|Lost to Follow-up|0|||
156988902|NCT04988477|566711888|FG000|Overall Study|Withdrawal by Subject|2|||
156988903|NCT04988477|566711889|FG001|Overall Study|Withdrawal by Subject|0|||
156988904|NCT04988477|566711890|FG002|Overall Study|Withdrawal by Subject|0|||
156988905|NCT04096365|566712870|FG000|Overall Study|Adverse Event|1|||
156988906|NCT01036087|566712873|FG000|Overall Study|Adverse Event|2|||
156988907|NCT01036087|566712873|FG000|Overall Study|Lack of Efficacy|1|||
156988908|NCT02206685|566712877|FG000|Overall Study|Surgery cancelled/changed|2|||
156988909|NCT02206685|566712878|FG001|Overall Study|Surgery cancelled/changed|3|||
156988910|NCT02206685|566712877|FG000|Overall Study|Withdrawal by Subject|1|||
156988911|NCT02206685|566712878|FG001|Overall Study|Withdrawal by Subject|2|||
156988912|NCT02206685|566712877|FG000|Overall Study|Protocol Violation|2|||
156988913|NCT02206685|566712878|FG001|Overall Study|Protocol Violation|2|||
156988914|NCT01616563|566712879|FG000|Overall Study|Lost to Follow-up|40|||
156988915|NCT00072475|566712880|FG000|Overall Study|Adverse Event|44|||
156988916|NCT00072475|566712880|FG000|Overall Study|Death|3|||
156988917|NCT00072475|566712880|FG000|Overall Study|Withdrawal by Subject|46|||
156988918|NCT00072475|566712880|FG000|Overall Study|Patient/Investigator Decision|4|||
156988919|NCT01450943|566712883|FG000|Overall Study|Screen failure, loss to follow-up|2|||
156988920|NCT01450943|566712884|FG001|Overall Study|Screen failure, loss to follow-up|7|||
156988921|NCT01450943|566712885|FG002|Overall Study|Screen failure, loss to follow-up|6|||
156988922|NCT03303105|566712886|FG000|Overall Study|Adverse Event|0|||
156988923|NCT03303105|566712887|FG001|Overall Study|Adverse Event|2|||
156988924|NCT03303105|566712886|FG000|Overall Study|Lack of Efficacy|1|||
156988925|NCT03303105|566712887|FG001|Overall Study|Lack of Efficacy|0|||
156988926|NCT03303105|566712886|FG000|Overall Study|Protocol Violation|1|||
156988927|NCT03303105|566712887|FG001|Overall Study|Protocol Violation|0|||
156988928|NCT03303105|566712886|FG000|Overall Study|Withdrawal by Subject|0|||
156988929|NCT03303105|566712887|FG001|Overall Study|Withdrawal by Subject|2|||
156988930|NCT01477749|566712902|FG000|Overall Study|Physician Decision|4|||
156988931|NCT04004208|566712909|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156988932|NCT04004208|566712910|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156988933|NCT04004208|566712909|FG000|Overall Study|Death|3|||
156988934|NCT04004208|566712910|FG001|Overall Study|Death|0|||
156988935|NCT04004208|566712909|FG000|Overall Study|COVID-19 pandemic|1|||
156988936|NCT04004208|566712910|FG001|Overall Study|COVID-19 pandemic|0|||
156988937|NCT04004208|566712909|FG000|Overall Study|Physician Decision|1|||
156988938|NCT04004208|566712910|FG001|Overall Study|Physician Decision|0|||
156988939|NCT04004208|566712909|FG000|Overall Study|Adverse Event|1|||
157096981|NCT00826111|567110910|FG001|Overall Study|Physician Decision|1|||
156988940|NCT04004208|566712910|FG001|Overall Study|Adverse Event|1|||
156988941|NCT02724020|566712916|FG000|Overall Study|Death|16|||
156988942|NCT02724020|566712917|FG001|Overall Study|Death|18|||
156988943|NCT02724020|566712918|FG002|Overall Study|Death|19|||
156988944|NCT02724020|566712916|FG000|Overall Study|Lost to Follow-up|0|||
156988945|NCT02724020|566712917|FG001|Overall Study|Lost to Follow-up|3|||
156988946|NCT02724020|566712918|FG002|Overall Study|Lost to Follow-up|0|||
156988947|NCT02724020|566712916|FG000|Overall Study|Site Terminated by Sponsor|15|||
156988948|NCT02724020|566712917|FG001|Overall Study|Site Terminated by Sponsor|8|||
156988949|NCT02724020|566712918|FG002|Overall Study|Site Terminated by Sponsor|8|||
156988950|NCT02724020|566712916|FG000|Overall Study|Withdrawal by Subject|1|||
156988951|NCT02724020|566712917|FG001|Overall Study|Withdrawal by Subject|3|||
156988952|NCT02724020|566712918|FG002|Overall Study|Withdrawal by Subject|5|||
156988953|NCT02059161|566712920|FG000|Overall Study|Pregnancy|0|||
156988954|NCT02059161|566712921|FG001|Overall Study|Pregnancy|2|||
156988955|NCT02059161|566712920|FG000|Overall Study|Adverse Event|2|||
156988956|NCT02059161|566712921|FG001|Overall Study|Adverse Event|6|||
156988957|NCT02059161|566712920|FG000|Overall Study|Lost to Follow-up|20|||
156988958|NCT02059161|566712921|FG001|Overall Study|Lost to Follow-up|12|||
156988959|NCT02059161|566712920|FG000|Overall Study|Physician Decision|4|||
156988960|NCT02059161|566712921|FG001|Overall Study|Physician Decision|4|||
156988961|NCT02059161|566712920|FG000|Overall Study|Protocol Violation|1|||
156988962|NCT02059161|566712921|FG001|Overall Study|Protocol Violation|1|||
156988963|NCT02059161|566712920|FG000|Overall Study|Withdrawal by Subject|16|||
156988964|NCT02059161|566712921|FG001|Overall Study|Withdrawal by Subject|13|||
156988965|NCT02059161|566712920|FG000|Overall Study|Randomized in error, no study drug|0|||
156988966|NCT02059161|566712921|FG001|Overall Study|Randomized in error, no study drug|1|||
156988967|NCT02059161|566712920|FG000|Overall Study|Non-compliance with study drug|6|||
156988968|NCT02059161|566712921|FG001|Overall Study|Non-compliance with study drug|2|||
156988969|NCT03100838|566712923|FG000|Overall Study|Adverse Event|1|||
156988970|NCT03100838|566712924|FG001|Overall Study|Adverse Event|0|||
156988971|NCT03100838|566712925|FG002|Overall Study|Adverse Event|0|||
156988972|NCT03100838|566712926|FG003|Overall Study|Adverse Event|0|||
156988973|NCT03100838|566712923|FG000|Overall Study|Physician Decision|1|||
156988974|NCT03100838|566712924|FG001|Overall Study|Physician Decision|1|||
156988975|NCT03100838|566712925|FG002|Overall Study|Physician Decision|1|||
156988976|NCT03100838|566712926|FG003|Overall Study|Physician Decision|1|||
156988977|NCT03100838|566712923|FG000|Overall Study|Pregnancy|0|||
156988978|NCT03100838|566712924|FG001|Overall Study|Pregnancy|1|||
156988979|NCT03100838|566712925|FG002|Overall Study|Pregnancy|0|||
156988980|NCT03100838|566712926|FG003|Overall Study|Pregnancy|0|||
156988981|NCT03100838|566712923|FG000|Overall Study|Lost to Follow-up|0|||
156988982|NCT03100838|566712924|FG001|Overall Study|Lost to Follow-up|0|||
156988983|NCT03100838|566712925|FG002|Overall Study|Lost to Follow-up|1|||
156988984|NCT03100838|566712926|FG003|Overall Study|Lost to Follow-up|0|||
156988985|NCT00801242|566712930|FG000|Overall Study|Adverse Event|10|||
156988986|NCT00801242|566712930|FG000|Overall Study|Withdrawal by Subject|13|||
156988987|NCT00801242|566712930|FG000|Overall Study|Protocol Violation|5|||
156988988|NCT00801242|566712930|FG000|Overall Study|Physician Decision|3|||
156988989|NCT00801242|566712930|FG000|Overall Study|Lost to Follow-up|1|||
156988990|NCT00801242|566712930|FG000|Overall Study|Miscellaneous reasons|20|||
156988991|NCT01347645|566712931|FG000|Overall Study|Death|1|||
156988992|NCT01347645|566712932|FG001|Overall Study|Death|5|||
156988993|NCT01347645|566712933|FG002|Overall Study|Death|2|||
156988994|NCT01347645|566712934|FG003|Overall Study|Death|7|||
156988995|NCT01347645|566712935|FG004|Overall Study|Death|7|||
156988996|NCT01347645|566712931|FG000|Overall Study|Lost to Follow-up|1|||
156988997|NCT01347645|566712932|FG001|Overall Study|Lost to Follow-up|1|||
156988998|NCT01347645|566712933|FG002|Overall Study|Lost to Follow-up|0|||
156988999|NCT01347645|566712934|FG003|Overall Study|Lost to Follow-up|1|||
156989000|NCT01347645|566712935|FG004|Overall Study|Lost to Follow-up|1|||
156989001|NCT01347645|566712931|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
156989002|NCT01347645|566712932|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
156989003|NCT01347645|566712933|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
156989004|NCT01347645|566712934|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
156989005|NCT01347645|566712935|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
156989006|NCT01347645|566712931|FG000|Overall Study|Other|1|||
156989007|NCT01347645|566712932|FG001|Overall Study|Other|0|||
156989008|NCT01347645|566712933|FG002|Overall Study|Other|0|||
156989009|NCT01347645|566712934|FG003|Overall Study|Other|0|||
156989010|NCT01347645|566712935|FG004|Overall Study|Other|1|||
156989011|NCT01347645|566712931|FG000|Overall Study|Withdrawal by Subject|0|||
156989012|NCT01347645|566712932|FG001|Overall Study|Withdrawal by Subject|0|||
156989013|NCT01347645|566712933|FG002|Overall Study|Withdrawal by Subject|0|||
156989014|NCT01347645|566712934|FG003|Overall Study|Withdrawal by Subject|3|||
156989015|NCT01347645|566712935|FG004|Overall Study|Withdrawal by Subject|3|||
156989016|NCT01347645|566712931|FG000|Overall Study|Physician Decision|0|||
156989017|NCT01347645|566712932|FG001|Overall Study|Physician Decision|0|||
156989018|NCT01347645|566712933|FG002|Overall Study|Physician Decision|0|||
156989019|NCT01347645|566712934|FG003|Overall Study|Physician Decision|0|||
156989020|NCT01347645|566712935|FG004|Overall Study|Physician Decision|1|||
156989021|NCT01347645|566712931|FG000|Overall Study|Adverse Event|0|||
156989022|NCT01347645|566712932|FG001|Overall Study|Adverse Event|0|||
157096982|NCT02805725|567110911|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
156989023|NCT01347645|566712933|FG002|Overall Study|Adverse Event|0|||
156989024|NCT01347645|566712934|FG003|Overall Study|Adverse Event|1|||
156989025|NCT01347645|566712935|FG004|Overall Study|Adverse Event|1|||
156989026|NCT00184028|566712936|FG000|Overall Study|Death|1|||
156989027|NCT00184028|566712936|FG000|Overall Study|Lack of Efficacy|4|||
156989028|NCT00184028|566712936|FG000|Overall Study|Adverse Event|2|||
156989029|NCT00184028|566712936|FG000|Overall Study|Withdrawal by Subject|1|||
156989030|NCT00184028|566712936|FG000|Overall Study|Non-compliance|2|||
156989031|NCT00388362|566712937|FG000|Enrolled|Ineligible|1|||
156989032|NCT00388362|566712937|FG000|Enrolled|Adverse Event|9|||
156989033|NCT00388362|566712937|FG000|Enrolled|Death|1|||
156989034|NCT00388362|566712937|FG000|Enrolled|Loss insurance|1|||
156989035|NCT00388362|566712937|FG000|Enrolled|Withdrawal by Subject|1|||
156989036|NCT00388362|566712937|FG000|Remained on Study Median of 514 Days|Death|2|||
156989037|NCT01141660|566712938|FG000|Overall Study|Physician Decision|0|||
156989038|NCT01141660|566712939|FG001|Overall Study|Physician Decision|12|||
156989039|NCT00209027|566712941|FG000|Overall Study|study terminated|10|||
156989040|NCT00209027|566712942|FG001|Overall Study|study terminated|0|||
156989041|NCT02335268|566712943|FG000|Overall Study|Physician Decision|5|||
156989042|NCT02335268|566712944|FG001|Overall Study|Physician Decision|1|||
156989043|NCT02335268|566712943|FG000|Overall Study|Lack of Efficacy|2|||
156989044|NCT02335268|566712944|FG001|Overall Study|Lack of Efficacy|1|||
156989045|NCT02335268|566712943|FG000|Overall Study|Adverse Event|5|||
156989046|NCT02335268|566712944|FG001|Overall Study|Adverse Event|2|||
156989047|NCT02335268|566712943|FG000|Overall Study|increase blasts|2|||
156989048|NCT02335268|566712944|FG001|Overall Study|increase blasts|0|||
156989049|NCT02335268|566712943|FG000|Overall Study|Withdrawal by Subject|3|||
156989050|NCT02335268|566712944|FG001|Overall Study|Withdrawal by Subject|2|||
156989051|NCT03259373|566712947|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
156989052|NCT03259373|566712948|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
156989053|NCT03259373|566712947|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
156989054|NCT03259373|566712948|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
156989055|NCT03259373|566712947|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
156989056|NCT03259373|566712948|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
156989057|NCT03259373|566712947|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
156989058|NCT03259373|566712948|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
156989059|NCT03259373|566712947|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
156989060|NCT03259373|566712948|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
156989061|NCT03259373|566712947|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
156989062|NCT03259373|566712948|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
156989063|NCT05893797|566712949|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
156989064|NCT05893797|566712949|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
156989065|NCT05893797|566712949|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
156989066|NCT05893797|566712949|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
156989067|NCT03077620|566712953|FG000|Overall Study|Unable to place lumbar catheter|1|||
156989068|NCT03077620|566712954|FG001|Overall Study|Unable to place lumbar catheter|0|||
156989069|NCT03077620|566712955|FG002|Overall Study|Unable to place lumbar catheter|1|||
156989070|NCT03077620|566712956|FG003|Overall Study|Unable to place lumbar catheter|0|||
156989071|NCT03077620|566712953|FG000|Overall Study|Withdrawal by Subject|0|||
156989072|NCT03077620|566712954|FG001|Overall Study|Withdrawal by Subject|1|||
156989073|NCT03077620|566712955|FG002|Overall Study|Withdrawal by Subject|0|||
156989074|NCT03077620|566712956|FG003|Overall Study|Withdrawal by Subject|0|||
156989075|NCT03077620|566712953|FG000|Overall Study|Physician Decision|0|||
156989076|NCT03077620|566712954|FG001|Overall Study|Physician Decision|0|||
156989077|NCT03077620|566712955|FG002|Overall Study|Physician Decision|1|||
156989078|NCT03077620|566712956|FG003|Overall Study|Physician Decision|0|||
156989079|NCT00245011|566712957|FG000|Overall Study|Lack of Efficacy|1|||
156989080|NCT00550173|566712958|FG000|Overall Study|Death|45|||
156989081|NCT00550173|566712959|FG001|Overall Study|Death|38|||
156989082|NCT00550173|566712960|FG002|Overall Study|Death|50|||
156989083|NCT00550173|566712958|FG000|Overall Study|Physician Decision|1|||
156989084|NCT00550173|566712959|FG001|Overall Study|Physician Decision|2|||
156989085|NCT00550173|566712960|FG002|Overall Study|Physician Decision|2|||
156989086|NCT00550173|566712958|FG000|Overall Study|Withdrawal by Subject|9|||
156989087|NCT00550173|566712959|FG001|Overall Study|Withdrawal by Subject|12|||
156989088|NCT00550173|566712960|FG002|Overall Study|Withdrawal by Subject|17|||
156989089|NCT00550173|566712958|FG000|Overall Study|Sponsor Decision|13|||
156989090|NCT00550173|566712959|FG001|Overall Study|Sponsor Decision|7|||
156989091|NCT00550173|566712960|FG002|Overall Study|Sponsor Decision|1|||
156989092|NCT00550173|566712958|FG000|Overall Study|Lost to Follow-up|4|||
156989093|NCT00550173|566712959|FG001|Overall Study|Lost to Follow-up|4|||
156989094|NCT00550173|566712960|FG002|Overall Study|Lost to Follow-up|3|||
156989095|NCT02419755|566712964|FG000|Overall Study|Death|1|||
156989096|NCT02419755|566712965|FG001|Overall Study|Death|3|||
156989097|NCT02419755|566712964|FG000|Overall Study|Relapse|0|||
156989098|NCT02419755|566712965|FG001|Overall Study|Relapse|1|||
156989099|NCT02419755|566712964|FG000|Overall Study|Ineligible|1|||
156989100|NCT02419755|566712965|FG001|Overall Study|Ineligible|0|||
156989101|NCT02419755|566712964|FG000|Overall Study|Withdrawal by Subject|1|||
156989102|NCT02419755|566712965|FG001|Overall Study|Withdrawal by Subject|0|||
156989103|NCT02684903|566712968|FG000|Overall Study|COVID-19 shutdown of lab|4|||
156989104|NCT02684903|566712969|FG001|Overall Study|COVID-19 shutdown of lab|6|||
156989105|NCT02684903|566712968|FG000|Overall Study|Lost to Follow-up|31|||
156989106|NCT02684903|566712969|FG001|Overall Study|Lost to Follow-up|41|||
156989107|NCT06403605|566712974|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
156989108|NCT06403605|566712975|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
156989109|NCT06403605|566712974|FG000|Follow-up|Adverse Event|4|||
156989110|NCT06403605|566712975|FG001|Follow-up|Adverse Event|2|||
156989111|NCT06403605|566712974|FG000|Follow-up|Withdrawal by Subject|2|||
156989112|NCT06403605|566712975|FG001|Follow-up|Withdrawal by Subject|3|||
156989113|NCT06403605|566712974|FG000|Follow-up|Lost to Follow-up|1|||
156989114|NCT06403605|566712975|FG001|Follow-up|Lost to Follow-up|0|||
156989115|NCT06403605|566712974|FG000|Follow-up|Death|1|||
156989116|NCT06403605|566712975|FG001|Follow-up|Death|0|||
156989117|NCT06403605|566712974|FG000|Follow-up|Other reasons|0|||
156989118|NCT06403605|566712975|FG001|Follow-up|Other reasons|4|||
156989119|NCT00394095|566714624|FG000|Screening|Withdrawal by Subject|1|||
156989120|NCT00394095|566714625|FG001|Screening|Withdrawal by Subject|0|||
156989121|NCT00394095|566714624|FG000|Randomized|Withdrawal by Subject|5|||
156989122|NCT00394095|566714625|FG001|Randomized|Withdrawal by Subject|1|||
156989123|NCT00394095|566714624|FG000|Randomized|Adverse Event|1|||
156989124|NCT00394095|566714625|FG001|Randomized|Adverse Event|1|||
156989125|NCT00394095|566714624|FG000|Randomized|Overdose|1|||
156989126|NCT00394095|566714625|FG001|Randomized|Overdose|0|||
156989127|NCT00394095|566714624|FG000|Randomized|Lost to Follow-up|1|||
156989128|NCT00394095|566714625|FG001|Randomized|Lost to Follow-up|2|||
156989129|NCT04213846|566714626|FG000|Overall Study|Withdrawal by Subject|7|||
156989130|NCT04213846|566714627|FG001|Overall Study|Withdrawal by Subject|6|||
156989131|NCT04213846|566714626|FG000|Overall Study|Lost to Follow-up|15|||
156989132|NCT04213846|566714627|FG001|Overall Study|Lost to Follow-up|21|||
156989133|NCT02401529|566714638|FG000|Overall Study|Lost to Follow-up|2|||
156989134|NCT02401529|566714639|FG001|Overall Study|Lost to Follow-up|1|||
156989135|NCT02401529|566714638|FG000|Overall Study|Physician Decision|2|||
156989136|NCT02401529|566714639|FG001|Overall Study|Physician Decision|6|||
156989137|NCT02401529|566714638|FG000|Overall Study|Protocol Violation|5|||
156989138|NCT02401529|566714639|FG001|Overall Study|Protocol Violation|0|||
156989139|NCT02491411|566714640|FG000|Overall Study|Physician Decision|4|||
156989140|NCT01106287|566714642|FG000|Overall Study|Adverse Event|1|||
156989141|NCT01106287|566714643|FG001|Overall Study|Adverse Event|0|||
157096983|NCT02805725|567110912|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
157096984|NCT02805725|567110913|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
157096985|NCT02805725|567110914|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
156989142|NCT01106287|566714644|FG002|Overall Study|Adverse Event|0|||
156989143|NCT01106287|566714645|FG003|Overall Study|Adverse Event|0|||
156989144|NCT02403674|566714650|FG000|Base Study|Death|1|||
156989145|NCT02403674|566714651|FG001|Base Study|Death|4|||
156989146|NCT02403674|566714650|FG000|Base Study|Adverse Event|11|||
156989147|NCT02403674|566714651|FG001|Base Study|Adverse Event|26|||
156989148|NCT02403674|566714650|FG000|Base Study|Lack of Efficacy|31|||
156989149|NCT02403674|566714651|FG001|Base Study|Lack of Efficacy|23|||
156989150|NCT02403674|566714650|FG000|Base Study|Lost to Follow-up|6|||
156989151|NCT02403674|566714651|FG001|Base Study|Lost to Follow-up|8|||
156989152|NCT02403674|566714650|FG000|Base Study|Withdrawal by Subject|10|||
156989153|NCT02403674|566714651|FG001|Base Study|Withdrawal by Subject|17|||
156989154|NCT02403674|566714650|FG000|Base Study|Physician Decision|2|||
156989155|NCT02403674|566714651|FG001|Base Study|Physician Decision|2|||
156989156|NCT02403674|566714650|FG000|Base Study|Pregnancy|2|||
156989157|NCT02403674|566714651|FG001|Base Study|Pregnancy|2|||
156989158|NCT02403674|566714650|FG000|Base Study|Protocol Violation|8|||
156989159|NCT02403674|566714651|FG001|Base Study|Protocol Violation|4|||
156989160|NCT02403674|566714650|FG000|Base Study|Non-Compliance with study drug|1|||
157096986|NCT02805725|567110915|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
156989161|NCT02403674|566714651|FG001|Base Study|Non-Compliance with study drug|4|||
156989162|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
156989163|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
156989164|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
156989165|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
156989166|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
156989167|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
156989168|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
156989169|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
156989170|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
156989171|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
156989172|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
156989173|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
156989174|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Death|1|||
156989175|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Death|0|||
156989176|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
156989177|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
156989178|NCT02403674|566714650|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
156989179|NCT02403674|566714651|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
156989180|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
156989181|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
156989182|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
156989183|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
156989184|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
156989185|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
156989186|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
156989187|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
156989188|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
156989189|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
156989190|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Death|2|||
156989191|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Death|2|||
156989192|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
156989193|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
156989194|NCT02403674|566714650|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
156989195|NCT02403674|566714651|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
156989196|NCT02403674|566714650|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
156989197|NCT02403674|566714651|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
156989198|NCT02403674|566714650|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
156989199|NCT02403674|566714651|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
156989200|NCT02403674|566714650|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
156989201|NCT02403674|566714651|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
156989202|NCT02403674|566714650|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
156989203|NCT02403674|566714651|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
156989204|NCT02403674|566714650|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
156989205|NCT02403674|566714651|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
156989206|NCT03487666|566714653|FG000|Overall Study|Disease progression|4|||
156989207|NCT03487666|566714654|FG001|Overall Study|Disease progression|2|||
156989208|NCT03487666|566714655|FG002|Overall Study|Disease progression|0|||
156989209|NCT03487666|566714653|FG000|Overall Study|Adverse Event|0|||
156989210|NCT03487666|566714654|FG001|Overall Study|Adverse Event|0|||
156989211|NCT03487666|566714655|FG002|Overall Study|Adverse Event|1|||
156989212|NCT03201757|566714656|FG000|Overall Study|Withdrawal by Subject|133|||
156989213|NCT03201757|566714656|FG000|Overall Study|Adverse Event|44|||
156989214|NCT03201757|566714656|FG000|Overall Study|Lost to Follow-up|37|||
156989215|NCT03201757|566714656|FG000|Overall Study|Pregnancy|2|||
156989216|NCT03201757|566714656|FG000|Overall Study|Lack of Efficacy|1|||
156989217|NCT03201757|566714656|FG000|Overall Study|Protocol Violation|20|||
156989218|NCT03201757|566714656|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
156989219|NCT03201757|566714656|FG000|Overall Study|Not Yet Determined|5|||
156989220|NCT03201757|566714656|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
156989221|NCT03201757|566714656|FG000|Overall Study|Other|20|||
156989222|NCT01254305|566714657|FG000|Overall Study|Adverse Event|6|||
156989223|NCT01254305|566714658|FG001|Overall Study|Adverse Event|3|||
156989224|NCT01254305|566714659|FG002|Overall Study|Adverse Event|2|||
156989225|NCT01254305|566714657|FG000|Overall Study|Lack of Efficacy|1|||
156989226|NCT01254305|566714658|FG001|Overall Study|Lack of Efficacy|0|||
156989227|NCT01254305|566714659|FG002|Overall Study|Lack of Efficacy|1|||
156989228|NCT01254305|566714657|FG000|Overall Study|Protocol Violation|1|||
156989229|NCT01254305|566714658|FG001|Overall Study|Protocol Violation|7|||
156989230|NCT01254305|566714659|FG002|Overall Study|Protocol Violation|3|||
156989231|NCT01254305|566714657|FG000|Overall Study|Withdrawal by Subject|4|||
156989232|NCT01254305|566714658|FG001|Overall Study|Withdrawal by Subject|2|||
156989233|NCT01254305|566714659|FG002|Overall Study|Withdrawal by Subject|4|||
156989234|NCT01254305|566714657|FG000|Overall Study|Lost to Follow-up|10|||
156989235|NCT01254305|566714658|FG001|Overall Study|Lost to Follow-up|6|||
156989236|NCT01254305|566714659|FG002|Overall Study|Lost to Follow-up|5|||
156989237|NCT01254305|566714657|FG000|Overall Study|Other Reasons|0|||
156989238|NCT01254305|566714658|FG001|Overall Study|Other Reasons|0|||
156989239|NCT01254305|566714659|FG002|Overall Study|Other Reasons|2|||
156989240|NCT02297503|566714660|FG000|Overall Study|Withdrawal by Subject|1|||
156989241|NCT02297503|566714661|FG001|Overall Study|Withdrawal by Subject|1|||
156989242|NCT02297503|566714660|FG000|Overall Study|Protocol Violation|1|||
156989243|NCT02297503|566714661|FG001|Overall Study|Protocol Violation|0|||
156989244|NCT02297503|566714660|FG000|Overall Study|Pregnancy|0|||
156989245|NCT02297503|566714661|FG001|Overall Study|Pregnancy|1|||
156989246|NCT02297503|566714660|FG000|Overall Study|Lost to Follow-up|0|||
156989247|NCT02297503|566714661|FG001|Overall Study|Lost to Follow-up|1|||
156989248|NCT02297503|566714660|FG000|Overall Study|Medical reason|0|||
156989249|NCT02297503|566714661|FG001|Overall Study|Medical reason|1|||
156989250|NCT00765362|566714662|FG000|Overall Study|Death|9|||
156989251|NCT00765362|566714662|FG000|Overall Study|Adverse Event|2|||
156989252|NCT00765362|566714662|FG000|Overall Study|Protocol Violation|18|||
156989253|NCT00765362|566714662|FG000|Overall Study|Withdrawal by Subject|13|||
156989254|NCT00765362|566714662|FG000|Overall Study|Lost to Follow-up|95|||
156989255|NCT03930186|566714663|FG000|Weeks 0 to 16|Adverse Event|6|||
156989256|NCT03930186|566714663|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
156989257|NCT03930186|566714663|FG000|Weeks 16 to 32|Adverse Event|1|||
156989258|NCT03930186|566714663|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
156989259|NCT00557505|566714668|FG000|Overall Study|Death|0|||
156989260|NCT00557505|566714669|FG001|Overall Study|Death|0|||
156989261|NCT00557505|566714670|FG002|Overall Study|Death|0|||
156989262|NCT00557505|566714671|FG003|Overall Study|Death|0|||
156989263|NCT00557505|566714672|FG004|Overall Study|Death|0|||
156989264|NCT00557505|566714673|FG005|Overall Study|Death|0|||
156989265|NCT00557505|566714674|FG006|Overall Study|Death|0|||
156989266|NCT00557505|566714675|FG007|Overall Study|Death|0|||
156989267|NCT00557505|566714676|FG008|Overall Study|Death|1|||
156989268|NCT00557505|566714668|FG000|Overall Study|Adverse Event|0|||
156989269|NCT00557505|566714669|FG001|Overall Study|Adverse Event|0|||
156989270|NCT00557505|566714670|FG002|Overall Study|Adverse Event|1|||
156989271|NCT00557505|566714671|FG003|Overall Study|Adverse Event|0|||
157096987|NCT02805725|567110911|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
156989272|NCT00557505|566714672|FG004|Overall Study|Adverse Event|0|||
156989273|NCT00557505|566714673|FG005|Overall Study|Adverse Event|0|||
156989274|NCT00557505|566714674|FG006|Overall Study|Adverse Event|1|||
156989275|NCT00557505|566714675|FG007|Overall Study|Adverse Event|0|||
156989276|NCT00557505|566714676|FG008|Overall Study|Adverse Event|0|||
156989277|NCT00557505|566714668|FG000|Overall Study|Global deterioration of health|1|||
156989278|NCT00557505|566714669|FG001|Overall Study|Global deterioration of health|0|||
156989279|NCT00557505|566714670|FG002|Overall Study|Global deterioration of health|0|||
156989280|NCT00557505|566714671|FG003|Overall Study|Global deterioration of health|0|||
156989281|NCT00557505|566714672|FG004|Overall Study|Global deterioration of health|0|||
156989282|NCT00557505|566714673|FG005|Overall Study|Global deterioration of health|0|||
156989283|NCT00557505|566714674|FG006|Overall Study|Global deterioration of health|0|||
156989284|NCT00557505|566714675|FG007|Overall Study|Global deterioration of health|0|||
156989285|NCT00557505|566714676|FG008|Overall Study|Global deterioration of health|0|||
156989286|NCT00557505|566714668|FG000|Overall Study|Objective progression or relapse|2|||
156989287|NCT00557505|566714669|FG001|Overall Study|Objective progression or relapse|3|||
156989288|NCT00557505|566714670|FG002|Overall Study|Objective progression or relapse|3|||
156989289|NCT00557505|566714671|FG003|Overall Study|Objective progression or relapse|2|||
156989290|NCT00557505|566714672|FG004|Overall Study|Objective progression or relapse|2|||
156989291|NCT00557505|566714673|FG005|Overall Study|Objective progression or relapse|3|||
156989292|NCT00557505|566714674|FG006|Overall Study|Objective progression or relapse|2|||
156989293|NCT00557505|566714675|FG007|Overall Study|Objective progression or relapse|5|||
156989294|NCT00557505|566714676|FG008|Overall Study|Objective progression or relapse|15|||
156989295|NCT00557505|566714668|FG000|Overall Study|Withdrawal by Subject|0|||
156989296|NCT00557505|566714669|FG001|Overall Study|Withdrawal by Subject|0|||
156989297|NCT00557505|566714670|FG002|Overall Study|Withdrawal by Subject|0|||
156989298|NCT00557505|566714671|FG003|Overall Study|Withdrawal by Subject|1|||
156989299|NCT00557505|566714672|FG004|Overall Study|Withdrawal by Subject|0|||
156989300|NCT00557505|566714673|FG005|Overall Study|Withdrawal by Subject|0|||
156989301|NCT00557505|566714674|FG006|Overall Study|Withdrawal by Subject|0|||
156989302|NCT00557505|566714675|FG007|Overall Study|Withdrawal by Subject|0|||
156989303|NCT00557505|566714676|FG008|Overall Study|Withdrawal by Subject|1|||
156989304|NCT03019458|566714677|FG000|Overall Study|Death|0|||
156989305|NCT03019458|566714678|FG001|Overall Study|Death|1|||
156989306|NCT01123161|566714682|FG000|Overall Study|Lost to Follow-up|1|||
156989307|NCT01123161|566714683|FG001|Overall Study|Lost to Follow-up|0|||
156989308|NCT01123161|566714682|FG000|Overall Study|Withdrawal by Subject|1|||
156989309|NCT01123161|566714683|FG001|Overall Study|Withdrawal by Subject|0|||
156989310|NCT01403987|566714684|FG000|Overall Study|Residents forgot their secret PIN|18|||
156989311|NCT01403987|566714685|FG001|Overall Study|Residents forgot their secret PIN|17|||
156989312|NCT01403987|566714686|FG002|Overall Study|Residents forgot their secret PIN|18|||
156989313|NCT00751790|566714688|FG000|Overall Study|Lost to Follow-up|1|||
156989314|NCT00751790|566714688|FG000|Overall Study|Death|3|||
156989315|NCT00751790|566714688|FG000|Overall Study|Withdrawal by Subject|1|||
156989316|NCT00180674|566714689|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
156989317|NCT00180674|566714689|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
156989318|NCT03302910|566714690|FG000|Overall Study|Protocol Violation|1|||
156989319|NCT03302910|566714691|FG001|Overall Study|Protocol Violation|0|||
156989320|NCT01106976|566714694|FG000|Overall Study|Lost to Follow-up|8|||
156989321|NCT00051311|566714704|FG000|Overall Study|Starting new study|0|||
156989322|NCT00051311|566714705|FG001|Overall Study|Starting new study|1|||
156989323|NCT00051311|566714704|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
156989324|NCT00051311|566714705|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
156989325|NCT00051311|566714704|FG000|Overall Study|Death of recipient|8|||
156989326|NCT00051311|566714705|FG001|Overall Study|Death of recipient|8|||
156989327|NCT00051311|566714704|FG000|Overall Study|Recipient taken off study|4|||
156989328|NCT00051311|566714705|FG001|Overall Study|Recipient taken off study|4|||
156989329|NCT04990440|566714706|FG000|Overall Study|Sponsor's Decision|0|||
156989330|NCT04990440|566714707|FG001|Overall Study|Sponsor's Decision|0|||
156989331|NCT04990440|566714708|FG002|Overall Study|Sponsor's Decision|1|||
156989332|NCT04170023|566714709|FG000|LTE Period|Withdrawal by Subject|1|||
156989333|NCT04170023|566714710|FG001|LTE Period|Withdrawal by Subject|0|||
156989334|NCT04170023|566714711|FG002|LTE Period|Withdrawal by Subject|0|||
156989335|NCT04170023|566714709|FG000|LTE Period|Study Termination|11|||
156989336|NCT04170023|566714710|FG001|LTE Period|Study Termination|11|||
156989337|NCT04170023|566714711|FG002|LTE Period|Study Termination|5|||
156989338|NCT03712098|566714712|FG000|Overall Study|Lost to Follow-up|3|||
156989339|NCT03712098|566714713|FG001|Overall Study|Lost to Follow-up|7|||
156989340|NCT03712098|566714712|FG000|Overall Study|Withdrawal by Subject|9|||
156989341|NCT03712098|566714713|FG001|Overall Study|Withdrawal by Subject|4|||
156989342|NCT03712098|566714712|FG000|Overall Study|Protocol Violation|2|||
156989343|NCT03712098|566714713|FG001|Overall Study|Protocol Violation|1|||
156989344|NCT00953160|566714716|FG000|Overall Study|Lost to Follow-up|23|||
156989345|NCT00953160|566714716|FG000|Overall Study|Withdrawal by Subject|4|||
156989346|NCT03566680|566714721|FG000|Overall Study|Pregnancy|1|||
156989347|NCT03566680|566714721|FG000|Overall Study|Lost to Follow-up|13|||
156989348|NCT03566680|566714721|FG000|Overall Study|Withdrawal by Subject|3|||
156989349|NCT03836664|566714722|FG000|Overall Study|Didn't complete forms and lost drug|3|||
156989350|NCT03836664|566714723|FG001|Overall Study|Didn't complete forms and lost drug|3|||
156989351|NCT00425503|566714725|FG000|Overall Study|Adverse Event|2|||
156989352|NCT00425503|566714725|FG000|Overall Study|Protocol Violation|1|||
156989353|NCT02179918|566714726|FG000|Overall Study|Death|0|||
156989354|NCT02179918|566714727|FG001|Overall Study|Death|0|||
156989355|NCT02179918|566714728|FG002|Overall Study|Death|0|||
156989356|NCT02179918|566714729|FG003|Overall Study|Death|1|||
156989357|NCT02179918|566714730|FG004|Overall Study|Death|0|||
156989358|NCT02179918|566714726|FG000|Overall Study|Lost to Follow-up|0|||
156989359|NCT02179918|566714727|FG001|Overall Study|Lost to Follow-up|0|||
156989360|NCT02179918|566714728|FG002|Overall Study|Lost to Follow-up|1|||
156989361|NCT02179918|566714729|FG003|Overall Study|Lost to Follow-up|0|||
156989362|NCT02179918|566714730|FG004|Overall Study|Lost to Follow-up|0|||
156989363|NCT02179918|566714726|FG000|Overall Study|Progressive Disease|4|||
156989364|NCT02179918|566714727|FG001|Overall Study|Progressive Disease|1|||
156989365|NCT02179918|566714728|FG002|Overall Study|Progressive Disease|1|||
156989366|NCT02179918|566714729|FG003|Overall Study|Progressive Disease|2|||
156989367|NCT02179918|566714730|FG004|Overall Study|Progressive Disease|6|||
156989368|NCT02179918|566714726|FG000|Overall Study|Other|0|||
156989369|NCT02179918|566714727|FG001|Overall Study|Other|1|||
156989370|NCT02179918|566714728|FG002|Overall Study|Other|0|||
156989371|NCT02179918|566714729|FG003|Overall Study|Other|0|||
156989372|NCT02179918|566714730|FG004|Overall Study|Other|1|||
156989373|NCT02179918|566714726|FG000|Overall Study|Subject refused further follow-up|0|||
156989374|NCT02179918|566714727|FG001|Overall Study|Subject refused further follow-up|1|||
156989375|NCT02179918|566714728|FG002|Overall Study|Subject refused further follow-up|0|||
156989376|NCT02179918|566714729|FG003|Overall Study|Subject refused further follow-up|0|||
156989377|NCT02179918|566714730|FG004|Overall Study|Subject refused further follow-up|1|||
156989378|NCT02118714|566714735|FG000|Overall Study|Lost to Follow-up|2|||
156989379|NCT02118714|566714735|FG000|Overall Study|Protocol Violation|1|||
156989380|NCT02954575|566714736|FG000|Overall Study|Withdrawal by Subject|2|||
156989381|NCT02954575|566714736|FG000|Overall Study|Adverse Event|1|||
156989382|NCT01066156|566714738|FG000|Overall Study|ineligible|2|||
156989383|NCT01066156|566714738|FG000|Overall Study|Lost to Follow-up|7|||
156989384|NCT01066156|566714738|FG000|Overall Study|Withdrawal by Subject|1|||
156989385|NCT00570661|566714739|FG000|Overall Study|Disease worsening|5|||
156989386|NCT00570661|566714739|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
156989387|NCT00570661|566714739|FG000|Overall Study|Adverse Event|1|||
156989388|NCT01734382|566714743|FG000|Part 1|Adverse Event|2|||
156989389|NCT01734382|566714744|FG001|Part 1|Adverse Event|0|||
156989390|NCT01734382|566714745|FG002|Part 1|Adverse Event|0|||
156989391|NCT01734382|566714743|FG000|Part 2|Adverse Event|0|||
156989392|NCT01734382|566714744|FG001|Part 2|Adverse Event|0|||
156989393|NCT01734382|566714745|FG002|Part 2|Adverse Event|1|||
156989394|NCT01734382|566714743|FG000|Part 2|Lack of Efficacy|0|||
156989395|NCT01734382|566714744|FG001|Part 2|Lack of Efficacy|1|||
156989396|NCT01734382|566714745|FG002|Part 2|Lack of Efficacy|1|||
156989397|NCT01734382|566714743|FG000|Part 2|Other|0|||
156989398|NCT01734382|566714744|FG001|Part 2|Other|0|||
156989399|NCT01734382|566714745|FG002|Part 2|Other|1|||
156989400|NCT01734382|566714743|FG000|Part 2|Physician Decision|0|||
156989401|NCT01734382|566714744|FG001|Part 2|Physician Decision|0|||
156989402|NCT01734382|566714745|FG002|Part 2|Physician Decision|3|||
156989403|NCT01734382|566714743|FG000|Part 2|Protocol Violation|0|||
156989404|NCT01734382|566714744|FG001|Part 2|Protocol Violation|1|||
156989405|NCT01734382|566714745|FG002|Part 2|Protocol Violation|0|||
156989406|NCT01734382|566714743|FG000|Part 2|Withdrawal by Subject|0|||
156989407|NCT01734382|566714744|FG001|Part 2|Withdrawal by Subject|0|||
156989408|NCT01734382|566714745|FG002|Part 2|Withdrawal by Subject|1|||
156989409|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
156989410|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
156989411|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
156989412|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
156989413|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
156989414|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
156989415|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
156989416|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
156989417|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
156989418|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
156989419|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
156989420|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
156989421|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
156989422|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
156989423|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
156989424|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
156989425|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
156989426|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
156989427|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
156989428|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
156989429|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
156989430|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
156989431|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
156989432|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
156989433|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
156989434|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156989435|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156989436|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
156989437|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156989438|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
156989439|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156989440|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
156989441|NCT03890120|566714746|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156989442|NCT03890120|566714747|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
156989443|NCT03890120|566714748|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156989444|NCT03890120|566714749|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
156989445|NCT03890120|566714746|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
156989446|NCT03890120|566714747|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
156989447|NCT03890120|566714748|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
156989448|NCT03890120|566714749|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
156989449|NCT03890120|566714746|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
156989450|NCT03890120|566714747|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
156989451|NCT03890120|566714748|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
156989452|NCT03890120|566714749|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
156989453|NCT03890120|566714746|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156989454|NCT03890120|566714747|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156989455|NCT03890120|566714748|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
156989456|NCT03890120|566714749|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
156989457|NCT03890120|566714746|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156989458|NCT03890120|566714747|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156989459|NCT03890120|566714748|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
156989460|NCT03890120|566714749|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
156989461|NCT04537949|566714750|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
156989462|NCT04537949|566714751|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
156989463|NCT04537949|566714752|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
156989464|NCT04537949|566714753|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
156989465|NCT04537949|566714754|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
156989466|NCT04537949|566714755|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
156989467|NCT04537949|566714756|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
156989468|NCT04537949|566714757|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
156989469|NCT04537949|566714750|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
156989470|NCT04537949|566714751|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156989471|NCT04537949|566714752|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
156989472|NCT04537949|566714753|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
156989473|NCT04537949|566714754|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156989474|NCT04537949|566714755|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
156989475|NCT04537949|566714756|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
156989476|NCT04537949|566714757|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
156989477|NCT04537949|566714750|FG000|Follow-up Phase|Lost to Follow-up|0|||
156989478|NCT04537949|566714751|FG001|Follow-up Phase|Lost to Follow-up|3|||
156989479|NCT04537949|566714752|FG002|Follow-up Phase|Lost to Follow-up|0|||
156989480|NCT04537949|566714753|FG003|Follow-up Phase|Lost to Follow-up|0|||
156989481|NCT04537949|566714754|FG004|Follow-up Phase|Lost to Follow-up|0|||
156989482|NCT04537949|566714755|FG005|Follow-up Phase|Lost to Follow-up|0|||
156989483|NCT04537949|566714756|FG006|Follow-up Phase|Lost to Follow-up|0|||
156989484|NCT04537949|566714757|FG007|Follow-up Phase|Lost to Follow-up|0|||
156989485|NCT04537949|566714750|FG000|Follow-up Phase|personal reasons|0|||
156989486|NCT04537949|566714751|FG001|Follow-up Phase|personal reasons|0|||
156989487|NCT04537949|566714752|FG002|Follow-up Phase|personal reasons|0|||
156989488|NCT04537949|566714753|FG003|Follow-up Phase|personal reasons|1|||
156989489|NCT04537949|566714754|FG004|Follow-up Phase|personal reasons|1|||
156989490|NCT04537949|566714755|FG005|Follow-up Phase|personal reasons|0|||
156989491|NCT04537949|566714756|FG006|Follow-up Phase|personal reasons|0|||
156989492|NCT04537949|566714757|FG007|Follow-up Phase|personal reasons|0|||
156989493|NCT04537949|566714750|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156989494|NCT04537949|566714751|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156989495|NCT04537949|566714752|FG002|Follow-up Phase|Withdrawal by Subject|0|||
156989496|NCT04537949|566714753|FG003|Follow-up Phase|Withdrawal by Subject|0|||
156989497|NCT04537949|566714754|FG004|Follow-up Phase|Withdrawal by Subject|1|||
156989498|NCT04537949|566714755|FG005|Follow-up Phase|Withdrawal by Subject|0|||
156989499|NCT04537949|566714756|FG006|Follow-up Phase|Withdrawal by Subject|0|||
156989500|NCT04537949|566714757|FG007|Follow-up Phase|Withdrawal by Subject|0|||
156989501|NCT01925170|566714760|FG000|Overall Study|Unverified cancer status|53|||
156989502|NCT02839681|566714768|FG000|Overall Study|Death|2|||
156989503|NCT01653847|566714769|FG000|Overall Study|Withdrawal by Subject|1|||
156989504|NCT01653847|566714770|FG001|Overall Study|Withdrawal by Subject|0|||
156989505|NCT02554513|566714771|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
156989506|NCT02554513|566714772|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
156989507|NCT02550873|566714773|FG000|Randomized Double Blind|Adverse Event|3|||
156989508|NCT02550873|566714774|FG001|Randomized Double Blind|Adverse Event|1|||
156989509|NCT02550873|566714775|FG002|Randomized Double Blind|Adverse Event|0|||
156989510|NCT02550873|566714773|FG000|Randomized Double Blind|Disease progression|1|||
156989511|NCT02550873|566714774|FG001|Randomized Double Blind|Disease progression|1|||
156989512|NCT02550873|566714775|FG002|Randomized Double Blind|Disease progression|0|||
156989513|NCT02550873|566714773|FG000|Open Label Extension|Study ongoing|0|||
156989514|NCT02550873|566714774|FG001|Open Label Extension|Study ongoing|0|||
156989515|NCT02550873|566714775|FG002|Open Label Extension|Study ongoing|111|||
156989516|NCT01822353|566714776|FG000|Overall Study|Adverse Event|1|||
156989517|NCT01822353|566714777|FG001|Overall Study|Adverse Event|3|||
156989518|NCT01822353|566714778|FG002|Overall Study|Adverse Event|1|||
156989519|NCT01822353|566714776|FG000|Overall Study|Pregnancy|0|||
156989520|NCT01822353|566714777|FG001|Overall Study|Pregnancy|1|||
156989521|NCT01822353|566714778|FG002|Overall Study|Pregnancy|0|||
156989522|NCT01822353|566714776|FG000|Overall Study|Withdrawal by Subject|3|||
156989523|NCT01822353|566714777|FG001|Overall Study|Withdrawal by Subject|1|||
156989524|NCT01822353|566714778|FG002|Overall Study|Withdrawal by Subject|0|||
156989525|NCT00885495|566714779|FG000|Overall Study|Adverse Event|1|||
156989526|NCT00885495|566714780|FG001|Overall Study|Adverse Event|2|||
156989527|NCT00885495|566714779|FG000|Overall Study|Protocol Violation|0|||
156989528|NCT00885495|566714780|FG001|Overall Study|Protocol Violation|1|||
156989529|NCT00885495|566714779|FG000|Overall Study|Withdrawal by Subject|1|||
156989530|NCT00885495|566714780|FG001|Overall Study|Withdrawal by Subject|0|||
156989531|NCT01400893|566714781|FG000|Overall Study|Death|27|||
156989532|NCT01400893|566714782|FG001|Overall Study|Death|21|||
156989533|NCT01400893|566714781|FG000|Overall Study|Lost to Follow-up|0|||
156989534|NCT01400893|566714782|FG001|Overall Study|Lost to Follow-up|6|||
156989535|NCT00519636|566714783|FG000|Treatment Period 1|Adverse Event|1|||
156989536|NCT00519636|566714784|FG001|Treatment Period 1|Adverse Event|0|||
156989537|NCT00519636|566714785|FG002|Treatment Period 1|Adverse Event|1|||
156989538|NCT00519636|566714786|FG003|Treatment Period 1|Adverse Event|0|||
156989539|NCT00519636|566714783|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
156989540|NCT00519636|566714784|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
156989541|NCT00519636|566714785|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
156989542|NCT00519636|566714786|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
156989543|NCT00519636|566714783|FG000|Washout Period|Adverse Event|2|||
156989544|NCT00519636|566714784|FG001|Washout Period|Adverse Event|1|||
156989545|NCT00519636|566714785|FG002|Washout Period|Adverse Event|1|||
156989546|NCT00519636|566714786|FG003|Washout Period|Adverse Event|0|||
156989547|NCT00519636|566714783|FG000|Washout Period|Lost to Follow-up|1|||
156989548|NCT00519636|566714784|FG001|Washout Period|Lost to Follow-up|0|||
156989549|NCT00519636|566714785|FG002|Washout Period|Lost to Follow-up|0|||
156989550|NCT00519636|566714786|FG003|Washout Period|Lost to Follow-up|0|||
156989551|NCT00519636|566714783|FG000|Washout Period|Protocol Violation|0|||
156989552|NCT00519636|566714784|FG001|Washout Period|Protocol Violation|0|||
156989553|NCT00519636|566714785|FG002|Washout Period|Protocol Violation|1|||
156989554|NCT00519636|566714786|FG003|Washout Period|Protocol Violation|2|||
156989555|NCT00519636|566714783|FG000|Washout Period|Withdrawal by Subject|1|||
156989556|NCT00519636|566714784|FG001|Washout Period|Withdrawal by Subject|0|||
156989557|NCT00519636|566714785|FG002|Washout Period|Withdrawal by Subject|1|||
156989558|NCT00519636|566714786|FG003|Washout Period|Withdrawal by Subject|0|||
156989559|NCT00519636|566714783|FG000|Washout Period|Failed to meet continuation criteria|14|||
156989560|NCT00519636|566714784|FG001|Washout Period|Failed to meet continuation criteria|11|||
156989561|NCT00519636|566714785|FG002|Washout Period|Failed to meet continuation criteria|9|||
156989562|NCT00519636|566714786|FG003|Washout Period|Failed to meet continuation criteria|3|||
156989563|NCT00519636|566714783|FG000|Washout Period|Out of pollen area > 48 hours|1|||
156989564|NCT00519636|566714784|FG001|Washout Period|Out of pollen area > 48 hours|0|||
156989565|NCT00519636|566714785|FG002|Washout Period|Out of pollen area > 48 hours|0|||
156989566|NCT00519636|566714786|FG003|Washout Period|Out of pollen area > 48 hours|0|||
156989567|NCT00519636|566714783|FG000|Washout Period|Participating in study at another site|1|||
156989568|NCT00519636|566714784|FG001|Washout Period|Participating in study at another site|0|||
156989569|NCT00519636|566714785|FG002|Washout Period|Participating in study at another site|0|||
156989570|NCT00519636|566714786|FG003|Washout Period|Participating in study at another site|0|||
156989571|NCT00519636|566714783|FG000|Washout Period|Non-compliant|0|||
156989572|NCT00519636|566714784|FG001|Washout Period|Non-compliant|1|||
156989573|NCT00519636|566714785|FG002|Washout Period|Non-compliant|0|||
156989574|NCT00519636|566714786|FG003|Washout Period|Non-compliant|0|||
156989575|NCT00519636|566714783|FG000|Washout Period|Per doctors request|0|||
156989576|NCT00519636|566714784|FG001|Washout Period|Per doctors request|1|||
156989577|NCT00519636|566714785|FG002|Washout Period|Per doctors request|0|||
156989578|NCT00519636|566714786|FG003|Washout Period|Per doctors request|0|||
156989579|NCT00519636|566714783|FG000|Washout Period|Subject randomized in error|0|||
156989580|NCT00519636|566714784|FG001|Washout Period|Subject randomized in error|0|||
156989581|NCT00519636|566714785|FG002|Washout Period|Subject randomized in error|1|||
156989582|NCT00519636|566714786|FG003|Washout Period|Subject randomized in error|0|||
156989583|NCT00519636|566714783|FG000|Washout Period|Prohibited medications|0|||
156989584|NCT00519636|566714784|FG001|Washout Period|Prohibited medications|0|||
156989585|NCT00519636|566714785|FG002|Washout Period|Prohibited medications|1|||
156989586|NCT00519636|566714786|FG003|Washout Period|Prohibited medications|0|||
156989587|NCT00519636|566714783|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156989588|NCT00519636|566714784|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156989589|NCT00519636|566714785|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
156989590|NCT00519636|566714786|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
156989591|NCT00519636|566714783|FG000|Treatment Period 2|Subject randomized in error|0|||
156989592|NCT00519636|566714784|FG001|Treatment Period 2|Subject randomized in error|1|||
156989593|NCT00519636|566714785|FG002|Treatment Period 2|Subject randomized in error|0|||
156989594|NCT00519636|566714786|FG003|Treatment Period 2|Subject randomized in error|0|||
156989595|NCT00519636|566714783|FG000|Treatment Period 2|Per doctors request|0|||
156989596|NCT00519636|566714784|FG001|Treatment Period 2|Per doctors request|0|||
156989597|NCT00519636|566714785|FG002|Treatment Period 2|Per doctors request|1|||
156989598|NCT00519636|566714786|FG003|Treatment Period 2|Per doctors request|0|||
156989599|NCT00519636|566714783|FG000|Treatment Period 2|Subject misrandomized|0|||
156989600|NCT00519636|566714784|FG001|Treatment Period 2|Subject misrandomized|0|||
156989601|NCT00519636|566714785|FG002|Treatment Period 2|Subject misrandomized|0|||
156989602|NCT00519636|566714786|FG003|Treatment Period 2|Subject misrandomized|1|||
156989603|NCT00519636|566714783|FG000|Post Study Period|Subject randomized in error|0|||
156989604|NCT00519636|566714784|FG001|Post Study Period|Subject randomized in error|0|||
156989605|NCT00519636|566714785|FG002|Post Study Period|Subject randomized in error|0|||
156989606|NCT00519636|566714786|FG003|Post Study Period|Subject randomized in error|1|||
156989607|NCT04504916|566714787|FG000|Overall Study|Study terminated|7|||
156989608|NCT04504916|566714788|FG001|Overall Study|Study terminated|8|||
156989609|NCT04504916|566714787|FG000|Overall Study|Death|54|||
156989610|NCT04504916|566714788|FG001|Overall Study|Death|18|||
156989611|NCT04504916|566714787|FG000|Overall Study|Lost to Follow-up|1|||
156989612|NCT04504916|566714788|FG001|Overall Study|Lost to Follow-up|1|||
156989613|NCT04504916|566714787|FG000|Overall Study|Withdrawal by Subject|8|||
156989614|NCT04504916|566714788|FG001|Overall Study|Withdrawal by Subject|4|||
156989615|NCT04504916|566714787|FG000|Overall Study|Did not agree to follow-up|0|||
156989616|NCT04504916|566714788|FG001|Overall Study|Did not agree to follow-up|1|||
156989617|NCT00003509|566714789|FG000|Overall Study|Not evaluable|5|||
156989618|NCT05194735|566716155|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
156989619|NCT05194735|566716156|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
156989620|NCT05194735|566716157|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
156989621|NCT05194735|566716155|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
156989622|NCT05194735|566716156|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
156989623|NCT05194735|566716157|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
156989624|NCT05194735|566716155|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
156989625|NCT05194735|566716156|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
157021609|NCT02913872|566830920|FG000|Overall Study|Withdrawal by Subject|1|||
156989626|NCT05194735|566716157|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
156989627|NCT05194735|566716155|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
156989628|NCT05194735|566716156|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
156989629|NCT05194735|566716157|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
156989630|NCT00731042|566716158|FG000|Second Intervention|Did not meet inclusion criteria|0|||
156989631|NCT00731042|566716159|FG001|Second Intervention|Did not meet inclusion criteria|2|||
156989632|NCT01256476|566716160|FG000|Overall Study|Adverse Event|2|||
156989633|NCT01256476|566716161|FG001|Overall Study|Adverse Event|1|||
156989634|NCT01256476|566716160|FG000|Overall Study|Withdrawal by Subject|2|||
156989635|NCT01256476|566716161|FG001|Overall Study|Withdrawal by Subject|1|||
156989636|NCT01256476|566716160|FG000|Overall Study|Lost to Follow-up|1|||
156989637|NCT01256476|566716161|FG001|Overall Study|Lost to Follow-up|2|||
156989638|NCT01256476|566716160|FG000|Overall Study|Persistent ALT or AST elevation|1|||
156989639|NCT01256476|566716161|FG001|Overall Study|Persistent ALT or AST elevation|0|||
156989640|NCT01256476|566716160|FG000|Overall Study|Physician Decision|0|||
156989641|NCT01256476|566716161|FG001|Overall Study|Physician Decision|1|||
156989642|NCT01256476|566716160|FG000|Overall Study|Subject non-compliance|0|||
156989643|NCT01256476|566716161|FG001|Overall Study|Subject non-compliance|1|||
156989644|NCT01256476|566716160|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
156989645|NCT01256476|566716161|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
156989646|NCT04034238|566716164|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
156989647|NCT04034238|566716165|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
156989648|NCT04034238|566716166|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156989649|NCT04034238|566716167|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156989650|NCT04034238|566716164|FG000|Dose Escalation Phase|Screen failures|0|||
156989651|NCT04034238|566716165|FG001|Dose Escalation Phase|Screen failures|0|||
156989652|NCT04034238|566716166|FG002|Dose Escalation Phase|Screen failures|0|||
156989653|NCT04034238|566716167|FG003|Dose Escalation Phase|Screen failures|2|||
156989654|NCT04034238|566716164|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
156989655|NCT04034238|566716165|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
156989656|NCT04034238|566716166|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
156989657|NCT04034238|566716167|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
156989658|NCT04034238|566716164|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156989659|NCT04034238|566716165|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156989660|NCT04034238|566716166|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
156989661|NCT04034238|566716167|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
156989662|NCT01345292|566716168|FG000|Overall Study|Withdrawal by Subject|2|||
156989663|NCT01345292|566716169|FG001|Overall Study|Withdrawal by Subject|0|||
156989664|NCT01345292|566716170|FG002|Overall Study|Withdrawal by Subject|1|||
156989665|NCT04822298|566716172|FG000|Overall Study|Death|3|||
156989666|NCT00465361|566716175|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
156989667|NCT05406791|566716176|FG000|Overall Study|Lost to Follow-up|13|||
156989668|NCT05406791|566716177|FG001|Overall Study|Lost to Follow-up|10|||
156989669|NCT01625338|566716181|FG000|Overall Study|Enrolled but not Treated|0|||
156989670|NCT01625338|566716182|FG001|Overall Study|Enrolled but not Treated|0|||
156989671|NCT01625338|566716183|FG002|Overall Study|Enrolled but not Treated|1|||
156989672|NCT01625338|566716181|FG000|Overall Study|Efficacy Failure|27|||
156989673|NCT01625338|566716182|FG001|Overall Study|Efficacy Failure|39|||
156989674|NCT01625338|566716183|FG002|Overall Study|Efficacy Failure|31|||
156989675|NCT01625338|566716181|FG000|Overall Study|Lost to Follow-up|3|||
156989676|NCT01625338|566716182|FG001|Overall Study|Lost to Follow-up|3|||
156989677|NCT01625338|566716183|FG002|Overall Study|Lost to Follow-up|2|||
156989678|NCT01625338|566716181|FG000|Overall Study|Investigator Decision|0|||
156989679|NCT01625338|566716182|FG001|Overall Study|Investigator Decision|2|||
156989680|NCT01625338|566716183|FG002|Overall Study|Investigator Decision|1|||
156989681|NCT01625338|566716181|FG000|Overall Study|Subject Withdrew Consent|1|||
156989682|NCT01625338|566716182|FG001|Overall Study|Subject Withdrew Consent|0|||
156989683|NCT01625338|566716183|FG002|Overall Study|Subject Withdrew Consent|2|||
156989684|NCT01625338|566716181|FG000|Overall Study|Adverse Event|1|||
156989685|NCT01625338|566716182|FG001|Overall Study|Adverse Event|0|||
156989686|NCT01625338|566716183|FG002|Overall Study|Adverse Event|1|||
157096988|NCT02805725|567110912|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
157096989|NCT02805725|567110913|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
156989687|NCT01625338|566716181|FG000|Overall Study|Study Discontinued by Sponsor|0|||
156989688|NCT01625338|566716182|FG001|Overall Study|Study Discontinued by Sponsor|0|||
156989689|NCT01625338|566716183|FG002|Overall Study|Study Discontinued by Sponsor|1|||
156989690|NCT01789203|566716184|FG000|Overall Study|Adverse Event|2|||
156989691|NCT01789203|566716185|FG001|Overall Study|Adverse Event|2|||
156989692|NCT01789203|566716184|FG000|Overall Study|Withdrawal by Subject|1|||
156989693|NCT01789203|566716185|FG001|Overall Study|Withdrawal by Subject|0|||
157096990|NCT02805725|567110914|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
156989694|NCT01789203|566716184|FG000|Overall Study|Death|1|||
156989695|NCT01789203|566716185|FG001|Overall Study|Death|0|||
156989696|NCT01789203|566716184|FG000|Overall Study|Protocol Violation|2|||
156989697|NCT01789203|566716185|FG001|Overall Study|Protocol Violation|1|||
156989698|NCT01789203|566716184|FG000|Overall Study|Other|1|||
156989699|NCT01789203|566716185|FG001|Overall Study|Other|1|||
156989700|NCT01789203|566716184|FG000|Overall Study|patient non-adherent|2|||
156989701|NCT01789203|566716185|FG001|Overall Study|patient non-adherent|0|||
156989702|NCT00515086|566716190|FG000|Overall Study|Adverse Event|1|||
156989703|NCT00515086|566716191|FG001|Overall Study|Adverse Event|1|||
156989704|NCT00515086|566716192|FG002|Overall Study|Adverse Event|2|||
156989705|NCT00515086|566716193|FG003|Overall Study|Adverse Event|3|||
156989706|NCT00515086|566716190|FG000|Overall Study|Administrative|1|||
156989707|NCT00515086|566716191|FG001|Overall Study|Administrative|1|||
156989708|NCT00515086|566716192|FG002|Overall Study|Administrative|0|||
156989709|NCT00515086|566716193|FG003|Overall Study|Administrative|0|||
156989710|NCT00515086|566716190|FG000|Overall Study|Withdrawal by Subject|1|||
156989711|NCT00515086|566716191|FG001|Overall Study|Withdrawal by Subject|0|||
156989712|NCT00515086|566716192|FG002|Overall Study|Withdrawal by Subject|0|||
156989713|NCT00515086|566716193|FG003|Overall Study|Withdrawal by Subject|1|||
156989714|NCT00515086|566716190|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156989715|NCT00515086|566716191|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156989716|NCT00515086|566716192|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
156989717|NCT00515086|566716193|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
156989718|NCT00515086|566716190|FG000|Overall Study|Lost to Follow-up|1|||
156989719|NCT00515086|566716191|FG001|Overall Study|Lost to Follow-up|0|||
156989720|NCT00515086|566716192|FG002|Overall Study|Lost to Follow-up|0|||
156989721|NCT00515086|566716193|FG003|Overall Study|Lost to Follow-up|0|||
156989722|NCT00515086|566716190|FG000|Overall Study|Study drug no longer required|0|||
156989723|NCT00515086|566716191|FG001|Overall Study|Study drug no longer required|1|||
156989724|NCT00515086|566716192|FG002|Overall Study|Study drug no longer required|0|||
156989725|NCT00515086|566716193|FG003|Overall Study|Study drug no longer required|0|||
156989726|NCT00515086|566716190|FG000|Overall Study|Death|2|||
156989727|NCT00515086|566716191|FG001|Overall Study|Death|0|||
156989728|NCT00515086|566716192|FG002|Overall Study|Death|0|||
156989729|NCT00515086|566716193|FG003|Overall Study|Death|0|||
156989730|NCT00031447|566716199|FG000|Overall Study|Lost to Follow-up|0|||
156989731|NCT00031447|566716200|FG001|Overall Study|Lost to Follow-up|1|||
156989732|NCT00031447|566716199|FG000|Overall Study|Non-compliant|1|||
156989733|NCT00031447|566716200|FG001|Overall Study|Non-compliant|1|||
156989734|NCT00031447|566716199|FG000|Overall Study|Re-activation of Disease|2|||
156989735|NCT00031447|566716200|FG001|Overall Study|Re-activation of Disease|1|||
156989736|NCT00031447|566716199|FG000|Overall Study|Disruption of blinded study drug supply|7|||
156989737|NCT00031447|566716200|FG001|Overall Study|Disruption of blinded study drug supply|4|||
156989738|NCT01636362|566716201|FG000|Overall Study|Physician Decision|6|||
156989739|NCT01636362|566716201|FG000|Overall Study|Subject healed, not returning|1|||
156989740|NCT01636362|566716201|FG000|Overall Study|Withdrawal by Subject|1|||
156989741|NCT01244763|566716202|FG000|Overall Study|Adverse Event|1|||
156989742|NCT01244763|566716203|FG001|Overall Study|Adverse Event|0|||
156989743|NCT01244763|566716204|FG002|Overall Study|Adverse Event|0|||
156989744|NCT01244763|566716205|FG003|Overall Study|Adverse Event|0|||
156989745|NCT01244763|566716206|FG004|Overall Study|Adverse Event|0|||
156989746|NCT01244763|566716207|FG005|Overall Study|Adverse Event|1|||
156989747|NCT01244763|566716202|FG000|Overall Study|Death|1|||
156989748|NCT01244763|566716203|FG001|Overall Study|Death|0|||
156989749|NCT01244763|566716204|FG002|Overall Study|Death|1|||
156989750|NCT01244763|566716205|FG003|Overall Study|Death|0|||
156989751|NCT01244763|566716206|FG004|Overall Study|Death|2|||
156989752|NCT01244763|566716207|FG005|Overall Study|Death|0|||
156989753|NCT01244763|566716202|FG000|Overall Study|Physician Decision|0|||
156989754|NCT01244763|566716203|FG001|Overall Study|Physician Decision|0|||
156989755|NCT01244763|566716204|FG002|Overall Study|Physician Decision|1|||
156989756|NCT01244763|566716205|FG003|Overall Study|Physician Decision|0|||
156989757|NCT01244763|566716206|FG004|Overall Study|Physician Decision|0|||
156989758|NCT01244763|566716207|FG005|Overall Study|Physician Decision|0|||
156989759|NCT01244763|566716202|FG000|Overall Study|Withdrawal by Subject|1|||
156989760|NCT01244763|566716203|FG001|Overall Study|Withdrawal by Subject|2|||
156989761|NCT01244763|566716204|FG002|Overall Study|Withdrawal by Subject|0|||
156989762|NCT01244763|566716205|FG003|Overall Study|Withdrawal by Subject|1|||
156989763|NCT01244763|566716206|FG004|Overall Study|Withdrawal by Subject|1|||
156989764|NCT01244763|566716207|FG005|Overall Study|Withdrawal by Subject|2|||
156989765|NCT01244763|566716202|FG000|Overall Study|Lost to Follow-up|0|||
156989766|NCT01244763|566716203|FG001|Overall Study|Lost to Follow-up|1|||
156989767|NCT01244763|566716204|FG002|Overall Study|Lost to Follow-up|0|||
156989768|NCT01244763|566716205|FG003|Overall Study|Lost to Follow-up|0|||
156989769|NCT01244763|566716206|FG004|Overall Study|Lost to Follow-up|0|||
156989770|NCT01244763|566716207|FG005|Overall Study|Lost to Follow-up|0|||
156989771|NCT01244763|566716202|FG000|Overall Study|Enrolled into the Extension Study|0|||
156989772|NCT01244763|566716203|FG001|Overall Study|Enrolled into the Extension Study|0|||
156989773|NCT01244763|566716204|FG002|Overall Study|Enrolled into the Extension Study|0|||
156989774|NCT01244763|566716205|FG003|Overall Study|Enrolled into the Extension Study|0|||
156989775|NCT01244763|566716206|FG004|Overall Study|Enrolled into the Extension Study|0|||
156989776|NCT01244763|566716207|FG005|Overall Study|Enrolled into the Extension Study|1|||
156989777|NCT02271594|566716208|FG000|Overall Study|Study closed; recruiting failure|19|||
156989778|NCT02271594|566716209|FG001|Overall Study|Study closed; recruiting failure|12|||
156989779|NCT00519779|566716210|FG000|Overall Study|Withdrawal by Subject|0|||
156989780|NCT00519779|566716211|FG001|Overall Study|Withdrawal by Subject|1|||
156989781|NCT03330119|566716214|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
156989782|NCT03330119|566716215|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
156989783|NCT01561079|566716216|FG000|Overall Study|Physician Decision|17|||
156989784|NCT01561079|566716216|FG000|Overall Study|Withdrawal by Subject|59|||
156989785|NCT01561079|566716216|FG000|Overall Study|Protocol Violation|2|||
156989786|NCT00664521|566716222|FG000|Overall Study|Adverse Event|4|||
156989787|NCT00664521|566716223|FG001|Overall Study|Adverse Event|1|||
156989788|NCT00664521|566716222|FG000|Overall Study|Lost to Follow-up|1|||
156989789|NCT00664521|566716223|FG001|Overall Study|Lost to Follow-up|0|||
156989790|NCT00664521|566716222|FG000|Overall Study|Other|1|||
156989791|NCT00664521|566716223|FG001|Overall Study|Other|0|||
156989792|NCT00550732|566716224|FG000|Overall Study|Death|4|||
156989793|NCT00550732|566716224|FG000|Overall Study|Withdrawal by Subject|2|||
156989794|NCT00550732|566716224|FG000|Overall Study|Physician Decision|2|||
156989795|NCT00550732|566716224|FG000|Overall Study|Lost to Follow-up|1|||
156989796|NCT00550732|566716224|FG000|Overall Study|Palliative care|1|||
156989797|NCT00550732|566716224|FG000|Overall Study|Adverse Event|1|||
156989798|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
156989799|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156989800|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156989801|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156989802|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156989803|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
156989804|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
156989805|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
156989806|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
156989807|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
156989808|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156989809|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
156989810|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156989811|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156989812|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156989813|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156989814|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156989815|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156989816|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156989817|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156989818|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156989819|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156989820|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
156989821|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
156989822|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156989823|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156989824|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156989825|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156989826|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156989827|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156989828|NCT01323660|566716226|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
156989829|NCT01323660|566716227|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156989830|NCT01323660|566716228|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156989831|NCT01323660|566716229|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156989832|NCT01323660|566716230|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
156989833|NCT01323660|566716231|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156989834|NCT01323660|566716226|FG000|Washout Period (14 Days)|Adverse Event|0|||
156989835|NCT01323660|566716227|FG001|Washout Period (14 Days)|Adverse Event|0|||
156989836|NCT01323660|566716228|FG002|Washout Period (14 Days)|Adverse Event|0|||
156989837|NCT01323660|566716229|FG003|Washout Period (14 Days)|Adverse Event|0|||
156989838|NCT01323660|566716230|FG004|Washout Period (14 Days)|Adverse Event|1|||
156989839|NCT01323660|566716231|FG005|Washout Period (14 Days)|Adverse Event|0|||
156989840|NCT01323660|566716226|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
156989841|NCT01323660|566716227|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
156989842|NCT01323660|566716228|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
156989843|NCT01323660|566716229|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
156989844|NCT01323660|566716230|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
156989845|NCT01323660|566716231|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
156989846|NCT01323660|566716226|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156989847|NCT01323660|566716227|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156989848|NCT01323660|566716228|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156989849|NCT01323660|566716229|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156989850|NCT01323660|566716230|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156989851|NCT01323660|566716231|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
156989852|NCT01323660|566716226|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
156989853|NCT01323660|566716227|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156989854|NCT01323660|566716228|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156989855|NCT01323660|566716229|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156989856|NCT01323660|566716230|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156989857|NCT01323660|566716231|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
156989858|NCT01323660|566716226|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156989859|NCT01323660|566716227|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156989860|NCT01323660|566716228|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156989861|NCT01323660|566716229|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156989862|NCT01323660|566716230|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
156989863|NCT01323660|566716231|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
156989864|NCT01323660|566716226|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156989865|NCT01323660|566716227|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156989866|NCT01323660|566716228|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156989867|NCT01323660|566716229|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156989868|NCT01323660|566716230|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156989869|NCT01323660|566716231|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156989870|NCT01323660|566716226|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156989871|NCT01323660|566716227|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156989872|NCT01323660|566716228|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156989873|NCT01323660|566716229|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156989874|NCT01323660|566716230|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
156989875|NCT01323660|566716231|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156989876|NCT00926393|566716232|FG000|Overall Study|Withdrawal by Subject|1|||
156989877|NCT00926393|566716233|FG001|Overall Study|Withdrawal by Subject|2|||
156989878|NCT00926393|566716232|FG000|Overall Study|Adverse Event|1|||
156989879|NCT00926393|566716233|FG001|Overall Study|Adverse Event|1|||
156989880|NCT04003974|566716245|FG000|Overall Study|Missing|1|||
156989881|NCT04003974|566716246|FG001|Overall Study|Missing|0|||
156989882|NCT04003974|566716245|FG000|Overall Study|Withdrawal by Subject|0|||
156989883|NCT04003974|566716246|FG001|Overall Study|Withdrawal by Subject|2|||
156989884|NCT02400307|566716247|FG000|Overall Study|Enrolled and Never Dosed|1|||
156989885|NCT02400307|566716248|FG001|Overall Study|Enrolled and Never Dosed|0|||
156989886|NCT01052662|566716251|FG000|Overall Study|Lost to Follow-up|15|||
156989887|NCT01052662|566716252|FG001|Overall Study|Lost to Follow-up|13|||
156989888|NCT01052662|566716253|FG002|Overall Study|Lost to Follow-up|18|||
156989889|NCT01052662|566716251|FG000|Overall Study|Withdrawal by Subject|3|||
156989890|NCT01052662|566716252|FG001|Overall Study|Withdrawal by Subject|2|||
156989891|NCT01052662|566716253|FG002|Overall Study|Withdrawal by Subject|1|||
156989892|NCT01052662|566716251|FG000|Overall Study|Pharmacy issue|1|||
156989893|NCT01052662|566716252|FG001|Overall Study|Pharmacy issue|3|||
156989894|NCT01052662|566716253|FG002|Overall Study|Pharmacy issue|3|||
156989895|NCT01052662|566716251|FG000|Overall Study|Adverse Event|1|||
156989896|NCT01052662|566716252|FG001|Overall Study|Adverse Event|1|||
156989897|NCT01052662|566716253|FG002|Overall Study|Adverse Event|0|||
156989898|NCT01052662|566716251|FG000|Overall Study|Legal Problem|2|||
156989899|NCT01052662|566716252|FG001|Overall Study|Legal Problem|0|||
156989900|NCT01052662|566716253|FG002|Overall Study|Legal Problem|0|||
156989901|NCT01052662|566716251|FG000|Overall Study|Administrative|0|||
156989902|NCT01052662|566716252|FG001|Overall Study|Administrative|3|||
156989903|NCT01052662|566716253|FG002|Overall Study|Administrative|0|||
156989904|NCT02015663|566716255|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
156989905|NCT02015663|566716256|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
156989906|NCT02015663|566716255|FG000|Overall Study|Withdrawal by Subject|1|||
156989907|NCT02015663|566716256|FG001|Overall Study|Withdrawal by Subject|0|||
156989908|NCT02015663|566716255|FG000|Overall Study|Protocol Violation|0|||
156989909|NCT02015663|566716256|FG001|Overall Study|Protocol Violation|1|||
156989910|NCT02015663|566716255|FG000|Overall Study|Adverse Event|3|||
156989911|NCT02015663|566716256|FG001|Overall Study|Adverse Event|0|||
156989912|NCT02015663|566716255|FG000|Overall Study|Administrative problems|10|||
156989913|NCT02015663|566716256|FG001|Overall Study|Administrative problems|11|||
156989914|NCT00479674|566716258|FG000|Overall Study|Adverse Event|18|||
156989915|NCT00479674|566716258|FG000|Overall Study|Withdrawal by Subject|6|||
156989916|NCT00479674|566716258|FG000|Overall Study|Physician Decision|14|||
156989917|NCT00479674|566716258|FG000|Overall Study|none provided|3|||
156989918|NCT02478359|566716262|FG000|Overall Study|Disenrolled from health plan|106|||
156989919|NCT02478359|566716263|FG001|Overall Study|Disenrolled from health plan|65|||
156989920|NCT03293485|566716265|FG000|Overall Study|Death|1|||
156989921|NCT03293485|566716265|FG000|Overall Study|Screen Failure|2|||
156989922|NCT03293485|566716265|FG000|Overall Study|Withdrawal by Subject|2|||
156989923|NCT01818700|566716266|FG000|Overall Study|Adverse Event|67|||
156989924|NCT01818700|566716266|FG000|Overall Study|Lack of Efficacy|2|||
156989925|NCT01818700|566716266|FG000|Overall Study|Lost to Follow-up|5|||
156989926|NCT01818700|566716266|FG000|Overall Study|Withdrawal by Subject|27|||
156989927|NCT01818700|566716266|FG000|Overall Study|Protocol Violation|2|||
156989928|NCT01818700|566716266|FG000|Overall Study|Other|1|||
156989929|NCT05968482|566716267|FG000|First Crossover Period|Withdrawal by Subject|0|||
156989930|NCT05968482|566716268|FG001|First Crossover Period|Withdrawal by Subject|0|||
156989931|NCT05968482|566716269|FG002|First Crossover Period|Withdrawal by Subject|1|||
156989932|NCT05968482|566716270|FG003|First Crossover Period|Withdrawal by Subject|0|||
156989933|NCT05968482|566716271|FG004|First Crossover Period|Withdrawal by Subject|0|||
156989934|NCT05968482|566716272|FG005|First Crossover Period|Withdrawal by Subject|0|||
156989935|NCT05968482|566716267|FG000|First Crossover Period|Adverse Event|0|||
156989936|NCT05968482|566716268|FG001|First Crossover Period|Adverse Event|0|||
156989937|NCT05968482|566716269|FG002|First Crossover Period|Adverse Event|0|||
156989938|NCT05968482|566716270|FG003|First Crossover Period|Adverse Event|0|||
156989939|NCT05968482|566716271|FG004|First Crossover Period|Adverse Event|0|||
156989940|NCT05968482|566716272|FG005|First Crossover Period|Adverse Event|1|||
156989941|NCT05968482|566716267|FG000|Second Crossover Period|Withdrawal by Subject|0|||
156989942|NCT05968482|566716268|FG001|Second Crossover Period|Withdrawal by Subject|0|||
156989943|NCT05968482|566716269|FG002|Second Crossover Period|Withdrawal by Subject|0|||
156989944|NCT05968482|566716270|FG003|Second Crossover Period|Withdrawal by Subject|0|||
156989945|NCT05968482|566716271|FG004|Second Crossover Period|Withdrawal by Subject|1|||
156989946|NCT05968482|566716272|FG005|Second Crossover Period|Withdrawal by Subject|0|||
156989947|NCT05968482|566716267|FG000|Third Crossover Period|Adverse Event|0|||
156989948|NCT05968482|566716268|FG001|Third Crossover Period|Adverse Event|0|||
156989949|NCT05968482|566716269|FG002|Third Crossover Period|Adverse Event|0|||
156989950|NCT05968482|566716270|FG003|Third Crossover Period|Adverse Event|0|||
156989951|NCT05968482|566716271|FG004|Third Crossover Period|Adverse Event|1|||
156989952|NCT05968482|566716272|FG005|Third Crossover Period|Adverse Event|0|||
156989953|NCT05968482|566716267|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
156989954|NCT05968482|566716268|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
156989955|NCT05968482|566716269|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
156989956|NCT05968482|566716270|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
156989957|NCT05968482|566716271|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
156989958|NCT05968482|566716272|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
156989959|NCT02559817|566716273|FG000|Treatment Period|Adverse Event|1|||
156989960|NCT02559817|566716274|FG001|Treatment Period|Adverse Event|0|||
156989961|NCT02559817|566716275|FG002|Treatment Period|Adverse Event|1|||
156989962|NCT02559817|566716276|FG003|Treatment Period|Adverse Event|0|||
156989963|NCT02559817|566716277|FG004|Treatment Period|Adverse Event|0|||
156989964|NCT02559817|566716273|FG000|Treatment Period|Lack of Efficacy|0|||
156989965|NCT02559817|566716274|FG001|Treatment Period|Lack of Efficacy|1|||
156989966|NCT02559817|566716275|FG002|Treatment Period|Lack of Efficacy|0|||
156989967|NCT02559817|566716276|FG003|Treatment Period|Lack of Efficacy|0|||
156989968|NCT02559817|566716277|FG004|Treatment Period|Lack of Efficacy|0|||
156989969|NCT02559817|566716273|FG000|Treatment Period|Lost to Follow-up|0|||
156989970|NCT02559817|566716274|FG001|Treatment Period|Lost to Follow-up|1|||
156989971|NCT02559817|566716275|FG002|Treatment Period|Lost to Follow-up|0|||
156989972|NCT02559817|566716276|FG003|Treatment Period|Lost to Follow-up|1|||
156989973|NCT02559817|566716277|FG004|Treatment Period|Lost to Follow-up|0|||
156989974|NCT02559817|566716273|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
156989975|NCT02559817|566716274|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
156989976|NCT02559817|566716275|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
156989977|NCT02559817|566716276|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
156989978|NCT02559817|566716277|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
156989979|NCT02559817|566716273|FG000|Treatment Period|Protocol Violation|0|||
156989980|NCT02559817|566716274|FG001|Treatment Period|Protocol Violation|0|||
156989981|NCT02559817|566716275|FG002|Treatment Period|Protocol Violation|0|||
156989982|NCT02559817|566716276|FG003|Treatment Period|Protocol Violation|1|||
156989983|NCT02559817|566716277|FG004|Treatment Period|Protocol Violation|0|||
156989984|NCT03389893|566716280|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
156989985|NCT03389893|566716281|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
156989986|NCT03389893|566716282|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
156989987|NCT03389893|566716283|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
156989988|NCT03389893|566716280|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
156989989|NCT03389893|566716281|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
156989990|NCT03389893|566716282|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
156989991|NCT03389893|566716283|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
156989992|NCT03389893|566716280|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
156989993|NCT03389893|566716281|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
156989994|NCT03389893|566716282|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
156989995|NCT03389893|566716283|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
156989996|NCT03389893|566716280|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
156989997|NCT03389893|566716281|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
156989998|NCT03389893|566716282|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
156989999|NCT03389893|566716283|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
156990000|NCT01719861|566716285|FG000|Cycle 1|Death|4|||
156990001|NCT01719861|566716285|FG000|Cycle 2|Death|1|||
156990002|NCT00958009|566716286|FG000|Overall Study|Adverse Event|1|||
156990003|NCT00958009|566716286|FG000|Overall Study|Subject found device difficult to use|1|||
156990004|NCT01077024|566716297|FG000|Overall Study|Lost to Follow-up|20|||
156990005|NCT01077024|566716298|FG001|Overall Study|Lost to Follow-up|14|||
156990006|NCT01077024|566716297|FG000|Overall Study|Withdrawal by Subject|0|||
156990007|NCT01077024|566716298|FG001|Overall Study|Withdrawal by Subject|2|||
156990008|NCT01077024|566716297|FG000|Overall Study|Incarcerated|7|||
156990009|NCT01077024|566716298|FG001|Overall Study|Incarcerated|8|||
156990010|NCT01077024|566716297|FG000|Overall Study|Other|4|||
156990011|NCT01077024|566716298|FG001|Overall Study|Other|4|||
156990012|NCT02034435|566716299|FG000|Overall Study|Withdrawal by Subject|1|||
156990013|NCT02034435|566716300|FG001|Overall Study|Withdrawal by Subject|0|||
156990014|NCT02034435|566716301|FG002|Overall Study|Withdrawal by Subject|0|||
156990015|NCT02034435|566716302|FG003|Overall Study|Withdrawal by Subject|0|||
156990016|NCT02034435|566716299|FG000|Overall Study|Illness|0|||
156990017|NCT02034435|566716300|FG001|Overall Study|Illness|2|||
156990018|NCT02034435|566716301|FG002|Overall Study|Illness|0|||
156990019|NCT02034435|566716302|FG003|Overall Study|Illness|0|||
156990020|NCT02034435|566716299|FG000|Overall Study|Inadequate IV access|1|||
156990021|NCT02034435|566716300|FG001|Overall Study|Inadequate IV access|0|||
156990022|NCT02034435|566716301|FG002|Overall Study|Inadequate IV access|0|||
156990023|NCT02034435|566716302|FG003|Overall Study|Inadequate IV access|1|||
156990024|NCT02300311|566716303|FG000|Overall Study|Other than the reason specified|1|||
156990025|NCT02300311|566716304|FG001|Overall Study|Other than the reason specified|0|||
156990026|NCT02300311|566716303|FG000|Overall Study|Refused to continue taking medication|18|||
156990027|NCT02300311|566716304|FG001|Overall Study|Refused to continue taking medication|0|||
156990028|NCT02687919|566716305|FG000|Overall Study|Withdrawal by Subject|6|||
156990029|NCT02687919|566716306|FG001|Overall Study|Withdrawal by Subject|6|||
156990030|NCT02687919|566716305|FG000|Overall Study|Protocol Violation|2|||
156990031|NCT02687919|566716306|FG001|Overall Study|Protocol Violation|0|||
156990032|NCT00848211|566716307|FG000|Overall Study|Protocol Violation|0|||
156990033|NCT00848211|566716308|FG001|Overall Study|Protocol Violation|1|||
156990034|NCT00848211|566716309|FG002|Overall Study|Protocol Violation|1|||
156990035|NCT00848211|566716310|FG003|Overall Study|Protocol Violation|0|||
156990036|NCT00848211|566716307|FG000|Overall Study|Adverse Event|0|||
156990037|NCT00848211|566716308|FG001|Overall Study|Adverse Event|0|||
156990038|NCT00848211|566716309|FG002|Overall Study|Adverse Event|0|||
156990039|NCT00848211|566716310|FG003|Overall Study|Adverse Event|0|||
156990040|NCT00419003|566716311|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
156990041|NCT00419003|566716312|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
156990042|NCT00419003|566716311|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
156990043|NCT00419003|566716312|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
156990044|NCT00772928|566716313|FG000|Overall Study|Lost to Follow-up|9|||
156990045|NCT00772928|566716314|FG001|Overall Study|Lost to Follow-up|6|||
156990046|NCT00772928|566716313|FG000|Overall Study|Protocol Violation|10|||
156990047|NCT00772928|566716314|FG001|Overall Study|Protocol Violation|12|||
156990048|NCT00772928|566716313|FG000|Overall Study|Withdrawal by Subject|25|||
156990049|NCT00772928|566716314|FG001|Overall Study|Withdrawal by Subject|22|||
156990050|NCT00772928|566716313|FG000|Overall Study|Did not receive vaccine|0|||
156990051|NCT00772928|566716314|FG001|Overall Study|Did not receive vaccine|1|||
156990052|NCT03738241|566719246|FG000|Overall Study|Withdrawal by Subject|0|||
156990053|NCT03738241|566719247|FG001|Overall Study|Withdrawal by Subject|0|||
156990054|NCT03738241|566719248|FG002|Overall Study|Withdrawal by Subject|0|||
156990055|NCT03738241|566719249|FG003|Overall Study|Withdrawal by Subject|0|||
156990056|NCT03738241|566719250|FG004|Overall Study|Withdrawal by Subject|0|||
156990057|NCT03738241|566719251|FG005|Overall Study|Withdrawal by Subject|0|||
156990058|NCT03738241|566719252|FG006|Overall Study|Withdrawal by Subject|0|||
156990059|NCT03738241|566719253|FG007|Overall Study|Withdrawal by Subject|0|||
156990060|NCT03738241|566719254|FG008|Overall Study|Withdrawal by Subject|0|||
156990061|NCT03738241|566719255|FG009|Overall Study|Withdrawal by Subject|1|||
156990062|NCT03738241|566719246|FG000|Overall Study|Physician Decision|0|||
156990063|NCT03738241|566719247|FG001|Overall Study|Physician Decision|0|||
156990064|NCT03738241|566719248|FG002|Overall Study|Physician Decision|0|||
156990065|NCT03738241|566719249|FG003|Overall Study|Physician Decision|0|||
156990066|NCT03738241|566719250|FG004|Overall Study|Physician Decision|0|||
156990067|NCT03738241|566719251|FG005|Overall Study|Physician Decision|0|||
156990068|NCT03738241|566719252|FG006|Overall Study|Physician Decision|0|||
156990069|NCT03738241|566719253|FG007|Overall Study|Physician Decision|0|||
156990070|NCT03738241|566719254|FG008|Overall Study|Physician Decision|1|||
156990071|NCT03738241|566719255|FG009|Overall Study|Physician Decision|0|||
156990072|NCT03738241|566719246|FG000|Overall Study|Adverse Event|1|||
156990073|NCT03738241|566719247|FG001|Overall Study|Adverse Event|0|||
156990074|NCT03738241|566719248|FG002|Overall Study|Adverse Event|0|||
156990075|NCT03738241|566719249|FG003|Overall Study|Adverse Event|0|||
156990076|NCT03738241|566719250|FG004|Overall Study|Adverse Event|0|||
156990077|NCT03738241|566719251|FG005|Overall Study|Adverse Event|0|||
156990078|NCT03738241|566719252|FG006|Overall Study|Adverse Event|0|||
156990079|NCT03738241|566719253|FG007|Overall Study|Adverse Event|0|||
156990080|NCT03738241|566719254|FG008|Overall Study|Adverse Event|0|||
156990081|NCT03738241|566719255|FG009|Overall Study|Adverse Event|0|||
156990082|NCT00495469|566719256|FG000|Overall Study|Adverse Event|0|||
156990083|NCT00495469|566719257|FG001|Overall Study|Adverse Event|1|||
156990084|NCT00495469|566719258|FG002|Overall Study|Adverse Event|3|||
156990085|NCT00495469|566719259|FG003|Overall Study|Adverse Event|0|||
156990086|NCT00495469|566719260|FG004|Overall Study|Adverse Event|1|||
156990087|NCT00495469|566719261|FG005|Overall Study|Adverse Event|1|||
156990088|NCT00495469|566719262|FG006|Overall Study|Adverse Event|1|||
156990089|NCT00495469|566719256|FG000|Overall Study|Lost to Follow-up|1|||
156990090|NCT00495469|566719257|FG001|Overall Study|Lost to Follow-up|1|||
156990091|NCT00495469|566719258|FG002|Overall Study|Lost to Follow-up|3|||
156990092|NCT00495469|566719259|FG003|Overall Study|Lost to Follow-up|1|||
156990093|NCT00495469|566719260|FG004|Overall Study|Lost to Follow-up|0|||
156990094|NCT00495469|566719261|FG005|Overall Study|Lost to Follow-up|0|||
156990095|NCT00495469|566719262|FG006|Overall Study|Lost to Follow-up|0|||
156990096|NCT00495469|566719256|FG000|Overall Study|Protocol Violation|0|||
156990097|NCT00495469|566719257|FG001|Overall Study|Protocol Violation|0|||
156990098|NCT00495469|566719258|FG002|Overall Study|Protocol Violation|0|||
156990099|NCT00495469|566719259|FG003|Overall Study|Protocol Violation|0|||
156990100|NCT00495469|566719260|FG004|Overall Study|Protocol Violation|1|||
156990101|NCT00495469|566719261|FG005|Overall Study|Protocol Violation|2|||
156990102|NCT00495469|566719262|FG006|Overall Study|Protocol Violation|0|||
156990103|NCT00495469|566719256|FG000|Overall Study|Withdrawal by Subject|5|||
156990104|NCT00495469|566719257|FG001|Overall Study|Withdrawal by Subject|3|||
156990105|NCT00495469|566719258|FG002|Overall Study|Withdrawal by Subject|1|||
156990106|NCT00495469|566719259|FG003|Overall Study|Withdrawal by Subject|3|||
156990107|NCT00495469|566719260|FG004|Overall Study|Withdrawal by Subject|3|||
156990108|NCT00495469|566719261|FG005|Overall Study|Withdrawal by Subject|2|||
156990109|NCT00495469|566719262|FG006|Overall Study|Withdrawal by Subject|3|||
156990110|NCT00495469|566719256|FG000|Overall Study|Lack of Efficacy|0|||
156990111|NCT00495469|566719257|FG001|Overall Study|Lack of Efficacy|0|||
156990112|NCT00495469|566719258|FG002|Overall Study|Lack of Efficacy|0|||
156990113|NCT00495469|566719259|FG003|Overall Study|Lack of Efficacy|0|||
156990114|NCT00495469|566719260|FG004|Overall Study|Lack of Efficacy|0|||
156990115|NCT00495469|566719261|FG005|Overall Study|Lack of Efficacy|0|||
156990116|NCT00495469|566719262|FG006|Overall Study|Lack of Efficacy|1|||
156990117|NCT00495469|566719256|FG000|Overall Study|Liver function test abnormality|0|||
156990118|NCT00495469|566719257|FG001|Overall Study|Liver function test abnormality|1|||
156990119|NCT00495469|566719258|FG002|Overall Study|Liver function test abnormality|0|||
156990120|NCT00495469|566719259|FG003|Overall Study|Liver function test abnormality|0|||
156990121|NCT00495469|566719260|FG004|Overall Study|Liver function test abnormality|0|||
156990122|NCT00495469|566719261|FG005|Overall Study|Liver function test abnormality|0|||
156990123|NCT00495469|566719262|FG006|Overall Study|Liver function test abnormality|0|||
156990124|NCT00495469|566719256|FG000|Overall Study|ST depression at randomisation in ECG|0|||
156990125|NCT00495469|566719257|FG001|Overall Study|ST depression at randomisation in ECG|1|||
156990126|NCT00495469|566719258|FG002|Overall Study|ST depression at randomisation in ECG|0|||
156990127|NCT00495469|566719259|FG003|Overall Study|ST depression at randomisation in ECG|0|||
156990128|NCT00495469|566719260|FG004|Overall Study|ST depression at randomisation in ECG|0|||
156990129|NCT00495469|566719261|FG005|Overall Study|ST depression at randomisation in ECG|0|||
156990130|NCT00495469|566719262|FG006|Overall Study|ST depression at randomisation in ECG|0|||
156990131|NCT02256969|566719269|FG000|Overall Study|Screenfailed or withdrew|2|||
156990132|NCT02256969|566719270|FG001|Overall Study|Screenfailed or withdrew|1|||
156990133|NCT02256969|566719271|FG002|Overall Study|Screenfailed or withdrew|1|||
156990134|NCT01427907|566719274|FG000|Overall Study|Withdrawal by Subject|3|||
156990135|NCT01427907|566719275|FG001|Overall Study|Withdrawal by Subject|4|||
156990136|NCT02412761|566719276|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156990137|NCT02412761|566719277|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156990138|NCT02412761|566719278|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156990139|NCT02412761|566719279|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156990140|NCT02412761|566719280|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156990141|NCT02412761|566719281|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156990142|NCT02013687|566719284|FG000|Overall Study|Lost to Follow-up|0|||
156990143|NCT02013687|566719285|FG001|Overall Study|Lost to Follow-up|0|||
156990144|NCT02013687|566719286|FG002|Overall Study|Lost to Follow-up|1|||
156990145|NCT02013687|566719287|FG003|Overall Study|Lost to Follow-up|0|||
156990146|NCT02013687|566719284|FG000|Overall Study|Protocol Violation|0|||
156990147|NCT02013687|566719285|FG001|Overall Study|Protocol Violation|0|||
156990148|NCT02013687|566719286|FG002|Overall Study|Protocol Violation|0|||
156990149|NCT02013687|566719287|FG003|Overall Study|Protocol Violation|1|||
156990150|NCT02013687|566719284|FG000|Overall Study|Withdrawal by Subject|0|||
156990151|NCT02013687|566719285|FG001|Overall Study|Withdrawal by Subject|0|||
156990152|NCT02013687|566719286|FG002|Overall Study|Withdrawal by Subject|0|||
156990153|NCT02013687|566719287|FG003|Overall Study|Withdrawal by Subject|1|||
156990154|NCT02013687|566719284|FG000|Overall Study|Missed visits due to patient travel|0|||
156990155|NCT02013687|566719285|FG001|Overall Study|Missed visits due to patient travel|0|||
156990156|NCT02013687|566719286|FG002|Overall Study|Missed visits due to patient travel|1|||
156990157|NCT02013687|566719287|FG003|Overall Study|Missed visits due to patient travel|0|||
156990158|NCT01272011|566719288|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
156990159|NCT01272011|566719289|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
156990160|NCT01272011|566719290|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
156990161|NCT01627340|566719291|FG000|Overall Study|Adverse Event|1|||
156990162|NCT01627340|566719292|FG001|Overall Study|Adverse Event|0|||
156990163|NCT01627340|566719291|FG000|Overall Study|Lost to Follow-up|8|||
156990164|NCT01627340|566719292|FG001|Overall Study|Lost to Follow-up|4|||
156990165|NCT01627340|566719291|FG000|Overall Study|Pregnancy|1|||
156990166|NCT01627340|566719292|FG001|Overall Study|Pregnancy|0|||
156990167|NCT01627340|566719291|FG000|Overall Study|Withdrawal by Subject|2|||
156990168|NCT01627340|566719292|FG001|Overall Study|Withdrawal by Subject|0|||
156990169|NCT02240680|566719295|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
156990170|NCT02240680|566719296|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
156990171|NCT02240680|566719297|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
156990172|NCT02240680|566719298|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
156990173|NCT02240680|566719295|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
156990174|NCT02240680|566719296|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
156990175|NCT02240680|566719297|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
156990176|NCT02240680|566719298|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
156990177|NCT02240680|566719295|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
156990178|NCT02240680|566719296|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156990179|NCT02240680|566719297|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156990180|NCT02240680|566719298|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
156990181|NCT02240680|566719295|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
156990182|NCT02240680|566719296|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
156990183|NCT02240680|566719297|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
156990184|NCT02240680|566719298|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
156990185|NCT02240680|566719295|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
156990186|NCT02240680|566719296|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156990187|NCT02240680|566719297|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156990188|NCT02240680|566719298|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
156990189|NCT02240680|566719295|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
156990190|NCT02240680|566719296|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
156990191|NCT02240680|566719297|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
156990192|NCT02240680|566719298|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
156990193|NCT02240680|566719295|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156990194|NCT02240680|566719296|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156990195|NCT02240680|566719297|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
156990196|NCT02240680|566719298|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
156990197|NCT02240680|566719295|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156990198|NCT02240680|566719296|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156990199|NCT02240680|566719297|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
156990200|NCT02240680|566719298|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
156990201|NCT01657032|566719299|FG000|Overall Study|Lost to Follow-up|0|||
156990202|NCT01657032|566719300|FG001|Overall Study|Lost to Follow-up|7|||
156990203|NCT01782326|566719301|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
156990204|NCT01782326|566719302|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
156990205|NCT01782326|566719301|FG000|Planned Treatment Epoch|Death|29|||
156990206|NCT01782326|566719302|FG001|Planned Treatment Epoch|Death|30|||
156990207|NCT01782326|566719301|FG000|Planned Treatment Epoch|Physician Decision|18|||
156990208|NCT01782326|566719302|FG001|Planned Treatment Epoch|Physician Decision|16|||
156990209|NCT01782326|566719301|FG000|Planned Treatment Epoch|Protocol deviation|2|||
156990210|NCT01782326|566719302|FG001|Planned Treatment Epoch|Protocol deviation|3|||
156990211|NCT01782326|566719301|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
156990212|NCT01782326|566719302|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
156990213|NCT01782326|566719301|FG000|Planned Treatment Epoch|Technical problems|0|||
156990214|NCT01782326|566719302|FG001|Planned Treatment Epoch|Technical problems|4|||
156990215|NCT01782326|566719301|FG000|Double-blind Treatment|Adverse Event|129|||
156990216|NCT01782326|566719302|FG001|Double-blind Treatment|Adverse Event|145|||
156990217|NCT01782326|566719301|FG000|Double-blind Treatment|Subject/guardian decision|111|||
156990218|NCT01782326|566719302|FG001|Double-blind Treatment|Subject/guardian decision|125|||
156990219|NCT01782326|566719301|FG000|Double-blind Treatment|Lack of Efficacy|17|||
156990220|NCT01782326|566719302|FG001|Double-blind Treatment|Lack of Efficacy|22|||
156990221|NCT01782326|566719301|FG000|Double-blind Treatment|Physician Decision|13|||
156990222|NCT01782326|566719302|FG001|Double-blind Treatment|Physician Decision|16|||
156990223|NCT01782326|566719301|FG000|Double-blind Treatment|Protocol deviation|8|||
156990224|NCT01782326|566719302|FG001|Double-blind Treatment|Protocol deviation|7|||
156990225|NCT01782326|566719301|FG000|Double-blind Treatment|Technical problems|0|||
156990226|NCT01782326|566719302|FG001|Double-blind Treatment|Technical problems|5|||
156990227|NCT03633903|566719303|FG000|Overall Study|Withdrawal by Subject|1|||
156990228|NCT03633903|566719304|FG001|Overall Study|Withdrawal by Subject|2|||
156990229|NCT03633903|566719303|FG000|Overall Study|Lost to Follow-up|5|||
156990230|NCT03633903|566719304|FG001|Overall Study|Lost to Follow-up|5|||
156990231|NCT01657682|566719311|FG000|Overall Study|Lost to Follow-up|1|||
156990232|NCT01657682|566719312|FG001|Overall Study|Lost to Follow-up|0|||
156990233|NCT01657682|566719313|FG002|Overall Study|Lost to Follow-up|0|||
156990234|NCT01657682|566719311|FG000|Overall Study|Withdrawal by Subject|0|||
156990235|NCT01657682|566719312|FG001|Overall Study|Withdrawal by Subject|1|||
156990236|NCT01657682|566719313|FG002|Overall Study|Withdrawal by Subject|1|||
156990237|NCT01657682|566719311|FG000|Overall Study|Adverse Event|0|||
156990238|NCT01657682|566719312|FG001|Overall Study|Adverse Event|1|||
156990239|NCT01657682|566719313|FG002|Overall Study|Adverse Event|0|||
156990240|NCT00087490|566719314|FG000|Overall Study|Death|6|||
156990241|NCT00087490|566719315|FG001|Overall Study|Death|4|||
156990242|NCT00087490|566719314|FG000|Overall Study|Adverse Event|3|||
156990243|NCT00087490|566719315|FG001|Overall Study|Adverse Event|8|||
156990244|NCT00087490|566719314|FG000|Overall Study|Lack of Efficacy|0|||
156990245|NCT00087490|566719315|FG001|Overall Study|Lack of Efficacy|2|||
156990246|NCT00087490|566719314|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
156990247|NCT00087490|566719315|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
156990248|NCT00087490|566719314|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
156990249|NCT00087490|566719315|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
156990250|NCT00087490|566719314|FG000|Overall Study|Randomized but not treated|7|||
156990251|NCT00087490|566719315|FG001|Overall Study|Randomized but not treated|18|||
156990252|NCT03379233|566719319|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
156990253|NCT03379233|566719320|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
156990254|NCT02531438|566719321|FG000|Overall Study|Adverse Event|7|||
156990255|NCT02531438|566719322|FG001|Overall Study|Adverse Event|9|||
156990256|NCT02531438|566719321|FG000|Overall Study|Lost to Follow-up|0|||
156990257|NCT02531438|566719322|FG001|Overall Study|Lost to Follow-up|3|||
156990258|NCT02531438|566719321|FG000|Overall Study|Withdrawal by Subject|7|||
156990259|NCT02531438|566719322|FG001|Overall Study|Withdrawal by Subject|8|||
156990260|NCT02531438|566719321|FG000|Overall Study|Physician Decision|0|||
156990261|NCT02531438|566719322|FG001|Overall Study|Physician Decision|1|||
156990262|NCT02531438|566719321|FG000|Overall Study|Death|6|||
156990263|NCT02531438|566719322|FG001|Overall Study|Death|3|||
156990264|NCT02531438|566719321|FG000|Overall Study|Randomized, but Not Treated|4|||
156990265|NCT02531438|566719322|FG001|Overall Study|Randomized, but Not Treated|0|||
156990266|NCT02531438|566719321|FG000|Overall Study|Missed EOT/PTE Visit|5|||
156990267|NCT02531438|566719322|FG001|Overall Study|Missed EOT/PTE Visit|2|||
156990268|NCT02531438|566719321|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
156990269|NCT02531438|566719322|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
156990270|NCT01653743|566719326|FG000|Overall Study|Withdrawal by Subject|1|||
156990271|NCT01653743|566719327|FG001|Overall Study|Withdrawal by Subject|0|||
156990272|NCT01653743|566719326|FG000|Overall Study|Investigator discretion|3|||
156990273|NCT01653743|566719327|FG001|Overall Study|Investigator discretion|0|||
156990274|NCT02015195|566719330|FG000|Overall Study|Adverse Event|0|||
156990275|NCT02015195|566719331|FG001|Overall Study|Adverse Event|0|||
156990276|NCT02015195|566719332|FG002|Overall Study|Adverse Event|0|||
156990277|NCT02015195|566719333|FG003|Overall Study|Adverse Event|1|||
156990278|NCT02015195|566719334|FG004|Overall Study|Adverse Event|0|||
156990279|NCT02015195|566719335|FG005|Overall Study|Adverse Event|0|||
156990280|NCT02015195|566719336|FG006|Overall Study|Adverse Event|0|||
156990281|NCT01318811|566719337|FG000|Overall Study|Physician Decision|1|||
156990282|NCT01318811|566719338|FG001|Overall Study|Physician Decision|1|||
156990283|NCT01318811|566719337|FG000|Overall Study|CRRT stopped for head CT|0|||
156990284|NCT01318811|566719338|FG001|Overall Study|CRRT stopped for head CT|1|||
156990285|NCT01318811|566719337|FG000|Overall Study|Death|0|||
157096991|NCT02805725|567110915|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
157096992|NCT02805725|567110911|FG000|Phase II|Protocol Violation|0|||
156990286|NCT01318811|566719338|FG001|Overall Study|Death|1|||
156990287|NCT01318811|566719337|FG000|Overall Study|CRRT stopped for head MRI|0|||
156990288|NCT01318811|566719338|FG001|Overall Study|CRRT stopped for head MRI|1|||
156990289|NCT00811187|566719339|FG000|Overall Study|Unable to place device / procedure abort|3|||
156990290|NCT00811187|566719340|FG001|Overall Study|Unable to place device / procedure abort|3|||
156990291|NCT02825043|566719341|FG000|Overall Study|Lost to Follow-up|4|||
156990292|NCT00131911|566719342|FG000|Overall Study|Withdrawal by Subject|1|||
156990293|NCT00131911|566719343|FG001|Overall Study|Withdrawal by Subject|0|||
156990294|NCT00329303|566719349|FG000|Overall Study|Lack of Efficacy|1|||
156990295|NCT00329303|566719350|FG001|Overall Study|Lack of Efficacy|0|||
156990296|NCT00329303|566719349|FG000|Overall Study|Decision of the sponsor|0|||
156990297|NCT00329303|566719350|FG001|Overall Study|Decision of the sponsor|1|||
156990298|NCT00329303|566719349|FG000|Overall Study|Patient no longer available|1|||
156990299|NCT00329303|566719350|FG001|Overall Study|Patient no longer available|0|||
156990300|NCT00329303|566719349|FG000|Overall Study|Patient relocated|0|||
156990301|NCT00329303|566719350|FG001|Overall Study|Patient relocated|1|||
156990302|NCT03582137|566719351|FG000|Overall Study|Adverse Event|1|||
156990303|NCT03582137|566719352|FG001|Overall Study|Adverse Event|0|||
156990304|NCT00558753|566719353|FG000|Overall Study|Lost to Follow-up|5|||
156990305|NCT00558753|566719354|FG001|Overall Study|Lost to Follow-up|7|||
156990306|NCT03704298|566719355|FG000|Overall Study|Death|3|||
156990307|NCT03704298|566719356|FG001|Overall Study|Death|1|||
156990308|NCT03704298|566719357|FG002|Overall Study|Death|1|||
156990309|NCT03704298|566719358|FG003|Overall Study|Death|0|||
156990310|NCT03704298|566719355|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
156990311|NCT03704298|566719356|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
156990312|NCT03704298|566719357|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
156990313|NCT03704298|566719358|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
156990314|NCT03704298|566719355|FG000|Overall Study|Withdrawal by Subject|1|||
156990315|NCT03704298|566719356|FG001|Overall Study|Withdrawal by Subject|0|||
156990316|NCT03704298|566719357|FG002|Overall Study|Withdrawal by Subject|0|||
156990317|NCT03704298|566719358|FG003|Overall Study|Withdrawal by Subject|0|||
156990318|NCT03704298|566719355|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156990319|NCT03704298|566719356|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
156990320|NCT03704298|566719357|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156990321|NCT03704298|566719358|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
156990322|NCT02303574|566719364|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990323|NCT02303574|566719365|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990324|NCT02303574|566719366|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
156990325|NCT02303574|566719367|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990326|NCT02303574|566719368|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990327|NCT02303574|566719369|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990328|NCT02303574|566719370|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990329|NCT02303574|566719371|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990330|NCT02303574|566719372|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990331|NCT02303574|566719373|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
156990332|NCT02303574|566719364|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990333|NCT02303574|566719365|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990334|NCT02303574|566719366|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990335|NCT02303574|566719367|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990336|NCT02303574|566719368|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990337|NCT02303574|566719369|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990338|NCT02303574|566719370|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990339|NCT02303574|566719371|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
156990340|NCT02303574|566719372|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990341|NCT02303574|566719373|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
156990342|NCT01606189|566719376|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
156990343|NCT01606189|566719377|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
156990344|NCT01606189|566719378|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
156990345|NCT01606189|566719379|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
156990346|NCT01606189|566719380|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
156990347|NCT01606189|566719381|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
156990348|NCT01606189|566719376|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156990349|NCT01606189|566719377|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156990350|NCT01606189|566719378|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156990351|NCT01606189|566719379|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156990352|NCT01606189|566719380|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
156990353|NCT01606189|566719381|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
156990354|NCT00162942|566719382|FG000|Overall Study|Adverse Event|10|||
156990355|NCT00162942|566719383|FG001|Overall Study|Adverse Event|6|||
156990356|NCT00162942|566719382|FG000|Overall Study|Death|1|||
156990357|NCT00162942|566719383|FG001|Overall Study|Death|0|||
156990358|NCT00162942|566719382|FG000|Overall Study|Withdrawal by Subject|3|||
156990359|NCT00162942|566719383|FG001|Overall Study|Withdrawal by Subject|6|||
156990360|NCT00162942|566719382|FG000|Overall Study|Physician Decision|1|||
156990361|NCT00162942|566719383|FG001|Overall Study|Physician Decision|0|||
156990362|NCT00162942|566719382|FG000|Overall Study|Enter Open-Label Study|76|||
156990363|NCT00162942|566719383|FG001|Overall Study|Enter Open-Label Study|35|||
156990364|NCT00162942|566719382|FG000|Overall Study|Alternate Therapy|6|||
156990365|NCT00162942|566719383|FG001|Overall Study|Alternate Therapy|2|||
156990366|NCT00162942|566719382|FG000|Overall Study|Lack of Efficacy|1|||
156990367|NCT00162942|566719383|FG001|Overall Study|Lack of Efficacy|0|||
156990368|NCT00162942|566719382|FG000|Overall Study|Flare During Active Treatment|7|||
156990369|NCT00162942|566719383|FG001|Overall Study|Flare During Active Treatment|3|||
156990370|NCT00162942|566719382|FG000|Overall Study|2 or more consecutive treatments missed|1|||
156990371|NCT00162942|566719383|FG001|Overall Study|2 or more consecutive treatments missed|0|||
156990372|NCT00410384|566719384|FG000|Overall Study|Withdrawal by Subject|28|||
156990373|NCT00410384|566719385|FG001|Overall Study|Withdrawal by Subject|17|||
156990374|NCT00410384|566719386|FG002|Overall Study|Withdrawal by Subject|20|||
156990375|NCT00410384|566719384|FG000|Overall Study|Adverse Event|23|||
156990376|NCT00410384|566719385|FG001|Overall Study|Adverse Event|18|||
156990377|NCT00410384|566719386|FG002|Overall Study|Adverse Event|23|||
156990378|NCT00410384|566719384|FG000|Overall Study|Lack of Efficacy|20|||
156990379|NCT00410384|566719385|FG001|Overall Study|Lack of Efficacy|12|||
156990380|NCT00410384|566719386|FG002|Overall Study|Lack of Efficacy|17|||
156990381|NCT00410384|566719384|FG000|Overall Study|Lack of Compliance|2|||
156990382|NCT00410384|566719385|FG001|Overall Study|Lack of Compliance|2|||
156990383|NCT00410384|566719386|FG002|Overall Study|Lack of Compliance|2|||
156990384|NCT00410384|566719384|FG000|Overall Study|Lost to Follow-up|4|||
156990385|NCT00410384|566719385|FG001|Overall Study|Lost to Follow-up|6|||
156990386|NCT00410384|566719386|FG002|Overall Study|Lost to Follow-up|6|||
156990387|NCT00410384|566719384|FG000|Overall Study|Protocol Violation|6|||
156990388|NCT00410384|566719385|FG001|Overall Study|Protocol Violation|6|||
156990389|NCT00410384|566719386|FG002|Overall Study|Protocol Violation|6|||
156990390|NCT00410384|566719384|FG000|Overall Study|Physician Decision|3|||
156990391|NCT00410384|566719385|FG001|Overall Study|Physician Decision|3|||
156990392|NCT00410384|566719386|FG002|Overall Study|Physician Decision|4|||
156990393|NCT00410384|566719384|FG000|Overall Study|Other|3|||
156990394|NCT00410384|566719385|FG001|Overall Study|Other|8|||
156990395|NCT00410384|566719386|FG002|Overall Study|Other|4|||
156990396|NCT01167023|566719387|FG000|Overall Study|Lost to Follow-up|0|||
156990397|NCT01167023|566719388|FG001|Overall Study|Lost to Follow-up|1|||
156990398|NCT01167023|566719389|FG002|Overall Study|Lost to Follow-up|1|||
156990399|NCT01167023|566719387|FG000|Overall Study|Screen Failure|0|||
156990400|NCT01167023|566719388|FG001|Overall Study|Screen Failure|1|||
156990401|NCT01167023|566719389|FG002|Overall Study|Screen Failure|0|||
156990402|NCT01167023|566719387|FG000|Overall Study|Sponsor Decision|0|||
156990403|NCT01167023|566719388|FG001|Overall Study|Sponsor Decision|1|||
156990404|NCT01167023|566719389|FG002|Overall Study|Sponsor Decision|0|||
156990405|NCT01167023|566719387|FG000|Overall Study|Withdrawal by Subject|0|||
156990406|NCT01167023|566719388|FG001|Overall Study|Withdrawal by Subject|0|||
156990407|NCT01167023|566719389|FG002|Overall Study|Withdrawal by Subject|1|||
156990408|NCT00577629|566719392|FG000|Treatment Period|Death|1|||
156990409|NCT00577629|566719392|FG000|Long Term Follow-Up|Death|15|||
156990410|NCT00577629|566719392|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
156990411|NCT00577629|566719392|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
156990412|NCT00577629|566719392|FG000|Long Term Follow-Up|Physician Decision|1|||
156990413|NCT04887285|566719393|FG000|Overall Study|Lost to Follow-up|0|||
156990414|NCT04887285|566719394|FG001|Overall Study|Lost to Follow-up|2|||
156990415|NCT04887285|566719395|FG002|Overall Study|Lost to Follow-up|3|||
156990416|NCT04640571|566719396|FG000|Overall Study|Withdrawal by Subject|0|||
156990417|NCT04640571|566719397|FG001|Overall Study|Withdrawal by Subject|0|||
156990418|NCT04640571|566719398|FG002|Overall Study|Withdrawal by Subject|0|||
156990419|NCT04640571|566719399|FG003|Overall Study|Withdrawal by Subject|0|||
156990420|NCT04640571|566719400|FG004|Overall Study|Withdrawal by Subject|0|||
156990421|NCT04640571|566719401|FG005|Overall Study|Withdrawal by Subject|2|||
156990422|NCT00832780|566719404|FG000|Overall Study|Death|16|||
156990423|NCT00832780|566719404|FG000|Overall Study|Lost to Follow-up|4|||
156990424|NCT00832780|566719404|FG000|Overall Study|no reason given|2|||
156990425|NCT00832780|566719404|FG000|Overall Study|other complicating condition|2|||
156990426|NCT00832780|566719404|FG000|Overall Study|Physician Decision|1|||
156990427|NCT05705167|566719405|FG000|Overall Study|Randomised but not Treated|0|||
156990428|NCT05705167|566719406|FG001|Overall Study|Randomised but not Treated|2|||
156990429|NCT05705167|566719407|FG002|Overall Study|Randomised but not Treated|0|||
156990430|NCT05705167|566719408|FG003|Overall Study|Randomised but not Treated|7|||
156990431|NCT05705167|566719409|FG004|Overall Study|Randomised but not Treated|0|||
156990432|NCT05705167|566719410|FG005|Overall Study|Randomised but not Treated|0|||
156990433|NCT05705167|566719411|FG006|Overall Study|Randomised but not Treated|0|||
156990434|NCT05705167|566719405|FG000|Overall Study|Death|0|||
156990435|NCT05705167|566719406|FG001|Overall Study|Death|0|||
156990436|NCT05705167|566719407|FG002|Overall Study|Death|3|||
156990437|NCT05705167|566719408|FG003|Overall Study|Death|0|||
156990438|NCT05705167|566719409|FG004|Overall Study|Death|1|||
156990439|NCT05705167|566719410|FG005|Overall Study|Death|1|||
156990440|NCT05705167|566719411|FG006|Overall Study|Death|1|||
156990441|NCT05705167|566719405|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156990442|NCT05705167|566719406|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156990443|NCT05705167|566719407|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156990444|NCT05705167|566719408|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156990445|NCT05705167|566719409|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156990446|NCT05705167|566719410|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
156990447|NCT05705167|566719411|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
156990448|NCT01670500|566719414|FG000|Overall Study|Withdrawal by Subject|1|||
156990449|NCT01670500|566719415|FG001|Overall Study|Withdrawal by Subject|0|||
156990450|NCT04955626|566719416|FG000|Blinded Period|Lost to Follow-up|28|||
156990451|NCT04955626|566719417|FG001|Blinded Period|Lost to Follow-up|28|||
156990452|NCT04955626|566719418|FG002|Blinded Period|Lost to Follow-up|7|||
156990453|NCT04955626|566719419|FG003|Blinded Period|Lost to Follow-up|14|||
156990454|NCT04955626|566719420|FG004|Blinded Period|Lost to Follow-up|3|||
156990455|NCT04955626|566719421|FG005|Blinded Period|Lost to Follow-up|2|||
156990456|NCT04955626|566719422|FG006|Blinded Period|Lost to Follow-up|6|||
156990457|NCT04955626|566719423|FG007|Blinded Period|Lost to Follow-up|4|||
156990458|NCT04955626|566719424|FG008|Blinded Period|Lost to Follow-up|5|||
156990459|NCT04955626|566719425|FG009|Blinded Period|Lost to Follow-up|8|||
156990460|NCT04955626|566719426|FG010|Blinded Period|Lost to Follow-up|10|||
156990461|NCT04955626|566719427|FG011|Blinded Period|Lost to Follow-up|32|||
156990462|NCT04955626|566719428|FG012|Blinded Period|Lost to Follow-up|0|||
156990463|NCT04955626|566719429|FG013|Blinded Period|Lost to Follow-up|0|||
156990464|NCT04955626|566719430|FG014|Blinded Period|Lost to Follow-up|0|||
156990465|NCT04955626|566719431|FG015|Blinded Period|Lost to Follow-up|12|||
156990466|NCT04955626|566719432|FG016|Blinded Period|Lost to Follow-up|2|||
156990467|NCT04955626|566719433|FG017|Blinded Period|Lost to Follow-up|5|||
156990468|NCT04955626|566719434|FG018|Blinded Period|Lost to Follow-up|0|||
156990469|NCT04955626|566719435|FG019|Blinded Period|Lost to Follow-up|0|||
156990470|NCT04955626|566719436|FG020|Blinded Period|Lost to Follow-up|0|||
156990471|NCT04955626|566719437|FG021|Blinded Period|Lost to Follow-up|0|||
156990472|NCT04955626|566719438|FG022|Blinded Period|Lost to Follow-up|0|||
156990473|NCT04955626|566719439|FG023|Blinded Period|Lost to Follow-up|0|||
156990474|NCT04955626|566719440|FG024|Blinded Period|Lost to Follow-up|3|||
156990475|NCT04955626|566719441|FG025|Blinded Period|Lost to Follow-up|1|||
156990476|NCT04955626|566719442|FG026|Blinded Period|Lost to Follow-up|2|||
156990477|NCT04955626|566719443|FG027|Blinded Period|Lost to Follow-up|2|||
156990478|NCT04955626|566719444|FG028|Blinded Period|Lost to Follow-up|2|||
156990479|NCT04955626|566719445|FG029|Blinded Period|Lost to Follow-up|0|||
156990480|NCT04955626|566719446|FG030|Blinded Period|Lost to Follow-up|0|||
156990481|NCT04955626|566719447|FG031|Blinded Period|Lost to Follow-up|0|||
156990482|NCT04955626|566719448|FG032|Blinded Period|Lost to Follow-up|0|||
156990483|NCT04955626|566719449|FG033|Blinded Period|Lost to Follow-up|0|||
156990484|NCT04955626|566719450|FG034|Blinded Period|Lost to Follow-up|0|||
156990485|NCT04955626|566719451|FG035|Blinded Period|Lost to Follow-up|0|||
156990486|NCT04955626|566719416|FG000|Blinded Period|Protocol Violation|5|||
156990487|NCT04955626|566719417|FG001|Blinded Period|Protocol Violation|14|||
156990488|NCT04955626|566719418|FG002|Blinded Period|Protocol Violation|0|||
156990489|NCT04955626|566719419|FG003|Blinded Period|Protocol Violation|1|||
156990490|NCT04955626|566719420|FG004|Blinded Period|Protocol Violation|2|||
156990491|NCT04955626|566719421|FG005|Blinded Period|Protocol Violation|2|||
156990492|NCT04955626|566719422|FG006|Blinded Period|Protocol Violation|0|||
156990493|NCT04955626|566719423|FG007|Blinded Period|Protocol Violation|0|||
156990494|NCT04955626|566719424|FG008|Blinded Period|Protocol Violation|0|||
156990495|NCT04955626|566719425|FG009|Blinded Period|Protocol Violation|4|||
156990496|NCT04955626|566719426|FG010|Blinded Period|Protocol Violation|6|||
156990497|NCT04955626|566719427|FG011|Blinded Period|Protocol Violation|1|||
156990498|NCT04955626|566719428|FG012|Blinded Period|Protocol Violation|0|||
156990499|NCT04955626|566719429|FG013|Blinded Period|Protocol Violation|0|||
156990500|NCT04955626|566719430|FG014|Blinded Period|Protocol Violation|2|||
156990501|NCT04955626|566719431|FG015|Blinded Period|Protocol Violation|6|||
156990502|NCT04955626|566719432|FG016|Blinded Period|Protocol Violation|4|||
156990503|NCT04955626|566719433|FG017|Blinded Period|Protocol Violation|6|||
156990504|NCT04955626|566719434|FG018|Blinded Period|Protocol Violation|0|||
156990505|NCT04955626|566719435|FG019|Blinded Period|Protocol Violation|1|||
156990506|NCT04955626|566719436|FG020|Blinded Period|Protocol Violation|0|||
156990507|NCT04955626|566719437|FG021|Blinded Period|Protocol Violation|1|||
156990508|NCT04955626|566719438|FG022|Blinded Period|Protocol Violation|0|||
156990509|NCT04955626|566719439|FG023|Blinded Period|Protocol Violation|0|||
156990510|NCT04955626|566719440|FG024|Blinded Period|Protocol Violation|4|||
156990511|NCT04955626|566719441|FG025|Blinded Period|Protocol Violation|6|||
156990512|NCT04955626|566719442|FG026|Blinded Period|Protocol Violation|5|||
156990513|NCT04955626|566719443|FG027|Blinded Period|Protocol Violation|3|||
156990514|NCT04955626|566719444|FG028|Blinded Period|Protocol Violation|4|||
156990515|NCT04955626|566719445|FG029|Blinded Period|Protocol Violation|3|||
156990516|NCT04955626|566719446|FG030|Blinded Period|Protocol Violation|0|||
156990517|NCT04955626|566719447|FG031|Blinded Period|Protocol Violation|0|||
156990518|NCT04955626|566719448|FG032|Blinded Period|Protocol Violation|0|||
156990519|NCT04955626|566719449|FG033|Blinded Period|Protocol Violation|0|||
156990520|NCT04955626|566719450|FG034|Blinded Period|Protocol Violation|0|||
156990521|NCT04955626|566719451|FG035|Blinded Period|Protocol Violation|0|||
156990522|NCT04955626|566719416|FG000|Blinded Period|Death|0|||
156990523|NCT04955626|566719417|FG001|Blinded Period|Death|2|||
156990524|NCT04955626|566719418|FG002|Blinded Period|Death|0|||
156990525|NCT04955626|566719419|FG003|Blinded Period|Death|0|||
156990526|NCT04955626|566719420|FG004|Blinded Period|Death|0|||
156990527|NCT04955626|566719421|FG005|Blinded Period|Death|0|||
156990528|NCT04955626|566719422|FG006|Blinded Period|Death|0|||
156990529|NCT04955626|566719423|FG007|Blinded Period|Death|2|||
156990530|NCT04955626|566719424|FG008|Blinded Period|Death|1|||
156990531|NCT04955626|566719425|FG009|Blinded Period|Death|1|||
156990532|NCT04955626|566719426|FG010|Blinded Period|Death|0|||
156990533|NCT04955626|566719427|FG011|Blinded Period|Death|2|||
156990534|NCT04955626|566719428|FG012|Blinded Period|Death|0|||
156990535|NCT04955626|566719429|FG013|Blinded Period|Death|0|||
156990536|NCT04955626|566719430|FG014|Blinded Period|Death|0|||
156990537|NCT04955626|566719431|FG015|Blinded Period|Death|0|||
156990538|NCT04955626|566719432|FG016|Blinded Period|Death|0|||
156990539|NCT04955626|566719433|FG017|Blinded Period|Death|0|||
156990540|NCT04955626|566719434|FG018|Blinded Period|Death|0|||
156990541|NCT04955626|566719435|FG019|Blinded Period|Death|0|||
156990542|NCT04955626|566719436|FG020|Blinded Period|Death|0|||
156990543|NCT04955626|566719437|FG021|Blinded Period|Death|0|||
156990544|NCT04955626|566719438|FG022|Blinded Period|Death|0|||
156990545|NCT04955626|566719439|FG023|Blinded Period|Death|1|||
156990546|NCT04955626|566719440|FG024|Blinded Period|Death|0|||
156990547|NCT04955626|566719441|FG025|Blinded Period|Death|0|||
156990548|NCT04955626|566719442|FG026|Blinded Period|Death|1|||
156990549|NCT04955626|566719443|FG027|Blinded Period|Death|1|||
156990550|NCT04955626|566719444|FG028|Blinded Period|Death|0|||
156990551|NCT04955626|566719445|FG029|Blinded Period|Death|1|||
156990552|NCT04955626|566719446|FG030|Blinded Period|Death|0|||
156990553|NCT04955626|566719447|FG031|Blinded Period|Death|0|||
156990554|NCT04955626|566719448|FG032|Blinded Period|Death|0|||
156990555|NCT04955626|566719449|FG033|Blinded Period|Death|0|||
156990556|NCT04955626|566719450|FG034|Blinded Period|Death|0|||
156990557|NCT04955626|566719451|FG035|Blinded Period|Death|0|||
156990558|NCT04955626|566719416|FG000|Blinded Period|Adverse Event|0|||
156990559|NCT04955626|566719417|FG001|Blinded Period|Adverse Event|1|||
156990560|NCT04955626|566719418|FG002|Blinded Period|Adverse Event|1|||
156990561|NCT04955626|566719419|FG003|Blinded Period|Adverse Event|1|||
156990562|NCT04955626|566719420|FG004|Blinded Period|Adverse Event|0|||
156990563|NCT04955626|566719421|FG005|Blinded Period|Adverse Event|0|||
156990564|NCT04955626|566719422|FG006|Blinded Period|Adverse Event|0|||
156990565|NCT04955626|566719423|FG007|Blinded Period|Adverse Event|0|||
156990566|NCT04955626|566719424|FG008|Blinded Period|Adverse Event|0|||
156990567|NCT04955626|566719425|FG009|Blinded Period|Adverse Event|1|||
156990568|NCT04955626|566719426|FG010|Blinded Period|Adverse Event|1|||
156990569|NCT04955626|566719427|FG011|Blinded Period|Adverse Event|0|||
156990570|NCT04955626|566719428|FG012|Blinded Period|Adverse Event|0|||
156990571|NCT04955626|566719429|FG013|Blinded Period|Adverse Event|0|||
156990572|NCT04955626|566719430|FG014|Blinded Period|Adverse Event|0|||
156990573|NCT04955626|566719431|FG015|Blinded Period|Adverse Event|0|||
156990574|NCT04955626|566719432|FG016|Blinded Period|Adverse Event|0|||
156990575|NCT04955626|566719433|FG017|Blinded Period|Adverse Event|0|||
156990576|NCT04955626|566719434|FG018|Blinded Period|Adverse Event|1|||
156990577|NCT04955626|566719435|FG019|Blinded Period|Adverse Event|0|||
156990578|NCT04955626|566719436|FG020|Blinded Period|Adverse Event|0|||
156990579|NCT04955626|566719437|FG021|Blinded Period|Adverse Event|0|||
156990580|NCT04955626|566719438|FG022|Blinded Period|Adverse Event|0|||
156990581|NCT04955626|566719439|FG023|Blinded Period|Adverse Event|0|||
156990582|NCT04955626|566719440|FG024|Blinded Period|Adverse Event|0|||
156990583|NCT04955626|566719441|FG025|Blinded Period|Adverse Event|0|||
156990584|NCT04955626|566719442|FG026|Blinded Period|Adverse Event|1|||
156990585|NCT04955626|566719443|FG027|Blinded Period|Adverse Event|0|||
156990586|NCT04955626|566719444|FG028|Blinded Period|Adverse Event|0|||
156990587|NCT04955626|566719445|FG029|Blinded Period|Adverse Event|0|||
156990588|NCT04955626|566719446|FG030|Blinded Period|Adverse Event|0|||
156990589|NCT04955626|566719447|FG031|Blinded Period|Adverse Event|0|||
156990590|NCT04955626|566719448|FG032|Blinded Period|Adverse Event|0|||
156990591|NCT04955626|566719449|FG033|Blinded Period|Adverse Event|0|||
156990592|NCT04955626|566719450|FG034|Blinded Period|Adverse Event|0|||
156990593|NCT04955626|566719451|FG035|Blinded Period|Adverse Event|0|||
156990594|NCT04955626|566719416|FG000|Blinded Period|No longer meets eligibility criteria|1|||
156990595|NCT04955626|566719417|FG001|Blinded Period|No longer meets eligibility criteria|2|||
156990596|NCT04955626|566719418|FG002|Blinded Period|No longer meets eligibility criteria|0|||
156990597|NCT04955626|566719419|FG003|Blinded Period|No longer meets eligibility criteria|1|||
156990598|NCT04955626|566719420|FG004|Blinded Period|No longer meets eligibility criteria|0|||
156990599|NCT04955626|566719421|FG005|Blinded Period|No longer meets eligibility criteria|0|||
156990600|NCT04955626|566719422|FG006|Blinded Period|No longer meets eligibility criteria|0|||
156990601|NCT04955626|566719423|FG007|Blinded Period|No longer meets eligibility criteria|0|||
156990602|NCT04955626|566719424|FG008|Blinded Period|No longer meets eligibility criteria|1|||
156990603|NCT04955626|566719425|FG009|Blinded Period|No longer meets eligibility criteria|0|||
156990604|NCT04955626|566719426|FG010|Blinded Period|No longer meets eligibility criteria|1|||
156990605|NCT04955626|566719427|FG011|Blinded Period|No longer meets eligibility criteria|1|||
156990606|NCT04955626|566719428|FG012|Blinded Period|No longer meets eligibility criteria|0|||
156990607|NCT04955626|566719429|FG013|Blinded Period|No longer meets eligibility criteria|0|||
156990608|NCT04955626|566719430|FG014|Blinded Period|No longer meets eligibility criteria|0|||
156990609|NCT04955626|566719431|FG015|Blinded Period|No longer meets eligibility criteria|3|||
156990610|NCT04955626|566719432|FG016|Blinded Period|No longer meets eligibility criteria|0|||
156990611|NCT04955626|566719433|FG017|Blinded Period|No longer meets eligibility criteria|2|||
156990612|NCT04955626|566719434|FG018|Blinded Period|No longer meets eligibility criteria|0|||
156990613|NCT04955626|566719435|FG019|Blinded Period|No longer meets eligibility criteria|0|||
156990614|NCT04955626|566719436|FG020|Blinded Period|No longer meets eligibility criteria|0|||
156990615|NCT04955626|566719437|FG021|Blinded Period|No longer meets eligibility criteria|0|||
156990616|NCT04955626|566719438|FG022|Blinded Period|No longer meets eligibility criteria|0|||
156990617|NCT04955626|566719439|FG023|Blinded Period|No longer meets eligibility criteria|0|||
156990618|NCT04955626|566719440|FG024|Blinded Period|No longer meets eligibility criteria|1|||
156990619|NCT04955626|566719441|FG025|Blinded Period|No longer meets eligibility criteria|0|||
156990620|NCT04955626|566719442|FG026|Blinded Period|No longer meets eligibility criteria|0|||
156990621|NCT04955626|566719443|FG027|Blinded Period|No longer meets eligibility criteria|1|||
156990622|NCT04955626|566719444|FG028|Blinded Period|No longer meets eligibility criteria|0|||
156990623|NCT04955626|566719445|FG029|Blinded Period|No longer meets eligibility criteria|0|||
156990624|NCT04955626|566719446|FG030|Blinded Period|No longer meets eligibility criteria|0|||
156990625|NCT04955626|566719447|FG031|Blinded Period|No longer meets eligibility criteria|0|||
156990626|NCT04955626|566719448|FG032|Blinded Period|No longer meets eligibility criteria|0|||
156990627|NCT04955626|566719449|FG033|Blinded Period|No longer meets eligibility criteria|0|||
156990628|NCT04955626|566719450|FG034|Blinded Period|No longer meets eligibility criteria|0|||
156990629|NCT04955626|566719451|FG035|Blinded Period|No longer meets eligibility criteria|0|||
156990630|NCT04955626|566719416|FG000|Blinded Period|Other|54|||
156990631|NCT04955626|566719417|FG001|Blinded Period|Other|3|||
156990632|NCT04955626|566719418|FG002|Blinded Period|Other|4|||
156990633|NCT04955626|566719419|FG003|Blinded Period|Other|2|||
156990634|NCT04955626|566719420|FG004|Blinded Period|Other|0|||
156990635|NCT04955626|566719421|FG005|Blinded Period|Other|0|||
156990636|NCT04955626|566719422|FG006|Blinded Period|Other|2|||
156990637|NCT04955626|566719423|FG007|Blinded Period|Other|2|||
156990638|NCT04955626|566719424|FG008|Blinded Period|Other|1|||
156990639|NCT04955626|566719425|FG009|Blinded Period|Other|0|||
156990640|NCT04955626|566719426|FG010|Blinded Period|Other|1|||
156990641|NCT04955626|566719427|FG011|Blinded Period|Other|1|||
156990642|NCT04955626|566719428|FG012|Blinded Period|Other|0|||
156990643|NCT04955626|566719429|FG013|Blinded Period|Other|0|||
156990644|NCT04955626|566719430|FG014|Blinded Period|Other|0|||
156990645|NCT04955626|566719431|FG015|Blinded Period|Other|0|||
156990646|NCT04955626|566719432|FG016|Blinded Period|Other|0|||
156990647|NCT04955626|566719433|FG017|Blinded Period|Other|1|||
156990648|NCT04955626|566719434|FG018|Blinded Period|Other|0|||
156990649|NCT04955626|566719435|FG019|Blinded Period|Other|0|||
156990650|NCT04955626|566719436|FG020|Blinded Period|Other|0|||
156990651|NCT04955626|566719437|FG021|Blinded Period|Other|0|||
156990652|NCT04955626|566719438|FG022|Blinded Period|Other|0|||
156990653|NCT04955626|566719439|FG023|Blinded Period|Other|0|||
156990654|NCT04955626|566719440|FG024|Blinded Period|Other|0|||
156990655|NCT04955626|566719441|FG025|Blinded Period|Other|0|||
156990656|NCT04955626|566719442|FG026|Blinded Period|Other|2|||
156990657|NCT04955626|566719443|FG027|Blinded Period|Other|0|||
156990658|NCT04955626|566719444|FG028|Blinded Period|Other|0|||
156990659|NCT04955626|566719445|FG029|Blinded Period|Other|0|||
156990660|NCT04955626|566719446|FG030|Blinded Period|Other|0|||
156990661|NCT04955626|566719447|FG031|Blinded Period|Other|0|||
157096993|NCT02805725|567110912|FG001|Phase II|Protocol Violation|0|||
157096994|NCT02805725|567110913|FG002|Phase II|Protocol Violation|0|||
156990662|NCT04955626|566719448|FG032|Blinded Period|Other|0|||
156990663|NCT04955626|566719449|FG033|Blinded Period|Other|0|||
156990664|NCT04955626|566719450|FG034|Blinded Period|Other|0|||
156990665|NCT04955626|566719451|FG035|Blinded Period|Other|0|||
156990666|NCT04955626|566719416|FG000|Blinded Period|Physician Decision|1|||
156990667|NCT04955626|566719417|FG001|Blinded Period|Physician Decision|1|||
156990668|NCT04955626|566719418|FG002|Blinded Period|Physician Decision|0|||
156990669|NCT04955626|566719419|FG003|Blinded Period|Physician Decision|3|||
156990670|NCT04955626|566719420|FG004|Blinded Period|Physician Decision|0|||
156990671|NCT04955626|566719421|FG005|Blinded Period|Physician Decision|0|||
156990672|NCT04955626|566719422|FG006|Blinded Period|Physician Decision|1|||
156990673|NCT04955626|566719423|FG007|Blinded Period|Physician Decision|1|||
157096995|NCT02805725|567110914|FG003|Phase II|Protocol Violation|0|||
156990674|NCT04955626|566719424|FG008|Blinded Period|Physician Decision|0|||
156990675|NCT04955626|566719425|FG009|Blinded Period|Physician Decision|0|||
156990676|NCT04955626|566719426|FG010|Blinded Period|Physician Decision|0|||
156990677|NCT04955626|566719427|FG011|Blinded Period|Physician Decision|5|||
156990678|NCT04955626|566719428|FG012|Blinded Period|Physician Decision|0|||
156990679|NCT04955626|566719429|FG013|Blinded Period|Physician Decision|0|||
156990680|NCT04955626|566719430|FG014|Blinded Period|Physician Decision|0|||
156990681|NCT04955626|566719431|FG015|Blinded Period|Physician Decision|0|||
156990682|NCT04955626|566719432|FG016|Blinded Period|Physician Decision|0|||
156990683|NCT04955626|566719433|FG017|Blinded Period|Physician Decision|0|||
156990684|NCT04955626|566719434|FG018|Blinded Period|Physician Decision|0|||
156990685|NCT04955626|566719435|FG019|Blinded Period|Physician Decision|0|||
156990686|NCT04955626|566719436|FG020|Blinded Period|Physician Decision|0|||
156990687|NCT04955626|566719437|FG021|Blinded Period|Physician Decision|0|||
156990688|NCT04955626|566719438|FG022|Blinded Period|Physician Decision|0|||
156990689|NCT04955626|566719439|FG023|Blinded Period|Physician Decision|0|||
156990690|NCT04955626|566719440|FG024|Blinded Period|Physician Decision|0|||
156990691|NCT04955626|566719441|FG025|Blinded Period|Physician Decision|0|||
156990692|NCT04955626|566719442|FG026|Blinded Period|Physician Decision|0|||
156990693|NCT04955626|566719443|FG027|Blinded Period|Physician Decision|0|||
156990694|NCT04955626|566719444|FG028|Blinded Period|Physician Decision|0|||
156990695|NCT04955626|566719445|FG029|Blinded Period|Physician Decision|0|||
156990696|NCT04955626|566719446|FG030|Blinded Period|Physician Decision|0|||
156990697|NCT04955626|566719447|FG031|Blinded Period|Physician Decision|0|||
156990698|NCT04955626|566719448|FG032|Blinded Period|Physician Decision|0|||
156990699|NCT04955626|566719449|FG033|Blinded Period|Physician Decision|0|||
156990700|NCT04955626|566719450|FG034|Blinded Period|Physician Decision|0|||
156990701|NCT04955626|566719451|FG035|Blinded Period|Physician Decision|0|||
156990702|NCT04955626|566719416|FG000|Blinded Period|Withdrawal by Subject|26|||
156990703|NCT04955626|566719417|FG001|Blinded Period|Withdrawal by Subject|62|||
156990704|NCT04955626|566719418|FG002|Blinded Period|Withdrawal by Subject|14|||
156990705|NCT04955626|566719419|FG003|Blinded Period|Withdrawal by Subject|16|||
156990706|NCT04955626|566719420|FG004|Blinded Period|Withdrawal by Subject|1|||
156990707|NCT04955626|566719421|FG005|Blinded Period|Withdrawal by Subject|2|||
156990708|NCT04955626|566719422|FG006|Blinded Period|Withdrawal by Subject|9|||
156990709|NCT04955626|566719423|FG007|Blinded Period|Withdrawal by Subject|5|||
156990710|NCT04955626|566719424|FG008|Blinded Period|Withdrawal by Subject|3|||
156990711|NCT04955626|566719425|FG009|Blinded Period|Withdrawal by Subject|15|||
156990712|NCT04955626|566719426|FG010|Blinded Period|Withdrawal by Subject|11|||
156990713|NCT04955626|566719427|FG011|Blinded Period|Withdrawal by Subject|7|||
156990714|NCT04955626|566719428|FG012|Blinded Period|Withdrawal by Subject|2|||
156990715|NCT04955626|566719429|FG013|Blinded Period|Withdrawal by Subject|0|||
156990716|NCT04955626|566719430|FG014|Blinded Period|Withdrawal by Subject|1|||
156990717|NCT04955626|566719431|FG015|Blinded Period|Withdrawal by Subject|11|||
156990718|NCT04955626|566719432|FG016|Blinded Period|Withdrawal by Subject|2|||
156990719|NCT04955626|566719433|FG017|Blinded Period|Withdrawal by Subject|5|||
156990720|NCT04955626|566719434|FG018|Blinded Period|Withdrawal by Subject|0|||
156990721|NCT04955626|566719435|FG019|Blinded Period|Withdrawal by Subject|0|||
156990722|NCT04955626|566719436|FG020|Blinded Period|Withdrawal by Subject|1|||
156990723|NCT04955626|566719437|FG021|Blinded Period|Withdrawal by Subject|0|||
156990724|NCT04955626|566719438|FG022|Blinded Period|Withdrawal by Subject|0|||
156990725|NCT04955626|566719439|FG023|Blinded Period|Withdrawal by Subject|0|||
156990726|NCT04955626|566719440|FG024|Blinded Period|Withdrawal by Subject|5|||
156990727|NCT04955626|566719441|FG025|Blinded Period|Withdrawal by Subject|1|||
156990728|NCT04955626|566719442|FG026|Blinded Period|Withdrawal by Subject|5|||
156990729|NCT04955626|566719443|FG027|Blinded Period|Withdrawal by Subject|1|||
156990730|NCT04955626|566719444|FG028|Blinded Period|Withdrawal by Subject|4|||
156990731|NCT04955626|566719445|FG029|Blinded Period|Withdrawal by Subject|2|||
156990732|NCT04955626|566719446|FG030|Blinded Period|Withdrawal by Subject|0|||
156990733|NCT04955626|566719447|FG031|Blinded Period|Withdrawal by Subject|0|||
156990734|NCT04955626|566719448|FG032|Blinded Period|Withdrawal by Subject|0|||
156990735|NCT04955626|566719449|FG033|Blinded Period|Withdrawal by Subject|0|||
156990736|NCT04955626|566719450|FG034|Blinded Period|Withdrawal by Subject|0|||
156990737|NCT04955626|566719451|FG035|Blinded Period|Withdrawal by Subject|0|||
156990738|NCT04955626|566719416|FG000|Blinded Period|Refused further study procedures|0|||
156990739|NCT04955626|566719417|FG001|Blinded Period|Refused further study procedures|0|||
156990740|NCT04955626|566719418|FG002|Blinded Period|Refused further study procedures|0|||
156990741|NCT04955626|566719419|FG003|Blinded Period|Refused further study procedures|0|||
156990742|NCT04955626|566719420|FG004|Blinded Period|Refused further study procedures|0|||
156990743|NCT04955626|566719421|FG005|Blinded Period|Refused further study procedures|0|||
156990744|NCT04955626|566719422|FG006|Blinded Period|Refused further study procedures|1|||
156990745|NCT04955626|566719423|FG007|Blinded Period|Refused further study procedures|0|||
156990746|NCT04955626|566719424|FG008|Blinded Period|Refused further study procedures|0|||
156990747|NCT04955626|566719425|FG009|Blinded Period|Refused further study procedures|0|||
156990748|NCT04955626|566719426|FG010|Blinded Period|Refused further study procedures|0|||
156990749|NCT04955626|566719427|FG011|Blinded Period|Refused further study procedures|2|||
156990750|NCT04955626|566719428|FG012|Blinded Period|Refused further study procedures|0|||
156990751|NCT04955626|566719429|FG013|Blinded Period|Refused further study procedures|0|||
156990752|NCT04955626|566719430|FG014|Blinded Period|Refused further study procedures|0|||
156990753|NCT04955626|566719431|FG015|Blinded Period|Refused further study procedures|0|||
156990754|NCT04955626|566719432|FG016|Blinded Period|Refused further study procedures|0|||
156990755|NCT04955626|566719433|FG017|Blinded Period|Refused further study procedures|0|||
156990756|NCT04955626|566719434|FG018|Blinded Period|Refused further study procedures|0|||
156990757|NCT04955626|566719435|FG019|Blinded Period|Refused further study procedures|0|||
156990758|NCT04955626|566719436|FG020|Blinded Period|Refused further study procedures|0|||
156990759|NCT04955626|566719437|FG021|Blinded Period|Refused further study procedures|0|||
156990760|NCT04955626|566719438|FG022|Blinded Period|Refused further study procedures|0|||
156990761|NCT04955626|566719439|FG023|Blinded Period|Refused further study procedures|0|||
156990762|NCT04955626|566719440|FG024|Blinded Period|Refused further study procedures|0|||
156990763|NCT04955626|566719441|FG025|Blinded Period|Refused further study procedures|0|||
156990764|NCT04955626|566719442|FG026|Blinded Period|Refused further study procedures|0|||
156990765|NCT04955626|566719443|FG027|Blinded Period|Refused further study procedures|0|||
156990766|NCT04955626|566719444|FG028|Blinded Period|Refused further study procedures|0|||
156990767|NCT04955626|566719445|FG029|Blinded Period|Refused further study procedures|0|||
156990768|NCT04955626|566719446|FG030|Blinded Period|Refused further study procedures|0|||
156990769|NCT04955626|566719447|FG031|Blinded Period|Refused further study procedures|0|||
156990770|NCT04955626|566719448|FG032|Blinded Period|Refused further study procedures|0|||
156990771|NCT04955626|566719449|FG033|Blinded Period|Refused further study procedures|0|||
156990772|NCT04955626|566719450|FG034|Blinded Period|Refused further study procedures|0|||
156990773|NCT04955626|566719451|FG035|Blinded Period|Refused further study procedures|0|||
156990774|NCT04955626|566719416|FG000|Blinded Period|Participants entered open label period|4544|||
156990775|NCT04955626|566719417|FG001|Blinded Period|Participants entered open label period|4906|||
156990776|NCT04955626|566719418|FG002|Blinded Period|Participants entered open label period|0|||
156990777|NCT04955626|566719419|FG003|Blinded Period|Participants entered open label period|0|||
156990778|NCT04955626|566719420|FG004|Blinded Period|Participants entered open label period|0|||
156990779|NCT04955626|566719421|FG005|Blinded Period|Participants entered open label period|0|||
156990780|NCT04955626|566719422|FG006|Blinded Period|Participants entered open label period|0|||
156990781|NCT04955626|566719423|FG007|Blinded Period|Participants entered open label period|0|||
156990782|NCT04955626|566719424|FG008|Blinded Period|Participants entered open label period|0|||
156990783|NCT04955626|566719425|FG009|Blinded Period|Participants entered open label period|0|||
156990784|NCT04955626|566719426|FG010|Blinded Period|Participants entered open label period|0|||
156990785|NCT04955626|566719427|FG011|Blinded Period|Participants entered open label period|0|||
156990786|NCT04955626|566719428|FG012|Blinded Period|Participants entered open label period|0|||
156990787|NCT04955626|566719429|FG013|Blinded Period|Participants entered open label period|0|||
156990788|NCT04955626|566719430|FG014|Blinded Period|Participants entered open label period|0|||
156990789|NCT04955626|566719431|FG015|Blinded Period|Participants entered open label period|0|||
156990790|NCT04955626|566719432|FG016|Blinded Period|Participants entered open label period|0|||
156990791|NCT04955626|566719433|FG017|Blinded Period|Participants entered open label period|0|||
156990792|NCT04955626|566719434|FG018|Blinded Period|Participants entered open label period|0|||
156990793|NCT04955626|566719435|FG019|Blinded Period|Participants entered open label period|0|||
156990794|NCT04955626|566719436|FG020|Blinded Period|Participants entered open label period|0|||
156990795|NCT04955626|566719437|FG021|Blinded Period|Participants entered open label period|0|||
156990796|NCT04955626|566719438|FG022|Blinded Period|Participants entered open label period|0|||
156990797|NCT04955626|566719439|FG023|Blinded Period|Participants entered open label period|0|||
156990798|NCT04955626|566719440|FG024|Blinded Period|Participants entered open label period|0|||
156990799|NCT04955626|566719441|FG025|Blinded Period|Participants entered open label period|0|||
156990800|NCT04955626|566719442|FG026|Blinded Period|Participants entered open label period|0|||
156990801|NCT04955626|566719443|FG027|Blinded Period|Participants entered open label period|0|||
156990802|NCT04955626|566719444|FG028|Blinded Period|Participants entered open label period|0|||
156990803|NCT04955626|566719445|FG029|Blinded Period|Participants entered open label period|0|||
156990804|NCT04955626|566719446|FG030|Blinded Period|Participants entered open label period|0|||
156990805|NCT04955626|566719447|FG031|Blinded Period|Participants entered open label period|0|||
156990806|NCT04955626|566719448|FG032|Blinded Period|Participants entered open label period|0|||
156990807|NCT04955626|566719449|FG033|Blinded Period|Participants entered open label period|0|||
156990808|NCT04955626|566719450|FG034|Blinded Period|Participants entered open label period|0|||
156990809|NCT04955626|566719451|FG035|Blinded Period|Participants entered open label period|0|||
156990810|NCT04955626|566719416|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
156990811|NCT04955626|566719417|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
156990812|NCT04955626|566719418|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
156990813|NCT04955626|566719419|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
156990814|NCT04955626|566719420|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
156990815|NCT04955626|566719421|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
157096996|NCT02805725|567110915|FG004|Phase II|Protocol Violation|6|||
156990816|NCT04955626|566719422|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
156990817|NCT04955626|566719423|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
156990818|NCT04955626|566719424|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
156990819|NCT04955626|566719425|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
156990820|NCT04955626|566719426|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
156990821|NCT04955626|566719427|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
156990822|NCT04955626|566719428|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
156990823|NCT04955626|566719429|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
157096997|NCT03511053|567110918|FG000|Overall Study|Withdrawal by Subject|1|||
157096998|NCT02425644|567110919|FG000|Overall Study|Lost to Follow-up|2|||
157096999|NCT02425644|567110920|FG001|Overall Study|Lost to Follow-up|3|||
157097000|NCT02425644|567110919|FG000|Overall Study|Withdrawal by Subject|41|||
157097001|NCT02425644|567110920|FG001|Overall Study|Withdrawal by Subject|36|||
157097002|NCT02425644|567110919|FG000|Overall Study|Lack of Efficacy|3|||
157097003|NCT02425644|567110920|FG001|Overall Study|Lack of Efficacy|10|||
157097004|NCT02425644|567110919|FG000|Overall Study|Adverse Event|13|||
157097005|NCT02425644|567110920|FG001|Overall Study|Adverse Event|3|||
157097006|NCT02425644|567110919|FG000|Overall Study|Death|0|||
157097007|NCT02425644|567110920|FG001|Overall Study|Death|2|||
157097008|NCT02425644|567110919|FG000|Overall Study|Other|18|||
157097009|NCT02425644|567110920|FG001|Overall Study|Other|17|||
157097010|NCT02720536|567110921|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
157097011|NCT02720536|567110921|FG000|Overall Study|PR - pregnancy|2|||
157097012|NCT02720536|567110921|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
157097013|NCT02720536|567110921|FG000|Overall Study|PR - death|1|||
157097014|NCT02720536|567110921|FG000|Overall Study|PR - adverse event|1|||
157097015|NCT02720536|567110921|FG000|Overall Study|PR - abnormal lab value(s)|1|||
157097016|NCT02720536|567110921|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
157097017|NCT01028222|567110922|FG000|Overall Study|Protocol deviation|1|||
157097018|NCT01028222|567110923|FG001|Overall Study|Protocol deviation|0|||
157097019|NCT01028222|567110922|FG000|Overall Study|Disease progression|33|||
157097020|NCT01028222|567110923|FG001|Overall Study|Disease progression|9|||
157097021|NCT01028222|567110922|FG000|Overall Study|Administrative problems|1|||
157097022|NCT01028222|567110923|FG001|Overall Study|Administrative problems|1|||
157097023|NCT01028222|567110922|FG000|Overall Study|Lost to Follow-up|0|||
157097024|NCT01028222|567110923|FG001|Overall Study|Lost to Follow-up|1|||
157097025|NCT01028222|567110922|FG000|Overall Study|Withdrawal by Subject|1|||
157097026|NCT01028222|567110923|FG001|Overall Study|Withdrawal by Subject|0|||
157097027|NCT01028222|567110922|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
157097028|NCT01028222|567110923|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
157097029|NCT01028222|567110922|FG000|Overall Study|Adverse Event|2|||
157097030|NCT01028222|567110923|FG001|Overall Study|Adverse Event|0|||
157097031|NCT00146328|567110924|FG000|Overall Study|Adverse Event|39|||
157097032|NCT00146328|567110925|FG001|Overall Study|Adverse Event|48|||
157097033|NCT00146328|567110926|FG002|Overall Study|Adverse Event|79|||
157097034|NCT00146328|567110924|FG000|Overall Study|Protocol Violation|11|||
157097035|NCT00146328|567110925|FG001|Overall Study|Protocol Violation|6|||
157097036|NCT00146328|567110926|FG002|Overall Study|Protocol Violation|12|||
157097037|NCT00146328|567110924|FG000|Overall Study|Lost to Follow-up|7|||
157097038|NCT00146328|567110925|FG001|Overall Study|Lost to Follow-up|4|||
157097039|NCT00146328|567110926|FG002|Overall Study|Lost to Follow-up|7|||
157097040|NCT00146328|567110924|FG000|Overall Study|Withdrawal by Subject|16|||
157097041|NCT00146328|567110925|FG001|Overall Study|Withdrawal by Subject|16|||
157097042|NCT00146328|567110926|FG002|Overall Study|Withdrawal by Subject|22|||
157097043|NCT00146328|567110924|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
157097044|NCT00146328|567110925|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
157097045|NCT00146328|567110926|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
157097046|NCT00146328|567110924|FG000|Overall Study|Trial ended/site closed|8|||
157097047|NCT00146328|567110925|FG001|Overall Study|Trial ended/site closed|2|||
157097048|NCT00146328|567110926|FG002|Overall Study|Trial ended/site closed|19|||
157097049|NCT00146328|567110924|FG000|Overall Study|Patient decision to end|0|||
157097050|NCT00146328|567110925|FG001|Overall Study|Patient decision to end|1|||
157097051|NCT00146328|567110926|FG002|Overall Study|Patient decision to end|6|||
157097052|NCT00146328|567110924|FG000|Overall Study|Enroll into other trial|2|||
156990824|NCT04955626|566719430|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
157097053|NCT00146328|567110925|FG001|Overall Study|Enroll into other trial|4|||
157097054|NCT00146328|567110926|FG002|Overall Study|Enroll into other trial|2|||
157097055|NCT00146328|567110924|FG000|Overall Study|Death|0|||
157097056|NCT00146328|567110925|FG001|Overall Study|Death|1|||
157097057|NCT00146328|567110926|FG002|Overall Study|Death|1|||
157097058|NCT00146328|567110924|FG000|Overall Study|Moved|2|||
157097059|NCT00146328|567110925|FG001|Overall Study|Moved|0|||
157097060|NCT00146328|567110926|FG002|Overall Study|Moved|0|||
157097061|NCT00146328|567110924|FG000|Overall Study|Interaction with other medication|2|||
157097062|NCT00146328|567110925|FG001|Overall Study|Interaction with other medication|0|||
157097063|NCT00146328|567110926|FG002|Overall Study|Interaction with other medication|1|||
157097064|NCT00567268|567110927|FG000|Overall Study|Protocol Violation|7|||
156990825|NCT04955626|566719431|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
156990826|NCT04955626|566719432|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
156990827|NCT04955626|566719433|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
156990828|NCT04955626|566719434|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
156990829|NCT04955626|566719435|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
156990830|NCT04955626|566719436|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
156990831|NCT04955626|566719437|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
156990832|NCT04955626|566719438|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
156990833|NCT04955626|566719439|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
156990834|NCT04955626|566719440|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
156990835|NCT04955626|566719441|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
156990836|NCT04955626|566719442|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
156990837|NCT04955626|566719443|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
156990838|NCT04955626|566719444|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
156990839|NCT04955626|566719445|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
156990840|NCT04955626|566719446|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
156990841|NCT04955626|566719447|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
156990842|NCT04955626|566719448|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
156990843|NCT04955626|566719449|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
156990844|NCT04955626|566719450|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
156990845|NCT04955626|566719451|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
156990846|NCT04955626|566719416|FG000|Blinded Period|Medication error|0|||
156990847|NCT04955626|566719417|FG001|Blinded Period|Medication error|0|||
156990848|NCT04955626|566719418|FG002|Blinded Period|Medication error|0|||
156990849|NCT04955626|566719419|FG003|Blinded Period|Medication error|0|||
156990850|NCT04955626|566719420|FG004|Blinded Period|Medication error|0|||
156990851|NCT04955626|566719421|FG005|Blinded Period|Medication error|0|||
156990852|NCT04955626|566719422|FG006|Blinded Period|Medication error|0|||
156990853|NCT04955626|566719423|FG007|Blinded Period|Medication error|0|||
156990854|NCT04955626|566719424|FG008|Blinded Period|Medication error|0|||
156990855|NCT04955626|566719425|FG009|Blinded Period|Medication error|0|||
156990856|NCT04955626|566719426|FG010|Blinded Period|Medication error|2|||
156990857|NCT04955626|566719427|FG011|Blinded Period|Medication error|0|||
156990858|NCT04955626|566719428|FG012|Blinded Period|Medication error|0|||
156990859|NCT04955626|566719429|FG013|Blinded Period|Medication error|0|||
156990860|NCT04955626|566719430|FG014|Blinded Period|Medication error|0|||
156990861|NCT04955626|566719431|FG015|Blinded Period|Medication error|0|||
156990862|NCT04955626|566719432|FG016|Blinded Period|Medication error|0|||
156990863|NCT04955626|566719433|FG017|Blinded Period|Medication error|0|||
156990864|NCT04955626|566719434|FG018|Blinded Period|Medication error|0|||
156990865|NCT04955626|566719435|FG019|Blinded Period|Medication error|0|||
156990866|NCT04955626|566719436|FG020|Blinded Period|Medication error|0|||
156990867|NCT04955626|566719437|FG021|Blinded Period|Medication error|0|||
156990868|NCT04955626|566719438|FG022|Blinded Period|Medication error|0|||
156990869|NCT04955626|566719439|FG023|Blinded Period|Medication error|0|||
156990870|NCT04955626|566719440|FG024|Blinded Period|Medication error|0|||
156990871|NCT04955626|566719441|FG025|Blinded Period|Medication error|0|||
156990872|NCT04955626|566719442|FG026|Blinded Period|Medication error|0|||
156990873|NCT04955626|566719443|FG027|Blinded Period|Medication error|0|||
156990874|NCT04955626|566719444|FG028|Blinded Period|Medication error|4|||
156990875|NCT04955626|566719445|FG029|Blinded Period|Medication error|0|||
156990876|NCT04955626|566719446|FG030|Blinded Period|Medication error|0|||
156990877|NCT04955626|566719447|FG031|Blinded Period|Medication error|0|||
156990878|NCT04955626|566719448|FG032|Blinded Period|Medication error|0|||
156990879|NCT04955626|566719449|FG033|Blinded Period|Medication error|0|||
156990880|NCT04955626|566719450|FG034|Blinded Period|Medication error|0|||
156990881|NCT04955626|566719451|FG035|Blinded Period|Medication error|0|||
156990882|NCT04955626|566719416|FG000|Open-Label Period|Lost to Follow-up|109|||
156990883|NCT04955626|566719417|FG001|Open-Label Period|Lost to Follow-up|41|||
156990884|NCT04955626|566719418|FG002|Open-Label Period|Lost to Follow-up|0|||
156990885|NCT04955626|566719419|FG003|Open-Label Period|Lost to Follow-up|0|||
156990886|NCT04955626|566719420|FG004|Open-Label Period|Lost to Follow-up|0|||
156990887|NCT04955626|566719421|FG005|Open-Label Period|Lost to Follow-up|0|||
156990888|NCT04955626|566719422|FG006|Open-Label Period|Lost to Follow-up|0|||
156990889|NCT04955626|566719423|FG007|Open-Label Period|Lost to Follow-up|0|||
156990890|NCT04955626|566719424|FG008|Open-Label Period|Lost to Follow-up|0|||
156990891|NCT04955626|566719425|FG009|Open-Label Period|Lost to Follow-up|0|||
156990892|NCT04955626|566719426|FG010|Open-Label Period|Lost to Follow-up|0|||
156990893|NCT04955626|566719427|FG011|Open-Label Period|Lost to Follow-up|0|||
156990894|NCT04955626|566719428|FG012|Open-Label Period|Lost to Follow-up|0|||
156990895|NCT04955626|566719429|FG013|Open-Label Period|Lost to Follow-up|0|||
156990896|NCT04955626|566719430|FG014|Open-Label Period|Lost to Follow-up|0|||
156990897|NCT04955626|566719431|FG015|Open-Label Period|Lost to Follow-up|0|||
156990898|NCT04955626|566719432|FG016|Open-Label Period|Lost to Follow-up|0|||
156990899|NCT04955626|566719433|FG017|Open-Label Period|Lost to Follow-up|0|||
156990900|NCT04955626|566719434|FG018|Open-Label Period|Lost to Follow-up|0|||
156990901|NCT04955626|566719435|FG019|Open-Label Period|Lost to Follow-up|0|||
156990902|NCT04955626|566719436|FG020|Open-Label Period|Lost to Follow-up|0|||
156990903|NCT04955626|566719437|FG021|Open-Label Period|Lost to Follow-up|0|||
156990904|NCT04955626|566719438|FG022|Open-Label Period|Lost to Follow-up|0|||
156990905|NCT04955626|566719439|FG023|Open-Label Period|Lost to Follow-up|0|||
156990906|NCT04955626|566719440|FG024|Open-Label Period|Lost to Follow-up|0|||
156990907|NCT04955626|566719441|FG025|Open-Label Period|Lost to Follow-up|0|||
156990908|NCT04955626|566719442|FG026|Open-Label Period|Lost to Follow-up|0|||
156990909|NCT04955626|566719443|FG027|Open-Label Period|Lost to Follow-up|0|||
156990910|NCT04955626|566719444|FG028|Open-Label Period|Lost to Follow-up|0|||
156990911|NCT04955626|566719445|FG029|Open-Label Period|Lost to Follow-up|0|||
156990912|NCT04955626|566719446|FG030|Open-Label Period|Lost to Follow-up|0|||
156990913|NCT04955626|566719447|FG031|Open-Label Period|Lost to Follow-up|0|||
156990914|NCT04955626|566719448|FG032|Open-Label Period|Lost to Follow-up|0|||
156990915|NCT04955626|566719449|FG033|Open-Label Period|Lost to Follow-up|0|||
156990916|NCT04955626|566719450|FG034|Open-Label Period|Lost to Follow-up|0|||
156990917|NCT04955626|566719451|FG035|Open-Label Period|Lost to Follow-up|0|||
156990918|NCT04955626|566719416|FG000|Open-Label Period|Protocol Violation|377|||
156990919|NCT04955626|566719417|FG001|Open-Label Period|Protocol Violation|48|||
156990920|NCT04955626|566719418|FG002|Open-Label Period|Protocol Violation|0|||
156990921|NCT04955626|566719419|FG003|Open-Label Period|Protocol Violation|0|||
156990922|NCT04955626|566719420|FG004|Open-Label Period|Protocol Violation|0|||
156990923|NCT04955626|566719421|FG005|Open-Label Period|Protocol Violation|0|||
156990924|NCT04955626|566719422|FG006|Open-Label Period|Protocol Violation|0|||
156990925|NCT04955626|566719423|FG007|Open-Label Period|Protocol Violation|0|||
156990926|NCT04955626|566719424|FG008|Open-Label Period|Protocol Violation|0|||
156990927|NCT04955626|566719425|FG009|Open-Label Period|Protocol Violation|0|||
156990928|NCT04955626|566719426|FG010|Open-Label Period|Protocol Violation|0|||
156990929|NCT04955626|566719427|FG011|Open-Label Period|Protocol Violation|0|||
156990930|NCT04955626|566719428|FG012|Open-Label Period|Protocol Violation|0|||
156990931|NCT04955626|566719429|FG013|Open-Label Period|Protocol Violation|0|||
156990932|NCT04955626|566719430|FG014|Open-Label Period|Protocol Violation|0|||
157097065|NCT00567268|567110927|FG000|Overall Study|Lost to Follow-up|36|||
157097066|NCT00567268|567110927|FG000|Overall Study|No Visit After First Day of Treatment|2|||
157097067|NCT00567268|567110927|FG000|Overall Study|No Drug Administration|4|||
157097068|NCT00567268|567110927|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
157097069|NCT01117454|567110930|FG000|Overall Study|Pregnancy|0|||
157097070|NCT01117454|567110931|FG001|Overall Study|Pregnancy|1|||
157097071|NCT00937833|567110934|FG000|Overall Study|Protocol Violation|1|||
157097072|NCT00937833|567110935|FG001|Overall Study|Protocol Violation|2|||
157097073|NCT00937833|567110934|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
157097074|NCT00937833|567110935|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
157097075|NCT00937833|567110934|FG000|Overall Study|Lost to Follow-up|10|||
157097076|NCT00937833|567110935|FG001|Overall Study|Lost to Follow-up|8|||
157097077|NCT00937833|567110934|FG000|Overall Study|Withdrawal by Subject|4|||
157097078|NCT00937833|567110935|FG001|Overall Study|Withdrawal by Subject|6|||
157097079|NCT03278106|567110937|FG000|Overall Study|No protocol treatment|1|||
157097080|NCT02175004|567110938|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
157097081|NCT02175004|567110939|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
157097082|NCT02175004|567110938|FG000|Overall Study|Investigator Judgment|1|||
157097083|NCT02175004|567110939|FG001|Overall Study|Investigator Judgment|4|||
157097084|NCT02175004|567110938|FG000|Overall Study|Voluntary Withdrawal|6|||
157097085|NCT02175004|567110939|FG001|Overall Study|Voluntary Withdrawal|19|||
157097086|NCT02175004|567110938|FG000|Overall Study|Liver Transplant|1|||
157097087|NCT02175004|567110939|FG001|Overall Study|Liver Transplant|0|||
157097088|NCT02175004|567110938|FG000|Overall Study|Disease Progression|1|||
157097089|NCT02175004|567110939|FG001|Overall Study|Disease Progression|0|||
157097090|NCT02175004|567110938|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
157097091|NCT02175004|567110939|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
157097092|NCT00162032|567110940|FG000|Overall Study|Lost to Follow-up|4|||
156990933|NCT04955626|566719431|FG015|Open-Label Period|Protocol Violation|0|||
156990934|NCT04955626|566719432|FG016|Open-Label Period|Protocol Violation|0|||
156990935|NCT04955626|566719433|FG017|Open-Label Period|Protocol Violation|0|||
156990936|NCT04955626|566719434|FG018|Open-Label Period|Protocol Violation|0|||
156990937|NCT04955626|566719435|FG019|Open-Label Period|Protocol Violation|0|||
156990938|NCT04955626|566719436|FG020|Open-Label Period|Protocol Violation|0|||
157097093|NCT00162032|567110941|FG001|Overall Study|Lost to Follow-up|2|||
157097094|NCT00162032|567110940|FG000|Overall Study|Reason not specified|1|||
157097095|NCT00162032|567110941|FG001|Overall Study|Reason not specified|0|||
157097096|NCT01137955|567110942|FG000|Overall Study|Withdrawal by Subject|5|||
157097097|NCT01137955|567110943|FG001|Overall Study|Withdrawal by Subject|4|||
157097098|NCT03285178|567110944|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
156990939|NCT04955626|566719437|FG021|Open-Label Period|Protocol Violation|0|||
156990940|NCT04955626|566719438|FG022|Open-Label Period|Protocol Violation|0|||
156990941|NCT04955626|566719439|FG023|Open-Label Period|Protocol Violation|0|||
156990942|NCT04955626|566719440|FG024|Open-Label Period|Protocol Violation|0|||
156990943|NCT04955626|566719441|FG025|Open-Label Period|Protocol Violation|0|||
156990944|NCT04955626|566719442|FG026|Open-Label Period|Protocol Violation|0|||
156990945|NCT04955626|566719443|FG027|Open-Label Period|Protocol Violation|0|||
156990946|NCT04955626|566719444|FG028|Open-Label Period|Protocol Violation|0|||
156990947|NCT04955626|566719445|FG029|Open-Label Period|Protocol Violation|0|||
156990948|NCT04955626|566719446|FG030|Open-Label Period|Protocol Violation|0|||
156990949|NCT04955626|566719447|FG031|Open-Label Period|Protocol Violation|0|||
156990950|NCT04955626|566719448|FG032|Open-Label Period|Protocol Violation|0|||
156990951|NCT04955626|566719449|FG033|Open-Label Period|Protocol Violation|0|||
156990952|NCT04955626|566719450|FG034|Open-Label Period|Protocol Violation|0|||
156990953|NCT04955626|566719451|FG035|Open-Label Period|Protocol Violation|0|||
156990954|NCT04955626|566719416|FG000|Open-Label Period|Death|5|||
156990955|NCT04955626|566719417|FG001|Open-Label Period|Death|5|||
156990956|NCT04955626|566719418|FG002|Open-Label Period|Death|0|||
156990957|NCT04955626|566719419|FG003|Open-Label Period|Death|0|||
156990958|NCT04955626|566719420|FG004|Open-Label Period|Death|0|||
156990959|NCT04955626|566719421|FG005|Open-Label Period|Death|0|||
156990960|NCT04955626|566719422|FG006|Open-Label Period|Death|0|||
156990961|NCT04955626|566719423|FG007|Open-Label Period|Death|0|||
156990962|NCT04955626|566719424|FG008|Open-Label Period|Death|0|||
156990963|NCT04955626|566719425|FG009|Open-Label Period|Death|0|||
156990964|NCT04955626|566719426|FG010|Open-Label Period|Death|0|||
156990965|NCT04955626|566719427|FG011|Open-Label Period|Death|0|||
156990966|NCT04955626|566719428|FG012|Open-Label Period|Death|0|||
156990967|NCT04955626|566719429|FG013|Open-Label Period|Death|0|||
156990968|NCT04955626|566719430|FG014|Open-Label Period|Death|0|||
156990969|NCT04955626|566719431|FG015|Open-Label Period|Death|0|||
156990970|NCT04955626|566719432|FG016|Open-Label Period|Death|0|||
156990971|NCT04955626|566719433|FG017|Open-Label Period|Death|0|||
156990972|NCT04955626|566719434|FG018|Open-Label Period|Death|0|||
156990973|NCT04955626|566719435|FG019|Open-Label Period|Death|0|||
156990974|NCT04955626|566719436|FG020|Open-Label Period|Death|0|||
156990975|NCT04955626|566719437|FG021|Open-Label Period|Death|0|||
156990976|NCT04955626|566719438|FG022|Open-Label Period|Death|0|||
156990977|NCT04955626|566719439|FG023|Open-Label Period|Death|0|||
156990978|NCT04955626|566719440|FG024|Open-Label Period|Death|0|||
156990979|NCT04955626|566719441|FG025|Open-Label Period|Death|0|||
156990980|NCT04955626|566719442|FG026|Open-Label Period|Death|0|||
156990981|NCT04955626|566719443|FG027|Open-Label Period|Death|0|||
156990982|NCT04955626|566719444|FG028|Open-Label Period|Death|0|||
156990983|NCT04955626|566719445|FG029|Open-Label Period|Death|0|||
156990984|NCT04955626|566719446|FG030|Open-Label Period|Death|0|||
156990985|NCT04955626|566719447|FG031|Open-Label Period|Death|0|||
156990986|NCT04955626|566719448|FG032|Open-Label Period|Death|0|||
156990987|NCT04955626|566719449|FG033|Open-Label Period|Death|0|||
156990988|NCT04955626|566719450|FG034|Open-Label Period|Death|0|||
156990989|NCT04955626|566719451|FG035|Open-Label Period|Death|0|||
156990990|NCT04955626|566719416|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
156990991|NCT04955626|566719417|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
156990992|NCT04955626|566719418|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
156990993|NCT04955626|566719419|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
156990994|NCT04955626|566719420|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
156990995|NCT04955626|566719421|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
156990996|NCT04955626|566719422|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
156990997|NCT04955626|566719423|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
156990998|NCT04955626|566719424|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
156990999|NCT04955626|566719425|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
156991000|NCT04955626|566719426|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
156991001|NCT04955626|566719427|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
156991002|NCT04955626|566719428|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
156991003|NCT04955626|566719429|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
157097099|NCT03285178|567110945|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156991004|NCT04955626|566719430|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
156991005|NCT04955626|566719431|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
156991006|NCT04955626|566719432|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
156991007|NCT04955626|566719433|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
156991008|NCT04955626|566719434|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
156991009|NCT04955626|566719435|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
156991010|NCT04955626|566719436|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
156991011|NCT04955626|566719437|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
156991012|NCT04955626|566719438|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
156991013|NCT04955626|566719439|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
156991014|NCT04955626|566719440|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
156991015|NCT04955626|566719441|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
156991016|NCT04955626|566719442|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
156991017|NCT04955626|566719443|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
156991018|NCT04955626|566719444|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
156991019|NCT04955626|566719445|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
156991020|NCT04955626|566719446|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
156991021|NCT04955626|566719447|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
156991022|NCT04955626|566719448|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
156991023|NCT04955626|566719449|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
156991024|NCT04955626|566719450|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
156991025|NCT04955626|566719451|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
156991026|NCT04955626|566719416|FG000|Open-Label Period|Other|621|||
156991027|NCT04955626|566719417|FG001|Open-Label Period|Other|429|||
156991028|NCT04955626|566719418|FG002|Open-Label Period|Other|0|||
156991029|NCT04955626|566719419|FG003|Open-Label Period|Other|0|||
156991030|NCT04955626|566719420|FG004|Open-Label Period|Other|0|||
156991031|NCT04955626|566719421|FG005|Open-Label Period|Other|0|||
156991032|NCT04955626|566719422|FG006|Open-Label Period|Other|0|||
156991033|NCT04955626|566719423|FG007|Open-Label Period|Other|0|||
156991034|NCT04955626|566719424|FG008|Open-Label Period|Other|0|||
156991035|NCT04955626|566719425|FG009|Open-Label Period|Other|0|||
156991036|NCT04955626|566719426|FG010|Open-Label Period|Other|0|||
156991037|NCT04955626|566719427|FG011|Open-Label Period|Other|0|||
156991038|NCT04955626|566719428|FG012|Open-Label Period|Other|0|||
156991039|NCT04955626|566719429|FG013|Open-Label Period|Other|0|||
156991040|NCT04955626|566719430|FG014|Open-Label Period|Other|0|||
156991041|NCT04955626|566719431|FG015|Open-Label Period|Other|0|||
156991042|NCT04955626|566719432|FG016|Open-Label Period|Other|0|||
156991043|NCT04955626|566719433|FG017|Open-Label Period|Other|0|||
156991044|NCT04955626|566719434|FG018|Open-Label Period|Other|0|||
156991045|NCT04955626|566719435|FG019|Open-Label Period|Other|0|||
156991046|NCT04955626|566719436|FG020|Open-Label Period|Other|0|||
156991047|NCT04955626|566719437|FG021|Open-Label Period|Other|0|||
156991048|NCT04955626|566719438|FG022|Open-Label Period|Other|0|||
156991049|NCT04955626|566719439|FG023|Open-Label Period|Other|0|||
156991050|NCT04955626|566719440|FG024|Open-Label Period|Other|0|||
156991051|NCT04955626|566719441|FG025|Open-Label Period|Other|0|||
156991052|NCT04955626|566719442|FG026|Open-Label Period|Other|0|||
156991053|NCT04955626|566719443|FG027|Open-Label Period|Other|0|||
156991054|NCT04955626|566719444|FG028|Open-Label Period|Other|0|||
156991055|NCT04955626|566719445|FG029|Open-Label Period|Other|0|||
156991056|NCT04955626|566719446|FG030|Open-Label Period|Other|0|||
156991057|NCT04955626|566719447|FG031|Open-Label Period|Other|0|||
156991058|NCT04955626|566719448|FG032|Open-Label Period|Other|0|||
156991059|NCT04955626|566719449|FG033|Open-Label Period|Other|0|||
156991060|NCT04955626|566719450|FG034|Open-Label Period|Other|0|||
156991061|NCT04955626|566719451|FG035|Open-Label Period|Other|0|||
156991062|NCT04955626|566719416|FG000|Open-Label Period|Physician Decision|2|||
156991063|NCT04955626|566719417|FG001|Open-Label Period|Physician Decision|0|||
156991064|NCT04955626|566719418|FG002|Open-Label Period|Physician Decision|0|||
156991065|NCT04955626|566719419|FG003|Open-Label Period|Physician Decision|0|||
156991066|NCT04955626|566719420|FG004|Open-Label Period|Physician Decision|0|||
156991067|NCT04955626|566719421|FG005|Open-Label Period|Physician Decision|0|||
156991068|NCT04955626|566719422|FG006|Open-Label Period|Physician Decision|0|||
156991069|NCT04955626|566719423|FG007|Open-Label Period|Physician Decision|0|||
156991070|NCT04955626|566719424|FG008|Open-Label Period|Physician Decision|0|||
156991071|NCT04955626|566719425|FG009|Open-Label Period|Physician Decision|0|||
156991072|NCT04955626|566719426|FG010|Open-Label Period|Physician Decision|0|||
156991073|NCT04955626|566719427|FG011|Open-Label Period|Physician Decision|0|||
156991074|NCT04955626|566719428|FG012|Open-Label Period|Physician Decision|0|||
156991075|NCT04955626|566719429|FG013|Open-Label Period|Physician Decision|0|||
156991076|NCT04955626|566719430|FG014|Open-Label Period|Physician Decision|0|||
156991077|NCT04955626|566719431|FG015|Open-Label Period|Physician Decision|0|||
156991078|NCT04955626|566719432|FG016|Open-Label Period|Physician Decision|0|||
156991079|NCT04955626|566719433|FG017|Open-Label Period|Physician Decision|0|||
156991080|NCT04955626|566719434|FG018|Open-Label Period|Physician Decision|0|||
156991081|NCT04955626|566719435|FG019|Open-Label Period|Physician Decision|0|||
156991082|NCT04955626|566719436|FG020|Open-Label Period|Physician Decision|0|||
156991083|NCT04955626|566719437|FG021|Open-Label Period|Physician Decision|0|||
156991084|NCT04955626|566719438|FG022|Open-Label Period|Physician Decision|0|||
156991085|NCT04955626|566719439|FG023|Open-Label Period|Physician Decision|0|||
156991086|NCT04955626|566719440|FG024|Open-Label Period|Physician Decision|0|||
156991087|NCT04955626|566719441|FG025|Open-Label Period|Physician Decision|0|||
156991088|NCT04955626|566719442|FG026|Open-Label Period|Physician Decision|0|||
156991089|NCT04955626|566719443|FG027|Open-Label Period|Physician Decision|0|||
156991090|NCT04955626|566719444|FG028|Open-Label Period|Physician Decision|0|||
156991091|NCT04955626|566719445|FG029|Open-Label Period|Physician Decision|0|||
156991092|NCT04955626|566719446|FG030|Open-Label Period|Physician Decision|0|||
156991093|NCT04955626|566719447|FG031|Open-Label Period|Physician Decision|0|||
156991094|NCT04955626|566719448|FG032|Open-Label Period|Physician Decision|0|||
156991095|NCT04955626|566719449|FG033|Open-Label Period|Physician Decision|0|||
156991096|NCT04955626|566719450|FG034|Open-Label Period|Physician Decision|0|||
156991097|NCT04955626|566719451|FG035|Open-Label Period|Physician Decision|0|||
156991098|NCT04955626|566719416|FG000|Open-Label Period|Withdrawal by Subject|135|||
156991099|NCT04955626|566719417|FG001|Open-Label Period|Withdrawal by Subject|25|||
156991100|NCT04955626|566719418|FG002|Open-Label Period|Withdrawal by Subject|0|||
156991101|NCT04955626|566719419|FG003|Open-Label Period|Withdrawal by Subject|0|||
156991102|NCT04955626|566719420|FG004|Open-Label Period|Withdrawal by Subject|0|||
156991103|NCT04955626|566719421|FG005|Open-Label Period|Withdrawal by Subject|0|||
156991104|NCT04955626|566719422|FG006|Open-Label Period|Withdrawal by Subject|0|||
156991105|NCT04955626|566719423|FG007|Open-Label Period|Withdrawal by Subject|0|||
156991106|NCT04955626|566719424|FG008|Open-Label Period|Withdrawal by Subject|0|||
156991107|NCT04955626|566719425|FG009|Open-Label Period|Withdrawal by Subject|0|||
156991108|NCT04955626|566719426|FG010|Open-Label Period|Withdrawal by Subject|0|||
156991109|NCT04955626|566719427|FG011|Open-Label Period|Withdrawal by Subject|0|||
156991110|NCT04955626|566719428|FG012|Open-Label Period|Withdrawal by Subject|0|||
156991111|NCT04955626|566719429|FG013|Open-Label Period|Withdrawal by Subject|0|||
156991112|NCT04955626|566719430|FG014|Open-Label Period|Withdrawal by Subject|0|||
156991113|NCT04955626|566719431|FG015|Open-Label Period|Withdrawal by Subject|0|||
156991114|NCT04955626|566719432|FG016|Open-Label Period|Withdrawal by Subject|0|||
156991115|NCT04955626|566719433|FG017|Open-Label Period|Withdrawal by Subject|0|||
156991116|NCT04955626|566719434|FG018|Open-Label Period|Withdrawal by Subject|0|||
156991117|NCT04955626|566719435|FG019|Open-Label Period|Withdrawal by Subject|0|||
156991118|NCT04955626|566719436|FG020|Open-Label Period|Withdrawal by Subject|0|||
156991119|NCT04955626|566719437|FG021|Open-Label Period|Withdrawal by Subject|0|||
156991120|NCT04955626|566719438|FG022|Open-Label Period|Withdrawal by Subject|0|||
156991121|NCT04955626|566719439|FG023|Open-Label Period|Withdrawal by Subject|0|||
156991122|NCT04955626|566719440|FG024|Open-Label Period|Withdrawal by Subject|0|||
156991123|NCT04955626|566719441|FG025|Open-Label Period|Withdrawal by Subject|0|||
156991124|NCT04955626|566719442|FG026|Open-Label Period|Withdrawal by Subject|0|||
156991125|NCT04955626|566719443|FG027|Open-Label Period|Withdrawal by Subject|0|||
156991126|NCT04955626|566719444|FG028|Open-Label Period|Withdrawal by Subject|0|||
156991127|NCT04955626|566719445|FG029|Open-Label Period|Withdrawal by Subject|0|||
156991128|NCT04955626|566719446|FG030|Open-Label Period|Withdrawal by Subject|0|||
156991129|NCT04955626|566719447|FG031|Open-Label Period|Withdrawal by Subject|0|||
156991130|NCT04955626|566719448|FG032|Open-Label Period|Withdrawal by Subject|0|||
156991131|NCT04955626|566719449|FG033|Open-Label Period|Withdrawal by Subject|0|||
156991132|NCT04955626|566719450|FG034|Open-Label Period|Withdrawal by Subject|0|||
156991133|NCT04955626|566719451|FG035|Open-Label Period|Withdrawal by Subject|0|||
156991134|NCT04955626|566719416|FG000|Open-Label Period|Refused further study procedures|1|||
156991135|NCT04955626|566719417|FG001|Open-Label Period|Refused further study procedures|0|||
156991136|NCT04955626|566719418|FG002|Open-Label Period|Refused further study procedures|0|||
156991137|NCT04955626|566719419|FG003|Open-Label Period|Refused further study procedures|0|||
156991138|NCT04955626|566719420|FG004|Open-Label Period|Refused further study procedures|0|||
156991139|NCT04955626|566719421|FG005|Open-Label Period|Refused further study procedures|0|||
156991140|NCT04955626|566719422|FG006|Open-Label Period|Refused further study procedures|0|||
156991141|NCT04955626|566719423|FG007|Open-Label Period|Refused further study procedures|0|||
156991142|NCT04955626|566719424|FG008|Open-Label Period|Refused further study procedures|0|||
156991143|NCT04955626|566719425|FG009|Open-Label Period|Refused further study procedures|0|||
156991144|NCT04955626|566719426|FG010|Open-Label Period|Refused further study procedures|0|||
156991145|NCT04955626|566719427|FG011|Open-Label Period|Refused further study procedures|0|||
156991146|NCT04955626|566719428|FG012|Open-Label Period|Refused further study procedures|0|||
156991147|NCT04955626|566719429|FG013|Open-Label Period|Refused further study procedures|0|||
156991148|NCT04955626|566719430|FG014|Open-Label Period|Refused further study procedures|0|||
156991149|NCT04955626|566719431|FG015|Open-Label Period|Refused further study procedures|0|||
156991150|NCT04955626|566719432|FG016|Open-Label Period|Refused further study procedures|0|||
156991151|NCT04955626|566719433|FG017|Open-Label Period|Refused further study procedures|0|||
156991152|NCT04955626|566719434|FG018|Open-Label Period|Refused further study procedures|0|||
156991153|NCT04955626|566719435|FG019|Open-Label Period|Refused further study procedures|0|||
156991154|NCT04955626|566719436|FG020|Open-Label Period|Refused further study procedures|0|||
156991155|NCT04955626|566719437|FG021|Open-Label Period|Refused further study procedures|0|||
156991156|NCT04955626|566719438|FG022|Open-Label Period|Refused further study procedures|0|||
156991157|NCT04955626|566719439|FG023|Open-Label Period|Refused further study procedures|0|||
156991158|NCT04955626|566719440|FG024|Open-Label Period|Refused further study procedures|0|||
156991159|NCT04955626|566719441|FG025|Open-Label Period|Refused further study procedures|0|||
156991160|NCT04955626|566719442|FG026|Open-Label Period|Refused further study procedures|0|||
156991161|NCT04955626|566719443|FG027|Open-Label Period|Refused further study procedures|0|||
156991162|NCT04955626|566719444|FG028|Open-Label Period|Refused further study procedures|0|||
156991163|NCT04955626|566719445|FG029|Open-Label Period|Refused further study procedures|0|||
156991164|NCT04955626|566719446|FG030|Open-Label Period|Refused further study procedures|0|||
156991165|NCT04955626|566719447|FG031|Open-Label Period|Refused further study procedures|0|||
156991166|NCT04955626|566719448|FG032|Open-Label Period|Refused further study procedures|0|||
156991167|NCT04955626|566719449|FG033|Open-Label Period|Refused further study procedures|0|||
156991168|NCT04955626|566719450|FG034|Open-Label Period|Refused further study procedures|0|||
156991169|NCT04955626|566719451|FG035|Open-Label Period|Refused further study procedures|0|||
156991170|NCT04955626|566719416|FG000|Open-Label Period|Adverse Event|1|||
156991171|NCT04955626|566719417|FG001|Open-Label Period|Adverse Event|0|||
156991172|NCT04955626|566719418|FG002|Open-Label Period|Adverse Event|0|||
156991173|NCT04955626|566719419|FG003|Open-Label Period|Adverse Event|0|||
156991174|NCT04955626|566719420|FG004|Open-Label Period|Adverse Event|0|||
156991175|NCT04955626|566719421|FG005|Open-Label Period|Adverse Event|0|||
156991176|NCT04955626|566719422|FG006|Open-Label Period|Adverse Event|0|||
156991177|NCT04955626|566719423|FG007|Open-Label Period|Adverse Event|0|||
156991178|NCT04955626|566719424|FG008|Open-Label Period|Adverse Event|0|||
156991179|NCT04955626|566719425|FG009|Open-Label Period|Adverse Event|0|||
156991180|NCT04955626|566719426|FG010|Open-Label Period|Adverse Event|0|||
156991181|NCT04955626|566719427|FG011|Open-Label Period|Adverse Event|0|||
156991182|NCT04955626|566719428|FG012|Open-Label Period|Adverse Event|0|||
156991183|NCT04955626|566719429|FG013|Open-Label Period|Adverse Event|0|||
156991184|NCT04955626|566719430|FG014|Open-Label Period|Adverse Event|0|||
156991185|NCT04955626|566719431|FG015|Open-Label Period|Adverse Event|0|||
156991186|NCT04955626|566719432|FG016|Open-Label Period|Adverse Event|0|||
156991187|NCT04955626|566719433|FG017|Open-Label Period|Adverse Event|0|||
156991188|NCT04955626|566719434|FG018|Open-Label Period|Adverse Event|0|||
156991189|NCT04955626|566719435|FG019|Open-Label Period|Adverse Event|0|||
156991190|NCT04955626|566719436|FG020|Open-Label Period|Adverse Event|0|||
156991191|NCT04955626|566719437|FG021|Open-Label Period|Adverse Event|0|||
156991192|NCT04955626|566719438|FG022|Open-Label Period|Adverse Event|0|||
156991193|NCT04955626|566719439|FG023|Open-Label Period|Adverse Event|0|||
156991194|NCT04955626|566719440|FG024|Open-Label Period|Adverse Event|0|||
156991195|NCT04955626|566719441|FG025|Open-Label Period|Adverse Event|0|||
156991196|NCT04955626|566719442|FG026|Open-Label Period|Adverse Event|0|||
156991197|NCT04955626|566719443|FG027|Open-Label Period|Adverse Event|0|||
156991198|NCT04955626|566719444|FG028|Open-Label Period|Adverse Event|0|||
156991199|NCT04955626|566719445|FG029|Open-Label Period|Adverse Event|0|||
156991200|NCT04955626|566719446|FG030|Open-Label Period|Adverse Event|0|||
156991201|NCT04955626|566719447|FG031|Open-Label Period|Adverse Event|0|||
156991202|NCT04955626|566719448|FG032|Open-Label Period|Adverse Event|0|||
156991203|NCT04955626|566719449|FG033|Open-Label Period|Adverse Event|0|||
156991204|NCT04955626|566719450|FG034|Open-Label Period|Adverse Event|0|||
156991205|NCT04955626|566719451|FG035|Open-Label Period|Adverse Event|0|||
156991206|NCT04955626|566719416|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
156991207|NCT04955626|566719417|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
156991208|NCT04955626|566719418|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
156991209|NCT04955626|566719419|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
156991210|NCT04955626|566719420|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
156991211|NCT04955626|566719421|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
156991212|NCT04955626|566719422|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
156991213|NCT04955626|566719423|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
156991214|NCT04955626|566719424|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
156991215|NCT04955626|566719425|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
156991216|NCT04955626|566719426|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
156991217|NCT04955626|566719427|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
156991218|NCT04955626|566719428|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
156991219|NCT04955626|566719429|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
156991220|NCT04955626|566719430|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
156991221|NCT04955626|566719431|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
156991222|NCT04955626|566719432|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
156991223|NCT04955626|566719433|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
156991224|NCT04955626|566719434|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
156991225|NCT04955626|566719435|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
156991226|NCT04955626|566719436|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
156991227|NCT04955626|566719437|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
156991228|NCT04955626|566719438|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
156991229|NCT04955626|566719439|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
156991230|NCT04955626|566719440|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
156991231|NCT04955626|566719441|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
156991232|NCT04955626|566719442|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
156991233|NCT04955626|566719443|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
156991234|NCT04955626|566719444|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
156991235|NCT04955626|566719445|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
156991236|NCT04955626|566719446|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
156991237|NCT04955626|566719447|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
156991238|NCT04955626|566719448|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
156991239|NCT04955626|566719449|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
156991240|NCT04955626|566719450|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
156991241|NCT04955626|566719451|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
156991242|NCT04955626|566719416|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991243|NCT04955626|566719417|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
156991244|NCT04955626|566719418|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991245|NCT04955626|566719419|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991246|NCT04955626|566719420|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991247|NCT04955626|566719421|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991248|NCT04955626|566719422|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991249|NCT04955626|566719423|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991250|NCT04955626|566719424|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991251|NCT04955626|566719425|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991252|NCT04955626|566719426|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991253|NCT04955626|566719427|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991254|NCT04955626|566719428|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991255|NCT04955626|566719429|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991256|NCT04955626|566719430|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991257|NCT04955626|566719431|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991258|NCT04955626|566719432|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991259|NCT04955626|566719433|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991260|NCT04955626|566719434|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991261|NCT04955626|566719435|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991262|NCT04955626|566719436|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991263|NCT04955626|566719437|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991264|NCT04955626|566719438|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991265|NCT04955626|566719439|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991266|NCT04955626|566719440|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991267|NCT04955626|566719441|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991268|NCT04955626|566719442|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991269|NCT04955626|566719443|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991270|NCT04955626|566719444|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991271|NCT04955626|566719445|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991272|NCT04955626|566719446|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991273|NCT04955626|566719447|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991274|NCT04955626|566719448|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991275|NCT04955626|566719449|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991276|NCT04955626|566719450|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991277|NCT04955626|566719451|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
156991278|NCT03658811|566719454|FG000|Overall Study|Lost to Follow-up|3|||
156991279|NCT04951479|566719455|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
156991280|NCT04209790|566719456|FG000|Overall Study|Physician Decision|1|||
156991281|NCT04060680|566719458|FG000|Overall Study|Unsuccessful implant|17|||
156991282|NCT04060680|566719459|FG001|Overall Study|Unsuccessful implant|2|||
156991283|NCT04060680|566719458|FG000|Overall Study|Adverse Event|3|||
156991284|NCT04060680|566719459|FG001|Overall Study|Adverse Event|0|||
156991285|NCT04060680|566719458|FG000|Overall Study|Death|2|||
156991286|NCT04060680|566719459|FG001|Overall Study|Death|0|||
156991287|NCT04060680|566719458|FG000|Overall Study|Study product no longer in use|1|||
156991288|NCT04060680|566719459|FG001|Overall Study|Study product no longer in use|0|||
156991289|NCT04060680|566719458|FG000|Overall Study|Withdrawal by Subject|1|||
156991290|NCT04060680|566719459|FG001|Overall Study|Withdrawal by Subject|0|||
156991291|NCT03803774|566719460|FG000|Dose Escalation|Withdrawal by Subject|0|||
156991292|NCT03803774|566719461|FG001|Dose Escalation|Withdrawal by Subject|0|||
156991293|NCT03803774|566719462|FG002|Dose Escalation|Withdrawal by Subject|0|||
156991294|NCT03803774|566719463|FG003|Dose Escalation|Withdrawal by Subject|1|||
156991295|NCT03803774|566719464|FG004|Dose Escalation|Withdrawal by Subject|0|||
156991296|NCT05617040|566719465|FG000|Overall Study|Adverse Event|0|||
156991297|NCT05617040|566719466|FG001|Overall Study|Adverse Event|1|||
156991298|NCT05617040|566719467|FG002|Overall Study|Adverse Event|0|||
156991299|NCT05617040|566719465|FG000|Overall Study|Death|0|||
156991300|NCT05617040|566719466|FG001|Overall Study|Death|0|||
156991301|NCT05617040|566719467|FG002|Overall Study|Death|1|||
156991302|NCT02711826|566719468|FG000|Overall Study|Physician Decision|0|||
156991303|NCT02711826|566719469|FG001|Overall Study|Physician Decision|0|||
156991304|NCT02711826|566719470|FG002|Overall Study|Physician Decision|0|||
156991305|NCT02711826|566719471|FG003|Overall Study|Physician Decision|1|||
156991306|NCT02711826|566719472|FG004|Overall Study|Physician Decision|0|||
156991307|NCT02711826|566719468|FG000|Overall Study|Withdrawal by Subject|0|||
156991308|NCT02711826|566719469|FG001|Overall Study|Withdrawal by Subject|1|||
156991309|NCT02711826|566719470|FG002|Overall Study|Withdrawal by Subject|0|||
156991310|NCT02711826|566719471|FG003|Overall Study|Withdrawal by Subject|4|||
156991311|NCT02711826|566719472|FG004|Overall Study|Withdrawal by Subject|0|||
156991312|NCT02711826|566719468|FG000|Overall Study|Failure to manufacture cellular product|0|||
156991313|NCT02711826|566719469|FG001|Overall Study|Failure to manufacture cellular product|0|||
156991314|NCT02711826|566719470|FG002|Overall Study|Failure to manufacture cellular product|5|||
156991315|NCT02711826|566719471|FG003|Overall Study|Failure to manufacture cellular product|0|||
156991316|NCT02711826|566719472|FG004|Overall Study|Failure to manufacture cellular product|0|||
156991317|NCT02711826|566719468|FG000|Overall Study|Infusion canceled for active infection|0|||
157097100|NCT03285178|567110946|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
157145129|NCT03237845|567277996|FG000|Overall Study|Withdrawal by Subject|3|||
156991318|NCT02711826|566719469|FG001|Overall Study|Infusion canceled for active infection|1|||
156991319|NCT02711826|566719470|FG002|Overall Study|Infusion canceled for active infection|0|||
156991320|NCT02711826|566719471|FG003|Overall Study|Infusion canceled for active infection|0|||
156991321|NCT02711826|566719472|FG004|Overall Study|Infusion canceled for active infection|0|||
156991322|NCT02711826|566719468|FG000|Overall Study|Screen failures|0|||
156991323|NCT02711826|566719469|FG001|Overall Study|Screen failures|0|||
156991324|NCT02711826|566719470|FG002|Overall Study|Screen failures|0|||
156991325|NCT02711826|566719471|FG003|Overall Study|Screen failures|4|||
156991326|NCT02711826|566719472|FG004|Overall Study|Screen failures|0|||
156991327|NCT00729690|566719473|FG000|Overall Study|IT Catheter Malfunction|0|||
156991328|NCT00729690|566719474|FG001|Overall Study|IT Catheter Malfunction|2|||
156991329|NCT00729690|566719475|FG002|Overall Study|IT Catheter Malfunction|2|||
156991330|NCT02169219|566719476|FG000|Overall Study|Lack of Efficacy|6|||
156991331|NCT04482855|566719477|FG000|Overall Study|Lost to Follow-up|1|||
156991332|NCT04482855|566719478|FG001|Overall Study|Lost to Follow-up|0|||
156991333|NCT04482855|566719477|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
156991334|NCT04482855|566719478|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
156991335|NCT04482855|566719477|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
156991336|NCT04482855|566719478|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
156991337|NCT02886936|566719482|FG000|Overall Study|Lost to Follow-up|4|||
156991338|NCT02886936|566719483|FG001|Overall Study|Lost to Follow-up|3|||
156991339|NCT02886936|566719484|FG002|Overall Study|Lost to Follow-up|0|||
156991340|NCT02507219|566719485|FG000|Overall Study|Physician Decision|1|||
156991341|NCT02507219|566719486|FG001|Overall Study|Physician Decision|0|||
156991342|NCT02507219|566719487|FG002|Overall Study|Physician Decision|0|||
156991343|NCT02507219|566719488|FG003|Overall Study|Physician Decision|0|||
156991344|NCT02507219|566719489|FG004|Overall Study|Physician Decision|0|||
156991345|NCT02507219|566719490|FG005|Overall Study|Physician Decision|0|||
156991346|NCT02507219|566719485|FG000|Overall Study|Withdrawal by Subject|0|||
156991347|NCT02507219|566719486|FG001|Overall Study|Withdrawal by Subject|0|||
156991348|NCT02507219|566719487|FG002|Overall Study|Withdrawal by Subject|0|||
156991349|NCT02507219|566719488|FG003|Overall Study|Withdrawal by Subject|0|||
157097101|NCT03285178|567110947|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
157097102|NCT03285178|567110948|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
157097103|NCT03285178|567110949|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
157097104|NCT03285178|567110950|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
156991350|NCT02507219|566719489|FG004|Overall Study|Withdrawal by Subject|1|||
156991351|NCT02507219|566719490|FG005|Overall Study|Withdrawal by Subject|0|||
156991352|NCT04562779|566719491|FG000|Overall Study|Lost to Follow-up|7|||
156991353|NCT04562779|566719492|FG001|Overall Study|Lost to Follow-up|5|||
156991354|NCT04562779|566719493|FG002|Overall Study|Lost to Follow-up|10|||
156991355|NCT04562779|566719491|FG000|Overall Study|Protocol Violation|2|||
156991356|NCT04562779|566719492|FG001|Overall Study|Protocol Violation|2|||
156991357|NCT04562779|566719493|FG002|Overall Study|Protocol Violation|0|||
156991358|NCT02320721|566719494|FG000|Overall Study|Adverse Event|6|||
156991359|NCT02320721|566719495|FG001|Overall Study|Adverse Event|6|||
156991360|NCT02320721|566719494|FG000|Overall Study|Lack of Efficacy|2|||
156991361|NCT02320721|566719495|FG001|Overall Study|Lack of Efficacy|0|||
156991362|NCT02320721|566719494|FG000|Overall Study|Poor compliance to protocol|3|||
156991363|NCT02320721|566719495|FG001|Overall Study|Poor compliance to protocol|7|||
156991364|NCT02320721|566719494|FG000|Overall Study|Randomized but not treated|0|||
156991365|NCT02320721|566719495|FG001|Overall Study|Randomized but not treated|1|||
156991366|NCT02320721|566719494|FG000|Overall Study|Hypoglycemia|1|||
156991367|NCT02320721|566719495|FG001|Overall Study|Hypoglycemia|0|||
156991368|NCT02320721|566719494|FG000|Overall Study|Other than specified above|15|||
156991369|NCT02320721|566719495|FG001|Overall Study|Other than specified above|20|||
156991370|NCT03173248|566719496|FG000|Overall Study|Death|28|||
156991371|NCT03173248|566719497|FG001|Overall Study|Death|46|||
156991372|NCT03173248|566719496|FG000|Overall Study|Lost to Follow-up|0|||
156991373|NCT03173248|566719497|FG001|Overall Study|Lost to Follow-up|1|||
156991374|NCT03173248|566719496|FG000|Overall Study|Withdrawal by Subject|6|||
156991375|NCT03173248|566719497|FG001|Overall Study|Withdrawal by Subject|4|||
156991376|NCT03173248|566719496|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
156991377|NCT03173248|566719497|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
156991378|NCT01544582|566719498|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
156991379|NCT01544582|566719499|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156991380|NCT01544582|566719500|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156991381|NCT01544582|566719501|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
156991382|NCT01544582|566719498|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
156991383|NCT01544582|566719499|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156991384|NCT01544582|566719500|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156991385|NCT01544582|566719501|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
156991386|NCT01544582|566719498|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
156991387|NCT01544582|566719499|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
156991388|NCT01544582|566719500|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
156991389|NCT01544582|566719501|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
156991390|NCT01544582|566719498|FG000|Analysis Population|Physician Decision|0|||
156991391|NCT01544582|566719499|FG001|Analysis Population|Physician Decision|13|||
156991392|NCT01544582|566719500|FG002|Analysis Population|Physician Decision|10|||
156991393|NCT01544582|566719501|FG003|Analysis Population|Physician Decision|9|||
156991394|NCT01544582|566719498|FG000|Analysis Population|Safety Reason|0|||
156991395|NCT01544582|566719499|FG001|Analysis Population|Safety Reason|33|||
156991396|NCT01544582|566719500|FG002|Analysis Population|Safety Reason|31|||
156991397|NCT01544582|566719501|FG003|Analysis Population|Safety Reason|8|||
156991398|NCT01544582|566719498|FG000|Analysis Population|Effectiveness Reason|0|||
156991399|NCT01544582|566719499|FG001|Analysis Population|Effectiveness Reason|48|||
156991400|NCT01544582|566719500|FG002|Analysis Population|Effectiveness Reason|29|||
156991401|NCT01544582|566719501|FG003|Analysis Population|Effectiveness Reason|12|||
156991402|NCT01544582|566719498|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156991403|NCT01544582|566719499|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156991404|NCT01544582|566719500|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
156991405|NCT01544582|566719501|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
156991406|NCT01544582|566719498|FG000|Analysis Population|Lost to Follow-up|0|||
156991407|NCT01544582|566719499|FG001|Analysis Population|Lost to Follow-up|6|||
156991408|NCT01544582|566719500|FG002|Analysis Population|Lost to Follow-up|6|||
156991409|NCT01544582|566719501|FG003|Analysis Population|Lost to Follow-up|5|||
156991410|NCT01544582|566719498|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
156991411|NCT01544582|566719499|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
156991412|NCT01544582|566719500|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
156991413|NCT01544582|566719501|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
156991414|NCT01544582|566719498|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156991415|NCT01544582|566719499|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156991416|NCT01544582|566719500|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
156991417|NCT01544582|566719501|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
156991418|NCT01544582|566719498|FG000|Analysis Population|Intolerance|0|||
156991419|NCT01544582|566719499|FG001|Analysis Population|Intolerance|1|||
156991420|NCT01544582|566719500|FG002|Analysis Population|Intolerance|0|||
156991421|NCT01544582|566719501|FG003|Analysis Population|Intolerance|0|||
156991422|NCT01544582|566719498|FG000|Analysis Population|Liver Transplantation|0|||
156991423|NCT01544582|566719499|FG001|Analysis Population|Liver Transplantation|0|||
156991424|NCT01544582|566719500|FG002|Analysis Population|Liver Transplantation|1|||
156991425|NCT01544582|566719501|FG003|Analysis Population|Liver Transplantation|0|||
156991426|NCT01544582|566719498|FG000|Analysis Population|No Social Insurance|0|||
156991427|NCT01544582|566719499|FG001|Analysis Population|No Social Insurance|0|||
156991428|NCT01544582|566719500|FG002|Analysis Population|No Social Insurance|1|||
156991429|NCT01544582|566719501|FG003|Analysis Population|No Social Insurance|0|||
156991430|NCT01544582|566719498|FG000|Analysis Population|Poor Adherence|0|||
156991431|NCT01544582|566719499|FG001|Analysis Population|Poor Adherence|0|||
156991432|NCT01544582|566719500|FG002|Analysis Population|Poor Adherence|1|||
156991433|NCT01544582|566719501|FG003|Analysis Population|Poor Adherence|0|||
156991434|NCT01544582|566719498|FG000|Analysis Population|Poor Participant Compliance|0|||
156991435|NCT01544582|566719499|FG001|Analysis Population|Poor Participant Compliance|1|||
156991436|NCT01544582|566719500|FG002|Analysis Population|Poor Participant Compliance|0|||
156991437|NCT01544582|566719501|FG003|Analysis Population|Poor Participant Compliance|0|||
156991438|NCT01544582|566719498|FG000|Analysis Population|Programmed Surgery|0|||
156991439|NCT01544582|566719499|FG001|Analysis Population|Programmed Surgery|1|||
156991440|NCT01544582|566719500|FG002|Analysis Population|Programmed Surgery|0|||
156991441|NCT01544582|566719501|FG003|Analysis Population|Programmed Surgery|0|||
156991442|NCT01544582|566719498|FG000|Analysis Population|Participant in Jail|0|||
156991443|NCT01544582|566719499|FG001|Analysis Population|Participant in Jail|0|||
156991444|NCT01544582|566719500|FG002|Analysis Population|Participant in Jail|1|||
156991445|NCT01544582|566719501|FG003|Analysis Population|Participant in Jail|0|||
156991446|NCT02624778|566721118|FG000|Overall Study|Lost to Follow-up|0|||
156991447|NCT02624778|566721119|FG001|Overall Study|Lost to Follow-up|0|||
156991448|NCT02624778|566721120|FG002|Overall Study|Lost to Follow-up|1|||
156991449|NCT02624778|566721121|FG003|Overall Study|Lost to Follow-up|0|||
156991450|NCT02624778|566721122|FG004|Overall Study|Lost to Follow-up|0|||
156991451|NCT02624778|566721123|FG005|Overall Study|Lost to Follow-up|0|||
156991452|NCT02624778|566721124|FG006|Overall Study|Lost to Follow-up|0|||
156991453|NCT02624778|566721125|FG007|Overall Study|Lost to Follow-up|0|||
156991454|NCT02624778|566721126|FG008|Overall Study|Lost to Follow-up|0|||
156991455|NCT02624778|566721118|FG000|Overall Study|Withdrawal by Subject|0|||
156991456|NCT02624778|566721119|FG001|Overall Study|Withdrawal by Subject|1|||
156991457|NCT02624778|566721120|FG002|Overall Study|Withdrawal by Subject|0|||
156991458|NCT02624778|566721121|FG003|Overall Study|Withdrawal by Subject|0|||
156991459|NCT02624778|566721122|FG004|Overall Study|Withdrawal by Subject|0|||
156991460|NCT02624778|566721123|FG005|Overall Study|Withdrawal by Subject|1|||
156991461|NCT02624778|566721124|FG006|Overall Study|Withdrawal by Subject|1|||
156991462|NCT02624778|566721125|FG007|Overall Study|Withdrawal by Subject|1|||
156991463|NCT02624778|566721126|FG008|Overall Study|Withdrawal by Subject|1|||
156991464|NCT02624778|566721118|FG000|Overall Study|Adverse Event|0|||
156991465|NCT02624778|566721119|FG001|Overall Study|Adverse Event|0|||
156991466|NCT02624778|566721120|FG002|Overall Study|Adverse Event|0|||
156991467|NCT02624778|566721121|FG003|Overall Study|Adverse Event|0|||
156991468|NCT02624778|566721122|FG004|Overall Study|Adverse Event|0|||
156991469|NCT02624778|566721123|FG005|Overall Study|Adverse Event|0|||
156991470|NCT02624778|566721124|FG006|Overall Study|Adverse Event|0|||
156991471|NCT02624778|566721125|FG007|Overall Study|Adverse Event|0|||
156991472|NCT02624778|566721126|FG008|Overall Study|Adverse Event|2|||
156991473|NCT02624778|566721118|FG000|Overall Study|Death|0|||
157097105|NCT03285178|567110944|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
156991474|NCT02624778|566721119|FG001|Overall Study|Death|0|||
156991475|NCT02624778|566721120|FG002|Overall Study|Death|0|||
156991476|NCT02624778|566721121|FG003|Overall Study|Death|0|||
156991477|NCT02624778|566721122|FG004|Overall Study|Death|0|||
156991478|NCT02624778|566721123|FG005|Overall Study|Death|0|||
156991479|NCT02624778|566721124|FG006|Overall Study|Death|1|||
156991480|NCT02624778|566721125|FG007|Overall Study|Death|0|||
156991481|NCT02624778|566721126|FG008|Overall Study|Death|0|||
156991482|NCT02624778|566721118|FG000|Overall Study|Physician Decision|0|||
156991483|NCT02624778|566721119|FG001|Overall Study|Physician Decision|0|||
156991484|NCT02624778|566721120|FG002|Overall Study|Physician Decision|0|||
156991485|NCT02624778|566721121|FG003|Overall Study|Physician Decision|0|||
156991486|NCT02624778|566721122|FG004|Overall Study|Physician Decision|0|||
156991487|NCT02624778|566721123|FG005|Overall Study|Physician Decision|0|||
156991488|NCT02624778|566721124|FG006|Overall Study|Physician Decision|0|||
156991489|NCT02624778|566721125|FG007|Overall Study|Physician Decision|3|||
156991490|NCT02624778|566721126|FG008|Overall Study|Physician Decision|3|||
156991491|NCT05296629|566721127|FG000|Overall Study|Withdrawal by Subject|3|||
156991492|NCT05296629|566721128|FG001|Overall Study|Withdrawal by Subject|10|||
156991493|NCT05296629|566721129|FG002|Overall Study|Withdrawal by Subject|4|||
156991494|NCT05296629|566721127|FG000|Overall Study|Lost to Follow-up|2|||
156991495|NCT05296629|566721128|FG001|Overall Study|Lost to Follow-up|7|||
156991496|NCT05296629|566721129|FG002|Overall Study|Lost to Follow-up|1|||
156991497|NCT05296629|566721127|FG000|Overall Study|Adverse Event|0|||
156991498|NCT05296629|566721128|FG001|Overall Study|Adverse Event|4|||
156991499|NCT05296629|566721129|FG002|Overall Study|Adverse Event|2|||
156991500|NCT05296629|566721127|FG000|Overall Study|Protocol Violation|0|||
156991501|NCT05296629|566721128|FG001|Overall Study|Protocol Violation|2|||
156991502|NCT05296629|566721129|FG002|Overall Study|Protocol Violation|0|||
156991503|NCT00231179|566721130|FG000|Overall Study|Lost to Follow-up|21|||
156991504|NCT00231179|566721131|FG001|Overall Study|Lost to Follow-up|21|||
156991505|NCT00231179|566721130|FG000|Overall Study|Withdrawal by Subject|3|||
156991506|NCT00231179|566721131|FG001|Overall Study|Withdrawal by Subject|3|||
156991507|NCT04610684|566721134|FG000|Study Treatment|Withdrawal by Subject|1|||
156991508|NCT04610684|566721134|FG000|Study Treatment|Disease Progression|2|||
156991509|NCT04610684|566721134|FG000|Follow up|Death|2|||
156991510|NCT04610684|566721134|FG000|Follow up|Withdrawal by Subject|1|||
156991511|NCT02153788|566721135|FG000|Overall Study|Physician Decision|2|||
156991512|NCT02153788|566721136|FG001|Overall Study|Physician Decision|1|||
156991513|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
156991514|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
156991515|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
156991516|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
156991517|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
156991518|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
156991519|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
156991520|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
156991521|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
156991522|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
156991523|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
156991524|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
156991525|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
156991526|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
156991527|NCT04672460|566721137|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
156991528|NCT04672460|566721138|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
156991529|NCT04672460|566721137|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
156991530|NCT04672460|566721138|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
156991531|NCT04672460|566721137|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
156991532|NCT04672460|566721138|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
156991533|NCT04672460|566721137|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
156991534|NCT04672460|566721138|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
156991535|NCT04672460|566721137|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
156991536|NCT04672460|566721138|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
156991537|NCT04672460|566721137|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
156991538|NCT04672460|566721138|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
156991539|NCT04672460|566721137|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
156991540|NCT04672460|566721138|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
156991541|NCT04672460|566721137|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
156991542|NCT04672460|566721138|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
156991543|NCT04672460|566721137|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
156991544|NCT04672460|566721138|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
156991545|NCT04672460|566721137|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
156991546|NCT04672460|566721138|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
156991547|NCT02949271|566721143|FG000|Overall Study|Lack of Efficacy|5|||
156991548|NCT02949271|566721144|FG001|Overall Study|Lack of Efficacy|4|||
156991549|NCT02949271|566721143|FG000|Overall Study|Lost to Follow-up|3|||
156991550|NCT02949271|566721144|FG001|Overall Study|Lost to Follow-up|6|||
156991551|NCT02949271|566721143|FG000|Overall Study|Physician Decision|5|||
156991552|NCT02949271|566721144|FG001|Overall Study|Physician Decision|5|||
156991553|NCT02949271|566721143|FG000|Overall Study|Protocol Violation|6|||
156991554|NCT02949271|566721144|FG001|Overall Study|Protocol Violation|3|||
156991555|NCT02949271|566721143|FG000|Overall Study|Withdrawal by Subject|1|||
156991556|NCT02949271|566721144|FG001|Overall Study|Withdrawal by Subject|0|||
156991557|NCT02949271|566721143|FG000|Overall Study|Delivered prior to intervention|7|||
156991558|NCT02949271|566721144|FG001|Overall Study|Delivered prior to intervention|9|||
156991559|NCT02949271|566721143|FG000|Overall Study|Outside the window for cervical dilation|2|||
156991560|NCT02949271|566721144|FG001|Overall Study|Outside the window for cervical dilation|3|||
156991561|NCT05458102|566721147|FG000|Overall Study|Withdrew consent|2|||
156991562|NCT05458102|566721148|FG001|Overall Study|Withdrew consent|0|||
156991563|NCT05458102|566721147|FG000|Overall Study|Adverse Event|1|||
156991564|NCT05458102|566721148|FG001|Overall Study|Adverse Event|0|||
156991565|NCT05458102|566721147|FG000|Overall Study|Enrolled but never treated|1|||
156991566|NCT05458102|566721148|FG001|Overall Study|Enrolled but never treated|0|||
156991567|NCT05458102|566721147|FG000|Overall Study|Protocol Violation|1|||
156991568|NCT05458102|566721148|FG001|Overall Study|Protocol Violation|0|||
156991569|NCT02373813|566721153|FG000|Run-In Period|Other, Not Specified|5|||
156991570|NCT02373813|566721154|FG001|Run-In Period|Other, Not Specified|0|||
156991571|NCT02373813|566721155|FG002|Run-In Period|Other, Not Specified|0|||
156991572|NCT02373813|566721156|FG003|Run-In Period|Other, Not Specified|0|||
156991573|NCT02373813|566721153|FG000|Run-In Period|Withdrawal by Subject|16|||
156991574|NCT02373813|566721154|FG001|Run-In Period|Withdrawal by Subject|0|||
156991575|NCT02373813|566721155|FG002|Run-In Period|Withdrawal by Subject|0|||
156991576|NCT02373813|566721156|FG003|Run-In Period|Withdrawal by Subject|0|||
156991577|NCT02373813|566721153|FG000|Run-In Period|Decision by Sponsor|11|||
156991578|NCT02373813|566721154|FG001|Run-In Period|Decision by Sponsor|0|||
156991579|NCT02373813|566721155|FG002|Run-In Period|Decision by Sponsor|0|||
156991580|NCT02373813|566721156|FG003|Run-In Period|Decision by Sponsor|0|||
156991581|NCT02373813|566721153|FG000|Run-In Period|Protocol Violation|75|||
156991582|NCT02373813|566721154|FG001|Run-In Period|Protocol Violation|0|||
156991583|NCT02373813|566721155|FG002|Run-In Period|Protocol Violation|0|||
156991584|NCT02373813|566721156|FG003|Run-In Period|Protocol Violation|0|||
156991585|NCT02373813|566721153|FG000|Run-In Period|Lost to Follow-up|2|||
156991586|NCT02373813|566721154|FG001|Run-In Period|Lost to Follow-up|0|||
156991587|NCT02373813|566721155|FG002|Run-In Period|Lost to Follow-up|0|||
156991588|NCT02373813|566721156|FG003|Run-In Period|Lost to Follow-up|0|||
156991589|NCT02373813|566721153|FG000|Run-In Period|Adverse Event|3|||
156991590|NCT02373813|566721154|FG001|Run-In Period|Adverse Event|0|||
156991591|NCT02373813|566721155|FG002|Run-In Period|Adverse Event|0|||
156991592|NCT02373813|566721156|FG003|Run-In Period|Adverse Event|0|||
156991593|NCT02373813|566721153|FG000|Run-In Period|Noncompliance|1|||
156991594|NCT02373813|566721154|FG001|Run-In Period|Noncompliance|0|||
156991595|NCT02373813|566721155|FG002|Run-In Period|Noncompliance|0|||
156991596|NCT02373813|566721156|FG003|Run-In Period|Noncompliance|0|||
156991597|NCT02373813|566721153|FG000|Run-In Period|Ineligibility Determined|3|||
156991598|NCT02373813|566721154|FG001|Run-In Period|Ineligibility Determined|0|||
156991599|NCT02373813|566721155|FG002|Run-In Period|Ineligibility Determined|0|||
156991600|NCT02373813|566721156|FG003|Run-In Period|Ineligibility Determined|0|||
156991601|NCT02373813|566721153|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
156991602|NCT02373813|566721154|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
156991603|NCT02373813|566721155|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
156991604|NCT02373813|566721156|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
156991605|NCT02373813|566721153|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156991606|NCT02373813|566721154|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
156991607|NCT02373813|566721155|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
156991608|NCT02373813|566721156|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
156991609|NCT02373813|566721153|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156991610|NCT02373813|566721154|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156991611|NCT02373813|566721155|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
156991612|NCT02373813|566721156|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
156991613|NCT02373813|566721153|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156991614|NCT02373813|566721154|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
156991615|NCT02373813|566721155|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
156991616|NCT02373813|566721156|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
156991617|NCT01511536|566721158|FG000|Phase 1|Other|0|||
156991618|NCT01511536|566721159|FG001|Phase 1|Other|1|||
156991619|NCT01511536|566721160|FG002|Phase 1|Other|0|||
156991620|NCT01511536|566721158|FG000|Phase 2|Other|0|||
156991621|NCT01511536|566721159|FG001|Phase 2|Other|0|||
156991622|NCT01511536|566721160|FG002|Phase 2|Other|9|||
156991623|NCT01764386|566721164|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
156991624|NCT01764386|566721165|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
156991625|NCT01764386|566721164|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
156991626|NCT01764386|566721165|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
156991627|NCT01764386|566721164|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
156991628|NCT01764386|566721165|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
156991629|NCT01764386|566721164|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
156991630|NCT01764386|566721165|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
156991631|NCT01764386|566721164|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
156991632|NCT01764386|566721165|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
156991633|NCT01764386|566721164|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
156991634|NCT01764386|566721165|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
156991635|NCT01764386|566721164|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
156991636|NCT01764386|566721165|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
156991637|NCT01764386|566721164|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
156991638|NCT01764386|566721165|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
156991639|NCT02703532|566721167|FG000|Overall Study|Withdrawal by Subject|0|||
156991640|NCT02703532|566721168|FG001|Overall Study|Withdrawal by Subject|1|||
156991641|NCT02703532|566721169|FG002|Overall Study|Withdrawal by Subject|0|||
156991642|NCT02703532|566721170|FG003|Overall Study|Withdrawal by Subject|1|||
156991643|NCT02703532|566721167|FG000|Overall Study|Lost to Follow-up|2|||
156991644|NCT02703532|566721168|FG001|Overall Study|Lost to Follow-up|0|||
156991645|NCT02703532|566721169|FG002|Overall Study|Lost to Follow-up|2|||
156991646|NCT02703532|566721170|FG003|Overall Study|Lost to Follow-up|0|||
156991647|NCT02788656|566721171|FG000|Overall Study|Withdrawal by Subject|1|||
156991648|NCT02788656|566721172|FG001|Overall Study|Withdrawal by Subject|0|||
156991649|NCT03169361|566721173|FG000|Overall Study|Protocol Violation|32|||
156991650|NCT03929302|566721182|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
156991651|NCT03929302|566721183|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
156991652|NCT03929302|566721184|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
156991653|NCT03929302|566721182|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
156991654|NCT03929302|566721183|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
156991655|NCT03929302|566721184|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
156991656|NCT03929302|566721182|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
156991657|NCT03929302|566721183|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
156991658|NCT03929302|566721184|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
156991659|NCT02459964|566721186|FG000|Overall Study|Withdrawal by Subject|0|||
156991660|NCT02459964|566721187|FG001|Overall Study|Withdrawal by Subject|0|||
156991661|NCT02459964|566721188|FG002|Overall Study|Withdrawal by Subject|1|||
156991662|NCT02459964|566721186|FG000|Overall Study|Abnormal EKG changes|0|||
156991663|NCT02459964|566721187|FG001|Overall Study|Abnormal EKG changes|0|||
156991664|NCT02459964|566721188|FG002|Overall Study|Abnormal EKG changes|1|||
156991665|NCT03239210|566721189|FG000|Overall Study|Lost to Follow-up|2|||
156991666|NCT03239210|566721190|FG001|Overall Study|Lost to Follow-up|2|||
156991667|NCT03239210|566721189|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
156991668|NCT03239210|566721190|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
156991669|NCT03239210|566721189|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
156991670|NCT03239210|566721190|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
156991671|NCT01575860|566721191|FG000|Overall Study|Withdrawal by Subject|1|||
156991672|NCT01575860|566721191|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
156991673|NCT00278564|566721194|FG000|Overall Study|Lack of Efficacy|4|||
156991674|NCT01094743|566721195|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
156991675|NCT02851511|566721196|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
156991676|NCT02851511|566721197|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
156991677|NCT02851511|566721198|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
156991678|NCT02851511|566721199|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
156991679|NCT02851511|566721196|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
156991680|NCT02851511|566721197|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
156991681|NCT02851511|566721198|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
156991682|NCT02851511|566721199|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
156991683|NCT02851511|566721196|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
156991684|NCT02851511|566721197|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
156991685|NCT02851511|566721198|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
156991686|NCT02851511|566721199|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
156991687|NCT02851511|566721196|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156991688|NCT02851511|566721197|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
156991689|NCT02851511|566721198|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156991690|NCT02851511|566721199|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
156991691|NCT02851511|566721196|FG000|Phase I|Physician Decision|0|||
156991692|NCT02851511|566721197|FG001|Phase I|Physician Decision|0|||
156991693|NCT02851511|566721198|FG002|Phase I|Physician Decision|0|||
156991694|NCT02851511|566721199|FG003|Phase I|Physician Decision|1|||
156991695|NCT02851511|566721196|FG000|Phase I|Withdrawal by Subject|2|||
156991696|NCT02851511|566721197|FG001|Phase I|Withdrawal by Subject|1|||
156991697|NCT02851511|566721198|FG002|Phase I|Withdrawal by Subject|0|||
156991698|NCT02851511|566721199|FG003|Phase I|Withdrawal by Subject|3|||
156991699|NCT02851511|566721196|FG000|Phase II|Physician Decision|18|||
156991700|NCT02851511|566721197|FG001|Phase II|Physician Decision|16|||
156991701|NCT02851511|566721198|FG002|Phase II|Physician Decision|0|||
156991702|NCT02851511|566721199|FG003|Phase II|Physician Decision|0|||
156991703|NCT02851511|566721196|FG000|Phase II|Withdrawal by Subject|18|||
156991704|NCT02851511|566721197|FG001|Phase II|Withdrawal by Subject|16|||
156991705|NCT02851511|566721198|FG002|Phase II|Withdrawal by Subject|0|||
156991706|NCT02851511|566721199|FG003|Phase II|Withdrawal by Subject|0|||
156991707|NCT02851511|566721196|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
156991708|NCT02851511|566721197|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
156991709|NCT02851511|566721198|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
156991710|NCT02851511|566721199|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
156991711|NCT02851511|566721196|FG000|Phase II|Lost to Follow-up|0|||
156991712|NCT02851511|566721197|FG001|Phase II|Lost to Follow-up|1|||
156991713|NCT02851511|566721198|FG002|Phase II|Lost to Follow-up|0|||
156991714|NCT02851511|566721199|FG003|Phase II|Lost to Follow-up|0|||
156991715|NCT00372567|566721200|FG000|Phase 3 Study|Adverse Event|5|||
156991716|NCT00372567|566721201|FG001|Phase 3 Study|Adverse Event|1|||
156991717|NCT00372567|566721202|FG002|Phase 3 Study|Adverse Event|1|||
156991718|NCT00372567|566721200|FG000|Phase 3 Study|Death|1|||
156991719|NCT00372567|566721201|FG001|Phase 3 Study|Death|1|||
156991720|NCT00372567|566721202|FG002|Phase 3 Study|Death|0|||
156991721|NCT00372567|566721200|FG000|Phase 3 Study|Protocol Violation|0|||
156991722|NCT00372567|566721201|FG001|Phase 3 Study|Protocol Violation|0|||
156991723|NCT00372567|566721202|FG002|Phase 3 Study|Protocol Violation|1|||
156991724|NCT00372567|566721200|FG000|Phase 3 Study|Objective progression or relapse|10|||
156991725|NCT00372567|566721201|FG001|Phase 3 Study|Objective progression or relapse|13|||
156991726|NCT00372567|566721202|FG002|Phase 3 Study|Objective progression or relapse|4|||
156991727|NCT00372567|566721200|FG000|Phase 3 Study|Global deterioration of health status|0|||
156991728|NCT00372567|566721201|FG001|Phase 3 Study|Global deterioration of health status|1|||
156991729|NCT00372567|566721202|FG002|Phase 3 Study|Global deterioration of health status|0|||
156991730|NCT00372567|566721200|FG000|Phase 3 Study|Other|2|||
156991731|NCT00372567|566721201|FG001|Phase 3 Study|Other|2|||
156991732|NCT00372567|566721202|FG002|Phase 3 Study|Other|1|||
156991733|NCT00372567|566721200|FG000|Phase 3 Study|study terminated by sponsor|13|||
156991734|NCT00372567|566721201|FG001|Phase 3 Study|study terminated by sponsor|8|||
156991735|NCT00372567|566721202|FG002|Phase 3 Study|study terminated by sponsor|5|||
156991736|NCT03278028|566721207|FG000|Overall Study|Lost to Follow-up|1|||
156991737|NCT03278028|566721208|FG001|Overall Study|Lost to Follow-up|0|||
156991738|NCT03278028|566721207|FG000|Overall Study|Withdrawal by Subject|3|||
156991739|NCT03278028|566721208|FG001|Overall Study|Withdrawal by Subject|1|||
156991740|NCT03278028|566721207|FG000|Overall Study|Pregnancy|0|||
156991741|NCT03278028|566721208|FG001|Overall Study|Pregnancy|1|||
156991742|NCT03023332|566721209|FG000|Overall Study|Withdrawal by Subject|10|||
156991743|NCT03023332|566721210|FG001|Overall Study|Withdrawal by Subject|5|||
156991744|NCT03023332|566721211|FG002|Overall Study|Withdrawal by Subject|4|||
156991745|NCT03023332|566721212|FG003|Overall Study|Withdrawal by Subject|7|||
156991746|NCT03023332|566721209|FG000|Overall Study|Lost to Follow-up|13|||
156991747|NCT03023332|566721210|FG001|Overall Study|Lost to Follow-up|16|||
156991748|NCT03023332|566721211|FG002|Overall Study|Lost to Follow-up|8|||
156991749|NCT03023332|566721212|FG003|Overall Study|Lost to Follow-up|13|||
156991750|NCT03023332|566721209|FG000|Overall Study|Death|1|||
156991751|NCT03023332|566721210|FG001|Overall Study|Death|0|||
156991752|NCT03023332|566721211|FG002|Overall Study|Death|0|||
156991753|NCT03023332|566721212|FG003|Overall Study|Death|0|||
156991754|NCT01813422|566721216|FG000|Overall Study|Withdrawal by Subject|14|||
156991755|NCT01813422|566721217|FG001|Overall Study|Withdrawal by Subject|8|||
156991756|NCT01813422|566721216|FG000|Overall Study|Death|2|||
156991757|NCT01813422|566721217|FG001|Overall Study|Death|3|||
156991758|NCT01813422|566721216|FG000|Overall Study|Sponsor Decision|2|||
156991759|NCT01813422|566721217|FG001|Overall Study|Sponsor Decision|1|||
156991760|NCT01813422|566721216|FG000|Overall Study|Lost to Follow-up|2|||
156991761|NCT01813422|566721217|FG001|Overall Study|Lost to Follow-up|4|||
156991762|NCT00859014|566721221|FG000|Overall Study|Death|4|||
156991763|NCT00859014|566721221|FG000|Overall Study|Lost to Follow-up|1|||
156991764|NCT04796935|566721222|FG000|Overall Study|Withdrawal by Subject|0|||
156991765|NCT04796935|566721223|FG001|Overall Study|Withdrawal by Subject|1|||
156991766|NCT04796935|566721222|FG000|Overall Study|Physician Decision|0|||
156991767|NCT04796935|566721223|FG001|Overall Study|Physician Decision|1|||
156991768|NCT04796935|566721222|FG000|Overall Study|Device not available|1|||
156991769|NCT04796935|566721223|FG001|Overall Study|Device not available|0|||
156991770|NCT04796935|566721222|FG000|Overall Study|Trained provider not available|1|||
156991771|NCT04796935|566721223|FG001|Overall Study|Trained provider not available|0|||
156991772|NCT01354938|566721224|FG000|Overall Study|Lost to Follow-up|1|||
156991773|NCT01253200|566721225|FG000|Overall Study|Death|1|||
156991774|NCT01253200|566721226|FG001|Overall Study|Death|0|||
156991775|NCT01253200|566721227|FG002|Overall Study|Death|0|||
156991776|NCT01253200|566721228|FG003|Overall Study|Death|0|||
156991777|NCT01253200|566721229|FG004|Overall Study|Death|0|||
156991778|NCT01253200|566721225|FG000|Overall Study|Lost to Follow-up|1|||
156991779|NCT01253200|566721226|FG001|Overall Study|Lost to Follow-up|1|||
156991780|NCT01253200|566721227|FG002|Overall Study|Lost to Follow-up|0|||
156991781|NCT01253200|566721228|FG003|Overall Study|Lost to Follow-up|0|||
156991782|NCT01253200|566721229|FG004|Overall Study|Lost to Follow-up|0|||
156991783|NCT01253200|566721225|FG000|Overall Study|Withdrawal by Subject|2|||
156991784|NCT01253200|566721226|FG001|Overall Study|Withdrawal by Subject|0|||
156991785|NCT01253200|566721227|FG002|Overall Study|Withdrawal by Subject|0|||
156991786|NCT01253200|566721228|FG003|Overall Study|Withdrawal by Subject|0|||
156991787|NCT01253200|566721229|FG004|Overall Study|Withdrawal by Subject|0|||
156991788|NCT01253200|566721225|FG000|Overall Study|Protocol Violation|1|||
156991789|NCT01253200|566721226|FG001|Overall Study|Protocol Violation|4|||
156991790|NCT01253200|566721227|FG002|Overall Study|Protocol Violation|0|||
156991791|NCT01253200|566721228|FG003|Overall Study|Protocol Violation|0|||
156991792|NCT01253200|566721229|FG004|Overall Study|Protocol Violation|5|||
156991793|NCT01253200|566721225|FG000|Overall Study|intents|10|||
156991794|NCT01253200|566721226|FG001|Overall Study|intents|10|||
156991795|NCT01253200|566721227|FG002|Overall Study|intents|1|||
156991796|NCT01253200|566721228|FG003|Overall Study|intents|3|||
156991797|NCT01253200|566721229|FG004|Overall Study|intents|0|||
156991798|NCT01253200|566721225|FG000|Overall Study|Attempts|6|||
156991799|NCT01253200|566721226|FG001|Overall Study|Attempts|4|||
156991800|NCT01253200|566721227|FG002|Overall Study|Attempts|1|||
156991801|NCT01253200|566721228|FG003|Overall Study|Attempts|2|||
156991802|NCT01253200|566721229|FG004|Overall Study|Attempts|0|||
156991803|NCT02049437|566721230|FG000|Period 1|Adverse Event|1|||
156991804|NCT02049437|566721231|FG001|Period 1|Adverse Event|1|||
156991805|NCT02049437|566721230|FG000|Period 1|Adverse Event|1|||
156991806|NCT02049437|566721231|FG001|Period 1|Adverse Event|0|||
156991807|NCT01163149|566721237|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
156991808|NCT01163149|566721238|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156991809|NCT01163149|566721239|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
156991810|NCT01163149|566721237|FG000|Extension Treatment Period|Adverse Event|0|||
156991811|NCT01163149|566721238|FG001|Extension Treatment Period|Adverse Event|1|||
156991812|NCT01163149|566721239|FG002|Extension Treatment Period|Adverse Event|0|||
156991813|NCT01163149|566721237|FG000|Extension Treatment Period|Noncompliance|0|||
156991814|NCT01163149|566721238|FG001|Extension Treatment Period|Noncompliance|0|||
156991815|NCT01163149|566721239|FG002|Extension Treatment Period|Noncompliance|1|||
156991816|NCT01192295|566721240|FG000|Overall Study|Adverse Event|3|||
156991817|NCT01192295|566721241|FG001|Overall Study|Adverse Event|7|||
156991818|NCT01192295|566721240|FG000|Overall Study|Withdrawal by Subject|3|||
156991819|NCT01192295|566721241|FG001|Overall Study|Withdrawal by Subject|4|||
156991820|NCT01192295|566721240|FG000|Overall Study|Lost to Follow-up|0|||
156991821|NCT01192295|566721241|FG001|Overall Study|Lost to Follow-up|1|||
156991822|NCT01192295|566721240|FG000|Overall Study|Lack of Efficacy|0|||
156991823|NCT01192295|566721241|FG001|Overall Study|Lack of Efficacy|5|||
156991824|NCT01192295|566721240|FG000|Overall Study|Administrative|4|||
156991825|NCT01192295|566721241|FG001|Overall Study|Administrative|6|||
156991826|NCT01027871|566721245|FG000|Overall Study|Physician Decision|1|||
156991827|NCT01027871|566721246|FG001|Overall Study|Physician Decision|5|||
156991828|NCT01027871|566721247|FG002|Overall Study|Physician Decision|0|||
156991829|NCT01027871|566721245|FG000|Overall Study|Protocol Violation|0|||
156991830|NCT01027871|566721246|FG001|Overall Study|Protocol Violation|2|||
156991831|NCT01027871|566721247|FG002|Overall Study|Protocol Violation|2|||
156991832|NCT01027871|566721245|FG000|Overall Study|Withdrawal by Subject|1|||
156991833|NCT01027871|566721246|FG001|Overall Study|Withdrawal by Subject|2|||
156991834|NCT01027871|566721247|FG002|Overall Study|Withdrawal by Subject|2|||
156991835|NCT01027871|566721245|FG000|Overall Study|Adverse Event|0|||
156991836|NCT01027871|566721246|FG001|Overall Study|Adverse Event|2|||
157097106|NCT03285178|567110945|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
157097107|NCT03285178|567110946|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
157097108|NCT03285178|567110947|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
157097109|NCT03285178|567110948|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
157097110|NCT03285178|567110949|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
157097111|NCT03285178|567110950|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
156991837|NCT01027871|566721247|FG002|Overall Study|Adverse Event|2|||
156991838|NCT01027871|566721245|FG000|Overall Study|Sponsor Decision|0|||
156991839|NCT01027871|566721246|FG001|Overall Study|Sponsor Decision|2|||
156991840|NCT01027871|566721247|FG002|Overall Study|Sponsor Decision|0|||
156991841|NCT01027871|566721245|FG000|Overall Study|Discontinued Prior to Treatment|0|||
156991842|NCT01027871|566721246|FG001|Overall Study|Discontinued Prior to Treatment|0|||
156991843|NCT01027871|566721247|FG002|Overall Study|Discontinued Prior to Treatment|1|||
156991844|NCT03782727|566721248|FG000|Overall Study|Lost to Follow-up|32|||
156991845|NCT02820051|566721251|FG000|Overall Study|Lost to Follow-up|7|||
156991846|NCT02820051|566721252|FG001|Overall Study|Lost to Follow-up|4|||
156991847|NCT04159896|566721255|FG000|Overall Study|Lack of Efficacy|7|||
156991848|NCT04159896|566721255|FG000|Overall Study|Withdrawal by Subject|1|||
156991849|NCT04159896|566721255|FG000|Overall Study|Adverse Event|1|||
156991850|NCT04159896|566721255|FG000|Overall Study|A transient ischaemic attack|1|||
156991851|NCT02338609|566721256|FG000|Overall Study|Physician Decision|1|||
156991852|NCT02338609|566721256|FG000|Overall Study|Death|1|||
156991853|NCT04736056|566721259|FG000|Overall Study|Death|0|||
156991854|NCT04736056|566721260|FG001|Overall Study|Death|0|||
156991855|NCT04736056|566721261|FG002|Overall Study|Death|0|||
156991856|NCT04736056|566721262|FG003|Overall Study|Death|1|||
156991857|NCT04736056|566721259|FG000|Overall Study|Lost to Follow-up|1|||
156991858|NCT04736056|566721260|FG001|Overall Study|Lost to Follow-up|0|||
156991859|NCT04736056|566721261|FG002|Overall Study|Lost to Follow-up|1|||
156991860|NCT04736056|566721262|FG003|Overall Study|Lost to Follow-up|1|||
156991861|NCT04736056|566721259|FG000|Overall Study|Withdrawal by Subject|2|||
156991862|NCT04736056|566721260|FG001|Overall Study|Withdrawal by Subject|0|||
156991863|NCT04736056|566721261|FG002|Overall Study|Withdrawal by Subject|0|||
156991864|NCT04736056|566721262|FG003|Overall Study|Withdrawal by Subject|0|||
156991865|NCT04736056|566721259|FG000|Overall Study|Physician Decision|1|||
156991866|NCT04736056|566721260|FG001|Overall Study|Physician Decision|0|||
156991867|NCT04736056|566721261|FG002|Overall Study|Physician Decision|1|||
156991868|NCT04736056|566721262|FG003|Overall Study|Physician Decision|0|||
156991869|NCT04529538|566721263|FG000|Overall Study|Lost to Follow-up|3|||
156991870|NCT04529538|566721264|FG001|Overall Study|Lost to Follow-up|2|||
156991871|NCT04529538|566721265|FG002|Overall Study|Lost to Follow-up|1|||
156991872|NCT04529538|566721266|FG003|Overall Study|Lost to Follow-up|0|||
156991873|NCT04529538|566721267|FG004|Overall Study|Lost to Follow-up|1|||
156991874|NCT04529538|566721268|FG005|Overall Study|Lost to Follow-up|1|||
156991875|NCT04529538|566721269|FG006|Overall Study|Lost to Follow-up|2|||
156991876|NCT04529538|566721270|FG007|Overall Study|Lost to Follow-up|0|||
156991877|NCT04529538|566721263|FG000|Overall Study|Not eligible at enrollment|0|||
156991878|NCT04529538|566721264|FG001|Overall Study|Not eligible at enrollment|1|||
156991879|NCT04529538|566721265|FG002|Overall Study|Not eligible at enrollment|2|||
156991880|NCT04529538|566721266|FG003|Overall Study|Not eligible at enrollment|1|||
156991881|NCT04529538|566721267|FG004|Overall Study|Not eligible at enrollment|0|||
156991882|NCT04529538|566721268|FG005|Overall Study|Not eligible at enrollment|0|||
156991883|NCT04529538|566721269|FG006|Overall Study|Not eligible at enrollment|0|||
156991884|NCT04529538|566721270|FG007|Overall Study|Not eligible at enrollment|1|||
156991885|NCT04529538|566721263|FG000|Overall Study|Withdrawal by Subject|0|||
156991886|NCT04529538|566721264|FG001|Overall Study|Withdrawal by Subject|1|||
156991887|NCT04529538|566721265|FG002|Overall Study|Withdrawal by Subject|1|||
156991888|NCT04529538|566721266|FG003|Overall Study|Withdrawal by Subject|2|||
156991889|NCT04529538|566721267|FG004|Overall Study|Withdrawal by Subject|0|||
156991890|NCT04529538|566721268|FG005|Overall Study|Withdrawal by Subject|2|||
156991891|NCT04529538|566721269|FG006|Overall Study|Withdrawal by Subject|3|||
156991892|NCT04529538|566721270|FG007|Overall Study|Withdrawal by Subject|0|||
156991893|NCT04529538|566721263|FG000|Overall Study|Other|0|||
156991894|NCT04529538|566721264|FG001|Overall Study|Other|1|||
156991895|NCT04529538|566721265|FG002|Overall Study|Other|0|||
156991896|NCT04529538|566721266|FG003|Overall Study|Other|0|||
156991897|NCT04529538|566721267|FG004|Overall Study|Other|0|||
156991898|NCT04529538|566721268|FG005|Overall Study|Other|0|||
156991899|NCT04529538|566721269|FG006|Overall Study|Other|0|||
156991900|NCT04529538|566721270|FG007|Overall Study|Other|0|||
156991901|NCT04529538|566721263|FG000|Overall Study|Adverse Event|0|||
156991902|NCT04529538|566721264|FG001|Overall Study|Adverse Event|0|||
156991903|NCT04529538|566721265|FG002|Overall Study|Adverse Event|0|||
156991904|NCT04529538|566721266|FG003|Overall Study|Adverse Event|1|||
156991905|NCT04529538|566721267|FG004|Overall Study|Adverse Event|0|||
156991906|NCT04529538|566721268|FG005|Overall Study|Adverse Event|0|||
156991907|NCT04529538|566721269|FG006|Overall Study|Adverse Event|0|||
156991908|NCT04529538|566721270|FG007|Overall Study|Adverse Event|0|||
156991909|NCT04529538|566721263|FG000|Overall Study|Protocol Deviation|0|||
156991910|NCT04529538|566721264|FG001|Overall Study|Protocol Deviation|0|||
156991911|NCT04529538|566721265|FG002|Overall Study|Protocol Deviation|0|||
156991912|NCT04529538|566721266|FG003|Overall Study|Protocol Deviation|1|||
157097112|NCT03285178|567110944|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
156991913|NCT04529538|566721267|FG004|Overall Study|Protocol Deviation|0|||
156991914|NCT04529538|566721268|FG005|Overall Study|Protocol Deviation|0|||
156991915|NCT04529538|566721269|FG006|Overall Study|Protocol Deviation|0|||
156991916|NCT04529538|566721270|FG007|Overall Study|Protocol Deviation|0|||
156991917|NCT04529538|566721263|FG000|Overall Study|Physician Decision|0|||
156991918|NCT04529538|566721264|FG001|Overall Study|Physician Decision|0|||
156991919|NCT04529538|566721265|FG002|Overall Study|Physician Decision|0|||
156991920|NCT04529538|566721266|FG003|Overall Study|Physician Decision|0|||
156991921|NCT04529538|566721267|FG004|Overall Study|Physician Decision|0|||
156991922|NCT04529538|566721268|FG005|Overall Study|Physician Decision|1|||
156991923|NCT04529538|566721269|FG006|Overall Study|Physician Decision|0|||
156991924|NCT04529538|566721270|FG007|Overall Study|Physician Decision|1|||
156991925|NCT00114959|566721274|FG000|Overall Study|Lack of Efficacy|6|||
156991926|NCT00114959|566721274|FG000|Overall Study|Physician Decision|1|||
156991927|NCT00114959|566721274|FG000|Overall Study|Death|1|||
156991928|NCT03706690|566721275|FG000|Overall Study|Withdrawal by Subject|8|||
156991929|NCT03706690|566721276|FG001|Overall Study|Withdrawal by Subject|8|||
156991930|NCT03706690|566721275|FG000|Overall Study|Death|143|||
156991931|NCT03706690|566721276|FG001|Overall Study|Death|75|||
156991932|NCT03706690|566721275|FG000|Overall Study|Ongoing at DCO|121|||
156991933|NCT03706690|566721276|FG001|Overall Study|Ongoing at DCO|52|||
156991934|NCT00665561|566721284|FG000|Overall Study|Death recorded on subject summary pages|75|||
156991935|NCT00665561|566721285|FG001|Overall Study|Death recorded on subject summary pages|75|||
156991936|NCT00665561|566721284|FG000|Overall Study|Does not meet entrance criteria|19|||
156991937|NCT00665561|566721285|FG001|Overall Study|Does not meet entrance criteria|21|||
156991938|NCT00665561|566721284|FG000|Overall Study|Lost to Follow-up|203|||
156991939|NCT00665561|566721285|FG001|Overall Study|Lost to Follow-up|264|||
156991940|NCT00665561|566721284|FG000|Overall Study|Withdrawal by Subject|74|||
156991941|NCT00665561|566721285|FG001|Overall Study|Withdrawal by Subject|65|||
156991942|NCT00665561|566721284|FG000|Overall Study|Other|123|||
156991943|NCT00665561|566721285|FG001|Overall Study|Other|108|||
156991944|NCT00665561|566721284|FG000|Overall Study|Site closed|8|||
156991945|NCT00665561|566721285|FG001|Overall Study|Site closed|0|||
156991946|NCT00665561|566721284|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156991947|NCT00665561|566721285|FG001|Overall Study|Withdrawn due to pregnancy|1|||
156991948|NCT02263885|566722641|FG000|Overall Study|Withdrawal by Subject|7|||
156991949|NCT02263885|566722641|FG000|Overall Study|Alternative Treatment|3|||
156991950|NCT00003377|566722644|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
156991951|NCT00003377|566722645|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
156991952|NCT00003377|566722646|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
156991953|NCT00003377|566722647|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
156991954|NCT00003377|566722648|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
156991955|NCT00003377|566722644|FG000|Period II|Ureteral stent complications|0|||
156991956|NCT00003377|566722645|FG001|Period II|Ureteral stent complications|0|||
156991957|NCT00003377|566722646|FG002|Period II|Ureteral stent complications|0|||
156991958|NCT00003377|566722647|FG003|Period II|Ureteral stent complications|0|||
156991959|NCT00003377|566722648|FG004|Period II|Ureteral stent complications|1|||
156991960|NCT00480441|566722652|FG000|Screening|Not Eligible|37|||
156991961|NCT00480441|566722653|FG001|Screening|Not Eligible|0|||
156991962|NCT00480441|566722654|FG002|Screening|Not Eligible|0|||
156991963|NCT00480441|566722652|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
156991964|NCT00480441|566722653|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
156991965|NCT00480441|566722654|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
156991966|NCT00480441|566722652|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
156991967|NCT00480441|566722653|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
156991968|NCT00480441|566722654|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
156991969|NCT00480441|566722652|FG000|Baseline Functional MRI|physical contraindication|4|||
156991970|NCT00480441|566722653|FG001|Baseline Functional MRI|physical contraindication|0|||
156991971|NCT00480441|566722654|FG002|Baseline Functional MRI|physical contraindication|0|||
156991972|NCT00480441|566722652|FG000|Randomization|Lost to Follow-up|0|||
156991973|NCT00480441|566722653|FG001|Randomization|Lost to Follow-up|7|||
156991974|NCT00480441|566722654|FG002|Randomization|Lost to Follow-up|2|||
156991975|NCT03532178|566722655|FG000|First Period|Withdrawal by Subject|1|||
156991976|NCT03532178|566722656|FG001|First Period|Withdrawal by Subject|3|||
156991977|NCT03532178|566722655|FG000|First Period|technical issues in data collection Technical issues|0|||
156991978|NCT03532178|566722656|FG001|First Period|technical issues in data collection Technical issues|1|||
156991979|NCT03532178|566722655|FG000|Second Period|Withdrawal by Subject|1|||
156991980|NCT03532178|566722656|FG001|Second Period|Withdrawal by Subject|1|||
156991981|NCT03532178|566722655|FG000|Second Period|Technical issues|0|||
156991982|NCT03532178|566722656|FG001|Second Period|Technical issues|1|||
156991983|NCT01113463|566722660|FG000|Overall Study|Physician Decision|5|||
157097113|NCT03285178|567110945|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
156991984|NCT00372528|566722661|FG000|Overall Study|Lack of Efficacy|1|||
156991985|NCT00372528|566722661|FG000|Overall Study|Adverse Event|1|||
156991986|NCT00372528|566722661|FG000|Overall Study|Study Terminated by Sponsor|18|||
156991987|NCT00372528|566722661|FG000|Overall Study|Other|1|||
156991988|NCT01417000|566722662|FG000|Overall Study|Death|59|||
156991989|NCT01417000|566722663|FG001|Overall Study|Death|28|||
156991990|NCT01417000|566722662|FG000|Overall Study|Lost to Follow-up|1|||
156991991|NCT01417000|566722663|FG001|Overall Study|Lost to Follow-up|0|||
156991992|NCT01417000|566722662|FG000|Overall Study|Study Terminated by Sponsor|1|||
156991993|NCT01417000|566722663|FG001|Overall Study|Study Terminated by Sponsor|1|||
156991994|NCT00562965|566722664|FG000|Overall Study|Withdrawal by Subject|0|||
156991995|NCT00562965|566722665|FG001|Overall Study|Withdrawal by Subject|1|||
156991996|NCT00562965|566722664|FG000|Overall Study|Death|2|||
156991997|NCT00562965|566722665|FG001|Overall Study|Death|4|||
156991998|NCT00562965|566722664|FG000|Overall Study|Lost to Follow-up|1|||
156991999|NCT00562965|566722665|FG001|Overall Study|Lost to Follow-up|0|||
156992000|NCT00562965|566722664|FG000|Overall Study|Other|0|||
156992001|NCT00562965|566722665|FG001|Overall Study|Other|1|||
156992002|NCT00761774|566722666|FG000|Overall Study|Adverse Event|17|||
156992003|NCT00761774|566722666|FG000|Overall Study|Lack of Efficacy|37|||
156992004|NCT00761774|566722666|FG000|Overall Study|Lost to Follow-up|2|||
156992005|NCT00761774|566722666|FG000|Overall Study|Withdrawal by Subject|9|||
156992006|NCT00761774|566722666|FG000|Overall Study|Non-compliance|4|||
156992007|NCT00761774|566722666|FG000|Overall Study|End of study|2|||
156992008|NCT00761774|566722666|FG000|Overall Study|Reclassification of seizures|1|||
156992009|NCT00761774|566722666|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
156992010|NCT00761774|566722666|FG000|Overall Study|Sponsor decision|1|||
156992011|NCT00761774|566722666|FG000|Overall Study|Investigator clinical judgement|1|||
156992012|NCT00761774|566722666|FG000|Overall Study|Patient moved out of study area|1|||
156992013|NCT00761774|566722666|FG000|Overall Study|Coordinator leaving site|1|||
156992014|NCT00761774|566722666|FG000|Overall Study|Subject IP non-compliance|1|||
156992015|NCT00761774|566722666|FG000|Overall Study|IP stopped by hospital physician|1|||
156992016|NCT00965484|566722667|FG000|Overall Study|Protocol Violation|1|||
156992017|NCT00965484|566722667|FG000|Overall Study|Withdrawal by Subject|1|||
156992018|NCT01124617|566722668|FG000|Overall Study|Adverse Event|5|||
156992019|NCT01124617|566722669|FG001|Overall Study|Adverse Event|2|||
156992020|NCT01124617|566722668|FG000|Overall Study|Lack of Efficacy|2|||
156992021|NCT01124617|566722669|FG001|Overall Study|Lack of Efficacy|1|||
156992022|NCT01124617|566722668|FG000|Overall Study|Protocol Violation|1|||
156992023|NCT01124617|566722669|FG001|Overall Study|Protocol Violation|1|||
156992024|NCT01124617|566722668|FG000|Overall Study|Withdrawal by Subject|9|||
156992025|NCT01124617|566722669|FG001|Overall Study|Withdrawal by Subject|1|||
156992026|NCT01124617|566722668|FG000|Overall Study|Other|2|||
156992027|NCT01124617|566722669|FG001|Overall Study|Other|1|||
156992028|NCT00994279|566722675|FG000|Overall Study|Withdrawal by Subject|2|||
156992029|NCT00994279|566722676|FG001|Overall Study|Withdrawal by Subject|2|||
156992030|NCT00994279|566722675|FG000|Overall Study|Toxicity|1|||
156992031|NCT00994279|566722676|FG001|Overall Study|Toxicity|0|||
156992032|NCT00994279|566722675|FG000|Overall Study|Multiple reasons|1|||
156992033|NCT00994279|566722676|FG001|Overall Study|Multiple reasons|3|||
156992034|NCT00783718|566722677|FG000|Induction Phase|Adverse Event|4|||
156992035|NCT00783718|566722678|FG001|Induction Phase|Adverse Event|0|||
156992036|NCT00783718|566722679|FG002|Induction Phase|Adverse Event|7|||
156992037|NCT00783718|566722680|FG003|Induction Phase|Adverse Event|0|||
156992038|NCT00783718|566722681|FG004|Induction Phase|Adverse Event|0|||
156992039|NCT00783718|566722682|FG005|Induction Phase|Adverse Event|0|||
156992040|NCT00783718|566722683|FG006|Induction Phase|Adverse Event|0|||
156992041|NCT00783718|566722677|FG000|Induction Phase|Protocol Violation|1|||
156992042|NCT00783718|566722678|FG001|Induction Phase|Protocol Violation|1|||
156992043|NCT00783718|566722679|FG002|Induction Phase|Protocol Violation|6|||
156992044|NCT00783718|566722680|FG003|Induction Phase|Protocol Violation|0|||
156992045|NCT00783718|566722681|FG004|Induction Phase|Protocol Violation|0|||
156992046|NCT00783718|566722682|FG005|Induction Phase|Protocol Violation|0|||
156992047|NCT00783718|566722683|FG006|Induction Phase|Protocol Violation|0|||
156992048|NCT00783718|566722677|FG000|Induction Phase|Lack of Efficacy|5|||
156992049|NCT00783718|566722678|FG001|Induction Phase|Lack of Efficacy|2|||
156992050|NCT00783718|566722679|FG002|Induction Phase|Lack of Efficacy|14|||
156992051|NCT00783718|566722680|FG003|Induction Phase|Lack of Efficacy|0|||
156992052|NCT00783718|566722681|FG004|Induction Phase|Lack of Efficacy|0|||
156992053|NCT00783718|566722682|FG005|Induction Phase|Lack of Efficacy|0|||
156992054|NCT00783718|566722683|FG006|Induction Phase|Lack of Efficacy|0|||
156992055|NCT00783718|566722677|FG000|Induction Phase|Withdrawal by Subject|3|||
156992056|NCT00783718|566722678|FG001|Induction Phase|Withdrawal by Subject|4|||
156992057|NCT00783718|566722679|FG002|Induction Phase|Withdrawal by Subject|8|||
156992058|NCT00783718|566722680|FG003|Induction Phase|Withdrawal by Subject|0|||
156992059|NCT00783718|566722681|FG004|Induction Phase|Withdrawal by Subject|0|||
156992060|NCT00783718|566722682|FG005|Induction Phase|Withdrawal by Subject|0|||
156992061|NCT00783718|566722683|FG006|Induction Phase|Withdrawal by Subject|0|||
156992062|NCT00783718|566722677|FG000|Induction Phase|Lost to Follow-up|1|||
156992063|NCT00783718|566722678|FG001|Induction Phase|Lost to Follow-up|0|||
156992064|NCT00783718|566722679|FG002|Induction Phase|Lost to Follow-up|1|||
156992065|NCT00783718|566722680|FG003|Induction Phase|Lost to Follow-up|0|||
156992066|NCT00783718|566722681|FG004|Induction Phase|Lost to Follow-up|0|||
156992067|NCT00783718|566722682|FG005|Induction Phase|Lost to Follow-up|0|||
156992068|NCT00783718|566722683|FG006|Induction Phase|Lost to Follow-up|0|||
156992069|NCT00783718|566722677|FG000|Maintenance Phase|Adverse Event|12|||
156992070|NCT00783718|566722678|FG001|Maintenance Phase|Adverse Event|0|||
157097114|NCT03285178|567110946|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
156992071|NCT00783718|566722679|FG002|Maintenance Phase|Adverse Event|0|||
156992072|NCT00783718|566722680|FG003|Maintenance Phase|Adverse Event|15|||
156992073|NCT00783718|566722681|FG004|Maintenance Phase|Adverse Event|7|||
156992074|NCT00783718|566722682|FG005|Maintenance Phase|Adverse Event|6|||
156992075|NCT00783718|566722683|FG006|Maintenance Phase|Adverse Event|16|||
157097115|NCT03285178|567110947|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
156992076|NCT00783718|566722677|FG000|Maintenance Phase|Protocol Violation|1|||
156992077|NCT00783718|566722678|FG001|Maintenance Phase|Protocol Violation|0|||
156992078|NCT00783718|566722679|FG002|Maintenance Phase|Protocol Violation|0|||
156992079|NCT00783718|566722680|FG003|Maintenance Phase|Protocol Violation|0|||
156992080|NCT00783718|566722681|FG004|Maintenance Phase|Protocol Violation|0|||
156992081|NCT00783718|566722682|FG005|Maintenance Phase|Protocol Violation|0|||
156992082|NCT00783718|566722683|FG006|Maintenance Phase|Protocol Violation|2|||
156992083|NCT00783718|566722677|FG000|Maintenance Phase|Lack of Efficacy|83|||
156992084|NCT00783718|566722678|FG001|Maintenance Phase|Lack of Efficacy|0|||
156992085|NCT00783718|566722679|FG002|Maintenance Phase|Lack of Efficacy|0|||
156992086|NCT00783718|566722680|FG003|Maintenance Phase|Lack of Efficacy|61|||
156992087|NCT00783718|566722681|FG004|Maintenance Phase|Lack of Efficacy|31|||
156992088|NCT00783718|566722682|FG005|Maintenance Phase|Lack of Efficacy|33|||
156992089|NCT00783718|566722683|FG006|Maintenance Phase|Lack of Efficacy|155|||
156992090|NCT00783718|566722677|FG000|Maintenance Phase|Withdrawal by Subject|6|||
156992091|NCT00783718|566722678|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156992092|NCT00783718|566722679|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156992093|NCT00783718|566722680|FG003|Maintenance Phase|Withdrawal by Subject|2|||
156992094|NCT00783718|566722681|FG004|Maintenance Phase|Withdrawal by Subject|5|||
156992095|NCT00783718|566722682|FG005|Maintenance Phase|Withdrawal by Subject|2|||
156992096|NCT00783718|566722683|FG006|Maintenance Phase|Withdrawal by Subject|20|||
156992097|NCT00783718|566722677|FG000|Maintenance Phase|Lost to Follow-up|3|||
156992098|NCT00783718|566722678|FG001|Maintenance Phase|Lost to Follow-up|0|||
156992099|NCT00783718|566722679|FG002|Maintenance Phase|Lost to Follow-up|0|||
156992100|NCT00783718|566722680|FG003|Maintenance Phase|Lost to Follow-up|0|||
156992101|NCT00783718|566722681|FG004|Maintenance Phase|Lost to Follow-up|2|||
156992102|NCT00783718|566722682|FG005|Maintenance Phase|Lost to Follow-up|0|||
156992103|NCT00783718|566722683|FG006|Maintenance Phase|Lost to Follow-up|2|||
156992104|NCT00630539|566722684|FG000|Overall Study|Adverse Event|1|||
156992105|NCT00630539|566722685|FG001|Overall Study|Adverse Event|3|||
156992106|NCT00630539|566722686|FG002|Overall Study|Adverse Event|1|||
156992107|NCT00630539|566722687|FG003|Overall Study|Adverse Event|2|||
156992108|NCT00630539|566722684|FG000|Overall Study|Withdrawal by Subject|0|||
156992109|NCT00630539|566722685|FG001|Overall Study|Withdrawal by Subject|1|||
156992110|NCT00630539|566722686|FG002|Overall Study|Withdrawal by Subject|0|||
156992111|NCT00630539|566722687|FG003|Overall Study|Withdrawal by Subject|1|||
156992112|NCT01700530|566722690|FG000|Overall Study|Withdrawal by Subject|0|||
156992113|NCT01700530|566722691|FG001|Overall Study|Withdrawal by Subject|3|||
156992114|NCT01700530|566722692|FG002|Overall Study|Withdrawal by Subject|1|||
156992115|NCT00578227|566722695|FG000|Overall Study|Lost to Follow-up|0|||
156992116|NCT00578227|566722696|FG001|Overall Study|Lost to Follow-up|1|||
156992117|NCT00578227|566722697|FG002|Overall Study|Lost to Follow-up|1|||
156992118|NCT00578227|566722695|FG000|Overall Study|Withdrawal by Subject|5|||
156992119|NCT00578227|566722696|FG001|Overall Study|Withdrawal by Subject|1|||
156992120|NCT00578227|566722697|FG002|Overall Study|Withdrawal by Subject|3|||
156992121|NCT00916006|566722706|FG000|Overall Study|Adverse Event|1|||
156992122|NCT00916006|566722707|FG001|Overall Study|Adverse Event|1|||
156992123|NCT00916006|566722706|FG000|Overall Study|Withdrawal by Subject|2|||
156992124|NCT00916006|566722707|FG001|Overall Study|Withdrawal by Subject|5|||
156992125|NCT00916006|566722706|FG000|Overall Study|Protocol Violation|0|||
156992126|NCT00916006|566722707|FG001|Overall Study|Protocol Violation|1|||
156992127|NCT01605136|566722712|FG000|Study Period|Withdrawal by Subject|2|||
156992128|NCT01605136|566722713|FG001|Study Period|Withdrawal by Subject|0|||
156992129|NCT01605136|566722712|FG000|Study Period|Physician Decision|1|||
156992130|NCT01605136|566722713|FG001|Study Period|Physician Decision|1|||
156992131|NCT01605136|566722712|FG000|Study Period|Lost to Follow-up|0|||
156992132|NCT01605136|566722713|FG001|Study Period|Lost to Follow-up|2|||
156992133|NCT01605136|566722712|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
156992134|NCT01605136|566722713|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
156992135|NCT02929108|566722714|FG000|Overall Study|Hospice patient death|100|||
156992136|NCT02929108|566722715|FG001|Overall Study|Hospice patient death|64|||
156992137|NCT02929108|566722716|FG002|Overall Study|Hospice patient death|28|||
156992138|NCT02929108|566722717|FG003|Overall Study|Hospice patient death|46|||
156992139|NCT02929108|566722718|FG004|Overall Study|Hospice patient death|55|||
156992140|NCT02929108|566722719|FG005|Overall Study|Hospice patient death|28|||
156992141|NCT02929108|566722720|FG006|Overall Study|Hospice patient death|78|||
156992142|NCT00052962|566722721|FG000|Overall Study|Not evaluable|0|||
156992143|NCT00052962|566722722|FG001|Overall Study|Not evaluable|2|||
156992144|NCT00052962|566722721|FG000|Overall Study|Not randomized/not evaluable|1|||
156992145|NCT00052962|566722722|FG001|Overall Study|Not randomized/not evaluable|0|||
156992146|NCT01414166|566722723|FG000|Overall Study|Adverse Event|10|||
156992147|NCT01414166|566722724|FG001|Overall Study|Adverse Event|2|||
156992148|NCT01414166|566722723|FG000|Overall Study|Lost to Follow-up|4|||
156992149|NCT01414166|566722724|FG001|Overall Study|Lost to Follow-up|1|||
156992150|NCT01414166|566722723|FG000|Overall Study|Non-compliance with study drug|2|||
156992151|NCT01414166|566722724|FG001|Overall Study|Non-compliance with study drug|0|||
156992152|NCT01414166|566722723|FG000|Overall Study|Physician Decision|2|||
156992153|NCT01414166|566722724|FG001|Overall Study|Physician Decision|0|||
156992154|NCT01414166|566722723|FG000|Overall Study|Protocol Violation|2|||
156992155|NCT01414166|566722724|FG001|Overall Study|Protocol Violation|0|||
156992156|NCT01414166|566722723|FG000|Overall Study|Study terminated by Sponsor|68|||
156992157|NCT01414166|566722724|FG001|Overall Study|Study terminated by Sponsor|75|||
156992158|NCT01414166|566722723|FG000|Overall Study|Withdrawal by Subject|3|||
156992159|NCT01414166|566722724|FG001|Overall Study|Withdrawal by Subject|5|||
156992160|NCT05489224|566722725|FG000|Treatment Period I|Withdrawal by Subject|6|||
156992161|NCT05489224|566722726|FG001|Treatment Period I|Withdrawal by Subject|5|||
156992162|NCT05489224|566722727|FG002|Treatment Period I|Withdrawal by Subject|0|||
156992163|NCT05489224|566722725|FG000|Treatment Period I|Adverse Event|3|||
156992164|NCT05489224|566722726|FG001|Treatment Period I|Adverse Event|11|||
156992165|NCT05489224|566722727|FG002|Treatment Period I|Adverse Event|0|||
156992166|NCT05489224|566722725|FG000|Treatment Period I|Lost to Follow-up|0|||
156992167|NCT05489224|566722726|FG001|Treatment Period I|Lost to Follow-up|1|||
156992168|NCT05489224|566722727|FG002|Treatment Period I|Lost to Follow-up|0|||
156992169|NCT05489224|566722725|FG000|Treatment Period I|Physician Decision|0|||
156992170|NCT05489224|566722726|FG001|Treatment Period I|Physician Decision|1|||
156992171|NCT05489224|566722727|FG002|Treatment Period I|Physician Decision|0|||
156992172|NCT05489224|566722725|FG000|Treatment Period II up to Week 32|Ongoing|222|||
156992173|NCT05489224|566722726|FG001|Treatment Period II up to Week 32|Ongoing|107|||
156992174|NCT05489224|566722727|FG002|Treatment Period II up to Week 32|Ongoing|107|||
156992175|NCT05489224|566722725|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
156992176|NCT05489224|566722726|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
156992177|NCT05489224|566722727|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
156992178|NCT05489224|566722725|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
156992179|NCT05489224|566722726|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
156992180|NCT05489224|566722727|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
156992181|NCT03008122|566722736|FG000|Overall Study|Physician Decision|3|||
156992182|NCT03008122|566722737|FG001|Overall Study|Physician Decision|2|||
156992183|NCT03008122|566722738|FG002|Overall Study|Physician Decision|0|||
156992184|NCT03008122|566722736|FG000|Overall Study|Withdrawal by Subject|1|||
156992185|NCT03008122|566722737|FG001|Overall Study|Withdrawal by Subject|3|||
156992186|NCT03008122|566722738|FG002|Overall Study|Withdrawal by Subject|0|||
156992187|NCT03008122|566722736|FG000|Overall Study|Lost to Follow-up|4|||
157097116|NCT03285178|567110948|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
157097117|NCT03285178|567110949|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
157097118|NCT03285178|567110950|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
157097119|NCT03285178|567110944|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
157097120|NCT03285178|567110945|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097121|NCT03285178|567110946|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097122|NCT03285178|567110947|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097123|NCT03285178|567110948|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097124|NCT03285178|567110949|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097125|NCT03285178|567110950|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
157097126|NCT03285178|567110944|FG000|Single-Blind Run-In Period|Physician Decision|2|||
157097127|NCT03285178|567110945|FG001|Single-Blind Run-In Period|Physician Decision|0|||
157097128|NCT03285178|567110946|FG002|Single-Blind Run-In Period|Physician Decision|0|||
157097129|NCT03285178|567110947|FG003|Single-Blind Run-In Period|Physician Decision|0|||
157097130|NCT03285178|567110948|FG004|Single-Blind Run-In Period|Physician Decision|0|||
157097131|NCT03285178|567110949|FG005|Single-Blind Run-In Period|Physician Decision|0|||
157097132|NCT03285178|567110950|FG006|Single-Blind Run-In Period|Physician Decision|0|||
157097133|NCT03285178|567110944|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
157097134|NCT03285178|567110945|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
157097135|NCT03285178|567110946|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
157097136|NCT03285178|567110947|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
157097137|NCT03285178|567110948|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
157097138|NCT03285178|567110949|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
157097139|NCT03285178|567110950|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
157097140|NCT03285178|567110944|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157097141|NCT03285178|567110945|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156992188|NCT03008122|566722737|FG001|Overall Study|Lost to Follow-up|8|||
156992189|NCT03008122|566722738|FG002|Overall Study|Lost to Follow-up|3|||
156992190|NCT03008122|566722736|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
156992191|NCT03008122|566722737|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156992192|NCT03008122|566722738|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156992193|NCT03008122|566722736|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
156992194|NCT03008122|566722737|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
156992195|NCT03008122|566722738|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
156992196|NCT03008122|566722736|FG000|Overall Study|Death|0|||
156992197|NCT03008122|566722737|FG001|Overall Study|Death|0|||
156992198|NCT03008122|566722738|FG002|Overall Study|Death|1|||
156992199|NCT01222247|566722740|FG000|Overall Study|Lost to Follow-up|2|||
156992200|NCT01222247|566722741|FG001|Overall Study|Lost to Follow-up|2|||
156992201|NCT02084082|566722742|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
156992202|NCT02084082|566722743|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
156992203|NCT02084082|566722744|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
156992204|NCT02084082|566722745|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
156992205|NCT02084082|566722742|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156992206|NCT02084082|566722743|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156992207|NCT02084082|566722744|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
156992208|NCT02084082|566722745|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
156992209|NCT03212365|566722749|FG000|Overall Study|Discharged prior to Xa level|12|||
156992210|NCT03212365|566722750|FG001|Overall Study|Discharged prior to Xa level|8|||
156992211|NCT03212365|566722749|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
156992212|NCT03212365|566722750|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
156992213|NCT03212365|566722749|FG000|Overall Study|Refused study medication|3|||
156992214|NCT03212365|566722750|FG001|Overall Study|Refused study medication|0|||
156992215|NCT03212365|566722749|FG000|Overall Study|Initiated heparin infusion on floor|1|||
156992216|NCT03212365|566722750|FG001|Overall Study|Initiated heparin infusion on floor|1|||
156992217|NCT03212365|566722749|FG000|Overall Study|Unexpected return to OR|1|||
156992218|NCT03212365|566722750|FG001|Overall Study|Unexpected return to OR|1|||
156992219|NCT03212365|566722749|FG000|Overall Study|Medication distribution error|1|||
156992220|NCT03212365|566722750|FG001|Overall Study|Medication distribution error|0|||
156992221|NCT03212365|566722749|FG000|Overall Study|Required epidural placement|1|||
156992222|NCT03212365|566722750|FG001|Overall Study|Required epidural placement|0|||
156992223|NCT03212365|566722749|FG000|Overall Study|Withdrawal by Subject|0|||
156992224|NCT03212365|566722750|FG001|Overall Study|Withdrawal by Subject|1|||
156992225|NCT03212365|566722749|FG000|Overall Study|developed acute renal failure|0|||
156992226|NCT03212365|566722750|FG001|Overall Study|developed acute renal failure|1|||
156992227|NCT02337361|566722751|FG000|3-month Follow-up|Lost to Follow-up|19|||
156992228|NCT02337361|566722752|FG001|3-month Follow-up|Lost to Follow-up|14|||
156992229|NCT02337361|566722751|FG000|6-month Follow-up|Lost to Follow-up|2|||
156992230|NCT02337361|566722752|FG001|6-month Follow-up|Lost to Follow-up|4|||
156992231|NCT01354106|566722755|FG000|Overall Study|Withdrawal by Subject|2|||
156992232|NCT00901485|566722756|FG000|Overall Study|Lack of Efficacy|0|||
156992233|NCT00901485|566722757|FG001|Overall Study|Lack of Efficacy|2|||
156992234|NCT00901485|566722756|FG000|Overall Study|Withdrawal by Subject|1|||
156992235|NCT00901485|566722757|FG001|Overall Study|Withdrawal by Subject|2|||
156992236|NCT01871285|566722758|FG000|First Intervention (1 Day)|Adverse Event|1|||
156992237|NCT01871285|566722759|FG001|First Intervention (1 Day)|Adverse Event|0|||
156992238|NCT01871285|566722760|FG002|First Intervention (1 Day)|Adverse Event|0|||
156992239|NCT01871285|566722761|FG003|First Intervention (1 Day)|Adverse Event|0|||
156992240|NCT01871285|566722758|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
156992241|NCT01871285|566722759|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
156992242|NCT01871285|566722760|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
156992243|NCT01871285|566722761|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
156992244|NCT05397470|566722762|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
156992245|NCT05397470|566722763|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
156992246|NCT05397470|566722764|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
156992247|NCT05397470|566722762|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
156992248|NCT05397470|566722763|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
156992249|NCT05397470|566722764|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
156992250|NCT05397470|566722762|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
156992251|NCT05397470|566722763|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
156992252|NCT05397470|566722764|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
156992253|NCT05397470|566722762|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
156992254|NCT05397470|566722763|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
156992255|NCT05397470|566722764|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
156992256|NCT05397470|566722762|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
156992257|NCT05397470|566722763|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
156992258|NCT05397470|566722764|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
156992259|NCT05397470|566722762|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
156992260|NCT05397470|566722763|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
156992261|NCT05397470|566722764|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
156992262|NCT05397470|566722762|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
156992263|NCT05397470|566722763|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
156992264|NCT05397470|566722764|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
156992265|NCT03015740|566722765|FG000|Overall Study|Adverse Event|1|||
156992266|NCT03015740|566722766|FG001|Overall Study|Adverse Event|0|||
156992267|NCT03015740|566722767|FG002|Overall Study|Adverse Event|0|||
156992268|NCT03015740|566722765|FG000|Overall Study|Death|3|||
156992269|NCT03015740|566722766|FG001|Overall Study|Death|5|||
156992270|NCT03015740|566722767|FG002|Overall Study|Death|0|||
156992271|NCT03015740|566722765|FG000|Overall Study|Withdrawal by Subject|2|||
156992272|NCT03015740|566722766|FG001|Overall Study|Withdrawal by Subject|0|||
156992273|NCT03015740|566722767|FG002|Overall Study|Withdrawal by Subject|0|||
156992274|NCT03253653|566722768|FG000|Overall Study|Withdrawal by Subject|4|||
156992275|NCT03253653|566722769|FG001|Overall Study|Withdrawal by Subject|1|||
156992276|NCT03253653|566722768|FG000|Overall Study|Protocol Violation|0|||
156992277|NCT03253653|566722769|FG001|Overall Study|Protocol Violation|5|||
156992278|NCT00079937|566724985|FG000|Overall Study|Adverse Event|2|||
156992279|NCT00079937|566724986|FG001|Overall Study|Adverse Event|1|||
156992280|NCT00079937|566724985|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156992281|NCT00079937|566724986|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156992282|NCT00079937|566724985|FG000|Overall Study|Subject no longer requires study drug|3|||
156992283|NCT00079937|566724986|FG001|Overall Study|Subject no longer requires study drug|0|||
156992284|NCT00079937|566724985|FG000|Overall Study|Protocol Violation|8|||
156992285|NCT00079937|566724986|FG001|Overall Study|Protocol Violation|6|||
156992286|NCT00079937|566724985|FG000|Overall Study|Withdrawal by Subject|21|||
156992287|NCT00079937|566724986|FG001|Overall Study|Withdrawal by Subject|7|||
156992288|NCT00079937|566724985|FG000|Overall Study|Lost to Follow-up|12|||
156992289|NCT00079937|566724986|FG001|Overall Study|Lost to Follow-up|5|||
156992290|NCT00079937|566724985|FG000|Overall Study|Administrative problems|22|||
156992291|NCT00079937|566724986|FG001|Overall Study|Administrative problems|11|||
156992292|NCT02857283|566724987|FG000|First Exposure|Withdrawal by Subject|1|||
156992293|NCT02857283|566724988|FG001|First Exposure|Withdrawal by Subject|0|||
156992294|NCT00093795|566724989|FG000|Overall Study|No follow up data|20|||
156992295|NCT00093795|566724990|FG001|Overall Study|No follow up data|16|||
156992296|NCT00093795|566724991|FG002|Overall Study|No follow up data|17|||
156992297|NCT00940017|566724992|FG000|Overall Study|did not meet entrance criteria|3|||
156992298|NCT00940017|566724992|FG000|Overall Study|Adverse Event|1|||
156992299|NCT00569946|566724993|FG000|Overall Study|Adverse Event|16|||
156992300|NCT00569946|566724993|FG000|Overall Study|Objective Progression or Relapse|42|||
156992301|NCT00569946|566724993|FG000|Overall Study|Global Deterioration of Health Status|1|||
156992302|NCT01684046|566724994|FG000|Period 1, First 30 Days|Adverse Event|0|||
156992303|NCT01684046|566724995|FG001|Period 1, First 30 Days|Adverse Event|2|||
156992304|NCT00852475|566724999|FG000|Overall Study|Lost to Follow-up|3|||
156992305|NCT00852475|566725000|FG001|Overall Study|Lost to Follow-up|4|||
156992306|NCT00946114|566725001|FG000|Overall Study|Death|5|||
156992307|NCT00946114|566725002|FG001|Overall Study|Death|2|||
156992308|NCT00946114|566725001|FG000|Overall Study|Other|1|||
156992309|NCT00946114|566725002|FG001|Overall Study|Other|0|||
156992310|NCT00946114|566725001|FG000|Overall Study|Withdrawal by Subject|2|||
156992311|NCT00946114|566725002|FG001|Overall Study|Withdrawal by Subject|0|||
156992312|NCT04531540|566725005|FG000|Overall Study|Adverse Event|1|||
156992313|NCT04531540|566725005|FG000|Overall Study|Protocol Violation|3|||
156992314|NCT04531540|566725005|FG000|Overall Study|Withdrawal by Subject|4|||
156992315|NCT04531540|566725005|FG000|Overall Study|Found to be Ineligible|1|||
156992316|NCT00582790|566725006|FG000|Overall Study|Rapid progression of disease|1|||
156992317|NCT02374957|566725010|FG000|Overall Study|Patient did not complete forms correctly|1|||
156992318|NCT02374957|566725011|FG001|Overall Study|Patient did not complete forms correctly|0|||
156992319|NCT00748969|566725012|FG000|Overall Study|Withdrawal by Subject|1|||
156992320|NCT00748969|566725013|FG001|Overall Study|Withdrawal by Subject|0|||
156992321|NCT00748969|566725012|FG000|Overall Study|Withdrawal by Subject|0|||
156992322|NCT00748969|566725013|FG001|Overall Study|Withdrawal by Subject|1|||
156992323|NCT00945477|566725017|FG000|Overall Study|Adverse Event|3|||
156992324|NCT00945477|566725017|FG000|Overall Study|Lack of Efficacy|2|||
156992325|NCT00945477|566725017|FG000|Overall Study|Withdrawal by Subject|1|||
156992326|NCT01072929|566725018|FG000|Overall Study|Adverse Event|8|||
156992327|NCT01072929|566725019|FG001|Overall Study|Adverse Event|11|||
156992328|NCT01072929|566725020|FG002|Overall Study|Adverse Event|2|||
156992329|NCT01072929|566725018|FG000|Overall Study|Lack of Efficacy|7|||
156992330|NCT01072929|566725019|FG001|Overall Study|Lack of Efficacy|4|||
156992331|NCT01072929|566725020|FG002|Overall Study|Lack of Efficacy|0|||
156992332|NCT01072929|566725018|FG000|Overall Study|Withdrawal by Subject|7|||
156992333|NCT01072929|566725019|FG001|Overall Study|Withdrawal by Subject|15|||
156992334|NCT01072929|566725020|FG002|Overall Study|Withdrawal by Subject|3|||
156992335|NCT01072929|566725018|FG000|Overall Study|Protocol Violation|13|||
156992336|NCT01072929|566725019|FG001|Overall Study|Protocol Violation|11|||
156992337|NCT01072929|566725020|FG002|Overall Study|Protocol Violation|2|||
156992338|NCT01072929|566725018|FG000|Overall Study|Lost to Follow-up|8|||
156992339|NCT01072929|566725019|FG001|Overall Study|Lost to Follow-up|4|||
156992340|NCT01072929|566725020|FG002|Overall Study|Lost to Follow-up|1|||
156992341|NCT01072929|566725018|FG000|Overall Study|Noncompliance with study medication|0|||
156992342|NCT01072929|566725019|FG001|Overall Study|Noncompliance with study medication|3|||
156992343|NCT01072929|566725020|FG002|Overall Study|Noncompliance with study medication|0|||
156992344|NCT01072929|566725018|FG000|Overall Study|Noncompliance with study procedures|1|||
156992345|NCT01072929|566725019|FG001|Overall Study|Noncompliance with study procedures|0|||
156992346|NCT01072929|566725020|FG002|Overall Study|Noncompliance with study procedures|1|||
156992347|NCT01072929|566725018|FG000|Overall Study|Other|0|||
156992348|NCT01072929|566725019|FG001|Overall Study|Other|3|||
156992349|NCT01072929|566725020|FG002|Overall Study|Other|0|||
156992350|NCT02806336|566725021|FG000|Overall Study|Physician Decision|1|||
156992351|NCT02806336|566725022|FG001|Overall Study|Physician Decision|0|||
156992352|NCT02806336|566725021|FG000|Overall Study|Withdrawal by Subject|2|||
156992353|NCT02806336|566725022|FG001|Overall Study|Withdrawal by Subject|4|||
156992354|NCT02806336|566725021|FG000|Overall Study|COVID-19 research shut down|3|||
156992355|NCT02806336|566725022|FG001|Overall Study|COVID-19 research shut down|4|||
156992356|NCT02806336|566725021|FG000|Overall Study|Lack of Efficacy|0|||
156992357|NCT02806336|566725022|FG001|Overall Study|Lack of Efficacy|1|||
156992358|NCT03682536|566725023|FG000|Randomization|Withdrawal by Subject|0|||
156992359|NCT03682536|566725024|FG001|Randomization|Withdrawal by Subject|2|||
156992360|NCT03682536|566725023|FG000|Treatment|Other Reasons|8|||
156992361|NCT03682536|566725024|FG001|Treatment|Other Reasons|7|||
156992362|NCT03682536|566725023|FG000|Treatment|Physician Decision|5|||
156992363|NCT03682536|566725024|FG001|Treatment|Physician Decision|5|||
156992364|NCT03682536|566725023|FG000|Treatment|Protocol Violation|1|||
156992365|NCT03682536|566725024|FG001|Treatment|Protocol Violation|0|||
156992366|NCT03682536|566725023|FG000|Treatment|Study Terminated by Sponsor|1|||
156992367|NCT03682536|566725024|FG001|Treatment|Study Terminated by Sponsor|2|||
156992368|NCT03682536|566725023|FG000|Treatment|Lost to Follow-up|0|||
156992369|NCT03682536|566725024|FG001|Treatment|Lost to Follow-up|1|||
156992370|NCT03682536|566725023|FG000|Treatment|Withdrawal by Subject|16|||
156992371|NCT03682536|566725024|FG001|Treatment|Withdrawal by Subject|18|||
156992372|NCT03682536|566725023|FG000|Treatment|Lack of Efficacy|41|||
156992373|NCT03682536|566725024|FG001|Treatment|Lack of Efficacy|68|||
156992374|NCT03682536|566725023|FG000|Treatment|Disease Progression|9|||
156992375|NCT03682536|566725024|FG001|Treatment|Disease Progression|7|||
156992376|NCT03682536|566725023|FG000|Treatment|Adverse Event|9|||
156992377|NCT03682536|566725024|FG001|Treatment|Adverse Event|5|||
156992378|NCT03682536|566725023|FG000|Treatment|Death|14|||
156992379|NCT03682536|566725024|FG001|Treatment|Death|13|||
156992380|NCT02223182|566725026|FG000|Double-Blind Period|Adverse Event|0|||
156992381|NCT02223182|566725027|FG001|Double-Blind Period|Adverse Event|2|||
156992382|NCT02223182|566725028|FG002|Double-Blind Period|Adverse Event|1|||
156992383|NCT02223182|566725029|FG003|Double-Blind Period|Adverse Event|0|||
156992384|NCT02223182|566725026|FG000|Double-Blind Period|Withdrawal by Subject|1|||
156992385|NCT02223182|566725027|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156992386|NCT02223182|566725028|FG002|Double-Blind Period|Withdrawal by Subject|1|||
156992387|NCT02223182|566725029|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156992388|NCT02223182|566725026|FG000|Double-Blind Period|Lost to Follow-up|0|||
156992389|NCT02223182|566725027|FG001|Double-Blind Period|Lost to Follow-up|1|||
156992390|NCT02223182|566725028|FG002|Double-Blind Period|Lost to Follow-up|0|||
156992391|NCT02223182|566725029|FG003|Double-Blind Period|Lost to Follow-up|0|||
156992392|NCT02223182|566725026|FG000|Double-Blind Period|Non Compliance|0|||
156992393|NCT02223182|566725027|FG001|Double-Blind Period|Non Compliance|0|||
156992394|NCT02223182|566725028|FG002|Double-Blind Period|Non Compliance|0|||
156992395|NCT02223182|566725029|FG003|Double-Blind Period|Non Compliance|1|||
156992396|NCT02223182|566725026|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
156992397|NCT02223182|566725027|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156992398|NCT02223182|566725028|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156992399|NCT02223182|566725029|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
156992400|NCT02223182|566725026|FG000|Open-Label 500 Period|Adverse Event|1|||
156992401|NCT02223182|566725027|FG001|Open-Label 500 Period|Adverse Event|0|||
156992402|NCT02223182|566725028|FG002|Open-Label 500 Period|Adverse Event|2|||
156992403|NCT02223182|566725029|FG003|Open-Label 500 Period|Adverse Event|1|||
156992404|NCT02223182|566725026|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
156992405|NCT02223182|566725027|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
156992406|NCT02223182|566725028|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
156992407|NCT02223182|566725029|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
156992408|NCT02223182|566725026|FG000|Open-Label 500 Period|Physician Decision|0|||
156992409|NCT02223182|566725027|FG001|Open-Label 500 Period|Physician Decision|0|||
156992410|NCT02223182|566725028|FG002|Open-Label 500 Period|Physician Decision|0|||
156992411|NCT02223182|566725029|FG003|Open-Label 500 Period|Physician Decision|1|||
156992412|NCT02223182|566725026|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156992413|NCT02223182|566725027|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156992414|NCT02223182|566725028|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
156992415|NCT02223182|566725029|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
156992416|NCT02223182|566725026|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
156992417|NCT02223182|566725027|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
156992418|NCT02223182|566725028|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
156992419|NCT02223182|566725029|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
156992420|NCT02223182|566725026|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
156992421|NCT02223182|566725027|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
156992422|NCT02223182|566725028|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
156992423|NCT02223182|566725029|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
156992424|NCT02223182|566725026|FG000|Open-Label 300 Period|Non Compliance|0|||
156992425|NCT02223182|566725027|FG001|Open-Label 300 Period|Non Compliance|2|||
156992426|NCT02223182|566725028|FG002|Open-Label 300 Period|Non Compliance|1|||
156992427|NCT02223182|566725029|FG003|Open-Label 300 Period|Non Compliance|0|||
156992428|NCT04956692|566725036|FG000|Overall Study|Death|115|||
156992429|NCT04956692|566725037|FG001|Overall Study|Death|47|||
156992430|NCT04956692|566725036|FG000|Overall Study|Lost to Follow-up|0|||
156992431|NCT04956692|566725037|FG001|Overall Study|Lost to Follow-up|1|||
156992432|NCT04956692|566725036|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156992433|NCT04956692|566725037|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156992434|NCT04956692|566725036|FG000|Overall Study|Withdrawal by Subject|5|||
156992435|NCT04956692|566725037|FG001|Overall Study|Withdrawal by Subject|2|||
156992436|NCT04956692|566725036|FG000|Overall Study|Ongoing in Study|236|||
156992437|NCT04956692|566725037|FG001|Overall Study|Ongoing in Study|123|||
156992438|NCT02099539|566725042|FG000|Overall Study|Progressive Disease|3|||
156992439|NCT02099539|566725043|FG001|Overall Study|Progressive Disease|2|||
156992440|NCT02099539|566725044|FG002|Overall Study|Progressive Disease|2|||
156992441|NCT02099539|566725045|FG003|Overall Study|Progressive Disease|1|||
156992442|NCT02099539|566725046|FG004|Overall Study|Progressive Disease|4|||
156992443|NCT02099539|566725047|FG005|Overall Study|Progressive Disease|2|||
156992444|NCT02099539|566725048|FG006|Overall Study|Progressive Disease|0|||
156992445|NCT02099539|566725042|FG000|Overall Study|Adverse Event|0|||
156992446|NCT02099539|566725043|FG001|Overall Study|Adverse Event|0|||
156992447|NCT02099539|566725044|FG002|Overall Study|Adverse Event|1|||
156992448|NCT02099539|566725045|FG003|Overall Study|Adverse Event|1|||
156992449|NCT02099539|566725046|FG004|Overall Study|Adverse Event|0|||
156992450|NCT02099539|566725047|FG005|Overall Study|Adverse Event|0|||
156992451|NCT02099539|566725048|FG006|Overall Study|Adverse Event|0|||
156992452|NCT02099539|566725042|FG000|Overall Study|Physician Decision|0|||
156992453|NCT02099539|566725043|FG001|Overall Study|Physician Decision|0|||
156992454|NCT02099539|566725044|FG002|Overall Study|Physician Decision|0|||
156992455|NCT02099539|566725045|FG003|Overall Study|Physician Decision|0|||
156992456|NCT02099539|566725046|FG004|Overall Study|Physician Decision|0|||
156992457|NCT02099539|566725047|FG005|Overall Study|Physician Decision|1|||
156992458|NCT02099539|566725048|FG006|Overall Study|Physician Decision|0|||
156992459|NCT03473756|566725050|FG000|Overall Study|Withdrawal by Subject|1|||
156992460|NCT03473756|566725051|FG001|Overall Study|Withdrawal by Subject|4|||
156992461|NCT03473756|566725050|FG000|Overall Study|Adverse Event|6|||
156992462|NCT03473756|566725051|FG001|Overall Study|Adverse Event|7|||
156992463|NCT03473756|566725050|FG000|Overall Study|Lack of Efficacy|3|||
156992464|NCT03473756|566725051|FG001|Overall Study|Lack of Efficacy|10|||
156992465|NCT03473756|566725050|FG000|Overall Study|Physician Decision|0|||
156992466|NCT03473756|566725051|FG001|Overall Study|Physician Decision|2|||
156992467|NCT03473756|566725050|FG000|Overall Study|End of study treatment|0|||
156992468|NCT03473756|566725051|FG001|Overall Study|End of study treatment|2|||
156992469|NCT03473756|566725050|FG000|Overall Study|Lost to Follow-up|0|||
156992470|NCT03473756|566725051|FG001|Overall Study|Lost to Follow-up|1|||
156992471|NCT03714022|566725052|FG000|Overall Study|Adverse Event|1|||
156992472|NCT03714022|566725053|FG001|Overall Study|Adverse Event|0|||
156992473|NCT03714022|566725052|FG000|Overall Study|Consent withdrawal|0|||
156992474|NCT03714022|566725053|FG001|Overall Study|Consent withdrawal|1|||
156992475|NCT03714022|566725052|FG000|Overall Study|Lost to Follow-up|3|||
156992476|NCT03714022|566725053|FG001|Overall Study|Lost to Follow-up|2|||
156992477|NCT01449721|566725054|FG000|Overall Study|Physician Decision|0|||
156992478|NCT01449721|566725055|FG001|Overall Study|Physician Decision|1|||
156992479|NCT01449721|566725054|FG000|Overall Study|Physician Decision|0|||
156992480|NCT01449721|566725055|FG001|Overall Study|Physician Decision|1|||
156992481|NCT02148718|566725058|FG000|Overall Study|Protocol Violation|26|||
156992482|NCT02148718|566725058|FG000|Overall Study|Discontinued Study Prematurely|5|||
156992483|NCT02234310|566725062|FG000|Overall Study|Physician Decision|1|||
156992484|NCT02234310|566725062|FG000|Overall Study|Adverse Event|1|||
156992485|NCT02234310|566725062|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
156992486|NCT02234310|566725062|FG000|Overall Study|Withdrawal by Subject|2|||
157097142|NCT03285178|567110946|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156992487|NCT02487446|566725063|FG000|Period 1|Physician Decision|0|||
156992488|NCT02487446|566725064|FG001|Period 1|Physician Decision|1|||
156992489|NCT02487446|566725063|FG000|Period 1|Lack of Efficacy|1|||
156992490|NCT02487446|566725064|FG001|Period 1|Lack of Efficacy|0|||
156992491|NCT02487446|566725063|FG000|Period 1|Protocol deviation|3|||
156992492|NCT02487446|566725064|FG001|Period 1|Protocol deviation|2|||
156992493|NCT02487446|566725063|FG000|Period 1|Lost to Follow-up|2|||
156992494|NCT02487446|566725064|FG001|Period 1|Lost to Follow-up|0|||
156992495|NCT02487446|566725063|FG000|Period 1|Withdrawal by Subject|2|||
156992496|NCT02487446|566725064|FG001|Period 1|Withdrawal by Subject|0|||
156992497|NCT02487446|566725063|FG000|Period 1|Adverse Event|5|||
156992498|NCT02487446|566725064|FG001|Period 1|Adverse Event|5|||
156992499|NCT02487446|566725063|FG000|Washout|Lost to Follow-up|0|||
156992500|NCT02487446|566725064|FG001|Washout|Lost to Follow-up|2|||
156992501|NCT02487446|566725063|FG000|Washout|Withdrawal by Subject|1|||
156992502|NCT02487446|566725064|FG001|Washout|Withdrawal by Subject|4|||
156992503|NCT02487446|566725063|FG000|Washout|Adverse Event|2|||
156992504|NCT02487446|566725064|FG001|Washout|Adverse Event|2|||
156992505|NCT02487446|566725063|FG000|Period 2|Protocol deviation|0|||
156992506|NCT02487446|566725064|FG001|Period 2|Protocol deviation|1|||
156992507|NCT02487446|566725063|FG000|Period 2|Lost to Follow-up|1|||
156992508|NCT02487446|566725064|FG001|Period 2|Lost to Follow-up|1|||
156992509|NCT02487446|566725063|FG000|Period 2|Withdrawal by Subject|1|||
156992510|NCT02487446|566725064|FG001|Period 2|Withdrawal by Subject|1|||
156992511|NCT02487446|566725063|FG000|Period 2|Adverse Event|6|||
156992512|NCT02487446|566725064|FG001|Period 2|Adverse Event|2|||
156992513|NCT03289455|566725066|FG000|Overall Study|Death|1|||
156992514|NCT03289455|566725067|FG001|Overall Study|Death|0|||
156992515|NCT03289455|566725068|FG002|Overall Study|Death|0|||
156992516|NCT03289455|566725066|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
156992517|NCT03289455|566725067|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
156992518|NCT03289455|566725068|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
156992519|NCT03289455|566725066|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
156992520|NCT03289455|566725067|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
156992521|NCT03289455|566725068|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
156992522|NCT03289455|566725066|FG000|Overall Study|Progressive disease|3|||
156992523|NCT03289455|566725067|FG001|Overall Study|Progressive disease|4|||
156992524|NCT03289455|566725068|FG002|Overall Study|Progressive disease|5|||
156992525|NCT01822821|566725069|FG000|Overall Study|Eligible surgery cancelled|1|||
156992526|NCT01822821|566725070|FG001|Overall Study|Eligible surgery cancelled|1|||
156992527|NCT01822821|566725069|FG000|Overall Study|Other reasons|1|||
156992528|NCT01822821|566725070|FG001|Overall Study|Other reasons|0|||
156992529|NCT00333788|566725071|FG000|Overall Study|Adverse Event|44|||
156992530|NCT00333788|566725071|FG000|Overall Study|Lack of Efficacy|80|||
156992531|NCT00333788|566725071|FG000|Overall Study|Lost to Follow-up|2|||
156992532|NCT00333788|566725071|FG000|Overall Study|Withdrawal by Subject|24|||
156992533|NCT00333788|566725071|FG000|Overall Study|Other: Non-compliance|2|||
156992534|NCT00333788|566725071|FG000|Overall Study|Other: Moved|2|||
156992535|NCT00333788|566725071|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
156992536|NCT00333788|566725071|FG000|Overall Study|Other: Investigator decision|1|||
156992537|NCT00333788|566725071|FG000|Overall Study|Other: Quality of life concern|1|||
156992538|NCT00333788|566725071|FG000|Overall Study|Other: Sponsor decision|1|||
156992539|NCT00333788|566725071|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
156992540|NCT00333788|566725071|FG000|Overall Study|Other: Medical monitor decision|1|||
156992541|NCT00333788|566725071|FG000|Overall Study|Other: Physician decision|1|||
156992542|NCT00333788|566725071|FG000|Overall Study|Other: Signed consent for another study|1|||
156992543|NCT03251378|566725072|FG000|Overall Study|Death|3|||
156992544|NCT03251378|566725073|FG001|Overall Study|Death|2|||
156992545|NCT03251378|566725074|FG002|Overall Study|Death|3|||
156992546|NCT03251378|566725075|FG003|Overall Study|Death|30|||
156992547|NCT03251378|566725076|FG004|Overall Study|Death|24|||
156992548|NCT03251378|566725077|FG005|Overall Study|Death|12|||
156992549|NCT03251378|566725078|FG006|Overall Study|Death|12|||
156992550|NCT03251378|566725072|FG000|Overall Study|Lost to Follow-up|0|||
156992551|NCT03251378|566725073|FG001|Overall Study|Lost to Follow-up|0|||
156992552|NCT03251378|566725074|FG002|Overall Study|Lost to Follow-up|1|||
156992553|NCT03251378|566725075|FG003|Overall Study|Lost to Follow-up|3|||
156992554|NCT03251378|566725076|FG004|Overall Study|Lost to Follow-up|0|||
156992555|NCT03251378|566725077|FG005|Overall Study|Lost to Follow-up|0|||
156992556|NCT03251378|566725078|FG006|Overall Study|Lost to Follow-up|0|||
156992557|NCT03251378|566725072|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156992558|NCT03251378|566725073|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156992559|NCT03251378|566725074|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
156992560|NCT03251378|566725075|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
156992561|NCT03251378|566725076|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
156992562|NCT03251378|566725077|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
156992563|NCT03251378|566725078|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
156992564|NCT03251378|566725072|FG000|Overall Study|Progressive disease|2|||
156992565|NCT03251378|566725073|FG001|Overall Study|Progressive disease|0|||
156992566|NCT03251378|566725074|FG002|Overall Study|Progressive disease|0|||
156992567|NCT03251378|566725075|FG003|Overall Study|Progressive disease|1|||
156992568|NCT03251378|566725076|FG004|Overall Study|Progressive disease|0|||
156992569|NCT03251378|566725077|FG005|Overall Study|Progressive disease|0|||
156992570|NCT03251378|566725078|FG006|Overall Study|Progressive disease|0|||
156992571|NCT03251378|566725072|FG000|Overall Study|Physician Decision|0|||
156992572|NCT03251378|566725073|FG001|Overall Study|Physician Decision|2|||
156992573|NCT03251378|566725074|FG002|Overall Study|Physician Decision|0|||
156992574|NCT03251378|566725075|FG003|Overall Study|Physician Decision|0|||
156992575|NCT03251378|566725076|FG004|Overall Study|Physician Decision|0|||
156992576|NCT03251378|566725077|FG005|Overall Study|Physician Decision|0|||
156992577|NCT03251378|566725078|FG006|Overall Study|Physician Decision|0|||
156992578|NCT03251378|566725072|FG000|Overall Study|Other|2|||
156992579|NCT03251378|566725073|FG001|Overall Study|Other|3|||
156992580|NCT03251378|566725074|FG002|Overall Study|Other|2|||
156992581|NCT03251378|566725075|FG003|Overall Study|Other|0|||
156992582|NCT03251378|566725076|FG004|Overall Study|Other|1|||
156992583|NCT03251378|566725077|FG005|Overall Study|Other|1|||
156992584|NCT03251378|566725078|FG006|Overall Study|Other|1|||
156992585|NCT03251378|566725072|FG000|Overall Study|Other|0|||
156992586|NCT03251378|566725073|FG001|Overall Study|Other|0|||
156992587|NCT03251378|566725074|FG002|Overall Study|Other|0|||
156992588|NCT03251378|566725075|FG003|Overall Study|Other|4|||
156992589|NCT03251378|566725076|FG004|Overall Study|Other|13|||
156992590|NCT03251378|566725077|FG005|Overall Study|Other|0|||
156992591|NCT03251378|566725078|FG006|Overall Study|Other|0|||
156992592|NCT02322775|566725083|FG000|Overall Study|Adverse Event|1|||
156992593|NCT02322775|566725084|FG001|Overall Study|Adverse Event|0|||
156992594|NCT02322775|566725083|FG000|Overall Study|Lost to Follow-up|0|||
156992595|NCT02322775|566725084|FG001|Overall Study|Lost to Follow-up|1|||
156992596|NCT02322775|566725083|FG000|Overall Study|Protocol Violation|1|||
156992597|NCT02322775|566725084|FG001|Overall Study|Protocol Violation|0|||
156992598|NCT02322775|566725083|FG000|Overall Study|Withdrawal by Subject|3|||
156992599|NCT02322775|566725084|FG001|Overall Study|Withdrawal by Subject|4|||
156992600|NCT02322775|566725083|FG000|Overall Study|Not willing to perform all FU visits|0|||
156992601|NCT02322775|566725084|FG001|Overall Study|Not willing to perform all FU visits|1|||
156992602|NCT02956967|566725085|FG000|Overall Study|Adverse Event|3|||
156992603|NCT02956967|566725085|FG000|Overall Study|Reason non-related to neutropenia|10|||
156992604|NCT02956967|566725085|FG000|Overall Study|Lost to Follow-up|5|||
156992605|NCT02956967|566725085|FG000|Overall Study|Missing|1|||
156992606|NCT02956967|566725085|FG000|Overall Study|Termination of Nivestim administration|29|||
156992607|NCT04739423|566725086|FG000|Overall Study|Protocol Violation|0|||
156992608|NCT04739423|566725087|FG001|Overall Study|Protocol Violation|1|||
156992609|NCT04739423|566725088|FG002|Overall Study|Protocol Violation|0|||
156992610|NCT04739423|566725089|FG003|Overall Study|Protocol Violation|0|||
156992611|NCT04739423|566725090|FG004|Overall Study|Protocol Violation|0|||
156992612|NCT04739423|566725091|FG005|Overall Study|Protocol Violation|0|||
156992613|NCT04739423|566725086|FG000|Overall Study|Adverse Event|0|||
156992614|NCT04739423|566725087|FG001|Overall Study|Adverse Event|0|||
156992615|NCT04739423|566725088|FG002|Overall Study|Adverse Event|1|||
156992616|NCT04739423|566725089|FG003|Overall Study|Adverse Event|0|||
156992617|NCT04739423|566725090|FG004|Overall Study|Adverse Event|1|||
156992618|NCT04739423|566725091|FG005|Overall Study|Adverse Event|0|||
156992619|NCT04739423|566725086|FG000|Overall Study|Withdrawal by Subject|0|||
156992620|NCT04739423|566725087|FG001|Overall Study|Withdrawal by Subject|0|||
156992621|NCT04739423|566725088|FG002|Overall Study|Withdrawal by Subject|0|||
156992622|NCT04739423|566725089|FG003|Overall Study|Withdrawal by Subject|0|||
156992623|NCT04739423|566725090|FG004|Overall Study|Withdrawal by Subject|0|||
156992624|NCT04739423|566725091|FG005|Overall Study|Withdrawal by Subject|1|||
156992625|NCT01007552|566725092|FG000|Overall Study|Withdrawal by Subject|1|||
156992626|NCT00764868|566725097|FG000|Overall Study|Adverse Event|18|||
156992627|NCT00764868|566725097|FG000|Overall Study|Withdrawal by Subject|31|||
156992628|NCT00764868|566725097|FG000|Overall Study|Non-compliance|16|||
156992629|NCT00764868|566725097|FG000|Overall Study|Lost to Follow-up|25|||
156992630|NCT00764868|566725097|FG000|Overall Study|Lack of Efficacy|5|||
156992631|NCT00764868|566725097|FG000|Overall Study|Subject moved|7|||
156992632|NCT00764868|566725097|FG000|Overall Study|Pregnancy|3|||
156992633|NCT00764868|566725097|FG000|Overall Study|Prohibited medication|1|||
156992634|NCT00764868|566725097|FG000|Overall Study|Out of town|1|||
156992635|NCT00764868|566725097|FG000|Overall Study|Misuse and compliance of study drug|1|||
156992636|NCT00764868|566725097|FG000|Overall Study|Subject sent to boarding school|1|||
156992637|NCT00764868|566725097|FG000|Overall Study|Met an exclusion criteria|1|||
156992638|NCT00764868|566725097|FG000|Overall Study|Positive drug screen|2|||
156992639|NCT00764868|566725097|FG000|Overall Study|Sponsor requested withdrawal|1|||
156992640|NCT00783692|566725104|FG000|Induction Phase|Adverse Event|7|||
156992641|NCT00783692|566725105|FG001|Induction Phase|Adverse Event|9|||
156992642|NCT00783692|566725106|FG002|Induction Phase|Adverse Event|24|||
156992643|NCT00783692|566725107|FG003|Induction Phase|Adverse Event|0|||
156992644|NCT00783692|566725108|FG004|Induction Phase|Adverse Event|0|||
156992645|NCT00783692|566725109|FG005|Induction Phase|Adverse Event|0|||
156992646|NCT00783692|566725110|FG006|Induction Phase|Adverse Event|0|||
156992647|NCT00783692|566725104|FG000|Induction Phase|Protocol Violation|0|||
156992648|NCT00783692|566725105|FG001|Induction Phase|Protocol Violation|0|||
156992649|NCT00783692|566725106|FG002|Induction Phase|Protocol Violation|1|||
156992650|NCT00783692|566725107|FG003|Induction Phase|Protocol Violation|0|||
156992651|NCT00783692|566725108|FG004|Induction Phase|Protocol Violation|0|||
156992652|NCT00783692|566725109|FG005|Induction Phase|Protocol Violation|0|||
156992653|NCT00783692|566725110|FG006|Induction Phase|Protocol Violation|0|||
156992654|NCT00783692|566725104|FG000|Induction Phase|Lack of Efficacy|1|||
156992655|NCT00783692|566725105|FG001|Induction Phase|Lack of Efficacy|3|||
156992656|NCT00783692|566725106|FG002|Induction Phase|Lack of Efficacy|28|||
156992657|NCT00783692|566725107|FG003|Induction Phase|Lack of Efficacy|0|||
156992658|NCT00783692|566725108|FG004|Induction Phase|Lack of Efficacy|0|||
156992659|NCT00783692|566725109|FG005|Induction Phase|Lack of Efficacy|0|||
156992660|NCT00783692|566725110|FG006|Induction Phase|Lack of Efficacy|0|||
156992661|NCT00783692|566725104|FG000|Induction Phase|Withdrawal by Subject|3|||
156992662|NCT00783692|566725105|FG001|Induction Phase|Withdrawal by Subject|9|||
156992663|NCT00783692|566725106|FG002|Induction Phase|Withdrawal by Subject|16|||
156992664|NCT00783692|566725107|FG003|Induction Phase|Withdrawal by Subject|0|||
156992665|NCT00783692|566725108|FG004|Induction Phase|Withdrawal by Subject|0|||
156992666|NCT00783692|566725109|FG005|Induction Phase|Withdrawal by Subject|0|||
156992667|NCT00783692|566725110|FG006|Induction Phase|Withdrawal by Subject|0|||
156992668|NCT00783692|566725104|FG000|Induction Phase|Lost to Follow-up|0|||
156992669|NCT00783692|566725105|FG001|Induction Phase|Lost to Follow-up|0|||
156992670|NCT00783692|566725106|FG002|Induction Phase|Lost to Follow-up|3|||
156992671|NCT00783692|566725107|FG003|Induction Phase|Lost to Follow-up|0|||
156992672|NCT00783692|566725108|FG004|Induction Phase|Lost to Follow-up|0|||
156992673|NCT00783692|566725109|FG005|Induction Phase|Lost to Follow-up|0|||
156992674|NCT00783692|566725110|FG006|Induction Phase|Lost to Follow-up|0|||
156992675|NCT00783692|566725104|FG000|Induction Phase|Other|0|||
156992676|NCT00783692|566725105|FG001|Induction Phase|Other|0|||
156992677|NCT00783692|566725106|FG002|Induction Phase|Other|2|||
156992678|NCT00783692|566725107|FG003|Induction Phase|Other|0|||
156992679|NCT00783692|566725108|FG004|Induction Phase|Other|0|||
156992680|NCT00783692|566725109|FG005|Induction Phase|Other|0|||
156992681|NCT00783692|566725110|FG006|Induction Phase|Other|0|||
156992682|NCT00783692|566725104|FG000|Maintenance Phase|Adverse Event|7|||
156992683|NCT00783692|566725105|FG001|Maintenance Phase|Adverse Event|0|||
156992684|NCT00783692|566725106|FG002|Maintenance Phase|Adverse Event|0|||
156992685|NCT00783692|566725107|FG003|Maintenance Phase|Adverse Event|15|||
156992686|NCT00783692|566725108|FG004|Maintenance Phase|Adverse Event|12|||
156992687|NCT00783692|566725109|FG005|Maintenance Phase|Adverse Event|9|||
156992688|NCT00783692|566725110|FG006|Maintenance Phase|Adverse Event|38|||
156992689|NCT00783692|566725104|FG000|Maintenance Phase|Protocol Violation|0|||
156992690|NCT00783692|566725105|FG001|Maintenance Phase|Protocol Violation|0|||
156992691|NCT00783692|566725106|FG002|Maintenance Phase|Protocol Violation|0|||
156992692|NCT00783692|566725107|FG003|Maintenance Phase|Protocol Violation|1|||
156992693|NCT00783692|566725108|FG004|Maintenance Phase|Protocol Violation|2|||
156992694|NCT00783692|566725109|FG005|Maintenance Phase|Protocol Violation|3|||
156992695|NCT00783692|566725110|FG006|Maintenance Phase|Protocol Violation|4|||
156992696|NCT00783692|566725104|FG000|Maintenance Phase|Lack of Efficacy|79|||
156992697|NCT00783692|566725105|FG001|Maintenance Phase|Lack of Efficacy|0|||
156992698|NCT00783692|566725106|FG002|Maintenance Phase|Lack of Efficacy|0|||
156992699|NCT00783692|566725107|FG003|Maintenance Phase|Lack of Efficacy|64|||
156992700|NCT00783692|566725108|FG004|Maintenance Phase|Lack of Efficacy|58|||
156992701|NCT00783692|566725109|FG005|Maintenance Phase|Lack of Efficacy|48|||
156992702|NCT00783692|566725110|FG006|Maintenance Phase|Lack of Efficacy|177|||
156992703|NCT00783692|566725104|FG000|Maintenance Phase|Withdrawal by Subject|7|||
156992704|NCT00783692|566725105|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156992705|NCT00783692|566725106|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156992706|NCT00783692|566725107|FG003|Maintenance Phase|Withdrawal by Subject|7|||
156992707|NCT00783692|566725108|FG004|Maintenance Phase|Withdrawal by Subject|6|||
156992708|NCT00783692|566725109|FG005|Maintenance Phase|Withdrawal by Subject|9|||
156992709|NCT00783692|566725110|FG006|Maintenance Phase|Withdrawal by Subject|24|||
156992710|NCT00783692|566725104|FG000|Maintenance Phase|Lost to Follow-up|2|||
156992711|NCT00783692|566725105|FG001|Maintenance Phase|Lost to Follow-up|0|||
156992712|NCT00783692|566725106|FG002|Maintenance Phase|Lost to Follow-up|0|||
156992713|NCT00783692|566725107|FG003|Maintenance Phase|Lost to Follow-up|1|||
156992714|NCT00783692|566725108|FG004|Maintenance Phase|Lost to Follow-up|3|||
156992715|NCT00783692|566725109|FG005|Maintenance Phase|Lost to Follow-up|2|||
156992716|NCT00783692|566725110|FG006|Maintenance Phase|Lost to Follow-up|5|||
156992717|NCT00783692|566725104|FG000|Maintenance Phase|Other|0|||
156992718|NCT00783692|566725105|FG001|Maintenance Phase|Other|0|||
156992719|NCT00783692|566725106|FG002|Maintenance Phase|Other|0|||
156992720|NCT00783692|566725107|FG003|Maintenance Phase|Other|1|||
156992721|NCT00783692|566725108|FG004|Maintenance Phase|Other|0|||
156992722|NCT00783692|566725109|FG005|Maintenance Phase|Other|1|||
156992723|NCT00783692|566725110|FG006|Maintenance Phase|Other|1|||
156992724|NCT00333138|566725116|FG000|Core Study (6 Months)|Adverse Event|4|||
156992725|NCT00333138|566725117|FG001|Core Study (6 Months)|Adverse Event|5|||
156992726|NCT00333138|566725118|FG002|Core Study (6 Months)|Adverse Event|8|||
156992727|NCT00333138|566725116|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
156992728|NCT00333138|566725117|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
156992729|NCT00333138|566725118|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
156992730|NCT00333138|566725116|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
156992731|NCT00333138|566725117|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
156992732|NCT00333138|566725118|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
156992733|NCT00333138|566725116|FG000|Core Study (6 Months)|Protocol Violation|1|||
156992734|NCT00333138|566725117|FG001|Core Study (6 Months)|Protocol Violation|0|||
156992735|NCT00333138|566725118|FG002|Core Study (6 Months)|Protocol Violation|1|||
156992736|NCT00333138|566725116|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
156992737|NCT00333138|566725117|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
157097143|NCT03285178|567110947|FG003|Double-Blind Treatment Period|Adverse Event|0|||
156992738|NCT00333138|566725118|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
156992739|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
156992740|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
156992741|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
156992742|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
156992743|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
156992744|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
156992745|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
156992746|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
156992747|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
156992748|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
156992749|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
156992750|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
156992751|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
156992752|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
156992753|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
156992754|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
156992755|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
156992756|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
156992757|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
156992758|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
156992759|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
156992760|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
156992761|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
156992762|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
156992763|NCT00333138|566725116|FG000|Extension Study (Month6 to End of Study)|Death|0|||
156992764|NCT00333138|566725117|FG001|Extension Study (Month6 to End of Study)|Death|1|||
156992765|NCT00333138|566725118|FG002|Extension Study (Month6 to End of Study)|Death|0|||
156992766|NCT03005288|566725119|FG000|Overall Study|Withdrawal by Subject|7|||
156992767|NCT03005288|566725120|FG001|Overall Study|Withdrawal by Subject|5|||
156992768|NCT03005288|566725119|FG000|Overall Study|Lost to Follow-up|0|||
156992769|NCT03005288|566725120|FG001|Overall Study|Lost to Follow-up|1|||
156992770|NCT03005288|566725119|FG000|Overall Study|Adverse Event|5|||
156992771|NCT03005288|566725120|FG001|Overall Study|Adverse Event|0|||
156992772|NCT03005288|566725119|FG000|Overall Study|Protocol deviation|0|||
156992773|NCT03005288|566725120|FG001|Overall Study|Protocol deviation|1|||
156992774|NCT03005288|566725119|FG000|Overall Study|Physician Decision|0|||
156992775|NCT03005288|566725120|FG001|Overall Study|Physician Decision|1|||
156992776|NCT04011033|566725121|FG000|Overall Study|Physician Decision|2|||
156992777|NCT04011033|566725122|FG001|Overall Study|Physician Decision|3|||
156992778|NCT04011033|566725121|FG000|Overall Study|Withdrawal by Subject|1|||
156992779|NCT04011033|566725122|FG001|Overall Study|Withdrawal by Subject|0|||
156992780|NCT02027935|566725123|FG000|Overall Study|Death|1|||
156992781|NCT02027935|566725123|FG000|Overall Study|Lack of Efficacy|5|||
156992782|NCT02027935|566725123|FG000|Overall Study|Study Closure|1|||
156992783|NCT00689104|566725124|FG000|Overall Study|Eligibility criterion not met|5|||
156992784|NCT00689104|566725125|FG001|Overall Study|Eligibility criterion not met|8|||
156992785|NCT00689104|566725126|FG002|Overall Study|Eligibility criterion not met|0|||
156992786|NCT00689104|566725127|FG003|Overall Study|Eligibility criterion not met|4|||
156992787|NCT00689104|566725124|FG000|Overall Study|Adverse Event|13|||
156992788|NCT00689104|566725125|FG001|Overall Study|Adverse Event|25|||
156992789|NCT00689104|566725126|FG002|Overall Study|Adverse Event|16|||
156992790|NCT00689104|566725127|FG003|Overall Study|Adverse Event|24|||
156992791|NCT00689104|566725124|FG000|Overall Study|Lack of Efficacy|5|||
156992792|NCT00689104|566725125|FG001|Overall Study|Lack of Efficacy|6|||
156992793|NCT00689104|566725126|FG002|Overall Study|Lack of Efficacy|2|||
156992794|NCT00689104|566725127|FG003|Overall Study|Lack of Efficacy|3|||
156992795|NCT00689104|566725124|FG000|Overall Study|Withdrawal by Subject|12|||
156992796|NCT00689104|566725125|FG001|Overall Study|Withdrawal by Subject|11|||
156992797|NCT00689104|566725126|FG002|Overall Study|Withdrawal by Subject|18|||
156992798|NCT00689104|566725127|FG003|Overall Study|Withdrawal by Subject|11|||
156992799|NCT00689104|566725124|FG000|Overall Study|Lost to Follow-up|4|||
156992800|NCT00689104|566725125|FG001|Overall Study|Lost to Follow-up|3|||
156992801|NCT00689104|566725126|FG002|Overall Study|Lost to Follow-up|2|||
156992802|NCT00689104|566725127|FG003|Overall Study|Lost to Follow-up|5|||
156992803|NCT00689104|566725124|FG000|Overall Study|Protocol Violation|2|||
156992804|NCT00689104|566725125|FG001|Overall Study|Protocol Violation|3|||
156992805|NCT00689104|566725126|FG002|Overall Study|Protocol Violation|5|||
156992806|NCT00689104|566725127|FG003|Overall Study|Protocol Violation|3|||
156992807|NCT00689104|566725124|FG000|Overall Study|Randomized but never received study drug|2|||
156992808|NCT00689104|566725125|FG001|Overall Study|Randomized but never received study drug|1|||
156992809|NCT00689104|566725126|FG002|Overall Study|Randomized but never received study drug|1|||
156992810|NCT00689104|566725127|FG003|Overall Study|Randomized but never received study drug|0|||
156992811|NCT00689104|566725124|FG000|Overall Study|Physician Decision|1|||
156992812|NCT00689104|566725125|FG001|Overall Study|Physician Decision|0|||
156992813|NCT00689104|566725126|FG002|Overall Study|Physician Decision|0|||
156992814|NCT00689104|566725127|FG003|Overall Study|Physician Decision|0|||
156992815|NCT00689104|566725124|FG000|Overall Study|Non-compliance with study procedures|0|||
156992816|NCT00689104|566725125|FG001|Overall Study|Non-compliance with study procedures|0|||
156992817|NCT00689104|566725126|FG002|Overall Study|Non-compliance with study procedures|1|||
156992818|NCT00689104|566725127|FG003|Overall Study|Non-compliance with study procedures|0|||
156992819|NCT04873817|566725128|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
156992820|NCT04873817|566725128|FG000|Overall Study|Lost to Follow-up|4|||
156992821|NCT04873817|566725128|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
156992822|NCT04873817|566725128|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
156992823|NCT04873817|566725128|FG000|Overall Study|Other Reasons|3|||
156992824|NCT01342887|566725132|FG000|Overall Study|Death|2|||
156992825|NCT00663962|566725133|FG000|Overall Study|somnolence|1|||
156992826|NCT00663962|566725134|FG001|Overall Study|somnolence|0|||
156992827|NCT02698436|566725139|FG000|Overall Study|Adverse Event|1|||
156992828|NCT02698436|566725140|FG001|Overall Study|Adverse Event|0|||
156992829|NCT02698436|566725139|FG000|Overall Study|Withdrawal by Subject|3|||
156992830|NCT02698436|566725140|FG001|Overall Study|Withdrawal by Subject|3|||
156992831|NCT02698436|566725139|FG000|Overall Study|Lost to Follow-up|2|||
156992832|NCT02698436|566725140|FG001|Overall Study|Lost to Follow-up|4|||
156992833|NCT02698436|566725139|FG000|Overall Study|Non-compliance with study regimen|1|||
156992834|NCT02698436|566725140|FG001|Overall Study|Non-compliance with study regimen|0|||
156992835|NCT00097370|566725145|FG000|Stage 1|Adverse Event|3|||
156992836|NCT00097370|566725145|FG000|Stage 1|Withdrawal by Subject|1|||
156992837|NCT00097370|566725145|FG000|Stage 1|Lack of Efficacy|2|||
156992838|NCT00097370|566725145|FG000|Stage 2|Adverse Event|5|||
156992839|NCT00097370|566725145|FG000|Stage 2|Withdrawal by Subject|1|||
156992840|NCT00097370|566725145|FG000|Stage 2|Lack of Efficacy|3|||
156992841|NCT00097370|566725145|FG000|Stage 2|Pregnancy|1|||
156992842|NCT00097370|566725145|FG000|Stage 2|Sponsor Terminated Study|2|||
156992843|NCT00097370|566725145|FG000|Stage 2|Lost to Follow-up|1|||
156992844|NCT00097370|566725145|FG000|Stage 3|Adverse Event|2|||
156992845|NCT00097370|566725145|FG000|Stage 3|Withdrawal by Subject|3|||
156992846|NCT00097370|566725145|FG000|Stage 3|Lack of Efficacy|1|||
156992847|NCT00097370|566725145|FG000|Stage 3|Sponsor Terminated Study|52|||
156992848|NCT00097370|566725145|FG000|Stage 3|Lost to Follow-up|1|||
156992849|NCT01394991|566725146|FG000|Overall Study|Adverse Event|0|||
156992850|NCT01394991|566725147|FG001|Overall Study|Adverse Event|4|||
156992851|NCT01394991|566725146|FG000|Overall Study|Lack of Efficacy|5|||
156992852|NCT01394991|566725147|FG001|Overall Study|Lack of Efficacy|7|||
156992853|NCT01394991|566725146|FG000|Overall Study|Lost to Follow-up|6|||
156992854|NCT01394991|566725147|FG001|Overall Study|Lost to Follow-up|8|||
156992855|NCT01394991|566725146|FG000|Overall Study|Physician Decision|1|||
156992856|NCT01394991|566725147|FG001|Overall Study|Physician Decision|3|||
156992857|NCT01394991|566725146|FG000|Overall Study|Protocol Violation|1|||
156992858|NCT01394991|566725147|FG001|Overall Study|Protocol Violation|1|||
156992859|NCT01394991|566725146|FG000|Overall Study|Withdrawal by Subject|20|||
156992860|NCT01394991|566725147|FG001|Overall Study|Withdrawal by Subject|17|||
156992861|NCT01394991|566725146|FG000|Overall Study|Chemotherapy Termination|10|||
156992862|NCT01394991|566725147|FG001|Overall Study|Chemotherapy Termination|15|||
156992863|NCT01394991|566725146|FG000|Overall Study|Disease Progression|7|||
156992864|NCT01394991|566725147|FG001|Overall Study|Disease Progression|7|||
156992865|NCT01394991|566725146|FG000|Overall Study|Prematurely Termination of Trial|9|||
156992866|NCT01394991|566725147|FG001|Overall Study|Prematurely Termination of Trial|10|||
156992867|NCT03073005|566725151|FG000|Overall Study|Death|6|||
156992868|NCT03073005|566725152|FG001|Overall Study|Death|0|||
156992869|NCT03073005|566725153|FG002|Overall Study|Death|7|||
156992870|NCT03073005|566725154|FG003|Overall Study|Death|0|||
156992871|NCT03073005|566725151|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
156992872|NCT03073005|566725152|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
156992873|NCT03073005|566725153|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
156992874|NCT03073005|566725154|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
156992875|NCT03073005|566725151|FG000|Overall Study|Lost to Follow-up|2|||
156992876|NCT03073005|566725152|FG001|Overall Study|Lost to Follow-up|2|||
156992877|NCT03073005|566725153|FG002|Overall Study|Lost to Follow-up|1|||
156992878|NCT03073005|566725154|FG003|Overall Study|Lost to Follow-up|2|||
156992879|NCT03073005|566725151|FG000|Overall Study|Withdrawal by Subject|0|||
156992880|NCT03073005|566725152|FG001|Overall Study|Withdrawal by Subject|4|||
156992881|NCT03073005|566725153|FG002|Overall Study|Withdrawal by Subject|4|||
156992882|NCT03073005|566725154|FG003|Overall Study|Withdrawal by Subject|4|||
156992883|NCT01734811|566725155|FG000|Overall Study|Lost to Follow-up|2|||
156992884|NCT01734811|566725156|FG001|Overall Study|Lost to Follow-up|3|||
156992885|NCT01734811|566725155|FG000|Overall Study|Withdrawal by Subject|2|||
156992886|NCT01734811|566725156|FG001|Overall Study|Withdrawal by Subject|0|||
156992887|NCT02427646|566725157|FG000|Overall Study|Lack of Efficacy|2|||
156992888|NCT02427646|566725158|FG001|Overall Study|Lack of Efficacy|3|||
156992889|NCT02427646|566725157|FG000|Overall Study|Physician Decision|1|||
156992890|NCT02427646|566725158|FG001|Overall Study|Physician Decision|4|||
156992891|NCT02427646|566725157|FG000|Overall Study|Protocol Violation|3|||
156992892|NCT02427646|566725158|FG001|Overall Study|Protocol Violation|3|||
156992893|NCT02427646|566725157|FG000|Overall Study|Bothersome hand weakness|2|||
156992894|NCT02427646|566725158|FG001|Overall Study|Bothersome hand weakness|4|||
156992895|NCT03824236|566725159|FG000|Overall Study|Lost to Follow-up|0|||
156992896|NCT03824236|566725160|FG001|Overall Study|Lost to Follow-up|0|||
156992897|NCT03824236|566725161|FG002|Overall Study|Lost to Follow-up|1|||
156992898|NCT01290094|566725162|FG000|Overall Study|Withdrawal by Subject|1|||
156992899|NCT01290094|566725162|FG000|Overall Study|Lost to Follow-up|5|||
156992900|NCT01101542|566725163|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
156992901|NCT01101542|566725163|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
156992902|NCT01101542|566725163|FG000|Year 4 Surveillance Period|Other|287|||
156992903|NCT01101542|566725163|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
156992904|NCT01101542|566725163|FG000|Year 5 Surveillance Period|Pregnancy|1|||
156992905|NCT01101542|566725163|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
156992906|NCT01101542|566725163|FG000|Year 6 Surveillance Period|Pregnancy|1|||
156992907|NCT01101542|566725163|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
156992908|NCT00701311|566725164|FG000|Overall Study|Lack of Efficacy|3|||
156992909|NCT00701311|566725164|FG000|Overall Study|Adverse Event|3|||
156992910|NCT00701311|566725164|FG000|Overall Study|Withdrawal by Subject|2|||
156992911|NCT00814489|566725190|FG000|Overall Study|Other|2|||
156992912|NCT00814489|566725191|FG001|Overall Study|Other|0|||
156992913|NCT00814489|566725192|FG002|Overall Study|Other|1|||
156992914|NCT01515319|566725193|FG000|Overall Study|Withdrawal by Subject|0|||
156992915|NCT01515319|566725194|FG001|Overall Study|Withdrawal by Subject|0|||
156992916|NCT01515319|566725195|FG002|Overall Study|Withdrawal by Subject|0|||
156992917|NCT01515319|566725196|FG003|Overall Study|Withdrawal by Subject|0|||
156992918|NCT01515319|566725197|FG004|Overall Study|Withdrawal by Subject|0|||
157097144|NCT03285178|567110948|FG004|Double-Blind Treatment Period|Adverse Event|0|||
157097145|NCT03285178|567110949|FG005|Double-Blind Treatment Period|Adverse Event|0|||
157097146|NCT03285178|567110950|FG006|Double-Blind Treatment Period|Adverse Event|2|||
156992919|NCT01515319|566725198|FG005|Overall Study|Withdrawal by Subject|0|||
156992920|NCT01515319|566725199|FG006|Overall Study|Withdrawal by Subject|1|||
156992921|NCT01515319|566725200|FG007|Overall Study|Withdrawal by Subject|0|||
156992922|NCT01515319|566725201|FG008|Overall Study|Withdrawal by Subject|0|||
156992923|NCT01515319|566725202|FG009|Overall Study|Withdrawal by Subject|0|||
157097147|NCT03285178|567110944|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156992924|NCT01515319|566725193|FG000|Overall Study|Adverse Event|0|||
156992925|NCT01515319|566725194|FG001|Overall Study|Adverse Event|0|||
156992926|NCT01515319|566725195|FG002|Overall Study|Adverse Event|0|||
156992927|NCT01515319|566725196|FG003|Overall Study|Adverse Event|0|||
156992928|NCT01515319|566725197|FG004|Overall Study|Adverse Event|0|||
156992929|NCT01515319|566725198|FG005|Overall Study|Adverse Event|0|||
156992930|NCT01515319|566725199|FG006|Overall Study|Adverse Event|0|||
156992931|NCT01515319|566725200|FG007|Overall Study|Adverse Event|0|||
156992932|NCT01515319|566725201|FG008|Overall Study|Adverse Event|3|||
157097148|NCT03285178|567110945|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
157097149|NCT03285178|567110946|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
157097150|NCT03285178|567110947|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
157097151|NCT03285178|567110948|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
157097152|NCT03285178|567110949|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
157097153|NCT03285178|567110950|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
157097154|NCT03285178|567110944|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157097155|NCT03285178|567110945|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157097156|NCT03285178|567110946|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157097157|NCT03285178|567110947|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157097158|NCT03285178|567110948|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157097159|NCT03285178|567110949|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
157097160|NCT03285178|567110950|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157097161|NCT03285178|567110944|FG000|Double-Blind Treatment Period|COVID-19|0|||
157097162|NCT03285178|567110945|FG001|Double-Blind Treatment Period|COVID-19|0|||
157097163|NCT03285178|567110946|FG002|Double-Blind Treatment Period|COVID-19|1|||
157097164|NCT03285178|567110947|FG003|Double-Blind Treatment Period|COVID-19|0|||
157097165|NCT03285178|567110948|FG004|Double-Blind Treatment Period|COVID-19|0|||
157097166|NCT03285178|567110949|FG005|Double-Blind Treatment Period|COVID-19|0|||
157097167|NCT03285178|567110950|FG006|Double-Blind Treatment Period|COVID-19|0|||
157097168|NCT00973362|567110951|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
157097169|NCT00973362|567110952|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
157097170|NCT00973362|567110951|FG000|Baseline Evaluation|No colposcopy visit|62|||
157097171|NCT00973362|567110952|FG001|Baseline Evaluation|No colposcopy visit|0|||
157097172|NCT00973362|567110951|FG000|Baseline Evaluation|Inevaluable|686|||
157097173|NCT00973362|567110952|FG001|Baseline Evaluation|Inevaluable|223|||
157097174|NCT00973362|567110951|FG000|3-Year Follow-up|Lost to Follow-up|17|||
157097175|NCT00973362|567110952|FG001|3-Year Follow-up|Lost to Follow-up|0|||
157097176|NCT05116046|567110957|FG000|Overall Study|Withdrawal by parent/guardian|2|||
157097177|NCT05116046|567110958|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157097178|NCT05116046|567110959|FG002|Overall Study|Withdrawal by parent/guardian|1|||
157097179|NCT05116046|567110957|FG000|Overall Study|Study terminated by sponsor|14|||
157097180|NCT05116046|567110958|FG001|Overall Study|Study terminated by sponsor|16|||
157097181|NCT05116046|567110959|FG002|Overall Study|Study terminated by sponsor|1|||
157097182|NCT00325039|567110960|FG000|Overall Study|Lost to Follow-up|18|||
157097183|NCT00325039|567110961|FG001|Overall Study|Lost to Follow-up|14|||
157097184|NCT02974088|567110965|FG000|Overall Study|Lost to Follow-up|0|||
157097185|NCT02974088|567110966|FG001|Overall Study|Lost to Follow-up|2|||
157097186|NCT02974088|567110965|FG000|Overall Study|Adverse Event|0|||
157097187|NCT02974088|567110966|FG001|Overall Study|Adverse Event|1|||
157097188|NCT00892723|567110967|FG000|Overall Study|Lost to Follow-up|1|||
157097189|NCT00892723|567110968|FG001|Overall Study|Lost to Follow-up|3|||
157097190|NCT00892723|567110969|FG002|Overall Study|Lost to Follow-up|1|||
156992933|NCT01515319|566725202|FG009|Overall Study|Adverse Event|0|||
156992934|NCT01515319|566725193|FG000|Overall Study|Protocol Violation|0|||
156992935|NCT01515319|566725194|FG001|Overall Study|Protocol Violation|0|||
156992936|NCT01515319|566725195|FG002|Overall Study|Protocol Violation|0|||
156992937|NCT01515319|566725196|FG003|Overall Study|Protocol Violation|0|||
156992938|NCT01515319|566725197|FG004|Overall Study|Protocol Violation|0|||
156992939|NCT01515319|566725198|FG005|Overall Study|Protocol Violation|0|||
156992940|NCT01515319|566725199|FG006|Overall Study|Protocol Violation|0|||
156992941|NCT01515319|566725200|FG007|Overall Study|Protocol Violation|0|||
156992942|NCT01515319|566725201|FG008|Overall Study|Protocol Violation|2|||
156992943|NCT01515319|566725202|FG009|Overall Study|Protocol Violation|0|||
156992944|NCT04880161|566725203|FG000|Overall Study|Withdrawal by Subject|1|||
156992945|NCT04880161|566725204|FG001|Overall Study|Withdrawal by Subject|0|||
156992946|NCT04880161|566725203|FG000|Overall Study|Lack of Compliance|1|||
156992947|NCT04880161|566725204|FG001|Overall Study|Lack of Compliance|1|||
156992948|NCT04880161|566725203|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
156992949|NCT04880161|566725204|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
156992950|NCT04880161|566725203|FG000|Overall Study|Screen Failure|0|||
156992951|NCT04880161|566725204|FG001|Overall Study|Screen Failure|1|||
156992952|NCT04091672|566727294|FG000|Overall Study|Death|6|||
156992953|NCT04091672|566727295|FG001|Overall Study|Death|6|||
156992954|NCT04091672|566727294|FG000|Overall Study|Lost to Follow-up|7|||
156992955|NCT04091672|566727295|FG001|Overall Study|Lost to Follow-up|7|||
156992956|NCT04091672|566727294|FG000|Overall Study|Withdrawal by Subject|3|||
156992957|NCT04091672|566727295|FG001|Overall Study|Withdrawal by Subject|3|||
156992958|NCT04091672|566727294|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
156992959|NCT04091672|566727295|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
156992960|NCT00359619|566727296|FG000|Overall Study|Adverse Event|0|||
156992961|NCT00359619|566727297|FG001|Overall Study|Adverse Event|0|||
156992962|NCT00359619|566727298|FG002|Overall Study|Adverse Event|1|||
156992963|NCT00359619|566727299|FG003|Overall Study|Adverse Event|0|||
156992964|NCT00359619|566727300|FG004|Overall Study|Adverse Event|0|||
156992965|NCT00359619|566727301|FG005|Overall Study|Adverse Event|0|||
156992966|NCT00359619|566727302|FG006|Overall Study|Adverse Event|1|||
156992967|NCT00359619|566727296|FG000|Overall Study|Withdrawal by Subject|3|||
156992968|NCT00359619|566727297|FG001|Overall Study|Withdrawal by Subject|1|||
156992969|NCT00359619|566727298|FG002|Overall Study|Withdrawal by Subject|4|||
156992970|NCT00359619|566727299|FG003|Overall Study|Withdrawal by Subject|2|||
156992971|NCT00359619|566727300|FG004|Overall Study|Withdrawal by Subject|2|||
156992972|NCT00359619|566727301|FG005|Overall Study|Withdrawal by Subject|0|||
156992973|NCT00359619|566727302|FG006|Overall Study|Withdrawal by Subject|3|||
156992974|NCT00359619|566727296|FG000|Overall Study|Other|1|||
156992975|NCT00359619|566727297|FG001|Overall Study|Other|0|||
156992976|NCT00359619|566727298|FG002|Overall Study|Other|0|||
156992977|NCT00359619|566727299|FG003|Overall Study|Other|0|||
156992978|NCT00359619|566727300|FG004|Overall Study|Other|0|||
156992979|NCT00359619|566727301|FG005|Overall Study|Other|0|||
156992980|NCT00359619|566727302|FG006|Overall Study|Other|0|||
156992981|NCT00359619|566727296|FG000|Overall Study|Lost to Follow-up|4|||
156992982|NCT00359619|566727297|FG001|Overall Study|Lost to Follow-up|4|||
157097191|NCT00892723|567110967|FG000|Overall Study|Withdrawal by Subject|1|||
156992983|NCT00359619|566727298|FG002|Overall Study|Lost to Follow-up|2|||
157097192|NCT00892723|567110968|FG001|Overall Study|Withdrawal by Subject|1|||
156992984|NCT00359619|566727299|FG003|Overall Study|Lost to Follow-up|1|||
156992985|NCT00359619|566727300|FG004|Overall Study|Lost to Follow-up|1|||
156992986|NCT00359619|566727301|FG005|Overall Study|Lost to Follow-up|5|||
156992987|NCT00359619|566727302|FG006|Overall Study|Lost to Follow-up|0|||
156992988|NCT04978363|566727308|FG000|Overall Study|Other medical issues unrelated to the study|0|||
156992989|NCT04978363|566727309|FG001|Overall Study|Other medical issues unrelated to the study|0|||
156992990|NCT04978363|566727310|FG002|Overall Study|Other medical issues unrelated to the study|0|||
156992991|NCT04978363|566727311|FG003|Overall Study|Other medical issues unrelated to the study|0|||
156992992|NCT04978363|566727312|FG004|Overall Study|Other medical issues unrelated to the study|1|||
156992993|NCT04978363|566727313|FG005|Overall Study|Other medical issues unrelated to the study|0|||
156992994|NCT04978363|566727314|FG006|Overall Study|Other medical issues unrelated to the study|0|||
156992995|NCT04978363|566727315|FG007|Overall Study|Other medical issues unrelated to the study|0|||
157097193|NCT00892723|567110969|FG002|Overall Study|Withdrawal by Subject|1|||
156992996|NCT04978363|566727316|FG008|Overall Study|Other medical issues unrelated to the study|0|||
156992997|NCT04978363|566727317|FG009|Overall Study|Other medical issues unrelated to the study|0|||
157097194|NCT00150969|567110972|FG000|24 Month Main Study|Adverse Event|3|||
156992998|NCT04978363|566727318|FG010|Overall Study|Other medical issues unrelated to the study|0|||
156992999|NCT04978363|566727308|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
156993000|NCT04978363|566727309|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
156993001|NCT04978363|566727310|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
156993002|NCT04978363|566727311|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
156993003|NCT04978363|566727312|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
156993004|NCT04978363|566727313|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
156993005|NCT04978363|566727314|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
156993006|NCT04978363|566727315|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
157097195|NCT00150969|567110973|FG001|24 Month Main Study|Adverse Event|4|||
157097196|NCT00150969|567110972|FG000|24 Month Main Study|Death|1|||
157097197|NCT00150969|567110973|FG001|24 Month Main Study|Death|1|||
157097198|NCT00150969|567110972|FG000|24 Month Main Study|Lack of Efficacy|1|||
156993007|NCT04978363|566727316|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
156993008|NCT04978363|566727317|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
156993009|NCT04978363|566727318|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
156993010|NCT04978363|566727308|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993011|NCT04978363|566727309|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
156993012|NCT04978363|566727310|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993013|NCT04978363|566727311|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993014|NCT04978363|566727312|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993015|NCT04978363|566727313|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993016|NCT04978363|566727314|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993017|NCT04978363|566727315|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993018|NCT04978363|566727316|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993019|NCT04978363|566727317|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993020|NCT04978363|566727318|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
156993021|NCT01251614|566727319|FG000|Overall Study|Adverse Event|1|||
156993022|NCT01251614|566727320|FG001|Overall Study|Adverse Event|0|||
156993023|NCT01251614|566727321|FG002|Overall Study|Adverse Event|1|||
156993024|NCT01251614|566727319|FG000|Overall Study|Lack of Efficacy|1|||
156993025|NCT01251614|566727320|FG001|Overall Study|Lack of Efficacy|9|||
156993026|NCT01251614|566727321|FG002|Overall Study|Lack of Efficacy|4|||
156993027|NCT01251614|566727319|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
156993028|NCT01251614|566727320|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
156993029|NCT01251614|566727321|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
156993030|NCT01251614|566727319|FG000|Overall Study|Pregnancy|0|||
156993031|NCT01251614|566727320|FG001|Overall Study|Pregnancy|0|||
156993032|NCT01251614|566727321|FG002|Overall Study|Pregnancy|2|||
156993033|NCT01251614|566727319|FG000|Overall Study|Loss of Disease Control|0|||
156993034|NCT01251614|566727320|FG001|Overall Study|Loss of Disease Control|1|||
156993035|NCT01251614|566727321|FG002|Overall Study|Loss of Disease Control|0|||
156993036|NCT01251614|566727319|FG000|Overall Study|Withdrawal by Subject|0|||
156993037|NCT01251614|566727320|FG001|Overall Study|Withdrawal by Subject|2|||
156993038|NCT01251614|566727321|FG002|Overall Study|Withdrawal by Subject|1|||
156993039|NCT01251614|566727319|FG000|Overall Study|Lost to Follow-up|0|||
156993040|NCT01251614|566727320|FG001|Overall Study|Lost to Follow-up|1|||
156993041|NCT01251614|566727321|FG002|Overall Study|Lost to Follow-up|0|||
156993042|NCT01876043|566727322|FG000|Overall Study|Death|1|||
156993043|NCT01876043|566727322|FG000|Overall Study|Withdrawal by Subject|1|||
156993044|NCT00049517|566727324|FG000|Induction|Disease progression|0|||
156993045|NCT00049517|566727325|FG001|Induction|Disease progression|0|||
156993046|NCT00049517|566727326|FG002|Induction|Disease progression|0|||
156993047|NCT00049517|566727327|FG003|Induction|Disease progression|0|||
156993048|NCT00049517|566727328|FG004|Induction|Disease progression|18|||
157097199|NCT00150969|567110973|FG001|24 Month Main Study|Lack of Efficacy|8|||
156993049|NCT00049517|566727329|FG005|Induction|Disease progression|11|||
156993050|NCT00049517|566727324|FG000|Induction|Adverse Event|0|||
156993051|NCT00049517|566727325|FG001|Induction|Adverse Event|0|||
156993052|NCT00049517|566727326|FG002|Induction|Adverse Event|0|||
156993053|NCT00049517|566727327|FG003|Induction|Adverse Event|0|||
156993054|NCT00049517|566727328|FG004|Induction|Adverse Event|5|||
156993055|NCT00049517|566727329|FG005|Induction|Adverse Event|7|||
156993056|NCT00049517|566727324|FG000|Induction|Death|0|||
156993057|NCT00049517|566727325|FG001|Induction|Death|0|||
156993058|NCT00049517|566727326|FG002|Induction|Death|0|||
156993059|NCT00049517|566727327|FG003|Induction|Death|0|||
156993060|NCT00049517|566727328|FG004|Induction|Death|9|||
156993061|NCT00049517|566727329|FG005|Induction|Death|6|||
156993062|NCT00049517|566727324|FG000|Induction|Withdrawal by Subject|0|||
156993063|NCT00049517|566727325|FG001|Induction|Withdrawal by Subject|0|||
156993064|NCT00049517|566727326|FG002|Induction|Withdrawal by Subject|0|||
156993065|NCT00049517|566727327|FG003|Induction|Withdrawal by Subject|0|||
156993066|NCT00049517|566727328|FG004|Induction|Withdrawal by Subject|1|||
156993067|NCT00049517|566727329|FG005|Induction|Withdrawal by Subject|3|||
156993068|NCT00049517|566727324|FG000|Induction|Alternative therapy|0|||
156993069|NCT00049517|566727325|FG001|Induction|Alternative therapy|0|||
156993070|NCT00049517|566727326|FG002|Induction|Alternative therapy|0|||
156993071|NCT00049517|566727327|FG003|Induction|Alternative therapy|0|||
156993072|NCT00049517|566727328|FG004|Induction|Alternative therapy|2|||
156993073|NCT00049517|566727329|FG005|Induction|Alternative therapy|2|||
157097200|NCT00150969|567110972|FG000|24 Month Main Study|Lost to Follow-up|3|||
156993074|NCT00049517|566727324|FG000|Induction|Other complicating disease|0|||
156993075|NCT00049517|566727325|FG001|Induction|Other complicating disease|0|||
156993076|NCT00049517|566727326|FG002|Induction|Other complicating disease|0|||
156993077|NCT00049517|566727327|FG003|Induction|Other complicating disease|0|||
156993078|NCT00049517|566727328|FG004|Induction|Other complicating disease|3|||
156993079|NCT00049517|566727329|FG005|Induction|Other complicating disease|0|||
156993080|NCT00049517|566727324|FG000|Induction|Reasons not reported|0|||
156993081|NCT00049517|566727325|FG001|Induction|Reasons not reported|0|||
156993082|NCT00049517|566727326|FG002|Induction|Reasons not reported|0|||
156993083|NCT00049517|566727327|FG003|Induction|Reasons not reported|0|||
156993084|NCT00049517|566727328|FG004|Induction|Reasons not reported|22|||
156993085|NCT00049517|566727329|FG005|Induction|Reasons not reported|25|||
156993086|NCT00049517|566727324|FG000|Conditioning/Transplant|Disease progression|14|||
156993087|NCT00049517|566727325|FG001|Conditioning/Transplant|Disease progression|6|||
156993088|NCT00049517|566727326|FG002|Conditioning/Transplant|Disease progression|10|||
156993089|NCT00049517|566727327|FG003|Conditioning/Transplant|Disease progression|6|||
156993090|NCT00049517|566727328|FG004|Conditioning/Transplant|Disease progression|0|||
156993091|NCT00049517|566727329|FG005|Conditioning/Transplant|Disease progression|0|||
156993092|NCT00049517|566727324|FG000|Conditioning/Transplant|Adverse Event|2|||
156993093|NCT00049517|566727325|FG001|Conditioning/Transplant|Adverse Event|1|||
156993094|NCT00049517|566727326|FG002|Conditioning/Transplant|Adverse Event|4|||
156993095|NCT00049517|566727327|FG003|Conditioning/Transplant|Adverse Event|8|||
156993096|NCT00049517|566727328|FG004|Conditioning/Transplant|Adverse Event|0|||
156993097|NCT00049517|566727329|FG005|Conditioning/Transplant|Adverse Event|0|||
156993098|NCT00049517|566727324|FG000|Conditioning/Transplant|Death|1|||
156993099|NCT00049517|566727325|FG001|Conditioning/Transplant|Death|0|||
156993100|NCT00049517|566727326|FG002|Conditioning/Transplant|Death|0|||
156993101|NCT00049517|566727327|FG003|Conditioning/Transplant|Death|2|||
156993102|NCT00049517|566727328|FG004|Conditioning/Transplant|Death|0|||
156993103|NCT00049517|566727329|FG005|Conditioning/Transplant|Death|0|||
156993104|NCT00049517|566727324|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
156993105|NCT00049517|566727325|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
156993106|NCT00049517|566727326|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
156993107|NCT00049517|566727327|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
156993108|NCT00049517|566727328|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
156993109|NCT00049517|566727329|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
156993110|NCT00049517|566727324|FG000|Conditioning/Transplant|Alternative therapy|4|||
156993111|NCT00049517|566727325|FG001|Conditioning/Transplant|Alternative therapy|4|||
156993112|NCT00049517|566727326|FG002|Conditioning/Transplant|Alternative therapy|2|||
156993113|NCT00049517|566727327|FG003|Conditioning/Transplant|Alternative therapy|1|||
156993114|NCT00049517|566727328|FG004|Conditioning/Transplant|Alternative therapy|1|||
156993115|NCT00049517|566727329|FG005|Conditioning/Transplant|Alternative therapy|0|||
156993116|NCT00049517|566727324|FG000|Conditioning/Transplant|Other complicating disease|2|||
156993117|NCT00049517|566727325|FG001|Conditioning/Transplant|Other complicating disease|0|||
156993118|NCT00049517|566727326|FG002|Conditioning/Transplant|Other complicating disease|0|||
156993119|NCT00049517|566727327|FG003|Conditioning/Transplant|Other complicating disease|4|||
156993120|NCT00049517|566727328|FG004|Conditioning/Transplant|Other complicating disease|0|||
156993121|NCT00049517|566727329|FG005|Conditioning/Transplant|Other complicating disease|1|||
156993122|NCT00049517|566727324|FG000|Conditioning/Transplant|Reasons not reported|25|||
156993123|NCT00049517|566727325|FG001|Conditioning/Transplant|Reasons not reported|31|||
156993124|NCT00049517|566727326|FG002|Conditioning/Transplant|Reasons not reported|18|||
156993125|NCT00049517|566727327|FG003|Conditioning/Transplant|Reasons not reported|15|||
156993126|NCT00049517|566727328|FG004|Conditioning/Transplant|Reasons not reported|5|||
156993127|NCT00049517|566727329|FG005|Conditioning/Transplant|Reasons not reported|5|||
156993128|NCT00613301|566727330|FG000|Overall Study|Adverse Event|49|||
156993129|NCT00613301|566727330|FG000|Overall Study|Lost to Follow-up|88|||
156993130|NCT00613301|566727330|FG000|Overall Study|Withdrawal by Subject|5|||
156993131|NCT00613301|566727330|FG000|Overall Study|Death|6|||
156993132|NCT00613301|566727330|FG000|Overall Study|Lack of Efficacy|13|||
156993133|NCT00613301|566727330|FG000|Overall Study|Physician Decision|2|||
156993134|NCT00613301|566727330|FG000|Overall Study|No data was collected|53|||
156993135|NCT00613301|566727330|FG000|Overall Study|Irregularly enrolled patients|12|||
156993136|NCT01306331|566727336|FG000|Overall Study|Adverse Event|28|||
156993137|NCT01306331|566727337|FG001|Overall Study|Adverse Event|25|||
156993138|NCT01306331|566727336|FG000|Overall Study|Lost to Follow-up|321|||
156993139|NCT01306331|566727337|FG001|Overall Study|Lost to Follow-up|323|||
156993140|NCT01306331|566727336|FG000|Overall Study|Physician Decision|26|||
156993141|NCT01306331|566727337|FG001|Overall Study|Physician Decision|22|||
156993142|NCT01306331|566727336|FG000|Overall Study|Pregnancy|136|||
156993143|NCT01306331|566727337|FG001|Overall Study|Pregnancy|151|||
156993144|NCT01306331|566727336|FG000|Overall Study|Protocol Violation|154|||
156993145|NCT01306331|566727337|FG001|Overall Study|Protocol Violation|124|||
156993146|NCT01306331|566727336|FG000|Overall Study|Withdrawal by Subject|163|||
156993147|NCT01306331|566727337|FG001|Overall Study|Withdrawal by Subject|152|||
156993148|NCT01306331|566727336|FG000|Overall Study|Not sexually active|29|||
156993149|NCT01306331|566727337|FG001|Overall Study|Not sexually active|28|||
156993150|NCT01306331|566727336|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
156993151|NCT01306331|566727337|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
156993152|NCT01306331|566727336|FG000|Overall Study|Other|34|||
156993153|NCT01306331|566727337|FG001|Overall Study|Other|32|||
156993154|NCT00172185|566727344|FG000|Overall Study|Adverse Event|0|||
156993155|NCT00172185|566727345|FG001|Overall Study|Adverse Event|1|||
156993156|NCT00172185|566727346|FG002|Overall Study|Adverse Event|3|||
156993157|NCT00172185|566727347|FG003|Overall Study|Adverse Event|4|||
156993158|NCT00172185|566727344|FG000|Overall Study|Physician Decision|0|||
156993159|NCT00172185|566727345|FG001|Overall Study|Physician Decision|0|||
156993160|NCT00172185|566727346|FG002|Overall Study|Physician Decision|1|||
156993161|NCT00172185|566727347|FG003|Overall Study|Physician Decision|0|||
156993162|NCT00172185|566727344|FG000|Overall Study|SPONSOR Decision|0|||
156993163|NCT00172185|566727345|FG001|Overall Study|SPONSOR Decision|1|||
156993164|NCT00172185|566727346|FG002|Overall Study|SPONSOR Decision|0|||
156993165|NCT00172185|566727347|FG003|Overall Study|SPONSOR Decision|0|||
156993166|NCT00172185|566727344|FG000|Overall Study|Withdrawal by Subject|0|||
156993167|NCT00172185|566727345|FG001|Overall Study|Withdrawal by Subject|0|||
156993168|NCT00172185|566727346|FG002|Overall Study|Withdrawal by Subject|1|||
156993169|NCT00172185|566727347|FG003|Overall Study|Withdrawal by Subject|0|||
156993170|NCT04048135|566727348|FG000|Overall Study|Withdrawal by Subject|1|||
156993171|NCT04048135|566727349|FG001|Overall Study|Withdrawal by Subject|1|||
156993172|NCT04048135|566727350|FG002|Overall Study|Withdrawal by Subject|1|||
156993173|NCT04048135|566727351|FG003|Overall Study|Withdrawal by Subject|2|||
156993174|NCT04048135|566727352|FG004|Overall Study|Withdrawal by Subject|0|||
156993175|NCT04048135|566727353|FG005|Overall Study|Withdrawal by Subject|0|||
156993176|NCT04048135|566727354|FG006|Overall Study|Withdrawal by Subject|1|||
156993177|NCT04048135|566727355|FG007|Overall Study|Withdrawal by Subject|1|||
156993178|NCT04048135|566727348|FG000|Overall Study|Adverse Event|0|||
156993179|NCT04048135|566727349|FG001|Overall Study|Adverse Event|0|||
156993180|NCT04048135|566727350|FG002|Overall Study|Adverse Event|0|||
156993181|NCT04048135|566727351|FG003|Overall Study|Adverse Event|1|||
156993182|NCT04048135|566727352|FG004|Overall Study|Adverse Event|1|||
156993183|NCT04048135|566727353|FG005|Overall Study|Adverse Event|0|||
156993184|NCT04048135|566727354|FG006|Overall Study|Adverse Event|0|||
156993185|NCT04048135|566727355|FG007|Overall Study|Adverse Event|0|||
156993186|NCT04048135|566727348|FG000|Overall Study|Protocol Violation|0|||
156993187|NCT04048135|566727349|FG001|Overall Study|Protocol Violation|0|||
156993188|NCT04048135|566727350|FG002|Overall Study|Protocol Violation|0|||
156993189|NCT04048135|566727351|FG003|Overall Study|Protocol Violation|0|||
156993190|NCT04048135|566727352|FG004|Overall Study|Protocol Violation|0|||
156993191|NCT04048135|566727353|FG005|Overall Study|Protocol Violation|1|||
156993192|NCT04048135|566727354|FG006|Overall Study|Protocol Violation|0|||
156993193|NCT04048135|566727355|FG007|Overall Study|Protocol Violation|0|||
156993194|NCT02790606|566727358|FG000|Overall Study|Death|27|||
156993195|NCT02790606|566727358|FG000|Overall Study|Lost to Follow-up|4|||
156993196|NCT02790606|566727358|FG000|Overall Study|Physician Decision|3|||
156993197|NCT02790606|566727358|FG000|Overall Study|Withdrawal by Subject|1|||
156993198|NCT02735915|566727359|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
156993199|NCT02735915|566727359|FG000|Overall Study|Withdrawal following SAE|2|||
156993200|NCT02735915|566727359|FG000|Overall Study|Withdrawal by Subject|1|||
156993201|NCT05328973|566727360|FG000|Overall Study|Withdrawal by Subject|0|||
156993202|NCT05328973|566727361|FG001|Overall Study|Withdrawal by Subject|1|||
156993203|NCT00409708|566727367|FG000|Treatment|Abnormal test procedure result(s)|1|||
156993204|NCT00409708|566727368|FG001|Treatment|Abnormal test procedure result(s)|0|||
156993205|NCT00409708|566727367|FG000|Treatment|Lack of Efficacy|0|||
156993206|NCT00409708|566727368|FG001|Treatment|Lack of Efficacy|1|||
156993207|NCT00409708|566727367|FG000|Treatment|Protocol Violation|6|||
156993208|NCT00409708|566727368|FG001|Treatment|Protocol Violation|2|||
156993209|NCT00409708|566727367|FG000|Treatment|Withdrawal by Subject|3|||
156993210|NCT00409708|566727368|FG001|Treatment|Withdrawal by Subject|8|||
156993211|NCT00409708|566727367|FG000|Treatment|Lost to Follow-up|0|||
157097201|NCT00150969|567110973|FG001|24 Month Main Study|Lost to Follow-up|2|||
157097202|NCT00150969|567110972|FG000|24 Month Main Study|Protocol Violation|4|||
157097203|NCT00150969|567110973|FG001|24 Month Main Study|Protocol Violation|2|||
157097204|NCT00150969|567110972|FG000|24 Month Main Study|Withdrawal by Subject|7|||
157097205|NCT00150969|567110973|FG001|24 Month Main Study|Withdrawal by Subject|4|||
157097206|NCT00150969|567110972|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
157097207|NCT00150969|567110973|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
157097208|NCT00150969|567110972|FG000|24-48 Month Extension|Lack of Efficacy|0|||
157097209|NCT00150969|567110973|FG001|24-48 Month Extension|Lack of Efficacy|1|||
157097210|NCT00150969|567110972|FG000|24-48 Month Extension|Adverse Event|1|||
157097211|NCT00150969|567110973|FG001|24-48 Month Extension|Adverse Event|3|||
156993212|NCT00409708|566727368|FG001|Treatment|Lost to Follow-up|6|||
156993213|NCT00409708|566727367|FG000|Treatment|Administrative problems|5|||
156993214|NCT00409708|566727368|FG001|Treatment|Administrative problems|0|||
156993215|NCT00409708|566727367|FG000|Washout|Lack of Efficacy|9|||
156993216|NCT00409708|566727368|FG001|Washout|Lack of Efficacy|1|||
156993217|NCT00409708|566727367|FG000|Washout|Protocol Violation|0|||
156993218|NCT00409708|566727368|FG001|Washout|Protocol Violation|1|||
156993219|NCT00409708|566727367|FG000|Washout|Withdrawal by Subject|11|||
156993220|NCT00409708|566727368|FG001|Washout|Withdrawal by Subject|5|||
156993221|NCT00409708|566727367|FG000|Washout|Lost to Follow-up|1|||
156993222|NCT00409708|566727368|FG001|Washout|Lost to Follow-up|3|||
156993223|NCT00723294|566727369|FG000|Overall Study|Lobular histology|2|||
156993224|NCT00723294|566727369|FG000|Overall Study|>25% intraductal component|1|||
156993225|NCT00723294|566727369|FG000|Overall Study|No MRI tumor enhancement|1|||
156993226|NCT00723294|566727369|FG000|Overall Study|1.0-Tesla MRI|1|||
156993227|NCT00723294|566727369|FG000|Overall Study|No cryoabalation|2|||
156993228|NCT00723294|566727369|FG000|Overall Study|Did not undergo surgery|1|||
156993229|NCT00723294|566727369|FG000|Overall Study|Treated prior to registration|1|||
156993230|NCT00723294|566727369|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
156993231|NCT00723294|566727369|FG000|Overall Study|Benign lesion|1|||
156993232|NCT00723294|566727369|FG000|Overall Study|Withdrawal by Subject|1|||
156993233|NCT00723294|566727369|FG000|Overall Study|No treatment due to probe failure|1|||
156993234|NCT01211665|566727370|FG000|Overall Study|Withdrawal by Subject|1|||
156993235|NCT01211665|566727371|FG001|Overall Study|Withdrawal by Subject|0|||
156993236|NCT01211665|566727370|FG000|Overall Study|Death|1|||
156993237|NCT01211665|566727371|FG001|Overall Study|Death|0|||
156993238|NCT00498186|566727374|FG000|Overall Study|Protocol Violation|10|||
156993239|NCT00498186|566727374|FG000|Overall Study|Lack of Efficacy|31|||
156993240|NCT00498186|566727374|FG000|Overall Study|Adverse Event|89|||
156993241|NCT00498186|566727374|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
156993242|NCT00498186|566727374|FG000|Overall Study|Withdrawal by Subject|18|||
156993243|NCT00498186|566727374|FG000|Overall Study|Lost to Follow-up|3|||
156993244|NCT00498186|566727374|FG000|Overall Study|Other|10|||
156993245|NCT04454567|566727375|FG000|Overall Study|Study Terminated by Sponsor|1|||
156993246|NCT04454567|566727376|FG001|Overall Study|Study Terminated by Sponsor|1|||
156993247|NCT02757885|566727377|FG000|Overall Study|Screen Failures|4|||
156993248|NCT01175707|566727378|FG000|Overall Study|Adverse Event|4|||
156993249|NCT01175707|566727379|FG001|Overall Study|Adverse Event|6|||
156993250|NCT01456780|566727380|FG000|Overall Study|Lost to Follow-up|3|||
156993251|NCT01456780|566727381|FG001|Overall Study|Lost to Follow-up|3|||
156993252|NCT01456780|566727382|FG002|Overall Study|Lost to Follow-up|0|||
156993253|NCT02688621|566727387|FG000|Overall Study|Pregnancy|1|||
156993254|NCT02688621|566727388|FG001|Overall Study|Pregnancy|3|||
156993255|NCT02688621|566727387|FG000|Overall Study|Lost to Follow-up|38|||
156993256|NCT02688621|566727388|FG001|Overall Study|Lost to Follow-up|15|||
156993257|NCT02688621|566727387|FG000|Overall Study|Withdrawal by Subject|1|||
156993258|NCT02688621|566727388|FG001|Overall Study|Withdrawal by Subject|0|||
156993259|NCT05349864|566727395|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
156993260|NCT05349864|566727396|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
156993261|NCT00984282|566727397|FG000|Double Blind Treatment|Adverse Event|40|||
156993262|NCT00984282|566727398|FG001|Double Blind Treatment|Adverse Event|6|||
156993263|NCT00984282|566727397|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
156993264|NCT00984282|566727398|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
156993265|NCT00984282|566727397|FG000|Double Blind Treatment|Physician Decision|1|||
156993266|NCT00984282|566727398|FG001|Double Blind Treatment|Physician Decision|2|||
156993267|NCT00984282|566727397|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
156993268|NCT00984282|566727398|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
156993269|NCT00984282|566727397|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
156993270|NCT00984282|566727398|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
156993271|NCT00984282|566727397|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
156993272|NCT00984282|566727398|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
156993273|NCT00984282|566727397|FG000|Double Blind Treatment|Lost to Follow-up|3|||
156993274|NCT00984282|566727398|FG001|Double Blind Treatment|Lost to Follow-up|0|||
156993275|NCT00984282|566727397|FG000|Double Blind Treatment|Death|8|||
156993276|NCT00984282|566727398|FG001|Double Blind Treatment|Death|4|||
156993277|NCT00984282|566727397|FG000|Double Blind Treatment|Not treated|0|||
156993278|NCT00984282|566727398|FG001|Double Blind Treatment|Not treated|1|||
156993279|NCT00984282|566727397|FG000|Double Blind Treatment|Switched to commercial drug|6|||
156993280|NCT00984282|566727398|FG001|Double Blind Treatment|Switched to commercial drug|1|||
156993281|NCT00984282|566727397|FG000|Double Blind Treatment|protocol driven decision point|1|||
156993282|NCT00984282|566727398|FG001|Double Blind Treatment|protocol driven decision point|1|||
156993283|NCT00984282|566727397|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
156993284|NCT00984282|566727398|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
156993285|NCT00984282|566727397|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
156993286|NCT00984282|566727398|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
156993287|NCT00984282|566727397|FG000|Open-label Treatment|Adverse Event|20|||
156993288|NCT00984282|566727398|FG001|Open-label Treatment|Adverse Event|30|||
156993289|NCT00984282|566727397|FG000|Open-label Treatment|Withdrawal by Subject|6|||
156993290|NCT00984282|566727398|FG001|Open-label Treatment|Withdrawal by Subject|21|||
156993291|NCT00984282|566727397|FG000|Open-label Treatment|Death|7|||
157097212|NCT00150969|567110972|FG000|24-48 Month Extension|Other Reason|81|||
157097213|NCT00150969|567110973|FG001|24-48 Month Extension|Other Reason|91|||
157097214|NCT00146757|567110974|FG000|Overall Study|Death|1|||
157097215|NCT00146757|567110975|FG001|Overall Study|Death|0|||
157097216|NCT00146757|567110974|FG000|Overall Study|Adverse Event|1|||
157097217|NCT00146757|567110975|FG001|Overall Study|Adverse Event|0|||
157097218|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
157097219|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
157097220|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
156993292|NCT00984282|566727398|FG001|Open-label Treatment|Death|15|||
156993293|NCT00984282|566727397|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
156993294|NCT00984282|566727398|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
156993295|NCT00984282|566727397|FG000|Open-label Treatment|Lost to Follow-up|1|||
156993296|NCT00984282|566727398|FG001|Open-label Treatment|Lost to Follow-up|1|||
156993297|NCT00984282|566727397|FG000|Open-label Treatment|Patient convenience|1|||
156993298|NCT00984282|566727398|FG001|Open-label Treatment|Patient convenience|0|||
156993299|NCT00984282|566727397|FG000|Open-label Treatment|Non-compliant with study medication|1|||
156993300|NCT00984282|566727398|FG001|Open-label Treatment|Non-compliant with study medication|0|||
156993301|NCT00984282|566727397|FG000|Open-label Treatment|Target lesion removed|0|||
156993302|NCT00984282|566727398|FG001|Open-label Treatment|Target lesion removed|1|||
156993303|NCT00984282|566727397|FG000|Open-label Treatment|Protocol driven decision point|1|||
156993304|NCT00984282|566727398|FG001|Open-label Treatment|Protocol driven decision point|1|||
156993305|NCT00984282|566727397|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
156993306|NCT00984282|566727398|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
156993307|NCT00984282|566727397|FG000|Open-label Treatment|Switched to commercial drug|6|||
156993308|NCT00984282|566727398|FG001|Open-label Treatment|Switched to commercial drug|7|||
156993309|NCT00984282|566727397|FG000|Open-label Treatment|Physician Decision|1|||
156993310|NCT00984282|566727398|FG001|Open-label Treatment|Physician Decision|0|||
156993311|NCT00984282|566727397|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
156993312|NCT00984282|566727398|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
156993313|NCT00984282|566727397|FG000|Long Term Follow-up|Death|27|||
156993314|NCT00984282|566727398|FG001|Long Term Follow-up|Death|68|||
156993315|NCT00984282|566727397|FG000|Long Term Follow-up|Lost to Follow-up|3|||
156993316|NCT00984282|566727398|FG001|Long Term Follow-up|Lost to Follow-up|6|||
156993317|NCT00984282|566727397|FG000|Long Term Follow-up|Protocol driven decision point|25|||
156993318|NCT00984282|566727398|FG001|Long Term Follow-up|Protocol driven decision point|26|||
156993319|NCT00984282|566727397|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
156993320|NCT00984282|566727398|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
156993321|NCT00984282|566727397|FG000|Long Term Follow-up|Switched to commercial drug|4|||
156993322|NCT00984282|566727398|FG001|Long Term Follow-up|Switched to commercial drug|2|||
156993323|NCT00984282|566727397|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
156993324|NCT00984282|566727398|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
156993325|NCT02223793|566727399|FG000|Overall Study|Lost to Follow-up|10|||
156993326|NCT02223793|566727400|FG001|Overall Study|Lost to Follow-up|1|||
157097221|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
157097222|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
157097223|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
157097224|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
157097225|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
157097226|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
157097227|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
157097228|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
157097229|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
157097230|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
157097231|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
157097232|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
157097233|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
157097234|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
156993327|NCT02223793|566727401|FG002|Overall Study|Lost to Follow-up|2|||
156993328|NCT02223793|566727399|FG000|Overall Study|Withdrawal by Subject|3|||
156993329|NCT02223793|566727400|FG001|Overall Study|Withdrawal by Subject|2|||
156993330|NCT02223793|566727401|FG002|Overall Study|Withdrawal by Subject|3|||
156993331|NCT02223793|566727399|FG000|Overall Study|Moved/studycenter unable to participate|4|||
157097235|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
157097236|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
157097237|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
157097238|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
157097239|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
157097240|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
157097241|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
157097242|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
157097243|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
157097244|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
157097245|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
157097246|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
157097247|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
157097248|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Other|10|||
157097249|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Other|7|||
157097250|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Other|8|||
156993332|NCT02223793|566727400|FG001|Overall Study|Moved/studycenter unable to participate|6|||
156993333|NCT02223793|566727401|FG002|Overall Study|Moved/studycenter unable to participate|8|||
156993334|NCT02321540|566727402|FG000|Overall Study|Death|0|||
156993335|NCT02321540|566727403|FG001|Overall Study|Death|1|||
156993336|NCT02321540|566727402|FG000|Overall Study|Progression|3|||
156993337|NCT02321540|566727403|FG001|Overall Study|Progression|9|||
156993338|NCT03606460|566727405|FG000|Overall Study|Lost to Follow-up|1|||
156993339|NCT03606460|566727406|FG001|Overall Study|Lost to Follow-up|8|||
156993340|NCT00303303|566727407|FG000|Overall Study|Withdrawal by Subject|0|||
156993341|NCT00303303|566727408|FG001|Overall Study|Withdrawal by Subject|0|||
156993342|NCT00303303|566727409|FG002|Overall Study|Withdrawal by Subject|1|||
156993343|NCT02390557|566727410|FG000|Wave 2|Survey non-respondent|72|||
156993344|NCT02390557|566727411|FG001|Wave 2|Survey non-respondent|41|||
156993345|NCT02390557|566727412|FG002|Wave 2|Survey non-respondent|23|||
156993346|NCT04337489|566727413|FG000|Overall Study|Withdrawal by Subject|1|||
156993347|NCT03686683|566727414|FG000|Overall Study|Withdrawal by Subject|52|||
156993348|NCT03686683|566727415|FG001|Overall Study|Withdrawal by Subject|32|||
156993349|NCT03686683|566727414|FG000|Overall Study|Lost to Follow-up|23|||
156993350|NCT03686683|566727415|FG001|Overall Study|Lost to Follow-up|19|||
156993351|NCT03686683|566727414|FG000|Overall Study|Adverse Event|1|||
156993352|NCT03686683|566727415|FG001|Overall Study|Adverse Event|0|||
156993353|NCT03686683|566727414|FG000|Overall Study|Death|10|||
156993354|NCT03686683|566727415|FG001|Overall Study|Death|5|||
156993355|NCT03686683|566727414|FG000|Overall Study|Progressive Disease|1|||
156993356|NCT03686683|566727415|FG001|Overall Study|Progressive Disease|1|||
156993357|NCT03686683|566727414|FG000|Overall Study|Noncompliance|1|||
156993358|NCT03686683|566727415|FG001|Overall Study|Noncompliance|0|||
156993359|NCT03686683|566727414|FG000|Overall Study|Physician Decision|1|||
156993360|NCT03686683|566727415|FG001|Overall Study|Physician Decision|1|||
156993361|NCT03686683|566727414|FG000|Overall Study|Screen fail post-randomization|1|||
156993362|NCT03686683|566727415|FG001|Overall Study|Screen fail post-randomization|0|||
156993363|NCT03686683|566727414|FG000|Overall Study|Protocol Violation|3|||
156993364|NCT03686683|566727415|FG001|Overall Study|Protocol Violation|0|||
156993365|NCT03686683|566727414|FG000|Overall Study|No data available|1|||
156993366|NCT03686683|566727415|FG001|Overall Study|No data available|0|||
156993367|NCT03255941|566727416|FG000|Overall Study|Not eligible or refused injection|37|||
156993368|NCT03255941|566727417|FG001|Overall Study|Not eligible or refused injection|44|||
156993369|NCT03255941|566727418|FG002|Overall Study|Not eligible or refused injection|5|||
156993370|NCT03255941|566727419|FG003|Overall Study|Not eligible or refused injection|6|||
156993371|NCT03255941|566727416|FG000|Overall Study|Did not complete exit interview|1|||
156993372|NCT03255941|566727417|FG001|Overall Study|Did not complete exit interview|2|||
156993373|NCT03255941|566727418|FG002|Overall Study|Did not complete exit interview|0|||
156993374|NCT03255941|566727419|FG003|Overall Study|Did not complete exit interview|0|||
156993375|NCT00335153|566727420|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
156993376|NCT00335153|566727420|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
156993377|NCT00335153|566727420|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
156993378|NCT00335153|566727420|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
156993379|NCT00335153|566727420|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
156993380|NCT00335153|566727420|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
156993381|NCT00335153|566727420|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
157097251|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Other|8|||
156993382|NCT00335153|566727420|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
156993383|NCT00335153|566727420|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
156993384|NCT00335153|566727420|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
156993385|NCT01770860|566727423|FG000|Overall Study|Withdrawal by Subject|4|||
156993386|NCT01770860|566727423|FG000|Overall Study|Lost to Follow-up|1|||
156993387|NCT01770860|566727423|FG000|Overall Study|Administrative decision made by the PI|1|||
156993388|NCT05124899|566727424|FG000|Overall Study|Lost to Follow-up|3|||
156993389|NCT01648283|566727429|FG000|Overall Study|Withdrawal by Subject|14|||
156993390|NCT00821236|566727432|FG000|Overall Study|Lost to Follow-up|3|||
156993391|NCT01582243|566727436|FG000|Overall Study|Withdrawal by Subject|1|||
156993392|NCT01582243|566727436|FG000|Overall Study|Adverse Event|1|||
156993393|NCT01582243|566727436|FG000|Overall Study|Lost to Follow-up|1|||
156993394|NCT01008748|566727438|FG000|Overall Study|Lost to Follow-up|80|||
156993395|NCT01008748|566727438|FG000|Overall Study|Other|1|||
157097252|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Other|0|||
157097253|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
156993396|NCT04824131|566727440|FG000|CAB LA Oral Phase|Adverse Event|1|||
156993397|NCT04824131|566727440|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
156993398|NCT04824131|566727440|FG000|Step 3|Withdrawal by Subject|2|||
157097254|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
157097255|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
157097256|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
157097257|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
156993399|NCT00819234|566727447|FG000|Overall Study|Withdrawal by Subject|8|||
156993400|NCT00819234|566727448|FG001|Overall Study|Withdrawal by Subject|13|||
156993401|NCT00819234|566727449|FG002|Overall Study|Withdrawal by Subject|6|||
156993402|NCT00819234|566727450|FG003|Overall Study|Withdrawal by Subject|3|||
156993403|NCT00819234|566727451|FG004|Overall Study|Withdrawal by Subject|0|||
156993404|NCT00819234|566727452|FG005|Overall Study|Withdrawal by Subject|4|||
156993405|NCT00819234|566727453|FG006|Overall Study|Withdrawal by Subject|4|||
156993406|NCT00819234|566727454|FG007|Overall Study|Withdrawal by Subject|8|||
156993407|NCT00819234|566727455|FG008|Overall Study|Withdrawal by Subject|5|||
156993408|NCT00819234|566727456|FG009|Overall Study|Withdrawal by Subject|3|||
156993409|NCT00819234|566727447|FG000|Overall Study|Adverse Event|0|||
156993410|NCT00819234|566727448|FG001|Overall Study|Adverse Event|0|||
156993411|NCT00819234|566727449|FG002|Overall Study|Adverse Event|1|||
156993412|NCT00819234|566727450|FG003|Overall Study|Adverse Event|0|||
156993413|NCT00819234|566727451|FG004|Overall Study|Adverse Event|0|||
156993414|NCT00819234|566727452|FG005|Overall Study|Adverse Event|2|||
156993415|NCT00819234|566727453|FG006|Overall Study|Adverse Event|0|||
156993416|NCT00819234|566727454|FG007|Overall Study|Adverse Event|0|||
156993417|NCT00819234|566727455|FG008|Overall Study|Adverse Event|0|||
156993418|NCT00819234|566727456|FG009|Overall Study|Adverse Event|0|||
156993419|NCT00819234|566727447|FG000|Overall Study|Physician Decision|0|||
156993420|NCT00819234|566727448|FG001|Overall Study|Physician Decision|0|||
156993421|NCT00819234|566727449|FG002|Overall Study|Physician Decision|0|||
156993422|NCT00819234|566727450|FG003|Overall Study|Physician Decision|1|||
156993423|NCT00819234|566727451|FG004|Overall Study|Physician Decision|0|||
156993424|NCT00819234|566727452|FG005|Overall Study|Physician Decision|0|||
156993425|NCT00819234|566727453|FG006|Overall Study|Physician Decision|0|||
156993426|NCT00819234|566727454|FG007|Overall Study|Physician Decision|0|||
156993427|NCT00819234|566727455|FG008|Overall Study|Physician Decision|0|||
156993428|NCT00819234|566727456|FG009|Overall Study|Physician Decision|2|||
156993429|NCT00819234|566727447|FG000|Overall Study|Protocol Violation|0|||
156993430|NCT00819234|566727448|FG001|Overall Study|Protocol Violation|0|||
156993431|NCT00819234|566727449|FG002|Overall Study|Protocol Violation|1|||
156993432|NCT00819234|566727450|FG003|Overall Study|Protocol Violation|0|||
156993433|NCT00819234|566727451|FG004|Overall Study|Protocol Violation|0|||
156993434|NCT00819234|566727452|FG005|Overall Study|Protocol Violation|0|||
156993435|NCT00819234|566727453|FG006|Overall Study|Protocol Violation|0|||
156993436|NCT00819234|566727454|FG007|Overall Study|Protocol Violation|0|||
156993437|NCT00819234|566727455|FG008|Overall Study|Protocol Violation|0|||
156993438|NCT00819234|566727456|FG009|Overall Study|Protocol Violation|0|||
156993439|NCT00819234|566727447|FG000|Overall Study|Lost to Follow-up|2|||
156993440|NCT00819234|566727448|FG001|Overall Study|Lost to Follow-up|2|||
156993441|NCT00819234|566727449|FG002|Overall Study|Lost to Follow-up|0|||
156993442|NCT00819234|566727450|FG003|Overall Study|Lost to Follow-up|2|||
156993443|NCT00819234|566727451|FG004|Overall Study|Lost to Follow-up|1|||
156993444|NCT00819234|566727452|FG005|Overall Study|Lost to Follow-up|1|||
156993445|NCT00819234|566727453|FG006|Overall Study|Lost to Follow-up|1|||
156993446|NCT00819234|566727454|FG007|Overall Study|Lost to Follow-up|1|||
156993447|NCT00819234|566727455|FG008|Overall Study|Lost to Follow-up|1|||
156993448|NCT00819234|566727456|FG009|Overall Study|Lost to Follow-up|2|||
156993449|NCT04438785|566727457|FG000|Overall Study|change of weight, give up intervention|2|||
156993450|NCT04438785|566727458|FG001|Overall Study|change of weight, give up intervention|10|||
156993451|NCT01823341|566727459|FG000|Overall Study|Failed run-in|7|||
156993452|NCT01823341|566727459|FG000|Overall Study|Withdrawal by Subject|7|||
156993453|NCT01823341|566727459|FG000|Overall Study|Adverse Event|1|||
156993454|NCT00062868|566727476|FG000|Dose Level 1|Death|2|||
156993455|NCT00062868|566727477|FG001|Dose Level 1|Death|0|||
156993456|NCT00062868|566727478|FG002|Dose Level 1|Death|0|||
156993457|NCT00062868|566727479|FG003|Dose Level 1|Death|2|||
156993458|NCT00062868|566727480|FG004|Dose Level 1|Death|0|||
156993459|NCT00062868|566727481|FG005|Dose Level 1|Death|0|||
156993460|NCT00062868|566727482|FG006|Dose Level 1|Death|3|||
156993461|NCT00062868|566727483|FG007|Dose Level 1|Death|0|||
156993462|NCT00062868|566727484|FG008|Dose Level 1|Death|0|||
156993463|NCT00062868|566727485|FG009|Dose Level 1|Death|0|||
156993464|NCT00062868|566727486|FG010|Dose Level 1|Death|0|||
156993465|NCT00062868|566727487|FG011|Dose Level 1|Death|0|||
156993466|NCT00062868|566727488|FG012|Dose Level 1|Death|0|||
156993467|NCT00062868|566727489|FG013|Dose Level 1|Death|0|||
156993468|NCT00062868|566727490|FG014|Dose Level 1|Death|0|||
156993469|NCT00062868|566727491|FG015|Dose Level 1|Death|0|||
156993470|NCT00062868|566727492|FG016|Dose Level 1|Death|0|||
156993471|NCT00062868|566727493|FG017|Dose Level 1|Death|0|||
156993472|NCT00062868|566727494|FG018|Dose Level 1|Death|7|||
156993473|NCT00062868|566727495|FG019|Dose Level 1|Death|0|||
156993474|NCT00062868|566727496|FG020|Dose Level 1|Death|1|||
156993475|NCT00062868|566727476|FG000|Dose Level 1|Lost to Follow-up|0|||
156993476|NCT00062868|566727477|FG001|Dose Level 1|Lost to Follow-up|0|||
156993477|NCT00062868|566727478|FG002|Dose Level 1|Lost to Follow-up|0|||
156993478|NCT00062868|566727479|FG003|Dose Level 1|Lost to Follow-up|0|||
156993479|NCT00062868|566727480|FG004|Dose Level 1|Lost to Follow-up|0|||
156993480|NCT00062868|566727481|FG005|Dose Level 1|Lost to Follow-up|0|||
157097258|NCT00615836|567110976|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
157097259|NCT00615836|567110977|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
157097260|NCT00615836|567110978|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
157097261|NCT00615836|567110979|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
157097262|NCT00615836|567110980|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
157097263|NCT01630434|567110981|FG000|Overall Study|Donor lungs turned down|1|||
157097264|NCT01630434|567110982|FG001|Overall Study|Donor lungs turned down|0|||
157097265|NCT01630434|567110981|FG000|Overall Study|Protocol Violation|9|||
157097266|NCT01630434|567110982|FG001|Overall Study|Protocol Violation|4|||
157097267|NCT01630434|567110981|FG000|Overall Study|Death|20|||
157097268|NCT01630434|567110982|FG001|Overall Study|Death|26|||
157097269|NCT00687973|567110983|FG000|Overall Study|Adverse Event|18|||
157097270|NCT00687973|567110984|FG001|Overall Study|Adverse Event|28|||
157097271|NCT00687973|567110983|FG000|Overall Study|Lack of Efficacy|2|||
157097272|NCT00687973|567110984|FG001|Overall Study|Lack of Efficacy|3|||
157097273|NCT00687973|567110983|FG000|Overall Study|Protocol Violation|1|||
157097274|NCT00687973|567110984|FG001|Overall Study|Protocol Violation|2|||
157097275|NCT00687973|567110983|FG000|Overall Study|Administrative Reasons|0|||
157097276|NCT00687973|567110984|FG001|Overall Study|Administrative Reasons|2|||
157097277|NCT00687973|567110983|FG000|Overall Study|Withdrawal by Subject|3|||
157097278|NCT00687973|567110984|FG001|Overall Study|Withdrawal by Subject|3|||
157097279|NCT02121834|567110986|FG000|Overall Study|Protocol Violation|0|||
157097280|NCT02121834|567110987|FG001|Overall Study|Protocol Violation|1|||
157097281|NCT02121834|567110988|FG002|Overall Study|Protocol Violation|0|||
157097282|NCT02121834|567110989|FG003|Overall Study|Protocol Violation|0|||
157097283|NCT02121834|567110990|FG004|Overall Study|Protocol Violation|0|||
157097284|NCT02121834|567110991|FG005|Overall Study|Protocol Violation|0|||
157097285|NCT02121834|567110992|FG006|Overall Study|Protocol Violation|0|||
157097286|NCT02121834|567110986|FG000|Overall Study|Withdrawal by Subject|0|||
157097287|NCT02121834|567110987|FG001|Overall Study|Withdrawal by Subject|1|||
157097288|NCT02121834|567110988|FG002|Overall Study|Withdrawal by Subject|1|||
157097289|NCT02121834|567110989|FG003|Overall Study|Withdrawal by Subject|0|||
157097290|NCT02121834|567110990|FG004|Overall Study|Withdrawal by Subject|0|||
157097291|NCT02121834|567110991|FG005|Overall Study|Withdrawal by Subject|0|||
157097292|NCT02121834|567110992|FG006|Overall Study|Withdrawal by Subject|0|||
157097293|NCT02121834|567110986|FG000|Overall Study|Lost to Follow-up|0|||
157097294|NCT02121834|567110987|FG001|Overall Study|Lost to Follow-up|0|||
157097295|NCT02121834|567110988|FG002|Overall Study|Lost to Follow-up|1|||
157097296|NCT02121834|567110989|FG003|Overall Study|Lost to Follow-up|0|||
157097297|NCT02121834|567110990|FG004|Overall Study|Lost to Follow-up|0|||
157097298|NCT02121834|567110991|FG005|Overall Study|Lost to Follow-up|0|||
157097299|NCT02121834|567110992|FG006|Overall Study|Lost to Follow-up|0|||
157097300|NCT02578862|567110993|FG000|Overall Study|Withdrawal by Subject|0|||
157097301|NCT02578862|567110994|FG001|Overall Study|Withdrawal by Subject|1|||
157097302|NCT02578862|567110993|FG000|Overall Study|Unplanned unilateral procedure|0|||
157097303|NCT02578862|567110994|FG001|Overall Study|Unplanned unilateral procedure|1|||
157097304|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
157097305|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
157097306|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Death|0|||
157097307|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Death|2|||
157097308|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
157097309|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
157097310|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
157097311|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
157097312|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
157097313|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
157097314|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
157097315|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
157097316|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
156993481|NCT00062868|566727482|FG006|Dose Level 1|Lost to Follow-up|0|||
156993482|NCT00062868|566727483|FG007|Dose Level 1|Lost to Follow-up|0|||
156993483|NCT00062868|566727484|FG008|Dose Level 1|Lost to Follow-up|0|||
156993484|NCT00062868|566727485|FG009|Dose Level 1|Lost to Follow-up|0|||
156993485|NCT00062868|566727486|FG010|Dose Level 1|Lost to Follow-up|0|||
156993486|NCT00062868|566727487|FG011|Dose Level 1|Lost to Follow-up|0|||
156993487|NCT00062868|566727488|FG012|Dose Level 1|Lost to Follow-up|1|||
157097317|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
157097318|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
157097319|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
156993488|NCT00062868|566727489|FG013|Dose Level 1|Lost to Follow-up|0|||
157097320|NCT00343252|567111004|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
157097321|NCT00343252|567111005|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
156993489|NCT00062868|566727490|FG014|Dose Level 1|Lost to Follow-up|0|||
156993490|NCT00062868|566727491|FG015|Dose Level 1|Lost to Follow-up|0|||
157097322|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
157097323|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
157097324|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Death|3|||
157097325|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Death|3|||
157097326|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
157097327|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
157097328|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
157097329|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
157097330|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
157097331|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
157097332|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
157097333|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
157097334|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
157097335|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
157097336|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
156993491|NCT00062868|566727492|FG016|Dose Level 1|Lost to Follow-up|0|||
156993492|NCT00062868|566727493|FG017|Dose Level 1|Lost to Follow-up|0|||
156993493|NCT00062868|566727494|FG018|Dose Level 1|Lost to Follow-up|2|||
156993494|NCT00062868|566727495|FG019|Dose Level 1|Lost to Follow-up|0|||
156993495|NCT00062868|566727496|FG020|Dose Level 1|Lost to Follow-up|1|||
156993496|NCT00062868|566727476|FG000|Dose Level 2|Death|0|||
156993497|NCT00062868|566727477|FG001|Dose Level 2|Death|3|||
156993498|NCT00062868|566727478|FG002|Dose Level 2|Death|0|||
156993499|NCT00062868|566727479|FG003|Dose Level 2|Death|0|||
156993500|NCT00062868|566727480|FG004|Dose Level 2|Death|2|||
156993501|NCT00062868|566727481|FG005|Dose Level 2|Death|0|||
156993502|NCT00062868|566727482|FG006|Dose Level 2|Death|0|||
156993503|NCT00062868|566727483|FG007|Dose Level 2|Death|0|||
156993504|NCT00062868|566727484|FG008|Dose Level 2|Death|0|||
156993505|NCT00062868|566727485|FG009|Dose Level 2|Death|0|||
156993506|NCT00062868|566727486|FG010|Dose Level 2|Death|1|||
156993507|NCT00062868|566727487|FG011|Dose Level 2|Death|0|||
156993508|NCT00062868|566727488|FG012|Dose Level 2|Death|0|||
156993509|NCT00062868|566727489|FG013|Dose Level 2|Death|0|||
156993510|NCT00062868|566727490|FG014|Dose Level 2|Death|0|||
156993511|NCT00062868|566727491|FG015|Dose Level 2|Death|0|||
156993512|NCT00062868|566727492|FG016|Dose Level 2|Death|2|||
156993513|NCT00062868|566727493|FG017|Dose Level 2|Death|0|||
156993514|NCT00062868|566727494|FG018|Dose Level 2|Death|0|||
156993515|NCT00062868|566727495|FG019|Dose Level 2|Death|0|||
156993516|NCT00062868|566727496|FG020|Dose Level 2|Death|0|||
156993517|NCT00062868|566727476|FG000|Dose Level 2|Lost to Follow-up|0|||
156993518|NCT00062868|566727477|FG001|Dose Level 2|Lost to Follow-up|0|||
156993519|NCT00062868|566727478|FG002|Dose Level 2|Lost to Follow-up|0|||
156993520|NCT00062868|566727479|FG003|Dose Level 2|Lost to Follow-up|0|||
156993521|NCT00062868|566727480|FG004|Dose Level 2|Lost to Follow-up|0|||
156993522|NCT00062868|566727481|FG005|Dose Level 2|Lost to Follow-up|0|||
156993523|NCT00062868|566727482|FG006|Dose Level 2|Lost to Follow-up|0|||
156993524|NCT00062868|566727483|FG007|Dose Level 2|Lost to Follow-up|0|||
156993525|NCT00062868|566727484|FG008|Dose Level 2|Lost to Follow-up|0|||
156993526|NCT00062868|566727485|FG009|Dose Level 2|Lost to Follow-up|0|||
156993527|NCT00062868|566727486|FG010|Dose Level 2|Lost to Follow-up|0|||
156993528|NCT00062868|566727487|FG011|Dose Level 2|Lost to Follow-up|0|||
156993529|NCT00062868|566727488|FG012|Dose Level 2|Lost to Follow-up|0|||
156993530|NCT00062868|566727489|FG013|Dose Level 2|Lost to Follow-up|1|||
156993531|NCT00062868|566727490|FG014|Dose Level 2|Lost to Follow-up|0|||
156993532|NCT00062868|566727491|FG015|Dose Level 2|Lost to Follow-up|0|||
156993533|NCT00062868|566727492|FG016|Dose Level 2|Lost to Follow-up|1|||
156993534|NCT00062868|566727493|FG017|Dose Level 2|Lost to Follow-up|0|||
156993535|NCT00062868|566727494|FG018|Dose Level 2|Lost to Follow-up|0|||
156993536|NCT00062868|566727495|FG019|Dose Level 2|Lost to Follow-up|0|||
156993537|NCT00062868|566727496|FG020|Dose Level 2|Lost to Follow-up|0|||
156993538|NCT00062868|566727476|FG000|Dose Level 3|Death|0|||
156993539|NCT00062868|566727477|FG001|Dose Level 3|Death|0|||
156993540|NCT00062868|566727478|FG002|Dose Level 3|Death|0|||
156993541|NCT00062868|566727479|FG003|Dose Level 3|Death|0|||
156993542|NCT00062868|566727480|FG004|Dose Level 3|Death|0|||
156993543|NCT00062868|566727481|FG005|Dose Level 3|Death|0|||
156993544|NCT00062868|566727482|FG006|Dose Level 3|Death|0|||
156993545|NCT00062868|566727483|FG007|Dose Level 3|Death|0|||
156993546|NCT00062868|566727484|FG008|Dose Level 3|Death|0|||
156993547|NCT00062868|566727485|FG009|Dose Level 3|Death|0|||
156993548|NCT00062868|566727486|FG010|Dose Level 3|Death|0|||
156993549|NCT00062868|566727487|FG011|Dose Level 3|Death|1|||
156993550|NCT00062868|566727488|FG012|Dose Level 3|Death|0|||
156993551|NCT00062868|566727489|FG013|Dose Level 3|Death|0|||
156993552|NCT00062868|566727490|FG014|Dose Level 3|Death|0|||
156993553|NCT00062868|566727491|FG015|Dose Level 3|Death|0|||
156993554|NCT00062868|566727492|FG016|Dose Level 3|Death|0|||
156993555|NCT00062868|566727493|FG017|Dose Level 3|Death|1|||
156993556|NCT00062868|566727494|FG018|Dose Level 3|Death|0|||
156993557|NCT00062868|566727495|FG019|Dose Level 3|Death|0|||
156993558|NCT00062868|566727496|FG020|Dose Level 3|Death|0|||
156993559|NCT00062868|566727476|FG000|Dose Level 3|Lost to Follow-up|0|||
156993560|NCT00062868|566727477|FG001|Dose Level 3|Lost to Follow-up|0|||
156993561|NCT00062868|566727478|FG002|Dose Level 3|Lost to Follow-up|0|||
156993562|NCT00062868|566727479|FG003|Dose Level 3|Lost to Follow-up|0|||
156993563|NCT00062868|566727480|FG004|Dose Level 3|Lost to Follow-up|0|||
156993564|NCT00062868|566727481|FG005|Dose Level 3|Lost to Follow-up|0|||
156993565|NCT00062868|566727482|FG006|Dose Level 3|Lost to Follow-up|0|||
156993566|NCT00062868|566727483|FG007|Dose Level 3|Lost to Follow-up|0|||
156993567|NCT00062868|566727484|FG008|Dose Level 3|Lost to Follow-up|0|||
156993568|NCT00062868|566727485|FG009|Dose Level 3|Lost to Follow-up|0|||
156993569|NCT00062868|566727486|FG010|Dose Level 3|Lost to Follow-up|0|||
157097337|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
157097338|NCT00343252|567111004|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
157097339|NCT00343252|567111005|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
157097340|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
157097341|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
157097342|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Death|4|||
157097343|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Death|5|||
157097344|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
157097345|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
157097346|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
157097347|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
157097348|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
157097349|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
157097350|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
156993570|NCT00062868|566727487|FG011|Dose Level 3|Lost to Follow-up|0|||
156993571|NCT00062868|566727488|FG012|Dose Level 3|Lost to Follow-up|0|||
156993572|NCT00062868|566727489|FG013|Dose Level 3|Lost to Follow-up|0|||
156993573|NCT00062868|566727490|FG014|Dose Level 3|Lost to Follow-up|1|||
156993574|NCT00062868|566727491|FG015|Dose Level 3|Lost to Follow-up|0|||
156993575|NCT00062868|566727492|FG016|Dose Level 3|Lost to Follow-up|0|||
156993576|NCT00062868|566727493|FG017|Dose Level 3|Lost to Follow-up|0|||
156993577|NCT00062868|566727494|FG018|Dose Level 3|Lost to Follow-up|0|||
156993578|NCT00062868|566727495|FG019|Dose Level 3|Lost to Follow-up|0|||
156993579|NCT00062868|566727496|FG020|Dose Level 3|Lost to Follow-up|0|||
156993580|NCT00062868|566727476|FG000|Dose Level 3|Withdrew|0|||
156993581|NCT00062868|566727477|FG001|Dose Level 3|Withdrew|0|||
156993582|NCT00062868|566727478|FG002|Dose Level 3|Withdrew|2|||
156993583|NCT00062868|566727479|FG003|Dose Level 3|Withdrew|0|||
156993584|NCT00062868|566727480|FG004|Dose Level 3|Withdrew|0|||
156993585|NCT00062868|566727481|FG005|Dose Level 3|Withdrew|0|||
156993586|NCT00062868|566727482|FG006|Dose Level 3|Withdrew|0|||
156993587|NCT00062868|566727483|FG007|Dose Level 3|Withdrew|0|||
156993588|NCT00062868|566727484|FG008|Dose Level 3|Withdrew|0|||
156993589|NCT00062868|566727485|FG009|Dose Level 3|Withdrew|0|||
156993590|NCT00062868|566727486|FG010|Dose Level 3|Withdrew|0|||
156993591|NCT00062868|566727487|FG011|Dose Level 3|Withdrew|0|||
156993592|NCT00062868|566727488|FG012|Dose Level 3|Withdrew|0|||
157097351|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
157097352|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
157097353|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
157097354|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
157097355|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
157097356|NCT00343252|567111004|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
157097357|NCT00343252|567111005|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
157097358|NCT01026454|567111006|FG000|Second Intervention|Pregnancy|1|||
157097359|NCT01026454|567111007|FG001|Second Intervention|Pregnancy|1|||
157097360|NCT00394953|567111010|FG000|First Treatment Period|Adverse Event|1|||
157097361|NCT00394953|567111011|FG001|First Treatment Period|Adverse Event|2|||
157097362|NCT00394953|567111010|FG000|First Treatment Period|Death|6|||
157097363|NCT00394953|567111011|FG001|First Treatment Period|Death|7|||
157097364|NCT00394953|567111010|FG000|First Treatment Period|Lack of Efficacy|1|||
157097365|NCT00394953|567111011|FG001|First Treatment Period|Lack of Efficacy|1|||
157097366|NCT00394953|567111010|FG000|First Treatment Period|Withdrawal by Subject|6|||
157097367|NCT00394953|567111011|FG001|First Treatment Period|Withdrawal by Subject|3|||
156993593|NCT00062868|566727489|FG013|Dose Level 3|Withdrew|0|||
156993594|NCT00062868|566727490|FG014|Dose Level 3|Withdrew|0|||
156993595|NCT00062868|566727491|FG015|Dose Level 3|Withdrew|0|||
156993596|NCT00062868|566727492|FG016|Dose Level 3|Withdrew|0|||
156993597|NCT00062868|566727493|FG017|Dose Level 3|Withdrew|0|||
156993598|NCT00062868|566727494|FG018|Dose Level 3|Withdrew|0|||
156993599|NCT00062868|566727495|FG019|Dose Level 3|Withdrew|0|||
156993600|NCT00062868|566727496|FG020|Dose Level 3|Withdrew|0|||
156993601|NCT01641861|566727497|FG000|Overall Study|Lost to Follow-up|21|||
156993602|NCT01641861|566727498|FG001|Overall Study|Lost to Follow-up|16|||
156993603|NCT01641861|566727497|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
156993604|NCT01641861|566727498|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
156993605|NCT01641861|566727497|FG000|Overall Study|Died due to drowning|0|||
156993606|NCT01641861|566727498|FG001|Overall Study|Died due to drowning|1|||
156993607|NCT01712685|566727499|FG000|Overall Study|pt declined to participate before trmt|1|||
156993608|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Adverse Event|5|||
156993609|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Adverse Event|13|||
156993610|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Adverse Event|0|||
157097368|NCT00394953|567111010|FG000|First Treatment Period|Lost to Follow-up|0|||
157097369|NCT00394953|567111011|FG001|First Treatment Period|Lost to Follow-up|1|||
157097370|NCT00394953|567111010|FG000|First Treatment Period|Renal transplant|11|||
157097371|NCT00394953|567111011|FG001|First Treatment Period|Renal transplant|7|||
157097372|NCT00394953|567111010|FG000|First Treatment Period|Not defined|4|||
157097373|NCT00394953|567111011|FG001|First Treatment Period|Not defined|1|||
157097374|NCT00394953|567111010|FG000|Second Treatment Period|Adverse Event|2|||
157097375|NCT00394953|567111011|FG001|Second Treatment Period|Adverse Event|5|||
157097376|NCT00394953|567111010|FG000|Second Treatment Period|Death|8|||
157097377|NCT00394953|567111011|FG001|Second Treatment Period|Death|4|||
157097378|NCT00394953|567111010|FG000|Second Treatment Period|Lack of Efficacy|9|||
157097379|NCT00394953|567111011|FG001|Second Treatment Period|Lack of Efficacy|47|||
157097380|NCT00394953|567111010|FG000|Second Treatment Period|Withdrawal by Subject|3|||
157097381|NCT00394953|567111011|FG001|Second Treatment Period|Withdrawal by Subject|3|||
157097382|NCT00394953|567111010|FG000|Second Treatment Period|Lost to Follow-up|0|||
157097383|NCT00394953|567111011|FG001|Second Treatment Period|Lost to Follow-up|1|||
157097384|NCT00394953|567111010|FG000|Second Treatment Period|Renal transplant|4|||
157097385|NCT00394953|567111011|FG001|Second Treatment Period|Renal transplant|6|||
157097386|NCT00394953|567111010|FG000|Second Treatment Period|Not defined|3|||
157097387|NCT00394953|567111011|FG001|Second Treatment Period|Not defined|8|||
157097388|NCT03021954|567111019|FG000|Overall Study|Lost to Follow-up|10|||
157097389|NCT03021954|567111020|FG001|Overall Study|Lost to Follow-up|43|||
157097390|NCT03021954|567111019|FG000|Overall Study|Subjects had avulsion trauma|4|||
157097391|NCT03021954|567111020|FG001|Overall Study|Subjects had avulsion trauma|1|||
157097392|NCT02196714|567111023|FG000|Overall Study|Protocol Violation|0|||
157097393|NCT02196714|567111024|FG001|Overall Study|Protocol Violation|0|||
157097394|NCT02196714|567111025|FG002|Overall Study|Protocol Violation|1|||
157097395|NCT02196714|567111026|FG003|Overall Study|Protocol Violation|0|||
157097396|NCT01592864|567111028|FG000|Overall Study|Withdrawal by Subject|0|||
157097397|NCT01592864|567111029|FG001|Overall Study|Withdrawal by Subject|1|||
157097398|NCT03037619|567111034|FG000|Overall Study|Lost to Follow-up|0|||
157097399|NCT03037619|567111035|FG001|Overall Study|Lost to Follow-up|1|||
157097400|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
157097401|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
157097402|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
157097403|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
157097404|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
157097405|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
157097406|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
157097407|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
157097408|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
157097409|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
157097410|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
157097411|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
157097412|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
157097413|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
157097414|NCT01294683|567111038|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
157097415|NCT01294683|567111039|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
157097416|NCT01294683|567111038|FG000|Post Crossover (Period III)|Adverse Event|6|||
157097417|NCT01294683|567111039|FG001|Post Crossover (Period III)|Adverse Event|6|||
157097418|NCT01294683|567111038|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
157097419|NCT01294683|567111039|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
157097420|NCT01294683|567111038|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
157097421|NCT01294683|567111039|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
157097422|NCT01294683|567111038|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
157097423|NCT01294683|567111039|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
157097424|NCT01881750|567111040|FG000|Overall Study|Changes in concomitant therapies|2|||
157097425|NCT01881750|567111041|FG001|Overall Study|Changes in concomitant therapies|3|||
157097426|NCT01881750|567111040|FG000|Overall Study|Lost to Follow-up|0|||
157097427|NCT01881750|567111041|FG001|Overall Study|Lost to Follow-up|1|||
157097428|NCT00307125|567111042|FG000|Screening Phase|Adverse Event|1|||
157097429|NCT00307125|567111043|FG001|Screening Phase|Adverse Event|0|||
157097430|NCT00307125|567111044|FG002|Screening Phase|Adverse Event|0|||
157097431|NCT00307125|567111042|FG000|Screening Phase|Protocol Violation|27|||
157097432|NCT00307125|567111043|FG001|Screening Phase|Protocol Violation|0|||
157097433|NCT00307125|567111044|FG002|Screening Phase|Protocol Violation|0|||
157097434|NCT00307125|567111042|FG000|Screening Phase|Lost to Follow-up|87|||
157097435|NCT00307125|567111043|FG001|Screening Phase|Lost to Follow-up|0|||
157097436|NCT00307125|567111044|FG002|Screening Phase|Lost to Follow-up|0|||
157097437|NCT00307125|567111042|FG000|Screening Phase|Death|10|||
157097438|NCT00307125|567111043|FG001|Screening Phase|Death|0|||
157097439|NCT00307125|567111044|FG002|Screening Phase|Death|0|||
157097440|NCT00307125|567111042|FG000|Screening Phase|Withdrawal by Subject|77|||
157097441|NCT00307125|567111043|FG001|Screening Phase|Withdrawal by Subject|0|||
157097442|NCT00307125|567111044|FG002|Screening Phase|Withdrawal by Subject|0|||
157097443|NCT00307125|567111042|FG000|Screening Phase|Physician Decision|26|||
157097444|NCT00307125|567111043|FG001|Screening Phase|Physician Decision|0|||
157097445|NCT00307125|567111044|FG002|Screening Phase|Physician Decision|0|||
157097446|NCT00307125|567111042|FG000|Screening Phase|Sponsor Decision|4|||
157097447|NCT00307125|567111043|FG001|Screening Phase|Sponsor Decision|0|||
157097448|NCT00307125|567111044|FG002|Screening Phase|Sponsor Decision|0|||
157097449|NCT00307125|567111042|FG000|Screening Phase|Study Terminated|17|||
157097450|NCT00307125|567111043|FG001|Screening Phase|Study Terminated|0|||
157097451|NCT00307125|567111044|FG002|Screening Phase|Study Terminated|0|||
157097452|NCT00307125|567111042|FG000|Screening Phase|Graft Loss|3|||
157097453|NCT00307125|567111043|FG001|Screening Phase|Graft Loss|0|||
157097454|NCT00307125|567111044|FG002|Screening Phase|Graft Loss|0|||
157097455|NCT00307125|567111042|FG000|Screening Phase|Graft Failure|8|||
157097456|NCT00307125|567111043|FG001|Screening Phase|Graft Failure|0|||
157097457|NCT00307125|567111044|FG002|Screening Phase|Graft Failure|0|||
157097458|NCT00307125|567111042|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
157097459|NCT00307125|567111043|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
157097460|NCT00307125|567111044|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
157097461|NCT00307125|567111042|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
157097462|NCT00307125|567111043|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
157097463|NCT00307125|567111044|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
157097464|NCT00307125|567111042|FG000|Screening Phase|Moved or transferred facilities|34|||
157097465|NCT00307125|567111043|FG001|Screening Phase|Moved or transferred facilities|0|||
157097466|NCT00307125|567111044|FG002|Screening Phase|Moved or transferred facilities|0|||
157097467|NCT00307125|567111042|FG000|Screening Phase|Received Pancreas Transplant|8|||
157097468|NCT00307125|567111043|FG001|Screening Phase|Received Pancreas Transplant|0|||
157097469|NCT00307125|567111044|FG002|Screening Phase|Received Pancreas Transplant|0|||
157097470|NCT00307125|567111042|FG000|Screening Phase|Ineligible for pilot|4|||
157097471|NCT00307125|567111043|FG001|Screening Phase|Ineligible for pilot|0|||
157097472|NCT00307125|567111044|FG002|Screening Phase|Ineligible for pilot|0|||
157097473|NCT00307125|567111042|FG000|Screening Phase|Try to get pregnant|1|||
157097474|NCT00307125|567111043|FG001|Screening Phase|Try to get pregnant|0|||
157097475|NCT00307125|567111044|FG002|Screening Phase|Try to get pregnant|0|||
157097476|NCT00307125|567111042|FG000|Screening Phase|Developed acute leukemia|1|||
157097477|NCT00307125|567111043|FG001|Screening Phase|Developed acute leukemia|0|||
157097478|NCT00307125|567111044|FG002|Screening Phase|Developed acute leukemia|0|||
157097479|NCT00307125|567111042|FG000|Screening Phase|Metastatic colon cancer|1|||
157097480|NCT00307125|567111043|FG001|Screening Phase|Metastatic colon cancer|0|||
157097481|NCT00307125|567111044|FG002|Screening Phase|Metastatic colon cancer|0|||
157097482|NCT00307125|567111042|FG000|Screening Phase|Malignancy|1|||
157097483|NCT00307125|567111043|FG001|Screening Phase|Malignancy|0|||
157097484|NCT00307125|567111044|FG002|Screening Phase|Malignancy|0|||
157097485|NCT00307125|567111042|FG000|Screening Phase|PAK|1|||
157097486|NCT00307125|567111043|FG001|Screening Phase|PAK|0|||
156993611|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
156993612|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
156993613|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
156993614|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
156993615|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
156993616|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
156993617|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
156993618|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
156993619|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
156993620|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
157097487|NCT00307125|567111044|FG002|Screening Phase|PAK|0|||
157097488|NCT00307125|567111042|FG000|Screening Phase|Ineligible|1|||
157097489|NCT00307125|567111043|FG001|Screening Phase|Ineligible|0|||
157097490|NCT00307125|567111044|FG002|Screening Phase|Ineligible|0|||
157097491|NCT00307125|567111042|FG000|Screening Phase|Screen Error|1|||
157097492|NCT00307125|567111043|FG001|Screening Phase|Screen Error|0|||
157097493|NCT00307125|567111044|FG002|Screening Phase|Screen Error|0|||
157097494|NCT00307125|567111042|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
157097495|NCT00307125|567111043|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
157097496|NCT00307125|567111044|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
157097497|NCT00307125|567111042|FG000|Screening Phase|AMR and treated with rituximab|1|||
157097498|NCT00307125|567111043|FG001|Screening Phase|AMR and treated with rituximab|0|||
157097499|NCT00307125|567111044|FG002|Screening Phase|AMR and treated with rituximab|0|||
157097500|NCT00307125|567111042|FG000|Screening Phase|Coronary artery bypass|1|||
157097501|NCT00307125|567111043|FG001|Screening Phase|Coronary artery bypass|0|||
157097502|NCT00307125|567111044|FG002|Screening Phase|Coronary artery bypass|0|||
157097503|NCT00307125|567111042|FG000|Pilot Phase|Lost to Follow-up|0|||
157097504|NCT00307125|567111043|FG001|Pilot Phase|Lost to Follow-up|1|||
157097505|NCT00307125|567111044|FG002|Pilot Phase|Lost to Follow-up|0|||
157097506|NCT00307125|567111042|FG000|Pilot Phase|Withdrawal by Subject|0|||
157097507|NCT00307125|567111043|FG001|Pilot Phase|Withdrawal by Subject|1|||
157097508|NCT00307125|567111044|FG002|Pilot Phase|Withdrawal by Subject|1|||
157097509|NCT00051363|567111045|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
157097510|NCT00051363|567111046|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
157097511|NCT00051363|567111045|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
157097512|NCT00051363|567111046|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
157097513|NCT00051363|567111045|FG000|Overall Study|Death|2|||
157097514|NCT00051363|567111046|FG001|Overall Study|Death|2|||
157097515|NCT00051363|567111045|FG000|Overall Study|Excluded Pre-Randomization|2|||
157097516|NCT00051363|567111046|FG001|Overall Study|Excluded Pre-Randomization|5|||
157097517|NCT02571049|567111047|FG000|Screening|Did not meet entry criteria|2|||
157097518|NCT02571049|567111048|FG001|Screening|Did not meet entry criteria|2|||
157097519|NCT02571049|567111047|FG000|Randomization|No migraine attack|0|||
157097520|NCT02571049|567111048|FG001|Randomization|No migraine attack|1|||
157097521|NCT02571049|567111047|FG000|Randomization|Adverse Event|0|||
157097522|NCT02571049|567111048|FG001|Randomization|Adverse Event|1|||
157097523|NCT01055262|567111051|FG000|Overall Study|Adverse Event|5|||
157097524|NCT01055262|567111051|FG000|Overall Study|Protocol Violation|3|||
157097525|NCT01055262|567111051|FG000|Overall Study|Uncooperativeness|1|||
157097526|NCT03370471|567111053|FG000|Overall Study|Withdrawal by Subject|6|||
157097527|NCT03370471|567111054|FG001|Overall Study|Withdrawal by Subject|1|||
157097528|NCT03370471|567111053|FG000|Overall Study|Unable to access veins for blood draw|0|||
157097529|NCT03370471|567111054|FG001|Overall Study|Unable to access veins for blood draw|1|||
157097530|NCT03370471|567111053|FG000|Overall Study|Screen fail|1|||
157097531|NCT03370471|567111054|FG001|Overall Study|Screen fail|0|||
157097532|NCT00421707|567111055|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
157097533|NCT00421707|567111056|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
157097534|NCT00421707|567111055|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
157097535|NCT00421707|567111056|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
157097536|NCT00421707|567111055|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
157097537|NCT00421707|567111056|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
157097538|NCT00421707|567111055|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
157097539|NCT00421707|567111056|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
157097540|NCT00421707|567111055|FG000|Period 2: Washout|Adverse Event|1|||
157097541|NCT00421707|567111056|FG001|Period 2: Washout|Adverse Event|1|||
157097542|NCT00421707|567111055|FG000|Period 2: Washout|Withdrawal by Subject|0|||
157097543|NCT00421707|567111056|FG001|Period 2: Washout|Withdrawal by Subject|1|||
157097544|NCT00421707|567111055|FG000|Period 2: Washout|Lost to Follow-up|0|||
157097545|NCT00421707|567111056|FG001|Period 2: Washout|Lost to Follow-up|1|||
157097546|NCT00421707|567111055|FG000|Period 2: Washout|Other: Pregnancy|0|||
157097547|NCT00421707|567111056|FG001|Period 2: Washout|Other: Pregnancy|1|||
157097548|NCT00421707|567111055|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
157097549|NCT00421707|567111056|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
157097550|NCT00421707|567111055|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
157097551|NCT00421707|567111056|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
157097552|NCT00421707|567111055|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
157097553|NCT00421707|567111056|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
157097554|NCT00971243|567111057|FG000|Double Blind Period|Adverse Event|2|||
157097555|NCT00971243|567111058|FG001|Double Blind Period|Adverse Event|3|||
157097556|NCT00971243|567111059|FG002|Double Blind Period|Adverse Event|2|||
157097557|NCT00971243|567111060|FG003|Double Blind Period|Adverse Event|2|||
157097558|NCT00971243|567111061|FG004|Double Blind Period|Adverse Event|3|||
157097559|NCT00971243|567111057|FG000|Double Blind Period|Lost to Follow-up|0|||
157097560|NCT00971243|567111058|FG001|Double Blind Period|Lost to Follow-up|1|||
157097561|NCT00971243|567111059|FG002|Double Blind Period|Lost to Follow-up|1|||
157097562|NCT00971243|567111060|FG003|Double Blind Period|Lost to Follow-up|0|||
157097563|NCT00971243|567111061|FG004|Double Blind Period|Lost to Follow-up|1|||
157097564|NCT00971243|567111057|FG000|Double Blind Period|Physician Decision|10|||
157097565|NCT00971243|567111058|FG001|Double Blind Period|Physician Decision|6|||
157097566|NCT00971243|567111059|FG002|Double Blind Period|Physician Decision|7|||
157097567|NCT00971243|567111060|FG003|Double Blind Period|Physician Decision|6|||
157097568|NCT00971243|567111061|FG004|Double Blind Period|Physician Decision|7|||
157097569|NCT00971243|567111057|FG000|Double Blind Period|Protocol Violation|2|||
157097570|NCT00971243|567111058|FG001|Double Blind Period|Protocol Violation|0|||
157097571|NCT00971243|567111059|FG002|Double Blind Period|Protocol Violation|3|||
157097572|NCT00971243|567111060|FG003|Double Blind Period|Protocol Violation|2|||
157097573|NCT00971243|567111061|FG004|Double Blind Period|Protocol Violation|2|||
157097574|NCT00971243|567111057|FG000|Double Blind Period|Withdrawal by Subject|4|||
157097575|NCT00971243|567111058|FG001|Double Blind Period|Withdrawal by Subject|1|||
157097576|NCT00971243|567111059|FG002|Double Blind Period|Withdrawal by Subject|4|||
157097577|NCT00971243|567111060|FG003|Double Blind Period|Withdrawal by Subject|4|||
157097578|NCT00971243|567111061|FG004|Double Blind Period|Withdrawal by Subject|4|||
157097579|NCT00971243|567111057|FG000|Double Blind Period|Other reasons|1|||
157097580|NCT00971243|567111058|FG001|Double Blind Period|Other reasons|0|||
157097581|NCT00971243|567111059|FG002|Double Blind Period|Other reasons|2|||
157097582|NCT00971243|567111060|FG003|Double Blind Period|Other reasons|0|||
157097583|NCT00971243|567111061|FG004|Double Blind Period|Other reasons|1|||
157097584|NCT00971243|567111057|FG000|Open-label Period|Adverse Event|1|||
157097585|NCT00971243|567111058|FG001|Open-label Period|Adverse Event|0|||
157097586|NCT00971243|567111059|FG002|Open-label Period|Adverse Event|1|||
157097587|NCT00971243|567111060|FG003|Open-label Period|Adverse Event|1|||
157097588|NCT00971243|567111061|FG004|Open-label Period|Adverse Event|0|||
157097589|NCT00971243|567111057|FG000|Open-label Period|Physician Decision|5|||
157097590|NCT00971243|567111058|FG001|Open-label Period|Physician Decision|9|||
157097591|NCT00971243|567111059|FG002|Open-label Period|Physician Decision|3|||
157097592|NCT00971243|567111060|FG003|Open-label Period|Physician Decision|7|||
157097593|NCT00971243|567111061|FG004|Open-label Period|Physician Decision|2|||
157097594|NCT00971243|567111057|FG000|Open-label Period|Protocol Violation|1|||
157097595|NCT00971243|567111058|FG001|Open-label Period|Protocol Violation|1|||
157097596|NCT00971243|567111059|FG002|Open-label Period|Protocol Violation|1|||
157097597|NCT00971243|567111060|FG003|Open-label Period|Protocol Violation|0|||
157097598|NCT00971243|567111061|FG004|Open-label Period|Protocol Violation|1|||
157097599|NCT00971243|567111057|FG000|Open-label Period|Withdrawal by Subject|1|||
157097600|NCT00971243|567111058|FG001|Open-label Period|Withdrawal by Subject|0|||
157097601|NCT00971243|567111059|FG002|Open-label Period|Withdrawal by Subject|0|||
157097602|NCT00971243|567111060|FG003|Open-label Period|Withdrawal by Subject|2|||
157097603|NCT00971243|567111061|FG004|Open-label Period|Withdrawal by Subject|1|||
157097604|NCT00971243|567111057|FG000|Open-label Period|Other reason|0|||
157097605|NCT00971243|567111058|FG001|Open-label Period|Other reason|0|||
157097606|NCT00971243|567111059|FG002|Open-label Period|Other reason|0|||
157097607|NCT00971243|567111060|FG003|Open-label Period|Other reason|0|||
157097608|NCT00971243|567111061|FG004|Open-label Period|Other reason|2|||
157097609|NCT00803270|567111062|FG000|Overall Study|Lost to Follow-up|1|||
157097610|NCT00803270|567111063|FG001|Overall Study|Lost to Follow-up|2|||
157097611|NCT02903368|567111066|FG000|Part 1|Adverse Event|3|||
157097612|NCT02903368|567111067|FG001|Part 1|Adverse Event|0|||
157097613|NCT02903368|567111068|FG002|Part 1|Adverse Event|0|||
157097614|NCT02903368|567111069|FG003|Part 1|Adverse Event|0|||
157097615|NCT02903368|567111066|FG000|Part 1|Withdrawal by Subject|1|||
157097616|NCT02903368|567111067|FG001|Part 1|Withdrawal by Subject|0|||
157097617|NCT02903368|567111068|FG002|Part 1|Withdrawal by Subject|0|||
157097618|NCT02903368|567111069|FG003|Part 1|Withdrawal by Subject|0|||
157097619|NCT02903368|567111066|FG000|Part 2|Adverse Event|0|||
157097620|NCT02903368|567111067|FG001|Part 2|Adverse Event|0|||
157097621|NCT02903368|567111068|FG002|Part 2|Adverse Event|5|||
157097622|NCT02903368|567111069|FG003|Part 2|Adverse Event|0|||
157097623|NCT02903368|567111066|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
157097624|NCT02903368|567111067|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
157097625|NCT02903368|567111068|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
157097626|NCT02903368|567111069|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
157097627|NCT02903368|567111066|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
157097628|NCT02903368|567111067|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
157097629|NCT02903368|567111068|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
157097630|NCT02903368|567111069|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
157097631|NCT02903368|567111066|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
157097632|NCT02903368|567111067|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
157097633|NCT02903368|567111068|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
157097634|NCT02903368|567111069|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
157097635|NCT03769181|567112939|FG000|Overall Study|Adverse Event|1|||
157097636|NCT03769181|567112940|FG001|Overall Study|Adverse Event|0|||
157097637|NCT03769181|567112941|FG002|Overall Study|Adverse Event|2|||
157097638|NCT03769181|567112942|FG003|Overall Study|Adverse Event|4|||
157097639|NCT03769181|567112939|FG000|Overall Study|Withdrawal by Subject|1|||
157097640|NCT03769181|567112940|FG001|Overall Study|Withdrawal by Subject|0|||
157097641|NCT03769181|567112941|FG002|Overall Study|Withdrawal by Subject|2|||
157097642|NCT03769181|567112942|FG003|Overall Study|Withdrawal by Subject|1|||
157097643|NCT03769181|567112939|FG000|Overall Study|Progressive disease|9|||
157097644|NCT03769181|567112940|FG001|Overall Study|Progressive disease|7|||
157097645|NCT03769181|567112941|FG002|Overall Study|Progressive disease|13|||
157097646|NCT03769181|567112942|FG003|Overall Study|Progressive disease|6|||
157097647|NCT03769181|567112939|FG000|Overall Study|Other - Unspecified|2|||
157097648|NCT03769181|567112940|FG001|Overall Study|Other - Unspecified|1|||
157097649|NCT03769181|567112941|FG002|Overall Study|Other - Unspecified|0|||
157097650|NCT03769181|567112942|FG003|Overall Study|Other - Unspecified|0|||
157097651|NCT01485354|567112943|FG000|Overall Study|Withdrawal by Subject|5|||
156993621|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
157097652|NCT03338192|567112944|FG000|Year One to Year Two|High Blood Pressure|7|||
157097653|NCT03338192|567112945|FG001|Year One to Year Two|High Blood Pressure|1|||
157097654|NCT03338192|567112944|FG000|Year One to Year Two|HIV +|1|||
157097655|NCT03338192|567112945|FG001|Year One to Year Two|HIV +|0|||
157097656|NCT03338192|567112944|FG000|Year Two to Year Four|High Blood Pressure|1|||
157097657|NCT03338192|567112945|FG001|Year Two to Year Four|High Blood Pressure|0|||
157097658|NCT03338192|567112944|FG000|Year Two to Year Four|HIV +|2|||
157097659|NCT03338192|567112945|FG001|Year Two to Year Four|HIV +|0|||
157097660|NCT03338192|567112944|FG000|Year Four to Year Six|High Blood Pressure|2|||
157097661|NCT03338192|567112945|FG001|Year Four to Year Six|High Blood Pressure|1|||
157097662|NCT00985166|567112948|FG000|Overall Study|Lost to Follow-up|3|||
157097663|NCT00985166|567112949|FG001|Overall Study|Lost to Follow-up|2|||
157097664|NCT00985166|567112950|FG002|Overall Study|Lost to Follow-up|2|||
157097665|NCT00985166|567112948|FG000|Overall Study|Withdrawal by Subject|3|||
157097666|NCT00985166|567112949|FG001|Overall Study|Withdrawal by Subject|2|||
157097667|NCT00985166|567112950|FG002|Overall Study|Withdrawal by Subject|0|||
157097668|NCT00985166|567112948|FG000|Overall Study|Test not done|2|||
157097669|NCT00985166|567112949|FG001|Overall Study|Test not done|0|||
157097670|NCT00985166|567112950|FG002|Overall Study|Test not done|4|||
157097671|NCT00985166|567112948|FG000|Overall Study|Other|1|||
157097672|NCT00985166|567112949|FG001|Overall Study|Other|0|||
157097673|NCT00985166|567112950|FG002|Overall Study|Other|1|||
157097674|NCT02276872|567112951|FG000|Overall Study|Adverse Event|1|||
157097675|NCT02276872|567112952|FG001|Overall Study|Adverse Event|0|||
157097676|NCT02276872|567112953|FG002|Overall Study|Adverse Event|0|||
157097677|NCT04175808|567112954|FG000|Part A|Miscellaneous|2|||
157097678|NCT04175808|567112955|FG001|Part A|Miscellaneous|0|||
157097679|NCT04175808|567112956|FG002|Part A|Miscellaneous|0|||
157097680|NCT04175808|567112957|FG003|Part A|Miscellaneous|0|||
157097681|NCT04175808|567112958|FG004|Part A|Miscellaneous|0|||
157097682|NCT04175808|567112959|FG005|Part A|Miscellaneous|0|||
157097683|NCT04175808|567112960|FG006|Part A|Miscellaneous|0|||
157097684|NCT04263909|567112961|FG000|Overall Study|Physician Decision|1|||
157097685|NCT04263909|567112962|FG001|Overall Study|Physician Decision|0|||
157097686|NCT04263909|567112963|FG002|Overall Study|Physician Decision|0|||
157097687|NCT04263909|567112961|FG000|Overall Study|Adverse Event|3|||
157097688|NCT04263909|567112962|FG001|Overall Study|Adverse Event|0|||
157097689|NCT04263909|567112963|FG002|Overall Study|Adverse Event|0|||
157097690|NCT04263909|567112961|FG000|Overall Study|Protocol Violation|5|||
157097691|NCT04263909|567112962|FG001|Overall Study|Protocol Violation|0|||
157097692|NCT04263909|567112963|FG002|Overall Study|Protocol Violation|0|||
157097693|NCT00068588|567112964|FG000|Overall Study|Adverse Event|0|||
157097694|NCT00068588|567112965|FG001|Overall Study|Adverse Event|0|||
157097695|NCT00068588|567112966|FG002|Overall Study|Adverse Event|2|||
157097696|NCT00068588|567112964|FG000|Overall Study|Withdrawal by Subject|0|||
157097697|NCT00068588|567112965|FG001|Overall Study|Withdrawal by Subject|0|||
157097698|NCT00068588|567112966|FG002|Overall Study|Withdrawal by Subject|1|||
157097699|NCT00068588|567112964|FG000|Overall Study|Poor KPS|0|||
157097700|NCT00068588|567112965|FG001|Overall Study|Poor KPS|0|||
157097701|NCT00068588|567112966|FG002|Overall Study|Poor KPS|1|||
157097702|NCT03840486|567112967|FG000|Overall Study|Withdrawal by Subject|0|||
157097703|NCT03840486|567112968|FG001|Overall Study|Withdrawal by Subject|1|||
156993622|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
156993623|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
156993624|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
156993625|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
156993626|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Physician Decision|2|||
156993627|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Physician Decision|3|||
156993628|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Physician Decision|0|||
156993629|NCT01449929|566727500|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
156993630|NCT01449929|566727501|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
157097704|NCT03840486|567112969|FG002|Overall Study|Withdrawal by Subject|0|||
157097705|NCT03840486|567112970|FG003|Overall Study|Withdrawal by Subject|0|||
157097706|NCT03840486|567112971|FG004|Overall Study|Withdrawal by Subject|0|||
157097707|NCT03840486|567112972|FG005|Overall Study|Withdrawal by Subject|0|||
157097708|NCT03840486|567112973|FG006|Overall Study|Withdrawal by Subject|0|||
157097709|NCT03840486|567112974|FG007|Overall Study|Withdrawal by Subject|0|||
157097710|NCT03840486|567112975|FG008|Overall Study|Withdrawal by Subject|0|||
157097711|NCT03840486|567112976|FG009|Overall Study|Withdrawal by Subject|0|||
157097712|NCT03840486|567112977|FG010|Overall Study|Withdrawal by Subject|0|||
157097713|NCT03840486|567112978|FG011|Overall Study|Withdrawal by Subject|0|||
157097714|NCT01128894|567112979|FG000|Overall Study|Adverse Event|31|||
157097715|NCT01128894|567112980|FG001|Overall Study|Adverse Event|41|||
157097716|NCT01128894|567112979|FG000|Overall Study|Protocol Violation|2|||
157097717|NCT01128894|567112980|FG001|Overall Study|Protocol Violation|1|||
157097718|NCT01128894|567112979|FG000|Overall Study|Noncompliance|4|||
157097719|NCT01128894|567112980|FG001|Overall Study|Noncompliance|5|||
157097720|NCT01128894|567112979|FG000|Overall Study|Lost to Follow-up|8|||
157097721|NCT01128894|567112980|FG001|Overall Study|Lost to Follow-up|8|||
157097722|NCT01128894|567112979|FG000|Overall Study|Withdrawal by Subject|10|||
157097723|NCT01128894|567112980|FG001|Overall Study|Withdrawal by Subject|12|||
156993631|NCT01449929|566727502|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
156993632|NCT01449929|566727500|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
156993633|NCT01449929|566727501|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
157097724|NCT01128894|567112979|FG000|Overall Study|Physician Decision|2|||
157097725|NCT01128894|567112980|FG001|Overall Study|Physician Decision|1|||
157097726|NCT01128894|567112979|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
157097727|NCT01128894|567112980|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
157097728|NCT03437278|567112981|FG000|Overall Study|Adverse Event|0|||
157097729|NCT03437278|567112982|FG001|Overall Study|Adverse Event|0|||
157097730|NCT03437278|567112983|FG002|Overall Study|Adverse Event|1|||
157097731|NCT03437278|567112981|FG000|Overall Study|Progressive disease|1|||
157097732|NCT03437278|567112982|FG001|Overall Study|Progressive disease|0|||
157097733|NCT03437278|567112983|FG002|Overall Study|Progressive disease|0|||
157097734|NCT03437278|567112981|FG000|Overall Study|Physician Decision|1|||
157097735|NCT03437278|567112982|FG001|Overall Study|Physician Decision|0|||
157097736|NCT03437278|567112983|FG002|Overall Study|Physician Decision|1|||
157097737|NCT01009203|567112985|FG000|Overall Study|Withdrawal by Subject|1|||
157097738|NCT01009203|567112985|FG000|Overall Study|Adverse Event|5|||
157097739|NCT01009203|567112985|FG000|Overall Study|Treatment-unrelated death|1|||
157097740|NCT02076178|567112986|FG000|Oral Phase|Adverse Event|0|||
157097741|NCT02076178|567112987|FG001|Oral Phase|Adverse Event|7|||
157097742|NCT02076178|567112986|FG000|Oral Phase|Withdrawal by Subject|0|||
157097743|NCT02076178|567112987|FG001|Oral Phase|Withdrawal by Subject|4|||
157097744|NCT02076178|567112986|FG000|Oral Phase|Physician Decision|0|||
157097745|NCT02076178|567112987|FG001|Oral Phase|Physician Decision|1|||
157097746|NCT02076178|567112986|FG000|Injection Phase|Protocol defined stopping criteria|1|||
157097747|NCT02076178|567112987|FG001|Injection Phase|Protocol defined stopping criteria|0|||
157097748|NCT02076178|567112986|FG000|Injection Phase|Withdrawal by Subject|0|||
157097749|NCT02076178|567112987|FG001|Injection Phase|Withdrawal by Subject|3|||
157097750|NCT02076178|567112986|FG000|Injection Phase|Physician Decision|0|||
157097751|NCT02076178|567112987|FG001|Injection Phase|Physician Decision|3|||
157097752|NCT02076178|567112986|FG000|Injection Phase|Lost to Follow-up|0|||
157097753|NCT02076178|567112987|FG001|Injection Phase|Lost to Follow-up|1|||
157097754|NCT02893930|567112988|FG000|Overall Study|Adverse Event|3|||
157097755|NCT02893930|567112988|FG000|Overall Study|Death|1|||
157097756|NCT02893930|567112988|FG000|Overall Study|Disease progression|5|||
157097757|NCT02893930|567112988|FG000|Overall Study|Withdrawal by Subject|2|||
157097758|NCT02893930|567112988|FG000|Overall Study|Physician Decision|1|||
157097759|NCT02893930|567112988|FG000|Overall Study|Ineligible|1|||
157097760|NCT01142596|567112989|FG000|Overall Study|Withdrawal by Subject|9|||
156993634|NCT01449929|566727502|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
156993635|NCT01449929|566727500|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
156993636|NCT01449929|566727501|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
156993637|NCT01449929|566727502|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
156993638|NCT01449929|566727500|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
156993639|NCT01449929|566727501|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
156993640|NCT01449929|566727502|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
156993641|NCT01919619|566727503|FG000|Overall Study|Physician Decision|1|||
156993642|NCT01919619|566727504|FG001|Overall Study|Physician Decision|1|||
156993643|NCT02268396|566729326|FG000|Overall Study|Adverse Event|3|||
156993644|NCT02268396|566729326|FG000|Overall Study|Administrative|2|||
156993645|NCT02268396|566729326|FG000|Overall Study|Withdrawal by Subject|1|||
156993646|NCT02268396|566729326|FG000|Overall Study|Lost to Follow-up|2|||
156993647|NCT02268396|566729326|FG000|Overall Study|Protocol-Specified Criteria|2|||
156993648|NCT02268396|566729326|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
156993649|NCT01304706|566729329|FG000|Overall Study|Adverse Event|2|||
156993650|NCT01304706|566729329|FG000|Overall Study|Lack of Efficacy|1|||
156993651|NCT01304706|566729329|FG000|Overall Study|Death|3|||
156993652|NCT01304706|566729329|FG000|Overall Study|Withdrawal by Subject|3|||
156993653|NCT01304706|566729329|FG000|Overall Study|Lost to Follow-up|7|||
156993654|NCT01304706|566729329|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
156993655|NCT01419717|566729330|FG000|Overall Study|Protocol-specified Criteria|62|||
157097761|NCT01142596|567112990|FG001|Overall Study|Withdrawal by Subject|35|||
157097762|NCT01142596|567112989|FG000|Overall Study|Adverse Event|8|||
157097763|NCT01142596|567112990|FG001|Overall Study|Adverse Event|35|||
157097764|NCT01142596|567112989|FG000|Overall Study|Lack of Efficacy|5|||
157097765|NCT01142596|567112990|FG001|Overall Study|Lack of Efficacy|9|||
156993656|NCT01419717|566729330|FG000|Overall Study|Adverse Event|19|||
156993657|NCT01419717|566729330|FG000|Overall Study|Death|17|||
157097766|NCT01142596|567112989|FG000|Overall Study|Lost to Follow-up|2|||
157097767|NCT01142596|567112990|FG001|Overall Study|Lost to Follow-up|3|||
157097768|NCT01142596|567112989|FG000|Overall Study|Other reason (not specified)|5|||
157097769|NCT01142596|567112990|FG001|Overall Study|Other reason (not specified)|4|||
157097770|NCT02349360|567112991|FG000|Overall Study|Withdrawal by Subject|0|||
157097771|NCT02349360|567112992|FG001|Overall Study|Withdrawal by Subject|1|||
157097772|NCT01054846|567112993|FG000|Overall Study|Lost to Follow-up|76|||
157097773|NCT01054846|567112994|FG001|Overall Study|Lost to Follow-up|17|||
157097774|NCT02446886|567113003|FG000|Overall Study|Adverse Event|1|||
157097775|NCT02446886|567113004|FG001|Overall Study|Adverse Event|3|||
157097776|NCT02446886|567113003|FG000|Overall Study|Withdrawal by Subject|1|||
157097777|NCT02446886|567113004|FG001|Overall Study|Withdrawal by Subject|1|||
157097778|NCT01290601|567113009|FG000|Overall Study|Adverse Event|0|||
157097779|NCT01290601|567113010|FG001|Overall Study|Adverse Event|2|||
157097780|NCT01290601|567113011|FG002|Overall Study|Adverse Event|0|||
157097781|NCT01290601|567113012|FG003|Overall Study|Adverse Event|0|||
157097782|NCT01290601|567113009|FG000|Overall Study|Lack of Efficacy|2|||
157097783|NCT01290601|567113010|FG001|Overall Study|Lack of Efficacy|1|||
157097784|NCT01290601|567113011|FG002|Overall Study|Lack of Efficacy|0|||
157097785|NCT01290601|567113012|FG003|Overall Study|Lack of Efficacy|0|||
157097786|NCT01290601|567113009|FG000|Overall Study|Lost to Follow-up|7|||
157097787|NCT01290601|567113010|FG001|Overall Study|Lost to Follow-up|2|||
156993658|NCT01419717|566729330|FG000|Overall Study|Withdrawal by Subject|10|||
156993659|NCT01419717|566729330|FG000|Overall Study|Disease Progression|9|||
156993660|NCT01419717|566729330|FG000|Overall Study|Other|4|||
156993661|NCT01419717|566729330|FG000|Overall Study|Lost to Follow-up|2|||
156993662|NCT01419717|566729330|FG000|Overall Study|Administrative Decision|1|||
156993663|NCT01419717|566729330|FG000|Overall Study|Noncompliance|1|||
156993664|NCT00797862|566729331|FG000|Overall Study|Adverse Event|86|||
156993665|NCT00797862|566729332|FG001|Overall Study|Adverse Event|44|||
156993666|NCT00797862|566729333|FG002|Overall Study|Adverse Event|58|||
156993667|NCT00797862|566729331|FG000|Overall Study|Abnormal Test Procedure Result|0|||
156993668|NCT00797862|566729332|FG001|Overall Study|Abnormal Test Procedure Result|1|||
156993669|NCT00797862|566729333|FG002|Overall Study|Abnormal Test Procedure Result|1|||
156993670|NCT00797862|566729331|FG000|Overall Study|Lack of Efficacy|1|||
156993671|NCT00797862|566729332|FG001|Overall Study|Lack of Efficacy|7|||
156993672|NCT00797862|566729333|FG002|Overall Study|Lack of Efficacy|6|||
156993673|NCT00797862|566729331|FG000|Overall Study|No longer required study medication|1|||
156993674|NCT00797862|566729332|FG001|Overall Study|No longer required study medication|0|||
157097788|NCT01290601|567113011|FG002|Overall Study|Lost to Follow-up|0|||
157097789|NCT01290601|567113012|FG003|Overall Study|Lost to Follow-up|0|||
157097790|NCT01290601|567113009|FG000|Overall Study|Other|1|||
157097791|NCT01290601|567113010|FG001|Overall Study|Other|0|||
157097792|NCT01290601|567113011|FG002|Overall Study|Other|0|||
157097793|NCT01290601|567113012|FG003|Overall Study|Other|0|||
157097794|NCT01290601|567113009|FG000|Overall Study|Protocol Violation|1|||
157097795|NCT01290601|567113010|FG001|Overall Study|Protocol Violation|0|||
157097796|NCT01290601|567113011|FG002|Overall Study|Protocol Violation|0|||
157097797|NCT01290601|567113012|FG003|Overall Study|Protocol Violation|0|||
157097798|NCT00775450|567113013|FG000|Overall Study|Serious Adverse Event|2|||
157097799|NCT00775450|567113014|FG001|Overall Study|Serious Adverse Event|0|||
157097800|NCT00775450|567113015|FG002|Overall Study|Serious Adverse Event|0|||
157097801|NCT00775450|567113016|FG003|Overall Study|Serious Adverse Event|0|||
156993675|NCT00797862|566729333|FG002|Overall Study|No longer required study medication|0|||
156993676|NCT00797862|566729331|FG000|Overall Study|Withdrawal by Subject|14|||
156993677|NCT00797862|566729332|FG001|Overall Study|Withdrawal by Subject|7|||
157097802|NCT00775450|567113017|FG004|Overall Study|Serious Adverse Event|0|||
157097803|NCT00775450|567113013|FG000|Overall Study|Protocol Violation|0|||
156993678|NCT00797862|566729333|FG002|Overall Study|Withdrawal by Subject|7|||
156993679|NCT00797862|566729331|FG000|Overall Study|Lost to Follow-up|11|||
156993680|NCT00797862|566729332|FG001|Overall Study|Lost to Follow-up|0|||
157097804|NCT00775450|567113014|FG001|Overall Study|Protocol Violation|0|||
157097805|NCT00775450|567113015|FG002|Overall Study|Protocol Violation|0|||
157097806|NCT00775450|567113016|FG003|Overall Study|Protocol Violation|0|||
157097807|NCT00775450|567113017|FG004|Overall Study|Protocol Violation|1|||
157097808|NCT00775450|567113013|FG000|Overall Study|Withdrawal by Subject|1|||
157097809|NCT00775450|567113014|FG001|Overall Study|Withdrawal by Subject|0|||
157097810|NCT00775450|567113015|FG002|Overall Study|Withdrawal by Subject|0|||
157097811|NCT00775450|567113016|FG003|Overall Study|Withdrawal by Subject|0|||
157097812|NCT00775450|567113017|FG004|Overall Study|Withdrawal by Subject|1|||
157097813|NCT01749540|567113025|FG000|Overall Study|Protocol Violation|0|||
157097814|NCT01749540|567113026|FG001|Overall Study|Protocol Violation|0|||
157097815|NCT01749540|567113027|FG002|Overall Study|Protocol Violation|0|||
157097816|NCT01749540|567113028|FG003|Overall Study|Protocol Violation|0|||
157097817|NCT01749540|567113029|FG004|Overall Study|Protocol Violation|0|||
157097818|NCT01749540|567113030|FG005|Overall Study|Protocol Violation|1|||
157097819|NCT01749540|567113031|FG006|Overall Study|Protocol Violation|1|||
157097820|NCT01749540|567113025|FG000|Overall Study|Withdrawal by Subject|0|||
157097821|NCT01749540|567113026|FG001|Overall Study|Withdrawal by Subject|0|||
157097822|NCT01749540|567113027|FG002|Overall Study|Withdrawal by Subject|0|||
157097823|NCT01749540|567113028|FG003|Overall Study|Withdrawal by Subject|1|||
157097824|NCT01749540|567113029|FG004|Overall Study|Withdrawal by Subject|0|||
157097825|NCT01749540|567113030|FG005|Overall Study|Withdrawal by Subject|0|||
157097826|NCT01749540|567113031|FG006|Overall Study|Withdrawal by Subject|0|||
157097827|NCT01749540|567113025|FG000|Overall Study|Initiated into extension study A536-06|0|||
157097828|NCT01749540|567113026|FG001|Overall Study|Initiated into extension study A536-06|0|||
157097829|NCT01749540|567113027|FG002|Overall Study|Initiated into extension study A536-06|0|||
157097830|NCT01749540|567113028|FG003|Overall Study|Initiated into extension study A536-06|0|||
157097831|NCT01749540|567113029|FG004|Overall Study|Initiated into extension study A536-06|0|||
157097832|NCT01749540|567113030|FG005|Overall Study|Initiated into extension study A536-06|2|||
157097833|NCT01749540|567113031|FG006|Overall Study|Initiated into extension study A536-06|24|||
157097834|NCT00752622|567113032|FG000|Induction Phase|Adverse Event|3|||
157097835|NCT00752622|567113032|FG000|Induction Phase|Other|3|||
157097836|NCT00752622|567113032|FG000|Induction Phase|Non-responder|14|||
157097837|NCT00752622|567113032|FG000|Induction Phase|Withdrawal by Subject|1|||
157097838|NCT00752622|567113032|FG000|Induction Phase|Premature study termination|14|||
157097839|NCT00752622|567113032|FG000|Observational Phase|Premature Study Termination|36|||
157097840|NCT00752622|567113032|FG000|Observational Phase|Non-responder|2|||
157097841|NCT00752622|567113032|FG000|Observational Phase|Withdrawal by Subject|2|||
157097842|NCT00752622|567113032|FG000|Observational Phase|Adverse Event|1|||
157097843|NCT00752622|567113032|FG000|Observational Phase|Other|2|||
157097844|NCT00752622|567113032|FG000|Interventional Phase|Non-responder|2|||
157097845|NCT00752622|567113032|FG000|Interventional Phase|Physician Decision|1|||
157097846|NCT00752622|567113032|FG000|Interventional Phase|Premature Study Termination|5|||
157097847|NCT00576836|567113033|FG000|Overall Study|Death|0|||
157097848|NCT00576836|567113034|FG001|Overall Study|Death|1|||
157097849|NCT00576836|567113033|FG000|Overall Study|Physician Decision|0|||
157097850|NCT00576836|567113034|FG001|Overall Study|Physician Decision|1|||
157097851|NCT00392327|567113037|FG000|Overall Study|Death|1|||
157097852|NCT00392327|567113038|FG001|Overall Study|Death|0|||
157097853|NCT00392327|567113039|FG002|Overall Study|Death|1|||
157097854|NCT00392327|567113040|FG003|Overall Study|Death|0|||
157097855|NCT00392327|567113041|FG004|Overall Study|Death|0|||
157097856|NCT00392327|567113042|FG005|Overall Study|Death|0|||
157097857|NCT00392327|567113043|FG006|Overall Study|Death|0|||
157097858|NCT00392327|567113044|FG007|Overall Study|Death|0|||
157097859|NCT00392327|567113037|FG000|Overall Study|Lack of Efficacy|8|||
157097860|NCT00392327|567113038|FG001|Overall Study|Lack of Efficacy|8|||
157097861|NCT00392327|567113039|FG002|Overall Study|Lack of Efficacy|9|||
157097862|NCT00392327|567113040|FG003|Overall Study|Lack of Efficacy|6|||
157097863|NCT00392327|567113041|FG004|Overall Study|Lack of Efficacy|3|||
157097864|NCT00392327|567113042|FG005|Overall Study|Lack of Efficacy|3|||
157097865|NCT00392327|567113043|FG006|Overall Study|Lack of Efficacy|3|||
157097866|NCT00392327|567113044|FG007|Overall Study|Lack of Efficacy|3|||
157097867|NCT00392327|567113037|FG000|Overall Study|Physician Decision|3|||
157097868|NCT00392327|567113038|FG001|Overall Study|Physician Decision|5|||
157097869|NCT00392327|567113039|FG002|Overall Study|Physician Decision|2|||
157097870|NCT00392327|567113040|FG003|Overall Study|Physician Decision|2|||
157097871|NCT00392327|567113041|FG004|Overall Study|Physician Decision|0|||
157097872|NCT00392327|567113042|FG005|Overall Study|Physician Decision|1|||
157097873|NCT00392327|567113043|FG006|Overall Study|Physician Decision|5|||
157097874|NCT00392327|567113044|FG007|Overall Study|Physician Decision|3|||
157097875|NCT00392327|567113037|FG000|Overall Study|Protocol Violation|0|||
157097876|NCT00392327|567113038|FG001|Overall Study|Protocol Violation|0|||
157097877|NCT00392327|567113039|FG002|Overall Study|Protocol Violation|1|||
157097878|NCT00392327|567113040|FG003|Overall Study|Protocol Violation|0|||
157097879|NCT00392327|567113041|FG004|Overall Study|Protocol Violation|0|||
157097880|NCT00392327|567113042|FG005|Overall Study|Protocol Violation|0|||
157097881|NCT00392327|567113043|FG006|Overall Study|Protocol Violation|0|||
157097882|NCT00392327|567113044|FG007|Overall Study|Protocol Violation|0|||
157097883|NCT00392327|567113037|FG000|Overall Study|Withdrawal by Subject|3|||
157097884|NCT00392327|567113038|FG001|Overall Study|Withdrawal by Subject|2|||
156993681|NCT00797862|566729333|FG002|Overall Study|Lost to Follow-up|5|||
156993682|NCT00797862|566729331|FG000|Overall Study|Administrative Problem|4|||
156993683|NCT00797862|566729332|FG001|Overall Study|Administrative Problem|0|||
156993684|NCT00797862|566729333|FG002|Overall Study|Administrative Problem|0|||
156993685|NCT00797862|566729331|FG000|Overall Study|Protocol Violation|4|||
156993686|NCT00797862|566729332|FG001|Overall Study|Protocol Violation|6|||
156993687|NCT00797862|566729333|FG002|Overall Study|Protocol Violation|8|||
156993688|NCT00797862|566729331|FG000|Overall Study|Mis-randomized|3|||
156993689|NCT00797862|566729332|FG001|Overall Study|Mis-randomized|3|||
156993690|NCT00797862|566729333|FG002|Overall Study|Mis-randomized|1|||
156993691|NCT04565249|566729334|FG000|Overall Study|Death|0|||
156993692|NCT04565249|566729335|FG001|Overall Study|Death|0|||
156993693|NCT04565249|566729336|FG002|Overall Study|Death|0|||
156993694|NCT04565249|566729337|FG003|Overall Study|Death|1|||
156993695|NCT02333630|566729340|FG000|Overall Study|Lost to Follow-up|5|||
156993696|NCT02333630|566729341|FG001|Overall Study|Lost to Follow-up|2|||
156993697|NCT00315055|566729342|FG000|Overall Study|Protocol Violation|2|||
156993698|NCT00315055|566729343|FG001|Overall Study|Protocol Violation|4|||
156993699|NCT00315055|566729342|FG000|Overall Study|Lost to Follow-up|1|||
156993700|NCT00315055|566729343|FG001|Overall Study|Lost to Follow-up|1|||
156993701|NCT02359435|566729344|FG000|Overall Study|Lost to Follow-up|4|||
156993702|NCT02359435|566729345|FG001|Overall Study|Lost to Follow-up|4|||
156993703|NCT04541186|566729349|FG000|Main Study|Adverse Event|0|||
156993704|NCT04541186|566729350|FG001|Main Study|Adverse Event|0|||
156993705|NCT04541186|566729351|FG002|Main Study|Adverse Event|4|||
156993706|NCT04541186|566729352|FG003|Main Study|Adverse Event|0|||
156993707|NCT04541186|566729353|FG004|Main Study|Adverse Event|0|||
156993708|NCT04541186|566729349|FG000|Main Study|Investigator Decision|0|||
156993709|NCT04541186|566729350|FG001|Main Study|Investigator Decision|0|||
156993710|NCT04541186|566729351|FG002|Main Study|Investigator Decision|1|||
156993711|NCT04541186|566729352|FG003|Main Study|Investigator Decision|1|||
156993712|NCT04541186|566729353|FG004|Main Study|Investigator Decision|0|||
156993713|NCT04541186|566729349|FG000|Main Study|Withdrawal by Subject|1|||
156993714|NCT04541186|566729350|FG001|Main Study|Withdrawal by Subject|1|||
156993715|NCT04541186|566729351|FG002|Main Study|Withdrawal by Subject|0|||
156993716|NCT04541186|566729352|FG003|Main Study|Withdrawal by Subject|0|||
156993717|NCT04541186|566729353|FG004|Main Study|Withdrawal by Subject|0|||
156993718|NCT04541186|566729349|FG000|Main Study|COVID-19-related Dose Interruption|0|||
156993719|NCT04541186|566729350|FG001|Main Study|COVID-19-related Dose Interruption|0|||
156993720|NCT04541186|566729351|FG002|Main Study|COVID-19-related Dose Interruption|0|||
156993721|NCT04541186|566729352|FG003|Main Study|COVID-19-related Dose Interruption|0|||
156993722|NCT04541186|566729353|FG004|Main Study|COVID-19-related Dose Interruption|1|||
156993723|NCT04541186|566729349|FG000|Main Study|Randomized in Error Not Treated|0|||
156993724|NCT04541186|566729350|FG001|Main Study|Randomized in Error Not Treated|0|||
156993725|NCT04541186|566729351|FG002|Main Study|Randomized in Error Not Treated|1|||
156993726|NCT04541186|566729352|FG003|Main Study|Randomized in Error Not Treated|0|||
156993727|NCT04541186|566729353|FG004|Main Study|Randomized in Error Not Treated|0|||
156993728|NCT04541186|566729349|FG000|Fibrate Expansion Study|Other than Specified|0|||
156993729|NCT04541186|566729350|FG001|Fibrate Expansion Study|Other than Specified|0|||
156993730|NCT04541186|566729351|FG002|Fibrate Expansion Study|Other than Specified|0|||
156993731|NCT04541186|566729352|FG003|Fibrate Expansion Study|Other than Specified|0|||
157097885|NCT00392327|567113039|FG002|Overall Study|Withdrawal by Subject|4|||
157097886|NCT00392327|567113040|FG003|Overall Study|Withdrawal by Subject|6|||
157097887|NCT00392327|567113041|FG004|Overall Study|Withdrawal by Subject|0|||
157097888|NCT00392327|567113042|FG005|Overall Study|Withdrawal by Subject|1|||
157097889|NCT00392327|567113043|FG006|Overall Study|Withdrawal by Subject|1|||
157097890|NCT00392327|567113044|FG007|Overall Study|Withdrawal by Subject|5|||
157097891|NCT00392327|567113037|FG000|Overall Study|Ineligible|0|||
157097892|NCT00392327|567113038|FG001|Overall Study|Ineligible|4|||
157097893|NCT00392327|567113039|FG002|Overall Study|Ineligible|3|||
157097894|NCT00392327|567113040|FG003|Overall Study|Ineligible|2|||
157097895|NCT00392327|567113041|FG004|Overall Study|Ineligible|0|||
157097896|NCT00392327|567113042|FG005|Overall Study|Ineligible|0|||
157097897|NCT00392327|567113043|FG006|Overall Study|Ineligible|0|||
157097898|NCT00392327|567113044|FG007|Overall Study|Ineligible|0|||
157097899|NCT00894686|567113045|FG000|Overall Study|Withdrawal by Subject|50|||
157097900|NCT00894686|567113045|FG000|Overall Study|Physician Decision|1|||
157097901|NCT00894686|567113045|FG000|Overall Study|Other|5|||
157097902|NCT00178126|567113046|FG000|Overall Study|Lost to Follow-up|21|||
157097903|NCT00178126|567113047|FG001|Overall Study|Lost to Follow-up|21|||
157097904|NCT00178126|567113046|FG000|Overall Study|did not receive intervention|4|||
157097905|NCT00178126|567113047|FG001|Overall Study|did not receive intervention|6|||
157097906|NCT05056987|567113048|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
157097907|NCT05056987|567113049|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
157097908|NCT05056987|567113048|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
157097909|NCT05056987|567113049|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
157097910|NCT01575028|567113050|FG000|Overall Study|Physician Decision|0|||
157097911|NCT01575028|567113051|FG001|Overall Study|Physician Decision|1|||
157097912|NCT01182194|567113052|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
157097913|NCT01182194|567113053|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
157097914|NCT01948908|567113054|FG000|Overall Study|Protocol Violation|1|||
157097915|NCT01948908|567113055|FG001|Overall Study|Protocol Violation|0|||
157097916|NCT01948908|567113056|FG002|Overall Study|Protocol Violation|2|||
157097917|NCT01585987|567113057|FG000|Randomized|Withdrawal by Subject|0|||
157097918|NCT01585987|567113058|FG001|Randomized|Withdrawal by Subject|4|||
157097919|NCT01585987|567113057|FG000|Randomized|No longer met criteria|0|||
157097920|NCT01585987|567113058|FG001|Randomized|No longer met criteria|2|||
157097921|NCT01585987|567113057|FG000|Treated|Disease Progression|39|||
157097922|NCT01585987|567113058|FG001|Treated|Disease Progression|36|||
157097923|NCT01585987|567113057|FG000|Treated|Study Drug Toxicity|9|||
157097924|NCT01585987|567113058|FG001|Treated|Study Drug Toxicity|5|||
157097925|NCT01585987|567113057|FG000|Treated|Adverse Event|3|||
157097926|NCT01585987|567113058|FG001|Treated|Adverse Event|0|||
157097927|NCT01585987|567113057|FG000|Treated|Withdrawal by Subject|1|||
157097928|NCT01585987|567113058|FG001|Treated|Withdrawal by Subject|2|||
157097929|NCT01585987|567113057|FG000|Treated|Death|1|||
157097930|NCT01585987|567113058|FG001|Treated|Death|0|||
157097931|NCT01585987|567113057|FG000|Treated|Lost to Follow-up|0|||
157097932|NCT01585987|567113058|FG001|Treated|Lost to Follow-up|1|||
157097933|NCT01585987|567113057|FG000|Treated|Maximum Clinical Benefit|0|||
157097934|NCT01585987|567113058|FG001|Treated|Maximum Clinical Benefit|1|||
157097935|NCT01585987|567113057|FG000|Treated|Non-Specified|1|||
157097936|NCT01585987|567113058|FG001|Treated|Non-Specified|2|||
157097937|NCT01585987|567113057|FG000|Treated|Subject Request|0|||
157097938|NCT01585987|567113058|FG001|Treated|Subject Request|1|||
157097939|NCT01585987|567113057|FG000|Treated|Poor/Non-Compliance|0|||
157097940|NCT01585987|567113058|FG001|Treated|Poor/Non-Compliance|1|||
157097941|NCT03291587|567113059|FG000|Overall Study|Lost to Follow-up|62|||
157097942|NCT03291587|567113060|FG001|Overall Study|Lost to Follow-up|43|||
157097943|NCT03291587|567113059|FG000|Overall Study|Refused to Answer|5|||
157097944|NCT03291587|567113060|FG001|Overall Study|Refused to Answer|2|||
157097945|NCT03291587|567113059|FG000|Overall Study|Death|2|||
157097946|NCT03291587|567113060|FG001|Overall Study|Death|4|||
157097947|NCT03291587|567113059|FG000|Overall Study|Not interested in participating|8|||
157097948|NCT03291587|567113060|FG001|Overall Study|Not interested in participating|6|||
157097949|NCT03291587|567113059|FG000|Overall Study|Too busy to participate|4|||
157097950|NCT03291587|567113060|FG001|Overall Study|Too busy to participate|2|||
157097951|NCT00796120|567113061|FG000|Overall Study|Death|3|||
157097952|NCT00796120|567113062|FG001|Overall Study|Death|0|||
157097953|NCT00796120|567113061|FG000|Overall Study|Adverse Event|11|||
157097954|NCT00796120|567113062|FG001|Overall Study|Adverse Event|6|||
157097955|NCT00796120|567113061|FG000|Overall Study|Progressive disease|22|||
157097956|NCT00796120|567113062|FG001|Overall Study|Progressive disease|13|||
157097957|NCT00796120|567113061|FG000|Overall Study|Participant refusal|3|||
157097958|NCT00796120|567113062|FG001|Overall Study|Participant refusal|4|||
157097959|NCT00796120|567113061|FG000|Overall Study|Other|6|||
157097960|NCT00796120|567113062|FG001|Overall Study|Other|17|||
157097961|NCT00796120|567113061|FG000|Overall Study|Physician Decision|16|||
157097962|NCT00796120|567113062|FG001|Overall Study|Physician Decision|17|||
157097963|NCT00796120|567113061|FG000|Overall Study|Randomized but not treated|0|||
157097964|NCT00796120|567113062|FG001|Overall Study|Randomized but not treated|3|||
157097965|NCT02520284|567113066|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
156993732|NCT04541186|566729353|FG004|Fibrate Expansion Study|Other than Specified|1|||
156993733|NCT02347943|566729355|FG000|Overall Study|Study was cancelled|140|||
156993734|NCT02347943|566729356|FG001|Overall Study|Study was cancelled|67|||
156993735|NCT02347943|566729357|FG002|Overall Study|Study was cancelled|45|||
156993736|NCT03085017|566729358|FG000|Overall Study|Death|0|||
156993737|NCT03085017|566729359|FG001|Overall Study|Death|3|||
156993738|NCT00058058|566729360|FG000|Overall Study|Withdrawal by Subject|4|||
156993739|NCT00058058|566729360|FG000|Overall Study|Ineligible|20|||
156993740|NCT00058058|566729360|FG000|Overall Study|Claustrophobic|5|||
156993741|NCT00058058|566729360|FG000|Overall Study|technical issues|6|||
156993742|NCT00058058|566729360|FG000|Overall Study|Poor positioning, illness,pain|3|||
156993743|NCT02680756|566729361|FG000|Overall Study|Adverse Event|10|||
156993744|NCT02680756|566729362|FG001|Overall Study|Adverse Event|2|||
156993745|NCT02680756|566729361|FG000|Overall Study|Lost to Follow-up|7|||
156993746|NCT02680756|566729362|FG001|Overall Study|Lost to Follow-up|6|||
156993747|NCT02680756|566729361|FG000|Overall Study|Withdrawal by Subject|5|||
156993748|NCT02680756|566729362|FG001|Overall Study|Withdrawal by Subject|5|||
156993749|NCT02680756|566729361|FG000|Overall Study|Physician Decision|4|||
156993750|NCT02680756|566729362|FG001|Overall Study|Physician Decision|1|||
156993751|NCT02680756|566729361|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
156993752|NCT02680756|566729362|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
156993753|NCT02680756|566729361|FG000|Overall Study|Blood transfusion for any reason|0|||
156993754|NCT02680756|566729362|FG001|Overall Study|Blood transfusion for any reason|1|||
156993755|NCT02680756|566729361|FG000|Overall Study|Death|1|||
156993756|NCT02680756|566729362|FG001|Overall Study|Death|0|||
156993757|NCT02680756|566729361|FG000|Overall Study|Protocol Violation|1|||
156993758|NCT02680756|566729362|FG001|Overall Study|Protocol Violation|0|||
156993759|NCT02680756|566729361|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
156993760|NCT02680756|566729362|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
156993761|NCT02680756|566729361|FG000|Overall Study|None of above or not recorded|3|||
156993762|NCT02680756|566729362|FG001|Overall Study|None of above or not recorded|2|||
156993763|NCT03302156|566729363|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
156993764|NCT03302156|566729364|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
156993765|NCT03302156|566729365|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
156993766|NCT03635112|566729367|FG000|Overall Study|Adverse Event|5|||
156993767|NCT03635112|566729368|FG001|Overall Study|Adverse Event|9|||
156993768|NCT03635112|566729369|FG002|Overall Study|Adverse Event|14|||
156993769|NCT03635112|566729367|FG000|Overall Study|Lost to Follow-up|1|||
156993770|NCT03635112|566729368|FG001|Overall Study|Lost to Follow-up|0|||
156993771|NCT03635112|566729369|FG002|Overall Study|Lost to Follow-up|1|||
156993772|NCT03635112|566729367|FG000|Overall Study|Physician Decision|5|||
156993773|NCT03635112|566729368|FG001|Overall Study|Physician Decision|7|||
156993774|NCT03635112|566729369|FG002|Overall Study|Physician Decision|5|||
156993775|NCT03635112|566729367|FG000|Overall Study|Protocol Violation|0|||
156993776|NCT03635112|566729368|FG001|Overall Study|Protocol Violation|0|||
156993777|NCT03635112|566729369|FG002|Overall Study|Protocol Violation|1|||
156993778|NCT03635112|566729367|FG000|Overall Study|Study Terminated by Sponsor|11|||
156993779|NCT03635112|566729368|FG001|Overall Study|Study Terminated by Sponsor|17|||
156993780|NCT03635112|566729369|FG002|Overall Study|Study Terminated by Sponsor|21|||
156993781|NCT03635112|566729367|FG000|Overall Study|Withdrawal by Subject|4|||
156993782|NCT03635112|566729368|FG001|Overall Study|Withdrawal by Subject|9|||
156993783|NCT03635112|566729369|FG002|Overall Study|Withdrawal by Subject|7|||
156993784|NCT03635112|566729367|FG000|Overall Study|Miscellaneous|0|||
156993785|NCT03635112|566729368|FG001|Overall Study|Miscellaneous|0|||
156993786|NCT03635112|566729369|FG002|Overall Study|Miscellaneous|1|||
156993787|NCT00463151|566729374|FG000|Overall Study|Adverse Event|0|||
156993788|NCT00463151|566729375|FG001|Overall Study|Adverse Event|0|||
156993789|NCT00463151|566729376|FG002|Overall Study|Adverse Event|1|||
156993790|NCT00463151|566729377|FG003|Overall Study|Adverse Event|0|||
156993791|NCT00463151|566729374|FG000|Overall Study|Lack of Efficacy|2|||
156993792|NCT00463151|566729375|FG001|Overall Study|Lack of Efficacy|5|||
156993793|NCT00463151|566729376|FG002|Overall Study|Lack of Efficacy|2|||
156993794|NCT00463151|566729377|FG003|Overall Study|Lack of Efficacy|5|||
156993795|NCT00463151|566729374|FG000|Overall Study|Protocol Violation|0|||
156993796|NCT00463151|566729375|FG001|Overall Study|Protocol Violation|0|||
156993797|NCT00463151|566729376|FG002|Overall Study|Protocol Violation|0|||
156993798|NCT00463151|566729377|FG003|Overall Study|Protocol Violation|1|||
156993799|NCT00463151|566729374|FG000|Overall Study|Withdrawal by Subject|0|||
156993800|NCT00463151|566729375|FG001|Overall Study|Withdrawal by Subject|0|||
156993801|NCT00463151|566729376|FG002|Overall Study|Withdrawal by Subject|0|||
156993802|NCT00463151|566729377|FG003|Overall Study|Withdrawal by Subject|1|||
156993803|NCT05349084|566729378|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
156993804|NCT00972543|566729379|FG000|Overall Study|Adverse Event|1|||
156993805|NCT00972543|566729380|FG001|Overall Study|Adverse Event|0|||
156993806|NCT00972543|566729379|FG000|Overall Study|Early study termination by sponsor|4|||
156993807|NCT00972543|566729380|FG001|Overall Study|Early study termination by sponsor|1|||
156993808|NCT00688688|566729381|FG000|Overall Study|Eligibility criterion not met|7|||
156993809|NCT00688688|566729382|FG001|Overall Study|Eligibility criterion not met|7|||
156993810|NCT00688688|566729383|FG002|Overall Study|Eligibility criterion not met|10|||
156993811|NCT00688688|566729381|FG000|Overall Study|Adverse Event|52|||
156993812|NCT00688688|566729382|FG001|Overall Study|Adverse Event|51|||
156993813|NCT00688688|566729383|FG002|Overall Study|Adverse Event|50|||
156993814|NCT00688688|566729381|FG000|Overall Study|Lack of Efficacy|34|||
156993815|NCT00688688|566729382|FG001|Overall Study|Lack of Efficacy|25|||
156993816|NCT00688688|566729383|FG002|Overall Study|Lack of Efficacy|45|||
156993817|NCT00688688|566729381|FG000|Overall Study|Withdrawal by Subject|66|||
156993818|NCT00688688|566729382|FG001|Overall Study|Withdrawal by Subject|75|||
156993819|NCT00688688|566729383|FG002|Overall Study|Withdrawal by Subject|65|||
156993820|NCT00688688|566729381|FG000|Overall Study|Lost to Follow-up|14|||
156993821|NCT00688688|566729382|FG001|Overall Study|Lost to Follow-up|7|||
156993822|NCT00688688|566729383|FG002|Overall Study|Lost to Follow-up|7|||
156993823|NCT00688688|566729381|FG000|Overall Study|Protocol Violation|6|||
156993824|NCT00688688|566729382|FG001|Overall Study|Protocol Violation|9|||
156993825|NCT00688688|566729383|FG002|Overall Study|Protocol Violation|11|||
156993826|NCT00688688|566729381|FG000|Overall Study|Randomized but never received study drug|1|||
156993827|NCT00688688|566729382|FG001|Overall Study|Randomized but never received study drug|0|||
156993828|NCT00688688|566729383|FG002|Overall Study|Randomized but never received study drug|0|||
156993829|NCT00688688|566729381|FG000|Overall Study|Non-compliance with study procedures|5|||
156993830|NCT00688688|566729382|FG001|Overall Study|Non-compliance with study procedures|3|||
156993831|NCT00688688|566729383|FG002|Overall Study|Non-compliance with study procedures|4|||
156993832|NCT00688688|566729381|FG000|Overall Study|Taking exclusionary medications|1|||
156993833|NCT00688688|566729382|FG001|Overall Study|Taking exclusionary medications|0|||
156993834|NCT00688688|566729383|FG002|Overall Study|Taking exclusionary medications|0|||
156993835|NCT00688688|566729381|FG000|Overall Study|Site closure|0|||
156993836|NCT00688688|566729382|FG001|Overall Study|Site closure|1|||
156993837|NCT00688688|566729383|FG002|Overall Study|Site closure|0|||
156993838|NCT00688688|566729381|FG000|Overall Study|Violation of exclusion criterion|0|||
156993839|NCT00688688|566729382|FG001|Overall Study|Violation of exclusion criterion|1|||
156993840|NCT00688688|566729383|FG002|Overall Study|Violation of exclusion criterion|0|||
156993841|NCT03283553|566729387|FG000|Patient Participant Flow|Death|5|||
156993842|NCT03283553|566729388|FG001|Patient Participant Flow|Death|10|||
156993843|NCT03283553|566729387|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
156993844|NCT03283553|566729388|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
156993845|NCT03283553|566729387|FG000|Patient Participant Flow|Lost to Follow-up|1|||
156993846|NCT03283553|566729388|FG001|Patient Participant Flow|Lost to Follow-up|1|||
156993847|NCT03283553|566729387|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
156993848|NCT03283553|566729388|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
156993849|NCT03283553|566729387|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
156993850|NCT03283553|566729388|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
156993851|NCT03283553|566729387|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
156993852|NCT03283553|566729388|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
156993853|NCT04296942|566729389|FG000|Overall Study|Study closure by sponsor|1|||
156993854|NCT04296942|566729390|FG001|Overall Study|Study closure by sponsor|0|||
156993855|NCT04296942|566729391|FG002|Overall Study|Study closure by sponsor|0|||
156993856|NCT01579578|566729403|FG000|Overall Study|Death|4|||
156993857|NCT01579578|566729404|FG001|Overall Study|Death|1|||
156993858|NCT01579578|566729403|FG000|Overall Study|Lost to Follow-up|1|||
156993859|NCT01579578|566729404|FG001|Overall Study|Lost to Follow-up|1|||
156993860|NCT01579578|566729403|FG000|Overall Study|Withdrawal by Subject|2|||
156993861|NCT01579578|566729404|FG001|Overall Study|Withdrawal by Subject|1|||
156993862|NCT01579578|566729403|FG000|Overall Study|Eligibility criteria|3|||
156993863|NCT01579578|566729404|FG001|Overall Study|Eligibility criteria|9|||
156993864|NCT01579578|566729403|FG000|Overall Study|Ongoing|3|||
156993865|NCT01579578|566729404|FG001|Overall Study|Ongoing|0|||
156993866|NCT01528709|566729407|FG000|Overall Study|Death|2|||
156993867|NCT01528709|566729408|FG001|Overall Study|Death|0|||
156993868|NCT01528709|566729407|FG000|Overall Study|Withdrawal by Subject|10|||
156993869|NCT01528709|566729408|FG001|Overall Study|Withdrawal by Subject|15|||
156993870|NCT01528709|566729407|FG000|Overall Study|allergy|1|||
156993871|NCT01528709|566729408|FG001|Overall Study|allergy|0|||
156993872|NCT03432533|566729412|FG000|Overall Study|Lost to Follow-up|1|||
156993873|NCT03432533|566729413|FG001|Overall Study|Lost to Follow-up|2|||
156993874|NCT03432533|566729412|FG000|Overall Study|Withdrawal by Subject|14|||
156993875|NCT03432533|566729413|FG001|Overall Study|Withdrawal by Subject|9|||
156993876|NCT01982760|566729415|FG000|Overall Study|Physician Decision|1|||
156993877|NCT01982760|566729416|FG001|Overall Study|Physician Decision|0|||
156993878|NCT00530777|566729418|FG000|Overall Study|Lost to Follow-up|0|||
156993879|NCT00530777|566729419|FG001|Overall Study|Lost to Follow-up|1|||
156993880|NCT00530777|566729418|FG000|Overall Study|Death|1|||
156993881|NCT00530777|566729419|FG001|Overall Study|Death|2|||
156993882|NCT00530777|566729418|FG000|Overall Study|Physician Decision|1|||
156993883|NCT00530777|566729419|FG001|Overall Study|Physician Decision|0|||
156993884|NCT00530777|566729418|FG000|Overall Study|Withdrawal by Subject|0|||
156993885|NCT00530777|566729419|FG001|Overall Study|Withdrawal by Subject|1|||
156993886|NCT00530777|566729418|FG000|Overall Study|Unable to adhere to visit schedule|5|||
156993887|NCT00530777|566729419|FG001|Overall Study|Unable to adhere to visit schedule|1|||
156993888|NCT03382821|566729423|FG000|Overall Study|Did not receive allocated intervention.|0|||
156993889|NCT03382821|566729424|FG001|Overall Study|Did not receive allocated intervention.|3|||
156993890|NCT00797225|566729425|FG000|Weeks 1 to 12|Adverse Event|0|||
156993891|NCT00797225|566729426|FG001|Weeks 1 to 12|Adverse Event|0|||
156993892|NCT00797225|566729427|FG002|Weeks 1 to 12|Adverse Event|1|||
156993893|NCT00797225|566729428|FG003|Weeks 1 to 12|Adverse Event|0|||
156993894|NCT00797225|566729429|FG004|Weeks 1 to 12|Adverse Event|0|||
156993895|NCT00797225|566729430|FG005|Weeks 1 to 12|Adverse Event|0|||
156993896|NCT00797225|566729431|FG006|Weeks 1 to 12|Adverse Event|0|||
156993897|NCT00797225|566729432|FG007|Weeks 1 to 12|Adverse Event|0|||
156993898|NCT00797225|566729425|FG000|Weeks 1 to 12|Non-compliance|0|||
156993899|NCT00797225|566729426|FG001|Weeks 1 to 12|Non-compliance|1|||
156993900|NCT00797225|566729427|FG002|Weeks 1 to 12|Non-compliance|0|||
156993901|NCT00797225|566729428|FG003|Weeks 1 to 12|Non-compliance|0|||
156993902|NCT00797225|566729429|FG004|Weeks 1 to 12|Non-compliance|0|||
156993903|NCT00797225|566729430|FG005|Weeks 1 to 12|Non-compliance|0|||
156993904|NCT00797225|566729431|FG006|Weeks 1 to 12|Non-compliance|0|||
156993905|NCT00797225|566729432|FG007|Weeks 1 to 12|Non-compliance|0|||
156993906|NCT00797225|566729425|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
156993907|NCT00797225|566729426|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
156993908|NCT00797225|566729427|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
156993909|NCT00797225|566729428|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
156993910|NCT00797225|566729429|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
156993911|NCT00797225|566729430|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
156993912|NCT00797225|566729431|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
156993913|NCT00797225|566729432|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
156993914|NCT00797225|566729425|FG000|Weeks 1 to 12|Sponsor Decision|1|||
156993915|NCT00797225|566729426|FG001|Weeks 1 to 12|Sponsor Decision|0|||
156993916|NCT00797225|566729427|FG002|Weeks 1 to 12|Sponsor Decision|0|||
156993917|NCT00797225|566729428|FG003|Weeks 1 to 12|Sponsor Decision|0|||
156993918|NCT00797225|566729429|FG004|Weeks 1 to 12|Sponsor Decision|0|||
156993919|NCT00797225|566729430|FG005|Weeks 1 to 12|Sponsor Decision|0|||
156993920|NCT00797225|566729431|FG006|Weeks 1 to 12|Sponsor Decision|0|||
156993921|NCT00797225|566729432|FG007|Weeks 1 to 12|Sponsor Decision|0|||
156993922|NCT00797225|566729425|FG000|Weeks 13 to 24|Non-compliance|0|||
156993923|NCT00797225|566729426|FG001|Weeks 13 to 24|Non-compliance|2|||
156993924|NCT00797225|566729427|FG002|Weeks 13 to 24|Non-compliance|0|||
156993925|NCT00797225|566729428|FG003|Weeks 13 to 24|Non-compliance|0|||
156993926|NCT00797225|566729429|FG004|Weeks 13 to 24|Non-compliance|0|||
156993927|NCT00797225|566729430|FG005|Weeks 13 to 24|Non-compliance|0|||
156993928|NCT00797225|566729431|FG006|Weeks 13 to 24|Non-compliance|0|||
156993929|NCT00797225|566729432|FG007|Weeks 13 to 24|Non-compliance|0|||
156993930|NCT00797225|566729425|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
156993931|NCT00797225|566729426|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
156993932|NCT00797225|566729427|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
156993933|NCT00797225|566729428|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
156993934|NCT00797225|566729429|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
156993935|NCT00797225|566729430|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
156993936|NCT00797225|566729431|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
156993937|NCT00797225|566729432|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
156993938|NCT00797225|566729425|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
156993939|NCT00797225|566729426|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
156993940|NCT00797225|566729427|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
156993941|NCT00797225|566729428|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
156993942|NCT00797225|566729429|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
156993943|NCT00797225|566729430|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
156993944|NCT00797225|566729431|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
156993945|NCT00797225|566729432|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
156993946|NCT00797225|566729425|FG000|Weeks 13 to 24|Adverse Event|0|||
156993947|NCT00797225|566729426|FG001|Weeks 13 to 24|Adverse Event|1|||
156993948|NCT00797225|566729427|FG002|Weeks 13 to 24|Adverse Event|0|||
156993949|NCT00797225|566729428|FG003|Weeks 13 to 24|Adverse Event|0|||
156993950|NCT00797225|566729429|FG004|Weeks 13 to 24|Adverse Event|0|||
156993951|NCT00797225|566729430|FG005|Weeks 13 to 24|Adverse Event|0|||
156993952|NCT00797225|566729431|FG006|Weeks 13 to 24|Adverse Event|1|||
156993953|NCT00797225|566729432|FG007|Weeks 13 to 24|Adverse Event|0|||
156993954|NCT00797225|566729425|FG000|Weeks 13 to 24|Sponsor Decision|0|||
156993955|NCT00797225|566729426|FG001|Weeks 13 to 24|Sponsor Decision|0|||
156993956|NCT00797225|566729427|FG002|Weeks 13 to 24|Sponsor Decision|0|||
156993957|NCT00797225|566729428|FG003|Weeks 13 to 24|Sponsor Decision|0|||
156993958|NCT00797225|566729429|FG004|Weeks 13 to 24|Sponsor Decision|0|||
156993959|NCT00797225|566729430|FG005|Weeks 13 to 24|Sponsor Decision|0|||
156993960|NCT00797225|566729431|FG006|Weeks 13 to 24|Sponsor Decision|1|||
156993961|NCT00797225|566729432|FG007|Weeks 13 to 24|Sponsor Decision|0|||
156993962|NCT02096003|566729435|FG000|Overall Study|Protocol Violation|0|||
156993963|NCT02096003|566729436|FG001|Overall Study|Protocol Violation|2|||
156993964|NCT02096003|566729435|FG000|Overall Study|additional surgery|2|||
156993965|NCT02096003|566729436|FG001|Overall Study|additional surgery|1|||
156993966|NCT04833855|566729439|FG000|Overall Study|Decision by sponsor|0|||
156993967|NCT04833855|566729440|FG001|Overall Study|Decision by sponsor|1|||
156993968|NCT04833855|566729441|FG002|Overall Study|Decision by sponsor|0|||
156993969|NCT04833855|566729442|FG003|Overall Study|Decision by sponsor|0|||
156993970|NCT04833855|566729439|FG000|Overall Study|Withdrawal by Subject|4|||
156993971|NCT04833855|566729440|FG001|Overall Study|Withdrawal by Subject|1|||
156993972|NCT04833855|566729441|FG002|Overall Study|Withdrawal by Subject|3|||
156993973|NCT04833855|566729442|FG003|Overall Study|Withdrawal by Subject|1|||
156993974|NCT04833855|566729439|FG000|Overall Study|Lost to Follow-up|1|||
156993975|NCT04833855|566729440|FG001|Overall Study|Lost to Follow-up|0|||
156993976|NCT04833855|566729441|FG002|Overall Study|Lost to Follow-up|2|||
157097966|NCT02520284|567113067|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
156993977|NCT04833855|566729442|FG003|Overall Study|Lost to Follow-up|2|||
156993978|NCT04833855|566729439|FG000|Overall Study|Protocol specified criteria|0|||
156993979|NCT04833855|566729440|FG001|Overall Study|Protocol specified criteria|0|||
156993980|NCT04833855|566729441|FG002|Overall Study|Protocol specified criteria|2|||
157097967|NCT02520284|567113068|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
157097968|NCT02520284|567113066|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
156993981|NCT04833855|566729442|FG003|Overall Study|Protocol specified criteria|1|||
156993982|NCT03686384|566729443|FG000|Overall Study|Lack of Efficacy|4|||
156993983|NCT03686384|566729444|FG001|Overall Study|Lack of Efficacy|13|||
156993984|NCT03686384|566729443|FG000|Overall Study|Lost to Follow-up|3|||
156993985|NCT03686384|566729444|FG001|Overall Study|Lost to Follow-up|0|||
156993986|NCT03686384|566729443|FG000|Overall Study|Physician Decision|0|||
156993987|NCT03686384|566729444|FG001|Overall Study|Physician Decision|1|||
156993988|NCT03686384|566729443|FG000|Overall Study|Took prohibited medication|0|||
156993989|NCT03686384|566729444|FG001|Overall Study|Took prohibited medication|1|||
156993990|NCT02431533|566729445|FG000|Overall Study|Withdrawal by Subject|1|||
157097969|NCT02520284|567113067|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
157097970|NCT02520284|567113068|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
157097971|NCT02520284|567113066|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
157097972|NCT02520284|567113067|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
157097973|NCT02520284|567113068|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
157097974|NCT02520284|567113066|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
157097975|NCT02520284|567113067|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
157097976|NCT02520284|567113068|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
157097977|NCT02520284|567113066|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
157097978|NCT02520284|567113067|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
157097979|NCT02520284|567113068|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
157097980|NCT02520284|567113066|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
157097981|NCT02520284|567113067|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
157097982|NCT02520284|567113068|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
157097983|NCT02520284|567113066|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
157097984|NCT02520284|567113067|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
157097985|NCT02520284|567113068|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
157097986|NCT02520284|567113066|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
157097987|NCT02520284|567113067|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
157097988|NCT02520284|567113068|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
157097989|NCT02520284|567113066|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
157097990|NCT02520284|567113067|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
157097991|NCT02520284|567113068|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
157097992|NCT02520284|567113066|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
157097993|NCT02520284|567113067|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
157097994|NCT02520284|567113068|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
157097995|NCT02520284|567113066|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
157097996|NCT02520284|567113067|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
157097997|NCT02520284|567113068|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
157097998|NCT03737474|567113069|FG000|Overall Study|Adverse Event|18|||
157097999|NCT03737474|567113070|FG001|Overall Study|Adverse Event|48|||
157098000|NCT03737474|567113069|FG000|Overall Study|Lack of Efficacy|1|||
157098001|NCT03737474|567113070|FG001|Overall Study|Lack of Efficacy|3|||
157098002|NCT03737474|567113069|FG000|Overall Study|Protocol Violation|0|||
157098003|NCT03737474|567113070|FG001|Overall Study|Protocol Violation|8|||
157098004|NCT03737474|567113069|FG000|Overall Study|Withdrawal by Subject|5|||
157098005|NCT03737474|567113070|FG001|Overall Study|Withdrawal by Subject|20|||
156993991|NCT02431533|566729446|FG001|Overall Study|Withdrawal by Subject|3|||
156993992|NCT02431533|566729445|FG000|Overall Study|Developed Exclusionary criteria|1|||
156993993|NCT02431533|566729446|FG001|Overall Study|Developed Exclusionary criteria|0|||
156993994|NCT05174065|566729451|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
156993995|NCT05174065|566729452|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
156993996|NCT05174065|566729453|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
156993997|NCT05174065|566729451|FG000|Placebo-controlled Period|Other|0|||
156993998|NCT05174065|566729452|FG001|Placebo-controlled Period|Other|1|||
156993999|NCT05174065|566729453|FG002|Placebo-controlled Period|Other|0|||
156994000|NCT05174065|566729451|FG000|Placebo-controlled Period|Adverse Event|1|||
156994001|NCT05174065|566729452|FG001|Placebo-controlled Period|Adverse Event|1|||
156994002|NCT05174065|566729453|FG002|Placebo-controlled Period|Adverse Event|0|||
156994003|NCT05174065|566729451|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
156994004|NCT05174065|566729452|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
156994005|NCT05174065|566729453|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
156994006|NCT05174065|566729451|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
156994007|NCT05174065|566729452|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
156994008|NCT05174065|566729453|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
156994009|NCT05174065|566729451|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
156994010|NCT05174065|566729452|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
156994011|NCT05174065|566729453|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
156994012|NCT01737268|566729455|FG000|Overall Study|Adverse Event|6|||
156994013|NCT01737268|566729455|FG000|Overall Study|Worsening of Target Disease|2|||
156994014|NCT01737268|566729455|FG000|Overall Study|In consideration of the patient's safety|1|||
156994015|NCT00924560|566729456|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
156994016|NCT00924560|566729457|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
156994017|NCT00924560|566729458|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
156994018|NCT00924560|566729456|FG000|Overall Study|Non Compliance with the Protocol|20|||
156994019|NCT00924560|566729457|FG001|Overall Study|Non Compliance with the Protocol|15|||
156994020|NCT00924560|566729458|FG002|Overall Study|Non Compliance with the Protocol|4|||
156994021|NCT00924560|566729456|FG000|Overall Study|Physician Decision|2|||
156994022|NCT00924560|566729457|FG001|Overall Study|Physician Decision|3|||
156994023|NCT00924560|566729458|FG002|Overall Study|Physician Decision|4|||
156994024|NCT00924560|566729456|FG000|Overall Study|Withdrawal by Subject|50|||
156994025|NCT00924560|566729457|FG001|Overall Study|Withdrawal by Subject|44|||
156994026|NCT00924560|566729458|FG002|Overall Study|Withdrawal by Subject|18|||
156994027|NCT00924560|566729456|FG000|Overall Study|Adverse Event|39|||
156994028|NCT00924560|566729457|FG001|Overall Study|Adverse Event|33|||
156994029|NCT00924560|566729458|FG002|Overall Study|Adverse Event|0|||
156994030|NCT00924560|566729456|FG000|Overall Study|Pregnancy|5|||
156994031|NCT00924560|566729457|FG001|Overall Study|Pregnancy|7|||
156994032|NCT00924560|566729458|FG002|Overall Study|Pregnancy|1|||
156994033|NCT00924560|566729456|FG000|Overall Study|Lost to Follow-up|78|||
156994034|NCT00924560|566729457|FG001|Overall Study|Lost to Follow-up|94|||
156994035|NCT00924560|566729458|FG002|Overall Study|Lost to Follow-up|45|||
156994036|NCT00924560|566729456|FG000|Overall Study|Miscellaneous Reasons|13|||
156994037|NCT00924560|566729457|FG001|Overall Study|Miscellaneous Reasons|10|||
156994038|NCT00924560|566729458|FG002|Overall Study|Miscellaneous Reasons|10|||
156994039|NCT00209274|566729461|FG000|Overall Study|Missed visit|3|||
156994040|NCT00209274|566729462|FG001|Overall Study|Missed visit|2|||
156994041|NCT00209274|566729461|FG000|Overall Study|Death|32|||
156994042|NCT00209274|566729462|FG001|Overall Study|Death|15|||
156994043|NCT00209274|566729461|FG000|Overall Study|Withdrawal by Subject|30|||
156994044|NCT00209274|566729462|FG001|Overall Study|Withdrawal by Subject|15|||
156994045|NCT00209274|566729461|FG000|Overall Study|Randomized not treated (RNT)|6|||
156994046|NCT00209274|566729462|FG001|Overall Study|Randomized not treated (RNT)|15|||
156994047|NCT00604786|566729466|FG000|Overall Study|Lost to Follow-up|2|||
156994048|NCT00604786|566729467|FG001|Overall Study|Lost to Follow-up|0|||
156994049|NCT01221181|566729468|FG000|Overall Study|Lost to Follow-up|1|||
156994050|NCT03369951|566729469|FG000|Overall Study|Withdrawal by Subject|3|||
156994051|NCT03369951|566729469|FG000|Overall Study|Death|1|||
156994052|NCT03369951|566729469|FG000|Overall Study|Lost to Follow-up|1|||
156994053|NCT03369951|566729469|FG000|Overall Study|Protocol Violation|1|||
156994054|NCT01311648|566731225|FG000|Main Study|Protocol Violation|0|||
156994055|NCT01311648|566731226|FG001|Main Study|Protocol Violation|1|||
156994056|NCT01311648|566731225|FG000|Main Study|Adverse Event|0|||
156994057|NCT01311648|566731226|FG001|Main Study|Adverse Event|1|||
156994058|NCT01311648|566731225|FG000|Main Study|Inhibitor management|0|||
156994059|NCT01311648|566731226|FG001|Main Study|Inhibitor management|17|||
156994060|NCT01311648|566731225|FG000|Main Study|Withdrawal by Subject|0|||
156994061|NCT01311648|566731226|FG001|Main Study|Withdrawal by Subject|2|||
156994062|NCT01311648|566731225|FG000|Extension Study|Physician Decision|0|||
156994063|NCT01311648|566731226|FG001|Extension Study|Physician Decision|1|||
156994064|NCT01311648|566731225|FG000|Extension Study|ITI therapy with marketed product|0|||
156994065|NCT01311648|566731226|FG001|Extension Study|ITI therapy with marketed product|1|||
156994066|NCT01311648|566731225|FG000|Extension Study|Incorrect visit planning|0|||
156994067|NCT01311648|566731226|FG001|Extension Study|Incorrect visit planning|1|||
156994068|NCT01311648|566731225|FG000|Extension Study|Family's decision|0|||
156994069|NCT01311648|566731226|FG001|Extension Study|Family's decision|1|||
156994070|NCT01311648|566731225|FG000|Extension Study|Failure of ITI therapy|0|||
156994071|NCT01311648|566731226|FG001|Extension Study|Failure of ITI therapy|3|||
156994072|NCT01311648|566731225|FG000|Extension Study|Long travel|0|||
156994073|NCT01311648|566731226|FG001|Extension Study|Long travel|1|||
156994074|NCT01311648|566731225|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
156994075|NCT01311648|566731226|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
156994076|NCT01311648|566731225|FG000|Extension Study|Withdrawal by Subject|0|||
156994077|NCT01311648|566731226|FG001|Extension Study|Withdrawal by Subject|1|||
156994078|NCT01311648|566731225|FG000|Extension Study|Inhibitor management|0|||
156994079|NCT01311648|566731226|FG001|Extension Study|Inhibitor management|2|||
156994080|NCT01645111|566731227|FG000|Overall Study|Did not require Clevidipine|15|||
156994081|NCT05526911|566731228|FG000|Overall Study|Adverse Event|2|||
156994082|NCT05025449|566731229|FG000|Overall Study|Withdrawal by Subject|1|||
156994083|NCT05025449|566731229|FG000|Overall Study|Patient emergently taken to operating room|1|||
156994084|NCT00587288|566731231|FG000|Overall Study|Adverse Event|0|||
156994085|NCT00587288|566731232|FG001|Overall Study|Adverse Event|1|||
156994086|NCT00587288|566731231|FG000|Overall Study|Lack of Efficacy|2|||
156994087|NCT00587288|566731232|FG001|Overall Study|Lack of Efficacy|8|||
156994088|NCT00587288|566731231|FG000|Overall Study|Protocol Violation|1|||
156994089|NCT00587288|566731232|FG001|Overall Study|Protocol Violation|0|||
156994090|NCT00762463|566731233|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
156994091|NCT00762463|566731234|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
156994092|NCT00762463|566731235|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
156994093|NCT00762463|566731236|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
156994094|NCT00762463|566731233|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
156994095|NCT00762463|566731234|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
156994096|NCT00762463|566731235|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
156994097|NCT00762463|566731236|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
156994098|NCT00762463|566731233|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
156994099|NCT00762463|566731234|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
156994100|NCT00762463|566731235|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
156994101|NCT00762463|566731236|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
156994102|NCT00762463|566731233|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
156994103|NCT00762463|566731234|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
156994104|NCT00762463|566731235|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
156994105|NCT00762463|566731236|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
156994106|NCT00762463|566731233|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
156994107|NCT00762463|566731234|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
156994108|NCT00762463|566731235|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
156994109|NCT00762463|566731236|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
156994110|NCT00762463|566731233|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156994111|NCT00762463|566731234|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156994112|NCT00762463|566731235|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
156994113|NCT00762463|566731236|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
156994114|NCT00762463|566731233|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
156994115|NCT00762463|566731234|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
156994116|NCT00762463|566731235|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
156994117|NCT00762463|566731236|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
156994118|NCT00762463|566731233|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
156994119|NCT00762463|566731234|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
156994120|NCT00762463|566731235|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
156994121|NCT00762463|566731236|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
156994122|NCT05074498|566731239|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156994123|NCT05074498|566731240|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156994124|NCT05074498|566731241|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156994125|NCT05074498|566731242|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
156994126|NCT05074498|566731243|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156994127|NCT05074498|566731244|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
156994128|NCT05074498|566731239|FG000|Part 1 (Upto Day 104)|Other|1|||
156994129|NCT05074498|566731240|FG001|Part 1 (Upto Day 104)|Other|0|||
156994130|NCT05074498|566731241|FG002|Part 1 (Upto Day 104)|Other|0|||
156994131|NCT05074498|566731242|FG003|Part 1 (Upto Day 104)|Other|0|||
156994132|NCT05074498|566731243|FG004|Part 1 (Upto Day 104)|Other|0|||
156994133|NCT05074498|566731244|FG005|Part 1 (Upto Day 104)|Other|0|||
156994134|NCT05074498|566731239|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156994135|NCT05074498|566731240|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156994136|NCT05074498|566731241|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156994137|NCT05074498|566731242|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156994138|NCT05074498|566731243|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
156994139|NCT05074498|566731244|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
156994140|NCT05074498|566731239|FG000|Part 2 (Upto Day 104)|Death|0|||
156994141|NCT05074498|566731240|FG001|Part 2 (Upto Day 104)|Death|0|||
156994142|NCT05074498|566731241|FG002|Part 2 (Upto Day 104)|Death|0|||
156994143|NCT05074498|566731242|FG003|Part 2 (Upto Day 104)|Death|0|||
156994144|NCT05074498|566731243|FG004|Part 2 (Upto Day 104)|Death|1|||
156994145|NCT05074498|566731244|FG005|Part 2 (Upto Day 104)|Death|0|||
156994146|NCT05074498|566731239|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156994147|NCT05074498|566731240|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156994148|NCT05074498|566731241|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156994149|NCT05074498|566731242|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
156994150|NCT05074498|566731243|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
156994151|NCT05074498|566731244|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
156994152|NCT05074498|566731239|FG000|Part 2 (Upto Day 104)|Other|0|||
156994153|NCT05074498|566731240|FG001|Part 2 (Upto Day 104)|Other|0|||
156994154|NCT05074498|566731241|FG002|Part 2 (Upto Day 104)|Other|0|||
156994155|NCT05074498|566731242|FG003|Part 2 (Upto Day 104)|Other|0|||
157098006|NCT03737474|567113069|FG000|Overall Study|Non-compliance With Study Drug|0|||
157098007|NCT03737474|567113070|FG001|Overall Study|Non-compliance With Study Drug|1|||
157098008|NCT03737474|567113069|FG000|Overall Study|Physician Decision|1|||
157098009|NCT03737474|567113070|FG001|Overall Study|Physician Decision|4|||
157098010|NCT01139658|567113073|FG000|Overall Study|Adverse Event|10|||
157098011|NCT01139658|567113074|FG001|Overall Study|Adverse Event|27|||
157098012|NCT01139658|567113073|FG000|Overall Study|Lack of Efficacy|15|||
157098013|NCT01139658|567113074|FG001|Overall Study|Lack of Efficacy|7|||
157098014|NCT01139658|567113073|FG000|Overall Study|Withdrawal by Subject|2|||
157098015|NCT01139658|567113074|FG001|Overall Study|Withdrawal by Subject|4|||
157098016|NCT01139658|567113073|FG000|Overall Study|No documentation of treatment|1|||
157098017|NCT01139658|567113074|FG001|Overall Study|No documentation of treatment|0|||
157098018|NCT01139658|567113073|FG000|Overall Study|Other|28|||
157098019|NCT01139658|567113074|FG001|Overall Study|Other|75|||
157098020|NCT03282240|567113075|FG000|Overall Study|Adverse Event|2|||
157098021|NCT03282240|567113076|FG001|Overall Study|Adverse Event|2|||
156994156|NCT05074498|566731243|FG004|Part 2 (Upto Day 104)|Other|1|||
156994157|NCT05074498|566731244|FG005|Part 2 (Upto Day 104)|Other|0|||
156994158|NCT01257503|566731246|FG000|Overall Study|Lost to Follow-up|7|||
156994159|NCT01257503|566731247|FG001|Overall Study|Lost to Follow-up|10|||
156994160|NCT01257503|566731246|FG000|Overall Study|Over 5 years old at enrollment|0|||
156994161|NCT01257503|566731247|FG001|Overall Study|Over 5 years old at enrollment|1|||
156994162|NCT01257503|566731246|FG000|Overall Study|strep culture positive at enrollment|1|||
156994163|NCT01257503|566731247|FG001|Overall Study|strep culture positive at enrollment|0|||
156994164|NCT00088465|566731248|FG000|Overall Study|Withdrawal by Subject|290|||
156994165|NCT00088465|566731248|FG000|Overall Study|Adverse Event|77|||
156994166|NCT00088465|566731248|FG000|Overall Study|Lost to Follow-up|57|||
156994167|NCT00088465|566731248|FG000|Overall Study|Physician Decision|45|||
156994168|NCT00088465|566731248|FG000|Overall Study|Sponsor Decision|37|||
156994169|NCT00088465|566731248|FG000|Overall Study|Lack of Efficacy|27|||
156994170|NCT00088465|566731248|FG000|Overall Study|Protocol Violation|17|||
156994171|NCT00088465|566731248|FG000|Overall Study|Death|11|||
156994172|NCT01390857|566731249|FG000|Overall Study|Protocol Violation|2|||
156994173|NCT01390857|566731249|FG000|Overall Study|Lost to Follow-up|1|||
156994174|NCT01390857|566731249|FG000|Overall Study|No Visit after the First Visit|7|||
156994175|NCT01474538|566731251|FG000|Treatment Period 1|Death|1|||
156994176|NCT01474538|566731252|FG001|Treatment Period 1|Death|0|||
156994177|NCT01474538|566731251|FG000|Treatment Period 1|Physician Decision|1|||
156994178|NCT01474538|566731252|FG001|Treatment Period 1|Physician Decision|0|||
156994179|NCT01474538|566731251|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156994180|NCT01474538|566731252|FG001|Treatment Period 1|Withdrawal by Subject|3|||
156994181|NCT01474538|566731251|FG000|Treatment Period 1|Protocol Violation|0|||
156994182|NCT01474538|566731252|FG001|Treatment Period 1|Protocol Violation|1|||
156994183|NCT01474538|566731251|FG000|Treatment Period 2|Death|1|||
156994184|NCT01474538|566731252|FG001|Treatment Period 2|Death|0|||
156994185|NCT01474538|566731251|FG000|Treatment Period 2|Adverse Event|1|||
156994186|NCT01474538|566731252|FG001|Treatment Period 2|Adverse Event|1|||
156994187|NCT01474538|566731251|FG000|Treatment Period 2|Withdrawal by Subject|2|||
156994188|NCT01474538|566731252|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156994189|NCT01474538|566731251|FG000|Treatment Period 2|Sponsor decision|1|||
156994190|NCT01474538|566731252|FG001|Treatment Period 2|Sponsor decision|0|||
156994191|NCT01474538|566731251|FG000|Treatment Period 2|Physician Decision|0|||
156994192|NCT01474538|566731252|FG001|Treatment Period 2|Physician Decision|1|||
156994193|NCT01474538|566731251|FG000|Treatment Period 2|Protocol Violation|1|||
156994194|NCT01474538|566731252|FG001|Treatment Period 2|Protocol Violation|0|||
157098022|NCT03282240|567113077|FG002|Overall Study|Adverse Event|0|||
157098023|NCT03282240|567113075|FG000|Overall Study|Lost to Follow-up|3|||
157098024|NCT03282240|567113076|FG001|Overall Study|Lost to Follow-up|0|||
157098025|NCT03282240|567113077|FG002|Overall Study|Lost to Follow-up|0|||
157098026|NCT03282240|567113075|FG000|Overall Study|Protocol Deviation|4|||
157098027|NCT03282240|567113076|FG001|Overall Study|Protocol Deviation|1|||
157098028|NCT03282240|567113077|FG002|Overall Study|Protocol Deviation|2|||
157098029|NCT03282240|567113075|FG000|Overall Study|Withdrawal by Subject|1|||
157098030|NCT03282240|567113076|FG001|Overall Study|Withdrawal by Subject|0|||
157098031|NCT03282240|567113077|FG002|Overall Study|Withdrawal by Subject|1|||
157098032|NCT01675479|567113078|FG000|Overall Study|Lost to Follow-up|11|||
157098033|NCT02910739|567113079|FG000|Overall Study|Adverse Event|1|||
157098034|NCT02910739|567113080|FG001|Overall Study|Adverse Event|0|||
157098035|NCT02910739|567113081|FG002|Overall Study|Adverse Event|0|||
157098036|NCT02910739|567113082|FG003|Overall Study|Adverse Event|0|||
157098037|NCT01572922|567113085|FG000|Overall Study|Adverse Event|1|||
157098038|NCT01572922|567113085|FG000|Overall Study|Protocol Violation|1|||
157098039|NCT01572922|567113085|FG000|Overall Study|Death|1|||
157098040|NCT06515483|567113087|FG000|Overall Study|Subject withdraw due to family issues|1|||
157098041|NCT06515483|567113088|FG001|Overall Study|Subject withdraw due to family issues|0|||
157098042|NCT00147823|567113094|FG000|Overall Study|Lost to Follow-up|6|||
157098043|NCT00147823|567113095|FG001|Overall Study|Lost to Follow-up|12|||
157098044|NCT00147823|567113094|FG000|Overall Study|Physician Decision|1|||
157098045|NCT00147823|567113095|FG001|Overall Study|Physician Decision|0|||
157098046|NCT00147823|567113094|FG000|Overall Study|Withdrawal by Subject|0|||
157098047|NCT00147823|567113095|FG001|Overall Study|Withdrawal by Subject|1|||
157098048|NCT00147823|567113094|FG000|Overall Study|Did not receive vitoss due to infection|6|||
157098049|NCT00147823|567113095|FG001|Overall Study|Did not receive vitoss due to infection|2|||
157098050|NCT04751656|567114523|FG000|Overall Study|Lost to Follow-up|1|||
157098051|NCT03566810|567114526|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
157098052|NCT03566810|567114527|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
156994195|NCT02501629|566731253|FG000|Overall Study|Death|0|||
156994196|NCT02501629|566731254|FG001|Overall Study|Death|1|||
156994197|NCT02501629|566731253|FG000|Overall Study|Withdrawn from study by sponsor|1|||
157098053|NCT03566810|567114528|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
157098054|NCT03566810|567114529|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
157098055|NCT01103245|567114530|FG000|Overall Study|Withdrawal by Subject|1|||
157098056|NCT01103245|567114531|FG001|Overall Study|Withdrawal by Subject|0|||
157098057|NCT01103245|567114532|FG002|Overall Study|Withdrawal by Subject|3|||
157098058|NCT01103245|567114533|FG003|Overall Study|Withdrawal by Subject|0|||
157098059|NCT01103245|567114530|FG000|Overall Study|Inadequate IV access|1|||
157098060|NCT01103245|567114531|FG001|Overall Study|Inadequate IV access|0|||
157098061|NCT01103245|567114532|FG002|Overall Study|Inadequate IV access|0|||
157098062|NCT01103245|567114533|FG003|Overall Study|Inadequate IV access|0|||
157098063|NCT01103245|567114530|FG000|Overall Study|Adverse Event|0|||
157098064|NCT01103245|567114531|FG001|Overall Study|Adverse Event|2|||
157098065|NCT01103245|567114532|FG002|Overall Study|Adverse Event|1|||
157098066|NCT01103245|567114533|FG003|Overall Study|Adverse Event|0|||
157098067|NCT01103245|567114530|FG000|Overall Study|Physician Decision|1|||
157098068|NCT01103245|567114531|FG001|Overall Study|Physician Decision|0|||
157098069|NCT01103245|567114532|FG002|Overall Study|Physician Decision|0|||
157098070|NCT01103245|567114533|FG003|Overall Study|Physician Decision|0|||
157098071|NCT04796896|567114538|FG000|Overall Study|Adverse Event|1|||
157098072|NCT04796896|567114539|FG001|Overall Study|Adverse Event|0|||
157098073|NCT04796896|567114540|FG002|Overall Study|Adverse Event|0|||
157098074|NCT04796896|567114541|FG003|Overall Study|Adverse Event|0|||
157098075|NCT04796896|567114542|FG004|Overall Study|Adverse Event|0|||
157098076|NCT04796896|567114543|FG005|Overall Study|Adverse Event|1|||
157098077|NCT04796896|567114544|FG006|Overall Study|Adverse Event|1|||
157098078|NCT04796896|567114545|FG007|Overall Study|Adverse Event|0|||
157098079|NCT04796896|567114546|FG008|Overall Study|Adverse Event|1|||
157098080|NCT04796896|567114547|FG009|Overall Study|Adverse Event|1|||
157098081|NCT04796896|567114548|FG010|Overall Study|Adverse Event|1|||
157098082|NCT04796896|567114549|FG011|Overall Study|Adverse Event|0|||
157098083|NCT04796896|567114538|FG000|Overall Study|Lost to Follow-up|24|||
157098084|NCT04796896|567114539|FG001|Overall Study|Lost to Follow-up|15|||
157098085|NCT04796896|567114540|FG002|Overall Study|Lost to Follow-up|6|||
157098086|NCT04796896|567114541|FG003|Overall Study|Lost to Follow-up|4|||
157098087|NCT04796896|567114542|FG004|Overall Study|Lost to Follow-up|21|||
157098088|NCT04796896|567114543|FG005|Overall Study|Lost to Follow-up|55|||
157098089|NCT04796896|567114544|FG006|Overall Study|Lost to Follow-up|237|||
157098090|NCT04796896|567114545|FG007|Overall Study|Lost to Follow-up|52|||
157098091|NCT04796896|567114546|FG008|Overall Study|Lost to Follow-up|221|||
157098092|NCT04796896|567114547|FG009|Overall Study|Lost to Follow-up|43|||
157098093|NCT04796896|567114548|FG010|Overall Study|Lost to Follow-up|142|||
157098094|NCT04796896|567114549|FG011|Overall Study|Lost to Follow-up|18|||
157098095|NCT04796896|567114538|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
157098096|NCT04796896|567114539|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
157098097|NCT04796896|567114540|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
157098098|NCT04796896|567114541|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
157098099|NCT04796896|567114542|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
157098100|NCT04796896|567114543|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
157098101|NCT04796896|567114544|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
157098102|NCT04796896|567114545|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
157098103|NCT04796896|567114546|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
157098104|NCT04796896|567114547|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
157098105|NCT04796896|567114548|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
157098106|NCT04796896|567114549|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
157098107|NCT04796896|567114538|FG000|Overall Study|Physician Decision|1|||
157098108|NCT04796896|567114539|FG001|Overall Study|Physician Decision|0|||
157098109|NCT04796896|567114540|FG002|Overall Study|Physician Decision|0|||
157098110|NCT04796896|567114541|FG003|Overall Study|Physician Decision|0|||
157098111|NCT04796896|567114542|FG004|Overall Study|Physician Decision|0|||
157098112|NCT04796896|567114543|FG005|Overall Study|Physician Decision|3|||
157098113|NCT04796896|567114544|FG006|Overall Study|Physician Decision|18|||
157098114|NCT04796896|567114545|FG007|Overall Study|Physician Decision|1|||
157098115|NCT04796896|567114546|FG008|Overall Study|Physician Decision|7|||
157098116|NCT04796896|567114547|FG009|Overall Study|Physician Decision|0|||
157098117|NCT04796896|567114548|FG010|Overall Study|Physician Decision|5|||
157098118|NCT04796896|567114549|FG011|Overall Study|Physician Decision|0|||
157098119|NCT04796896|567114538|FG000|Overall Study|Withdrawal by Subject|36|||
157098120|NCT04796896|567114539|FG001|Overall Study|Withdrawal by Subject|31|||
157098121|NCT04796896|567114540|FG002|Overall Study|Withdrawal by Subject|11|||
157098122|NCT04796896|567114541|FG003|Overall Study|Withdrawal by Subject|8|||
157098123|NCT04796896|567114542|FG004|Overall Study|Withdrawal by Subject|16|||
157098124|NCT04796896|567114543|FG005|Overall Study|Withdrawal by Subject|162|||
157098125|NCT04796896|567114544|FG006|Overall Study|Withdrawal by Subject|299|||
157098126|NCT04796896|567114545|FG007|Overall Study|Withdrawal by Subject|149|||
157098127|NCT04796896|567114546|FG008|Overall Study|Withdrawal by Subject|303|||
157098128|NCT04796896|567114547|FG009|Overall Study|Withdrawal by Subject|94|||
157098129|NCT04796896|567114548|FG010|Overall Study|Withdrawal by Subject|192|||
157098130|NCT04796896|567114549|FG011|Overall Study|Withdrawal by Subject|16|||
157098131|NCT04796896|567114538|FG000|Overall Study|Other Than Specified|6|||
157098132|NCT04796896|567114539|FG001|Overall Study|Other Than Specified|5|||
157098133|NCT04796896|567114540|FG002|Overall Study|Other Than Specified|3|||
157098134|NCT04796896|567114541|FG003|Overall Study|Other Than Specified|2|||
157098135|NCT04796896|567114542|FG004|Overall Study|Other Than Specified|6|||
157098136|NCT04796896|567114543|FG005|Overall Study|Other Than Specified|31|||
157098137|NCT04796896|567114544|FG006|Overall Study|Other Than Specified|86|||
157098138|NCT04796896|567114545|FG007|Overall Study|Other Than Specified|66|||
157098139|NCT04796896|567114546|FG008|Overall Study|Other Than Specified|388|||
157098140|NCT04796896|567114547|FG009|Overall Study|Other Than Specified|48|||
157098141|NCT04796896|567114548|FG010|Overall Study|Other Than Specified|258|||
157098142|NCT04796896|567114549|FG011|Overall Study|Other Than Specified|4|||
157098143|NCT04796896|567114538|FG000|Overall Study|Protocol Deviation|0|||
157098144|NCT04796896|567114539|FG001|Overall Study|Protocol Deviation|0|||
157098145|NCT04796896|567114540|FG002|Overall Study|Protocol Deviation|0|||
157098146|NCT04796896|567114541|FG003|Overall Study|Protocol Deviation|1|||
157098147|NCT04796896|567114542|FG004|Overall Study|Protocol Deviation|1|||
157098148|NCT04796896|567114543|FG005|Overall Study|Protocol Deviation|2|||
157098149|NCT04796896|567114544|FG006|Overall Study|Protocol Deviation|2|||
157098150|NCT04796896|567114545|FG007|Overall Study|Protocol Deviation|2|||
157098151|NCT04796896|567114546|FG008|Overall Study|Protocol Deviation|2|||
157098152|NCT04796896|567114547|FG009|Overall Study|Protocol Deviation|1|||
157098153|NCT04796896|567114548|FG010|Overall Study|Protocol Deviation|0|||
157098154|NCT04796896|567114549|FG011|Overall Study|Protocol Deviation|0|||
157098155|NCT04796896|567114538|FG000|Overall Study|Missing|0|||
157098156|NCT04796896|567114539|FG001|Overall Study|Missing|0|||
157098157|NCT04796896|567114540|FG002|Overall Study|Missing|0|||
157098158|NCT04796896|567114541|FG003|Overall Study|Missing|0|||
157098159|NCT04796896|567114542|FG004|Overall Study|Missing|0|||
157098160|NCT04796896|567114543|FG005|Overall Study|Missing|0|||
157098161|NCT04796896|567114544|FG006|Overall Study|Missing|2|||
157098162|NCT04796896|567114545|FG007|Overall Study|Missing|1|||
157098163|NCT04796896|567114546|FG008|Overall Study|Missing|2|||
157098164|NCT04796896|567114547|FG009|Overall Study|Missing|1|||
157098165|NCT04796896|567114548|FG010|Overall Study|Missing|1|||
157098166|NCT04796896|567114549|FG011|Overall Study|Missing|0|||
157098167|NCT04796896|567114538|FG000|Overall Study|Death|0|||
157098168|NCT04796896|567114539|FG001|Overall Study|Death|0|||
157098169|NCT04796896|567114540|FG002|Overall Study|Death|0|||
157098170|NCT04796896|567114541|FG003|Overall Study|Death|0|||
157098171|NCT04796896|567114542|FG004|Overall Study|Death|0|||
157098172|NCT04796896|567114543|FG005|Overall Study|Death|0|||
157098173|NCT04796896|567114544|FG006|Overall Study|Death|0|||
157098174|NCT04796896|567114545|FG007|Overall Study|Death|0|||
157098175|NCT04796896|567114546|FG008|Overall Study|Death|1|||
157098176|NCT04796896|567114547|FG009|Overall Study|Death|0|||
157098177|NCT04796896|567114548|FG010|Overall Study|Death|0|||
157098178|NCT04796896|567114549|FG011|Overall Study|Death|0|||
157098179|NCT05972733|567114552|FG000|Overall Study|Lost to Follow-up|2|||
157098180|NCT05972733|567114552|FG000|Overall Study|Withdrawal by Subject|1|||
157098181|NCT01177787|567114553|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
157098182|NCT01177787|567114553|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
157098183|NCT01177787|567114553|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
157098184|NCT01676909|567114558|FG000|Overall Study|Withdrawal by Subject|3|||
157098185|NCT01676909|567114559|FG001|Overall Study|Withdrawal by Subject|5|||
157098186|NCT01676909|567114558|FG000|Overall Study|Lost to Follow-up|15|||
157098187|NCT01676909|567114559|FG001|Overall Study|Lost to Follow-up|9|||
157098188|NCT04615247|567114560|FG000|Overall Study|Adverse Event|0|||
157098189|NCT04615247|567114561|FG001|Overall Study|Adverse Event|2|||
157098190|NCT04615247|567114560|FG000|Overall Study|Withdrawal by Subject|1|||
157098191|NCT04615247|567114561|FG001|Overall Study|Withdrawal by Subject|1|||
157098192|NCT00823901|567114562|FG000|Overall Study|Adverse Event|1|||
157098193|NCT00823901|567114563|FG001|Overall Study|Adverse Event|1|||
157098194|NCT00823901|567114562|FG000|Overall Study|Lack of Efficacy|1|||
157098195|NCT00823901|567114563|FG001|Overall Study|Lack of Efficacy|0|||
157098196|NCT00823901|567114562|FG000|Overall Study|Lost to Follow-up|2|||
157098197|NCT00823901|567114563|FG001|Overall Study|Lost to Follow-up|1|||
157098198|NCT01369511|567114564|FG000|Overall Study|Adverse Event|1|||
157098199|NCT01369511|567114565|FG001|Overall Study|Adverse Event|1|||
157098200|NCT01369511|567114566|FG002|Overall Study|Adverse Event|5|||
157098201|NCT01369511|567114567|FG003|Overall Study|Adverse Event|0|||
157098202|NCT01369511|567114564|FG000|Overall Study|Entry criteria not met|2|||
157098203|NCT01369511|567114565|FG001|Overall Study|Entry criteria not met|0|||
157098204|NCT01369511|567114566|FG002|Overall Study|Entry criteria not met|0|||
157098205|NCT01369511|567114567|FG003|Overall Study|Entry criteria not met|1|||
157098206|NCT01369511|567114564|FG000|Overall Study|Lost to Follow-up|0|||
156994198|NCT02501629|566731254|FG001|Overall Study|Withdrawn from study by sponsor|0|||
156994199|NCT02501629|566731253|FG000|Overall Study|Early termination by sponsor|1|||
156994200|NCT02501629|566731254|FG001|Overall Study|Early termination by sponsor|0|||
156994201|NCT02501629|566731253|FG000|Overall Study|Withdrawal by Subject|3|||
156994202|NCT02501629|566731254|FG001|Overall Study|Withdrawal by Subject|5|||
156994203|NCT02501629|566731253|FG000|Overall Study|Subject did not return to site|0|||
156994204|NCT02501629|566731254|FG001|Overall Study|Subject did not return to site|1|||
156994205|NCT00672256|566731259|FG000|Overall Study|PI dropped, bad data|44|||
156994206|NCT02334306|566731266|FG000|Double-blind Period|Adverse Event|0|||
156994207|NCT02334306|566731267|FG001|Double-blind Period|Adverse Event|1|||
156994208|NCT02334306|566731266|FG000|Double-blind Period|Withdrawal by Subject|1|||
156994209|NCT02334306|566731267|FG001|Double-blind Period|Withdrawal by Subject|1|||
156994210|NCT00465985|566731268|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
156994211|NCT00465985|566731269|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
156994212|NCT00465985|566731268|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
156994213|NCT00465985|566731269|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
156994214|NCT00465985|566731268|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
156994215|NCT00465985|566731269|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
156994216|NCT00465985|566731268|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
156994217|NCT00465985|566731269|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
156994218|NCT01687270|566731270|FG000|Overall Study|Lack of Efficacy|11|||
156994219|NCT01687270|566731270|FG000|Overall Study|Lost to Follow-up|1|||
156994220|NCT02950545|566731271|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156994221|NCT02950545|566731272|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156994222|NCT02950545|566731273|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156994223|NCT02950545|566731274|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156994224|NCT02950545|566731275|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
156994225|NCT02950545|566731276|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
156994226|NCT02950545|566731271|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
156994227|NCT02950545|566731272|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156994228|NCT02950545|566731273|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156994229|NCT02950545|566731274|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
156994230|NCT02950545|566731275|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
156994231|NCT02950545|566731276|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
157098207|NCT01369511|567114565|FG001|Overall Study|Lost to Follow-up|1|||
157098208|NCT01369511|567114566|FG002|Overall Study|Lost to Follow-up|1|||
157098209|NCT01369511|567114567|FG003|Overall Study|Lost to Follow-up|2|||
157098210|NCT01369511|567114564|FG000|Overall Study|Protocol Violation|0|||
157098211|NCT01369511|567114565|FG001|Overall Study|Protocol Violation|1|||
157098212|NCT01369511|567114566|FG002|Overall Study|Protocol Violation|0|||
157098213|NCT01369511|567114567|FG003|Overall Study|Protocol Violation|2|||
157098214|NCT01369511|567114564|FG000|Overall Study|Physician Decision|3|||
157098215|NCT01369511|567114565|FG001|Overall Study|Physician Decision|4|||
157098216|NCT01369511|567114566|FG002|Overall Study|Physician Decision|0|||
157098217|NCT01369511|567114567|FG003|Overall Study|Physician Decision|0|||
157098218|NCT01369511|567114564|FG000|Overall Study|Sponsor decision|2|||
157098219|NCT01369511|567114565|FG001|Overall Study|Sponsor decision|0|||
156994232|NCT02950545|566731271|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156994233|NCT02950545|566731272|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156994234|NCT02950545|566731273|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156994235|NCT02950545|566731274|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156994236|NCT02950545|566731275|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
156994237|NCT02950545|566731276|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
156994238|NCT02950545|566731271|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
157098220|NCT01369511|567114566|FG002|Overall Study|Sponsor decision|1|||
157098221|NCT01369511|567114567|FG003|Overall Study|Sponsor decision|0|||
157098222|NCT01369511|567114564|FG000|Overall Study|Withdrawal by Subject|5|||
157098223|NCT01369511|567114565|FG001|Overall Study|Withdrawal by Subject|6|||
156994239|NCT02950545|566731272|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156994240|NCT02950545|566731273|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156994241|NCT02950545|566731274|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156994242|NCT02950545|566731275|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156994243|NCT02950545|566731276|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
156994244|NCT02950545|566731271|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156994245|NCT02950545|566731272|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156994246|NCT02950545|566731273|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156994247|NCT02950545|566731274|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156994248|NCT02950545|566731275|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
156994249|NCT02950545|566731276|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
156994250|NCT01004263|566731277|FG000|Overall Study|Adverse Event|15|||
156994251|NCT01004263|566731277|FG000|Overall Study|Withdrawal by Subject|58|||
156994252|NCT01004263|566731277|FG000|Overall Study|Protocol Violation|10|||
156994253|NCT01004263|566731277|FG000|Overall Study|Lost to Follow-up|64|||
156994254|NCT01004263|566731277|FG000|Overall Study|Lack of Efficacy|13|||
156994255|NCT01004263|566731277|FG000|Overall Study|Pregnancy|2|||
156994256|NCT01004263|566731277|FG000|Overall Study|Physician Decision|15|||
156994257|NCT01004263|566731277|FG000|Overall Study|Lack of Qualifying Event|2|||
156994258|NCT03398356|566731278|FG000|Before Treatment|Lost to Follow-up|1|||
156994259|NCT03398356|566731279|FG001|Before Treatment|Lost to Follow-up|2|||
156994260|NCT03398356|566731280|FG002|Before Treatment|Lost to Follow-up|0|||
156994261|NCT03398356|566731278|FG000|Before Treatment|drug intolerance|2|||
156994262|NCT03398356|566731279|FG001|Before Treatment|drug intolerance|1|||
156994263|NCT03398356|566731280|FG002|Before Treatment|drug intolerance|0|||
156994264|NCT03398356|566731278|FG000|Before Treatment|Withdrawal by Subject|0|||
156994265|NCT03398356|566731279|FG001|Before Treatment|Withdrawal by Subject|5|||
156994266|NCT03398356|566731280|FG002|Before Treatment|Withdrawal by Subject|0|||
156994267|NCT03398356|566731278|FG000|Before Treatment|Physician Decision|0|||
156994268|NCT03398356|566731279|FG001|Before Treatment|Physician Decision|0|||
156994269|NCT03398356|566731280|FG002|Before Treatment|Physician Decision|11|||
156994270|NCT03398356|566731278|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
156994271|NCT03398356|566731279|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
156994272|NCT03398356|566731280|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
156994273|NCT00282438|566731281|FG000|Overall Study|Lack of Efficacy|1|||
156994274|NCT00282438|566731282|FG001|Overall Study|Lack of Efficacy|0|||
156994275|NCT00282438|566731281|FG000|Overall Study|Death|0|||
156994276|NCT00282438|566731282|FG001|Overall Study|Death|1|||
156994277|NCT02954055|566731287|FG000|Overall Study|Did not initiate therapy|6|||
156994278|NCT02954055|566731288|FG001|Overall Study|Did not initiate therapy|1|||
156994279|NCT01119703|566731293|FG000|Overall Study|Adverse Event|0|||
156994280|NCT01119703|566731294|FG001|Overall Study|Adverse Event|1|||
156994281|NCT01511250|566731295|FG000|Overall Study|Withdrawal of Consent|1|||
156994282|NCT01511250|566731296|FG001|Overall Study|Withdrawal of Consent|0|||
156994283|NCT01511250|566731297|FG002|Overall Study|Withdrawal of Consent|0|||
156994284|NCT01511250|566731298|FG003|Overall Study|Withdrawal of Consent|0|||
156994285|NCT01511250|566731299|FG004|Overall Study|Withdrawal of Consent|0|||
156994286|NCT01511250|566731300|FG005|Overall Study|Withdrawal of Consent|0|||
156994287|NCT01511250|566731301|FG006|Overall Study|Withdrawal of Consent|0|||
156994288|NCT01511250|566731302|FG007|Overall Study|Withdrawal of Consent|1|||
156994289|NCT01511250|566731303|FG008|Overall Study|Withdrawal of Consent|1|||
156994290|NCT01511250|566731304|FG009|Overall Study|Withdrawal of Consent|0|||
156994291|NCT01511250|566731295|FG000|Overall Study|Sponsor/Investigator Decision|1|||
156994292|NCT01511250|566731296|FG001|Overall Study|Sponsor/Investigator Decision|0|||
156994293|NCT01511250|566731297|FG002|Overall Study|Sponsor/Investigator Decision|0|||
156994294|NCT01511250|566731298|FG003|Overall Study|Sponsor/Investigator Decision|0|||
156994295|NCT01511250|566731299|FG004|Overall Study|Sponsor/Investigator Decision|0|||
156994296|NCT01511250|566731300|FG005|Overall Study|Sponsor/Investigator Decision|0|||
156994297|NCT01511250|566731301|FG006|Overall Study|Sponsor/Investigator Decision|0|||
156994298|NCT01511250|566731302|FG007|Overall Study|Sponsor/Investigator Decision|0|||
156994299|NCT01511250|566731303|FG008|Overall Study|Sponsor/Investigator Decision|0|||
156994300|NCT01511250|566731304|FG009|Overall Study|Sponsor/Investigator Decision|0|||
156994301|NCT01511250|566731295|FG000|Overall Study|Lost to Follow-up|7|||
156994302|NCT01511250|566731296|FG001|Overall Study|Lost to Follow-up|3|||
156994303|NCT01511250|566731297|FG002|Overall Study|Lost to Follow-up|3|||
156994304|NCT01511250|566731298|FG003|Overall Study|Lost to Follow-up|3|||
156994305|NCT01511250|566731299|FG004|Overall Study|Lost to Follow-up|0|||
156994306|NCT01511250|566731300|FG005|Overall Study|Lost to Follow-up|0|||
156994307|NCT01511250|566731301|FG006|Overall Study|Lost to Follow-up|2|||
156994308|NCT01511250|566731302|FG007|Overall Study|Lost to Follow-up|3|||
156994309|NCT01511250|566731303|FG008|Overall Study|Lost to Follow-up|13|||
156994310|NCT01511250|566731304|FG009|Overall Study|Lost to Follow-up|5|||
156994311|NCT01511250|566731295|FG000|Overall Study|Protocol Violation|0|||
156994312|NCT01511250|566731296|FG001|Overall Study|Protocol Violation|2|||
156994313|NCT01511250|566731297|FG002|Overall Study|Protocol Violation|1|||
156994314|NCT01511250|566731298|FG003|Overall Study|Protocol Violation|0|||
156994315|NCT01511250|566731299|FG004|Overall Study|Protocol Violation|0|||
156994316|NCT01511250|566731300|FG005|Overall Study|Protocol Violation|0|||
156994317|NCT01511250|566731301|FG006|Overall Study|Protocol Violation|0|||
156994318|NCT01511250|566731302|FG007|Overall Study|Protocol Violation|0|||
156994319|NCT01511250|566731303|FG008|Overall Study|Protocol Violation|0|||
156994320|NCT01511250|566731304|FG009|Overall Study|Protocol Violation|0|||
156994321|NCT01763047|566731305|FG000|Period 1|Test Article Not Available|4|||
156994322|NCT01763047|566731306|FG001|Period 1|Test Article Not Available|1|||
156994323|NCT01763047|566731305|FG000|Period 1|Protocol Violation|4|||
156994324|NCT01763047|566731306|FG001|Period 1|Protocol Violation|4|||
156994325|NCT01763047|566731305|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
156994326|NCT01763047|566731306|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
156994327|NCT01763047|566731305|FG000|Period 1|Adverse Event|0|||
156994328|NCT01763047|566731306|FG001|Period 1|Adverse Event|1|||
156994329|NCT01763047|566731305|FG000|Period 1|Unsatisfactory Visual Response|0|||
156994330|NCT01763047|566731306|FG001|Period 1|Unsatisfactory Visual Response|3|||
156994331|NCT01763047|566731305|FG000|Period 1|Lens Power Not Available|0|||
156994332|NCT01763047|566731306|FG001|Period 1|Lens Power Not Available|1|||
156994333|NCT01763047|566731305|FG000|Period 1|Study Site office Closed|0|||
156994334|NCT01763047|566731306|FG001|Period 1|Study Site office Closed|1|||
156994335|NCT01763047|566731305|FG000|Period 2|Lens Discomfort|1|||
156994336|NCT01763047|566731306|FG001|Period 2|Lens Discomfort|0|||
156994337|NCT01763047|566731305|FG000|Period 2|No longer meets Eligibility Criteria|1|||
156994338|NCT01763047|566731306|FG001|Period 2|No longer meets Eligibility Criteria|0|||
156994339|NCT01763047|566731305|FG000|Period 2|Study Site office Closed|1|||
156994340|NCT01763047|566731306|FG001|Period 2|Study Site office Closed|1|||
156994341|NCT01763047|566731305|FG000|Period 2|Unsatisfactory Visual Response|1|||
156994342|NCT01763047|566731306|FG001|Period 2|Unsatisfactory Visual Response|1|||
156994343|NCT01763047|566731305|FG000|Period 2|Protocol Violation|0|||
156994344|NCT01763047|566731306|FG001|Period 2|Protocol Violation|2|||
156994345|NCT01763047|566731305|FG000|Period 2|Unsatisfactory lens Fitting|0|||
156994346|NCT01763047|566731306|FG001|Period 2|Unsatisfactory lens Fitting|1|||
156994347|NCT01941316|566731312|FG000|Overall Study|Adverse Event|0|||
156994348|NCT01941316|566731313|FG001|Overall Study|Adverse Event|1|||
156994349|NCT01941316|566731314|FG002|Overall Study|Adverse Event|0|||
156994350|NCT01941316|566731315|FG003|Overall Study|Adverse Event|7|||
156994351|NCT01941316|566731312|FG000|Overall Study|Progressive Disease|3|||
156994352|NCT01941316|566731313|FG001|Overall Study|Progressive Disease|6|||
156994353|NCT01941316|566731314|FG002|Overall Study|Progressive Disease|2|||
156994354|NCT01941316|566731315|FG003|Overall Study|Progressive Disease|29|||
156994355|NCT01941316|566731312|FG000|Overall Study|Withdrawal by Subject|0|||
156994356|NCT01941316|566731313|FG001|Overall Study|Withdrawal by Subject|2|||
156994357|NCT01941316|566731314|FG002|Overall Study|Withdrawal by Subject|1|||
156994358|NCT01941316|566731315|FG003|Overall Study|Withdrawal by Subject|8|||
156994359|NCT01941316|566731312|FG000|Overall Study|Death|0|||
156994360|NCT01941316|566731313|FG001|Overall Study|Death|0|||
156994361|NCT01941316|566731314|FG002|Overall Study|Death|0|||
156994362|NCT01941316|566731315|FG003|Overall Study|Death|3|||
156994363|NCT01941316|566731312|FG000|Overall Study|Physician Decision|0|||
156994364|NCT01941316|566731313|FG001|Overall Study|Physician Decision|0|||
156994365|NCT01941316|566731314|FG002|Overall Study|Physician Decision|0|||
156994366|NCT01941316|566731315|FG003|Overall Study|Physician Decision|3|||
156994367|NCT01941316|566731312|FG000|Overall Study|Protocol Violation|0|||
156994368|NCT01941316|566731313|FG001|Overall Study|Protocol Violation|0|||
156994369|NCT01941316|566731314|FG002|Overall Study|Protocol Violation|0|||
156994370|NCT01941316|566731315|FG003|Overall Study|Protocol Violation|3|||
156994371|NCT01941316|566731312|FG000|Overall Study|Intercurrent illness|0|||
156994372|NCT01941316|566731313|FG001|Overall Study|Intercurrent illness|0|||
156994373|NCT01941316|566731314|FG002|Overall Study|Intercurrent illness|0|||
156994374|NCT01941316|566731315|FG003|Overall Study|Intercurrent illness|1|||
156994375|NCT01941316|566731312|FG000|Overall Study|Other, not specified|0|||
156994376|NCT01941316|566731313|FG001|Overall Study|Other, not specified|0|||
156994377|NCT01941316|566731314|FG002|Overall Study|Other, not specified|0|||
156994378|NCT01941316|566731315|FG003|Overall Study|Other, not specified|1|||
156994379|NCT02775435|566731316|FG000|Overall Study|Adverse Event|32|||
156994380|NCT02775435|566731317|FG001|Overall Study|Adverse Event|27|||
156994381|NCT02775435|566731316|FG000|Overall Study|Lost to Follow-up|2|||
156994382|NCT02775435|566731317|FG001|Overall Study|Lost to Follow-up|2|||
156994383|NCT02775435|566731316|FG000|Overall Study|Sponsor decision|44|||
156994384|NCT02775435|566731317|FG001|Overall Study|Sponsor decision|19|||
156994385|NCT02775435|566731316|FG000|Overall Study|Withdrawal by Subject|4|||
156994386|NCT02775435|566731317|FG001|Overall Study|Withdrawal by Subject|9|||
156994387|NCT02775435|566731316|FG000|Overall Study|Death|196|||
156994388|NCT02775435|566731317|FG001|Overall Study|Death|224|||
156994389|NCT02282527|566731318|FG000|Overall Study|Lost to Follow-up|0|||
156994390|NCT02282527|566731319|FG001|Overall Study|Lost to Follow-up|1|||
156994391|NCT02282527|566731318|FG000|Overall Study|Lack of home health aid|1|||
156994392|NCT02282527|566731319|FG001|Overall Study|Lack of home health aid|0|||
156994393|NCT00941031|566731320|FG000|Induction Period|Lack of Efficacy|2|||
156994394|NCT00941031|566731321|FG001|Induction Period|Lack of Efficacy|1|||
156994395|NCT00941031|566731322|FG002|Induction Period|Lack of Efficacy|0|||
156994396|NCT00941031|566731323|FG003|Induction Period|Lack of Efficacy|5|||
156994397|NCT00941031|566731324|FG004|Induction Period|Lack of Efficacy|0|||
156994398|NCT00941031|566731325|FG005|Induction Period|Lack of Efficacy|0|||
156994399|NCT00941031|566731326|FG006|Induction Period|Lack of Efficacy|0|||
156994400|NCT00941031|566731320|FG000|Induction Period|Withdrawal by Subject|1|||
156994401|NCT00941031|566731321|FG001|Induction Period|Withdrawal by Subject|2|||
156994402|NCT00941031|566731322|FG002|Induction Period|Withdrawal by Subject|2|||
156994403|NCT00941031|566731323|FG003|Induction Period|Withdrawal by Subject|2|||
156994404|NCT00941031|566731324|FG004|Induction Period|Withdrawal by Subject|0|||
157098224|NCT01369511|567114566|FG002|Overall Study|Withdrawal by Subject|4|||
157098225|NCT01369511|567114567|FG003|Overall Study|Withdrawal by Subject|6|||
157098226|NCT01376349|567114569|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
157098227|NCT01376349|567114570|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
157098228|NCT01376349|567114571|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
157098229|NCT01376349|567114569|FG000|Raondomized Treatment|Adverse Event|13|||
157098230|NCT01376349|567114570|FG001|Raondomized Treatment|Adverse Event|17|||
157098231|NCT01376349|567114571|FG002|Raondomized Treatment|Adverse Event|14|||
157098232|NCT01376349|567114569|FG000|Raondomized Treatment|Unkown|1|||
157098233|NCT01376349|567114570|FG001|Raondomized Treatment|Unkown|2|||
157098234|NCT01376349|567114571|FG002|Raondomized Treatment|Unkown|1|||
157098235|NCT01376349|567114569|FG000|Raondomized Treatment|Alternative Treatment|0|||
157098236|NCT01376349|567114570|FG001|Raondomized Treatment|Alternative Treatment|0|||
157098237|NCT01376349|567114571|FG002|Raondomized Treatment|Alternative Treatment|1|||
157098238|NCT00718640|567114572|FG000|Overall Study|Adverse Event|4|||
157098239|NCT00718640|567114572|FG000|Overall Study|Death|1|||
157098240|NCT00718640|567114572|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
157098241|NCT00818389|567114573|FG000|Overall Study|Death|1|||
157098242|NCT00818389|567114574|FG001|Overall Study|Death|3|||
157098243|NCT00818389|567114573|FG000|Overall Study|ALS Disease Progression|1|||
157098244|NCT00818389|567114574|FG001|Overall Study|ALS Disease Progression|0|||
157098245|NCT00818389|567114573|FG000|Overall Study|Withdrawal by Subject|2|||
157098246|NCT00818389|567114574|FG001|Overall Study|Withdrawal by Subject|2|||
157098247|NCT00818389|567114573|FG000|Overall Study|Adverse Event|0|||
157098248|NCT00818389|567114574|FG001|Overall Study|Adverse Event|1|||
157098249|NCT05193500|567114577|FG000|Overall Study|Withdrawal by Subject|7|||
157098250|NCT05193500|567114578|FG001|Overall Study|Withdrawal by Subject|4|||
157098251|NCT05193500|567114579|FG002|Overall Study|Withdrawal by Subject|3|||
157098252|NCT05193500|567114580|FG003|Overall Study|Withdrawal by Subject|5|||
157098253|NCT02982187|567114581|FG000|Overall Study|Withdrawal by Subject|0|||
157098254|NCT02982187|567114582|FG001|Overall Study|Withdrawal by Subject|0|||
157098255|NCT02982187|567114583|FG002|Overall Study|Withdrawal by Subject|0|||
157098256|NCT02982187|567114584|FG003|Overall Study|Withdrawal by Subject|0|||
157098257|NCT02982187|567114585|FG004|Overall Study|Withdrawal by Subject|0|||
157098258|NCT02982187|567114586|FG005|Overall Study|Withdrawal by Subject|0|||
157098259|NCT02982187|567114587|FG006|Overall Study|Withdrawal by Subject|1|||
157098260|NCT02982187|567114588|FG007|Overall Study|Withdrawal by Subject|0|||
157098261|NCT01978262|567114589|FG000|Overall Study|Withdrawal by Subject|9|||
157098262|NCT01978262|567114589|FG000|Overall Study|Lost to Follow-up|2|||
157098263|NCT02202551|567114590|FG000|Overall Study|Adverse Event|8|||
157098264|NCT02202551|567114591|FG001|Overall Study|Adverse Event|19|||
157098265|NCT02202551|567114592|FG002|Overall Study|Adverse Event|5|||
157098266|NCT02202551|567114593|FG003|Overall Study|Adverse Event|9|||
157098267|NCT02202551|567114590|FG000|Overall Study|Death|3|||
157098268|NCT02202551|567114591|FG001|Overall Study|Death|2|||
157098269|NCT02202551|567114592|FG002|Overall Study|Death|1|||
157098270|NCT02202551|567114593|FG003|Overall Study|Death|1|||
157098271|NCT02202551|567114590|FG000|Overall Study|Lost to Follow-up|0|||
157098272|NCT02202551|567114591|FG001|Overall Study|Lost to Follow-up|1|||
157098273|NCT02202551|567114592|FG002|Overall Study|Lost to Follow-up|0|||
157098274|NCT02202551|567114593|FG003|Overall Study|Lost to Follow-up|1|||
157098275|NCT02202551|567114590|FG000|Overall Study|Needed to take excluded medication|0|||
157098276|NCT02202551|567114591|FG001|Overall Study|Needed to take excluded medication|2|||
157098277|NCT02202551|567114592|FG002|Overall Study|Needed to take excluded medication|0|||
157098278|NCT02202551|567114593|FG003|Overall Study|Needed to take excluded medication|1|||
157098279|NCT02202551|567114590|FG000|Overall Study|Subject moved away|0|||
157098280|NCT02202551|567114591|FG001|Overall Study|Subject moved away|1|||
157098281|NCT02202551|567114592|FG002|Overall Study|Subject moved away|0|||
157098282|NCT02202551|567114593|FG003|Overall Study|Subject moved away|0|||
157098283|NCT02202551|567114590|FG000|Overall Study|DBS surgery|3|||
157098284|NCT02202551|567114591|FG001|Overall Study|DBS surgery|0|||
157098285|NCT02202551|567114592|FG002|Overall Study|DBS surgery|0|||
157098286|NCT02202551|567114593|FG003|Overall Study|DBS surgery|0|||
157098287|NCT02202551|567114590|FG000|Overall Study|Dyskinesia upon taper|1|||
157098288|NCT02202551|567114591|FG001|Overall Study|Dyskinesia upon taper|0|||
157098289|NCT02202551|567114592|FG002|Overall Study|Dyskinesia upon taper|0|||
157098290|NCT02202551|567114593|FG003|Overall Study|Dyskinesia upon taper|0|||
157098291|NCT02202551|567114590|FG000|Overall Study|Lack of Efficacy|0|||
157098292|NCT02202551|567114591|FG001|Overall Study|Lack of Efficacy|1|||
157098293|NCT02202551|567114592|FG002|Overall Study|Lack of Efficacy|0|||
157098294|NCT02202551|567114593|FG003|Overall Study|Lack of Efficacy|0|||
157098295|NCT02202551|567114590|FG000|Overall Study|Physician Decision|1|||
157098296|NCT02202551|567114591|FG001|Overall Study|Physician Decision|0|||
157098297|NCT02202551|567114592|FG002|Overall Study|Physician Decision|0|||
157098298|NCT02202551|567114593|FG003|Overall Study|Physician Decision|0|||
157098299|NCT02202551|567114590|FG000|Overall Study|Site closure|3|||
157098300|NCT02202551|567114591|FG001|Overall Study|Site closure|0|||
157098301|NCT02202551|567114592|FG002|Overall Study|Site closure|0|||
157098302|NCT02202551|567114593|FG003|Overall Study|Site closure|1|||
157098303|NCT02202551|567114590|FG000|Overall Study|Unable to complete visits per protocol|1|||
157098304|NCT02202551|567114591|FG001|Overall Study|Unable to complete visits per protocol|0|||
157098305|NCT02202551|567114592|FG002|Overall Study|Unable to complete visits per protocol|0|||
157098306|NCT02202551|567114593|FG003|Overall Study|Unable to complete visits per protocol|0|||
157098307|NCT02202551|567114590|FG000|Overall Study|Worsening Dyskinesia|0|||
157098308|NCT02202551|567114591|FG001|Overall Study|Worsening Dyskinesia|0|||
157098309|NCT02202551|567114592|FG002|Overall Study|Worsening Dyskinesia|0|||
157098310|NCT02202551|567114593|FG003|Overall Study|Worsening Dyskinesia|1|||
157098311|NCT02202551|567114590|FG000|Overall Study|Protocol Violation|0|||
157098312|NCT02202551|567114591|FG001|Overall Study|Protocol Violation|1|||
157098313|NCT02202551|567114592|FG002|Overall Study|Protocol Violation|0|||
157098314|NCT02202551|567114593|FG003|Overall Study|Protocol Violation|0|||
157098315|NCT02202551|567114590|FG000|Overall Study|Sponsor's decision|2|||
157098316|NCT02202551|567114591|FG001|Overall Study|Sponsor's decision|0|||
157098317|NCT02202551|567114592|FG002|Overall Study|Sponsor's decision|0|||
157098318|NCT02202551|567114593|FG003|Overall Study|Sponsor's decision|0|||
157098319|NCT02202551|567114590|FG000|Overall Study|Subject unwilling to proceed|1|||
157098320|NCT02202551|567114591|FG001|Overall Study|Subject unwilling to proceed|5|||
157098321|NCT02202551|567114592|FG002|Overall Study|Subject unwilling to proceed|3|||
157098322|NCT02202551|567114593|FG003|Overall Study|Subject unwilling to proceed|5|||
157098323|NCT02202551|567114590|FG000|Overall Study|Subject consent withdrawn|0|||
157098324|NCT02202551|567114591|FG001|Overall Study|Subject consent withdrawn|3|||
157098325|NCT02202551|567114592|FG002|Overall Study|Subject consent withdrawn|1|||
157098326|NCT02202551|567114593|FG003|Overall Study|Subject consent withdrawn|2|||
157098327|NCT02202551|567114590|FG000|Overall Study|eGFR<50mL/min/m2|2|||
157098328|NCT02202551|567114591|FG001|Overall Study|eGFR<50mL/min/m2|2|||
157098329|NCT02202551|567114592|FG002|Overall Study|eGFR<50mL/min/m2|0|||
157098330|NCT02202551|567114593|FG003|Overall Study|eGFR<50mL/min/m2|1|||
157098331|NCT02349451|567114594|FG000|Overall Study|Withdrawal by Subject|0|||
156994405|NCT00941031|566731325|FG005|Induction Period|Withdrawal by Subject|0|||
156994406|NCT00941031|566731326|FG006|Induction Period|Withdrawal by Subject|0|||
156994407|NCT00941031|566731320|FG000|Induction Period|Adminstative Problems|1|||
156994408|NCT00941031|566731321|FG001|Induction Period|Adminstative Problems|1|||
156994409|NCT00941031|566731322|FG002|Induction Period|Adminstative Problems|1|||
156994410|NCT00941031|566731323|FG003|Induction Period|Adminstative Problems|0|||
156994411|NCT00941031|566731324|FG004|Induction Period|Adminstative Problems|0|||
156994412|NCT00941031|566731325|FG005|Induction Period|Adminstative Problems|0|||
156994413|NCT00941031|566731326|FG006|Induction Period|Adminstative Problems|0|||
156994414|NCT00941031|566731320|FG000|Induction Period|Adverse Event|1|||
156994415|NCT00941031|566731321|FG001|Induction Period|Adverse Event|0|||
156994416|NCT00941031|566731322|FG002|Induction Period|Adverse Event|3|||
156994417|NCT00941031|566731323|FG003|Induction Period|Adverse Event|2|||
156994418|NCT00941031|566731324|FG004|Induction Period|Adverse Event|0|||
156994419|NCT00941031|566731325|FG005|Induction Period|Adverse Event|0|||
156994420|NCT00941031|566731326|FG006|Induction Period|Adverse Event|0|||
156994421|NCT00941031|566731320|FG000|Maintenance Period|Withdrawal by Subject|0|||
156994422|NCT00941031|566731321|FG001|Maintenance Period|Withdrawal by Subject|0|||
156994423|NCT00941031|566731322|FG002|Maintenance Period|Withdrawal by Subject|0|||
156994424|NCT00941031|566731323|FG003|Maintenance Period|Withdrawal by Subject|0|||
156994425|NCT00941031|566731324|FG004|Maintenance Period|Withdrawal by Subject|6|||
156994426|NCT00941031|566731325|FG005|Maintenance Period|Withdrawal by Subject|2|||
156994427|NCT00941031|566731326|FG006|Maintenance Period|Withdrawal by Subject|13|||
156994428|NCT00941031|566731320|FG000|Maintenance Period|Administrative Problems|0|||
156994429|NCT00941031|566731321|FG001|Maintenance Period|Administrative Problems|0|||
156994430|NCT00941031|566731322|FG002|Maintenance Period|Administrative Problems|0|||
156994431|NCT00941031|566731323|FG003|Maintenance Period|Administrative Problems|0|||
156994432|NCT00941031|566731324|FG004|Maintenance Period|Administrative Problems|1|||
156994433|NCT00941031|566731325|FG005|Maintenance Period|Administrative Problems|0|||
156994434|NCT00941031|566731326|FG006|Maintenance Period|Administrative Problems|1|||
156994435|NCT00941031|566731320|FG000|Maintenance Period|Protocol Violation|0|||
157098332|NCT02349451|567114595|FG001|Overall Study|Withdrawal by Subject|1|||
157098333|NCT02349451|567114596|FG002|Overall Study|Withdrawal by Subject|2|||
157098334|NCT02349451|567114597|FG003|Overall Study|Withdrawal by Subject|1|||
157098335|NCT02168842|567114598|FG000|Overall Study|Withdrawal by Subject|5|||
157098336|NCT02168842|567114599|FG001|Overall Study|Withdrawal by Subject|3|||
157098337|NCT02168842|567114598|FG000|Overall Study|Lost to Follow-up|0|||
157098338|NCT02168842|567114599|FG001|Overall Study|Lost to Follow-up|2|||
157098339|NCT02168842|567114598|FG000|Overall Study|Death|2|||
156994436|NCT00941031|566731321|FG001|Maintenance Period|Protocol Violation|0|||
156994437|NCT00941031|566731322|FG002|Maintenance Period|Protocol Violation|0|||
156994438|NCT00941031|566731323|FG003|Maintenance Period|Protocol Violation|0|||
156994439|NCT00941031|566731324|FG004|Maintenance Period|Protocol Violation|0|||
157098340|NCT02168842|567114599|FG001|Overall Study|Death|1|||
156994440|NCT00941031|566731325|FG005|Maintenance Period|Protocol Violation|0|||
156994441|NCT00941031|566731326|FG006|Maintenance Period|Protocol Violation|1|||
156994442|NCT00941031|566731320|FG000|Maintenance Period|Adverse Event|0|||
156994443|NCT00941031|566731321|FG001|Maintenance Period|Adverse Event|0|||
156994444|NCT00941031|566731322|FG002|Maintenance Period|Adverse Event|0|||
156994445|NCT00941031|566731323|FG003|Maintenance Period|Adverse Event|0|||
156994446|NCT00941031|566731324|FG004|Maintenance Period|Adverse Event|0|||
156994447|NCT00941031|566731325|FG005|Maintenance Period|Adverse Event|2|||
156994448|NCT00941031|566731326|FG006|Maintenance Period|Adverse Event|8|||
156994449|NCT00941031|566731320|FG000|Maintenance Period|Lost to Follow-up|0|||
156994450|NCT00941031|566731321|FG001|Maintenance Period|Lost to Follow-up|0|||
156994451|NCT00941031|566731322|FG002|Maintenance Period|Lost to Follow-up|0|||
156994452|NCT00941031|566731323|FG003|Maintenance Period|Lost to Follow-up|0|||
156994453|NCT00941031|566731324|FG004|Maintenance Period|Lost to Follow-up|2|||
156994454|NCT00941031|566731325|FG005|Maintenance Period|Lost to Follow-up|2|||
156994455|NCT00941031|566731326|FG006|Maintenance Period|Lost to Follow-up|7|||
156994456|NCT00941031|566731320|FG000|Maintenance Period|Lack of Efficacy|0|||
156994457|NCT00941031|566731321|FG001|Maintenance Period|Lack of Efficacy|0|||
156994458|NCT00941031|566731322|FG002|Maintenance Period|Lack of Efficacy|0|||
156994459|NCT00941031|566731323|FG003|Maintenance Period|Lack of Efficacy|0|||
156994460|NCT00941031|566731324|FG004|Maintenance Period|Lack of Efficacy|0|||
156994461|NCT00941031|566731325|FG005|Maintenance Period|Lack of Efficacy|0|||
156994462|NCT00941031|566731326|FG006|Maintenance Period|Lack of Efficacy|13|||
156994463|NCT04555044|566731329|FG000|Overall Study|Adverse Event|0|||
156994464|NCT04555044|566731330|FG001|Overall Study|Adverse Event|1|||
156994465|NCT00631917|566731332|FG000|Overall Study|Adverse Event|34|||
156994466|NCT00631917|566731333|FG001|Overall Study|Adverse Event|45|||
156994467|NCT00631917|566731332|FG000|Overall Study|Abnormal laboratory value(s)|2|||
156994468|NCT00631917|566731333|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156994469|NCT00631917|566731332|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156994470|NCT00631917|566731333|FG001|Overall Study|Abnormal test procedure result(s)|2|||
156994471|NCT00631917|566731332|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
156994472|NCT00631917|566731333|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
156994473|NCT00631917|566731332|FG000|Overall Study|No longer required study drug|0|||
156994474|NCT00631917|566731333|FG001|Overall Study|No longer required study drug|1|||
156994475|NCT00631917|566731332|FG000|Overall Study|Protocol deviation|6|||
156994476|NCT00631917|566731333|FG001|Overall Study|Protocol deviation|5|||
156994477|NCT00631917|566731332|FG000|Overall Study|Subject withdrew consent|25|||
156994478|NCT00631917|566731333|FG001|Overall Study|Subject withdrew consent|33|||
156994479|NCT00631917|566731332|FG000|Overall Study|Lost to Follow-up|7|||
156994480|NCT00631917|566731333|FG001|Overall Study|Lost to Follow-up|7|||
156994481|NCT00631917|566731332|FG000|Overall Study|Administrative problems|2|||
156994482|NCT00631917|566731333|FG001|Overall Study|Administrative problems|0|||
156994483|NCT00631917|566731332|FG000|Overall Study|Death|1|||
156994484|NCT00631917|566731333|FG001|Overall Study|Death|0|||
156994485|NCT01767909|566731336|FG000|Overall Study|Withdrawal by Subject|4|||
156994486|NCT01767909|566731337|FG001|Overall Study|Withdrawal by Subject|7|||
156994487|NCT01767909|566731336|FG000|Overall Study|Adverse Event|3|||
156994488|NCT01767909|566731337|FG001|Overall Study|Adverse Event|1|||
156994489|NCT01767909|566731336|FG000|Overall Study|Withdrawal by Study Partner|3|||
156994490|NCT01767909|566731337|FG001|Overall Study|Withdrawal by Study Partner|1|||
156994491|NCT01767909|566731336|FG000|Overall Study|Non-Compliance|2|||
156994492|NCT01767909|566731337|FG001|Overall Study|Non-Compliance|0|||
156994493|NCT01767909|566731336|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156994494|NCT01767909|566731337|FG001|Overall Study|Perceived Lack of Efficacy|0|||
156994495|NCT01767909|566731336|FG000|Overall Study|Investigator Recommendation|0|||
156994496|NCT01767909|566731337|FG001|Overall Study|Investigator Recommendation|1|||
156994497|NCT01767909|566731336|FG000|Overall Study|Lost to Follow-up|0|||
156994498|NCT01767909|566731337|FG001|Overall Study|Lost to Follow-up|1|||
156994499|NCT01767909|566731336|FG000|Overall Study|LP uncessessful|0|||
156994500|NCT01767909|566731337|FG001|Overall Study|LP uncessessful|1|||
156994501|NCT02696785|566731345|FG000|Blinded Treatment Period|Adverse Event|0|||
156994502|NCT02696785|566731346|FG001|Blinded Treatment Period|Adverse Event|1|||
156994503|NCT02696785|566731347|FG002|Blinded Treatment Period|Adverse Event|3|||
156994504|NCT02696785|566731348|FG003|Blinded Treatment Period|Adverse Event|0|||
156994505|NCT02696785|566731345|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
156994506|NCT02696785|566731346|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
156994507|NCT02696785|566731347|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
156994508|NCT02696785|566731348|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
156994509|NCT02696785|566731345|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
156994510|NCT02696785|566731346|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
156994511|NCT02696785|566731347|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
156994512|NCT02696785|566731348|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
156994513|NCT02696785|566731345|FG000|Blinded Treatment Period|Screen Failure|1|||
156994514|NCT02696785|566731346|FG001|Blinded Treatment Period|Screen Failure|0|||
156994515|NCT02696785|566731347|FG002|Blinded Treatment Period|Screen Failure|0|||
157098341|NCT02168842|567114598|FG000|Overall Study|Physician Decision|1|||
157098342|NCT02168842|567114599|FG001|Overall Study|Physician Decision|2|||
157098343|NCT02147353|567114600|FG000|Overall Study|Lost to Follow-up|2|||
157098344|NCT02147353|567114601|FG001|Overall Study|Lost to Follow-up|0|||
157098345|NCT02147353|567114600|FG000|Overall Study|unable to make visits|4|||
157098346|NCT02147353|567114601|FG001|Overall Study|unable to make visits|0|||
157098347|NCT02147353|567114600|FG000|Overall Study|medication noncompliance|3|||
157098348|NCT02147353|567114601|FG001|Overall Study|medication noncompliance|0|||
157098349|NCT01971203|567114617|FG000|Overall Study|Protocol Violation|3|||
157098350|NCT01971203|567114618|FG001|Overall Study|Protocol Violation|2|||
157098351|NCT01971203|567114617|FG000|Overall Study|Withdrawal by Subject|5|||
157098352|NCT01971203|567114618|FG001|Overall Study|Withdrawal by Subject|6|||
157098353|NCT01971203|567114617|FG000|Overall Study|Adverse Event|1|||
157098354|NCT01971203|567114618|FG001|Overall Study|Adverse Event|0|||
157098355|NCT01794923|567114619|FG000|Overall Study|Adverse Event|0|||
157098356|NCT01794923|567114620|FG001|Overall Study|Adverse Event|0|||
157098357|NCT01794923|567114621|FG002|Overall Study|Adverse Event|1|||
157098358|NCT03267940|567114637|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
157098359|NCT03267940|567114638|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
157098360|NCT03267940|567114639|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
157098361|NCT03267940|567114640|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
157098362|NCT03267940|567114641|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
157098363|NCT03267940|567114642|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
157098364|NCT03267940|567114637|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
157098365|NCT03267940|567114638|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
157098366|NCT03267940|567114639|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
157098367|NCT03267940|567114640|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
157098368|NCT03267940|567114641|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
157098369|NCT03267940|567114642|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
157098370|NCT03267940|567114637|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
157098371|NCT03267940|567114638|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
157098372|NCT03267940|567114639|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
157098373|NCT03267940|567114640|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
157098374|NCT03267940|567114641|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
157098375|NCT03267940|567114642|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
157098376|NCT03267940|567114637|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
157098377|NCT03267940|567114638|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
156994516|NCT02696785|566731348|FG003|Blinded Treatment Period|Screen Failure|0|||
156994517|NCT02696785|566731345|FG000|Washout Period|Withdrawal by Subject|0|||
156994518|NCT02696785|566731346|FG001|Washout Period|Withdrawal by Subject|1|||
156994519|NCT02696785|566731347|FG002|Washout Period|Withdrawal by Subject|0|||
156994520|NCT02696785|566731348|FG003|Washout Period|Withdrawal by Subject|0|||
156994521|NCT02696785|566731345|FG000|Washout Period|Lack of Efficacy|0|||
156994522|NCT02696785|566731346|FG001|Washout Period|Lack of Efficacy|1|||
156994523|NCT02696785|566731347|FG002|Washout Period|Lack of Efficacy|0|||
156994524|NCT02696785|566731348|FG003|Washout Period|Lack of Efficacy|0|||
156994525|NCT02696785|566731345|FG000|Extended Treatment Period|Adverse Event|2|||
156994526|NCT02696785|566731346|FG001|Extended Treatment Period|Adverse Event|3|||
156994527|NCT02696785|566731347|FG002|Extended Treatment Period|Adverse Event|2|||
156994528|NCT02696785|566731348|FG003|Extended Treatment Period|Adverse Event|1|||
156994529|NCT02696785|566731345|FG000|Extended Treatment Period|Lack of Efficacy|0|||
156994530|NCT02696785|566731346|FG001|Extended Treatment Period|Lack of Efficacy|1|||
156994531|NCT02696785|566731347|FG002|Extended Treatment Period|Lack of Efficacy|0|||
156994532|NCT02696785|566731348|FG003|Extended Treatment Period|Lack of Efficacy|0|||
156994533|NCT02696785|566731345|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
156994534|NCT02696785|566731346|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
156994535|NCT02696785|566731347|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
156994536|NCT02696785|566731348|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
156994537|NCT02696785|566731345|FG000|Follow-up Period|Adverse Event|0|||
156994538|NCT02696785|566731346|FG001|Follow-up Period|Adverse Event|0|||
156994539|NCT02696785|566731347|FG002|Follow-up Period|Adverse Event|8|||
157098378|NCT03267940|567114639|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
157098379|NCT03267940|567114640|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
157098380|NCT03267940|567114641|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
157098381|NCT03267940|567114642|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
156994540|NCT02696785|566731348|FG003|Follow-up Period|Adverse Event|2|||
156994541|NCT02696785|566731345|FG000|Follow-up Period|Lost to Follow-up|0|||
156994542|NCT02696785|566731346|FG001|Follow-up Period|Lost to Follow-up|0|||
156994543|NCT02696785|566731347|FG002|Follow-up Period|Lost to Follow-up|0|||
156994544|NCT02696785|566731348|FG003|Follow-up Period|Lost to Follow-up|1|||
156994545|NCT02696785|566731345|FG000|Follow-up Period|Lack of Efficacy|0|||
156994546|NCT02696785|566731346|FG001|Follow-up Period|Lack of Efficacy|0|||
156994547|NCT02696785|566731347|FG002|Follow-up Period|Lack of Efficacy|0|||
156994548|NCT02696785|566731348|FG003|Follow-up Period|Lack of Efficacy|1|||
157098382|NCT03267940|567114637|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
157098383|NCT03267940|567114638|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
157098384|NCT03267940|567114639|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
156994549|NCT02696785|566731345|FG000|Follow-up Period|Withdrawal by Subject|1|||
156994550|NCT02696785|566731346|FG001|Follow-up Period|Withdrawal by Subject|0|||
156994551|NCT02696785|566731347|FG002|Follow-up Period|Withdrawal by Subject|5|||
156994552|NCT02696785|566731348|FG003|Follow-up Period|Withdrawal by Subject|4|||
156994553|NCT04863898|566731350|FG000|Overall Study|Away from study clinic during intervention training period|2|||
156994554|NCT04863898|566731350|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
156994555|NCT04863898|566731350|FG000|Overall Study|Lost to Follow-up|3|||
156994556|NCT04863898|566731350|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
156994557|NCT04863898|566731350|FG000|Overall Study|No longer employed at clinic|3|||
156994558|NCT00614744|566731351|FG000|Overall Study|Lost to Follow-up|5|||
156994559|NCT00614744|566731352|FG001|Overall Study|Lost to Follow-up|4|||
156994560|NCT00614744|566731351|FG000|Overall Study|Incomplete for Behavior Issues|0|||
156994561|NCT00614744|566731352|FG001|Overall Study|Incomplete for Behavior Issues|2|||
156994562|NCT02320253|566731353|FG000|Overall Study|Withdrawal by Subject|3|||
156994563|NCT02320253|566731354|FG001|Overall Study|Withdrawal by Subject|0|||
156994564|NCT02320253|566731355|FG002|Overall Study|Withdrawal by Subject|0|||
156994565|NCT02320253|566731353|FG000|Overall Study|Lost to Follow-up|2|||
156994566|NCT02320253|566731354|FG001|Overall Study|Lost to Follow-up|2|||
156994567|NCT02320253|566731355|FG002|Overall Study|Lost to Follow-up|1|||
156994568|NCT02320253|566731353|FG000|Overall Study|Death|1|||
156994569|NCT02320253|566731354|FG001|Overall Study|Death|0|||
156994570|NCT02320253|566731355|FG002|Overall Study|Death|1|||
156994571|NCT01516892|566731357|FG000|Overall Study|Adverse Event|25|||
156994572|NCT01516892|566731357|FG000|Overall Study|Lack of Efficacy|35|||
156994573|NCT01516892|566731357|FG000|Overall Study|Pregnancy|5|||
156994574|NCT01516892|566731357|FG000|Overall Study|Lost to Follow-up|82|||
156994575|NCT01516892|566731357|FG000|Overall Study|Subject Withdrew Consent|92|||
156994576|NCT01516892|566731357|FG000|Overall Study|Protocol Violation|60|||
156994577|NCT01516892|566731357|FG000|Overall Study|Other Miscellaneous Reasons|43|||
156994578|NCT01516892|566731357|FG000|Overall Study|Missing|1|||
156994579|NCT05780047|566731358|FG000|Overall Study|Did not submit baseline urine test kit|226|||
156994580|NCT05780047|566731358|FG000|Overall Study|Lost to Follow-up|34|||
156994581|NCT05780047|566731358|FG000|Overall Study|Did not submit second urine test kit|124|||
156994582|NCT01096056|566731365|FG000|Overall Study|Lost to Follow-up|0|||
156994583|NCT01096056|566731366|FG001|Overall Study|Lost to Follow-up|1|||
156994584|NCT04831775|566731367|FG000|Overall Study|Lost to Follow-up|11|||
156994585|NCT04831775|566731368|FG001|Overall Study|Lost to Follow-up|13|||
156994586|NCT00337818|566731369|FG000|Overall Study|Lost to Follow-up|289|||
156994587|NCT00337818|566731370|FG001|Overall Study|Lost to Follow-up|91|||
156994588|NCT00337818|566731371|FG002|Overall Study|Lost to Follow-up|107|||
156994589|NCT03115346|566731374|FG000|Overall Study|Did not have AAA surgery|28|||
156994590|NCT03115346|566731375|FG001|Overall Study|Did not have AAA surgery|15|||
156994591|NCT03115346|566731374|FG000|Overall Study|Death|3|||
156994592|NCT03115346|566731375|FG001|Overall Study|Death|1|||
156994593|NCT03115346|566731374|FG000|Overall Study|Withdrawal by Subject|0|||
156994594|NCT03115346|566731375|FG001|Overall Study|Withdrawal by Subject|3|||
156994595|NCT03115346|566731374|FG000|Overall Study|Lost to Follow-up|0|||
156994596|NCT03115346|566731375|FG001|Overall Study|Lost to Follow-up|3|||
156994597|NCT02753530|566731377|FG000|Overall Study|Adverse Event|7|||
156994598|NCT02753530|566731378|FG001|Overall Study|Adverse Event|1|||
156994599|NCT02753530|566731377|FG000|Overall Study|Death|0|||
156994600|NCT02753530|566731378|FG001|Overall Study|Death|1|||
156994601|NCT02753530|566731377|FG000|Overall Study|Physician Decision|0|||
156994602|NCT02753530|566731378|FG001|Overall Study|Physician Decision|1|||
156994603|NCT02753530|566731377|FG000|Overall Study|Protocol Violation|1|||
156994604|NCT02753530|566731378|FG001|Overall Study|Protocol Violation|0|||
156994605|NCT02753530|566731377|FG000|Overall Study|Withdrawal by Subject|4|||
156994606|NCT02753530|566731378|FG001|Overall Study|Withdrawal by Subject|3|||
156994607|NCT03590743|566731379|FG000|Overall Study|Withdrawal by Subject|0|||
156994608|NCT03590743|566731380|FG001|Overall Study|Withdrawal by Subject|1|||
156994609|NCT02696226|566731381|FG000|Overall Study|Study terminated - lack of enrollment|1|||
156994610|NCT02696226|566731382|FG001|Overall Study|Study terminated - lack of enrollment|0|||
156994611|NCT02696226|566731383|FG002|Overall Study|Study terminated - lack of enrollment|2|||
156994612|NCT02696226|566731384|FG003|Overall Study|Study terminated - lack of enrollment|0|||
156994613|NCT01190176|566731385|FG000|Overall Study|Withdrawal by Subject|1|||
156994614|NCT01190176|566731385|FG000|Overall Study|Lost to Follow-up|1|||
156994615|NCT02414828|566731391|FG000|Overall Study|Lost to Follow-up|0|||
156994616|NCT02414828|566731392|FG001|Overall Study|Lost to Follow-up|1|||
156994617|NCT02414828|566731393|FG002|Overall Study|Lost to Follow-up|1|||
156994618|NCT02414828|566731394|FG003|Overall Study|Lost to Follow-up|2|||
156994619|NCT04580407|566731397|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
156994620|NCT04949399|566731398|FG000|Overall Study|Lost to Follow-up|11|||
156994621|NCT04949399|566731399|FG001|Overall Study|Lost to Follow-up|6|||
156994622|NCT04949399|566731398|FG000|Overall Study|Withdrawal by Subject|2|||
156994623|NCT04949399|566731399|FG001|Overall Study|Withdrawal by Subject|3|||
156994624|NCT00670540|566731400|FG000|Overall Study|ineligible|17|||
156994625|NCT00670540|566731400|FG000|Overall Study|not living in France|348|||
156994626|NCT00670540|566731400|FG000|Overall Study|refused to participate|189|||
156994627|NCT00670540|566731400|FG000|Overall Study|controls randomised for no follow up|2770|||
156994628|NCT00670540|566731400|FG000|Overall Study|missing information inclusion criteria|1|||
156994629|NCT01866917|566731401|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
156994630|NCT01866917|566731402|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
156994631|NCT00531479|566733283|FG000|Overall Study|Death|68|||
156994632|NCT00531479|566733284|FG001|Overall Study|Death|71|||
156994633|NCT00531479|566733283|FG000|Overall Study|Lost to Follow-up|0|||
156994634|NCT00531479|566733284|FG001|Overall Study|Lost to Follow-up|2|||
156994635|NCT00531479|566733283|FG000|Overall Study|Other|0|||
156994636|NCT00531479|566733284|FG001|Overall Study|Other|1|||
156994637|NCT00531479|566733283|FG000|Overall Study|Withdrawal by Subject|6|||
156994638|NCT00531479|566733284|FG001|Overall Study|Withdrawal by Subject|6|||
156994639|NCT00531479|566733283|FG000|Overall Study|Did not receive treatment|2|||
156994640|NCT00531479|566733284|FG001|Overall Study|Did not receive treatment|3|||
156994641|NCT01240356|566733285|FG000|Overall Study|Withdrawal by Subject|2|||
156994642|NCT01240356|566733286|FG001|Overall Study|Withdrawal by Subject|0|||
156994643|NCT01240356|566733285|FG000|Overall Study|MRI contraindication|1|||
156994644|NCT01240356|566733286|FG001|Overall Study|MRI contraindication|0|||
156994645|NCT01677936|566733287|FG000|Overall Study|Lost to Follow-up|4|||
156994646|NCT01677936|566733288|FG001|Overall Study|Lost to Follow-up|1|||
156994647|NCT01677936|566733287|FG000|Overall Study|Protocol Violation|3|||
156994648|NCT01677936|566733288|FG001|Overall Study|Protocol Violation|0|||
156994649|NCT01677936|566733287|FG000|Overall Study|Adverse Event|1|||
156994650|NCT01677936|566733288|FG001|Overall Study|Adverse Event|0|||
156994651|NCT01677936|566733287|FG000|Overall Study|Lost to Follow-up|1|||
156994652|NCT01677936|566733288|FG001|Overall Study|Lost to Follow-up|0|||
156994653|NCT01677936|566733287|FG000|Overall Study|Protocol Violation|0|||
156994654|NCT01677936|566733288|FG001|Overall Study|Protocol Violation|4|||
156994655|NCT03837028|566733291|FG000|Overall Study|Lost to Follow-up|4|||
156994656|NCT03837028|566733292|FG001|Overall Study|Lost to Follow-up|0|||
156994657|NCT03837028|566733293|FG002|Overall Study|Lost to Follow-up|2|||
156994658|NCT03837028|566733294|FG003|Overall Study|Lost to Follow-up|0|||
156994659|NCT03837028|566733291|FG000|Overall Study|Withdrawal by Subject|12|||
156994660|NCT03837028|566733292|FG001|Overall Study|Withdrawal by Subject|11|||
156994661|NCT03837028|566733293|FG002|Overall Study|Withdrawal by Subject|11|||
156994662|NCT03837028|566733294|FG003|Overall Study|Withdrawal by Subject|7|||
156994663|NCT00157014|566733295|FG000|Overall Study|Death|4|||
156994664|NCT00157014|566733296|FG001|Overall Study|Death|2|||
156994665|NCT00157014|566733297|FG002|Overall Study|Death|1|||
156994666|NCT00157014|566733298|FG003|Overall Study|Death|1|||
156994667|NCT00157014|566733295|FG000|Overall Study|Physician Decision|0|||
156994668|NCT00157014|566733296|FG001|Overall Study|Physician Decision|1|||
156994669|NCT00157014|566733297|FG002|Overall Study|Physician Decision|0|||
156994670|NCT00157014|566733298|FG003|Overall Study|Physician Decision|0|||
156994671|NCT00157014|566733295|FG000|Overall Study|Medications withdrawn on family request|0|||
156994672|NCT00157014|566733296|FG001|Overall Study|Medications withdrawn on family request|1|||
156994673|NCT00157014|566733297|FG002|Overall Study|Medications withdrawn on family request|0|||
156994674|NCT00157014|566733298|FG003|Overall Study|Medications withdrawn on family request|0|||
156994675|NCT00157014|566733295|FG000|Overall Study|Patient withdrawn by investigator|1|||
156994676|NCT00157014|566733296|FG001|Overall Study|Patient withdrawn by investigator|0|||
156994677|NCT00157014|566733297|FG002|Overall Study|Patient withdrawn by investigator|0|||
156994678|NCT00157014|566733298|FG003|Overall Study|Patient withdrawn by investigator|0|||
156994679|NCT00157014|566733295|FG000|Overall Study|Patient unable to return in nursing home|1|||
156994680|NCT00157014|566733296|FG001|Overall Study|Patient unable to return in nursing home|0|||
156994681|NCT00157014|566733297|FG002|Overall Study|Patient unable to return in nursing home|0|||
156994682|NCT00157014|566733298|FG003|Overall Study|Patient unable to return in nursing home|0|||
156994683|NCT00157014|566733295|FG000|Overall Study|Patient would not receive transplant|0|||
156994684|NCT00157014|566733296|FG001|Overall Study|Patient would not receive transplant|1|||
156994685|NCT00157014|566733297|FG002|Overall Study|Patient would not receive transplant|0|||
156994686|NCT00157014|566733298|FG003|Overall Study|Patient would not receive transplant|0|||
156994687|NCT00157014|566733295|FG000|Overall Study|Withdrawal by Subject|1|||
156994688|NCT00157014|566733296|FG001|Overall Study|Withdrawal by Subject|0|||
156994689|NCT00157014|566733297|FG002|Overall Study|Withdrawal by Subject|0|||
156994690|NCT00157014|566733298|FG003|Overall Study|Withdrawal by Subject|0|||
156994691|NCT01362491|566733299|FG000|Overall Study|Ineligible|1|||
156994692|NCT01362491|566733300|FG001|Overall Study|Ineligible|0|||
156994693|NCT01362491|566733301|FG002|Overall Study|Ineligible|0|||
156994694|NCT04867902|566733302|FG000|Overall Study|Lost to Follow-up|1|||
156994695|NCT04867902|566733302|FG000|Overall Study|Withdrawal by Subject|2|||
156994696|NCT04867902|566733302|FG000|Overall Study|Protocol Violation|1|||
156994697|NCT00448864|566733305|FG000|Overall Study|Death|1|||
156994698|NCT00448864|566733306|FG001|Overall Study|Death|0|||
156994699|NCT00448864|566733307|FG002|Overall Study|Death|0|||
156994700|NCT00448864|566733305|FG000|Overall Study|Lost to Follow-up|3|||
156994701|NCT00448864|566733306|FG001|Overall Study|Lost to Follow-up|1|||
156994702|NCT00448864|566733307|FG002|Overall Study|Lost to Follow-up|0|||
156994703|NCT00448864|566733305|FG000|Overall Study|Physician Decision|1|||
156994704|NCT00448864|566733306|FG001|Overall Study|Physician Decision|0|||
156994705|NCT00448864|566733307|FG002|Overall Study|Physician Decision|1|||
156994706|NCT00448864|566733305|FG000|Overall Study|Withdrawal by Subject|0|||
156994707|NCT00448864|566733306|FG001|Overall Study|Withdrawal by Subject|2|||
156994708|NCT00448864|566733307|FG002|Overall Study|Withdrawal by Subject|0|||
156994709|NCT00448864|566733305|FG000|Overall Study|Protocol Violation|0|||
156994710|NCT00448864|566733306|FG001|Overall Study|Protocol Violation|2|||
156994711|NCT00448864|566733307|FG002|Overall Study|Protocol Violation|0|||
156994712|NCT00367237|566733308|FG000|Overall Study|Adverse Event|7|||
156994713|NCT00367237|566733309|FG001|Overall Study|Adverse Event|2|||
156994714|NCT00367237|566733308|FG000|Overall Study|Lost to Follow-up|1|||
156994715|NCT00367237|566733309|FG001|Overall Study|Lost to Follow-up|0|||
156994716|NCT00367237|566733308|FG000|Overall Study|Withdrawal by Subject|0|||
156994717|NCT00367237|566733309|FG001|Overall Study|Withdrawal by Subject|4|||
156994718|NCT00367237|566733308|FG000|Overall Study|Protocol Violation|2|||
156994719|NCT00367237|566733309|FG001|Overall Study|Protocol Violation|5|||
156994720|NCT03120676|566733312|FG000|Overall Study|Not treated|1|||
156994721|NCT00886613|566733317|FG000|Overall Study|Protocol deviation (Part B)|1|||
156994722|NCT00886613|566733318|FG001|Overall Study|Protocol deviation (Part B)|0|||
156994723|NCT00886613|566733319|FG002|Overall Study|Protocol deviation (Part B)|0|||
156994724|NCT00886613|566733317|FG000|Overall Study|Lost to follow-up (Part B)|1|||
156994725|NCT00886613|566733318|FG001|Overall Study|Lost to follow-up (Part B)|0|||
156994726|NCT00886613|566733319|FG002|Overall Study|Lost to follow-up (Part B)|1|||
156994727|NCT00886613|566733317|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
156994728|NCT00886613|566733318|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
156994729|NCT00886613|566733319|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
156994730|NCT01289119|566733323|FG000|Overall Study|Adverse Event|2|||
156994731|NCT01289119|566733324|FG001|Overall Study|Adverse Event|1|||
156994732|NCT01289119|566733325|FG002|Overall Study|Adverse Event|0|||
156994733|NCT01289119|566733326|FG003|Overall Study|Adverse Event|2|||
156994734|NCT01289119|566733327|FG004|Overall Study|Adverse Event|1|||
156994735|NCT01289119|566733328|FG005|Overall Study|Adverse Event|0|||
156994736|NCT01289119|566733323|FG000|Overall Study|Major Protocol Deviation|2|||
156994737|NCT01289119|566733324|FG001|Overall Study|Major Protocol Deviation|1|||
156994738|NCT01289119|566733325|FG002|Overall Study|Major Protocol Deviation|3|||
156994739|NCT01289119|566733326|FG003|Overall Study|Major Protocol Deviation|0|||
156994740|NCT01289119|566733327|FG004|Overall Study|Major Protocol Deviation|2|||
156994741|NCT01289119|566733328|FG005|Overall Study|Major Protocol Deviation|1|||
156994742|NCT01289119|566733323|FG000|Overall Study|Lost to Follow-up|0|||
156994743|NCT01289119|566733324|FG001|Overall Study|Lost to Follow-up|3|||
156994744|NCT01289119|566733325|FG002|Overall Study|Lost to Follow-up|0|||
156994745|NCT01289119|566733326|FG003|Overall Study|Lost to Follow-up|0|||
156994746|NCT01289119|566733327|FG004|Overall Study|Lost to Follow-up|0|||
156994747|NCT01289119|566733328|FG005|Overall Study|Lost to Follow-up|1|||
156994748|NCT01289119|566733323|FG000|Overall Study|Withdrawal by Subject|4|||
156994749|NCT01289119|566733324|FG001|Overall Study|Withdrawal by Subject|2|||
156994750|NCT01289119|566733325|FG002|Overall Study|Withdrawal by Subject|4|||
156994751|NCT01289119|566733326|FG003|Overall Study|Withdrawal by Subject|3|||
156994752|NCT01289119|566733327|FG004|Overall Study|Withdrawal by Subject|1|||
156994753|NCT01289119|566733328|FG005|Overall Study|Withdrawal by Subject|1|||
156994754|NCT01289119|566733323|FG000|Overall Study|Pregnancy|0|||
156994755|NCT01289119|566733324|FG001|Overall Study|Pregnancy|1|||
156994756|NCT01289119|566733325|FG002|Overall Study|Pregnancy|0|||
156994757|NCT01289119|566733326|FG003|Overall Study|Pregnancy|0|||
156994758|NCT01289119|566733327|FG004|Overall Study|Pregnancy|0|||
156994759|NCT01289119|566733328|FG005|Overall Study|Pregnancy|0|||
156994760|NCT01289119|566733323|FG000|Overall Study|Lack of Efficacy|0|||
156994761|NCT01289119|566733324|FG001|Overall Study|Lack of Efficacy|1|||
156994762|NCT01289119|566733325|FG002|Overall Study|Lack of Efficacy|1|||
156994763|NCT01289119|566733326|FG003|Overall Study|Lack of Efficacy|1|||
156994764|NCT01289119|566733327|FG004|Overall Study|Lack of Efficacy|1|||
156994765|NCT01289119|566733328|FG005|Overall Study|Lack of Efficacy|1|||
156994766|NCT01289119|566733323|FG000|Overall Study|Other|1|||
156994767|NCT01289119|566733324|FG001|Overall Study|Other|0|||
156994768|NCT01289119|566733325|FG002|Overall Study|Other|1|||
156994769|NCT01289119|566733326|FG003|Overall Study|Other|0|||
156994770|NCT01289119|566733327|FG004|Overall Study|Other|0|||
156994771|NCT01289119|566733328|FG005|Overall Study|Other|0|||
156994772|NCT01704846|566733329|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156994773|NCT01704846|566733330|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156994774|NCT00530335|566733333|FG000|Overall Study|Adverse Event|3|||
156994775|NCT00530335|566733333|FG000|Overall Study|Protocol Violation|1|||
156994776|NCT00530335|566733333|FG000|Overall Study|Withdrawal by Subject|1|||
156994777|NCT00530335|566733333|FG000|Overall Study|Physician Decision|1|||
156994778|NCT01244984|566733334|FG000|Overall Study|Adverse Event|2|||
156994779|NCT01244984|566733335|FG001|Overall Study|Adverse Event|11|||
156994780|NCT01244984|566733336|FG002|Overall Study|Adverse Event|2|||
156994781|NCT01244984|566733334|FG000|Overall Study|Protocol Violation|1|||
156994782|NCT01244984|566733335|FG001|Overall Study|Protocol Violation|0|||
156994783|NCT01244984|566733336|FG002|Overall Study|Protocol Violation|0|||
156994784|NCT01244984|566733334|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
156994785|NCT01244984|566733335|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
156994786|NCT01244984|566733336|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
156994787|NCT01244984|566733334|FG000|Overall Study|Withdrawal by Subject|1|||
156994788|NCT01244984|566733335|FG001|Overall Study|Withdrawal by Subject|2|||
156994789|NCT01244984|566733336|FG002|Overall Study|Withdrawal by Subject|2|||
156994790|NCT04577183|566733338|FG000|Overall Study|Death|1|||
156994791|NCT04577183|566733338|FG000|Overall Study|Withdrawal by Subject|3|||
156994792|NCT04577183|566733338|FG000|Overall Study|Early termination|2|||
156994793|NCT00691028|566733340|FG000|Open-label Period|Adverse Event|0|||
156994794|NCT00691028|566733341|FG001|Open-label Period|Adverse Event|0|||
156994795|NCT00691028|566733342|FG002|Open-label Period|Adverse Event|0|||
156994796|NCT00691028|566733343|FG003|Open-label Period|Adverse Event|16|||
156994797|NCT00691028|566733340|FG000|Open-label Period|Withdrawal by Subject|0|||
156994798|NCT00691028|566733341|FG001|Open-label Period|Withdrawal by Subject|0|||
156994799|NCT00691028|566733342|FG002|Open-label Period|Withdrawal by Subject|0|||
156994800|NCT00691028|566733343|FG003|Open-label Period|Withdrawal by Subject|3|||
156994801|NCT00691028|566733340|FG000|Open-label Period|not come to a hospital|0|||
156994802|NCT00691028|566733341|FG001|Open-label Period|not come to a hospital|0|||
156994803|NCT00691028|566733342|FG002|Open-label Period|not come to a hospital|0|||
156994804|NCT00691028|566733343|FG003|Open-label Period|not come to a hospital|1|||
156994805|NCT00691028|566733340|FG000|Double-blind Period|Adverse Event|8|||
156994806|NCT00691028|566733341|FG001|Double-blind Period|Adverse Event|9|||
156994807|NCT00691028|566733342|FG002|Double-blind Period|Adverse Event|6|||
156994808|NCT00691028|566733343|FG003|Double-blind Period|Adverse Event|0|||
156994809|NCT00691028|566733340|FG000|Double-blind Period|Lack of Efficacy|4|||
156994810|NCT00691028|566733341|FG001|Double-blind Period|Lack of Efficacy|3|||
156994811|NCT00691028|566733342|FG002|Double-blind Period|Lack of Efficacy|2|||
156994812|NCT00691028|566733343|FG003|Double-blind Period|Lack of Efficacy|0|||
156994813|NCT00691028|566733340|FG000|Double-blind Period|Withdrawal by Subject|1|||
156994814|NCT00691028|566733341|FG001|Double-blind Period|Withdrawal by Subject|0|||
156994815|NCT00691028|566733342|FG002|Double-blind Period|Withdrawal by Subject|1|||
156994816|NCT00691028|566733343|FG003|Double-blind Period|Withdrawal by Subject|0|||
156994817|NCT00691028|566733340|FG000|Double-blind Period|not come to a hospital.|0|||
156994818|NCT00691028|566733341|FG001|Double-blind Period|not come to a hospital.|1|||
156994819|NCT00691028|566733342|FG002|Double-blind Period|not come to a hospital.|0|||
156994820|NCT00691028|566733343|FG003|Double-blind Period|not come to a hospital.|0|||
156994821|NCT01124162|566733346|FG000|First Intervention|Adverse Event|2|||
156994822|NCT01124162|566733347|FG001|First Intervention|Adverse Event|0|||
156994823|NCT01124162|566733346|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156994824|NCT01124162|566733347|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156994825|NCT03681691|566733353|FG000|Overall Study|COVID|1|||
156994826|NCT03681691|566733354|FG001|Overall Study|COVID|0|||
156994827|NCT03681691|566733353|FG000|Overall Study|prolonged bleeding|1|||
156994828|NCT03681691|566733354|FG001|Overall Study|prolonged bleeding|0|||
156994829|NCT03681691|566733353|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
156994830|NCT03681691|566733354|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
156994831|NCT02534896|566733355|FG000|Overall Study|Adverse Event|2|||
156994832|NCT02534896|566733356|FG001|Overall Study|Adverse Event|1|||
156994833|NCT02534896|566733357|FG002|Overall Study|Adverse Event|1|||
156994834|NCT02534896|566733355|FG000|Overall Study|Insufficient therapeutic response|2|||
156994835|NCT02534896|566733356|FG001|Overall Study|Insufficient therapeutic response|0|||
156994836|NCT02534896|566733357|FG002|Overall Study|Insufficient therapeutic response|0|||
156994837|NCT00711646|566733358|FG000|Overall Study|Adverse Event|6|||
156994838|NCT00711646|566733359|FG001|Overall Study|Adverse Event|1|||
156994839|NCT00711646|566733358|FG000|Overall Study|Withdrawal by Subject|4|||
156994840|NCT00711646|566733359|FG001|Overall Study|Withdrawal by Subject|0|||
156994841|NCT00711646|566733358|FG000|Overall Study|Protocol Violation|0|||
156994842|NCT00711646|566733359|FG001|Overall Study|Protocol Violation|1|||
156994843|NCT00711646|566733358|FG000|Overall Study|Lost to Follow-up|1|||
156994844|NCT00711646|566733359|FG001|Overall Study|Lost to Follow-up|0|||
156994845|NCT00711646|566733358|FG000|Overall Study|administrative decision|0|||
156994846|NCT00711646|566733359|FG001|Overall Study|administrative decision|1|||
156994847|NCT00711646|566733358|FG000|Overall Study|patient non-compliance|1|||
156994848|NCT00711646|566733359|FG001|Overall Study|patient non-compliance|0|||
156994849|NCT03441360|566733360|FG000|Overall Study|Radiological disease progression|5|||
156994850|NCT03441360|566733361|FG001|Overall Study|Radiological disease progression|6|||
156994851|NCT03441360|566733362|FG002|Overall Study|Radiological disease progression|4|||
156994852|NCT03441360|566733360|FG000|Overall Study|Clinical disease progression|2|||
156994853|NCT03441360|566733361|FG001|Overall Study|Clinical disease progression|2|||
156994854|NCT03441360|566733362|FG002|Overall Study|Clinical disease progression|0|||
156994855|NCT03441360|566733360|FG000|Overall Study|Adverse Event|1|||
156994856|NCT03441360|566733361|FG001|Overall Study|Adverse Event|0|||
156994857|NCT03441360|566733362|FG002|Overall Study|Adverse Event|1|||
156994858|NCT00269399|566733363|FG000|Overall Study|Lack of Efficacy|27|||
156994859|NCT00269399|566733364|FG001|Overall Study|Lack of Efficacy|10|||
156994860|NCT00269399|566733363|FG000|Overall Study|Adverse Event|10|||
156994861|NCT00269399|566733364|FG001|Overall Study|Adverse Event|4|||
156994862|NCT00269399|566733363|FG000|Overall Study|Withdrawal by Subject|2|||
156994863|NCT00269399|566733364|FG001|Overall Study|Withdrawal by Subject|5|||
156994864|NCT00269399|566733363|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
156994865|NCT00269399|566733364|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
156994866|NCT00269399|566733363|FG000|Overall Study|Other|0|||
156994867|NCT00269399|566733364|FG001|Overall Study|Other|4|||
156994868|NCT00269399|566733363|FG000|Overall Study|Development of exclusion criteria|0|||
156994869|NCT00269399|566733364|FG001|Overall Study|Development of exclusion criteria|1|||
156994870|NCT03439124|566733365|FG000|Overall Study|Adverse Event|2|||
156994871|NCT03439124|566733366|FG001|Overall Study|Adverse Event|0|||
156994872|NCT03439124|566733365|FG000|Overall Study|Lost to Follow-up|1|||
156994873|NCT03439124|566733366|FG001|Overall Study|Lost to Follow-up|0|||
156994874|NCT03439124|566733365|FG000|Overall Study|Other reasons|1|||
156994875|NCT03439124|566733366|FG001|Overall Study|Other reasons|0|||
156994876|NCT01360840|566733368|FG000|Overall Study|Ongoing at data cut-off|10|||
156994877|NCT01360840|566733369|FG001|Overall Study|Ongoing at data cut-off|10|||
156994878|NCT01360840|566733370|FG002|Overall Study|Ongoing at data cut-off|9|||
156994879|NCT00920686|566733372|FG000|Overall Study|Lost to Follow-up|2|||
156994880|NCT00920686|566733373|FG001|Overall Study|Lost to Follow-up|3|||
156994881|NCT00920686|566733374|FG002|Overall Study|Lost to Follow-up|1|||
156994882|NCT00920686|566733372|FG000|Overall Study|Study drug dosing criteria not met|17|||
156994883|NCT00920686|566733373|FG001|Overall Study|Study drug dosing criteria not met|19|||
156994884|NCT00920686|566733374|FG002|Overall Study|Study drug dosing criteria not met|12|||
156994885|NCT03006341|566733375|FG000|Overall Study|Not linked in the EMR|25069|||
156994886|NCT03006341|566733376|FG001|Overall Study|Not linked in the EMR|67505|||
156994887|NCT03006341|566733377|FG002|Overall Study|Not linked in the EMR|30993|||
156994888|NCT03006341|566733378|FG003|Overall Study|Not linked in the EMR|10685|||
156994889|NCT00293462|566733379|FG000|Overall Study|Withdrawal by Subject|4|||
156994890|NCT00293462|566733380|FG001|Overall Study|Withdrawal by Subject|3|||
156994891|NCT00293462|566733381|FG002|Overall Study|Withdrawal by Subject|8|||
156994892|NCT00293462|566733379|FG000|Overall Study|Death|1|||
156994893|NCT00293462|566733380|FG001|Overall Study|Death|0|||
156994894|NCT00293462|566733381|FG002|Overall Study|Death|0|||
156994895|NCT00293462|566733379|FG000|Overall Study|Lost to Follow-up|0|||
156994896|NCT00293462|566733380|FG001|Overall Study|Lost to Follow-up|1|||
156994897|NCT00293462|566733381|FG002|Overall Study|Lost to Follow-up|0|||
156994898|NCT00293462|566733379|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
156994899|NCT00293462|566733380|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
156994900|NCT00293462|566733381|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
156994901|NCT00293462|566733379|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
156994902|NCT00293462|566733380|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
156994903|NCT00293462|566733381|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
156994904|NCT00293462|566733379|FG000|Overall Study|Refuse Radiation Treatment|1|||
156994905|NCT00293462|566733380|FG001|Overall Study|Refuse Radiation Treatment|0|||
156994906|NCT00293462|566733381|FG002|Overall Study|Refuse Radiation Treatment|0|||
156994907|NCT00293462|566733379|FG000|Overall Study|No Show|0|||
156994908|NCT00293462|566733380|FG001|Overall Study|No Show|0|||
156994909|NCT00293462|566733381|FG002|Overall Study|No Show|1|||
157098385|NCT03267940|567114640|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
157098386|NCT03267940|567114641|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
157098387|NCT03267940|567114642|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
157098388|NCT03267940|567114637|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
157098389|NCT03267940|567114638|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
157098390|NCT03267940|567114639|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
157098391|NCT03267940|567114640|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
157098392|NCT03267940|567114641|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
157098393|NCT03267940|567114642|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
157098394|NCT03267940|567114637|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
157098395|NCT03267940|567114638|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
157098396|NCT03267940|567114639|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
157098397|NCT03267940|567114640|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
157098398|NCT03267940|567114641|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
157098399|NCT03267940|567114642|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
157098400|NCT03267940|567114637|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
157098401|NCT03267940|567114638|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
157098402|NCT03267940|567114639|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
157098403|NCT03267940|567114640|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
157098404|NCT03267940|567114641|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
157098405|NCT03267940|567114642|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
157098406|NCT03267940|567114637|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
157098407|NCT03267940|567114638|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
157098408|NCT03267940|567114639|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
157098409|NCT03267940|567114640|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
157098410|NCT03267940|567114641|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
157098411|NCT03267940|567114642|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
157098412|NCT01074216|567114643|FG000|Overall Study|Physician Decision|1|||
157098413|NCT01074216|567114643|FG000|Overall Study|Not Treated|12|||
157098414|NCT01323634|567114644|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
157098415|NCT01323634|567114645|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
157098416|NCT01323634|567114646|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
157098417|NCT01323634|567114644|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
157098418|NCT01323634|567114645|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
157098419|NCT01323634|567114646|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
157098420|NCT01323634|567114644|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
157098421|NCT01323634|567114645|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
157098422|NCT01323634|567114646|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
157098423|NCT01323634|567114644|FG000|2-week Run-in Period|Physician Decision|5|||
157098424|NCT01323634|567114645|FG001|2-week Run-in Period|Physician Decision|0|||
157098425|NCT01323634|567114646|FG002|2-week Run-in Period|Physician Decision|0|||
157098426|NCT01323634|567114644|FG000|2-week Run-in Period|Protocol Violation|1|||
157098427|NCT01323634|567114645|FG001|2-week Run-in Period|Protocol Violation|0|||
157098428|NCT01323634|567114646|FG002|2-week Run-in Period|Protocol Violation|0|||
157098429|NCT01323634|567114644|FG000|2-week Run-in Period|Adverse Event|1|||
157098430|NCT01323634|567114645|FG001|2-week Run-in Period|Adverse Event|0|||
157098431|NCT01323634|567114646|FG002|2-week Run-in Period|Adverse Event|0|||
157098432|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157098433|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
157098434|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
157098435|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157098436|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157098437|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
157098438|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157098439|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
157098440|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
157098441|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157098442|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157098443|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157098444|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
157098445|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
157098446|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
157098447|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157098448|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
157098449|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
157098450|NCT01323634|567114644|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
157098451|NCT01323634|567114645|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
157098452|NCT01323634|567114646|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
156994910|NCT00293462|566733379|FG000|Overall Study|Went back to his home country|0|||
156994911|NCT00293462|566733380|FG001|Overall Study|Went back to his home country|0|||
156994912|NCT00293462|566733381|FG002|Overall Study|Went back to his home country|1|||
156994913|NCT00293462|566733379|FG000|Overall Study|Blood clot after chemotherapy|0|||
156994914|NCT00293462|566733380|FG001|Overall Study|Blood clot after chemotherapy|0|||
156994915|NCT00293462|566733381|FG002|Overall Study|Blood clot after chemotherapy|1|||
156994916|NCT00293462|566733379|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
156994917|NCT00293462|566733380|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
156994918|NCT00293462|566733381|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
156994919|NCT00293462|566733379|FG000|Overall Study|Possible Tracheostomy leakage|0|||
156994920|NCT00293462|566733380|FG001|Overall Study|Possible Tracheostomy leakage|1|||
156994921|NCT00293462|566733381|FG002|Overall Study|Possible Tracheostomy leakage|0|||
156994922|NCT00293462|566733379|FG000|Overall Study|Low radiation dose in oral cavity|0|||
156994923|NCT00293462|566733380|FG001|Overall Study|Low radiation dose in oral cavity|1|||
156994924|NCT00293462|566733381|FG002|Overall Study|Low radiation dose in oral cavity|0|||
156994925|NCT00293462|566733379|FG000|Overall Study|Physician Decision|0|||
156994926|NCT00293462|566733380|FG001|Overall Study|Physician Decision|1|||
157098453|NCT01759407|567114647|FG000|Overall Study|Protocol Violation|0|||
157098454|NCT01759407|567114648|FG001|Overall Study|Protocol Violation|2|||
157098455|NCT02092220|567114653|FG000|Period 1|Unrelated Illness|0|||
157098456|NCT02092220|567114654|FG001|Period 1|Unrelated Illness|2|||
157098457|NCT02092220|567114653|FG000|Period 2|Severe Hypoglycaemia|1|||
157098458|NCT02092220|567114654|FG001|Period 2|Severe Hypoglycaemia|0|||
157098459|NCT02092220|567114653|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
157098460|NCT02092220|567114654|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
157098461|NCT00960531|567114655|FG000|Overall Study|Lack of Efficacy|1|||
157098462|NCT00960531|567114656|FG001|Overall Study|Lack of Efficacy|0|||
157098463|NCT00960531|567114657|FG002|Overall Study|Lack of Efficacy|0|||
157098464|NCT00960531|567114658|FG003|Overall Study|Lack of Efficacy|0|||
157098465|NCT00960531|567114659|FG004|Overall Study|Lack of Efficacy|0|||
157098466|NCT00960531|567114660|FG005|Overall Study|Lack of Efficacy|0|||
157098467|NCT00960531|567114661|FG006|Overall Study|Lack of Efficacy|0|||
157098468|NCT00960531|567114662|FG007|Overall Study|Lack of Efficacy|0|||
157098469|NCT00960531|567114663|FG008|Overall Study|Lack of Efficacy|0|||
157098470|NCT00960531|567114664|FG009|Overall Study|Lack of Efficacy|0|||
157098471|NCT00960531|567114655|FG000|Overall Study|Withdrawal by Subject|1|||
157098472|NCT00960531|567114656|FG001|Overall Study|Withdrawal by Subject|0|||
156994927|NCT00293462|566733381|FG002|Overall Study|Physician Decision|0|||
156994928|NCT00372060|566733382|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
156994929|NCT00372060|566733383|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
156994930|NCT00372060|566733382|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
156994931|NCT00372060|566733383|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
156994932|NCT00372060|566733382|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
156994933|NCT00372060|566733383|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
156994934|NCT00372060|566733382|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
156994935|NCT00372060|566733383|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
156994936|NCT00372060|566733382|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
156994937|NCT00372060|566733383|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
156994938|NCT00372060|566733382|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
156994939|NCT00372060|566733383|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
156994940|NCT01237678|566733384|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
156994941|NCT01237678|566733385|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
156994942|NCT01237678|566733386|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
156994943|NCT01237678|566733384|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
156994944|NCT01237678|566733385|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
156994945|NCT01237678|566733386|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
156994946|NCT01237678|566733384|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
156994947|NCT01237678|566733385|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
156994948|NCT01237678|566733386|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
156994949|NCT01237678|566733384|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
156994950|NCT01237678|566733385|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
156994951|NCT01237678|566733386|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
157098473|NCT00960531|567114657|FG002|Overall Study|Withdrawal by Subject|5|||
157098474|NCT00960531|567114658|FG003|Overall Study|Withdrawal by Subject|2|||
157098475|NCT00960531|567114659|FG004|Overall Study|Withdrawal by Subject|0|||
157098476|NCT00960531|567114660|FG005|Overall Study|Withdrawal by Subject|0|||
157098477|NCT00960531|567114661|FG006|Overall Study|Withdrawal by Subject|2|||
157098478|NCT00960531|567114662|FG007|Overall Study|Withdrawal by Subject|0|||
157098479|NCT00960531|567114663|FG008|Overall Study|Withdrawal by Subject|1|||
157098480|NCT00960531|567114664|FG009|Overall Study|Withdrawal by Subject|0|||
157098481|NCT00960531|567114655|FG000|Overall Study|Caregiver Request|2|||
157098482|NCT00960531|567114656|FG001|Overall Study|Caregiver Request|0|||
157098483|NCT00960531|567114657|FG002|Overall Study|Caregiver Request|6|||
157098484|NCT00960531|567114658|FG003|Overall Study|Caregiver Request|5|||
157098485|NCT00960531|567114659|FG004|Overall Study|Caregiver Request|0|||
157098486|NCT00960531|567114660|FG005|Overall Study|Caregiver Request|2|||
157098487|NCT00960531|567114661|FG006|Overall Study|Caregiver Request|3|||
157098488|NCT00960531|567114662|FG007|Overall Study|Caregiver Request|1|||
157098489|NCT00960531|567114663|FG008|Overall Study|Caregiver Request|3|||
157098490|NCT00960531|567114664|FG009|Overall Study|Caregiver Request|0|||
157098491|NCT00960531|567114655|FG000|Overall Study|Investigator Request|0|||
157098492|NCT00960531|567114656|FG001|Overall Study|Investigator Request|0|||
157098493|NCT00960531|567114657|FG002|Overall Study|Investigator Request|1|||
157098494|NCT00960531|567114658|FG003|Overall Study|Investigator Request|0|||
157098495|NCT00960531|567114659|FG004|Overall Study|Investigator Request|0|||
157098496|NCT00960531|567114660|FG005|Overall Study|Investigator Request|0|||
157098497|NCT00960531|567114661|FG006|Overall Study|Investigator Request|0|||
157098498|NCT00960531|567114662|FG007|Overall Study|Investigator Request|0|||
157098499|NCT00960531|567114663|FG008|Overall Study|Investigator Request|0|||
157098500|NCT00960531|567114664|FG009|Overall Study|Investigator Request|0|||
157098501|NCT00960531|567114655|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
157098502|NCT00960531|567114656|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
157098503|NCT00960531|567114657|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
157098504|NCT00960531|567114658|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
157098505|NCT00960531|567114659|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
157098506|NCT00960531|567114660|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
157098507|NCT00960531|567114661|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
157098508|NCT00960531|567114662|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
157098509|NCT00960531|567114663|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
157098510|NCT00960531|567114664|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
157098511|NCT00960531|567114655|FG000|Overall Study|Lost to Follow-up|0|||
157098512|NCT00960531|567114656|FG001|Overall Study|Lost to Follow-up|0|||
157098513|NCT00960531|567114657|FG002|Overall Study|Lost to Follow-up|1|||
157098514|NCT00960531|567114658|FG003|Overall Study|Lost to Follow-up|0|||
157098515|NCT00960531|567114659|FG004|Overall Study|Lost to Follow-up|0|||
157098516|NCT00960531|567114660|FG005|Overall Study|Lost to Follow-up|0|||
157098517|NCT00960531|567114661|FG006|Overall Study|Lost to Follow-up|1|||
157098518|NCT00960531|567114662|FG007|Overall Study|Lost to Follow-up|0|||
157098519|NCT00960531|567114663|FG008|Overall Study|Lost to Follow-up|0|||
157098520|NCT00960531|567114664|FG009|Overall Study|Lost to Follow-up|0|||
157098521|NCT00960531|567114655|FG000|Overall Study|Failed to Return|2|||
157098522|NCT00960531|567114656|FG001|Overall Study|Failed to Return|0|||
157098523|NCT00960531|567114657|FG002|Overall Study|Failed to Return|0|||
156994952|NCT01237678|566733384|FG000|Phase II|Adverse Event|0|||
156994953|NCT01237678|566733385|FG001|Phase II|Adverse Event|39|||
156994954|NCT01237678|566733386|FG002|Phase II|Adverse Event|9|||
156994955|NCT01237678|566733384|FG000|Phase II|Death|0|||
156994956|NCT01237678|566733385|FG001|Phase II|Death|0|||
156994957|NCT01237678|566733386|FG002|Phase II|Death|2|||
156994958|NCT01237678|566733384|FG000|Phase II|Lack of Efficacy|0|||
156994959|NCT01237678|566733385|FG001|Phase II|Lack of Efficacy|25|||
156994960|NCT01237678|566733386|FG002|Phase II|Lack of Efficacy|3|||
156994961|NCT01237678|566733384|FG000|Phase II|Withdrawal by Subject|0|||
156994962|NCT01237678|566733385|FG001|Phase II|Withdrawal by Subject|1|||
156994963|NCT01237678|566733386|FG002|Phase II|Withdrawal by Subject|5|||
156994964|NCT01237678|566733384|FG000|Phase II|Completed Cycles 4-6|0|||
157098524|NCT00960531|567114658|FG003|Overall Study|Failed to Return|0|||
157098525|NCT00960531|567114659|FG004|Overall Study|Failed to Return|0|||
157098526|NCT00960531|567114660|FG005|Overall Study|Failed to Return|0|||
157098527|NCT00960531|567114661|FG006|Overall Study|Failed to Return|0|||
157098528|NCT00960531|567114662|FG007|Overall Study|Failed to Return|2|||
157098529|NCT00960531|567114663|FG008|Overall Study|Failed to Return|0|||
157098530|NCT00960531|567114664|FG009|Overall Study|Failed to Return|0|||
157098531|NCT00960531|567114655|FG000|Overall Study|Adverse Event (AE)|2|||
157098532|NCT00960531|567114656|FG001|Overall Study|Adverse Event (AE)|0|||
157098533|NCT00960531|567114657|FG002|Overall Study|Adverse Event (AE)|0|||
156994965|NCT01237678|566733385|FG001|Phase II|Completed Cycles 4-6|11|||
156994966|NCT01237678|566733386|FG002|Phase II|Completed Cycles 4-6|21|||
156994967|NCT01237678|566733384|FG000|Phase II|Sponsor Decision/Study Closed|0|||
156994968|NCT01237678|566733385|FG001|Phase II|Sponsor Decision/Study Closed|18|||
157098534|NCT00960531|567114658|FG003|Overall Study|Adverse Event (AE)|0|||
157098535|NCT00960531|567114659|FG004|Overall Study|Adverse Event (AE)|0|||
157098536|NCT00960531|567114660|FG005|Overall Study|Adverse Event (AE)|1|||
157098537|NCT00960531|567114661|FG006|Overall Study|Adverse Event (AE)|2|||
157098538|NCT00960531|567114662|FG007|Overall Study|Adverse Event (AE)|0|||
156994969|NCT01237678|566733386|FG002|Phase II|Sponsor Decision/Study Closed|7|||
156994970|NCT01237678|566733384|FG000|Phase II|Randomized but were not treated|0|||
156994971|NCT01237678|566733385|FG001|Phase II|Randomized but were not treated|4|||
156994972|NCT01237678|566733386|FG002|Phase II|Randomized but were not treated|3|||
156994973|NCT00647348|566733389|FG000|Overall Study|Lost to Follow-up|3|||
156994974|NCT00647348|566733390|FG001|Overall Study|Lost to Follow-up|6|||
156994975|NCT02397889|566733391|FG000|Overall Study|Physician Decision|1|||
156994976|NCT02397889|566733392|FG001|Overall Study|Physician Decision|0|||
156994977|NCT03178201|566733393|FG000|Overall Study|Off study|5|||
156994978|NCT04668144|566733394|FG000|Overall Study|Protocol Violation|0|||
156994979|NCT04668144|566733395|FG001|Overall Study|Protocol Violation|1|||
156994980|NCT04668144|566733396|FG002|Overall Study|Protocol Violation|2|||
156994981|NCT02095158|566733400|FG000|Overall Study|Adverse Event|14|||
156994982|NCT02095158|566733400|FG000|Overall Study|Lack of Efficacy|3|||
156994983|NCT02095158|566733400|FG000|Overall Study|Pregnancy|1|||
156994984|NCT02095158|566733400|FG000|Overall Study|Lost to Follow-up|20|||
156994985|NCT02095158|566733400|FG000|Overall Study|Personal Reasons|35|||
156994986|NCT02095158|566733400|FG000|Overall Study|Protocol Violation|1|||
156994987|NCT02095158|566733400|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156994988|NCT00320489|566733401|FG000|Overall Study|Adverse Event|26|||
156994989|NCT00320489|566733402|FG001|Overall Study|Adverse Event|25|||
156994990|NCT00320489|566733401|FG000|Overall Study|Clinical Relapse|26|||
157098539|NCT00960531|567114663|FG008|Overall Study|Adverse Event (AE)|2|||
157098540|NCT00960531|567114664|FG009|Overall Study|Adverse Event (AE)|0|||
157098541|NCT00960531|567114655|FG000|Overall Study|Reason not Specified|2|||
157098542|NCT00960531|567114656|FG001|Overall Study|Reason not Specified|1|||
157098543|NCT00960531|567114657|FG002|Overall Study|Reason not Specified|13|||
157098544|NCT00960531|567114658|FG003|Overall Study|Reason not Specified|1|||
157098545|NCT00960531|567114659|FG004|Overall Study|Reason not Specified|2|||
157098546|NCT00960531|567114660|FG005|Overall Study|Reason not Specified|0|||
157098547|NCT00960531|567114661|FG006|Overall Study|Reason not Specified|16|||
157098548|NCT00960531|567114662|FG007|Overall Study|Reason not Specified|0|||
157098549|NCT00960531|567114663|FG008|Overall Study|Reason not Specified|8|||
157098550|NCT00960531|567114664|FG009|Overall Study|Reason not Specified|1|||
157098551|NCT00593957|567114665|FG000|Overall Study|Physician Decision|0|||
157098552|NCT00593957|567114666|FG001|Overall Study|Physician Decision|1|||
157098553|NCT00593957|567114667|FG002|Overall Study|Physician Decision|2|||
157098554|NCT02411578|567114668|FG000|Crossover Trial Phase|Pregnancy|0|||
157098555|NCT02411578|567114669|FG001|Crossover Trial Phase|Pregnancy|1|||
157098556|NCT00494481|567114670|FG000|Overall Study|Condition under investigation worsened|11|||
156994991|NCT00320489|566733402|FG001|Overall Study|Clinical Relapse|20|||
156994992|NCT00320489|566733401|FG000|Overall Study|Death|0|||
156994993|NCT00320489|566733402|FG001|Overall Study|Death|2|||
156994994|NCT00320489|566733401|FG000|Overall Study|Entry Criteria Exclusion|2|||
157098557|NCT00494481|567114671|FG001|Overall Study|Condition under investigation worsened|13|||
157098558|NCT00494481|567114670|FG000|Overall Study|Adverse Event|15|||
157098559|NCT00494481|567114671|FG001|Overall Study|Adverse Event|11|||
157098560|NCT00494481|567114670|FG000|Overall Study|Other|1|||
157098561|NCT00494481|567114671|FG001|Overall Study|Other|0|||
157098562|NCT00494481|567114670|FG000|Overall Study|Never received IP|2|||
157098563|NCT00494481|567114671|FG001|Overall Study|Never received IP|0|||
157098564|NCT00332189|567114672|FG000|Overall Study|Adverse Event|3|||
157098565|NCT00332189|567114672|FG000|Overall Study|Uncooperative/Noncompliant|3|||
156994995|NCT00320489|566733402|FG001|Overall Study|Entry Criteria Exclusion|4|||
156994996|NCT00320489|566733401|FG000|Overall Study|Lack of Efficacy|16|||
156994997|NCT00320489|566733402|FG001|Overall Study|Lack of Efficacy|7|||
156994998|NCT00320489|566733401|FG000|Overall Study|Lost to Follow-up|21|||
156994999|NCT00320489|566733402|FG001|Overall Study|Lost to Follow-up|22|||
156995000|NCT00320489|566733401|FG000|Overall Study|Physician Decision|8|||
156995001|NCT00320489|566733402|FG001|Overall Study|Physician Decision|8|||
156995002|NCT00320489|566733401|FG000|Overall Study|Protocol Violation|4|||
157098566|NCT00332189|567114672|FG000|Overall Study|Withdrawal by Subject|9|||
157098567|NCT00332189|567114672|FG000|Overall Study|Lack of Efficacy|4|||
157098568|NCT00332189|567114672|FG000|Overall Study|Moved out of country|2|||
157098569|NCT02225353|567114675|FG000|Overall Study|Lost to Follow-up|0|||
157098570|NCT02225353|567114676|FG001|Overall Study|Lost to Follow-up|1|||
157098571|NCT02225353|567114677|FG002|Overall Study|Lost to Follow-up|3|||
157098572|NCT02225353|567114675|FG000|Overall Study|Protocol Violation|4|||
157098573|NCT02225353|567114676|FG001|Overall Study|Protocol Violation|5|||
157098574|NCT02225353|567114677|FG002|Overall Study|Protocol Violation|12|||
157098575|NCT01411839|567114679|FG000|Overall Study|Lost to Follow-up|4|||
157098576|NCT01411839|567114680|FG001|Overall Study|Lost to Follow-up|3|||
157098577|NCT00959647|567114681|FG000|Overall Study|Adverse Event|2|||
157098578|NCT00959647|567114681|FG000|Overall Study|Progressive disease|6|||
157098579|NCT00959647|567114681|FG000|Overall Study|Study terminated by sponsor|4|||
157098580|NCT00959647|567114681|FG000|Overall Study|Withdrawal by Subject|7|||
157098581|NCT01444651|567116420|FG000|Overall Study|Adverse Event|3|||
157098582|NCT01444651|567116421|FG001|Overall Study|Adverse Event|2|||
157098583|NCT01444651|567116420|FG000|Overall Study|Lost to Follow-up|5|||
157098584|NCT01444651|567116421|FG001|Overall Study|Lost to Follow-up|5|||
157098585|NCT01444651|567116420|FG000|Overall Study|Non-fasting|2|||
157098586|NCT01444651|567116421|FG001|Overall Study|Non-fasting|1|||
157098587|NCT01444651|567116420|FG000|Overall Study|Missing data|1|||
157098588|NCT01444651|567116421|FG001|Overall Study|Missing data|1|||
157098589|NCT01929980|567116424|FG000|Overall Study|Physician Decision|1|||
157098590|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
157098591|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
157098592|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
157098593|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
157098594|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
157098595|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
157098596|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
157098597|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
157098598|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
157098599|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
157098600|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
157098601|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
157098602|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Death|3|||
157098603|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Death|1|||
157098604|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
157098605|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
157098606|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Adverse Event|7|||
157098607|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Adverse Event|8|||
157098608|NCT03236246|567116425|FG000|24-Week Dose Titration Period|Captured as Other|1|||
157098609|NCT03236246|567116426|FG001|24-Week Dose Titration Period|Captured as Other|2|||
157098610|NCT03236246|567116425|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
157098611|NCT03236246|567116426|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
157098612|NCT03236246|567116425|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
157098613|NCT03236246|567116426|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
157098614|NCT03236246|567116425|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
157098615|NCT03236246|567116426|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
157098616|NCT03236246|567116425|FG000|24-Week Dose Maintenance Period|Death|0|||
157098617|NCT03236246|567116426|FG001|24-Week Dose Maintenance Period|Death|1|||
157098618|NCT03236246|567116425|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
157098619|NCT03236246|567116426|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
157098620|NCT02952001|567116429|FG000|Overall Study|Adverse Event|3|||
157098621|NCT02952001|567116430|FG001|Overall Study|Adverse Event|0|||
157098622|NCT02952001|567116429|FG000|Overall Study|Prohibited therapy|10|||
157098623|NCT02952001|567116430|FG001|Overall Study|Prohibited therapy|3|||
157098624|NCT02952001|567116429|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
157098625|NCT02952001|567116430|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
157098626|NCT01681628|567116433|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
157098627|NCT01681628|567116434|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
157098628|NCT01681628|567116433|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
157098629|NCT01681628|567116434|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
157098630|NCT01681628|567116433|FG000|19 Months Follow-up|Death|1|||
157098631|NCT01681628|567116434|FG001|19 Months Follow-up|Death|0|||
157098632|NCT01681628|567116433|FG000|19 Months Follow-up|Lost to Follow-up|61|||
157098633|NCT01681628|567116434|FG001|19 Months Follow-up|Lost to Follow-up|43|||
157098634|NCT01794520|567116435|FG000|Overall Study|Adverse events- related to progression|0|||
157098635|NCT01794520|567116436|FG001|Overall Study|Adverse events- related to progression|0|||
157098636|NCT01794520|567116437|FG002|Overall Study|Adverse events- related to progression|1|||
157098637|NCT01794520|567116438|FG003|Overall Study|Adverse events- related to progression|2|||
157098638|NCT01794520|567116439|FG004|Overall Study|Adverse events- related to progression|0|||
157098639|NCT01794520|567116440|FG005|Overall Study|Adverse events- related to progression|1|||
157098640|NCT01794520|567116441|FG006|Overall Study|Adverse events- related to progression|0|||
157098641|NCT01794520|567116435|FG000|Overall Study|Adverse event- not related to progression|1|||
157098642|NCT01794520|567116436|FG001|Overall Study|Adverse event- not related to progression|1|||
157098643|NCT01794520|567116437|FG002|Overall Study|Adverse event- not related to progression|0|||
157098644|NCT01794520|567116438|FG003|Overall Study|Adverse event- not related to progression|0|||
157098645|NCT01794520|567116439|FG004|Overall Study|Adverse event- not related to progression|2|||
157098646|NCT01794520|567116440|FG005|Overall Study|Adverse event- not related to progression|0|||
157098647|NCT01794520|567116441|FG006|Overall Study|Adverse event- not related to progression|0|||
156995003|NCT00320489|566733402|FG001|Overall Study|Protocol Violation|4|||
156995004|NCT00320489|566733401|FG000|Overall Study|Sponsor Decision|3|||
156995005|NCT00320489|566733402|FG001|Overall Study|Sponsor Decision|3|||
156995006|NCT00320489|566733401|FG000|Overall Study|Withdrawal by Subject|39|||
156995007|NCT00320489|566733402|FG001|Overall Study|Withdrawal by Subject|41|||
156995008|NCT01872611|566733404|FG000|Overall Study|Adverse Event|3|||
156995009|NCT01872611|566733405|FG001|Overall Study|Adverse Event|1|||
156995010|NCT01872611|566733404|FG000|Overall Study|Adverse Event, prior to treatment|0|||
156995011|NCT01872611|566733405|FG001|Overall Study|Adverse Event, prior to treatment|1|||
156995012|NCT01872611|566733404|FG000|Overall Study|Death|0|||
156995013|NCT01872611|566733405|FG001|Overall Study|Death|1|||
157098648|NCT01794520|567116435|FG000|Overall Study|Progressive disease|5|||
157098649|NCT01794520|567116436|FG001|Overall Study|Progressive disease|6|||
157098650|NCT01794520|567116437|FG002|Overall Study|Progressive disease|2|||
157098651|NCT01794520|567116438|FG003|Overall Study|Progressive disease|5|||
157098652|NCT01794520|567116439|FG004|Overall Study|Progressive disease|27|||
157098653|NCT01794520|567116440|FG005|Overall Study|Progressive disease|18|||
157098654|NCT01794520|567116441|FG006|Overall Study|Progressive disease|0|||
157098655|NCT01794520|567116435|FG000|Overall Study|Withdrew consent|0|||
157098656|NCT01794520|567116436|FG001|Overall Study|Withdrew consent|0|||
157098657|NCT01794520|567116437|FG002|Overall Study|Withdrew consent|1|||
157098658|NCT01794520|567116438|FG003|Overall Study|Withdrew consent|1|||
157098659|NCT01794520|567116439|FG004|Overall Study|Withdrew consent|0|||
157098660|NCT01794520|567116440|FG005|Overall Study|Withdrew consent|0|||
157098661|NCT01794520|567116441|FG006|Overall Study|Withdrew consent|0|||
157098662|NCT01794520|567116435|FG000|Overall Study|Lost to Follow-up|0|||
157098663|NCT01794520|567116436|FG001|Overall Study|Lost to Follow-up|0|||
157098664|NCT01794520|567116437|FG002|Overall Study|Lost to Follow-up|0|||
157098665|NCT01794520|567116438|FG003|Overall Study|Lost to Follow-up|0|||
157098666|NCT01794520|567116439|FG004|Overall Study|Lost to Follow-up|1|||
157098667|NCT01794520|567116440|FG005|Overall Study|Lost to Follow-up|0|||
157098668|NCT01794520|567116441|FG006|Overall Study|Lost to Follow-up|0|||
157098669|NCT01794520|567116435|FG000|Overall Study|Toxicity|0|||
157098670|NCT01794520|567116436|FG001|Overall Study|Toxicity|2|||
157098671|NCT01794520|567116437|FG002|Overall Study|Toxicity|0|||
157098672|NCT01794520|567116438|FG003|Overall Study|Toxicity|0|||
157098673|NCT01794520|567116439|FG004|Overall Study|Toxicity|0|||
157098674|NCT01794520|567116440|FG005|Overall Study|Toxicity|0|||
157098675|NCT01794520|567116441|FG006|Overall Study|Toxicity|0|||
157098676|NCT01794520|567116435|FG000|Overall Study|Study terminated by sponsor|0|||
157098677|NCT01794520|567116436|FG001|Overall Study|Study terminated by sponsor|0|||
157098678|NCT01794520|567116437|FG002|Overall Study|Study terminated by sponsor|1|||
157098679|NCT01794520|567116438|FG003|Overall Study|Study terminated by sponsor|0|||
157098680|NCT01794520|567116439|FG004|Overall Study|Study terminated by sponsor|1|||
157098681|NCT01794520|567116440|FG005|Overall Study|Study terminated by sponsor|0|||
157098682|NCT01794520|567116441|FG006|Overall Study|Study terminated by sponsor|7|||
157098683|NCT01794520|567116435|FG000|Overall Study|Death|0|||
157098684|NCT01794520|567116436|FG001|Overall Study|Death|0|||
157098685|NCT01794520|567116437|FG002|Overall Study|Death|0|||
157098686|NCT01794520|567116438|FG003|Overall Study|Death|0|||
157098687|NCT01794520|567116439|FG004|Overall Study|Death|1|||
157098688|NCT01794520|567116440|FG005|Overall Study|Death|0|||
157098689|NCT01794520|567116441|FG006|Overall Study|Death|22|||
157098690|NCT01794520|567116435|FG000|Overall Study|Other, not specified|0|||
157098691|NCT01794520|567116436|FG001|Overall Study|Other, not specified|0|||
157098692|NCT01794520|567116437|FG002|Overall Study|Other, not specified|1|||
157098693|NCT01794520|567116438|FG003|Overall Study|Other, not specified|1|||
156995014|NCT01872611|566733404|FG000|Overall Study|Death, prior to treatment|0|||
156995015|NCT01872611|566733405|FG001|Overall Study|Death, prior to treatment|1|||
157098694|NCT01794520|567116439|FG004|Overall Study|Other, not specified|4|||
157098695|NCT01794520|567116440|FG005|Overall Study|Other, not specified|1|||
157098696|NCT01794520|567116441|FG006|Overall Study|Other, not specified|2|||
157098697|NCT02021292|567116442|FG000|Overall Study|Physician Decision|0|||
157098698|NCT02021292|567116443|FG001|Overall Study|Physician Decision|1|||
157098699|NCT02021292|567116442|FG000|Overall Study|Lost to Follow-up|0|||
157098700|NCT02021292|567116443|FG001|Overall Study|Lost to Follow-up|1|||
157098701|NCT02021292|567116442|FG000|Overall Study|Death|0|||
157098702|NCT02021292|567116443|FG001|Overall Study|Death|1|||
157098703|NCT04658186|567116446|FG000|Overall Study|Adverse Event|4|||
157098704|NCT04658186|567116447|FG001|Overall Study|Adverse Event|18|||
157098705|NCT04658186|567116448|FG002|Overall Study|Adverse Event|15|||
157098706|NCT04658186|567116446|FG000|Overall Study|Lack of Efficacy|1|||
157098707|NCT04658186|567116447|FG001|Overall Study|Lack of Efficacy|1|||
157098708|NCT04658186|567116448|FG002|Overall Study|Lack of Efficacy|0|||
157098709|NCT04658186|567116446|FG000|Overall Study|Protocol Violation|0|||
157098710|NCT04658186|567116447|FG001|Overall Study|Protocol Violation|0|||
157098711|NCT04658186|567116448|FG002|Overall Study|Protocol Violation|1|||
157098712|NCT04658186|567116446|FG000|Overall Study|Lost to Follow-up|0|||
157098713|NCT04658186|567116447|FG001|Overall Study|Lost to Follow-up|0|||
157098714|NCT04658186|567116448|FG002|Overall Study|Lost to Follow-up|2|||
157098715|NCT04658186|567116446|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
157098716|NCT04658186|567116447|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
157098717|NCT04658186|567116448|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
157098718|NCT04658186|567116446|FG000|Overall Study|Participant is Moving in Another Province|0|||
157098719|NCT04658186|567116447|FG001|Overall Study|Participant is Moving in Another Province|1|||
157098720|NCT04658186|567116448|FG002|Overall Study|Participant is Moving in Another Province|0|||
157098721|NCT04658186|567116446|FG000|Overall Study|Non-Compliance|0|||
157098722|NCT04658186|567116447|FG001|Overall Study|Non-Compliance|1|||
157098723|NCT04658186|567116448|FG002|Overall Study|Non-Compliance|1|||
157098724|NCT04658186|567116446|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
157098725|NCT04658186|567116447|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
157098726|NCT04658186|567116448|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
157098727|NCT04658186|567116446|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
157098728|NCT04658186|567116447|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
157098729|NCT04658186|567116448|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
157098730|NCT04658186|567116446|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
157098731|NCT04658186|567116447|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
157098732|NCT04658186|567116448|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
157098733|NCT04658186|567116446|FG000|Overall Study|PI Decision due to Participant Safety|0|||
157098734|NCT04658186|567116447|FG001|Overall Study|PI Decision due to Participant Safety|0|||
157098735|NCT04658186|567116448|FG002|Overall Study|PI Decision due to Participant Safety|1|||
157098736|NCT04658186|567116446|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
157098737|NCT04658186|567116447|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
157098738|NCT04658186|567116448|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
157098739|NCT04098068|567116449|FG000|Overall Study|Disease Progression|7|||
157098740|NCT04098068|567116449|FG000|Overall Study|Withdrawal by Subject|2|||
157098741|NCT04098068|567116449|FG000|Overall Study|New Cancer Diagnosis|1|||
157098742|NCT03871829|567116450|FG000|Overall Study|Lost to Follow-up|0|||
157098743|NCT03871829|567116451|FG001|Overall Study|Lost to Follow-up|1|||
157098744|NCT03871829|567116450|FG000|Overall Study|Withdrawal by Subject|1|||
157098745|NCT03871829|567116451|FG001|Overall Study|Withdrawal by Subject|1|||
157098746|NCT03871829|567116450|FG000|Overall Study|Death|12|||
157098747|NCT03871829|567116451|FG001|Overall Study|Death|8|||
157098748|NCT03871829|567116450|FG000|Overall Study|Study terminated by sponsor|31|||
157098749|NCT03871829|567116451|FG001|Overall Study|Study terminated by sponsor|34|||
157098750|NCT02993523|567116452|FG000|Overall Study|Withdrew Consent|0|||
157098751|NCT02993523|567116453|FG001|Overall Study|Withdrew Consent|0|||
157098752|NCT02993523|567116454|FG002|Overall Study|Withdrew Consent|2|||
157098753|NCT02993523|567116455|FG003|Overall Study|Withdrew Consent|9|||
157098754|NCT02993523|567116456|FG004|Overall Study|Withdrew Consent|0|||
157098755|NCT02993523|567116452|FG000|Overall Study|Lost to Follow-up|0|||
157098756|NCT02993523|567116453|FG001|Overall Study|Lost to Follow-up|0|||
157098757|NCT02993523|567116454|FG002|Overall Study|Lost to Follow-up|3|||
157098758|NCT02993523|567116455|FG003|Overall Study|Lost to Follow-up|6|||
157098759|NCT02993523|567116456|FG004|Overall Study|Lost to Follow-up|0|||
157098760|NCT02993523|567116452|FG000|Overall Study|Death|1|||
157098761|NCT02993523|567116453|FG001|Overall Study|Death|1|||
157098762|NCT02993523|567116454|FG002|Overall Study|Death|138|||
157098763|NCT02993523|567116455|FG003|Overall Study|Death|222|||
157098764|NCT02993523|567116456|FG004|Overall Study|Death|6|||
157098765|NCT02993523|567116452|FG000|Overall Study|Reason not Specified|0|||
157098766|NCT02993523|567116453|FG001|Overall Study|Reason not Specified|0|||
157098767|NCT02993523|567116454|FG002|Overall Study|Reason not Specified|1|||
157098768|NCT02993523|567116455|FG003|Overall Study|Reason not Specified|1|||
157098769|NCT02993523|567116456|FG004|Overall Study|Reason not Specified|0|||
157098770|NCT03694418|567116457|FG000|Overall Study|Lost to Follow-up|115|||
157098771|NCT03694418|567116458|FG001|Overall Study|Lost to Follow-up|23|||
157098772|NCT03694418|567116459|FG002|Overall Study|Lost to Follow-up|12|||
157098773|NCT03694418|567116460|FG003|Overall Study|Lost to Follow-up|12|||
157098774|NCT03694418|567116461|FG004|Overall Study|Lost to Follow-up|13|||
156995016|NCT01872611|566733404|FG000|Overall Study|Lost to Follow-up|8|||
156995017|NCT01872611|566733405|FG001|Overall Study|Lost to Follow-up|1|||
156995018|NCT01872611|566733404|FG000|Overall Study|Physician Decision|1|||
156995019|NCT01872611|566733405|FG001|Overall Study|Physician Decision|0|||
156995020|NCT01872611|566733404|FG000|Overall Study|Withdrawal by Subject|6|||
156995021|NCT01872611|566733405|FG001|Overall Study|Withdrawal by Subject|1|||
156995022|NCT01872611|566733404|FG000|Overall Study|Reason not provided|6|||
156995023|NCT01872611|566733405|FG001|Overall Study|Reason not provided|6|||
156995024|NCT03441984|566733406|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995025|NCT03441984|566733407|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995026|NCT03441984|566733408|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
157098775|NCT04288778|567116464|FG000|Overall Study|Withdrawal by Subject|2|||
157098776|NCT04288778|567116464|FG000|Overall Study|Adverse Event|5|||
157098777|NCT04288778|567116464|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157098778|NCT04288778|567116464|FG000|Overall Study|Other|1|||
157098779|NCT04288778|567116464|FG000|Overall Study|Started but not treated|2|||
157098780|NCT04442737|567116465|FG000|Overall Study|Lost to Follow-up|1|||
157098781|NCT04442737|567116466|FG001|Overall Study|Lost to Follow-up|3|||
157098782|NCT04442737|567116465|FG000|Overall Study|Withdrawal by Subject|3|||
157098783|NCT04442737|567116466|FG001|Overall Study|Withdrawal by Subject|2|||
157098784|NCT04442737|567116465|FG000|Overall Study|Adverse Event|3|||
157098785|NCT04442737|567116466|FG001|Overall Study|Adverse Event|2|||
157098786|NCT04442737|567116465|FG000|Overall Study|Death|0|||
157098787|NCT04442737|567116466|FG001|Overall Study|Death|1|||
157098788|NCT04442737|567116465|FG000|Overall Study|Protocol Violation|0|||
157098789|NCT04442737|567116466|FG001|Overall Study|Protocol Violation|2|||
157098790|NCT04442737|567116465|FG000|Overall Study|Other|1|||
157098791|NCT04442737|567116466|FG001|Overall Study|Other|1|||
157098792|NCT01139021|567116467|FG000|Overall Study|Adverse Event|0|||
157098793|NCT01139021|567116468|FG001|Overall Study|Adverse Event|0|||
157098794|NCT01139021|567116469|FG002|Overall Study|Adverse Event|0|||
157098795|NCT01139021|567116470|FG003|Overall Study|Adverse Event|0|||
157098796|NCT01139021|567116471|FG004|Overall Study|Adverse Event|1|||
157098797|NCT01139021|567116472|FG005|Overall Study|Adverse Event|0|||
157098798|NCT01139021|567116467|FG000|Overall Study|Lost to Follow-up|0|||
157098799|NCT01139021|567116468|FG001|Overall Study|Lost to Follow-up|0|||
157098800|NCT01139021|567116469|FG002|Overall Study|Lost to Follow-up|0|||
157098801|NCT01139021|567116470|FG003|Overall Study|Lost to Follow-up|0|||
157098802|NCT01139021|567116471|FG004|Overall Study|Lost to Follow-up|2|||
157098803|NCT01139021|567116472|FG005|Overall Study|Lost to Follow-up|0|||
157098804|NCT01139021|567116467|FG000|Overall Study|Protocol Violation|1|||
157098805|NCT01139021|567116468|FG001|Overall Study|Protocol Violation|0|||
157098806|NCT01139021|567116469|FG002|Overall Study|Protocol Violation|0|||
157098807|NCT01139021|567116470|FG003|Overall Study|Protocol Violation|0|||
157098808|NCT01139021|567116471|FG004|Overall Study|Protocol Violation|2|||
157098809|NCT01139021|567116472|FG005|Overall Study|Protocol Violation|0|||
157098810|NCT01139021|567116467|FG000|Overall Study|Withdrawal by Subject|0|||
157098811|NCT01139021|567116468|FG001|Overall Study|Withdrawal by Subject|0|||
157098812|NCT01139021|567116469|FG002|Overall Study|Withdrawal by Subject|0|||
157098813|NCT01139021|567116470|FG003|Overall Study|Withdrawal by Subject|1|||
157098814|NCT01139021|567116471|FG004|Overall Study|Withdrawal by Subject|4|||
157098815|NCT01139021|567116472|FG005|Overall Study|Withdrawal by Subject|0|||
157098816|NCT00784693|567116477|FG000|Overall Study|Lost to Follow-up|0|||
157098817|NCT00784693|567116478|FG001|Overall Study|Lost to Follow-up|1|||
157098818|NCT00784693|567116477|FG000|Overall Study|Lack of Efficacy|1|||
156995027|NCT03441984|566733409|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995028|NCT03441984|566733410|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995029|NCT03441984|566733411|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995030|NCT03441984|566733412|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995031|NCT03441984|566733413|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995032|NCT03441984|566733414|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995033|NCT03441984|566733415|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995034|NCT03441984|566733416|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995035|NCT03441984|566733417|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
156995036|NCT04939428|566733420|FG000|Overall Study|Death|0|||
156995037|NCT04939428|566733421|FG001|Overall Study|Death|1|||
156995038|NCT04939428|566733422|FG002|Overall Study|Death|0|||
156995039|NCT04939428|566733420|FG000|Overall Study|Lost to Follow-up|0|||
156995040|NCT04939428|566733421|FG001|Overall Study|Lost to Follow-up|5|||
156995041|NCT04939428|566733422|FG002|Overall Study|Lost to Follow-up|0|||
156995042|NCT04939428|566733420|FG000|Overall Study|Physician Decision|1|||
156995043|NCT04939428|566733421|FG001|Overall Study|Physician Decision|0|||
156995044|NCT04939428|566733422|FG002|Overall Study|Physician Decision|0|||
156995045|NCT04939428|566733420|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156995046|NCT04939428|566733421|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156995047|NCT04939428|566733422|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156995048|NCT04939428|566733420|FG000|Overall Study|Withdrawal by Subject|10|||
156995049|NCT04939428|566733421|FG001|Overall Study|Withdrawal by Subject|11|||
156995050|NCT04939428|566733422|FG002|Overall Study|Withdrawal by Subject|0|||
156995051|NCT04939428|566733420|FG000|Overall Study|Unkown|6|||
156995052|NCT04939428|566733421|FG001|Overall Study|Unkown|3|||
156995053|NCT04939428|566733422|FG002|Overall Study|Unkown|0|||
156995054|NCT04939428|566733420|FG000|Overall Study|Discotinued per protocol|0|||
156995055|NCT04939428|566733421|FG001|Overall Study|Discotinued per protocol|0|||
156995056|NCT04939428|566733422|FG002|Overall Study|Discotinued per protocol|902|||
156995057|NCT00877851|566733426|FG000|Overall Study|Lost to Follow-up|5|||
156995058|NCT00877851|566733427|FG001|Overall Study|Lost to Follow-up|5|||
156995059|NCT00877851|566733426|FG000|Overall Study|computer problem|3|||
156995060|NCT00877851|566733427|FG001|Overall Study|computer problem|0|||
156995061|NCT00877851|566733426|FG000|Overall Study|no longer interested in participating|1|||
156995062|NCT00877851|566733427|FG001|Overall Study|no longer interested in participating|0|||
156995063|NCT00490555|566733428|FG000|Overall Study|noncompliant with drug administration|0|||
156995064|NCT00490555|566733429|FG001|Overall Study|noncompliant with drug administration|0|||
156995065|NCT00490555|566733430|FG002|Overall Study|noncompliant with drug administration|2|||
156995066|NCT00490555|566733431|FG003|Overall Study|noncompliant with drug administration|0|||
156995067|NCT01959880|566733434|FG000|Overall Study|Withdrawal by Subject|11|||
156995068|NCT01959880|566733435|FG001|Overall Study|Withdrawal by Subject|13|||
156995069|NCT01959880|566733436|FG002|Overall Study|Withdrawal by Subject|8|||
156995070|NCT01959880|566733437|FG003|Overall Study|Withdrawal by Subject|7|||
156995071|NCT01959880|566733434|FG000|Overall Study|Death|1|||
156995072|NCT01959880|566733435|FG001|Overall Study|Death|10|||
156995073|NCT01959880|566733436|FG002|Overall Study|Death|1|||
156995074|NCT01959880|566733437|FG003|Overall Study|Death|2|||
156995075|NCT01959880|566733434|FG000|Overall Study|Lost to Follow-up|95|||
156995076|NCT01959880|566733435|FG001|Overall Study|Lost to Follow-up|18|||
156995077|NCT01959880|566733436|FG002|Overall Study|Lost to Follow-up|15|||
156995078|NCT01959880|566733437|FG003|Overall Study|Lost to Follow-up|8|||
156995079|NCT01959880|566733434|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
156995080|NCT01959880|566733435|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
156995081|NCT01959880|566733436|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
156995082|NCT01959880|566733437|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
156995083|NCT01959880|566733434|FG000|Overall Study|Study completed early-FDA approved|1003|||
156995084|NCT01959880|566733435|FG001|Overall Study|Study completed early-FDA approved|311|||
156995085|NCT01959880|566733436|FG002|Overall Study|Study completed early-FDA approved|179|||
156995086|NCT01959880|566733437|FG003|Overall Study|Study completed early-FDA approved|152|||
156995087|NCT02738840|566735058|FG000|Overall Study|MRI Scan not Performed|5|||
156995088|NCT02738840|566735058|FG000|Overall Study|Lost to Follow-up|1|||
156995089|NCT02738840|566735058|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
156995090|NCT02738840|566735058|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
156995091|NCT00256308|566735064|FG000|Overall Study|Death|2|||
156995092|NCT01537133|566735065|FG000|Overall Study|Withdrawal by Subject|2|||
157098819|NCT00784693|567116478|FG001|Overall Study|Lack of Efficacy|1|||
157098820|NCT00784693|567116477|FG000|Overall Study|Withdrawal by Subject|0|||
157098821|NCT00784693|567116478|FG001|Overall Study|Withdrawal by Subject|4|||
157098822|NCT00784693|567116477|FG000|Overall Study|Randomized but not Treated|1|||
157098823|NCT00784693|567116478|FG001|Overall Study|Randomized but not Treated|0|||
157098824|NCT00784693|567116477|FG000|Overall Study|Other|1|||
157098825|NCT00784693|567116478|FG001|Overall Study|Other|0|||
157098826|NCT05458479|567116479|FG000|Overall Study|Lost to Follow-up|1|||
157098827|NCT01176773|567116481|FG000|Overall Study|Screen Failure|2|||
157098828|NCT01176773|567116481|FG000|Overall Study|Withdrew consent|1|||
157098829|NCT01498289|567116486|FG000|Overall Study|Adverse Event|16|||
157098830|NCT01498289|567116487|FG001|Overall Study|Adverse Event|18|||
157098831|NCT01498289|567116486|FG000|Overall Study|Death|6|||
157098832|NCT01498289|567116487|FG001|Overall Study|Death|8|||
157098833|NCT01498289|567116486|FG000|Overall Study|Withdrawal unrelated to AE|16|||
157098834|NCT01498289|567116487|FG001|Overall Study|Withdrawal unrelated to AE|16|||
157098835|NCT01498289|567116486|FG000|Overall Study|Progression/relapse|53|||
157098836|NCT01498289|567116487|FG001|Overall Study|Progression/relapse|59|||
157098837|NCT01498289|567116486|FG000|Overall Study|Not protocol specified|7|||
157098838|NCT01498289|567116487|FG001|Overall Study|Not protocol specified|2|||
157098839|NCT01498289|567116486|FG000|Overall Study|Reason under review|0|||
157098840|NCT01498289|567116487|FG001|Overall Study|Reason under review|1|||
157098841|NCT02513745|567116495|FG000|Overall Study|Criteria at time of surgery not met.|3|||
157098842|NCT02513745|567116496|FG001|Overall Study|Criteria at time of surgery not met.|3|||
157098843|NCT01116882|567116497|FG000|30-day|Lost to Follow-up|50|||
157098844|NCT01116882|567116498|FG001|30-day|Lost to Follow-up|21|||
157098845|NCT01116882|567116497|FG000|30-day|Withdrawal by Subject|2|||
157098846|NCT01116882|567116498|FG001|30-day|Withdrawal by Subject|4|||
157098847|NCT01116882|567116497|FG000|30-day|Other Reasons|16|||
157098848|NCT01116882|567116498|FG001|30-day|Other Reasons|6|||
157098849|NCT01116882|567116497|FG000|12-month|Lost to Follow-up|111|||
157098850|NCT01116882|567116498|FG001|12-month|Lost to Follow-up|42|||
157098851|NCT01116882|567116497|FG000|12-month|Other Reasons|151|||
157098852|NCT01116882|567116498|FG001|12-month|Other Reasons|49|||
157098853|NCT01116882|567116497|FG000|12-month|Withdrawal by Subject|5|||
157098854|NCT01116882|567116498|FG001|12-month|Withdrawal by Subject|8|||
157098855|NCT00547365|567116499|FG000|Overall Study|Physician Decision|1|||
157098856|NCT00547365|567116499|FG000|Overall Study|Lost to Follow-up|1|||
157098857|NCT00547365|567116499|FG000|Overall Study|Protocol Violation|2|||
157098858|NCT00547365|567116499|FG000|Overall Study|death (not related to study)|4|||
157098859|NCT00504881|567116502|FG000|Overall Study|Lack of Efficacy|1|||
157098860|NCT00504881|567116503|FG001|Overall Study|Lack of Efficacy|5|||
157098861|NCT00504881|567116502|FG000|Overall Study|Lost to Follow-up|0|||
157098862|NCT00504881|567116503|FG001|Overall Study|Lost to Follow-up|2|||
157098863|NCT00504881|567116502|FG000|Overall Study|Withdrawal by Subject|1|||
157098864|NCT00504881|567116503|FG001|Overall Study|Withdrawal by Subject|4|||
157098865|NCT00504881|567116502|FG000|Overall Study|Non-Compliance|1|||
157098866|NCT00504881|567116503|FG001|Overall Study|Non-Compliance|0|||
157098867|NCT00504881|567116502|FG000|Overall Study|No Birth Control|0|||
157098868|NCT00504881|567116503|FG001|Overall Study|No Birth Control|1|||
157098869|NCT00504881|567116502|FG000|Overall Study|Safety Visit not performed|0|||
157098870|NCT00504881|567116503|FG001|Overall Study|Safety Visit not performed|1|||
157098871|NCT00504881|567116502|FG000|Overall Study|AE, serious fatal|0|||
157098872|NCT00504881|567116503|FG001|Overall Study|AE, serious fatal|1|||
157098873|NCT00504881|567116502|FG000|Overall Study|SAE, non-fatal|2|||
157098874|NCT00504881|567116503|FG001|Overall Study|SAE, non-fatal|6|||
157098875|NCT00504881|567116502|FG000|Overall Study|AE, non-serious non-fatal|4|||
157098876|NCT00504881|567116503|FG001|Overall Study|AE, non-serious non-fatal|14|||
157098877|NCT00504881|567116502|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
157098878|NCT00504881|567116503|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
157098879|NCT00504881|567116502|FG000|Overall Study|AE of unknown type|1|||
157098880|NCT00504881|567116503|FG001|Overall Study|AE of unknown type|0|||
157098881|NCT01777269|567116504|FG000|Overall Study|Adverse Event|24|||
157098882|NCT01777269|567116505|FG001|Overall Study|Adverse Event|33|||
157098883|NCT01777269|567116504|FG000|Overall Study|Lack of Efficacy|8|||
157098884|NCT01777269|567116505|FG001|Overall Study|Lack of Efficacy|10|||
157098885|NCT01777269|567116504|FG000|Overall Study|Protocol Violation|4|||
157098886|NCT01777269|567116505|FG001|Overall Study|Protocol Violation|4|||
157098887|NCT01777269|567116504|FG000|Overall Study|Participants reached stopping criteria|1|||
157098888|NCT01777269|567116505|FG001|Overall Study|Participants reached stopping criteria|1|||
157098889|NCT01777269|567116504|FG000|Overall Study|Lost to Follow-up|4|||
157098890|NCT01777269|567116505|FG001|Overall Study|Lost to Follow-up|0|||
157098891|NCT01777269|567116504|FG000|Overall Study|Physician Decision|5|||
157098892|NCT01777269|567116505|FG001|Overall Study|Physician Decision|2|||
157098893|NCT01777269|567116504|FG000|Overall Study|Withdrawal by Subject|9|||
157098894|NCT01777269|567116505|FG001|Overall Study|Withdrawal by Subject|9|||
157098895|NCT00753272|567116513|FG000|Overall Study|Adverse Event|878|||
157098896|NCT00753272|567116514|FG001|Overall Study|Adverse Event|869|||
157098897|NCT00753272|567116513|FG000|Overall Study|Protocol Violation|28|||
157098898|NCT00753272|567116514|FG001|Overall Study|Protocol Violation|46|||
157098899|NCT00753272|567116513|FG000|Overall Study|Withdrawal by Subject|2481|||
157098900|NCT00753272|567116514|FG001|Overall Study|Withdrawal by Subject|2407|||
157098901|NCT00753272|567116513|FG000|Overall Study|Lost to Follow-up|491|||
157098902|NCT00753272|567116514|FG001|Overall Study|Lost to Follow-up|497|||
157098903|NCT00753272|567116513|FG000|Overall Study|Other|1104|||
157098904|NCT00753272|567116514|FG001|Overall Study|Other|1088|||
157098905|NCT02370043|567116515|FG000|Overall Study|Withdrawal by Subject|0|||
157098906|NCT02370043|567116516|FG001|Overall Study|Withdrawal by Subject|0|||
157098907|NCT02370043|567116517|FG002|Overall Study|Withdrawal by Subject|0|||
157098908|NCT02370043|567116518|FG003|Overall Study|Withdrawal by Subject|0|||
156995093|NCT01537133|566735066|FG001|Overall Study|Withdrawal by Subject|0|||
156995094|NCT01537133|566735067|FG002|Overall Study|Withdrawal by Subject|0|||
156995095|NCT01537133|566735068|FG003|Overall Study|Withdrawal by Subject|0|||
156995096|NCT01537133|566735065|FG000|Overall Study|Lost to Follow-up|1|||
156995097|NCT01537133|566735066|FG001|Overall Study|Lost to Follow-up|0|||
156995098|NCT01537133|566735067|FG002|Overall Study|Lost to Follow-up|0|||
156995099|NCT01537133|566735068|FG003|Overall Study|Lost to Follow-up|0|||
156995100|NCT02466516|566735071|FG000|Overall Study|Adverse Event|1|||
156995101|NCT02466516|566735072|FG001|Overall Study|Adverse Event|1|||
156995102|NCT02466516|566735073|FG002|Overall Study|Adverse Event|0|||
156995103|NCT02466516|566735074|FG003|Overall Study|Adverse Event|0|||
156995104|NCT02466516|566735075|FG004|Overall Study|Adverse Event|0|||
156995105|NCT02466516|566735071|FG000|Overall Study|Withdrew Consent|1|||
156995106|NCT02466516|566735072|FG001|Overall Study|Withdrew Consent|0|||
156995107|NCT02466516|566735073|FG002|Overall Study|Withdrew Consent|0|||
156995108|NCT02466516|566735074|FG003|Overall Study|Withdrew Consent|0|||
156995109|NCT02466516|566735075|FG004|Overall Study|Withdrew Consent|0|||
156995110|NCT02466516|566735071|FG000|Overall Study|Lost to Follow-up|2|||
156995111|NCT02466516|566735072|FG001|Overall Study|Lost to Follow-up|0|||
156995112|NCT02466516|566735073|FG002|Overall Study|Lost to Follow-up|1|||
156995113|NCT02466516|566735074|FG003|Overall Study|Lost to Follow-up|0|||
156995114|NCT02466516|566735075|FG004|Overall Study|Lost to Follow-up|0|||
156995115|NCT04358549|566735076|FG000|Overall Study|Adverse Event|0|||
156995116|NCT04358549|566735077|FG001|Overall Study|Adverse Event|1|||
156995117|NCT04358549|566735076|FG000|Overall Study|Death|1|||
156995118|NCT04358549|566735077|FG001|Overall Study|Death|0|||
156995119|NCT04358549|566735076|FG000|Overall Study|Lost to Follow-up|2|||
156995120|NCT04358549|566735077|FG001|Overall Study|Lost to Follow-up|1|||
156995121|NCT04358549|566735076|FG000|Overall Study|Withdrawal by Subject|6|||
156995122|NCT04358549|566735077|FG001|Overall Study|Withdrawal by Subject|6|||
156995123|NCT04358549|566735076|FG000|Overall Study|Start remdesivir|1|||
156995124|NCT04358549|566735077|FG001|Overall Study|Start remdesivir|0|||
156995125|NCT03712930|566735078|FG000|Overall Study|Death|7|||
156995126|NCT03712930|566735078|FG000|Overall Study|Physician Decision|1|||
156995127|NCT03712930|566735078|FG000|Overall Study|Study Terminated by Sponsor|3|||
156995128|NCT03712930|566735078|FG000|Overall Study|Progressive Disease|2|||
156995129|NCT01062126|566735082|FG000|Overall Study|Death|209|||
156995130|NCT01062126|566735082|FG000|Overall Study|All Withdrawals|324|||
156995131|NCT00646451|566735083|FG000|Overall Study|Adverse Event|3|||
156995132|NCT00646451|566735084|FG001|Overall Study|Adverse Event|0|||
156995133|NCT00646451|566735083|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
156995134|NCT00646451|566735084|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
156995135|NCT03784963|566735085|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
156995136|NCT03784963|566735086|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
156995137|NCT03784963|566735087|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
156751714|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751715|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751716|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751717|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751718|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751719|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751720|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751721|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751722|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751723|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751724|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
156751725|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
156751726|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751727|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751728|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751729|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751730|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751731|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751732|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751733|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751734|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
156751735|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751736|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
156751737|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751738|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
156751739|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
156751740|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751741|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751742|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751743|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751744|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751745|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751746|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751747|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751748|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
156751749|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751750|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751751|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
156751752|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
156751753|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
156751754|NCT01483599|565842077|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
156751755|NCT01483599|565842078|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
156751756|NCT01483599|565842079|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
156751757|NCT01483599|565842080|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
156751758|NCT01483599|565842081|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
156751759|NCT01483599|565842082|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
156751760|NCT01483599|565842083|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
156995138|NCT03784963|566735088|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
156995139|NCT05355116|566735089|FG000|Overall Study|Withdrawal by Subject|2|||
156995140|NCT00868231|566735090|FG000|Treatment Period 1|Adverse Event|0|||
156995141|NCT00868231|566735091|FG001|Treatment Period 1|Adverse Event|0|||
156995142|NCT00868231|566735092|FG002|Treatment Period 1|Adverse Event|0|||
156995143|NCT00868231|566735093|FG003|Treatment Period 1|Adverse Event|0|||
156995144|NCT00868231|566735094|FG004|Treatment Period 1|Adverse Event|1|||
156995145|NCT00868231|566735095|FG005|Treatment Period 1|Adverse Event|0|||
156995146|NCT00868231|566735090|FG000|Treatment Period 2|Adverse Event|1|||
156995147|NCT00868231|566735091|FG001|Treatment Period 2|Adverse Event|0|||
156995148|NCT00868231|566735092|FG002|Treatment Period 2|Adverse Event|0|||
156995149|NCT00868231|566735093|FG003|Treatment Period 2|Adverse Event|0|||
156995150|NCT00868231|566735094|FG004|Treatment Period 2|Adverse Event|0|||
156995151|NCT00868231|566735095|FG005|Treatment Period 2|Adverse Event|0|||
156995152|NCT00868231|566735090|FG000|Treatment Period 3|Adverse Event|0|||
156995153|NCT00868231|566735091|FG001|Treatment Period 3|Adverse Event|0|||
156995154|NCT00868231|566735092|FG002|Treatment Period 3|Adverse Event|1|||
156995155|NCT00868231|566735093|FG003|Treatment Period 3|Adverse Event|0|||
156995156|NCT00868231|566735094|FG004|Treatment Period 3|Adverse Event|0|||
156995157|NCT00868231|566735095|FG005|Treatment Period 3|Adverse Event|0|||
156995158|NCT01168401|566735099|FG000|Overall Study|Lost to Follow-up|1|||
156995159|NCT01168401|566735100|FG001|Overall Study|Lost to Follow-up|1|||
156995160|NCT01168401|566735101|FG002|Overall Study|Lost to Follow-up|2|||
156995161|NCT01168401|566735102|FG003|Overall Study|Lost to Follow-up|1|||
156995162|NCT01168401|566735103|FG004|Overall Study|Lost to Follow-up|0|||
156995163|NCT01168401|566735104|FG005|Overall Study|Lost to Follow-up|0|||
156995164|NCT01168401|566735105|FG006|Overall Study|Lost to Follow-up|0|||
156995165|NCT01168401|566735106|FG007|Overall Study|Lost to Follow-up|0|||
156995166|NCT01168401|566735107|FG008|Overall Study|Lost to Follow-up|0|||
156995167|NCT01168401|566735108|FG009|Overall Study|Lost to Follow-up|0|||
156995168|NCT01168401|566735109|FG010|Overall Study|Lost to Follow-up|0|||
156995169|NCT01168401|566735099|FG000|Overall Study|Withdrawal by Subject|0|||
156995170|NCT01168401|566735100|FG001|Overall Study|Withdrawal by Subject|0|||
156995171|NCT01168401|566735101|FG002|Overall Study|Withdrawal by Subject|0|||
156995172|NCT01168401|566735102|FG003|Overall Study|Withdrawal by Subject|1|||
156995173|NCT01168401|566735103|FG004|Overall Study|Withdrawal by Subject|0|||
156995174|NCT01168401|566735104|FG005|Overall Study|Withdrawal by Subject|0|||
156995175|NCT01168401|566735105|FG006|Overall Study|Withdrawal by Subject|0|||
156995176|NCT01168401|566735106|FG007|Overall Study|Withdrawal by Subject|0|||
156995177|NCT01168401|566735107|FG008|Overall Study|Withdrawal by Subject|0|||
156995178|NCT01168401|566735108|FG009|Overall Study|Withdrawal by Subject|0|||
156995179|NCT01168401|566735109|FG010|Overall Study|Withdrawal by Subject|0|||
156995180|NCT01801930|566735112|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
156995181|NCT01801930|566735113|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
156995182|NCT01801930|566735114|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
156995183|NCT01801930|566735115|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
156995184|NCT01801930|566735112|FG000|Overall Study|DLT occurs|0|||
156995185|NCT01801930|566735113|FG001|Overall Study|DLT occurs|1|||
156995186|NCT01801930|566735114|FG002|Overall Study|DLT occurs|0|||
156995187|NCT01801930|566735115|FG003|Overall Study|DLT occurs|0|||
156751761|NCT01483599|565842084|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
156751762|NCT01483599|565842085|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
156995188|NCT02072226|566735116|FG000|Overall Study|Lost to Follow-up|11|||
156995189|NCT02072226|566735117|FG001|Overall Study|Lost to Follow-up|7|||
156995190|NCT02072226|566735116|FG000|Overall Study|Patient Non-compliance|2|||
156995191|NCT02072226|566735117|FG001|Overall Study|Patient Non-compliance|3|||
156995192|NCT02072226|566735116|FG000|Overall Study|Death|1|||
156995193|NCT02072226|566735117|FG001|Overall Study|Death|0|||
156995194|NCT02072226|566735116|FG000|Overall Study|Patient Withdrawal of Consent|1|||
156995195|NCT02072226|566735117|FG001|Overall Study|Patient Withdrawal of Consent|0|||
156995196|NCT03255018|566735119|FG000|Overall Study|Death on study|0|||
157098909|NCT02370043|567116519|FG004|Overall Study|Withdrawal by Subject|1|||
156751763|NCT01483599|565842086|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
156751764|NCT01483599|565842087|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
156751765|NCT01483599|565842088|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
156751766|NCT01483599|565842089|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
156751767|NCT01483599|565842090|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
156751768|NCT00401193|565844031|FG000|Overall Study|Adverse Event|1|||
156751769|NCT00401193|565844032|FG001|Overall Study|Adverse Event|3|||
156751770|NCT00401193|565844033|FG002|Overall Study|Adverse Event|1|||
156751771|NCT00401193|565844031|FG000|Overall Study|Protocol Violation|3|||
156751772|NCT00401193|565844032|FG001|Overall Study|Protocol Violation|1|||
156751773|NCT00401193|565844033|FG002|Overall Study|Protocol Violation|1|||
156751774|NCT00401193|565844031|FG000|Overall Study|Lost to Follow-up|6|||
156995197|NCT03255018|566735120|FG001|Overall Study|Death on study|5|||
156995198|NCT03255018|566735119|FG000|Overall Study|Withdrawal by Subject|0|||
156995199|NCT03255018|566735120|FG001|Overall Study|Withdrawal by Subject|2|||
156995200|NCT01720043|566735122|FG000|Overall Study|Withdrawal by Subject|1|||
156995201|NCT01688973|566735123|FG000|Overall Study|Ineligible|2|||
156995202|NCT01688973|566735124|FG001|Overall Study|Ineligible|3|||
156995203|NCT03613129|566735128|FG000|Pre-treatment Assessment|Protocol Violation|2|||
156995204|NCT03613129|566735129|FG001|Pre-treatment Assessment|Protocol Violation|0|||
156995205|NCT03613129|566735130|FG002|Pre-treatment Assessment|Protocol Violation|0|||
156995206|NCT03613129|566735131|FG003|Pre-treatment Assessment|Protocol Violation|0|||
156995207|NCT03613129|566735132|FG004|Pre-treatment Assessment|Protocol Violation|0|||
156995208|NCT03613129|566735128|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
156995209|NCT03613129|566735129|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
156995210|NCT03613129|566735130|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
156995211|NCT03613129|566735131|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
156995212|NCT03613129|566735132|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
156995213|NCT03396835|566735135|FG000|Overall Study|Withdrawn prior to completion|1|||
156995214|NCT03396835|566735135|FG000|Overall Study|Did not meet criteria for data analysis|1|||
156995215|NCT01451814|566735136|FG000|Overall Study|Withdrawal by Subject|1|||
156995216|NCT01451814|566735137|FG001|Overall Study|Withdrawal by Subject|1|||
156995217|NCT01451814|566735136|FG000|Overall Study|Lost to Follow-up|5|||
156995218|NCT01451814|566735137|FG001|Overall Study|Lost to Follow-up|4|||
156995219|NCT02049866|566735138|FG000|Overall Study|Withdrawal by Subject|1|||
156995220|NCT04353037|566735140|FG000|Overall Study|Lost to Follow-up|0|||
156995221|NCT04353037|566735141|FG001|Overall Study|Lost to Follow-up|1|||
156995222|NCT04353037|566735142|FG002|Overall Study|Lost to Follow-up|2|||
156995223|NCT04353037|566735143|FG003|Overall Study|Lost to Follow-up|3|||
156995224|NCT04353037|566735140|FG000|Overall Study|Withdrawal by Subject|0|||
156995225|NCT04353037|566735141|FG001|Overall Study|Withdrawal by Subject|2|||
156995226|NCT04353037|566735142|FG002|Overall Study|Withdrawal by Subject|3|||
156995227|NCT04353037|566735143|FG003|Overall Study|Withdrawal by Subject|5|||
156995228|NCT04353037|566735140|FG000|Overall Study|Adverse Event|0|||
156995229|NCT04353037|566735141|FG001|Overall Study|Adverse Event|0|||
156995230|NCT04353037|566735142|FG002|Overall Study|Adverse Event|2|||
156995231|NCT04353037|566735143|FG003|Overall Study|Adverse Event|0|||
156995232|NCT04353037|566735140|FG000|Overall Study|Exposure Change|0|||
156995233|NCT04353037|566735141|FG001|Overall Study|Exposure Change|0|||
156995234|NCT04353037|566735142|FG002|Overall Study|Exposure Change|0|||
156995235|NCT04353037|566735143|FG003|Overall Study|Exposure Change|2|||
156995236|NCT03101592|566735144|FG000|Overall Study|participant files could not be located|111|||
156995237|NCT03101592|566735145|FG001|Overall Study|participant files could not be located|170|||
156995238|NCT03101592|566735146|FG002|Overall Study|participant files could not be located|118|||
156995239|NCT03537651|566735151|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
156995240|NCT03537651|566735151|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
156995241|NCT03537651|566735151|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
156995242|NCT03537651|566735151|FG000|Part A (Up to 96 Weeks)|Other|1|||
156995243|NCT03537651|566735151|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
156995244|NCT03537651|566735151|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156751775|NCT00401193|565844032|FG001|Overall Study|Lost to Follow-up|5|||
156995245|NCT03537651|566735151|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
156995246|NCT03537651|566735151|FG000|Part B (Up to 192 Weeks)|Other|1|||
156995247|NCT01835899|566735152|FG000|Overall Study|Adverse Event|0|||
156995248|NCT01835899|566735153|FG001|Overall Study|Adverse Event|0|||
156995249|NCT01835899|566735154|FG002|Overall Study|Adverse Event|1|||
156995250|NCT01835899|566735152|FG000|Overall Study|Other than stated above|0|||
156995251|NCT01835899|566735153|FG001|Overall Study|Other than stated above|1|||
156995252|NCT01835899|566735154|FG002|Overall Study|Other than stated above|0|||
156995253|NCT04319094|566735157|FG000|Baseline|Lost to Follow-up|4|||
156995254|NCT04319094|566735158|FG001|Baseline|Lost to Follow-up|5|||
156995255|NCT04319094|566735157|FG000|Baseline|Protocol Violation|0|||
156995256|NCT04319094|566735158|FG001|Baseline|Protocol Violation|3|||
156751776|NCT00401193|565844033|FG002|Overall Study|Lost to Follow-up|1|||
156751777|NCT00401193|565844031|FG000|Overall Study|Withdrawal by Subject|2|||
156751778|NCT00401193|565844032|FG001|Overall Study|Withdrawal by Subject|0|||
156751779|NCT00401193|565844033|FG002|Overall Study|Withdrawal by Subject|1|||
156751780|NCT00401193|565844031|FG000|Overall Study|Other Event|3|||
156751781|NCT00401193|565844032|FG001|Overall Study|Other Event|2|||
156751782|NCT00401193|565844033|FG002|Overall Study|Other Event|2|||
156751783|NCT04378569|565844037|FG000|Overall Study|Adverse Event|0|||
156751784|NCT04378569|565844038|FG001|Overall Study|Adverse Event|0|||
156751785|NCT04378569|565844039|FG002|Overall Study|Adverse Event|2|||
156751786|NCT04378569|565844040|FG003|Overall Study|Adverse Event|0|||
156751787|NCT04378569|565844041|FG004|Overall Study|Adverse Event|3|||
156751788|NCT04378569|565844042|FG005|Overall Study|Adverse Event|3|||
156751789|NCT04378569|565844037|FG000|Overall Study|Lost to Follow-up|0|||
156751790|NCT04378569|565844038|FG001|Overall Study|Lost to Follow-up|3|||
156751791|NCT04378569|565844039|FG002|Overall Study|Lost to Follow-up|1|||
156751792|NCT04378569|565844040|FG003|Overall Study|Lost to Follow-up|0|||
156751793|NCT04378569|565844041|FG004|Overall Study|Lost to Follow-up|1|||
156751794|NCT04378569|565844042|FG005|Overall Study|Lost to Follow-up|1|||
156751795|NCT04378569|565844037|FG000|Overall Study|Protocol Violation|0|||
156751796|NCT04378569|565844038|FG001|Overall Study|Protocol Violation|0|||
156751797|NCT04378569|565844039|FG002|Overall Study|Protocol Violation|0|||
156751798|NCT04378569|565844040|FG003|Overall Study|Protocol Violation|0|||
156751799|NCT04378569|565844041|FG004|Overall Study|Protocol Violation|0|||
156751800|NCT04378569|565844042|FG005|Overall Study|Protocol Violation|1|||
156751801|NCT04378569|565844037|FG000|Overall Study|Withdrawal by Subject|0|||
156751802|NCT04378569|565844038|FG001|Overall Study|Withdrawal by Subject|6|||
156751803|NCT04378569|565844039|FG002|Overall Study|Withdrawal by Subject|7|||
156751804|NCT04378569|565844040|FG003|Overall Study|Withdrawal by Subject|4|||
156751805|NCT04378569|565844041|FG004|Overall Study|Withdrawal by Subject|5|||
156751806|NCT04378569|565844042|FG005|Overall Study|Withdrawal by Subject|4|||
156751807|NCT04378569|565844037|FG000|Overall Study|Lack of response|0|||
156751808|NCT04378569|565844038|FG001|Overall Study|Lack of response|0|||
156751809|NCT04378569|565844039|FG002|Overall Study|Lack of response|1|||
156751810|NCT04378569|565844040|FG003|Overall Study|Lack of response|0|||
156751811|NCT04378569|565844041|FG004|Overall Study|Lack of response|1|||
156751812|NCT04378569|565844042|FG005|Overall Study|Lack of response|1|||
156751813|NCT01048944|565844043|FG000|Overall Study|Protocol Violation|8|||
156751814|NCT01048944|565844044|FG001|Overall Study|Protocol Violation|10|||
156751815|NCT01048944|565844045|FG002|Overall Study|Protocol Violation|10|||
156751816|NCT01048944|565844046|FG003|Overall Study|Protocol Violation|2|||
156751817|NCT01962948|565844047|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
156751818|NCT01962948|565844048|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
156751819|NCT01962948|565844049|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
156751820|NCT01962948|565844050|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
156751821|NCT00376532|565844051|FG000|Overall Study|Lack sufficient blood sample|6|||
156751822|NCT00376532|565844052|FG001|Overall Study|Lack sufficient blood sample|6|||
156751823|NCT01844817|565844053|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
156751824|NCT01844817|565844054|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
156751825|NCT01844817|565844053|FG000|Treatment|Progressive Disease|27|||
156751826|NCT01844817|565844054|FG001|Treatment|Progressive Disease|36|||
156751827|NCT01844817|565844053|FG000|Treatment|Adverse Event|17|||
156995257|NCT04319094|566735157|FG000|Baseline|Withdrawal by Subject|2|||
156995258|NCT04319094|566735158|FG001|Baseline|Withdrawal by Subject|1|||
156995259|NCT04319094|566735157|FG000|Post-Intervention|Death|0|||
156995260|NCT04319094|566735158|FG001|Post-Intervention|Death|1|||
156995261|NCT04319094|566735157|FG000|Post-Intervention|Lost to Follow-up|4|||
156995262|NCT04319094|566735158|FG001|Post-Intervention|Lost to Follow-up|4|||
156995263|NCT04319094|566735157|FG000|Post-Intervention|Withdrawal by Subject|8|||
156995264|NCT04319094|566735158|FG001|Post-Intervention|Withdrawal by Subject|5|||
156995265|NCT04319094|566735157|FG000|Post-Intervention|Incomplete Data Collection|1|||
156995266|NCT04319094|566735158|FG001|Post-Intervention|Incomplete Data Collection|3|||
156995267|NCT04319094|566735157|FG000|3-month|Death|1|||
156995268|NCT04319094|566735158|FG001|3-month|Death|0|||
156751828|NCT01844817|565844054|FG001|Treatment|Adverse Event|9|||
156751829|NCT01844817|565844053|FG000|Treatment|Withdrawal by Subject|10|||
156751830|NCT01844817|565844054|FG001|Treatment|Withdrawal by Subject|6|||
156751831|NCT01844817|565844053|FG000|Treatment|Death|10|||
156751832|NCT01844817|565844054|FG001|Treatment|Death|8|||
156751833|NCT01844817|565844053|FG000|Treatment|Lost to Follow-up|0|||
156751834|NCT01844817|565844054|FG001|Treatment|Lost to Follow-up|1|||
156751835|NCT01844817|565844053|FG000|Treatment|Other|0|||
156995269|NCT04319094|566735157|FG000|3-month|Lost to Follow-up|2|||
156995270|NCT04319094|566735158|FG001|3-month|Lost to Follow-up|2|||
156995271|NCT04319094|566735157|FG000|3-month|Withdrawal by Subject|0|||
156995272|NCT04319094|566735158|FG001|3-month|Withdrawal by Subject|3|||
156995273|NCT04319094|566735157|FG000|3-month|Incomplete data collection|9|||
156995274|NCT04319094|566735158|FG001|3-month|Incomplete data collection|7|||
156751836|NCT01844817|565844054|FG001|Treatment|Other|3|||
156751837|NCT01133704|565844055|FG000|Overall Study|Death|44|||
156751838|NCT01133704|565844056|FG001|Overall Study|Death|26|||
156751839|NCT01133704|565844055|FG000|Overall Study|Patient refused to continue|4|||
156751840|NCT01133704|565844056|FG001|Overall Study|Patient refused to continue|0|||
156751841|NCT01133704|565844055|FG000|Overall Study|Study Closure|1|||
156751842|NCT01133704|565844056|FG001|Overall Study|Study Closure|0|||
156751843|NCT02207400|565844057|FG000|Overall Study|Adverse Event|1|||
156751844|NCT02207400|565844058|FG001|Overall Study|Adverse Event|1|||
156751845|NCT02207400|565844057|FG000|Overall Study|Lost to Follow-up|6|||
156751846|NCT02207400|565844058|FG001|Overall Study|Lost to Follow-up|7|||
156751847|NCT02207400|565844057|FG000|Overall Study|Protocol Violation|1|||
156751848|NCT02207400|565844058|FG001|Overall Study|Protocol Violation|1|||
156751849|NCT02207400|565844057|FG000|Overall Study|Withdrawal by Subject|8|||
156751850|NCT02207400|565844058|FG001|Overall Study|Withdrawal by Subject|4|||
156751851|NCT02207400|565844057|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
156751852|NCT02207400|565844058|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
156751853|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
156751854|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
156751855|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
156751856|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
156751857|NCT02849704|565844059|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
156751858|NCT02849704|565844060|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
156751859|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
156751860|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751861|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751862|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
156751863|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
156751864|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751865|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751866|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
156751867|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
156751868|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
156751869|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
156751870|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
156751871|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
156751872|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751873|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751874|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
156751875|NCT02362425|565844066|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
156751876|NCT02362425|565844067|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
156751877|NCT02362425|565844068|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
156751878|NCT02362425|565844069|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
156751879|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751880|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751881|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
156751882|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
156751883|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751884|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751885|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
156751886|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
156751887|NCT02362425|565844066|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751888|NCT02362425|565844067|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751889|NCT02362425|565844068|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
156751890|NCT02362425|565844069|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
156751891|NCT00314808|565844077|FG000|Overall Study|Disease Progression without AE|4|||
156751892|NCT00314808|565844077|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
156751893|NCT04304508|565844078|FG000|Overall Study|Subject Decision|29|||
156751894|NCT04304508|565844079|FG001|Overall Study|Subject Decision|39|||
156751895|NCT04304508|565844080|FG002|Overall Study|Subject Decision|37|||
156751896|NCT04304508|565844081|FG003|Overall Study|Subject Decision|48|||
156751897|NCT04304508|565844078|FG000|Overall Study|Death|6|||
156751898|NCT04304508|565844079|FG001|Overall Study|Death|1|||
156751899|NCT04304508|565844080|FG002|Overall Study|Death|8|||
156751900|NCT04304508|565844081|FG003|Overall Study|Death|5|||
156751901|NCT04304508|565844078|FG000|Overall Study|Non-compliance With Study Drug|3|||
156751902|NCT04304508|565844079|FG001|Overall Study|Non-compliance With Study Drug|1|||
156751903|NCT04304508|565844080|FG002|Overall Study|Non-compliance With Study Drug|2|||
156751904|NCT04304508|565844081|FG003|Overall Study|Non-compliance With Study Drug|0|||
156751905|NCT04304508|565844078|FG000|Overall Study|Switching To Other Therapy|1|||
156751906|NCT04304508|565844079|FG001|Overall Study|Switching To Other Therapy|1|||
156751907|NCT04304508|565844080|FG002|Overall Study|Switching To Other Therapy|1|||
156751908|NCT04304508|565844081|FG003|Overall Study|Switching To Other Therapy|2|||
156751909|NCT04304508|565844078|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
156751910|NCT04304508|565844079|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
156751911|NCT04304508|565844080|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
156751912|NCT04304508|565844081|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
156751913|NCT04304508|565844078|FG000|Overall Study|Withdrawal by Subject|7|||
156751914|NCT04304508|565844079|FG001|Overall Study|Withdrawal by Subject|5|||
156751915|NCT04304508|565844080|FG002|Overall Study|Withdrawal by Subject|11|||
156751916|NCT04304508|565844081|FG003|Overall Study|Withdrawal by Subject|6|||
156751917|NCT04304508|565844078|FG000|Overall Study|Logistical Difficulties|2|||
156751918|NCT04304508|565844079|FG001|Overall Study|Logistical Difficulties|2|||
156751919|NCT04304508|565844080|FG002|Overall Study|Logistical Difficulties|3|||
156751920|NCT04304508|565844081|FG003|Overall Study|Logistical Difficulties|2|||
156751921|NCT04304508|565844078|FG000|Overall Study|Missing Information|1|||
156751922|NCT04304508|565844079|FG001|Overall Study|Missing Information|2|||
156751923|NCT04304508|565844080|FG002|Overall Study|Missing Information|1|||
156751924|NCT04304508|565844081|FG003|Overall Study|Missing Information|3|||
156751925|NCT04304508|565844078|FG000|Overall Study|Other|7|||
156751926|NCT04304508|565844079|FG001|Overall Study|Other|6|||
156751927|NCT04304508|565844080|FG002|Overall Study|Other|5|||
156751928|NCT04304508|565844081|FG003|Overall Study|Other|4|||
156751929|NCT04304508|565844078|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
156751930|NCT04304508|565844079|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751931|NCT04304508|565844080|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751932|NCT04304508|565844081|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
156751933|NCT04304508|565844078|FG000|Overall Study|Physician Decision|3|||
156751934|NCT04304508|565844079|FG001|Overall Study|Physician Decision|4|||
156751935|NCT04304508|565844080|FG002|Overall Study|Physician Decision|9|||
156751936|NCT04304508|565844081|FG003|Overall Study|Physician Decision|7|||
156751937|NCT04304508|565844078|FG000|Overall Study|Study drug never administered|10|||
156751938|NCT04304508|565844079|FG001|Overall Study|Study drug never administered|4|||
156751939|NCT04304508|565844080|FG002|Overall Study|Study drug never administered|4|||
156751940|NCT04304508|565844081|FG003|Overall Study|Study drug never administered|4|||
156751941|NCT04304508|565844078|FG000|Overall Study|Adverse Event|49|||
156751942|NCT04304508|565844079|FG001|Overall Study|Adverse Event|50|||
156751943|NCT04304508|565844080|FG002|Overall Study|Adverse Event|51|||
156751944|NCT04304508|565844081|FG003|Overall Study|Adverse Event|56|||
156751945|NCT04304508|565844078|FG000|Overall Study|Lost to Follow-up|1|||
156751946|NCT04304508|565844079|FG001|Overall Study|Lost to Follow-up|5|||
156751947|NCT04304508|565844080|FG002|Overall Study|Lost to Follow-up|2|||
156751948|NCT04304508|565844081|FG003|Overall Study|Lost to Follow-up|3|||
156751949|NCT02688764|565844088|FG000|Overall Study|Adverse Event|3|||
156751950|NCT02688764|565844089|FG001|Overall Study|Adverse Event|3|||
156751951|NCT02688764|565844088|FG000|Overall Study|AE/Kidney transplant|1|||
156751952|NCT02688764|565844089|FG001|Overall Study|AE/Kidney transplant|0|||
156751953|NCT02688764|565844088|FG000|Overall Study|AE/Lack of efficacy|1|||
156751954|NCT02688764|565844089|FG001|Overall Study|AE/Lack of efficacy|0|||
156751955|NCT02688764|565844088|FG000|Overall Study|AE/Non-compl.|1|||
156751956|NCT02688764|565844089|FG001|Overall Study|AE/Non-compl.|0|||
156751957|NCT02688764|565844088|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
156751958|NCT02688764|565844089|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
156751959|NCT02688764|565844088|FG000|Overall Study|AE/Other|0|||
156751960|NCT02688764|565844089|FG001|Overall Study|AE/Other|1|||
156751961|NCT02688764|565844088|FG000|Overall Study|AE/Physician decision|1|||
156751962|NCT02688764|565844089|FG001|Overall Study|AE/Physician decision|0|||
156751963|NCT02688764|565844088|FG000|Overall Study|AE/Withd. parent|3|||
156995275|NCT04319094|566735157|FG000|6-month|Lost to Follow-up|1|||
156995276|NCT04319094|566735158|FG001|6-month|Lost to Follow-up|1|||
156995277|NCT04319094|566735157|FG000|6-month|Withdrawal by Subject|0|||
156995278|NCT04319094|566735158|FG001|6-month|Withdrawal by Subject|3|||
156995279|NCT04319094|566735157|FG000|6-month|Incomplete data collection|14|||
156995280|NCT04319094|566735158|FG001|6-month|Incomplete data collection|9|||
156995281|NCT04319094|566735157|FG000|9-month|Lost to Follow-up|8|||
156995282|NCT04319094|566735158|FG001|9-month|Lost to Follow-up|4|||
156995283|NCT04319094|566735157|FG000|9-month|Withdrawal by Subject|0|||
156995284|NCT04319094|566735158|FG001|9-month|Withdrawal by Subject|1|||
156995285|NCT04319094|566735157|FG000|9-month|Incomplete data collection|8|||
156995286|NCT04319094|566735158|FG001|9-month|Incomplete data collection|5|||
156995287|NCT04319094|566735157|FG000|12-month|Lost to Follow-up|11|||
156751964|NCT02688764|565844089|FG001|Overall Study|AE/Withd. parent|0|||
156995288|NCT04319094|566735158|FG001|12-month|Lost to Follow-up|8|||
156751965|NCT02688764|565844088|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
156995289|NCT03285711|566735159|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
156995290|NCT03285711|566735160|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
156995291|NCT03285711|566735161|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
157098910|NCT02370043|567116520|FG005|Overall Study|Withdrawal by Subject|1|||
157098911|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
157098912|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
157098913|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
157098914|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
157098915|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
157098916|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
157098917|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
157098918|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
157098919|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
157098920|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
157098921|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
157098922|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
157098923|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
157098924|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
157098925|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
157098926|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
157098927|NCT01231516|567116521|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
157098928|NCT01231516|567116522|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
157098929|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
157098930|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
157098931|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
157098932|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
157098933|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
157098934|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
157098935|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
157098936|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
157098937|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
157098938|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
157098939|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
157098940|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
156995292|NCT03285711|566735162|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
156995293|NCT03285711|566735159|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
156995294|NCT03285711|566735160|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156995295|NCT03285711|566735161|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156995296|NCT03285711|566735162|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
156995297|NCT03285711|566735159|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156995298|NCT03285711|566735160|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156995299|NCT03285711|566735161|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
156995300|NCT03285711|566735162|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
156995301|NCT03285711|566735159|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156995302|NCT03285711|566735160|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
156995303|NCT03285711|566735161|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156995304|NCT03285711|566735162|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
156995305|NCT03424239|566735165|FG000|Overall Study|Withdrawal by Subject|2|||
156995306|NCT00770211|566735173|FG000|Overall Study|Lost to Follow-up|1|||
156995307|NCT00770211|566735174|FG001|Overall Study|Lost to Follow-up|0|||
156995308|NCT00770211|566735173|FG000|Overall Study|Withdrawal by Subject|0|||
156995309|NCT00770211|566735174|FG001|Overall Study|Withdrawal by Subject|2|||
156995310|NCT00235495|566735175|FG000|Overall Study|Death|52|||
156995311|NCT00235495|566735176|FG001|Overall Study|Death|42|||
156995312|NCT00235495|566735175|FG000|Overall Study|Withdrawal by Subject|5|||
156995313|NCT00235495|566735176|FG001|Overall Study|Withdrawal by Subject|3|||
156995314|NCT00235495|566735175|FG000|Overall Study|Lost to Follow-up|11|||
156995315|NCT00235495|566735176|FG001|Overall Study|Lost to Follow-up|13|||
156995316|NCT00235495|566735175|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
156995317|NCT00235495|566735176|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
156995318|NCT01446003|566735177|FG000|Period 1|Protocol Violation|2|||
156995319|NCT01446003|566735178|FG001|Period 1|Protocol Violation|0|||
156995320|NCT01446003|566735177|FG000|Period 2|Adverse Event|1|||
156995321|NCT01446003|566735178|FG001|Period 2|Adverse Event|0|||
156995322|NCT00318656|566735179|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
156995323|NCT00318656|566735180|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
156995324|NCT00318656|566735179|FG000|Overall Study|Did not receive any treatment|0|||
157098941|NCT01231516|567116521|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
156995325|NCT00318656|566735180|FG001|Overall Study|Did not receive any treatment|1|||
156995326|NCT03905135|566735182|FG000|Dose Escalation|Adverse Event|1|||
156995327|NCT03905135|566735183|FG001|Dose Escalation|Adverse Event|1|||
156995328|NCT03905135|566735182|FG000|Dose Escalation|Progressive disease|3|||
156995329|NCT03905135|566735183|FG001|Dose Escalation|Progressive disease|1|||
156995330|NCT03905135|566735182|FG000|Dose Escalation|Intercurrent illness|1|||
156995331|NCT03905135|566735183|FG001|Dose Escalation|Intercurrent illness|0|||
156995332|NCT01740557|566735184|FG000|Overall Study|Ineligible|1|||
156995333|NCT01740557|566735184|FG000|Overall Study|Screen failure|1|||
156995334|NCT01007149|566735185|FG000|Overall Study|Administrative problems|0|||
156995335|NCT01007149|566735186|FG001|Overall Study|Administrative problems|1|||
156995336|NCT03568162|566735187|FG000|Overall Study|Adverse Event|0|||
156995337|NCT03568162|566735188|FG001|Overall Study|Adverse Event|1|||
156995338|NCT03568162|566735189|FG002|Overall Study|Adverse Event|2|||
156995339|NCT03568162|566735190|FG003|Overall Study|Adverse Event|0|||
156995340|NCT03568162|566735191|FG004|Overall Study|Adverse Event|0|||
156995341|NCT03568162|566735192|FG005|Overall Study|Adverse Event|1|||
156995342|NCT03568162|566735187|FG000|Overall Study|Death|0|||
156995343|NCT03568162|566735188|FG001|Overall Study|Death|0|||
156995344|NCT03568162|566735189|FG002|Overall Study|Death|0|||
156995345|NCT03568162|566735190|FG003|Overall Study|Death|0|||
156995346|NCT03568162|566735191|FG004|Overall Study|Death|1|||
156995347|NCT03568162|566735192|FG005|Overall Study|Death|0|||
156995348|NCT03568162|566735187|FG000|Overall Study|Lost to Follow-up|3|||
156995349|NCT03568162|566735188|FG001|Overall Study|Lost to Follow-up|2|||
156995350|NCT03568162|566735189|FG002|Overall Study|Lost to Follow-up|4|||
156995351|NCT03568162|566735190|FG003|Overall Study|Lost to Follow-up|2|||
156995352|NCT03568162|566735191|FG004|Overall Study|Lost to Follow-up|3|||
156995353|NCT03568162|566735192|FG005|Overall Study|Lost to Follow-up|2|||
156995354|NCT03568162|566735187|FG000|Overall Study|Physician Decision|0|||
156995355|NCT03568162|566735188|FG001|Overall Study|Physician Decision|1|||
156995356|NCT03568162|566735189|FG002|Overall Study|Physician Decision|1|||
156995357|NCT03568162|566735190|FG003|Overall Study|Physician Decision|0|||
156995358|NCT03568162|566735191|FG004|Overall Study|Physician Decision|1|||
156995359|NCT03568162|566735192|FG005|Overall Study|Physician Decision|0|||
156995360|NCT03568162|566735187|FG000|Overall Study|Pregnancy|0|||
156995361|NCT03568162|566735188|FG001|Overall Study|Pregnancy|0|||
156995362|NCT03568162|566735189|FG002|Overall Study|Pregnancy|0|||
156995363|NCT03568162|566735190|FG003|Overall Study|Pregnancy|1|||
156995364|NCT03568162|566735191|FG004|Overall Study|Pregnancy|0|||
156995365|NCT03568162|566735192|FG005|Overall Study|Pregnancy|0|||
156995366|NCT03568162|566735187|FG000|Overall Study|Protocol Violation|1|||
156995367|NCT03568162|566735188|FG001|Overall Study|Protocol Violation|0|||
156995368|NCT03568162|566735189|FG002|Overall Study|Protocol Violation|1|||
156995369|NCT03568162|566735190|FG003|Overall Study|Protocol Violation|1|||
156995370|NCT03568162|566735191|FG004|Overall Study|Protocol Violation|1|||
156995371|NCT03568162|566735192|FG005|Overall Study|Protocol Violation|1|||
156995372|NCT03568162|566735187|FG000|Overall Study|Withdrawal by Subject|15|||
156995373|NCT03568162|566735188|FG001|Overall Study|Withdrawal by Subject|15|||
156995374|NCT03568162|566735189|FG002|Overall Study|Withdrawal by Subject|26|||
156995375|NCT03568162|566735190|FG003|Overall Study|Withdrawal by Subject|22|||
157098942|NCT01231516|567116522|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
157098943|NCT05266586|567116523|FG000|Overall Study|Adverse Event|2|||
157098944|NCT05266586|567116524|FG001|Overall Study|Adverse Event|2|||
157098945|NCT05266586|567116525|FG002|Overall Study|Adverse Event|1|||
157098946|NCT05266586|567116523|FG000|Overall Study|Withdrawal by Subject|1|||
157098947|NCT05266586|567116524|FG001|Overall Study|Withdrawal by Subject|0|||
157098948|NCT05266586|567116525|FG002|Overall Study|Withdrawal by Subject|1|||
157098949|NCT05266586|567116523|FG000|Overall Study|Non-compliance with study drug|0|||
157098950|NCT05266586|567116524|FG001|Overall Study|Non-compliance with study drug|1|||
157098951|NCT05266586|567116525|FG002|Overall Study|Non-compliance with study drug|0|||
157098952|NCT05266586|567116523|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
157098953|NCT05266586|567116524|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
157098954|NCT05266586|567116525|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
157098955|NCT03707925|567116526|FG000|Overall Study|Inevaluable|1|||
157098956|NCT01193920|567116527|FG000|Overall Study|Withdrawal by Subject|1|||
157098957|NCT01193920|567116528|FG001|Overall Study|Withdrawal by Subject|0|||
157098958|NCT01193920|567116529|FG002|Overall Study|Withdrawal by Subject|5|||
157098959|NCT01193920|567116530|FG003|Overall Study|Withdrawal by Subject|1|||
157098960|NCT01193920|567116531|FG004|Overall Study|Withdrawal by Subject|3|||
157098961|NCT01193920|567116532|FG005|Overall Study|Withdrawal by Subject|1|||
157098962|NCT01193920|567116533|FG006|Overall Study|Withdrawal by Subject|3|||
157098963|NCT01193920|567116534|FG007|Overall Study|Withdrawal by Subject|0|||
157098964|NCT01193920|567116535|FG008|Overall Study|Withdrawal by Subject|1|||
157098965|NCT01193920|567116536|FG009|Overall Study|Withdrawal by Subject|0|||
157098966|NCT01193920|567116527|FG000|Overall Study|Lost to Follow-up|1|||
157098967|NCT01193920|567116528|FG001|Overall Study|Lost to Follow-up|0|||
157098968|NCT01193920|567116529|FG002|Overall Study|Lost to Follow-up|1|||
157098969|NCT01193920|567116530|FG003|Overall Study|Lost to Follow-up|1|||
157098970|NCT01193920|567116531|FG004|Overall Study|Lost to Follow-up|3|||
157098971|NCT01193920|567116532|FG005|Overall Study|Lost to Follow-up|3|||
157098972|NCT01193920|567116533|FG006|Overall Study|Lost to Follow-up|1|||
157098973|NCT01193920|567116534|FG007|Overall Study|Lost to Follow-up|0|||
157098974|NCT01193920|567116535|FG008|Overall Study|Lost to Follow-up|2|||
157098975|NCT01193920|567116536|FG009|Overall Study|Lost to Follow-up|3|||
157098976|NCT01193920|567116527|FG000|Overall Study|Protocol Violation|1|||
157098977|NCT01193920|567116528|FG001|Overall Study|Protocol Violation|0|||
157098978|NCT01193920|567116529|FG002|Overall Study|Protocol Violation|0|||
157098979|NCT01193920|567116530|FG003|Overall Study|Protocol Violation|0|||
157098980|NCT01193920|567116531|FG004|Overall Study|Protocol Violation|0|||
157098981|NCT01193920|567116532|FG005|Overall Study|Protocol Violation|0|||
157098982|NCT01193920|567116533|FG006|Overall Study|Protocol Violation|0|||
157098983|NCT01193920|567116534|FG007|Overall Study|Protocol Violation|0|||
157098984|NCT01193920|567116535|FG008|Overall Study|Protocol Violation|0|||
157098985|NCT01193920|567116536|FG009|Overall Study|Protocol Violation|0|||
157098986|NCT01193920|567116527|FG000|Overall Study|Death|0|||
157098987|NCT01193920|567116528|FG001|Overall Study|Death|0|||
157098988|NCT01193920|567116529|FG002|Overall Study|Death|0|||
157098989|NCT01193920|567116530|FG003|Overall Study|Death|1|||
157098990|NCT01193920|567116531|FG004|Overall Study|Death|0|||
157098991|NCT01193920|567116532|FG005|Overall Study|Death|0|||
157098992|NCT01193920|567116533|FG006|Overall Study|Death|2|||
157098993|NCT01193920|567116534|FG007|Overall Study|Death|3|||
157098994|NCT01193920|567116535|FG008|Overall Study|Death|2|||
157098995|NCT01193920|567116536|FG009|Overall Study|Death|4|||
157098996|NCT01193920|567116527|FG000|Overall Study|Unable to classify|0|||
157098997|NCT01193920|567116528|FG001|Overall Study|Unable to classify|0|||
157098998|NCT01193920|567116529|FG002|Overall Study|Unable to classify|0|||
157098999|NCT01193920|567116530|FG003|Overall Study|Unable to classify|1|||
157099000|NCT01193920|567116531|FG004|Overall Study|Unable to classify|0|||
157099001|NCT01193920|567116532|FG005|Overall Study|Unable to classify|0|||
157099002|NCT01193920|567116533|FG006|Overall Study|Unable to classify|0|||
157099003|NCT01193920|567116534|FG007|Overall Study|Unable to classify|1|||
157099004|NCT01193920|567116535|FG008|Overall Study|Unable to classify|0|||
157099005|NCT01193920|567116536|FG009|Overall Study|Unable to classify|0|||
157099006|NCT01117857|567116539|FG000|Overall Study|Lost to Follow-up|4|||
157099007|NCT01117857|567116539|FG000|Overall Study|Withdrawal by Subject|4|||
157099008|NCT01117857|567116539|FG000|Overall Study|Physician Decision|1|||
157099009|NCT02876835|567116540|FG000|Treatment Period (51.1 Month)|Other|1|||
157099010|NCT02876835|567116541|FG001|Treatment Period (51.1 Month)|Other|0|||
157099011|NCT02876835|567116540|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
157099012|NCT02876835|567116541|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
157099013|NCT02876835|567116540|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
157099014|NCT02876835|567116541|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
156751966|NCT02688764|565844089|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
156751967|NCT02688764|565844088|FG000|Overall Study|AE/Withd. subject|1|||
157099015|NCT02876835|567116540|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
157099016|NCT02876835|567116541|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
157099017|NCT04683731|567116542|FG000|Overall Study|Withdrawal by Subject|1|||
157099018|NCT04683731|567116543|FG001|Overall Study|Withdrawal by Subject|0|||
157099019|NCT04683731|567116544|FG002|Overall Study|Withdrawal by Subject|3|||
157099020|NCT04683731|567116545|FG003|Overall Study|Withdrawal by Subject|2|||
157099021|NCT04683731|567116542|FG000|Overall Study|Determined patient was not eligible|3|||
157099022|NCT04683731|567116543|FG001|Overall Study|Determined patient was not eligible|3|||
157099023|NCT04683731|567116544|FG002|Overall Study|Determined patient was not eligible|12|||
156995376|NCT03568162|566735191|FG004|Overall Study|Withdrawal by Subject|6|||
156995377|NCT03568162|566735192|FG005|Overall Study|Withdrawal by Subject|9|||
156995378|NCT03568162|566735187|FG000|Overall Study|Others|3|||
156995379|NCT03568162|566735188|FG001|Overall Study|Others|4|||
156995380|NCT03568162|566735189|FG002|Overall Study|Others|1|||
156995381|NCT03568162|566735190|FG003|Overall Study|Others|4|||
156995382|NCT03568162|566735191|FG004|Overall Study|Others|2|||
156995383|NCT03568162|566735192|FG005|Overall Study|Others|1|||
156995384|NCT00938340|566735193|FG000|Overall Study|Withdrawal by Subject|3|||
156995385|NCT00938340|566735193|FG000|Overall Study|Protocol Violation|1|||
156995386|NCT00938340|566735193|FG000|Overall Study|Adverse Event|1|||
156995387|NCT02909101|566735194|FG000|Overall Study|Lost to Follow-up|1|||
156995388|NCT02909101|566735195|FG001|Overall Study|Lost to Follow-up|1|||
156995389|NCT02189863|566735196|FG000|First 2 Weeks|Motion Sickness|4|||
156995390|NCT02189863|566735197|FG001|First 2 Weeks|Motion Sickness|2|||
156995391|NCT03697460|566735198|FG000|Overall Study|Withdrawal by Subject|3|||
156995392|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
156995393|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
156995394|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
156995395|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
156995396|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
156995397|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
156995398|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
156995399|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
156995400|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Death|1|||
156995401|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Death|0|||
156995402|NCT01080131|566735200|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
156995403|NCT01080131|566735201|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
156995404|NCT01080131|566735200|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
156995405|NCT01080131|566735201|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
156995406|NCT01080131|566735200|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
156995407|NCT01080131|566735201|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
156995408|NCT01080131|566735200|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
156995409|NCT01080131|566735201|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
156995410|NCT01080131|566735200|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
156995411|NCT01080131|566735201|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
156995412|NCT01080131|566735200|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
156995413|NCT01080131|566735201|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
156995414|NCT01080131|566735200|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
156995415|NCT01080131|566735201|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
157099024|NCT04683731|567116545|FG003|Overall Study|Determined patient was not eligible|3|||
157099025|NCT00883051|567116546|FG000|Overall Study|Lost to Follow-up|0|||
157099026|NCT00883051|567116547|FG001|Overall Study|Lost to Follow-up|0|||
156751968|NCT02688764|565844089|FG001|Overall Study|AE/Withd. subject|0|||
156751969|NCT02688764|565844088|FG000|Overall Study|Kidney transplant|10|||
156995416|NCT01080131|566735200|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
156995417|NCT01080131|566735201|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
156995418|NCT00299702|566735202|FG000|Overall Study|Death|1|||
156751970|NCT02688764|565844089|FG001|Overall Study|Kidney transplant|4|||
156751971|NCT02688764|565844088|FG000|Overall Study|Lack of Efficacy|3|||
156751972|NCT02688764|565844089|FG001|Overall Study|Lack of Efficacy|2|||
156751973|NCT02688764|565844088|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
156751974|NCT02688764|565844089|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
156751975|NCT02688764|565844088|FG000|Overall Study|Non-compliance with study drug|4|||
156751976|NCT02688764|565844089|FG001|Overall Study|Non-compliance with study drug|0|||
156751977|NCT02688764|565844088|FG000|Overall Study|Non-compl./Physician decision|2|||
156751978|NCT02688764|565844089|FG001|Overall Study|Non-compl./Physician decision|0|||
156995419|NCT00299702|566735203|FG001|Overall Study|Death|0|||
156995420|NCT00299702|566735202|FG000|Overall Study|Adverse Event|0|||
156995421|NCT00299702|566735203|FG001|Overall Study|Adverse Event|4|||
156995422|NCT00299702|566735202|FG000|Overall Study|Lost to Follow-up|18|||
156995423|NCT00299702|566735203|FG001|Overall Study|Lost to Follow-up|10|||
156995424|NCT00299702|566735202|FG000|Overall Study|Withdrawal by Subject|25|||
156995425|NCT00299702|566735203|FG001|Overall Study|Withdrawal by Subject|23|||
156995426|NCT00299702|566735202|FG000|Overall Study|Pregnancy|0|||
156995427|NCT00299702|566735203|FG001|Overall Study|Pregnancy|1|||
156995428|NCT00299702|566735202|FG000|Overall Study|Insufficient Response|4|||
156995429|NCT00299702|566735203|FG001|Overall Study|Insufficient Response|3|||
156995430|NCT00299702|566735202|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
156995431|NCT00299702|566735203|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
156995432|NCT01560949|566735204|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
156995433|NCT01560949|566735204|FG000|Surgery Phase|Physician Decision|3|||
156995434|NCT01140347|566735208|FG000|Overall Study|Lost to Follow-up|5|||
156995435|NCT01140347|566735209|FG001|Overall Study|Lost to Follow-up|6|||
156995436|NCT01140347|566735208|FG000|Overall Study|Withdrawal by Subject|13|||
156995437|NCT01140347|566735209|FG001|Overall Study|Withdrawal by Subject|8|||
156995438|NCT00349908|566737470|FG000|Overall Study|Withdrawal by Subject|0|||
156995439|NCT00349908|566737471|FG001|Overall Study|Withdrawal by Subject|4|||
156995440|NCT03710564|566737477|FG000|Overall Study|Study Terminated by Sponsor|104|||
156995441|NCT03710564|566737478|FG001|Overall Study|Study Terminated by Sponsor|55|||
156995442|NCT03710564|566737477|FG000|Overall Study|Withdrawal by Subject|57|||
156995443|NCT03710564|566737478|FG001|Overall Study|Withdrawal by Subject|25|||
156995444|NCT03710564|566737477|FG000|Overall Study|Death|10|||
156995445|NCT03710564|566737478|FG001|Overall Study|Death|4|||
156995446|NCT03710564|566737477|FG000|Overall Study|Lost to Follow-up|5|||
156995447|NCT03710564|566737478|FG001|Overall Study|Lost to Follow-up|4|||
156995448|NCT03710564|566737477|FG000|Overall Study|Protocol Violation|3|||
156995449|NCT03710564|566737478|FG001|Overall Study|Protocol Violation|2|||
156995450|NCT03710564|566737477|FG000|Overall Study|Adverse Event|3|||
156995451|NCT03710564|566737478|FG001|Overall Study|Adverse Event|0|||
156995452|NCT03710564|566737477|FG000|Overall Study|Physician Decision|2|||
156995453|NCT03710564|566737478|FG001|Overall Study|Physician Decision|3|||
156995454|NCT02219490|566737482|FG000|Overall Study|Adverse Event|24|||
156995455|NCT02219490|566737482|FG000|Overall Study|Withdrew consent|96|||
156995456|NCT02219490|566737482|FG000|Overall Study|Lost to Follow-up|126|||
156995457|NCT02219490|566737482|FG000|Overall Study|COVID-19 infection|2|||
156995458|NCT02219490|566737482|FG000|Overall Study|COVID-19 logistical restrictions|33|||
156995459|NCT02219490|566737482|FG000|Overall Study|Other, not specified|57|||
156995460|NCT01928940|566737486|FG000|Overall Study|Adverse Event|0|||
156995461|NCT01928940|566737487|FG001|Overall Study|Adverse Event|1|||
156995462|NCT01352507|566737490|FG000|Treatment Period 1|Adverse Event|3|||
156995463|NCT01352507|566737491|FG001|Treatment Period 1|Adverse Event|0|||
156995464|NCT01352507|566737490|FG000|Treatment Period 1|Lost to Follow-up|3|||
156995465|NCT01352507|566737491|FG001|Treatment Period 1|Lost to Follow-up|4|||
156995466|NCT01352507|566737490|FG000|Treatment Period 1|Withdrawal by Subject|7|||
156995467|NCT01352507|566737491|FG001|Treatment Period 1|Withdrawal by Subject|5|||
156995468|NCT01352507|566737490|FG000|Treatment Period 1|Physician Decision|1|||
156995469|NCT01352507|566737491|FG001|Treatment Period 1|Physician Decision|0|||
156995470|NCT01352507|566737490|FG000|Washout Period|Withdrawal by Subject|0|||
156995471|NCT01352507|566737491|FG001|Washout Period|Withdrawal by Subject|1|||
156995472|NCT01352507|566737490|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
156995473|NCT01352507|566737491|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
156995474|NCT01352507|566737490|FG000|Treatment Period 2|Withdrawal by Subject|4|||
156995475|NCT01352507|566737491|FG001|Treatment Period 2|Withdrawal by Subject|3|||
156995476|NCT01352507|566737490|FG000|Treatment Period 2|Lack of Efficacy|1|||
156751979|NCT02688764|565844088|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
156751980|NCT02688764|565844089|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
156751981|NCT02688764|565844088|FG000|Overall Study|Non-compl./Withd. subject|0|||
156995477|NCT01352507|566737491|FG001|Treatment Period 2|Lack of Efficacy|0|||
156995478|NCT04088188|566737494|FG000|Overall Study|Withdrawal by Subject|2|||
156995479|NCT04088188|566737495|FG001|Overall Study|Withdrawal by Subject|0|||
156995480|NCT04088188|566737494|FG000|Overall Study|Adverse Event|2|||
156995481|NCT04088188|566737495|FG001|Overall Study|Adverse Event|0|||
156995482|NCT00197236|566737496|FG000|Overall Study|Adverse Event|1|||
156995483|NCT00197236|566737497|FG001|Overall Study|Adverse Event|0|||
157099027|NCT00883051|567116548|FG002|Overall Study|Lost to Follow-up|0|||
157099028|NCT00883051|567116549|FG003|Overall Study|Lost to Follow-up|0|||
157099029|NCT00883051|567116550|FG004|Overall Study|Lost to Follow-up|1|||
157099030|NCT00883051|567116546|FG000|Overall Study|Did not use study medication|24|||
157099031|NCT00883051|567116547|FG001|Overall Study|Did not use study medication|22|||
157099032|NCT00883051|567116548|FG002|Overall Study|Did not use study medication|29|||
157099033|NCT00883051|567116549|FG003|Overall Study|Did not use study medication|29|||
157099034|NCT00883051|567116550|FG004|Overall Study|Did not use study medication|17|||
157099035|NCT01335009|567116551|FG000|Overall Study|Too ill to travel to study sites|1|||
157099036|NCT01335009|567116552|FG001|Overall Study|Too ill to travel to study sites|0|||
157099037|NCT01335009|567116551|FG000|Overall Study|Death|28|||
157099038|NCT01335009|567116552|FG001|Overall Study|Death|32|||
157099039|NCT01335009|567116551|FG000|Overall Study|Withdrawal by Subject|1|||
157099040|NCT01335009|567116552|FG001|Overall Study|Withdrawal by Subject|1|||
157099041|NCT01335009|567116551|FG000|Overall Study|Lost to Follow-up|1|||
157099042|NCT01335009|567116552|FG001|Overall Study|Lost to Follow-up|0|||
157099043|NCT04824521|567116553|FG000|Overall Study|Lost to Follow-up|1|||
157099044|NCT01598311|567116554|FG000|Overall Study|Physician Decision|4|||
157099045|NCT01598311|567116555|FG001|Overall Study|Physician Decision|5|||
157099046|NCT01598311|567116554|FG000|Overall Study|Adverse Event|9|||
157099047|NCT01598311|567116555|FG001|Overall Study|Adverse Event|13|||
157099048|NCT01598311|567116554|FG000|Overall Study|Lost to Follow-up|7|||
157099049|NCT01598311|567116555|FG001|Overall Study|Lost to Follow-up|12|||
157099050|NCT01598311|567116554|FG000|Overall Study|Withdrawal by Subject|9|||
157099051|NCT01598311|567116555|FG001|Overall Study|Withdrawal by Subject|13|||
157099052|NCT01598311|567116554|FG000|Overall Study|No reason provided.|0|||
157099053|NCT01598311|567116555|FG001|Overall Study|No reason provided.|5|||
157099054|NCT01598311|567116554|FG000|Overall Study|Randomized but never treated|8|||
157099055|NCT01598311|567116555|FG001|Overall Study|Randomized but never treated|5|||
157099056|NCT01598311|567116554|FG000|Overall Study|Treated but no confirmed CDAD|9|||
157099057|NCT01598311|567116555|FG001|Overall Study|Treated but no confirmed CDAD|8|||
157099058|NCT01598311|567116554|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
157099059|NCT01598311|567116555|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
157099060|NCT00688103|567116556|FG000|Overall Study|Adverse Event|4|||
157099061|NCT00688103|567116557|FG001|Overall Study|Adverse Event|1|||
157099062|NCT00688103|567116556|FG000|Overall Study|Lack of Efficacy|11|||
157099063|NCT00688103|567116557|FG001|Overall Study|Lack of Efficacy|1|||
157099064|NCT00688103|567116556|FG000|Overall Study|Withdrawal by Subject|4|||
157099065|NCT00688103|567116557|FG001|Overall Study|Withdrawal by Subject|2|||
156751982|NCT02688764|565844089|FG001|Overall Study|Non-compl./Withd. subject|2|||
156751983|NCT02688764|565844088|FG000|Overall Study|Phosphorus level outside safe range|0|||
156751984|NCT02688764|565844089|FG001|Overall Study|Phosphorus level outside safe range|1|||
156751985|NCT02688764|565844088|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
156751986|NCT02688764|565844089|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
156751987|NCT02688764|565844088|FG000|Overall Study|Study drug taste/Withd. parent|1|||
156751988|NCT02688764|565844089|FG001|Overall Study|Study drug taste/Withd. parent|0|||
156751989|NCT02688764|565844088|FG000|Overall Study|Subject moving out|2|||
156751990|NCT02688764|565844089|FG001|Overall Study|Subject moving out|0|||
156751991|NCT02688764|565844088|FG000|Overall Study|Subject taken off dialysis|1|||
156751992|NCT02688764|565844089|FG001|Overall Study|Subject taken off dialysis|0|||
156751993|NCT02688764|565844088|FG000|Overall Study|Withdrawal by parent|3|||
156751994|NCT02688764|565844089|FG001|Overall Study|Withdrawal by parent|0|||
156751995|NCT02113007|565844090|FG000|Overall Study|Progressive disease|2|||
156751996|NCT00885378|565844091|FG000|Overall Study|Lack of Efficacy|2|||
156751997|NCT00885378|565844092|FG001|Overall Study|Lack of Efficacy|2|||
156751998|NCT00885378|565844091|FG000|Overall Study|Withdrawal by Subject|1|||
156751999|NCT00885378|565844092|FG001|Overall Study|Withdrawal by Subject|2|||
156752000|NCT00885378|565844091|FG000|Overall Study|Lost to Follow-up|1|||
156752001|NCT00885378|565844092|FG001|Overall Study|Lost to Follow-up|2|||
156752002|NCT00885378|565844091|FG000|Overall Study|Poor/Noncompliance|2|||
156752003|NCT00885378|565844092|FG001|Overall Study|Poor/Noncompliance|2|||
156752004|NCT00885378|565844091|FG000|Overall Study|Protocol Violation|2|||
156752005|NCT00885378|565844092|FG001|Overall Study|Protocol Violation|0|||
156752006|NCT02579382|565844093|FG000|Main Study Phase|Lost to Follow-up|0|||
156752007|NCT02579382|565844094|FG001|Main Study Phase|Lost to Follow-up|0|||
156752008|NCT02579382|565844095|FG002|Main Study Phase|Lost to Follow-up|2|||
156752009|NCT02579382|565844096|FG003|Main Study Phase|Lost to Follow-up|0|||
156752010|NCT02579382|565844093|FG000|Main Study Phase|Withdrew Consent|0|||
156752011|NCT02579382|565844094|FG001|Main Study Phase|Withdrew Consent|0|||
157099066|NCT00688103|567116556|FG000|Overall Study|complex reasons|11|||
156995484|NCT00197236|566737498|FG002|Overall Study|Adverse Event|1|||
156995485|NCT00197236|566737496|FG000|Overall Study|Lost to Follow-up|5|||
156995486|NCT00197236|566737497|FG001|Overall Study|Lost to Follow-up|14|||
156995487|NCT00197236|566737498|FG002|Overall Study|Lost to Follow-up|6|||
156995488|NCT00197236|566737496|FG000|Overall Study|Protocol Violation|0|||
156995489|NCT00197236|566737497|FG001|Overall Study|Protocol Violation|0|||
156995490|NCT00197236|566737498|FG002|Overall Study|Protocol Violation|1|||
156995491|NCT00197236|566737496|FG000|Overall Study|Withdrawal by Subject|7|||
156995492|NCT00197236|566737497|FG001|Overall Study|Withdrawal by Subject|3|||
156995493|NCT00197236|566737498|FG002|Overall Study|Withdrawal by Subject|11|||
156995494|NCT00197236|566737496|FG000|Overall Study|Study drug/medication expiration|1|||
156995495|NCT00197236|566737497|FG001|Overall Study|Study drug/medication expiration|0|||
156995496|NCT00197236|566737498|FG002|Overall Study|Study drug/medication expiration|3|||
156995497|NCT00197236|566737496|FG000|Overall Study|Returned out of specified time window|0|||
156995498|NCT00197236|566737497|FG001|Overall Study|Returned out of specified time window|0|||
156995499|NCT00197236|566737498|FG002|Overall Study|Returned out of specified time window|1|||
156995500|NCT02524288|566737499|FG000|Overall Study|Adverse Event|115|||
156995501|NCT02524288|566737499|FG000|Overall Study|Lost to Follow-up|216|||
156995502|NCT02524288|566737499|FG000|Overall Study|Non-Compliance With Protocol|32|||
156995503|NCT02524288|566737499|FG000|Overall Study|Non-Compliance With Study Drug|14|||
156995504|NCT02524288|566737499|FG000|Overall Study|Pregnancy Wish|6|||
156995505|NCT02524288|566737499|FG000|Overall Study|Protocol Violation|6|||
156995506|NCT02524288|566737499|FG000|Overall Study|Screen Failure|2|||
156995507|NCT02524288|566737499|FG000|Overall Study|Site Discontinued Study Participation|1|||
156995508|NCT02524288|566737499|FG000|Overall Study|Study Terminated By Sponsor|1417|||
156995509|NCT02524288|566737499|FG000|Overall Study|Subject Moved|32|||
156995510|NCT02524288|566737499|FG000|Overall Study|Withdrawal by Subject|76|||
156995511|NCT02524288|566737499|FG000|Overall Study|Pregnancy|22|||
156995512|NCT02524288|566737499|FG000|Overall Study|Physician Decision|2|||
156995513|NCT02616263|566737501|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
156995514|NCT02616263|566737502|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
156995515|NCT02616263|566737501|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
156995516|NCT02616263|566737502|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
156995517|NCT02616263|566737501|FG000|6 Month to 1.5 Year|Death|1|||
156995518|NCT02616263|566737502|FG001|6 Month to 1.5 Year|Death|0|||
156995519|NCT02616263|566737501|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
156995520|NCT02616263|566737502|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
156995521|NCT02616263|566737501|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
156995522|NCT02616263|566737502|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
156995523|NCT02616263|566737501|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
156995524|NCT02616263|566737502|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
156995525|NCT02939183|566737506|FG000|Overall Study|Death|0|||
156995526|NCT02939183|566737507|FG001|Overall Study|Death|0|||
156995527|NCT02939183|566737508|FG002|Overall Study|Death|1|||
156995528|NCT02939183|566737509|FG003|Overall Study|Death|0|||
156995529|NCT02939183|566737510|FG004|Overall Study|Death|0|||
156995530|NCT02939183|566737511|FG005|Overall Study|Death|2|||
156995531|NCT02939183|566737512|FG006|Overall Study|Death|1|||
156995532|NCT02939183|566737513|FG007|Overall Study|Death|0|||
156995533|NCT02939183|566737514|FG008|Overall Study|Death|0|||
156995534|NCT02939183|566737506|FG000|Overall Study|Sponsor decision|0|||
156995535|NCT02939183|566737507|FG001|Overall Study|Sponsor decision|1|||
156995536|NCT02939183|566737508|FG002|Overall Study|Sponsor decision|0|||
156995537|NCT02939183|566737509|FG003|Overall Study|Sponsor decision|1|||
156995538|NCT02939183|566737510|FG004|Overall Study|Sponsor decision|2|||
156995539|NCT02939183|566737511|FG005|Overall Study|Sponsor decision|0|||
156995540|NCT02939183|566737512|FG006|Overall Study|Sponsor decision|3|||
156995541|NCT02939183|566737513|FG007|Overall Study|Sponsor decision|1|||
156995542|NCT02939183|566737514|FG008|Overall Study|Sponsor decision|4|||
156995543|NCT02939183|566737506|FG000|Overall Study|Withdrawal by Subject|0|||
156995544|NCT02939183|566737507|FG001|Overall Study|Withdrawal by Subject|2|||
156995545|NCT02939183|566737508|FG002|Overall Study|Withdrawal by Subject|0|||
156995546|NCT02939183|566737509|FG003|Overall Study|Withdrawal by Subject|1|||
156995547|NCT02939183|566737510|FG004|Overall Study|Withdrawal by Subject|0|||
156995548|NCT02939183|566737511|FG005|Overall Study|Withdrawal by Subject|0|||
157099067|NCT00688103|567116557|FG001|Overall Study|complex reasons|9|||
157099068|NCT03144804|567116558|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
157099069|NCT04223856|567116559|FG000|Overall Study|Progressive disease|153|||
156752012|NCT02579382|565844095|FG002|Main Study Phase|Withdrew Consent|0|||
156752013|NCT02579382|565844096|FG003|Main Study Phase|Withdrew Consent|2|||
156752014|NCT02579382|565844093|FG000|Main Study Phase|Lack of Efficacy|0|||
157099070|NCT04223856|567116560|FG001|Overall Study|Progressive disease|73|||
157099071|NCT04223856|567116559|FG000|Overall Study|Adverse Event|97|||
156752015|NCT02579382|565844094|FG001|Main Study Phase|Lack of Efficacy|0|||
156752016|NCT02579382|565844095|FG002|Main Study Phase|Lack of Efficacy|0|||
156752017|NCT02579382|565844096|FG003|Main Study Phase|Lack of Efficacy|1|||
156752018|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
156752019|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
156752020|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
156752021|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
156752022|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
156752023|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
156752024|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
156752025|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
156752026|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
156752027|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752028|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752029|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
156752030|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752031|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
156752032|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752033|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
156752034|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752035|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
156752036|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752037|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
156752038|NCT02579382|565844093|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752039|NCT02579382|565844094|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
156752040|NCT02579382|565844095|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752041|NCT02579382|565844096|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
156752042|NCT01775787|565844097|FG000|First 7-10 Days|Adverse Event|0|||
156752043|NCT01775787|565844098|FG001|First 7-10 Days|Adverse Event|1|||
156752044|NCT01775787|565844097|FG000|First 7-10 Days|family emergency|0|||
156752045|NCT01775787|565844098|FG001|First 7-10 Days|family emergency|1|||
156752046|NCT01775787|565844097|FG000|First 7-10 Days|time commitment|0|||
156752047|NCT01775787|565844098|FG001|First 7-10 Days|time commitment|2|||
156752048|NCT01775787|565844097|FG000|First 7-10 Days|concerns with using IV|1|||
156752049|NCT01775787|565844098|FG001|First 7-10 Days|concerns with using IV|2|||
156752050|NCT01775787|565844097|FG000|Second 7-10 Days|time commitment|0|||
156752051|NCT01775787|565844098|FG001|Second 7-10 Days|time commitment|1|||
156752052|NCT01775787|565844097|FG000|Second 7-10 Days|concerns with using IV|0|||
156752053|NCT01775787|565844098|FG001|Second 7-10 Days|concerns with using IV|1|||
156752054|NCT03026283|565844099|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
156752055|NCT03026283|565844100|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
156752056|NCT03026283|565844101|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
156752057|NCT03026283|565844102|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
156752058|NCT03026283|565844103|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
156752059|NCT03026283|565844104|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
156752060|NCT03026283|565844105|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
156752061|NCT03026283|565844106|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
156752062|NCT03026283|565844099|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
156752063|NCT03026283|565844100|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
156752064|NCT03026283|565844101|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
156752065|NCT03026283|565844102|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
156752066|NCT03026283|565844103|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
156752067|NCT03026283|565844104|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
156752068|NCT03026283|565844105|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
157099072|NCT04223856|567116560|FG001|Overall Study|Adverse Event|62|||
156752069|NCT03026283|565844106|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
156752070|NCT03026283|565844099|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
157099073|NCT04223856|567116559|FG000|Overall Study|Physician Decision|9|||
157099074|NCT04223856|567116560|FG001|Overall Study|Physician Decision|28|||
157099075|NCT04223856|567116559|FG000|Overall Study|Withdrawal by Subject|22|||
156752071|NCT03026283|565844100|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
156752072|NCT03026283|565844101|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752073|NCT03026283|565844102|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
157099076|NCT04223856|567116560|FG001|Overall Study|Withdrawal by Subject|24|||
157099077|NCT04223856|567116559|FG000|Overall Study|Other|7|||
157099078|NCT04223856|567116560|FG001|Overall Study|Other|2|||
157099079|NCT04223856|567116559|FG000|Overall Study|Randomized but not treated|2|||
157099080|NCT04223856|567116560|FG001|Overall Study|Randomized but not treated|11|||
157099081|NCT04223856|567116559|FG000|Overall Study|On-treatment|144|||
157099082|NCT04223856|567116560|FG001|Overall Study|On-treatment|0|||
157099083|NCT05959629|567116563|FG000|Overall Study|partially necrotic/technical issues|2|||
156752074|NCT03026283|565844103|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752075|NCT03026283|565844104|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752076|NCT03026283|565844105|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752077|NCT03026283|565844106|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
156752078|NCT03026283|565844099|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752079|NCT03026283|565844100|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752080|NCT03026283|565844101|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
156752081|NCT03026283|565844102|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752082|NCT03026283|565844103|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752083|NCT03026283|565844104|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752084|NCT03026283|565844105|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752085|NCT03026283|565844106|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
156752086|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752087|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752088|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752089|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
156752090|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
156752091|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752092|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752093|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
156752094|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752095|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752096|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752097|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
156752098|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
156752099|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
156752100|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752101|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
156752102|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752103|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752104|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752105|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
156752106|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752107|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
156752108|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752109|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
156752110|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752111|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752112|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752113|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
156752114|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752115|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752116|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752117|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
156752118|NCT03026283|565844099|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752119|NCT03026283|565844100|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752120|NCT03026283|565844101|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752121|NCT03026283|565844102|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752122|NCT03026283|565844103|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
156752123|NCT03026283|565844104|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
156752124|NCT03026283|565844105|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752125|NCT03026283|565844106|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
156752126|NCT00824655|565844107|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
157099084|NCT05959629|567116564|FG001|Overall Study|partially necrotic/technical issues|2|||
157099085|NCT03078907|567118196|FG000|Overall Study|Adverse Event|2|||
157099086|NCT03078907|567118197|FG001|Overall Study|Adverse Event|0|||
156995549|NCT02939183|566737512|FG006|Overall Study|Withdrawal by Subject|2|||
156995550|NCT02939183|566737513|FG007|Overall Study|Withdrawal by Subject|2|||
156995551|NCT02939183|566737514|FG008|Overall Study|Withdrawal by Subject|2|||
156995552|NCT02939183|566737506|FG000|Overall Study|Not treated due to adverse event|0|||
156995553|NCT02939183|566737507|FG001|Overall Study|Not treated due to adverse event|0|||
156995554|NCT02939183|566737508|FG002|Overall Study|Not treated due to adverse event|0|||
156995555|NCT02939183|566737509|FG003|Overall Study|Not treated due to adverse event|1|||
156995556|NCT02939183|566737510|FG004|Overall Study|Not treated due to adverse event|0|||
156995557|NCT02939183|566737511|FG005|Overall Study|Not treated due to adverse event|0|||
156995558|NCT02939183|566737512|FG006|Overall Study|Not treated due to adverse event|1|||
156995559|NCT02939183|566737513|FG007|Overall Study|Not treated due to adverse event|0|||
156995560|NCT02939183|566737514|FG008|Overall Study|Not treated due to adverse event|0|||
156995561|NCT05015478|566737515|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
156995562|NCT05015478|566737516|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
156995563|NCT05015478|566737517|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
156995564|NCT05015478|566737518|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
156995565|NCT04523181|566737521|FG000|Overall Study|Withdrawal by Subject|4|||
156995566|NCT04523181|566737522|FG001|Overall Study|Withdrawal by Subject|5|||
156995567|NCT04523181|566737521|FG000|Overall Study|Lost to Follow-up|2|||
156995568|NCT04523181|566737522|FG001|Overall Study|Lost to Follow-up|3|||
156995569|NCT04523181|566737521|FG000|Overall Study|Physician Decision|1|||
156995570|NCT04523181|566737522|FG001|Overall Study|Physician Decision|0|||
156995571|NCT04523181|566737521|FG000|Overall Study|Transferred to external facility.|1|||
157099087|NCT03078907|567118196|FG000|Overall Study|Other|1|||
157099088|NCT03078907|567118197|FG001|Overall Study|Other|0|||
156752127|NCT00824655|565844108|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
156752128|NCT00824655|565844107|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
156752129|NCT00824655|565844108|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
156752130|NCT03252145|565844109|FG000|Overall Study|Withdrawal by Subject|1|||
156752131|NCT03252145|565844110|FG001|Overall Study|Withdrawal by Subject|0|||
156752132|NCT03252145|565844109|FG000|Overall Study|Complicating Disease|1|||
156752133|NCT03252145|565844110|FG001|Overall Study|Complicating Disease|2|||
156752134|NCT03091738|565844111|FG000|Overall Study|Adverse Event|1|||
156752135|NCT03091738|565844111|FG000|Overall Study|Lost to Follow-up|1|||
156752136|NCT01763827|565844119|FG000|Overall Study|Withdrawal by Subject|1|||
156752137|NCT01763827|565844120|FG001|Overall Study|Withdrawal by Subject|0|||
156752138|NCT01763827|565844121|FG002|Overall Study|Withdrawal by Subject|0|||
156752139|NCT01763827|565844122|FG003|Overall Study|Withdrawal by Subject|0|||
156752140|NCT01763827|565844123|FG004|Overall Study|Withdrawal by Subject|2|||
156752141|NCT01763827|565844124|FG005|Overall Study|Withdrawal by Subject|0|||
156752142|NCT01763827|565844119|FG000|Overall Study|Decision by sponsor|2|||
156752143|NCT01763827|565844120|FG001|Overall Study|Decision by sponsor|0|||
156752144|NCT01763827|565844121|FG002|Overall Study|Decision by sponsor|3|||
156752145|NCT01763827|565844122|FG003|Overall Study|Decision by sponsor|0|||
156752146|NCT01763827|565844123|FG004|Overall Study|Decision by sponsor|2|||
156752147|NCT01763827|565844124|FG005|Overall Study|Decision by sponsor|1|||
156752148|NCT01763827|565844119|FG000|Overall Study|Lost to Follow-up|0|||
156752149|NCT01763827|565844120|FG001|Overall Study|Lost to Follow-up|1|||
156752150|NCT01763827|565844121|FG002|Overall Study|Lost to Follow-up|1|||
156752151|NCT01763827|565844122|FG003|Overall Study|Lost to Follow-up|1|||
156752152|NCT01763827|565844123|FG004|Overall Study|Lost to Follow-up|2|||
156752153|NCT01763827|565844124|FG005|Overall Study|Lost to Follow-up|1|||
156752154|NCT01826981|565844127|FG000|Overall Study|Lack of Efficacy|0|||
156752155|NCT01826981|565844128|FG001|Overall Study|Lack of Efficacy|1|||
156752156|NCT01826981|565844129|FG002|Overall Study|Lack of Efficacy|0|||
156752157|NCT01826981|565844130|FG003|Overall Study|Lack of Efficacy|0|||
156752158|NCT01826981|565844131|FG004|Overall Study|Lack of Efficacy|5|||
156752159|NCT01826981|565844132|FG005|Overall Study|Lack of Efficacy|0|||
156752160|NCT01826981|565844133|FG006|Overall Study|Lack of Efficacy|0|||
156752161|NCT01826981|565844134|FG007|Overall Study|Lack of Efficacy|8|||
156752162|NCT01826981|565844135|FG008|Overall Study|Lack of Efficacy|7|||
156752163|NCT01826981|565844136|FG009|Overall Study|Lack of Efficacy|0|||
156752164|NCT01826981|565844137|FG010|Overall Study|Lack of Efficacy|1|||
156752165|NCT01826981|565844138|FG011|Overall Study|Lack of Efficacy|0|||
156752166|NCT01826981|565844139|FG012|Overall Study|Lack of Efficacy|0|||
156752167|NCT01826981|565844140|FG013|Overall Study|Lack of Efficacy|3|||
156752168|NCT01826981|565844141|FG014|Overall Study|Lack of Efficacy|0|||
156752169|NCT01826981|565844127|FG000|Overall Study|Lost to Follow-up|0|||
156752170|NCT01826981|565844128|FG001|Overall Study|Lost to Follow-up|0|||
156995572|NCT04523181|566737522|FG001|Overall Study|Transferred to external facility.|1|||
156995573|NCT02042443|566737523|FG000|Overall Study|Adverse Event|2|||
156995574|NCT02042443|566737524|FG001|Overall Study|Adverse Event|1|||
156995575|NCT02042443|566737523|FG000|Overall Study|Withdrawal by Subject|0|||
156995576|NCT02042443|566737524|FG001|Overall Study|Withdrawal by Subject|1|||
156995577|NCT02042443|566737523|FG000|Overall Study|Progression|21|||
156995578|NCT02042443|566737524|FG001|Overall Study|Progression|17|||
156995579|NCT02042443|566737523|FG000|Overall Study|not protocol specified|1|||
156995580|NCT02042443|566737524|FG001|Overall Study|not protocol specified|1|||
156995581|NCT02042443|566737523|FG000|Overall Study|Not eligible/not analyzable|3|||
156995582|NCT02042443|566737524|FG001|Overall Study|Not eligible/not analyzable|6|||
156995583|NCT02784704|566737525|FG000|Overall Study|Adverse Event|4|||
156995584|NCT02784704|566737526|FG001|Overall Study|Adverse Event|2|||
156995585|NCT02784704|566737525|FG000|Overall Study|Lost to Follow-up|6|||
156995586|NCT02784704|566737526|FG001|Overall Study|Lost to Follow-up|4|||
156995587|NCT02784704|566737525|FG000|Overall Study|Withdrawal by Subject|1|||
156995588|NCT02784704|566737526|FG001|Overall Study|Withdrawal by Subject|3|||
156995589|NCT02784704|566737525|FG000|Overall Study|Subject Non Compliance|2|||
156752171|NCT01826981|565844129|FG002|Overall Study|Lost to Follow-up|0|||
156752172|NCT01826981|565844130|FG003|Overall Study|Lost to Follow-up|0|||
156752173|NCT01826981|565844131|FG004|Overall Study|Lost to Follow-up|1|||
156752174|NCT01826981|565844132|FG005|Overall Study|Lost to Follow-up|1|||
156752175|NCT01826981|565844133|FG006|Overall Study|Lost to Follow-up|0|||
156752176|NCT01826981|565844134|FG007|Overall Study|Lost to Follow-up|1|||
156752177|NCT01826981|565844135|FG008|Overall Study|Lost to Follow-up|0|||
156752178|NCT01826981|565844136|FG009|Overall Study|Lost to Follow-up|1|||
156995590|NCT02784704|566737526|FG001|Overall Study|Subject Non Compliance|0|||
156995591|NCT01913340|566737527|FG000|Overall Study|Death|2|||
156995592|NCT01913340|566737528|FG001|Overall Study|Death|5|||
156995593|NCT01913340|566737527|FG000|Overall Study|Lost to Follow-up|1|||
156995594|NCT01913340|566737528|FG001|Overall Study|Lost to Follow-up|1|||
156995595|NCT00603538|566737529|FG000|Overall Study|Adverse Event|0|||
156752179|NCT01826981|565844137|FG010|Overall Study|Lost to Follow-up|1|||
156995596|NCT00603538|566737530|FG001|Overall Study|Adverse Event|4|||
156752180|NCT01826981|565844138|FG011|Overall Study|Lost to Follow-up|1|||
157099089|NCT03078907|567118196|FG000|Overall Study|Protocol Violation|0|||
156752181|NCT01826981|565844139|FG012|Overall Study|Lost to Follow-up|1|||
156752182|NCT01826981|565844140|FG013|Overall Study|Lost to Follow-up|0|||
156752183|NCT01826981|565844141|FG014|Overall Study|Lost to Follow-up|0|||
156752184|NCT01826981|565844127|FG000|Overall Study|Withdrew Consent|0|||
156752185|NCT01826981|565844128|FG001|Overall Study|Withdrew Consent|0|||
156752186|NCT01826981|565844129|FG002|Overall Study|Withdrew Consent|0|||
156752187|NCT01826981|565844130|FG003|Overall Study|Withdrew Consent|0|||
156752188|NCT01826981|565844131|FG004|Overall Study|Withdrew Consent|0|||
156752189|NCT01826981|565844132|FG005|Overall Study|Withdrew Consent|0|||
156752190|NCT01826981|565844133|FG006|Overall Study|Withdrew Consent|1|||
156752191|NCT01826981|565844134|FG007|Overall Study|Withdrew Consent|1|||
156752192|NCT01826981|565844135|FG008|Overall Study|Withdrew Consent|0|||
156752193|NCT01826981|565844136|FG009|Overall Study|Withdrew Consent|0|||
156752194|NCT01826981|565844137|FG010|Overall Study|Withdrew Consent|0|||
156752195|NCT01826981|565844138|FG011|Overall Study|Withdrew Consent|1|||
156752196|NCT01826981|565844139|FG012|Overall Study|Withdrew Consent|0|||
156752197|NCT01826981|565844140|FG013|Overall Study|Withdrew Consent|1|||
156752198|NCT01826981|565844141|FG014|Overall Study|Withdrew Consent|0|||
156752199|NCT01826981|565844127|FG000|Overall Study|Adverse Event|0|||
156752200|NCT01826981|565844128|FG001|Overall Study|Adverse Event|0|||
156752201|NCT01826981|565844129|FG002|Overall Study|Adverse Event|0|||
156752202|NCT01826981|565844130|FG003|Overall Study|Adverse Event|0|||
156752203|NCT01826981|565844131|FG004|Overall Study|Adverse Event|1|||
156752204|NCT01826981|565844132|FG005|Overall Study|Adverse Event|0|||
156752205|NCT01826981|565844133|FG006|Overall Study|Adverse Event|0|||
156752206|NCT01826981|565844134|FG007|Overall Study|Adverse Event|0|||
156752207|NCT01826981|565844135|FG008|Overall Study|Adverse Event|0|||
156752208|NCT01826981|565844136|FG009|Overall Study|Adverse Event|0|||
156752209|NCT01826981|565844137|FG010|Overall Study|Adverse Event|0|||
156752210|NCT01826981|565844138|FG011|Overall Study|Adverse Event|0|||
156752211|NCT01826981|565844139|FG012|Overall Study|Adverse Event|0|||
156752212|NCT01826981|565844140|FG013|Overall Study|Adverse Event|0|||
156752213|NCT01826981|565844141|FG014|Overall Study|Adverse Event|0|||
156752214|NCT01826981|565844127|FG000|Overall Study|Upper G-I Haemorrhage|0|||
156752215|NCT01826981|565844128|FG001|Overall Study|Upper G-I Haemorrhage|0|||
156752216|NCT01826981|565844129|FG002|Overall Study|Upper G-I Haemorrhage|0|||
156752217|NCT01826981|565844130|FG003|Overall Study|Upper G-I Haemorrhage|0|||
156752218|NCT01826981|565844131|FG004|Overall Study|Upper G-I Haemorrhage|0|||
156752219|NCT01826981|565844132|FG005|Overall Study|Upper G-I Haemorrhage|0|||
156752220|NCT01826981|565844133|FG006|Overall Study|Upper G-I Haemorrhage|0|||
156752221|NCT01826981|565844134|FG007|Overall Study|Upper G-I Haemorrhage|0|||
156752222|NCT01826981|565844135|FG008|Overall Study|Upper G-I Haemorrhage|0|||
156752223|NCT01826981|565844136|FG009|Overall Study|Upper G-I Haemorrhage|0|||
156752224|NCT01826981|565844137|FG010|Overall Study|Upper G-I Haemorrhage|0|||
156752225|NCT01826981|565844138|FG011|Overall Study|Upper G-I Haemorrhage|0|||
156752226|NCT01826981|565844139|FG012|Overall Study|Upper G-I Haemorrhage|0|||
156752227|NCT01826981|565844140|FG013|Overall Study|Upper G-I Haemorrhage|1|||
156752228|NCT01826981|565844141|FG014|Overall Study|Upper G-I Haemorrhage|0|||
156752229|NCT01826981|565844127|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752230|NCT01826981|565844128|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
156995597|NCT00603538|566737531|FG002|Overall Study|Adverse Event|2|||
156995598|NCT00603538|566737529|FG000|Overall Study|Objective progression or relapse|3|||
156995599|NCT00603538|566737530|FG001|Overall Study|Objective progression or relapse|0|||
156995600|NCT00603538|566737531|FG002|Overall Study|Objective progression or relapse|0|||
156995601|NCT05750745|566737533|FG000|Overall Study|Adverse Event|1|||
156995602|NCT05750745|566737534|FG001|Overall Study|Adverse Event|0|||
156995603|NCT05750745|566737535|FG002|Overall Study|Adverse Event|0|||
156995604|NCT05750745|566737533|FG000|Overall Study|Protocol Violation|1|||
156995605|NCT05750745|566737534|FG001|Overall Study|Protocol Violation|0|||
156995606|NCT05750745|566737535|FG002|Overall Study|Protocol Violation|0|||
156995607|NCT05750745|566737533|FG000|Overall Study|Withdrawal by Subject|0|||
156995608|NCT05750745|566737534|FG001|Overall Study|Withdrawal by Subject|1|||
156995609|NCT05750745|566737535|FG002|Overall Study|Withdrawal by Subject|0|||
156995610|NCT04794179|566737537|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
156995611|NCT04794179|566737538|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
156995612|NCT04927975|566737539|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
156995613|NCT04927975|566737540|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
156752231|NCT01826981|565844129|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752232|NCT01826981|565844130|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
156995614|NCT04927975|566737541|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
156752233|NCT01826981|565844131|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752234|NCT01826981|565844132|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752235|NCT01826981|565844133|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752236|NCT01826981|565844134|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
156752237|NCT01826981|565844135|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752238|NCT01826981|565844136|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752239|NCT01826981|565844137|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752240|NCT01826981|565844138|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752241|NCT01826981|565844139|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752242|NCT01826981|565844140|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752243|NCT01826981|565844141|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
156752244|NCT03746405|565844146|FG000|Overall Study|Withdrawal by Subject|3|||
156752245|NCT03746405|565844147|FG001|Overall Study|Withdrawal by Subject|0|||
156752246|NCT03746405|565844146|FG000|Overall Study|technical difficulties|0|||
156752247|NCT03746405|565844147|FG001|Overall Study|technical difficulties|2|||
156752248|NCT03479008|565844148|FG000|Overall Study|Withdrawal by Subject|3|||
156752249|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
156752250|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
156752251|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
156752252|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
156752253|NCT00412932|565844149|FG000|Olmesartan (Olm) 20 mg|Other|1|||
156752254|NCT00412932|565844149|FG000|Olmesartan 40 mg|Adverse Event|4|||
156752255|NCT00412932|565844149|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
156752256|NCT00412932|565844149|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
156752257|NCT00412932|565844149|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
156752258|NCT00412932|565844149|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
156995615|NCT04927975|566737542|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
156995616|NCT04927975|566737543|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
156752259|NCT00412932|565844149|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
156752260|NCT00412932|565844149|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
156752261|NCT00667563|565844150|FG000|Overall Study|Protocol Violation|24|||
156752262|NCT02384538|565844167|FG000|Overall Study|Adverse Event|1|||
156752263|NCT02384538|565844168|FG001|Overall Study|Adverse Event|4|||
156752264|NCT02384538|565844167|FG000|Overall Study|Lack of Efficacy|4|||
156995617|NCT04927975|566737544|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
156995618|NCT04927975|566737539|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156995619|NCT04927975|566737540|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156995620|NCT04927975|566737541|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156995621|NCT04927975|566737542|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
156995622|NCT04927975|566737543|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
156995623|NCT04927975|566737544|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
156995624|NCT04927975|566737539|FG000|Period 1 (Baseline-Week 24)|Death|0|||
156995625|NCT04927975|566737540|FG001|Period 1 (Baseline-Week 24)|Death|0|||
156995626|NCT04927975|566737541|FG002|Period 1 (Baseline-Week 24)|Death|0|||
156995627|NCT04927975|566737542|FG003|Period 1 (Baseline-Week 24)|Death|0|||
156995628|NCT04927975|566737543|FG004|Period 1 (Baseline-Week 24)|Death|0|||
156995629|NCT04927975|566737544|FG005|Period 1 (Baseline-Week 24)|Death|1|||
156995630|NCT04927975|566737539|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
156995631|NCT04927975|566737540|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
156995632|NCT04927975|566737541|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
156995633|NCT04927975|566737542|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
156995634|NCT04927975|566737543|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
156995635|NCT04927975|566737544|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
156995636|NCT04927975|566737539|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
156995637|NCT04927975|566737540|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156995638|NCT04927975|566737541|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156995639|NCT04927975|566737542|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
156995640|NCT04927975|566737543|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156995641|NCT04927975|566737544|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
156995642|NCT03781804|566737546|FG000|Overall Study|Adverse Event|2|||
156995643|NCT03781804|566737547|FG001|Overall Study|Adverse Event|2|||
156995644|NCT03781804|566737548|FG002|Overall Study|Adverse Event|3|||
156995645|NCT03781804|566737546|FG000|Overall Study|Lost to Follow-up|1|||
156995646|NCT03781804|566737547|FG001|Overall Study|Lost to Follow-up|1|||
156995647|NCT03781804|566737548|FG002|Overall Study|Lost to Follow-up|2|||
156995648|NCT03781804|566737546|FG000|Overall Study|Lack of Efficacy|4|||
156995649|NCT03781804|566737547|FG001|Overall Study|Lack of Efficacy|2|||
156995650|NCT03781804|566737548|FG002|Overall Study|Lack of Efficacy|9|||
156995651|NCT03781804|566737546|FG000|Overall Study|Protocol Violation|0|||
156995652|NCT03781804|566737547|FG001|Overall Study|Protocol Violation|0|||
156995653|NCT03781804|566737548|FG002|Overall Study|Protocol Violation|1|||
156995654|NCT03781804|566737546|FG000|Overall Study|Withdrawal by Subject|0|||
156995655|NCT03781804|566737547|FG001|Overall Study|Withdrawal by Subject|1|||
156995656|NCT03781804|566737548|FG002|Overall Study|Withdrawal by Subject|1|||
156752265|NCT02384538|565844168|FG001|Overall Study|Lack of Efficacy|4|||
156752266|NCT02384538|565844167|FG000|Overall Study|Withdrew Consent|0|||
156995657|NCT03781804|566737546|FG000|Overall Study|Reason not provided|2|||
156995658|NCT03781804|566737547|FG001|Overall Study|Reason not provided|2|||
156995659|NCT03781804|566737548|FG002|Overall Study|Reason not provided|0|||
156995660|NCT00768066|566737549|FG000|Overall Study|Did not receive study product injection.|3|||
156752267|NCT02384538|565844168|FG001|Overall Study|Withdrew Consent|4|||
156752268|NCT02384538|565844167|FG000|Overall Study|Other|1|||
156752269|NCT02384538|565844168|FG001|Overall Study|Other|3|||
156752270|NCT01763203|565844173|FG000|Overall Study|Death|4|||
156752271|NCT01763203|565844174|FG001|Overall Study|Death|7|||
156752272|NCT01763203|565844173|FG000|Overall Study|Lost to Follow-up|12|||
156752273|NCT01763203|565844174|FG001|Overall Study|Lost to Follow-up|12|||
156752274|NCT01763203|565844173|FG000|Overall Study|Withdrawal by Subject|8|||
156752275|NCT01763203|565844174|FG001|Overall Study|Withdrawal by Subject|12|||
156752276|NCT01763203|565844173|FG000|Overall Study|Moved out of study region|7|||
156752277|NCT01763203|565844174|FG001|Overall Study|Moved out of study region|10|||
156752278|NCT01763203|565844173|FG000|Overall Study|Physician Decision|2|||
156752279|NCT01763203|565844174|FG001|Overall Study|Physician Decision|1|||
156752280|NCT02187861|565844175|FG000|Overall Study|Adverse Event|2|||
156752281|NCT02187861|565844176|FG001|Overall Study|Adverse Event|1|||
156752282|NCT02187861|565844177|FG002|Overall Study|Adverse Event|2|||
156752283|NCT02187861|565844178|FG003|Overall Study|Adverse Event|1|||
156752284|NCT02187861|565844175|FG000|Overall Study|Death|0|||
156752285|NCT02187861|565844176|FG001|Overall Study|Death|3|||
156752286|NCT02187861|565844177|FG002|Overall Study|Death|1|||
156752287|NCT02187861|565844178|FG003|Overall Study|Death|2|||
156752288|NCT02187861|565844175|FG000|Overall Study|Physician Decision|0|||
156752289|NCT02187861|565844176|FG001|Overall Study|Physician Decision|1|||
156752290|NCT02187861|565844177|FG002|Overall Study|Physician Decision|0|||
156752291|NCT02187861|565844178|FG003|Overall Study|Physician Decision|3|||
156752292|NCT02187861|565844175|FG000|Overall Study|Progressive Disease|4|||
156752293|NCT02187861|565844176|FG001|Overall Study|Progressive Disease|42|||
156752294|NCT02187861|565844177|FG002|Overall Study|Progressive Disease|19|||
156752295|NCT02187861|565844178|FG003|Overall Study|Progressive Disease|22|||
156752296|NCT02187861|565844175|FG000|Overall Study|Withdrawal by Subject|0|||
156752297|NCT02187861|565844176|FG001|Overall Study|Withdrawal by Subject|0|||
156752298|NCT02187861|565844177|FG002|Overall Study|Withdrawal by Subject|3|||
156752299|NCT02187861|565844178|FG003|Overall Study|Withdrawal by Subject|3|||
156752300|NCT02187861|565844175|FG000|Overall Study|Other|0|||
156752301|NCT02187861|565844176|FG001|Overall Study|Other|1|||
156752302|NCT02187861|565844177|FG002|Overall Study|Other|7|||
156752303|NCT02187861|565844178|FG003|Overall Study|Other|1|||
156752304|NCT02756819|565844179|FG000|Overall Study|Lost for observation|23|||
156752305|NCT02756819|565844179|FG000|Overall Study|Patient's unwillingness|16|||
156752306|NCT02756819|565844179|FG000|Overall Study|Insufficient efficacy|2|||
156752307|NCT02756819|565844179|FG000|Overall Study|Adverse Event|2|||
156752308|NCT02756819|565844179|FG000|Overall Study|Reason not Specified|9|||
156752309|NCT01491841|565844181|FG000|Overall Study|Screen Failure|10|||
156752310|NCT01491841|565844181|FG000|Overall Study|Withdrawal by Subject|1|||
156752311|NCT00741598|565844182|FG000|Overall Study|Lost to Follow-up|3|||
156752312|NCT00741598|565844183|FG001|Overall Study|Lost to Follow-up|4|||
156752313|NCT00741598|565844182|FG000|Overall Study|Lack of Efficacy|1|||
156752314|NCT00741598|565844183|FG001|Overall Study|Lack of Efficacy|2|||
156752315|NCT00741598|565844182|FG000|Overall Study|Physician Decision|1|||
156752316|NCT00741598|565844183|FG001|Overall Study|Physician Decision|1|||
156752317|NCT00741598|565844182|FG000|Overall Study|Pregnancy|1|||
156752318|NCT00741598|565844183|FG001|Overall Study|Pregnancy|0|||
156752319|NCT00741598|565844182|FG000|Overall Study|Withdrawal by Subject|3|||
156995661|NCT00768066|566737550|FG001|Overall Study|Did not receive study product injection.|3|||
156995662|NCT00768066|566737551|FG002|Overall Study|Did not receive study product injection.|0|||
156995663|NCT00429793|566737557|FG000|Overall Study|Improper pre-protocol treatment|3|||
156995664|NCT00429793|566737557|FG000|Overall Study|Required test not done|1|||
156995665|NCT00429793|566737557|FG000|Overall Study|Never treated|1|||
156995666|NCT00429793|566737557|FG000|Overall Study|Non-measurable|1|||
156995667|NCT03677375|566737559|FG000|Overall Study|Incomplete procedure|8|||
156995668|NCT03677375|566737559|FG000|Overall Study|Adverse Event|3|||
156995669|NCT03677375|566737559|FG000|Overall Study|Physician Decision|1|||
156995670|NCT00725010|566737560|FG000|Overall Study|Toxicity|9|||
156995671|NCT00725010|566737560|FG000|Overall Study|Tumor Progression|7|||
156995672|NCT00725010|566737560|FG000|Overall Study|Withdrawal by Subject|2|||
156995673|NCT00725010|566737560|FG000|Overall Study|Death|1|||
156995674|NCT00725010|566737560|FG000|Overall Study|Lost to Follow-up|1|||
156995675|NCT00725010|566737560|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
156995676|NCT00725010|566737560|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
156995677|NCT00725010|566737560|FG000|Overall Study|No further documentation|1|||
156995678|NCT00725010|566737560|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
156995679|NCT00445692|566737561|FG000|Overall Study|Adverse Event|11|||
156995680|NCT00445692|566737561|FG000|Overall Study|Lack of Efficacy|5|||
156995681|NCT01143077|566737565|FG000|Overall Study|Lack of Efficacy|0|||
156995682|NCT01143077|566737566|FG001|Overall Study|Lack of Efficacy|2|||
156995683|NCT01143077|566737567|FG002|Overall Study|Lack of Efficacy|1|||
156752320|NCT00741598|565844183|FG001|Overall Study|Withdrawal by Subject|2|||
156752321|NCT01951573|565844188|FG000|Washout Period|Adverse Event|0|||
156752322|NCT01951573|565844189|FG001|Washout Period|Adverse Event|1|||
156995684|NCT01143077|566737565|FG000|Overall Study|Adverse Event|5|||
156752323|NCT04217317|565844192|FG000|Overall Study|Lack of Efficacy|4|||
156752324|NCT04217317|565844192|FG000|Overall Study|Physician Decision|1|||
156752325|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
156752326|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
156752327|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
156752328|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
156752329|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
156752330|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
156752331|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
156752332|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
156752333|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
156752334|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
156752335|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
156752336|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
156752337|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
156752338|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
156752339|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
156752340|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
156752341|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752342|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
156752343|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752344|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
156752345|NCT02087943|565844193|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752346|NCT02087943|565844194|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
156752347|NCT02087943|565844195|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752348|NCT02087943|565844196|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752349|NCT02087943|565844197|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
156752350|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
156752351|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
156752352|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
156752353|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
156752354|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
156752355|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
156752356|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
156752357|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
156752358|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
156752359|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
156752360|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752361|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752362|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
156752363|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752364|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
156752365|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752366|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752367|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752368|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
156752369|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
156752370|NCT02087943|565844193|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156752371|NCT02087943|565844194|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156995685|NCT01143077|566737566|FG001|Overall Study|Adverse Event|6|||
156995686|NCT01143077|566737567|FG002|Overall Study|Adverse Event|5|||
156995687|NCT01143077|566737565|FG000|Overall Study|Lost to Follow-up|2|||
156995688|NCT01143077|566737566|FG001|Overall Study|Lost to Follow-up|3|||
156995689|NCT01143077|566737567|FG002|Overall Study|Lost to Follow-up|4|||
156995690|NCT01143077|566737565|FG000|Overall Study|Protocol Violation|2|||
156995691|NCT01143077|566737566|FG001|Overall Study|Protocol Violation|0|||
156995692|NCT01143077|566737567|FG002|Overall Study|Protocol Violation|0|||
156995693|NCT01143077|566737565|FG000|Overall Study|Withdrawal by Subject|4|||
156995694|NCT01143077|566737566|FG001|Overall Study|Withdrawal by Subject|3|||
156995695|NCT01143077|566737567|FG002|Overall Study|Withdrawal by Subject|3|||
156995696|NCT01143077|566737565|FG000|Overall Study|Non-compliance with study drug|0|||
156995697|NCT01143077|566737566|FG001|Overall Study|Non-compliance with study drug|1|||
156995698|NCT01143077|566737567|FG002|Overall Study|Non-compliance with study drug|1|||
156995699|NCT01143077|566737565|FG000|Overall Study|Administrative|1|||
156995700|NCT01143077|566737566|FG001|Overall Study|Administrative|0|||
156995701|NCT01143077|566737567|FG002|Overall Study|Administrative|0|||
156995702|NCT01143077|566737565|FG000|Overall Study|Principal Investigator Decision|2|||
156995703|NCT01143077|566737566|FG001|Overall Study|Principal Investigator Decision|0|||
156995704|NCT01143077|566737567|FG002|Overall Study|Principal Investigator Decision|1|||
157099090|NCT03078907|567118197|FG001|Overall Study|Protocol Violation|1|||
156752372|NCT02087943|565844195|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
156752373|NCT02087943|565844196|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
156752374|NCT02087943|565844197|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
156752375|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
156752376|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
156752377|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
156752378|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752379|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752380|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
156752381|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
156752382|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752383|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752384|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752385|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752386|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156752387|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
156752388|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
156752389|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752390|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752391|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752392|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156752393|NCT01690299|565844198|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
156752394|NCT01690299|565844199|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
156752395|NCT01690299|565844200|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
156752396|NCT01690299|565844201|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752397|NCT01690299|565844202|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752398|NCT01690299|565844203|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
156752399|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752400|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752401|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
156752402|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
156752403|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
156752404|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
156752405|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752406|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752407|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
156752408|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
156752409|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
156752410|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
156752411|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752412|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752413|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752414|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
156752415|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
156752416|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
156752417|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752418|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752419|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
156752420|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
156752421|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
156752422|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
156752423|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752424|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752425|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
156752426|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
156752427|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
156752428|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
156752429|NCT01690299|565844198|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752430|NCT01690299|565844199|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752431|NCT01690299|565844200|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752432|NCT01690299|565844201|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
157099091|NCT01955122|567118198|FG000|Overall Study|Physician Decision|5|||
156752433|NCT01690299|565844202|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
156752434|NCT01690299|565844203|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
156752435|NCT03836209|565844204|FG000|Overall Study|Adverse Event|5|||
156752436|NCT03836209|565844205|FG001|Overall Study|Adverse Event|2|||
156752437|NCT03836209|565844204|FG000|Overall Study|Death|4|||
156752438|NCT03836209|565844205|FG001|Overall Study|Death|1|||
156752439|NCT03836209|565844204|FG000|Overall Study|Lack of Efficacy|7|||
156752440|NCT03836209|565844205|FG001|Overall Study|Lack of Efficacy|10|||
156752441|NCT03836209|565844204|FG000|Overall Study|Physician Decision|7|||
156752442|NCT03836209|565844205|FG001|Overall Study|Physician Decision|11|||
156752443|NCT03836209|565844204|FG000|Overall Study|Protocol Violation|0|||
156752444|NCT03836209|565844205|FG001|Overall Study|Protocol Violation|3|||
156752445|NCT03836209|565844204|FG000|Overall Study|Withdrawal by Subject|2|||
156752446|NCT03836209|565844205|FG001|Overall Study|Withdrawal by Subject|10|||
156752447|NCT03836209|565844204|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
156752448|NCT03836209|565844205|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
156752449|NCT03739710|565844206|FG000|Overall Study|Screen Failed|81|||
156752450|NCT01753115|565844207|FG000|Overall Study|Lost to Follow-up|3|||
156752451|NCT01753115|565844208|FG001|Overall Study|Lost to Follow-up|6|||
156752452|NCT01753115|565844209|FG002|Overall Study|Lost to Follow-up|8|||
156752453|NCT01753115|565844207|FG000|Overall Study|Withdrawal by Subject|6|||
156752454|NCT01753115|565844208|FG001|Overall Study|Withdrawal by Subject|5|||
156752455|NCT01753115|565844209|FG002|Overall Study|Withdrawal by Subject|6|||
156752456|NCT01753115|565844207|FG000|Overall Study|Subject non-compliant|3|||
156752457|NCT01753115|565844208|FG001|Overall Study|Subject non-compliant|3|||
156752458|NCT01753115|565844209|FG002|Overall Study|Subject non-compliant|0|||
156752459|NCT01753115|565844207|FG000|Overall Study|Used excluded drug|0|||
156752460|NCT01753115|565844208|FG001|Overall Study|Used excluded drug|1|||
156752461|NCT01753115|565844209|FG002|Overall Study|Used excluded drug|0|||
156752462|NCT04313400|565844213|FG000|Overall Study|Withdrawal by Subject|0|||
156752463|NCT04313400|565844214|FG001|Overall Study|Withdrawal by Subject|0|||
156752464|NCT04313400|565844215|FG002|Overall Study|Withdrawal by Subject|0|||
156752465|NCT04313400|565844216|FG003|Overall Study|Withdrawal by Subject|0|||
156752466|NCT04313400|565844217|FG004|Overall Study|Withdrawal by Subject|0|||
156752467|NCT04313400|565844218|FG005|Overall Study|Withdrawal by Subject|4|||
156752468|NCT04313400|565844219|FG006|Overall Study|Withdrawal by Subject|1|||
156752469|NCT04313400|565844213|FG000|Overall Study|Adverse Event|0|||
156752470|NCT04313400|565844214|FG001|Overall Study|Adverse Event|0|||
156752471|NCT04313400|565844215|FG002|Overall Study|Adverse Event|0|||
156752472|NCT04313400|565844216|FG003|Overall Study|Adverse Event|0|||
156752473|NCT04313400|565844217|FG004|Overall Study|Adverse Event|0|||
156752474|NCT04313400|565844218|FG005|Overall Study|Adverse Event|1|||
156995705|NCT00630864|566737571|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
156995706|NCT00630864|566737571|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
156995707|NCT00430677|566737572|FG000|Short-term Period|Death|1|||
156995708|NCT00430677|566737573|FG001|Short-term Period|Death|1|||
156995709|NCT00430677|566737574|FG002|Short-term Period|Death|5|||
156995710|NCT00430677|566737572|FG000|Short-term Period|Adverse Event|15|||
156995711|NCT00430677|566737573|FG001|Short-term Period|Adverse Event|13|||
156995712|NCT00430677|566737574|FG002|Short-term Period|Adverse Event|9|||
156995713|NCT00430677|566737572|FG000|Short-term Period|Lack of Efficacy|5|||
156995714|NCT00430677|566737573|FG001|Short-term Period|Lack of Efficacy|6|||
156995715|NCT00430677|566737574|FG002|Short-term Period|Lack of Efficacy|4|||
156995716|NCT00430677|566737572|FG000|Short-term Period|Withdrawal by Subject|1|||
156995717|NCT00430677|566737573|FG001|Short-term Period|Withdrawal by Subject|1|||
156995718|NCT00430677|566737574|FG002|Short-term Period|Withdrawal by Subject|2|||
156995719|NCT00430677|566737572|FG000|Short-term Period|Participant no longer met study criteria|1|||
156995720|NCT00430677|566737573|FG001|Short-term Period|Participant no longer met study criteria|1|||
156995721|NCT00430677|566737574|FG002|Short-term Period|Participant no longer met study criteria|2|||
156752475|NCT04313400|565844219|FG006|Overall Study|Adverse Event|0|||
156752476|NCT04313400|565844213|FG000|Overall Study|Lost to Follow-up|0|||
156752477|NCT04313400|565844214|FG001|Overall Study|Lost to Follow-up|0|||
156752478|NCT04313400|565844215|FG002|Overall Study|Lost to Follow-up|0|||
156995722|NCT00430677|566737572|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
156995723|NCT00430677|566737573|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
156995724|NCT00430677|566737574|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
156995725|NCT00430677|566737572|FG000|Short-term Period|Pregnancy|0|||
156995726|NCT00430677|566737573|FG001|Short-term Period|Pregnancy|2|||
156995727|NCT00430677|566737574|FG002|Short-term Period|Pregnancy|0|||
156995728|NCT00430677|566737572|FG000|Long-term Extension Period|Death|1|||
156752479|NCT04313400|565844216|FG003|Overall Study|Lost to Follow-up|0|||
156752480|NCT04313400|565844217|FG004|Overall Study|Lost to Follow-up|0|||
156752481|NCT04313400|565844218|FG005|Overall Study|Lost to Follow-up|1|||
156995729|NCT00430677|566737573|FG001|Long-term Extension Period|Death|0|||
156995730|NCT00430677|566737574|FG002|Long-term Extension Period|Death|0|||
156995731|NCT00430677|566737572|FG000|Long-term Extension Period|Adverse Event|3|||
156752482|NCT04313400|565844219|FG006|Overall Study|Lost to Follow-up|0|||
156752483|NCT01882803|565844224|FG000|Overall Study|Disease Progression|1|||
157099092|NCT01955122|567118199|FG001|Overall Study|Physician Decision|5|||
157099093|NCT01672788|567118200|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
157099094|NCT01672788|567118201|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
157099095|NCT01672788|567118202|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
157099096|NCT01672788|567118203|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
157099097|NCT03329196|567118206|FG000|Overall Study|Adverse Event|10|||
157099098|NCT03329196|567118207|FG001|Overall Study|Adverse Event|5|||
157099099|NCT03329196|567118206|FG000|Overall Study|Physician Decision|2|||
157099100|NCT03329196|567118207|FG001|Overall Study|Physician Decision|2|||
157099101|NCT03329196|567118206|FG000|Overall Study|Withdrawal by Subject|11|||
157099102|NCT03329196|567118207|FG001|Overall Study|Withdrawal by Subject|3|||
157099103|NCT03329196|567118206|FG000|Overall Study|Hepatic function abnormalities|0|||
157099104|NCT03329196|567118207|FG001|Overall Study|Hepatic function abnormalities|1|||
157099105|NCT03329196|567118206|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
157099106|NCT03329196|567118207|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
157099107|NCT03329196|567118206|FG000|Overall Study|Difficult to control Hb|2|||
157099108|NCT03329196|567118207|FG001|Overall Study|Difficult to control Hb|3|||
157099109|NCT03329196|567118206|FG000|Overall Study|Dialysis or renal transplant|13|||
157099110|NCT03329196|567118207|FG001|Overall Study|Dialysis or renal transplant|15|||
156752484|NCT01882803|565844224|FG000|Overall Study|Withdrawal by Subject|9|||
156752485|NCT01882803|565844224|FG000|Overall Study|Death|68|||
156752486|NCT01882803|565844224|FG000|Overall Study|Physician Decision|3|||
156752487|NCT01882803|565844224|FG000|Overall Study|Lost to Follow-up|3|||
156752488|NCT01882803|565844224|FG000|Overall Study|Follow-up Completed|39|||
156752489|NCT01882803|565844224|FG000|Overall Study|Study Terminated by the Sponsor|6|||
156752490|NCT02869893|565844225|FG000|Overall Study|participant aversion to IV|5|||
156752491|NCT02869893|565844225|FG000|Overall Study|participant fear of MRI scanner|2|||
156752492|NCT01563913|565844226|FG000|Overall Study|Physician Decision|1|||
156752493|NCT01563913|565844227|FG001|Overall Study|Physician Decision|0|||
156752494|NCT01563913|565844226|FG000|Overall Study|Spouse Passed Away|1|||
156752495|NCT01563913|565844227|FG001|Overall Study|Spouse Passed Away|0|||
156752496|NCT03066778|565844228|FG000|Overall Study|Death|195|||
156752497|NCT03066778|565844229|FG001|Overall Study|Death|205|||
156752498|NCT03066778|565844228|FG000|Overall Study|Withdrawal by Subject|5|||
156752499|NCT03066778|565844229|FG001|Overall Study|Withdrawal by Subject|7|||
156752500|NCT00329745|565844230|FG000|Overall Study|Protocol Violation|1|||
156752501|NCT00329745|565844231|FG001|Overall Study|Protocol Violation|0|||
156752502|NCT00329745|565844230|FG000|Overall Study|Withdrawal by Subject|0|||
156752503|NCT00329745|565844231|FG001|Overall Study|Withdrawal by Subject|1|||
156752504|NCT00329745|565844230|FG000|Overall Study|Lost to Follow-up|86|||
156752505|NCT00329745|565844231|FG001|Overall Study|Lost to Follow-up|101|||
156752506|NCT03146741|565844232|FG000|Overall Study|Txp with non-HCV+ heart|4|||
156752507|NCT03146741|565844232|FG000|Overall Study|Listeted for MOT|2|||
156752508|NCT03146741|565844232|FG000|Overall Study|Physician Decision|2|||
156752509|NCT03146741|565844232|FG000|Overall Study|Awaiting txp|2|||
156752510|NCT03224624|565844233|FG000|Overall Study|Lost to Follow-up|9|||
156752511|NCT03224624|565844234|FG001|Overall Study|Lost to Follow-up|4|||
156752512|NCT03224624|565844233|FG000|Overall Study|Death|1|||
156752513|NCT03224624|565844234|FG001|Overall Study|Death|0|||
156752514|NCT05980013|565845745|FG000|Overall Study|Withdrawal by Subject|0|||
156752515|NCT05980013|565845746|FG001|Overall Study|Withdrawal by Subject|1|||
156752516|NCT05980013|565845745|FG000|Overall Study|Device Error|0|||
156995732|NCT00430677|566737573|FG001|Long-term Extension Period|Adverse Event|2|||
156995733|NCT00430677|566737574|FG002|Long-term Extension Period|Adverse Event|5|||
156752517|NCT05980013|565845746|FG001|Overall Study|Device Error|1|||
156752518|NCT02091414|565845753|FG000|Overall Study|Withdrawal by Subject|2|||
156995734|NCT00430677|566737572|FG000|Long-term Extension Period|Lack of Efficacy|5|||
156752519|NCT02091414|565845753|FG000|Overall Study|Death|2|||
156995735|NCT00430677|566737573|FG001|Long-term Extension Period|Lack of Efficacy|3|||
156995736|NCT00430677|566737574|FG002|Long-term Extension Period|Lack of Efficacy|8|||
156995737|NCT00430677|566737572|FG000|Long-term Extension Period|Lost to Follow-up|1|||
156995738|NCT00430677|566737573|FG001|Long-term Extension Period|Lost to Follow-up|1|||
156995739|NCT00430677|566737574|FG002|Long-term Extension Period|Lost to Follow-up|1|||
156995740|NCT00430677|566737572|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
156995741|NCT00430677|566737573|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
156995742|NCT00430677|566737574|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
156995743|NCT00430677|566737572|FG000|Long-term Extension Period|Pregnancy|1|||
156995744|NCT00430677|566737573|FG001|Long-term Extension Period|Pregnancy|1|||
156995745|NCT00430677|566737574|FG002|Long-term Extension Period|Pregnancy|0|||
156995746|NCT00430677|566737572|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
156995747|NCT00430677|566737573|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
156995748|NCT00430677|566737574|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
156995749|NCT00430677|566737572|FG000|Long-term Extension Period|Other|2|||
156995750|NCT00430677|566737573|FG001|Long-term Extension Period|Other|1|||
156995751|NCT00430677|566737574|FG002|Long-term Extension Period|Other|1|||
156995752|NCT00430677|566737572|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
156995753|NCT00430677|566737573|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
156995754|NCT00430677|566737574|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
156995755|NCT01555762|566737577|FG000|Overall Study|No information on Bevacizumab intake|11|||
156995756|NCT01555762|566737577|FG000|Overall Study|Missing start date of infusion|8|||
156995757|NCT01555762|566737577|FG000|Overall Study|75 years old or more ticked No|1|||
156995758|NCT01555762|566737577|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
156995759|NCT01555762|566737577|FG000|Overall Study|Death linked to progression of disease|165|||
156995760|NCT01555762|566737577|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
156995761|NCT01555762|566737577|FG000|Overall Study|Investigator's decision|10|||
156995762|NCT01555762|566737577|FG000|Overall Study|Participant not wishing to continue|5|||
156995763|NCT01555762|566737577|FG000|Overall Study|Missing data|1|||
156752520|NCT04676724|565845758|FG000|Overall Study|Adverse Event|2|||
156752521|NCT04676724|565845759|FG001|Overall Study|Adverse Event|0|||
156995764|NCT01555762|566737577|FG000|Overall Study|Death linked to an adverse event|14|||
156995765|NCT00819910|566737578|FG000|Overall Study|Adverse Event|0|||
156752522|NCT04676724|565845758|FG000|Overall Study|Lost to Follow-up|1|||
156752523|NCT04676724|565845759|FG001|Overall Study|Lost to Follow-up|0|||
156752524|NCT04676724|565845758|FG000|Overall Study|Physician Decision|0|||
156752525|NCT04676724|565845759|FG001|Overall Study|Physician Decision|1|||
156752526|NCT04676724|565845758|FG000|Overall Study|Withdrawal by Subject|3|||
156752527|NCT04676724|565845759|FG001|Overall Study|Withdrawal by Subject|2|||
156752528|NCT02782377|565845762|FG000|Overall Study|Physician Decision|5|||
156752529|NCT00398047|565845766|FG000|Overall Study|all patient progressed before completion|3|||
156995766|NCT00819910|566737579|FG001|Overall Study|Adverse Event|0|||
156995767|NCT00819910|566737580|FG002|Overall Study|Adverse Event|2|||
156995768|NCT00819910|566737581|FG003|Overall Study|Adverse Event|1|||
156995769|NCT00819910|566737578|FG000|Overall Study|Withdrawal by Subject|1|||
156995770|NCT00819910|566737579|FG001|Overall Study|Withdrawal by Subject|1|||
156995771|NCT00819910|566737580|FG002|Overall Study|Withdrawal by Subject|1|||
156995772|NCT00819910|566737581|FG003|Overall Study|Withdrawal by Subject|0|||
156995773|NCT00819910|566737578|FG000|Overall Study|Lost to Follow-up|1|||
156995774|NCT00819910|566737579|FG001|Overall Study|Lost to Follow-up|0|||
156995775|NCT00819910|566737580|FG002|Overall Study|Lost to Follow-up|0|||
156995776|NCT00819910|566737581|FG003|Overall Study|Lost to Follow-up|0|||
156995777|NCT00836810|566737584|FG000|Overall Study|New diagnosis|1|||
156995778|NCT00836810|566737585|FG001|Overall Study|New diagnosis|0|||
156995779|NCT00389519|566737587|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
156995780|NCT00389519|566737588|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
156995781|NCT00389519|566737589|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
156995782|NCT00389519|566737590|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
156995783|NCT00389519|566737587|FG000|Placebo Run-In|Withdrawal by Subject|19|||
156995784|NCT00389519|566737588|FG001|Placebo Run-In|Withdrawal by Subject|0|||
156995785|NCT00389519|566737589|FG002|Placebo Run-In|Withdrawal by Subject|0|||
156995786|NCT00389519|566737590|FG003|Placebo Run-In|Withdrawal by Subject|0|||
156995787|NCT00389519|566737587|FG000|Placebo Run-In|Reason not specified|40|||
156995788|NCT00389519|566737588|FG001|Placebo Run-In|Reason not specified|0|||
156995789|NCT00389519|566737589|FG002|Placebo Run-In|Reason not specified|0|||
156995790|NCT00389519|566737590|FG003|Placebo Run-In|Reason not specified|0|||
156995791|NCT00389519|566737587|FG000|Randomized|Did not receive study drug|2|||
156995792|NCT00389519|566737588|FG001|Randomized|Did not receive study drug|0|||
156995793|NCT00389519|566737589|FG002|Randomized|Did not receive study drug|0|||
156995794|NCT00389519|566737590|FG003|Randomized|Did not receive study drug|0|||
156995795|NCT00389519|566737587|FG000|Treated|Adverse Event|1|||
156995796|NCT00389519|566737588|FG001|Treated|Adverse Event|0|||
156995797|NCT00389519|566737589|FG002|Treated|Adverse Event|0|||
156995798|NCT00389519|566737590|FG003|Treated|Adverse Event|2|||
156995799|NCT00389519|566737587|FG000|Treated|Reason not specified|1|||
156995800|NCT00389519|566737588|FG001|Treated|Reason not specified|1|||
156995801|NCT00389519|566737589|FG002|Treated|Reason not specified|0|||
156995802|NCT00389519|566737590|FG003|Treated|Reason not specified|2|||
156995803|NCT03425539|566737593|FG000|Overall Study|Randomized but not treated|0|||
156995804|NCT03425539|566737594|FG001|Overall Study|Randomized but not treated|1|||
156995805|NCT03425539|566737593|FG000|Overall Study|Adverse Event|2|||
156995806|NCT03425539|566737594|FG001|Overall Study|Adverse Event|2|||
156995807|NCT03425539|566737593|FG000|Overall Study|Withdrawal by Subject|3|||
156995808|NCT03425539|566737594|FG001|Overall Study|Withdrawal by Subject|0|||
156995809|NCT03425539|566737593|FG000|Overall Study|Lost to Follow-up|0|||
156995810|NCT03425539|566737594|FG001|Overall Study|Lost to Follow-up|1|||
156995811|NCT01772719|566737595|FG000|Overall Study|Withdrawal by Subject|3|||
156995812|NCT01772719|566737595|FG000|Overall Study|Adverse Event|2|||
156995813|NCT01772719|566737595|FG000|Overall Study|Protocol Violation|1|||
156995814|NCT01772719|566737595|FG000|Overall Study|Lost to Follow-up|1|||
156995815|NCT02040844|566737600|FG000|Overall Study|Adverse Event|0|||
156995816|NCT02040844|566737601|FG001|Overall Study|Adverse Event|0|||
156995817|NCT02040844|566737602|FG002|Overall Study|Adverse Event|1|||
156995818|NCT02040844|566737600|FG000|Overall Study|Withdrawal by Subject|16|||
156995819|NCT02040844|566737601|FG001|Overall Study|Withdrawal by Subject|22|||
156995820|NCT02040844|566737602|FG002|Overall Study|Withdrawal by Subject|25|||
156995821|NCT02040844|566737600|FG000|Overall Study|Lost to Follow-up|12|||
156995822|NCT02040844|566737601|FG001|Overall Study|Lost to Follow-up|9|||
156995823|NCT02040844|566737602|FG002|Overall Study|Lost to Follow-up|13|||
156995824|NCT02040844|566737600|FG000|Overall Study|Missing|13|||
156995825|NCT02040844|566737601|FG001|Overall Study|Missing|3|||
156995826|NCT02040844|566737602|FG002|Overall Study|Missing|2|||
156752530|NCT02521792|565845767|FG000|Overall Study|Study Terminated|6|||
156995827|NCT02040844|566737600|FG000|Overall Study|Non-specified|8|||
156995828|NCT02040844|566737601|FG001|Overall Study|Non-specified|2|||
156995829|NCT02040844|566737602|FG002|Overall Study|Non-specified|5|||
156995830|NCT02040844|566737600|FG000|Overall Study|Concomitant medication|1|||
156995831|NCT02040844|566737601|FG001|Overall Study|Concomitant medication|3|||
156995832|NCT02040844|566737602|FG002|Overall Study|Concomitant medication|1|||
156995833|NCT00946192|566737603|FG000|Overall Study|Lost to Follow-up|6|||
156995834|NCT00946192|566737604|FG001|Overall Study|Lost to Follow-up|11|||
156995835|NCT00946192|566737605|FG002|Overall Study|Lost to Follow-up|9|||
156995836|NCT00946192|566737603|FG000|Overall Study|Withdrawal by Subject|10|||
156995837|NCT00946192|566737604|FG001|Overall Study|Withdrawal by Subject|7|||
156752531|NCT01188668|565845768|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
156752532|NCT01188668|565845768|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
156752533|NCT01188668|565845768|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
156752534|NCT00902746|565845769|FG000|Overall Study|Protocol Violation|7|||
156752535|NCT00902746|565845769|FG000|Overall Study|Withdrawal by Subject|16|||
156752536|NCT00902746|565845769|FG000|Overall Study|Adverse Event|8|||
156752537|NCT00902746|565845769|FG000|Overall Study|Lost to Follow-up|3|||
156752538|NCT00902746|565845769|FG000|Overall Study|Physician Decision|2|||
156752539|NCT02081001|565845771|FG000|Overall Study|Adverse Event|0|||
156752540|NCT02081001|565845772|FG001|Overall Study|Adverse Event|0|||
156752541|NCT02081001|565845773|FG002|Overall Study|Adverse Event|0|||
156752542|NCT02081001|565845774|FG003|Overall Study|Adverse Event|0|||
156752543|NCT02081001|565845775|FG004|Overall Study|Adverse Event|1|||
156752544|NCT02081001|565845776|FG005|Overall Study|Adverse Event|0|||
156752545|NCT02081001|565845777|FG006|Overall Study|Adverse Event|0|||
156752546|NCT02081001|565845778|FG007|Overall Study|Adverse Event|0|||
156752547|NCT02081001|565845779|FG008|Overall Study|Adverse Event|0|||
156752548|NCT02081001|565845780|FG009|Overall Study|Adverse Event|0|||
156752549|NCT02081001|565845781|FG010|Overall Study|Adverse Event|0|||
156752550|NCT02081001|565845782|FG011|Overall Study|Adverse Event|0|||
156752551|NCT00359294|565845783|FG000|Overall Study|Progressive disease|1|||
156752552|NCT00359294|565845784|FG001|Overall Study|Progressive disease|1|||
156752553|NCT00359294|565845785|FG002|Overall Study|Progressive disease|2|||
156752554|NCT00359294|565845786|FG003|Overall Study|Progressive disease|3|||
156752555|NCT00359294|565845787|FG004|Overall Study|Progressive disease|2|||
156752556|NCT00359294|565845783|FG000|Overall Study|Withdrawal by Subject|0|||
156752557|NCT00359294|565845784|FG001|Overall Study|Withdrawal by Subject|0|||
156752558|NCT00359294|565845785|FG002|Overall Study|Withdrawal by Subject|0|||
156752559|NCT00359294|565845786|FG003|Overall Study|Withdrawal by Subject|0|||
156752560|NCT00359294|565845787|FG004|Overall Study|Withdrawal by Subject|1|||
156752561|NCT00359294|565845783|FG000|Overall Study|Not treated|0|||
156752562|NCT00359294|565845784|FG001|Overall Study|Not treated|0|||
156752563|NCT00359294|565845785|FG002|Overall Study|Not treated|0|||
156752564|NCT00359294|565845786|FG003|Overall Study|Not treated|1|||
156752565|NCT00359294|565845787|FG004|Overall Study|Not treated|0|||
156752566|NCT00359294|565845783|FG000|Overall Study|Physician Decision|0|||
156752567|NCT00359294|565845784|FG001|Overall Study|Physician Decision|0|||
156752568|NCT00359294|565845785|FG002|Overall Study|Physician Decision|1|||
156752569|NCT00359294|565845786|FG003|Overall Study|Physician Decision|0|||
156752570|NCT00359294|565845787|FG004|Overall Study|Physician Decision|0|||
156995838|NCT00946192|566737605|FG002|Overall Study|Withdrawal by Subject|3|||
156995839|NCT00946192|566737603|FG000|Overall Study|Did not start medication|2|||
156995840|NCT00946192|566737604|FG001|Overall Study|Did not start medication|0|||
156995841|NCT00946192|566737605|FG002|Overall Study|Did not start medication|0|||
156995842|NCT02014558|566737606|FG000|Overall Study|Never Received Study Drug|0|||
156995843|NCT02014558|566737607|FG001|Overall Study|Never Received Study Drug|0|||
156995844|NCT02014558|566737608|FG002|Overall Study|Never Received Study Drug|0|||
156995845|NCT02014558|566737609|FG003|Overall Study|Never Received Study Drug|0|||
156995846|NCT02014558|566737610|FG004|Overall Study|Never Received Study Drug|1|||
156995847|NCT02014558|566737611|FG005|Overall Study|Never Received Study Drug|0|||
156995848|NCT02014558|566737612|FG006|Overall Study|Never Received Study Drug|1|||
156995849|NCT02014558|566737613|FG007|Overall Study|Never Received Study Drug|0|||
156995850|NCT02014558|566737614|FG008|Overall Study|Never Received Study Drug|2|||
156995851|NCT02014558|566737615|FG009|Overall Study|Never Received Study Drug|0|||
156995852|NCT02014558|566737616|FG010|Overall Study|Never Received Study Drug|2|||
156995853|NCT02014558|566737617|FG011|Overall Study|Never Received Study Drug|2|||
156995854|NCT02014558|566737618|FG012|Overall Study|Never Received Study Drug|0|||
156995855|NCT02014558|566737606|FG000|Overall Study|Adverse Event|0|||
156995856|NCT02014558|566737607|FG001|Overall Study|Adverse Event|0|||
156995857|NCT02014558|566737608|FG002|Overall Study|Adverse Event|0|||
156995858|NCT02014558|566737609|FG003|Overall Study|Adverse Event|0|||
156995859|NCT02014558|566737610|FG004|Overall Study|Adverse Event|1|||
156995860|NCT02014558|566737611|FG005|Overall Study|Adverse Event|0|||
156995861|NCT02014558|566737612|FG006|Overall Study|Adverse Event|0|||
156995862|NCT02014558|566737613|FG007|Overall Study|Adverse Event|0|||
156995863|NCT02014558|566737614|FG008|Overall Study|Adverse Event|2|||
156995864|NCT02014558|566737615|FG009|Overall Study|Adverse Event|2|||
156752571|NCT04208412|565845794|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
156752572|NCT04208412|565845795|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
156752573|NCT04208412|565845794|FG000|Overall Study|Withdrawal by Subject|1|||
156752574|NCT04208412|565845795|FG001|Overall Study|Withdrawal by Subject|0|||
156995865|NCT02014558|566737616|FG010|Overall Study|Adverse Event|5|||
156995866|NCT02014558|566737617|FG011|Overall Study|Adverse Event|21|||
156995867|NCT02014558|566737618|FG012|Overall Study|Adverse Event|3|||
156995868|NCT02014558|566737606|FG000|Overall Study|Death|1|||
156995869|NCT02014558|566737607|FG001|Overall Study|Death|0|||
156995870|NCT02014558|566737608|FG002|Overall Study|Death|0|||
156752575|NCT04208412|565845794|FG000|Overall Study|Lost to Follow-up|0|||
156752576|NCT04208412|565845795|FG001|Overall Study|Lost to Follow-up|1|||
156752577|NCT02588092|565845798|FG000|Overall Study|Death|4|||
156752578|NCT02588092|565845799|FG001|Overall Study|Death|3|||
157099111|NCT02464228|567118208|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
157099112|NCT02464228|567118209|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
157099113|NCT02464228|567118210|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
157099114|NCT02464228|567118211|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
157099115|NCT02464228|567118208|FG000|Overall Study|Physician Decision|2|||
157099116|NCT02464228|567118209|FG001|Overall Study|Physician Decision|0|||
157099117|NCT02464228|567118210|FG002|Overall Study|Physician Decision|1|||
157099118|NCT02464228|567118211|FG003|Overall Study|Physician Decision|0|||
157099119|NCT02464228|567118208|FG000|Overall Study|Miscellaneous|1|||
157099120|NCT02464228|567118209|FG001|Overall Study|Miscellaneous|0|||
157099121|NCT02464228|567118210|FG002|Overall Study|Miscellaneous|1|||
156752579|NCT02588092|565845800|FG002|Overall Study|Death|3|||
156752580|NCT02588092|565845801|FG003|Overall Study|Death|3|||
157099122|NCT02464228|567118211|FG003|Overall Study|Miscellaneous|0|||
157099123|NCT02464228|567118208|FG000|Overall Study|Adverse Event|9|||
156752581|NCT02588092|565845802|FG004|Overall Study|Death|2|||
156752582|NCT02588092|565845803|FG005|Overall Study|Death|2|||
156752583|NCT02588092|565845804|FG006|Overall Study|Death|2|||
156752584|NCT02588092|565845805|FG007|Overall Study|Death|1|||
156752585|NCT02588092|565845806|FG008|Overall Study|Death|5|||
156752586|NCT02588092|565845807|FG009|Overall Study|Death|2|||
156752587|NCT02588092|565845798|FG000|Overall Study|Withdrawal by Subject|0|||
156752588|NCT02588092|565845799|FG001|Overall Study|Withdrawal by Subject|0|||
156752589|NCT02588092|565845800|FG002|Overall Study|Withdrawal by Subject|0|||
156752590|NCT02588092|565845801|FG003|Overall Study|Withdrawal by Subject|0|||
156752591|NCT02588092|565845802|FG004|Overall Study|Withdrawal by Subject|0|||
156752592|NCT02588092|565845803|FG005|Overall Study|Withdrawal by Subject|1|||
156752593|NCT02588092|565845804|FG006|Overall Study|Withdrawal by Subject|1|||
156752594|NCT02588092|565845805|FG007|Overall Study|Withdrawal by Subject|2|||
156752595|NCT02588092|565845806|FG008|Overall Study|Withdrawal by Subject|0|||
156752596|NCT02588092|565845807|FG009|Overall Study|Withdrawal by Subject|0|||
156752597|NCT02588092|565845798|FG000|Overall Study|Started Another Treatment|0|||
156752598|NCT02588092|565845799|FG001|Overall Study|Started Another Treatment|0|||
156752599|NCT02588092|565845800|FG002|Overall Study|Started Another Treatment|0|||
156752600|NCT02588092|565845801|FG003|Overall Study|Started Another Treatment|0|||
156752601|NCT02588092|565845802|FG004|Overall Study|Started Another Treatment|1|||
156752602|NCT02588092|565845803|FG005|Overall Study|Started Another Treatment|0|||
156752603|NCT02588092|565845804|FG006|Overall Study|Started Another Treatment|0|||
156752604|NCT02588092|565845805|FG007|Overall Study|Started Another Treatment|1|||
156752605|NCT02588092|565845806|FG008|Overall Study|Started Another Treatment|0|||
156752606|NCT02588092|565845807|FG009|Overall Study|Started Another Treatment|0|||
156752607|NCT02588092|565845798|FG000|Overall Study|Sponsor Decision|0|||
156752608|NCT02588092|565845799|FG001|Overall Study|Sponsor Decision|0|||
156752609|NCT02588092|565845800|FG002|Overall Study|Sponsor Decision|0|||
156752610|NCT02588092|565845801|FG003|Overall Study|Sponsor Decision|0|||
156752611|NCT02588092|565845802|FG004|Overall Study|Sponsor Decision|0|||
156752612|NCT02588092|565845803|FG005|Overall Study|Sponsor Decision|0|||
156752613|NCT02588092|565845804|FG006|Overall Study|Sponsor Decision|0|||
156752614|NCT02588092|565845805|FG007|Overall Study|Sponsor Decision|0|||
156752615|NCT02588092|565845806|FG008|Overall Study|Sponsor Decision|1|||
156752616|NCT02588092|565845807|FG009|Overall Study|Sponsor Decision|1|||
156752617|NCT01348100|565845808|FG000|Overall Study|Subject Withdrew Consent|0|||
156752618|NCT01348100|565845809|FG001|Overall Study|Subject Withdrew Consent|0|||
156752619|NCT01348100|565845810|FG002|Overall Study|Subject Withdrew Consent|2|||
156752620|NCT01348100|565845811|FG003|Overall Study|Subject Withdrew Consent|0|||
156752621|NCT01348100|565845812|FG004|Overall Study|Subject Withdrew Consent|1|||
156752622|NCT01348100|565845813|FG005|Overall Study|Subject Withdrew Consent|0|||
156752623|NCT01348100|565845814|FG006|Overall Study|Subject Withdrew Consent|1|||
156752624|NCT01348100|565845808|FG000|Overall Study|Protocol Deviation|0|||
156752625|NCT01348100|565845809|FG001|Overall Study|Protocol Deviation|0|||
156752626|NCT01348100|565845810|FG002|Overall Study|Protocol Deviation|0|||
156752627|NCT01348100|565845811|FG003|Overall Study|Protocol Deviation|1|||
156752628|NCT01348100|565845812|FG004|Overall Study|Protocol Deviation|0|||
156752629|NCT01348100|565845813|FG005|Overall Study|Protocol Deviation|0|||
156752630|NCT01348100|565845814|FG006|Overall Study|Protocol Deviation|0|||
156752631|NCT01348100|565845808|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156995871|NCT02014558|566737609|FG003|Overall Study|Death|0|||
156995872|NCT02014558|566737610|FG004|Overall Study|Death|0|||
156995873|NCT02014558|566737611|FG005|Overall Study|Death|0|||
156995874|NCT02014558|566737612|FG006|Overall Study|Death|1|||
156995875|NCT02014558|566737613|FG007|Overall Study|Death|1|||
156995876|NCT02014558|566737614|FG008|Overall Study|Death|2|||
156995877|NCT02014558|566737615|FG009|Overall Study|Death|5|||
156995878|NCT02014558|566737616|FG010|Overall Study|Death|5|||
156995879|NCT02014558|566737617|FG011|Overall Study|Death|19|||
156995880|NCT02014558|566737618|FG012|Overall Study|Death|2|||
156995881|NCT02014558|566737606|FG000|Overall Study|Lack of Efficacy|1|||
156752632|NCT01348100|565845809|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752633|NCT01348100|565845810|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752634|NCT01348100|565845811|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752635|NCT01348100|565845812|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752636|NCT01348100|565845813|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156752637|NCT01348100|565845814|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156752638|NCT01348100|565845808|FG000|Overall Study|Lost to Follow-up|0|||
156752639|NCT01348100|565845809|FG001|Overall Study|Lost to Follow-up|0|||
156752640|NCT01348100|565845810|FG002|Overall Study|Lost to Follow-up|0|||
156752641|NCT01348100|565845811|FG003|Overall Study|Lost to Follow-up|0|||
156752642|NCT01348100|565845812|FG004|Overall Study|Lost to Follow-up|0|||
156752643|NCT01348100|565845813|FG005|Overall Study|Lost to Follow-up|0|||
156995882|NCT02014558|566737607|FG001|Overall Study|Lack of Efficacy|2|||
156995883|NCT02014558|566737608|FG002|Overall Study|Lack of Efficacy|1|||
156752644|NCT01348100|565845814|FG006|Overall Study|Lost to Follow-up|1|||
156995884|NCT02014558|566737609|FG003|Overall Study|Lack of Efficacy|1|||
156995885|NCT02014558|566737610|FG004|Overall Study|Lack of Efficacy|0|||
156752645|NCT01348100|565845808|FG000|Overall Study|Administrative Problems|0|||
156752646|NCT01348100|565845809|FG001|Overall Study|Administrative Problems|0|||
156752647|NCT01348100|565845810|FG002|Overall Study|Administrative Problems|0|||
157099124|NCT02464228|567118209|FG001|Overall Study|Adverse Event|0|||
157099125|NCT02464228|567118210|FG002|Overall Study|Adverse Event|3|||
157099126|NCT02464228|567118211|FG003|Overall Study|Adverse Event|0|||
157099127|NCT02464228|567118208|FG000|Overall Study|Withdrawal by Subject|1|||
157099128|NCT02464228|567118209|FG001|Overall Study|Withdrawal by Subject|1|||
157099129|NCT02464228|567118210|FG002|Overall Study|Withdrawal by Subject|1|||
157099130|NCT02464228|567118211|FG003|Overall Study|Withdrawal by Subject|0|||
157099131|NCT02464228|567118208|FG000|Overall Study|Disease Progression|22|||
157099132|NCT02464228|567118209|FG001|Overall Study|Disease Progression|12|||
157099133|NCT02464228|567118210|FG002|Overall Study|Disease Progression|5|||
157099134|NCT02464228|567118211|FG003|Overall Study|Disease Progression|2|||
157099135|NCT04356183|567118216|FG000|Overall Study|Lost to Follow-up|1|||
157099136|NCT04356183|567118217|FG001|Overall Study|Lost to Follow-up|0|||
157099137|NCT04356183|567118216|FG000|Overall Study|Withdrawal by Subject|1|||
157099138|NCT04356183|567118217|FG001|Overall Study|Withdrawal by Subject|1|||
157099139|NCT01637623|567118218|FG000|Overall Study|Lost to Follow-up|0|||
157099140|NCT01637623|567118219|FG001|Overall Study|Lost to Follow-up|0|||
157099141|NCT01637623|567118220|FG002|Overall Study|Lost to Follow-up|2|||
157099142|NCT01637623|567118218|FG000|Overall Study|Physician Decision|1|||
157099143|NCT01637623|567118219|FG001|Overall Study|Physician Decision|0|||
157099144|NCT01637623|567118220|FG002|Overall Study|Physician Decision|1|||
157099145|NCT02824263|567118221|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
157099146|NCT02824263|567118222|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
157099147|NCT02824263|567118221|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
157099148|NCT02824263|567118222|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
157099149|NCT00568321|567118223|FG000|Overall Study|Adverse Event|1|||
157099150|NCT00568321|567118224|FG001|Overall Study|Adverse Event|0|||
157099151|NCT00568321|567118225|FG002|Overall Study|Adverse Event|0|||
157099152|NCT00568321|567118223|FG000|Overall Study|Lack of Efficacy|8|||
156752648|NCT01348100|565845811|FG003|Overall Study|Administrative Problems|0|||
156752649|NCT01348100|565845812|FG004|Overall Study|Administrative Problems|0|||
156752650|NCT01348100|565845813|FG005|Overall Study|Administrative Problems|1|||
156752651|NCT01348100|565845814|FG006|Overall Study|Administrative Problems|1|||
156752652|NCT03882957|565845817|FG000|Overall Study|Did not complete all three arms|1|||
156752653|NCT03762681|565845821|FG000|Part 1|Withdrawal by Subject|0|||
156752654|NCT03762681|565845822|FG001|Part 1|Withdrawal by Subject|0|||
156752655|NCT03762681|565845823|FG002|Part 1|Withdrawal by Subject|0|||
156752656|NCT03762681|565845824|FG003|Part 1|Withdrawal by Subject|1|||
156752657|NCT03762681|565845825|FG004|Part 1|Withdrawal by Subject|0|||
156752658|NCT03762681|565845826|FG005|Part 1|Withdrawal by Subject|0|||
156752659|NCT03762681|565845827|FG006|Part 1|Withdrawal by Subject|0|||
156752660|NCT03762681|565845828|FG007|Part 1|Withdrawal by Subject|0|||
156752661|NCT03762681|565845821|FG000|Part 2a|Pandemic Travel Restrictions|0|||
156752662|NCT03762681|565845822|FG001|Part 2a|Pandemic Travel Restrictions|0|||
156752663|NCT03762681|565845823|FG002|Part 2a|Pandemic Travel Restrictions|0|||
156752664|NCT03762681|565845824|FG003|Part 2a|Pandemic Travel Restrictions|0|||
156752665|NCT03762681|565845825|FG004|Part 2a|Pandemic Travel Restrictions|0|||
156752666|NCT03762681|565845826|FG005|Part 2a|Pandemic Travel Restrictions|0|||
156752667|NCT03762681|565845827|FG006|Part 2a|Pandemic Travel Restrictions|0|||
156752668|NCT03762681|565845828|FG007|Part 2a|Pandemic Travel Restrictions|1|||
156752669|NCT03148067|565845830|FG000|Overall Study|Lost to Follow-up|3|||
156752670|NCT03148067|565845830|FG000|Overall Study|Death|1|||
156752671|NCT00524680|565845832|FG000|Overall Study|progression|0|||
156752672|NCT00524680|565845833|FG001|Overall Study|progression|0|||
156752673|NCT00524680|565845834|FG002|Overall Study|progression|0|||
156752674|NCT00524680|565845835|FG003|Overall Study|progression|1|||
156752675|NCT00524680|565845832|FG000|Overall Study|Adverse Event|2|||
156752676|NCT00524680|565845833|FG001|Overall Study|Adverse Event|0|||
156752677|NCT00524680|565845834|FG002|Overall Study|Adverse Event|0|||
157099153|NCT00568321|567118224|FG001|Overall Study|Lack of Efficacy|5|||
157099154|NCT00568321|567118225|FG002|Overall Study|Lack of Efficacy|6|||
157099155|NCT00568321|567118223|FG000|Overall Study|Lost to Follow-up|0|||
157099156|NCT00568321|567118224|FG001|Overall Study|Lost to Follow-up|0|||
156752678|NCT00524680|565845835|FG003|Overall Study|Adverse Event|1|||
156752679|NCT00524680|565845832|FG000|Overall Study|Other|0|||
156752680|NCT00524680|565845833|FG001|Overall Study|Other|1|||
156752681|NCT00524680|565845834|FG002|Overall Study|Other|2|||
156752682|NCT00524680|565845835|FG003|Overall Study|Other|3|||
156752683|NCT00524680|565845832|FG000|Overall Study|Withdrawal by Subject|1|||
156752684|NCT00524680|565845833|FG001|Overall Study|Withdrawal by Subject|0|||
156752685|NCT00524680|565845834|FG002|Overall Study|Withdrawal by Subject|1|||
156752686|NCT00524680|565845835|FG003|Overall Study|Withdrawal by Subject|1|||
157099157|NCT00568321|567118225|FG002|Overall Study|Lost to Follow-up|1|||
157099158|NCT00568321|567118223|FG000|Overall Study|Withdrawal by Subject|2|||
156752687|NCT01146561|565845836|FG000|Overall Study|Withdrawal by Subject|1|||
157099159|NCT00568321|567118224|FG001|Overall Study|Withdrawal by Subject|0|||
156752688|NCT01146561|565845836|FG000|Overall Study|Lost to Follow-up|1|||
156752689|NCT00830518|565845844|FG000|Overall Study|Progressive Disease|18|||
156752690|NCT00830518|565845845|FG001|Overall Study|Progressive Disease|8|||
156752691|NCT00830518|565845844|FG000|Overall Study|Symptomatic Deterioration|4|||
156752692|NCT00830518|565845845|FG001|Overall Study|Symptomatic Deterioration|1|||
156752693|NCT00830518|565845844|FG000|Overall Study|Adverse Event|14|||
156752694|NCT00830518|565845845|FG001|Overall Study|Adverse Event|1|||
156752695|NCT00830518|565845844|FG000|Overall Study|Withdrawal by Patient|2|||
156752696|NCT00830518|565845845|FG001|Overall Study|Withdrawal by Patient|0|||
156752697|NCT00830518|565845844|FG000|Overall Study|Reason not Specified|8|||
156752698|NCT00830518|565845845|FG001|Overall Study|Reason not Specified|1|||
156752699|NCT04318132|565845846|FG000|Overall Study|Protocol Violation|0|||
156752700|NCT04318132|565845847|FG001|Overall Study|Protocol Violation|0|||
156752701|NCT04318132|565845848|FG002|Overall Study|Protocol Violation|3|||
156752702|NCT04318132|565845849|FG003|Overall Study|Protocol Violation|0|||
156752703|NCT03337048|565845850|FG000|Overall Study|Withdrawal by Subject|2|||
156752704|NCT03337048|565845851|FG001|Overall Study|Withdrawal by Subject|0|||
156752705|NCT03337048|565845852|FG002|Overall Study|Withdrawal by Subject|0|||
156752706|NCT00586898|565845855|FG000|Overall Study|Adverse Event|1|||
156752707|NCT00586898|565845855|FG000|Overall Study|Patiemt Non-compliance|1|||
156752708|NCT00586898|565845855|FG000|Overall Study|Evaluable for Toxicity Only|5|||
156752709|NCT00492232|565845856|FG000|Placebo Run-in|Adverse Event|0|||
156752710|NCT00492232|565845857|FG001|Placebo Run-in|Adverse Event|2|||
156752711|NCT00492232|565845856|FG000|Placebo Run-in|Protocol Violation|0|||
156752712|NCT00492232|565845857|FG001|Placebo Run-in|Protocol Violation|3|||
156752713|NCT00492232|565845856|FG000|Placebo Run-in|Lost to Follow-up|0|||
156752714|NCT00492232|565845857|FG001|Placebo Run-in|Lost to Follow-up|3|||
156752715|NCT00492232|565845856|FG000|Placebo Run-in|Withdrawal by Subject|0|||
156752716|NCT00492232|565845857|FG001|Placebo Run-in|Withdrawal by Subject|8|||
156752717|NCT00492232|565845856|FG000|Placebo Run-in|Pregnancy|0|||
156752718|NCT00492232|565845857|FG001|Placebo Run-in|Pregnancy|1|||
156752719|NCT00492232|565845856|FG000|Placebo Run-in|Entrance criteria not met|0|||
156752720|NCT00492232|565845857|FG001|Placebo Run-in|Entrance criteria not met|45|||
156752721|NCT00492232|565845856|FG000|Placebo Run-in|Other|0|||
156752722|NCT00492232|565845857|FG001|Placebo Run-in|Other|6|||
156752723|NCT00492232|565845856|FG000|Placebo Run-in|Missing|0|||
156752724|NCT00492232|565845857|FG001|Placebo Run-in|Missing|2|||
156752725|NCT00492232|565845856|FG000|Double-Blind Treatment|Adverse Event|1|||
156752726|NCT00492232|565845857|FG001|Double-Blind Treatment|Adverse Event|2|||
156752727|NCT00492232|565845856|FG000|Double-Blind Treatment|Protocol Violation|3|||
156752728|NCT00492232|565845857|FG001|Double-Blind Treatment|Protocol Violation|7|||
156752729|NCT00492232|565845856|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
156752730|NCT00492232|565845857|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
156752731|NCT00492232|565845856|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
156752732|NCT00492232|565845857|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
156752733|NCT00492232|565845856|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
156752734|NCT00492232|565845857|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
156752735|NCT00492232|565845856|FG000|Double-Blind Treatment|Other|6|||
156752736|NCT00492232|565845857|FG001|Double-Blind Treatment|Other|5|||
156752737|NCT00492232|565845856|FG000|Double-Blind Treatment|Randomized not treated|1|||
156752738|NCT00492232|565845857|FG001|Double-Blind Treatment|Randomized not treated|0|||
156752739|NCT00492232|565845856|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
156752740|NCT00492232|565845857|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156752741|NCT01994902|565845859|FG000|Test Period 1|Withdrawal by Subject|3|||
156752742|NCT01994902|565845860|FG001|Test Period 1|Withdrawal by Subject|0|||
156752743|NCT01994902|565845859|FG000|Test Period 1|device deficiency with adverse event|0|||
156752744|NCT01994902|565845860|FG001|Test Period 1|device deficiency with adverse event|1|||
156752745|NCT01994902|565845859|FG000|Test Period 1|Adverse Event|2|||
156752746|NCT01994902|565845860|FG001|Test Period 1|Adverse Event|1|||
156752747|NCT01994902|565845859|FG000|Test Period 1|Lack of Efficacy|0|||
156752748|NCT01994902|565845860|FG001|Test Period 1|Lack of Efficacy|1|||
156752749|NCT01994902|565845859|FG000|Test Period 1|bag too small|1|||
156752750|NCT01994902|565845860|FG001|Test Period 1|bag too small|0|||
156995886|NCT02014558|566737611|FG005|Overall Study|Lack of Efficacy|0|||
156995887|NCT02014558|566737612|FG006|Overall Study|Lack of Efficacy|1|||
156995888|NCT02014558|566737613|FG007|Overall Study|Lack of Efficacy|3|||
156995889|NCT02014558|566737614|FG008|Overall Study|Lack of Efficacy|3|||
156995890|NCT02014558|566737615|FG009|Overall Study|Lack of Efficacy|3|||
156995891|NCT02014558|566737616|FG010|Overall Study|Lack of Efficacy|16|||
156752751|NCT01994902|565845859|FG000|Test Period 2|Withdrawal by Subject|0|||
156752752|NCT01994902|565845860|FG001|Test Period 2|Withdrawal by Subject|2|||
156752753|NCT01994902|565845859|FG000|Test Period 2|Lack of Efficacy|0|||
156995892|NCT02014558|566737617|FG011|Overall Study|Lack of Efficacy|8|||
156995893|NCT02014558|566737618|FG012|Overall Study|Lack of Efficacy|5|||
156752754|NCT01994902|565845860|FG001|Test Period 2|Lack of Efficacy|1|||
156752755|NCT01994902|565845859|FG000|Test Period 2|Other|0|||
156752756|NCT01994902|565845860|FG001|Test Period 2|Other|3|||
156995894|NCT02014558|566737606|FG000|Overall Study|Lost to Follow-up|0|||
156995895|NCT02014558|566737607|FG001|Overall Study|Lost to Follow-up|0|||
156995896|NCT02014558|566737608|FG002|Overall Study|Lost to Follow-up|0|||
156995897|NCT02014558|566737609|FG003|Overall Study|Lost to Follow-up|0|||
156995898|NCT02014558|566737610|FG004|Overall Study|Lost to Follow-up|0|||
156995899|NCT02014558|566737611|FG005|Overall Study|Lost to Follow-up|0|||
156995900|NCT02014558|566737612|FG006|Overall Study|Lost to Follow-up|0|||
156995901|NCT02014558|566737613|FG007|Overall Study|Lost to Follow-up|0|||
156995902|NCT02014558|566737614|FG008|Overall Study|Lost to Follow-up|0|||
156995903|NCT02014558|566737615|FG009|Overall Study|Lost to Follow-up|0|||
156995904|NCT02014558|566737616|FG010|Overall Study|Lost to Follow-up|1|||
156995905|NCT02014558|566737617|FG011|Overall Study|Lost to Follow-up|0|||
156995906|NCT02014558|566737618|FG012|Overall Study|Lost to Follow-up|0|||
156995907|NCT02014558|566737606|FG000|Overall Study|Progressive Disease|1|||
156995908|NCT02014558|566737607|FG001|Overall Study|Progressive Disease|0|||
157099160|NCT00568321|567118225|FG002|Overall Study|Withdrawal by Subject|0|||
156995909|NCT02014558|566737608|FG002|Overall Study|Progressive Disease|1|||
156995910|NCT02014558|566737609|FG003|Overall Study|Progressive Disease|1|||
157099161|NCT00568321|567118223|FG000|Overall Study|Protocol Violation|0|||
157099162|NCT00568321|567118224|FG001|Overall Study|Protocol Violation|0|||
157099163|NCT00568321|567118225|FG002|Overall Study|Protocol Violation|1|||
157099164|NCT00568321|567118223|FG000|Overall Study|Randomized, not treated|2|||
157099165|NCT00568321|567118224|FG001|Overall Study|Randomized, not treated|0|||
157099166|NCT00568321|567118225|FG002|Overall Study|Randomized, not treated|1|||
157099167|NCT01180998|567118228|FG000|Overall Study|Poor Vision|0|||
157099168|NCT01180998|567118229|FG001|Overall Study|Poor Vision|2|||
157099169|NCT01180998|567118230|FG002|Overall Study|Poor Vision|2|||
157099170|NCT01180998|567118228|FG000|Overall Study|Lost to Follow-up|0|||
157099171|NCT01180998|567118229|FG001|Overall Study|Lost to Follow-up|0|||
157099172|NCT01180998|567118230|FG002|Overall Study|Lost to Follow-up|1|||
157099173|NCT01180998|567118228|FG000|Overall Study|Protocol Violation|1|||
157099174|NCT01180998|567118229|FG001|Overall Study|Protocol Violation|2|||
157099175|NCT01180998|567118230|FG002|Overall Study|Protocol Violation|0|||
157099176|NCT01180998|567118228|FG000|Overall Study|Withdrawal by Subject|0|||
157099177|NCT01180998|567118229|FG001|Overall Study|Withdrawal by Subject|0|||
157099178|NCT01180998|567118230|FG002|Overall Study|Withdrawal by Subject|1|||
157099179|NCT01180998|567118228|FG000|Overall Study|Poor comfort|3|||
157099180|NCT01180998|567118229|FG001|Overall Study|Poor comfort|0|||
157099181|NCT01180998|567118230|FG002|Overall Study|Poor comfort|4|||
157099182|NCT01180998|567118228|FG000|Overall Study|Poor lens handling|0|||
157099183|NCT01180998|567118229|FG001|Overall Study|Poor lens handling|0|||
157099184|NCT01180998|567118230|FG002|Overall Study|Poor lens handling|2|||
157099185|NCT01176968|567118231|FG000|Overall Study|Adverse Event|10|||
157099186|NCT01176968|567118232|FG001|Overall Study|Adverse Event|11|||
157099187|NCT01176968|567118231|FG000|Overall Study|Death|2|||
157099188|NCT01176968|567118232|FG001|Overall Study|Death|3|||
157099189|NCT01176968|567118231|FG000|Overall Study|Lack of Efficacy|0|||
157099190|NCT01176968|567118232|FG001|Overall Study|Lack of Efficacy|1|||
157099191|NCT01176968|567118231|FG000|Overall Study|Lost to Follow-up|16|||
157099192|NCT01176968|567118232|FG001|Overall Study|Lost to Follow-up|14|||
157099193|NCT01176968|567118231|FG000|Overall Study|Withdrawal by Subject|48|||
157099194|NCT01176968|567118232|FG001|Overall Study|Withdrawal by Subject|48|||
157099195|NCT01176968|567118231|FG000|Overall Study|Protocol Violation|2|||
156995911|NCT02014558|566737610|FG004|Overall Study|Progressive Disease|1|||
156995912|NCT02014558|566737611|FG005|Overall Study|Progressive Disease|2|||
156995913|NCT02014558|566737612|FG006|Overall Study|Progressive Disease|1|||
157099196|NCT01176968|567118232|FG001|Overall Study|Protocol Violation|1|||
157099197|NCT01176968|567118231|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
157099198|NCT01176968|567118232|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
157099199|NCT01176968|567118231|FG000|Overall Study|Study terminated by sponsor|0|||
157099200|NCT01176968|567118232|FG001|Overall Study|Study terminated by sponsor|1|||
157099201|NCT01176968|567118231|FG000|Overall Study|Reason not defined|5|||
156752757|NCT03796676|565845861|FG000|Overall Study|Adverse Event|2|||
156752758|NCT03796676|565845862|FG001|Overall Study|Adverse Event|1|||
156752759|NCT03796676|565845863|FG002|Overall Study|Adverse Event|2|||
156752760|NCT03796676|565845861|FG000|Overall Study|Lost to Follow-up|2|||
156752761|NCT03796676|565845862|FG001|Overall Study|Lost to Follow-up|1|||
156752762|NCT03796676|565845863|FG002|Overall Study|Lost to Follow-up|0|||
156752763|NCT03796676|565845861|FG000|Overall Study|Protocol Violation|0|||
156752764|NCT03796676|565845862|FG001|Overall Study|Protocol Violation|0|||
156752765|NCT03796676|565845863|FG002|Overall Study|Protocol Violation|1|||
156752766|NCT03796676|565845861|FG000|Overall Study|Withdrawal by Subject|1|||
156752767|NCT03796676|565845862|FG001|Overall Study|Withdrawal by Subject|1|||
156752768|NCT03796676|565845863|FG002|Overall Study|Withdrawal by Subject|0|||
156752769|NCT03796676|565845861|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
156752770|NCT03796676|565845862|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
156752771|NCT03796676|565845863|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
156752772|NCT02772809|565845865|FG000|Overall Study|not completed some tasks|6|||
156752773|NCT00723697|565845871|FG000|Overall Study|Physician questionnaires not received|2|||
156752774|NCT00723697|565845871|FG000|Overall Study|Missing Informed Consent Form|10|||
156752775|NCT00723697|565845871|FG000|Overall Study|Other exclusion criteria applied|6|||
156752776|NCT00534105|565845872|FG000|Overall Study|Lost to Follow-up|23|||
156752777|NCT00534105|565845873|FG001|Overall Study|Lost to Follow-up|39|||
156752778|NCT01289574|565845874|FG000|Overall Study|Lack of Efficacy|4|||
156752779|NCT01289574|565845875|FG001|Overall Study|Lack of Efficacy|0|||
156752780|NCT01289574|565845876|FG002|Overall Study|Lack of Efficacy|1|||
156752781|NCT01289574|565845874|FG000|Overall Study|Lost to Follow-up|2|||
156752782|NCT01289574|565845875|FG001|Overall Study|Lost to Follow-up|0|||
156752783|NCT01289574|565845876|FG002|Overall Study|Lost to Follow-up|1|||
156752784|NCT01289574|565845874|FG000|Overall Study|Withdrawal by Subject|1|||
156752785|NCT01289574|565845875|FG001|Overall Study|Withdrawal by Subject|1|||
156752786|NCT01289574|565845876|FG002|Overall Study|Withdrawal by Subject|1|||
156752787|NCT01289574|565845874|FG000|Overall Study|Adverse Event|0|||
156752788|NCT01289574|565845875|FG001|Overall Study|Adverse Event|1|||
156752789|NCT01289574|565845876|FG002|Overall Study|Adverse Event|0|||
156752790|NCT01289574|565845874|FG000|Overall Study|Subject wanted alternate treatment|0|||
156752791|NCT01289574|565845875|FG001|Overall Study|Subject wanted alternate treatment|1|||
156752792|NCT01289574|565845876|FG002|Overall Study|Subject wanted alternate treatment|0|||
156752793|NCT00978341|565845881|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
156752794|NCT00978341|565845882|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
156752795|NCT02452554|565845883|FG000|Overall Study|Death|2|||
156752796|NCT02452554|565845884|FG001|Overall Study|Death|1|||
156752797|NCT02452554|565845885|FG002|Overall Study|Death|0|||
156752798|NCT02452554|565845886|FG003|Overall Study|Death|0|||
156752799|NCT02452554|565845887|FG004|Overall Study|Death|0|||
156752800|NCT02452554|565845888|FG005|Overall Study|Death|0|||
156752801|NCT02452554|565845883|FG000|Overall Study|Lack of Efficacy|13|||
156752802|NCT02452554|565845884|FG001|Overall Study|Lack of Efficacy|14|||
156752803|NCT02452554|565845885|FG002|Overall Study|Lack of Efficacy|9|||
156752804|NCT02452554|565845886|FG003|Overall Study|Lack of Efficacy|1|||
156752805|NCT02452554|565845887|FG004|Overall Study|Lack of Efficacy|5|||
156752806|NCT02452554|565845888|FG005|Overall Study|Lack of Efficacy|8|||
156752807|NCT02452554|565845883|FG000|Overall Study|Physician Decision|0|||
156752808|NCT02452554|565845884|FG001|Overall Study|Physician Decision|1|||
156752809|NCT02452554|565845885|FG002|Overall Study|Physician Decision|0|||
156752810|NCT02452554|565845886|FG003|Overall Study|Physician Decision|0|||
156752811|NCT02452554|565845887|FG004|Overall Study|Physician Decision|0|||
156752812|NCT02452554|565845888|FG005|Overall Study|Physician Decision|0|||
156752813|NCT02452554|565845883|FG000|Overall Study|Withdrawal by Subject|1|||
156752814|NCT02452554|565845884|FG001|Overall Study|Withdrawal by Subject|0|||
156752815|NCT02452554|565845885|FG002|Overall Study|Withdrawal by Subject|2|||
156752816|NCT02452554|565845886|FG003|Overall Study|Withdrawal by Subject|0|||
156752817|NCT02452554|565845887|FG004|Overall Study|Withdrawal by Subject|0|||
156752818|NCT02452554|565845888|FG005|Overall Study|Withdrawal by Subject|1|||
156752819|NCT02452554|565845883|FG000|Overall Study|Ineligible|0|||
156752820|NCT02452554|565845884|FG001|Overall Study|Ineligible|1|||
156752821|NCT02452554|565845885|FG002|Overall Study|Ineligible|0|||
156752822|NCT02452554|565845886|FG003|Overall Study|Ineligible|0|||
156752823|NCT02452554|565845887|FG004|Overall Study|Ineligible|0|||
156752824|NCT02452554|565845888|FG005|Overall Study|Ineligible|0|||
156752825|NCT02452554|565845883|FG000|Overall Study|Never Received Treatment|1|||
156752826|NCT02452554|565845884|FG001|Overall Study|Never Received Treatment|0|||
156752827|NCT02452554|565845885|FG002|Overall Study|Never Received Treatment|0|||
156752828|NCT02452554|565845886|FG003|Overall Study|Never Received Treatment|0|||
156752829|NCT02452554|565845887|FG004|Overall Study|Never Received Treatment|0|||
156752830|NCT02452554|565845888|FG005|Overall Study|Never Received Treatment|0|||
156752831|NCT01451554|565845889|FG000|Overall Study|Withdrawal by Subject|14|||
156752832|NCT01451554|565845890|FG001|Overall Study|Withdrawal by Subject|9|||
156752833|NCT01790516|565845891|FG000|Overall Study|Physician Decision|1|||
156752834|NCT01790516|565845892|FG001|Overall Study|Physician Decision|0|||
156752835|NCT01085084|565845893|FG000|Overall Study|Withdrawal by Subject|1|||
156752836|NCT01085084|565845894|FG001|Overall Study|Withdrawal by Subject|0|||
156752837|NCT01085084|565845895|FG002|Overall Study|Withdrawal by Subject|0|||
156752838|NCT01085084|565845893|FG000|Overall Study|Lost to Follow-up|2|||
156752839|NCT01085084|565845894|FG001|Overall Study|Lost to Follow-up|1|||
156752840|NCT01085084|565845895|FG002|Overall Study|Lost to Follow-up|1|||
156752841|NCT01085084|565845893|FG000|Overall Study|Adverse Event|4|||
156752842|NCT01085084|565845894|FG001|Overall Study|Adverse Event|3|||
156752843|NCT01085084|565845895|FG002|Overall Study|Adverse Event|6|||
156752844|NCT01085084|565845893|FG000|Overall Study|Treatment Failure|0|||
156752845|NCT01085084|565845894|FG001|Overall Study|Treatment Failure|1|||
156752846|NCT01085084|565845895|FG002|Overall Study|Treatment Failure|2|||
156752847|NCT02749799|565845896|FG000|Overall Study|Adverse Event|2|||
156752848|NCT02749799|565845896|FG000|Overall Study|Lost to Follow-up|4|||
156752849|NCT02749799|565845896|FG000|Overall Study|Protocol Violation|1|||
156752850|NCT02749799|565845896|FG000|Overall Study|Withdrawal by Subject|1|||
156752851|NCT02070978|565845897|FG000|Overall Study|Adverse Event|6|||
156752852|NCT02070978|565845898|FG001|Overall Study|Adverse Event|2|||
156752853|NCT02070978|565845899|FG002|Overall Study|Adverse Event|0|||
156752854|NCT02070978|565845897|FG000|Overall Study|Lost to Follow-up|1|||
156752855|NCT02070978|565845898|FG001|Overall Study|Lost to Follow-up|3|||
156752856|NCT02070978|565845899|FG002|Overall Study|Lost to Follow-up|4|||
156752857|NCT02070978|565845897|FG000|Overall Study|Withdrawal by Subject|3|||
156752858|NCT02070978|565845898|FG001|Overall Study|Withdrawal by Subject|5|||
156752859|NCT02070978|565845899|FG002|Overall Study|Withdrawal by Subject|3|||
156752860|NCT02070978|565845897|FG000|Overall Study|Protocol Violation|1|||
156752861|NCT02070978|565845898|FG001|Overall Study|Protocol Violation|0|||
156752862|NCT02070978|565845899|FG002|Overall Study|Protocol Violation|3|||
156752863|NCT02070978|565845897|FG000|Overall Study|Lack of Efficacy|0|||
156752864|NCT02070978|565845898|FG001|Overall Study|Lack of Efficacy|1|||
156995914|NCT02014558|566737613|FG007|Overall Study|Progressive Disease|6|||
156995915|NCT02014558|566737614|FG008|Overall Study|Progressive Disease|5|||
156995916|NCT02014558|566737615|FG009|Overall Study|Progressive Disease|6|||
156995917|NCT02014558|566737616|FG010|Overall Study|Progressive Disease|22|||
156995918|NCT02014558|566737617|FG011|Overall Study|Progressive Disease|31|||
156995919|NCT02014558|566737618|FG012|Overall Study|Progressive Disease|6|||
156995920|NCT02014558|566737606|FG000|Overall Study|Withdrawal by Subject|0|||
156995921|NCT02014558|566737607|FG001|Overall Study|Withdrawal by Subject|0|||
156995922|NCT02014558|566737608|FG002|Overall Study|Withdrawal by Subject|0|||
156995923|NCT02014558|566737609|FG003|Overall Study|Withdrawal by Subject|0|||
156995924|NCT02014558|566737610|FG004|Overall Study|Withdrawal by Subject|1|||
156995925|NCT02014558|566737611|FG005|Overall Study|Withdrawal by Subject|0|||
156995926|NCT02014558|566737612|FG006|Overall Study|Withdrawal by Subject|0|||
156995927|NCT02014558|566737613|FG007|Overall Study|Withdrawal by Subject|0|||
156995928|NCT02014558|566737614|FG008|Overall Study|Withdrawal by Subject|0|||
156995929|NCT02014558|566737615|FG009|Overall Study|Withdrawal by Subject|2|||
156995930|NCT02014558|566737616|FG010|Overall Study|Withdrawal by Subject|6|||
156995931|NCT02014558|566737617|FG011|Overall Study|Withdrawal by Subject|10|||
156995932|NCT02014558|566737618|FG012|Overall Study|Withdrawal by Subject|0|||
156995933|NCT02014558|566737606|FG000|Overall Study|Miscellaneous|2|||
156995934|NCT02014558|566737607|FG001|Overall Study|Miscellaneous|1|||
156995935|NCT02014558|566737608|FG002|Overall Study|Miscellaneous|1|||
156995936|NCT02014558|566737609|FG003|Overall Study|Miscellaneous|1|||
156995937|NCT02014558|566737610|FG004|Overall Study|Miscellaneous|0|||
156995938|NCT02014558|566737611|FG005|Overall Study|Miscellaneous|1|||
156995939|NCT02014558|566737612|FG006|Overall Study|Miscellaneous|0|||
156995940|NCT02014558|566737613|FG007|Overall Study|Miscellaneous|1|||
156995941|NCT02014558|566737614|FG008|Overall Study|Miscellaneous|1|||
156995942|NCT02014558|566737615|FG009|Overall Study|Miscellaneous|3|||
156995943|NCT02014558|566737616|FG010|Overall Study|Miscellaneous|12|||
156995944|NCT02014558|566737617|FG011|Overall Study|Miscellaneous|11|||
156995945|NCT02014558|566737618|FG012|Overall Study|Miscellaneous|1|||
156995946|NCT00751036|566737619|FG000|Overall Study|Disease Progression|28|||
156995947|NCT00751036|566737620|FG001|Overall Study|Disease Progression|29|||
156995948|NCT00751036|566737619|FG000|Overall Study|Adverse Event|6|||
156995949|NCT00751036|566737620|FG001|Overall Study|Adverse Event|4|||
156995950|NCT00751036|566737619|FG000|Overall Study|Administrative Problems|3|||
156995951|NCT00751036|566737620|FG001|Overall Study|Administrative Problems|4|||
156752865|NCT02070978|565845899|FG002|Overall Study|Lack of Efficacy|0|||
156752866|NCT02070978|565845897|FG000|Overall Study|Death|0|||
156752867|NCT02070978|565845898|FG001|Overall Study|Death|0|||
156752868|NCT02070978|565845899|FG002|Overall Study|Death|2|||
156995952|NCT00751036|566737619|FG000|Overall Study|Withdrawal by Subject|5|||
156995953|NCT00751036|566737620|FG001|Overall Study|Withdrawal by Subject|2|||
156995954|NCT00751036|566737619|FG000|Overall Study|Death|3|||
156995955|NCT00751036|566737620|FG001|Overall Study|Death|3|||
156752869|NCT02070978|565845897|FG000|Overall Study|Un-specified|3|||
156752870|NCT02070978|565845898|FG001|Overall Study|Un-specified|2|||
156752871|NCT02070978|565845899|FG002|Overall Study|Un-specified|2|||
156995956|NCT00751036|566737619|FG000|Overall Study|Lost to Follow-up|0|||
156752872|NCT02070978|565845897|FG000|Overall Study|Terminated by Sponsor|33|||
156752873|NCT02070978|565845898|FG001|Overall Study|Terminated by Sponsor|40|||
156752874|NCT02070978|565845899|FG002|Overall Study|Terminated by Sponsor|39|||
156752875|NCT02669043|565845905|FG000|Overall Study|Didn't meet I/E criteria|4|||
156752876|NCT00520767|565845908|FG000|Overall Study|Death|2|||
156752877|NCT02753816|565848204|FG000|Overall Study|Protocol Violation|0|||
156752878|NCT02753816|565848205|FG001|Overall Study|Protocol Violation|1|||
156752879|NCT02753816|565848206|FG002|Overall Study|Protocol Violation|0|||
156752880|NCT01473940|565848207|FG000|Induction Therapy|Death|0|||
156752881|NCT01473940|565848208|FG001|Induction Therapy|Death|0|||
156752882|NCT01473940|565848209|FG002|Induction Therapy|Death|1|||
156752883|NCT01473940|565848210|FG003|Induction Therapy|Death|1|||
156752884|NCT01473940|565848207|FG000|Induction Therapy|Progressive Disease|0|||
156752885|NCT01473940|565848208|FG001|Induction Therapy|Progressive Disease|1|||
156752886|NCT01473940|565848209|FG002|Induction Therapy|Progressive Disease|1|||
156752887|NCT01473940|565848210|FG003|Induction Therapy|Progressive Disease|0|||
156752888|NCT01473940|565848207|FG000|Maintenance Therapy|Progressive Disease|1|||
156752889|NCT01473940|565848208|FG001|Maintenance Therapy|Progressive Disease|2|||
156752890|NCT01473940|565848209|FG002|Maintenance Therapy|Progressive Disease|1|||
156752891|NCT01473940|565848210|FG003|Maintenance Therapy|Progressive Disease|4|||
156752892|NCT02849171|565848211|FG000|Overall Study|Withdrawal by Subject|1|||
156752893|NCT02849171|565848211|FG000|Overall Study|Not treated|1|||
156752894|NCT02630563|565848218|FG000|Overall Study|Administrative|1|||
156752895|NCT03084302|565848219|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
156752896|NCT03084302|565848219|FG000|Overall Study|No valid objective monitor data|6|||
156752897|NCT00621257|565848220|FG000|Overall Study|Lost to Follow-up|4|||
156752898|NCT00621257|565848221|FG001|Overall Study|Lost to Follow-up|0|||
156752899|NCT00621257|565848222|FG002|Overall Study|Lost to Follow-up|2|||
156752900|NCT00621257|565848223|FG003|Overall Study|Lost to Follow-up|4|||
156752901|NCT00621257|565848224|FG004|Overall Study|Lost to Follow-up|7|||
156752902|NCT00621257|565848220|FG000|Overall Study|Adverse Event|0|||
156752903|NCT00621257|565848221|FG001|Overall Study|Adverse Event|1|||
156752904|NCT00621257|565848222|FG002|Overall Study|Adverse Event|1|||
156752905|NCT00621257|565848223|FG003|Overall Study|Adverse Event|0|||
156752906|NCT00621257|565848224|FG004|Overall Study|Adverse Event|0|||
156752907|NCT00621257|565848220|FG000|Overall Study|Physician Decision|0|||
156752908|NCT00621257|565848221|FG001|Overall Study|Physician Decision|2|||
156752909|NCT00621257|565848222|FG002|Overall Study|Physician Decision|0|||
156752910|NCT00621257|565848223|FG003|Overall Study|Physician Decision|1|||
156752911|NCT00621257|565848224|FG004|Overall Study|Physician Decision|1|||
156752912|NCT00621257|565848220|FG000|Overall Study|Withdrawal by Subject|0|||
156752913|NCT00621257|565848221|FG001|Overall Study|Withdrawal by Subject|0|||
156752914|NCT00621257|565848222|FG002|Overall Study|Withdrawal by Subject|0|||
156752915|NCT00621257|565848223|FG003|Overall Study|Withdrawal by Subject|1|||
156752916|NCT00621257|565848224|FG004|Overall Study|Withdrawal by Subject|1|||
156752917|NCT01255904|565848225|FG000|Overall Study|Physician Decision|1|||
156752918|NCT01255904|565848226|FG001|Overall Study|Physician Decision|4|||
156752919|NCT02061813|565848228|FG000|Overall Study|Withdrawal by Subject|1|||
156752920|NCT02061813|565848228|FG000|Overall Study|Protocol Violation|2|||
156752921|NCT01705080|565848229|FG000|Overall Study|Missed visit|10|||
156752922|NCT01705080|565848230|FG001|Overall Study|Missed visit|4|||
156752923|NCT01705080|565848231|FG002|Overall Study|Missed visit|1|||
156752924|NCT01705080|565848229|FG000|Overall Study|Death|4|||
156752925|NCT01705080|565848230|FG001|Overall Study|Death|4|||
156752926|NCT01705080|565848231|FG002|Overall Study|Death|6|||
156752927|NCT01705080|565848229|FG000|Overall Study|Withdrawal by Subject|61|||
156752928|NCT01705080|565848230|FG001|Overall Study|Withdrawal by Subject|44|||
156752929|NCT01705080|565848231|FG002|Overall Study|Withdrawal by Subject|9|||
156995957|NCT00751036|566737620|FG001|Overall Study|Lost to Follow-up|1|||
156995958|NCT00751036|566737619|FG000|Overall Study|Protocol Violation|1|||
156995959|NCT00751036|566737620|FG001|Overall Study|Protocol Violation|0|||
156995960|NCT00751036|566737619|FG000|Overall Study|Missing end of Treatment Page|2|||
156995961|NCT00751036|566737620|FG001|Overall Study|Missing end of Treatment Page|3|||
156995962|NCT02931396|566737623|FG000|Overall Study|Lost to Follow-up|3|||
156995963|NCT02931396|566737624|FG001|Overall Study|Lost to Follow-up|0|||
156995964|NCT02931396|566737623|FG000|Overall Study|Withdrawal by Subject|2|||
156995965|NCT02931396|566737624|FG001|Overall Study|Withdrawal by Subject|0|||
156995966|NCT05460663|566737627|FG000|Overall Study|Withdrawal by Subject|2|||
156995967|NCT05460663|566737628|FG001|Overall Study|Withdrawal by Subject|5|||
156995968|NCT00681811|566737629|FG000|Overall Study|Adverse Event|1|||
156995969|NCT00681811|566737630|FG001|Overall Study|Adverse Event|1|||
156995970|NCT00681811|566737629|FG000|Overall Study|Withdrawal by Subject|2|||
156995971|NCT00681811|566737630|FG001|Overall Study|Withdrawal by Subject|2|||
156995972|NCT00681811|566737629|FG000|Overall Study|Non-compliance|0|||
156995973|NCT00681811|566737630|FG001|Overall Study|Non-compliance|1|||
156995974|NCT02068885|566737631|FG000|Overall Study|Withdrew|3|||
156995975|NCT02068885|566737632|FG001|Overall Study|Withdrew|5|||
156995976|NCT02068885|566737633|FG002|Overall Study|Withdrew|8|||
156995977|NCT05273801|566737639|FG000|Overall Study|Physician Decision|1|||
156752930|NCT01704755|565848236|FG000|Overall Study|Adverse Event|4|||
156752931|NCT01704755|565848237|FG001|Overall Study|Adverse Event|1|||
156752932|NCT01704755|565848236|FG000|Overall Study|Lost to Follow-up|3|||
156752933|NCT01704755|565848237|FG001|Overall Study|Lost to Follow-up|4|||
156752934|NCT01704755|565848236|FG000|Overall Study|Withdrew consent|1|||
156752935|NCT01704755|565848237|FG001|Overall Study|Withdrew consent|1|||
156752936|NCT01704755|565848236|FG000|Overall Study|Other (not specified)|3|||
156752937|NCT01704755|565848237|FG001|Overall Study|Other (not specified)|1|||
156752938|NCT01704755|565848236|FG000|Overall Study|Withdrew consent and personal issues|1|||
156752939|NCT01704755|565848237|FG001|Overall Study|Withdrew consent and personal issues|0|||
156752940|NCT02075008|565848250|FG000|Overall Study|Technical problems|1|||
156752941|NCT02075008|565848250|FG000|Overall Study|Pregnancy|1|||
156752942|NCT02075008|565848250|FG000|Overall Study|Physician Decision|1|||
156752943|NCT02075008|565848250|FG000|Overall Study|Lost to Follow-up|1|||
156752944|NCT02075008|565848250|FG000|Overall Study|Lack of Efficacy|1|||
156752945|NCT02075008|565848250|FG000|Overall Study|Death|1|||
156752946|NCT02075008|565848250|FG000|Overall Study|Adverse Event|5|||
156752947|NCT02075008|565848250|FG000|Overall Study|Withdrawal by Subject|6|||
156752948|NCT02075008|565848250|FG000|Overall Study|Study terminated by Sponsor|159|||
156752949|NCT03130959|565848251|FG000|Overall Study|Disease progression|19|||
156752950|NCT03130959|565848252|FG001|Overall Study|Disease progression|7|||
156752951|NCT03130959|565848253|FG002|Overall Study|Disease progression|12|||
156752952|NCT03130959|565848254|FG003|Overall Study|Disease progression|7|||
156752953|NCT03130959|565848255|FG004|Overall Study|Disease progression|12|||
156752954|NCT03130959|565848256|FG005|Overall Study|Disease progression|3|||
156752955|NCT03130959|565848257|FG006|Overall Study|Disease progression|6|||
156752956|NCT03130959|565848258|FG007|Overall Study|Disease progression|3|||
156752957|NCT03130959|565848259|FG008|Overall Study|Disease progression|15|||
156752958|NCT03130959|565848260|FG009|Overall Study|Disease progression|8|||
156752959|NCT03130959|565848251|FG000|Overall Study|Study drug toxicity|2|||
156752960|NCT03130959|565848252|FG001|Overall Study|Study drug toxicity|2|||
156752961|NCT03130959|565848253|FG002|Overall Study|Study drug toxicity|1|||
156752962|NCT03130959|565848254|FG003|Overall Study|Study drug toxicity|2|||
156752963|NCT03130959|565848255|FG004|Overall Study|Study drug toxicity|1|||
156752964|NCT03130959|565848256|FG005|Overall Study|Study drug toxicity|1|||
156752965|NCT03130959|565848257|FG006|Overall Study|Study drug toxicity|3|||
156752966|NCT03130959|565848258|FG007|Overall Study|Study drug toxicity|0|||
156752967|NCT03130959|565848259|FG008|Overall Study|Study drug toxicity|3|||
156752968|NCT03130959|565848260|FG009|Overall Study|Study drug toxicity|3|||
156752969|NCT03130959|565848251|FG000|Overall Study|Other reasons|0|||
156752970|NCT03130959|565848252|FG001|Overall Study|Other reasons|0|||
156752971|NCT03130959|565848253|FG002|Overall Study|Other reasons|0|||
156752972|NCT03130959|565848254|FG003|Overall Study|Other reasons|0|||
156752973|NCT03130959|565848255|FG004|Overall Study|Other reasons|0|||
156752974|NCT03130959|565848256|FG005|Overall Study|Other reasons|1|||
156752975|NCT03130959|565848257|FG006|Overall Study|Other reasons|1|||
156752976|NCT03130959|565848258|FG007|Overall Study|Other reasons|0|||
156752977|NCT03130959|565848259|FG008|Overall Study|Other reasons|0|||
156752978|NCT03130959|565848260|FG009|Overall Study|Other reasons|0|||
156752979|NCT03130959|565848251|FG000|Overall Study|Subject request to discontinue therapy|0|||
156752980|NCT03130959|565848252|FG001|Overall Study|Subject request to discontinue therapy|0|||
156752981|NCT03130959|565848253|FG002|Overall Study|Subject request to discontinue therapy|1|||
156752982|NCT03130959|565848254|FG003|Overall Study|Subject request to discontinue therapy|1|||
156752983|NCT03130959|565848255|FG004|Overall Study|Subject request to discontinue therapy|0|||
156752984|NCT03130959|565848256|FG005|Overall Study|Subject request to discontinue therapy|0|||
156752985|NCT03130959|565848257|FG006|Overall Study|Subject request to discontinue therapy|1|||
156752986|NCT03130959|565848258|FG007|Overall Study|Subject request to discontinue therapy|1|||
156752987|NCT03130959|565848259|FG008|Overall Study|Subject request to discontinue therapy|0|||
156752988|NCT03130959|565848260|FG009|Overall Study|Subject request to discontinue therapy|0|||
156752989|NCT03130959|565848251|FG000|Overall Study|Not reported|0|||
156752990|NCT03130959|565848252|FG001|Overall Study|Not reported|0|||
156995978|NCT00828919|566737643|FG000|Overall Study|Death|0|||
156752991|NCT03130959|565848253|FG002|Overall Study|Not reported|0|||
156752992|NCT03130959|565848254|FG003|Overall Study|Not reported|1|||
156752993|NCT03130959|565848255|FG004|Overall Study|Not reported|0|||
156995979|NCT00828919|566737644|FG001|Overall Study|Death|1|||
156995980|NCT00828919|566737645|FG002|Overall Study|Death|2|||
156995981|NCT00828919|566737646|FG003|Overall Study|Death|0|||
156995982|NCT00828919|566737647|FG004|Overall Study|Death|0|||
156752994|NCT03130959|565848256|FG005|Overall Study|Not reported|1|||
156752995|NCT03130959|565848257|FG006|Overall Study|Not reported|0|||
156752996|NCT03130959|565848258|FG007|Overall Study|Not reported|0|||
156752997|NCT03130959|565848259|FG008|Overall Study|Not reported|0|||
156752998|NCT03130959|565848260|FG009|Overall Study|Not reported|1|||
156752999|NCT03130959|565848251|FG000|Overall Study|Adverse Event unrelated to drug|0|||
156753000|NCT03130959|565848252|FG001|Overall Study|Adverse Event unrelated to drug|0|||
156753001|NCT03130959|565848253|FG002|Overall Study|Adverse Event unrelated to drug|1|||
156995983|NCT00828919|566737643|FG000|Overall Study|Adverse Event|2|||
156753002|NCT03130959|565848254|FG003|Overall Study|Adverse Event unrelated to drug|1|||
156753003|NCT03130959|565848255|FG004|Overall Study|Adverse Event unrelated to drug|1|||
156753004|NCT03130959|565848256|FG005|Overall Study|Adverse Event unrelated to drug|0|||
156753005|NCT03130959|565848257|FG006|Overall Study|Adverse Event unrelated to drug|1|||
156753006|NCT03130959|565848258|FG007|Overall Study|Adverse Event unrelated to drug|0|||
156753007|NCT03130959|565848259|FG008|Overall Study|Adverse Event unrelated to drug|1|||
156753008|NCT03130959|565848260|FG009|Overall Study|Adverse Event unrelated to drug|1|||
156753009|NCT03130959|565848251|FG000|Overall Study|Participant withdrew consent|0|||
156753010|NCT03130959|565848252|FG001|Overall Study|Participant withdrew consent|1|||
156753011|NCT03130959|565848253|FG002|Overall Study|Participant withdrew consent|0|||
156753012|NCT03130959|565848254|FG003|Overall Study|Participant withdrew consent|2|||
156753013|NCT03130959|565848255|FG004|Overall Study|Participant withdrew consent|1|||
156753014|NCT03130959|565848256|FG005|Overall Study|Participant withdrew consent|0|||
156753015|NCT03130959|565848257|FG006|Overall Study|Participant withdrew consent|0|||
156753016|NCT03130959|565848258|FG007|Overall Study|Participant withdrew consent|0|||
156753017|NCT03130959|565848259|FG008|Overall Study|Participant withdrew consent|0|||
156753018|NCT03130959|565848260|FG009|Overall Study|Participant withdrew consent|2|||
156753019|NCT03130959|565848251|FG000|Overall Study|Administrative reason by sponsor|1|||
156753020|NCT03130959|565848252|FG001|Overall Study|Administrative reason by sponsor|0|||
156753021|NCT03130959|565848253|FG002|Overall Study|Administrative reason by sponsor|1|||
156753022|NCT03130959|565848254|FG003|Overall Study|Administrative reason by sponsor|0|||
156753023|NCT03130959|565848255|FG004|Overall Study|Administrative reason by sponsor|0|||
156753024|NCT03130959|565848256|FG005|Overall Study|Administrative reason by sponsor|0|||
156753025|NCT03130959|565848257|FG006|Overall Study|Administrative reason by sponsor|0|||
156753026|NCT03130959|565848258|FG007|Overall Study|Administrative reason by sponsor|0|||
156753027|NCT03130959|565848259|FG008|Overall Study|Administrative reason by sponsor|0|||
156753028|NCT03130959|565848260|FG009|Overall Study|Administrative reason by sponsor|0|||
156753029|NCT03130959|565848251|FG000|Overall Study|Lost to Follow-up|1|||
156753030|NCT03130959|565848252|FG001|Overall Study|Lost to Follow-up|0|||
156753031|NCT03130959|565848253|FG002|Overall Study|Lost to Follow-up|0|||
156753032|NCT03130959|565848254|FG003|Overall Study|Lost to Follow-up|0|||
156753033|NCT03130959|565848255|FG004|Overall Study|Lost to Follow-up|0|||
156753034|NCT03130959|565848256|FG005|Overall Study|Lost to Follow-up|0|||
156753035|NCT03130959|565848257|FG006|Overall Study|Lost to Follow-up|0|||
156753036|NCT03130959|565848258|FG007|Overall Study|Lost to Follow-up|0|||
156753037|NCT03130959|565848259|FG008|Overall Study|Lost to Follow-up|0|||
156753038|NCT03130959|565848260|FG009|Overall Study|Lost to Follow-up|0|||
156753039|NCT04446429|565848261|FG000|Overall Study|Lost to Follow-up|6|||
156753040|NCT04446429|565848262|FG001|Overall Study|Lost to Follow-up|0|||
156753041|NCT05205005|565848263|FG000|Overall Study|Withdrawal by Subject|1|||
156753042|NCT05205005|565848264|FG001|Overall Study|Withdrawal by Subject|0|||
156753043|NCT05205005|565848263|FG000|Overall Study|Adverse Event|1|||
156753044|NCT05205005|565848264|FG001|Overall Study|Adverse Event|0|||
156753045|NCT02821416|565848265|FG000|Overall Study|Adverse Event|0|||
156753046|NCT02821416|565848266|FG001|Overall Study|Adverse Event|1|||
156753047|NCT02821416|565848265|FG000|Overall Study|Withdrawal by Subject|2|||
156753048|NCT02821416|565848266|FG001|Overall Study|Withdrawal by Subject|0|||
156753049|NCT02821416|565848265|FG000|Overall Study|Lost to Follow-up|1|||
156753050|NCT02821416|565848266|FG001|Overall Study|Lost to Follow-up|0|||
156753051|NCT03042910|565848271|FG000|Overall Study|Adverse Event|1|||
156753052|NCT03042910|565848271|FG000|Overall Study|Disease Progression|2|||
156753053|NCT03042910|565848271|FG000|Overall Study|Withdrawal by Subject|3|||
156753054|NCT03042910|565848271|FG000|Overall Study|Enrolled but not treated|1|||
156753055|NCT02256917|565848272|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
156753056|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
156753057|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
156753058|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
156753059|NCT02256917|565848272|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
156753060|NCT02933528|565848273|FG000|Overall Study|Lost to Follow-up|2|||
156753061|NCT01301079|565848276|FG000|Overall Study|Lost to Follow-up|2|||
156753062|NCT01301079|565848277|FG001|Overall Study|Lost to Follow-up|2|||
156753063|NCT00313586|565848278|FG000|Overall Study|Disease progression|14|||
156753064|NCT00313586|565848279|FG001|Overall Study|Disease progression|19|||
156753065|NCT00313586|565848280|FG002|Overall Study|Disease progression|10|||
156753066|NCT00313586|565848281|FG003|Overall Study|Disease progression|3|||
156753067|NCT00313586|565848278|FG000|Overall Study|Adverse Event|12|||
156753068|NCT00313586|565848279|FG001|Overall Study|Adverse Event|18|||
156753069|NCT00313586|565848280|FG002|Overall Study|Adverse Event|3|||
156753070|NCT00313586|565848281|FG003|Overall Study|Adverse Event|10|||
156753071|NCT00313586|565848278|FG000|Overall Study|Death|11|||
156753072|NCT00313586|565848279|FG001|Overall Study|Death|8|||
156753073|NCT00313586|565848280|FG002|Overall Study|Death|1|||
156753074|NCT00313586|565848281|FG003|Overall Study|Death|7|||
156753075|NCT00313586|565848278|FG000|Overall Study|Withdrawal by Subject|13|||
156753076|NCT00313586|565848279|FG001|Overall Study|Withdrawal by Subject|6|||
156995984|NCT00828919|566737644|FG001|Overall Study|Adverse Event|2|||
157099202|NCT01176968|567118232|FG001|Overall Study|Reason not defined|3|||
157099203|NCT04485104|567118247|FG000|Overall Study|Physician Decision|2|||
157099204|NCT04485104|567118248|FG001|Overall Study|Physician Decision|0|||
157099205|NCT04485104|567118247|FG000|Overall Study|Decision by sponsor|0|||
157099206|NCT04485104|567118248|FG001|Overall Study|Decision by sponsor|1|||
157099207|NCT00744523|567118249|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
157099208|NCT00744523|567118250|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
157099209|NCT05057247|567118251|FG000|Overall Study|Death|4|||
157099210|NCT05057247|567118251|FG000|Overall Study|Physician Decision|3|||
157099211|NCT05057247|567118251|FG000|Overall Study|Progressive Disease|7|||
157099212|NCT05057247|567118251|FG000|Overall Study|Withdrawal by Subject|3|||
157099213|NCT05057247|567118251|FG000|Overall Study|Adverse Event|6|||
157099214|NCT05057247|567118251|FG000|Overall Study|Subject Non-Compliance|1|||
157099215|NCT05057247|567118251|FG000|Overall Study|On treatment|2|||
157099216|NCT03588728|567118255|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
157099217|NCT03588728|567118256|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
157099218|NCT03588728|567118257|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
156753077|NCT00313586|565848280|FG002|Overall Study|Withdrawal by Subject|6|||
156753078|NCT00313586|565848281|FG003|Overall Study|Withdrawal by Subject|2|||
156753079|NCT00313586|565848278|FG000|Overall Study|Alternative therapy|3|||
156753080|NCT00313586|565848279|FG001|Overall Study|Alternative therapy|6|||
156753081|NCT00313586|565848280|FG002|Overall Study|Alternative therapy|2|||
156753082|NCT00313586|565848281|FG003|Overall Study|Alternative therapy|0|||
156753083|NCT00313586|565848278|FG000|Overall Study|Other complicating disease|2|||
156753084|NCT00313586|565848279|FG001|Overall Study|Other complicating disease|2|||
156753085|NCT00313586|565848280|FG002|Overall Study|Other complicating disease|0|||
156753086|NCT00313586|565848281|FG003|Overall Study|Other complicating disease|0|||
156753087|NCT00313586|565848278|FG000|Overall Study|Did not achieve HI-major/better response|10|||
156753088|NCT00313586|565848279|FG001|Overall Study|Did not achieve HI-major/better response|7|||
156753089|NCT00313586|565848280|FG002|Overall Study|Did not achieve HI-major/better response|2|||
156753090|NCT00313586|565848281|FG003|Overall Study|Did not achieve HI-major/better response|1|||
156753091|NCT00313586|565848278|FG000|Overall Study|Physician Decision|2|||
156753092|NCT00313586|565848279|FG001|Overall Study|Physician Decision|1|||
156753093|NCT00313586|565848280|FG002|Overall Study|Physician Decision|0|||
156753094|NCT00313586|565848281|FG003|Overall Study|Physician Decision|0|||
156753095|NCT00313586|565848278|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
156753096|NCT00313586|565848279|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
156753097|NCT00313586|565848280|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
156753098|NCT00313586|565848281|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
156753099|NCT00313586|565848278|FG000|Overall Study|Lost insurance|0|||
156753100|NCT00313586|565848279|FG001|Overall Study|Lost insurance|1|||
156753101|NCT00313586|565848280|FG002|Overall Study|Lost insurance|0|||
156753102|NCT00313586|565848281|FG003|Overall Study|Lost insurance|0|||
156753103|NCT00313586|565848278|FG000|Overall Study|Moved|0|||
156753104|NCT00313586|565848279|FG001|Overall Study|Moved|1|||
156753105|NCT00313586|565848280|FG002|Overall Study|Moved|0|||
156753106|NCT00313586|565848281|FG003|Overall Study|Moved|0|||
156753107|NCT00313586|565848278|FG000|Overall Study|Death before starting treatment|1|||
156753108|NCT00313586|565848279|FG001|Overall Study|Death before starting treatment|0|||
156753109|NCT00313586|565848280|FG002|Overall Study|Death before starting treatment|0|||
156753110|NCT00313586|565848281|FG003|Overall Study|Death before starting treatment|0|||
156753111|NCT01639703|565848282|FG000|Overall Study|Withdrawal by Subject|5|||
156753112|NCT01639703|565848282|FG000|Overall Study|Other reason|7|||
156753113|NCT02087670|565848283|FG000|Overall Study|Withdrawal by Subject|3|||
156753114|NCT02087670|565848284|FG001|Overall Study|Withdrawal by Subject|2|||
156753115|NCT00264290|565848286|FG000|Intervention (8 Weeks)|Adverse Event|1|||
156753116|NCT00264290|565848287|FG001|Intervention (8 Weeks)|Adverse Event|0|||
156753117|NCT04472494|565848288|FG000|Pre-treatment|Other reasons|2|||
156753118|NCT04472494|565848289|FG001|Pre-treatment|Other reasons|0|||
156753119|NCT04472494|565848288|FG000|Treatment|Death|5|||
156753120|NCT04472494|565848289|FG001|Treatment|Death|2|||
156995985|NCT00828919|566737645|FG002|Overall Study|Adverse Event|2|||
156995986|NCT00828919|566737646|FG003|Overall Study|Adverse Event|1|||
156995987|NCT00828919|566737647|FG004|Overall Study|Adverse Event|3|||
156995988|NCT00828919|566737643|FG000|Overall Study|Objective progression or relapse|4|||
156995989|NCT00828919|566737644|FG001|Overall Study|Objective progression or relapse|4|||
156995990|NCT00828919|566737645|FG002|Overall Study|Objective progression or relapse|11|||
156995991|NCT00828919|566737646|FG003|Overall Study|Objective progression or relapse|0|||
156995992|NCT00828919|566737647|FG004|Overall Study|Objective progression or relapse|5|||
156995993|NCT00828919|566737643|FG000|Overall Study|No longer willing to participate in study|0|||
156995994|NCT00828919|566737644|FG001|Overall Study|No longer willing to participate in study|0|||
156995995|NCT00828919|566737645|FG002|Overall Study|No longer willing to participate in study|2|||
156995996|NCT00828919|566737646|FG003|Overall Study|No longer willing to participate in study|0|||
156995997|NCT00828919|566737647|FG004|Overall Study|No longer willing to participate in study|0|||
156995998|NCT00828919|566737643|FG000|Overall Study|Insufficient Clinical Response|0|||
156995999|NCT00828919|566737644|FG001|Overall Study|Insufficient Clinical Response|1|||
156996000|NCT00828919|566737645|FG002|Overall Study|Insufficient Clinical Response|2|||
156996001|NCT00828919|566737646|FG003|Overall Study|Insufficient Clinical Response|0|||
156996002|NCT00828919|566737647|FG004|Overall Study|Insufficient Clinical Response|0|||
156996003|NCT00828919|566737643|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156996004|NCT00828919|566737644|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
157021610|NCT04739956|566830923|FG000|Overall Study|Withdrawal by Subject|1|||
156753121|NCT04472494|565848288|FG000|Treatment|Hospital discharge|1|||
156753122|NCT04472494|565848289|FG001|Treatment|Hospital discharge|1|||
156753123|NCT03519919|565848290|FG000|Overall Study|Withdrawal by Subject|1|||
156753124|NCT03519919|565848290|FG000|Overall Study|Lack of Efficacy|1|||
156753125|NCT03519919|565848290|FG000|Overall Study|Screen Failure|1|||
156753126|NCT03076996|565848291|FG000|Overall Study|Withdrawal by Subject|2|||
156753127|NCT03076996|565848291|FG000|Overall Study|Lost to Follow-up|3|||
156753128|NCT03076996|565848291|FG000|Overall Study|Literacy precluded participation|1|||
156753129|NCT00587795|565848292|FG000|Overall Study|Withdrawal by Subject|1|||
156753130|NCT00587795|565848293|FG001|Overall Study|Withdrawal by Subject|0|||
156753131|NCT02144077|565848294|FG000|Overall Study|Withdrawal by Subject|3|||
156753132|NCT02144077|565848295|FG001|Overall Study|Withdrawal by Subject|3|||
156753133|NCT02144077|565848294|FG000|Overall Study|Adverse Event|2|||
156753134|NCT02144077|565848295|FG001|Overall Study|Adverse Event|3|||
156753135|NCT02144077|565848294|FG000|Overall Study|Lost to Follow-up|2|||
156753136|NCT02144077|565848295|FG001|Overall Study|Lost to Follow-up|2|||
156753137|NCT02144077|565848294|FG000|Overall Study|Protocol Violation|1|||
156753138|NCT02144077|565848295|FG001|Overall Study|Protocol Violation|2|||
156753139|NCT02144077|565848294|FG000|Overall Study|Death|0|||
156753140|NCT02144077|565848295|FG001|Overall Study|Death|1|||
156753141|NCT02144077|565848294|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
156753142|NCT02144077|565848295|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
156753143|NCT01869777|565848296|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
156753144|NCT00943592|565848297|FG000|Overall Study|Death|3|||
156753145|NCT01909973|565848298|FG000|Overall Study|Lost to Follow-up|1|||
156753146|NCT01909973|565848299|FG001|Overall Study|Lost to Follow-up|0|||
156753147|NCT02072941|565848300|FG000|Overall Study|Withdrawal by Subject|29|||
156753148|NCT02072941|565848301|FG001|Overall Study|Withdrawal by Subject|21|||
156753149|NCT02072941|565848300|FG000|Overall Study|Lost to Follow-up|4|||
156753150|NCT02072941|565848301|FG001|Overall Study|Lost to Follow-up|4|||
156753151|NCT02072941|565848300|FG000|Overall Study|Death|3|||
156753152|NCT02072941|565848301|FG001|Overall Study|Death|2|||
156753153|NCT02072941|565848300|FG000|Overall Study|Removed by Study Staff|2|||
156753154|NCT02072941|565848301|FG001|Overall Study|Removed by Study Staff|2|||
156753155|NCT01247350|565848304|FG000|Overall Study|Adverse Event|0|||
156753156|NCT01247350|565848305|FG001|Overall Study|Adverse Event|0|||
156753157|NCT01247350|565848306|FG002|Overall Study|Adverse Event|1|||
156753158|NCT01247350|565848307|FG003|Overall Study|Adverse Event|0|||
156753159|NCT01247350|565848308|FG004|Overall Study|Adverse Event|0|||
156753160|NCT01247350|565848304|FG000|Overall Study|Withdrawal by Subject|0|||
156753161|NCT01247350|565848305|FG001|Overall Study|Withdrawal by Subject|0|||
156753162|NCT01247350|565848306|FG002|Overall Study|Withdrawal by Subject|0|||
156753163|NCT01247350|565848307|FG003|Overall Study|Withdrawal by Subject|1|||
156753164|NCT01247350|565848308|FG004|Overall Study|Withdrawal by Subject|0|||
156753165|NCT01247350|565848304|FG000|Overall Study|Entry criteria not met|0|||
156753166|NCT01247350|565848305|FG001|Overall Study|Entry criteria not met|0|||
156753167|NCT01247350|565848306|FG002|Overall Study|Entry criteria not met|0|||
156753168|NCT01247350|565848307|FG003|Overall Study|Entry criteria not met|0|||
156753169|NCT01247350|565848308|FG004|Overall Study|Entry criteria not met|1|||
156753170|NCT00169104|565848309|FG000|Overall Study|Withdrawal by Subject|2|||
156753171|NCT00169104|565848310|FG001|Overall Study|Withdrawal by Subject|0|||
156753172|NCT00169104|565848309|FG000|Overall Study|Protocol Violation|0|||
156753173|NCT00169104|565848310|FG001|Overall Study|Protocol Violation|1|||
156753174|NCT00169104|565848309|FG000|Overall Study|Physician Decision|0|||
156753175|NCT00169104|565848310|FG001|Overall Study|Physician Decision|1|||
156753176|NCT00715299|565848317|FG000|Overall Study|Withdrawal by Subject|1|||
156753177|NCT00715299|565848317|FG000|Overall Study|Adverse Event|3|||
156753178|NCT00715299|565848317|FG000|Overall Study|failed the pre-screen exercise test|2|||
156753179|NCT02020889|565848318|FG000|Overall Study|Adverse Event|0|||
156753180|NCT02020889|565848319|FG001|Overall Study|Adverse Event|1|||
156753181|NCT02020889|565848318|FG000|Overall Study|Lack of Efficacy|1|||
156753182|NCT02020889|565848319|FG001|Overall Study|Lack of Efficacy|0|||
156753183|NCT02020889|565848318|FG000|Overall Study|Lost to Follow-up|1|||
156753184|NCT02020889|565848319|FG001|Overall Study|Lost to Follow-up|0|||
156753185|NCT02020889|565848318|FG000|Overall Study|Physician Decision|2|||
156753186|NCT02020889|565848319|FG001|Overall Study|Physician Decision|0|||
156753187|NCT02020889|565848318|FG000|Overall Study|Withdrawal by Subject|3|||
156753188|NCT02020889|565848319|FG001|Overall Study|Withdrawal by Subject|2|||
156753189|NCT01540981|565848320|FG000|Overall Study|Withdrawal by Subject|1|||
156753190|NCT01540981|565848321|FG001|Overall Study|Withdrawal by Subject|0|||
156753191|NCT00809094|565848322|FG000|Overall Study|Lost to Follow-up|0|||
156753192|NCT00809094|565848323|FG001|Overall Study|Lost to Follow-up|1|||
156753193|NCT00232557|565848324|FG000|Overall Study|Lost to Follow-up|3|||
156753194|NCT00232557|565848325|FG001|Overall Study|Lost to Follow-up|5|||
156753195|NCT02438280|565848328|FG000|Overall Study|Physician Decision|1|||
156753196|NCT02438280|565848329|FG001|Overall Study|Physician Decision|0|||
156753197|NCT04435808|565848332|FG000|Overall Study|Study stopped by DSMB|0|||
156753198|NCT04435808|565848333|FG001|Overall Study|Study stopped by DSMB|1|||
156753199|NCT02457195|565848334|FG000|Overall Study|Adverse Event|3|||
156753200|NCT02457195|565848334|FG000|Overall Study|Protocol Violation|2|||
156753201|NCT02457195|565848334|FG000|Overall Study|Withdrawal by Subject|4|||
156753202|NCT02768792|565848336|FG000|Overall Study|Adverse Event|1|||
156753203|NCT04819438|565848337|FG000|Overall Study|Withdrawal by Subject|1|||
156753204|NCT04819438|565848338|FG001|Overall Study|Withdrawal by Subject|0|||
156753205|NCT04819438|565848337|FG000|Overall Study|Adverse Event|0|||
156753206|NCT04819438|565848338|FG001|Overall Study|Adverse Event|1|||
156753207|NCT04819438|565848337|FG000|Overall Study|Protocol Violation|0|||
156996005|NCT00828919|566737645|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156996006|NCT00828919|566737646|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
156996007|NCT00828919|566737647|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
156996008|NCT00828919|566737643|FG000|Overall Study|Other|1|||
156996009|NCT00828919|566737644|FG001|Overall Study|Other|0|||
156996010|NCT00828919|566737645|FG002|Overall Study|Other|1|||
156996011|NCT00828919|566737646|FG003|Overall Study|Other|1|||
156996012|NCT00828919|566737647|FG004|Overall Study|Other|0|||
156996013|NCT00828919|566737643|FG000|Overall Study|Lost to Follow-up|0|||
156996014|NCT00828919|566737644|FG001|Overall Study|Lost to Follow-up|1|||
156996015|NCT00828919|566737645|FG002|Overall Study|Lost to Follow-up|0|||
156996016|NCT00828919|566737646|FG003|Overall Study|Lost to Follow-up|0|||
156996017|NCT00828919|566737647|FG004|Overall Study|Lost to Follow-up|0|||
156996018|NCT01562743|566737648|FG000|Overall Study|Adverse Event|29|||
156996019|NCT01562743|566737648|FG000|Overall Study|Lack of Efficacy|3|||
156996020|NCT01562743|566737648|FG000|Overall Study|Withdrawal by Subject|13|||
156996021|NCT01562743|566737648|FG000|Overall Study|Protocol Violation|1|||
156996022|NCT01562743|566737648|FG000|Overall Study|Discontinuation criteria|2|||
156996023|NCT01562743|566737648|FG000|Overall Study|Lost to Follow-up|2|||
156996024|NCT01562743|566737648|FG000|Overall Study|Physician Decision|2|||
156996025|NCT05567159|566737649|FG000|Overall Study|Adverse Event|4|||
156996026|NCT05567159|566737649|FG000|Overall Study|Physician Decision|3|||
156996027|NCT05567159|566737649|FG000|Overall Study|Protocol deviation|1|||
156996028|NCT04155424|566737652|FG000|Overall Study|Other than specified|3|||
156996029|NCT04155424|566737652|FG000|Overall Study|Withdrawal by Subject|1|||
156996030|NCT04155424|566737652|FG000|Overall Study|Adverse Event|1|||
156996031|NCT03227757|566739431|FG000|Overall Study|Death|25|||
156996032|NCT03227757|566739431|FG000|Overall Study|Withdrawal|10|||
156996033|NCT03227757|566739431|FG000|Overall Study|Missed visits|1|||
156996034|NCT03227757|566739431|FG000|Overall Study|Lost to Follow-up|2|||
156996035|NCT04381494|566739436|FG000|Overall Study|Early termination of trial|19|||
156996036|NCT04381494|566739436|FG000|Overall Study|Investigator's discretion|1|||
156996037|NCT04381494|566739436|FG000|Overall Study|Withdrawal by Subject|9|||
156996038|NCT04381494|566739436|FG000|Overall Study|NSCLC disease progression|4|||
156996039|NCT04381494|566739436|FG000|Overall Study|Device-Related Adverse Event|2|||
156996040|NCT03467724|566739437|FG000|Overall Study|Lost to Follow-up|5|||
156996041|NCT03467724|566739437|FG000|Overall Study|Withdrawal by Subject|1|||
156996042|NCT03467724|566739437|FG000|Overall Study|Protocol Violation|1|||
156996043|NCT03467724|566739437|FG000|Overall Study|Adverse Event|1|||
156996044|NCT04310579|566739438|FG000|Overall Study|Adverse Event|0|||
156996045|NCT04310579|566739439|FG001|Overall Study|Adverse Event|0|||
156996046|NCT04310579|566739440|FG002|Overall Study|Adverse Event|0|||
156996047|NCT04310579|566739441|FG003|Overall Study|Adverse Event|0|||
156996048|NCT04310579|566739442|FG004|Overall Study|Adverse Event|0|||
156996049|NCT04310579|566739443|FG005|Overall Study|Adverse Event|0|||
156996050|NCT04310579|566739444|FG006|Overall Study|Adverse Event|2|||
156996051|NCT04310579|566739445|FG007|Overall Study|Adverse Event|0|||
156996052|NCT04310579|566739446|FG008|Overall Study|Adverse Event|1|||
156996053|NCT04310579|566739447|FG009|Overall Study|Adverse Event|1|||
156996054|NCT04310579|566739448|FG010|Overall Study|Adverse Event|0|||
156996055|NCT04310579|566739438|FG000|Overall Study|Withdrawal by Subject|0|||
156996056|NCT04310579|566739439|FG001|Overall Study|Withdrawal by Subject|0|||
156996057|NCT04310579|566739440|FG002|Overall Study|Withdrawal by Subject|0|||
156996058|NCT04310579|566739441|FG003|Overall Study|Withdrawal by Subject|0|||
156996059|NCT04310579|566739442|FG004|Overall Study|Withdrawal by Subject|0|||
156996060|NCT04310579|566739443|FG005|Overall Study|Withdrawal by Subject|1|||
156996061|NCT04310579|566739444|FG006|Overall Study|Withdrawal by Subject|0|||
156996062|NCT04310579|566739445|FG007|Overall Study|Withdrawal by Subject|0|||
156996063|NCT04310579|566739446|FG008|Overall Study|Withdrawal by Subject|0|||
156996064|NCT04310579|566739447|FG009|Overall Study|Withdrawal by Subject|0|||
156996065|NCT04310579|566739448|FG010|Overall Study|Withdrawal by Subject|0|||
156996066|NCT04310579|566739438|FG000|Overall Study|Positive COVID-19 test|0|||
156996067|NCT04310579|566739439|FG001|Overall Study|Positive COVID-19 test|0|||
156996068|NCT04310579|566739440|FG002|Overall Study|Positive COVID-19 test|0|||
156996069|NCT04310579|566739441|FG003|Overall Study|Positive COVID-19 test|0|||
156996070|NCT04310579|566739442|FG004|Overall Study|Positive COVID-19 test|0|||
156996071|NCT04310579|566739443|FG005|Overall Study|Positive COVID-19 test|0|||
156996072|NCT04310579|566739444|FG006|Overall Study|Positive COVID-19 test|0|||
156996073|NCT04310579|566739445|FG007|Overall Study|Positive COVID-19 test|0|||
156996074|NCT04310579|566739446|FG008|Overall Study|Positive COVID-19 test|0|||
156996075|NCT04310579|566739447|FG009|Overall Study|Positive COVID-19 test|0|||
156996076|NCT04310579|566739448|FG010|Overall Study|Positive COVID-19 test|1|||
157099219|NCT03588728|567118258|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
156996077|NCT03721016|566739449|FG000|Overall Study|Adverse Event|0|||
156996078|NCT03721016|566739450|FG001|Overall Study|Adverse Event|1|||
156996079|NCT03721016|566739451|FG002|Overall Study|Adverse Event|1|||
156996080|NCT03721016|566739449|FG000|Overall Study|Withdrawal by Subject|8|||
156753208|NCT04819438|565848338|FG001|Overall Study|Protocol Violation|1|||
156753209|NCT05359952|565848340|FG000|Overall Study|Lost to Follow-up|1|||
156753210|NCT05359952|565848341|FG001|Overall Study|Lost to Follow-up|0|||
156753211|NCT00237692|565848343|FG000|Overall Study|Lost to Follow-up|9|||
156753212|NCT00237692|565848344|FG001|Overall Study|Lost to Follow-up|3|||
156753213|NCT00237692|565848345|FG002|Overall Study|Lost to Follow-up|5|||
156753214|NCT00237692|565848346|FG003|Overall Study|Lost to Follow-up|3|||
156753215|NCT00237692|565848343|FG000|Overall Study|Death|1|||
156753216|NCT00237692|565848344|FG001|Overall Study|Death|2|||
156753217|NCT00237692|565848345|FG002|Overall Study|Death|2|||
156753218|NCT00237692|565848346|FG003|Overall Study|Death|3|||
156753219|NCT00237692|565848343|FG000|Overall Study|Excluded - did not meet criteria|4|||
156753220|NCT00237692|565848344|FG001|Overall Study|Excluded - did not meet criteria|3|||
156753221|NCT00237692|565848345|FG002|Overall Study|Excluded - did not meet criteria|5|||
156753222|NCT00237692|565848346|FG003|Overall Study|Excluded - did not meet criteria|9|||
156753223|NCT00237692|565848343|FG000|Overall Study|Withdrawal by Subject|4|||
156753224|NCT00237692|565848344|FG001|Overall Study|Withdrawal by Subject|6|||
156753225|NCT00237692|565848345|FG002|Overall Study|Withdrawal by Subject|10|||
156753226|NCT00237692|565848346|FG003|Overall Study|Withdrawal by Subject|4|||
156753227|NCT01386944|565848353|FG000|Overall Study|Adverse Event|26|||
156753228|NCT01386944|565848353|FG000|Overall Study|Lack of Efficacy|14|||
156753229|NCT01386944|565848353|FG000|Overall Study|Lost to Follow-up|8|||
156753230|NCT01386944|565848353|FG000|Overall Study|Unspecified reason|8|||
156753231|NCT04186221|565848354|FG000|Overall Study|Death|1|||
156753232|NCT00531947|565848355|FG000|Overall Study|Adverse Event|5|||
156753233|NCT00531947|565848356|FG001|Overall Study|Adverse Event|10|||
156753234|NCT00531947|565848355|FG000|Overall Study|Lost to Follow-up|12|||
156753235|NCT00531947|565848356|FG001|Overall Study|Lost to Follow-up|9|||
156753236|NCT00531947|565848355|FG000|Overall Study|Withdrawal by Subject|14|||
156753237|NCT00531947|565848356|FG001|Overall Study|Withdrawal by Subject|19|||
156753238|NCT00531947|565848355|FG000|Overall Study|Protocol Violation|2|||
156753239|NCT00531947|565848356|FG001|Overall Study|Protocol Violation|1|||
156753240|NCT00531947|565848355|FG000|Overall Study|Non-Compliance|4|||
156753241|NCT00531947|565848356|FG001|Overall Study|Non-Compliance|7|||
156753242|NCT00531947|565848355|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
156753243|NCT00531947|565848356|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
156753244|NCT02348008|565848357|FG000|Overall Study|Adverse Event|2|||
156753245|NCT02348008|565848358|FG001|Overall Study|Adverse Event|3|||
156753246|NCT02348008|565848359|FG002|Overall Study|Adverse Event|3|||
156753247|NCT02348008|565848357|FG000|Overall Study|Disease Progression|1|||
156753248|NCT02348008|565848358|FG001|Overall Study|Disease Progression|5|||
156753249|NCT02348008|565848359|FG002|Overall Study|Disease Progression|16|||
156753250|NCT02348008|565848357|FG000|Overall Study|Withdrawal by Subject|0|||
156753251|NCT02348008|565848358|FG001|Overall Study|Withdrawal by Subject|1|||
156753252|NCT02348008|565848359|FG002|Overall Study|Withdrawal by Subject|0|||
156753253|NCT02348008|565848357|FG000|Overall Study|Symptomatic Deterioration|0|||
156753254|NCT02348008|565848358|FG001|Overall Study|Symptomatic Deterioration|1|||
156753255|NCT02348008|565848359|FG002|Overall Study|Symptomatic Deterioration|0|||
156753256|NCT00893971|565848360|FG000|Overall Study|Physician Decision|3|||
156753257|NCT03268005|565848361|FG000|Overall Study|Death|2|||
156753258|NCT03268005|565848362|FG001|Overall Study|Death|1|||
156753259|NCT03268005|565848361|FG000|Overall Study|Lost to Follow-up|2|||
156753260|NCT03268005|565848362|FG001|Overall Study|Lost to Follow-up|2|||
156753261|NCT03268005|565848361|FG000|Overall Study|Withdrawal by Subject|11|||
156753262|NCT03268005|565848362|FG001|Overall Study|Withdrawal by Subject|11|||
156753263|NCT01926197|565848364|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
156753264|NCT01926197|565848365|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
156753265|NCT01926197|565848364|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
156753266|NCT01926197|565848365|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
156753267|NCT02756364|565848366|FG000|Overall Study|Site Terminated by Sponsor|24|||
156753268|NCT02756364|565848367|FG001|Overall Study|Site Terminated by Sponsor|30|||
156753269|NCT02756364|565848368|FG002|Overall Study|Site Terminated by Sponsor|21|||
156753270|NCT02756364|565848366|FG000|Overall Study|Death|20|||
156753271|NCT02756364|565848367|FG001|Overall Study|Death|15|||
156753272|NCT02756364|565848368|FG002|Overall Study|Death|18|||
156753273|NCT02756364|565848366|FG000|Overall Study|Withdrawal by Patient|2|||
156753274|NCT02756364|565848367|FG001|Overall Study|Withdrawal by Patient|1|||
156753275|NCT02756364|565848368|FG002|Overall Study|Withdrawal by Patient|8|||
156753276|NCT02756364|565848366|FG000|Overall Study|Lost to Follow-up|0|||
156753277|NCT02756364|565848367|FG001|Overall Study|Lost to Follow-up|1|||
156753278|NCT02756364|565848368|FG002|Overall Study|Lost to Follow-up|1|||
156753279|NCT02223364|565848369|FG000|Overall Study|Protocol Violation|3|||
156753280|NCT02223364|565848370|FG001|Overall Study|Protocol Violation|0|||
156753281|NCT02223364|565848371|FG002|Overall Study|Protocol Violation|3|||
156753282|NCT02223364|565848369|FG000|Overall Study|subject expired before surgery|1|||
156753283|NCT02223364|565848370|FG001|Overall Study|subject expired before surgery|0|||
156753284|NCT02223364|565848371|FG002|Overall Study|subject expired before surgery|0|||
156753285|NCT02223364|565848369|FG000|Overall Study|Physician Decision|1|||
156753286|NCT02223364|565848370|FG001|Overall Study|Physician Decision|0|||
156753287|NCT02223364|565848371|FG002|Overall Study|Physician Decision|0|||
156753288|NCT01416155|565848372|FG000|Overall Study|Adverse Event|8|||
156753289|NCT01416155|565848372|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
156753290|NCT01416155|565848372|FG000|Overall Study|Withdrawal by Subject|33|||
156753291|NCT01416155|565848372|FG000|Overall Study|Investigator decision|8|||
156753292|NCT01416155|565848372|FG000|Overall Study|Other|7|||
156753293|NCT00829829|565848376|FG000|Overall Study|Protocol Violation|0|||
156753294|NCT00829829|565848377|FG001|Overall Study|Protocol Violation|3|||
156753295|NCT00829829|565848378|FG002|Overall Study|Protocol Violation|0|||
156753296|NCT00829829|565848376|FG000|Overall Study|Adverse Event|4|||
156753297|NCT00829829|565848377|FG001|Overall Study|Adverse Event|4|||
156753298|NCT00829829|565848378|FG002|Overall Study|Adverse Event|3|||
156753299|NCT00829829|565848376|FG000|Overall Study|Withdrawal by Subject|8|||
156753300|NCT00829829|565848377|FG001|Overall Study|Withdrawal by Subject|4|||
156753301|NCT00829829|565848378|FG002|Overall Study|Withdrawal by Subject|2|||
156753302|NCT00829829|565848376|FG000|Overall Study|Decision by the Sponsor|1|||
156753303|NCT00829829|565848377|FG001|Overall Study|Decision by the Sponsor|0|||
156753304|NCT00829829|565848378|FG002|Overall Study|Decision by the Sponsor|2|||
156753305|NCT00829829|565848376|FG000|Overall Study|Lost to Follow-up|7|||
156753306|NCT00829829|565848377|FG001|Overall Study|Lost to Follow-up|3|||
156753307|NCT00829829|565848378|FG002|Overall Study|Lost to Follow-up|3|||
156753308|NCT00829829|565848376|FG000|Overall Study|Other than specified above|2|||
156753309|NCT00829829|565848377|FG001|Overall Study|Other than specified above|2|||
156753310|NCT00829829|565848378|FG002|Overall Study|Other than specified above|1|||
156753311|NCT02685072|565848379|FG000|Treatment Period|Lost to Follow-up|12|||
156753312|NCT02685072|565848380|FG001|Treatment Period|Lost to Follow-up|6|||
156753313|NCT02685072|565848379|FG000|Treatment Period|Withdrawal by Subject|1|||
156753314|NCT02685072|565848380|FG001|Treatment Period|Withdrawal by Subject|3|||
156753315|NCT02685072|565848379|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
156753316|NCT02685072|565848380|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
156753317|NCT00382109|565848383|FG000|Overall Study|Adverse Event|3|||
156753318|NCT00382109|565848384|FG001|Overall Study|Adverse Event|0|||
156753319|NCT00382109|565848383|FG000|Overall Study|Physician Decision|6|||
156753320|NCT00382109|565848384|FG001|Overall Study|Physician Decision|1|||
156753321|NCT00382109|565848383|FG000|Overall Study|Withdrawal by Subject|1|||
156753322|NCT00382109|565848384|FG001|Overall Study|Withdrawal by Subject|0|||
156753323|NCT00382109|565848383|FG000|Overall Study|ineligible|2|||
156753324|NCT00382109|565848384|FG001|Overall Study|ineligible|0|||
156753325|NCT00382109|565848383|FG000|Overall Study|Other|0|||
156753326|NCT00382109|565848384|FG001|Overall Study|Other|2|||
156753327|NCT00382109|565848383|FG000|Overall Study|consent withdrawal|0|||
156753328|NCT00382109|565848384|FG001|Overall Study|consent withdrawal|1|||
156753329|NCT01249833|565848385|FG000|Overall Study|Lost to Follow-up|0|||
156753330|NCT01249833|565848386|FG001|Overall Study|Lost to Follow-up|1|||
156753331|NCT02774005|565848387|FG000|Overall Study|Adverse Event|8|||
156753332|NCT02774005|565848387|FG000|Overall Study|Withdrawal by Subject|23|||
156753333|NCT02774005|565848387|FG000|Overall Study|Lost to Follow-up|7|||
156753334|NCT02774005|565848387|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
156753335|NCT02774005|565848387|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
156753336|NCT02774005|565848387|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
156753337|NCT02774005|565848387|FG000|Overall Study|Death|1|||
156753338|NCT02774005|565848387|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
156753339|NCT02774005|565848387|FG000|Overall Study|Lack of compliance with study medication|4|||
156753340|NCT02774005|565848387|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
156753341|NCT02774005|565848387|FG000|Overall Study|another study|1|||
156753342|NCT02774005|565848387|FG000|Overall Study|cardiologist imposed travel restriction|1|||
156753343|NCT03885999|565848388|FG000|Overall Study|Adverse Event|1|||
156753344|NCT01402986|565848389|FG000|Overall Study|Withdrawal by Subject|7|||
156753345|NCT01402986|565848390|FG001|Overall Study|Withdrawal by Subject|10|||
156753346|NCT01402986|565848391|FG002|Overall Study|Withdrawal by Subject|7|||
156753347|NCT01402986|565848392|FG003|Overall Study|Withdrawal by Subject|13|||
156753348|NCT01402986|565848389|FG000|Overall Study|Death|0|||
156753349|NCT01402986|565848390|FG001|Overall Study|Death|0|||
156753350|NCT01402986|565848391|FG002|Overall Study|Death|0|||
156753351|NCT01402986|565848392|FG003|Overall Study|Death|2|||
156753352|NCT01402986|565848389|FG000|Overall Study|Lost to Follow-up|0|||
156753353|NCT01402986|565848390|FG001|Overall Study|Lost to Follow-up|0|||
156753354|NCT01402986|565848391|FG002|Overall Study|Lost to Follow-up|0|||
156753355|NCT01402986|565848392|FG003|Overall Study|Lost to Follow-up|1|||
156753356|NCT01402986|565848389|FG000|Overall Study|Other|2|||
156753357|NCT01402986|565848390|FG001|Overall Study|Other|5|||
156753358|NCT01402986|565848391|FG002|Overall Study|Other|1|||
156753359|NCT01402986|565848392|FG003|Overall Study|Other|6|||
156753360|NCT03749109|565848393|FG000|Overall Study|Adverse Event|2|||
156753361|NCT03749109|565848394|FG001|Overall Study|Adverse Event|0|||
156753362|NCT03178851|565848395|FG000|Overall Study|Death|48|||
156996081|NCT03721016|566739450|FG001|Overall Study|Withdrawal by Subject|16|||
156996082|NCT03721016|566739451|FG002|Overall Study|Withdrawal by Subject|13|||
156996083|NCT03721016|566739449|FG000|Overall Study|Lost to Follow-up|4|||
156996084|NCT03721016|566739450|FG001|Overall Study|Lost to Follow-up|6|||
156996085|NCT03721016|566739451|FG002|Overall Study|Lost to Follow-up|5|||
156996086|NCT03721016|566739449|FG000|Overall Study|Physician Decision|0|||
156996087|NCT03721016|566739450|FG001|Overall Study|Physician Decision|1|||
156996088|NCT03721016|566739451|FG002|Overall Study|Physician Decision|2|||
156996089|NCT03721016|566739449|FG000|Overall Study|Protocol Violation|0|||
156996090|NCT03721016|566739450|FG001|Overall Study|Protocol Violation|1|||
156996091|NCT03721016|566739451|FG002|Overall Study|Protocol Violation|0|||
156996092|NCT03721016|566739449|FG000|Overall Study|Site terminated by sponsor|3|||
156996093|NCT03721016|566739450|FG001|Overall Study|Site terminated by sponsor|7|||
156996094|NCT03721016|566739451|FG002|Overall Study|Site terminated by sponsor|6|||
156996095|NCT03721016|566739449|FG000|Overall Study|Subject exited early due to COVID-19|1|||
156996096|NCT03721016|566739450|FG001|Overall Study|Subject exited early due to COVID-19|0|||
156996097|NCT03721016|566739451|FG002|Overall Study|Subject exited early due to COVID-19|0|||
156996098|NCT01149681|566739454|FG000|Overall Study|Withdrawal by Subject|7|||
156996099|NCT01149681|566739454|FG000|Overall Study|Progressive disease|1|||
156996100|NCT01149681|566739454|FG000|Overall Study|Physician Decision|2|||
156996101|NCT01149681|566739454|FG000|Overall Study|adverse events nonrelated study drug|2|||
156996102|NCT00817635|566739455|FG000|Overall Study|Adverse Event|1|||
156996103|NCT00817635|566739456|FG001|Overall Study|Adverse Event|0|||
156996104|NCT00817635|566739457|FG002|Overall Study|Adverse Event|0|||
156996105|NCT00817635|566739458|FG003|Overall Study|Adverse Event|1|||
156996106|NCT00817635|566739459|FG004|Overall Study|Adverse Event|1|||
156996107|NCT00817635|566739455|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156996108|NCT00817635|566739456|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156996109|NCT00817635|566739457|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156996110|NCT00817635|566739458|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
156996111|NCT00817635|566739459|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
156996112|NCT00817635|566739455|FG000|Overall Study|Withdrawal by Subject|2|||
156996113|NCT00817635|566739456|FG001|Overall Study|Withdrawal by Subject|1|||
156996114|NCT00817635|566739457|FG002|Overall Study|Withdrawal by Subject|0|||
156996115|NCT00817635|566739458|FG003|Overall Study|Withdrawal by Subject|1|||
156996116|NCT00817635|566739459|FG004|Overall Study|Withdrawal by Subject|2|||
156996117|NCT00817635|566739455|FG000|Overall Study|Lost to Follow-up|0|||
156996118|NCT00817635|566739456|FG001|Overall Study|Lost to Follow-up|1|||
156996119|NCT00817635|566739457|FG002|Overall Study|Lost to Follow-up|0|||
156996120|NCT00817635|566739458|FG003|Overall Study|Lost to Follow-up|1|||
156996121|NCT00817635|566739459|FG004|Overall Study|Lost to Follow-up|0|||
156996122|NCT00817635|566739455|FG000|Overall Study|Administrative Problems|0|||
156996123|NCT00817635|566739456|FG001|Overall Study|Administrative Problems|0|||
156996124|NCT00817635|566739457|FG002|Overall Study|Administrative Problems|0|||
156996125|NCT00817635|566739458|FG003|Overall Study|Administrative Problems|0|||
156996126|NCT00817635|566739459|FG004|Overall Study|Administrative Problems|1|||
156996127|NCT00817635|566739455|FG000|Overall Study|Protocol Violation|5|||
156996128|NCT00817635|566739456|FG001|Overall Study|Protocol Violation|1|||
156996129|NCT00817635|566739457|FG002|Overall Study|Protocol Violation|3|||
156996130|NCT00817635|566739458|FG003|Overall Study|Protocol Violation|2|||
156996131|NCT00817635|566739459|FG004|Overall Study|Protocol Violation|3|||
156996132|NCT00918957|566739460|FG000|Overall Study|Adverse Event|2|||
156996133|NCT00918957|566739461|FG001|Overall Study|Adverse Event|0|||
156996134|NCT00918957|566739460|FG000|Overall Study|Withdrawal by Subject|1|||
156996135|NCT00918957|566739461|FG001|Overall Study|Withdrawal by Subject|0|||
156996136|NCT03107611|566739462|FG000|Overall Study|Adverse Event|1|||
156996137|NCT03107611|566739463|FG001|Overall Study|Adverse Event|0|||
156996138|NCT03107611|566739464|FG002|Overall Study|Adverse Event|2|||
156996139|NCT03107611|566739462|FG000|Overall Study|Lost to Follow-up|3|||
156996140|NCT03107611|566739463|FG001|Overall Study|Lost to Follow-up|3|||
156996141|NCT03107611|566739464|FG002|Overall Study|Lost to Follow-up|3|||
156996142|NCT03107611|566739462|FG000|Overall Study|Protocol Violation|0|||
156996143|NCT03107611|566739463|FG001|Overall Study|Protocol Violation|0|||
157099220|NCT03588728|567118255|FG000|Overall Study|Lab shut down due to COVID-19|0|||
157099221|NCT03588728|567118256|FG001|Overall Study|Lab shut down due to COVID-19|0|||
157099222|NCT03588728|567118257|FG002|Overall Study|Lab shut down due to COVID-19|0|||
157099223|NCT03588728|567118258|FG003|Overall Study|Lab shut down due to COVID-19|1|||
156996144|NCT03107611|566739464|FG002|Overall Study|Protocol Violation|1|||
156996145|NCT03107611|566739462|FG000|Overall Study|Withdrawal by Subject|1|||
156996146|NCT03107611|566739463|FG001|Overall Study|Withdrawal by Subject|0|||
156996147|NCT03107611|566739464|FG002|Overall Study|Withdrawal by Subject|1|||
156996148|NCT03107611|566739462|FG000|Overall Study|Worsening signs/symptoms|2|||
156996149|NCT03107611|566739463|FG001|Overall Study|Worsening signs/symptoms|1|||
156996150|NCT03107611|566739464|FG002|Overall Study|Worsening signs/symptoms|2|||
156996151|NCT01720446|566739467|FG000|Overall Study|Lost to Follow-up|12|||
156996152|NCT01720446|566739468|FG001|Overall Study|Lost to Follow-up|6|||
156996153|NCT01720446|566739469|FG002|Overall Study|Lost to Follow-up|16|||
156753363|NCT03178851|565848396|FG001|Overall Study|Death|2|||
156753364|NCT03178851|565848397|FG002|Overall Study|Death|25|||
156753365|NCT03178851|565848395|FG000|Overall Study|Withdrawal by Subject|8|||
156753366|NCT03178851|565848396|FG001|Overall Study|Withdrawal by Subject|0|||
156753367|NCT03178851|565848397|FG002|Overall Study|Withdrawal by Subject|0|||
156753368|NCT03178851|565848395|FG000|Overall Study|Lost to Follow-up|5|||
156753369|NCT03178851|565848396|FG001|Overall Study|Lost to Follow-up|2|||
156753370|NCT03178851|565848397|FG002|Overall Study|Lost to Follow-up|0|||
156753371|NCT03178851|565848395|FG000|Overall Study|Adverse Event|0|||
156753372|NCT03178851|565848396|FG001|Overall Study|Adverse Event|0|||
156753373|NCT03178851|565848397|FG002|Overall Study|Adverse Event|1|||
156753374|NCT03178851|565848395|FG000|Overall Study|Study Termination by Sponsor|31|||
156753375|NCT03178851|565848396|FG001|Overall Study|Study Termination by Sponsor|7|||
156753376|NCT03178851|565848397|FG002|Overall Study|Study Termination by Sponsor|26|||
156753377|NCT02226120|565848398|FG000|Overall Study|Adverse Event|60|||
156753378|NCT02226120|565848398|FG000|Overall Study|Death|172|||
156753379|NCT02226120|565848398|FG000|Overall Study|Study terminated by sponsor|1|||
156753380|NCT02226120|565848398|FG000|Overall Study|Technical problems|4|||
156753381|NCT02226120|565848398|FG000|Overall Study|Lost to Follow-up|13|||
156753382|NCT02226120|565848398|FG000|Overall Study|Physician Decision|21|||
156753383|NCT02226120|565848398|FG000|Overall Study|Withdrawal by parent/guardian|36|||
156753384|NCT02226120|565848398|FG000|Overall Study|Non-compliance with study drug|10|||
156753385|NCT02226120|565848398|FG000|Overall Study|Protocol deviation|1|||
156753386|NCT02226120|565848398|FG000|Overall Study|missing treatment disposition pages|2|||
156753387|NCT03034135|565848399|FG000|Overall Study|Withdrawal by Subject|2|||
156753388|NCT02447328|565851327|FG000|Overall Study|Withdrawal by Subject|1|||
156753389|NCT03859648|565851330|FG000|Overall Study|Lost to Follow-up|1|||
156753390|NCT03859648|565851330|FG000|Overall Study|Adverse Event|1|||
156753391|NCT02501161|565851331|FG000|Overall Study|Adverse Event|2|||
156753392|NCT02501161|565851332|FG001|Overall Study|Adverse Event|6|||
156753393|NCT02501161|565851331|FG000|Overall Study|Lost to Follow-up|7|||
156753394|NCT02501161|565851332|FG001|Overall Study|Lost to Follow-up|4|||
156753395|NCT02501161|565851331|FG000|Overall Study|Withdrawal by Subject|10|||
156753396|NCT02501161|565851332|FG001|Overall Study|Withdrawal by Subject|15|||
156753397|NCT02501161|565851331|FG000|Overall Study|Other|3|||
156753398|NCT02501161|565851332|FG001|Overall Study|Other|0|||
156753399|NCT04336475|565851333|FG000|Overall Study|pain|1|||
156753400|NCT04336475|565851334|FG001|Overall Study|pain|0|||
156753401|NCT04336475|565851333|FG000|Overall Study|upper respiratory infection|1|||
156753402|NCT04336475|565851334|FG001|Overall Study|upper respiratory infection|0|||
156753403|NCT04336475|565851333|FG000|Overall Study|Lost to Follow-up|0|||
156753404|NCT04336475|565851334|FG001|Overall Study|Lost to Follow-up|2|||
156753405|NCT02906579|565851339|FG000|Overall Study|Adverse Event|1|||
156753406|NCT02906579|565851339|FG000|Overall Study|Physician Decision|1|||
156753407|NCT02030119|565851340|FG000|Overall Study|Withdrawal by Subject|3|||
156753408|NCT02030119|565851341|FG001|Overall Study|Withdrawal by Subject|1|||
156753409|NCT02030119|565851342|FG002|Overall Study|Withdrawal by Subject|5|||
156753410|NCT02030119|565851343|FG003|Overall Study|Withdrawal by Subject|3|||
156753411|NCT02030119|565851340|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
156753412|NCT02030119|565851341|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
156753413|NCT02030119|565851342|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
156753414|NCT02030119|565851343|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
156753415|NCT00759655|565851344|FG000|Overall Study|Termination of the study by sponsor|1|||
156753416|NCT00905567|565851353|FG000|Washout|Withdrawal by Subject|0|||
156753417|NCT00905567|565851354|FG001|Washout|Withdrawal by Subject|1|||
156753418|NCT01465230|565851355|FG000|Overall Study|Withdrawal by Subject|2|||
156753419|NCT01738919|565851356|FG000|Overall Study|Lost to Follow-up|1|||
156753420|NCT01738919|565851357|FG001|Overall Study|Lost to Follow-up|0|||
156753421|NCT01738919|565851356|FG000|Overall Study|Immigrated|0|||
156753422|NCT01738919|565851357|FG001|Overall Study|Immigrated|1|||
156753423|NCT01738919|565851356|FG000|Overall Study|Withdrawal by Subject|0|||
156753424|NCT01738919|565851357|FG001|Overall Study|Withdrawal by Subject|1|||
156753425|NCT01738919|565851356|FG000|Overall Study|Not treated in accordance to guidelines|0|||
156753426|NCT01738919|565851357|FG001|Overall Study|Not treated in accordance to guidelines|1|||
156753427|NCT00534248|565851358|FG000|Overall Study|Adverse Event|19|||
156753428|NCT00534248|565851359|FG001|Overall Study|Adverse Event|29|||
156753429|NCT00534248|565851358|FG000|Overall Study|Lost to Follow-up|353|||
156753430|NCT00534248|565851359|FG001|Overall Study|Lost to Follow-up|375|||
156753431|NCT00534248|565851358|FG000|Overall Study|Other protocol specified criteria|13|||
156753432|NCT00534248|565851359|FG001|Overall Study|Other protocol specified criteria|3|||
156753433|NCT00534248|565851358|FG000|Overall Study|Physician Decision|10|||
156753434|NCT00534248|565851359|FG001|Overall Study|Physician Decision|7|||
156753435|NCT00534248|565851358|FG000|Overall Study|Protocol Violation|3|||
156753436|NCT00534248|565851359|FG001|Overall Study|Protocol Violation|4|||
156753437|NCT00534248|565851358|FG000|Overall Study|Withdrawal by Subject|263|||
156753438|NCT00534248|565851359|FG001|Overall Study|Withdrawal by Subject|255|||
156753439|NCT02532257|565851360|FG000|Overall Study|Adverse Event|2|||
156753440|NCT02532257|565851360|FG000|Overall Study|Physician Decision|4|||
156996154|NCT01720446|566739470|FG003|Overall Study|Lost to Follow-up|16|||
156996155|NCT01720446|566739467|FG000|Overall Study|Withdrawal by Subject|2|||
156996156|NCT01720446|566739468|FG001|Overall Study|Withdrawal by Subject|5|||
156996157|NCT01720446|566739469|FG002|Overall Study|Withdrawal by Subject|4|||
156996158|NCT01720446|566739470|FG003|Overall Study|Withdrawal by Subject|4|||
156996159|NCT01020838|566739471|FG000|Overall Study|Death|90|||
156996160|NCT01020838|566739471|FG000|Overall Study|Adverse Event|1|||
156996161|NCT01020838|566739471|FG000|Overall Study|Withdrawal by Subject|9|||
156996162|NCT01020838|566739471|FG000|Overall Study|Lost to Follow-up|6|||
156996163|NCT01020838|566739471|FG000|Overall Study|Most common: Study ended by sponsor|77|||
156996164|NCT01167426|566739472|FG000|Overall Study|Lost to Follow-up|6|||
156996165|NCT01167426|566739472|FG000|Overall Study|Protocol Violation|1|||
156996166|NCT01167426|566739472|FG000|Overall Study|Withdrawal by Subject|2|||
156996167|NCT01167426|566739472|FG000|Overall Study|Sponsor Decision|1|||
156996168|NCT02993471|566739473|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
156996169|NCT02993471|566739473|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
156996170|NCT01908634|566739475|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
156996171|NCT01908634|566739475|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
156996172|NCT04176458|566739476|FG000|Overall Study|Covid 19|4|||
156996173|NCT00742274|566739479|FG000|Overall Study|Death|1|||
156996174|NCT00742274|566739480|FG001|Overall Study|Death|0|||
156996175|NCT00742274|566739479|FG000|Overall Study|Withdrawal by Subject|1|||
156996176|NCT00742274|566739480|FG001|Overall Study|Withdrawal by Subject|2|||
156996177|NCT00742274|566739479|FG000|Overall Study|Removed for medical reasons|1|||
156996178|NCT00742274|566739480|FG001|Overall Study|Removed for medical reasons|1|||
156996179|NCT00619151|566739481|FG000|Overall Study|Study terminated prior to followup|1|||
156996180|NCT00619151|566739482|FG001|Overall Study|Study terminated prior to followup|0|||
156996181|NCT03124108|566739485|FG000|Overall Study|Adverse Event|0|||
156996182|NCT03124108|566739486|FG001|Overall Study|Adverse Event|1|||
156996183|NCT03124108|566739487|FG002|Overall Study|Adverse Event|0|||
156996184|NCT00746330|566739490|FG000|Period 1|Abnormal test procedure result|0|||
156996185|NCT00746330|566739491|FG001|Period 1|Abnormal test procedure result|0|||
156996186|NCT00746330|566739492|FG002|Period 1|Abnormal test procedure result|1|||
156996187|NCT00746330|566739493|FG003|Period 1|Abnormal test procedure result|0|||
156996188|NCT01076335|566739494|FG000|Overall Study|Withdrawal by Subject|3|||
156996189|NCT01076335|566739494|FG000|Overall Study|Withdrawal without treatment|1|||
156996190|NCT00517933|566739496|FG000|Period 1|Death|2|||
156996191|NCT00517933|566739497|FG001|Period 1|Death|1|||
156996192|NCT00517933|566739496|FG000|Period 1|Adverse Event|4|||
156996193|NCT00517933|566739497|FG001|Period 1|Adverse Event|4|||
156996194|NCT00517933|566739496|FG000|Period 1|Lost to Follow-up|2|||
156996195|NCT00517933|566739497|FG001|Period 1|Lost to Follow-up|0|||
156996196|NCT00517933|566739496|FG000|Period 1|Underwent lung transplant|0|||
156996197|NCT00517933|566739497|FG001|Period 1|Underwent lung transplant|1|||
156996198|NCT00517933|566739496|FG000|Period 2|Death|2|||
156996199|NCT00517933|566739497|FG001|Period 2|Death|4|||
156996200|NCT00517933|566739496|FG000|Period 2|Adverse Event|2|||
156996201|NCT00517933|566739497|FG001|Period 2|Adverse Event|4|||
156996202|NCT00517933|566739496|FG000|Period 2|Physician Decision|1|||
156996203|NCT00517933|566739497|FG001|Period 2|Physician Decision|0|||
156996204|NCT00517933|566739496|FG000|Period 2|Withdrawal by Subject|1|||
156996205|NCT00517933|566739497|FG001|Period 2|Withdrawal by Subject|3|||
156996206|NCT00517933|566739496|FG000|Period 2|Underwent lung transplant|0|||
156996207|NCT00517933|566739497|FG001|Period 2|Underwent lung transplant|2|||
156996208|NCT01018511|566739498|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
156996209|NCT01018511|566739499|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
156996210|NCT01018511|566739500|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
156996211|NCT01018511|566739501|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
156996212|NCT01018511|566739498|FG000|Overall Study|Adverse Event|5|||
156753441|NCT02532257|565851360|FG000|Overall Study|Withdrawal by Subject|3|||
156753442|NCT02532257|565851360|FG000|Overall Study|Progressive Disease|10|||
156753443|NCT02259400|565851361|FG000|Overall Study|Death|0|||
156753444|NCT02259400|565851362|FG001|Overall Study|Death|2|||
156753445|NCT03498313|565851366|FG000|Experimental Period 1|Adverse Event|1|||
156753446|NCT03498313|565851367|FG001|Experimental Period 1|Adverse Event|0|||
156753447|NCT03498313|565851368|FG002|Experimental Period 1|Adverse Event|0|||
156753448|NCT03498313|565851369|FG003|Experimental Period 1|Adverse Event|1|||
156753449|NCT03498313|565851370|FG004|Experimental Period 1|Adverse Event|0|||
156753450|NCT03498313|565851371|FG005|Experimental Period 1|Adverse Event|0|||
156753451|NCT03498313|565851366|FG000|Experimental Period 1|Withdrawal by Subject|0|||
156753452|NCT03498313|565851367|FG001|Experimental Period 1|Withdrawal by Subject|1|||
156753453|NCT03498313|565851368|FG002|Experimental Period 1|Withdrawal by Subject|0|||
156753454|NCT03498313|565851369|FG003|Experimental Period 1|Withdrawal by Subject|0|||
156753455|NCT03498313|565851370|FG004|Experimental Period 1|Withdrawal by Subject|0|||
156753456|NCT03498313|565851371|FG005|Experimental Period 1|Withdrawal by Subject|0|||
156753457|NCT03498313|565851366|FG000|Washout Period 1|Anovulation|1|||
156753458|NCT03498313|565851367|FG001|Washout Period 1|Anovulation|0|||
156753459|NCT03498313|565851368|FG002|Washout Period 1|Anovulation|0|||
156753460|NCT03498313|565851369|FG003|Washout Period 1|Anovulation|0|||
156753461|NCT03498313|565851370|FG004|Washout Period 1|Anovulation|0|||
156753462|NCT03498313|565851371|FG005|Washout Period 1|Anovulation|0|||
156753463|NCT03498313|565851366|FG000|Washout Period 1|Withdrawal by Subject|0|||
156753464|NCT03498313|565851367|FG001|Washout Period 1|Withdrawal by Subject|3|||
156753465|NCT03498313|565851368|FG002|Washout Period 1|Withdrawal by Subject|0|||
156753466|NCT03498313|565851369|FG003|Washout Period 1|Withdrawal by Subject|1|||
156753467|NCT03498313|565851370|FG004|Washout Period 1|Withdrawal by Subject|0|||
156753468|NCT03498313|565851371|FG005|Washout Period 1|Withdrawal by Subject|1|||
156753469|NCT03498313|565851366|FG000|Experimental Period 2|Adverse Event|0|||
156753470|NCT03498313|565851367|FG001|Experimental Period 2|Adverse Event|0|||
156753471|NCT03498313|565851368|FG002|Experimental Period 2|Adverse Event|0|||
156753472|NCT03498313|565851369|FG003|Experimental Period 2|Adverse Event|0|||
156753473|NCT03498313|565851370|FG004|Experimental Period 2|Adverse Event|1|||
156753474|NCT03498313|565851371|FG005|Experimental Period 2|Adverse Event|2|||
156753475|NCT03498313|565851366|FG000|Washout Period 2|Physician Decision|1|||
156753476|NCT03498313|565851367|FG001|Washout Period 2|Physician Decision|0|||
156753477|NCT03498313|565851368|FG002|Washout Period 2|Physician Decision|0|||
156753478|NCT03498313|565851369|FG003|Washout Period 2|Physician Decision|1|||
156753479|NCT03498313|565851370|FG004|Washout Period 2|Physician Decision|0|||
156753480|NCT03498313|565851371|FG005|Washout Period 2|Physician Decision|1|||
156753481|NCT03498313|565851366|FG000|Washout Period 2|Withdrawal by Subject|3|||
156753482|NCT03498313|565851367|FG001|Washout Period 2|Withdrawal by Subject|2|||
156753483|NCT03498313|565851368|FG002|Washout Period 2|Withdrawal by Subject|0|||
156753484|NCT03498313|565851369|FG003|Washout Period 2|Withdrawal by Subject|0|||
156753485|NCT03498313|565851370|FG004|Washout Period 2|Withdrawal by Subject|2|||
156753486|NCT03498313|565851371|FG005|Washout Period 2|Withdrawal by Subject|0|||
156753487|NCT03498313|565851366|FG000|Washout Period 2|Anovulation|0|||
156753488|NCT03498313|565851367|FG001|Washout Period 2|Anovulation|0|||
156753489|NCT03498313|565851368|FG002|Washout Period 2|Anovulation|0|||
156753490|NCT03498313|565851369|FG003|Washout Period 2|Anovulation|0|||
156753491|NCT03498313|565851370|FG004|Washout Period 2|Anovulation|0|||
156753492|NCT03498313|565851371|FG005|Washout Period 2|Anovulation|1|||
156753493|NCT02372383|565851375|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
156753494|NCT02372383|565851376|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
156753495|NCT02372383|565851377|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
156753496|NCT00929994|565851378|FG000|Overall Study|Withdrawal by Subject|1|||
156753497|NCT00929994|565851378|FG000|Overall Study|medical issue unrelated to intervention|4|||
156753498|NCT00929994|565851378|FG000|Overall Study|employment|1|||
156753499|NCT00184002|565851379|FG000|Overall Study|Adverse Event|9|||
156753500|NCT00184002|565851379|FG000|Overall Study|Death|3|||
156753501|NCT00184002|565851379|FG000|Overall Study|Physician Decision|1|||
156753502|NCT00184002|565851379|FG000|Overall Study|Withdrawal by Subject|4|||
156753503|NCT00694356|565851380|FG000|Overall Study|Adverse Event|1|||
156753504|NCT00694356|565851381|FG001|Overall Study|Adverse Event|0|||
156753505|NCT00694356|565851382|FG002|Overall Study|Adverse Event|0|||
156753506|NCT00694356|565851380|FG000|Overall Study|Progressive Disease|2|||
156753507|NCT00694356|565851381|FG001|Overall Study|Progressive Disease|6|||
156753508|NCT00694356|565851382|FG002|Overall Study|Progressive Disease|6|||
156753509|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
156753510|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
156753511|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
156753512|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
156753513|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
156753514|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753515|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753516|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
156753517|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
156753518|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
156753519|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
156753520|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
156753521|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753522|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753523|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
156753524|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
156753525|NCT01042392|565851383|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
156753526|NCT01042392|565851384|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753527|NCT01042392|565851385|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753528|NCT01042392|565851386|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
156753529|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753530|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753531|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
156753532|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
156753533|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
156753534|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753535|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753536|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
156753537|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753538|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753539|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
156753540|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
156753541|NCT01042392|565851383|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
156753542|NCT01042392|565851384|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753543|NCT01042392|565851385|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753544|NCT01042392|565851386|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
156753545|NCT03117361|565851387|FG000|Overall Study|Progressive disease|5|||
156753546|NCT03117361|565851387|FG000|Overall Study|Death|1|||
156753547|NCT03117361|565851387|FG000|Overall Study|Physician Decision|2|||
156753548|NCT03117361|565851387|FG000|Overall Study|On study treatment at the end of study|1|||
156753549|NCT03117361|565851387|FG000|Overall Study|Treatment-related adverse event|1|||
156753550|NCT00878800|565851388|FG000|Overall Study|Adverse Event|0|||
156753551|NCT00878800|565851389|FG001|Overall Study|Adverse Event|0|||
156753552|NCT00878800|565851390|FG002|Overall Study|Adverse Event|2|||
156753553|NCT00878800|565851391|FG003|Overall Study|Adverse Event|0|||
156753554|NCT00878800|565851392|FG004|Overall Study|Adverse Event|1|||
156753555|NCT00878800|565851388|FG000|Overall Study|Progressive disease|1|||
156753556|NCT00878800|565851389|FG001|Overall Study|Progressive disease|5|||
156753557|NCT00878800|565851390|FG002|Overall Study|Progressive disease|6|||
156753558|NCT00878800|565851391|FG003|Overall Study|Progressive disease|5|||
156753559|NCT00878800|565851392|FG004|Overall Study|Progressive disease|13|||
156753560|NCT00878800|565851388|FG000|Overall Study|Withdrew consent|1|||
156753561|NCT00878800|565851389|FG001|Overall Study|Withdrew consent|1|||
156753562|NCT00878800|565851390|FG002|Overall Study|Withdrew consent|0|||
156753563|NCT00878800|565851391|FG003|Overall Study|Withdrew consent|1|||
156753564|NCT00878800|565851392|FG004|Overall Study|Withdrew consent|1|||
156753565|NCT00878800|565851388|FG000|Overall Study|Death|0|||
156753566|NCT00878800|565851389|FG001|Overall Study|Death|0|||
156753567|NCT00878800|565851390|FG002|Overall Study|Death|1|||
156753568|NCT00878800|565851391|FG003|Overall Study|Death|0|||
156753569|NCT00878800|565851392|FG004|Overall Study|Death|0|||
156753570|NCT00878800|565851388|FG000|Overall Study|Other|1|||
156753571|NCT00878800|565851389|FG001|Overall Study|Other|1|||
156753572|NCT00878800|565851390|FG002|Overall Study|Other|0|||
156753573|NCT00878800|565851391|FG003|Overall Study|Other|0|||
156753574|NCT00878800|565851392|FG004|Overall Study|Other|1|||
156753575|NCT02982863|565851393|FG000|Overall Study|Not eligible patients|809|||
156753576|NCT02982863|565851394|FG001|Overall Study|Not eligible patients|4261|||
156753577|NCT02982863|565851395|FG002|Overall Study|Not eligible patients|1852|||
156753578|NCT02982863|565851396|FG003|Overall Study|Not eligible patients|1400|||
156753579|NCT02982863|565851397|FG004|Overall Study|Not eligible patients|492|||
156753580|NCT02328937|565851399|FG000|Period 1|Lost to Follow-up|0|||
156753581|NCT02328937|565851400|FG001|Period 1|Lost to Follow-up|0|||
156996213|NCT01018511|566739499|FG001|Overall Study|Adverse Event|9|||
156996214|NCT01018511|566739500|FG002|Overall Study|Adverse Event|13|||
156753582|NCT02328937|565851401|FG002|Period 1|Lost to Follow-up|0|||
156753583|NCT02328937|565851402|FG003|Period 1|Lost to Follow-up|1|||
156753584|NCT02328937|565851403|FG004|Period 1|Lost to Follow-up|0|||
156753585|NCT02328937|565851404|FG005|Period 1|Lost to Follow-up|0|||
156753586|NCT02328937|565851399|FG000|Period 2|Adverse Event|0|||
156753587|NCT02328937|565851400|FG001|Period 2|Adverse Event|0|||
156753588|NCT02328937|565851401|FG002|Period 2|Adverse Event|1|||
156753589|NCT02328937|565851402|FG003|Period 2|Adverse Event|0|||
156753590|NCT02328937|565851403|FG004|Period 2|Adverse Event|0|||
156753591|NCT02328937|565851404|FG005|Period 2|Adverse Event|0|||
156753592|NCT00435461|565851405|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
156753593|NCT00435461|565851406|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
156753594|NCT00435461|565851407|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
156753595|NCT00435461|565851405|FG000|Overall Study|Protocol Violation|6|||
156753596|NCT00435461|565851406|FG001|Overall Study|Protocol Violation|9|||
156753597|NCT00435461|565851407|FG002|Overall Study|Protocol Violation|10|||
156753598|NCT00435461|565851405|FG000|Overall Study|Participant randomized(inadequate score)|1|||
156753599|NCT00435461|565851406|FG001|Overall Study|Participant randomized(inadequate score)|0|||
156753600|NCT00435461|565851407|FG002|Overall Study|Participant randomized(inadequate score)|0|||
156753601|NCT00435461|565851405|FG000|Overall Study|Compliance less than 80 percent|1|||
156753602|NCT00435461|565851406|FG001|Overall Study|Compliance less than 80 percent|0|||
156753603|NCT00435461|565851407|FG002|Overall Study|Compliance less than 80 percent|0|||
156753604|NCT00435461|565851405|FG000|Overall Study|In error, two study medications switched|1|||
156753605|NCT00435461|565851406|FG001|Overall Study|In error, two study medications switched|0|||
156753606|NCT00435461|565851407|FG002|Overall Study|In error, two study medications switched|0|||
156753607|NCT00435461|565851405|FG000|Overall Study|Lack of Efficacy|2|||
156753608|NCT00435461|565851406|FG001|Overall Study|Lack of Efficacy|1|||
156753609|NCT00435461|565851407|FG002|Overall Study|Lack of Efficacy|0|||
156753610|NCT00435461|565851405|FG000|Overall Study|Withdrawal by Subject|1|||
156753611|NCT00435461|565851406|FG001|Overall Study|Withdrawal by Subject|0|||
156753612|NCT00435461|565851407|FG002|Overall Study|Withdrawal by Subject|2|||
156753613|NCT00435461|565851405|FG000|Overall Study|Randomized in error|1|||
156753614|NCT00435461|565851406|FG001|Overall Study|Randomized in error|0|||
156753615|NCT00435461|565851407|FG002|Overall Study|Randomized in error|0|||
156753616|NCT00435461|565851405|FG000|Overall Study|Participant could not tolerate symptoms|0|||
156753617|NCT00435461|565851406|FG001|Overall Study|Participant could not tolerate symptoms|0|||
156753618|NCT00435461|565851407|FG002|Overall Study|Participant could not tolerate symptoms|1|||
156753619|NCT00435461|565851405|FG000|Overall Study|Participant could not swallow capsule|0|||
156753620|NCT00435461|565851406|FG001|Overall Study|Participant could not swallow capsule|0|||
156996215|NCT01018511|566739501|FG003|Overall Study|Adverse Event|10|||
156996216|NCT01018511|566739498|FG000|Overall Study|Lack of Efficacy|4|||
156996217|NCT01018511|566739499|FG001|Overall Study|Lack of Efficacy|1|||
156996218|NCT01018511|566739500|FG002|Overall Study|Lack of Efficacy|1|||
156996219|NCT01018511|566739501|FG003|Overall Study|Lack of Efficacy|2|||
156996220|NCT01018511|566739498|FG000|Overall Study|Withdrawal by Subject|6|||
156996221|NCT01018511|566739499|FG001|Overall Study|Withdrawal by Subject|5|||
156996222|NCT01018511|566739500|FG002|Overall Study|Withdrawal by Subject|11|||
156996223|NCT01018511|566739501|FG003|Overall Study|Withdrawal by Subject|9|||
156996224|NCT01018511|566739498|FG000|Overall Study|Lost to Follow-up|0|||
156996225|NCT01018511|566739499|FG001|Overall Study|Lost to Follow-up|0|||
156996226|NCT01018511|566739500|FG002|Overall Study|Lost to Follow-up|1|||
156996227|NCT01018511|566739501|FG003|Overall Study|Lost to Follow-up|0|||
156996228|NCT01018511|566739498|FG000|Overall Study|Protocol Violation|5|||
156996229|NCT01018511|566739499|FG001|Overall Study|Protocol Violation|8|||
156996230|NCT01018511|566739500|FG002|Overall Study|Protocol Violation|7|||
156996231|NCT01018511|566739501|FG003|Overall Study|Protocol Violation|9|||
156996232|NCT01018511|566739498|FG000|Overall Study|Miscellaneous|0|||
156996233|NCT01018511|566739499|FG001|Overall Study|Miscellaneous|2|||
156996234|NCT01018511|566739500|FG002|Overall Study|Miscellaneous|0|||
156996235|NCT01018511|566739501|FG003|Overall Study|Miscellaneous|0|||
156996236|NCT00654238|566739502|FG000|Overall Study|Screen Failures|4|||
156996237|NCT01268566|566739508|FG000|Overall Study|Lost to Follow-up|1|||
156996238|NCT01268566|566739508|FG000|Overall Study|Withdrawal by Subject|12|||
156996239|NCT01268566|566739508|FG000|Overall Study|Death|30|||
156996240|NCT01649427|566739515|FG000|Overall Study|Adverse Event|1|||
156996241|NCT01649427|566739516|FG001|Overall Study|Adverse Event|1|||
156996242|NCT01649427|566739515|FG000|Overall Study|Withdrawal by Subject|8|||
156996243|NCT01649427|566739516|FG001|Overall Study|Withdrawal by Subject|7|||
156996244|NCT01649427|566739515|FG000|Overall Study|Lost to Follow-up|0|||
156996245|NCT01649427|566739516|FG001|Overall Study|Lost to Follow-up|1|||
156996246|NCT01649427|566739515|FG000|Overall Study|Graft loss|0|||
156996247|NCT01649427|566739516|FG001|Overall Study|Graft loss|1|||
156753621|NCT00435461|565851407|FG002|Overall Study|Participant could not swallow capsule|1|||
156753622|NCT00435461|565851405|FG000|Overall Study|Pregnancy|2|||
156753623|NCT00435461|565851406|FG001|Overall Study|Pregnancy|0|||
156753624|NCT00435461|565851407|FG002|Overall Study|Pregnancy|0|||
156753625|NCT00435461|565851405|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
156996248|NCT01649427|566739515|FG000|Overall Study|Surgical problems during nephrectomy|2|||
156996249|NCT01649427|566739516|FG001|Overall Study|Surgical problems during nephrectomy|2|||
156996250|NCT02138916|566739517|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
156753626|NCT00435461|565851406|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
156753627|NCT00435461|565851407|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
156753628|NCT00435461|565851405|FG000|Overall Study|Participant ended study one day early|1|||
156753629|NCT00435461|565851406|FG001|Overall Study|Participant ended study one day early|0|||
156753630|NCT00435461|565851407|FG002|Overall Study|Participant ended study one day early|0|||
156753631|NCT00435461|565851405|FG000|Overall Study|Noncompliance with study requirements|1|||
156753632|NCT00435461|565851406|FG001|Overall Study|Noncompliance with study requirements|1|||
156753633|NCT00435461|565851407|FG002|Overall Study|Noncompliance with study requirements|1|||
156753634|NCT00435461|565851405|FG000|Overall Study|Adverse Event|1|||
156753635|NCT00435461|565851406|FG001|Overall Study|Adverse Event|2|||
156753636|NCT00435461|565851407|FG002|Overall Study|Adverse Event|6|||
156753637|NCT00435461|565851405|FG000|Overall Study|Non-Compliance of diary|2|||
156753638|NCT00435461|565851406|FG001|Overall Study|Non-Compliance of diary|0|||
156753639|NCT00435461|565851407|FG002|Overall Study|Non-Compliance of diary|1|||
156753640|NCT00435461|565851405|FG000|Overall Study|Lost to Follow-up|1|||
156753641|NCT00435461|565851406|FG001|Overall Study|Lost to Follow-up|1|||
156753642|NCT00435461|565851407|FG002|Overall Study|Lost to Follow-up|2|||
156753643|NCT01768559|565851408|FG000|Overall Study|Randomized but not treated|0|||
156753644|NCT01768559|565851409|FG001|Overall Study|Randomized but not treated|0|||
156753645|NCT01768559|565851410|FG002|Overall Study|Randomized but not treated|1|||
156753646|NCT01768559|565851408|FG000|Overall Study|Adverse Event|15|||
156753647|NCT01768559|565851409|FG001|Overall Study|Adverse Event|2|||
156753648|NCT01768559|565851410|FG002|Overall Study|Adverse Event|5|||
156753649|NCT01768559|565851408|FG000|Overall Study|Lack of Efficacy|6|||
156753650|NCT01768559|565851409|FG001|Overall Study|Lack of Efficacy|4|||
156753651|NCT01768559|565851410|FG002|Overall Study|Lack of Efficacy|0|||
156753652|NCT01768559|565851408|FG000|Overall Study|Poor compliance to protocol|0|||
156753653|NCT01768559|565851409|FG001|Overall Study|Poor compliance to protocol|3|||
156753654|NCT01768559|565851410|FG002|Overall Study|Poor compliance to protocol|2|||
156753655|NCT01768559|565851408|FG000|Overall Study|Other than specified|9|||
156753656|NCT01768559|565851409|FG001|Overall Study|Other than specified|8|||
156753657|NCT01768559|565851410|FG002|Overall Study|Other than specified|5|||
156753658|NCT01737879|565851413|FG000|Overall Study|Death|1|||
156753659|NCT01737879|565851413|FG000|Overall Study|Sponsor decision|40|||
156753660|NCT03883477|565851414|FG000|Overall Study|Death|1|||
156753661|NCT03883477|565851415|FG001|Overall Study|Death|0|||
156753662|NCT03883477|565851414|FG000|Overall Study|Protocol Violation|0|||
156753663|NCT03883477|565851415|FG001|Overall Study|Protocol Violation|1|||
156753664|NCT04399538|565851424|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
156753665|NCT04399538|565851425|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
156753666|NCT04399538|565851426|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
156753667|NCT04399538|565851427|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
156753668|NCT04399538|565851428|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
156753669|NCT04399538|565851424|FG000|Double-Blind Treatment|Adverse Event|0|||
156753670|NCT04399538|565851425|FG001|Double-Blind Treatment|Adverse Event|0|||
156753671|NCT04399538|565851426|FG002|Double-Blind Treatment|Adverse Event|0|||
156753672|NCT04399538|565851427|FG003|Double-Blind Treatment|Adverse Event|0|||
156753673|NCT04399538|565851428|FG004|Double-Blind Treatment|Adverse Event|1|||
156753674|NCT04399538|565851424|FG000|Follow-Up|Adverse Event|0|||
156753675|NCT04399538|565851425|FG001|Follow-Up|Adverse Event|0|||
156753676|NCT04399538|565851426|FG002|Follow-Up|Adverse Event|0|||
156753677|NCT04399538|565851427|FG003|Follow-Up|Adverse Event|0|||
156753678|NCT04399538|565851428|FG004|Follow-Up|Adverse Event|1|||
156753679|NCT04399538|565851424|FG000|Follow-Up|Withdrawal by Subject|0|||
156753680|NCT04399538|565851425|FG001|Follow-Up|Withdrawal by Subject|0|||
156753681|NCT04399538|565851426|FG002|Follow-Up|Withdrawal by Subject|0|||
156753682|NCT04399538|565851427|FG003|Follow-Up|Withdrawal by Subject|2|||
156753683|NCT04399538|565851428|FG004|Follow-Up|Withdrawal by Subject|0|||
156753684|NCT01588405|565851430|FG000|Overall Study|Adverse Event|1|||
156753685|NCT01588405|565851430|FG000|Overall Study|Clinical Worsening|1|||
156753686|NCT00980655|565851432|FG000|Overall Study|Adverse Event|13|||
156753687|NCT00980655|565851433|FG001|Overall Study|Adverse Event|31|||
156753688|NCT00980655|565851432|FG000|Overall Study|Death|0|||
156753689|NCT00980655|565851433|FG001|Overall Study|Death|7|||
156753690|NCT00980655|565851432|FG000|Overall Study|Protocol Violation|2|||
156753691|NCT00980655|565851433|FG001|Overall Study|Protocol Violation|7|||
156753692|NCT00980655|565851432|FG000|Overall Study|Withdrawal by Subject|0|||
156753693|NCT00980655|565851433|FG001|Overall Study|Withdrawal by Subject|4|||
156753694|NCT00980655|565851432|FG000|Overall Study|Lost to Follow-up|0|||
156753695|NCT00980655|565851433|FG001|Overall Study|Lost to Follow-up|1|||
156753696|NCT00980655|565851432|FG000|Overall Study|Parent/legal guardian request|1|||
156753697|NCT00980655|565851433|FG001|Overall Study|Parent/legal guardian request|0|||
156753698|NCT00980655|565851432|FG000|Overall Study|Other|0|||
156753699|NCT00980655|565851433|FG001|Overall Study|Other|1|||
156753700|NCT04162795|565851434|FG000|Overall Study|Other|16|||
156753701|NCT04162795|565851434|FG000|Overall Study|Screen failures|10|||
156753702|NCT02029274|565851438|FG000|Overall Study|Adverse Event|1|||
156753703|NCT02029274|565851439|FG001|Overall Study|Adverse Event|0|||
156753704|NCT02029274|565851440|FG002|Overall Study|Adverse Event|2|||
156753705|NCT02029274|565851441|FG003|Overall Study|Adverse Event|2|||
156753706|NCT00845676|565851444|FG000|Overall Study|Virologic breakthrough at week 20|1|||
156753707|NCT00845676|565851444|FG000|Overall Study|Adverse Event|1|||
156753708|NCT02984267|565851445|FG000|Overall Study|Protocol Violation|1|||
156753709|NCT02984267|565851446|FG001|Overall Study|Protocol Violation|0|||
156753710|NCT02984267|565851445|FG000|Overall Study|Withdrawal by Subject|0|||
156753711|NCT02984267|565851446|FG001|Overall Study|Withdrawal by Subject|1|||
156753712|NCT03597139|565851448|FG000|Overall Study|Adverse Event|3|||
156753713|NCT03597139|565851449|FG001|Overall Study|Adverse Event|0|||
156753714|NCT03597139|565851448|FG000|Overall Study|Protocol Non-compliance|1|||
156753715|NCT03597139|565851449|FG001|Overall Study|Protocol Non-compliance|0|||
156753716|NCT04811664|565851450|FG000|Overall Study|Lost to Follow-up|78|||
156753717|NCT04811664|565851451|FG001|Overall Study|Lost to Follow-up|125|||
156753718|NCT04811664|565851452|FG002|Overall Study|Lost to Follow-up|46|||
156753719|NCT04811664|565851450|FG000|Overall Study|Withdrawal by Subject|39|||
156753720|NCT04811664|565851451|FG001|Overall Study|Withdrawal by Subject|76|||
156753721|NCT04811664|565851452|FG002|Overall Study|Withdrawal by Subject|12|||
156753722|NCT04811664|565851450|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
156753723|NCT04811664|565851451|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
156753724|NCT04811664|565851452|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
156753725|NCT04811664|565851450|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
156753726|NCT04811664|565851451|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
156753727|NCT04811664|565851452|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
156753728|NCT04811664|565851450|FG000|Overall Study|Protocol Violation|0|||
156753729|NCT04811664|565851451|FG001|Overall Study|Protocol Violation|5|||
156753730|NCT04811664|565851452|FG002|Overall Study|Protocol Violation|11|||
156753731|NCT04811664|565851450|FG000|Overall Study|Study Terminated by Sponsor|4|||
156753732|NCT04811664|565851451|FG001|Overall Study|Study Terminated by Sponsor|3|||
156753733|NCT04811664|565851452|FG002|Overall Study|Study Terminated by Sponsor|34|||
156753734|NCT04811664|565851450|FG000|Overall Study|Early Study Closure|3|||
156753735|NCT04811664|565851451|FG001|Overall Study|Early Study Closure|7|||
156753736|NCT04811664|565851452|FG002|Overall Study|Early Study Closure|79|||
156753737|NCT04811664|565851450|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
156753738|NCT04811664|565851451|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
156753739|NCT04811664|565851452|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
156753740|NCT02717442|565851453|FG000|Overall Study|Study Terminated by Sponsor|31|||
156753741|NCT02717442|565851454|FG001|Overall Study|Study Terminated by Sponsor|29|||
156753742|NCT02717442|565851453|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
156753743|NCT02717442|565851454|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
156753744|NCT02717442|565851453|FG000|Overall Study|Other - Not Specified|2|||
156753745|NCT02717442|565851454|FG001|Overall Study|Other - Not Specified|0|||
156753746|NCT05052697|565851455|FG000|Substudy A|Lost to Follow-up|0|||
156753747|NCT05052697|565851456|FG001|Substudy A|Lost to Follow-up|0|||
156753748|NCT05052697|565851457|FG002|Substudy A|Lost to Follow-up|0|||
156753749|NCT05052697|565851458|FG003|Substudy A|Lost to Follow-up|0|||
156753750|NCT05052697|565851459|FG004|Substudy A|Lost to Follow-up|0|||
156753751|NCT05052697|565851460|FG005|Substudy A|Lost to Follow-up|1|||
156753752|NCT05052697|565851461|FG006|Substudy A|Lost to Follow-up|0|||
156753753|NCT05052697|565851462|FG007|Substudy A|Lost to Follow-up|0|||
156753754|NCT05052697|565851463|FG008|Substudy A|Lost to Follow-up|0|||
156753755|NCT05052697|565851464|FG009|Substudy A|Lost to Follow-up|0|||
156753756|NCT05052697|565851465|FG010|Substudy A|Lost to Follow-up|0|||
156753757|NCT05052697|565851466|FG011|Substudy A|Lost to Follow-up|0|||
156753758|NCT05052697|565851467|FG012|Substudy A|Lost to Follow-up|0|||
156753759|NCT05052697|565851468|FG013|Substudy A|Lost to Follow-up|0|||
156753760|NCT05052697|565851469|FG014|Substudy A|Lost to Follow-up|0|||
156753761|NCT05052697|565851470|FG015|Substudy A|Lost to Follow-up|2|||
156753762|NCT05052697|565851471|FG016|Substudy A|Lost to Follow-up|0|||
156753763|NCT05052697|565851472|FG017|Substudy A|Lost to Follow-up|0|||
156753764|NCT05052697|565851473|FG018|Substudy A|Lost to Follow-up|0|||
156753765|NCT05052697|565851474|FG019|Substudy A|Lost to Follow-up|0|||
156753766|NCT05052697|565851475|FG020|Substudy A|Lost to Follow-up|0|||
156753767|NCT05052697|565851476|FG021|Substudy A|Lost to Follow-up|0|||
156753768|NCT05052697|565851477|FG022|Substudy A|Lost to Follow-up|0|||
156753769|NCT05052697|565851478|FG023|Substudy A|Lost to Follow-up|0|||
156753770|NCT05052697|565851479|FG024|Substudy A|Lost to Follow-up|0|||
156753771|NCT05052697|565851480|FG025|Substudy A|Lost to Follow-up|0|||
156753772|NCT05052697|565851481|FG026|Substudy A|Lost to Follow-up|0|||
156753773|NCT05052697|565851482|FG027|Substudy A|Lost to Follow-up|0|||
156753774|NCT05052697|565851483|FG028|Substudy A|Lost to Follow-up|0|||
156753775|NCT05052697|565851484|FG029|Substudy A|Lost to Follow-up|0|||
157099224|NCT03588728|567118255|FG000|Overall Study|multiple technical issues|1|||
156753776|NCT05052697|565851485|FG030|Substudy A|Lost to Follow-up|0|||
156753777|NCT05052697|565851486|FG031|Substudy A|Lost to Follow-up|0|||
156753778|NCT05052697|565851487|FG032|Substudy A|Lost to Follow-up|0|||
156753779|NCT05052697|565851488|FG033|Substudy A|Lost to Follow-up|0|||
156753780|NCT05052697|565851455|FG000|Substudy A|No longer met eligibility criteria|0|||
156753781|NCT05052697|565851456|FG001|Substudy A|No longer met eligibility criteria|0|||
156753782|NCT05052697|565851457|FG002|Substudy A|No longer met eligibility criteria|0|||
156753783|NCT05052697|565851458|FG003|Substudy A|No longer met eligibility criteria|0|||
156753784|NCT05052697|565851459|FG004|Substudy A|No longer met eligibility criteria|0|||
156753785|NCT05052697|565851460|FG005|Substudy A|No longer met eligibility criteria|0|||
156753786|NCT05052697|565851461|FG006|Substudy A|No longer met eligibility criteria|0|||
156753787|NCT05052697|565851462|FG007|Substudy A|No longer met eligibility criteria|0|||
156753788|NCT05052697|565851463|FG008|Substudy A|No longer met eligibility criteria|0|||
156753789|NCT05052697|565851464|FG009|Substudy A|No longer met eligibility criteria|0|||
156753790|NCT05052697|565851465|FG010|Substudy A|No longer met eligibility criteria|0|||
156753791|NCT05052697|565851466|FG011|Substudy A|No longer met eligibility criteria|0|||
156753792|NCT05052697|565851467|FG012|Substudy A|No longer met eligibility criteria|0|||
156753793|NCT05052697|565851468|FG013|Substudy A|No longer met eligibility criteria|1|||
156753794|NCT05052697|565851469|FG014|Substudy A|No longer met eligibility criteria|0|||
156753795|NCT05052697|565851470|FG015|Substudy A|No longer met eligibility criteria|0|||
156753796|NCT05052697|565851471|FG016|Substudy A|No longer met eligibility criteria|0|||
156753797|NCT05052697|565851472|FG017|Substudy A|No longer met eligibility criteria|0|||
156753798|NCT05052697|565851473|FG018|Substudy A|No longer met eligibility criteria|0|||
156753799|NCT05052697|565851474|FG019|Substudy A|No longer met eligibility criteria|0|||
156753800|NCT05052697|565851475|FG020|Substudy A|No longer met eligibility criteria|0|||
156753801|NCT05052697|565851476|FG021|Substudy A|No longer met eligibility criteria|0|||
156753802|NCT05052697|565851477|FG022|Substudy A|No longer met eligibility criteria|0|||
156753803|NCT05052697|565851478|FG023|Substudy A|No longer met eligibility criteria|0|||
156753804|NCT05052697|565851479|FG024|Substudy A|No longer met eligibility criteria|0|||
156753805|NCT05052697|565851480|FG025|Substudy A|No longer met eligibility criteria|0|||
156753806|NCT05052697|565851481|FG026|Substudy A|No longer met eligibility criteria|0|||
156753807|NCT05052697|565851482|FG027|Substudy A|No longer met eligibility criteria|0|||
156753808|NCT05052697|565851483|FG028|Substudy A|No longer met eligibility criteria|0|||
156753809|NCT05052697|565851484|FG029|Substudy A|No longer met eligibility criteria|0|||
156753810|NCT05052697|565851485|FG030|Substudy A|No longer met eligibility criteria|0|||
156753811|NCT05052697|565851486|FG031|Substudy A|No longer met eligibility criteria|0|||
156753812|NCT05052697|565851487|FG032|Substudy A|No longer met eligibility criteria|0|||
156753813|NCT05052697|565851488|FG033|Substudy A|No longer met eligibility criteria|0|||
156753814|NCT05052697|565851455|FG000|Substudy A|Not vaccinated|0|||
156753815|NCT05052697|565851456|FG001|Substudy A|Not vaccinated|0|||
156753816|NCT05052697|565851457|FG002|Substudy A|Not vaccinated|0|||
156753817|NCT05052697|565851458|FG003|Substudy A|Not vaccinated|1|||
156753818|NCT05052697|565851459|FG004|Substudy A|Not vaccinated|0|||
156753819|NCT05052697|565851460|FG005|Substudy A|Not vaccinated|0|||
156753820|NCT05052697|565851461|FG006|Substudy A|Not vaccinated|0|||
156753821|NCT05052697|565851462|FG007|Substudy A|Not vaccinated|0|||
156753822|NCT05052697|565851463|FG008|Substudy A|Not vaccinated|1|||
156753823|NCT05052697|565851464|FG009|Substudy A|Not vaccinated|0|||
156753824|NCT05052697|565851465|FG010|Substudy A|Not vaccinated|0|||
156753825|NCT05052697|565851466|FG011|Substudy A|Not vaccinated|0|||
156753826|NCT05052697|565851467|FG012|Substudy A|Not vaccinated|0|||
156753827|NCT05052697|565851468|FG013|Substudy A|Not vaccinated|0|||
156753828|NCT05052697|565851469|FG014|Substudy A|Not vaccinated|0|||
156753829|NCT05052697|565851470|FG015|Substudy A|Not vaccinated|0|||
156753830|NCT05052697|565851471|FG016|Substudy A|Not vaccinated|0|||
156753831|NCT05052697|565851472|FG017|Substudy A|Not vaccinated|0|||
156753832|NCT05052697|565851473|FG018|Substudy A|Not vaccinated|0|||
156753833|NCT05052697|565851474|FG019|Substudy A|Not vaccinated|0|||
156753834|NCT05052697|565851475|FG020|Substudy A|Not vaccinated|0|||
156753835|NCT05052697|565851476|FG021|Substudy A|Not vaccinated|0|||
156753836|NCT05052697|565851477|FG022|Substudy A|Not vaccinated|0|||
156753837|NCT05052697|565851478|FG023|Substudy A|Not vaccinated|0|||
156753838|NCT05052697|565851479|FG024|Substudy A|Not vaccinated|0|||
156753839|NCT05052697|565851480|FG025|Substudy A|Not vaccinated|0|||
156753840|NCT05052697|565851481|FG026|Substudy A|Not vaccinated|0|||
156753841|NCT05052697|565851482|FG027|Substudy A|Not vaccinated|0|||
156753842|NCT05052697|565851483|FG028|Substudy A|Not vaccinated|0|||
156753843|NCT05052697|565851484|FG029|Substudy A|Not vaccinated|0|||
156753844|NCT05052697|565851485|FG030|Substudy A|Not vaccinated|0|||
156753845|NCT05052697|565851486|FG031|Substudy A|Not vaccinated|0|||
156753846|NCT05052697|565851487|FG032|Substudy A|Not vaccinated|0|||
156753847|NCT05052697|565851488|FG033|Substudy A|Not vaccinated|0|||
156753848|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753849|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753850|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753851|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753852|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753853|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753854|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753855|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753856|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753857|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753858|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753859|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753860|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753861|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753862|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753863|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753864|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753865|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753866|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156996251|NCT02138916|566739518|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
156996252|NCT02138916|566739519|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
156996253|NCT02138916|566739517|FG000|Overall Study|Death|14|||
156996254|NCT02138916|566739518|FG001|Overall Study|Death|11|||
156996255|NCT02138916|566739519|FG002|Overall Study|Death|12|||
156996256|NCT02138916|566739517|FG000|Overall Study|Withdrawal by Subject|27|||
156753867|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156753868|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753869|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
156996257|NCT02138916|566739518|FG001|Overall Study|Withdrawal by Subject|31|||
156753870|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
156996258|NCT02138916|566739519|FG002|Overall Study|Withdrawal by Subject|32|||
156753871|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753872|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753873|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753874|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753875|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753876|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753877|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753878|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753879|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753880|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753881|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
156753882|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753883|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753884|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753885|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753886|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753887|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753888|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753889|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753890|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753891|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753892|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753893|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753894|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753895|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753896|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753897|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753898|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753899|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
156753900|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753901|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753902|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753903|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753904|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753905|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753906|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753907|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753908|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753909|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753910|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753911|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753912|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753913|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753914|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753915|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
156753916|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753917|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753918|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753919|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753920|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753921|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753922|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753923|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753924|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753925|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753926|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753927|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753928|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753929|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753930|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753931|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753932|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753933|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753934|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753935|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
156753936|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753937|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753938|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753939|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753940|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753941|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753942|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753943|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753944|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753945|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753946|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753947|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753948|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753949|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
156753950|NCT05052697|565851455|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753951|NCT05052697|565851456|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753952|NCT05052697|565851457|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753953|NCT05052697|565851458|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753954|NCT05052697|565851459|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753955|NCT05052697|565851460|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753956|NCT05052697|565851461|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753957|NCT05052697|565851462|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753958|NCT05052697|565851463|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753959|NCT05052697|565851464|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753960|NCT05052697|565851465|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753961|NCT05052697|565851466|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753962|NCT05052697|565851467|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753963|NCT05052697|565851468|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753964|NCT05052697|565851469|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753965|NCT05052697|565851470|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753966|NCT05052697|565851471|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753967|NCT05052697|565851472|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753968|NCT05052697|565851473|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753969|NCT05052697|565851474|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753970|NCT05052697|565851475|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753971|NCT05052697|565851476|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753972|NCT05052697|565851477|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753973|NCT05052697|565851478|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753974|NCT05052697|565851479|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753975|NCT05052697|565851480|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753976|NCT05052697|565851481|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753977|NCT05052697|565851482|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
156753978|NCT05052697|565851483|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753979|NCT05052697|565851484|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753980|NCT05052697|565851485|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753981|NCT05052697|565851486|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753982|NCT05052697|565851487|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753983|NCT05052697|565851488|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
156753984|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753985|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753986|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753987|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753988|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753989|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753990|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753991|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753992|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753993|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753994|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753995|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753996|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753997|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753998|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156753999|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754000|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754001|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754002|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754003|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754004|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
157099225|NCT03588728|567118256|FG001|Overall Study|multiple technical issues|0|||
157099226|NCT03588728|567118257|FG002|Overall Study|multiple technical issues|0|||
157099227|NCT03588728|567118258|FG003|Overall Study|multiple technical issues|0|||
157099228|NCT03588728|567118255|FG000|Overall Study|Hospitalized for COVID|1|||
156754005|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754006|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754007|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754008|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754009|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754010|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754011|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754012|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
156754013|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754014|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754015|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754016|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
156754017|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
156754018|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754019|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754020|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754021|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754022|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754023|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754024|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754025|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754026|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754027|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754028|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754029|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754030|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754031|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754032|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754033|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754034|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754035|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754036|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754037|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754038|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754039|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754040|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754041|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754042|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754043|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754044|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754045|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754046|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
156754047|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
156754048|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
156754049|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
156754050|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
156754051|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
156754052|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754053|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754054|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754055|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754056|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754057|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754058|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754059|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754060|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754061|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754062|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754063|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754064|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754065|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754066|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754067|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754068|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754069|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156996259|NCT02138916|566739517|FG000|Overall Study|Study specific withdrawal criteria|0|||
156996260|NCT02138916|566739518|FG001|Overall Study|Study specific withdrawal criteria|0|||
156996261|NCT02138916|566739519|FG002|Overall Study|Study specific withdrawal criteria|1|||
156754070|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754071|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754072|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754073|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754074|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754075|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754076|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754077|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754078|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754079|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754080|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754081|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754082|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754083|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754084|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
156754085|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
156754086|NCT05052697|565851455|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754087|NCT05052697|565851456|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754088|NCT05052697|565851457|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754089|NCT05052697|565851458|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754090|NCT05052697|565851459|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754091|NCT05052697|565851460|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754092|NCT05052697|565851461|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754093|NCT05052697|565851462|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754094|NCT05052697|565851463|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754095|NCT05052697|565851464|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754096|NCT05052697|565851465|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754097|NCT05052697|565851466|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754098|NCT05052697|565851467|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754099|NCT05052697|565851468|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754100|NCT05052697|565851469|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754101|NCT05052697|565851470|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754102|NCT05052697|565851471|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754103|NCT05052697|565851472|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754104|NCT05052697|565851473|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754105|NCT05052697|565851474|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754106|NCT05052697|565851475|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754107|NCT05052697|565851476|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754108|NCT05052697|565851477|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754109|NCT05052697|565851478|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754110|NCT05052697|565851479|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754111|NCT05052697|565851480|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754112|NCT05052697|565851481|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754113|NCT05052697|565851482|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754114|NCT05052697|565851483|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
156754115|NCT05052697|565851484|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
156754116|NCT05052697|565851485|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
156754117|NCT05052697|565851486|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754118|NCT05052697|565851487|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754119|NCT05052697|565851488|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
156754120|NCT01900899|565851491|FG000|Overall Study|Withdrawal by Subject|7|||
156996262|NCT02138916|566739517|FG000|Overall Study|incorrect enrolment|1|||
156996263|NCT02138916|566739518|FG001|Overall Study|incorrect enrolment|1|||
156996264|NCT02138916|566739519|FG002|Overall Study|incorrect enrolment|0|||
156996265|NCT02138916|566739517|FG000|Overall Study|Severe non-compliance|1|||
156996266|NCT02138916|566739518|FG001|Overall Study|Severe non-compliance|2|||
156996267|NCT02138916|566739519|FG002|Overall Study|Severe non-compliance|1|||
156996268|NCT02138916|566739517|FG000|Overall Study|Lost to Follow-up|4|||
156996269|NCT02138916|566739518|FG001|Overall Study|Lost to Follow-up|2|||
156996270|NCT02138916|566739519|FG002|Overall Study|Lost to Follow-up|3|||
156996271|NCT02138916|566739517|FG000|Overall Study|Adverse Event|4|||
156996272|NCT02138916|566739518|FG001|Overall Study|Adverse Event|4|||
156996273|NCT02138916|566739519|FG002|Overall Study|Adverse Event|3|||
156996274|NCT05096884|566739521|FG000|Overall Study|Excluded based on negative tilt table test|4|||
156996275|NCT02482233|566739526|FG000|Overall Study|Lost to Follow-up|1|||
156996276|NCT02482233|566739527|FG001|Overall Study|Lost to Follow-up|1|||
156996277|NCT04888585|566739528|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156996278|NCT04888585|566739529|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156996279|NCT04888585|566739530|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
156996280|NCT04888585|566739531|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
156996281|NCT04888585|566739532|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
156996282|NCT04888585|566739533|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996283|NCT04888585|566739534|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996284|NCT04888585|566739535|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996285|NCT04888585|566739536|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996286|NCT04888585|566739537|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996287|NCT04888585|566739538|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
156996288|NCT04888585|566739528|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996289|NCT04888585|566739529|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
156996290|NCT04888585|566739530|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
156996291|NCT04888585|566739531|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
156996292|NCT04888585|566739532|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
156996293|NCT04888585|566739533|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996294|NCT04888585|566739534|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996295|NCT04888585|566739535|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996296|NCT04888585|566739536|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996297|NCT04888585|566739537|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996298|NCT04888585|566739538|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
156996299|NCT04888585|566739528|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996300|NCT04888585|566739529|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996301|NCT04888585|566739530|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
156996302|NCT04888585|566739531|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996303|NCT04888585|566739532|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
156996304|NCT04888585|566739533|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996305|NCT04888585|566739534|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996306|NCT04888585|566739535|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996307|NCT04888585|566739536|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996308|NCT04888585|566739537|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996309|NCT04888585|566739538|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
156996310|NCT04888585|566739528|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996311|NCT04888585|566739529|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996312|NCT04888585|566739530|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996313|NCT04888585|566739531|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996314|NCT04888585|566739532|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996315|NCT04888585|566739533|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996316|NCT04888585|566739534|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996317|NCT04888585|566739535|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
156996318|NCT04888585|566739536|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996319|NCT04888585|566739537|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
156996320|NCT04888585|566739538|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
156996321|NCT04888585|566739528|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156996322|NCT04888585|566739529|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156996323|NCT04888585|566739530|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156996324|NCT04888585|566739531|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156996325|NCT04888585|566739532|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
156996326|NCT04888585|566739533|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
156996327|NCT04888585|566739534|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
156996328|NCT04888585|566739535|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
156996329|NCT04888585|566739536|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
157099229|NCT03588728|567118256|FG001|Overall Study|Hospitalized for COVID|0|||
156754121|NCT01900899|565851492|FG001|Overall Study|Withdrawal by Subject|1|||
156754122|NCT01900899|565851491|FG000|Overall Study|Migrated from study area|2|||
156754123|NCT01900899|565851492|FG001|Overall Study|Migrated from study area|0|||
156754124|NCT03275389|565851493|FG000|Overall Study|Lost to Follow-up|10|||
156754125|NCT03275389|565851494|FG001|Overall Study|Lost to Follow-up|10|||
156754126|NCT03275389|565851495|FG002|Overall Study|Lost to Follow-up|19|||
156754127|NCT03275389|565851496|FG003|Overall Study|Lost to Follow-up|12|||
156754128|NCT03275389|565851497|FG004|Overall Study|Lost to Follow-up|11|||
156754129|NCT03275389|565851498|FG005|Overall Study|Lost to Follow-up|12|||
156754130|NCT03275389|565851499|FG006|Overall Study|Lost to Follow-up|21|||
156754131|NCT03275389|565851500|FG007|Overall Study|Lost to Follow-up|15|||
156754132|NCT03275389|565851501|FG008|Overall Study|Lost to Follow-up|12|||
156754133|NCT03275389|565851502|FG009|Overall Study|Lost to Follow-up|14|||
156754134|NCT03275389|565851493|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754135|NCT03275389|565851494|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754136|NCT03275389|565851495|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754137|NCT03275389|565851496|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754138|NCT03275389|565851497|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754139|NCT03275389|565851498|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
156754140|NCT03275389|565851499|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754141|NCT03275389|565851500|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754142|NCT03275389|565851501|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
156754143|NCT03275389|565851502|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
156754144|NCT03275389|565851493|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156754145|NCT03275389|565851494|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156754146|NCT03275389|565851495|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156754147|NCT03275389|565851496|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
156754148|NCT03275389|565851497|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754149|NCT03275389|565851498|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754150|NCT03275389|565851499|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754151|NCT03275389|565851500|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
156754152|NCT03275389|565851501|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156754153|NCT03275389|565851502|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156754154|NCT03275389|565851493|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754155|NCT03275389|565851494|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156754156|NCT03275389|565851495|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754157|NCT03275389|565851496|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156754158|NCT03275389|565851497|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754159|NCT03275389|565851498|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754160|NCT03275389|565851499|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156754161|NCT03275389|565851500|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754162|NCT03275389|565851501|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754163|NCT03275389|565851502|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156754164|NCT03275389|565851493|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754165|NCT03275389|565851494|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754166|NCT03275389|565851495|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156754167|NCT03275389|565851496|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754168|NCT03275389|565851497|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754169|NCT03275389|565851498|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754170|NCT03275389|565851499|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754171|NCT03275389|565851500|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754172|NCT03275389|565851501|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
156754173|NCT03275389|565851502|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
156754174|NCT03275389|565851493|FG000|Overall Study|Other|0|||
156754175|NCT03275389|565851494|FG001|Overall Study|Other|4|||
156754176|NCT03275389|565851495|FG002|Overall Study|Other|3|||
156754177|NCT03275389|565851496|FG003|Overall Study|Other|2|||
156754178|NCT03275389|565851497|FG004|Overall Study|Other|2|||
156754179|NCT03275389|565851498|FG005|Overall Study|Other|2|||
156754180|NCT03275389|565851499|FG006|Overall Study|Other|0|||
156754181|NCT03275389|565851500|FG007|Overall Study|Other|0|||
156754182|NCT03275389|565851501|FG008|Overall Study|Other|1|||
156754183|NCT03275389|565851502|FG009|Overall Study|Other|0|||
156754184|NCT03035916|565851503|FG000|Overall Study|Puncture failed|0|||
156754185|NCT03035916|565851504|FG001|Overall Study|Puncture failed|2|||
156754186|NCT03035916|565851505|FG002|Overall Study|Puncture failed|0|||
156754187|NCT02427802|565851506|FG000|Overall Study|Adverse Event|11|||
156754188|NCT02427802|565851507|FG001|Overall Study|Adverse Event|3|||
156754189|NCT02427802|565851508|FG002|Overall Study|Adverse Event|7|||
156754190|NCT02427802|565851506|FG000|Overall Study|Death|0|||
156754191|NCT02427802|565851507|FG001|Overall Study|Death|4|||
156754192|NCT02427802|565851508|FG002|Overall Study|Death|1|||
156754193|NCT02427802|565851506|FG000|Overall Study|Lost to Follow-up|13|||
156754194|NCT02427802|565851507|FG001|Overall Study|Lost to Follow-up|8|||
156754195|NCT02427802|565851508|FG002|Overall Study|Lost to Follow-up|8|||
156754196|NCT02427802|565851506|FG000|Overall Study|Physician Decision|4|||
156754197|NCT02427802|565851507|FG001|Overall Study|Physician Decision|2|||
156754198|NCT02427802|565851508|FG002|Overall Study|Physician Decision|4|||
156754199|NCT02427802|565851506|FG000|Overall Study|Withdrawal by Subject|10|||
156754200|NCT02427802|565851507|FG001|Overall Study|Withdrawal by Subject|5|||
156754201|NCT02427802|565851508|FG002|Overall Study|Withdrawal by Subject|11|||
156754202|NCT02427802|565851506|FG000|Overall Study|Protocol Violation|3|||
156754203|NCT02427802|565851507|FG001|Overall Study|Protocol Violation|1|||
156754204|NCT02427802|565851508|FG002|Overall Study|Protocol Violation|1|||
156754205|NCT02427802|565851506|FG000|Overall Study|protocol specific treatment unrelated|18|||
156754206|NCT02427802|565851507|FG001|Overall Study|protocol specific treatment unrelated|11|||
156754207|NCT02427802|565851508|FG002|Overall Study|protocol specific treatment unrelated|11|||
156754208|NCT02634983|565851509|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
156754209|NCT02634983|565851510|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
156754210|NCT00467558|565851512|FG000|Overall Study|Lost to Follow-up|2|||
156754211|NCT00467558|565851513|FG001|Overall Study|Lost to Follow-up|0|||
156754212|NCT05188729|565851515|FG000|Overall Study|Withdrawal by Subject|0|||
156754213|NCT05188729|565851516|FG001|Overall Study|Withdrawal by Subject|0|||
156754214|NCT05188729|565851517|FG002|Overall Study|Withdrawal by Subject|0|||
156754215|NCT05188729|565851518|FG003|Overall Study|Withdrawal by Subject|0|||
156754216|NCT05188729|565851519|FG004|Overall Study|Withdrawal by Subject|0|||
156754217|NCT05188729|565851520|FG005|Overall Study|Withdrawal by Subject|0|||
156754218|NCT05188729|565851521|FG006|Overall Study|Withdrawal by Subject|0|||
156754219|NCT05188729|565851522|FG007|Overall Study|Withdrawal by Subject|0|||
156754220|NCT05188729|565851523|FG008|Overall Study|Withdrawal by Subject|0|||
156754221|NCT05188729|565851524|FG009|Overall Study|Withdrawal by Subject|1|||
156754222|NCT05188729|565851525|FG010|Overall Study|Withdrawal by Subject|0|||
156754223|NCT05188729|565851526|FG011|Overall Study|Withdrawal by Subject|0|||
156754224|NCT05188729|565851527|FG012|Overall Study|Withdrawal by Subject|0|||
156754225|NCT05188729|565851515|FG000|Overall Study|Lost to Follow-up|0|||
156754226|NCT05188729|565851516|FG001|Overall Study|Lost to Follow-up|0|||
156754227|NCT05188729|565851517|FG002|Overall Study|Lost to Follow-up|0|||
156754228|NCT05188729|565851518|FG003|Overall Study|Lost to Follow-up|0|||
156754229|NCT05188729|565851519|FG004|Overall Study|Lost to Follow-up|0|||
156754230|NCT05188729|565851520|FG005|Overall Study|Lost to Follow-up|0|||
156754231|NCT05188729|565851521|FG006|Overall Study|Lost to Follow-up|0|||
156754232|NCT05188729|565851522|FG007|Overall Study|Lost to Follow-up|0|||
156754233|NCT05188729|565851523|FG008|Overall Study|Lost to Follow-up|0|||
156754234|NCT05188729|565851524|FG009|Overall Study|Lost to Follow-up|0|||
156754235|NCT05188729|565851525|FG010|Overall Study|Lost to Follow-up|1|||
156754236|NCT05188729|565851526|FG011|Overall Study|Lost to Follow-up|1|||
156754237|NCT05188729|565851527|FG012|Overall Study|Lost to Follow-up|0|||
156754238|NCT03638466|565853131|FG000|Overall Study|Early Termination|0|||
156754239|NCT03638466|565853132|FG001|Overall Study|Early Termination|1|||
156754240|NCT02576977|565853133|FG000|Overall Study|Adverse Event|13|||
156754241|NCT02576977|565853134|FG001|Overall Study|Adverse Event|2|||
156754242|NCT02576977|565853133|FG000|Overall Study|Death|73|||
156754243|NCT02576977|565853134|FG001|Overall Study|Death|60|||
156754244|NCT02576977|565853133|FG000|Overall Study|Screen failure|1|||
156754245|NCT02576977|565853134|FG001|Overall Study|Screen failure|0|||
156754246|NCT02576977|565853133|FG000|Overall Study|Study Terminated at Selected Sites|27|||
156754247|NCT02576977|565853134|FG001|Overall Study|Study Terminated at Selected Sites|50|||
156754248|NCT02576977|565853133|FG000|Overall Study|Withdrawal by Subject|11|||
156754249|NCT02576977|565853134|FG001|Overall Study|Withdrawal by Subject|11|||
156754250|NCT02576977|565853133|FG000|Overall Study|Final Disposition Unknown|0|||
156754251|NCT02576977|565853134|FG001|Overall Study|Final Disposition Unknown|1|||
156754252|NCT02576977|565853133|FG000|Overall Study|Lost to Follow-up|1|||
156754253|NCT02576977|565853134|FG001|Overall Study|Lost to Follow-up|0|||
156754254|NCT02576977|565853133|FG000|Overall Study|Progressive Disease|0|||
156754255|NCT02576977|565853134|FG001|Overall Study|Progressive Disease|1|||
156754256|NCT03251482|565853135|FG000|Overall Study|Withdrawal by Subject|0|||
156754257|NCT03251482|565853136|FG001|Overall Study|Withdrawal by Subject|1|||
156754258|NCT03251482|565853137|FG002|Overall Study|Withdrawal by Subject|0|||
156754259|NCT03251482|565853138|FG003|Overall Study|Withdrawal by Subject|0|||
156754260|NCT03251482|565853139|FG004|Overall Study|Withdrawal by Subject|0|||
156754261|NCT02823470|565853146|FG000|Overall Study|Adverse Event|1|||
156754262|NCT02823470|565853147|FG001|Overall Study|Adverse Event|0|||
156754263|NCT02823470|565853146|FG000|Overall Study|Study terminated by sponsor|8|||
156754264|NCT02823470|565853147|FG001|Overall Study|Study terminated by sponsor|15|||
156754265|NCT02155309|565853148|FG000|Overall Study|Protocol Violation|0|||
156754266|NCT02155309|565853149|FG001|Overall Study|Protocol Violation|0|||
156754267|NCT02155309|565853150|FG002|Overall Study|Protocol Violation|1|||
156754268|NCT01073163|565853151|FG000|Overall Study|Adverse Event|1|||
156754269|NCT01073163|565853151|FG000|Overall Study|Disease Progression|1|||
156754270|NCT01073163|565853151|FG000|Overall Study|Early termination|1|||
156754271|NCT00802672|565853152|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
156754272|NCT00802672|565853153|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
156754273|NCT00802672|565853154|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
156754274|NCT00802672|565853152|FG000|Overall Study|Adverse Event|1|||
156754275|NCT00802672|565853153|FG001|Overall Study|Adverse Event|1|||
156754276|NCT00802672|565853154|FG002|Overall Study|Adverse Event|1|||
156754277|NCT00802672|565853152|FG000|Overall Study|Protocol Violation|2|||
156754278|NCT00802672|565853153|FG001|Overall Study|Protocol Violation|1|||
156754279|NCT00802672|565853154|FG002|Overall Study|Protocol Violation|1|||
156754280|NCT00802672|565853152|FG000|Overall Study|Lost to Follow-up|5|||
156754281|NCT00802672|565853153|FG001|Overall Study|Lost to Follow-up|5|||
156754282|NCT00802672|565853154|FG002|Overall Study|Lost to Follow-up|3|||
156754283|NCT00802672|565853152|FG000|Overall Study|Withdrawal by Subject|1|||
156754284|NCT00802672|565853153|FG001|Overall Study|Withdrawal by Subject|1|||
156754285|NCT00802672|565853154|FG002|Overall Study|Withdrawal by Subject|2|||
156754286|NCT00802672|565853152|FG000|Overall Study|other|3|||
156754287|NCT00802672|565853153|FG001|Overall Study|other|1|||
156754288|NCT00802672|565853154|FG002|Overall Study|other|2|||
156754289|NCT00703677|565853156|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
156754290|NCT04441788|565853157|FG000|Overall Study|Voluntary Withdrawl|0|||
156754291|NCT04441788|565853158|FG001|Overall Study|Voluntary Withdrawl|1|||
156754292|NCT04441788|565853159|FG002|Overall Study|Voluntary Withdrawl|0|||
156754293|NCT04441788|565853157|FG000|Overall Study|Ineligibility|1|||
156754294|NCT04441788|565853158|FG001|Overall Study|Ineligibility|0|||
156754295|NCT04441788|565853159|FG002|Overall Study|Ineligibility|0|||
156754296|NCT04441788|565853157|FG000|Overall Study|Adverse Event|0|||
156754297|NCT04441788|565853158|FG001|Overall Study|Adverse Event|0|||
156754298|NCT04441788|565853159|FG002|Overall Study|Adverse Event|4|||
156754299|NCT04441788|565853157|FG000|Overall Study|Study Terminated by Sponsor|16|||
156754300|NCT04441788|565853158|FG001|Overall Study|Study Terminated by Sponsor|16|||
156754301|NCT04441788|565853159|FG002|Overall Study|Study Terminated by Sponsor|12|||
156754302|NCT02315664|565853160|FG000|Overall Study|Lost to Follow-up|1|||
156754303|NCT02315664|565853161|FG001|Overall Study|Lost to Follow-up|1|||
156754304|NCT02315664|565853160|FG000|Overall Study|Withdrawal by Subject|0|||
156754305|NCT02315664|565853161|FG001|Overall Study|Withdrawal by Subject|3|||
156754306|NCT01677182|565853162|FG000|Overall Study|Adverse Event|2|||
156754307|NCT01677182|565853163|FG001|Overall Study|Adverse Event|1|||
156754308|NCT01677182|565853164|FG002|Overall Study|Adverse Event|8|||
156754309|NCT01677182|565853162|FG000|Overall Study|Protocol Violation|5|||
156754310|NCT01677182|565853163|FG001|Overall Study|Protocol Violation|1|||
156754311|NCT01677182|565853164|FG002|Overall Study|Protocol Violation|4|||
156754312|NCT01677182|565853162|FG000|Overall Study|Lost to Follow-up|4|||
156754313|NCT01677182|565853163|FG001|Overall Study|Lost to Follow-up|0|||
156754314|NCT01677182|565853164|FG002|Overall Study|Lost to Follow-up|3|||
156754315|NCT01677182|565853162|FG000|Overall Study|Withdrawal by Subject|7|||
156754316|NCT01677182|565853163|FG001|Overall Study|Withdrawal by Subject|12|||
156754317|NCT01677182|565853164|FG002|Overall Study|Withdrawal by Subject|10|||
156754318|NCT01677182|565853162|FG000|Overall Study|Study termination|12|||
156754319|NCT01677182|565853163|FG001|Overall Study|Study termination|9|||
156754320|NCT01677182|565853164|FG002|Overall Study|Study termination|11|||
156754321|NCT01677182|565853162|FG000|Overall Study|Lack of Efficacy|3|||
156754322|NCT01677182|565853163|FG001|Overall Study|Lack of Efficacy|0|||
156754323|NCT01677182|565853164|FG002|Overall Study|Lack of Efficacy|1|||
156754324|NCT01677182|565853162|FG000|Overall Study|Other reasons|1|||
156754325|NCT01677182|565853163|FG001|Overall Study|Other reasons|5|||
156754326|NCT01677182|565853164|FG002|Overall Study|Other reasons|2|||
156754327|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
156754328|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
156754329|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
156754330|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
156754331|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754332|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754333|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
156754334|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
156754335|NCT00667992|565853169|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754336|NCT00667992|565853170|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754337|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
156754338|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
156754339|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
156754340|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
156754341|NCT00667992|565853169|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
156754342|NCT00667992|565853170|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
156754343|NCT00667992|565853169|FG000|Wash-out|Not within one doubling dilution|4|||
156754344|NCT00667992|565853170|FG001|Wash-out|Not within one doubling dilution|3|||
156754345|NCT00667992|565853169|FG000|Wash-out|Failure to wash-out|2|||
156754346|NCT00667992|565853170|FG001|Wash-out|Failure to wash-out|2|||
156754347|NCT00667992|565853169|FG000|Wash-out|Withdrawal by Subject|1|||
156754348|NCT00667992|565853170|FG001|Wash-out|Withdrawal by Subject|0|||
156754349|NCT00667992|565853169|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
156754350|NCT00667992|565853170|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
156754351|NCT00667992|565853169|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
156754352|NCT00667992|565853170|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
156754353|NCT00762762|565853173|FG000|Overall Study|Did not return for appointments|6|||
156754354|NCT00762762|565853174|FG001|Overall Study|Did not return for appointments|8|||
156754355|NCT02489448|565853175|FG000|Overall Study|Death|3|||
156754356|NCT02489448|565853175|FG000|Overall Study|Withdrawal by Subject|2|||
156754357|NCT02748057|565853176|FG000|Overall Study|Adverse Event|1|||
156754358|NCT02748057|565853177|FG001|Overall Study|Adverse Event|0|||
156754359|NCT02748057|565853176|FG000|Overall Study|Physician Decision|0|||
156754360|NCT02748057|565853177|FG001|Overall Study|Physician Decision|1|||
156754361|NCT02748057|565853176|FG000|Overall Study|Protocol Violation|2|||
156754362|NCT02748057|565853177|FG001|Overall Study|Protocol Violation|1|||
156754363|NCT02748057|565853176|FG000|Overall Study|Participant Moved|1|||
156754364|NCT02748057|565853177|FG001|Overall Study|Participant Moved|0|||
156754365|NCT02748057|565853176|FG000|Overall Study|Withdrawal by Subject|1|||
156754366|NCT02748057|565853177|FG001|Overall Study|Withdrawal by Subject|0|||
156754367|NCT01990573|565853178|FG000|Overall Study|Physician Decision|0|||
156754368|NCT01990573|565853179|FG001|Overall Study|Physician Decision|0|||
156754369|NCT01990573|565853180|FG002|Overall Study|Physician Decision|1|||
156754370|NCT02793947|565853194|FG000|Overall Study|Death|1|||
156754371|NCT02793947|565853195|FG001|Overall Study|Death|0|||
156754372|NCT02793947|565853194|FG000|Overall Study|Physician Decision|1|||
156754373|NCT02793947|565853195|FG001|Overall Study|Physician Decision|5|||
156754374|NCT02213380|565853197|FG000|Underwent Randomization|Withdrawal by Subject|2|||
156754375|NCT02213380|565853198|FG001|Underwent Randomization|Withdrawal by Subject|0|||
156754376|NCT02213380|565853197|FG000|Underwent Randomization|Not treated|3|||
156754377|NCT02213380|565853198|FG001|Underwent Randomization|Not treated|3|||
156754378|NCT02213380|565853197|FG000|Per-protocol Analysis|Protocol Violation|32|||
156754379|NCT02213380|565853198|FG001|Per-protocol Analysis|Protocol Violation|36|||
156754380|NCT01310127|565853202|FG000|Overall Study|Protocol Violation|1|||
156754381|NCT01310127|565853203|FG001|Overall Study|Protocol Violation|1|||
156754382|NCT01310127|565853202|FG000|Overall Study|advanced psc cataract outlier|1|||
156754383|NCT01310127|565853203|FG001|Overall Study|advanced psc cataract outlier|0|||
156754384|NCT01490840|565853204|FG000|Phase 1|Lost to Follow-up|1|||
156754385|NCT01490840|565853205|FG001|Phase 1|Lost to Follow-up|0|||
156754386|NCT01490840|565853204|FG000|Phase 1|Adverse Event|2|||
156754387|NCT01490840|565853205|FG001|Phase 1|Adverse Event|1|||
156754388|NCT01490840|565853204|FG000|Phase 1|Withdrawal by Subject|6|||
156754389|NCT01490840|565853205|FG001|Phase 1|Withdrawal by Subject|5|||
156754390|NCT01490840|565853204|FG000|Phase 1|Visit 6a omitted|1|||
156754391|NCT01490840|565853205|FG001|Phase 1|Visit 6a omitted|0|||
156754392|NCT01490840|565853204|FG000|Phase 2|Withdrawal by Subject|4|||
156754393|NCT01490840|565853205|FG001|Phase 2|Withdrawal by Subject|3|||
156754394|NCT01490840|565853204|FG000|Phase 2|Permanent interruption of fingolimod|0|||
156754395|NCT01490840|565853205|FG001|Phase 2|Permanent interruption of fingolimod|1|||
156754396|NCT01490840|565853204|FG000|Phase 2|Lost to Follow-up|1|||
156754397|NCT01490840|565853205|FG001|Phase 2|Lost to Follow-up|1|||
156754398|NCT01490840|565853204|FG000|Phase 2|Adverse Event|1|||
156754399|NCT01490840|565853205|FG001|Phase 2|Adverse Event|1|||
156754400|NCT01025284|565853209|FG000|Overall Study|Investigator Decision|0|||
156754401|NCT01025284|565853210|FG001|Overall Study|Investigator Decision|1|||
156754402|NCT01025284|565853211|FG002|Overall Study|Investigator Decision|0|||
156754403|NCT01025284|565853209|FG000|Overall Study|Withdrawal by Subject|0|||
156754404|NCT01025284|565853210|FG001|Overall Study|Withdrawal by Subject|1|||
156754405|NCT01025284|565853211|FG002|Overall Study|Withdrawal by Subject|0|||
156754406|NCT02542397|565853212|FG000|Overall Study|Death|2|||
156754407|NCT02542397|565853212|FG000|Overall Study|Physician Decision|6|||
156754408|NCT02542397|565853212|FG000|Overall Study|Withdrawal by Subject|6|||
156754409|NCT02542397|565853212|FG000|Overall Study|Lost to Follow-up|2|||
156754410|NCT00547248|565853219|FG000|Overall Study|Protocol Violation|0|||
156754411|NCT00547248|565853220|FG001|Overall Study|Protocol Violation|0|||
157099230|NCT03588728|567118257|FG002|Overall Study|Hospitalized for COVID|0|||
157099231|NCT03588728|567118258|FG003|Overall Study|Hospitalized for COVID|0|||
157099232|NCT03588728|567118255|FG000|Overall Study|Schedule change unable to attend sessions|1|||
157099233|NCT03588728|567118256|FG001|Overall Study|Schedule change unable to attend sessions|0|||
156754412|NCT00547248|565853221|FG002|Overall Study|Protocol Violation|1|||
156754413|NCT00547248|565853222|FG003|Overall Study|Protocol Violation|1|||
156754414|NCT00547248|565853219|FG000|Overall Study|Migrated/moved from study area|0|||
156754415|NCT00547248|565853220|FG001|Overall Study|Migrated/moved from study area|0|||
156754416|NCT00547248|565853221|FG002|Overall Study|Migrated/moved from study area|2|||
156754417|NCT00547248|565853222|FG003|Overall Study|Migrated/moved from study area|0|||
156754418|NCT00547248|565853219|FG000|Overall Study|Withdrawal by Subject|0|||
156754419|NCT00547248|565853220|FG001|Overall Study|Withdrawal by Subject|0|||
156754420|NCT00547248|565853221|FG002|Overall Study|Withdrawal by Subject|7|||
156754421|NCT00547248|565853222|FG003|Overall Study|Withdrawal by Subject|1|||
156754422|NCT02090283|565853225|FG000|Overall Study|Withdrawal by Subject|6|||
156754423|NCT02090283|565853226|FG001|Overall Study|Withdrawal by Subject|6|||
156754424|NCT02090283|565853227|FG002|Overall Study|Withdrawal by Subject|6|||
156754425|NCT02090283|565853225|FG000|Overall Study|Sponsor Terminated Study|6|||
156754426|NCT02090283|565853226|FG001|Overall Study|Sponsor Terminated Study|6|||
156754427|NCT02090283|565853227|FG002|Overall Study|Sponsor Terminated Study|1|||
156754428|NCT02090283|565853225|FG000|Overall Study|Lost to Follow-up|2|||
156754429|NCT02090283|565853226|FG001|Overall Study|Lost to Follow-up|2|||
156754430|NCT02090283|565853227|FG002|Overall Study|Lost to Follow-up|3|||
156754431|NCT02090283|565853225|FG000|Overall Study|Adverse Event|1|||
156754432|NCT02090283|565853226|FG001|Overall Study|Adverse Event|1|||
156754433|NCT02090283|565853227|FG002|Overall Study|Adverse Event|0|||
156754434|NCT02090283|565853225|FG000|Overall Study|Protocol Violation|2|||
156754435|NCT02090283|565853226|FG001|Overall Study|Protocol Violation|0|||
156754436|NCT02090283|565853227|FG002|Overall Study|Protocol Violation|0|||
156754437|NCT00697593|565853230|FG000|Overall Study|Adverse Event|3|||
156754438|NCT00697593|565853230|FG000|Overall Study|Protocol Violation|1|||
156754439|NCT00697593|565853230|FG000|Overall Study|Lack of Efficacy|3|||
156754440|NCT00697593|565853230|FG000|Overall Study|Suspension of the study by sponsor|12|||
156754441|NCT00540644|565853231|FG000|Overall Study|Adverse Event|3|||
156754442|NCT00540644|565853232|FG001|Overall Study|Adverse Event|1|||
156754443|NCT00540644|565853231|FG000|Overall Study|Disease Progression|3|||
156754444|NCT00540644|565853232|FG001|Overall Study|Disease Progression|1|||
156754445|NCT00540644|565853231|FG000|Overall Study|Physician Decision|0|||
156754446|NCT00540644|565853232|FG001|Overall Study|Physician Decision|5|||
156754447|NCT00540644|565853231|FG000|Overall Study|Withdrawal by Subject|2|||
156754448|NCT00540644|565853232|FG001|Overall Study|Withdrawal by Subject|2|||
156754449|NCT00540644|565853231|FG000|Overall Study|Noncomplilance|1|||
156754450|NCT00540644|565853232|FG001|Overall Study|Noncomplilance|0|||
156754451|NCT01765569|565853243|FG000|Period B|Withdrawal by Subject|1|||
156754452|NCT01765569|565853243|FG000|Period C|Death|1|||
156754453|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
156754454|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
156754455|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
156754456|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
156754457|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
156754458|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
156754459|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|Death|0|||
156754460|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|Death|1|||
156754461|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|Death|0|||
156754462|NCT01030718|565853244|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
156754463|NCT01030718|565853245|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
156754464|NCT01030718|565853246|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
156754465|NCT01030718|565853244|FG000|Study CA180-036 Only|insufficient effect|1|||
156754466|NCT01030718|565853245|FG001|Study CA180-036 Only|insufficient effect|1|||
156754467|NCT01030718|565853246|FG002|Study CA180-036 Only|insufficient effect|5|||
156754468|NCT01030718|565853244|FG000|Study CA180-036 Only|Adverse Event|2|||
156754469|NCT01030718|565853245|FG001|Study CA180-036 Only|Adverse Event|3|||
156754470|NCT01030718|565853246|FG002|Study CA180-036 Only|Adverse Event|0|||
156754471|NCT01030718|565853244|FG000|Study CA180-036 Only|Death|0|||
156754472|NCT01030718|565853245|FG001|Study CA180-036 Only|Death|1|||
156754473|NCT01030718|565853246|FG002|Study CA180-036 Only|Death|0|||
156754474|NCT01030718|565853244|FG000|Study CA180-036 Only|Other Reasons|0|||
156754475|NCT01030718|565853245|FG001|Study CA180-036 Only|Other Reasons|2|||
156754476|NCT01030718|565853246|FG002|Study CA180-036 Only|Other Reasons|0|||
156754477|NCT03853291|565853247|FG000|Overall Study|Lost to Follow-up|1|||
156754478|NCT03853291|565853248|FG001|Overall Study|Lost to Follow-up|2|||
156754479|NCT03853291|565853249|FG002|Overall Study|Lost to Follow-up|0|||
156754480|NCT03853291|565853250|FG003|Overall Study|Lost to Follow-up|0|||
156754481|NCT03853291|565853251|FG004|Overall Study|Lost to Follow-up|0|||
156754482|NCT03853291|565853252|FG005|Overall Study|Lost to Follow-up|0|||
156754483|NCT03853291|565853247|FG000|Overall Study|Determined to be ineligible|1|||
156754484|NCT03853291|565853248|FG001|Overall Study|Determined to be ineligible|1|||
156754485|NCT03853291|565853249|FG002|Overall Study|Determined to be ineligible|0|||
156754486|NCT03853291|565853250|FG003|Overall Study|Determined to be ineligible|0|||
156754487|NCT03853291|565853251|FG004|Overall Study|Determined to be ineligible|0|||
156754488|NCT03853291|565853252|FG005|Overall Study|Determined to be ineligible|0|||
156754489|NCT02383355|565853253|FG000|Overall Study|Adverse Event|2|||
156754490|NCT02383355|565853254|FG001|Overall Study|Adverse Event|0|||
156754491|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
156754492|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
156754493|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
156754494|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
156754495|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
156754496|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
156754497|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
156754498|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
156754499|NCT00972283|565853255|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
156754500|NCT00972283|565853256|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
156754501|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
156754502|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
156754503|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
156754504|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
156754505|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
156754506|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
156754507|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
156754508|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
156754509|NCT00972283|565853255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
156754510|NCT00972283|565853256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
156754511|NCT03092791|565853260|FG000|Overall Study|Lost to Follow-up|0|||
156754512|NCT03092791|565853261|FG001|Overall Study|Lost to Follow-up|0|||
156754513|NCT03092791|565853262|FG002|Overall Study|Lost to Follow-up|0|||
156754514|NCT03092791|565853263|FG003|Overall Study|Lost to Follow-up|0|||
156754515|NCT03092791|565853264|FG004|Overall Study|Lost to Follow-up|0|||
156754516|NCT03092791|565853265|FG005|Overall Study|Lost to Follow-up|0|||
156754517|NCT03092791|565853266|FG006|Overall Study|Lost to Follow-up|1|||
156754518|NCT03092791|565853267|FG007|Overall Study|Lost to Follow-up|0|||
156754519|NCT03092791|565853260|FG000|Overall Study|Withdrawal of Consent|0|||
156754520|NCT03092791|565853261|FG001|Overall Study|Withdrawal of Consent|0|||
156754521|NCT03092791|565853262|FG002|Overall Study|Withdrawal of Consent|0|||
156754522|NCT03092791|565853263|FG003|Overall Study|Withdrawal of Consent|0|||
156754523|NCT03092791|565853264|FG004|Overall Study|Withdrawal of Consent|4|||
156754524|NCT03092791|565853265|FG005|Overall Study|Withdrawal of Consent|12|||
156754525|NCT03092791|565853266|FG006|Overall Study|Withdrawal of Consent|6|||
156754526|NCT03092791|565853267|FG007|Overall Study|Withdrawal of Consent|4|||
156754527|NCT03092791|565853260|FG000|Overall Study|Study Termination|0|||
156754528|NCT03092791|565853261|FG001|Overall Study|Study Termination|0|||
156754529|NCT03092791|565853262|FG002|Overall Study|Study Termination|0|||
156754530|NCT03092791|565853263|FG003|Overall Study|Study Termination|0|||
156754531|NCT03092791|565853264|FG004|Overall Study|Study Termination|55|||
156754532|NCT03092791|565853265|FG005|Overall Study|Study Termination|46|||
156754533|NCT03092791|565853266|FG006|Overall Study|Study Termination|53|||
156754534|NCT03092791|565853267|FG007|Overall Study|Study Termination|55|||
156754535|NCT03092791|565853260|FG000|Overall Study|Death|0|||
156754536|NCT03092791|565853261|FG001|Overall Study|Death|0|||
156754537|NCT03092791|565853262|FG002|Overall Study|Death|0|||
156754538|NCT03092791|565853263|FG003|Overall Study|Death|0|||
156754539|NCT03092791|565853264|FG004|Overall Study|Death|0|||
156754540|NCT03092791|565853265|FG005|Overall Study|Death|1|||
156754541|NCT03092791|565853266|FG006|Overall Study|Death|0|||
156754542|NCT03092791|565853267|FG007|Overall Study|Death|1|||
156754543|NCT03092791|565853260|FG000|Overall Study|Reason Not Specified|0|||
156754544|NCT03092791|565853261|FG001|Overall Study|Reason Not Specified|0|||
156754545|NCT03092791|565853262|FG002|Overall Study|Reason Not Specified|0|||
156754546|NCT03092791|565853263|FG003|Overall Study|Reason Not Specified|0|||
156754547|NCT03092791|565853264|FG004|Overall Study|Reason Not Specified|1|||
156754548|NCT03092791|565853265|FG005|Overall Study|Reason Not Specified|1|||
156754549|NCT03092791|565853266|FG006|Overall Study|Reason Not Specified|0|||
156754550|NCT03092791|565853267|FG007|Overall Study|Reason Not Specified|0|||
156754551|NCT02182830|565853268|FG000|Overall Study|Not Treated|1|||
156754552|NCT02182830|565853269|FG001|Overall Study|Not Treated|1|||
156754553|NCT02182830|565853268|FG000|Overall Study|Trial stopped, reason missing|3|||
156754554|NCT02182830|565853269|FG001|Overall Study|Trial stopped, reason missing|3|||
156754555|NCT02182830|565853268|FG000|Overall Study|Consent withdrawn|8|||
156754556|NCT02182830|565853269|FG001|Overall Study|Consent withdrawn|8|||
156754557|NCT02182830|565853268|FG000|Overall Study|Lost to Follow-up|3|||
156754558|NCT02182830|565853269|FG001|Overall Study|Lost to Follow-up|3|||
156754559|NCT00913770|565853270|FG000|Overall Study|Unable to contact|24|||
156754560|NCT00913770|565853271|FG001|Overall Study|Unable to contact|19|||
156754561|NCT00913770|565853272|FG002|Overall Study|Unable to contact|13|||
156754562|NCT00913770|565853270|FG000|Overall Study|Refused|11|||
156754563|NCT00913770|565853271|FG001|Overall Study|Refused|10|||
156754564|NCT00913770|565853272|FG002|Overall Study|Refused|8|||
156754565|NCT01990768|565853273|FG000|Intervention Started|Found to be ineligible|14|||
156754566|NCT01990768|565853274|FG001|Intervention Started|Found to be ineligible|13|||
156754567|NCT01990768|565853275|FG002|Intervention Started|Found to be ineligible|11|||
156754568|NCT01990768|565853273|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
156754569|NCT01990768|565853274|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
156754570|NCT01990768|565853275|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
156754571|NCT01990768|565853273|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
156754572|NCT01990768|565853274|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
156754573|NCT01990768|565853275|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
156754574|NCT01990768|565853273|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
156754575|NCT01990768|565853274|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
156754576|NCT01990768|565853275|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
156754577|NCT01990768|565853273|FG000|Intervention Started|Patient care priority|1|||
156754578|NCT01990768|565853274|FG001|Intervention Started|Patient care priority|2|||
156754579|NCT01990768|565853275|FG002|Intervention Started|Patient care priority|3|||
156754580|NCT01990768|565853273|FG000|Intervention Started|IV lost|2|||
156754581|NCT01990768|565853274|FG001|Intervention Started|IV lost|2|||
156754582|NCT01990768|565853275|FG002|Intervention Started|IV lost|2|||
156754583|NCT01990768|565853273|FG000|Intervention Started|Required CPR|1|||
156754584|NCT01990768|565853274|FG001|Intervention Started|Required CPR|1|||
156754585|NCT01990768|565853275|FG002|Intervention Started|Required CPR|0|||
156754586|NCT01990768|565853273|FG000|Intervention Started|Seizure or hx of seizure|0|||
156754587|NCT01990768|565853274|FG001|Intervention Started|Seizure or hx of seizure|0|||
156754588|NCT01990768|565853275|FG002|Intervention Started|Seizure or hx of seizure|2|||
156754589|NCT01990768|565853273|FG000|Intervention Started|Discovered to be pregnant|0|||
156754590|NCT01990768|565853274|FG001|Intervention Started|Discovered to be pregnant|1|||
156754591|NCT01990768|565853275|FG002|Intervention Started|Discovered to be pregnant|0|||
156754592|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
156754593|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
156754594|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
156754595|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
156754596|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
156754597|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
156754598|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
156754599|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
156754600|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
156754601|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
156754602|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
156754603|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
156754604|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Death|3|||
156754605|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Death|1|||
156754606|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Death|1|||
156754607|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Discharged|2|||
156754608|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Discharged|1|||
156754609|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Discharged|0|||
156754610|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
156754611|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
156754612|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
156754613|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
156754614|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
156754615|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
156754616|NCT01990768|565853273|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
156754617|NCT01990768|565853274|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
156754618|NCT01990768|565853275|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
156754619|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
156754620|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
156754621|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
156754622|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
156754623|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
156754624|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
156754625|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
156754626|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
156754627|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
156754628|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
156754629|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
156754630|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
156754631|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
156754632|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
156754633|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
156754634|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
156754635|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
156754636|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
156754637|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
156754638|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
156754639|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
156754640|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
156754641|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
156754642|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
156754643|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
156754644|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
156754645|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
156754646|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
156754647|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
156754648|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
156754649|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754650|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754651|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
156754652|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
156754653|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
156754654|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
156754655|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
156754656|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
156754657|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
156754658|NCT01990768|565853273|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
156754659|NCT01990768|565853274|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
156754660|NCT01990768|565853275|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
156754661|NCT01990768|565853273|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
156754662|NCT01990768|565853274|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
156754663|NCT01990768|565853275|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
156754664|NCT01990768|565853273|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
156754665|NCT01990768|565853274|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
156754666|NCT01990768|565853275|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
156754667|NCT01990768|565853273|FG000|6-Month Follow-up|No contact information|5|||
156754668|NCT01990768|565853274|FG001|6-Month Follow-up|No contact information|6|||
156754669|NCT01990768|565853275|FG002|6-Month Follow-up|No contact information|5|||
156754670|NCT01990768|565853273|FG000|6-Month Follow-up|Homeless|4|||
156754671|NCT01990768|565853274|FG001|6-Month Follow-up|Homeless|3|||
156754672|NCT01990768|565853275|FG002|6-Month Follow-up|Homeless|6|||
156754673|NCT01990768|565853273|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
156754674|NCT01990768|565853274|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
156754675|NCT01990768|565853275|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
156754676|NCT01990768|565853273|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
156754677|NCT01990768|565853274|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
156754678|NCT01990768|565853275|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
156754679|NCT01990768|565853273|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
156754680|NCT01990768|565853274|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
156754681|NCT01990768|565853275|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
156754682|NCT00334295|565853276|FG000|Overall Study|Patients received fewer than 3 injection|5|||
156754683|NCT00248833|565853281|FG000|Overall Study|Adverse Event|2|||
156754684|NCT00248833|565853282|FG001|Overall Study|Adverse Event|0|||
156754685|NCT00248833|565853283|FG002|Overall Study|Adverse Event|0|||
156754686|NCT00248833|565853281|FG000|Overall Study|Withdrawal by Subject|0|||
156754687|NCT00248833|565853282|FG001|Overall Study|Withdrawal by Subject|1|||
156754688|NCT00248833|565853283|FG002|Overall Study|Withdrawal by Subject|1|||
156754689|NCT00248833|565853281|FG000|Overall Study|Lost to Follow-up|1|||
156754690|NCT00248833|565853282|FG001|Overall Study|Lost to Follow-up|1|||
156754691|NCT00248833|565853283|FG002|Overall Study|Lost to Follow-up|1|||
156754692|NCT00248833|565853281|FG000|Overall Study|Other|0|||
156754693|NCT00248833|565853282|FG001|Overall Study|Other|1|||
156754694|NCT00248833|565853283|FG002|Overall Study|Other|0|||
156754695|NCT02636439|565853284|FG000|Overall Study|Adverse Event|2|||
156754696|NCT02636439|565853285|FG001|Overall Study|Adverse Event|2|||
156754697|NCT02636439|565853284|FG000|Overall Study|Lost to Follow-up|1|||
156754698|NCT02636439|565853285|FG001|Overall Study|Lost to Follow-up|0|||
156754699|NCT02636439|565853284|FG000|Overall Study|Non-compliance|1|||
156754700|NCT02636439|565853285|FG001|Overall Study|Non-compliance|1|||
156754701|NCT02636439|565853284|FG000|Overall Study|Personal reasons|2|||
156754702|NCT02636439|565853285|FG001|Overall Study|Personal reasons|0|||
156754703|NCT02494401|565853286|FG000|Overall Study|Lost to Follow-up|22|||
156754704|NCT02494401|565853287|FG001|Overall Study|Lost to Follow-up|25|||
156754705|NCT02494401|565853286|FG000|Overall Study|Withdrawal by Subject|3|||
156754706|NCT02494401|565853287|FG001|Overall Study|Withdrawal by Subject|2|||
156754707|NCT04530838|565855005|FG000|Overall Study|Other|2|||
156754708|NCT04530838|565855006|FG001|Overall Study|Other|1|||
156754709|NCT04530838|565855007|FG002|Overall Study|Other|0|||
156754710|NCT04530838|565855005|FG000|Overall Study|Physician Decision|0|||
156754711|NCT04530838|565855006|FG001|Overall Study|Physician Decision|0|||
156754712|NCT04530838|565855007|FG002|Overall Study|Physician Decision|1|||
156754713|NCT04530838|565855005|FG000|Overall Study|Death|0|||
156754714|NCT04530838|565855006|FG001|Overall Study|Death|0|||
156754715|NCT04530838|565855007|FG002|Overall Study|Death|1|||
156754716|NCT04530838|565855005|FG000|Overall Study|Adverse Event|0|||
156754717|NCT04530838|565855006|FG001|Overall Study|Adverse Event|1|||
156754718|NCT04530838|565855007|FG002|Overall Study|Adverse Event|0|||
156754719|NCT04530838|565855005|FG000|Overall Study|No longer meets eligibility criteria|1|||
156754720|NCT04530838|565855006|FG001|Overall Study|No longer meets eligibility criteria|0|||
156754721|NCT04530838|565855007|FG002|Overall Study|No longer meets eligibility criteria|2|||
156754722|NCT04530838|565855005|FG000|Overall Study|Withdrawal by parent/guardian|5|||
156754723|NCT04530838|565855006|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156754724|NCT04530838|565855007|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156754725|NCT00803712|565855008|FG000|Overall Study|Noncompliance|3|||
156754726|NCT00803712|565855009|FG001|Overall Study|Noncompliance|0|||
156754727|NCT00803712|565855008|FG000|Overall Study|Adverse Event|5|||
156754728|NCT00803712|565855009|FG001|Overall Study|Adverse Event|0|||
156754729|NCT00803712|565855008|FG000|Overall Study|Death|8|||
156754730|NCT00803712|565855009|FG001|Overall Study|Death|7|||
156754731|NCT00803712|565855008|FG000|Overall Study|Lost to Follow-up|3|||
156754732|NCT00803712|565855009|FG001|Overall Study|Lost to Follow-up|1|||
156754733|NCT00803712|565855008|FG000|Overall Study|Withdrawal by Subject|2|||
156754734|NCT00803712|565855009|FG001|Overall Study|Withdrawal by Subject|4|||
156754735|NCT00803712|565855008|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
156754736|NCT00803712|565855009|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
156754737|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (other)|0|||
156754738|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (other)|2|||
156754739|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
156754740|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
156754741|NCT00803712|565855008|FG000|Overall Study|Administrative decision|2|||
156754742|NCT00803712|565855009|FG001|Overall Study|Administrative decision|3|||
156754743|NCT00803712|565855008|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
156754744|NCT00803712|565855009|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
156754745|NCT00305227|565855024|FG000|Overall Study|Lost to Follow-up|7|||
156754746|NCT00305227|565855025|FG001|Overall Study|Lost to Follow-up|6|||
156754747|NCT05133323|565855027|FG000|Overall Study|Lack of Efficacy|0|||
156754748|NCT05133323|565855028|FG001|Overall Study|Lack of Efficacy|0|||
156754749|NCT05133323|565855029|FG002|Overall Study|Lack of Efficacy|1|||
156754750|NCT05133323|565855027|FG000|Overall Study|Withdrawal by Subject|2|||
156754751|NCT05133323|565855028|FG001|Overall Study|Withdrawal by Subject|1|||
156754752|NCT05133323|565855029|FG002|Overall Study|Withdrawal by Subject|0|||
156754753|NCT00632125|565855030|FG000|Overall Study|Death|82|||
156754754|NCT00632125|565855030|FG000|Overall Study|Withdrawal by Subject|44|||
156754755|NCT00632125|565855030|FG000|Overall Study|Adverse Event|36|||
156754756|NCT00632125|565855030|FG000|Overall Study|Renal transplantation|17|||
156754757|NCT00632125|565855030|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
156754758|NCT00632125|565855030|FG000|Overall Study|Non-compliance|8|||
156754759|NCT00632125|565855030|FG000|Overall Study|Development of uncontrolled hypertension|5|||
156754760|NCT00632125|565855030|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
156754761|NCT00577772|565855037|FG000|Overall Study|Lost to Follow-up|0|||
156754762|NCT00577772|565855038|FG001|Overall Study|Lost to Follow-up|1|||
156754763|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
156754764|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
156754765|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
156754766|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
156754767|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
156754768|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
156754769|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
156754770|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
156754771|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
156754772|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
156754773|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
156754774|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
156754775|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
156754776|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
156754777|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Death|1|||
156754778|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Death|0|||
156754779|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
156754780|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
156754781|NCT00105989|565855045|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
156754782|NCT00105989|565855046|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
156754783|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
156754784|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
156754785|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
156754786|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
156754787|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
156754788|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
156754789|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
156754790|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
156754791|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
156754792|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
156754793|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
156754794|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
156754795|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
156754796|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
156754797|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Death|0|||
156754798|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Death|0|||
156754799|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
156754800|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
156754801|NCT00105989|565855045|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
156754802|NCT00105989|565855046|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
156754803|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
156754804|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
156754805|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
156754806|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
156754807|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
156754808|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
156754809|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
156754810|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
156754811|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
156754812|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
156754813|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
156754814|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
156754815|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
156754816|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
156754817|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
156754818|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
156754819|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
156754820|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
156754821|NCT00105989|565855045|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
156754822|NCT00105989|565855046|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
156754823|NCT01716663|565855047|FG000|Overall Study|Withdrawn prior to procedure|4|||
156754824|NCT01716663|565855047|FG000|Overall Study|Treated with non-study catheter|2|||
156754825|NCT01029262|565855050|FG000|Overall Study|Adverse Event|9|||
156754826|NCT01029262|565855051|FG001|Overall Study|Adverse Event|52|||
156754827|NCT01029262|565855050|FG000|Overall Study|Lack of therapeutic effect|57|||
156754828|NCT01029262|565855051|FG001|Overall Study|Lack of therapeutic effect|76|||
156754829|NCT01029262|565855050|FG000|Overall Study|Withdrawal by Subject|10|||
156754830|NCT01029262|565855051|FG001|Overall Study|Withdrawal by Subject|17|||
156754831|NCT01029262|565855050|FG000|Overall Study|Protocol Violation|2|||
156754832|NCT01029262|565855051|FG001|Overall Study|Protocol Violation|3|||
156754833|NCT01029262|565855050|FG000|Overall Study|Miscellaneous|1|||
156754834|NCT01029262|565855051|FG001|Overall Study|Miscellaneous|9|||
156754835|NCT01029262|565855050|FG000|Overall Study|Death|0|||
156754836|NCT01029262|565855051|FG001|Overall Study|Death|3|||
156754837|NCT00807612|565855055|FG000|Overall Study|Death|8|||
156754838|NCT00807612|565855055|FG000|Overall Study|Study early termination|5|||
156754839|NCT00807612|565855055|FG000|Overall Study|Withdrawal by Subject|1|||
156754840|NCT04607135|565855056|FG000|Overall Study|Physician Decision|1|||
156754841|NCT04607135|565855056|FG000|Overall Study|Withdrawal by Subject|1|||
156754842|NCT04607135|565855056|FG000|Overall Study|Equipment not working|3|||
156996330|NCT04888585|566739537|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
156996331|NCT04888585|566739538|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
156996332|NCT04888585|566739528|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156996333|NCT04888585|566739529|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156996334|NCT04888585|566739530|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156754843|NCT03465709|565855057|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
156754844|NCT03465709|565855057|FG000|Overall Study|Withdrawal by Subject|3|||
156754845|NCT04892446|565855058|FG000|Overall Study|Death|4|||
156754846|NCT04892446|565855059|FG001|Overall Study|Death|4|||
156754847|NCT04892446|565855060|FG002|Overall Study|Death|0|||
156754848|NCT04892446|565855058|FG000|Overall Study|Withdrew consent|3|||
156754849|NCT04892446|565855059|FG001|Overall Study|Withdrew consent|0|||
156754850|NCT04892446|565855060|FG002|Overall Study|Withdrew consent|1|||
156754851|NCT04892446|565855058|FG000|Overall Study|Investigator's discretion|1|||
156754852|NCT04892446|565855059|FG001|Overall Study|Investigator's discretion|1|||
156754853|NCT04892446|565855060|FG002|Overall Study|Investigator's discretion|0|||
156754854|NCT04892446|565855058|FG000|Overall Study|Study terminated by sponsor|0|||
156754855|NCT04892446|565855059|FG001|Overall Study|Study terminated by sponsor|0|||
156754856|NCT04892446|565855060|FG002|Overall Study|Study terminated by sponsor|2|||
156754857|NCT00705341|565855061|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
156754858|NCT00705341|565855062|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
156754859|NCT00705341|565855063|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
156754860|NCT00705341|565855064|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
156754861|NCT00705341|565855061|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156754862|NCT00705341|565855062|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156754863|NCT00705341|565855063|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
156754864|NCT00705341|565855064|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
156996335|NCT04888585|566739531|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156996336|NCT04888585|566739532|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
156754865|NCT03665077|565855067|FG000|Overall Study|Lost to Follow-up|2|||
156754866|NCT03665077|565855067|FG000|Overall Study|Physician Decision|2|||
157099234|NCT03588728|567118257|FG002|Overall Study|Schedule change unable to attend sessions|0|||
157099235|NCT03588728|567118258|FG003|Overall Study|Schedule change unable to attend sessions|0|||
157099236|NCT01388790|567118259|FG000|Overall Study|Ongoing at data cut-off date|8|||
157099237|NCT00908232|567118260|FG000|Cycle 1 to 4|Death|5|||
157099238|NCT00908232|567118261|FG001|Cycle 1 to 4|Death|0|||
157099239|NCT00908232|567118262|FG002|Cycle 1 to 4|Death|0|||
157099240|NCT00908232|567118263|FG003|Cycle 1 to 4|Death|0|||
157099241|NCT00908232|567118260|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
156754867|NCT03173456|565855070|FG000|Baseline|Medication dispensing system malfunction'|0|||
156754868|NCT03173456|565855071|FG001|Baseline|Medication dispensing system malfunction'|1|||
156754869|NCT03173456|565855072|FG002|Baseline|Medication dispensing system malfunction'|0|||
156754870|NCT03173456|565855073|FG003|Baseline|Medication dispensing system malfunction'|0|||
156754871|NCT03173456|565855074|FG004|Baseline|Medication dispensing system malfunction'|2|||
156754872|NCT03173456|565855070|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
156754873|NCT03173456|565855071|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
156754874|NCT03173456|565855072|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
156754875|NCT03173456|565855073|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
156754876|NCT03173456|565855074|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
156754877|NCT00685360|565855075|FG000|Overall Study|Lost to Follow-up|0|||
156754878|NCT00685360|565855076|FG001|Overall Study|Lost to Follow-up|1|||
156754879|NCT00685360|565855077|FG002|Overall Study|Lost to Follow-up|2|||
156754880|NCT00685360|565855075|FG000|Overall Study|Adverse Event|4|||
156754881|NCT00685360|565855076|FG001|Overall Study|Adverse Event|6|||
156754882|NCT00685360|565855077|FG002|Overall Study|Adverse Event|4|||
156754883|NCT00685360|565855075|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
156754884|NCT00685360|565855076|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
156754885|NCT00685360|565855077|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
156754886|NCT00685360|565855075|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
156754887|NCT00685360|565855076|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
156754888|NCT00685360|565855077|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
156754889|NCT00685360|565855075|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
156754890|NCT00685360|565855076|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
156754891|NCT00685360|565855077|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
156754892|NCT00685360|565855075|FG000|Overall Study|Protocol Deviation|0|||
156754893|NCT00685360|565855076|FG001|Overall Study|Protocol Deviation|1|||
156754894|NCT00685360|565855077|FG002|Overall Study|Protocol Deviation|1|||
156754895|NCT04978337|565855078|FG000|Overall Study|Withdrawal by Subject|0|||
156754896|NCT04978337|565855079|FG001|Overall Study|Withdrawal by Subject|1|||
156754897|NCT01408901|565855080|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
156754898|NCT01408901|565855081|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
156754899|NCT01408901|565855082|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
156754900|NCT01408901|565855083|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
156754901|NCT01408901|565855080|FG000|6-Week Follow-Up|Death|1|||
156754902|NCT01408901|565855081|FG001|6-Week Follow-Up|Death|0|||
156754903|NCT01408901|565855082|FG002|6-Week Follow-Up|Death|0|||
156754904|NCT01408901|565855083|FG003|6-Week Follow-Up|Death|0|||
156754905|NCT01408901|565855080|FG000|6-Week Follow-Up|Cancelled visit|0|||
156754906|NCT01408901|565855081|FG001|6-Week Follow-Up|Cancelled visit|1|||
156754907|NCT01408901|565855082|FG002|6-Week Follow-Up|Cancelled visit|0|||
156754908|NCT01408901|565855083|FG003|6-Week Follow-Up|Cancelled visit|2|||
156754909|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754910|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754911|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
156754912|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
156754913|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
156754914|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754915|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754916|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
156754917|NCT01408901|565855080|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
156754918|NCT01408901|565855081|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
156754919|NCT01408901|565855082|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
156754920|NCT01408901|565855083|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
156754921|NCT01408901|565855080|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
156754922|NCT01408901|565855081|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
156754923|NCT01408901|565855082|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
156754924|NCT01408901|565855083|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
156754925|NCT01408901|565855080|FG000|26-Week Follow-Up|Death|0|||
156754926|NCT01408901|565855081|FG001|26-Week Follow-Up|Death|1|||
156754927|NCT01408901|565855082|FG002|26-Week Follow-Up|Death|0|||
156754928|NCT01408901|565855083|FG003|26-Week Follow-Up|Death|0|||
156754929|NCT01436227|565855086|FG000|Overall Study|Adverse Event|7|||
156754930|NCT01436227|565855086|FG000|Overall Study|Death|1|||
156754931|NCT01436227|565855086|FG000|Overall Study|Lack of Efficacy|1|||
156754932|NCT01436227|565855086|FG000|Overall Study|Lost to Follow-up|3|||
156754933|NCT01436227|565855086|FG000|Overall Study|Physician Decision|1|||
156754934|NCT01436227|565855086|FG000|Overall Study|Withdrawal by Subject|7|||
156754935|NCT01436227|565855086|FG000|Overall Study|Disease progression, relapse|6|||
156754936|NCT04865419|565855087|FG000|Overall Study|Other|1|||
156754937|NCT04865419|565855088|FG001|Overall Study|Other|2|||
156754938|NCT04865419|565855089|FG002|Overall Study|Other|2|||
156754939|NCT04865419|565855090|FG003|Overall Study|Other|1|||
156754940|NCT04865419|565855091|FG004|Overall Study|Other|3|||
156754941|NCT04865419|565855092|FG005|Overall Study|Other|0|||
156754942|NCT04865419|565855093|FG006|Overall Study|Other|0|||
156754943|NCT04865419|565855094|FG007|Overall Study|Other|1|||
156754944|NCT04865419|565855095|FG008|Overall Study|Other|0|||
156754945|NCT04865419|565855096|FG009|Overall Study|Other|0|||
156754946|NCT04865419|565855097|FG010|Overall Study|Other|0|||
156754947|NCT04865419|565855087|FG000|Overall Study|Withdrawal by Subject|0|||
156754948|NCT04865419|565855088|FG001|Overall Study|Withdrawal by Subject|1|||
156754949|NCT04865419|565855089|FG002|Overall Study|Withdrawal by Subject|1|||
156754950|NCT04865419|565855090|FG003|Overall Study|Withdrawal by Subject|0|||
156754951|NCT04865419|565855091|FG004|Overall Study|Withdrawal by Subject|0|||
156754952|NCT04865419|565855092|FG005|Overall Study|Withdrawal by Subject|0|||
156754953|NCT04865419|565855093|FG006|Overall Study|Withdrawal by Subject|0|||
156754954|NCT04865419|565855094|FG007|Overall Study|Withdrawal by Subject|1|||
156754955|NCT04865419|565855095|FG008|Overall Study|Withdrawal by Subject|2|||
156754956|NCT04865419|565855096|FG009|Overall Study|Withdrawal by Subject|1|||
156754957|NCT04865419|565855097|FG010|Overall Study|Withdrawal by Subject|0|||
156754958|NCT04865419|565855087|FG000|Overall Study|Study terminated by Sponsor|0|||
156754959|NCT04865419|565855088|FG001|Overall Study|Study terminated by Sponsor|0|||
156754960|NCT04865419|565855089|FG002|Overall Study|Study terminated by Sponsor|0|||
156754961|NCT04865419|565855090|FG003|Overall Study|Study terminated by Sponsor|2|||
156754962|NCT04865419|565855091|FG004|Overall Study|Study terminated by Sponsor|2|||
156754963|NCT04865419|565855092|FG005|Overall Study|Study terminated by Sponsor|0|||
156754964|NCT04865419|565855093|FG006|Overall Study|Study terminated by Sponsor|0|||
156754965|NCT04865419|565855094|FG007|Overall Study|Study terminated by Sponsor|0|||
156754966|NCT04865419|565855095|FG008|Overall Study|Study terminated by Sponsor|0|||
156754967|NCT04865419|565855096|FG009|Overall Study|Study terminated by Sponsor|0|||
156754968|NCT04865419|565855097|FG010|Overall Study|Study terminated by Sponsor|1|||
156754969|NCT04865419|565855087|FG000|Overall Study|Death|3|||
156754970|NCT04865419|565855088|FG001|Overall Study|Death|1|||
156754971|NCT04865419|565855089|FG002|Overall Study|Death|4|||
156754972|NCT04865419|565855090|FG003|Overall Study|Death|2|||
156754973|NCT04865419|565855091|FG004|Overall Study|Death|5|||
156754974|NCT04865419|565855092|FG005|Overall Study|Death|2|||
156754975|NCT04865419|565855093|FG006|Overall Study|Death|1|||
156754976|NCT04865419|565855094|FG007|Overall Study|Death|1|||
156754977|NCT04865419|565855095|FG008|Overall Study|Death|2|||
156754978|NCT04865419|565855096|FG009|Overall Study|Death|2|||
156754979|NCT04865419|565855097|FG010|Overall Study|Death|1|||
156754980|NCT04865419|565855087|FG000|Overall Study|Lost to Follow-up|0|||
156754981|NCT04865419|565855088|FG001|Overall Study|Lost to Follow-up|0|||
156754982|NCT04865419|565855089|FG002|Overall Study|Lost to Follow-up|0|||
156754983|NCT04865419|565855090|FG003|Overall Study|Lost to Follow-up|0|||
156754984|NCT04865419|565855091|FG004|Overall Study|Lost to Follow-up|0|||
156754985|NCT04865419|565855092|FG005|Overall Study|Lost to Follow-up|0|||
156754986|NCT04865419|565855093|FG006|Overall Study|Lost to Follow-up|0|||
156754987|NCT04865419|565855094|FG007|Overall Study|Lost to Follow-up|0|||
156754988|NCT04865419|565855095|FG008|Overall Study|Lost to Follow-up|0|||
156754989|NCT04865419|565855096|FG009|Overall Study|Lost to Follow-up|1|||
156754990|NCT04865419|565855097|FG010|Overall Study|Lost to Follow-up|0|||
156754991|NCT05446142|565855098|FG000|Period 2|Adverse Event|1|||
156754992|NCT05446142|565855099|FG001|Period 2|Adverse Event|0|||
156754993|NCT05446142|565855100|FG002|Period 2|Adverse Event|0|||
156754994|NCT05446142|565855101|FG003|Period 2|Adverse Event|0|||
156754995|NCT05446142|565855102|FG004|Period 2|Adverse Event|0|||
156754996|NCT05446142|565855103|FG005|Period 2|Adverse Event|0|||
156754997|NCT00547157|565855104|FG000|Overall Study|Other|1|||
156754998|NCT00547157|565855105|FG001|Overall Study|Other|0|||
156754999|NCT00547157|565855104|FG000|Overall Study|Death|38|||
156755000|NCT00547157|565855105|FG001|Overall Study|Death|18|||
156755001|NCT00547157|565855104|FG000|Overall Study|Withdrawal by Subject|3|||
156755002|NCT00547157|565855105|FG001|Overall Study|Withdrawal by Subject|1|||
156755003|NCT00547157|565855104|FG000|Overall Study|Administrative decision|3|||
156755004|NCT00547157|565855105|FG001|Overall Study|Administrative decision|2|||
156755005|NCT00547157|565855104|FG000|Overall Study|Lost to Follow-up|4|||
156755006|NCT00547157|565855105|FG001|Overall Study|Lost to Follow-up|2|||
156755007|NCT01151345|565855107|FG000|First Intervention Period|Protocol Violation|0|||
156755008|NCT01151345|565855108|FG001|First Intervention Period|Protocol Violation|1|||
156755009|NCT00423813|565855109|FG000|Overall Study|Adverse Event|11|||
156755010|NCT00423813|565855110|FG001|Overall Study|Adverse Event|30|||
156755011|NCT00423813|565855111|FG002|Overall Study|Adverse Event|40|||
156755012|NCT00423813|565855109|FG000|Overall Study|Withdrawal by Subject|6|||
156755013|NCT00423813|565855110|FG001|Overall Study|Withdrawal by Subject|8|||
156755014|NCT00423813|565855111|FG002|Overall Study|Withdrawal by Subject|5|||
156755015|NCT00423813|565855109|FG000|Overall Study|Lost to Follow-up|5|||
156755016|NCT00423813|565855110|FG001|Overall Study|Lost to Follow-up|4|||
156755017|NCT00423813|565855111|FG002|Overall Study|Lost to Follow-up|4|||
156755018|NCT00423813|565855109|FG000|Overall Study|Lack of Efficacy|23|||
156755019|NCT00423813|565855110|FG001|Overall Study|Lack of Efficacy|18|||
156755020|NCT00423813|565855111|FG002|Overall Study|Lack of Efficacy|19|||
156755021|NCT00423813|565855109|FG000|Overall Study|Physician Decision|2|||
156755022|NCT00423813|565855110|FG001|Overall Study|Physician Decision|0|||
156755023|NCT00423813|565855111|FG002|Overall Study|Physician Decision|0|||
156755024|NCT00423813|565855109|FG000|Overall Study|Sponsor Decision|0|||
156755025|NCT00423813|565855110|FG001|Overall Study|Sponsor Decision|1|||
156755026|NCT00423813|565855111|FG002|Overall Study|Sponsor Decision|0|||
156755027|NCT00423813|565855109|FG000|Overall Study|Protocol Violation|9|||
156755028|NCT00423813|565855110|FG001|Overall Study|Protocol Violation|4|||
156755029|NCT00423813|565855111|FG002|Overall Study|Protocol Violation|4|||
156755030|NCT00423813|565855109|FG000|Overall Study|Pregnancy|0|||
156755031|NCT00423813|565855110|FG001|Overall Study|Pregnancy|0|||
156755032|NCT00423813|565855111|FG002|Overall Study|Pregnancy|1|||
156755033|NCT00423813|565855109|FG000|Overall Study|Subject started night shift work|1|||
156755034|NCT00423813|565855110|FG001|Overall Study|Subject started night shift work|0|||
156755035|NCT00423813|565855111|FG002|Overall Study|Subject started night shift work|0|||
156755036|NCT00423813|565855109|FG000|Overall Study|Will start exclusionary medications|0|||
156755037|NCT00423813|565855110|FG001|Overall Study|Will start exclusionary medications|1|||
156755038|NCT00423813|565855111|FG002|Overall Study|Will start exclusionary medications|0|||
156755039|NCT00423813|565855109|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
156755040|NCT00423813|565855110|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
156755041|NCT00423813|565855111|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
156755042|NCT01904032|565855119|FG000|Overall Study|Adverse Event|3|||
156755043|NCT01904032|565855120|FG001|Overall Study|Adverse Event|1|||
156755044|NCT01904032|565855119|FG000|Overall Study|Lost to Follow-up|4|||
156755045|NCT01904032|565855120|FG001|Overall Study|Lost to Follow-up|2|||
156755046|NCT01658904|565855121|FG000|Overall Study|Principal Investigator discretion|2|||
156755047|NCT01658904|565855122|FG001|Overall Study|Principal Investigator discretion|0|||
156755048|NCT01658904|565855123|FG002|Overall Study|Principal Investigator discretion|0|||
156755049|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
156755050|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
156755051|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
156755052|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
156755053|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
156755054|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
156755055|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
156755056|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
156755057|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
156755058|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
156755059|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755060|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755061|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755062|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
156755063|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755064|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755065|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
156755066|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
156755067|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755068|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
156755069|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755070|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755071|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
156755072|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755073|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755074|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755075|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755076|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755077|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755078|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
156755079|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755080|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755081|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755082|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755083|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755084|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
156755085|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755086|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
156755087|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755088|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
156755089|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755090|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755091|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755092|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755093|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
156755094|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
156755095|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755096|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755097|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755098|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
156755099|NCT04074330|565855133|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755100|NCT04074330|565855134|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755101|NCT04074330|565855135|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755102|NCT04074330|565855136|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755103|NCT04074330|565855137|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755104|NCT04074330|565855138|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
156755105|NCT04074330|565855139|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755106|NCT04074330|565855140|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755107|NCT04074330|565855141|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755108|NCT04074330|565855142|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
156755109|NCT04074330|565855133|FG000|Dose Expansion (up to 42 Months)|Death|0|||
156755110|NCT04074330|565855134|FG001|Dose Expansion (up to 42 Months)|Death|0|||
156755111|NCT04074330|565855135|FG002|Dose Expansion (up to 42 Months)|Death|0|||
156755112|NCT04074330|565855136|FG003|Dose Expansion (up to 42 Months)|Death|0|||
156755113|NCT04074330|565855137|FG004|Dose Expansion (up to 42 Months)|Death|0|||
156755114|NCT04074330|565855138|FG005|Dose Expansion (up to 42 Months)|Death|0|||
156755115|NCT04074330|565855139|FG006|Dose Expansion (up to 42 Months)|Death|0|||
156755116|NCT04074330|565855140|FG007|Dose Expansion (up to 42 Months)|Death|0|||
156755117|NCT04074330|565855141|FG008|Dose Expansion (up to 42 Months)|Death|1|||
156755118|NCT04074330|565855142|FG009|Dose Expansion (up to 42 Months)|Death|0|||
156755119|NCT04074330|565855133|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755120|NCT04074330|565855134|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755121|NCT04074330|565855135|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755122|NCT04074330|565855136|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755123|NCT04074330|565855137|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755124|NCT04074330|565855138|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755125|NCT04074330|565855139|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755126|NCT04074330|565855140|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
156755127|NCT04074330|565855141|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
156755128|NCT04074330|565855142|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
156755129|NCT03124537|565855146|FG000|Overall Study|Lost to Follow-up|3|||
156755130|NCT03124537|565855147|FG001|Overall Study|Lost to Follow-up|5|||
156755131|NCT03124537|565855146|FG000|Overall Study|App Crash, Incomplete Data|7|||
156755132|NCT03124537|565855147|FG001|Overall Study|App Crash, Incomplete Data|8|||
156755133|NCT02903420|565855152|FG000|Overall Study|Death|3|||
156755134|NCT02787083|565855153|FG000|Overall Study|Adverse Event|1|||
156755135|NCT02787083|565855154|FG001|Overall Study|Adverse Event|0|||
156755136|NCT02787083|565855153|FG000|Overall Study|Withdrawal by Subject|2|||
156755137|NCT02787083|565855154|FG001|Overall Study|Withdrawal by Subject|2|||
156755138|NCT03162328|565855155|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
156996337|NCT04888585|566739533|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
156996338|NCT04888585|566739534|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
156996339|NCT04888585|566739535|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
156996340|NCT04888585|566739536|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
156755139|NCT03162328|565855156|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
156755140|NCT03162328|565855157|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
156755141|NCT03162328|565855155|FG000|Screening Period|Withdrawal by Subject|1|||
156755142|NCT03162328|565855156|FG001|Screening Period|Withdrawal by Subject|0|||
156755143|NCT03162328|565855157|FG002|Screening Period|Withdrawal by Subject|0|||
156755144|NCT03162328|565855155|FG000|Study Period|Withdrawal by Subject|0|||
156755145|NCT03162328|565855156|FG001|Study Period|Withdrawal by Subject|0|||
156755146|NCT03162328|565855157|FG002|Study Period|Withdrawal by Subject|1|||
156755147|NCT03373461|565855160|FG000|Part 2|Adverse Event|0|||
156755148|NCT03373461|565855161|FG001|Part 2|Adverse Event|1|||
156755149|NCT03373461|565855162|FG002|Part 2|Adverse Event|0|||
156755150|NCT03373461|565855163|FG003|Part 2|Adverse Event|0|||
156755151|NCT03373461|565855164|FG004|Part 2|Adverse Event|1|||
156755152|NCT01243177|565855166|FG000|Overall Study|Lack of Efficacy|47|||
156755153|NCT01243177|565855167|FG001|Overall Study|Lack of Efficacy|31|||
156755154|NCT01243177|565855166|FG000|Overall Study|Protocol Violation|11|||
156755155|NCT01243177|565855167|FG001|Overall Study|Protocol Violation|10|||
156755156|NCT01243177|565855166|FG000|Overall Study|Lost to Follow-up|15|||
156755157|NCT01243177|565855167|FG001|Overall Study|Lost to Follow-up|18|||
156755158|NCT01243177|565855166|FG000|Overall Study|Withdrawal by Subject|46|||
156755159|NCT01243177|565855167|FG001|Overall Study|Withdrawal by Subject|38|||
156755160|NCT01243177|565855166|FG000|Overall Study|AE, serious fatal|0|||
156755161|NCT01243177|565855167|FG001|Overall Study|AE, serious fatal|1|||
156755162|NCT01243177|565855166|FG000|Overall Study|SAE, non-fatal|7|||
156755163|NCT01243177|565855167|FG001|Overall Study|SAE, non-fatal|9|||
156755164|NCT01243177|565855166|FG000|Overall Study|AE, non-serious non-fatal|40|||
156755165|NCT01243177|565855167|FG001|Overall Study|AE, non-serious non-fatal|58|||
156755166|NCT01243177|565855166|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
156755167|NCT01243177|565855167|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
156755168|NCT01243177|565855166|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156755169|NCT01243177|565855167|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
156755170|NCT01243177|565855166|FG000|Overall Study|Other Reason|11|||
156755171|NCT01243177|565855167|FG001|Overall Study|Other Reason|12|||
156755172|NCT03335813|565856924|FG000|Overall Study|Withdrawal by Subject|1|||
156755173|NCT02861664|565856925|FG000|Overall Study|Withdrawal of Consent|0|||
156755174|NCT02861664|565856926|FG001|Overall Study|Withdrawal of Consent|1|||
156755175|NCT00905632|565856927|FG000|Overall Study|Adverse Event|0|||
156755176|NCT00905632|565856928|FG001|Overall Study|Adverse Event|0|||
156755177|NCT00905632|565856929|FG002|Overall Study|Adverse Event|0|||
156755178|NCT00905632|565856930|FG003|Overall Study|Adverse Event|0|||
156755179|NCT00905632|565856931|FG004|Overall Study|Adverse Event|0|||
156755180|NCT00905632|565856932|FG005|Overall Study|Adverse Event|1|||
156755181|NCT00905632|565856933|FG006|Overall Study|Adverse Event|4|||
156755182|NCT02964338|565856936|FG000|Overall Study|Sponsor terminated study for futility|12|||
156755183|NCT02964338|565856937|FG001|Overall Study|Sponsor terminated study for futility|15|||
156755184|NCT02964338|565856938|FG002|Overall Study|Sponsor terminated study for futility|14|||
156755185|NCT02964338|565856936|FG000|Overall Study|Lack of Efficacy|0|||
156755186|NCT02964338|565856937|FG001|Overall Study|Lack of Efficacy|3|||
156755187|NCT02964338|565856938|FG002|Overall Study|Lack of Efficacy|0|||
156755188|NCT02964338|565856936|FG000|Overall Study|Lost to Follow-up|1|||
156755189|NCT02964338|565856937|FG001|Overall Study|Lost to Follow-up|0|||
156755190|NCT02964338|565856938|FG002|Overall Study|Lost to Follow-up|3|||
156755191|NCT02964338|565856936|FG000|Overall Study|Protocol Violation|0|||
156755192|NCT02964338|565856937|FG001|Overall Study|Protocol Violation|1|||
156755193|NCT02964338|565856938|FG002|Overall Study|Protocol Violation|0|||
156755194|NCT02964338|565856936|FG000|Overall Study|Withdrawal by Subject|1|||
156755195|NCT02964338|565856937|FG001|Overall Study|Withdrawal by Subject|3|||
156755196|NCT02964338|565856938|FG002|Overall Study|Withdrawal by Subject|1|||
156755197|NCT02964338|565856936|FG000|Overall Study|Adverse Event|2|||
156755198|NCT02964338|565856937|FG001|Overall Study|Adverse Event|1|||
156755199|NCT02964338|565856938|FG002|Overall Study|Adverse Event|1|||
156755200|NCT02964338|565856936|FG000|Overall Study|Non-compliant with e-diary|0|||
156755201|NCT02964338|565856937|FG001|Overall Study|Non-compliant with e-diary|1|||
156755202|NCT02964338|565856938|FG002|Overall Study|Non-compliant with e-diary|0|||
156755203|NCT02964338|565856936|FG000|Overall Study|Did not meet criteria|1|||
156755204|NCT02964338|565856937|FG001|Overall Study|Did not meet criteria|0|||
156755205|NCT02964338|565856938|FG002|Overall Study|Did not meet criteria|0|||
156755206|NCT02239640|565856939|FG000|Overall Study|Withdrawal by Subject|3|||
156755207|NCT02239640|565856939|FG000|Overall Study|Lost to Follow-up|72|||
156996341|NCT04888585|566739537|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
156755208|NCT02239640|565856939|FG000|Overall Study|Death|142|||
156755209|NCT02171429|565856945|FG000|Overall Study|Other|0|||
156755210|NCT02171429|565856946|FG001|Overall Study|Other|1|||
156755211|NCT02171429|565856947|FG002|Overall Study|Other|1|||
156755212|NCT02171429|565856945|FG000|Overall Study|Non-Compliance|0|||
156755213|NCT02171429|565856946|FG001|Overall Study|Non-Compliance|0|||
156755214|NCT02171429|565856947|FG002|Overall Study|Non-Compliance|1|||
156755215|NCT02171429|565856945|FG000|Overall Study|Physician Decision|0|||
156755216|NCT02171429|565856946|FG001|Overall Study|Physician Decision|0|||
156755217|NCT02171429|565856947|FG002|Overall Study|Physician Decision|1|||
156755218|NCT02171429|565856945|FG000|Overall Study|Withdrawal by Subject|1|||
156755219|NCT02171429|565856946|FG001|Overall Study|Withdrawal by Subject|1|||
156755220|NCT02171429|565856947|FG002|Overall Study|Withdrawal by Subject|1|||
156755221|NCT02171429|565856945|FG000|Overall Study|Lost to Follow-up|0|||
156755222|NCT02171429|565856946|FG001|Overall Study|Lost to Follow-up|1|||
156755223|NCT02171429|565856947|FG002|Overall Study|Lost to Follow-up|0|||
156755224|NCT02171429|565856945|FG000|Overall Study|Death|0|||
156755225|NCT02171429|565856946|FG001|Overall Study|Death|0|||
156755226|NCT02171429|565856947|FG002|Overall Study|Death|1|||
156755227|NCT01724177|565856948|FG000|Overall Study|Adverse Event|8|||
156755228|NCT01724177|565856948|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
156755229|NCT01724177|565856948|FG000|Overall Study|Nervous participant|1|||
156755230|NCT01724177|565856948|FG000|Overall Study|Serious Adverse Event Related|1|||
156755231|NCT00327340|565856953|FG000|Overall Study|Withdrawal by Subject|1|||
156755232|NCT00327340|565856954|FG001|Overall Study|Withdrawal by Subject|5|||
156755233|NCT00327340|565856953|FG000|Overall Study|Physician Decision|1|||
156755234|NCT00327340|565856954|FG001|Overall Study|Physician Decision|1|||
156755235|NCT00327340|565856953|FG000|Overall Study|Disease Progression|10|||
156755236|NCT00327340|565856954|FG001|Overall Study|Disease Progression|19|||
156755237|NCT00327340|565856953|FG000|Overall Study|Symptomatic Disease|0|||
156755238|NCT00327340|565856954|FG001|Overall Study|Symptomatic Disease|2|||
156755239|NCT00327340|565856953|FG000|Overall Study|Adverse Event|3|||
156755240|NCT00327340|565856954|FG001|Overall Study|Adverse Event|3|||
156755241|NCT00206427|565856958|FG000|Overall Study|Adverse Event|2|||
156755242|NCT04085601|565856959|FG000|Overall Study|Lost to Follow-up|1|||
156755243|NCT04085601|565856960|FG001|Overall Study|Lost to Follow-up|0|||
156755244|NCT04085601|565856959|FG000|Overall Study|Death|1|||
156755245|NCT04085601|565856960|FG001|Overall Study|Death|1|||
156755246|NCT03872843|565856961|FG000|Overall Study|Lost to Follow-up|5|||
156755247|NCT03872843|565856962|FG001|Overall Study|Lost to Follow-up|7|||
156755248|NCT00281697|565856963|FG000|Overall Study|> 60 days since last dose of study drug|4|||
156755249|NCT00281697|565856964|FG001|Overall Study|> 60 days since last dose of study drug|4|||
156755250|NCT00281697|565856963|FG000|Overall Study|Adverse Event|54|||
156755251|NCT00281697|565856964|FG001|Overall Study|Adverse Event|15|||
156755252|NCT00281697|565856963|FG000|Overall Study|Death|8|||
156755253|NCT00281697|565856964|FG001|Overall Study|Death|3|||
156755254|NCT00281697|565856963|FG000|Overall Study|Disease progression|279|||
156755255|NCT00281697|565856964|FG001|Overall Study|Disease progression|149|||
156755256|NCT00281697|565856963|FG000|Overall Study|Other|5|||
156755257|NCT00281697|565856964|FG001|Overall Study|Other|6|||
156755258|NCT00281697|565856963|FG000|Overall Study|Physician's decision to withdraw|15|||
156755259|NCT00281697|565856964|FG001|Overall Study|Physician's decision to withdraw|12|||
156755260|NCT00281697|565856963|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
156755261|NCT00281697|565856964|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
156755262|NCT00281697|565856963|FG000|Overall Study|Did not receive study drug|3|||
156755263|NCT00281697|565856964|FG001|Overall Study|Did not receive study drug|2|||
156755264|NCT00572455|565856967|FG000|Stage I (14 Days)|Adverse Event|0|||
156755265|NCT00572455|565856968|FG001|Stage I (14 Days)|Adverse Event|0|||
156755266|NCT00572455|565856969|FG002|Stage I (14 Days)|Adverse Event|0|||
156755267|NCT00572455|565856970|FG003|Stage I (14 Days)|Adverse Event|0|||
156755268|NCT00572455|565856971|FG004|Stage I (14 Days)|Adverse Event|0|||
156755269|NCT00572455|565856972|FG005|Stage I (14 Days)|Adverse Event|3|||
156755270|NCT00572455|565856973|FG006|Stage I (14 Days)|Adverse Event|0|||
156755271|NCT00572455|565856974|FG007|Stage I (14 Days)|Adverse Event|0|||
156755272|NCT00572455|565856975|FG008|Stage I (14 Days)|Adverse Event|0|||
156755273|NCT00572455|565856976|FG009|Stage I (14 Days)|Adverse Event|0|||
156755274|NCT00572455|565856977|FG010|Stage I (14 Days)|Adverse Event|0|||
156755275|NCT00572455|565856978|FG011|Stage I (14 Days)|Adverse Event|0|||
156755276|NCT00572455|565856979|FG012|Stage I (14 Days)|Adverse Event|0|||
156755277|NCT00572455|565856980|FG013|Stage I (14 Days)|Adverse Event|0|||
156755278|NCT00572455|565856967|FG000|Stage I (14 Days)|Other|0|||
156755279|NCT00572455|565856968|FG001|Stage I (14 Days)|Other|0|||
156755280|NCT00572455|565856969|FG002|Stage I (14 Days)|Other|0|||
156755281|NCT00572455|565856970|FG003|Stage I (14 Days)|Other|0|||
156755282|NCT00572455|565856971|FG004|Stage I (14 Days)|Other|1|||
156755283|NCT00572455|565856972|FG005|Stage I (14 Days)|Other|0|||
156755284|NCT00572455|565856973|FG006|Stage I (14 Days)|Other|0|||
156755285|NCT00572455|565856974|FG007|Stage I (14 Days)|Other|0|||
156755286|NCT00572455|565856975|FG008|Stage I (14 Days)|Other|0|||
156755287|NCT00572455|565856976|FG009|Stage I (14 Days)|Other|0|||
156755288|NCT00572455|565856977|FG010|Stage I (14 Days)|Other|0|||
156755289|NCT00572455|565856978|FG011|Stage I (14 Days)|Other|0|||
156755290|NCT00572455|565856979|FG012|Stage I (14 Days)|Other|0|||
156755291|NCT00572455|565856980|FG013|Stage I (14 Days)|Other|0|||
156755292|NCT00572455|565856967|FG000|Stage II (28 Days)|Adverse Event|0|||
156755293|NCT00572455|565856968|FG001|Stage II (28 Days)|Adverse Event|0|||
156755294|NCT00572455|565856969|FG002|Stage II (28 Days)|Adverse Event|0|||
156755295|NCT00572455|565856970|FG003|Stage II (28 Days)|Adverse Event|0|||
156755296|NCT00572455|565856971|FG004|Stage II (28 Days)|Adverse Event|0|||
156755297|NCT00572455|565856972|FG005|Stage II (28 Days)|Adverse Event|0|||
156755298|NCT00572455|565856973|FG006|Stage II (28 Days)|Adverse Event|0|||
156755299|NCT00572455|565856974|FG007|Stage II (28 Days)|Adverse Event|0|||
156755300|NCT00572455|565856975|FG008|Stage II (28 Days)|Adverse Event|1|||
156755301|NCT00572455|565856976|FG009|Stage II (28 Days)|Adverse Event|3|||
156755302|NCT00572455|565856977|FG010|Stage II (28 Days)|Adverse Event|3|||
156755303|NCT00572455|565856978|FG011|Stage II (28 Days)|Adverse Event|4|||
156755304|NCT00572455|565856979|FG012|Stage II (28 Days)|Adverse Event|5|||
156755305|NCT00572455|565856980|FG013|Stage II (28 Days)|Adverse Event|1|||
156755306|NCT00572455|565856967|FG000|Stage II (28 Days)|Death|0|||
156755307|NCT00572455|565856968|FG001|Stage II (28 Days)|Death|0|||
156755308|NCT00572455|565856969|FG002|Stage II (28 Days)|Death|0|||
156755309|NCT00572455|565856970|FG003|Stage II (28 Days)|Death|0|||
156755310|NCT00572455|565856971|FG004|Stage II (28 Days)|Death|0|||
156755311|NCT00572455|565856972|FG005|Stage II (28 Days)|Death|0|||
156755312|NCT00572455|565856973|FG006|Stage II (28 Days)|Death|0|||
156755313|NCT00572455|565856974|FG007|Stage II (28 Days)|Death|0|||
156755314|NCT00572455|565856975|FG008|Stage II (28 Days)|Death|1|||
156755315|NCT00572455|565856976|FG009|Stage II (28 Days)|Death|0|||
156755316|NCT00572455|565856977|FG010|Stage II (28 Days)|Death|0|||
156755317|NCT00572455|565856978|FG011|Stage II (28 Days)|Death|0|||
156755318|NCT00572455|565856979|FG012|Stage II (28 Days)|Death|0|||
156755319|NCT00572455|565856980|FG013|Stage II (28 Days)|Death|0|||
156755320|NCT00572455|565856967|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
156755321|NCT00572455|565856968|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
156755322|NCT00572455|565856969|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
156755323|NCT00572455|565856970|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
156755324|NCT00572455|565856971|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
156755325|NCT00572455|565856972|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
156755326|NCT00572455|565856973|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
156755327|NCT00572455|565856974|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
156755328|NCT00572455|565856975|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
156755329|NCT00572455|565856976|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
156755330|NCT00572455|565856977|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
156755331|NCT00572455|565856978|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
156755332|NCT00572455|565856979|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
156755333|NCT00572455|565856980|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
156755334|NCT00572455|565856967|FG000|Stage II (28 Days)|Other|0|||
156755335|NCT00572455|565856968|FG001|Stage II (28 Days)|Other|0|||
156755336|NCT00572455|565856969|FG002|Stage II (28 Days)|Other|0|||
156755337|NCT00572455|565856970|FG003|Stage II (28 Days)|Other|0|||
156755338|NCT00572455|565856971|FG004|Stage II (28 Days)|Other|0|||
156755339|NCT00572455|565856972|FG005|Stage II (28 Days)|Other|0|||
156755340|NCT00572455|565856973|FG006|Stage II (28 Days)|Other|0|||
156755341|NCT00572455|565856974|FG007|Stage II (28 Days)|Other|0|||
156755342|NCT00572455|565856975|FG008|Stage II (28 Days)|Other|1|||
156755343|NCT00572455|565856976|FG009|Stage II (28 Days)|Other|0|||
156755344|NCT00572455|565856977|FG010|Stage II (28 Days)|Other|0|||
156755345|NCT00572455|565856978|FG011|Stage II (28 Days)|Other|0|||
156755346|NCT00572455|565856979|FG012|Stage II (28 Days)|Other|0|||
156755347|NCT00572455|565856980|FG013|Stage II (28 Days)|Other|0|||
156755348|NCT00572455|565856967|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
156755349|NCT00572455|565856968|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
156755350|NCT00572455|565856969|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
156755351|NCT00572455|565856970|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
156755352|NCT00572455|565856971|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
156755353|NCT00572455|565856972|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
157099242|NCT00908232|567118261|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
157099243|NCT00908232|567118262|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
156755354|NCT00572455|565856973|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
156755355|NCT00572455|565856974|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
156755356|NCT00572455|565856975|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
156755357|NCT00572455|565856976|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
156755358|NCT00572455|565856977|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
156755359|NCT00572455|565856978|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
156755360|NCT00572455|565856979|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
156755361|NCT00572455|565856980|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
156755362|NCT04152083|565856983|FG000|Overall Study|Lost to Follow-up|2|||
156755363|NCT04152083|565856984|FG001|Overall Study|Lost to Follow-up|1|||
156755364|NCT04152083|565856983|FG000|Overall Study|Adverse Event|1|||
156755365|NCT04152083|565856984|FG001|Overall Study|Adverse Event|0|||
156755366|NCT04152083|565856983|FG000|Overall Study|Randomized but not treated|3|||
156755367|NCT04152083|565856984|FG001|Overall Study|Randomized but not treated|2|||
156755368|NCT00856999|565856985|FG000|Overall Study|Withdrawal by Subject|5|||
156755369|NCT02465437|565856986|FG000|Overall Study|Physician Decision|0|||
156755370|NCT02465437|565856987|FG001|Overall Study|Physician Decision|0|||
156755371|NCT02465437|565856988|FG002|Overall Study|Physician Decision|1|||
156755372|NCT02465437|565856989|FG003|Overall Study|Physician Decision|0|||
156755373|NCT02465437|565856986|FG000|Overall Study|Withdrawal by Subject|1|||
157099244|NCT00908232|567118263|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
157099245|NCT00908232|567118260|FG000|Cycle 1 to 4|Progressive Disease|6|||
157099246|NCT00908232|567118261|FG001|Cycle 1 to 4|Progressive Disease|0|||
157099247|NCT00908232|567118262|FG002|Cycle 1 to 4|Progressive Disease|0|||
156755374|NCT02465437|565856987|FG001|Overall Study|Withdrawal by Subject|0|||
156755375|NCT02465437|565856988|FG002|Overall Study|Withdrawal by Subject|0|||
157099248|NCT00908232|567118263|FG003|Cycle 1 to 4|Progressive Disease|0|||
157099249|NCT00908232|567118260|FG000|Cycle 1 to 4|Adverse Event|12|||
156755376|NCT02465437|565856989|FG003|Overall Study|Withdrawal by Subject|1|||
156755377|NCT02465437|565856986|FG000|Overall Study|Adverse Event|0|||
157099250|NCT00908232|567118261|FG001|Cycle 1 to 4|Adverse Event|0|||
157099251|NCT00908232|567118262|FG002|Cycle 1 to 4|Adverse Event|0|||
156755378|NCT02465437|565856987|FG001|Overall Study|Adverse Event|1|||
156755379|NCT02465437|565856988|FG002|Overall Study|Adverse Event|0|||
156755380|NCT02465437|565856989|FG003|Overall Study|Adverse Event|0|||
156755381|NCT00003483|565856990|FG000|Overall Study|Not evaluable|1|||
156755382|NCT02609386|565856991|FG000|Overall Study|Withdrawal by Subject|6|||
156755383|NCT02609386|565856992|FG001|Overall Study|Withdrawal by Subject|1|||
156755384|NCT02609386|565856991|FG000|Overall Study|Lost to Follow-up|3|||
156755385|NCT02609386|565856992|FG001|Overall Study|Lost to Follow-up|5|||
156755386|NCT02609386|565856991|FG000|Overall Study|Death|19|||
156755387|NCT02609386|565856992|FG001|Overall Study|Death|9|||
156755388|NCT02609386|565856991|FG000|Overall Study|Physician Decision|0|||
156755389|NCT02609386|565856992|FG001|Overall Study|Physician Decision|2|||
156755390|NCT01308463|565856993|FG000|Overall Study|Study Discontinued|23|||
156755391|NCT01308463|565856993|FG000|Overall Study|Death|4|||
156755392|NCT01308463|565856993|FG000|Overall Study|Revision|2|||
156755393|NCT00103662|565856994|FG000|Overall Study|Entered Rescue Procedure|0|||
156755394|NCT00103662|565856995|FG001|Overall Study|Entered Rescue Procedure|7|||
156755395|NCT00103662|565856994|FG000|Overall Study|Death|7|||
156755396|NCT00103662|565856995|FG001|Overall Study|Death|7|||
156755397|NCT00103662|565856994|FG000|Overall Study|Elective Withdrawal|5|||
156755398|NCT00103662|565856995|FG001|Overall Study|Elective Withdrawal|5|||
156755399|NCT00103662|565856994|FG000|Overall Study|Lost to Follow-up|0|||
156755400|NCT00103662|565856995|FG001|Overall Study|Lost to Follow-up|1|||
156755401|NCT00103662|565856994|FG000|Overall Study|Other|6|||
156755402|NCT00103662|565856995|FG001|Overall Study|Other|9|||
156755403|NCT00103662|565856994|FG000|Overall Study|Failed mobilization|0|||
156755404|NCT00103662|565856995|FG001|Overall Study|Failed mobilization|4|||
156755405|NCT00103662|565856994|FG000|Overall Study|Intercurrent illness|1|||
156755406|NCT00103662|565856995|FG001|Overall Study|Intercurrent illness|0|||
156755407|NCT03280056|565856997|FG000|Overall Study|Withdrawal by Subject|12|||
156755408|NCT03280056|565856998|FG001|Overall Study|Withdrawal by Subject|14|||
156755409|NCT03280056|565856997|FG000|Overall Study|Death|9|||
156755410|NCT03280056|565856998|FG001|Overall Study|Death|2|||
156755411|NCT03280056|565856997|FG000|Overall Study|Adverse Event|1|||
156755412|NCT03280056|565856998|FG001|Overall Study|Adverse Event|3|||
156755413|NCT03280056|565856997|FG000|Overall Study|Lost to Follow-up|1|||
156755414|NCT03280056|565856998|FG001|Overall Study|Lost to Follow-up|1|||
156755415|NCT03280056|565856997|FG000|Overall Study|Physician Decision|0|||
156755416|NCT03280056|565856998|FG001|Overall Study|Physician Decision|1|||
156755417|NCT03280056|565856997|FG000|Overall Study|Early Discontinuation|1|||
156755418|NCT03280056|565856998|FG001|Overall Study|Early Discontinuation|0|||
156755419|NCT00610168|565856999|FG000|Overall Study|Withdrawal by Subject|2|||
156755420|NCT00610168|565857000|FG001|Overall Study|Withdrawal by Subject|0|||
156755421|NCT01135524|565857001|FG000|Overall Study|Withdrawal by Subject|14|||
156755422|NCT01135524|565857001|FG000|Overall Study|Adverse Event|20|||
156755423|NCT01135524|565857001|FG000|Overall Study|Lost to Follow-up|3|||
156755424|NCT01135524|565857001|FG000|Overall Study|Administrative|151|||
156996342|NCT04888585|566739538|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
156996343|NCT04888585|566739528|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
156755425|NCT01135524|565857001|FG000|Overall Study|Lack of Efficacy|8|||
156755426|NCT03318003|565857002|FG000|Overall Study|Withdrawal by Subject|1|||
156755427|NCT03318003|565857003|FG001|Overall Study|Withdrawal by Subject|1|||
156755428|NCT03318003|565857002|FG000|Overall Study|fetal loss|0|||
156755429|NCT03318003|565857003|FG001|Overall Study|fetal loss|1|||
156755430|NCT00411450|565857004|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
156755431|NCT00397189|565857005|FG000|3 Weeks Period|Lost to Follow-up|5|||
156755432|NCT00397189|565857006|FG001|3 Weeks Period|Lost to Follow-up|4|||
156755433|NCT00397189|565857005|FG000|3 Weeks Period|Adverse Event|3|||
156755434|NCT00397189|565857006|FG001|3 Weeks Period|Adverse Event|2|||
156755435|NCT00397189|565857005|FG000|3 Weeks Period|Withdrawal by Subject|13|||
156755436|NCT00397189|565857006|FG001|3 Weeks Period|Withdrawal by Subject|9|||
156755437|NCT00397189|565857005|FG000|3 Weeks Period|Physician Decision|0|||
156755438|NCT00397189|565857006|FG001|3 Weeks Period|Physician Decision|2|||
156755439|NCT00397189|565857005|FG000|3 Weeks Period|Protocol Violation|0|||
156755440|NCT00397189|565857006|FG001|3 Weeks Period|Protocol Violation|3|||
156755441|NCT00397189|565857005|FG000|3 Weeks Period|Other|0|||
156755442|NCT00397189|565857006|FG001|3 Weeks Period|Other|2|||
156755443|NCT01059773|565857007|FG000|Overall Study|Adverse Event|2|||
156755444|NCT01059773|565857008|FG001|Overall Study|Adverse Event|2|||
156755445|NCT01059773|565857007|FG000|Overall Study|Withdrawal by Subject|1|||
156755446|NCT01059773|565857008|FG001|Overall Study|Withdrawal by Subject|5|||
156755447|NCT01059773|565857007|FG000|Overall Study|Lost to Follow-up|1|||
156755448|NCT01059773|565857008|FG001|Overall Study|Lost to Follow-up|1|||
156755449|NCT01059773|565857007|FG000|Overall Study|Pregnancy|1|||
156755450|NCT01059773|565857008|FG001|Overall Study|Pregnancy|1|||
156755451|NCT01059773|565857007|FG000|Overall Study|Protocol Violation|6|||
156755452|NCT01059773|565857008|FG001|Overall Study|Protocol Violation|2|||
156755453|NCT01059773|565857007|FG000|Overall Study|Physician Decision|5|||
156755454|NCT01059773|565857008|FG001|Overall Study|Physician Decision|4|||
156755455|NCT01059773|565857007|FG000|Overall Study|Lack of Efficacy|3|||
156755456|NCT01059773|565857008|FG001|Overall Study|Lack of Efficacy|3|||
156755457|NCT01059773|565857007|FG000|Overall Study|Death|0|||
156755458|NCT01059773|565857008|FG001|Overall Study|Death|1|||
156755459|NCT01059773|565857007|FG000|Overall Study|Malignancy including squamous cell skin|0|||
156755460|NCT01059773|565857008|FG001|Overall Study|Malignancy including squamous cell skin|1|||
156755461|NCT01059773|565857007|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
156755462|NCT01059773|565857008|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
156755463|NCT01059773|565857007|FG000|Overall Study|Other|1|||
156755464|NCT01059773|565857008|FG001|Overall Study|Other|3|||
156755465|NCT00141518|565857012|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
156755466|NCT00141518|565857013|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
156755467|NCT00141518|565857014|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
156755468|NCT00141518|565857012|FG000|Overall Study|Adverse Event|7|||
156755469|NCT00141518|565857013|FG001|Overall Study|Adverse Event|5|||
156755470|NCT00141518|565857014|FG002|Overall Study|Adverse Event|2|||
156755471|NCT00141518|565857012|FG000|Overall Study|Withdrawal by Subject|2|||
156755472|NCT00141518|565857013|FG001|Overall Study|Withdrawal by Subject|0|||
156755473|NCT00141518|565857014|FG002|Overall Study|Withdrawal by Subject|2|||
156755474|NCT00141518|565857012|FG000|Overall Study|Protocol Violation|1|||
156755475|NCT00141518|565857013|FG001|Overall Study|Protocol Violation|1|||
156755476|NCT00141518|565857014|FG002|Overall Study|Protocol Violation|2|||
156755477|NCT00141518|565857012|FG000|Overall Study|Lack of Efficacy|5|||
156755478|NCT00141518|565857013|FG001|Overall Study|Lack of Efficacy|0|||
156755479|NCT00141518|565857014|FG002|Overall Study|Lack of Efficacy|0|||
156755480|NCT01806168|565857015|FG000|Overall Study|Adverse Event|1|||
156755481|NCT01806168|565857016|FG001|Overall Study|Adverse Event|0|||
156755482|NCT01806168|565857017|FG002|Overall Study|Adverse Event|0|||
156755483|NCT01806168|565857015|FG000|Overall Study|Withdrawal by Subject|0|||
156755484|NCT01806168|565857016|FG001|Overall Study|Withdrawal by Subject|1|||
156755485|NCT01806168|565857017|FG002|Overall Study|Withdrawal by Subject|2|||
156755486|NCT01806168|565857015|FG000|Overall Study|Protocol Violation|0|||
156755487|NCT01806168|565857016|FG001|Overall Study|Protocol Violation|0|||
156755488|NCT01806168|565857017|FG002|Overall Study|Protocol Violation|1|||
156755489|NCT03904420|565857020|FG000|Overall Study|Study terminated|2|||
156755490|NCT03904420|565857021|FG001|Overall Study|Study terminated|2|||
156755491|NCT00614874|565857022|FG000|Overall Study|Protocol Violation|1|||
156755492|NCT00614874|565857022|FG000|Overall Study|Withdrawal by Subject|1|||
156755493|NCT01468454|565857023|FG000|Overall Study|Did not have surgery after PET|9|||
156755494|NCT02620787|565857024|FG000|Overall Study|Adverse Event|1|||
156755495|NCT02620787|565857025|FG001|Overall Study|Adverse Event|0|||
156755496|NCT02620787|565857024|FG000|Overall Study|Eligibility Criteria Not Met|1|||
156755497|NCT02620787|565857025|FG001|Overall Study|Eligibility Criteria Not Met|0|||
156755498|NCT01509664|565857026|FG000|Overall Study|Lost to Follow-up|15|||
156755499|NCT01509664|565857027|FG001|Overall Study|Lost to Follow-up|21|||
156755500|NCT02959918|565857030|FG000|Overall Study|Adverse Event|1|||
156755501|NCT02959918|565857031|FG001|Overall Study|Adverse Event|1|||
156755502|NCT02959918|565857032|FG002|Overall Study|Adverse Event|2|||
156755503|NCT02959918|565857033|FG003|Overall Study|Adverse Event|0|||
156755504|NCT02959918|565857034|FG004|Overall Study|Adverse Event|0|||
156755505|NCT02959918|565857035|FG005|Overall Study|Adverse Event|2|||
156755506|NCT02959918|565857036|FG006|Overall Study|Adverse Event|2|||
156755507|NCT02959918|565857037|FG007|Overall Study|Adverse Event|1|||
156755508|NCT02959918|565857038|FG008|Overall Study|Adverse Event|2|||
156755509|NCT02959918|565857039|FG009|Overall Study|Adverse Event|1|||
156755510|NCT02959918|565857040|FG010|Overall Study|Adverse Event|1|||
156755511|NCT02959918|565857041|FG011|Overall Study|Adverse Event|3|||
156755512|NCT02959918|565857042|FG012|Overall Study|Adverse Event|2|||
156755513|NCT02959918|565857043|FG013|Overall Study|Adverse Event|4|||
156755514|NCT02959918|565857030|FG000|Overall Study|Lost to Follow-up|0|||
156755515|NCT02959918|565857031|FG001|Overall Study|Lost to Follow-up|0|||
156755516|NCT02959918|565857032|FG002|Overall Study|Lost to Follow-up|0|||
156755517|NCT02959918|565857033|FG003|Overall Study|Lost to Follow-up|0|||
156755518|NCT02959918|565857034|FG004|Overall Study|Lost to Follow-up|0|||
156755519|NCT02959918|565857035|FG005|Overall Study|Lost to Follow-up|0|||
156755520|NCT02959918|565857036|FG006|Overall Study|Lost to Follow-up|0|||
156755521|NCT02959918|565857037|FG007|Overall Study|Lost to Follow-up|0|||
156755522|NCT02959918|565857038|FG008|Overall Study|Lost to Follow-up|0|||
156755523|NCT02959918|565857039|FG009|Overall Study|Lost to Follow-up|1|||
156755524|NCT02959918|565857040|FG010|Overall Study|Lost to Follow-up|0|||
156755525|NCT02959918|565857041|FG011|Overall Study|Lost to Follow-up|0|||
156755526|NCT02959918|565857042|FG012|Overall Study|Lost to Follow-up|1|||
156755527|NCT02959918|565857043|FG013|Overall Study|Lost to Follow-up|0|||
156755528|NCT02959918|565857030|FG000|Overall Study|Withdrawal by Subject|0|||
156755529|NCT02959918|565857031|FG001|Overall Study|Withdrawal by Subject|0|||
156755530|NCT02959918|565857032|FG002|Overall Study|Withdrawal by Subject|1|||
156755531|NCT02959918|565857033|FG003|Overall Study|Withdrawal by Subject|2|||
156755532|NCT02959918|565857034|FG004|Overall Study|Withdrawal by Subject|0|||
156755533|NCT02959918|565857035|FG005|Overall Study|Withdrawal by Subject|0|||
156755534|NCT02959918|565857036|FG006|Overall Study|Withdrawal by Subject|1|||
156755535|NCT02959918|565857037|FG007|Overall Study|Withdrawal by Subject|0|||
156755536|NCT02959918|565857038|FG008|Overall Study|Withdrawal by Subject|1|||
156755537|NCT02959918|565857039|FG009|Overall Study|Withdrawal by Subject|1|||
156755538|NCT02959918|565857040|FG010|Overall Study|Withdrawal by Subject|2|||
156755539|NCT02959918|565857041|FG011|Overall Study|Withdrawal by Subject|3|||
156755540|NCT02959918|565857042|FG012|Overall Study|Withdrawal by Subject|1|||
156755541|NCT02959918|565857043|FG013|Overall Study|Withdrawal by Subject|1|||
156755542|NCT02959918|565857030|FG000|Overall Study|Protocol Violation|0|||
156755543|NCT02959918|565857031|FG001|Overall Study|Protocol Violation|0|||
156755544|NCT02959918|565857032|FG002|Overall Study|Protocol Violation|1|||
156755545|NCT02959918|565857033|FG003|Overall Study|Protocol Violation|0|||
156755546|NCT02959918|565857034|FG004|Overall Study|Protocol Violation|0|||
156755547|NCT02959918|565857035|FG005|Overall Study|Protocol Violation|1|||
156755548|NCT02959918|565857036|FG006|Overall Study|Protocol Violation|0|||
156755549|NCT02959918|565857037|FG007|Overall Study|Protocol Violation|0|||
156755550|NCT02959918|565857038|FG008|Overall Study|Protocol Violation|2|||
156755551|NCT02959918|565857039|FG009|Overall Study|Protocol Violation|1|||
156996344|NCT04888585|566739529|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
156996345|NCT04888585|566739530|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
156996346|NCT04888585|566739531|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
156996347|NCT04888585|566739532|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
156996348|NCT04888585|566739533|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
156996349|NCT04888585|566739534|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
156996350|NCT04888585|566739535|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
156996351|NCT04888585|566739536|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
156755552|NCT02959918|565857040|FG010|Overall Study|Protocol Violation|0|||
156755553|NCT02959918|565857041|FG011|Overall Study|Protocol Violation|1|||
156755554|NCT02959918|565857042|FG012|Overall Study|Protocol Violation|1|||
156755555|NCT02959918|565857043|FG013|Overall Study|Protocol Violation|0|||
156996352|NCT04888585|566739537|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
156755556|NCT02959918|565857030|FG000|Overall Study|Stopping Rule Met|1|||
156755557|NCT02959918|565857031|FG001|Overall Study|Stopping Rule Met|0|||
156755558|NCT02959918|565857032|FG002|Overall Study|Stopping Rule Met|3|||
156755559|NCT02959918|565857033|FG003|Overall Study|Stopping Rule Met|4|||
156755560|NCT02959918|565857034|FG004|Overall Study|Stopping Rule Met|5|||
156755561|NCT02959918|565857035|FG005|Overall Study|Stopping Rule Met|3|||
156755562|NCT02959918|565857036|FG006|Overall Study|Stopping Rule Met|2|||
156755563|NCT02959918|565857037|FG007|Overall Study|Stopping Rule Met|4|||
156755564|NCT02959918|565857038|FG008|Overall Study|Stopping Rule Met|1|||
156755565|NCT02959918|565857039|FG009|Overall Study|Stopping Rule Met|1|||
156755566|NCT02959918|565857040|FG010|Overall Study|Stopping Rule Met|3|||
156755567|NCT02959918|565857041|FG011|Overall Study|Stopping Rule Met|5|||
156755568|NCT02959918|565857042|FG012|Overall Study|Stopping Rule Met|2|||
156755569|NCT02959918|565857043|FG013|Overall Study|Stopping Rule Met|1|||
156755570|NCT02959918|565857030|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
156755571|NCT02959918|565857031|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
156755572|NCT02959918|565857032|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
156755573|NCT02959918|565857033|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
156755574|NCT02959918|565857034|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755575|NCT02959918|565857035|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755576|NCT02959918|565857036|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755577|NCT02959918|565857037|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755578|NCT02959918|565857038|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755579|NCT02959918|565857039|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755580|NCT02959918|565857040|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755581|NCT02959918|565857041|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755582|NCT02959918|565857042|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755583|NCT02959918|565857043|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
156755584|NCT02959918|565857030|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755585|NCT02959918|565857031|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755586|NCT02959918|565857032|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755587|NCT02959918|565857033|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755588|NCT02959918|565857034|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755589|NCT02959918|565857035|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755590|NCT02959918|565857036|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755591|NCT02959918|565857037|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
156755592|NCT02959918|565857038|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755593|NCT02959918|565857039|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755594|NCT02959918|565857040|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755595|NCT02959918|565857041|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755596|NCT02959918|565857042|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755597|NCT02959918|565857043|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
156755598|NCT02959918|565857030|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755599|NCT02959918|565857031|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755600|NCT02959918|565857032|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755601|NCT02959918|565857033|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755602|NCT02959918|565857034|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755603|NCT02959918|565857035|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755604|NCT02959918|565857036|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755605|NCT02959918|565857037|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755606|NCT02959918|565857038|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
156755607|NCT02959918|565857039|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755608|NCT02959918|565857040|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755609|NCT02959918|565857041|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755610|NCT02959918|565857042|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755611|NCT02959918|565857043|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
156755612|NCT02959918|565857030|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755613|NCT02959918|565857031|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755614|NCT02959918|565857032|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755615|NCT02959918|565857033|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755616|NCT02959918|565857034|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755617|NCT02959918|565857035|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755618|NCT02959918|565857036|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755619|NCT02959918|565857037|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755620|NCT02959918|565857038|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755621|NCT02959918|565857039|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
156755622|NCT02959918|565857040|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755623|NCT02959918|565857041|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755624|NCT02959918|565857042|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755625|NCT02959918|565857043|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
156755626|NCT00837967|565857044|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
156755627|NCT00837967|565857045|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
156755628|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
156755629|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
156755630|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
156755631|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
156755632|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
156755633|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
156755634|NCT01733121|565857047|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
156755635|NCT01733121|565857048|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
156755636|NCT03061188|565857051|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
156755637|NCT03061188|565857052|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
156755638|NCT03061188|565857053|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
156755639|NCT03061188|565857054|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
156755640|NCT03061188|565857051|FG000|On Follow-up for 3 Years|Death|0|||
156755641|NCT03061188|565857052|FG001|On Follow-up for 3 Years|Death|3|||
156755642|NCT03061188|565857053|FG002|On Follow-up for 3 Years|Death|5|||
156755643|NCT03061188|565857054|FG003|On Follow-up for 3 Years|Death|4|||
156755644|NCT03061188|565857051|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755645|NCT03061188|565857052|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755646|NCT03061188|565857053|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
156755647|NCT03061188|565857054|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
156755648|NCT02504320|565857058|FG000|Treatment Period 1|Positive Drug Screen|0|||
156755649|NCT02504320|565857059|FG001|Treatment Period 1|Positive Drug Screen|0|||
156755650|NCT02504320|565857060|FG002|Treatment Period 1|Positive Drug Screen|1|||
156755651|NCT02504320|565857061|FG003|Treatment Period 1|Positive Drug Screen|0|||
156755652|NCT02504320|565857058|FG000|Treatment Period 2|Positive Drug Screen|0|||
156755653|NCT02504320|565857059|FG001|Treatment Period 2|Positive Drug Screen|1|||
156755654|NCT02504320|565857060|FG002|Treatment Period 2|Positive Drug Screen|0|||
156755655|NCT02504320|565857061|FG003|Treatment Period 2|Positive Drug Screen|0|||
156755656|NCT02504320|565857058|FG000|Treatment Period 3|Positive Drug Screen|0|||
156755657|NCT02504320|565857059|FG001|Treatment Period 3|Positive Drug Screen|0|||
156755658|NCT02504320|565857060|FG002|Treatment Period 3|Positive Drug Screen|0|||
156755659|NCT02504320|565857061|FG003|Treatment Period 3|Positive Drug Screen|1|||
156755660|NCT02504320|565857058|FG000|Treatment Period 3|Adverse Event|0|||
156755661|NCT02504320|565857059|FG001|Treatment Period 3|Adverse Event|0|||
156755662|NCT02504320|565857060|FG002|Treatment Period 3|Adverse Event|1|||
156755663|NCT02504320|565857061|FG003|Treatment Period 3|Adverse Event|0|||
156755664|NCT02306850|565857064|FG000|Overall Study|Lack of Efficacy|2|||
156755665|NCT02420262|565857065|FG000|Overall Study|Adverse Event|1|||
156755666|NCT02420262|565857066|FG001|Overall Study|Adverse Event|0|||
156755667|NCT02420262|565857065|FG000|Overall Study|Withdrawal by Subject|1|||
156755668|NCT02420262|565857066|FG001|Overall Study|Withdrawal by Subject|4|||
156755669|NCT02420262|565857065|FG000|Overall Study|Unclassified|0|||
156755670|NCT02420262|565857066|FG001|Overall Study|Unclassified|1|||
156755671|NCT00941304|565857067|FG000|Overall Study|Lost to Follow-up|1|||
156755672|NCT00941304|565857068|FG001|Overall Study|Lost to Follow-up|0|||
156755673|NCT00941304|565857069|FG002|Overall Study|Lost to Follow-up|0|||
156755674|NCT00941304|565857070|FG003|Overall Study|Lost to Follow-up|0|||
156755675|NCT00941304|565857071|FG004|Overall Study|Lost to Follow-up|0|||
156755676|NCT03293394|565857072|FG000|Follow-up (6 Months)|Adverse Event|4|||
156755677|NCT03293394|565857073|FG001|Follow-up (6 Months)|Adverse Event|2|||
156755678|NCT02497404|565857074|FG000|Overall Study|Adverse Event|1|||
156755679|NCT00110357|565857081|FG000|Overall Study|Deterioration without progression|2|||
156755680|NCT00110357|565857082|FG001|Overall Study|Deterioration without progression|0|||
156755681|NCT00110357|565857081|FG000|Overall Study|Disease progression/relapse|20|||
156755682|NCT00110357|565857082|FG001|Overall Study|Disease progression/relapse|15|||
156755683|NCT00110357|565857081|FG000|Overall Study|Study Closure|1|||
156755684|NCT00110357|565857082|FG001|Overall Study|Study Closure|0|||
156755685|NCT00110357|565857081|FG000|Overall Study|Study Drug Toxicity|1|||
156755686|NCT00110357|565857082|FG001|Overall Study|Study Drug Toxicity|3|||
156755687|NCT00110357|565857081|FG000|Overall Study|Withdrawal by Subject|3|||
156755688|NCT00110357|565857082|FG001|Overall Study|Withdrawal by Subject|1|||
156755689|NCT04004260|565857086|FG000|Overall Study|Withdrawal by Subject|7|||
156755690|NCT04004260|565857087|FG001|Overall Study|Withdrawal by Subject|3|||
156755691|NCT04004260|565857086|FG000|Overall Study|Lost to Follow-up|22|||
156755692|NCT04004260|565857087|FG001|Overall Study|Lost to Follow-up|12|||
156755693|NCT04004260|565857086|FG000|Overall Study|Did not engage in intervention|13|||
156755694|NCT04004260|565857087|FG001|Overall Study|Did not engage in intervention|17|||
156755695|NCT04633226|565857091|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156996353|NCT04888585|566739538|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
156996354|NCT04888585|566739528|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996355|NCT04888585|566739529|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996356|NCT04888585|566739530|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996357|NCT04888585|566739531|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996358|NCT04888585|566739532|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996359|NCT04888585|566739533|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996360|NCT04888585|566739534|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
156996361|NCT04888585|566739535|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
156996362|NCT04888585|566739536|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
156996363|NCT04888585|566739537|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
156996364|NCT04888585|566739538|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
156996365|NCT03717194|566739545|FG000|Overall Study|Withdrawal by Subject|2|||
156996366|NCT03717194|566739546|FG001|Overall Study|Withdrawal by Subject|4|||
156996367|NCT03717194|566739545|FG000|Overall Study|Adverse Event|1|||
156996368|NCT03717194|566739546|FG001|Overall Study|Adverse Event|1|||
156996369|NCT04678830|566739547|FG000|Overall Study|Lack of Efficacy|2|||
156996370|NCT04678830|566739548|FG001|Overall Study|Lack of Efficacy|0|||
156996371|NCT04678830|566739547|FG000|Overall Study|Withdrawal by Subject|0|||
156996372|NCT04678830|566739548|FG001|Overall Study|Withdrawal by Subject|1|||
156996373|NCT05550337|566739549|FG000|Overall Study|Lack of Efficacy|0|||
156996374|NCT05550337|566739550|FG001|Overall Study|Lack of Efficacy|0|||
156996375|NCT05550337|566739551|FG002|Overall Study|Lack of Efficacy|1|||
156996376|NCT05550337|566739549|FG000|Overall Study|Adverse Event|1|||
156996377|NCT05550337|566739550|FG001|Overall Study|Adverse Event|5|||
156996378|NCT05550337|566739551|FG002|Overall Study|Adverse Event|0|||
156996379|NCT05550337|566739549|FG000|Overall Study|Withdrawal by Subject|8|||
156996380|NCT05550337|566739550|FG001|Overall Study|Withdrawal by Subject|14|||
156996381|NCT05550337|566739551|FG002|Overall Study|Withdrawal by Subject|10|||
156996382|NCT05550337|566739549|FG000|Overall Study|Pregnancy|0|||
156996383|NCT05550337|566739550|FG001|Overall Study|Pregnancy|0|||
156996384|NCT05550337|566739551|FG002|Overall Study|Pregnancy|1|||
156996385|NCT05550337|566739549|FG000|Overall Study|Protocol Violation|1|||
156996386|NCT05550337|566739550|FG001|Overall Study|Protocol Violation|3|||
156996387|NCT05550337|566739551|FG002|Overall Study|Protocol Violation|4|||
156996388|NCT05550337|566739549|FG000|Overall Study|Physician Decision|2|||
156996389|NCT05550337|566739550|FG001|Overall Study|Physician Decision|1|||
156996390|NCT05550337|566739551|FG002|Overall Study|Physician Decision|1|||
156755696|NCT04633226|565857091|FG000|Overall Study|Randomized by mistake without study treatment|1|||
156755697|NCT05415462|565857096|FG000|Overall Study|Death|18|||
156755698|NCT05415462|565857097|FG001|Overall Study|Death|10|||
156755699|NCT05415462|565857096|FG000|Overall Study|Lost to Follow-up|72|||
156755700|NCT05415462|565857097|FG001|Overall Study|Lost to Follow-up|64|||
156755701|NCT05415462|565857096|FG000|Overall Study|Physician Decision|5|||
156755702|NCT05415462|565857097|FG001|Overall Study|Physician Decision|5|||
156755703|NCT05415462|565857096|FG000|Overall Study|Protocol Deviation|1|||
156755704|NCT05415462|565857097|FG001|Overall Study|Protocol Deviation|0|||
156755705|NCT05415462|565857096|FG000|Overall Study|Withdrawal by Subject|129|||
156755706|NCT05415462|565857097|FG001|Overall Study|Withdrawal by Subject|101|||
156755707|NCT05415462|565857096|FG000|Overall Study|Other Than Specified|8|||
156755708|NCT05415462|565857097|FG001|Overall Study|Other Than Specified|8|||
156755709|NCT02998996|565857099|FG000|Overall Study|Lost to Follow-up|0|||
156755710|NCT02998996|565857100|FG001|Overall Study|Lost to Follow-up|0|||
156755711|NCT02998996|565857101|FG002|Overall Study|Lost to Follow-up|1|||
156755712|NCT02998996|565857102|FG003|Overall Study|Lost to Follow-up|0|||
156755713|NCT02998996|565857103|FG004|Overall Study|Lost to Follow-up|0|||
156755714|NCT02998996|565857104|FG005|Overall Study|Lost to Follow-up|0|||
156755715|NCT02998996|565857099|FG000|Overall Study|Pregnancy|0|||
156755716|NCT02998996|565857100|FG001|Overall Study|Pregnancy|1|||
156755717|NCT02998996|565857101|FG002|Overall Study|Pregnancy|0|||
156755718|NCT02998996|565857102|FG003|Overall Study|Pregnancy|0|||
156755719|NCT02998996|565857103|FG004|Overall Study|Pregnancy|0|||
156755720|NCT02998996|565857104|FG005|Overall Study|Pregnancy|0|||
156755721|NCT02998996|565857099|FG000|Overall Study|Family reasons|0|||
156755722|NCT02998996|565857100|FG001|Overall Study|Family reasons|0|||
156755723|NCT02998996|565857101|FG002|Overall Study|Family reasons|0|||
156755724|NCT02998996|565857102|FG003|Overall Study|Family reasons|0|||
156755725|NCT02998996|565857103|FG004|Overall Study|Family reasons|1|||
156755726|NCT02998996|565857104|FG005|Overall Study|Family reasons|0|||
156755727|NCT01087203|565857105|FG000|Overall Study|Lost to Follow-up|2|||
156755728|NCT01087203|565857106|FG001|Overall Study|Lost to Follow-up|0|||
156755729|NCT01087203|565857105|FG000|Overall Study|Withdrawal by Subject|2|||
156755730|NCT01087203|565857106|FG001|Overall Study|Withdrawal by Subject|6|||
156755731|NCT01087203|565857105|FG000|Overall Study|Lack of Efficacy|1|||
156755732|NCT01087203|565857106|FG001|Overall Study|Lack of Efficacy|2|||
156755733|NCT01087203|565857105|FG000|Overall Study|Study terminated by sponsor|27|||
156755734|NCT01087203|565857106|FG001|Overall Study|Study terminated by sponsor|27|||
156755735|NCT05259163|565858484|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
156755736|NCT05259163|565858485|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
156755737|NCT05251233|565858486|FG000|Overall Study|Disease progression - did not start treatment|0|||
156755738|NCT05251233|565858487|FG001|Overall Study|Disease progression - did not start treatment|0|||
156755739|NCT05251233|565858488|FG002|Overall Study|Disease progression - did not start treatment|5|||
156755740|NCT05251233|565858486|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
156755741|NCT05251233|565858487|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
156755742|NCT05251233|565858488|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
156755743|NCT05251233|565858486|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
156755744|NCT05251233|565858487|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
156755745|NCT05251233|565858488|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
156755746|NCT05251233|565858486|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
156755747|NCT05251233|565858487|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
156755748|NCT05251233|565858488|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
156755749|NCT05251233|565858486|FG000|Overall Study|Death - did not start treatment|3|||
156755750|NCT05251233|565858487|FG001|Overall Study|Death - did not start treatment|0|||
156755751|NCT05251233|565858488|FG002|Overall Study|Death - did not start treatment|0|||
156755752|NCT05251233|565858486|FG000|Overall Study|Withdrawal by Subject|2|||
156755753|NCT05251233|565858487|FG001|Overall Study|Withdrawal by Subject|2|||
156755754|NCT05251233|565858488|FG002|Overall Study|Withdrawal by Subject|0|||
156755755|NCT05251233|565858486|FG000|Overall Study|Other complicating disease|2|||
156755756|NCT05251233|565858487|FG001|Overall Study|Other complicating disease|1|||
156755757|NCT05251233|565858488|FG002|Overall Study|Other complicating disease|0|||
156755758|NCT05251233|565858486|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
156755759|NCT05251233|565858487|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
156755760|NCT05251233|565858488|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
156755761|NCT05251233|565858486|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
156755762|NCT05251233|565858487|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
156755763|NCT05251233|565858488|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
156755764|NCT00452439|565858490|FG000|Overall Study|Lost to Follow-up|1|||
156755765|NCT00452439|565858491|FG001|Overall Study|Lost to Follow-up|1|||
156755766|NCT00452439|565858490|FG000|Overall Study|Refused Treatment|4|||
156755767|NCT00452439|565858491|FG001|Overall Study|Refused Treatment|3|||
156755768|NCT00452439|565858490|FG000|Overall Study|Death|3|||
156755769|NCT00452439|565858491|FG001|Overall Study|Death|1|||
156755770|NCT00452439|565858490|FG000|Overall Study|Bone Marrow Transplant|0|||
156755771|NCT00452439|565858491|FG001|Overall Study|Bone Marrow Transplant|1|||
156755772|NCT00452439|565858490|FG000|Overall Study|Too Ill to Continue|0|||
156755773|NCT00452439|565858491|FG001|Overall Study|Too Ill to Continue|1|||
156755774|NCT00452439|565858490|FG000|Overall Study|Failed to achieve complete response|2|||
156755775|NCT00452439|565858491|FG001|Overall Study|Failed to achieve complete response|0|||
156755776|NCT00452439|565858490|FG000|Overall Study|Relapse|3|||
156755777|NCT00452439|565858491|FG001|Overall Study|Relapse|0|||
156755778|NCT00452439|565858490|FG000|Overall Study|Fracture|1|||
156755779|NCT00452439|565858491|FG001|Overall Study|Fracture|0|||
156755780|NCT00463801|565858495|FG000|Overall Study|Protocol Violation|1|||
156755781|NCT00463801|565858495|FG000|Overall Study|Lack of Efficacy|2|||
156755782|NCT00463801|565858495|FG000|Overall Study|Adverse Event|4|||
156755783|NCT00463801|565858495|FG000|Overall Study|Lost to Follow-up|5|||
156755784|NCT00463801|565858495|FG000|Overall Study|No longer require therapy|1|||
156755785|NCT00669318|565858496|FG000|Overall Study|Withdrawal by Subject|2|||
156755786|NCT03512353|565858501|FG000|Overall Study|Sponsor Decision|3|||
156755787|NCT03512353|565858501|FG000|Overall Study|Death|1|||
156755788|NCT02581488|565858504|FG000|Overall Study|Adverse Event|6|||
156755789|NCT02581488|565858505|FG001|Overall Study|Adverse Event|7|||
156755790|NCT02581488|565858504|FG000|Overall Study|Lost to Follow-up|1|||
156755791|NCT02581488|565858505|FG001|Overall Study|Lost to Follow-up|0|||
156755792|NCT02581488|565858504|FG000|Overall Study|Withdrawal by Subject|1|||
156755793|NCT02581488|565858505|FG001|Overall Study|Withdrawal by Subject|0|||
156755794|NCT02581488|565858504|FG000|Overall Study|Non-Compliance|1|||
156755795|NCT02581488|565858505|FG001|Overall Study|Non-Compliance|0|||
156755796|NCT02581488|565858504|FG000|Overall Study|Protocol Violation|0|||
156755797|NCT02581488|565858505|FG001|Overall Study|Protocol Violation|4|||
156755798|NCT01639144|565858506|FG000|Overall Study|Withdrawal by Subject|4|||
156755799|NCT01639144|565858507|FG001|Overall Study|Withdrawal by Subject|2|||
156755800|NCT01639144|565858506|FG000|Overall Study|Physician Decision|2|||
156755801|NCT01639144|565858507|FG001|Overall Study|Physician Decision|0|||
156755802|NCT01639144|565858506|FG000|Overall Study|Met postoperative exclusion criteria|4|||
156755803|NCT01639144|565858507|FG001|Overall Study|Met postoperative exclusion criteria|3|||
156755804|NCT03492437|565858508|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156755805|NCT03492437|565858509|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156755806|NCT01048541|565858512|FG000|Overall Study|Withdrawal by Subject|1|||
156755807|NCT01048541|565858513|FG001|Overall Study|Withdrawal by Subject|0|||
156755808|NCT03060291|565858515|FG000|3-month Follow-up|Declined to respond|8|||
157099252|NCT00908232|567118263|FG003|Cycle 1 to 4|Adverse Event|0|||
157099253|NCT00908232|567118260|FG000|Cycle 1 to 4|Other|1|||
157099254|NCT00908232|567118261|FG001|Cycle 1 to 4|Other|0|||
157099255|NCT00908232|567118262|FG002|Cycle 1 to 4|Other|0|||
157099256|NCT00908232|567118263|FG003|Cycle 1 to 4|Other|0|||
157099257|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
157099258|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
157099259|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
157099260|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
157099261|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
157099262|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
157099263|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
157099264|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
157099265|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
157099266|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
157099267|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
157099268|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
157099269|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
157099270|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
156755809|NCT03060291|565858516|FG001|3-month Follow-up|Declined to respond|10|||
156755810|NCT03060291|565858517|FG002|3-month Follow-up|Declined to respond|2|||
156755811|NCT03060291|565858515|FG000|6-month Follow-up|Declined to respond|7|||
156755812|NCT03060291|565858516|FG001|6-month Follow-up|Declined to respond|13|||
156755813|NCT03060291|565858517|FG002|6-month Follow-up|Declined to respond|4|||
156755814|NCT03060291|565858515|FG000|12-month Follow-up|Declined to respond|7|||
157099271|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
157099272|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
157099273|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
156755815|NCT03060291|565858516|FG001|12-month Follow-up|Declined to respond|16|||
156755816|NCT03060291|565858517|FG002|12-month Follow-up|Declined to respond|6|||
156755817|NCT00618826|565858520|FG000|Overall Study|Adverse Event|1|||
156755818|NCT03193047|565858521|FG000|Overall Study|Physician Decision|1|||
156755819|NCT03193047|565858522|FG001|Overall Study|Physician Decision|0|||
156755820|NCT03193047|565858521|FG000|Overall Study|Participant Left State|1|||
156755821|NCT03193047|565858522|FG001|Overall Study|Participant Left State|0|||
156755822|NCT02105285|565858526|FG000|Overall Study|Adverse Event|1|||
156755823|NCT02105285|565858527|FG001|Overall Study|Adverse Event|1|||
156755824|NCT02105285|565858528|FG002|Overall Study|Adverse Event|0|||
156755825|NCT02105285|565858526|FG000|Overall Study|Protocol Violation|0|||
156755826|NCT02105285|565858527|FG001|Overall Study|Protocol Violation|1|||
156755827|NCT02105285|565858528|FG002|Overall Study|Protocol Violation|0|||
156755828|NCT02105285|565858526|FG000|Overall Study|Withdrawal by Subject|1|||
156755829|NCT02105285|565858527|FG001|Overall Study|Withdrawal by Subject|0|||
156755830|NCT02105285|565858528|FG002|Overall Study|Withdrawal by Subject|0|||
156755831|NCT01210222|565858529|FG000|Overall Study|Ineligible|2|||
156755832|NCT01210222|565858529|FG000|Overall Study|Never treated|1|||
156755833|NCT02098395|565858530|FG000|Overall Study|Protocol Violation|2|||
156755834|NCT02098395|565858531|FG001|Overall Study|Protocol Violation|2|||
156755835|NCT02098395|565858532|FG002|Overall Study|Protocol Violation|0|||
156755836|NCT02098395|565858533|FG003|Overall Study|Protocol Violation|7|||
156755837|NCT02098395|565858530|FG000|Overall Study|Withdrawal by Subject|10|||
156755838|NCT02098395|565858531|FG001|Overall Study|Withdrawal by Subject|10|||
156755839|NCT02098395|565858532|FG002|Overall Study|Withdrawal by Subject|5|||
156755840|NCT02098395|565858533|FG003|Overall Study|Withdrawal by Subject|13|||
156755841|NCT02098395|565858530|FG000|Overall Study|Adverse Event|12|||
156755842|NCT02098395|565858531|FG001|Overall Study|Adverse Event|19|||
156755843|NCT02098395|565858532|FG002|Overall Study|Adverse Event|34|||
156755844|NCT02098395|565858533|FG003|Overall Study|Adverse Event|2|||
156755845|NCT02098395|565858530|FG000|Overall Study|Lost to Follow-up|2|||
156755846|NCT02098395|565858531|FG001|Overall Study|Lost to Follow-up|1|||
156755847|NCT02098395|565858532|FG002|Overall Study|Lost to Follow-up|0|||
156755848|NCT02098395|565858533|FG003|Overall Study|Lost to Follow-up|3|||
156755849|NCT02098395|565858530|FG000|Overall Study|Unclassified|0|||
156755850|NCT02098395|565858531|FG001|Overall Study|Unclassified|0|||
156755851|NCT02098395|565858532|FG002|Overall Study|Unclassified|3|||
156755852|NCT02098395|565858533|FG003|Overall Study|Unclassified|2|||
156755853|NCT02360280|565858535|FG000|Overall Study|Withdrawal by Subject|2|||
156755854|NCT02360280|565858536|FG001|Overall Study|Withdrawal by Subject|0|||
156755855|NCT02360280|565858535|FG000|Overall Study|Adverse Event|0|||
156755856|NCT02360280|565858536|FG001|Overall Study|Adverse Event|1|||
156755857|NCT02360280|565858535|FG000|Overall Study|Lost to Follow-up|1|||
156755858|NCT02360280|565858536|FG001|Overall Study|Lost to Follow-up|0|||
156755859|NCT00003896|565858544|FG000|Overall Study|Adverse Event|16|||
156755860|NCT00003896|565858544|FG000|Overall Study|Withdrawal by Subject|1|||
156755861|NCT00003896|565858544|FG000|Overall Study|Lack of Efficacy|1|||
156755862|NCT00003896|565858544|FG000|Overall Study|Death|3|||
156755863|NCT00003896|565858544|FG000|Overall Study|not protocol specified|3|||
156755864|NCT00003896|565858544|FG000|Overall Study|ineligible|5|||
156755865|NCT01398358|565858545|FG000|Overall Study|Lost to Follow-up|11|||
156755866|NCT01398358|565858546|FG001|Overall Study|Lost to Follow-up|21|||
156755867|NCT01398358|565858547|FG002|Overall Study|Lost to Follow-up|18|||
156755868|NCT01398358|565858545|FG000|Overall Study|Withdrawal by Subject|3|||
156755869|NCT01398358|565858546|FG001|Overall Study|Withdrawal by Subject|2|||
156755870|NCT01398358|565858547|FG002|Overall Study|Withdrawal by Subject|2|||
156755871|NCT01398358|565858545|FG000|Overall Study|no longer eligible|1|||
156755872|NCT01398358|565858546|FG001|Overall Study|no longer eligible|0|||
156755873|NCT01398358|565858547|FG002|Overall Study|no longer eligible|1|||
156755874|NCT02559570|565858549|FG000|Overall Study|Adverse Event|0|||
156755875|NCT02559570|565858550|FG001|Overall Study|Adverse Event|2|||
156755876|NCT02559570|565858551|FG002|Overall Study|Adverse Event|0|||
156996391|NCT05550337|566739549|FG000|Overall Study|Lost to Follow-up|16|||
156996392|NCT05550337|566739550|FG001|Overall Study|Lost to Follow-up|11|||
156996393|NCT05550337|566739551|FG002|Overall Study|Lost to Follow-up|11|||
156996394|NCT01836458|566739554|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156996395|NCT01836458|566739555|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156996396|NCT01836458|566739556|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
156996397|NCT01836458|566739557|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
157021611|NCT04739956|566830924|FG001|Overall Study|Withdrawal by Subject|1|||
156755877|NCT02559570|565858552|FG003|Overall Study|Adverse Event|1|||
156755878|NCT02559570|565858553|FG004|Overall Study|Adverse Event|0|||
156755879|NCT02559570|565858549|FG000|Overall Study|Withdrawal of Consent|0|||
156755880|NCT02559570|565858550|FG001|Overall Study|Withdrawal of Consent|0|||
156755881|NCT02559570|565858551|FG002|Overall Study|Withdrawal of Consent|1|||
156755882|NCT02559570|565858552|FG003|Overall Study|Withdrawal of Consent|2|||
156755883|NCT02559570|565858553|FG004|Overall Study|Withdrawal of Consent|1|||
156755884|NCT02559570|565858549|FG000|Overall Study|Lost to Follow-up|1|||
156755885|NCT02559570|565858550|FG001|Overall Study|Lost to Follow-up|0|||
156755886|NCT02559570|565858551|FG002|Overall Study|Lost to Follow-up|0|||
156755887|NCT02559570|565858552|FG003|Overall Study|Lost to Follow-up|0|||
156755888|NCT02559570|565858553|FG004|Overall Study|Lost to Follow-up|0|||
156755889|NCT02559570|565858549|FG000|Overall Study|Protocol Violation|1|||
156755890|NCT02559570|565858550|FG001|Overall Study|Protocol Violation|0|||
156996398|NCT03499600|566739558|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
156996399|NCT03499600|566739559|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
156996400|NCT00561574|566739560|FG000|Overall Study|Adverse Event|21|||
156996401|NCT00561574|566739561|FG001|Overall Study|Adverse Event|24|||
156996402|NCT00561574|566739560|FG000|Overall Study|Lack of Efficacy|11|||
156996403|NCT00561574|566739561|FG001|Overall Study|Lack of Efficacy|21|||
156996404|NCT00561574|566739560|FG000|Overall Study|Withdrawal by Subject|4|||
156996405|NCT00561574|566739561|FG001|Overall Study|Withdrawal by Subject|4|||
156996406|NCT00561574|566739560|FG000|Overall Study|Reason Unrelated to Trial|6|||
156996407|NCT00561574|566739561|FG001|Overall Study|Reason Unrelated to Trial|2|||
156996408|NCT00561574|566739560|FG000|Overall Study|Lost to Follow-up|1|||
156996409|NCT00561574|566739561|FG001|Overall Study|Lost to Follow-up|0|||
156996410|NCT00561574|566739560|FG000|Overall Study|Other|5|||
156996411|NCT00561574|566739561|FG001|Overall Study|Other|7|||
156996412|NCT03971357|566739562|FG000|Overall Study|Lack of Efficacy|0|||
156996413|NCT03971357|566739563|FG001|Overall Study|Lack of Efficacy|1|||
156996414|NCT04159506|566739564|FG000|Overall Study|Lost to Follow-up|2|||
156996415|NCT04159506|566739565|FG001|Overall Study|Lost to Follow-up|5|||
156996416|NCT02449044|566739566|FG000|Overall Study|Lost to Follow-up|2|||
156996417|NCT02449044|566739566|FG000|Overall Study|Withdrawal by Subject|13|||
156996418|NCT02449044|566739566|FG000|Overall Study|Adverse Event|30|||
156996419|NCT02449044|566739566|FG000|Overall Study|Met Withdrawal Criteria|7|||
156996420|NCT02449044|566739566|FG000|Overall Study|Physician Decision|9|||
156996421|NCT02449044|566739566|FG000|Overall Study|Sponsor Discontinued Trial|3|||
156996422|NCT01144468|566740879|FG000|Overall Study|Lost to Follow-up|4|||
156996423|NCT01144468|566740880|FG001|Overall Study|Lost to Follow-up|7|||
156996424|NCT01144468|566740879|FG000|Overall Study|Adverse Event|3|||
156996425|NCT01144468|566740880|FG001|Overall Study|Adverse Event|2|||
156996426|NCT01144468|566740879|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
156996427|NCT01144468|566740880|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
156996428|NCT02960659|566740881|FG000|Overall Study|Withdrawal by Subject|1|||
156996429|NCT02960659|566740882|FG001|Overall Study|Withdrawal by Subject|0|||
156996430|NCT02960659|566740881|FG000|Overall Study|Poor compliance|0|||
156996431|NCT02960659|566740882|FG001|Overall Study|Poor compliance|1|||
156996432|NCT03068468|566740884|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
156996433|NCT03068468|566740885|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
156996434|NCT03068468|566740886|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
156996435|NCT03068468|566740887|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
156996436|NCT03068468|566740884|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
156755891|NCT02559570|565858551|FG002|Overall Study|Protocol Violation|0|||
156755892|NCT02559570|565858552|FG003|Overall Study|Protocol Violation|0|||
156755893|NCT02559570|565858553|FG004|Overall Study|Protocol Violation|1|||
156755894|NCT02559570|565858549|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156755895|NCT02559570|565858550|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156755896|NCT02559570|565858551|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156755897|NCT02559570|565858552|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156755898|NCT02559570|565858553|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156755899|NCT00184093|565858557|FG000|Overall Study|Adverse Event|3|||
156755900|NCT00184093|565858557|FG000|Overall Study|Lost to Follow-up|3|||
156755901|NCT00184093|565858557|FG000|Overall Study|Physician Decision|1|||
156755902|NCT00184093|565858557|FG000|Overall Study|Withdrawal by Subject|2|||
156755903|NCT01903993|565858558|FG000|Overall Study|Death|118|||
156996437|NCT03068468|566740885|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
156996438|NCT03068468|566740886|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
156996439|NCT03068468|566740887|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
156996440|NCT03068468|566740884|FG000|Placebo-Controlled Period|Adverse Event|16|||
156996441|NCT03068468|566740885|FG001|Placebo-Controlled Period|Adverse Event|21|||
156996442|NCT03068468|566740886|FG002|Placebo-Controlled Period|Adverse Event|0|||
156996443|NCT03068468|566740887|FG003|Placebo-Controlled Period|Adverse Event|0|||
156996444|NCT03068468|566740884|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
156996445|NCT03068468|566740885|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
156996446|NCT03068468|566740886|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
156996447|NCT03068468|566740887|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
156996448|NCT03068468|566740884|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
156996449|NCT03068468|566740885|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
156996450|NCT03068468|566740886|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156996451|NCT03068468|566740887|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
156996452|NCT03068468|566740884|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
156996453|NCT03068468|566740885|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
156996454|NCT03068468|566740886|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
156996455|NCT03068468|566740887|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
156996456|NCT03068468|566740884|FG000|Placebo-Controlled Period|Death|0|||
156996457|NCT03068468|566740885|FG001|Placebo-Controlled Period|Death|1|||
156996458|NCT03068468|566740886|FG002|Placebo-Controlled Period|Death|0|||
156996459|NCT03068468|566740887|FG003|Placebo-Controlled Period|Death|0|||
156996460|NCT03068468|566740884|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
156996461|NCT03068468|566740885|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
156996462|NCT03068468|566740886|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
156996463|NCT03068468|566740887|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
156996464|NCT03068468|566740884|FG000|Open-Label Extension Period|Adverse Event|0|||
156996465|NCT03068468|566740885|FG001|Open-Label Extension Period|Adverse Event|0|||
156996466|NCT03068468|566740886|FG002|Open-Label Extension Period|Adverse Event|13|||
156996467|NCT03068468|566740887|FG003|Open-Label Extension Period|Adverse Event|17|||
156996468|NCT03068468|566740884|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
156996469|NCT03068468|566740885|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
156996470|NCT03068468|566740886|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
156996471|NCT03068468|566740887|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
156996472|NCT03068468|566740884|FG000|Open-Label Extension Period|Death|0|||
156996473|NCT03068468|566740885|FG001|Open-Label Extension Period|Death|0|||
156996474|NCT03068468|566740886|FG002|Open-Label Extension Period|Death|0|||
156996475|NCT03068468|566740887|FG003|Open-Label Extension Period|Death|1|||
156996476|NCT03068468|566740884|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
156996477|NCT03068468|566740885|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
156996478|NCT03068468|566740886|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
156996479|NCT03068468|566740887|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
156996480|NCT03068468|566740884|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156996481|NCT03068468|566740885|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156996482|NCT03068468|566740886|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
156996483|NCT03068468|566740887|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
156996484|NCT03068468|566740884|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
156996485|NCT03068468|566740885|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
156996486|NCT03068468|566740886|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
156996487|NCT03068468|566740887|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
156996488|NCT03068468|566740884|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
156996489|NCT03068468|566740885|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
157021612|NCT03519581|566830927|FG000|Overall Study|Lost to Follow-up|3|||
156755904|NCT01903993|565858559|FG001|Overall Study|Death|121|||
156755905|NCT01903993|565858558|FG000|Overall Study|Withdrawal by Subject|15|||
156755906|NCT01903993|565858559|FG001|Overall Study|Withdrawal by Subject|4|||
156755907|NCT01903993|565858558|FG000|Overall Study|Lost to Follow-up|2|||
156755908|NCT01903993|565858559|FG001|Overall Study|Lost to Follow-up|3|||
156755909|NCT01903993|565858558|FG000|Overall Study|Study Terminated by Sponsor|8|||
156755910|NCT01903993|565858559|FG001|Overall Study|Study Terminated by Sponsor|14|||
156755911|NCT01903993|565858558|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
156755912|NCT01903993|565858559|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
156755913|NCT05095311|565858560|FG000|Overall Study|Lost to Follow-up|7|||
156755914|NCT05095311|565858561|FG001|Overall Study|Lost to Follow-up|0|||
156755915|NCT05095311|565858562|FG002|Overall Study|Lost to Follow-up|0|||
156755916|NCT03283930|565858564|FG000|Overall Study|Scheduling conflict|8|||
156755917|NCT03283930|565858565|FG001|Overall Study|Scheduling conflict|10|||
156755918|NCT03283930|565858564|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
156755919|NCT03283930|565858565|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
156755920|NCT03283930|565858564|FG000|Overall Study|Technical software issue|2|||
156755921|NCT03283930|565858565|FG001|Overall Study|Technical software issue|2|||
156755922|NCT00805129|565858566|FG000|Overall Study|Not treated|1|||
156755923|NCT00571662|565858569|FG000|Overall Study|Withdrawal by Subject|2|||
156755924|NCT00571662|565858569|FG000|Overall Study|psychiatric instability|1|||
156755925|NCT00571662|565858569|FG000|Overall Study|Adverse Event|5|||
156755926|NCT02588664|565858572|FG000|Overall Study|Death|56|||
156755927|NCT02588664|565858573|FG001|Overall Study|Death|55|||
156755928|NCT02588664|565858572|FG000|Overall Study|Lost to Follow-up|1305|||
156755929|NCT02588664|565858573|FG001|Overall Study|Lost to Follow-up|990|||
156755930|NCT01429298|565858574|FG000|Overall Study|Protocol Violation|4|||
156755931|NCT01429298|565858575|FG001|Overall Study|Protocol Violation|6|||
156755932|NCT03681184|565858576|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
156755933|NCT03681184|565858577|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
156755934|NCT02500719|565858580|FG000|Overall Study|Lost to Follow-up|2|||
156755935|NCT02500719|565858581|FG001|Overall Study|Lost to Follow-up|3|||
156755936|NCT02500719|565858580|FG000|Overall Study|Trauma history|1|||
156755937|NCT02500719|565858581|FG001|Overall Study|Trauma history|0|||
156755938|NCT02500719|565858580|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
156755939|NCT02500719|565858581|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
156755940|NCT02500719|565858580|FG000|Overall Study|Did not meet criteria for PTSD|0|||
156755941|NCT02500719|565858581|FG001|Overall Study|Did not meet criteria for PTSD|1|||
156755942|NCT02500719|565858580|FG000|Overall Study|Claustrophobia|0|||
156755943|NCT02500719|565858581|FG001|Overall Study|Claustrophobia|1|||
156755944|NCT02500719|565858580|FG000|Overall Study|History of head trauma|0|||
156755945|NCT02500719|565858581|FG001|Overall Study|History of head trauma|1|||
156755946|NCT02710084|565858582|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
156755947|NCT02710084|565858583|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
156755948|NCT00181883|565858584|FG000|Overall Study|Lack of Efficacy|2|||
156755949|NCT00181883|565858584|FG000|Overall Study|Treatment Limiting AEs|3|||
156755950|NCT00181883|565858584|FG000|Overall Study|Withdrawal by Subject|4|||
156755951|NCT00181883|565858584|FG000|Overall Study|Lost to Follow-up|1|||
156755952|NCT05305989|565858585|FG000|Overall Study|Other|3|||
156755953|NCT05305989|565858586|FG001|Overall Study|Other|2|||
156755954|NCT05305989|565858587|FG002|Overall Study|Other|0|||
156755955|NCT05305989|565858585|FG000|Overall Study|Sponsor decision|2|||
156755956|NCT05305989|565858586|FG001|Overall Study|Sponsor decision|1|||
156755957|NCT05305989|565858587|FG002|Overall Study|Sponsor decision|0|||
156755958|NCT05305989|565858585|FG000|Overall Study|Protocol Violation|0|||
156755959|NCT05305989|565858586|FG001|Overall Study|Protocol Violation|1|||
156755960|NCT05305989|565858587|FG002|Overall Study|Protocol Violation|0|||
156755961|NCT05305989|565858585|FG000|Overall Study|Investigator decision|1|||
156755962|NCT05305989|565858586|FG001|Overall Study|Investigator decision|2|||
156755963|NCT05305989|565858587|FG002|Overall Study|Investigator decision|0|||
156755964|NCT05305989|565858585|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
156755965|NCT05305989|565858586|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
156755966|NCT05305989|565858587|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
156755967|NCT05305989|565858585|FG000|Overall Study|Adverse Event|1|||
156755968|NCT05305989|565858586|FG001|Overall Study|Adverse Event|1|||
156755969|NCT05305989|565858587|FG002|Overall Study|Adverse Event|0|||
156755970|NCT05305989|565858585|FG000|Overall Study|Enrolled but never dosed|3|||
156755971|NCT05305989|565858586|FG001|Overall Study|Enrolled but never dosed|2|||
157021613|NCT03519581|566830928|FG001|Overall Study|Lost to Follow-up|2|||
156755972|NCT05305989|565858587|FG002|Overall Study|Enrolled but never dosed|1|||
156755973|NCT00282152|565858588|FG000|Overall Study|Withdrawal by Subject|1|||
156755974|NCT00282152|565858589|FG001|Overall Study|Withdrawal by Subject|0|||
156755975|NCT03301831|565858590|FG000|Overall Study|Lost to Follow-up|5|||
156755976|NCT03301831|565858591|FG001|Overall Study|Lost to Follow-up|3|||
156755977|NCT03301831|565858590|FG000|Overall Study|Protocol Violation|4|||
156755978|NCT03301831|565858591|FG001|Overall Study|Protocol Violation|0|||
156755979|NCT03301831|565858590|FG000|Overall Study|Withdrawal by Subject|11|||
156755980|NCT03301831|565858591|FG001|Overall Study|Withdrawal by Subject|0|||
156755981|NCT00585325|565858592|FG000|Overall Study|Withdrawal by Subject|1|||
156755982|NCT00585325|565858593|FG001|Overall Study|Withdrawal by Subject|1|||
156755983|NCT00154375|565858594|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
156755984|NCT00154375|565858595|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
156755985|NCT00154375|565858594|FG000|Overall Study|Adverse Event|18|||
156755986|NCT00154375|565858595|FG001|Overall Study|Adverse Event|20|||
156755987|NCT00154375|565858594|FG000|Overall Study|Withdrawal by Subject|14|||
156755988|NCT00154375|565858595|FG001|Overall Study|Withdrawal by Subject|10|||
156755989|NCT00154375|565858594|FG000|Overall Study|Death|5|||
156755990|NCT00154375|565858595|FG001|Overall Study|Death|13|||
156755991|NCT00154375|565858594|FG000|Overall Study|Study drug no longer required|5|||
156755992|NCT00154375|565858595|FG001|Overall Study|Study drug no longer required|3|||
156755993|NCT00154375|565858594|FG000|Overall Study|Lost to Follow-up|2|||
156755994|NCT00154375|565858595|FG001|Overall Study|Lost to Follow-up|1|||
156755995|NCT00154375|565858594|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156755996|NCT00154375|565858595|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156755997|NCT00154375|565858594|FG000|Overall Study|Protocol Violation|0|||
156755998|NCT00154375|565858595|FG001|Overall Study|Protocol Violation|1|||
156755999|NCT00154375|565858594|FG000|Overall Study|Suspected progression of disease|44|||
156756000|NCT00154375|565858595|FG001|Overall Study|Suspected progression of disease|30|||
156756001|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
156756002|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756003|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756004|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
156756005|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
156756006|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756007|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756008|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
156756009|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
156756010|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756011|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756012|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
156756013|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
156756014|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756015|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756016|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
156756017|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
156756018|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756019|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756020|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
156756021|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
156756022|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756023|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756024|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
156756025|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
156756026|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756027|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756028|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
156756029|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
156756030|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756031|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756032|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
156756033|NCT03538691|565858596|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
156756034|NCT03538691|565858597|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756035|NCT03538691|565858598|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756036|NCT03538691|565858599|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
156756037|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156756038|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
156756039|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156756040|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
156756041|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756042|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
156756043|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756044|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
156756045|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756046|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
157021614|NCT03519581|566830927|FG000|Overall Study|Adverse Event|5|||
157021615|NCT03519581|566830928|FG001|Overall Study|Adverse Event|2|||
157021616|NCT03519581|566830927|FG000|Overall Study|Withdrawal by Subject|2|||
157099274|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
157099275|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
157099276|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
157099277|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
157099278|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
157099279|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
157099280|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
157099281|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
157099282|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
157099283|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
156756047|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756048|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
156756049|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756050|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
156756051|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756052|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
156756053|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756054|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
156756055|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756056|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
156756057|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756058|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
156756059|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756060|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
156756061|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756062|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
156756063|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756064|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
156756065|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756066|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
156756067|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756068|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
156756069|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756070|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
156756071|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756072|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
156756073|NCT03538691|565858596|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756074|NCT03538691|565858597|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
156756075|NCT03538691|565858598|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756076|NCT03538691|565858599|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756077|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
156756078|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
156756079|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
156756080|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
156756081|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
156756082|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
156996490|NCT03068468|566740886|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
156996491|NCT03068468|566740887|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
156996492|NCT03068468|566740884|FG000|Open-Label Extension Period|Reason not Specified|0|||
156996493|NCT03068468|566740885|FG001|Open-Label Extension Period|Reason not Specified|0|||
156996494|NCT03068468|566740886|FG002|Open-Label Extension Period|Reason not Specified|1|||
156996495|NCT03068468|566740887|FG003|Open-Label Extension Period|Reason not Specified|4|||
156996496|NCT03895034|566740888|FG000|Overall Study|Lost to Follow-up|2|||
156996497|NCT01118377|566740893|FG000|Overall Study|Did Not Receive Study Medication|1|||
156996498|NCT01118377|566740893|FG000|Overall Study|Death|38|||
156996499|NCT01118377|566740893|FG000|Overall Study|Failure to Return|3|||
156996500|NCT00739102|566740894|FG000|Overall Study|Death|5|||
156996501|NCT00739102|566740894|FG000|Overall Study|Withdrawal by Subject|10|||
156996502|NCT01331824|566740896|FG000|Overall Study|Adverse Event|2|||
156996503|NCT01331824|566740896|FG000|Overall Study|Death|1|||
156996504|NCT01331824|566740896|FG000|Overall Study|Disease Progression|9|||
156996505|NCT01331824|566740896|FG000|Overall Study|Withdrawal by Subject|1|||
156996506|NCT01091454|566740899|FG000|Overall Study|Ineligible|1|||
156996507|NCT01510912|566740900|FG000|Overall Study|Adverse Event|99|||
156996508|NCT01510912|566740900|FG000|Overall Study|Lack of Efficacy|12|||
156996509|NCT01510912|566740900|FG000|Overall Study|Non-compliance with trial drug|23|||
156996510|NCT01510912|566740900|FG000|Overall Study|Withdrawal by Subject|49|||
156996511|NCT01510912|566740900|FG000|Overall Study|Physician Decision|1|||
156996512|NCT01510912|566740900|FG000|Overall Study|Protocol Violation|27|||
156996513|NCT01510912|566740900|FG000|Overall Study|Lost to Follow-up|26|||
156996514|NCT01510912|566740900|FG000|Overall Study|Other, including joint replacement|5|||
156996515|NCT03181958|566740901|FG000|Overall Study|Lost to Follow-up|17|||
156996516|NCT03181958|566740902|FG001|Overall Study|Lost to Follow-up|21|||
156996517|NCT03181958|566740903|FG002|Overall Study|Lost to Follow-up|15|||
157099284|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
156996518|NCT00991276|566740905|FG000|First Intervention Period|Adverse Event|0|||
156996519|NCT00991276|566740906|FG001|First Intervention Period|Adverse Event|1|||
156996520|NCT00991276|566740907|FG002|First Intervention Period|Adverse Event|0|||
157099285|NCT00908232|567118260|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
157099286|NCT00908232|567118261|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
157099287|NCT00908232|567118262|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
157099288|NCT00908232|567118263|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
156756083|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
156756084|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
157099289|NCT03153137|567118264|FG000|Overall Study|Lost to Follow-up|1|||
157099290|NCT03153137|567118265|FG001|Overall Study|Lost to Follow-up|0|||
157099291|NCT03153137|567118264|FG000|Overall Study|Withdrawal by Subject|2|||
157099292|NCT03153137|567118265|FG001|Overall Study|Withdrawal by Subject|1|||
157099293|NCT03153137|567118264|FG000|Overall Study|Physician Decision|0|||
157099294|NCT03153137|567118265|FG001|Overall Study|Physician Decision|3|||
156996521|NCT00991276|566740908|FG003|First Intervention Period|Adverse Event|1|||
156996522|NCT00991276|566740909|FG004|First Intervention Period|Adverse Event|0|||
156996523|NCT00991276|566740910|FG005|First Intervention Period|Adverse Event|0|||
156996524|NCT00991276|566740905|FG000|First Intervention Period|Protocol Violation|0|||
156996525|NCT00991276|566740906|FG001|First Intervention Period|Protocol Violation|0|||
156996526|NCT00991276|566740907|FG002|First Intervention Period|Protocol Violation|0|||
156996527|NCT00991276|566740908|FG003|First Intervention Period|Protocol Violation|0|||
156996528|NCT00991276|566740909|FG004|First Intervention Period|Protocol Violation|2|||
156996529|NCT00991276|566740910|FG005|First Intervention Period|Protocol Violation|0|||
156996530|NCT00991276|566740905|FG000|First Intervention Period|Insufficient clinical response|0|||
156996531|NCT00991276|566740906|FG001|First Intervention Period|Insufficient clinical response|0|||
156996532|NCT00991276|566740907|FG002|First Intervention Period|Insufficient clinical response|0|||
156996533|NCT00991276|566740908|FG003|First Intervention Period|Insufficient clinical response|0|||
156996534|NCT00991276|566740909|FG004|First Intervention Period|Insufficient clinical response|1|||
156996535|NCT00991276|566740910|FG005|First Intervention Period|Insufficient clinical response|0|||
156996536|NCT00991276|566740905|FG000|First Intervention Period|Other|0|||
156996537|NCT00991276|566740906|FG001|First Intervention Period|Other|0|||
157099295|NCT00195507|567118269|FG000|Overall Study|Adverse Event|24|||
156756085|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
156756086|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
156756087|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
156756088|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
156756089|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
156756090|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
156756091|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
156756092|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
156756093|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
156756094|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
156756095|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
156756096|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
156756097|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756098|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756099|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
156756100|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
156756101|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
156756102|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
156756103|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
156756104|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
156756105|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756106|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756107|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
156756108|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
156756109|NCT03538691|565858596|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756110|NCT03538691|565858597|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
156756111|NCT03538691|565858598|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
156756112|NCT03538691|565858599|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
156756113|NCT00792116|565858604|FG000|Overall Study|Lost to Follow-up|0|||
156996538|NCT00991276|566740907|FG002|First Intervention Period|Other|0|||
156996539|NCT00991276|566740908|FG003|First Intervention Period|Other|1|||
156996540|NCT00991276|566740909|FG004|First Intervention Period|Other|1|||
156996541|NCT00991276|566740910|FG005|First Intervention Period|Other|0|||
156996542|NCT00991276|566740905|FG000|First Intervention Period|Withdrawal by Subject|0|||
156996543|NCT00991276|566740906|FG001|First Intervention Period|Withdrawal by Subject|1|||
156996544|NCT00991276|566740907|FG002|First Intervention Period|Withdrawal by Subject|0|||
156996545|NCT00991276|566740908|FG003|First Intervention Period|Withdrawal by Subject|1|||
156996546|NCT00991276|566740909|FG004|First Intervention Period|Withdrawal by Subject|0|||
156996547|NCT00991276|566740910|FG005|First Intervention Period|Withdrawal by Subject|1|||
156996548|NCT00991276|566740905|FG000|First Intervention Period|Lost to Follow-up|0|||
156996549|NCT00991276|566740906|FG001|First Intervention Period|Lost to Follow-up|1|||
156996550|NCT00991276|566740907|FG002|First Intervention Period|Lost to Follow-up|0|||
156996551|NCT00991276|566740908|FG003|First Intervention Period|Lost to Follow-up|1|||
156996552|NCT00991276|566740909|FG004|First Intervention Period|Lost to Follow-up|0|||
156996553|NCT00991276|566740910|FG005|First Intervention Period|Lost to Follow-up|0|||
156996554|NCT00991276|566740905|FG000|Second Intervention Period|Adverse Event|0|||
156996555|NCT00991276|566740906|FG001|Second Intervention Period|Adverse Event|2|||
156996556|NCT00991276|566740907|FG002|Second Intervention Period|Adverse Event|0|||
156996557|NCT00991276|566740908|FG003|Second Intervention Period|Adverse Event|1|||
156996558|NCT00991276|566740909|FG004|Second Intervention Period|Adverse Event|1|||
156996559|NCT00991276|566740910|FG005|Second Intervention Period|Adverse Event|0|||
156996560|NCT00991276|566740905|FG000|Second Intervention Period|Protocol Violation|1|||
156996561|NCT00991276|566740906|FG001|Second Intervention Period|Protocol Violation|0|||
156996562|NCT00991276|566740907|FG002|Second Intervention Period|Protocol Violation|0|||
156996563|NCT00991276|566740908|FG003|Second Intervention Period|Protocol Violation|0|||
156996564|NCT00991276|566740909|FG004|Second Intervention Period|Protocol Violation|0|||
156996565|NCT00991276|566740910|FG005|Second Intervention Period|Protocol Violation|0|||
156996566|NCT00991276|566740905|FG000|Second Intervention Period|Other|0|||
156996567|NCT00991276|566740906|FG001|Second Intervention Period|Other|0|||
156996568|NCT00991276|566740907|FG002|Second Intervention Period|Other|0|||
156996569|NCT00991276|566740908|FG003|Second Intervention Period|Other|1|||
156996570|NCT00991276|566740909|FG004|Second Intervention Period|Other|0|||
156996571|NCT00991276|566740910|FG005|Second Intervention Period|Other|1|||
156996572|NCT00991276|566740905|FG000|Third Intervention Period|Protocol Violation|1|||
156996573|NCT00991276|566740906|FG001|Third Intervention Period|Protocol Violation|0|||
156996574|NCT00991276|566740907|FG002|Third Intervention Period|Protocol Violation|0|||
156756114|NCT00792116|565858605|FG001|Overall Study|Lost to Follow-up|1|||
156756115|NCT00792116|565858604|FG000|Overall Study|Discontnued intervention|1|||
156756116|NCT00792116|565858605|FG001|Overall Study|Discontnued intervention|0|||
156756117|NCT02453256|565858606|FG000|Double Blind Period|Death|1|||
156756118|NCT02453256|565858607|FG001|Double Blind Period|Death|1|||
156756119|NCT02453256|565858606|FG000|Double Blind Period|Adverse Event|3|||
156756120|NCT02453256|565858607|FG001|Double Blind Period|Adverse Event|2|||
156756121|NCT02453256|565858606|FG000|Double Blind Period|Withdrawal by Subject|9|||
156756122|NCT02453256|565858607|FG001|Double Blind Period|Withdrawal by Subject|5|||
156756123|NCT02453256|565858606|FG000|Double Blind Period|Other|0|||
156756124|NCT02453256|565858607|FG001|Double Blind Period|Other|1|||
156756125|NCT02453256|565858606|FG000|Open Label Period|Adverse Event|1|||
156756126|NCT02453256|565858607|FG001|Open Label Period|Adverse Event|3|||
156756127|NCT02453256|565858606|FG000|Open Label Period|Death|0|||
156756128|NCT02453256|565858607|FG001|Open Label Period|Death|1|||
156756129|NCT02453256|565858606|FG000|Open Label Period|Lost to Follow-up|1|||
156756130|NCT02453256|565858607|FG001|Open Label Period|Lost to Follow-up|0|||
156756131|NCT02453256|565858606|FG000|Open Label Period|Other|0|||
156756132|NCT02453256|565858607|FG001|Open Label Period|Other|2|||
156756133|NCT02453256|565858606|FG000|Open Label Period|Withdrawal by Subject|5|||
156756134|NCT02453256|565858607|FG001|Open Label Period|Withdrawal by Subject|1|||
156756135|NCT01066871|565858609|FG000|Overall Study|Lost to Follow-up|0|||
156756136|NCT01066871|565858610|FG001|Overall Study|Lost to Follow-up|2|||
156756137|NCT01066871|565858611|FG002|Overall Study|Lost to Follow-up|2|||
156756138|NCT01066871|565858612|FG003|Overall Study|Lost to Follow-up|0|||
156756139|NCT01066871|565858609|FG000|Overall Study|Protocol Violation|1|||
156756140|NCT01066871|565858610|FG001|Overall Study|Protocol Violation|0|||
156756141|NCT01066871|565858611|FG002|Overall Study|Protocol Violation|3|||
156756142|NCT01066871|565858612|FG003|Overall Study|Protocol Violation|2|||
156756143|NCT01066871|565858609|FG000|Overall Study|Lack of Efficacy|0|||
156756144|NCT01066871|565858610|FG001|Overall Study|Lack of Efficacy|0|||
156756145|NCT01066871|565858611|FG002|Overall Study|Lack of Efficacy|0|||
156756146|NCT01066871|565858612|FG003|Overall Study|Lack of Efficacy|1|||
156756147|NCT01066871|565858609|FG000|Overall Study|Withdrawal by Subject|3|||
156756148|NCT01066871|565858610|FG001|Overall Study|Withdrawal by Subject|1|||
156756149|NCT01066871|565858611|FG002|Overall Study|Withdrawal by Subject|0|||
156756150|NCT01066871|565858612|FG003|Overall Study|Withdrawal by Subject|0|||
156756151|NCT01066871|565858609|FG000|Overall Study|Other|0|||
156756152|NCT01066871|565858610|FG001|Overall Study|Other|2|||
156756153|NCT01066871|565858611|FG002|Overall Study|Other|1|||
156756154|NCT01066871|565858612|FG003|Overall Study|Other|2|||
156756155|NCT01366638|565858616|FG000|Overall Study|Withdrawal by Subject|0|||
156756156|NCT01366638|565858617|FG001|Overall Study|Withdrawal by Subject|0|||
156756157|NCT01366638|565858618|FG002|Overall Study|Withdrawal by Subject|6|||
156756158|NCT01366638|565858616|FG000|Overall Study|Other|1|||
156756159|NCT01366638|565858617|FG001|Overall Study|Other|0|||
156756160|NCT01366638|565858618|FG002|Overall Study|Other|0|||
156756161|NCT01554163|565858619|FG000|Overall Study|Adverse Event|3|||
156756162|NCT01554163|565858620|FG001|Overall Study|Adverse Event|0|||
156756163|NCT01554163|565858619|FG000|Overall Study|Lack of Efficacy|1|||
156756164|NCT01554163|565858620|FG001|Overall Study|Lack of Efficacy|0|||
156756165|NCT01554163|565858619|FG000|Overall Study|Lost to Follow-up|1|||
156756166|NCT01554163|565858620|FG001|Overall Study|Lost to Follow-up|0|||
156756167|NCT01554163|565858619|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156756168|NCT01554163|565858620|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156756169|NCT01554163|565858619|FG000|Overall Study|Protocol Violation|0|||
156756170|NCT01554163|565858620|FG001|Overall Study|Protocol Violation|4|||
156756171|NCT01554163|565858619|FG000|Overall Study|Withdrawal by Subject|1|||
156756172|NCT01554163|565858620|FG001|Overall Study|Withdrawal by Subject|5|||
156756173|NCT01554163|565858619|FG000|Overall Study|Not Treated|1|||
156756174|NCT01554163|565858620|FG001|Overall Study|Not Treated|0|||
156756175|NCT01941537|565858621|FG000|Overall Study|Lack of Efficacy|1|||
156756176|NCT01941537|565858622|FG001|Overall Study|Lack of Efficacy|2|||
156756177|NCT01941537|565858621|FG000|Overall Study|Lost to Follow-up|1|||
156756178|NCT01941537|565858622|FG001|Overall Study|Lost to Follow-up|0|||
156756179|NCT01941537|565858621|FG000|Overall Study|Pregnancy|1|||
156756180|NCT01941537|565858622|FG001|Overall Study|Pregnancy|0|||
156756181|NCT01941537|565858621|FG000|Overall Study|Adverse Event|1|||
156756182|NCT01941537|565858622|FG001|Overall Study|Adverse Event|0|||
156756183|NCT01941537|565858621|FG000|Overall Study|Withdrawal by Subject|0|||
156756184|NCT01941537|565858622|FG001|Overall Study|Withdrawal by Subject|1|||
156756185|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
156756186|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
156756187|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
156756188|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
156756189|NCT01972464|565858626|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
157099296|NCT00195507|567118270|FG001|Overall Study|Adverse Event|13|||
156756190|NCT01972464|565858627|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
156756191|NCT01972464|565858626|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
156756192|NCT01972464|565858627|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
156756193|NCT01381926|565860507|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
156756194|NCT01381926|565860508|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
156756195|NCT01381926|565860507|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
156756196|NCT01381926|565860508|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
156756197|NCT02624947|565860513|FG000|Maternal Participants|Adverse Event|5|||
156756198|NCT02624947|565860514|FG001|Maternal Participants|Adverse Event|0|||
156756199|NCT02624947|565860513|FG000|Maternal Participants|Investigator Decision|5|||
156996575|NCT00991276|566740908|FG003|Third Intervention Period|Protocol Violation|0|||
156996576|NCT00991276|566740909|FG004|Third Intervention Period|Protocol Violation|0|||
156996577|NCT00991276|566740910|FG005|Third Intervention Period|Protocol Violation|0|||
156996578|NCT00991276|566740905|FG000|Third Intervention Period|Other|0|||
156996579|NCT00991276|566740906|FG001|Third Intervention Period|Other|0|||
156996580|NCT00991276|566740907|FG002|Third Intervention Period|Other|0|||
156996581|NCT00991276|566740908|FG003|Third Intervention Period|Other|0|||
156996582|NCT00991276|566740909|FG004|Third Intervention Period|Other|0|||
156996583|NCT00991276|566740910|FG005|Third Intervention Period|Other|1|||
156996584|NCT00991276|566740905|FG000|Third Intervention Period|Adverse Event|0|||
156996585|NCT00991276|566740906|FG001|Third Intervention Period|Adverse Event|0|||
156996586|NCT00991276|566740907|FG002|Third Intervention Period|Adverse Event|1|||
156996587|NCT00991276|566740908|FG003|Third Intervention Period|Adverse Event|0|||
156996588|NCT00991276|566740909|FG004|Third Intervention Period|Adverse Event|0|||
156996589|NCT00991276|566740910|FG005|Third Intervention Period|Adverse Event|0|||
156996590|NCT00991276|566740905|FG000|Third Intervention Period|Withdrawal by Subject|0|||
156996591|NCT00991276|566740906|FG001|Third Intervention Period|Withdrawal by Subject|0|||
156996592|NCT00991276|566740907|FG002|Third Intervention Period|Withdrawal by Subject|0|||
156996593|NCT00991276|566740908|FG003|Third Intervention Period|Withdrawal by Subject|1|||
156996594|NCT00991276|566740909|FG004|Third Intervention Period|Withdrawal by Subject|0|||
156996595|NCT00991276|566740910|FG005|Third Intervention Period|Withdrawal by Subject|0|||
156996596|NCT01268891|566740912|FG000|Overall Study|Adverse Event|3|||
156996597|NCT01268891|566740913|FG001|Overall Study|Adverse Event|7|||
156996598|NCT01268891|566740912|FG000|Overall Study|Lack of Efficacy|1|||
156996599|NCT01268891|566740913|FG001|Overall Study|Lack of Efficacy|0|||
156996600|NCT01268891|566740912|FG000|Overall Study|Withdrawal of Consent|3|||
156996601|NCT01268891|566740913|FG001|Overall Study|Withdrawal of Consent|1|||
156996602|NCT01268891|566740912|FG000|Overall Study|Administrative or other reason(s)|1|||
156996603|NCT01268891|566740913|FG001|Overall Study|Administrative or other reason(s)|0|||
156996604|NCT01063036|566740917|FG000|Participants Treated With Study Drug|Adverse Event|1|||
156996605|NCT01063036|566740917|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
156996606|NCT01063036|566740917|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
156996607|NCT01063036|566740917|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
156996608|NCT01063036|566740917|FG000|Participants Treated With Study Drug|Pregnancy|1|||
156996609|NCT01063036|566740917|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
156996610|NCT01063036|566740917|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
156996611|NCT01063036|566740917|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
156996612|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
156996613|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
156996614|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
156996615|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
156996616|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Adverse Event|198|||
156996617|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Adverse Event|0|||
156996618|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Adverse Event|0|||
156996619|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Adverse Event|0|||
156996620|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Death|62|||
156996621|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Death|0|||
156996622|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Death|0|||
156996623|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Death|0|||
156996624|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
156996625|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156996626|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156996627|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
156996628|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Complicating disease|13|||
156996629|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Complicating disease|0|||
156996630|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Complicating disease|0|||
156996631|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Complicating disease|0|||
156996632|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
156756200|NCT02624947|565860514|FG001|Maternal Participants|Investigator Decision|3|||
156996633|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
156996634|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
156996635|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
156996636|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
156996637|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156756201|NCT02624947|565860513|FG000|Maternal Participants|Lost to Follow-up|54|||
156756202|NCT02624947|565860514|FG001|Maternal Participants|Lost to Follow-up|24|||
156756203|NCT02624947|565860513|FG000|Maternal Participants|Non Compliance|8|||
156756204|NCT02624947|565860514|FG001|Maternal Participants|Non Compliance|5|||
156756205|NCT02624947|565860513|FG000|Maternal Participants|Sponsor Request|1|||
156756206|NCT02624947|565860514|FG001|Maternal Participants|Sponsor Request|1|||
156756207|NCT02624947|565860513|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
156756208|NCT02624947|565860514|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
156756209|NCT02624947|565860513|FG000|Maternal Participants|Miscellaneous|23|||
156756210|NCT02624947|565860514|FG001|Maternal Participants|Miscellaneous|15|||
156756211|NCT02624947|565860513|FG000|Infant Participants|Adverse Event|18|||
156756212|NCT02624947|565860514|FG001|Infant Participants|Adverse Event|11|||
156756213|NCT02624947|565860513|FG000|Infant Participants|Investigator Decision|5|||
156756214|NCT02624947|565860514|FG001|Infant Participants|Investigator Decision|4|||
156756215|NCT02624947|565860513|FG000|Infant Participants|Lost to Follow-up|93|||
156756216|NCT02624947|565860514|FG001|Infant Participants|Lost to Follow-up|58|||
156756217|NCT02624947|565860513|FG000|Infant Participants|Non Compliance|17|||
156756218|NCT02624947|565860514|FG001|Infant Participants|Non Compliance|7|||
156756219|NCT02624947|565860513|FG000|Infant Participants|Sponsor Request|0|||
156756220|NCT02624947|565860514|FG001|Infant Participants|Sponsor Request|1|||
156756221|NCT02624947|565860513|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
156756222|NCT02624947|565860514|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
156756223|NCT02624947|565860513|FG000|Infant Participants|Miscellaneous|50|||
156756224|NCT02624947|565860514|FG001|Infant Participants|Miscellaneous|26|||
156756225|NCT03654729|565860523|FG000|Overall Study|Death|9|||
156756226|NCT03654729|565860524|FG001|Overall Study|Death|9|||
156756227|NCT03654729|565860525|FG002|Overall Study|Death|16|||
156756228|NCT03654729|565860523|FG000|Overall Study|Withdrawal by Subject|8|||
156756229|NCT03654729|565860524|FG001|Overall Study|Withdrawal by Subject|6|||
156756230|NCT03654729|565860525|FG002|Overall Study|Withdrawal by Subject|4|||
156756231|NCT03654729|565860523|FG000|Overall Study|Study terminated by Sponsor|3|||
156756232|NCT03654729|565860524|FG001|Overall Study|Study terminated by Sponsor|5|||
156756233|NCT03654729|565860525|FG002|Overall Study|Study terminated by Sponsor|4|||
156756234|NCT03654729|565860523|FG000|Overall Study|Not reported|2|||
156756235|NCT03654729|565860524|FG001|Overall Study|Not reported|4|||
156756236|NCT03654729|565860525|FG002|Overall Study|Not reported|5|||
156756237|NCT03654729|565860523|FG000|Overall Study|Progressive disease|3|||
156756238|NCT03654729|565860524|FG001|Overall Study|Progressive disease|0|||
156756239|NCT03654729|565860525|FG002|Overall Study|Progressive disease|0|||
156756240|NCT03654729|565860523|FG000|Overall Study|Lost to Follow-up|2|||
156756241|NCT03654729|565860524|FG001|Overall Study|Lost to Follow-up|0|||
156756242|NCT03654729|565860525|FG002|Overall Study|Lost to Follow-up|0|||
156756243|NCT03654729|565860523|FG000|Overall Study|Physician Decision|2|||
156756244|NCT03654729|565860524|FG001|Overall Study|Physician Decision|0|||
156756245|NCT03654729|565860525|FG002|Overall Study|Physician Decision|0|||
156756246|NCT03654729|565860523|FG000|Overall Study|Protocol Violation|1|||
156756247|NCT03654729|565860524|FG001|Overall Study|Protocol Violation|1|||
156756248|NCT03654729|565860525|FG002|Overall Study|Protocol Violation|0|||
156756249|NCT03654729|565860523|FG000|Overall Study|Non-compliance with study drug|0|||
156756250|NCT03654729|565860524|FG001|Overall Study|Non-compliance with study drug|1|||
156756251|NCT03654729|565860525|FG002|Overall Study|Non-compliance with study drug|0|||
156756252|NCT03654729|565860523|FG000|Overall Study|Site terminated by Sponsor|1|||
156756253|NCT03654729|565860524|FG001|Overall Study|Site terminated by Sponsor|0|||
156756254|NCT03654729|565860525|FG002|Overall Study|Site terminated by Sponsor|0|||
156756255|NCT00215644|565860531|FG000|Overall Study|Disease Progression|28|||
156756256|NCT00215644|565860532|FG001|Overall Study|Disease Progression|10|||
156756257|NCT00215644|565860531|FG000|Overall Study|Adverse Event|2|||
156756258|NCT00215644|565860532|FG001|Overall Study|Adverse Event|9|||
156756259|NCT00215644|565860531|FG000|Overall Study|Death|1|||
156756260|NCT00215644|565860532|FG001|Overall Study|Death|2|||
156996638|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156996639|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
156756261|NCT00215644|565860531|FG000|Overall Study|Withdrawal by Subject|1|||
157099297|NCT00195507|567118269|FG000|Overall Study|Death|0|||
157099298|NCT00195507|567118270|FG001|Overall Study|Death|1|||
157099299|NCT00195507|567118269|FG000|Overall Study|Failed to Return|4|||
157099300|NCT00195507|567118270|FG001|Overall Study|Failed to Return|3|||
156756262|NCT00215644|565860532|FG001|Overall Study|Withdrawal by Subject|0|||
156756263|NCT00215644|565860531|FG000|Overall Study|Other|3|||
156756264|NCT00215644|565860532|FG001|Overall Study|Other|15|||
156756265|NCT00215644|565860531|FG000|Overall Study|Randomized but Not Treated|1|||
156756266|NCT00215644|565860532|FG001|Overall Study|Randomized but Not Treated|0|||
156756267|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
156756268|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
156756269|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
156756270|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
156756271|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
156756272|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
156756273|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
156756274|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
156756275|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
156756276|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
156756277|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
156756278|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
156756279|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
156756280|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
156756281|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
156756282|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
156756283|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
156756284|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
156756285|NCT03569098|565860535|FG000|Double-Blind Treatment Cycle 1|Other|1|||
156756286|NCT03569098|565860536|FG001|Double-Blind Treatment Cycle 1|Other|0|||
156756287|NCT03569098|565860537|FG002|Double-Blind Treatment Cycle 1|Other|1|||
156756288|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
156756289|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
156756290|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
156756291|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
157099301|NCT00195507|567118269|FG000|Overall Study|Physician Decision|1|||
157099302|NCT00195507|567118270|FG001|Overall Study|Physician Decision|2|||
157099303|NCT00195507|567118269|FG000|Overall Study|Lost to Follow-up|3|||
156756292|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
156756293|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
156756294|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
156756295|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
156756296|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
156756297|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
156756298|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
156756299|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
156756300|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
156756301|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
156756302|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
157099304|NCT00195507|567118270|FG001|Overall Study|Lost to Follow-up|2|||
157099305|NCT00195507|567118269|FG000|Overall Study|Protocol Violation|5|||
157099306|NCT00195507|567118270|FG001|Overall Study|Protocol Violation|4|||
157099307|NCT00195507|567118269|FG000|Overall Study|Lack of Efficacy|40|||
157099308|NCT00195507|567118270|FG001|Overall Study|Lack of Efficacy|67|||
157099309|NCT00195507|567118269|FG000|Overall Study|Withdrawal by Subject|16|||
157099310|NCT00195507|567118270|FG001|Overall Study|Withdrawal by Subject|23|||
157099311|NCT00195507|567118269|FG000|Overall Study|Protocol Deviation|6|||
157099312|NCT00195507|567118270|FG001|Overall Study|Protocol Deviation|3|||
157099313|NCT00528866|567118271|FG000|Overall Study|Protocol Violation|6|||
157099314|NCT00993915|567118275|FG000|Overall Study|Insufficient clinical response|3|||
157099315|NCT00993915|567118275|FG000|Overall Study|Withdrawal by Subject|2|||
157099316|NCT00993915|567118275|FG000|Overall Study|Other|1|||
157099317|NCT00993915|567118275|FG000|Overall Study|Ongoing|3|||
157099318|NCT01386658|567118276|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
157099319|NCT01386658|567118277|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
157099320|NCT01386658|567118276|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
157099321|NCT01386658|567118277|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
156756303|NCT03569098|565860535|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
157099322|NCT02465463|567118283|FG000|Overall Study|Lost to Follow-up|2|||
157099323|NCT02465463|567118284|FG001|Overall Study|Lost to Follow-up|1|||
157099324|NCT02465463|567118283|FG000|Overall Study|Death|1|||
157099325|NCT02465463|567118284|FG001|Overall Study|Death|0|||
157099326|NCT02465463|567118283|FG000|Overall Study|Protocol Violation|1|||
156996640|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Non-compliance|4|||
156996641|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Non-compliance|0|||
156996642|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Non-compliance|0|||
156996643|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Non-compliance|0|||
156996644|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Pain|4|||
156996645|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Pain|0|||
156996646|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Pain|0|||
157099327|NCT02465463|567118284|FG001|Overall Study|Protocol Violation|0|||
157099328|NCT01067326|567118289|FG000|Overall Study|Adverse Event|0|||
157099329|NCT01067326|567118290|FG001|Overall Study|Adverse Event|2|||
157099330|NCT01067326|567118289|FG000|Overall Study|Withdrawal by Subject|1|||
156756304|NCT03569098|565860536|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
156756305|NCT03569098|565860537|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
156756306|NCT00493012|565860543|FG000|Overall Study|Lost to Follow-up|18|||
156756307|NCT00493012|565860544|FG001|Overall Study|Lost to Follow-up|17|||
156756308|NCT02915159|565860545|FG000|Overall Study|Participant no longer meets criteria|2|||
156756309|NCT02915159|565860546|FG001|Overall Study|Participant no longer meets criteria|0|||
156756310|NCT02915159|565860545|FG000|Overall Study|poor/non-compliance|1|||
156756311|NCT02915159|565860546|FG001|Overall Study|poor/non-compliance|0|||
156756312|NCT02915159|565860545|FG000|Overall Study|Participant withdrew consent|5|||
156756313|NCT02915159|565860546|FG001|Overall Study|Participant withdrew consent|1|||
156756314|NCT02915159|565860545|FG000|Overall Study|Request to discontinue treatment|1|||
156756315|NCT02915159|565860546|FG001|Overall Study|Request to discontinue treatment|2|||
156756316|NCT02915159|565860545|FG000|Overall Study|Adverse Event|2|||
156756317|NCT02915159|565860546|FG001|Overall Study|Adverse Event|2|||
156756318|NCT02915159|565860545|FG000|Overall Study|Lack of Efficacy|0|||
156756319|NCT02915159|565860546|FG001|Overall Study|Lack of Efficacy|3|||
156756320|NCT04534517|565860547|FG000|Overall Study|Adverse Event|1|||
156756321|NCT04534517|565860547|FG000|Overall Study|Withdrawal by Subject|1|||
156756322|NCT04534517|565860547|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156756323|NCT04534517|565860547|FG000|Overall Study|COVID-19 Related|1|||
156756324|NCT02121795|565860548|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
156756325|NCT02121795|565860549|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
156756326|NCT02121795|565860548|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
156756327|NCT02121795|565860549|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
156756328|NCT02121795|565860548|FG000|Double-Blind Phase|Lost to Follow-up|7|||
156756329|NCT02121795|565860549|FG001|Double-Blind Phase|Lost to Follow-up|4|||
156756330|NCT02121795|565860548|FG000|Double-Blind Phase|Physician Decision|2|||
156756331|NCT02121795|565860549|FG001|Double-Blind Phase|Physician Decision|5|||
156756332|NCT02121795|565860548|FG000|Double-Blind Phase|Adverse Event|5|||
156756333|NCT02121795|565860549|FG001|Double-Blind Phase|Adverse Event|0|||
156756334|NCT02121795|565860548|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
156756335|NCT02121795|565860549|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156756336|NCT02121795|565860548|FG000|Double-Blind Phase|Protocol Violation|0|||
156756337|NCT02121795|565860549|FG001|Double-Blind Phase|Protocol Violation|3|||
156756338|NCT02121795|565860548|FG000|Double-Blind Phase|Death|1|||
156756339|NCT02121795|565860549|FG001|Double-Blind Phase|Death|1|||
156756340|NCT02121795|565860548|FG000|Open-Label Phase|Physician Decision|8|||
156756341|NCT02121795|565860549|FG001|Open-Label Phase|Physician Decision|8|||
156756342|NCT02121795|565860548|FG000|Open-Label Phase|Withdrawal by Subject|3|||
156756343|NCT02121795|565860549|FG001|Open-Label Phase|Withdrawal by Subject|2|||
156756344|NCT02121795|565860548|FG000|Open-Label Phase|Lost to Follow-up|1|||
156756345|NCT02121795|565860549|FG001|Open-Label Phase|Lost to Follow-up|0|||
156756346|NCT00613821|565860562|FG000|Overall Study|Withdrawal by Subject|1|||
156996647|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Pain|0|||
156996648|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
156996649|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
156996650|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
156996651|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
156996652|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Hospice care|1|||
156996653|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Hospice care|0|||
156996654|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Hospice care|0|||
156996655|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Hospice care|0|||
156996656|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Physician Decision|1|||
156996657|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Physician Decision|0|||
156996658|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Physician Decision|0|||
156996659|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Physician Decision|0|||
156996660|NCT01107626|566740918|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
157099331|NCT01067326|567118290|FG001|Overall Study|Withdrawal by Subject|0|||
156996661|NCT01107626|566740919|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
157099332|NCT01067326|567118289|FG000|Overall Study|Early Study Termination|1|||
157099333|NCT01067326|567118290|FG001|Overall Study|Early Study Termination|1|||
156756347|NCT00613821|565860563|FG001|Overall Study|Withdrawal by Subject|0|||
156756348|NCT00613821|565860562|FG000|Overall Study|Physician Decision|1|||
156756349|NCT00613821|565860563|FG001|Overall Study|Physician Decision|1|||
156996662|NCT01107626|566740920|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
156996663|NCT01107626|566740921|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
156996664|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
156996665|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
156996666|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
156996667|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
156996668|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
156996669|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
156996670|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
156996671|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
156996672|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Death|0|||
156996673|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Death|8|||
156996674|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Death|2|||
156996675|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Death|13|||
156996676|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
156996677|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
156996678|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
156996679|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
156996680|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
156996681|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
156996682|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
156996683|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
156996684|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
156996685|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
156996686|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
156996687|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
156996688|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
156996689|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
156996690|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
156996691|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
156996692|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
156996693|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
156996694|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
156996695|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
156996696|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
156996697|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
156996698|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
156996699|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
156996700|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
156996701|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
156996702|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
156996703|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
156996704|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
156996705|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
156996706|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
156996707|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
156996708|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
156996709|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
156996710|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
156996711|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
156996712|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
156996713|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
156996714|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
156996715|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
156996716|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Pain|0|||
156996717|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Pain|0|||
156996718|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Pain|0|||
156996719|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Pain|1|||
156996720|NCT01107626|566740918|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
156996721|NCT01107626|566740919|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
156996722|NCT01107626|566740920|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
156996723|NCT01107626|566740921|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
156996724|NCT01977612|566740922|FG000|Overall Study|Lost to Follow-up|1|||
156996725|NCT01977612|566740923|FG001|Overall Study|Lost to Follow-up|1|||
156996726|NCT02236559|566740927|FG000|Overall Study|Met Exclusion|3|||
156996727|NCT02236559|566740928|FG001|Overall Study|Met Exclusion|6|||
156996728|NCT02236559|566740927|FG000|Overall Study|Did not Meet Inclusion|3|||
156996729|NCT02236559|566740928|FG001|Overall Study|Did not Meet Inclusion|3|||
156996730|NCT02236559|566740927|FG000|Overall Study|Subject Did Not Consent|4|||
156996731|NCT02236559|566740928|FG001|Overall Study|Subject Did Not Consent|2|||
156756350|NCT01266824|565860565|FG000|Overall Study|Study terminated prior to completion|2|||
156756351|NCT01266824|565860566|FG001|Overall Study|Study terminated prior to completion|3|||
156756352|NCT02302846|565860567|FG000|Overall Study|Withdrawal by Subject|1|||
156756353|NCT00872521|565860568|FG000|Completed PAD Induction|Patient choice|0|||
156756354|NCT00872521|565860569|FG001|Completed PAD Induction|Patient choice|1|||
156756355|NCT00872521|565860570|FG002|Completed PAD Induction|Patient choice|0|||
156756356|NCT00872521|565860568|FG000|Completed PAD Induction|Disease progression|0|||
156756357|NCT00872521|565860569|FG001|Completed PAD Induction|Disease progression|2|||
156756358|NCT00872521|565860570|FG002|Completed PAD Induction|Disease progression|0|||
156756359|NCT00872521|565860568|FG000|Completed PAD Induction|Adverse Event|4|||
156756360|NCT00872521|565860569|FG001|Completed PAD Induction|Adverse Event|0|||
156756361|NCT00872521|565860570|FG002|Completed PAD Induction|Adverse Event|0|||
156756362|NCT00872521|565860568|FG000|Completed PAD Induction|Death|1|||
156756363|NCT00872521|565860569|FG001|Completed PAD Induction|Death|1|||
156756364|NCT00872521|565860570|FG002|Completed PAD Induction|Death|0|||
156756365|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Other|1|||
156756366|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Other|2|||
156756367|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Other|0|||
156756368|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Patient choice|0|||
156756369|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Patient choice|1|||
156756370|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Patient choice|0|||
156756371|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
156756372|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
156756373|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
156756374|NCT00872521|565860568|FG000|Primary Endpoint Analysis|Patient response missing|0|||
156756375|NCT00872521|565860569|FG001|Primary Endpoint Analysis|Patient response missing|0|||
156756376|NCT00872521|565860570|FG002|Primary Endpoint Analysis|Patient response missing|1|||
156756377|NCT00872521|565860568|FG000|Completed 3-month Follow up|Other|0|||
156756378|NCT00872521|565860569|FG001|Completed 3-month Follow up|Other|2|||
156756379|NCT00872521|565860570|FG002|Completed 3-month Follow up|Other|0|||
156756380|NCT00872521|565860568|FG000|Completed 3-month Follow up|Physician Decision|0|||
156756381|NCT00872521|565860569|FG001|Completed 3-month Follow up|Physician Decision|1|||
156756382|NCT00872521|565860570|FG002|Completed 3-month Follow up|Physician Decision|0|||
156756383|NCT00872521|565860568|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
156756384|NCT00872521|565860569|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
156756385|NCT00872521|565860570|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
156756386|NCT05225558|565860574|FG000|Overall Study|Withdrawal by Subject|4|||
156756387|NCT05225558|565860575|FG001|Overall Study|Withdrawal by Subject|3|||
156756388|NCT05225558|565860574|FG000|Overall Study|Adverse Event|1|||
156756389|NCT05225558|565860575|FG001|Overall Study|Adverse Event|0|||
156756390|NCT05225558|565860574|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
156756391|NCT05225558|565860575|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
156756392|NCT05225558|565860574|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
156756393|NCT05225558|565860575|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
156756394|NCT01001910|565860576|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
156756395|NCT01089127|565860577|FG000|Overall Study|Adverse Event|5|||
156756396|NCT01089127|565860578|FG001|Overall Study|Adverse Event|1|||
156756397|NCT01089127|565860579|FG002|Overall Study|Adverse Event|1|||
156756398|NCT01089127|565860580|FG003|Overall Study|Adverse Event|0|||
156756399|NCT01089127|565860581|FG004|Overall Study|Adverse Event|0|||
156756400|NCT01089127|565860582|FG005|Overall Study|Adverse Event|1|||
156756401|NCT01089127|565860577|FG000|Overall Study|Subject withdrew consent|0|||
156756402|NCT01089127|565860578|FG001|Overall Study|Subject withdrew consent|1|||
156756403|NCT01089127|565860579|FG002|Overall Study|Subject withdrew consent|1|||
156756404|NCT01089127|565860580|FG003|Overall Study|Subject withdrew consent|1|||
156756405|NCT01089127|565860581|FG004|Overall Study|Subject withdrew consent|0|||
156756406|NCT01089127|565860582|FG005|Overall Study|Subject withdrew consent|2|||
156756407|NCT01089127|565860577|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156756408|NCT01089127|565860578|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156756409|NCT01089127|565860579|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156756410|NCT01089127|565860580|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156756411|NCT01089127|565860581|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156756412|NCT01089127|565860582|FG005|Overall Study|Abnormal test procedure result(s)|0|||
156756413|NCT01089127|565860577|FG000|Overall Study|Lost to Follow-up|1|||
156756414|NCT01089127|565860578|FG001|Overall Study|Lost to Follow-up|1|||
156756415|NCT01089127|565860579|FG002|Overall Study|Lost to Follow-up|0|||
156756416|NCT01089127|565860580|FG003|Overall Study|Lost to Follow-up|0|||
156756417|NCT01089127|565860581|FG004|Overall Study|Lost to Follow-up|1|||
156756418|NCT01089127|565860582|FG005|Overall Study|Lost to Follow-up|0|||
156756419|NCT01089127|565860577|FG000|Overall Study|Protocol deviation|0|||
156756420|NCT01089127|565860578|FG001|Overall Study|Protocol deviation|1|||
156756421|NCT01089127|565860579|FG002|Overall Study|Protocol deviation|0|||
156756422|NCT01089127|565860580|FG003|Overall Study|Protocol deviation|0|||
156756423|NCT01089127|565860581|FG004|Overall Study|Protocol deviation|1|||
156756424|NCT01089127|565860582|FG005|Overall Study|Protocol deviation|0|||
156756425|NCT03200548|565860583|FG000|Overall Study|Withdrawal by Subject|5|||
156756426|NCT03200548|565860584|FG001|Overall Study|Withdrawal by Subject|11|||
156756427|NCT03200548|565860585|FG002|Overall Study|Withdrawal by Subject|7|||
156756428|NCT03200548|565860586|FG003|Overall Study|Withdrawal by Subject|6|||
156756429|NCT00511810|565860589|FG000|Overall Study|Lost to Follow-up|1|||
156756430|NCT00511810|565860590|FG001|Overall Study|Lost to Follow-up|2|||
156756431|NCT00511810|565860589|FG000|Overall Study|Lack of Efficacy|0|||
156756432|NCT00511810|565860590|FG001|Overall Study|Lack of Efficacy|2|||
156756433|NCT00511810|565860589|FG000|Overall Study|Refused second scn|0|||
156756434|NCT00511810|565860590|FG001|Overall Study|Refused second scn|1|||
156756435|NCT02896569|565860591|FG000|Overall Study|Lost to Follow-up|2|||
156756436|NCT02896569|565860592|FG001|Overall Study|Lost to Follow-up|1|||
156756437|NCT02896569|565860591|FG000|Overall Study|Physician Decision|1|||
156756438|NCT02896569|565860592|FG001|Overall Study|Physician Decision|3|||
156756439|NCT02896569|565860591|FG000|Overall Study|Adverse Event|0|||
156756440|NCT02896569|565860592|FG001|Overall Study|Adverse Event|1|||
156756441|NCT02896569|565860591|FG000|Overall Study|Withdrawal by Subject|1|||
156756442|NCT02896569|565860592|FG001|Overall Study|Withdrawal by Subject|0|||
156756443|NCT01462630|565860593|FG000|Overall Study|Did not initiate therapy|3|||
156756444|NCT01462630|565860593|FG000|Overall Study|Death|1|||
156756445|NCT01462630|565860593|FG000|Overall Study|Protocol Violation|2|||
156756446|NCT01462630|565860593|FG000|Overall Study|Adverse Event|1|||
156756447|NCT01896193|565860594|FG000|Overall Study|Lack of Efficacy|20|||
156756448|NCT01896193|565860595|FG001|Overall Study|Lack of Efficacy|11|||
156756449|NCT01896193|565860594|FG000|Overall Study|Protocol Violation|0|||
156756450|NCT01896193|565860595|FG001|Overall Study|Protocol Violation|1|||
156756451|NCT01896193|565860594|FG000|Overall Study|Withdrew Consent|1|||
156756452|NCT01896193|565860595|FG001|Overall Study|Withdrew Consent|0|||
156756453|NCT02592447|565860598|FG000|Overall Study|Lost to Follow-up|1|||
156756454|NCT02592447|565860599|FG001|Overall Study|Lost to Follow-up|0|||
156756455|NCT02592447|565860598|FG000|Overall Study|Ineligible after randomization|1|||
156756456|NCT02592447|565860599|FG001|Overall Study|Ineligible after randomization|0|||
156756457|NCT02592447|565860598|FG000|Overall Study|Withdrawal by Subject|0|||
156756458|NCT02592447|565860599|FG001|Overall Study|Withdrawal by Subject|1|||
156756459|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
156756460|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756461|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
156756462|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
156756463|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756464|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756465|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756466|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756467|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756468|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756469|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756470|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756471|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756472|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756473|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756474|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756475|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756476|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756477|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
156756478|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
156756479|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
156756480|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
156756481|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
156756482|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756483|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756484|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756485|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756486|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756487|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756488|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756489|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756490|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756491|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756492|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756493|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156996732|NCT02236559|566740927|FG000|Overall Study|Physician Decision|1|||
157099334|NCT01230788|567118295|FG000|Overall Study|Prescribed exclusion drug|1|||
157099335|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
157099336|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
157099337|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Death|0|||
157099338|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Death|1|||
157099339|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
157099340|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
157099341|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
157099342|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
157099343|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
157099344|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
157099345|NCT00323297|567118296|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
157099346|NCT00323297|567118297|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
157099347|NCT00323297|567118296|FG000|Part B (Open-label)|Death|0|||
157099348|NCT00323297|567118297|FG001|Part B (Open-label)|Death|1|||
157099349|NCT00323297|567118296|FG000|Part B (Open-label)|Reason unspecified|0|||
157099350|NCT00323297|567118297|FG001|Part B (Open-label)|Reason unspecified|1|||
157099351|NCT00323297|567118296|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
157099352|NCT00323297|567118297|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
157099353|NCT00323297|567118296|FG000|Part B (Open-label)|Lack of Efficacy|3|||
157099354|NCT00323297|567118297|FG001|Part B (Open-label)|Lack of Efficacy|1|||
157099355|NCT00323297|567118296|FG000|Part B (Open-label)|Adverse Event|5|||
157099356|NCT00323297|567118297|FG001|Part B (Open-label)|Adverse Event|5|||
157099357|NCT00323297|567118296|FG000|Part B (Open-label)|Protocol Violation|0|||
157099358|NCT00323297|567118297|FG001|Part B (Open-label)|Protocol Violation|1|||
157099359|NCT01423253|567118298|FG000|Overall Study|Adverse Event|2|||
157099360|NCT01423253|567118298|FG000|Overall Study|Lack of Efficacy|2|||
157099361|NCT01423253|567118298|FG000|Overall Study|Lost to Follow-up|1|||
156996733|NCT02236559|566740928|FG001|Overall Study|Physician Decision|1|||
156996734|NCT02236559|566740927|FG000|Overall Study|Withdrawal by Subject|1|||
157099362|NCT01423253|567118298|FG000|Overall Study|Protocol Violation|2|||
157099363|NCT01423253|567118298|FG000|Overall Study|Withdrawal by Subject|2|||
157099364|NCT02804178|567118300|FG000|Overall Study|Adverse Event|1|||
157099365|NCT00564018|567118301|FG000|Overall Study|Withdrawal by Subject|2|||
157099366|NCT00564018|567118302|FG001|Overall Study|Withdrawal by Subject|3|||
157099367|NCT00564018|567118303|FG002|Overall Study|Withdrawal by Subject|1|||
157099368|NCT00986440|567118304|FG000|Overall Study|Progressive disease|27|||
157099369|NCT00986440|567118305|FG001|Overall Study|Progressive disease|37|||
157099370|NCT00986440|567118304|FG000|Overall Study|Serious adverse event or adverse event|9|||
157099371|NCT00986440|567118305|FG001|Overall Study|Serious adverse event or adverse event|2|||
157099372|NCT00986440|567118304|FG000|Overall Study|Withdrawal by Subject|1|||
157099373|NCT00986440|567118305|FG001|Overall Study|Withdrawal by Subject|2|||
157099374|NCT00986440|567118304|FG000|Overall Study|Screen failure (not dosed)|4|||
157099375|NCT00986440|567118305|FG001|Overall Study|Screen failure (not dosed)|2|||
157099376|NCT00954421|567118313|FG000|Screening|screen failures|3|||
157099377|NCT00954421|567118313|FG000|6 Months of DBS|Withdrawal by Subject|1|||
157099378|NCT00954421|567118313|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
157099379|NCT00458341|567118324|FG000|Cycle 1|Adverse Event|1|||
157099380|NCT00458341|567118325|FG001|Cycle 1|Adverse Event|0|||
157099381|NCT05461794|567118326|FG000|Overall Study|Withdrawal by Subject|1|||
157099382|NCT05461794|567118327|FG001|Overall Study|Withdrawal by Subject|1|||
157099383|NCT05461794|567118328|FG002|Overall Study|Withdrawal by Subject|3|||
157099384|NCT05461794|567118326|FG000|Overall Study|Study Terminated By Sponsor|18|||
157099385|NCT05461794|567118327|FG001|Overall Study|Study Terminated By Sponsor|13|||
157099386|NCT05461794|567118328|FG002|Overall Study|Study Terminated By Sponsor|16|||
156996735|NCT02236559|566740928|FG001|Overall Study|Withdrawal by Subject|0|||
156996736|NCT01280591|566740929|FG000|Overall Study|Withdrawal by Subject|0|||
156996737|NCT01280591|566740930|FG001|Overall Study|Withdrawal by Subject|0|||
156996738|NCT01280591|566740931|FG002|Overall Study|Withdrawal by Subject|0|||
156996739|NCT01280591|566740932|FG003|Overall Study|Withdrawal by Subject|2|||
156996740|NCT01280591|566740929|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
156996741|NCT01280591|566740930|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
156996742|NCT01280591|566740931|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
156996743|NCT01280591|566740932|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
156996744|NCT02955069|566740933|FG000|Overall Study|Adverse Event|7|||
156996745|NCT02955069|566740934|FG001|Overall Study|Adverse Event|2|||
156996746|NCT02955069|566740933|FG000|Overall Study|Death|7|||
156996747|NCT02955069|566740934|FG001|Overall Study|Death|3|||
156996748|NCT02955069|566740933|FG000|Overall Study|Physician Decision|10|||
156996749|NCT02955069|566740934|FG001|Overall Study|Physician Decision|2|||
156996750|NCT02955069|566740933|FG000|Overall Study|Progressive disease|64|||
156996751|NCT02955069|566740934|FG001|Overall Study|Progressive disease|13|||
156996752|NCT02955069|566740933|FG000|Overall Study|Study terminated by sponsor|4|||
156996753|NCT02955069|566740934|FG001|Overall Study|Study terminated by sponsor|0|||
156996754|NCT02955069|566740933|FG000|Overall Study|Subject/Guardian decision|3|||
156996755|NCT02955069|566740934|FG001|Overall Study|Subject/Guardian decision|1|||
157099387|NCT05461794|567118326|FG000|Overall Study|Death|20|||
157099388|NCT05461794|567118327|FG001|Overall Study|Death|5|||
157099389|NCT05461794|567118328|FG002|Overall Study|Death|19|||
157099390|NCT02730598|567118329|FG000|Overall Study|Withdrawal by Subject|3|||
157099391|NCT02730598|567118330|FG001|Overall Study|Withdrawal by Subject|3|||
157099392|NCT02730598|567118329|FG000|Overall Study|Protocol Violation|0|||
157099393|NCT02730598|567118330|FG001|Overall Study|Protocol Violation|1|||
157099394|NCT02730598|567118329|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
157099395|NCT02730598|567118330|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
157099396|NCT00810394|567118331|FG000|Overall Study|Withdrawal by Subject|3|||
157099397|NCT03254485|567118334|FG000|Overall Study|Adverse Event|3|||
157099398|NCT03254485|567118335|FG001|Overall Study|Adverse Event|0|||
157099399|NCT03254485|567118336|FG002|Overall Study|Adverse Event|0|||
157099400|NCT03254485|567118337|FG003|Overall Study|Adverse Event|6|||
157099401|NCT03254485|567118334|FG000|Overall Study|Protocol Violation|6|||
157099402|NCT03254485|567118335|FG001|Overall Study|Protocol Violation|0|||
157099403|NCT03254485|567118336|FG002|Overall Study|Protocol Violation|0|||
157099404|NCT03254485|567118337|FG003|Overall Study|Protocol Violation|2|||
157099405|NCT03254485|567118334|FG000|Overall Study|Withdrawal by Subject|1|||
157099406|NCT03254485|567118335|FG001|Overall Study|Withdrawal by Subject|0|||
157099407|NCT03254485|567118336|FG002|Overall Study|Withdrawal by Subject|0|||
157099408|NCT03254485|567118337|FG003|Overall Study|Withdrawal by Subject|4|||
157099409|NCT03254485|567118334|FG000|Overall Study|Death|0|||
157099410|NCT03254485|567118335|FG001|Overall Study|Death|0|||
157099411|NCT03254485|567118336|FG002|Overall Study|Death|0|||
157099412|NCT03254485|567118337|FG003|Overall Study|Death|1|||
157099413|NCT03254485|567118334|FG000|Overall Study|Lost to Follow-up|1|||
157099414|NCT03254485|567118335|FG001|Overall Study|Lost to Follow-up|0|||
157099415|NCT03254485|567118336|FG002|Overall Study|Lost to Follow-up|0|||
157099416|NCT03254485|567118337|FG003|Overall Study|Lost to Follow-up|0|||
157099417|NCT03254485|567118334|FG000|Overall Study|Other|1|||
157099418|NCT03254485|567118335|FG001|Overall Study|Other|0|||
157099419|NCT03254485|567118336|FG002|Overall Study|Other|0|||
157099420|NCT03254485|567118337|FG003|Overall Study|Other|2|||
157099421|NCT00467285|567118338|FG000|Overall Study|Lost to Follow-up|4|||
157099422|NCT00467285|567118339|FG001|Overall Study|Lost to Follow-up|4|||
157099423|NCT03891524|567118340|FG000|Overall Study|Death|0|||
157099424|NCT03891524|567118341|FG001|Overall Study|Death|0|||
157099425|NCT03891524|567118342|FG002|Overall Study|Death|0|||
157099426|NCT03891524|567118343|FG003|Overall Study|Death|0|||
157099427|NCT03891524|567118344|FG004|Overall Study|Death|0|||
157099428|NCT03891524|567118345|FG005|Overall Study|Death|0|||
157099429|NCT03891524|567118346|FG006|Overall Study|Death|0|||
157099430|NCT03891524|567118347|FG007|Overall Study|Death|1|||
157099431|NCT03891524|567118340|FG000|Overall Study|Withdrawal by Subject|0|||
157099432|NCT03891524|567118341|FG001|Overall Study|Withdrawal by Subject|1|||
157099433|NCT03891524|567118342|FG002|Overall Study|Withdrawal by Subject|2|||
157099434|NCT03891524|567118343|FG003|Overall Study|Withdrawal by Subject|1|||
157099435|NCT03891524|567118344|FG004|Overall Study|Withdrawal by Subject|2|||
157099436|NCT03891524|567118345|FG005|Overall Study|Withdrawal by Subject|2|||
157099437|NCT03891524|567118346|FG006|Overall Study|Withdrawal by Subject|2|||
157099438|NCT03891524|567118347|FG007|Overall Study|Withdrawal by Subject|1|||
157099439|NCT02958267|567118349|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
157099440|NCT02958267|567118350|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
157099441|NCT02958267|567118349|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
157099442|NCT02958267|567118350|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
157099443|NCT02958267|567118349|FG000|Follow-up Visits|Additional treatment pursued|2|||
157099444|NCT02958267|567118350|FG001|Follow-up Visits|Additional treatment pursued|1|||
157099445|NCT00475033|567118353|FG000|Infant Series|Failed to return|3|||
157099446|NCT00475033|567118354|FG001|Infant Series|Failed to return|4|||
157099447|NCT00475033|567118353|FG000|Infant Series|Parent or legal guardian request|1|||
157099448|NCT00475033|567118354|FG001|Infant Series|Parent or legal guardian request|5|||
157099449|NCT00475033|567118353|FG000|Infant Series|Protocol Violation|1|||
157099450|NCT00475033|567118354|FG001|Infant Series|Protocol Violation|2|||
157099451|NCT00475033|567118353|FG000|Infant Series|Lost to Follow-up|2|||
157099452|NCT00475033|567118354|FG001|Infant Series|Lost to Follow-up|0|||
157099453|NCT00475033|567118353|FG000|Infant Series|Adverse Event|0|||
157099454|NCT00475033|567118354|FG001|Infant Series|Adverse Event|2|||
157099455|NCT00475033|567118353|FG000|After the Infant Series|Adverse Event|0|||
157099456|NCT00475033|567118354|FG001|After the Infant Series|Adverse Event|4|||
157099457|NCT00475033|567118353|FG000|After the Infant Series|Parent or legal guardian request|2|||
157099458|NCT00475033|567118354|FG001|After the Infant Series|Parent or legal guardian request|2|||
157099459|NCT00475033|567118353|FG000|After the Infant Series|Failed to return|2|||
157099460|NCT00475033|567118354|FG001|After the Infant Series|Failed to return|1|||
157099461|NCT00475033|567118353|FG000|After the Infant Series|Protocol Violation|1|||
157099462|NCT00475033|567118354|FG001|After the Infant Series|Protocol Violation|0|||
157099463|NCT00475033|567118353|FG000|After the Infant Series|Lost to Follow-up|1|||
157099464|NCT00475033|567118354|FG001|After the Infant Series|Lost to Follow-up|0|||
157099465|NCT00475033|567118353|FG000|After the Infant Series|Other|0|||
157099466|NCT00475033|567118354|FG001|After the Infant Series|Other|1|||
157099467|NCT00475033|567118353|FG000|Toddler Dose|Parent or legal guardian request|2|||
157099468|NCT00475033|567118354|FG001|Toddler Dose|Parent or legal guardian request|0|||
157099469|NCT00475033|567118353|FG000|Toddler Dose|Failed to return|1|||
156996756|NCT02131324|566740935|FG000|Overall Study|Withdrawal by Subject|1|||
156996757|NCT02131324|566740936|FG001|Overall Study|Withdrawal by Subject|2|||
156996758|NCT02131324|566740935|FG000|Overall Study|Lost to Follow-up|1|||
156996759|NCT02131324|566740936|FG001|Overall Study|Lost to Follow-up|1|||
156996760|NCT00891618|566740937|FG000|Overall Study|Withdrawal by Subject|1|||
156996761|NCT04582877|566740940|FG000|Overall Study|Did not use device measurement|5|||
156996762|NCT04582877|566740940|FG000|Overall Study|No fractional flow reserve test results|2|||
156996763|NCT04582877|566740940|FG000|Overall Study|Protocol Violation|1|||
156996764|NCT00003656|566740941|FG000|Overall Study|Adverse Event|0|||
156996765|NCT00003656|566740942|FG001|Overall Study|Adverse Event|1|||
156996766|NCT02759731|566740943|FG000|Overall Study|Did not complete treatment.|8|||
156996767|NCT00763282|566740946|FG000|Overall Study|Withdrawal by Subject|6|||
156996768|NCT00763282|566740947|FG001|Overall Study|Withdrawal by Subject|5|||
156996769|NCT00763282|566740946|FG000|Overall Study|Death|4|||
156996770|NCT00763282|566740947|FG001|Overall Study|Death|3|||
156996771|NCT00763282|566740946|FG000|Overall Study|Lost to Follow-up|22|||
156996772|NCT00763282|566740947|FG001|Overall Study|Lost to Follow-up|26|||
156996773|NCT01101165|566740948|FG000|Period 1|Adverse Event|1|||
156996774|NCT01101165|566740949|FG001|Period 1|Adverse Event|2|||
156996775|NCT01101165|566740948|FG000|Period 1|Withdrawal by Subject|0|||
156996776|NCT01101165|566740949|FG001|Period 1|Withdrawal by Subject|2|||
156996777|NCT01101165|566740948|FG000|Period 1|Positive Drug Screen|0|||
156996778|NCT01101165|566740949|FG001|Period 1|Positive Drug Screen|1|||
156996779|NCT01101165|566740948|FG000|Period 1|Lost to Follow-up|1|||
156996780|NCT01101165|566740949|FG001|Period 1|Lost to Follow-up|0|||
156996781|NCT01101165|566740948|FG000|Period 2|Withdrawal by Subject|3|||
156996782|NCT01101165|566740949|FG001|Period 2|Withdrawal by Subject|1|||
156996783|NCT01101165|566740948|FG000|Period 2|Adverse Event|1|||
156996784|NCT01101165|566740949|FG001|Period 2|Adverse Event|0|||
156996785|NCT03095508|566740953|FG000|Overall Study|Adverse Event|0|||
156996786|NCT03095508|566740954|FG001|Overall Study|Adverse Event|1|||
156996787|NCT00335556|566740955|FG000|Overall Study|Death|0|||
156996788|NCT00335556|566740956|FG001|Overall Study|Death|5|||
156996789|NCT00335556|566740957|FG002|Overall Study|Death|0|||
156996790|NCT00335556|566740958|FG003|Overall Study|Death|0|||
156996791|NCT00335556|566740959|FG004|Overall Study|Death|1|||
156996792|NCT00335556|566740960|FG005|Overall Study|Death|0|||
156996793|NCT00335556|566740955|FG000|Overall Study|Lack of Efficacy|0|||
156996794|NCT00335556|566740956|FG001|Overall Study|Lack of Efficacy|19|||
156996795|NCT00335556|566740957|FG002|Overall Study|Lack of Efficacy|3|||
156996796|NCT00335556|566740958|FG003|Overall Study|Lack of Efficacy|3|||
156996797|NCT00335556|566740959|FG004|Overall Study|Lack of Efficacy|0|||
156996798|NCT00335556|566740960|FG005|Overall Study|Lack of Efficacy|1|||
156996799|NCT00335556|566740955|FG000|Overall Study|Physician Decision|0|||
156996800|NCT00335556|566740956|FG001|Overall Study|Physician Decision|6|||
156996801|NCT00335556|566740957|FG002|Overall Study|Physician Decision|2|||
156996802|NCT00335556|566740958|FG003|Overall Study|Physician Decision|1|||
156996803|NCT00335556|566740959|FG004|Overall Study|Physician Decision|0|||
156996804|NCT00335556|566740960|FG005|Overall Study|Physician Decision|0|||
156996805|NCT00335556|566740955|FG000|Overall Study|Ineligible|2|||
156996806|NCT00335556|566740956|FG001|Overall Study|Ineligible|0|||
156996807|NCT00335556|566740957|FG002|Overall Study|Ineligible|0|||
156996808|NCT00335556|566740958|FG003|Overall Study|Ineligible|0|||
156996809|NCT00335556|566740959|FG004|Overall Study|Ineligible|0|||
156996810|NCT00335556|566740960|FG005|Overall Study|Ineligible|0|||
156996811|NCT00335556|566740955|FG000|Overall Study|Refusal of further protocol therapy|0|||
156996812|NCT00335556|566740956|FG001|Overall Study|Refusal of further protocol therapy|4|||
156996813|NCT00335556|566740957|FG002|Overall Study|Refusal of further protocol therapy|0|||
156996814|NCT00335556|566740958|FG003|Overall Study|Refusal of further protocol therapy|1|||
156996815|NCT00335556|566740959|FG004|Overall Study|Refusal of further protocol therapy|0|||
156996816|NCT00335556|566740960|FG005|Overall Study|Refusal of further protocol therapy|0|||
156996817|NCT02365298|566740961|FG000|Period 2|incorrect Rx dispensed|1|||
156996818|NCT02365298|566740962|FG001|Period 2|incorrect Rx dispensed|0|||
156996819|NCT02365298|566740961|FG000|Period 2|Discontinued at request of Sponsor|1|||
156996820|NCT02365298|566740962|FG001|Period 2|Discontinued at request of Sponsor|0|||
156996821|NCT02365298|566740961|FG000|Period 2|Test Article longer available|0|||
156996822|NCT02365298|566740962|FG001|Period 2|Test Article longer available|1|||
156996823|NCT02365298|566740961|FG000|Period 2|Protocol Violation|0|||
156996824|NCT02365298|566740962|FG001|Period 2|Protocol Violation|1|||
156996825|NCT01670019|566740965|FG000|Overall Study|Adverse Event|3|||
156996826|NCT01670019|566740966|FG001|Overall Study|Adverse Event|0|||
156996827|NCT01670019|566740965|FG000|Overall Study|Withdrawal by Subject|6|||
156996828|NCT01670019|566740966|FG001|Overall Study|Withdrawal by Subject|0|||
156996829|NCT05487703|566740967|FG000|Overall Study|Other|19|||
156996830|NCT05487703|566740967|FG000|Overall Study|Participant not well|5|||
156996831|NCT05487703|566740967|FG000|Overall Study|Insurance Reasons|6|||
156996832|NCT05487703|566740967|FG000|Overall Study|Physician Decision|19|||
156996833|NCT05487703|566740967|FG000|Overall Study|Lack of Efficacy|60|||
156996834|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
156996835|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
157099470|NCT00475033|567118354|FG001|Toddler Dose|Failed to return|0|||
157099471|NCT00475033|567118353|FG000|Toddler Dose|Lost to Follow-up|1|||
157099472|NCT00475033|567118354|FG001|Toddler Dose|Lost to Follow-up|0|||
157099473|NCT01128361|567120348|FG000|Overall Study|Lost to Follow-up|0|||
157099474|NCT01128361|567120349|FG001|Overall Study|Lost to Follow-up|1|||
157099475|NCT01128361|567120348|FG000|Overall Study|Withdrawal by Subject|5|||
157099476|NCT01128361|567120349|FG001|Overall Study|Withdrawal by Subject|2|||
157099477|NCT05736211|567120362|FG000|Overall Study|Lost to Follow-up|6|||
157099478|NCT05736211|567120363|FG001|Overall Study|Lost to Follow-up|0|||
157099479|NCT02634346|567120366|FG000|Overall Study|Withdrawal by Subject|8|||
157099480|NCT02634346|567120367|FG001|Overall Study|Withdrawal by Subject|9|||
157099481|NCT02634346|567120368|FG002|Overall Study|Withdrawal by Subject|8|||
157099482|NCT02634346|567120366|FG000|Overall Study|Adverse Event|2|||
157099483|NCT02634346|567120367|FG001|Overall Study|Adverse Event|2|||
157099484|NCT02634346|567120368|FG002|Overall Study|Adverse Event|7|||
157099485|NCT02634346|567120366|FG000|Overall Study|Lack of Efficacy|1|||
157099486|NCT02634346|567120367|FG001|Overall Study|Lack of Efficacy|2|||
157099487|NCT02634346|567120368|FG002|Overall Study|Lack of Efficacy|8|||
157099488|NCT02634346|567120366|FG000|Overall Study|Lost to Follow-up|1|||
157099489|NCT02634346|567120367|FG001|Overall Study|Lost to Follow-up|0|||
157099490|NCT02634346|567120368|FG002|Overall Study|Lost to Follow-up|0|||
157099491|NCT02634346|567120366|FG000|Overall Study|Protocol Violation|0|||
157099492|NCT02634346|567120367|FG001|Overall Study|Protocol Violation|1|||
157099493|NCT02634346|567120368|FG002|Overall Study|Protocol Violation|0|||
157099494|NCT00992511|567120369|FG000|Overall Study|Migrated/moved from study area|1|||
157099495|NCT00992511|567120370|FG001|Overall Study|Migrated/moved from study area|0|||
157099496|NCT00992511|567120371|FG002|Overall Study|Migrated/moved from study area|1|||
157099497|NCT00992511|567120372|FG003|Overall Study|Migrated/moved from study area|2|||
157099498|NCT00992511|567120369|FG000|Overall Study|Lost to Follow-up|1|||
157099499|NCT00992511|567120370|FG001|Overall Study|Lost to Follow-up|0|||
157099500|NCT00992511|567120371|FG002|Overall Study|Lost to Follow-up|0|||
157099501|NCT00992511|567120372|FG003|Overall Study|Lost to Follow-up|2|||
157099502|NCT00992511|567120369|FG000|Overall Study|Withdrawal by Subject|0|||
157099503|NCT00992511|567120370|FG001|Overall Study|Withdrawal by Subject|0|||
157099504|NCT00992511|567120371|FG002|Overall Study|Withdrawal by Subject|1|||
157099505|NCT00992511|567120372|FG003|Overall Study|Withdrawal by Subject|1|||
157099506|NCT02076113|567120375|FG000|Overall Study|Lost to Follow-up|4|||
157099507|NCT02076113|567120376|FG001|Overall Study|Lost to Follow-up|1|||
157099508|NCT02076113|567120375|FG000|Overall Study|Withdrawal by Subject|2|||
157099509|NCT02076113|567120376|FG001|Overall Study|Withdrawal by Subject|3|||
157099510|NCT02076113|567120375|FG000|Overall Study|Death|1|||
157099511|NCT02076113|567120376|FG001|Overall Study|Death|3|||
157099512|NCT00769860|567120382|FG000|Overall Study|Withdrawal by Subject|2|||
157099513|NCT00769860|567120383|FG001|Overall Study|Withdrawal by Subject|0|||
157099514|NCT00448435|567120386|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
157099515|NCT00448435|567120387|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
157099516|NCT00412971|567120392|FG000|Overall Study|Lost to Follow-up|17|||
157099517|NCT00412971|567120393|FG001|Overall Study|Lost to Follow-up|9|||
157099518|NCT00412971|567120392|FG000|Overall Study|Protocol Violation|13|||
157099519|NCT00412971|567120393|FG001|Overall Study|Protocol Violation|1|||
157099520|NCT01774084|567120396|FG000|Overall Study|Personal reasons|1|||
157099521|NCT01774084|567120397|FG001|Overall Study|Personal reasons|0|||
157099522|NCT01106404|567120398|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
157099523|NCT01106404|567120399|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
157099524|NCT01106404|567120398|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
157099525|NCT01106404|567120399|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
157099526|NCT01106404|567120398|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
157099527|NCT01106404|567120399|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
157099528|NCT01106404|567120398|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
157099529|NCT01106404|567120399|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
157099530|NCT01387230|567120400|FG000|Overall Study|Adverse Event|0|||
157099531|NCT01387230|567120401|FG001|Overall Study|Adverse Event|1|||
157099532|NCT01387230|567120402|FG002|Overall Study|Adverse Event|3|||
157099533|NCT01387230|567120400|FG000|Overall Study|Lack of Efficacy|8|||
157099534|NCT01387230|567120401|FG001|Overall Study|Lack of Efficacy|5|||
157099535|NCT01387230|567120402|FG002|Overall Study|Lack of Efficacy|4|||
157099536|NCT01387230|567120400|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
157099537|NCT01387230|567120401|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
157099538|NCT01387230|567120402|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
157099539|NCT01387230|567120400|FG000|Overall Study|Lost to Follow-up|0|||
157099540|NCT01387230|567120401|FG001|Overall Study|Lost to Follow-up|0|||
157099541|NCT01387230|567120402|FG002|Overall Study|Lost to Follow-up|1|||
157099542|NCT01387230|567120400|FG000|Overall Study|Withdrawal by Subject|4|||
157099543|NCT01387230|567120401|FG001|Overall Study|Withdrawal by Subject|1|||
157099544|NCT01387230|567120402|FG002|Overall Study|Withdrawal by Subject|0|||
157099545|NCT03026127|567120406|FG000|CRISP R61|Adverse Event|5|||
157099546|NCT03026127|567120407|FG001|CRISP R61|Adverse Event|0|||
157099547|NCT03026127|567120408|FG002|CRISP R61|Adverse Event|0|||
157099548|NCT03026127|567120406|FG000|CRISP R61|Lost to Follow-up|2|||
157099549|NCT03026127|567120407|FG001|CRISP R61|Lost to Follow-up|0|||
157099550|NCT03026127|567120408|FG002|CRISP R61|Lost to Follow-up|0|||
157099551|NCT03026127|567120406|FG000|CRISP R61|Dropped before therapy|5|||
157099552|NCT03026127|567120407|FG001|CRISP R61|Dropped before therapy|0|||
157099553|NCT03026127|567120408|FG002|CRISP R61|Dropped before therapy|0|||
157099554|NCT03026127|567120406|FG000|CRISP R33|Lost to Follow-up|0|||
157099555|NCT03026127|567120407|FG001|CRISP R33|Lost to Follow-up|5|||
157099556|NCT03026127|567120408|FG002|CRISP R33|Lost to Follow-up|4|||
157099557|NCT03026127|567120406|FG000|CRISP R33|Adverse Event|0|||
157099558|NCT03026127|567120407|FG001|CRISP R33|Adverse Event|9|||
157099559|NCT03026127|567120408|FG002|CRISP R33|Adverse Event|5|||
157099560|NCT03026127|567120406|FG000|CRISP R33|Withdrawal by Subject|0|||
157099561|NCT03026127|567120407|FG001|CRISP R33|Withdrawal by Subject|9|||
157099562|NCT03026127|567120408|FG002|CRISP R33|Withdrawal by Subject|1|||
157099563|NCT03026127|567120406|FG000|CRISP R33|Lack of Efficacy|0|||
157099564|NCT03026127|567120407|FG001|CRISP R33|Lack of Efficacy|3|||
157099565|NCT03026127|567120408|FG002|CRISP R33|Lack of Efficacy|2|||
157099566|NCT03026127|567120406|FG000|CRISP R33|Physician Decision|0|||
157099567|NCT03026127|567120407|FG001|CRISP R33|Physician Decision|3|||
157099568|NCT03026127|567120408|FG002|CRISP R33|Physician Decision|1|||
157099569|NCT03026127|567120406|FG000|CRISP R33|Transportation|0|||
157099570|NCT03026127|567120407|FG001|CRISP R33|Transportation|2|||
157099571|NCT03026127|567120408|FG002|CRISP R33|Transportation|1|||
157099572|NCT03027557|567120409|FG000|Overall Study|Adverse Event|1|||
157099573|NCT03027557|567120410|FG001|Overall Study|Adverse Event|0|||
157099574|NCT03027557|567120411|FG002|Overall Study|Adverse Event|0|||
157099575|NCT02430051|567120414|FG000|Overall Study|Withdrawal by Subject|6|||
157099576|NCT02430051|567120415|FG001|Overall Study|Withdrawal by Subject|3|||
157099577|NCT02430051|567120414|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
157099578|NCT02430051|567120415|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
157099579|NCT02430051|567120414|FG000|Overall Study|Protocol Violation|1|||
157099580|NCT02430051|567120415|FG001|Overall Study|Protocol Violation|0|||
157099581|NCT02030405|567120421|FG000|Overall Study|Withdrawal by Subject|1|||
157099582|NCT02030405|567120421|FG000|Overall Study|Lost to Follow-up|1|||
157099583|NCT00132496|567120422|FG000|Overall Study|Withdrawal by Subject|1|||
157099584|NCT00132496|567120423|FG001|Overall Study|Withdrawal by Subject|2|||
157099585|NCT00132496|567120422|FG000|Overall Study|Physician Decision|1|||
157099586|NCT00132496|567120423|FG001|Overall Study|Physician Decision|0|||
157099587|NCT00388154|567120426|FG000|Overall Study|Withdrawal by Subject|1|||
157099588|NCT04526197|567120432|FG000|Period 1|Adverse Event|0|||
157099589|NCT04526197|567120433|FG001|Period 1|Adverse Event|1|||
157099590|NCT04526197|567120432|FG000|Period 1|Withdrawal by Subject|1|||
157099591|NCT04526197|567120433|FG001|Period 1|Withdrawal by Subject|0|||
157099592|NCT04526197|567120432|FG000|Period 2|Adverse Event|0|||
157099593|NCT04526197|567120433|FG001|Period 2|Adverse Event|1|||
157099594|NCT04526197|567120432|FG000|Period 2|Withdrawal by Subject|0|||
157099595|NCT04526197|567120433|FG001|Period 2|Withdrawal by Subject|1|||
157099596|NCT01209143|567120434|FG000|Overall Study|Adverse Event|2|||
157099597|NCT01209143|567120435|FG001|Overall Study|Adverse Event|1|||
157099598|NCT01209143|567120434|FG000|Overall Study|Death|0|||
157099599|NCT01209143|567120435|FG001|Overall Study|Death|1|||
157099600|NCT01209143|567120434|FG000|Overall Study|Physician Decision|3|||
157099601|NCT01209143|567120435|FG001|Overall Study|Physician Decision|1|||
157099602|NCT01209143|567120434|FG000|Overall Study|Lost to Follow-up|1|||
157099603|NCT01209143|567120435|FG001|Overall Study|Lost to Follow-up|0|||
156756494|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
157099604|NCT01209143|567120434|FG000|Overall Study|Withdrawal by Subject|2|||
157099605|NCT01209143|567120435|FG001|Overall Study|Withdrawal by Subject|1|||
157099606|NCT01209143|567120434|FG000|Overall Study|Disease progression|11|||
157099607|NCT01209143|567120435|FG001|Overall Study|Disease progression|16|||
156756495|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
157099608|NCT00381303|567120436|FG000|Overall Study|Lost to Follow-up|25|||
157099609|NCT00381303|567120437|FG001|Overall Study|Lost to Follow-up|9|||
157099610|NCT00381303|567120436|FG000|Overall Study|AE/HIV-related event|22|||
157099611|NCT00381303|567120437|FG001|Overall Study|AE/HIV-related event|6|||
157099612|NCT00381303|567120436|FG000|Overall Study|Non-Adherence|13|||
157099613|NCT00381303|567120437|FG001|Overall Study|Non-Adherence|6|||
157099614|NCT00381303|567120436|FG000|Overall Study|Withdrawal by Subject|13|||
157099615|NCT00381303|567120437|FG001|Overall Study|Withdrawal by Subject|6|||
157099616|NCT00381303|567120436|FG000|Overall Study|Virologic failure|6|||
157099617|NCT00381303|567120437|FG001|Overall Study|Virologic failure|4|||
157099618|NCT00381303|567120436|FG000|Overall Study|Ineligible to continue the trial|2|||
157099619|NCT00381303|567120437|FG001|Overall Study|Ineligible to continue the trial|1|||
157099620|NCT00381303|567120436|FG000|Overall Study|Pregnancy|2|||
157099621|NCT00381303|567120437|FG001|Overall Study|Pregnancy|0|||
157099622|NCT00381303|567120436|FG000|Overall Study|Physician Decision|1|||
157099623|NCT00381303|567120437|FG001|Overall Study|Physician Decision|0|||
157099624|NCT00381303|567120436|FG000|Overall Study|Physician's decision to close the site|3|||
157099625|NCT00381303|567120437|FG001|Overall Study|Physician's decision to close the site|1|||
157099626|NCT00381303|567120436|FG000|Overall Study|Subject moved out of state|2|||
157099627|NCT00381303|567120437|FG001|Overall Study|Subject moved out of state|0|||
157099628|NCT00381303|567120436|FG000|Overall Study|Subject taking too many different meds|1|||
157099629|NCT00381303|567120437|FG001|Overall Study|Subject taking too many different meds|0|||
157099630|NCT00381303|567120436|FG000|Overall Study|No virologic response by week 12|1|||
157099631|NCT00381303|567120437|FG001|Overall Study|No virologic response by week 12|0|||
157099632|NCT00381303|567120436|FG000|Overall Study|Subject was too busy for appointments|1|||
157099633|NCT00381303|567120437|FG001|Overall Study|Subject was too busy for appointments|0|||
157099634|NCT00381303|567120436|FG000|Overall Study|Subject did not continue visits|1|||
157099635|NCT00381303|567120437|FG001|Overall Study|Subject did not continue visits|0|||
157099636|NCT00381303|567120436|FG000|Overall Study|Subject primary physician's decision|1|||
157099637|NCT00381303|567120437|FG001|Overall Study|Subject primary physician's decision|0|||
157099638|NCT01136811|567120440|FG000|Overall Study|Physician Decision|11|||
157099639|NCT01211522|567120441|FG000|Overall Study|Withdrawal by Subject|3|||
157099640|NCT01211522|567120442|FG001|Overall Study|Withdrawal by Subject|7|||
157099641|NCT01211522|567120443|FG002|Overall Study|Withdrawal by Subject|5|||
157099642|NCT01145755|567120444|FG000|Overall Study|Adverse Event|2|||
157099643|NCT01145755|567120445|FG001|Overall Study|Adverse Event|4|||
157099644|NCT01145755|567120446|FG002|Overall Study|Adverse Event|2|||
157099645|NCT01145755|567120444|FG000|Overall Study|Withdrawal by Subject|2|||
157099646|NCT01145755|567120445|FG001|Overall Study|Withdrawal by Subject|2|||
157099647|NCT01145755|567120446|FG002|Overall Study|Withdrawal by Subject|2|||
157099648|NCT01145755|567120444|FG000|Overall Study|Lost to Follow-up|2|||
157099649|NCT01145755|567120445|FG001|Overall Study|Lost to Follow-up|3|||
157099650|NCT01145755|567120446|FG002|Overall Study|Lost to Follow-up|1|||
157099651|NCT01145755|567120444|FG000|Overall Study|Protocol Violation|0|||
157099652|NCT01145755|567120445|FG001|Overall Study|Protocol Violation|3|||
157099653|NCT01145755|567120446|FG002|Overall Study|Protocol Violation|1|||
157099654|NCT01145755|567120444|FG000|Overall Study|Study Closure|14|||
157099655|NCT01145755|567120445|FG001|Overall Study|Study Closure|14|||
157099656|NCT01145755|567120446|FG002|Overall Study|Study Closure|17|||
157099657|NCT01145755|567120444|FG000|Overall Study|Lack of Efficacy|0|||
157099658|NCT01145755|567120445|FG001|Overall Study|Lack of Efficacy|1|||
157099659|NCT01145755|567120446|FG002|Overall Study|Lack of Efficacy|0|||
157099660|NCT01145755|567120444|FG000|Overall Study|Patient could not swollow medication|0|||
157099661|NCT01145755|567120445|FG001|Overall Study|Patient could not swollow medication|0|||
157099662|NCT01145755|567120446|FG002|Overall Study|Patient could not swollow medication|1|||
157099663|NCT01145755|567120444|FG000|Overall Study|Withdrawal by Subject|0|||
157099664|NCT01145755|567120445|FG001|Overall Study|Withdrawal by Subject|0|||
157099665|NCT01145755|567120446|FG002|Overall Study|Withdrawal by Subject|1|||
157099666|NCT01145755|567120444|FG000|Overall Study|Positive urine ethanol|0|||
157099667|NCT01145755|567120445|FG001|Overall Study|Positive urine ethanol|1|||
157099668|NCT01145755|567120446|FG002|Overall Study|Positive urine ethanol|0|||
157099669|NCT00372385|567120453|FG000|Overall Study|Adverse Event|6|||
157099670|NCT00372385|567120454|FG001|Overall Study|Adverse Event|11|||
157099671|NCT00372385|567120455|FG002|Overall Study|Adverse Event|9|||
157099672|NCT00372385|567120456|FG003|Overall Study|Adverse Event|7|||
157099673|NCT00372385|567120453|FG000|Overall Study|Noncompliance|0|||
157099674|NCT00372385|567120454|FG001|Overall Study|Noncompliance|1|||
157099675|NCT00372385|567120455|FG002|Overall Study|Noncompliance|1|||
157099676|NCT00372385|567120456|FG003|Overall Study|Noncompliance|1|||
157099677|NCT00372385|567120453|FG000|Overall Study|Physician Decision|1|||
157099678|NCT00372385|567120454|FG001|Overall Study|Physician Decision|0|||
157099679|NCT00372385|567120455|FG002|Overall Study|Physician Decision|0|||
157099680|NCT00372385|567120456|FG003|Overall Study|Physician Decision|0|||
157099681|NCT00372385|567120453|FG000|Overall Study|Lost to Follow-up|2|||
157099682|NCT00372385|567120454|FG001|Overall Study|Lost to Follow-up|0|||
157099683|NCT00372385|567120455|FG002|Overall Study|Lost to Follow-up|0|||
157099684|NCT00372385|567120456|FG003|Overall Study|Lost to Follow-up|0|||
157099685|NCT00372385|567120453|FG000|Overall Study|Withdrawal by Subject|2|||
157099686|NCT00372385|567120454|FG001|Overall Study|Withdrawal by Subject|1|||
157099687|NCT00372385|567120455|FG002|Overall Study|Withdrawal by Subject|0|||
157099688|NCT00372385|567120456|FG003|Overall Study|Withdrawal by Subject|0|||
157099689|NCT00372385|567120453|FG000|Overall Study|Refusal of Treatment|3|||
157099690|NCT00372385|567120454|FG001|Overall Study|Refusal of Treatment|6|||
157099691|NCT00372385|567120455|FG002|Overall Study|Refusal of Treatment|0|||
157099692|NCT00372385|567120456|FG003|Overall Study|Refusal of Treatment|0|||
157099693|NCT00372385|567120453|FG000|Overall Study|No Response|1|||
157099694|NCT00372385|567120454|FG001|Overall Study|No Response|1|||
157099695|NCT00372385|567120455|FG002|Overall Study|No Response|0|||
157099696|NCT00372385|567120456|FG003|Overall Study|No Response|0|||
156756496|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
156756497|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756498|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
156756499|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
156996836|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
156996837|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Death|3|||
156996838|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Death|0|||
156996839|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Death|0|||
156996840|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
156996841|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156996842|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156996843|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
156996844|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
156996845|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
156996846|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
156996847|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
156996848|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
156996849|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
156996850|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
156996851|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
156996852|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
156996853|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
156996854|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
156996855|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Other|1|||
156996856|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Other|0|||
156996857|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Other|0|||
156996858|NCT02403323|566740968|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
156996859|NCT02403323|566740969|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156996860|NCT02403323|566740970|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156996861|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156996862|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
156996863|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156996864|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
156996865|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
156996866|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
156996867|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
156996868|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
156996869|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
156996870|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156996871|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
156996872|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156996873|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156996874|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
156996875|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
156996876|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156996877|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
156996878|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156996879|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
156996880|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
156996881|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
156996882|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
156996883|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
156996884|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
156996885|NCT02403323|566740968|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
156996886|NCT02403323|566740969|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
156996887|NCT02403323|566740970|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
156996888|NCT03885596|566740974|FG000|Overall Study|Withdrawal by Subject|2|||
156996889|NCT03885596|566740975|FG001|Overall Study|Withdrawal by Subject|1|||
156996890|NCT03885596|566740976|FG002|Overall Study|Withdrawal by Subject|0|||
156996891|NCT03885596|566740977|FG003|Overall Study|Withdrawal by Subject|0|||
156996892|NCT04639947|566740980|FG000|Overall Study|Screen fail|1|||
156996893|NCT00813488|566740981|FG000|Titration Period 1|Adverse Event|6|||
156996894|NCT00813488|566740982|FG001|Titration Period 1|Adverse Event|1|||
156996895|NCT00813488|566740981|FG000|Titration Period 1|Lack of Efficacy|9|||
156996896|NCT00813488|566740982|FG001|Titration Period 1|Lack of Efficacy|7|||
156996897|NCT00813488|566740981|FG000|Titration Period 1|Withdrawal by Subject|2|||
156996898|NCT00813488|566740982|FG001|Titration Period 1|Withdrawal by Subject|2|||
156996899|NCT00813488|566740981|FG000|Titration Period 1|Protocol Violation|4|||
156996900|NCT00813488|566740982|FG001|Titration Period 1|Protocol Violation|3|||
156996901|NCT00813488|566740981|FG000|Titration Period 1|Non-compliance to study medication|4|||
156996902|NCT00813488|566740982|FG001|Titration Period 1|Non-compliance to study medication|1|||
156996903|NCT00813488|566740981|FG000|Titration Period 1|Non-compliance to study procedures|2|||
156996904|NCT00813488|566740982|FG001|Titration Period 1|Non-compliance to study procedures|2|||
156996905|NCT00813488|566740981|FG000|Titration Period 1|Technical Difficulties|0|||
156996906|NCT00813488|566740982|FG001|Titration Period 1|Technical Difficulties|1|||
156996907|NCT00813488|566740981|FG000|Titration Period 2|Adverse Event|2|||
156996908|NCT00813488|566740982|FG001|Titration Period 2|Adverse Event|3|||
156996909|NCT00813488|566740981|FG000|Titration Period 2|Lack of Efficacy|8|||
156996910|NCT00813488|566740982|FG001|Titration Period 2|Lack of Efficacy|4|||
156996911|NCT00813488|566740981|FG000|Titration Period 2|Protocol Violation|3|||
156996912|NCT00813488|566740982|FG001|Titration Period 2|Protocol Violation|2|||
156996913|NCT00813488|566740981|FG000|Titration Period 2|Lost to Follow-up|1|||
156996914|NCT00813488|566740982|FG001|Titration Period 2|Lost to Follow-up|0|||
156996915|NCT00813488|566740981|FG000|Titration Period 2|Non-compliance with study procedures|2|||
156996916|NCT00813488|566740982|FG001|Titration Period 2|Non-compliance with study procedures|1|||
156996917|NCT00813488|566740981|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
156996918|NCT00813488|566740982|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
156996919|NCT00813488|566740981|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
156996920|NCT00813488|566740982|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
156996921|NCT00813488|566740981|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
156996922|NCT00813488|566740982|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
156996923|NCT00813488|566740981|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
156996924|NCT00813488|566740982|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
156996925|NCT00813488|566740981|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
156996926|NCT00813488|566740982|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
156996927|NCT00813488|566740981|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156996928|NCT00813488|566740982|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156996929|NCT00813488|566740981|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
156996930|NCT00813488|566740982|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
156996931|NCT00813488|566740981|FG000|Double-blind Treatment Period 2|Other|1|||
156996932|NCT00813488|566740982|FG001|Double-blind Treatment Period 2|Other|0|||
156996933|NCT00813488|566740981|FG000|Open-label Extension|Adverse Event|1|||
156996934|NCT00813488|566740982|FG001|Open-label Extension|Adverse Event|2|||
156996935|NCT00813488|566740981|FG000|Open-label Extension|Lack of Efficacy|3|||
156996936|NCT00813488|566740982|FG001|Open-label Extension|Lack of Efficacy|0|||
156996937|NCT00813488|566740981|FG000|Open-label Extension|Withdrawal by Subject|0|||
156996938|NCT00813488|566740982|FG001|Open-label Extension|Withdrawal by Subject|2|||
156996939|NCT00813488|566740981|FG000|Open-label Extension|Protocol Violation|1|||
156996940|NCT00813488|566740982|FG001|Open-label Extension|Protocol Violation|2|||
156996941|NCT00813488|566740981|FG000|Open-label Extension|Non-compliance study medication|4|||
156996942|NCT00813488|566740982|FG001|Open-label Extension|Non-compliance study medication|0|||
156996943|NCT00813488|566740981|FG000|Open-label Extension|Non-compliance study procedures|2|||
156996944|NCT00813488|566740982|FG001|Open-label Extension|Non-compliance study procedures|1|||
156996945|NCT00813488|566740981|FG000|Open-label Extension|Other|1|||
156996946|NCT00813488|566740982|FG001|Open-label Extension|Other|0|||
156996947|NCT02926937|566740983|FG000|Overall Study|Adverse Event|0|||
156996948|NCT02926937|566740984|FG001|Overall Study|Adverse Event|1|||
156996949|NCT02926937|566740985|FG002|Overall Study|Adverse Event|1|||
156996950|NCT02926937|566740983|FG000|Overall Study|Poor Compliance to Protocol|1|||
156996951|NCT02926937|566740984|FG001|Overall Study|Poor Compliance to Protocol|0|||
156996952|NCT02926937|566740985|FG002|Overall Study|Poor Compliance to Protocol|0|||
156996953|NCT02926937|566740983|FG000|Overall Study|Lost to Follow-up|4|||
156996954|NCT02926937|566740984|FG001|Overall Study|Lost to Follow-up|5|||
156996955|NCT02926937|566740985|FG002|Overall Study|Lost to Follow-up|0|||
156996956|NCT02926937|566740983|FG000|Overall Study|At the Participant's own Request|11|||
156996957|NCT02926937|566740984|FG001|Overall Study|At the Participant's own Request|5|||
156996958|NCT02926937|566740985|FG002|Overall Study|At the Participant's own Request|8|||
156996959|NCT02926937|566740983|FG000|Overall Study|Reason not Specified|3|||
156996960|NCT02926937|566740984|FG001|Overall Study|Reason not Specified|4|||
156996961|NCT02926937|566740985|FG002|Overall Study|Reason not Specified|2|||
156756500|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156996962|NCT01559090|566740986|FG000|Stage I|Withdrawal by Subject|2|||
156996963|NCT01559090|566740987|FG001|Stage I|Withdrawal by Subject|2|||
156996964|NCT01559090|566740988|FG002|Stage I|Withdrawal by Subject|3|||
156996965|NCT01559090|566740986|FG000|Stage II|Withdrawal by Subject|1|||
156996966|NCT01559090|566740987|FG001|Stage II|Withdrawal by Subject|0|||
156996967|NCT01559090|566740988|FG002|Stage II|Withdrawal by Subject|0|||
156996968|NCT01729871|566740992|FG000|Overall Study|Adverse Event|7|||
156996969|NCT01729871|566740993|FG001|Overall Study|Adverse Event|7|||
156996970|NCT01729871|566740992|FG000|Overall Study|Death|0|||
156996971|NCT01729871|566740993|FG001|Overall Study|Death|1|||
156996972|NCT01729871|566740992|FG000|Overall Study|Lack of Efficacy|0|||
156996973|NCT01729871|566740993|FG001|Overall Study|Lack of Efficacy|1|||
156996974|NCT01729871|566740992|FG000|Overall Study|Physician Decision|0|||
156996975|NCT01729871|566740993|FG001|Overall Study|Physician Decision|2|||
156996976|NCT01729871|566740992|FG000|Overall Study|Protocol Violation|1|||
156996977|NCT01729871|566740993|FG001|Overall Study|Protocol Violation|0|||
156996978|NCT01729871|566740992|FG000|Overall Study|Withdrawal by Subject|0|||
156996979|NCT01729871|566740993|FG001|Overall Study|Withdrawal by Subject|3|||
156996980|NCT01729871|566740992|FG000|Overall Study|Other|4|||
156996981|NCT01729871|566740993|FG001|Overall Study|Other|9|||
156996982|NCT01333514|566740994|FG000|Overall Study|Withdrawal by Subject|1|||
156996983|NCT01333514|566740995|FG001|Overall Study|Withdrawal by Subject|0|||
156996984|NCT00871429|566740996|FG000|Overall Study|Lost to Follow-up|6|||
156996985|NCT00871429|566740996|FG000|Overall Study|Withdrawal by Subject|17|||
156996986|NCT00871429|566740996|FG000|Overall Study|Questionnaire not completed|1|||
156996987|NCT03102242|566740997|FG000|Overall Study|Adverse Event|2|||
156996988|NCT00477412|566740998|FG000|Overall Study|Death|0|||
156996989|NCT00477412|566740999|FG001|Overall Study|Death|0|||
156996990|NCT00477412|566741000|FG002|Overall Study|Death|0|||
156996991|NCT00477412|566741001|FG003|Overall Study|Death|4|||
156996992|NCT00477412|566740998|FG000|Overall Study|Lost to Follow-up|0|||
156996993|NCT00477412|566740999|FG001|Overall Study|Lost to Follow-up|0|||
156996994|NCT00477412|566741000|FG002|Overall Study|Lost to Follow-up|0|||
156996995|NCT00477412|566741001|FG003|Overall Study|Lost to Follow-up|1|||
156996996|NCT00477412|566740998|FG000|Overall Study|Withdrawal by Subject|0|||
156996997|NCT00477412|566740999|FG001|Overall Study|Withdrawal by Subject|0|||
156996998|NCT00477412|566741000|FG002|Overall Study|Withdrawal by Subject|0|||
156996999|NCT00477412|566741001|FG003|Overall Study|Withdrawal by Subject|2|||
156997000|NCT00477412|566740998|FG000|Overall Study|Second Malignancy|0|||
156997001|NCT00477412|566740999|FG001|Overall Study|Second Malignancy|0|||
156997002|NCT00477412|566741000|FG002|Overall Study|Second Malignancy|0|||
156997003|NCT00477412|566741001|FG003|Overall Study|Second Malignancy|1|||
156997004|NCT00477412|566740998|FG000|Overall Study|Adverse Event|1|||
156997005|NCT00477412|566740999|FG001|Overall Study|Adverse Event|0|||
156997006|NCT00477412|566741000|FG002|Overall Study|Adverse Event|1|||
156997007|NCT00477412|566741001|FG003|Overall Study|Adverse Event|0|||
156997008|NCT00662909|566741003|FG000|Overall Study|Adverse Event|17|||
156997009|NCT00662909|566741004|FG001|Overall Study|Adverse Event|18|||
156997010|NCT00662909|566741005|FG002|Overall Study|Adverse Event|19|||
156997011|NCT00662909|566741003|FG000|Overall Study|Lack of Efficacy|9|||
156997012|NCT00662909|566741004|FG001|Overall Study|Lack of Efficacy|1|||
156997013|NCT00662909|566741005|FG002|Overall Study|Lack of Efficacy|5|||
156997014|NCT00662909|566741003|FG000|Overall Study|Withdrawal by Subject|29|||
156997015|NCT00662909|566741004|FG001|Overall Study|Withdrawal by Subject|22|||
156997016|NCT00662909|566741005|FG002|Overall Study|Withdrawal by Subject|16|||
156997017|NCT00662909|566741003|FG000|Overall Study|Lost to Follow-up|2|||
156997018|NCT00662909|566741004|FG001|Overall Study|Lost to Follow-up|9|||
156997019|NCT00662909|566741005|FG002|Overall Study|Lost to Follow-up|3|||
156997020|NCT00662909|566741003|FG000|Overall Study|Protocol Violation|7|||
156997021|NCT00662909|566741004|FG001|Overall Study|Protocol Violation|4|||
156997022|NCT00662909|566741005|FG002|Overall Study|Protocol Violation|5|||
156997023|NCT00662909|566741003|FG000|Overall Study|Randomized- never received study drug|1|||
156997024|NCT00662909|566741004|FG001|Overall Study|Randomized- never received study drug|0|||
156997025|NCT00662909|566741005|FG002|Overall Study|Randomized- never received study drug|0|||
156997026|NCT00662909|566741003|FG000|Overall Study|Non-compliance with study procedures|3|||
156997027|NCT00662909|566741004|FG001|Overall Study|Non-compliance with study procedures|3|||
156997028|NCT00662909|566741005|FG002|Overall Study|Non-compliance with study procedures|2|||
156997029|NCT00662909|566741003|FG000|Overall Study|Physician Decision|1|||
156997030|NCT00662909|566741004|FG001|Overall Study|Physician Decision|1|||
156997031|NCT00662909|566741005|FG002|Overall Study|Physician Decision|2|||
156997032|NCT00662909|566741003|FG000|Overall Study|Eligibility criterion not met|0|||
156997033|NCT00662909|566741004|FG001|Overall Study|Eligibility criterion not met|1|||
156997034|NCT00662909|566741005|FG002|Overall Study|Eligibility criterion not met|1|||
156997035|NCT04257058|566742597|FG000|Overall Study|Lost to Follow-up|31|||
156997036|NCT04199728|566742602|FG000|Overall Study|Adverse Event|1|||
156997037|NCT04199728|566742603|FG001|Overall Study|Adverse Event|0|||
156997038|NCT04199728|566742602|FG000|Overall Study|Withdrawal by Subject|8|||
156997039|NCT04199728|566742603|FG001|Overall Study|Withdrawal by Subject|3|||
156997040|NCT04199728|566742602|FG000|Overall Study|Screen fail after consent|0|||
156997041|NCT04199728|566742603|FG001|Overall Study|Screen fail after consent|1|||
156997042|NCT04199728|566742602|FG000|Overall Study|Early withdraw criteria met|0|||
156997043|NCT04199728|566742603|FG001|Overall Study|Early withdraw criteria met|1|||
156997044|NCT04199728|566742602|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
156997045|NCT04199728|566742603|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
156997046|NCT04057196|566742604|FG000|Overall Study|Withdrawal by Subject|3|||
156997047|NCT04057196|566742604|FG000|Overall Study|Death|3|||
156997048|NCT00109967|566742610|FG000|Overall Study|Cancel Prior to Treatment|2|||
156997049|NCT00109967|566742611|FG001|Overall Study|Cancel Prior to Treatment|0|||
157099697|NCT00372385|567120453|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
157099698|NCT00372385|567120454|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
156997050|NCT00109967|566742610|FG000|Overall Study|Adverse Event|12|||
156997051|NCT00109967|566742611|FG001|Overall Study|Adverse Event|1|||
156997052|NCT00109967|566742610|FG000|Overall Study|Withdrawal by Subject|5|||
156997053|NCT00109967|566742611|FG001|Overall Study|Withdrawal by Subject|0|||
156997054|NCT00109967|566742610|FG000|Overall Study|Physician Decision|1|||
156997055|NCT00109967|566742611|FG001|Overall Study|Physician Decision|3|||
156997056|NCT00109967|566742610|FG000|Overall Study|Death|0|||
156997057|NCT00109967|566742611|FG001|Overall Study|Death|2|||
156997058|NCT02715258|566742618|FG000|Overall Study|Withdrawal by Subject|6|||
156997059|NCT02715258|566742619|FG001|Overall Study|Withdrawal by Subject|1|||
156997060|NCT02715258|566742618|FG000|Overall Study|Lost to Follow-up|7|||
156997061|NCT02715258|566742619|FG001|Overall Study|Lost to Follow-up|1|||
156997062|NCT02715258|566742618|FG000|Overall Study|Terminated by Sponsor|0|||
156997063|NCT02715258|566742619|FG001|Overall Study|Terminated by Sponsor|1|||
156997064|NCT02715258|566742618|FG000|Overall Study|Death|0|||
156997065|NCT02715258|566742619|FG001|Overall Study|Death|1|||
156997066|NCT02715258|566742618|FG000|Overall Study|Subject non-compliant|1|||
156997067|NCT02715258|566742619|FG001|Overall Study|Subject non-compliant|1|||
156997068|NCT02715258|566742618|FG000|Overall Study|GCP violation|2|||
156997069|NCT02715258|566742619|FG001|Overall Study|GCP violation|1|||
156997070|NCT02263508|566742620|FG000|Overall Study|Withdrawal by Subject|1|||
156997071|NCT02263508|566742621|FG001|Overall Study|Withdrawal by Subject|23|||
156997072|NCT02263508|566742622|FG002|Overall Study|Withdrawal by Subject|17|||
156997073|NCT02263508|566742620|FG000|Overall Study|Sponsor Decision|12|||
156997074|NCT02263508|566742621|FG001|Overall Study|Sponsor Decision|165|||
156997075|NCT02263508|566742622|FG002|Overall Study|Sponsor Decision|182|||
156997076|NCT02263508|566742620|FG000|Overall Study|Lost to Follow-up|2|||
156997077|NCT02263508|566742621|FG001|Overall Study|Lost to Follow-up|7|||
156997078|NCT02263508|566742622|FG002|Overall Study|Lost to Follow-up|7|||
156997079|NCT02263508|566742620|FG000|Overall Study|Death|6|||
156997080|NCT02263508|566742621|FG001|Overall Study|Death|151|||
156997081|NCT02263508|566742622|FG002|Overall Study|Death|140|||
156997082|NCT01117480|566742623|FG000|Overall Study|Protocol Violation|8|||
156997083|NCT01117480|566742623|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
156997084|NCT04148937|566742625|FG000|Overall Study|Withdrawal by Subject|0|||
156997085|NCT04148937|566742626|FG001|Overall Study|Withdrawal by Subject|0|||
156997086|NCT04148937|566742627|FG002|Overall Study|Withdrawal by Subject|0|||
156997087|NCT04148937|566742628|FG003|Overall Study|Withdrawal by Subject|1|||
156997088|NCT04148937|566742629|FG004|Overall Study|Withdrawal by Subject|0|||
156997089|NCT04148937|566742630|FG005|Overall Study|Withdrawal by Subject|1|||
156997090|NCT04148937|566742631|FG006|Overall Study|Withdrawal by Subject|1|||
156997091|NCT04148937|566742632|FG007|Overall Study|Withdrawal by Subject|0|||
156997092|NCT04148937|566742625|FG000|Overall Study|Lost to Follow-up|0|||
156997093|NCT04148937|566742626|FG001|Overall Study|Lost to Follow-up|0|||
156997094|NCT04148937|566742627|FG002|Overall Study|Lost to Follow-up|1|||
156997095|NCT04148937|566742628|FG003|Overall Study|Lost to Follow-up|0|||
156997096|NCT04148937|566742629|FG004|Overall Study|Lost to Follow-up|0|||
156997097|NCT04148937|566742630|FG005|Overall Study|Lost to Follow-up|2|||
156997098|NCT04148937|566742631|FG006|Overall Study|Lost to Follow-up|0|||
156997099|NCT04148937|566742632|FG007|Overall Study|Lost to Follow-up|0|||
156997100|NCT01259102|566742633|FG000|Overall Study|Adverse Event|1|||
156997101|NCT01259102|566742634|FG001|Overall Study|Adverse Event|0|||
156997102|NCT01259102|566742635|FG002|Overall Study|Adverse Event|1|||
156997103|NCT01259102|566742636|FG003|Overall Study|Adverse Event|1|||
156997104|NCT01259102|566742637|FG004|Overall Study|Adverse Event|0|||
156997105|NCT01259102|566742633|FG000|Overall Study|Other|0|||
156997106|NCT01259102|566742634|FG001|Overall Study|Other|0|||
156997107|NCT01259102|566742635|FG002|Overall Study|Other|1|||
156997108|NCT01259102|566742636|FG003|Overall Study|Other|1|||
156997109|NCT01259102|566742637|FG004|Overall Study|Other|1|||
156997110|NCT00686517|566742639|FG000|Treatment|Serious Adverse Event|1|||
157099699|NCT00372385|567120455|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
157099700|NCT00372385|567120456|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
157099701|NCT00372385|567120453|FG000|Overall Study|Virologic Stopping Rule|17|||
157099702|NCT00372385|567120454|FG001|Overall Study|Virologic Stopping Rule|0|||
156997111|NCT00686517|566742640|FG001|Treatment|Serious Adverse Event|2|||
156997112|NCT00686517|566742641|FG002|Treatment|Serious Adverse Event|1|||
156997113|NCT00686517|566742639|FG000|Treatment|Adverse Event|2|||
157099703|NCT00372385|567120455|FG002|Overall Study|Virologic Stopping Rule|0|||
157099704|NCT00372385|567120456|FG003|Overall Study|Virologic Stopping Rule|0|||
156997114|NCT00686517|566742640|FG001|Treatment|Adverse Event|0|||
156997115|NCT00686517|566742641|FG002|Treatment|Adverse Event|0|||
156997116|NCT00686517|566742639|FG000|Treatment|Poor Protocol Compliance|1|||
156997117|NCT00686517|566742640|FG001|Treatment|Poor Protocol Compliance|0|||
156997118|NCT00686517|566742641|FG002|Treatment|Poor Protocol Compliance|0|||
156997119|NCT00686517|566742639|FG000|Treatment|Protocol Violation|2|||
156997120|NCT00686517|566742640|FG001|Treatment|Protocol Violation|1|||
156997121|NCT00686517|566742641|FG002|Treatment|Protocol Violation|0|||
156997122|NCT01803646|566742642|FG000|Overall Study|Protocol Violation|1|||
156997123|NCT01803646|566742643|FG001|Overall Study|Protocol Violation|0|||
156997124|NCT01803646|566742642|FG000|Overall Study|Adverse Event|1|||
156997125|NCT01803646|566742643|FG001|Overall Study|Adverse Event|1|||
156997126|NCT01803646|566742642|FG000|Overall Study|Withdrawal by Subject|9|||
156997127|NCT01803646|566742643|FG001|Overall Study|Withdrawal by Subject|6|||
156997128|NCT01803646|566742642|FG000|Overall Study|Randomization error|1|||
156997129|NCT01803646|566742643|FG001|Overall Study|Randomization error|2|||
156997130|NCT01803646|566742642|FG000|Overall Study|Lost to Follow-up|5|||
156997131|NCT01803646|566742643|FG001|Overall Study|Lost to Follow-up|1|||
156997132|NCT01072357|566742646|FG000|Overall Study|Lost to Follow-up|0|||
156997133|NCT01072357|566742647|FG001|Overall Study|Lost to Follow-up|1|||
156997134|NCT01876511|566742648|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
156997135|NCT01876511|566742649|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
156997136|NCT01876511|566742650|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
156997137|NCT01876511|566742648|FG000|Overall Study|Death (unrelated)|3|||
156997138|NCT01876511|566742649|FG001|Overall Study|Death (unrelated)|0|||
156997139|NCT01876511|566742650|FG002|Overall Study|Death (unrelated)|2|||
156997140|NCT01876511|566742648|FG000|Overall Study|Drug-related Toxicity|5|||
156997141|NCT01876511|566742649|FG001|Overall Study|Drug-related Toxicity|1|||
156997142|NCT01876511|566742650|FG002|Overall Study|Drug-related Toxicity|6|||
156997143|NCT01876511|566742648|FG000|Overall Study|Patient Decision|3|||
156997144|NCT01876511|566742649|FG001|Overall Study|Patient Decision|0|||
156997145|NCT01876511|566742650|FG002|Overall Study|Patient Decision|6|||
156997146|NCT01876511|566742648|FG000|Overall Study|Physician Decision|1|||
156997147|NCT01876511|566742649|FG001|Overall Study|Physician Decision|0|||
156997148|NCT01876511|566742650|FG002|Overall Study|Physician Decision|1|||
156997149|NCT01048788|566742651|FG000|Overall Study|Adverse Event|5|||
156997150|NCT01048788|566742652|FG001|Overall Study|Adverse Event|1|||
156997151|NCT01048788|566742653|FG002|Overall Study|Adverse Event|1|||
156997152|NCT01048788|566742651|FG000|Overall Study|Lack of Efficacy|0|||
156997153|NCT01048788|566742652|FG001|Overall Study|Lack of Efficacy|0|||
156997154|NCT01048788|566742653|FG002|Overall Study|Lack of Efficacy|1|||
156997155|NCT01048788|566742651|FG000|Overall Study|Withdrawal by Subject|0|||
156997156|NCT01048788|566742652|FG001|Overall Study|Withdrawal by Subject|1|||
156997157|NCT01048788|566742653|FG002|Overall Study|Withdrawal by Subject|0|||
156997158|NCT02145182|566742654|FG000|Overall Study|Adverse Event|4|||
156997159|NCT02145182|566742655|FG001|Overall Study|Adverse Event|1|||
156997160|NCT02145182|566742654|FG000|Overall Study|Death|7|||
156997161|NCT02145182|566742655|FG001|Overall Study|Death|7|||
156997162|NCT02145182|566742654|FG000|Overall Study|Lost to Follow-up|2|||
156997163|NCT02145182|566742655|FG001|Overall Study|Lost to Follow-up|2|||
156997164|NCT02145182|566742654|FG000|Overall Study|Pre-transplant Withdrawal|0|||
156997165|NCT02145182|566742655|FG001|Overall Study|Pre-transplant Withdrawal|2|||
156997166|NCT02145182|566742654|FG000|Overall Study|Withdrawal by Subject|5|||
156997167|NCT02145182|566742655|FG001|Overall Study|Withdrawal by Subject|4|||
156997168|NCT01196988|566742656|FG000|Overall Study|Adverse Event|1|||
156997169|NCT01196988|566742657|FG001|Overall Study|Adverse Event|2|||
156997170|NCT01196988|566742658|FG002|Overall Study|Adverse Event|0|||
156997171|NCT01196988|566742659|FG003|Overall Study|Adverse Event|0|||
156997172|NCT01196988|566742656|FG000|Overall Study|Withdrawal by Subject|5|||
156997173|NCT01196988|566742657|FG001|Overall Study|Withdrawal by Subject|1|||
156997174|NCT01196988|566742658|FG002|Overall Study|Withdrawal by Subject|4|||
156997175|NCT01196988|566742659|FG003|Overall Study|Withdrawal by Subject|0|||
156997176|NCT01196988|566742656|FG000|Overall Study|Lost to Follow-up|16|||
156997177|NCT01196988|566742657|FG001|Overall Study|Lost to Follow-up|29|||
156997178|NCT01196988|566742658|FG002|Overall Study|Lost to Follow-up|21|||
156997179|NCT01196988|566742659|FG003|Overall Study|Lost to Follow-up|1|||
157099705|NCT01966471|567120457|FG000|Overall Study|Death|44|||
156997180|NCT01196988|566742656|FG000|Overall Study|Other|2|||
156997181|NCT01196988|566742657|FG001|Overall Study|Other|0|||
156997182|NCT01196988|566742658|FG002|Overall Study|Other|0|||
156997183|NCT01196988|566742659|FG003|Overall Study|Other|0|||
156997184|NCT01233050|566742660|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
156997185|NCT01233050|566742661|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
156997186|NCT03999554|566742664|FG000|Overall Study|Lost to Follow-up|4|||
156997187|NCT03999554|566742665|FG001|Overall Study|Lost to Follow-up|5|||
156997188|NCT03999554|566742666|FG002|Overall Study|Lost to Follow-up|4|||
156997189|NCT03999554|566742667|FG003|Overall Study|Lost to Follow-up|5|||
156997190|NCT03999554|566742668|FG004|Overall Study|Lost to Follow-up|8|||
156997191|NCT03999554|566742664|FG000|Overall Study|Protocol Violation|0|||
156997192|NCT03999554|566742665|FG001|Overall Study|Protocol Violation|0|||
156997193|NCT03999554|566742666|FG002|Overall Study|Protocol Violation|5|||
156997194|NCT03999554|566742667|FG003|Overall Study|Protocol Violation|0|||
156997195|NCT03999554|566742668|FG004|Overall Study|Protocol Violation|0|||
156997196|NCT03999554|566742664|FG000|Overall Study|Pregnancy|0|||
156997197|NCT03999554|566742665|FG001|Overall Study|Pregnancy|0|||
156997198|NCT03999554|566742666|FG002|Overall Study|Pregnancy|1|||
157099706|NCT01966471|567120458|FG001|Overall Study|Death|56|||
156756501|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756502|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756503|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756504|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756505|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756506|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756507|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756508|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756509|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756510|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756511|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156997199|NCT03999554|566742667|FG003|Overall Study|Pregnancy|0|||
156997200|NCT03999554|566742668|FG004|Overall Study|Pregnancy|0|||
156997201|NCT03999554|566742664|FG000|Overall Study|Withdrawal by Subject|2|||
156997202|NCT03999554|566742665|FG001|Overall Study|Withdrawal by Subject|2|||
156997203|NCT03999554|566742666|FG002|Overall Study|Withdrawal by Subject|2|||
156997204|NCT03999554|566742667|FG003|Overall Study|Withdrawal by Subject|1|||
156997205|NCT03999554|566742668|FG004|Overall Study|Withdrawal by Subject|1|||
156997206|NCT03999554|566742664|FG000|Overall Study|failure to comply with protocol requirements|0|||
156997207|NCT03999554|566742665|FG001|Overall Study|failure to comply with protocol requirements|0|||
156997208|NCT03999554|566742666|FG002|Overall Study|failure to comply with protocol requirements|0|||
156997209|NCT03999554|566742667|FG003|Overall Study|failure to comply with protocol requirements|1|||
156997210|NCT03999554|566742668|FG004|Overall Study|failure to comply with protocol requirements|0|||
156997211|NCT02082158|566742669|FG000|Overall Study|Withdrawal by Subject|0|||
156997212|NCT02082158|566742670|FG001|Overall Study|Withdrawal by Subject|0|||
156997213|NCT02082158|566742671|FG002|Overall Study|Withdrawal by Subject|0|||
156997214|NCT02082158|566742672|FG003|Overall Study|Withdrawal by Subject|0|||
156997215|NCT02082158|566742673|FG004|Overall Study|Withdrawal by Subject|1|||
156997216|NCT02082158|566742674|FG005|Overall Study|Withdrawal by Subject|0|||
156997217|NCT02082158|566742669|FG000|Overall Study|Failed Fit-testing|8|||
156997218|NCT02082158|566742670|FG001|Overall Study|Failed Fit-testing|8|||
156997219|NCT02082158|566742671|FG002|Overall Study|Failed Fit-testing|14|||
156997220|NCT02082158|566742672|FG003|Overall Study|Failed Fit-testing|4|||
156997221|NCT02082158|566742673|FG004|Overall Study|Failed Fit-testing|3|||
156997222|NCT02082158|566742674|FG005|Overall Study|Failed Fit-testing|7|||
156997223|NCT04304534|566742675|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
156997224|NCT04304534|566742676|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
156997225|NCT04304534|566742677|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
156997226|NCT04304534|566742678|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
156997227|NCT04304534|566742675|FG000|Overall Study|Non-Compliance with study drug|0|||
156997228|NCT04304534|566742676|FG001|Overall Study|Non-Compliance with study drug|1|||
156997229|NCT04304534|566742677|FG002|Overall Study|Non-Compliance with study drug|1|||
156997230|NCT04304534|566742678|FG003|Overall Study|Non-Compliance with study drug|1|||
156997231|NCT04304534|566742675|FG000|Overall Study|Lost to Follow-up|0|||
156997232|NCT04304534|566742676|FG001|Overall Study|Lost to Follow-up|1|||
156997233|NCT04304534|566742677|FG002|Overall Study|Lost to Follow-up|2|||
156997234|NCT04304534|566742678|FG003|Overall Study|Lost to Follow-up|3|||
156997235|NCT04304534|566742675|FG000|Overall Study|Unspecific|4|||
156997236|NCT04304534|566742676|FG001|Overall Study|Unspecific|2|||
156997237|NCT04304534|566742677|FG002|Overall Study|Unspecific|2|||
156997238|NCT04304534|566742678|FG003|Overall Study|Unspecific|2|||
156997239|NCT04304534|566742675|FG000|Overall Study|Technical Problems|2|||
156997240|NCT04304534|566742676|FG001|Overall Study|Technical Problems|2|||
156997241|NCT04304534|566742677|FG002|Overall Study|Technical Problems|3|||
156997242|NCT04304534|566742678|FG003|Overall Study|Technical Problems|4|||
156997243|NCT04304534|566742675|FG000|Overall Study|Death|7|||
156997244|NCT04304534|566742676|FG001|Overall Study|Death|2|||
156997245|NCT04304534|566742677|FG002|Overall Study|Death|4|||
156997246|NCT04304534|566742678|FG003|Overall Study|Death|3|||
156997247|NCT04304534|566742675|FG000|Overall Study|Withdrawal by Subject|7|||
156997248|NCT04304534|566742676|FG001|Overall Study|Withdrawal by Subject|2|||
156997249|NCT04304534|566742677|FG002|Overall Study|Withdrawal by Subject|7|||
156997250|NCT04304534|566742678|FG003|Overall Study|Withdrawal by Subject|4|||
156997251|NCT04304534|566742675|FG000|Overall Study|Physician Decision|4|||
156997252|NCT04304534|566742676|FG001|Overall Study|Physician Decision|9|||
156997253|NCT04304534|566742677|FG002|Overall Study|Physician Decision|9|||
156997254|NCT04304534|566742678|FG003|Overall Study|Physician Decision|5|||
156997255|NCT04304534|566742675|FG000|Overall Study|Subject Decision|34|||
156997256|NCT04304534|566742676|FG001|Overall Study|Subject Decision|25|||
156997257|NCT04304534|566742677|FG002|Overall Study|Subject Decision|25|||
156997258|NCT04304534|566742678|FG003|Overall Study|Subject Decision|26|||
156997259|NCT04304534|566742675|FG000|Overall Study|Adverse Event|35|||
156997260|NCT04304534|566742676|FG001|Overall Study|Adverse Event|40|||
156997261|NCT04304534|566742677|FG002|Overall Study|Adverse Event|39|||
156997262|NCT04304534|566742678|FG003|Overall Study|Adverse Event|44|||
156997263|NCT04012853|566742679|FG000|Overall Study|Withdrawal by Subject|1|||
156997264|NCT04012853|566742680|FG001|Overall Study|Withdrawal by Subject|1|||
156997265|NCT04012853|566742679|FG000|Overall Study|Protocol Violation|1|||
156997266|NCT04012853|566742680|FG001|Overall Study|Protocol Violation|0|||
156997267|NCT04012853|566742679|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
156997268|NCT04012853|566742680|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
156997269|NCT01695317|566742681|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
156997270|NCT01695317|566742682|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
156997271|NCT01695317|566742681|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
156997272|NCT01695317|566742682|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
156997273|NCT00464672|566742683|FG000|Overall Study|withdrawal of consent|0|||
156997274|NCT00464672|566742684|FG001|Overall Study|withdrawal of consent|0|||
156997275|NCT00464672|566742685|FG002|Overall Study|withdrawal of consent|0|||
156997276|NCT00464672|566742686|FG003|Overall Study|withdrawal of consent|1|||
156997277|NCT00464672|566742687|FG004|Overall Study|withdrawal of consent|9|||
156997278|NCT00464672|566742688|FG005|Overall Study|withdrawal of consent|4|||
156997279|NCT00464672|566742683|FG000|Overall Study|Lost to Follow-up|25|||
156997280|NCT00464672|566742684|FG001|Overall Study|Lost to Follow-up|10|||
156997281|NCT00464672|566742685|FG002|Overall Study|Lost to Follow-up|0|||
156997282|NCT00464672|566742686|FG003|Overall Study|Lost to Follow-up|0|||
156997283|NCT00464672|566742687|FG004|Overall Study|Lost to Follow-up|1|||
156997284|NCT00464672|566742688|FG005|Overall Study|Lost to Follow-up|0|||
156997285|NCT03055767|566742689|FG000|Open-Label Period|Lost to Follow-up|0|||
156997286|NCT03055767|566742690|FG001|Open-Label Period|Lost to Follow-up|0|||
156997287|NCT03055767|566742691|FG002|Open-Label Period|Lost to Follow-up|2|||
156997288|NCT03055767|566742692|FG003|Open-Label Period|Lost to Follow-up|0|||
156997289|NCT03055767|566742689|FG000|Open-Label Period|Withdrawal by Subject|0|||
156997290|NCT03055767|566742690|FG001|Open-Label Period|Withdrawal by Subject|0|||
156997291|NCT03055767|566742691|FG002|Open-Label Period|Withdrawal by Subject|0|||
156997292|NCT03055767|566742692|FG003|Open-Label Period|Withdrawal by Subject|1|||
156997293|NCT01466881|566742693|FG000|Overall Study|Ineligible|5|||
156997294|NCT01466881|566742693|FG000|Overall Study|Adverse Event|6|||
156997295|NCT01466881|566742693|FG000|Overall Study|Progression/relapse|20|||
156997296|NCT01466881|566742693|FG000|Overall Study|Death|4|||
156997297|NCT01466881|566742693|FG000|Overall Study|Other reason not protocol specified|5|||
156997298|NCT04580303|566742694|FG000|Overall Study|Adverse Event|0|||
156997299|NCT04580303|566742695|FG001|Overall Study|Adverse Event|1|||
156997300|NCT04580303|566742696|FG002|Overall Study|Adverse Event|0|||
156997301|NCT04580303|566742697|FG003|Overall Study|Adverse Event|0|||
156997302|NCT04580303|566742694|FG000|Overall Study|Withdrawal by Subject|0|||
156997303|NCT04580303|566742695|FG001|Overall Study|Withdrawal by Subject|0|||
156997304|NCT04580303|566742696|FG002|Overall Study|Withdrawal by Subject|1|||
156997305|NCT04580303|566742697|FG003|Overall Study|Withdrawal by Subject|0|||
156997306|NCT01456936|566742701|FG000|Overall Study|Other reason|41|||
156997307|NCT01456936|566742702|FG001|Overall Study|Other reason|30|||
156997308|NCT01456936|566742703|FG002|Overall Study|Other reason|36|||
156997309|NCT01456936|566742704|FG003|Overall Study|Other reason|33|||
156997310|NCT01456936|566742701|FG000|Overall Study|No longer meets eligibility criteria|4|||
156997311|NCT01456936|566742702|FG001|Overall Study|No longer meets eligibility criteria|8|||
156997312|NCT01456936|566742703|FG002|Overall Study|No longer meets eligibility criteria|6|||
156997313|NCT01456936|566742704|FG003|Overall Study|No longer meets eligibility criteria|5|||
156997314|NCT01456936|566742701|FG000|Overall Study|Protocol Violation|4|||
156997315|NCT01456936|566742702|FG001|Overall Study|Protocol Violation|2|||
156997316|NCT01456936|566742703|FG002|Overall Study|Protocol Violation|5|||
156997317|NCT01456936|566742704|FG003|Overall Study|Protocol Violation|5|||
156997318|NCT01456936|566742701|FG000|Overall Study|Pregnancy|1|||
156997319|NCT01456936|566742702|FG001|Overall Study|Pregnancy|0|||
156997320|NCT01456936|566742703|FG002|Overall Study|Pregnancy|0|||
156997321|NCT01456936|566742704|FG003|Overall Study|Pregnancy|1|||
156997322|NCT01456936|566742701|FG000|Overall Study|Insufficient clinical response|4|||
156997323|NCT01456936|566742702|FG001|Overall Study|Insufficient clinical response|4|||
156997324|NCT01456936|566742703|FG002|Overall Study|Insufficient clinical response|14|||
156997325|NCT01456936|566742704|FG003|Overall Study|Insufficient clinical response|13|||
156997326|NCT01456936|566742701|FG000|Overall Study|No longer willing to participate|195|||
156997327|NCT01456936|566742702|FG001|Overall Study|No longer willing to participate|218|||
156997328|NCT01456936|566742703|FG002|Overall Study|No longer willing to participate|224|||
156997329|NCT01456936|566742704|FG003|Overall Study|No longer willing to participate|248|||
156997330|NCT01456936|566742701|FG000|Overall Study|Lost to Follow-up|135|||
156997331|NCT01456936|566742702|FG001|Overall Study|Lost to Follow-up|126|||
156997332|NCT01456936|566742703|FG002|Overall Study|Lost to Follow-up|144|||
156997333|NCT01456936|566742704|FG003|Overall Study|Lost to Follow-up|127|||
156997334|NCT01456936|566742701|FG000|Overall Study|Medication error|0|||
156997335|NCT01456936|566742702|FG001|Overall Study|Medication error|1|||
156756512|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756513|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756514|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756515|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
156756516|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
156756517|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756518|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756519|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756520|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756521|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756522|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756523|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156997336|NCT01456936|566742703|FG002|Overall Study|Medication error|0|||
156997337|NCT01456936|566742704|FG003|Overall Study|Medication error|1|||
156997338|NCT01456936|566742701|FG000|Overall Study|Adverse event (study drug)|25|||
156997339|NCT01456936|566742702|FG001|Overall Study|Adverse event (study drug)|21|||
156997340|NCT01456936|566742703|FG002|Overall Study|Adverse event (study drug)|26|||
156997341|NCT01456936|566742704|FG003|Overall Study|Adverse event (study drug)|17|||
156997342|NCT01456936|566742701|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
156997343|NCT01456936|566742702|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
156997344|NCT01456936|566742703|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
156997345|NCT01456936|566742704|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
156997346|NCT01456936|566742701|FG000|Overall Study|Death|0|||
156997347|NCT01456936|566742702|FG001|Overall Study|Death|3|||
156997348|NCT01456936|566742703|FG002|Overall Study|Death|1|||
156997349|NCT01456936|566742704|FG003|Overall Study|Death|3|||
156997350|NCT01456936|566742701|FG000|Overall Study|Randomized but not treated|21|||
156997351|NCT01456936|566742702|FG001|Overall Study|Randomized but not treated|28|||
156997352|NCT01456936|566742703|FG002|Overall Study|Randomized but not treated|16|||
156997353|NCT01456936|566742704|FG003|Overall Study|Randomized but not treated|21|||
156997354|NCT02317705|566742705|FG000|Overall Study|Withdrawal by Subject|3|||
156997355|NCT02317705|566742705|FG000|Overall Study|Physician Decision|1|||
156997356|NCT02317705|566742705|FG000|Overall Study|Drug not usable|1|||
156997357|NCT01674569|566742706|FG000|Overall Study|Adverse Event|0|||
156997358|NCT01674569|566742707|FG001|Overall Study|Adverse Event|2|||
156997359|NCT01674569|566742708|FG002|Overall Study|Adverse Event|0|||
156997360|NCT01674569|566742709|FG003|Overall Study|Adverse Event|1|||
156997361|NCT01674569|566742710|FG004|Overall Study|Adverse Event|2|||
156997362|NCT01674569|566742711|FG005|Overall Study|Adverse Event|2|||
156997363|NCT01674569|566742706|FG000|Overall Study|Protocol Violation|0|||
156997364|NCT01674569|566742707|FG001|Overall Study|Protocol Violation|1|||
156997365|NCT01674569|566742708|FG002|Overall Study|Protocol Violation|1|||
156997366|NCT01674569|566742709|FG003|Overall Study|Protocol Violation|0|||
156997367|NCT01674569|566742710|FG004|Overall Study|Protocol Violation|0|||
156997368|NCT01674569|566742711|FG005|Overall Study|Protocol Violation|0|||
156997369|NCT01674569|566742706|FG000|Overall Study|Withdrawal by Subject|0|||
156997370|NCT01674569|566742707|FG001|Overall Study|Withdrawal by Subject|0|||
156997371|NCT01674569|566742708|FG002|Overall Study|Withdrawal by Subject|1|||
156997372|NCT01674569|566742709|FG003|Overall Study|Withdrawal by Subject|0|||
156997373|NCT01674569|566742710|FG004|Overall Study|Withdrawal by Subject|0|||
156997374|NCT01674569|566742711|FG005|Overall Study|Withdrawal by Subject|0|||
156997375|NCT01599325|566742712|FG000|Primary Parent Phase|Adverse Event|5|||
156997376|NCT01599325|566742712|FG000|Primary Parent Phase|Disease Progression|7|||
156997377|NCT01599325|566742712|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
156997378|NCT01599325|566742712|FG000|Primary Parent Phase|Death|13|||
156997379|NCT01599325|566742712|FG000|Primary Parent Phase|Protocol Violation|1|||
156997380|NCT01599325|566742712|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
156997381|NCT01599325|566742712|FG000|Primary Parent Phase|Other|2|||
156997382|NCT01599325|566742712|FG000|Extension Phase|Study Closure|1|||
156756524|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756525|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756526|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756527|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156997383|NCT01599325|566742712|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
156997384|NCT01599325|566742712|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
156997385|NCT01599325|566742712|FG000|Extension Phase|Disease Progression|1|||
156997386|NCT01599325|566742712|FG000|Extension Phase|Withdrawal by Subject|8|||
156997387|NCT01878890|566742713|FG000|Overall Study|Protocol Violation|0|||
156997388|NCT01878890|566742714|FG001|Overall Study|Protocol Violation|1|||
156997389|NCT01878890|566742715|FG002|Overall Study|Protocol Violation|0|||
156997390|NCT01878890|566742716|FG003|Overall Study|Protocol Violation|0|||
156997391|NCT01710514|566742718|FG000|Overall Study|Adverse Event|6|||
156997392|NCT01710514|566742719|FG001|Overall Study|Adverse Event|7|||
157099707|NCT01966471|567120457|FG000|Overall Study|Lost to Follow-up|46|||
157099708|NCT01966471|567120458|FG001|Overall Study|Lost to Follow-up|39|||
157099709|NCT01966471|567120457|FG000|Overall Study|Various reasons|4|||
157099710|NCT01966471|567120458|FG001|Overall Study|Various reasons|4|||
157099711|NCT01966471|567120457|FG000|Overall Study|Physician Decision|7|||
157099712|NCT01966471|567120458|FG001|Overall Study|Physician Decision|5|||
157099713|NCT01966471|567120457|FG000|Overall Study|Study Terminated By Sponsor|758|||
157099714|NCT01966471|567120458|FG001|Overall Study|Study Terminated By Sponsor|773|||
157099715|NCT01966471|567120457|FG000|Overall Study|Withdrawal by Subject|59|||
157099716|NCT01966471|567120458|FG001|Overall Study|Withdrawal by Subject|51|||
157099717|NCT01030198|567120462|FG000|Overall Study|Could not measure efficacy accurately|0|||
157099718|NCT01030198|567120463|FG001|Overall Study|Could not measure efficacy accurately|7|||
157099719|NCT03431857|567120464|FG000|Overall Study|Death|6|||
157099720|NCT03431857|567120464|FG000|Overall Study|Lost to Follow-up|41|||
157099721|NCT03431857|567120464|FG000|Overall Study|Adverse Event|6|||
157099722|NCT03431857|567120464|FG000|Overall Study|Withdrawal by Subject|1|||
157099723|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
157099724|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
157099725|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
157099726|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
157099727|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
157099728|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
157099729|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
157099730|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
157099731|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
157099732|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
157099733|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
157099734|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
157099735|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
157099736|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
157099737|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
157099738|NCT01323621|567120465|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
157099739|NCT01323621|567120466|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
157099740|NCT01323621|567120467|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
157099741|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
157099742|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
157099743|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
157099744|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
157099745|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
157099746|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
157099747|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
157099748|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
157099749|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
157099750|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157099751|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
157099752|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157099753|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
157099754|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
157099755|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
157099756|NCT01323621|567120465|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
157099757|NCT01323621|567120466|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
157099758|NCT01323621|567120467|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
157099759|NCT04226833|567120468|FG000|Overall Study|Death|0|||
157099760|NCT04226833|567120469|FG001|Overall Study|Death|0|||
157099761|NCT04226833|567120470|FG002|Overall Study|Death|1|||
157099762|NCT04226833|567120471|FG003|Overall Study|Death|0|||
157099763|NCT01163721|567120474|FG000|Overall Study|Adverse Event|5|||
157099764|NCT01163721|567120475|FG001|Overall Study|Adverse Event|6|||
157099765|NCT01163721|567120474|FG000|Overall Study|Withdrawal by Subject|3|||
157099766|NCT01163721|567120475|FG001|Overall Study|Withdrawal by Subject|4|||
157099767|NCT01163721|567120474|FG000|Overall Study|Lost to Follow-up|0|||
157099768|NCT01163721|567120475|FG001|Overall Study|Lost to Follow-up|1|||
157099769|NCT01163721|567120474|FG000|Overall Study|Physician Decision|0|||
157099770|NCT01163721|567120475|FG001|Overall Study|Physician Decision|1|||
157099771|NCT00364156|567120476|FG000|Overall Study|Withdrawal by Subject|73|||
157099772|NCT00364156|567120477|FG001|Overall Study|Withdrawal by Subject|80|||
157099773|NCT00364156|567120476|FG000|Overall Study|Protocol Violation|6|||
157099774|NCT00364156|567120477|FG001|Overall Study|Protocol Violation|1|||
157099775|NCT01050205|567120478|FG000|Overall Study|Lost to Follow-up|7|||
157099776|NCT01050205|567120479|FG001|Overall Study|Lost to Follow-up|1|||
157099777|NCT01050205|567120478|FG000|Overall Study|Withdrawal by Subject|1|||
157099778|NCT01050205|567120479|FG001|Overall Study|Withdrawal by Subject|1|||
157099779|NCT01050205|567120478|FG000|Overall Study|Relocated from area|1|||
157099780|NCT01050205|567120479|FG001|Overall Study|Relocated from area|2|||
157099781|NCT01050205|567120478|FG000|Overall Study|Discontinued Intervention|2|||
157099782|NCT01050205|567120479|FG001|Overall Study|Discontinued Intervention|0|||
157099783|NCT01119001|567120482|FG000|Overall Study|Withdrawal by Subject|2|||
157099784|NCT00403754|567120483|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
157099785|NCT00403754|567120484|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
157099786|NCT00403754|567120485|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
157099787|NCT00403754|567120486|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
157099788|NCT00403754|567120483|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
157099789|NCT00403754|567120484|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
157099790|NCT00403754|567120485|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
157099791|NCT00403754|567120486|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
157099792|NCT05245097|567120487|FG000|Overall Study|Adverse Event|13|||
157099793|NCT05245097|567120488|FG001|Overall Study|Adverse Event|2|||
157099794|NCT05245097|567120487|FG000|Overall Study|Protocol Violation|8|||
157099795|NCT05245097|567120488|FG001|Overall Study|Protocol Violation|6|||
157099796|NCT05245097|567120487|FG000|Overall Study|Withdrawal by Subject|18|||
157099797|NCT05245097|567120488|FG001|Overall Study|Withdrawal by Subject|0|||
157099798|NCT05245097|567120487|FG000|Overall Study|Death|6|||
157099799|NCT05245097|567120488|FG001|Overall Study|Death|7|||
157099800|NCT05245097|567120487|FG000|Overall Study|Physician Decision|6|||
157099801|NCT05245097|567120488|FG001|Overall Study|Physician Decision|0|||
157099802|NCT05245097|567120487|FG000|Overall Study|Relocation|4|||
157099803|NCT05245097|567120488|FG001|Overall Study|Relocation|3|||
157099804|NCT03604523|567120489|FG000|Overall Study|Physician Decision|1|||
157099805|NCT03604523|567120490|FG001|Overall Study|Physician Decision|0|||
157099806|NCT01696942|567120499|FG000|Overall Study|Withdrawal by Subject|1|||
157099807|NCT01696942|567120500|FG001|Overall Study|Withdrawal by Subject|0|||
157099808|NCT01696942|567120499|FG000|Overall Study|Protocol Violation|1|||
157099809|NCT01696942|567120500|FG001|Overall Study|Protocol Violation|2|||
157099810|NCT01696942|567120499|FG000|Overall Study|screen failure|0|||
157099811|NCT01696942|567120500|FG001|Overall Study|screen failure|1|||
157099812|NCT01422850|567120501|FG000|Overall Study|Physician Decision|3|||
157099813|NCT04484831|567120502|FG000|Overall Study|Withdrawal by Subject|1|||
157099814|NCT04484831|567120503|FG001|Overall Study|Withdrawal by Subject|0|||
157099815|NCT02244996|567120505|FG000|Overall Study|Lack of Efficacy|2|||
157099816|NCT02244996|567120506|FG001|Overall Study|Lack of Efficacy|6|||
157099817|NCT03231943|567120507|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099818|NCT03231943|567120508|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
157099819|NCT03231943|567120509|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
157099820|NCT03231943|567120510|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099821|NCT03231943|567120511|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099822|NCT03231943|567120512|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099823|NCT03231943|567120513|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099824|NCT03231943|567120514|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099825|NCT03231943|567120515|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099826|NCT03231943|567120516|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099827|NCT03231943|567120517|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099828|NCT03231943|567120518|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099829|NCT03231943|567120519|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
157099830|NCT03231943|567120507|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099831|NCT03231943|567120508|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
157099832|NCT03231943|567120509|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099833|NCT03231943|567120510|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099834|NCT03231943|567120511|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099835|NCT03231943|567120512|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099836|NCT03231943|567120513|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099837|NCT03231943|567120514|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099838|NCT03231943|567120515|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099839|NCT03231943|567120516|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099840|NCT03231943|567120517|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099841|NCT03231943|567120518|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099842|NCT03231943|567120519|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
157099843|NCT03231943|567120507|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
157099844|NCT03231943|567120508|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099845|NCT03231943|567120509|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099846|NCT03231943|567120510|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099847|NCT03231943|567120511|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099848|NCT03231943|567120512|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
156997393|NCT01710514|566742718|FG000|Overall Study|Withdrawal by Subject|1|||
156997394|NCT01710514|566742719|FG001|Overall Study|Withdrawal by Subject|0|||
156997395|NCT03404843|566742722|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
156997396|NCT03404843|566742723|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
156997397|NCT04044664|566742724|FG000|Stage 1|Adverse Event|3|||
156997398|NCT04044664|566742725|FG001|Stage 1|Adverse Event|3|||
156997399|NCT04044664|566742726|FG002|Stage 1|Adverse Event|1|||
156997400|NCT04044664|566742724|FG000|Stage 1|Lost to Follow-up|3|||
156997401|NCT04044664|566742725|FG001|Stage 1|Lost to Follow-up|2|||
156997402|NCT04044664|566742726|FG002|Stage 1|Lost to Follow-up|2|||
156997403|NCT04044664|566742724|FG000|Stage 1|Withdrawal by Subject|9|||
156997404|NCT04044664|566742725|FG001|Stage 1|Withdrawal by Subject|1|||
156997405|NCT04044664|566742726|FG002|Stage 1|Withdrawal by Subject|0|||
156997406|NCT04044664|566742724|FG000|Stage 1|noncompliance, personal reason|2|||
156997407|NCT04044664|566742725|FG001|Stage 1|noncompliance, personal reason|0|||
156997408|NCT04044664|566742726|FG002|Stage 1|noncompliance, personal reason|0|||
156997409|NCT04044664|566742724|FG000|Stage 1|randomization error|0|||
156997410|NCT04044664|566742725|FG001|Stage 1|randomization error|1|||
156997411|NCT04044664|566742726|FG002|Stage 1|randomization error|0|||
156997412|NCT04044664|566742724|FG000|Stage 2|Adverse Event|2|||
156997413|NCT04044664|566742725|FG001|Stage 2|Adverse Event|0|||
156997414|NCT04044664|566742726|FG002|Stage 2|Adverse Event|0|||
156997415|NCT04044664|566742724|FG000|Stage 2|Lost to Follow-up|3|||
156997416|NCT04044664|566742725|FG001|Stage 2|Lost to Follow-up|2|||
156997417|NCT04044664|566742726|FG002|Stage 2|Lost to Follow-up|1|||
156997418|NCT04044664|566742724|FG000|Stage 2|Withdrawal by Subject|3|||
156997419|NCT04044664|566742725|FG001|Stage 2|Withdrawal by Subject|0|||
156997420|NCT04044664|566742726|FG002|Stage 2|Withdrawal by Subject|0|||
156997421|NCT04044664|566742724|FG000|Stage 2|protocol deviation|1|||
156997422|NCT04044664|566742725|FG001|Stage 2|protocol deviation|0|||
156997423|NCT04044664|566742726|FG002|Stage 2|protocol deviation|0|||
156997424|NCT03822351|566742743|FG000|Overall Study|Death|27|||
156997425|NCT03822351|566742744|FG001|Overall Study|Death|23|||
156997426|NCT03822351|566742745|FG002|Overall Study|Death|24|||
156997427|NCT03822351|566742743|FG000|Overall Study|Lost to Follow-up|6|||
156997428|NCT03822351|566742744|FG001|Overall Study|Lost to Follow-up|2|||
156997429|NCT03822351|566742745|FG002|Overall Study|Lost to Follow-up|1|||
156997430|NCT03822351|566742743|FG000|Overall Study|Withdrawal by Subject|10|||
156997431|NCT03822351|566742744|FG001|Overall Study|Withdrawal by Subject|4|||
156997432|NCT03822351|566742745|FG002|Overall Study|Withdrawal by Subject|6|||
156997433|NCT03822351|566742743|FG000|Overall Study|Progressive Disease|2|||
156997434|NCT03822351|566742744|FG001|Overall Study|Progressive Disease|1|||
156997435|NCT03822351|566742745|FG002|Overall Study|Progressive Disease|0|||
156997436|NCT03822351|566742743|FG000|Overall Study|Not Treated|1|||
156997437|NCT03822351|566742744|FG001|Overall Study|Not Treated|1|||
156997438|NCT03822351|566742745|FG002|Overall Study|Not Treated|1|||
156997439|NCT02081391|566742746|FG000|12-hour Treatment|Withdrawal by Subject|3|||
156997440|NCT02081391|566742747|FG001|12-hour Treatment|Withdrawal by Subject|2|||
156997441|NCT02081391|566742748|FG002|12-hour Treatment|Withdrawal by Subject|0|||
156997442|NCT02081391|566742749|FG003|12-hour Treatment|Withdrawal by Subject|0|||
156997443|NCT02081391|566742746|FG000|12-hour Treatment|Physician Decision|4|||
156997444|NCT02081391|566742747|FG001|12-hour Treatment|Physician Decision|1|||
156997445|NCT02081391|566742748|FG002|12-hour Treatment|Physician Decision|0|||
156997446|NCT02081391|566742749|FG003|12-hour Treatment|Physician Decision|0|||
156997447|NCT02081391|566742746|FG000|12-hour Treatment|Lack of Efficacy|3|||
156997448|NCT02081391|566742747|FG001|12-hour Treatment|Lack of Efficacy|0|||
156997449|NCT02081391|566742748|FG002|12-hour Treatment|Lack of Efficacy|0|||
156997450|NCT02081391|566742749|FG003|12-hour Treatment|Lack of Efficacy|0|||
156997451|NCT02081391|566742746|FG000|12-hour Treatment|Adverse Event|4|||
156997452|NCT02081391|566742747|FG001|12-hour Treatment|Adverse Event|2|||
156997453|NCT02081391|566742748|FG002|12-hour Treatment|Adverse Event|0|||
156997454|NCT02081391|566742749|FG003|12-hour Treatment|Adverse Event|0|||
156997455|NCT02081391|566742746|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
156997456|NCT02081391|566742747|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
156997457|NCT02081391|566742748|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
156997458|NCT02081391|566742749|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
156997459|NCT02081391|566742746|FG000|12-hour Treatment|Further reasons|2|||
156997460|NCT02081391|566742747|FG001|12-hour Treatment|Further reasons|1|||
156997461|NCT02081391|566742748|FG002|12-hour Treatment|Further reasons|0|||
156997462|NCT02081391|566742749|FG003|12-hour Treatment|Further reasons|0|||
156997463|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
156997464|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
156997465|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
156997466|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
156997467|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
156997468|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
156997469|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
156997470|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
156997471|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
156997472|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
156997473|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
156997474|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
156997475|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
156997476|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
156997477|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
156997478|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
156997479|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
156997480|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
156997481|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
156997482|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
156997483|NCT02081391|566742746|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
156997484|NCT02081391|566742747|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
156997485|NCT02081391|566742748|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
156997486|NCT02081391|566742749|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
156997487|NCT01458275|566742750|FG000|Overall Study|Adverse Event|3|||
156997488|NCT01458275|566742751|FG001|Overall Study|Adverse Event|4|||
156997489|NCT01458275|566742752|FG002|Overall Study|Adverse Event|1|||
156997490|NCT01458275|566742750|FG000|Overall Study|Lost to Follow-up|3|||
156997491|NCT01458275|566742751|FG001|Overall Study|Lost to Follow-up|2|||
156997492|NCT01458275|566742752|FG002|Overall Study|Lost to Follow-up|5|||
156997493|NCT01458275|566742750|FG000|Overall Study|Protocol Violation|5|||
156997494|NCT01458275|566742751|FG001|Overall Study|Protocol Violation|5|||
156997495|NCT01458275|566742752|FG002|Overall Study|Protocol Violation|2|||
156997496|NCT01458275|566742750|FG000|Overall Study|Withdrawal by Subject|3|||
156997497|NCT01458275|566742751|FG001|Overall Study|Withdrawal by Subject|2|||
156997498|NCT01458275|566742752|FG002|Overall Study|Withdrawal by Subject|1|||
156997499|NCT02501811|566742754|FG000|Overall Study|Death|1|||
156997500|NCT02501811|566742755|FG001|Overall Study|Death|3|||
156997501|NCT02501811|566742756|FG002|Overall Study|Death|2|||
156997502|NCT02501811|566742757|FG003|Overall Study|Death|3|||
156997503|NCT02501811|566742754|FG000|Overall Study|Withdrawal by Subject|3|||
156997504|NCT02501811|566742755|FG001|Overall Study|Withdrawal by Subject|3|||
156997505|NCT02501811|566742756|FG002|Overall Study|Withdrawal by Subject|2|||
156997506|NCT02501811|566742757|FG003|Overall Study|Withdrawal by Subject|3|||
156997507|NCT02501811|566742754|FG000|Overall Study|Lost to Follow-up|0|||
156997508|NCT02501811|566742755|FG001|Overall Study|Lost to Follow-up|0|||
156997509|NCT02501811|566742756|FG002|Overall Study|Lost to Follow-up|2|||
156997510|NCT02501811|566742757|FG003|Overall Study|Lost to Follow-up|1|||
156997511|NCT01875250|566744709|FG000|Overall Study|Adverse Event|2|||
156997512|NCT01875250|566744710|FG001|Overall Study|Adverse Event|0|||
156997513|NCT03140176|566744716|FG000|Overall Study|Reason missing|23|||
156997514|NCT03140176|566744716|FG000|Overall Study|Death|33|||
156997515|NCT03140176|566744716|FG000|Overall Study|Disease progression|1|||
156997516|NCT03140176|566744716|FG000|Overall Study|Physician Decision|1|||
156997517|NCT03140176|566744716|FG000|Overall Study|Withdrawal by Subject|1|||
156997518|NCT03140176|566744716|FG000|Overall Study|Lost to Follow-up|15|||
156997519|NCT03179787|566744722|FG000|Overall Study|Lost to Follow-up|15|||
156997520|NCT03179787|566744722|FG000|Overall Study|Case report failures|2|||
156756528|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756529|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756530|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756531|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756532|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756533|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756534|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
156756535|NCT03428100|565860600|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756536|NCT03428100|565860601|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
156756537|NCT03428100|565860602|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756538|NCT03428100|565860603|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756539|NCT03428100|565860604|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756540|NCT03428100|565860605|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756541|NCT03428100|565860606|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756542|NCT03428100|565860607|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756543|NCT03428100|565860608|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756544|NCT03428100|565860609|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756545|NCT03428100|565860610|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756546|NCT03428100|565860611|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756547|NCT03428100|565860612|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756548|NCT03428100|565860613|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756549|NCT03428100|565860614|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756550|NCT03428100|565860615|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756551|NCT03428100|565860616|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756552|NCT03428100|565860617|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756553|NCT03428100|565860618|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
156756554|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756555|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756556|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756557|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756558|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756559|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
156756560|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756561|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
156756562|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756563|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756564|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756565|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756566|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
156756567|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756568|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756569|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
156756570|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
156756571|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756572|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
156756573|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
156756574|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
156756575|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
156756576|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
156756577|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
156756578|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
156756579|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
156756580|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
156756581|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
156756582|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
156756583|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
156756584|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
156756585|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
156756586|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
156756587|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
156756588|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
156997521|NCT03179787|566744722|FG000|Overall Study|Treatment not administered|1|||
156997522|NCT02030028|566744723|FG000|Overall Study|Withdrawal by Subject|4|||
156997523|NCT02030028|566744723|FG000|Overall Study|lack of transportation|1|||
156997524|NCT00661778|566744724|FG000|Overall Study|Disease Progression|23|||
156997525|NCT00661778|566744724|FG000|Overall Study|Adverse Event|18|||
157099849|NCT03231943|567120513|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099850|NCT03231943|567120514|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099851|NCT03231943|567120515|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099852|NCT03231943|567120516|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099853|NCT03231943|567120517|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099854|NCT03231943|567120518|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099855|NCT03231943|567120519|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
157099856|NCT03231943|567120507|FG000|Part 2|Adverse Event|0|||
157099857|NCT03231943|567120508|FG001|Part 2|Adverse Event|0|||
157099858|NCT03231943|567120509|FG002|Part 2|Adverse Event|0|||
157099859|NCT03231943|567120510|FG003|Part 2|Adverse Event|0|||
157099860|NCT03231943|567120511|FG004|Part 2|Adverse Event|0|||
157099861|NCT03231943|567120512|FG005|Part 2|Adverse Event|0|||
157099862|NCT03231943|567120513|FG006|Part 2|Adverse Event|0|||
157099863|NCT03231943|567120514|FG007|Part 2|Adverse Event|0|||
157099864|NCT03231943|567120515|FG008|Part 2|Adverse Event|0|||
157099865|NCT03231943|567120516|FG009|Part 2|Adverse Event|0|||
157099866|NCT03231943|567120517|FG010|Part 2|Adverse Event|1|||
156997526|NCT00661778|566744724|FG000|Overall Study|Reason not Specified|6|||
156997527|NCT00661778|566744724|FG000|Overall Study|Protocol Violation|2|||
156997528|NCT00661778|566744724|FG000|Overall Study|Withdrawal of Consent|1|||
156997529|NCT00149630|566744729|FG000|Overall Study|Incarceration|2|||
156997530|NCT00149630|566744730|FG001|Overall Study|Incarceration|0|||
156997531|NCT00149630|566744729|FG000|Overall Study|Treatment Programs|4|||
156997532|NCT00149630|566744730|FG001|Overall Study|Treatment Programs|5|||
156997533|NCT00149630|566744729|FG000|Overall Study|Adverse Event|2|||
156997534|NCT00149630|566744730|FG001|Overall Study|Adverse Event|0|||
156997535|NCT05298111|566744734|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
156997536|NCT05298111|566744735|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
156997537|NCT02001623|566744745|FG000|Overall Study|Disease Progression|2|||
156997538|NCT02001623|566744746|FG001|Overall Study|Disease Progression|2|||
156997539|NCT02001623|566744747|FG002|Overall Study|Disease Progression|3|||
156997540|NCT02001623|566744748|FG003|Overall Study|Disease Progression|2|||
156997541|NCT02001623|566744749|FG004|Overall Study|Disease Progression|3|||
156997542|NCT02001623|566744750|FG005|Overall Study|Disease Progression|2|||
156997543|NCT02001623|566744751|FG006|Overall Study|Disease Progression|3|||
156997544|NCT02001623|566744752|FG007|Overall Study|Disease Progression|3|||
156997545|NCT02001623|566744753|FG008|Overall Study|Disease Progression|7|||
156997546|NCT02001623|566744754|FG009|Overall Study|Disease Progression|40|||
156997547|NCT02001623|566744755|FG010|Overall Study|Disease Progression|5|||
156997548|NCT02001623|566744756|FG011|Overall Study|Disease Progression|9|||
156997549|NCT02001623|566744757|FG012|Overall Study|Disease Progression|9|||
156997550|NCT02001623|566744758|FG013|Overall Study|Disease Progression|20|||
156997551|NCT02001623|566744759|FG014|Overall Study|Disease Progression|9|||
156997552|NCT02001623|566744745|FG000|Overall Study|Physician Decision|0|||
156997553|NCT02001623|566744746|FG001|Overall Study|Physician Decision|0|||
156997554|NCT02001623|566744747|FG002|Overall Study|Physician Decision|0|||
156997555|NCT02001623|566744748|FG003|Overall Study|Physician Decision|0|||
156997556|NCT02001623|566744749|FG004|Overall Study|Physician Decision|0|||
156997557|NCT02001623|566744750|FG005|Overall Study|Physician Decision|0|||
156997558|NCT02001623|566744751|FG006|Overall Study|Physician Decision|0|||
156997559|NCT02001623|566744752|FG007|Overall Study|Physician Decision|0|||
156997560|NCT02001623|566744753|FG008|Overall Study|Physician Decision|3|||
156997561|NCT02001623|566744754|FG009|Overall Study|Physician Decision|2|||
156997562|NCT02001623|566744755|FG010|Overall Study|Physician Decision|3|||
156997563|NCT02001623|566744756|FG011|Overall Study|Physician Decision|3|||
156997564|NCT02001623|566744757|FG012|Overall Study|Physician Decision|1|||
156997565|NCT02001623|566744758|FG013|Overall Study|Physician Decision|2|||
156997566|NCT02001623|566744759|FG014|Overall Study|Physician Decision|1|||
156997567|NCT02001623|566744745|FG000|Overall Study|Death|0|||
156997568|NCT02001623|566744746|FG001|Overall Study|Death|1|||
156997569|NCT02001623|566744747|FG002|Overall Study|Death|0|||
156997570|NCT02001623|566744748|FG003|Overall Study|Death|0|||
157099867|NCT03231943|567120518|FG011|Part 2|Adverse Event|0|||
156997571|NCT02001623|566744749|FG004|Overall Study|Death|0|||
156997572|NCT02001623|566744750|FG005|Overall Study|Death|0|||
156997573|NCT02001623|566744751|FG006|Overall Study|Death|0|||
156997574|NCT02001623|566744752|FG007|Overall Study|Death|0|||
156997575|NCT02001623|566744753|FG008|Overall Study|Death|0|||
156997576|NCT02001623|566744754|FG009|Overall Study|Death|0|||
156997577|NCT02001623|566744755|FG010|Overall Study|Death|0|||
156997578|NCT02001623|566744756|FG011|Overall Study|Death|0|||
156997579|NCT02001623|566744757|FG012|Overall Study|Death|0|||
156997580|NCT02001623|566744758|FG013|Overall Study|Death|0|||
156997581|NCT02001623|566744759|FG014|Overall Study|Death|0|||
156997582|NCT02001623|566744745|FG000|Overall Study|Adverse Event|0|||
157099868|NCT03231943|567120519|FG012|Part 2|Adverse Event|0|||
157099869|NCT03231943|567120507|FG000|Part 2|Withdrawal by Subject|0|||
157099870|NCT03231943|567120508|FG001|Part 2|Withdrawal by Subject|0|||
157099871|NCT03231943|567120509|FG002|Part 2|Withdrawal by Subject|0|||
157099872|NCT03231943|567120510|FG003|Part 2|Withdrawal by Subject|0|||
157099873|NCT03231943|567120511|FG004|Part 2|Withdrawal by Subject|0|||
156756589|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
156756590|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
156997583|NCT02001623|566744746|FG001|Overall Study|Adverse Event|0|||
156997584|NCT02001623|566744747|FG002|Overall Study|Adverse Event|0|||
156997585|NCT02001623|566744748|FG003|Overall Study|Adverse Event|0|||
156997586|NCT02001623|566744749|FG004|Overall Study|Adverse Event|0|||
156997587|NCT02001623|566744750|FG005|Overall Study|Adverse Event|1|||
156997588|NCT02001623|566744751|FG006|Overall Study|Adverse Event|0|||
156997589|NCT02001623|566744752|FG007|Overall Study|Adverse Event|3|||
156997590|NCT02001623|566744753|FG008|Overall Study|Adverse Event|4|||
156997591|NCT02001623|566744754|FG009|Overall Study|Adverse Event|6|||
156997592|NCT02001623|566744755|FG010|Overall Study|Adverse Event|4|||
156997593|NCT02001623|566744756|FG011|Overall Study|Adverse Event|0|||
156997594|NCT02001623|566744757|FG012|Overall Study|Adverse Event|3|||
156997595|NCT02001623|566744758|FG013|Overall Study|Adverse Event|5|||
156997596|NCT02001623|566744759|FG014|Overall Study|Adverse Event|6|||
156997597|NCT02001623|566744745|FG000|Overall Study|Other - Miscellaneous|0|||
156997598|NCT02001623|566744746|FG001|Overall Study|Other - Miscellaneous|0|||
156997599|NCT02001623|566744747|FG002|Overall Study|Other - Miscellaneous|0|||
156997600|NCT02001623|566744748|FG003|Overall Study|Other - Miscellaneous|0|||
156997601|NCT02001623|566744749|FG004|Overall Study|Other - Miscellaneous|0|||
156997602|NCT02001623|566744750|FG005|Overall Study|Other - Miscellaneous|0|||
156997603|NCT02001623|566744751|FG006|Overall Study|Other - Miscellaneous|0|||
156997604|NCT02001623|566744752|FG007|Overall Study|Other - Miscellaneous|0|||
156997605|NCT02001623|566744753|FG008|Overall Study|Other - Miscellaneous|0|||
156997606|NCT02001623|566744754|FG009|Overall Study|Other - Miscellaneous|1|||
156997607|NCT02001623|566744755|FG010|Overall Study|Other - Miscellaneous|0|||
156997608|NCT02001623|566744756|FG011|Overall Study|Other - Miscellaneous|0|||
156997609|NCT02001623|566744757|FG012|Overall Study|Other - Miscellaneous|0|||
156997610|NCT02001623|566744758|FG013|Overall Study|Other - Miscellaneous|1|||
156997611|NCT02001623|566744759|FG014|Overall Study|Other - Miscellaneous|0|||
156997612|NCT02001623|566744745|FG000|Overall Study|Withdrawal by Subject|1|||
156997613|NCT02001623|566744746|FG001|Overall Study|Withdrawal by Subject|0|||
156997614|NCT02001623|566744747|FG002|Overall Study|Withdrawal by Subject|0|||
156997615|NCT02001623|566744748|FG003|Overall Study|Withdrawal by Subject|0|||
156997616|NCT02001623|566744749|FG004|Overall Study|Withdrawal by Subject|0|||
156997617|NCT02001623|566744750|FG005|Overall Study|Withdrawal by Subject|0|||
156997618|NCT02001623|566744751|FG006|Overall Study|Withdrawal by Subject|0|||
156997619|NCT02001623|566744752|FG007|Overall Study|Withdrawal by Subject|0|||
156997620|NCT02001623|566744753|FG008|Overall Study|Withdrawal by Subject|1|||
156997621|NCT02001623|566744754|FG009|Overall Study|Withdrawal by Subject|3|||
156997622|NCT02001623|566744755|FG010|Overall Study|Withdrawal by Subject|2|||
156997623|NCT02001623|566744756|FG011|Overall Study|Withdrawal by Subject|2|||
156997624|NCT02001623|566744757|FG012|Overall Study|Withdrawal by Subject|1|||
156997625|NCT02001623|566744758|FG013|Overall Study|Withdrawal by Subject|5|||
156997626|NCT02001623|566744759|FG014|Overall Study|Withdrawal by Subject|2|||
156997627|NCT02001623|566744745|FG000|Overall Study|Lost to Follow-up|0|||
156997628|NCT02001623|566744746|FG001|Overall Study|Lost to Follow-up|0|||
156997629|NCT02001623|566744747|FG002|Overall Study|Lost to Follow-up|0|||
156756591|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
156756592|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156997630|NCT02001623|566744748|FG003|Overall Study|Lost to Follow-up|0|||
156997631|NCT02001623|566744749|FG004|Overall Study|Lost to Follow-up|0|||
156997632|NCT02001623|566744750|FG005|Overall Study|Lost to Follow-up|0|||
156997633|NCT02001623|566744751|FG006|Overall Study|Lost to Follow-up|0|||
156997634|NCT02001623|566744752|FG007|Overall Study|Lost to Follow-up|0|||
156997635|NCT02001623|566744753|FG008|Overall Study|Lost to Follow-up|0|||
156997636|NCT02001623|566744754|FG009|Overall Study|Lost to Follow-up|1|||
156997637|NCT02001623|566744755|FG010|Overall Study|Lost to Follow-up|0|||
156997638|NCT02001623|566744756|FG011|Overall Study|Lost to Follow-up|0|||
156997639|NCT02001623|566744757|FG012|Overall Study|Lost to Follow-up|0|||
156997640|NCT02001623|566744758|FG013|Overall Study|Lost to Follow-up|0|||
156756593|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756594|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756595|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756596|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
156756597|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
156756598|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
156756599|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756600|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756601|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756602|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756603|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
156756604|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
156756605|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
156756606|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
156997641|NCT02001623|566744759|FG014|Overall Study|Lost to Follow-up|0|||
156997642|NCT02001623|566744745|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
156997643|NCT02001623|566744746|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
156997644|NCT02001623|566744747|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
156997645|NCT02001623|566744748|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
156997646|NCT02001623|566744749|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
156997647|NCT02001623|566744750|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
156997648|NCT02001623|566744751|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
156997649|NCT02001623|566744752|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
156997650|NCT02001623|566744753|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
156997651|NCT02001623|566744754|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
156997652|NCT02001623|566744755|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
156997653|NCT02001623|566744756|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
156997654|NCT02001623|566744757|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
156997655|NCT02001623|566744758|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
156997656|NCT02001623|566744759|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
156997657|NCT02001623|566744745|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
156997658|NCT02001623|566744746|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
156997659|NCT02001623|566744747|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
156997660|NCT02001623|566744748|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
156997661|NCT02001623|566744749|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
156997662|NCT02001623|566744750|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
156997663|NCT02001623|566744751|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
156997664|NCT02001623|566744752|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
156997665|NCT02001623|566744753|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
156997666|NCT02001623|566744754|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
156997667|NCT02001623|566744755|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
156997668|NCT02001623|566744756|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
156997669|NCT02001623|566744757|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
156997670|NCT02001623|566744758|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
156997671|NCT02001623|566744759|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
156997672|NCT00943605|566744767|FG000|Overall Study|Study termination|30|||
156997673|NCT00943605|566744768|FG001|Overall Study|Study termination|30|||
156997674|NCT02232178|566744769|FG000|Overall Study|Lost to Follow-up|0|||
156997675|NCT02232178|566744770|FG001|Overall Study|Lost to Follow-up|1|||
156997676|NCT02232178|566744771|FG002|Overall Study|Lost to Follow-up|0|||
156997677|NCT02232178|566744769|FG000|Overall Study|ineligibility|0|||
156997678|NCT02232178|566744770|FG001|Overall Study|ineligibility|0|||
156997679|NCT02232178|566744771|FG002|Overall Study|ineligibility|1|||
156997680|NCT02232178|566744769|FG000|Overall Study|surgical complication|1|||
156997681|NCT02232178|566744770|FG001|Overall Study|surgical complication|0|||
156997682|NCT02232178|566744771|FG002|Overall Study|surgical complication|0|||
156997683|NCT03357341|566744772|FG000|Overall Study|Withdrawal by Subject|3|||
156997684|NCT03357341|566744773|FG001|Overall Study|Withdrawal by Subject|6|||
156997685|NCT03357341|566744772|FG000|Overall Study|Lost to Follow-up|4|||
156997686|NCT03357341|566744773|FG001|Overall Study|Lost to Follow-up|5|||
156997687|NCT03357341|566744772|FG000|Overall Study|Death|0|||
156997688|NCT03357341|566744773|FG001|Overall Study|Death|1|||
156997689|NCT05257798|566744774|FG000|Follow-up Phase|Lost to Follow-up|1|||
156997690|NCT05257798|566744775|FG001|Follow-up Phase|Lost to Follow-up|0|||
156997691|NCT00703911|566744778|FG000|Overall Study|Death|1|||
156997692|NCT00703911|566744778|FG000|Overall Study|Physician Decision|6|||
156997693|NCT00703911|566744778|FG000|Overall Study|Lost to Follow-up|1|||
156997694|NCT00703911|566744778|FG000|Overall Study|Withdrawal by Subject|2|||
156997695|NCT01064817|566744779|FG000|Study Completion|Physician Decision|1|||
156997696|NCT01064817|566744780|FG001|Study Completion|Physician Decision|0|||
156997697|NCT01064817|566744779|FG000|Study Completion|Withdrawal by Subject|1|||
156997698|NCT01064817|566744780|FG001|Study Completion|Withdrawal by Subject|0|||
156756607|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
156756608|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756609|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
156756610|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
156756611|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756612|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756613|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756614|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156997699|NCT01368406|566744781|FG000|Overall Study|Lost to Follow-up|8|||
156997700|NCT01368406|566744782|FG001|Overall Study|Lost to Follow-up|4|||
156997701|NCT01368406|566744781|FG000|Overall Study|Withdrawal by Subject|8|||
156997702|NCT01368406|566744782|FG001|Overall Study|Withdrawal by Subject|4|||
156997703|NCT01368406|566744781|FG000|Overall Study|relapse of the disease|3|||
156997704|NCT01368406|566744782|FG001|Overall Study|relapse of the disease|2|||
156997705|NCT01368406|566744781|FG000|Overall Study|started working|2|||
156997706|NCT01368406|566744782|FG001|Overall Study|started working|3|||
156997707|NCT00957229|566744785|FG000|Study Start|Adverse Event|0|||
156997708|NCT00957229|566744786|FG001|Study Start|Adverse Event|3|||
156997709|NCT00957229|566744785|FG000|Study Start|Disease Progression|1|||
156997710|NCT00957229|566744786|FG001|Study Start|Disease Progression|0|||
156997711|NCT00957229|566744785|FG000|Reallocated to or Continued Vismodegib|Death|1|||
156997712|NCT00957229|566744786|FG001|Reallocated to or Continued Vismodegib|Death|1|||
156997713|NCT00957229|566744785|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
156997714|NCT00957229|566744786|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
156997715|NCT00606580|566744787|FG000|Overall Study|Lost to Follow-up|1|||
156997716|NCT00606580|566744788|FG001|Overall Study|Lost to Follow-up|1|||
156997717|NCT00606580|566744789|FG002|Overall Study|Lost to Follow-up|4|||
156997718|NCT00606580|566744787|FG000|Overall Study|Clinical failures|1|||
156997719|NCT00606580|566744788|FG001|Overall Study|Clinical failures|0|||
156997720|NCT00606580|566744789|FG002|Overall Study|Clinical failures|12|||
156997721|NCT00606580|566744787|FG000|Overall Study|Withdrawal by investigator|0|||
156997722|NCT00606580|566744788|FG001|Overall Study|Withdrawal by investigator|1|||
156997723|NCT00606580|566744789|FG002|Overall Study|Withdrawal by investigator|6|||
156997724|NCT00606580|566744787|FG000|Overall Study|Withdrawal by Subject|0|||
156997725|NCT00606580|566744788|FG001|Overall Study|Withdrawal by Subject|1|||
156997726|NCT00606580|566744789|FG002|Overall Study|Withdrawal by Subject|0|||
156997727|NCT01833065|566744790|FG000|Overall Study|Adverse Event|6|||
156997728|NCT01833065|566744791|FG001|Overall Study|Adverse Event|1|||
156997729|NCT01833065|566744792|FG002|Overall Study|Adverse Event|0|||
156997730|NCT01833065|566744793|FG003|Overall Study|Adverse Event|2|||
156997731|NCT01833065|566744794|FG004|Overall Study|Adverse Event|3|||
156997732|NCT01833065|566744790|FG000|Overall Study|Protocol Violation|1|||
156997733|NCT01833065|566744791|FG001|Overall Study|Protocol Violation|0|||
156997734|NCT01833065|566744792|FG002|Overall Study|Protocol Violation|0|||
156997735|NCT01833065|566744793|FG003|Overall Study|Protocol Violation|0|||
156997736|NCT01833065|566744794|FG004|Overall Study|Protocol Violation|2|||
156997737|NCT01833065|566744790|FG000|Overall Study|Lost to Follow-up|1|||
156997738|NCT01833065|566744791|FG001|Overall Study|Lost to Follow-up|0|||
156997739|NCT01833065|566744792|FG002|Overall Study|Lost to Follow-up|0|||
156997740|NCT01833065|566744793|FG003|Overall Study|Lost to Follow-up|0|||
156997741|NCT01833065|566744794|FG004|Overall Study|Lost to Follow-up|3|||
156997742|NCT01833065|566744790|FG000|Overall Study|Withdrawal by Subject|6|||
156997743|NCT01833065|566744791|FG001|Overall Study|Withdrawal by Subject|2|||
156997744|NCT01833065|566744792|FG002|Overall Study|Withdrawal by Subject|4|||
156997745|NCT01833065|566744793|FG003|Overall Study|Withdrawal by Subject|3|||
156997746|NCT01833065|566744794|FG004|Overall Study|Withdrawal by Subject|11|||
156997747|NCT01833065|566744790|FG000|Overall Study|Subject's substantial non-compliance|0|||
156997748|NCT01833065|566744791|FG001|Overall Study|Subject's substantial non-compliance|1|||
156997749|NCT01833065|566744792|FG002|Overall Study|Subject's substantial non-compliance|0|||
156997750|NCT01833065|566744793|FG003|Overall Study|Subject's substantial non-compliance|0|||
156997751|NCT01833065|566744794|FG004|Overall Study|Subject's substantial non-compliance|0|||
156997752|NCT01833065|566744790|FG000|Overall Study|Trial terminated by sponsor|8|||
156997753|NCT01833065|566744791|FG001|Overall Study|Trial terminated by sponsor|8|||
156997754|NCT01833065|566744792|FG002|Overall Study|Trial terminated by sponsor|7|||
156997755|NCT01833065|566744793|FG003|Overall Study|Trial terminated by sponsor|3|||
156997756|NCT01833065|566744794|FG004|Overall Study|Trial terminated by sponsor|13|||
156997757|NCT01833065|566744790|FG000|Overall Study|Others|2|||
156997758|NCT01833065|566744791|FG001|Overall Study|Others|1|||
156997759|NCT01833065|566744792|FG002|Overall Study|Others|1|||
156997760|NCT01833065|566744793|FG003|Overall Study|Others|1|||
156997761|NCT01833065|566744794|FG004|Overall Study|Others|4|||
156997762|NCT00927823|566744797|FG000|Continuous Dosing Period|Death|0|||
156997763|NCT00927823|566744798|FG001|Continuous Dosing Period|Death|0|||
156997764|NCT00927823|566744799|FG002|Continuous Dosing Period|Death|6|||
156997765|NCT00927823|566744800|FG003|Continuous Dosing Period|Death|0|||
156997766|NCT00927823|566744797|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
157099874|NCT03231943|567120512|FG005|Part 2|Withdrawal by Subject|0|||
157099875|NCT03231943|567120513|FG006|Part 2|Withdrawal by Subject|0|||
157099876|NCT03231943|567120514|FG007|Part 2|Withdrawal by Subject|0|||
157099877|NCT03231943|567120515|FG008|Part 2|Withdrawal by Subject|0|||
157099878|NCT03231943|567120516|FG009|Part 2|Withdrawal by Subject|0|||
157099879|NCT03231943|567120517|FG010|Part 2|Withdrawal by Subject|0|||
157099880|NCT03231943|567120518|FG011|Part 2|Withdrawal by Subject|1|||
157099881|NCT03231943|567120519|FG012|Part 2|Withdrawal by Subject|0|||
157099882|NCT00047320|567120520|FG000|Overall Study|Lack of Efficacy|8|||
157099883|NCT00047320|567120520|FG000|Overall Study|Lost to Follow-up|1|||
157099884|NCT00047320|567120520|FG000|Overall Study|Physician Decision|8|||
157099885|NCT00047320|567120520|FG000|Overall Study|Withdrawal by Subject|9|||
157099886|NCT00047320|567120520|FG000|Overall Study|Ineligible|2|||
157099887|NCT03471871|567120521|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
157099888|NCT03471871|567120522|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
157099889|NCT03471871|567120523|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
157099890|NCT03471871|567120524|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
157099891|NCT03471871|567120525|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
157099892|NCT03471871|567120521|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
157099893|NCT03471871|567120522|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
157099894|NCT03471871|567120523|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
157099895|NCT03471871|567120524|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
157099896|NCT03471871|567120525|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
157099897|NCT03471871|567120521|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
157099898|NCT03471871|567120522|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
157099899|NCT03471871|567120523|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
157099900|NCT03471871|567120524|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
157099901|NCT03471871|567120525|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
157099902|NCT03471871|567120521|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
157099903|NCT03471871|567120522|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
157099904|NCT03471871|567120523|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
157099905|NCT03471871|567120524|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
157099906|NCT03471871|567120525|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
157099907|NCT03471871|567120521|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
157099908|NCT03471871|567120522|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
157099909|NCT03471871|567120523|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
157099910|NCT03471871|567120524|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
157099911|NCT03471871|567120525|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
157099912|NCT04821869|567120526|FG000|Overall Study|Adverse Event|4|||
157099913|NCT04821869|567120526|FG000|Overall Study|Withdrawal by Subject|2|||
157099914|NCT04821869|567120526|FG000|Overall Study|Did not meet FEV1 criteria|1|||
157099915|NCT00658684|567120527|FG000|Overall Study|Adverse Event|10|||
157099916|NCT00658684|567120528|FG001|Overall Study|Adverse Event|8|||
157099917|NCT00658684|567120529|FG002|Overall Study|Adverse Event|2|||
157099918|NCT00658684|567120530|FG003|Overall Study|Adverse Event|0|||
157099919|NCT00658684|567120527|FG000|Overall Study|Withdrawal by Subject|6|||
157099920|NCT00658684|567120528|FG001|Overall Study|Withdrawal by Subject|4|||
157099921|NCT00658684|567120529|FG002|Overall Study|Withdrawal by Subject|1|||
157099922|NCT00658684|567120530|FG003|Overall Study|Withdrawal by Subject|1|||
157099923|NCT00658684|567120527|FG000|Overall Study|Lack of Efficacy|1|||
157099924|NCT00658684|567120528|FG001|Overall Study|Lack of Efficacy|1|||
157099925|NCT00658684|567120529|FG002|Overall Study|Lack of Efficacy|0|||
157099926|NCT00658684|567120530|FG003|Overall Study|Lack of Efficacy|0|||
157099927|NCT00658684|567120527|FG000|Overall Study|Protocol Violation|1|||
157099928|NCT00658684|567120528|FG001|Overall Study|Protocol Violation|1|||
157099929|NCT00658684|567120529|FG002|Overall Study|Protocol Violation|0|||
157099930|NCT00658684|567120530|FG003|Overall Study|Protocol Violation|0|||
157099931|NCT00658684|567120527|FG000|Overall Study|Pregnancy|1|||
157099932|NCT00658684|567120528|FG001|Overall Study|Pregnancy|1|||
157099933|NCT00658684|567120529|FG002|Overall Study|Pregnancy|0|||
157099934|NCT00658684|567120530|FG003|Overall Study|Pregnancy|0|||
157099935|NCT03226275|567120533|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
156756615|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756616|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156997767|NCT00927823|566744798|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
156997768|NCT00927823|566744799|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
156997769|NCT00927823|566744800|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
156997770|NCT00927823|566744797|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
156997771|NCT00927823|566744798|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
156997772|NCT00927823|566744799|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
156997773|NCT00927823|566744800|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
156997774|NCT00927823|566744797|FG000|Continuous Dosing Period|Other|1|||
156997775|NCT00927823|566744798|FG001|Continuous Dosing Period|Other|2|||
156997776|NCT00927823|566744799|FG002|Continuous Dosing Period|Other|9|||
156997777|NCT00927823|566744800|FG003|Continuous Dosing Period|Other|3|||
156997778|NCT00828672|566744801|FG000|Study Treatment|Lost to Follow-up|1|||
156997779|NCT00828672|566744802|FG001|Study Treatment|Lost to Follow-up|0|||
156997780|NCT00828672|566744801|FG000|Study Treatment|Adverse Event|0|||
156997781|NCT00828672|566744802|FG001|Study Treatment|Adverse Event|1|||
156997782|NCT00828672|566744801|FG000|Study Treatment|Complete response, no surgery|1|||
156997783|NCT00828672|566744802|FG001|Study Treatment|Complete response, no surgery|1|||
156997784|NCT00828672|566744801|FG000|Post-surgery (<30 Days)|No central review materials|0|||
156997785|NCT00828672|566744802|FG001|Post-surgery (<30 Days)|No central review materials|1|||
156997786|NCT00601640|566744803|FG000|Overall Study|Withdrawal by Subject|3|||
156997787|NCT00601640|566744804|FG001|Overall Study|Withdrawal by Subject|0|||
156997788|NCT00601640|566744805|FG002|Overall Study|Withdrawal by Subject|7|||
156997789|NCT00601640|566744803|FG000|Overall Study|Death|1|||
156997790|NCT00601640|566744804|FG001|Overall Study|Death|0|||
156997791|NCT00601640|566744805|FG002|Overall Study|Death|0|||
156997792|NCT00601640|566744803|FG000|Overall Study|Adverse Event|0|||
156997793|NCT00601640|566744804|FG001|Overall Study|Adverse Event|4|||
156997794|NCT00601640|566744805|FG002|Overall Study|Adverse Event|2|||
156997795|NCT00601640|566744803|FG000|Overall Study|intercurrent illness|1|||
156997796|NCT00601640|566744804|FG001|Overall Study|intercurrent illness|0|||
156997797|NCT00601640|566744805|FG002|Overall Study|intercurrent illness|0|||
156997798|NCT00601640|566744803|FG000|Overall Study|change in eligibility status|0|||
156997799|NCT00601640|566744804|FG001|Overall Study|change in eligibility status|1|||
156997800|NCT00601640|566744805|FG002|Overall Study|change in eligibility status|1|||
156997801|NCT00015457|566744811|FG000|First Intervention|Adverse Event|0|||
156997802|NCT00015457|566744812|FG001|First Intervention|Adverse Event|2|||
156997803|NCT00015457|566744811|FG000|First Intervention|Lack of Efficacy|0|||
156997804|NCT00015457|566744812|FG001|First Intervention|Lack of Efficacy|1|||
156997805|NCT00015457|566744811|FG000|Second Intervention|Withdrawal by Subject|1|||
156997806|NCT00015457|566744812|FG001|Second Intervention|Withdrawal by Subject|0|||
156997807|NCT00543725|566744817|FG000|Overall Study|Adverse Event|18|||
156997808|NCT00543725|566744818|FG001|Overall Study|Adverse Event|27|||
156997809|NCT00543725|566744817|FG000|Overall Study|Sponsor's Decision|0|||
156997810|NCT00543725|566744818|FG001|Overall Study|Sponsor's Decision|1|||
156997811|NCT00543725|566744817|FG000|Overall Study|Subject Non-Compliant|4|||
156997812|NCT00543725|566744818|FG001|Overall Study|Subject Non-Compliant|4|||
156997813|NCT00543725|566744817|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
156997814|NCT00543725|566744818|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
156997815|NCT00543725|566744817|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
156997816|NCT00543725|566744818|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
156997817|NCT00543725|566744817|FG000|Overall Study|Protocol Violation|0|||
156997818|NCT00543725|566744818|FG001|Overall Study|Protocol Violation|1|||
157099936|NCT03226275|567120534|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
157099937|NCT03226275|567120535|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
157099938|NCT03226275|567120536|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
157099939|NCT03226275|567120533|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
157099940|NCT03226275|567120534|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
157099941|NCT03226275|567120535|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
157099942|NCT03226275|567120536|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
157099943|NCT03442114|567120537|FG000|Overall Study|Lost to Follow-up|13|||
157099944|NCT03442114|567120538|FG001|Overall Study|Lost to Follow-up|13|||
157099945|NCT03442114|567120537|FG000|Overall Study|Physician Decision|2|||
157099946|NCT03442114|567120538|FG001|Overall Study|Physician Decision|2|||
157099947|NCT03442114|567120537|FG000|Overall Study|Protocol Violation|0|||
157099948|NCT03442114|567120538|FG001|Overall Study|Protocol Violation|2|||
157099949|NCT03442114|567120537|FG000|Overall Study|Withdrawal by Subject|1|||
157099950|NCT03442114|567120538|FG001|Overall Study|Withdrawal by Subject|3|||
157099951|NCT03442114|567120537|FG000|Overall Study|Guardianship Change|0|||
157099952|NCT03442114|567120538|FG001|Overall Study|Guardianship Change|1|||
157099953|NCT01306890|567121876|FG000|Overall Study|Adverse Event|2|||
157099954|NCT01306890|567121876|FG000|Overall Study|Death|1223|||
157099955|NCT01306890|567121876|FG000|Overall Study|Lost to Follow-up|58|||
157099956|NCT01306890|567121876|FG000|Overall Study|Withdrawal by Subject|88|||
157099957|NCT01306890|567121876|FG000|Overall Study|Unspecified reasons|104|||
157099958|NCT01306890|567121876|FG000|Overall Study|Study Termination|3|||
157099959|NCT01306890|567121876|FG000|Overall Study|No discontinuation documentation|41|||
157099960|NCT02217436|567121877|FG000|Overall Study|Protocol Violation|1|||
157099961|NCT02217436|567121878|FG001|Overall Study|Protocol Violation|1|||
157099962|NCT02217436|567121877|FG000|Overall Study|Incomplete data|0|||
157099963|NCT02217436|567121878|FG001|Overall Study|Incomplete data|1|||
157099964|NCT04641299|567121891|FG000|Overall Study|Adverse Event|0|||
157099965|NCT04641299|567121892|FG001|Overall Study|Adverse Event|0|||
157099966|NCT04641299|567121893|FG002|Overall Study|Adverse Event|2|||
157099967|NCT04641299|567121894|FG003|Overall Study|Adverse Event|0|||
157099968|NCT04641299|567121891|FG000|Overall Study|Lost to Follow-up|0|||
157099969|NCT04641299|567121892|FG001|Overall Study|Lost to Follow-up|1|||
157099970|NCT04641299|567121893|FG002|Overall Study|Lost to Follow-up|0|||
157099971|NCT04641299|567121894|FG003|Overall Study|Lost to Follow-up|0|||
156756617|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756618|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756619|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
157099972|NCT04641299|567121891|FG000|Overall Study|Withdrawal by Subject|1|||
157099973|NCT04641299|567121892|FG001|Overall Study|Withdrawal by Subject|0|||
157099974|NCT04641299|567121893|FG002|Overall Study|Withdrawal by Subject|0|||
157099975|NCT04641299|567121894|FG003|Overall Study|Withdrawal by Subject|0|||
157099976|NCT04641299|567121891|FG000|Overall Study|Reason not given|1|||
157099977|NCT04641299|567121892|FG001|Overall Study|Reason not given|0|||
157099978|NCT04641299|567121893|FG002|Overall Study|Reason not given|0|||
156997819|NCT00543725|566744817|FG000|Overall Study|Withdrawal by Subject|4|||
156997820|NCT00543725|566744818|FG001|Overall Study|Withdrawal by Subject|13|||
156997821|NCT00543725|566744817|FG000|Overall Study|Lost to Follow-up|15|||
156997822|NCT00543725|566744818|FG001|Overall Study|Lost to Follow-up|11|||
156997823|NCT00543725|566744817|FG000|Overall Study|Other|3|||
156997824|NCT00543725|566744818|FG001|Overall Study|Other|3|||
156997825|NCT01250002|566744819|FG000|Overall Study|Change to open surgical procedure|4|||
156997826|NCT01250002|566744820|FG001|Overall Study|Change to open surgical procedure|3|||
156997827|NCT00831792|566744831|FG000|Overall Study|Not Eligible|3|||
156997828|NCT00831792|566744831|FG000|Overall Study|Adverse Event|1|||
156997829|NCT00831792|566744831|FG000|Overall Study|Death|1|||
156997830|NCT00831792|566744831|FG000|Overall Study|Lack of Efficacy|1|||
156997831|NCT03736785|566744832|FG000|Overall Study|Adverse Event|1|||
156997832|NCT03736785|566744833|FG001|Overall Study|Adverse Event|1|||
156997833|NCT03736785|566744834|FG002|Overall Study|Adverse Event|1|||
156997834|NCT03736785|566744832|FG000|Overall Study|Death|1|||
156997835|NCT03736785|566744833|FG001|Overall Study|Death|0|||
156997836|NCT03736785|566744834|FG002|Overall Study|Death|1|||
156997837|NCT03736785|566744832|FG000|Overall Study|Lost to Follow-up|0|||
156997838|NCT03736785|566744833|FG001|Overall Study|Lost to Follow-up|2|||
156997839|NCT03736785|566744834|FG002|Overall Study|Lost to Follow-up|3|||
156997840|NCT03736785|566744832|FG000|Overall Study|Non compliance with study drug|1|||
156997841|NCT03736785|566744833|FG001|Overall Study|Non compliance with study drug|1|||
156997842|NCT03736785|566744834|FG002|Overall Study|Non compliance with study drug|0|||
156997843|NCT03736785|566744832|FG000|Overall Study|Physician Decision|0|||
156997844|NCT03736785|566744833|FG001|Overall Study|Physician Decision|1|||
156997845|NCT03736785|566744834|FG002|Overall Study|Physician Decision|1|||
156997846|NCT03736785|566744832|FG000|Overall Study|Protocol Violation|1|||
156997847|NCT03736785|566744833|FG001|Overall Study|Protocol Violation|4|||
156997848|NCT03736785|566744834|FG002|Overall Study|Protocol Violation|3|||
156997849|NCT03736785|566744832|FG000|Overall Study|Sponsor Decision|1|||
156997850|NCT03736785|566744833|FG001|Overall Study|Sponsor Decision|0|||
156997851|NCT03736785|566744834|FG002|Overall Study|Sponsor Decision|0|||
156997852|NCT03736785|566744832|FG000|Overall Study|Unknown/Missing data|3|||
156997853|NCT03736785|566744833|FG001|Overall Study|Unknown/Missing data|2|||
156997854|NCT03736785|566744834|FG002|Overall Study|Unknown/Missing data|1|||
156997855|NCT03736785|566744832|FG000|Overall Study|Withdrawal by Subject|9|||
156997856|NCT03736785|566744833|FG001|Overall Study|Withdrawal by Subject|6|||
156997857|NCT03736785|566744834|FG002|Overall Study|Withdrawal by Subject|4|||
156997858|NCT02974010|566744836|FG000|Overall Study|Lost to Follow-up|3|||
156997859|NCT02974010|566744837|FG001|Overall Study|Lost to Follow-up|1|||
156997860|NCT02974010|566744838|FG002|Overall Study|Lost to Follow-up|0|||
156997861|NCT02974010|566744839|FG003|Overall Study|Lost to Follow-up|0|||
156997862|NCT02974010|566744836|FG000|Overall Study|Withdrawal by Subject|2|||
156997863|NCT02974010|566744837|FG001|Overall Study|Withdrawal by Subject|1|||
156997864|NCT02974010|566744838|FG002|Overall Study|Withdrawal by Subject|0|||
156997865|NCT02974010|566744839|FG003|Overall Study|Withdrawal by Subject|0|||
156997866|NCT02974010|566744836|FG000|Overall Study|Adverse Event|0|||
156997867|NCT02974010|566744837|FG001|Overall Study|Adverse Event|1|||
156997868|NCT02974010|566744838|FG002|Overall Study|Adverse Event|0|||
156997869|NCT02974010|566744839|FG003|Overall Study|Adverse Event|0|||
156997870|NCT02974010|566744836|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
156997871|NCT02974010|566744837|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
156997872|NCT02974010|566744838|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
156997873|NCT02974010|566744839|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
156997874|NCT02974010|566744836|FG000|Overall Study|Lack of Efficacy|0|||
156997875|NCT02974010|566744837|FG001|Overall Study|Lack of Efficacy|0|||
156997876|NCT02974010|566744838|FG002|Overall Study|Lack of Efficacy|1|||
156997877|NCT02974010|566744839|FG003|Overall Study|Lack of Efficacy|0|||
156997878|NCT00880906|566744840|FG000|Overall Study|Lost to Follow-up|0|||
156997879|NCT00880906|566744841|FG001|Overall Study|Lost to Follow-up|1|||
156997880|NCT00880906|566744840|FG000|Overall Study|Did not meet criteria following patholog|12|||
156997881|NCT00880906|566744841|FG001|Overall Study|Did not meet criteria following patholog|6|||
156997882|NCT01664104|566744842|FG000|Overall Study|Adverse Event|6|||
156997883|NCT01664104|566744842|FG000|Overall Study|Lack of Efficacy|2|||
156997884|NCT01664104|566744842|FG000|Overall Study|Withdrawal by Subject|1|||
156997885|NCT01664104|566744842|FG000|Overall Study|Lost to Follow-up|4|||
156997886|NCT01664104|566744842|FG000|Overall Study|Other|1|||
156997887|NCT01664104|566744842|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
156997888|NCT03586167|566744844|FG000|Overall Study|Other|1|||
156997889|NCT03586167|566744845|FG001|Overall Study|Other|0|||
156997890|NCT04163458|566744848|FG000|Overall Study|Protocol Deviation|7|||
156997891|NCT04163458|566744849|FG001|Overall Study|Protocol Deviation|13|||
156997892|NCT04163458|566744848|FG000|Overall Study|Adverse Event|5|||
156997893|NCT04163458|566744849|FG001|Overall Study|Adverse Event|8|||
156997894|NCT04163458|566744848|FG000|Overall Study|Due to COVID-19 pandemic|4|||
156997895|NCT04163458|566744849|FG001|Overall Study|Due to COVID-19 pandemic|2|||
156997896|NCT04163458|566744848|FG000|Overall Study|Participant withdrew consent|2|||
156997897|NCT04163458|566744849|FG001|Overall Study|Participant withdrew consent|3|||
156997898|NCT04163458|566744848|FG000|Overall Study|Randomization failure|2|||
156997899|NCT04163458|566744849|FG001|Overall Study|Randomization failure|2|||
156997900|NCT04163458|566744848|FG000|Overall Study|Other|4|||
156997901|NCT04163458|566744849|FG001|Overall Study|Other|2|||
156997902|NCT03852433|566744855|FG000|Overall Study|Withdrawal of consent|5|||
156997903|NCT03852433|566744856|FG001|Overall Study|Withdrawal of consent|8|||
156997904|NCT03852433|566744857|FG002|Overall Study|Withdrawal of consent|1|||
156997905|NCT03852433|566744858|FG003|Overall Study|Withdrawal of consent|1|||
156997906|NCT03852433|566744855|FG000|Overall Study|Adverse Event|1|||
156997907|NCT03852433|566744856|FG001|Overall Study|Adverse Event|1|||
156997908|NCT03852433|566744857|FG002|Overall Study|Adverse Event|1|||
156997909|NCT03852433|566744858|FG003|Overall Study|Adverse Event|1|||
156997910|NCT03852433|566744855|FG000|Overall Study|Lost to Follow-up|0|||
156997911|NCT03852433|566744856|FG001|Overall Study|Lost to Follow-up|1|||
156997912|NCT03852433|566744857|FG002|Overall Study|Lost to Follow-up|0|||
156997913|NCT03852433|566744858|FG003|Overall Study|Lost to Follow-up|1|||
156997914|NCT03852433|566744855|FG000|Overall Study|Pregnancy|0|||
156997915|NCT03852433|566744856|FG001|Overall Study|Pregnancy|1|||
156997916|NCT03852433|566744857|FG002|Overall Study|Pregnancy|1|||
156997917|NCT03852433|566744858|FG003|Overall Study|Pregnancy|0|||
156997918|NCT03852433|566744855|FG000|Overall Study|Protocol Violation|0|||
156997919|NCT03852433|566744856|FG001|Overall Study|Protocol Violation|0|||
156997920|NCT03852433|566744857|FG002|Overall Study|Protocol Violation|1|||
156997921|NCT03852433|566744858|FG003|Overall Study|Protocol Violation|1|||
156997922|NCT03852433|566744855|FG000|Overall Study|Death|0|||
156997923|NCT03852433|566744856|FG001|Overall Study|Death|0|||
156997924|NCT03852433|566744857|FG002|Overall Study|Death|1|||
156997925|NCT03852433|566744858|FG003|Overall Study|Death|0|||
156997926|NCT03852433|566744855|FG000|Overall Study|Lack of Efficacy|0|||
156997927|NCT03852433|566744856|FG001|Overall Study|Lack of Efficacy|1|||
156997928|NCT03852433|566744857|FG002|Overall Study|Lack of Efficacy|0|||
156997929|NCT03852433|566744858|FG003|Overall Study|Lack of Efficacy|0|||
156997930|NCT03852433|566744855|FG000|Overall Study|Non-compliance with study drug|0|||
156997931|NCT03852433|566744856|FG001|Overall Study|Non-compliance with study drug|0|||
156997932|NCT03852433|566744857|FG002|Overall Study|Non-compliance with study drug|0|||
156997933|NCT03852433|566744858|FG003|Overall Study|Non-compliance with study drug|1|||
156997934|NCT03852433|566744855|FG000|Overall Study|Physician Decision|1|||
156997935|NCT03852433|566744856|FG001|Overall Study|Physician Decision|0|||
156997936|NCT03852433|566744857|FG002|Overall Study|Physician Decision|0|||
156997937|NCT03852433|566744858|FG003|Overall Study|Physician Decision|0|||
156997938|NCT03852433|566744855|FG000|Overall Study|Randomized but never treated|1|||
156997939|NCT03852433|566744856|FG001|Overall Study|Randomized but never treated|0|||
156997940|NCT03852433|566744857|FG002|Overall Study|Randomized but never treated|0|||
156997941|NCT03852433|566744858|FG003|Overall Study|Randomized but never treated|0|||
156997942|NCT01467700|566744859|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
156997943|NCT01467700|566744860|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
156997944|NCT01467700|566744861|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
156997945|NCT01467700|566744862|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
156997946|NCT01467700|566744859|FG000|Overall Study|Major Protocol Deviation|3|||
156997947|NCT01467700|566744860|FG001|Overall Study|Major Protocol Deviation|3|||
156997948|NCT01467700|566744861|FG002|Overall Study|Major Protocol Deviation|2|||
156997949|NCT01467700|566744862|FG003|Overall Study|Major Protocol Deviation|3|||
156997950|NCT01467700|566744859|FG000|Overall Study|Lost to Follow-up|6|||
156997951|NCT01467700|566744860|FG001|Overall Study|Lost to Follow-up|5|||
156997952|NCT01467700|566744861|FG002|Overall Study|Lost to Follow-up|2|||
156997953|NCT01467700|566744862|FG003|Overall Study|Lost to Follow-up|3|||
156997954|NCT01467700|566744859|FG000|Overall Study|Voluntary Withdrawal|5|||
156997955|NCT01467700|566744860|FG001|Overall Study|Voluntary Withdrawal|7|||
156997956|NCT01467700|566744861|FG002|Overall Study|Voluntary Withdrawal|6|||
156997957|NCT01467700|566744862|FG003|Overall Study|Voluntary Withdrawal|2|||
156997958|NCT01467700|566744859|FG000|Overall Study|Study Termination|6|||
156997959|NCT01467700|566744860|FG001|Overall Study|Study Termination|5|||
156997960|NCT01467700|566744861|FG002|Overall Study|Study Termination|10|||
156997961|NCT01467700|566744862|FG003|Overall Study|Study Termination|7|||
156997962|NCT01467700|566744859|FG000|Overall Study|Pregnancy|0|||
156997963|NCT01467700|566744860|FG001|Overall Study|Pregnancy|1|||
156997964|NCT01467700|566744861|FG002|Overall Study|Pregnancy|1|||
156997965|NCT01467700|566744862|FG003|Overall Study|Pregnancy|0|||
156997966|NCT01467700|566744859|FG000|Overall Study|Lack of Efficacy|2|||
156997967|NCT01467700|566744860|FG001|Overall Study|Lack of Efficacy|0|||
156997968|NCT01467700|566744861|FG002|Overall Study|Lack of Efficacy|2|||
157099979|NCT04641299|567121894|FG003|Overall Study|Reason not given|0|||
157099980|NCT01890148|567121898|FG000|Overall Study|Adverse Event|1|||
157099981|NCT00234494|567121899|FG000|Overall Study|Protocol Violation|2|||
157099982|NCT05104476|567121904|FG000|Overall Study|Randomized But Not Treated|1|||
157099983|NCT05104476|567121905|FG001|Overall Study|Randomized But Not Treated|2|||
157099984|NCT05104476|567121904|FG000|Overall Study|Adverse Event|2|||
157099985|NCT05104476|567121905|FG001|Overall Study|Adverse Event|2|||
157099986|NCT05104476|567121904|FG000|Overall Study|Withdrawal by Subject|3|||
157099987|NCT05104476|567121905|FG001|Overall Study|Withdrawal by Subject|3|||
157099988|NCT05104476|567121904|FG000|Overall Study|Other Than Specified|0|||
157099989|NCT05104476|567121905|FG001|Overall Study|Other Than Specified|3|||
157099990|NCT02170389|567121908|FG000|Overall Study|Study terminated prior to start of treat|1|||
157099991|NCT01862640|567121911|FG000|Overall Study|Adverse Event|4|||
157099992|NCT01862640|567121912|FG001|Overall Study|Adverse Event|10|||
157099993|NCT01862640|567121913|FG002|Overall Study|Adverse Event|6|||
157099994|NCT01862640|567121914|FG003|Overall Study|Adverse Event|8|||
157099995|NCT01862640|567121911|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156756620|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756621|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756622|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
156756623|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756624|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756625|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
156756626|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756627|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756628|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
156756629|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
156756630|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
156756631|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
156756632|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
156756633|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
156756634|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
156756635|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
156756636|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
156756637|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
156756638|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
156756639|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
156756640|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
156756641|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
156756642|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
156756643|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
157099996|NCT01862640|567121912|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
157099997|NCT01862640|567121913|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
157099998|NCT01862640|567121914|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
157099999|NCT01862640|567121911|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
157100000|NCT01862640|567121912|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
157100001|NCT01862640|567121913|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
156997969|NCT01467700|566744862|FG003|Overall Study|Lack of Efficacy|1|||
156997970|NCT01467700|566744859|FG000|Overall Study|Reason not Specified|1|||
156997971|NCT01467700|566744860|FG001|Overall Study|Reason not Specified|3|||
156997972|NCT01467700|566744861|FG002|Overall Study|Reason not Specified|2|||
156997973|NCT01467700|566744862|FG003|Overall Study|Reason not Specified|8|||
156997974|NCT00121199|566744870|FG000|Overall Study|Adverse Event|11|||
156997975|NCT00121199|566744870|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156997976|NCT00121199|566744870|FG000|Overall Study|Progression/Relapse|1|||
156997977|NCT00121199|566744870|FG000|Overall Study|Death|3|||
156997978|NCT00121199|566744870|FG000|Overall Study|Other - Not Protocol Specified|3|||
156997979|NCT00121199|566744870|FG000|Overall Study|Ineligible|9|||
156997980|NCT03168438|566744871|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
156997981|NCT03168438|566744872|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
156997982|NCT04109118|566744875|FG000|Overall Study|Lost to Follow-up|3|||
156997983|NCT03235349|566744878|FG000|Overall Study|Adverse Event|1|||
156997984|NCT03235349|566744878|FG000|Overall Study|Other|1|||
156997985|NCT03394027|566744879|FG000|Overall Study|Ineligible|3|||
156997986|NCT03394027|566744880|FG001|Overall Study|Ineligible|1|||
156997987|NCT03394027|566744881|FG002|Overall Study|Ineligible|3|||
156997988|NCT03394027|566744879|FG000|Overall Study|Participant declined to participate before treatment started|0|||
156997989|NCT03394027|566744880|FG001|Overall Study|Participant declined to participate before treatment started|0|||
156997990|NCT03394027|566744881|FG002|Overall Study|Participant declined to participate before treatment started|1|||
156997991|NCT04305912|566744885|FG000|First Intervention|COVID-19 Suspension|2|||
156997992|NCT04305912|566744886|FG001|First Intervention|COVID-19 Suspension|0|||
156997993|NCT04305912|566744885|FG000|First Intervention|Withdrawal by Subject|0|||
156997994|NCT04305912|566744886|FG001|First Intervention|Withdrawal by Subject|1|||
156997995|NCT04305912|566744885|FG000|Second Intervention|Adverse Event|0|||
156997996|NCT04305912|566744886|FG001|Second Intervention|Adverse Event|1|||
156997997|NCT01348087|566744888|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
156997998|NCT01348087|566744888|FG000|Overall Study|Administrative problems|79|||
156997999|NCT01348087|566744888|FG000|Overall Study|protocol deviation|1|||
156998000|NCT01348087|566744888|FG000|Overall Study|Lost to Follow-up|1|||
156998001|NCT01348087|566744888|FG000|Overall Study|Subject withdrew consent|7|||
156998002|NCT01348087|566744888|FG000|Overall Study|Adverse Event|25|||
156998003|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
156998004|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
156998005|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
156998006|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156998007|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156998008|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
156998009|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
156998010|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
156998011|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
156998012|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
156998013|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
156998014|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
156998015|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156998016|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156998017|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156998018|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
156998019|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156998020|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
156998021|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
156998022|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
156998023|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
156998024|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998025|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998026|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998027|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998028|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998029|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
156998030|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
156998031|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
157100002|NCT01862640|567121914|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
156998032|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
156998033|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156998034|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156998035|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156998036|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156998037|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156756644|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
157100003|NCT01862640|567121911|FG000|Overall Study|Withdrawal by Subject|2|||
157100004|NCT01862640|567121912|FG001|Overall Study|Withdrawal by Subject|4|||
157100005|NCT01862640|567121913|FG002|Overall Study|Withdrawal by Subject|8|||
157100006|NCT01862640|567121914|FG003|Overall Study|Withdrawal by Subject|5|||
157100007|NCT01862640|567121911|FG000|Overall Study|Protocol Deviation|0|||
157100008|NCT01862640|567121912|FG001|Overall Study|Protocol Deviation|0|||
157100009|NCT01862640|567121913|FG002|Overall Study|Protocol Deviation|1|||
157100010|NCT01862640|567121914|FG003|Overall Study|Protocol Deviation|0|||
157100011|NCT05085665|567121915|FG000|Overall Study|Physician Decision|2|||
157100012|NCT01717768|567121916|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100013|NCT01717768|567121917|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
157100014|NCT01717768|567121918|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100015|NCT01717768|567121919|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100016|NCT01717768|567121920|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100017|NCT01717768|567121921|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100018|NCT01717768|567121922|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100019|NCT01717768|567121923|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100020|NCT01717768|567121924|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100021|NCT01717768|567121925|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100022|NCT01717768|567121926|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100023|NCT01717768|567121927|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
157100024|NCT01717768|567121916|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100025|NCT01717768|567121917|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100026|NCT01717768|567121918|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100027|NCT01717768|567121919|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100028|NCT01717768|567121920|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100029|NCT01717768|567121921|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100030|NCT01717768|567121922|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100031|NCT01717768|567121923|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100032|NCT01717768|567121924|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100033|NCT01717768|567121925|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100034|NCT01717768|567121926|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
157100035|NCT01717768|567121927|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
157100036|NCT01717768|567121916|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100037|NCT01717768|567121917|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100038|NCT01717768|567121918|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100039|NCT01717768|567121919|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100040|NCT01717768|567121920|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100041|NCT01717768|567121921|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100042|NCT01717768|567121922|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100043|NCT01717768|567121923|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
157100044|NCT01717768|567121924|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100045|NCT01717768|567121925|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100046|NCT01717768|567121926|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100047|NCT01717768|567121927|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
157100048|NCT01717768|567121916|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100049|NCT01717768|567121917|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100050|NCT01717768|567121918|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100051|NCT01717768|567121919|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100052|NCT01717768|567121920|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100053|NCT01717768|567121921|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100054|NCT01717768|567121922|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100055|NCT01717768|567121923|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100056|NCT01717768|567121924|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100057|NCT01717768|567121925|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
157100058|NCT01717768|567121926|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100059|NCT01717768|567121927|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
157100060|NCT01009554|567121929|FG000|Overall Study|Adverse Event|1|||
157100061|NCT01009554|567121930|FG001|Overall Study|Adverse Event|1|||
157100062|NCT01009554|567121929|FG000|Overall Study|Withdrawal by Subject|1|||
157100063|NCT01009554|567121930|FG001|Overall Study|Withdrawal by Subject|3|||
157100064|NCT01009554|567121929|FG000|Overall Study|Noncompliant with Study Product|0|||
157100065|NCT01009554|567121930|FG001|Overall Study|Noncompliant with Study Product|3|||
157100066|NCT02973048|567121933|FG000|Overall Study|Epidural catheter insertion failure|1|||
157100067|NCT02973048|567121934|FG001|Overall Study|Epidural catheter insertion failure|0|||
157100068|NCT02973048|567121933|FG000|Overall Study|Withdrawal by Subject|0|||
157100069|NCT02973048|567121934|FG001|Overall Study|Withdrawal by Subject|3|||
157100070|NCT04427501|567121937|FG000|Overall Study|Death|0|||
157100071|NCT04427501|567121938|FG001|Overall Study|Death|0|||
157100072|NCT04427501|567121939|FG002|Overall Study|Death|0|||
157100073|NCT04427501|567121940|FG003|Overall Study|Death|0|||
157100074|NCT04427501|567121941|FG004|Overall Study|Death|0|||
157100075|NCT04427501|567121942|FG005|Overall Study|Death|15|||
157100076|NCT04427501|567121943|FG006|Overall Study|Death|0|||
157100077|NCT04427501|567121944|FG007|Overall Study|Death|0|||
157100078|NCT04427501|567121945|FG008|Overall Study|Death|0|||
157100079|NCT04427501|567121946|FG009|Overall Study|Death|0|||
157100080|NCT04427501|567121947|FG010|Overall Study|Death|0|||
157100081|NCT04427501|567121948|FG011|Overall Study|Death|0|||
157100082|NCT04427501|567121937|FG000|Overall Study|Lost to Follow-up|5|||
157100083|NCT04427501|567121938|FG001|Overall Study|Lost to Follow-up|1|||
156998038|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
156998039|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
156998040|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
156998041|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
156998042|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156998043|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156998044|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156998045|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
156998046|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156998047|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
156998048|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
156998049|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998050|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998051|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998052|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998053|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998054|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998055|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998056|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
156998057|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998058|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
156998059|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998060|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
157100084|NCT04427501|567121939|FG002|Overall Study|Lost to Follow-up|2|||
157100085|NCT04427501|567121940|FG003|Overall Study|Lost to Follow-up|0|||
157100086|NCT04427501|567121941|FG004|Overall Study|Lost to Follow-up|2|||
157100087|NCT04427501|567121942|FG005|Overall Study|Lost to Follow-up|11|||
157100088|NCT04427501|567121943|FG006|Overall Study|Lost to Follow-up|10|||
157100089|NCT04427501|567121944|FG007|Overall Study|Lost to Follow-up|10|||
157100090|NCT04427501|567121945|FG008|Overall Study|Lost to Follow-up|2|||
157100091|NCT04427501|567121946|FG009|Overall Study|Lost to Follow-up|5|||
157100092|NCT04427501|567121947|FG010|Overall Study|Lost to Follow-up|2|||
157100093|NCT04427501|567121948|FG011|Overall Study|Lost to Follow-up|0|||
157100094|NCT04427501|567121937|FG000|Overall Study|Physician Decision|0|||
157100095|NCT04427501|567121938|FG001|Overall Study|Physician Decision|3|||
157100096|NCT04427501|567121939|FG002|Overall Study|Physician Decision|0|||
157100097|NCT04427501|567121940|FG003|Overall Study|Physician Decision|0|||
157100098|NCT04427501|567121941|FG004|Overall Study|Physician Decision|0|||
157100099|NCT04427501|567121942|FG005|Overall Study|Physician Decision|0|||
157100100|NCT04427501|567121943|FG006|Overall Study|Physician Decision|2|||
157100101|NCT04427501|567121944|FG007|Overall Study|Physician Decision|0|||
157100102|NCT04427501|567121945|FG008|Overall Study|Physician Decision|0|||
157100103|NCT04427501|567121946|FG009|Overall Study|Physician Decision|0|||
157100104|NCT04427501|567121947|FG010|Overall Study|Physician Decision|0|||
157100105|NCT04427501|567121948|FG011|Overall Study|Physician Decision|0|||
157100106|NCT04427501|567121937|FG000|Overall Study|Withdrawal by Subject|9|||
157100107|NCT04427501|567121938|FG001|Overall Study|Withdrawal by Subject|2|||
157100108|NCT04427501|567121939|FG002|Overall Study|Withdrawal by Subject|2|||
157100109|NCT04427501|567121940|FG003|Overall Study|Withdrawal by Subject|3|||
157100110|NCT04427501|567121941|FG004|Overall Study|Withdrawal by Subject|7|||
157100111|NCT04427501|567121942|FG005|Overall Study|Withdrawal by Subject|25|||
157100112|NCT04427501|567121943|FG006|Overall Study|Withdrawal by Subject|15|||
157100113|NCT04427501|567121944|FG007|Overall Study|Withdrawal by Subject|7|||
157100114|NCT04427501|567121945|FG008|Overall Study|Withdrawal by Subject|4|||
157100115|NCT04427501|567121946|FG009|Overall Study|Withdrawal by Subject|1|||
157100116|NCT04427501|567121947|FG010|Overall Study|Withdrawal by Subject|4|||
157100117|NCT04427501|567121948|FG011|Overall Study|Withdrawal by Subject|0|||
157100118|NCT04427501|567121937|FG000|Overall Study|Other - as reported by the investigator|1|||
157100119|NCT04427501|567121938|FG001|Overall Study|Other - as reported by the investigator|0|||
157100120|NCT04427501|567121939|FG002|Overall Study|Other - as reported by the investigator|0|||
157100121|NCT04427501|567121940|FG003|Overall Study|Other - as reported by the investigator|0|||
157100122|NCT04427501|567121941|FG004|Overall Study|Other - as reported by the investigator|0|||
157100123|NCT04427501|567121942|FG005|Overall Study|Other - as reported by the investigator|6|||
157100124|NCT04427501|567121943|FG006|Overall Study|Other - as reported by the investigator|6|||
157100125|NCT04427501|567121944|FG007|Overall Study|Other - as reported by the investigator|0|||
157100126|NCT04427501|567121945|FG008|Overall Study|Other - as reported by the investigator|0|||
157100127|NCT04427501|567121946|FG009|Overall Study|Other - as reported by the investigator|0|||
157100128|NCT04427501|567121947|FG010|Overall Study|Other - as reported by the investigator|0|||
157100129|NCT04427501|567121948|FG011|Overall Study|Other - as reported by the investigator|0|||
157100130|NCT04427501|567121937|FG000|Overall Study|Other|0|||
157100131|NCT04427501|567121938|FG001|Overall Study|Other|0|||
157100132|NCT04427501|567121939|FG002|Overall Study|Other|0|||
157100133|NCT04427501|567121940|FG003|Overall Study|Other|0|||
157100134|NCT04427501|567121941|FG004|Overall Study|Other|0|||
157100135|NCT04427501|567121942|FG005|Overall Study|Other|0|||
157100136|NCT04427501|567121943|FG006|Overall Study|Other|0|||
157100137|NCT04427501|567121944|FG007|Overall Study|Other|0|||
157100138|NCT04427501|567121945|FG008|Overall Study|Other|0|||
157100139|NCT04427501|567121946|FG009|Overall Study|Other|0|||
157100140|NCT04427501|567121947|FG010|Overall Study|Other|0|||
157100141|NCT04427501|567121948|FG011|Overall Study|Other|1|||
157100142|NCT03170154|567121949|FG000|Overall Study|Lost to Follow-up|4|||
157100143|NCT03170154|567121949|FG000|Overall Study|Death|2|||
157100144|NCT03170154|567121949|FG000|Overall Study|Withdrawal by Subject|2|||
157100145|NCT01906346|567121952|FG000|Overall Study|AEs|1|||
157100146|NCT02279862|567121953|FG000|Overall Study|Study drug toxicity|3|||
157100147|NCT02279862|567121954|FG001|Overall Study|Study drug toxicity|6|||
157100148|NCT02279862|567121953|FG000|Overall Study|No longer meets criteria|0|||
157100149|NCT02279862|567121954|FG001|Overall Study|No longer meets criteria|1|||
157100150|NCT02279862|567121953|FG000|Overall Study|Administrative reason by sponsor|0|||
157100151|NCT02279862|567121954|FG001|Overall Study|Administrative reason by sponsor|1|||
157100152|NCT02279862|567121953|FG000|Overall Study|Disease progression|5|||
157100153|NCT02279862|567121954|FG001|Overall Study|Disease progression|2|||
157100154|NCT02279862|567121953|FG000|Overall Study|Study closed by sponsor|16|||
157100155|NCT02279862|567121954|FG001|Overall Study|Study closed by sponsor|13|||
157100156|NCT02279862|567121953|FG000|Overall Study|Other|1|||
157100157|NCT02279862|567121954|FG001|Overall Study|Other|2|||
157100158|NCT02279862|567121953|FG000|Overall Study|Withdrawal by Subject|1|||
157100159|NCT02279862|567121954|FG001|Overall Study|Withdrawal by Subject|0|||
157100160|NCT04343248|567121960|FG000|Overall Study|Withdrawal by Subject|5|||
157100161|NCT04343248|567121961|FG001|Overall Study|Withdrawal by Subject|6|||
157100162|NCT04343248|567121960|FG000|Overall Study|Death|1|||
157100163|NCT04343248|567121961|FG001|Overall Study|Death|2|||
157100164|NCT04343248|567121960|FG000|Overall Study|Lost to Follow-up|9|||
157100165|NCT04343248|567121961|FG001|Overall Study|Lost to Follow-up|6|||
157100166|NCT04343248|567121960|FG000|Overall Study|Physician Decision|0|||
157100167|NCT04343248|567121961|FG001|Overall Study|Physician Decision|1|||
157100168|NCT04343248|567121960|FG000|Overall Study|Adverse Event|1|||
157100169|NCT04343248|567121961|FG001|Overall Study|Adverse Event|0|||
157100170|NCT02708095|567121962|FG000|Overall Study|Adverse Event|4|||
157100171|NCT02708095|567121963|FG001|Overall Study|Adverse Event|10|||
157100172|NCT02708095|567121964|FG002|Overall Study|Adverse Event|11|||
157100173|NCT02708095|567121962|FG000|Overall Study|Lack of Efficacy|9|||
157100174|NCT02708095|567121963|FG001|Overall Study|Lack of Efficacy|3|||
157100175|NCT02708095|567121964|FG002|Overall Study|Lack of Efficacy|0|||
157100176|NCT02708095|567121962|FG000|Overall Study|Lost to Follow-up|2|||
157100177|NCT02708095|567121963|FG001|Overall Study|Lost to Follow-up|0|||
157100178|NCT02708095|567121964|FG002|Overall Study|Lost to Follow-up|0|||
157100179|NCT02708095|567121962|FG000|Overall Study|Physician Decision|2|||
157100180|NCT02708095|567121963|FG001|Overall Study|Physician Decision|3|||
157100181|NCT02708095|567121964|FG002|Overall Study|Physician Decision|2|||
157100182|NCT02708095|567121962|FG000|Overall Study|Protocol Violation|0|||
157100183|NCT02708095|567121963|FG001|Overall Study|Protocol Violation|0|||
157100184|NCT02708095|567121964|FG002|Overall Study|Protocol Violation|1|||
157100185|NCT02708095|567121962|FG000|Overall Study|Withdrawal by Subject|5|||
157100186|NCT02708095|567121963|FG001|Overall Study|Withdrawal by Subject|3|||
157100187|NCT02708095|567121964|FG002|Overall Study|Withdrawal by Subject|4|||
157100188|NCT01210118|567121979|FG000|Overall Study|Lost to Follow-up|1|||
157100189|NCT01210118|567121980|FG001|Overall Study|Lost to Follow-up|1|||
157100190|NCT01210118|567121979|FG000|Overall Study|Protocol Violation|1|||
157100191|NCT01210118|567121980|FG001|Overall Study|Protocol Violation|1|||
157100192|NCT01210118|567121979|FG000|Overall Study|Spontaneous abortion|1|||
157100193|NCT01210118|567121980|FG001|Overall Study|Spontaneous abortion|3|||
157100194|NCT00777946|567121981|FG000|Overall Study|Adverse Event|11|||
157100195|NCT00777946|567121982|FG001|Overall Study|Adverse Event|1|||
157100196|NCT00777946|567121983|FG002|Overall Study|Adverse Event|3|||
157100197|NCT00777946|567121981|FG000|Overall Study|Lack of Efficacy|0|||
157100198|NCT00777946|567121982|FG001|Overall Study|Lack of Efficacy|0|||
157100199|NCT00777946|567121983|FG002|Overall Study|Lack of Efficacy|9|||
157100200|NCT00777946|567121981|FG000|Overall Study|Condition no longer required study drug|1|||
157100201|NCT00777946|567121982|FG001|Overall Study|Condition no longer required study drug|0|||
157100202|NCT00777946|567121983|FG002|Overall Study|Condition no longer required study drug|0|||
157100203|NCT00777946|567121981|FG000|Overall Study|Patient withdrew consent|3|||
157100204|NCT00777946|567121982|FG001|Overall Study|Patient withdrew consent|2|||
157100205|NCT00777946|567121983|FG002|Overall Study|Patient withdrew consent|3|||
157100206|NCT00777946|567121981|FG000|Overall Study|Lost to Follow-up|3|||
157100207|NCT00777946|567121982|FG001|Overall Study|Lost to Follow-up|1|||
157100208|NCT00777946|567121983|FG002|Overall Study|Lost to Follow-up|0|||
157100209|NCT00777946|567121981|FG000|Overall Study|Protocol deviation|2|||
157100210|NCT00777946|567121982|FG001|Overall Study|Protocol deviation|1|||
157100211|NCT00777946|567121983|FG002|Overall Study|Protocol deviation|1|||
157100212|NCT00777946|567121981|FG000|Overall Study|Randomized in error|1|||
157100213|NCT00777946|567121982|FG001|Overall Study|Randomized in error|1|||
157100214|NCT00777946|567121983|FG002|Overall Study|Randomized in error|0|||
157100215|NCT01079130|567121984|FG000|Overall Study|Adverse Event|1|||
157100216|NCT01079130|567121985|FG001|Overall Study|Adverse Event|1|||
157100217|NCT01079130|567121986|FG002|Overall Study|Adverse Event|0|||
157100218|NCT01079130|567121987|FG003|Overall Study|Adverse Event|1|||
157100219|NCT01079130|567121988|FG004|Overall Study|Adverse Event|5|||
157100220|NCT01079130|567121989|FG005|Overall Study|Adverse Event|1|||
157100221|NCT01079130|567121984|FG000|Overall Study|Administrative problems|1|||
157100222|NCT01079130|567121985|FG001|Overall Study|Administrative problems|3|||
157100223|NCT01079130|567121986|FG002|Overall Study|Administrative problems|0|||
157100224|NCT01079130|567121987|FG003|Overall Study|Administrative problems|0|||
157100225|NCT01079130|567121988|FG004|Overall Study|Administrative problems|0|||
157100226|NCT01079130|567121989|FG005|Overall Study|Administrative problems|1|||
157100227|NCT01079130|567121984|FG000|Overall Study|Withdrawal by Subject|0|||
157100228|NCT01079130|567121985|FG001|Overall Study|Withdrawal by Subject|1|||
157100229|NCT01079130|567121986|FG002|Overall Study|Withdrawal by Subject|0|||
157100230|NCT01079130|567121987|FG003|Overall Study|Withdrawal by Subject|0|||
157100231|NCT01079130|567121988|FG004|Overall Study|Withdrawal by Subject|1|||
157100232|NCT01079130|567121989|FG005|Overall Study|Withdrawal by Subject|3|||
157100233|NCT01079130|567121984|FG000|Overall Study|Protocol deviation|0|||
157100234|NCT01079130|567121985|FG001|Overall Study|Protocol deviation|2|||
157100235|NCT01079130|567121986|FG002|Overall Study|Protocol deviation|1|||
156756645|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
156756646|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
156756647|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
156756648|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
156756649|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756650|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756651|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756652|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756653|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
157100236|NCT01079130|567121987|FG003|Overall Study|Protocol deviation|2|||
157100237|NCT01079130|567121988|FG004|Overall Study|Protocol deviation|0|||
157100238|NCT01079130|567121989|FG005|Overall Study|Protocol deviation|0|||
157100239|NCT01079130|567121984|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157100240|NCT01079130|567121985|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157100241|NCT01079130|567121986|FG002|Overall Study|Abnormal test procedure result(s)|0|||
157100242|NCT01079130|567121987|FG003|Overall Study|Abnormal test procedure result(s)|0|||
157100243|NCT01079130|567121988|FG004|Overall Study|Abnormal test procedure result(s)|1|||
157100244|NCT01079130|567121989|FG005|Overall Study|Abnormal test procedure result(s)|0|||
157100245|NCT01079130|567121984|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157100246|NCT01079130|567121985|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157100247|NCT01079130|567121986|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
157100248|NCT01079130|567121987|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
157100249|NCT01079130|567121988|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
156756654|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156998061|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998062|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998063|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998064|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998065|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998066|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998067|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998068|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
156998069|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998070|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998071|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998072|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998073|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998074|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
156998075|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
156998076|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998077|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998078|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998079|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998080|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998081|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998082|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998083|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
156998084|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
156998085|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998086|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998087|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998088|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998089|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998090|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998091|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998092|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
156998093|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
156998094|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998095|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998096|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998097|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
157100250|NCT01079130|567121989|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
157100251|NCT01079130|567121984|FG000|Overall Study|Lost to Follow-up|0|||
157100252|NCT01079130|567121985|FG001|Overall Study|Lost to Follow-up|0|||
157100253|NCT01079130|567121986|FG002|Overall Study|Lost to Follow-up|0|||
157100254|NCT01079130|567121987|FG003|Overall Study|Lost to Follow-up|0|||
157100255|NCT01079130|567121988|FG004|Overall Study|Lost to Follow-up|1|||
157100256|NCT01079130|567121989|FG005|Overall Study|Lost to Follow-up|0|||
157100257|NCT00174265|567121996|FG000|Overall Study|Adverse Event|7|||
157100258|NCT00174265|567121997|FG001|Overall Study|Adverse Event|4|||
157100259|NCT00174265|567121996|FG000|Overall Study|Lack of Efficacy|2|||
157100260|NCT00174265|567121997|FG001|Overall Study|Lack of Efficacy|2|||
157100261|NCT00174265|567121996|FG000|Overall Study|Withdrawal by Subject|3|||
157100262|NCT00174265|567121997|FG001|Overall Study|Withdrawal by Subject|5|||
157100263|NCT00174265|567121996|FG000|Overall Study|Lost to Follow-up|1|||
157100264|NCT00174265|567121997|FG001|Overall Study|Lost to Follow-up|0|||
157100265|NCT00174265|567121996|FG000|Overall Study|Other (Not specified)|16|||
157100266|NCT00174265|567121997|FG001|Overall Study|Other (Not specified)|10|||
157100267|NCT03040622|567121998|FG000|Overall Study|unable to implant device|3|||
157100268|NCT02818920|567121999|FG000|Overall Study|Unresectable|4|||
157100269|NCT02818920|567121999|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
157100270|NCT02818920|567121999|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
157100271|NCT02818920|567121999|FG000|Overall Study|Adverse Event|3|||
157100272|NCT02818920|567121999|FG000|Overall Study|Developed Other Disease|1|||
157100273|NCT02818920|567121999|FG000|Overall Study|Refused Further Treatment|1|||
157100274|NCT00445068|567122000|FG000|Overall Study|Disease progression|26|||
157100275|NCT00445068|567122000|FG000|Overall Study|Adverse Event|5|||
157100276|NCT00445068|567122000|FG000|Overall Study|Abnormal laboratory value|2|||
157100277|NCT00445068|567122000|FG000|Overall Study|Withdrawal by Subject|2|||
157100278|NCT00445068|567122000|FG000|Overall Study|Death|1|||
157100279|NCT02673619|567122001|FG000|Overall Study|Lost to Follow-up|1|||
157100280|NCT02673619|567122002|FG001|Overall Study|Lost to Follow-up|0|||
157100281|NCT02673619|567122003|FG002|Overall Study|Lost to Follow-up|0|||
157100282|NCT02673619|567122004|FG003|Overall Study|Lost to Follow-up|0|||
157100283|NCT02673619|567122001|FG000|Overall Study|Withdrawal by Subject|1|||
157100284|NCT02673619|567122002|FG001|Overall Study|Withdrawal by Subject|1|||
157100285|NCT02673619|567122003|FG002|Overall Study|Withdrawal by Subject|1|||
157100286|NCT02673619|567122004|FG003|Overall Study|Withdrawal by Subject|0|||
157100287|NCT02673619|567122001|FG000|Overall Study|Adverse Event|0|||
157100288|NCT02673619|567122002|FG001|Overall Study|Adverse Event|0|||
157100289|NCT02673619|567122003|FG002|Overall Study|Adverse Event|1|||
157100290|NCT02673619|567122004|FG003|Overall Study|Adverse Event|0|||
157100291|NCT02673619|567122001|FG000|Overall Study|Lack of Efficacy|0|||
157100292|NCT02673619|567122002|FG001|Overall Study|Lack of Efficacy|0|||
157100293|NCT02673619|567122003|FG002|Overall Study|Lack of Efficacy|1|||
157100294|NCT02673619|567122004|FG003|Overall Study|Lack of Efficacy|0|||
157100295|NCT03444324|567122005|FG000|Overall Study|Withdrawal by Subject|0|||
157100296|NCT03444324|567122006|FG001|Overall Study|Withdrawal by Subject|1|||
157100297|NCT03444324|567122005|FG000|Overall Study|Lost to Follow-up|4|||
157100298|NCT03444324|567122006|FG001|Overall Study|Lost to Follow-up|2|||
157100299|NCT03444324|567122005|FG000|Overall Study|Protocol Violation|0|||
157100300|NCT03444324|567122006|FG001|Overall Study|Protocol Violation|1|||
157100301|NCT03444324|567122005|FG000|Overall Study|Lack of Trial Compliance|1|||
157100302|NCT03444324|567122006|FG001|Overall Study|Lack of Trial Compliance|1|||
157100303|NCT03444324|567122005|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
157100304|NCT03444324|567122006|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
157100305|NCT06071754|567122010|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
157100306|NCT06069778|567123513|FG000|Overall Study|Withdrawal by Subject|1|||
157100307|NCT03801902|567123514|FG000|Overall Study|Did not receive protocol treatment.|1|||
157100308|NCT03801902|567123515|FG001|Overall Study|Did not receive protocol treatment.|0|||
157100309|NCT03801902|567123516|FG002|Overall Study|Did not receive protocol treatment.|0|||
157100310|NCT03801902|567123517|FG003|Overall Study|Did not receive protocol treatment.|0|||
157100311|NCT02260882|567123518|FG000|Overall Study|Protocol Violation|0|||
157100312|NCT02260882|567123519|FG001|Overall Study|Protocol Violation|1|||
157100313|NCT00954174|567123526|FG000|Overall Study|Adverse Event|28|||
157100314|NCT00954174|567123527|FG001|Overall Study|Adverse Event|23|||
157100315|NCT00954174|567123528|FG002|Overall Study|Adverse Event|4|||
157100316|NCT00954174|567123529|FG003|Overall Study|Adverse Event|9|||
157100317|NCT00954174|567123526|FG000|Overall Study|Death|4|||
157100318|NCT00954174|567123527|FG001|Overall Study|Death|2|||
157100319|NCT00954174|567123528|FG002|Overall Study|Death|0|||
157100320|NCT00954174|567123529|FG003|Overall Study|Death|0|||
157100321|NCT00954174|567123526|FG000|Overall Study|Lack of Efficacy|32|||
157100322|NCT00954174|567123527|FG001|Overall Study|Lack of Efficacy|22|||
157100323|NCT00954174|567123528|FG002|Overall Study|Lack of Efficacy|8|||
157100324|NCT00954174|567123529|FG003|Overall Study|Lack of Efficacy|6|||
157100325|NCT00954174|567123526|FG000|Overall Study|Withdrawal by Subject|14|||
157100326|NCT00954174|567123527|FG001|Overall Study|Withdrawal by Subject|10|||
157100327|NCT00954174|567123528|FG002|Overall Study|Withdrawal by Subject|4|||
157100328|NCT00954174|567123529|FG003|Overall Study|Withdrawal by Subject|3|||
157100329|NCT00954174|567123526|FG000|Overall Study|Medical Reason|4|||
157100330|NCT00954174|567123527|FG001|Overall Study|Medical Reason|2|||
157100331|NCT00954174|567123528|FG002|Overall Study|Medical Reason|1|||
157100332|NCT00954174|567123529|FG003|Overall Study|Medical Reason|0|||
157100333|NCT00954174|567123526|FG000|Overall Study|Ineligible|40|||
157100334|NCT00954174|567123527|FG001|Overall Study|Ineligible|47|||
157100335|NCT00954174|567123528|FG002|Overall Study|Ineligible|7|||
157100336|NCT00954174|567123529|FG003|Overall Study|Ineligible|4|||
157100337|NCT00954174|567123526|FG000|Overall Study|Never Treated|4|||
157100338|NCT00954174|567123527|FG001|Overall Study|Never Treated|17|||
157100339|NCT00954174|567123528|FG002|Overall Study|Never Treated|0|||
157100340|NCT00954174|567123529|FG003|Overall Study|Never Treated|3|||
157100341|NCT02234323|567123530|FG000|All Enrolled|Not Treated: Completed study in database|2|||
157100342|NCT02234323|567123530|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
157100343|NCT02234323|567123530|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
157100344|NCT02234323|567123530|FG000|All Treated|Death|1|||
157100345|NCT02234323|567123530|FG000|All Treated|Physician Decision|5|||
157100346|NCT02234323|567123530|FG000|All Treated|Lack of Efficacy|3|||
157100347|NCT02234323|567123530|FG000|All Treated|Exceeded lab value limit|2|||
157100348|NCT02234323|567123530|FG000|All Treated|Other|7|||
157100349|NCT04209621|567123531|FG000|Overall Study|Death|1|||
157100350|NCT04209621|567123531|FG000|Overall Study|Study Terminated Early|2|||
157100351|NCT02249767|567123532|FG000|Overall Study|Did not use medication|8|||
157100352|NCT02249767|567123533|FG001|Overall Study|Did not use medication|9|||
157100353|NCT02249767|567123534|FG002|Overall Study|Did not use medication|8|||
157100354|NCT02644941|567123535|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
157100355|NCT02644941|567123536|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
157100356|NCT04585646|567123537|FG000|First Intervention|Physician Decision|1|||
157100357|NCT04585646|567123538|FG001|First Intervention|Physician Decision|0|||
157100358|NCT04585646|567123537|FG000|First Intervention|Lost to Follow-up|0|||
157100359|NCT04585646|567123538|FG001|First Intervention|Lost to Follow-up|3|||
157100360|NCT04585646|567123537|FG000|First Intervention|Withdrawal by Subject|0|||
157100361|NCT04585646|567123538|FG001|First Intervention|Withdrawal by Subject|1|||
157100362|NCT01145495|567123539|FG000|Overall Study|Adverse Event|6|||
157100363|NCT01145495|567123539|FG000|Overall Study|Withdrawal by Subject|6|||
157100364|NCT01145495|567123539|FG000|Overall Study|Disease progression after respone|2|||
157100365|NCT04614662|567123542|FG000|Overall Study|Withdrawal by Subject|0|||
157100366|NCT04614662|567123543|FG001|Overall Study|Withdrawal by Subject|1|||
157100367|NCT01603082|567123548|FG000|Overall Study|Adverse Event|0|||
157100368|NCT01603082|567123549|FG001|Overall Study|Adverse Event|1|||
157100369|NCT01603082|567123548|FG000|Overall Study|Withdrawal by Subject|1|||
157100370|NCT01603082|567123549|FG001|Overall Study|Withdrawal by Subject|0|||
157100371|NCT01603082|567123548|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
156998098|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998099|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998100|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998101|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
156998102|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998103|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
156998104|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
156998105|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998106|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998107|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998108|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998109|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
157100372|NCT01603082|567123549|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
157100373|NCT03294109|567123558|FG000|Overall Study|Withdrawal by Subject|6|||
157100374|NCT03294109|567123559|FG001|Overall Study|Withdrawal by Subject|5|||
157100375|NCT04195581|567123560|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
157100376|NCT04195581|567123560|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
157100377|NCT04195581|567123560|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
157100378|NCT04195581|567123560|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
157100379|NCT04195581|567123560|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
157100380|NCT04195581|567123560|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
157100381|NCT00821431|567123561|FG000|Overall Study|Adverse Event|6|||
157100382|NCT00821431|567123562|FG001|Overall Study|Adverse Event|3|||
157100383|NCT00821431|567123561|FG000|Overall Study|Withdrawal by Subject|5|||
157100384|NCT00821431|567123562|FG001|Overall Study|Withdrawal by Subject|0|||
157100385|NCT00821431|567123561|FG000|Overall Study|Lost to Follow-up|1|||
157100386|NCT00821431|567123562|FG001|Overall Study|Lost to Follow-up|0|||
157100387|NCT00821431|567123561|FG000|Overall Study|Protocol Violation|3|||
157100388|NCT00821431|567123562|FG001|Overall Study|Protocol Violation|1|||
157100389|NCT00821431|567123561|FG000|Overall Study|Physician Decision|0|||
157100390|NCT00821431|567123562|FG001|Overall Study|Physician Decision|1|||
157100391|NCT01699789|567123566|FG000|Overall Study|Withdrawal by Subject|18|||
157100392|NCT01699789|567123567|FG001|Overall Study|Withdrawal by Subject|23|||
157100393|NCT01699789|567123566|FG000|Overall Study|Death|1|||
157100394|NCT01699789|567123567|FG001|Overall Study|Death|2|||
157100395|NCT01699789|567123566|FG000|Overall Study|Lost to Follow-up|83|||
157100396|NCT01699789|567123567|FG001|Overall Study|Lost to Follow-up|101|||
157100397|NCT02554903|567123568|FG000|Overall Study|Death|1|||
157100398|NCT02554903|567123569|FG001|Overall Study|Death|1|||
157100399|NCT02554903|567123568|FG000|Overall Study|Physician Decision|2|||
157100400|NCT02554903|567123569|FG001|Overall Study|Physician Decision|2|||
157100401|NCT02554903|567123568|FG000|Overall Study|Heart Transplant|1|||
157100402|NCT02554903|567123569|FG001|Overall Study|Heart Transplant|2|||
157100403|NCT04936841|567123570|FG000|Overall Study|Death|1|||
157100404|NCT00639223|567123571|FG000|Overall Study|Lost to Follow-up|0|||
157100405|NCT00639223|567123572|FG001|Overall Study|Lost to Follow-up|2|||
157100406|NCT01891721|567123574|FG000|Overall Study|Lost to Follow-up|10|||
157100407|NCT01891721|567123575|FG001|Overall Study|Lost to Follow-up|5|||
157100408|NCT01891721|567123576|FG002|Overall Study|Lost to Follow-up|1|||
157100409|NCT00633061|567123581|FG000|Overall Study|Study closed|86|||
157100410|NCT00633061|567123582|FG001|Overall Study|Study closed|0|||
157100411|NCT02000427|567123583|FG000|Overall Study|Death|22|||
157100412|NCT05125679|567123586|FG000|Overall Study|Study Terminated by Sponsor|2|||
157100413|NCT05125679|567123587|FG001|Overall Study|Study Terminated by Sponsor|5|||
157100414|NCT03829319|567123588|FG000|Overall Study|Sponsor's Decision|4|||
157100415|NCT03829319|567123589|FG001|Overall Study|Sponsor's Decision|90|||
157100416|NCT03829319|567123590|FG002|Overall Study|Sponsor's Decision|102|||
157100417|NCT03829319|567123588|FG000|Overall Study|Withdrawal by Subject|1|||
157100418|NCT03829319|567123589|FG001|Overall Study|Withdrawal by Subject|5|||
157100419|NCT03829319|567123590|FG002|Overall Study|Withdrawal by Subject|4|||
157100420|NCT03829319|567123588|FG000|Overall Study|Physician Decision|0|||
157100421|NCT03829319|567123589|FG001|Overall Study|Physician Decision|3|||
157100422|NCT03829319|567123590|FG002|Overall Study|Physician Decision|0|||
157100423|NCT03829319|567123588|FG000|Overall Study|Lost to Follow-up|0|||
157100424|NCT03829319|567123589|FG001|Overall Study|Lost to Follow-up|0|||
157100425|NCT03829319|567123590|FG002|Overall Study|Lost to Follow-up|1|||
157100426|NCT03829319|567123588|FG000|Overall Study|Death|8|||
157100427|NCT03829319|567123589|FG001|Overall Study|Death|277|||
157100428|NCT03829319|567123590|FG002|Overall Study|Death|266|||
157100429|NCT04484259|567123591|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
157100430|NCT04484259|567123592|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
157100431|NCT04484259|567123593|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
157100432|NCT04484259|567123594|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
157100433|NCT04484259|567123595|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
157100434|NCT04484259|567123591|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
157100435|NCT04484259|567123592|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
157100436|NCT04484259|567123593|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
157100437|NCT04484259|567123594|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
157100438|NCT04484259|567123595|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
157100439|NCT04484259|567123591|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
157100440|NCT04484259|567123592|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
157100441|NCT04484259|567123593|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
157100442|NCT04484259|567123594|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
157100443|NCT04484259|567123595|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
157100444|NCT04484259|567123591|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
157100445|NCT04484259|567123592|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
157100446|NCT04484259|567123593|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
157100447|NCT04484259|567123594|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
157100448|NCT04484259|567123595|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
157100449|NCT04484259|567123591|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
157100450|NCT04484259|567123592|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
157100451|NCT04484259|567123593|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
157100452|NCT04484259|567123594|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
157100453|NCT04484259|567123595|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
157100454|NCT04484259|567123591|FG000|Randomized Treatment|Withdrawal by Subject|1|||
156756655|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
156998110|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
156998111|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
156998112|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
156998113|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998114|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998115|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998116|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998117|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998118|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998119|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
156998120|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998121|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
156998122|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998123|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998124|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998125|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998126|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998127|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998128|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
156998129|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998130|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
156998131|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998132|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998133|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998134|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998135|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998136|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998137|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
156998138|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998139|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998140|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
156998141|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998142|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998143|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998144|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998145|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998146|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
156998147|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998148|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998149|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
156998150|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998151|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998152|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998153|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998154|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998155|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
156998156|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998157|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998158|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
156998159|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998160|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998161|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998162|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998163|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998164|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
156998165|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998166|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156756656|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
157100455|NCT04484259|567123592|FG001|Randomized Treatment|Withdrawal by Subject|0|||
156998167|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998168|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998169|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998170|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998171|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
156998172|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998173|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
156998174|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
156998175|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
156998176|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998177|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998178|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998179|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998180|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998181|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998182|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
156998183|NCT03598790|566747300|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998184|NCT03598790|566747301|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998185|NCT03598790|566747302|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
156998186|NCT03598790|566747303|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998187|NCT03598790|566747304|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998188|NCT03598790|566747305|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998189|NCT03598790|566747306|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998190|NCT03598790|566747307|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998191|NCT03598790|566747308|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
156998192|NCT03598790|566747300|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998193|NCT03598790|566747301|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998194|NCT03598790|566747302|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998195|NCT03598790|566747303|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
156998196|NCT03598790|566747304|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
156998197|NCT03598790|566747305|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
156998198|NCT03598790|566747306|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998199|NCT03598790|566747307|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998200|NCT03598790|566747308|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
156998201|NCT03598790|566747300|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998202|NCT03598790|566747301|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998203|NCT03598790|566747302|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998204|NCT03598790|566747303|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
156998205|NCT03598790|566747304|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998206|NCT03598790|566747305|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998207|NCT03598790|566747306|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998208|NCT03598790|566747307|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998209|NCT03598790|566747308|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
156998210|NCT03598790|566747300|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998211|NCT03598790|566747301|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998212|NCT03598790|566747302|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998213|NCT03598790|566747303|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
156998214|NCT03598790|566747304|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998215|NCT03598790|566747305|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998216|NCT03598790|566747306|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998217|NCT03598790|566747307|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998218|NCT03598790|566747308|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
156998219|NCT03598790|566747300|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998220|NCT03598790|566747301|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998221|NCT03598790|566747302|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998222|NCT03598790|566747303|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
156998223|NCT03598790|566747304|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
156998224|NCT03598790|566747305|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998225|NCT03598790|566747306|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998226|NCT03598790|566747307|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998227|NCT03598790|566747308|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
156998228|NCT03598790|566747300|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998229|NCT03598790|566747301|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998230|NCT03598790|566747302|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998231|NCT03598790|566747303|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
156998232|NCT03598790|566747304|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998233|NCT03598790|566747305|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998234|NCT03598790|566747306|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998235|NCT03598790|566747307|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998236|NCT03598790|566747308|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
156998237|NCT05570006|566747309|FG000|Overall Study|Lost to Follow-up|2|||
156998238|NCT05570006|566747309|FG000|Overall Study|Withdrawal by Subject|5|||
156998239|NCT05570006|566747309|FG000|Overall Study|Other than Specified|5|||
156998240|NCT01956669|566747324|FG000|Overall Study|Disease Progression|12|||
156998241|NCT01956669|566747325|FG001|Overall Study|Disease Progression|7|||
156998242|NCT01956669|566747326|FG002|Overall Study|Disease Progression|7|||
156998243|NCT01956669|566747327|FG003|Overall Study|Disease Progression|8|||
156998244|NCT01956669|566747328|FG004|Overall Study|Disease Progression|4|||
156998245|NCT01956669|566747329|FG005|Overall Study|Disease Progression|3|||
156998246|NCT01956669|566747330|FG006|Overall Study|Disease Progression|5|||
156998247|NCT01956669|566747324|FG000|Overall Study|Adverse Event|0|||
156998248|NCT01956669|566747325|FG001|Overall Study|Adverse Event|2|||
156998249|NCT01956669|566747326|FG002|Overall Study|Adverse Event|2|||
156998250|NCT01956669|566747327|FG003|Overall Study|Adverse Event|1|||
156998251|NCT01956669|566747328|FG004|Overall Study|Adverse Event|0|||
156998252|NCT01956669|566747329|FG005|Overall Study|Adverse Event|0|||
156998253|NCT01956669|566747330|FG006|Overall Study|Adverse Event|0|||
156998254|NCT01956669|566747324|FG000|Overall Study|Physician Decision|0|||
156998255|NCT01956669|566747325|FG001|Overall Study|Physician Decision|2|||
156998256|NCT01956669|566747326|FG002|Overall Study|Physician Decision|0|||
156998257|NCT01956669|566747327|FG003|Overall Study|Physician Decision|0|||
156998258|NCT01956669|566747328|FG004|Overall Study|Physician Decision|0|||
156998259|NCT01956669|566747329|FG005|Overall Study|Physician Decision|1|||
156998260|NCT01956669|566747330|FG006|Overall Study|Physician Decision|0|||
156998261|NCT01956669|566747324|FG000|Overall Study|Withdrawal by Subject|0|||
156998262|NCT01956669|566747325|FG001|Overall Study|Withdrawal by Subject|0|||
156998263|NCT01956669|566747326|FG002|Overall Study|Withdrawal by Subject|1|||
156998264|NCT01956669|566747327|FG003|Overall Study|Withdrawal by Subject|1|||
156998265|NCT01956669|566747328|FG004|Overall Study|Withdrawal by Subject|0|||
156998266|NCT01956669|566747329|FG005|Overall Study|Withdrawal by Subject|0|||
156998267|NCT01956669|566747330|FG006|Overall Study|Withdrawal by Subject|1|||
156998268|NCT00930813|566747331|FG000|Overall Study|Death|4|||
156998269|NCT00930813|566747332|FG001|Overall Study|Death|5|||
156998270|NCT00930813|566747331|FG000|Overall Study|Withdrawal by Subject|2|||
156998271|NCT00930813|566747332|FG001|Overall Study|Withdrawal by Subject|5|||
156998272|NCT00930813|566747331|FG000|Overall Study|Lost to Follow-up|2|||
156998273|NCT00930813|566747332|FG001|Overall Study|Lost to Follow-up|4|||
156998274|NCT01570751|566747333|FG000|Period A (16 Weeks)|Protocol Violation|1|||
156998275|NCT01570751|566747334|FG001|Period A (16 Weeks)|Protocol Violation|1|||
156998276|NCT01570751|566747333|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
156998277|NCT01570751|566747334|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
156998278|NCT01570751|566747333|FG000|Period A (16 Weeks)|Unclassified|2|||
156998279|NCT01570751|566747334|FG001|Period A (16 Weeks)|Unclassified|3|||
156998280|NCT01570751|566747333|FG000|Period B (16 Weeks)|Adverse Event|1|||
156998281|NCT01570751|566747334|FG001|Period B (16 Weeks)|Adverse Event|0|||
156998282|NCT01570751|566747333|FG000|Period B (16 Weeks)|Protocol Violation|0|||
156998283|NCT01570751|566747334|FG001|Period B (16 Weeks)|Protocol Violation|1|||
156998284|NCT01693614|566747339|FG000|Overall Study|Adverse Event|7|||
156998285|NCT01693614|566747340|FG001|Overall Study|Adverse Event|11|||
156998286|NCT01693614|566747341|FG002|Overall Study|Adverse Event|5|||
156998287|NCT01693614|566747339|FG000|Overall Study|Disease progression|11|||
156998288|NCT01693614|566747340|FG001|Overall Study|Disease progression|8|||
156998289|NCT01693614|566747341|FG002|Overall Study|Disease progression|7|||
156998290|NCT01693614|566747339|FG000|Overall Study|Protocol Violation|5|||
156998291|NCT01693614|566747340|FG001|Overall Study|Protocol Violation|2|||
156756657|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156998292|NCT01693614|566747341|FG002|Overall Study|Protocol Violation|1|||
156998293|NCT01693614|566747339|FG000|Overall Study|Death|1|||
156998294|NCT01693614|566747340|FG001|Overall Study|Death|0|||
156998295|NCT01693614|566747341|FG002|Overall Study|Death|0|||
156998296|NCT01693614|566747339|FG000|Overall Study|Physician Decision|1|||
156998297|NCT01693614|566747340|FG001|Overall Study|Physician Decision|1|||
156998298|NCT01693614|566747341|FG002|Overall Study|Physician Decision|4|||
156998299|NCT01693614|566747339|FG000|Overall Study|Withdrawal by subject/guardian|0|||
156998300|NCT01693614|566747340|FG001|Overall Study|Withdrawal by subject/guardian|0|||
156998301|NCT01693614|566747341|FG002|Overall Study|Withdrawal by subject/guardian|2|||
157100456|NCT04484259|567123593|FG002|Randomized Treatment|Withdrawal by Subject|0|||
157100457|NCT04484259|567123594|FG003|Randomized Treatment|Withdrawal by Subject|0|||
157100458|NCT04484259|567123595|FG004|Randomized Treatment|Withdrawal by Subject|0|||
157100459|NCT03951220|567123596|FG000|Overall Study|Withdrawal by Subject|9|||
157100460|NCT03951220|567123597|FG001|Overall Study|Withdrawal by Subject|2|||
157100461|NCT03951220|567123598|FG002|Overall Study|Withdrawal by Subject|0|||
157100462|NCT04498832|567123599|FG000|Overall Study|Adverse Event|1|||
157100463|NCT04498832|567123600|FG001|Overall Study|Adverse Event|3|||
157100464|NCT04498832|567123599|FG000|Overall Study|Withdrawal by Subject|0|||
157100465|NCT04498832|567123600|FG001|Overall Study|Withdrawal by Subject|1|||
157100466|NCT06268288|567123605|FG000|Overall Study|Withdrawal by Subject|1|||
157100467|NCT06268288|567123606|FG001|Overall Study|Withdrawal by Subject|2|||
157100468|NCT02146326|567123609|FG000|Overall Study|Lost to Follow-up|3|||
157100469|NCT02146326|567123610|FG001|Overall Study|Lost to Follow-up|3|||
157100470|NCT02146326|567123611|FG002|Overall Study|Lost to Follow-up|11|||
157100471|NCT02146326|567123612|FG003|Overall Study|Lost to Follow-up|19|||
157100472|NCT02146326|567123609|FG000|Overall Study|Withdrawal by Subject|2|||
157100473|NCT02146326|567123610|FG001|Overall Study|Withdrawal by Subject|1|||
157100474|NCT02146326|567123611|FG002|Overall Study|Withdrawal by Subject|15|||
157100475|NCT02146326|567123612|FG003|Overall Study|Withdrawal by Subject|11|||
157100476|NCT02146326|567123609|FG000|Overall Study|Separated from mental health center|23|||
157100477|NCT02146326|567123610|FG001|Overall Study|Separated from mental health center|33|||
157100478|NCT02146326|567123611|FG002|Overall Study|Separated from mental health center|0|||
157100479|NCT02146326|567123612|FG003|Overall Study|Separated from mental health center|0|||
157100480|NCT02146326|567123609|FG000|Overall Study|Incarcerated|0|||
157100481|NCT02146326|567123610|FG001|Overall Study|Incarcerated|0|||
157100482|NCT02146326|567123611|FG002|Overall Study|Incarcerated|3|||
157100483|NCT02146326|567123612|FG003|Overall Study|Incarcerated|8|||
157100484|NCT02146326|567123609|FG000|Overall Study|Death|0|||
157100485|NCT02146326|567123610|FG001|Overall Study|Death|0|||
157100486|NCT02146326|567123611|FG002|Overall Study|Death|4|||
157100487|NCT02146326|567123612|FG003|Overall Study|Death|4|||
157100488|NCT02146326|567123609|FG000|Overall Study|Unable to complete interview|0|||
157100489|NCT02146326|567123610|FG001|Overall Study|Unable to complete interview|0|||
157100490|NCT02146326|567123611|FG002|Overall Study|Unable to complete interview|10|||
157100491|NCT02146326|567123612|FG003|Overall Study|Unable to complete interview|6|||
157100492|NCT03153111|567123613|FG000|Overall Study|Death|2|||
157100493|NCT03153111|567123614|FG001|Overall Study|Death|5|||
157100494|NCT03153111|567123613|FG000|Overall Study|Lost to Follow-up|1|||
157100495|NCT03153111|567123614|FG001|Overall Study|Lost to Follow-up|0|||
157100496|NCT03153111|567123613|FG000|Overall Study|Physician Decision|5|||
157100497|NCT03153111|567123614|FG001|Overall Study|Physician Decision|1|||
157100498|NCT03153111|567123613|FG000|Overall Study|Withdrawal by Subject|3|||
157100499|NCT03153111|567123614|FG001|Overall Study|Withdrawal by Subject|3|||
157100500|NCT05066724|567123615|FG000|Overall Study|Adverse Event|1|||
157100501|NCT05066724|567123615|FG000|Overall Study|Non-Compliance With Study Drug|5|||
157100502|NCT05066724|567123615|FG000|Overall Study|Withdrawal by Subject|6|||
157100503|NCT05066724|567123615|FG000|Overall Study|Physician Decision|2|||
157100504|NCT01313117|567123627|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
157100505|NCT01313117|567123627|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
157100506|NCT03602261|567123632|FG000|Overall Study|Adverse Event|5|||
157100507|NCT03602261|567123633|FG001|Overall Study|Adverse Event|1|||
157100508|NCT03602261|567123632|FG000|Overall Study|Physician Decision|1|||
157100509|NCT03602261|567123633|FG001|Overall Study|Physician Decision|0|||
157100510|NCT03602261|567123632|FG000|Overall Study|Withdrawal by Subject|1|||
157100511|NCT03602261|567123633|FG001|Overall Study|Withdrawal by Subject|1|||
157100512|NCT03602261|567123632|FG000|Overall Study|Lack of Efficacy|0|||
157100513|NCT03602261|567123633|FG001|Overall Study|Lack of Efficacy|1|||
157100514|NCT03602261|567123632|FG000|Overall Study|Subject moving out of state|1|||
157100515|NCT03602261|567123633|FG001|Overall Study|Subject moving out of state|0|||
157100516|NCT04567615|567123634|FG000|Randomization|Participant withdrew consent|1|||
157100517|NCT04567615|567123635|FG001|Randomization|Participant withdrew consent|0|||
157100518|NCT04567615|567123636|FG002|Randomization|Participant withdrew consent|0|||
157100519|NCT04567615|567123634|FG000|Randomization|Adverse event unrelated to study drug|0|||
157100520|NCT04567615|567123635|FG001|Randomization|Adverse event unrelated to study drug|1|||
157100521|NCT04567615|567123636|FG002|Randomization|Adverse event unrelated to study drug|0|||
157100522|NCT04567615|567123634|FG000|Treatment Period|Participant Withdrew Consent|2|||
157100523|NCT04567615|567123635|FG001|Treatment Period|Participant Withdrew Consent|5|||
157100524|NCT04567615|567123636|FG002|Treatment Period|Participant Withdrew Consent|1|||
157100525|NCT04567615|567123634|FG000|Treatment Period|Death|1|||
157100526|NCT04567615|567123635|FG001|Treatment Period|Death|2|||
157100527|NCT04567615|567123636|FG002|Treatment Period|Death|0|||
157100528|NCT04567615|567123634|FG000|Treatment Period|Lost to Follow-up|0|||
157100529|NCT04567615|567123635|FG001|Treatment Period|Lost to Follow-up|1|||
157100530|NCT04567615|567123636|FG002|Treatment Period|Lost to Follow-up|0|||
157100531|NCT04567615|567123634|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
157100532|NCT04567615|567123635|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156998302|NCT01693614|566747339|FG000|Overall Study|Withdrawal by Subject|1|||
156998303|NCT01693614|566747340|FG001|Overall Study|Withdrawal by Subject|0|||
156998304|NCT01693614|566747341|FG002|Overall Study|Withdrawal by Subject|5|||
156998305|NCT05790408|566747342|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
156998306|NCT01131494|566747343|FG000|Overall Study|Withdrawal by Subject|2|||
156998307|NCT05419557|566747345|FG000|Overall Study|Lost to Follow-up|11|||
156998308|NCT05419557|566747346|FG001|Overall Study|Lost to Follow-up|4|||
156998309|NCT00588666|566747347|FG000|Overall Study|Adverse Event|4|||
156998310|NCT02281318|566747348|FG000|Overall Study|Adverse Event|2|||
156998311|NCT02281318|566747349|FG001|Overall Study|Adverse Event|2|||
156998312|NCT02281318|566747348|FG000|Overall Study|Lack of Efficacy|2|||
156998313|NCT02281318|566747349|FG001|Overall Study|Lack of Efficacy|0|||
156998314|NCT02281318|566747348|FG000|Overall Study|Lost to Follow-up|2|||
156998315|NCT02281318|566747349|FG001|Overall Study|Lost to Follow-up|1|||
156998316|NCT02281318|566747348|FG000|Overall Study|Physician Decision|2|||
156998317|NCT02281318|566747349|FG001|Overall Study|Physician Decision|0|||
156998318|NCT02281318|566747348|FG000|Overall Study|Withdrawal by Subject|6|||
156998319|NCT02281318|566747349|FG001|Overall Study|Withdrawal by Subject|2|||
156998320|NCT03102710|566747350|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
156998321|NCT03102710|566747351|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
156998322|NCT03102710|566747352|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
156998323|NCT03102710|566747350|FG000|Overall Study|Technical issues during final MRI scan|0|||
156998324|NCT03102710|566747351|FG001|Overall Study|Technical issues during final MRI scan|1|||
156998325|NCT03102710|566747352|FG002|Overall Study|Technical issues during final MRI scan|0|||
156998326|NCT03102710|566747350|FG000|Overall Study|Nausea during MRI scan|0|||
156998327|NCT03102710|566747351|FG001|Overall Study|Nausea during MRI scan|1|||
156998328|NCT03102710|566747352|FG002|Overall Study|Nausea during MRI scan|0|||
156998329|NCT03102710|566747350|FG000|Overall Study|Subject unable to attend final session|0|||
156998330|NCT03102710|566747351|FG001|Overall Study|Subject unable to attend final session|1|||
156998331|NCT03102710|566747352|FG002|Overall Study|Subject unable to attend final session|0|||
156998332|NCT01313182|566747353|FG000|Overall Study|Protocol Violation|66|||
156998333|NCT01313182|566747354|FG001|Overall Study|Protocol Violation|92|||
156998334|NCT02299635|566747357|FG000|Overall Study|Adverse Event|2|||
156998335|NCT02299635|566747357|FG000|Overall Study|Death|1|||
156998336|NCT02299635|566747357|FG000|Overall Study|Global deterioration of health status|1|||
156998337|NCT02299635|566747357|FG000|Overall Study|Objective progression or relapse|10|||
156998338|NCT02299635|566747357|FG000|Overall Study|Withdrawal by Subject|2|||
156998339|NCT02299635|566747357|FG000|Overall Study|Other|3|||
156998340|NCT04889118|566747358|FG000|Overall Study|Death|49|||
156998341|NCT04889118|566747359|FG001|Overall Study|Death|47|||
156998342|NCT04889118|566747358|FG000|Overall Study|Sponsor Decision|15|||
156998343|NCT04889118|566747359|FG001|Overall Study|Sponsor Decision|20|||
156998344|NCT00906698|566747360|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
156998345|NCT00906698|566747361|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
156998346|NCT00906698|566747362|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
156998347|NCT00906698|566747363|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
157100533|NCT04567615|567123636|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
157100534|NCT04567615|567123634|FG000|Treatment Period|Disease Progression|85|||
157100535|NCT04567615|567123635|FG001|Treatment Period|Disease Progression|63|||
157100536|NCT04567615|567123636|FG002|Treatment Period|Disease Progression|16|||
157100537|NCT04567615|567123634|FG000|Treatment Period|Study Drug Toxicity|3|||
157100538|NCT04567615|567123635|FG001|Treatment Period|Study Drug Toxicity|10|||
157100539|NCT04567615|567123636|FG002|Treatment Period|Study Drug Toxicity|4|||
157100540|NCT04567615|567123634|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
157100541|NCT04567615|567123635|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
157100542|NCT04567615|567123636|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
157100543|NCT04567615|567123634|FG000|Treatment Period|Other Reasons|1|||
157100544|NCT04567615|567123635|FG001|Treatment Period|Other Reasons|2|||
157100545|NCT04567615|567123636|FG002|Treatment Period|Other Reasons|0|||
157100546|NCT04567615|567123634|FG000|Treatment Period|Still On-going Treatment|21|||
157100547|NCT04567615|567123635|FG001|Treatment Period|Still On-going Treatment|22|||
157100548|NCT04567615|567123636|FG002|Treatment Period|Still On-going Treatment|2|||
157100549|NCT00523718|567125490|FG000|Overall Study|Withdrawal by Subject|1|||
157100550|NCT00523718|567125491|FG001|Overall Study|Withdrawal by Subject|0|||
157100551|NCT00523718|567125490|FG000|Overall Study|Protocol Violation|2|||
157100552|NCT00523718|567125491|FG001|Overall Study|Protocol Violation|0|||
157100553|NCT01436071|567125492|FG000|Overall Study|Adverse Event|1|||
157100554|NCT01436071|567125493|FG001|Overall Study|Adverse Event|0|||
157100555|NCT01436071|567125492|FG000|Overall Study|Lack of Efficacy|16|||
157100556|NCT01436071|567125493|FG001|Overall Study|Lack of Efficacy|7|||
157100557|NCT01436071|567125492|FG000|Overall Study|Protocol Violation|0|||
157100558|NCT01436071|567125493|FG001|Overall Study|Protocol Violation|1|||
157100559|NCT01436071|567125492|FG000|Overall Study|Lost to Follow-up|3|||
157100560|NCT01436071|567125493|FG001|Overall Study|Lost to Follow-up|1|||
157100561|NCT01436071|567125492|FG000|Overall Study|Physician Decision|1|||
157100562|NCT01436071|567125493|FG001|Overall Study|Physician Decision|0|||
157100563|NCT01436071|567125492|FG000|Overall Study|Withdrawal by Subject|2|||
157100564|NCT01436071|567125493|FG001|Overall Study|Withdrawal by Subject|2|||
157100565|NCT01436071|567125492|FG000|Overall Study|Did Not Receive Trial Medication|3|||
157100566|NCT01436071|567125493|FG001|Overall Study|Did Not Receive Trial Medication|3|||
157100567|NCT01940354|567125496|FG000|Overall Study|Withdrawal by Subject|4|||
157100568|NCT01940354|567125497|FG001|Overall Study|Withdrawal by Subject|2|||
157100569|NCT01215175|567125498|FG000|Overall Study|Lost to Follow-up|0|||
157100570|NCT01215175|567125499|FG001|Overall Study|Lost to Follow-up|1|||
157100571|NCT01215175|567125500|FG002|Overall Study|Lost to Follow-up|0|||
157100572|NCT01215175|567125501|FG003|Overall Study|Lost to Follow-up|1|||
157100573|NCT01215175|567125502|FG004|Overall Study|Lost to Follow-up|0|||
157100574|NCT03872453|567125503|FG000|Overall Study|Adverse Event|1|||
157100575|NCT03872453|567125504|FG001|Overall Study|Adverse Event|1|||
157100576|NCT03872453|567125505|FG002|Overall Study|Adverse Event|0|||
157100577|NCT03872453|567125506|FG003|Overall Study|Adverse Event|0|||
157100578|NCT03872453|567125503|FG000|Overall Study|Lost to Follow-up|8|||
157100579|NCT03872453|567125504|FG001|Overall Study|Lost to Follow-up|7|||
157100580|NCT03872453|567125505|FG002|Overall Study|Lost to Follow-up|4|||
157100581|NCT03872453|567125506|FG003|Overall Study|Lost to Follow-up|4|||
157100582|NCT03872453|567125503|FG000|Overall Study|Never Treated Migraine|19|||
157100583|NCT03872453|567125504|FG001|Overall Study|Never Treated Migraine|17|||
157100584|NCT03872453|567125505|FG002|Overall Study|Never Treated Migraine|13|||
157100585|NCT03872453|567125506|FG003|Overall Study|Never Treated Migraine|12|||
157100586|NCT03872453|567125503|FG000|Overall Study|Pregnancy|1|||
157100587|NCT03872453|567125504|FG001|Overall Study|Pregnancy|0|||
157100588|NCT03872453|567125505|FG002|Overall Study|Pregnancy|0|||
157100589|NCT03872453|567125506|FG003|Overall Study|Pregnancy|0|||
157100590|NCT03872453|567125503|FG000|Overall Study|Protocol Deviation|2|||
157100591|NCT03872453|567125504|FG001|Overall Study|Protocol Deviation|0|||
157100592|NCT03872453|567125505|FG002|Overall Study|Protocol Deviation|0|||
157100593|NCT03872453|567125506|FG003|Overall Study|Protocol Deviation|2|||
157100594|NCT03872453|567125503|FG000|Overall Study|Withdrawal by Subject|0|||
157100595|NCT03872453|567125504|FG001|Overall Study|Withdrawal by Subject|1|||
157100596|NCT03872453|567125505|FG002|Overall Study|Withdrawal by Subject|2|||
157100597|NCT03872453|567125506|FG003|Overall Study|Withdrawal by Subject|0|||
157100598|NCT03872453|567125503|FG000|Overall Study|Other Than Specified|1|||
157100599|NCT03872453|567125504|FG001|Overall Study|Other Than Specified|0|||
157100600|NCT03872453|567125505|FG002|Overall Study|Other Than Specified|0|||
157100601|NCT03872453|567125506|FG003|Overall Study|Other Than Specified|0|||
157100602|NCT00352885|567125507|FG000|Overall Study|Withdrawal by Subject|0|||
157100603|NCT00352885|567125508|FG001|Overall Study|Withdrawal by Subject|3|||
157100604|NCT00352885|567125507|FG000|Overall Study|Development of major depression|0|||
157100605|NCT00352885|567125508|FG001|Overall Study|Development of major depression|1|||
157100606|NCT00352885|567125507|FG000|Overall Study|Progression of metastatic melanoma|5|||
157100607|NCT00352885|567125508|FG001|Overall Study|Progression of metastatic melanoma|3|||
157100608|NCT00352885|567125507|FG000|Overall Study|Side effects of IL-2 administration|1|||
157100609|NCT00352885|567125508|FG001|Overall Study|Side effects of IL-2 administration|0|||
157100610|NCT01678209|567125509|FG000|Overall Study|could not scan twice|1|||
157100611|NCT01678209|567125510|FG001|Overall Study|could not scan twice|1|||
157100612|NCT01678209|567125511|FG002|Overall Study|could not scan twice|1|||
157100613|NCT01678209|567125509|FG000|Overall Study|scheduling conflicts|0|||
157100614|NCT01678209|567125510|FG001|Overall Study|scheduling conflicts|0|||
157100615|NCT01678209|567125511|FG002|Overall Study|scheduling conflicts|1|||
157100616|NCT01678209|567125509|FG000|Overall Study|screen fail|16|||
157100617|NCT01678209|567125510|FG001|Overall Study|screen fail|17|||
157100618|NCT01678209|567125511|FG002|Overall Study|screen fail|16|||
157100619|NCT03756350|567125512|FG000|Overall Study|Lost to Follow-up|1|||
157100620|NCT00928564|567125514|FG000|Overall Study|Lost to Follow-up|6|||
157100621|NCT00928564|567125515|FG001|Overall Study|Lost to Follow-up|0|||
157100622|NCT01096342|567125518|FG000|Overall Study|Protocol Violation|1|||
157100623|NCT03434353|567125519|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
157100624|NCT03434353|567125520|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
157100625|NCT03434353|567125521|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
157100626|NCT03434353|567125522|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
157100627|NCT03434353|567125523|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
157100628|NCT03434353|567125519|FG000|Overall Study|Withdrew consent|1|||
157100629|NCT03434353|567125520|FG001|Overall Study|Withdrew consent|0|||
157100630|NCT03434353|567125521|FG002|Overall Study|Withdrew consent|3|||
157100631|NCT03434353|567125522|FG003|Overall Study|Withdrew consent|0|||
157100632|NCT03434353|567125523|FG004|Overall Study|Withdrew consent|0|||
157100633|NCT03434353|567125519|FG000|Overall Study|Adverse Event|1|||
157100634|NCT03434353|567125520|FG001|Overall Study|Adverse Event|0|||
157100635|NCT03434353|567125521|FG002|Overall Study|Adverse Event|0|||
157100636|NCT03434353|567125522|FG003|Overall Study|Adverse Event|0|||
157100637|NCT03434353|567125523|FG004|Overall Study|Adverse Event|1|||
157100638|NCT03434353|567125519|FG000|Overall Study|Lost to Follow-up|2|||
157100639|NCT03434353|567125520|FG001|Overall Study|Lost to Follow-up|0|||
157100640|NCT03434353|567125521|FG002|Overall Study|Lost to Follow-up|0|||
157100641|NCT03434353|567125522|FG003|Overall Study|Lost to Follow-up|0|||
157100642|NCT03434353|567125523|FG004|Overall Study|Lost to Follow-up|0|||
157100643|NCT00929656|567125524|FG000|Overall Study|Lost to Follow-up|0|||
157100644|NCT00929656|567125525|FG001|Overall Study|Lost to Follow-up|1|||
157100645|NCT03739762|567125526|FG000|Overall Study|Lost to Follow-up|1|||
157100646|NCT03739762|567125527|FG001|Overall Study|Lost to Follow-up|1|||
157100647|NCT03739762|567125526|FG000|Overall Study|Withdrawal by Subject|2|||
157100648|NCT03739762|567125527|FG001|Overall Study|Withdrawal by Subject|6|||
157100649|NCT00607880|567125528|FG000|Overall Study|Unable to place port due to occlusion|1|||
157100650|NCT00607880|567125529|FG001|Overall Study|Unable to place port due to occlusion|0|||
157100651|NCT01990534|567125530|FG000|Overall Study|Death|22|||
157100652|NCT01990534|567125530|FG000|Overall Study|Progressive disease|3|||
157100653|NCT01990534|567125530|FG000|Overall Study|Protocol Violation|1|||
157100654|NCT01990534|567125530|FG000|Overall Study|Withdrawal of Informed Consent|2|||
157100655|NCT01990534|567125530|FG000|Overall Study|Symptomatic Deterioration|1|||
157100656|NCT01990534|567125530|FG000|Overall Study|Withdrawal by Subject|3|||
157100657|NCT01990534|567125530|FG000|Overall Study|Reason not Specified|2|||
157100658|NCT01990534|567125530|FG000|Overall Study|Lost to Follow-up|1|||
157100659|NCT01831544|567125531|FG000|Overall Study|Death|1|||
157100660|NCT01831544|567125531|FG000|Overall Study|Still on original MVAD device|2|||
157100661|NCT03422172|567125532|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
157100662|NCT03422172|567125532|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
157100663|NCT03422172|567125532|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
157100664|NCT00293722|567125541|FG000|Overall Study|Other|427|||
157100665|NCT04498169|567125544|FG000|Study Completion|Adverse Event|1|||
157100666|NCT04498169|567125545|FG001|Study Completion|Adverse Event|1|||
157100667|NCT00833911|567125546|FG000|Titration|Adverse Event|18|||
157100668|NCT00833911|567125546|FG000|Titration|Withdrawal by Subject|3|||
157100669|NCT00833911|567125546|FG000|Maintenance Phase I|Adverse Event|73|||
157100670|NCT00833911|567125546|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
157100671|NCT00833911|567125546|FG000|Maintenance Phase I|Physician Decision|10|||
157100672|NCT00833911|567125546|FG000|Maintenance Phase I|Lack of Efficacy|4|||
157100673|NCT00833911|567125546|FG000|Maintenance Phase II|Adverse Event|6|||
157100674|NCT00833911|567125546|FG000|Maintenance Phase II|Physician Decision|2|||
157100675|NCT00833911|567125546|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
157100676|NCT00833911|567125546|FG000|Maintenance Phase II|Lack of Efficacy|1|||
157100677|NCT01383161|567125547|FG000|Overall Study|Adverse Event|5|||
157100678|NCT01383161|567125548|FG001|Overall Study|Adverse Event|1|||
157100679|NCT01383161|567125547|FG000|Overall Study|Withdrawal by Subject|0|||
157100680|NCT01383161|567125548|FG001|Overall Study|Withdrawal by Subject|2|||
157100681|NCT01383161|567125547|FG000|Overall Study|Lack of Efficacy|0|||
157100682|NCT01383161|567125548|FG001|Overall Study|Lack of Efficacy|1|||
157100683|NCT03942406|567125557|FG000|Overall Study|Lost to Follow-up|4|||
157100684|NCT03942406|567125558|FG001|Overall Study|Lost to Follow-up|5|||
157100685|NCT03942406|567125559|FG002|Overall Study|Lost to Follow-up|3|||
157100686|NCT03942406|567125560|FG003|Overall Study|Lost to Follow-up|7|||
157100687|NCT03942406|567125561|FG004|Overall Study|Lost to Follow-up|1|||
157100688|NCT03942406|567125562|FG005|Overall Study|Lost to Follow-up|0|||
157100689|NCT03942406|567125563|FG006|Overall Study|Lost to Follow-up|0|||
157100690|NCT03942406|567125557|FG000|Overall Study|Withdrawal by Subject|3|||
157100691|NCT03942406|567125558|FG001|Overall Study|Withdrawal by Subject|1|||
157100692|NCT03942406|567125559|FG002|Overall Study|Withdrawal by Subject|1|||
157100693|NCT03942406|567125560|FG003|Overall Study|Withdrawal by Subject|3|||
157100694|NCT03942406|567125561|FG004|Overall Study|Withdrawal by Subject|0|||
157100695|NCT03942406|567125562|FG005|Overall Study|Withdrawal by Subject|0|||
157100696|NCT03942406|567125563|FG006|Overall Study|Withdrawal by Subject|0|||
157100697|NCT03942406|567125557|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
157100698|NCT03942406|567125558|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
157100699|NCT03942406|567125559|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
157100700|NCT03942406|567125560|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
157100701|NCT03942406|567125561|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
157100702|NCT03942406|567125562|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
157100703|NCT03942406|567125563|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
157100704|NCT01423812|567125564|FG000|Overall Study|Lost to Follow-up|2|||
157100705|NCT01423812|567125565|FG001|Overall Study|Lost to Follow-up|2|||
157100706|NCT01423812|567125564|FG000|Overall Study|Withdrawal by Subject|1|||
157100707|NCT01423812|567125565|FG001|Overall Study|Withdrawal by Subject|2|||
157100708|NCT01207596|567125566|FG000|Overall Study|Physician Decision|4|||
157100709|NCT01207596|567125566|FG000|Overall Study|Lack of Efficacy|1|||
157100710|NCT01207596|567125566|FG000|Overall Study|Adverse Event|3|||
157100711|NCT01207596|567125566|FG000|Overall Study|Withdrawal by Subject|1|||
157100712|NCT02596620|567125569|FG000|Overall Study|Lost to Follow-up|1|||
157100713|NCT02596620|567125570|FG001|Overall Study|Lost to Follow-up|1|||
157100714|NCT01054144|567125571|FG000|Overall Study|Death|2|||
157100715|NCT02616614|567125572|FG000|Overall Study|Withdrawal by Subject|10|||
157100716|NCT02616614|567125573|FG001|Overall Study|Withdrawal by Subject|5|||
157100717|NCT02616614|567125574|FG002|Overall Study|Withdrawal by Subject|6|||
157100718|NCT02616614|567125572|FG000|Overall Study|Physician Decision|2|||
157100719|NCT02616614|567125573|FG001|Overall Study|Physician Decision|1|||
157100720|NCT02616614|567125574|FG002|Overall Study|Physician Decision|0|||
157100721|NCT02616614|567125572|FG000|Overall Study|Adverse Event|1|||
157100722|NCT02616614|567125573|FG001|Overall Study|Adverse Event|4|||
157100723|NCT02616614|567125574|FG002|Overall Study|Adverse Event|1|||
157100724|NCT02616614|567125572|FG000|Overall Study|Protocol Violation|0|||
157100725|NCT02616614|567125573|FG001|Overall Study|Protocol Violation|3|||
157100726|NCT02616614|567125574|FG002|Overall Study|Protocol Violation|1|||
157100727|NCT02616614|567125572|FG000|Overall Study|Prohibited Medication|12|||
157100728|NCT02616614|567125573|FG001|Overall Study|Prohibited Medication|9|||
157100729|NCT02616614|567125574|FG002|Overall Study|Prohibited Medication|5|||
157100730|NCT02616614|567125572|FG000|Overall Study|More than 3 applications missed|6|||
157100731|NCT02616614|567125573|FG001|Overall Study|More than 3 applications missed|8|||
157100732|NCT02616614|567125574|FG002|Overall Study|More than 3 applications missed|1|||
157100733|NCT02616614|567125572|FG000|Overall Study|Lost to Follow-up|31|||
157100734|NCT02616614|567125573|FG001|Overall Study|Lost to Follow-up|28|||
157100735|NCT02616614|567125574|FG002|Overall Study|Lost to Follow-up|13|||
157100736|NCT02616614|567125572|FG000|Overall Study|Pregnancy|2|||
157100737|NCT02616614|567125573|FG001|Overall Study|Pregnancy|0|||
157100738|NCT02616614|567125574|FG002|Overall Study|Pregnancy|1|||
157100739|NCT02616614|567125572|FG000|Overall Study|Other|1|||
157100740|NCT02616614|567125573|FG001|Overall Study|Other|2|||
157100741|NCT02616614|567125574|FG002|Overall Study|Other|1|||
157100742|NCT02748018|567125575|FG000|Study Period|Adverse Event|1|||
157100743|NCT02748018|567125576|FG001|Study Period|Adverse Event|3|||
157100744|NCT02748018|567125577|FG002|Study Period|Adverse Event|4|||
157100745|NCT02748018|567125578|FG003|Study Period|Adverse Event|0|||
157100746|NCT02748018|567125579|FG004|Study Period|Adverse Event|3|||
157100747|NCT02748018|567125580|FG005|Study Period|Adverse Event|3|||
157100748|NCT02748018|567125575|FG000|Study Period|Withdrawal by Subject|7|||
157100749|NCT02748018|567125576|FG001|Study Period|Withdrawal by Subject|4|||
157100750|NCT02748018|567125577|FG002|Study Period|Withdrawal by Subject|4|||
157100751|NCT02748018|567125578|FG003|Study Period|Withdrawal by Subject|11|||
157100752|NCT02748018|567125579|FG004|Study Period|Withdrawal by Subject|12|||
157100753|NCT02748018|567125580|FG005|Study Period|Withdrawal by Subject|10|||
157100754|NCT02748018|567125575|FG000|Study Period|Pregnancy|0|||
157100755|NCT02748018|567125576|FG001|Study Period|Pregnancy|1|||
157100756|NCT02748018|567125577|FG002|Study Period|Pregnancy|0|||
157100757|NCT02748018|567125578|FG003|Study Period|Pregnancy|0|||
157100758|NCT02748018|567125579|FG004|Study Period|Pregnancy|1|||
157100759|NCT02748018|567125580|FG005|Study Period|Pregnancy|0|||
157100760|NCT02748018|567125575|FG000|Study Period|Physician Decision|2|||
156998348|NCT00906698|566747364|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
156998349|NCT00906698|566747365|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
156998350|NCT00906698|566747360|FG000|Overall Study|Adverse Event|0|||
156998351|NCT00906698|566747361|FG001|Overall Study|Adverse Event|0|||
156998352|NCT00906698|566747362|FG002|Overall Study|Adverse Event|2|||
156998353|NCT00906698|566747363|FG003|Overall Study|Adverse Event|0|||
156998354|NCT00906698|566747364|FG004|Overall Study|Adverse Event|4|||
156998355|NCT00906698|566747365|FG005|Overall Study|Adverse Event|1|||
156998356|NCT00906698|566747360|FG000|Overall Study|Disease progression|3|||
156998357|NCT00906698|566747361|FG001|Overall Study|Disease progression|12|||
156998358|NCT00906698|566747362|FG002|Overall Study|Disease progression|4|||
156998359|NCT00906698|566747363|FG003|Overall Study|Disease progression|4|||
156998360|NCT00906698|566747364|FG004|Overall Study|Disease progression|12|||
156998361|NCT00906698|566747365|FG005|Overall Study|Disease progression|4|||
156998362|NCT00906698|566747360|FG000|Overall Study|Withdrawal by Subject|0|||
156998363|NCT00906698|566747361|FG001|Overall Study|Withdrawal by Subject|0|||
156998364|NCT00906698|566747362|FG002|Overall Study|Withdrawal by Subject|0|||
156998365|NCT00906698|566747363|FG003|Overall Study|Withdrawal by Subject|0|||
156998366|NCT00906698|566747364|FG004|Overall Study|Withdrawal by Subject|1|||
156998367|NCT00906698|566747365|FG005|Overall Study|Withdrawal by Subject|0|||
156998368|NCT00906698|566747360|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
156998369|NCT00906698|566747361|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
156998370|NCT00906698|566747362|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
156998371|NCT00906698|566747363|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
156998372|NCT00906698|566747364|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
156998373|NCT00906698|566747365|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
156998374|NCT02846415|566747369|FG000|Overall Study|Lost to Follow-up|2|||
156998375|NCT02846415|566747370|FG001|Overall Study|Lost to Follow-up|0|||
156998376|NCT02846415|566747369|FG000|Overall Study|Withdrawal by Subject|1|||
156998377|NCT02846415|566747370|FG001|Overall Study|Withdrawal by Subject|1|||
156998378|NCT00567164|566747371|FG000|Overall Study|Withdrawal by Subject|171|||
156998379|NCT00567164|566747372|FG001|Overall Study|Withdrawal by Subject|21|||
156998380|NCT00567164|566747373|FG002|Overall Study|Withdrawal by Subject|17|||
156998381|NCT00567164|566747371|FG000|Overall Study|Protocol Violation|23|||
156998382|NCT00567164|566747372|FG001|Overall Study|Protocol Violation|4|||
156998383|NCT00567164|566747373|FG002|Overall Study|Protocol Violation|2|||
156998384|NCT00567164|566747371|FG000|Overall Study|Adverse Event|92|||
156998385|NCT00567164|566747372|FG001|Overall Study|Adverse Event|13|||
156998386|NCT00567164|566747373|FG002|Overall Study|Adverse Event|9|||
156998387|NCT00567164|566747371|FG000|Overall Study|Death|0|||
156998388|NCT00567164|566747372|FG001|Overall Study|Death|0|||
156998389|NCT00567164|566747373|FG002|Overall Study|Death|1|||
156998390|NCT00567164|566747371|FG000|Overall Study|Lost to Follow-up|202|||
156998391|NCT00567164|566747372|FG001|Overall Study|Lost to Follow-up|23|||
156998392|NCT00567164|566747373|FG002|Overall Study|Lost to Follow-up|21|||
156998393|NCT00567164|566747371|FG000|Overall Study|Pregnancy|20|||
156998394|NCT00567164|566747372|FG001|Overall Study|Pregnancy|4|||
156998395|NCT00567164|566747373|FG002|Overall Study|Pregnancy|6|||
156998396|NCT00567164|566747371|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
156998397|NCT00567164|566747372|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
156998398|NCT00567164|566747373|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
156998399|NCT00567164|566747371|FG000|Overall Study|Missing|1|||
156998400|NCT00567164|566747372|FG001|Overall Study|Missing|0|||
156998401|NCT00567164|566747373|FG002|Overall Study|Missing|0|||
156998402|NCT00001575|566747374|FG000|Overall Study|Screening failures-Ph I portion|22|||
156998403|NCT00001575|566747374|FG000|Overall Study|Withdrawn/deaths|23|||
156998404|NCT03256344|566747383|FG000|Overall Study|Death|6|||
156998405|NCT03256344|566747384|FG001|Overall Study|Death|22|||
156998406|NCT03256344|566747383|FG000|Overall Study|Withdrawal by Subject|3|||
156998407|NCT03256344|566747384|FG001|Overall Study|Withdrawal by Subject|3|||
156998408|NCT03256344|566747383|FG000|Overall Study|Sponsor Decision|1|||
156998409|NCT03256344|566747384|FG001|Overall Study|Sponsor Decision|0|||
156998410|NCT00404079|566747387|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
156998411|NCT00404079|566747388|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
156998412|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Other|4|||
156998413|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Other|0|||
156998414|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
156998415|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
156998416|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
156998417|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
156998418|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
156998419|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
156998420|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
156998421|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
157100761|NCT02748018|567125576|FG001|Study Period|Physician Decision|2|||
157100762|NCT02748018|567125577|FG002|Study Period|Physician Decision|1|||
157100763|NCT02748018|567125578|FG003|Study Period|Physician Decision|0|||
157100764|NCT02748018|567125579|FG004|Study Period|Physician Decision|2|||
157100765|NCT02748018|567125580|FG005|Study Period|Physician Decision|0|||
157100766|NCT02748018|567125575|FG000|Study Period|Lost to Follow-up|0|||
157100767|NCT02748018|567125576|FG001|Study Period|Lost to Follow-up|0|||
157100768|NCT02748018|567125577|FG002|Study Period|Lost to Follow-up|0|||
157100769|NCT02748018|567125578|FG003|Study Period|Lost to Follow-up|2|||
157100770|NCT02748018|567125579|FG004|Study Period|Lost to Follow-up|0|||
157100771|NCT02748018|567125580|FG005|Study Period|Lost to Follow-up|1|||
157100772|NCT02748018|567125575|FG000|Continuation Period|Adverse Event|2|||
157100773|NCT02748018|567125576|FG001|Continuation Period|Adverse Event|0|||
157100774|NCT02748018|567125577|FG002|Continuation Period|Adverse Event|1|||
157100775|NCT02748018|567125578|FG003|Continuation Period|Adverse Event|1|||
157100776|NCT02748018|567125579|FG004|Continuation Period|Adverse Event|1|||
157100777|NCT02748018|567125580|FG005|Continuation Period|Adverse Event|4|||
157100778|NCT02748018|567125575|FG000|Continuation Period|Withdrawal by Subject|3|||
157100779|NCT02748018|567125576|FG001|Continuation Period|Withdrawal by Subject|5|||
157100780|NCT02748018|567125577|FG002|Continuation Period|Withdrawal by Subject|3|||
157100781|NCT02748018|567125578|FG003|Continuation Period|Withdrawal by Subject|9|||
157100782|NCT02748018|567125579|FG004|Continuation Period|Withdrawal by Subject|11|||
157100783|NCT02748018|567125580|FG005|Continuation Period|Withdrawal by Subject|1|||
157100784|NCT02748018|567125575|FG000|Continuation Period|Lost to Follow-up|0|||
157100785|NCT02748018|567125576|FG001|Continuation Period|Lost to Follow-up|2|||
157100786|NCT02748018|567125577|FG002|Continuation Period|Lost to Follow-up|1|||
157100787|NCT02748018|567125578|FG003|Continuation Period|Lost to Follow-up|0|||
157100788|NCT02748018|567125579|FG004|Continuation Period|Lost to Follow-up|1|||
157100789|NCT02748018|567125580|FG005|Continuation Period|Lost to Follow-up|0|||
157100790|NCT02748018|567125575|FG000|Continuation Period|Pregnancy|1|||
157100791|NCT02748018|567125576|FG001|Continuation Period|Pregnancy|2|||
157100792|NCT02748018|567125577|FG002|Continuation Period|Pregnancy|0|||
157100793|NCT02748018|567125578|FG003|Continuation Period|Pregnancy|0|||
157100794|NCT02748018|567125579|FG004|Continuation Period|Pregnancy|0|||
157100795|NCT02748018|567125580|FG005|Continuation Period|Pregnancy|0|||
157100796|NCT02748018|567125575|FG000|Continuation Period|Physician Decision|0|||
157100797|NCT02748018|567125576|FG001|Continuation Period|Physician Decision|1|||
157100798|NCT02748018|567125577|FG002|Continuation Period|Physician Decision|2|||
157100799|NCT02748018|567125578|FG003|Continuation Period|Physician Decision|0|||
157100800|NCT02748018|567125579|FG004|Continuation Period|Physician Decision|2|||
157100801|NCT02748018|567125580|FG005|Continuation Period|Physician Decision|1|||
157100802|NCT02748018|567125575|FG000|Continuation Period|Protocol Violation|0|||
157100803|NCT02748018|567125576|FG001|Continuation Period|Protocol Violation|1|||
157100804|NCT02748018|567125577|FG002|Continuation Period|Protocol Violation|0|||
157100805|NCT02748018|567125578|FG003|Continuation Period|Protocol Violation|0|||
157100806|NCT02748018|567125579|FG004|Continuation Period|Protocol Violation|0|||
157100807|NCT02748018|567125580|FG005|Continuation Period|Protocol Violation|0|||
157100808|NCT02310672|567125584|FG000|Overall Study|Death|1|||
157100809|NCT02310672|567125584|FG000|Overall Study|Lost to Follow-up|1|||
157100810|NCT02310672|567125584|FG000|Overall Study|Withdrawal by Subject|1|||
157100811|NCT02310672|567125584|FG000|Overall Study|Sponsor's decision|12|||
157100812|NCT04704336|567125588|FG000|Overall Study|Death|2|||
157100813|NCT04704336|567125589|FG001|Overall Study|Death|2|||
157100814|NCT04704336|567125588|FG000|Overall Study|Lost to Follow-up|33|||
157100815|NCT04704336|567125589|FG001|Overall Study|Lost to Follow-up|40|||
157100816|NCT03118674|567125590|FG000|Overall Study|Lost to Follow-up|2|||
157100817|NCT03118674|567125590|FG000|Overall Study|Screen Faliure|8|||
157100818|NCT03118674|567125590|FG000|Overall Study|Withdrawal by Subject|5|||
157100819|NCT02119325|567125591|FG000|Washout Period 1|Adverse Event|0|||
157100820|NCT02119325|567125592|FG001|Washout Period 1|Adverse Event|1|||
157100821|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
157100822|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
157100823|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
157100824|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
157100825|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
157100826|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
157100827|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
157100828|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
157100829|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Death|1|||
157100830|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Death|1|||
157100831|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
157100832|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
157100833|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
157100834|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
157100835|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
157100836|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
157100837|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
157100838|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
157100839|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
157100840|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
157100841|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
157100842|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
157100843|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
157100844|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
157100845|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
157100846|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
157100847|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
157100848|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
157100849|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
157100850|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
157100851|NCT00559585|567125595|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
157100852|NCT00559585|567125596|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
157100853|NCT00559585|567125595|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
157100854|NCT00559585|567125596|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
157100855|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
157100856|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
157100857|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
157100858|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
157100859|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
157100860|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
157100861|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
157100862|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
157100863|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
157100864|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
157100865|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
157100866|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
157100867|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
157100868|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
157100869|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
157100870|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
157100871|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
157100872|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
157100873|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
157100874|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
157100875|NCT00559585|567125595|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
157100876|NCT00559585|567125596|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
157100877|NCT01372410|567125597|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
157100878|NCT01372410|567125598|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
157100879|NCT01372410|567125599|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
157100880|NCT01372410|567125600|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
157100881|NCT01372410|567125601|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
157100882|NCT01372410|567125602|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
157100883|NCT01372410|567125603|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
157100884|NCT01372410|567125604|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
157100885|NCT01372410|567125597|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100886|NCT01372410|567125598|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
157100887|NCT01372410|567125599|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100888|NCT01372410|567125600|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100889|NCT01372410|567125601|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100890|NCT01372410|567125602|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100891|NCT01372410|567125603|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
157100892|NCT01372410|567125604|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
157100893|NCT01372410|567125597|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100894|NCT01372410|567125598|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100895|NCT01372410|567125599|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100896|NCT01372410|567125600|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100897|NCT01372410|567125601|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
157100898|NCT01372410|567125602|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100899|NCT01372410|567125603|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100900|NCT01372410|567125604|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
157100901|NCT01372410|567125597|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100902|NCT01372410|567125598|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100903|NCT01372410|567125599|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100904|NCT01372410|567125600|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100905|NCT01372410|567125601|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100906|NCT01372410|567125602|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100907|NCT01372410|567125603|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
157100908|NCT01372410|567125604|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
157100909|NCT01372410|567125597|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
157100910|NCT01372410|567125598|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100911|NCT01372410|567125599|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100912|NCT01372410|567125600|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100913|NCT01372410|567125601|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100914|NCT01372410|567125602|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100915|NCT01372410|567125603|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
157100916|NCT01372410|567125604|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
157100917|NCT01372410|567125597|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100918|NCT01372410|567125598|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100919|NCT01372410|567125599|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100920|NCT01372410|567125600|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100921|NCT01372410|567125601|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
157100922|NCT01372410|567125602|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100923|NCT01372410|567125603|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100924|NCT01372410|567125604|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
157100925|NCT01372410|567125597|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
157100926|NCT01372410|567125598|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
157100927|NCT01372410|567125599|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
157100928|NCT01372410|567125600|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
157100929|NCT01372410|567125601|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
157100930|NCT01372410|567125602|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
157100931|NCT01372410|567125603|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
157100932|NCT01372410|567125604|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
157100933|NCT01372410|567125597|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100934|NCT01372410|567125598|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100935|NCT01372410|567125599|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100936|NCT01372410|567125600|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100937|NCT01372410|567125601|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100938|NCT01372410|567125602|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100939|NCT01372410|567125603|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
157100940|NCT01372410|567125604|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
157100941|NCT01372410|567125597|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100942|NCT01372410|567125598|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100943|NCT01372410|567125599|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
157100944|NCT01372410|567125600|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100945|NCT01372410|567125601|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100946|NCT01372410|567125602|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100947|NCT01372410|567125603|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100948|NCT01372410|567125604|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
157100949|NCT01372410|567125597|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100950|NCT01372410|567125598|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100951|NCT01372410|567125599|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100952|NCT01372410|567125600|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100953|NCT01372410|567125601|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100954|NCT01372410|567125602|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
157100955|NCT01372410|567125603|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100956|NCT01372410|567125604|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
157100957|NCT00867113|567125605|FG000|Treatment Period|Adverse Event|15|||
157100958|NCT00867113|567125605|FG000|Treatment Period|Death|2|||
157100959|NCT00867113|567125605|FG000|Treatment Period|Withdrawal by Subject|19|||
157100960|NCT00867113|567125605|FG000|Treatment Period|Lost to Follow-up|3|||
157100961|NCT00867113|567125605|FG000|Treatment Period|Administrative problems|1|||
157100962|NCT00867113|567125605|FG000|Treatment Period|Disease progression/relapse|1|||
157100963|NCT00867113|567125605|FG000|Treatment Period|Protocol Violation|4|||
157100964|NCT00867113|567125605|FG000|Post Treatment After Survival Follow-up|Death|1|||
157100965|NCT00867113|567125605|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
157100966|NCT00867113|567125605|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
157100967|NCT00867113|567125605|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
157100968|NCT01886313|567125608|FG000|Overall Study|Adverse Event|1|||
157100969|NCT01886313|567125609|FG001|Overall Study|Adverse Event|1|||
157100970|NCT02178553|567125611|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
157100971|NCT02178553|567125612|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
157100972|NCT02178553|567125611|FG000|Overall Study|Physician Decision|0|||
157100973|NCT02178553|567125612|FG001|Overall Study|Physician Decision|4|||
157100974|NCT02178553|567125611|FG000|Overall Study|Technical problem with injection|1|||
157100975|NCT02178553|567125612|FG001|Overall Study|Technical problem with injection|3|||
157100976|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
157100977|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
157100978|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
157100979|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
157100980|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
157100981|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
157100982|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
157100983|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
157100984|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
157100985|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
157100986|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
157100987|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
157100988|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
157100989|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
157100990|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
157100991|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
156998422|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
156998423|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
156998424|NCT00853827|566747389|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
156998425|NCT00853827|566747390|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
156998426|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
156998427|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
156998428|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
156998429|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
156998430|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
156998431|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
156998432|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
156998433|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
157100992|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
157100993|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
157100994|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
157100995|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
157100996|NCT01641809|567125614|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
157100997|NCT01641809|567125615|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
157100998|NCT01641809|567125616|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
157100999|NCT01641809|567125617|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
157101000|NCT01641809|567125614|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
157101001|NCT01641809|567125615|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
157101002|NCT01641809|567125616|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
157101003|NCT01641809|567125617|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
157101004|NCT01641809|567125614|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
157101005|NCT01641809|567125615|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
157101006|NCT01641809|567125616|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
157101007|NCT01641809|567125617|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
157101008|NCT01641809|567125614|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
157101009|NCT01641809|567125615|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
157101010|NCT01641809|567125616|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
157101011|NCT01641809|567125617|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
157101012|NCT01641809|567125614|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
157101013|NCT01641809|567125615|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
157101014|NCT01641809|567125616|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
157101015|NCT01641809|567125617|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
157101016|NCT01641809|567125614|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
157101017|NCT01641809|567125615|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
157101018|NCT01641809|567125616|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
157101019|NCT01641809|567125617|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
157101020|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
156756658|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756659|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756660|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756661|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756662|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756663|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756664|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756665|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756666|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
156756667|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
156756668|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756669|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
157101021|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
157101022|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
157101023|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
157101024|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
157101025|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
157101026|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
156756670|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756671|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
156756672|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
156998434|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
156998435|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
156998436|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
156998437|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
156998438|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
156998439|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
156998440|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
156998441|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
156998442|NCT00853827|566747389|FG000|Double Blind Period (103 Weeks)|Death|1|||
156998443|NCT00853827|566747390|FG001|Double Blind Period (103 Weeks)|Death|6|||
156998444|NCT00580801|566747401|FG000|Overall Study|Physician Decision|1|||
156998445|NCT00580801|566747402|FG001|Overall Study|Physician Decision|0|||
156998446|NCT00580801|566747403|FG002|Overall Study|Physician Decision|0|||
156998447|NCT00580801|566747401|FG000|Overall Study|Adverse Event|2|||
156998448|NCT00580801|566747402|FG001|Overall Study|Adverse Event|0|||
156998449|NCT00580801|566747403|FG002|Overall Study|Adverse Event|0|||
156998450|NCT00580801|566747401|FG000|Overall Study|Lost to Follow-up|2|||
156998451|NCT00580801|566747402|FG001|Overall Study|Lost to Follow-up|0|||
156998452|NCT00580801|566747403|FG002|Overall Study|Lost to Follow-up|0|||
156998453|NCT00580801|566747401|FG000|Overall Study|Reached a virologic endpoint|0|||
157101027|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
157101028|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
157101029|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
157101030|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
157101031|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
157101032|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
157101033|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
157101034|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
156756673|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
157101035|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
157101036|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
157101037|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
157101038|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
157101039|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
157101040|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
157101041|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
157101042|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
157101043|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
157101044|NCT01641809|567125614|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
157101045|NCT01641809|567125615|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
157101046|NCT01641809|567125616|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
157101047|NCT01641809|567125617|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
157101048|NCT01182766|567125618|FG000|Overall Study|Lost to Follow-up|32|||
157101049|NCT01182766|567125619|FG001|Overall Study|Lost to Follow-up|36|||
157101050|NCT01182766|567125620|FG002|Overall Study|Lost to Follow-up|29|||
157101051|NCT01182766|567125618|FG000|Overall Study|Withdrawal by Subject|14|||
157101052|NCT01182766|567125619|FG001|Overall Study|Withdrawal by Subject|3|||
157101053|NCT01182766|567125620|FG002|Overall Study|Withdrawal by Subject|6|||
157101054|NCT01182766|567125618|FG000|Overall Study|Physician Decision|1|||
157101055|NCT01182766|567125619|FG001|Overall Study|Physician Decision|0|||
157101056|NCT01182766|567125620|FG002|Overall Study|Physician Decision|0|||
157101057|NCT01182766|567125618|FG000|Overall Study|Non-compliance|1|||
157101058|NCT01182766|567125619|FG001|Overall Study|Non-compliance|1|||
157101059|NCT01182766|567125620|FG002|Overall Study|Non-compliance|1|||
157101060|NCT01605253|567125621|FG000|Overall Study|Physician Decision|3|||
157101061|NCT01605253|567125622|FG001|Overall Study|Physician Decision|2|||
157101062|NCT01605253|567125621|FG000|Overall Study|Lost to Follow-up|3|||
157101063|NCT01605253|567125622|FG001|Overall Study|Lost to Follow-up|1|||
157101064|NCT00651157|567125629|FG000|Overall Study|Death|1|||
157101065|NCT00651157|567125629|FG000|Overall Study|Protocol Violation|1|||
157101066|NCT00688181|567125631|FG000|Overall Study|Lost to Follow-up|17|||
157101067|NCT00688181|567125631|FG000|Overall Study|Unknown Reason|4|||
157101068|NCT00688181|567125631|FG000|Overall Study|Non-clinical Reason|2|||
157101069|NCT01472380|567125635|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
157101070|NCT01472380|567125635|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
157101071|NCT02511678|567125636|FG000|Overall Study|Withdrawal by Subject|2|||
157101072|NCT02511678|567125636|FG000|Overall Study|Lost to Follow-up|4|||
157101073|NCT02511678|567125636|FG000|Overall Study|Death|19|||
157101074|NCT02511678|567125636|FG000|Overall Study|Adverse Event|1|||
157101075|NCT02511678|567125636|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
157101076|NCT02511678|567125636|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
156756674|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756675|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756676|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
156756677|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
156756678|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
156756679|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
156756680|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
156756681|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
156756682|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
156756683|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
156756684|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
157101077|NCT02511678|567125636|FG000|Overall Study|Required Radiofrequency Ablation|1|||
157101078|NCT02511678|567125636|FG000|Overall Study|Biopsy was Negative|1|||
157101079|NCT02511678|567125636|FG000|Overall Study|Protocol Violation|1|||
157101080|NCT02511678|567125636|FG000|Overall Study|Received Radiation Treatment|1|||
157101081|NCT01295281|567125637|FG000|First Intervention (7 Days)|Death|0|||
157101082|NCT01295281|567125638|FG001|First Intervention (7 Days)|Death|1|||
157101083|NCT00292461|567125639|FG000|Overall Study|Adverse Event|4|||
157101084|NCT00292461|567125640|FG001|Overall Study|Adverse Event|2|||
157101085|NCT00292461|567125639|FG000|Overall Study|Lack of Efficacy|1|||
157101086|NCT00292461|567125640|FG001|Overall Study|Lack of Efficacy|0|||
157101087|NCT00292461|567125639|FG000|Overall Study|Withdrawal by Subject|0|||
157101088|NCT00292461|567125640|FG001|Overall Study|Withdrawal by Subject|1|||
157101089|NCT00292461|567125639|FG000|Overall Study|Protocol Violation|4|||
157101090|NCT00292461|567125640|FG001|Overall Study|Protocol Violation|3|||
157101091|NCT00292461|567125639|FG000|Overall Study|Lost to Follow-up|1|||
157101092|NCT00292461|567125640|FG001|Overall Study|Lost to Follow-up|0|||
157101093|NCT03049735|567125642|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
157101094|NCT03049735|567125643|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
157101095|NCT03049735|567125644|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
157101096|NCT03049735|567125642|FG000|Overall Study|Other|5|||
157101097|NCT03049735|567125643|FG001|Overall Study|Other|3|||
157101098|NCT03049735|567125644|FG002|Overall Study|Other|1|||
157101099|NCT03049735|567125642|FG000|Overall Study|Lack of Efficacy|4|||
157101100|NCT03049735|567125643|FG001|Overall Study|Lack of Efficacy|0|||
157101101|NCT03049735|567125644|FG002|Overall Study|Lack of Efficacy|3|||
157101102|NCT03049735|567125642|FG000|Overall Study|Protocol deviation|1|||
157101103|NCT03049735|567125643|FG001|Overall Study|Protocol deviation|0|||
157101104|NCT03049735|567125644|FG002|Overall Study|Protocol deviation|0|||
157101105|NCT03049735|567125642|FG000|Overall Study|Pregnancy|0|||
157101106|NCT03049735|567125643|FG001|Overall Study|Pregnancy|0|||
157101107|NCT03049735|567125644|FG002|Overall Study|Pregnancy|1|||
157101108|NCT03049735|567125642|FG000|Overall Study|Adverse Event|7|||
157101109|NCT03049735|567125643|FG001|Overall Study|Adverse Event|18|||
157101110|NCT03049735|567125644|FG002|Overall Study|Adverse Event|5|||
157101111|NCT03049735|567125642|FG000|Overall Study|Withdrawal by Subject|10|||
157101112|NCT03049735|567125643|FG001|Overall Study|Withdrawal by Subject|3|||
157101113|NCT03049735|567125644|FG002|Overall Study|Withdrawal by Subject|7|||
157101114|NCT03049735|567125642|FG000|Overall Study|Lost to Follow-up|1|||
157101115|NCT03049735|567125643|FG001|Overall Study|Lost to Follow-up|5|||
157101116|NCT03049735|567125644|FG002|Overall Study|Lost to Follow-up|5|||
157101117|NCT02684357|567125647|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
157101118|NCT02684357|567125648|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
157101119|NCT02684357|567125649|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
157101120|NCT02684357|567125650|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
157101121|NCT02684357|567125651|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
157101122|NCT02684357|567125652|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
157101123|NCT02684357|567125647|FG000|Part A|Lost to Follow-up|0|||
157101124|NCT02684357|567125648|FG001|Part A|Lost to Follow-up|2|||
157101125|NCT02684357|567125649|FG002|Part A|Lost to Follow-up|2|||
157101126|NCT02684357|567125650|FG003|Part A|Lost to Follow-up|0|||
157101127|NCT02684357|567125651|FG004|Part A|Lost to Follow-up|0|||
157101128|NCT02684357|567125652|FG005|Part A|Lost to Follow-up|0|||
157101129|NCT02684357|567125647|FG000|Part A|Withdrawal by Subject|3|||
157101130|NCT02684357|567125648|FG001|Part A|Withdrawal by Subject|0|||
157101131|NCT02684357|567125649|FG002|Part A|Withdrawal by Subject|0|||
157101132|NCT02684357|567125650|FG003|Part A|Withdrawal by Subject|0|||
157101133|NCT02684357|567125651|FG004|Part A|Withdrawal by Subject|0|||
157101134|NCT02684357|567125652|FG005|Part A|Withdrawal by Subject|0|||
157101135|NCT02684357|567125647|FG000|Part A|Other|0|||
157101136|NCT02684357|567125648|FG001|Part A|Other|1|||
157101137|NCT02684357|567125649|FG002|Part A|Other|0|||
157101138|NCT02684357|567125650|FG003|Part A|Other|0|||
157101139|NCT02684357|567125651|FG004|Part A|Other|0|||
157101140|NCT02684357|567125652|FG005|Part A|Other|0|||
157101141|NCT02684357|567125647|FG000|Part B|Adverse Event (Other)|0|||
157101142|NCT02684357|567125648|FG001|Part B|Adverse Event (Other)|0|||
157101143|NCT02684357|567125649|FG002|Part B|Adverse Event (Other)|0|||
157101144|NCT02684357|567125650|FG003|Part B|Adverse Event (Other)|1|||
157101145|NCT02684357|567125651|FG004|Part B|Adverse Event (Other)|1|||
157101146|NCT02684357|567125652|FG005|Part B|Adverse Event (Other)|1|||
157101147|NCT02684357|567125647|FG000|Part B|Lost to Follow-up|0|||
157101148|NCT02684357|567125648|FG001|Part B|Lost to Follow-up|0|||
157101149|NCT02684357|567125649|FG002|Part B|Lost to Follow-up|0|||
157101150|NCT02684357|567125650|FG003|Part B|Lost to Follow-up|1|||
157101151|NCT02684357|567125651|FG004|Part B|Lost to Follow-up|1|||
157101152|NCT02684357|567125652|FG005|Part B|Lost to Follow-up|7|||
157101153|NCT02684357|567125647|FG000|Part B|Withdrawal by Subject|0|||
157101154|NCT02684357|567125648|FG001|Part B|Withdrawal by Subject|0|||
157101155|NCT02684357|567125649|FG002|Part B|Withdrawal by Subject|0|||
157101156|NCT02684357|567125650|FG003|Part B|Withdrawal by Subject|0|||
157101157|NCT02684357|567125651|FG004|Part B|Withdrawal by Subject|2|||
157101158|NCT02684357|567125652|FG005|Part B|Withdrawal by Subject|4|||
157101159|NCT02684357|567125647|FG000|Part B|Other|0|||
157101160|NCT02684357|567125648|FG001|Part B|Other|0|||
157101161|NCT02684357|567125649|FG002|Part B|Other|0|||
157101162|NCT02684357|567125650|FG003|Part B|Other|1|||
157101163|NCT02684357|567125651|FG004|Part B|Other|0|||
157101164|NCT02684357|567125652|FG005|Part B|Other|1|||
157101165|NCT01853982|567125653|FG000|Overall Study|Withdrawal by Subject|1|||
157101166|NCT01853982|567125654|FG001|Overall Study|Withdrawal by Subject|0|||
157101167|NCT01853982|567125653|FG000|Overall Study|Death|1|||
157101168|NCT01853982|567125654|FG001|Overall Study|Death|0|||
157101169|NCT01853982|567125653|FG000|Overall Study|Lost to Follow-up|0|||
157101170|NCT01853982|567125654|FG001|Overall Study|Lost to Follow-up|1|||
157101171|NCT00390910|567125655|FG000|Overall Study|Adverse Event|1|||
157101172|NCT00390910|567125656|FG001|Overall Study|Adverse Event|0|||
157101173|NCT00390910|567125657|FG002|Overall Study|Adverse Event|0|||
157101174|NCT00390910|567125655|FG000|Overall Study|Lost to Follow-up|0|||
157101175|NCT00390910|567125656|FG001|Overall Study|Lost to Follow-up|1|||
157101176|NCT00390910|567125657|FG002|Overall Study|Lost to Follow-up|5|||
157101177|NCT00390910|567125655|FG000|Overall Study|Withdrawal by Subject|1|||
157101178|NCT00390910|567125656|FG001|Overall Study|Withdrawal by Subject|3|||
157101179|NCT00390910|567125657|FG002|Overall Study|Withdrawal by Subject|2|||
157101180|NCT00390910|567125655|FG000|Overall Study|Migrated/moved from study area|0|||
157101181|NCT00390910|567125656|FG001|Overall Study|Migrated/moved from study area|0|||
157101182|NCT00390910|567125657|FG002|Overall Study|Migrated/moved from study area|3|||
157101183|NCT01839487|567125658|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
157101184|NCT01839487|567125659|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
157101185|NCT01839487|567125660|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
157101186|NCT01839487|567125661|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
157101187|NCT01839487|567125662|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
157101188|NCT01839487|567125663|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
157101189|NCT01839487|567125658|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
157101190|NCT01839487|567125659|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
157101191|NCT01839487|567125660|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
157101192|NCT01839487|567125661|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
157101193|NCT01839487|567125662|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
157101194|NCT01839487|567125663|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
157101195|NCT01839487|567125658|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
157101196|NCT01839487|567125659|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
157101197|NCT01839487|567125660|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
157101198|NCT01839487|567125661|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
157101199|NCT01839487|567125662|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
157101200|NCT01839487|567125663|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
157101201|NCT01839487|567125658|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
157101202|NCT01839487|567125659|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
157101203|NCT01839487|567125660|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
157101204|NCT01839487|567125661|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
157101205|NCT01839487|567125662|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
157101206|NCT01839487|567125663|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
157101207|NCT01839487|567125658|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
157101208|NCT01839487|567125659|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
157101209|NCT01839487|567125660|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
157101210|NCT01839487|567125661|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
157101211|NCT01839487|567125662|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
157101212|NCT01839487|567125663|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
157101213|NCT01839487|567125658|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
157101214|NCT01839487|567125659|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
157101215|NCT01839487|567125660|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
157101216|NCT01839487|567125661|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
157101217|NCT01839487|567125662|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
157101218|NCT01839487|567125663|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
157101219|NCT01839487|567125658|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
157101220|NCT01839487|567125659|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
157101221|NCT01839487|567125660|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
157101222|NCT01839487|567125661|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
157101223|NCT01839487|567125662|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
157101224|NCT01839487|567125663|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
157101225|NCT01839487|567125658|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
157101226|NCT01839487|567125659|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
157101227|NCT01839487|567125660|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
157101228|NCT01839487|567125661|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
157101229|NCT01839487|567125662|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
157101230|NCT01839487|567125663|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
157101231|NCT01839487|567125658|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
157101232|NCT01839487|567125659|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
157101233|NCT01839487|567125660|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
157101234|NCT01839487|567125661|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
157101235|NCT01839487|567125662|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
157101236|NCT01839487|567125663|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
157101237|NCT03808688|567127109|FG000|Overall Study|Adverse Event|13|||
157101238|NCT03808688|567127110|FG001|Overall Study|Adverse Event|17|||
157101239|NCT03808688|567127109|FG000|Overall Study|Lack of Efficacy|2|||
157101240|NCT03808688|567127110|FG001|Overall Study|Lack of Efficacy|0|||
157101241|NCT03808688|567127109|FG000|Overall Study|Lost to Follow-up|0|||
157101242|NCT03808688|567127110|FG001|Overall Study|Lost to Follow-up|2|||
157101243|NCT03808688|567127109|FG000|Overall Study|Withdrawal by Subject|1|||
157101244|NCT03808688|567127110|FG001|Overall Study|Withdrawal by Subject|0|||
157101245|NCT03808688|567127109|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
157101246|NCT03808688|567127110|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
157101247|NCT03808688|567127109|FG000|Overall Study|IOP Too High|1|||
157101248|NCT03808688|567127110|FG001|Overall Study|IOP Too High|1|||
157101249|NCT03808688|567127109|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
157101250|NCT03808688|567127110|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
157101251|NCT03808688|567127109|FG000|Overall Study|Visit Out of Window|0|||
157101252|NCT03808688|567127110|FG001|Overall Study|Visit Out of Window|1|||
157101253|NCT03808688|567127109|FG000|Overall Study|Medication Non-Compliance|0|||
157101254|NCT03808688|567127110|FG001|Overall Study|Medication Non-Compliance|1|||
157101255|NCT01016964|567127114|FG000|Overall Study|Lost to Follow-up|3|||
157101256|NCT01016964|567127115|FG001|Overall Study|Lost to Follow-up|3|||
157101257|NCT01920594|567127116|FG000|Overall Study|Adverse Event|4|||
157101258|NCT01920594|567127117|FG001|Overall Study|Adverse Event|2|||
157101259|NCT01920594|567127116|FG000|Overall Study|Lost to Follow-up|1|||
157101260|NCT01920594|567127117|FG001|Overall Study|Lost to Follow-up|0|||
157101261|NCT01920594|567127116|FG000|Overall Study|Recovery|2|||
157101262|NCT01920594|567127117|FG001|Overall Study|Recovery|0|||
157101263|NCT01920594|567127116|FG000|Overall Study|Investigator discretion|0|||
157101264|NCT01920594|567127117|FG001|Overall Study|Investigator discretion|1|||
157101265|NCT00440700|567127124|FG000|Overall Study|Withdrawal by Subject|8|||
157101266|NCT00440700|567127125|FG001|Overall Study|Withdrawal by Subject|8|||
157101267|NCT00440700|567127126|FG002|Overall Study|Withdrawal by Subject|4|||
157101268|NCT00909792|567127127|FG000|Period 1|Did not meet inclusion criteria|0|||
157101269|NCT00909792|567127128|FG001|Period 1|Did not meet inclusion criteria|1|||
157101270|NCT00909792|567127127|FG000|Period 2|Biomicroscopy|1|||
157101271|NCT00909792|567127128|FG001|Period 2|Biomicroscopy|0|||
157101272|NCT00909792|567127127|FG000|Period 2|Lost to Follow-up|0|||
157101273|NCT00909792|567127128|FG001|Period 2|Lost to Follow-up|1|||
157101274|NCT04906616|567127129|FG000|Overall Study|Divorce|3|||
157101275|NCT04906616|567127130|FG001|Overall Study|Divorce|2|||
157101276|NCT01521897|567127133|FG000|Overall Study|Protocol Violation|18|||
157101277|NCT01521897|567127133|FG000|Overall Study|Lost to Follow-up|5|||
157101278|NCT00385203|567127134|FG000|Overall Study|Adverse Event|5|||
157101279|NCT00385203|567127135|FG001|Overall Study|Adverse Event|4|||
157101280|NCT00385203|567127134|FG000|Overall Study|Death|1|||
157101281|NCT00385203|567127135|FG001|Overall Study|Death|0|||
157101282|NCT00385203|567127134|FG000|Overall Study|Condition under investigation worsened|18|||
157101283|NCT00385203|567127135|FG001|Overall Study|Condition under investigation worsened|3|||
157101284|NCT00385203|567127134|FG000|Overall Study|Incorrect enrollment|2|||
157101285|NCT00385203|567127135|FG001|Overall Study|Incorrect enrollment|0|||
157101286|NCT03308942|567127136|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
157101287|NCT03308942|567127137|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
157101288|NCT03308942|567127138|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
157101289|NCT03308942|567127139|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
157101290|NCT03308942|567127140|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
157101291|NCT03308942|567127136|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
157101292|NCT03308942|567127137|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
157101293|NCT03308942|567127138|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
157101294|NCT03308942|567127139|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
157101295|NCT03308942|567127140|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
157101296|NCT03308942|567127136|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
157101297|NCT03308942|567127137|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
157101298|NCT03308942|567127138|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
157101299|NCT03308942|567127139|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
157101300|NCT03308942|567127140|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
157101301|NCT03308942|567127136|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
157101302|NCT03308942|567127137|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
157101303|NCT03308942|567127138|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
157101304|NCT03308942|567127139|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
157101305|NCT03308942|567127140|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
157101306|NCT03308942|567127136|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
157101307|NCT03308942|567127137|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
157101308|NCT03308942|567127138|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
157101309|NCT03308942|567127139|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
157101310|NCT03308942|567127140|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
157101311|NCT03308942|567127136|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
157101312|NCT03308942|567127137|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
157101313|NCT03308942|567127138|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
157101314|NCT03308942|567127139|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
157101315|NCT03308942|567127140|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
157101316|NCT03308942|567127136|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
157101317|NCT03308942|567127137|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
157101318|NCT03308942|567127138|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
157101319|NCT03308942|567127139|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
157101320|NCT03308942|567127140|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
157101321|NCT01131351|567127141|FG000|Overall Study|Adverse Event|0|||
157101322|NCT01131351|567127142|FG001|Overall Study|Adverse Event|2|||
157101323|NCT01131351|567127141|FG000|Overall Study|Protocol Deviation|0|||
157101324|NCT01131351|567127142|FG001|Overall Study|Protocol Deviation|1|||
157101325|NCT02194062|567127143|FG000|Overall Study|Lost to Follow-up|2|||
157101326|NCT02194062|567127144|FG001|Overall Study|Lost to Follow-up|2|||
157101327|NCT02194062|567127145|FG002|Overall Study|Lost to Follow-up|5|||
157101328|NCT04147234|567127149|FG000|Overall Study|Clinical deterioration|0|||
157101329|NCT04147234|567127150|FG001|Overall Study|Clinical deterioration|0|||
157101330|NCT04147234|567127151|FG002|Overall Study|Clinical deterioration|1|||
157101331|NCT04147234|567127152|FG003|Overall Study|Clinical deterioration|0|||
157101332|NCT04147234|567127153|FG004|Overall Study|Clinical deterioration|0|||
157101333|NCT04147234|567127154|FG005|Overall Study|Clinical deterioration|0|||
157101334|NCT04147234|567127155|FG006|Overall Study|Clinical deterioration|0|||
157101335|NCT04147234|567127149|FG000|Overall Study|Withdrawal by Subject|0|||
157101336|NCT04147234|567127150|FG001|Overall Study|Withdrawal by Subject|1|||
157101337|NCT04147234|567127151|FG002|Overall Study|Withdrawal by Subject|1|||
157101338|NCT04147234|567127152|FG003|Overall Study|Withdrawal by Subject|0|||
157101339|NCT04147234|567127153|FG004|Overall Study|Withdrawal by Subject|0|||
157101340|NCT04147234|567127154|FG005|Overall Study|Withdrawal by Subject|0|||
157101341|NCT04147234|567127155|FG006|Overall Study|Withdrawal by Subject|0|||
157101342|NCT04147234|567127149|FG000|Overall Study|Clinical disease progression|1|||
157101343|NCT04147234|567127150|FG001|Overall Study|Clinical disease progression|3|||
157101344|NCT04147234|567127151|FG002|Overall Study|Clinical disease progression|1|||
157101345|NCT04147234|567127152|FG003|Overall Study|Clinical disease progression|1|||
157101346|NCT04147234|567127153|FG004|Overall Study|Clinical disease progression|0|||
157101347|NCT04147234|567127154|FG005|Overall Study|Clinical disease progression|1|||
157101348|NCT04147234|567127155|FG006|Overall Study|Clinical disease progression|0|||
157101349|NCT04147234|567127149|FG000|Overall Study|Objective disease progression|6|||
157101350|NCT04147234|567127150|FG001|Overall Study|Objective disease progression|4|||
157101351|NCT04147234|567127151|FG002|Overall Study|Objective disease progression|3|||
157101352|NCT04147234|567127152|FG003|Overall Study|Objective disease progression|3|||
157101353|NCT04147234|567127153|FG004|Overall Study|Objective disease progression|5|||
157101354|NCT04147234|567127154|FG005|Overall Study|Objective disease progression|2|||
157101355|NCT04147234|567127155|FG006|Overall Study|Objective disease progression|3|||
157101356|NCT04147234|567127149|FG000|Overall Study|Adverse Event|0|||
157101357|NCT04147234|567127150|FG001|Overall Study|Adverse Event|0|||
157101358|NCT04147234|567127151|FG002|Overall Study|Adverse Event|0|||
157101359|NCT04147234|567127152|FG003|Overall Study|Adverse Event|0|||
157101360|NCT04147234|567127153|FG004|Overall Study|Adverse Event|1|||
157101361|NCT04147234|567127154|FG005|Overall Study|Adverse Event|0|||
157101362|NCT04147234|567127155|FG006|Overall Study|Adverse Event|0|||
157101363|NCT01008696|567127157|FG000|Overall Study|Participant's evasion of hospital visit|5|||
157101364|NCT01008696|567127158|FG001|Overall Study|Participant's evasion of hospital visit|4|||
157101365|NCT01008696|567127157|FG000|Overall Study|Withdrawal by Subject|2|||
157101366|NCT01008696|567127158|FG001|Overall Study|Withdrawal by Subject|4|||
157101367|NCT01008696|567127157|FG000|Overall Study|Physician Decision|5|||
157101368|NCT01008696|567127158|FG001|Overall Study|Physician Decision|1|||
157101369|NCT01008696|567127157|FG000|Overall Study|Adverse Event|1|||
157101370|NCT01008696|567127158|FG001|Overall Study|Adverse Event|0|||
157101371|NCT01008696|567127157|FG000|Overall Study|Participants' non-cooperation|2|||
157101372|NCT01008696|567127158|FG001|Overall Study|Participants' non-cooperation|3|||
157101373|NCT01008696|567127157|FG000|Overall Study|Other|2|||
157101374|NCT01008696|567127158|FG001|Overall Study|Other|3|||
157101375|NCT01008696|567127157|FG000|Overall Study|Other|0|||
157101376|NCT01008696|567127158|FG001|Overall Study|Other|2|||
157101377|NCT01754857|567127159|FG000|Overall Study|Adverse Event|7|||
156756685|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
156756686|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
156756687|NCT03428100|565860600|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756688|NCT03428100|565860601|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756689|NCT03428100|565860602|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756690|NCT03428100|565860603|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756691|NCT03428100|565860604|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756692|NCT03428100|565860605|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756693|NCT03428100|565860606|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756694|NCT03428100|565860607|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756695|NCT03428100|565860608|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756696|NCT03428100|565860609|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
156756697|NCT03428100|565860610|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
156756698|NCT03428100|565860611|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756699|NCT03428100|565860612|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756700|NCT03428100|565860613|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
156756701|NCT03428100|565860614|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
156756702|NCT03428100|565860615|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756703|NCT03428100|565860616|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
156756704|NCT03428100|565860617|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
156756705|NCT03428100|565860618|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
156756706|NCT01300247|565860624|FG000|Overall Study|Death|1|||
156756707|NCT01300247|565860625|FG001|Overall Study|Death|1|||
156756708|NCT01300247|565860624|FG000|Overall Study|Lost to Follow-up|2|||
156756709|NCT01300247|565860625|FG001|Overall Study|Lost to Follow-up|0|||
156756710|NCT01300247|565860624|FG000|Overall Study|Withdrawal by Subject|1|||
156756711|NCT01300247|565860625|FG001|Overall Study|Withdrawal by Subject|0|||
156756712|NCT01300247|565860624|FG000|Overall Study|Non-Compliance|0|||
156756713|NCT01300247|565860625|FG001|Overall Study|Non-Compliance|1|||
156756714|NCT00922116|565860626|FG000|Overall Study|Adverse Event|4|||
156756715|NCT00922116|565860626|FG000|Overall Study|Death|1|||
156756716|NCT00922116|565860626|FG000|Overall Study|Lost to Follow-up|1|||
156756717|NCT00922116|565860626|FG000|Overall Study|Withdrawal by Subject|4|||
156756718|NCT00922116|565860626|FG000|Overall Study|Other|5|||
156756719|NCT02364388|565860627|FG000|Overall Study|Protocol Violation|1|||
156756720|NCT02364388|565860627|FG000|Overall Study|Technical Failure|3|||
156756721|NCT02364388|565860627|FG000|Overall Study|No OA/US data|2|||
156756722|NCT02364388|565860627|FG000|Overall Study|No Biopsy|2|||
156756723|NCT03231306|565860628|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
156756724|NCT03231306|565860628|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
156756725|NCT03231306|565860628|FG000|Overall Study|Treatment delay > 21 days|2|||
156756726|NCT03231306|565860628|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
156756727|NCT03231306|565860628|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
156756728|NCT03231306|565860628|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
156756729|NCT03231306|565860628|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
156756730|NCT03231306|565860628|FG000|Overall Study|More than 1 Reason|2|||
156756731|NCT02585713|565860629|FG000|Overall Study|Withdrew prior to treatment|2|||
156756732|NCT02585713|565860630|FG001|Overall Study|Withdrew prior to treatment|7|||
156756733|NCT02585713|565860629|FG000|Overall Study|Other|3|||
156756734|NCT02585713|565860630|FG001|Overall Study|Other|1|||
156756735|NCT02609984|565860636|FG000|Overall Study|Death|29|||
157101378|NCT01754857|567127159|FG000|Overall Study|Disease progression|3|||
157101379|NCT01754857|567127159|FG000|Overall Study|Physician Decision|2|||
157101380|NCT01754857|567127159|FG000|Overall Study|Withdrawal by Subject|3|||
157101381|NCT01754857|567127159|FG000|Overall Study|other complicating disease|1|||
157101382|NCT01754857|567127159|FG000|Overall Study|ineligible to continue onto maintenance|1|||
156756736|NCT02609984|565860637|FG001|Overall Study|Death|26|||
156756737|NCT02609984|565860636|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
156756738|NCT02609984|565860637|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
156756739|NCT02609984|565860636|FG000|Overall Study|Lost to Follow-up|1|||
156756740|NCT02609984|565860637|FG001|Overall Study|Lost to Follow-up|2|||
156756741|NCT02609984|565860636|FG000|Overall Study|Withdrawal by Subject|0|||
156756742|NCT02609984|565860637|FG001|Overall Study|Withdrawal by Subject|1|||
156756743|NCT02609984|565860636|FG000|Overall Study|Disease Progression|2|||
156756744|NCT02609984|565860637|FG001|Overall Study|Disease Progression|0|||
156756745|NCT01843803|565860639|FG000|Overall Study|not a Veteran, did not see provider|1|||
156756746|NCT01843803|565860640|FG001|Overall Study|not a Veteran, did not see provider|3|||
156756747|NCT00784719|565860646|FG000|Overall Study|Adverse Event|0|||
156756748|NCT00784719|565860647|FG001|Overall Study|Adverse Event|2|||
156756749|NCT00784719|565860648|FG002|Overall Study|Adverse Event|0|||
156998454|NCT00580801|566747402|FG001|Overall Study|Reached a virologic endpoint|1|||
156998455|NCT00580801|566747403|FG002|Overall Study|Reached a virologic endpoint|2|||
156998456|NCT00580801|566747401|FG000|Overall Study|Participant non-compliant|0|||
156998457|NCT00580801|566747402|FG001|Overall Study|Participant non-compliant|0|||
156998458|NCT00580801|566747403|FG002|Overall Study|Participant non-compliant|1|||
156998459|NCT00580801|566747401|FG000|Overall Study|Travel|1|||
156998460|NCT00580801|566747402|FG001|Overall Study|Travel|0|||
156998461|NCT00580801|566747403|FG002|Overall Study|Travel|0|||
156998462|NCT02595398|566747404|FG000|Overall Study|Non-compliance|1|||
156998463|NCT02595398|566747405|FG001|Overall Study|Non-compliance|0|||
156998464|NCT02595398|566747404|FG000|Overall Study|Withdrawal by Subject|2|||
156998465|NCT02595398|566747405|FG001|Overall Study|Withdrawal by Subject|1|||
156998466|NCT02595398|566747404|FG000|Overall Study|Lost to Follow-up|1|||
156998467|NCT02595398|566747405|FG001|Overall Study|Lost to Follow-up|0|||
156998468|NCT00502593|566747406|FG000|Overall Study|Withdrawn unspecified reason|1|||
156998469|NCT00502593|566747407|FG001|Overall Study|Withdrawn unspecified reason|1|||
156998470|NCT00502593|566747408|FG002|Overall Study|Withdrawn unspecified reason|3|||
156998471|NCT00502593|566747409|FG003|Overall Study|Withdrawn unspecified reason|1|||
156998472|NCT00502593|566747410|FG004|Overall Study|Withdrawn unspecified reason|2|||
156998473|NCT00502593|566747411|FG005|Overall Study|Withdrawn unspecified reason|0|||
156998474|NCT00502593|566747412|FG006|Overall Study|Withdrawn unspecified reason|2|||
156998475|NCT00502593|566747413|FG007|Overall Study|Withdrawn unspecified reason|0|||
156998476|NCT00502593|566747414|FG008|Overall Study|Withdrawn unspecified reason|0|||
156998477|NCT00502593|566747415|FG009|Overall Study|Withdrawn unspecified reason|0|||
156998478|NCT00502593|566747416|FG010|Overall Study|Withdrawn unspecified reason|0|||
156998479|NCT00502593|566747417|FG011|Overall Study|Withdrawn unspecified reason|0|||
156998480|NCT00502593|566747406|FG000|Overall Study|Withdrawal by Subject|0|||
156998481|NCT00502593|566747407|FG001|Overall Study|Withdrawal by Subject|0|||
156998482|NCT00502593|566747408|FG002|Overall Study|Withdrawal by Subject|6|||
156998483|NCT00502593|566747409|FG003|Overall Study|Withdrawal by Subject|2|||
156998484|NCT00502593|566747410|FG004|Overall Study|Withdrawal by Subject|2|||
156998485|NCT00502593|566747411|FG005|Overall Study|Withdrawal by Subject|0|||
156998486|NCT00502593|566747412|FG006|Overall Study|Withdrawal by Subject|3|||
156998487|NCT00502593|566747413|FG007|Overall Study|Withdrawal by Subject|0|||
156998488|NCT00502593|566747414|FG008|Overall Study|Withdrawal by Subject|3|||
156998489|NCT00502593|566747415|FG009|Overall Study|Withdrawal by Subject|0|||
156998490|NCT00502593|566747416|FG010|Overall Study|Withdrawal by Subject|1|||
156998491|NCT00502593|566747417|FG011|Overall Study|Withdrawal by Subject|0|||
156998492|NCT00502593|566747406|FG000|Overall Study|Lost to Follow-up|2|||
156998493|NCT00502593|566747407|FG001|Overall Study|Lost to Follow-up|1|||
156998494|NCT00502593|566747408|FG002|Overall Study|Lost to Follow-up|1|||
156998495|NCT00502593|566747409|FG003|Overall Study|Lost to Follow-up|1|||
156998496|NCT00502593|566747410|FG004|Overall Study|Lost to Follow-up|0|||
156998497|NCT00502593|566747411|FG005|Overall Study|Lost to Follow-up|0|||
156998498|NCT00502593|566747412|FG006|Overall Study|Lost to Follow-up|0|||
156998499|NCT00502593|566747413|FG007|Overall Study|Lost to Follow-up|0|||
156998500|NCT00502593|566747414|FG008|Overall Study|Lost to Follow-up|3|||
156998501|NCT00502593|566747415|FG009|Overall Study|Lost to Follow-up|0|||
156998502|NCT00502593|566747416|FG010|Overall Study|Lost to Follow-up|1|||
156998503|NCT00502593|566747417|FG011|Overall Study|Lost to Follow-up|0|||
156998504|NCT05576051|566747418|FG000|Overall Study|Lack of Efficacy|543|||
156998505|NCT05576051|566747419|FG001|Overall Study|Lack of Efficacy|343|||
156998506|NCT05576051|566747420|FG002|Overall Study|Lack of Efficacy|108|||
156998507|NCT05576051|566747421|FG003|Overall Study|Lack of Efficacy|72|||
156998508|NCT05576051|566747422|FG004|Overall Study|Lack of Efficacy|28|||
156998509|NCT05576051|566747423|FG005|Overall Study|Lack of Efficacy|50|||
156998510|NCT05576051|566747418|FG000|Overall Study|Safety|78|||
156998511|NCT05576051|566747419|FG001|Overall Study|Safety|74|||
156998512|NCT05576051|566747420|FG002|Overall Study|Safety|16|||
156998513|NCT05576051|566747421|FG003|Overall Study|Safety|14|||
156998514|NCT05576051|566747422|FG004|Overall Study|Safety|4|||
156998515|NCT05576051|566747423|FG005|Overall Study|Safety|5|||
156998516|NCT05576051|566747418|FG000|Overall Study|Efficacy + Safety|10|||
156998517|NCT05576051|566747419|FG001|Overall Study|Efficacy + Safety|7|||
156998518|NCT05576051|566747420|FG002|Overall Study|Efficacy + Safety|3|||
156998519|NCT05576051|566747421|FG003|Overall Study|Efficacy + Safety|0|||
156998520|NCT05576051|566747422|FG004|Overall Study|Efficacy + Safety|0|||
156756750|NCT00784719|565860649|FG003|Overall Study|Adverse Event|0|||
156756751|NCT00784719|565860650|FG004|Overall Study|Adverse Event|1|||
156756752|NCT00784719|565860651|FG005|Overall Study|Adverse Event|1|||
156756753|NCT00784719|565860652|FG006|Overall Study|Adverse Event|1|||
156756754|NCT00784719|565860646|FG000|Overall Study|Lost to Follow-up|0|||
156998521|NCT05576051|566747423|FG005|Overall Study|Efficacy + Safety|0|||
156998522|NCT05576051|566747418|FG000|Overall Study|Other|231|||
156998523|NCT05576051|566747419|FG001|Overall Study|Other|127|||
156998524|NCT05576051|566747420|FG002|Overall Study|Other|35|||
156998525|NCT05576051|566747421|FG003|Overall Study|Other|14|||
156998526|NCT05576051|566747422|FG004|Overall Study|Other|6|||
156998527|NCT05576051|566747423|FG005|Overall Study|Other|0|||
156998528|NCT00544440|566747424|FG000|Overall Study|Other|1|||
156998529|NCT00544440|566747424|FG000|Overall Study|Adverse Event|1|||
156998530|NCT00544440|566747424|FG000|Overall Study|Withdrawal by Subject|2|||
156998531|NCT00544440|566747424|FG000|Overall Study|Subject Non-compliance|1|||
156998532|NCT00544440|566747424|FG000|Overall Study|Progressive Disease|47|||
156998533|NCT00544440|566747424|FG000|Overall Study|Other|5|||
156998534|NCT03601507|566747425|FG000|Overall Study|Adverse Event|1|||
156998535|NCT05650333|566747426|FG000|Treatment Period (7 Days)|Adverse Event|1|||
156998536|NCT01460342|566747429|FG000|Overall Study|Adverse Event|5|||
156998537|NCT01460342|566747430|FG001|Overall Study|Adverse Event|4|||
156998538|NCT01460342|566747429|FG000|Overall Study|Lost to Follow-up|1|||
156998539|NCT01460342|566747430|FG001|Overall Study|Lost to Follow-up|2|||
156998540|NCT01460342|566747429|FG000|Overall Study|Protocol Violation|0|||
156998541|NCT01460342|566747430|FG001|Overall Study|Protocol Violation|1|||
156998542|NCT01460342|566747429|FG000|Overall Study|Withdrawal by Subject|3|||
156998543|NCT01460342|566747430|FG001|Overall Study|Withdrawal by Subject|4|||
156998544|NCT01460342|566747429|FG000|Overall Study|Physician Decision|1|||
156998545|NCT01460342|566747430|FG001|Overall Study|Physician Decision|3|||
156998546|NCT01460342|566747429|FG000|Overall Study|Lack of Efficacy|1|||
156998547|NCT01460342|566747430|FG001|Overall Study|Lack of Efficacy|0|||
156998548|NCT02107014|566747431|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
156998549|NCT00591838|566747432|FG000|Overall Study|Withdrawal by Subject|0|||
156998550|NCT00591838|566747433|FG001|Overall Study|Withdrawal by Subject|0|||
156998551|NCT00591838|566747434|FG002|Overall Study|Withdrawal by Subject|0|||
156998552|NCT00591838|566747435|FG003|Overall Study|Withdrawal by Subject|1|||
156998553|NCT00591838|566747436|FG004|Overall Study|Withdrawal by Subject|0|||
156998554|NCT03761784|566747437|FG000|Overall Study|Adverse Event|4|||
156998555|NCT03761784|566747438|FG001|Overall Study|Adverse Event|0|||
156998556|NCT03761784|566747437|FG000|Overall Study|Lost to Follow-up|10|||
156998557|NCT03761784|566747438|FG001|Overall Study|Lost to Follow-up|7|||
156998558|NCT03761784|566747437|FG000|Overall Study|Pregnancy|1|||
156998559|NCT03761784|566747438|FG001|Overall Study|Pregnancy|0|||
156998560|NCT03761784|566747437|FG000|Overall Study|Protocol Violation|2|||
156998561|NCT03761784|566747438|FG001|Overall Study|Protocol Violation|0|||
156998562|NCT03761784|566747437|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
156998563|NCT03761784|566747438|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
156998564|NCT03761784|566747437|FG000|Overall Study|Withdrawal by Subject|9|||
156998565|NCT03761784|566747438|FG001|Overall Study|Withdrawal by Subject|4|||
156998566|NCT03761784|566747437|FG000|Overall Study|Physician Decision|1|||
156998567|NCT03761784|566747438|FG001|Overall Study|Physician Decision|0|||
156998568|NCT03761784|566747437|FG000|Overall Study|Other Than Specified|1|||
156998569|NCT03761784|566747438|FG001|Overall Study|Other Than Specified|0|||
156998570|NCT00586339|566747439|FG000|Overall Study|Withdrawal by Subject|1|||
156998571|NCT00586339|566747440|FG001|Overall Study|Withdrawal by Subject|3|||
156998572|NCT00586339|566747441|FG002|Overall Study|Withdrawal by Subject|1|||
156998573|NCT00586339|566747439|FG000|Overall Study|Migrated/moved from study area|3|||
156998574|NCT00586339|566747440|FG001|Overall Study|Migrated/moved from study area|2|||
156998575|NCT00586339|566747441|FG002|Overall Study|Migrated/moved from study area|4|||
156998576|NCT00586339|566747439|FG000|Overall Study|Lost to Follow-up|3|||
156998577|NCT00586339|566747440|FG001|Overall Study|Lost to Follow-up|2|||
156998578|NCT00586339|566747441|FG002|Overall Study|Lost to Follow-up|1|||
156756755|NCT00784719|565860647|FG001|Overall Study|Lost to Follow-up|0|||
156756756|NCT00784719|565860648|FG002|Overall Study|Lost to Follow-up|0|||
156998579|NCT00559949|566747442|FG000|Overall Study|Progressive Disease during cycle 1|1|||
156998580|NCT00559949|566747442|FG000|Overall Study|Adverse Event|1|||
156998581|NCT00559949|566747442|FG000|Overall Study|Withdrawal by Subject|4|||
156998582|NCT00559949|566747442|FG000|Overall Study|No disease evaluation per protocol|1|||
156998583|NCT02512042|566747443|FG000|Overall Study|Adverse Event|0|||
156998584|NCT02512042|566747444|FG001|Overall Study|Adverse Event|4|||
156998585|NCT02512042|566747443|FG000|Overall Study|Withdrawal by Subject|6|||
156998586|NCT02512042|566747444|FG001|Overall Study|Withdrawal by Subject|6|||
156998587|NCT02512042|566747443|FG000|Overall Study|Non-compliance with study drug|1|||
156998588|NCT02512042|566747444|FG001|Overall Study|Non-compliance with study drug|2|||
156998589|NCT02512042|566747443|FG000|Overall Study|Lost to Follow-up|5|||
156998590|NCT02512042|566747444|FG001|Overall Study|Lost to Follow-up|2|||
156998591|NCT02512042|566747443|FG000|Overall Study|Other|11|||
156756757|NCT00784719|565860649|FG003|Overall Study|Lost to Follow-up|0|||
156756758|NCT00784719|565860650|FG004|Overall Study|Lost to Follow-up|1|||
157101383|NCT01754857|567127159|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
157101384|NCT01754857|567127159|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
157101385|NCT04964960|567127160|FG000|Overall Study|Withdrawal by Subject|1|||
157101386|NCT04964960|567127160|FG000|Overall Study|Did not complete cycles|1|||
157101387|NCT02960854|567127163|FG000|Overall Study|Not Disclosed|2|||
157101388|NCT02960854|567127164|FG001|Overall Study|Not Disclosed|2|||
157101389|NCT02960854|567127163|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
157101390|NCT02960854|567127164|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
157101391|NCT02960854|567127163|FG000|Overall Study|Subject Withdrew Consent|0|||
157101392|NCT02960854|567127164|FG001|Overall Study|Subject Withdrew Consent|1|||
157101393|NCT02960854|567127163|FG000|Overall Study|Death|4|||
157101394|NCT02960854|567127164|FG001|Overall Study|Death|6|||
157101395|NCT00221195|567127165|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
157101396|NCT00221195|567127166|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
157101397|NCT00221195|567127165|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
157101398|NCT00221195|567127166|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
157101399|NCT00221195|567127165|FG000|Washout Period (Months 7-9)|Death|0|||
157101400|NCT00221195|567127166|FG001|Washout Period (Months 7-9)|Death|1|||
157101401|NCT00221195|567127165|FG000|Therapy 2 (Months 10-15)|Death|1|||
157101402|NCT00221195|567127166|FG001|Therapy 2 (Months 10-15)|Death|0|||
157101403|NCT00221195|567127165|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
157101404|NCT00221195|567127166|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
157101405|NCT00216203|567127168|FG000|Overall Study|Withdrawal by Subject|2|||
157101406|NCT03155373|567127178|FG000|Overall Study|No longer required surgery|1|||
157101407|NCT03155373|567127178|FG000|Overall Study|Protocol Violation|1|||
157101408|NCT03155373|567127178|FG000|Overall Study|Death|2|||
157101409|NCT03155373|567127178|FG000|Overall Study|Withdrawal by Subject|3|||
157101410|NCT02856893|567127179|FG000|Overall Study|Lack of Efficacy|27|||
157101411|NCT02856893|567127180|FG001|Overall Study|Lack of Efficacy|15|||
157101412|NCT02856893|567127181|FG002|Overall Study|Lack of Efficacy|19|||
157101413|NCT02856893|567127179|FG000|Overall Study|Death|1|||
157101414|NCT02856893|567127180|FG001|Overall Study|Death|0|||
157101415|NCT02856893|567127181|FG002|Overall Study|Death|0|||
157101416|NCT02856893|567127179|FG000|Overall Study|Adverse Event|2|||
157101417|NCT02856893|567127180|FG001|Overall Study|Adverse Event|0|||
157101418|NCT02856893|567127181|FG002|Overall Study|Adverse Event|0|||
157101419|NCT02856893|567127179|FG000|Overall Study|Physician Decision|0|||
157101420|NCT02856893|567127180|FG001|Overall Study|Physician Decision|2|||
157101421|NCT02856893|567127181|FG002|Overall Study|Physician Decision|3|||
157101422|NCT02856893|567127179|FG000|Overall Study|Withdrawal by Subject|1|||
157101423|NCT02856893|567127180|FG001|Overall Study|Withdrawal by Subject|1|||
157101424|NCT02856893|567127181|FG002|Overall Study|Withdrawal by Subject|0|||
157101425|NCT02856893|567127179|FG000|Overall Study|Other reasons|2|||
157101426|NCT02856893|567127180|FG001|Overall Study|Other reasons|1|||
157101427|NCT02856893|567127181|FG002|Overall Study|Other reasons|2|||
157101428|NCT01324323|567127186|FG000|Overall Study|Withdrawal by Subject|1|||
157101429|NCT00537485|567127187|FG000|Overall Study|Adverse Event|10|||
157101430|NCT00537485|567127188|FG001|Overall Study|Adverse Event|5|||
157101431|NCT00537485|567127187|FG000|Overall Study|Withdrawal by Subject|3|||
157101432|NCT00537485|567127188|FG001|Overall Study|Withdrawal by Subject|2|||
157101433|NCT00537485|567127187|FG000|Overall Study|Withdrawal by Subject|1|||
157101434|NCT00537485|567127188|FG001|Overall Study|Withdrawal by Subject|3|||
157101435|NCT00537485|567127187|FG000|Overall Study|Physician Decision|1|||
157101436|NCT00537485|567127188|FG001|Overall Study|Physician Decision|0|||
157101437|NCT01601847|567127192|FG000|Overall Study|Death|1|||
157101438|NCT01601847|567127193|FG001|Overall Study|Death|0|||
157101439|NCT01601847|567127192|FG000|Overall Study|Withdrawal by Subject|11|||
157101440|NCT01601847|567127193|FG001|Overall Study|Withdrawal by Subject|7|||
157101441|NCT01601847|567127192|FG000|Overall Study|Lost to Follow-up|1|||
157101442|NCT01601847|567127193|FG001|Overall Study|Lost to Follow-up|3|||
157101443|NCT00974090|567127194|FG000|Period 1: Double Blind Period|Adverse Event|2|||
157101444|NCT00974090|567127195|FG001|Period 1: Double Blind Period|Adverse Event|1|||
157101445|NCT00974090|567127194|FG000|Period 1: Double Blind Period|Physician Decision|1|||
157101446|NCT00974090|567127195|FG001|Period 1: Double Blind Period|Physician Decision|0|||
157101447|NCT00974090|567127194|FG000|Period 2: Open-label Period|Adverse Event|4|||
157101448|NCT00974090|567127195|FG001|Period 2: Open-label Period|Adverse Event|6|||
157101449|NCT00974090|567127194|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
157101450|NCT00974090|567127195|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
157101451|NCT00974090|567127194|FG000|Period 2: Open-label Period|Physician Decision|0|||
157101452|NCT00974090|567127195|FG001|Period 2: Open-label Period|Physician Decision|3|||
156756759|NCT00784719|565860651|FG005|Overall Study|Lost to Follow-up|1|||
157101453|NCT00974090|567127194|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
157101454|NCT00974090|567127195|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
157101455|NCT01284062|567127196|FG000|Overall Study|Adverse Event|4|||
156756760|NCT00784719|565860652|FG006|Overall Study|Lost to Follow-up|0|||
157101456|NCT01284062|567127197|FG001|Overall Study|Adverse Event|5|||
157101457|NCT01284062|567127198|FG002|Overall Study|Adverse Event|0|||
157101458|NCT01284062|567127199|FG003|Overall Study|Adverse Event|5|||
157101459|NCT01284062|567127196|FG000|Overall Study|Lack of Efficacy|3|||
157101460|NCT01284062|567127197|FG001|Overall Study|Lack of Efficacy|2|||
157101461|NCT01284062|567127198|FG002|Overall Study|Lack of Efficacy|2|||
157101462|NCT01284062|567127199|FG003|Overall Study|Lack of Efficacy|1|||
157101463|NCT01284062|567127196|FG000|Overall Study|Medication error without adverse event|0|||
157101464|NCT01284062|567127197|FG001|Overall Study|Medication error without adverse event|0|||
157101465|NCT01284062|567127198|FG002|Overall Study|Medication error without adverse event|1|||
157101466|NCT01284062|567127199|FG003|Overall Study|Medication error without adverse event|0|||
157101467|NCT01284062|567127196|FG000|Overall Study|Protocol Violation|1|||
157101468|NCT01284062|567127197|FG001|Overall Study|Protocol Violation|0|||
157101469|NCT01284062|567127198|FG002|Overall Study|Protocol Violation|0|||
157101470|NCT01284062|567127199|FG003|Overall Study|Protocol Violation|2|||
157101471|NCT01284062|567127196|FG000|Overall Study|Withdrawal by Subject|3|||
157101472|NCT01284062|567127197|FG001|Overall Study|Withdrawal by Subject|1|||
157101473|NCT01284062|567127198|FG002|Overall Study|Withdrawal by Subject|2|||
157101474|NCT01284062|567127199|FG003|Overall Study|Withdrawal by Subject|5|||
157101475|NCT01284062|567127196|FG000|Overall Study|Other|0|||
157101476|NCT01284062|567127197|FG001|Overall Study|Other|0|||
157101477|NCT01284062|567127198|FG002|Overall Study|Other|0|||
157101478|NCT01284062|567127199|FG003|Overall Study|Other|1|||
157101479|NCT01284062|567127196|FG000|Overall Study|Site Closed|0|||
157101480|NCT01284062|567127197|FG001|Overall Study|Site Closed|0|||
157101481|NCT01284062|567127198|FG002|Overall Study|Site Closed|1|||
157101482|NCT01284062|567127199|FG003|Overall Study|Site Closed|0|||
157101483|NCT00634010|567127204|FG000|Overall Study|Adverse Event|2|||
157101484|NCT00634010|567127205|FG001|Overall Study|Adverse Event|5|||
157101485|NCT00634010|567127204|FG000|Overall Study|Withdrawal by Subject|5|||
157101486|NCT00634010|567127205|FG001|Overall Study|Withdrawal by Subject|6|||
157101487|NCT00634010|567127204|FG000|Overall Study|Physician Decision|1|||
157101488|NCT00634010|567127205|FG001|Overall Study|Physician Decision|1|||
157101489|NCT00634010|567127204|FG000|Overall Study|Disease Progression|1|||
157101490|NCT00634010|567127205|FG001|Overall Study|Disease Progression|1|||
157101491|NCT00634010|567127204|FG000|Overall Study|Non-Compliant|1|||
157101492|NCT00634010|567127205|FG001|Overall Study|Non-Compliant|1|||
157101493|NCT04233164|567127206|FG000|Overall Study|Unable to obtain specimen|0|||
157101494|NCT04233164|567127207|FG001|Overall Study|Unable to obtain specimen|1|||
157101495|NCT02014740|567127208|FG000|Overall Study|Lost to Follow-up|4|||
157101496|NCT02014740|567127209|FG001|Overall Study|Lost to Follow-up|4|||
157101497|NCT02014740|567127208|FG000|Overall Study|Withdrawal by Subject|2|||
157101498|NCT02014740|567127209|FG001|Overall Study|Withdrawal by Subject|1|||
157101499|NCT01843218|567127212|FG000|Overall Study|Withdrawal by Subject|5|||
157101500|NCT01431534|567127213|FG000|Treatment Phase|Adverse Event|0|||
157101501|NCT01431534|567127214|FG001|Treatment Phase|Adverse Event|0|||
157101502|NCT01431534|567127215|FG002|Treatment Phase|Adverse Event|1|||
157101503|NCT01431534|567127213|FG000|Treatment Phase|Progressive Disease|4|||
157101504|NCT01431534|567127214|FG001|Treatment Phase|Progressive Disease|3|||
157101505|NCT01431534|567127215|FG002|Treatment Phase|Progressive Disease|10|||
157101506|NCT04201821|567127218|FG000|Overall Study|Withdrawal by Subject|2|||
157101507|NCT01395316|567127219|FG000|Overall Study|Lost to Follow-up|2|||
157101508|NCT01395316|567127219|FG000|Overall Study|poor MRI quality|1|||
157101509|NCT01313650|567127220|FG000|Overall Study|Adverse Event|9|||
157101510|NCT01313650|567127221|FG001|Overall Study|Adverse Event|34|||
157101511|NCT01313650|567127222|FG002|Overall Study|Adverse Event|24|||
157101512|NCT01313650|567127223|FG003|Overall Study|Adverse Event|23|||
157101513|NCT01313650|567127220|FG000|Overall Study|Lack of Efficacy|37|||
157101514|NCT01313650|567127221|FG001|Overall Study|Lack of Efficacy|20|||
157101515|NCT01313650|567127222|FG002|Overall Study|Lack of Efficacy|32|||
157101516|NCT01313650|567127223|FG003|Overall Study|Lack of Efficacy|20|||
157101517|NCT01313650|567127220|FG000|Overall Study|Lost to Follow-up|1|||
157101518|NCT01313650|567127221|FG001|Overall Study|Lost to Follow-up|0|||
157101519|NCT01313650|567127222|FG002|Overall Study|Lost to Follow-up|3|||
157101520|NCT01313650|567127223|FG003|Overall Study|Lost to Follow-up|2|||
157101521|NCT01313650|567127220|FG000|Overall Study|Withdrawal by Subject|16|||
157101522|NCT01313650|567127221|FG001|Overall Study|Withdrawal by Subject|20|||
157101523|NCT01313650|567127222|FG002|Overall Study|Withdrawal by Subject|15|||
157101524|NCT01313650|567127223|FG003|Overall Study|Withdrawal by Subject|15|||
157101525|NCT01313650|567127220|FG000|Overall Study|Protocol Violation|4|||
157101526|NCT01313650|567127221|FG001|Overall Study|Protocol Violation|7|||
157101527|NCT01313650|567127222|FG002|Overall Study|Protocol Violation|5|||
157101528|NCT01313650|567127223|FG003|Overall Study|Protocol Violation|6|||
157101529|NCT01313650|567127220|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
157101530|NCT01313650|567127221|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
157101531|NCT01313650|567127222|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
157101532|NCT01313650|567127223|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
157101533|NCT04029480|567127224|FG000|Overall Study|Physician Decision|0|||
157101534|NCT04029480|567127225|FG001|Overall Study|Physician Decision|0|||
157101535|NCT04029480|567127226|FG002|Overall Study|Physician Decision|2|||
157101536|NCT04029480|567127227|FG003|Overall Study|Physician Decision|1|||
157101537|NCT04029480|567127224|FG000|Overall Study|Withdrawal by Subject|2|||
157101538|NCT04029480|567127225|FG001|Overall Study|Withdrawal by Subject|0|||
157101539|NCT04029480|567127226|FG002|Overall Study|Withdrawal by Subject|1|||
157101540|NCT04029480|567127227|FG003|Overall Study|Withdrawal by Subject|1|||
157101541|NCT04786119|567127228|FG000|Overall Study|Withdrawal by Subject|4|||
157101542|NCT04786119|567127229|FG001|Overall Study|Withdrawal by Subject|5|||
157101543|NCT04786119|567127228|FG000|Overall Study|Lost to Follow-up|5|||
157101544|NCT04786119|567127229|FG001|Overall Study|Lost to Follow-up|5|||
157101545|NCT04786119|567127228|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
157101546|NCT04786119|567127229|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
157101547|NCT00447382|567127238|FG000|Overall Study|Adverse Event|1|||
157101548|NCT00447382|567127239|FG001|Overall Study|Adverse Event|1|||
157101549|NCT00447382|567127238|FG000|Overall Study|Lack of Efficacy|1|||
157101550|NCT00447382|567127239|FG001|Overall Study|Lack of Efficacy|0|||
157101551|NCT00447382|567127238|FG000|Overall Study|Protocol Violation|2|||
157101552|NCT00447382|567127239|FG001|Overall Study|Protocol Violation|0|||
157101553|NCT00447382|567127238|FG000|Overall Study|Unclassified|2|||
157101554|NCT00447382|567127239|FG001|Overall Study|Unclassified|5|||
157101555|NCT02408861|567127240|FG000|Overall Study|Death|0|||
157101556|NCT02408861|567127241|FG001|Overall Study|Death|3|||
157101557|NCT02408861|567127242|FG002|Overall Study|Death|1|||
157101558|NCT02408861|567127243|FG003|Overall Study|Death|2|||
157101559|NCT02408861|567127244|FG004|Overall Study|Death|4|||
157101560|NCT02408861|567127245|FG005|Overall Study|Death|1|||
157101561|NCT02408861|567127246|FG006|Overall Study|Death|0|||
157101562|NCT02408861|567127240|FG000|Overall Study|Lost to Follow-up|0|||
157101563|NCT02408861|567127241|FG001|Overall Study|Lost to Follow-up|0|||
157101564|NCT02408861|567127242|FG002|Overall Study|Lost to Follow-up|1|||
157101565|NCT02408861|567127243|FG003|Overall Study|Lost to Follow-up|1|||
157101566|NCT02408861|567127244|FG004|Overall Study|Lost to Follow-up|4|||
157101567|NCT02408861|567127245|FG005|Overall Study|Lost to Follow-up|2|||
157101568|NCT02408861|567127246|FG006|Overall Study|Lost to Follow-up|1|||
157101569|NCT02408861|567127240|FG000|Overall Study|Disease Progression|0|||
157101570|NCT02408861|567127241|FG001|Overall Study|Disease Progression|0|||
157101571|NCT02408861|567127242|FG002|Overall Study|Disease Progression|1|||
157101572|NCT02408861|567127243|FG003|Overall Study|Disease Progression|0|||
157101573|NCT02408861|567127244|FG004|Overall Study|Disease Progression|3|||
157101574|NCT02408861|567127245|FG005|Overall Study|Disease Progression|1|||
157101575|NCT02408861|567127246|FG006|Overall Study|Disease Progression|1|||
157101576|NCT02408861|567127240|FG000|Overall Study|Adverse Event|1|||
157101577|NCT02408861|567127241|FG001|Overall Study|Adverse Event|0|||
157101578|NCT02408861|567127242|FG002|Overall Study|Adverse Event|1|||
157101579|NCT02408861|567127243|FG003|Overall Study|Adverse Event|0|||
157101580|NCT02408861|567127244|FG004|Overall Study|Adverse Event|2|||
157101581|NCT02408861|567127245|FG005|Overall Study|Adverse Event|0|||
157101582|NCT02408861|567127246|FG006|Overall Study|Adverse Event|0|||
157101583|NCT02408861|567127240|FG000|Overall Study|Physician Decision|1|||
157101584|NCT02408861|567127241|FG001|Overall Study|Physician Decision|1|||
157101585|NCT02408861|567127242|FG002|Overall Study|Physician Decision|1|||
157101586|NCT02408861|567127243|FG003|Overall Study|Physician Decision|0|||
157101587|NCT02408861|567127244|FG004|Overall Study|Physician Decision|0|||
157101588|NCT02408861|567127245|FG005|Overall Study|Physician Decision|1|||
157101589|NCT02408861|567127246|FG006|Overall Study|Physician Decision|0|||
157101590|NCT02408861|567127240|FG000|Overall Study|Protocol Violation|1|||
157101591|NCT02408861|567127241|FG001|Overall Study|Protocol Violation|0|||
157101592|NCT02408861|567127242|FG002|Overall Study|Protocol Violation|0|||
157101593|NCT02408861|567127243|FG003|Overall Study|Protocol Violation|0|||
157101594|NCT02408861|567127244|FG004|Overall Study|Protocol Violation|0|||
157101595|NCT02408861|567127245|FG005|Overall Study|Protocol Violation|0|||
157101596|NCT02408861|567127246|FG006|Overall Study|Protocol Violation|0|||
157101597|NCT02408861|567127240|FG000|Overall Study|Withdrawal by Subject|0|||
157101598|NCT02408861|567127241|FG001|Overall Study|Withdrawal by Subject|0|||
157101599|NCT02408861|567127242|FG002|Overall Study|Withdrawal by Subject|0|||
157101600|NCT02408861|567127243|FG003|Overall Study|Withdrawal by Subject|0|||
157101601|NCT02408861|567127244|FG004|Overall Study|Withdrawal by Subject|1|||
157101602|NCT02408861|567127245|FG005|Overall Study|Withdrawal by Subject|1|||
157101603|NCT02408861|567127246|FG006|Overall Study|Withdrawal by Subject|0|||
157101604|NCT02408861|567127240|FG000|Overall Study|Other Treatment|0|||
157101605|NCT02408861|567127241|FG001|Overall Study|Other Treatment|0|||
157101606|NCT02408861|567127242|FG002|Overall Study|Other Treatment|0|||
157101607|NCT02408861|567127243|FG003|Overall Study|Other Treatment|0|||
157101608|NCT02408861|567127244|FG004|Overall Study|Other Treatment|0|||
157101609|NCT02408861|567127245|FG005|Overall Study|Other Treatment|1|||
157101610|NCT02408861|567127246|FG006|Overall Study|Other Treatment|1|||
157101611|NCT05028517|567127247|FG000|Overall Study|Lost to Follow-up|13|||
157101612|NCT05028517|567127248|FG001|Overall Study|Lost to Follow-up|20|||
156998592|NCT02512042|566747444|FG001|Overall Study|Other|11|||
156998593|NCT01194258|566747448|FG000|Titration Period|Withdrawal by Subject|6|||
156998594|NCT01194258|566747449|FG001|Titration Period|Withdrawal by Subject|0|||
156998595|NCT01194258|566747450|FG002|Titration Period|Withdrawal by Subject|0|||
156998596|NCT01194258|566747451|FG003|Titration Period|Withdrawal by Subject|0|||
156998597|NCT01194258|566747452|FG004|Titration Period|Withdrawal by Subject|0|||
156998598|NCT01194258|566747448|FG000|Titration Period|Lost to Follow-up|2|||
156998599|NCT01194258|566747449|FG001|Titration Period|Lost to Follow-up|0|||
156998600|NCT01194258|566747450|FG002|Titration Period|Lost to Follow-up|0|||
156998601|NCT01194258|566747451|FG003|Titration Period|Lost to Follow-up|0|||
156998602|NCT01194258|566747452|FG004|Titration Period|Lost to Follow-up|0|||
156998603|NCT01194258|566747448|FG000|Titration Period|Titration failure|3|||
156998604|NCT01194258|566747449|FG001|Titration Period|Titration failure|0|||
156998605|NCT01194258|566747450|FG002|Titration Period|Titration failure|0|||
156998606|NCT01194258|566747451|FG003|Titration Period|Titration failure|0|||
156998607|NCT01194258|566747452|FG004|Titration Period|Titration failure|0|||
156998608|NCT01194258|566747448|FG000|Period 1 (12 Weeks)|Death|0|||
156998609|NCT01194258|566747449|FG001|Period 1 (12 Weeks)|Death|0|||
156998610|NCT01194258|566747450|FG002|Period 1 (12 Weeks)|Death|0|||
156998611|NCT01194258|566747451|FG003|Period 1 (12 Weeks)|Death|0|||
156998612|NCT01194258|566747452|FG004|Period 1 (12 Weeks)|Death|1|||
156998613|NCT01194258|566747448|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156998614|NCT01194258|566747449|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156998615|NCT01194258|566747450|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156998616|NCT01194258|566747451|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
156998617|NCT01194258|566747452|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
156998618|NCT01194258|566747448|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
156998619|NCT01194258|566747449|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
156998620|NCT01194258|566747450|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
156998621|NCT01194258|566747451|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
156998622|NCT01194258|566747452|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
156998623|NCT01194258|566747448|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156998624|NCT01194258|566747449|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156998625|NCT01194258|566747450|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156998626|NCT01194258|566747451|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156998627|NCT01194258|566747452|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156998628|NCT01981850|566747453|FG000|Main Phase Stage 1|Death|2|||
156998629|NCT01981850|566747454|FG001|Main Phase Stage 1|Death|0|||
156998630|NCT01981850|566747455|FG002|Main Phase Stage 1|Death|0|||
156998631|NCT01981850|566747456|FG003|Main Phase Stage 1|Death|0|||
156998632|NCT01981850|566747457|FG004|Main Phase Stage 1|Death|0|||
156998633|NCT01981850|566747458|FG005|Main Phase Stage 1|Death|0|||
156998634|NCT01981850|566747459|FG006|Main Phase Stage 1|Death|0|||
156998635|NCT01981850|566747460|FG007|Main Phase Stage 1|Death|0|||
156998636|NCT01981850|566747461|FG008|Main Phase Stage 1|Death|0|||
156998637|NCT01981850|566747462|FG009|Main Phase Stage 1|Death|0|||
156998638|NCT01981850|566747453|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
156998639|NCT01981850|566747454|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998640|NCT01981850|566747455|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998641|NCT01981850|566747456|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998642|NCT01981850|566747457|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998643|NCT01981850|566747458|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998644|NCT01981850|566747459|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998645|NCT01981850|566747460|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998646|NCT01981850|566747461|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998647|NCT01981850|566747462|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
156998648|NCT01981850|566747453|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
156998649|NCT01981850|566747454|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
156998650|NCT01981850|566747455|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
156998651|NCT01981850|566747456|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
156998652|NCT01981850|566747457|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
156998653|NCT01981850|566747458|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
156998654|NCT01981850|566747459|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
156998655|NCT01981850|566747460|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
156998656|NCT01981850|566747461|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
156998657|NCT01981850|566747462|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
156756761|NCT00784719|565860646|FG000|Overall Study|Other|2|||
156756762|NCT00784719|565860647|FG001|Overall Study|Other|1|||
156756763|NCT00784719|565860648|FG002|Overall Study|Other|1|||
156756764|NCT00784719|565860649|FG003|Overall Study|Other|0|||
156756765|NCT00784719|565860650|FG004|Overall Study|Other|2|||
156756766|NCT00784719|565860651|FG005|Overall Study|Other|1|||
156756767|NCT00784719|565860652|FG006|Overall Study|Other|3|||
156998658|NCT01981850|566747453|FG000|Main Phase Stage 1|Various reasons|0|||
156998659|NCT01981850|566747454|FG001|Main Phase Stage 1|Various reasons|0|||
156998660|NCT01981850|566747455|FG002|Main Phase Stage 1|Various reasons|2|||
156998661|NCT01981850|566747456|FG003|Main Phase Stage 1|Various reasons|0|||
156998662|NCT01981850|566747457|FG004|Main Phase Stage 1|Various reasons|0|||
156998663|NCT01981850|566747458|FG005|Main Phase Stage 1|Various reasons|0|||
156998664|NCT01981850|566747459|FG006|Main Phase Stage 1|Various reasons|0|||
156998665|NCT01981850|566747460|FG007|Main Phase Stage 1|Various reasons|0|||
156998666|NCT01981850|566747461|FG008|Main Phase Stage 1|Various reasons|0|||
156998667|NCT01981850|566747462|FG009|Main Phase Stage 1|Various reasons|0|||
156998668|NCT01981850|566747453|FG000|Main Phase Stage 2|Adverse Event|0|||
156998669|NCT01981850|566747454|FG001|Main Phase Stage 2|Adverse Event|0|||
156998670|NCT01981850|566747455|FG002|Main Phase Stage 2|Adverse Event|0|||
156998671|NCT01981850|566747456|FG003|Main Phase Stage 2|Adverse Event|0|||
156998672|NCT01981850|566747457|FG004|Main Phase Stage 2|Adverse Event|6|||
156998673|NCT01981850|566747458|FG005|Main Phase Stage 2|Adverse Event|5|||
156998674|NCT01981850|566747459|FG006|Main Phase Stage 2|Adverse Event|7|||
156998675|NCT01981850|566747460|FG007|Main Phase Stage 2|Adverse Event|0|||
156998676|NCT01981850|566747461|FG008|Main Phase Stage 2|Adverse Event|0|||
156998677|NCT01981850|566747462|FG009|Main Phase Stage 2|Adverse Event|0|||
156998678|NCT01981850|566747453|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998679|NCT01981850|566747454|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998680|NCT01981850|566747455|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998681|NCT01981850|566747456|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998682|NCT01981850|566747457|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
156998683|NCT01981850|566747458|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
156998684|NCT01981850|566747459|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
156998685|NCT01981850|566747460|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998686|NCT01981850|566747461|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998687|NCT01981850|566747462|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
156998688|NCT01981850|566747453|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
156998689|NCT01981850|566747454|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
156998690|NCT01981850|566747455|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
156998691|NCT01981850|566747456|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
156998692|NCT01981850|566747457|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
156998693|NCT01981850|566747458|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
156998694|NCT01981850|566747459|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
156998695|NCT01981850|566747460|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
156998696|NCT01981850|566747461|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
156998697|NCT01981850|566747462|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
156998698|NCT01981850|566747453|FG000|Main Phase Stage 2|Various reasons|0|||
156998699|NCT01981850|566747454|FG001|Main Phase Stage 2|Various reasons|0|||
157101613|NCT05028517|567127249|FG002|Overall Study|Lost to Follow-up|12|||
157101614|NCT05028517|567127247|FG000|Overall Study|Withdrawal by Subject|0|||
157101615|NCT05028517|567127248|FG001|Overall Study|Withdrawal by Subject|0|||
157101616|NCT05028517|567127249|FG002|Overall Study|Withdrawal by Subject|1|||
156756768|NCT00784719|565860646|FG000|Overall Study|Withdrawal by Subject|1|||
156756769|NCT00784719|565860647|FG001|Overall Study|Withdrawal by Subject|0|||
156756770|NCT00784719|565860648|FG002|Overall Study|Withdrawal by Subject|0|||
156756771|NCT00784719|565860649|FG003|Overall Study|Withdrawal by Subject|0|||
156756772|NCT00784719|565860650|FG004|Overall Study|Withdrawal by Subject|2|||
156756773|NCT00784719|565860651|FG005|Overall Study|Withdrawal by Subject|0|||
156756774|NCT00784719|565860652|FG006|Overall Study|Withdrawal by Subject|1|||
156756775|NCT05285787|565860655|FG000|Overall Study|Withdrawal by Subject|1|||
156756776|NCT03382418|565860656|FG000|Overall Study|Withdrawal by Subject|1|||
156756777|NCT03382418|565860657|FG001|Overall Study|Withdrawal by Subject|0|||
156756778|NCT03382418|565860658|FG002|Overall Study|Withdrawal by Subject|0|||
156756779|NCT03382418|565860656|FG000|Overall Study|Lost to Follow-up|2|||
156998700|NCT01981850|566747455|FG002|Main Phase Stage 2|Various reasons|0|||
156998701|NCT01981850|566747456|FG003|Main Phase Stage 2|Various reasons|0|||
156998702|NCT01981850|566747457|FG004|Main Phase Stage 2|Various reasons|2|||
156998703|NCT01981850|566747458|FG005|Main Phase Stage 2|Various reasons|0|||
156998704|NCT01981850|566747459|FG006|Main Phase Stage 2|Various reasons|1|||
156998705|NCT01981850|566747460|FG007|Main Phase Stage 2|Various reasons|0|||
157101617|NCT04890054|567128581|FG000|Overall Study|Lost to Follow-up|202|||
156756780|NCT03382418|565860657|FG001|Overall Study|Lost to Follow-up|3|||
156756781|NCT03382418|565860658|FG002|Overall Study|Lost to Follow-up|0|||
156756782|NCT01051817|565860659|FG000|Overall Study|Adverse Event|0|||
156756783|NCT01051817|565860660|FG001|Overall Study|Adverse Event|2|||
156756784|NCT01051817|565860659|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
156998706|NCT01981850|566747461|FG008|Main Phase Stage 2|Various reasons|0|||
156998707|NCT01981850|566747462|FG009|Main Phase Stage 2|Various reasons|0|||
156998708|NCT01981850|566747453|FG000|Main Phase Stage 2|Progressive Disease|0|||
156998709|NCT01981850|566747454|FG001|Main Phase Stage 2|Progressive Disease|0|||
156998710|NCT01981850|566747455|FG002|Main Phase Stage 2|Progressive Disease|0|||
156998711|NCT01981850|566747456|FG003|Main Phase Stage 2|Progressive Disease|0|||
156998712|NCT01981850|566747457|FG004|Main Phase Stage 2|Progressive Disease|0|||
156998713|NCT01981850|566747458|FG005|Main Phase Stage 2|Progressive Disease|6|||
156998714|NCT01981850|566747459|FG006|Main Phase Stage 2|Progressive Disease|6|||
156998715|NCT01981850|566747460|FG007|Main Phase Stage 2|Progressive Disease|0|||
156998716|NCT01981850|566747461|FG008|Main Phase Stage 2|Progressive Disease|0|||
156998717|NCT01981850|566747462|FG009|Main Phase Stage 2|Progressive Disease|0|||
156998718|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Adverse Event|0|||
156998719|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Adverse Event|0|||
156998720|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Adverse Event|0|||
156998721|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Adverse Event|0|||
156998722|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Adverse Event|0|||
156998723|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Adverse Event|0|||
156998724|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Adverse Event|0|||
156998725|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Adverse Event|2|||
156998726|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Adverse Event|1|||
156998727|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Adverse Event|8|||
156998728|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998729|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998730|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998731|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998732|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998733|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998734|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
156998735|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
156998736|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
156998737|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
156998738|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Various reasons|0|||
156998739|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Various reasons|0|||
156998740|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Various reasons|0|||
156998741|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Various reasons|0|||
156998742|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Various reasons|0|||
156998743|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Various reasons|0|||
156998744|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Various reasons|0|||
156998745|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Various reasons|3|||
156998746|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Various reasons|1|||
156998747|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Various reasons|3|||
156998748|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
156998749|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
156998750|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
156998751|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
156998752|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
156998753|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
156998754|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
156998755|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
156998756|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
156998757|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
156998758|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998759|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998760|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998761|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998762|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998763|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998764|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998765|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998766|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
156998767|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
156998768|NCT01981850|566747453|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998769|NCT01981850|566747454|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998770|NCT01981850|566747455|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998771|NCT01981850|566747456|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998772|NCT01981850|566747457|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998773|NCT01981850|566747458|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998774|NCT01981850|566747459|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998775|NCT01981850|566747460|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998776|NCT01981850|566747461|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
156998777|NCT01981850|566747462|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
156998778|NCT03381274|566747465|FG000|Overall Study|Death|2|||
156998779|NCT03381274|566747466|FG001|Overall Study|Death|9|||
156998780|NCT03381274|566747467|FG002|Overall Study|Death|3|||
156998781|NCT03381274|566747468|FG003|Overall Study|Death|2|||
156998782|NCT03381274|566747469|FG004|Overall Study|Death|3|||
156998783|NCT03381274|566747465|FG000|Overall Study|Lost to Follow-up|0|||
156998784|NCT03381274|566747466|FG001|Overall Study|Lost to Follow-up|0|||
156998785|NCT03381274|566747467|FG002|Overall Study|Lost to Follow-up|0|||
156998786|NCT03381274|566747468|FG003|Overall Study|Lost to Follow-up|1|||
157101618|NCT04890054|567128582|FG001|Overall Study|Lost to Follow-up|219|||
157101619|NCT05586269|567128583|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
157101620|NCT05586269|567128584|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
157101621|NCT05586269|567128585|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
157101622|NCT05586269|567128586|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
157101623|NCT05586269|567128583|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
157101624|NCT05586269|567128584|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
157101625|NCT05586269|567128585|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
157101626|NCT05586269|567128586|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
157101627|NCT04752475|567128587|FG000|Overall Study|Withdrawal by Subject|1|||
157101628|NCT04752475|567128588|FG001|Overall Study|Withdrawal by Subject|1|||
157101629|NCT03335163|567128589|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
157101630|NCT03335163|567128589|FG000|Overall Study|Withdrawal by Subject|18|||
157101631|NCT00702845|567128590|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
157101632|NCT00702845|567128591|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
156998787|NCT03381274|566747469|FG004|Overall Study|Lost to Follow-up|0|||
157101633|NCT00702845|567128590|FG000|Overall Study|Too high ovarian response|5|||
157101634|NCT00702845|567128591|FG001|Overall Study|Too high ovarian response|1|||
157101635|NCT00702845|567128590|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
156756785|NCT01051817|565860660|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
156756786|NCT01051817|565860659|FG000|Overall Study|Withdrawal by Subject|3|||
156998788|NCT03381274|566747465|FG000|Overall Study|Withdrawal by Subject|2|||
156998789|NCT03381274|566747466|FG001|Overall Study|Withdrawal by Subject|1|||
156998790|NCT03381274|566747467|FG002|Overall Study|Withdrawal by Subject|3|||
156998791|NCT03381274|566747468|FG003|Overall Study|Withdrawal by Subject|1|||
156998792|NCT03381274|566747469|FG004|Overall Study|Withdrawal by Subject|0|||
156998793|NCT03381274|566747465|FG000|Overall Study|Other|1|||
156998794|NCT03381274|566747466|FG001|Overall Study|Other|11|||
156998795|NCT03381274|566747467|FG002|Overall Study|Other|0|||
156998796|NCT03381274|566747468|FG003|Overall Study|Other|2|||
156998797|NCT03381274|566747469|FG004|Overall Study|Other|2|||
156998798|NCT04982575|566747470|FG000|Overall Study|Withdrawal by Subject|2|||
156998799|NCT04982575|566747471|FG001|Overall Study|Withdrawal by Subject|0|||
156998800|NCT04982575|566747472|FG002|Overall Study|Withdrawal by Subject|2|||
156998801|NCT04948333|566747475|FG000|Overall Study|Adverse Event|6|||
156998802|NCT04948333|566747476|FG001|Overall Study|Adverse Event|4|||
156998803|NCT04948333|566747477|FG002|Overall Study|Adverse Event|0|||
156998804|NCT04948333|566747478|FG003|Overall Study|Adverse Event|2|||
156998805|NCT04948333|566747475|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156998806|NCT04948333|566747476|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156998807|NCT04948333|566747477|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156998808|NCT04948333|566747478|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156998809|NCT04948333|566747475|FG000|Overall Study|Progressive Disease|1|||
156998810|NCT04948333|566747476|FG001|Overall Study|Progressive Disease|5|||
156998811|NCT04948333|566747477|FG002|Overall Study|Progressive Disease|0|||
156998812|NCT04948333|566747478|FG003|Overall Study|Progressive Disease|0|||
156998813|NCT04948333|566747475|FG000|Overall Study|Physician Decision|2|||
156998814|NCT04948333|566747476|FG001|Overall Study|Physician Decision|2|||
156998815|NCT04948333|566747477|FG002|Overall Study|Physician Decision|0|||
156998816|NCT04948333|566747478|FG003|Overall Study|Physician Decision|0|||
156998817|NCT04948333|566747475|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
156998818|NCT04948333|566747476|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
156998819|NCT04948333|566747477|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
156998820|NCT04948333|566747478|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
156998821|NCT04948333|566747475|FG000|Overall Study|Withdrawal by Subject|2|||
156998822|NCT04948333|566747476|FG001|Overall Study|Withdrawal by Subject|0|||
156998823|NCT04948333|566747477|FG002|Overall Study|Withdrawal by Subject|0|||
156998824|NCT04948333|566747478|FG003|Overall Study|Withdrawal by Subject|1|||
156998825|NCT04948333|566747475|FG000|Overall Study|Protocol Violation|0|||
156998826|NCT04948333|566747476|FG001|Overall Study|Protocol Violation|1|||
156998827|NCT04948333|566747477|FG002|Overall Study|Protocol Violation|0|||
156998828|NCT04948333|566747478|FG003|Overall Study|Protocol Violation|0|||
156998829|NCT04948333|566747475|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
156998830|NCT04948333|566747476|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
156998831|NCT04948333|566747477|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
156998832|NCT04948333|566747478|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
156998833|NCT03887936|566747479|FG000|Overall Study|Relocation|2|||
156998834|NCT03887936|566747480|FG001|Overall Study|Relocation|2|||
156998835|NCT03887936|566747479|FG000|Overall Study|Physician Decision|0|||
156998836|NCT03887936|566747480|FG001|Overall Study|Physician Decision|1|||
156998837|NCT03887936|566747479|FG000|Overall Study|Withdrawal by Subject|0|||
156998838|NCT03887936|566747480|FG001|Overall Study|Withdrawal by Subject|1|||
156998839|NCT02824432|566747482|FG000|Overall Study|Major Protocol Deviation|1|||
156998840|NCT02824432|566747483|FG001|Overall Study|Major Protocol Deviation|0|||
156998841|NCT00117988|566747487|FG000|Overall Study|Death|3|||
156998842|NCT00117988|566747487|FG000|Overall Study|Adverse Event|1|||
156998843|NCT02912260|566747488|FG000|Main Study|Lost to Follow-up|5|||
156998844|NCT02912260|566747489|FG001|Main Study|Lost to Follow-up|4|||
156998845|NCT02912260|566747488|FG000|Main Study|Withdrawal by Subject|2|||
156998846|NCT02912260|566747489|FG001|Main Study|Withdrawal by Subject|2|||
156998847|NCT02912260|566747488|FG000|Main Study|Adverse Event|3|||
156998848|NCT02912260|566747489|FG001|Main Study|Adverse Event|0|||
156998849|NCT02912260|566747488|FG000|Main Study|Physician Decision|0|||
156998850|NCT02912260|566747489|FG001|Main Study|Physician Decision|1|||
156998851|NCT02912260|566747488|FG000|Extension Study|Withdrawal by Subject|1|||
156998852|NCT02912260|566747489|FG001|Extension Study|Withdrawal by Subject|1|||
156998853|NCT00124982|566747491|FG000|Short-term Period|Death|1|||
156998854|NCT00124982|566747492|FG001|Short-term Period|Death|1|||
156998855|NCT00124982|566747493|FG002|Short-term Period|Death|0|||
156998856|NCT00124982|566747491|FG000|Short-term Period|Adverse Event|17|||
156756787|NCT01051817|565860660|FG001|Overall Study|Withdrawal by Subject|5|||
156998857|NCT00124982|566747492|FG001|Short-term Period|Adverse Event|22|||
156998858|NCT00124982|566747493|FG002|Short-term Period|Adverse Event|0|||
156998859|NCT00124982|566747491|FG000|Short-term Period|Lack of Efficacy|32|||
156998860|NCT00124982|566747492|FG001|Short-term Period|Lack of Efficacy|73|||
156998861|NCT00124982|566747493|FG002|Short-term Period|Lack of Efficacy|0|||
157101636|NCT00702845|567128591|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
157101637|NCT00702845|567128590|FG000|Overall Study|Insufficient ovarian response|1|||
157101638|NCT00702845|567128591|FG001|Overall Study|Insufficient ovarian response|0|||
157101639|NCT00702845|567128590|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
157101640|NCT00702845|567128591|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
157101641|NCT00702845|567128590|FG000|Overall Study|No or abnormal fertilization|4|||
157101642|NCT00702845|567128591|FG001|Overall Study|No or abnormal fertilization|2|||
157101643|NCT00702845|567128590|FG000|Overall Study|Patient's decision|2|||
157101644|NCT00702845|567128591|FG001|Overall Study|Patient's decision|1|||
157101645|NCT00702845|567128590|FG000|Overall Study|Not randomized|0|||
157101646|NCT00702845|567128591|FG001|Overall Study|Not randomized|1|||
157101647|NCT01448213|567128596|FG000|Overall Study|Lost to Follow-up|12|||
157101648|NCT01448213|567128597|FG001|Overall Study|Lost to Follow-up|10|||
157101649|NCT01448213|567128596|FG000|Overall Study|Adverse Event|4|||
157101650|NCT01448213|567128597|FG001|Overall Study|Adverse Event|10|||
157101651|NCT01448213|567128596|FG000|Overall Study|Protocol Violation|1|||
157101652|NCT01448213|567128597|FG001|Overall Study|Protocol Violation|2|||
157101653|NCT04606771|567128603|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
157101654|NCT04606771|567128604|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
157101655|NCT04606771|567128603|FG000|Overall Study|Death|5|||
157101656|NCT04606771|567128604|FG001|Overall Study|Death|6|||
157101657|NCT04606771|567128603|FG000|Overall Study|Wrong randomisation|0|||
157101658|NCT04606771|567128604|FG001|Overall Study|Wrong randomisation|1|||
157101659|NCT03083847|567128607|FG000|Main|Physician Decision|0|||
157101660|NCT03083847|567128608|FG001|Main|Physician Decision|0|||
157101661|NCT03083847|567128609|FG002|Main|Physician Decision|0|||
157101662|NCT03083847|567128610|FG003|Main|Physician Decision|0|||
157101663|NCT03083847|567128611|FG004|Main|Physician Decision|0|||
157101664|NCT03083847|567128612|FG005|Main|Physician Decision|1|||
157101665|NCT03083847|567128613|FG006|Main|Physician Decision|0|||
157101666|NCT03083847|567128614|FG007|Main|Physician Decision|0|||
157101667|NCT03083847|567128615|FG008|Main|Physician Decision|0|||
157101668|NCT03083847|567128616|FG009|Main|Physician Decision|0|||
157101669|NCT03083847|567128607|FG000|Main|Pregnancy|0|||
157101670|NCT03083847|567128608|FG001|Main|Pregnancy|0|||
157101671|NCT03083847|567128609|FG002|Main|Pregnancy|0|||
157101672|NCT03083847|567128610|FG003|Main|Pregnancy|0|||
157101673|NCT03083847|567128611|FG004|Main|Pregnancy|0|||
157101674|NCT03083847|567128612|FG005|Main|Pregnancy|0|||
157101675|NCT03083847|567128613|FG006|Main|Pregnancy|0|||
157101676|NCT03083847|567128614|FG007|Main|Pregnancy|1|||
157101677|NCT03083847|567128615|FG008|Main|Pregnancy|0|||
157101678|NCT03083847|567128616|FG009|Main|Pregnancy|0|||
157101679|NCT03083847|567128607|FG000|Main|Adverse Event|0|||
157101680|NCT03083847|567128608|FG001|Main|Adverse Event|0|||
157101681|NCT03083847|567128609|FG002|Main|Adverse Event|0|||
157101682|NCT03083847|567128610|FG003|Main|Adverse Event|0|||
157101683|NCT03083847|567128611|FG004|Main|Adverse Event|0|||
157101684|NCT03083847|567128612|FG005|Main|Adverse Event|0|||
157101685|NCT03083847|567128613|FG006|Main|Adverse Event|0|||
157101686|NCT03083847|567128614|FG007|Main|Adverse Event|2|||
157101687|NCT03083847|567128615|FG008|Main|Adverse Event|0|||
157101688|NCT03083847|567128616|FG009|Main|Adverse Event|0|||
157101689|NCT03083847|567128607|FG000|Main|Withdrawal by Subject|0|||
157101690|NCT03083847|567128608|FG001|Main|Withdrawal by Subject|0|||
157101691|NCT03083847|567128609|FG002|Main|Withdrawal by Subject|0|||
157101692|NCT03083847|567128610|FG003|Main|Withdrawal by Subject|0|||
157101693|NCT03083847|567128611|FG004|Main|Withdrawal by Subject|0|||
157101694|NCT03083847|567128612|FG005|Main|Withdrawal by Subject|0|||
157101695|NCT03083847|567128613|FG006|Main|Withdrawal by Subject|1|||
157101696|NCT03083847|567128614|FG007|Main|Withdrawal by Subject|1|||
157101697|NCT03083847|567128615|FG008|Main|Withdrawal by Subject|0|||
157101698|NCT03083847|567128616|FG009|Main|Withdrawal by Subject|0|||
157101699|NCT01214187|567128617|FG000|Overall Study|Adverse Event|6|||
157101700|NCT01214187|567128618|FG001|Overall Study|Adverse Event|2|||
157101701|NCT01214187|567128617|FG000|Overall Study|Death|1|||
157101702|NCT01214187|567128618|FG001|Overall Study|Death|1|||
157101703|NCT01214187|567128617|FG000|Overall Study|Withdrawal by Subject|0|||
157101704|NCT01214187|567128618|FG001|Overall Study|Withdrawal by Subject|3|||
157101705|NCT02308007|567128623|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
157101706|NCT02308007|567128624|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
157101707|NCT02308007|567128625|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
157101708|NCT02308007|567128623|FG000|Overall Study|Positive for STD at Baseline|7|||
157101709|NCT02308007|567128624|FG001|Overall Study|Positive for STD at Baseline|11|||
157101710|NCT02308007|567128625|FG002|Overall Study|Positive for STD at Baseline|7|||
157101711|NCT02308007|567128623|FG000|Overall Study|Lost to Follow-up|3|||
157101712|NCT02308007|567128624|FG001|Overall Study|Lost to Follow-up|0|||
157101713|NCT02308007|567128625|FG002|Overall Study|Lost to Follow-up|1|||
157101714|NCT01233869|567128626|FG000|Initial Treatment Period (24 Months)|Death|1|||
157101715|NCT01233869|567128627|FG001|Initial Treatment Period (24 Months)|Death|0|||
157101716|NCT01233869|567128628|FG002|Initial Treatment Period (24 Months)|Death|0|||
156756788|NCT01051817|565860659|FG000|Overall Study|Protocol Violation|0|||
156756789|NCT01051817|565860660|FG001|Overall Study|Protocol Violation|1|||
157101717|NCT01233869|567128629|FG003|Initial Treatment Period (24 Months)|Death|0|||
157101718|NCT01233869|567128626|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
157101719|NCT01233869|567128627|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
157101720|NCT01233869|567128628|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
157101721|NCT01233869|567128629|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
157101722|NCT01233869|567128626|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
157101723|NCT01233869|567128627|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
157101724|NCT01233869|567128628|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
157101725|NCT01233869|567128629|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
157101726|NCT01233869|567128626|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
157101727|NCT01233869|567128627|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
157101728|NCT01233869|567128628|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
157101729|NCT01233869|567128629|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
157101730|NCT01233869|567128626|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
157101731|NCT01233869|567128627|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
157101732|NCT01233869|567128628|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
157101733|NCT01233869|567128629|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
157101734|NCT01233869|567128626|FG000|Extended Treatment Period (46 Months)|Other|3|||
157101735|NCT01233869|567128627|FG001|Extended Treatment Period (46 Months)|Other|0|||
157101736|NCT01233869|567128628|FG002|Extended Treatment Period (46 Months)|Other|0|||
157101737|NCT01233869|567128629|FG003|Extended Treatment Period (46 Months)|Other|3|||
157101738|NCT01233869|567128626|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
157101739|NCT01233869|567128627|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
157101740|NCT01233869|567128628|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
157101741|NCT01233869|567128629|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
157101742|NCT00631189|567128635|FG000|Initial Phase|Protocol Violation|347|||
157101743|NCT00631189|567128636|FG001|Initial Phase|Protocol Violation|0|||
157101744|NCT00631189|567128637|FG002|Initial Phase|Protocol Violation|0|||
157101745|NCT00631189|567128638|FG003|Initial Phase|Protocol Violation|0|||
156756790|NCT02472886|565860662|FG000|Overall Study|Lack of Efficacy|0|||
156756791|NCT02472886|565860663|FG001|Overall Study|Lack of Efficacy|2|||
156756792|NCT02472886|565860664|FG002|Overall Study|Lack of Efficacy|1|||
156756793|NCT00320788|565860665|FG000|Overall Study|Adverse Event|0|||
156756794|NCT00320788|565860666|FG001|Overall Study|Adverse Event|0|||
156756795|NCT00320788|565860667|FG002|Overall Study|Adverse Event|0|||
156756796|NCT00320788|565860668|FG003|Overall Study|Adverse Event|1|||
156756797|NCT00320788|565860669|FG004|Overall Study|Adverse Event|0|||
156756798|NCT00320788|565860665|FG000|Overall Study|Death|0|||
156756799|NCT00320788|565860666|FG001|Overall Study|Death|0|||
156756800|NCT00320788|565860667|FG002|Overall Study|Death|1|||
156756801|NCT00320788|565860668|FG003|Overall Study|Death|0|||
156756802|NCT00320788|565860669|FG004|Overall Study|Death|1|||
156756803|NCT00320788|565860665|FG000|Overall Study|Lost to Follow-up|0|||
156756804|NCT00320788|565860666|FG001|Overall Study|Lost to Follow-up|2|||
156756805|NCT00320788|565860667|FG002|Overall Study|Lost to Follow-up|1|||
156998862|NCT00124982|566747491|FG000|Short-term Period|Lost to Follow-up|8|||
156998863|NCT00124982|566747492|FG001|Short-term Period|Lost to Follow-up|5|||
156998864|NCT00124982|566747493|FG002|Short-term Period|Lost to Follow-up|0|||
156998865|NCT00124982|566747491|FG000|Short-term Period|Withdrawal of Consent|7|||
156998866|NCT00124982|566747492|FG001|Short-term Period|Withdrawal of Consent|9|||
156998867|NCT00124982|566747493|FG002|Short-term Period|Withdrawal of Consent|0|||
156998868|NCT00124982|566747491|FG000|Short-term Period|Poor/Non-compliance|3|||
156998869|NCT00124982|566747492|FG001|Short-term Period|Poor/Non-compliance|1|||
156998870|NCT00124982|566747493|FG002|Short-term Period|Poor/Non-compliance|0|||
156998871|NCT00124982|566747491|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
156998872|NCT00124982|566747492|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
156998873|NCT00124982|566747493|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
156998874|NCT00124982|566747491|FG000|Short-term Period|Participant Decision|1|||
156998875|NCT00124982|566747492|FG001|Short-term Period|Participant Decision|0|||
156998876|NCT00124982|566747493|FG002|Short-term Period|Participant Decision|0|||
156998877|NCT00124982|566747491|FG000|Short-term Period|Participant Chose Own Doctor|0|||
156998878|NCT00124982|566747492|FG001|Short-term Period|Participant Chose Own Doctor|1|||
157101746|NCT00631189|567128635|FG000|Initial Phase|Withdrawal by Subject|4|||
156756806|NCT00320788|565860668|FG003|Overall Study|Lost to Follow-up|0|||
156756807|NCT00320788|565860669|FG004|Overall Study|Lost to Follow-up|0|||
156756808|NCT00320788|565860665|FG000|Overall Study|Decision by the Sponsor|1|||
157101747|NCT00631189|567128636|FG001|Initial Phase|Withdrawal by Subject|0|||
157101748|NCT00631189|567128637|FG002|Initial Phase|Withdrawal by Subject|0|||
157101749|NCT00631189|567128638|FG003|Initial Phase|Withdrawal by Subject|0|||
156756809|NCT00320788|565860666|FG001|Overall Study|Decision by the Sponsor|1|||
156756810|NCT00320788|565860667|FG002|Overall Study|Decision by the Sponsor|0|||
156998879|NCT00124982|566747493|FG002|Short-term Period|Participant Chose Own Doctor|0|||
156998880|NCT00124982|566747491|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
156998881|NCT00124982|566747492|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
156998882|NCT00124982|566747493|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
156998883|NCT00124982|566747491|FG000|Short-term Period|Participant Had Lymphopenia|1|||
156998884|NCT00124982|566747492|FG001|Short-term Period|Participant Had Lymphopenia|0|||
156998885|NCT00124982|566747493|FG002|Short-term Period|Participant Had Lymphopenia|0|||
156998886|NCT00124982|566747491|FG000|Long-term Period|Death|0|||
156998887|NCT00124982|566747492|FG001|Long-term Period|Death|0|||
156998888|NCT00124982|566747493|FG002|Long-term Period|Death|1|||
156998889|NCT00124982|566747491|FG000|Long-term Period|Adverse Event|0|||
156998890|NCT00124982|566747492|FG001|Long-term Period|Adverse Event|0|||
156998891|NCT00124982|566747493|FG002|Long-term Period|Adverse Event|17|||
156998892|NCT00124982|566747491|FG000|Long-term Period|Lack of Efficacy|0|||
156998893|NCT00124982|566747492|FG001|Long-term Period|Lack of Efficacy|0|||
156998894|NCT00124982|566747493|FG002|Long-term Period|Lack of Efficacy|46|||
156998895|NCT00124982|566747491|FG000|Long-term Period|Lost to Follow-up|0|||
156998896|NCT00124982|566747492|FG001|Long-term Period|Lost to Follow-up|0|||
157101750|NCT00631189|567128635|FG000|Treatment Phase|Withdrawal by Subject|0|||
157101751|NCT00631189|567128636|FG001|Treatment Phase|Withdrawal by Subject|2|||
157101752|NCT00631189|567128637|FG002|Treatment Phase|Withdrawal by Subject|1|||
157101753|NCT00631189|567128638|FG003|Treatment Phase|Withdrawal by Subject|1|||
157101754|NCT00631189|567128635|FG000|Treatment Phase|Protocol Violation|0|||
157101755|NCT00631189|567128636|FG001|Treatment Phase|Protocol Violation|1|||
157101756|NCT00631189|567128637|FG002|Treatment Phase|Protocol Violation|6|||
157101757|NCT00631189|567128638|FG003|Treatment Phase|Protocol Violation|2|||
157101758|NCT00631189|567128635|FG000|Treatment Phase|Adverse Event|0|||
157101759|NCT00631189|567128636|FG001|Treatment Phase|Adverse Event|3|||
157101760|NCT00631189|567128637|FG002|Treatment Phase|Adverse Event|2|||
157101761|NCT00631189|567128638|FG003|Treatment Phase|Adverse Event|4|||
157101762|NCT00631189|567128635|FG000|Treatment Phase|Lost to Follow-up|0|||
157101763|NCT00631189|567128636|FG001|Treatment Phase|Lost to Follow-up|1|||
157101764|NCT00631189|567128637|FG002|Treatment Phase|Lost to Follow-up|0|||
157101765|NCT00631189|567128638|FG003|Treatment Phase|Lost to Follow-up|0|||
157101766|NCT00631189|567128635|FG000|Treatment Phase|Pregnancy|0|||
157101767|NCT00631189|567128636|FG001|Treatment Phase|Pregnancy|0|||
157101768|NCT00631189|567128637|FG002|Treatment Phase|Pregnancy|1|||
157101769|NCT00631189|567128638|FG003|Treatment Phase|Pregnancy|0|||
157101770|NCT00631189|567128635|FG000|Treatment Phase|patient did not take pravastatin|0|||
157101771|NCT00631189|567128636|FG001|Treatment Phase|patient did not take pravastatin|0|||
157101772|NCT00631189|567128637|FG002|Treatment Phase|patient did not take pravastatin|1|||
157101773|NCT00631189|567128638|FG003|Treatment Phase|patient did not take pravastatin|0|||
157101774|NCT04464265|567128639|FG000|Overall Study|Physician Decision|2|||
157101775|NCT03189862|567128640|FG000|Overall Study|Withdrawal by Subject|1|||
157101776|NCT03189862|567128641|FG001|Overall Study|Withdrawal by Subject|0|||
157101777|NCT03189862|567128640|FG000|Overall Study|Lost to Follow-up|54|||
157101778|NCT03189862|567128641|FG001|Overall Study|Lost to Follow-up|62|||
157101779|NCT00931944|567128643|FG000|Overall Study|Adverse Event|4|||
157101780|NCT00931944|567128643|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
157101781|NCT00931944|567128643|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
157101782|NCT00931944|567128643|FG000|Overall Study|Death|28|||
157101783|NCT00931944|567128643|FG000|Overall Study|Other|2|||
157101784|NCT01026142|567128644|FG000|Overall Study|Death|136|||
157101785|NCT01026142|567128645|FG001|Overall Study|Death|134|||
157101786|NCT01026142|567128644|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
157101787|NCT01026142|567128645|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
157101788|NCT01019317|567128646|FG000|Overall Study|Not Eligible|4|||
157101789|NCT02545322|567128647|FG000|Overall Study|Withdrawal by Subject|3|||
157101790|NCT00041067|567128648|FG000|Overall Study|Adverse Event|20|||
157101791|NCT00041067|567128648|FG000|Overall Study|Progression|19|||
157101792|NCT00041067|567128648|FG000|Overall Study|Patient refusal|12|||
157101793|NCT00041067|567128648|FG000|Overall Study|Other reasons|23|||
157101794|NCT00041067|567128648|FG000|Overall Study|Ineligible|2|||
157101795|NCT00778622|567128649|FG000|Overall Study|Adverse Event|5|||
157101796|NCT00778622|567128650|FG001|Overall Study|Adverse Event|4|||
157101797|NCT00778622|567128651|FG002|Overall Study|Adverse Event|7|||
157101798|NCT00778622|567128649|FG000|Overall Study|Withdrawal by Subject|4|||
157101799|NCT00778622|567128650|FG001|Overall Study|Withdrawal by Subject|5|||
157101800|NCT00778622|567128651|FG002|Overall Study|Withdrawal by Subject|5|||
157101801|NCT00778622|567128649|FG000|Overall Study|Lost to Follow-up|3|||
157101802|NCT00778622|567128650|FG001|Overall Study|Lost to Follow-up|3|||
157101803|NCT00778622|567128651|FG002|Overall Study|Lost to Follow-up|2|||
157101804|NCT00778622|567128649|FG000|Overall Study|Protocol Violation|0|||
157101805|NCT00778622|567128650|FG001|Overall Study|Protocol Violation|3|||
157101806|NCT00778622|567128651|FG002|Overall Study|Protocol Violation|0|||
157101807|NCT00778622|567128649|FG000|Overall Study|Lack of Efficacy|2|||
157101808|NCT00778622|567128650|FG001|Overall Study|Lack of Efficacy|0|||
157101809|NCT00778622|567128651|FG002|Overall Study|Lack of Efficacy|0|||
157101810|NCT00778622|567128649|FG000|Overall Study|immigration|1|||
157101811|NCT00778622|567128650|FG001|Overall Study|immigration|0|||
157101812|NCT00778622|567128651|FG002|Overall Study|immigration|0|||
157101813|NCT00778622|567128649|FG000|Overall Study|Other|1|||
157101814|NCT00778622|567128650|FG001|Overall Study|Other|0|||
157101815|NCT00778622|567128651|FG002|Overall Study|Other|1|||
157101816|NCT04744285|567128652|FG000|Overall Study|Withdrawal by Subject|1|||
157101817|NCT04744285|567128653|FG001|Overall Study|Withdrawal by Subject|1|||
157101818|NCT04744285|567128654|FG002|Overall Study|Withdrawal by Subject|2|||
157101819|NCT04744285|567128655|FG003|Overall Study|Withdrawal by Subject|1|||
157101820|NCT01251120|567128659|FG000|Overall Study|Lack of Efficacy|0|||
157101821|NCT01251120|567128660|FG001|Overall Study|Lack of Efficacy|1|||
157101822|NCT01822522|567128663|FG000|Overall Study|Adverse Event|1|||
157101823|NCT01822522|567128664|FG001|Overall Study|Adverse Event|1|||
157101824|NCT01822522|567128665|FG002|Overall Study|Adverse Event|1|||
156756811|NCT00320788|565860668|FG003|Overall Study|Decision by the Sponsor|0|||
156756812|NCT00320788|565860669|FG004|Overall Study|Decision by the Sponsor|1|||
156756813|NCT00320788|565860665|FG000|Overall Study|Other|1|||
156756814|NCT00320788|565860666|FG001|Overall Study|Other|2|||
156756815|NCT00320788|565860667|FG002|Overall Study|Other|1|||
156756816|NCT00320788|565860668|FG003|Overall Study|Other|1|||
156756817|NCT00320788|565860669|FG004|Overall Study|Other|1|||
156756818|NCT00320788|565860665|FG000|Overall Study|Physician Decision|1|||
156756819|NCT00320788|565860666|FG001|Overall Study|Physician Decision|1|||
156756820|NCT00320788|565860667|FG002|Overall Study|Physician Decision|0|||
156756821|NCT00320788|565860668|FG003|Overall Study|Physician Decision|0|||
156756822|NCT00320788|565860669|FG004|Overall Study|Physician Decision|0|||
156756823|NCT00320788|565860665|FG000|Overall Study|Protocol Violation|0|||
156756824|NCT00320788|565860666|FG001|Overall Study|Protocol Violation|0|||
156756825|NCT00320788|565860667|FG002|Overall Study|Protocol Violation|0|||
156756826|NCT00320788|565860668|FG003|Overall Study|Protocol Violation|0|||
156998897|NCT00124982|566747493|FG002|Long-term Period|Lost to Follow-up|4|||
156998898|NCT00124982|566747491|FG000|Long-term Period|Withdrawal by Subject|0|||
156998899|NCT00124982|566747492|FG001|Long-term Period|Withdrawal by Subject|0|||
156998900|NCT00124982|566747493|FG002|Long-term Period|Withdrawal by Subject|16|||
156998901|NCT00124982|566747491|FG000|Long-term Period|Pregnancy|0|||
156998902|NCT00124982|566747492|FG001|Long-term Period|Pregnancy|0|||
156998903|NCT00124982|566747493|FG002|Long-term Period|Pregnancy|1|||
156998904|NCT00124982|566747491|FG000|Long-term Period|Poor/Non-compliance|0|||
156998905|NCT00124982|566747492|FG001|Long-term Period|Poor/Non-compliance|0|||
156998906|NCT00124982|566747493|FG002|Long-term Period|Poor/Non-compliance|2|||
156998907|NCT00124982|566747491|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
156998908|NCT00124982|566747492|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
156998909|NCT00124982|566747493|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
156998910|NCT00124982|566747491|FG000|Long-term Period|Neurologist Recommendation|0|||
156998911|NCT00124982|566747492|FG001|Long-term Period|Neurologist Recommendation|0|||
156998912|NCT00124982|566747493|FG002|Long-term Period|Neurologist Recommendation|1|||
156998913|NCT03410992|566748580|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998914|NCT03410992|566748581|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
156998915|NCT03410992|566748582|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998916|NCT03410992|566748583|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998917|NCT03410992|566748584|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998918|NCT03410992|566748585|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998919|NCT03410992|566748586|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998920|NCT03410992|566748587|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998921|NCT03410992|566748588|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998922|NCT03410992|566748589|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998923|NCT03410992|566748590|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
156998924|NCT03410992|566748580|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
156998925|NCT03410992|566748581|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
156998926|NCT03410992|566748582|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998927|NCT03410992|566748583|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998928|NCT03410992|566748584|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998929|NCT03410992|566748585|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998930|NCT03410992|566748586|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998931|NCT03410992|566748587|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998932|NCT03410992|566748588|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998933|NCT03410992|566748589|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998934|NCT03410992|566748590|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
156998935|NCT03410992|566748580|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
156998936|NCT03410992|566748581|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
156998937|NCT03410992|566748582|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998938|NCT03410992|566748583|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998939|NCT03410992|566748584|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998940|NCT03410992|566748585|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998941|NCT03410992|566748586|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998942|NCT03410992|566748587|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998943|NCT03410992|566748588|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156756827|NCT00320788|565860669|FG004|Overall Study|Protocol Violation|1|||
156998944|NCT03410992|566748589|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156998945|NCT03410992|566748590|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
156756828|NCT00320788|565860665|FG000|Overall Study|Withdrawal by Subject|3|||
156756829|NCT00320788|565860666|FG001|Overall Study|Withdrawal by Subject|0|||
156756830|NCT00320788|565860667|FG002|Overall Study|Withdrawal by Subject|0|||
156756831|NCT00320788|565860668|FG003|Overall Study|Withdrawal by Subject|3|||
156756832|NCT00320788|565860669|FG004|Overall Study|Withdrawal by Subject|1|||
157101825|NCT01822522|567128666|FG003|Overall Study|Adverse Event|0|||
157101826|NCT01822522|567128667|FG004|Overall Study|Adverse Event|0|||
157101827|NCT01822522|567128668|FG005|Overall Study|Adverse Event|1|||
157101828|NCT01822522|567128663|FG000|Overall Study|Death|3|||
157101829|NCT01822522|567128664|FG001|Overall Study|Death|0|||
157101830|NCT01822522|567128665|FG002|Overall Study|Death|2|||
157101831|NCT01822522|567128666|FG003|Overall Study|Death|0|||
157101832|NCT01822522|567128667|FG004|Overall Study|Death|0|||
157101833|NCT01822522|567128668|FG005|Overall Study|Death|0|||
157101834|NCT01822522|567128663|FG000|Overall Study|Lost to Follow-up|0|||
157101835|NCT01822522|567128664|FG001|Overall Study|Lost to Follow-up|0|||
157101836|NCT01822522|567128665|FG002|Overall Study|Lost to Follow-up|1|||
157101837|NCT01822522|567128666|FG003|Overall Study|Lost to Follow-up|1|||
157101838|NCT01822522|567128667|FG004|Overall Study|Lost to Follow-up|0|||
157101839|NCT01822522|567128668|FG005|Overall Study|Lost to Follow-up|1|||
157101840|NCT01822522|567128663|FG000|Overall Study|Withdrawal by Subject|0|||
157101841|NCT01822522|567128664|FG001|Overall Study|Withdrawal by Subject|0|||
157101842|NCT01822522|567128665|FG002|Overall Study|Withdrawal by Subject|0|||
157101843|NCT01822522|567128666|FG003|Overall Study|Withdrawal by Subject|1|||
157101844|NCT01822522|567128667|FG004|Overall Study|Withdrawal by Subject|0|||
157101845|NCT01822522|567128668|FG005|Overall Study|Withdrawal by Subject|0|||
157101846|NCT01822522|567128663|FG000|Overall Study|Lack of Efficacy|0|||
157101847|NCT01822522|567128664|FG001|Overall Study|Lack of Efficacy|0|||
157101848|NCT01822522|567128665|FG002|Overall Study|Lack of Efficacy|0|||
157101849|NCT01822522|567128666|FG003|Overall Study|Lack of Efficacy|0|||
157101850|NCT01822522|567128667|FG004|Overall Study|Lack of Efficacy|0|||
157101851|NCT01822522|567128668|FG005|Overall Study|Lack of Efficacy|2|||
157101852|NCT01807923|567128669|FG000|Overall Study|Adverse Event|2|||
157101853|NCT01807923|567128670|FG001|Overall Study|Adverse Event|1|||
157101854|NCT01807923|567128671|FG002|Overall Study|Adverse Event|2|||
157101855|NCT01807923|567128669|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
157101856|NCT01807923|567128670|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
157101857|NCT01807923|567128671|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
157101858|NCT01807923|567128669|FG000|Overall Study|Physician Decision|0|||
157101859|NCT01807923|567128670|FG001|Overall Study|Physician Decision|0|||
157101860|NCT01807923|567128671|FG002|Overall Study|Physician Decision|1|||
157101861|NCT01807923|567128669|FG000|Overall Study|Not Eligible (Genotype)|0|||
157101862|NCT01807923|567128670|FG001|Overall Study|Not Eligible (Genotype)|0|||
157101863|NCT01807923|567128671|FG002|Overall Study|Not Eligible (Genotype)|1|||
157101864|NCT01807923|567128669|FG000|Overall Study|Randomized But Not Treated|3|||
157101865|NCT01807923|567128670|FG001|Overall Study|Randomized But Not Treated|2|||
157101866|NCT01807923|567128671|FG002|Overall Study|Randomized But Not Treated|5|||
157101867|NCT00890929|567128673|FG000|Overall Study|Death before treatment|2|||
157101868|NCT00890929|567128673|FG000|Overall Study|Withdrawal by Subject|3|||
157101869|NCT00890929|567128673|FG000|Overall Study|Physician Decision|1|||
157101870|NCT00108069|567128674|FG000|Overall Study|Never rec'd study drug|0|||
157101871|NCT00108069|567128675|FG001|Overall Study|Never rec'd study drug|1|||
157101872|NCT00108069|567128674|FG000|Overall Study|Adverse Event|1|||
157101873|NCT00108069|567128675|FG001|Overall Study|Adverse Event|1|||
157101874|NCT00108069|567128674|FG000|Overall Study|Withdrawal by Subject|1|||
157101875|NCT00108069|567128675|FG001|Overall Study|Withdrawal by Subject|0|||
157101876|NCT00108069|567128674|FG000|Overall Study|Death|1|||
157101877|NCT00108069|567128675|FG001|Overall Study|Death|0|||
157101878|NCT00108069|567128674|FG000|Overall Study|Progessive disease|27|||
157101879|NCT00108069|567128675|FG001|Overall Study|Progessive disease|11|||
157101880|NCT03836807|567128676|FG000|Overall Study|Physician Decision|1|||
157101881|NCT03836807|567128677|FG001|Overall Study|Physician Decision|0|||
157101882|NCT04029116|567128678|FG000|Overall Study|Adverse Event|0|||
157101883|NCT04029116|567128679|FG001|Overall Study|Adverse Event|2|||
157101884|NCT04029116|567128678|FG000|Overall Study|Lost to Follow-up|3|||
157101885|NCT04029116|567128679|FG001|Overall Study|Lost to Follow-up|5|||
157101886|NCT04029116|567128678|FG000|Overall Study|Physician Decision|2|||
157101887|NCT04029116|567128679|FG001|Overall Study|Physician Decision|0|||
157101888|NCT04029116|567128678|FG000|Overall Study|Pregnancy|1|||
157101889|NCT04029116|567128679|FG001|Overall Study|Pregnancy|2|||
157101890|NCT04029116|567128678|FG000|Overall Study|Withdrawal by Subject|4|||
157101891|NCT04029116|567128679|FG001|Overall Study|Withdrawal by Subject|6|||
157101892|NCT04029116|567128678|FG000|Overall Study|Other|2|||
157101893|NCT04029116|567128679|FG001|Overall Study|Other|1|||
157101894|NCT02469896|567128682|FG000|Overall Study|Withdrawal by Subject|2|||
157101895|NCT02469896|567128683|FG001|Overall Study|Withdrawal by Subject|0|||
157101896|NCT02510560|567128684|FG000|Overall Study|Discontinued from Treatment|27|||
157101897|NCT02510560|567128685|FG001|Overall Study|Discontinued from Treatment|18|||
157101898|NCT02510560|567128686|FG002|Overall Study|Discontinued from Treatment|19|||
157101899|NCT02510560|567128684|FG000|Overall Study|Other|4|||
157101900|NCT02510560|567128685|FG001|Overall Study|Other|4|||
157101901|NCT02510560|567128686|FG002|Overall Study|Other|3|||
157101902|NCT00882310|567128687|FG000|Overall Study|Screen Failure|10|||
157101903|NCT00882310|567128687|FG000|Overall Study|Never received treatment|1|||
157101904|NCT00882310|567128687|FG000|Overall Study|Death|6|||
157101905|NCT00882310|567128687|FG000|Overall Study|Progression of disease|4|||
157101906|NCT00882310|567128687|FG000|Overall Study|Adverse Event|1|||
157101907|NCT03684642|567128692|FG000|Overall Study|Adverse Event|6|||
157101908|NCT03684642|567128693|FG001|Overall Study|Adverse Event|15|||
157101909|NCT03684642|567128694|FG002|Overall Study|Adverse Event|11|||
157101910|NCT03684642|567128692|FG000|Overall Study|Withdrawal by Subject|35|||
157101911|NCT03684642|567128693|FG001|Overall Study|Withdrawal by Subject|53|||
157101912|NCT03684642|567128694|FG002|Overall Study|Withdrawal by Subject|23|||
157101913|NCT03684642|567128692|FG000|Overall Study|Lack of Efficacy|0|||
157101914|NCT03684642|567128693|FG001|Overall Study|Lack of Efficacy|0|||
157101915|NCT03684642|567128694|FG002|Overall Study|Lack of Efficacy|1|||
157101916|NCT03684642|567128692|FG000|Overall Study|Poor compliance to protocol|0|||
157101917|NCT03684642|567128693|FG001|Overall Study|Poor compliance to protocol|4|||
157101918|NCT03684642|567128694|FG002|Overall Study|Poor compliance to protocol|1|||
157101919|NCT03684642|567128692|FG000|Overall Study|Other than specified|62|||
157101920|NCT03684642|567128693|FG001|Overall Study|Other than specified|60|||
157101921|NCT03684642|567128694|FG002|Overall Study|Other than specified|67|||
157101922|NCT03684642|567128692|FG000|Overall Study|Randomized and not treated|0|||
157101923|NCT03684642|567128693|FG001|Overall Study|Randomized and not treated|0|||
157101924|NCT03684642|567128694|FG002|Overall Study|Randomized and not treated|1|||
157101925|NCT03684642|567128692|FG000|Overall Study|Missing completion status but alive at last contact|0|||
157101926|NCT03684642|567128693|FG001|Overall Study|Missing completion status but alive at last contact|1|||
157101927|NCT03684642|567128694|FG002|Overall Study|Missing completion status but alive at last contact|2|||
157101928|NCT02540538|567128695|FG000|Overall Study|Pregnancy|0|||
157101929|NCT02540538|567128696|FG001|Overall Study|Pregnancy|1|||
157101930|NCT02540538|567128697|FG002|Overall Study|Pregnancy|0|||
157101931|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
157101932|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
157101933|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
157101934|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
157101935|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
157101936|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
157101937|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
157101938|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
157101939|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
157101940|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
157101941|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
157101942|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
157101943|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
157101944|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
157101945|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
157101946|NCT04908189|567128698|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
157101947|NCT04908189|567128699|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
157101948|NCT04908189|567128700|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
157101949|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
157101950|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
157101951|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
157101952|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
157101953|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
157101954|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
157101955|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
157101956|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
157101957|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
157101958|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
157101959|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
157101960|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
157101961|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
157101962|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
157101963|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
157101964|NCT04908189|567128698|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
157101965|NCT04908189|567128699|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
157101966|NCT04908189|567128700|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
157101967|NCT05579990|567128707|FG000|Overall Study|Lost to Follow-up|3|||
156998946|NCT03410992|566748580|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
156998947|NCT03410992|566748581|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998948|NCT03410992|566748582|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998949|NCT03410992|566748583|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998950|NCT03410992|566748584|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998951|NCT03410992|566748585|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998952|NCT03410992|566748586|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998953|NCT03410992|566748587|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998954|NCT03410992|566748588|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998955|NCT03410992|566748589|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998956|NCT03410992|566748590|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
156998957|NCT03410992|566748580|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
156998958|NCT03410992|566748581|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
156998959|NCT03410992|566748582|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998960|NCT03410992|566748583|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998961|NCT03410992|566748584|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998962|NCT03410992|566748585|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998963|NCT03410992|566748586|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998964|NCT03410992|566748587|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998965|NCT03410992|566748588|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998966|NCT03410992|566748589|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998967|NCT03410992|566748590|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
156998968|NCT03410992|566748580|FG000|Week 16 Assessment|Incorrect escapers|0|||
156998969|NCT03410992|566748581|FG001|Week 16 Assessment|Incorrect escapers|6|||
156998970|NCT03410992|566748582|FG002|Week 16 Assessment|Incorrect escapers|0|||
156998971|NCT03410992|566748583|FG003|Week 16 Assessment|Incorrect escapers|0|||
156998972|NCT03410992|566748584|FG004|Week 16 Assessment|Incorrect escapers|0|||
156998973|NCT03410992|566748585|FG005|Week 16 Assessment|Incorrect escapers|0|||
156998974|NCT03410992|566748586|FG006|Week 16 Assessment|Incorrect escapers|0|||
156998975|NCT03410992|566748587|FG007|Week 16 Assessment|Incorrect escapers|0|||
156998976|NCT03410992|566748588|FG008|Week 16 Assessment|Incorrect escapers|0|||
156998977|NCT03410992|566748589|FG009|Week 16 Assessment|Incorrect escapers|0|||
156998978|NCT03410992|566748590|FG010|Week 16 Assessment|Incorrect escapers|0|||
156998979|NCT03410992|566748580|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998980|NCT03410992|566748581|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998981|NCT03410992|566748582|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998982|NCT03410992|566748583|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
156998983|NCT03410992|566748584|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
156998984|NCT03410992|566748585|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998985|NCT03410992|566748586|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998986|NCT03410992|566748587|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998987|NCT03410992|566748588|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998988|NCT03410992|566748589|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998989|NCT03410992|566748590|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
156998990|NCT03410992|566748580|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156998991|NCT03410992|566748581|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156998992|NCT03410992|566748582|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156998993|NCT03410992|566748583|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
156998994|NCT03410992|566748584|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
156998995|NCT03410992|566748585|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
156998996|NCT03410992|566748586|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156998997|NCT03410992|566748587|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
157101968|NCT00607022|567128708|FG000|Overall Study|Withdrawal by Subject|1|||
157101969|NCT00607022|567128709|FG001|Overall Study|Withdrawal by Subject|0|||
157101970|NCT00607022|567128710|FG002|Overall Study|Withdrawal by Subject|0|||
157101971|NCT01012739|567128711|FG000|Treatment Period 1|Adverse Event|0|||
157101972|NCT01012739|567128712|FG001|Treatment Period 1|Adverse Event|0|||
157101973|NCT01012739|567128713|FG002|Treatment Period 1|Adverse Event|0|||
157101974|NCT01012739|567128714|FG003|Treatment Period 1|Adverse Event|1|||
157101975|NCT01012739|567128711|FG000|Treatment Period 2|Abnormal test procedure results|0|||
157101976|NCT01012739|567128712|FG001|Treatment Period 2|Abnormal test procedure results|0|||
157101977|NCT01012739|567128713|FG002|Treatment Period 2|Abnormal test procedure results|0|||
157101978|NCT01012739|567128714|FG003|Treatment Period 2|Abnormal test procedure results|1|||
157101979|NCT04540133|567128715|FG000|Overall Study|Lost to Follow-up|1|||
157101980|NCT04540133|567128716|FG001|Overall Study|Lost to Follow-up|0|||
157101981|NCT01658826|567128721|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
157101982|NCT01658826|567128722|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
157101983|NCT01658826|567128721|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
157101984|NCT01658826|567128722|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
157101985|NCT01658826|567128721|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
157101986|NCT01658826|567128722|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
157101987|NCT01658826|567128721|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
157101988|NCT01658826|567128722|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
157101989|NCT01658826|567128721|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
157101990|NCT01658826|567128722|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
157101991|NCT01658826|567128721|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
157101992|NCT01658826|567128722|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
157101993|NCT01658826|567128721|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
157101994|NCT01658826|567128722|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
157101995|NCT01658826|567128721|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
157101996|NCT01658826|567128722|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
157101997|NCT01658826|567128721|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
157101998|NCT01658826|567128722|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
157101999|NCT00866697|567128724|FG000|Overall Study|Study closed/terminated|156|||
157102000|NCT00866697|567128725|FG001|Overall Study|Study closed/terminated|138|||
157102001|NCT00866697|567128724|FG000|Overall Study|Lost to Follow-up|22|||
157102002|NCT00866697|567128725|FG001|Overall Study|Lost to Follow-up|28|||
157102003|NCT00866697|567128724|FG000|Overall Study|Physician Decision|3|||
157102004|NCT00866697|567128725|FG001|Overall Study|Physician Decision|5|||
157102005|NCT00866697|567128724|FG000|Overall Study|Withdrawal by Subject|33|||
157102006|NCT00866697|567128725|FG001|Overall Study|Withdrawal by Subject|57|||
157102007|NCT04313153|567130671|FG000|Overall Study|Adverse Event (includes Death)|14|||
157102008|NCT04313153|567130672|FG001|Overall Study|Adverse Event (includes Death)|19|||
157102009|NCT04313153|567130673|FG002|Overall Study|Adverse Event (includes Death)|10|||
157102010|NCT04313153|567130671|FG000|Overall Study|Physician Decision|4|||
157102011|NCT04313153|567130672|FG001|Overall Study|Physician Decision|2|||
157102012|NCT04313153|567130673|FG002|Overall Study|Physician Decision|1|||
157102013|NCT04313153|567130671|FG000|Overall Study|Withdrawal by Subject|7|||
157102014|NCT04313153|567130672|FG001|Overall Study|Withdrawal by Subject|6|||
157102015|NCT04313153|567130673|FG002|Overall Study|Withdrawal by Subject|2|||
157102016|NCT04313153|567130671|FG000|Overall Study|Lack of Efficacy|3|||
157102017|NCT04313153|567130672|FG001|Overall Study|Lack of Efficacy|3|||
157102018|NCT04313153|567130673|FG002|Overall Study|Lack of Efficacy|0|||
157102019|NCT04313153|567130671|FG000|Overall Study|Lost to Follow-up|1|||
157102020|NCT04313153|567130672|FG001|Overall Study|Lost to Follow-up|0|||
157102021|NCT04313153|567130673|FG002|Overall Study|Lost to Follow-up|2|||
157102022|NCT04313153|567130671|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
157102023|NCT04313153|567130672|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
157102024|NCT04313153|567130673|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
157102025|NCT04313153|567130671|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
157102026|NCT04313153|567130672|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
157102027|NCT04313153|567130673|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
157102028|NCT04313153|567130671|FG000|Overall Study|Change in Dialysis Modality|0|||
157102029|NCT04313153|567130672|FG001|Overall Study|Change in Dialysis Modality|1|||
157102030|NCT04313153|567130673|FG002|Overall Study|Change in Dialysis Modality|2|||
157102031|NCT04313153|567130671|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
157102032|NCT04313153|567130672|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
157102033|NCT04313153|567130673|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
157102034|NCT04313153|567130671|FG000|Overall Study|Other|5|||
157102035|NCT04313153|567130672|FG001|Overall Study|Other|3|||
157102036|NCT04313153|567130673|FG002|Overall Study|Other|2|||
157102037|NCT01310803|567130679|FG000|Overall Study|Subject terminated by Sponsor|1|||
157102038|NCT01310803|567130680|FG001|Overall Study|Subject terminated by Sponsor|0|||
157102039|NCT02113579|567130683|FG000|Overall Study|Adverse Event|1|||
157102040|NCT02113579|567130684|FG001|Overall Study|Adverse Event|0|||
157102041|NCT02113579|567130683|FG000|Overall Study|Withdrawal by Subject|3|||
157102042|NCT02113579|567130684|FG001|Overall Study|Withdrawal by Subject|2|||
157102043|NCT02113579|567130683|FG000|Overall Study|Lost to Follow-up|6|||
157102044|NCT02113579|567130684|FG001|Overall Study|Lost to Follow-up|2|||
157102045|NCT03047551|567130685|FG000|Overall Study|Did not receive TAS|1|||
157102046|NCT03047551|567130686|FG001|Overall Study|Did not receive TAS|0|||
157102047|NCT03047551|567130685|FG000|Overall Study|Physician Decision|1|||
157102048|NCT03047551|567130686|FG001|Overall Study|Physician Decision|0|||
157102049|NCT03047551|567130685|FG000|Overall Study|Withdrawal by Subject|0|||
157102050|NCT03047551|567130686|FG001|Overall Study|Withdrawal by Subject|1|||
157102051|NCT03047551|567130685|FG000|Overall Study|Probe malfunction|0|||
157102052|NCT03047551|567130686|FG001|Overall Study|Probe malfunction|1|||
157102053|NCT03047551|567130685|FG000|Overall Study|Ineligible|0|||
157102054|NCT03047551|567130686|FG001|Overall Study|Ineligible|1|||
157102055|NCT00726622|567130687|FG000|Overall Study|Withdrawal by Subject|16|||
157102056|NCT00726622|567130688|FG001|Overall Study|Withdrawal by Subject|2|||
157102057|NCT00726622|567130687|FG000|Overall Study|Physician Decision|0|||
157102058|NCT00726622|567130688|FG001|Overall Study|Physician Decision|1|||
157102059|NCT00726622|567130687|FG000|Overall Study|Metastasis|2|||
157102060|NCT00726622|567130688|FG001|Overall Study|Metastasis|0|||
157102061|NCT02462928|567130690|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
157102062|NCT02462928|567130691|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
157102063|NCT02462928|567130692|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
157102064|NCT02462928|567130690|FG000|Overall Study|Adverse Event|47|||
157102065|NCT02462928|567130691|FG001|Overall Study|Adverse Event|51|||
157102066|NCT02462928|567130692|FG002|Overall Study|Adverse Event|25|||
157102067|NCT02462928|567130690|FG000|Overall Study|Lack of Efficacy|3|||
157102068|NCT02462928|567130691|FG001|Overall Study|Lack of Efficacy|8|||
157102069|NCT02462928|567130692|FG002|Overall Study|Lack of Efficacy|3|||
157102070|NCT02462928|567130690|FG000|Overall Study|Lost to Follow-up|4|||
157102071|NCT02462928|567130691|FG001|Overall Study|Lost to Follow-up|4|||
157102072|NCT02462928|567130692|FG002|Overall Study|Lost to Follow-up|1|||
157102073|NCT02462928|567130690|FG000|Overall Study|Withdrawal by Patient|31|||
157102074|NCT02462928|567130691|FG001|Overall Study|Withdrawal by Patient|21|||
157102075|NCT02462928|567130692|FG002|Overall Study|Withdrawal by Patient|21|||
157102076|NCT02462928|567130690|FG000|Overall Study|Protocol Violation|0|||
157102077|NCT02462928|567130691|FG001|Overall Study|Protocol Violation|1|||
157102078|NCT02462928|567130692|FG002|Overall Study|Protocol Violation|0|||
157102079|NCT02462928|567130690|FG000|Overall Study|Reason not Specified|4|||
157102080|NCT02462928|567130691|FG001|Overall Study|Reason not Specified|6|||
157102081|NCT02462928|567130692|FG002|Overall Study|Reason not Specified|5|||
157102082|NCT00395863|567130693|FG000|Overall Study|Patients did not complete both exams|2|||
157102083|NCT00395863|567130694|FG001|Overall Study|Patients did not complete both exams|3|||
157102084|NCT02020863|567130699|FG000|Overall Study|Discovery of Metastatic disease|4|||
157102085|NCT02020863|567130699|FG000|Overall Study|Team chose not to place an a line|1|||
157102086|NCT03873493|567130700|FG000|Overall Study|Withdrawal by Subject|1|||
157102087|NCT03873493|567130700|FG000|Overall Study|Death|9|||
157102088|NCT03873493|567130700|FG000|Overall Study|Lost to Follow-up|1|||
157102089|NCT03873493|567130700|FG000|Overall Study|Study Terminated by Sponsor|1|||
157102090|NCT03873493|567130700|FG000|Overall Study|Other|2|||
157102091|NCT02973425|567130707|FG000|Overall Study|Lost to Follow-up|49|||
157102092|NCT02973425|567130708|FG001|Overall Study|Lost to Follow-up|53|||
157102093|NCT03503513|567130709|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
157102094|NCT03503513|567130709|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
157102095|NCT03503513|567130709|FG000|Overall Study|Physician Decision|3|||
157102096|NCT03503513|567130709|FG000|Overall Study|Withdrawal by Subject|2|||
157102097|NCT03503513|567130709|FG000|Overall Study|Lost to Follow-up|1|||
157102098|NCT01170039|567130710|FG000|Overall Study|Withdrawal by Subject|5|||
157102099|NCT01170039|567130711|FG001|Overall Study|Withdrawal by Subject|3|||
157102100|NCT01170039|567130710|FG000|Overall Study|Lack of funding, drug not available|3|||
157102101|NCT01170039|567130711|FG001|Overall Study|Lack of funding, drug not available|3|||
157102102|NCT01524133|567130714|FG000|Treatment Phase|Withdrawal by Subject|13|||
157102103|NCT01524133|567130715|FG001|Treatment Phase|Withdrawal by Subject|28|||
157102104|NCT01524133|567130716|FG002|Treatment Phase|Withdrawal by Subject|31|||
157102105|NCT01524133|567130714|FG000|Treatment Phase|Physician Decision|6|||
156756833|NCT04533438|565860673|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
156756834|NCT04533438|565860674|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
156756835|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
156756836|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
156756837|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
156756838|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
156756839|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
156756840|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
156756841|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
156756842|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756843|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756844|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
156756845|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
156756846|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
156756847|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
156756848|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
156756849|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
156756850|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
156756851|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
156756852|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756853|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756854|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
156756855|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
156756856|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756857|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756858|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756859|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
156756860|NCT02137226|565860696|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
156756861|NCT02137226|565860697|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
156756862|NCT02137226|565860698|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
156756863|NCT02137226|565860699|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
156756864|NCT02137226|565860700|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
156756865|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
156756866|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
156756867|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
156756868|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
156998998|NCT03410992|566748588|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156998999|NCT03410992|566748589|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156999000|NCT03410992|566748590|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
156999001|NCT03410992|566748580|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999002|NCT03410992|566748581|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999003|NCT03410992|566748582|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999004|NCT03410992|566748583|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999005|NCT03410992|566748584|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999006|NCT03410992|566748585|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
156999007|NCT03410992|566748586|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999008|NCT03410992|566748587|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999009|NCT03410992|566748588|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999010|NCT03410992|566748589|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999011|NCT03410992|566748590|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
156999012|NCT03410992|566748580|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999013|NCT03410992|566748581|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999014|NCT03410992|566748582|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999015|NCT03410992|566748583|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
156999016|NCT03410992|566748584|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
156999017|NCT03410992|566748585|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
156999018|NCT03410992|566748586|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999019|NCT03410992|566748587|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999020|NCT03410992|566748588|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999021|NCT03410992|566748589|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156999022|NCT03410992|566748590|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
156756869|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
156756870|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
156756871|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
157102106|NCT01524133|567130715|FG001|Treatment Phase|Physician Decision|3|||
157102107|NCT01524133|567130716|FG002|Treatment Phase|Physician Decision|3|||
157102108|NCT01524133|567130714|FG000|Treatment Phase|Lost to Follow-up|0|||
157102109|NCT01524133|567130715|FG001|Treatment Phase|Lost to Follow-up|1|||
157102110|NCT01524133|567130716|FG002|Treatment Phase|Lost to Follow-up|2|||
157102111|NCT01524133|567130714|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
157102112|NCT01524133|567130715|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
157102113|NCT01524133|567130716|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
157102114|NCT01524133|567130714|FG000|Overall Study 52 Weeks|Physician Decision|1|||
157102115|NCT01524133|567130715|FG001|Overall Study 52 Weeks|Physician Decision|0|||
157102116|NCT01524133|567130716|FG002|Overall Study 52 Weeks|Physician Decision|2|||
157102117|NCT01524133|567130714|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
157102118|NCT01524133|567130715|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
157102119|NCT01524133|567130716|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
157102120|NCT00059839|567130718|FG000|Overall Study|Death|1|||
157102121|NCT00059839|567130719|FG001|Overall Study|Death|1|||
157102122|NCT00059839|567130718|FG000|Overall Study|Lack of Efficacy|6|||
157102123|NCT00059839|567130719|FG001|Overall Study|Lack of Efficacy|5|||
157102124|NCT00059839|567130718|FG000|Overall Study|Lost to Follow-up|2|||
157102125|NCT00059839|567130719|FG001|Overall Study|Lost to Follow-up|0|||
157102126|NCT00059839|567130718|FG000|Overall Study|Physician Decision|1|||
157102127|NCT00059839|567130719|FG001|Overall Study|Physician Decision|2|||
157102128|NCT00059839|567130718|FG000|Overall Study|Withdrawal by Subject|1|||
157102129|NCT00059839|567130719|FG001|Overall Study|Withdrawal by Subject|6|||
157102130|NCT00059839|567130718|FG000|Overall Study|Ineligible|1|||
157102131|NCT00059839|567130719|FG001|Overall Study|Ineligible|3|||
157102132|NCT01330914|567130720|FG000|Overall Study|Withdrawal by Subject|4|||
157102133|NCT01330914|567130720|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
157102134|NCT05352048|567130725|FG000|Overall Study|Lost to Follow-up|1|||
157102135|NCT05352048|567130725|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
157102136|NCT00528567|567130726|FG000|Overall Study|Death|4|||
157102137|NCT00528567|567130727|FG001|Overall Study|Death|5|||
157102138|NCT00528567|567130726|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
157102139|NCT00528567|567130727|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
157102140|NCT00528567|567130726|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
157102141|NCT00528567|567130727|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
157102142|NCT00528567|567130726|FG000|Overall Study|Violation Criteria at Entry|3|||
157102143|NCT00528567|567130727|FG001|Overall Study|Violation Criteria at Entry|17|||
157102144|NCT00528567|567130726|FG000|Overall Study|Withdrew Consent|59|||
157102145|NCT00528567|567130727|FG001|Overall Study|Withdrew Consent|55|||
157102146|NCT00528567|567130726|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
157102147|NCT00528567|567130727|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
157102148|NCT00528567|567130726|FG000|Overall Study|Failure to Return|1|||
157102149|NCT00528567|567130727|FG001|Overall Study|Failure to Return|4|||
157102150|NCT00528567|567130726|FG000|Overall Study|Other Protocol Violation|5|||
157102151|NCT00528567|567130727|FG001|Overall Study|Other Protocol Violation|21|||
157102152|NCT00528567|567130726|FG000|Overall Study|Administrative/Other|22|||
157102153|NCT00528567|567130727|FG001|Overall Study|Administrative/Other|75|||
157102154|NCT00056862|567130732|FG000|Overall Study|Protocol Violation|1|||
157102155|NCT00056862|567130733|FG001|Overall Study|Protocol Violation|0|||
157102156|NCT03974334|567130739|FG000|Overall Study|Lost to Follow-up|1|||
157102157|NCT00728481|567130745|FG000|Overall Study|Withdrawal by Subject|0|||
157102158|NCT00728481|567130746|FG001|Overall Study|Withdrawal by Subject|1|||
157102159|NCT00728481|567130745|FG000|Overall Study|Adverse Event|0|||
157102160|NCT00728481|567130746|FG001|Overall Study|Adverse Event|1|||
157102161|NCT00728481|567130745|FG000|Overall Study|Study medication non-compliance|0|||
157102162|NCT00728481|567130746|FG001|Overall Study|Study medication non-compliance|2|||
157102163|NCT00728481|567130745|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
157102164|NCT00728481|567130746|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
157102165|NCT03690141|567130747|FG000|Overall Study|Adverse Event|5|||
157102166|NCT03690141|567130747|FG000|Overall Study|Withdrawal by Subject|3|||
157102167|NCT03690141|567130747|FG000|Overall Study|Physician Decision|4|||
157102168|NCT03690141|567130747|FG000|Overall Study|Disease progression|4|||
157102169|NCT01968070|567130748|FG000|Period 1|Withdrawal by Subject|0|||
157102170|NCT01968070|567130749|FG001|Period 1|Withdrawal by Subject|1|||
157102171|NCT01968070|567130750|FG002|Period 1|Withdrawal by Subject|0|||
157102172|NCT01968070|567130751|FG003|Period 1|Withdrawal by Subject|0|||
157102173|NCT01968070|567130752|FG004|Period 1|Withdrawal by Subject|0|||
157102174|NCT01968070|567130753|FG005|Period 1|Withdrawal by Subject|0|||
157102175|NCT01968070|567130754|FG006|Period 1|Withdrawal by Subject|1|||
157102176|NCT01968070|567130755|FG007|Period 1|Withdrawal by Subject|0|||
157102177|NCT01968070|567130756|FG008|Period 1|Withdrawal by Subject|0|||
157102178|NCT01968070|567130757|FG009|Period 1|Withdrawal by Subject|0|||
157102179|NCT01968070|567130758|FG010|Period 1|Withdrawal by Subject|0|||
156756872|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
156756873|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
156756874|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
156756875|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
156756876|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
156756877|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
156756878|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
156756879|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
156756880|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756881|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756882|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
156756883|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756884|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
156756885|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756886|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756887|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
156756888|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756889|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
156756890|NCT02137226|565860696|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
156756891|NCT02137226|565860697|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
156756892|NCT02137226|565860698|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
156756893|NCT02137226|565860699|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
156756894|NCT02137226|565860700|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
156756895|NCT00985686|565860703|FG000|Overall Study|Lost to Follow-up|1|||
156756896|NCT00985686|565860704|FG001|Overall Study|Lost to Follow-up|1|||
156756897|NCT00985686|565860705|FG002|Overall Study|Lost to Follow-up|0|||
156756898|NCT00985686|565860706|FG003|Overall Study|Lost to Follow-up|2|||
156756899|NCT03134911|565860707|FG000|Overall Study|Screen failure|31|||
156756900|NCT03134911|565860707|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
156756901|NCT00588146|565862753|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
156999023|NCT03410992|566748580|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999024|NCT03410992|566748581|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999025|NCT03410992|566748582|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999026|NCT03410992|566748583|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999027|NCT03410992|566748584|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999028|NCT03410992|566748585|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999029|NCT03410992|566748586|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999030|NCT03410992|566748587|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
156999031|NCT03410992|566748588|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999032|NCT03410992|566748589|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999033|NCT03410992|566748590|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
156999034|NCT03410992|566748580|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999035|NCT03410992|566748581|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999036|NCT03410992|566748582|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999037|NCT03410992|566748583|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999038|NCT03410992|566748584|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999039|NCT03410992|566748585|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999040|NCT03410992|566748586|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999041|NCT03410992|566748587|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999042|NCT03410992|566748588|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
156999043|NCT03410992|566748589|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999044|NCT03410992|566748590|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
156999045|NCT04804605|566748591|FG000|Overall Study|Withdrawal by Subject|46|||
156999046|NCT04804605|566748592|FG001|Overall Study|Withdrawal by Subject|26|||
156999047|NCT04804605|566748593|FG002|Overall Study|Withdrawal by Subject|37|||
156999048|NCT04804605|566748594|FG003|Overall Study|Withdrawal by Subject|21|||
156999049|NCT04804605|566748591|FG000|Overall Study|Lost to Follow-up|47|||
156999050|NCT04804605|566748592|FG001|Overall Study|Lost to Follow-up|21|||
156999051|NCT04804605|566748593|FG002|Overall Study|Lost to Follow-up|30|||
156999052|NCT04804605|566748594|FG003|Overall Study|Lost to Follow-up|17|||
156999053|NCT04804605|566748591|FG000|Overall Study|Lack of Efficacy|28|||
156999054|NCT04804605|566748592|FG001|Overall Study|Lack of Efficacy|11|||
156756902|NCT00588146|565862754|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
156756903|NCT01239394|565862756|FG000|Overall Study|Adverse Event|1|||
156756904|NCT01000974|565862761|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
156756905|NCT01000974|565862762|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
156999055|NCT04804605|566748593|FG002|Overall Study|Lack of Efficacy|37|||
156999056|NCT04804605|566748594|FG003|Overall Study|Lack of Efficacy|8|||
156999057|NCT04804605|566748591|FG000|Overall Study|Adverse Event|10|||
156999058|NCT04804605|566748592|FG001|Overall Study|Adverse Event|10|||
156999059|NCT04804605|566748593|FG002|Overall Study|Adverse Event|10|||
156999060|NCT04804605|566748594|FG003|Overall Study|Adverse Event|7|||
156999061|NCT04804605|566748591|FG000|Overall Study|Non-compliance|8|||
156756906|NCT01000974|565862763|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
156756907|NCT01000974|565862761|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
156756908|NCT01000974|565862762|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
156756909|NCT01000974|565862763|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
156756910|NCT01000974|565862761|FG000|Primary Vaccination Phase|Protocol Violation|40|||
156756911|NCT01000974|565862762|FG001|Primary Vaccination Phase|Protocol Violation|3|||
156756912|NCT01000974|565862763|FG002|Primary Vaccination Phase|Protocol Violation|2|||
156756913|NCT01000974|565862761|FG000|Primary Vaccination Phase|Adverse Event|14|||
156756914|NCT01000974|565862762|FG001|Primary Vaccination Phase|Adverse Event|2|||
156756915|NCT01000974|565862763|FG002|Primary Vaccination Phase|Adverse Event|2|||
156756916|NCT01000974|565862761|FG000|Primary Vaccination Phase|Other|4|||
156756917|NCT01000974|565862762|FG001|Primary Vaccination Phase|Other|9|||
156756918|NCT01000974|565862763|FG002|Primary Vaccination Phase|Other|12|||
156756919|NCT01000974|565862761|FG000|Booster Vaccination Phase|Protocol Violation|0|||
156756920|NCT01000974|565862762|FG001|Booster Vaccination Phase|Protocol Violation|0|||
156756921|NCT01000974|565862763|FG002|Booster Vaccination Phase|Protocol Violation|2|||
156756922|NCT01000974|565862761|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
156756923|NCT01000974|565862762|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
156756924|NCT01000974|565862763|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
156756925|NCT01000974|565862761|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
156756926|NCT01000974|565862762|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
156756927|NCT01000974|565862763|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
156756928|NCT01000974|565862761|FG000|Booster Vaccination Phase|Other|24|||
156756929|NCT01000974|565862762|FG001|Booster Vaccination Phase|Other|6|||
156756930|NCT01000974|565862763|FG002|Booster Vaccination Phase|Other|4|||
156756931|NCT01307891|565862764|FG000|Overall Study|Progressive Disease|3|||
156756932|NCT01307891|565862765|FG001|Overall Study|Progressive Disease|1|||
156756933|NCT03365934|565862766|FG000|Overall Study|Adverse Event|1|||
156756934|NCT03365934|565862766|FG000|Overall Study|Withdrawal by Subject|1|||
156756935|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
156756936|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
156756937|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
156756938|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
156756939|NCT02937740|565862767|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
156756940|NCT02937740|565862768|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
156756941|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
156756942|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
156756943|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
156756944|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
156756945|NCT02937740|565862767|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
156756946|NCT02937740|565862768|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
156756947|NCT02291029|565862771|FG000|Overall Study|Withdrawal by Subject|0|||
156756948|NCT02291029|565862772|FG001|Overall Study|Withdrawal by Subject|0|||
156756949|NCT02291029|565862773|FG002|Overall Study|Withdrawal by Subject|1|||
156756950|NCT02291029|565862774|FG003|Overall Study|Withdrawal by Subject|0|||
156756951|NCT02291029|565862775|FG004|Overall Study|Withdrawal by Subject|0|||
156756952|NCT02291029|565862776|FG005|Overall Study|Withdrawal by Subject|0|||
156756953|NCT02291029|565862771|FG000|Overall Study|Adverse Event|0|||
156756954|NCT02291029|565862772|FG001|Overall Study|Adverse Event|1|||
156756955|NCT02291029|565862773|FG002|Overall Study|Adverse Event|0|||
156756956|NCT02291029|565862774|FG003|Overall Study|Adverse Event|0|||
156756957|NCT02291029|565862775|FG004|Overall Study|Adverse Event|0|||
156756958|NCT02291029|565862776|FG005|Overall Study|Adverse Event|0|||
156756959|NCT04147247|565862777|FG000|Overall Study|Progressive disease|3|||
156756960|NCT04147247|565862778|FG001|Overall Study|Progressive disease|3|||
156756961|NCT04147247|565862779|FG002|Overall Study|Progressive disease|4|||
156756962|NCT04147247|565862780|FG003|Overall Study|Progressive disease|4|||
156756963|NCT04147247|565862781|FG004|Overall Study|Progressive disease|3|||
156756964|NCT04147247|565862777|FG000|Overall Study|Physician Decision|0|||
156756965|NCT04147247|565862778|FG001|Overall Study|Physician Decision|1|||
156756966|NCT04147247|565862779|FG002|Overall Study|Physician Decision|0|||
156756967|NCT04147247|565862780|FG003|Overall Study|Physician Decision|0|||
156756968|NCT04147247|565862781|FG004|Overall Study|Physician Decision|0|||
156756969|NCT04147247|565862777|FG000|Overall Study|Clinical Disease Progression|0|||
156756970|NCT04147247|565862778|FG001|Overall Study|Clinical Disease Progression|0|||
156756971|NCT04147247|565862779|FG002|Overall Study|Clinical Disease Progression|0|||
156756972|NCT04147247|565862780|FG003|Overall Study|Clinical Disease Progression|0|||
156756973|NCT04147247|565862781|FG004|Overall Study|Clinical Disease Progression|1|||
156756974|NCT04147247|565862777|FG000|Overall Study|Adverse Event|0|||
156756975|NCT04147247|565862778|FG001|Overall Study|Adverse Event|0|||
156756976|NCT04147247|565862779|FG002|Overall Study|Adverse Event|1|||
156756977|NCT04147247|565862780|FG003|Overall Study|Adverse Event|0|||
156756978|NCT04147247|565862781|FG004|Overall Study|Adverse Event|1|||
156756979|NCT03373760|565862782|FG000|Overall Study|Adverse Event|8|||
156756980|NCT03373760|565862782|FG000|Overall Study|Disease Progression|46|||
157102180|NCT01968070|567130759|FG011|Period 1|Withdrawal by Subject|0|||
157102181|NCT01968070|567130760|FG012|Period 1|Withdrawal by Subject|0|||
157102182|NCT01968070|567130761|FG013|Period 1|Withdrawal by Subject|0|||
157102183|NCT01968070|567130762|FG014|Period 1|Withdrawal by Subject|0|||
157102184|NCT01968070|567130763|FG015|Period 1|Withdrawal by Subject|1|||
157102185|NCT01968070|567130764|FG016|Period 1|Withdrawal by Subject|0|||
157102186|NCT01968070|567130765|FG017|Period 1|Withdrawal by Subject|0|||
157102187|NCT01968070|567130748|FG000|Period 1|Protocol Violation|0|||
157102188|NCT01968070|567130749|FG001|Period 1|Protocol Violation|0|||
157102189|NCT01968070|567130750|FG002|Period 1|Protocol Violation|0|||
157102190|NCT01968070|567130751|FG003|Period 1|Protocol Violation|1|||
157102191|NCT01968070|567130752|FG004|Period 1|Protocol Violation|1|||
157102192|NCT01968070|567130753|FG005|Period 1|Protocol Violation|0|||
157102193|NCT01968070|567130754|FG006|Period 1|Protocol Violation|0|||
157102194|NCT01968070|567130755|FG007|Period 1|Protocol Violation|0|||
157102195|NCT01968070|567130756|FG008|Period 1|Protocol Violation|0|||
157102196|NCT01968070|567130757|FG009|Period 1|Protocol Violation|0|||
157102197|NCT01968070|567130758|FG010|Period 1|Protocol Violation|0|||
157102198|NCT01968070|567130759|FG011|Period 1|Protocol Violation|0|||
157102199|NCT01968070|567130760|FG012|Period 1|Protocol Violation|0|||
157102200|NCT01968070|567130761|FG013|Period 1|Protocol Violation|0|||
157102201|NCT01968070|567130762|FG014|Period 1|Protocol Violation|0|||
157102202|NCT01968070|567130763|FG015|Period 1|Protocol Violation|0|||
157102203|NCT01968070|567130764|FG016|Period 1|Protocol Violation|0|||
157102204|NCT01968070|567130765|FG017|Period 1|Protocol Violation|0|||
157102205|NCT01968070|567130748|FG000|Period 1|Lost to Follow-up|0|||
157102206|NCT01968070|567130749|FG001|Period 1|Lost to Follow-up|0|||
157102207|NCT01968070|567130750|FG002|Period 1|Lost to Follow-up|0|||
157102208|NCT01968070|567130751|FG003|Period 1|Lost to Follow-up|1|||
157102209|NCT01968070|567130752|FG004|Period 1|Lost to Follow-up|0|||
156756981|NCT03373760|565862782|FG000|Overall Study|Death|4|||
156756982|NCT02907463|565862783|FG000|Overall Study|Lost to Follow-up|17|||
156756983|NCT02907463|565862783|FG000|Overall Study|Death|10|||
156756984|NCT02907463|565862783|FG000|Overall Study|Withdrawal by Subject|4|||
156756985|NCT02907463|565862783|FG000|Overall Study|MIS Approach was not used|2|||
156756986|NCT02907463|565862783|FG000|Overall Study|Not Implanted with Study Device|2|||
156756987|NCT02907463|565862783|FG000|Overall Study|Device Explanted|1|||
156756988|NCT02907463|565862783|FG000|Overall Study|Missing Exit Form|1|||
156756989|NCT01447407|565862784|FG000|Overall Study|Withdrawal by Subject|2|||
156756990|NCT01447407|565862785|FG001|Overall Study|Withdrawal by Subject|0|||
156756991|NCT01447407|565862786|FG002|Overall Study|Withdrawal by Subject|0|||
156756992|NCT01447407|565862787|FG003|Overall Study|Withdrawal by Subject|1|||
156756993|NCT01447407|565862784|FG000|Overall Study|Physician Decision|0|||
156756994|NCT01447407|565862785|FG001|Overall Study|Physician Decision|0|||
156756995|NCT01447407|565862786|FG002|Overall Study|Physician Decision|1|||
156756996|NCT01447407|565862787|FG003|Overall Study|Physician Decision|1|||
156756997|NCT00875563|565862791|FG000|Overall Study|Death|4|||
156756998|NCT00875563|565862791|FG000|Overall Study|Withdrawal by Subject|7|||
156756999|NCT00875563|565862791|FG000|Overall Study|No long-term (3-5 year) consent|6|||
156757000|NCT00875563|565862791|FG000|Overall Study|Still be eligible for follow-up|7|||
156757001|NCT02258659|565862794|FG000|Overall Study|Withdrawal by Subject|1|||
156757002|NCT03990051|565862795|FG000|Masked Period|Lost to Follow-up|1|||
156757003|NCT03990051|565862796|FG001|Masked Period|Lost to Follow-up|0|||
156757004|NCT03990051|565862795|FG000|Long Term Period|Death|1|||
156757005|NCT03990051|565862796|FG001|Long Term Period|Death|1|||
156757006|NCT03990051|565862795|FG000|Long Term Period|Lost to Follow-up|7|||
156757007|NCT03990051|565862796|FG001|Long Term Period|Lost to Follow-up|2|||
156757008|NCT01411852|565862797|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
156757009|NCT01411852|565862798|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
156757010|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
156757011|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
156757012|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Found to be under age|0|||
156757013|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Found to be under age|1|||
156757014|NCT01411852|565862797|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
156757015|NCT01411852|565862798|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
156757016|NCT01411852|565862797|FG000|Hospital Intervention Phase|Severe head injury|5|||
156757017|NCT01411852|565862798|FG001|Hospital Intervention Phase|Severe head injury|4|||
156757018|NCT01411852|565862797|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
157102210|NCT01968070|567130753|FG005|Period 1|Lost to Follow-up|0|||
157102211|NCT01968070|567130754|FG006|Period 1|Lost to Follow-up|0|||
157102212|NCT01968070|567130755|FG007|Period 1|Lost to Follow-up|0|||
157102213|NCT01968070|567130756|FG008|Period 1|Lost to Follow-up|0|||
157102214|NCT01968070|567130757|FG009|Period 1|Lost to Follow-up|0|||
156757019|NCT01411852|565862798|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
157102215|NCT01968070|567130758|FG010|Period 1|Lost to Follow-up|0|||
157102216|NCT01968070|567130759|FG011|Period 1|Lost to Follow-up|0|||
157102217|NCT01968070|567130760|FG012|Period 1|Lost to Follow-up|0|||
156999062|NCT04804605|566748592|FG001|Overall Study|Non-compliance|3|||
156999063|NCT04804605|566748593|FG002|Overall Study|Non-compliance|5|||
156999064|NCT04804605|566748594|FG003|Overall Study|Non-compliance|1|||
156999065|NCT04804605|566748591|FG000|Overall Study|Physician Decision|3|||
156999066|NCT04804605|566748592|FG001|Overall Study|Physician Decision|0|||
156999067|NCT04804605|566748593|FG002|Overall Study|Physician Decision|5|||
156999068|NCT04804605|566748594|FG003|Overall Study|Physician Decision|0|||
156999069|NCT04804605|566748591|FG000|Overall Study|Protocol Violation|1|||
156999070|NCT04804605|566748592|FG001|Overall Study|Protocol Violation|0|||
156999071|NCT04804605|566748593|FG002|Overall Study|Protocol Violation|0|||
156999072|NCT04804605|566748594|FG003|Overall Study|Protocol Violation|1|||
156999073|NCT04804605|566748591|FG000|Overall Study|Miscellaneous|7|||
156999074|NCT04804605|566748592|FG001|Overall Study|Miscellaneous|3|||
156999075|NCT04804605|566748593|FG002|Overall Study|Miscellaneous|4|||
156999076|NCT04804605|566748594|FG003|Overall Study|Miscellaneous|2|||
156999077|NCT04018066|566748597|FG000|Overall Study|participants started taking medications during the study period|3|||
156999078|NCT04018066|566748597|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
156999079|NCT03568318|566748598|FG000|Overall Study|Adverse Event|3|||
156999080|NCT03568318|566748599|FG001|Overall Study|Adverse Event|1|||
156999081|NCT03568318|566748600|FG002|Overall Study|Adverse Event|1|||
156999082|NCT03568318|566748601|FG003|Overall Study|Adverse Event|0|||
156999083|NCT03568318|566748602|FG004|Overall Study|Adverse Event|1|||
156999084|NCT03568318|566748603|FG005|Overall Study|Adverse Event|0|||
156999085|NCT03568318|566748598|FG000|Overall Study|Withdrawal by Subject|6|||
156999086|NCT03568318|566748599|FG001|Overall Study|Withdrawal by Subject|5|||
156999087|NCT03568318|566748600|FG002|Overall Study|Withdrawal by Subject|2|||
156999088|NCT03568318|566748601|FG003|Overall Study|Withdrawal by Subject|1|||
156999089|NCT03568318|566748602|FG004|Overall Study|Withdrawal by Subject|0|||
156999090|NCT03568318|566748603|FG005|Overall Study|Withdrawal by Subject|0|||
156999091|NCT03568318|566748598|FG000|Overall Study|Lost to Follow-up|3|||
156999092|NCT03568318|566748599|FG001|Overall Study|Lost to Follow-up|2|||
156999093|NCT03568318|566748600|FG002|Overall Study|Lost to Follow-up|2|||
156999094|NCT03568318|566748601|FG003|Overall Study|Lost to Follow-up|2|||
156999095|NCT03568318|566748602|FG004|Overall Study|Lost to Follow-up|1|||
156999096|NCT03568318|566748603|FG005|Overall Study|Lost to Follow-up|0|||
156999097|NCT03568318|566748598|FG000|Overall Study|Other|3|||
156999098|NCT03568318|566748599|FG001|Overall Study|Other|1|||
156999099|NCT03568318|566748600|FG002|Overall Study|Other|3|||
156999100|NCT03568318|566748601|FG003|Overall Study|Other|0|||
156999101|NCT03568318|566748602|FG004|Overall Study|Other|0|||
156999102|NCT03568318|566748603|FG005|Overall Study|Other|0|||
156999103|NCT03568318|566748598|FG000|Overall Study|Ongoing at Time of Analysis|5|||
156999104|NCT03568318|566748599|FG001|Overall Study|Ongoing at Time of Analysis|3|||
156999105|NCT03568318|566748600|FG002|Overall Study|Ongoing at Time of Analysis|2|||
156999106|NCT03568318|566748601|FG003|Overall Study|Ongoing at Time of Analysis|1|||
156999107|NCT03568318|566748602|FG004|Overall Study|Ongoing at Time of Analysis|0|||
156999108|NCT03568318|566748603|FG005|Overall Study|Ongoing at Time of Analysis|0|||
156999109|NCT04988295|566748604|FG000|Overall Study|Withdrawal by Subject|9|||
156999110|NCT04988295|566748605|FG001|Overall Study|Withdrawal by Subject|29|||
156999111|NCT04988295|566748606|FG002|Overall Study|Withdrawal by Subject|6|||
156999112|NCT04988295|566748607|FG003|Overall Study|Withdrawal by Subject|0|||
156999113|NCT04988295|566748604|FG000|Overall Study|Lost to Follow-up|1|||
156999114|NCT04988295|566748605|FG001|Overall Study|Lost to Follow-up|0|||
156999115|NCT04988295|566748606|FG002|Overall Study|Lost to Follow-up|0|||
156999116|NCT04988295|566748607|FG003|Overall Study|Lost to Follow-up|0|||
156999117|NCT04988295|566748604|FG000|Overall Study|Study participation ongoing|186|||
156999118|NCT04988295|566748605|FG001|Overall Study|Study participation ongoing|169|||
156999119|NCT04988295|566748606|FG002|Overall Study|Study participation ongoing|99|||
156999120|NCT04988295|566748607|FG003|Overall Study|Study participation ongoing|119|||
156999121|NCT04083976|566748608|FG000|Overall Study|Lost to Follow-up|3|||
156999122|NCT04083976|566748609|FG001|Overall Study|Lost to Follow-up|0|||
156999123|NCT04083976|566748610|FG002|Overall Study|Lost to Follow-up|0|||
156999124|NCT04083976|566748611|FG003|Overall Study|Lost to Follow-up|1|||
156999125|NCT04083976|566748608|FG000|Overall Study|Withdrawal by Subject|16|||
156999126|NCT04083976|566748609|FG001|Overall Study|Withdrawal by Subject|1|||
156999127|NCT04083976|566748610|FG002|Overall Study|Withdrawal by Subject|9|||
157102218|NCT01968070|567130761|FG013|Period 1|Lost to Follow-up|0|||
157102219|NCT01968070|567130762|FG014|Period 1|Lost to Follow-up|0|||
156999128|NCT04083976|566748611|FG003|Overall Study|Withdrawal by Subject|0|||
156999129|NCT04083976|566748608|FG000|Overall Study|Sponsor Decision|14|||
156999130|NCT04083976|566748609|FG001|Overall Study|Sponsor Decision|0|||
157102220|NCT01968070|567130763|FG015|Period 1|Lost to Follow-up|0|||
156999131|NCT04083976|566748610|FG002|Overall Study|Sponsor Decision|0|||
156999132|NCT04083976|566748611|FG003|Overall Study|Sponsor Decision|7|||
156999133|NCT04083976|566748608|FG000|Overall Study|Other|1|||
157102221|NCT01968070|567130764|FG016|Period 1|Lost to Follow-up|0|||
156999134|NCT04083976|566748609|FG001|Overall Study|Other|0|||
156999135|NCT04083976|566748610|FG002|Overall Study|Other|1|||
157102222|NCT01968070|567130765|FG017|Period 1|Lost to Follow-up|0|||
157102223|NCT01968070|567130748|FG000|Period 1|Adverse Event|0|||
157102224|NCT01968070|567130749|FG001|Period 1|Adverse Event|0|||
157102225|NCT01968070|567130750|FG002|Period 1|Adverse Event|0|||
157102226|NCT01968070|567130751|FG003|Period 1|Adverse Event|0|||
157102227|NCT01968070|567130752|FG004|Period 1|Adverse Event|0|||
157102228|NCT01968070|567130753|FG005|Period 1|Adverse Event|0|||
157102229|NCT01968070|567130754|FG006|Period 1|Adverse Event|1|||
157102230|NCT01968070|567130755|FG007|Period 1|Adverse Event|0|||
157102231|NCT01968070|567130756|FG008|Period 1|Adverse Event|0|||
157102232|NCT01968070|567130757|FG009|Period 1|Adverse Event|0|||
157102233|NCT01968070|567130758|FG010|Period 1|Adverse Event|0|||
157102234|NCT01968070|567130759|FG011|Period 1|Adverse Event|0|||
157102235|NCT01968070|567130760|FG012|Period 1|Adverse Event|0|||
157102236|NCT01968070|567130761|FG013|Period 1|Adverse Event|0|||
157102237|NCT01968070|567130762|FG014|Period 1|Adverse Event|0|||
157102238|NCT01968070|567130763|FG015|Period 1|Adverse Event|0|||
157102239|NCT01968070|567130764|FG016|Period 1|Adverse Event|0|||
157102240|NCT01968070|567130765|FG017|Period 1|Adverse Event|0|||
157102241|NCT01968070|567130748|FG000|Period 1|Physician Decision|0|||
156757020|NCT01411852|565862797|FG000|Hospital Intervention Phase|Miscommunication error|1|||
156757021|NCT01411852|565862798|FG001|Hospital Intervention Phase|Miscommunication error|2|||
156757022|NCT01411852|565862797|FG000|Hospital Intervention Phase|CPR administered|3|||
156757023|NCT01411852|565862798|FG001|Hospital Intervention Phase|CPR administered|1|||
156757024|NCT01411852|565862797|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
156757025|NCT01411852|565862798|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
156757026|NCT01411852|565862797|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
156757027|NCT01411852|565862798|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
156757028|NCT01411852|565862797|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
156757029|NCT01411852|565862798|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
156757030|NCT01411852|565862797|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
156757031|NCT01411852|565862798|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
156757032|NCT01411852|565862797|FG000|Hospital Intervention Phase|Other ineligible|2|||
156757033|NCT01411852|565862798|FG001|Hospital Intervention Phase|Other ineligible|2|||
156757034|NCT01411852|565862797|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
156757035|NCT01411852|565862798|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
156757036|NCT01411852|565862797|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
156757037|NCT01411852|565862798|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
156757038|NCT01411852|565862797|FG000|Hospital Intervention Phase|Vascular access failed|1|||
156757039|NCT01411852|565862798|FG001|Hospital Intervention Phase|Vascular access failed|0|||
156757040|NCT00272844|565862799|FG000|Overall Study|Withdrawal by Subject|5|||
156757041|NCT03743025|565862802|FG000|Overall Study|Surgery was cancelled|2|||
156757042|NCT03743025|565862803|FG001|Overall Study|Surgery was cancelled|1|||
156757043|NCT00791700|565862804|FG000|Overall Study|Insufficient clinical response|1|||
156757044|NCT00791700|565862805|FG001|Overall Study|Insufficient clinical response|4|||
156757045|NCT00791700|565862806|FG002|Overall Study|Insufficient clinical response|1|||
156757046|NCT00791700|565862807|FG003|Overall Study|Insufficient clinical response|8|||
156757047|NCT00791700|565862804|FG000|Overall Study|No longer willing to participate|1|||
156757048|NCT00791700|565862805|FG001|Overall Study|No longer willing to participate|1|||
156757049|NCT00791700|565862806|FG002|Overall Study|No longer willing to participate|0|||
156757050|NCT00791700|565862807|FG003|Overall Study|No longer willing to participate|8|||
156757051|NCT00791700|565862804|FG000|Overall Study|Non-compliance with study treatment|0|||
156757052|NCT00791700|565862805|FG001|Overall Study|Non-compliance with study treatment|2|||
156757053|NCT00791700|565862806|FG002|Overall Study|Non-compliance with study treatment|0|||
156757054|NCT00791700|565862807|FG003|Overall Study|Non-compliance with study treatment|4|||
156757055|NCT00791700|565862804|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156757056|NCT00791700|565862805|FG001|Overall Study|Withdrawn due to pregnancy|0|||
156757057|NCT00791700|565862806|FG002|Overall Study|Withdrawn due to pregnancy|0|||
156757058|NCT00791700|565862807|FG003|Overall Study|Withdrawn due to pregnancy|1|||
156757059|NCT00791700|565862804|FG000|Overall Study|Other|0|||
156757060|NCT00791700|565862805|FG001|Overall Study|Other|1|||
157102242|NCT01968070|567130749|FG001|Period 1|Physician Decision|0|||
157102243|NCT01968070|567130750|FG002|Period 1|Physician Decision|0|||
157102244|NCT01968070|567130751|FG003|Period 1|Physician Decision|0|||
157102245|NCT01968070|567130752|FG004|Period 1|Physician Decision|0|||
157102246|NCT01968070|567130753|FG005|Period 1|Physician Decision|0|||
157102247|NCT01968070|567130754|FG006|Period 1|Physician Decision|0|||
157102248|NCT01968070|567130755|FG007|Period 1|Physician Decision|0|||
157102249|NCT01968070|567130756|FG008|Period 1|Physician Decision|0|||
157102250|NCT01968070|567130757|FG009|Period 1|Physician Decision|0|||
157102251|NCT01968070|567130758|FG010|Period 1|Physician Decision|0|||
157102252|NCT01968070|567130759|FG011|Period 1|Physician Decision|1|||
157102253|NCT01968070|567130760|FG012|Period 1|Physician Decision|0|||
157102254|NCT01968070|567130761|FG013|Period 1|Physician Decision|0|||
157102255|NCT01968070|567130762|FG014|Period 1|Physician Decision|0|||
157102256|NCT01968070|567130763|FG015|Period 1|Physician Decision|0|||
157102257|NCT01968070|567130764|FG016|Period 1|Physician Decision|0|||
156757061|NCT00791700|565862806|FG002|Overall Study|Other|0|||
156757062|NCT00791700|565862807|FG003|Overall Study|Other|1|||
156757063|NCT00791700|565862804|FG000|Overall Study|Death|0|||
156757064|NCT00791700|565862805|FG001|Overall Study|Death|0|||
156757065|NCT00791700|565862806|FG002|Overall Study|Death|0|||
156757066|NCT00791700|565862807|FG003|Overall Study|Death|1|||
156757067|NCT00791700|565862804|FG000|Overall Study|Lost to Follow-up|4|||
156757068|NCT00791700|565862805|FG001|Overall Study|Lost to Follow-up|3|||
156757069|NCT00791700|565862806|FG002|Overall Study|Lost to Follow-up|4|||
156757070|NCT00791700|565862807|FG003|Overall Study|Lost to Follow-up|6|||
156757071|NCT00791700|565862804|FG000|Overall Study|Adverse Event|0|||
156757072|NCT00791700|565862805|FG001|Overall Study|Adverse Event|0|||
156757073|NCT00791700|565862806|FG002|Overall Study|Adverse Event|1|||
156757074|NCT00791700|565862807|FG003|Overall Study|Adverse Event|1|||
156757075|NCT00996034|565862810|FG000|Overall Study|Lost to Follow-up|2|||
156757076|NCT00996034|565862810|FG000|Overall Study|withdrawn by PI|1|||
156757077|NCT01720524|565862811|FG000|Part A|Insufficient Clinical Response|2|||
156757078|NCT01720524|565862812|FG001|Part A|Insufficient Clinical Response|4|||
156999136|NCT04083976|566748611|FG003|Overall Study|Other|0|||
156999137|NCT04618471|566748612|FG000|Overall Study|Screen Failure|62|||
156999138|NCT04618471|566748612|FG000|Overall Study|Withdrawal by Subject|6|||
156999139|NCT04618471|566748612|FG000|Overall Study|Physician Decision|2|||
156999140|NCT04618471|566748612|FG000|Overall Study|Lost to Follow-up|1|||
156999141|NCT04618471|566748612|FG000|Overall Study|Various other reasons|2|||
156999142|NCT04618471|566748612|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
156999143|NCT05197049|566748614|FG000|Overall Study|Death|0|||
156999144|NCT05197049|566748615|FG001|Overall Study|Death|1|||
156999145|NCT05197049|566748616|FG002|Overall Study|Death|0|||
156999146|NCT05197049|566748614|FG000|Overall Study|Lost to Follow-up|3|||
156999147|NCT05197049|566748615|FG001|Overall Study|Lost to Follow-up|1|||
156999148|NCT05197049|566748616|FG002|Overall Study|Lost to Follow-up|0|||
156999149|NCT05197049|566748614|FG000|Overall Study|Withdrawal by Subject|15|||
156999150|NCT05197049|566748615|FG001|Overall Study|Withdrawal by Subject|3|||
156999151|NCT05197049|566748616|FG002|Overall Study|Withdrawal by Subject|1|||
156999152|NCT05197049|566748614|FG000|Overall Study|GCP non-compliance|1|||
156999153|NCT05197049|566748615|FG001|Overall Study|GCP non-compliance|2|||
156999154|NCT05197049|566748616|FG002|Overall Study|GCP non-compliance|0|||
156999155|NCT04154943|566748617|FG000|Overall Study|Study Ongoing|68|||
156999156|NCT04154943|566748617|FG000|Overall Study|Lost to Follow-up|1|||
156999157|NCT04154943|566748617|FG000|Overall Study|Decision by the Investigator|1|||
156999158|NCT04154943|566748617|FG000|Overall Study|Death|5|||
156999159|NCT04154943|566748617|FG000|Overall Study|Withdrawal by Subject|4|||
156999160|NCT05916170|566748618|FG000|No Warning Control|Lost to Follow-up|12|||
156999161|NCT05916170|566748618|FG000|No Warning Control|Withdrawal by Subject|15|||
156999162|NCT05916170|566748618|FG000|No Warning Control|Noncompliance with protocol|1|||
156999163|NCT05916170|566748618|FG000|Health Warning Intervention|Lost to Follow-up|15|||
156999164|NCT05916170|566748618|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
156999165|NCT05916170|566748618|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
156999166|NCT04075266|566748619|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
156999167|NCT04075266|566748620|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
156999168|NCT04075266|566748619|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
156999169|NCT04075266|566748620|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
156999170|NCT03038022|566748627|FG000|Overall Study|Withdrawal by Subject|2|||
156999171|NCT03038022|566748628|FG001|Overall Study|Withdrawal by Subject|0|||
156999172|NCT03038022|566748627|FG000|Overall Study|Adverse Event|4|||
156999173|NCT03038022|566748628|FG001|Overall Study|Adverse Event|2|||
156999174|NCT01467427|566748629|FG000|Overall Study|Withdrawal by Subject|1|||
156999175|NCT01467427|566748630|FG001|Overall Study|Withdrawal by Subject|0|||
156999176|NCT01467427|566748629|FG000|Overall Study|Not continuing in extension phase|0|||
156999177|NCT01467427|566748630|FG001|Overall Study|Not continuing in extension phase|2|||
156999178|NCT01467427|566748629|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
156999179|NCT01467427|566748630|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
156999180|NCT01467427|566748629|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
156999181|NCT01467427|566748630|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
156999182|NCT01467427|566748629|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
156999183|NCT01467427|566748630|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
156999184|NCT01467427|566748629|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
157102258|NCT01968070|567130765|FG017|Period 1|Physician Decision|0|||
157102259|NCT01968070|567130748|FG000|Period 2|Withdrawal by Subject|0|||
156999185|NCT01467427|566748630|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
156999186|NCT04181827|566748631|FG000|Overall Study|Ongoing|124|||
156999187|NCT04181827|566748632|FG001|Overall Study|Ongoing|157|||
156999188|NCT04181827|566748631|FG000|Overall Study|Death|82|||
156999189|NCT04181827|566748632|FG001|Overall Study|Death|50|||
156757079|NCT01720524|565862811|FG000|Part A|Adverse Event|2|||
156757080|NCT01720524|565862812|FG001|Part A|Adverse Event|2|||
157102260|NCT01968070|567130749|FG001|Period 2|Withdrawal by Subject|0|||
157102261|NCT01968070|567130750|FG002|Period 2|Withdrawal by Subject|0|||
157102262|NCT01968070|567130751|FG003|Period 2|Withdrawal by Subject|0|||
157102263|NCT01968070|567130752|FG004|Period 2|Withdrawal by Subject|1|||
157102264|NCT01968070|567130753|FG005|Period 2|Withdrawal by Subject|0|||
157102265|NCT01968070|567130754|FG006|Period 2|Withdrawal by Subject|0|||
157102266|NCT01968070|567130755|FG007|Period 2|Withdrawal by Subject|0|||
157102267|NCT01968070|567130756|FG008|Period 2|Withdrawal by Subject|0|||
157102268|NCT01968070|567130757|FG009|Period 2|Withdrawal by Subject|0|||
157102269|NCT01968070|567130758|FG010|Period 2|Withdrawal by Subject|0|||
157102270|NCT01968070|567130759|FG011|Period 2|Withdrawal by Subject|0|||
157102271|NCT01968070|567130760|FG012|Period 2|Withdrawal by Subject|0|||
157102272|NCT01968070|567130761|FG013|Period 2|Withdrawal by Subject|0|||
157102273|NCT01968070|567130762|FG014|Period 2|Withdrawal by Subject|0|||
157102274|NCT01968070|567130763|FG015|Period 2|Withdrawal by Subject|0|||
157102275|NCT01968070|567130764|FG016|Period 2|Withdrawal by Subject|0|||
157102276|NCT01968070|567130765|FG017|Period 2|Withdrawal by Subject|0|||
157102277|NCT01237340|567130771|FG000|Overall Study|Adverse Event|3|||
157102278|NCT01237340|567130771|FG000|Overall Study|Withdrawal by Subject|1|||
157102279|NCT01237340|567130771|FG000|Overall Study|Early termination of the trial|36|||
157102280|NCT00685685|567130772|FG000|Washout Period of 7 Days|Adverse Event|2|||
157102281|NCT00685685|567130773|FG001|Washout Period of 7 Days|Adverse Event|0|||
157102282|NCT00685685|567130772|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
157102283|NCT00685685|567130773|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
157102284|NCT02019420|567130774|FG000|Overall Study|Did not receive study drug|2|||
157102285|NCT02019420|567130775|FG001|Overall Study|Did not receive study drug|2|||
157102286|NCT02019420|567130774|FG000|Overall Study|Withdrawal by Subject|1|||
157102287|NCT02019420|567130775|FG001|Overall Study|Withdrawal by Subject|3|||
157102288|NCT02019420|567130774|FG000|Overall Study|At request of sponsor or investigator|0|||
157102289|NCT02019420|567130775|FG001|Overall Study|At request of sponsor or investigator|1|||
157102290|NCT02019420|567130774|FG000|Overall Study|Death|104|||
157102291|NCT02019420|567130775|FG001|Overall Study|Death|99|||
157102292|NCT02019420|567130774|FG000|Overall Study|Transferred to other care facility|1|||
157102293|NCT02019420|567130775|FG001|Overall Study|Transferred to other care facility|1|||
157102294|NCT02401412|567130776|FG000|Overall Study|Lost to Follow-up|1|||
157102295|NCT02401412|567130777|FG001|Overall Study|Lost to Follow-up|0|||
157102296|NCT02401412|567130776|FG000|Overall Study|Discontinued Intervention|15|||
157102297|NCT02401412|567130777|FG001|Overall Study|Discontinued Intervention|21|||
156757081|NCT01720524|565862811|FG000|Part A|Death|2|||
156757082|NCT01720524|565862812|FG001|Part A|Death|1|||
156757083|NCT01720524|565862811|FG000|Part A|Lost to Follow-up|0|||
156757084|NCT01720524|565862812|FG001|Part A|Lost to Follow-up|1|||
156757085|NCT01720524|565862811|FG000|Part A|Missed 28 day follow-up visit|1|||
156757086|NCT01720524|565862812|FG001|Part A|Missed 28 day follow-up visit|1|||
156757087|NCT01720524|565862811|FG000|Part A|Withdrawal by Subject|0|||
156757088|NCT01720524|565862812|FG001|Part A|Withdrawal by Subject|1|||
156757089|NCT01720524|565862811|FG000|Part A|Other|0|||
156757090|NCT01720524|565862812|FG001|Part A|Other|1|||
156757091|NCT01720524|565862811|FG000|Part A|Lost to Follow-up|0|||
156757092|NCT01720524|565862812|FG001|Part A|Lost to Follow-up|1|||
156757093|NCT01720524|565862811|FG000|Part B|No longer willing to participate in study|1|||
156757094|NCT01720524|565862812|FG001|Part B|No longer willing to participate in study|4|||
156757095|NCT01720524|565862811|FG000|Part B|Other|2|||
156757096|NCT01720524|565862812|FG001|Part B|Other|0|||
156757097|NCT01720524|565862811|FG000|Part B|Lost to Follow-up|2|||
156757098|NCT01720524|565862812|FG001|Part B|Lost to Follow-up|3|||
156757099|NCT01720524|565862811|FG000|Part B|Death|0|||
156757100|NCT01720524|565862812|FG001|Part B|Death|2|||
156757101|NCT00527826|565862816|FG000|Overall Study|Adverse Event|10|||
156757102|NCT00527826|565862817|FG001|Overall Study|Adverse Event|10|||
156757103|NCT00527826|565862816|FG000|Overall Study|Lost to Follow-up|3|||
156757104|NCT00527826|565862817|FG001|Overall Study|Lost to Follow-up|2|||
156757105|NCT00527826|565862816|FG000|Overall Study|Withdrawal by Subject|5|||
156757106|NCT00527826|565862817|FG001|Overall Study|Withdrawal by Subject|8|||
156757107|NCT00527826|565862816|FG000|Overall Study|Inclusion Criteria Not Met|3|||
156757108|NCT00527826|565862817|FG001|Overall Study|Inclusion Criteria Not Met|3|||
156757109|NCT00527826|565862816|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
156757110|NCT00527826|565862817|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
156757111|NCT00527826|565862816|FG000|Overall Study|Additional Intake of Viani forte|0|||
156757112|NCT00527826|565862817|FG001|Overall Study|Additional Intake of Viani forte|1|||
156757113|NCT00527826|565862816|FG000|Overall Study|Participant moved away|0|||
156757114|NCT00527826|565862817|FG001|Overall Study|Participant moved away|1|||
156757115|NCT00158262|565862818|FG000|Overall Study|Lost to Follow-up|1|||
156757116|NCT00158262|565862819|FG001|Overall Study|Lost to Follow-up|1|||
156757117|NCT01421641|565862820|FG000|Overall Study|Protocol Violation|2|||
156757118|NCT01421641|565862821|FG001|Overall Study|Protocol Violation|2|||
156999190|NCT04181827|566748631|FG000|Overall Study|Lost to Follow-up|0|||
156999191|NCT04181827|566748632|FG001|Overall Study|Lost to Follow-up|1|||
156999192|NCT04181827|566748631|FG000|Overall Study|Withdrawal by Subject|5|||
156999193|NCT04181827|566748632|FG001|Overall Study|Withdrawal by Subject|0|||
156999194|NCT00539591|566748633|FG000|Overall Study|Toxicity|3|||
156999195|NCT00539591|566748634|FG001|Overall Study|Toxicity|0|||
156999196|NCT00539591|566748635|FG002|Overall Study|Toxicity|0|||
156999197|NCT00539591|566748633|FG000|Overall Study|Disease progression|2|||
156999198|NCT00539591|566748634|FG001|Overall Study|Disease progression|2|||
156999199|NCT00539591|566748635|FG002|Overall Study|Disease progression|3|||
156999200|NCT06269367|566748636|FG000|Phase I|Unable to perform study procedures|0|||
156999201|NCT06269367|566748637|FG001|Phase I|Unable to perform study procedures|1|||
156999202|NCT06269367|566748636|FG000|Phase I|Could not continue study for personal reasons.|1|||
156999203|NCT06269367|566748637|FG001|Phase I|Could not continue study for personal reasons.|0|||
156999204|NCT01137292|566748639|FG000|Overall Study|Death|30|||
156999205|NCT01137292|566748639|FG000|Overall Study|Adverse Event|3|||
156999206|NCT01137292|566748639|FG000|Overall Study|Lack of Efficacy|13|||
156999207|NCT01137292|566748639|FG000|Overall Study|Lost to Follow-up|1|||
156999208|NCT01137292|566748639|FG000|Overall Study|Other|7|||
156999209|NCT01311713|566748640|FG000|Overall Study|Death|0|||
156999210|NCT01311713|566748641|FG001|Overall Study|Death|0|||
156757119|NCT02420119|565862823|FG000|Overall Study|insufficient laboratory data|5|||
156757120|NCT01808261|565862824|FG000|Overall Study|Physician Decision|0|||
156757121|NCT01808261|565862825|FG001|Overall Study|Physician Decision|2|||
156757122|NCT01808261|565862824|FG000|Overall Study|Study Closed/Terminated|25|||
156757123|NCT01808261|565862825|FG001|Overall Study|Study Closed/Terminated|23|||
156757124|NCT01808261|565862824|FG000|Overall Study|Adverse event, non-fatal|2|||
156757125|NCT01808261|565862825|FG001|Overall Study|Adverse event, non-fatal|0|||
156757126|NCT01808261|565862824|FG000|Overall Study|Consent withdrawn by subject|6|||
156757127|NCT01808261|565862825|FG001|Overall Study|Consent withdrawn by subject|7|||
156757128|NCT01808261|565862824|FG000|Overall Study|Lost to Follow-up|3|||
156757129|NCT01808261|565862825|FG001|Overall Study|Lost to Follow-up|1|||
156757130|NCT04501952|565862828|FG000|Overall Study|Adverse Event|0|||
156757131|NCT04501952|565862829|FG001|Overall Study|Adverse Event|3|||
156757132|NCT04501952|565862828|FG000|Overall Study|Investigator's Discretion|0|||
156999211|NCT01311713|566748642|FG002|Overall Study|Death|1|||
156999212|NCT01311713|566748643|FG003|Overall Study|Death|1|||
156999213|NCT01311713|566748644|FG004|Overall Study|Death|0|||
156999214|NCT01311713|566748645|FG005|Overall Study|Death|1|||
156999215|NCT01311713|566748646|FG006|Overall Study|Death|0|||
156757133|NCT04501952|565862829|FG001|Overall Study|Investigator's Discretion|1|||
156757134|NCT04501952|565862828|FG000|Overall Study|Protocol Violation|1|||
156757135|NCT04501952|565862829|FG001|Overall Study|Protocol Violation|1|||
156757136|NCT04501952|565862828|FG000|Overall Study|Withdrew Consent|5|||
156757137|NCT04501952|565862829|FG001|Overall Study|Withdrew Consent|4|||
156757138|NCT04501952|565862828|FG000|Overall Study|Lost to Follow-up|7|||
156757139|NCT04501952|565862829|FG001|Overall Study|Lost to Follow-up|2|||
156757140|NCT04501952|565862828|FG000|Overall Study|Randomized and Never Treated|13|||
156757141|NCT04501952|565862829|FG001|Overall Study|Randomized and Never Treated|9|||
156757142|NCT02080364|565862830|FG000|Baseline Period|Protocol Violation|2|||
156757143|NCT02080364|565862831|FG001|Baseline Period|Protocol Violation|1|||
156757144|NCT02080364|565862832|FG002|Baseline Period|Protocol Violation|0|||
156757145|NCT02080364|565862833|FG003|Baseline Period|Protocol Violation|0|||
156757146|NCT02080364|565862830|FG000|Baseline Period|Other|0|||
156757147|NCT02080364|565862831|FG001|Baseline Period|Other|1|||
156757148|NCT02080364|565862832|FG002|Baseline Period|Other|1|||
156757149|NCT02080364|565862833|FG003|Baseline Period|Other|0|||
156757150|NCT02080364|565862830|FG000|Treatment Period|Adverse Event|10|||
156757151|NCT02080364|565862831|FG001|Treatment Period|Adverse Event|15|||
156757152|NCT02080364|565862832|FG002|Treatment Period|Adverse Event|11|||
156757153|NCT02080364|565862833|FG003|Treatment Period|Adverse Event|14|||
156757154|NCT02080364|565862830|FG000|Treatment Period|Lost to Follow-up|2|||
156757155|NCT02080364|565862831|FG001|Treatment Period|Lost to Follow-up|3|||
156757156|NCT02080364|565862832|FG002|Treatment Period|Lost to Follow-up|5|||
156757157|NCT02080364|565862833|FG003|Treatment Period|Lost to Follow-up|0|||
156757158|NCT02080364|565862830|FG000|Treatment Period|Protocol Violation|5|||
156757159|NCT02080364|565862831|FG001|Treatment Period|Protocol Violation|3|||
156757160|NCT02080364|565862832|FG002|Treatment Period|Protocol Violation|5|||
156757161|NCT02080364|565862833|FG003|Treatment Period|Protocol Violation|1|||
156757162|NCT02080364|565862830|FG000|Treatment Period|Withdrawal by Subject|16|||
156757163|NCT02080364|565862831|FG001|Treatment Period|Withdrawal by Subject|16|||
156757164|NCT02080364|565862832|FG002|Treatment Period|Withdrawal by Subject|15|||
156757165|NCT02080364|565862833|FG003|Treatment Period|Withdrawal by Subject|10|||
156757166|NCT02080364|565862830|FG000|Treatment Period|Study Terminated by Sponsor|0|||
156757167|NCT02080364|565862831|FG001|Treatment Period|Study Terminated by Sponsor|0|||
156757168|NCT02080364|565862832|FG002|Treatment Period|Study Terminated by Sponsor|180|||
156757169|NCT02080364|565862833|FG003|Treatment Period|Study Terminated by Sponsor|183|||
156757170|NCT02080364|565862830|FG000|Treatment Period|Other|14|||
156757171|NCT02080364|565862831|FG001|Treatment Period|Other|12|||
156757172|NCT02080364|565862832|FG002|Treatment Period|Other|21|||
156757173|NCT02080364|565862833|FG003|Treatment Period|Other|16|||
156757174|NCT02256839|565862834|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
156757175|NCT02256839|565862835|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
156757176|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Adverse Event|2|||
156757177|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Adverse Event|0|||
156757178|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Adverse Event|0|||
156757179|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Adverse Event|0|||
156757180|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Adverse Event|0|||
156757181|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Adverse Event|0|||
156757182|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
156757183|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
156757184|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
156757185|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
156999216|NCT01311713|566748640|FG000|Overall Study|Adverse Event|0|||
156999217|NCT01311713|566748641|FG001|Overall Study|Adverse Event|1|||
156999218|NCT01311713|566748642|FG002|Overall Study|Adverse Event|0|||
156999219|NCT01311713|566748643|FG003|Overall Study|Adverse Event|2|||
156999220|NCT01311713|566748644|FG004|Overall Study|Adverse Event|0|||
156999221|NCT01311713|566748645|FG005|Overall Study|Adverse Event|0|||
156999222|NCT01311713|566748646|FG006|Overall Study|Adverse Event|2|||
156999223|NCT01311713|566748640|FG000|Overall Study|Withdrawal by Subject|0|||
156999224|NCT01311713|566748641|FG001|Overall Study|Withdrawal by Subject|1|||
156999225|NCT01311713|566748642|FG002|Overall Study|Withdrawal by Subject|1|||
156999226|NCT01311713|566748643|FG003|Overall Study|Withdrawal by Subject|0|||
156999227|NCT01311713|566748644|FG004|Overall Study|Withdrawal by Subject|0|||
156999228|NCT01311713|566748645|FG005|Overall Study|Withdrawal by Subject|1|||
157102298|NCT02401412|567130776|FG000|Overall Study|Withdrawal by Subject|4|||
156757186|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
156757187|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
156757188|NCT00436826|565862836|FG000|Double Blind Period (DBP)|Other|10|||
157102299|NCT02401412|567130777|FG001|Overall Study|Withdrawal by Subject|4|||
156757189|NCT00436826|565862837|FG001|Double Blind Period (DBP)|Other|11|||
156757190|NCT00436826|565862838|FG002|Double Blind Period (DBP)|Other|0|||
156757191|NCT00436826|565862839|FG003|Double Blind Period (DBP)|Other|0|||
156757192|NCT00436826|565862840|FG004|Double Blind Period (DBP)|Other|0|||
156757193|NCT00436826|565862841|FG005|Double Blind Period (DBP)|Other|0|||
156999229|NCT01311713|566748646|FG006|Overall Study|Withdrawal by Subject|2|||
156999230|NCT01311713|566748640|FG000|Overall Study|Disease progression|3|||
156999231|NCT01311713|566748641|FG001|Overall Study|Disease progression|4|||
156999232|NCT01311713|566748642|FG002|Overall Study|Disease progression|3|||
156999233|NCT01311713|566748643|FG003|Overall Study|Disease progression|2|||
156999234|NCT01311713|566748644|FG004|Overall Study|Disease progression|4|||
156999235|NCT01311713|566748645|FG005|Overall Study|Disease progression|4|||
156999236|NCT01311713|566748646|FG006|Overall Study|Disease progression|5|||
156999237|NCT01311713|566748640|FG000|Overall Study|Lost to Follow-up|0|||
156999238|NCT01311713|566748641|FG001|Overall Study|Lost to Follow-up|0|||
156999239|NCT01311713|566748642|FG002|Overall Study|Lost to Follow-up|1|||
156999240|NCT01311713|566748643|FG003|Overall Study|Lost to Follow-up|0|||
156999241|NCT01311713|566748644|FG004|Overall Study|Lost to Follow-up|0|||
156999242|NCT01311713|566748645|FG005|Overall Study|Lost to Follow-up|0|||
156999243|NCT01311713|566748646|FG006|Overall Study|Lost to Follow-up|0|||
156999244|NCT01311713|566748640|FG000|Overall Study|Stopped taking study medication|0|||
156999245|NCT01311713|566748641|FG001|Overall Study|Stopped taking study medication|0|||
156999246|NCT01311713|566748642|FG002|Overall Study|Stopped taking study medication|0|||
156999247|NCT01311713|566748643|FG003|Overall Study|Stopped taking study medication|1|||
156999248|NCT01311713|566748644|FG004|Overall Study|Stopped taking study medication|1|||
156999249|NCT01311713|566748645|FG005|Overall Study|Stopped taking study medication|0|||
156999250|NCT01311713|566748646|FG006|Overall Study|Stopped taking study medication|0|||
156999251|NCT01311713|566748640|FG000|Overall Study|Enrolled but not treated|0|||
156999252|NCT01311713|566748641|FG001|Overall Study|Enrolled but not treated|0|||
156999253|NCT01311713|566748642|FG002|Overall Study|Enrolled but not treated|1|||
156999254|NCT01311713|566748643|FG003|Overall Study|Enrolled but not treated|0|||
156999255|NCT01311713|566748644|FG004|Overall Study|Enrolled but not treated|0|||
156999256|NCT01311713|566748645|FG005|Overall Study|Enrolled but not treated|0|||
156999257|NCT01311713|566748646|FG006|Overall Study|Enrolled but not treated|0|||
156999258|NCT01311713|566748640|FG000|Overall Study|Other than specified|0|||
156999259|NCT01311713|566748641|FG001|Overall Study|Other than specified|1|||
156999260|NCT01311713|566748642|FG002|Overall Study|Other than specified|2|||
156999261|NCT01311713|566748643|FG003|Overall Study|Other than specified|0|||
156999262|NCT01311713|566748644|FG004|Overall Study|Other than specified|0|||
156999263|NCT01311713|566748645|FG005|Overall Study|Other than specified|0|||
156999264|NCT01311713|566748646|FG006|Overall Study|Other than specified|0|||
156999265|NCT00980538|566748649|FG000|Overall Study|Lost to Follow-up|20|||
156999266|NCT00980538|566748649|FG000|Overall Study|Sponsor's Decision|4|||
156999267|NCT00980538|566748649|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
156999268|NCT00980538|566748649|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
156999269|NCT00980538|566748649|FG000|Overall Study|Switch to Commercially Available Medication|25|||
156999270|NCT00980538|566748649|FG000|Overall Study|Participant Non-Compliant|9|||
156999271|NCT00980538|566748649|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
156999272|NCT00980538|566748649|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
156999273|NCT00980538|566748649|FG000|Overall Study|Other|60|||
156999274|NCT00980538|566748649|FG000|Overall Study|Other|1|||
156999275|NCT03878446|566748650|FG000|Overall Study|Withdrawn by parent or guardian|1|||
156999276|NCT03878446|566748651|FG001|Overall Study|Withdrawn by parent or guardian|0|||
156999277|NCT03878446|566748652|FG002|Overall Study|Withdrawn by parent or guardian|0|||
156999278|NCT03878446|566748653|FG003|Overall Study|Withdrawn by parent or guardian|0|||
156999279|NCT03878446|566748654|FG004|Overall Study|Withdrawn by parent or guardian|0|||
156999280|NCT05803720|566748655|FG000|Overall Study|Lost to Follow-up|3|||
156999281|NCT05803720|566748656|FG001|Overall Study|Lost to Follow-up|4|||
156999282|NCT05803720|566748655|FG000|Overall Study|Family leave/emergency|1|||
156999283|NCT05803720|566748656|FG001|Overall Study|Family leave/emergency|1|||
156999284|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
156999285|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
156999286|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
156999287|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
156999288|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
156999289|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
156999290|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Death|1|||
156999291|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Death|1|||
156999292|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Death|1|||
156999293|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Death|0|||
156999294|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Death|0|||
156999295|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Death|0|||
156999296|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
157102300|NCT02401412|567130776|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
156999297|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
156999298|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156999299|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156999300|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156999301|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
156999302|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156999303|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
157102301|NCT02401412|567130777|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
157102302|NCT02401412|567130776|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
157102303|NCT02401412|567130777|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
157102304|NCT02742766|567130786|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102305|NCT02742766|567130787|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102306|NCT02742766|567130788|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102307|NCT02742766|567130789|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102308|NCT02742766|567130790|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102309|NCT02742766|567130791|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102310|NCT02742766|567130792|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102311|NCT02742766|567130793|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102312|NCT02742766|567130794|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102313|NCT02742766|567130795|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102314|NCT02742766|567130796|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102315|NCT02742766|567130797|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102316|NCT02742766|567130798|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102317|NCT02742766|567130799|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
157102318|NCT02742766|567130800|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102319|NCT02742766|567130801|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102320|NCT02742766|567130802|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102321|NCT02742766|567130803|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102322|NCT02742766|567130804|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
157102323|NCT02742766|567130786|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102324|NCT02742766|567130787|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102325|NCT02742766|567130788|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102326|NCT02742766|567130789|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
156757194|NCT00436826|565862836|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757195|NCT00436826|565862837|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757196|NCT00436826|565862838|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757197|NCT00436826|565862839|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
156999304|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
156999305|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156999306|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156999307|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
156999308|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156999309|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
156999310|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156999311|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156999312|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156999313|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
156999314|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
156999315|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
156999316|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
156999317|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156999318|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156999319|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
156999320|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
156999321|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
156999322|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
156999323|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
156999324|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
156999325|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
156999326|NCT03370133|566748657|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
156999327|NCT03370133|566748658|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
156999328|NCT03370133|566748659|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
156999329|NCT03370133|566748660|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
156999330|NCT03370133|566748661|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
156999331|NCT03370133|566748662|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
156999332|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156999333|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156999334|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
156999335|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
156999336|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
156999337|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
156999338|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
157102327|NCT02742766|567130790|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102328|NCT02742766|567130791|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102329|NCT02742766|567130792|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
156999339|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156999340|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156999341|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
156999342|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
156999343|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
156999344|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156999345|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156999346|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156999347|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
156999348|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
156999349|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
156999350|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156999351|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156999352|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156999353|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
156999354|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
156999355|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
156999356|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156999357|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156999358|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
156999359|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
156999360|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
156999361|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
156999362|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156999363|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156999364|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156999365|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156999366|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
156999367|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
156999368|NCT03370133|566748657|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156999369|NCT03370133|566748658|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156999370|NCT03370133|566748659|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156999371|NCT03370133|566748660|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156999372|NCT03370133|566748661|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
156999373|NCT03370133|566748662|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
156999374|NCT06688370|566748663|FG000|Overall Study|Discontinued the treatment|1|||
156999375|NCT06688370|566748663|FG000|Overall Study|Prohibited treatment taken|4|||
156999376|NCT04540835|566748664|FG000|Week 1|Lost to Follow-up|1|||
156999377|NCT04540835|566748664|FG000|Week 6|Pregnancy|1|||
156999378|NCT04540835|566748664|FG000|Week 6|Lack of Efficacy|1|||
156999379|NCT04487080|566748665|FG000|Overall Study|Withdrawal by Subject|19|||
156999380|NCT04487080|566748666|FG001|Overall Study|Withdrawal by Subject|18|||
156999381|NCT04487080|566748667|FG002|Overall Study|Withdrawal by Subject|13|||
156999382|NCT04487080|566748665|FG000|Overall Study|Lost to Follow-up|3|||
156999383|NCT04487080|566748666|FG001|Overall Study|Lost to Follow-up|1|||
156999384|NCT04487080|566748667|FG002|Overall Study|Lost to Follow-up|0|||
156999385|NCT04487080|566748665|FG000|Overall Study|Ongoing|313|||
156999386|NCT04487080|566748666|FG001|Overall Study|Ongoing|297|||
156999387|NCT04487080|566748667|FG002|Overall Study|Ongoing|149|||
156999388|NCT03944512|566748668|FG000|Overall Study|Death|0|||
156999389|NCT03944512|566748669|FG001|Overall Study|Death|0|||
156999390|NCT03944512|566748670|FG002|Overall Study|Death|1|||
156999391|NCT03944512|566748671|FG003|Overall Study|Death|2|||
156757198|NCT00436826|565862840|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
157102330|NCT02742766|567130793|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102331|NCT02742766|567130794|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102332|NCT02742766|567130795|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102333|NCT02742766|567130796|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102334|NCT02742766|567130797|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102335|NCT02742766|567130798|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
157102336|NCT02742766|567130799|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
157102337|NCT02742766|567130800|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102338|NCT02742766|567130801|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
157102339|NCT02742766|567130802|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102340|NCT02742766|567130803|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102341|NCT02742766|567130804|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
157102342|NCT03359590|567130806|FG000|First Intervention|Withdrawal by Subject|1|||
157102343|NCT03359590|567130807|FG001|First Intervention|Withdrawal by Subject|1|||
157102344|NCT03359590|567130806|FG000|First Intervention|Protocol Violation|0|||
157102345|NCT03359590|567130807|FG001|First Intervention|Protocol Violation|1|||
157102346|NCT02846532|567130808|FG000|Overall Study|Lost to Follow-up|0|||
157102347|NCT02846532|567130809|FG001|Overall Study|Lost to Follow-up|1|||
157102348|NCT02846532|567130810|FG002|Overall Study|Lost to Follow-up|1|||
157102349|NCT02846532|567130808|FG000|Overall Study|Withdrawal by Subject|1|||
157102350|NCT02846532|567130809|FG001|Overall Study|Withdrawal by Subject|2|||
157102351|NCT02846532|567130810|FG002|Overall Study|Withdrawal by Subject|0|||
157102352|NCT04598477|567130812|FG000|Overall Study|Adverse Event|2|||
157102353|NCT04598477|567130813|FG001|Overall Study|Adverse Event|0|||
157102354|NCT04598477|567130812|FG000|Overall Study|Death|0|||
157102355|NCT04598477|567130813|FG001|Overall Study|Death|1|||
157102356|NCT04598477|567130812|FG000|Overall Study|Lost to Follow-up|1|||
157102357|NCT04598477|567130813|FG001|Overall Study|Lost to Follow-up|0|||
157102358|NCT04598477|567130812|FG000|Overall Study|Physician Decision|7|||
157102359|NCT04598477|567130813|FG001|Overall Study|Physician Decision|2|||
157102360|NCT04598477|567130812|FG000|Overall Study|Pregnancy|0|||
157102361|NCT04598477|567130813|FG001|Overall Study|Pregnancy|1|||
157102362|NCT04598477|567130812|FG000|Overall Study|Requires Prohibited Medication|0|||
157102363|NCT04598477|567130813|FG001|Overall Study|Requires Prohibited Medication|1|||
157102364|NCT04598477|567130812|FG000|Overall Study|Study Terminated by Sponsor|18|||
157102365|NCT04598477|567130813|FG001|Overall Study|Study Terminated by Sponsor|12|||
157102366|NCT04598477|567130812|FG000|Overall Study|Withdrawal by Subject|16|||
157102367|NCT04598477|567130813|FG001|Overall Study|Withdrawal by Subject|12|||
157102368|NCT04598477|567130812|FG000|Overall Study|Other|15|||
157102369|NCT04598477|567130813|FG001|Overall Study|Other|8|||
157102370|NCT05359003|567130814|FG000|Overall Study|Withdrawal by Subject|1|||
157102371|NCT05359003|567130815|FG001|Overall Study|Withdrawal by Subject|3|||
157102372|NCT05118204|567130818|FG000|Overall Study|Lost to Follow-up|3|||
157102373|NCT05118204|567130819|FG001|Overall Study|Lost to Follow-up|2|||
157102374|NCT05118204|567130818|FG000|Overall Study|Withdrawal by Subject|0|||
157102375|NCT05118204|567130819|FG001|Overall Study|Withdrawal by Subject|2|||
157102376|NCT04014361|567130820|FG000|Period 2|Physician Decision|0|||
157102377|NCT04014361|567130821|FG001|Period 2|Physician Decision|0|||
157102378|NCT04014361|567130822|FG002|Period 2|Physician Decision|0|||
157102379|NCT04014361|567130823|FG003|Period 2|Physician Decision|1|||
157102380|NCT04014361|567130824|FG004|Period 2|Physician Decision|0|||
157102381|NCT04014361|567130825|FG005|Period 2|Physician Decision|0|||
157102382|NCT04014361|567130826|FG006|Period 2|Physician Decision|0|||
157102383|NCT04014361|567130827|FG007|Period 2|Physician Decision|0|||
157102384|NCT06308666|567130828|FG000|Overall Study|Withdrawal by Subject|1|||
157102385|NCT06308666|567130828|FG000|Overall Study|Protocol Violation|2|||
157102386|NCT02593786|567130830|FG000|Overall Study|Disease progression|12|||
157102387|NCT02593786|567130831|FG001|Overall Study|Disease progression|16|||
157102388|NCT02593786|567130832|FG002|Overall Study|Disease progression|10|||
157102389|NCT02593786|567130833|FG003|Overall Study|Disease progression|7|||
157102390|NCT02593786|567130830|FG000|Overall Study|Study drug toxicity|1|||
157102391|NCT02593786|567130831|FG001|Overall Study|Study drug toxicity|0|||
157102392|NCT02593786|567130832|FG002|Overall Study|Study drug toxicity|0|||
157102393|NCT02593786|567130833|FG003|Overall Study|Study drug toxicity|0|||
157102394|NCT02593786|567130830|FG000|Overall Study|Adverse event unrelated to study drug|1|||
157102395|NCT02593786|567130831|FG001|Overall Study|Adverse event unrelated to study drug|1|||
157102396|NCT02593786|567130832|FG002|Overall Study|Adverse event unrelated to study drug|1|||
157102397|NCT02593786|567130833|FG003|Overall Study|Adverse event unrelated to study drug|0|||
157102398|NCT02593786|567130830|FG000|Overall Study|Participant request to discontinue study therapy|0|||
157102399|NCT02593786|567130831|FG001|Overall Study|Participant request to discontinue study therapy|2|||
156757199|NCT00436826|565862841|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
156757200|NCT00436826|565862836|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156757201|NCT00436826|565862837|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156757202|NCT00436826|565862838|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
156757203|NCT00436826|565862839|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
156757204|NCT00436826|565862840|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156999392|NCT03944512|566748668|FG000|Overall Study|Lost to Follow-up|0|||
156999393|NCT03944512|566748669|FG001|Overall Study|Lost to Follow-up|0|||
156999394|NCT03944512|566748670|FG002|Overall Study|Lost to Follow-up|4|||
156999395|NCT03944512|566748671|FG003|Overall Study|Lost to Follow-up|4|||
156999396|NCT03944512|566748668|FG000|Overall Study|refused follow-up|0|||
156999397|NCT03944512|566748669|FG001|Overall Study|refused follow-up|0|||
156999398|NCT03944512|566748670|FG002|Overall Study|refused follow-up|2|||
156999399|NCT03944512|566748671|FG003|Overall Study|refused follow-up|2|||
156999400|NCT00151996|566749975|FG000|Overall Study|Adverse Event|3|||
156999401|NCT00151996|566749976|FG001|Overall Study|Adverse Event|2|||
156999402|NCT00151996|566749975|FG000|Overall Study|Withdrawal by Subject|1|||
156999403|NCT00151996|566749976|FG001|Overall Study|Withdrawal by Subject|1|||
156999404|NCT00151996|566749975|FG000|Overall Study|Protocol Violation|1|||
156999405|NCT00151996|566749976|FG001|Overall Study|Protocol Violation|2|||
156999406|NCT00151996|566749975|FG000|Overall Study|Sponsor's decision|0|||
156999407|NCT00151996|566749976|FG001|Overall Study|Sponsor's decision|2|||
156999408|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999409|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
156999410|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999411|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999412|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999413|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999414|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999415|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999416|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999417|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999418|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999419|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999420|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
156999421|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Death|0|||
156999422|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Death|0|||
156999423|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Death|0|||
156999424|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Death|1|||
156999425|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Death|0|||
156999426|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Death|0|||
156999427|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Death|0|||
156999428|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Death|0|||
156999429|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Death|0|||
156999430|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Death|0|||
156999431|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Death|0|||
156999432|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Death|0|||
156999433|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Death|0|||
156999434|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999435|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156999436|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156999437|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
156999438|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
156999439|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999440|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999441|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999442|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999443|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999444|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999445|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999446|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
156999447|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999448|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
156999449|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156757205|NCT00436826|565862841|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
156999450|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999451|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999452|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999453|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
157102400|NCT02593786|567130832|FG002|Overall Study|Participant request to discontinue study therapy|0|||
157102401|NCT02593786|567130833|FG003|Overall Study|Participant request to discontinue study therapy|0|||
157102402|NCT02593786|567130830|FG000|Overall Study|Other reasons|1|||
157102403|NCT02593786|567130831|FG001|Overall Study|Other reasons|1|||
157102404|NCT02593786|567130832|FG002|Overall Study|Other reasons|0|||
157102405|NCT02593786|567130833|FG003|Overall Study|Other reasons|5|||
157102406|NCT01130051|567130834|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
157102407|NCT01130051|567130835|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
157102408|NCT01130051|567130834|FG000|Washout Period of 14 Days|Protocol Violation|1|||
157102409|NCT01130051|567130835|FG001|Washout Period of 14 Days|Protocol Violation|1|||
157102410|NCT00835120|567130837|FG000|Overall Study|Lack of Efficacy|1|||
157102411|NCT00835120|567130837|FG000|Overall Study|Lost to Follow-up|3|||
157102412|NCT00835120|567130837|FG000|Overall Study|Adverse Event|2|||
157102413|NCT00835120|567130837|FG000|Overall Study|Withdrawal by Subject|2|||
157102414|NCT01019980|567130838|FG000|Overall Study|Drug not available.|2|||
157102415|NCT01019980|567130839|FG001|Overall Study|Drug not available.|0|||
157102416|NCT03610165|567130840|FG000|Overall Study|Device didn't work|0|||
157102417|NCT03610165|567130841|FG001|Overall Study|Device didn't work|1|||
157102418|NCT00708175|567130853|FG000|Overall Study|Adverse Event|4|||
157102419|NCT00708175|567130854|FG001|Overall Study|Adverse Event|5|||
157102420|NCT00708175|567130853|FG000|Overall Study|Protocol Violation|2|||
157102421|NCT00708175|567130854|FG001|Overall Study|Protocol Violation|3|||
157102422|NCT00708175|567130853|FG000|Overall Study|Lost to Follow-up|5|||
157102423|NCT00708175|567130854|FG001|Overall Study|Lost to Follow-up|3|||
157102424|NCT00708175|567130853|FG000|Overall Study|Withdrawal by Subject|5|||
157102425|NCT00708175|567130854|FG001|Overall Study|Withdrawal by Subject|7|||
157102426|NCT00708175|567130853|FG000|Overall Study|BMD loss >7%|2|||
157102427|NCT00708175|567130854|FG001|Overall Study|BMD loss >7%|3|||
157102428|NCT02038920|567130862|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
157102429|NCT02038920|567130863|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
157102430|NCT02038920|567130864|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
157102431|NCT02038920|567130865|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
157102432|NCT02038920|567130866|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
157102433|NCT02038920|567130867|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
157102434|NCT02038920|567130862|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
157102435|NCT02038920|567130863|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
157102436|NCT02038920|567130864|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
157102437|NCT02038920|567130865|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
157102438|NCT02038920|567130866|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
157102439|NCT02038920|567130867|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
157102440|NCT02038920|567130862|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
157102441|NCT02038920|567130863|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
157102442|NCT02038920|567130864|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
157102443|NCT02038920|567130865|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
157102444|NCT02038920|567130866|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
157102445|NCT02038920|567130867|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
157102446|NCT02038920|567130862|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
157102447|NCT02038920|567130863|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
157102448|NCT02038920|567130864|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
157102449|NCT02038920|567130865|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
157102450|NCT02038920|567130866|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
157102451|NCT02038920|567130867|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
157102452|NCT02038920|567130862|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
157102453|NCT02038920|567130863|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
157102454|NCT02038920|567130864|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
157102455|NCT02038920|567130865|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
157102456|NCT02038920|567130866|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
157102457|NCT02038920|567130867|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
157102458|NCT02038920|567130862|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
157102459|NCT02038920|567130863|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
157102460|NCT02038920|567130864|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
157102461|NCT02038920|567130865|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
157102462|NCT02038920|567130866|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
157102463|NCT02038920|567130867|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
157102464|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
157102465|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
157102466|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
157102467|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
156757206|NCT00436826|565862836|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757207|NCT00436826|565862837|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757208|NCT00436826|565862838|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
156757209|NCT00436826|565862839|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
157102468|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
157102469|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
157102470|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
157102471|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
157102472|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
157102473|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
157102474|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
157102475|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
157102476|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
157102477|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
157102478|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
157102479|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
157102480|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
157102481|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
157102482|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
157102483|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
157102484|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
157102485|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
157102486|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
157102487|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
157102488|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
157102489|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
157102490|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
157102491|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
157102492|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
157102493|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
157102494|NCT02038920|567130862|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
157102495|NCT02038920|567130863|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
157102496|NCT02038920|567130864|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
157102497|NCT02038920|567130865|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
157102498|NCT02038920|567130866|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
157102499|NCT02038920|567130867|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
157102500|NCT02383589|567130868|FG000|Treatment Period|Adverse Event|1|||
157102501|NCT02383589|567130869|FG001|Treatment Period|Adverse Event|3|||
157102502|NCT02383589|567130868|FG000|Treatment Period|Lost to Follow-up|0|||
157102503|NCT02383589|567130869|FG001|Treatment Period|Lost to Follow-up|1|||
157102504|NCT02383589|567130868|FG000|Treatment Period|Withdrawal by Subject|0|||
157102505|NCT02383589|567130869|FG001|Treatment Period|Withdrawal by Subject|5|||
157102506|NCT02383589|567130868|FG000|Treatment Period|Non-compliance with study drug|0|||
157102507|NCT02383589|567130869|FG001|Treatment Period|Non-compliance with study drug|1|||
157102508|NCT02383589|567130868|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
157102509|NCT02383589|567130869|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
157102510|NCT02383589|567130868|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
157102511|NCT02383589|567130869|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
157102512|NCT02383589|567130868|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
157102513|NCT02383589|567130869|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
157102514|NCT02906787|567130872|FG000|Overall Study|Withdrawal by Subject|12|||
157102515|NCT02906787|567130873|FG001|Overall Study|Withdrawal by Subject|10|||
157102516|NCT02906787|567130872|FG000|Overall Study|Missed|24|||
157102517|NCT02906787|567130873|FG001|Overall Study|Missed|22|||
157102518|NCT03901053|567130878|FG000|Overall Study|Lost to Follow-up|6|||
157102519|NCT03901053|567130879|FG001|Overall Study|Lost to Follow-up|2|||
157102520|NCT03901053|567130878|FG000|Overall Study|Withdrawal by Subject|4|||
157102521|NCT03901053|567130879|FG001|Overall Study|Withdrawal by Subject|3|||
157102522|NCT03901053|567130878|FG000|Overall Study|Unsatisfactory Device|1|||
156757210|NCT00436826|565862840|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
157102523|NCT03901053|567130879|FG001|Overall Study|Unsatisfactory Device|2|||
156757211|NCT00436826|565862841|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
157102524|NCT03901053|567130878|FG000|Overall Study|No longer meets study criteria|1|||
157102525|NCT03901053|567130879|FG001|Overall Study|No longer meets study criteria|3|||
157102526|NCT03901053|567130878|FG000|Overall Study|Subject's Medical Status|0|||
156757212|NCT04346199|565862850|FG000|Overall Study|Death|8|||
156757213|NCT04346199|565862851|FG001|Overall Study|Death|9|||
156757214|NCT04346199|565862850|FG000|Overall Study|Lost to Follow-up|0|||
156757215|NCT04346199|565862851|FG001|Overall Study|Lost to Follow-up|1|||
157102527|NCT03901053|567130879|FG001|Overall Study|Subject's Medical Status|1|||
157102528|NCT03901053|567130878|FG000|Overall Study|Screening Failure|1|||
157102529|NCT03901053|567130879|FG001|Overall Study|Screening Failure|0|||
157102530|NCT04600336|567130880|FG000|Initial Treatment|Withdrawal by Subject|1|||
157102531|NCT04600336|567130881|FG001|Initial Treatment|Withdrawal by Subject|2|||
157102532|NCT04600336|567130882|FG002|Initial Treatment|Withdrawal by Subject|0|||
157102533|NCT04600336|567130883|FG003|Initial Treatment|Withdrawal by Subject|0|||
157102534|NCT04600336|567130880|FG000|Initial Treatment|Adverse Event|0|||
157102535|NCT04600336|567130881|FG001|Initial Treatment|Adverse Event|2|||
157102536|NCT04600336|567130882|FG002|Initial Treatment|Adverse Event|0|||
157102537|NCT04600336|567130883|FG003|Initial Treatment|Adverse Event|0|||
157102538|NCT04600336|567130880|FG000|Initial Treatment|Other complicating disease|0|||
157102539|NCT04600336|567130881|FG001|Initial Treatment|Other complicating disease|0|||
157102540|NCT04600336|567130882|FG002|Initial Treatment|Other complicating disease|1|||
157102541|NCT04600336|567130883|FG003|Initial Treatment|Other complicating disease|0|||
157102542|NCT04600336|567130880|FG000|Crossover Treatment|Withdrawal by Subject|0|||
157102543|NCT04600336|567130881|FG001|Crossover Treatment|Withdrawal by Subject|0|||
157102544|NCT04600336|567130882|FG002|Crossover Treatment|Withdrawal by Subject|2|||
157102545|NCT04600336|567130883|FG003|Crossover Treatment|Withdrawal by Subject|1|||
157102546|NCT04600336|567130880|FG000|Crossover Treatment|Adverse Event|0|||
157102547|NCT04600336|567130881|FG001|Crossover Treatment|Adverse Event|0|||
157102548|NCT04600336|567130882|FG002|Crossover Treatment|Adverse Event|1|||
157102549|NCT04600336|567130883|FG003|Crossover Treatment|Adverse Event|1|||
157102550|NCT02366728|567132819|FG000|Overall Study|Death|0|||
157102551|NCT02366728|567132820|FG001|Overall Study|Death|0|||
157102552|NCT02366728|567132821|FG002|Overall Study|Death|1|||
157102553|NCT02366728|567132819|FG000|Overall Study|Adverse Event|1|||
157102554|NCT02366728|567132820|FG001|Overall Study|Adverse Event|0|||
157102555|NCT02366728|567132821|FG002|Overall Study|Adverse Event|0|||
157102556|NCT02366728|567132819|FG000|Overall Study|Screen Failure|2|||
157102557|NCT02366728|567132820|FG001|Overall Study|Screen Failure|1|||
157102558|NCT02366728|567132821|FG002|Overall Study|Screen Failure|0|||
157102559|NCT02366728|567132819|FG000|Overall Study|Only yielded 2 vaccines|1|||
157102560|NCT02366728|567132820|FG001|Overall Study|Only yielded 2 vaccines|0|||
157102561|NCT02366728|567132821|FG002|Overall Study|Only yielded 2 vaccines|0|||
157102562|NCT00733304|567132822|FG000|Overall Study|Adverse Event|3|||
157102563|NCT00733304|567132823|FG001|Overall Study|Adverse Event|0|||
157102564|NCT00733304|567132824|FG002|Overall Study|Adverse Event|0|||
157102565|NCT00733304|567132822|FG000|Overall Study|Lack of Efficacy|0|||
157102566|NCT00733304|567132823|FG001|Overall Study|Lack of Efficacy|0|||
157102567|NCT00733304|567132824|FG002|Overall Study|Lack of Efficacy|2|||
157102568|NCT00733304|567132822|FG000|Overall Study|Lost to Follow-up|0|||
157102569|NCT00733304|567132823|FG001|Overall Study|Lost to Follow-up|1|||
157102570|NCT00733304|567132824|FG002|Overall Study|Lost to Follow-up|0|||
157102571|NCT00733304|567132822|FG000|Overall Study|Physician Decision|3|||
157102572|NCT00733304|567132823|FG001|Overall Study|Physician Decision|1|||
157102573|NCT00733304|567132824|FG002|Overall Study|Physician Decision|3|||
157102574|NCT00733304|567132822|FG000|Overall Study|Withdrawal by Subject|1|||
157102575|NCT00733304|567132823|FG001|Overall Study|Withdrawal by Subject|1|||
157102576|NCT00733304|567132824|FG002|Overall Study|Withdrawal by Subject|0|||
157102577|NCT03085758|567132825|FG000|Overall Study|Death|26|||
157102578|NCT03085758|567132826|FG001|Overall Study|Death|24|||
157102579|NCT03085758|567132827|FG002|Overall Study|Death|53|||
157102580|NCT03085758|567132825|FG000|Overall Study|Lost to Follow-up|1|||
157102581|NCT03085758|567132826|FG001|Overall Study|Lost to Follow-up|1|||
157102582|NCT03085758|567132827|FG002|Overall Study|Lost to Follow-up|1|||
157102583|NCT03085758|567132825|FG000|Overall Study|Withdrawal by Subject|2|||
157102584|NCT03085758|567132826|FG001|Overall Study|Withdrawal by Subject|2|||
157102585|NCT03085758|567132827|FG002|Overall Study|Withdrawal by Subject|1|||
157102586|NCT03085758|567132825|FG000|Overall Study|Refusal to recall it up to day 90|0|||
157102587|NCT03085758|567132826|FG001|Overall Study|Refusal to recall it up to day 90|0|||
157102588|NCT03085758|567132827|FG002|Overall Study|Refusal to recall it up to day 90|1|||
157102589|NCT03085758|567132825|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
157102590|NCT03085758|567132826|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
157102591|NCT03085758|567132827|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
157102592|NCT01122576|567132828|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
157102593|NCT01122576|567132829|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
157102594|NCT01122576|567132830|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
157102595|NCT01122576|567132828|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
157102596|NCT01122576|567132829|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
157102597|NCT01122576|567132830|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
157102598|NCT01122576|567132828|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
157102599|NCT01122576|567132829|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
157102600|NCT01122576|567132830|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
157102601|NCT05696236|567132831|FG000|Overall Study|Lost to Follow-up|1|||
157102602|NCT05696236|567132832|FG001|Overall Study|Lost to Follow-up|0|||
157102603|NCT05696236|567132831|FG000|Overall Study|Later determined to not be eligible for participation|0|||
156757216|NCT04346199|565862850|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
156757217|NCT04346199|565862851|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
156999454|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999455|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999456|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999457|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999458|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999459|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
156999460|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999461|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999462|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
156999463|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999464|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999465|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999466|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999467|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999468|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999469|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999470|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999471|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999472|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
156999473|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
156999474|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
156999475|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
156999476|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
156999477|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
156999478|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999479|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999480|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999481|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999482|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999483|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999484|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999485|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
156999486|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999487|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999488|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999489|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999490|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
156999491|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999492|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999493|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999494|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999495|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999496|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999497|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999498|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
156999499|NCT04936035|566749985|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
156999500|NCT04936035|566749986|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999501|NCT04936035|566749987|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999502|NCT04936035|566749988|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999503|NCT04936035|566749989|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999504|NCT04936035|566749990|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999505|NCT04936035|566749991|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999506|NCT04936035|566749992|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999507|NCT04936035|566749993|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999508|NCT04936035|566749994|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999509|NCT04936035|566749995|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999510|NCT04936035|566749996|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
156999511|NCT04936035|566749997|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
157102604|NCT05696236|567132832|FG001|Overall Study|Later determined to not be eligible for participation|1|||
157102605|NCT05696236|567132831|FG000|Overall Study|Withdrawal by Subject|2|||
157102606|NCT05696236|567132832|FG001|Overall Study|Withdrawal by Subject|2|||
157102607|NCT01829360|567132833|FG000|Overall Study|Protocol Violation|0|||
157102608|NCT01829360|567132834|FG001|Overall Study|Protocol Violation|0|||
157102609|NCT01829360|567132835|FG002|Overall Study|Protocol Violation|1|||
157102610|NCT01829360|567132836|FG003|Overall Study|Protocol Violation|0|||
157102611|NCT00024167|567132838|FG000|Overall Study|Death|53|||
157102612|NCT00024167|567132839|FG001|Overall Study|Death|47|||
157102613|NCT01109173|567132840|FG000|Overall Study|Adverse Event|15|||
157102614|NCT01109173|567132841|FG001|Overall Study|Adverse Event|17|||
157102615|NCT01109173|567132842|FG002|Overall Study|Adverse Event|9|||
157102616|NCT01109173|567132843|FG003|Overall Study|Adverse Event|6|||
157102617|NCT01109173|567132840|FG000|Overall Study|Lost to Follow-up|0|||
157102618|NCT01109173|567132841|FG001|Overall Study|Lost to Follow-up|1|||
157102619|NCT01109173|567132842|FG002|Overall Study|Lost to Follow-up|0|||
157102620|NCT01109173|567132843|FG003|Overall Study|Lost to Follow-up|0|||
157102621|NCT01109173|567132840|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
157102622|NCT01109173|567132841|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
157102623|NCT01109173|567132842|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
157102624|NCT01109173|567132843|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
157102625|NCT01109173|567132840|FG000|Overall Study|Noncompliance|0|||
157102626|NCT01109173|567132841|FG001|Overall Study|Noncompliance|1|||
157102627|NCT01109173|567132842|FG002|Overall Study|Noncompliance|0|||
157102628|NCT01109173|567132843|FG003|Overall Study|Noncompliance|0|||
157102629|NCT01109173|567132840|FG000|Overall Study|Treatment Failure|25|||
157102630|NCT01109173|567132841|FG001|Overall Study|Treatment Failure|32|||
157102631|NCT01109173|567132842|FG002|Overall Study|Treatment Failure|69|||
157102632|NCT01109173|567132843|FG003|Overall Study|Treatment Failure|64|||
157102633|NCT01109173|567132840|FG000|Overall Study|Protocol Violation|4|||
157102634|NCT01109173|567132841|FG001|Overall Study|Protocol Violation|5|||
157102635|NCT01109173|567132842|FG002|Overall Study|Protocol Violation|1|||
157102636|NCT01109173|567132843|FG003|Overall Study|Protocol Violation|2|||
157102637|NCT01109173|567132840|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
157102638|NCT01109173|567132841|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
157102639|NCT01109173|567132842|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
157102640|NCT01109173|567132843|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
157102641|NCT01109173|567132840|FG000|Overall Study|Not Specifiied|5|||
157102642|NCT01109173|567132841|FG001|Overall Study|Not Specifiied|4|||
157102643|NCT01109173|567132842|FG002|Overall Study|Not Specifiied|9|||
157102644|NCT01109173|567132843|FG003|Overall Study|Not Specifiied|14|||
157102645|NCT01132612|567132844|FG000|Overall Study|Death|0|||
157102646|NCT01132612|567132845|FG001|Overall Study|Death|0|||
157102647|NCT01132612|567132846|FG002|Overall Study|Death|1|||
157102648|NCT01132612|567132844|FG000|Overall Study|Protocol deviation|0|||
157102649|NCT01132612|567132845|FG001|Overall Study|Protocol deviation|0|||
157102650|NCT01132612|567132846|FG002|Overall Study|Protocol deviation|3|||
157102651|NCT01132612|567132844|FG000|Overall Study|Lost to Follow-up|2|||
157102652|NCT01132612|567132845|FG001|Overall Study|Lost to Follow-up|2|||
157102653|NCT01132612|567132846|FG002|Overall Study|Lost to Follow-up|7|||
157102654|NCT01132612|567132844|FG000|Overall Study|Adverse Event|5|||
157102655|NCT01132612|567132845|FG001|Overall Study|Adverse Event|2|||
157102656|NCT01132612|567132846|FG002|Overall Study|Adverse Event|15|||
157102657|NCT01132612|567132844|FG000|Overall Study|Withdrawal by Subject|5|||
157102658|NCT01132612|567132845|FG001|Overall Study|Withdrawal by Subject|8|||
157102659|NCT01132612|567132846|FG002|Overall Study|Withdrawal by Subject|19|||
157102660|NCT01132612|567132844|FG000|Overall Study|Administrative problems|5|||
157102661|NCT01132612|567132845|FG001|Overall Study|Administrative problems|1|||
157102662|NCT01132612|567132846|FG002|Overall Study|Administrative problems|52|||
157102663|NCT01132612|567132844|FG000|Overall Study|Lack of Efficacy|23|||
157102664|NCT01132612|567132845|FG001|Overall Study|Lack of Efficacy|22|||
157102665|NCT01132612|567132846|FG002|Overall Study|Lack of Efficacy|73|||
157102666|NCT02252536|567132847|FG000|Overall Study|Lost to Follow-up|5|||
157102667|NCT02252536|567132848|FG001|Overall Study|Lost to Follow-up|3|||
157102668|NCT01438151|567132850|FG000|Overall Study|study terminated|8|||
157102669|NCT00006392|567132857|FG000|Overall Study|Ineligible|11|||
157102670|NCT00006392|567132858|FG001|Overall Study|Ineligible|3|||
157102671|NCT00006392|567132859|FG002|Overall Study|Ineligible|5|||
157102672|NCT00006392|567132860|FG003|Overall Study|Ineligible|5|||
157102673|NCT00006392|567132857|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
157102674|NCT00006392|567132858|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
157102675|NCT00006392|567132859|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
157102676|NCT00006392|567132860|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
157102677|NCT02459769|567132862|FG000|Overall Study|Withdrawal by Subject|7|||
157102678|NCT02459769|567132863|FG001|Overall Study|Withdrawal by Subject|4|||
157102679|NCT02459769|567132864|FG002|Overall Study|Withdrawal by Subject|8|||
157102680|NCT02459769|567132865|FG003|Overall Study|Withdrawal by Subject|5|||
156757218|NCT04346199|565862850|FG000|Overall Study|Withdrawal by Subject|5|||
156757219|NCT04346199|565862851|FG001|Overall Study|Withdrawal by Subject|1|||
156757220|NCT00627926|565862852|FG000|Overall Study|Adverse Event|26|||
156757221|NCT00627926|565862853|FG001|Overall Study|Adverse Event|37|||
156757222|NCT00627926|565862854|FG002|Overall Study|Adverse Event|36|||
156757223|NCT00627926|565862852|FG000|Overall Study|Death|1|||
156757224|NCT00627926|565862853|FG001|Overall Study|Death|0|||
156757225|NCT00627926|565862854|FG002|Overall Study|Death|0|||
156757226|NCT00627926|565862852|FG000|Overall Study|Lost to Follow-up|4|||
156757227|NCT00627926|565862853|FG001|Overall Study|Lost to Follow-up|3|||
156757228|NCT00627926|565862854|FG002|Overall Study|Lost to Follow-up|4|||
156757229|NCT00627926|565862852|FG000|Overall Study|Withdrawal by Subject|2|||
156757230|NCT00627926|565862853|FG001|Overall Study|Withdrawal by Subject|1|||
156757231|NCT00627926|565862854|FG002|Overall Study|Withdrawal by Subject|0|||
156757232|NCT00627926|565862852|FG000|Overall Study|Lack of Efficacy|118|||
156757233|NCT00627926|565862853|FG001|Overall Study|Lack of Efficacy|40|||
156757234|NCT00627926|565862854|FG002|Overall Study|Lack of Efficacy|38|||
156757235|NCT00627926|565862852|FG000|Overall Study|Noncompliance/unspecified|8|||
156757236|NCT00627926|565862853|FG001|Overall Study|Noncompliance/unspecified|23|||
156757237|NCT00627926|565862854|FG002|Overall Study|Noncompliance/unspecified|17|||
156757238|NCT01189461|565862856|FG000|Overall Study|Lack of Efficacy|13|||
156757239|NCT01189461|565862856|FG000|Overall Study|Lost to Follow-up|1|||
156757240|NCT01189461|565862856|FG000|Overall Study|Withdrawal by Subject|6|||
156757241|NCT01189461|565862856|FG000|Overall Study|Protocol Violation|1|||
156757242|NCT01189461|565862856|FG000|Overall Study|Adverse Event|2|||
156757243|NCT01189461|565862856|FG000|Overall Study|Did not meet entrance criteria|3|||
156757244|NCT01189461|565862856|FG000|Overall Study|Other|8|||
156757245|NCT01868165|565862862|FG000|Overall Study|Withdrawal by Subject|36|||
156757246|NCT01868165|565862862|FG000|Overall Study|Physician Decision|2|||
156757247|NCT01868165|565862862|FG000|Overall Study|Lost to Follow-up|3|||
156757248|NCT01868165|565862862|FG000|Overall Study|Death|4|||
156757249|NCT00396383|565862863|FG000|Overall Study|Death|2|||
156757250|NCT00396383|565862863|FG000|Overall Study|Lost to Follow-up|1|||
156757251|NCT01839916|565862864|FG000|Overall Study|Death|9|||
156757252|NCT01839916|565862864|FG000|Overall Study|Physician Decision|17|||
156757253|NCT01839916|565862864|FG000|Overall Study|Relapse|12|||
156757254|NCT01839916|565862864|FG000|Overall Study|GVHD|2|||
156757255|NCT01839916|565862864|FG000|Overall Study|Graft Failure|1|||
156757256|NCT02385110|565862867|FG000|Overall Study|Early Death|1|||
156757257|NCT02385110|565862868|FG001|Overall Study|Early Death|0|||
156757258|NCT00534638|565862869|FG000|Overall Study|Withdrawal by Subject|3|||
156757259|NCT00534638|565862870|FG001|Overall Study|Withdrawal by Subject|4|||
156757260|NCT00534638|565862869|FG000|Overall Study|Migrated/moved from study area|13|||
156757261|NCT00534638|565862870|FG001|Overall Study|Migrated/moved from study area|11|||
156757262|NCT00534638|565862869|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
156757263|NCT00534638|565862870|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
156757264|NCT00534638|565862869|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
156757265|NCT00534638|565862870|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
156757266|NCT00534638|565862869|FG000|Overall Study|Other|1685|||
156757267|NCT00534638|565862870|FG001|Overall Study|Other|902|||
156757268|NCT01124292|565862872|FG000|Overall Study|Lost to Follow-up|2|||
156757269|NCT01124292|565862873|FG001|Overall Study|Lost to Follow-up|4|||
156757270|NCT01124292|565862874|FG002|Overall Study|Lost to Follow-up|3|||
156757271|NCT01124292|565862872|FG000|Overall Study|Physician Decision|0|||
156757272|NCT01124292|565862873|FG001|Overall Study|Physician Decision|3|||
156757273|NCT01124292|565862874|FG002|Overall Study|Physician Decision|2|||
156757274|NCT01124292|565862872|FG000|Overall Study|Withdrawal by Subject|0|||
156757275|NCT01124292|565862873|FG001|Overall Study|Withdrawal by Subject|6|||
156757276|NCT01124292|565862874|FG002|Overall Study|Withdrawal by Subject|2|||
156757277|NCT01124292|565862872|FG000|Overall Study|medical issue unrelated to the study|0|||
156757278|NCT01124292|565862873|FG001|Overall Study|medical issue unrelated to the study|0|||
156757279|NCT01124292|565862874|FG002|Overall Study|medical issue unrelated to the study|2|||
156757280|NCT01124292|565862872|FG000|Overall Study|piercing track closed|0|||
156757281|NCT01124292|565862873|FG001|Overall Study|piercing track closed|2|||
156757282|NCT01124292|565862874|FG002|Overall Study|piercing track closed|1|||
156757283|NCT00481767|565862875|FG000|Overall Study|Withdrawal by Subject|16|||
156757284|NCT00481767|565862876|FG001|Overall Study|Withdrawal by Subject|11|||
156757285|NCT00481767|565862875|FG000|Overall Study|Lost to Follow-up|16|||
156757286|NCT00481767|565862876|FG001|Overall Study|Lost to Follow-up|10|||
156757287|NCT00636636|565862877|FG000|Overall Study|Other reason|4|||
156757288|NCT00636636|565862878|FG001|Overall Study|Other reason|6|||
156757289|NCT00636636|565862877|FG000|Overall Study|Adverse Event|19|||
156757290|NCT00636636|565862878|FG001|Overall Study|Adverse Event|8|||
156757291|NCT00636636|565862877|FG000|Overall Study|Lack of Efficacy|7|||
156757292|NCT00636636|565862878|FG001|Overall Study|Lack of Efficacy|12|||
156757293|NCT00636636|565862877|FG000|Overall Study|Protocol Violation|2|||
156757294|NCT00636636|565862878|FG001|Overall Study|Protocol Violation|2|||
156757295|NCT00636636|565862877|FG000|Overall Study|Lost to Follow-up|0|||
156999512|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999513|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999514|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999515|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999516|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999517|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
156999518|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
156999519|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999520|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
156999521|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
156999522|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
156999523|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
156999524|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
156999525|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999526|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999527|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999528|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999529|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999530|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156999531|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156999532|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999533|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
156999534|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
156999535|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156999536|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
156757296|NCT00636636|565862878|FG001|Overall Study|Lost to Follow-up|1|||
157102681|NCT02459769|567132862|FG000|Overall Study|Lost to Follow-up|1|||
157102682|NCT02459769|567132863|FG001|Overall Study|Lost to Follow-up|0|||
157102683|NCT02459769|567132864|FG002|Overall Study|Lost to Follow-up|1|||
157102684|NCT02459769|567132865|FG003|Overall Study|Lost to Follow-up|0|||
157102685|NCT01186796|567132866|FG000|Overall Study|Adverse Event|3|||
157102686|NCT01186796|567132867|FG001|Overall Study|Adverse Event|0|||
157102687|NCT01186796|567132866|FG000|Overall Study|Withdrawal by Subject|1|||
157102688|NCT01186796|567132867|FG001|Overall Study|Withdrawal by Subject|1|||
157102689|NCT01186796|567132866|FG000|Overall Study|Protocol Violation|0|||
157102690|NCT01186796|567132867|FG001|Overall Study|Protocol Violation|1|||
157102691|NCT03838198|567132869|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
157102692|NCT03838198|567132870|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
157102693|NCT03838198|567132871|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
157102694|NCT03838198|567132872|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
157102695|NCT03838198|567132869|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
157102696|NCT03838198|567132870|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
157102697|NCT03838198|567132871|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
157102698|NCT03838198|567132872|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
157102699|NCT02378220|567132876|FG000|Overall Study|Death|6|||
157102700|NCT02378220|567132877|FG001|Overall Study|Death|1|||
157102701|NCT00578786|567132878|FG000|Overall Study|Adverse Event|27|||
157102702|NCT00578786|567132879|FG001|Overall Study|Adverse Event|37|||
157102703|NCT00578786|567132880|FG002|Overall Study|Adverse Event|17|||
157102704|NCT00578786|567132878|FG000|Overall Study|Lack of Efficacy|2|||
157102705|NCT00578786|567132879|FG001|Overall Study|Lack of Efficacy|5|||
157102706|NCT00578786|567132880|FG002|Overall Study|Lack of Efficacy|2|||
157102707|NCT00578786|567132878|FG000|Overall Study|Early Escape from Prior Study|2|||
157102708|NCT00578786|567132879|FG001|Overall Study|Early Escape from Prior Study|1|||
157102709|NCT00578786|567132880|FG002|Overall Study|Early Escape from Prior Study|2|||
157102710|NCT00578786|567132878|FG000|Overall Study|Withdrawal by Subject|7|||
157102711|NCT00578786|567132879|FG001|Overall Study|Withdrawal by Subject|8|||
157102712|NCT00578786|567132880|FG002|Overall Study|Withdrawal by Subject|5|||
157102713|NCT00578786|567132878|FG000|Overall Study|Protocol Violation|0|||
157102714|NCT00578786|567132879|FG001|Overall Study|Protocol Violation|3|||
157102715|NCT00578786|567132880|FG002|Overall Study|Protocol Violation|1|||
157102716|NCT00578786|567132878|FG000|Overall Study|Physician Decision|1|||
157102717|NCT00578786|567132879|FG001|Overall Study|Physician Decision|0|||
157102718|NCT00578786|567132880|FG002|Overall Study|Physician Decision|1|||
157102719|NCT00578786|567132878|FG000|Overall Study|Sponsor Decision|0|||
157102720|NCT00578786|567132879|FG001|Overall Study|Sponsor Decision|0|||
157102721|NCT00578786|567132880|FG002|Overall Study|Sponsor Decision|1|||
157102722|NCT00578786|567132878|FG000|Overall Study|Lost to Follow-up|0|||
157102723|NCT00578786|567132879|FG001|Overall Study|Lost to Follow-up|4|||
157102724|NCT00578786|567132880|FG002|Overall Study|Lost to Follow-up|0|||
157102725|NCT00578786|567132878|FG000|Overall Study|Pregnancy|0|||
157102726|NCT00578786|567132879|FG001|Overall Study|Pregnancy|1|||
157102727|NCT00578786|567132880|FG002|Overall Study|Pregnancy|0|||
157102728|NCT00578786|567132878|FG000|Overall Study|Not Otherwise Specified|0|||
157102729|NCT00578786|567132879|FG001|Overall Study|Not Otherwise Specified|4|||
157102730|NCT00578786|567132880|FG002|Overall Study|Not Otherwise Specified|1|||
157102731|NCT00578786|567132878|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
157102732|NCT00578786|567132879|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
157102733|NCT00578786|567132880|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
157102734|NCT00312221|567132881|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
157102735|NCT00312221|567132882|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
157102736|NCT00312221|567132883|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
157102737|NCT00312221|567132884|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
157102738|NCT00312221|567132881|FG000|Open-label Run-in Period|Adverse Event|74|||
157102739|NCT00312221|567132882|FG001|Open-label Run-in Period|Adverse Event|0|||
157102740|NCT00312221|567132883|FG002|Open-label Run-in Period|Adverse Event|0|||
157102741|NCT00312221|567132884|FG003|Open-label Run-in Period|Adverse Event|0|||
157102742|NCT00312221|567132881|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
157102743|NCT00312221|567132882|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
157102744|NCT00312221|567132883|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
157102745|NCT00312221|567132884|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
157102746|NCT00312221|567132881|FG000|Open-label Run-in Period|Administrative|42|||
157102747|NCT00312221|567132882|FG001|Open-label Run-in Period|Administrative|0|||
157102748|NCT00312221|567132883|FG002|Open-label Run-in Period|Administrative|0|||
157102749|NCT00312221|567132884|FG003|Open-label Run-in Period|Administrative|0|||
156757297|NCT00636636|565862877|FG000|Overall Study|Death|0|||
157102750|NCT00312221|567132881|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
157102751|NCT00312221|567132882|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
157102752|NCT00312221|567132883|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
157102753|NCT00312221|567132884|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
157102754|NCT00312221|567132881|FG000|Open-label Run-in Period|Did not qualify|5|||
157102755|NCT00312221|567132882|FG001|Open-label Run-in Period|Did not qualify|0|||
157102756|NCT00312221|567132883|FG002|Open-label Run-in Period|Did not qualify|0|||
157102757|NCT00312221|567132884|FG003|Open-label Run-in Period|Did not qualify|0|||
157102758|NCT00312221|567132881|FG000|Double-blind Phase|Withdrawal by Subject|0|||
157102759|NCT00312221|567132882|FG001|Double-blind Phase|Withdrawal by Subject|6|||
157102760|NCT00312221|567132883|FG002|Double-blind Phase|Withdrawal by Subject|8|||
157102761|NCT00312221|567132884|FG003|Double-blind Phase|Withdrawal by Subject|7|||
157102762|NCT00312221|567132881|FG000|Double-blind Phase|Adverse Event|0|||
157102763|NCT00312221|567132882|FG001|Double-blind Phase|Adverse Event|10|||
157102764|NCT00312221|567132883|FG002|Double-blind Phase|Adverse Event|19|||
157102765|NCT00312221|567132884|FG003|Double-blind Phase|Adverse Event|18|||
157102766|NCT00312221|567132881|FG000|Double-blind Phase|Lost to Follow-up|0|||
157102767|NCT00312221|567132882|FG001|Double-blind Phase|Lost to Follow-up|0|||
157102768|NCT00312221|567132883|FG002|Double-blind Phase|Lost to Follow-up|2|||
157102769|NCT00312221|567132884|FG003|Double-blind Phase|Lost to Follow-up|2|||
157102770|NCT00312221|567132881|FG000|Double-blind Phase|Administrative|0|||
157102771|NCT00312221|567132882|FG001|Double-blind Phase|Administrative|26|||
157102772|NCT00312221|567132883|FG002|Double-blind Phase|Administrative|37|||
157102773|NCT00312221|567132884|FG003|Double-blind Phase|Administrative|33|||
157102774|NCT00312221|567132881|FG000|Double-blind Phase|Lack of Efficacy|0|||
157102775|NCT00312221|567132882|FG001|Double-blind Phase|Lack of Efficacy|17|||
157102776|NCT00312221|567132883|FG002|Double-blind Phase|Lack of Efficacy|6|||
157102777|NCT00312221|567132884|FG003|Double-blind Phase|Lack of Efficacy|10|||
157102778|NCT02060721|567132885|FG000|Overall Study|Lost to Follow-up|1|||
157102779|NCT02060721|567132885|FG000|Overall Study|Physician Decision|2|||
157102780|NCT02060721|567132885|FG000|Overall Study|Death|14|||
157102781|NCT02060721|567132885|FG000|Overall Study|Withdrawal by Subject|2|||
157102782|NCT02060721|567132885|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
157102783|NCT05105789|567132886|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
157102784|NCT05211739|567132890|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
156757298|NCT00636636|565862878|FG001|Overall Study|Death|1|||
156757299|NCT00636636|565862877|FG000|Overall Study|Withdrawal by Subject|4|||
156757300|NCT00636636|565862878|FG001|Overall Study|Withdrawal by Subject|9|||
156757301|NCT00524173|565862879|FG000|Overall Study|Lost to Follow-up|0|||
156757302|NCT00524173|565862880|FG001|Overall Study|Lost to Follow-up|1|||
156757303|NCT00524173|565862879|FG000|Overall Study|Death|1|||
156757304|NCT00524173|565862880|FG001|Overall Study|Death|0|||
156757305|NCT00524173|565862879|FG000|Overall Study|Had not reached endpoint at study close|4|||
156757306|NCT00524173|565862880|FG001|Overall Study|Had not reached endpoint at study close|1|||
156757307|NCT00103285|565864737|FG000|Induction|Adverse Event|14|||
156757308|NCT00103285|565864738|FG001|Induction|Adverse Event|0|||
156757309|NCT00103285|565864739|FG002|Induction|Adverse Event|0|||
156757310|NCT00103285|565864740|FG003|Induction|Adverse Event|0|||
156757311|NCT00103285|565864741|FG004|Induction|Adverse Event|0|||
156757312|NCT00103285|565864742|FG005|Induction|Adverse Event|0|||
156757313|NCT00103285|565864743|FG006|Induction|Adverse Event|0|||
156757314|NCT00103285|565864744|FG007|Induction|Adverse Event|0|||
156757315|NCT00103285|565864737|FG000|Induction|Death|24|||
156757316|NCT00103285|565864738|FG001|Induction|Death|0|||
156757317|NCT00103285|565864739|FG002|Induction|Death|0|||
156757318|NCT00103285|565864740|FG003|Induction|Death|0|||
156757319|NCT00103285|565864741|FG004|Induction|Death|0|||
156757320|NCT00103285|565864742|FG005|Induction|Death|0|||
156757321|NCT00103285|565864743|FG006|Induction|Death|0|||
156757322|NCT00103285|565864744|FG007|Induction|Death|0|||
156757323|NCT00103285|565864737|FG000|Induction|Physician Decision|103|||
156757324|NCT00103285|565864738|FG001|Induction|Physician Decision|0|||
157102785|NCT05211739|567132891|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
157102786|NCT05211739|567132890|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
157102787|NCT05211739|567132891|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
156757325|NCT00103285|565864739|FG002|Induction|Physician Decision|0|||
156757326|NCT00103285|565864740|FG003|Induction|Physician Decision|0|||
156757327|NCT00103285|565864741|FG004|Induction|Physician Decision|0|||
157102788|NCT05211739|567132890|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
157102789|NCT05211739|567132891|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
156757328|NCT00103285|565864742|FG005|Induction|Physician Decision|0|||
156757329|NCT00103285|565864743|FG006|Induction|Physician Decision|0|||
156757330|NCT00103285|565864744|FG007|Induction|Physician Decision|0|||
156757331|NCT00103285|565864737|FG000|Induction|Withdrawal by Subject|1|||
156757332|NCT00103285|565864738|FG001|Induction|Withdrawal by Subject|0|||
156757333|NCT00103285|565864739|FG002|Induction|Withdrawal by Subject|0|||
156757334|NCT00103285|565864740|FG003|Induction|Withdrawal by Subject|0|||
156757335|NCT00103285|565864741|FG004|Induction|Withdrawal by Subject|0|||
156757336|NCT00103285|565864742|FG005|Induction|Withdrawal by Subject|0|||
156757337|NCT00103285|565864743|FG006|Induction|Withdrawal by Subject|0|||
156757338|NCT00103285|565864744|FG007|Induction|Withdrawal by Subject|0|||
156999537|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
156999538|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999539|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999540|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999541|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999542|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999543|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999544|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999545|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999546|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999547|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
156999548|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999549|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
156999550|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
156999551|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999552|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999553|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999554|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999555|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999556|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
156999557|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999558|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
156999559|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999560|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999561|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999562|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999563|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
156999564|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Death|0|||
156999565|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Death|0|||
156999566|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Death|0|||
156999567|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Death|0|||
156999568|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Death|0|||
156999569|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Death|0|||
156999570|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Death|0|||
156999571|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Death|0|||
156999572|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Death|0|||
156999573|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Death|1|||
156999574|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Death|0|||
156999575|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Death|0|||
156999576|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Death|0|||
156999577|NCT04936035|566749985|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999578|NCT04936035|566749986|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999579|NCT04936035|566749987|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999580|NCT04936035|566749988|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999581|NCT04936035|566749989|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999582|NCT04936035|566749990|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
156999583|NCT04936035|566749991|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999584|NCT04936035|566749992|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999585|NCT04936035|566749993|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999586|NCT04936035|566749994|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
156999587|NCT04936035|566749995|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
156999588|NCT04936035|566749996|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999589|NCT04936035|566749997|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
156999590|NCT03673124|566749998|FG000|Overall Study|Eligible with no protocol therapy|2|||
156999591|NCT05827926|566750003|FG000|Overall Study|Lost to Follow-up|1|||
156999592|NCT05827926|566750004|FG001|Overall Study|Lost to Follow-up|0|||
156999593|NCT05827926|566750005|FG002|Overall Study|Lost to Follow-up|0|||
156757339|NCT00103285|565864737|FG000|Induction|Ineligible|43|||
156757340|NCT00103285|565864738|FG001|Induction|Ineligible|0|||
156757341|NCT00103285|565864739|FG002|Induction|Ineligible|0|||
156757342|NCT00103285|565864740|FG003|Induction|Ineligible|0|||
156757343|NCT00103285|565864741|FG004|Induction|Ineligible|0|||
156757344|NCT00103285|565864742|FG005|Induction|Ineligible|0|||
156757345|NCT00103285|565864743|FG006|Induction|Ineligible|0|||
156757346|NCT00103285|565864744|FG007|Induction|Ineligible|0|||
156757347|NCT00103285|565864737|FG000|Induction|Refusal|906|||
156757348|NCT00103285|565864738|FG001|Induction|Refusal|0|||
156757349|NCT00103285|565864739|FG002|Induction|Refusal|0|||
156757350|NCT00103285|565864740|FG003|Induction|Refusal|0|||
156757351|NCT00103285|565864741|FG004|Induction|Refusal|0|||
156757352|NCT00103285|565864742|FG005|Induction|Refusal|0|||
156757353|NCT00103285|565864743|FG006|Induction|Refusal|0|||
156757354|NCT00103285|565864744|FG007|Induction|Refusal|0|||
156757355|NCT00103285|565864737|FG000|Induction|Other|258|||
156757356|NCT00103285|565864738|FG001|Induction|Other|0|||
156757357|NCT00103285|565864739|FG002|Induction|Other|0|||
156757358|NCT00103285|565864740|FG003|Induction|Other|0|||
156757359|NCT00103285|565864741|FG004|Induction|Other|0|||
156757360|NCT00103285|565864742|FG005|Induction|Other|0|||
156757361|NCT00103285|565864743|FG006|Induction|Other|0|||
156757362|NCT00103285|565864744|FG007|Induction|Other|0|||
156757363|NCT00103285|565864737|FG000|Response Assignment|Adverse Event|0|||
156757364|NCT00103285|565864738|FG001|Response Assignment|Adverse Event|8|||
156757365|NCT00103285|565864739|FG002|Response Assignment|Adverse Event|3|||
156757366|NCT00103285|565864740|FG003|Response Assignment|Adverse Event|2|||
156757367|NCT00103285|565864741|FG004|Response Assignment|Adverse Event|3|||
156757368|NCT00103285|565864742|FG005|Response Assignment|Adverse Event|1|||
156757369|NCT00103285|565864743|FG006|Response Assignment|Adverse Event|1|||
156757370|NCT00103285|565864744|FG007|Response Assignment|Adverse Event|2|||
156757371|NCT00103285|565864737|FG000|Response Assignment|Death|0|||
156757372|NCT00103285|565864738|FG001|Response Assignment|Death|5|||
156757373|NCT00103285|565864739|FG002|Response Assignment|Death|2|||
156757374|NCT00103285|565864740|FG003|Response Assignment|Death|2|||
156757375|NCT00103285|565864741|FG004|Response Assignment|Death|3|||
156757376|NCT00103285|565864742|FG005|Response Assignment|Death|1|||
156757377|NCT00103285|565864743|FG006|Response Assignment|Death|0|||
156757378|NCT00103285|565864744|FG007|Response Assignment|Death|8|||
156999594|NCT05827926|566750006|FG003|Overall Study|Lost to Follow-up|0|||
156999595|NCT05827926|566750007|FG004|Overall Study|Lost to Follow-up|0|||
156999596|NCT05827926|566750008|FG005|Overall Study|Lost to Follow-up|1|||
156999597|NCT05827926|566750009|FG006|Overall Study|Lost to Follow-up|0|||
156999598|NCT05827926|566750010|FG007|Overall Study|Lost to Follow-up|0|||
156999599|NCT05827926|566750011|FG008|Overall Study|Lost to Follow-up|0|||
156999600|NCT05827926|566750012|FG009|Overall Study|Lost to Follow-up|0|||
156999601|NCT05827926|566750013|FG010|Overall Study|Lost to Follow-up|0|||
156999602|NCT05827926|566750014|FG011|Overall Study|Lost to Follow-up|0|||
156999603|NCT05827926|566750015|FG012|Overall Study|Lost to Follow-up|1|||
156999604|NCT05827926|566750016|FG013|Overall Study|Lost to Follow-up|1|||
156999605|NCT05827926|566750017|FG014|Overall Study|Lost to Follow-up|0|||
156999606|NCT05827926|566750018|FG015|Overall Study|Lost to Follow-up|1|||
156999607|NCT05827926|566750019|FG016|Overall Study|Lost to Follow-up|2|||
156999608|NCT05827926|566750020|FG017|Overall Study|Lost to Follow-up|0|||
156999609|NCT05827926|566750021|FG018|Overall Study|Lost to Follow-up|0|||
156999610|NCT05827926|566750022|FG019|Overall Study|Lost to Follow-up|0|||
156999611|NCT05827926|566750023|FG020|Overall Study|Lost to Follow-up|1|||
156999612|NCT05827926|566750024|FG021|Overall Study|Lost to Follow-up|2|||
156999613|NCT05827926|566750025|FG022|Overall Study|Lost to Follow-up|1|||
156999614|NCT05827926|566750026|FG023|Overall Study|Lost to Follow-up|1|||
156999615|NCT05827926|566750027|FG024|Overall Study|Lost to Follow-up|2|||
156999616|NCT05827926|566750028|FG025|Overall Study|Lost to Follow-up|1|||
156757379|NCT00103285|565864737|FG000|Response Assignment|Lost to Follow-up|0|||
156757380|NCT00103285|565864738|FG001|Response Assignment|Lost to Follow-up|9|||
156757381|NCT00103285|565864739|FG002|Response Assignment|Lost to Follow-up|5|||
156757382|NCT00103285|565864740|FG003|Response Assignment|Lost to Follow-up|5|||
156757383|NCT00103285|565864741|FG004|Response Assignment|Lost to Follow-up|1|||
156999617|NCT05827926|566750029|FG026|Overall Study|Lost to Follow-up|4|||
156999618|NCT05827926|566750030|FG027|Overall Study|Lost to Follow-up|1|||
156999619|NCT05827926|566750031|FG028|Overall Study|Lost to Follow-up|2|||
156757384|NCT00103285|565864742|FG005|Response Assignment|Lost to Follow-up|2|||
156999620|NCT05827926|566750032|FG029|Overall Study|Lost to Follow-up|1|||
156999621|NCT05827926|566750033|FG030|Overall Study|Lost to Follow-up|5|||
156999622|NCT05827926|566750034|FG031|Overall Study|Lost to Follow-up|0|||
156999623|NCT05827926|566750035|FG032|Overall Study|Lost to Follow-up|3|||
156999624|NCT05827926|566750036|FG033|Overall Study|Lost to Follow-up|2|||
156999625|NCT05827926|566750037|FG034|Overall Study|Lost to Follow-up|1|||
156999626|NCT05827926|566750038|FG035|Overall Study|Lost to Follow-up|3|||
156999627|NCT05827926|566750039|FG036|Overall Study|Lost to Follow-up|4|||
156999628|NCT05827926|566750003|FG000|Overall Study|Withdrawal by Subject|1|||
156999629|NCT05827926|566750004|FG001|Overall Study|Withdrawal by Subject|0|||
156999630|NCT05827926|566750005|FG002|Overall Study|Withdrawal by Subject|1|||
156999631|NCT05827926|566750006|FG003|Overall Study|Withdrawal by Subject|1|||
157102790|NCT05211739|567132890|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
157102791|NCT05211739|567132891|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
157102792|NCT04178967|567132892|FG000|Induction Period|Adverse Event|4|||
157102793|NCT04178967|567132893|FG001|Induction Period|Adverse Event|6|||
157102794|NCT04178967|567132894|FG002|Induction Period|Adverse Event|0|||
157102795|NCT04178967|567132895|FG003|Induction Period|Adverse Event|0|||
157102796|NCT04178967|567132896|FG004|Induction Period|Adverse Event|0|||
157102797|NCT04178967|567132897|FG005|Induction Period|Adverse Event|0|||
157102798|NCT04178967|567132898|FG006|Induction Period|Adverse Event|0|||
157102799|NCT04178967|567132899|FG007|Induction Period|Adverse Event|0|||
157102800|NCT04178967|567132900|FG008|Induction Period|Adverse Event|0|||
157102801|NCT04178967|567132901|FG009|Induction Period|Adverse Event|0|||
157102802|NCT04178967|567132902|FG010|Induction Period|Adverse Event|0|||
157102803|NCT04178967|567132892|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
157102804|NCT04178967|567132893|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
157102805|NCT04178967|567132894|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
157102806|NCT04178967|567132895|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
157102807|NCT04178967|567132896|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
157102808|NCT04178967|567132897|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
157102809|NCT04178967|567132898|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
157102810|NCT04178967|567132899|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
157102811|NCT04178967|567132900|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
157102812|NCT04178967|567132901|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
157102813|NCT04178967|567132902|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
157102814|NCT04178967|567132892|FG000|Induction Period|Lack of Efficacy|4|||
157102815|NCT04178967|567132893|FG001|Induction Period|Lack of Efficacy|1|||
157102816|NCT04178967|567132894|FG002|Induction Period|Lack of Efficacy|0|||
157102817|NCT04178967|567132895|FG003|Induction Period|Lack of Efficacy|0|||
157102818|NCT04178967|567132896|FG004|Induction Period|Lack of Efficacy|0|||
157102819|NCT04178967|567132897|FG005|Induction Period|Lack of Efficacy|0|||
157102820|NCT04178967|567132898|FG006|Induction Period|Lack of Efficacy|0|||
157102821|NCT04178967|567132899|FG007|Induction Period|Lack of Efficacy|0|||
157102822|NCT04178967|567132900|FG008|Induction Period|Lack of Efficacy|0|||
157102823|NCT04178967|567132901|FG009|Induction Period|Lack of Efficacy|0|||
157102824|NCT04178967|567132902|FG010|Induction Period|Lack of Efficacy|0|||
157102825|NCT04178967|567132892|FG000|Induction Period|Protocol Violation|0|||
157102826|NCT04178967|567132893|FG001|Induction Period|Protocol Violation|6|||
157102827|NCT04178967|567132894|FG002|Induction Period|Protocol Violation|0|||
157102828|NCT04178967|567132895|FG003|Induction Period|Protocol Violation|0|||
157102829|NCT04178967|567132896|FG004|Induction Period|Protocol Violation|0|||
157102830|NCT04178967|567132897|FG005|Induction Period|Protocol Violation|0|||
157102831|NCT04178967|567132898|FG006|Induction Period|Protocol Violation|0|||
157102832|NCT04178967|567132899|FG007|Induction Period|Protocol Violation|0|||
157102833|NCT04178967|567132900|FG008|Induction Period|Protocol Violation|0|||
157102834|NCT04178967|567132901|FG009|Induction Period|Protocol Violation|0|||
157102835|NCT04178967|567132902|FG010|Induction Period|Protocol Violation|0|||
157102836|NCT04178967|567132892|FG000|Induction Period|Withdrawal by Subject|6|||
157102837|NCT04178967|567132893|FG001|Induction Period|Withdrawal by Subject|4|||
157102838|NCT04178967|567132894|FG002|Induction Period|Withdrawal by Subject|0|||
157102839|NCT04178967|567132895|FG003|Induction Period|Withdrawal by Subject|0|||
157102840|NCT04178967|567132896|FG004|Induction Period|Withdrawal by Subject|0|||
157102841|NCT04178967|567132897|FG005|Induction Period|Withdrawal by Subject|0|||
157102842|NCT04178967|567132898|FG006|Induction Period|Withdrawal by Subject|0|||
157102843|NCT04178967|567132899|FG007|Induction Period|Withdrawal by Subject|0|||
157102844|NCT04178967|567132900|FG008|Induction Period|Withdrawal by Subject|0|||
157102845|NCT04178967|567132901|FG009|Induction Period|Withdrawal by Subject|0|||
157102846|NCT04178967|567132902|FG010|Induction Period|Withdrawal by Subject|0|||
157102847|NCT04178967|567132892|FG000|Induction Period|Lost to Follow-up|2|||
157102848|NCT04178967|567132893|FG001|Induction Period|Lost to Follow-up|0|||
157102849|NCT04178967|567132894|FG002|Induction Period|Lost to Follow-up|0|||
157102850|NCT04178967|567132895|FG003|Induction Period|Lost to Follow-up|0|||
157102851|NCT04178967|567132896|FG004|Induction Period|Lost to Follow-up|0|||
157102852|NCT04178967|567132897|FG005|Induction Period|Lost to Follow-up|0|||
157102853|NCT04178967|567132898|FG006|Induction Period|Lost to Follow-up|0|||
157102854|NCT04178967|567132899|FG007|Induction Period|Lost to Follow-up|0|||
157102855|NCT04178967|567132900|FG008|Induction Period|Lost to Follow-up|0|||
157102856|NCT04178967|567132901|FG009|Induction Period|Lost to Follow-up|0|||
157102857|NCT04178967|567132902|FG010|Induction Period|Lost to Follow-up|0|||
157102858|NCT04178967|567132892|FG000|Induction Period|Participant Missed Study Visits|0|||
157102859|NCT04178967|567132893|FG001|Induction Period|Participant Missed Study Visits|1|||
157102860|NCT04178967|567132894|FG002|Induction Period|Participant Missed Study Visits|0|||
157102861|NCT04178967|567132895|FG003|Induction Period|Participant Missed Study Visits|0|||
157102862|NCT04178967|567132896|FG004|Induction Period|Participant Missed Study Visits|0|||
157102863|NCT04178967|567132897|FG005|Induction Period|Participant Missed Study Visits|0|||
157102864|NCT04178967|567132898|FG006|Induction Period|Participant Missed Study Visits|0|||
157102865|NCT04178967|567132899|FG007|Induction Period|Participant Missed Study Visits|0|||
157102866|NCT04178967|567132900|FG008|Induction Period|Participant Missed Study Visits|0|||
157102867|NCT04178967|567132901|FG009|Induction Period|Participant Missed Study Visits|0|||
157102868|NCT04178967|567132902|FG010|Induction Period|Participant Missed Study Visits|0|||
157102869|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102870|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102871|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102872|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102873|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102874|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
157102875|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
157102876|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
157102877|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102878|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102879|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
157102880|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102881|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102882|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102883|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102884|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102885|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
157102886|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102887|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102888|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102889|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102890|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
157102891|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102892|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102893|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102894|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
157102895|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102896|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102897|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102898|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102899|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102900|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102901|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
157102902|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102903|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102904|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102905|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102906|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102907|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102908|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
156757385|NCT00103285|565864743|FG006|Response Assignment|Lost to Follow-up|2|||
156757386|NCT00103285|565864744|FG007|Response Assignment|Lost to Follow-up|5|||
156757387|NCT00103285|565864737|FG000|Response Assignment|Physician Decision|0|||
156757388|NCT00103285|565864738|FG001|Response Assignment|Physician Decision|13|||
156757389|NCT00103285|565864739|FG002|Response Assignment|Physician Decision|14|||
156757390|NCT00103285|565864740|FG003|Response Assignment|Physician Decision|9|||
156999632|NCT05827926|566750007|FG004|Overall Study|Withdrawal by Subject|0|||
156999633|NCT05827926|566750008|FG005|Overall Study|Withdrawal by Subject|0|||
156999634|NCT05827926|566750009|FG006|Overall Study|Withdrawal by Subject|0|||
156999635|NCT05827926|566750010|FG007|Overall Study|Withdrawal by Subject|0|||
156999636|NCT05827926|566750011|FG008|Overall Study|Withdrawal by Subject|0|||
156999637|NCT05827926|566750012|FG009|Overall Study|Withdrawal by Subject|0|||
156999638|NCT05827926|566750013|FG010|Overall Study|Withdrawal by Subject|0|||
156999639|NCT05827926|566750014|FG011|Overall Study|Withdrawal by Subject|0|||
156999640|NCT05827926|566750015|FG012|Overall Study|Withdrawal by Subject|1|||
156999641|NCT05827926|566750016|FG013|Overall Study|Withdrawal by Subject|1|||
156999642|NCT05827926|566750017|FG014|Overall Study|Withdrawal by Subject|1|||
156999643|NCT05827926|566750018|FG015|Overall Study|Withdrawal by Subject|2|||
156999644|NCT05827926|566750019|FG016|Overall Study|Withdrawal by Subject|1|||
156999645|NCT05827926|566750020|FG017|Overall Study|Withdrawal by Subject|1|||
156999646|NCT05827926|566750021|FG018|Overall Study|Withdrawal by Subject|0|||
156999647|NCT05827926|566750022|FG019|Overall Study|Withdrawal by Subject|0|||
156999648|NCT05827926|566750023|FG020|Overall Study|Withdrawal by Subject|1|||
156999649|NCT05827926|566750024|FG021|Overall Study|Withdrawal by Subject|0|||
156999650|NCT05827926|566750025|FG022|Overall Study|Withdrawal by Subject|0|||
156999651|NCT05827926|566750026|FG023|Overall Study|Withdrawal by Subject|2|||
156999652|NCT05827926|566750027|FG024|Overall Study|Withdrawal by Subject|1|||
156999653|NCT05827926|566750028|FG025|Overall Study|Withdrawal by Subject|0|||
156999654|NCT05827926|566750029|FG026|Overall Study|Withdrawal by Subject|0|||
156999655|NCT05827926|566750030|FG027|Overall Study|Withdrawal by Subject|1|||
156999656|NCT05827926|566750031|FG028|Overall Study|Withdrawal by Subject|0|||
156999657|NCT05827926|566750032|FG029|Overall Study|Withdrawal by Subject|0|||
156999658|NCT05827926|566750033|FG030|Overall Study|Withdrawal by Subject|0|||
156999659|NCT05827926|566750034|FG031|Overall Study|Withdrawal by Subject|2|||
156999660|NCT05827926|566750035|FG032|Overall Study|Withdrawal by Subject|0|||
156999661|NCT05827926|566750036|FG033|Overall Study|Withdrawal by Subject|0|||
156999662|NCT05827926|566750037|FG034|Overall Study|Withdrawal by Subject|0|||
156999663|NCT05827926|566750038|FG035|Overall Study|Withdrawal by Subject|0|||
156999664|NCT05827926|566750039|FG036|Overall Study|Withdrawal by Subject|1|||
156999665|NCT05827926|566750003|FG000|Overall Study|Other Than Specified|0|||
156999666|NCT05827926|566750004|FG001|Overall Study|Other Than Specified|0|||
156999667|NCT05827926|566750005|FG002|Overall Study|Other Than Specified|0|||
156999668|NCT05827926|566750006|FG003|Overall Study|Other Than Specified|1|||
156999669|NCT05827926|566750007|FG004|Overall Study|Other Than Specified|0|||
156999670|NCT05827926|566750008|FG005|Overall Study|Other Than Specified|0|||
156999671|NCT05827926|566750009|FG006|Overall Study|Other Than Specified|1|||
156999672|NCT05827926|566750010|FG007|Overall Study|Other Than Specified|0|||
156999673|NCT05827926|566750011|FG008|Overall Study|Other Than Specified|0|||
156999674|NCT05827926|566750012|FG009|Overall Study|Other Than Specified|0|||
156999675|NCT05827926|566750013|FG010|Overall Study|Other Than Specified|0|||
156999676|NCT05827926|566750014|FG011|Overall Study|Other Than Specified|0|||
156999677|NCT05827926|566750015|FG012|Overall Study|Other Than Specified|0|||
156999678|NCT05827926|566750016|FG013|Overall Study|Other Than Specified|1|||
156999679|NCT05827926|566750017|FG014|Overall Study|Other Than Specified|0|||
156999680|NCT05827926|566750018|FG015|Overall Study|Other Than Specified|1|||
156999681|NCT05827926|566750019|FG016|Overall Study|Other Than Specified|0|||
156999682|NCT05827926|566750020|FG017|Overall Study|Other Than Specified|0|||
156999683|NCT05827926|566750021|FG018|Overall Study|Other Than Specified|0|||
156999684|NCT05827926|566750022|FG019|Overall Study|Other Than Specified|0|||
156999685|NCT05827926|566750023|FG020|Overall Study|Other Than Specified|0|||
156999686|NCT05827926|566750024|FG021|Overall Study|Other Than Specified|1|||
156999687|NCT05827926|566750025|FG022|Overall Study|Other Than Specified|1|||
156999688|NCT05827926|566750026|FG023|Overall Study|Other Than Specified|0|||
156757391|NCT00103285|565864741|FG004|Response Assignment|Physician Decision|13|||
156999689|NCT05827926|566750027|FG024|Overall Study|Other Than Specified|0|||
156999690|NCT05827926|566750028|FG025|Overall Study|Other Than Specified|1|||
156999691|NCT05827926|566750029|FG026|Overall Study|Other Than Specified|0|||
156999692|NCT05827926|566750030|FG027|Overall Study|Other Than Specified|0|||
156999693|NCT05827926|566750031|FG028|Overall Study|Other Than Specified|0|||
156999694|NCT05827926|566750032|FG029|Overall Study|Other Than Specified|0|||
156999695|NCT05827926|566750033|FG030|Overall Study|Other Than Specified|0|||
156999696|NCT05827926|566750034|FG031|Overall Study|Other Than Specified|1|||
156999697|NCT05827926|566750035|FG032|Overall Study|Other Than Specified|0|||
156999698|NCT05827926|566750036|FG033|Overall Study|Other Than Specified|0|||
156999699|NCT05827926|566750037|FG034|Overall Study|Other Than Specified|0|||
156999700|NCT05827926|566750038|FG035|Overall Study|Other Than Specified|0|||
156999701|NCT05827926|566750039|FG036|Overall Study|Other Than Specified|0|||
156999702|NCT05827926|566750003|FG000|Overall Study|Physician Decision|0|||
156999703|NCT05827926|566750004|FG001|Overall Study|Physician Decision|0|||
156999704|NCT05827926|566750005|FG002|Overall Study|Physician Decision|0|||
156999705|NCT05827926|566750006|FG003|Overall Study|Physician Decision|0|||
156999706|NCT05827926|566750007|FG004|Overall Study|Physician Decision|0|||
156999707|NCT05827926|566750008|FG005|Overall Study|Physician Decision|0|||
156999708|NCT05827926|566750009|FG006|Overall Study|Physician Decision|0|||
156999709|NCT05827926|566750010|FG007|Overall Study|Physician Decision|0|||
156999710|NCT05827926|566750011|FG008|Overall Study|Physician Decision|0|||
156999711|NCT05827926|566750012|FG009|Overall Study|Physician Decision|0|||
156999712|NCT05827926|566750013|FG010|Overall Study|Physician Decision|0|||
156999713|NCT05827926|566750014|FG011|Overall Study|Physician Decision|0|||
156999714|NCT05827926|566750015|FG012|Overall Study|Physician Decision|0|||
156999715|NCT05827926|566750016|FG013|Overall Study|Physician Decision|0|||
156999716|NCT05827926|566750017|FG014|Overall Study|Physician Decision|0|||
156999717|NCT05827926|566750018|FG015|Overall Study|Physician Decision|0|||
156999718|NCT05827926|566750019|FG016|Overall Study|Physician Decision|0|||
156999719|NCT05827926|566750020|FG017|Overall Study|Physician Decision|0|||
156999720|NCT05827926|566750021|FG018|Overall Study|Physician Decision|1|||
156999721|NCT05827926|566750022|FG019|Overall Study|Physician Decision|0|||
156999722|NCT05827926|566750023|FG020|Overall Study|Physician Decision|0|||
156999723|NCT05827926|566750024|FG021|Overall Study|Physician Decision|0|||
156999724|NCT05827926|566750025|FG022|Overall Study|Physician Decision|0|||
156999725|NCT05827926|566750026|FG023|Overall Study|Physician Decision|0|||
156999726|NCT05827926|566750027|FG024|Overall Study|Physician Decision|0|||
156999727|NCT05827926|566750028|FG025|Overall Study|Physician Decision|0|||
156999728|NCT05827926|566750029|FG026|Overall Study|Physician Decision|0|||
156999729|NCT05827926|566750030|FG027|Overall Study|Physician Decision|0|||
156999730|NCT05827926|566750031|FG028|Overall Study|Physician Decision|0|||
156999731|NCT05827926|566750032|FG029|Overall Study|Physician Decision|0|||
156999732|NCT05827926|566750033|FG030|Overall Study|Physician Decision|0|||
156999733|NCT05827926|566750034|FG031|Overall Study|Physician Decision|0|||
156999734|NCT05827926|566750035|FG032|Overall Study|Physician Decision|0|||
156999735|NCT05827926|566750036|FG033|Overall Study|Physician Decision|0|||
156999736|NCT05827926|566750037|FG034|Overall Study|Physician Decision|0|||
156999737|NCT05827926|566750038|FG035|Overall Study|Physician Decision|0|||
156999738|NCT05827926|566750039|FG036|Overall Study|Physician Decision|0|||
156999739|NCT01744691|566750046|FG000|Overall Study|Progressive Disease|18|||
156999740|NCT01744691|566750046|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
156999741|NCT01744691|566750046|FG000|Overall Study|Withdrawal of consent for treatment|3|||
156999742|NCT01744691|566750046|FG000|Overall Study|Physician Decision|4|||
156999743|NCT02701361|566750048|FG000|Overall Study|Lost to Follow-up|5|||
156999744|NCT02701361|566750049|FG001|Overall Study|Lost to Follow-up|2|||
156999745|NCT02701361|566750050|FG002|Overall Study|Lost to Follow-up|1|||
156999746|NCT02701361|566750048|FG000|Overall Study|Withdrawal by Subject|4|||
156999747|NCT02701361|566750049|FG001|Overall Study|Withdrawal by Subject|0|||
156999748|NCT02701361|566750050|FG002|Overall Study|Withdrawal by Subject|0|||
156999749|NCT02701361|566750048|FG000|Overall Study|timed out in rehab center|0|||
156999750|NCT02701361|566750049|FG001|Overall Study|timed out in rehab center|1|||
156999751|NCT02701361|566750050|FG002|Overall Study|timed out in rehab center|0|||
156999752|NCT02701361|566750048|FG000|Overall Study|incarceration|0|||
156999753|NCT02701361|566750049|FG001|Overall Study|incarceration|0|||
156999754|NCT02701361|566750050|FG002|Overall Study|incarceration|1|||
156999755|NCT04588480|566750051|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
156999756|NCT04588480|566750052|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
156999757|NCT04588480|566750053|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
156999758|NCT04588480|566750051|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
156999759|NCT04588480|566750052|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
156999760|NCT04588480|566750053|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
156999761|NCT01242085|566750054|FG000|Overall Study|Withdrawal by Subject|4|||
156999762|NCT01242085|566750055|FG001|Overall Study|Withdrawal by Subject|2|||
156999763|NCT01242085|566750056|FG002|Overall Study|Withdrawal by Subject|0|||
156999764|NCT01242085|566750054|FG000|Overall Study|medically unable to have surgery|4|||
156999765|NCT01242085|566750055|FG001|Overall Study|medically unable to have surgery|5|||
156999766|NCT01242085|566750056|FG002|Overall Study|medically unable to have surgery|0|||
156999767|NCT01178762|566750057|FG000|Overall Study|Lost to Follow-up|15|||
157102909|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102910|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102911|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
156999768|NCT02322216|566750060|FG000|Overall Study|Adverse Event|1|||
156999769|NCT02322216|566750061|FG001|Overall Study|Adverse Event|0|||
156999770|NCT02322216|566750060|FG000|Overall Study|Withdrawal by Subject|1|||
156999771|NCT02322216|566750061|FG001|Overall Study|Withdrawal by Subject|4|||
156999772|NCT02430532|566750063|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
156999773|NCT02430532|566750064|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
157102912|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
157102913|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102914|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102915|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102916|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102917|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
157102918|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
157102919|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102920|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
157102921|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102922|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102923|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
157102924|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
157102925|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
157102926|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
157102927|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
157102928|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
157102929|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
157102930|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
157102931|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
157102932|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
157102933|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
157102934|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
157102935|NCT04178967|567132892|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102936|NCT04178967|567132893|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102937|NCT04178967|567132894|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102938|NCT04178967|567132895|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
157102939|NCT04178967|567132896|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102940|NCT04178967|567132897|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
157102941|NCT04178967|567132898|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
157102942|NCT04178967|567132899|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
157102943|NCT04178967|567132900|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102944|NCT04178967|567132901|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102945|NCT04178967|567132902|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
157102946|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102947|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102948|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102949|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102950|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102951|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102952|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102953|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102954|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
156757392|NCT00103285|565864742|FG005|Response Assignment|Physician Decision|7|||
156757393|NCT00103285|565864743|FG006|Response Assignment|Physician Decision|4|||
156757394|NCT00103285|565864744|FG007|Response Assignment|Physician Decision|35|||
156757395|NCT00103285|565864737|FG000|Response Assignment|Protocol Violation|0|||
156757396|NCT00103285|565864738|FG001|Response Assignment|Protocol Violation|2|||
156757397|NCT00103285|565864739|FG002|Response Assignment|Protocol Violation|0|||
156757398|NCT00103285|565864740|FG003|Response Assignment|Protocol Violation|0|||
156757399|NCT00103285|565864741|FG004|Response Assignment|Protocol Violation|0|||
156757400|NCT00103285|565864742|FG005|Response Assignment|Protocol Violation|0|||
156757401|NCT00103285|565864743|FG006|Response Assignment|Protocol Violation|0|||
156757402|NCT00103285|565864744|FG007|Response Assignment|Protocol Violation|0|||
156757403|NCT00103285|565864737|FG000|Response Assignment|Withdrawal by Subject|0|||
156757404|NCT00103285|565864738|FG001|Response Assignment|Withdrawal by Subject|4|||
156757405|NCT00103285|565864739|FG002|Response Assignment|Withdrawal by Subject|1|||
156757406|NCT00103285|565864740|FG003|Response Assignment|Withdrawal by Subject|1|||
156757407|NCT00103285|565864741|FG004|Response Assignment|Withdrawal by Subject|2|||
156757408|NCT00103285|565864742|FG005|Response Assignment|Withdrawal by Subject|2|||
156757409|NCT00103285|565864743|FG006|Response Assignment|Withdrawal by Subject|0|||
156757410|NCT00103285|565864744|FG007|Response Assignment|Withdrawal by Subject|2|||
156757411|NCT00103285|565864737|FG000|Response Assignment|Ineligible|0|||
156757412|NCT00103285|565864738|FG001|Response Assignment|Ineligible|8|||
156757413|NCT00103285|565864739|FG002|Response Assignment|Ineligible|6|||
156757414|NCT00103285|565864740|FG003|Response Assignment|Ineligible|2|||
156757415|NCT00103285|565864741|FG004|Response Assignment|Ineligible|0|||
156757416|NCT00103285|565864742|FG005|Response Assignment|Ineligible|3|||
156757417|NCT00103285|565864743|FG006|Response Assignment|Ineligible|1|||
156757418|NCT00103285|565864744|FG007|Response Assignment|Ineligible|5|||
156757419|NCT00103285|565864737|FG000|Response Assignment|Refusal|0|||
156757420|NCT00103285|565864738|FG001|Response Assignment|Refusal|53|||
156757421|NCT00103285|565864739|FG002|Response Assignment|Refusal|5|||
156757422|NCT00103285|565864740|FG003|Response Assignment|Refusal|3|||
157102955|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
157102956|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
157102957|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102958|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102959|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102960|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102961|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102962|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102963|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102964|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157102965|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
157102966|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
157102967|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
157102968|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102969|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102970|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102971|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102972|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102973|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102974|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102975|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102976|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102977|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
157102978|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157102979|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102980|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102981|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102982|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102983|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102984|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102985|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102986|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157102987|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
157102988|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
157102989|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
157102990|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102991|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102992|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102993|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102994|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102995|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102996|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102997|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102998|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157102999|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
157103000|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
157103001|NCT04178967|567132892|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103002|NCT04178967|567132893|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103003|NCT04178967|567132894|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103004|NCT04178967|567132895|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103005|NCT04178967|567132896|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103006|NCT04178967|567132897|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103007|NCT04178967|567132898|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103008|NCT04178967|567132899|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103009|NCT04178967|567132900|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103010|NCT04178967|567132901|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
157103011|NCT04178967|567132902|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
157103012|NCT00628251|567132903|FG000|Randomised Part|Withdrawal by Subject|0|||
157103013|NCT00628251|567132904|FG001|Randomised Part|Withdrawal by Subject|0|||
157103014|NCT00628251|567132905|FG002|Randomised Part|Withdrawal by Subject|1|||
157103015|NCT00628251|567132903|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
156999774|NCT02430532|566750063|FG000|Overall Study|Consent Withdrawn|0|||
156999775|NCT02430532|566750064|FG001|Overall Study|Consent Withdrawn|2|||
156999776|NCT02430532|566750063|FG000|Overall Study|Adverse Event|0|||
156999777|NCT02430532|566750064|FG001|Overall Study|Adverse Event|1|||
156999778|NCT01190150|566750065|FG000|First Treatment|Withdrawal by Subject|1|||
156999779|NCT01190150|566750066|FG001|First Treatment|Withdrawal by Subject|0|||
156999780|NCT01190150|566750065|FG000|Washout|Withdrawal by Subject|0|||
156999781|NCT01190150|566750066|FG001|Washout|Withdrawal by Subject|1|||
156999782|NCT01190150|566750065|FG000|Washout|Difficulty in adherence|0|||
156999783|NCT01190150|566750066|FG001|Washout|Difficulty in adherence|1|||
156999784|NCT02873754|566750070|FG000|Overall Study|Lost to Follow-up|5|||
156999785|NCT02873754|566750070|FG000|Overall Study|Couldn't complete study procedures|1|||
156999786|NCT01081145|566750074|FG000|Open-Label Phase|Lack of Efficacy|56|||
156999787|NCT01081145|566750075|FG001|Open-Label Phase|Lack of Efficacy|0|||
156999788|NCT01081145|566750074|FG000|Open-Label Phase|Response criteria not met|46|||
156999789|NCT01081145|566750075|FG001|Open-Label Phase|Response criteria not met|0|||
156999790|NCT01081145|566750074|FG000|Open-Label Phase|Adverse Event|42|||
156999791|NCT01081145|566750075|FG001|Open-Label Phase|Adverse Event|0|||
156999792|NCT01081145|566750074|FG000|Open-Label Phase|Withdrawal by Subject|41|||
156999793|NCT01081145|566750075|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156999794|NCT01081145|566750074|FG000|Open-Label Phase|Other|12|||
156999795|NCT01081145|566750075|FG001|Open-Label Phase|Other|0|||
156999796|NCT01081145|566750074|FG000|Open-Label Phase|Lost to Follow-up|11|||
156999797|NCT01081145|566750075|FG001|Open-Label Phase|Lost to Follow-up|0|||
156999798|NCT01081145|566750074|FG000|Open-Label Phase|Protocol Violation|4|||
156999799|NCT01081145|566750075|FG001|Open-Label Phase|Protocol Violation|0|||
156999800|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
156999801|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
156999802|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
156999803|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
156999804|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
156999805|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
156999806|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
156999807|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
156999808|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
156999809|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
156999810|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
156999811|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
156999812|NCT01081145|566750074|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
156999813|NCT01081145|566750075|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
156999814|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
156999815|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
156999816|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
156999817|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
156999818|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
156999819|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
156999820|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
156999821|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
156999822|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
156999823|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
156999824|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
156999825|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
156999826|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
156999827|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
156999828|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
156999829|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
156999830|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
156999831|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
156999832|NCT03412747|566750076|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
156999833|NCT03412747|566750077|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
156999834|NCT03412747|566750078|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
156999835|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
156999836|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
156999837|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
156999838|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
156999839|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
156999840|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
156999841|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
156999842|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
156757423|NCT00103285|565864741|FG004|Response Assignment|Refusal|25|||
156757424|NCT00103285|565864742|FG005|Response Assignment|Refusal|15|||
156757425|NCT00103285|565864743|FG006|Response Assignment|Refusal|30|||
156757426|NCT00103285|565864744|FG007|Response Assignment|Refusal|10|||
156757427|NCT00103285|565864737|FG000|Response Assignment|Other|0|||
156757428|NCT00103285|565864738|FG001|Response Assignment|Other|30|||
156757429|NCT00103285|565864739|FG002|Response Assignment|Other|48|||
156999843|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
156999844|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
156999845|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
156999846|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
156999847|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
156999848|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
156999849|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
156999850|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
156999851|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
156999852|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
156999853|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
156999854|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
156999855|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
156999856|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
156999857|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
156999858|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
156999859|NCT03412747|566750076|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
156999860|NCT03412747|566750077|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
156999861|NCT03412747|566750078|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
156999862|NCT03643211|566750082|FG000|Overall Study|Contract violation/deficiency|12|||
156999863|NCT03643211|566750082|FG000|Overall Study|Invalid registration|3|||
156999864|NCT03643211|566750082|FG000|Overall Study|No treatment information|2|||
156999865|NCT03643211|566750082|FG000|Overall Study|No adverse event information - No revisit|4|||
156999866|NCT04858425|566750083|FG000|Overall Study|Adverse Event|2|||
156999867|NCT04858425|566750084|FG001|Overall Study|Adverse Event|2|||
156999868|NCT04858425|566750083|FG000|Overall Study|Withdrawal by Subject|3|||
156999869|NCT04858425|566750084|FG001|Overall Study|Withdrawal by Subject|1|||
156999870|NCT04858425|566750083|FG000|Overall Study|Lost to Follow-up|4|||
156999871|NCT04858425|566750084|FG001|Overall Study|Lost to Follow-up|2|||
156999872|NCT04858425|566750083|FG000|Overall Study|Lost to Follow-up|1|||
156999873|NCT04858425|566750084|FG001|Overall Study|Lost to Follow-up|0|||
156999874|NCT03473743|566750085|FG000|Overall Study|Withdrawal by Subject|0|||
156999875|NCT03473743|566750086|FG001|Overall Study|Withdrawal by Subject|0|||
156999876|NCT03473743|566750087|FG002|Overall Study|Withdrawal by Subject|0|||
156999877|NCT03473743|566750088|FG003|Overall Study|Withdrawal by Subject|0|||
156999878|NCT03473743|566750089|FG004|Overall Study|Withdrawal by Subject|0|||
156999879|NCT03473743|566750090|FG005|Overall Study|Withdrawal by Subject|0|||
156999880|NCT03473743|566750091|FG006|Overall Study|Withdrawal by Subject|0|||
156999881|NCT03473743|566750092|FG007|Overall Study|Withdrawal by Subject|3|||
156999882|NCT03473743|566750085|FG000|Overall Study|Other|0|||
156999883|NCT03473743|566750086|FG001|Overall Study|Other|0|||
156999884|NCT03473743|566750087|FG002|Overall Study|Other|0|||
156999885|NCT03473743|566750088|FG003|Overall Study|Other|1|||
156999886|NCT03473743|566750089|FG004|Overall Study|Other|0|||
156999887|NCT03473743|566750090|FG005|Overall Study|Other|0|||
156999888|NCT03473743|566750091|FG006|Overall Study|Other|0|||
156999889|NCT03473743|566750092|FG007|Overall Study|Other|0|||
156999890|NCT03473743|566750085|FG000|Overall Study|Ongoing|0|||
156999891|NCT03473743|566750086|FG001|Overall Study|Ongoing|0|||
156999892|NCT03473743|566750087|FG002|Overall Study|Ongoing|6|||
156999893|NCT03473743|566750088|FG003|Overall Study|Ongoing|8|||
156999894|NCT03473743|566750089|FG004|Overall Study|Ongoing|1|||
156999895|NCT03473743|566750090|FG005|Overall Study|Ongoing|1|||
156999896|NCT03473743|566750091|FG006|Overall Study|Ongoing|22|||
156999897|NCT03473743|566750092|FG007|Overall Study|Ongoing|24|||
156999898|NCT03473743|566750085|FG000|Overall Study|Randomized but not treated|0|||
156999899|NCT03473743|566750086|FG001|Overall Study|Randomized but not treated|0|||
156999900|NCT03473743|566750087|FG002|Overall Study|Randomized but not treated|0|||
156999901|NCT03473743|566750088|FG003|Overall Study|Randomized but not treated|0|||
156999902|NCT03473743|566750089|FG004|Overall Study|Randomized but not treated|0|||
156999903|NCT03473743|566750090|FG005|Overall Study|Randomized but not treated|0|||
156999904|NCT03473743|566750091|FG006|Overall Study|Randomized but not treated|1|||
156999905|NCT03473743|566750092|FG007|Overall Study|Randomized but not treated|1|||
156999906|NCT02864992|566750093|FG000|Overall Study|still on treatment|15|||
156999907|NCT02864992|566750094|FG001|Overall Study|still on treatment|1|||
156999908|NCT02864992|566750095|FG002|Overall Study|still on treatment|33|||
156757430|NCT00103285|565864740|FG003|Response Assignment|Other|38|||
156757431|NCT00103285|565864741|FG004|Response Assignment|Other|37|||
157103016|NCT00628251|567132904|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
157103017|NCT00628251|567132905|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
157103018|NCT00628251|567132903|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
157103019|NCT00628251|567132904|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
157103020|NCT00628251|567132905|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
157103021|NCT00628251|567132903|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
157103022|NCT00628251|567132904|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
157103023|NCT00628251|567132905|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
157103024|NCT00628251|567132903|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
157103025|NCT00628251|567132904|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
157103026|NCT00628251|567132905|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
157103027|NCT00628251|567132903|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
157103028|NCT00628251|567132904|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
156999909|NCT04536077|566750097|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
156999910|NCT04536077|566750098|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
156999911|NCT04536077|566750097|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
156999912|NCT04536077|566750098|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
156999913|NCT03805295|566750099|FG000|Overall Study|Lost to Follow-up|17|||
156999914|NCT03805295|566750100|FG001|Overall Study|Lost to Follow-up|43|||
156999915|NCT04925752|566750101|FG000|Overall Study|Still on Study|1826|||
156999916|NCT04925752|566750102|FG001|Overall Study|Still on Study|926|||
156999917|NCT04925752|566750101|FG000|Overall Study|Withdrew Consent|128|||
156999918|NCT04925752|566750102|FG001|Overall Study|Withdrew Consent|59|||
156999919|NCT04925752|566750101|FG000|Overall Study|Lost to Follow-up|73|||
156999920|NCT04925752|566750102|FG001|Overall Study|Lost to Follow-up|47|||
156999921|NCT04925752|566750101|FG000|Overall Study|Randomized but Never Treated|12|||
156999922|NCT04925752|566750102|FG001|Overall Study|Randomized but Never Treated|9|||
156999923|NCT04925752|566750101|FG000|Overall Study|Hiv-1 Infection|6|||
156999924|NCT04925752|566750102|FG001|Overall Study|Hiv-1 Infection|7|||
156999925|NCT04925752|566750101|FG000|Overall Study|Investigator's discretion|8|||
156999926|NCT04925752|566750102|FG001|Overall Study|Investigator's discretion|5|||
156999927|NCT04925752|566750101|FG000|Overall Study|Non-compliance with Study Drug|8|||
156999928|NCT04925752|566750102|FG001|Overall Study|Non-compliance with Study Drug|5|||
156999929|NCT04925752|566750101|FG000|Overall Study|Adverse Event|5|||
156999930|NCT04925752|566750102|FG001|Overall Study|Adverse Event|2|||
156999931|NCT04925752|566750101|FG000|Overall Study|Death|4|||
156999932|NCT04925752|566750102|FG001|Overall Study|Death|2|||
156999933|NCT04925752|566750101|FG000|Overall Study|Protocol Violation|1|||
156999934|NCT04925752|566750102|FG001|Overall Study|Protocol Violation|3|||
156999935|NCT04925752|566750101|FG000|Overall Study|Withdrew Assent|1|||
156999936|NCT04925752|566750102|FG001|Overall Study|Withdrew Assent|0|||
156999937|NCT04269200|566750103|FG000|Global Cohort|Death|72|||
156999938|NCT04269200|566750104|FG001|Global Cohort|Death|54|||
156999939|NCT04269200|566750105|FG002|Global Cohort|Death|49|||
156999940|NCT04269200|566750103|FG000|Global Cohort|Lost to Follow-up|0|||
156999941|NCT04269200|566750104|FG001|Global Cohort|Lost to Follow-up|0|||
156999942|NCT04269200|566750105|FG002|Global Cohort|Lost to Follow-up|2|||
156999943|NCT04269200|566750103|FG000|Global Cohort|Withdrawal by Subject|22|||
156999944|NCT04269200|566750104|FG001|Global Cohort|Withdrawal by Subject|25|||
156999945|NCT04269200|566750105|FG002|Global Cohort|Withdrawal by Subject|18|||
156999946|NCT04269200|566750103|FG000|China Cohort|Death|12|||
156999947|NCT04269200|566750104|FG001|China Cohort|Death|11|||
156999948|NCT04269200|566750105|FG002|China Cohort|Death|13|||
156999949|NCT04269200|566750103|FG000|China Cohort|Lost to Follow-up|0|||
156999950|NCT04269200|566750104|FG001|China Cohort|Lost to Follow-up|1|||
156999951|NCT04269200|566750105|FG002|China Cohort|Lost to Follow-up|1|||
156999952|NCT04269200|566750103|FG000|China Cohort|Withdrawal by Subject|2|||
156999953|NCT04269200|566750104|FG001|China Cohort|Withdrawal by Subject|2|||
156999954|NCT04269200|566750105|FG002|China Cohort|Withdrawal by Subject|4|||
156999955|NCT03331250|566750106|FG000|Overall Study|Withdrawal by Subject|1|||
156999956|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
156999957|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
156999958|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
156999959|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
156999960|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
156999961|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
156999962|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
156999963|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
156999964|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
156999965|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
156999966|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
156999967|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
157103029|NCT00628251|567132905|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
157103030|NCT02558231|567132906|FG000|Overall Study|Death|4|||
157103031|NCT02558231|567132907|FG001|Overall Study|Death|12|||
157103032|NCT02558231|567132906|FG000|Overall Study|Lost to Follow-up|7|||
157103033|NCT02558231|567132907|FG001|Overall Study|Lost to Follow-up|4|||
157103034|NCT02558231|567132906|FG000|Overall Study|Withdrawal by Subject|7|||
157103035|NCT02558231|567132907|FG001|Overall Study|Withdrawal by Subject|4|||
157103036|NCT02558231|567132906|FG000|Overall Study|Physician Decision|7|||
157103037|NCT02558231|567132907|FG001|Overall Study|Physician Decision|5|||
157103038|NCT02558231|567132906|FG000|Overall Study|Sponsor Decision|0|||
157103039|NCT02558231|567132907|FG001|Overall Study|Sponsor Decision|1|||
157103040|NCT03933397|567132908|FG000|Overall Study|No emergency department visit|65|||
157103041|NCT03933397|567132909|FG001|Overall Study|No emergency department visit|71|||
157103042|NCT03933397|567132908|FG000|Overall Study|Missed emergency department visit|25|||
157103043|NCT03933397|567132909|FG001|Overall Study|Missed emergency department visit|30|||
157103044|NCT03933397|567132908|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
157103045|NCT03933397|567132909|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
157103046|NCT03933397|567132908|FG000|Overall Study|Withdrawal by Subject|1|||
157103047|NCT03933397|567132909|FG001|Overall Study|Withdrawal by Subject|0|||
157103048|NCT03933397|567132908|FG000|Overall Study|Physician Decision|1|||
157103049|NCT03933397|567132909|FG001|Overall Study|Physician Decision|1|||
157103050|NCT03933397|567132908|FG000|Overall Study|missing pain score|1|||
157103051|NCT03933397|567132909|FG001|Overall Study|missing pain score|1|||
157103052|NCT03933397|567132908|FG000|Overall Study|Confirmed COVID-19|1|||
157103053|NCT03933397|567132909|FG001|Overall Study|Confirmed COVID-19|2|||
157103054|NCT02066051|567132911|FG000|Overall Study|Subject developed active GVHD|1|||
157103055|NCT01610687|567132914|FG000|Overall Study|Lack of Efficacy|26|||
157103056|NCT01610687|567132914|FG000|Overall Study|Adverse Event|18|||
157103057|NCT01610687|567132914|FG000|Overall Study|Moved out of area|6|||
157103058|NCT01610687|567132914|FG000|Overall Study|Withdrawal by Subject|7|||
157103059|NCT01610687|567132914|FG000|Overall Study|Lost to Follow-up|4|||
157103060|NCT01610687|567132914|FG000|Overall Study|Symptom control without study medication|2|||
157103061|NCT01610687|567132914|FG000|Overall Study|Unable to make journey|1|||
157103062|NCT01610687|567132914|FG000|Overall Study|Death|1|||
157103063|NCT01610687|567132914|FG000|Overall Study|Cannabis affecting job|1|||
157103064|NCT01610687|567132914|FG000|Overall Study|Felt more alter without study medication|1|||
157103065|NCT01272947|567132915|FG000|Overall Study|Abnormal Laboratory Value|2|||
157103066|NCT01272947|567132916|FG001|Overall Study|Abnormal Laboratory Value|2|||
157103067|NCT01294150|567132917|FG000|Overall Study|Physician Decision|2|||
157103068|NCT01294150|567132918|FG001|Overall Study|Physician Decision|2|||
157103069|NCT03675776|567132919|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
157103070|NCT03675776|567132920|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
157103071|NCT03675776|567132921|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
157103072|NCT03675776|567132919|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
157103073|NCT03675776|567132920|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
157103074|NCT03675776|567132921|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
157103075|NCT01093625|567132922|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
157103076|NCT01093625|567132923|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
157103077|NCT01093625|567132922|FG000|2-Week Visit|Withdrawal by Subject|1|||
157103078|NCT01093625|567132923|FG001|2-Week Visit|Withdrawal by Subject|0|||
157103079|NCT01093625|567132922|FG000|1-Month Visit|Lost to Follow-up|2|||
157103080|NCT01093625|567132923|FG001|1-Month Visit|Lost to Follow-up|0|||
157103081|NCT01093625|567132922|FG000|3-Month Visit|Lost to Follow-up|2|||
157103082|NCT01093625|567132923|FG001|3-Month Visit|Lost to Follow-up|0|||
157103083|NCT01093625|567132922|FG000|6-Month Visit|Withdrawal by Subject|6|||
157103084|NCT01093625|567132923|FG001|6-Month Visit|Withdrawal by Subject|7|||
157103085|NCT01093625|567132922|FG000|6-Month Visit|Lost to Follow-up|2|||
157103086|NCT01093625|567132923|FG001|6-Month Visit|Lost to Follow-up|2|||
157103087|NCT01093625|567132922|FG000|1-Year Visit|Lost to Follow-up|5|||
156757432|NCT00103285|565864742|FG005|Response Assignment|Other|17|||
156757433|NCT00103285|565864743|FG006|Response Assignment|Other|11|||
156757434|NCT00103285|565864744|FG007|Response Assignment|Other|53|||
156757435|NCT02100839|565864748|FG000|Multiple Ascending Dose|Adverse Event|2|||
156757436|NCT02100839|565864749|FG001|Multiple Ascending Dose|Adverse Event|0|||
157103088|NCT01093625|567132923|FG001|1-Year Visit|Lost to Follow-up|3|||
157103089|NCT02608879|567132924|FG000|Overall Study|Lost to Follow-up|1|||
157103090|NCT02608879|567132925|FG001|Overall Study|Lost to Follow-up|0|||
157103091|NCT02608879|567132926|FG002|Overall Study|Lost to Follow-up|0|||
157103092|NCT02608879|567132924|FG000|Overall Study|Did not meet continuation criteria|0|||
157103093|NCT02608879|567132925|FG001|Overall Study|Did not meet continuation criteria|0|||
157103094|NCT02608879|567132926|FG002|Overall Study|Did not meet continuation criteria|3|||
157103095|NCT01840605|567132927|FG000|Overall Study|Adverse Event|0|||
157103096|NCT01840605|567132928|FG001|Overall Study|Adverse Event|1|||
157103097|NCT01840605|567132927|FG000|Overall Study|Physician Decision|2|||
157103098|NCT01840605|567132928|FG001|Overall Study|Physician Decision|1|||
157103099|NCT03739437|567132929|FG000|Overall Study|Lost to Follow-up|2|||
156757437|NCT02100839|565864748|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
156757438|NCT02100839|565864749|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
156757439|NCT03272347|565864752|FG000|Overall Study|Death|0|||
156757440|NCT03272347|565864753|FG001|Overall Study|Death|0|||
156757441|NCT03272347|565864754|FG002|Overall Study|Death|0|||
156757442|NCT03272347|565864755|FG003|Overall Study|Death|1|||
156757443|NCT03272347|565864752|FG000|Overall Study|Lost to Follow-up|1|||
156757444|NCT03272347|565864753|FG001|Overall Study|Lost to Follow-up|3|||
156757445|NCT03272347|565864754|FG002|Overall Study|Lost to Follow-up|5|||
156757446|NCT03272347|565864755|FG003|Overall Study|Lost to Follow-up|1|||
156757447|NCT03272347|565864752|FG000|Overall Study|Physician Decision|4|||
156757448|NCT03272347|565864753|FG001|Overall Study|Physician Decision|2|||
156757449|NCT03272347|565864754|FG002|Overall Study|Physician Decision|5|||
156757450|NCT03272347|565864755|FG003|Overall Study|Physician Decision|4|||
156757451|NCT03272347|565864752|FG000|Overall Study|Screen Failure|1|||
156757452|NCT03272347|565864753|FG001|Overall Study|Screen Failure|0|||
156757453|NCT03272347|565864754|FG002|Overall Study|Screen Failure|0|||
156757454|NCT03272347|565864755|FG003|Overall Study|Screen Failure|0|||
156757455|NCT03272347|565864752|FG000|Overall Study|Withdrawal by Subject|5|||
156757456|NCT03272347|565864753|FG001|Overall Study|Withdrawal by Subject|1|||
156757457|NCT03272347|565864754|FG002|Overall Study|Withdrawal by Subject|2|||
156757458|NCT03272347|565864755|FG003|Overall Study|Withdrawal by Subject|1|||
156999968|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
156999969|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
156999970|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
156999971|NCT02137850|566750109|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
156999972|NCT02137850|566750110|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
156999973|NCT02137850|566750111|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
156999974|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156999975|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
156999976|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
156999977|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
156999978|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
156999979|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
156999980|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
156999981|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
156999982|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
156999983|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
156999984|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
156999985|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
156999986|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Other|0|||
156999987|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Other|1|||
156999988|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Other|0|||
156999989|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
156999990|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
156999991|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
156999992|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Early site closure|0|||
156999993|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Early site closure|2|||
156999994|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Early site closure|0|||
156999995|NCT02137850|566750109|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
156999996|NCT02137850|566750110|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
156999997|NCT02137850|566750111|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
156999998|NCT02137850|566750109|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
156999999|NCT02137850|566750110|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
157000000|NCT02137850|566750111|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
157000001|NCT02137850|566750109|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
157000002|NCT02137850|566750110|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
157000003|NCT02137850|566750111|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
157000004|NCT02137850|566750109|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
157000005|NCT02137850|566750110|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
157000006|NCT02137850|566750111|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
157000007|NCT02137850|566750109|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
157000008|NCT02137850|566750110|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
157000009|NCT02137850|566750111|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
157000010|NCT02137850|566750109|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
157000011|NCT02137850|566750110|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
157000012|NCT02137850|566750111|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
157000013|NCT02137850|566750109|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
157000014|NCT02137850|566750110|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
157000015|NCT02137850|566750111|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
157000016|NCT02137850|566750109|FG000|Extension Phase: Prophylaxis|Other|0|||
157000017|NCT02137850|566750110|FG001|Extension Phase: Prophylaxis|Other|1|||
156757459|NCT00940888|565864756|FG000|Overall Study|Unsuccessful Implant|4|||
157000018|NCT02137850|566750111|FG002|Extension Phase: Prophylaxis|Other|0|||
157000019|NCT02137850|566750109|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
157000020|NCT02137850|566750110|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
157000021|NCT02137850|566750111|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
157000022|NCT03431350|566750112|FG000|Overall Study|ONGOING|0|||
157000023|NCT03431350|566750113|FG001|Overall Study|ONGOING|0|||
157000024|NCT03431350|566750114|FG002|Overall Study|ONGOING|2|||
157000025|NCT03431350|566750115|FG003|Overall Study|ONGOING|0|||
157000026|NCT03431350|566750116|FG004|Overall Study|ONGOING|1|||
157000027|NCT03431350|566750117|FG005|Overall Study|ONGOING|3|||
157000028|NCT03431350|566750118|FG006|Overall Study|ONGOING|0|||
157000029|NCT03431350|566750119|FG007|Overall Study|ONGOING|1|||
157000030|NCT03431350|566750120|FG008|Overall Study|ONGOING|3|||
157000031|NCT03431350|566750121|FG009|Overall Study|ONGOING|4|||
157000032|NCT03431350|566750122|FG010|Overall Study|ONGOING|2|||
157000033|NCT03431350|566750123|FG011|Overall Study|ONGOING|1|||
157000034|NCT03431350|566750112|FG000|Overall Study|Death|6|||
157000035|NCT03431350|566750113|FG001|Overall Study|Death|5|||
157000036|NCT03431350|566750114|FG002|Overall Study|Death|18|||
157000037|NCT03431350|566750115|FG003|Overall Study|Death|7|||
157000038|NCT03431350|566750116|FG004|Overall Study|Death|4|||
157000039|NCT03431350|566750117|FG005|Overall Study|Death|3|||
157000040|NCT03431350|566750118|FG006|Overall Study|Death|2|||
157000041|NCT03431350|566750119|FG007|Overall Study|Death|0|||
157000042|NCT03431350|566750120|FG008|Overall Study|Death|0|||
157000043|NCT03431350|566750121|FG009|Overall Study|Death|0|||
157000044|NCT03431350|566750122|FG010|Overall Study|Death|4|||
157000045|NCT03431350|566750123|FG011|Overall Study|Death|0|||
157000046|NCT03431350|566750112|FG000|Overall Study|Lost to Follow-up|0|||
157000047|NCT03431350|566750113|FG001|Overall Study|Lost to Follow-up|1|||
157000048|NCT03431350|566750114|FG002|Overall Study|Lost to Follow-up|0|||
157000049|NCT03431350|566750115|FG003|Overall Study|Lost to Follow-up|0|||
157000050|NCT03431350|566750116|FG004|Overall Study|Lost to Follow-up|0|||
157000051|NCT03431350|566750117|FG005|Overall Study|Lost to Follow-up|0|||
157000052|NCT03431350|566750118|FG006|Overall Study|Lost to Follow-up|0|||
157000053|NCT03431350|566750119|FG007|Overall Study|Lost to Follow-up|0|||
157000054|NCT03431350|566750120|FG008|Overall Study|Lost to Follow-up|0|||
157000055|NCT03431350|566750121|FG009|Overall Study|Lost to Follow-up|0|||
157000056|NCT03431350|566750122|FG010|Overall Study|Lost to Follow-up|0|||
157000057|NCT03431350|566750123|FG011|Overall Study|Lost to Follow-up|0|||
157000058|NCT03431350|566750112|FG000|Overall Study|Withdrawal by Subject|0|||
157000059|NCT03431350|566750113|FG001|Overall Study|Withdrawal by Subject|0|||
157000060|NCT03431350|566750114|FG002|Overall Study|Withdrawal by Subject|0|||
157000061|NCT03431350|566750115|FG003|Overall Study|Withdrawal by Subject|1|||
157000062|NCT03431350|566750116|FG004|Overall Study|Withdrawal by Subject|1|||
157000063|NCT03431350|566750117|FG005|Overall Study|Withdrawal by Subject|1|||
157000064|NCT03431350|566750118|FG006|Overall Study|Withdrawal by Subject|0|||
157000065|NCT03431350|566750119|FG007|Overall Study|Withdrawal by Subject|0|||
157000066|NCT03431350|566750120|FG008|Overall Study|Withdrawal by Subject|0|||
157000067|NCT03431350|566750121|FG009|Overall Study|Withdrawal by Subject|2|||
157000068|NCT03431350|566750122|FG010|Overall Study|Withdrawal by Subject|0|||
157000069|NCT03431350|566750123|FG011|Overall Study|Withdrawal by Subject|1|||
157000070|NCT03431350|566750112|FG000|Overall Study|Other|0|||
157000071|NCT03431350|566750113|FG001|Overall Study|Other|0|||
157000072|NCT03431350|566750114|FG002|Overall Study|Other|1|||
157000073|NCT03431350|566750115|FG003|Overall Study|Other|3|||
157000074|NCT03431350|566750116|FG004|Overall Study|Other|2|||
157000075|NCT03431350|566750117|FG005|Overall Study|Other|2|||
157000076|NCT03431350|566750118|FG006|Overall Study|Other|4|||
157000077|NCT03431350|566750119|FG007|Overall Study|Other|0|||
157000078|NCT03431350|566750120|FG008|Overall Study|Other|14|||
157000079|NCT03431350|566750121|FG009|Overall Study|Other|11|||
157000080|NCT03431350|566750122|FG010|Overall Study|Other|11|||
157000081|NCT03431350|566750123|FG011|Overall Study|Other|15|||
157000082|NCT03563053|566750124|FG000|Overall Study|Withdrawal by Subject|17|||
157000083|NCT03563053|566750124|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
157000084|NCT03563053|566750124|FG000|Overall Study|Adverse Event|3|||
157000085|NCT03563053|566750124|FG000|Overall Study|Physician Decision|1|||
157000086|NCT03563053|566750124|FG000|Overall Study|study terminated by sponsor|71|||
157103100|NCT03739437|567132930|FG001|Overall Study|Lost to Follow-up|5|||
157103101|NCT01130974|567132931|FG000|Overall Study|Protocol Violation|10|||
157000087|NCT05663866|566750126|FG000|Overall Study|Adverse Event|0|||
157000088|NCT05663866|566750127|FG001|Overall Study|Adverse Event|0|||
157000089|NCT05663866|566750128|FG002|Overall Study|Adverse Event|1|||
157000090|NCT05663866|566750129|FG003|Overall Study|Adverse Event|0|||
157000091|NCT05663866|566750126|FG000|Overall Study|Physician Decision|0|||
157000092|NCT05663866|566750127|FG001|Overall Study|Physician Decision|0|||
157000093|NCT05663866|566750128|FG002|Overall Study|Physician Decision|0|||
157000094|NCT05663866|566750129|FG003|Overall Study|Physician Decision|1|||
157000095|NCT05663866|566750126|FG000|Overall Study|Withdrawal by Subject|0|||
157000096|NCT05663866|566750127|FG001|Overall Study|Withdrawal by Subject|2|||
157000097|NCT05663866|566750128|FG002|Overall Study|Withdrawal by Subject|1|||
156757460|NCT00940888|565864756|FG000|Overall Study|Death|461|||
156757461|NCT00940888|565864756|FG000|Overall Study|Withdrawn - Non-Death|364|||
156757462|NCT00940888|565864756|FG000|Overall Study|Lost to Follow-up|6|||
156757463|NCT00391872|565864757|FG000|Overall Study|Protocol Violation|7|||
156757464|NCT00391872|565864758|FG001|Overall Study|Protocol Violation|2|||
156757465|NCT00391872|565864757|FG000|Overall Study|Withdrawal by Subject|296|||
156757466|NCT00391872|565864758|FG001|Overall Study|Withdrawal by Subject|249|||
156757467|NCT00391872|565864757|FG000|Overall Study|Reason unknown|2|||
156757468|NCT00391872|565864758|FG001|Overall Study|Reason unknown|4|||
156757469|NCT00391872|565864757|FG000|Overall Study|Lost to Follow-up|2|||
156757470|NCT00391872|565864758|FG001|Overall Study|Lost to Follow-up|0|||
156757471|NCT01409915|565864759|FG000|Overall Study|Adverse Event|0|||
156757472|NCT01409915|565864760|FG001|Overall Study|Adverse Event|2|||
156757473|NCT01409915|565864759|FG000|Overall Study|Withdrawal by Subject|0|||
156757474|NCT01409915|565864760|FG001|Overall Study|Withdrawal by Subject|1|||
156757475|NCT01409915|565864759|FG000|Overall Study|Protocol Violation|1|||
156757476|NCT01409915|565864760|FG001|Overall Study|Protocol Violation|0|||
156757477|NCT04826484|565864761|FG000|Overall Study|Lost to Follow-up|2|||
156757478|NCT04826484|565864762|FG001|Overall Study|Lost to Follow-up|0|||
156757479|NCT01516736|565864769|FG000|Overall Study|Withdrawal by Subject|10|||
156757480|NCT01516736|565864770|FG001|Overall Study|Withdrawal by Subject|4|||
156757481|NCT01516736|565864769|FG000|Overall Study|Adverse Event|4|||
156757482|NCT01516736|565864770|FG001|Overall Study|Adverse Event|5|||
156757483|NCT01516736|565864769|FG000|Overall Study|Death|3|||
156757484|NCT01516736|565864770|FG001|Overall Study|Death|1|||
156757485|NCT01516736|565864769|FG000|Overall Study|Physician Decision|2|||
156757486|NCT01516736|565864770|FG001|Overall Study|Physician Decision|1|||
156757487|NCT01516736|565864769|FG000|Overall Study|Lack of Efficacy|1|||
156757488|NCT01516736|565864770|FG001|Overall Study|Lack of Efficacy|0|||
156757489|NCT01516736|565864769|FG000|Overall Study|Protocol Violation|0|||
156757490|NCT01516736|565864770|FG001|Overall Study|Protocol Violation|1|||
156757491|NCT01516736|565864769|FG000|Overall Study|Other (not specified)|0|||
156757492|NCT01516736|565864770|FG001|Overall Study|Other (not specified)|1|||
156757493|NCT02781818|565864771|FG000|Overall Study|Lost to Follow-up|4|||
156757494|NCT02781818|565864772|FG001|Overall Study|Lost to Follow-up|2|||
156757495|NCT02781818|565864773|FG002|Overall Study|Lost to Follow-up|1|||
156757496|NCT00524771|565864774|FG000|Overall Study|Protocol Violation|220|||
156757497|NCT00524771|565864775|FG001|Overall Study|Protocol Violation|585|||
156757498|NCT01877668|565864776|FG000|Overall Study|Death|0|||
156757499|NCT01877668|565864777|FG001|Overall Study|Death|0|||
157000098|NCT05663866|566750129|FG003|Overall Study|Withdrawal by Subject|2|||
157000099|NCT05663866|566750126|FG000|Overall Study|Progressive disease|4|||
157000100|NCT05663866|566750127|FG001|Overall Study|Progressive disease|8|||
157000101|NCT05663866|566750128|FG002|Overall Study|Progressive disease|5|||
157000102|NCT05663866|566750129|FG003|Overall Study|Progressive disease|2|||
157000103|NCT05663866|566750126|FG000|Overall Study|Other|1|||
157000104|NCT05663866|566750127|FG001|Overall Study|Other|0|||
157000105|NCT05663866|566750128|FG002|Overall Study|Other|0|||
157000106|NCT05663866|566750129|FG003|Overall Study|Other|0|||
157000107|NCT05663866|566750126|FG000|Overall Study|Ongoing|1|||
157000108|NCT05663866|566750127|FG001|Overall Study|Ongoing|27|||
157000109|NCT05663866|566750128|FG002|Overall Study|Ongoing|6|||
157000110|NCT05663866|566750129|FG003|Overall Study|Ongoing|1|||
157000111|NCT04845620|566750130|FG000|Overall Study|Withdrawal by Subject|11|||
157000112|NCT04845620|566750131|FG001|Overall Study|Withdrawal by Subject|10|||
157000113|NCT04845620|566750130|FG000|Overall Study|Adverse Event|5|||
157000114|NCT04845620|566750131|FG001|Overall Study|Adverse Event|4|||
157000115|NCT04845620|566750130|FG000|Overall Study|Lost to Follow-up|5|||
157000116|NCT04845620|566750131|FG001|Overall Study|Lost to Follow-up|4|||
157000117|NCT04845620|566750130|FG000|Overall Study|Lack of Efficacy|4|||
156757500|NCT01877668|565864778|FG002|Overall Study|Death|0|||
156757501|NCT01877668|565864779|FG003|Overall Study|Death|1|||
156757502|NCT01877668|565864780|FG004|Overall Study|Death|0|||
156757503|NCT01877668|565864776|FG000|Overall Study|No longer met study criteria|1|||
156757504|NCT01877668|565864777|FG001|Overall Study|No longer met study criteria|0|||
156757505|NCT01877668|565864778|FG002|Overall Study|No longer met study criteria|1|||
156757506|NCT01877668|565864779|FG003|Overall Study|No longer met study criteria|0|||
156757507|NCT01877668|565864780|FG004|Overall Study|No longer met study criteria|0|||
156757508|NCT01877668|565864776|FG000|Overall Study|Insufficient clinical response|0|||
156757509|NCT01877668|565864777|FG001|Overall Study|Insufficient clinical response|1|||
157000118|NCT04845620|566750131|FG001|Overall Study|Lack of Efficacy|4|||
157000119|NCT04845620|566750130|FG000|Overall Study|Physician Decision|2|||
157000120|NCT04845620|566750131|FG001|Overall Study|Physician Decision|1|||
157000121|NCT03105336|566750132|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
156757510|NCT01877668|565864778|FG002|Overall Study|Insufficient clinical response|2|||
156757511|NCT01877668|565864779|FG003|Overall Study|Insufficient clinical response|2|||
156757512|NCT01877668|565864780|FG004|Overall Study|Insufficient clinical response|0|||
156757513|NCT01877668|565864776|FG000|Overall Study|Lost to Follow-up|0|||
157000122|NCT03105336|566750133|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
157000123|NCT03105336|566750132|FG000|Overall Study|Death|40|||
157000124|NCT03105336|566750133|FG001|Overall Study|Death|8|||
157000125|NCT03105336|566750132|FG000|Overall Study|Lost to Follow-up|13|||
157000126|NCT03105336|566750133|FG001|Overall Study|Lost to Follow-up|2|||
157000127|NCT03105336|566750132|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
157000128|NCT03105336|566750133|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
157000129|NCT03105336|566750132|FG000|Overall Study|Reason Not Specified|3|||
157000130|NCT03105336|566750133|FG001|Overall Study|Reason Not Specified|3|||
157000131|NCT03105336|566750132|FG000|Overall Study|Investigator Decision|3|||
157000132|NCT03105336|566750133|FG001|Overall Study|Investigator Decision|0|||
157000133|NCT03518112|566751298|FG000|Overall Study|Withdrawal by Subject|1|||
157000134|NCT01546155|566751299|FG000|Overall Study|could not tolerate long scan duration|3|||
157000135|NCT02930343|566751300|FG000|Overall Study|Lost to Follow-up|9|||
157000136|NCT02930343|566751301|FG001|Overall Study|Lost to Follow-up|7|||
157000137|NCT01729819|566751305|FG000|Overall Study|Adverse Event|2|||
157000138|NCT01729819|566751306|FG001|Overall Study|Adverse Event|4|||
157000139|NCT01729819|566751305|FG000|Overall Study|Lack of Efficacy|1|||
157000140|NCT01729819|566751306|FG001|Overall Study|Lack of Efficacy|0|||
157000141|NCT01729819|566751305|FG000|Overall Study|Lost to Follow-up|2|||
157000142|NCT01729819|566751306|FG001|Overall Study|Lost to Follow-up|0|||
157000143|NCT01729819|566751305|FG000|Overall Study|Other reason|1|||
157000144|NCT01729819|566751306|FG001|Overall Study|Other reason|0|||
157000145|NCT01729819|566751305|FG000|Overall Study|Protocol Violation|0|||
157000146|NCT01729819|566751306|FG001|Overall Study|Protocol Violation|1|||
157000147|NCT01729819|566751305|FG000|Overall Study|Withdrawal by Subject|0|||
157000148|NCT01729819|566751306|FG001|Overall Study|Withdrawal by Subject|2|||
157000149|NCT01025843|566751307|FG000|Washout 4|Withdrawal by Subject|0|||
157000150|NCT01025843|566751308|FG001|Washout 4|Withdrawal by Subject|0|||
157000151|NCT01025843|566751309|FG002|Washout 4|Withdrawal by Subject|1|||
157000152|NCT01025843|566751310|FG003|Washout 4|Withdrawal by Subject|1|||
157000153|NCT01025843|566751311|FG004|Washout 4|Withdrawal by Subject|0|||
157000154|NCT01025843|566751312|FG005|Washout 4|Withdrawal by Subject|0|||
157000155|NCT01025843|566751313|FG006|Washout 4|Withdrawal by Subject|0|||
157000156|NCT01025843|566751314|FG007|Washout 4|Withdrawal by Subject|0|||
157000157|NCT01025843|566751315|FG008|Washout 4|Withdrawal by Subject|0|||
157000158|NCT01025843|566751316|FG009|Washout 4|Withdrawal by Subject|0|||
157000159|NCT01649791|566751317|FG000|Overall Study|Disease Progression|2|||
157000160|NCT01649791|566751317|FG000|Overall Study|Adverse Event|1|||
157000161|NCT00364286|566751318|FG000|Overall Study|Withdrawal by Subject|1|||
157000162|NCT00364286|566751318|FG000|Overall Study|Adverse Event|2|||
157000163|NCT02814643|566751319|FG000|Overall Study|Lost to Follow-up|0|||
157000164|NCT02814643|566751320|FG001|Overall Study|Lost to Follow-up|1|||
157000165|NCT02814643|566751319|FG000|Overall Study|Withdrawal by Subject|1|||
157000166|NCT02814643|566751320|FG001|Overall Study|Withdrawal by Subject|2|||
157000167|NCT01227278|566751323|FG000|Overall Study|Withdrawal by Subject|4|||
157000168|NCT01227278|566751324|FG001|Overall Study|Withdrawal by Subject|4|||
157000169|NCT01227278|566751323|FG000|Overall Study|Death|0|||
157000170|NCT01227278|566751324|FG001|Overall Study|Death|2|||
157000171|NCT01227278|566751323|FG000|Overall Study|Other|1|||
157000172|NCT01227278|566751324|FG001|Overall Study|Other|2|||
157000173|NCT00420316|566751325|FG000|Overall Study|Withdrawal by Subject|0|||
157000174|NCT00420316|566751326|FG001|Overall Study|Withdrawal by Subject|1|||
157000175|NCT00420316|566751325|FG000|Overall Study|Lost to Follow-up|12|||
157000176|NCT00420316|566751326|FG001|Overall Study|Lost to Follow-up|8|||
157000177|NCT01281813|566751335|FG000|Overall Study|Adverse Event|0|||
157000178|NCT01281813|566751336|FG001|Overall Study|Adverse Event|0|||
157000179|NCT01281813|566751337|FG002|Overall Study|Adverse Event|10|||
157000180|NCT01281813|566751335|FG000|Overall Study|Lost to Follow-up|0|||
157000181|NCT01281813|566751336|FG001|Overall Study|Lost to Follow-up|0|||
157103102|NCT01130974|567132932|FG001|Overall Study|Protocol Violation|10|||
157103103|NCT01130974|567132931|FG000|Overall Study|Withdrawal by Subject|0|||
157103104|NCT01130974|567132932|FG001|Overall Study|Withdrawal by Subject|1|||
157103105|NCT01130974|567132931|FG000|Overall Study|Ineligibility criteria|5|||
157103106|NCT01130974|567132932|FG001|Overall Study|Ineligibility criteria|2|||
157103107|NCT02966223|567132933|FG000|Overall Study|Physician Decision|3|||
157103108|NCT02966223|567132933|FG000|Overall Study|Withdrawal by Subject|11|||
157103109|NCT02966223|567132933|FG000|Overall Study|Lost to Follow-up|1|||
157103110|NCT01557348|567132934|FG000|Overall Study|Adverse Event|6|||
157103111|NCT01557348|567132935|FG001|Overall Study|Adverse Event|16|||
157103112|NCT01557348|567132934|FG000|Overall Study|Infusion reaction event|5|||
157103113|NCT01557348|567132935|FG001|Overall Study|Infusion reaction event|5|||
157103114|NCT01557348|567132934|FG000|Overall Study|Death|7|||
157103115|NCT01557348|567132935|FG001|Overall Study|Death|4|||
157103116|NCT01557348|567132934|FG000|Overall Study|Insufficient Therapeutic Response|13|||
157103117|NCT01557348|567132935|FG001|Overall Study|Insufficient Therapeutic Response|28|||
157103118|NCT01557348|567132934|FG000|Overall Study|Withdrawal by Subject|5|||
157103119|NCT01557348|567132935|FG001|Overall Study|Withdrawal by Subject|4|||
157103120|NCT01557348|567132934|FG000|Overall Study|Lost to Follow-up|26|||
157103121|NCT01557348|567132935|FG001|Overall Study|Lost to Follow-up|22|||
157103122|NCT01557348|567132934|FG000|Overall Study|Administrative|18|||
157103123|NCT01557348|567132935|FG001|Overall Study|Administrative|11|||
157103124|NCT06132425|567132936|FG000|Overall Study|Withdrawal by Subject|3|||
157103125|NCT06132425|567132937|FG001|Overall Study|Withdrawal by Subject|0|||
157103126|NCT06132425|567132936|FG000|Overall Study|Did not follow study instructions|0|||
157103127|NCT06132425|567132937|FG001|Overall Study|Did not follow study instructions|2|||
157103128|NCT06132425|567132936|FG000|Overall Study|Lost to Follow-up|3|||
157103129|NCT06132425|567132937|FG001|Overall Study|Lost to Follow-up|5|||
157103130|NCT05393037|567132943|FG000|Part A|Death|1|||
157103131|NCT05393037|567132944|FG001|Part A|Death|0|||
157103132|NCT05393037|567132943|FG000|Part A|Lost to Follow-up|1|||
157103133|NCT05393037|567132944|FG001|Part A|Lost to Follow-up|1|||
157103134|NCT05393037|567132943|FG000|Part A|Withdrawal by Subject|2|||
157103135|NCT05393037|567132944|FG001|Part A|Withdrawal by Subject|4|||
157103136|NCT05393037|567132943|FG000|Part B|Lost to Follow-up|1|||
157103137|NCT05393037|567132944|FG001|Part B|Lost to Follow-up|0|||
157103138|NCT04409353|567132945|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
157103139|NCT04409353|567132946|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
157103140|NCT04409353|567132947|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
157103141|NCT04409353|567132945|FG000|Overall Study|Lost to Follow-up|6|||
157103142|NCT04409353|567132946|FG001|Overall Study|Lost to Follow-up|8|||
157103143|NCT04409353|567132947|FG002|Overall Study|Lost to Follow-up|7|||
157103144|NCT04409353|567132945|FG000|Overall Study|Major surgery during participation window|4|||
157103145|NCT04409353|567132946|FG001|Overall Study|Major surgery during participation window|3|||
157103146|NCT04409353|567132947|FG002|Overall Study|Major surgery during participation window|3|||
157103147|NCT04409353|567132945|FG000|Overall Study|Life event occurred during participation window|3|||
157103148|NCT04409353|567132946|FG001|Overall Study|Life event occurred during participation window|2|||
157103149|NCT04409353|567132947|FG002|Overall Study|Life event occurred during participation window|4|||
157103150|NCT04409353|567132945|FG000|Overall Study|Lack of Efficacy|4|||
157103151|NCT04409353|567132946|FG001|Overall Study|Lack of Efficacy|1|||
157103152|NCT04409353|567132947|FG002|Overall Study|Lack of Efficacy|3|||
157103153|NCT04409353|567132945|FG000|Overall Study|Adverse Event|2|||
157103154|NCT04409353|567132946|FG001|Overall Study|Adverse Event|1|||
157103155|NCT04409353|567132947|FG002|Overall Study|Adverse Event|1|||
157103156|NCT04409353|567132945|FG000|Overall Study|Disease burden - unable to participate|0|||
157103157|NCT04409353|567132946|FG001|Overall Study|Disease burden - unable to participate|1|||
157103158|NCT04409353|567132947|FG002|Overall Study|Disease burden - unable to participate|1|||
157103159|NCT04409353|567132945|FG000|Overall Study|Intervention too complicated|1|||
157103160|NCT04409353|567132946|FG001|Overall Study|Intervention too complicated|0|||
157103161|NCT04409353|567132947|FG002|Overall Study|Intervention too complicated|1|||
157103162|NCT04252287|567132949|FG000|Overall Study|Death|5|||
156757514|NCT01877668|565864777|FG001|Overall Study|Lost to Follow-up|2|||
156757515|NCT01877668|565864778|FG002|Overall Study|Lost to Follow-up|1|||
156757516|NCT01877668|565864779|FG003|Overall Study|Lost to Follow-up|0|||
156757517|NCT01877668|565864780|FG004|Overall Study|Lost to Follow-up|0|||
157103163|NCT04252287|567132950|FG001|Overall Study|Death|3|||
157103164|NCT04252287|567132949|FG000|Overall Study|Lost to Follow-up|4|||
156757518|NCT01877668|565864776|FG000|Overall Study|Withdrawal by Subject|2|||
156757519|NCT01877668|565864777|FG001|Overall Study|Withdrawal by Subject|0|||
156757520|NCT01877668|565864778|FG002|Overall Study|Withdrawal by Subject|3|||
157103165|NCT04252287|567132950|FG001|Overall Study|Lost to Follow-up|6|||
157103166|NCT04252287|567132949|FG000|Overall Study|Withdrawal by Subject|19|||
157103167|NCT04252287|567132950|FG001|Overall Study|Withdrawal by Subject|16|||
157103168|NCT04252287|567132949|FG000|Overall Study|Protocol Violation|3|||
157103169|NCT04252287|567132950|FG001|Overall Study|Protocol Violation|4|||
157103170|NCT02499770|567132954|FG000|Overall Study|Death|17|||
157103171|NCT02499770|567132955|FG001|Overall Study|Death|56|||
157103172|NCT02499770|567132954|FG000|Overall Study|Study completion|1|||
157103173|NCT02499770|567132955|FG001|Overall Study|Study completion|10|||
157103174|NCT02499770|567132954|FG000|Overall Study|Withdrawal by Subject|0|||
157103175|NCT02499770|567132955|FG001|Overall Study|Withdrawal by Subject|7|||
157000182|NCT01281813|566751337|FG002|Overall Study|Lost to Follow-up|31|||
157000183|NCT01281813|566751335|FG000|Overall Study|Withdrawal by Subject|0|||
157000184|NCT01281813|566751336|FG001|Overall Study|Withdrawal by Subject|0|||
157000185|NCT01281813|566751337|FG002|Overall Study|Withdrawal by Subject|13|||
157000186|NCT01281813|566751335|FG000|Overall Study|Subject Non-Compliant|0|||
157000187|NCT01281813|566751336|FG001|Overall Study|Subject Non-Compliant|0|||
157000188|NCT01281813|566751337|FG002|Overall Study|Subject Non-Compliant|6|||
157000189|NCT01281813|566751335|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
157000190|NCT01281813|566751336|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
157000191|NCT01281813|566751337|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
157000192|NCT01281813|566751335|FG000|Overall Study|Sponsor's Decision|4|||
157000193|NCT01281813|566751336|FG001|Overall Study|Sponsor's Decision|3|||
157000194|NCT01281813|566751337|FG002|Overall Study|Sponsor's Decision|7|||
157000195|NCT01281813|566751335|FG000|Overall Study|Switched to Commercially Available Medication|0|||
157000196|NCT01281813|566751336|FG001|Overall Study|Switched to Commercially Available Medication|0|||
157000197|NCT01281813|566751337|FG002|Overall Study|Switched to Commercially Available Medication|26|||
157000198|NCT01281813|566751335|FG000|Overall Study|Other|0|||
157000199|NCT01281813|566751336|FG001|Overall Study|Other|1|||
157000200|NCT01281813|566751337|FG002|Overall Study|Other|39|||
157000201|NCT03546907|566751338|FG000|Overall Study|Lack of Efficacy|1|||
157000202|NCT03546907|566751339|FG001|Overall Study|Lack of Efficacy|1|||
157000203|NCT03546907|566751338|FG000|Overall Study|Withdrawal by Subject|8|||
157000204|NCT03546907|566751339|FG001|Overall Study|Withdrawal by Subject|9|||
157000205|NCT03546907|566751338|FG000|Overall Study|Adverse events (AEs)|7|||
157000206|NCT03546907|566751339|FG001|Overall Study|Adverse events (AEs)|10|||
157000207|NCT03546907|566751338|FG000|Overall Study|Other-unspecified|1|||
157000208|NCT03546907|566751339|FG001|Overall Study|Other-unspecified|1|||
157000209|NCT03720210|566751346|FG000|Overall Study|Lost to Follow-up|1|||
157000210|NCT04033432|566751347|FG000|Overall Study|Progressive Disease|8|||
157000211|NCT04033432|566751347|FG000|Overall Study|Adverse Event|4|||
157000212|NCT04033432|566751347|FG000|Overall Study|Death|1|||
157000213|NCT02274493|566751353|FG000|Overall Study|Withdrawal by Subject|1|||
157000214|NCT00558363|566751354|FG000|Overall Study|Physician Decision|18|||
157000215|NCT00558363|566751355|FG001|Overall Study|Physician Decision|4|||
157000216|NCT00558363|566751354|FG000|Overall Study|Withdrawal by Subject|11|||
157000217|NCT00558363|566751355|FG001|Overall Study|Withdrawal by Subject|4|||
157000218|NCT00558363|566751354|FG000|Overall Study|Adverse Event|5|||
157000219|NCT00558363|566751355|FG001|Overall Study|Adverse Event|5|||
157000220|NCT00558363|566751354|FG000|Overall Study|Lack of Efficacy|2|||
157000221|NCT00558363|566751355|FG001|Overall Study|Lack of Efficacy|2|||
157000222|NCT00558363|566751354|FG000|Overall Study|Protocol Violation|2|||
157000223|NCT00558363|566751355|FG001|Overall Study|Protocol Violation|1|||
157000224|NCT00558363|566751354|FG000|Overall Study|Lost to Follow-up|0|||
157000225|NCT00558363|566751355|FG001|Overall Study|Lost to Follow-up|1|||
157000226|NCT00558363|566751354|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
157000227|NCT00558363|566751355|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
157000228|NCT00558363|566751354|FG000|Overall Study|Randomized in Error|1|||
157000229|NCT00558363|566751355|FG001|Overall Study|Randomized in Error|2|||
157000230|NCT00558363|566751354|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
157000231|NCT00558363|566751355|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
157000232|NCT02174562|566751356|FG000|Overall Study|Withdrawal by Subject|7|||
157000233|NCT02174562|566751357|FG001|Overall Study|Withdrawal by Subject|2|||
157000234|NCT02174562|566751356|FG000|Overall Study|Death|2|||
157000235|NCT02174562|566751357|FG001|Overall Study|Death|0|||
157000236|NCT02174562|566751356|FG000|Overall Study|Lost to Follow-up|0|||
157000237|NCT02174562|566751357|FG001|Overall Study|Lost to Follow-up|3|||
157000238|NCT03201809|566751358|FG000|Overall Study|Lost to Follow-up|2|||
157000239|NCT03201809|566751359|FG001|Overall Study|Lost to Follow-up|0|||
157000240|NCT03247543|566751361|FG000|Overall Study|Adverse Event|3|||
157000241|NCT03247543|566751362|FG001|Overall Study|Adverse Event|6|||
157000242|NCT03247543|566751363|FG002|Overall Study|Adverse Event|4|||
157000243|NCT03247543|566751361|FG000|Overall Study|Lost to Follow-up|10|||
157000244|NCT03247543|566751362|FG001|Overall Study|Lost to Follow-up|7|||
157000245|NCT03247543|566751363|FG002|Overall Study|Lost to Follow-up|8|||
157000246|NCT03247543|566751361|FG000|Overall Study|Consent withdrawn by caregiver|2|||
157000247|NCT03247543|566751362|FG001|Overall Study|Consent withdrawn by caregiver|2|||
157000248|NCT03247543|566751363|FG002|Overall Study|Consent withdrawn by caregiver|9|||
156757521|NCT01877668|565864779|FG003|Overall Study|Withdrawal by Subject|2|||
156757522|NCT01877668|565864780|FG004|Overall Study|Withdrawal by Subject|2|||
156757523|NCT01877668|565864776|FG000|Overall Study|Other|1|||
156757524|NCT01877668|565864777|FG001|Overall Study|Other|1|||
156757525|NCT01877668|565864778|FG002|Overall Study|Other|1|||
156757526|NCT01877668|565864779|FG003|Overall Study|Other|1|||
156757527|NCT01877668|565864780|FG004|Overall Study|Other|3|||
156757528|NCT01877668|565864776|FG000|Overall Study|Protocol Violation|1|||
156757529|NCT01877668|565864777|FG001|Overall Study|Protocol Violation|1|||
156757530|NCT01877668|565864778|FG002|Overall Study|Protocol Violation|0|||
156757531|NCT01877668|565864779|FG003|Overall Study|Protocol Violation|0|||
156757532|NCT01877668|565864780|FG004|Overall Study|Protocol Violation|3|||
156757533|NCT01877668|565864776|FG000|Overall Study|Adverse event related to study drug|2|||
156757534|NCT01877668|565864777|FG001|Overall Study|Adverse event related to study drug|2|||
156757535|NCT01877668|565864778|FG002|Overall Study|Adverse event related to study drug|2|||
156757536|NCT01877668|565864779|FG003|Overall Study|Adverse event related to study drug|2|||
156757537|NCT01877668|565864780|FG004|Overall Study|Adverse event related to study drug|1|||
156757538|NCT01877668|565864776|FG000|Overall Study|Adverse event unrelated to study drug|4|||
156757539|NCT01877668|565864777|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156757540|NCT01877668|565864778|FG002|Overall Study|Adverse event unrelated to study drug|2|||
156757541|NCT01877668|565864779|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156757542|NCT01877668|565864780|FG004|Overall Study|Adverse event unrelated to study drug|1|||
157000249|NCT03247543|566751361|FG000|Overall Study|Withdrawal by Subject|0|||
157000250|NCT03247543|566751362|FG001|Overall Study|Withdrawal by Subject|0|||
157000251|NCT03247543|566751363|FG002|Overall Study|Withdrawal by Subject|1|||
157000252|NCT03247543|566751361|FG000|Overall Study|Failure to Follow study procedures|1|||
157000253|NCT03247543|566751362|FG001|Overall Study|Failure to Follow study procedures|3|||
157000254|NCT03247543|566751363|FG002|Overall Study|Failure to Follow study procedures|1|||
157000255|NCT03247543|566751361|FG000|Overall Study|Lack of Efficacy|1|||
157000256|NCT03247543|566751362|FG001|Overall Study|Lack of Efficacy|0|||
157000257|NCT03247543|566751363|FG002|Overall Study|Lack of Efficacy|0|||
157000258|NCT03247543|566751361|FG000|Overall Study|Non-compliance with study visits|0|||
157000259|NCT03247543|566751362|FG001|Overall Study|Non-compliance with study visits|1|||
157000260|NCT03247543|566751363|FG002|Overall Study|Non-compliance with study visits|0|||
157000261|NCT02059980|566751370|FG000|Overall Study|Lost to Follow-up|2|||
157000262|NCT02059980|566751371|FG001|Overall Study|Lost to Follow-up|1|||
157000263|NCT01321606|566751372|FG000|Overall Study|Lost to Follow-up|0|||
157000264|NCT01321606|566751373|FG001|Overall Study|Lost to Follow-up|0|||
157000265|NCT01321606|566751374|FG002|Overall Study|Lost to Follow-up|0|||
157000266|NCT01321606|566751375|FG003|Overall Study|Lost to Follow-up|1|||
157000267|NCT01253226|566751376|FG000|Overall Study|Adverse Event|0|||
157000268|NCT01253226|566751377|FG001|Overall Study|Adverse Event|0|||
157000269|NCT01253226|566751378|FG002|Overall Study|Adverse Event|1|||
157000270|NCT01253226|566751379|FG003|Overall Study|Adverse Event|0|||
157000271|NCT01253226|566751380|FG004|Overall Study|Adverse Event|0|||
157000272|NCT01253226|566751376|FG000|Overall Study|Death|0|||
157000273|NCT01253226|566751377|FG001|Overall Study|Death|1|||
157000274|NCT01253226|566751378|FG002|Overall Study|Death|0|||
157000275|NCT01253226|566751379|FG003|Overall Study|Death|0|||
157000276|NCT01253226|566751380|FG004|Overall Study|Death|0|||
157000277|NCT01253226|566751376|FG000|Overall Study|Physician Decision|0|||
157000278|NCT01253226|566751377|FG001|Overall Study|Physician Decision|0|||
157000279|NCT01253226|566751378|FG002|Overall Study|Physician Decision|0|||
157000280|NCT01253226|566751379|FG003|Overall Study|Physician Decision|0|||
157000281|NCT01253226|566751380|FG004|Overall Study|Physician Decision|2|||
157000282|NCT01253226|566751376|FG000|Overall Study|Withdrawal by Subject|0|||
157000283|NCT01253226|566751377|FG001|Overall Study|Withdrawal by Subject|0|||
157000284|NCT01253226|566751378|FG002|Overall Study|Withdrawal by Subject|0|||
157000285|NCT01253226|566751379|FG003|Overall Study|Withdrawal by Subject|1|||
157000286|NCT01253226|566751380|FG004|Overall Study|Withdrawal by Subject|0|||
157000287|NCT01582945|566751381|FG000|Overall Study|Intolerable side-effects|1|||
157000288|NCT01582945|566751381|FG000|Overall Study|Scheduling conflicts|1|||
157000289|NCT01726023|566751382|FG000|Overall Study|Death|1|||
157000290|NCT01726023|566751383|FG001|Overall Study|Death|1|||
157000291|NCT01726023|566751382|FG000|Overall Study|Lost to Follow-up|5|||
157000292|NCT01726023|566751383|FG001|Overall Study|Lost to Follow-up|10|||
156757543|NCT00954122|565864781|FG000|Overall Study|Withdrawal by Subject|5|||
156757544|NCT00954122|565864781|FG000|Overall Study|Adverse Event|1|||
156757545|NCT00954122|565864781|FG000|Overall Study|Safety Reason|1|||
156757546|NCT01957579|565864784|FG000|Overall Study|Withdrawal of concent|0|||
157000293|NCT01726023|566751382|FG000|Overall Study|Other Eligibility criteria|7|||
157000294|NCT01726023|566751383|FG001|Overall Study|Other Eligibility criteria|7|||
157000295|NCT01726023|566751382|FG000|Overall Study|Withdrawal by Subject|16|||
157000296|NCT01726023|566751383|FG001|Overall Study|Withdrawal by Subject|8|||
157000297|NCT01155869|566751393|FG000|Overall Study|Lost to Follow-up|3|||
157000298|NCT01155869|566751394|FG001|Overall Study|Lost to Follow-up|1|||
157000299|NCT00881335|566751396|FG000|Overall Study|Lost to Follow-up|3|||
157000300|NCT00881335|566751397|FG001|Overall Study|Lost to Follow-up|2|||
157000301|NCT05824351|566751398|FG000|Overall Study|Adverse Event|6|||
157000302|NCT04538664|566751399|FG000|Overall Study|Withdrawal by Subject|5|||
157000303|NCT04538664|566751400|FG001|Overall Study|Withdrawal by Subject|9|||
157000304|NCT04538664|566751399|FG000|Overall Study|Lost to Follow-up|2|||
157000305|NCT04538664|566751400|FG001|Overall Study|Lost to Follow-up|1|||
157000306|NCT04538664|566751399|FG000|Overall Study|Ongoing|106|||
157000307|NCT04538664|566751400|FG001|Overall Study|Ongoing|115|||
157000308|NCT03681678|566751401|FG000|Overall Study|Lost to Follow-up|20|||
157000309|NCT02141074|566751404|FG000|Pre-prophylaxis|Adverse Event|3|||
157000310|NCT02141074|566751405|FG001|Pre-prophylaxis|Adverse Event|0|||
157000311|NCT02141074|566751404|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
157000312|NCT02141074|566751405|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
157000313|NCT02141074|566751404|FG000|Prophylaxis|Adverse Event|0|||
157000314|NCT02141074|566751405|FG001|Prophylaxis|Adverse Event|4|||
157000315|NCT02141074|566751404|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
157000316|NCT02141074|566751405|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
157000317|NCT02141074|566751404|FG000|Prophylaxis|Withdrawal by Subject|0|||
157000318|NCT02141074|566751405|FG001|Prophylaxis|Withdrawal by Subject|1|||
157000319|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
157000320|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
157000321|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000322|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000323|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000324|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000325|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000326|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000327|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000328|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000329|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000330|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
157000331|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000332|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
157000333|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000334|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000335|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000336|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000337|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000338|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000339|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000340|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000341|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000342|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
157000343|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
157000344|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
157000345|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000346|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000347|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000348|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000349|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000350|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000351|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000352|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000353|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000354|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
157000355|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000356|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
157000357|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000358|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000359|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000360|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000361|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000362|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000363|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000364|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157103176|NCT02499770|567132954|FG000|Overall Study|Lost to Follow-up|0|||
157103177|NCT02499770|567132955|FG001|Overall Study|Lost to Follow-up|2|||
157103178|NCT02499770|567132954|FG000|Overall Study|Subject declined further treatment|1|||
157103179|NCT02499770|567132955|FG001|Overall Study|Subject declined further treatment|0|||
157103180|NCT02499770|567132954|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
157103181|NCT02499770|567132955|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
157103182|NCT02499770|567132954|FG000|Overall Study|Randomized but not enrolled|0|||
157103183|NCT02499770|567132955|FG001|Overall Study|Randomized but not enrolled|1|||
157103184|NCT00671554|567132958|FG000|Overall Study|Disease progression|3|||
157103185|NCT04275297|567132960|FG000|Overall Study|Lost to Follow-up|1|||
157103186|NCT04275297|567132961|FG001|Overall Study|Lost to Follow-up|1|||
157103187|NCT01093326|567132964|FG000|Overall Study|Death|0|||
157103188|NCT01093326|567132965|FG001|Overall Study|Death|1|||
157103189|NCT01093326|567132966|FG002|Overall Study|Death|0|||
157103190|NCT01093326|567132964|FG000|Overall Study|Lack of Efficacy|7|||
157103191|NCT01093326|567132965|FG001|Overall Study|Lack of Efficacy|6|||
157103192|NCT01093326|567132966|FG002|Overall Study|Lack of Efficacy|3|||
157103193|NCT01093326|567132964|FG000|Overall Study|Lost to Follow-up|2|||
157103194|NCT01093326|567132965|FG001|Overall Study|Lost to Follow-up|5|||
157103195|NCT01093326|567132966|FG002|Overall Study|Lost to Follow-up|4|||
157103196|NCT01093326|567132964|FG000|Overall Study|Physician Decision|3|||
157103197|NCT01093326|567132965|FG001|Overall Study|Physician Decision|1|||
157103198|NCT01093326|567132966|FG002|Overall Study|Physician Decision|3|||
157103199|NCT01093326|567132964|FG000|Overall Study|Withdrawal by Subject|30|||
157103200|NCT01093326|567132965|FG001|Overall Study|Withdrawal by Subject|27|||
157103201|NCT01093326|567132966|FG002|Overall Study|Withdrawal by Subject|26|||
157103202|NCT01093326|567132964|FG000|Overall Study|Adverse Event|2|||
157103203|NCT01093326|567132965|FG001|Overall Study|Adverse Event|1|||
157103204|NCT01093326|567132966|FG002|Overall Study|Adverse Event|4|||
157103205|NCT01093326|567132964|FG000|Overall Study|Other|0|||
157103206|NCT01093326|567132965|FG001|Overall Study|Other|0|||
157103207|NCT01093326|567132966|FG002|Overall Study|Other|1|||
157103208|NCT04435782|567132967|FG000|Overall Study|Study terminated by sponsor|4|||
157103209|NCT03672461|567132968|FG000|Overall Study|COVID Related|4|||
157103210|NCT03672461|567132969|FG001|Overall Study|COVID Related|2|||
157103211|NCT03672461|567132968|FG000|Overall Study|Adverse Event|2|||
157103212|NCT03672461|567132969|FG001|Overall Study|Adverse Event|0|||
157103213|NCT03672461|567132968|FG000|Overall Study|Serious Adverse Event|0|||
157103214|NCT03672461|567132969|FG001|Overall Study|Serious Adverse Event|1|||
157103215|NCT03672461|567132968|FG000|Overall Study|Too Busy|3|||
157103216|NCT03672461|567132969|FG001|Overall Study|Too Busy|1|||
157103217|NCT03672461|567132968|FG000|Overall Study|Lost to Follow-up|1|||
157103218|NCT03672461|567132969|FG001|Overall Study|Lost to Follow-up|2|||
157103219|NCT03672461|567132968|FG000|Overall Study|Family|2|||
157103220|NCT03672461|567132969|FG001|Overall Study|Family|2|||
157103221|NCT03672461|567132968|FG000|Overall Study|No remote technology access|0|||
157103222|NCT03672461|567132969|FG001|Overall Study|No remote technology access|1|||
157103223|NCT03672461|567132968|FG000|Overall Study|Withdrawal by Subject|1|||
157103224|NCT03672461|567132969|FG001|Overall Study|Withdrawal by Subject|0|||
157103225|NCT03672461|567132968|FG000|Overall Study|Cannot tolerate intervention|1|||
157103226|NCT03672461|567132969|FG001|Overall Study|Cannot tolerate intervention|0|||
157103227|NCT03672461|567132968|FG000|Overall Study|Incomplete outcome data|6|||
157103228|NCT03672461|567132969|FG001|Overall Study|Incomplete outcome data|1|||
157103229|NCT04225806|567132970|FG000|Overall Study|Trial termination|15|||
157103230|NCT00977574|567132973|FG000|Overall Study|Never Treated|4|||
157103231|NCT00977574|567132974|FG001|Overall Study|Never Treated|2|||
157103232|NCT00977574|567132975|FG002|Overall Study|Never Treated|4|||
157103233|NCT04223791|567132976|FG000|Overall Study|Lost to Follow-up|0|||
157103234|NCT04223791|567132977|FG001|Overall Study|Lost to Follow-up|4|||
157103235|NCT04223791|567132976|FG000|Overall Study|Physician Decision|5|||
157103236|NCT04223791|567132977|FG001|Overall Study|Physician Decision|1|||
157103237|NCT04223791|567132976|FG000|Overall Study|Protocol Violation|1|||
157103238|NCT04223791|567132977|FG001|Overall Study|Protocol Violation|1|||
157103239|NCT04223791|567132976|FG000|Overall Study|Withdrawal by Subject|10|||
157103240|NCT04223791|567132977|FG001|Overall Study|Withdrawal by Subject|12|||
157103241|NCT04223791|567132976|FG000|Overall Study|Pregnancy|1|||
157103242|NCT04223791|567132977|FG001|Overall Study|Pregnancy|1|||
157103243|NCT04223791|567132976|FG000|Overall Study|Ongoing in Study|305|||
157103244|NCT04223791|567132977|FG001|Overall Study|Ongoing in Study|302|||
157103245|NCT04667247|567132978|FG000|Overall Study|Withdrawal by Subject|0|||
157103246|NCT04667247|567132979|FG001|Overall Study|Withdrawal by Subject|1|||
157103247|NCT05460273|567132980|FG000|Overall Study|Death|43|||
157103248|NCT05460273|567132981|FG001|Overall Study|Death|9|||
157103249|NCT05460273|567132980|FG000|Overall Study|Lost to Follow-up|7|||
157103250|NCT05460273|567132981|FG001|Overall Study|Lost to Follow-up|0|||
157103251|NCT05460273|567132980|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
157103252|NCT05460273|567132981|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
157103253|NCT04124614|567132982|FG000|Placebo Run-in Period|Not Randomized|34|||
157103254|NCT04124614|567132983|FG001|Placebo Run-in Period|Not Randomized|0|||
156757547|NCT01957579|565864785|FG001|Overall Study|Withdrawal of concent|1|||
156757548|NCT01957579|565864786|FG002|Overall Study|Withdrawal of concent|0|||
156757549|NCT01957579|565864787|FG003|Overall Study|Withdrawal of concent|0|||
156757550|NCT01957579|565864784|FG000|Overall Study|Death|0|||
156757551|NCT01957579|565864785|FG001|Overall Study|Death|0|||
156757552|NCT01957579|565864786|FG002|Overall Study|Death|2|||
156757553|NCT01957579|565864787|FG003|Overall Study|Death|0|||
156757554|NCT00377637|565864788|FG000|Induction Phase|Adverse Event|12|||
156757555|NCT00377637|565864789|FG001|Induction Phase|Adverse Event|21|||
156757556|NCT00377637|565864790|FG002|Induction Phase|Adverse Event|0|||
156757557|NCT00377637|565864791|FG003|Induction Phase|Adverse Event|0|||
156757558|NCT00377637|565864788|FG000|Induction Phase|Deterioration/serum creatinine|2|||
156757559|NCT00377637|565864789|FG001|Induction Phase|Deterioration/serum creatinine|0|||
156757560|NCT00377637|565864790|FG002|Induction Phase|Deterioration/serum creatinine|0|||
156757561|NCT00377637|565864791|FG003|Induction Phase|Deterioration/serum creatinine|0|||
156757562|NCT00377637|565864788|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757563|NCT00377637|565864789|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
156757564|NCT00377637|565864790|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757565|NCT00377637|565864791|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
156757566|NCT00377637|565864788|FG000|Induction Phase|Lost to Follow-up|2|||
156757567|NCT00377637|565864789|FG001|Induction Phase|Lost to Follow-up|1|||
156757568|NCT00377637|565864790|FG002|Induction Phase|Lost to Follow-up|0|||
156757569|NCT00377637|565864791|FG003|Induction Phase|Lost to Follow-up|0|||
156757570|NCT00377637|565864788|FG000|Induction Phase|Death|1|||
156757571|NCT00377637|565864789|FG001|Induction Phase|Death|3|||
157000365|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000366|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
157000367|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000368|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
157000369|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000370|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000371|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000372|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000373|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000374|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000375|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000376|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000377|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157103255|NCT04124614|567132984|FG002|Placebo Run-in Period|Not Randomized|0|||
157103256|NCT04124614|567132982|FG000|Double Blind Treatment Period|Adverse Event|0|||
157103257|NCT04124614|567132983|FG001|Double Blind Treatment Period|Adverse Event|7|||
156757572|NCT00377637|565864790|FG002|Induction Phase|Death|0|||
156757573|NCT00377637|565864791|FG003|Induction Phase|Death|0|||
156757574|NCT00377637|565864788|FG000|Induction Phase|Withdrawal by Subject|5|||
156757575|NCT00377637|565864789|FG001|Induction Phase|Withdrawal by Subject|6|||
156757576|NCT00377637|565864790|FG002|Induction Phase|Withdrawal by Subject|0|||
156757577|NCT00377637|565864791|FG003|Induction Phase|Withdrawal by Subject|0|||
156757578|NCT00377637|565864788|FG000|Induction Phase|Physician Decision|3|||
157000378|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
157000379|NCT03536884|566751406|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000380|NCT03536884|566751407|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
157000381|NCT03536884|566751408|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000382|NCT03536884|566751409|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000383|NCT03536884|566751410|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000384|NCT03536884|566751411|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000385|NCT03536884|566751412|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000386|NCT03536884|566751413|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000387|NCT03536884|566751414|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000388|NCT03536884|566751415|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000389|NCT03536884|566751416|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000390|NCT03536884|566751417|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
157000391|NCT03536884|566751406|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000392|NCT03536884|566751407|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000393|NCT03536884|566751408|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
157000394|NCT03536884|566751409|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000395|NCT03536884|566751410|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
157000396|NCT03536884|566751411|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000397|NCT03536884|566751412|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000398|NCT03536884|566751413|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000399|NCT03536884|566751414|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000400|NCT03536884|566751415|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000401|NCT03536884|566751416|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000402|NCT03536884|566751417|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
157000403|NCT03536884|566751406|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000404|NCT03536884|566751407|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000405|NCT03536884|566751408|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
157000406|NCT03536884|566751409|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
157000407|NCT03536884|566751410|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
157000408|NCT03536884|566751411|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000409|NCT03536884|566751412|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000410|NCT03536884|566751413|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000411|NCT03536884|566751414|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000412|NCT03536884|566751415|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000413|NCT03536884|566751416|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000414|NCT03536884|566751417|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
157000415|NCT03536884|566751406|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000416|NCT03536884|566751407|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000417|NCT03536884|566751408|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000418|NCT03536884|566751409|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
157000419|NCT03536884|566751410|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
157000420|NCT03536884|566751411|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000421|NCT03536884|566751412|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000422|NCT03536884|566751413|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000423|NCT03536884|566751414|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000424|NCT03536884|566751415|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000425|NCT03536884|566751416|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000426|NCT03536884|566751417|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
157000427|NCT03536884|566751406|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000428|NCT03536884|566751407|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000429|NCT03536884|566751408|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
157000430|NCT03536884|566751409|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
157000431|NCT03536884|566751410|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
157000432|NCT03536884|566751411|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000433|NCT03536884|566751412|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000434|NCT03536884|566751413|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000435|NCT03536884|566751414|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000436|NCT03536884|566751415|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000437|NCT03536884|566751416|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000438|NCT03536884|566751417|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
157000439|NCT03536884|566751406|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000440|NCT03536884|566751407|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000441|NCT03536884|566751408|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
157000442|NCT03536884|566751409|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
157000443|NCT03536884|566751410|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
157000444|NCT03536884|566751411|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000445|NCT03536884|566751412|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000446|NCT03536884|566751413|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000447|NCT03536884|566751414|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000448|NCT03536884|566751415|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000449|NCT03536884|566751416|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000450|NCT03536884|566751417|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
157000451|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000452|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000453|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000454|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000455|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000456|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
157000457|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
157000458|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
157000459|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
157000460|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000461|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000462|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
157000463|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000464|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000465|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000466|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000467|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000468|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
157000469|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
157000470|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
157000471|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
157000472|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000473|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000474|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
157000475|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000476|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000477|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000478|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000479|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000480|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
157000481|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000482|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
156757579|NCT00377637|565864789|FG001|Induction Phase|Physician Decision|1|||
156757580|NCT00377637|565864790|FG002|Induction Phase|Physician Decision|0|||
156757581|NCT00377637|565864791|FG003|Induction Phase|Physician Decision|0|||
156757582|NCT00377637|565864788|FG000|Induction Phase|Sponsor decision|1|||
156757583|NCT00377637|565864789|FG001|Induction Phase|Sponsor decision|2|||
156757584|NCT00377637|565864790|FG002|Induction Phase|Sponsor decision|0|||
156757585|NCT00377637|565864791|FG003|Induction Phase|Sponsor decision|0|||
157000483|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000484|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000485|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000486|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
157000487|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000488|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000489|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000490|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000491|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000492|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
157000493|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000494|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
157000495|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
157000496|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000497|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000498|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
157000499|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000500|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000501|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000502|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000503|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000504|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
157000505|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
157000506|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
157000507|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
157000508|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000509|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000510|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
157000511|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000512|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000513|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000514|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000515|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000516|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
157000517|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000518|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000519|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000520|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000521|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000522|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
157000523|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000524|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000525|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000526|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000527|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000528|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000529|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
157000530|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000531|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000532|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000533|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000534|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
157000535|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000536|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
156757586|NCT00377637|565864788|FG000|Induction Phase|Non-Compliance|1|||
156757587|NCT00377637|565864789|FG001|Induction Phase|Non-Compliance|0|||
156757588|NCT00377637|565864790|FG002|Induction Phase|Non-Compliance|0|||
156757589|NCT00377637|565864791|FG003|Induction Phase|Non-Compliance|0|||
156757590|NCT00377637|565864788|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
157000537|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000538|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000539|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000540|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000541|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
157000542|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000543|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000544|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000545|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000546|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
157000547|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000548|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000549|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000550|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000551|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000552|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
157000553|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000554|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000555|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000556|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000557|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000558|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
157000559|NCT03536884|566751406|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000560|NCT03536884|566751407|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000561|NCT03536884|566751408|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157103258|NCT04124614|567132984|FG002|Double Blind Treatment Period|Adverse Event|22|||
157103259|NCT04124614|567132982|FG000|Double Blind Treatment Period|Death|0|||
157103260|NCT04124614|567132983|FG001|Double Blind Treatment Period|Death|0|||
157103261|NCT04124614|567132984|FG002|Double Blind Treatment Period|Death|1|||
157103262|NCT04124614|567132982|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
157103263|NCT04124614|567132983|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
157103264|NCT04124614|567132984|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
157103265|NCT04124614|567132982|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
157103266|NCT04124614|567132983|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
157103267|NCT04124614|567132984|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
157103268|NCT04124614|567132982|FG000|Double Blind Treatment Period|Physician Decision|0|||
157103269|NCT04124614|567132983|FG001|Double Blind Treatment Period|Physician Decision|0|||
157103270|NCT04124614|567132984|FG002|Double Blind Treatment Period|Physician Decision|3|||
157103271|NCT04124614|567132982|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
157103272|NCT04124614|567132983|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
157103273|NCT04124614|567132984|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
157103274|NCT04124614|567132982|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
157103275|NCT04124614|567132983|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
157103276|NCT04124614|567132984|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
157103277|NCT04124614|567132982|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
157103278|NCT04124614|567132983|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
157103279|NCT04124614|567132984|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
157103280|NCT02953639|567134485|FG000|Overall Study|Adverse Event|2|||
157103281|NCT02953639|567134486|FG001|Overall Study|Adverse Event|0|||
157103282|NCT02953639|567134487|FG002|Overall Study|Adverse Event|1|||
157103283|NCT02953639|567134485|FG000|Overall Study|Lost to Follow-up|8|||
157103284|NCT02953639|567134486|FG001|Overall Study|Lost to Follow-up|4|||
157103285|NCT02953639|567134487|FG002|Overall Study|Lost to Follow-up|3|||
157103286|NCT02953639|567134485|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157103287|NCT02953639|567134486|FG001|Overall Study|Non-Compliance With Study Drug|2|||
157103288|NCT02953639|567134487|FG002|Overall Study|Non-Compliance With Study Drug|1|||
157103289|NCT02953639|567134485|FG000|Overall Study|Multiple Reasons|1|||
157103290|NCT02953639|567134486|FG001|Overall Study|Multiple Reasons|0|||
157103291|NCT02953639|567134487|FG002|Overall Study|Multiple Reasons|1|||
157103292|NCT02953639|567134485|FG000|Overall Study|Physician Decision|1|||
157103293|NCT02953639|567134486|FG001|Overall Study|Physician Decision|0|||
157103294|NCT02953639|567134487|FG002|Overall Study|Physician Decision|0|||
157103295|NCT02953639|567134485|FG000|Overall Study|Withdrawal by Subject|7|||
157103296|NCT02953639|567134486|FG001|Overall Study|Withdrawal by Subject|8|||
157103297|NCT02953639|567134487|FG002|Overall Study|Withdrawal by Subject|10|||
157103298|NCT02953639|567134485|FG000|Overall Study|Completed or Discontinued information is missing|1|||
157103299|NCT02953639|567134486|FG001|Overall Study|Completed or Discontinued information is missing|0|||
157103300|NCT02953639|567134487|FG002|Overall Study|Completed or Discontinued information is missing|0|||
157103301|NCT01830855|567134488|FG000|Overall Study|Other|7|||
157103302|NCT01830855|567134489|FG001|Overall Study|Other|1|||
157103303|NCT01830855|567134490|FG002|Overall Study|Other|4|||
157103304|NCT01830855|567134491|FG003|Overall Study|Other|4|||
157103305|NCT01830855|567134488|FG000|Overall Study|Medication error without associated AE|1|||
157103306|NCT01830855|567134489|FG001|Overall Study|Medication error without associated AE|0|||
157103307|NCT01830855|567134490|FG002|Overall Study|Medication error without associated AE|0|||
157103308|NCT01830855|567134491|FG003|Overall Study|Medication error without associated AE|1|||
157103309|NCT01830855|567134488|FG000|Overall Study|Pregnancy|3|||
157103310|NCT01830855|567134489|FG001|Overall Study|Pregnancy|1|||
157103311|NCT01830855|567134490|FG002|Overall Study|Pregnancy|2|||
157103312|NCT01830855|567134491|FG003|Overall Study|Pregnancy|1|||
157103313|NCT01830855|567134488|FG000|Overall Study|No longer meets eligibility criteria|11|||
157103314|NCT01830855|567134489|FG001|Overall Study|No longer meets eligibility criteria|2|||
157103315|NCT01830855|567134490|FG002|Overall Study|No longer meets eligibility criteria|3|||
157103316|NCT01830855|567134491|FG003|Overall Study|No longer meets eligibility criteria|5|||
157103317|NCT01830855|567134488|FG000|Overall Study|Adverse Event|11|||
157103318|NCT01830855|567134489|FG001|Overall Study|Adverse Event|5|||
157103319|NCT01830855|567134490|FG002|Overall Study|Adverse Event|6|||
157103320|NCT01830855|567134491|FG003|Overall Study|Adverse Event|3|||
157103321|NCT01830855|567134488|FG000|Overall Study|Protocol deviation|10|||
157103322|NCT01830855|567134489|FG001|Overall Study|Protocol deviation|5|||
157103323|NCT01830855|567134490|FG002|Overall Study|Protocol deviation|6|||
157103324|NCT01830855|567134491|FG003|Overall Study|Protocol deviation|6|||
157103325|NCT01830855|567134488|FG000|Overall Study|Withdrawal by Subject|33|||
157103326|NCT01830855|567134489|FG001|Overall Study|Withdrawal by Subject|14|||
156757591|NCT00377637|565864789|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
156757592|NCT00377637|565864790|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
156757593|NCT00377637|565864791|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
156757594|NCT00377637|565864788|FG000|Maintenance Phase|Adverse Event|0|||
156757595|NCT00377637|565864789|FG001|Maintenance Phase|Adverse Event|0|||
156757596|NCT00377637|565864790|FG002|Maintenance Phase|Adverse Event|29|||
156757597|NCT00377637|565864791|FG003|Maintenance Phase|Adverse Event|43|||
156757598|NCT00377637|565864788|FG000|Maintenance Phase|Physician Decision|0|||
156757599|NCT00377637|565864789|FG001|Maintenance Phase|Physician Decision|0|||
156757600|NCT00377637|565864790|FG002|Maintenance Phase|Physician Decision|5|||
156757601|NCT00377637|565864791|FG003|Maintenance Phase|Physician Decision|4|||
156757602|NCT00377637|565864788|FG000|Maintenance Phase|Lost to Follow-up|0|||
156757603|NCT00377637|565864789|FG001|Maintenance Phase|Lost to Follow-up|0|||
156757604|NCT00377637|565864790|FG002|Maintenance Phase|Lost to Follow-up|3|||
156757605|NCT00377637|565864791|FG003|Maintenance Phase|Lost to Follow-up|1|||
156757606|NCT00377637|565864788|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156757607|NCT00377637|565864789|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156757608|NCT00377637|565864790|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156757609|NCT00377637|565864791|FG003|Maintenance Phase|Withdrawal by Subject|3|||
156757610|NCT00377637|565864788|FG000|Maintenance Phase|Sponsor decision|0|||
156757611|NCT00377637|565864789|FG001|Maintenance Phase|Sponsor decision|0|||
156757612|NCT00377637|565864790|FG002|Maintenance Phase|Sponsor decision|2|||
156757613|NCT00377637|565864791|FG003|Maintenance Phase|Sponsor decision|3|||
156757614|NCT00377637|565864788|FG000|Maintenance Phase|Non-compliance|0|||
156757615|NCT00377637|565864789|FG001|Maintenance Phase|Non-compliance|0|||
156757616|NCT00377637|565864790|FG002|Maintenance Phase|Non-compliance|1|||
156757617|NCT00377637|565864791|FG003|Maintenance Phase|Non-compliance|1|||
156757618|NCT00377637|565864788|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
156757619|NCT00377637|565864789|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
156757620|NCT00377637|565864790|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
156757621|NCT00377637|565864791|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
156757622|NCT00377637|565864788|FG000|Maintenance Phase|Death|0|||
156757623|NCT00377637|565864789|FG001|Maintenance Phase|Death|0|||
156757624|NCT00377637|565864790|FG002|Maintenance Phase|Death|0|||
156757625|NCT00377637|565864791|FG003|Maintenance Phase|Death|1|||
156757626|NCT00003537|565864804|FG000|Overall Study|Not evalauable|1|||
156757627|NCT01001520|565864805|FG000|Medication Period 1|Withdrawal by Subject|2|||
156757628|NCT01001520|565864806|FG001|Medication Period 1|Withdrawal by Subject|2|||
156757629|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
156757630|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
156757631|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
156757632|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
156757633|NCT01001520|565864805|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
156757634|NCT01001520|565864806|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
156757635|NCT01001520|565864805|FG000|Washout Period|Withdrawal by Subject|2|||
156757636|NCT01001520|565864806|FG001|Washout Period|Withdrawal by Subject|1|||
156757637|NCT01001520|565864805|FG000|Medication Period 2|Withdrawal by Subject|0|||
156757638|NCT01001520|565864806|FG001|Medication Period 2|Withdrawal by Subject|3|||
156757639|NCT04668209|565864807|FG000|Overall Study|Withdrawal by Subject|2|||
156757640|NCT04668209|565864808|FG001|Overall Study|Withdrawal by Subject|2|||
156757641|NCT04668209|565864807|FG000|Overall Study|Lost to Follow-up|3|||
156757642|NCT04668209|565864808|FG001|Overall Study|Lost to Follow-up|4|||
156757643|NCT04668209|565864807|FG000|Overall Study|Subject Expired|2|||
157000562|NCT03536884|566751409|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000563|NCT03536884|566751410|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000564|NCT03536884|566751411|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000565|NCT03536884|566751412|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000566|NCT03536884|566751413|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000567|NCT03536884|566751414|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
157000568|NCT03536884|566751415|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000569|NCT03536884|566751416|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157103327|NCT01830855|567134490|FG002|Overall Study|Withdrawal by Subject|10|||
156757644|NCT04668209|565864808|FG001|Overall Study|Subject Expired|0|||
156757645|NCT04668209|565864807|FG000|Overall Study|Withdrawn from study|0|||
156757646|NCT04668209|565864808|FG001|Overall Study|Withdrawn from study|1|||
156757647|NCT04668209|565864807|FG000|Overall Study|Adverse Event|0|||
156757648|NCT04668209|565864808|FG001|Overall Study|Adverse Event|1|||
157103328|NCT01830855|567134491|FG003|Overall Study|Withdrawal by Subject|12|||
157103329|NCT01830855|567134488|FG000|Overall Study|No longer willing to participate|32|||
156757649|NCT00268983|565864815|FG000|Overall Study|Death|3|||
157103330|NCT01830855|567134489|FG001|Overall Study|No longer willing to participate|13|||
156757650|NCT00268983|565864816|FG001|Overall Study|Death|0|||
156757651|NCT00313846|565864819|FG000|Overall Study|Withdrawal by Subject|2|||
156757652|NCT00313846|565864820|FG001|Overall Study|Withdrawal by Subject|0|||
157103331|NCT01830855|567134490|FG002|Overall Study|No longer willing to participate|12|||
157103332|NCT01830855|567134491|FG003|Overall Study|No longer willing to participate|17|||
157103333|NCT01830855|567134488|FG000|Overall Study|Lost to Follow-up|47|||
157103334|NCT01830855|567134489|FG001|Overall Study|Lost to Follow-up|20|||
157103335|NCT01830855|567134490|FG002|Overall Study|Lost to Follow-up|23|||
157103336|NCT01830855|567134491|FG003|Overall Study|Lost to Follow-up|33|||
157103337|NCT01667081|567134492|FG000|Overall Study|Death|43|||
157103338|NCT01667081|567134493|FG001|Overall Study|Death|3|||
156757653|NCT00313846|565864819|FG000|Overall Study|Adverse Event|1|||
156757654|NCT00313846|565864820|FG001|Overall Study|Adverse Event|8|||
156757655|NCT00313846|565864819|FG000|Overall Study|Administrative|2|||
157103339|NCT01667081|567134492|FG000|Overall Study|Lost to Follow-up|99|||
157103340|NCT01667081|567134493|FG001|Overall Study|Lost to Follow-up|48|||
157103341|NCT01667081|567134492|FG000|Overall Study|Physician Decision|16|||
157103342|NCT01667081|567134493|FG001|Overall Study|Physician Decision|2|||
157103343|NCT01667081|567134492|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
157103344|NCT01667081|567134493|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
157103345|NCT01667081|567134492|FG000|Overall Study|Withdrawal by Subject|90|||
157103346|NCT01667081|567134493|FG001|Overall Study|Withdrawal by Subject|35|||
157103347|NCT03034460|567134494|FG000|Overall Study|Adverse Event|0|||
157103348|NCT03034460|567134495|FG001|Overall Study|Adverse Event|1|||
157103349|NCT03034460|567134494|FG000|Overall Study|Withdrawal by Subject|2|||
157103350|NCT03034460|567134495|FG001|Overall Study|Withdrawal by Subject|2|||
157103351|NCT03034460|567134494|FG000|Overall Study|Personal Reasons|1|||
157103352|NCT03034460|567134495|FG001|Overall Study|Personal Reasons|0|||
156757656|NCT00313846|565864820|FG001|Overall Study|Administrative|3|||
156757657|NCT03478371|565864821|FG000|Overall Study|non-compliance|1|||
156757658|NCT03478371|565864821|FG000|Overall Study|Lost to Follow-up|4|||
156757659|NCT01096160|565864825|FG000|Overall Study|Adverse Event|0|||
156757660|NCT01096160|565864826|FG001|Overall Study|Adverse Event|0|||
156757661|NCT01096160|565864827|FG002|Overall Study|Adverse Event|1|||
156757662|NCT01096160|565864828|FG003|Overall Study|Adverse Event|0|||
156757663|NCT01096160|565864829|FG004|Overall Study|Adverse Event|0|||
156757664|NCT01096160|565864830|FG005|Overall Study|Adverse Event|0|||
156757665|NCT01096160|565864831|FG006|Overall Study|Adverse Event|0|||
156757666|NCT01096160|565864832|FG007|Overall Study|Adverse Event|0|||
156757667|NCT01096160|565864833|FG008|Overall Study|Adverse Event|0|||
156757668|NCT01096160|565864834|FG009|Overall Study|Adverse Event|1|||
156757669|NCT01096160|565864825|FG000|Overall Study|Met stopping criteria per protocol|0|||
156757670|NCT01096160|565864826|FG001|Overall Study|Met stopping criteria per protocol|0|||
156757671|NCT01096160|565864827|FG002|Overall Study|Met stopping criteria per protocol|0|||
156757672|NCT01096160|565864828|FG003|Overall Study|Met stopping criteria per protocol|0|||
156757673|NCT01096160|565864829|FG004|Overall Study|Met stopping criteria per protocol|1|||
156757674|NCT01096160|565864830|FG005|Overall Study|Met stopping criteria per protocol|0|||
156757675|NCT01096160|565864831|FG006|Overall Study|Met stopping criteria per protocol|2|||
156757676|NCT01096160|565864832|FG007|Overall Study|Met stopping criteria per protocol|0|||
156757677|NCT01096160|565864833|FG008|Overall Study|Met stopping criteria per protocol|2|||
156757678|NCT01096160|565864834|FG009|Overall Study|Met stopping criteria per protocol|0|||
156757679|NCT00627497|565864835|FG000|Overall Study|Lost to Follow-up|1|||
156757680|NCT00627497|565864836|FG001|Overall Study|Lost to Follow-up|1|||
156757681|NCT00627497|565864837|FG002|Overall Study|Lost to Follow-up|0|||
156757682|NCT00627497|565864838|FG003|Overall Study|Lost to Follow-up|0|||
156757683|NCT02028507|565864839|FG000|Overall Study|Progressive Disease|122|||
156757684|NCT02028507|565864840|FG001|Overall Study|Progressive Disease|90|||
156757685|NCT02028507|565864841|FG002|Overall Study|Progressive Disease|102|||
156757686|NCT02028507|565864842|FG003|Overall Study|Progressive Disease|89|||
156757687|NCT02028507|565864839|FG000|Overall Study|Adverse Event|8|||
156757688|NCT02028507|565864840|FG001|Overall Study|Adverse Event|25|||
156757689|NCT02028507|565864841|FG002|Overall Study|Adverse Event|3|||
156757690|NCT02028507|565864842|FG003|Overall Study|Adverse Event|16|||
156757691|NCT02028507|565864839|FG000|Overall Study|Withdrawal by Subject|6|||
156757692|NCT02028507|565864840|FG001|Overall Study|Withdrawal by Subject|8|||
156757693|NCT02028507|565864841|FG002|Overall Study|Withdrawal by Subject|5|||
156757694|NCT02028507|565864842|FG003|Overall Study|Withdrawal by Subject|9|||
156757695|NCT02028507|565864839|FG000|Overall Study|Protocol Violation|2|||
156757696|NCT02028507|565864840|FG001|Overall Study|Protocol Violation|4|||
157103353|NCT00295633|567134498|FG000|Overall Study|Lack of Efficacy|19|||
157103354|NCT00295633|567134499|FG001|Overall Study|Lack of Efficacy|7|||
157103355|NCT00295633|567134500|FG002|Overall Study|Lack of Efficacy|16|||
157103356|NCT00295633|567134498|FG000|Overall Study|Withdrawal of consent by subject|16|||
156757697|NCT02028507|565864841|FG002|Overall Study|Protocol Violation|1|||
156757698|NCT02028507|565864842|FG003|Overall Study|Protocol Violation|3|||
156757699|NCT02028507|565864839|FG000|Overall Study|Physician Decision|0|||
156757700|NCT02028507|565864840|FG001|Overall Study|Physician Decision|4|||
156757701|NCT02028507|565864841|FG002|Overall Study|Physician Decision|0|||
157103357|NCT00295633|567134499|FG001|Overall Study|Withdrawal of consent by subject|16|||
157103358|NCT00295633|567134500|FG002|Overall Study|Withdrawal of consent by subject|26|||
156757702|NCT02028507|565864842|FG003|Overall Study|Physician Decision|0|||
156757703|NCT02028507|565864839|FG000|Overall Study|Death|1|||
156757704|NCT02028507|565864840|FG001|Overall Study|Death|0|||
156757705|NCT02028507|565864841|FG002|Overall Study|Death|1|||
156757706|NCT02028507|565864842|FG003|Overall Study|Death|3|||
156757707|NCT02028507|565864839|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
156757708|NCT02028507|565864840|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
156757709|NCT02028507|565864841|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
156757710|NCT02028507|565864842|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
156757711|NCT02028507|565864839|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
156757712|NCT02028507|565864840|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
156757713|NCT02028507|565864841|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
156757714|NCT02028507|565864842|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
156757715|NCT02028507|565864839|FG000|Overall Study|Randomized But Not Treated|3|||
156757716|NCT02028507|565864840|FG001|Overall Study|Randomized But Not Treated|6|||
156757717|NCT02028507|565864841|FG002|Overall Study|Randomized But Not Treated|0|||
156757718|NCT02028507|565864842|FG003|Overall Study|Randomized But Not Treated|4|||
156757719|NCT02028507|565864839|FG000|Overall Study|Enzyme defect|0|||
156757720|NCT02028507|565864840|FG001|Overall Study|Enzyme defect|0|||
156757721|NCT02028507|565864841|FG002|Overall Study|Enzyme defect|0|||
156757722|NCT02028507|565864842|FG003|Overall Study|Enzyme defect|1|||
156757723|NCT02028507|565864839|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757724|NCT02028507|565864840|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757725|NCT02028507|565864841|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
156757726|NCT02028507|565864842|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
156757727|NCT02028507|565864839|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
156757728|NCT02028507|565864840|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
156757729|NCT02028507|565864841|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
156757730|NCT02028507|565864842|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
156757731|NCT01556932|565864843|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
156757732|NCT01556932|565864844|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
156757733|NCT00991289|565864847|FG000|Overall Study|Adverse Event|1|||
156757734|NCT00991289|565864847|FG000|Overall Study|Physician Decision|2|||
156757735|NCT00991289|565864847|FG000|Overall Study|Withdrawal by Subject|3|||
156757736|NCT00991289|565864847|FG000|Overall Study|Lost to Follow-up|4|||
156757737|NCT00991289|565864847|FG000|Overall Study|Protocol Violation|2|||
156757738|NCT05464420|565864849|FG000|Overall Study|Death|0|||
156757739|NCT05464420|565864850|FG001|Overall Study|Death|0|||
156757740|NCT05464420|565864851|FG002|Overall Study|Death|0|||
156757741|NCT05464420|565864852|FG003|Overall Study|Death|1|||
156757742|NCT05464420|565864849|FG000|Overall Study|Lost to Follow-up|16|||
156757743|NCT05464420|565864850|FG001|Overall Study|Lost to Follow-up|11|||
156757744|NCT05464420|565864851|FG002|Overall Study|Lost to Follow-up|11|||
156757745|NCT05464420|565864852|FG003|Overall Study|Lost to Follow-up|11|||
156757746|NCT05464420|565864849|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
156757747|NCT05464420|565864850|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
156757748|NCT05464420|565864851|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
156757749|NCT05464420|565864852|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
156757750|NCT05464420|565864849|FG000|Overall Study|Withdrawal by Subject|4|||
156757751|NCT05464420|565864850|FG001|Overall Study|Withdrawal by Subject|8|||
156757752|NCT05464420|565864851|FG002|Overall Study|Withdrawal by Subject|3|||
156757753|NCT05464420|565864852|FG003|Overall Study|Withdrawal by Subject|1|||
156757754|NCT05464420|565864849|FG000|Overall Study|Protocol Violation|0|||
156757755|NCT05464420|565864850|FG001|Overall Study|Protocol Violation|0|||
156757756|NCT05464420|565864851|FG002|Overall Study|Protocol Violation|1|||
156757757|NCT05464420|565864852|FG003|Overall Study|Protocol Violation|1|||
157103359|NCT00295633|567134498|FG000|Overall Study|Adverse Event|9|||
157103360|NCT00295633|567134499|FG001|Overall Study|Adverse Event|17|||
157103361|NCT00295633|567134500|FG002|Overall Study|Adverse Event|9|||
157103362|NCT00295633|567134498|FG000|Overall Study|Lost to Follow-up|6|||
157103363|NCT00295633|567134499|FG001|Overall Study|Lost to Follow-up|11|||
157103364|NCT00295633|567134500|FG002|Overall Study|Lost to Follow-up|7|||
157103365|NCT00295633|567134498|FG000|Overall Study|Physician Decision|9|||
157103366|NCT00295633|567134499|FG001|Overall Study|Physician Decision|10|||
157103367|NCT00295633|567134500|FG002|Overall Study|Physician Decision|8|||
156757758|NCT05464420|565864849|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
156757759|NCT05464420|565864850|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
156757760|NCT05464420|565864851|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
156757761|NCT05464420|565864852|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
156757762|NCT01383018|565864853|FG000|Overall Study|Adverse Event|14|||
156757763|NCT01383018|565864853|FG000|Overall Study|Death|10|||
156757764|NCT01383018|565864853|FG000|Overall Study|Lost to Follow-up|5|||
156757765|NCT01383018|565864853|FG000|Overall Study|Physician Decision|5|||
157103368|NCT00295633|567134498|FG000|Overall Study|Poor/Noncompliance|2|||
157103369|NCT00295633|567134499|FG001|Overall Study|Poor/Noncompliance|2|||
157103370|NCT00295633|567134500|FG002|Overall Study|Poor/Noncompliance|6|||
157103371|NCT00295633|567134498|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
157103372|NCT00295633|567134499|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
157103373|NCT00295633|567134500|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
157103374|NCT00295633|567134498|FG000|Overall Study|Death|1|||
157103375|NCT00295633|567134499|FG001|Overall Study|Death|1|||
157103376|NCT00295633|567134500|FG002|Overall Study|Death|0|||
157103377|NCT00295633|567134498|FG000|Overall Study|Administrative reason by sponsor|0|||
157103378|NCT00295633|567134499|FG001|Overall Study|Administrative reason by sponsor|0|||
157103379|NCT00295633|567134500|FG002|Overall Study|Administrative reason by sponsor|1|||
157103380|NCT01798992|567134501|FG000|Overall Study|Administrative withdrawal|0|||
157103381|NCT01798992|567134502|FG001|Overall Study|Administrative withdrawal|1|||
157103382|NCT01798992|567134503|FG002|Overall Study|Administrative withdrawal|0|||
157103383|NCT01798992|567134504|FG003|Overall Study|Administrative withdrawal|1|||
157103384|NCT01798992|567134501|FG000|Overall Study|Lost to Follow-up|0|||
157103385|NCT01798992|567134502|FG001|Overall Study|Lost to Follow-up|1|||
157103386|NCT01798992|567134503|FG002|Overall Study|Lost to Follow-up|1|||
157103387|NCT01798992|567134504|FG003|Overall Study|Lost to Follow-up|0|||
157103388|NCT01798992|567134501|FG000|Overall Study|Insufficient biopsy tissue|0|||
157103389|NCT01798992|567134502|FG001|Overall Study|Insufficient biopsy tissue|0|||
157103390|NCT01798992|567134503|FG002|Overall Study|Insufficient biopsy tissue|1|||
157103391|NCT01798992|567134504|FG003|Overall Study|Insufficient biopsy tissue|0|||
157103392|NCT02294682|567134505|FG000|Overall Study|Could not swallow pills|1|||
157103393|NCT02294682|567134506|FG001|Overall Study|Could not swallow pills|0|||
157103394|NCT01516970|567134507|FG000|Overall Study|Lost to Follow-up|7|||
157103395|NCT01516970|567134508|FG001|Overall Study|Lost to Follow-up|8|||
157103396|NCT01516970|567134507|FG000|Overall Study|Adverse Event|1|||
157103397|NCT01516970|567134508|FG001|Overall Study|Adverse Event|5|||
157103398|NCT01516970|567134507|FG000|Overall Study|Withdrawal by Subject|1|||
157103399|NCT01516970|567134508|FG001|Overall Study|Withdrawal by Subject|1|||
157103400|NCT01516970|567134507|FG000|Overall Study|Other|9|||
157103401|NCT01516970|567134508|FG001|Overall Study|Other|7|||
157103402|NCT00434421|567134509|FG000|Overall Study|Withdrawal by Subject|1|||
157103403|NCT00434421|567134509|FG000|Overall Study|Non-compliance with study treatment|1|||
157103404|NCT01205438|567134510|FG000|Overall Study|Adverse Event|19|||
157103405|NCT01205438|567134511|FG001|Overall Study|Adverse Event|17|||
157103406|NCT01205438|567134512|FG002|Overall Study|Adverse Event|24|||
157103407|NCT01205438|567134510|FG000|Overall Study|Death|1|||
157103408|NCT01205438|567134511|FG001|Overall Study|Death|1|||
157103409|NCT01205438|567134512|FG002|Overall Study|Death|3|||
157103410|NCT01205438|567134510|FG000|Overall Study|Entry Criteria Not Met|16|||
157103411|NCT01205438|567134511|FG001|Overall Study|Entry Criteria Not Met|15|||
157103412|NCT01205438|567134512|FG002|Overall Study|Entry Criteria Not Met|13|||
157103413|NCT01205438|567134510|FG000|Overall Study|Lack of Efficacy|14|||
157103414|NCT01205438|567134511|FG001|Overall Study|Lack of Efficacy|11|||
157103415|NCT01205438|567134512|FG002|Overall Study|Lack of Efficacy|14|||
157103416|NCT01205438|567134510|FG000|Overall Study|Lost to Follow-up|6|||
157103417|NCT01205438|567134511|FG001|Overall Study|Lost to Follow-up|7|||
157103418|NCT01205438|567134512|FG002|Overall Study|Lost to Follow-up|8|||
157103419|NCT01205438|567134510|FG000|Overall Study|Withdrawal by Subject|19|||
157103420|NCT01205438|567134511|FG001|Overall Study|Withdrawal by Subject|25|||
157103421|NCT01205438|567134512|FG002|Overall Study|Withdrawal by Subject|19|||
157103422|NCT01205438|567134510|FG000|Overall Study|Physician Decision|0|||
157103423|NCT01205438|567134511|FG001|Overall Study|Physician Decision|3|||
157103424|NCT01205438|567134512|FG002|Overall Study|Physician Decision|2|||
157103425|NCT01205438|567134510|FG000|Overall Study|Protocol Violation|2|||
157103426|NCT01205438|567134511|FG001|Overall Study|Protocol Violation|7|||
157103427|NCT01205438|567134512|FG002|Overall Study|Protocol Violation|4|||
157103428|NCT01205438|567134510|FG000|Overall Study|Sponsor Decision|0|||
157103429|NCT01205438|567134511|FG001|Overall Study|Sponsor Decision|1|||
157103430|NCT01205438|567134512|FG002|Overall Study|Sponsor Decision|1|||
157103431|NCT03823404|567134513|FG000|Overall Study|Lost to Follow-up|1|||
157103432|NCT03823404|567134514|FG001|Overall Study|Lost to Follow-up|2|||
157103433|NCT03823404|567134515|FG002|Overall Study|Lost to Follow-up|3|||
157103434|NCT03823404|567134513|FG000|Overall Study|Protocol Violation|2|||
157103435|NCT03823404|567134514|FG001|Overall Study|Protocol Violation|0|||
157103436|NCT03823404|567134515|FG002|Overall Study|Protocol Violation|2|||
157103437|NCT03823404|567134513|FG000|Overall Study|Adverse Event|35|||
157103438|NCT03823404|567134514|FG001|Overall Study|Adverse Event|38|||
157103439|NCT03823404|567134515|FG002|Overall Study|Adverse Event|8|||
157103440|NCT03823404|567134513|FG000|Overall Study|Withdrawal by Subject|38|||
157103441|NCT03823404|567134514|FG001|Overall Study|Withdrawal by Subject|40|||
157103442|NCT03823404|567134515|FG002|Overall Study|Withdrawal by Subject|35|||
157103443|NCT03823404|567134513|FG000|Overall Study|Death|4|||
157103444|NCT03823404|567134514|FG001|Overall Study|Death|0|||
157103445|NCT03823404|567134515|FG002|Overall Study|Death|0|||
157103446|NCT03823404|567134513|FG000|Overall Study|Other: Various reasons provided|5|||
156757766|NCT01383018|565864853|FG000|Overall Study|Withdrawal by Subject|9|||
156757767|NCT01383018|565864853|FG000|Overall Study|Subject not implanted|76|||
156757768|NCT01383018|565864853|FG000|Overall Study|Missed Visit|247|||
156757769|NCT01383018|565864853|FG000|Overall Study|Site closed early-not compliance related|7|||
157103447|NCT03823404|567134514|FG001|Overall Study|Other: Various reasons provided|5|||
157103448|NCT03823404|567134515|FG002|Overall Study|Other: Various reasons provided|6|||
157103449|NCT01087957|567134518|FG000|Overall Study|Death|2|||
157103450|NCT01087957|567134519|FG001|Overall Study|Death|2|||
157103451|NCT01087957|567134518|FG000|Overall Study|Lost to Follow-up|3|||
157103452|NCT01087957|567134519|FG001|Overall Study|Lost to Follow-up|4|||
157103453|NCT01087957|567134518|FG000|Overall Study|Protocol Violation|13|||
157103454|NCT01087957|567134519|FG001|Overall Study|Protocol Violation|25|||
157103455|NCT01087957|567134518|FG000|Overall Study|Withdrawal by Subject|18|||
157103456|NCT01087957|567134519|FG001|Overall Study|Withdrawal by Subject|15|||
157103457|NCT01087957|567134518|FG000|Overall Study|Physician Decision|5|||
157103458|NCT01087957|567134519|FG001|Overall Study|Physician Decision|9|||
157103459|NCT03842163|567134521|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
157103460|NCT03842163|567134521|FG000|Overall Study|Scintigraphy was not performed|44|||
157103461|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
157103462|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
157103463|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
157103464|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
157103465|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
157103466|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
157103467|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
157103468|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
157103469|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
157103470|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
157103471|NCT03829241|567134525|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
157103472|NCT03829241|567134526|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
157103473|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
157103474|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
157103475|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
157103476|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
157103477|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
157103478|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
157103479|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
157103480|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
157103481|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
157103482|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
157103483|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
157103484|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
157103485|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
157103486|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
157103487|NCT03829241|567134525|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
157103488|NCT03829241|567134526|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
157103489|NCT00698451|567134527|FG000|Overall Study|Adverse Event|22|||
157103490|NCT00698451|567134527|FG000|Overall Study|Physician Decision|2|||
157103491|NCT00698451|567134527|FG000|Overall Study|Protocol Violation|6|||
157103492|NCT00698451|567134527|FG000|Overall Study|Withdrawal by Subject|6|||
157103493|NCT00698451|567134527|FG000|Overall Study|Disease progression|3|||
157103494|NCT02224599|567134530|FG000|Overall Study|Physician Decision|1|||
157103495|NCT02224599|567134530|FG000|Overall Study|Progression of Disease|1|||
157103496|NCT01187550|567134532|FG000|Overall Study|Protocol Violation|3|||
157103497|NCT01187550|567134533|FG001|Overall Study|Protocol Violation|1|||
157103498|NCT01187550|567134532|FG000|Overall Study|Other|3|||
157103499|NCT01187550|567134533|FG001|Overall Study|Other|0|||
157103500|NCT01187550|567134532|FG000|Overall Study|Randomized but not treated|8|||
157103501|NCT01187550|567134533|FG001|Overall Study|Randomized but not treated|0|||
156757770|NCT01383018|565864853|FG000|Overall Study|Patient moved away from site|1|||
156757771|NCT01383018|565864853|FG000|Overall Study|Subject Incarcerated|1|||
157103502|NCT00129623|567134534|FG000|Overall Study|Adverse Event|3|||
157103503|NCT00129623|567134535|FG001|Overall Study|Adverse Event|7|||
157103504|NCT00129623|567134534|FG000|Overall Study|Refused Treatment|5|||
157103505|NCT00129623|567134535|FG001|Overall Study|Refused Treatment|3|||
157103506|NCT00129623|567134534|FG000|Overall Study|Failure to Return|1|||
157103507|NCT00129623|567134535|FG001|Overall Study|Failure to Return|1|||
157103508|NCT00129623|567134534|FG000|Overall Study|Relocated job out of state|1|||
157103509|NCT00129623|567134535|FG001|Overall Study|Relocated job out of state|0|||
157103510|NCT00129623|567134534|FG000|Overall Study|Uncertainty to return|0|||
156757772|NCT03414229|565864854|FG000|Overall Study|Adverse Event|1|||
157103511|NCT00129623|567134535|FG001|Overall Study|Uncertainty to return|1|||
157103512|NCT00596934|567134536|FG000|Overall Study|Protocol Violation|1|||
157103513|NCT00596934|567134536|FG000|Overall Study|Withdrawal by Subject|1|||
157103514|NCT02315898|567134539|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
157103515|NCT02315898|567134540|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
157103516|NCT02315898|567134541|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
157103517|NCT02315898|567134542|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
157103518|NCT02445755|567134543|FG000|Overall Study|Withdrawal by Subject|2|||
157103519|NCT02445755|567134543|FG000|Overall Study|Protocol Violation|6|||
157103520|NCT02445755|567134543|FG000|Overall Study|Screen Failure|5|||
157103521|NCT01296035|567134554|FG000|Overall Study|Withdrawal by Subject|1|||
157103522|NCT01674712|567134555|FG000|Overall Study|Adverse Event|5|||
157103523|NCT01674712|567134556|FG001|Overall Study|Adverse Event|6|||
157103524|NCT01674712|567134557|FG002|Overall Study|Adverse Event|3|||
157103525|NCT01674712|567134558|FG003|Overall Study|Adverse Event|4|||
157103526|NCT01674712|567134559|FG004|Overall Study|Adverse Event|6|||
157103527|NCT01674712|567134555|FG000|Overall Study|Lost to Follow-up|1|||
157103528|NCT01674712|567134556|FG001|Overall Study|Lost to Follow-up|0|||
157103529|NCT01674712|567134557|FG002|Overall Study|Lost to Follow-up|0|||
157103530|NCT01674712|567134558|FG003|Overall Study|Lost to Follow-up|0|||
157103531|NCT01674712|567134559|FG004|Overall Study|Lost to Follow-up|0|||
157103532|NCT01674712|567134555|FG000|Overall Study|Protocol Violation|2|||
157103533|NCT01674712|567134556|FG001|Overall Study|Protocol Violation|0|||
157103534|NCT01674712|567134557|FG002|Overall Study|Protocol Violation|0|||
157103535|NCT01674712|567134558|FG003|Overall Study|Protocol Violation|0|||
157103536|NCT01674712|567134559|FG004|Overall Study|Protocol Violation|0|||
157103537|NCT01674712|567134555|FG000|Overall Study|Withdrawal by Subject|2|||
157103538|NCT01674712|567134556|FG001|Overall Study|Withdrawal by Subject|2|||
157103539|NCT01674712|567134557|FG002|Overall Study|Withdrawal by Subject|5|||
157103540|NCT01674712|567134558|FG003|Overall Study|Withdrawal by Subject|4|||
157103541|NCT01674712|567134559|FG004|Overall Study|Withdrawal by Subject|3|||
157103542|NCT01674712|567134555|FG000|Overall Study|Administrative|0|||
157103543|NCT01674712|567134556|FG001|Overall Study|Administrative|1|||
157103544|NCT01674712|567134557|FG002|Overall Study|Administrative|0|||
157103545|NCT01674712|567134558|FG003|Overall Study|Administrative|0|||
157103546|NCT01674712|567134559|FG004|Overall Study|Administrative|1|||
157103547|NCT01674712|567134555|FG000|Overall Study|Lack of Efficacy|0|||
157103548|NCT01674712|567134556|FG001|Overall Study|Lack of Efficacy|0|||
157103549|NCT01674712|567134557|FG002|Overall Study|Lack of Efficacy|1|||
157103550|NCT01674712|567134558|FG003|Overall Study|Lack of Efficacy|0|||
157103551|NCT01674712|567134559|FG004|Overall Study|Lack of Efficacy|1|||
157103552|NCT05372653|567134566|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
157103553|NCT05372653|567134567|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
157103554|NCT05372653|567134566|FG000|Overall Study|Adverse Event|0|||
157103555|NCT05372653|567134567|FG001|Overall Study|Adverse Event|1|||
157103556|NCT00117507|567134568|FG000|Overall Study|Adverse Event|4|||
157103557|NCT00117507|567134568|FG000|Overall Study|Abnormal laboratory values|3|||
157103558|NCT00117507|567134568|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157103559|NCT00117507|567134568|FG000|Overall Study|Patient withdrew consent|4|||
157103560|NCT00117507|567134568|FG000|Overall Study|Death|3|||
157103561|NCT00866723|567134569|FG000|Overall Study|Withdrawal by Subject|1|||
157103562|NCT00866723|567134569|FG000|Overall Study|Disease Progression|4|||
157103563|NCT03740997|567134572|FG000|Overall Study|Withdrawal by Subject|1|||
157103564|NCT03740997|567134573|FG001|Overall Study|Withdrawal by Subject|0|||
157103565|NCT03740997|567134572|FG000|Overall Study|Participant was unable to complete study procedures|1|||
157103566|NCT03740997|567134573|FG001|Overall Study|Participant was unable to complete study procedures|0|||
157103567|NCT01003990|567134574|FG000|Overall Study|Adverse Event|8|||
157103568|NCT01003990|567134575|FG001|Overall Study|Adverse Event|5|||
157103569|NCT01003990|567134576|FG002|Overall Study|Adverse Event|11|||
157103570|NCT01003990|567134574|FG000|Overall Study|Death|0|||
156757773|NCT03414229|565864855|FG001|Overall Study|Adverse Event|0|||
156757774|NCT03414229|565864856|FG002|Overall Study|Adverse Event|2|||
156757775|NCT03414229|565864857|FG003|Overall Study|Adverse Event|1|||
156757776|NCT03414229|565864854|FG000|Overall Study|Lack of Efficacy|7|||
156757777|NCT03414229|565864855|FG001|Overall Study|Lack of Efficacy|4|||
157103571|NCT01003990|567134575|FG001|Overall Study|Death|8|||
157103572|NCT01003990|567134576|FG002|Overall Study|Death|1|||
157103573|NCT01003990|567134574|FG000|Overall Study|Lack of Efficacy|10|||
157103574|NCT01003990|567134575|FG001|Overall Study|Lack of Efficacy|2|||
157103575|NCT01003990|567134576|FG002|Overall Study|Lack of Efficacy|3|||
157103576|NCT01003990|567134574|FG000|Overall Study|Lost to Follow-up|30|||
157103577|NCT01003990|567134575|FG001|Overall Study|Lost to Follow-up|12|||
157103578|NCT01003990|567134576|FG002|Overall Study|Lost to Follow-up|7|||
157103579|NCT01003990|567134574|FG000|Overall Study|Reasons Not Identified|14|||
157103580|NCT01003990|567134575|FG001|Overall Study|Reasons Not Identified|13|||
156757778|NCT03414229|565864856|FG002|Overall Study|Lack of Efficacy|1|||
156757779|NCT03414229|565864857|FG003|Overall Study|Lack of Efficacy|9|||
156757780|NCT03414229|565864854|FG000|Overall Study|Change in therapy|1|||
156757781|NCT03414229|565864855|FG001|Overall Study|Change in therapy|0|||
156757782|NCT03414229|565864856|FG002|Overall Study|Change in therapy|0|||
156757783|NCT03414229|565864857|FG003|Overall Study|Change in therapy|0|||
156757784|NCT03414229|565864854|FG000|Overall Study|Pregnancy|0|||
156757785|NCT03414229|565864855|FG001|Overall Study|Pregnancy|0|||
156757786|NCT03414229|565864856|FG002|Overall Study|Pregnancy|1|||
156757787|NCT03414229|565864857|FG003|Overall Study|Pregnancy|0|||
156757788|NCT03414229|565864854|FG000|Overall Study|Withdrawal by Subject|0|||
156757789|NCT03414229|565864855|FG001|Overall Study|Withdrawal by Subject|1|||
156757790|NCT03414229|565864856|FG002|Overall Study|Withdrawal by Subject|1|||
156757791|NCT03414229|565864857|FG003|Overall Study|Withdrawal by Subject|0|||
156757792|NCT05568797|565864860|FG000|Overall Study|Adverse Event|0|||
156757793|NCT05568797|565864861|FG001|Overall Study|Adverse Event|8|||
156757794|NCT05568797|565864860|FG000|Overall Study|Lost to Follow-up|2|||
156757795|NCT05568797|565864861|FG001|Overall Study|Lost to Follow-up|3|||
156757796|NCT05568797|565864860|FG000|Overall Study|Withdrawal by Subject|1|||
156757797|NCT05568797|565864861|FG001|Overall Study|Withdrawal by Subject|10|||
156757798|NCT05568797|565864860|FG000|Overall Study|Other|2|||
156757799|NCT05568797|565864861|FG001|Overall Study|Other|2|||
156757800|NCT00099632|565864862|FG000|Overall Study|Lost to Follow-up|1|||
156757801|NCT00099632|565864863|FG001|Overall Study|Lost to Follow-up|0|||
156757802|NCT00099632|565864864|FG002|Overall Study|Lost to Follow-up|3|||
156757803|NCT00099632|565864865|FG003|Overall Study|Lost to Follow-up|1|||
156757804|NCT00099632|565864866|FG004|Overall Study|Lost to Follow-up|1|||
156757805|NCT00099632|565864867|FG005|Overall Study|Lost to Follow-up|0|||
156757806|NCT00099632|565864862|FG000|Overall Study|Withdrawal by Subject|0|||
156757807|NCT00099632|565864863|FG001|Overall Study|Withdrawal by Subject|1|||
156757808|NCT00099632|565864864|FG002|Overall Study|Withdrawal by Subject|0|||
156757809|NCT00099632|565864865|FG003|Overall Study|Withdrawal by Subject|0|||
156757810|NCT00099632|565864866|FG004|Overall Study|Withdrawal by Subject|0|||
156757811|NCT00099632|565864867|FG005|Overall Study|Withdrawal by Subject|1|||
156757812|NCT00099632|565864862|FG000|Overall Study|Protocol Violation|0|||
156757813|NCT00099632|565864863|FG001|Overall Study|Protocol Violation|0|||
156757814|NCT00099632|565864864|FG002|Overall Study|Protocol Violation|0|||
156757815|NCT00099632|565864865|FG003|Overall Study|Protocol Violation|0|||
156757816|NCT00099632|565864866|FG004|Overall Study|Protocol Violation|0|||
156757817|NCT00099632|565864867|FG005|Overall Study|Protocol Violation|1|||
156757818|NCT03131687|565864868|FG000|Overall Study|Adverse Event|0|||
156757819|NCT03131687|565864869|FG001|Overall Study|Adverse Event|1|||
156757820|NCT03131687|565864870|FG002|Overall Study|Adverse Event|0|||
156757821|NCT03131687|565864871|FG003|Overall Study|Adverse Event|1|||
156757822|NCT03131687|565864872|FG004|Overall Study|Adverse Event|2|||
156757823|NCT03131687|565864873|FG005|Overall Study|Adverse Event|2|||
156757824|NCT03131687|565864868|FG000|Overall Study|Death|1|||
156757825|NCT03131687|565864869|FG001|Overall Study|Death|0|||
157103581|NCT01003990|567134576|FG002|Overall Study|Reasons Not Identified|8|||
157103582|NCT01003990|567134574|FG000|Overall Study|Poor/Non-compliance|4|||
157103583|NCT01003990|567134575|FG001|Overall Study|Poor/Non-compliance|3|||
157103584|NCT01003990|567134576|FG002|Overall Study|Poor/Non-compliance|2|||
157103585|NCT01003990|567134574|FG000|Overall Study|Pregnancy|10|||
157103586|NCT01003990|567134575|FG001|Overall Study|Pregnancy|2|||
157103587|NCT01003990|567134576|FG002|Overall Study|Pregnancy|4|||
157103588|NCT01003990|567134574|FG000|Overall Study|No Longer Met Study Criteria|4|||
157103589|NCT01003990|567134575|FG001|Overall Study|No Longer Met Study Criteria|1|||
157103590|NCT01003990|567134576|FG002|Overall Study|No Longer Met Study Criteria|0|||
157103591|NCT01003990|567134574|FG000|Overall Study|Subject Withdrew Consent|12|||
157103592|NCT01003990|567134575|FG001|Overall Study|Subject Withdrew Consent|5|||
157103593|NCT01003990|567134576|FG002|Overall Study|Subject Withdrew Consent|7|||
157103594|NCT01271803|567134577|FG000|Overall Study|Progressive disease|0|||
157103595|NCT01271803|567134578|FG001|Overall Study|Progressive disease|0|||
157103596|NCT01271803|567134579|FG002|Overall Study|Progressive disease|2|||
156757826|NCT03131687|565864870|FG002|Overall Study|Death|0|||
156757827|NCT03131687|565864871|FG003|Overall Study|Death|0|||
157103597|NCT01271803|567134577|FG000|Overall Study|Death|53|||
156757828|NCT03131687|565864872|FG004|Overall Study|Death|0|||
157103598|NCT01271803|567134578|FG001|Overall Study|Death|34|||
157103599|NCT01271803|567134579|FG002|Overall Study|Death|0|||
156757829|NCT03131687|565864873|FG005|Overall Study|Death|0|||
156757830|NCT03131687|565864868|FG000|Overall Study|Withdrawal by Subject|3|||
156757831|NCT03131687|565864869|FG001|Overall Study|Withdrawal by Subject|3|||
157103600|NCT01271803|567134577|FG000|Overall Study|Withdrawal by Subject|1|||
157103601|NCT01271803|567134578|FG001|Overall Study|Withdrawal by Subject|5|||
156757832|NCT03131687|565864870|FG002|Overall Study|Withdrawal by Subject|3|||
156757833|NCT03131687|565864871|FG003|Overall Study|Withdrawal by Subject|1|||
156757834|NCT03131687|565864872|FG004|Overall Study|Withdrawal by Subject|2|||
156757835|NCT03131687|565864873|FG005|Overall Study|Withdrawal by Subject|1|||
157103602|NCT01271803|567134579|FG002|Overall Study|Withdrawal by Subject|0|||
157103603|NCT01271803|567134577|FG000|Overall Study|Lost to Follow-up|1|||
157103604|NCT01271803|567134578|FG001|Overall Study|Lost to Follow-up|0|||
156757836|NCT03131687|565864868|FG000|Overall Study|Lost to Follow-up|1|||
156757837|NCT03131687|565864869|FG001|Overall Study|Lost to Follow-up|4|||
156757838|NCT03131687|565864870|FG002|Overall Study|Lost to Follow-up|0|||
156757839|NCT03131687|565864871|FG003|Overall Study|Lost to Follow-up|1|||
156757840|NCT03131687|565864872|FG004|Overall Study|Lost to Follow-up|4|||
156757841|NCT03131687|565864873|FG005|Overall Study|Lost to Follow-up|2|||
156757842|NCT03131687|565864868|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
156757843|NCT03131687|565864869|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
156757844|NCT03131687|565864870|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
156757845|NCT03131687|565864871|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
156757846|NCT03131687|565864872|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
156757847|NCT03131687|565864873|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
156757848|NCT03131687|565864868|FG000|Overall Study|Principle Investigator Decision|0|||
156757849|NCT03131687|565864869|FG001|Overall Study|Principle Investigator Decision|1|||
156757850|NCT03131687|565864870|FG002|Overall Study|Principle Investigator Decision|0|||
156757851|NCT03131687|565864871|FG003|Overall Study|Principle Investigator Decision|0|||
156757852|NCT03131687|565864872|FG004|Overall Study|Principle Investigator Decision|0|||
156757853|NCT03131687|565864873|FG005|Overall Study|Principle Investigator Decision|0|||
156757854|NCT03131687|565864868|FG000|Overall Study|Inadvertent Enrollment|0|||
156757855|NCT03131687|565864869|FG001|Overall Study|Inadvertent Enrollment|0|||
156757856|NCT03131687|565864870|FG002|Overall Study|Inadvertent Enrollment|0|||
156757857|NCT03131687|565864871|FG003|Overall Study|Inadvertent Enrollment|1|||
156757858|NCT03131687|565864872|FG004|Overall Study|Inadvertent Enrollment|0|||
156757859|NCT03131687|565864873|FG005|Overall Study|Inadvertent Enrollment|0|||
156757860|NCT02797678|565864874|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
156757861|NCT02797678|565864875|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757862|NCT02797678|565864876|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757863|NCT02797678|565864877|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
156757864|NCT02797678|565864874|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
157000570|NCT03536884|566751417|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
157000571|NCT03536884|566751406|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000572|NCT03536884|566751407|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000573|NCT03536884|566751408|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000574|NCT03536884|566751409|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000575|NCT03536884|566751410|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000576|NCT03536884|566751411|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000577|NCT03536884|566751412|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000578|NCT03536884|566751413|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000579|NCT03536884|566751414|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
157000580|NCT03536884|566751415|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
157000581|NCT03536884|566751416|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
157000582|NCT03536884|566751417|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
157000583|NCT03536884|566751406|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000584|NCT03536884|566751407|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000585|NCT03536884|566751408|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000586|NCT03536884|566751409|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000587|NCT03536884|566751410|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000588|NCT03536884|566751411|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000589|NCT03536884|566751412|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000590|NCT03536884|566751413|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000591|NCT03536884|566751414|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
157000592|NCT03536884|566751415|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
157000593|NCT03536884|566751416|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
157000594|NCT03536884|566751417|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
157000595|NCT03536884|566751406|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000596|NCT03536884|566751407|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000597|NCT03536884|566751408|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000598|NCT03536884|566751409|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000599|NCT03536884|566751410|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000600|NCT03536884|566751411|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000601|NCT03536884|566751412|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000602|NCT03536884|566751413|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000603|NCT03536884|566751414|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
156757865|NCT02797678|565864875|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
156757866|NCT02797678|565864876|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
156757867|NCT02797678|565864877|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
157103605|NCT01271803|567134579|FG002|Overall Study|Lost to Follow-up|0|||
157103606|NCT01975428|567134583|FG000|Overall Study|Lost to Follow-up|17|||
157103607|NCT01975428|567134584|FG001|Overall Study|Lost to Follow-up|4|||
157103608|NCT01975428|567134583|FG000|Overall Study|Withdrawal by Subject|3|||
156757868|NCT02797678|565864874|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757869|NCT02797678|565864875|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757870|NCT02797678|565864876|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
156757871|NCT02797678|565864877|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
156757872|NCT02401035|565864878|FG000|Overall Study|Withdrawal by Subject|1|||
156757873|NCT02401035|565864879|FG001|Overall Study|Withdrawal by Subject|0|||
156757874|NCT00869128|565864880|FG000|Overall Study|lack of Compliance|6|||
156757875|NCT00869128|565864881|FG001|Overall Study|lack of Compliance|6|||
156757876|NCT01118663|565864888|FG000|Overall Study|Adverse Event|2|||
156757877|NCT01118663|565864889|FG001|Overall Study|Adverse Event|1|||
156757878|NCT01118663|565864888|FG000|Overall Study|Withdrawal by Subject|0|||
156757879|NCT01118663|565864889|FG001|Overall Study|Withdrawal by Subject|1|||
156757880|NCT03046953|565864896|FG000|Overall Study|Relapse/progressive disease|21|||
156757881|NCT03046953|565864896|FG000|Overall Study|Death|2|||
156757882|NCT03046953|565864896|FG000|Overall Study|Withdrawal by Subject|3|||
156757883|NCT04039204|565864897|FG000|Overall Study|Withdrawal by Subject|0|||
156757884|NCT04039204|565864898|FG001|Overall Study|Withdrawal by Subject|2|||
156757885|NCT00420628|565864899|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
156757886|NCT00420628|565864900|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
156757887|NCT00420628|565864899|FG000|Overall Study|Lost to Follow-up|3|||
156757888|NCT00420628|565864900|FG001|Overall Study|Lost to Follow-up|2|||
156757889|NCT00420628|565864899|FG000|Overall Study|Adverse Event|1|||
156757890|NCT00420628|565864900|FG001|Overall Study|Adverse Event|0|||
156757891|NCT02716584|565864901|FG000|Overall Study|Lost to Follow-up|8|||
156757892|NCT02716584|565864902|FG001|Overall Study|Lost to Follow-up|5|||
156757893|NCT00656175|565864905|FG000|Overall Study|Adverse Event|1|||
157103609|NCT01975428|567134584|FG001|Overall Study|Withdrawal by Subject|10|||
157103610|NCT01505010|567134585|FG000|Overall Study|Protocol Violation|0|||
157103611|NCT01505010|567134586|FG001|Overall Study|Protocol Violation|1|||
157103612|NCT01505010|567134585|FG000|Overall Study|Lost to Follow-up|0|||
157103613|NCT01505010|567134586|FG001|Overall Study|Lost to Follow-up|1|||
157103614|NCT00995007|567134591|FG000|Overall Study|Withdrew consent|1|||
157103615|NCT00995007|567134592|FG001|Overall Study|Withdrew consent|0|||
157103616|NCT00995007|567134591|FG000|Overall Study|Refused further treatment|8|||
157103617|NCT00995007|567134592|FG001|Overall Study|Refused further treatment|2|||
157103618|NCT00995007|567134591|FG000|Overall Study|Toxicity|8|||
157103619|NCT00995007|567134592|FG001|Overall Study|Toxicity|0|||
157103620|NCT01621542|567134593|FG000|Overall Study|Adverse Event|0|||
157103621|NCT01621542|567134594|FG001|Overall Study|Adverse Event|0|||
157103622|NCT01621542|567134595|FG002|Overall Study|Adverse Event|1|||
157103623|NCT01621542|567134596|FG003|Overall Study|Adverse Event|3|||
157103624|NCT01621542|567134597|FG004|Overall Study|Adverse Event|0|||
157103625|NCT01621542|567134598|FG005|Overall Study|Adverse Event|0|||
157103626|NCT01621542|567134593|FG000|Overall Study|Death|0|||
157103627|NCT01621542|567134594|FG001|Overall Study|Death|1|||
157103628|NCT01621542|567134595|FG002|Overall Study|Death|0|||
157103629|NCT01621542|567134596|FG003|Overall Study|Death|0|||
157103630|NCT01621542|567134597|FG004|Overall Study|Death|0|||
157103631|NCT01621542|567134598|FG005|Overall Study|Death|0|||
157103632|NCT01621542|567134593|FG000|Overall Study|Physician Decision|1|||
157103633|NCT01621542|567134594|FG001|Overall Study|Physician Decision|0|||
156757894|NCT00656175|565864906|FG001|Overall Study|Adverse Event|0|||
156757895|NCT00656175|565864905|FG000|Overall Study|Transportation issues|0|||
156757896|NCT00656175|565864906|FG001|Overall Study|Transportation issues|1|||
156757897|NCT01216332|565864907|FG000|Overall Study|Withdrawal by Subject|4|||
156757898|NCT01216332|565864908|FG001|Overall Study|Withdrawal by Subject|0|||
156757899|NCT01237327|565864909|FG000|Overall Study|Protocol Violation: Core Study|1|||
156757900|NCT01237327|565864910|FG001|Overall Study|Protocol Violation: Core Study|0|||
156757901|NCT01237327|565864909|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
157103634|NCT01621542|567134595|FG002|Overall Study|Physician Decision|1|||
157103635|NCT01621542|567134596|FG003|Overall Study|Physician Decision|13|||
156757902|NCT01237327|565864910|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
157103636|NCT01621542|567134597|FG004|Overall Study|Physician Decision|3|||
157103637|NCT01621542|567134598|FG005|Overall Study|Physician Decision|1|||
156757903|NCT01237327|565864909|FG000|Overall Study|Progression of Disease: Core Study|18|||
156757904|NCT01237327|565864910|FG001|Overall Study|Progression of Disease: Core Study|22|||
156757905|NCT01237327|565864909|FG000|Overall Study|Progression of Disease: Extension Study|15|||
157103638|NCT01621542|567134593|FG000|Overall Study|Withdrawal by Subject|2|||
157103639|NCT01621542|567134594|FG001|Overall Study|Withdrawal by Subject|0|||
157103640|NCT01621542|567134595|FG002|Overall Study|Withdrawal by Subject|1|||
157103641|NCT01621542|567134596|FG003|Overall Study|Withdrawal by Subject|3|||
157103642|NCT01621542|567134597|FG004|Overall Study|Withdrawal by Subject|3|||
157103643|NCT01621542|567134598|FG005|Overall Study|Withdrawal by Subject|3|||
157103644|NCT01621542|567134593|FG000|Overall Study|progression/treatment failure|2|||
157103645|NCT01621542|567134594|FG001|Overall Study|progression/treatment failure|4|||
157103646|NCT01621542|567134595|FG002|Overall Study|progression/treatment failure|3|||
157103647|NCT01621542|567134596|FG003|Overall Study|progression/treatment failure|7|||
157103648|NCT01621542|567134597|FG004|Overall Study|progression/treatment failure|3|||
157103649|NCT01621542|567134598|FG005|Overall Study|progression/treatment failure|5|||
157103650|NCT01621542|567134593|FG000|Overall Study|Protocol Violation|0|||
157103651|NCT01621542|567134594|FG001|Overall Study|Protocol Violation|0|||
157103652|NCT01621542|567134595|FG002|Overall Study|Protocol Violation|0|||
157103653|NCT01621542|567134596|FG003|Overall Study|Protocol Violation|1|||
156757906|NCT01237327|565864910|FG001|Overall Study|Progression of Disease: Extension Study|13|||
156757907|NCT01237327|565864909|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
156757908|NCT01237327|565864910|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
156757909|NCT01237327|565864909|FG000|Overall Study|Withdrawal by Subject|1|||
156757910|NCT01237327|565864910|FG001|Overall Study|Withdrawal by Subject|3|||
156757911|NCT01237327|565864909|FG000|Overall Study|Lost to Follow-up|3|||
156757912|NCT01237327|565864910|FG001|Overall Study|Lost to Follow-up|0|||
156757913|NCT03300180|565864911|FG000|Baseline|Withdrawal by Subject|4|||
156757914|NCT03300180|565864912|FG001|Baseline|Withdrawal by Subject|6|||
156757915|NCT03300180|565864913|FG002|Baseline|Withdrawal by Subject|4|||
156757916|NCT03300180|565864911|FG000|6 Month Outcome|Withdrawal by Subject|12|||
156757917|NCT03300180|565864912|FG001|6 Month Outcome|Withdrawal by Subject|12|||
156757918|NCT03300180|565864913|FG002|6 Month Outcome|Withdrawal by Subject|19|||
156757919|NCT03300180|565864911|FG000|6 Month Outcome|Death|2|||
156757920|NCT03300180|565864912|FG001|6 Month Outcome|Death|4|||
156757921|NCT03300180|565864913|FG002|6 Month Outcome|Death|3|||
156757922|NCT03300180|565864911|FG000|6 Month Outcome|Missed Assessment|43|||
156757923|NCT03300180|565864912|FG001|6 Month Outcome|Missed Assessment|52|||
156757924|NCT03300180|565864913|FG002|6 Month Outcome|Missed Assessment|46|||
157103654|NCT01621542|567134597|FG004|Overall Study|Protocol Violation|0|||
157103655|NCT01621542|567134598|FG005|Overall Study|Protocol Violation|0|||
157103656|NCT01621542|567134593|FG000|Overall Study|study stopped by sponsor|0|||
157103657|NCT01621542|567134594|FG001|Overall Study|study stopped by sponsor|0|||
157103658|NCT01621542|567134595|FG002|Overall Study|study stopped by sponsor|0|||
157103659|NCT01621542|567134596|FG003|Overall Study|study stopped by sponsor|1|||
157103660|NCT01621542|567134597|FG004|Overall Study|study stopped by sponsor|0|||
157103661|NCT01621542|567134598|FG005|Overall Study|study stopped by sponsor|0|||
157103662|NCT01368042|567134599|FG000|Overall Study|Death|14|||
157103663|NCT01368042|567134599|FG000|Overall Study|Protocol Violation|11|||
157103664|NCT01368042|567134599|FG000|Overall Study|Lost to Follow-up|4|||
157103665|NCT01368042|567134599|FG000|Overall Study|Transplanted|1|||
157103666|NCT00544648|567134604|FG000|Overall Study|Withdrawal by Subject|1|||
157103667|NCT00544648|567134605|FG001|Overall Study|Withdrawal by Subject|0|||
157103668|NCT00544648|567134604|FG000|Overall Study|Adverse Event|1|||
157103669|NCT00544648|567134605|FG001|Overall Study|Adverse Event|1|||
157103670|NCT00544648|567134604|FG000|Overall Study|progression of disease|1|||
157103671|NCT00544648|567134605|FG001|Overall Study|progression of disease|0|||
157103672|NCT02663271|567134606|FG000|Overall Study|Withdrawal by Subject|5|||
157103673|NCT02663271|567134606|FG000|Overall Study|Lack of Efficacy|1|||
157103674|NCT00999713|567134607|FG000|Overall Study|Physician Decision|2|||
157103675|NCT00999713|567134608|FG001|Overall Study|Physician Decision|0|||
157103676|NCT01351623|567134610|FG000|Overall Study|Protocol Violation|2|||
157103677|NCT01351623|567134610|FG000|Overall Study|Adverse Event|4|||
157103678|NCT01351623|567134610|FG000|Overall Study|Withdrawal by Subject|1|||
157103679|NCT01351623|567134610|FG000|Overall Study|Death|2|||
157103680|NCT04399122|567134613|FG000|Overall Study|Lost to Follow-up|2|||
157103681|NCT04399122|567134614|FG001|Overall Study|Lost to Follow-up|0|||
157103682|NCT04399122|567134613|FG000|Overall Study|Withdrawal by Subject|1|||
156757925|NCT03300180|565864911|FG000|12 Month Outcome|Withdrawal by Subject|3|||
156757926|NCT03300180|565864912|FG001|12 Month Outcome|Withdrawal by Subject|6|||
156757927|NCT03300180|565864913|FG002|12 Month Outcome|Withdrawal by Subject|6|||
156757928|NCT03300180|565864911|FG000|12 Month Outcome|Death|9|||
156757929|NCT03300180|565864912|FG001|12 Month Outcome|Death|6|||
156757930|NCT03300180|565864913|FG002|12 Month Outcome|Death|6|||
156757931|NCT03300180|565864911|FG000|12 Month Outcome|Missed Assessment|62|||
157103683|NCT04399122|567134614|FG001|Overall Study|Withdrawal by Subject|0|||
157103684|NCT02322229|567134615|FG000|Overall Study|Physician Decision|2|||
157103685|NCT00705432|567134616|FG000|Treatment Period|Adverse Event|45|||
157103686|NCT00705432|567134617|FG001|Treatment Period|Adverse Event|37|||
157103687|NCT00705432|567134618|FG002|Treatment Period|Adverse Event|51|||
157103688|NCT00705432|567134619|FG003|Treatment Period|Adverse Event|12|||
156757932|NCT03300180|565864912|FG001|12 Month Outcome|Missed Assessment|59|||
156757933|NCT03300180|565864913|FG002|12 Month Outcome|Missed Assessment|58|||
156757934|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
157103689|NCT00705432|567134620|FG004|Treatment Period|Adverse Event|8|||
157103690|NCT00705432|567134621|FG005|Treatment Period|Adverse Event|9|||
157103691|NCT00705432|567134616|FG000|Treatment Period|Treatment failure|92|||
156757935|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
156757936|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
156757937|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Death|8|||
156757938|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Death|5|||
156757939|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Death|5|||
156757940|NCT03300180|565864911|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
157103692|NCT00705432|567134617|FG001|Treatment Period|Treatment failure|42|||
157103693|NCT00705432|567134618|FG002|Treatment Period|Treatment failure|33|||
156757941|NCT03300180|565864912|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
156757942|NCT03300180|565864913|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
156757943|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
156757944|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
156757945|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
157103694|NCT00705432|567134619|FG003|Treatment Period|Treatment failure|25|||
157103695|NCT00705432|567134620|FG004|Treatment Period|Treatment failure|13|||
157103696|NCT00705432|567134621|FG005|Treatment Period|Treatment failure|14|||
157103697|NCT00705432|567134616|FG000|Treatment Period|Non medical reason|26|||
157103698|NCT00705432|567134617|FG001|Treatment Period|Non medical reason|32|||
157103699|NCT00705432|567134618|FG002|Treatment Period|Non medical reason|37|||
157103700|NCT00705432|567134619|FG003|Treatment Period|Non medical reason|4|||
157103701|NCT00705432|567134620|FG004|Treatment Period|Non medical reason|7|||
157103702|NCT00705432|567134621|FG005|Treatment Period|Non medical reason|7|||
157103703|NCT00705432|567134616|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
157103704|NCT00705432|567134617|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
157103705|NCT00705432|567134618|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
157103706|NCT00705432|567134619|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
157103707|NCT00705432|567134620|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
157103708|NCT00705432|567134621|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
157103709|NCT00705432|567134616|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
157103710|NCT00705432|567134617|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
157103711|NCT00705432|567134618|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
157103712|NCT00705432|567134619|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
157103713|NCT00705432|567134620|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
157103714|NCT00705432|567134621|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
157103715|NCT00521053|567134622|FG000|Observation Phase|Disease Progression|55|||
157103716|NCT00521053|567134622|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
157103717|NCT00521053|567134622|FG000|Observation Phase|Death|2|||
157103718|NCT00521053|567134622|FG000|Observation Phase|Adverse Event|1|||
157103719|NCT00521053|567134622|FG000|Observation Phase|Other non-study melanoma treatment|1|||
157103720|NCT00521053|567134622|FG000|Observation Phase|Physician Decision|1|||
157103721|NCT05749952|567134627|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
157103722|NCT00332839|567136329|FG000|Core (Months 0 - 12)|Administrative problems|1|||
157103723|NCT00332839|567136330|FG001|Core (Months 0 - 12)|Administrative problems|1|||
157103724|NCT00332839|567136329|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
157103725|NCT00332839|567136330|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
157103726|NCT00332839|567136329|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
157103727|NCT00332839|567136330|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
157103728|NCT00332839|567136329|FG000|Core (Months 0 - 12)|Adverse Event|5|||
157103729|NCT00332839|567136330|FG001|Core (Months 0 - 12)|Adverse Event|15|||
156757946|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Death|13|||
156757947|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Death|13|||
156757948|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Death|3|||
156757949|NCT03300180|565864911|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
156757950|NCT03300180|565864912|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
156757951|NCT03300180|565864913|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
156757952|NCT02557516|565864918|FG000|Overall Study|Adverse Event|1|||
156757953|NCT02557516|565864919|FG001|Overall Study|Adverse Event|0|||
156757954|NCT02557516|565864920|FG002|Overall Study|Adverse Event|2|||
156757955|NCT02557516|565864921|FG003|Overall Study|Adverse Event|1|||
156757956|NCT02557516|565864918|FG000|Overall Study|Disease progression|0|||
156757957|NCT02557516|565864919|FG001|Overall Study|Disease progression|2|||
156757958|NCT02557516|565864920|FG002|Overall Study|Disease progression|0|||
157103730|NCT00332839|567136329|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
157103731|NCT00332839|567136330|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
157103732|NCT00332839|567136329|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
157103733|NCT00332839|567136330|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
157103734|NCT00332839|567136329|FG000|Follow-up (Months 12 - 60)|Death|1|||
156757959|NCT02557516|565864921|FG003|Overall Study|Disease progression|0|||
157103735|NCT00332839|567136330|FG001|Follow-up (Months 12 - 60)|Death|1|||
156757960|NCT02557516|565864918|FG000|Overall Study|Physician Decision|0|||
156757961|NCT02557516|565864919|FG001|Overall Study|Physician Decision|2|||
156757962|NCT02557516|565864920|FG002|Overall Study|Physician Decision|0|||
156757963|NCT02557516|565864921|FG003|Overall Study|Physician Decision|0|||
156757964|NCT02557516|565864918|FG000|Overall Study|Sponsor decision|0|||
157000604|NCT03536884|566751415|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000605|NCT03536884|566751416|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
157000606|NCT03536884|566751417|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
157000607|NCT03536884|566751406|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000608|NCT03536884|566751407|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000609|NCT03536884|566751408|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000610|NCT03536884|566751409|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000611|NCT03536884|566751410|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000612|NCT03536884|566751411|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000613|NCT03536884|566751412|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000614|NCT03536884|566751413|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000615|NCT03536884|566751414|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000616|NCT03536884|566751415|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000617|NCT03536884|566751416|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
157000618|NCT03536884|566751417|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
157000619|NCT03536884|566751406|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000620|NCT03536884|566751407|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000621|NCT03536884|566751408|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000622|NCT03536884|566751409|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000623|NCT03536884|566751410|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000624|NCT03536884|566751411|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000625|NCT03536884|566751412|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000626|NCT03536884|566751413|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000627|NCT03536884|566751414|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000628|NCT03536884|566751415|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000629|NCT03536884|566751416|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
157000630|NCT03536884|566751417|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
157000631|NCT03301220|566751418|FG000|Overall Study|Death|26|||
157000632|NCT03301220|566751419|FG001|Overall Study|Death|15|||
157000633|NCT03301220|566751418|FG000|Overall Study|Withdrawal by Subject|23|||
157000634|NCT03301220|566751419|FG001|Overall Study|Withdrawal by Subject|12|||
157000635|NCT03301220|566751418|FG000|Overall Study|Lost to Follow-up|1|||
157000636|NCT03301220|566751419|FG001|Overall Study|Lost to Follow-up|1|||
157000637|NCT03301220|566751418|FG000|Overall Study|Randomized in error|1|||
157000638|NCT03301220|566751419|FG001|Overall Study|Randomized in error|1|||
157000639|NCT03301220|566751418|FG000|Overall Study|Randomized but not treated|0|||
157000640|NCT03301220|566751419|FG001|Overall Study|Randomized but not treated|1|||
157000641|NCT03301220|566751418|FG000|Overall Study|Ongoing followup|145|||
157000642|NCT03301220|566751419|FG001|Overall Study|Ongoing followup|163|||
157000643|NCT03301220|566751418|FG000|Overall Study|Principal Investigator and participant decision|0|||
157000644|NCT03301220|566751419|FG001|Overall Study|Principal Investigator and participant decision|1|||
157000645|NCT03451851|566751420|FG000|PCP: Week 0 -16|Adverse Event|1|||
157000646|NCT03451851|566751421|FG001|PCP: Week 0 -16|Adverse Event|0|||
157000647|NCT03451851|566751422|FG002|PCP: Week 0 -16|Adverse Event|0|||
157000648|NCT03451851|566751423|FG003|PCP: Week 0 -16|Adverse Event|0|||
157000649|NCT03451851|566751424|FG004|PCP: Week 0 -16|Adverse Event|0|||
157000650|NCT03451851|566751425|FG005|PCP: Week 0 -16|Adverse Event|0|||
157000651|NCT03451851|566751426|FG006|PCP: Week 0 -16|Adverse Event|1|||
157000652|NCT03451851|566751427|FG007|PCP: Week 0 -16|Adverse Event|0|||
157000653|NCT03451851|566751420|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000654|NCT03451851|566751421|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000655|NCT03451851|566751422|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
157000656|NCT03451851|566751423|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000657|NCT03451851|566751424|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000658|NCT03451851|566751425|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000659|NCT03451851|566751426|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000660|NCT03451851|566751427|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
157000661|NCT03451851|566751420|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000662|NCT03451851|566751421|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000663|NCT03451851|566751422|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
157000664|NCT03451851|566751423|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000665|NCT03451851|566751424|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000666|NCT03451851|566751425|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000667|NCT03451851|566751426|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157000668|NCT03451851|566751427|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
157103736|NCT00594516|567136334|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
157103737|NCT00594516|567136335|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
156757965|NCT02557516|565864919|FG001|Overall Study|Sponsor decision|1|||
156757966|NCT02557516|565864920|FG002|Overall Study|Sponsor decision|2|||
156757967|NCT02557516|565864921|FG003|Overall Study|Sponsor decision|8|||
157000669|NCT03451851|566751420|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000670|NCT03451851|566751421|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000671|NCT03451851|566751422|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000672|NCT03451851|566751423|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000673|NCT03451851|566751424|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
157000674|NCT03451851|566751425|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
157000675|NCT03451851|566751426|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000676|NCT03451851|566751427|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
157000677|NCT03451851|566751420|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000678|NCT03451851|566751421|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000679|NCT03451851|566751422|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000680|NCT03451851|566751423|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000681|NCT03451851|566751424|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
157000682|NCT03451851|566751425|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000683|NCT03451851|566751426|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000684|NCT03451851|566751427|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
157000685|NCT03451851|566751420|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000686|NCT03451851|566751421|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000687|NCT03451851|566751422|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000688|NCT03451851|566751423|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000689|NCT03451851|566751424|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
157000690|NCT03451851|566751425|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000691|NCT03451851|566751426|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000692|NCT03451851|566751427|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
157000693|NCT07214922|566751430|FG000|Overall Study|Adverse Event|0|||
157000694|NCT07214922|566751431|FG001|Overall Study|Adverse Event|0|||
157000695|NCT07214922|566751432|FG002|Overall Study|Adverse Event|1|||
157000696|NCT07214922|566751433|FG003|Overall Study|Adverse Event|0|||
157000697|NCT07214922|566751430|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
157000698|NCT07214922|566751431|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
157000699|NCT07214922|566751432|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
157000700|NCT07214922|566751433|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
157000701|NCT00482729|566752618|FG000|Overall Study|Adverse Event|29|||
157000702|NCT00482729|566752619|FG001|Overall Study|Adverse Event|33|||
157000703|NCT00482729|566752618|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
157000704|NCT00482729|566752619|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
157000705|NCT00482729|566752618|FG000|Overall Study|Hyperglycemia Criteria|7|||
157000706|NCT00482729|566752619|FG001|Overall Study|Hyperglycemia Criteria|5|||
157000707|NCT00482729|566752618|FG000|Overall Study|Lack of Efficacy|4|||
157000708|NCT00482729|566752619|FG001|Overall Study|Lack of Efficacy|16|||
157000709|NCT00482729|566752618|FG000|Overall Study|Lost to Follow-up|86|||
157000710|NCT00482729|566752619|FG001|Overall Study|Lost to Follow-up|66|||
157000711|NCT00482729|566752618|FG000|Overall Study|Physician Decision|10|||
157000712|NCT00482729|566752619|FG001|Overall Study|Physician Decision|7|||
157000713|NCT00482729|566752618|FG000|Overall Study|Pregnancy|4|||
157000714|NCT00482729|566752619|FG001|Overall Study|Pregnancy|2|||
157000715|NCT00482729|566752618|FG000|Overall Study|Protocol Violation|10|||
157000716|NCT00482729|566752619|FG001|Overall Study|Protocol Violation|18|||
157000717|NCT00482729|566752618|FG000|Overall Study|Withdrawal by Subject|67|||
157000718|NCT00482729|566752619|FG001|Overall Study|Withdrawal by Subject|69|||
157000719|NCT01090024|566752624|FG000|Period 1|Met exclusion criteria|0|||
157000720|NCT01090024|566752625|FG001|Period 1|Met exclusion criteria|0|||
157000721|NCT01090024|566752626|FG002|Period 1|Met exclusion criteria|0|||
157000722|NCT01090024|566752627|FG003|Period 1|Met exclusion criteria|0|||
157000723|NCT01090024|566752628|FG004|Period 1|Met exclusion criteria|0|||
157000724|NCT01090024|566752629|FG005|Period 1|Met exclusion criteria|0|||
157000725|NCT01090024|566752630|FG006|Period 1|Met exclusion criteria|0|||
156757968|NCT01919164|565866322|FG000|Overall Study|Adverse Event|6|||
156757969|NCT01919164|565866323|FG001|Overall Study|Adverse Event|4|||
157000726|NCT01090024|566752631|FG007|Period 1|Met exclusion criteria|0|||
157000727|NCT01090024|566752632|FG008|Period 1|Met exclusion criteria|0|||
157000728|NCT01090024|566752633|FG009|Period 1|Met exclusion criteria|0|||
157000729|NCT01090024|566752634|FG010|Period 1|Met exclusion criteria|0|||
157000730|NCT01090024|566752635|FG011|Period 1|Met exclusion criteria|0|||
157000731|NCT01090024|566752636|FG012|Period 1|Met exclusion criteria|0|||
157000732|NCT01090024|566752637|FG013|Period 1|Met exclusion criteria|0|||
156757970|NCT01919164|565866324|FG002|Overall Study|Adverse Event|9|||
156757971|NCT01919164|565866325|FG003|Overall Study|Adverse Event|3|||
157103738|NCT00594516|567136336|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
157103739|NCT00594516|567136334|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
157103740|NCT00594516|567136335|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
157103741|NCT00594516|567136336|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
157103742|NCT00594516|567136334|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
157103743|NCT00594516|567136335|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
157103744|NCT00594516|567136336|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
157103745|NCT00594516|567136334|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
157103746|NCT00594516|567136335|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
157103747|NCT00594516|567136336|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
157103748|NCT00594516|567136334|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
157103749|NCT00594516|567136335|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
157103750|NCT00594516|567136336|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
157103751|NCT00594516|567136334|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
157103752|NCT00594516|567136335|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
157103753|NCT00594516|567136336|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
157103754|NCT00594516|567136334|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
157103755|NCT00594516|567136335|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
157103756|NCT00594516|567136336|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
157103757|NCT00594516|567136334|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
157103758|NCT00594516|567136335|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
157103759|NCT00594516|567136336|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
157103760|NCT00594516|567136334|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
157103761|NCT00594516|567136335|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
157103762|NCT00594516|567136336|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
157103763|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
157103764|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
157103765|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
157103766|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
157103767|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
157103768|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
157103769|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
157103770|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
157103771|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
157103772|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
157103773|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
157103774|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
157103775|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
157103776|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
157103777|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
157103778|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
157103779|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
157103780|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
157103781|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Early termination|0|||
157103782|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Early termination|0|||
157103783|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Early termination|34|||
157103784|NCT01493557|567136337|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
157103785|NCT01493557|567136338|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
157103786|NCT01493557|567136339|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
157103787|NCT01493557|567136337|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
157103788|NCT01493557|567136338|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
157103789|NCT01493557|567136339|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
157103790|NCT01493557|567136337|FG000|Randomized to Management Strategies|Other adverse event|8|||
157103791|NCT01493557|567136338|FG001|Randomized to Management Strategies|Other adverse event|5|||
157103792|NCT01493557|567136339|FG002|Randomized to Management Strategies|Other adverse event|0|||
157103793|NCT01493557|567136337|FG000|Randomized to Management Strategies|Protocol Violation|3|||
157103794|NCT01493557|567136338|FG001|Randomized to Management Strategies|Protocol Violation|0|||
157103795|NCT01493557|567136339|FG002|Randomized to Management Strategies|Protocol Violation|0|||
157103796|NCT01493557|567136337|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
157103797|NCT01493557|567136338|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
157103798|NCT01493557|567136339|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
156757972|NCT01919164|565866326|FG004|Overall Study|Adverse Event|2|||
156757973|NCT01919164|565866322|FG000|Overall Study|Lost to Follow-up|2|||
156757974|NCT01919164|565866323|FG001|Overall Study|Lost to Follow-up|2|||
156757975|NCT01919164|565866324|FG002|Overall Study|Lost to Follow-up|2|||
156757976|NCT01919164|565866325|FG003|Overall Study|Lost to Follow-up|0|||
156757977|NCT01919164|565866326|FG004|Overall Study|Lost to Follow-up|4|||
156757978|NCT01919164|565866322|FG000|Overall Study|Death|1|||
156757979|NCT01919164|565866323|FG001|Overall Study|Death|0|||
157103799|NCT01493557|567136337|FG000|Randomized to Management Strategies|Other than stated above|1|||
157103800|NCT01493557|567136338|FG001|Randomized to Management Strategies|Other than stated above|3|||
157103801|NCT01493557|567136339|FG002|Randomized to Management Strategies|Other than stated above|0|||
157103802|NCT01493557|567136337|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
157103803|NCT01493557|567136338|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
157103804|NCT01493557|567136339|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
157103805|NCT01493557|567136337|FG000|Adding the Second Strategy|Other adverse event|1|||
157103806|NCT01493557|567136338|FG001|Adding the Second Strategy|Other adverse event|2|||
157103807|NCT01493557|567136339|FG002|Adding the Second Strategy|Other adverse event|0|||
157103808|NCT01493557|567136337|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
157103809|NCT01493557|567136338|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
157103810|NCT01493557|567136339|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
157103811|NCT01876251|567136342|FG000|Overall Study|Clinical progression|1|||
157103812|NCT01876251|567136343|FG001|Overall Study|Clinical progression|0|||
157103813|NCT01876251|567136344|FG002|Overall Study|Clinical progression|0|||
157103814|NCT01876251|567136342|FG000|Overall Study|Death|2|||
157103815|NCT01876251|567136343|FG001|Overall Study|Death|0|||
157103816|NCT01876251|567136344|FG002|Overall Study|Death|1|||
157103817|NCT01876251|567136342|FG000|Overall Study|Participant started new treatment|1|||
157103818|NCT01876251|567136343|FG001|Overall Study|Participant started new treatment|0|||
157103819|NCT01876251|567136344|FG002|Overall Study|Participant started new treatment|1|||
157103820|NCT01876251|567136342|FG000|Overall Study|Participant refused further follow-up|0|||
157103821|NCT01876251|567136343|FG001|Overall Study|Participant refused further follow-up|0|||
157103822|NCT01876251|567136344|FG002|Overall Study|Participant refused further follow-up|1|||
157103823|NCT01876251|567136342|FG000|Overall Study|Study terminated|1|||
157103824|NCT01876251|567136343|FG001|Overall Study|Study terminated|0|||
157103825|NCT01876251|567136344|FG002|Overall Study|Study terminated|0|||
157103826|NCT01876251|567136342|FG000|Overall Study|Objective progression or relapse|10|||
157103827|NCT01876251|567136343|FG001|Overall Study|Objective progression or relapse|3|||
157103828|NCT01876251|567136344|FG002|Overall Study|Objective progression or relapse|8|||
157103829|NCT02460497|567136351|FG000|Overall Study|Participant Requested Withdrawal|4|||
157103830|NCT02460497|567136351|FG000|Overall Study|Non-Compliance|1|||
157103831|NCT02460497|567136351|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
157103832|NCT02460497|567136351|FG000|Overall Study|Lost to Follow-up|2|||
157103833|NCT02460497|567136351|FG000|Overall Study|Investigator Decision|1|||
157103834|NCT02012296|567136352|FG000|Overall Study|Lack of Efficacy|0|||
157103835|NCT02012296|567136353|FG001|Overall Study|Lack of Efficacy|0|||
157103836|NCT02012296|567136354|FG002|Overall Study|Lack of Efficacy|15|||
157103837|NCT02012296|567136352|FG000|Overall Study|Adverse Event|0|||
157103838|NCT02012296|567136353|FG001|Overall Study|Adverse Event|0|||
157103839|NCT02012296|567136354|FG002|Overall Study|Adverse Event|2|||
157103840|NCT02012296|567136352|FG000|Overall Study|Early study closure|0|||
157103841|NCT02012296|567136353|FG001|Overall Study|Early study closure|0|||
157103842|NCT02012296|567136354|FG002|Overall Study|Early study closure|5|||
157103843|NCT02012296|567136352|FG000|Overall Study|Protocol Violation|0|||
157103844|NCT02012296|567136353|FG001|Overall Study|Protocol Violation|1|||
157103845|NCT02012296|567136354|FG002|Overall Study|Protocol Violation|0|||
157103846|NCT03876171|567136355|FG000|Overall Study|Withdrawal by Subject|3|||
157103847|NCT03876171|567136356|FG001|Overall Study|Withdrawal by Subject|3|||
157103848|NCT03876171|567136355|FG000|Overall Study|Re-arrest|0|||
157103849|NCT03876171|567136356|FG001|Overall Study|Re-arrest|4|||
157103850|NCT00727649|567136359|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
157103851|NCT00727649|567136360|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
157103852|NCT00727649|567136359|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
157103853|NCT00727649|567136360|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
157103854|NCT00727649|567136359|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
157103855|NCT00727649|567136360|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
156757980|NCT01919164|565866324|FG002|Overall Study|Death|0|||
157103856|NCT00727649|567136359|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
157103857|NCT00727649|567136360|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
157103858|NCT00727649|567136359|FG000|Second Intervention (4-weeks)|Death|1|||
157103859|NCT00727649|567136360|FG001|Second Intervention (4-weeks)|Death|0|||
157103860|NCT00727649|567136359|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
157103861|NCT00727649|567136360|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
157103862|NCT00727649|567136359|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
157103863|NCT00727649|567136360|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
157103864|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
156757981|NCT01919164|565866325|FG003|Overall Study|Death|0|||
156757982|NCT01919164|565866326|FG004|Overall Study|Death|0|||
156757983|NCT01919164|565866322|FG000|Overall Study|Protocol Violation|6|||
156757984|NCT01919164|565866323|FG001|Overall Study|Protocol Violation|0|||
156757985|NCT01919164|565866324|FG002|Overall Study|Protocol Violation|3|||
156757986|NCT01919164|565866325|FG003|Overall Study|Protocol Violation|2|||
156757987|NCT01919164|565866326|FG004|Overall Study|Protocol Violation|2|||
156757988|NCT01919164|565866322|FG000|Overall Study|Disease progression|2|||
156757989|NCT01919164|565866323|FG001|Overall Study|Disease progression|2|||
156757990|NCT01919164|565866324|FG002|Overall Study|Disease progression|1|||
156757991|NCT01919164|565866325|FG003|Overall Study|Disease progression|2|||
156757992|NCT01919164|565866326|FG004|Overall Study|Disease progression|1|||
156757993|NCT01919164|565866322|FG000|Overall Study|Withdrew consent|13|||
156757994|NCT01919164|565866323|FG001|Overall Study|Withdrew consent|13|||
156757995|NCT01919164|565866324|FG002|Overall Study|Withdrew consent|14|||
156757996|NCT01919164|565866325|FG003|Overall Study|Withdrew consent|14|||
156757997|NCT01919164|565866326|FG004|Overall Study|Withdrew consent|9|||
156757998|NCT01919164|565866322|FG000|Overall Study|Other Un-specified|13|||
156757999|NCT01919164|565866323|FG001|Overall Study|Other Un-specified|9|||
156758000|NCT01919164|565866324|FG002|Overall Study|Other Un-specified|8|||
156758001|NCT01919164|565866325|FG003|Overall Study|Other Un-specified|7|||
156758002|NCT01919164|565866326|FG004|Overall Study|Other Un-specified|15|||
156758003|NCT01971567|565866331|FG000|Overall Study|Withdrawal by Subject|3|||
156758004|NCT01971567|565866332|FG001|Overall Study|Withdrawal by Subject|2|||
156758005|NCT01971567|565866331|FG000|Overall Study|Lost to Follow-up|1|||
156758006|NCT01971567|565866332|FG001|Overall Study|Lost to Follow-up|0|||
156758007|NCT02019550|565866335|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156758008|NCT02019550|565866336|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
156758009|NCT02750332|565866338|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156758010|NCT02750332|565866339|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156758011|NCT04194489|565866340|FG000|Overall Study|Withdrawal by Subject|5|||
156758012|NCT04194489|565866340|FG000|Overall Study|Lost to Follow-up|48|||
156758013|NCT02485483|565866344|FG000|Overall Study|Depression at baseline|15|||
156758014|NCT02485483|565866345|FG001|Overall Study|Depression at baseline|0|||
156758015|NCT02485483|565866344|FG000|Overall Study|Discontinued after baseline|39|||
156758016|NCT02485483|565866345|FG001|Overall Study|Discontinued after baseline|0|||
156758017|NCT00823264|565866347|FG000|Overall Study|Protocol Violation|2|||
156758018|NCT00823264|565866348|FG001|Overall Study|Protocol Violation|0|||
156758019|NCT00113295|565866349|FG000|Overall Study|Adverse Event|4|||
156758020|NCT00113295|565866350|FG001|Overall Study|Adverse Event|1|||
156758021|NCT00113295|565866349|FG000|Overall Study|Unrelated Medical Illness|1|||
156758022|NCT00113295|565866350|FG001|Overall Study|Unrelated Medical Illness|0|||
156758023|NCT01714544|565866351|FG000|Overall Study|Lost to Follow-up|1|||
156758024|NCT01714544|565866351|FG000|Overall Study|Physician Decision|1|||
156758025|NCT01714544|565866351|FG000|Overall Study|Withdrawal by Subject|1|||
156758026|NCT01914393|565866352|FG000|Overall Study|Protocol Violation|11|||
156758027|NCT01914393|565866353|FG001|Overall Study|Protocol Violation|3|||
156758028|NCT01914393|565866354|FG002|Overall Study|Protocol Violation|19|||
156758029|NCT01914393|565866352|FG000|Overall Study|Lack of Efficacy|11|||
156758030|NCT01914393|565866353|FG001|Overall Study|Lack of Efficacy|16|||
156758031|NCT01914393|565866354|FG002|Overall Study|Lack of Efficacy|5|||
156758032|NCT01914393|565866352|FG000|Overall Study|no reason given|14|||
156758033|NCT01914393|565866353|FG001|Overall Study|no reason given|8|||
156758034|NCT01914393|565866354|FG002|Overall Study|no reason given|16|||
156758035|NCT01914393|565866352|FG000|Overall Study|Adverse Event|29|||
157000733|NCT01090024|566752638|FG014|Period 1|Met exclusion criteria|1|||
157000734|NCT01090024|566752639|FG015|Period 1|Met exclusion criteria|0|||
157000735|NCT01090024|566752640|FG016|Period 1|Met exclusion criteria|0|||
157000736|NCT01090024|566752641|FG017|Period 1|Met exclusion criteria|0|||
157000737|NCT01090024|566752624|FG000|Period 1|Adverse Event|0|||
157000738|NCT01090024|566752625|FG001|Period 1|Adverse Event|0|||
157000739|NCT01090024|566752626|FG002|Period 1|Adverse Event|0|||
157000740|NCT01090024|566752627|FG003|Period 1|Adverse Event|0|||
157000741|NCT01090024|566752628|FG004|Period 1|Adverse Event|0|||
157000742|NCT01090024|566752629|FG005|Period 1|Adverse Event|0|||
157000743|NCT01090024|566752630|FG006|Period 1|Adverse Event|0|||
157000744|NCT01090024|566752631|FG007|Period 1|Adverse Event|0|||
157000745|NCT01090024|566752632|FG008|Period 1|Adverse Event|0|||
157000746|NCT01090024|566752633|FG009|Period 1|Adverse Event|1|||
157000747|NCT01090024|566752634|FG010|Period 1|Adverse Event|0|||
157000748|NCT01090024|566752635|FG011|Period 1|Adverse Event|1|||
157000749|NCT01090024|566752636|FG012|Period 1|Adverse Event|0|||
157000750|NCT01090024|566752637|FG013|Period 1|Adverse Event|0|||
157000751|NCT01090024|566752638|FG014|Period 1|Adverse Event|0|||
157103865|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
157000752|NCT01090024|566752639|FG015|Period 1|Adverse Event|0|||
156758036|NCT01914393|565866353|FG001|Overall Study|Adverse Event|18|||
156758037|NCT01914393|565866354|FG002|Overall Study|Adverse Event|31|||
156758038|NCT01914393|565866352|FG000|Overall Study|Withdrawal by Subject|38|||
156758039|NCT01914393|565866353|FG001|Overall Study|Withdrawal by Subject|20|||
157000753|NCT01090024|566752640|FG016|Period 1|Adverse Event|0|||
157000754|NCT01090024|566752641|FG017|Period 1|Adverse Event|1|||
157103866|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
157103867|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
157103868|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
157103869|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
157103870|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
157103871|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
157103872|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
157103873|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
157103874|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
157103875|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
157103876|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
157103877|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
157103878|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
157103879|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
157103880|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
157103881|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
157103882|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
157103883|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
157103884|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
157103885|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
157103886|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
157103887|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
157103888|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
157103889|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
157103890|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
157103891|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
157103892|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
157103893|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
157103894|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
157103895|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
157103896|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
157103897|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
157103898|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
157103899|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
157103900|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
157103901|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
157103902|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
157103903|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
157103904|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
157103905|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
157103906|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
157103907|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
157103908|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
157103909|NCT03627767|567136361|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
157103910|NCT03627767|567136362|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
157103911|NCT03627767|567136363|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
157103912|NCT03627767|567136364|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
157103913|NCT03627767|567136365|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
157103914|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
157103915|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
157103916|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
157103917|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
157103918|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
157103919|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
157103920|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
157103921|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
157103922|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
157103923|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
157103924|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
157103925|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
157103926|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
157103927|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
156758040|NCT01914393|565866354|FG002|Overall Study|Withdrawal by Subject|47|||
156758041|NCT01914393|565866352|FG000|Overall Study|Lost to Follow-up|12|||
156758042|NCT01914393|565866353|FG001|Overall Study|Lost to Follow-up|6|||
156758043|NCT01914393|565866354|FG002|Overall Study|Lost to Follow-up|19|||
156758044|NCT01914393|565866352|FG000|Overall Study|subject never dosed|0|||
156758045|NCT01914393|565866353|FG001|Overall Study|subject never dosed|0|||
156758046|NCT01914393|565866354|FG002|Overall Study|subject never dosed|1|||
156758047|NCT00666211|565866355|FG000|Overall Study|Withdrawal by Subject|10|||
156758048|NCT00666211|565866356|FG001|Overall Study|Withdrawal by Subject|13|||
156758049|NCT00666211|565866355|FG000|Overall Study|went off medication, no more pain|1|||
156758050|NCT00666211|565866356|FG001|Overall Study|went off medication, no more pain|0|||
156758051|NCT00666211|565866355|FG000|Overall Study|patient non-compliant|6|||
156758052|NCT00666211|565866356|FG001|Overall Study|patient non-compliant|6|||
156758053|NCT00666211|565866355|FG000|Overall Study|disease progression|1|||
156758054|NCT00666211|565866356|FG001|Overall Study|disease progression|8|||
156758055|NCT00666211|565866355|FG000|Overall Study|Lost to Follow-up|2|||
156758056|NCT00666211|565866356|FG001|Overall Study|Lost to Follow-up|0|||
156758057|NCT00666211|565866355|FG000|Overall Study|toxicity|0|||
156758058|NCT00666211|565866356|FG001|Overall Study|toxicity|2|||
156758059|NCT00666211|565866355|FG000|Overall Study|hospital admission|0|||
156758060|NCT00666211|565866356|FG001|Overall Study|hospital admission|5|||
156758061|NCT00666211|565866355|FG000|Overall Study|Death|0|||
156758062|NCT00666211|565866356|FG001|Overall Study|Death|2|||
156758063|NCT00666211|565866355|FG000|Overall Study|off tx for other complicating disease|0|||
156758064|NCT00666211|565866356|FG001|Overall Study|off tx for other complicating disease|1|||
156758065|NCT00666211|565866355|FG000|Overall Study|Physician Decision|0|||
156758066|NCT00666211|565866356|FG001|Overall Study|Physician Decision|1|||
156758067|NCT02806713|565866357|FG000|Overall Study|Urethral injury during procedure|1|||
156758068|NCT02806713|565866358|FG001|Overall Study|Urethral injury during procedure|0|||
156758069|NCT02806713|565866357|FG000|Overall Study|cancelled surgery|1|||
156758070|NCT02806713|565866358|FG001|Overall Study|cancelled surgery|2|||
156758071|NCT02999789|565866361|FG000|Overall Study|Withdrawal by Subject|0|||
156758072|NCT02999789|565866362|FG001|Overall Study|Withdrawal by Subject|1|||
156758073|NCT02999789|565866361|FG000|Overall Study|Became ineligible|1|||
156758074|NCT02999789|565866362|FG001|Overall Study|Became ineligible|2|||
156758075|NCT02824224|565866365|FG000|Overall Study|Discontinued, IUS expulsion|0|||
156758076|NCT02824224|565866366|FG001|Overall Study|Discontinued, IUS expulsion|1|||
156758077|NCT02824224|565866365|FG000|Overall Study|Did not show up for allocation visit|2|||
156758078|NCT02824224|565866366|FG001|Overall Study|Did not show up for allocation visit|0|||
156758079|NCT00613366|565866367|FG000|Overall Study|Withdrawal by Subject|3|||
156758080|NCT00613366|565866368|FG001|Overall Study|Withdrawal by Subject|2|||
156758081|NCT01178125|565866370|FG000|Overall Study|Lost to Follow-up|397|||
156758082|NCT01178125|565866370|FG000|Overall Study|Adverse Event|244|||
156758083|NCT01178125|565866370|FG000|Overall Study|Withdrawal by Subject|209|||
156758084|NCT01178125|565866370|FG000|Overall Study|Noncompliance|184|||
156758085|NCT01178125|565866370|FG000|Overall Study|Pregnancy|55|||
156758086|NCT01178125|565866370|FG000|Overall Study|Other Reason|39|||
156758087|NCT01178125|565866370|FG000|Overall Study|Sponsor Decision|28|||
156758088|NCT01178125|565866370|FG000|Overall Study|Protocol Violation|17|||
156758089|NCT01178125|565866370|FG000|Overall Study|Investigator Decision|5|||
156758090|NCT01719380|565866371|FG000|Overall Study|Adverse Event|0|||
156758091|NCT01719380|565866372|FG001|Overall Study|Adverse Event|0|||
156758092|NCT01719380|565866373|FG002|Overall Study|Adverse Event|1|||
156758093|NCT01719380|565866374|FG003|Overall Study|Adverse Event|2|||
156758094|NCT01719380|565866375|FG004|Overall Study|Adverse Event|0|||
156758095|NCT01719380|565866376|FG005|Overall Study|Adverse Event|1|||
156758096|NCT01719380|565866377|FG006|Overall Study|Adverse Event|0|||
156758097|NCT01719380|565866378|FG007|Overall Study|Adverse Event|1|||
156758098|NCT01719380|565866379|FG008|Overall Study|Adverse Event|4|||
156758099|NCT01719380|565866380|FG009|Overall Study|Adverse Event|3|||
156758100|NCT01719380|565866371|FG000|Overall Study|Death|0|||
156758101|NCT01719380|565866372|FG001|Overall Study|Death|1|||
156758102|NCT01719380|565866373|FG002|Overall Study|Death|0|||
156758103|NCT01719380|565866374|FG003|Overall Study|Death|0|||
156758104|NCT01719380|565866375|FG004|Overall Study|Death|0|||
156758105|NCT01719380|565866376|FG005|Overall Study|Death|0|||
156758106|NCT01719380|565866377|FG006|Overall Study|Death|0|||
156758107|NCT01719380|565866378|FG007|Overall Study|Death|0|||
156758108|NCT01719380|565866379|FG008|Overall Study|Death|3|||
156758109|NCT01719380|565866380|FG009|Overall Study|Death|3|||
156758110|NCT01719380|565866371|FG000|Overall Study|Participant/Guardian Decision|0|||
156758111|NCT01719380|565866372|FG001|Overall Study|Participant/Guardian Decision|0|||
156758112|NCT01719380|565866373|FG002|Overall Study|Participant/Guardian Decision|1|||
156758113|NCT01719380|565866374|FG003|Overall Study|Participant/Guardian Decision|0|||
156758114|NCT01719380|565866375|FG004|Overall Study|Participant/Guardian Decision|0|||
156758115|NCT01719380|565866376|FG005|Overall Study|Participant/Guardian Decision|0|||
156758116|NCT01719380|565866377|FG006|Overall Study|Participant/Guardian Decision|0|||
156758117|NCT01719380|565866378|FG007|Overall Study|Participant/Guardian Decision|0|||
156758118|NCT01719380|565866379|FG008|Overall Study|Participant/Guardian Decision|2|||
156758119|NCT01719380|565866380|FG009|Overall Study|Participant/Guardian Decision|2|||
156758120|NCT01719380|565866371|FG000|Overall Study|Physician Decision|0|||
156758121|NCT01719380|565866372|FG001|Overall Study|Physician Decision|0|||
156758122|NCT01719380|565866373|FG002|Overall Study|Physician Decision|2|||
156758123|NCT01719380|565866374|FG003|Overall Study|Physician Decision|0|||
156758124|NCT01719380|565866375|FG004|Overall Study|Physician Decision|0|||
156758125|NCT01719380|565866376|FG005|Overall Study|Physician Decision|0|||
156758126|NCT01719380|565866377|FG006|Overall Study|Physician Decision|0|||
156758127|NCT01719380|565866378|FG007|Overall Study|Physician Decision|0|||
156758128|NCT01719380|565866379|FG008|Overall Study|Physician Decision|1|||
156758129|NCT01719380|565866380|FG009|Overall Study|Physician Decision|1|||
156758130|NCT01719380|565866371|FG000|Overall Study|Lack of Efficacy|2|||
156758131|NCT01719380|565866372|FG001|Overall Study|Lack of Efficacy|6|||
156758132|NCT01719380|565866373|FG002|Overall Study|Lack of Efficacy|5|||
156758133|NCT01719380|565866374|FG003|Overall Study|Lack of Efficacy|6|||
156758134|NCT01719380|565866375|FG004|Overall Study|Lack of Efficacy|3|||
156758135|NCT01719380|565866376|FG005|Overall Study|Lack of Efficacy|7|||
156758136|NCT01719380|565866377|FG006|Overall Study|Lack of Efficacy|10|||
156758137|NCT01719380|565866378|FG007|Overall Study|Lack of Efficacy|6|||
156758138|NCT01719380|565866379|FG008|Overall Study|Lack of Efficacy|39|||
156758139|NCT01719380|565866380|FG009|Overall Study|Lack of Efficacy|42|||
156758140|NCT01719380|565866371|FG000|Overall Study|Progressive Disease|0|||
156758141|NCT01719380|565866372|FG001|Overall Study|Progressive Disease|0|||
156758142|NCT01719380|565866373|FG002|Overall Study|Progressive Disease|0|||
156758143|NCT01719380|565866374|FG003|Overall Study|Progressive Disease|0|||
156758144|NCT01719380|565866375|FG004|Overall Study|Progressive Disease|0|||
156758145|NCT01719380|565866376|FG005|Overall Study|Progressive Disease|0|||
156758146|NCT01719380|565866377|FG006|Overall Study|Progressive Disease|0|||
156758147|NCT01719380|565866378|FG007|Overall Study|Progressive Disease|0|||
156758148|NCT01719380|565866379|FG008|Overall Study|Progressive Disease|1|||
156758149|NCT01719380|565866380|FG009|Overall Study|Progressive Disease|0|||
156758150|NCT02532374|565866381|FG000|Overall Study|Withdrawal by Subject|1|||
156758151|NCT02532374|565866381|FG000|Overall Study|Physician Decision|1|||
156758152|NCT02762084|565866382|FG000|Overall Study|Withdrawal by Subject|1|||
156758153|NCT02762084|565866383|FG001|Overall Study|Withdrawal by Subject|0|||
156758154|NCT02762084|565866384|FG002|Overall Study|Withdrawal by Subject|0|||
156758155|NCT02762084|565866382|FG000|Overall Study|Adverse Event|0|||
156758156|NCT02762084|565866383|FG001|Overall Study|Adverse Event|0|||
156758157|NCT02762084|565866384|FG002|Overall Study|Adverse Event|1|||
156758158|NCT01348139|565866385|FG000|Period 1|Adverse Event|1|||
156758159|NCT01348139|565866386|FG001|Period 1|Adverse Event|0|||
156758160|NCT01348139|565866387|FG002|Period 1|Adverse Event|0|||
156758161|NCT01348139|565866388|FG003|Period 1|Adverse Event|0|||
156758162|NCT01348139|565866389|FG004|Period 1|Adverse Event|0|||
156758163|NCT01348139|565866390|FG005|Period 1|Adverse Event|0|||
156758164|NCT02254772|565866393|FG000|Overall Study|Ineligible|1|||
156758165|NCT02254772|565866393|FG000|Overall Study|Withdrawal by Subject|1|||
156758166|NCT03006562|565866394|FG000|Overall Study|Lost to Follow-up|0|||
156758167|NCT03006562|565866395|FG001|Overall Study|Lost to Follow-up|1|||
156758168|NCT02427841|565866404|FG000|Overall Study|Lack of Efficacy|5|||
156758169|NCT02427841|565866404|FG000|Overall Study|Physician Decision|2|||
157000755|NCT01090024|566752624|FG000|Period 1|Withdrawal by Subject|0|||
157000756|NCT01090024|566752625|FG001|Period 1|Withdrawal by Subject|0|||
157000757|NCT01090024|566752626|FG002|Period 1|Withdrawal by Subject|0|||
157000758|NCT01090024|566752627|FG003|Period 1|Withdrawal by Subject|1|||
157000759|NCT01090024|566752628|FG004|Period 1|Withdrawal by Subject|0|||
157000760|NCT01090024|566752629|FG005|Period 1|Withdrawal by Subject|0|||
157000761|NCT01090024|566752630|FG006|Period 1|Withdrawal by Subject|0|||
157000762|NCT01090024|566752631|FG007|Period 1|Withdrawal by Subject|0|||
157000763|NCT01090024|566752632|FG008|Period 1|Withdrawal by Subject|0|||
157000764|NCT01090024|566752633|FG009|Period 1|Withdrawal by Subject|0|||
156758170|NCT02427841|565866404|FG000|Overall Study|Withdrawal by Subject|1|||
156758171|NCT01765296|565866405|FG000|Overall Study|Protocol Violation|0|||
156758172|NCT01765296|565866406|FG001|Overall Study|Protocol Violation|5|||
156758173|NCT01765296|565866407|FG002|Overall Study|Protocol Violation|4|||
156758174|NCT01765296|565866405|FG000|Overall Study|Withdrawal by Subject|4|||
156758175|NCT01765296|565866406|FG001|Overall Study|Withdrawal by Subject|2|||
156758176|NCT01765296|565866407|FG002|Overall Study|Withdrawal by Subject|2|||
156758177|NCT01765296|565866405|FG000|Overall Study|Adverse Event|1|||
156758178|NCT01765296|565866406|FG001|Overall Study|Adverse Event|13|||
157000765|NCT01090024|566752634|FG010|Period 1|Withdrawal by Subject|0|||
156758179|NCT01765296|565866407|FG002|Overall Study|Adverse Event|5|||
156758180|NCT01765296|565866405|FG000|Overall Study|Lack of Efficacy|0|||
156758181|NCT01765296|565866406|FG001|Overall Study|Lack of Efficacy|0|||
156758182|NCT01765296|565866407|FG002|Overall Study|Lack of Efficacy|2|||
156758183|NCT03257436|565866408|FG000|Overall Study|Withdrawal by Subject|76|||
156758184|NCT03257436|565866408|FG000|Overall Study|Death|19|||
156758185|NCT01619852|565866409|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
157000766|NCT01090024|566752635|FG011|Period 1|Withdrawal by Subject|0|||
157000767|NCT01090024|566752636|FG012|Period 1|Withdrawal by Subject|0|||
156758186|NCT01619852|565866410|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
156758187|NCT01619852|565866409|FG000|3 Month Follow up|Lost to Follow-up|31|||
156758188|NCT01619852|565866410|FG001|3 Month Follow up|Lost to Follow-up|34|||
156758189|NCT00970489|565866411|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
156758190|NCT00970489|565866412|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
156758191|NCT02659943|565866413|FG000|Overall Study|Switched to alternative treatment|1|||
156758192|NCT02659943|565866414|FG001|Overall Study|Switched to alternative treatment|1|||
156758193|NCT02659943|565866415|FG002|Overall Study|Switched to alternative treatment|0|||
156758194|NCT02659943|565866416|FG003|Overall Study|Switched to alternative treatment|2|||
156758195|NCT02659943|565866417|FG004|Overall Study|Switched to alternative treatment|1|||
156758196|NCT02659943|565866418|FG005|Overall Study|Switched to alternative treatment|0|||
156758197|NCT02659943|565866419|FG006|Overall Study|Switched to alternative treatment|1|||
156758198|NCT02659943|565866413|FG000|Overall Study|Disease progression on study|0|||
156758199|NCT02659943|565866414|FG001|Overall Study|Disease progression on study|1|||
156758200|NCT02659943|565866415|FG002|Overall Study|Disease progression on study|1|||
156758201|NCT02659943|565866416|FG003|Overall Study|Disease progression on study|1|||
156758202|NCT02659943|565866417|FG004|Overall Study|Disease progression on study|1|||
156758203|NCT02659943|565866418|FG005|Overall Study|Disease progression on study|4|||
156758204|NCT02659943|565866419|FG006|Overall Study|Disease progression on study|0|||
156758205|NCT02659943|565866413|FG000|Overall Study|Patient's condition per principal investigator|0|||
156758206|NCT02659943|565866414|FG001|Overall Study|Patient's condition per principal investigator|0|||
156758207|NCT02659943|565866415|FG002|Overall Study|Patient's condition per principal investigator|0|||
156758208|NCT02659943|565866416|FG003|Overall Study|Patient's condition per principal investigator|0|||
156758209|NCT02659943|565866417|FG004|Overall Study|Patient's condition per principal investigator|0|||
156758210|NCT02659943|565866418|FG005|Overall Study|Patient's condition per principal investigator|1|||
156758211|NCT02659943|565866419|FG006|Overall Study|Patient's condition per principal investigator|0|||
156758212|NCT02659943|565866413|FG000|Overall Study|Ineligible|0|||
156758213|NCT02659943|565866414|FG001|Overall Study|Ineligible|0|||
156758214|NCT02659943|565866415|FG002|Overall Study|Ineligible|0|||
156758215|NCT02659943|565866416|FG003|Overall Study|Ineligible|0|||
156758216|NCT02659943|565866417|FG004|Overall Study|Ineligible|0|||
156758217|NCT02659943|565866418|FG005|Overall Study|Ineligible|0|||
156758218|NCT02659943|565866419|FG006|Overall Study|Ineligible|1|||
156758219|NCT02659943|565866413|FG000|Overall Study|No longer meets eligibility|0|||
156758220|NCT02659943|565866414|FG001|Overall Study|No longer meets eligibility|0|||
156758221|NCT02659943|565866415|FG002|Overall Study|No longer meets eligibility|0|||
156758222|NCT02659943|565866416|FG003|Overall Study|No longer meets eligibility|0|||
156758223|NCT02659943|565866417|FG004|Overall Study|No longer meets eligibility|0|||
156758224|NCT02659943|565866418|FG005|Overall Study|No longer meets eligibility|0|||
156758225|NCT02659943|565866419|FG006|Overall Study|No longer meets eligibility|1|||
156758226|NCT02659943|565866413|FG000|Overall Study|No treatment, per protocol|0|||
156758227|NCT02659943|565866414|FG001|Overall Study|No treatment, per protocol|0|||
156758228|NCT02659943|565866415|FG002|Overall Study|No treatment, per protocol|0|||
156758229|NCT02659943|565866416|FG003|Overall Study|No treatment, per protocol|0|||
156758230|NCT02659943|565866417|FG004|Overall Study|No treatment, per protocol|0|||
156758231|NCT02659943|565866418|FG005|Overall Study|No treatment, per protocol|0|||
156758232|NCT02659943|565866419|FG006|Overall Study|No treatment, per protocol|3|||
156758233|NCT06060496|565866424|FG000|Overall Study|Withdrawal by Subject|2|||
156758234|NCT06060496|565866424|FG000|Overall Study|Lost to Follow-up|2|||
156758235|NCT03361306|565866425|FG000|Overall Study|Death|6|||
156758236|NCT02282163|565866428|FG000|Overall Study|Protocol Violation|1|||
156758237|NCT03472521|565866429|FG000|Overall Study|Lost to Follow-up|3|||
156758238|NCT03472521|565866430|FG001|Overall Study|Lost to Follow-up|2|||
156758239|NCT03472521|565866429|FG000|Overall Study|Discontinued intervention|3|||
156758240|NCT03472521|565866430|FG001|Overall Study|Discontinued intervention|1|||
156758241|NCT01603407|565866431|FG000|Overall Study|Adverse Event|1|||
156758242|NCT01603407|565866432|FG001|Overall Study|Adverse Event|1|||
156758243|NCT01603407|565866433|FG002|Overall Study|Adverse Event|1|||
156758244|NCT01603407|565866431|FG000|Overall Study|Protocol Violation|2|||
156758245|NCT01603407|565866432|FG001|Overall Study|Protocol Violation|2|||
156758246|NCT01603407|565866433|FG002|Overall Study|Protocol Violation|0|||
157000768|NCT01090024|566752637|FG013|Period 1|Withdrawal by Subject|0|||
156758247|NCT01603407|565866431|FG000|Overall Study|Withdrawal by Subject|8|||
156758248|NCT01603407|565866432|FG001|Overall Study|Withdrawal by Subject|5|||
156758249|NCT01603407|565866433|FG002|Overall Study|Withdrawal by Subject|7|||
156758250|NCT01603407|565866431|FG000|Overall Study|Lost to Follow-up|0|||
156758251|NCT01603407|565866432|FG001|Overall Study|Lost to Follow-up|3|||
156758252|NCT01603407|565866433|FG002|Overall Study|Lost to Follow-up|2|||
156758253|NCT01801111|565866441|FG000|Overall Study|Adverse Event|12|||
156758254|NCT01801111|565866441|FG000|Overall Study|Death|8|||
156758255|NCT01801111|565866441|FG000|Overall Study|Physician Decision|5|||
156758256|NCT01801111|565866441|FG000|Overall Study|Other|1|||
156758257|NCT01801111|565866441|FG000|Overall Study|Withdrawal by Subject|4|||
156758258|NCT01801111|565866441|FG000|Overall Study|Study Terminated by Sponsor|27|||
157000769|NCT01090024|566752638|FG014|Period 1|Withdrawal by Subject|0|||
156758259|NCT01801111|565866441|FG000|Overall Study|Progressive Disease|81|||
156758260|NCT01210482|565866442|FG000|Overall Study|Protocol Violation|1|||
156758261|NCT01210482|565866442|FG000|Overall Study|Case Report Forms were not collected|18|||
156758262|NCT01210482|565866442|FG000|Overall Study|Duplicated|2|||
156758263|NCT01210482|565866442|FG000|Overall Study|No Drug Administration|28|||
156758264|NCT01223937|565866443|FG000|Overall Study|Withdrawal by Subject|3|||
156758265|NCT01223937|565866444|FG001|Overall Study|Withdrawal by Subject|2|||
156758266|NCT01223937|565866443|FG000|Overall Study|Lost to Follow-up|1|||
156758267|NCT01223937|565866444|FG001|Overall Study|Lost to Follow-up|4|||
156758268|NCT01223937|565866443|FG000|Overall Study|Adverse Event|1|||
156758269|NCT01223937|565866444|FG001|Overall Study|Adverse Event|4|||
156758270|NCT01223937|565866443|FG000|Overall Study|Protocol Violation|8|||
156758271|NCT01223937|565866444|FG001|Overall Study|Protocol Violation|7|||
156758272|NCT01223937|565866443|FG000|Overall Study|Other|4|||
156758273|NCT01223937|565866444|FG001|Overall Study|Other|1|||
156758274|NCT03284853|565866445|FG000|Overall Study|Adverse Event|40|||
156758275|NCT03284853|565866446|FG001|Overall Study|Adverse Event|4|||
156758276|NCT03284853|565866445|FG000|Overall Study|Withdrawal by Subject|5|||
156758277|NCT03284853|565866446|FG001|Overall Study|Withdrawal by Subject|1|||
156758278|NCT03284853|565866445|FG000|Overall Study|Lost to Follow-up|1|||
156758279|NCT03284853|565866446|FG001|Overall Study|Lost to Follow-up|0|||
156758280|NCT03284853|565866445|FG000|Overall Study|Lack of Efficacy|1|||
156758281|NCT03284853|565866446|FG001|Overall Study|Lack of Efficacy|0|||
156758282|NCT03284853|565866445|FG000|Overall Study|Disallowed Concurrent Medication|1|||
156758283|NCT03284853|565866446|FG001|Overall Study|Disallowed Concurrent Medication|1|||
156758284|NCT03284853|565866445|FG000|Overall Study|Protocol Violation|3|||
156758285|NCT03284853|565866446|FG001|Overall Study|Protocol Violation|3|||
156758286|NCT03284853|565866445|FG000|Overall Study|Death|0|||
156758287|NCT03284853|565866446|FG001|Overall Study|Death|1|||
156758288|NCT03284853|565866445|FG000|Overall Study|Other - Reason not reported in CSR|4|||
156758289|NCT03284853|565866446|FG001|Overall Study|Other - Reason not reported in CSR|3|||
156758290|NCT03677869|565866448|FG000|Overall Study|Withdrawal by Subject|1|||
156758291|NCT05219968|565866449|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
156758292|NCT05219968|565866450|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758293|NCT05219968|565866451|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758294|NCT05219968|565866452|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758295|NCT05219968|565866453|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
156758296|NCT05219968|565866449|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
156758297|NCT05219968|565866450|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758298|NCT05219968|565866451|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758299|NCT05219968|565866452|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758300|NCT05219968|565866453|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
156758301|NCT05219968|565866449|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
156758302|NCT05219968|565866450|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
156758303|NCT05219968|565866451|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758304|NCT05219968|565866452|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758305|NCT05219968|565866453|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
156758306|NCT05219968|565866449|FG000|Week 24 Treatment Period|Adverse Event|3|||
156758307|NCT05219968|565866450|FG001|Week 24 Treatment Period|Adverse Event|0|||
156758308|NCT05219968|565866451|FG002|Week 24 Treatment Period|Adverse Event|0|||
156758309|NCT05219968|565866452|FG003|Week 24 Treatment Period|Adverse Event|0|||
156758310|NCT05219968|565866453|FG004|Week 24 Treatment Period|Adverse Event|0|||
156758311|NCT05219968|565866449|FG000|Week 24 Treatment Period|Physician Decision|0|||
156758312|NCT05219968|565866450|FG001|Week 24 Treatment Period|Physician Decision|1|||
156758313|NCT05219968|565866451|FG002|Week 24 Treatment Period|Physician Decision|0|||
156758314|NCT05219968|565866452|FG003|Week 24 Treatment Period|Physician Decision|0|||
156758315|NCT05219968|565866453|FG004|Week 24 Treatment Period|Physician Decision|0|||
156758316|NCT05219968|565866449|FG000|Week 24 Treatment Period|Other, not specified|3|||
156758317|NCT05219968|565866450|FG001|Week 24 Treatment Period|Other, not specified|0|||
156758318|NCT05219968|565866451|FG002|Week 24 Treatment Period|Other, not specified|0|||
156758319|NCT05219968|565866452|FG003|Week 24 Treatment Period|Other, not specified|0|||
156758320|NCT05219968|565866453|FG004|Week 24 Treatment Period|Other, not specified|0|||
156758321|NCT05219968|565866449|FG000|Safety Extension Period|Treatment administration failure|0|||
156758322|NCT05219968|565866450|FG001|Safety Extension Period|Treatment administration failure|0|||
156758323|NCT05219968|565866451|FG002|Safety Extension Period|Treatment administration failure|0|||
156758324|NCT05219968|565866452|FG003|Safety Extension Period|Treatment administration failure|1|||
156758325|NCT05219968|565866453|FG004|Safety Extension Period|Treatment administration failure|4|||
156758326|NCT05219968|565866449|FG000|Safety Extension Period|Bilateral dislodgement|0|||
156758327|NCT05219968|565866450|FG001|Safety Extension Period|Bilateral dislodgement|0|||
156758328|NCT05219968|565866451|FG002|Safety Extension Period|Bilateral dislodgement|4|||
156758329|NCT05219968|565866452|FG003|Safety Extension Period|Bilateral dislodgement|0|||
156758330|NCT05219968|565866453|FG004|Safety Extension Period|Bilateral dislodgement|1|||
156758331|NCT05219968|565866449|FG000|Safety Extension Period|Withdrawal by Subject|0|||
156758332|NCT05219968|565866450|FG001|Safety Extension Period|Withdrawal by Subject|0|||
156758333|NCT05219968|565866451|FG002|Safety Extension Period|Withdrawal by Subject|2|||
156758334|NCT05219968|565866452|FG003|Safety Extension Period|Withdrawal by Subject|0|||
156758335|NCT05219968|565866453|FG004|Safety Extension Period|Withdrawal by Subject|4|||
156758336|NCT05219968|565866449|FG000|Safety Extension Period|Adverse Event|0|||
156758337|NCT05219968|565866450|FG001|Safety Extension Period|Adverse Event|0|||
156758338|NCT05219968|565866451|FG002|Safety Extension Period|Adverse Event|2|||
156758339|NCT05219968|565866452|FG003|Safety Extension Period|Adverse Event|1|||
156758340|NCT05219968|565866453|FG004|Safety Extension Period|Adverse Event|1|||
156758341|NCT05219968|565866449|FG000|Safety Extension Period|Lost to Follow-up|0|||
156758342|NCT05219968|565866450|FG001|Safety Extension Period|Lost to Follow-up|0|||
156758343|NCT05219968|565866451|FG002|Safety Extension Period|Lost to Follow-up|0|||
156758344|NCT05219968|565866452|FG003|Safety Extension Period|Lost to Follow-up|1|||
156758345|NCT05219968|565866453|FG004|Safety Extension Period|Lost to Follow-up|0|||
156758346|NCT04587336|565866456|FG000|Overall Study|Lost to Follow-up|1|||
156758347|NCT04587336|565866457|FG001|Overall Study|Lost to Follow-up|0|||
156758348|NCT02250300|565867984|FG000|Expansion Phase|Death|6|||
156758349|NCT02250300|565867985|FG001|Expansion Phase|Death|7|||
156758350|NCT02250300|565867986|FG002|Expansion Phase|Death|0|||
156758351|NCT02250300|565867987|FG003|Expansion Phase|Death|0|||
156758352|NCT01845597|565867990|FG000|Overall Study|Death|8|||
156758353|NCT01845597|565867990|FG000|Overall Study|Lost to Follow-up|22|||
156758354|NCT01223404|565867991|FG000|First Intervention (1 Day)|Adverse Event|0|||
156758355|NCT01223404|565867992|FG001|First Intervention (1 Day)|Adverse Event|0|||
156758356|NCT01223404|565867993|FG002|First Intervention (1 Day)|Adverse Event|0|||
156758357|NCT01223404|565867994|FG003|First Intervention (1 Day)|Adverse Event|1|||
156758358|NCT01223404|565867995|FG004|First Intervention (1 Day)|Adverse Event|0|||
156758359|NCT01223404|565867996|FG005|First Intervention (1 Day)|Adverse Event|0|||
156758360|NCT01223404|565867991|FG000|Second Intervention (1 Day)|Adverse Event|1|||
156758361|NCT01223404|565867992|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156758362|NCT01223404|565867993|FG002|Second Intervention (1 Day)|Adverse Event|0|||
156758363|NCT01223404|565867994|FG003|Second Intervention (1 Day)|Adverse Event|0|||
156758364|NCT01223404|565867995|FG004|Second Intervention (1 Day)|Adverse Event|0|||
156758365|NCT01223404|565867996|FG005|Second Intervention (1 Day)|Adverse Event|0|||
156758366|NCT01223404|565867991|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758367|NCT01223404|565867992|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758368|NCT01223404|565867993|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758369|NCT01223404|565867994|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
156758370|NCT01223404|565867995|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758371|NCT01223404|565867996|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
156758372|NCT02922153|565867997|FG000|Overall Study|Death|8|||
156758373|NCT02922153|565867998|FG001|Overall Study|Death|1|||
156758374|NCT02922153|565867997|FG000|Overall Study|Lost to Follow-up|1|||
156758375|NCT02922153|565867998|FG001|Overall Study|Lost to Follow-up|0|||
156758376|NCT02922153|565867997|FG000|Overall Study|Physician Decision|1|||
156758377|NCT02922153|565867998|FG001|Overall Study|Physician Decision|1|||
156758378|NCT00522548|565867999|FG000|Overall Study|Adverse Event|2|||
156758379|NCT00522548|565868000|FG001|Overall Study|Adverse Event|2|||
156758380|NCT00522548|565867999|FG000|Overall Study|Withdrawal by Subject|0|||
156758381|NCT00522548|565868000|FG001|Overall Study|Withdrawal by Subject|2|||
156758382|NCT03506438|565868001|FG000|Overall Study|Lost to Follow-up|8|||
156758383|NCT03506438|565868002|FG001|Overall Study|Lost to Follow-up|7|||
156758384|NCT03506438|565868003|FG002|Overall Study|Lost to Follow-up|8|||
156758385|NCT03506438|565868004|FG003|Overall Study|Lost to Follow-up|7|||
156758386|NCT03506438|565868005|FG004|Overall Study|Lost to Follow-up|0|||
156758387|NCT03506438|565868006|FG005|Overall Study|Lost to Follow-up|0|||
156758388|NCT01128296|565868007|FG000|Overall Study|Physician Decision|0|||
156758389|NCT01128296|565868008|FG001|Overall Study|Physician Decision|0|||
156758390|NCT01128296|565868009|FG002|Overall Study|Physician Decision|0|||
156758391|NCT01128296|565868010|FG003|Overall Study|Physician Decision|0|||
156758392|NCT01128296|565868011|FG004|Overall Study|Physician Decision|0|||
156758393|NCT01128296|565868012|FG005|Overall Study|Physician Decision|3|||
156758394|NCT01128296|565868007|FG000|Overall Study|Withdrawal by Subject|0|||
156758395|NCT01128296|565868008|FG001|Overall Study|Withdrawal by Subject|0|||
156758396|NCT01128296|565868009|FG002|Overall Study|Withdrawal by Subject|0|||
156758397|NCT01128296|565868010|FG003|Overall Study|Withdrawal by Subject|0|||
156758398|NCT01128296|565868011|FG004|Overall Study|Withdrawal by Subject|0|||
156758399|NCT01128296|565868012|FG005|Overall Study|Withdrawal by Subject|2|||
156758400|NCT04155463|565868013|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
156758401|NCT04155463|565868014|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
156758402|NCT01053741|565868015|FG000|2nd Study Intervention|Physician Decision|0|||
157103928|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
156758403|NCT01053741|565868016|FG001|2nd Study Intervention|Physician Decision|1|||
156758404|NCT00368108|565868017|FG000|Overall Study|Adverse Event|38|||
156758405|NCT00368108|565868018|FG001|Overall Study|Adverse Event|26|||
157103929|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
157103930|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
157103931|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
156758406|NCT00368108|565868019|FG002|Overall Study|Adverse Event|44|||
156758407|NCT00368108|565868017|FG000|Overall Study|Abnormal Laboratory Value|0|||
156758408|NCT00368108|565868018|FG001|Overall Study|Abnormal Laboratory Value|0|||
156758409|NCT00368108|565868019|FG002|Overall Study|Abnormal Laboratory Value|3|||
156758410|NCT00368108|565868017|FG000|Overall Study|Protocol Violation|5|||
156758411|NCT00368108|565868018|FG001|Overall Study|Protocol Violation|9|||
156758412|NCT00368108|565868019|FG002|Overall Study|Protocol Violation|9|||
156758413|NCT00368108|565868017|FG000|Overall Study|Withdrawal by Subject|9|||
156758414|NCT00368108|565868018|FG001|Overall Study|Withdrawal by Subject|3|||
156758415|NCT00368108|565868019|FG002|Overall Study|Withdrawal by Subject|5|||
156758416|NCT00368108|565868017|FG000|Overall Study|Lack of Efficacy|7|||
156758417|NCT00368108|565868018|FG001|Overall Study|Lack of Efficacy|8|||
156758418|NCT00368108|565868019|FG002|Overall Study|Lack of Efficacy|5|||
156758419|NCT00368108|565868017|FG000|Overall Study|Physician Decision|2|||
156758420|NCT00368108|565868018|FG001|Overall Study|Physician Decision|0|||
156758421|NCT00368108|565868019|FG002|Overall Study|Physician Decision|1|||
156758422|NCT00368108|565868017|FG000|Overall Study|Other|3|||
156758423|NCT00368108|565868018|FG001|Overall Study|Other|7|||
156758424|NCT00368108|565868019|FG002|Overall Study|Other|1|||
156758425|NCT02299388|565868022|FG000|Overall Study|Withdrawal by Subject|0|||
156758426|NCT02299388|565868023|FG001|Overall Study|Withdrawal by Subject|1|||
156758427|NCT03334188|565868024|FG000|Overall Study|Withdrawal by Subject|0|||
156758428|NCT03334188|565868025|FG001|Overall Study|Withdrawal by Subject|1|||
156758429|NCT03334188|565868024|FG000|Overall Study|Death|1|||
156758430|NCT03334188|565868025|FG001|Overall Study|Death|0|||
156758431|NCT03334188|565868024|FG000|Overall Study|Never had qualifying clinic visit|7|||
156758432|NCT03334188|565868025|FG001|Overall Study|Never had qualifying clinic visit|7|||
156758433|NCT01093586|565868030|FG000|Overall Study|Failed to engraft|3|||
156758434|NCT03442088|565868031|FG000|Overall Study|Adverse Event|1|||
156758435|NCT03442088|565868031|FG000|Overall Study|Lack of Efficacy|2|||
156758436|NCT03442088|565868031|FG000|Overall Study|Lost to Follow-up|2|||
156758437|NCT00357877|565868032|FG000|Overall Study|Death|2|||
156758438|NCT00357877|565868033|FG001|Overall Study|Death|1|||
156758439|NCT00357877|565868032|FG000|Overall Study|Lost to Follow-up|20|||
156758440|NCT00357877|565868033|FG001|Overall Study|Lost to Follow-up|23|||
156758441|NCT00357877|565868032|FG000|Overall Study|Withdrawal by Subject|3|||
156758442|NCT00357877|565868033|FG001|Overall Study|Withdrawal by Subject|3|||
156758443|NCT00357877|565868032|FG000|Overall Study|Administrative withdrawal|1|||
156758444|NCT00357877|565868033|FG001|Overall Study|Administrative withdrawal|1|||
156758445|NCT00357877|565868032|FG000|Overall Study|Other|0|||
156758446|NCT00357877|565868033|FG001|Overall Study|Other|2|||
156758447|NCT01051557|565868036|FG000|Overall Study|Physician Decision|1|||
156758448|NCT01051557|565868037|FG001|Overall Study|Physician Decision|0|||
156758449|NCT01051557|565868038|FG002|Overall Study|Physician Decision|0|||
156758450|NCT01051557|565868039|FG003|Overall Study|Physician Decision|0|||
156758451|NCT01051557|565868040|FG004|Overall Study|Physician Decision|0|||
156758452|NCT01051557|565868041|FG005|Overall Study|Physician Decision|0|||
156758453|NCT01051557|565868042|FG006|Overall Study|Physician Decision|0|||
156758454|NCT01051557|565868036|FG000|Overall Study|disease progression|3|||
156758455|NCT01051557|565868037|FG001|Overall Study|disease progression|3|||
156758456|NCT01051557|565868038|FG002|Overall Study|disease progression|5|||
156758457|NCT01051557|565868039|FG003|Overall Study|disease progression|2|||
156758458|NCT01051557|565868040|FG004|Overall Study|disease progression|4|||
156758459|NCT01051557|565868041|FG005|Overall Study|disease progression|3|||
156758460|NCT01051557|565868042|FG006|Overall Study|disease progression|1|||
157103932|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
157103933|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
157103934|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
157103935|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
157103936|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
156758461|NCT01051557|565868036|FG000|Overall Study|Withdrawal by Subject|0|||
156758462|NCT01051557|565868037|FG001|Overall Study|Withdrawal by Subject|0|||
156758463|NCT01051557|565868038|FG002|Overall Study|Withdrawal by Subject|1|||
156758464|NCT01051557|565868039|FG003|Overall Study|Withdrawal by Subject|0|||
156758465|NCT01051557|565868040|FG004|Overall Study|Withdrawal by Subject|2|||
156758466|NCT01051557|565868041|FG005|Overall Study|Withdrawal by Subject|0|||
156758467|NCT01051557|565868042|FG006|Overall Study|Withdrawal by Subject|1|||
156758468|NCT01051557|565868036|FG000|Overall Study|Adverse Event|0|||
156758469|NCT01051557|565868037|FG001|Overall Study|Adverse Event|0|||
156758470|NCT01051557|565868038|FG002|Overall Study|Adverse Event|0|||
156758471|NCT01051557|565868039|FG003|Overall Study|Adverse Event|1|||
156758472|NCT01051557|565868040|FG004|Overall Study|Adverse Event|1|||
156758473|NCT01051557|565868041|FG005|Overall Study|Adverse Event|3|||
156758474|NCT01051557|565868042|FG006|Overall Study|Adverse Event|4|||
156758475|NCT00943397|565868049|FG000|Overall Study|Adverse Event|0|||
156758476|NCT00943397|565868050|FG001|Overall Study|Adverse Event|6|||
156758477|NCT00943397|565868049|FG000|Overall Study|Lost to Follow-up|0|||
156758478|NCT00943397|565868050|FG001|Overall Study|Lost to Follow-up|4|||
156758479|NCT00943397|565868049|FG000|Overall Study|Protocol Violation|2|||
156758480|NCT00943397|565868050|FG001|Overall Study|Protocol Violation|5|||
156758481|NCT00943397|565868049|FG000|Overall Study|Withdrawal by Subject|1|||
156758482|NCT00943397|565868050|FG001|Overall Study|Withdrawal by Subject|1|||
156758483|NCT00943397|565868049|FG000|Overall Study|Site terminated and other|12|||
156758484|NCT00943397|565868050|FG001|Overall Study|Site terminated and other|56|||
156758485|NCT04878055|565868051|FG000|Overall Study|Patient transferred in another department|0|||
156758486|NCT04878055|565868052|FG001|Overall Study|Patient transferred in another department|2|||
156758487|NCT04878055|565868051|FG000|Overall Study|Physician Decision|1|||
156758488|NCT04878055|565868052|FG001|Overall Study|Physician Decision|1|||
156758489|NCT04878055|565868051|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
156758490|NCT04878055|565868052|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
156758491|NCT04878055|565868051|FG000|Overall Study|Adverse Event|12|||
156758492|NCT04878055|565868052|FG001|Overall Study|Adverse Event|7|||
156758493|NCT04878055|565868051|FG000|Overall Study|Other|5|||
156758494|NCT04878055|565868052|FG001|Overall Study|Other|0|||
156758495|NCT04878055|565868051|FG000|Overall Study|Withdrawal by Subject|7|||
156758496|NCT04878055|565868052|FG001|Overall Study|Withdrawal by Subject|3|||
156758497|NCT04878055|565868051|FG000|Overall Study|Lost to Follow-up|10|||
156758498|NCT04878055|565868052|FG001|Overall Study|Lost to Follow-up|1|||
156758499|NCT01968811|565868053|FG000|Overall Study|Protocol Violation|4|||
156758500|NCT01968811|565868053|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
156758501|NCT00369915|565868054|FG000|Overall Study|expected side effects|2|||
156758502|NCT00369915|565868055|FG001|Overall Study|expected side effects|1|||
156758503|NCT00369915|565868054|FG000|Overall Study|Withdrawal by Subject|4|||
157103937|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
156758504|NCT00369915|565868055|FG001|Overall Study|Withdrawal by Subject|1|||
157103938|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
157103939|NCT03627767|567136361|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
157103940|NCT03627767|567136362|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
157103941|NCT03627767|567136363|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
157103942|NCT03627767|567136364|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
157103943|NCT03627767|567136365|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
157103944|NCT03627767|567136361|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
157103945|NCT03627767|567136362|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156758505|NCT00369915|565868054|FG000|Overall Study|W/drawl by investigators|0|||
156758506|NCT00369915|565868055|FG001|Overall Study|W/drawl by investigators|1|||
156758507|NCT00249873|565868058|FG000|Overall Study|Not treated|7|||
156758508|NCT00249873|565868059|FG001|Overall Study|Not treated|8|||
156758509|NCT00249873|565868058|FG000|Overall Study|Significant thrombocytopenia|9|||
156758510|NCT00249873|565868059|FG001|Overall Study|Significant thrombocytopenia|8|||
156758511|NCT00249873|565868058|FG000|Overall Study|Severe allergic reaction|8|||
156758512|NCT00249873|565868059|FG001|Overall Study|Severe allergic reaction|1|||
156758513|NCT00249873|565868058|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
156758514|NCT00249873|565868059|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
156758515|NCT00249873|565868058|FG000|Overall Study|Other Serious Adverse Event|86|||
156758516|NCT00249873|565868059|FG001|Overall Study|Other Serious Adverse Event|97|||
156758517|NCT00249873|565868058|FG000|Overall Study|Qualifying condition not present|20|||
156758518|NCT00249873|565868059|FG001|Overall Study|Qualifying condition not present|23|||
156758519|NCT00249873|565868058|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
156758520|NCT00249873|565868059|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
156758521|NCT00249873|565868058|FG000|Overall Study|Withdrawal by Subject|504|||
156758522|NCT00249873|565868059|FG001|Overall Study|Withdrawal by Subject|466|||
156758523|NCT00249873|565868058|FG000|Overall Study|Lost to Follow-up|4|||
156758524|NCT00249873|565868059|FG001|Overall Study|Lost to Follow-up|7|||
156758525|NCT00249873|565868058|FG000|Overall Study|Minor bleeding|99|||
156758526|NCT00249873|565868059|FG001|Overall Study|Minor bleeding|37|||
157103946|NCT03627767|567136363|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
156758527|NCT00249873|565868058|FG000|Overall Study|Non-compliance|41|||
156758528|NCT00249873|565868059|FG001|Overall Study|Non-compliance|46|||
156758529|NCT00249873|565868058|FG000|Overall Study|Other non serious Adverse Event|112|||
156758530|NCT00249873|565868059|FG001|Overall Study|Other non serious Adverse Event|108|||
156758531|NCT00249873|565868058|FG000|Overall Study|Other contraindicated medication|1|||
156758532|NCT00249873|565868059|FG001|Overall Study|Other contraindicated medication|0|||
157103947|NCT03627767|567136364|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
157103948|NCT03627767|567136365|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
156758533|NCT00249873|565868058|FG000|Overall Study|Patient not wish to continue after May08|3|||
156758534|NCT00249873|565868059|FG001|Overall Study|Patient not wish to continue after May08|4|||
156758535|NCT00249873|565868058|FG000|Overall Study|Physician withdrew consent|59|||
157103949|NCT03627767|567136361|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
156758536|NCT00249873|565868059|FG001|Overall Study|Physician withdrew consent|60|||
156758537|NCT00249873|565868058|FG000|Overall Study|Open label clopidogrel required|31|||
156758538|NCT00249873|565868059|FG001|Overall Study|Open label clopidogrel required|42|||
156758539|NCT00249873|565868058|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
156758540|NCT00249873|565868059|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
156758541|NCT00249873|565868058|FG000|Overall Study|Oral anticoagulant required|159|||
156758542|NCT00249873|565868059|FG001|Overall Study|Oral anticoagulant required|157|||
156758543|NCT00249873|565868058|FG000|Overall Study|Study drug intolerance|5|||
156758544|NCT00249873|565868059|FG001|Overall Study|Study drug intolerance|0|||
156758545|NCT00249873|565868058|FG000|Overall Study|Surgery/ procedure|9|||
156758546|NCT00249873|565868059|FG001|Overall Study|Surgery/ procedure|9|||
156758547|NCT00249873|565868058|FG000|Overall Study|Event related to cardiac condition|12|||
156758548|NCT00249873|565868059|FG001|Overall Study|Event related to cardiac condition|21|||
156758549|NCT00249873|565868058|FG000|Overall Study|Thromboembolic/outcome event|82|||
156758550|NCT00249873|565868059|FG001|Overall Study|Thromboembolic/outcome event|122|||
156758551|NCT00447772|565868060|FG000|Overall Study|Lack of Efficacy|3|||
156758552|NCT00447772|565868060|FG000|Overall Study|Insufficient compliance|6|||
156758553|NCT00447772|565868060|FG000|Overall Study|Discontinuation of drug therapy|1|||
156758554|NCT00447772|565868060|FG000|Overall Study|Lost to Follow-up|9|||
156758555|NCT00447772|565868060|FG000|Overall Study|Withdrawal by Subject|1|||
156758556|NCT00447772|565868060|FG000|Overall Study|Unable to attend all study visits|2|||
156758557|NCT00447772|565868060|FG000|Overall Study|Adverse Event|1|||
156758558|NCT00447772|565868060|FG000|Overall Study|Patient relocated|1|||
156758559|NCT00447772|565868060|FG000|Overall Study|Incomplete documentation at visit 1|1|||
156758560|NCT00447772|565868060|FG000|Overall Study|Chemotherapy for lung cancer|1|||
156758561|NCT00447772|565868060|FG000|Overall Study|Premature re-injection required|1|||
156758562|NCT01576575|565868061|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
156758563|NCT01576575|565868061|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
156758564|NCT01576575|565868061|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
156758565|NCT01723072|565868066|FG000|Overall Study|Withdrawal by Subject|7|||
156758566|NCT01723072|565868067|FG001|Overall Study|Withdrawal by Subject|13|||
156758567|NCT01723072|565868066|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
156758568|NCT01723072|565868067|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
156758569|NCT01723072|565868066|FG000|Overall Study|Other|4|||
156758570|NCT01723072|565868067|FG001|Overall Study|Other|3|||
156758571|NCT01841970|565868068|FG000|Overall Study|Withdrawal by Subject|1|||
156758572|NCT01841970|565868068|FG000|Overall Study|Physician Decision|2|||
156758573|NCT01841970|565868068|FG000|Overall Study|Lost to Follow-up|8|||
156758574|NCT01610037|565868074|FG000|All Patients|Adverse Event|27|||
156758575|NCT01610037|565868075|FG001|All Patients|Adverse Event|22|||
156758576|NCT01610037|565868076|FG002|All Patients|Adverse Event|26|||
156758577|NCT01610037|565868074|FG000|All Patients|Withdrawal by Subject|12|||
156758578|NCT01610037|565868075|FG001|All Patients|Withdrawal by Subject|10|||
156758579|NCT01610037|565868076|FG002|All Patients|Withdrawal by Subject|20|||
156758580|NCT01610037|565868074|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
157000770|NCT01090024|566752639|FG015|Period 1|Withdrawal by Subject|0|||
157000771|NCT01090024|566752640|FG016|Period 1|Withdrawal by Subject|0|||
157000772|NCT01090024|566752641|FG017|Period 1|Withdrawal by Subject|0|||
157000773|NCT01090024|566752624|FG000|Period 1|Lost to Follow-up|0|||
157000774|NCT01090024|566752625|FG001|Period 1|Lost to Follow-up|1|||
157000775|NCT01090024|566752626|FG002|Period 1|Lost to Follow-up|0|||
157000776|NCT01090024|566752627|FG003|Period 1|Lost to Follow-up|0|||
157000777|NCT01090024|566752628|FG004|Period 1|Lost to Follow-up|0|||
157000778|NCT01090024|566752629|FG005|Period 1|Lost to Follow-up|0|||
157000779|NCT01090024|566752630|FG006|Period 1|Lost to Follow-up|0|||
157000780|NCT01090024|566752631|FG007|Period 1|Lost to Follow-up|0|||
157000781|NCT01090024|566752632|FG008|Period 1|Lost to Follow-up|0|||
157000782|NCT01090024|566752633|FG009|Period 1|Lost to Follow-up|0|||
157000783|NCT01090024|566752634|FG010|Period 1|Lost to Follow-up|0|||
157000784|NCT01090024|566752635|FG011|Period 1|Lost to Follow-up|0|||
157000785|NCT01090024|566752636|FG012|Period 1|Lost to Follow-up|0|||
157000786|NCT01090024|566752637|FG013|Period 1|Lost to Follow-up|0|||
157000787|NCT01090024|566752638|FG014|Period 1|Lost to Follow-up|0|||
156758581|NCT01610037|565868075|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
156758582|NCT01610037|565868076|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
156758583|NCT01610037|565868074|FG000|All Patients|Death|4|||
156758584|NCT01610037|565868075|FG001|All Patients|Death|2|||
156758585|NCT01610037|565868076|FG002|All Patients|Death|1|||
156758586|NCT01610037|565868074|FG000|All Patients|Protocol deviation|4|||
157000788|NCT01090024|566752639|FG015|Period 1|Lost to Follow-up|0|||
157000789|NCT01090024|566752640|FG016|Period 1|Lost to Follow-up|0|||
157000790|NCT01090024|566752641|FG017|Period 1|Lost to Follow-up|0|||
156758587|NCT01610037|565868075|FG001|All Patients|Protocol deviation|3|||
156758588|NCT01610037|565868076|FG002|All Patients|Protocol deviation|3|||
157000791|NCT01090024|566752624|FG000|Period 2|Lost to Follow-up|0|||
157000792|NCT01090024|566752625|FG001|Period 2|Lost to Follow-up|0|||
157000793|NCT01090024|566752626|FG002|Period 2|Lost to Follow-up|0|||
157103950|NCT03627767|567136362|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
157103951|NCT03627767|567136363|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
157103952|NCT03627767|567136364|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
157103953|NCT03627767|567136365|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
157103954|NCT03627767|567136361|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
157103955|NCT03627767|567136362|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
157103956|NCT03627767|567136363|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
157103957|NCT03627767|567136364|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
157103958|NCT03627767|567136365|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
157103959|NCT03627767|567136361|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
157103960|NCT03627767|567136362|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
157103961|NCT03627767|567136363|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
157103962|NCT03627767|567136364|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
156758589|NCT01610037|565868074|FG000|All Patients|Abnormal laboratory value|1|||
156758590|NCT01610037|565868075|FG001|All Patients|Abnormal laboratory value|1|||
156758591|NCT01610037|565868076|FG002|All Patients|Abnormal laboratory value|0|||
156758592|NCT01610037|565868074|FG000|All Patients|Administrative problems|1|||
156758593|NCT01610037|565868075|FG001|All Patients|Administrative problems|4|||
156758594|NCT01610037|565868076|FG002|All Patients|Administrative problems|4|||
156758595|NCT01610037|565868074|FG000|All Patients|Lost to Follow-up|1|||
156758596|NCT01610037|565868075|FG001|All Patients|Lost to Follow-up|0|||
156758597|NCT01610037|565868076|FG002|All Patients|Lost to Follow-up|0|||
156758598|NCT01610037|565868074|FG000|All Patients|Abnormal test procedure result(s)|0|||
156758599|NCT01610037|565868075|FG001|All Patients|Abnormal test procedure result(s)|1|||
156758600|NCT01610037|565868076|FG002|All Patients|Abnormal test procedure result(s)|3|||
156758601|NCT01610037|565868074|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
156758602|NCT01610037|565868075|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
156758603|NCT01610037|565868076|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
156758604|NCT01610037|565868074|FG000|Treatment and Follow up Period|Death|10|||
156758605|NCT01610037|565868075|FG001|Treatment and Follow up Period|Death|5|||
156758606|NCT01610037|565868076|FG002|Treatment and Follow up Period|Death|4|||
156758607|NCT01610037|565868074|FG000|Treatment and Follow up Period|Administrative problems|1|||
156758608|NCT01610037|565868075|FG001|Treatment and Follow up Period|Administrative problems|3|||
156758609|NCT01610037|565868076|FG002|Treatment and Follow up Period|Administrative problems|2|||
156758610|NCT01610037|565868074|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
156758611|NCT01610037|565868075|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
156758612|NCT01610037|565868076|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
156758613|NCT00274742|565868077|FG000|Overall Study|Adverse Event|0|||
156758614|NCT00274742|565868078|FG001|Overall Study|Adverse Event|4|||
156758615|NCT00274742|565868079|FG002|Overall Study|Adverse Event|1|||
156758616|NCT00274742|565868080|FG003|Overall Study|Adverse Event|4|||
156758617|NCT00274742|565868081|FG004|Overall Study|Adverse Event|12|||
156758618|NCT00274742|565868082|FG005|Overall Study|Adverse Event|3|||
156758619|NCT00274742|565868077|FG000|Overall Study|Lost to Follow-up|0|||
156758620|NCT00274742|565868078|FG001|Overall Study|Lost to Follow-up|0|||
156758621|NCT00274742|565868079|FG002|Overall Study|Lost to Follow-up|0|||
156758622|NCT00274742|565868080|FG003|Overall Study|Lost to Follow-up|0|||
156758623|NCT00274742|565868081|FG004|Overall Study|Lost to Follow-up|1|||
156758624|NCT00274742|565868082|FG005|Overall Study|Lost to Follow-up|0|||
156758625|NCT00274742|565868077|FG000|Overall Study|End of Study|0|||
156758626|NCT00274742|565868078|FG001|Overall Study|End of Study|0|||
156758627|NCT00274742|565868079|FG002|Overall Study|End of Study|0|||
156758628|NCT00274742|565868080|FG003|Overall Study|End of Study|1|||
156758629|NCT00274742|565868081|FG004|Overall Study|End of Study|0|||
156758630|NCT00274742|565868082|FG005|Overall Study|End of Study|0|||
156758631|NCT00274742|565868077|FG000|Overall Study|Disease Progression|0|||
156758632|NCT00274742|565868078|FG001|Overall Study|Disease Progression|1|||
156758633|NCT00274742|565868079|FG002|Overall Study|Disease Progression|1|||
157103963|NCT03627767|567136365|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
157103964|NCT01069120|567136366|FG000|Overall Study|Study prematurely terminated|27|||
156758634|NCT00274742|565868080|FG003|Overall Study|Disease Progression|0|||
156758635|NCT00274742|565868081|FG004|Overall Study|Disease Progression|1|||
156758636|NCT00274742|565868082|FG005|Overall Study|Disease Progression|0|||
156758637|NCT00274742|565868077|FG000|Overall Study|Other|0|||
156758638|NCT00274742|565868078|FG001|Overall Study|Other|3|||
156758639|NCT00274742|565868079|FG002|Overall Study|Other|0|||
156758640|NCT00274742|565868080|FG003|Overall Study|Other|0|||
156758641|NCT00274742|565868081|FG004|Overall Study|Other|2|||
156758642|NCT00274742|565868082|FG005|Overall Study|Other|0|||
156758643|NCT00149396|565868089|FG000|Overall Study|Death|15|||
156758644|NCT00149396|565868089|FG000|Overall Study|Withdrawal by Subject|1|||
156758645|NCT00149396|565868089|FG000|Overall Study|Subject noncompliance|2|||
156758646|NCT00149396|565868089|FG000|Overall Study|other treatment|5|||
156758647|NCT00807885|565868090|FG000|Overall Study|Lost to Follow-up|0|||
156758648|NCT00807885|565868091|FG001|Overall Study|Lost to Follow-up|0|||
156758649|NCT00807885|565868092|FG002|Overall Study|Lost to Follow-up|0|||
156758650|NCT00807885|565868093|FG003|Overall Study|Lost to Follow-up|0|||
156758651|NCT00807885|565868094|FG004|Overall Study|Lost to Follow-up|0|||
156758652|NCT00807885|565868095|FG005|Overall Study|Lost to Follow-up|1|||
156758653|NCT00807885|565868096|FG006|Overall Study|Lost to Follow-up|0|||
156758654|NCT00807885|565868097|FG007|Overall Study|Lost to Follow-up|0|||
156758655|NCT00807885|565868098|FG008|Overall Study|Lost to Follow-up|0|||
156758656|NCT03489343|565868099|FG000|Overall Study|Documented progressive disease|1|||
156758657|NCT03489343|565868100|FG001|Overall Study|Documented progressive disease|0|||
156758658|NCT03489343|565868101|FG002|Overall Study|Documented progressive disease|3|||
156758659|NCT03489343|565868102|FG003|Overall Study|Documented progressive disease|1|||
156758660|NCT03489343|565868103|FG004|Overall Study|Documented progressive disease|3|||
156758661|NCT03489343|565868104|FG005|Overall Study|Documented progressive disease|5|||
156758662|NCT03489343|565868105|FG006|Overall Study|Documented progressive disease|4|||
156758663|NCT03489343|565868099|FG000|Overall Study|Adverse Event|0|||
156758664|NCT03489343|565868100|FG001|Overall Study|Adverse Event|1|||
156758665|NCT03489343|565868101|FG002|Overall Study|Adverse Event|0|||
156758666|NCT03489343|565868102|FG003|Overall Study|Adverse Event|0|||
156758667|NCT03489343|565868103|FG004|Overall Study|Adverse Event|0|||
156758668|NCT03489343|565868104|FG005|Overall Study|Adverse Event|1|||
156758669|NCT03489343|565868105|FG006|Overall Study|Adverse Event|0|||
156758670|NCT03489343|565868099|FG000|Overall Study|Withdrawal by Subject|0|||
156758671|NCT03489343|565868100|FG001|Overall Study|Withdrawal by Subject|0|||
156758672|NCT03489343|565868101|FG002|Overall Study|Withdrawal by Subject|0|||
156758673|NCT03489343|565868102|FG003|Overall Study|Withdrawal by Subject|1|||
156758674|NCT03489343|565868103|FG004|Overall Study|Withdrawal by Subject|0|||
156758675|NCT03489343|565868104|FG005|Overall Study|Withdrawal by Subject|1|||
156758676|NCT03489343|565868105|FG006|Overall Study|Withdrawal by Subject|1|||
156758677|NCT03489343|565868099|FG000|Overall Study|Clinical progression|0|||
156758678|NCT03489343|565868100|FG001|Overall Study|Clinical progression|0|||
156758679|NCT03489343|565868101|FG002|Overall Study|Clinical progression|0|||
156758680|NCT03489343|565868102|FG003|Overall Study|Clinical progression|1|||
156758681|NCT03489343|565868103|FG004|Overall Study|Clinical progression|0|||
156758682|NCT03489343|565868104|FG005|Overall Study|Clinical progression|0|||
156758683|NCT03489343|565868105|FG006|Overall Study|Clinical progression|1|||
156758684|NCT00327717|565868106|FG000|Overall Study|Adverse Event|6|||
156758685|NCT00327717|565868107|FG001|Overall Study|Adverse Event|6|||
156758686|NCT00327717|565868106|FG000|Overall Study|Lack of Efficacy|0|||
156758687|NCT00327717|565868107|FG001|Overall Study|Lack of Efficacy|1|||
156758688|NCT00327717|565868106|FG000|Overall Study|Withdrawal by Subject|3|||
156758689|NCT00327717|565868107|FG001|Overall Study|Withdrawal by Subject|7|||
156758690|NCT01630135|565868109|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
156758691|NCT01630135|565868110|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
156758692|NCT04767373|565868112|FG000|Overall Study|Death|6|||
156758693|NCT04767373|565868113|FG001|Overall Study|Death|3|||
156758694|NCT04767373|565868112|FG000|Overall Study|Lost to Follow-up|67|||
156758695|NCT04767373|565868113|FG001|Overall Study|Lost to Follow-up|35|||
156758696|NCT04767373|565868112|FG000|Overall Study|Physician Decision|15|||
156758697|NCT04767373|565868113|FG001|Overall Study|Physician Decision|4|||
156758698|NCT04767373|565868112|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156758699|NCT04767373|565868113|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156758700|NCT04767373|565868112|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
156758701|NCT04767373|565868113|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
156758702|NCT04767373|565868112|FG000|Overall Study|Other|1|||
156758703|NCT04767373|565868113|FG001|Overall Study|Other|2|||
156758704|NCT01502033|565868114|FG000|Overall Study|1 participant had scalp discomfort|1|||
156758705|NCT01502033|565868114|FG000|Overall Study|1 participant had worsening depression|1|||
157103965|NCT01446016|567136367|FG000|Overall Study|Lost to Follow-up|3|||
157103966|NCT01446016|567136367|FG000|Overall Study|Withdrawal by Subject|1|||
157103967|NCT01446016|567136367|FG000|Overall Study|Toxicity|3|||
157103968|NCT00404066|567136374|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
157103969|NCT00404066|567136374|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
157103970|NCT01399190|567136377|FG000|Overall Study|Not Eligible for Final Analysis|5|||
157103971|NCT01399190|567136377|FG000|Overall Study|Adverse Event|8|||
157103972|NCT01399190|567136377|FG000|Overall Study|Participant's Request|5|||
156758706|NCT01502033|565868114|FG000|Overall Study|1 participant went back to school|1|||
156758707|NCT02983045|565868115|FG000|Overall Study|Withdrawal by Subject|0|||
156758708|NCT02983045|565868116|FG001|Overall Study|Withdrawal by Subject|1|||
156758709|NCT02983045|565868117|FG002|Overall Study|Withdrawal by Subject|0|||
156758710|NCT02983045|565868118|FG003|Overall Study|Withdrawal by Subject|5|||
156758711|NCT02983045|565868119|FG004|Overall Study|Withdrawal by Subject|0|||
156758712|NCT02983045|565868120|FG005|Overall Study|Withdrawal by Subject|72|||
156758713|NCT02983045|565868121|FG006|Overall Study|Withdrawal by Subject|0|||
156758714|NCT02983045|565868122|FG007|Overall Study|Withdrawal by Subject|0|||
156758715|NCT02983045|565868123|FG008|Overall Study|Withdrawal by Subject|0|||
156758716|NCT02983045|565868124|FG009|Overall Study|Withdrawal by Subject|2|||
157103973|NCT01399190|567136377|FG000|Overall Study|Physician Decision|2|||
156758717|NCT02983045|565868115|FG000|Overall Study|Lost to Follow-up|0|||
156758718|NCT02983045|565868116|FG001|Overall Study|Lost to Follow-up|0|||
156758719|NCT02983045|565868117|FG002|Overall Study|Lost to Follow-up|0|||
156758720|NCT02983045|565868118|FG003|Overall Study|Lost to Follow-up|0|||
156758721|NCT02983045|565868119|FG004|Overall Study|Lost to Follow-up|0|||
156758722|NCT02983045|565868120|FG005|Overall Study|Lost to Follow-up|10|||
156758723|NCT02983045|565868121|FG006|Overall Study|Lost to Follow-up|0|||
156758724|NCT02983045|565868122|FG007|Overall Study|Lost to Follow-up|0|||
157000794|NCT01090024|566752627|FG003|Period 2|Lost to Follow-up|1|||
157000795|NCT01090024|566752628|FG004|Period 2|Lost to Follow-up|0|||
157000796|NCT01090024|566752629|FG005|Period 2|Lost to Follow-up|0|||
157000797|NCT01090024|566752630|FG006|Period 2|Lost to Follow-up|0|||
157000798|NCT01090024|566752631|FG007|Period 2|Lost to Follow-up|0|||
157000799|NCT01090024|566752632|FG008|Period 2|Lost to Follow-up|0|||
157000800|NCT01090024|566752633|FG009|Period 2|Lost to Follow-up|0|||
157000801|NCT01090024|566752634|FG010|Period 2|Lost to Follow-up|0|||
157000802|NCT01090024|566752635|FG011|Period 2|Lost to Follow-up|0|||
157000803|NCT01090024|566752636|FG012|Period 2|Lost to Follow-up|0|||
157000804|NCT01090024|566752637|FG013|Period 2|Lost to Follow-up|0|||
157000805|NCT01090024|566752638|FG014|Period 2|Lost to Follow-up|0|||
157000806|NCT01090024|566752639|FG015|Period 2|Lost to Follow-up|0|||
157000807|NCT01090024|566752640|FG016|Period 2|Lost to Follow-up|0|||
157000808|NCT01090024|566752641|FG017|Period 2|Lost to Follow-up|0|||
157000809|NCT01090024|566752624|FG000|Period 2|Adverse Event|1|||
157000810|NCT01090024|566752625|FG001|Period 2|Adverse Event|0|||
157000811|NCT01090024|566752626|FG002|Period 2|Adverse Event|0|||
157000812|NCT01090024|566752627|FG003|Period 2|Adverse Event|0|||
157000813|NCT01090024|566752628|FG004|Period 2|Adverse Event|0|||
157000814|NCT01090024|566752629|FG005|Period 2|Adverse Event|0|||
157000815|NCT01090024|566752630|FG006|Period 2|Adverse Event|0|||
157000816|NCT01090024|566752631|FG007|Period 2|Adverse Event|0|||
157000817|NCT01090024|566752632|FG008|Period 2|Adverse Event|0|||
157000818|NCT01090024|566752633|FG009|Period 2|Adverse Event|0|||
157000819|NCT01090024|566752634|FG010|Period 2|Adverse Event|0|||
157000820|NCT01090024|566752635|FG011|Period 2|Adverse Event|0|||
157000821|NCT01090024|566752636|FG012|Period 2|Adverse Event|0|||
157000822|NCT01090024|566752637|FG013|Period 2|Adverse Event|0|||
157000823|NCT01090024|566752638|FG014|Period 2|Adverse Event|0|||
157000824|NCT01090024|566752639|FG015|Period 2|Adverse Event|0|||
157000825|NCT01090024|566752640|FG016|Period 2|Adverse Event|0|||
157000826|NCT01090024|566752641|FG017|Period 2|Adverse Event|0|||
157000827|NCT01090024|566752624|FG000|Period 3|Withdrawal by Subject|0|||
157000828|NCT01090024|566752625|FG001|Period 3|Withdrawal by Subject|0|||
157000829|NCT01090024|566752626|FG002|Period 3|Withdrawal by Subject|0|||
157000830|NCT01090024|566752627|FG003|Period 3|Withdrawal by Subject|0|||
157000831|NCT01090024|566752628|FG004|Period 3|Withdrawal by Subject|0|||
157000832|NCT01090024|566752629|FG005|Period 3|Withdrawal by Subject|0|||
157000833|NCT01090024|566752630|FG006|Period 3|Withdrawal by Subject|0|||
157000834|NCT01090024|566752631|FG007|Period 3|Withdrawal by Subject|0|||
157000835|NCT01090024|566752632|FG008|Period 3|Withdrawal by Subject|0|||
157000836|NCT01090024|566752633|FG009|Period 3|Withdrawal by Subject|0|||
157000837|NCT01090024|566752634|FG010|Period 3|Withdrawal by Subject|0|||
157000838|NCT01090024|566752635|FG011|Period 3|Withdrawal by Subject|0|||
157000839|NCT01090024|566752636|FG012|Period 3|Withdrawal by Subject|0|||
157000840|NCT01090024|566752637|FG013|Period 3|Withdrawal by Subject|0|||
157000841|NCT01090024|566752638|FG014|Period 3|Withdrawal by Subject|0|||
157000842|NCT01090024|566752639|FG015|Period 3|Withdrawal by Subject|1|||
157000843|NCT01090024|566752640|FG016|Period 3|Withdrawal by Subject|0|||
157000844|NCT01090024|566752641|FG017|Period 3|Withdrawal by Subject|0|||
157000845|NCT01090024|566752624|FG000|Period 3|Protocol Violation|0|||
157103974|NCT05395104|567136378|FG000|Overall Study|Met Liver Stopping Criteria|1|||
157000846|NCT01090024|566752625|FG001|Period 3|Protocol Violation|0|||
157000847|NCT01090024|566752626|FG002|Period 3|Protocol Violation|0|||
157000848|NCT01090024|566752627|FG003|Period 3|Protocol Violation|0|||
157000849|NCT01090024|566752628|FG004|Period 3|Protocol Violation|0|||
156758725|NCT02983045|565868123|FG008|Overall Study|Lost to Follow-up|0|||
156758726|NCT02983045|565868124|FG009|Overall Study|Lost to Follow-up|0|||
157000850|NCT01090024|566752629|FG005|Period 3|Protocol Violation|0|||
157000851|NCT01090024|566752630|FG006|Period 3|Protocol Violation|0|||
157000852|NCT01090024|566752631|FG007|Period 3|Protocol Violation|0|||
157000853|NCT01090024|566752632|FG008|Period 3|Protocol Violation|1|||
157000854|NCT01090024|566752633|FG009|Period 3|Protocol Violation|0|||
157000855|NCT01090024|566752634|FG010|Period 3|Protocol Violation|0|||
157000856|NCT01090024|566752635|FG011|Period 3|Protocol Violation|0|||
157000857|NCT01090024|566752636|FG012|Period 3|Protocol Violation|0|||
157103975|NCT05395104|567136378|FG000|Overall Study|Withdrawal by Subject|1|||
156758727|NCT02658669|565868125|FG000|Overall Study|Lost to Follow-up|7|||
157000858|NCT01090024|566752637|FG013|Period 3|Protocol Violation|0|||
157000859|NCT01090024|566752638|FG014|Period 3|Protocol Violation|0|||
157000860|NCT01090024|566752639|FG015|Period 3|Protocol Violation|0|||
157000861|NCT01090024|566752640|FG016|Period 3|Protocol Violation|0|||
157000862|NCT01090024|566752641|FG017|Period 3|Protocol Violation|0|||
157000863|NCT01090024|566752624|FG000|Period 3|Adverse Event|0|||
156758728|NCT02658669|565868126|FG001|Overall Study|Lost to Follow-up|5|||
156758729|NCT00838097|565868127|FG000|Overall Study|Ineligibility determined|6|||
156758730|NCT00838097|565868127|FG000|Overall Study|Adverse Event|2|||
156758731|NCT00838097|565868127|FG000|Overall Study|Withdrawal by Subject|3|||
156758732|NCT00838097|565868127|FG000|Overall Study|Requirement for alternative therapy|2|||
156758733|NCT00838097|565868127|FG000|Overall Study|Physician Decision|4|||
156758734|NCT00838097|565868127|FG000|Overall Study|Lost to Follow-up|11|||
156758735|NCT00838097|565868127|FG000|Overall Study|Death|6|||
156758736|NCT00838097|565868127|FG000|Overall Study|Protocol-specified criteria|142|||
156758737|NCT02149264|565868133|FG000|Overall Study|Withdrawal by Subject|9|||
156758738|NCT02149264|565868133|FG000|Overall Study|Adverse Event|7|||
156758739|NCT02149264|565868133|FG000|Overall Study|Physician Decision|3|||
156758740|NCT02149264|565868133|FG000|Overall Study|Protocol Violation|1|||
156758741|NCT02824627|565868137|FG000|Overall Study|Adverse Event|1|||
156758742|NCT02824627|565868138|FG001|Overall Study|Adverse Event|2|||
156758743|NCT02824627|565868137|FG000|Overall Study|Lost to Follow-up|2|||
156758744|NCT02824627|565868138|FG001|Overall Study|Lost to Follow-up|1|||
156758745|NCT00672633|565868139|FG000|Overall Study|Withdrawal by Subject|0|||
156758746|NCT00672633|565868140|FG001|Overall Study|Withdrawal by Subject|1|||
156758747|NCT01938846|565868141|FG000|Overall Study|Progressive disease|26|||
156758748|NCT01938846|565868142|FG001|Overall Study|Progressive disease|18|||
156758749|NCT01938846|565868143|FG002|Overall Study|Progressive disease|16|||
156758750|NCT01938846|565868141|FG000|Overall Study|Adverse Event|8|||
156758751|NCT01938846|565868142|FG001|Overall Study|Adverse Event|4|||
156758752|NCT01938846|565868143|FG002|Overall Study|Adverse Event|3|||
156758753|NCT01938846|565868141|FG000|Overall Study|Withdrawal by Subject|2|||
156758754|NCT01938846|565868142|FG001|Overall Study|Withdrawal by Subject|2|||
156758755|NCT01938846|565868143|FG002|Overall Study|Withdrawal by Subject|1|||
156758756|NCT01938846|565868141|FG000|Overall Study|Other than listed|5|||
156758757|NCT01938846|565868142|FG001|Overall Study|Other than listed|1|||
156758758|NCT01938846|565868143|FG002|Overall Study|Other than listed|4|||
156758759|NCT02499120|565868149|FG000|Overall Study|Death|52|||
156758760|NCT02499120|565868150|FG001|Overall Study|Death|43|||
156758761|NCT02499120|565868149|FG000|Overall Study|Lost to Follow-up|1|||
156758762|NCT02499120|565868150|FG001|Overall Study|Lost to Follow-up|2|||
156758763|NCT02499120|565868149|FG000|Overall Study|Participant refused further follow-up|1|||
156758764|NCT02499120|565868150|FG001|Overall Study|Participant refused further follow-up|0|||
156758765|NCT02499120|565868149|FG000|Overall Study|Withdrawal by Subject|2|||
156758766|NCT02499120|565868150|FG001|Overall Study|Withdrawal by Subject|5|||
156758767|NCT02499120|565868149|FG000|Overall Study|Other|9|||
156758768|NCT02499120|565868150|FG001|Overall Study|Other|10|||
156758769|NCT05176717|565868155|FG000|Overall Study|Sponsor Decision|1|||
156758770|NCT05176717|565868156|FG001|Overall Study|Sponsor Decision|2|||
156758771|NCT05176717|565868157|FG002|Overall Study|Sponsor Decision|2|||
156758772|NCT00765817|565868158|FG000|Overall Study|Adverse Event|13|||
156758773|NCT00765817|565868159|FG001|Overall Study|Adverse Event|1|||
156758774|NCT00765817|565868158|FG000|Overall Study|Death|0|||
156758775|NCT00765817|565868159|FG001|Overall Study|Death|1|||
156758776|NCT00765817|565868158|FG000|Overall Study|Entry criteria not met|2|||
156758777|NCT00765817|565868159|FG001|Overall Study|Entry criteria not met|2|||
156758778|NCT00765817|565868158|FG000|Overall Study|Loss of glucose control|0|||
156758779|NCT00765817|565868159|FG001|Overall Study|Loss of glucose control|2|||
156758780|NCT00765817|565868158|FG000|Overall Study|Lost to Follow-up|1|||
156758781|NCT00765817|565868159|FG001|Overall Study|Lost to Follow-up|3|||
156758782|NCT00765817|565868158|FG000|Overall Study|Physician Decision|2|||
156758783|NCT00765817|565868159|FG001|Overall Study|Physician Decision|1|||
156758784|NCT00765817|565868158|FG000|Overall Study|Protocol Violation|1|||
156758785|NCT00765817|565868159|FG001|Overall Study|Protocol Violation|1|||
156758786|NCT00765817|565868158|FG000|Overall Study|Subject decision|7|||
156758787|NCT00765817|565868159|FG001|Overall Study|Subject decision|11|||
156758788|NCT02143024|565868161|FG000|Overall Study|Lost to Follow-up|1|||
157000864|NCT01090024|566752625|FG001|Period 3|Adverse Event|0|||
157000865|NCT01090024|566752626|FG002|Period 3|Adverse Event|0|||
156758789|NCT02143024|565868162|FG001|Overall Study|Lost to Follow-up|1|||
156758790|NCT02143024|565868161|FG000|Overall Study|Withdrawal by Subject|1|||
156758791|NCT02143024|565868162|FG001|Overall Study|Withdrawal by Subject|0|||
156758792|NCT02308228|565868163|FG000|Overall Study|Adverse Event|3|||
156758793|NCT02308228|565868164|FG001|Overall Study|Adverse Event|4|||
156758794|NCT02308228|565868163|FG000|Overall Study|Withdrawal by Subject|5|||
156758795|NCT02308228|565868164|FG001|Overall Study|Withdrawal by Subject|3|||
156758796|NCT06597084|565868165|FG000|Overall Study|Withdrawal by Subject|4|||
156758797|NCT06597084|565868166|FG001|Overall Study|Withdrawal by Subject|9|||
156758798|NCT06597084|565868165|FG000|Overall Study|Consent was not given by the patient until V2|0|||
156758799|NCT06597084|565868166|FG001|Overall Study|Consent was not given by the patient until V2|3|||
156758800|NCT06597084|565868165|FG000|Overall Study|Physician Decision|1|||
156758801|NCT06597084|565868166|FG001|Overall Study|Physician Decision|0|||
156758802|NCT06597084|565868165|FG000|Overall Study|Adverse Event|3|||
156758803|NCT06597084|565868166|FG001|Overall Study|Adverse Event|2|||
156758804|NCT06597084|565868165|FG000|Overall Study|Death|4|||
156758805|NCT06597084|565868166|FG001|Overall Study|Death|0|||
156758806|NCT06597084|565868165|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
156758807|NCT06597084|565868166|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
156758808|NCT06597084|565868165|FG000|Overall Study|Lost to Follow-up|4|||
156758809|NCT06597084|565868166|FG001|Overall Study|Lost to Follow-up|2|||
156758810|NCT06597084|565868165|FG000|Overall Study|Other. Not specified|1|||
156758811|NCT06597084|565868166|FG001|Overall Study|Other. Not specified|0|||
156758812|NCT03999749|565868169|FG000|Overall Study|Toxicity|16|||
156758813|NCT03999749|565868169|FG000|Overall Study|Withdrawal by Subject|3|||
156758814|NCT03999749|565868169|FG000|Overall Study|Disease progression|26|||
156758815|NCT03999749|565868169|FG000|Overall Study|Physician Decision|4|||
156758816|NCT03999749|565868169|FG000|Overall Study|Death|5|||
156758817|NCT03999749|565868169|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
156758818|NCT00758498|565869763|FG000|Overall Study|Adverse Event|2|||
156758819|NCT00758498|565869764|FG001|Overall Study|Adverse Event|2|||
156758820|NCT00758498|565869765|FG002|Overall Study|Adverse Event|3|||
156758821|NCT00758498|565869763|FG000|Overall Study|Subject legally detained out of state|1|||
156758822|NCT00758498|565869764|FG001|Overall Study|Subject legally detained out of state|0|||
156758823|NCT00758498|565869765|FG002|Overall Study|Subject legally detained out of state|0|||
156758824|NCT00758498|565869763|FG000|Overall Study|Withdrawal by Subject|0|||
156758825|NCT00758498|565869764|FG001|Overall Study|Withdrawal by Subject|0|||
156758826|NCT00758498|565869765|FG002|Overall Study|Withdrawal by Subject|1|||
156758827|NCT00758498|565869763|FG000|Overall Study|Noncompliance to study procedures|0|||
156758828|NCT00758498|565869764|FG001|Overall Study|Noncompliance to study procedures|0|||
156758829|NCT00758498|565869765|FG002|Overall Study|Noncompliance to study procedures|1|||
156758830|NCT02317991|565869766|FG000|Overall Study|Adverse Event|12|||
156758831|NCT02317991|565869766|FG000|Overall Study|Death|4|||
156758832|NCT02317991|565869766|FG000|Overall Study|Withdrawal by Subject|8|||
156758833|NCT02317991|565869766|FG000|Overall Study|Progressive Disease|41|||
156758834|NCT02492165|565869767|FG000|Overall Study|Withdrawal by Subject|0|||
156758835|NCT02492165|565869768|FG001|Overall Study|Withdrawal by Subject|1|||
156758836|NCT02492165|565869769|FG002|Overall Study|Withdrawal by Subject|0|||
156758837|NCT02492165|565869770|FG003|Overall Study|Withdrawal by Subject|0|||
156758838|NCT00707057|565869771|FG000|Overall Study|Withdrawal by Subject|8|||
156758839|NCT00707057|565869772|FG001|Overall Study|Withdrawal by Subject|3|||
156758840|NCT00707057|565869771|FG000|Overall Study|Dosed incorrectly|0|||
156758841|NCT00707057|565869772|FG001|Overall Study|Dosed incorrectly|1|||
156758842|NCT01697800|565869773|FG000|Overall Study|Death|0|||
156758843|NCT01697800|565869774|FG001|Overall Study|Death|1|||
156758844|NCT00823134|565869777|FG000|Overall Study|Invalid measurement|1|||
156758845|NCT02692586|565869782|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
156758846|NCT02692586|565869782|FG000|Overall Study|Received adjunctive thrombolytics|2|||
156758847|NCT00956839|565869783|FG000|Overall Study|Lost to Follow-up|3|||
156758848|NCT00956839|565869784|FG001|Overall Study|Lost to Follow-up|0|||
156758849|NCT00956839|565869785|FG002|Overall Study|Lost to Follow-up|3|||
156758850|NCT03316586|565869793|FG000|Overall Study|Adverse Event|2|||
157103976|NCT00381563|567136379|FG000|Overall Study|Withdrawal by Subject|5|||
157103977|NCT00381563|567136380|FG001|Overall Study|Withdrawal by Subject|5|||
157103978|NCT00381563|567136379|FG000|Overall Study|Lost to Follow-up|2|||
157103979|NCT00381563|567136380|FG001|Overall Study|Lost to Follow-up|0|||
157103980|NCT00381563|567136379|FG000|Overall Study|Protocol Violation|0|||
157103981|NCT00381563|567136380|FG001|Overall Study|Protocol Violation|1|||
157103982|NCT01287364|567136381|FG000|Overall Study|Adverse Event|0|||
157103983|NCT01287364|567136382|FG001|Overall Study|Adverse Event|3|||
157103984|NCT01287364|567136381|FG000|Overall Study|Protocol Violation|5|||
157103985|NCT01287364|567136382|FG001|Overall Study|Protocol Violation|5|||
157103986|NCT01287364|567136381|FG000|Overall Study|Other Reason|4|||
157103987|NCT01287364|567136382|FG001|Overall Study|Other Reason|2|||
156758851|NCT03316586|565869793|FG000|Overall Study|Physician Decision|3|||
156758852|NCT03316586|565869793|FG000|Overall Study|Lack of Efficacy|10|||
157103988|NCT04422990|567136383|FG000|Overall Study|Withdrawal by Subject|0|||
157103989|NCT04422990|567136384|FG001|Overall Study|Withdrawal by Subject|1|||
157103990|NCT04422990|567136383|FG000|Overall Study|Travel|3|||
157103991|NCT04422990|567136384|FG001|Overall Study|Travel|0|||
157103992|NCT01829425|567136393|FG000|Overall Study|Withdrawal by Subject|4|||
156758853|NCT03316586|565869793|FG000|Overall Study|still on treatment|1|||
156758854|NCT03316586|565869793|FG000|Overall Study|Patient needed radiation therapy|1|||
156758855|NCT03316586|565869793|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
156758856|NCT00994110|565869794|FG000|Overall Study|Withdrawal by Subject|9|||
156758857|NCT00994110|565869795|FG001|Overall Study|Withdrawal by Subject|9|||
156758858|NCT00994110|565869794|FG000|Overall Study|Not Treated|4|||
156758859|NCT00994110|565869795|FG001|Overall Study|Not Treated|8|||
156758860|NCT00994110|565869794|FG000|Overall Study|Adverse Event|1|||
157103993|NCT01829425|567136394|FG001|Overall Study|Withdrawal by Subject|3|||
157103994|NCT01829425|567136393|FG000|Overall Study|Lost to Follow-up|2|||
157103995|NCT01829425|567136394|FG001|Overall Study|Lost to Follow-up|1|||
157103996|NCT03681951|567136395|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
157000866|NCT01090024|566752627|FG003|Period 3|Adverse Event|0|||
157000867|NCT01090024|566752628|FG004|Period 3|Adverse Event|0|||
157000868|NCT01090024|566752629|FG005|Period 3|Adverse Event|1|||
157000869|NCT01090024|566752630|FG006|Period 3|Adverse Event|0|||
157000870|NCT01090024|566752631|FG007|Period 3|Adverse Event|0|||
157000871|NCT01090024|566752632|FG008|Period 3|Adverse Event|0|||
157000872|NCT01090024|566752633|FG009|Period 3|Adverse Event|0|||
157000873|NCT01090024|566752634|FG010|Period 3|Adverse Event|0|||
157000874|NCT01090024|566752635|FG011|Period 3|Adverse Event|0|||
157000875|NCT01090024|566752636|FG012|Period 3|Adverse Event|0|||
157000876|NCT01090024|566752637|FG013|Period 3|Adverse Event|0|||
157000877|NCT01090024|566752638|FG014|Period 3|Adverse Event|0|||
157000878|NCT01090024|566752639|FG015|Period 3|Adverse Event|0|||
157000879|NCT01090024|566752640|FG016|Period 3|Adverse Event|0|||
157000880|NCT01090024|566752641|FG017|Period 3|Adverse Event|0|||
157000881|NCT00567879|566752643|FG000|Overall Study|Adverse Event|2|||
157000882|NCT00567879|566752644|FG001|Overall Study|Adverse Event|0|||
157000883|NCT00567879|566752645|FG002|Overall Study|Adverse Event|1|||
157000884|NCT00567879|566752646|FG003|Overall Study|Adverse Event|0|||
157000885|NCT00567879|566752647|FG004|Overall Study|Adverse Event|1|||
157000886|NCT00567879|566752648|FG005|Overall Study|Adverse Event|0|||
157000887|NCT00567879|566752643|FG000|Overall Study|Abnormal test procedure(s)|0|||
157000888|NCT00567879|566752644|FG001|Overall Study|Abnormal test procedure(s)|0|||
157000889|NCT00567879|566752645|FG002|Overall Study|Abnormal test procedure(s)|1|||
157000890|NCT00567879|566752646|FG003|Overall Study|Abnormal test procedure(s)|0|||
157000891|NCT00567879|566752647|FG004|Overall Study|Abnormal test procedure(s)|0|||
157000892|NCT00567879|566752648|FG005|Overall Study|Abnormal test procedure(s)|0|||
157000893|NCT00567879|566752643|FG000|Overall Study|Withdrawal by Subject|0|||
157000894|NCT00567879|566752644|FG001|Overall Study|Withdrawal by Subject|0|||
156758861|NCT00994110|565869795|FG001|Overall Study|Adverse Event|0|||
156758862|NCT00994110|565869794|FG000|Overall Study|Patient not resected|41|||
156758863|NCT00994110|565869795|FG001|Overall Study|Patient not resected|52|||
156758864|NCT00994110|565869794|FG000|Overall Study|Pt not eligible|10|||
156758865|NCT00994110|565869795|FG001|Overall Study|Pt not eligible|5|||
156758866|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
156758867|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758868|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758869|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758870|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
156758871|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
156758872|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758873|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758874|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758875|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
156758876|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
156758877|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758878|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758879|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758880|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
156758881|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
156758882|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758883|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758884|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758885|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
156758886|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
156758887|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
157000895|NCT00567879|566752645|FG002|Overall Study|Withdrawal by Subject|3|||
157000896|NCT00567879|566752646|FG003|Overall Study|Withdrawal by Subject|1|||
157000897|NCT00567879|566752647|FG004|Overall Study|Withdrawal by Subject|0|||
157000898|NCT00567879|566752648|FG005|Overall Study|Withdrawal by Subject|0|||
157000899|NCT00567879|566752643|FG000|Overall Study|New cancer therapy|0|||
157000900|NCT00567879|566752644|FG001|Overall Study|New cancer therapy|0|||
157000901|NCT00567879|566752645|FG002|Overall Study|New cancer therapy|1|||
157000902|NCT00567879|566752646|FG003|Overall Study|New cancer therapy|0|||
157000903|NCT00567879|566752647|FG004|Overall Study|New cancer therapy|0|||
157000904|NCT00567879|566752648|FG005|Overall Study|New cancer therapy|0|||
157000905|NCT00567879|566752643|FG000|Overall Study|Disease progression|5|||
157000906|NCT00567879|566752644|FG001|Overall Study|Disease progression|7|||
157000907|NCT00567879|566752645|FG002|Overall Study|Disease progression|15|||
157000908|NCT00567879|566752646|FG003|Overall Study|Disease progression|5|||
157000909|NCT00567879|566752647|FG004|Overall Study|Disease progression|11|||
157000910|NCT00567879|566752648|FG005|Overall Study|Disease progression|3|||
157000911|NCT00470626|566752649|FG000|Overall Study|Lost to Follow-up|10|||
157000912|NCT00470626|566752649|FG000|Overall Study|Withdrawal by Subject|7|||
157000913|NCT01249092|566752650|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
157000914|NCT01249092|566752650|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
157000915|NCT02380742|566752651|FG000|Overall Study|Withdrawal by Subject|1|||
157000916|NCT02380742|566752652|FG001|Overall Study|Withdrawal by Subject|0|||
157000917|NCT01897233|566752653|FG000|Part B (24 Weeks)|Adverse Event|1|||
157000918|NCT01897233|566752653|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
157000919|NCT01897233|566752653|FG000|Part B (24 Weeks)|Physician Decision|1|||
157000920|NCT00628862|566752658|FG000|Overall Study|Adverse Event|6|||
157000921|NCT00628862|566752659|FG001|Overall Study|Adverse Event|8|||
157000922|NCT00628862|566752660|FG002|Overall Study|Adverse Event|10|||
157000923|NCT00628862|566752658|FG000|Overall Study|Withdrawal by Subject|4|||
157000924|NCT00628862|566752659|FG001|Overall Study|Withdrawal by Subject|6|||
157000925|NCT00628862|566752660|FG002|Overall Study|Withdrawal by Subject|11|||
157000926|NCT00628862|566752658|FG000|Overall Study|Lost to Follow-up|0|||
157000927|NCT00628862|566752659|FG001|Overall Study|Lost to Follow-up|2|||
157000928|NCT00628862|566752660|FG002|Overall Study|Lost to Follow-up|1|||
157000929|NCT00628862|566752658|FG000|Overall Study|Protocol Violation|1|||
157103997|NCT03681951|567136396|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
157103998|NCT03681951|567136397|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
157103999|NCT03681951|567136398|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
157104000|NCT03681951|567136399|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
157104001|NCT03681951|567136400|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156758888|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758889|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758890|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
156758891|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
156758892|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
157000930|NCT00628862|566752659|FG001|Overall Study|Protocol Violation|0|||
157104002|NCT03681951|567136401|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
157104003|NCT03681951|567136402|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
156758893|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758894|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758895|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
156758896|NCT01111565|565869796|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
156758897|NCT01111565|565869797|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758898|NCT01111565|565869798|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758899|NCT01111565|565869799|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758900|NCT01111565|565869800|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
156758901|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758902|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758903|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758904|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
156758905|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156758906|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758907|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758908|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
156758909|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758910|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156758911|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
156758912|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
156758913|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
156758914|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
156758915|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
156758916|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758917|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758918|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758919|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
156758920|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
156758921|NCT01111565|565869796|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758922|NCT01111565|565869797|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758923|NCT01111565|565869798|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758924|NCT01111565|565869799|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
156758925|NCT01111565|565869800|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
156758926|NCT04131712|565869801|FG000|Overall Study|COVID related|0|||
156758927|NCT04131712|565869802|FG001|Overall Study|COVID related|0|||
156758928|NCT04131712|565869803|FG002|Overall Study|COVID related|2|||
156758929|NCT04131712|565869804|FG003|Overall Study|COVID related|0|||
156758930|NCT04131712|565869801|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758931|NCT04131712|565869802|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758932|NCT04131712|565869803|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
156758933|NCT04131712|565869804|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
156758934|NCT00130689|565869808|FG000|Overall Study|Progressive Disease|29|||
156758935|NCT00130689|565869808|FG000|Overall Study|Death|1|||
156758936|NCT00130689|565869808|FG000|Overall Study|Clinical Deterioration|4|||
156758937|NCT00130689|565869808|FG000|Overall Study|Withdrawal by Subject|3|||
156758938|NCT00130689|565869808|FG000|Overall Study|Ineligible|6|||
157104004|NCT03681951|567136395|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
157104005|NCT03681951|567136396|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104006|NCT03681951|567136397|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104007|NCT03681951|567136398|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104008|NCT03681951|567136399|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104009|NCT03681951|567136400|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104010|NCT03681951|567136401|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104011|NCT03681951|567136402|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
157104012|NCT03681951|567136395|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
157104013|NCT03681951|567136396|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
157104014|NCT03681951|567136397|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
157104015|NCT03681951|567136398|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156758939|NCT00766597|565869809|FG000|Overall Study|Unexpected closure of study|4|||
156758940|NCT00766597|565869809|FG000|Overall Study|Without CCR5-tropic virus|5|||
156758941|NCT01254656|565869810|FG000|Overall Study|Discontinued due to termination of study|40|||
156758942|NCT01254656|565869811|FG001|Overall Study|Discontinued due to termination of study|39|||
156758943|NCT01254656|565869812|FG002|Overall Study|Discontinued due to termination of study|13|||
157104016|NCT03681951|567136399|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
156758944|NCT01254656|565869810|FG000|Overall Study|Lack of Efficacy|3|||
156758945|NCT01254656|565869811|FG001|Overall Study|Lack of Efficacy|0|||
156758946|NCT01254656|565869812|FG002|Overall Study|Lack of Efficacy|0|||
156758947|NCT01254656|565869810|FG000|Overall Study|Lost to Follow-up|1|||
156758948|NCT01254656|565869811|FG001|Overall Study|Lost to Follow-up|0|||
156758949|NCT01254656|565869812|FG002|Overall Study|Lost to Follow-up|2|||
156758950|NCT01254656|565869810|FG000|Overall Study|Withdrawal by Subject|2|||
156758951|NCT01254656|565869811|FG001|Overall Study|Withdrawal by Subject|2|||
156758952|NCT01254656|565869812|FG002|Overall Study|Withdrawal by Subject|1|||
156758953|NCT01254656|565869810|FG000|Overall Study|Pregnancy|0|||
156758954|NCT01254656|565869811|FG001|Overall Study|Pregnancy|0|||
156758955|NCT01254656|565869812|FG002|Overall Study|Pregnancy|2|||
156758956|NCT01254656|565869810|FG000|Overall Study|Adverse Event|1|||
156758957|NCT01254656|565869811|FG001|Overall Study|Adverse Event|1|||
156758958|NCT01254656|565869812|FG002|Overall Study|Adverse Event|0|||
156758959|NCT01254656|565869810|FG000|Overall Study|Death|0|||
156758960|NCT01254656|565869811|FG001|Overall Study|Death|1|||
156758961|NCT01254656|565869812|FG002|Overall Study|Death|0|||
156758962|NCT02948829|565869815|FG000|Overall Study|Lost to Follow-up|2|||
156758963|NCT02948829|565869815|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
156758964|NCT02948829|565869815|FG000|Overall Study|Pregnancy|1|||
156758965|NCT02948829|565869815|FG000|Overall Study|Other: Reason not Specified|8|||
156758966|NCT01004978|565869816|FG000|Overall Study|Disease progression|31|||
156758967|NCT01004978|565869817|FG001|Overall Study|Disease progression|48|||
156758968|NCT01004978|565869816|FG000|Overall Study|Adverse Event|42|||
156758969|NCT01004978|565869817|FG001|Overall Study|Adverse Event|22|||
156758970|NCT01004978|565869816|FG000|Overall Study|Death|3|||
156758971|NCT01004978|565869817|FG001|Overall Study|Death|2|||
156758972|NCT01004978|565869816|FG000|Overall Study|Withdrawal by Subject|16|||
156758973|NCT01004978|565869817|FG001|Overall Study|Withdrawal by Subject|16|||
156758974|NCT01004978|565869816|FG000|Overall Study|Alternative therapy|4|||
156758975|NCT01004978|565869817|FG001|Overall Study|Alternative therapy|8|||
156758976|NCT01004978|565869816|FG000|Overall Study|Physician Decision|6|||
156758977|NCT01004978|565869817|FG001|Overall Study|Physician Decision|3|||
156758978|NCT01004978|565869816|FG000|Overall Study|Other complicating disease|2|||
156758979|NCT01004978|565869817|FG001|Overall Study|Other complicating disease|2|||
156758980|NCT01004978|565869816|FG000|Overall Study|Protocol Violation|2|||
156758981|NCT01004978|565869817|FG001|Overall Study|Protocol Violation|3|||
156758982|NCT01004978|565869816|FG000|Overall Study|Non-compliance|3|||
156758983|NCT01004978|565869817|FG001|Overall Study|Non-compliance|2|||
156758984|NCT01004978|565869816|FG000|Overall Study|Ineligible|1|||
156758985|NCT01004978|565869817|FG001|Overall Study|Ineligible|0|||
156758986|NCT01004978|565869816|FG000|Overall Study|Unblinded|0|||
156758987|NCT01004978|565869817|FG001|Overall Study|Unblinded|1|||
156758988|NCT01004978|565869816|FG000|Overall Study|Performance status worsening|0|||
156758989|NCT01004978|565869817|FG001|Overall Study|Performance status worsening|1|||
156758990|NCT01004978|565869816|FG000|Overall Study|Never started treatment|8|||
156758991|NCT01004978|565869817|FG001|Overall Study|Never started treatment|9|||
156758992|NCT03311841|565869834|FG000|14-day Wash-out|Adverse Event|0|||
156758993|NCT03311841|565869835|FG001|14-day Wash-out|Adverse Event|1|||
156758994|NCT03311841|565869836|FG002|14-day Wash-out|Adverse Event|0|||
156758995|NCT03311841|565869837|FG003|14-day Wash-out|Adverse Event|0|||
156758996|NCT03311841|565869838|FG004|14-day Wash-out|Adverse Event|0|||
156758997|NCT03311841|565869834|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
156758998|NCT03311841|565869835|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
156758999|NCT03311841|565869836|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
156759000|NCT03311841|565869837|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
156759001|NCT03311841|565869838|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
156759002|NCT00977613|565869855|FG000|Overall Study|Lost to Follow-up|16|||
156759003|NCT01598610|565869860|FG000|Overall Study|Adverse Event|1|||
156759004|NCT02989402|565869868|FG000|Overall Study|Adverse event, or serious adverse event|4|||
156759005|NCT02989402|565869868|FG000|Overall Study|Death|2|||
156759006|NCT02989402|565869868|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
156759007|NCT02989402|565869868|FG000|Overall Study|Lost to Follow-up|8|||
156759008|NCT02989402|565869868|FG000|Overall Study|Patient no longer on monotherapy|1|||
156759009|NCT02989402|565869868|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
156759010|NCT02989402|565869868|FG000|Overall Study|Withdrawal by Subject|7|||
156759011|NCT02989402|565869868|FG000|Overall Study|Other|2|||
156759012|NCT03066830|565869869|FG000|Overall Study|At the Participant's own Request|16|||
156759013|NCT03066830|565869870|FG001|Overall Study|At the Participant's own Request|17|||
156759014|NCT03066830|565869869|FG000|Overall Study|Other|3|||
156759015|NCT03066830|565869870|FG001|Overall Study|Other|0|||
157000931|NCT00628862|566752660|FG002|Overall Study|Protocol Violation|0|||
157000932|NCT00628862|566752658|FG000|Overall Study|COPD Exacerbation|0|||
157000933|NCT00628862|566752659|FG001|Overall Study|COPD Exacerbation|1|||
157000934|NCT00628862|566752660|FG002|Overall Study|COPD Exacerbation|0|||
157000935|NCT00868192|566752663|FG000|Overall Study|Ineligible|4|||
157000936|NCT00798096|566752666|FG000|Overall Study|Ongoing|2|||
157000937|NCT03670602|566752667|FG000|Overall Study|Lost to Follow-up|1|||
157104017|NCT03681951|567136400|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
157104018|NCT03681951|567136401|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
157104019|NCT03681951|567136402|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
157104020|NCT02187809|567136403|FG000|Overall Study|The study was terminated|3|||
157104021|NCT01020448|567136404|FG000|Pre-assignment|Adverse Event|6|||
157104022|NCT01020448|567136404|FG000|Pre-assignment|Withdrawal by Subject|5|||
157104023|NCT01020448|567136404|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
157104024|NCT01020448|567136404|FG000|Treatment|Adverse Event|11|||
157104025|NCT01020448|567136404|FG000|Treatment|Consent Withdrawn|3|||
157104026|NCT01020448|567136404|FG000|Treatment|Disease Progression|2|||
157104027|NCT01020448|567136404|FG000|Treatment|Lack of Efficacy|8|||
157104028|NCT01020448|567136404|FG000|Treatment|Lost to Follow-up|2|||
157104029|NCT01230554|567136405|FG000|Overall Study|Lost to Follow-up|2|||
157104030|NCT01230554|567136405|FG000|Overall Study|Inability to maintain visit schedule|1|||
157104031|NCT00698932|567136410|FG000|Overall Study|Adverse Event|0|||
157104032|NCT00698932|567136411|FG001|Overall Study|Adverse Event|2|||
156759016|NCT03066830|565869869|FG000|Overall Study|Poor Compliance to Protocol|1|||
156759017|NCT03066830|565869870|FG001|Overall Study|Poor Compliance to Protocol|0|||
157104033|NCT00698932|567136410|FG000|Overall Study|Incorrect enrollment|0|||
157104034|NCT00698932|567136411|FG001|Overall Study|Incorrect enrollment|2|||
157104035|NCT00698932|567136410|FG000|Overall Study|Study specific discontinuation criteria|3|||
157104036|NCT00698932|567136411|FG001|Overall Study|Study specific discontinuation criteria|4|||
157104037|NCT00698932|567136410|FG000|Overall Study|Withdrawal by Subject|11|||
157104038|NCT00698932|567136411|FG001|Overall Study|Withdrawal by Subject|23|||
157104039|NCT00698932|567136410|FG000|Overall Study|Lost to Follow-up|6|||
157104040|NCT00698932|567136411|FG001|Overall Study|Lost to Follow-up|1|||
157104041|NCT00698932|567136410|FG000|Overall Study|Severe non-compliance to protocol|1|||
157104042|NCT00698932|567136411|FG001|Overall Study|Severe non-compliance to protocol|2|||
157104043|NCT00698932|567136410|FG000|Overall Study|Safety reasons|0|||
156759018|NCT03066830|565869869|FG000|Overall Study|Adverse Event|2|||
156759019|NCT03066830|565869870|FG001|Overall Study|Adverse Event|2|||
156759020|NCT03066830|565869869|FG000|Overall Study|Lost to Follow-up|11|||
156759021|NCT03066830|565869870|FG001|Overall Study|Lost to Follow-up|3|||
156759022|NCT02039778|565869872|FG000|Overall Study|Death|2|||
156759023|NCT02039778|565869872|FG000|Overall Study|Withdrawal by Subject|1|||
156759024|NCT02039778|565869872|FG000|Overall Study|Never started the protocol treatment|1|||
156759025|NCT01670045|565869878|FG000|Overall Study|Withdrawal by Subject|3|||
156759026|NCT01670045|565869878|FG000|Overall Study|Adverse Event|1|||
156759027|NCT01670045|565869878|FG000|Overall Study|Death|1|||
156759028|NCT01670045|565869878|FG000|Overall Study|Lost to Follow-up|11|||
156759029|NCT03360019|565869879|FG000|Overall Study|Withdrawal by Subject|2|||
156759030|NCT03360019|565869880|FG001|Overall Study|Withdrawal by Subject|0|||
156759031|NCT03360019|565869881|FG002|Overall Study|Withdrawal by Subject|0|||
156759032|NCT03360019|565869879|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
156759033|NCT03360019|565869880|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
156759034|NCT03360019|565869881|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
156759035|NCT00753675|565869882|FG000|Overall Study|other reason|11|||
156759036|NCT00753675|565869883|FG001|Overall Study|other reason|12|||
156759037|NCT00753675|565869884|FG002|Overall Study|other reason|13|||
156759038|NCT00753675|565869882|FG000|Overall Study|Death|1|||
156759039|NCT00753675|565869883|FG001|Overall Study|Death|2|||
156759040|NCT00753675|565869884|FG002|Overall Study|Death|4|||
156759041|NCT00753675|565869882|FG000|Overall Study|Adverse Event|11|||
156759042|NCT00753675|565869883|FG001|Overall Study|Adverse Event|9|||
157104044|NCT00698932|567136411|FG001|Overall Study|Safety reasons|2|||
157104045|NCT00698932|567136410|FG000|Overall Study|Death|1|||
157104046|NCT00698932|567136411|FG001|Overall Study|Death|0|||
157104047|NCT01245387|567136412|FG000|Overall Study|Lost to Follow-up|106|||
157104048|NCT01245387|567136412|FG000|Overall Study|Lack of Efficacy|195|||
157104049|NCT01245387|567136412|FG000|Overall Study|Adverse Event|9|||
156759043|NCT00753675|565869884|FG002|Overall Study|Adverse Event|4|||
156759044|NCT00753675|565869882|FG000|Overall Study|Objective progression of disease|35|||
156759045|NCT00753675|565869883|FG001|Overall Study|Objective progression of disease|35|||
156759046|NCT00753675|565869884|FG002|Overall Study|Objective progression of disease|35|||
156759047|NCT00753675|565869882|FG000|Overall Study|Withdrawal by Subject|0|||
157104050|NCT01245387|567136412|FG000|Overall Study|Death|3|||
157000938|NCT03670602|566752668|FG001|Overall Study|Lost to Follow-up|0|||
157000939|NCT03670602|566752667|FG000|Overall Study|Withdrawal by Subject|0|||
157000940|NCT03670602|566752668|FG001|Overall Study|Withdrawal by Subject|3|||
157000941|NCT03383887|566752669|FG000|Overall Study|Lost to Follow-up|0|||
157000942|NCT03383887|566752670|FG001|Overall Study|Lost to Follow-up|1|||
157000943|NCT00975806|566752677|FG000|Overall Study|Adverse Event|2|||
157000944|NCT00975806|566752678|FG001|Overall Study|Adverse Event|1|||
157000945|NCT00975806|566752679|FG002|Overall Study|Adverse Event|2|||
157000946|NCT00975806|566752677|FG000|Overall Study|Disease Progression|1|||
157000947|NCT00975806|566752678|FG001|Overall Study|Disease Progression|5|||
157000948|NCT00975806|566752679|FG002|Overall Study|Disease Progression|1|||
157000949|NCT00975806|566752677|FG000|Overall Study|Withdrawal by Subject|1|||
157000950|NCT00975806|566752678|FG001|Overall Study|Withdrawal by Subject|0|||
157000951|NCT00975806|566752679|FG002|Overall Study|Withdrawal by Subject|0|||
157000952|NCT00975806|566752677|FG000|Overall Study|Death|0|||
157000953|NCT00975806|566752678|FG001|Overall Study|Death|1|||
157000954|NCT00975806|566752679|FG002|Overall Study|Death|0|||
157000955|NCT00975806|566752677|FG000|Overall Study|Physician decision and disease related|1|||
157000956|NCT00975806|566752678|FG001|Overall Study|Physician decision and disease related|0|||
157000957|NCT00975806|566752679|FG002|Overall Study|Physician decision and disease related|1|||
157000958|NCT00246012|566752680|FG000|Overall Study|Adverse Event|0|||
157000959|NCT00246012|566752681|FG001|Overall Study|Adverse Event|0|||
157000960|NCT00246012|566752682|FG002|Overall Study|Adverse Event|0|||
157000961|NCT00246012|566752683|FG003|Overall Study|Adverse Event|0|||
157000962|NCT00246012|566752684|FG004|Overall Study|Adverse Event|0|||
157000963|NCT00246012|566752685|FG005|Overall Study|Adverse Event|1|||
157000964|NCT00246012|566752686|FG006|Overall Study|Adverse Event|0|||
157000965|NCT00246012|566752687|FG007|Overall Study|Adverse Event|0|||
157000966|NCT00246012|566752688|FG008|Overall Study|Adverse Event|2|||
157000967|NCT00246012|566752680|FG000|Overall Study|Withdrawal by Subject|0|||
157000968|NCT00246012|566752681|FG001|Overall Study|Withdrawal by Subject|0|||
157000969|NCT00246012|566752682|FG002|Overall Study|Withdrawal by Subject|0|||
157000970|NCT00246012|566752683|FG003|Overall Study|Withdrawal by Subject|0|||
157000971|NCT00246012|566752684|FG004|Overall Study|Withdrawal by Subject|0|||
157000972|NCT00246012|566752685|FG005|Overall Study|Withdrawal by Subject|1|||
157000973|NCT00246012|566752686|FG006|Overall Study|Withdrawal by Subject|0|||
157000974|NCT00246012|566752687|FG007|Overall Study|Withdrawal by Subject|0|||
157000975|NCT00246012|566752688|FG008|Overall Study|Withdrawal by Subject|0|||
157000976|NCT00246012|566752680|FG000|Overall Study|Disease progression|3|||
157000977|NCT00246012|566752681|FG001|Overall Study|Disease progression|1|||
157000978|NCT00246012|566752682|FG002|Overall Study|Disease progression|2|||
157000979|NCT00246012|566752683|FG003|Overall Study|Disease progression|3|||
157000980|NCT00246012|566752684|FG004|Overall Study|Disease progression|3|||
157000981|NCT00246012|566752685|FG005|Overall Study|Disease progression|25|||
157000982|NCT00246012|566752686|FG006|Overall Study|Disease progression|30|||
157000983|NCT00246012|566752687|FG007|Overall Study|Disease progression|27|||
157000984|NCT00246012|566752688|FG008|Overall Study|Disease progression|26|||
157000985|NCT00246012|566752680|FG000|Overall Study|Other|0|||
157000986|NCT00246012|566752681|FG001|Overall Study|Other|0|||
157000987|NCT00246012|566752682|FG002|Overall Study|Other|0|||
157000988|NCT00246012|566752683|FG003|Overall Study|Other|0|||
157000989|NCT00246012|566752684|FG004|Overall Study|Other|0|||
157000990|NCT00246012|566752685|FG005|Overall Study|Other|0|||
157000991|NCT00246012|566752686|FG006|Overall Study|Other|0|||
157000992|NCT00246012|566752687|FG007|Overall Study|Other|1|||
157000993|NCT00246012|566752688|FG008|Overall Study|Other|0|||
157000994|NCT00246012|566752680|FG000|Overall Study|Randomly assigned but not treated|0|||
157000995|NCT00246012|566752681|FG001|Overall Study|Randomly assigned but not treated|0|||
157000996|NCT00246012|566752682|FG002|Overall Study|Randomly assigned but not treated|0|||
157000997|NCT00246012|566752683|FG003|Overall Study|Randomly assigned but not treated|0|||
157000998|NCT00246012|566752684|FG004|Overall Study|Randomly assigned but not treated|0|||
157000999|NCT00246012|566752685|FG005|Overall Study|Randomly assigned but not treated|1|||
157001000|NCT00246012|566752686|FG006|Overall Study|Randomly assigned but not treated|1|||
157001001|NCT00246012|566752687|FG007|Overall Study|Randomly assigned but not treated|0|||
157001002|NCT00246012|566752688|FG008|Overall Study|Randomly assigned but not treated|0|||
157001003|NCT01651949|566752694|FG000|Overall Study|Unknown status|4|||
157001004|NCT01651949|566752695|FG001|Overall Study|Unknown status|4|||
157001005|NCT01651949|566752696|FG002|Overall Study|Unknown status|0|||
157001006|NCT01651949|566752694|FG000|Overall Study|Lost to Follow-up|30|||
156759048|NCT00753675|565869883|FG001|Overall Study|Withdrawal by Subject|1|||
156759049|NCT00753675|565869884|FG002|Overall Study|Withdrawal by Subject|0|||
156759050|NCT00753675|565869882|FG000|Overall Study|Lost to Follow-up|1|||
156759051|NCT00753675|565869883|FG001|Overall Study|Lost to Follow-up|0|||
156759052|NCT00753675|565869884|FG002|Overall Study|Lost to Follow-up|0|||
156759053|NCT01462110|565869885|FG000|Overall Study|Adverse Event|1|||
156759054|NCT01462110|565869886|FG001|Overall Study|Adverse Event|0|||
156759055|NCT05279131|565869888|FG000|Overall Study|Lost to Follow-up|1|||
156759056|NCT05279131|565869888|FG000|Overall Study|Death|1|||
156759057|NCT05279131|565869888|FG000|Overall Study|Physician Decision|1|||
156759058|NCT00964028|565869894|FG000|Overall Study|Withdrawal by Subject|0|||
156759059|NCT00964028|565869895|FG001|Overall Study|Withdrawal by Subject|1|||
156759060|NCT02106351|565869896|FG000|Treatment Cycle 1|Adverse Event|2|||
156759061|NCT02106351|565869897|FG001|Treatment Cycle 1|Adverse Event|0|||
156759062|NCT02106351|565869898|FG002|Treatment Cycle 1|Adverse Event|0|||
156759063|NCT02106351|565869896|FG000|Treatment Cycle 1|Consent withdrawn|1|||
156759064|NCT02106351|565869897|FG001|Treatment Cycle 1|Consent withdrawn|0|||
156759065|NCT02106351|565869898|FG002|Treatment Cycle 1|Consent withdrawn|2|||
156759066|NCT02106351|565869896|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156759067|NCT02106351|565869897|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
156759068|NCT02106351|565869898|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
156759069|NCT02106351|565869896|FG000|Treatment Cycle 1|Other|0|||
156759070|NCT02106351|565869897|FG001|Treatment Cycle 1|Other|3|||
156759071|NCT02106351|565869898|FG002|Treatment Cycle 1|Other|1|||
156759072|NCT02106351|565869896|FG000|Treatment Cycle 1|Randomised but not treated|1|||
156759073|NCT02106351|565869897|FG001|Treatment Cycle 1|Randomised but not treated|0|||
156759074|NCT02106351|565869898|FG002|Treatment Cycle 1|Randomised but not treated|1|||
156759075|NCT02106351|565869896|FG000|Treatment Cycle 2|Adverse Event|0|||
156759076|NCT02106351|565869897|FG001|Treatment Cycle 2|Adverse Event|2|||
156759077|NCT02106351|565869898|FG002|Treatment Cycle 2|Adverse Event|0|||
156759078|NCT02106351|565869896|FG000|Treatment Cycle 2|Consent withdrawn|0|||
156759079|NCT02106351|565869897|FG001|Treatment Cycle 2|Consent withdrawn|1|||
156759080|NCT02106351|565869898|FG002|Treatment Cycle 2|Consent withdrawn|1|||
156759081|NCT02106351|565869896|FG000|Treatment Cycle 2|Other|0|||
156759082|NCT02106351|565869897|FG001|Treatment Cycle 2|Other|2|||
156759083|NCT02106351|565869898|FG002|Treatment Cycle 2|Other|2|||
156759084|NCT02106351|565869896|FG000|Treatment Cycle 3|Adverse Event|0|||
156759085|NCT02106351|565869897|FG001|Treatment Cycle 3|Adverse Event|1|||
156759086|NCT02106351|565869898|FG002|Treatment Cycle 3|Adverse Event|0|||
156759087|NCT02106351|565869896|FG000|Treatment Cycle 3|Consent withdrawn|0|||
156759088|NCT02106351|565869897|FG001|Treatment Cycle 3|Consent withdrawn|0|||
156759089|NCT02106351|565869898|FG002|Treatment Cycle 3|Consent withdrawn|2|||
156759090|NCT02106351|565869896|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
156759091|NCT02106351|565869897|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
156759092|NCT02106351|565869898|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
156759093|NCT02106351|565869896|FG000|Treatment Cycle 3|Other|0|||
156759094|NCT02106351|565869897|FG001|Treatment Cycle 3|Other|2|||
156759095|NCT02106351|565869898|FG002|Treatment Cycle 3|Other|3|||
156759096|NCT02106351|565869896|FG000|Treatment Cycle 4|Consent withdrawn|0|||
156759097|NCT02106351|565869897|FG001|Treatment Cycle 4|Consent withdrawn|0|||
156759098|NCT02106351|565869898|FG002|Treatment Cycle 4|Consent withdrawn|2|||
156759099|NCT02106351|565869896|FG000|Treatment Cycle 4|Other|0|||
156759100|NCT02106351|565869897|FG001|Treatment Cycle 4|Other|1|||
156759101|NCT02106351|565869898|FG002|Treatment Cycle 4|Other|0|||
156759102|NCT00069823|565869899|FG000|Overall Study|Did not have follow-up diary cards|6|||
156759103|NCT00069823|565869900|FG001|Overall Study|Did not have follow-up diary cards|3|||
156759104|NCT02058589|565869902|FG000|Overall Study|Serious Adverse Event|1|||
156759105|NCT02058589|565869903|FG001|Overall Study|Serious Adverse Event|1|||
156759106|NCT02058589|565869902|FG000|Overall Study|Non-Serious Adverse Event|1|||
156759107|NCT02058589|565869903|FG001|Overall Study|Non-Serious Adverse Event|0|||
156759108|NCT02058589|565869902|FG000|Overall Study|Withdrawal by Subject|0|||
156759109|NCT02058589|565869903|FG001|Overall Study|Withdrawal by Subject|1|||
157001007|NCT01651949|566752695|FG001|Overall Study|Lost to Follow-up|56|||
157001008|NCT01651949|566752696|FG002|Overall Study|Lost to Follow-up|20|||
157001009|NCT01651949|566752694|FG000|Overall Study|Protocol Violation|0|||
157001010|NCT01651949|566752695|FG001|Overall Study|Protocol Violation|2|||
156759110|NCT00490971|565869906|FG000|Acute/Continuation|Adverse Event|62|||
156759111|NCT00490971|565869907|FG001|Acute/Continuation|Adverse Event|13|||
156759112|NCT00490971|565869908|FG002|Acute/Continuation|Adverse Event|0|||
156759113|NCT00490971|565869909|FG003|Acute/Continuation|Adverse Event|0|||
156759114|NCT00490971|565869910|FG004|Acute/Continuation|Adverse Event|0|||
156759115|NCT00490971|565869906|FG000|Acute/Continuation|Death|2|||
156759116|NCT00490971|565869907|FG001|Acute/Continuation|Death|0|||
156759117|NCT00490971|565869908|FG002|Acute/Continuation|Death|0|||
156759118|NCT00490971|565869909|FG003|Acute/Continuation|Death|0|||
156759119|NCT00490971|565869910|FG004|Acute/Continuation|Death|0|||
156759120|NCT00490971|565869906|FG000|Acute/Continuation|Lack of Efficacy|106|||
156759121|NCT00490971|565869907|FG001|Acute/Continuation|Lack of Efficacy|12|||
156759122|NCT00490971|565869908|FG002|Acute/Continuation|Lack of Efficacy|0|||
157001011|NCT01651949|566752696|FG002|Overall Study|Protocol Violation|1|||
157001012|NCT01651949|566752694|FG000|Overall Study|Physician Decision|0|||
157001013|NCT01651949|566752695|FG001|Overall Study|Physician Decision|2|||
157001014|NCT01651949|566752696|FG002|Overall Study|Physician Decision|0|||
157001015|NCT01651949|566752694|FG000|Overall Study|Adverse Event|0|||
157001016|NCT01651949|566752695|FG001|Overall Study|Adverse Event|2|||
157001017|NCT01651949|566752696|FG002|Overall Study|Adverse Event|1|||
157001018|NCT01651949|566752694|FG000|Overall Study|Screen failure|2|||
157001019|NCT01651949|566752695|FG001|Overall Study|Screen failure|2|||
157001020|NCT01651949|566752696|FG002|Overall Study|Screen failure|0|||
157001021|NCT01651949|566752694|FG000|Overall Study|Withdrawal by Subject|17|||
157001022|NCT01651949|566752695|FG001|Overall Study|Withdrawal by Subject|18|||
157001023|NCT01651949|566752696|FG002|Overall Study|Withdrawal by Subject|9|||
157001024|NCT01806714|566752697|FG000|Overall Study|No functioning phone number|200|||
157001025|NCT01806714|566752698|FG001|Overall Study|No functioning phone number|170|||
157001026|NCT02155829|566752699|FG000|Overall Study|Adverse Event|1|||
157001027|NCT02155829|566752700|FG001|Overall Study|Adverse Event|0|||
157001028|NCT02155829|566752699|FG000|Overall Study|Withdrawal by Subject|3|||
157001029|NCT02155829|566752700|FG001|Overall Study|Withdrawal by Subject|3|||
157001030|NCT02155829|566752699|FG000|Overall Study|Protocol Violation|2|||
157001031|NCT02155829|566752700|FG001|Overall Study|Protocol Violation|0|||
157001032|NCT00678795|566752701|FG000|Overall Study|Adverse Event|7|||
157001033|NCT00678795|566752702|FG001|Overall Study|Adverse Event|3|||
157001034|NCT00678795|566752701|FG000|Overall Study|Withdrawal by Subject|3|||
156759123|NCT00490971|565869909|FG003|Acute/Continuation|Lack of Efficacy|0|||
157001035|NCT00678795|566752702|FG001|Overall Study|Withdrawal by Subject|0|||
157001036|NCT00678795|566752701|FG000|Overall Study|Protocol Violation|0|||
157001037|NCT00678795|566752702|FG001|Overall Study|Protocol Violation|1|||
156759124|NCT00490971|565869910|FG004|Acute/Continuation|Lack of Efficacy|0|||
156759125|NCT00490971|565869906|FG000|Acute/Continuation|Lost to Follow-up|23|||
156759126|NCT00490971|565869907|FG001|Acute/Continuation|Lost to Follow-up|7|||
156759127|NCT00490971|565869908|FG002|Acute/Continuation|Lost to Follow-up|0|||
156759128|NCT00490971|565869909|FG003|Acute/Continuation|Lost to Follow-up|0|||
156759129|NCT00490971|565869910|FG004|Acute/Continuation|Lost to Follow-up|0|||
157104051|NCT01245387|567136412|FG000|Overall Study|Other|131|||
157104052|NCT01245387|567136412|FG000|Overall Study|Missing discontinuation status|369|||
157104053|NCT00601705|567136413|FG000|Overall Study|Withdrawal by Subject|1|||
157104054|NCT04513665|567136414|FG000|Overall Study|Adverse Event|2|||
157104055|NCT04513665|567136415|FG001|Overall Study|Adverse Event|0|||
157104056|NCT04513665|567136414|FG000|Overall Study|Lack of Efficacy|14|||
157104057|NCT04513665|567136415|FG001|Overall Study|Lack of Efficacy|0|||
157104058|NCT02146599|567136419|FG000|Overall Study|Failed to meet inclusion criteria|5|||
157104059|NCT04246801|567136420|FG000|Overall Study|Adverse Event|1|||
157104060|NCT04246801|567136421|FG001|Overall Study|Adverse Event|1|||
157104061|NCT04246801|567136420|FG000|Overall Study|Protocol Violation|1|||
157104062|NCT04246801|567136421|FG001|Overall Study|Protocol Violation|1|||
157104063|NCT04246801|567136420|FG000|Overall Study|Lack of Efficacy|0|||
157104064|NCT04246801|567136421|FG001|Overall Study|Lack of Efficacy|2|||
157104065|NCT04246801|567136420|FG000|Overall Study|Lost to Follow-up|1|||
157104066|NCT04246801|567136421|FG001|Overall Study|Lost to Follow-up|1|||
157104067|NCT04246801|567136420|FG000|Overall Study|Withdrawal by Subject|2|||
157104068|NCT04246801|567136421|FG001|Overall Study|Withdrawal by Subject|1|||
157104069|NCT02632721|567136425|FG000|Overall Study|Adverse Event|0|||
157104070|NCT02632721|567136426|FG001|Overall Study|Adverse Event|0|||
156759130|NCT00490971|565869906|FG000|Acute/Continuation|Protocol Violation|10|||
156759131|NCT00490971|565869907|FG001|Acute/Continuation|Protocol Violation|2|||
156759132|NCT00490971|565869908|FG002|Acute/Continuation|Protocol Violation|0|||
156759133|NCT00490971|565869909|FG003|Acute/Continuation|Protocol Violation|0|||
156759134|NCT00490971|565869910|FG004|Acute/Continuation|Protocol Violation|0|||
156759135|NCT00490971|565869906|FG000|Acute/Continuation|Withdrawal by Subject|92|||
156759136|NCT00490971|565869907|FG001|Acute/Continuation|Withdrawal by Subject|24|||
156759137|NCT00490971|565869908|FG002|Acute/Continuation|Withdrawal by Subject|0|||
156759138|NCT00490971|565869909|FG003|Acute/Continuation|Withdrawal by Subject|0|||
156759139|NCT00490971|565869910|FG004|Acute/Continuation|Withdrawal by Subject|0|||
156759140|NCT00490971|565869906|FG000|Acute/Continuation|Other|11|||
156759141|NCT00490971|565869907|FG001|Acute/Continuation|Other|4|||
156759142|NCT00490971|565869908|FG002|Acute/Continuation|Other|0|||
156759143|NCT00490971|565869909|FG003|Acute/Continuation|Other|0|||
156759144|NCT00490971|565869910|FG004|Acute/Continuation|Other|0|||
156759145|NCT00490971|565869906|FG000|Maintenance|Adverse Event|0|||
156759146|NCT00490971|565869907|FG001|Maintenance|Adverse Event|0|||
156759147|NCT00490971|565869908|FG002|Maintenance|Adverse Event|4|||
156759148|NCT00490971|565869909|FG003|Maintenance|Adverse Event|5|||
156759149|NCT00490971|565869910|FG004|Maintenance|Adverse Event|7|||
156759150|NCT00490971|565869906|FG000|Maintenance|Death|0|||
156759151|NCT00490971|565869907|FG001|Maintenance|Death|0|||
156759152|NCT00490971|565869908|FG002|Maintenance|Death|0|||
156759153|NCT00490971|565869909|FG003|Maintenance|Death|2|||
156759154|NCT00490971|565869910|FG004|Maintenance|Death|0|||
156759155|NCT00490971|565869906|FG000|Maintenance|Lost to Follow-up|0|||
156759156|NCT00490971|565869907|FG001|Maintenance|Lost to Follow-up|0|||
156759157|NCT00490971|565869908|FG002|Maintenance|Lost to Follow-up|5|||
156759158|NCT00490971|565869909|FG003|Maintenance|Lost to Follow-up|8|||
156759159|NCT00490971|565869910|FG004|Maintenance|Lost to Follow-up|10|||
156759160|NCT00490971|565869906|FG000|Maintenance|Pregnancy|0|||
156759161|NCT00490971|565869907|FG001|Maintenance|Pregnancy|0|||
156759162|NCT00490971|565869908|FG002|Maintenance|Pregnancy|1|||
156759163|NCT00490971|565869909|FG003|Maintenance|Pregnancy|0|||
156759164|NCT00490971|565869910|FG004|Maintenance|Pregnancy|0|||
157104071|NCT02632721|567136427|FG002|Overall Study|Adverse Event|2|||
156759165|NCT00490971|565869906|FG000|Maintenance|Protocol Violation|0|||
156759166|NCT00490971|565869907|FG001|Maintenance|Protocol Violation|0|||
156759167|NCT00490971|565869908|FG002|Maintenance|Protocol Violation|4|||
156759168|NCT00490971|565869909|FG003|Maintenance|Protocol Violation|1|||
157104072|NCT02632721|567136428|FG003|Overall Study|Adverse Event|5|||
157104073|NCT02632721|567136429|FG004|Overall Study|Adverse Event|3|||
157104074|NCT02632721|567136425|FG000|Overall Study|Dose limiting toxicity|0|||
157104075|NCT02632721|567136426|FG001|Overall Study|Dose limiting toxicity|0|||
157104076|NCT02632721|567136427|FG002|Overall Study|Dose limiting toxicity|0|||
156759169|NCT00490971|565869910|FG004|Maintenance|Protocol Violation|1|||
156759170|NCT00490971|565869906|FG000|Maintenance|Withdrawal by Subject|0|||
156759171|NCT00490971|565869907|FG001|Maintenance|Withdrawal by Subject|0|||
156759172|NCT00490971|565869908|FG002|Maintenance|Withdrawal by Subject|26|||
156759173|NCT00490971|565869909|FG003|Maintenance|Withdrawal by Subject|28|||
156759174|NCT00490971|565869910|FG004|Maintenance|Withdrawal by Subject|18|||
156759175|NCT00490971|565869906|FG000|Maintenance|Other|0|||
156759176|NCT00490971|565869907|FG001|Maintenance|Other|0|||
156759177|NCT00490971|565869908|FG002|Maintenance|Other|11|||
156759178|NCT00490971|565869909|FG003|Maintenance|Other|9|||
157104077|NCT02632721|567136428|FG003|Overall Study|Dose limiting toxicity|1|||
157001038|NCT00678795|566752701|FG000|Overall Study|Lost to Follow-up|0|||
157001039|NCT00678795|566752702|FG001|Overall Study|Lost to Follow-up|1|||
157001040|NCT00678795|566752701|FG000|Overall Study|Lack of Efficacy|1|||
157001041|NCT00678795|566752702|FG001|Overall Study|Lack of Efficacy|1|||
157001042|NCT04107805|566752703|FG000|Overall Study|Adverse Event|0|||
157001043|NCT04107805|566752704|FG001|Overall Study|Adverse Event|0|||
157001044|NCT04107805|566752705|FG002|Overall Study|Adverse Event|0|||
156759179|NCT00490971|565869910|FG004|Maintenance|Other|3|||
156759180|NCT00255164|565869912|FG000|Overall Study|Adverse Event|10|||
156759181|NCT00255164|565869913|FG001|Overall Study|Adverse Event|6|||
156759182|NCT00255164|565869914|FG002|Overall Study|Adverse Event|9|||
156759183|NCT00255164|565869912|FG000|Overall Study|Lost to Follow-up|4|||
156759184|NCT00255164|565869913|FG001|Overall Study|Lost to Follow-up|3|||
156759185|NCT00255164|565869914|FG002|Overall Study|Lost to Follow-up|4|||
156759186|NCT00255164|565869912|FG000|Overall Study|Withdrawal by Subject|18|||
156759187|NCT00255164|565869913|FG001|Overall Study|Withdrawal by Subject|17|||
156759188|NCT00255164|565869914|FG002|Overall Study|Withdrawal by Subject|8|||
156759189|NCT00255164|565869912|FG000|Overall Study|Noncompliance|0|||
156759190|NCT00255164|565869913|FG001|Overall Study|Noncompliance|1|||
156759191|NCT00255164|565869914|FG002|Overall Study|Noncompliance|2|||
156759192|NCT00255164|565869912|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
156759193|NCT00255164|565869913|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
156759194|NCT00255164|565869914|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
156759195|NCT00255164|565869912|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
156759196|NCT00255164|565869913|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
156759197|NCT00255164|565869914|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
156759198|NCT00255164|565869912|FG000|Overall Study|Possible Barrett's Esophagus|1|||
156759199|NCT00255164|565869913|FG001|Overall Study|Possible Barrett's Esophagus|3|||
156759200|NCT00255164|565869914|FG002|Overall Study|Possible Barrett's Esophagus|8|||
156759201|NCT00255164|565869912|FG000|Overall Study|Esophageal Stricture|0|||
156759202|NCT00255164|565869913|FG001|Overall Study|Esophageal Stricture|0|||
156759203|NCT00255164|565869914|FG002|Overall Study|Esophageal Stricture|1|||
156759204|NCT00255164|565869912|FG000|Overall Study|Therapeutic Failure|11|||
156759205|NCT00255164|565869913|FG001|Overall Study|Therapeutic Failure|2|||
156759206|NCT00255164|565869914|FG002|Overall Study|Therapeutic Failure|3|||
156759207|NCT02358031|565871950|FG000|Overall Study|Death|253|||
156759208|NCT02358031|565871951|FG001|Overall Study|Death|237|||
156759209|NCT02358031|565871952|FG002|Overall Study|Death|266|||
156759210|NCT02358031|565871950|FG000|Overall Study|Lost to Follow-up|1|||
156759211|NCT02358031|565871951|FG001|Overall Study|Lost to Follow-up|1|||
156759212|NCT02358031|565871952|FG002|Overall Study|Lost to Follow-up|0|||
156759213|NCT02358031|565871950|FG000|Overall Study|Withdrawal by Subject|19|||
156759214|NCT02358031|565871951|FG001|Overall Study|Withdrawal by Subject|14|||
156759215|NCT02358031|565871952|FG002|Overall Study|Withdrawal by Subject|18|||
156759216|NCT02358031|565871950|FG000|Overall Study|Sponsor Decision|26|||
156759217|NCT02358031|565871951|FG001|Overall Study|Sponsor Decision|28|||
156759218|NCT02358031|565871952|FG002|Overall Study|Sponsor Decision|16|||
156759219|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
156759220|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
156759221|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
156759222|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
156759223|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
156759224|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
156759225|NCT01212094|565871953|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
156759226|NCT01212094|565871954|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
156759227|NCT01212094|565871955|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
156759228|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
156759229|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
156759230|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
156759231|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
156759232|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
157001045|NCT04107805|566752706|FG003|Overall Study|Adverse Event|1|||
157001046|NCT04107805|566752707|FG004|Overall Study|Adverse Event|0|||
157001047|NCT04107805|566752708|FG005|Overall Study|Adverse Event|1|||
157001048|NCT04107805|566752709|FG006|Overall Study|Adverse Event|0|||
157001049|NCT04107805|566752710|FG007|Overall Study|Adverse Event|0|||
157001050|NCT04107805|566752711|FG008|Overall Study|Adverse Event|1|||
157001051|NCT01191086|566752712|FG000|Overall Study|Adverse Event|20|||
157001052|NCT01191086|566752712|FG000|Overall Study|Lack of Efficacy|10|||
157001053|NCT01191086|566752712|FG000|Overall Study|Lost to Follow-up|4|||
157001054|NCT01191086|566752712|FG000|Overall Study|Physician Decision|2|||
157001055|NCT01191086|566752712|FG000|Overall Study|Withdrawal by Subject|24|||
156759233|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
156759234|NCT01212094|565871953|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
157001056|NCT01191086|566752712|FG000|Overall Study|Discontinuation criterion met|1|||
157001057|NCT01191086|566752712|FG000|Overall Study|Other|1|||
156759235|NCT01212094|565871954|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
156759236|NCT01212094|565871955|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
156759237|NCT05664581|565871959|FG000|Overall Study|Withdrawal by Subject|2|||
156759238|NCT03101150|565871962|FG000|Overall Study|Lost to Follow-up|2|||
156759239|NCT03101150|565871963|FG001|Overall Study|Lost to Follow-up|4|||
156759240|NCT03101150|565871962|FG000|Overall Study|Miscarriage|3|||
156759241|NCT03101150|565871963|FG001|Overall Study|Miscarriage|6|||
156759242|NCT01317641|565871969|FG000|Overall Study|Not treated|0|||
156759243|NCT01317641|565871970|FG001|Overall Study|Not treated|0|||
156759244|NCT01317641|565871971|FG002|Overall Study|Not treated|0|||
156759245|NCT01317641|565871972|FG003|Overall Study|Not treated|0|||
156759246|NCT01317641|565871973|FG004|Overall Study|Not treated|0|||
156759247|NCT01317641|565871974|FG005|Overall Study|Not treated|0|||
156759248|NCT01317641|565871975|FG006|Overall Study|Not treated|0|||
156759249|NCT01317641|565871976|FG007|Overall Study|Not treated|1|||
156759250|NCT01317641|565871977|FG008|Overall Study|Not treated|1|||
156759251|NCT01317641|565871969|FG000|Overall Study|Adverse Event|0|||
156759252|NCT01317641|565871970|FG001|Overall Study|Adverse Event|1|||
156759253|NCT01317641|565871971|FG002|Overall Study|Adverse Event|0|||
156759254|NCT01317641|565871972|FG003|Overall Study|Adverse Event|1|||
156759255|NCT01317641|565871973|FG004|Overall Study|Adverse Event|0|||
156759256|NCT01317641|565871974|FG005|Overall Study|Adverse Event|0|||
156759257|NCT01317641|565871975|FG006|Overall Study|Adverse Event|2|||
156759258|NCT01317641|565871976|FG007|Overall Study|Adverse Event|1|||
156759259|NCT01317641|565871977|FG008|Overall Study|Adverse Event|0|||
156759260|NCT01317641|565871969|FG000|Overall Study|Protocol Violation|1|||
156759261|NCT01317641|565871970|FG001|Overall Study|Protocol Violation|0|||
156759262|NCT01317641|565871971|FG002|Overall Study|Protocol Violation|0|||
156759263|NCT01317641|565871972|FG003|Overall Study|Protocol Violation|0|||
156759264|NCT01317641|565871973|FG004|Overall Study|Protocol Violation|0|||
156759265|NCT01317641|565871974|FG005|Overall Study|Protocol Violation|0|||
156759266|NCT01317641|565871975|FG006|Overall Study|Protocol Violation|0|||
156759267|NCT01317641|565871976|FG007|Overall Study|Protocol Violation|0|||
156759268|NCT01317641|565871977|FG008|Overall Study|Protocol Violation|0|||
156759269|NCT01317641|565871969|FG000|Overall Study|Disease progression|0|||
156759270|NCT01317641|565871970|FG001|Overall Study|Disease progression|0|||
156759271|NCT01317641|565871971|FG002|Overall Study|Disease progression|0|||
156759272|NCT01317641|565871972|FG003|Overall Study|Disease progression|0|||
156759273|NCT01317641|565871973|FG004|Overall Study|Disease progression|0|||
157001058|NCT00771849|566752714|FG000|Overall Study|Lost to Follow-up|1|||
157001059|NCT00771849|566752715|FG001|Overall Study|Lost to Follow-up|2|||
157001060|NCT00771849|566752714|FG000|Overall Study|Withdrawal by Subject|1|||
157001061|NCT00771849|566752715|FG001|Overall Study|Withdrawal by Subject|1|||
157001062|NCT00771849|566752714|FG000|Overall Study|Not vaccinated|0|||
157001063|NCT00771849|566752715|FG001|Overall Study|Not vaccinated|1|||
157001064|NCT00608907|566752720|FG000|Overall Study|Adverse Event|6|||
157001065|NCT00608907|566752721|FG001|Overall Study|Adverse Event|0|||
157001066|NCT00608907|566752722|FG002|Overall Study|Adverse Event|1|||
157001067|NCT00608907|566752720|FG000|Overall Study|Death|1|||
157001068|NCT00608907|566752721|FG001|Overall Study|Death|0|||
157001069|NCT00608907|566752722|FG002|Overall Study|Death|0|||
157001070|NCT00608907|566752720|FG000|Overall Study|Withdrawal by Subject|4|||
157001071|NCT00608907|566752721|FG001|Overall Study|Withdrawal by Subject|0|||
157001072|NCT00608907|566752722|FG002|Overall Study|Withdrawal by Subject|0|||
157001073|NCT00608907|566752720|FG000|Overall Study|Progressive Disease|1|||
157001074|NCT00608907|566752721|FG001|Overall Study|Progressive Disease|0|||
157001075|NCT00608907|566752722|FG002|Overall Study|Progressive Disease|0|||
157001076|NCT03058991|566752723|FG000|Overall Study|Lost to Follow-up|17|||
157001077|NCT03058991|566752724|FG001|Overall Study|Lost to Follow-up|12|||
157001078|NCT03058991|566752725|FG002|Overall Study|Lost to Follow-up|12|||
157001079|NCT03058991|566752723|FG000|Overall Study|Withdrawal by Subject|1|||
157001080|NCT03058991|566752724|FG001|Overall Study|Withdrawal by Subject|0|||
157001081|NCT03058991|566752725|FG002|Overall Study|Withdrawal by Subject|0|||
157001082|NCT01689519|566752726|FG000|Intent to Treat|Death|157|||
156759274|NCT01317641|565871974|FG005|Overall Study|Disease progression|0|||
156759275|NCT01317641|565871975|FG006|Overall Study|Disease progression|0|||
157001083|NCT01689519|566752727|FG001|Intent to Treat|Death|167|||
157001084|NCT01689519|566752726|FG000|Intent to Treat|Lost to Follow-up|4|||
157001085|NCT01689519|566752727|FG001|Intent to Treat|Lost to Follow-up|8|||
157001086|NCT01689519|566752726|FG000|Intent to Treat|Other|2|||
157001087|NCT01689519|566752727|FG001|Intent to Treat|Other|4|||
157001088|NCT01689519|566752726|FG000|Intent to Treat|Physician Decision|4|||
157001089|NCT01689519|566752727|FG001|Intent to Treat|Physician Decision|1|||
156759276|NCT01317641|565871976|FG007|Overall Study|Disease progression|3|||
156759277|NCT01317641|565871977|FG008|Overall Study|Disease progression|4|||
156759278|NCT01317641|565871969|FG000|Overall Study|Withdrawal by Subject|0|||
157001090|NCT01689519|566752726|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
157001091|NCT01689519|566752727|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
157001092|NCT01689519|566752726|FG000|Intent to Treat|Withdrawal by Subject|21|||
157001093|NCT01689519|566752727|FG001|Intent to Treat|Withdrawal by Subject|20|||
157001094|NCT01689519|566752726|FG000|Safety Population|Death|158|||
157001095|NCT01689519|566752727|FG001|Safety Population|Death|165|||
157001096|NCT01689519|566752726|FG000|Safety Population|Lost to Follow-up|4|||
156759279|NCT01317641|565871970|FG001|Overall Study|Withdrawal by Subject|0|||
156759280|NCT01317641|565871971|FG002|Overall Study|Withdrawal by Subject|0|||
156759281|NCT01317641|565871972|FG003|Overall Study|Withdrawal by Subject|0|||
157001097|NCT01689519|566752727|FG001|Safety Population|Lost to Follow-up|8|||
157104078|NCT02632721|567136429|FG004|Overall Study|Dose limiting toxicity|0|||
157104079|NCT02632721|567136425|FG000|Overall Study|Progressive disease|3|||
157104080|NCT02632721|567136426|FG001|Overall Study|Progressive disease|0|||
157104081|NCT02632721|567136427|FG002|Overall Study|Progressive disease|4|||
157104082|NCT02632721|567136428|FG003|Overall Study|Progressive disease|6|||
157104083|NCT02632721|567136429|FG004|Overall Study|Progressive disease|5|||
157104084|NCT02632721|567136425|FG000|Overall Study|Refused to continue taking trial medication|0|||
157104085|NCT02632721|567136426|FG001|Overall Study|Refused to continue taking trial medication|1|||
157104086|NCT02632721|567136427|FG002|Overall Study|Refused to continue taking trial medication|1|||
157104087|NCT02632721|567136428|FG003|Overall Study|Refused to continue taking trial medication|1|||
157104088|NCT02632721|567136429|FG004|Overall Study|Refused to continue taking trial medication|2|||
157104089|NCT02632721|567136425|FG000|Overall Study|Inadequate clinical condition|0|||
157104090|NCT02632721|567136426|FG001|Overall Study|Inadequate clinical condition|0|||
157104091|NCT02632721|567136427|FG002|Overall Study|Inadequate clinical condition|0|||
157104092|NCT02632721|567136428|FG003|Overall Study|Inadequate clinical condition|0|||
157104093|NCT02632721|567136429|FG004|Overall Study|Inadequate clinical condition|1|||
157104094|NCT02632721|567136425|FG000|Overall Study|No meet eligibility|0|||
157104095|NCT02632721|567136426|FG001|Overall Study|No meet eligibility|0|||
157104096|NCT02632721|567136427|FG002|Overall Study|No meet eligibility|0|||
157104097|NCT02632721|567136428|FG003|Overall Study|No meet eligibility|0|||
156759282|NCT01317641|565871973|FG004|Overall Study|Withdrawal by Subject|0|||
156759283|NCT01317641|565871974|FG005|Overall Study|Withdrawal by Subject|0|||
156759284|NCT01317641|565871975|FG006|Overall Study|Withdrawal by Subject|1|||
156759285|NCT01317641|565871976|FG007|Overall Study|Withdrawal by Subject|0|||
156759286|NCT01317641|565871977|FG008|Overall Study|Withdrawal by Subject|0|||
156759287|NCT04980014|565871978|FG000|Overall Study|Participants who are Duplicated|1|||
156759288|NCT04980014|565871978|FG000|Overall Study|Follow-up Failure|13|||
156759289|NCT04980014|565871978|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
156759290|NCT04980014|565871978|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
156759291|NCT04980014|565871978|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
156759292|NCT00715559|565871979|FG000|Overall Study|medication not tolerated - nausea|1|||
156759293|NCT01302418|565871980|FG000|Overall Study|Protocol Violation|9|||
156759294|NCT01302418|565871980|FG000|Overall Study|Non-evaluable|9|||
156759295|NCT02787304|565871985|FG000|Overall Study|Adverse Event|9|||
156759296|NCT02787304|565871986|FG001|Overall Study|Adverse Event|3|||
156759297|NCT02787304|565871987|FG002|Overall Study|Adverse Event|8|||
156759298|NCT02787304|565871988|FG003|Overall Study|Adverse Event|1|||
156759299|NCT02787304|565871985|FG000|Overall Study|Withdrawal by Subject|1|||
156759300|NCT02787304|565871986|FG001|Overall Study|Withdrawal by Subject|4|||
156759301|NCT02787304|565871987|FG002|Overall Study|Withdrawal by Subject|0|||
156759302|NCT02787304|565871988|FG003|Overall Study|Withdrawal by Subject|0|||
156759303|NCT02787304|565871985|FG000|Overall Study|Lost to Follow-up|1|||
156759304|NCT02787304|565871986|FG001|Overall Study|Lost to Follow-up|0|||
156759305|NCT02787304|565871987|FG002|Overall Study|Lost to Follow-up|0|||
156759306|NCT02787304|565871988|FG003|Overall Study|Lost to Follow-up|1|||
156759307|NCT02787304|565871985|FG000|Overall Study|Noncompliance with study drug|0|||
156759308|NCT02787304|565871986|FG001|Overall Study|Noncompliance with study drug|0|||
156759309|NCT02787304|565871987|FG002|Overall Study|Noncompliance with study drug|1|||
156759310|NCT02787304|565871988|FG003|Overall Study|Noncompliance with study drug|0|||
156759311|NCT02787304|565871985|FG000|Overall Study|Physician Decision|0|||
156759312|NCT02787304|565871986|FG001|Overall Study|Physician Decision|0|||
156759313|NCT02787304|565871987|FG002|Overall Study|Physician Decision|1|||
156759314|NCT02787304|565871988|FG003|Overall Study|Physician Decision|0|||
156759315|NCT02787304|565871985|FG000|Overall Study|Study terminated by sponsor|25|||
156759316|NCT02787304|565871986|FG001|Overall Study|Study terminated by sponsor|31|||
156759317|NCT02787304|565871987|FG002|Overall Study|Study terminated by sponsor|31|||
156759318|NCT02787304|565871988|FG003|Overall Study|Study terminated by sponsor|32|||
156759319|NCT04771013|565871992|FG000|Overall Study|Withdrawal by Subject|2|||
156759320|NCT04771013|565871993|FG001|Overall Study|Withdrawal by Subject|0|||
156759321|NCT04771013|565871992|FG000|Overall Study|Death|0|||
156759322|NCT04771013|565871993|FG001|Overall Study|Death|5|||
157104098|NCT02632721|567136429|FG004|Overall Study|No meet eligibility|1|||
157104099|NCT02632721|567136425|FG000|Overall Study|Allergic reaction|0|||
156759323|NCT04771013|565871992|FG000|Overall Study|Referred to another hospital before day 20|0|||
157104100|NCT02632721|567136426|FG001|Overall Study|Allergic reaction|0|||
157104101|NCT02632721|567136427|FG002|Overall Study|Allergic reaction|0|||
157104102|NCT02632721|567136428|FG003|Overall Study|Allergic reaction|1|||
157104103|NCT02632721|567136429|FG004|Overall Study|Allergic reaction|0|||
156759324|NCT04771013|565871993|FG001|Overall Study|Referred to another hospital before day 20|1|||
156759325|NCT00419757|565871995|FG000|Overall Study|Adverse Event|1|||
156759326|NCT00419757|565871996|FG001|Overall Study|Adverse Event|4|||
156759327|NCT00419757|565871995|FG000|Overall Study|Lost to Follow-up|1|||
156759328|NCT00419757|565871996|FG001|Overall Study|Lost to Follow-up|4|||
156759329|NCT00419757|565871995|FG000|Overall Study|Withdrawal by Subject|7|||
156759330|NCT00419757|565871996|FG001|Overall Study|Withdrawal by Subject|1|||
157001098|NCT01689519|566752726|FG000|Safety Population|Other|2|||
157001099|NCT01689519|566752727|FG001|Safety Population|Other|4|||
157001100|NCT01689519|566752726|FG000|Safety Population|Physician Decision|4|||
157001101|NCT01689519|566752727|FG001|Safety Population|Physician Decision|1|||
157001102|NCT01689519|566752726|FG000|Safety Population|Study Terminated By Sponsor|60|||
157001103|NCT01689519|566752727|FG001|Safety Population|Study Terminated By Sponsor|47|||
157001104|NCT01689519|566752726|FG000|Safety Population|Withdrawal by Subject|20|||
157001105|NCT01689519|566752727|FG001|Safety Population|Withdrawal by Subject|20|||
157001106|NCT02982213|566752733|FG000|Overall Study|Did not complete follow up questionnaire|5|||
157001107|NCT02982213|566752734|FG001|Overall Study|Did not complete follow up questionnaire|1|||
157001108|NCT01549652|566752735|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
157001109|NCT01549652|566752736|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
157001110|NCT01549652|566752737|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
156759331|NCT00419757|565871995|FG000|Overall Study|Protocol Violation|2|||
156759332|NCT00419757|565871996|FG001|Overall Study|Protocol Violation|3|||
156759333|NCT00419757|565871995|FG000|Overall Study|Study specific discontinuation criteria|4|||
156759334|NCT00419757|565871996|FG001|Overall Study|Study specific discontinuation criteria|8|||
156759335|NCT00419757|565871995|FG000|Overall Study|Multiple reasons|3|||
156759336|NCT00419757|565871996|FG001|Overall Study|Multiple reasons|1|||
156759337|NCT01051921|565871997|FG000|Overall Study|Physician Decision|9|||
156759338|NCT01051921|565871997|FG000|Overall Study|Adverse Event|8|||
156759339|NCT01051921|565871997|FG000|Overall Study|Withdrawal by Subject|7|||
156759340|NCT01051921|565871997|FG000|Overall Study|Lost to Follow-up|4|||
156759341|NCT01051921|565871997|FG000|Overall Study|virological failure|1|||
156759342|NCT01051921|565871997|FG000|Overall Study|patient moved|1|||
156759343|NCT00379834|565872001|FG000|Overall Study|Time constraints|2|||
156759344|NCT01519817|565872002|FG000|Overall Study|Withdrawal by Subject|1|||
157001111|NCT01549652|566752738|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
157001112|NCT01549652|566752735|FG000|Overall Study|Study Drug Titration Failure|5|||
157001113|NCT01549652|566752736|FG001|Overall Study|Study Drug Titration Failure|6|||
157001114|NCT01549652|566752737|FG002|Overall Study|Study Drug Titration Failure|0|||
157001115|NCT01549652|566752738|FG003|Overall Study|Study Drug Titration Failure|0|||
157001116|NCT01549652|566752735|FG000|Overall Study|Withdrawal Effect|0|||
157001117|NCT01549652|566752736|FG001|Overall Study|Withdrawal Effect|2|||
157001118|NCT01549652|566752737|FG002|Overall Study|Withdrawal Effect|0|||
157001119|NCT01549652|566752738|FG003|Overall Study|Withdrawal Effect|0|||
157001120|NCT01549652|566752735|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
157001121|NCT01549652|566752736|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
157001122|NCT01549652|566752737|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
157001123|NCT01549652|566752738|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
157001124|NCT01549652|566752735|FG000|Overall Study|Problem with Infusion|1|||
157001125|NCT01549652|566752736|FG001|Overall Study|Problem with Infusion|0|||
157001126|NCT01549652|566752737|FG002|Overall Study|Problem with Infusion|0|||
157001127|NCT01549652|566752738|FG003|Overall Study|Problem with Infusion|0|||
156759345|NCT01519817|565872003|FG001|Overall Study|Withdrawal by Subject|0|||
157001128|NCT01549652|566752735|FG000|Overall Study|Titration Non-Compliance|1|||
157001129|NCT01549652|566752736|FG001|Overall Study|Titration Non-Compliance|3|||
157001130|NCT01549652|566752737|FG002|Overall Study|Titration Non-Compliance|4|||
156759346|NCT01519817|565872004|FG002|Overall Study|Withdrawal by Subject|0|||
156759347|NCT01519817|565872005|FG003|Overall Study|Withdrawal by Subject|0|||
156759348|NCT01519817|565872002|FG000|Overall Study|Off study due to infection|0|||
156759349|NCT01519817|565872003|FG001|Overall Study|Off study due to infection|0|||
156759350|NCT01519817|565872004|FG002|Overall Study|Off study due to infection|0|||
156759351|NCT01519817|565872005|FG003|Overall Study|Off study due to infection|1|||
156759352|NCT01325350|565872008|FG000|Overall Study|Adverse Event|3|||
156759353|NCT01325350|565872009|FG001|Overall Study|Adverse Event|3|||
156759354|NCT01325350|565872010|FG002|Overall Study|Adverse Event|3|||
156759355|NCT01325350|565872011|FG003|Overall Study|Adverse Event|1|||
156759356|NCT01325350|565872012|FG004|Overall Study|Adverse Event|2|||
156759357|NCT01325350|565872008|FG000|Overall Study|Pregnancy|0|||
156759358|NCT01325350|565872009|FG001|Overall Study|Pregnancy|0|||
156759359|NCT01325350|565872010|FG002|Overall Study|Pregnancy|1|||
156759360|NCT01325350|565872011|FG003|Overall Study|Pregnancy|0|||
156759361|NCT01325350|565872012|FG004|Overall Study|Pregnancy|1|||
156759362|NCT01325350|565872008|FG000|Overall Study|Lost to Follow-up|1|||
156759363|NCT01325350|565872009|FG001|Overall Study|Lost to Follow-up|0|||
156759364|NCT01325350|565872010|FG002|Overall Study|Lost to Follow-up|5|||
156759365|NCT01325350|565872011|FG003|Overall Study|Lost to Follow-up|1|||
156759366|NCT01325350|565872012|FG004|Overall Study|Lost to Follow-up|5|||
156759367|NCT01325350|565872008|FG000|Overall Study|Personal Reasons|2|||
156759368|NCT01325350|565872009|FG001|Overall Study|Personal Reasons|1|||
156759369|NCT01325350|565872010|FG002|Overall Study|Personal Reasons|6|||
156759370|NCT01325350|565872011|FG003|Overall Study|Personal Reasons|5|||
156759371|NCT01325350|565872012|FG004|Overall Study|Personal Reasons|3|||
156759372|NCT01325350|565872008|FG000|Overall Study|Protocol Violation|0|||
156759373|NCT01325350|565872009|FG001|Overall Study|Protocol Violation|0|||
156759374|NCT01325350|565872010|FG002|Overall Study|Protocol Violation|0|||
156759375|NCT01325350|565872011|FG003|Overall Study|Protocol Violation|1|||
156759376|NCT01325350|565872012|FG004|Overall Study|Protocol Violation|0|||
156759377|NCT01325350|565872008|FG000|Overall Study|Withdrawal by Subject|0|||
156759378|NCT01325350|565872009|FG001|Overall Study|Withdrawal by Subject|0|||
156759379|NCT01325350|565872010|FG002|Overall Study|Withdrawal by Subject|1|||
156759380|NCT01325350|565872011|FG003|Overall Study|Withdrawal by Subject|1|||
156759381|NCT01325350|565872012|FG004|Overall Study|Withdrawal by Subject|0|||
156759382|NCT01325350|565872008|FG000|Overall Study|Did Not Receive Treatment|0|||
156759383|NCT01325350|565872009|FG001|Overall Study|Did Not Receive Treatment|1|||
156759384|NCT01325350|565872010|FG002|Overall Study|Did Not Receive Treatment|1|||
156759385|NCT01325350|565872011|FG003|Overall Study|Did Not Receive Treatment|0|||
156759386|NCT01325350|565872012|FG004|Overall Study|Did Not Receive Treatment|1|||
156759387|NCT01716806|565872017|FG000|Overall Study|Patient withdrawal of consent|4|||
156759388|NCT01716806|565872018|FG001|Overall Study|Patient withdrawal of consent|2|||
156759389|NCT01716806|565872019|FG002|Overall Study|Patient withdrawal of consent|4|||
156759390|NCT01716806|565872020|FG003|Overall Study|Patient withdrawal of consent|3|||
156759391|NCT01716806|565872021|FG004|Overall Study|Patient withdrawal of consent|2|||
156759392|NCT01716806|565872022|FG005|Overall Study|Patient withdrawal of consent|0|||
156759393|NCT01716806|565872017|FG000|Overall Study|Lost to Follow-up|3|||
156759394|NCT01716806|565872018|FG001|Overall Study|Lost to Follow-up|3|||
156759395|NCT01716806|565872019|FG002|Overall Study|Lost to Follow-up|0|||
156759396|NCT01716806|565872020|FG003|Overall Study|Lost to Follow-up|2|||
156759397|NCT01716806|565872021|FG004|Overall Study|Lost to Follow-up|1|||
156759398|NCT01716806|565872022|FG005|Overall Study|Lost to Follow-up|0|||
156759399|NCT01716806|565872017|FG000|Overall Study|Death|13|||
156759400|NCT01716806|565872018|FG001|Overall Study|Death|9|||
156759401|NCT01716806|565872019|FG002|Overall Study|Death|12|||
156759402|NCT01716806|565872020|FG003|Overall Study|Death|4|||
156759403|NCT01716806|565872021|FG004|Overall Study|Death|10|||
156759404|NCT01716806|565872022|FG005|Overall Study|Death|5|||
156759405|NCT01716806|565872017|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759406|NCT01716806|565872018|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759407|NCT01716806|565872019|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759408|NCT01716806|565872020|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
156759409|NCT01716806|565872021|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
156759410|NCT01716806|565872022|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
156759411|NCT01716806|565872017|FG000|Overall Study|PI decision|0|||
156759412|NCT01716806|565872018|FG001|Overall Study|PI decision|0|||
156759413|NCT01716806|565872019|FG002|Overall Study|PI decision|0|||
156759414|NCT01716806|565872020|FG003|Overall Study|PI decision|0|||
156759415|NCT01716806|565872021|FG004|Overall Study|PI decision|1|||
156759416|NCT01716806|565872022|FG005|Overall Study|PI decision|0|||
156759417|NCT01716806|565872017|FG000|Overall Study|Change in performance status|1|||
156759418|NCT01716806|565872018|FG001|Overall Study|Change in performance status|0|||
156759419|NCT01716806|565872019|FG002|Overall Study|Change in performance status|0|||
156759420|NCT01716806|565872020|FG003|Overall Study|Change in performance status|0|||
156759421|NCT01716806|565872021|FG004|Overall Study|Change in performance status|0|||
156759422|NCT01716806|565872022|FG005|Overall Study|Change in performance status|0|||
156759423|NCT01716806|565872017|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759424|NCT01716806|565872018|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759425|NCT01716806|565872019|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
156759426|NCT01716806|565872020|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759427|NCT01716806|565872021|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759428|NCT01716806|565872022|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
156759429|NCT01716806|565872017|FG000|Overall Study|Sponsor direction|7|||
156759430|NCT01716806|565872018|FG001|Overall Study|Sponsor direction|8|||
156759431|NCT01716806|565872019|FG002|Overall Study|Sponsor direction|5|||
156759432|NCT01716806|565872020|FG003|Overall Study|Sponsor direction|12|||
156759433|NCT01716806|565872021|FG004|Overall Study|Sponsor direction|16|||
156759434|NCT01716806|565872022|FG005|Overall Study|Sponsor direction|1|||
156759435|NCT03934216|565872025|FG000|Overall Study|Other Reasons|5|||
156759436|NCT03934216|565872026|FG001|Overall Study|Other Reasons|5|||
156759437|NCT03934216|565872025|FG000|Overall Study|Adverse Event|22|||
156759438|NCT03934216|565872026|FG001|Overall Study|Adverse Event|11|||
156759439|NCT03934216|565872025|FG000|Overall Study|Lack of Efficacy|8|||
156759440|NCT03934216|565872026|FG001|Overall Study|Lack of Efficacy|7|||
156759441|NCT03934216|565872025|FG000|Overall Study|Lost to Follow-up|2|||
156759442|NCT03934216|565872026|FG001|Overall Study|Lost to Follow-up|0|||
156759443|NCT03934216|565872025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156759444|NCT03934216|565872026|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156759445|NCT03934216|565872025|FG000|Overall Study|Pregnancy|1|||
156759446|NCT03934216|565872026|FG001|Overall Study|Pregnancy|0|||
156759447|NCT03934216|565872025|FG000|Overall Study|Withdrawal by Subject|18|||
156759448|NCT03934216|565872026|FG001|Overall Study|Withdrawal by Subject|6|||
156759449|NCT03934216|565872025|FG000|Overall Study|Randomized but not treated|1|||
156759450|NCT03934216|565872026|FG001|Overall Study|Randomized but not treated|1|||
156759451|NCT01396083|565872032|FG000|Overall Study|Adverse Event|2|||
156759452|NCT01396083|565872033|FG001|Overall Study|Adverse Event|28|||
156759453|NCT01396083|565872032|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156759454|NCT01396083|565872033|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156759455|NCT01396083|565872032|FG000|Overall Study|Consent withdrawn|4|||
156759456|NCT01396083|565872033|FG001|Overall Study|Consent withdrawn|5|||
156759457|NCT01396083|565872032|FG000|Overall Study|Protocol deviation(s)|0|||
156759458|NCT01396083|565872033|FG001|Overall Study|Protocol deviation(s)|1|||
156759459|NCT01396083|565872032|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156759460|NCT01396083|565872033|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156759461|NCT01396083|565872032|FG000|Overall Study|Administrative problems|1|||
156759462|NCT01396083|565872033|FG001|Overall Study|Administrative problems|0|||
156759463|NCT01396083|565872032|FG000|Overall Study|Lost to Follow-up|1|||
156759464|NCT01396083|565872033|FG001|Overall Study|Lost to Follow-up|0|||
156759465|NCT00619827|565872034|FG000|Overall Study|Adverse Event|1|||
156759466|NCT00619827|565872035|FG001|Overall Study|Adverse Event|2|||
156759467|NCT00619827|565872034|FG000|Overall Study|Withdrawal by Subject|2|||
156759468|NCT00619827|565872035|FG001|Overall Study|Withdrawal by Subject|2|||
156759469|NCT01063855|565872037|FG000|Overall Study|Adverse Event|4|||
156759470|NCT01063855|565872038|FG001|Overall Study|Adverse Event|4|||
156759471|NCT01063855|565872037|FG000|Overall Study|Death|0|||
156759472|NCT01063855|565872038|FG001|Overall Study|Death|1|||
156759473|NCT01063855|565872037|FG000|Overall Study|Lost to Follow-up|8|||
156759474|NCT01063855|565872038|FG001|Overall Study|Lost to Follow-up|4|||
156759475|NCT01063855|565872037|FG000|Overall Study|Pregnancy|1|||
156759476|NCT01063855|565872038|FG001|Overall Study|Pregnancy|0|||
156759477|NCT01063855|565872037|FG000|Overall Study|Lack of Efficacy|0|||
156759478|NCT01063855|565872038|FG001|Overall Study|Lack of Efficacy|1|||
156759479|NCT01063855|565872037|FG000|Overall Study|Withdrawal by Subject|11|||
156759480|NCT01063855|565872038|FG001|Overall Study|Withdrawal by Subject|8|||
156759481|NCT01063855|565872037|FG000|Overall Study|Reason not specified|13|||
156759482|NCT01063855|565872038|FG001|Overall Study|Reason not specified|11|||
156759483|NCT00735709|565872039|FG000|Overall Study|Adverse Event|2|||
156759484|NCT00735709|565872040|FG001|Overall Study|Adverse Event|3|||
156759485|NCT00735709|565872041|FG002|Overall Study|Adverse Event|1|||
156759486|NCT00735709|565872042|FG003|Overall Study|Adverse Event|5|||
156759487|NCT00735709|565872039|FG000|Overall Study|Lack of Efficacy|8|||
156759488|NCT00735709|565872040|FG001|Overall Study|Lack of Efficacy|4|||
156759489|NCT00735709|565872041|FG002|Overall Study|Lack of Efficacy|2|||
156759490|NCT00735709|565872042|FG003|Overall Study|Lack of Efficacy|3|||
156759491|NCT00735709|565872039|FG000|Overall Study|Noncompliance|0|||
156759492|NCT00735709|565872040|FG001|Overall Study|Noncompliance|0|||
156759493|NCT00735709|565872041|FG002|Overall Study|Noncompliance|1|||
156759494|NCT00735709|565872042|FG003|Overall Study|Noncompliance|0|||
156759495|NCT00735709|565872039|FG000|Overall Study|Protocol deviations|1|||
156759496|NCT00735709|565872040|FG001|Overall Study|Protocol deviations|2|||
156759497|NCT00735709|565872041|FG002|Overall Study|Protocol deviations|1|||
156759498|NCT00735709|565872042|FG003|Overall Study|Protocol deviations|1|||
156759499|NCT00735709|565872039|FG000|Overall Study|Voluntary Withdrawal|1|||
156759500|NCT00735709|565872040|FG001|Overall Study|Voluntary Withdrawal|3|||
156759501|NCT00735709|565872041|FG002|Overall Study|Voluntary Withdrawal|5|||
156759502|NCT00735709|565872042|FG003|Overall Study|Voluntary Withdrawal|7|||
156759503|NCT00735709|565872039|FG000|Overall Study|Lost to Follow-up|0|||
156759504|NCT00735709|565872040|FG001|Overall Study|Lost to Follow-up|1|||
156759505|NCT00735709|565872041|FG002|Overall Study|Lost to Follow-up|1|||
156759506|NCT00735709|565872042|FG003|Overall Study|Lost to Follow-up|1|||
156759507|NCT00735709|565872039|FG000|Overall Study|Excluded medication|1|||
156759508|NCT00735709|565872040|FG001|Overall Study|Excluded medication|0|||
156759509|NCT00735709|565872041|FG002|Overall Study|Excluded medication|0|||
156759510|NCT00735709|565872042|FG003|Overall Study|Excluded medication|1|||
156759511|NCT01165307|565872043|FG000|Overall Study|Lost to Follow-up|11|||
156759512|NCT01165307|565872044|FG001|Overall Study|Lost to Follow-up|3|||
156759513|NCT01165307|565872043|FG000|Overall Study|Withdrawal by Subject|2|||
156759514|NCT01165307|565872044|FG001|Overall Study|Withdrawal by Subject|0|||
156759515|NCT01165307|565872043|FG000|Overall Study|Subject not available for contact|1|||
156759516|NCT01165307|565872044|FG001|Overall Study|Subject not available for contact|0|||
156759517|NCT03234036|565872046|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
156759518|NCT03234036|565872047|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
156759519|NCT03234036|565872048|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
156759520|NCT03234036|565872049|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
156759521|NCT02163395|565872054|FG000|Overall Study|Withdrawal by Subject|1|||
156759522|NCT02163395|565872054|FG000|Overall Study|Lost to Follow-up|3|||
156759523|NCT02163395|565872054|FG000|Overall Study|Adverse Event|1|||
156759524|NCT02683239|565872072|FG000|Overall Study|Protocol Violation|35|||
156759525|NCT02683239|565872073|FG001|Overall Study|Protocol Violation|23|||
156759526|NCT02683239|565872074|FG002|Overall Study|Protocol Violation|26|||
156759527|NCT02683239|565872075|FG003|Overall Study|Protocol Violation|4|||
156759528|NCT02683239|565872076|FG004|Overall Study|Protocol Violation|35|||
156759529|NCT02683239|565872077|FG005|Overall Study|Protocol Violation|4|||
156759530|NCT02683239|565872078|FG006|Overall Study|Protocol Violation|5|||
156759531|NCT02683239|565872072|FG000|Overall Study|Adverse Event|64|||
156759532|NCT02683239|565872073|FG001|Overall Study|Adverse Event|39|||
156759533|NCT02683239|565872074|FG002|Overall Study|Adverse Event|42|||
156759534|NCT02683239|565872075|FG003|Overall Study|Adverse Event|16|||
156759535|NCT02683239|565872076|FG004|Overall Study|Adverse Event|189|||
156759536|NCT02683239|565872077|FG005|Overall Study|Adverse Event|9|||
156759537|NCT02683239|565872078|FG006|Overall Study|Adverse Event|9|||
156759538|NCT02683239|565872072|FG000|Overall Study|Physician Decision|38|||
156759539|NCT02683239|565872073|FG001|Overall Study|Physician Decision|19|||
156759540|NCT02683239|565872074|FG002|Overall Study|Physician Decision|14|||
156759541|NCT02683239|565872075|FG003|Overall Study|Physician Decision|73|||
156759542|NCT02683239|565872076|FG004|Overall Study|Physician Decision|143|||
156759543|NCT02683239|565872077|FG005|Overall Study|Physician Decision|14|||
156759544|NCT02683239|565872078|FG006|Overall Study|Physician Decision|15|||
156759545|NCT02683239|565872072|FG000|Overall Study|Withdrawal by Subject|187|||
156759546|NCT02683239|565872073|FG001|Overall Study|Withdrawal by Subject|99|||
156759547|NCT02683239|565872074|FG002|Overall Study|Withdrawal by Subject|91|||
156759548|NCT02683239|565872075|FG003|Overall Study|Withdrawal by Subject|18|||
156759549|NCT02683239|565872076|FG004|Overall Study|Withdrawal by Subject|248|||
156759550|NCT02683239|565872077|FG005|Overall Study|Withdrawal by Subject|22|||
157001131|NCT01549652|566752738|FG003|Overall Study|Titration Non-Compliance|5|||
157001132|NCT01549652|566752735|FG000|Overall Study|Titration Side Effects|0|||
157001133|NCT01549652|566752736|FG001|Overall Study|Titration Side Effects|0|||
157001134|NCT01549652|566752737|FG002|Overall Study|Titration Side Effects|6|||
157001135|NCT01549652|566752738|FG003|Overall Study|Titration Side Effects|3|||
157001136|NCT01549652|566752735|FG000|Overall Study|Withdrawal by Subject|0|||
157001137|NCT01549652|566752736|FG001|Overall Study|Withdrawal by Subject|0|||
157001138|NCT01549652|566752737|FG002|Overall Study|Withdrawal by Subject|5|||
157001139|NCT01549652|566752738|FG003|Overall Study|Withdrawal by Subject|3|||
157001140|NCT02596035|566752743|FG000|Overall Study|Disease Progression|64|||
156759551|NCT02683239|565872078|FG006|Overall Study|Withdrawal by Subject|28|||
156759552|NCT02683239|565872072|FG000|Overall Study|Lost to Follow-up|77|||
156759553|NCT02683239|565872073|FG001|Overall Study|Lost to Follow-up|24|||
156759554|NCT02683239|565872074|FG002|Overall Study|Lost to Follow-up|25|||
156759555|NCT02683239|565872075|FG003|Overall Study|Lost to Follow-up|7|||
156759556|NCT02683239|565872076|FG004|Overall Study|Lost to Follow-up|88|||
156759557|NCT02683239|565872077|FG005|Overall Study|Lost to Follow-up|8|||
156759558|NCT02683239|565872078|FG006|Overall Study|Lost to Follow-up|11|||
156759559|NCT02683239|565872072|FG000|Overall Study|Death|9|||
156759560|NCT02683239|565872073|FG001|Overall Study|Death|5|||
156759561|NCT02683239|565872074|FG002|Overall Study|Death|8|||
156759562|NCT02683239|565872075|FG003|Overall Study|Death|0|||
157001141|NCT02596035|566752744|FG001|Overall Study|Disease Progression|32|||
157001142|NCT02596035|566752745|FG002|Overall Study|Disease Progression|1|||
157001143|NCT02596035|566752743|FG000|Overall Study|study drug toxicity|12|||
156759563|NCT02683239|565872076|FG004|Overall Study|Death|12|||
156759564|NCT02683239|565872077|FG005|Overall Study|Death|1|||
156759565|NCT02683239|565872078|FG006|Overall Study|Death|0|||
156759566|NCT02683239|565872072|FG000|Overall Study|Lack of Efficacy|50|||
156759567|NCT02683239|565872073|FG001|Overall Study|Lack of Efficacy|23|||
156759568|NCT02683239|565872074|FG002|Overall Study|Lack of Efficacy|12|||
157104104|NCT02632721|567136425|FG000|Overall Study|Receiving Decitabine locally|0|||
157104105|NCT02632721|567136426|FG001|Overall Study|Receiving Decitabine locally|0|||
157104106|NCT02632721|567136427|FG002|Overall Study|Receiving Decitabine locally|1|||
157104107|NCT02632721|567136428|FG003|Overall Study|Receiving Decitabine locally|0|||
157104108|NCT02632721|567136429|FG004|Overall Study|Receiving Decitabine locally|0|||
157104109|NCT02632721|567136425|FG000|Overall Study|No benefit from study treatment|1|||
157104110|NCT02632721|567136426|FG001|Overall Study|No benefit from study treatment|1|||
157104111|NCT02632721|567136427|FG002|Overall Study|No benefit from study treatment|0|||
157104112|NCT02632721|567136428|FG003|Overall Study|No benefit from study treatment|0|||
157104113|NCT02632721|567136429|FG004|Overall Study|No benefit from study treatment|1|||
157104114|NCT02632721|567136425|FG000|Overall Study|Patient wish for other treatment|0|||
157104115|NCT02632721|567136426|FG001|Overall Study|Patient wish for other treatment|1|||
157104116|NCT02632721|567136427|FG002|Overall Study|Patient wish for other treatment|0|||
157104117|NCT02632721|567136428|FG003|Overall Study|Patient wish for other treatment|0|||
157104118|NCT02632721|567136429|FG004|Overall Study|Patient wish for other treatment|0|||
157104119|NCT02632721|567136425|FG000|Overall Study|Relapsed Pneumonia|0|||
157104120|NCT02632721|567136426|FG001|Overall Study|Relapsed Pneumonia|0|||
157104121|NCT02632721|567136427|FG002|Overall Study|Relapsed Pneumonia|0|||
157104122|NCT02632721|567136428|FG003|Overall Study|Relapsed Pneumonia|0|||
157104123|NCT02632721|567136429|FG004|Overall Study|Relapsed Pneumonia|1|||
157104124|NCT02632721|567136425|FG000|Overall Study|Therapy refractory AML|0|||
157104125|NCT02632721|567136426|FG001|Overall Study|Therapy refractory AML|0|||
157104126|NCT02632721|567136427|FG002|Overall Study|Therapy refractory AML|0|||
157104127|NCT02632721|567136428|FG003|Overall Study|Therapy refractory AML|0|||
157104128|NCT02632721|567136429|FG004|Overall Study|Therapy refractory AML|1|||
157104129|NCT02632721|567136425|FG000|Overall Study|Increase of white blood cell count|0|||
157104130|NCT02632721|567136426|FG001|Overall Study|Increase of white blood cell count|0|||
157104131|NCT02632721|567136427|FG002|Overall Study|Increase of white blood cell count|0|||
156759569|NCT02683239|565872075|FG003|Overall Study|Lack of Efficacy|2|||
156759570|NCT02683239|565872076|FG004|Overall Study|Lack of Efficacy|29|||
156759571|NCT02683239|565872077|FG005|Overall Study|Lack of Efficacy|2|||
156759572|NCT02683239|565872078|FG006|Overall Study|Lack of Efficacy|3|||
156759573|NCT02683239|565872072|FG000|Overall Study|Missing data|0|||
156759574|NCT02683239|565872073|FG001|Overall Study|Missing data|1|||
156759575|NCT02683239|565872074|FG002|Overall Study|Missing data|1|||
156759576|NCT02683239|565872075|FG003|Overall Study|Missing data|0|||
156759577|NCT02683239|565872076|FG004|Overall Study|Missing data|1|||
156759578|NCT02683239|565872077|FG005|Overall Study|Missing data|0|||
156759579|NCT02683239|565872078|FG006|Overall Study|Missing data|0|||
156759580|NCT00521365|565872081|FG000|Overall Study|Adverse Event|3|||
156759581|NCT00521365|565872081|FG000|Overall Study|Lost to Follow-up|6|||
156759582|NCT00521365|565872081|FG000|Overall Study|Protocol deviation|2|||
156759583|NCT00521365|565872081|FG000|Overall Study|Drug compliance|3|||
156759584|NCT00521365|565872081|FG000|Overall Study|Usage of not allowed drugs|6|||
156759585|NCT03627832|565872082|FG000|Overall Study|Withdrawal by Subject|10|||
156759586|NCT03627832|565872083|FG001|Overall Study|Withdrawal by Subject|1|||
156759587|NCT03150082|565872087|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
156759588|NCT03150082|565872088|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
156759589|NCT01718483|565872089|FG000|Overall Study|Withdrawal by Subject|14|||
156759590|NCT01718483|565872090|FG001|Overall Study|Withdrawal by Subject|12|||
156759591|NCT01718483|565872089|FG000|Overall Study|Adverse Event|5|||
156759592|NCT01718483|565872090|FG001|Overall Study|Adverse Event|12|||
156759593|NCT01718483|565872089|FG000|Overall Study|Lost to Follow-up|8|||
156759594|NCT01718483|565872090|FG001|Overall Study|Lost to Follow-up|3|||
156759595|NCT01718483|565872089|FG000|Overall Study|Protocol Violation|4|||
156759596|NCT01718483|565872090|FG001|Overall Study|Protocol Violation|2|||
156759597|NCT01718483|565872089|FG000|Overall Study|Other|1|||
156759598|NCT01718483|565872090|FG001|Overall Study|Other|4|||
156759599|NCT01718483|565872089|FG000|Overall Study|Pregnancy|1|||
156759600|NCT01718483|565872090|FG001|Overall Study|Pregnancy|1|||
156759601|NCT01718483|565872089|FG000|Overall Study|Lack of Efficacy|1|||
156759602|NCT01718483|565872090|FG001|Overall Study|Lack of Efficacy|0|||
156759603|NCT04547140|565872093|FG000|Overall Study|Adverse Event|0|||
156759604|NCT04547140|565872094|FG001|Overall Study|Adverse Event|1|||
157104132|NCT02632721|567136428|FG003|Overall Study|Increase of white blood cell count|0|||
157104133|NCT02632721|567136429|FG004|Overall Study|Increase of white blood cell count|1|||
157104134|NCT02632721|567136425|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156759605|NCT04547140|565872093|FG000|Overall Study|Withdrawal by Subject|0|||
156759606|NCT04547140|565872094|FG001|Overall Study|Withdrawal by Subject|1|||
156759607|NCT04547140|565872093|FG000|Overall Study|Lost to Follow-up|3|||
156759608|NCT04547140|565872094|FG001|Overall Study|Lost to Follow-up|1|||
156759609|NCT04547140|565872093|FG000|Overall Study|Death|2|||
156759610|NCT04547140|565872094|FG001|Overall Study|Death|1|||
156759611|NCT04547140|565872093|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
156759612|NCT04547140|565872094|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
156759613|NCT04547140|565872093|FG000|Overall Study|Pregnancy|1|||
156759614|NCT04547140|565872094|FG001|Overall Study|Pregnancy|0|||
156759615|NCT04547140|565872093|FG000|Overall Study|Reason Not Specified|4|||
156759616|NCT04547140|565872094|FG001|Overall Study|Reason Not Specified|1|||
156759617|NCT02119299|565872095|FG000|Overall Study|Withdrawal by Subject|7|||
156759618|NCT02119299|565872095|FG000|Overall Study|Lack of Efficacy|1|||
156759619|NCT02119299|565872095|FG000|Overall Study|Pregnancy|1|||
156759620|NCT04613739|565872098|FG000|Overall Study|Lost to Follow-up|6|||
156759621|NCT04613739|565872099|FG001|Overall Study|Lost to Follow-up|9|||
156759622|NCT04613739|565872098|FG000|Overall Study|potentially duplicative/fraudulent|1|||
156759623|NCT04613739|565872099|FG001|Overall Study|potentially duplicative/fraudulent|3|||
156759624|NCT01265394|565872119|FG000|Overall Study|Subjects withdrawn|37|||
156759625|NCT04754542|565872132|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
156759626|NCT04754542|565872133|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
156759627|NCT00873730|565873828|FG000|Overall Study|Protocol Deviation|5|||
156759628|NCT00873730|565873829|FG001|Overall Study|Protocol Deviation|2|||
156759629|NCT00873730|565873828|FG000|Overall Study|Adverse Event|0|||
156759630|NCT00873730|565873829|FG001|Overall Study|Adverse Event|2|||
156759631|NCT00873730|565873828|FG000|Overall Study|Withdrawal by Subject|0|||
156759632|NCT00873730|565873829|FG001|Overall Study|Withdrawal by Subject|1|||
156759633|NCT00873730|565873828|FG000|Overall Study|Sponsor decision|1|||
156759634|NCT00873730|565873829|FG001|Overall Study|Sponsor decision|0|||
156759635|NCT00048035|565873830|FG000|Core Period|Early Withdrawals|4|||
156759636|NCT00048035|565873831|FG001|Core Period|Early Withdrawals|2|||
156759637|NCT00048035|565873832|FG002|Core Period|Early Withdrawals|1|||
156759638|NCT00048035|565873833|FG003|Core Period|Early Withdrawals|1|||
156759639|NCT00048035|565873834|FG004|Core Period|Early Withdrawals|1|||
156759640|NCT00048035|565873835|FG005|Core Period|Early Withdrawals|1|||
156759641|NCT00048035|565873836|FG006|Core Period|Early Withdrawals|0|||
156759642|NCT00048035|565873837|FG007|Core Period|Early Withdrawals|0|||
156759643|NCT00048035|565873830|FG000|Extension Year 1|Early Withdrawals|0|||
156759644|NCT00048035|565873831|FG001|Extension Year 1|Early Withdrawals|0|||
156759645|NCT00048035|565873832|FG002|Extension Year 1|Early Withdrawals|0|||
156759646|NCT00048035|565873833|FG003|Extension Year 1|Early Withdrawals|0|||
156759647|NCT00048035|565873834|FG004|Extension Year 1|Early Withdrawals|0|||
156759648|NCT00048035|565873835|FG005|Extension Year 1|Early Withdrawals|0|||
157001144|NCT02596035|566752744|FG001|Overall Study|study drug toxicity|3|||
157001145|NCT02596035|566752745|FG002|Overall Study|study drug toxicity|0|||
157001146|NCT02596035|566752743|FG000|Overall Study|AE unrelated to study drug|5|||
157001147|NCT02596035|566752744|FG001|Overall Study|AE unrelated to study drug|2|||
157001148|NCT02596035|566752745|FG002|Overall Study|AE unrelated to study drug|0|||
157001149|NCT02596035|566752743|FG000|Overall Study|participant request to discontinue study treatment|2|||
157001150|NCT02596035|566752744|FG001|Overall Study|participant request to discontinue study treatment|0|||
157001151|NCT02596035|566752745|FG002|Overall Study|participant request to discontinue study treatment|0|||
157001152|NCT02596035|566752743|FG000|Overall Study|participant withdrew consent|2|||
157001153|NCT02596035|566752744|FG001|Overall Study|participant withdrew consent|2|||
157001154|NCT02596035|566752745|FG002|Overall Study|participant withdrew consent|0|||
157001155|NCT02596035|566752743|FG000|Overall Study|Poor/Non Comlpiance|0|||
157001156|NCT02596035|566752744|FG001|Overall Study|Poor/Non Comlpiance|1|||
157001157|NCT02596035|566752745|FG002|Overall Study|Poor/Non Comlpiance|0|||
157001158|NCT02596035|566752743|FG000|Overall Study|participant no longer meets study criteria|1|||
157001159|NCT02596035|566752744|FG001|Overall Study|participant no longer meets study criteria|0|||
157001160|NCT02596035|566752745|FG002|Overall Study|participant no longer meets study criteria|0|||
157001161|NCT02596035|566752743|FG000|Overall Study|other reasons|11|||
157001162|NCT02596035|566752744|FG001|Overall Study|other reasons|4|||
157001163|NCT02596035|566752745|FG002|Overall Study|other reasons|0|||
157001164|NCT03523962|566752749|FG000|Closed Fractures|Death|86|||
157001165|NCT03523962|566752750|FG001|Closed Fractures|Death|71|||
157001166|NCT03523962|566752751|FG002|Closed Fractures|Death|0|||
157001167|NCT03523962|566752752|FG003|Closed Fractures|Death|0|||
157001168|NCT03523962|566752749|FG000|Closed Fractures|Lost to Follow-up|62|||
157001169|NCT03523962|566752750|FG001|Closed Fractures|Lost to Follow-up|36|||
156759649|NCT00048035|565873836|FG006|Extension Year 1|Early Withdrawals|11|||
156759650|NCT00048035|565873837|FG007|Extension Year 1|Early Withdrawals|11|||
156759651|NCT00048035|565873830|FG000|Extension Year 2|Early Withdrawals|0|||
157001170|NCT03523962|566752751|FG002|Closed Fractures|Lost to Follow-up|0|||
157001171|NCT03523962|566752752|FG003|Closed Fractures|Lost to Follow-up|0|||
157001172|NCT03523962|566752749|FG000|Closed Fractures|Withdrawal by Subject|19|||
156759652|NCT00048035|565873831|FG001|Extension Year 2|Early Withdrawals|0|||
156759653|NCT00048035|565873832|FG002|Extension Year 2|Early Withdrawals|0|||
156759654|NCT00048035|565873833|FG003|Extension Year 2|Early Withdrawals|0|||
157001173|NCT03523962|566752750|FG001|Closed Fractures|Withdrawal by Subject|29|||
157001174|NCT03523962|566752751|FG002|Closed Fractures|Withdrawal by Subject|0|||
157001175|NCT03523962|566752752|FG003|Closed Fractures|Withdrawal by Subject|0|||
157001176|NCT03523962|566752749|FG000|Closed Fractures|Incarceration|1|||
157001177|NCT03523962|566752750|FG001|Closed Fractures|Incarceration|4|||
157001178|NCT03523962|566752751|FG002|Closed Fractures|Incarceration|0|||
157001179|NCT03523962|566752752|FG003|Closed Fractures|Incarceration|0|||
157001180|NCT03523962|566752749|FG000|Open Fractures|Death|0|||
157001181|NCT03523962|566752750|FG001|Open Fractures|Death|0|||
157001182|NCT03523962|566752751|FG002|Open Fractures|Death|11|||
157001183|NCT03523962|566752752|FG003|Open Fractures|Death|6|||
157001184|NCT03523962|566752749|FG000|Open Fractures|Lost to Follow-up|0|||
157001185|NCT03523962|566752750|FG001|Open Fractures|Lost to Follow-up|0|||
157001186|NCT03523962|566752751|FG002|Open Fractures|Lost to Follow-up|15|||
157001187|NCT03523962|566752752|FG003|Open Fractures|Lost to Follow-up|8|||
157001188|NCT03523962|566752749|FG000|Open Fractures|Withdrawal by Subject|0|||
157001189|NCT03523962|566752750|FG001|Open Fractures|Withdrawal by Subject|0|||
157001190|NCT03523962|566752751|FG002|Open Fractures|Withdrawal by Subject|6|||
157001191|NCT03523962|566752752|FG003|Open Fractures|Withdrawal by Subject|2|||
157001192|NCT03523962|566752749|FG000|Open Fractures|Incarceration|0|||
157001193|NCT03523962|566752750|FG001|Open Fractures|Incarceration|0|||
157001194|NCT03523962|566752751|FG002|Open Fractures|Incarceration|1|||
157001195|NCT03523962|566752752|FG003|Open Fractures|Incarceration|0|||
157001196|NCT00835380|566752753|FG000|Overall Study|Withdrawal by Subject|2|||
157001197|NCT03593070|566752754|FG000|Overall Study|administrative withdrawal|1|||
157001198|NCT03593070|566752755|FG001|Overall Study|administrative withdrawal|1|||
157001199|NCT03722446|566752756|FG000|Overall Study|Protocol Violation|15|||
157001200|NCT03722446|566752757|FG001|Overall Study|Protocol Violation|2|||
157001201|NCT03425643|566752760|FG000|Overall Study|Withdrawal by Subject|10|||
157001202|NCT03425643|566752761|FG001|Overall Study|Withdrawal by Subject|12|||
157001203|NCT03425643|566752760|FG000|Overall Study|Lost to Follow-up|2|||
157001204|NCT03425643|566752761|FG001|Overall Study|Lost to Follow-up|0|||
157001205|NCT03425643|566752760|FG000|Overall Study|Death|109|||
157001206|NCT03425643|566752761|FG001|Overall Study|Death|141|||
157001207|NCT03425643|566752760|FG000|Overall Study|Ongoing in study|276|||
157001208|NCT03425643|566752761|FG001|Overall Study|Ongoing in study|247|||
157001209|NCT04133363|566752762|FG000|Overall Study|Lost to Follow-up|2|||
157001210|NCT04133363|566752763|FG001|Overall Study|Lost to Follow-up|1|||
157001211|NCT04133363|566752764|FG002|Overall Study|Lost to Follow-up|4|||
157001212|NCT01838200|566752765|FG000|Overall Study|Adverse Event|0|||
157001213|NCT01838200|566752766|FG001|Overall Study|Adverse Event|2|||
157001214|NCT01838200|566752765|FG000|Overall Study|Progressive disease|3|||
157001215|NCT01838200|566752766|FG001|Overall Study|Progressive disease|0|||
157001216|NCT03354390|566752767|FG000|Level 1|Death|2|||
157001217|NCT03354390|566752768|FG001|Level 1|Death|0|||
157001218|NCT03354390|566752769|FG002|Level 1|Death|0|||
157001219|NCT03354390|566752770|FG003|Level 1|Death|0|||
157001220|NCT03354390|566752767|FG000|Level 1|Physician Decision|1|||
157001221|NCT03354390|566752768|FG001|Level 1|Physician Decision|0|||
157001222|NCT03354390|566752769|FG002|Level 1|Physician Decision|0|||
157001223|NCT03354390|566752770|FG003|Level 1|Physician Decision|0|||
157001224|NCT03354390|566752767|FG000|Level 2|Physician Decision|0|||
157001225|NCT03354390|566752768|FG001|Level 2|Physician Decision|2|||
157001226|NCT03354390|566752769|FG002|Level 2|Physician Decision|0|||
157001227|NCT03354390|566752770|FG003|Level 2|Physician Decision|0|||
157001228|NCT03354390|566752767|FG000|Level 2|Lack of Efficacy|0|||
157001229|NCT03354390|566752768|FG001|Level 2|Lack of Efficacy|1|||
157001230|NCT03354390|566752769|FG002|Level 2|Lack of Efficacy|0|||
157001231|NCT03354390|566752770|FG003|Level 2|Lack of Efficacy|0|||
157001232|NCT03354390|566752767|FG000|Level 2|Lost to Follow-up|0|||
157001233|NCT03354390|566752768|FG001|Level 2|Lost to Follow-up|1|||
157001234|NCT03354390|566752769|FG002|Level 2|Lost to Follow-up|0|||
157001235|NCT03354390|566752770|FG003|Level 2|Lost to Follow-up|0|||
157001236|NCT03354390|566752767|FG000|Level 3|Death|0|||
157001237|NCT03354390|566752768|FG001|Level 3|Death|0|||
157001238|NCT03354390|566752769|FG002|Level 3|Death|1|||
157001239|NCT03354390|566752770|FG003|Level 3|Death|0|||
157001240|NCT03354390|566752767|FG000|Level 3|Physician Decision|0|||
157001241|NCT03354390|566752768|FG001|Level 3|Physician Decision|0|||
157001242|NCT03354390|566752769|FG002|Level 3|Physician Decision|2|||
156759655|NCT00048035|565873834|FG004|Extension Year 2|Early Withdrawals|0|||
157001243|NCT03354390|566752770|FG003|Level 3|Physician Decision|0|||
157001244|NCT03354390|566752767|FG000|Level 4|Death|0|||
157001245|NCT03354390|566752768|FG001|Level 4|Death|0|||
157001246|NCT03354390|566752769|FG002|Level 4|Death|0|||
157001247|NCT03354390|566752770|FG003|Level 4|Death|3|||
157001248|NCT00777556|566754229|FG000|Overall Study|Inappropriate self-selection|34|||
157001249|NCT00777556|566754229|FG000|Overall Study|Dispensed but did not use product|12|||
157001250|NCT00777556|566754229|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
157001251|NCT00486759|566754230|FG000|Treatment|Adverse event/intercurrent illness|86|||
157001252|NCT00486759|566754231|FG001|Treatment|Adverse event/intercurrent illness|39|||
157001253|NCT00486759|566754230|FG000|Treatment|Insufficient therapeutic response|37|||
157001254|NCT00486759|566754231|FG001|Treatment|Insufficient therapeutic response|39|||
156759656|NCT00048035|565873835|FG005|Extension Year 2|Early Withdrawals|0|||
156759657|NCT00048035|565873836|FG006|Extension Year 2|Early Withdrawals|3|||
156759658|NCT00048035|565873837|FG007|Extension Year 2|Early Withdrawals|3|||
156759659|NCT04110314|565873838|FG000|Overall Study|Did not meet inclusion criteria|35255|||
156759660|NCT04110314|565873839|FG001|Overall Study|Did not meet inclusion criteria|35104|||
156759661|NCT04110314|565873840|FG002|Overall Study|Did not meet inclusion criteria|35636|||
156759662|NCT04110314|565873841|FG003|Overall Study|Did not meet inclusion criteria|35135|||
156759663|NCT04110314|565873842|FG004|Overall Study|Did not meet inclusion criteria|35247|||
156759664|NCT04110314|565873843|FG005|Overall Study|Did not meet inclusion criteria|35727|||
156759665|NCT05137717|565873848|FG000|Overall Study|Death|2|||
156759666|NCT05137717|565873848|FG000|Overall Study|Withdrawal by Subject|6|||
156759667|NCT02619617|565873849|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
156759668|NCT02619617|565873850|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
156759669|NCT02619617|565873849|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
156759670|NCT02619617|565873850|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
156759671|NCT00509899|565873851|FG000|Overall Study|Progressive disease|1|||
156759672|NCT00509899|565873852|FG001|Overall Study|Progressive disease|3|||
156759673|NCT00509899|565873853|FG002|Overall Study|Progressive disease|5|||
156759674|NCT00509899|565873854|FG003|Overall Study|Progressive disease|1|||
156759675|NCT00509899|565873855|FG004|Overall Study|Progressive disease|0|||
156759676|NCT00509899|565873856|FG005|Overall Study|Progressive disease|1|||
156759677|NCT00509899|565873857|FG006|Overall Study|Progressive disease|0|||
156759678|NCT00509899|565873858|FG007|Overall Study|Progressive disease|0|||
156759679|NCT00509899|565873851|FG000|Overall Study|Unacceptable Toxicity|1|||
156759680|NCT00509899|565873852|FG001|Overall Study|Unacceptable Toxicity|0|||
156759681|NCT00509899|565873853|FG002|Overall Study|Unacceptable Toxicity|0|||
156759682|NCT00509899|565873854|FG003|Overall Study|Unacceptable Toxicity|2|||
156759683|NCT00509899|565873855|FG004|Overall Study|Unacceptable Toxicity|0|||
156759684|NCT00509899|565873856|FG005|Overall Study|Unacceptable Toxicity|0|||
156759685|NCT00509899|565873857|FG006|Overall Study|Unacceptable Toxicity|0|||
156759686|NCT00509899|565873858|FG007|Overall Study|Unacceptable Toxicity|0|||
156759687|NCT00509899|565873851|FG000|Overall Study|Withdrawal by Subject|6|||
156759688|NCT00509899|565873852|FG001|Overall Study|Withdrawal by Subject|2|||
156759689|NCT00509899|565873853|FG002|Overall Study|Withdrawal by Subject|3|||
156759690|NCT00509899|565873854|FG003|Overall Study|Withdrawal by Subject|0|||
156759691|NCT00509899|565873855|FG004|Overall Study|Withdrawal by Subject|3|||
156759692|NCT00509899|565873856|FG005|Overall Study|Withdrawal by Subject|2|||
156759693|NCT00509899|565873857|FG006|Overall Study|Withdrawal by Subject|0|||
156759694|NCT00509899|565873858|FG007|Overall Study|Withdrawal by Subject|0|||
156759695|NCT00509899|565873851|FG000|Overall Study|Physician Decision|4|||
156759696|NCT00509899|565873852|FG001|Overall Study|Physician Decision|2|||
156759697|NCT00509899|565873853|FG002|Overall Study|Physician Decision|7|||
156759698|NCT00509899|565873854|FG003|Overall Study|Physician Decision|0|||
156759699|NCT00509899|565873855|FG004|Overall Study|Physician Decision|1|||
156759700|NCT00509899|565873856|FG005|Overall Study|Physician Decision|4|||
156759701|NCT00509899|565873857|FG006|Overall Study|Physician Decision|0|||
156759702|NCT00509899|565873858|FG007|Overall Study|Physician Decision|0|||
156759703|NCT00509899|565873851|FG000|Overall Study|Intercurrent Illness|1|||
156759704|NCT00509899|565873852|FG001|Overall Study|Intercurrent Illness|0|||
156759705|NCT00509899|565873853|FG002|Overall Study|Intercurrent Illness|0|||
156759706|NCT00509899|565873854|FG003|Overall Study|Intercurrent Illness|1|||
156759707|NCT00509899|565873855|FG004|Overall Study|Intercurrent Illness|0|||
156759708|NCT00509899|565873856|FG005|Overall Study|Intercurrent Illness|1|||
156759709|NCT00509899|565873857|FG006|Overall Study|Intercurrent Illness|0|||
156759710|NCT00509899|565873858|FG007|Overall Study|Intercurrent Illness|0|||
156759711|NCT00509899|565873851|FG000|Overall Study|Death|2|||
157104135|NCT02632721|567136426|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
157104136|NCT02632721|567136427|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
157104137|NCT02632721|567136428|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
156759712|NCT00509899|565873852|FG001|Overall Study|Death|2|||
156759713|NCT00509899|565873853|FG002|Overall Study|Death|3|||
156759714|NCT00509899|565873854|FG003|Overall Study|Death|0|||
156759715|NCT00509899|565873855|FG004|Overall Study|Death|1|||
156759716|NCT00509899|565873856|FG005|Overall Study|Death|1|||
156759717|NCT00509899|565873857|FG006|Overall Study|Death|1|||
156759718|NCT00509899|565873858|FG007|Overall Study|Death|1|||
156759719|NCT00509899|565873851|FG000|Overall Study|Lack of Efficacy|1|||
156759720|NCT00509899|565873852|FG001|Overall Study|Lack of Efficacy|0|||
156759721|NCT00509899|565873853|FG002|Overall Study|Lack of Efficacy|2|||
156759722|NCT00509899|565873854|FG003|Overall Study|Lack of Efficacy|0|||
156759723|NCT00509899|565873855|FG004|Overall Study|Lack of Efficacy|0|||
156759724|NCT00509899|565873856|FG005|Overall Study|Lack of Efficacy|1|||
156759725|NCT00509899|565873857|FG006|Overall Study|Lack of Efficacy|0|||
156759726|NCT00509899|565873858|FG007|Overall Study|Lack of Efficacy|0|||
156759727|NCT01711983|565873861|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
156759728|NCT01711983|565873861|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
156759729|NCT01711983|565873861|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
156759730|NCT01711983|565873861|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
156759731|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759732|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
156759733|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
156759734|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759735|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759736|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759737|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759738|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759739|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759740|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759741|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759742|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759743|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759744|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759745|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156759746|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156759747|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
156759748|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759749|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759750|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759751|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759752|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759753|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759754|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759755|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759756|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759757|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759758|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759759|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759760|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156759761|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
156759762|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
156759763|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
156759764|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759765|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759766|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759767|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759768|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759769|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759770|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759771|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759772|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759773|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759774|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759775|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156759776|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759777|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759778|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
156759779|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759780|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759781|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759782|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759783|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759784|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759785|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
157001255|NCT00486759|566754230|FG000|Treatment|Death|17|||
157001256|NCT00486759|566754231|FG001|Treatment|Death|10|||
157001257|NCT00486759|566754230|FG000|Treatment|Withdrew consent|15|||
156759786|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759787|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759788|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759789|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759790|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
156759791|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759792|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759793|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
156759794|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759795|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759796|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759797|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
157001258|NCT00486759|566754231|FG001|Treatment|Withdrew consent|12|||
157001259|NCT00486759|566754230|FG000|Treatment|Administrative/reason not specified|17|||
157001260|NCT00486759|566754231|FG001|Treatment|Administrative/reason not specified|21|||
157001261|NCT00486759|566754230|FG000|Treatment|Refused treatment|10|||
157001262|NCT00486759|566754231|FG001|Treatment|Refused treatment|7|||
157001263|NCT00486759|566754230|FG000|Treatment|Violation of selection criteria at entry|3|||
157001264|NCT00486759|566754231|FG001|Treatment|Violation of selection criteria at entry|3|||
157001265|NCT00486759|566754230|FG000|Treatment|Other protocol violation|1|||
157001266|NCT00486759|566754231|FG001|Treatment|Other protocol violation|5|||
157001267|NCT00486759|566754230|FG000|Treatment|Failure to return|1|||
157001268|NCT00486759|566754231|FG001|Treatment|Failure to return|1|||
157001269|NCT00486759|566754230|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
157001270|NCT00486759|566754231|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
157001271|NCT00486759|566754230|FG000|Safety Follow-up|Death|40|||
157001272|NCT00486759|566754231|FG001|Safety Follow-up|Death|29|||
157001273|NCT00486759|566754230|FG000|Safety Follow-up|Withdrew consent|32|||
157001274|NCT00486759|566754231|FG001|Safety Follow-up|Withdrew consent|23|||
157001275|NCT00486759|566754230|FG000|Safety Follow-up|Failure to return|9|||
157001276|NCT00486759|566754231|FG001|Safety Follow-up|Failure to return|6|||
157001277|NCT00486759|566754230|FG000|Safety Follow-up|Administrative/not specified|8|||
157001278|NCT00486759|566754231|FG001|Safety Follow-up|Administrative/not specified|6|||
157001279|NCT00486759|566754230|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
157001280|NCT00486759|566754231|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
157001281|NCT00486759|566754230|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
157001282|NCT00486759|566754231|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
157001283|NCT01185522|566754232|FG000|Overall Study|Lack of Efficacy|28|||
157001284|NCT01185522|566754232|FG000|Overall Study|Lost to Follow-up|19|||
157001285|NCT01185522|566754232|FG000|Overall Study|Withdrawal by Subject|10|||
157001286|NCT01185522|566754232|FG000|Overall Study|Poor tolerance|39|||
157001287|NCT01185522|566754232|FG000|Overall Study|Other reasons|12|||
157001288|NCT00377455|566754235|FG000|Overall Study|Withdrawal by Subject|1|||
157001289|NCT00771667|566754236|FG000|Induction Phase|Adverse Event|5|||
157001290|NCT00771667|566754237|FG001|Induction Phase|Adverse Event|2|||
157001291|NCT00771667|566754238|FG002|Induction Phase|Adverse Event|4|||
157001292|NCT00771667|566754239|FG003|Induction Phase|Adverse Event|1|||
157001293|NCT00771667|566754240|FG004|Induction Phase|Adverse Event|0|||
157001294|NCT00771667|566754241|FG005|Induction Phase|Adverse Event|0|||
157001295|NCT00771667|566754242|FG006|Induction Phase|Adverse Event|0|||
157001296|NCT00771667|566754243|FG007|Induction Phase|Adverse Event|0|||
157001297|NCT00771667|566754244|FG008|Induction Phase|Adverse Event|0|||
157001298|NCT00771667|566754245|FG009|Induction Phase|Adverse Event|0|||
157001299|NCT00771667|566754236|FG000|Induction Phase|Lack of Efficacy|9|||
157001300|NCT00771667|566754237|FG001|Induction Phase|Lack of Efficacy|2|||
157001301|NCT00771667|566754238|FG002|Induction Phase|Lack of Efficacy|4|||
157001302|NCT00771667|566754239|FG003|Induction Phase|Lack of Efficacy|3|||
157001303|NCT00771667|566754240|FG004|Induction Phase|Lack of Efficacy|0|||
157001304|NCT00771667|566754241|FG005|Induction Phase|Lack of Efficacy|0|||
157001305|NCT00771667|566754242|FG006|Induction Phase|Lack of Efficacy|0|||
157001306|NCT00771667|566754243|FG007|Induction Phase|Lack of Efficacy|0|||
157001307|NCT00771667|566754244|FG008|Induction Phase|Lack of Efficacy|0|||
157001308|NCT00771667|566754245|FG009|Induction Phase|Lack of Efficacy|0|||
157001309|NCT00771667|566754236|FG000|Induction Phase|Lost to Follow-up|1|||
157001310|NCT00771667|566754237|FG001|Induction Phase|Lost to Follow-up|0|||
157001311|NCT00771667|566754238|FG002|Induction Phase|Lost to Follow-up|1|||
157001312|NCT00771667|566754239|FG003|Induction Phase|Lost to Follow-up|0|||
157001313|NCT00771667|566754240|FG004|Induction Phase|Lost to Follow-up|0|||
157001314|NCT00771667|566754241|FG005|Induction Phase|Lost to Follow-up|0|||
157001315|NCT00771667|566754242|FG006|Induction Phase|Lost to Follow-up|0|||
157001316|NCT00771667|566754243|FG007|Induction Phase|Lost to Follow-up|0|||
157001317|NCT00771667|566754244|FG008|Induction Phase|Lost to Follow-up|0|||
157001318|NCT00771667|566754245|FG009|Induction Phase|Lost to Follow-up|0|||
157001319|NCT00771667|566754236|FG000|Induction Phase|Other|4|||
156759798|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759799|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759800|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
157001320|NCT00771667|566754237|FG001|Induction Phase|Other|6|||
157001321|NCT00771667|566754238|FG002|Induction Phase|Other|3|||
157001322|NCT00771667|566754239|FG003|Induction Phase|Other|4|||
157001323|NCT00771667|566754240|FG004|Induction Phase|Other|0|||
157001324|NCT00771667|566754241|FG005|Induction Phase|Other|0|||
157001325|NCT00771667|566754242|FG006|Induction Phase|Other|0|||
156759801|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759802|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759803|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759804|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759805|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
156759806|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759807|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759808|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
156759809|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759810|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759811|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759812|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759813|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759814|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759815|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759816|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759817|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759818|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759819|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759820|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
156759821|NCT02326272|565873862|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759822|NCT02326272|565873863|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759823|NCT02326272|565873864|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
156759824|NCT02326272|565873865|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759825|NCT02326272|565873866|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759826|NCT02326272|565873867|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759827|NCT02326272|565873868|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759828|NCT02326272|565873869|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759829|NCT02326272|565873870|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759830|NCT02326272|565873871|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759831|NCT02326272|565873872|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759832|NCT02326272|565873873|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759833|NCT02326272|565873874|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759834|NCT02326272|565873875|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759835|NCT02326272|565873876|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
156759836|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759837|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759838|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759839|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759840|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156759841|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
156759842|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
156759843|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156759844|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156759845|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759846|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759847|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759848|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759849|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759850|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156759851|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759852|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759853|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759854|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759855|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759856|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
156759857|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759858|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759859|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759860|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156759861|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759862|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759863|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759864|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759865|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156759866|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
157104138|NCT02632721|567136429|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
157104139|NCT01572675|567136432|FG000|Overall Study|End of prescribed treatment|140|||
157104140|NCT01572675|567136433|FG001|Overall Study|End of prescribed treatment|118|||
157104141|NCT01572675|567136432|FG000|Overall Study|Recovery|16|||
157104142|NCT01572675|567136433|FG001|Overall Study|Recovery|23|||
157104143|NCT01572675|567136432|FG000|Overall Study|Lack of Efficacy|31|||
157104144|NCT01572675|567136433|FG001|Overall Study|Lack of Efficacy|31|||
157104145|NCT01572675|567136432|FG000|Overall Study|Intolerance|6|||
157104146|NCT01572675|567136433|FG001|Overall Study|Intolerance|5|||
157104147|NCT01572675|567136432|FG000|Overall Study|Improved symptoms|8|||
157104148|NCT01572675|567136433|FG001|Overall Study|Improved symptoms|2|||
157104149|NCT01572675|567136432|FG000|Overall Study|Surgical intervention|3|||
157104150|NCT01572675|567136433|FG001|Overall Study|Surgical intervention|6|||
157104151|NCT01572675|567136432|FG000|Overall Study|Withdrawal by Subject|5|||
157104152|NCT01572675|567136433|FG001|Overall Study|Withdrawal by Subject|1|||
157104153|NCT01572675|567136432|FG000|Overall Study|Physician Decision|2|||
157104154|NCT01572675|567136433|FG001|Overall Study|Physician Decision|2|||
157104155|NCT01572675|567136432|FG000|Overall Study|Death unrelated to coxibs|1|||
157104156|NCT01572675|567136433|FG001|Overall Study|Death unrelated to coxibs|1|||
157104157|NCT01572675|567136432|FG000|Overall Study|Other disease detected|1|||
157104158|NCT01572675|567136433|FG001|Overall Study|Other disease detected|1|||
157104159|NCT01572675|567136432|FG000|Overall Study|Unknown reason|1|||
157104160|NCT01572675|567136433|FG001|Overall Study|Unknown reason|1|||
157104161|NCT01572675|567136432|FG000|Overall Study|Rheumatologist new evaluation|0|||
157104162|NCT01572675|567136433|FG001|Overall Study|Rheumatologist new evaluation|1|||
157104163|NCT01572675|567136432|FG000|Overall Study|Missing data|1|||
157104164|NCT01572675|567136433|FG001|Overall Study|Missing data|4|||
157104165|NCT01572675|567136432|FG000|Overall Study|Lost to Follow-up|22|||
157104166|NCT01572675|567136433|FG001|Overall Study|Lost to Follow-up|27|||
157104167|NCT05390580|567136434|FG000|Overall Study|Physician Decision|3|||
157104168|NCT05390580|567136435|FG001|Overall Study|Physician Decision|2|||
157104169|NCT04448756|567136436|FG000|Overall Study|Adverse Event|0|||
157104170|NCT04448756|567136437|FG001|Overall Study|Adverse Event|1|||
157104171|NCT04448756|567136438|FG002|Overall Study|Adverse Event|0|||
157104172|NCT04448756|567136436|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
157104173|NCT04448756|567136437|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
156759867|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
157104174|NCT04448756|567136438|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
157104175|NCT04448756|567136436|FG000|Overall Study|Withdrawal by Subject|0|||
157104176|NCT04448756|567136437|FG001|Overall Study|Withdrawal by Subject|3|||
157104177|NCT04448756|567136438|FG002|Overall Study|Withdrawal by Subject|1|||
157104178|NCT04448756|567136436|FG000|Overall Study|Death|2|||
157104179|NCT04448756|567136437|FG001|Overall Study|Death|1|||
157104180|NCT04448756|567136438|FG002|Overall Study|Death|0|||
157104181|NCT02733185|567136439|FG000|Overall Study|Withdrawal by Subject|12|||
157104182|NCT02733185|567136440|FG001|Overall Study|Withdrawal by Subject|10|||
157104183|NCT02733185|567136441|FG002|Overall Study|Withdrawal by Subject|17|||
157104184|NCT02733185|567136442|FG003|Overall Study|Withdrawal by Subject|21|||
157104185|NCT02733185|567136439|FG000|Overall Study|Death|46|||
157104186|NCT02733185|567136440|FG001|Overall Study|Death|34|||
157104187|NCT02733185|567136441|FG002|Overall Study|Death|35|||
157104188|NCT02733185|567136442|FG003|Overall Study|Death|43|||
157104189|NCT02733185|567136439|FG000|Overall Study|Lost to Follow-up|17|||
157104190|NCT02733185|567136440|FG001|Overall Study|Lost to Follow-up|18|||
157104191|NCT02733185|567136441|FG002|Overall Study|Lost to Follow-up|16|||
157104192|NCT02733185|567136442|FG003|Overall Study|Lost to Follow-up|11|||
157104193|NCT02129205|567136443|FG000|Overall Study|Withdrawal by Subject|0|||
156759868|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759869|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759870|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759871|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
157104194|NCT02129205|567136444|FG001|Overall Study|Withdrawal by Subject|0|||
157104195|NCT02129205|567136445|FG002|Overall Study|Withdrawal by Subject|0|||
157104196|NCT02129205|567136446|FG003|Overall Study|Withdrawal by Subject|0|||
156759872|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
157104197|NCT02129205|567136447|FG004|Overall Study|Withdrawal by Subject|1|||
157104198|NCT02129205|567136448|FG005|Overall Study|Withdrawal by Subject|1|||
157104199|NCT02129205|567136449|FG006|Overall Study|Withdrawal by Subject|1|||
157104200|NCT02129205|567136450|FG007|Overall Study|Withdrawal by Subject|0|||
157104201|NCT02129205|567136451|FG008|Overall Study|Withdrawal by Subject|1|||
157104202|NCT02129205|567136452|FG009|Overall Study|Withdrawal by Subject|0|||
156759873|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
156759874|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759875|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759876|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759877|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759878|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759879|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759880|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156759881|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759882|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759883|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759884|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759885|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759886|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
156759887|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759888|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759889|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759890|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156759891|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759892|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759893|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759894|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759895|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156759896|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759897|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759898|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759899|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759900|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759901|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759902|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759903|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
156759904|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759905|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759906|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759907|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759908|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759909|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759910|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
156759911|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759912|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759913|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759914|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759915|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759916|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759917|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
156759918|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759919|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759920|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759921|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759922|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759923|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759924|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
157001326|NCT00771667|566754243|FG007|Induction Phase|Other|0|||
157001327|NCT00771667|566754244|FG008|Induction Phase|Other|0|||
157001328|NCT00771667|566754245|FG009|Induction Phase|Other|0|||
157001329|NCT00771667|566754236|FG000|Maintenance Phase|Adverse Event|0|||
157001330|NCT00771667|566754237|FG001|Maintenance Phase|Adverse Event|0|||
157001331|NCT00771667|566754238|FG002|Maintenance Phase|Adverse Event|0|||
157001332|NCT00771667|566754239|FG003|Maintenance Phase|Adverse Event|0|||
157001333|NCT00771667|566754240|FG004|Maintenance Phase|Adverse Event|1|||
157001334|NCT00771667|566754241|FG005|Maintenance Phase|Adverse Event|3|||
157104203|NCT02129205|567136443|FG000|Overall Study|Other|1|||
157104204|NCT02129205|567136444|FG001|Overall Study|Other|0|||
157104205|NCT02129205|567136445|FG002|Overall Study|Other|0|||
157104206|NCT02129205|567136446|FG003|Overall Study|Other|0|||
157104207|NCT02129205|567136447|FG004|Overall Study|Other|2|||
156759925|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156759926|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759927|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759928|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759929|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759930|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759931|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759932|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759933|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759934|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
156759935|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759936|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759937|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759938|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759939|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759940|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
156759941|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759942|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759943|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759944|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759945|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759946|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
156759947|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
156759948|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
156759949|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
156759950|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759951|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759952|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759953|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759954|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759955|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156759956|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759957|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759958|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759959|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759960|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759961|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
156759962|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759963|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759964|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759965|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759966|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759967|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759968|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759969|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759970|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
156759971|NCT02326272|565873862|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759972|NCT02326272|565873863|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759973|NCT02326272|565873864|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759974|NCT02326272|565873865|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759975|NCT02326272|565873866|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759976|NCT02326272|565873867|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759977|NCT02326272|565873868|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
156759978|NCT02326272|565873869|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759979|NCT02326272|565873870|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759980|NCT02326272|565873871|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759981|NCT02326272|565873872|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759982|NCT02326272|565873873|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759983|NCT02326272|565873874|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759984|NCT02326272|565873875|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
157001335|NCT00771667|566754242|FG006|Maintenance Phase|Adverse Event|5|||
157001336|NCT00771667|566754243|FG007|Maintenance Phase|Adverse Event|1|||
157001337|NCT00771667|566754244|FG008|Maintenance Phase|Adverse Event|8|||
157001338|NCT00771667|566754245|FG009|Maintenance Phase|Adverse Event|7|||
157001339|NCT00771667|566754236|FG000|Maintenance Phase|Lack of Efficacy|0|||
157001340|NCT00771667|566754237|FG001|Maintenance Phase|Lack of Efficacy|0|||
157001341|NCT00771667|566754238|FG002|Maintenance Phase|Lack of Efficacy|0|||
157001342|NCT00771667|566754239|FG003|Maintenance Phase|Lack of Efficacy|0|||
157001343|NCT00771667|566754240|FG004|Maintenance Phase|Lack of Efficacy|1|||
157001344|NCT00771667|566754241|FG005|Maintenance Phase|Lack of Efficacy|3|||
157001345|NCT00771667|566754242|FG006|Maintenance Phase|Lack of Efficacy|3|||
157001346|NCT00771667|566754243|FG007|Maintenance Phase|Lack of Efficacy|2|||
157001347|NCT00771667|566754244|FG008|Maintenance Phase|Lack of Efficacy|11|||
157001348|NCT00771667|566754245|FG009|Maintenance Phase|Lack of Efficacy|7|||
157001349|NCT00771667|566754236|FG000|Maintenance Phase|Other|0|||
157001350|NCT00771667|566754237|FG001|Maintenance Phase|Other|0|||
157001351|NCT00771667|566754238|FG002|Maintenance Phase|Other|0|||
157001352|NCT00771667|566754239|FG003|Maintenance Phase|Other|0|||
157001353|NCT00771667|566754240|FG004|Maintenance Phase|Other|0|||
157001354|NCT00771667|566754241|FG005|Maintenance Phase|Other|1|||
157001355|NCT00771667|566754242|FG006|Maintenance Phase|Other|2|||
157001356|NCT00771667|566754243|FG007|Maintenance Phase|Other|2|||
157001357|NCT00771667|566754244|FG008|Maintenance Phase|Other|3|||
157001358|NCT00771667|566754245|FG009|Maintenance Phase|Other|3|||
157001359|NCT01883492|566754246|FG000|Overall Study|Lost to Follow-up|3|||
157001360|NCT01883492|566754247|FG001|Overall Study|Lost to Follow-up|4|||
157001361|NCT01883492|566754246|FG000|Overall Study|Surgery on contra-lateral hip|0|||
157001362|NCT01883492|566754247|FG001|Overall Study|Surgery on contra-lateral hip|1|||
157001363|NCT01883492|566754246|FG000|Overall Study|Poor X-ray quality|7|||
157001364|NCT01883492|566754247|FG001|Overall Study|Poor X-ray quality|4|||
157001365|NCT01883492|566754246|FG000|Overall Study|Withdrawal by Subject|1|||
157001366|NCT01883492|566754247|FG001|Overall Study|Withdrawal by Subject|0|||
157001367|NCT01883492|566754246|FG000|Overall Study|inappropriate implant used|1|||
157001368|NCT01883492|566754247|FG001|Overall Study|inappropriate implant used|1|||
157001369|NCT01883492|566754246|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
157001370|NCT01883492|566754247|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
157001371|NCT03265210|566754248|FG000|Overall Study|Withdrawal by Subject|7|||
157001372|NCT03265210|566754249|FG001|Overall Study|Withdrawal by Subject|9|||
157001373|NCT03265210|566754248|FG000|Overall Study|Lost to Follow-up|2|||
157001374|NCT03265210|566754249|FG001|Overall Study|Lost to Follow-up|0|||
157001375|NCT03265210|566754248|FG000|Overall Study|Physician Decision|2|||
157001376|NCT03265210|566754249|FG001|Overall Study|Physician Decision|0|||
157001377|NCT03265210|566754248|FG000|Overall Study|Adverse Event|1|||
157001378|NCT03265210|566754249|FG001|Overall Study|Adverse Event|0|||
157001379|NCT00549848|566754251|FG000|Overall Study|Death|1|||
157001380|NCT00549848|566754252|FG001|Overall Study|Death|4|||
157001381|NCT00549848|566754253|FG002|Overall Study|Death|13|||
157001382|NCT00549848|566754251|FG000|Overall Study|Physician Decision|0|||
157001383|NCT00549848|566754252|FG001|Overall Study|Physician Decision|0|||
157001384|NCT00549848|566754253|FG002|Overall Study|Physician Decision|4|||
157001385|NCT00549848|566754251|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
157001386|NCT00549848|566754252|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
157001387|NCT00549848|566754253|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
157001388|NCT00549848|566754251|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
157001389|NCT00549848|566754252|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
157001390|NCT00549848|566754253|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
157001391|NCT00549848|566754251|FG000|Overall Study|Participant/Family Withdraw|2|||
157001392|NCT00549848|566754252|FG001|Overall Study|Participant/Family Withdraw|3|||
157001393|NCT00549848|566754253|FG002|Overall Study|Participant/Family Withdraw|5|||
157001394|NCT00549848|566754251|FG000|Overall Study|Second Malignancy|1|||
157001395|NCT00549848|566754252|FG001|Overall Study|Second Malignancy|0|||
157001396|NCT00549848|566754253|FG002|Overall Study|Second Malignancy|0|||
157001397|NCT00549848|566754251|FG000|Overall Study|Transplant|3|||
157001398|NCT00549848|566754252|FG001|Overall Study|Transplant|3|||
157001399|NCT00549848|566754253|FG002|Overall Study|Transplant|18|||
157001400|NCT00549848|566754251|FG000|Overall Study|Unacceptable Toxicity|1|||
157104208|NCT02129205|567136448|FG005|Overall Study|Other|3|||
157001401|NCT00549848|566754252|FG001|Overall Study|Unacceptable Toxicity|6|||
157104209|NCT02129205|567136449|FG006|Overall Study|Other|3|||
157104210|NCT02129205|567136450|FG007|Overall Study|Other|2|||
157001402|NCT00549848|566754253|FG002|Overall Study|Unacceptable Toxicity|6|||
157001403|NCT02377362|566754254|FG000|Part A Second Treatment|Protocol Violation|0|||
157001404|NCT02377362|566754255|FG001|Part A Second Treatment|Protocol Violation|0|||
157001405|NCT02377362|566754256|FG002|Part A Second Treatment|Protocol Violation|0|||
157001406|NCT02377362|566754257|FG003|Part A Second Treatment|Protocol Violation|0|||
157001407|NCT02377362|566754258|FG004|Part A Second Treatment|Protocol Violation|1|||
157001408|NCT02377362|566754259|FG005|Part A Second Treatment|Protocol Violation|0|||
157104211|NCT02129205|567136451|FG008|Overall Study|Other|1|||
156759985|NCT02326272|565873876|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
156759986|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
156759987|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
156759988|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
156759989|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
156759990|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
156759991|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
156759992|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
156759993|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
156759994|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
156759995|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
156759996|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
156759997|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
156759998|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
156759999|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
156760000|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
156760001|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760002|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760003|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760004|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760005|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760006|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760007|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760008|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760009|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760010|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760011|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
156760012|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
156760013|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156760014|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156760015|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
156760016|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760017|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760018|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760019|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760020|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760021|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760022|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760023|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760024|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760025|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760026|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156760027|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760028|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156760029|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760030|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156760031|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760032|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760033|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760034|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760035|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760036|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760037|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760038|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760039|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760040|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760041|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760042|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
156760043|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760044|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760045|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156760046|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760047|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760048|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
157104212|NCT02129205|567136452|FG009|Overall Study|Other|0|||
157104213|NCT02877927|567136453|FG000|Overall Study|Adverse Event|1|||
157104214|NCT02877927|567136454|FG001|Overall Study|Adverse Event|0|||
157104215|NCT02877927|567136453|FG000|Overall Study|Lost to Follow-up|37|||
157104216|NCT02877927|567136454|FG001|Overall Study|Lost to Follow-up|38|||
157104217|NCT02877927|567136453|FG000|Overall Study|Withdrawal by Subject|11|||
157104218|NCT02877927|567136454|FG001|Overall Study|Withdrawal by Subject|12|||
157104219|NCT02877927|567136453|FG000|Overall Study|Physician Decision|0|||
157104220|NCT02877927|567136454|FG001|Overall Study|Physician Decision|1|||
157104221|NCT02877927|567136453|FG000|Overall Study|Missed EOT/PTE Visit|5|||
157104222|NCT02877927|567136454|FG001|Overall Study|Missed EOT/PTE Visit|6|||
157104223|NCT00601250|567136455|FG000|Overall Study|Adverse Event|3|||
157104224|NCT00601250|567136456|FG001|Overall Study|Adverse Event|9|||
157104225|NCT00601250|567136455|FG000|Overall Study|Protocol Violation|3|||
157104226|NCT00601250|567136456|FG001|Overall Study|Protocol Violation|2|||
157001409|NCT02377362|566754260|FG006|Part A Second Treatment|Protocol Violation|0|||
157001410|NCT02377362|566754261|FG007|Part A Second Treatment|Protocol Violation|0|||
157001411|NCT02377362|566754262|FG008|Part A Second Treatment|Protocol Violation|0|||
157001412|NCT02377362|566754263|FG009|Part A Second Treatment|Protocol Violation|0|||
157001413|NCT02377362|566754264|FG010|Part A Second Treatment|Protocol Violation|0|||
157001414|NCT02377362|566754265|FG011|Part A Second Treatment|Protocol Violation|0|||
157001415|NCT02377362|566754266|FG012|Part A Second Treatment|Protocol Violation|0|||
157001416|NCT02377362|566754254|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001417|NCT02377362|566754255|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001418|NCT02377362|566754256|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001419|NCT02377362|566754257|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
157001420|NCT02377362|566754258|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
157001421|NCT02377362|566754259|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
157001422|NCT02377362|566754260|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001423|NCT02377362|566754261|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001424|NCT02377362|566754262|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001425|NCT02377362|566754263|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001426|NCT02377362|566754264|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001427|NCT02377362|566754265|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001428|NCT02377362|566754266|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
157001429|NCT02377362|566754254|FG000|Part B Overall|Protocol Violation|0|||
157001430|NCT02377362|566754255|FG001|Part B Overall|Protocol Violation|0|||
157001431|NCT02377362|566754256|FG002|Part B Overall|Protocol Violation|0|||
157001432|NCT02377362|566754257|FG003|Part B Overall|Protocol Violation|0|||
157001433|NCT02377362|566754258|FG004|Part B Overall|Protocol Violation|0|||
157001434|NCT02377362|566754259|FG005|Part B Overall|Protocol Violation|0|||
157001435|NCT02377362|566754260|FG006|Part B Overall|Protocol Violation|0|||
157001436|NCT02377362|566754261|FG007|Part B Overall|Protocol Violation|0|||
157001437|NCT02377362|566754262|FG008|Part B Overall|Protocol Violation|0|||
157001438|NCT02377362|566754263|FG009|Part B Overall|Protocol Violation|1|||
157001439|NCT02377362|566754264|FG010|Part B Overall|Protocol Violation|0|||
157001440|NCT02377362|566754265|FG011|Part B Overall|Protocol Violation|0|||
157001441|NCT02377362|566754266|FG012|Part B Overall|Protocol Violation|0|||
157001442|NCT02377362|566754254|FG000|Part B Overall|Adverse Event|0|||
157001443|NCT02377362|566754255|FG001|Part B Overall|Adverse Event|0|||
157001444|NCT02377362|566754256|FG002|Part B Overall|Adverse Event|0|||
157001445|NCT02377362|566754257|FG003|Part B Overall|Adverse Event|0|||
157001446|NCT02377362|566754258|FG004|Part B Overall|Adverse Event|0|||
157001447|NCT02377362|566754259|FG005|Part B Overall|Adverse Event|0|||
157001448|NCT02377362|566754260|FG006|Part B Overall|Adverse Event|1|||
157001449|NCT02377362|566754261|FG007|Part B Overall|Adverse Event|1|||
157001450|NCT02377362|566754262|FG008|Part B Overall|Adverse Event|0|||
157001451|NCT02377362|566754263|FG009|Part B Overall|Adverse Event|0|||
157001452|NCT02377362|566754264|FG010|Part B Overall|Adverse Event|0|||
157001453|NCT02377362|566754265|FG011|Part B Overall|Adverse Event|0|||
157001454|NCT02377362|566754266|FG012|Part B Overall|Adverse Event|0|||
157001455|NCT02377362|566754254|FG000|Part B Overall|Withdrawal by Subject|0|||
157001456|NCT02377362|566754255|FG001|Part B Overall|Withdrawal by Subject|0|||
157001457|NCT02377362|566754256|FG002|Part B Overall|Withdrawal by Subject|0|||
157001458|NCT02377362|566754257|FG003|Part B Overall|Withdrawal by Subject|0|||
157104227|NCT00601250|567136455|FG000|Overall Study|Lost to Follow-up|2|||
157001459|NCT02377362|566754258|FG004|Part B Overall|Withdrawal by Subject|0|||
157001460|NCT02377362|566754259|FG005|Part B Overall|Withdrawal by Subject|0|||
157001461|NCT02377362|566754260|FG006|Part B Overall|Withdrawal by Subject|1|||
157001462|NCT02377362|566754261|FG007|Part B Overall|Withdrawal by Subject|0|||
157104228|NCT00601250|567136456|FG001|Overall Study|Lost to Follow-up|6|||
157104229|NCT00601250|567136455|FG000|Overall Study|Withdrawal by Subject|4|||
157104230|NCT00601250|567136456|FG001|Overall Study|Withdrawal by Subject|13|||
157104231|NCT00601250|567136455|FG000|Overall Study|Other incl. lack of efficacy|2|||
157104232|NCT00601250|567136456|FG001|Overall Study|Other incl. lack of efficacy|9|||
157104233|NCT04376060|567136457|FG000|Overall Study|Physician Decision|1|||
157104234|NCT01791803|567136458|FG000|Overall Study|Withdrawal by Subject|0|||
157104235|NCT01791803|567136459|FG001|Overall Study|Withdrawal by Subject|0|||
157104236|NCT01791803|567136460|FG002|Overall Study|Withdrawal by Subject|0|||
157104237|NCT01791803|567136461|FG003|Overall Study|Withdrawal by Subject|2|||
157104238|NCT01791803|567136458|FG000|Overall Study|Physician Decision|0|||
156760049|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
157001463|NCT02377362|566754262|FG008|Part B Overall|Withdrawal by Subject|0|||
157104239|NCT01791803|567136459|FG001|Overall Study|Physician Decision|2|||
157104240|NCT01791803|567136460|FG002|Overall Study|Physician Decision|0|||
157104241|NCT01791803|567136461|FG003|Overall Study|Physician Decision|1|||
157104242|NCT01791803|567136458|FG000|Overall Study|Death|0|||
157104243|NCT01791803|567136459|FG001|Overall Study|Death|0|||
157104244|NCT01791803|567136460|FG002|Overall Study|Death|2|||
157104245|NCT01791803|567136461|FG003|Overall Study|Death|2|||
157104246|NCT04572854|567136462|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
157104247|NCT04572854|567136463|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
157104248|NCT04572854|567136464|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
157104249|NCT04572854|567136465|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
157104250|NCT04572854|567136462|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
157104251|NCT04572854|567136463|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
157104252|NCT04572854|567136464|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
157104253|NCT04572854|567136465|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
157104254|NCT00972777|567136468|FG000|Overall Study|Adverse Event|3|||
157104255|NCT00972777|567136469|FG001|Overall Study|Adverse Event|2|||
157104256|NCT00972777|567136468|FG000|Overall Study|Lost to Follow-up|0|||
157104257|NCT00972777|567136469|FG001|Overall Study|Lost to Follow-up|4|||
157104258|NCT00972777|567136468|FG000|Overall Study|Withdrawal by Subject|4|||
157104259|NCT00972777|567136469|FG001|Overall Study|Withdrawal by Subject|5|||
157104260|NCT00972777|567136468|FG000|Overall Study|Physician Decision|4|||
157104261|NCT00972777|567136469|FG001|Overall Study|Physician Decision|0|||
157104262|NCT00972777|567136468|FG000|Overall Study|Protocol Violation|0|||
157104263|NCT00972777|567136469|FG001|Overall Study|Protocol Violation|2|||
157104264|NCT00972777|567136468|FG000|Overall Study|Screening Failure|2|||
157104265|NCT00972777|567136469|FG001|Overall Study|Screening Failure|1|||
157104266|NCT00972777|567136468|FG000|Overall Study|Missed visit|1|||
157104267|NCT00972777|567136469|FG001|Overall Study|Missed visit|0|||
157104268|NCT07052682|567136472|FG000|Overall Study|Withdrawal by Subject|4|||
157104269|NCT02229539|567137884|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
157001464|NCT02377362|566754263|FG009|Part B Overall|Withdrawal by Subject|0|||
157001465|NCT02377362|566754264|FG010|Part B Overall|Withdrawal by Subject|0|||
157001466|NCT02377362|566754265|FG011|Part B Overall|Withdrawal by Subject|1|||
157001467|NCT02377362|566754266|FG012|Part B Overall|Withdrawal by Subject|0|||
157001468|NCT01585038|566754267|FG000|Overall Study|Adverse Event|2|||
157001469|NCT01585038|566754268|FG001|Overall Study|Adverse Event|2|||
157001470|NCT02750709|566754271|FG000|Treatment Period 1|Adverse Event|0|||
157001471|NCT02750709|566754272|FG001|Treatment Period 1|Adverse Event|0|||
157001472|NCT02750709|566754273|FG002|Treatment Period 1|Adverse Event|0|||
157001473|NCT02750709|566754274|FG003|Treatment Period 1|Adverse Event|0|||
157001474|NCT02750709|566754275|FG004|Treatment Period 1|Adverse Event|0|||
157001475|NCT02750709|566754276|FG005|Treatment Period 1|Adverse Event|1|||
157001476|NCT01120275|566754279|FG000|Overall Study|Adverse Event|3|||
157001477|NCT01120275|566754279|FG000|Overall Study|Progression|27|||
157001478|NCT01120275|566754279|FG000|Overall Study|Ineligible|3|||
157104270|NCT02229539|567137885|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
157104271|NCT02229539|567137886|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
157104272|NCT02229539|567137884|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
157104273|NCT02229539|567137885|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
157104274|NCT02229539|567137886|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
157104275|NCT02229539|567137884|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
157104276|NCT02229539|567137885|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
157104277|NCT02229539|567137886|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
157104278|NCT02229539|567137884|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
157104279|NCT02229539|567137885|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
157104280|NCT02229539|567137886|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
157104281|NCT02229539|567137884|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
157104282|NCT02229539|567137885|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
157104283|NCT02229539|567137886|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
157104284|NCT02229539|567137884|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
156760050|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760051|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760052|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760053|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760054|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760055|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760056|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156760057|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760058|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
157104285|NCT02229539|567137885|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
157104286|NCT02229539|567137886|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
157104287|NCT02060383|567137887|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
157104288|NCT02060383|567137888|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
157104289|NCT02060383|567137889|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
157104290|NCT02060383|567137890|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
157104291|NCT02060383|567137891|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
157104292|NCT02060383|567137887|FG000|Core Phase|Adverse Event|2|||
157104293|NCT02060383|567137888|FG001|Core Phase|Adverse Event|0|||
157104294|NCT02060383|567137889|FG002|Core Phase|Adverse Event|0|||
157104295|NCT02060383|567137890|FG003|Core Phase|Adverse Event|2|||
157104296|NCT02060383|567137891|FG004|Core Phase|Adverse Event|6|||
157104297|NCT02060383|567137887|FG000|Core Phase|Administrative problems|0|||
157104298|NCT02060383|567137888|FG001|Core Phase|Administrative problems|1|||
157104299|NCT02060383|567137889|FG002|Core Phase|Administrative problems|0|||
157104300|NCT02060383|567137890|FG003|Core Phase|Administrative problems|0|||
157104301|NCT02060383|567137891|FG004|Core Phase|Administrative problems|0|||
157104302|NCT02060383|567137887|FG000|Core Phase|Protocol Violation|0|||
157104303|NCT02060383|567137888|FG001|Core Phase|Protocol Violation|0|||
157104304|NCT02060383|567137889|FG002|Core Phase|Protocol Violation|0|||
157104305|NCT02060383|567137890|FG003|Core Phase|Protocol Violation|1|||
157104306|NCT02060383|567137891|FG004|Core Phase|Protocol Violation|0|||
157104307|NCT02060383|567137887|FG000|Core Phase|Withdrawal by Subject|0|||
157104308|NCT02060383|567137888|FG001|Core Phase|Withdrawal by Subject|0|||
157104309|NCT02060383|567137889|FG002|Core Phase|Withdrawal by Subject|0|||
157104310|NCT02060383|567137890|FG003|Core Phase|Withdrawal by Subject|4|||
157104311|NCT02060383|567137891|FG004|Core Phase|Withdrawal by Subject|2|||
157104312|NCT02060383|567137887|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
157104313|NCT02060383|567137888|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
157104314|NCT02060383|567137889|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
157104315|NCT02060383|567137890|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
157104316|NCT02060383|567137891|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
157104317|NCT02060383|567137887|FG000|Extension Phase|Adverse Event|1|||
157104318|NCT02060383|567137888|FG001|Extension Phase|Adverse Event|1|||
157104319|NCT02060383|567137889|FG002|Extension Phase|Adverse Event|2|||
157104320|NCT02060383|567137890|FG003|Extension Phase|Adverse Event|0|||
157104321|NCT02060383|567137891|FG004|Extension Phase|Adverse Event|1|||
157104322|NCT02060383|567137887|FG000|Extension Phase|Withdrawal by Subject|0|||
157104323|NCT02060383|567137888|FG001|Extension Phase|Withdrawal by Subject|1|||
157104324|NCT02060383|567137889|FG002|Extension Phase|Withdrawal by Subject|0|||
157104325|NCT02060383|567137890|FG003|Extension Phase|Withdrawal by Subject|0|||
157104326|NCT02060383|567137891|FG004|Extension Phase|Withdrawal by Subject|2|||
157104327|NCT02060383|567137887|FG000|Extension Phase|Administrative problems|1|||
157104328|NCT02060383|567137888|FG001|Extension Phase|Administrative problems|0|||
157104329|NCT02060383|567137889|FG002|Extension Phase|Administrative problems|0|||
157104330|NCT02060383|567137890|FG003|Extension Phase|Administrative problems|0|||
157104331|NCT02060383|567137891|FG004|Extension Phase|Administrative problems|0|||
157104332|NCT02060383|567137887|FG000|Extension Phase|Death|0|||
157104333|NCT02060383|567137888|FG001|Extension Phase|Death|0|||
156760059|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156760060|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156760061|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760062|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
157104334|NCT02060383|567137889|FG002|Extension Phase|Death|1|||
156760063|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760064|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760065|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760066|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
157104335|NCT02060383|567137890|FG003|Extension Phase|Death|0|||
157104336|NCT02060383|567137891|FG004|Extension Phase|Death|1|||
157104337|NCT02060383|567137887|FG000|Extension Phase|Protocol Violation|0|||
157104338|NCT02060383|567137888|FG001|Extension Phase|Protocol Violation|0|||
156760067|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
157104339|NCT02060383|567137889|FG002|Extension Phase|Protocol Violation|0|||
156760068|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760069|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760070|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760071|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760072|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
156760073|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760074|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156760075|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
156760076|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760077|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760078|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760079|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760080|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760081|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760082|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760083|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760084|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760085|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760086|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760087|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
156760088|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156760089|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156760090|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156760091|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760092|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760093|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
157001479|NCT01120275|566754279|FG000|Overall Study|Withdrawal by Subject|1|||
157001480|NCT01120275|566754279|FG000|Overall Study|Refusal|1|||
157001481|NCT01120275|566754279|FG000|Overall Study|Not specific|1|||
157001482|NCT00290732|566754281|FG000|Overall Study|Inability to instill drug intraductally.|0|||
157001483|NCT00290732|566754282|FG001|Overall Study|Inability to instill drug intraductally.|1|||
157001484|NCT00290732|566754283|FG002|Overall Study|Inability to instill drug intraductally.|1|||
157001485|NCT00290732|566754284|FG003|Overall Study|Inability to instill drug intraductally.|0|||
157001486|NCT00290732|566754285|FG004|Overall Study|Inability to instill drug intraductally.|0|||
157001487|NCT02736799|566754286|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
157001488|NCT02736799|566754287|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
157001489|NCT02736799|566754288|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
157001490|NCT02736799|566754289|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
157001491|NCT01833832|566754290|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
157001492|NCT01156116|566754291|FG000|Overall Study|Withdrawal by Subject|3|||
157001493|NCT01156116|566754292|FG001|Overall Study|Withdrawal by Subject|1|||
157001494|NCT01156116|566754291|FG000|Overall Study|CPAP intolerance|2|||
157001495|NCT01156116|566754292|FG001|Overall Study|CPAP intolerance|0|||
157001496|NCT00843193|566754293|FG000|Overall Study|Adverse Event|2|||
157001497|NCT00843193|566754294|FG001|Overall Study|Adverse Event|4|||
157001498|NCT00843193|566754293|FG000|Overall Study|Lack of Efficacy|1|||
157001499|NCT00843193|566754294|FG001|Overall Study|Lack of Efficacy|1|||
157001500|NCT00843193|566754293|FG000|Overall Study|Protocol Violation|1|||
157001501|NCT00843193|566754294|FG001|Overall Study|Protocol Violation|2|||
157001502|NCT00843193|566754293|FG000|Overall Study|Lost to Follow-up|1|||
157001503|NCT00843193|566754294|FG001|Overall Study|Lost to Follow-up|0|||
157001504|NCT00843193|566754293|FG000|Overall Study|Physician Decision|0|||
157001505|NCT00843193|566754294|FG001|Overall Study|Physician Decision|1|||
157001506|NCT00843193|566754293|FG000|Overall Study|Withdrawal by Subject|3|||
157001507|NCT00843193|566754294|FG001|Overall Study|Withdrawal by Subject|3|||
157001508|NCT00542386|566754295|FG000|Overall Study|Adverse Event|1|||
157001509|NCT00542386|566754296|FG001|Overall Study|Adverse Event|7|||
157001510|NCT00542386|566754297|FG002|Overall Study|Adverse Event|7|||
157001511|NCT00542386|566754298|FG003|Overall Study|Adverse Event|8|||
157001512|NCT00542386|566754299|FG004|Overall Study|Adverse Event|13|||
157001513|NCT00542386|566754300|FG005|Overall Study|Adverse Event|4|||
157001514|NCT00542386|566754295|FG000|Overall Study|Death|0|||
157001515|NCT00542386|566754296|FG001|Overall Study|Death|0|||
157001516|NCT00542386|566754297|FG002|Overall Study|Death|1|||
157001517|NCT00542386|566754298|FG003|Overall Study|Death|2|||
157001518|NCT00542386|566754299|FG004|Overall Study|Death|1|||
157001519|NCT00542386|566754300|FG005|Overall Study|Death|2|||
157001520|NCT00542386|566754295|FG000|Overall Study|Lack of Efficacy|32|||
157001521|NCT00542386|566754296|FG001|Overall Study|Lack of Efficacy|12|||
157001522|NCT00542386|566754297|FG002|Overall Study|Lack of Efficacy|10|||
157104340|NCT02060383|567137890|FG003|Extension Phase|Protocol Violation|0|||
157104341|NCT02060383|567137891|FG004|Extension Phase|Protocol Violation|1|||
157104342|NCT03441334|567137892|FG000|Overall Study|Withdrawal by Subject|1|||
157104343|NCT03441334|567137893|FG001|Overall Study|Withdrawal by Subject|0|||
157104344|NCT00088907|567137894|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
157104345|NCT00088907|567137895|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
157104346|NCT00088907|567137894|FG000|Randomized Study (Step 1)|Adverse Event|14|||
157104347|NCT00088907|567137895|FG001|Randomized Study (Step 1)|Adverse Event|19|||
157104348|NCT00088907|567137894|FG000|Randomized Study (Step 1)|Death|11|||
157104349|NCT00088907|567137895|FG001|Randomized Study (Step 1)|Death|12|||
157104350|NCT00088907|567137894|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
157104351|NCT00088907|567137895|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
157104352|NCT00088907|567137894|FG000|Randomized Study (Step 1)|complicating disease|3|||
157104353|NCT00088907|567137895|FG001|Randomized Study (Step 1)|complicating disease|1|||
157104354|NCT00088907|567137894|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
157104355|NCT00088907|567137895|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
157104356|NCT00088907|567137894|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
157104357|NCT00088907|567137895|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
157104358|NCT00088907|567137894|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
157104359|NCT00088907|567137895|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
157104360|NCT00088907|567137894|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
157104361|NCT00088907|567137895|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
157104362|NCT00088907|567137894|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
157104363|NCT00088907|567137895|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
157104364|NCT00088907|567137894|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
157104365|NCT00088907|567137895|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
157104366|NCT03426787|567137900|FG000|Overall Study|Withdrawal by Subject|6|||
157104367|NCT03426787|567137900|FG000|Overall Study|Lost to Follow-up|7|||
157104368|NCT03426787|567137900|FG000|Overall Study|Unrelated to intervention death|1|||
157104369|NCT00257166|567137904|FG000|Overall Study|Adverse Event|18|||
157104370|NCT00257166|567137905|FG001|Overall Study|Adverse Event|13|||
157104371|NCT00257166|567137904|FG000|Overall Study|Laboratory abnormality|1|||
157104372|NCT00257166|567137905|FG001|Overall Study|Laboratory abnormality|0|||
157104373|NCT00257166|567137904|FG000|Overall Study|Lost to Follow-up|8|||
157104374|NCT00257166|567137905|FG001|Overall Study|Lost to Follow-up|1|||
157104375|NCT00257166|567137904|FG000|Overall Study|Withdrawal by Subject|9|||
157104376|NCT00257166|567137905|FG001|Overall Study|Withdrawal by Subject|2|||
157104377|NCT00257166|567137904|FG000|Overall Study|Other|16|||
157104378|NCT00257166|567137905|FG001|Overall Study|Other|21|||
157104379|NCT00257166|567137904|FG000|Overall Study|Randomized, but not treated|1|||
157104380|NCT00257166|567137905|FG001|Overall Study|Randomized, but not treated|0|||
157104381|NCT02592551|567137906|FG000|Overall Study|Not evaluable|1|||
157104382|NCT02592551|567137907|FG001|Overall Study|Not evaluable|3|||
157104383|NCT02592551|567137908|FG002|Overall Study|Not evaluable|0|||
157104384|NCT02553265|567137910|FG000|Enrollment|Death|0|||
157104385|NCT02553265|567137911|FG001|Enrollment|Death|0|||
157104386|NCT02553265|567137912|FG002|Enrollment|Death|1|||
157104387|NCT02553265|567137910|FG000|First Intervention (28 Days)|Adverse Event|1|||
157104388|NCT02553265|567137911|FG001|First Intervention (28 Days)|Adverse Event|0|||
157104389|NCT02553265|567137912|FG002|First Intervention (28 Days)|Adverse Event|0|||
157104390|NCT02553265|567137910|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
157104391|NCT02553265|567137911|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
157104392|NCT02553265|567137912|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
157104393|NCT02553265|567137910|FG000|Second Intervention (28 Days)|Adverse Event|1|||
157104394|NCT02553265|567137911|FG001|Second Intervention (28 Days)|Adverse Event|0|||
157104395|NCT02553265|567137912|FG002|Second Intervention (28 Days)|Adverse Event|0|||
157104396|NCT02553265|567137910|FG000|Third Intervention (28 Days)|Adverse Event|1|||
156760094|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760095|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760096|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760097|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760098|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
157104397|NCT02553265|567137911|FG001|Third Intervention (28 Days)|Adverse Event|0|||
157104398|NCT02553265|567137912|FG002|Third Intervention (28 Days)|Adverse Event|0|||
157104399|NCT02553265|567137910|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
157104400|NCT02553265|567137911|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
157104401|NCT02553265|567137912|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
157104402|NCT00908583|567137917|FG000|Phase 1|Withdrawal by Subject|1|||
157104403|NCT00908583|567137917|FG000|Phase 1|Adverse Event|4|||
157104404|NCT00908583|567137917|FG000|Phase 2|Physician Decision|1|||
157104405|NCT00908583|567137917|FG000|Phase 2|Adverse Event|1|||
157104406|NCT00908583|567137917|FG000|Phase 3|Adverse Event|2|||
157104407|NCT00908583|567137917|FG000|Phase 4|Adverse Event|1|||
156760099|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
157104408|NCT00908583|567137917|FG000|Phase 4|Physician Decision|1|||
156760100|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
157104409|NCT00908583|567137917|FG000|Phase 5|Adverse Event|3|||
157104410|NCT00993954|567137918|FG000|Overall Study|Protocol Violation|21|||
157104411|NCT00993954|567137919|FG001|Overall Study|Protocol Violation|2|||
157104412|NCT00860951|567137922|FG000|Overall Study|Withdrawal by Subject|2|||
157104413|NCT00860951|567137922|FG000|Overall Study|Lost to Follow-up|5|||
156760101|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760102|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
156760103|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
157104414|NCT00659529|567137928|FG000|Overall Study|Withdrawal by Subject|4|||
157104415|NCT00659529|567137928|FG000|Overall Study|Protocol Violation|3|||
157104416|NCT00659529|567137928|FG000|Overall Study|Screen failure|9|||
157104417|NCT00283049|567137934|FG000|Overall Study|Adverse Event|6|||
156760104|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760105|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
156760106|NCT02326272|565873862|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760107|NCT02326272|565873863|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760108|NCT02326272|565873864|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760109|NCT02326272|565873865|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760110|NCT02326272|565873866|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760111|NCT02326272|565873867|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760112|NCT02326272|565873868|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760113|NCT02326272|565873869|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760114|NCT02326272|565873870|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760115|NCT02326272|565873871|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760116|NCT02326272|565873872|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760117|NCT02326272|565873873|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760118|NCT02326272|565873874|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
156760119|NCT02326272|565873875|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760120|NCT02326272|565873876|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
156760121|NCT00737100|565873877|FG000|Overall Study|Adverse Event|6|||
156760122|NCT00737100|565873878|FG001|Overall Study|Adverse Event|5|||
156760123|NCT00737100|565873879|FG002|Overall Study|Adverse Event|3|||
156760124|NCT00737100|565873877|FG000|Overall Study|Lost to Follow-up|0|||
156760125|NCT00737100|565873878|FG001|Overall Study|Lost to Follow-up|1|||
156760126|NCT00737100|565873879|FG002|Overall Study|Lost to Follow-up|0|||
156760127|NCT00737100|565873877|FG000|Overall Study|Withdrawal by Subject|0|||
156760128|NCT00737100|565873878|FG001|Overall Study|Withdrawal by Subject|0|||
156760129|NCT00737100|565873879|FG002|Overall Study|Withdrawal by Subject|3|||
156760130|NCT00737100|565873877|FG000|Overall Study|Reason discontinued not explained above|1|||
156760131|NCT00737100|565873878|FG001|Overall Study|Reason discontinued not explained above|1|||
156760132|NCT00737100|565873879|FG002|Overall Study|Reason discontinued not explained above|1|||
156760133|NCT00735943|565873884|FG000|Overall Study|Lost to Follow-up|1|||
156760134|NCT00735943|565873884|FG000|Overall Study|Adverse Event|1|||
156760135|NCT00115778|565873887|FG000|Overall Study|Withdrawal by Subject|0|||
156760136|NCT00115778|565873888|FG001|Overall Study|Withdrawal by Subject|1|||
156760137|NCT01607593|565873889|FG000|Overall Study|Adverse Event|15|||
156760138|NCT01607593|565873889|FG000|Overall Study|Lack of Efficacy|16|||
156760139|NCT01607593|565873889|FG000|Overall Study|Lost to Follow-up|25|||
157104418|NCT00283049|567137935|FG001|Overall Study|Adverse Event|1|||
157104419|NCT00283049|567137936|FG002|Overall Study|Adverse Event|4|||
157104420|NCT00283049|567137934|FG000|Overall Study|Protocol Violation|3|||
156760140|NCT01607593|565873889|FG000|Overall Study|Continuation|33|||
156760141|NCT01607593|565873889|FG000|Overall Study|Other|4|||
156760142|NCT03713684|565873894|FG000|Overall Study|Adverse Event|1|||
156760143|NCT03713684|565873895|FG001|Overall Study|Adverse Event|3|||
156760144|NCT03713684|565873896|FG002|Overall Study|Adverse Event|1|||
156760145|NCT03713684|565873897|FG003|Overall Study|Adverse Event|0|||
156760146|NCT03713684|565873894|FG000|Overall Study|Poor compliance to protocol|2|||
157104421|NCT00283049|567137935|FG001|Overall Study|Protocol Violation|0|||
157104422|NCT00283049|567137936|FG002|Overall Study|Protocol Violation|3|||
157104423|NCT00283049|567137934|FG000|Overall Study|Death|1|||
156760147|NCT03713684|565873895|FG001|Overall Study|Poor compliance to protocol|1|||
156760148|NCT03713684|565873896|FG002|Overall Study|Poor compliance to protocol|0|||
156760149|NCT03713684|565873897|FG003|Overall Study|Poor compliance to protocol|1|||
156760150|NCT03713684|565873894|FG000|Overall Study|Withdrawal by Subject|14|||
156760151|NCT03713684|565873895|FG001|Overall Study|Withdrawal by Subject|6|||
156760152|NCT03713684|565873896|FG002|Overall Study|Withdrawal by Subject|14|||
157104424|NCT00283049|567137935|FG001|Overall Study|Death|1|||
157104425|NCT00283049|567137936|FG002|Overall Study|Death|1|||
157104426|NCT00283049|567137934|FG000|Overall Study|Lack of Efficacy|0|||
157104427|NCT00283049|567137935|FG001|Overall Study|Lack of Efficacy|1|||
157104428|NCT00283049|567137936|FG002|Overall Study|Lack of Efficacy|1|||
157104429|NCT00283049|567137934|FG000|Overall Study|Lost to Follow-up|4|||
156760153|NCT03713684|565873897|FG003|Overall Study|Withdrawal by Subject|16|||
156760154|NCT03713684|565873894|FG000|Overall Study|Other than specified|69|||
156760155|NCT03713684|565873895|FG001|Overall Study|Other than specified|77|||
156760156|NCT03713684|565873896|FG002|Overall Study|Other than specified|73|||
156760157|NCT03713684|565873897|FG003|Overall Study|Other than specified|70|||
156760158|NCT00528424|565873898|FG000|Overall Study|Lost to Follow-up|13|||
156760159|NCT00528424|565873898|FG000|Overall Study|Withdrew consent|2|||
156760160|NCT00528424|565873898|FG000|Overall Study|Administrative reason|2|||
156760161|NCT00528424|565873898|FG000|Overall Study|Other|12|||
156760162|NCT02515630|565873899|FG000|Overall Study|Withdrawal by Subject|5|||
156760163|NCT02515630|565873899|FG000|Overall Study|Adverse Event|4|||
156760164|NCT02515630|565873899|FG000|Overall Study|Physician Decision|4|||
156760165|NCT02515630|565873899|FG000|Overall Study|Death|2|||
156760166|NCT02515630|565873899|FG000|Overall Study|Disease Progression|1|||
156760167|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
156760168|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
156760169|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
156760170|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Death|0|||
156760171|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Death|1|||
156760172|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Death|0|||
156760173|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
156760174|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
156760175|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
156760176|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
156760177|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
156760178|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
156760179|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156760180|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156760181|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156760182|NCT01064414|565873902|FG000|Core Period: Baseline to Week 26|Other|4|||
156760183|NCT01064414|565873903|FG001|Core Period: Baseline to Week 26|Other|7|||
156760184|NCT01064414|565873904|FG002|Core Period: Baseline to Week 26|Other|2|||
156760185|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156760186|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156760187|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
156760188|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Death|0|||
156760189|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Death|1|||
156760190|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156760191|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
156760192|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156760193|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156760194|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
156760195|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156760196|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156760197|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156760198|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156760199|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156760200|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
156760201|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156760202|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156760203|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760204|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760205|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156760206|NCT01064414|565873902|FG000|Extension Period: Week 26 to Week 52|Other|5|||
156760207|NCT01064414|565873903|FG001|Extension Period: Week 26 to Week 52|Other|2|||
156760208|NCT01064414|565873904|FG002|Extension Period: Week 26 to Week 52|Other|1|||
156760209|NCT02185417|565873905|FG000|Overall Study|Death|448|||
156760210|NCT02185417|565873906|FG001|Overall Study|Death|446|||
156760211|NCT02185417|565873907|FG002|Overall Study|Death|0|||
156760212|NCT02185417|565873905|FG000|Overall Study|Withdrawal by Subject|7|||
156760213|NCT02185417|565873906|FG001|Overall Study|Withdrawal by Subject|12|||
156760214|NCT02185417|565873907|FG002|Overall Study|Withdrawal by Subject|0|||
156760215|NCT02595502|565873910|FG000|Period 1|Adverse Event|0|||
156760216|NCT02595502|565873911|FG001|Period 1|Adverse Event|1|||
156760217|NCT02595502|565873910|FG000|Period 1|Withdrawal by Subject|1|||
156760218|NCT02595502|565873911|FG001|Period 1|Withdrawal by Subject|0|||
156760219|NCT02595502|565873910|FG000|Period 1|Lost to Follow-up|0|||
156760220|NCT02595502|565873911|FG001|Period 1|Lost to Follow-up|1|||
156760221|NCT02595502|565873910|FG000|Period 2|Adverse Event|1|||
156760222|NCT02595502|565873911|FG001|Period 2|Adverse Event|1|||
156760223|NCT02595502|565873910|FG000|Period 2|Received incorrect lens at Period 1|0|||
157001523|NCT00542386|566754298|FG003|Overall Study|Lack of Efficacy|13|||
157104430|NCT00283049|567137935|FG001|Overall Study|Lost to Follow-up|2|||
157104431|NCT00283049|567137936|FG002|Overall Study|Lost to Follow-up|5|||
157104432|NCT00283049|567137934|FG000|Overall Study|Withdrawal by Subject|26|||
157104433|NCT00283049|567137935|FG001|Overall Study|Withdrawal by Subject|24|||
157104434|NCT00283049|567137936|FG002|Overall Study|Withdrawal by Subject|19|||
157104435|NCT00283049|567137934|FG000|Overall Study|Discontinuation of Study|18|||
157104436|NCT00283049|567137935|FG001|Overall Study|Discontinuation of Study|16|||
157104437|NCT00283049|567137936|FG002|Overall Study|Discontinuation of Study|20|||
157104438|NCT00283049|567137934|FG000|Overall Study|No longer requires study treatment|0|||
157104439|NCT00283049|567137935|FG001|Overall Study|No longer requires study treatment|0|||
157104440|NCT00283049|567137936|FG002|Overall Study|No longer requires study treatment|1|||
157104441|NCT01950247|567137937|FG000|Overall Study|Withdrawal by Subject|28|||
157104442|NCT01950247|567137938|FG001|Overall Study|Withdrawal by Subject|13|||
157104443|NCT01950247|567137937|FG000|Overall Study|Lost to Follow-up|18|||
157104444|NCT01950247|567137938|FG001|Overall Study|Lost to Follow-up|16|||
157104445|NCT01950247|567137937|FG000|Overall Study|Physician Decision|3|||
157104446|NCT01950247|567137938|FG001|Overall Study|Physician Decision|4|||
157104447|NCT01950247|567137937|FG000|Overall Study|Adverse Event|3|||
157104448|NCT01950247|567137938|FG001|Overall Study|Adverse Event|2|||
157104449|NCT01950247|567137937|FG000|Overall Study|Death|1|||
157104450|NCT01950247|567137938|FG001|Overall Study|Death|1|||
157104451|NCT01950247|567137937|FG000|Overall Study|Not Defined|4|||
157104452|NCT01950247|567137938|FG001|Overall Study|Not Defined|10|||
157104453|NCT00763971|567137941|FG000|Overall Study|Adverse Event|5|||
157104454|NCT00763971|567137942|FG001|Overall Study|Adverse Event|2|||
157104455|NCT00763971|567137943|FG002|Overall Study|Adverse Event|4|||
157104456|NCT00763971|567137941|FG000|Overall Study|Protocol Violation|3|||
157104457|NCT00763971|567137942|FG001|Overall Study|Protocol Violation|3|||
157104458|NCT00763971|567137943|FG002|Overall Study|Protocol Violation|2|||
157104459|NCT00763971|567137941|FG000|Overall Study|Withdrawal by Subject|4|||
157104460|NCT00763971|567137942|FG001|Overall Study|Withdrawal by Subject|5|||
157104461|NCT00763971|567137943|FG002|Overall Study|Withdrawal by Subject|5|||
157104462|NCT00763971|567137941|FG000|Overall Study|Lost to Follow-up|0|||
157104463|NCT00763971|567137942|FG001|Overall Study|Lost to Follow-up|1|||
157104464|NCT00763971|567137943|FG002|Overall Study|Lost to Follow-up|0|||
157104465|NCT00763971|567137941|FG000|Overall Study|Lack of Efficacy|11|||
157104466|NCT00763971|567137942|FG001|Overall Study|Lack of Efficacy|22|||
157104467|NCT00763971|567137943|FG002|Overall Study|Lack of Efficacy|54|||
157104468|NCT00763971|567137941|FG000|Overall Study|Unable to swallow capsule|2|||
157104469|NCT00763971|567137942|FG001|Overall Study|Unable to swallow capsule|1|||
157104470|NCT00763971|567137943|FG002|Overall Study|Unable to swallow capsule|1|||
157104471|NCT00763971|567137941|FG000|Overall Study|Personal reason|3|||
157104472|NCT00763971|567137942|FG001|Overall Study|Personal reason|0|||
157104473|NCT00763971|567137943|FG002|Overall Study|Personal reason|0|||
157104474|NCT00763971|567137941|FG000|Overall Study|Exclusion criteria met|1|||
157104475|NCT00763971|567137942|FG001|Overall Study|Exclusion criteria met|0|||
156760224|NCT02595502|565873911|FG001|Period 2|Received incorrect lens at Period 1|1|||
156760225|NCT02595502|565873910|FG000|Period 3|Protocol Violation|0|||
156760226|NCT02595502|565873911|FG001|Period 3|Protocol Violation|1|||
156760227|NCT02595502|565873910|FG000|Period 3|Lost to Follow-up|1|||
156760228|NCT02595502|565873911|FG001|Period 3|Lost to Follow-up|0|||
156760229|NCT02595502|565873910|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
156760230|NCT02595502|565873911|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
156760231|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
156760232|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
156760233|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Death|561|||
156760234|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Death|298|||
156760235|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
156760236|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
156760237|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
156760238|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
156760239|NCT00974311|565873912|FG000|DB Phase (up to 24 Months)|Other|1|||
156760240|NCT00974311|565873913|FG001|DB Phase (up to 24 Months)|Other|0|||
156760241|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Death|14|||
156760242|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Death|21|||
156760243|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
156760244|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
156760245|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Other|15|||
156760246|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Other|2|||
156760247|NCT00974311|565873912|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
156760248|NCT00974311|565873913|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
156760249|NCT03131167|565873914|FG000|Overall Study|Other (Unspecified)|0|||
156760250|NCT03131167|565873915|FG001|Overall Study|Other (Unspecified)|0|||
156760251|NCT03131167|565873916|FG002|Overall Study|Other (Unspecified)|0|||
156760252|NCT03131167|565873917|FG003|Overall Study|Other (Unspecified)|0|||
156760253|NCT03131167|565873918|FG004|Overall Study|Other (Unspecified)|0|||
156760254|NCT03131167|565873919|FG005|Overall Study|Other (Unspecified)|1|||
156760255|NCT03131167|565873920|FG006|Overall Study|Other (Unspecified)|0|||
156760256|NCT03131167|565873921|FG007|Overall Study|Other (Unspecified)|0|||
156760257|NCT03131167|565873922|FG008|Overall Study|Other (Unspecified)|0|||
156760258|NCT03131167|565873923|FG009|Overall Study|Other (Unspecified)|0|||
156760259|NCT03131167|565873924|FG010|Overall Study|Other (Unspecified)|0|||
156760260|NCT03131167|565873925|FG011|Overall Study|Other (Unspecified)|0|||
156760261|NCT03131167|565873926|FG012|Overall Study|Other (Unspecified)|0|||
156760262|NCT03286218|565873927|FG000|Qualification Phase Period 1|Adverse Event|1|||
156760263|NCT03286218|565873928|FG001|Qualification Phase Period 1|Adverse Event|0|||
156760264|NCT03286218|565873929|FG002|Qualification Phase Period 1|Adverse Event|0|||
156760265|NCT03286218|565873930|FG003|Qualification Phase Period 1|Adverse Event|0|||
156760266|NCT03286218|565873931|FG004|Qualification Phase Period 1|Adverse Event|0|||
156760267|NCT03286218|565873932|FG005|Qualification Phase Period 1|Adverse Event|0|||
156760268|NCT03286218|565873933|FG006|Qualification Phase Period 1|Adverse Event|0|||
156760269|NCT03286218|565873934|FG007|Qualification Phase Period 1|Adverse Event|0|||
156760270|NCT03286218|565873935|FG008|Qualification Phase Period 1|Adverse Event|0|||
156760271|NCT03286218|565873936|FG009|Qualification Phase Period 1|Adverse Event|0|||
156760272|NCT03286218|565873937|FG010|Qualification Phase Period 1|Adverse Event|0|||
156760273|NCT03286218|565873938|FG011|Qualification Phase Period 1|Adverse Event|0|||
156760274|NCT03286218|565873927|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760275|NCT03286218|565873928|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
156760276|NCT03286218|565873929|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
157001524|NCT00542386|566754299|FG004|Overall Study|Lack of Efficacy|7|||
157001525|NCT00542386|566754300|FG005|Overall Study|Lack of Efficacy|31|||
157001526|NCT00542386|566754295|FG000|Overall Study|Physician Decision|1|||
157001527|NCT00542386|566754296|FG001|Overall Study|Physician Decision|0|||
157001528|NCT00542386|566754297|FG002|Overall Study|Physician Decision|0|||
157001529|NCT00542386|566754298|FG003|Overall Study|Physician Decision|1|||
157001530|NCT00542386|566754299|FG004|Overall Study|Physician Decision|0|||
157001531|NCT00542386|566754300|FG005|Overall Study|Physician Decision|0|||
156760277|NCT03286218|565873930|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
157001532|NCT00542386|566754295|FG000|Overall Study|Protocol Violation|0|||
156760278|NCT03286218|565873931|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760279|NCT03286218|565873932|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760280|NCT03286218|565873933|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760281|NCT03286218|565873934|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760282|NCT03286218|565873935|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760283|NCT03286218|565873936|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760284|NCT03286218|565873937|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760285|NCT03286218|565873938|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
156760286|NCT03286218|565873927|FG000|Qualification Phase Period 2|Adverse Event|0|||
157001533|NCT00542386|566754296|FG001|Overall Study|Protocol Violation|0|||
157001534|NCT00542386|566754297|FG002|Overall Study|Protocol Violation|1|||
156760287|NCT03286218|565873928|FG001|Qualification Phase Period 2|Adverse Event|1|||
156760288|NCT03286218|565873929|FG002|Qualification Phase Period 2|Adverse Event|0|||
156760289|NCT03286218|565873930|FG003|Qualification Phase Period 2|Adverse Event|0|||
156760290|NCT03286218|565873931|FG004|Qualification Phase Period 2|Adverse Event|0|||
156760291|NCT03286218|565873932|FG005|Qualification Phase Period 2|Adverse Event|0|||
156760292|NCT03286218|565873933|FG006|Qualification Phase Period 2|Adverse Event|0|||
156760293|NCT03286218|565873934|FG007|Qualification Phase Period 2|Adverse Event|0|||
156760294|NCT03286218|565873935|FG008|Qualification Phase Period 2|Adverse Event|0|||
156760295|NCT03286218|565873936|FG009|Qualification Phase Period 2|Adverse Event|0|||
156760296|NCT03286218|565873937|FG010|Qualification Phase Period 2|Adverse Event|0|||
156760297|NCT03286218|565873938|FG011|Qualification Phase Period 2|Adverse Event|0|||
156760298|NCT03286218|565873927|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
156760299|NCT03286218|565873928|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
156760300|NCT03286218|565873929|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760301|NCT03286218|565873930|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760302|NCT03286218|565873931|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760303|NCT03286218|565873932|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760304|NCT03286218|565873933|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760305|NCT03286218|565873934|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760306|NCT03286218|565873935|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760307|NCT03286218|565873936|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760308|NCT03286218|565873937|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760309|NCT03286218|565873938|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
156760310|NCT03286218|565873927|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
156760311|NCT03286218|565873928|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
156760312|NCT03286218|565873929|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
156760313|NCT03286218|565873930|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
156760314|NCT03286218|565873931|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
156760315|NCT03286218|565873932|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
156760316|NCT03286218|565873933|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
156760317|NCT03286218|565873934|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
156760318|NCT03286218|565873935|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
156760319|NCT03286218|565873936|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
156760320|NCT03286218|565873937|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
156760321|NCT03286218|565873938|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
156760322|NCT03286218|565873927|FG000|Qualification Phase Period 2|Protocol Violation|2|||
156760323|NCT03286218|565873928|FG001|Qualification Phase Period 2|Protocol Violation|0|||
156760324|NCT03286218|565873929|FG002|Qualification Phase Period 2|Protocol Violation|0|||
156760325|NCT03286218|565873930|FG003|Qualification Phase Period 2|Protocol Violation|0|||
156760326|NCT03286218|565873931|FG004|Qualification Phase Period 2|Protocol Violation|0|||
156760327|NCT03286218|565873932|FG005|Qualification Phase Period 2|Protocol Violation|0|||
156760328|NCT03286218|565873933|FG006|Qualification Phase Period 2|Protocol Violation|0|||
156760329|NCT03286218|565873934|FG007|Qualification Phase Period 2|Protocol Violation|0|||
156760330|NCT03286218|565873935|FG008|Qualification Phase Period 2|Protocol Violation|0|||
156760331|NCT03286218|565873936|FG009|Qualification Phase Period 2|Protocol Violation|0|||
156760332|NCT03286218|565873937|FG010|Qualification Phase Period 2|Protocol Violation|0|||
156760333|NCT03286218|565873938|FG011|Qualification Phase Period 2|Protocol Violation|0|||
156760334|NCT03286218|565873927|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
156760335|NCT03286218|565873928|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
156760336|NCT03286218|565873929|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760337|NCT03286218|565873930|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760338|NCT03286218|565873931|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760339|NCT03286218|565873932|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760340|NCT03286218|565873933|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760341|NCT03286218|565873934|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760342|NCT03286218|565873935|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760343|NCT03286218|565873936|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
157001535|NCT00542386|566754298|FG003|Overall Study|Protocol Violation|0|||
157001536|NCT00542386|566754299|FG004|Overall Study|Protocol Violation|0|||
157001537|NCT00542386|566754300|FG005|Overall Study|Protocol Violation|4|||
157001538|NCT00542386|566754295|FG000|Overall Study|Withdrawal by Subject|5|||
157001539|NCT00542386|566754296|FG001|Overall Study|Withdrawal by Subject|8|||
157001540|NCT00542386|566754297|FG002|Overall Study|Withdrawal by Subject|10|||
157001541|NCT00542386|566754298|FG003|Overall Study|Withdrawal by Subject|11|||
157001542|NCT00542386|566754299|FG004|Overall Study|Withdrawal by Subject|15|||
157001543|NCT00542386|566754300|FG005|Overall Study|Withdrawal by Subject|7|||
157001544|NCT00542386|566754295|FG000|Overall Study|Other Reasons|4|||
157001545|NCT00542386|566754296|FG001|Overall Study|Other Reasons|1|||
157001546|NCT00542386|566754297|FG002|Overall Study|Other Reasons|4|||
157001547|NCT00542386|566754298|FG003|Overall Study|Other Reasons|3|||
157001548|NCT00542386|566754299|FG004|Overall Study|Other Reasons|4|||
157001549|NCT00542386|566754300|FG005|Overall Study|Other Reasons|2|||
157001550|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
157001551|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
157001552|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
157001553|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
157104476|NCT00763971|567137943|FG002|Overall Study|Exclusion criteria met|0|||
157104477|NCT00763971|567137941|FG000|Overall Study|Sponsor decision|1|||
157104478|NCT00763971|567137942|FG001|Overall Study|Sponsor decision|0|||
157104479|NCT00763971|567137943|FG002|Overall Study|Sponsor decision|0|||
157104480|NCT00763971|567137941|FG000|Overall Study|Due to holiday season|2|||
157104481|NCT00763971|567137942|FG001|Overall Study|Due to holiday season|0|||
157104482|NCT00763971|567137943|FG002|Overall Study|Due to holiday season|1|||
157104483|NCT00763971|567137941|FG000|Overall Study|Randomization error|0|||
156760344|NCT03286218|565873937|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760345|NCT03286218|565873938|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
156760346|NCT03286218|565873927|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760347|NCT03286218|565873928|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760348|NCT03286218|565873929|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760349|NCT03286218|565873930|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760350|NCT03286218|565873931|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760351|NCT03286218|565873932|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760352|NCT03286218|565873933|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760353|NCT03286218|565873934|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760354|NCT03286218|565873935|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760355|NCT03286218|565873936|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760356|NCT03286218|565873937|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
156760357|NCT03286218|565873938|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
156760358|NCT03286218|565873927|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760359|NCT03286218|565873928|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760360|NCT03286218|565873929|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760361|NCT03286218|565873930|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760362|NCT03286218|565873931|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760363|NCT03286218|565873932|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760364|NCT03286218|565873933|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760365|NCT03286218|565873934|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760366|NCT03286218|565873935|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760367|NCT03286218|565873936|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760368|NCT03286218|565873937|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
156760369|NCT03286218|565873938|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
156760370|NCT02346708|565873941|FG000|Overall Study|Adverse Event|2|||
156760371|NCT02346708|565873942|FG001|Overall Study|Adverse Event|0|||
156760372|NCT02346708|565873941|FG000|Overall Study|Protocol Violation|0|||
156760373|NCT02346708|565873942|FG001|Overall Study|Protocol Violation|1|||
156760374|NCT00483652|565873945|FG000|Double-blind Treatment Period|Protocol Violation|2|||
156760375|NCT00483652|565873946|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156760376|NCT00483652|565873945|FG000|Double-blind Treatment Period|Adverse Event|3|||
156760377|NCT00483652|565873946|FG001|Double-blind Treatment Period|Adverse Event|4|||
156760378|NCT00483652|565873945|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
156760379|NCT00483652|565873946|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
156760380|NCT00483652|565873945|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
156760381|NCT00483652|565873946|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
156760382|NCT00928434|565873947|FG000|Overall Study|Adverse Event|14|||
156760383|NCT00928434|565873948|FG001|Overall Study|Adverse Event|5|||
156760384|NCT00928434|565873949|FG002|Overall Study|Adverse Event|18|||
156760385|NCT00928434|565873947|FG000|Overall Study|Protocol Violation|5|||
156760386|NCT00928434|565873948|FG001|Overall Study|Protocol Violation|0|||
156760387|NCT00928434|565873949|FG002|Overall Study|Protocol Violation|8|||
156760388|NCT00928434|565873947|FG000|Overall Study|Physician Decision|2|||
156760389|NCT00928434|565873948|FG001|Overall Study|Physician Decision|0|||
156760390|NCT00928434|565873949|FG002|Overall Study|Physician Decision|3|||
156760391|NCT00928434|565873947|FG000|Overall Study|Lost to Follow-up|1|||
156760392|NCT00928434|565873948|FG001|Overall Study|Lost to Follow-up|0|||
156760393|NCT00928434|565873949|FG002|Overall Study|Lost to Follow-up|3|||
156760394|NCT00928434|565873947|FG000|Overall Study|Withdrawal by Subject|5|||
156760395|NCT00928434|565873948|FG001|Overall Study|Withdrawal by Subject|3|||
156760396|NCT00928434|565873949|FG002|Overall Study|Withdrawal by Subject|2|||
156760397|NCT00928434|565873947|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
156760398|NCT00928434|565873948|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
156760399|NCT00928434|565873949|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
157104484|NCT00763971|567137942|FG001|Overall Study|Randomization error|0|||
157104485|NCT00763971|567137943|FG002|Overall Study|Randomization error|1|||
157104486|NCT00763971|567137941|FG000|Overall Study|Medical monitor decision|0|||
157104487|NCT00763971|567137942|FG001|Overall Study|Medical monitor decision|0|||
157104488|NCT00763971|567137943|FG002|Overall Study|Medical monitor decision|1|||
157104489|NCT00763971|567137941|FG000|Overall Study|Moved to another country|0|||
157104490|NCT00763971|567137942|FG001|Overall Study|Moved to another country|1|||
156760400|NCT00928434|565873947|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
156760401|NCT00928434|565873948|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
156760402|NCT00928434|565873949|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
156760403|NCT00928434|565873947|FG000|Overall Study|Other (not meeting above criteria)|5|||
156760404|NCT00928434|565873948|FG001|Overall Study|Other (not meeting above criteria)|1|||
156760405|NCT00928434|565873949|FG002|Overall Study|Other (not meeting above criteria)|2|||
156760406|NCT01781962|565873950|FG000|Overall Study|Other Miscellaneous Reasons|5|||
156760407|NCT00716456|565873953|FG000|Overall Study|Adverse Event|0|||
156760408|NCT00716456|565873954|FG001|Overall Study|Adverse Event|2|||
156760409|NCT00716456|565873955|FG002|Overall Study|Adverse Event|0|||
156760410|NCT02154139|565873958|FG000|Overall Study|Injection not administered|2|||
156760411|NCT02154139|565873958|FG000|Overall Study|Other|2|||
156760412|NCT02154139|565873958|FG000|Overall Study|Investigator transferred|3|||
156760413|NCT05417412|565873962|FG000|Overall Study|Lost to Follow-up|2|||
156760414|NCT04556760|565873965|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760415|NCT04556760|565873966|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
156760416|NCT04556760|565873967|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760417|NCT04556760|565873968|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760418|NCT04556760|565873969|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760419|NCT04556760|565873970|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
156760420|NCT04556760|565873965|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760421|NCT04556760|565873966|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760422|NCT04556760|565873967|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760423|NCT04556760|565873968|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
156760424|NCT04556760|565873969|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760425|NCT04556760|565873970|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
156760426|NCT02849743|565873972|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
156760427|NCT02849743|565873973|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
156760428|NCT02849743|565873972|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
156760429|NCT02849743|565873973|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156760430|NCT03075267|565873981|FG000|Overall Study|Protocol Violation|1|||
156760431|NCT03075267|565873982|FG001|Overall Study|Protocol Violation|0|||
156760432|NCT03075267|565873983|FG002|Overall Study|Protocol Violation|0|||
156760433|NCT02168491|565873984|FG000|Overall Study|Withdrawal by Subject|1|||
156760434|NCT00809445|565873985|FG000|1 Month Follow-up|Lost contact|1|||
156760435|NCT00809445|565873986|FG001|1 Month Follow-up|Lost contact|2|||
156760436|NCT00809445|565873987|FG002|1 Month Follow-up|Lost contact|1|||
156760437|NCT00809445|565873985|FG000|1 Month Follow-up|Withdrew consent|1|||
156760438|NCT00809445|565873986|FG001|1 Month Follow-up|Withdrew consent|1|||
156760439|NCT00809445|565873987|FG002|1 Month Follow-up|Withdrew consent|1|||
156760440|NCT00809445|565873985|FG000|1 Month Follow-up|Death|0|||
156760441|NCT00809445|565873986|FG001|1 Month Follow-up|Death|1|||
156760442|NCT00809445|565873987|FG002|1 Month Follow-up|Death|1|||
156760443|NCT00809445|565873985|FG000|1 Month Follow-up|Incarcerated|0|||
156760444|NCT00809445|565873986|FG001|1 Month Follow-up|Incarcerated|0|||
156760445|NCT00809445|565873987|FG002|1 Month Follow-up|Incarcerated|1|||
156760446|NCT00809445|565873985|FG000|6 Month Follow-up|Lost contact|16|||
156760447|NCT00809445|565873986|FG001|6 Month Follow-up|Lost contact|14|||
156760448|NCT00809445|565873987|FG002|6 Month Follow-up|Lost contact|14|||
156760449|NCT00809445|565873985|FG000|6 Month Follow-up|Death|2|||
156760450|NCT00809445|565873986|FG001|6 Month Follow-up|Death|1|||
156760451|NCT00809445|565873987|FG002|6 Month Follow-up|Death|1|||
156760452|NCT00809445|565873985|FG000|6 Month Follow-up|Incarcerated|6|||
156760453|NCT00809445|565873986|FG001|6 Month Follow-up|Incarcerated|8|||
156760454|NCT00809445|565873987|FG002|6 Month Follow-up|Incarcerated|8|||
156760455|NCT00809445|565873985|FG000|6 Month Follow-up|Withdrew consent|0|||
156760456|NCT00809445|565873986|FG001|6 Month Follow-up|Withdrew consent|0|||
156760457|NCT00809445|565873987|FG002|6 Month Follow-up|Withdrew consent|1|||
156760458|NCT03874013|565873988|FG000|Overall Study|Adverse Event|0|||
156760459|NCT03874013|565873989|FG001|Overall Study|Adverse Event|1|||
156760460|NCT04919317|565873990|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
156760461|NCT04919317|565873991|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
157001554|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
157001555|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
157001556|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
157001557|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
156760462|NCT04919317|565873990|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
156760463|NCT04919317|565873991|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
156760464|NCT01566604|565873994|FG000|Overall Study|Patient's inability to use the device|1|||
156760465|NCT01566604|565873995|FG001|Overall Study|Patient's inability to use the device|0|||
156760466|NCT01566604|565873994|FG000|Overall Study|Administrative problems|1|||
157001558|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
157001559|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
156760467|NCT01566604|565873995|FG001|Overall Study|Administrative problems|0|||
156760468|NCT01566604|565873994|FG000|Overall Study|Lack of Efficacy|1|||
156760469|NCT01566604|565873995|FG001|Overall Study|Lack of Efficacy|2|||
156760470|NCT01566604|565873994|FG000|Overall Study|Protocol deviation|2|||
156760471|NCT01566604|565873995|FG001|Overall Study|Protocol deviation|0|||
156760472|NCT01566604|565873994|FG000|Overall Study|Abnormal laboratory value|2|||
156760473|NCT01566604|565873995|FG001|Overall Study|Abnormal laboratory value|0|||
156760474|NCT01566604|565873994|FG000|Overall Study|Death|4|||
156760475|NCT01566604|565873995|FG001|Overall Study|Death|1|||
156760476|NCT01566604|565873994|FG000|Overall Study|Adverse Event|4|||
156760477|NCT01566604|565873995|FG001|Overall Study|Adverse Event|2|||
156760478|NCT01566604|565873994|FG000|Overall Study|Withdrawal by Subject|9|||
156760479|NCT01566604|565873995|FG001|Overall Study|Withdrawal by Subject|6|||
156760480|NCT00661089|565874000|FG000|Overall Study|1 subject withdrawal|0|||
156760481|NCT00661089|565874001|FG001|Overall Study|1 subject withdrawal|1|||
156760482|NCT00661089|565874000|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
156760483|NCT00661089|565874001|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
156760484|NCT01443858|565874005|FG000|Overall Study|Withdrawal by Subject|9|||
156760485|NCT01443858|565874006|FG001|Overall Study|Withdrawal by Subject|8|||
156760486|NCT01443858|565874007|FG002|Overall Study|Withdrawal by Subject|5|||
156760487|NCT01443858|565874005|FG000|Overall Study|Lack of Efficacy|1|||
156760488|NCT01443858|565874006|FG001|Overall Study|Lack of Efficacy|0|||
156760489|NCT01443858|565874007|FG002|Overall Study|Lack of Efficacy|0|||
156760490|NCT01443858|565874005|FG000|Overall Study|Lost to Follow-up|5|||
156760491|NCT01443858|565874006|FG001|Overall Study|Lost to Follow-up|5|||
156760492|NCT01443858|565874007|FG002|Overall Study|Lost to Follow-up|2|||
156760493|NCT00321906|565874010|FG000|Overall Study|Adverse Event|36|||
156760494|NCT00321906|565874011|FG001|Overall Study|Adverse Event|44|||
156760495|NCT00321906|565874010|FG000|Overall Study|Death|9|||
156760496|NCT00321906|565874011|FG001|Overall Study|Death|6|||
156760497|NCT00321906|565874010|FG000|Overall Study|Lost to Follow-up|1|||
156760498|NCT00321906|565874011|FG001|Overall Study|Lost to Follow-up|2|||
156760499|NCT00321906|565874010|FG000|Overall Study|Withdrawal by Subject|0|||
156760500|NCT00321906|565874011|FG001|Overall Study|Withdrawal by Subject|4|||
156760501|NCT02899065|565874012|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
156760502|NCT02899065|565874013|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
156760503|NCT02899065|565874012|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
156760504|NCT02899065|565874013|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
156760505|NCT02899065|565874012|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
156760506|NCT02899065|565874013|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
156760507|NCT00186485|565874014|FG000|Overall Study|Lost to Follow-up|3|||
156760508|NCT03771963|565874021|FG000|Overall Study|Lost to Follow-up|22|||
156760509|NCT03771963|565874021|FG000|Overall Study|Withdrawal of Consent|10|||
156760510|NCT01026948|565874022|FG000|Overall Study|Physician Decision|8|||
156760511|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
156760512|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
156760513|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Adverse Event|57|||
156760514|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Adverse Event|49|||
156760515|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
156760516|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
156760517|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Site closure|3|||
156760518|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Site closure|2|||
156760519|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
156760520|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
156760521|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Physician Decision|48|||
156760522|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Physician Decision|38|||
156760523|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
156760524|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
156760525|NCT01705977|565874023|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
156760526|NCT01705977|565874024|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
156760527|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
156760528|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
156760529|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
156760530|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
156760531|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
156760532|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
156760533|NCT01705977|565874023|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
156760534|NCT01705977|565874024|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
157104491|NCT00763971|567137943|FG002|Overall Study|Moved to another country|0|||
156760535|NCT00520039|565874028|FG000|Overall Study|Exclusion criteria met at first visit|7|||
156760536|NCT00520039|565874029|FG001|Overall Study|Exclusion criteria met at first visit|5|||
156760537|NCT03560869|565874030|FG000|Overall Study|Withdrawal by Subject|3|||
156760538|NCT03560869|565874031|FG001|Overall Study|Withdrawal by Subject|4|||
156760539|NCT03560869|565874030|FG000|Overall Study|Screening failure|4|||
156760540|NCT03560869|565874031|FG001|Overall Study|Screening failure|4|||
156760541|NCT03560869|565874030|FG000|Overall Study|Withdrawal by PI|0|||
156760542|NCT03560869|565874031|FG001|Overall Study|Withdrawal by PI|1|||
156760543|NCT00325819|565874032|FG000|Overall Study|Study product lost in mail|2|||
156760544|NCT00325819|565874033|FG001|Overall Study|Study product lost in mail|1|||
156760545|NCT00325819|565874032|FG000|Overall Study|Did not take a dose of study product|4|||
156760546|NCT00325819|565874033|FG001|Overall Study|Did not take a dose of study product|9|||
156760547|NCT00325819|565874032|FG000|Overall Study|Lost to Follow-up|3|||
156760548|NCT00325819|565874033|FG001|Overall Study|Lost to Follow-up|3|||
156760549|NCT00458003|565875708|FG000|Overall Study|Non protocol spinal anesthesia|1|||
156760550|NCT00458003|565875709|FG001|Overall Study|Non protocol spinal anesthesia|1|||
156760551|NCT01272908|565875719|FG000|Initial Treatment Period|Adverse Event|1|||
156760552|NCT01272908|565875719|FG000|Initial Treatment Period|Lack of Efficacy|5|||
156760553|NCT01272908|565875719|FG000|Initial Treatment Period|Protocol Violation|1|||
156760554|NCT01272908|565875719|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
156760555|NCT01272908|565875719|FG000|Re-Treatment Period|Adverse Event|2|||
156760556|NCT01272908|565875719|FG000|Re-Treatment Period|Lack of Efficacy|3|||
156760557|NCT01272908|565875719|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
156760558|NCT02221648|565875720|FG000|Overall Study|Withdrawal by Subject|3|||
156760559|NCT02221648|565875721|FG001|Overall Study|Withdrawal by Subject|3|||
156760560|NCT00810069|565875723|FG000|Lead-in Period I|Adverse Event|43|||
156760561|NCT00810069|565875724|FG001|Lead-in Period I|Adverse Event|0|||
156760562|NCT00810069|565875725|FG002|Lead-in Period I|Adverse Event|0|||
156760563|NCT00810069|565875723|FG000|Lead-in Period I|Lack of Efficacy|1|||
156760564|NCT00810069|565875724|FG001|Lead-in Period I|Lack of Efficacy|0|||
156760565|NCT00810069|565875725|FG002|Lead-in Period I|Lack of Efficacy|0|||
156760566|NCT00810069|565875723|FG000|Lead-in Period I|Lost to Follow-up|19|||
156760567|NCT00810069|565875724|FG001|Lead-in Period I|Lost to Follow-up|0|||
156760568|NCT00810069|565875725|FG002|Lead-in Period I|Lost to Follow-up|0|||
156760569|NCT00810069|565875723|FG000|Lead-in Period I|Physician Decision|1|||
156760570|NCT00810069|565875724|FG001|Lead-in Period I|Physician Decision|0|||
156760571|NCT00810069|565875725|FG002|Lead-in Period I|Physician Decision|0|||
156760572|NCT00810069|565875723|FG000|Lead-in Period I|Protocol Violation|1|||
156760573|NCT00810069|565875724|FG001|Lead-in Period I|Protocol Violation|0|||
156760574|NCT00810069|565875725|FG002|Lead-in Period I|Protocol Violation|0|||
156760575|NCT00810069|565875723|FG000|Lead-in Period I|Withdrawal by Subject|46|||
156760576|NCT00810069|565875724|FG001|Lead-in Period I|Withdrawal by Subject|0|||
156760577|NCT00810069|565875725|FG002|Lead-in Period I|Withdrawal by Subject|0|||
156760578|NCT00810069|565875723|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
156760579|NCT00810069|565875724|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
156760580|NCT00810069|565875725|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
156760581|NCT00810069|565875723|FG000|Lead-in Period I|Randomization criteria not met|158|||
156760582|NCT00810069|565875724|FG001|Lead-in Period I|Randomization criteria not met|0|||
156760583|NCT00810069|565875725|FG002|Lead-in Period I|Randomization criteria not met|0|||
156760584|NCT00810069|565875723|FG000|Double-Blind Period II|Adverse Event|0|||
156760585|NCT00810069|565875724|FG001|Double-Blind Period II|Adverse Event|9|||
156760586|NCT00810069|565875725|FG002|Double-Blind Period II|Adverse Event|8|||
156760587|NCT00810069|565875723|FG000|Double-Blind Period II|Lack of Efficacy|0|||
156760588|NCT00810069|565875724|FG001|Double-Blind Period II|Lack of Efficacy|7|||
156760589|NCT00810069|565875725|FG002|Double-Blind Period II|Lack of Efficacy|12|||
156760590|NCT00810069|565875723|FG000|Double-Blind Period II|Lost to Follow-up|0|||
156760591|NCT00810069|565875724|FG001|Double-Blind Period II|Lost to Follow-up|9|||
156760592|NCT00810069|565875725|FG002|Double-Blind Period II|Lost to Follow-up|9|||
156760593|NCT00810069|565875723|FG000|Double-Blind Period II|Physician Decision|0|||
156760594|NCT00810069|565875724|FG001|Double-Blind Period II|Physician Decision|0|||
156760595|NCT00810069|565875725|FG002|Double-Blind Period II|Physician Decision|1|||
157001560|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
157001561|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
157001562|NCT02057718|566754301|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
157001563|NCT02057718|566754302|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
156760596|NCT00810069|565875723|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
156760597|NCT00810069|565875724|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
156760598|NCT00810069|565875725|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
156760599|NCT00810069|565875723|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
156760600|NCT00810069|565875724|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
156760601|NCT00810069|565875725|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
156760602|NCT00810069|565875723|FG000|Double-Blind Period II|Clinical relapse|0|||
156760603|NCT00810069|565875724|FG001|Double-Blind Period II|Clinical relapse|3|||
156760604|NCT00810069|565875725|FG002|Double-Blind Period II|Clinical relapse|0|||
156760605|NCT00810069|565875723|FG000|Double-Blind Period II|Protocol Violation|0|||
156760606|NCT00810069|565875724|FG001|Double-Blind Period II|Protocol Violation|7|||
156760607|NCT00810069|565875725|FG002|Double-Blind Period II|Protocol Violation|6|||
156760608|NCT00905424|565875729|FG000|Overall Study|Lost to Follow-up|3|||
156760609|NCT00905424|565875730|FG001|Overall Study|Lost to Follow-up|3|||
156760610|NCT00905424|565875729|FG000|Overall Study|Withdrawal by Subject|1|||
156760611|NCT00905424|565875730|FG001|Overall Study|Withdrawal by Subject|2|||
156760612|NCT00905424|565875729|FG000|Overall Study|Adverse Event|4|||
156760613|NCT00905424|565875730|FG001|Overall Study|Adverse Event|2|||
156760614|NCT00905424|565875729|FG000|Overall Study|Non-compliance with study medication|2|||
156760615|NCT00905424|565875730|FG001|Overall Study|Non-compliance with study medication|0|||
156760616|NCT00905424|565875729|FG000|Overall Study|Sponsor decision|1|||
156760617|NCT00905424|565875730|FG001|Overall Study|Sponsor decision|0|||
156760618|NCT00905424|565875729|FG000|Overall Study|Positive urine drug screen|0|||
156760619|NCT00905424|565875730|FG001|Overall Study|Positive urine drug screen|1|||
156760620|NCT00905424|565875729|FG000|Overall Study|Non-adherence to visit schedule|0|||
156760621|NCT00905424|565875730|FG001|Overall Study|Non-adherence to visit schedule|1|||
156760622|NCT00426764|565875731|FG000|Overall Study|Protocol Violation|1|||
156760623|NCT00426764|565875731|FG000|Overall Study|Withdrawal by Subject|4|||
156760624|NCT00426764|565875731|FG000|Overall Study|Physician Decision|6|||
156760625|NCT00426764|565875731|FG000|Overall Study|Compassionate Use|1|||
156760626|NCT00426764|565875731|FG000|Overall Study|Progressive Disease|83|||
156760627|NCT00426764|565875731|FG000|Overall Study|Adverse Event|24|||
156760628|NCT00426764|565875731|FG000|Overall Study|Other|1|||
156760629|NCT00426764|565875731|FG000|Overall Study|Death|1|||
156760630|NCT00426764|565875731|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
156760631|NCT00379899|565875732|FG000|Overall Study|Adverse Event|7|||
156760632|NCT00379899|565875733|FG001|Overall Study|Adverse Event|3|||
156760633|NCT00379899|565875732|FG000|Overall Study|Death|10|||
156760634|NCT00379899|565875733|FG001|Overall Study|Death|10|||
156760635|NCT00379899|565875732|FG000|Overall Study|Lost to Follow-up|2|||
156760636|NCT00379899|565875733|FG001|Overall Study|Lost to Follow-up|4|||
156760637|NCT00379899|565875732|FG000|Overall Study|Physician Decision|3|||
156760638|NCT00379899|565875733|FG001|Overall Study|Physician Decision|4|||
156760639|NCT00379899|565875732|FG000|Overall Study|Withdrawal by Subject|5|||
156760640|NCT00379899|565875733|FG001|Overall Study|Withdrawal by Subject|5|||
156760641|NCT00379899|565875732|FG000|Overall Study|Ineligibility determined|0|||
156760642|NCT00379899|565875733|FG001|Overall Study|Ineligibility determined|1|||
156760643|NCT00379899|565875732|FG000|Overall Study|Noncompliance|1|||
156760644|NCT00379899|565875733|FG001|Overall Study|Noncompliance|1|||
156760645|NCT00379899|565875732|FG000|Overall Study|Parathyroidectomy|0|||
156760646|NCT00379899|565875733|FG001|Overall Study|Parathyroidectomy|2|||
156760647|NCT00379899|565875732|FG000|Overall Study|Renal transplantation|5|||
156760648|NCT00379899|565875733|FG001|Overall Study|Renal transplantation|4|||
156760649|NCT00379899|565875732|FG000|Overall Study|Coronary artery bypass graft|1|||
156760650|NCT00379899|565875733|FG001|Overall Study|Coronary artery bypass graft|1|||
156760651|NCT00379899|565875732|FG000|Overall Study|Other protocol-specified criteria|3|||
156760652|NCT00379899|565875733|FG001|Overall Study|Other protocol-specified criteria|4|||
156760653|NCT00379899|565875732|FG000|Overall Study|Other|3|||
156760654|NCT00379899|565875733|FG001|Overall Study|Other|1|||
156760655|NCT01922258|565875734|FG000|Overall Study|Lost to Follow-up|1|||
156760656|NCT01922258|565875735|FG001|Overall Study|Lost to Follow-up|1|||
156760657|NCT01922258|565875734|FG000|Overall Study|Adverse Event|9|||
156760658|NCT01922258|565875735|FG001|Overall Study|Adverse Event|2|||
156760659|NCT01922258|565875734|FG000|Overall Study|Met Withdrawal Criteria|0|||
156760660|NCT01922258|565875735|FG001|Overall Study|Met Withdrawal Criteria|4|||
156760661|NCT01922258|565875734|FG000|Overall Study|Withdrawn by the Investigator|1|||
156760662|NCT01922258|565875735|FG001|Overall Study|Withdrawn by the Investigator|4|||
156760663|NCT01922258|565875734|FG000|Overall Study|Withdrawal by participant|5|||
156760664|NCT01922258|565875735|FG001|Overall Study|Withdrawal by participant|5|||
156760665|NCT01166750|565875736|FG000|Overall Study|Lost to Follow-up|1|||
156760666|NCT01166750|565875737|FG001|Overall Study|Lost to Follow-up|0|||
156760667|NCT05225389|565875738|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
156760668|NCT02417753|565875739|FG000|Overall Study|Death|1|||
156760669|NCT03113968|565875740|FG000|Overall Study|Withdrawal by Subject|31|||
156760670|NCT03113968|565875741|FG001|Overall Study|Withdrawal by Subject|4|||
156760671|NCT04805671|565875744|FG000|Overall Study|Death|2|||
156760672|NCT04805671|565875745|FG001|Overall Study|Death|7|||
156760673|NCT04805671|565875744|FG000|Overall Study|Lost to Follow-up|1|||
156760674|NCT04805671|565875745|FG001|Overall Study|Lost to Follow-up|0|||
156760675|NCT04805671|565875744|FG000|Overall Study|Withdrawal by Subject|9|||
156760676|NCT04805671|565875745|FG001|Overall Study|Withdrawal by Subject|7|||
156760677|NCT04805671|565875744|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
156760678|NCT04805671|565875745|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
157104492|NCT00763971|567137941|FG000|Overall Study|Subject wanted dose reduction|0|||
156760679|NCT00901342|565875746|FG000|Overall Study|Adverse Event|1|||
156760680|NCT00901342|565875746|FG000|Overall Study|Death|4|||
156760681|NCT00901342|565875746|FG000|Overall Study|Disease progression|1|||
156760682|NCT00901342|565875746|FG000|Overall Study|Withdrawal by Subject|9|||
157104493|NCT00763971|567137942|FG001|Overall Study|Subject wanted dose reduction|1|||
157104494|NCT00763971|567137943|FG002|Overall Study|Subject wanted dose reduction|0|||
157104495|NCT00763971|567137941|FG000|Overall Study|Lack of availability|0|||
157104496|NCT00763971|567137942|FG001|Overall Study|Lack of availability|1|||
157104497|NCT00763971|567137943|FG002|Overall Study|Lack of availability|0|||
157104498|NCT00763971|567137941|FG000|Overall Study|Performed final visit on phone|0|||
157104499|NCT00763971|567137942|FG001|Overall Study|Performed final visit on phone|1|||
157104500|NCT00763971|567137943|FG002|Overall Study|Performed final visit on phone|0|||
157104501|NCT00763971|567137941|FG000|Overall Study|Participation in 489-326 required|1|||
157104502|NCT00763971|567137942|FG001|Overall Study|Participation in 489-326 required|0|||
157104503|NCT00763971|567137943|FG002|Overall Study|Participation in 489-326 required|0|||
157104504|NCT02713542|567137948|FG000|Overall Study|Use of prohibited medication|14|||
157104505|NCT02713542|567137949|FG001|Overall Study|Use of prohibited medication|5|||
157104506|NCT02713542|567137948|FG000|Overall Study|Withdrawal by Subject|4|||
157104507|NCT02713542|567137949|FG001|Overall Study|Withdrawal by Subject|1|||
157104508|NCT03631667|567137950|FG000|Overall Study|Withdrawal by Subject|3|||
157104509|NCT00884325|567137962|FG000|Overall Study|Lost to Follow-up|1|||
157104510|NCT00884325|567137963|FG001|Overall Study|Lost to Follow-up|2|||
157104511|NCT00884325|567137962|FG000|Overall Study|Lack of Efficacy|0|||
157104512|NCT00884325|567137963|FG001|Overall Study|Lack of Efficacy|1|||
157104513|NCT00884325|567137962|FG000|Overall Study|Withdrawal by Subject|1|||
157104514|NCT00884325|567137963|FG001|Overall Study|Withdrawal by Subject|1|||
157104515|NCT00884325|567137962|FG000|Overall Study|Not provided|1|||
157104516|NCT00884325|567137963|FG001|Overall Study|Not provided|0|||
157104517|NCT01641237|567137964|FG000|Period II|Withdrawal by Subject|1|||
157104518|NCT01641237|567137965|FG001|Period II|Withdrawal by Subject|0|||
157104519|NCT01641237|567137966|FG002|Period II|Withdrawal by Subject|0|||
157104520|NCT01641237|567137967|FG003|Period II|Withdrawal by Subject|0|||
156760683|NCT03804268|565875747|FG000|Overall Study|Adverse Event|2|||
156760684|NCT03804268|565875748|FG001|Overall Study|Adverse Event|2|||
156760685|NCT03804268|565875747|FG000|Overall Study|Withdrawal by Subject|2|||
156760686|NCT03804268|565875748|FG001|Overall Study|Withdrawal by Subject|0|||
156760687|NCT03804268|565875747|FG000|Overall Study|Lost to Follow-up|1|||
156760688|NCT03804268|565875748|FG001|Overall Study|Lost to Follow-up|0|||
156760689|NCT03804268|565875747|FG000|Overall Study|Physician Decision|2|||
156760690|NCT03804268|565875748|FG001|Overall Study|Physician Decision|0|||
156760691|NCT02849587|565875749|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
157001564|NCT02057718|566754301|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
157001565|NCT02057718|566754302|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
157001566|NCT02057718|566754301|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
157001567|NCT02057718|566754302|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
157001568|NCT02057718|566754301|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
157001569|NCT02057718|566754302|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
157001570|NCT02057718|566754301|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
157001571|NCT02057718|566754302|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
157001572|NCT00197015|566754303|FG000|Overall Study|Adverse Event|3|||
157001573|NCT00197015|566754304|FG001|Overall Study|Adverse Event|0|||
157001574|NCT00197015|566754305|FG002|Overall Study|Adverse Event|1|||
157001575|NCT00197015|566754303|FG000|Overall Study|Protocol Violation|0|||
157001576|NCT00197015|566754304|FG001|Overall Study|Protocol Violation|3|||
157001577|NCT00197015|566754305|FG002|Overall Study|Protocol Violation|3|||
157001578|NCT00197015|566754303|FG000|Overall Study|Withdrawal by Subject|17|||
157001579|NCT00197015|566754304|FG001|Overall Study|Withdrawal by Subject|37|||
157001580|NCT00197015|566754305|FG002|Overall Study|Withdrawal by Subject|34|||
157001581|NCT00197015|566754303|FG000|Overall Study|Lost to Follow-up|28|||
157001582|NCT00197015|566754304|FG001|Overall Study|Lost to Follow-up|46|||
157001583|NCT00197015|566754305|FG002|Overall Study|Lost to Follow-up|37|||
157001584|NCT00197015|566754303|FG000|Overall Study|Other|2|||
157001585|NCT00197015|566754304|FG001|Overall Study|Other|3|||
157001586|NCT00197015|566754305|FG002|Overall Study|Other|2|||
157001587|NCT04511650|566754308|FG000|Overall Study|Lost to Follow-up|1|||
157001588|NCT04511650|566754309|FG001|Overall Study|Lost to Follow-up|0|||
157001589|NCT04511650|566754310|FG002|Overall Study|Lost to Follow-up|0|||
157001590|NCT04511650|566754308|FG000|Overall Study|Withdrawal by Subject|1|||
157001591|NCT04511650|566754309|FG001|Overall Study|Withdrawal by Subject|0|||
157001592|NCT04511650|566754310|FG002|Overall Study|Withdrawal by Subject|0|||
157001593|NCT04511650|566754308|FG000|Overall Study|reason not provided|0|||
157001594|NCT04511650|566754309|FG001|Overall Study|reason not provided|0|||
157001595|NCT04511650|566754310|FG002|Overall Study|reason not provided|1|||
157001596|NCT04511650|566754308|FG000|Overall Study|Death|1|||
157001597|NCT04511650|566754309|FG001|Overall Study|Death|1|||
157001598|NCT04511650|566754310|FG002|Overall Study|Death|1|||
157001599|NCT04550039|566754323|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
157001600|NCT04550039|566754324|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
157001601|NCT04550039|566754323|FG000|Overall Study|patient self-withdrew from study|0|||
157001602|NCT04550039|566754324|FG001|Overall Study|patient self-withdrew from study|1|||
157001603|NCT00554801|566754327|FG000|Overall Study|left area before completion|5|||
157001604|NCT00554801|566754328|FG001|Overall Study|left area before completion|0|||
157001605|NCT00554801|566754327|FG000|Overall Study|Withdrawal by Subject|14|||
157001606|NCT00554801|566754328|FG001|Overall Study|Withdrawal by Subject|0|||
157001607|NCT05196737|566754329|FG000|Non-intervention Week|Lost to Follow-up|2|||
157001608|NCT05196737|566754329|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
157001609|NCT00828945|566754332|FG000|Overall Study|Death|4|||
157001610|NCT00828945|566754332|FG000|Overall Study|Participant was missing|1|||
157001611|NCT00828945|566754332|FG000|Overall Study|Other|36|||
157001612|NCT04222959|566754333|FG000|Overall Study|Lost to Follow-up|76|||
157001613|NCT04222959|566754334|FG001|Overall Study|Lost to Follow-up|28|||
157001614|NCT02163915|566754341|FG000|Overall Study|Withdrawal by Subject|2|||
157001615|NCT02163915|566754342|FG001|Overall Study|Withdrawal by Subject|0|||
157001616|NCT02163915|566754343|FG002|Overall Study|Withdrawal by Subject|2|||
157001617|NCT02163915|566754344|FG003|Overall Study|Withdrawal by Subject|2|||
157001618|NCT02163915|566754345|FG004|Overall Study|Withdrawal by Subject|2|||
157001619|NCT02163915|566754341|FG000|Overall Study|Study termination|1|||
157104521|NCT01641237|567137964|FG000|Period III|Lost to Follow-up|1|||
156760692|NCT02849587|565875750|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
156760693|NCT02849587|565875751|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
156760694|NCT02849587|565875749|FG000|Overall Study|Withdrawal by Subject|0|||
157104522|NCT01641237|567137965|FG001|Period III|Lost to Follow-up|0|||
157001620|NCT02163915|566754342|FG001|Overall Study|Study termination|0|||
157001621|NCT02163915|566754343|FG002|Overall Study|Study termination|0|||
157001622|NCT02163915|566754344|FG003|Overall Study|Study termination|0|||
157001623|NCT02163915|566754345|FG004|Overall Study|Study termination|2|||
157001624|NCT02163915|566754341|FG000|Overall Study|Physician Decision|0|||
156760695|NCT02849587|565875750|FG001|Overall Study|Withdrawal by Subject|1|||
156760696|NCT02849587|565875751|FG002|Overall Study|Withdrawal by Subject|0|||
156760697|NCT03380377|565875754|FG000|Overall Study|Physician Decision|1|||
156760698|NCT03380377|565875754|FG000|Overall Study|Withdrawal by Subject|1|||
156760699|NCT02716779|565875755|FG000|Monotherapy|Adverse Event|0|||
156760700|NCT02716779|565875756|FG001|Monotherapy|Adverse Event|1|||
156760701|NCT02716779|565875757|FG002|Monotherapy|Adverse Event|1|||
156760702|NCT02716779|565875755|FG000|Combination Therapy|Adverse Event|0|||
156760703|NCT02716779|565875756|FG001|Combination Therapy|Adverse Event|2|||
156760704|NCT02716779|565875757|FG002|Combination Therapy|Adverse Event|1|||
156760705|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
156760706|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
156760707|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
156760708|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
156760709|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
156760710|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
156760711|NCT00385918|565875762|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
156760712|NCT00385918|565875763|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
156760713|NCT00385918|565875764|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
156760714|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
156760715|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
156760716|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
156760717|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Physician Decision|1|||
156760718|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Physician Decision|0|||
156760719|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Physician Decision|0|||
156760720|NCT00385918|565875762|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
156760721|NCT00385918|565875763|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
156760722|NCT00385918|565875764|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
156760723|NCT00128661|565875765|FG000|Overall Study|Adverse Event|14|||
156760724|NCT00128661|565875766|FG001|Overall Study|Adverse Event|11|||
156760725|NCT00128661|565875765|FG000|Overall Study|Lost to Follow-up|10|||
156760726|NCT00128661|565875766|FG001|Overall Study|Lost to Follow-up|7|||
156760727|NCT00128661|565875765|FG000|Overall Study|Withdrawal by Subject|243|||
156760728|NCT00128661|565875766|FG001|Overall Study|Withdrawal by Subject|232|||
156760729|NCT00128661|565875765|FG000|Overall Study|Other|7|||
156760730|NCT00128661|565875766|FG001|Overall Study|Other|8|||
156760731|NCT03421379|565875767|FG000|Period 1|Withdrawal by Subject|0|||
156760732|NCT03421379|565875768|FG001|Period 1|Withdrawal by Subject|1|||
156760733|NCT03421379|565875767|FG000|Period 1|Physician Decision|1|||
156760734|NCT03421379|565875768|FG001|Period 1|Physician Decision|1|||
157001625|NCT02163915|566754342|FG001|Overall Study|Physician Decision|0|||
157001626|NCT02163915|566754343|FG002|Overall Study|Physician Decision|0|||
157001627|NCT02163915|566754344|FG003|Overall Study|Physician Decision|1|||
157001628|NCT02163915|566754345|FG004|Overall Study|Physician Decision|0|||
157001629|NCT01751724|566754348|FG000|Overall Study|extubated bef.start assigned treatment|1|||
157001630|NCT01751724|566754349|FG001|Overall Study|extubated bef.start assigned treatment|0|||
157001631|NCT01751724|566754348|FG000|Overall Study|withdrawn by parent|0|||
157001632|NCT01751724|566754349|FG001|Overall Study|withdrawn by parent|2|||
157001633|NCT03395353|566754350|FG000|Overall Study|Adverse Event|20|||
157001634|NCT03395353|566754350|FG000|Overall Study|Protocol Violation|1|||
157001635|NCT03395353|566754350|FG000|Overall Study|Lack of Efficacy|3|||
157001636|NCT03395353|566754350|FG000|Overall Study|Withdrawal by Subject|24|||
157001637|NCT03395353|566754350|FG000|Overall Study|Discontinued visit|1|||
157001638|NCT03395353|566754350|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
157001639|NCT03395353|566754350|FG000|Overall Study|Physician Decision|4|||
157001640|NCT03395353|566754350|FG000|Overall Study|Early termination of overall study|33|||
157001641|NCT02685033|566754351|FG000|Overall Study|Withdrawal of Consent|0|||
157001642|NCT02685033|566754352|FG001|Overall Study|Withdrawal of Consent|1|||
157001643|NCT02685033|566754351|FG000|Overall Study|Lost to Follow-up|2|||
157001644|NCT02685033|566754352|FG001|Overall Study|Lost to Follow-up|1|||
156760735|NCT03421379|565875767|FG000|Period 1|Did not receive treatment|1|||
156760736|NCT03421379|565875768|FG001|Period 1|Did not receive treatment|2|||
156760737|NCT01951417|565875770|FG000|Overall Study|Withdrawal by Subject|1|||
156760738|NCT01951417|565875770|FG000|Overall Study|Protocol Violation|2|||
156760739|NCT01951417|565875770|FG000|Overall Study|Lost to Follow-up|6|||
156760740|NCT04010461|565875771|FG000|Overall Study|COVID based withdrawal|5|||
156760741|NCT04010461|565875771|FG000|Overall Study|Withdrawal by Subject|5|||
156760742|NCT04010461|565875771|FG000|Overall Study|Adverse Event|1|||
157001645|NCT02685033|566754351|FG000|Overall Study|Adverse Event|1|||
157001646|NCT02685033|566754352|FG001|Overall Study|Adverse Event|0|||
156760743|NCT04010461|565875771|FG000|Overall Study|No Motor Threshold obtainable|1|||
156760744|NCT04010461|565875771|FG000|Overall Study|Physician Decision|1|||
156760745|NCT02324361|565875776|FG000|Overall Study|Lost to Follow-up|5|||
157001647|NCT02013037|566754357|FG000|Overall Study|Death|6|||
156760746|NCT02324361|565875777|FG001|Overall Study|Lost to Follow-up|2|||
156760747|NCT00715403|565875785|FG000|Overall Study|Progressive disease|0|||
156760748|NCT00715403|565875786|FG001|Overall Study|Progressive disease|1|||
156760749|NCT00715403|565875787|FG002|Overall Study|Progressive disease|3|||
156760750|NCT00715403|565875788|FG003|Overall Study|Progressive disease|9|||
156760751|NCT00715403|565875789|FG004|Overall Study|Progressive disease|5|||
156760752|NCT00715403|565875790|FG005|Overall Study|Progressive disease|14|||
156760753|NCT00715403|565875791|FG006|Overall Study|Progressive disease|1|||
156760754|NCT00715403|565875785|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760755|NCT00715403|565875786|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760756|NCT00715403|565875787|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760757|NCT00715403|565875788|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760758|NCT00715403|565875789|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760759|NCT00715403|565875790|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
156760760|NCT00715403|565875791|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
156760761|NCT00715403|565875785|FG000|Overall Study|Other Adverse Event than DLT|1|||
156760762|NCT00715403|565875786|FG001|Overall Study|Other Adverse Event than DLT|0|||
156760763|NCT00715403|565875787|FG002|Overall Study|Other Adverse Event than DLT|0|||
156760764|NCT00715403|565875788|FG003|Overall Study|Other Adverse Event than DLT|0|||
156760765|NCT00715403|565875789|FG004|Overall Study|Other Adverse Event than DLT|0|||
156760766|NCT00715403|565875790|FG005|Overall Study|Other Adverse Event than DLT|2|||
156760767|NCT00715403|565875791|FG006|Overall Study|Other Adverse Event than DLT|0|||
156760768|NCT00715403|565875785|FG000|Overall Study|Protocol Violation|0|||
156760769|NCT00715403|565875786|FG001|Overall Study|Protocol Violation|0|||
156760770|NCT00715403|565875787|FG002|Overall Study|Protocol Violation|0|||
156760771|NCT00715403|565875788|FG003|Overall Study|Protocol Violation|0|||
156760772|NCT00715403|565875789|FG004|Overall Study|Protocol Violation|0|||
156760773|NCT00715403|565875790|FG005|Overall Study|Protocol Violation|1|||
156760774|NCT00715403|565875791|FG006|Overall Study|Protocol Violation|0|||
156760775|NCT00715403|565875785|FG000|Overall Study|Other reason not defined above|0|||
156760776|NCT00715403|565875786|FG001|Overall Study|Other reason not defined above|0|||
156760777|NCT00715403|565875787|FG002|Overall Study|Other reason not defined above|1|||
156760778|NCT00715403|565875788|FG003|Overall Study|Other reason not defined above|0|||
156760779|NCT00715403|565875789|FG004|Overall Study|Other reason not defined above|1|||
156760780|NCT00715403|565875790|FG005|Overall Study|Other reason not defined above|1|||
156760781|NCT00715403|565875791|FG006|Overall Study|Other reason not defined above|0|||
156760782|NCT00101868|565875799|FG000|Overall Study|Death|10|||
156760783|NCT00101868|565875800|FG001|Overall Study|Death|10|||
156760784|NCT00101868|565875799|FG000|Overall Study|Withdrawal by Subject|8|||
156760785|NCT00101868|565875800|FG001|Overall Study|Withdrawal by Subject|9|||
156760786|NCT00101868|565875799|FG000|Overall Study|Protocol Violation|3|||
156760787|NCT00101868|565875800|FG001|Overall Study|Protocol Violation|0|||
156760788|NCT00101868|565875799|FG000|Overall Study|Lost to Follow-up|8|||
156760789|NCT00101868|565875800|FG001|Overall Study|Lost to Follow-up|13|||
156760790|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
156760791|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
156760792|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
156760793|NCT04001803|565875801|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
156760794|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
156760795|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
156760796|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
156760797|NCT04001803|565875801|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
156760798|NCT04001803|565875801|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
156760799|NCT04001803|565875801|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
157001648|NCT02013037|566754357|FG000|Overall Study|Withdrawal by Subject|1|||
157001649|NCT02013037|566754357|FG000|Overall Study|Awaiting Transplantation|7|||
157001650|NCT02013037|566754357|FG000|Overall Study|Transplanted without DSA|2|||
157001651|NCT00708097|566754358|FG000|Period 1|Protocol Violation|0|||
157001652|NCT00708097|566754359|FG001|Period 1|Protocol Violation|1|||
157001653|NCT00708097|566754360|FG002|Period 1|Protocol Violation|0|||
157001654|NCT00708097|566754361|FG003|Period 1|Protocol Violation|2|||
157001655|NCT00708097|566754362|FG004|Period 1|Protocol Violation|0|||
156760800|NCT01931397|565875804|FG000|Overall Study|Physician Decision|2|||
156760801|NCT01931397|565875804|FG000|Overall Study|Withdrawal by Subject|8|||
156760802|NCT01931397|565875804|FG000|Overall Study|moved out of state|1|||
156760803|NCT02329327|565875808|FG000|Overall Study|Death|78|||
156760804|NCT02329327|565875809|FG001|Overall Study|Death|0|||
156760805|NCT02329327|565875808|FG000|Overall Study|Withdrawal by Subject|3|||
156760806|NCT02329327|565875809|FG001|Overall Study|Withdrawal by Subject|0|||
156760807|NCT02329327|565875808|FG000|Overall Study|Lost to Follow-up|4|||
156760808|NCT02329327|565875809|FG001|Overall Study|Lost to Follow-up|0|||
156760809|NCT02493517|565875810|FG000|Overall Study|Protocol Violation|1|||
156760810|NCT02493517|565875811|FG001|Overall Study|Protocol Violation|2|||
156760811|NCT02493517|565875810|FG000|Overall Study|Withdrawal by Subject|1|||
157001656|NCT00708097|566754358|FG000|Period 1|Other Reason|0|||
156760812|NCT02493517|565875811|FG001|Overall Study|Withdrawal by Subject|2|||
156760813|NCT02493517|565875810|FG000|Overall Study|Adverse Event|0|||
156760814|NCT02493517|565875811|FG001|Overall Study|Adverse Event|2|||
156760815|NCT02493517|565875810|FG000|Overall Study|Missed study visit|0|||
156760816|NCT02493517|565875811|FG001|Overall Study|Missed study visit|1|||
156760817|NCT01367249|565875812|FG000|Overall Study|Withdrawal by Subject|6|||
156760818|NCT01367249|565875813|FG001|Overall Study|Withdrawal by Subject|6|||
156760819|NCT01367249|565875812|FG000|Overall Study|Other|3|||
157104523|NCT01641237|567137966|FG002|Period III|Lost to Follow-up|0|||
157104524|NCT01641237|567137967|FG003|Period III|Lost to Follow-up|0|||
157104525|NCT00832117|567137968|FG000|Overall Study|Death|1|||
157104526|NCT00832117|567137968|FG000|Overall Study|Disease Progression|11|||
157104527|NCT01301456|567137969|FG000|Stage 1|Withdrawal by Subject|0|||
157104528|NCT01301456|567137970|FG001|Stage 1|Withdrawal by Subject|0|||
157104529|NCT01301456|567137971|FG002|Stage 1|Withdrawal by Subject|1|||
157104530|NCT01301456|567137972|FG003|Stage 1|Withdrawal by Subject|0|||
157104531|NCT01301456|567137973|FG004|Stage 1|Withdrawal by Subject|1|||
157104532|NCT01301456|567137974|FG005|Stage 1|Withdrawal by Subject|0|||
157104533|NCT01301456|567137975|FG006|Stage 1|Withdrawal by Subject|0|||
157104534|NCT01301456|567137976|FG007|Stage 1|Withdrawal by Subject|0|||
157001657|NCT00708097|566754359|FG001|Period 1|Other Reason|0|||
157001658|NCT00708097|566754360|FG002|Period 1|Other Reason|0|||
157001659|NCT00708097|566754361|FG003|Period 1|Other Reason|0|||
157001660|NCT00708097|566754362|FG004|Period 1|Other Reason|1|||
157001661|NCT00708097|566754358|FG000|Period 2|Protocol Violation|0|||
157001662|NCT00708097|566754359|FG001|Period 2|Protocol Violation|1|||
157001663|NCT00708097|566754360|FG002|Period 2|Protocol Violation|1|||
157001664|NCT00708097|566754361|FG003|Period 2|Protocol Violation|1|||
157104535|NCT01301456|567137977|FG008|Stage 1|Withdrawal by Subject|0|||
157104536|NCT01301456|567137978|FG009|Stage 1|Withdrawal by Subject|0|||
157104537|NCT01301456|567137979|FG010|Stage 1|Withdrawal by Subject|0|||
157104538|NCT01301456|567137980|FG011|Stage 1|Withdrawal by Subject|0|||
157104539|NCT01301456|567137969|FG000|Stage 1|Randomized but not treated|0|||
157104540|NCT01301456|567137970|FG001|Stage 1|Randomized but not treated|0|||
157104541|NCT01301456|567137971|FG002|Stage 1|Randomized but not treated|0|||
157104542|NCT01301456|567137972|FG003|Stage 1|Randomized but not treated|0|||
156760820|NCT01367249|565875813|FG001|Overall Study|Other|10|||
156760821|NCT03718429|565875814|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
156760822|NCT03718429|565875815|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
156760823|NCT03718429|565875816|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
156760824|NCT03718429|565875817|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
156760825|NCT05404711|565875818|FG000|Completed Study Visit|Withdrawal by Subject|1|||
156760826|NCT05404711|565875818|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
156760827|NCT05404711|565875818|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
156760828|NCT05404711|565875818|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
156760829|NCT05404711|565875818|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
156760830|NCT05404711|565875818|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
156760831|NCT02346877|565875819|FG000|Overall Study|Adverse Event|1|||
156760832|NCT02346877|565875820|FG001|Overall Study|Adverse Event|0|||
156760833|NCT02346877|565875819|FG000|Overall Study|Administrative Decision|1|||
156760834|NCT02346877|565875820|FG001|Overall Study|Administrative Decision|0|||
156760835|NCT02346877|565875819|FG000|Overall Study|Sponsor Decision|12|||
156760836|NCT02346877|565875820|FG001|Overall Study|Sponsor Decision|0|||
156760837|NCT02346877|565875819|FG000|Overall Study|Missing|5|||
156760838|NCT02346877|565875820|FG001|Overall Study|Missing|0|||
156760839|NCT01683604|565875823|FG000|Overall Study|Adverse Event|2|||
156760840|NCT01683604|565875823|FG000|Overall Study|Lack of Efficacy|1|||
156760841|NCT01683604|565875823|FG000|Overall Study|Other|2|||
157001665|NCT00708097|566754362|FG004|Period 2|Protocol Violation|0|||
157001666|NCT00603447|566754363|FG000|Overall Study|Adverse Event|0|||
157001667|NCT00603447|566754364|FG001|Overall Study|Adverse Event|1|||
157001668|NCT00603447|566754365|FG002|Overall Study|Adverse Event|1|||
157104543|NCT01301456|567137973|FG004|Stage 1|Randomized but not treated|0|||
156760842|NCT03430856|565875824|FG000|Overall Study|Adverse Event|0|||
157104544|NCT01301456|567137974|FG005|Stage 1|Randomized but not treated|0|||
157104545|NCT01301456|567137975|FG006|Stage 1|Randomized but not treated|1|||
157104546|NCT01301456|567137976|FG007|Stage 1|Randomized but not treated|0|||
157104547|NCT01301456|567137977|FG008|Stage 1|Randomized but not treated|0|||
156760843|NCT03430856|565875825|FG001|Overall Study|Adverse Event|1|||
156760844|NCT03430856|565875826|FG002|Overall Study|Adverse Event|0|||
156760845|NCT03430856|565875824|FG000|Overall Study|Rescue criteria|1|||
156760846|NCT03430856|565875825|FG001|Overall Study|Rescue criteria|1|||
157001669|NCT00603447|566754366|FG003|Overall Study|Adverse Event|2|||
157001670|NCT00603447|566754367|FG004|Overall Study|Adverse Event|1|||
157001671|NCT00603447|566754368|FG005|Overall Study|Adverse Event|2|||
157104548|NCT01301456|567137978|FG009|Stage 1|Randomized but not treated|0|||
157104549|NCT01301456|567137979|FG010|Stage 1|Randomized but not treated|0|||
157104550|NCT01301456|567137980|FG011|Stage 1|Randomized but not treated|0|||
157104551|NCT01301456|567137969|FG000|Stage 2|Adverse Event|0|||
157104552|NCT01301456|567137970|FG001|Stage 2|Adverse Event|0|||
157104553|NCT01301456|567137971|FG002|Stage 2|Adverse Event|0|||
157104554|NCT01301456|567137972|FG003|Stage 2|Adverse Event|0|||
157104555|NCT01301456|567137973|FG004|Stage 2|Adverse Event|0|||
157104556|NCT01301456|567137974|FG005|Stage 2|Adverse Event|0|||
157104557|NCT01301456|567137975|FG006|Stage 2|Adverse Event|0|||
157104558|NCT01301456|567137976|FG007|Stage 2|Adverse Event|0|||
157104559|NCT01301456|567137977|FG008|Stage 2|Adverse Event|0|||
157104560|NCT01301456|567137978|FG009|Stage 2|Adverse Event|0|||
157104561|NCT01301456|567137979|FG010|Stage 2|Adverse Event|1|||
157104562|NCT01301456|567137980|FG011|Stage 2|Adverse Event|0|||
157104563|NCT03239483|567137981|FG000|Overall Study|Lost to Follow-up|1|||
157104564|NCT03239483|567137982|FG001|Overall Study|Lost to Follow-up|0|||
157104565|NCT03239483|567137981|FG000|Overall Study|Withdrawal by Subject|1|||
157104566|NCT03239483|567137982|FG001|Overall Study|Withdrawal by Subject|0|||
157104567|NCT03678103|567137983|FG000|Overall Study|Withdrawn prior to completion|4|||
156760847|NCT03430856|565875826|FG002|Overall Study|Rescue criteria|0|||
156760848|NCT03430856|565875824|FG000|Overall Study|Voluntary withdrawal of consent|1|||
156760849|NCT03430856|565875825|FG001|Overall Study|Voluntary withdrawal of consent|1|||
156760850|NCT03430856|565875826|FG002|Overall Study|Voluntary withdrawal of consent|1|||
156760851|NCT02481050|565877838|FG000|Overall Study|Adverse Event|1|||
156760852|NCT02481050|565877838|FG000|Overall Study|Disease Progression|47|||
156760853|NCT02481050|565877838|FG000|Overall Study|Withdrawal by Subject|7|||
156760854|NCT02481050|565877838|FG000|Overall Study|Other|3|||
156760855|NCT01386606|565877839|FG000|Overall Study|Adverse Event|0|||
156760856|NCT01386606|565877840|FG001|Overall Study|Adverse Event|1|||
156760857|NCT01386606|565877841|FG002|Overall Study|Adverse Event|0|||
156760858|NCT01386606|565877842|FG003|Overall Study|Adverse Event|0|||
156760859|NCT01386606|565877839|FG000|Overall Study|Withdrawal by Subject|0|||
156760860|NCT01386606|565877840|FG001|Overall Study|Withdrawal by Subject|1|||
156760861|NCT01386606|565877841|FG002|Overall Study|Withdrawal by Subject|1|||
156760862|NCT01386606|565877842|FG003|Overall Study|Withdrawal by Subject|0|||
156760863|NCT01386606|565877839|FG000|Overall Study|Protocol Violation|1|||
156760864|NCT01386606|565877840|FG001|Overall Study|Protocol Violation|0|||
156760865|NCT01386606|565877841|FG002|Overall Study|Protocol Violation|1|||
156760866|NCT01386606|565877842|FG003|Overall Study|Protocol Violation|1|||
156760867|NCT01386606|565877839|FG000|Overall Study|Lost to Follow-up|2|||
156760868|NCT01386606|565877840|FG001|Overall Study|Lost to Follow-up|0|||
156760869|NCT01386606|565877841|FG002|Overall Study|Lost to Follow-up|0|||
156760870|NCT01386606|565877842|FG003|Overall Study|Lost to Follow-up|0|||
156760871|NCT01386606|565877839|FG000|Overall Study|Subject incarcerated|0|||
156760872|NCT01386606|565877840|FG001|Overall Study|Subject incarcerated|1|||
156760873|NCT01386606|565877841|FG002|Overall Study|Subject incarcerated|0|||
156760874|NCT01386606|565877842|FG003|Overall Study|Subject incarcerated|0|||
156760875|NCT01386606|565877839|FG000|Overall Study|Unable to draw PK|1|||
156760876|NCT01386606|565877840|FG001|Overall Study|Unable to draw PK|0|||
156760877|NCT01386606|565877841|FG002|Overall Study|Unable to draw PK|0|||
156760878|NCT01386606|565877842|FG003|Overall Study|Unable to draw PK|0|||
156760879|NCT01386606|565877839|FG000|Overall Study|T levels too high|0|||
156760880|NCT01386606|565877840|FG001|Overall Study|T levels too high|1|||
156760881|NCT01386606|565877841|FG002|Overall Study|T levels too high|1|||
156760882|NCT01386606|565877842|FG003|Overall Study|T levels too high|0|||
156760883|NCT01548599|565877845|FG000|Overall Study|Lost to Follow-up|0|||
156760884|NCT01548599|565877846|FG001|Overall Study|Lost to Follow-up|1|||
156760885|NCT01548599|565877845|FG000|Overall Study|Withdrawal by Subject|4|||
156760886|NCT01548599|565877846|FG001|Overall Study|Withdrawal by Subject|0|||
156760887|NCT01548599|565877845|FG000|Overall Study|Death|2|||
156760888|NCT01548599|565877846|FG001|Overall Study|Death|1|||
156760889|NCT03638128|565877847|FG000|Overall Study|Withdrawal by Subject|1|||
157104568|NCT00770770|567137991|FG000|Overall Study|Lost to Follow-up|1|||
157104569|NCT00770770|567137992|FG001|Overall Study|Lost to Follow-up|0|||
156760890|NCT03638128|565877848|FG001|Overall Study|Withdrawal by Subject|7|||
156760891|NCT03638128|565877849|FG002|Overall Study|Withdrawal by Subject|6|||
156760892|NCT03638128|565877847|FG000|Overall Study|Sponsor Decision|15|||
156760893|NCT03638128|565877848|FG001|Overall Study|Sponsor Decision|12|||
156760894|NCT03638128|565877849|FG002|Overall Study|Sponsor Decision|19|||
156760895|NCT03638128|565877847|FG000|Overall Study|Lost to Follow-up|0|||
157104570|NCT00770770|567137991|FG000|Overall Study|Withdrawal by Subject|1|||
157104571|NCT00770770|567137992|FG001|Overall Study|Withdrawal by Subject|0|||
156760896|NCT03638128|565877848|FG001|Overall Study|Lost to Follow-up|0|||
156760897|NCT03638128|565877849|FG002|Overall Study|Lost to Follow-up|1|||
156760898|NCT00611806|565877850|FG000|Overall Study|Withdrawal by Subject|8|||
156760899|NCT00611806|565877851|FG001|Overall Study|Withdrawal by Subject|2|||
156760900|NCT00611806|565877850|FG000|Overall Study|Adverse Event|2|||
156760901|NCT00611806|565877851|FG001|Overall Study|Adverse Event|1|||
157104572|NCT00770770|567137991|FG000|Overall Study|Death|0|||
157104573|NCT00770770|567137992|FG001|Overall Study|Death|1|||
157104574|NCT00770770|567137991|FG000|Overall Study|Study Terminated|8|||
157104575|NCT00770770|567137992|FG001|Overall Study|Study Terminated|0|||
156760902|NCT00611806|565877850|FG000|Overall Study|Lost to Follow-up|6|||
156760903|NCT00611806|565877851|FG001|Overall Study|Lost to Follow-up|0|||
156760904|NCT00329108|565877853|FG000|Overall Study|Adverse Event|2|||
156760905|NCT00329108|565877854|FG001|Overall Study|Adverse Event|2|||
156760906|NCT00329108|565877853|FG000|Overall Study|Lack of Efficacy|3|||
156760907|NCT00329108|565877854|FG001|Overall Study|Lack of Efficacy|3|||
156760908|NCT00329108|565877853|FG000|Overall Study|Withdrawal by Subject|0|||
156760909|NCT00329108|565877854|FG001|Overall Study|Withdrawal by Subject|2|||
156760910|NCT00329108|565877853|FG000|Overall Study|symptomatic deterioration|1|||
156760911|NCT00329108|565877854|FG001|Overall Study|symptomatic deterioration|1|||
156760912|NCT00329108|565877853|FG000|Overall Study|Subject no longer willing to participate|2|||
156760913|NCT00329108|565877854|FG001|Overall Study|Subject no longer willing to participate|2|||
156760914|NCT00329108|565877853|FG000|Overall Study|study terminated by sponsor|1|||
156760915|NCT00329108|565877854|FG001|Overall Study|study terminated by sponsor|0|||
156760916|NCT00329108|565877853|FG000|Overall Study|withdrew patient after SAE resolved|1|||
156760917|NCT00329108|565877854|FG001|Overall Study|withdrew patient after SAE resolved|0|||
156760918|NCT00329108|565877853|FG000|Overall Study|Protocol Violation|0|||
156760919|NCT00329108|565877854|FG001|Overall Study|Protocol Violation|2|||
156760920|NCT00754741|565877855|FG000|Overall Study|Died or disenrolled|57|||
156760921|NCT00754741|565877856|FG001|Overall Study|Died or disenrolled|69|||
156760922|NCT00754741|565877857|FG002|Overall Study|Died or disenrolled|54|||
156760923|NCT04152200|565877859|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
156760924|NCT04152200|565877860|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
156760925|NCT04969289|565877861|FG000|Overall Study|Lost to Follow-up|13|||
156760926|NCT04969289|565877862|FG001|Overall Study|Lost to Follow-up|9|||
156760927|NCT00593814|565877863|FG000|Overall Study|Death|7|||
156760928|NCT00593814|565877864|FG001|Overall Study|Death|0|||
156760929|NCT00593814|565877863|FG000|Overall Study|Withdrawal by Subject|7|||
156760930|NCT00593814|565877864|FG001|Overall Study|Withdrawal by Subject|0|||
156760931|NCT00593814|565877863|FG000|Overall Study|Lost to Follow-up|7|||
156760932|NCT00593814|565877864|FG001|Overall Study|Lost to Follow-up|0|||
156760933|NCT00593814|565877863|FG000|Overall Study|Physician Decision|3|||
156760934|NCT00593814|565877864|FG001|Overall Study|Physician Decision|0|||
156760935|NCT01921517|565877865|FG000|Overall Study|Lost to Follow-up|5|||
156760936|NCT01921517|565877866|FG001|Overall Study|Lost to Follow-up|0|||
156760937|NCT01921517|565877865|FG000|Overall Study|Newly diagnosed health concern|2|||
156760938|NCT01921517|565877866|FG001|Overall Study|Newly diagnosed health concern|0|||
156760939|NCT01921517|565877865|FG000|Overall Study|Physician Decision|0|||
156760940|NCT01921517|565877866|FG001|Overall Study|Physician Decision|2|||
156760941|NCT01921517|565877865|FG000|Overall Study|Withdrawal by Subject|7|||
156760942|NCT01921517|565877866|FG001|Overall Study|Withdrawal by Subject|3|||
156760943|NCT01921517|565877865|FG000|Overall Study|Subject missed final imaging|1|||
156760944|NCT01921517|565877866|FG001|Overall Study|Subject missed final imaging|4|||
156760945|NCT04069715|565877869|FG000|Overall Study|Lost to Follow-up|1|||
156760946|NCT04069715|565877870|FG001|Overall Study|Lost to Follow-up|1|||
156760947|NCT04069715|565877869|FG000|Overall Study|Physician Decision|1|||
156760948|NCT04069715|565877870|FG001|Overall Study|Physician Decision|1|||
156760949|NCT04069715|565877869|FG000|Overall Study|Withdrawal by Subject|3|||
156760950|NCT04069715|565877870|FG001|Overall Study|Withdrawal by Subject|3|||
156760951|NCT02723188|565877871|FG000|Overall Study|Withdrawal by Subject|1|||
156760952|NCT02723188|565877872|FG001|Overall Study|Withdrawal by Subject|0|||
156760953|NCT02723188|565877873|FG002|Overall Study|Withdrawal by Subject|0|||
156760954|NCT03110354|565877874|FG000|Overall Study|Death|1|||
156760955|NCT03110354|565877875|FG001|Overall Study|Death|0|||
156760956|NCT03110354|565877876|FG002|Overall Study|Death|0|||
156760957|NCT03110354|565877877|FG003|Overall Study|Death|1|||
156760958|NCT03110354|565877878|FG004|Overall Study|Death|0|||
156760959|NCT03110354|565877874|FG000|Overall Study|Start of new therapy|0|||
156760960|NCT03110354|565877875|FG001|Overall Study|Start of new therapy|0|||
156760961|NCT03110354|565877876|FG002|Overall Study|Start of new therapy|0|||
156760962|NCT03110354|565877877|FG003|Overall Study|Start of new therapy|0|||
156760963|NCT03110354|565877878|FG004|Overall Study|Start of new therapy|1|||
156760964|NCT03110354|565877874|FG000|Overall Study|Failure to achieve response|2|||
157001672|NCT00603447|566754369|FG006|Overall Study|Adverse Event|10|||
157001673|NCT00603447|566754363|FG000|Overall Study|Other|0|||
156760965|NCT03110354|565877875|FG001|Overall Study|Failure to achieve response|3|||
156760966|NCT03110354|565877876|FG002|Overall Study|Failure to achieve response|0|||
156760967|NCT03110354|565877877|FG003|Overall Study|Failure to achieve response|2|||
156760968|NCT03110354|565877878|FG004|Overall Study|Failure to achieve response|1|||
156760969|NCT03110354|565877874|FG000|Overall Study|Progressive disease|1|||
156760970|NCT03110354|565877875|FG001|Overall Study|Progressive disease|1|||
156760971|NCT03110354|565877876|FG002|Overall Study|Progressive disease|3|||
156760972|NCT03110354|565877877|FG003|Overall Study|Progressive disease|4|||
156760973|NCT03110354|565877878|FG004|Overall Study|Progressive disease|2|||
156760974|NCT03110354|565877874|FG000|Overall Study|Adverse Event|0|||
156760975|NCT03110354|565877875|FG001|Overall Study|Adverse Event|0|||
157001674|NCT00603447|566754364|FG001|Overall Study|Other|0|||
156760976|NCT03110354|565877876|FG002|Overall Study|Adverse Event|0|||
156760977|NCT03110354|565877877|FG003|Overall Study|Adverse Event|2|||
156760978|NCT03110354|565877878|FG004|Overall Study|Adverse Event|2|||
156760979|NCT03110354|565877874|FG000|Overall Study|Other|0|||
156760980|NCT03110354|565877875|FG001|Overall Study|Other|0|||
156760981|NCT03110354|565877876|FG002|Overall Study|Other|0|||
156760982|NCT03110354|565877877|FG003|Overall Study|Other|1|||
156760983|NCT03110354|565877878|FG004|Overall Study|Other|1|||
156760984|NCT01965327|565877882|FG000|Overall Study|Physician Decision|2|||
156760985|NCT01145482|565877884|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156760986|NCT01145482|565877885|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156760987|NCT00165503|565877886|FG000|Overall Study|Death|1|||
156760988|NCT00165503|565877886|FG000|Overall Study|Lost to Follow-up|12|||
156760989|NCT00165503|565877886|FG000|Overall Study|Unresectable|3|||
156760990|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Death|20|||
156760991|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Death|26|||
156760992|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
156760993|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
156760994|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
156760995|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
156760996|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
156760997|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
156760998|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
156760999|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
156761000|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
156761001|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
156761002|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
156761003|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
156761004|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
156761005|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
156761006|NCT00643201|565877887|FG000|Randomized, Completed 6 Months of Study|Other|107|||
156761007|NCT00643201|565877888|FG001|Randomized, Completed 6 Months of Study|Other|107|||
156761008|NCT00643201|565877887|FG000|Completed Study Follow Up|Death|28|||
156761009|NCT00643201|565877888|FG001|Completed Study Follow Up|Death|34|||
156761010|NCT00643201|565877887|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
156761011|NCT00643201|565877888|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
156761012|NCT00643201|565877887|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
156761013|NCT00643201|565877888|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
156761014|NCT00643201|565877887|FG000|Completed Study Follow Up|non-specified|1|||
156761015|NCT00643201|565877888|FG001|Completed Study Follow Up|non-specified|0|||
156761016|NCT02976519|565877889|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761017|NCT02976519|565877890|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
156761018|NCT02976519|565877891|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761019|NCT02976519|565877892|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761020|NCT02976519|565877893|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761021|NCT02976519|565877894|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761022|NCT02976519|565877895|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
156761023|NCT02976519|565877889|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761024|NCT02976519|565877890|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761025|NCT02976519|565877891|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761026|NCT02976519|565877892|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
156761027|NCT02976519|565877893|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761028|NCT02976519|565877894|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761029|NCT02976519|565877895|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
156761030|NCT02976519|565877889|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761031|NCT02976519|565877890|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761032|NCT02976519|565877891|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761033|NCT02976519|565877892|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761034|NCT02976519|565877893|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761035|NCT02976519|565877894|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
156761036|NCT02976519|565877895|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
156761037|NCT02976519|565877889|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761038|NCT02976519|565877890|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761039|NCT02976519|565877891|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761040|NCT02976519|565877892|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761041|NCT02976519|565877893|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
157104576|NCT02486653|567137993|FG000|Overall Study|Withdrawal by Subject|1|||
157104577|NCT02486653|567137994|FG001|Overall Study|Withdrawal by Subject|3|||
157104578|NCT02486653|567137993|FG000|Overall Study|Protocol Violation|1|||
157104579|NCT02486653|567137994|FG001|Overall Study|Protocol Violation|0|||
156761042|NCT02976519|565877894|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
156761043|NCT02976519|565877895|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
156761044|NCT02976519|565877889|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761045|NCT02976519|565877890|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761046|NCT02976519|565877891|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761047|NCT02976519|565877892|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761048|NCT02976519|565877893|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761049|NCT02976519|565877894|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
156761050|NCT02976519|565877895|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
156761051|NCT01278342|565877896|FG000|Overall Study|Physician Decision|0|||
156761052|NCT01278342|565877897|FG001|Overall Study|Physician Decision|1|||
156761053|NCT01278342|565877898|FG002|Overall Study|Physician Decision|0|||
156761054|NCT01278342|565877896|FG000|Overall Study|Lost to Follow-up|1|||
156761055|NCT01278342|565877897|FG001|Overall Study|Lost to Follow-up|0|||
156761056|NCT01278342|565877898|FG002|Overall Study|Lost to Follow-up|0|||
156761057|NCT01278342|565877896|FG000|Overall Study|Administrative problems|2|||
156761058|NCT01278342|565877897|FG001|Overall Study|Administrative problems|0|||
156761059|NCT01278342|565877898|FG002|Overall Study|Administrative problems|0|||
156761060|NCT01278342|565877896|FG000|Overall Study|Other|1|||
156761061|NCT01278342|565877897|FG001|Overall Study|Other|0|||
156761062|NCT01278342|565877898|FG002|Overall Study|Other|0|||
156761063|NCT00473655|565877906|FG000|Overall Study|Lost to Follow-up|9|||
156761064|NCT00473655|565877907|FG001|Overall Study|Lost to Follow-up|5|||
156761065|NCT00473655|565877908|FG002|Overall Study|Lost to Follow-up|8|||
156761066|NCT00891813|565877909|FG000|Overall Study|Adverse Event|3|||
156761067|NCT00891813|565877909|FG000|Overall Study|Withdrawal by Subject|1|||
156761068|NCT00891813|565877909|FG000|Overall Study|Patient Noncompliance|6|||
156761069|NCT00891813|565877909|FG000|Overall Study|Protocol Violation|2|||
156761070|NCT00243919|565877917|FG000|Overall Study|Death|3|||
156761071|NCT00243919|565877918|FG001|Overall Study|Death|4|||
156761072|NCT00243919|565877919|FG002|Overall Study|Death|6|||
156761073|NCT00243919|565877917|FG000|Overall Study|Withdrawal by Subject|6|||
156761074|NCT00243919|565877918|FG001|Overall Study|Withdrawal by Subject|6|||
156761075|NCT00243919|565877919|FG002|Overall Study|Withdrawal by Subject|2|||
156761076|NCT00243919|565877917|FG000|Overall Study|Lost to Follow-up|6|||
156761077|NCT00243919|565877918|FG001|Overall Study|Lost to Follow-up|7|||
156761078|NCT00243919|565877919|FG002|Overall Study|Lost to Follow-up|3|||
156761079|NCT00243919|565877917|FG000|Overall Study|Administrative Error|1|||
156761080|NCT00243919|565877918|FG001|Overall Study|Administrative Error|0|||
156761081|NCT00243919|565877919|FG002|Overall Study|Administrative Error|0|||
156761082|NCT00243919|565877917|FG000|Overall Study|Physician Decision|1|||
156761083|NCT00243919|565877918|FG001|Overall Study|Physician Decision|1|||
156761084|NCT00243919|565877919|FG002|Overall Study|Physician Decision|0|||
156761085|NCT02513550|565877920|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
156761086|NCT02513550|565877921|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
156761087|NCT02513550|565877922|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
156761088|NCT02513550|565877923|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761089|NCT02513550|565877924|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761090|NCT02513550|565877925|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
156761091|NCT02513550|565877920|FG000|Double Blind Treatment Period|Adverse Event|5|||
156761092|NCT02513550|565877921|FG001|Double Blind Treatment Period|Adverse Event|13|||
156761093|NCT02513550|565877922|FG002|Double Blind Treatment Period|Adverse Event|17|||
156761094|NCT02513550|565877923|FG003|Double Blind Treatment Period|Adverse Event|0|||
156761095|NCT02513550|565877924|FG004|Double Blind Treatment Period|Adverse Event|1|||
156761096|NCT02513550|565877925|FG005|Double Blind Treatment Period|Adverse Event|0|||
156761097|NCT02513550|565877920|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
156761098|NCT02513550|565877921|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
156761099|NCT02513550|565877922|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
156761100|NCT02513550|565877923|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
156761101|NCT02513550|565877924|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
156761102|NCT02513550|565877925|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
156761103|NCT02513550|565877920|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
156761104|NCT02513550|565877921|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
156761105|NCT02513550|565877922|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
156761106|NCT02513550|565877923|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156761107|NCT02513550|565877924|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
156761108|NCT02513550|565877925|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
156761109|NCT02513550|565877920|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156761110|NCT02513550|565877921|FG001|Double Blind Treatment Period|Protocol Violation|1|||
156761111|NCT02513550|565877922|FG002|Double Blind Treatment Period|Protocol Violation|4|||
156761112|NCT02513550|565877923|FG003|Double Blind Treatment Period|Protocol Violation|0|||
156761113|NCT02513550|565877924|FG004|Double Blind Treatment Period|Protocol Violation|0|||
156761114|NCT02513550|565877925|FG005|Double Blind Treatment Period|Protocol Violation|0|||
156761115|NCT02513550|565877920|FG000|Double Blind Treatment Period|Physician Decision|2|||
156761116|NCT02513550|565877921|FG001|Double Blind Treatment Period|Physician Decision|0|||
156761117|NCT02513550|565877922|FG002|Double Blind Treatment Period|Physician Decision|4|||
156761118|NCT02513550|565877923|FG003|Double Blind Treatment Period|Physician Decision|0|||
156761119|NCT02513550|565877924|FG004|Double Blind Treatment Period|Physician Decision|0|||
156761120|NCT02513550|565877925|FG005|Double Blind Treatment Period|Physician Decision|0|||
156761121|NCT02513550|565877920|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
156761122|NCT02513550|565877921|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
156761123|NCT02513550|565877922|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
156761124|NCT02513550|565877923|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761125|NCT02513550|565877924|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761126|NCT02513550|565877925|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
156761127|NCT02513550|565877920|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761128|NCT02513550|565877921|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761129|NCT02513550|565877922|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
156761130|NCT02513550|565877923|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761131|NCT02513550|565877924|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761132|NCT02513550|565877925|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
156761133|NCT02513550|565877920|FG000|Double Blind Treatment Period|Due to personal business|2|||
156761134|NCT02513550|565877921|FG001|Double Blind Treatment Period|Due to personal business|0|||
156761135|NCT02513550|565877922|FG002|Double Blind Treatment Period|Due to personal business|1|||
156761136|NCT02513550|565877923|FG003|Double Blind Treatment Period|Due to personal business|0|||
156761137|NCT02513550|565877924|FG004|Double Blind Treatment Period|Due to personal business|0|||
156761138|NCT02513550|565877925|FG005|Double Blind Treatment Period|Due to personal business|0|||
157104580|NCT02486653|567137993|FG000|Overall Study|surgery cancelled|4|||
157104581|NCT02486653|567137994|FG001|Overall Study|surgery cancelled|1|||
157104582|NCT01006265|567137995|FG000|Overall Study|Lost to Follow-up|1|||
157104583|NCT01006265|567137996|FG001|Overall Study|Lost to Follow-up|0|||
157104584|NCT01006265|567137997|FG002|Overall Study|Lost to Follow-up|1|||
157104585|NCT01006265|567137998|FG003|Overall Study|Lost to Follow-up|0|||
157104586|NCT01006265|567137995|FG000|Overall Study|Withdrawal by Subject|4|||
157104587|NCT01006265|567137996|FG001|Overall Study|Withdrawal by Subject|7|||
157104588|NCT01006265|567137997|FG002|Overall Study|Withdrawal by Subject|5|||
157104589|NCT01006265|567137998|FG003|Overall Study|Withdrawal by Subject|5|||
157104590|NCT01006265|567137995|FG000|Overall Study|Administrative reason|1|||
157104591|NCT01006265|567137996|FG001|Overall Study|Administrative reason|2|||
157104592|NCT01006265|567137997|FG002|Overall Study|Administrative reason|3|||
157104593|NCT01006265|567137998|FG003|Overall Study|Administrative reason|0|||
157104594|NCT02101021|567137999|FG000|Overall Study|Death|4|||
157104595|NCT02101021|567138000|FG001|Overall Study|Death|3|||
157104596|NCT02101021|567138001|FG002|Overall Study|Death|6|||
157104597|NCT02101021|567138002|FG003|Overall Study|Death|0|||
157104598|NCT02101021|567138003|FG004|Overall Study|Death|3|||
157104599|NCT02101021|567137999|FG000|Overall Study|Withdrew Consent from study|1|||
157104600|NCT02101021|567138000|FG001|Overall Study|Withdrew Consent from study|1|||
157104601|NCT02101021|567138001|FG002|Overall Study|Withdrew Consent from study|0|||
157104602|NCT02101021|567138002|FG003|Overall Study|Withdrew Consent from study|2|||
157104603|NCT02101021|567138003|FG004|Overall Study|Withdrew Consent from study|0|||
156761139|NCT02513550|565877920|FG000|Double Blind Treatment Period|Death|1|||
156761140|NCT02513550|565877921|FG001|Double Blind Treatment Period|Death|0|||
156761141|NCT02513550|565877922|FG002|Double Blind Treatment Period|Death|2|||
156761142|NCT02513550|565877923|FG003|Double Blind Treatment Period|Death|0|||
156761143|NCT02513550|565877924|FG004|Double Blind Treatment Period|Death|0|||
156761144|NCT02513550|565877925|FG005|Double Blind Treatment Period|Death|0|||
156761145|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
156761146|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
156761147|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
156761148|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761149|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761150|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
156761151|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
156761152|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
156761153|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
156761154|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
156761155|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
156761156|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
157104604|NCT02101021|567137999|FG000|Overall Study|Lost to Follow-up|1|||
157104605|NCT02101021|567138000|FG001|Overall Study|Lost to Follow-up|0|||
157104606|NCT02101021|567138001|FG002|Overall Study|Lost to Follow-up|0|||
157104607|NCT02101021|567138002|FG003|Overall Study|Lost to Follow-up|0|||
157104608|NCT02101021|567138003|FG004|Overall Study|Lost to Follow-up|0|||
156761157|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
156761158|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
156761159|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
156761160|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761161|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761162|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
156761163|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
156761164|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
156761165|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
156761166|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
156761167|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
156761168|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
156761169|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
156761170|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
156761171|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
156761172|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
156761173|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
156761174|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
156761175|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Death|0|||
156761176|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Death|0|||
156761177|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Death|1|||
156761178|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Death|0|||
156761179|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Death|0|||
156761180|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Death|0|||
156761181|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761182|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761183|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
156761184|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761185|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761186|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
156761187|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761188|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761189|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
156761190|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761191|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761192|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
156761193|NCT02513550|565877920|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761194|NCT02513550|565877921|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761195|NCT02513550|565877922|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
156761196|NCT02513550|565877923|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761197|NCT02513550|565877924|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761198|NCT02513550|565877925|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
156761199|NCT04176939|565877926|FG000|Overall Study|Withdrawal by Subject|5|||
156761200|NCT04176939|565877926|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
156761201|NCT04176939|565877926|FG000|Overall Study|Lost to Follow-up|2|||
157001675|NCT00603447|566754365|FG002|Overall Study|Other|1|||
157001676|NCT00603447|566754366|FG003|Overall Study|Other|0|||
157001677|NCT00603447|566754367|FG004|Overall Study|Other|3|||
157001678|NCT00603447|566754368|FG005|Overall Study|Other|0|||
157001679|NCT00603447|566754369|FG006|Overall Study|Other|13|||
157001680|NCT00603447|566754363|FG000|Overall Study|Withdrew Consent|0|||
157001681|NCT00603447|566754364|FG001|Overall Study|Withdrew Consent|2|||
157001682|NCT00603447|566754365|FG002|Overall Study|Withdrew Consent|0|||
157001683|NCT00603447|566754366|FG003|Overall Study|Withdrew Consent|0|||
157001684|NCT00603447|566754367|FG004|Overall Study|Withdrew Consent|1|||
157001685|NCT00603447|566754368|FG005|Overall Study|Withdrew Consent|0|||
157001686|NCT00603447|566754369|FG006|Overall Study|Withdrew Consent|1|||
157001687|NCT01049503|566755951|FG000|Overall Study|Lost to Follow-up|11|||
157001688|NCT01049503|566755952|FG001|Overall Study|Lost to Follow-up|12|||
157001689|NCT01049503|566755953|FG002|Overall Study|Lost to Follow-up|24|||
157001690|NCT01049503|566755954|FG003|Overall Study|Lost to Follow-up|26|||
157001691|NCT01049503|566755955|FG004|Overall Study|Lost to Follow-up|27|||
157001692|NCT01049503|566755956|FG005|Overall Study|Lost to Follow-up|8|||
156761202|NCT04176939|565877926|FG000|Overall Study|Unspecified reason|4|||
156761203|NCT04176939|565877926|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
156761204|NCT02157519|565877927|FG000|Overall Study|Death|3|||
156761205|NCT02157519|565877928|FG001|Overall Study|Death|1|||
156761206|NCT02157519|565877927|FG000|Overall Study|Withdrawal by Subject|7|||
156761207|NCT02157519|565877928|FG001|Overall Study|Withdrawal by Subject|0|||
157001693|NCT00726596|566755957|FG000|Overall Study|Adverse Event|2|||
157001694|NCT00726596|566755958|FG001|Overall Study|Adverse Event|1|||
157001695|NCT00726596|566755957|FG000|Overall Study|Withdrawal by Subject|3|||
157001696|NCT00726596|566755958|FG001|Overall Study|Withdrawal by Subject|3|||
157001697|NCT02689349|566755960|FG000|Overall Study|Not implanted|4|||
157001698|NCT02689349|566755961|FG001|Overall Study|Not implanted|0|||
157001699|NCT02689349|566755960|FG000|Overall Study|Withdrawal by Subject|9|||
157001700|NCT02689349|566755961|FG001|Overall Study|Withdrawal by Subject|0|||
157001701|NCT00954707|566755970|FG000|Overall Study|Death|34|||
157001702|NCT00954707|566755970|FG000|Overall Study|Withdrawal by Subject|100|||
157001703|NCT00954707|566755970|FG000|Overall Study|Lost to Follow-up|33|||
157001704|NCT02987543|566755971|FG000|Overall Study|Ongoing study at data cut off|49|||
157001705|NCT02987543|566755972|FG001|Overall Study|Ongoing study at data cut off|21|||
157001706|NCT02987543|566755973|FG002|Overall Study|Ongoing study at data cut off|19|||
157001707|NCT02987543|566755974|FG003|Overall Study|Ongoing study at data cut off|12|||
157001708|NCT02987543|566755971|FG000|Overall Study|Death|88|||
157001709|NCT02987543|566755972|FG001|Overall Study|Death|54|||
157001710|NCT02987543|566755973|FG002|Overall Study|Death|67|||
157001711|NCT02987543|566755974|FG003|Overall Study|Death|28|||
157001712|NCT02987543|566755971|FG000|Overall Study|Lost to Follow-up|3|||
157001713|NCT02987543|566755972|FG001|Overall Study|Lost to Follow-up|0|||
157001714|NCT02987543|566755973|FG002|Overall Study|Lost to Follow-up|1|||
157001715|NCT02987543|566755974|FG003|Overall Study|Lost to Follow-up|0|||
157001716|NCT02987543|566755971|FG000|Overall Study|Screen failure|0|||
157001717|NCT02987543|566755972|FG001|Overall Study|Screen failure|0|||
157001718|NCT02987543|566755973|FG002|Overall Study|Screen failure|0|||
157001719|NCT02987543|566755974|FG003|Overall Study|Screen failure|1|||
157001720|NCT02987543|566755971|FG000|Overall Study|Withdrawal by Subject|21|||
157001721|NCT02987543|566755972|FG001|Overall Study|Withdrawal by Subject|7|||
157001722|NCT02987543|566755973|FG002|Overall Study|Withdrawal by Subject|7|||
157001723|NCT02987543|566755974|FG003|Overall Study|Withdrawal by Subject|6|||
157001724|NCT02987543|566755971|FG000|Overall Study|Study terminated by sponsor|1|||
157001725|NCT02987543|566755972|FG001|Overall Study|Study terminated by sponsor|0|||
157001726|NCT02987543|566755973|FG002|Overall Study|Study terminated by sponsor|0|||
157001727|NCT02987543|566755974|FG003|Overall Study|Study terminated by sponsor|0|||
157001728|NCT02987543|566755971|FG000|Overall Study|Investigator decision|0|||
157001729|NCT02987543|566755972|FG001|Overall Study|Investigator decision|1|||
157001730|NCT02987543|566755973|FG002|Overall Study|Investigator decision|0|||
157001731|NCT02987543|566755974|FG003|Overall Study|Investigator decision|0|||
157001732|NCT02987543|566755971|FG000|Overall Study|Disease progression|0|||
157001733|NCT02987543|566755972|FG001|Overall Study|Disease progression|0|||
157001734|NCT02987543|566755973|FG002|Overall Study|Disease progression|0|||
157001735|NCT02987543|566755974|FG003|Overall Study|Disease progression|1|||
157104609|NCT02101021|567137999|FG000|Overall Study|Study Terminated by Sponsor|1|||
156761208|NCT02157519|565877927|FG000|Overall Study|Lost to Follow-up|1|||
156761209|NCT02157519|565877928|FG001|Overall Study|Lost to Follow-up|0|||
156761210|NCT01656395|565877929|FG000|Overall Study|Adverse Event|1|||
156761211|NCT01656395|565877930|FG001|Overall Study|Adverse Event|14|||
156761212|NCT01656395|565877931|FG002|Overall Study|Adverse Event|5|||
156761213|NCT01656395|565877932|FG003|Overall Study|Adverse Event|4|||
156761214|NCT01656395|565877933|FG004|Overall Study|Adverse Event|5|||
156761215|NCT01656395|565877934|FG005|Overall Study|Adverse Event|7|||
156761216|NCT01656395|565877935|FG006|Overall Study|Adverse Event|0|||
156761217|NCT01656395|565877936|FG007|Overall Study|Adverse Event|0|||
156761218|NCT01656395|565877929|FG000|Overall Study|Lack of Efficacy|1|||
156761219|NCT01656395|565877930|FG001|Overall Study|Lack of Efficacy|8|||
156761220|NCT01656395|565877931|FG002|Overall Study|Lack of Efficacy|6|||
156761221|NCT01656395|565877932|FG003|Overall Study|Lack of Efficacy|1|||
156761222|NCT01656395|565877933|FG004|Overall Study|Lack of Efficacy|1|||
156761223|NCT01656395|565877934|FG005|Overall Study|Lack of Efficacy|6|||
156761224|NCT01656395|565877935|FG006|Overall Study|Lack of Efficacy|0|||
156761225|NCT01656395|565877936|FG007|Overall Study|Lack of Efficacy|0|||
156761226|NCT01656395|565877929|FG000|Overall Study|Lost to Follow-up|1|||
156761227|NCT01656395|565877930|FG001|Overall Study|Lost to Follow-up|0|||
156761228|NCT01656395|565877931|FG002|Overall Study|Lost to Follow-up|0|||
156761229|NCT01656395|565877932|FG003|Overall Study|Lost to Follow-up|0|||
156761230|NCT01656395|565877933|FG004|Overall Study|Lost to Follow-up|0|||
156761231|NCT01656395|565877934|FG005|Overall Study|Lost to Follow-up|0|||
156761232|NCT01656395|565877935|FG006|Overall Study|Lost to Follow-up|0|||
156761233|NCT01656395|565877936|FG007|Overall Study|Lost to Follow-up|0|||
156761234|NCT01656395|565877929|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156761235|NCT01656395|565877930|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156761236|NCT01656395|565877931|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156761237|NCT01656395|565877932|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156761238|NCT01656395|565877933|FG004|Overall Study|Non-Compliance with Study Drug|1|||
156761239|NCT01656395|565877934|FG005|Overall Study|Non-Compliance with Study Drug|1|||
156761240|NCT01656395|565877935|FG006|Overall Study|Non-Compliance with Study Drug|0|||
156761241|NCT01656395|565877936|FG007|Overall Study|Non-Compliance with Study Drug|0|||
156761242|NCT01656395|565877929|FG000|Overall Study|Other|0|||
156761243|NCT01656395|565877930|FG001|Overall Study|Other|0|||
156761244|NCT01656395|565877931|FG002|Overall Study|Other|1|||
156761245|NCT01656395|565877932|FG003|Overall Study|Other|0|||
156761246|NCT01656395|565877933|FG004|Overall Study|Other|0|||
156761247|NCT01656395|565877934|FG005|Overall Study|Other|1|||
156761248|NCT01656395|565877935|FG006|Overall Study|Other|0|||
156761249|NCT01656395|565877936|FG007|Overall Study|Other|0|||
156761250|NCT01656395|565877929|FG000|Overall Study|Physician Decision|2|||
156761251|NCT01656395|565877930|FG001|Overall Study|Physician Decision|3|||
157001736|NCT03646669|566755975|FG000|Overall Study|Withdrawal by Subject|5|||
157001737|NCT03646669|566755976|FG001|Overall Study|Withdrawal by Subject|0|||
157001738|NCT00309452|566755977|FG000|Overall Study|Withdrawal by Subject|3|||
157001739|NCT00309452|566755978|FG001|Overall Study|Withdrawal by Subject|0|||
157001740|NCT02962674|566755979|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
157001741|NCT02488980|566755989|FG000|Overall Study|Protocol Violation|2|||
157001742|NCT02488980|566755990|FG001|Overall Study|Protocol Violation|2|||
157001743|NCT02488980|566755991|FG002|Overall Study|Protocol Violation|2|||
157001744|NCT05193318|566755995|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
157001745|NCT05193318|566755995|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
157001746|NCT00957658|566755996|FG000|Overall Study|Death|1|||
157001747|NCT00957658|566755996|FG000|Overall Study|Lost to Follow-up|4|||
157001748|NCT00957658|566755996|FG000|Overall Study|Withdrawal by Subject|12|||
157001749|NCT00957658|566755996|FG000|Overall Study|Revision|1|||
157001750|NCT00957658|566755996|FG000|Overall Study|Incomplete 2 yr data|28|||
157001751|NCT00957658|566755996|FG000|Overall Study|Site termination|10|||
157001752|NCT00957658|566755996|FG000|Overall Study|unwilling/unable to return|2|||
157001753|NCT00957658|566755996|FG000|Overall Study|surgery cancelled|2|||
157001754|NCT00957658|566755996|FG000|Overall Study|Protocol Violation|5|||
157104610|NCT02101021|567138000|FG001|Overall Study|Study Terminated by Sponsor|0|||
157104611|NCT02101021|567138001|FG002|Overall Study|Study Terminated by Sponsor|1|||
156761252|NCT01656395|565877931|FG002|Overall Study|Physician Decision|3|||
156761253|NCT01656395|565877932|FG003|Overall Study|Physician Decision|2|||
156761254|NCT01656395|565877933|FG004|Overall Study|Physician Decision|3|||
156761255|NCT01656395|565877934|FG005|Overall Study|Physician Decision|3|||
157104612|NCT02101021|567138002|FG003|Overall Study|Study Terminated by Sponsor|1|||
157104613|NCT02101021|567138003|FG004|Overall Study|Study Terminated by Sponsor|1|||
156761256|NCT01656395|565877935|FG006|Overall Study|Physician Decision|0|||
156761257|NCT01656395|565877936|FG007|Overall Study|Physician Decision|0|||
156761258|NCT01656395|565877929|FG000|Overall Study|Pregnancy|0|||
156761259|NCT01656395|565877930|FG001|Overall Study|Pregnancy|0|||
156761260|NCT01656395|565877931|FG002|Overall Study|Pregnancy|1|||
156761261|NCT01656395|565877932|FG003|Overall Study|Pregnancy|0|||
156761262|NCT01656395|565877933|FG004|Overall Study|Pregnancy|0|||
156761263|NCT01656395|565877934|FG005|Overall Study|Pregnancy|0|||
156761264|NCT01656395|565877935|FG006|Overall Study|Pregnancy|0|||
156761265|NCT01656395|565877936|FG007|Overall Study|Pregnancy|0|||
156761266|NCT01656395|565877929|FG000|Overall Study|Progressive Disease|0|||
156761267|NCT01656395|565877930|FG001|Overall Study|Progressive Disease|0|||
156761268|NCT01656395|565877931|FG002|Overall Study|Progressive Disease|0|||
156761269|NCT01656395|565877932|FG003|Overall Study|Progressive Disease|0|||
156761270|NCT01656395|565877933|FG004|Overall Study|Progressive Disease|0|||
156761271|NCT01656395|565877934|FG005|Overall Study|Progressive Disease|1|||
156761272|NCT01656395|565877935|FG006|Overall Study|Progressive Disease|0|||
156761273|NCT01656395|565877936|FG007|Overall Study|Progressive Disease|0|||
156761274|NCT01656395|565877929|FG000|Overall Study|Protocol Violation|6|||
156761275|NCT01656395|565877930|FG001|Overall Study|Protocol Violation|6|||
156761276|NCT01656395|565877931|FG002|Overall Study|Protocol Violation|9|||
156761277|NCT01656395|565877932|FG003|Overall Study|Protocol Violation|2|||
156761278|NCT01656395|565877933|FG004|Overall Study|Protocol Violation|4|||
156761279|NCT01656395|565877934|FG005|Overall Study|Protocol Violation|10|||
157104614|NCT03346057|567138006|FG000|Overall Study|Death|1|||
156761280|NCT01656395|565877935|FG006|Overall Study|Protocol Violation|0|||
156761281|NCT01656395|565877936|FG007|Overall Study|Protocol Violation|0|||
156761282|NCT01656395|565877929|FG000|Overall Study|Screen Failure|2|||
156761283|NCT01656395|565877930|FG001|Overall Study|Screen Failure|1|||
156761284|NCT01656395|565877931|FG002|Overall Study|Screen Failure|7|||
156761285|NCT01656395|565877932|FG003|Overall Study|Screen Failure|1|||
156761286|NCT01656395|565877933|FG004|Overall Study|Screen Failure|0|||
156761287|NCT01656395|565877934|FG005|Overall Study|Screen Failure|8|||
156761288|NCT01656395|565877935|FG006|Overall Study|Screen Failure|0|||
156761289|NCT01656395|565877936|FG007|Overall Study|Screen Failure|0|||
156761290|NCT01656395|565877929|FG000|Overall Study|Withdrawal by Subject|3|||
156761291|NCT01656395|565877930|FG001|Overall Study|Withdrawal by Subject|1|||
156761292|NCT01656395|565877931|FG002|Overall Study|Withdrawal by Subject|4|||
156761293|NCT01656395|565877932|FG003|Overall Study|Withdrawal by Subject|2|||
156761294|NCT01656395|565877933|FG004|Overall Study|Withdrawal by Subject|0|||
156761295|NCT01656395|565877934|FG005|Overall Study|Withdrawal by Subject|3|||
156761296|NCT01656395|565877935|FG006|Overall Study|Withdrawal by Subject|0|||
156761297|NCT01656395|565877936|FG007|Overall Study|Withdrawal by Subject|0|||
156761298|NCT00230048|565877940|FG000|Overall Study|Lost to Follow-up|13|||
156761299|NCT00230048|565877941|FG001|Overall Study|Lost to Follow-up|18|||
156761300|NCT00676403|565877942|FG000|Overall Study|Adverse Event|1|||
156761301|NCT00676403|565877943|FG001|Overall Study|Adverse Event|2|||
156761302|NCT00676403|565877944|FG002|Overall Study|Adverse Event|0|||
156761303|NCT00676403|565877945|FG003|Overall Study|Adverse Event|5|||
156761304|NCT00676403|565877946|FG004|Overall Study|Adverse Event|1|||
156761305|NCT00676403|565877947|FG005|Overall Study|Adverse Event|2|||
156761306|NCT00676403|565877942|FG000|Overall Study|Lost to Follow-up|0|||
156761307|NCT00676403|565877943|FG001|Overall Study|Lost to Follow-up|0|||
156761308|NCT00676403|565877944|FG002|Overall Study|Lost to Follow-up|0|||
156761309|NCT00676403|565877945|FG003|Overall Study|Lost to Follow-up|0|||
156761310|NCT00676403|565877946|FG004|Overall Study|Lost to Follow-up|0|||
156761311|NCT00676403|565877947|FG005|Overall Study|Lost to Follow-up|1|||
156761312|NCT00676403|565877942|FG000|Overall Study|Reason Unspecified|1|||
156761313|NCT00676403|565877943|FG001|Overall Study|Reason Unspecified|0|||
156761314|NCT00676403|565877944|FG002|Overall Study|Reason Unspecified|1|||
156761315|NCT00676403|565877945|FG003|Overall Study|Reason Unspecified|0|||
156761316|NCT00676403|565877946|FG004|Overall Study|Reason Unspecified|0|||
156761317|NCT00676403|565877947|FG005|Overall Study|Reason Unspecified|1|||
156761318|NCT00676403|565877942|FG000|Overall Study|Withdrawal by Subject|0|||
156761319|NCT00676403|565877943|FG001|Overall Study|Withdrawal by Subject|0|||
156761320|NCT00676403|565877944|FG002|Overall Study|Withdrawal by Subject|0|||
157104615|NCT03346057|567138007|FG001|Overall Study|Death|2|||
157104616|NCT03346057|567138008|FG002|Overall Study|Death|0|||
157104617|NCT03346057|567138009|FG003|Overall Study|Death|0|||
157104618|NCT03346057|567138006|FG000|Overall Study|Lost to Follow-up|0|||
157104619|NCT03346057|567138007|FG001|Overall Study|Lost to Follow-up|2|||
156761321|NCT00676403|565877945|FG003|Overall Study|Withdrawal by Subject|0|||
156761322|NCT00676403|565877946|FG004|Overall Study|Withdrawal by Subject|0|||
156761323|NCT00676403|565877947|FG005|Overall Study|Withdrawal by Subject|1|||
156761324|NCT03225170|565877948|FG000|Overall Study|Lost to Follow-up|4|||
156761325|NCT03225170|565877949|FG001|Overall Study|Lost to Follow-up|4|||
156761326|NCT03225170|565877950|FG002|Overall Study|Lost to Follow-up|0|||
156761327|NCT03225170|565877948|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
156761328|NCT03225170|565877949|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
156761329|NCT03225170|565877950|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
156761330|NCT00971867|565877951|FG000|Overall Study|Adverse Event|4|||
157104620|NCT03346057|567138008|FG002|Overall Study|Lost to Follow-up|1|||
156761331|NCT00971867|565877951|FG000|Overall Study|Participant Withdrew Consent|1|||
156761332|NCT00971867|565877951|FG000|Overall Study|Disease Progression|6|||
157104621|NCT03346057|567138009|FG003|Overall Study|Lost to Follow-up|0|||
157104622|NCT03346057|567138006|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
156761333|NCT00673257|565877955|FG000|Overall Study|Withdrawal by Subject|4|||
156761334|NCT00673257|565877955|FG000|Overall Study|Unable to obtain specimen|1|||
156761335|NCT01585246|565877962|FG000|Overall Study|Lost to Follow-up|0|||
156761336|NCT01585246|565877963|FG001|Overall Study|Lost to Follow-up|0|||
156761337|NCT01585246|565877964|FG002|Overall Study|Lost to Follow-up|2|||
156761338|NCT01585246|565877965|FG003|Overall Study|Lost to Follow-up|1|||
156761339|NCT01585246|565877966|FG004|Overall Study|Lost to Follow-up|0|||
156761340|NCT01585246|565877962|FG000|Overall Study|Protocol Violation|0|||
156761341|NCT01585246|565877963|FG001|Overall Study|Protocol Violation|0|||
156761342|NCT01585246|565877964|FG002|Overall Study|Protocol Violation|0|||
156761343|NCT01585246|565877965|FG003|Overall Study|Protocol Violation|0|||
156761344|NCT01585246|565877966|FG004|Overall Study|Protocol Violation|1|||
156761345|NCT01585246|565877962|FG000|Overall Study|Withdrawal by Subject|0|||
156761346|NCT01585246|565877963|FG001|Overall Study|Withdrawal by Subject|0|||
156761347|NCT01585246|565877964|FG002|Overall Study|Withdrawal by Subject|1|||
156761348|NCT01585246|565877965|FG003|Overall Study|Withdrawal by Subject|2|||
156761349|NCT01585246|565877966|FG004|Overall Study|Withdrawal by Subject|1|||
156761350|NCT01585246|565877962|FG000|Overall Study|Other|0|||
156761351|NCT01585246|565877963|FG001|Overall Study|Other|1|||
156761352|NCT01585246|565877964|FG002|Overall Study|Other|1|||
156761353|NCT01585246|565877965|FG003|Overall Study|Other|1|||
156761354|NCT01585246|565877966|FG004|Overall Study|Other|0|||
156761355|NCT04396626|565877967|FG000|Overall Study|Premature termination of study|975|||
156761356|NCT02111174|565877970|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
156761357|NCT02111174|565877971|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
156761358|NCT02111174|565877970|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
156761359|NCT02111174|565877971|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
156761360|NCT02111174|565877970|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
156761361|NCT02111174|565877971|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
156761362|NCT02111174|565877970|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
156761363|NCT02111174|565877971|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
156761364|NCT04552132|565877972|FG000|Overall Study|Lost to Follow-up|4|||
156761365|NCT04552132|565877973|FG001|Overall Study|Lost to Follow-up|3|||
156761366|NCT04552132|565877972|FG000|Overall Study|Protocol Violation|1|||
156761367|NCT04552132|565877973|FG001|Overall Study|Protocol Violation|0|||
156761368|NCT01657162|565877974|FG000|Overall Study|Adverse Event|26|||
156761369|NCT01657162|565877975|FG001|Overall Study|Adverse Event|36|||
156761370|NCT01657162|565877974|FG000|Overall Study|Withdrawal by Subject|13|||
156761371|NCT01657162|565877975|FG001|Overall Study|Withdrawal by Subject|13|||
156761372|NCT01657162|565877974|FG000|Overall Study|Continuing Significant Deterioration|9|||
156761373|NCT01657162|565877975|FG001|Overall Study|Continuing Significant Deterioration|3|||
156761374|NCT01657162|565877974|FG000|Overall Study|Refusal of Treatment|4|||
156761375|NCT01657162|565877975|FG001|Overall Study|Refusal of Treatment|6|||
156761376|NCT01657162|565877974|FG000|Overall Study|Lost to Follow-up|3|||
156761377|NCT01657162|565877975|FG001|Overall Study|Lost to Follow-up|4|||
156761378|NCT01657162|565877974|FG000|Overall Study|Death|2|||
156761379|NCT01657162|565877975|FG001|Overall Study|Death|3|||
156761380|NCT01657162|565877974|FG000|Overall Study|Inability to Complete Study Procedures|1|||
156761381|NCT01657162|565877975|FG001|Overall Study|Inability to Complete Study Procedures|7|||
156761382|NCT01657162|565877974|FG000|Overall Study|Protocol Violation|1|||
156761383|NCT01657162|565877975|FG001|Overall Study|Protocol Violation|0|||
156761384|NCT01657162|565877974|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
156761385|NCT01657162|565877975|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
157001755|NCT00906035|566756000|FG000|Overall Study|Withdrawal by Subject|2|||
157001756|NCT00906035|566756001|FG001|Overall Study|Withdrawal by Subject|3|||
157001757|NCT00906035|566756002|FG002|Overall Study|Withdrawal by Subject|0|||
157001758|NCT00130637|566756003|FG000|Overall Study|Adverse Event|2|||
157001759|NCT00130637|566756003|FG000|Overall Study|Withdrawal by Subject|1|||
157001760|NCT00139737|566756004|FG000|Overall Study|Withdrawal by Subject|190|||
157001761|NCT00139737|566756004|FG000|Overall Study|Adverse Event|58|||
157001762|NCT00139737|566756004|FG000|Overall Study|Lack of Efficacy|40|||
157001763|NCT00139737|566756004|FG000|Overall Study|Lost to Follow-up|8|||
157001764|NCT00139737|566756004|FG000|Overall Study|Death|3|||
157001765|NCT00139737|566756004|FG000|Overall Study|Laboratory Abnormality|2|||
157001766|NCT00139737|566756004|FG000|Overall Study|Protocol Violation|18|||
157001767|NCT00139737|566756004|FG000|Overall Study|Withdrew During Screening Phase|8|||
157001768|NCT00139737|566756004|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
157001769|NCT00139737|566756004|FG000|Overall Study|Screened, Not Treated|13|||
157001770|NCT00217672|566756007|FG000|Allocation|Ineligible|2|||
156761386|NCT01657162|565877974|FG000|Overall Study|Other than Specified|0|||
156761387|NCT01657162|565877975|FG001|Overall Study|Other than Specified|2|||
156761388|NCT02600923|565877978|FG000|Overall Study|Death|10|||
156761389|NCT02600923|565877978|FG000|Overall Study|Adverse Event|3|||
156761390|NCT02600923|565877978|FG000|Overall Study|Global deterioration of health status|2|||
156761391|NCT02600923|565877978|FG000|Overall Study|Insufficient clinical response|6|||
156761392|NCT02600923|565877978|FG000|Overall Study|Lost to Follow-up|1|||
157104623|NCT03346057|567138007|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
157104624|NCT03346057|567138008|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
157104625|NCT03346057|567138009|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
157104626|NCT03346057|567138006|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
157104627|NCT03346057|567138007|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
157104628|NCT03346057|567138008|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
157104629|NCT03346057|567138009|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
157104630|NCT03346057|567138006|FG000|Overall Study|Physician Decision|3|||
157104631|NCT03346057|567138007|FG001|Overall Study|Physician Decision|2|||
157104632|NCT03346057|567138008|FG002|Overall Study|Physician Decision|0|||
157104633|NCT03346057|567138009|FG003|Overall Study|Physician Decision|2|||
156761393|NCT02600923|565877978|FG000|Overall Study|Withdrawal by Subject|5|||
157104634|NCT03346057|567138006|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
157104635|NCT03346057|567138007|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
156761394|NCT02600923|565877978|FG000|Overall Study|Objective progression or relapse|50|||
157001771|NCT00217672|566756008|FG001|Allocation|Ineligible|0|||
157001772|NCT00217672|566756007|FG000|Treatment|disease progression|33|||
157001773|NCT00217672|566756008|FG001|Treatment|disease progression|4|||
157001774|NCT00217672|566756007|FG000|Treatment|Adverse Event|18|||
157001775|NCT00217672|566756008|FG001|Treatment|Adverse Event|2|||
157001776|NCT00217672|566756007|FG000|Treatment|reqd treatment not permitted by protocol|6|||
157001777|NCT00217672|566756008|FG001|Treatment|reqd treatment not permitted by protocol|0|||
157001778|NCT00217672|566756007|FG000|Treatment|Physician Decision|6|||
157104636|NCT03346057|567138008|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
157104637|NCT03346057|567138009|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
157104638|NCT03346057|567138006|FG000|Overall Study|Withdrawal by Subject|1|||
157104639|NCT03346057|567138007|FG001|Overall Study|Withdrawal by Subject|0|||
157104640|NCT03346057|567138008|FG002|Overall Study|Withdrawal by Subject|0|||
157104641|NCT03346057|567138009|FG003|Overall Study|Withdrawal by Subject|0|||
157104642|NCT02921269|567138010|FG000|Overall Study|Did not complete DLT period|1|||
157104643|NCT01326728|567138011|FG000|Overall Study|Death|13|||
157104644|NCT01326728|567138012|FG001|Overall Study|Death|0|||
157104645|NCT01326728|567138011|FG000|Overall Study|Early closure of study|34|||
157104646|NCT01326728|567138012|FG001|Overall Study|Early closure of study|9|||
157104647|NCT01184053|567138013|FG000|Overall Study|progression while on treatment|3|||
157104648|NCT02536755|567138017|FG000|Overall Study|Adverse Event|4|||
157104649|NCT02301936|567138018|FG000|Overall Study|Lost to Follow-up|1|||
157104650|NCT02301936|567138019|FG001|Overall Study|Lost to Follow-up|0|||
156761395|NCT02600923|565877978|FG000|Overall Study|Study terminated by Sponsor|53|||
156761396|NCT02600923|565877978|FG000|Overall Study|Not treated|1|||
156761397|NCT00792909|565877979|FG000|Overall Study|Withdrawal by Subject|0|||
156761398|NCT00792909|565877980|FG001|Overall Study|Withdrawal by Subject|1|||
156761399|NCT00792909|565877981|FG002|Overall Study|Withdrawal by Subject|0|||
156761400|NCT01261390|565877985|FG000|Overall Study|Significant Concurrent Illness|1|||
156761401|NCT01261390|565877986|FG001|Overall Study|Significant Concurrent Illness|0|||
156761402|NCT01261390|565877987|FG002|Overall Study|Significant Concurrent Illness|1|||
156761403|NCT01261390|565877988|FG003|Overall Study|Significant Concurrent Illness|0|||
156761404|NCT01261390|565877985|FG000|Overall Study|Dissatisfaction with Treatment|2|||
156761405|NCT01261390|565877986|FG001|Overall Study|Dissatisfaction with Treatment|1|||
156761406|NCT01261390|565877987|FG002|Overall Study|Dissatisfaction with Treatment|1|||
156761407|NCT01261390|565877988|FG003|Overall Study|Dissatisfaction with Treatment|2|||
156761408|NCT01261390|565877985|FG000|Overall Study|Relocation|0|||
156761409|NCT01261390|565877986|FG001|Overall Study|Relocation|1|||
156761410|NCT01261390|565877987|FG002|Overall Study|Relocation|0|||
156761411|NCT01261390|565877988|FG003|Overall Study|Relocation|0|||
156761412|NCT01261390|565877985|FG000|Overall Study|Loss of Interest in the Study|3|||
156761413|NCT01261390|565877986|FG001|Overall Study|Loss of Interest in the Study|1|||
156761414|NCT01261390|565877987|FG002|Overall Study|Loss of Interest in the Study|0|||
156761415|NCT01261390|565877988|FG003|Overall Study|Loss of Interest in the Study|0|||
156761416|NCT01261390|565877985|FG000|Overall Study|Lost to Follow-up|1|||
156761417|NCT01261390|565877986|FG001|Overall Study|Lost to Follow-up|6|||
156761418|NCT01261390|565877987|FG002|Overall Study|Lost to Follow-up|5|||
156761419|NCT01261390|565877988|FG003|Overall Study|Lost to Follow-up|6|||
156761420|NCT02421419|565877989|FG000|Overall Study|Physician Decision|0|||
156761421|NCT02421419|565877990|FG001|Overall Study|Physician Decision|0|||
157001779|NCT00217672|566756008|FG001|Treatment|Physician Decision|0|||
157001780|NCT00217672|566756007|FG000|Treatment|insurance issues|1|||
157001781|NCT00217672|566756008|FG001|Treatment|insurance issues|1|||
157001782|NCT00217672|566756007|FG000|Treatment|Death|2|||
157001783|NCT00217672|566756008|FG001|Treatment|Death|0|||
157001784|NCT00217672|566756007|FG000|Treatment|secondary malignancy|1|||
157001785|NCT00217672|566756008|FG001|Treatment|secondary malignancy|0|||
157001786|NCT00217672|566756007|FG000|Follow-up|Withdrawal by Subject|4|||
157001787|NCT00217672|566756008|FG001|Follow-up|Withdrawal by Subject|0|||
157001788|NCT00217672|566756007|FG000|Follow-up|Lost to Follow-up|1|||
157001789|NCT00217672|566756008|FG001|Follow-up|Lost to Follow-up|0|||
157001790|NCT01591616|566756009|FG000|Overall Study|Withdrawal by Subject|1|||
157001791|NCT03525119|566756010|FG000|Overall Study|Adverse Event|0|||
157001792|NCT03525119|566756011|FG001|Overall Study|Adverse Event|1|||
157001793|NCT03525119|566756012|FG002|Overall Study|Adverse Event|0|||
157001794|NCT03525119|566756010|FG000|Overall Study|Lost to Follow-up|32|||
157001795|NCT03525119|566756011|FG001|Overall Study|Lost to Follow-up|33|||
157001796|NCT03525119|566756012|FG002|Overall Study|Lost to Follow-up|37|||
157001797|NCT03525119|566756010|FG000|Overall Study|Withdrawal by Subject|5|||
157001798|NCT03525119|566756011|FG001|Overall Study|Withdrawal by Subject|4|||
157001799|NCT03525119|566756012|FG002|Overall Study|Withdrawal by Subject|2|||
157001800|NCT03525119|566756010|FG000|Overall Study|Reason not Specified|2|||
157001801|NCT03525119|566756011|FG001|Overall Study|Reason not Specified|1|||
157001802|NCT03525119|566756012|FG002|Overall Study|Reason not Specified|2|||
157001803|NCT03525119|566756010|FG000|Overall Study|Randomized but not Vaccinated|1|||
157001804|NCT03525119|566756011|FG001|Overall Study|Randomized but not Vaccinated|0|||
157001805|NCT03525119|566756012|FG002|Overall Study|Randomized but not Vaccinated|2|||
157001806|NCT03781336|566756013|FG000|Overall Study|Withdrawal by Subject|2|||
157001807|NCT03781336|566756014|FG001|Overall Study|Withdrawal by Subject|2|||
157001808|NCT01972152|566756015|FG000|First Treatment Visit|Lost to Follow-up|0|||
157001809|NCT01972152|566756016|FG001|First Treatment Visit|Lost to Follow-up|1|||
157001810|NCT01972152|566756017|FG002|First Treatment Visit|Lost to Follow-up|0|||
157001811|NCT01972152|566756018|FG003|First Treatment Visit|Lost to Follow-up|0|||
157001812|NCT01972152|566756019|FG004|First Treatment Visit|Lost to Follow-up|0|||
157104651|NCT01667107|567138020|FG000|Overall Study|Adverse Event|4|||
157104652|NCT01667107|567138021|FG001|Overall Study|Adverse Event|3|||
156761422|NCT02421419|565877991|FG002|Overall Study|Physician Decision|1|||
156761423|NCT04058028|565877993|FG000|Overall Study|Withdrawal of Consent from Study|12|||
157001813|NCT01972152|566756020|FG005|First Treatment Visit|Lost to Follow-up|0|||
157001814|NCT01972152|566756015|FG000|Second Treatment Visit|Protocol Violation|0|||
156761424|NCT04058028|565877994|FG001|Overall Study|Withdrawal of Consent from Study|8|||
156761425|NCT04058028|565877995|FG002|Overall Study|Withdrawal of Consent from Study|6|||
156761426|NCT04058028|565877996|FG003|Overall Study|Withdrawal of Consent from Study|7|||
156761427|NCT04058028|565877993|FG000|Overall Study|Decision by Sponsor|13|||
156761428|NCT04058028|565877994|FG001|Overall Study|Decision by Sponsor|4|||
156761429|NCT04058028|565877995|FG002|Overall Study|Decision by Sponsor|1|||
157001815|NCT01972152|566756016|FG001|Second Treatment Visit|Protocol Violation|1|||
157001816|NCT01972152|566756017|FG002|Second Treatment Visit|Protocol Violation|0|||
157001817|NCT01972152|566756018|FG003|Second Treatment Visit|Protocol Violation|0|||
157001818|NCT01972152|566756019|FG004|Second Treatment Visit|Protocol Violation|0|||
156761430|NCT04058028|565877996|FG003|Overall Study|Decision by Sponsor|35|||
156761431|NCT04058028|565877993|FG000|Overall Study|Lost to Follow-up|1|||
156761432|NCT04058028|565877994|FG001|Overall Study|Lost to Follow-up|1|||
156761433|NCT04058028|565877995|FG002|Overall Study|Lost to Follow-up|1|||
156761434|NCT04058028|565877996|FG003|Overall Study|Lost to Follow-up|0|||
156761435|NCT04058028|565877993|FG000|Overall Study|Death|0|||
156761436|NCT04058028|565877994|FG001|Overall Study|Death|1|||
156761437|NCT04058028|565877995|FG002|Overall Study|Death|0|||
156761438|NCT04058028|565877996|FG003|Overall Study|Death|0|||
156761439|NCT02227784|565877997|FG000|Double-Blind Phase|Adverse Event|3|||
156761440|NCT02227784|565877998|FG001|Double-Blind Phase|Adverse Event|2|||
156761441|NCT02227784|565877999|FG002|Double-Blind Phase|Adverse Event|1|||
156761442|NCT02227784|565878000|FG003|Double-Blind Phase|Adverse Event|3|||
156761443|NCT02227784|565878001|FG004|Double-Blind Phase|Adverse Event|0|||
156761444|NCT02227784|565877997|FG000|Double-Blind Phase|Physician Decision|1|||
156761445|NCT02227784|565877998|FG001|Double-Blind Phase|Physician Decision|0|||
156761446|NCT02227784|565877999|FG002|Double-Blind Phase|Physician Decision|0|||
156761447|NCT02227784|565878000|FG003|Double-Blind Phase|Physician Decision|1|||
156761448|NCT02227784|565878001|FG004|Double-Blind Phase|Physician Decision|0|||
156761449|NCT02227784|565877997|FG000|Double-Blind Phase|Protocol Violation|0|||
156761450|NCT02227784|565877998|FG001|Double-Blind Phase|Protocol Violation|0|||
156761451|NCT02227784|565877999|FG002|Double-Blind Phase|Protocol Violation|1|||
156761452|NCT02227784|565878000|FG003|Double-Blind Phase|Protocol Violation|1|||
156761453|NCT02227784|565878001|FG004|Double-Blind Phase|Protocol Violation|0|||
156761454|NCT02227784|565877997|FG000|Double-Blind Phase|Sponsor Decision|34|||
156761455|NCT02227784|565877998|FG001|Double-Blind Phase|Sponsor Decision|15|||
156761456|NCT02227784|565877999|FG002|Double-Blind Phase|Sponsor Decision|14|||
156761457|NCT02227784|565878000|FG003|Double-Blind Phase|Sponsor Decision|32|||
156761458|NCT02227784|565878001|FG004|Double-Blind Phase|Sponsor Decision|0|||
156761459|NCT02227784|565877997|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156761460|NCT02227784|565877998|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
156761461|NCT02227784|565877999|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
156761462|NCT02227784|565878000|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
156761463|NCT02227784|565878001|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156761464|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156761465|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
157001819|NCT01972152|566756020|FG005|Second Treatment Visit|Protocol Violation|0|||
157001820|NCT01959412|566756021|FG000|Overall Study|Protocol deviation|1|||
157001821|NCT01959412|566756022|FG001|Overall Study|Protocol deviation|1|||
157001822|NCT01959412|566756023|FG002|Overall Study|Protocol deviation|0|||
157001823|NCT01959412|566756024|FG003|Overall Study|Protocol deviation|1|||
157001824|NCT01959412|566756025|FG004|Overall Study|Protocol deviation|3|||
157001825|NCT01959412|566756026|FG005|Overall Study|Protocol deviation|0|||
157001826|NCT01959412|566756021|FG000|Overall Study|Adverse Event|0|||
157001827|NCT01959412|566756022|FG001|Overall Study|Adverse Event|0|||
157001828|NCT01959412|566756023|FG002|Overall Study|Adverse Event|0|||
157001829|NCT01959412|566756024|FG003|Overall Study|Adverse Event|1|||
157001830|NCT01959412|566756025|FG004|Overall Study|Adverse Event|0|||
157001831|NCT01959412|566756026|FG005|Overall Study|Adverse Event|0|||
157001832|NCT01186848|566756027|FG000|Overall Study|Lost to Follow-up|4|||
157001833|NCT01186848|566756027|FG000|Overall Study|Withdrawal by Subject|2|||
157001834|NCT01186848|566756027|FG000|Overall Study|Adverse Event|2|||
157001835|NCT04379713|566756032|FG000|Overall Study|Adverse Event|2|||
157001836|NCT04379713|566756033|FG001|Overall Study|Adverse Event|0|||
157001837|NCT04379713|566756032|FG000|Overall Study|Physician Decision|2|||
157001838|NCT04379713|566756033|FG001|Overall Study|Physician Decision|1|||
157001839|NCT04379713|566756032|FG000|Overall Study|Protocol Violation|11|||
157001840|NCT04379713|566756033|FG001|Overall Study|Protocol Violation|6|||
157001841|NCT04379713|566756032|FG000|Overall Study|No longer met eligibility criteria|14|||
157001842|NCT04379713|566756033|FG001|Overall Study|No longer met eligibility criteria|11|||
157001843|NCT04379713|566756032|FG000|Overall Study|Withdrawal by parent/guardian|36|||
157001844|NCT04379713|566756033|FG001|Overall Study|Withdrawal by parent/guardian|15|||
157001845|NCT04379713|566756032|FG000|Overall Study|Lost to Follow-up|31|||
157001846|NCT04379713|566756033|FG001|Overall Study|Lost to Follow-up|21|||
157001847|NCT00158054|566756034|FG000|Overall Study|Refused to continue|3|||
157001848|NCT00158054|566756035|FG001|Overall Study|Refused to continue|0|||
157001849|NCT00158054|566756034|FG000|Overall Study|Unavailable for follow up|7|||
157001850|NCT00158054|566756035|FG001|Overall Study|Unavailable for follow up|3|||
157001851|NCT00509769|566756036|FG000|Overall Study|Progressive disease|77|||
157001852|NCT00509769|566756036|FG000|Overall Study|Adverse Event|4|||
157001853|NCT00509769|566756036|FG000|Overall Study|Patient's decision|1|||
157001854|NCT00509769|566756036|FG000|Overall Study|Physician Decision|8|||
156761466|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
157001855|NCT00509769|566756036|FG000|Overall Study|Use of prohibited therapies during study|1|||
156761467|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
156761468|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
157001856|NCT04567888|566756037|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
156761469|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Death|0|||
156761470|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Death|0|||
156761471|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Death|0|||
156761472|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Death|0|||
156761473|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Death|1|||
156761474|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761475|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761476|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761477|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156761478|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
156761479|NCT02227784|565877997|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761480|NCT02227784|565877998|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761481|NCT02227784|565877999|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761482|NCT02227784|565878000|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
156761483|NCT02227784|565878001|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
156761484|NCT00102596|565878002|FG000|Part A|Screen failures|6|||
156761485|NCT00102596|565878003|FG001|Part A|Screen failures|0|||
156761486|NCT00102596|565878002|FG000|Part A|Adverse Event|1|||
156761487|NCT00102596|565878003|FG001|Part A|Adverse Event|0|||
156761488|NCT00248651|565878006|FG000|Overall Study|Withdrawal by Subject|28|||
156761489|NCT00248651|565878007|FG001|Overall Study|Withdrawal by Subject|40|||
156761490|NCT00248651|565878008|FG002|Overall Study|Withdrawal by Subject|32|||
156761491|NCT01275144|565878009|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
156761492|NCT01275144|565878010|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
156761493|NCT00828113|565878011|FG000|Overall Study|Withdrawal by Subject|27|||
156761494|NCT00828113|565878012|FG001|Overall Study|Withdrawal by Subject|26|||
156761495|NCT00828113|565878011|FG000|Overall Study|Lost to Follow-up|3|||
156761496|NCT00828113|565878012|FG001|Overall Study|Lost to Follow-up|5|||
156761497|NCT01365130|565878013|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
156761498|NCT05607576|565878014|FG000|Overall Study|immediate sensor error|2|||
156761499|NCT05607576|565878014|FG000|Overall Study|Physician Decision|2|||
156761500|NCT05116202|565878015|FG000|Overall Study|Study Terminated by Sponsor|21|||
156761501|NCT05116202|565878016|FG001|Overall Study|Study Terminated by Sponsor|38|||
156761502|NCT05116202|565878017|FG002|Overall Study|Study Terminated by Sponsor|17|||
156761503|NCT05116202|565878018|FG003|Overall Study|Study Terminated by Sponsor|18|||
156761504|NCT05116202|565878019|FG004|Overall Study|Study Terminated by Sponsor|0|||
156761505|NCT05116202|565878015|FG000|Overall Study|Withdrawal by Subject|0|||
156761506|NCT05116202|565878016|FG001|Overall Study|Withdrawal by Subject|1|||
156761507|NCT05116202|565878017|FG002|Overall Study|Withdrawal by Subject|1|||
156761508|NCT05116202|565878018|FG003|Overall Study|Withdrawal by Subject|1|||
156761509|NCT05116202|565878019|FG004|Overall Study|Withdrawal by Subject|1|||
156761510|NCT05116202|565878015|FG000|Overall Study|Lost to Follow-up|0|||
156761511|NCT05116202|565878016|FG001|Overall Study|Lost to Follow-up|0|||
156761512|NCT05116202|565878017|FG002|Overall Study|Lost to Follow-up|0|||
156761513|NCT05116202|565878018|FG003|Overall Study|Lost to Follow-up|0|||
156761514|NCT05116202|565878019|FG004|Overall Study|Lost to Follow-up|2|||
156761515|NCT05116202|565878015|FG000|Overall Study|Death|1|||
156761516|NCT05116202|565878016|FG001|Overall Study|Death|1|||
156761517|NCT05116202|565878017|FG002|Overall Study|Death|2|||
156761518|NCT05116202|565878018|FG003|Overall Study|Death|1|||
156761519|NCT05116202|565878019|FG004|Overall Study|Death|5|||
156761520|NCT05067972|565878020|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761521|NCT05067972|565878021|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761522|NCT05067972|565878022|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761523|NCT05067972|565878023|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761524|NCT05067972|565878024|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761525|NCT05067972|565878025|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
156761526|NCT05067972|565878026|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
156761527|NCT05067972|565878020|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
156761528|NCT05067972|565878021|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
156761529|NCT05067972|565878022|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
156761530|NCT05067972|565878023|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
156761531|NCT05067972|565878024|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
156761532|NCT05067972|565878025|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
156761533|NCT05067972|565878026|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
156761534|NCT05067972|565878020|FG000|Part 1: Treatment|Progressive Disease|3|||
156761535|NCT05067972|565878021|FG001|Part 1: Treatment|Progressive Disease|3|||
156761536|NCT05067972|565878022|FG002|Part 1: Treatment|Progressive Disease|4|||
156761537|NCT05067972|565878023|FG003|Part 1: Treatment|Progressive Disease|2|||
156761538|NCT05067972|565878024|FG004|Part 1: Treatment|Progressive Disease|3|||
156761539|NCT05067972|565878025|FG005|Part 1: Treatment|Progressive Disease|0|||
157001857|NCT04567888|566756038|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
157001858|NCT04567888|566756037|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
157001859|NCT04567888|566756038|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
156761540|NCT05067972|565878026|FG006|Part 1: Treatment|Progressive Disease|2|||
157001860|NCT04567888|566756037|FG000|Overall Study|Reported Unusual Birth Year|2|||
157001861|NCT04567888|566756038|FG001|Overall Study|Reported Unusual Birth Year|3|||
157001862|NCT04567888|566756037|FG000|Overall Study|Duplicate Responses|0|||
157001863|NCT04567888|566756038|FG001|Overall Study|Duplicate Responses|1|||
156761541|NCT05067972|565878020|FG000|Part 1: Treatment|Physician Decision|0|||
157001864|NCT00414648|566756039|FG000|Overall Study|Adverse Event|5|||
157001865|NCT00414648|566756040|FG001|Overall Study|Adverse Event|5|||
156761542|NCT05067972|565878021|FG001|Part 1: Treatment|Physician Decision|0|||
156761543|NCT05067972|565878022|FG002|Part 1: Treatment|Physician Decision|0|||
156761544|NCT05067972|565878023|FG003|Part 1: Treatment|Physician Decision|1|||
156761545|NCT05067972|565878024|FG004|Part 1: Treatment|Physician Decision|0|||
156761546|NCT05067972|565878025|FG005|Part 1: Treatment|Physician Decision|0|||
156761547|NCT05067972|565878026|FG006|Part 1: Treatment|Physician Decision|0|||
156761548|NCT05067972|565878020|FG000|Part 1: Treatment|Death|0|||
156761549|NCT05067972|565878021|FG001|Part 1: Treatment|Death|0|||
156761550|NCT05067972|565878022|FG002|Part 1: Treatment|Death|0|||
156761551|NCT05067972|565878023|FG003|Part 1: Treatment|Death|2|||
156761552|NCT05067972|565878024|FG004|Part 1: Treatment|Death|0|||
156761553|NCT05067972|565878025|FG005|Part 1: Treatment|Death|0|||
156761554|NCT05067972|565878026|FG006|Part 1: Treatment|Death|0|||
156761555|NCT05067972|565878020|FG000|Part 1: Treatment|Adverse Event|0|||
156761556|NCT05067972|565878021|FG001|Part 1: Treatment|Adverse Event|0|||
156761557|NCT05067972|565878022|FG002|Part 1: Treatment|Adverse Event|0|||
156761558|NCT05067972|565878023|FG003|Part 1: Treatment|Adverse Event|0|||
156761559|NCT05067972|565878024|FG004|Part 1: Treatment|Adverse Event|0|||
156761560|NCT05067972|565878025|FG005|Part 1: Treatment|Adverse Event|2|||
156761561|NCT05067972|565878026|FG006|Part 1: Treatment|Adverse Event|1|||
156761562|NCT05067972|565878020|FG000|Part 1: Follow-up|Adverse Event|0|||
156761563|NCT05067972|565878021|FG001|Part 1: Follow-up|Adverse Event|0|||
156761564|NCT05067972|565878022|FG002|Part 1: Follow-up|Adverse Event|0|||
156761565|NCT05067972|565878023|FG003|Part 1: Follow-up|Adverse Event|0|||
156761566|NCT05067972|565878024|FG004|Part 1: Follow-up|Adverse Event|0|||
156761567|NCT05067972|565878025|FG005|Part 1: Follow-up|Adverse Event|1|||
156761568|NCT05067972|565878026|FG006|Part 1: Follow-up|Adverse Event|0|||
156761569|NCT05067972|565878020|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
156761570|NCT05067972|565878021|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
156761571|NCT05067972|565878022|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
156761572|NCT05067972|565878023|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
156761573|NCT05067972|565878024|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
156761574|NCT05067972|565878025|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
156761575|NCT05067972|565878026|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
156761576|NCT05067972|565878020|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761577|NCT05067972|565878021|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761578|NCT05067972|565878022|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761579|NCT05067972|565878023|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761580|NCT05067972|565878024|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761581|NCT05067972|565878025|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
156761582|NCT05067972|565878026|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
156761583|NCT05067972|565878020|FG000|Part 1: Follow-up|Physician Decision|0|||
156761584|NCT05067972|565878021|FG001|Part 1: Follow-up|Physician Decision|0|||
156761585|NCT05067972|565878022|FG002|Part 1: Follow-up|Physician Decision|0|||
156761586|NCT05067972|565878023|FG003|Part 1: Follow-up|Physician Decision|1|||
156761587|NCT05067972|565878024|FG004|Part 1: Follow-up|Physician Decision|0|||
156761588|NCT05067972|565878025|FG005|Part 1: Follow-up|Physician Decision|0|||
156761589|NCT05067972|565878026|FG006|Part 1: Follow-up|Physician Decision|0|||
156761590|NCT05067972|565878020|FG000|Part 1: Follow-up|Death|1|||
156761591|NCT05067972|565878021|FG001|Part 1: Follow-up|Death|2|||
156761592|NCT05067972|565878022|FG002|Part 1: Follow-up|Death|1|||
156761593|NCT05067972|565878023|FG003|Part 1: Follow-up|Death|0|||
156761594|NCT05067972|565878024|FG004|Part 1: Follow-up|Death|1|||
156761595|NCT05067972|565878025|FG005|Part 1: Follow-up|Death|0|||
156761596|NCT05067972|565878026|FG006|Part 1: Follow-up|Death|1|||
156761597|NCT00096538|565878033|FG000|Overall Study|Withdrawal by Subject|1|||
156761598|NCT00003471|565878036|FG000|Overall Study|Not evaluable|4|||
156761599|NCT00735007|565878037|FG000|Overall Study|Adverse Event|4|||
156761600|NCT00735007|565878037|FG000|Overall Study|Protocol Violation|1|||
156761601|NCT03839394|565878038|FG000|Overall Study|Lost to Follow-up|6|||
157001866|NCT00414648|566756039|FG000|Overall Study|Death|0|||
157001867|NCT00414648|566756040|FG001|Overall Study|Death|1|||
157001868|NCT00414648|566756039|FG000|Overall Study|Lack of Efficacy|0|||
157001869|NCT00414648|566756040|FG001|Overall Study|Lack of Efficacy|2|||
157001870|NCT00414648|566756039|FG000|Overall Study|Withdrawal by Subject|0|||
157001871|NCT00414648|566756040|FG001|Overall Study|Withdrawal by Subject|1|||
157001872|NCT01157182|566756041|FG000|Washout of 28 Days|Adverse Event|2|||
157001873|NCT01157182|566756042|FG001|Washout of 28 Days|Adverse Event|0|||
157001874|NCT01490580|566756043|FG000|Overall Study|Parents withdrew consent|0|||
156761602|NCT03839394|565878039|FG001|Overall Study|Lost to Follow-up|8|||
157104653|NCT01667107|567138020|FG000|Overall Study|Tolerability issues|0|||
156761603|NCT03839394|565878038|FG000|Overall Study|Withdrawal by Subject|0|||
156761604|NCT03839394|565878039|FG001|Overall Study|Withdrawal by Subject|2|||
157104654|NCT01667107|567138021|FG001|Overall Study|Tolerability issues|2|||
156761605|NCT00565604|565878042|FG000|Overall Study|Failure to treat|2|||
156761606|NCT00565604|565878042|FG000|Overall Study|Lost to Follow-up|2|||
156761607|NCT03877224|565878043|FG000|Overall Study|Death|3|||
156761608|NCT03877224|565878044|FG001|Overall Study|Death|2|||
156761609|NCT03877224|565878043|FG000|Overall Study|Withdrawal by Subject|1|||
157001875|NCT01490580|566756044|FG001|Overall Study|Parents withdrew consent|2|||
157001876|NCT00878722|566756045|FG000|Overall Study|Progressive disease|3|||
157001877|NCT00878722|566756046|FG001|Overall Study|Progressive disease|3|||
157001878|NCT00878722|566756047|FG002|Overall Study|Progressive disease|3|||
157001879|NCT00878722|566756048|FG003|Overall Study|Progressive disease|7|||
157001880|NCT00878722|566756049|FG004|Overall Study|Progressive disease|7|||
157001881|NCT00878722|566756050|FG005|Overall Study|Progressive disease|1|||
156761610|NCT03877224|565878044|FG001|Overall Study|Withdrawal by Subject|6|||
156761611|NCT03877224|565878043|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
156761612|NCT03877224|565878044|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
156761613|NCT02486692|565879815|FG000|Overall Study|did not login for randomization|4|||
156761614|NCT02486692|565879816|FG001|Overall Study|did not login for randomization|7|||
156761615|NCT00116688|565879820|FG000|Overall Study|Protocol deviation|1|||
156761616|NCT00116688|565879821|FG001|Overall Study|Protocol deviation|0|||
156761617|NCT00116688|565879820|FG000|Overall Study|Noncompliance|3|||
156761618|NCT00116688|565879821|FG001|Overall Study|Noncompliance|1|||
156761619|NCT00116688|565879820|FG000|Overall Study|Adverse Event|11|||
156761620|NCT00116688|565879821|FG001|Overall Study|Adverse Event|0|||
156761621|NCT00116688|565879820|FG000|Overall Study|Withdrawal by Subject|26|||
156761622|NCT00116688|565879821|FG001|Overall Study|Withdrawal by Subject|2|||
156761623|NCT00116688|565879820|FG000|Overall Study|Requirement for alternative therapy|11|||
156761624|NCT00116688|565879821|FG001|Overall Study|Requirement for alternative therapy|1|||
156761625|NCT00116688|565879820|FG000|Overall Study|Physician Decision|7|||
156761626|NCT00116688|565879821|FG001|Overall Study|Physician Decision|0|||
156761627|NCT00116688|565879820|FG000|Overall Study|Lost to Follow-up|3|||
156761628|NCT00116688|565879821|FG001|Overall Study|Lost to Follow-up|0|||
156761629|NCT00116688|565879820|FG000|Overall Study|Death|15|||
156761630|NCT00116688|565879821|FG001|Overall Study|Death|0|||
156761631|NCT00116688|565879820|FG000|Overall Study|Protocol-specified criteria|3|||
156761632|NCT00116688|565879821|FG001|Overall Study|Protocol-specified criteria|0|||
156761633|NCT00116688|565879820|FG000|Overall Study|Pregnancy|1|||
156761634|NCT00116688|565879821|FG001|Overall Study|Pregnancy|0|||
156761635|NCT00116688|565879820|FG000|Overall Study|Other|11|||
156761636|NCT00116688|565879821|FG001|Overall Study|Other|0|||
156761637|NCT01775670|565879823|FG000|Overall Study|Lost to Follow-up|1|||
156761638|NCT01775670|565879824|FG001|Overall Study|Lost to Follow-up|1|||
156761639|NCT01298700|565879826|FG000|Overall Study|Adverse Event|50|||
156761640|NCT01298700|565879827|FG001|Overall Study|Adverse Event|51|||
156761641|NCT01298700|565879826|FG000|Overall Study|Lack of Efficacy|9|||
156761642|NCT01298700|565879827|FG001|Overall Study|Lack of Efficacy|14|||
156761643|NCT01298700|565879826|FG000|Overall Study|Lost to Follow-up|5|||
156761644|NCT01298700|565879827|FG001|Overall Study|Lost to Follow-up|2|||
156761645|NCT01298700|565879826|FG000|Overall Study|Withdrawal by Subject|12|||
156761646|NCT01298700|565879827|FG001|Overall Study|Withdrawal by Subject|9|||
156761647|NCT01298700|565879826|FG000|Overall Study|Protocol Violation|6|||
156761648|NCT01298700|565879827|FG001|Overall Study|Protocol Violation|4|||
156761649|NCT01298700|565879826|FG000|Overall Study|Other Miscellaneous Reasons|16|||
156761650|NCT01298700|565879827|FG001|Overall Study|Other Miscellaneous Reasons|15|||
156761651|NCT01298700|565879826|FG000|Overall Study|Did not Receive Study Drug|3|||
156761652|NCT01298700|565879827|FG001|Overall Study|Did not Receive Study Drug|5|||
156761653|NCT04006145|565879828|FG000|Overall Study|Lost to Follow-up|0|||
156761654|NCT04006145|565879829|FG001|Overall Study|Lost to Follow-up|1|||
156761655|NCT04006145|565879828|FG000|Overall Study|Other|1|||
156761656|NCT04006145|565879829|FG001|Overall Study|Other|2|||
156761657|NCT01001429|565879830|FG000|Overall Study|surgery cancelled|0|||
156761658|NCT01001429|565879831|FG001|Overall Study|surgery cancelled|1|||
156761659|NCT00010257|565879834|FG000|Overall Study|Withdrawal by Subject|1|||
156761660|NCT00010257|565879835|FG001|Overall Study|Withdrawal by Subject|0|||
156761661|NCT00643760|565879838|FG000|Overall Study|Adverse Event|11|||
156761662|NCT00643760|565879839|FG001|Overall Study|Adverse Event|5|||
156761663|NCT00643760|565879840|FG002|Overall Study|Adverse Event|12|||
156761664|NCT00643760|565879841|FG003|Overall Study|Adverse Event|21|||
156761665|NCT00643760|565879842|FG004|Overall Study|Adverse Event|6|||
156761666|NCT00643760|565879838|FG000|Overall Study|Lack of Efficacy|3|||
156761667|NCT00643760|565879839|FG001|Overall Study|Lack of Efficacy|1|||
156761668|NCT00643760|565879840|FG002|Overall Study|Lack of Efficacy|0|||
156761669|NCT00643760|565879841|FG003|Overall Study|Lack of Efficacy|4|||
156761670|NCT00643760|565879842|FG004|Overall Study|Lack of Efficacy|3|||
156761671|NCT00643760|565879838|FG000|Overall Study|Protocol Violation|7|||
156761672|NCT00643760|565879839|FG001|Overall Study|Protocol Violation|6|||
156761673|NCT00643760|565879840|FG002|Overall Study|Protocol Violation|4|||
156761674|NCT00643760|565879841|FG003|Overall Study|Protocol Violation|4|||
156761675|NCT00643760|565879842|FG004|Overall Study|Protocol Violation|6|||
156761676|NCT00643760|565879838|FG000|Overall Study|Lost to Follow-up|6|||
156761677|NCT00643760|565879839|FG001|Overall Study|Lost to Follow-up|2|||
156761678|NCT00643760|565879840|FG002|Overall Study|Lost to Follow-up|1|||
156761679|NCT00643760|565879841|FG003|Overall Study|Lost to Follow-up|3|||
156761680|NCT00643760|565879842|FG004|Overall Study|Lost to Follow-up|3|||
156761681|NCT00643760|565879838|FG000|Overall Study|Investigator Discretion|0|||
156761682|NCT00643760|565879839|FG001|Overall Study|Investigator Discretion|0|||
156761683|NCT00643760|565879840|FG002|Overall Study|Investigator Discretion|0|||
156761684|NCT00643760|565879841|FG003|Overall Study|Investigator Discretion|2|||
156761685|NCT00643760|565879842|FG004|Overall Study|Investigator Discretion|0|||
156761686|NCT00643760|565879838|FG000|Overall Study|Withdrawal by Subject|3|||
156761687|NCT00643760|565879839|FG001|Overall Study|Withdrawal by Subject|1|||
156761688|NCT00643760|565879840|FG002|Overall Study|Withdrawal by Subject|2|||
156761689|NCT00643760|565879841|FG003|Overall Study|Withdrawal by Subject|4|||
156761690|NCT00643760|565879842|FG004|Overall Study|Withdrawal by Subject|1|||
156761691|NCT02063672|565879846|FG000|Overall Study|Ongoing Follow-up|27|||
156761692|NCT02063672|565879847|FG001|Overall Study|Ongoing Follow-up|14|||
156761693|NCT02063672|565879846|FG000|Overall Study|Death|5|||
156761694|NCT02063672|565879847|FG001|Overall Study|Death|3|||
156761695|NCT02063672|565879846|FG000|Overall Study|Lost to Follow-up|1|||
156761696|NCT02063672|565879847|FG001|Overall Study|Lost to Follow-up|3|||
156761697|NCT02063672|565879846|FG000|Overall Study|Withdrawal by Subject|2|||
156761698|NCT02063672|565879847|FG001|Overall Study|Withdrawal by Subject|2|||
156761699|NCT01307787|565879849|FG000|Overall Study|Withdrawal by Subject|2|||
156761700|NCT01307787|565879850|FG001|Overall Study|Withdrawal by Subject|0|||
156761701|NCT03353792|565879854|FG000|Overall Study|Lost to Follow-up|1|||
156761702|NCT03353792|565879855|FG001|Overall Study|Lost to Follow-up|0|||
156761703|NCT03353792|565879854|FG000|Overall Study|Participant Unable to Manage Device|1|||
156761704|NCT03353792|565879855|FG001|Overall Study|Participant Unable to Manage Device|0|||
156761705|NCT00789321|565879856|FG000|Overall Study|Adverse Event|0|||
156761706|NCT00789321|565879857|FG001|Overall Study|Adverse Event|1|||
156761707|NCT00104052|565879858|FG000|Overall Study|Adverse Event|1|||
156761708|NCT00104052|565879858|FG000|Overall Study|Lack of Efficacy|26|||
156761709|NCT00104052|565879858|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
156761710|NCT02498678|565879861|FG000|Overall Study|interference from the surgical team|0|||
156761711|NCT02498678|565879862|FG001|Overall Study|interference from the surgical team|2|||
156761712|NCT03652818|565879863|FG000|Overall Study|Adverse Event|1|||
156761713|NCT03652818|565879864|FG001|Overall Study|Adverse Event|0|||
156761714|NCT03652818|565879865|FG002|Overall Study|Adverse Event|0|||
156761715|NCT03652818|565879866|FG003|Overall Study|Adverse Event|0|||
156761716|NCT03652818|565879867|FG004|Overall Study|Adverse Event|0|||
156761717|NCT03652818|565879863|FG000|Overall Study|Physician Decision|1|||
156761718|NCT03652818|565879864|FG001|Overall Study|Physician Decision|0|||
156761719|NCT03652818|565879865|FG002|Overall Study|Physician Decision|0|||
156761720|NCT03652818|565879866|FG003|Overall Study|Physician Decision|0|||
156761721|NCT03652818|565879867|FG004|Overall Study|Physician Decision|0|||
156761722|NCT03652818|565879863|FG000|Overall Study|Lost to Follow-up|0|||
156761723|NCT03652818|565879864|FG001|Overall Study|Lost to Follow-up|1|||
156761724|NCT03652818|565879865|FG002|Overall Study|Lost to Follow-up|2|||
156761725|NCT03652818|565879866|FG003|Overall Study|Lost to Follow-up|1|||
156761726|NCT03652818|565879867|FG004|Overall Study|Lost to Follow-up|1|||
156761727|NCT01294423|565879872|FG000|Overall Study|Adverse Event|1|||
156761728|NCT01294423|565879873|FG001|Overall Study|Adverse Event|2|||
157104655|NCT01667107|567138020|FG000|Overall Study|Protocol Violation|0|||
157104656|NCT01667107|567138021|FG001|Overall Study|Protocol Violation|1|||
157104657|NCT01667107|567138020|FG000|Overall Study|Lack of Efficacy|0|||
157104658|NCT01667107|567138021|FG001|Overall Study|Lack of Efficacy|1|||
157104659|NCT03427125|567138022|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
157104660|NCT03427125|567138023|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
157104661|NCT03427125|567138024|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
157104662|NCT02281357|567138025|FG000|Overall Study|Adverse Event|2|||
157104663|NCT02281357|567138026|FG001|Overall Study|Adverse Event|1|||
157104664|NCT02281357|567138025|FG000|Overall Study|Lost to Follow-up|1|||
157104665|NCT02281357|567138026|FG001|Overall Study|Lost to Follow-up|0|||
157104666|NCT02281357|567138025|FG000|Overall Study|Withdrawal by Subject|4|||
157104667|NCT02281357|567138026|FG001|Overall Study|Withdrawal by Subject|3|||
157104668|NCT01162239|567138027|FG000|Treatment Phase|Withdrawal by Subject|1|||
157104669|NCT01162239|567138028|FG001|Treatment Phase|Withdrawal by Subject|3|||
157104670|NCT01162239|567138029|FG002|Treatment Phase|Withdrawal by Subject|2|||
157104671|NCT01162239|567138030|FG003|Treatment Phase|Withdrawal by Subject|3|||
157104672|NCT01162239|567138027|FG000|Treatment Phase|Death|0|||
157104673|NCT01162239|567138028|FG001|Treatment Phase|Death|0|||
157104674|NCT01162239|567138029|FG002|Treatment Phase|Death|0|||
157104675|NCT01162239|567138030|FG003|Treatment Phase|Death|1|||
157104676|NCT01162239|567138027|FG000|Treatment Phase|Lost to Follow-up|5|||
157104677|NCT01162239|567138028|FG001|Treatment Phase|Lost to Follow-up|4|||
157104678|NCT01162239|567138029|FG002|Treatment Phase|Lost to Follow-up|2|||
156761729|NCT01294423|565879874|FG002|Overall Study|Adverse Event|3|||
156761730|NCT01294423|565879872|FG000|Overall Study|Withdrawal by Subject|1|||
156761731|NCT01294423|565879873|FG001|Overall Study|Withdrawal by Subject|2|||
156761732|NCT01294423|565879874|FG002|Overall Study|Withdrawal by Subject|2|||
156761733|NCT01294423|565879872|FG000|Overall Study|subject no longer meets study criteria|2|||
156761734|NCT01294423|565879873|FG001|Overall Study|subject no longer meets study criteria|5|||
156761735|NCT01294423|565879874|FG002|Overall Study|subject no longer meets study criteria|2|||
156761736|NCT01294423|565879872|FG000|Overall Study|poor/non-compliance|1|||
157104679|NCT01162239|567138030|FG003|Treatment Phase|Lost to Follow-up|1|||
157104680|NCT01162239|567138027|FG000|Extended Follow-up|Lost to Follow-up|8|||
157104681|NCT01162239|567138028|FG001|Extended Follow-up|Lost to Follow-up|13|||
157104682|NCT01162239|567138029|FG002|Extended Follow-up|Lost to Follow-up|8|||
156761737|NCT01294423|565879873|FG001|Overall Study|poor/non-compliance|0|||
156761738|NCT01294423|565879874|FG002|Overall Study|poor/non-compliance|1|||
156761739|NCT01241279|565879875|FG000|Overall Study|Lost to Follow-up|0|||
156761740|NCT01241279|565879876|FG001|Overall Study|Lost to Follow-up|1|||
156761741|NCT00705757|565879879|FG000|Overall Study|Lack of Efficacy|5|||
156761742|NCT00705757|565879880|FG001|Overall Study|Lack of Efficacy|1|||
156761743|NCT00705757|565879881|FG002|Overall Study|Lack of Efficacy|3|||
156761744|NCT00705757|565879879|FG000|Overall Study|Lost to Follow-up|7|||
156761745|NCT00705757|565879880|FG001|Overall Study|Lost to Follow-up|6|||
156761746|NCT00705757|565879881|FG002|Overall Study|Lost to Follow-up|6|||
156761747|NCT00705757|565879879|FG000|Overall Study|Withdrawal by Subject|1|||
156761748|NCT00705757|565879880|FG001|Overall Study|Withdrawal by Subject|1|||
156761749|NCT00705757|565879881|FG002|Overall Study|Withdrawal by Subject|2|||
156761750|NCT04742673|565879882|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
156761751|NCT04742673|565879883|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
156761752|NCT04073303|565879888|FG000|Overall Study|Adverse Event|0|||
156761753|NCT04073303|565879889|FG001|Overall Study|Adverse Event|2|||
156761754|NCT04073303|565879888|FG000|Overall Study|Withdrawal by Subject|16|||
156761755|NCT04073303|565879889|FG001|Overall Study|Withdrawal by Subject|36|||
156761756|NCT04073303|565879888|FG000|Overall Study|Lost to Follow-up|6|||
156761757|NCT04073303|565879889|FG001|Overall Study|Lost to Follow-up|1|||
156761758|NCT04073303|565879888|FG000|Overall Study|Protocol Deviation|0|||
156761759|NCT04073303|565879889|FG001|Overall Study|Protocol Deviation|4|||
156761760|NCT04073303|565879888|FG000|Overall Study|Other|1|||
156761761|NCT04073303|565879889|FG001|Overall Study|Other|1|||
156761762|NCT01158261|565879895|FG000|Overall Study|Lost to Follow-up|9|||
156761763|NCT01158261|565879895|FG000|Overall Study|Death|7|||
156761764|NCT01158261|565879895|FG000|Overall Study|Withdrawal by Subject|1|||
156761765|NCT05227118|565879896|FG000|Overall Study|Adverse Event|0|||
156761766|NCT05227118|565879897|FG001|Overall Study|Adverse Event|0|||
156761767|NCT05227118|565879898|FG002|Overall Study|Adverse Event|1|||
156761768|NCT05227118|565879899|FG003|Overall Study|Adverse Event|0|||
156761769|NCT05227118|565879896|FG000|Overall Study|Withdrawal by Subject|0|||
156761770|NCT05227118|565879897|FG001|Overall Study|Withdrawal by Subject|0|||
156761771|NCT05227118|565879898|FG002|Overall Study|Withdrawal by Subject|2|||
156761772|NCT05227118|565879899|FG003|Overall Study|Withdrawal by Subject|0|||
157001882|NCT00878722|566756051|FG006|Overall Study|Progressive disease|4|||
157001883|NCT00878722|566756052|FG007|Overall Study|Progressive disease|3|||
157104683|NCT01162239|567138030|FG003|Extended Follow-up|Lost to Follow-up|6|||
157104684|NCT01810016|567138035|FG000|Overall Study|Progressive disease|1|||
157104685|NCT01810016|567138036|FG001|Overall Study|Progressive disease|1|||
157104686|NCT01810016|567138037|FG002|Overall Study|Progressive disease|0|||
157104687|NCT01810016|567138035|FG000|Overall Study|Death|0|||
157104688|NCT01810016|567138036|FG001|Overall Study|Death|0|||
157104689|NCT01810016|567138037|FG002|Overall Study|Death|1|||
157104690|NCT04263896|567138038|FG000|Overall Study|Withdrawal by Subject|2|||
157104691|NCT04263896|567138039|FG001|Overall Study|Withdrawal by Subject|4|||
157104692|NCT04263896|567138038|FG000|Overall Study|converted to open procedure|0|||
157104693|NCT04263896|567138039|FG001|Overall Study|converted to open procedure|1|||
157104694|NCT04263896|567138038|FG000|Overall Study|Lost to Follow-up|9|||
157104695|NCT04263896|567138039|FG001|Overall Study|Lost to Follow-up|11|||
156761773|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
156761774|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
157001884|NCT00878722|566756045|FG000|Overall Study|Death|0|||
157001885|NCT00878722|566756046|FG001|Overall Study|Death|0|||
157001886|NCT00878722|566756047|FG002|Overall Study|Death|0|||
157001887|NCT00878722|566756048|FG003|Overall Study|Death|1|||
157001888|NCT00878722|566756049|FG004|Overall Study|Death|0|||
157001889|NCT00878722|566756050|FG005|Overall Study|Death|1|||
157001890|NCT00878722|566756051|FG006|Overall Study|Death|0|||
157001891|NCT00878722|566756052|FG007|Overall Study|Death|2|||
157001892|NCT00878722|566756045|FG000|Overall Study|Adverse Event|0|||
157001893|NCT00878722|566756046|FG001|Overall Study|Adverse Event|0|||
157001894|NCT00878722|566756047|FG002|Overall Study|Adverse Event|0|||
157001895|NCT00878722|566756048|FG003|Overall Study|Adverse Event|0|||
157104696|NCT04263896|567138038|FG000|Overall Study|surveys lost in mail|5|||
157104697|NCT04263896|567138039|FG001|Overall Study|surveys lost in mail|3|||
157104698|NCT04263896|567138038|FG000|Overall Study|excluded from analysis|1|||
157104699|NCT04263896|567138039|FG001|Overall Study|excluded from analysis|0|||
157104700|NCT06950879|567138040|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
157104701|NCT02246582|567139283|FG000|Overall Study|Withdrawal by Subject|3|||
157104702|NCT02246582|567139284|FG001|Overall Study|Withdrawal by Subject|4|||
157104703|NCT00682448|567139292|FG000|Overall Study|Adverse Event|1|||
157104704|NCT00682448|567139293|FG001|Overall Study|Adverse Event|2|||
157104705|NCT00682448|567139292|FG000|Overall Study|Lack of Efficacy|1|||
157104706|NCT00682448|567139293|FG001|Overall Study|Lack of Efficacy|0|||
156761775|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
156761776|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
157001896|NCT00878722|566756049|FG004|Overall Study|Adverse Event|0|||
157001897|NCT00878722|566756050|FG005|Overall Study|Adverse Event|0|||
157104707|NCT00682448|567139292|FG000|Overall Study|Lost to Follow-up|1|||
157104708|NCT00682448|567139293|FG001|Overall Study|Lost to Follow-up|3|||
157104709|NCT00682448|567139292|FG000|Overall Study|Pregnancy|0|||
157104710|NCT00682448|567139293|FG001|Overall Study|Pregnancy|1|||
157104711|NCT00682448|567139292|FG000|Overall Study|Withdrawal by Subject|2|||
157104712|NCT00682448|567139293|FG001|Overall Study|Withdrawal by Subject|0|||
157104713|NCT04050670|567139296|FG000|Period 3|Physician Decision|0|||
157104714|NCT04050670|567139297|FG001|Period 3|Physician Decision|1|||
157104715|NCT04050670|567139298|FG002|Period 3|Physician Decision|0|||
157104716|NCT00761306|567139299|FG000|Overall Study|Adverse Event|5|||
157104717|NCT00761306|567139299|FG000|Overall Study|Lack of Efficacy|4|||
157104718|NCT00761306|567139299|FG000|Overall Study|Protocol Violation|2|||
157104719|NCT00761306|567139299|FG000|Overall Study|Withdrawal of Consent|3|||
157104720|NCT00761306|567139299|FG000|Overall Study|Lost to Follow-up|1|||
157104721|NCT00761306|567139299|FG000|Overall Study|Administrative or Other Reasons|5|||
157104722|NCT00268437|567139300|FG000|Overall Study|Ineligible|1|||
157104723|NCT05162027|567139301|FG000|Overall Study|Adverse Event|1|||
157104724|NCT05162027|567139302|FG001|Overall Study|Adverse Event|0|||
157104725|NCT00525044|567139303|FG000|Overall Study|Lost to Follow-up|0|||
157104726|NCT00525044|567139304|FG001|Overall Study|Lost to Follow-up|1|||
157104727|NCT02982239|567139305|FG000|Overall Study|Lost to Follow-up|3|||
157104728|NCT02982239|567139306|FG001|Overall Study|Lost to Follow-up|2|||
157104729|NCT01650285|567139307|FG000|Overall Study|Adverse Event|1|||
157104730|NCT00907257|567139308|FG000|Overall Study|Adverse Event|0|||
157104731|NCT00907257|567139309|FG001|Overall Study|Adverse Event|4|||
157104732|NCT00907257|567139308|FG000|Overall Study|Protocol Violation|1|||
157104733|NCT00907257|567139309|FG001|Overall Study|Protocol Violation|2|||
157104734|NCT00907257|567139308|FG000|Overall Study|Lost to Follow-up|3|||
157104735|NCT00907257|567139309|FG001|Overall Study|Lost to Follow-up|3|||
157104736|NCT00907257|567139308|FG000|Overall Study|Withdrawal by Subject|1|||
157104737|NCT00907257|567139309|FG001|Overall Study|Withdrawal by Subject|2|||
157104738|NCT00907257|567139308|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
157104739|NCT00907257|567139309|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
157104740|NCT00907257|567139308|FG000|Overall Study|Moved|1|||
157104741|NCT00907257|567139309|FG001|Overall Study|Moved|0|||
157104742|NCT00907257|567139308|FG000|Overall Study|Personal Reasons|6|||
157104743|NCT00907257|567139309|FG001|Overall Study|Personal Reasons|1|||
157104744|NCT00880555|567139310|FG000|Overall Study|Physician Decision|0|||
157104745|NCT00880555|567139311|FG001|Overall Study|Physician Decision|8|||
157104746|NCT00880555|567139312|FG002|Overall Study|Physician Decision|0|||
157104747|NCT00880555|567139313|FG003|Overall Study|Physician Decision|2|||
157104748|NCT00880555|567139314|FG004|Overall Study|Physician Decision|1|||
157104749|NCT00880555|567139315|FG005|Overall Study|Physician Decision|0|||
157104750|NCT00880555|567139310|FG000|Overall Study|Withdrawal by Subject|1|||
157104751|NCT00880555|567139311|FG001|Overall Study|Withdrawal by Subject|1|||
157104752|NCT00880555|567139312|FG002|Overall Study|Withdrawal by Subject|0|||
157104753|NCT00880555|567139313|FG003|Overall Study|Withdrawal by Subject|0|||
157104754|NCT00880555|567139314|FG004|Overall Study|Withdrawal by Subject|0|||
157104755|NCT00880555|567139315|FG005|Overall Study|Withdrawal by Subject|0|||
157104756|NCT00880555|567139310|FG000|Overall Study|Lack of resources (hired rater)|9|||
157104757|NCT00880555|567139311|FG001|Overall Study|Lack of resources (hired rater)|7|||
157104758|NCT00880555|567139312|FG002|Overall Study|Lack of resources (hired rater)|5|||
157104759|NCT00880555|567139313|FG003|Overall Study|Lack of resources (hired rater)|0|||
157001898|NCT00878722|566756051|FG006|Overall Study|Adverse Event|2|||
157001899|NCT00878722|566756052|FG007|Overall Study|Adverse Event|0|||
157001900|NCT00878722|566756045|FG000|Overall Study|Withdrawal by Subject|0|||
157001901|NCT00878722|566756046|FG001|Overall Study|Withdrawal by Subject|0|||
157001902|NCT00878722|566756047|FG002|Overall Study|Withdrawal by Subject|0|||
157001903|NCT00878722|566756048|FG003|Overall Study|Withdrawal by Subject|0|||
157001904|NCT00878722|566756049|FG004|Overall Study|Withdrawal by Subject|0|||
157001905|NCT00878722|566756050|FG005|Overall Study|Withdrawal by Subject|0|||
157001906|NCT00878722|566756051|FG006|Overall Study|Withdrawal by Subject|0|||
157104760|NCT00880555|567139314|FG004|Overall Study|Lack of resources (hired rater)|0|||
157104761|NCT00880555|567139315|FG005|Overall Study|Lack of resources (hired rater)|0|||
157104762|NCT00880555|567139310|FG000|Overall Study|Death|0|||
157104763|NCT00880555|567139311|FG001|Overall Study|Death|0|||
157104764|NCT00880555|567139312|FG002|Overall Study|Death|0|||
157104765|NCT00880555|567139313|FG003|Overall Study|Death|0|||
157104766|NCT00880555|567139314|FG004|Overall Study|Death|0|||
157104767|NCT00880555|567139315|FG005|Overall Study|Death|1|||
157104768|NCT00880555|567139310|FG000|Overall Study|Lost to Follow-up|0|||
157104769|NCT00880555|567139311|FG001|Overall Study|Lost to Follow-up|1|||
157104770|NCT00880555|567139312|FG002|Overall Study|Lost to Follow-up|0|||
157104771|NCT00880555|567139313|FG003|Overall Study|Lost to Follow-up|0|||
157104772|NCT00880555|567139314|FG004|Overall Study|Lost to Follow-up|0|||
157104773|NCT00880555|567139315|FG005|Overall Study|Lost to Follow-up|0|||
157104774|NCT04163900|567139316|FG000|Overall Study|Radiological disease progression|112|||
157104775|NCT04163900|567139317|FG001|Overall Study|Radiological disease progression|127|||
157104776|NCT04163900|567139316|FG000|Overall Study|Study closure|98|||
157104777|NCT04163900|567139317|FG001|Overall Study|Study closure|133|||
157104778|NCT04163900|567139316|FG000|Overall Study|Adverse Event|78|||
157104779|NCT04163900|567139317|FG001|Overall Study|Adverse Event|32|||
157104780|NCT04163900|567139316|FG000|Overall Study|Withdrawal by Subject|37|||
157104781|NCT04163900|567139317|FG001|Overall Study|Withdrawal by Subject|34|||
157104782|NCT04163900|567139316|FG000|Overall Study|Death|29|||
157104783|NCT04163900|567139317|FG001|Overall Study|Death|16|||
157104784|NCT04163900|567139316|FG000|Overall Study|Physician Decision|17|||
157104785|NCT04163900|567139317|FG001|Overall Study|Physician Decision|25|||
157104786|NCT04163900|567139316|FG000|Overall Study|Clinical disease progression|14|||
157104787|NCT04163900|567139317|FG001|Overall Study|Clinical disease progression|13|||
157104788|NCT04163900|567139316|FG000|Overall Study|Protocol Violation|3|||
157104789|NCT04163900|567139317|FG001|Overall Study|Protocol Violation|4|||
157104790|NCT04163900|567139316|FG000|Overall Study|Lost to Follow-up|0|||
157104791|NCT04163900|567139317|FG001|Overall Study|Lost to Follow-up|1|||
157104792|NCT01873417|567139319|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
157104793|NCT01873417|567139319|FG000|Overall Study|Adverse Event|24|||
157104794|NCT01873417|567139319|FG000|Overall Study|Lost to Follow-up|2|||
157104795|NCT01873417|567139319|FG000|Overall Study|Withdrawal by Subject|2|||
157104796|NCT01873417|567139319|FG000|Overall Study|Physician Decision|3|||
157104797|NCT00785044|567139320|FG000|Overall Study|Dosed at non-participating sites|152|||
157104798|NCT00785044|567139320|FG000|Overall Study|Death|77|||
157104799|NCT00785044|567139320|FG000|Overall Study|Lost to Follow-up|266|||
157104800|NCT00785044|567139320|FG000|Overall Study|Withdrawal by Subject|1|||
157104801|NCT01628107|567139321|FG000|Overall Study|Withdrawal by Subject|17|||
157104802|NCT01628107|567139321|FG000|Overall Study|Lost to Follow-up|4|||
157104803|NCT01628107|567139321|FG000|Overall Study|Adverse Event|33|||
157104804|NCT01628107|567139321|FG000|Overall Study|Physician Decision|2|||
157104805|NCT01628107|567139321|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
157001907|NCT00878722|566756052|FG007|Overall Study|Withdrawal by Subject|2|||
157001908|NCT00878722|566756045|FG000|Overall Study|Relapse|0|||
157001909|NCT00878722|566756046|FG001|Overall Study|Relapse|0|||
157001910|NCT00878722|566756047|FG002|Overall Study|Relapse|0|||
157001911|NCT00878722|566756048|FG003|Overall Study|Relapse|1|||
157001912|NCT00878722|566756049|FG004|Overall Study|Relapse|0|||
157001913|NCT00878722|566756050|FG005|Overall Study|Relapse|0|||
157001914|NCT00878722|566756051|FG006|Overall Study|Relapse|0|||
157001915|NCT00878722|566756052|FG007|Overall Study|Relapse|0|||
157001916|NCT00383188|566756053|FG000|Overall Study|Adverse Event|4|||
157001917|NCT00383188|566756054|FG001|Overall Study|Adverse Event|7|||
157001918|NCT00383188|566756055|FG002|Overall Study|Adverse Event|9|||
157001919|NCT00383188|566756056|FG003|Overall Study|Adverse Event|8|||
157001920|NCT00383188|566756057|FG004|Overall Study|Adverse Event|8|||
157001921|NCT00383188|566756053|FG000|Overall Study|Lack of Efficacy|9|||
157001922|NCT00383188|566756054|FG001|Overall Study|Lack of Efficacy|3|||
157001923|NCT00383188|566756055|FG002|Overall Study|Lack of Efficacy|3|||
157001924|NCT00383188|566756056|FG003|Overall Study|Lack of Efficacy|2|||
157001925|NCT00383188|566756057|FG004|Overall Study|Lack of Efficacy|6|||
157001926|NCT00383188|566756053|FG000|Overall Study|Other|3|||
157001927|NCT00383188|566756054|FG001|Overall Study|Other|1|||
157001928|NCT00383188|566756055|FG002|Overall Study|Other|0|||
157001929|NCT00383188|566756056|FG003|Overall Study|Other|2|||
157001930|NCT00383188|566756057|FG004|Overall Study|Other|6|||
157001931|NCT00383188|566756053|FG000|Overall Study|No longer willing to participate|1|||
157001932|NCT00383188|566756054|FG001|Overall Study|No longer willing to participate|0|||
157001933|NCT00383188|566756055|FG002|Overall Study|No longer willing to participate|1|||
157001934|NCT00383188|566756056|FG003|Overall Study|No longer willing to participate|0|||
157001935|NCT00383188|566756057|FG004|Overall Study|No longer willing to participate|2|||
157001936|NCT00383188|566756053|FG000|Overall Study|Lost to Follow-up|0|||
157001937|NCT00383188|566756054|FG001|Overall Study|Lost to Follow-up|0|||
157001938|NCT00383188|566756055|FG002|Overall Study|Lost to Follow-up|0|||
157001939|NCT00383188|566756056|FG003|Overall Study|Lost to Follow-up|0|||
157104806|NCT01628107|567139321|FG000|Overall Study|Non-compliant with Study Procedures|10|||
157104807|NCT01628107|567139321|FG000|Overall Study|Not Treated|8|||
157001940|NCT00383188|566756057|FG004|Overall Study|Lost to Follow-up|1|||
157001941|NCT01104415|566756061|FG000|Core Phase|Consent withdrawn by subjects|1|||
157104808|NCT01628107|567139321|FG000|Overall Study|Sponsor Decision|11|||
157104809|NCT01628107|567139321|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
157104810|NCT01628107|567139321|FG000|Overall Study|Relocated|8|||
157104811|NCT01628107|567139321|FG000|Overall Study|Kidney Transplant|9|||
157104812|NCT01628107|567139321|FG000|Overall Study|Use of Standard of Care|9|||
157104813|NCT01086410|567139322|FG000|Overall Study|Adverse Event|1|||
157104814|NCT01086410|567139323|FG001|Overall Study|Adverse Event|0|||
157104815|NCT01086410|567139324|FG002|Overall Study|Adverse Event|0|||
157104816|NCT01086410|567139325|FG003|Overall Study|Adverse Event|2|||
157001942|NCT01104415|566756062|FG001|Core Phase|Consent withdrawn by subjects|0|||
157001943|NCT01104415|566756061|FG000|Extension Period|Progressive disease|0|||
157001944|NCT01104415|566756062|FG001|Extension Period|Progressive disease|4|||
157001945|NCT01104415|566756061|FG000|Extension Period|Death|0|||
157001946|NCT01104415|566756062|FG001|Extension Period|Death|1|||
157001947|NCT01104415|566756061|FG000|Extension Period|Physician Decision|0|||
157104817|NCT01086410|567139322|FG000|Overall Study|Lack of Efficacy|1|||
157104818|NCT01086410|567139323|FG001|Overall Study|Lack of Efficacy|1|||
157104819|NCT01086410|567139324|FG002|Overall Study|Lack of Efficacy|0|||
157104820|NCT01086410|567139325|FG003|Overall Study|Lack of Efficacy|0|||
157104821|NCT01086410|567139322|FG000|Overall Study|Protocol Violation|1|||
157104822|NCT01086410|567139323|FG001|Overall Study|Protocol Violation|1|||
157104823|NCT01086410|567139324|FG002|Overall Study|Protocol Violation|0|||
157104824|NCT01086410|567139325|FG003|Overall Study|Protocol Violation|0|||
157104825|NCT01086410|567139322|FG000|Overall Study|Lost to Follow-up|0|||
157104826|NCT01086410|567139323|FG001|Overall Study|Lost to Follow-up|0|||
157104827|NCT01086410|567139324|FG002|Overall Study|Lost to Follow-up|1|||
157104828|NCT01086410|567139325|FG003|Overall Study|Lost to Follow-up|0|||
157104829|NCT00621751|567139326|FG000|Overall Study|Adverse Event|0|||
157104830|NCT00621751|567139327|FG001|Overall Study|Adverse Event|1|||
157104831|NCT02023242|567139328|FG000|Overall Study|Lost to Follow-up|3|||
157104832|NCT02023242|567139329|FG001|Overall Study|Lost to Follow-up|1|||
157104833|NCT02023242|567139328|FG000|Overall Study|Death|0|||
157104834|NCT02023242|567139329|FG001|Overall Study|Death|1|||
157104835|NCT00710879|567139333|FG000|Overall Study|Lost to Follow-up|2|||
157104836|NCT00710879|567139334|FG001|Overall Study|Lost to Follow-up|1|||
157104837|NCT00710879|567139333|FG000|Overall Study|Protocol Violation|0|||
157104838|NCT00710879|567139334|FG001|Overall Study|Protocol Violation|3|||
157104839|NCT01809132|567139335|FG000|Overall Study|Withdrawal by Subject|0|||
157104840|NCT01809132|567139336|FG001|Overall Study|Withdrawal by Subject|0|||
157104841|NCT01809132|567139337|FG002|Overall Study|Withdrawal by Subject|1|||
157104842|NCT04854434|567139338|FG000|Overall Study|Death|1|||
157104843|NCT04854434|567139339|FG001|Overall Study|Death|3|||
157104844|NCT04854434|567139340|FG002|Overall Study|Death|4|||
157104845|NCT04854434|567139338|FG000|Overall Study|Study Terminated by Sponsor|2|||
157104846|NCT04854434|567139339|FG001|Overall Study|Study Terminated by Sponsor|0|||
157104847|NCT04854434|567139340|FG002|Overall Study|Study Terminated by Sponsor|0|||
157104848|NCT04854434|567139338|FG000|Overall Study|Other|1|||
157104849|NCT04854434|567139339|FG001|Overall Study|Other|1|||
157104850|NCT04854434|567139340|FG002|Overall Study|Other|0|||
157001948|NCT01104415|566756062|FG001|Extension Period|Physician Decision|1|||
157001949|NCT01104415|566756061|FG000|Extension Period|Transition to Study LX1606.302|0|||
157001950|NCT01104415|566756062|FG001|Extension Period|Transition to Study LX1606.302|4|||
157001951|NCT01104415|566756061|FG000|Extension Period|Heart surgery/feeling miserable|0|||
157001952|NCT01104415|566756062|FG001|Extension Period|Heart surgery/feeling miserable|1|||
157001953|NCT00988637|566756063|FG000|Overall Study|Lost to Follow-up|2|||
157001954|NCT00988637|566756064|FG001|Overall Study|Lost to Follow-up|1|||
157001955|NCT00988637|566756063|FG000|Overall Study|Withdrawal by Subject|1|||
157001956|NCT00988637|566756064|FG001|Overall Study|Withdrawal by Subject|1|||
157001957|NCT00988637|566756063|FG000|Overall Study|non-compliance with study drug|0|||
157001958|NCT00988637|566756064|FG001|Overall Study|non-compliance with study drug|1|||
157001959|NCT01839877|566756068|FG000|Overall Study|Protocol Violation|1|||
157001960|NCT00597519|566756071|FG000|Overall Study|Death|1|||
157001961|NCT03098030|566756072|FG000|Overall Study|Death|10|||
157001962|NCT03098030|566756073|FG001|Overall Study|Death|156|||
157001963|NCT03098030|566756074|FG002|Overall Study|Death|156|||
157001964|NCT03098030|566756075|FG003|Overall Study|Death|82|||
157001965|NCT03098030|566756072|FG000|Overall Study|Withdrawal by Subject|0|||
157001966|NCT03098030|566756073|FG001|Overall Study|Withdrawal by Subject|7|||
157001967|NCT03098030|566756074|FG002|Overall Study|Withdrawal by Subject|8|||
157001968|NCT03098030|566756075|FG003|Overall Study|Withdrawal by Subject|2|||
157001969|NCT03098030|566756072|FG000|Overall Study|Lost to Follow-up|0|||
157001970|NCT03098030|566756073|FG001|Overall Study|Lost to Follow-up|0|||
157001971|NCT03098030|566756074|FG002|Overall Study|Lost to Follow-up|2|||
157001972|NCT03098030|566756075|FG003|Overall Study|Lost to Follow-up|1|||
157001973|NCT05484726|566756076|FG000|Overall Study|Protocol Violation|3|||
157001974|NCT05484726|566756077|FG001|Overall Study|Protocol Violation|3|||
157001975|NCT05484726|566756076|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
157001976|NCT05484726|566756077|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
157001977|NCT05484726|566756076|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
157001978|NCT05484726|566756077|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
157001979|NCT05484726|566756076|FG000|Overall Study|continued need of mechanical ventilation|2|||
157001980|NCT05484726|566756077|FG001|Overall Study|continued need of mechanical ventilation|3|||
157001981|NCT05484726|566756076|FG000|Overall Study|Withdrawal by Subject|2|||
157104851|NCT03349775|567139341|FG000|Overall Study|Side Effects|1|||
157104852|NCT03349775|567139342|FG001|Overall Study|Side Effects|2|||
157104853|NCT03349775|567139341|FG000|Overall Study|Withdrawal by Subject|1|||
157104854|NCT03349775|567139342|FG001|Overall Study|Withdrawal by Subject|1|||
157104855|NCT03349775|567139341|FG000|Overall Study|No primary outcome measurements|0|||
157104856|NCT03349775|567139342|FG001|Overall Study|No primary outcome measurements|1|||
157104857|NCT03383289|567139352|FG000|Overall Study|Death|83|||
157104858|NCT03383289|567139353|FG001|Overall Study|Death|78|||
157104859|NCT03383289|567139352|FG000|Overall Study|discharge from facility|84|||
157104860|NCT03383289|567139353|FG001|Overall Study|discharge from facility|84|||
157104861|NCT03383289|567139352|FG000|Overall Study|Withdrawal by Subject|4|||
157104862|NCT03383289|567139353|FG001|Overall Study|Withdrawal by Subject|1|||
157104863|NCT04439071|567139354|FG000|Overall Study|Lost to Follow-up|0|||
157104864|NCT04439071|567139355|FG001|Overall Study|Lost to Follow-up|3|||
157104865|NCT04439071|567139354|FG000|Overall Study|Withdrawal by Subject|3|||
157104866|NCT04439071|567139355|FG001|Overall Study|Withdrawal by Subject|8|||
157104867|NCT04439071|567139354|FG000|Overall Study|Death|6|||
157104868|NCT04439071|567139355|FG001|Overall Study|Death|4|||
157104869|NCT04439071|567139354|FG000|Overall Study|Other than specified|3|||
157104870|NCT04439071|567139355|FG001|Overall Study|Other than specified|3|||
157104871|NCT04439071|567139354|FG000|Overall Study|Randomized but not treated|2|||
157104872|NCT04439071|567139355|FG001|Overall Study|Randomized but not treated|0|||
157104873|NCT00892177|567139356|FG000|Phase II|Ineligible|0|||
157104874|NCT00892177|567139357|FG001|Phase II|Ineligible|0|||
157104875|NCT00892177|567139358|FG002|Phase II|Ineligible|0|||
157104876|NCT00892177|567139359|FG003|Phase II|Ineligible|0|||
157104877|NCT00892177|567139360|FG004|Phase II|Ineligible|1|||
157104878|NCT00892177|567139361|FG005|Phase II|Ineligible|1|||
157104879|NCT00892177|567139356|FG000|Phase II|Withdrawal by Subject|0|||
157104880|NCT00892177|567139357|FG001|Phase II|Withdrawal by Subject|0|||
157104881|NCT00892177|567139358|FG002|Phase II|Withdrawal by Subject|0|||
157104882|NCT00892177|567139359|FG003|Phase II|Withdrawal by Subject|0|||
157104883|NCT00892177|567139360|FG004|Phase II|Withdrawal by Subject|4|||
157104884|NCT00892177|567139361|FG005|Phase II|Withdrawal by Subject|1|||
157104885|NCT03583450|567139362|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
157104886|NCT03583450|567139363|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
157104887|NCT05097716|567139368|FG000|Period 1|Adverse Event|1|||
157104888|NCT05097716|567139368|FG000|Period 1|Close contact with highly-transmissible infection|1|||
157104889|NCT00698204|567139369|FG000|Overall Study|Withdrawal by Subject|1|||
157104890|NCT00698204|567139370|FG001|Overall Study|Withdrawal by Subject|0|||
157104891|NCT01949155|567139371|FG000|Overall Study|Lost to Follow-up|1|||
157104892|NCT01949155|567139372|FG001|Overall Study|Lost to Follow-up|0|||
157104893|NCT01949155|567139371|FG000|Overall Study|Protocol Violation|1|||
157104894|NCT01949155|567139372|FG001|Overall Study|Protocol Violation|0|||
157104895|NCT00851682|567139377|FG000|Overall Study|screen failure|5|||
157104896|NCT00851682|567139378|FG001|Overall Study|screen failure|0|||
157104897|NCT00800436|567139384|FG000|Overall Study|Withdrawal by Subject|0|||
157104898|NCT00800436|567139385|FG001|Overall Study|Withdrawal by Subject|0|||
157104899|NCT00800436|567139386|FG002|Overall Study|Withdrawal by Subject|1|||
157104900|NCT00800436|567139387|FG003|Overall Study|Withdrawal by Subject|1|||
157104901|NCT00800436|567139388|FG004|Overall Study|Withdrawal by Subject|0|||
157104902|NCT00800436|567139389|FG005|Overall Study|Withdrawal by Subject|0|||
157104903|NCT00800436|567139390|FG006|Overall Study|Withdrawal by Subject|0|||
157104904|NCT01177384|567139400|FG000|Overall Study|Adverse Event|6|||
157104905|NCT01177384|567139401|FG001|Overall Study|Adverse Event|4|||
157104906|NCT01177384|567139400|FG000|Overall Study|Lack of Efficacy|0|||
157104907|NCT01177384|567139401|FG001|Overall Study|Lack of Efficacy|1|||
157104908|NCT01177384|567139400|FG000|Overall Study|Lost to Follow-up|3|||
157104909|NCT01177384|567139401|FG001|Overall Study|Lost to Follow-up|4|||
157104910|NCT01177384|567139400|FG000|Overall Study|Physician Decision|0|||
157104911|NCT01177384|567139401|FG001|Overall Study|Physician Decision|3|||
157104912|NCT01177384|567139400|FG000|Overall Study|Protocol Violation|0|||
157104913|NCT01177384|567139401|FG001|Overall Study|Protocol Violation|2|||
157104914|NCT01177384|567139400|FG000|Overall Study|Withdrawal by Subject|5|||
157104915|NCT01177384|567139401|FG001|Overall Study|Withdrawal by Subject|12|||
157104916|NCT01849497|567139402|FG000|Overall Study|Withdrawal by Subject|1|||
157104917|NCT01849497|567139403|FG001|Overall Study|Withdrawal by Subject|2|||
157104918|NCT01849497|567139402|FG000|Overall Study|Sponsor Decision|0|||
157104919|NCT01849497|567139403|FG001|Overall Study|Sponsor Decision|1|||
157104920|NCT01849497|567139402|FG000|Overall Study|Lost to Follow-up|0|||
157104921|NCT01849497|567139403|FG001|Overall Study|Lost to Follow-up|1|||
157104922|NCT03065023|567139407|FG000|Overall Study|Progressive Disease|0|||
157104923|NCT03065023|567139408|FG001|Overall Study|Progressive Disease|1|||
157104924|NCT03065023|567139409|FG002|Overall Study|Progressive Disease|0|||
157104925|NCT03065023|567139410|FG003|Overall Study|Progressive Disease|0|||
157104926|NCT03065023|567139411|FG004|Overall Study|Progressive Disease|0|||
157104927|NCT03065023|567139407|FG000|Overall Study|Death|2|||
157104928|NCT03065023|567139408|FG001|Overall Study|Death|0|||
157104929|NCT03065023|567139409|FG002|Overall Study|Death|1|||
157104930|NCT03065023|567139410|FG003|Overall Study|Death|1|||
157104931|NCT03065023|567139411|FG004|Overall Study|Death|0|||
157104932|NCT03065023|567139407|FG000|Overall Study|Lost to Follow-up|0|||
157104933|NCT03065023|567139408|FG001|Overall Study|Lost to Follow-up|1|||
157104934|NCT03065023|567139409|FG002|Overall Study|Lost to Follow-up|0|||
157104935|NCT03065023|567139410|FG003|Overall Study|Lost to Follow-up|0|||
157104936|NCT03065023|567139411|FG004|Overall Study|Lost to Follow-up|0|||
157104937|NCT03065023|567139407|FG000|Overall Study|Participant Decision|0|||
157104938|NCT03065023|567139408|FG001|Overall Study|Participant Decision|0|||
157104939|NCT03065023|567139409|FG002|Overall Study|Participant Decision|0|||
156761777|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
156761778|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
156761779|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
156761780|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761781|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761782|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761783|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761784|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
156761785|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
156761786|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761787|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761788|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761789|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761790|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
156761791|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
156761792|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761793|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761794|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761795|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761796|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
156761797|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
156761798|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761799|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
157001982|NCT05484726|566756077|FG001|Overall Study|Withdrawal by Subject|3|||
157001983|NCT05484726|566756076|FG000|Overall Study|IVH (G III & IV)|2|||
157001984|NCT05484726|566756077|FG001|Overall Study|IVH (G III & IV)|1|||
157001985|NCT05484726|566756076|FG000|Overall Study|NEC (stage II & III)|2|||
157001986|NCT05484726|566756077|FG001|Overall Study|NEC (stage II & III)|3|||
157001987|NCT02104765|566756080|FG000|Overall Study|Lost to Follow-up|0|||
157001988|NCT02104765|566756081|FG001|Overall Study|Lost to Follow-up|0|||
157001989|NCT02104765|566756082|FG002|Overall Study|Lost to Follow-up|1|||
157001990|NCT02104765|566756083|FG003|Overall Study|Lost to Follow-up|0|||
157001991|NCT02104765|566756084|FG004|Overall Study|Lost to Follow-up|0|||
157001992|NCT02104765|566756085|FG005|Overall Study|Lost to Follow-up|0|||
157001993|NCT02104765|566756086|FG006|Overall Study|Lost to Follow-up|0|||
157001994|NCT02104765|566756080|FG000|Overall Study|Withdrawal by Subject|0|||
157001995|NCT02104765|566756081|FG001|Overall Study|Withdrawal by Subject|0|||
157001996|NCT02104765|566756082|FG002|Overall Study|Withdrawal by Subject|0|||
157001997|NCT02104765|566756083|FG003|Overall Study|Withdrawal by Subject|1|||
157001998|NCT02104765|566756084|FG004|Overall Study|Withdrawal by Subject|1|||
157001999|NCT02104765|566756085|FG005|Overall Study|Withdrawal by Subject|0|||
157002000|NCT02104765|566756086|FG006|Overall Study|Withdrawal by Subject|1|||
157002001|NCT04771273|566756087|FG000|Dose Escalation Period|Not treated with trial medication|0|||
157002002|NCT04771273|566756088|FG001|Dose Escalation Period|Not treated with trial medication|1|||
157002003|NCT04771273|566756089|FG002|Dose Escalation Period|Not treated with trial medication|1|||
157002004|NCT04771273|566756090|FG003|Dose Escalation Period|Not treated with trial medication|0|||
157002005|NCT04771273|566756087|FG000|Dose Escalation Period|Other reasons than listed|2|||
157002006|NCT04771273|566756088|FG001|Dose Escalation Period|Other reasons than listed|0|||
157002007|NCT04771273|566756089|FG002|Dose Escalation Period|Other reasons than listed|2|||
157002008|NCT04771273|566756090|FG003|Dose Escalation Period|Other reasons than listed|1|||
157002009|NCT04771273|566756087|FG000|Dose Escalation Period|Protocol Violation|0|||
157002010|NCT04771273|566756088|FG001|Dose Escalation Period|Protocol Violation|0|||
157002011|NCT04771273|566756089|FG002|Dose Escalation Period|Protocol Violation|3|||
157002012|NCT04771273|566756090|FG003|Dose Escalation Period|Protocol Violation|1|||
157002013|NCT04771273|566756087|FG000|Dose Escalation Period|Burden of study procedures|1|||
157002014|NCT04771273|566756088|FG001|Dose Escalation Period|Burden of study procedures|0|||
157002015|NCT04771273|566756089|FG002|Dose Escalation Period|Burden of study procedures|0|||
157002016|NCT04771273|566756090|FG003|Dose Escalation Period|Burden of study procedures|0|||
157002017|NCT04771273|566756087|FG000|Dose Escalation Period|Change of residence|0|||
157002018|NCT04771273|566756088|FG001|Dose Escalation Period|Change of residence|0|||
157002019|NCT04771273|566756089|FG002|Dose Escalation Period|Change of residence|0|||
157002020|NCT04771273|566756090|FG003|Dose Escalation Period|Change of residence|1|||
157002021|NCT04771273|566756087|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
157002022|NCT04771273|566756088|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
157002023|NCT04771273|566756089|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
157002024|NCT04771273|566756090|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
157002025|NCT04771273|566756087|FG000|Dose Escalation Period|Adverse Event|8|||
157002026|NCT04771273|566756088|FG001|Dose Escalation Period|Adverse Event|9|||
157002027|NCT04771273|566756089|FG002|Dose Escalation Period|Adverse Event|12|||
157002028|NCT04771273|566756090|FG003|Dose Escalation Period|Adverse Event|2|||
157002029|NCT04771273|566756087|FG000|Maintenance Period|Other than listed|4|||
156761800|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761801|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761802|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761803|NCT01435759|565879900|FG000|Antidepressant Lead-in Phase|Other|119|||
156761804|NCT01435759|565879901|FG001|Antidepressant Lead-in Phase|Other|0|||
156761805|NCT01435759|565879902|FG002|Antidepressant Lead-in Phase|Other|0|||
156761806|NCT01435759|565879903|FG003|Antidepressant Lead-in Phase|Other|0|||
156761807|NCT01435759|565879904|FG004|Antidepressant Lead-in Phase|Other|0|||
156761808|NCT01435759|565879905|FG005|Antidepressant Lead-in Phase|Other|0|||
156761809|NCT01435759|565879900|FG000|Double-blind Phase|Adverse Event|7|||
156761810|NCT01435759|565879901|FG001|Double-blind Phase|Adverse Event|0|||
156761811|NCT01435759|565879902|FG002|Double-blind Phase|Adverse Event|1|||
156761812|NCT01435759|565879903|FG003|Double-blind Phase|Adverse Event|1|||
156761813|NCT01435759|565879904|FG004|Double-blind Phase|Adverse Event|1|||
156761814|NCT01435759|565879905|FG005|Double-blind Phase|Adverse Event|3|||
156761815|NCT01435759|565879900|FG000|Double-blind Phase|Protocol Violation|2|||
156761816|NCT01435759|565879901|FG001|Double-blind Phase|Protocol Violation|0|||
156761817|NCT01435759|565879902|FG002|Double-blind Phase|Protocol Violation|1|||
156761818|NCT01435759|565879903|FG003|Double-blind Phase|Protocol Violation|2|||
156761819|NCT01435759|565879904|FG004|Double-blind Phase|Protocol Violation|0|||
156761820|NCT01435759|565879905|FG005|Double-blind Phase|Protocol Violation|1|||
156761821|NCT01435759|565879900|FG000|Double-blind Phase|Withdrawal by Subject|17|||
156761822|NCT01435759|565879901|FG001|Double-blind Phase|Withdrawal by Subject|4|||
156761823|NCT01435759|565879902|FG002|Double-blind Phase|Withdrawal by Subject|3|||
156761824|NCT01435759|565879903|FG003|Double-blind Phase|Withdrawal by Subject|4|||
156761825|NCT01435759|565879904|FG004|Double-blind Phase|Withdrawal by Subject|2|||
156761826|NCT01435759|565879905|FG005|Double-blind Phase|Withdrawal by Subject|2|||
156761827|NCT01435759|565879900|FG000|Double-blind Phase|Lost to Follow-up|31|||
156761828|NCT01435759|565879901|FG001|Double-blind Phase|Lost to Follow-up|1|||
156761829|NCT01435759|565879902|FG002|Double-blind Phase|Lost to Follow-up|2|||
156761830|NCT01435759|565879903|FG003|Double-blind Phase|Lost to Follow-up|0|||
156761831|NCT01435759|565879904|FG004|Double-blind Phase|Lost to Follow-up|3|||
156761832|NCT01435759|565879905|FG005|Double-blind Phase|Lost to Follow-up|3|||
156761833|NCT01435759|565879900|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
156761834|NCT01435759|565879901|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761835|NCT01435759|565879902|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761836|NCT01435759|565879903|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761837|NCT01435759|565879904|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
156761838|NCT01435759|565879905|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
156761839|NCT01435759|565879900|FG000|Double-blind Phase|Other|8|||
156761840|NCT01435759|565879901|FG001|Double-blind Phase|Other|2|||
156761841|NCT01435759|565879902|FG002|Double-blind Phase|Other|0|||
156761842|NCT01435759|565879903|FG003|Double-blind Phase|Other|2|||
156761843|NCT01435759|565879904|FG004|Double-blind Phase|Other|0|||
156761844|NCT01435759|565879905|FG005|Double-blind Phase|Other|0|||
156761845|NCT03727841|565879908|FG000|Overall Study|Physician Decision|3|||
156761846|NCT03727841|565879909|FG001|Overall Study|Physician Decision|1|||
156761847|NCT03126786|565879910|FG000|Overall Study|Adverse Event|3|||
156761848|NCT03126786|565879911|FG001|Overall Study|Adverse Event|0|||
156761849|NCT03126786|565879910|FG000|Overall Study|Lost to Follow-up|0|||
156761850|NCT03126786|565879911|FG001|Overall Study|Lost to Follow-up|1|||
156761851|NCT03126786|565879910|FG000|Overall Study|Withdrawal by Subject|3|||
156761852|NCT03126786|565879911|FG001|Overall Study|Withdrawal by Subject|1|||
156761853|NCT01601496|565879912|FG000|Overall Study|Physician Decision|1|||
156761854|NCT01601496|565879912|FG000|Overall Study|Withdrawal by Subject|1|||
156761855|NCT01601496|565879912|FG000|Overall Study|Lost to Follow-up|6|||
156761856|NCT01601496|565879912|FG000|Overall Study|Death|4|||
156761857|NCT01601496|565879912|FG000|Overall Study|Other: patient refusal to continue|3|||
156761858|NCT03243305|565879913|FG000|Overall Study|Lost to Follow-up|250|||
156761859|NCT03243305|565879913|FG000|Overall Study|Withdrawal by Subject|170|||
156761860|NCT03243305|565879913|FG000|Overall Study|Pregnancy|104|||
156761861|NCT03243305|565879913|FG000|Overall Study|Non-Compliance with Study Drug|38|||
156761862|NCT03243305|565879913|FG000|Overall Study|Adverse Event|23|||
156761863|NCT03243305|565879913|FG000|Overall Study|No sexually active|26|||
156761864|NCT03243305|565879913|FG000|Overall Study|Physician Decision|22|||
157104940|NCT03065023|567139410|FG003|Overall Study|Participant Decision|1|||
157104941|NCT03065023|567139411|FG004|Overall Study|Participant Decision|0|||
157104942|NCT03065023|567139407|FG000|Overall Study|Withdrawal by Subject|0|||
157104943|NCT03065023|567139408|FG001|Overall Study|Withdrawal by Subject|0|||
157104944|NCT03065023|567139409|FG002|Overall Study|Withdrawal by Subject|0|||
157104945|NCT03065023|567139410|FG003|Overall Study|Withdrawal by Subject|1|||
157104946|NCT03065023|567139411|FG004|Overall Study|Withdrawal by Subject|0|||
157104947|NCT01102803|567139412|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
157104948|NCT01102803|567139413|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
157104949|NCT01102803|567139412|FG000|Post to Follow-Up|Lost to Follow-up|1|||
157104950|NCT01102803|567139413|FG001|Post to Follow-Up|Lost to Follow-up|3|||
156761865|NCT03243305|565879913|FG000|Overall Study|Protocol Violation|22|||
156761866|NCT03243305|565879913|FG000|Overall Study|Study method no longer primary method|12|||
156761867|NCT03243305|565879913|FG000|Overall Study|Study Terminated by Sponsor|1|||
156761868|NCT03243305|565879913|FG000|Overall Study|Early terminations|267|||
157002030|NCT04771273|566756088|FG001|Maintenance Period|Other than listed|2|||
157002031|NCT04771273|566756089|FG002|Maintenance Period|Other than listed|0|||
157002032|NCT04771273|566756090|FG003|Maintenance Period|Other than listed|3|||
157002033|NCT04771273|566756087|FG000|Maintenance Period|Burden of study procedures|1|||
157002034|NCT04771273|566756088|FG001|Maintenance Period|Burden of study procedures|0|||
157002035|NCT04771273|566756089|FG002|Maintenance Period|Burden of study procedures|0|||
157002036|NCT04771273|566756090|FG003|Maintenance Period|Burden of study procedures|0|||
157002037|NCT04771273|566756087|FG000|Maintenance Period|Change of residence|0|||
157002038|NCT04771273|566756088|FG001|Maintenance Period|Change of residence|1|||
157002039|NCT04771273|566756089|FG002|Maintenance Period|Change of residence|3|||
157002040|NCT04771273|566756090|FG003|Maintenance Period|Change of residence|0|||
157002041|NCT04771273|566756087|FG000|Maintenance Period|Perceived lack of efficacy|0|||
157002042|NCT04771273|566756088|FG001|Maintenance Period|Perceived lack of efficacy|0|||
157002043|NCT04771273|566756089|FG002|Maintenance Period|Perceived lack of efficacy|0|||
157002044|NCT04771273|566756090|FG003|Maintenance Period|Perceived lack of efficacy|1|||
157002045|NCT04771273|566756087|FG000|Maintenance Period|Adverse Event|4|||
157002046|NCT04771273|566756088|FG001|Maintenance Period|Adverse Event|5|||
157002047|NCT04771273|566756089|FG002|Maintenance Period|Adverse Event|5|||
157002048|NCT04771273|566756090|FG003|Maintenance Period|Adverse Event|0|||
157002049|NCT00462943|566756091|FG000|Overall Study|Failure to achieve a response|5|||
157002050|NCT00462943|566756092|FG001|Overall Study|Failure to achieve a response|5|||
157002051|NCT00462943|566756093|FG002|Overall Study|Failure to achieve a response|1|||
157002052|NCT00462943|566756091|FG000|Overall Study|Adverse Event|6|||
157002053|NCT00462943|566756092|FG001|Overall Study|Adverse Event|4|||
157002054|NCT00462943|566756093|FG002|Overall Study|Adverse Event|1|||
157002055|NCT00462943|566756091|FG000|Overall Study|Protocol Violation|1|||
157002056|NCT00462943|566756092|FG001|Overall Study|Protocol Violation|0|||
157002057|NCT00462943|566756093|FG002|Overall Study|Protocol Violation|0|||
157002058|NCT00462943|566756091|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
157002059|NCT00462943|566756092|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
157002060|NCT00462943|566756093|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
157002061|NCT00462943|566756091|FG000|Overall Study|Disease Progression|15|||
157002062|NCT00462943|566756092|FG001|Overall Study|Disease Progression|15|||
157002063|NCT00462943|566756093|FG002|Overall Study|Disease Progression|9|||
157002064|NCT00462943|566756091|FG000|Overall Study|Death|5|||
157002065|NCT00462943|566756092|FG001|Overall Study|Death|2|||
157002066|NCT00462943|566756093|FG002|Overall Study|Death|7|||
157002067|NCT00462943|566756091|FG000|Overall Study|Stem Cell Transplant|1|||
157002068|NCT00462943|566756092|FG001|Overall Study|Stem Cell Transplant|1|||
157002069|NCT00462943|566756093|FG002|Overall Study|Stem Cell Transplant|0|||
157002070|NCT00462943|566756091|FG000|Overall Study|Bone Marrow Transplant|1|||
157002071|NCT00462943|566756092|FG001|Overall Study|Bone Marrow Transplant|0|||
157002072|NCT00462943|566756093|FG002|Overall Study|Bone Marrow Transplant|0|||
157002073|NCT00462943|566756091|FG000|Overall Study|Required Lymphocyte Infusion|1|||
157002074|NCT00462943|566756092|FG001|Overall Study|Required Lymphocyte Infusion|0|||
157002075|NCT00462943|566756093|FG002|Overall Study|Required Lymphocyte Infusion|0|||
157002076|NCT00462943|566756091|FG000|Overall Study|Transplant - not specified|1|||
157002077|NCT00462943|566756092|FG001|Overall Study|Transplant - not specified|0|||
157002078|NCT00462943|566756093|FG002|Overall Study|Transplant - not specified|1|||
157002079|NCT00462943|566756091|FG000|Overall Study|Physician Decision|1|||
157002080|NCT00462943|566756092|FG001|Overall Study|Physician Decision|0|||
157002081|NCT00462943|566756093|FG002|Overall Study|Physician Decision|0|||
157002082|NCT00462943|566756091|FG000|Overall Study|Withdrawal by Subject|0|||
157002083|NCT00462943|566756092|FG001|Overall Study|Withdrawal by Subject|1|||
157002084|NCT00462943|566756093|FG002|Overall Study|Withdrawal by Subject|0|||
157002085|NCT00995709|566756094|FG000|Overall Study|Adverse Event|4|||
157002086|NCT00995709|566756095|FG001|Overall Study|Adverse Event|2|||
157002087|NCT00995709|566756096|FG002|Overall Study|Adverse Event|0|||
157002088|NCT00995709|566756094|FG000|Overall Study|Lack of Efficacy|0|||
157002089|NCT00995709|566756095|FG001|Overall Study|Lack of Efficacy|1|||
157002090|NCT00995709|566756096|FG002|Overall Study|Lack of Efficacy|4|||
157002091|NCT00995709|566756094|FG000|Overall Study|Withdrawal by Subject|0|||
157002092|NCT00995709|566756095|FG001|Overall Study|Withdrawal by Subject|4|||
157002093|NCT00995709|566756096|FG002|Overall Study|Withdrawal by Subject|1|||
157002094|NCT00995709|566756094|FG000|Overall Study|Lost to Follow-up|1|||
157002095|NCT00995709|566756095|FG001|Overall Study|Lost to Follow-up|0|||
157002096|NCT00995709|566756096|FG002|Overall Study|Lost to Follow-up|0|||
157002097|NCT00995709|566756094|FG000|Overall Study|Death|0|||
157002098|NCT00995709|566756095|FG001|Overall Study|Death|1|||
157002099|NCT00995709|566756096|FG002|Overall Study|Death|0|||
157002100|NCT00995709|566756094|FG000|Overall Study|Protocol Violation|2|||
157002101|NCT00995709|566756095|FG001|Overall Study|Protocol Violation|1|||
157002102|NCT00995709|566756096|FG002|Overall Study|Protocol Violation|0|||
157104951|NCT00232141|567139414|FG000|Overall Study|Adverse Event|9|||
157104952|NCT00232141|567139415|FG001|Overall Study|Adverse Event|4|||
157104953|NCT00232141|567139414|FG000|Overall Study|Lack of Efficacy|0|||
157104954|NCT00232141|567139415|FG001|Overall Study|Lack of Efficacy|3|||
157104955|NCT00232141|567139414|FG000|Overall Study|Lost to Follow-up|9|||
157104956|NCT00232141|567139415|FG001|Overall Study|Lost to Follow-up|6|||
157104957|NCT00232141|567139414|FG000|Overall Study|Other|8|||
157104958|NCT00232141|567139415|FG001|Overall Study|Other|10|||
157104959|NCT00232141|567139414|FG000|Overall Study|Withdrawal by Subject|5|||
157104960|NCT00232141|567139415|FG001|Overall Study|Withdrawal by Subject|3|||
157104961|NCT04196803|567141526|FG000|Overall Study|Withdrawal by Subject|1|||
157104962|NCT04196803|567141527|FG001|Overall Study|Withdrawal by Subject|3|||
157104963|NCT04196803|567141526|FG000|Overall Study|Adverse Event|4|||
157104964|NCT04196803|567141527|FG001|Overall Study|Adverse Event|2|||
157104965|NCT04196803|567141526|FG000|Overall Study|Lost to Follow-up|0|||
157104966|NCT04196803|567141527|FG001|Overall Study|Lost to Follow-up|1|||
157104967|NCT01022996|567141528|FG000|Overall Study|Adverse Event|14|||
157104968|NCT01022996|567141528|FG000|Overall Study|Withdrawal by Subject|3|||
157104969|NCT01022996|567141528|FG000|Overall Study|Lost to Follow-up|1|||
157104970|NCT01022996|567141528|FG000|Overall Study|Administrative problems|6|||
157104971|NCT01022996|567141528|FG000|Overall Study|Disease Progression|32|||
157104972|NCT01022996|567141528|FG000|Overall Study|Protocol Violation|1|||
157104973|NCT02767323|567141529|FG000|Overall Study|Withdrawal by Subject|17|||
157104974|NCT02767323|567141530|FG001|Overall Study|Withdrawal by Subject|5|||
157104975|NCT02767323|567141531|FG002|Overall Study|Withdrawal by Subject|13|||
157104976|NCT02767323|567141532|FG003|Overall Study|Withdrawal by Subject|0|||
157104977|NCT02767323|567141529|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
157104978|NCT02767323|567141530|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
157104979|NCT02767323|567141531|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
157104980|NCT02767323|567141532|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
157104981|NCT00930722|567141533|FG000|Overall Study|Lost to Follow-up|16|||
157104982|NCT00930722|567141533|FG000|Overall Study|No longer willing to participate|9|||
157104983|NCT00930722|567141533|FG000|Overall Study|Study terminated by sponsor|2|||
157104984|NCT02230254|567141534|FG000|Overall Study|Lost to Follow-up|3|||
157104985|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Adverse Event|2|||
157104986|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Adverse Event|2|||
157104987|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Adverse Event|4|||
157104988|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Adverse Event|0|||
157104989|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Adverse Event|0|||
157104990|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Progressive disease|0|||
157104991|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Progressive disease|0|||
157104992|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Progressive disease|1|||
157104993|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Progressive disease|0|||
157104994|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Progressive disease|0|||
157104995|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
157104996|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
157104997|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
157104998|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
157104999|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
157105000|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
157105001|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
157105002|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
157105003|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
157105004|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
157105005|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
157105006|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
157105007|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
157105008|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
157105009|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
157105010|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
157105011|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
157105012|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
157105013|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
157105014|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
157105015|NCT03523728|567141535|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
157105016|NCT03523728|567141536|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
157105017|NCT03523728|567141537|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
157105018|NCT03523728|567141538|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
157105019|NCT03523728|567141539|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
157105020|NCT03523728|567141535|FG000|Stage 2 (24 Months)|Adverse Event|0|||
157105021|NCT03523728|567141536|FG001|Stage 2 (24 Months)|Adverse Event|0|||
157105022|NCT03523728|567141537|FG002|Stage 2 (24 Months)|Adverse Event|0|||
157105023|NCT03523728|567141538|FG003|Stage 2 (24 Months)|Adverse Event|1|||
157105024|NCT03523728|567141539|FG004|Stage 2 (24 Months)|Adverse Event|2|||
157105025|NCT03523728|567141535|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
157105026|NCT03523728|567141536|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
157105027|NCT03523728|567141537|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
157105028|NCT03523728|567141538|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
157105029|NCT03523728|567141539|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
157105030|NCT03523728|567141535|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
157105031|NCT03523728|567141536|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
157105032|NCT03523728|567141537|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
157105033|NCT03523728|567141538|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
157105034|NCT03523728|567141539|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
157105035|NCT03523728|567141535|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
157105036|NCT03523728|567141536|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
157105037|NCT03523728|567141537|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
157105038|NCT03523728|567141538|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
157105039|NCT03523728|567141539|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
157105040|NCT03523728|567141535|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
157105041|NCT03523728|567141536|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
156761869|NCT02689804|565879914|FG000|Overall Study|Withdrawal by Subject|2|||
156761870|NCT02689804|565879915|FG001|Overall Study|Withdrawal by Subject|0|||
156761871|NCT00227539|565879916|FG000|Overall Study|Protocol Violation|1|||
156761872|NCT02782741|565879919|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
156761873|NCT02782741|565879920|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
156761874|NCT02782741|565879921|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
157002103|NCT01697319|566756098|FG000|Primary Phase|Withdrawal by Subject|1|||
156761875|NCT02782741|565879919|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
156761876|NCT02782741|565879920|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
156761877|NCT02782741|565879921|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
156761878|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
156761879|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
156761880|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
156761881|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
156761882|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
156761883|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
156761884|NCT02782741|565879919|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
156761885|NCT02782741|565879920|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
156761886|NCT02782741|565879921|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
156761887|NCT04157088|565879922|FG000|Overall Study|Study terminated by sponsor|23|||
157002104|NCT01697319|566756098|FG000|Extension Phase|Terminated by Sponsor|15|||
157002105|NCT00604721|566756103|FG000|Overall Study|Physician Decision|1|||
157002106|NCT00604721|566756103|FG000|Overall Study|Withdrawal by Subject|1|||
157002107|NCT01838551|566756107|FG000|Overall Study|Adverse Event|16|||
157002108|NCT01838551|566756107|FG000|Overall Study|Death|1|||
157105042|NCT03523728|567141537|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
157105043|NCT03523728|567141538|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
157105044|NCT03523728|567141539|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
157105045|NCT00419120|567141542|FG000|Long Term Follow up Period|study ongoing|10|||
157105046|NCT02667275|567141545|FG000|Overall Study|Protocol Violation|11|||
157105047|NCT02667275|567141546|FG001|Overall Study|Protocol Violation|7|||
157105048|NCT02667275|567141545|FG000|Overall Study|Lost to Follow-up|0|||
157105049|NCT02667275|567141546|FG001|Overall Study|Lost to Follow-up|2|||
157105050|NCT02667275|567141545|FG000|Overall Study|Withdrawal by Subject|0|||
157105051|NCT02667275|567141546|FG001|Overall Study|Withdrawal by Subject|5|||
157105052|NCT02667275|567141545|FG000|Overall Study|Discontinued early without completing|0|||
157105053|NCT02667275|567141546|FG001|Overall Study|Discontinued early without completing|1|||
157105054|NCT01756040|567141547|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
157105055|NCT01756040|567141547|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
157105056|NCT01756040|567141547|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
157105057|NCT01274715|567141548|FG000|Overall Study|Lost to Follow-up|1|||
157105058|NCT01274715|567141548|FG000|Overall Study|After consent, met exclusion criteria.|1|||
157002109|NCT01838551|566756107|FG000|Overall Study|Lack of Efficacy|10|||
157002110|NCT01838551|566756107|FG000|Overall Study|Physician Decision|4|||
157002111|NCT01838551|566756107|FG000|Overall Study|Withdrawal by Subject|10|||
157002112|NCT01838551|566756107|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
157002113|NCT00906282|566756108|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
157002114|NCT00906282|566756108|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
157105059|NCT01274715|567141548|FG000|Overall Study|After consent, met exclusion criteria.|1|||
157105060|NCT01274715|567141548|FG000|Overall Study|After consent, met exclusion criteria.|1|||
157105061|NCT04479436|567141549|FG000|Overall Study|Progressive disease|26|||
157105062|NCT04479436|567141550|FG001|Overall Study|Progressive disease|1|||
157105063|NCT04479436|567141549|FG000|Overall Study|Adverse Event|6|||
157105064|NCT04479436|567141550|FG001|Overall Study|Adverse Event|0|||
157105065|NCT04479436|567141549|FG000|Overall Study|Withdrawal by Subject|5|||
157105066|NCT04479436|567141550|FG001|Overall Study|Withdrawal by Subject|0|||
157105067|NCT04479436|567141549|FG000|Overall Study|Clinical progression|1|||
157105068|NCT04479436|567141550|FG001|Overall Study|Clinical progression|0|||
157105069|NCT04479436|567141549|FG000|Overall Study|Physician Decision|1|||
157105070|NCT04479436|567141550|FG001|Overall Study|Physician Decision|0|||
157105071|NCT01186939|567141555|FG000|Overall Study|Death|7|||
157105072|NCT01186939|567141555|FG000|Overall Study|Withdrawal by Subject|2|||
157105073|NCT01186939|567141555|FG000|Overall Study|No longer receiving clinical benefit|17|||
157105074|NCT01186939|567141555|FG000|Overall Study|Program closed|5|||
156761888|NCT04157088|565879922|FG000|Overall Study|Withdrawal by Subject|4|||
157105075|NCT01186939|567141555|FG000|Overall Study|Sponsor decision|4|||
157105076|NCT01186939|567141555|FG000|Overall Study|Started additional treatment|1|||
156761889|NCT04157088|565879922|FG000|Overall Study|Lost to Follow-up|2|||
156761890|NCT04157088|565879922|FG000|Overall Study|Death|1|||
157105077|NCT01186939|567141555|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
157105078|NCT01186939|567141555|FG000|Overall Study|Myocardial infarction|1|||
157105079|NCT01186939|567141555|FG000|Overall Study|Bone marrow transplant|1|||
157105080|NCT01186939|567141555|FG000|Overall Study|Transformation to AML|1|||
157105081|NCT03945591|567141558|FG000|Overall Study|Participant not transplanted|1|||
157105082|NCT03945591|567141558|FG000|Overall Study|Change in treatment plan|3|||
157105083|NCT03945591|567141558|FG000|Overall Study|Adverse Event|1|||
157105084|NCT00791258|567141561|FG000|Overall Study|Adverse Event|87|||
157105085|NCT00791258|567141561|FG000|Overall Study|Lost to Follow-up|18|||
157105086|NCT00791258|567141561|FG000|Overall Study|Protocol Violation|109|||
157105087|NCT00791258|567141561|FG000|Overall Study|Withdrawal by Subject|40|||
157105088|NCT00791258|567141561|FG000|Overall Study|Did not take medication for >3 days|1|||
157105089|NCT00791258|567141561|FG000|Overall Study|subject left area|2|||
157105090|NCT00791258|567141561|FG000|Overall Study|non-compliance|3|||
157105091|NCT00791258|567141561|FG000|Overall Study|Subject incarcerated|1|||
157105092|NCT00791258|567141561|FG000|Overall Study|Subject required restricted medication|1|||
157105093|NCT00791258|567141561|FG000|Overall Study|Lack of Efficacy|1|||
157105094|NCT00436618|567141562|FG000|Overall Study|Withdrawal by Subject|5|||
157105095|NCT00436618|567141563|FG001|Overall Study|Withdrawal by Subject|8|||
157105096|NCT00436618|567141564|FG002|Overall Study|Withdrawal by Subject|11|||
157105097|NCT00436618|567141562|FG000|Overall Study|Adverse Event|8|||
157105098|NCT00436618|567141563|FG001|Overall Study|Adverse Event|8|||
157105099|NCT00436618|567141564|FG002|Overall Study|Adverse Event|9|||
157105100|NCT00436618|567141562|FG000|Overall Study|Alternate Treatment|3|||
157105101|NCT00436618|567141563|FG001|Overall Study|Alternate Treatment|4|||
157105102|NCT00436618|567141564|FG002|Overall Study|Alternate Treatment|12|||
157105103|NCT00436618|567141562|FG000|Overall Study|Other Medical Problems|3|||
157105104|NCT00436618|567141563|FG001|Overall Study|Other Medical Problems|1|||
157105105|NCT00436618|567141564|FG002|Overall Study|Other Medical Problems|7|||
157105106|NCT00436618|567141562|FG000|Overall Study|Death|4|||
157105107|NCT00436618|567141563|FG001|Overall Study|Death|2|||
157105108|NCT00436618|567141564|FG002|Overall Study|Death|3|||
157105109|NCT00436618|567141562|FG000|Overall Study|New Primary or Other Reasons|6|||
157105110|NCT00436618|567141563|FG001|Overall Study|New Primary or Other Reasons|2|||
157105111|NCT00436618|567141564|FG002|Overall Study|New Primary or Other Reasons|12|||
157105112|NCT00436618|567141562|FG000|Overall Study|Still on treatment|1|||
157105113|NCT00436618|567141563|FG001|Overall Study|Still on treatment|2|||
157105114|NCT00436618|567141564|FG002|Overall Study|Still on treatment|7|||
157105115|NCT01179672|567141565|FG000|Overall Study|Adverse Event|17|||
157105116|NCT01179672|567141566|FG001|Overall Study|Adverse Event|8|||
157105117|NCT01179672|567141565|FG000|Overall Study|Withdrawal by Subject|10|||
157105118|NCT01179672|567141566|FG001|Overall Study|Withdrawal by Subject|12|||
157105119|NCT01179672|567141565|FG000|Overall Study|Entry Criteria Not Met|0|||
157105120|NCT01179672|567141566|FG001|Overall Study|Entry Criteria Not Met|2|||
157105121|NCT01179672|567141565|FG000|Overall Study|Lost to Follow-up|0|||
157105122|NCT01179672|567141566|FG001|Overall Study|Lost to Follow-up|1|||
157105123|NCT01179672|567141565|FG000|Overall Study|Protocol Violation|2|||
157105124|NCT01179672|567141566|FG001|Overall Study|Protocol Violation|2|||
157105125|NCT01179672|567141565|FG000|Overall Study|Physician Decision|1|||
157105126|NCT01179672|567141566|FG001|Overall Study|Physician Decision|1|||
157105127|NCT01994382|567141567|FG000|Overall Study|Informed consent withdrawn|0|||
157105128|NCT01994382|567141568|FG001|Overall Study|Informed consent withdrawn|0|||
157105129|NCT01994382|567141569|FG002|Overall Study|Informed consent withdrawn|0|||
157105130|NCT01994382|567141570|FG003|Overall Study|Informed consent withdrawn|0|||
157105131|NCT01994382|567141571|FG004|Overall Study|Informed consent withdrawn|0|||
157105132|NCT01994382|567141572|FG005|Overall Study|Informed consent withdrawn|0|||
157105133|NCT01994382|567141573|FG006|Overall Study|Informed consent withdrawn|1|||
157105134|NCT01994382|567141574|FG007|Overall Study|Informed consent withdrawn|0|||
157105135|NCT01994382|567141575|FG008|Overall Study|Informed consent withdrawn|0|||
157105136|NCT01994382|567141576|FG009|Overall Study|Informed consent withdrawn|0|||
157105137|NCT01994382|567141577|FG010|Overall Study|Informed consent withdrawn|0|||
157105138|NCT01994382|567141578|FG011|Overall Study|Informed consent withdrawn|0|||
157105139|NCT01994382|567141579|FG012|Overall Study|Informed consent withdrawn|0|||
157105140|NCT01994382|567141580|FG013|Overall Study|Informed consent withdrawn|0|||
157002115|NCT00906282|566756108|FG000|Preoperative Chemotherapy|Progressive disease|6|||
157002116|NCT00906282|566756108|FG000|Preoperative Chemotherapy|Toxicity|1|||
157002117|NCT00589667|566757389|FG000|Overall Study|Adverse Event|2|||
157002118|NCT00589667|566757389|FG000|Overall Study|Withdrawal by Subject|1|||
157002119|NCT02810080|566757392|FG000|Overall Study|Adverse Event|3|||
157002120|NCT02810080|566757393|FG001|Overall Study|Adverse Event|0|||
157002121|NCT02810080|566757392|FG000|Overall Study|Death|0|||
157002122|NCT02810080|566757393|FG001|Overall Study|Death|2|||
157002123|NCT02810080|566757392|FG000|Overall Study|Physician Decision|4|||
157002124|NCT02810080|566757393|FG001|Overall Study|Physician Decision|0|||
157002125|NCT02810080|566757392|FG000|Overall Study|Withdrawal by Subject|0|||
157002126|NCT02810080|566757393|FG001|Overall Study|Withdrawal by Subject|2|||
157002127|NCT02614560|566757397|FG000|Overall Study|Death|6|||
157002128|NCT02614560|566757398|FG001|Overall Study|Death|2|||
157002129|NCT02192606|566757399|FG000|Overall Study|surgery type was changed|1|||
157002130|NCT02192606|566757400|FG001|Overall Study|surgery type was changed|1|||
157002131|NCT02192606|566757399|FG000|Overall Study|Physician Decision|1|||
157002132|NCT02192606|566757400|FG001|Overall Study|Physician Decision|2|||
157002133|NCT02192606|566757399|FG000|Overall Study|3D equipment rep unable to join|0|||
157002134|NCT02192606|566757400|FG001|Overall Study|3D equipment rep unable to join|1|||
157002135|NCT00738699|566757401|FG000|Overall Study|Withdrawal by Subject|5|||
157002136|NCT00738699|566757402|FG001|Overall Study|Withdrawal by Subject|0|||
157002137|NCT00738699|566757401|FG000|Overall Study|Lost to Follow-up|1|||
157002138|NCT00738699|566757402|FG001|Overall Study|Lost to Follow-up|0|||
157002139|NCT00738699|566757401|FG000|Overall Study|Death|144|||
157002140|NCT00738699|566757402|FG001|Overall Study|Death|68|||
157002141|NCT00738699|566757401|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
157002142|NCT00738699|566757402|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
157002143|NCT00738699|566757401|FG000|Overall Study|Other|2|||
157002144|NCT00738699|566757402|FG001|Overall Study|Other|0|||
157002145|NCT05174013|566757403|FG000|Overall Study|Lost to Follow-up|0|||
157002146|NCT05174013|566757404|FG001|Overall Study|Lost to Follow-up|0|||
157002147|NCT05174013|566757405|FG002|Overall Study|Lost to Follow-up|0|||
157002148|NCT05174013|566757406|FG003|Overall Study|Lost to Follow-up|1|||
157105141|NCT01994382|567141581|FG014|Overall Study|Informed consent withdrawn|0|||
157105142|NCT01994382|567141582|FG015|Overall Study|Informed consent withdrawn|0|||
157105143|NCT01994382|567141583|FG016|Overall Study|Informed consent withdrawn|0|||
157105144|NCT01994382|567141567|FG000|Overall Study|Progressive disease|3|||
157105145|NCT01994382|567141568|FG001|Overall Study|Progressive disease|4|||
157105146|NCT01994382|567141569|FG002|Overall Study|Progressive disease|4|||
157105147|NCT01994382|567141570|FG003|Overall Study|Progressive disease|3|||
157105148|NCT01994382|567141571|FG004|Overall Study|Progressive disease|2|||
157105149|NCT01994382|567141572|FG005|Overall Study|Progressive disease|3|||
157105150|NCT01994382|567141573|FG006|Overall Study|Progressive disease|3|||
157105151|NCT01994382|567141574|FG007|Overall Study|Progressive disease|6|||
157105152|NCT01994382|567141575|FG008|Overall Study|Progressive disease|2|||
157105153|NCT01994382|567141576|FG009|Overall Study|Progressive disease|2|||
157105154|NCT01994382|567141577|FG010|Overall Study|Progressive disease|13|||
157105155|NCT01994382|567141578|FG011|Overall Study|Progressive disease|8|||
157105156|NCT01994382|567141579|FG012|Overall Study|Progressive disease|7|||
157105157|NCT01994382|567141580|FG013|Overall Study|Progressive disease|3|||
157105158|NCT01994382|567141581|FG014|Overall Study|Progressive disease|6|||
157105159|NCT01994382|567141582|FG015|Overall Study|Progressive disease|44|||
157105160|NCT01994382|567141583|FG016|Overall Study|Progressive disease|28|||
157105161|NCT01994382|567141567|FG000|Overall Study|Physician Decision|0|||
157105162|NCT01994382|567141568|FG001|Overall Study|Physician Decision|1|||
157105163|NCT01994382|567141569|FG002|Overall Study|Physician Decision|0|||
157105164|NCT01994382|567141570|FG003|Overall Study|Physician Decision|0|||
157105165|NCT01994382|567141571|FG004|Overall Study|Physician Decision|0|||
157105166|NCT01994382|567141572|FG005|Overall Study|Physician Decision|0|||
157105167|NCT01994382|567141573|FG006|Overall Study|Physician Decision|0|||
157105168|NCT01994382|567141574|FG007|Overall Study|Physician Decision|0|||
157105169|NCT01994382|567141575|FG008|Overall Study|Physician Decision|0|||
157105170|NCT01994382|567141576|FG009|Overall Study|Physician Decision|0|||
157105171|NCT01994382|567141577|FG010|Overall Study|Physician Decision|3|||
157105172|NCT01994382|567141578|FG011|Overall Study|Physician Decision|1|||
157105173|NCT01994382|567141579|FG012|Overall Study|Physician Decision|1|||
157105174|NCT01994382|567141580|FG013|Overall Study|Physician Decision|0|||
157105175|NCT01994382|567141581|FG014|Overall Study|Physician Decision|1|||
157105176|NCT01994382|567141582|FG015|Overall Study|Physician Decision|4|||
157105177|NCT01994382|567141583|FG016|Overall Study|Physician Decision|2|||
157105178|NCT01994382|567141567|FG000|Overall Study|Death|0|||
157105179|NCT01994382|567141568|FG001|Overall Study|Death|0|||
157105180|NCT01994382|567141569|FG002|Overall Study|Death|0|||
157105181|NCT01994382|567141570|FG003|Overall Study|Death|0|||
157105182|NCT01994382|567141571|FG004|Overall Study|Death|1|||
157105183|NCT01994382|567141572|FG005|Overall Study|Death|0|||
157105184|NCT01994382|567141573|FG006|Overall Study|Death|0|||
157105185|NCT01994382|567141574|FG007|Overall Study|Death|0|||
157105186|NCT01994382|567141575|FG008|Overall Study|Death|1|||
157002149|NCT05174013|566757407|FG004|Overall Study|Lost to Follow-up|0|||
157002150|NCT05174013|566757408|FG005|Overall Study|Lost to Follow-up|0|||
157002151|NCT05174013|566757403|FG000|Overall Study|Withdrawal by Subject|0|||
157002152|NCT05174013|566757404|FG001|Overall Study|Withdrawal by Subject|0|||
157002153|NCT05174013|566757405|FG002|Overall Study|Withdrawal by Subject|1|||
157002154|NCT05174013|566757406|FG003|Overall Study|Withdrawal by Subject|0|||
157002155|NCT05174013|566757407|FG004|Overall Study|Withdrawal by Subject|0|||
157002156|NCT05174013|566757408|FG005|Overall Study|Withdrawal by Subject|0|||
157002157|NCT00753012|566757412|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
157002158|NCT00753012|566757413|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
157002159|NCT00753012|566757412|FG000|Overall Study|Adverse Event|2|||
157002160|NCT00753012|566757413|FG001|Overall Study|Adverse Event|0|||
157002161|NCT00753012|566757412|FG000|Overall Study|Withdrawal by Subject|0|||
157002162|NCT00753012|566757413|FG001|Overall Study|Withdrawal by Subject|1|||
157002163|NCT00753012|566757412|FG000|Overall Study|Lost to Follow-up|4|||
157002164|NCT00753012|566757413|FG001|Overall Study|Lost to Follow-up|0|||
157002165|NCT00753012|566757412|FG000|Overall Study|Confounded endpoint data|1|||
157002166|NCT00753012|566757413|FG001|Overall Study|Confounded endpoint data|0|||
157002167|NCT00864682|566757414|FG000|Overall Study|Protocol Violation|2|||
157002168|NCT00864682|566757415|FG001|Overall Study|Protocol Violation|1|||
157002169|NCT00864682|566757416|FG002|Overall Study|Protocol Violation|2|||
157002170|NCT00094809|566757418|FG000|Overall Study|Protocol deviation|2|||
157002171|NCT00094809|566757419|FG001|Overall Study|Protocol deviation|2|||
157002172|NCT00094809|566757418|FG000|Overall Study|Noncompliance|1|||
157002173|NCT00094809|566757419|FG001|Overall Study|Noncompliance|0|||
157002174|NCT00094809|566757418|FG000|Overall Study|Adverse Event|3|||
157002175|NCT00094809|566757419|FG001|Overall Study|Adverse Event|1|||
157002176|NCT00094809|566757418|FG000|Overall Study|Withdrawal by Subject|8|||
157002177|NCT00094809|566757419|FG001|Overall Study|Withdrawal by Subject|9|||
157002178|NCT00094809|566757418|FG000|Overall Study|Disease progression|3|||
157002179|NCT00094809|566757419|FG001|Overall Study|Disease progression|3|||
157002180|NCT00094809|566757418|FG000|Overall Study|Physician Decision|3|||
157002181|NCT00094809|566757419|FG001|Overall Study|Physician Decision|5|||
157002182|NCT00094809|566757418|FG000|Overall Study|Lost to Follow-up|6|||
157002183|NCT00094809|566757419|FG001|Overall Study|Lost to Follow-up|6|||
157002184|NCT00094809|566757418|FG000|Overall Study|Death|19|||
157002185|NCT00094809|566757419|FG001|Overall Study|Death|25|||
157002186|NCT00094809|566757418|FG000|Overall Study|Protocol-specified criteria|1|||
157002187|NCT00094809|566757419|FG001|Overall Study|Protocol-specified criteria|1|||
157002188|NCT00094809|566757418|FG000|Overall Study|Other|2|||
157002189|NCT00094809|566757419|FG001|Overall Study|Other|4|||
157002190|NCT00094809|566757418|FG000|Overall Study|Informed consent signed after treatment|1|||
157002191|NCT00094809|566757419|FG001|Overall Study|Informed consent signed after treatment|0|||
157002192|NCT00094809|566757418|FG000|Overall Study|Study drug not received|2|||
157002193|NCT00094809|566757419|FG001|Overall Study|Study drug not received|8|||
157002194|NCT00094809|566757418|FG000|Overall Study|Other|1|||
157002195|NCT00094809|566757419|FG001|Overall Study|Other|1|||
157002196|NCT04889664|566757420|FG000|Screen|Lost to Follow-up|1|||
157002197|NCT04889664|566757420|FG000|Screen|Failed to meet screening criteria|1|||
157002198|NCT04889664|566757420|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
157002199|NCT02469064|566757426|FG000|Overall Study|Request not to receive intervention.|1|||
157002200|NCT02469064|566757427|FG001|Overall Study|Request not to receive intervention.|3|||
157002201|NCT00770965|566757428|FG000|Safety Set|Withdrawal by Subject|0|||
157002202|NCT00770965|566757429|FG001|Safety Set|Withdrawal by Subject|0|||
157002203|NCT00770965|566757430|FG002|Safety Set|Withdrawal by Subject|0|||
157002204|NCT00770965|566757431|FG003|Safety Set|Withdrawal by Subject|1|||
157002205|NCT00770965|566757428|FG000|Safety Set|Protocol deviation|0|||
157002206|NCT00770965|566757429|FG001|Safety Set|Protocol deviation|0|||
157002207|NCT00770965|566757430|FG002|Safety Set|Protocol deviation|1|||
157002208|NCT00770965|566757431|FG003|Safety Set|Protocol deviation|0|||
157002209|NCT00770965|566757428|FG000|Excluded Set|Administrative problems|14|||
157002210|NCT00770965|566757429|FG001|Excluded Set|Administrative problems|12|||
157002211|NCT00770965|566757430|FG002|Excluded Set|Administrative problems|12|||
157002212|NCT00770965|566757431|FG003|Excluded Set|Administrative problems|10|||
157002213|NCT00770965|566757428|FG000|Excluded Set|Withdrawal by Subject|1|||
157002214|NCT00770965|566757429|FG001|Excluded Set|Withdrawal by Subject|1|||
157002215|NCT00770965|566757430|FG002|Excluded Set|Withdrawal by Subject|2|||
157002216|NCT00770965|566757431|FG003|Excluded Set|Withdrawal by Subject|3|||
157002217|NCT02371746|566757432|FG000|Overall Study|Consent withdrawn|0|||
157002218|NCT02371746|566757433|FG001|Overall Study|Consent withdrawn|0|||
157002219|NCT02371746|566757434|FG002|Overall Study|Consent withdrawn|0|||
157002220|NCT02371746|566757435|FG003|Overall Study|Consent withdrawn|0|||
157002221|NCT02371746|566757436|FG004|Overall Study|Consent withdrawn|0|||
157002222|NCT02371746|566757437|FG005|Overall Study|Consent withdrawn|0|||
157002223|NCT02371746|566757438|FG006|Overall Study|Consent withdrawn|1|||
157002224|NCT00754936|566757439|FG000|Overall Study|Lost to Follow-up|3|||
157002225|NCT00754936|566757439|FG000|Overall Study|Physician Decision|1|||
157002226|NCT00754936|566757439|FG000|Overall Study|Withdrawal by Subject|2|||
157002227|NCT00754936|566757439|FG000|Overall Study|Side Effects|3|||
157002228|NCT00754936|566757439|FG000|Overall Study|Inter-current medical events|3|||
157002229|NCT00619645|566757440|FG000|Overall Study|Adverse Event|1|||
157002230|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
157002231|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
157002232|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
157002233|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
157002234|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
157002235|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
157002236|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
157002237|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
157002238|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
157002239|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
157002240|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
157002241|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
157002242|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Death|7|||
157002243|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Death|4|||
157002244|NCT00410124|566757441|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
157002245|NCT00410124|566757442|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
157002246|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
157002247|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
157002248|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
157002249|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
157002250|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
157002251|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
157002252|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
157002253|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
157002254|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
157002255|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
157002256|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
157002257|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
157002258|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
157002259|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
157002260|NCT00410124|566757441|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
157002261|NCT00410124|566757442|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
157002262|NCT00319436|566757443|FG000|Overall Study|Withdrawal by Subject|6|||
157105187|NCT01994382|567141576|FG009|Overall Study|Death|1|||
157105188|NCT01994382|567141577|FG010|Overall Study|Death|0|||
157105189|NCT01994382|567141578|FG011|Overall Study|Death|0|||
157105190|NCT01994382|567141579|FG012|Overall Study|Death|0|||
157105191|NCT01994382|567141580|FG013|Overall Study|Death|0|||
157105192|NCT01994382|567141581|FG014|Overall Study|Death|0|||
157105193|NCT01994382|567141582|FG015|Overall Study|Death|1|||
157105194|NCT01994382|567141583|FG016|Overall Study|Death|0|||
157105195|NCT01994382|567141567|FG000|Overall Study|Adverse Event|0|||
157105196|NCT01994382|567141568|FG001|Overall Study|Adverse Event|1|||
157105197|NCT01994382|567141569|FG002|Overall Study|Adverse Event|2|||
157105198|NCT01994382|567141570|FG003|Overall Study|Adverse Event|0|||
157105199|NCT01994382|567141571|FG004|Overall Study|Adverse Event|0|||
157105200|NCT01994382|567141572|FG005|Overall Study|Adverse Event|0|||
157105201|NCT01994382|567141573|FG006|Overall Study|Adverse Event|0|||
157105202|NCT01994382|567141574|FG007|Overall Study|Adverse Event|0|||
157105203|NCT01994382|567141575|FG008|Overall Study|Adverse Event|0|||
157105204|NCT01994382|567141576|FG009|Overall Study|Adverse Event|0|||
157105205|NCT01994382|567141577|FG010|Overall Study|Adverse Event|15|||
157105206|NCT01994382|567141578|FG011|Overall Study|Adverse Event|2|||
157105207|NCT01994382|567141579|FG012|Overall Study|Adverse Event|7|||
157105208|NCT01994382|567141580|FG013|Overall Study|Adverse Event|3|||
157105209|NCT01994382|567141581|FG014|Overall Study|Adverse Event|17|||
157105210|NCT01994382|567141582|FG015|Overall Study|Adverse Event|6|||
157105211|NCT01994382|567141583|FG016|Overall Study|Adverse Event|3|||
157105212|NCT01994382|567141567|FG000|Overall Study|Other than specified|0|||
157105213|NCT01994382|567141568|FG001|Overall Study|Other than specified|0|||
157105214|NCT01994382|567141569|FG002|Overall Study|Other than specified|0|||
157105215|NCT01994382|567141570|FG003|Overall Study|Other than specified|0|||
157105216|NCT01994382|567141571|FG004|Overall Study|Other than specified|0|||
157105217|NCT01994382|567141572|FG005|Overall Study|Other than specified|0|||
157105218|NCT01994382|567141573|FG006|Overall Study|Other than specified|0|||
157105219|NCT01994382|567141574|FG007|Overall Study|Other than specified|0|||
157105220|NCT01994382|567141575|FG008|Overall Study|Other than specified|0|||
157105221|NCT01994382|567141576|FG009|Overall Study|Other than specified|0|||
157105222|NCT01994382|567141577|FG010|Overall Study|Other than specified|2|||
157105223|NCT01994382|567141578|FG011|Overall Study|Other than specified|0|||
157105224|NCT01994382|567141579|FG012|Overall Study|Other than specified|2|||
157105225|NCT01994382|567141580|FG013|Overall Study|Other than specified|0|||
157105226|NCT01994382|567141581|FG014|Overall Study|Other than specified|0|||
157105227|NCT01994382|567141582|FG015|Overall Study|Other than specified|4|||
157105228|NCT01994382|567141583|FG016|Overall Study|Other than specified|4|||
157105229|NCT01994382|567141567|FG000|Overall Study|Withdrawal by Subject|0|||
157105230|NCT01994382|567141568|FG001|Overall Study|Withdrawal by Subject|0|||
157105231|NCT01994382|567141569|FG002|Overall Study|Withdrawal by Subject|0|||
157105232|NCT01994382|567141570|FG003|Overall Study|Withdrawal by Subject|0|||
157105233|NCT01994382|567141571|FG004|Overall Study|Withdrawal by Subject|0|||
157105234|NCT01994382|567141572|FG005|Overall Study|Withdrawal by Subject|0|||
157105235|NCT01994382|567141573|FG006|Overall Study|Withdrawal by Subject|0|||
157105236|NCT01994382|567141574|FG007|Overall Study|Withdrawal by Subject|0|||
157105237|NCT01994382|567141575|FG008|Overall Study|Withdrawal by Subject|0|||
157105238|NCT01994382|567141576|FG009|Overall Study|Withdrawal by Subject|0|||
157105239|NCT01994382|567141577|FG010|Overall Study|Withdrawal by Subject|6|||
157105240|NCT01994382|567141578|FG011|Overall Study|Withdrawal by Subject|0|||
157105241|NCT01994382|567141579|FG012|Overall Study|Withdrawal by Subject|2|||
157105242|NCT01994382|567141580|FG013|Overall Study|Withdrawal by Subject|0|||
157105243|NCT01994382|567141581|FG014|Overall Study|Withdrawal by Subject|4|||
157105244|NCT01994382|567141582|FG015|Overall Study|Withdrawal by Subject|3|||
157105245|NCT01994382|567141583|FG016|Overall Study|Withdrawal by Subject|0|||
157105246|NCT01994382|567141567|FG000|Overall Study|Lost to Follow-up|0|||
157105247|NCT01994382|567141568|FG001|Overall Study|Lost to Follow-up|0|||
157105248|NCT01994382|567141569|FG002|Overall Study|Lost to Follow-up|0|||
157105249|NCT01994382|567141570|FG003|Overall Study|Lost to Follow-up|0|||
157105250|NCT01994382|567141571|FG004|Overall Study|Lost to Follow-up|0|||
157105251|NCT01994382|567141572|FG005|Overall Study|Lost to Follow-up|0|||
157105252|NCT01994382|567141573|FG006|Overall Study|Lost to Follow-up|0|||
157105253|NCT01994382|567141574|FG007|Overall Study|Lost to Follow-up|0|||
157105254|NCT01994382|567141575|FG008|Overall Study|Lost to Follow-up|0|||
157105255|NCT01994382|567141576|FG009|Overall Study|Lost to Follow-up|0|||
157105256|NCT01994382|567141577|FG010|Overall Study|Lost to Follow-up|1|||
157105257|NCT01994382|567141578|FG011|Overall Study|Lost to Follow-up|0|||
157105258|NCT01994382|567141579|FG012|Overall Study|Lost to Follow-up|0|||
157105259|NCT01994382|567141580|FG013|Overall Study|Lost to Follow-up|0|||
157105260|NCT01994382|567141581|FG014|Overall Study|Lost to Follow-up|0|||
157105261|NCT01994382|567141582|FG015|Overall Study|Lost to Follow-up|0|||
157105262|NCT01994382|567141583|FG016|Overall Study|Lost to Follow-up|0|||
157105263|NCT01994382|567141567|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105264|NCT01994382|567141568|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105265|NCT01994382|567141569|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105266|NCT01994382|567141570|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105267|NCT01994382|567141571|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105268|NCT01994382|567141572|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105269|NCT01994382|567141573|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105270|NCT01994382|567141574|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105271|NCT01994382|567141575|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105272|NCT01994382|567141576|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105273|NCT01994382|567141577|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
157105274|NCT01994382|567141578|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105275|NCT01994382|567141579|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
157105276|NCT01994382|567141580|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105277|NCT01994382|567141581|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
157105278|NCT01994382|567141582|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
157105279|NCT01994382|567141583|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
157105280|NCT01994382|567141567|FG000|Overall Study|Protocol violation/noncompliance|0|||
157105281|NCT01994382|567141568|FG001|Overall Study|Protocol violation/noncompliance|0|||
157105282|NCT01994382|567141569|FG002|Overall Study|Protocol violation/noncompliance|0|||
157105283|NCT01994382|567141570|FG003|Overall Study|Protocol violation/noncompliance|0|||
157105284|NCT01994382|567141571|FG004|Overall Study|Protocol violation/noncompliance|0|||
157105285|NCT01994382|567141572|FG005|Overall Study|Protocol violation/noncompliance|0|||
157105286|NCT01994382|567141573|FG006|Overall Study|Protocol violation/noncompliance|0|||
157105287|NCT01994382|567141574|FG007|Overall Study|Protocol violation/noncompliance|0|||
157105288|NCT01994382|567141575|FG008|Overall Study|Protocol violation/noncompliance|0|||
157105289|NCT01994382|567141576|FG009|Overall Study|Protocol violation/noncompliance|0|||
157105290|NCT01994382|567141577|FG010|Overall Study|Protocol violation/noncompliance|0|||
157105291|NCT01994382|567141578|FG011|Overall Study|Protocol violation/noncompliance|1|||
157105292|NCT01994382|567141579|FG012|Overall Study|Protocol violation/noncompliance|0|||
157105293|NCT01994382|567141580|FG013|Overall Study|Protocol violation/noncompliance|0|||
157105294|NCT01994382|567141581|FG014|Overall Study|Protocol violation/noncompliance|0|||
157105295|NCT01994382|567141582|FG015|Overall Study|Protocol violation/noncompliance|0|||
157105296|NCT01994382|567141583|FG016|Overall Study|Protocol violation/noncompliance|2|||
157105297|NCT01994382|567141567|FG000|Overall Study|Rolled over to Phase 2a|0|||
157105298|NCT01994382|567141568|FG001|Overall Study|Rolled over to Phase 2a|0|||
157105299|NCT01994382|567141569|FG002|Overall Study|Rolled over to Phase 2a|1|||
157105300|NCT01994382|567141570|FG003|Overall Study|Rolled over to Phase 2a|0|||
157105301|NCT01994382|567141571|FG004|Overall Study|Rolled over to Phase 2a|0|||
157105302|NCT01994382|567141572|FG005|Overall Study|Rolled over to Phase 2a|0|||
157105303|NCT01994382|567141573|FG006|Overall Study|Rolled over to Phase 2a|0|||
157105304|NCT01994382|567141574|FG007|Overall Study|Rolled over to Phase 2a|0|||
157105305|NCT01994382|567141575|FG008|Overall Study|Rolled over to Phase 2a|0|||
157105306|NCT01994382|567141576|FG009|Overall Study|Rolled over to Phase 2a|2|||
157105307|NCT01994382|567141577|FG010|Overall Study|Rolled over to Phase 2a|0|||
157105308|NCT01994382|567141578|FG011|Overall Study|Rolled over to Phase 2a|0|||
157105309|NCT01994382|567141579|FG012|Overall Study|Rolled over to Phase 2a|0|||
157105310|NCT01994382|567141580|FG013|Overall Study|Rolled over to Phase 2a|0|||
157105311|NCT01994382|567141581|FG014|Overall Study|Rolled over to Phase 2a|0|||
157105312|NCT01994382|567141582|FG015|Overall Study|Rolled over to Phase 2a|0|||
157105313|NCT01994382|567141583|FG016|Overall Study|Rolled over to Phase 2a|0|||
157105314|NCT00314249|567141584|FG000|Overall Study|Adverse Event|73|||
157105315|NCT00314249|567141585|FG001|Overall Study|Adverse Event|94|||
157105316|NCT00314249|567141584|FG000|Overall Study|Lack of Efficacy|33|||
157105317|NCT00314249|567141585|FG001|Overall Study|Lack of Efficacy|24|||
157105318|NCT00314249|567141584|FG000|Overall Study|Withdrawal by Subject|21|||
157105319|NCT00314249|567141585|FG001|Overall Study|Withdrawal by Subject|28|||
157105320|NCT00314249|567141584|FG000|Overall Study|Lost to Follow-up|15|||
157105321|NCT00314249|567141585|FG001|Overall Study|Lost to Follow-up|9|||
157105322|NCT00314249|567141584|FG000|Overall Study|Physician Decision|1|||
157105323|NCT00314249|567141585|FG001|Overall Study|Physician Decision|1|||
157105324|NCT00314249|567141584|FG000|Overall Study|Withdrawn for other reasons|4|||
157105325|NCT00314249|567141585|FG001|Overall Study|Withdrawn for other reasons|1|||
157105326|NCT00314249|567141584|FG000|Overall Study|Non-Compliant|5|||
157105327|NCT00314249|567141585|FG001|Overall Study|Non-Compliant|6|||
157105328|NCT04667377|567141586|FG000|Dose Escalation Period|Other not specified below|3|||
157105329|NCT04667377|567141587|FG001|Dose Escalation Period|Other not specified below|3|||
157105330|NCT04667377|567141588|FG002|Dose Escalation Period|Other not specified below|2|||
157105331|NCT04667377|567141589|FG003|Dose Escalation Period|Other not specified below|1|||
157105332|NCT04667377|567141590|FG004|Dose Escalation Period|Other not specified below|3|||
157105333|NCT04667377|567141586|FG000|Dose Escalation Period|Protocol Violation|2|||
157105334|NCT04667377|567141587|FG001|Dose Escalation Period|Protocol Violation|2|||
157105335|NCT04667377|567141588|FG002|Dose Escalation Period|Protocol Violation|0|||
157105336|NCT04667377|567141589|FG003|Dose Escalation Period|Protocol Violation|2|||
157105337|NCT04667377|567141590|FG004|Dose Escalation Period|Protocol Violation|1|||
157105338|NCT04667377|567141586|FG000|Dose Escalation Period|Burden of study procedures|2|||
157105339|NCT04667377|567141587|FG001|Dose Escalation Period|Burden of study procedures|1|||
157105340|NCT04667377|567141588|FG002|Dose Escalation Period|Burden of study procedures|1|||
157105341|NCT04667377|567141589|FG003|Dose Escalation Period|Burden of study procedures|1|||
157105342|NCT04667377|567141590|FG004|Dose Escalation Period|Burden of study procedures|5|||
157105343|NCT04667377|567141586|FG000|Dose Escalation Period|Change of residence|0|||
157105344|NCT04667377|567141587|FG001|Dose Escalation Period|Change of residence|0|||
157105345|NCT04667377|567141588|FG002|Dose Escalation Period|Change of residence|1|||
157105346|NCT04667377|567141589|FG003|Dose Escalation Period|Change of residence|0|||
157105347|NCT04667377|567141590|FG004|Dose Escalation Period|Change of residence|0|||
157105348|NCT04667377|567141586|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
157105349|NCT04667377|567141587|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
157105350|NCT04667377|567141588|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
157105351|NCT04667377|567141589|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
157105352|NCT04667377|567141590|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
157105353|NCT04667377|567141586|FG000|Dose Escalation Period|Adverse Event|9|||
157105354|NCT04667377|567141587|FG001|Dose Escalation Period|Adverse Event|10|||
157105355|NCT04667377|567141588|FG002|Dose Escalation Period|Adverse Event|12|||
157105356|NCT04667377|567141589|FG003|Dose Escalation Period|Adverse Event|17|||
157105357|NCT04667377|567141590|FG004|Dose Escalation Period|Adverse Event|3|||
157105358|NCT04667377|567141586|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
157105359|NCT04667377|567141587|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
157105360|NCT04667377|567141588|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
157105361|NCT04667377|567141589|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
157105362|NCT04667377|567141590|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
157105363|NCT04667377|567141586|FG000|Dose Escalation Period|Not treated|1|||
157105364|NCT04667377|567141587|FG001|Dose Escalation Period|Not treated|0|||
157105365|NCT04667377|567141588|FG002|Dose Escalation Period|Not treated|0|||
157105366|NCT04667377|567141589|FG003|Dose Escalation Period|Not treated|0|||
157105367|NCT04667377|567141590|FG004|Dose Escalation Period|Not treated|0|||
157105368|NCT04667377|567141586|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
157105369|NCT04667377|567141587|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
157105370|NCT04667377|567141588|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
157105371|NCT04667377|567141589|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
157105372|NCT04667377|567141590|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
156761891|NCT01747499|565879923|FG000|Overall Study|Steroid refractory aGvHD|1|||
156761892|NCT01747499|565879924|FG001|Overall Study|Steroid refractory aGvHD|0|||
156761893|NCT01747499|565879925|FG002|Overall Study|Steroid refractory aGvHD|0|||
156761894|NCT01747499|565879926|FG003|Overall Study|Steroid refractory aGvHD|1|||
157105373|NCT04667377|567141586|FG000|Dose Escalation Period|Lost to Follow-up|0|||
156761895|NCT01747499|565879927|FG004|Overall Study|Steroid refractory aGvHD|4|||
157105374|NCT04667377|567141587|FG001|Dose Escalation Period|Lost to Follow-up|1|||
157105375|NCT04667377|567141588|FG002|Dose Escalation Period|Lost to Follow-up|0|||
157105376|NCT04667377|567141589|FG003|Dose Escalation Period|Lost to Follow-up|0|||
157105377|NCT04667377|567141590|FG004|Dose Escalation Period|Lost to Follow-up|0|||
157105378|NCT04667377|567141586|FG000|Maintenance Period|Perceived lack of efficacy|0|||
157105379|NCT04667377|567141587|FG001|Maintenance Period|Perceived lack of efficacy|2|||
157105380|NCT04667377|567141588|FG002|Maintenance Period|Perceived lack of efficacy|1|||
157105381|NCT04667377|567141589|FG003|Maintenance Period|Perceived lack of efficacy|0|||
157105382|NCT04667377|567141590|FG004|Maintenance Period|Perceived lack of efficacy|1|||
157105383|NCT04667377|567141586|FG000|Maintenance Period|Adverse Event|2|||
157105384|NCT04667377|567141587|FG001|Maintenance Period|Adverse Event|8|||
157105385|NCT04667377|567141588|FG002|Maintenance Period|Adverse Event|5|||
157105386|NCT04667377|567141589|FG003|Maintenance Period|Adverse Event|4|||
157105387|NCT04667377|567141590|FG004|Maintenance Period|Adverse Event|1|||
157105388|NCT04667377|567141586|FG000|Maintenance Period|Adverse event: COVID infection|0|||
157105389|NCT04667377|567141587|FG001|Maintenance Period|Adverse event: COVID infection|1|||
157105390|NCT04667377|567141588|FG002|Maintenance Period|Adverse event: COVID infection|0|||
157105391|NCT04667377|567141589|FG003|Maintenance Period|Adverse event: COVID infection|0|||
157105392|NCT04667377|567141590|FG004|Maintenance Period|Adverse event: COVID infection|0|||
157105393|NCT04667377|567141586|FG000|Maintenance Period|COVID-related|0|||
157105394|NCT04667377|567141587|FG001|Maintenance Period|COVID-related|0|||
157105395|NCT04667377|567141588|FG002|Maintenance Period|COVID-related|1|||
157105396|NCT04667377|567141589|FG003|Maintenance Period|COVID-related|1|||
157105397|NCT04667377|567141590|FG004|Maintenance Period|COVID-related|0|||
157105398|NCT04667377|567141586|FG000|Maintenance Period|Protocol Violation|1|||
157105399|NCT04667377|567141587|FG001|Maintenance Period|Protocol Violation|0|||
157105400|NCT04667377|567141588|FG002|Maintenance Period|Protocol Violation|0|||
157105401|NCT04667377|567141589|FG003|Maintenance Period|Protocol Violation|0|||
157105402|NCT04667377|567141590|FG004|Maintenance Period|Protocol Violation|1|||
157105403|NCT04667377|567141586|FG000|Maintenance Period|Burden of study procedures|1|||
157105404|NCT04667377|567141587|FG001|Maintenance Period|Burden of study procedures|2|||
157105405|NCT04667377|567141588|FG002|Maintenance Period|Burden of study procedures|0|||
157105406|NCT04667377|567141589|FG003|Maintenance Period|Burden of study procedures|1|||
157105407|NCT04667377|567141590|FG004|Maintenance Period|Burden of study procedures|0|||
157105408|NCT04667377|567141586|FG000|Maintenance Period|Change of residence|0|||
157105409|NCT04667377|567141587|FG001|Maintenance Period|Change of residence|1|||
157105410|NCT04667377|567141588|FG002|Maintenance Period|Change of residence|0|||
157105411|NCT04667377|567141589|FG003|Maintenance Period|Change of residence|0|||
157105412|NCT04667377|567141590|FG004|Maintenance Period|Change of residence|1|||
157105413|NCT04667377|567141586|FG000|Maintenance Period|Missing|1|||
157105414|NCT04667377|567141587|FG001|Maintenance Period|Missing|0|||
157105415|NCT04667377|567141588|FG002|Maintenance Period|Missing|0|||
157105416|NCT04667377|567141589|FG003|Maintenance Period|Missing|0|||
157105417|NCT04667377|567141590|FG004|Maintenance Period|Missing|0|||
157105418|NCT04667377|567141586|FG000|Maintenance Period|Other than listed above|2|||
157105419|NCT04667377|567141587|FG001|Maintenance Period|Other than listed above|0|||
157105420|NCT04667377|567141588|FG002|Maintenance Period|Other than listed above|3|||
157105421|NCT04667377|567141589|FG003|Maintenance Period|Other than listed above|2|||
157105422|NCT04667377|567141590|FG004|Maintenance Period|Other than listed above|6|||
157105423|NCT04667377|567141586|FG000|Maintenance Period|Withdrawal by Subject|0|||
157105424|NCT04667377|567141587|FG001|Maintenance Period|Withdrawal by Subject|1|||
157105425|NCT04667377|567141588|FG002|Maintenance Period|Withdrawal by Subject|0|||
157105426|NCT04667377|567141589|FG003|Maintenance Period|Withdrawal by Subject|0|||
157105427|NCT04667377|567141590|FG004|Maintenance Period|Withdrawal by Subject|0|||
157105428|NCT04667377|567141586|FG000|Maintenance Period|Lost to Follow-up|1|||
157105429|NCT04667377|567141587|FG001|Maintenance Period|Lost to Follow-up|0|||
157105430|NCT04667377|567141588|FG002|Maintenance Period|Lost to Follow-up|1|||
157105431|NCT04667377|567141589|FG003|Maintenance Period|Lost to Follow-up|0|||
157105432|NCT04667377|567141590|FG004|Maintenance Period|Lost to Follow-up|1|||
157105433|NCT00058552|567141591|FG000|Overall Study|Died prior to receiving treatment|4|||
157105434|NCT00058552|567141592|FG001|Overall Study|Died prior to receiving treatment|2|||
157105435|NCT00058552|567141591|FG000|Overall Study|Disease progression|52|||
157105436|NCT00058552|567141592|FG001|Overall Study|Disease progression|44|||
157105437|NCT00058552|567141591|FG000|Overall Study|Adverse Event|4|||
157105438|NCT00058552|567141592|FG001|Overall Study|Adverse Event|2|||
157105439|NCT00058552|567141591|FG000|Overall Study|Withdrawal by Subject|3|||
157105440|NCT00058552|567141592|FG001|Overall Study|Withdrawal by Subject|5|||
157105441|NCT00058552|567141591|FG000|Overall Study|Physician Decision|2|||
157105442|NCT00058552|567141592|FG001|Overall Study|Physician Decision|5|||
157105443|NCT00058552|567141591|FG000|Overall Study|Clinical disease progression|0|||
157105444|NCT00058552|567141592|FG001|Overall Study|Clinical disease progression|4|||
157105445|NCT02428855|567141593|FG000|Overall Study|Withdrawal by Subject|2|||
157105446|NCT00210184|567141594|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
157105447|NCT03861936|567141595|FG000|Overall Study|Withdrawal by Subject|4|||
157105448|NCT03861936|567141596|FG001|Overall Study|Withdrawal by Subject|1|||
157105449|NCT03861936|567141597|FG002|Overall Study|Withdrawal by Subject|3|||
157105450|NCT03861936|567141595|FG000|Overall Study|Lost to Follow-up|5|||
157105451|NCT03861936|567141596|FG001|Overall Study|Lost to Follow-up|3|||
157105452|NCT03861936|567141597|FG002|Overall Study|Lost to Follow-up|3|||
157105453|NCT03861936|567141595|FG000|Overall Study|Physician Decision|0|||
157105454|NCT03861936|567141596|FG001|Overall Study|Physician Decision|1|||
157105455|NCT03861936|567141597|FG002|Overall Study|Physician Decision|0|||
157105456|NCT03861936|567141595|FG000|Overall Study|Protocol Deviation|0|||
157105457|NCT03861936|567141596|FG001|Overall Study|Protocol Deviation|0|||
157105458|NCT03861936|567141597|FG002|Overall Study|Protocol Deviation|1|||
157105459|NCT03861936|567141595|FG000|Overall Study|Reason not Specified|5|||
157105460|NCT03861936|567141596|FG001|Overall Study|Reason not Specified|5|||
157105461|NCT03861936|567141597|FG002|Overall Study|Reason not Specified|3|||
157105462|NCT00359021|567141598|FG000|Overall Study|Adverse Event|26|||
157105463|NCT00359021|567141599|FG001|Overall Study|Adverse Event|8|||
157105464|NCT00359021|567141598|FG000|Overall Study|Subject Non-Compliant|1|||
157105465|NCT00359021|567141599|FG001|Overall Study|Subject Non-Compliant|2|||
157105466|NCT00359021|567141598|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
157105467|NCT00359021|567141599|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
157105468|NCT00359021|567141598|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
157105469|NCT00359021|567141599|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
157105470|NCT00359021|567141598|FG000|Overall Study|Withdrawal by Subject|2|||
157105471|NCT00359021|567141599|FG001|Overall Study|Withdrawal by Subject|9|||
157105472|NCT00359021|567141598|FG000|Overall Study|Lost to Follow-up|1|||
157105473|NCT00359021|567141599|FG001|Overall Study|Lost to Follow-up|0|||
157105474|NCT00359021|567141598|FG000|Overall Study|Other|4|||
157105475|NCT00359021|567141599|FG001|Overall Study|Other|1|||
157105476|NCT00359021|567141598|FG000|Overall Study|Pregnancy|1|||
157105477|NCT00359021|567141599|FG001|Overall Study|Pregnancy|0|||
157105478|NCT02066311|567141600|FG000|Overall Study|Adverse Event|4|||
157105479|NCT02066311|567141600|FG000|Overall Study|Withdrawal by Subject|1|||
157105480|NCT01372150|567141603|FG000|Overall Study|Lack of Efficacy|3|||
157105481|NCT01372150|567141604|FG001|Overall Study|Lack of Efficacy|0|||
157105482|NCT01372150|567141605|FG002|Overall Study|Lack of Efficacy|1|||
157105483|NCT01372150|567141603|FG000|Overall Study|Lost to Follow-up|4|||
157105484|NCT01372150|567141604|FG001|Overall Study|Lost to Follow-up|5|||
157105485|NCT01372150|567141605|FG002|Overall Study|Lost to Follow-up|6|||
157105486|NCT01372150|567141603|FG000|Overall Study|Protocol Violation|1|||
157105487|NCT01372150|567141604|FG001|Overall Study|Protocol Violation|0|||
157105488|NCT01372150|567141605|FG002|Overall Study|Protocol Violation|3|||
157105489|NCT01372150|567141603|FG000|Overall Study|Withdrawal by Subject|2|||
157105490|NCT01372150|567141604|FG001|Overall Study|Withdrawal by Subject|7|||
157105491|NCT01372150|567141605|FG002|Overall Study|Withdrawal by Subject|2|||
157105492|NCT01372150|567141603|FG000|Overall Study|Other|1|||
157105493|NCT01372150|567141604|FG001|Overall Study|Other|0|||
157105494|NCT01372150|567141605|FG002|Overall Study|Other|2|||
157105495|NCT01372150|567141603|FG000|Overall Study|Adverse Event|2|||
157105496|NCT01372150|567141604|FG001|Overall Study|Adverse Event|1|||
157105497|NCT01372150|567141605|FG002|Overall Study|Adverse Event|2|||
157105498|NCT01372150|567141603|FG000|Overall Study|Randomized but not treated|0|||
157105499|NCT01372150|567141604|FG001|Overall Study|Randomized but not treated|1|||
157105500|NCT01372150|567141605|FG002|Overall Study|Randomized but not treated|0|||
157105501|NCT05418673|567141606|FG000|Overall Study|Study Terminated by Sponsor|2|||
157105502|NCT05418673|567141607|FG001|Overall Study|Study Terminated by Sponsor|4|||
157105503|NCT05418673|567141606|FG000|Overall Study|Lost to Follow-up|1|||
157105504|NCT05418673|567141607|FG001|Overall Study|Lost to Follow-up|0|||
157105505|NCT02316340|567141608|FG000|First Progression|Clinical progression|2|||
157105506|NCT02316340|567141609|FG001|First Progression|Clinical progression|1|||
157105507|NCT02316340|567141608|FG000|First Progression|Withdrawal by Subject|1|||
157105508|NCT02316340|567141609|FG001|First Progression|Withdrawal by Subject|0|||
157105509|NCT02234284|567141610|FG000|Overall Study|Death|4|||
157105510|NCT02234284|567141611|FG001|Overall Study|Death|2|||
157105511|NCT02234284|567141610|FG000|Overall Study|Withdrawal by Subject|1|||
157105512|NCT02234284|567141611|FG001|Overall Study|Withdrawal by Subject|0|||
157105513|NCT02234284|567141610|FG000|Overall Study|Lost to Follow-up|20|||
157105514|NCT02234284|567141611|FG001|Overall Study|Lost to Follow-up|7|||
157105515|NCT01835015|567141612|FG000|Overall Study|Adverse Event|0|||
157105516|NCT01835015|567141613|FG001|Overall Study|Adverse Event|0|||
157105517|NCT01835015|567141614|FG002|Overall Study|Adverse Event|1|||
157105518|NCT01835015|567141615|FG003|Overall Study|Adverse Event|0|||
157105519|NCT01835015|567141616|FG004|Overall Study|Adverse Event|0|||
157105520|NCT03781323|567141619|FG000|Overall Study|Withdrawal by Subject|1|||
157105521|NCT00975715|567141623|FG000|Titration Period|Adverse Event|6|||
157105522|NCT00975715|567141624|FG001|Titration Period|Adverse Event|0|||
157105523|NCT00975715|567141623|FG000|Titration Period|Protocol Violation|1|||
157105524|NCT00975715|567141624|FG001|Titration Period|Protocol Violation|0|||
157105525|NCT00975715|567141623|FG000|Maintenance Period|Adverse Event|2|||
157105526|NCT00975715|567141624|FG001|Maintenance Period|Adverse Event|1|||
157105527|NCT01241552|567141625|FG000|Overall Study|Lack of Efficacy|1|||
157105528|NCT01241552|567141626|FG001|Overall Study|Lack of Efficacy|0|||
157105529|NCT01241552|567141627|FG002|Overall Study|Lack of Efficacy|0|||
157105530|NCT01241552|567141628|FG003|Overall Study|Lack of Efficacy|0|||
157105531|NCT01241552|567141625|FG000|Overall Study|Death|26|||
157105532|NCT01241552|567141626|FG001|Overall Study|Death|30|||
157105533|NCT01241552|567141627|FG002|Overall Study|Death|20|||
157105534|NCT01241552|567141628|FG003|Overall Study|Death|25|||
157105535|NCT01241552|567141625|FG000|Overall Study|Adverse Event|1|||
157105536|NCT01241552|567141626|FG001|Overall Study|Adverse Event|1|||
157105537|NCT01241552|567141627|FG002|Overall Study|Adverse Event|0|||
157105538|NCT01241552|567141628|FG003|Overall Study|Adverse Event|0|||
157105539|NCT01241552|567141625|FG000|Overall Study|Technical Problems|2|||
157105540|NCT01241552|567141626|FG001|Overall Study|Technical Problems|0|||
157105541|NCT01241552|567141627|FG002|Overall Study|Technical Problems|2|||
157105542|NCT01241552|567141628|FG003|Overall Study|Technical Problems|2|||
157105543|NCT01241552|567141625|FG000|Overall Study|Progressive Disease|0|||
157105544|NCT01241552|567141626|FG001|Overall Study|Progressive Disease|0|||
157105545|NCT01241552|567141627|FG002|Overall Study|Progressive Disease|1|||
157105546|NCT01241552|567141628|FG003|Overall Study|Progressive Disease|2|||
157105547|NCT01241552|567141625|FG000|Overall Study|Protocol Violation|0|||
157105548|NCT01241552|567141626|FG001|Overall Study|Protocol Violation|2|||
157105549|NCT01241552|567141627|FG002|Overall Study|Protocol Violation|6|||
157105550|NCT01241552|567141628|FG003|Overall Study|Protocol Violation|1|||
157105551|NCT01241552|567141625|FG000|Overall Study|Withdrawal by Subject|7|||
157105552|NCT01241552|567141626|FG001|Overall Study|Withdrawal by Subject|15|||
157105553|NCT01241552|567141627|FG002|Overall Study|Withdrawal by Subject|14|||
157105554|NCT01241552|567141628|FG003|Overall Study|Withdrawal by Subject|15|||
157105555|NCT01241552|567141625|FG000|Overall Study|Physician Decision|2|||
157105556|NCT01241552|567141626|FG001|Overall Study|Physician Decision|4|||
157105557|NCT01241552|567141627|FG002|Overall Study|Physician Decision|2|||
157105558|NCT01241552|567141628|FG003|Overall Study|Physician Decision|3|||
157105559|NCT01241552|567141625|FG000|Overall Study|Lost to Follow-up|2|||
157105560|NCT01241552|567141626|FG001|Overall Study|Lost to Follow-up|11|||
157105561|NCT01241552|567141627|FG002|Overall Study|Lost to Follow-up|15|||
157105562|NCT01241552|567141628|FG003|Overall Study|Lost to Follow-up|16|||
157105563|NCT04004429|567141629|FG000|Overall Study|Protocol Violation|1|||
157105564|NCT04004429|567141630|FG001|Overall Study|Protocol Violation|0|||
157105565|NCT04004429|567141631|FG002|Overall Study|Protocol Violation|0|||
157105566|NCT04004429|567141629|FG000|Overall Study|Physician Decision|0|||
157105567|NCT04004429|567141630|FG001|Overall Study|Physician Decision|1|||
157105568|NCT04004429|567141631|FG002|Overall Study|Physician Decision|1|||
157105569|NCT04004429|567141629|FG000|Overall Study|Withdrawal by Subject|1|||
157105570|NCT04004429|567141630|FG001|Overall Study|Withdrawal by Subject|1|||
157105571|NCT04004429|567141631|FG002|Overall Study|Withdrawal by Subject|1|||
157105572|NCT00718549|567141632|FG000|Induction Phase|Disease Progression|1|||
157105573|NCT00718549|567141633|FG001|Induction Phase|Disease Progression|0|||
157105574|NCT00718549|567141634|FG002|Induction Phase|Disease Progression|0|||
157105575|NCT00718549|567141632|FG000|Induction Phase|Eligibility Criteria Violation|2|||
157105576|NCT00718549|567141633|FG001|Induction Phase|Eligibility Criteria Violation|0|||
157105577|NCT00718549|567141634|FG002|Induction Phase|Eligibility Criteria Violation|0|||
157105578|NCT00718549|567141632|FG000|Induction Phase|Early Termination - No Additional Info|59|||
157105579|NCT00718549|567141633|FG001|Induction Phase|Early Termination - No Additional Info|0|||
157105580|NCT00718549|567141634|FG002|Induction Phase|Early Termination - No Additional Info|0|||
157105581|NCT00718549|567141632|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
157105582|NCT00718549|567141633|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
157105583|NCT00718549|567141634|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
157105584|NCT00718549|567141632|FG000|Maintenance/ Observation Phase|Death|0|||
157105585|NCT00718549|567141633|FG001|Maintenance/ Observation Phase|Death|1|||
157105586|NCT00718549|567141634|FG002|Maintenance/ Observation Phase|Death|2|||
157105587|NCT00718549|567141632|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
157105588|NCT00718549|567141633|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
157105589|NCT00718549|567141634|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
157105590|NCT00718549|567141632|FG000|Maintenance/ Observation Phase|Progression|0|||
157105591|NCT00718549|567141633|FG001|Maintenance/ Observation Phase|Progression|5|||
157002263|NCT00319436|566757444|FG001|Overall Study|Withdrawal by Subject|7|||
157002264|NCT03612804|566757447|FG000|Overall Study|Death|0|||
157002265|NCT03612804|566757448|FG001|Overall Study|Death|7|||
157002266|NCT03612804|566757449|FG002|Overall Study|Death|0|||
157002267|NCT03612804|566757450|FG003|Overall Study|Death|8|||
157002268|NCT03612804|566757447|FG000|Overall Study|Medication copay coverage issues|0|||
157002269|NCT03612804|566757448|FG001|Overall Study|Medication copay coverage issues|0|||
157002270|NCT03612804|566757449|FG002|Overall Study|Medication copay coverage issues|0|||
157002271|NCT03612804|566757450|FG003|Overall Study|Medication copay coverage issues|17|||
157002272|NCT03612804|566757447|FG000|Overall Study|Not current smoker at time of screening|0|||
157002273|NCT03612804|566757448|FG001|Overall Study|Not current smoker at time of screening|1|||
157002274|NCT03612804|566757449|FG002|Overall Study|Not current smoker at time of screening|0|||
157002275|NCT03612804|566757450|FG003|Overall Study|Not current smoker at time of screening|3|||
157002276|NCT03612804|566757447|FG000|Overall Study|Non-veteran status|0|||
157002277|NCT03612804|566757448|FG001|Overall Study|Non-veteran status|1|||
157002278|NCT03612804|566757449|FG002|Overall Study|Non-veteran status|0|||
157002279|NCT03612804|566757450|FG003|Overall Study|Non-veteran status|0|||
157002280|NCT03612804|566757447|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
157002281|NCT03612804|566757448|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
157002282|NCT03612804|566757449|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
157002283|NCT03612804|566757450|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
157002284|NCT03612804|566757447|FG000|Overall Study|Provider retired from VA|0|||
157002285|NCT03612804|566757448|FG001|Overall Study|Provider retired from VA|0|||
157002286|NCT03612804|566757449|FG002|Overall Study|Provider retired from VA|2|||
157002287|NCT03612804|566757450|FG003|Overall Study|Provider retired from VA|0|||
157002288|NCT03612804|566757447|FG000|Overall Study|Withdrawal by Subject|0|||
157002289|NCT03612804|566757448|FG001|Overall Study|Withdrawal by Subject|0|||
157002290|NCT03612804|566757449|FG002|Overall Study|Withdrawal by Subject|7|||
157002291|NCT03612804|566757450|FG003|Overall Study|Withdrawal by Subject|0|||
157002292|NCT03612804|566757447|FG000|Overall Study|Provider involved with study activities|1|||
157002293|NCT03612804|566757448|FG001|Overall Study|Provider involved with study activities|0|||
157105592|NCT00718549|567141634|FG002|Maintenance/ Observation Phase|Progression|14|||
157105593|NCT00718549|567141632|FG000|Maintenance/ Observation Phase|Relapse|0|||
157105594|NCT00718549|567141633|FG001|Maintenance/ Observation Phase|Relapse|3|||
157105595|NCT00718549|567141634|FG002|Maintenance/ Observation Phase|Relapse|2|||
157105596|NCT02606461|567141635|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
157105597|NCT02606461|567141636|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
157105598|NCT02606461|567141637|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
157105599|NCT02606461|567141638|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
157105600|NCT02606461|567141639|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
157105601|NCT02606461|567141640|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
157105602|NCT00239226|567141641|FG000|Overall Study|permAF during stabilization period|0|||
157105603|NCT00239226|567141642|FG001|Overall Study|permAF during stabilization period|0|||
157105604|NCT00239226|567141643|FG002|Overall Study|permAF during stabilization period|0|||
157105605|NCT00239226|567141644|FG003|Overall Study|permAF during stabilization period|3|||
157105606|NCT00239226|567141641|FG000|Overall Study|Lost to Follow-up|1|||
157105607|NCT00239226|567141642|FG001|Overall Study|Lost to Follow-up|0|||
157105608|NCT00239226|567141643|FG002|Overall Study|Lost to Follow-up|1|||
157105609|NCT00239226|567141644|FG003|Overall Study|Lost to Follow-up|0|||
157105610|NCT01303965|567141647|FG000|Overall Study|Adverse Event|1|||
157105611|NCT01303965|567141648|FG001|Overall Study|Adverse Event|1|||
157105612|NCT01303965|567141647|FG000|Overall Study|Death|0|||
157105613|NCT01303965|567141648|FG001|Overall Study|Death|3|||
157105614|NCT01303965|567141647|FG000|Overall Study|Withdrawal by Subject|1|||
157105615|NCT01303965|567141648|FG001|Overall Study|Withdrawal by Subject|0|||
157105616|NCT01303965|567141647|FG000|Overall Study|Disease Progression|1|||
157105617|NCT01303965|567141648|FG001|Overall Study|Disease Progression|6|||
157105618|NCT02448225|567141649|FG000|Overall Study|Withdrawal by Subject|1|||
157105619|NCT02448225|567141649|FG000|Overall Study|Did not get FSPG scan|18|||
157105620|NCT02448225|567141649|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
157105621|NCT04060563|567141650|FG000|Overall Study|Lost to Follow-up|1|||
157105622|NCT04060563|567141651|FG001|Overall Study|Lost to Follow-up|1|||
157105623|NCT04060563|567141650|FG000|Overall Study|Physician Decision|0|||
157105624|NCT04060563|567141651|FG001|Overall Study|Physician Decision|1|||
157105625|NCT01379573|567141660|FG000|Overall Study|Lost to Follow-up|1|||
157105626|NCT01379573|567141660|FG000|Overall Study|Screen Failure|10|||
157105627|NCT00711529|567141661|FG000|Overall Study|Protocol Violation|2|||
157105628|NCT00711529|567141662|FG001|Overall Study|Protocol Violation|0|||
157105629|NCT00711529|567141661|FG000|Overall Study|Withdrawal by Subject|2|||
157105630|NCT00711529|567141662|FG001|Overall Study|Withdrawal by Subject|6|||
157105631|NCT02871778|567141665|FG000|Part A: Treatment Period 1|Adverse Event|1|||
157105632|NCT02871778|567141666|FG001|Part A: Treatment Period 1|Adverse Event|1|||
157105633|NCT02871778|567141667|FG002|Part A: Treatment Period 1|Adverse Event|1|||
157105634|NCT02871778|567141668|FG003|Part A: Treatment Period 1|Adverse Event|0|||
156761896|NCT01747499|565879923|FG000|Overall Study|Physician Decision|0|||
156761897|NCT01747499|565879924|FG001|Overall Study|Physician Decision|1|||
156761898|NCT01747499|565879925|FG002|Overall Study|Physician Decision|0|||
157105635|NCT02871778|567141669|FG004|Part A: Treatment Period 1|Adverse Event|0|||
157105636|NCT02871778|567141670|FG005|Part A: Treatment Period 1|Adverse Event|0|||
157105637|NCT02871778|567141671|FG006|Part A: Treatment Period 1|Adverse Event|0|||
157105638|NCT02871778|567141672|FG007|Part A: Treatment Period 1|Adverse Event|0|||
157105639|NCT02871778|567141665|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
157105640|NCT02871778|567141666|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
157105641|NCT02871778|567141667|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
157105642|NCT02871778|567141668|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
157105643|NCT02871778|567141669|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
157105644|NCT02871778|567141670|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
157105645|NCT02871778|567141671|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
157105646|NCT02871778|567141672|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
157105647|NCT02871778|567141665|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105648|NCT02871778|567141666|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105649|NCT02871778|567141667|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
157105650|NCT02871778|567141668|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105651|NCT02871778|567141669|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105652|NCT02871778|567141670|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105653|NCT02871778|567141671|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105654|NCT02871778|567141672|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
157105655|NCT02871778|567141665|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105656|NCT02871778|567141666|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105657|NCT02871778|567141667|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
157105658|NCT02871778|567141668|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105659|NCT02871778|567141669|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105660|NCT02871778|567141670|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105661|NCT02871778|567141671|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105662|NCT02871778|567141672|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
157105663|NCT02871778|567141665|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105664|NCT02871778|567141666|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
156761899|NCT01747499|565879926|FG003|Overall Study|Physician Decision|0|||
156761900|NCT01747499|565879927|FG004|Overall Study|Physician Decision|2|||
156761901|NCT01747499|565879923|FG000|Overall Study|Death|0|||
157105665|NCT02871778|567141667|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105666|NCT02871778|567141668|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105667|NCT02871778|567141669|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105668|NCT02871778|567141670|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105669|NCT02871778|567141671|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105670|NCT02871778|567141672|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
157105671|NCT02871778|567141665|FG000|Part A: Treatment Period 2|Adverse Event|2|||
157105672|NCT02871778|567141666|FG001|Part A: Treatment Period 2|Adverse Event|2|||
156761902|NCT01747499|565879924|FG001|Overall Study|Death|0|||
156761903|NCT01747499|565879925|FG002|Overall Study|Death|0|||
156761904|NCT01747499|565879926|FG003|Overall Study|Death|1|||
156761905|NCT01747499|565879927|FG004|Overall Study|Death|1|||
156761906|NCT01747499|565879923|FG000|Overall Study|Withdrawal by Subject|0|||
156761907|NCT01747499|565879924|FG001|Overall Study|Withdrawal by Subject|0|||
156761908|NCT01747499|565879925|FG002|Overall Study|Withdrawal by Subject|0|||
156761909|NCT01747499|565879926|FG003|Overall Study|Withdrawal by Subject|0|||
156761910|NCT01747499|565879927|FG004|Overall Study|Withdrawal by Subject|6|||
156761911|NCT01747499|565879923|FG000|Overall Study|Developed AML and death|0|||
156761912|NCT01747499|565879924|FG001|Overall Study|Developed AML and death|0|||
156761913|NCT01747499|565879925|FG002|Overall Study|Developed AML and death|0|||
156761914|NCT01747499|565879926|FG003|Overall Study|Developed AML and death|0|||
156761915|NCT01747499|565879927|FG004|Overall Study|Developed AML and death|1|||
156761916|NCT01747499|565879923|FG000|Overall Study|Determined not to be eligible|0|||
156761917|NCT01747499|565879924|FG001|Overall Study|Determined not to be eligible|0|||
156761918|NCT01747499|565879925|FG002|Overall Study|Determined not to be eligible|0|||
156761919|NCT01747499|565879926|FG003|Overall Study|Determined not to be eligible|0|||
156761920|NCT01747499|565879927|FG004|Overall Study|Determined not to be eligible|1|||
156761921|NCT01676701|565879928|FG000|Overall Study|Protocol Violation|1|||
156761922|NCT01676701|565879929|FG001|Overall Study|Protocol Violation|0|||
156761923|NCT01676701|565879928|FG000|Overall Study|Sponsor Decision|3|||
156761924|NCT01676701|565879929|FG001|Overall Study|Sponsor Decision|4|||
156761925|NCT02115607|565879930|FG000|Overall Study|Withdrawal by Subject|1|||
156761926|NCT00196105|565879934|FG000|Overall Study|Lost to Follow-up|4|||
156761927|NCT00196105|565879935|FG001|Overall Study|Lost to Follow-up|5|||
156761928|NCT00196105|565879936|FG002|Overall Study|Lost to Follow-up|7|||
156761929|NCT04863872|565879937|FG000|Overall Study|Withdrawal by Subject|4|||
156761930|NCT04863872|565879938|FG001|Overall Study|Withdrawal by Subject|15|||
156761931|NCT04863872|565879937|FG000|Overall Study|Death|5|||
156761932|NCT04863872|565879938|FG001|Overall Study|Death|2|||
156761933|NCT04863872|565879937|FG000|Overall Study|Lost to Follow-up|2|||
157002294|NCT03612804|566757449|FG002|Overall Study|Provider involved with study activities|0|||
156761934|NCT04863872|565879938|FG001|Overall Study|Lost to Follow-up|1|||
156761935|NCT01497067|565879939|FG000|Overall Study|Lost to Follow-up|56|||
156761936|NCT01497067|565879939|FG000|Overall Study|Adverse Event|3|||
156761937|NCT01497067|565879939|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
156761938|NCT01497067|565879939|FG000|Overall Study|Other|13|||
156761939|NCT05616013|565879944|FG000|Overall Study|Adverse Event|6|||
156761940|NCT05616013|565879945|FG001|Overall Study|Adverse Event|12|||
156761941|NCT05616013|565879946|FG002|Overall Study|Adverse Event|8|||
156761942|NCT05616013|565879947|FG003|Overall Study|Adverse Event|4|||
156761943|NCT05616013|565879948|FG004|Overall Study|Adverse Event|6|||
156761944|NCT05616013|565879949|FG005|Overall Study|Adverse Event|8|||
156761945|NCT05616013|565879950|FG006|Overall Study|Adverse Event|3|||
156761946|NCT05616013|565879951|FG007|Overall Study|Adverse Event|6|||
156761947|NCT05616013|565879952|FG008|Overall Study|Adverse Event|1|||
156761948|NCT05616013|565879944|FG000|Overall Study|Lost to Follow-up|5|||
157002295|NCT03612804|566757450|FG003|Overall Study|Provider involved with study activities|0|||
157002296|NCT04391309|566757451|FG000|Overall Study|Death|1|||
157002297|NCT04391309|566757452|FG001|Overall Study|Death|1|||
157002298|NCT04391309|566757451|FG000|Overall Study|Lost to Follow-up|3|||
157002299|NCT04391309|566757452|FG001|Overall Study|Lost to Follow-up|2|||
157002300|NCT04391309|566757451|FG000|Overall Study|Withdrawal by Subject|2|||
157002301|NCT04391309|566757452|FG001|Overall Study|Withdrawal by Subject|2|||
157002302|NCT02781584|566757453|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
157002303|NCT02781584|566757454|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
157002304|NCT02781584|566757455|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
157002305|NCT02781584|566757456|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
157002306|NCT02781584|566757457|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
157002307|NCT02781584|566757458|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
157002308|NCT02781584|566757459|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
157002309|NCT02781584|566757460|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
157002310|NCT02781584|566757461|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
156761949|NCT05616013|565879945|FG001|Overall Study|Lost to Follow-up|4|||
156761950|NCT05616013|565879946|FG002|Overall Study|Lost to Follow-up|3|||
156761951|NCT05616013|565879947|FG003|Overall Study|Lost to Follow-up|2|||
156761952|NCT05616013|565879948|FG004|Overall Study|Lost to Follow-up|0|||
156761953|NCT05616013|565879949|FG005|Overall Study|Lost to Follow-up|5|||
156761954|NCT05616013|565879950|FG006|Overall Study|Lost to Follow-up|2|||
157002311|NCT02781584|566757462|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
157002312|NCT02781584|566757463|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
157002313|NCT02781584|566757464|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
156761955|NCT05616013|565879951|FG007|Overall Study|Lost to Follow-up|1|||
156761956|NCT05616013|565879952|FG008|Overall Study|Lost to Follow-up|2|||
156761957|NCT05616013|565879944|FG000|Overall Study|Non-compliance with study requirements|2|||
156761958|NCT05616013|565879945|FG001|Overall Study|Non-compliance with study requirements|2|||
157002314|NCT02781584|566757465|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
157002315|NCT02781584|566757453|FG000|Pre-treatment Phase|Adverse Event|0|||
157002316|NCT02781584|566757454|FG001|Pre-treatment Phase|Adverse Event|0|||
157002317|NCT02781584|566757455|FG002|Pre-treatment Phase|Adverse Event|0|||
157002318|NCT02781584|566757456|FG003|Pre-treatment Phase|Adverse Event|0|||
157002319|NCT02781584|566757457|FG004|Pre-treatment Phase|Adverse Event|0|||
157002320|NCT02781584|566757458|FG005|Pre-treatment Phase|Adverse Event|0|||
157002321|NCT02781584|566757459|FG006|Pre-treatment Phase|Adverse Event|0|||
157002322|NCT02781584|566757460|FG007|Pre-treatment Phase|Adverse Event|0|||
157002323|NCT02781584|566757461|FG008|Pre-treatment Phase|Adverse Event|0|||
157002324|NCT02781584|566757462|FG009|Pre-treatment Phase|Adverse Event|0|||
157002325|NCT02781584|566757463|FG010|Pre-treatment Phase|Adverse Event|0|||
157002326|NCT02781584|566757464|FG011|Pre-treatment Phase|Adverse Event|1|||
157002327|NCT02781584|566757465|FG012|Pre-treatment Phase|Adverse Event|0|||
157002328|NCT02781584|566757453|FG000|Treatment Phase|Withdrew Consent|0|||
157002329|NCT02781584|566757454|FG001|Treatment Phase|Withdrew Consent|0|||
157002330|NCT02781584|566757455|FG002|Treatment Phase|Withdrew Consent|0|||
157002331|NCT02781584|566757456|FG003|Treatment Phase|Withdrew Consent|0|||
157002332|NCT02781584|566757457|FG004|Treatment Phase|Withdrew Consent|0|||
157002333|NCT02781584|566757458|FG005|Treatment Phase|Withdrew Consent|1|||
157002334|NCT02781584|566757459|FG006|Treatment Phase|Withdrew Consent|0|||
157002335|NCT02781584|566757460|FG007|Treatment Phase|Withdrew Consent|0|||
157002336|NCT02781584|566757461|FG008|Treatment Phase|Withdrew Consent|0|||
157002337|NCT02781584|566757462|FG009|Treatment Phase|Withdrew Consent|0|||
157002338|NCT02781584|566757463|FG010|Treatment Phase|Withdrew Consent|1|||
157002339|NCT02781584|566757464|FG011|Treatment Phase|Withdrew Consent|2|||
157002340|NCT02781584|566757465|FG012|Treatment Phase|Withdrew Consent|0|||
157002341|NCT02781584|566757453|FG000|Treatment Phase|Adverse Event|0|||
157002342|NCT02781584|566757454|FG001|Treatment Phase|Adverse Event|0|||
157002343|NCT02781584|566757455|FG002|Treatment Phase|Adverse Event|0|||
157002344|NCT02781584|566757456|FG003|Treatment Phase|Adverse Event|0|||
157002345|NCT02781584|566757457|FG004|Treatment Phase|Adverse Event|0|||
157002346|NCT02781584|566757458|FG005|Treatment Phase|Adverse Event|0|||
157002347|NCT02781584|566757459|FG006|Treatment Phase|Adverse Event|0|||
157002348|NCT02781584|566757460|FG007|Treatment Phase|Adverse Event|1|||
156761959|NCT05616013|565879946|FG002|Overall Study|Non-compliance with study requirements|2|||
157002349|NCT02781584|566757461|FG008|Treatment Phase|Adverse Event|0|||
157002350|NCT02781584|566757462|FG009|Treatment Phase|Adverse Event|0|||
157002351|NCT02781584|566757463|FG010|Treatment Phase|Adverse Event|0|||
157002352|NCT02781584|566757464|FG011|Treatment Phase|Adverse Event|0|||
157002353|NCT02781584|566757465|FG012|Treatment Phase|Adverse Event|0|||
157002354|NCT03396913|566757466|FG000|Overall Study|Lost to Follow-up|0|||
157002355|NCT03396913|566757467|FG001|Overall Study|Lost to Follow-up|6|||
157002356|NCT05826431|566757468|FG000|Overall Study|Withdrawal by Subject|1|||
157002357|NCT00768651|566757471|FG000|Overall Study|Withdrawal by Subject|1|||
157002358|NCT04436120|566757475|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
157002359|NCT04436120|566757476|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
157002360|NCT04436120|566757477|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
157002361|NCT04436120|566757478|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
157002362|NCT04436120|566757479|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
157002363|NCT04436120|566757480|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
157002364|NCT04436120|566757481|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
157002365|NCT02357784|566757482|FG000|Overall Study|Withdrawal by Subject|1|||
157002366|NCT02698241|566757491|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
157002367|NCT02698241|566757491|FG000|Overall Study|Screening not met|7|||
157002368|NCT02698241|566757491|FG000|Overall Study|Withdrawal by Subject|7|||
157002369|NCT02698241|566757491|FG000|Overall Study|Physician Decision|2|||
157002370|NCT02698241|566757491|FG000|Overall Study|Subject underwent system modification|2|||
157002371|NCT02698241|566757491|FG000|Overall Study|Lost to Follow-up|3|||
157002372|NCT02698241|566757491|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
157002373|NCT02698241|566757491|FG000|Overall Study|geographic and licensing issue|1|||
157002374|NCT02698241|566757491|FG000|Overall Study|Death|2|||
157002375|NCT01543685|566757494|FG000|Overall Study|Lack of Efficacy|1|||
157002376|NCT01543685|566757495|FG001|Overall Study|Lack of Efficacy|2|||
157002377|NCT01543685|566757496|FG002|Overall Study|Lack of Efficacy|2|||
157002378|NCT01543685|566757497|FG003|Overall Study|Lack of Efficacy|0|||
157002379|NCT01543685|566757498|FG004|Overall Study|Lack of Efficacy|2|||
157002380|NCT01543685|566757494|FG000|Overall Study|Adverse Event|2|||
157002381|NCT01543685|566757495|FG001|Overall Study|Adverse Event|1|||
157002382|NCT01543685|566757496|FG002|Overall Study|Adverse Event|0|||
157002383|NCT01543685|566757497|FG003|Overall Study|Adverse Event|0|||
157002384|NCT01543685|566757498|FG004|Overall Study|Adverse Event|2|||
157002385|NCT04776213|566757499|FG000|Overall Study|Other|1|||
157002386|NCT04776213|566757499|FG000|Overall Study|Withdrawal by Subject|7|||
157002387|NCT04776213|566757499|FG000|Overall Study|Protocol Violation|1|||
157002388|NCT04776213|566757499|FG000|Overall Study|Lost to Follow-up|2|||
157002389|NCT02908464|566757500|FG000|Overall Study|Withdrawal by Subject|2|||
157002390|NCT02908464|566757501|FG001|Overall Study|Withdrawal by Subject|1|||
157002391|NCT02908464|566757500|FG000|Overall Study|Found ineligible after randomization|0|||
157002392|NCT02908464|566757501|FG001|Overall Study|Found ineligible after randomization|2|||
157002393|NCT00038103|566757502|FG000|Overall Study|Adverse Event|5|||
157002394|NCT00038103|566757503|FG001|Overall Study|Adverse Event|6|||
157002395|NCT00038103|566757502|FG000|Overall Study|Lack of Efficacy|48|||
157002396|NCT00038103|566757503|FG001|Overall Study|Lack of Efficacy|41|||
157002397|NCT00038103|566757502|FG000|Overall Study|Withdrawal by Subject|0|||
157002398|NCT00038103|566757503|FG001|Overall Study|Withdrawal by Subject|3|||
157002399|NCT00038103|566757502|FG000|Overall Study|Lost to Follow-up|0|||
157002400|NCT00038103|566757503|FG001|Overall Study|Lost to Follow-up|3|||
157002401|NCT00038103|566757502|FG000|Overall Study|Protocol Violation|0|||
157002402|NCT00038103|566757503|FG001|Overall Study|Protocol Violation|2|||
157002403|NCT00038103|566757502|FG000|Overall Study|Sponsor Decision|0|||
157002404|NCT00038103|566757503|FG001|Overall Study|Sponsor Decision|1|||
157002405|NCT00038103|566757502|FG000|Overall Study|Randomized/never treated|2|||
157002406|NCT00038103|566757503|FG001|Overall Study|Randomized/never treated|0|||
157002407|NCT01144182|566757506|FG000|Overall Study|Death|5|||
157002408|NCT01144182|566757507|FG001|Overall Study|Death|6|||
157002409|NCT01144182|566757506|FG000|Overall Study|Withdrawal by Subject|3|||
157002410|NCT01144182|566757507|FG001|Overall Study|Withdrawal by Subject|6|||
157002411|NCT01144182|566757506|FG000|Overall Study|Lost to Follow-up|9|||
157105673|NCT02871778|567141667|FG002|Part A: Treatment Period 2|Adverse Event|0|||
157105674|NCT02871778|567141668|FG003|Part A: Treatment Period 2|Adverse Event|0|||
157105675|NCT02871778|567141669|FG004|Part A: Treatment Period 2|Adverse Event|0|||
157105676|NCT02871778|567141670|FG005|Part A: Treatment Period 2|Adverse Event|0|||
157105677|NCT02871778|567141671|FG006|Part A: Treatment Period 2|Adverse Event|0|||
157105678|NCT02871778|567141672|FG007|Part A: Treatment Period 2|Adverse Event|0|||
157105679|NCT02871778|567141665|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105680|NCT02871778|567141666|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105681|NCT02871778|567141667|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105682|NCT02871778|567141668|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
157105683|NCT02871778|567141669|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105684|NCT02871778|567141670|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105685|NCT02871778|567141671|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105686|NCT02871778|567141672|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
157105687|NCT02871778|567141665|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
157105688|NCT02871778|567141666|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105689|NCT02871778|567141667|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
157105690|NCT02871778|567141668|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105691|NCT02871778|567141669|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105692|NCT02871778|567141670|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105693|NCT02871778|567141671|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105694|NCT02871778|567141672|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
157105695|NCT02871778|567141665|FG000|Part B: Treatment Period 3|Adverse Event|0|||
157105696|NCT02871778|567141666|FG001|Part B: Treatment Period 3|Adverse Event|0|||
157105697|NCT02871778|567141667|FG002|Part B: Treatment Period 3|Adverse Event|0|||
157105698|NCT02871778|567141668|FG003|Part B: Treatment Period 3|Adverse Event|0|||
157105699|NCT02871778|567141669|FG004|Part B: Treatment Period 3|Adverse Event|1|||
157105700|NCT02871778|567141670|FG005|Part B: Treatment Period 3|Adverse Event|1|||
157105701|NCT02871778|567141671|FG006|Part B: Treatment Period 3|Adverse Event|1|||
157105702|NCT02871778|567141672|FG007|Part B: Treatment Period 3|Adverse Event|0|||
157105703|NCT02653300|567141673|FG000|Overall Study|Withdrawal by Subject|2|||
157105704|NCT02289352|567141682|FG000|Overall Study|Withdrawal by Subject|1|||
157105705|NCT02289352|567141683|FG001|Overall Study|Withdrawal by Subject|1|||
157105706|NCT02289352|567141684|FG002|Overall Study|Withdrawal by Subject|0|||
157105707|NCT01390272|567141685|FG000|Overall Study|Death|3|||
157105708|NCT01390272|567141686|FG001|Overall Study|Death|2|||
157105709|NCT01390272|567141685|FG000|Overall Study|Withdrawal by Subject|9|||
157105710|NCT01390272|567141686|FG001|Overall Study|Withdrawal by Subject|5|||
157105711|NCT01390272|567141685|FG000|Overall Study|Patient moved, no longer eligible|5|||
157105712|NCT01390272|567141686|FG001|Overall Study|Patient moved, no longer eligible|8|||
157105713|NCT03606980|567141687|FG000|Overall Study|Lost to Follow-up|3|||
157105714|NCT03606980|567141688|FG001|Overall Study|Lost to Follow-up|2|||
157105715|NCT03606980|567141689|FG002|Overall Study|Lost to Follow-up|3|||
157105716|NCT03606980|567141687|FG000|Overall Study|Withdrawal by Subject|1|||
157105717|NCT03606980|567141688|FG001|Overall Study|Withdrawal by Subject|0|||
157105718|NCT03606980|567141689|FG002|Overall Study|Withdrawal by Subject|4|||
157105719|NCT00307333|567141690|FG000|Overall Study|Lost to Follow-up|11|||
157105720|NCT00307333|567141691|FG001|Overall Study|Lost to Follow-up|3|||
157105721|NCT04166383|567141692|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
157105722|NCT04166383|567141692|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
157105723|NCT04166383|567141692|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
157105724|NCT03044886|567141693|FG000|Overall Study|Lost to Follow-up|15|||
157105725|NCT03044886|567141694|FG001|Overall Study|Lost to Follow-up|10|||
157105726|NCT03044886|567141695|FG002|Overall Study|Lost to Follow-up|12|||
157105727|NCT00387764|567141708|FG000|Overall Study|Adverse Event|12|||
157105728|NCT00387764|567141708|FG000|Overall Study|Withdrawal by Subject|8|||
157105729|NCT00387764|567141708|FG000|Overall Study|Sponsor Terminated Study|1|||
157105730|NCT00387764|567141708|FG000|Overall Study|Physician Decision|1|||
157105731|NCT00387764|567141708|FG000|Overall Study|Other|2|||
157105732|NCT00387764|567141708|FG000|Overall Study|Death|7|||
157105733|NCT01174238|567141711|FG000|Overall Study|Lost to Follow-up|2|||
157105734|NCT00732251|567141713|FG000|Overall Study|Lost to Follow-up|3|||
157105735|NCT00732251|567141713|FG000|Overall Study|Withdrawal by Subject|3|||
157105736|NCT00732251|567141713|FG000|Overall Study|Early Term due to Site Closure|1|||
157105737|NCT00375219|567141714|FG000|Overall Study|Failure to achieve a response|16|||
157105738|NCT00375219|567141715|FG001|Overall Study|Failure to achieve a response|2|||
157105739|NCT00375219|567141716|FG002|Overall Study|Failure to achieve a response|0|||
157105740|NCT00375219|567141714|FG000|Overall Study|Adverse Event|8|||
157105741|NCT00375219|567141715|FG001|Overall Study|Adverse Event|2|||
157105742|NCT00375219|567141716|FG002|Overall Study|Adverse Event|1|||
157105743|NCT00375219|567141714|FG000|Overall Study|Protocol Violation|1|||
157105744|NCT00375219|567141715|FG001|Overall Study|Protocol Violation|0|||
157105745|NCT00375219|567141716|FG002|Overall Study|Protocol Violation|1|||
157105746|NCT00375219|567141714|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
157105747|NCT00375219|567141715|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
157105748|NCT00375219|567141716|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
157105749|NCT00375219|567141714|FG000|Overall Study|Lost to Follow-up|1|||
157105750|NCT00375219|567141715|FG001|Overall Study|Lost to Follow-up|1|||
157105751|NCT00375219|567141716|FG002|Overall Study|Lost to Follow-up|0|||
157105752|NCT00375219|567141714|FG000|Overall Study|Disease progression|18|||
157105753|NCT00375219|567141715|FG001|Overall Study|Disease progression|9|||
157105754|NCT00375219|567141716|FG002|Overall Study|Disease progression|12|||
157105755|NCT00375219|567141714|FG000|Overall Study|Death|4|||
157105756|NCT00375219|567141715|FG001|Overall Study|Death|3|||
157105757|NCT00375219|567141716|FG002|Overall Study|Death|7|||
157105758|NCT00375219|567141714|FG000|Overall Study|Hematologic resistance|1|||
157105759|NCT00375219|567141715|FG001|Overall Study|Hematologic resistance|0|||
157105760|NCT00375219|567141716|FG002|Overall Study|Hematologic resistance|0|||
157105761|NCT00375219|567141714|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
157105762|NCT00375219|567141715|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
157105763|NCT00375219|567141716|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
157105764|NCT00375219|567141714|FG000|Overall Study|Allograft|2|||
157105765|NCT00375219|567141715|FG001|Overall Study|Allograft|0|||
157105766|NCT00375219|567141716|FG002|Overall Study|Allograft|0|||
157105767|NCT00375219|567141714|FG000|Overall Study|Cord blood transplantation|1|||
157105768|NCT00375219|567141715|FG001|Overall Study|Cord blood transplantation|0|||
157105769|NCT00375219|567141716|FG002|Overall Study|Cord blood transplantation|0|||
157002412|NCT01144182|566757507|FG001|Overall Study|Lost to Follow-up|9|||
157002413|NCT03254394|566757517|FG000|Overall Study|Withdrawal by Subject|0|||
157002414|NCT03254394|566757518|FG001|Overall Study|Withdrawal by Subject|2|||
157002415|NCT01981356|566757519|FG000|Overall Study|Lost to Follow-up|4|||
157002416|NCT01981356|566757520|FG001|Overall Study|Lost to Follow-up|1|||
157002417|NCT01981356|566757519|FG000|Overall Study|Withdrawal by Subject|1|||
157002418|NCT01981356|566757520|FG001|Overall Study|Withdrawal by Subject|1|||
157002419|NCT01981356|566757519|FG000|Overall Study|Protocol Violation|2|||
157002420|NCT01981356|566757520|FG001|Overall Study|Protocol Violation|0|||
157002421|NCT02317016|566757521|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
157002422|NCT02317016|566757521|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
157002423|NCT02317016|566757521|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
157002424|NCT02317016|566757521|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
157002425|NCT02317016|566757521|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
157002426|NCT02317016|566757521|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
157002427|NCT02317016|566757521|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
157002428|NCT01867580|566757526|FG000|Overall Study|Withdrawal by Subject|2|||
157002429|NCT01867580|566757527|FG001|Overall Study|Withdrawal by Subject|3|||
157002430|NCT01867580|566757526|FG000|Overall Study|Physician Decision|17|||
157002431|NCT01867580|566757527|FG001|Overall Study|Physician Decision|12|||
157002432|NCT01867580|566757526|FG000|Overall Study|Lost to Follow-up|3|||
157002433|NCT01867580|566757527|FG001|Overall Study|Lost to Follow-up|5|||
157002434|NCT01867580|566757526|FG000|Overall Study|Sponsor terminated study|1|||
157002435|NCT01867580|566757527|FG001|Overall Study|Sponsor terminated study|0|||
157002436|NCT01867580|566757526|FG000|Overall Study|Missed follow-up assessment|2|||
157002437|NCT01867580|566757527|FG001|Overall Study|Missed follow-up assessment|1|||
157002438|NCT01867580|566757526|FG000|Overall Study|Interruption to therapy|3|||
157002439|NCT01867580|566757527|FG001|Overall Study|Interruption to therapy|0|||
157002440|NCT01867580|566757526|FG000|Overall Study|Osteomyelitis|0|||
157002441|NCT01867580|566757527|FG001|Overall Study|Osteomyelitis|1|||
157002442|NCT01867580|566757526|FG000|Overall Study|Continuation of therapy|0|||
157002443|NCT01867580|566757527|FG001|Overall Study|Continuation of therapy|1|||
157002444|NCT01867580|566757526|FG000|Overall Study|Wound recurrence|0|||
157002445|NCT01867580|566757527|FG001|Overall Study|Wound recurrence|1|||
157002446|NCT02465359|566757528|FG000|Overall Study|Lack of Efficacy|1|||
157002447|NCT02465359|566757528|FG000|Overall Study|Withdrawal by Subject|1|||
157002448|NCT02465359|566757528|FG000|Overall Study|Adverse Event|1|||
157002449|NCT01278862|566757529|FG000|Overall Study|Lost to Follow-up|1|||
157002450|NCT01278862|566757530|FG001|Overall Study|Lost to Follow-up|1|||
157002451|NCT02952261|566757532|FG000|Overall Study|Withdrawal by Subject|4|||
157002452|NCT02952261|566757533|FG001|Overall Study|Withdrawal by Subject|5|||
157002453|NCT02952261|566757532|FG000|Overall Study|Protocol Violation|1|||
157002454|NCT02952261|566757533|FG001|Overall Study|Protocol Violation|0|||
157002455|NCT00798265|566757534|FG000|Overall Study|Lost to Follow-up|1|||
157002456|NCT00798265|566757535|FG001|Overall Study|Lost to Follow-up|10|||
157002457|NCT00798265|566757534|FG000|Overall Study|Study closing|7|||
157002458|NCT00798265|566757535|FG001|Overall Study|Study closing|6|||
157002459|NCT00798265|566757534|FG000|Overall Study|Withdrawal by Subject|0|||
157002460|NCT00798265|566757535|FG001|Overall Study|Withdrawal by Subject|1|||
157002461|NCT00798265|566757534|FG000|Overall Study|Screen failure|0|||
157002462|NCT00798265|566757535|FG001|Overall Study|Screen failure|1|||
157002463|NCT03141788|566757536|FG000|Overall Study|Lost to Follow-up|1|||
157002464|NCT03141788|566757536|FG000|Overall Study|Protocol Violation|3|||
157002465|NCT03141788|566757536|FG000|Overall Study|Withdrawal by Subject|4|||
157002466|NCT02812966|566757539|FG000|Overall Study|Death|1|||
157002467|NCT02812966|566757540|FG001|Overall Study|Death|0|||
157002468|NCT01066923|566757541|FG000|Overall Study|Withdrawal by Subject|3|||
157002469|NCT01066923|566757542|FG001|Overall Study|Withdrawal by Subject|3|||
157002470|NCT01066923|566757543|FG002|Overall Study|Withdrawal by Subject|8|||
157002471|NCT01066923|566757544|FG003|Overall Study|Withdrawal by Subject|8|||
157002472|NCT03538041|566760037|FG000|12-Week Treatment Period|Adverse Event|1|||
157002473|NCT03538041|566760038|FG001|12-Week Treatment Period|Adverse Event|1|||
157002474|NCT03538041|566760037|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
157002475|NCT03538041|566760038|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
157002476|NCT03538041|566760037|FG000|Treatment Extension Period|Adverse Event|4|||
157002477|NCT03538041|566760038|FG001|Treatment Extension Period|Adverse Event|1|||
157002478|NCT03538041|566760037|FG000|Treatment Extension Period|Physician Decision|1|||
157002479|NCT03538041|566760038|FG001|Treatment Extension Period|Physician Decision|1|||
157002480|NCT03538041|566760037|FG000|Treatment Extension Period|Lack of Efficacy|1|||
157002481|NCT03538041|566760038|FG001|Treatment Extension Period|Lack of Efficacy|4|||
157002482|NCT03538041|566760037|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
157002483|NCT03538041|566760038|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
157002484|NCT03538041|566760037|FG000|Treatment Extension Period|Death|0|||
157002485|NCT03538041|566760038|FG001|Treatment Extension Period|Death|1|||
157002486|NCT02577523|566760042|FG000|Overall Study|Adverse Event|1|||
157002487|NCT02577523|566760043|FG001|Overall Study|Adverse Event|1|||
157105770|NCT00375219|567141714|FG000|Overall Study|Withdrawal by Subject|1|||
157105771|NCT00375219|567141715|FG001|Overall Study|Withdrawal by Subject|0|||
157105772|NCT00375219|567141716|FG002|Overall Study|Withdrawal by Subject|0|||
157105773|NCT02684279|567141719|FG000|Overall Study|Adverse Event|87|||
157105774|NCT02684279|567141719|FG000|Overall Study|Lack of Efficacy|4|||
157105775|NCT02684279|567141719|FG000|Overall Study|Lost to Follow-up|61|||
157105776|NCT02684279|567141719|FG000|Overall Study|Protocol Violation|6|||
157105777|NCT02684279|567141719|FG000|Overall Study|Pregnancy|8|||
157105778|NCT02684279|567141719|FG000|Overall Study|Withdrawal by Subject|92|||
157105779|NCT02684279|567141719|FG000|Overall Study|non-compliance with study drug|9|||
157105780|NCT02684279|567141719|FG000|Overall Study|non compliance with study visits|2|||
157105781|NCT02684279|567141719|FG000|Overall Study|subject to have surgery|1|||
157105782|NCT02684279|567141719|FG000|Overall Study|family emergency|1|||
157105783|NCT02684279|567141719|FG000|Overall Study|Site closures|7|||
157105784|NCT02684279|567141719|FG000|Overall Study|Physician Decision|1|||
157105785|NCT00228566|567141720|FG000|Overall Study|Adverse Event|31|||
157105786|NCT00228566|567141720|FG000|Overall Study|Lack of Efficacy|14|||
157105787|NCT00228566|567141720|FG000|Overall Study|Lost to Follow-up|16|||
157105788|NCT00228566|567141720|FG000|Overall Study|Physician Decision|5|||
157105789|NCT00228566|567141720|FG000|Overall Study|Withdrawal by Subject|4|||
157105790|NCT00228566|567141720|FG000|Overall Study|Miscellaneous|1|||
157105791|NCT05975840|567141721|FG000|Overall Study|Other|1|||
157105792|NCT05975840|567141722|FG001|Overall Study|Other|0|||
157105793|NCT05975840|567141723|FG002|Overall Study|Other|0|||
157105794|NCT05975840|567141724|FG003|Overall Study|Other|0|||
157105795|NCT05975840|567141725|FG004|Overall Study|Other|1|||
157105796|NCT05975840|567141726|FG005|Overall Study|Other|0|||
157105797|NCT05975840|567141727|FG006|Overall Study|Other|0|||
157105798|NCT05975840|567141728|FG007|Overall Study|Other|0|||
157105799|NCT05975840|567141721|FG000|Overall Study|Lost to Follow-up|3|||
157105800|NCT05975840|567141722|FG001|Overall Study|Lost to Follow-up|6|||
157105801|NCT05975840|567141723|FG002|Overall Study|Lost to Follow-up|3|||
157105802|NCT05975840|567141724|FG003|Overall Study|Lost to Follow-up|1|||
157105803|NCT05975840|567141725|FG004|Overall Study|Lost to Follow-up|4|||
157105804|NCT05975840|567141726|FG005|Overall Study|Lost to Follow-up|1|||
157105805|NCT05975840|567141727|FG006|Overall Study|Lost to Follow-up|2|||
157105806|NCT05975840|567141728|FG007|Overall Study|Lost to Follow-up|4|||
157105807|NCT05975840|567141721|FG000|Overall Study|Migrated/moved from the study area|1|||
157105808|NCT05975840|567141722|FG001|Overall Study|Migrated/moved from the study area|0|||
157105809|NCT05975840|567141723|FG002|Overall Study|Migrated/moved from the study area|0|||
157105810|NCT05975840|567141724|FG003|Overall Study|Migrated/moved from the study area|0|||
157105811|NCT05975840|567141725|FG004|Overall Study|Migrated/moved from the study area|0|||
157105812|NCT05975840|567141726|FG005|Overall Study|Migrated/moved from the study area|0|||
157105813|NCT05975840|567141727|FG006|Overall Study|Migrated/moved from the study area|0|||
157105814|NCT05975840|567141728|FG007|Overall Study|Migrated/moved from the study area|0|||
157105815|NCT05975840|567141721|FG000|Overall Study|Withdrawal by Subject|0|||
157105816|NCT05975840|567141722|FG001|Overall Study|Withdrawal by Subject|5|||
157105817|NCT05975840|567141723|FG002|Overall Study|Withdrawal by Subject|2|||
157105818|NCT05975840|567141724|FG003|Overall Study|Withdrawal by Subject|2|||
157105819|NCT05975840|567141725|FG004|Overall Study|Withdrawal by Subject|0|||
157105820|NCT05975840|567141726|FG005|Overall Study|Withdrawal by Subject|2|||
157105821|NCT05975840|567141727|FG006|Overall Study|Withdrawal by Subject|2|||
157105822|NCT05975840|567141728|FG007|Overall Study|Withdrawal by Subject|1|||
157105823|NCT05975840|567141721|FG000|Overall Study|Protocol Violation|0|||
157002488|NCT02577523|566760042|FG000|Overall Study|Lack of Efficacy|1|||
157002489|NCT02577523|566760043|FG001|Overall Study|Lack of Efficacy|1|||
157002490|NCT02577523|566760042|FG000|Overall Study|Withdrawal by Subject|1|||
157002491|NCT02577523|566760043|FG001|Overall Study|Withdrawal by Subject|0|||
157002492|NCT00357396|566760044|FG000|Overall Study|Adverse Event|1|||
157002493|NCT00357396|566760045|FG001|Overall Study|Adverse Event|0|||
157002494|NCT00487578|566760046|FG000|Overall Study|Adverse Event|1|||
157002495|NCT00487578|566760047|FG001|Overall Study|Adverse Event|2|||
157002496|NCT00487578|566760046|FG000|Overall Study|Lack of Efficacy|0|||
157002497|NCT00487578|566760047|FG001|Overall Study|Lack of Efficacy|1|||
157002498|NCT00487578|566760046|FG000|Overall Study|Lost to Follow-up|0|||
157105824|NCT05975840|567141722|FG001|Overall Study|Protocol Violation|1|||
157105825|NCT05975840|567141723|FG002|Overall Study|Protocol Violation|0|||
157105826|NCT05975840|567141724|FG003|Overall Study|Protocol Violation|0|||
157105827|NCT05975840|567141725|FG004|Overall Study|Protocol Violation|0|||
157105828|NCT05975840|567141726|FG005|Overall Study|Protocol Violation|0|||
157105829|NCT05975840|567141727|FG006|Overall Study|Protocol Violation|0|||
157105830|NCT05975840|567141728|FG007|Overall Study|Protocol Violation|0|||
157105831|NCT05975840|567141721|FG000|Overall Study|Adverse Event|0|||
157105832|NCT05975840|567141722|FG001|Overall Study|Adverse Event|0|||
157105833|NCT05975840|567141723|FG002|Overall Study|Adverse Event|0|||
157105834|NCT05975840|567141724|FG003|Overall Study|Adverse Event|1|||
157105835|NCT05975840|567141725|FG004|Overall Study|Adverse Event|0|||
157105836|NCT05975840|567141726|FG005|Overall Study|Adverse Event|0|||
157105837|NCT05975840|567141727|FG006|Overall Study|Adverse Event|0|||
157105838|NCT05975840|567141728|FG007|Overall Study|Adverse Event|0|||
157105839|NCT05975840|567141721|FG000|Overall Study|Death|0|||
157105840|NCT05975840|567141722|FG001|Overall Study|Death|1|||
157105841|NCT05975840|567141723|FG002|Overall Study|Death|0|||
157105842|NCT05975840|567141724|FG003|Overall Study|Death|0|||
157105843|NCT05975840|567141725|FG004|Overall Study|Death|0|||
157105844|NCT05975840|567141726|FG005|Overall Study|Death|0|||
157105845|NCT05975840|567141727|FG006|Overall Study|Death|0|||
157105846|NCT05975840|567141728|FG007|Overall Study|Death|1|||
157105847|NCT01986920|567142901|FG000|A- 101 25%|Withdrawal by Subject|1|||
157105848|NCT01986920|567142902|FG001|A- 101 25%|Withdrawal by Subject|0|||
157105849|NCT01986920|567142903|FG002|A- 101 25%|Withdrawal by Subject|0|||
157105850|NCT01986920|567142904|FG003|A- 101 25%|Withdrawal by Subject|0|||
157105851|NCT01986920|567142901|FG000|A-101 32.5%|Withdrawal by Subject|0|||
157105852|NCT01986920|567142902|FG001|A-101 32.5%|Withdrawal by Subject|1|||
157105853|NCT01986920|567142903|FG002|A-101 32.5%|Withdrawal by Subject|0|||
157105854|NCT01986920|567142904|FG003|A-101 32.5%|Withdrawal by Subject|0|||
157105855|NCT01986920|567142901|FG000|A-101 40%|Withdrawal by Subject|0|||
157105856|NCT01986920|567142902|FG001|A-101 40%|Withdrawal by Subject|0|||
157105857|NCT01986920|567142903|FG002|A-101 40%|Withdrawal by Subject|1|||
157105858|NCT01986920|567142904|FG003|A-101 40%|Withdrawal by Subject|0|||
157105859|NCT01986920|567142901|FG000|Placebo|Withdrawal by Subject|0|||
157105860|NCT01986920|567142902|FG001|Placebo|Withdrawal by Subject|0|||
157105861|NCT01986920|567142903|FG002|Placebo|Withdrawal by Subject|0|||
157105862|NCT01986920|567142904|FG003|Placebo|Withdrawal by Subject|1|||
157105863|NCT01338415|567142905|FG000|Core + Extension|Adverse Event|8|||
157105864|NCT01338415|567142906|FG001|Core + Extension|Adverse Event|6|||
157105865|NCT01338415|567142907|FG002|Core + Extension|Adverse Event|0|||
157105866|NCT01338415|567142905|FG000|Core + Extension|Withdrawal by Subject|1|||
157105867|NCT01338415|567142906|FG001|Core + Extension|Withdrawal by Subject|1|||
157105868|NCT01338415|567142907|FG002|Core + Extension|Withdrawal by Subject|0|||
157105869|NCT01338415|567142905|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
157105870|NCT01338415|567142906|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
157105871|NCT01338415|567142907|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
157105872|NCT01338415|567142905|FG000|Core + Extension|Other (administrative reason)|1|||
157105873|NCT01338415|567142906|FG001|Core + Extension|Other (administrative reason)|0|||
157105874|NCT01338415|567142907|FG002|Core + Extension|Other (administrative reason)|0|||
157105875|NCT01338415|567142905|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
157105876|NCT01338415|567142906|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
157105877|NCT01338415|567142907|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
157105878|NCT01338415|567142905|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
157105879|NCT01338415|567142906|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
157105880|NCT01338415|567142907|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
157105881|NCT01338415|567142905|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
157105882|NCT01338415|567142906|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
157105883|NCT01338415|567142907|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
157105884|NCT01338415|567142905|FG000|Exceptional Use Treatment Period|Death|0|||
157002499|NCT00487578|566760047|FG001|Overall Study|Lost to Follow-up|1|||
157002500|NCT02525796|566760048|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
157002501|NCT02525796|566760049|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
157002502|NCT02525796|566760050|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
157002503|NCT02525796|566760048|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
157002504|NCT02525796|566760049|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
157002505|NCT02525796|566760050|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
157002506|NCT02525796|566760048|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
157002507|NCT02525796|566760049|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
157002508|NCT02525796|566760050|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
157002509|NCT02525796|566760048|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
157002510|NCT02525796|566760049|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
157002511|NCT02525796|566760050|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
157002512|NCT02525796|566760048|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
157002513|NCT02525796|566760049|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
157002514|NCT02525796|566760050|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
157002515|NCT00726999|566760053|FG000|Overall Study|Physician Decision|0|||
157002516|NCT00726999|566760054|FG001|Overall Study|Physician Decision|1|||
157002517|NCT00726999|566760053|FG000|Overall Study|Withdrawal by Subject|2|||
157002518|NCT00726999|566760054|FG001|Overall Study|Withdrawal by Subject|0|||
157105885|NCT01338415|567142906|FG001|Exceptional Use Treatment Period|Death|0|||
157105886|NCT01338415|567142907|FG002|Exceptional Use Treatment Period|Death|1|||
157105887|NCT01118325|567142908|FG000|Overall Study|Adverse Event|1|||
157105888|NCT01118325|567142909|FG001|Overall Study|Adverse Event|0|||
157105889|NCT01118325|567142910|FG002|Overall Study|Adverse Event|1|||
157105890|NCT03334409|567142911|FG000|Overall Study|Did not meet inclusion criteria|1|||
157105891|NCT03334409|567142912|FG001|Overall Study|Did not meet inclusion criteria|0|||
157105892|NCT00233363|567142917|FG000|Overall Study|Adverse Event|1|||
157105893|NCT00233363|567142918|FG001|Overall Study|Adverse Event|2|||
157105894|NCT00233363|567142917|FG000|Overall Study|Lack of Efficacy|0|||
157105895|NCT00233363|567142918|FG001|Overall Study|Lack of Efficacy|2|||
157105896|NCT00233363|567142917|FG000|Overall Study|Withdrawal by Subject|1|||
157105897|NCT00233363|567142918|FG001|Overall Study|Withdrawal by Subject|1|||
157105898|NCT00233363|567142917|FG000|Overall Study|Aggravation of complication|1|||
157105899|NCT00233363|567142918|FG001|Overall Study|Aggravation of complication|0|||
157105900|NCT01526551|567142921|FG000|Overall Study|Lack of returned parental consent form|424|||
157105901|NCT05215262|567142922|FG000|Overall Study|Lost to Follow-up|12|||
157105902|NCT05215262|567142923|FG001|Overall Study|Lost to Follow-up|0|||
157105903|NCT04880447|567142924|FG000|Overall Study|No vaccination information|1|||
157105904|NCT04880447|567142924|FG000|Overall Study|No adverse event information (missing information)|1|||
157105905|NCT04880447|567142924|FG000|Overall Study|Disease not covered in this study|35|||
157105906|NCT01576172|567142925|FG000|Overall Study|Ineligible|2|||
157105907|NCT01576172|567142926|FG001|Overall Study|Ineligible|1|||
157105908|NCT01576172|567142925|FG000|Overall Study|Withdrawal by Subject|2|||
157105909|NCT01576172|567142926|FG001|Overall Study|Withdrawal by Subject|0|||
157105910|NCT01576172|567142925|FG000|Overall Study|Insurance issue|1|||
157105911|NCT01576172|567142926|FG001|Overall Study|Insurance issue|0|||
157105912|NCT02092350|567142927|FG000|Overall Study|Adverse Event|0|||
157105913|NCT02092350|567142928|FG001|Overall Study|Adverse Event|3|||
157105914|NCT02092350|567142927|FG000|Overall Study|Death|2|||
157105915|NCT02092350|567142928|FG001|Overall Study|Death|5|||
157105916|NCT02092350|567142927|FG000|Overall Study|Lost to Follow-up|3|||
157105917|NCT02092350|567142928|FG001|Overall Study|Lost to Follow-up|1|||
157105918|NCT02092350|567142927|FG000|Overall Study|Protocol Violation|1|||
157105919|NCT02092350|567142928|FG001|Overall Study|Protocol Violation|0|||
157105920|NCT02092350|567142927|FG000|Overall Study|Physician Decision|1|||
157105921|NCT02092350|567142928|FG001|Overall Study|Physician Decision|1|||
157105922|NCT02092350|567142927|FG000|Overall Study|Screen Failure|1|||
157105923|NCT02092350|567142928|FG001|Overall Study|Screen Failure|0|||
157105924|NCT02092350|567142927|FG000|Overall Study|Withdrawal by Subject|2|||
157002519|NCT00726999|566760053|FG000|Overall Study|Protocol Violation|1|||
157002520|NCT00726999|566760054|FG001|Overall Study|Protocol Violation|0|||
157002521|NCT00970307|566760058|FG000|Overall Study|Serious Adverse Event|1|||
157002522|NCT00970307|566760059|FG001|Overall Study|Serious Adverse Event|0|||
157002523|NCT00970307|566760060|FG002|Overall Study|Serious Adverse Event|0|||
157002524|NCT00970307|566760058|FG000|Overall Study|Withdrawal by Subject|2|||
157002525|NCT00970307|566760059|FG001|Overall Study|Withdrawal by Subject|3|||
157002526|NCT00970307|566760060|FG002|Overall Study|Withdrawal by Subject|2|||
157002527|NCT02034916|566760067|FG000|Overall Study|Death|39|||
157002528|NCT02034916|566760068|FG001|Overall Study|Death|28|||
157002529|NCT02034916|566760067|FG000|Overall Study|Withdrawal by Subject|2|||
157002530|NCT02034916|566760068|FG001|Overall Study|Withdrawal by Subject|1|||
157002531|NCT02034916|566760067|FG000|Overall Study|Lost to Follow-up|4|||
157002532|NCT02034916|566760068|FG001|Overall Study|Lost to Follow-up|1|||
157002533|NCT02034916|566760067|FG000|Overall Study|Study terminated by sponsor|4|||
157002534|NCT02034916|566760068|FG001|Overall Study|Study terminated by sponsor|5|||
157002535|NCT02506257|566760077|FG000|Overall Study|Adverse Event|0|||
157002536|NCT02506257|566760078|FG001|Overall Study|Adverse Event|2|||
157002537|NCT02506257|566760079|FG002|Overall Study|Adverse Event|3|||
157002538|NCT02506257|566760080|FG003|Overall Study|Adverse Event|0|||
157002539|NCT02506257|566760077|FG000|Overall Study|Protocol Violation|0|||
157002540|NCT02506257|566760078|FG001|Overall Study|Protocol Violation|0|||
157002541|NCT02506257|566760079|FG002|Overall Study|Protocol Violation|1|||
157002542|NCT02506257|566760080|FG003|Overall Study|Protocol Violation|0|||
157002543|NCT00964366|566760081|FG000|Overall Study|Did not qualify at Day 1|1|||
157002544|NCT00964366|566760082|FG001|Overall Study|Did not qualify at Day 1|0|||
157002545|NCT00964366|566760081|FG000|Overall Study|Withdrawal by Subject|0|||
157002546|NCT00964366|566760082|FG001|Overall Study|Withdrawal by Subject|1|||
157002547|NCT01370694|566760084|FG000|Overall Study|Switched to rituximab|4|||
157002548|NCT01370694|566760084|FG000|Overall Study|Progressive disease|2|||
157002549|NCT02046616|566760085|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
157002550|NCT02046616|566760085|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
157002551|NCT02046616|566760085|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
157002552|NCT02046616|566760085|FG000|24-Week Treatment Period|Physician Decision|3|||
157105925|NCT02092350|567142928|FG001|Overall Study|Withdrawal by Subject|2|||
157105926|NCT00962390|567142929|FG000|Overall Study|Adverse Event|0|||
156761960|NCT05616013|565879947|FG003|Overall Study|Non-compliance with study requirements|3|||
157002553|NCT02046616|566760085|FG000|24-Week Treatment Period|Other|1|||
157105927|NCT00962390|567142930|FG001|Overall Study|Adverse Event|0|||
157105928|NCT00962390|567142931|FG002|Overall Study|Adverse Event|3|||
157105929|NCT00962390|567142932|FG003|Overall Study|Adverse Event|1|||
157105930|NCT00962390|567142929|FG000|Overall Study|Lost to Follow-up|2|||
157105931|NCT00962390|567142930|FG001|Overall Study|Lost to Follow-up|2|||
157105932|NCT00962390|567142931|FG002|Overall Study|Lost to Follow-up|0|||
157105933|NCT00962390|567142932|FG003|Overall Study|Lost to Follow-up|0|||
157105934|NCT00962390|567142929|FG000|Overall Study|Protocol Violation|1|||
157105935|NCT00962390|567142930|FG001|Overall Study|Protocol Violation|0|||
157105936|NCT00962390|567142931|FG002|Overall Study|Protocol Violation|0|||
157105937|NCT00962390|567142932|FG003|Overall Study|Protocol Violation|0|||
157105938|NCT00962390|567142929|FG000|Overall Study|Withdrawal by Subject|1|||
157105939|NCT00962390|567142930|FG001|Overall Study|Withdrawal by Subject|1|||
157105940|NCT00962390|567142931|FG002|Overall Study|Withdrawal by Subject|1|||
157105941|NCT00962390|567142932|FG003|Overall Study|Withdrawal by Subject|0|||
157105942|NCT02613884|567142933|FG000|Overall Study|Death|1|||
157105943|NCT02613884|567142933|FG000|Overall Study|Lost to Follow-up|1|||
157105944|NCT03024970|567142939|FG000|First Intervention|Adverse Event|1|||
157105945|NCT03024970|567142940|FG001|First Intervention|Adverse Event|0|||
157105946|NCT03024970|567142939|FG000|Second Intervention|Lost to Follow-up|1|||
157105947|NCT03024970|567142940|FG001|Second Intervention|Lost to Follow-up|0|||
157105948|NCT00356889|567142942|FG000|Overall Study|Protocol Violation|2|||
157105949|NCT00356889|567142942|FG000|Overall Study|Adverse Event|1|||
157105950|NCT02678416|567142943|FG000|Part 1|Withdrawal by Subject|1|||
157105951|NCT02678416|567142943|FG000|Part 2|Adverse Event|2|||
157105952|NCT02678416|567142943|FG000|Part 2|Withdrawal by Subject|1|||
157105953|NCT01910116|567142948|FG000|Overall Study|Adverse Event|0|||
157105954|NCT01910116|567142949|FG001|Overall Study|Adverse Event|3|||
157105955|NCT01910116|567142948|FG000|Overall Study|Lack of Efficacy|3|||
157105956|NCT01910116|567142949|FG001|Overall Study|Lack of Efficacy|4|||
157105957|NCT01910116|567142948|FG000|Overall Study|Lost to Follow-up|1|||
157105958|NCT01910116|567142949|FG001|Overall Study|Lost to Follow-up|0|||
157105959|NCT01910116|567142948|FG000|Overall Study|Protocol Violation|1|||
157105960|NCT01910116|567142949|FG001|Overall Study|Protocol Violation|2|||
157105961|NCT01910116|567142948|FG000|Overall Study|Withdrawal by Subject|8|||
157105962|NCT01910116|567142949|FG001|Overall Study|Withdrawal by Subject|3|||
157105963|NCT01910116|567142948|FG000|Overall Study|uncertain allocation|1|||
157105964|NCT01910116|567142949|FG001|Overall Study|uncertain allocation|3|||
157105965|NCT01910116|567142948|FG000|Overall Study|incomplete data|0|||
157105966|NCT01910116|567142949|FG001|Overall Study|incomplete data|1|||
157105967|NCT00736034|567142952|FG000|Overall Study|Adverse Event|2|||
157105968|NCT00911625|567142957|FG000|Overall Study|Lost to Follow-up|7|||
157105969|NCT00911625|567142958|FG001|Overall Study|Lost to Follow-up|0|||
157105970|NCT00590044|567142959|FG000|Overall Study|Withdrawal by Subject|2|||
157105971|NCT00590044|567142960|FG001|Overall Study|Withdrawal by Subject|2|||
157105972|NCT00590044|567142959|FG000|Overall Study|wrong insulin arm assigned|1|||
157105973|NCT00590044|567142960|FG001|Overall Study|wrong insulin arm assigned|0|||
157105974|NCT00590044|567142959|FG000|Overall Study|Protocol Violation|1|||
157105975|NCT00590044|567142960|FG001|Overall Study|Protocol Violation|0|||
157105976|NCT01514136|567142961|FG000|Test Period 1; Test A|Protocol Violation|1|||
157105977|NCT01514136|567142962|FG001|Test Period 1; Test A|Protocol Violation|0|||
157105978|NCT01514136|567142963|FG002|Test Period 1; Test A|Protocol Violation|0|||
157105979|NCT01514136|567142964|FG003|Test Period 1; Test A|Protocol Violation|0|||
157105980|NCT01514136|567142965|FG004|Test Period 1; Test A|Protocol Violation|0|||
157105981|NCT01514136|567142966|FG005|Test Period 1; Test A|Protocol Violation|0|||
157105982|NCT01514136|567142967|FG006|Test Period 1; Test A|Protocol Violation|0|||
157105983|NCT01514136|567142968|FG007|Test Period 1; Test A|Protocol Violation|0|||
157105984|NCT01514136|567142961|FG000|Test Period 1; Test A|Break from study holiday|2|||
157105985|NCT01514136|567142962|FG001|Test Period 1; Test A|Break from study holiday|0|||
157105986|NCT01514136|567142963|FG002|Test Period 1; Test A|Break from study holiday|0|||
157105987|NCT01514136|567142964|FG003|Test Period 1; Test A|Break from study holiday|0|||
157105988|NCT01514136|567142965|FG004|Test Period 1; Test A|Break from study holiday|0|||
157105989|NCT01514136|567142966|FG005|Test Period 1; Test A|Break from study holiday|0|||
157105990|NCT01514136|567142967|FG006|Test Period 1; Test A|Break from study holiday|0|||
157105991|NCT01514136|567142968|FG007|Test Period 1; Test A|Break from study holiday|0|||
157105992|NCT01514136|567142961|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
157105993|NCT01514136|567142962|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
157105994|NCT01514136|567142963|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
157105995|NCT01514136|567142964|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
157105996|NCT01514136|567142965|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
157105997|NCT01514136|567142966|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
157105998|NCT01514136|567142967|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
157105999|NCT01514136|567142968|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
157106000|NCT01514136|567142961|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106001|NCT01514136|567142962|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106002|NCT01514136|567142963|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106003|NCT01514136|567142964|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
157106004|NCT01514136|567142965|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106005|NCT01514136|567142966|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106006|NCT01514136|567142967|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106007|NCT01514136|567142968|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
157106008|NCT01514136|567142961|FG000|Test Period 2; Test A*|Adverse Event|0|||
157106009|NCT01514136|567142962|FG001|Test Period 2; Test A*|Adverse Event|0|||
157106010|NCT01514136|567142963|FG002|Test Period 2; Test A*|Adverse Event|0|||
157106011|NCT01514136|567142964|FG003|Test Period 2; Test A*|Adverse Event|0|||
157106012|NCT01514136|567142965|FG004|Test Period 2; Test A*|Adverse Event|1|||
157106013|NCT01514136|567142966|FG005|Test Period 2; Test A*|Adverse Event|0|||
157106014|NCT01514136|567142967|FG006|Test Period 2; Test A*|Adverse Event|0|||
157106015|NCT01514136|567142968|FG007|Test Period 2; Test A*|Adverse Event|0|||
157002554|NCT02046616|566760085|FG000|8-Week FU Period|Lost to Follow-up|1|||
157002555|NCT02957539|566760088|FG000|Baseline to Week 16|Lost to Follow-up|8|||
157002556|NCT02957539|566760089|FG001|Baseline to Week 16|Lost to Follow-up|10|||
157002557|NCT02957539|566760090|FG002|Baseline to Week 16|Lost to Follow-up|16|||
157002558|NCT02957539|566760088|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
157002559|NCT02957539|566760089|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
157002560|NCT02957539|566760090|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
157002561|NCT02957539|566760088|FG000|Week 16 to 32|Withdrawal by Subject|3|||
157002562|NCT02957539|566760089|FG001|Week 16 to 32|Withdrawal by Subject|3|||
157002563|NCT02957539|566760090|FG002|Week 16 to 32|Withdrawal by Subject|1|||
157002564|NCT02957539|566760088|FG000|Week 16 to 32|Lost to Follow-up|8|||
157002565|NCT02957539|566760089|FG001|Week 16 to 32|Lost to Follow-up|7|||
157002566|NCT02957539|566760090|FG002|Week 16 to 32|Lost to Follow-up|5|||
157002567|NCT02957539|566760088|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
157002568|NCT02957539|566760089|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
157002569|NCT02957539|566760090|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
157002570|NCT02957539|566760088|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
157002571|NCT02957539|566760089|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
157002572|NCT02957539|566760090|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
157002573|NCT04842604|566760095|FG000|Overall Study|Death|1|||
157002574|NCT04842604|566760096|FG001|Overall Study|Death|0|||
157002575|NCT04842604|566760095|FG000|Overall Study|Other|4|||
157002576|NCT04842604|566760096|FG001|Overall Study|Other|4|||
157002577|NCT04842604|566760095|FG000|Overall Study|Randomized but not treated|1|||
157002578|NCT04842604|566760096|FG001|Overall Study|Randomized but not treated|0|||
157002579|NCT00344019|566760098|FG000|Overall Study|did not meet final inclusion criteria|0|||
157002580|NCT00344019|566760099|FG001|Overall Study|did not meet final inclusion criteria|0|||
157002581|NCT00344019|566760100|FG002|Overall Study|did not meet final inclusion criteria|74|||
157002582|NCT01193153|566760101|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
157002583|NCT01193153|566760102|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
157002584|NCT01193153|566760101|FG000|Open-label Lead in Period|Pregnancy|1|||
157002585|NCT01193153|566760102|FG001|Open-label Lead in Period|Pregnancy|0|||
157002586|NCT01193153|566760101|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
157002587|NCT01193153|566760102|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
157002588|NCT01193153|566760101|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
157002589|NCT01193153|566760102|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
157002590|NCT01193153|566760101|FG000|Open-label Lead in Period|Other|14|||
157002591|NCT01193153|566760102|FG001|Open-label Lead in Period|Other|0|||
157002592|NCT01193153|566760101|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
157002593|NCT01193153|566760102|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
157002594|NCT01193153|566760101|FG000|Open-label Lead in Period|Adverse Event|41|||
157002595|NCT01193153|566760102|FG001|Open-label Lead in Period|Adverse Event|0|||
157002596|NCT01193153|566760101|FG000|Open-label Lead in Period|Death|1|||
157002597|NCT01193153|566760102|FG001|Open-label Lead in Period|Death|0|||
157002598|NCT01193153|566760101|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
157002599|NCT01193153|566760102|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
157002600|NCT01193153|566760101|FG000|Open-label Stabilization Period|Adverse Event|9|||
157002601|NCT01193153|566760102|FG001|Open-label Stabilization Period|Adverse Event|0|||
157002602|NCT01193153|566760101|FG000|Open-label Stabilization Period|Death|2|||
157002603|NCT01193153|566760102|FG001|Open-label Stabilization Period|Death|0|||
157002604|NCT01193153|566760101|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
157002605|NCT01193153|566760102|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
157002606|NCT01193153|566760101|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
157002607|NCT01193153|566760102|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
157002608|NCT01193153|566760101|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
157002609|NCT01193153|566760102|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
157002610|NCT01193153|566760101|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
157002611|NCT01193153|566760102|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
157002612|NCT01193153|566760101|FG000|Open-label Stabilization Period|Other|8|||
157002613|NCT01193153|566760102|FG001|Open-label Stabilization Period|Other|0|||
157002614|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Other|2|||
157002615|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Other|3|||
157106016|NCT01514136|567142961|FG000|Test Period 2; Test A*|Holiday|0|||
157106017|NCT01514136|567142962|FG001|Test Period 2; Test A*|Holiday|0|||
157106018|NCT01514136|567142963|FG002|Test Period 2; Test A*|Holiday|0|||
157106019|NCT01514136|567142964|FG003|Test Period 2; Test A*|Holiday|0|||
157106020|NCT01514136|567142965|FG004|Test Period 2; Test A*|Holiday|1|||
157106021|NCT01514136|567142966|FG005|Test Period 2; Test A*|Holiday|0|||
157106022|NCT01514136|567142967|FG006|Test Period 2; Test A*|Holiday|0|||
157106023|NCT01514136|567142968|FG007|Test Period 2; Test A*|Holiday|0|||
157106024|NCT01514136|567142961|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106025|NCT01514136|567142962|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106026|NCT01514136|567142963|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106027|NCT01514136|567142964|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106028|NCT01514136|567142965|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106029|NCT01514136|567142966|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
157106030|NCT01514136|567142967|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106031|NCT01514136|567142968|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
157106032|NCT01514136|567142961|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106033|NCT01514136|567142962|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106034|NCT01514136|567142963|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106035|NCT01514136|567142964|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106036|NCT01514136|567142965|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106037|NCT01514136|567142966|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106038|NCT01514136|567142967|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
157106039|NCT01514136|567142968|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
157106040|NCT01514136|567142961|FG000|Test Period 2; Test C*|holiday|0|||
157106041|NCT01514136|567142962|FG001|Test Period 2; Test C*|holiday|0|||
157106042|NCT01514136|567142963|FG002|Test Period 2; Test C*|holiday|0|||
157106043|NCT01514136|567142964|FG003|Test Period 2; Test C*|holiday|0|||
157106044|NCT01514136|567142965|FG004|Test Period 2; Test C*|holiday|0|||
157106045|NCT01514136|567142966|FG005|Test Period 2; Test C*|holiday|0|||
157106046|NCT01514136|567142967|FG006|Test Period 2; Test C*|holiday|1|||
157106047|NCT01514136|567142968|FG007|Test Period 2; Test C*|holiday|0|||
157106048|NCT01514136|567142961|FG000|Test Period 2; Test C*|Protocol Violation|0|||
157106049|NCT01514136|567142962|FG001|Test Period 2; Test C*|Protocol Violation|0|||
157106050|NCT01514136|567142963|FG002|Test Period 2; Test C*|Protocol Violation|0|||
157106051|NCT01514136|567142964|FG003|Test Period 2; Test C*|Protocol Violation|0|||
157106052|NCT01514136|567142965|FG004|Test Period 2; Test C*|Protocol Violation|0|||
157106053|NCT01514136|567142966|FG005|Test Period 2; Test C*|Protocol Violation|0|||
157106054|NCT01514136|567142967|FG006|Test Period 2; Test C*|Protocol Violation|1|||
157106055|NCT01514136|567142968|FG007|Test Period 2; Test C*|Protocol Violation|0|||
157106056|NCT02729740|567142973|FG000|Overall Study|Early Termination|130|||
157106057|NCT02729740|567142973|FG000|Overall Study|Other|1|||
157106058|NCT00888381|567142974|FG000|Overall Study|Lost to Follow-up|0|||
157106059|NCT00888381|567142975|FG001|Overall Study|Lost to Follow-up|1|||
157106060|NCT00757003|567142979|FG000|Overall Study|Death|33|||
157106061|NCT00757003|567142979|FG000|Overall Study|Lost to Follow-up|9|||
157106062|NCT00757003|567142979|FG000|Overall Study|Withdrawal by Subject|4|||
157106063|NCT00757003|567142979|FG000|Overall Study|Surgically explanted|2|||
157106064|NCT00757003|567142979|FG000|Overall Study|Not implanted|1|||
157106065|NCT03044249|567142982|FG000|Overall Study|Adverse Event|4|||
157106066|NCT03044249|567142983|FG001|Overall Study|Adverse Event|9|||
157106067|NCT03044249|567142982|FG000|Overall Study|Lost to Follow-up|1|||
157106068|NCT03044249|567142983|FG001|Overall Study|Lost to Follow-up|0|||
157106069|NCT03044249|567142982|FG000|Overall Study|Non-compliance with Study Drug|1|||
157106070|NCT03044249|567142983|FG001|Overall Study|Non-compliance with Study Drug|0|||
157106071|NCT03044249|567142982|FG000|Overall Study|Study Terminated by Sponsor|2|||
157106072|NCT03044249|567142983|FG001|Overall Study|Study Terminated by Sponsor|0|||
157106073|NCT03044249|567142982|FG000|Overall Study|Withdrawal by Subject|2|||
157106074|NCT03044249|567142983|FG001|Overall Study|Withdrawal by Subject|5|||
157106075|NCT00955279|567142984|FG000|Overall Study|Other|0|||
157106076|NCT00955279|567142985|FG001|Overall Study|Other|0|||
157106077|NCT00955279|567142986|FG002|Overall Study|Other|3|||
157106078|NCT00955279|567142984|FG000|Overall Study|Death|1|||
157106079|NCT00955279|567142985|FG001|Overall Study|Death|1|||
157106080|NCT00955279|567142986|FG002|Overall Study|Death|1|||
157106081|NCT00955279|567142984|FG000|Overall Study|Lost to Follow-up|0|||
157106082|NCT00955279|567142985|FG001|Overall Study|Lost to Follow-up|3|||
157106083|NCT00955279|567142986|FG002|Overall Study|Lost to Follow-up|1|||
157106084|NCT00955279|567142984|FG000|Overall Study|Withdrawal by Subject|2|||
157106085|NCT00955279|567142985|FG001|Overall Study|Withdrawal by Subject|0|||
157106086|NCT00955279|567142986|FG002|Overall Study|Withdrawal by Subject|3|||
157106087|NCT03785678|567142987|FG000|Overall Study|Death|44|||
157106088|NCT03785678|567142988|FG001|Overall Study|Death|42|||
157106089|NCT03785678|567142987|FG000|Overall Study|Lost to Follow-up|4|||
157106090|NCT03785678|567142988|FG001|Overall Study|Lost to Follow-up|2|||
157106091|NCT03785678|567142987|FG000|Overall Study|Physician Decision|0|||
157106092|NCT03785678|567142988|FG001|Overall Study|Physician Decision|2|||
157106093|NCT03785678|567142987|FG000|Overall Study|Withdrawal by Subject|5|||
157106094|NCT03785678|567142988|FG001|Overall Study|Withdrawal by Subject|3|||
157106095|NCT01159912|567142989|FG000|Overall Study|Adverse Event|2|||
157002616|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
157002617|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
157002618|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Death|2|||
157002619|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Death|0|||
157002620|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
157002621|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
157002622|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
157002623|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
157002624|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
157002625|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
157002626|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
157002627|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
157002628|NCT01193153|566760101|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
157002629|NCT01193153|566760102|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
157002630|NCT01563354|566760105|FG000|Core Phase|Adverse Event|5|||
157002631|NCT01563354|566760106|FG001|Core Phase|Adverse Event|15|||
157002632|NCT01563354|566760107|FG002|Core Phase|Adverse Event|13|||
157002633|NCT01563354|566760105|FG000|Core Phase|Withdrawal by Subject|1|||
157002634|NCT01563354|566760106|FG001|Core Phase|Withdrawal by Subject|0|||
157002635|NCT01563354|566760107|FG002|Core Phase|Withdrawal by Subject|3|||
157002636|NCT01563354|566760105|FG000|Core Phase|Lost to Follow-up|1|||
157002637|NCT01563354|566760106|FG001|Core Phase|Lost to Follow-up|0|||
157002638|NCT01563354|566760107|FG002|Core Phase|Lost to Follow-up|0|||
157002639|NCT01563354|566760105|FG000|Core Phase|Death|1|||
157002640|NCT01563354|566760106|FG001|Core Phase|Death|5|||
157002641|NCT01563354|566760107|FG002|Core Phase|Death|2|||
157002642|NCT01563354|566760105|FG000|Core Phase|Diseasse progression|18|||
157002643|NCT01563354|566760106|FG001|Core Phase|Diseasse progression|7|||
157002644|NCT01563354|566760107|FG002|Core Phase|Diseasse progression|8|||
157002645|NCT01563354|566760105|FG000|Core Phase|Protocol deviation|2|||
157002646|NCT01563354|566760106|FG001|Core Phase|Protocol deviation|0|||
157002647|NCT01563354|566760107|FG002|Core Phase|Protocol deviation|0|||
157002648|NCT01563354|566760105|FG000|Core Phase|PI decision - did not enter extension|0|||
157002649|NCT01563354|566760106|FG001|Core Phase|PI decision - did not enter extension|1|||
157002650|NCT01563354|566760107|FG002|Core Phase|PI decision - did not enter extension|0|||
157002651|NCT01563354|566760105|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
157002652|NCT01563354|566760106|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
157002653|NCT01563354|566760107|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
157002654|NCT01563354|566760105|FG000|Extension Phase|Adverse Event|0|||
157002655|NCT01563354|566760106|FG001|Extension Phase|Adverse Event|3|||
157002656|NCT01563354|566760107|FG002|Extension Phase|Adverse Event|2|||
157002657|NCT01563354|566760105|FG000|Extension Phase|Withdrawal by Subject|0|||
157002658|NCT01563354|566760106|FG001|Extension Phase|Withdrawal by Subject|1|||
157002659|NCT01563354|566760107|FG002|Extension Phase|Withdrawal by Subject|0|||
157002660|NCT01563354|566760105|FG000|Extension Phase|Administration problems|3|||
157002661|NCT01563354|566760106|FG001|Extension Phase|Administration problems|2|||
157002662|NCT01563354|566760107|FG002|Extension Phase|Administration problems|3|||
157002663|NCT01563354|566760105|FG000|Extension Phase|Disease progression|9|||
157002664|NCT01563354|566760106|FG001|Extension Phase|Disease progression|8|||
157002665|NCT01563354|566760107|FG002|Extension Phase|Disease progression|10|||
157002666|NCT02503202|566760108|FG000|Base Study: Up to Month 6|Death|1|||
157002667|NCT02503202|566760109|FG001|Base Study: Up to Month 6|Death|1|||
157002668|NCT02503202|566760110|FG002|Base Study: Up to Month 6|Death|0|||
157002669|NCT02503202|566760111|FG003|Base Study: Up to Month 6|Death|0|||
157002670|NCT02503202|566760112|FG004|Base Study: Up to Month 6|Death|0|||
157002671|NCT02503202|566760108|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
157002672|NCT02503202|566760109|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
157002673|NCT02503202|566760110|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
157002674|NCT02503202|566760111|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
157002675|NCT02503202|566760112|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
157002676|NCT02503202|566760108|FG000|Base Study: Up to Month 6|Physician Decision|0|||
157002677|NCT02503202|566760109|FG001|Base Study: Up to Month 6|Physician Decision|0|||
157002678|NCT02503202|566760110|FG002|Base Study: Up to Month 6|Physician Decision|0|||
157002679|NCT02503202|566760111|FG003|Base Study: Up to Month 6|Physician Decision|0|||
157002680|NCT02503202|566760112|FG004|Base Study: Up to Month 6|Physician Decision|1|||
157002681|NCT02503202|566760108|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
157106096|NCT01159912|567142990|FG001|Overall Study|Adverse Event|2|||
157106097|NCT01159912|567142991|FG002|Overall Study|Adverse Event|3|||
157106098|NCT01159912|567142989|FG000|Overall Study|Lack of Efficacy|23|||
157106099|NCT01159912|567142990|FG001|Overall Study|Lack of Efficacy|15|||
157106100|NCT01159912|567142991|FG002|Overall Study|Lack of Efficacy|14|||
157106101|NCT01159912|567142989|FG000|Overall Study|Protocol Violation|1|||
157106102|NCT01159912|567142990|FG001|Overall Study|Protocol Violation|2|||
157106103|NCT01159912|567142991|FG002|Overall Study|Protocol Violation|3|||
157106104|NCT01159912|567142989|FG000|Overall Study|Lost to Follow-up|4|||
157106105|NCT01159912|567142990|FG001|Overall Study|Lost to Follow-up|0|||
157106106|NCT01159912|567142991|FG002|Overall Study|Lost to Follow-up|0|||
157106107|NCT01159912|567142989|FG000|Overall Study|Physician Decision|0|||
157106108|NCT01159912|567142990|FG001|Overall Study|Physician Decision|0|||
157106109|NCT01159912|567142991|FG002|Overall Study|Physician Decision|3|||
157106110|NCT01159912|567142989|FG000|Overall Study|Withdrawal by Subject|10|||
157106111|NCT01159912|567142990|FG001|Overall Study|Withdrawal by Subject|3|||
157106112|NCT01159912|567142991|FG002|Overall Study|Withdrawal by Subject|3|||
157106113|NCT02374021|567142995|FG000|Overall Study|Adverse Event|1|||
157106114|NCT02374021|567142996|FG001|Overall Study|Adverse Event|0|||
157106115|NCT02374021|567142995|FG000|Overall Study|Lost to Follow-up|3|||
157106116|NCT02374021|567142996|FG001|Overall Study|Lost to Follow-up|2|||
157106117|NCT02374021|567142995|FG000|Overall Study|Physician Decision|0|||
157106118|NCT02374021|567142996|FG001|Overall Study|Physician Decision|3|||
157106119|NCT02374021|567142995|FG000|Overall Study|Withdrawal by Subject|6|||
157106120|NCT02374021|567142996|FG001|Overall Study|Withdrawal by Subject|5|||
157106121|NCT02374021|567142995|FG000|Overall Study|Poor Adherence|0|||
157106122|NCT02374021|567142996|FG001|Overall Study|Poor Adherence|1|||
157106123|NCT02374021|567142995|FG000|Overall Study|Scan protocol not followed|0|||
157106124|NCT02374021|567142996|FG001|Overall Study|Scan protocol not followed|1|||
157106125|NCT02374021|567142995|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
157106126|NCT02374021|567142996|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
157106127|NCT00688155|567142997|FG000|Overall Study|Withdrawal by Subject|2|||
157106128|NCT00688155|567142998|FG001|Overall Study|Withdrawal by Subject|2|||
157106129|NCT00688155|567142999|FG002|Overall Study|Withdrawal by Subject|1|||
157106130|NCT00688155|567143000|FG003|Overall Study|Withdrawal by Subject|1|||
157106131|NCT03007979|567143005|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
157106132|NCT03734016|567143006|FG000|Overall Study|Sponsor Ended Study|225|||
157106133|NCT03734016|567143007|FG001|Overall Study|Sponsor Ended Study|200|||
157106134|NCT03734016|567143006|FG000|Overall Study|Death|69|||
157002682|NCT02503202|566760109|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
157002683|NCT02503202|566760110|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
157002684|NCT02503202|566760111|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
157002685|NCT02503202|566760112|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
157002686|NCT02503202|566760108|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
157002687|NCT02503202|566760109|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
157002688|NCT02503202|566760110|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
157002689|NCT02503202|566760111|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
157002690|NCT02503202|566760112|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
157002691|NCT02503202|566760108|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
157002692|NCT02503202|566760109|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
157002693|NCT02503202|566760110|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
157002694|NCT02503202|566760111|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
157002695|NCT02503202|566760112|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
157002696|NCT02503202|566760108|FG000|Extension: Month 6 to 24|Death|1|||
157002697|NCT02503202|566760109|FG001|Extension: Month 6 to 24|Death|0|||
157002698|NCT02503202|566760110|FG002|Extension: Month 6 to 24|Death|0|||
157002699|NCT02503202|566760111|FG003|Extension: Month 6 to 24|Death|0|||
157002700|NCT02503202|566760112|FG004|Extension: Month 6 to 24|Death|0|||
157002701|NCT02503202|566760108|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
157002702|NCT02503202|566760109|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
157002703|NCT02503202|566760110|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
157002704|NCT02503202|566760111|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
157002705|NCT02503202|566760112|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
157106135|NCT03734016|567143007|FG001|Overall Study|Death|83|||
157106136|NCT03734016|567143006|FG000|Overall Study|Withdrawal by Subject|21|||
157106137|NCT03734016|567143007|FG001|Overall Study|Withdrawal by Subject|27|||
157106138|NCT03734016|567143006|FG000|Overall Study|Physician Decision|1|||
157106139|NCT03734016|567143007|FG001|Overall Study|Physician Decision|12|||
157106140|NCT03734016|567143006|FG000|Overall Study|Lost to Follow-up|6|||
157106141|NCT03734016|567143007|FG001|Overall Study|Lost to Follow-up|2|||
157106142|NCT03734016|567143006|FG000|Overall Study|Miscellaneous|5|||
157106143|NCT03734016|567143007|FG001|Overall Study|Miscellaneous|1|||
157106144|NCT01624259|567143008|FG000|Overall Study|Adverse Event|18|||
157106145|NCT01624259|567143009|FG001|Overall Study|Adverse Event|18|||
157106146|NCT01624259|567143008|FG000|Overall Study|Protocol Violation|1|||
157106147|NCT01624259|567143009|FG001|Overall Study|Protocol Violation|2|||
157106148|NCT01624259|567143008|FG000|Overall Study|Withdrawal by Subject|5|||
157106149|NCT01624259|567143009|FG001|Overall Study|Withdrawal by Subject|7|||
157106150|NCT01624259|567143008|FG000|Overall Study|Physician Decision|1|||
157106151|NCT01624259|567143009|FG001|Overall Study|Physician Decision|1|||
157106152|NCT01624259|567143008|FG000|Overall Study|Lost to Follow-up|2|||
157106153|NCT01624259|567143009|FG001|Overall Study|Lost to Follow-up|3|||
157106154|NCT01624259|567143008|FG000|Overall Study|Abnormal laboratory measure|3|||
157106155|NCT01624259|567143009|FG001|Overall Study|Abnormal laboratory measure|0|||
157106156|NCT01298518|567143010|FG000|Overall Study|Withdrawal by Subject|0|||
157106157|NCT01298518|567143011|FG001|Overall Study|Withdrawal by Subject|0|||
157106158|NCT01298518|567143012|FG002|Overall Study|Withdrawal by Subject|1|||
157106159|NCT02273726|567143013|FG000|Overall Study|Death|70|||
157106160|NCT02273726|567143014|FG001|Overall Study|Death|62|||
157106161|NCT02273726|567143013|FG000|Overall Study|Withdrawal by Subject|41|||
157106162|NCT02273726|567143014|FG001|Overall Study|Withdrawal by Subject|29|||
157106163|NCT02273726|567143013|FG000|Overall Study|Kidney transplant|31|||
157106164|NCT02273726|567143014|FG001|Overall Study|Kidney transplant|39|||
157002706|NCT02503202|566760108|FG000|Extension: Month 6 to 24|Physician Decision|1|||
157002707|NCT02503202|566760109|FG001|Extension: Month 6 to 24|Physician Decision|0|||
157002708|NCT02503202|566760110|FG002|Extension: Month 6 to 24|Physician Decision|1|||
157002709|NCT02503202|566760111|FG003|Extension: Month 6 to 24|Physician Decision|3|||
157002710|NCT02503202|566760112|FG004|Extension: Month 6 to 24|Physician Decision|0|||
157002711|NCT02503202|566760108|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
157002712|NCT02503202|566760109|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
157002713|NCT02503202|566760110|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
157002714|NCT02503202|566760111|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
157002715|NCT02503202|566760112|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
157002716|NCT01119950|566760113|FG000|Overall Study|Adverse Event|25|||
157002717|NCT01119950|566760113|FG000|Overall Study|Withdrawal by Subject|9|||
157002718|NCT01119950|566760113|FG000|Overall Study|Protocol Violation|5|||
157002719|NCT01119950|566760113|FG000|Overall Study|Lost to Follow-up|4|||
157002720|NCT01119950|566760113|FG000|Overall Study|Administrative|2|||
157002721|NCT01119950|566760113|FG000|Overall Study|Abnormal lab value|1|||
157002722|NCT01119950|566760113|FG000|Overall Study|Death|1|||
157002723|NCT02613364|566760141|FG000|Overall Study|Other|19|||
157002724|NCT02613364|566760142|FG001|Overall Study|Other|29|||
157002725|NCT02613364|566760143|FG002|Overall Study|Other|17|||
157002726|NCT02613364|566760141|FG000|Overall Study|Too time consuming|21|||
157002727|NCT02613364|566760142|FG001|Overall Study|Too time consuming|26|||
157002728|NCT02613364|566760143|FG002|Overall Study|Too time consuming|26|||
157002729|NCT02613364|566760141|FG000|Overall Study|Withdrawal by Subject|13|||
157002730|NCT02613364|566760142|FG001|Overall Study|Withdrawal by Subject|18|||
157002731|NCT02613364|566760143|FG002|Overall Study|Withdrawal by Subject|17|||
157002732|NCT02613364|566760141|FG000|Overall Study|Medical|12|||
157002733|NCT02613364|566760142|FG001|Overall Study|Medical|13|||
157002734|NCT02613364|566760143|FG002|Overall Study|Medical|9|||
157002735|NCT02613364|566760141|FG000|Overall Study|Disliked Study Procedure|1|||
157002736|NCT02613364|566760142|FG001|Overall Study|Disliked Study Procedure|1|||
157002737|NCT02613364|566760143|FG002|Overall Study|Disliked Study Procedure|4|||
157002738|NCT02613364|566760141|FG000|Overall Study|Disliked Intervention|0|||
157002739|NCT02613364|566760142|FG001|Overall Study|Disliked Intervention|3|||
157002740|NCT02613364|566760143|FG002|Overall Study|Disliked Intervention|3|||
157002741|NCT01909336|566760144|FG000|Overall Study|Lost to Follow-up|4|||
157002742|NCT01909336|566760145|FG001|Overall Study|Lost to Follow-up|2|||
157002743|NCT01909336|566760146|FG002|Overall Study|Lost to Follow-up|2|||
157002744|NCT01909336|566760144|FG000|Overall Study|Physician Decision|0|||
157002745|NCT01909336|566760145|FG001|Overall Study|Physician Decision|1|||
157002746|NCT01909336|566760146|FG002|Overall Study|Physician Decision|1|||
157002747|NCT01235949|566760147|FG000|Primary Phase|Migrated/moved from study area|1|||
157002748|NCT01235949|566760148|FG001|Primary Phase|Migrated/moved from study area|1|||
157002749|NCT01235949|566760149|FG002|Primary Phase|Migrated/moved from study area|0|||
157002750|NCT01235949|566760150|FG003|Primary Phase|Migrated/moved from study area|0|||
157002751|NCT01235949|566760151|FG004|Primary Phase|Migrated/moved from study area|1|||
157002752|NCT01235949|566760152|FG005|Primary Phase|Migrated/moved from study area|2|||
157002753|NCT01235949|566760153|FG006|Primary Phase|Migrated/moved from study area|0|||
157002754|NCT01235949|566760154|FG007|Primary Phase|Migrated/moved from study area|0|||
157002755|NCT01235949|566760155|FG008|Primary Phase|Migrated/moved from study area|0|||
157106165|NCT02273726|567143013|FG000|Overall Study|Physician Decision|30|||
157106166|NCT02273726|567143014|FG001|Overall Study|Physician Decision|15|||
157106167|NCT02273726|567143013|FG000|Overall Study|Adverse Event|27|||
157106168|NCT02273726|567143014|FG001|Overall Study|Adverse Event|9|||
157002756|NCT01235949|566760156|FG009|Primary Phase|Migrated/moved from study area|0|||
157002757|NCT01235949|566760157|FG010|Primary Phase|Migrated/moved from study area|0|||
157002758|NCT01235949|566760158|FG011|Primary Phase|Migrated/moved from study area|0|||
157002759|NCT01235949|566760159|FG012|Primary Phase|Migrated/moved from study area|0|||
157002760|NCT01235949|566760160|FG013|Primary Phase|Migrated/moved from study area|0|||
157106169|NCT02273726|567143013|FG000|Overall Study|Lost to Follow-up|6|||
157106170|NCT02273726|567143014|FG001|Overall Study|Lost to Follow-up|3|||
157106171|NCT02273726|567143013|FG000|Overall Study|Lack of Efficacy|6|||
157106172|NCT02273726|567143014|FG001|Overall Study|Lack of Efficacy|1|||
157106173|NCT02273726|567143013|FG000|Overall Study|Protocol Violation|4|||
157106174|NCT02273726|567143014|FG001|Overall Study|Protocol Violation|0|||
157106175|NCT02273726|567143013|FG000|Overall Study|Other than specified|28|||
157106176|NCT02273726|567143014|FG001|Overall Study|Other than specified|30|||
157106177|NCT01979835|567143015|FG000|Primary Outcome SA Measurment|failed insertion|18|||
157106178|NCT01979835|567143015|FG000|Follow-up|Lost to Follow-up|32|||
157106179|NCT01479829|567143016|FG000|Overall Study|Withdrawal by Subject|8|||
157106180|NCT01479829|567143017|FG001|Overall Study|Withdrawal by Subject|10|||
157106181|NCT01444456|567143022|FG000|Overall Study|Withdrawal by Subject|21|||
157106182|NCT01444456|567143022|FG000|Overall Study|Physician Decision|9|||
157106183|NCT01444456|567143022|FG000|Overall Study|Lost to Follow-up|37|||
157106184|NCT01444456|567143022|FG000|Overall Study|Death|73|||
157106185|NCT01444456|567143022|FG000|Overall Study|Ineligibility determined|23|||
157106186|NCT01444456|567143022|FG000|Overall Study|Other|18|||
157106187|NCT01444456|567143022|FG000|Overall Study|Not treated|104|||
157106188|NCT02142738|567145151|FG000|Overall Study|Adverse Event|13|||
157106189|NCT02142738|567145152|FG001|Overall Study|Adverse Event|9|||
157106190|NCT02142738|567145151|FG000|Overall Study|Death|92|||
157106191|NCT02142738|567145152|FG001|Overall Study|Death|112|||
157106192|NCT02142738|567145151|FG000|Overall Study|Lost to Follow-up|0|||
157106193|NCT02142738|567145152|FG001|Overall Study|Lost to Follow-up|3|||
157106194|NCT02142738|567145151|FG000|Overall Study|Withdrawal by Subject|6|||
157106195|NCT02142738|567145152|FG001|Overall Study|Withdrawal by Subject|7|||
157106196|NCT02142738|567145151|FG000|Overall Study|Follow up ended by sponsor|43|||
157106197|NCT02142738|567145152|FG001|Overall Study|Follow up ended by sponsor|20|||
157106198|NCT01168973|567145154|FG000|Overall Study|Progressive Disease|341|||
157106199|NCT01168973|567145155|FG001|Overall Study|Progressive Disease|429|||
157106200|NCT01168973|567145154|FG000|Overall Study|Adverse Event|94|||
157106201|NCT01168973|567145155|FG001|Overall Study|Adverse Event|55|||
157106202|NCT01168973|567145154|FG000|Overall Study|Withdrawal by Subject|90|||
157106203|NCT01168973|567145155|FG001|Overall Study|Withdrawal by Subject|53|||
157106204|NCT01168973|567145154|FG000|Overall Study|Death|42|||
157106205|NCT01168973|567145155|FG001|Overall Study|Death|45|||
157106206|NCT01168973|567145154|FG000|Overall Study|Physician Decision|37|||
157106207|NCT01168973|567145155|FG001|Overall Study|Physician Decision|19|||
157106208|NCT01168973|567145154|FG000|Overall Study|Sponsor Decision|2|||
157002761|NCT01235949|566760161|FG014|Primary Phase|Migrated/moved from study area|0|||
157002762|NCT01235949|566760162|FG015|Primary Phase|Migrated/moved from study area|0|||
157002763|NCT01235949|566760163|FG016|Primary Phase|Migrated/moved from study area|0|||
157002764|NCT01235949|566760164|FG017|Primary Phase|Migrated/moved from study area|0|||
157002765|NCT01235949|566760147|FG000|Primary Phase|Adverse Event|0|||
157002766|NCT01235949|566760148|FG001|Primary Phase|Adverse Event|0|||
157002767|NCT01235949|566760149|FG002|Primary Phase|Adverse Event|0|||
157002768|NCT01235949|566760150|FG003|Primary Phase|Adverse Event|1|||
157002769|NCT01235949|566760151|FG004|Primary Phase|Adverse Event|0|||
157002770|NCT01235949|566760152|FG005|Primary Phase|Adverse Event|0|||
157002771|NCT01235949|566760153|FG006|Primary Phase|Adverse Event|0|||
157002772|NCT01235949|566760154|FG007|Primary Phase|Adverse Event|0|||
157002773|NCT01235949|566760155|FG008|Primary Phase|Adverse Event|0|||
157002774|NCT01235949|566760156|FG009|Primary Phase|Adverse Event|0|||
157002775|NCT01235949|566760157|FG010|Primary Phase|Adverse Event|0|||
157002776|NCT01235949|566760158|FG011|Primary Phase|Adverse Event|0|||
157002777|NCT01235949|566760159|FG012|Primary Phase|Adverse Event|0|||
157002778|NCT01235949|566760160|FG013|Primary Phase|Adverse Event|0|||
157002779|NCT01235949|566760161|FG014|Primary Phase|Adverse Event|0|||
157002780|NCT01235949|566760162|FG015|Primary Phase|Adverse Event|0|||
157002781|NCT01235949|566760163|FG016|Primary Phase|Adverse Event|0|||
157002782|NCT01235949|566760164|FG017|Primary Phase|Adverse Event|0|||
157002783|NCT01235949|566760147|FG000|Primary Phase|Withdrawal by Subject|3|||
157002784|NCT01235949|566760148|FG001|Primary Phase|Withdrawal by Subject|2|||
157002785|NCT01235949|566760149|FG002|Primary Phase|Withdrawal by Subject|2|||
157002786|NCT01235949|566760150|FG003|Primary Phase|Withdrawal by Subject|0|||
157002787|NCT01235949|566760151|FG004|Primary Phase|Withdrawal by Subject|0|||
157106209|NCT01168973|567145155|FG001|Overall Study|Sponsor Decision|1|||
157002788|NCT01235949|566760152|FG005|Primary Phase|Withdrawal by Subject|3|||
157002789|NCT01235949|566760153|FG006|Primary Phase|Withdrawal by Subject|0|||
157106210|NCT01168973|567145154|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
157106211|NCT01168973|567145155|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
157106212|NCT00388505|567145159|FG000|Overall Study|Adverse Event or Death|43|||
157002790|NCT01235949|566760154|FG007|Primary Phase|Withdrawal by Subject|0|||
157106213|NCT00388505|567145160|FG001|Overall Study|Adverse Event or Death|17|||
157106214|NCT00388505|567145159|FG000|Overall Study|Withdrawal by Subject|24|||
157106215|NCT00388505|567145160|FG001|Overall Study|Withdrawal by Subject|9|||
157106216|NCT00388505|567145159|FG000|Overall Study|Lost to Follow-up|5|||
157106217|NCT00388505|567145160|FG001|Overall Study|Lost to Follow-up|3|||
157106218|NCT00388505|567145159|FG000|Overall Study|Inappropriate Enrollment|0|||
157106219|NCT00388505|567145160|FG001|Overall Study|Inappropriate Enrollment|1|||
157106220|NCT00388505|567145159|FG000|Overall Study|Administrative Reason|1|||
157106221|NCT00388505|567145160|FG001|Overall Study|Administrative Reason|0|||
157106222|NCT00388505|567145159|FG000|Overall Study|Protocol Violation|6|||
157106223|NCT00388505|567145160|FG001|Overall Study|Protocol Violation|5|||
157106224|NCT00388505|567145159|FG000|Overall Study|Unable to classify|4|||
157106225|NCT00388505|567145160|FG001|Overall Study|Unable to classify|3|||
157106226|NCT02163187|567145161|FG000|Overall Study|Device removed|1|||
157106227|NCT02163187|567145162|FG001|Overall Study|Device removed|0|||
157106228|NCT02163187|567145161|FG000|Overall Study|Progressive disease|1|||
157106229|NCT02163187|567145162|FG001|Overall Study|Progressive disease|0|||
157106230|NCT03281668|567145164|FG000|Overall Study|Physician Decision|1|||
157106231|NCT03281668|567145164|FG000|Overall Study|scheduling conflict, family circumstance|2|||
157106232|NCT03281668|567145164|FG000|Overall Study|Withdrawal by Subject|4|||
157106233|NCT03281668|567145164|FG000|Overall Study|Lost to Follow-up|1|||
157106234|NCT02285920|567145166|FG000|Overall Study|Kidney transplantation|2|||
157106235|NCT02285920|567145167|FG001|Overall Study|Kidney transplantation|2|||
157106236|NCT02285920|567145168|FG002|Overall Study|Kidney transplantation|2|||
157106237|NCT02285920|567145169|FG003|Overall Study|Kidney transplantation|0|||
157106238|NCT02285920|567145166|FG000|Overall Study|Change to peritoneal dialysis|0|||
157106239|NCT02285920|567145167|FG001|Overall Study|Change to peritoneal dialysis|0|||
157106240|NCT02285920|567145168|FG002|Overall Study|Change to peritoneal dialysis|1|||
157002791|NCT01235949|566760155|FG008|Primary Phase|Withdrawal by Subject|0|||
157002792|NCT01235949|566760156|FG009|Primary Phase|Withdrawal by Subject|0|||
157002793|NCT01235949|566760157|FG010|Primary Phase|Withdrawal by Subject|0|||
157002794|NCT01235949|566760158|FG011|Primary Phase|Withdrawal by Subject|0|||
157002795|NCT01235949|566760159|FG012|Primary Phase|Withdrawal by Subject|0|||
157002796|NCT01235949|566760160|FG013|Primary Phase|Withdrawal by Subject|0|||
157002797|NCT01235949|566760161|FG014|Primary Phase|Withdrawal by Subject|0|||
157002798|NCT01235949|566760162|FG015|Primary Phase|Withdrawal by Subject|0|||
157002799|NCT01235949|566760163|FG016|Primary Phase|Withdrawal by Subject|0|||
157002800|NCT01235949|566760164|FG017|Primary Phase|Withdrawal by Subject|0|||
157002801|NCT01235949|566760147|FG000|Primary Phase|Lost to Follow-up|0|||
157002802|NCT01235949|566760148|FG001|Primary Phase|Lost to Follow-up|0|||
157002803|NCT01235949|566760149|FG002|Primary Phase|Lost to Follow-up|1|||
157002804|NCT01235949|566760150|FG003|Primary Phase|Lost to Follow-up|1|||
157002805|NCT01235949|566760151|FG004|Primary Phase|Lost to Follow-up|0|||
157002806|NCT01235949|566760152|FG005|Primary Phase|Lost to Follow-up|2|||
157002807|NCT01235949|566760153|FG006|Primary Phase|Lost to Follow-up|0|||
157002808|NCT01235949|566760154|FG007|Primary Phase|Lost to Follow-up|0|||
157002809|NCT01235949|566760155|FG008|Primary Phase|Lost to Follow-up|0|||
157002810|NCT01235949|566760156|FG009|Primary Phase|Lost to Follow-up|0|||
157002811|NCT01235949|566760157|FG010|Primary Phase|Lost to Follow-up|0|||
157002812|NCT01235949|566760158|FG011|Primary Phase|Lost to Follow-up|0|||
157002813|NCT01235949|566760159|FG012|Primary Phase|Lost to Follow-up|0|||
157002814|NCT01235949|566760160|FG013|Primary Phase|Lost to Follow-up|0|||
157002815|NCT01235949|566760161|FG014|Primary Phase|Lost to Follow-up|0|||
157002816|NCT01235949|566760162|FG015|Primary Phase|Lost to Follow-up|0|||
157002817|NCT01235949|566760163|FG016|Primary Phase|Lost to Follow-up|0|||
157002818|NCT01235949|566760164|FG017|Primary Phase|Lost to Follow-up|0|||
157002819|NCT01235949|566760147|FG000|Booster Phase|Migrated/moved from study area|0|||
157002820|NCT01235949|566760148|FG001|Booster Phase|Migrated/moved from study area|0|||
157002821|NCT01235949|566760149|FG002|Booster Phase|Migrated/moved from study area|0|||
157002822|NCT01235949|566760150|FG003|Booster Phase|Migrated/moved from study area|0|||
157002823|NCT01235949|566760151|FG004|Booster Phase|Migrated/moved from study area|0|||
157002824|NCT01235949|566760152|FG005|Booster Phase|Migrated/moved from study area|0|||
157002825|NCT01235949|566760153|FG006|Booster Phase|Migrated/moved from study area|0|||
157002826|NCT01235949|566760154|FG007|Booster Phase|Migrated/moved from study area|0|||
157106241|NCT02285920|567145169|FG003|Overall Study|Change to peritoneal dialysis|0|||
157106242|NCT02285920|567145166|FG000|Overall Study|Transfer to non-participating unit|0|||
157106243|NCT02285920|567145167|FG001|Overall Study|Transfer to non-participating unit|1|||
157106244|NCT02285920|567145168|FG002|Overall Study|Transfer to non-participating unit|0|||
157106245|NCT02285920|567145169|FG003|Overall Study|Transfer to non-participating unit|0|||
157106246|NCT02285920|567145166|FG000|Overall Study|Dialysis discontinuation|0|||
157106247|NCT02285920|567145167|FG001|Overall Study|Dialysis discontinuation|1|||
157106248|NCT02285920|567145168|FG002|Overall Study|Dialysis discontinuation|0|||
157106249|NCT02285920|567145169|FG003|Overall Study|Dialysis discontinuation|0|||
157002827|NCT01235949|566760155|FG008|Booster Phase|Migrated/moved from study area|0|||
157002828|NCT01235949|566760156|FG009|Booster Phase|Migrated/moved from study area|0|||
157002829|NCT01235949|566760157|FG010|Booster Phase|Migrated/moved from study area|0|||
157002830|NCT01235949|566760158|FG011|Booster Phase|Migrated/moved from study area|1|||
157002831|NCT01235949|566760159|FG012|Booster Phase|Migrated/moved from study area|1|||
157002832|NCT01235949|566760160|FG013|Booster Phase|Migrated/moved from study area|0|||
157002833|NCT01235949|566760161|FG014|Booster Phase|Migrated/moved from study area|0|||
157106250|NCT02285920|567145166|FG000|Overall Study|Death|2|||
157106251|NCT02285920|567145167|FG001|Overall Study|Death|0|||
157106252|NCT02285920|567145168|FG002|Overall Study|Death|2|||
157106253|NCT02285920|567145169|FG003|Overall Study|Death|1|||
157106254|NCT01383096|567145172|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
157106255|NCT01383096|567145173|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
157106256|NCT01383096|567145174|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
157106257|NCT01383096|567145172|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
157106258|NCT01383096|567145173|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
157106259|NCT01383096|567145174|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
157106260|NCT01383096|567145172|FG000|Third Intervention (8 Days)|Elevated AST|0|||
157106261|NCT01383096|567145173|FG001|Third Intervention (8 Days)|Elevated AST|1|||
157106262|NCT01383096|567145174|FG002|Third Intervention (8 Days)|Elevated AST|0|||
157106263|NCT01383096|567145172|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
157106264|NCT01383096|567145173|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
157106265|NCT01383096|567145174|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
157106266|NCT01383096|567145172|FG000|Third Intervention (8 Days)|Adverse Event|1|||
157106267|NCT01383096|567145173|FG001|Third Intervention (8 Days)|Adverse Event|0|||
157106268|NCT01383096|567145174|FG002|Third Intervention (8 Days)|Adverse Event|0|||
157106269|NCT01383096|567145172|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
157106270|NCT01383096|567145173|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
157106271|NCT01383096|567145174|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
157106272|NCT01383096|567145172|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
157106273|NCT01383096|567145173|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
157106274|NCT01383096|567145174|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
157106275|NCT01383096|567145172|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
157106276|NCT01383096|567145173|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
157106277|NCT01383096|567145174|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
157106278|NCT01383096|567145172|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
157106279|NCT01383096|567145173|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
157106280|NCT01383096|567145174|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
157106281|NCT01383096|567145172|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
157106282|NCT01383096|567145173|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
157106283|NCT01383096|567145174|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
157106284|NCT01383096|567145172|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
157106285|NCT01383096|567145173|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
157106286|NCT01383096|567145174|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
157106287|NCT00616434|567145179|FG000|Overall Study|Adverse Event|5|||
157106288|NCT00616434|567145180|FG001|Overall Study|Adverse Event|2|||
157106289|NCT00616434|567145179|FG000|Overall Study|Physician Decision|0|||
157106290|NCT00616434|567145180|FG001|Overall Study|Physician Decision|4|||
157106291|NCT00616434|567145179|FG000|Overall Study|Withdrawal by Subject|1|||
157106292|NCT00616434|567145180|FG001|Overall Study|Withdrawal by Subject|1|||
157106293|NCT00616434|567145179|FG000|Overall Study|Protocol deviation|0|||
157106294|NCT00616434|567145180|FG001|Overall Study|Protocol deviation|1|||
157106295|NCT00467779|567145181|FG000|Stage 1|Adverse Event|1|||
157106296|NCT00467779|567145182|FG001|Stage 1|Adverse Event|0|||
157106297|NCT00467779|567145183|FG002|Stage 1|Adverse Event|0|||
157106298|NCT00467779|567145184|FG003|Stage 1|Adverse Event|0|||
157106299|NCT00467779|567145185|FG004|Stage 1|Adverse Event|0|||
157106300|NCT00467779|567145186|FG005|Stage 1|Adverse Event|1|||
157106301|NCT00467779|567145187|FG006|Stage 1|Adverse Event|2|||
157106302|NCT00467779|567145188|FG007|Stage 1|Adverse Event|1|||
157106303|NCT00467779|567145189|FG008|Stage 1|Adverse Event|0|||
157106304|NCT00467779|567145190|FG009|Stage 1|Adverse Event|0|||
157106305|NCT00467779|567145191|FG010|Stage 1|Adverse Event|0|||
157106306|NCT00467779|567145192|FG011|Stage 1|Adverse Event|0|||
157106307|NCT00467779|567145193|FG012|Stage 1|Adverse Event|0|||
157106308|NCT00467779|567145194|FG013|Stage 1|Adverse Event|0|||
157106309|NCT00467779|567145195|FG014|Stage 1|Adverse Event|0|||
157106310|NCT00467779|567145181|FG000|Stage 1|Disease Progression|2|||
157106311|NCT00467779|567145182|FG001|Stage 1|Disease Progression|2|||
157106312|NCT00467779|567145183|FG002|Stage 1|Disease Progression|2|||
157106313|NCT00467779|567145184|FG003|Stage 1|Disease Progression|3|||
157106314|NCT00467779|567145185|FG004|Stage 1|Disease Progression|2|||
157106315|NCT00467779|567145186|FG005|Stage 1|Disease Progression|2|||
157106316|NCT00467779|567145187|FG006|Stage 1|Disease Progression|4|||
157106317|NCT00467779|567145188|FG007|Stage 1|Disease Progression|5|||
157106318|NCT00467779|567145189|FG008|Stage 1|Disease Progression|0|||
157106319|NCT00467779|567145190|FG009|Stage 1|Disease Progression|0|||
157106320|NCT00467779|567145191|FG010|Stage 1|Disease Progression|0|||
157106321|NCT00467779|567145192|FG011|Stage 1|Disease Progression|0|||
157106322|NCT00467779|567145193|FG012|Stage 1|Disease Progression|0|||
157106323|NCT00467779|567145194|FG013|Stage 1|Disease Progression|0|||
157106324|NCT00467779|567145195|FG014|Stage 1|Disease Progression|0|||
157106325|NCT00467779|567145181|FG000|Stage 1|Unspecified Reason|1|||
157106326|NCT00467779|567145182|FG001|Stage 1|Unspecified Reason|0|||
157106327|NCT00467779|567145183|FG002|Stage 1|Unspecified Reason|1|||
157106328|NCT00467779|567145184|FG003|Stage 1|Unspecified Reason|0|||
157106329|NCT00467779|567145185|FG004|Stage 1|Unspecified Reason|1|||
157106330|NCT00467779|567145186|FG005|Stage 1|Unspecified Reason|2|||
157106331|NCT00467779|567145187|FG006|Stage 1|Unspecified Reason|0|||
157106332|NCT00467779|567145188|FG007|Stage 1|Unspecified Reason|0|||
157106333|NCT00467779|567145189|FG008|Stage 1|Unspecified Reason|0|||
157106334|NCT00467779|567145190|FG009|Stage 1|Unspecified Reason|0|||
157106335|NCT00467779|567145191|FG010|Stage 1|Unspecified Reason|0|||
157106336|NCT00467779|567145192|FG011|Stage 1|Unspecified Reason|0|||
157106337|NCT00467779|567145193|FG012|Stage 1|Unspecified Reason|0|||
157106338|NCT00467779|567145194|FG013|Stage 1|Unspecified Reason|0|||
157106339|NCT00467779|567145195|FG014|Stage 1|Unspecified Reason|0|||
157106340|NCT00467779|567145181|FG000|Stage 1|Physician Decision|0|||
157106341|NCT00467779|567145182|FG001|Stage 1|Physician Decision|1|||
157106342|NCT00467779|567145183|FG002|Stage 1|Physician Decision|0|||
157106343|NCT00467779|567145184|FG003|Stage 1|Physician Decision|0|||
157106344|NCT00467779|567145185|FG004|Stage 1|Physician Decision|0|||
157106345|NCT00467779|567145186|FG005|Stage 1|Physician Decision|0|||
157106346|NCT00467779|567145187|FG006|Stage 1|Physician Decision|0|||
157106347|NCT00467779|567145188|FG007|Stage 1|Physician Decision|0|||
157106348|NCT00467779|567145189|FG008|Stage 1|Physician Decision|0|||
157106349|NCT00467779|567145190|FG009|Stage 1|Physician Decision|0|||
157106350|NCT00467779|567145191|FG010|Stage 1|Physician Decision|0|||
157106351|NCT00467779|567145192|FG011|Stage 1|Physician Decision|0|||
157106352|NCT00467779|567145193|FG012|Stage 1|Physician Decision|0|||
157106353|NCT00467779|567145194|FG013|Stage 1|Physician Decision|0|||
157106354|NCT00467779|567145195|FG014|Stage 1|Physician Decision|0|||
157106355|NCT00467779|567145181|FG000|Stage 1|Withdrawal by Subject|0|||
157106356|NCT00467779|567145182|FG001|Stage 1|Withdrawal by Subject|0|||
157106357|NCT00467779|567145183|FG002|Stage 1|Withdrawal by Subject|0|||
157106358|NCT00467779|567145184|FG003|Stage 1|Withdrawal by Subject|0|||
157106359|NCT00467779|567145185|FG004|Stage 1|Withdrawal by Subject|0|||
157106360|NCT00467779|567145186|FG005|Stage 1|Withdrawal by Subject|0|||
157106361|NCT00467779|567145187|FG006|Stage 1|Withdrawal by Subject|1|||
157106362|NCT00467779|567145188|FG007|Stage 1|Withdrawal by Subject|1|||
157106363|NCT00467779|567145189|FG008|Stage 1|Withdrawal by Subject|0|||
157106364|NCT00467779|567145190|FG009|Stage 1|Withdrawal by Subject|0|||
157106365|NCT00467779|567145191|FG010|Stage 1|Withdrawal by Subject|0|||
157106366|NCT00467779|567145192|FG011|Stage 1|Withdrawal by Subject|0|||
157106367|NCT00467779|567145193|FG012|Stage 1|Withdrawal by Subject|0|||
157106368|NCT00467779|567145194|FG013|Stage 1|Withdrawal by Subject|0|||
157106369|NCT00467779|567145195|FG014|Stage 1|Withdrawal by Subject|0|||
157106370|NCT00467779|567145181|FG000|Stage 1A|Adverse Event|0|||
157106371|NCT00467779|567145182|FG001|Stage 1A|Adverse Event|0|||
157106372|NCT00467779|567145183|FG002|Stage 1A|Adverse Event|0|||
157106373|NCT00467779|567145184|FG003|Stage 1A|Adverse Event|0|||
157106374|NCT00467779|567145185|FG004|Stage 1A|Adverse Event|0|||
157106375|NCT00467779|567145186|FG005|Stage 1A|Adverse Event|0|||
156761961|NCT05616013|565879948|FG004|Overall Study|Non-compliance with study requirements|0|||
157106376|NCT00467779|567145187|FG006|Stage 1A|Adverse Event|0|||
157106377|NCT00467779|567145188|FG007|Stage 1A|Adverse Event|0|||
157106378|NCT00467779|567145189|FG008|Stage 1A|Adverse Event|0|||
157106379|NCT00467779|567145190|FG009|Stage 1A|Adverse Event|0|||
157106380|NCT00467779|567145191|FG010|Stage 1A|Adverse Event|0|||
157106381|NCT00467779|567145192|FG011|Stage 1A|Adverse Event|0|||
157106382|NCT00467779|567145193|FG012|Stage 1A|Adverse Event|1|||
157106383|NCT00467779|567145194|FG013|Stage 1A|Adverse Event|0|||
157106384|NCT00467779|567145195|FG014|Stage 1A|Adverse Event|0|||
157106385|NCT00467779|567145181|FG000|Stage 1A|Death|0|||
157106386|NCT00467779|567145182|FG001|Stage 1A|Death|0|||
157106387|NCT00467779|567145183|FG002|Stage 1A|Death|0|||
157106388|NCT00467779|567145184|FG003|Stage 1A|Death|0|||
157106389|NCT00467779|567145185|FG004|Stage 1A|Death|0|||
157106390|NCT00467779|567145186|FG005|Stage 1A|Death|0|||
157106391|NCT00467779|567145187|FG006|Stage 1A|Death|0|||
157106392|NCT00467779|567145188|FG007|Stage 1A|Death|0|||
157106393|NCT00467779|567145189|FG008|Stage 1A|Death|0|||
157106394|NCT00467779|567145190|FG009|Stage 1A|Death|0|||
157106395|NCT00467779|567145191|FG010|Stage 1A|Death|0|||
157106396|NCT00467779|567145192|FG011|Stage 1A|Death|1|||
157106397|NCT00467779|567145193|FG012|Stage 1A|Death|1|||
157106398|NCT00467779|567145194|FG013|Stage 1A|Death|0|||
157106399|NCT00467779|567145195|FG014|Stage 1A|Death|0|||
157106400|NCT00467779|567145181|FG000|Stage 1A|Disease Progression|0|||
157106401|NCT00467779|567145182|FG001|Stage 1A|Disease Progression|0|||
157106402|NCT00467779|567145183|FG002|Stage 1A|Disease Progression|0|||
157106403|NCT00467779|567145184|FG003|Stage 1A|Disease Progression|0|||
157106404|NCT00467779|567145185|FG004|Stage 1A|Disease Progression|0|||
157106405|NCT00467779|567145186|FG005|Stage 1A|Disease Progression|0|||
157106406|NCT00467779|567145187|FG006|Stage 1A|Disease Progression|0|||
157106407|NCT00467779|567145188|FG007|Stage 1A|Disease Progression|0|||
157106408|NCT00467779|567145189|FG008|Stage 1A|Disease Progression|0|||
157106409|NCT00467779|567145190|FG009|Stage 1A|Disease Progression|2|||
157106410|NCT00467779|567145191|FG010|Stage 1A|Disease Progression|2|||
157106411|NCT00467779|567145192|FG011|Stage 1A|Disease Progression|5|||
157106412|NCT00467779|567145193|FG012|Stage 1A|Disease Progression|2|||
157106413|NCT00467779|567145194|FG013|Stage 1A|Disease Progression|0|||
157106414|NCT00467779|567145195|FG014|Stage 1A|Disease Progression|0|||
157106415|NCT00467779|567145181|FG000|Stage 1A|Physician Decision|0|||
157106416|NCT00467779|567145182|FG001|Stage 1A|Physician Decision|0|||
157106417|NCT00467779|567145183|FG002|Stage 1A|Physician Decision|0|||
157106418|NCT00467779|567145184|FG003|Stage 1A|Physician Decision|0|||
157106419|NCT00467779|567145185|FG004|Stage 1A|Physician Decision|0|||
157106420|NCT00467779|567145186|FG005|Stage 1A|Physician Decision|0|||
157106421|NCT00467779|567145187|FG006|Stage 1A|Physician Decision|0|||
157106422|NCT00467779|567145188|FG007|Stage 1A|Physician Decision|0|||
157106423|NCT00467779|567145189|FG008|Stage 1A|Physician Decision|0|||
157106424|NCT00467779|567145190|FG009|Stage 1A|Physician Decision|1|||
157106425|NCT00467779|567145191|FG010|Stage 1A|Physician Decision|0|||
157106426|NCT00467779|567145192|FG011|Stage 1A|Physician Decision|0|||
157106427|NCT00467779|567145193|FG012|Stage 1A|Physician Decision|0|||
157106428|NCT00467779|567145194|FG013|Stage 1A|Physician Decision|0|||
157106429|NCT00467779|567145195|FG014|Stage 1A|Physician Decision|0|||
157106430|NCT00467779|567145181|FG000|Stage 1A|Withdrawal by Subject|0|||
157106431|NCT00467779|567145182|FG001|Stage 1A|Withdrawal by Subject|0|||
157106432|NCT00467779|567145183|FG002|Stage 1A|Withdrawal by Subject|0|||
157106433|NCT00467779|567145184|FG003|Stage 1A|Withdrawal by Subject|0|||
157106434|NCT00467779|567145185|FG004|Stage 1A|Withdrawal by Subject|0|||
157106435|NCT00467779|567145186|FG005|Stage 1A|Withdrawal by Subject|0|||
157106436|NCT00467779|567145187|FG006|Stage 1A|Withdrawal by Subject|0|||
157106437|NCT00467779|567145188|FG007|Stage 1A|Withdrawal by Subject|0|||
157106438|NCT00467779|567145189|FG008|Stage 1A|Withdrawal by Subject|0|||
157106439|NCT00467779|567145190|FG009|Stage 1A|Withdrawal by Subject|0|||
157106440|NCT00467779|567145191|FG010|Stage 1A|Withdrawal by Subject|1|||
157106441|NCT00467779|567145192|FG011|Stage 1A|Withdrawal by Subject|1|||
157106442|NCT00467779|567145193|FG012|Stage 1A|Withdrawal by Subject|1|||
157106443|NCT00467779|567145194|FG013|Stage 1A|Withdrawal by Subject|0|||
157106444|NCT00467779|567145195|FG014|Stage 1A|Withdrawal by Subject|0|||
157106445|NCT00467779|567145181|FG000|Stage 1A|Unspecified Reason|0|||
157106446|NCT00467779|567145182|FG001|Stage 1A|Unspecified Reason|0|||
157106447|NCT00467779|567145183|FG002|Stage 1A|Unspecified Reason|0|||
157106448|NCT00467779|567145184|FG003|Stage 1A|Unspecified Reason|0|||
157106449|NCT00467779|567145185|FG004|Stage 1A|Unspecified Reason|0|||
157106450|NCT00467779|567145186|FG005|Stage 1A|Unspecified Reason|0|||
157106451|NCT00467779|567145187|FG006|Stage 1A|Unspecified Reason|0|||
157106452|NCT00467779|567145188|FG007|Stage 1A|Unspecified Reason|0|||
157106453|NCT00467779|567145189|FG008|Stage 1A|Unspecified Reason|0|||
157106454|NCT00467779|567145190|FG009|Stage 1A|Unspecified Reason|0|||
157106455|NCT00467779|567145191|FG010|Stage 1A|Unspecified Reason|0|||
157106456|NCT00467779|567145192|FG011|Stage 1A|Unspecified Reason|1|||
157106457|NCT00467779|567145193|FG012|Stage 1A|Unspecified Reason|1|||
157106458|NCT00467779|567145194|FG013|Stage 1A|Unspecified Reason|0|||
157106459|NCT00467779|567145195|FG014|Stage 1A|Unspecified Reason|0|||
157106460|NCT00467779|567145181|FG000|Stage 2|Adverse Event|0|||
157106461|NCT00467779|567145182|FG001|Stage 2|Adverse Event|0|||
157106462|NCT00467779|567145183|FG002|Stage 2|Adverse Event|0|||
157106463|NCT00467779|567145184|FG003|Stage 2|Adverse Event|0|||
157106464|NCT00467779|567145185|FG004|Stage 2|Adverse Event|0|||
157106465|NCT00467779|567145186|FG005|Stage 2|Adverse Event|0|||
157106466|NCT00467779|567145187|FG006|Stage 2|Adverse Event|0|||
157106467|NCT00467779|567145188|FG007|Stage 2|Adverse Event|0|||
157106468|NCT00467779|567145189|FG008|Stage 2|Adverse Event|1|||
157106469|NCT00467779|567145190|FG009|Stage 2|Adverse Event|0|||
157106470|NCT00467779|567145191|FG010|Stage 2|Adverse Event|0|||
157106471|NCT00467779|567145192|FG011|Stage 2|Adverse Event|0|||
157106472|NCT00467779|567145193|FG012|Stage 2|Adverse Event|0|||
157106473|NCT00467779|567145194|FG013|Stage 2|Adverse Event|0|||
157106474|NCT00467779|567145195|FG014|Stage 2|Adverse Event|0|||
157106475|NCT00467779|567145181|FG000|Stage 2|Death|0|||
157106476|NCT00467779|567145182|FG001|Stage 2|Death|0|||
157106477|NCT00467779|567145183|FG002|Stage 2|Death|0|||
157106478|NCT00467779|567145184|FG003|Stage 2|Death|0|||
157106479|NCT00467779|567145185|FG004|Stage 2|Death|0|||
157106480|NCT00467779|567145186|FG005|Stage 2|Death|0|||
157106481|NCT00467779|567145187|FG006|Stage 2|Death|0|||
157106482|NCT00467779|567145188|FG007|Stage 2|Death|0|||
157106483|NCT00467779|567145189|FG008|Stage 2|Death|1|||
157106484|NCT00467779|567145190|FG009|Stage 2|Death|0|||
157106485|NCT00467779|567145191|FG010|Stage 2|Death|0|||
157106486|NCT00467779|567145192|FG011|Stage 2|Death|0|||
157106487|NCT00467779|567145193|FG012|Stage 2|Death|0|||
157106488|NCT00467779|567145194|FG013|Stage 2|Death|0|||
157106489|NCT00467779|567145195|FG014|Stage 2|Death|0|||
157106490|NCT00467779|567145181|FG000|Stage 2|Disease Progression|0|||
157106491|NCT00467779|567145182|FG001|Stage 2|Disease Progression|0|||
157106492|NCT00467779|567145183|FG002|Stage 2|Disease Progression|0|||
157106493|NCT00467779|567145184|FG003|Stage 2|Disease Progression|0|||
157106494|NCT00467779|567145185|FG004|Stage 2|Disease Progression|0|||
157106495|NCT00467779|567145186|FG005|Stage 2|Disease Progression|0|||
157106496|NCT00467779|567145187|FG006|Stage 2|Disease Progression|0|||
157106497|NCT00467779|567145188|FG007|Stage 2|Disease Progression|0|||
157106498|NCT00467779|567145189|FG008|Stage 2|Disease Progression|16|||
157106499|NCT00467779|567145190|FG009|Stage 2|Disease Progression|0|||
157106500|NCT00467779|567145191|FG010|Stage 2|Disease Progression|0|||
157106501|NCT00467779|567145192|FG011|Stage 2|Disease Progression|0|||
157106502|NCT00467779|567145193|FG012|Stage 2|Disease Progression|0|||
157106503|NCT00467779|567145194|FG013|Stage 2|Disease Progression|0|||
157106504|NCT00467779|567145195|FG014|Stage 2|Disease Progression|0|||
157106505|NCT00467779|567145181|FG000|Stage 2|Unspecified Reason|0|||
157106506|NCT00467779|567145182|FG001|Stage 2|Unspecified Reason|0|||
157106507|NCT00467779|567145183|FG002|Stage 2|Unspecified Reason|0|||
157106508|NCT00467779|567145184|FG003|Stage 2|Unspecified Reason|0|||
157106509|NCT00467779|567145185|FG004|Stage 2|Unspecified Reason|0|||
157106510|NCT00467779|567145186|FG005|Stage 2|Unspecified Reason|0|||
157106511|NCT00467779|567145187|FG006|Stage 2|Unspecified Reason|0|||
157106512|NCT00467779|567145188|FG007|Stage 2|Unspecified Reason|0|||
157106513|NCT00467779|567145189|FG008|Stage 2|Unspecified Reason|3|||
157106514|NCT00467779|567145190|FG009|Stage 2|Unspecified Reason|0|||
157106515|NCT00467779|567145191|FG010|Stage 2|Unspecified Reason|0|||
157106516|NCT00467779|567145192|FG011|Stage 2|Unspecified Reason|0|||
157106517|NCT00467779|567145193|FG012|Stage 2|Unspecified Reason|0|||
157106518|NCT00467779|567145194|FG013|Stage 2|Unspecified Reason|0|||
157106519|NCT00467779|567145195|FG014|Stage 2|Unspecified Reason|0|||
157106520|NCT00467779|567145181|FG000|Stage 2A|Adverse Event|0|||
157106521|NCT00467779|567145182|FG001|Stage 2A|Adverse Event|0|||
157106522|NCT00467779|567145183|FG002|Stage 2A|Adverse Event|0|||
157106523|NCT00467779|567145184|FG003|Stage 2A|Adverse Event|0|||
157106524|NCT00467779|567145185|FG004|Stage 2A|Adverse Event|0|||
157106525|NCT00467779|567145186|FG005|Stage 2A|Adverse Event|0|||
157106526|NCT00467779|567145187|FG006|Stage 2A|Adverse Event|0|||
157106527|NCT00467779|567145188|FG007|Stage 2A|Adverse Event|0|||
157106528|NCT00467779|567145189|FG008|Stage 2A|Adverse Event|0|||
157106529|NCT00467779|567145190|FG009|Stage 2A|Adverse Event|0|||
157106530|NCT00467779|567145191|FG010|Stage 2A|Adverse Event|0|||
157106531|NCT00467779|567145192|FG011|Stage 2A|Adverse Event|0|||
157106532|NCT00467779|567145193|FG012|Stage 2A|Adverse Event|0|||
157106533|NCT00467779|567145194|FG013|Stage 2A|Adverse Event|2|||
157106534|NCT00467779|567145195|FG014|Stage 2A|Adverse Event|0|||
157106535|NCT00467779|567145181|FG000|Stage 2A|Death|0|||
157106536|NCT00467779|567145182|FG001|Stage 2A|Death|0|||
157106537|NCT00467779|567145183|FG002|Stage 2A|Death|0|||
157106538|NCT00467779|567145184|FG003|Stage 2A|Death|0|||
157106539|NCT00467779|567145185|FG004|Stage 2A|Death|0|||
157106540|NCT00467779|567145186|FG005|Stage 2A|Death|0|||
157106541|NCT00467779|567145187|FG006|Stage 2A|Death|0|||
157106542|NCT00467779|567145188|FG007|Stage 2A|Death|0|||
157106543|NCT00467779|567145189|FG008|Stage 2A|Death|0|||
157106544|NCT00467779|567145190|FG009|Stage 2A|Death|0|||
157106545|NCT00467779|567145191|FG010|Stage 2A|Death|0|||
157106546|NCT00467779|567145192|FG011|Stage 2A|Death|0|||
157106547|NCT00467779|567145193|FG012|Stage 2A|Death|0|||
157106548|NCT00467779|567145194|FG013|Stage 2A|Death|1|||
157106549|NCT00467779|567145195|FG014|Stage 2A|Death|0|||
157106550|NCT00467779|567145181|FG000|Stage 2A|Disease Progression|0|||
157106551|NCT00467779|567145182|FG001|Stage 2A|Disease Progression|0|||
157106552|NCT00467779|567145183|FG002|Stage 2A|Disease Progression|0|||
157106553|NCT00467779|567145184|FG003|Stage 2A|Disease Progression|0|||
157106554|NCT00467779|567145185|FG004|Stage 2A|Disease Progression|0|||
157106555|NCT00467779|567145186|FG005|Stage 2A|Disease Progression|0|||
157106556|NCT00467779|567145187|FG006|Stage 2A|Disease Progression|0|||
157106557|NCT00467779|567145188|FG007|Stage 2A|Disease Progression|0|||
157106558|NCT00467779|567145189|FG008|Stage 2A|Disease Progression|0|||
157106559|NCT00467779|567145190|FG009|Stage 2A|Disease Progression|0|||
157106560|NCT00467779|567145191|FG010|Stage 2A|Disease Progression|0|||
157106561|NCT00467779|567145192|FG011|Stage 2A|Disease Progression|0|||
157106562|NCT00467779|567145193|FG012|Stage 2A|Disease Progression|0|||
157106563|NCT00467779|567145194|FG013|Stage 2A|Disease Progression|10|||
157106564|NCT00467779|567145195|FG014|Stage 2A|Disease Progression|0|||
157106565|NCT00467779|567145181|FG000|Stage 2A|Unspecified Reason|0|||
157002834|NCT01235949|566760162|FG015|Booster Phase|Migrated/moved from study area|0|||
157002835|NCT01235949|566760163|FG016|Booster Phase|Migrated/moved from study area|0|||
157002836|NCT01235949|566760164|FG017|Booster Phase|Migrated/moved from study area|1|||
157002837|NCT01235949|566760147|FG000|Booster Phase|Adverse Event|0|||
157002838|NCT01235949|566760148|FG001|Booster Phase|Adverse Event|0|||
157002839|NCT01235949|566760149|FG002|Booster Phase|Adverse Event|0|||
157002840|NCT01235949|566760150|FG003|Booster Phase|Adverse Event|0|||
157002841|NCT01235949|566760151|FG004|Booster Phase|Adverse Event|0|||
157002842|NCT01235949|566760152|FG005|Booster Phase|Adverse Event|0|||
157002843|NCT01235949|566760153|FG006|Booster Phase|Adverse Event|0|||
157002844|NCT01235949|566760154|FG007|Booster Phase|Adverse Event|0|||
157002845|NCT01235949|566760155|FG008|Booster Phase|Adverse Event|0|||
157002846|NCT01235949|566760156|FG009|Booster Phase|Adverse Event|0|||
157002847|NCT01235949|566760157|FG010|Booster Phase|Adverse Event|0|||
157002848|NCT01235949|566760158|FG011|Booster Phase|Adverse Event|0|||
157002849|NCT01235949|566760159|FG012|Booster Phase|Adverse Event|0|||
157002850|NCT01235949|566760160|FG013|Booster Phase|Adverse Event|0|||
157002851|NCT01235949|566760161|FG014|Booster Phase|Adverse Event|0|||
157002852|NCT01235949|566760162|FG015|Booster Phase|Adverse Event|1|||
157002853|NCT01235949|566760163|FG016|Booster Phase|Adverse Event|0|||
157002854|NCT01235949|566760164|FG017|Booster Phase|Adverse Event|0|||
157002855|NCT01235949|566760147|FG000|Booster Phase|Withdrawal by Subject|0|||
157002856|NCT01235949|566760148|FG001|Booster Phase|Withdrawal by Subject|0|||
157002857|NCT01235949|566760149|FG002|Booster Phase|Withdrawal by Subject|0|||
157002858|NCT01235949|566760150|FG003|Booster Phase|Withdrawal by Subject|0|||
157002859|NCT01235949|566760151|FG004|Booster Phase|Withdrawal by Subject|0|||
157002860|NCT01235949|566760152|FG005|Booster Phase|Withdrawal by Subject|0|||
157002861|NCT01235949|566760153|FG006|Booster Phase|Withdrawal by Subject|0|||
157002862|NCT01235949|566760154|FG007|Booster Phase|Withdrawal by Subject|1|||
157002863|NCT01235949|566760155|FG008|Booster Phase|Withdrawal by Subject|1|||
157002864|NCT01235949|566760156|FG009|Booster Phase|Withdrawal by Subject|0|||
157002865|NCT01235949|566760157|FG010|Booster Phase|Withdrawal by Subject|1|||
157002866|NCT01235949|566760158|FG011|Booster Phase|Withdrawal by Subject|1|||
157002867|NCT01235949|566760159|FG012|Booster Phase|Withdrawal by Subject|2|||
157002868|NCT01235949|566760160|FG013|Booster Phase|Withdrawal by Subject|0|||
157002869|NCT01235949|566760161|FG014|Booster Phase|Withdrawal by Subject|2|||
157002870|NCT01235949|566760162|FG015|Booster Phase|Withdrawal by Subject|0|||
157002871|NCT01235949|566760163|FG016|Booster Phase|Withdrawal by Subject|0|||
157002872|NCT01235949|566760164|FG017|Booster Phase|Withdrawal by Subject|0|||
157002873|NCT01235949|566760147|FG000|Booster Phase|Lost to Follow-up|0|||
157002874|NCT01235949|566760148|FG001|Booster Phase|Lost to Follow-up|0|||
157002875|NCT01235949|566760149|FG002|Booster Phase|Lost to Follow-up|0|||
157002876|NCT01235949|566760150|FG003|Booster Phase|Lost to Follow-up|0|||
157002877|NCT01235949|566760151|FG004|Booster Phase|Lost to Follow-up|0|||
157002878|NCT01235949|566760152|FG005|Booster Phase|Lost to Follow-up|0|||
157002879|NCT01235949|566760153|FG006|Booster Phase|Lost to Follow-up|0|||
157002880|NCT01235949|566760154|FG007|Booster Phase|Lost to Follow-up|0|||
157002881|NCT01235949|566760155|FG008|Booster Phase|Lost to Follow-up|1|||
157002882|NCT01235949|566760156|FG009|Booster Phase|Lost to Follow-up|1|||
157002883|NCT01235949|566760157|FG010|Booster Phase|Lost to Follow-up|1|||
157002884|NCT01235949|566760158|FG011|Booster Phase|Lost to Follow-up|1|||
157106566|NCT00467779|567145182|FG001|Stage 2A|Unspecified Reason|0|||
157002885|NCT01235949|566760159|FG012|Booster Phase|Lost to Follow-up|0|||
157002886|NCT01235949|566760160|FG013|Booster Phase|Lost to Follow-up|0|||
157002887|NCT01235949|566760161|FG014|Booster Phase|Lost to Follow-up|0|||
157002888|NCT01235949|566760162|FG015|Booster Phase|Lost to Follow-up|0|||
157002889|NCT01235949|566760163|FG016|Booster Phase|Lost to Follow-up|0|||
157002890|NCT01235949|566760164|FG017|Booster Phase|Lost to Follow-up|1|||
157002891|NCT00436644|566760165|FG000|Overall Study|Adverse Event|2|||
157106567|NCT00467779|567145183|FG002|Stage 2A|Unspecified Reason|0|||
157106568|NCT00467779|567145184|FG003|Stage 2A|Unspecified Reason|0|||
157106569|NCT00467779|567145185|FG004|Stage 2A|Unspecified Reason|0|||
157002892|NCT00436644|566760165|FG000|Overall Study|Death|1|||
157002893|NCT04364269|566760170|FG000|Overall Study|Adverse Event|1|||
157002894|NCT04364269|566760171|FG001|Overall Study|Adverse Event|0|||
157002895|NCT04364269|566760172|FG002|Overall Study|Adverse Event|0|||
157002896|NCT04364269|566760170|FG000|Overall Study|Withdrawal by Subject|0|||
157002897|NCT04364269|566760171|FG001|Overall Study|Withdrawal by Subject|1|||
157002898|NCT04364269|566760172|FG002|Overall Study|Withdrawal by Subject|0|||
157002899|NCT02026258|566760173|FG000|Randomized|Did not start treatment|2|||
157002900|NCT02026258|566760174|FG001|Randomized|Did not start treatment|1|||
157002901|NCT02026258|566760173|FG000|Randomized|Change in treatment plan|1|||
157002902|NCT02026258|566760174|FG001|Randomized|Change in treatment plan|0|||
157002903|NCT02026258|566760173|FG000|Randomized|Presence of periodontal disease|1|||
157002904|NCT02026258|566760174|FG001|Randomized|Presence of periodontal disease|1|||
157002905|NCT02026258|566760173|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
157002906|NCT02026258|566760174|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
157002907|NCT02026258|566760173|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
157002908|NCT02026258|566760174|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
157002909|NCT00371566|566760177|FG000|Treatment Phase|Withdrawal by Subject|0|||
157002910|NCT00371566|566760178|FG001|Treatment Phase|Withdrawal by Subject|1|||
157002911|NCT00371566|566760177|FG000|Treatment Phase|Adverse Event|0|||
157002912|NCT00371566|566760178|FG001|Treatment Phase|Adverse Event|1|||
157002913|NCT00371566|566760177|FG000|Treatment Phase|Protocol Violation|0|||
157002914|NCT00371566|566760178|FG001|Treatment Phase|Protocol Violation|1|||
157002915|NCT00371566|566760177|FG000|Chemoradiation Phase|Physician Decision|2|||
157002916|NCT00371566|566760178|FG001|Chemoradiation Phase|Physician Decision|0|||
157002917|NCT00371566|566760177|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
157002918|NCT00371566|566760178|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
157002919|NCT00371566|566760177|FG000|Chemoradiation Phase|Non compliant|0|||
157002920|NCT00371566|566760178|FG001|Chemoradiation Phase|Non compliant|1|||
157002921|NCT00371566|566760177|FG000|Chemoradiation Phase|Progressive Disease|1|||
157002922|NCT00371566|566760178|FG001|Chemoradiation Phase|Progressive Disease|1|||
157002923|NCT00371566|566760177|FG000|Chemoradiation Phase|Death|2|||
157002924|NCT00371566|566760178|FG001|Chemoradiation Phase|Death|0|||
157002925|NCT00371566|566760177|FG000|Follow Up Phase|Death|0|||
157002926|NCT00371566|566760178|FG001|Follow Up Phase|Death|5|||
157002927|NCT00371566|566760177|FG000|Follow Up Phase|Disease progression|1|||
157002928|NCT00371566|566760178|FG001|Follow Up Phase|Disease progression|0|||
157002929|NCT00371566|566760177|FG000|Follow Up Phase|Withdrawal by Subject|0|||
157002930|NCT00371566|566760178|FG001|Follow Up Phase|Withdrawal by Subject|1|||
157002931|NCT00371566|566760177|FG000|Follow Up Phase|Physician Decision|1|||
157002932|NCT00371566|566760178|FG001|Follow Up Phase|Physician Decision|1|||
157002933|NCT00371566|566760177|FG000|Follow Up Phase|Lost to Follow-up|1|||
157002934|NCT00371566|566760178|FG001|Follow Up Phase|Lost to Follow-up|0|||
157106570|NCT00467779|567145186|FG005|Stage 2A|Unspecified Reason|0|||
157106571|NCT00467779|567145187|FG006|Stage 2A|Unspecified Reason|0|||
157106572|NCT00467779|567145188|FG007|Stage 2A|Unspecified Reason|0|||
157106573|NCT00467779|567145189|FG008|Stage 2A|Unspecified Reason|0|||
157106574|NCT00467779|567145190|FG009|Stage 2A|Unspecified Reason|0|||
157106575|NCT00467779|567145191|FG010|Stage 2A|Unspecified Reason|0|||
157106576|NCT00467779|567145192|FG011|Stage 2A|Unspecified Reason|0|||
157106577|NCT00467779|567145193|FG012|Stage 2A|Unspecified Reason|0|||
157106578|NCT00467779|567145194|FG013|Stage 2A|Unspecified Reason|7|||
157106579|NCT00467779|567145195|FG014|Stage 2A|Unspecified Reason|0|||
157002935|NCT02534350|566760179|FG000|Overall Study|Randomized But Not Treated|1|||
157002936|NCT02534350|566760180|FG001|Overall Study|Randomized But Not Treated|0|||
157002937|NCT02534350|566760179|FG000|Overall Study|Protocol Violation|1|||
157002938|NCT02534350|566760180|FG001|Overall Study|Protocol Violation|0|||
157002939|NCT02534350|566760179|FG000|Overall Study|Withdrew Consent|2|||
157002940|NCT02534350|566760180|FG001|Overall Study|Withdrew Consent|0|||
157002941|NCT02341625|566760185|FG000|Overall Study|Disease Progression|2|||
157002942|NCT02341625|566760186|FG001|Overall Study|Disease Progression|2|||
157106580|NCT00467779|567145181|FG000|Stage 2A|Withdrawal by Subject|0|||
157002943|NCT02341625|566760187|FG002|Overall Study|Disease Progression|3|||
157002944|NCT02341625|566760188|FG003|Overall Study|Disease Progression|6|||
157002945|NCT02341625|566760189|FG004|Overall Study|Disease Progression|7|||
157002946|NCT02341625|566760190|FG005|Overall Study|Disease Progression|7|||
157002947|NCT02341625|566760191|FG006|Overall Study|Disease Progression|28|||
157002948|NCT02341625|566760192|FG007|Overall Study|Disease Progression|5|||
157002949|NCT02341625|566760193|FG008|Overall Study|Disease Progression|4|||
157002950|NCT02341625|566760194|FG009|Overall Study|Disease Progression|19|||
157002951|NCT02341625|566760185|FG000|Overall Study|Study Drug Toxicity|0|||
157002952|NCT02341625|566760186|FG001|Overall Study|Study Drug Toxicity|0|||
157002953|NCT02341625|566760187|FG002|Overall Study|Study Drug Toxicity|0|||
157002954|NCT02341625|566760188|FG003|Overall Study|Study Drug Toxicity|1|||
157002955|NCT02341625|566760189|FG004|Overall Study|Study Drug Toxicity|0|||
157002956|NCT02341625|566760190|FG005|Overall Study|Study Drug Toxicity|3|||
157002957|NCT02341625|566760191|FG006|Overall Study|Study Drug Toxicity|10|||
157002958|NCT02341625|566760192|FG007|Overall Study|Study Drug Toxicity|0|||
157002959|NCT02341625|566760193|FG008|Overall Study|Study Drug Toxicity|0|||
157002960|NCT02341625|566760194|FG009|Overall Study|Study Drug Toxicity|3|||
157002961|NCT02341625|566760185|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002962|NCT02341625|566760186|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002963|NCT02341625|566760187|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002964|NCT02341625|566760188|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002965|NCT02341625|566760189|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002966|NCT02341625|566760190|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002967|NCT02341625|566760191|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
157002968|NCT02341625|566760192|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
157002969|NCT02341625|566760193|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157002970|NCT02341625|566760194|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
157002971|NCT02341625|566760185|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002972|NCT02341625|566760186|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002973|NCT02341625|566760187|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002974|NCT02341625|566760188|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002975|NCT02341625|566760189|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002976|NCT02341625|566760190|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002977|NCT02341625|566760191|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
157002978|NCT02341625|566760192|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
157002979|NCT02341625|566760193|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002980|NCT02341625|566760194|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
157002981|NCT02341625|566760185|FG000|Overall Study|Participant Withdrew Consent|0|||
157002982|NCT02341625|566760186|FG001|Overall Study|Participant Withdrew Consent|0|||
157002983|NCT02341625|566760187|FG002|Overall Study|Participant Withdrew Consent|0|||
157002984|NCT02341625|566760188|FG003|Overall Study|Participant Withdrew Consent|1|||
157002985|NCT02341625|566760189|FG004|Overall Study|Participant Withdrew Consent|0|||
157002986|NCT02341625|566760190|FG005|Overall Study|Participant Withdrew Consent|0|||
157002987|NCT02341625|566760191|FG006|Overall Study|Participant Withdrew Consent|0|||
157002988|NCT02341625|566760192|FG007|Overall Study|Participant Withdrew Consent|0|||
157002989|NCT02341625|566760193|FG008|Overall Study|Participant Withdrew Consent|0|||
157002990|NCT02341625|566760194|FG009|Overall Study|Participant Withdrew Consent|0|||
157002991|NCT02341625|566760185|FG000|Overall Study|Completed Treatment as per Protocol|0|||
157002992|NCT02341625|566760186|FG001|Overall Study|Completed Treatment as per Protocol|0|||
157002993|NCT02341625|566760187|FG002|Overall Study|Completed Treatment as per Protocol|0|||
157002994|NCT02341625|566760188|FG003|Overall Study|Completed Treatment as per Protocol|0|||
157002995|NCT02341625|566760189|FG004|Overall Study|Completed Treatment as per Protocol|0|||
157002996|NCT02341625|566760190|FG005|Overall Study|Completed Treatment as per Protocol|0|||
157002997|NCT02341625|566760191|FG006|Overall Study|Completed Treatment as per Protocol|0|||
157002998|NCT02341625|566760192|FG007|Overall Study|Completed Treatment as per Protocol|0|||
157002999|NCT02341625|566760193|FG008|Overall Study|Completed Treatment as per Protocol|0|||
157003000|NCT02341625|566760194|FG009|Overall Study|Completed Treatment as per Protocol|1|||
157003001|NCT02341625|566760185|FG000|Overall Study|Other Reasons|0|||
157003002|NCT02341625|566760186|FG001|Overall Study|Other Reasons|0|||
157003003|NCT02341625|566760187|FG002|Overall Study|Other Reasons|0|||
157003004|NCT02341625|566760188|FG003|Overall Study|Other Reasons|0|||
157003005|NCT02341625|566760189|FG004|Overall Study|Other Reasons|1|||
157003006|NCT02341625|566760190|FG005|Overall Study|Other Reasons|0|||
157003007|NCT02341625|566760191|FG006|Overall Study|Other Reasons|5|||
157003008|NCT02341625|566760192|FG007|Overall Study|Other Reasons|0|||
157003009|NCT02341625|566760193|FG008|Overall Study|Other Reasons|0|||
157003010|NCT02341625|566760194|FG009|Overall Study|Other Reasons|2|||
157003011|NCT02341625|566760185|FG000|Overall Study|Not Reported|0|||
157003012|NCT02341625|566760186|FG001|Overall Study|Not Reported|0|||
157003013|NCT02341625|566760187|FG002|Overall Study|Not Reported|0|||
157106581|NCT00467779|567145182|FG001|Stage 2A|Withdrawal by Subject|0|||
157106582|NCT00467779|567145183|FG002|Stage 2A|Withdrawal by Subject|0|||
157106583|NCT00467779|567145184|FG003|Stage 2A|Withdrawal by Subject|0|||
157106584|NCT00467779|567145185|FG004|Stage 2A|Withdrawal by Subject|0|||
157106585|NCT00467779|567145186|FG005|Stage 2A|Withdrawal by Subject|0|||
157106586|NCT00467779|567145187|FG006|Stage 2A|Withdrawal by Subject|0|||
157106587|NCT00467779|567145188|FG007|Stage 2A|Withdrawal by Subject|0|||
157106588|NCT00467779|567145189|FG008|Stage 2A|Withdrawal by Subject|0|||
157106589|NCT00467779|567145190|FG009|Stage 2A|Withdrawal by Subject|0|||
157106590|NCT00467779|567145191|FG010|Stage 2A|Withdrawal by Subject|0|||
157106591|NCT00467779|567145192|FG011|Stage 2A|Withdrawal by Subject|0|||
157106592|NCT00467779|567145193|FG012|Stage 2A|Withdrawal by Subject|0|||
157106593|NCT00467779|567145194|FG013|Stage 2A|Withdrawal by Subject|1|||
157106594|NCT00467779|567145195|FG014|Stage 2A|Withdrawal by Subject|0|||
157106595|NCT00467779|567145181|FG000|Stage 3|Adverse Event|0|||
157106596|NCT00467779|567145182|FG001|Stage 3|Adverse Event|0|||
157106597|NCT00467779|567145183|FG002|Stage 3|Adverse Event|0|||
157106598|NCT00467779|567145184|FG003|Stage 3|Adverse Event|0|||
157106599|NCT00467779|567145185|FG004|Stage 3|Adverse Event|0|||
157106600|NCT00467779|567145186|FG005|Stage 3|Adverse Event|0|||
157106601|NCT00467779|567145187|FG006|Stage 3|Adverse Event|0|||
157106602|NCT00467779|567145188|FG007|Stage 3|Adverse Event|0|||
157106603|NCT00467779|567145189|FG008|Stage 3|Adverse Event|0|||
157106604|NCT00467779|567145190|FG009|Stage 3|Adverse Event|0|||
157106605|NCT00467779|567145191|FG010|Stage 3|Adverse Event|0|||
157106606|NCT00467779|567145192|FG011|Stage 3|Adverse Event|0|||
157106607|NCT00467779|567145193|FG012|Stage 3|Adverse Event|0|||
157106608|NCT00467779|567145194|FG013|Stage 3|Adverse Event|0|||
157106609|NCT00467779|567145195|FG014|Stage 3|Adverse Event|2|||
157106610|NCT00467779|567145181|FG000|Stage 3|Death|0|||
157106611|NCT00467779|567145182|FG001|Stage 3|Death|0|||
157106612|NCT00467779|567145183|FG002|Stage 3|Death|0|||
157106613|NCT00467779|567145184|FG003|Stage 3|Death|0|||
157106614|NCT00467779|567145185|FG004|Stage 3|Death|0|||
157106615|NCT00467779|567145186|FG005|Stage 3|Death|0|||
157106616|NCT00467779|567145187|FG006|Stage 3|Death|0|||
157106617|NCT00467779|567145188|FG007|Stage 3|Death|0|||
157106618|NCT00467779|567145189|FG008|Stage 3|Death|0|||
157106619|NCT00467779|567145190|FG009|Stage 3|Death|0|||
157106620|NCT00467779|567145191|FG010|Stage 3|Death|0|||
157106621|NCT00467779|567145192|FG011|Stage 3|Death|0|||
157106622|NCT00467779|567145193|FG012|Stage 3|Death|0|||
157106623|NCT00467779|567145194|FG013|Stage 3|Death|0|||
157106624|NCT00467779|567145195|FG014|Stage 3|Death|1|||
157106625|NCT00467779|567145181|FG000|Stage 3|Disease Progression|0|||
157106626|NCT00467779|567145182|FG001|Stage 3|Disease Progression|0|||
157106627|NCT00467779|567145183|FG002|Stage 3|Disease Progression|0|||
157106628|NCT00467779|567145184|FG003|Stage 3|Disease Progression|0|||
157106629|NCT00467779|567145185|FG004|Stage 3|Disease Progression|0|||
157106630|NCT00467779|567145186|FG005|Stage 3|Disease Progression|0|||
157106631|NCT00467779|567145187|FG006|Stage 3|Disease Progression|0|||
157106632|NCT00467779|567145188|FG007|Stage 3|Disease Progression|0|||
157106633|NCT00467779|567145189|FG008|Stage 3|Disease Progression|0|||
157106634|NCT00467779|567145190|FG009|Stage 3|Disease Progression|0|||
157106635|NCT00467779|567145191|FG010|Stage 3|Disease Progression|0|||
157106636|NCT00467779|567145192|FG011|Stage 3|Disease Progression|0|||
157106637|NCT00467779|567145193|FG012|Stage 3|Disease Progression|0|||
157106638|NCT00467779|567145194|FG013|Stage 3|Disease Progression|0|||
157106639|NCT00467779|567145195|FG014|Stage 3|Disease Progression|9|||
157106640|NCT00467779|567145181|FG000|Stage 3|Unspecified Reason|0|||
157106641|NCT00467779|567145182|FG001|Stage 3|Unspecified Reason|0|||
157106642|NCT00467779|567145183|FG002|Stage 3|Unspecified Reason|0|||
157106643|NCT00467779|567145184|FG003|Stage 3|Unspecified Reason|0|||
157106644|NCT00467779|567145185|FG004|Stage 3|Unspecified Reason|0|||
157106645|NCT00467779|567145186|FG005|Stage 3|Unspecified Reason|0|||
157106646|NCT00467779|567145187|FG006|Stage 3|Unspecified Reason|0|||
157106647|NCT00467779|567145188|FG007|Stage 3|Unspecified Reason|0|||
157106648|NCT00467779|567145189|FG008|Stage 3|Unspecified Reason|0|||
157106649|NCT00467779|567145190|FG009|Stage 3|Unspecified Reason|0|||
157106650|NCT00467779|567145191|FG010|Stage 3|Unspecified Reason|0|||
157106651|NCT00467779|567145192|FG011|Stage 3|Unspecified Reason|0|||
157106652|NCT00467779|567145193|FG012|Stage 3|Unspecified Reason|0|||
157106653|NCT00467779|567145194|FG013|Stage 3|Unspecified Reason|0|||
157106654|NCT00467779|567145195|FG014|Stage 3|Unspecified Reason|5|||
157106655|NCT01509079|567145196|FG000|Overall Study|Lack of Efficacy|0|||
157106656|NCT01509079|567145197|FG001|Overall Study|Lack of Efficacy|2|||
157106657|NCT01509079|567145196|FG000|Overall Study|started an excluded medication|0|||
157106658|NCT01509079|567145197|FG001|Overall Study|started an excluded medication|1|||
157106659|NCT04912245|567145198|FG000|Overall Study|Withdrawal by Subject|21|||
157106660|NCT04912245|567145199|FG001|Overall Study|Withdrawal by Subject|4|||
157106661|NCT04912245|567145198|FG000|Overall Study|Lost to Follow-up|5|||
157106662|NCT04912245|567145199|FG001|Overall Study|Lost to Follow-up|11|||
157106663|NCT01205230|567145200|FG000|Overall Study|Adverse Event|4|||
157106664|NCT01205230|567145201|FG001|Overall Study|Adverse Event|0|||
157106665|NCT01205230|567145200|FG000|Overall Study|Physician Decision|1|||
157106666|NCT01205230|567145201|FG001|Overall Study|Physician Decision|0|||
157106667|NCT00041080|567145202|FG000|Overall Study|Adverse Event|21|||
157106668|NCT00041080|567145203|FG001|Overall Study|Adverse Event|1|||
157106669|NCT00041080|567145202|FG000|Overall Study|Withdrawal by Subject|6|||
157106670|NCT00041080|567145203|FG001|Overall Study|Withdrawal by Subject|6|||
157106671|NCT00041080|567145202|FG000|Overall Study|Concommitant Illness/Other|1|||
157106672|NCT00041080|567145203|FG001|Overall Study|Concommitant Illness/Other|2|||
157106673|NCT00041080|567145202|FG000|Overall Study|Did not start therapy|1|||
157106674|NCT00041080|567145203|FG001|Overall Study|Did not start therapy|1|||
157106675|NCT00041080|567145202|FG000|Overall Study|Ineligible|1|||
157106676|NCT00041080|567145203|FG001|Overall Study|Ineligible|0|||
157106677|NCT03198520|567145204|FG000|Overall Study|Physician Decision|2|||
157106678|NCT03198520|567145204|FG000|Overall Study|Protocol Violation|2|||
157106679|NCT03198520|567145204|FG000|Overall Study|Withdrawal by Subject|1|||
157106680|NCT03198520|567145204|FG000|Overall Study|Study Ended|1|||
157106681|NCT01670539|567145205|FG000|Overall Study|Death|3|||
157106682|NCT01670539|567145206|FG001|Overall Study|Death|5|||
157106683|NCT01670539|567145205|FG000|Overall Study|Withdrawal by Subject|3|||
157106684|NCT01670539|567145206|FG001|Overall Study|Withdrawal by Subject|0|||
157106685|NCT04353596|567145207|FG000|Overall Study|Protocol Violation|4|||
157106686|NCT04353596|567145208|FG001|Overall Study|Protocol Violation|4|||
157106687|NCT04353596|567145207|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
157106688|NCT04353596|567145208|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
157106689|NCT02665052|567145209|FG000|Overall Study|Lost to Follow-up|1|||
157106690|NCT02665052|567145210|FG001|Overall Study|Lost to Follow-up|0|||
157106691|NCT02665052|567145211|FG002|Overall Study|Lost to Follow-up|0|||
157106692|NCT02665052|567145212|FG003|Overall Study|Lost to Follow-up|0|||
157106693|NCT02665052|567145209|FG000|Overall Study|Withdrawal by Subject|1|||
157106694|NCT02665052|567145210|FG001|Overall Study|Withdrawal by Subject|1|||
157106695|NCT02665052|567145211|FG002|Overall Study|Withdrawal by Subject|0|||
157106696|NCT02665052|567145212|FG003|Overall Study|Withdrawal by Subject|5|||
157106697|NCT02665052|567145209|FG000|Overall Study|Adverse Event|1|||
157106698|NCT02665052|567145210|FG001|Overall Study|Adverse Event|1|||
157106699|NCT02665052|567145211|FG002|Overall Study|Adverse Event|0|||
157106700|NCT02665052|567145212|FG003|Overall Study|Adverse Event|0|||
157106701|NCT03023059|567145213|FG000|Overall Study|Withdrawal by Subject|5|||
157106702|NCT00536809|567145214|FG000|Phase II|Adverse Event|1|||
157106703|NCT00536809|567145214|FG000|Phase II|Referred for surgical resection|1|||
157106704|NCT00874770|567145220|FG000|Overall Study|Lack of Efficacy|2|||
157106705|NCT00874770|567145221|FG001|Overall Study|Lack of Efficacy|0|||
157106706|NCT00874770|567145222|FG002|Overall Study|Lack of Efficacy|0|||
157106707|NCT00874770|567145223|FG003|Overall Study|Lack of Efficacy|2|||
157106708|NCT00874770|567145220|FG000|Overall Study|Adverse Event|1|||
157106709|NCT00874770|567145221|FG001|Overall Study|Adverse Event|1|||
157106710|NCT00874770|567145222|FG002|Overall Study|Adverse Event|4|||
157106711|NCT00874770|567145223|FG003|Overall Study|Adverse Event|2|||
157106712|NCT00874770|567145220|FG000|Overall Study|Lost to Follow-up|1|||
157106713|NCT00874770|567145221|FG001|Overall Study|Lost to Follow-up|0|||
157106714|NCT00874770|567145222|FG002|Overall Study|Lost to Follow-up|0|||
157106715|NCT00874770|567145223|FG003|Overall Study|Lost to Follow-up|1|||
157106716|NCT00874770|567145220|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
157106717|NCT00874770|567145221|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
157106718|NCT00874770|567145222|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
157106719|NCT00874770|567145223|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
157106720|NCT01353508|567145230|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
157106721|NCT01353508|567145231|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
157106722|NCT01353508|567145232|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
157106723|NCT01353508|567145233|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
157106724|NCT01353508|567145230|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
157106725|NCT01353508|567145231|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
157106726|NCT01353508|567145232|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
157106727|NCT01353508|567145233|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
157106728|NCT00646906|567145239|FG000|Crossover Period 1|Withdrawal by Subject|1|||
157106729|NCT00646906|567145240|FG001|Crossover Period 1|Withdrawal by Subject|0|||
157106730|NCT00646906|567145241|FG002|Crossover Period 1|Withdrawal by Subject|0|||
157106731|NCT00646906|567145242|FG003|Crossover Period 1|Withdrawal by Subject|0|||
157106732|NCT00646906|567145243|FG004|Crossover Period 1|Withdrawal by Subject|0|||
157106733|NCT00646906|567145244|FG005|Crossover Period 1|Withdrawal by Subject|1|||
157106734|NCT00646906|567145245|FG006|Crossover Period 1|Withdrawal by Subject|0|||
157106735|NCT00646906|567145239|FG000|Crossover Period 2|Withdrawal by Subject|0|||
157106736|NCT00646906|567145240|FG001|Crossover Period 2|Withdrawal by Subject|1|||
157106737|NCT00646906|567145241|FG002|Crossover Period 2|Withdrawal by Subject|2|||
157106738|NCT00646906|567145242|FG003|Crossover Period 2|Withdrawal by Subject|1|||
157106739|NCT00646906|567145243|FG004|Crossover Period 2|Withdrawal by Subject|0|||
157106740|NCT00646906|567145244|FG005|Crossover Period 2|Withdrawal by Subject|0|||
157106741|NCT00646906|567145245|FG006|Crossover Period 2|Withdrawal by Subject|0|||
157003014|NCT02341625|566760188|FG003|Overall Study|Not Reported|0|||
157003015|NCT02341625|566760189|FG004|Overall Study|Not Reported|0|||
157003016|NCT02341625|566760190|FG005|Overall Study|Not Reported|0|||
157003017|NCT02341625|566760191|FG006|Overall Study|Not Reported|0|||
157003018|NCT02341625|566760192|FG007|Overall Study|Not Reported|0|||
157003019|NCT02341625|566760193|FG008|Overall Study|Not Reported|0|||
157003020|NCT02341625|566760194|FG009|Overall Study|Not Reported|3|||
157003021|NCT00177216|566760195|FG000|Overall Study|Withdrawal by Subject|6|||
157003022|NCT00177216|566760196|FG001|Overall Study|Withdrawal by Subject|3|||
157003023|NCT00177216|566760197|FG002|Overall Study|Withdrawal by Subject|1|||
157003024|NCT00639002|566760198|FG000|Overall Study|Death|1|||
157003025|NCT00639002|566760198|FG000|Overall Study|Adverse Event|1|||
157003026|NCT00639002|566760198|FG000|Overall Study|Protocol Violation|1|||
157003027|NCT00639002|566760198|FG000|Overall Study|Disease progression|3|||
157003028|NCT00639002|566760198|FG000|Overall Study|Physician Decision|6|||
157003029|NCT00639002|566760198|FG000|Overall Study|Lack of Efficacy|1|||
157003030|NCT01161498|566760199|FG000|Overall Study|Disease Progression|0|||
157003031|NCT01161498|566760200|FG001|Overall Study|Disease Progression|1|||
157003032|NCT03310983|566760207|FG000|Overall Study|Lost to Follow-up|15|||
157003033|NCT03310983|566760208|FG001|Overall Study|Lost to Follow-up|17|||
157003034|NCT03368001|566760210|FG000|Allocation|Lost to Pretest|16|||
157003035|NCT03368001|566760211|FG001|Allocation|Lost to Pretest|25|||
157003036|NCT03368001|566760210|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
157003037|NCT03368001|566760211|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
157003038|NCT03368001|566760210|FG000|Posttest|Lost to Posttest|7|||
157003039|NCT03368001|566760211|FG001|Posttest|Lost to Posttest|11|||
157003040|NCT03368001|566760210|FG000|Posttest|Discontinued Intervention|6|||
157003041|NCT03368001|566760211|FG001|Posttest|Discontinued Intervention|19|||
157003042|NCT03368001|566760210|FG000|Follow-up|Lost to Follow-up|6|||
157003043|NCT03368001|566760211|FG001|Follow-up|Lost to Follow-up|3|||
157003044|NCT01656304|566760219|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
157003045|NCT01093534|566760220|FG000|Overall Study|Adverse Event|2|||
157003046|NCT01093534|566760221|FG001|Overall Study|Adverse Event|5|||
157003047|NCT01093534|566760222|FG002|Overall Study|Adverse Event|2|||
157003048|NCT01093534|566760220|FG000|Overall Study|Lack of Efficacy|2|||
157003049|NCT01093534|566760221|FG001|Overall Study|Lack of Efficacy|1|||
157003050|NCT01093534|566760222|FG002|Overall Study|Lack of Efficacy|1|||
157003051|NCT01093534|566760220|FG000|Overall Study|Withdrawal by Subject|5|||
157003052|NCT01093534|566760221|FG001|Overall Study|Withdrawal by Subject|7|||
157003053|NCT01093534|566760222|FG002|Overall Study|Withdrawal by Subject|2|||
157003054|NCT01093534|566760220|FG000|Overall Study|Other|1|||
157003055|NCT01093534|566760221|FG001|Overall Study|Other|3|||
157003056|NCT01093534|566760222|FG002|Overall Study|Other|4|||
157003057|NCT00741988|566760223|FG000|Overall Study|Adverse Event|2|||
157003058|NCT00741988|566760224|FG001|Overall Study|Adverse Event|4|||
157003059|NCT00741988|566760223|FG000|Overall Study|Lack of Efficacy|2|||
157003060|NCT00741988|566760224|FG001|Overall Study|Lack of Efficacy|0|||
157003061|NCT03008915|566760227|FG000|Treatment 1|Withdrawal by Subject|0|||
157003062|NCT03008915|566760228|FG001|Treatment 1|Withdrawal by Subject|1|||
157003063|NCT00712166|566760231|FG000|Overall Study|Noncompliance|0|||
157003064|NCT00712166|566760232|FG001|Overall Study|Noncompliance|1|||
157003065|NCT01773122|566760233|FG000|Overall Study|Due to amended age eligibility criteria|3|||
157003066|NCT01773122|566760234|FG001|Overall Study|Due to amended age eligibility criteria|1|||
157003067|NCT01773122|566760235|FG002|Overall Study|Due to amended age eligibility criteria|0|||
157003068|NCT01773122|566760236|FG003|Overall Study|Due to amended age eligibility criteria|1|||
157106742|NCT00646906|567145239|FG000|Crossover Period 2|Physician Decision|0|||
157106743|NCT00646906|567145240|FG001|Crossover Period 2|Physician Decision|0|||
157106744|NCT00646906|567145241|FG002|Crossover Period 2|Physician Decision|0|||
157106745|NCT00646906|567145242|FG003|Crossover Period 2|Physician Decision|0|||
157106746|NCT00646906|567145243|FG004|Crossover Period 2|Physician Decision|0|||
157106747|NCT00646906|567145244|FG005|Crossover Period 2|Physician Decision|0|||
157106748|NCT00646906|567145245|FG006|Crossover Period 2|Physician Decision|1|||
157106749|NCT00433914|567145252|FG000|Overall Study|Withdrawal by Subject|0|||
157106750|NCT00433914|567145253|FG001|Overall Study|Withdrawal by Subject|2|||
157106751|NCT00433914|567145252|FG000|Overall Study|Lost to Follow-up|0|||
157003069|NCT02540213|566760237|FG000|Overall Study|Death/adverse event|18|||
157003070|NCT02540213|566760237|FG000|Overall Study|Administrative reasons|3|||
157003071|NCT02540213|566760237|FG000|Overall Study|Kidney transplant|3|||
157003072|NCT02540213|566760237|FG000|Overall Study|Lack of Efficacy|6|||
157003073|NCT02540213|566760237|FG000|Overall Study|Consent withdrawn|7|||
157003074|NCT02540213|566760237|FG000|Overall Study|Enrolled but not treated|2|||
157003075|NCT00536380|566760240|FG000|Overall Study|Adverse Event|0|||
157003076|NCT00536380|566760241|FG001|Overall Study|Adverse Event|2|||
157003077|NCT00536380|566760242|FG002|Overall Study|Adverse Event|2|||
157003078|NCT00536380|566760240|FG000|Overall Study|Lost to Follow-up|0|||
157003079|NCT00536380|566760241|FG001|Overall Study|Lost to Follow-up|0|||
157003080|NCT00536380|566760242|FG002|Overall Study|Lost to Follow-up|1|||
157106752|NCT00433914|567145253|FG001|Overall Study|Lost to Follow-up|1|||
157106753|NCT02844920|567145254|FG000|Overall Study|Lost to Follow-up|2|||
157106754|NCT04534491|567145255|FG000|Overall Study|Not completed end-of-study interview|24|||
157106755|NCT04534491|567145255|FG000|Overall Study|Non-users|70|||
157106756|NCT04534491|567145255|FG000|Overall Study|Non-verifiable users|58|||
157106757|NCT00766090|567145258|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106758|NCT00766090|567145259|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106759|NCT00766090|567145260|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106760|NCT00766090|567145261|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106761|NCT00766090|567145262|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106762|NCT00766090|567145263|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106763|NCT00766090|567145264|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106764|NCT00766090|567145265|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106765|NCT00766090|567145266|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
157106766|NCT00766090|567145267|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157003081|NCT00536380|566760240|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
157106767|NCT00766090|567145268|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106768|NCT00766090|567145269|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157106769|NCT00766090|567145258|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
157106770|NCT00766090|567145259|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157003082|NCT00536380|566760241|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
157003083|NCT00536380|566760242|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
157003084|NCT00536380|566760240|FG000|Overall Study|Withdrawal related to study drug|7|||
157003085|NCT00536380|566760241|FG001|Overall Study|Withdrawal related to study drug|5|||
157003086|NCT00536380|566760242|FG002|Overall Study|Withdrawal related to study drug|2|||
157003087|NCT00536380|566760240|FG000|Overall Study|Noncompliance with protocol|3|||
157003088|NCT00536380|566760241|FG001|Overall Study|Noncompliance with protocol|2|||
157003089|NCT00536380|566760242|FG002|Overall Study|Noncompliance with protocol|2|||
157003090|NCT00536380|566760240|FG000|Overall Study|Did not meet protocol eligibility|0|||
157003091|NCT00536380|566760241|FG001|Overall Study|Did not meet protocol eligibility|0|||
157003092|NCT00536380|566760242|FG002|Overall Study|Did not meet protocol eligibility|1|||
157003093|NCT00536380|566760240|FG000|Overall Study|Administrative|0|||
157003094|NCT00536380|566760241|FG001|Overall Study|Administrative|0|||
157003095|NCT00536380|566760242|FG002|Overall Study|Administrative|1|||
157003096|NCT00387465|566760243|FG000|Overall Study|Withdrawal by Subject|0|||
157003097|NCT00387465|566760244|FG001|Overall Study|Withdrawal by Subject|1|||
157003098|NCT00387465|566760245|FG002|Overall Study|Withdrawal by Subject|0|||
157003099|NCT03418324|566760246|FG000|Overall Study|Death|0|||
157003100|NCT03418324|566760247|FG001|Overall Study|Death|1|||
157003101|NCT03418324|566760246|FG000|Overall Study|Physician Decision|1|||
157003102|NCT03418324|566760247|FG001|Overall Study|Physician Decision|1|||
157003103|NCT01768676|566760249|FG000|Overall Study|Adverse Event|3|||
157003104|NCT01768676|566760250|FG001|Overall Study|Adverse Event|3|||
157003105|NCT01768676|566760249|FG000|Overall Study|Lost to Follow-up|13|||
157003106|NCT01768676|566760250|FG001|Overall Study|Lost to Follow-up|16|||
157003107|NCT01768676|566760249|FG000|Overall Study|Protocol Violation|1|||
157003108|NCT01768676|566760250|FG001|Overall Study|Protocol Violation|1|||
157003109|NCT01768676|566760249|FG000|Overall Study|Physician Decision|4|||
157003110|NCT01768676|566760250|FG001|Overall Study|Physician Decision|1|||
157003111|NCT01768676|566760249|FG000|Overall Study|Withdrawal by Subject|3|||
157003112|NCT01768676|566760250|FG001|Overall Study|Withdrawal by Subject|10|||
157003113|NCT03121950|566760252|FG000|Overall Study|Withdrawal by Subject|11|||
157003114|NCT03121950|566760253|FG001|Overall Study|Withdrawal by Subject|2|||
157003115|NCT04248829|566760259|FG000|Overall Study|Disease progression|44|||
157003116|NCT04248829|566760260|FG001|Overall Study|Disease progression|109|||
157003117|NCT04248829|566760259|FG000|Overall Study|Adverse Event|19|||
157003118|NCT04248829|566760260|FG001|Overall Study|Adverse Event|18|||
157003119|NCT04248829|566760259|FG000|Overall Study|Withdrawal by Subject|11|||
157003120|NCT04248829|566760260|FG001|Overall Study|Withdrawal by Subject|2|||
157003121|NCT04248829|566760259|FG000|Overall Study|Lost to Follow-up|0|||
157003122|NCT04248829|566760260|FG001|Overall Study|Lost to Follow-up|1|||
157003123|NCT04248829|566760259|FG000|Overall Study|Death|12|||
157003124|NCT04248829|566760260|FG001|Overall Study|Death|14|||
157003125|NCT04248829|566760259|FG000|Overall Study|Physician Decision|2|||
157003126|NCT04248829|566760260|FG001|Overall Study|Physician Decision|4|||
157003127|NCT04248829|566760259|FG000|Overall Study|Any reason not specifically recorded|0|||
157003128|NCT04248829|566760260|FG001|Overall Study|Any reason not specifically recorded|2|||
157003129|NCT02132702|566760261|FG000|Overall Study|Protocol Violation|2|||
157106771|NCT00766090|567145260|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106772|NCT00766090|567145261|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157003130|NCT02132702|566760261|FG000|Overall Study|Adverse Event|3|||
157003131|NCT02132702|566760261|FG000|Overall Study|Withdrawal by Subject|3|||
157003132|NCT02299336|566760262|FG000|Overall Study|Withdrawal by Subject|11|||
157003133|NCT02299336|566760262|FG000|Overall Study|Adverse Event|1|||
157003134|NCT02299336|566760262|FG000|Overall Study|Death|1|||
157003135|NCT02299336|566760262|FG000|Overall Study|Lost to Follow-up|1|||
157106773|NCT00766090|567145262|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106774|NCT00766090|567145263|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106775|NCT00766090|567145264|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106776|NCT00766090|567145265|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106777|NCT00766090|567145266|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106778|NCT00766090|567145267|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106779|NCT00766090|567145268|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106780|NCT00766090|567145269|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
157106781|NCT00766090|567145258|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
157106782|NCT00766090|567145259|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106783|NCT00766090|567145260|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106784|NCT00766090|567145261|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
157106785|NCT00766090|567145262|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157003136|NCT01304147|566760265|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
157003137|NCT01304147|566760266|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
157003138|NCT01070888|566762433|FG000|First Intervention (14 Days)|Adverse Event|0|||
157003139|NCT01070888|566762434|FG001|First Intervention (14 Days)|Adverse Event|1|||
157003140|NCT01070888|566762433|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
157003141|NCT01070888|566762434|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
157003142|NCT01070888|566762433|FG000|Washout (14 Days)|Physician Decision|1|||
157003143|NCT01070888|566762434|FG001|Washout (14 Days)|Physician Decision|0|||
157003144|NCT02631148|566762435|FG000|Overall Study|8 were ineligible|8|||
157003145|NCT02631148|566762436|FG001|Overall Study|8 were ineligible|0|||
157003146|NCT02631148|566762435|FG000|Overall Study|Withdrawal by Subject|1|||
157003147|NCT02631148|566762436|FG001|Overall Study|Withdrawal by Subject|0|||
157003148|NCT02631148|566762435|FG000|Overall Study|PAH not available to study participant|1|||
157003149|NCT02631148|566762436|FG001|Overall Study|PAH not available to study participant|0|||
157003150|NCT00955825|566762438|FG000|Overall Study|Adverse Event|15|||
157003151|NCT00955825|566762439|FG001|Overall Study|Adverse Event|2|||
157003152|NCT00955825|566762438|FG000|Overall Study|Withdrawal by Subject|4|||
157003153|NCT00955825|566762439|FG001|Overall Study|Withdrawal by Subject|6|||
157003154|NCT00955825|566762438|FG000|Overall Study|Any other reason not above-mentioned|7|||
157003155|NCT00955825|566762439|FG001|Overall Study|Any other reason not above-mentioned|9|||
157003156|NCT01198275|566762440|FG000|Overall Study|Adverse Event|2|||
157003157|NCT01198275|566762441|FG001|Overall Study|Adverse Event|3|||
157003158|NCT01198275|566762440|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
157003159|NCT01198275|566762441|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
157003160|NCT00391846|566762442|FG000|Overall Study|Adverse Event|4|||
157003161|NCT00391846|566762443|FG001|Overall Study|Adverse Event|1|||
157003162|NCT00391846|566762442|FG000|Overall Study|Did not meet the required elig. crit|2|||
157003163|NCT00391846|566762443|FG001|Overall Study|Did not meet the required elig. crit|2|||
157003164|NCT00391846|566762442|FG000|Overall Study|Withdrawal by Subject|2|||
157003165|NCT00391846|566762443|FG001|Overall Study|Withdrawal by Subject|3|||
157003166|NCT00391846|566762442|FG000|Overall Study|Developed study specific DC criteria|0|||
157003167|NCT00391846|566762443|FG001|Overall Study|Developed study specific DC criteria|1|||
157003168|NCT04035668|566762444|FG000|Overall Study|Adverse Event|3|||
157003169|NCT04035668|566762445|FG001|Overall Study|Adverse Event|4|||
157003170|NCT04035668|566762446|FG002|Overall Study|Adverse Event|2|||
157003171|NCT04035668|566762444|FG000|Overall Study|Lost to Follow-up|0|||
157003172|NCT04035668|566762445|FG001|Overall Study|Lost to Follow-up|1|||
157003173|NCT04035668|566762446|FG002|Overall Study|Lost to Follow-up|0|||
157003174|NCT04035668|566762444|FG000|Overall Study|Physician Decision|2|||
157003175|NCT04035668|566762445|FG001|Overall Study|Physician Decision|1|||
157003176|NCT04035668|566762446|FG002|Overall Study|Physician Decision|1|||
157003177|NCT04035668|566762444|FG000|Overall Study|Subject Decision|2|||
157003178|NCT04035668|566762445|FG001|Overall Study|Subject Decision|2|||
157003179|NCT04035668|566762446|FG002|Overall Study|Subject Decision|0|||
157003180|NCT02477670|566762447|FG000|Stage 1|Adverse Event|2|||
157003181|NCT02477670|566762448|FG001|Stage 1|Adverse Event|7|||
157003182|NCT02477670|566762449|FG002|Stage 1|Adverse Event|0|||
157003183|NCT02477670|566762450|FG003|Stage 1|Adverse Event|0|||
157003184|NCT02477670|566762451|FG004|Stage 1|Adverse Event|0|||
157106786|NCT00766090|567145263|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106787|NCT00766090|567145264|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157003185|NCT02477670|566762452|FG005|Stage 1|Adverse Event|0|||
157003186|NCT02477670|566762453|FG006|Stage 1|Adverse Event|0|||
157003187|NCT02477670|566762447|FG000|Stage 1|Lost to Follow-up|0|||
157003188|NCT02477670|566762448|FG001|Stage 1|Lost to Follow-up|2|||
157003189|NCT02477670|566762449|FG002|Stage 1|Lost to Follow-up|0|||
157003190|NCT02477670|566762450|FG003|Stage 1|Lost to Follow-up|0|||
157003191|NCT02477670|566762451|FG004|Stage 1|Lost to Follow-up|0|||
157003192|NCT02477670|566762452|FG005|Stage 1|Lost to Follow-up|0|||
157003193|NCT02477670|566762453|FG006|Stage 1|Lost to Follow-up|0|||
157003194|NCT02477670|566762447|FG000|Stage 1|Withdrawal by Subject|1|||
157106788|NCT00766090|567145265|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106789|NCT00766090|567145266|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106790|NCT00766090|567145267|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106791|NCT00766090|567145268|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106792|NCT00766090|567145269|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157106793|NCT00766090|567145258|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106794|NCT00766090|567145259|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106795|NCT00766090|567145260|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
157106796|NCT00766090|567145261|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106797|NCT00766090|567145262|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106798|NCT00766090|567145263|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106799|NCT00766090|567145264|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106800|NCT00766090|567145265|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106801|NCT00766090|567145266|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106802|NCT00766090|567145267|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106803|NCT00766090|567145268|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106804|NCT00766090|567145269|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
157106805|NCT00766090|567145258|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106806|NCT00766090|567145259|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106807|NCT00766090|567145260|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106808|NCT00766090|567145261|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106809|NCT00766090|567145262|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
157106810|NCT00766090|567145263|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106811|NCT00766090|567145264|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106812|NCT00766090|567145265|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106813|NCT00766090|567145266|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106814|NCT00766090|567145267|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106815|NCT00766090|567145268|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106816|NCT00766090|567145269|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157106817|NCT00766090|567145258|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106818|NCT00766090|567145259|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106819|NCT00766090|567145260|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
157106820|NCT00766090|567145261|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106821|NCT00766090|567145262|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106822|NCT00766090|567145263|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106823|NCT00766090|567145264|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106824|NCT00766090|567145265|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106825|NCT00766090|567145266|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106826|NCT00766090|567145267|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106827|NCT00766090|567145268|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106828|NCT00766090|567145269|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
157106829|NCT00766090|567145258|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
157106830|NCT00766090|567145259|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
157106831|NCT00766090|567145260|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
157106832|NCT00766090|567145261|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
157106833|NCT00766090|567145262|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
157106834|NCT00766090|567145263|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
157106835|NCT00766090|567145264|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
157106836|NCT00766090|567145265|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
157106837|NCT00766090|567145266|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
157106838|NCT00766090|567145267|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
157106839|NCT00766090|567145268|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
157106840|NCT00766090|567145269|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
157106841|NCT00766090|567145258|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106842|NCT00766090|567145259|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106843|NCT00766090|567145260|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106844|NCT00766090|567145261|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106845|NCT00766090|567145262|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106846|NCT00766090|567145263|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
157106847|NCT00766090|567145264|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106848|NCT00766090|567145265|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106849|NCT00766090|567145266|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106850|NCT00766090|567145267|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106851|NCT00766090|567145268|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106852|NCT00766090|567145269|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
157106853|NCT00766090|567145258|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106854|NCT00766090|567145259|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
157106855|NCT00766090|567145260|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106856|NCT00766090|567145261|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
157106857|NCT00766090|567145262|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157003195|NCT02477670|566762448|FG001|Stage 1|Withdrawal by Subject|2|||
157003196|NCT02477670|566762449|FG002|Stage 1|Withdrawal by Subject|0|||
157003197|NCT02477670|566762450|FG003|Stage 1|Withdrawal by Subject|0|||
157003198|NCT02477670|566762451|FG004|Stage 1|Withdrawal by Subject|0|||
157003199|NCT02477670|566762452|FG005|Stage 1|Withdrawal by Subject|0|||
157003200|NCT02477670|566762453|FG006|Stage 1|Withdrawal by Subject|0|||
157003201|NCT02477670|566762447|FG000|Stage 1|Non-compliance with Study Drug|1|||
157003202|NCT02477670|566762448|FG001|Stage 1|Non-compliance with Study Drug|2|||
157003203|NCT02477670|566762449|FG002|Stage 1|Non-compliance with Study Drug|0|||
157003204|NCT02477670|566762450|FG003|Stage 1|Non-compliance with Study Drug|0|||
157003205|NCT02477670|566762451|FG004|Stage 1|Non-compliance with Study Drug|0|||
157003206|NCT02477670|566762452|FG005|Stage 1|Non-compliance with Study Drug|0|||
157003207|NCT02477670|566762453|FG006|Stage 1|Non-compliance with Study Drug|0|||
157003208|NCT02477670|566762447|FG000|Stage 2|Adverse Event|0|||
157003209|NCT02477670|566762448|FG001|Stage 2|Adverse Event|0|||
157003210|NCT02477670|566762449|FG002|Stage 2|Adverse Event|1|||
157003211|NCT02477670|566762450|FG003|Stage 2|Adverse Event|0|||
157003212|NCT02477670|566762451|FG004|Stage 2|Adverse Event|0|||
157003213|NCT02477670|566762452|FG005|Stage 2|Adverse Event|0|||
157003214|NCT02477670|566762453|FG006|Stage 2|Adverse Event|0|||
157003215|NCT02477670|566762447|FG000|Stage 2|Antipsychotic Medication Changed|0|||
157003216|NCT02477670|566762448|FG001|Stage 2|Antipsychotic Medication Changed|0|||
157003217|NCT02477670|566762449|FG002|Stage 2|Antipsychotic Medication Changed|1|||
157003218|NCT02477670|566762450|FG003|Stage 2|Antipsychotic Medication Changed|0|||
157003219|NCT02477670|566762451|FG004|Stage 2|Antipsychotic Medication Changed|0|||
157003220|NCT02477670|566762452|FG005|Stage 2|Antipsychotic Medication Changed|0|||
157003221|NCT02477670|566762453|FG006|Stage 2|Antipsychotic Medication Changed|0|||
157003222|NCT02477670|566762447|FG000|Stage 2|Withdrawal by Subject|0|||
157003223|NCT02477670|566762448|FG001|Stage 2|Withdrawal by Subject|0|||
157003224|NCT02477670|566762449|FG002|Stage 2|Withdrawal by Subject|0|||
157003225|NCT02477670|566762450|FG003|Stage 2|Withdrawal by Subject|1|||
157003226|NCT02477670|566762451|FG004|Stage 2|Withdrawal by Subject|0|||
157003227|NCT02477670|566762452|FG005|Stage 2|Withdrawal by Subject|0|||
157003228|NCT02477670|566762453|FG006|Stage 2|Withdrawal by Subject|0|||
157003229|NCT02937831|566762454|FG000|Overall Study|Protocol Violation|4|||
157003230|NCT02224924|566762459|FG000|Overall Study|Withdrawal by Subject|7|||
157003231|NCT02224924|566762460|FG001|Overall Study|Withdrawal by Subject|6|||
157003232|NCT02224924|566762459|FG000|Overall Study|Biopsy cancelled|20|||
157003233|NCT02224924|566762460|FG001|Overall Study|Biopsy cancelled|14|||
157003234|NCT02224924|566762459|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
157003235|NCT02224924|566762460|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
157003236|NCT02224924|566762459|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
157106858|NCT00766090|567145263|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106859|NCT00766090|567145264|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106860|NCT00766090|567145265|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106861|NCT00766090|567145266|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106862|NCT00766090|567145267|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157106863|NCT00766090|567145268|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
157003237|NCT02224924|566762460|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
157003238|NCT01988233|566762470|FG000|Overall Study|Lost to Follow-up|64|||
157003239|NCT01988233|566762471|FG001|Overall Study|Lost to Follow-up|51|||
157003240|NCT01191788|566762477|FG000|Overall Study|Lost to Follow-up|21|||
157003241|NCT01191788|566762478|FG001|Overall Study|Lost to Follow-up|22|||
157003242|NCT03621761|566762479|FG000|Overall Study|Lost to Follow-up|1|||
157003243|NCT03621761|566762480|FG001|Overall Study|Lost to Follow-up|1|||
157003244|NCT03621761|566762481|FG002|Overall Study|Lost to Follow-up|2|||
157003245|NCT03621761|566762479|FG000|Overall Study|Withdrawal by Subject|2|||
157003246|NCT03621761|566762480|FG001|Overall Study|Withdrawal by Subject|1|||
157003247|NCT03621761|566762481|FG002|Overall Study|Withdrawal by Subject|1|||
157003248|NCT03621761|566762479|FG000|Overall Study|Became Ineligible|0|||
157003249|NCT03621761|566762480|FG001|Overall Study|Became Ineligible|2|||
157003250|NCT03621761|566762481|FG002|Overall Study|Became Ineligible|0|||
157003251|NCT01050569|566762482|FG000|Overall Study|Lost to Follow-up|20|||
157003252|NCT01050569|566762483|FG001|Overall Study|Lost to Follow-up|14|||
157106864|NCT00766090|567145269|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
157003253|NCT01050569|566762484|FG002|Overall Study|Lost to Follow-up|16|||
157106865|NCT00766090|567145258|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157003254|NCT01050569|566762482|FG000|Overall Study|Withdrawal by Subject|9|||
157003255|NCT01050569|566762483|FG001|Overall Study|Withdrawal by Subject|3|||
157106866|NCT00766090|567145259|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157003256|NCT01050569|566762484|FG002|Overall Study|Withdrawal by Subject|11|||
157003257|NCT01050569|566762482|FG000|Overall Study|Lack of Efficacy|5|||
157003258|NCT01050569|566762483|FG001|Overall Study|Lack of Efficacy|4|||
157003259|NCT01050569|566762484|FG002|Overall Study|Lack of Efficacy|3|||
157003260|NCT01050569|566762482|FG000|Overall Study|Adverse Event|1|||
157003261|NCT01050569|566762483|FG001|Overall Study|Adverse Event|0|||
157003262|NCT01050569|566762484|FG002|Overall Study|Adverse Event|0|||
157106867|NCT00766090|567145260|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106868|NCT00766090|567145261|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106869|NCT00766090|567145262|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
157106870|NCT00766090|567145263|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106871|NCT00766090|567145264|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106872|NCT00766090|567145265|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106873|NCT00766090|567145266|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106874|NCT00766090|567145267|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106875|NCT00766090|567145268|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106876|NCT00766090|567145269|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
157106877|NCT00131469|567145270|FG000|Overall Study|Withdrawal by Subject|3|||
157106878|NCT00131469|567145271|FG001|Overall Study|Withdrawal by Subject|4|||
157106879|NCT00131469|567145270|FG000|Overall Study|Protocol Violation|3|||
157106880|NCT00131469|567145271|FG001|Overall Study|Protocol Violation|1|||
157106881|NCT00131469|567145270|FG000|Overall Study|Death|0|||
157106882|NCT00131469|567145271|FG001|Overall Study|Death|1|||
157106883|NCT00131469|567145270|FG000|Overall Study|Lost to Follow-up|0|||
157106884|NCT00131469|567145271|FG001|Overall Study|Lost to Follow-up|1|||
157106885|NCT00131469|567145270|FG000|Overall Study|scan not analyzable|3|||
157106886|NCT00131469|567145271|FG001|Overall Study|scan not analyzable|6|||
157106887|NCT00574288|567145272|FG000|Overall Study|Adverse Event|2|||
157106888|NCT00574288|567145273|FG001|Overall Study|Adverse Event|0|||
157106889|NCT00574288|567145274|FG002|Overall Study|Adverse Event|0|||
157106890|NCT00574288|567145275|FG003|Overall Study|Adverse Event|0|||
157106891|NCT00574288|567145276|FG004|Overall Study|Adverse Event|1|||
157106892|NCT00574288|567145277|FG005|Overall Study|Adverse Event|0|||
157106893|NCT00574288|567145278|FG006|Overall Study|Adverse Event|0|||
157106894|NCT00574288|567145272|FG000|Overall Study|Death|0|||
157106895|NCT00574288|567145273|FG001|Overall Study|Death|0|||
157106896|NCT00574288|567145274|FG002|Overall Study|Death|0|||
157106897|NCT00574288|567145275|FG003|Overall Study|Death|0|||
157106898|NCT00574288|567145276|FG004|Overall Study|Death|0|||
157106899|NCT00574288|567145277|FG005|Overall Study|Death|25|||
157106900|NCT00574288|567145278|FG006|Overall Study|Death|21|||
157106901|NCT00574288|567145272|FG000|Overall Study|Lost to Follow-up|0|||
157106902|NCT00574288|567145273|FG001|Overall Study|Lost to Follow-up|0|||
157106903|NCT00574288|567145274|FG002|Overall Study|Lost to Follow-up|0|||
157106904|NCT00574288|567145275|FG003|Overall Study|Lost to Follow-up|0|||
157106905|NCT00574288|567145276|FG004|Overall Study|Lost to Follow-up|0|||
157106906|NCT00574288|567145277|FG005|Overall Study|Lost to Follow-up|1|||
157106907|NCT00574288|567145278|FG006|Overall Study|Lost to Follow-up|2|||
157106908|NCT00574288|567145272|FG000|Overall Study|Study Terminated By Sponsor|0|||
157106909|NCT00574288|567145273|FG001|Overall Study|Study Terminated By Sponsor|0|||
157106910|NCT00574288|567145274|FG002|Overall Study|Study Terminated By Sponsor|0|||
157106911|NCT00574288|567145275|FG003|Overall Study|Study Terminated By Sponsor|0|||
157106912|NCT00574288|567145276|FG004|Overall Study|Study Terminated By Sponsor|0|||
157106913|NCT00574288|567145277|FG005|Overall Study|Study Terminated By Sponsor|0|||
157106914|NCT00574288|567145278|FG006|Overall Study|Study Terminated By Sponsor|5|||
157106915|NCT00574288|567145272|FG000|Overall Study|Progressive Disease|17|||
157106916|NCT00574288|567145273|FG001|Overall Study|Progressive Disease|2|||
157106917|NCT00574288|567145274|FG002|Overall Study|Progressive Disease|3|||
157106918|NCT00574288|567145275|FG003|Overall Study|Progressive Disease|2|||
157106919|NCT00574288|567145276|FG004|Overall Study|Progressive Disease|1|||
157106920|NCT00574288|567145277|FG005|Overall Study|Progressive Disease|0|||
157106921|NCT00574288|567145278|FG006|Overall Study|Progressive Disease|0|||
157106922|NCT00574288|567145272|FG000|Overall Study|Other|1|||
157106923|NCT00574288|567145273|FG001|Overall Study|Other|1|||
157106924|NCT00574288|567145274|FG002|Overall Study|Other|0|||
157106925|NCT00574288|567145275|FG003|Overall Study|Other|0|||
157106926|NCT00574288|567145276|FG004|Overall Study|Other|0|||
157106927|NCT00574288|567145277|FG005|Overall Study|Other|0|||
157106928|NCT00574288|567145278|FG006|Overall Study|Other|0|||
157106929|NCT01106027|567145279|FG000|Overall Study|Lost graft early, discontinued|1|||
157106930|NCT02247960|567145281|FG000|Patient Consent and Randomization|Physician Decision|2|||
157106931|NCT02247960|567145282|FG001|Patient Consent and Randomization|Physician Decision|2|||
157106932|NCT02247960|567145281|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
157106933|NCT02247960|567145282|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
157106934|NCT02247960|567145281|FG000|Catheter Removed|Lost to Follow-up|7|||
157106935|NCT02247960|567145282|FG001|Catheter Removed|Lost to Follow-up|10|||
157106936|NCT01848353|567145283|FG000|Phase 1|Withdrawal by Subject|3|||
157106937|NCT01848353|567145284|FG001|Phase 1|Withdrawal by Subject|1|||
157106938|NCT01848353|567145285|FG002|Phase 1|Withdrawal by Subject|0|||
157106939|NCT01848353|567145286|FG003|Phase 1|Withdrawal by Subject|0|||
157106940|NCT01848353|567145283|FG000|Phase 2|Withdrawal by Subject|3|||
157106941|NCT01848353|567145284|FG001|Phase 2|Withdrawal by Subject|2|||
157106942|NCT01848353|567145285|FG002|Phase 2|Withdrawal by Subject|0|||
157106943|NCT01848353|567145286|FG003|Phase 2|Withdrawal by Subject|0|||
157106944|NCT01848353|567145283|FG000|Phase 3|Withdrawal by Subject|1|||
157106945|NCT01848353|567145284|FG001|Phase 3|Withdrawal by Subject|1|||
157003263|NCT01050569|566762482|FG000|Overall Study|Physician Decision|3|||
157003264|NCT01050569|566762483|FG001|Overall Study|Physician Decision|3|||
157003265|NCT01050569|566762484|FG002|Overall Study|Physician Decision|3|||
157003266|NCT01713530|566762489|FG000|Overall Study|Adverse Event|0|||
157003267|NCT01713530|566762490|FG001|Overall Study|Adverse Event|5|||
157003268|NCT01713530|566762489|FG000|Overall Study|Withdrawal criteria|21|||
157003269|NCT01713530|566762490|FG001|Overall Study|Withdrawal criteria|12|||
157003270|NCT01713530|566762489|FG000|Overall Study|Unclassified|4|||
157003271|NCT01713530|566762490|FG001|Overall Study|Unclassified|2|||
157003272|NCT00758602|566762491|FG000|Overall Study|Adverse Event|11|||
157003273|NCT00758602|566762492|FG001|Overall Study|Adverse Event|10|||
157003274|NCT00758602|566762491|FG000|Overall Study|Lost to Follow-up|4|||
157003275|NCT00758602|566762492|FG001|Overall Study|Lost to Follow-up|3|||
157003276|NCT00758602|566762491|FG000|Overall Study|Withdrawal by Subject|1|||
157003277|NCT00758602|566762492|FG001|Overall Study|Withdrawal by Subject|3|||
157003278|NCT00758602|566762491|FG000|Overall Study|Protocol Violation|0|||
157003279|NCT00758602|566762492|FG001|Overall Study|Protocol Violation|2|||
157003280|NCT00758602|566762491|FG000|Overall Study|Death|0|||
157003281|NCT00758602|566762492|FG001|Overall Study|Death|1|||
157003282|NCT00758602|566762491|FG000|Overall Study|Reason not specified|3|||
157003283|NCT00758602|566762492|FG001|Overall Study|Reason not specified|3|||
157003284|NCT03939819|566762493|FG000|Overall Study|Death|2|||
157003285|NCT03939819|566762494|FG001|Overall Study|Death|0|||
157003286|NCT05046132|566762495|FG000|Overall Study|Adverse Event|4|||
157003287|NCT05046132|566762496|FG001|Overall Study|Adverse Event|0|||
157003288|NCT05046132|566762497|FG002|Overall Study|Adverse Event|0|||
157003289|NCT05046132|566762495|FG000|Overall Study|Withdrawal by Subject|3|||
157003290|NCT05046132|566762496|FG001|Overall Study|Withdrawal by Subject|0|||
157003291|NCT05046132|566762497|FG002|Overall Study|Withdrawal by Subject|0|||
157003292|NCT05046132|566762495|FG000|Overall Study|Positive Covid19 Result.|0|||
157003293|NCT05046132|566762496|FG001|Overall Study|Positive Covid19 Result.|1|||
157003294|NCT05046132|566762497|FG002|Overall Study|Positive Covid19 Result.|0|||
157003295|NCT02441036|566762498|FG000|Overall Study|No tissue resected|0|||
157003296|NCT02441036|566762499|FG001|Overall Study|No tissue resected|1|||
157003297|NCT02441036|566762500|FG002|Overall Study|No tissue resected|0|||
157003298|NCT02441036|566762501|FG003|Overall Study|No tissue resected|1|||
157003299|NCT02441036|566762502|FG004|Overall Study|No tissue resected|0|||
157003300|NCT02148133|566762507|FG000|Overall Study|Investigator discretion|1|||
157003301|NCT02148133|566762507|FG000|Overall Study|Lack of Efficacy|1|||
157003302|NCT02148133|566762507|FG000|Overall Study|Protocol deviation|1|||
157003303|NCT02148133|566762507|FG000|Overall Study|Protocol-defined stopping criteria|2|||
157003304|NCT03808883|566762508|FG000|Overall Study|Withdrawal by Subject|2|||
157003305|NCT03808883|566762509|FG001|Overall Study|Withdrawal by Subject|0|||
157003306|NCT03808883|566762508|FG000|Overall Study|Did not complete pre test or post test survey|4|||
157003307|NCT03808883|566762509|FG001|Overall Study|Did not complete pre test or post test survey|3|||
157003308|NCT00855465|566762511|FG000|Treatment Period|Adverse Event|4|||
157003309|NCT00855465|566762512|FG001|Treatment Period|Adverse Event|2|||
157003310|NCT00855465|566762511|FG000|Treatment Period|Death|2|||
157003311|NCT00855465|566762512|FG001|Treatment Period|Death|2|||
157003312|NCT00855465|566762511|FG000|Treatment Period|Lack of Efficacy|2|||
157003313|NCT00855465|566762512|FG001|Treatment Period|Lack of Efficacy|1|||
157003314|NCT00855465|566762511|FG000|Treatment Period|Non-compliance|1|||
157003315|NCT00855465|566762512|FG001|Treatment Period|Non-compliance|0|||
157003316|NCT00855465|566762511|FG000|Treatment Period|Protocol Violation|2|||
157003317|NCT00855465|566762512|FG001|Treatment Period|Protocol Violation|0|||
157003318|NCT00855465|566762511|FG000|Treatment Period|Withdrawal by Subject|2|||
157003319|NCT00855465|566762512|FG001|Treatment Period|Withdrawal by Subject|0|||
157003320|NCT00855465|566762511|FG000|Treatment Period|Not treated|1|||
157003321|NCT00855465|566762512|FG001|Treatment Period|Not treated|0|||
157003322|NCT00855465|566762511|FG000|Follow-up Period (FUP)|Adverse Event|0|||
157003323|NCT00855465|566762512|FG001|Follow-up Period (FUP)|Adverse Event|1|||
157003324|NCT00855465|566762511|FG000|Follow-up Period (FUP)|Death|0|||
157003325|NCT00855465|566762512|FG001|Follow-up Period (FUP)|Death|1|||
157003326|NCT00855465|566762511|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
157003327|NCT00855465|566762512|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
157003328|NCT00855465|566762511|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
157003329|NCT00855465|566762512|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
157106946|NCT01848353|567145285|FG002|Phase 3|Withdrawal by Subject|0|||
157106947|NCT01848353|567145286|FG003|Phase 3|Withdrawal by Subject|0|||
157106948|NCT03123250|567145292|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
157106949|NCT00773136|567145322|FG000|Overall Study|Physician Decision|2|||
157106950|NCT02463071|567145324|FG000|Overall Study|Adverse Event|3|||
157003330|NCT00855465|566762511|FG000|Follow-up Period (FUP)|Missing|1|||
157003331|NCT00855465|566762512|FG001|Follow-up Period (FUP)|Missing|0|||
157003332|NCT00079183|566762523|FG000|Overall Study|Withdrawal by Subject|4|||
157003333|NCT00079183|566762523|FG000|Overall Study|Study medication non-compliance|2|||
157003334|NCT00079183|566762523|FG000|Overall Study|Specimen collection non-compliance|1|||
157003335|NCT04173572|566762524|FG000|Overall Study|Withdrawal by Subject|1|||
157106951|NCT02463071|567145325|FG001|Overall Study|Adverse Event|5|||
157106952|NCT02463071|567145326|FG002|Overall Study|Adverse Event|1|||
157106953|NCT02463071|567145324|FG000|Overall Study|Death|1|||
157106954|NCT02463071|567145325|FG001|Overall Study|Death|0|||
157106955|NCT02463071|567145326|FG002|Overall Study|Death|0|||
157106956|NCT02463071|567145324|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
157106957|NCT02463071|567145325|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
157106958|NCT02463071|567145326|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
157106959|NCT02463071|567145324|FG000|Overall Study|Reason not specified|7|||
157106960|NCT02463071|567145325|FG001|Overall Study|Reason not specified|9|||
157106961|NCT02463071|567145326|FG002|Overall Study|Reason not specified|4|||
157003336|NCT04173572|566762525|FG001|Overall Study|Withdrawal by Subject|5|||
157003337|NCT04173572|566762524|FG000|Overall Study|Lost to Follow-up|3|||
157003338|NCT04173572|566762525|FG001|Overall Study|Lost to Follow-up|1|||
157003339|NCT03743246|566762526|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
157003340|NCT03743246|566762527|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
157003341|NCT03743246|566762528|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
157003342|NCT03743246|566762529|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
157003343|NCT03743246|566762526|FG000|Pre-Treatment Period|Death|0|||
157003344|NCT03743246|566762527|FG001|Pre-Treatment Period|Death|1|||
157003345|NCT03743246|566762528|FG002|Pre-Treatment Period|Death|0|||
157003346|NCT03743246|566762529|FG003|Pre-Treatment Period|Death|1|||
157003347|NCT03743246|566762526|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
157003348|NCT03743246|566762527|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
157003349|NCT03743246|566762528|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
157003350|NCT03743246|566762529|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
157003351|NCT03743246|566762526|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
157003352|NCT03743246|566762527|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
157003353|NCT03743246|566762528|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
157003354|NCT03743246|566762529|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
157003355|NCT03743246|566762526|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
157003356|NCT03743246|566762527|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
157003357|NCT03743246|566762528|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
157003358|NCT03743246|566762529|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
157003359|NCT03743246|566762526|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
157003360|NCT03743246|566762527|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
157003361|NCT03743246|566762528|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
157003362|NCT03743246|566762529|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
157003363|NCT03743246|566762526|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
157003364|NCT03743246|566762527|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
157003365|NCT03743246|566762528|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
157003366|NCT03743246|566762529|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
157003367|NCT03743246|566762526|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
157003368|NCT03743246|566762527|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
157003369|NCT03743246|566762528|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
157003370|NCT03743246|566762529|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
157003371|NCT03743246|566762526|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
157003372|NCT03743246|566762527|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
157003373|NCT03743246|566762528|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
157003374|NCT03743246|566762529|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
157003375|NCT04439799|566762530|FG000|Overall Study|Lost to Follow-up|6|||
157003376|NCT04439799|566762531|FG001|Overall Study|Lost to Follow-up|6|||
157003377|NCT04439799|566762530|FG000|Overall Study|Withdrawal by Subject|2|||
157003378|NCT04439799|566762531|FG001|Overall Study|Withdrawal by Subject|6|||
157003379|NCT04439799|566762530|FG000|Overall Study|Adverse Event|2|||
157003380|NCT04439799|566762531|FG001|Overall Study|Adverse Event|5|||
157003381|NCT00530842|566762532|FG000|Overall Study|Adverse Event|10|||
157003382|NCT00530842|566762533|FG001|Overall Study|Adverse Event|6|||
157003383|NCT00530842|566762532|FG000|Overall Study|Lack of Efficacy|2|||
157003384|NCT00530842|566762533|FG001|Overall Study|Lack of Efficacy|1|||
157003385|NCT00530842|566762532|FG000|Overall Study|Lost to Follow-up|0|||
157003386|NCT00530842|566762533|FG001|Overall Study|Lost to Follow-up|4|||
157003387|NCT00530842|566762532|FG000|Overall Study|Protocol Violation|3|||
157003388|NCT00530842|566762533|FG001|Overall Study|Protocol Violation|2|||
157003389|NCT00530842|566762532|FG000|Overall Study|Withdrawal by Subject|4|||
157003390|NCT00530842|566762533|FG001|Overall Study|Withdrawal by Subject|5|||
157106962|NCT02463071|567145324|FG000|Overall Study|Protocol Violation|0|||
157106963|NCT02463071|567145325|FG001|Overall Study|Protocol Violation|2|||
157106964|NCT02463071|567145326|FG002|Overall Study|Protocol Violation|0|||
157003391|NCT00530842|566762532|FG000|Overall Study|Individual different reasons|4|||
157003392|NCT00530842|566762533|FG001|Overall Study|Individual different reasons|3|||
157106965|NCT02463071|567145324|FG000|Overall Study|Lost to Follow-up|0|||
157003393|NCT00530842|566762532|FG000|Period 1|Adverse Event|7|||
157003394|NCT00530842|566762533|FG001|Period 1|Adverse Event|3|||
157003395|NCT00530842|566762532|FG000|Period 1|Lack of Efficacy|1|||
157003396|NCT00530842|566762533|FG001|Period 1|Lack of Efficacy|1|||
157003397|NCT00530842|566762532|FG000|Period 1|Protocol Violation|2|||
157003398|NCT00530842|566762533|FG001|Period 1|Protocol Violation|1|||
157003399|NCT00530842|566762532|FG000|Period 1|Withdrawal by Subject|2|||
157003400|NCT00530842|566762533|FG001|Period 1|Withdrawal by Subject|3|||
157003401|NCT00530842|566762532|FG000|Period 1|Individual different reasons|2|||
157003402|NCT00530842|566762533|FG001|Period 1|Individual different reasons|3|||
157003403|NCT00530842|566762532|FG000|Period 2|Adverse Event|3|||
157003404|NCT00530842|566762533|FG001|Period 2|Adverse Event|3|||
157003405|NCT00530842|566762532|FG000|Period 2|Lack of Efficacy|1|||
157003406|NCT00530842|566762533|FG001|Period 2|Lack of Efficacy|0|||
157003407|NCT00530842|566762532|FG000|Period 2|Lost to Follow-up|0|||
157003408|NCT00530842|566762533|FG001|Period 2|Lost to Follow-up|4|||
157003409|NCT00530842|566762532|FG000|Period 2|Protocol Violation|1|||
157003410|NCT00530842|566762533|FG001|Period 2|Protocol Violation|0|||
157003411|NCT00530842|566762532|FG000|Period 2|Withdrawal by Subject|1|||
157003412|NCT00530842|566762533|FG001|Period 2|Withdrawal by Subject|2|||
157003413|NCT00530842|566762532|FG000|Period 2|Individual different reasons|2|||
157003414|NCT00530842|566762533|FG001|Period 2|Individual different reasons|0|||
157003415|NCT00972504|566762546|FG000|Overall Study|Adverse Event|2|||
157003416|NCT00972504|566762546|FG000|Overall Study|Investigator discretion|1|||
157003417|NCT00716144|566762550|FG000|Overall Study|Withdrawal by Subject|4|||
157003418|NCT00716144|566762551|FG001|Overall Study|Withdrawal by Subject|2|||
157003419|NCT00716144|566762552|FG002|Overall Study|Withdrawal by Subject|6|||
157003420|NCT00716144|566762553|FG003|Overall Study|Withdrawal by Subject|6|||
157003421|NCT00716144|566762550|FG000|Overall Study|Lost to Follow-up|2|||
157003422|NCT00716144|566762551|FG001|Overall Study|Lost to Follow-up|2|||
157003423|NCT00716144|566762552|FG002|Overall Study|Lost to Follow-up|1|||
157003424|NCT00716144|566762553|FG003|Overall Study|Lost to Follow-up|2|||
157003425|NCT00716144|566762550|FG000|Overall Study|Adverse Event|0|||
157003426|NCT00716144|566762551|FG001|Overall Study|Adverse Event|0|||
157003427|NCT00716144|566762552|FG002|Overall Study|Adverse Event|0|||
157003428|NCT00716144|566762553|FG003|Overall Study|Adverse Event|2|||
157003429|NCT00716144|566762550|FG000|Overall Study|Non-compliance|1|||
157003430|NCT00716144|566762551|FG001|Overall Study|Non-compliance|0|||
157003431|NCT00716144|566762552|FG002|Overall Study|Non-compliance|0|||
157003432|NCT00716144|566762553|FG003|Overall Study|Non-compliance|0|||
157003433|NCT00716144|566762550|FG000|Overall Study|Protocol Violation|2|||
157003434|NCT00716144|566762551|FG001|Overall Study|Protocol Violation|0|||
157003435|NCT00716144|566762552|FG002|Overall Study|Protocol Violation|1|||
157003436|NCT00716144|566762553|FG003|Overall Study|Protocol Violation|0|||
157003437|NCT00716144|566762550|FG000|Overall Study|Physician Decision|0|||
157003438|NCT00716144|566762551|FG001|Overall Study|Physician Decision|1|||
157003439|NCT00716144|566762552|FG002|Overall Study|Physician Decision|2|||
157003440|NCT00716144|566762553|FG003|Overall Study|Physician Decision|2|||
157003441|NCT00716144|566762550|FG000|Overall Study|Intercurrent illness|0|||
157003442|NCT00716144|566762551|FG001|Overall Study|Intercurrent illness|0|||
157003443|NCT00716144|566762552|FG002|Overall Study|Intercurrent illness|1|||
157003444|NCT00716144|566762553|FG003|Overall Study|Intercurrent illness|0|||
157003445|NCT00716144|566762550|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
157106966|NCT02463071|567145325|FG001|Overall Study|Lost to Follow-up|0|||
157106967|NCT02463071|567145326|FG002|Overall Study|Lost to Follow-up|1|||
157106968|NCT00175877|567145342|FG000|Overall Study|Adverse Event|136|||
157106969|NCT00175877|567145342|FG000|Overall Study|Withdrawal by Subject|141|||
157106970|NCT00175877|567145342|FG000|Overall Study|Lost to Follow-up|9|||
157106971|NCT00175877|567145342|FG000|Overall Study|Lack of Efficacy|26|||
157106972|NCT00175877|567145342|FG000|Overall Study|Protocol Violation|15|||
157106973|NCT00175877|567145342|FG000|Overall Study|Other Reason|20|||
157106974|NCT00175877|567145342|FG000|Overall Study|AE & Other|1|||
157106975|NCT00175877|567145342|FG000|Overall Study|Withdrawal by subject & Other|1|||
157106976|NCT00805025|567145346|FG000|Overall Study|Screened but not enrolled/treated|42|||
157106977|NCT00805025|567145346|FG000|Overall Study|Adverse Event|4|||
157106978|NCT00805025|567145346|FG000|Overall Study|Withdrawal by Subject|2|||
157106979|NCT00805025|567145346|FG000|Overall Study|Physician Decision|1|||
157106980|NCT04029961|567145347|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
157106981|NCT04029961|567145348|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
157106982|NCT04029961|567145347|FG000|Overall Study|Change in Treatment Course|0|||
157106983|NCT04029961|567145348|FG001|Overall Study|Change in Treatment Course|1|||
157106984|NCT02737852|567146810|FG000|Overall Study|Withdrawal by Subject|2|||
157003446|NCT00716144|566762551|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
157003447|NCT00716144|566762552|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
157003448|NCT00716144|566762553|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
157003449|NCT00716144|566762550|FG000|Overall Study|Adverse event: left foot pain|0|||
157003450|NCT00716144|566762551|FG001|Overall Study|Adverse event: left foot pain|1|||
157003451|NCT00716144|566762552|FG002|Overall Study|Adverse event: left foot pain|0|||
157106985|NCT03688880|567146811|FG000|Overall Study|Withdrawal by Subject|0|||
157106986|NCT03688880|567146812|FG001|Overall Study|Withdrawal by Subject|2|||
157106987|NCT03688880|567146811|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
157106988|NCT03688880|567146812|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
157106989|NCT03688880|567146811|FG000|Overall Study|Lost to Follow-up|4|||
157106990|NCT03688880|567146812|FG001|Overall Study|Lost to Follow-up|7|||
157106991|NCT03688880|567146811|FG000|Overall Study|Adverse Event|0|||
157106992|NCT03688880|567146812|FG001|Overall Study|Adverse Event|2|||
157106993|NCT03688880|567146811|FG000|Overall Study|Device deficiencies|0|||
157106994|NCT03688880|567146812|FG001|Overall Study|Device deficiencies|2|||
157106995|NCT03688880|567146811|FG000|Overall Study|Other|10|||
157106996|NCT03688880|567146812|FG001|Overall Study|Other|16|||
157106997|NCT01704287|567146814|FG000|Initial Treatment Period|Death|139|||
157106998|NCT01704287|567146815|FG001|Initial Treatment Period|Death|129|||
157106999|NCT01704287|567146816|FG002|Initial Treatment Period|Death|71|||
157107000|NCT01704287|567146817|FG003|Initial Treatment Period|Death|0|||
157107001|NCT01704287|567146818|FG004|Initial Treatment Period|Death|0|||
157107002|NCT01704287|567146814|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
157107003|NCT01704287|567146815|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
157107004|NCT01704287|567146816|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
157107005|NCT01704287|567146817|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
157107006|NCT01704287|567146818|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
157107007|NCT01704287|567146814|FG000|Initial Treatment Period|Lost to Follow-up|5|||
157107008|NCT01704287|567146815|FG001|Initial Treatment Period|Lost to Follow-up|3|||
157107009|NCT01704287|567146816|FG002|Initial Treatment Period|Lost to Follow-up|0|||
157107010|NCT01704287|567146817|FG003|Initial Treatment Period|Lost to Follow-up|0|||
157107011|NCT01704287|567146818|FG004|Initial Treatment Period|Lost to Follow-up|0|||
157107012|NCT01704287|567146814|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
157107013|NCT01704287|567146815|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
157107014|NCT01704287|567146816|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
157107015|NCT01704287|567146817|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
157107016|NCT01704287|567146818|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
157107017|NCT01704287|567146814|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
157107018|NCT01704287|567146815|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
157107019|NCT01704287|567146816|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
157107020|NCT01704287|567146817|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
157107021|NCT01704287|567146818|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
157107022|NCT01704287|567146814|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
157107023|NCT01704287|567146815|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
157107024|NCT01704287|567146816|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
157107025|NCT01704287|567146817|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
157107026|NCT01704287|567146818|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
157107027|NCT01704287|567146814|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
157107028|NCT01704287|567146815|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
157107029|NCT01704287|567146816|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
157107030|NCT01704287|567146817|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
157107031|NCT01704287|567146818|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
157107032|NCT04042740|567146819|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
157107033|NCT04042740|567146819|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
157107034|NCT02615470|567146820|FG000|Overall Study|Lost to Follow-up|21|||
157107035|NCT02615470|567146821|FG001|Overall Study|Lost to Follow-up|32|||
157107036|NCT03713034|567146822|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
157107037|NCT03713034|567146823|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
157107038|NCT01717287|567146827|FG000|Overall Study|Lost to Follow-up|0|||
157107039|NCT01717287|567146828|FG001|Overall Study|Lost to Follow-up|2|||
157107040|NCT01717287|567146827|FG000|Overall Study|Protocol Violation|0|||
157107041|NCT01717287|567146828|FG001|Overall Study|Protocol Violation|1|||
157107042|NCT02982590|567146831|FG000|Overall Study|Lost to Follow-up|0|||
157107043|NCT02982590|567146832|FG001|Overall Study|Lost to Follow-up|1|||
157107044|NCT02982590|567146831|FG000|Overall Study|Death|4|||
157107045|NCT02982590|567146832|FG001|Overall Study|Death|0|||
157107046|NCT01858532|567146834|FG000|Overall Study|Adverse Event|58|||
157107047|NCT01858532|567146835|FG001|Overall Study|Adverse Event|50|||
157107048|NCT01858532|567146836|FG002|Overall Study|Adverse Event|23|||
157107049|NCT01858532|567146837|FG003|Overall Study|Adverse Event|28|||
157107050|NCT01858532|567146834|FG000|Overall Study|Withdrew consent|71|||
157107051|NCT01858532|567146835|FG001|Overall Study|Withdrew consent|93|||
157107052|NCT01858532|567146836|FG002|Overall Study|Withdrew consent|46|||
157107053|NCT01858532|567146837|FG003|Overall Study|Withdrew consent|27|||
157107054|NCT01858532|567146834|FG000|Overall Study|Lost to Follow-up|17|||
157107055|NCT01858532|567146835|FG001|Overall Study|Lost to Follow-up|26|||
157107056|NCT01858532|567146836|FG002|Overall Study|Lost to Follow-up|11|||
157107057|NCT01858532|567146837|FG003|Overall Study|Lost to Follow-up|14|||
157107058|NCT01858532|567146834|FG000|Overall Study|Deterioration of medical status|3|||
157107059|NCT01858532|567146835|FG001|Overall Study|Deterioration of medical status|4|||
157107060|NCT01858532|567146836|FG002|Overall Study|Deterioration of medical status|3|||
157107061|NCT01858532|567146837|FG003|Overall Study|Deterioration of medical status|7|||
157107062|NCT01858532|567146834|FG000|Overall Study|Investigator request|3|||
157107063|NCT01858532|567146835|FG001|Overall Study|Investigator request|4|||
157107064|NCT01858532|567146836|FG002|Overall Study|Investigator request|2|||
157107065|NCT01858532|567146837|FG003|Overall Study|Investigator request|6|||
157107066|NCT01858532|567146834|FG000|Overall Study|Other, not specified|29|||
157107067|NCT01858532|567146835|FG001|Overall Study|Other, not specified|15|||
157107068|NCT01858532|567146836|FG002|Overall Study|Other, not specified|13|||
157107069|NCT01858532|567146837|FG003|Overall Study|Other, not specified|11|||
157107070|NCT00514514|567146838|FG000|Pre-phase|Death|10|||
157107071|NCT00514514|567146839|FG001|Pre-phase|Death|0|||
157107072|NCT00514514|567146840|FG002|Pre-phase|Death|0|||
157107073|NCT00514514|567146838|FG000|Pre-phase|administrative problems|2|||
157107074|NCT00514514|567146839|FG001|Pre-phase|administrative problems|0|||
157107075|NCT00514514|567146840|FG002|Pre-phase|administrative problems|0|||
157107076|NCT00514514|567146838|FG000|Pre-phase|Protocol Violation|6|||
157003452|NCT00716144|566762553|FG003|Overall Study|Adverse event: left foot pain|0|||
157003453|NCT00716144|566762550|FG000|Overall Study|Clinical Depression|0|||
157003454|NCT00716144|566762551|FG001|Overall Study|Clinical Depression|1|||
157003455|NCT00716144|566762552|FG002|Overall Study|Clinical Depression|0|||
157003456|NCT00716144|566762553|FG003|Overall Study|Clinical Depression|0|||
157003457|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
157003458|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
157003459|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
157003460|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
157003461|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
157003462|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
157003463|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
157003464|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
157003465|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
157003466|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
157003467|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
157003468|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
157003469|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
157003470|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
157003471|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
157003472|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
157003473|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
157003474|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
157003475|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
157003476|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
157003477|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
157003478|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
157003479|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
157003480|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
157003481|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
157003482|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
157003483|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
157003484|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
157003485|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
157003486|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
157003487|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
157003488|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
157003489|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
157003490|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003491|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
157003492|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
157003493|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
157003494|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003495|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157107077|NCT00514514|567146839|FG001|Pre-phase|Protocol Violation|0|||
157107078|NCT00514514|567146840|FG002|Pre-phase|Protocol Violation|0|||
157107079|NCT00514514|567146838|FG000|Pre-phase|condition no longer requires study drug|7|||
157003496|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003497|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003498|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003499|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157107080|NCT00514514|567146839|FG001|Pre-phase|condition no longer requires study drug|0|||
157107081|NCT00514514|567146840|FG002|Pre-phase|condition no longer requires study drug|0|||
157107082|NCT00514514|567146838|FG000|Pre-phase|abnormal test procedure results|15|||
157107083|NCT00514514|567146839|FG001|Pre-phase|abnormal test procedure results|0|||
157107084|NCT00514514|567146840|FG002|Pre-phase|abnormal test procedure results|0|||
157107085|NCT00514514|567146838|FG000|Pre-phase|Lost to Follow-up|2|||
157107086|NCT00514514|567146839|FG001|Pre-phase|Lost to Follow-up|0|||
157107087|NCT00514514|567146840|FG002|Pre-phase|Lost to Follow-up|0|||
157107088|NCT00514514|567146838|FG000|Pre-phase|abnormal lab values|23|||
157107089|NCT00514514|567146839|FG001|Pre-phase|abnormal lab values|0|||
157107090|NCT00514514|567146840|FG002|Pre-phase|abnormal lab values|0|||
157107091|NCT00514514|567146838|FG000|Pre-phase|Lack of Efficacy|35|||
157107092|NCT00514514|567146839|FG001|Pre-phase|Lack of Efficacy|0|||
157107093|NCT00514514|567146840|FG002|Pre-phase|Lack of Efficacy|0|||
157107094|NCT00514514|567146838|FG000|Pre-phase|Adverse Event|137|||
157107095|NCT00514514|567146839|FG001|Pre-phase|Adverse Event|0|||
157107096|NCT00514514|567146840|FG002|Pre-phase|Adverse Event|0|||
157107097|NCT00514514|567146838|FG000|Pre-phase|Withdrawal by Subject|66|||
157107098|NCT00514514|567146839|FG001|Pre-phase|Withdrawal by Subject|0|||
157107099|NCT00514514|567146840|FG002|Pre-phase|Withdrawal by Subject|0|||
157107100|NCT00514514|567146838|FG000|Randomized - 9 Month|Death|3|||
157107101|NCT00514514|567146839|FG001|Randomized - 9 Month|Death|2|||
157107102|NCT00514514|567146840|FG002|Randomized - 9 Month|Death|2|||
157107103|NCT00514514|567146838|FG000|Randomized - 9 Month|Administrative problems|1|||
157107104|NCT00514514|567146839|FG001|Randomized - 9 Month|Administrative problems|1|||
157107105|NCT00514514|567146840|FG002|Randomized - 9 Month|Administrative problems|2|||
157107106|NCT00514514|567146838|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
157107107|NCT00514514|567146839|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
157107108|NCT00514514|567146840|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
157107109|NCT00514514|567146838|FG000|Randomized - 9 Month|Protocol Violation|1|||
157107110|NCT00514514|567146839|FG001|Randomized - 9 Month|Protocol Violation|1|||
157107111|NCT00514514|567146840|FG002|Randomized - 9 Month|Protocol Violation|0|||
157107112|NCT00514514|567146838|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
157107113|NCT00514514|567146839|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
157107114|NCT00514514|567146840|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
157107115|NCT00514514|567146838|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
157107116|NCT00514514|567146839|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
157107117|NCT00514514|567146840|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
157107118|NCT00514514|567146838|FG000|Randomized - 9 Month|Adverse Event|25|||
157107119|NCT00514514|567146839|FG001|Randomized - 9 Month|Adverse Event|44|||
157107120|NCT00514514|567146840|FG002|Randomized - 9 Month|Adverse Event|27|||
157107121|NCT00514514|567146838|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
157107122|NCT00514514|567146839|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
157107123|NCT00514514|567146840|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
157107124|NCT00514514|567146838|FG000|Extension - 4 Years|Lost to Follow-up|12|||
157107125|NCT00514514|567146839|FG001|Extension - 4 Years|Lost to Follow-up|10|||
157107126|NCT00514514|567146840|FG002|Extension - 4 Years|Lost to Follow-up|9|||
157107127|NCT00514514|567146838|FG000|Extension - 4 Years|Administrative problems|3|||
157107128|NCT00514514|567146839|FG001|Extension - 4 Years|Administrative problems|1|||
157107129|NCT00514514|567146840|FG002|Extension - 4 Years|Administrative problems|1|||
157107130|NCT00514514|567146838|FG000|Extension - 4 Years|Death|8|||
157107131|NCT00514514|567146839|FG001|Extension - 4 Years|Death|3|||
157107132|NCT00514514|567146840|FG002|Extension - 4 Years|Death|6|||
157107133|NCT00514514|567146838|FG000|Extension - 4 Years|Adverse Event|9|||
157107134|NCT00514514|567146839|FG001|Extension - 4 Years|Adverse Event|6|||
157107135|NCT00514514|567146840|FG002|Extension - 4 Years|Adverse Event|3|||
157107136|NCT02234479|567146842|FG000|Overall Study|Withdrawal by Subject|1|||
157107137|NCT02234479|567146843|FG001|Overall Study|Withdrawal by Subject|3|||
157107138|NCT02357134|567146846|FG000|Overall Study|Lost to Follow-up|1|||
157107139|NCT02357134|567146847|FG001|Overall Study|Lost to Follow-up|0|||
157107140|NCT02357134|567146848|FG002|Overall Study|Lost to Follow-up|0|||
157107141|NCT02357134|567146849|FG003|Overall Study|Lost to Follow-up|0|||
157107142|NCT02716675|567146850|FG000|Overall Study|Death|2|||
157107143|NCT02716675|567146851|FG001|Overall Study|Death|3|||
157107144|NCT02716675|567146852|FG002|Overall Study|Death|0|||
157107145|NCT02716675|567146850|FG000|Overall Study|Physician Decision|2|||
157107146|NCT02716675|567146851|FG001|Overall Study|Physician Decision|1|||
157107147|NCT02716675|567146852|FG002|Overall Study|Physician Decision|1|||
157107148|NCT02716675|567146850|FG000|Overall Study|Lost to Follow-up|100|||
157107149|NCT02716675|567146851|FG001|Overall Study|Lost to Follow-up|87|||
157107150|NCT02716675|567146852|FG002|Overall Study|Lost to Follow-up|99|||
157107151|NCT02716675|567146850|FG000|Overall Study|Withdrawal by Subject|22|||
157107152|NCT02716675|567146851|FG001|Overall Study|Withdrawal by Subject|25|||
157107153|NCT02716675|567146852|FG002|Overall Study|Withdrawal by Subject|20|||
157107154|NCT02716675|567146850|FG000|Overall Study|Protocol Violation|0|||
157107155|NCT02716675|567146851|FG001|Overall Study|Protocol Violation|3|||
157107156|NCT02716675|567146852|FG002|Overall Study|Protocol Violation|1|||
157107157|NCT02716675|567146850|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
157107158|NCT02716675|567146851|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
157107159|NCT02716675|567146852|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
157107160|NCT02716675|567146850|FG000|Overall Study|Other|38|||
157107161|NCT02716675|567146851|FG001|Overall Study|Other|47|||
157107162|NCT02716675|567146852|FG002|Overall Study|Other|48|||
157107163|NCT01211535|567146859|FG000|Overall Study|Adverse Event|0|||
157107164|NCT01211535|567146860|FG001|Overall Study|Adverse Event|1|||
157107165|NCT03593850|567146862|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
157107166|NCT03593850|567146863|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
157107167|NCT00003895|567146864|FG000|Overall Study|Adverse Event|4|||
157107168|NCT00003895|567146865|FG001|Overall Study|Adverse Event|0|||
157107169|NCT00003895|567146864|FG000|Overall Study|Lack of Efficacy|1|||
157107170|NCT00003895|567146865|FG001|Overall Study|Lack of Efficacy|1|||
157107171|NCT00003895|567146864|FG000|Overall Study|Patient Vacation|2|||
157107172|NCT00003895|567146865|FG001|Overall Study|Patient Vacation|0|||
157107173|NCT00003895|567146864|FG000|Overall Study|Withdrawal by Subject|0|||
157107174|NCT00003895|567146865|FG001|Overall Study|Withdrawal by Subject|3|||
157107175|NCT01380730|567146866|FG000|Overall Study|Death|0|||
157107176|NCT01380730|567146867|FG001|Overall Study|Death|0|||
157107177|NCT01380730|567146868|FG002|Overall Study|Death|0|||
157107178|NCT01380730|567146869|FG003|Overall Study|Death|0|||
157107179|NCT01380730|567146870|FG004|Overall Study|Death|1|||
157107180|NCT01380730|567146871|FG005|Overall Study|Death|0|||
157107181|NCT01380730|567146872|FG006|Overall Study|Death|0|||
157107182|NCT01380730|567146873|FG007|Overall Study|Death|0|||
157107183|NCT02490475|567146874|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
157107184|NCT02490475|567146875|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
157107185|NCT02490475|567146876|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
157107186|NCT02490475|567146877|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
157107187|NCT02490475|567146874|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
157107188|NCT02490475|567146875|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
157107189|NCT02490475|567146876|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
157107190|NCT02490475|567146877|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
157107191|NCT02490475|567146874|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
157107192|NCT02490475|567146875|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
157107193|NCT02490475|567146876|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
157107194|NCT02490475|567146877|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
157107195|NCT02490475|567146874|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
157107196|NCT02490475|567146875|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
157107197|NCT02490475|567146876|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
157107198|NCT02490475|567146877|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
157107199|NCT02490475|567146874|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
157107200|NCT02490475|567146875|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
157107201|NCT02490475|567146876|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
157107202|NCT02490475|567146877|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
157107203|NCT02490475|567146874|FG000|Period 2: Extension Phase|Refused Treatment|0|||
157107204|NCT02490475|567146875|FG001|Period 2: Extension Phase|Refused Treatment|0|||
157107205|NCT02490475|567146876|FG002|Period 2: Extension Phase|Refused Treatment|0|||
157107206|NCT02490475|567146877|FG003|Period 2: Extension Phase|Refused Treatment|1|||
157107207|NCT02490475|567146874|FG000|Period 2: Extension Phase|Adverse Event|0|||
157107208|NCT02490475|567146875|FG001|Period 2: Extension Phase|Adverse Event|0|||
157107209|NCT02490475|567146876|FG002|Period 2: Extension Phase|Adverse Event|1|||
157107210|NCT02490475|567146877|FG003|Period 2: Extension Phase|Adverse Event|0|||
157107211|NCT01195090|567146883|FG000|Overall Study|Adverse Event|1|||
157107212|NCT01195090|567146884|FG001|Overall Study|Adverse Event|2|||
157107213|NCT01195090|567146883|FG000|Overall Study|Lost to Follow-up|2|||
157107214|NCT01195090|567146884|FG001|Overall Study|Lost to Follow-up|2|||
157107215|NCT01195090|567146883|FG000|Overall Study|Protocol Violation|3|||
157107216|NCT01195090|567146884|FG001|Overall Study|Protocol Violation|4|||
157107217|NCT05111041|567146887|FG000|Overall Study|Lost to Follow-up|6|||
157107218|NCT05111041|567146888|FG001|Overall Study|Lost to Follow-up|7|||
157107219|NCT05111041|567146887|FG000|Overall Study|Withdrawal by Subject|1|||
157107220|NCT05111041|567146888|FG001|Overall Study|Withdrawal by Subject|0|||
157107221|NCT01011439|567146889|FG000|Overall Study|Death|37|||
157107222|NCT01011439|567146889|FG000|Overall Study|Lost to Follow-up|4|||
157107223|NCT01011439|567146889|FG000|Overall Study|Withdrawal by Subject|1|||
157107224|NCT01011439|567146889|FG000|Overall Study|Sponsor's decision|15|||
157107225|NCT01236573|567146892|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107226|NCT01236573|567146893|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107227|NCT01236573|567146894|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107228|NCT01236573|567146895|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107229|NCT01236573|567146896|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157003500|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
157003501|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003502|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003503|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003504|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003505|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
157003506|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003507|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003508|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003509|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003510|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003511|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
157003512|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
157003513|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003514|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003515|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003516|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003517|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003518|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003519|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003520|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003521|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003522|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
157003523|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
157003524|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
157003525|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
157003526|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
157003527|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
157003528|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
157003529|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
157003530|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
157003531|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
157003532|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
157003533|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
157003534|NCT02914522|566762554|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003535|NCT02914522|566762555|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
157003536|NCT02914522|566762556|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003537|NCT02914522|566762557|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003538|NCT02914522|566762558|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
157003539|NCT02914522|566762559|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
157003540|NCT02914522|566762560|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003541|NCT02914522|566762561|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003542|NCT02914522|566762562|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003543|NCT02914522|566762563|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003544|NCT02914522|566762564|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
157003545|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003546|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003547|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003548|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003549|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003550|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
157003551|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
157003552|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
157003553|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
157003554|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
157003555|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
157107230|NCT01236573|567146897|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107231|NCT01236573|567146898|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
157107232|NCT01236573|567146899|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107233|NCT01236573|567146900|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
157107234|NCT01236573|567146901|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
157107235|NCT01236573|567146902|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
157107236|NCT01236573|567146892|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107237|NCT01236573|567146893|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107238|NCT01236573|567146894|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107239|NCT01236573|567146895|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157003556|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003557|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003558|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003559|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003560|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003561|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
157003562|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
157003563|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
157003564|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
157003565|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
157003566|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
157003567|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003568|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003569|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003570|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003571|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003572|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003573|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
157003574|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
157003575|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
157003576|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
157003577|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
157003578|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003579|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003580|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003581|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003582|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003583|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
157003584|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
157003585|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
157003586|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
157003587|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
157003588|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
157003589|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
157003590|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
157003591|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
157003592|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
157003593|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
157003594|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
157003595|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
157003596|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
157003597|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
157003598|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
157003599|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
157003600|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003601|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003602|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003603|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003604|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003605|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003606|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003607|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
157003608|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
157003609|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003610|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
157003611|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003612|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003613|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003614|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003615|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003616|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003617|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003618|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003619|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
157107240|NCT01236573|567146896|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107241|NCT01236573|567146897|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107242|NCT01236573|567146898|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107243|NCT01236573|567146899|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107244|NCT01236573|567146900|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
157107245|NCT01236573|567146901|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107246|NCT01236573|567146902|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
157107247|NCT01236573|567146892|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107248|NCT01236573|567146893|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107249|NCT01236573|567146894|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107250|NCT01236573|567146895|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107251|NCT01236573|567146896|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107252|NCT01236573|567146897|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107253|NCT01236573|567146898|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107254|NCT01236573|567146899|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107255|NCT01236573|567146900|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107256|NCT01236573|567146901|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
157107257|NCT01236573|567146902|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
157107258|NCT00823823|567146905|FG000|Overall Study|Lost to Follow-up|3|||
157107259|NCT00823823|567146906|FG001|Overall Study|Lost to Follow-up|1|||
157107260|NCT00823823|567146905|FG000|Overall Study|Protocol Violation|5|||
157107261|NCT00823823|567146906|FG001|Overall Study|Protocol Violation|5|||
157107262|NCT00369785|567146911|FG000|Overall Study|Physician Decision|3|||
157107263|NCT00369785|567146912|FG001|Overall Study|Physician Decision|2|||
157107264|NCT00369785|567146911|FG000|Overall Study|Death|1|||
157107265|NCT00369785|567146912|FG001|Overall Study|Death|2|||
157107266|NCT00369785|567146911|FG000|Overall Study|Withdrawal by Subject|7|||
157107267|NCT00369785|567146912|FG001|Overall Study|Withdrawal by Subject|6|||
157107268|NCT00369785|567146911|FG000|Overall Study|Toxicity|6|||
157107269|NCT00369785|567146912|FG001|Overall Study|Toxicity|4|||
157107270|NCT00369785|567146911|FG000|Overall Study|Never started|0|||
157107271|NCT00369785|567146912|FG001|Overall Study|Never started|2|||
157107272|NCT00369785|567146911|FG000|Overall Study|Progression|4|||
157107273|NCT00369785|567146912|FG001|Overall Study|Progression|4|||
157107274|NCT00369785|567146911|FG000|Overall Study|Multiple reasons|6|||
157107275|NCT00369785|567146912|FG001|Overall Study|Multiple reasons|5|||
157107276|NCT00800683|567146913|FG000|Overall Study|Adverse Event|11|||
157107277|NCT00800683|567146914|FG001|Overall Study|Adverse Event|8|||
157107278|NCT00800683|567146913|FG000|Overall Study|Lost to Follow-up|3|||
157107279|NCT00800683|567146914|FG001|Overall Study|Lost to Follow-up|1|||
157107280|NCT00800683|567146913|FG000|Overall Study|Withdrawal by Subject|1|||
157107281|NCT00800683|567146914|FG001|Overall Study|Withdrawal by Subject|7|||
157107282|NCT00800683|567146913|FG000|Overall Study|Lack of Efficacy|1|||
157107283|NCT00800683|567146914|FG001|Overall Study|Lack of Efficacy|1|||
157107284|NCT00800683|567146913|FG000|Overall Study|Other|1|||
157107285|NCT00800683|567146914|FG001|Overall Study|Other|2|||
157107286|NCT02361944|567146915|FG000|Overall Study|surgery cancellation|0|||
157107287|NCT02361944|567146916|FG001|Overall Study|surgery cancellation|1|||
157107288|NCT04305275|567146919|FG000|Overall Study|Adverse Event|4|||
157107289|NCT04305275|567146920|FG001|Overall Study|Adverse Event|0|||
157107290|NCT04305275|567146919|FG000|Overall Study|Lost to Follow-up|1|||
157107291|NCT04305275|567146920|FG001|Overall Study|Lost to Follow-up|1|||
157107292|NCT04305275|567146919|FG000|Overall Study|Withdrawal by Participant|8|||
157107293|NCT04305275|567146920|FG001|Overall Study|Withdrawal by Participant|1|||
157107294|NCT00199836|567146923|FG000|Overall Study|Progressive Disease|5|||
157107295|NCT00199836|567146923|FG000|Overall Study|Death|1|||
157107296|NCT03061175|567146924|FG000|Baseline|Participant was deemed ineligible|1|||
157107297|NCT03061175|567146925|FG001|Baseline|Participant was deemed ineligible|0|||
157107298|NCT03061175|567146924|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
157107299|NCT03061175|567146925|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
157107300|NCT03061175|567146924|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
157107301|NCT03061175|567146925|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
157107302|NCT03061175|567146924|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
157107303|NCT03061175|567146925|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
157107304|NCT00760669|567146926|FG000|Overall Study|Not assessed for overall improvement|18|||
157107305|NCT00760669|567146926|FG000|Overall Study|Participants missing efficacy assessment|6|||
157107306|NCT00760669|567146926|FG000|Overall Study|Participants with overlapping cases|1|||
157107307|NCT00760669|567146926|FG000|Overall Study|Took drug before entering in contract|5|||
157107308|NCT02003014|567146928|FG000|Overall Study|Case report forms uncollected|9|||
157107309|NCT02003014|567146928|FG000|Overall Study|Treatment started after contract period|1|||
157107310|NCT02003014|567146928|FG000|Overall Study|Patient did not visit the study site|5|||
157107311|NCT02003014|567146928|FG000|Overall Study|Investigator's transfer|4|||
157107312|NCT02456662|567146931|FG000|Overall Study|Lost to Follow-up|2|||
157107313|NCT02456662|567146932|FG001|Overall Study|Lost to Follow-up|1|||
157107314|NCT00504153|567146937|FG000|Overall Study|Withdrawal by Subject|1|||
157107315|NCT00504153|567146937|FG000|Overall Study|Adverse Event|4|||
157107316|NCT00504153|567146937|FG000|Overall Study|Death|1|||
157107317|NCT00074581|567146939|FG000|Overall Study|Death|15|||
157107318|NCT00074581|567146940|FG001|Overall Study|Death|16|||
157107319|NCT00074581|567146939|FG000|Overall Study|Withdrawal by Subject|50|||
157107320|NCT00074581|567146940|FG001|Overall Study|Withdrawal by Subject|49|||
157107321|NCT00074581|567146939|FG000|Overall Study|Unable to adhere to visit schedule|13|||
157107322|NCT00074581|567146940|FG001|Overall Study|Unable to adhere to visit schedule|14|||
157107323|NCT00074581|567146939|FG000|Overall Study|Relocated|14|||
157107324|NCT00074581|567146940|FG001|Overall Study|Relocated|9|||
157107325|NCT00074581|567146939|FG000|Overall Study|Were withdrawn by investigator|5|||
157107326|NCT00074581|567146940|FG001|Overall Study|Were withdrawn by investigator|2|||
157107327|NCT00074581|567146939|FG000|Overall Study|Lost to Follow-up|16|||
157107328|NCT00074581|567146940|FG001|Overall Study|Lost to Follow-up|11|||
157107329|NCT00074581|567146939|FG000|Overall Study|Ended relationship w. index participant|117|||
157107330|NCT00074581|567146940|FG001|Overall Study|Ended relationship w. index participant|106|||
157107331|NCT00074581|567146939|FG000|Overall Study|Other|14|||
157107332|NCT00074581|567146940|FG001|Overall Study|Other|19|||
157107333|NCT01708291|567146941|FG000|Overall Study|fighting|2|||
157107334|NCT01708291|567146942|FG001|Overall Study|fighting|1|||
157107335|NCT00617604|567146943|FG000|Overall Study|Death|2|||
157107336|NCT00617604|567146944|FG001|Overall Study|Death|1|||
157107337|NCT00617604|567146943|FG000|Overall Study|Lost to Follow-up|1|||
157107338|NCT00617604|567146944|FG001|Overall Study|Lost to Follow-up|0|||
157107339|NCT00617604|567146943|FG000|Overall Study|Miscellaneous Reasons|8|||
157107340|NCT00617604|567146944|FG001|Overall Study|Miscellaneous Reasons|10|||
157107341|NCT00617604|567146943|FG000|Overall Study|Withdrawal by Subject|4|||
157107342|NCT00617604|567146944|FG001|Overall Study|Withdrawal by Subject|6|||
157107343|NCT00617604|567146943|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
157107344|NCT00617604|567146944|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
157107345|NCT02303704|567146945|FG000|Overall Study|Protocol Violation|5|||
157107346|NCT02303704|567146946|FG001|Overall Study|Protocol Violation|9|||
157107347|NCT04411628|567146948|FG000|Overall Study|Withdrawal by Subject|1|||
157107348|NCT04411628|567146949|FG001|Overall Study|Withdrawal by Subject|1|||
157107349|NCT04411628|567146950|FG002|Overall Study|Withdrawal by Subject|2|||
157107350|NCT04411628|567146951|FG003|Overall Study|Withdrawal by Subject|0|||
157107351|NCT04411628|567146948|FG000|Overall Study|Lost to Follow-up|0|||
157107352|NCT04411628|567146949|FG001|Overall Study|Lost to Follow-up|1|||
157107353|NCT04411628|567146950|FG002|Overall Study|Lost to Follow-up|0|||
157107354|NCT04411628|567146951|FG003|Overall Study|Lost to Follow-up|0|||
157107355|NCT02322125|567148513|FG000|Overall Study|Withdrawal by Subject|2|||
157107356|NCT00382720|567148514|FG000|Overall Study|Adverse Event|21|||
157107357|NCT00382720|567148515|FG001|Overall Study|Adverse Event|23|||
157107358|NCT00382720|567148516|FG002|Overall Study|Adverse Event|15|||
157107359|NCT00382720|567148514|FG000|Overall Study|Protocol Violation|2|||
157107360|NCT00382720|567148515|FG001|Overall Study|Protocol Violation|5|||
157107361|NCT00382720|567148516|FG002|Overall Study|Protocol Violation|1|||
157107362|NCT00382720|567148514|FG000|Overall Study|Death|0|||
157107363|NCT00382720|567148515|FG001|Overall Study|Death|1|||
157107364|NCT00382720|567148516|FG002|Overall Study|Death|2|||
157107365|NCT00382720|567148514|FG000|Overall Study|Progressive disease|37|||
157107366|NCT00382720|567148515|FG001|Overall Study|Progressive disease|28|||
157107367|NCT00382720|567148516|FG002|Overall Study|Progressive disease|38|||
157107368|NCT00382720|567148514|FG000|Overall Study|Withdrew consent|1|||
157107369|NCT00382720|567148515|FG001|Overall Study|Withdrew consent|1|||
157107370|NCT00382720|567148516|FG002|Overall Study|Withdrew consent|2|||
157107371|NCT00382720|567148514|FG000|Overall Study|Withdrawal by Subject|11|||
157107372|NCT00382720|567148515|FG001|Overall Study|Withdrawal by Subject|20|||
157107373|NCT00382720|567148516|FG002|Overall Study|Withdrawal by Subject|12|||
157107374|NCT00382720|567148514|FG000|Overall Study|Surgery|1|||
157107375|NCT00382720|567148515|FG001|Overall Study|Surgery|1|||
157107376|NCT00382720|567148516|FG002|Overall Study|Surgery|4|||
157107377|NCT00382720|567148514|FG000|Overall Study|Patient did not receive study medication|1|||
157107378|NCT00382720|567148515|FG001|Overall Study|Patient did not receive study medication|1|||
157107379|NCT00382720|567148516|FG002|Overall Study|Patient did not receive study medication|4|||
157107380|NCT00382720|567148514|FG000|Overall Study|Clinically progressive disease|0|||
157107381|NCT00382720|567148515|FG001|Overall Study|Clinically progressive disease|1|||
157107382|NCT00382720|567148516|FG002|Overall Study|Clinically progressive disease|0|||
157107383|NCT00382720|567148514|FG000|Overall Study|Good prognosis|0|||
157107384|NCT00382720|567148515|FG001|Overall Study|Good prognosis|1|||
157107385|NCT00382720|567148516|FG002|Overall Study|Good prognosis|0|||
157107386|NCT00382720|567148514|FG000|Overall Study|Investigator/Clinical decision|5|||
157107387|NCT00382720|567148515|FG001|Overall Study|Investigator/Clinical decision|6|||
157107388|NCT00382720|567148516|FG002|Overall Study|Investigator/Clinical decision|6|||
157107389|NCT00382720|567148514|FG000|Overall Study|Discontinued at end of study|0|||
157107390|NCT00382720|567148515|FG001|Overall Study|Discontinued at end of study|1|||
157107391|NCT00382720|567148516|FG002|Overall Study|Discontinued at end of study|2|||
157107392|NCT01183143|567148519|FG000|Overall Study|Protocol Violation|115|||
157107393|NCT01183143|567148519|FG000|Overall Study|Withdrawal by Subject|19|||
157107394|NCT01183143|567148519|FG000|Overall Study|Subject Questionnaires not returned|5|||
157107395|NCT01183143|567148519|FG000|Overall Study|Subjects enrolled, but not treated|11|||
157107396|NCT04096274|567148520|FG000|Phase I|Lost to Follow-up|5|||
157107397|NCT04096274|567148521|FG001|Phase I|Lost to Follow-up|5|||
157107398|NCT04096274|567148520|FG000|Phase II|Lost to Follow-up|11|||
157107399|NCT04096274|567148521|FG001|Phase II|Lost to Follow-up|11|||
157107400|NCT04024228|567148522|FG000|Overall Study|Adverse Event|1|||
157107401|NCT04024228|567148523|FG001|Overall Study|Adverse Event|0|||
157107402|NCT04024228|567148522|FG000|Overall Study|Protocol Deviation|0|||
157107403|NCT04024228|567148523|FG001|Overall Study|Protocol Deviation|2|||
157107404|NCT04024228|567148522|FG000|Overall Study|Withdrawal by Subject|3|||
157107405|NCT04024228|567148523|FG001|Overall Study|Withdrawal by Subject|4|||
157107406|NCT04490395|567148525|FG000|Overall Study|Lost to Follow-up|0|||
157107407|NCT04490395|567148526|FG001|Overall Study|Lost to Follow-up|1|||
157107408|NCT05092919|567148528|FG000|Overall Study|Lost to Follow-up|7|||
157107409|NCT05092919|567148528|FG000|Overall Study|Withdrawal by Subject|2|||
157107410|NCT01942148|567148532|FG000|Overall Study|Adverse Event|4|||
157107411|NCT01942148|567148532|FG000|Overall Study|Lack of Efficacy|2|||
157107412|NCT01942148|567148532|FG000|Overall Study|Physician Decision|11|||
157107413|NCT01942148|567148532|FG000|Overall Study|Protocol Violation|1|||
157107414|NCT01942148|567148532|FG000|Overall Study|Withdrawal by Subject|8|||
157107415|NCT01942148|567148532|FG000|Overall Study|Use of the prohibition medicine|1|||
157107416|NCT02248259|567148533|FG000|Treatment Period 1|Adverse Event|0|||
157107417|NCT02248259|567148534|FG001|Treatment Period 1|Adverse Event|0|||
157107418|NCT02248259|567148535|FG002|Treatment Period 1|Adverse Event|1|||
157107419|NCT02248259|567148536|FG003|Treatment Period 1|Adverse Event|0|||
157107420|NCT02807480|567148541|FG000|Overall Study|Withdrawal by Subject|14|||
157107421|NCT02807480|567148542|FG001|Overall Study|Withdrawal by Subject|10|||
157107422|NCT02369848|567148543|FG000|Overall Study|Death|1|||
157107423|NCT02369848|567148543|FG000|Overall Study|Withdrawal by Subject|2|||
157107424|NCT02369848|567148543|FG000|Overall Study|Lost to Follow-up|1|||
157107425|NCT02081534|567148550|FG000|Overall Study|Adverse Event|5|||
157107426|NCT02081534|567148551|FG001|Overall Study|Adverse Event|4|||
157107427|NCT02081534|567148552|FG002|Overall Study|Adverse Event|3|||
157107428|NCT02081534|567148553|FG003|Overall Study|Adverse Event|10|||
157107429|NCT02081534|567148554|FG004|Overall Study|Adverse Event|2|||
157107430|NCT02081534|567148555|FG005|Overall Study|Adverse Event|8|||
157107431|NCT02081534|567148556|FG006|Overall Study|Adverse Event|2|||
157107432|NCT02081534|567148550|FG000|Overall Study|Withdrawal by Subject|0|||
157107433|NCT02081534|567148551|FG001|Overall Study|Withdrawal by Subject|1|||
157107434|NCT02081534|567148552|FG002|Overall Study|Withdrawal by Subject|1|||
157107435|NCT02081534|567148553|FG003|Overall Study|Withdrawal by Subject|1|||
157107436|NCT02081534|567148554|FG004|Overall Study|Withdrawal by Subject|1|||
157107437|NCT02081534|567148555|FG005|Overall Study|Withdrawal by Subject|0|||
157107438|NCT02081534|567148556|FG006|Overall Study|Withdrawal by Subject|1|||
157107439|NCT02081534|567148550|FG000|Overall Study|Protocol Violation|0|||
157107440|NCT02081534|567148551|FG001|Overall Study|Protocol Violation|3|||
157107441|NCT02081534|567148552|FG002|Overall Study|Protocol Violation|0|||
157107442|NCT02081534|567148553|FG003|Overall Study|Protocol Violation|0|||
157107443|NCT02081534|567148554|FG004|Overall Study|Protocol Violation|0|||
157107444|NCT02081534|567148555|FG005|Overall Study|Protocol Violation|0|||
157107445|NCT02081534|567148556|FG006|Overall Study|Protocol Violation|1|||
157107446|NCT02081534|567148550|FG000|Overall Study|Lost to Follow-up|0|||
157107447|NCT02081534|567148551|FG001|Overall Study|Lost to Follow-up|0|||
157107448|NCT02081534|567148552|FG002|Overall Study|Lost to Follow-up|0|||
157107449|NCT02081534|567148553|FG003|Overall Study|Lost to Follow-up|2|||
157107450|NCT02081534|567148554|FG004|Overall Study|Lost to Follow-up|1|||
157107451|NCT02081534|567148555|FG005|Overall Study|Lost to Follow-up|1|||
157107452|NCT02081534|567148556|FG006|Overall Study|Lost to Follow-up|0|||
157107453|NCT00762892|567148557|FG000|Overall Study|Lost to Follow-up|2|||
157107454|NCT00762892|567148558|FG001|Overall Study|Lost to Follow-up|5|||
157107455|NCT00762892|567148557|FG000|Overall Study|Withdrawal by Subject|0|||
157107456|NCT00762892|567148558|FG001|Overall Study|Withdrawal by Subject|1|||
157107457|NCT00762892|567148557|FG000|Overall Study|Death|1|||
157107458|NCT00762892|567148558|FG001|Overall Study|Death|0|||
157107459|NCT00762892|567148557|FG000|Overall Study|Pregnancy|1|||
157107460|NCT00762892|567148558|FG001|Overall Study|Pregnancy|0|||
157107461|NCT00762892|567148557|FG000|Overall Study|Incarceration|1|||
157107462|NCT00762892|567148558|FG001|Overall Study|Incarceration|0|||
157107463|NCT01848288|567148561|FG000|Overall Study|Death|1|||
157107464|NCT01848288|567148561|FG000|Overall Study|Protocol Violation|1|||
157107465|NCT01848288|567148561|FG000|Overall Study|Withdrawal by Subject|1|||
157107466|NCT01007032|567148563|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
157107467|NCT01007032|567148564|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
157107468|NCT01007032|567148565|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
157107469|NCT01007032|567148566|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
157107470|NCT01007032|567148563|FG000|Overall Study|Withdrawal by Subject|0|||
157107471|NCT01007032|567148564|FG001|Overall Study|Withdrawal by Subject|0|||
157107472|NCT01007032|567148565|FG002|Overall Study|Withdrawal by Subject|0|||
157107473|NCT01007032|567148566|FG003|Overall Study|Withdrawal by Subject|1|||
157107474|NCT01841749|567148567|FG000|Overall Study|Protocol Violation|1|||
157107475|NCT00677820|567148568|FG000|Overall Study|Lost to Follow-up|1|||
157107476|NCT00677820|567148569|FG001|Overall Study|Lost to Follow-up|0|||
157107477|NCT01480284|567148577|FG000|Overall Study|Withdrawal by Subject|2|||
157107478|NCT01480284|567148578|FG001|Overall Study|Withdrawal by Subject|0|||
157107479|NCT01480284|567148577|FG000|Overall Study|Adverse Event|1|||
157107480|NCT01480284|567148578|FG001|Overall Study|Adverse Event|0|||
157107481|NCT01480284|567148577|FG000|Overall Study|Study closed/terminated|3|||
157107482|NCT01480284|567148578|FG001|Overall Study|Study closed/terminated|0|||
157107483|NCT01480284|567148577|FG000|Overall Study|Lost to Follow-up|1|||
157107484|NCT01480284|567148578|FG001|Overall Study|Lost to Follow-up|0|||
157107485|NCT01480284|567148577|FG000|Overall Study|Physician Decision|1|||
157107486|NCT01480284|567148578|FG001|Overall Study|Physician Decision|0|||
157107487|NCT00066742|567148581|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
157107488|NCT00066742|567148581|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
157107489|NCT00066742|567148581|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
157107490|NCT00066742|567148581|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
157107491|NCT00066742|567148581|FG000|Induction Chemoradiotherapy|Ineligible|3|||
157107492|NCT00066742|567148581|FG000|Consolidation Chemotherapy|not protocol specified|1|||
157107493|NCT00066742|567148581|FG000|Consolidation Chemotherapy|Ineligible|2|||
157107494|NCT00290290|567148583|FG000|Overall Study|Death|3|||
157107495|NCT00290290|567148584|FG001|Overall Study|Death|4|||
157107496|NCT00290290|567148583|FG000|Overall Study|Withdrawal by Subject|2|||
157107497|NCT00290290|567148584|FG001|Overall Study|Withdrawal by Subject|2|||
157107498|NCT00290290|567148583|FG000|Overall Study|Underwent clean surgical procedure|13|||
157107499|NCT00290290|567148584|FG001|Overall Study|Underwent clean surgical procedure|12|||
157107500|NCT03374995|567148587|FG000|Overall Study|Withdrawal by Subject|0|||
157107501|NCT03374995|567148588|FG001|Overall Study|Withdrawal by Subject|1|||
157107502|NCT04784897|567148591|FG000|Overall Study|Death|4|||
157107503|NCT04784897|567148592|FG001|Overall Study|Death|2|||
157107504|NCT04784897|567148593|FG002|Overall Study|Death|1|||
157107505|NCT04784897|567148591|FG000|Overall Study|Withdrawal by Subject|0|||
157107506|NCT04784897|567148592|FG001|Overall Study|Withdrawal by Subject|0|||
157107507|NCT04784897|567148593|FG002|Overall Study|Withdrawal by Subject|1|||
157107508|NCT04754802|567148598|FG000|Overall Study|Lost to Follow-up|0|||
157107509|NCT04754802|567148599|FG001|Overall Study|Lost to Follow-up|2|||
157107510|NCT04754802|567148598|FG000|Overall Study|Withdrawal by Subject|2|||
157107511|NCT04754802|567148599|FG001|Overall Study|Withdrawal by Subject|0|||
157107512|NCT00701090|567148600|FG000|Overall Study|Adverse Event|11|||
157107513|NCT00701090|567148601|FG001|Overall Study|Adverse Event|2|||
157107514|NCT00701090|567148600|FG000|Overall Study|Death|0|||
157107515|NCT00701090|567148601|FG001|Overall Study|Death|1|||
157107516|NCT00701090|567148600|FG000|Overall Study|Lack of Efficacy|5|||
157107517|NCT00701090|567148601|FG001|Overall Study|Lack of Efficacy|4|||
157107518|NCT00701090|567148600|FG000|Overall Study|Lost to Follow-up|9|||
157107519|NCT00701090|567148601|FG001|Overall Study|Lost to Follow-up|9|||
157107520|NCT00701090|567148600|FG000|Overall Study|Physician Decision|3|||
157107521|NCT00701090|567148601|FG001|Overall Study|Physician Decision|4|||
157107522|NCT00701090|567148600|FG000|Overall Study|Protocol Violation|2|||
157107523|NCT00701090|567148601|FG001|Overall Study|Protocol Violation|3|||
157107524|NCT00701090|567148600|FG000|Overall Study|Withdrawal by Subject|11|||
157107525|NCT00701090|567148601|FG001|Overall Study|Withdrawal by Subject|16|||
157107526|NCT00701090|567148600|FG000|Overall Study|Other|7|||
157107527|NCT00701090|567148601|FG001|Overall Study|Other|12|||
157107528|NCT00873366|567148602|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
157107529|NCT00873366|567148602|FG000|Overall Study|Off tamoxifen due to side effects|2|||
157107530|NCT00873366|567148602|FG000|Overall Study|Refused to continue DM-BT testing|3|||
157107531|NCT01490814|567148614|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
157107532|NCT01490814|567148615|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
157107533|NCT01490814|567148614|FG000|Overall Study|Physician Decision|1|||
157107534|NCT01490814|567148615|FG001|Overall Study|Physician Decision|0|||
157107535|NCT01490814|567148614|FG000|Overall Study|Withdrawal by Subject|0|||
157107536|NCT01490814|567148615|FG001|Overall Study|Withdrawal by Subject|5|||
157107537|NCT00496730|567148616|FG000|Overall Study|Lost to Follow-up|4|||
157107538|NCT00496730|567148617|FG001|Overall Study|Lost to Follow-up|3|||
157107539|NCT00496730|567148616|FG000|Overall Study|Withdrawal by Subject|2|||
157107540|NCT00496730|567148617|FG001|Overall Study|Withdrawal by Subject|2|||
157107541|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
157107542|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
157107543|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
157107544|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
157107545|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
157107546|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
157107547|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
157107548|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
157107549|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
157107550|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
157107551|NCT01299376|567148618|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
157107552|NCT01299376|567148619|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
157107553|NCT01299376|567148618|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
157107554|NCT01299376|567148619|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
157107555|NCT01299376|567148618|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
157107556|NCT01299376|567148619|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
157107557|NCT01299376|567148618|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
157107558|NCT01299376|567148619|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
157107559|NCT01299376|567148618|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
157107560|NCT01299376|567148619|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
157107561|NCT01299376|567148618|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
157107562|NCT01299376|567148619|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
157107563|NCT00935272|567148625|FG000|Overall Study|Lost to Follow-up|10|||
157107564|NCT00935272|567148626|FG001|Overall Study|Lost to Follow-up|3|||
157107565|NCT00935272|567148625|FG000|Overall Study|Withdrawal by Subject|8|||
157107566|NCT00935272|567148626|FG001|Overall Study|Withdrawal by Subject|2|||
157107567|NCT00935272|567148625|FG000|Overall Study|Physician Decision|1|||
157107568|NCT00935272|567148626|FG001|Overall Study|Physician Decision|0|||
157107569|NCT00935272|567148625|FG000|Overall Study|Protocol Violation|0|||
157107570|NCT00935272|567148626|FG001|Overall Study|Protocol Violation|1|||
157107571|NCT04340557|567148630|FG000|Overall Study|Transferred to ICU and/or death|1|||
157107572|NCT04340557|567148631|FG001|Overall Study|Transferred to ICU and/or death|2|||
157107573|NCT00529451|567148632|FG000|Overall Study|Subject withdrew consent|16|||
157107574|NCT00529451|567148633|FG001|Overall Study|Subject withdrew consent|21|||
157107575|NCT00529451|567148634|FG002|Overall Study|Subject withdrew consent|13|||
157107576|NCT00529451|567148635|FG003|Overall Study|Subject withdrew consent|12|||
157107577|NCT00529451|567148632|FG000|Overall Study|Adverse Event|9|||
157107578|NCT00529451|567148633|FG001|Overall Study|Adverse Event|16|||
157107579|NCT00529451|567148634|FG002|Overall Study|Adverse Event|14|||
157107580|NCT00529451|567148635|FG003|Overall Study|Adverse Event|8|||
157107581|NCT00529451|567148632|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
157107582|NCT00529451|567148633|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
157107583|NCT00529451|567148634|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
157107584|NCT00529451|567148635|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
157107585|NCT00529451|567148632|FG000|Overall Study|Lost to Follow-up|4|||
157107586|NCT00529451|567148633|FG001|Overall Study|Lost to Follow-up|7|||
157107587|NCT00529451|567148634|FG002|Overall Study|Lost to Follow-up|4|||
157107588|NCT00529451|567148635|FG003|Overall Study|Lost to Follow-up|4|||
157107589|NCT00529451|567148632|FG000|Overall Study|Protocol deviation|1|||
157107590|NCT00529451|567148633|FG001|Overall Study|Protocol deviation|1|||
157107591|NCT00529451|567148634|FG002|Overall Study|Protocol deviation|4|||
157107592|NCT00529451|567148635|FG003|Overall Study|Protocol deviation|1|||
157107593|NCT00529451|567148632|FG000|Overall Study|Administrative problems|1|||
157107594|NCT00529451|567148633|FG001|Overall Study|Administrative problems|1|||
157107595|NCT00529451|567148634|FG002|Overall Study|Administrative problems|0|||
157107596|NCT00529451|567148635|FG003|Overall Study|Administrative problems|2|||
157107597|NCT03700320|567148636|FG000|Overall Study|Adverse Event|5|||
157107598|NCT03700320|567148637|FG001|Overall Study|Adverse Event|31|||
157107599|NCT03700320|567148636|FG000|Overall Study|Lack of Efficacy|2|||
157107600|NCT03700320|567148637|FG001|Overall Study|Lack of Efficacy|5|||
157107601|NCT03700320|567148636|FG000|Overall Study|Withdrawal by Subject|29|||
157107602|NCT03700320|567148637|FG001|Overall Study|Withdrawal by Subject|75|||
157107603|NCT03700320|567148636|FG000|Overall Study|Lost to Follow-up|16|||
157107604|NCT03700320|567148637|FG001|Overall Study|Lost to Follow-up|23|||
157107605|NCT03700320|567148636|FG000|Overall Study|Pregnancy|2|||
157107606|NCT03700320|567148637|FG001|Overall Study|Pregnancy|4|||
157107607|NCT03700320|567148636|FG000|Overall Study|Protocol Deviation|7|||
157107608|NCT03700320|567148637|FG001|Overall Study|Protocol Deviation|31|||
157107609|NCT03700320|567148636|FG000|Overall Study|Non-compliance with Study Drug|1|||
157107610|NCT03700320|567148637|FG001|Overall Study|Non-compliance with Study Drug|3|||
157107611|NCT03700320|567148636|FG000|Overall Study|Reason not Specified|0|||
157107612|NCT03700320|567148637|FG001|Overall Study|Reason not Specified|1|||
157107613|NCT02054325|567148638|FG000|Overall Study|Lost to Follow-up|8|||
157107614|NCT02054325|567148639|FG001|Overall Study|Lost to Follow-up|5|||
157107615|NCT00932425|567148642|FG000|Overall Study|Lost to Follow-up|0|||
157107616|NCT00932425|567148643|FG001|Overall Study|Lost to Follow-up|1|||
157107617|NCT00932425|567148642|FG000|Overall Study|Withdrawal by Subject|0|||
157107618|NCT00932425|567148643|FG001|Overall Study|Withdrawal by Subject|1|||
157107619|NCT02844816|567148646|FG000|Overall Study|No protocol treatment received|5|||
157003620|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
157003621|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
157003622|NCT02914522|566762554|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003623|NCT02914522|566762555|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003624|NCT02914522|566762556|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003625|NCT02914522|566762557|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003626|NCT02914522|566762558|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003627|NCT02914522|566762559|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003628|NCT02914522|566762560|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003629|NCT02914522|566762561|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003630|NCT02914522|566762562|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003631|NCT02914522|566762563|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
157003632|NCT02914522|566762564|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
157003633|NCT02807493|566762570|FG000|Overall Study|Adverse Event|5|||
157003634|NCT02807493|566762571|FG001|Overall Study|Adverse Event|2|||
157003635|NCT02807493|566762570|FG000|Overall Study|Lost to Follow-up|6|||
157003636|NCT02807493|566762571|FG001|Overall Study|Lost to Follow-up|0|||
157003637|NCT02807493|566762570|FG000|Overall Study|Physician Decision|4|||
157003638|NCT02807493|566762571|FG001|Overall Study|Physician Decision|1|||
157003639|NCT02807493|566762570|FG000|Overall Study|Protocol Violation|7|||
157003640|NCT02807493|566762571|FG001|Overall Study|Protocol Violation|0|||
157003641|NCT02807493|566762570|FG000|Overall Study|Withdrawal by Subject|17|||
157003642|NCT02807493|566762571|FG001|Overall Study|Withdrawal by Subject|10|||
157003643|NCT02807493|566762570|FG000|Overall Study|Other withdrawal|17|||
157003644|NCT02807493|566762571|FG001|Overall Study|Other withdrawal|0|||
157003645|NCT02807493|566762570|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
157003646|NCT02807493|566762571|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
157003647|NCT01227707|566762572|FG000|Overall Study|Adverse Event|10|||
157003648|NCT01227707|566762572|FG000|Overall Study|Progression of disease|3|||
157003649|NCT01227707|566762572|FG000|Overall Study|Withdrawal by Subject|1|||
157003650|NCT01227707|566762572|FG000|Overall Study|Patient non-compliance|3|||
157003651|NCT01227707|566762572|FG000|Overall Study|Medical decision|6|||
157003652|NCT01227707|566762572|FG000|Overall Study|Death|1|||
157003653|NCT00823979|566762575|FG000|Overall Study|Lack of Efficacy|13|||
157003654|NCT00823979|566762576|FG001|Overall Study|Lack of Efficacy|16|||
157003655|NCT00823979|566762577|FG002|Overall Study|Lack of Efficacy|9|||
157003656|NCT00823979|566762575|FG000|Overall Study|Lost to Follow-up|2|||
157003657|NCT00823979|566762576|FG001|Overall Study|Lost to Follow-up|1|||
157003658|NCT00823979|566762577|FG002|Overall Study|Lost to Follow-up|0|||
157003659|NCT00823979|566762575|FG000|Overall Study|Withdrawal by Subject|2|||
157003660|NCT00823979|566762576|FG001|Overall Study|Withdrawal by Subject|3|||
157003661|NCT00823979|566762577|FG002|Overall Study|Withdrawal by Subject|2|||
157003662|NCT00823979|566762575|FG000|Overall Study|Protocol Violation|1|||
157003663|NCT00823979|566762576|FG001|Overall Study|Protocol Violation|1|||
157003664|NCT00823979|566762577|FG002|Overall Study|Protocol Violation|0|||
157003665|NCT00823979|566762575|FG000|Overall Study|Pregnancy|0|||
157003666|NCT00823979|566762576|FG001|Overall Study|Pregnancy|1|||
157003667|NCT00823979|566762577|FG002|Overall Study|Pregnancy|0|||
157003668|NCT00823979|566762575|FG000|Overall Study|Adverse Event|0|||
157003669|NCT00823979|566762576|FG001|Overall Study|Adverse Event|2|||
157003670|NCT00823979|566762577|FG002|Overall Study|Adverse Event|4|||
157003671|NCT00823979|566762575|FG000|Overall Study|Other|2|||
157003672|NCT00823979|566762576|FG001|Overall Study|Other|0|||
157003673|NCT00823979|566762577|FG002|Overall Study|Other|1|||
157003674|NCT00823979|566762575|FG000|Overall Study|Randomized but not Treated|4|||
157003675|NCT00823979|566762576|FG001|Overall Study|Randomized but not Treated|3|||
157003676|NCT00823979|566762577|FG002|Overall Study|Randomized but not Treated|1|||
157003677|NCT00823979|566762575|FG000|Overall Study|Study Terminated by Sponsor|5|||
157003678|NCT00823979|566762576|FG001|Overall Study|Study Terminated by Sponsor|5|||
157003679|NCT00823979|566762577|FG002|Overall Study|Study Terminated by Sponsor|7|||
157003680|NCT02289560|566762580|FG000|Overall Study|Lost to Follow-up|6|||
157003681|NCT02289560|566762580|FG000|Overall Study|Alternative Treatment|4|||
157003682|NCT02289560|566762580|FG000|Overall Study|Inadequate Treatment|2|||
157003683|NCT02289560|566762580|FG000|Overall Study|Withdrawal by Subject|23|||
157003684|NCT01264718|566762581|FG000|Overall Study|Lost to Follow-up|3|||
157003685|NCT01264718|566762582|FG001|Overall Study|Lost to Follow-up|2|||
157003686|NCT01264718|566762581|FG000|Overall Study|Withdrawal by Subject|9|||
157003687|NCT01264718|566762582|FG001|Overall Study|Withdrawal by Subject|15|||
157003688|NCT01264718|566762581|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
157003689|NCT01264718|566762582|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
157003690|NCT03386929|566762583|FG000|Overall Study|Death|0|||
157003691|NCT03386929|566762584|FG001|Overall Study|Death|0|||
157003692|NCT03386929|566762585|FG002|Overall Study|Death|1|||
157003693|NCT03386929|566762583|FG000|Overall Study|Withdrawal by Subject|0|||
157107620|NCT02844816|567148647|FG001|Overall Study|No protocol treatment received|1|||
157107621|NCT02844816|567148646|FG000|Overall Study|Ineligible|22|||
157107622|NCT02844816|567148647|FG001|Overall Study|Ineligible|15|||
157107623|NCT02844816|567148646|FG000|Overall Study|Participant refusal|5|||
157107624|NCT02844816|567148647|FG001|Overall Study|Participant refusal|5|||
157107625|NCT02844816|567148646|FG000|Overall Study|Adverse Event|5|||
157107626|NCT02844816|567148647|FG001|Overall Study|Adverse Event|4|||
157107627|NCT02844816|567148646|FG000|Overall Study|Death|0|||
157107628|NCT02844816|567148647|FG001|Overall Study|Death|1|||
157107629|NCT02844816|567148646|FG000|Overall Study|Disease progression/recurrence|50|||
157107630|NCT02844816|567148647|FG001|Overall Study|Disease progression/recurrence|24|||
157107631|NCT02844816|567148646|FG000|Overall Study|Physician Decision|1|||
157107632|NCT02844816|567148647|FG001|Overall Study|Physician Decision|1|||
157107633|NCT01200238|567148649|FG000|Overall Study|Adverse Event|2|||
157107634|NCT01200238|567148650|FG001|Overall Study|Adverse Event|1|||
157107635|NCT01200238|567148649|FG000|Overall Study|Progressive Disease|5|||
157107636|NCT01200238|567148650|FG001|Overall Study|Progressive Disease|8|||
157107637|NCT01200238|567148649|FG000|Overall Study|Withdrawal by Subject|0|||
157107638|NCT01200238|567148650|FG001|Overall Study|Withdrawal by Subject|1|||
157107639|NCT02717754|567148651|FG000|Overall Study|Incorrect Infusion Duration|0|||
157107640|NCT02717754|567148652|FG001|Overall Study|Incorrect Infusion Duration|0|||
157107641|NCT02717754|567148653|FG002|Overall Study|Incorrect Infusion Duration|0|||
157107642|NCT02717754|567148654|FG003|Overall Study|Incorrect Infusion Duration|10|||
157107643|NCT02717754|567148655|FG004|Overall Study|Incorrect Infusion Duration|20|||
157107644|NCT02717754|567148656|FG005|Overall Study|Incorrect Infusion Duration|20|||
157107645|NCT00482703|567148657|FG000|Overall Study|Poor compliance|1|||
157107646|NCT00482703|567148658|FG001|Overall Study|Poor compliance|0|||
157107647|NCT00667823|567148660|FG000|Overall Study|Lost to Follow-up|5|||
157107648|NCT00667823|567148660|FG000|Overall Study|Adverse Event|7|||
157107649|NCT00667823|567148660|FG000|Overall Study|Death|182|||
157107650|NCT00667823|567148660|FG000|Overall Study|Withdrawal by Subject|12|||
157107651|NCT00667823|567148660|FG000|Overall Study|Other|8|||
157107652|NCT00667823|567148660|FG000|Overall Study|Missing (completion page missing)|2|||
157107653|NCT01428661|567148663|FG000|Double-Masked Phase|Protocol Violation|9|||
157107654|NCT01428661|567148664|FG001|Double-Masked Phase|Protocol Violation|4|||
157107655|NCT01428661|567148665|FG002|Double-Masked Phase|Protocol Violation|0|||
157107656|NCT01428661|567148663|FG000|Double-Masked Phase|Adverse Event|13|||
157107657|NCT01428661|567148664|FG001|Double-Masked Phase|Adverse Event|4|||
157107658|NCT01428661|567148665|FG002|Double-Masked Phase|Adverse Event|0|||
157107659|NCT01428661|567148663|FG000|Double-Masked Phase|Lost to Follow-up|14|||
157107660|NCT01428661|567148664|FG001|Double-Masked Phase|Lost to Follow-up|14|||
157107661|NCT01428661|567148665|FG002|Double-Masked Phase|Lost to Follow-up|0|||
157107662|NCT01428661|567148663|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
157107663|NCT01428661|567148664|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
157107664|NCT01428661|567148665|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
157107665|NCT01428661|567148663|FG000|Double-Masked Phase|Lack of Efficacy|2|||
157107666|NCT01428661|567148664|FG001|Double-Masked Phase|Lack of Efficacy|1|||
157107667|NCT01428661|567148665|FG002|Double-Masked Phase|Lack of Efficacy|0|||
157107668|NCT01428661|567148663|FG000|Double-Masked Phase|*Various|1|||
157107669|NCT01428661|567148664|FG001|Double-Masked Phase|*Various|6|||
157107670|NCT01428661|567148665|FG002|Double-Masked Phase|*Various|0|||
157107671|NCT01428661|567148663|FG000|Open Label Extension|Protocol Violation|0|||
157107672|NCT01428661|567148664|FG001|Open Label Extension|Protocol Violation|0|||
157107673|NCT01428661|567148665|FG002|Open Label Extension|Protocol Violation|9|||
157107674|NCT01428661|567148663|FG000|Open Label Extension|Adverse Event|0|||
157107675|NCT01428661|567148664|FG001|Open Label Extension|Adverse Event|0|||
157107676|NCT01428661|567148665|FG002|Open Label Extension|Adverse Event|15|||
157107677|NCT01428661|567148663|FG000|Open Label Extension|Lost to Follow-up|0|||
157107678|NCT01428661|567148664|FG001|Open Label Extension|Lost to Follow-up|0|||
157107679|NCT01428661|567148665|FG002|Open Label Extension|Lost to Follow-up|38|||
157107680|NCT01428661|567148663|FG000|Open Label Extension|Withdrawal by Subject|0|||
157107681|NCT01428661|567148664|FG001|Open Label Extension|Withdrawal by Subject|0|||
157107682|NCT01428661|567148665|FG002|Open Label Extension|Withdrawal by Subject|49|||
157107683|NCT01428661|567148663|FG000|Open Label Extension|Lack of Efficacy|0|||
157107684|NCT01428661|567148664|FG001|Open Label Extension|Lack of Efficacy|0|||
157107685|NCT01428661|567148665|FG002|Open Label Extension|Lack of Efficacy|24|||
157107686|NCT01428661|567148663|FG000|Open Label Extension|**Various|0|||
157107687|NCT01428661|567148664|FG001|Open Label Extension|**Various|0|||
157107688|NCT01428661|567148665|FG002|Open Label Extension|**Various|185|||
157107689|NCT03828292|567148666|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
157107690|NCT03828292|567148667|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
157107691|NCT03828292|567148668|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
157107692|NCT03828292|567148669|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
157107693|NCT03828292|567148670|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
157107694|NCT03828292|567148671|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
157107695|NCT03828292|567148666|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
157107696|NCT03828292|567148667|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
157107697|NCT03828292|567148668|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
157107698|NCT03828292|567148669|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
157107699|NCT03828292|567148670|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
157107700|NCT03828292|567148671|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
157107701|NCT03828292|567148666|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
157107702|NCT03828292|567148667|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
157107703|NCT03828292|567148668|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
157107704|NCT03828292|567148669|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
157107705|NCT03828292|567148670|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
157107706|NCT03828292|567148671|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
157107707|NCT03828292|567148666|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
157107708|NCT03828292|567148667|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
157107709|NCT03828292|567148668|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
157107710|NCT03828292|567148669|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
157107711|NCT03828292|567148670|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
157107712|NCT03828292|567148671|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
157107713|NCT03828292|567148666|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
157107714|NCT03828292|567148667|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
157107715|NCT03828292|567148668|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
157107716|NCT03828292|567148669|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
157107717|NCT03828292|567148670|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
157107718|NCT03828292|567148671|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
157107719|NCT04376827|567148672|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
157107720|NCT04376827|567148673|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
157107721|NCT04376827|567148672|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
157107722|NCT04376827|567148673|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
157107723|NCT04376827|567148672|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
157107724|NCT04376827|567148673|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
157107725|NCT04376827|567148672|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
157107726|NCT04376827|567148673|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
157107727|NCT04376827|567148672|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
157107728|NCT04376827|567148673|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
157107729|NCT03697720|567150151|FG000|Overall Study|Lost to Follow-up|7|||
157107730|NCT03496012|567150152|FG000|Overall Study|Withdrawal by Subject|2|||
157107731|NCT03496012|567150153|FG001|Overall Study|Withdrawal by Subject|0|||
157107732|NCT03496012|567150154|FG002|Overall Study|Withdrawal by Subject|2|||
157107733|NCT03496012|567150152|FG000|Overall Study|Adverse Event|0|||
157107734|NCT03496012|567150153|FG001|Overall Study|Adverse Event|0|||
157107735|NCT03496012|567150154|FG002|Overall Study|Adverse Event|1|||
157107736|NCT03496012|567150152|FG000|Overall Study|Reason Not Specified|2|||
157107737|NCT03496012|567150153|FG001|Overall Study|Reason Not Specified|0|||
157107738|NCT03496012|567150154|FG002|Overall Study|Reason Not Specified|1|||
157107739|NCT01490450|567150157|FG000|Period 1|Lack of Efficacy|2|||
157107740|NCT01490450|567150158|FG001|Period 1|Lack of Efficacy|0|||
157107741|NCT01490450|567150159|FG002|Period 1|Lack of Efficacy|3|||
157107742|NCT01490450|567150160|FG003|Period 1|Lack of Efficacy|0|||
157107743|NCT01490450|567150157|FG000|Period 1|Adverse Event|0|||
157107744|NCT01490450|567150158|FG001|Period 1|Adverse Event|0|||
157107745|NCT01490450|567150159|FG002|Period 1|Adverse Event|0|||
157107746|NCT01490450|567150160|FG003|Period 1|Adverse Event|5|||
157107747|NCT01490450|567150157|FG000|Period 1|Request to discontinue treatment|1|||
157107748|NCT01490450|567150158|FG001|Period 1|Request to discontinue treatment|0|||
157107749|NCT01490450|567150159|FG002|Period 1|Request to discontinue treatment|0|||
157107750|NCT01490450|567150160|FG003|Period 1|Request to discontinue treatment|0|||
157107751|NCT01490450|567150157|FG000|Period 1|Withdrawal by Subject|0|||
157107752|NCT01490450|567150158|FG001|Period 1|Withdrawal by Subject|0|||
157107753|NCT01490450|567150159|FG002|Period 1|Withdrawal by Subject|0|||
157107754|NCT01490450|567150160|FG003|Period 1|Withdrawal by Subject|3|||
157107755|NCT01490450|567150157|FG000|Period 1|No longer met study criteria|0|||
157107756|NCT01490450|567150158|FG001|Period 1|No longer met study criteria|1|||
157107757|NCT01490450|567150159|FG002|Period 1|No longer met study criteria|1|||
157107758|NCT01490450|567150160|FG003|Period 1|No longer met study criteria|0|||
157107759|NCT01490450|567150157|FG000|Period 2|Lack of Efficacy|0|||
157107760|NCT01490450|567150158|FG001|Period 2|Lack of Efficacy|0|||
157107761|NCT01490450|567150159|FG002|Period 2|Lack of Efficacy|0|||
157107762|NCT01490450|567150160|FG003|Period 2|Lack of Efficacy|1|||
157107763|NCT01490450|567150157|FG000|Period 2|Adverse Event|1|||
157107764|NCT01490450|567150158|FG001|Period 2|Adverse Event|1|||
157107765|NCT01490450|567150159|FG002|Period 2|Adverse Event|0|||
157107766|NCT01490450|567150160|FG003|Period 2|Adverse Event|1|||
157107767|NCT01490450|567150157|FG000|Period 2|Withdrawal by Subject|1|||
157107768|NCT01490450|567150158|FG001|Period 2|Withdrawal by Subject|0|||
157107769|NCT01490450|567150159|FG002|Period 2|Withdrawal by Subject|0|||
157107770|NCT01490450|567150160|FG003|Period 2|Withdrawal by Subject|0|||
157107771|NCT01490450|567150157|FG000|Period 2|Lost to Follow-up|0|||
157107772|NCT01490450|567150158|FG001|Period 2|Lost to Follow-up|0|||
157107773|NCT01490450|567150159|FG002|Period 2|Lost to Follow-up|0|||
157107774|NCT01490450|567150160|FG003|Period 2|Lost to Follow-up|2|||
157107775|NCT00404820|567150161|FG000|Overall Study|Adverse Event|4|||
157107776|NCT00404820|567150162|FG001|Overall Study|Adverse Event|16|||
157107777|NCT00404820|567150161|FG000|Overall Study|Withdrawal by Subject|5|||
157107778|NCT00404820|567150162|FG001|Overall Study|Withdrawal by Subject|3|||
157107779|NCT00404820|567150161|FG000|Overall Study|Lost to Follow-up|7|||
157107780|NCT00404820|567150162|FG001|Overall Study|Lost to Follow-up|3|||
157107781|NCT00404820|567150161|FG000|Overall Study|Administrative problems|2|||
157107782|NCT00404820|567150162|FG001|Overall Study|Administrative problems|0|||
157107783|NCT00404820|567150161|FG000|Overall Study|Death|1|||
157107784|NCT00404820|567150162|FG001|Overall Study|Death|0|||
157107785|NCT00404820|567150161|FG000|Overall Study|Other|0|||
157107786|NCT00404820|567150162|FG001|Overall Study|Other|2|||
157107787|NCT00938717|567150163|FG000|Overall Study|Adverse Event|10|||
157107788|NCT00938717|567150164|FG001|Overall Study|Adverse Event|41|||
157107789|NCT00938717|567150163|FG000|Overall Study|Protocol Violation|11|||
157107790|NCT00938717|567150164|FG001|Overall Study|Protocol Violation|8|||
157107791|NCT00938717|567150163|FG000|Overall Study|Withdrawal by Subject|26|||
157107792|NCT00938717|567150164|FG001|Overall Study|Withdrawal by Subject|24|||
157107793|NCT00938717|567150163|FG000|Overall Study|Lost to Follow-up|13|||
157107794|NCT00938717|567150164|FG001|Overall Study|Lost to Follow-up|18|||
157107795|NCT00938717|567150163|FG000|Overall Study|Lack of Efficacy|33|||
157107796|NCT00938717|567150164|FG001|Overall Study|Lack of Efficacy|15|||
157107797|NCT00938717|567150163|FG000|Overall Study|Other reason|5|||
157107798|NCT00938717|567150164|FG001|Overall Study|Other reason|2|||
157107799|NCT00096785|567150166|FG000|Overall Study|Lost to Follow-up|1|||
157107800|NCT00096785|567150167|FG001|Overall Study|Lost to Follow-up|0|||
157107801|NCT00096785|567150166|FG000|Overall Study|Withdrawal by Subject|0|||
157107802|NCT00096785|567150167|FG001|Overall Study|Withdrawal by Subject|1|||
157107803|NCT00096785|567150166|FG000|Overall Study|Relocated|1|||
157107804|NCT00096785|567150167|FG001|Overall Study|Relocated|0|||
157107805|NCT01838616|567150168|FG000|Titration Period|Adverse Event|18|||
157107806|NCT01838616|567150169|FG001|Titration Period|Adverse Event|48|||
157107807|NCT01838616|567150168|FG000|Titration Period|Lack of Efficacy|5|||
157107808|NCT01838616|567150169|FG001|Titration Period|Lack of Efficacy|12|||
157107809|NCT01838616|567150168|FG000|Titration Period|Withdrawal by Subject|5|||
157107810|NCT01838616|567150169|FG001|Titration Period|Withdrawal by Subject|5|||
157107811|NCT01838616|567150168|FG000|Titration Period|Technical problems|1|||
157107812|NCT01838616|567150169|FG001|Titration Period|Technical problems|0|||
157107813|NCT01838616|567150168|FG000|Titration Period|Other|1|||
157107814|NCT01838616|567150169|FG001|Titration Period|Other|0|||
157107815|NCT01838616|567150168|FG000|Titration Period|Protocol Violation|0|||
157107816|NCT01838616|567150169|FG001|Titration Period|Protocol Violation|1|||
157107817|NCT01838616|567150168|FG000|Continuation Period|Lack of Efficacy|3|||
157107818|NCT01838616|567150169|FG001|Continuation Period|Lack of Efficacy|5|||
157107819|NCT01838616|567150168|FG000|Continuation Period|Adverse Event|8|||
157107820|NCT01838616|567150169|FG001|Continuation Period|Adverse Event|4|||
157107821|NCT01838616|567150168|FG000|Continuation Period|Protocol Violation|2|||
157107822|NCT01838616|567150169|FG001|Continuation Period|Protocol Violation|0|||
157107823|NCT01838616|567150168|FG000|Continuation Period|Lost to Follow-up|1|||
157107824|NCT01838616|567150169|FG001|Continuation Period|Lost to Follow-up|0|||
157107825|NCT01838616|567150168|FG000|Continuation Period|Withdrawal by Subject|0|||
157107826|NCT01838616|567150169|FG001|Continuation Period|Withdrawal by Subject|4|||
157107827|NCT01838616|567150168|FG000|Continuation Period|Technical problems|0|||
157107828|NCT01838616|567150169|FG001|Continuation Period|Technical problems|1|||
157107829|NCT01838616|567150168|FG000|Pick-up Arm|Lack of Efficacy|4|||
157107830|NCT01838616|567150169|FG001|Pick-up Arm|Lack of Efficacy|0|||
157107831|NCT01838616|567150168|FG000|Pick-up Arm|Adverse Event|9|||
157107832|NCT01838616|567150169|FG001|Pick-up Arm|Adverse Event|0|||
157107833|NCT01838616|567150168|FG000|Pick-up Arm|Withdrawal by Subject|1|||
157107834|NCT01838616|567150169|FG001|Pick-up Arm|Withdrawal by Subject|0|||
157107835|NCT01838616|567150168|FG000|Pick-up Arm|Technical problems|1|||
157107836|NCT01838616|567150169|FG001|Pick-up Arm|Technical problems|0|||
157107837|NCT00257725|567150170|FG000|Overall Study|Adverse Event|3|||
157107838|NCT02573870|567150171|FG000|Overall Study|Adverse Event|0|||
157107839|NCT02573870|567150172|FG001|Overall Study|Adverse Event|2|||
157107840|NCT02573870|567150171|FG000|Overall Study|Lack of Efficacy|0|||
157107841|NCT02573870|567150172|FG001|Overall Study|Lack of Efficacy|1|||
157107842|NCT02573870|567150171|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
157107843|NCT02573870|567150172|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
157107844|NCT02573870|567150171|FG000|Overall Study|Lost to Follow-up|0|||
157107845|NCT02573870|567150172|FG001|Overall Study|Lost to Follow-up|1|||
157107846|NCT02573870|567150171|FG000|Overall Study|Other: Fail to Meet Visit|0|||
157107847|NCT02573870|567150172|FG001|Overall Study|Other: Fail to Meet Visit|2|||
157107848|NCT00709111|567150174|FG000|Overall Study|Withdrawal by Subject|1|||
157107849|NCT00709111|567150174|FG000|Overall Study|Unable to attend clinic visits|1|||
157107850|NCT00915772|567150175|FG000|Overall Study|Adverse Event|12|||
157107851|NCT00915772|567150176|FG001|Overall Study|Adverse Event|13|||
157107852|NCT00915772|567150177|FG002|Overall Study|Adverse Event|11|||
157107853|NCT00915772|567150175|FG000|Overall Study|Protocol Violation|4|||
157107854|NCT00915772|567150176|FG001|Overall Study|Protocol Violation|1|||
157107855|NCT00915772|567150177|FG002|Overall Study|Protocol Violation|2|||
157107856|NCT00915772|567150175|FG000|Overall Study|Lost to Follow-up|1|||
157107857|NCT00915772|567150176|FG001|Overall Study|Lost to Follow-up|2|||
157107858|NCT00915772|567150177|FG002|Overall Study|Lost to Follow-up|2|||
157107859|NCT00915772|567150175|FG000|Overall Study|Lack of Efficacy|9|||
157107860|NCT00915772|567150176|FG001|Overall Study|Lack of Efficacy|15|||
157107861|NCT00915772|567150177|FG002|Overall Study|Lack of Efficacy|3|||
157107862|NCT00915772|567150175|FG000|Overall Study|Refused to continue trial medication|6|||
157107863|NCT00915772|567150176|FG001|Overall Study|Refused to continue trial medication|8|||
157107864|NCT00915772|567150177|FG002|Overall Study|Refused to continue trial medication|4|||
157107865|NCT00915772|567150175|FG000|Overall Study|Any other reason|4|||
157107866|NCT00915772|567150176|FG001|Overall Study|Any other reason|7|||
157107867|NCT00915772|567150177|FG002|Overall Study|Any other reason|7|||
157107868|NCT00549939|567150181|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
157107869|NCT00549939|567150182|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
157107870|NCT00549939|567150183|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
157107871|NCT00549939|567150181|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
157107872|NCT00549939|567150182|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
157107873|NCT00549939|567150183|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
157107874|NCT00549939|567150181|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
157107875|NCT00549939|567150182|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
157107876|NCT00549939|567150183|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
157107877|NCT00549939|567150181|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
157107878|NCT00549939|567150182|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
157107879|NCT00549939|567150183|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
157107880|NCT00549939|567150181|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
157107881|NCT00549939|567150182|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
157107882|NCT00549939|567150183|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
157107883|NCT00549939|567150181|FG000|40-week Open Label Treatment Period|Other|0|||
157107884|NCT00549939|567150182|FG001|40-week Open Label Treatment Period|Other|1|||
157107885|NCT00549939|567150183|FG002|40-week Open Label Treatment Period|Other|4|||
157107886|NCT01735279|567150184|FG000|Overall Study|Lost to Follow-up|11|||
157107887|NCT01735279|567150185|FG001|Overall Study|Lost to Follow-up|8|||
157107888|NCT00806195|567150186|FG000|Overall Study|Death|6|||
157107889|NCT00806195|567150187|FG001|Overall Study|Death|0|||
157107890|NCT00806195|567150188|FG002|Overall Study|Death|1|||
157107891|NCT00806195|567150189|FG003|Overall Study|Death|0|||
157107892|NCT00806195|567150186|FG000|Overall Study|Adverse Event|25|||
157107893|NCT00806195|567150187|FG001|Overall Study|Adverse Event|5|||
157107894|NCT00806195|567150188|FG002|Overall Study|Adverse Event|11|||
157107895|NCT00806195|567150189|FG003|Overall Study|Adverse Event|2|||
157107896|NCT00806195|567150186|FG000|Overall Study|Withdrawal by Subject|119|||
157107897|NCT00806195|567150187|FG001|Overall Study|Withdrawal by Subject|31|||
157107898|NCT00806195|567150188|FG002|Overall Study|Withdrawal by Subject|76|||
157107899|NCT00806195|567150189|FG003|Overall Study|Withdrawal by Subject|35|||
157107900|NCT00806195|567150186|FG000|Overall Study|Lost to Follow-up|217|||
157107901|NCT00806195|567150187|FG001|Overall Study|Lost to Follow-up|66|||
157107902|NCT00806195|567150188|FG002|Overall Study|Lost to Follow-up|90|||
157107903|NCT00806195|567150189|FG003|Overall Study|Lost to Follow-up|34|||
157107904|NCT00806195|567150186|FG000|Overall Study|Inappropriate Enrollment|0|||
157107905|NCT00806195|567150187|FG001|Overall Study|Inappropriate Enrollment|1|||
157107906|NCT00806195|567150188|FG002|Overall Study|Inappropriate Enrollment|0|||
157107907|NCT00806195|567150189|FG003|Overall Study|Inappropriate Enrollment|0|||
157107908|NCT00806195|567150186|FG000|Overall Study|Administrative Reason|113|||
157107909|NCT00806195|567150187|FG001|Overall Study|Administrative Reason|35|||
157107910|NCT00806195|567150188|FG002|Overall Study|Administrative Reason|66|||
157107911|NCT00806195|567150189|FG003|Overall Study|Administrative Reason|26|||
157107912|NCT00806195|567150186|FG000|Overall Study|Protocol Violation|34|||
157107913|NCT00806195|567150187|FG001|Overall Study|Protocol Violation|24|||
157107914|NCT00806195|567150188|FG002|Overall Study|Protocol Violation|26|||
157107915|NCT00806195|567150189|FG003|Overall Study|Protocol Violation|9|||
157107916|NCT02319668|567150193|FG000|Overall Study|Other (Not specified)|0|||
157107917|NCT02319668|567150194|FG001|Overall Study|Other (Not specified)|2|||
157107918|NCT01161043|567150195|FG000|Overall Study|Withdrawal by Subject|3|||
157107919|NCT02164929|567150196|FG000|Overall Study|Converted to open procedure|1|||
157107920|NCT02164929|567150197|FG001|Overall Study|Converted to open procedure|0|||
157107921|NCT02164929|567150198|FG002|Overall Study|Converted to open procedure|0|||
157107922|NCT02164929|567150199|FG003|Overall Study|Converted to open procedure|2|||
157107923|NCT02164929|567150196|FG000|Overall Study|Failed regional block|0|||
157107924|NCT02164929|567150197|FG001|Overall Study|Failed regional block|0|||
157107925|NCT02164929|567150198|FG002|Overall Study|Failed regional block|1|||
157107926|NCT02164929|567150199|FG003|Overall Study|Failed regional block|0|||
157107927|NCT00365456|567150200|FG000|Trial Period I (12 Months)|Adverse Event|84|||
157107928|NCT00365456|567150201|FG001|Trial Period I (12 Months)|Adverse Event|0|||
157107929|NCT00365456|567150200|FG000|Trial Period I (12 Months)|Non-compliance|3|||
157107930|NCT00365456|567150201|FG001|Trial Period I (12 Months)|Non-compliance|0|||
157107931|NCT00365456|567150200|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
157107932|NCT00365456|567150201|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
157107933|NCT00365456|567150200|FG000|Trial Period I (12 Months)|Other|11|||
157107934|NCT00365456|567150201|FG001|Trial Period I (12 Months)|Other|0|||
157107935|NCT00365456|567150200|FG000|Trial Period II (12 Months)|Adverse Event|0|||
157107936|NCT00365456|567150201|FG001|Trial Period II (12 Months)|Adverse Event|6|||
157107937|NCT00365456|567150200|FG000|Trial Period II (12 Months)|Non-compliance|0|||
157107938|NCT00365456|567150201|FG001|Trial Period II (12 Months)|Non-compliance|2|||
157107939|NCT00365456|567150200|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
157107940|NCT00365456|567150201|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
157107941|NCT00365456|567150200|FG000|Trial Period II (12 Months)|Other|0|||
157107942|NCT00365456|567150201|FG001|Trial Period II (12 Months)|Other|1|||
157107943|NCT00365456|567150200|FG000|Trial Period III (12 Months)|Adverse Event|13|||
157107944|NCT00365456|567150201|FG001|Trial Period III (12 Months)|Adverse Event|3|||
157107945|NCT00365456|567150200|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
157107946|NCT00365456|567150201|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
157107947|NCT00365456|567150200|FG000|Trial Period III (12 Months)|Other|1|||
157107948|NCT00365456|567150201|FG001|Trial Period III (12 Months)|Other|1|||
157107949|NCT01537198|567150203|FG000|Overall Study|RSV infection|2|||
157107950|NCT01537198|567150203|FG000|Overall Study|Adverse Event|4|||
157107951|NCT01537198|567150203|FG000|Overall Study|No Further Visits to the Clinic|37|||
157107952|NCT01537198|567150203|FG000|Overall Study|Other|111|||
157107953|NCT00113074|567150210|FG000|Overall Study|Lost to Follow-up|10|||
157107954|NCT00113074|567150211|FG001|Overall Study|Lost to Follow-up|10|||
157107955|NCT00113074|567150212|FG002|Overall Study|Lost to Follow-up|14|||
157107956|NCT03680911|567150213|FG000|At Home Treatment|Study Termination|3|||
157107957|NCT03680911|567150214|FG001|At Home Treatment|Study Termination|0|||
157107958|NCT03680911|567150213|FG000|At Home Treatment|Lost to Follow-up|0|||
157107959|NCT03680911|567150214|FG001|At Home Treatment|Lost to Follow-up|1|||
157107960|NCT03680911|567150213|FG000|At Home Treatment|Withdrawal by Subject|0|||
157107961|NCT03680911|567150214|FG001|At Home Treatment|Withdrawal by Subject|2|||
157107962|NCT03680911|567150213|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
157107963|NCT03680911|567150214|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
157107964|NCT03962738|567150217|FG000|Overall Study|Protocol Deviation|3|||
157107965|NCT03962738|567150218|FG001|Overall Study|Protocol Deviation|0|||
157107966|NCT03962738|567150219|FG002|Overall Study|Protocol Deviation|1|||
157107967|NCT03962738|567150220|FG003|Overall Study|Protocol Deviation|1|||
157107968|NCT03962738|567150217|FG000|Overall Study|Withdrawal by Subject|4|||
157107969|NCT03962738|567150218|FG001|Overall Study|Withdrawal by Subject|0|||
157107970|NCT03962738|567150219|FG002|Overall Study|Withdrawal by Subject|0|||
157107971|NCT03962738|567150220|FG003|Overall Study|Withdrawal by Subject|0|||
157107972|NCT03962738|567150217|FG000|Overall Study|Lost to Follow-up|0|||
157107973|NCT03962738|567150218|FG001|Overall Study|Lost to Follow-up|0|||
157107974|NCT03962738|567150219|FG002|Overall Study|Lost to Follow-up|1|||
157107975|NCT03962738|567150220|FG003|Overall Study|Lost to Follow-up|0|||
157107976|NCT02170779|567150221|FG000|Overall Study|Withdrawal by Subject|1|||
157107977|NCT02170779|567150222|FG001|Overall Study|Withdrawal by Subject|0|||
157107978|NCT02170779|567150221|FG000|Overall Study|Lost to Follow-up|0|||
157107979|NCT02170779|567150222|FG001|Overall Study|Lost to Follow-up|1|||
157107980|NCT03492554|567150223|FG000|Overall Study|Protocol Violation|0|||
157107981|NCT03492554|567150224|FG001|Overall Study|Protocol Violation|14|||
157107982|NCT01478360|567150225|FG000|Overall Study|Lost to Follow-up|1|||
157107983|NCT01478360|567150226|FG001|Overall Study|Lost to Follow-up|0|||
157107984|NCT01478360|567150225|FG000|Overall Study|Adverse Event|0|||
157107985|NCT01478360|567150226|FG001|Overall Study|Adverse Event|1|||
157107986|NCT01478360|567150225|FG000|Overall Study|Administrative problems|1|||
157107987|NCT01478360|567150226|FG001|Overall Study|Administrative problems|2|||
157107988|NCT01221727|567150227|FG000|Overall Study|Physician Decision|2|||
157107989|NCT01221727|567150228|FG001|Overall Study|Physician Decision|0|||
157107990|NCT01221727|567150227|FG000|Overall Study|Withdrawal by Subject|1|||
157107991|NCT01221727|567150228|FG001|Overall Study|Withdrawal by Subject|1|||
157107992|NCT02566577|567150229|FG000|Overall Study|Withdrawal by Subject|1|||
157107993|NCT02566577|567150230|FG001|Overall Study|Withdrawal by Subject|1|||
157107994|NCT02566577|567150229|FG000|Overall Study|Equipment failure|1|||
157107995|NCT02566577|567150230|FG001|Overall Study|Equipment failure|1|||
157107996|NCT02566577|567150229|FG000|Overall Study|Physical limitation|1|||
157107997|NCT02566577|567150230|FG001|Overall Study|Physical limitation|0|||
156761962|NCT05616013|565879949|FG005|Overall Study|Non-compliance with study requirements|2|||
156761963|NCT05616013|565879950|FG006|Overall Study|Non-compliance with study requirements|1|||
157003694|NCT03386929|566762584|FG001|Overall Study|Withdrawal by Subject|1|||
157003695|NCT03386929|566762585|FG002|Overall Study|Withdrawal by Subject|0|||
157003696|NCT03386929|566762583|FG000|Overall Study|Physician Decision|0|||
157003697|NCT03386929|566762584|FG001|Overall Study|Physician Decision|0|||
157003698|NCT03386929|566762585|FG002|Overall Study|Physician Decision|1|||
157003699|NCT03386929|566762583|FG000|Overall Study|Progression|4|||
157003700|NCT03386929|566762584|FG001|Overall Study|Progression|4|||
157003701|NCT03386929|566762585|FG002|Overall Study|Progression|0|||
157003702|NCT03386929|566762583|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
157003703|NCT03386929|566762584|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
157003704|NCT03386929|566762585|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
157003705|NCT03386929|566762583|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
157003706|NCT03386929|566762584|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
157003707|NCT03386929|566762585|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
157003708|NCT03545984|566762586|FG000|Overall Study|CSF cases not present during rotation|11|||
157003709|NCT03545984|566762587|FG001|Overall Study|CSF cases not present during rotation|9|||
157003710|NCT01244828|566762588|FG000|Overall Study|Adverse Event|37|||
157003711|NCT01244828|566762588|FG000|Overall Study|Withdrawal by Subject|31|||
157003712|NCT01244828|566762588|FG000|Overall Study|Lack of Efficacy|7|||
157003713|NCT01244828|566762588|FG000|Overall Study|Lost to Follow-up|2|||
157003714|NCT01244828|566762588|FG000|Overall Study|Other reason (not specified)|1|||
157003715|NCT05233085|566762589|FG000|Overall Study|Adverse Event|1|||
157003716|NCT05233085|566762590|FG001|Overall Study|Adverse Event|0|||
157003717|NCT05233085|566762591|FG002|Overall Study|Adverse Event|0|||
157003718|NCT05233085|566762592|FG003|Overall Study|Adverse Event|0|||
157003719|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
157003720|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
157003721|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
157003722|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003723|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003724|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003725|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003726|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003727|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157003728|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
157003729|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
157003730|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
157003731|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003732|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003733|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003734|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003735|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003736|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157003737|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
157003738|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
157003739|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
157003740|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003741|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003742|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003743|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003744|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003745|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157003746|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
157003747|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003748|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
157003749|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003750|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003751|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003752|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003753|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003754|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157003755|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
157003756|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
157003757|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
157003758|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003759|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003760|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003761|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003762|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003763|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157003764|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003765|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
157003766|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
157003767|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003768|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003769|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003770|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003771|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003772|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157003773|NCT01212757|566762593|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
157003774|NCT01212757|566762594|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
157003775|NCT01212757|566762595|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003776|NCT01212757|566762596|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003777|NCT01212757|566762597|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003778|NCT01212757|566762598|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003779|NCT01212757|566762599|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003780|NCT01212757|566762600|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003781|NCT01212757|566762601|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157003782|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
157003783|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
157003784|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
157003785|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
157003786|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
157003787|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
157003788|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
157003789|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
157003790|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
157003791|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
157003792|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
157003793|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
157003794|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
157003795|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
157003796|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
157003797|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
157003798|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
157003799|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
157003800|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003801|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003802|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
157003803|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003804|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003805|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003806|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003807|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157003808|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
157107998|NCT01289821|567150231|FG000|Treatment Period|Withdrawal by Subject|1|||
157107999|NCT01289821|567150231|FG000|Treatment Period|Physician Decision|3|||
157108000|NCT01289821|567150231|FG000|Treatment Period|Adverse Event|4|||
157108001|NCT01289821|567150231|FG000|Treatment Period|Radiological Progression|43|||
157108002|NCT01289821|567150231|FG000|Treatment Period|Clinical Progression|2|||
157108003|NCT01289821|567150231|FG000|Treatment Period|Therapeutic procedure required|1|||
157108004|NCT01289821|567150231|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
157108005|NCT01289821|567150231|FG000|Safety Follow-up Period|Protocol Violation|3|||
157108006|NCT01289821|567150231|FG000|Safety Follow-up Period|Unspecified reason|1|||
157108007|NCT01289821|567150231|FG000|Survival Follow-up Period|Protocol Violation|1|||
157108008|NCT01289821|567150231|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
157108009|NCT01289821|567150231|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
157108010|NCT02941926|567150232|FG000|Core Phase|Progressive disease|1109|||
157108011|NCT02941926|567150232|FG000|Core Phase|Adverse Event|504|||
157108012|NCT02941926|567150232|FG000|Core Phase|Subject/guardian decision|127|||
157108013|NCT02941926|567150232|FG000|Core Phase|Physician Decision|112|||
157003809|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
157003810|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
157003811|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
157003812|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
157003813|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
157003814|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
157003815|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
157003816|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
157003817|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
157003818|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003819|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
157003820|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003821|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003822|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
157003823|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003824|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003825|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003826|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
157003827|NCT01212757|566762593|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003828|NCT01212757|566762594|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
157003829|NCT01212757|566762595|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
157003830|NCT01212757|566762596|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003831|NCT01212757|566762597|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003832|NCT01212757|566762598|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003833|NCT01212757|566762599|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003834|NCT01212757|566762600|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003835|NCT01212757|566762601|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
157003836|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003837|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003838|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003839|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003840|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003841|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003842|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003843|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
157003844|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
157003845|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
157003846|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
157003847|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
157003848|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
157003849|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
157003850|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
157003851|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
157003852|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
157003853|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
157003854|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003855|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
157003856|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
157003857|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003858|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003859|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003860|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003861|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
157003862|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
157003863|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157003864|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
157003865|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
157003866|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157003867|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157003868|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157003869|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157003870|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
157003871|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
157003872|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003873|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003874|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
157003875|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157108014|NCT02941926|567150232|FG000|Core Phase|Death|46|||
157003876|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003877|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003878|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003879|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003880|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
157003881|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003882|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
157003883|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
157003884|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003885|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003886|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003887|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003888|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
157003889|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
157003890|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
157003891|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
157003892|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
157003893|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
157003894|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
157003895|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
157003896|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
157003897|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
157003898|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
157003899|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003900|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003901|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
157003902|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003903|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003904|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003905|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003906|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003907|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
157003908|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157003909|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
157003910|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
157003911|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157003912|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157003913|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157003914|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157003915|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
157003916|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
157003917|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003918|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003919|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003920|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003921|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003922|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003923|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003924|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
157003925|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
157003926|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003927|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
157003928|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003929|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003930|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003931|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003932|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003933|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003934|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
157003935|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003936|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003937|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
157003938|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003939|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003940|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003941|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157003942|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
157108015|NCT02941926|567150232|FG000|Core Phase|Protocol deviation|34|||
157108016|NCT02941926|567150232|FG000|Core Phase|Lost to Follow-up|8|||
157108017|NCT02941926|567150232|FG000|Core Phase|Technical problems|5|||
157108018|NCT02941926|567150232|FG000|Extension Phase|Physician Decision|155|||
157108019|NCT02941926|567150232|FG000|Extension Phase|Progressive disease|115|||
157108020|NCT02941926|567150232|FG000|Extension Phase|Adverse Event|13|||
157108021|NCT02941926|567150232|FG000|Extension Phase|Subject/Guardian decision|12|||
157108022|NCT02941926|567150232|FG000|Extension Phase|Death|6|||
157108023|NCT00097773|567150233|FG000|Overall Study|Lost to Follow-up|2|||
157108024|NCT00097773|567150234|FG001|Overall Study|Lost to Follow-up|2|||
157108025|NCT00097773|567150235|FG002|Overall Study|Lost to Follow-up|0|||
157108026|NCT00097773|567150236|FG003|Overall Study|Lost to Follow-up|1|||
157108027|NCT00097773|567150233|FG000|Overall Study|Physician Decision|2|||
157108028|NCT00097773|567150234|FG001|Overall Study|Physician Decision|2|||
157108029|NCT00097773|567150235|FG002|Overall Study|Physician Decision|3|||
157108030|NCT00097773|567150236|FG003|Overall Study|Physician Decision|1|||
157108031|NCT00097773|567150233|FG000|Overall Study|Withdrawal by Subject|3|||
157108032|NCT00097773|567150234|FG001|Overall Study|Withdrawal by Subject|3|||
157108033|NCT00097773|567150235|FG002|Overall Study|Withdrawal by Subject|3|||
157108034|NCT00097773|567150236|FG003|Overall Study|Withdrawal by Subject|1|||
157108035|NCT00097773|567150233|FG000|Overall Study|Adverse Event|0|||
157108036|NCT00097773|567150234|FG001|Overall Study|Adverse Event|1|||
157108037|NCT00097773|567150235|FG002|Overall Study|Adverse Event|0|||
157108038|NCT00097773|567150236|FG003|Overall Study|Adverse Event|0|||
157108039|NCT00097773|567150233|FG000|Overall Study|Other|1|||
157108040|NCT00097773|567150234|FG001|Overall Study|Other|0|||
157108041|NCT00097773|567150235|FG002|Overall Study|Other|2|||
157108042|NCT00097773|567150236|FG003|Overall Study|Other|0|||
157108043|NCT01009034|567150237|FG000|Overall Study|Lost to Follow-up|2|||
157108044|NCT01009034|567150237|FG000|Overall Study|Withdrawal by Subject|2|||
157108045|NCT00474708|567150238|FG000|Overall Study|Lack of Efficacy|11|||
157108046|NCT00474708|567150239|FG001|Overall Study|Lack of Efficacy|5|||
157108047|NCT00474708|567150238|FG000|Overall Study|Suicide ideation/behavior|0|||
157108048|NCT00474708|567150239|FG001|Overall Study|Suicide ideation/behavior|1|||
157108049|NCT00474708|567150238|FG000|Overall Study|Withdrawal by Subject|7|||
157108050|NCT00474708|567150239|FG001|Overall Study|Withdrawal by Subject|0|||
157108051|NCT00474708|567150238|FG000|Overall Study|Lack of compliance|12|||
157108052|NCT00474708|567150239|FG001|Overall Study|Lack of compliance|4|||
157108053|NCT00474708|567150238|FG000|Overall Study|Lost to Follow-up|18|||
157108054|NCT00474708|567150239|FG001|Overall Study|Lost to Follow-up|9|||
157108055|NCT00474708|567150238|FG000|Overall Study|Physician Decision|9|||
157108056|NCT00474708|567150239|FG001|Overall Study|Physician Decision|6|||
157108057|NCT02243865|567150243|FG000|Overall Study|Protocol Violation|1|||
157108058|NCT02243865|567150244|FG001|Overall Study|Protocol Violation|3|||
157108059|NCT02243865|567150243|FG000|Overall Study|Lost to Follow-up|1|||
157108060|NCT02243865|567150244|FG001|Overall Study|Lost to Follow-up|1|||
157108061|NCT02243865|567150243|FG000|Overall Study|Withdrawal by Subject|1|||
157108062|NCT02243865|567150244|FG001|Overall Study|Withdrawal by Subject|0|||
157108063|NCT02243865|567150243|FG000|Overall Study|Adverse Event|1|||
157108064|NCT02243865|567150244|FG001|Overall Study|Adverse Event|1|||
157108065|NCT01235793|567150245|FG000|Overall Study|Death|6|||
157108066|NCT05093322|567150253|FG000|Overall Study|Death|6|||
157108067|NCT05093322|567150254|FG001|Overall Study|Death|2|||
157108068|NCT05093322|567150253|FG000|Overall Study|Other|4|||
157108069|NCT05093322|567150254|FG001|Overall Study|Other|1|||
157108070|NCT00898443|567150255|FG000|Overall Study|Withdrawal by Subject|1|||
157108071|NCT00898443|567150256|FG001|Overall Study|Withdrawal by Subject|0|||
157108072|NCT01770912|567150257|FG000|Overall Study|Lost to Follow-up|2|||
157108073|NCT01770912|567150258|FG001|Overall Study|Lost to Follow-up|0|||
157108074|NCT03250832|567150259|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
157108075|NCT03250832|567150260|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
157108076|NCT03250832|567150261|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
157108077|NCT03250832|567150262|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
157108078|NCT03250832|567150263|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
157108079|NCT03250832|567150264|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
157108080|NCT03250832|567150265|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
157108081|NCT03250832|567150266|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
157108082|NCT03250832|567150267|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
157108083|NCT03250832|567150268|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
157108084|NCT03250832|567150269|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
157108085|NCT03250832|567150270|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
157108086|NCT03250832|567150259|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
157108087|NCT03250832|567150260|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
157108088|NCT03250832|567150261|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
157108089|NCT03250832|567150262|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
157108090|NCT03250832|567150263|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
157108091|NCT03250832|567150264|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
157108092|NCT03250832|567150265|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
157108093|NCT03250832|567150266|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
157108094|NCT03250832|567150267|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
157108095|NCT03250832|567150268|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
157108096|NCT03250832|567150269|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
157108097|NCT03250832|567150270|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
157108098|NCT03250832|567150259|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108099|NCT03250832|567150260|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108100|NCT03250832|567150261|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
157108101|NCT03250832|567150262|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108102|NCT03250832|567150263|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108103|NCT03250832|567150264|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108104|NCT03250832|567150265|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108105|NCT03250832|567150266|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108106|NCT03250832|567150267|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108107|NCT03250832|567150268|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108108|NCT03250832|567150269|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108109|NCT03250832|567150270|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
157108110|NCT03250832|567150259|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108111|NCT03250832|567150260|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108112|NCT03250832|567150261|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108113|NCT03250832|567150262|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108114|NCT03250832|567150263|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108115|NCT03250832|567150264|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108116|NCT03250832|567150265|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108117|NCT03250832|567150266|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
157108118|NCT03250832|567150267|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108119|NCT03250832|567150268|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108120|NCT03250832|567150269|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108121|NCT03250832|567150270|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
157108122|NCT03250832|567150259|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108123|NCT03250832|567150260|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108124|NCT03250832|567150261|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108125|NCT03250832|567150262|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108126|NCT03250832|567150263|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108127|NCT03250832|567150264|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108128|NCT03250832|567150265|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108129|NCT03250832|567150266|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
157108130|NCT03250832|567150267|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108131|NCT03250832|567150268|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108132|NCT03250832|567150269|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108133|NCT03250832|567150270|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
157108134|NCT03250832|567150259|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108135|NCT03250832|567150260|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108136|NCT03250832|567150261|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108137|NCT03250832|567150262|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108138|NCT03250832|567150263|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108139|NCT03250832|567150264|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108140|NCT03250832|567150265|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108141|NCT03250832|567150266|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
157108142|NCT03250832|567150267|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108143|NCT03250832|567150268|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108144|NCT03250832|567150269|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108145|NCT03250832|567150270|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
157108146|NCT03250832|567150259|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108147|NCT03250832|567150260|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108148|NCT03250832|567150261|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108149|NCT03250832|567150262|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108150|NCT03250832|567150263|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108151|NCT03250832|567150264|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108152|NCT03250832|567150265|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108153|NCT03250832|567150266|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
157108154|NCT03250832|567150267|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108155|NCT03250832|567150268|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108156|NCT03250832|567150269|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108157|NCT03250832|567150270|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
157108158|NCT03250832|567150259|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108159|NCT03250832|567150260|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108160|NCT03250832|567150261|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108161|NCT03250832|567150262|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108162|NCT03250832|567150263|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108163|NCT03250832|567150264|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108164|NCT03250832|567150265|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108165|NCT03250832|567150266|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
157108166|NCT03250832|567150267|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108167|NCT03250832|567150268|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108168|NCT03250832|567150269|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108169|NCT03250832|567150270|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
157108170|NCT03250832|567150259|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108171|NCT03250832|567150260|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108172|NCT03250832|567150261|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108173|NCT03250832|567150262|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108174|NCT03250832|567150263|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108175|NCT03250832|567150264|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108176|NCT03250832|567150265|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108177|NCT03250832|567150266|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108178|NCT03250832|567150267|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
157108179|NCT03250832|567150268|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
157108180|NCT03250832|567150269|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108181|NCT03250832|567150270|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
157108182|NCT03250832|567150259|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157003943|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
157003944|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003945|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
157003946|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003947|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003948|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003949|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003950|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003951|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
157003952|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
157003953|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
157003954|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
157003955|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
157003956|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
157003957|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
157003958|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
157003959|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
157003960|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
157003961|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
157003962|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
157003963|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
157003964|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
157003965|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
157003966|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
157003967|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
157003968|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
157003969|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
157003970|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
157003971|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157003972|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
157003973|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
157003974|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157003975|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157003976|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157003977|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157003978|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
157003979|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
157108183|NCT03250832|567150260|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108184|NCT03250832|567150261|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157003980|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
157108185|NCT03250832|567150262|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157003981|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
157003982|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
157003983|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
157003984|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
157003985|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
157003986|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
157003987|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
157003988|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
157003989|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003990|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003991|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003992|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003993|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003994|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003995|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003996|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
157003997|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
157003998|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157003999|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
157004000|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
157004001|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157004002|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157004003|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157004004|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157004005|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
157004006|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
157004007|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004008|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
157004009|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
157004010|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004011|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004012|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004013|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004014|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
157004015|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
157004016|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
157004017|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
157004018|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
157004019|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
157004020|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
157004021|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
157004022|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
157004023|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
157004024|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
157004025|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004026|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
157004027|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004028|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004029|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004030|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004031|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004032|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004033|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
157004034|NCT01212757|566762593|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004035|NCT01212757|566762594|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
157004036|NCT01212757|566762595|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
157004037|NCT01212757|566762596|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004038|NCT01212757|566762597|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004039|NCT01212757|566762598|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004040|NCT01212757|566762599|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004041|NCT01212757|566762600|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004042|NCT01212757|566762601|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
157004043|NCT00573833|566762602|FG000|Overall Study|Not Treated|2|||
157004044|NCT05052983|566762603|FG000|Overall Study|Lack of Efficacy|3|||
157004045|NCT05052983|566762604|FG001|Overall Study|Lack of Efficacy|12|||
157004046|NCT05052983|566762603|FG000|Overall Study|Adverse Event|1|||
157004047|NCT05052983|566762604|FG001|Overall Study|Adverse Event|0|||
157004048|NCT03544515|566764135|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
157004049|NCT03544515|566764136|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
157004050|NCT03544515|566764135|FG000|Overall Study|Lost to Follow-up|2|||
157004051|NCT03544515|566764136|FG001|Overall Study|Lost to Follow-up|0|||
157108186|NCT03250832|567150263|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157004052|NCT03169244|566764137|FG000|Overall Study|Lost to Follow-up|1|||
157004053|NCT03169244|566764138|FG001|Overall Study|Lost to Follow-up|2|||
157108187|NCT03250832|567150264|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108188|NCT03250832|567150265|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108189|NCT03250832|567150266|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108190|NCT03250832|567150267|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
157108191|NCT03250832|567150268|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
157108192|NCT03250832|567150269|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108193|NCT03250832|567150270|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
157108194|NCT03250832|567150259|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108195|NCT03250832|567150260|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108196|NCT03250832|567150261|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108197|NCT03250832|567150262|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108198|NCT03250832|567150263|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108199|NCT03250832|567150264|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108200|NCT03250832|567150265|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108201|NCT03250832|567150266|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108202|NCT03250832|567150267|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
157108203|NCT03250832|567150268|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
157108204|NCT03250832|567150269|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108205|NCT03250832|567150270|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
157108206|NCT03250832|567150259|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108207|NCT03250832|567150260|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108208|NCT03250832|567150261|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108209|NCT03250832|567150262|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108210|NCT03250832|567150263|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108211|NCT03250832|567150264|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108212|NCT03250832|567150265|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157004054|NCT03169244|566764137|FG000|Overall Study|Adverse Event|1|||
157004055|NCT03169244|566764138|FG001|Overall Study|Adverse Event|0|||
157004056|NCT03169244|566764137|FG000|Overall Study|Withdrawal by Subject|2|||
157004057|NCT03169244|566764138|FG001|Overall Study|Withdrawal by Subject|2|||
157004058|NCT03169244|566764137|FG000|Overall Study|Physician Decision|1|||
157004059|NCT03169244|566764138|FG001|Overall Study|Physician Decision|0|||
157004060|NCT00178399|566764139|FG000|Overall Study|Physician Decision|4|||
157004061|NCT00178399|566764139|FG000|Overall Study|Withdrawal by Subject|8|||
157004062|NCT00178399|566764139|FG000|Overall Study|Lost to Follow-up|1|||
157004063|NCT00150176|566764140|FG000|Overall Study|Adverse Event|16|||
157004064|NCT00150176|566764141|FG001|Overall Study|Adverse Event|53|||
157004065|NCT00150176|566764140|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
157004066|NCT00150176|566764141|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
157004067|NCT00150176|566764140|FG000|Overall Study|Withdrawal by Subject|19|||
157004068|NCT00150176|566764141|FG001|Overall Study|Withdrawal by Subject|12|||
157004069|NCT00150176|566764140|FG000|Overall Study|Lost to Follow-up|3|||
157004070|NCT00150176|566764141|FG001|Overall Study|Lost to Follow-up|3|||
157004071|NCT00150176|566764140|FG000|Overall Study|OTHER|11|||
157004072|NCT00150176|566764141|FG001|Overall Study|OTHER|13|||
157004073|NCT02385669|566764142|FG000|Overall Study|Adverse Event|2|||
157004074|NCT00004124|566764143|FG000|Overall Study|Received no protocol therapy|12|||
157004075|NCT00004124|566764144|FG001|Overall Study|Received no protocol therapy|20|||
157004076|NCT01376089|566764145|FG000|Overall Study|Patient received no contrast media|3|||
157004077|NCT01376089|566764146|FG001|Overall Study|Patient received no contrast media|4|||
157004078|NCT03923491|566764147|FG000|Overall Study|Lost to Follow-up|5|||
157004079|NCT03923491|566764148|FG001|Overall Study|Lost to Follow-up|8|||
157004080|NCT03923491|566764147|FG000|Overall Study|Withdrawal by Subject|4|||
157004081|NCT03923491|566764148|FG001|Overall Study|Withdrawal by Subject|6|||
157004082|NCT03823300|566764153|FG000|Overall Study|Withdrawal by Subject|16|||
157004083|NCT03823300|566764154|FG001|Overall Study|Withdrawal by Subject|22|||
157004084|NCT03823300|566764153|FG000|Overall Study|Death|10|||
157004085|NCT03823300|566764154|FG001|Overall Study|Death|14|||
157004086|NCT03823300|566764153|FG000|Overall Study|Adverse Event|3|||
157004087|NCT03823300|566764154|FG001|Overall Study|Adverse Event|5|||
157004088|NCT03823300|566764153|FG000|Overall Study|Physician Decision|1|||
157004089|NCT03823300|566764154|FG001|Overall Study|Physician Decision|7|||
157004090|NCT03823300|566764153|FG000|Overall Study|Lost to Follow-up|1|||
157004091|NCT03823300|566764154|FG001|Overall Study|Lost to Follow-up|3|||
157108213|NCT03250832|567150266|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
156761964|NCT05616013|565879951|FG007|Overall Study|Non-compliance with study requirements|1|||
157004092|NCT03823300|566764153|FG000|Overall Study|Protocol Violation|1|||
157004093|NCT03823300|566764154|FG001|Overall Study|Protocol Violation|1|||
157004094|NCT03823300|566764153|FG000|Overall Study|Lack of Efficacy|1|||
157004095|NCT03823300|566764154|FG001|Overall Study|Lack of Efficacy|1|||
157108214|NCT03250832|567150267|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108215|NCT03250832|567150268|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108216|NCT03250832|567150269|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
157108217|NCT03250832|567150270|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
157108218|NCT01034540|567150271|FG000|Overall Study|Adverse Event|0|||
157108219|NCT01034540|567150272|FG001|Overall Study|Adverse Event|1|||
157108220|NCT01721876|567150273|FG000|Overall Study|Not treated|1|||
157108221|NCT01721876|567150274|FG001|Overall Study|Not treated|4|||
157108222|NCT01721876|567150273|FG000|Overall Study|Disease progression / relapse|123|||
157108223|NCT01721876|567150274|FG001|Overall Study|Disease progression / relapse|156|||
157108224|NCT01721876|567150273|FG000|Overall Study|Death|6|||
157108225|NCT01721876|567150274|FG001|Overall Study|Death|13|||
157108226|NCT01721876|567150273|FG000|Overall Study|Adverse Event|41|||
157108227|NCT01721876|567150274|FG001|Overall Study|Adverse Event|165|||
157108228|NCT01721876|567150273|FG000|Overall Study|Protocol Violation|2|||
157108229|NCT01721876|567150274|FG001|Overall Study|Protocol Violation|1|||
157108230|NCT01721876|567150273|FG000|Overall Study|Withdrawal by Subject|15|||
157108231|NCT01721876|567150274|FG001|Overall Study|Withdrawal by Subject|38|||
157108232|NCT01721876|567150273|FG000|Overall Study|Reason not listed|34|||
157108233|NCT01721876|567150274|FG001|Overall Study|Reason not listed|63|||
157108234|NCT01721876|567150273|FG000|Overall Study|Sponsor terminated trial|0|||
157108235|NCT01721876|567150274|FG001|Overall Study|Sponsor terminated trial|4|||
157108236|NCT01252810|567150275|FG000|Overall Study|Withdrawal by Subject|4|||
157108237|NCT01252810|567150276|FG001|Overall Study|Withdrawal by Subject|1|||
157108238|NCT01252810|567150275|FG000|Overall Study|Lost to Follow-up|0|||
157108239|NCT01252810|567150276|FG001|Overall Study|Lost to Follow-up|1|||
157108240|NCT01252810|567150275|FG000|Overall Study|Physician Decision|2|||
157108241|NCT01252810|567150276|FG001|Overall Study|Physician Decision|1|||
157108242|NCT01252810|567150275|FG000|Overall Study|Various reasons|8|||
157108243|NCT01252810|567150276|FG001|Overall Study|Various reasons|0|||
157108244|NCT03805750|567150277|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
157108245|NCT03805750|567150278|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
157108246|NCT02811549|567150279|FG000|Overall Study|Lost to Follow-up|1|||
157108247|NCT02811549|567150279|FG000|Overall Study|Withdrawal by Subject|3|||
157108248|NCT02811549|567150279|FG000|Overall Study|Subject screen failed|4|||
157108249|NCT02811549|567150279|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
157108250|NCT05293743|567150280|FG000|Overall Study|Withdrawal by Subject|1|||
157108251|NCT05293743|567150281|FG001|Overall Study|Withdrawal by Subject|0|||
157108252|NCT03184077|567150288|FG000|Overall Study|Lost to Follow-up|21|||
156761965|NCT05616013|565879952|FG008|Overall Study|Non-compliance with study requirements|4|||
157004096|NCT03823300|566764153|FG000|Overall Study|Not Eligible|0|||
157004097|NCT03823300|566764154|FG001|Overall Study|Not Eligible|1|||
157108253|NCT03184077|567150289|FG001|Overall Study|Lost to Follow-up|21|||
157108254|NCT01889238|567150290|FG000|Overall Study|Death|1|||
157108255|NCT01889238|567150290|FG000|Overall Study|Withdrawal by Subject|1|||
157004098|NCT03823300|566764153|FG000|Overall Study|Other|1|||
157004099|NCT03823300|566764154|FG001|Overall Study|Other|0|||
157004100|NCT03622580|566764155|FG000|Overall Study|Death|16|||
157004101|NCT03622580|566764156|FG001|Overall Study|Death|21|||
157004102|NCT03622580|566764157|FG002|Overall Study|Death|13|||
157004103|NCT03622580|566764155|FG000|Overall Study|Adverse Event|6|||
157004104|NCT03622580|566764156|FG001|Overall Study|Adverse Event|6|||
157004105|NCT03622580|566764157|FG002|Overall Study|Adverse Event|5|||
157004106|NCT03622580|566764155|FG000|Overall Study|Withdrawal by Subject|12|||
157004107|NCT03622580|566764156|FG001|Overall Study|Withdrawal by Subject|7|||
157004108|NCT03622580|566764157|FG002|Overall Study|Withdrawal by Subject|19|||
157004109|NCT03622580|566764155|FG000|Overall Study|Lost to Follow-up|12|||
157004110|NCT03622580|566764156|FG001|Overall Study|Lost to Follow-up|9|||
157004111|NCT03622580|566764157|FG002|Overall Study|Lost to Follow-up|9|||
157004112|NCT03622580|566764155|FG000|Overall Study|Protocol Violation|1|||
157004113|NCT03622580|566764156|FG001|Overall Study|Protocol Violation|0|||
157004114|NCT03622580|566764157|FG002|Overall Study|Protocol Violation|1|||
157004115|NCT03622580|566764155|FG000|Overall Study|Physician Decision|3|||
157004116|NCT03622580|566764156|FG001|Overall Study|Physician Decision|0|||
157108256|NCT01889238|567150290|FG000|Overall Study|Adverse Event|6|||
157108257|NCT01889238|567150290|FG000|Overall Study|Disease Progression|104|||
157108258|NCT01889238|567150290|FG000|Overall Study|Other|6|||
157108259|NCT04136184|567150291|FG000|Overall Study|Lost to Follow-up|0|||
157108260|NCT04136184|567150292|FG001|Overall Study|Lost to Follow-up|3|||
157108261|NCT04136184|567150291|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
157108262|NCT04136184|567150292|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
157108263|NCT03318978|567150296|FG000|Overall Study|Withdrawal by Subject|1|||
157108264|NCT02592018|567150300|FG000|Overall Study|Adverse Event|1|||
157004117|NCT03622580|566764157|FG002|Overall Study|Physician Decision|1|||
157004118|NCT03622580|566764155|FG000|Overall Study|Pregnancy|0|||
157004119|NCT03622580|566764156|FG001|Overall Study|Pregnancy|1|||
157004120|NCT03622580|566764157|FG002|Overall Study|Pregnancy|0|||
157004121|NCT03622580|566764155|FG000|Overall Study|Lack of Efficacy|0|||
157004122|NCT03622580|566764156|FG001|Overall Study|Lack of Efficacy|0|||
157004123|NCT03622580|566764157|FG002|Overall Study|Lack of Efficacy|1|||
157004124|NCT03622580|566764155|FG000|Overall Study|Other|2|||
157004125|NCT03622580|566764156|FG001|Overall Study|Other|0|||
157004126|NCT03622580|566764157|FG002|Overall Study|Other|3|||
157004127|NCT01930045|566764162|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
157004128|NCT01930045|566764163|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
157004129|NCT01930045|566764164|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
157004130|NCT01930045|566764165|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
157004131|NCT01930045|566764166|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
157004132|NCT01930045|566764167|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
157004133|NCT01930045|566764162|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
157004134|NCT01930045|566764163|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
157004135|NCT01930045|566764164|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
157004136|NCT01930045|566764165|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
157004137|NCT01930045|566764166|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
157004138|NCT01930045|566764167|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
157004139|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
157004140|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
157004141|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
157004142|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
157004143|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
157004144|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
157004145|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
157004146|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
157004147|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
157004148|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
157004149|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
157004150|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
157004151|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
157004152|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
157004153|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
157004154|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
157004155|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
157004156|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
157004157|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
157004158|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
157004159|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
157004160|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
157004161|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
157004162|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
157004163|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
157004164|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
157004165|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
157004166|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
157004167|NCT00241644|566764168|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
157004168|NCT00241644|566764169|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
157004169|NCT00241644|566764170|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
157004170|NCT00241644|566764171|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
157004171|NCT00241644|566764168|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
157004172|NCT00241644|566764169|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
157004173|NCT00241644|566764170|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
157004174|NCT00241644|566764171|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
157004175|NCT00241644|566764168|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
157004176|NCT00241644|566764169|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
157004177|NCT00241644|566764170|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
157004178|NCT00241644|566764171|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
157004179|NCT00241644|566764168|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
157004180|NCT00241644|566764169|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
157004181|NCT00241644|566764170|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
157004182|NCT00241644|566764171|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
157004183|NCT00241644|566764168|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
157004184|NCT00241644|566764169|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
157004185|NCT00241644|566764170|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
157004186|NCT00241644|566764171|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
157004187|NCT00241644|566764168|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
157004188|NCT00241644|566764169|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
157004189|NCT00241644|566764170|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
157108265|NCT02592018|567150300|FG000|Overall Study|Lost to Follow-up|1|||
157108266|NCT06156215|567150303|FG000|Overall Study|Withdrawal by Subject|2|||
157108267|NCT06156215|567150304|FG001|Overall Study|Withdrawal by Subject|4|||
157108268|NCT06156215|567150305|FG002|Overall Study|Withdrawal by Subject|4|||
157108269|NCT06156215|567150306|FG003|Overall Study|Withdrawal by Subject|0|||
157108270|NCT06156215|567150307|FG004|Overall Study|Withdrawal by Subject|2|||
157108271|NCT06156215|567150308|FG005|Overall Study|Withdrawal by Subject|2|||
157108272|NCT06156215|567150303|FG000|Overall Study|Left ED without completing study|9|||
157108273|NCT06156215|567150304|FG001|Overall Study|Left ED without completing study|3|||
157108274|NCT06156215|567150305|FG002|Overall Study|Left ED without completing study|9|||
157108275|NCT06156215|567150306|FG003|Overall Study|Left ED without completing study|0|||
157108276|NCT06156215|567150307|FG004|Overall Study|Left ED without completing study|8|||
157108277|NCT06156215|567150308|FG005|Overall Study|Left ED without completing study|16|||
157108278|NCT06156215|567150303|FG000|Overall Study|Physician Decision|1|||
157108279|NCT06156215|567150304|FG001|Overall Study|Physician Decision|0|||
157108280|NCT06156215|567150305|FG002|Overall Study|Physician Decision|0|||
157108281|NCT06156215|567150306|FG003|Overall Study|Physician Decision|0|||
157108282|NCT06156215|567150307|FG004|Overall Study|Physician Decision|0|||
157108283|NCT06156215|567150308|FG005|Overall Study|Physician Decision|0|||
157108284|NCT06156215|567150303|FG000|Overall Study|Became or found ineligible|2|||
157108285|NCT06156215|567150304|FG001|Overall Study|Became or found ineligible|0|||
157108286|NCT06156215|567150305|FG002|Overall Study|Became or found ineligible|2|||
157108287|NCT06156215|567150306|FG003|Overall Study|Became or found ineligible|0|||
157108288|NCT06156215|567150307|FG004|Overall Study|Became or found ineligible|1|||
157108289|NCT06156215|567150308|FG005|Overall Study|Became or found ineligible|2|||
157108290|NCT01524198|567152064|FG000|Overall Study|Protocol Violation|8|||
157108291|NCT01524198|567152065|FG001|Overall Study|Protocol Violation|6|||
157108292|NCT01524198|567152064|FG000|Overall Study|Withdrawal by Subject|15|||
157108293|NCT01524198|567152065|FG001|Overall Study|Withdrawal by Subject|10|||
157108294|NCT02232802|567152066|FG000|Period 1|Sponsor request|1|||
157108295|NCT02232802|567152067|FG001|Period 1|Sponsor request|0|||
157108296|NCT02232802|567152066|FG000|Period 1|Adverse Event|1|||
157108297|NCT02232802|567152067|FG001|Period 1|Adverse Event|1|||
157108298|NCT00885703|567152072|FG000|Overall Study|Death|9|||
157108299|NCT00885703|567152073|FG001|Overall Study|Death|7|||
157108300|NCT00885703|567152074|FG002|Overall Study|Death|8|||
157108301|NCT00885703|567152075|FG003|Overall Study|Death|7|||
157108302|NCT00885703|567152076|FG004|Overall Study|Death|7|||
157108303|NCT00885703|567152077|FG005|Overall Study|Death|8|||
157108304|NCT00885703|567152078|FG006|Overall Study|Death|4|||
157108305|NCT00885703|567152072|FG000|Overall Study|Lost to Follow-up|0|||
157108306|NCT00885703|567152073|FG001|Overall Study|Lost to Follow-up|0|||
157108307|NCT00885703|567152074|FG002|Overall Study|Lost to Follow-up|1|||
157108308|NCT00885703|567152075|FG003|Overall Study|Lost to Follow-up|0|||
157108309|NCT00885703|567152076|FG004|Overall Study|Lost to Follow-up|0|||
157108310|NCT00885703|567152077|FG005|Overall Study|Lost to Follow-up|1|||
157108311|NCT00885703|567152078|FG006|Overall Study|Lost to Follow-up|0|||
157108312|NCT00885703|567152072|FG000|Overall Study|Withdrawal by Subject|0|||
157108313|NCT00885703|567152073|FG001|Overall Study|Withdrawal by Subject|0|||
157108314|NCT00885703|567152074|FG002|Overall Study|Withdrawal by Subject|0|||
157108315|NCT00885703|567152075|FG003|Overall Study|Withdrawal by Subject|1|||
157108316|NCT00885703|567152076|FG004|Overall Study|Withdrawal by Subject|3|||
157108317|NCT00885703|567152077|FG005|Overall Study|Withdrawal by Subject|1|||
157108318|NCT00885703|567152078|FG006|Overall Study|Withdrawal by Subject|1|||
157108319|NCT00885703|567152072|FG000|Overall Study|Ineligible (no CM)|1|||
157108320|NCT00885703|567152073|FG001|Overall Study|Ineligible (no CM)|3|||
157108321|NCT00885703|567152074|FG002|Overall Study|Ineligible (no CM)|2|||
157108322|NCT00885703|567152075|FG003|Overall Study|Ineligible (no CM)|1|||
157108323|NCT00885703|567152076|FG004|Overall Study|Ineligible (no CM)|2|||
157108324|NCT00885703|567152077|FG005|Overall Study|Ineligible (no CM)|3|||
157108325|NCT00885703|567152078|FG006|Overall Study|Ineligible (no CM)|1|||
157108326|NCT01462435|567152079|FG000|Overall Study|Lack of Efficacy|1|||
157108327|NCT01462435|567152080|FG001|Overall Study|Lack of Efficacy|0|||
157108328|NCT01462435|567152081|FG002|Overall Study|Lack of Efficacy|0|||
157108329|NCT01462435|567152082|FG003|Overall Study|Lack of Efficacy|3|||
157108330|NCT01462435|567152079|FG000|Overall Study|Physician Decision|0|||
157108331|NCT01462435|567152080|FG001|Overall Study|Physician Decision|0|||
157108332|NCT01462435|567152081|FG002|Overall Study|Physician Decision|1|||
157108333|NCT01462435|567152082|FG003|Overall Study|Physician Decision|0|||
157108334|NCT01462435|567152079|FG000|Overall Study|Withdrawal by Subject|0|||
157108335|NCT01462435|567152080|FG001|Overall Study|Withdrawal by Subject|0|||
157108336|NCT01462435|567152081|FG002|Overall Study|Withdrawal by Subject|0|||
157108337|NCT01462435|567152082|FG003|Overall Study|Withdrawal by Subject|1|||
157108338|NCT01462435|567152079|FG000|Overall Study|Lost to Follow-up|0|||
157108339|NCT01462435|567152080|FG001|Overall Study|Lost to Follow-up|0|||
157108340|NCT01462435|567152081|FG002|Overall Study|Lost to Follow-up|0|||
157108341|NCT01462435|567152082|FG003|Overall Study|Lost to Follow-up|1|||
157108342|NCT01543152|567152085|FG000|Overall Study|Withdrawal by Subject|0|||
157108343|NCT01543152|567152086|FG001|Overall Study|Withdrawal by Subject|2|||
157108344|NCT01543152|567152087|FG002|Overall Study|Withdrawal by Subject|0|||
157108345|NCT01543152|567152088|FG003|Overall Study|Withdrawal by Subject|0|||
157108346|NCT01543152|567152089|FG004|Overall Study|Withdrawal by Subject|0|||
157108347|NCT02687542|567152092|FG000|Overall Study|Medication error without associated AEs|0|||
157108348|NCT02687542|567152093|FG001|Overall Study|Medication error without associated AEs|0|||
157108349|NCT02687542|567152094|FG002|Overall Study|Medication error without associated AEs|0|||
157108350|NCT02687542|567152095|FG003|Overall Study|Medication error without associated AEs|0|||
157108351|NCT02687542|567152096|FG004|Overall Study|Medication error without associated AEs|1|||
157108352|NCT02687542|567152092|FG000|Overall Study|Lost to Follow-up|0|||
157108353|NCT02687542|567152093|FG001|Overall Study|Lost to Follow-up|0|||
157108354|NCT02687542|567152094|FG002|Overall Study|Lost to Follow-up|0|||
157108355|NCT02687542|567152095|FG003|Overall Study|Lost to Follow-up|0|||
157108356|NCT02687542|567152096|FG004|Overall Study|Lost to Follow-up|1|||
157108357|NCT02687542|567152092|FG000|Overall Study|Protocol Violation|0|||
157108358|NCT02687542|567152093|FG001|Overall Study|Protocol Violation|1|||
157108359|NCT02687542|567152094|FG002|Overall Study|Protocol Violation|0|||
157108360|NCT02687542|567152095|FG003|Overall Study|Protocol Violation|0|||
157108361|NCT02687542|567152096|FG004|Overall Study|Protocol Violation|0|||
157108362|NCT02687542|567152092|FG000|Overall Study|Other|5|||
157108363|NCT02687542|567152093|FG001|Overall Study|Other|9|||
157108364|NCT02687542|567152094|FG002|Overall Study|Other|10|||
157108365|NCT02687542|567152095|FG003|Overall Study|Other|6|||
157108366|NCT02687542|567152096|FG004|Overall Study|Other|5|||
157108367|NCT02687542|567152092|FG000|Overall Study|Adverse Event|3|||
157108368|NCT02687542|567152093|FG001|Overall Study|Adverse Event|1|||
157108369|NCT02687542|567152094|FG002|Overall Study|Adverse Event|3|||
157108370|NCT02687542|567152095|FG003|Overall Study|Adverse Event|2|||
157108371|NCT02687542|567152096|FG004|Overall Study|Adverse Event|9|||
157108372|NCT02687542|567152092|FG000|Overall Study|Withdrawal by Subject|0|||
157108373|NCT02687542|567152093|FG001|Overall Study|Withdrawal by Subject|1|||
157108374|NCT02687542|567152094|FG002|Overall Study|Withdrawal by Subject|1|||
157108375|NCT02687542|567152095|FG003|Overall Study|Withdrawal by Subject|2|||
157108376|NCT02687542|567152096|FG004|Overall Study|Withdrawal by Subject|4|||
157108377|NCT03785925|567152097|FG000|Overall Study|Withdrawal by Subject|15|||
157108378|NCT03785925|567152097|FG000|Overall Study|Lost to Follow-up|1|||
157108379|NCT01227187|567152098|FG000|Overall Study|Physician Decision|0|||
157108380|NCT01227187|567152099|FG001|Overall Study|Physician Decision|0|||
157108381|NCT01227187|567152100|FG002|Overall Study|Physician Decision|0|||
157108382|NCT01227187|567152101|FG003|Overall Study|Physician Decision|1|||
157108383|NCT00957528|567152102|FG000|Overall Study|Protocol Violation|0|||
157108384|NCT00957528|567152103|FG001|Overall Study|Protocol Violation|1|||
157108385|NCT00957528|567152104|FG002|Overall Study|Protocol Violation|0|||
157108386|NCT00957528|567152102|FG000|Overall Study|Withdrawal by Subject|0|||
157108387|NCT00957528|567152103|FG001|Overall Study|Withdrawal by Subject|0|||
157108388|NCT00957528|567152104|FG002|Overall Study|Withdrawal by Subject|1|||
157108389|NCT01101438|567152106|FG000|Overall Study|Withdrawal by Subject|8|||
157108390|NCT01101438|567152107|FG001|Overall Study|Withdrawal by Subject|9|||
157108391|NCT03677596|567152123|FG000|Overall Study|Adverse Event|0|||
157108392|NCT03677596|567152124|FG001|Overall Study|Adverse Event|1|||
157108393|NCT03677596|567152123|FG000|Overall Study|Death|10|||
157108394|NCT03677596|567152124|FG001|Overall Study|Death|6|||
157108395|NCT03677596|567152123|FG000|Overall Study|Lost to Follow-up|0|||
157108396|NCT03677596|567152124|FG001|Overall Study|Lost to Follow-up|1|||
157108397|NCT03677596|567152123|FG000|Overall Study|Progressive Disease|8|||
157108398|NCT03677596|567152124|FG001|Overall Study|Progressive Disease|8|||
157108399|NCT03677596|567152123|FG000|Overall Study|Withdrawal by Subject|3|||
157108400|NCT03677596|567152124|FG001|Overall Study|Withdrawal by Subject|0|||
157108401|NCT03677596|567152123|FG000|Overall Study|Disease Relapse|2|||
157108402|NCT03677596|567152124|FG001|Overall Study|Disease Relapse|2|||
157108403|NCT03677596|567152123|FG000|Overall Study|Other|0|||
157108404|NCT03677596|567152124|FG001|Overall Study|Other|1|||
157108405|NCT00914927|567152129|FG000|Overall Study|Adverse Event|0|||
157108406|NCT00914927|567152130|FG001|Overall Study|Adverse Event|0|||
157108407|NCT00914927|567152131|FG002|Overall Study|Adverse Event|0|||
157108408|NCT00914927|567152132|FG003|Overall Study|Adverse Event|0|||
157108409|NCT00914927|567152133|FG004|Overall Study|Adverse Event|1|||
157108410|NCT00914927|567152134|FG005|Overall Study|Adverse Event|0|||
157108411|NCT00914927|567152135|FG006|Overall Study|Adverse Event|0|||
157108412|NCT00914927|567152129|FG000|Overall Study|Withdrawal by Subject|0|||
157108413|NCT00914927|567152130|FG001|Overall Study|Withdrawal by Subject|1|||
157108414|NCT00914927|567152131|FG002|Overall Study|Withdrawal by Subject|0|||
157108415|NCT00914927|567152132|FG003|Overall Study|Withdrawal by Subject|1|||
157108416|NCT00914927|567152133|FG004|Overall Study|Withdrawal by Subject|0|||
157108417|NCT00914927|567152134|FG005|Overall Study|Withdrawal by Subject|0|||
157108418|NCT00914927|567152135|FG006|Overall Study|Withdrawal by Subject|0|||
157108419|NCT00914927|567152129|FG000|Overall Study|Lost to Follow-up|0|||
157108420|NCT00914927|567152130|FG001|Overall Study|Lost to Follow-up|0|||
157108421|NCT00914927|567152131|FG002|Overall Study|Lost to Follow-up|0|||
157108422|NCT00914927|567152132|FG003|Overall Study|Lost to Follow-up|1|||
157108423|NCT00914927|567152133|FG004|Overall Study|Lost to Follow-up|0|||
157108424|NCT00914927|567152134|FG005|Overall Study|Lost to Follow-up|0|||
157108425|NCT00914927|567152135|FG006|Overall Study|Lost to Follow-up|0|||
157108426|NCT00914927|567152129|FG000|Overall Study|Administrative/Other|2|||
157108427|NCT00914927|567152130|FG001|Overall Study|Administrative/Other|1|||
157108428|NCT00914927|567152131|FG002|Overall Study|Administrative/Other|0|||
157108429|NCT00914927|567152132|FG003|Overall Study|Administrative/Other|0|||
157108430|NCT00914927|567152133|FG004|Overall Study|Administrative/Other|1|||
157108431|NCT00914927|567152134|FG005|Overall Study|Administrative/Other|0|||
157108432|NCT00914927|567152135|FG006|Overall Study|Administrative/Other|0|||
157108433|NCT01519934|567152136|FG000|Overall Study|Lost to Follow-up|3|||
157108434|NCT00922480|567152137|FG000|Main Study|Protocol Violation|3|||
157108435|NCT00922480|567152138|FG001|Main Study|Protocol Violation|6|||
157108436|NCT00922480|567152137|FG000|Main Study|Adverse Event|6|||
157108437|NCT00922480|567152138|FG001|Main Study|Adverse Event|7|||
157108438|NCT00922480|567152137|FG000|Main Study|Lack of Efficacy|3|||
157108439|NCT00922480|567152138|FG001|Main Study|Lack of Efficacy|0|||
157108440|NCT00922480|567152137|FG000|Main Study|Withdrawal by Subject|20|||
157108441|NCT00922480|567152138|FG001|Main Study|Withdrawal by Subject|15|||
157108442|NCT00922480|567152137|FG000|Main Study|Lost to Follow-up|5|||
157108443|NCT00922480|567152138|FG001|Main Study|Lost to Follow-up|0|||
157108444|NCT00922480|567152137|FG000|Main Study|Physician Decision|0|||
157108445|NCT00922480|567152138|FG001|Main Study|Physician Decision|1|||
157108446|NCT00922480|567152137|FG000|Extension Study|Protocol Violation|3|||
157108447|NCT00922480|567152138|FG001|Extension Study|Protocol Violation|0|||
157108448|NCT00922480|567152137|FG000|Extension Study|Adverse Event|1|||
157108449|NCT00922480|567152138|FG001|Extension Study|Adverse Event|1|||
157108450|NCT00922480|567152137|FG000|Extension Study|Withdrawal by Subject|1|||
157108451|NCT00922480|567152138|FG001|Extension Study|Withdrawal by Subject|1|||
157108452|NCT00922480|567152137|FG000|Extension Study|Others|0|||
157108453|NCT00922480|567152138|FG001|Extension Study|Others|1|||
157108454|NCT00971178|567152143|FG000|Overall Study|Lost to Follow-up|2|||
157108455|NCT00971178|567152144|FG001|Overall Study|Lost to Follow-up|2|||
157108456|NCT00971178|567152145|FG002|Overall Study|Lost to Follow-up|2|||
157108457|NCT00326209|567152150|FG000|Overall Study|Adverse Event|28|||
157108458|NCT00326209|567152150|FG000|Overall Study|Withdrawal by Subject|22|||
157108459|NCT00326209|567152150|FG000|Overall Study|Lack of Efficacy|31|||
157108460|NCT00326209|567152150|FG000|Overall Study|Lost to Follow-up|18|||
157108461|NCT00326209|567152150|FG000|Overall Study|Participant non-compliant|6|||
157108462|NCT00326209|567152150|FG000|Overall Study|Sponsor closed study|173|||
157108463|NCT00326209|567152150|FG000|Overall Study|Prohibited medication use|1|||
157108464|NCT00326209|567152150|FG000|Overall Study|Violation of entry criteria|1|||
157108465|NCT00326209|567152150|FG000|Overall Study|Withdrawn in error|1|||
157108466|NCT00326209|567152150|FG000|Overall Study|Pregnancy|1|||
157108467|NCT03716050|567152152|FG000|Overall Study|Lost to Follow-up|0|||
157108468|NCT03716050|567152153|FG001|Overall Study|Lost to Follow-up|0|||
157108469|NCT03716050|567152154|FG002|Overall Study|Lost to Follow-up|1|||
157108470|NCT03716050|567152155|FG003|Overall Study|Lost to Follow-up|0|||
157108471|NCT03716050|567152156|FG004|Overall Study|Lost to Follow-up|0|||
157108472|NCT03716050|567152157|FG005|Overall Study|Lost to Follow-up|0|||
157108473|NCT03716050|567152158|FG006|Overall Study|Lost to Follow-up|0|||
157108474|NCT03716050|567152159|FG007|Overall Study|Lost to Follow-up|0|||
157108475|NCT03716050|567152152|FG000|Overall Study|Physician Decision|0|||
157108476|NCT03716050|567152153|FG001|Overall Study|Physician Decision|0|||
157108477|NCT03716050|567152154|FG002|Overall Study|Physician Decision|0|||
157108478|NCT03716050|567152155|FG003|Overall Study|Physician Decision|1|||
157108479|NCT03716050|567152156|FG004|Overall Study|Physician Decision|0|||
157108480|NCT03716050|567152157|FG005|Overall Study|Physician Decision|0|||
157108481|NCT03716050|567152158|FG006|Overall Study|Physician Decision|0|||
157108482|NCT03716050|567152159|FG007|Overall Study|Physician Decision|0|||
157108483|NCT03716050|567152152|FG000|Overall Study|Protocol Violation|0|||
157108484|NCT03716050|567152153|FG001|Overall Study|Protocol Violation|0|||
157108485|NCT03716050|567152154|FG002|Overall Study|Protocol Violation|0|||
157108486|NCT03716050|567152155|FG003|Overall Study|Protocol Violation|1|||
157108487|NCT03716050|567152156|FG004|Overall Study|Protocol Violation|0|||
157108488|NCT03716050|567152157|FG005|Overall Study|Protocol Violation|0|||
157108489|NCT03716050|567152158|FG006|Overall Study|Protocol Violation|0|||
157108490|NCT03716050|567152159|FG007|Overall Study|Protocol Violation|2|||
157108491|NCT01010633|567152162|FG000|Overall Study|Adverse Event|1|||
157108492|NCT01010633|567152163|FG001|Overall Study|Adverse Event|1|||
157108493|NCT01010633|567152162|FG000|Overall Study|Protocol Violation|1|||
157108494|NCT01010633|567152163|FG001|Overall Study|Protocol Violation|2|||
157108495|NCT01010633|567152162|FG000|Overall Study|Withdrawal by Subject|2|||
157108496|NCT01010633|567152163|FG001|Overall Study|Withdrawal by Subject|1|||
157108497|NCT01010633|567152162|FG000|Overall Study|Investigator decision|0|||
157108498|NCT01010633|567152163|FG001|Overall Study|Investigator decision|1|||
157108499|NCT00073528|567152164|FG000|Overall Study|Death|488|||
157108500|NCT00073528|567152165|FG001|Overall Study|Death|473|||
157108501|NCT00073528|567152164|FG000|Overall Study|Lost to Follow-up|52|||
157108502|NCT00073528|567152165|FG001|Overall Study|Lost to Follow-up|45|||
157108503|NCT00073528|567152164|FG000|Overall Study|Withdrawal by Subject|50|||
157004190|NCT00241644|566764171|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
157004191|NCT03959241|566764172|FG000|Overall Study|Withdrawal by Subject|7|||
157004192|NCT03959241|566764173|FG001|Overall Study|Withdrawal by Subject|8|||
157004193|NCT03959241|566764172|FG000|Overall Study|Lost to Follow-up|1|||
157004194|NCT03959241|566764173|FG001|Overall Study|Lost to Follow-up|0|||
157004195|NCT03959241|566764172|FG000|Overall Study|Move to Hospice Care|1|||
157004196|NCT03959241|566764173|FG001|Overall Study|Move to Hospice Care|0|||
157004197|NCT03959241|566764172|FG000|Overall Study|Screen Failure|1|||
157004198|NCT03959241|566764173|FG001|Overall Study|Screen Failure|0|||
157004199|NCT03959241|566764172|FG000|Overall Study|Disease Relapse|0|||
157004200|NCT03959241|566764173|FG001|Overall Study|Disease Relapse|1|||
157004201|NCT03959241|566764172|FG000|Overall Study|Off Study|1|||
157004202|NCT03959241|566764173|FG001|Overall Study|Off Study|0|||
157004203|NCT00545844|566764174|FG000|Overall Study|Lost to Follow-up|9|||
157004204|NCT00545844|566764174|FG000|Overall Study|Protocol Violation|1|||
157004205|NCT00545844|566764174|FG000|Overall Study|Withdrawal by Subject|2|||
157004206|NCT01565928|566764175|FG000|Overall Study|Adverse Event|3|||
157004207|NCT01565928|566764175|FG000|Overall Study|Other|3|||
157004208|NCT01565928|566764175|FG000|Overall Study|Progressive Disease|13|||
157004209|NCT01565928|566764175|FG000|Overall Study|Withdrawal by Subject|1|||
157004210|NCT01565928|566764175|FG000|Overall Study|Death|2|||
157004211|NCT01183780|566764179|FG000|Overall Study|Withdrawal by Subject|25|||
157004212|NCT01183780|566764180|FG001|Overall Study|Withdrawal by Subject|14|||
157004213|NCT01183780|566764179|FG000|Overall Study|Lost to Follow-up|6|||
157004214|NCT01183780|566764180|FG001|Overall Study|Lost to Follow-up|11|||
157004215|NCT00762606|566764183|FG000|Overall Study|Lost to Follow-up|18|||
157004216|NCT00762606|566764184|FG001|Overall Study|Lost to Follow-up|13|||
157004217|NCT01596504|566764185|FG000|Overall Study|Participant's Private Reason|0|||
157004218|NCT01596504|566764186|FG001|Overall Study|Participant's Private Reason|1|||
157004219|NCT01596504|566764187|FG002|Overall Study|Participant's Private Reason|0|||
157004220|NCT01596504|566764185|FG000|Overall Study|Adverse Event|1|||
157004221|NCT01596504|566764186|FG001|Overall Study|Adverse Event|2|||
157004222|NCT01596504|566764187|FG002|Overall Study|Adverse Event|1|||
157004223|NCT01596504|566764185|FG000|Overall Study|Withdrawal by Subject|1|||
157004224|NCT01596504|566764186|FG001|Overall Study|Withdrawal by Subject|0|||
157004225|NCT01596504|566764187|FG002|Overall Study|Withdrawal by Subject|0|||
157004226|NCT00395018|566764188|FG000|On-Treatment|Death|4|||
157004227|NCT00395018|566764188|FG000|On-Treatment|Other Reason|2|||
157004228|NCT00395018|566764188|FG000|On-Treatment|Poor/non-compliance|2|||
157004229|NCT00395018|566764188|FG000|On-Treatment|Subject no longer meets study criteria|2|||
157004230|NCT00395018|566764188|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
157004231|NCT00395018|566764188|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
157004232|NCT00395018|566764188|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
157004233|NCT00949975|566764193|FG000|Overall Study|Voluntary discontinuation|6|||
157004234|NCT00949975|566764194|FG001|Overall Study|Voluntary discontinuation|5|||
157004235|NCT00949975|566764195|FG002|Overall Study|Voluntary discontinuation|3|||
157004236|NCT00949975|566764196|FG003|Overall Study|Voluntary discontinuation|6|||
157004237|NCT00949975|566764193|FG000|Overall Study|Adverse Event|11|||
157004238|NCT00949975|566764194|FG001|Overall Study|Adverse Event|11|||
157004239|NCT00949975|566764195|FG002|Overall Study|Adverse Event|10|||
157004240|NCT00949975|566764196|FG003|Overall Study|Adverse Event|10|||
157004241|NCT00949975|566764193|FG000|Overall Study|Safety reason|0|||
157004242|NCT00949975|566764194|FG001|Overall Study|Safety reason|1|||
157004243|NCT00949975|566764195|FG002|Overall Study|Safety reason|0|||
157004244|NCT00949975|566764196|FG003|Overall Study|Safety reason|0|||
157004245|NCT00949975|566764193|FG000|Overall Study|Study-specific criteria|0|||
157004246|NCT00949975|566764194|FG001|Overall Study|Study-specific criteria|1|||
157004247|NCT00949975|566764195|FG002|Overall Study|Study-specific criteria|1|||
157004248|NCT00949975|566764196|FG003|Overall Study|Study-specific criteria|0|||
157004249|NCT00949975|566764193|FG000|Overall Study|Incorrect enrolment|5|||
157004250|NCT00949975|566764194|FG001|Overall Study|Incorrect enrolment|10|||
157004251|NCT00949975|566764195|FG002|Overall Study|Incorrect enrolment|4|||
157004252|NCT00949975|566764196|FG003|Overall Study|Incorrect enrolment|7|||
157004253|NCT00949975|566764193|FG000|Overall Study|Severe non-compliance|3|||
157004254|NCT00949975|566764194|FG001|Overall Study|Severe non-compliance|1|||
157004255|NCT00949975|566764195|FG002|Overall Study|Severe non-compliance|0|||
157004256|NCT00949975|566764196|FG003|Overall Study|Severe non-compliance|2|||
157004257|NCT00949975|566764193|FG000|Overall Study|Lost to Follow-up|1|||
157004258|NCT00949975|566764194|FG001|Overall Study|Lost to Follow-up|0|||
157004259|NCT00949975|566764195|FG002|Overall Study|Lost to Follow-up|1|||
157004260|NCT00949975|566764196|FG003|Overall Study|Lost to Follow-up|3|||
157004261|NCT00949975|566764193|FG000|Overall Study|Other|1|||
157004262|NCT00949975|566764194|FG001|Overall Study|Other|0|||
157004263|NCT00949975|566764195|FG002|Overall Study|Other|0|||
157004264|NCT00949975|566764196|FG003|Overall Study|Other|0|||
157004265|NCT03257813|566764197|FG000|Overall Study|Protocol Violation|6|||
157004266|NCT03257813|566764198|FG001|Overall Study|Protocol Violation|3|||
157004267|NCT03478696|566764199|FG000|Overall Study|Adverse Event|1|||
157004268|NCT03478696|566764200|FG001|Overall Study|Adverse Event|5|||
157108504|NCT00073528|567152165|FG001|Overall Study|Withdrawal by Subject|45|||
157108505|NCT00073528|567152164|FG000|Overall Study|Study terminated by Sponsor|10|||
157108506|NCT00073528|567152165|FG001|Overall Study|Study terminated by Sponsor|29|||
157108507|NCT00073528|567152164|FG000|Overall Study|Other|18|||
157108508|NCT00073528|567152165|FG001|Overall Study|Other|19|||
157108509|NCT00073528|567152164|FG000|Overall Study|Other|9|||
157108510|NCT00073528|567152165|FG001|Overall Study|Other|12|||
157108511|NCT00073528|567152164|FG000|Overall Study|Protocol Violation|3|||
157108512|NCT00073528|567152165|FG001|Overall Study|Protocol Violation|5|||
157108513|NCT03086057|567152166|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
157108514|NCT03086057|567152167|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
157108515|NCT03086057|567152168|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
157108516|NCT03086057|567152169|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
157108517|NCT03086057|567152166|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
157108518|NCT03086057|567152167|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
157108519|NCT03086057|567152168|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
157108520|NCT03086057|567152169|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
157108521|NCT03086057|567152166|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
157108522|NCT03086057|567152167|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
157108523|NCT03086057|567152168|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
157108524|NCT03086057|567152169|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
157108525|NCT03086057|567152166|FG000|Stage 1: PrEP Uptake|Death|1|||
157108526|NCT03086057|567152167|FG001|Stage 1: PrEP Uptake|Death|0|||
157108527|NCT03086057|567152168|FG002|Stage 1: PrEP Uptake|Death|0|||
157108528|NCT03086057|567152169|FG003|Stage 1: PrEP Uptake|Death|0|||
157108529|NCT03086057|567152166|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
157108530|NCT03086057|567152167|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
157108531|NCT03086057|567152168|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
157108532|NCT03086057|567152169|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
157108533|NCT03086057|567152166|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
157108534|NCT03086057|567152167|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
157108535|NCT03086057|567152168|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
157108536|NCT03086057|567152169|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
157108537|NCT03086057|567152166|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
157108538|NCT03086057|567152167|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
157108539|NCT03086057|567152168|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
157108540|NCT03086057|567152169|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
157108541|NCT01494350|567152174|FG000|Overall Study|Worsening of lesion|1|||
157108542|NCT03654976|567152184|FG000|Overall Study|Withdrawal by Subject|12|||
157108543|NCT03654976|567152185|FG001|Overall Study|Withdrawal by Subject|11|||
157108544|NCT03654976|567152184|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
157108545|NCT03654976|567152185|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
157108546|NCT03654976|567152184|FG000|Overall Study|Adverse Event|5|||
157108547|NCT03654976|567152185|FG001|Overall Study|Adverse Event|0|||
157108548|NCT03654976|567152184|FG000|Overall Study|Lost to Follow-up|2|||
157108549|NCT03654976|567152185|FG001|Overall Study|Lost to Follow-up|0|||
157108550|NCT03654976|567152184|FG000|Overall Study|Lack of Efficacy|0|||
157108551|NCT03654976|567152185|FG001|Overall Study|Lack of Efficacy|1|||
157108552|NCT03098836|567152186|FG000|Overall Study|Adverse Event|1|||
157108553|NCT03098836|567152187|FG001|Overall Study|Adverse Event|3|||
157108554|NCT03098836|567152186|FG000|Overall Study|Lack of Efficacy|30|||
157108555|NCT03098836|567152187|FG001|Overall Study|Lack of Efficacy|15|||
157108556|NCT03098836|567152186|FG000|Overall Study|Physician Decision|2|||
157108557|NCT03098836|567152187|FG001|Overall Study|Physician Decision|1|||
157108558|NCT03098836|567152186|FG000|Overall Study|Withdrawal by Subject|3|||
157108559|NCT03098836|567152187|FG001|Overall Study|Withdrawal by Subject|2|||
157108560|NCT03986866|567152188|FG000|Overall Study|Withdrawal by Subject|0|||
157108561|NCT03986866|567152189|FG001|Overall Study|Withdrawal by Subject|3|||
157108562|NCT03986866|567152188|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
157108563|NCT03986866|567152189|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
157108564|NCT00545064|567152190|FG000|Overall Study|Lost to Follow-up|3|||
157108565|NCT00545064|567152190|FG000|Overall Study|Withdrawal by Subject|2|||
157108566|NCT00545064|567152190|FG000|Overall Study|did not complete course of treatment|1|||
157108567|NCT00545064|567152190|FG000|Overall Study|cancel all appointments, no rebooking|1|||
157108568|NCT00545064|567152190|FG000|Overall Study|inclement weather|1|||
157108569|NCT01660451|567152191|FG000|Overall Study|Protocol Violation|0|||
157108570|NCT01660451|567152192|FG001|Overall Study|Protocol Violation|1|||
157108571|NCT01660451|567152193|FG002|Overall Study|Protocol Violation|1|||
157108572|NCT01660451|567152191|FG000|Overall Study|AE not associated with clinical disease progression|13|||
157108573|NCT01660451|567152192|FG001|Overall Study|AE not associated with clinical disease progression|10|||
157108574|NCT01660451|567152193|FG002|Overall Study|AE not associated with clinical disease progression|40|||
157108575|NCT01660451|567152191|FG000|Overall Study|AE associated with clinical disease progression|1|||
157108576|NCT01660451|567152192|FG001|Overall Study|AE associated with clinical disease progression|3|||
157108577|NCT01660451|567152193|FG002|Overall Study|AE associated with clinical disease progression|11|||
157108578|NCT01660451|567152191|FG000|Overall Study|Sponsor Decision|0|||
157108579|NCT01660451|567152192|FG001|Overall Study|Sponsor Decision|0|||
157108580|NCT01660451|567152193|FG002|Overall Study|Sponsor Decision|1|||
157108581|NCT01660451|567152191|FG000|Overall Study|Protocol Deviation|0|||
157108582|NCT01660451|567152192|FG001|Overall Study|Protocol Deviation|0|||
157108583|NCT01660451|567152193|FG002|Overall Study|Protocol Deviation|1|||
157108584|NCT01660451|567152191|FG000|Overall Study|Physician Decision|1|||
157108585|NCT01660451|567152192|FG001|Overall Study|Physician Decision|2|||
157108586|NCT01660451|567152193|FG002|Overall Study|Physician Decision|5|||
157108587|NCT01660451|567152191|FG000|Overall Study|Withdrawal by Subject|1|||
157108588|NCT01660451|567152192|FG001|Overall Study|Withdrawal by Subject|1|||
157108589|NCT01660451|567152193|FG002|Overall Study|Withdrawal by Subject|20|||
157108590|NCT01660451|567152191|FG000|Overall Study|Trial closure.|0|||
157108591|NCT01660451|567152192|FG001|Overall Study|Trial closure.|0|||
157108592|NCT01660451|567152193|FG002|Overall Study|Trial closure.|1|||
157108593|NCT01660451|567152191|FG000|Overall Study|Switching to other therapy|0|||
157108594|NCT01660451|567152192|FG001|Overall Study|Switching to other therapy|1|||
157108595|NCT01660451|567152193|FG002|Overall Study|Switching to other therapy|1|||
157108596|NCT01660451|567152191|FG000|Overall Study|Progressive disease - clinical progression|4|||
157108597|NCT01660451|567152192|FG001|Overall Study|Progressive disease - clinical progression|10|||
157108598|NCT01660451|567152193|FG002|Overall Study|Progressive disease - clinical progression|9|||
157108599|NCT01660451|567152191|FG000|Overall Study|Progressive disease - radiological progression|12|||
157108600|NCT01660451|567152192|FG001|Overall Study|Progressive disease - radiological progression|23|||
157108601|NCT01660451|567152193|FG002|Overall Study|Progressive disease - radiological progression|50|||
157108602|NCT01660451|567152191|FG000|Overall Study|Death|1|||
157108603|NCT01660451|567152192|FG001|Overall Study|Death|0|||
157108604|NCT01660451|567152193|FG002|Overall Study|Death|1|||
157108605|NCT01660451|567152191|FG000|Overall Study|Other|0|||
157108606|NCT01660451|567152192|FG001|Overall Study|Other|0|||
157108607|NCT01660451|567152193|FG002|Overall Study|Other|1|||
157108608|NCT01536951|567152199|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108609|NCT01536951|567152200|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108610|NCT01536951|567152201|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
157108611|NCT01536951|567152202|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108612|NCT01536951|567152203|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108613|NCT01536951|567152204|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108614|NCT01536951|567152205|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108615|NCT01536951|567152206|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108616|NCT01536951|567152207|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
157108617|NCT01536951|567152199|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
157108618|NCT01536951|567152200|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
157108619|NCT01536951|567152201|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
157108620|NCT01536951|567152202|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
157108621|NCT01536951|567152203|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
157108622|NCT01536951|567152204|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
157108623|NCT01536951|567152205|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
157108624|NCT01536951|567152206|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
157108625|NCT01536951|567152207|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
157108626|NCT01843972|567152208|FG000|Overall Study|Withdrawal by Subject|0|||
157108627|NCT01843972|567152209|FG001|Overall Study|Withdrawal by Subject|0|||
157108628|NCT01843972|567152210|FG002|Overall Study|Withdrawal by Subject|0|||
157108629|NCT01843972|567152211|FG003|Overall Study|Withdrawal by Subject|0|||
157108630|NCT01843972|567152212|FG004|Overall Study|Withdrawal by Subject|1|||
157108631|NCT01843972|567152213|FG005|Overall Study|Withdrawal by Subject|0|||
157108632|NCT01843972|567152214|FG006|Overall Study|Withdrawal by Subject|0|||
157108633|NCT01843972|567152215|FG007|Overall Study|Withdrawal by Subject|0|||
157108634|NCT01843972|567152216|FG008|Overall Study|Withdrawal by Subject|0|||
157108635|NCT01843972|567152217|FG009|Overall Study|Withdrawal by Subject|0|||
157108636|NCT00545402|567152220|FG000|Overall Study|Discontinuation of treatment|17|||
157108637|NCT00545402|567152221|FG001|Overall Study|Discontinuation of treatment|9|||
157108638|NCT00545402|567152220|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
157108639|NCT00545402|567152221|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
157108640|NCT00545402|567152220|FG000|Overall Study|Death|5|||
157108641|NCT00545402|567152221|FG001|Overall Study|Death|7|||
157108642|NCT00545402|567152220|FG000|Overall Study|Graft loss|2|||
157108643|NCT00545402|567152221|FG001|Overall Study|Graft loss|4|||
157108644|NCT00545402|567152220|FG000|Overall Study|Withdrawal by Subject|0|||
157108645|NCT00545402|567152221|FG001|Overall Study|Withdrawal by Subject|1|||
157108646|NCT00545402|567152220|FG000|Overall Study|Protocol Violation|1|||
157108647|NCT00545402|567152221|FG001|Overall Study|Protocol Violation|0|||
157108648|NCT00545402|567152220|FG000|Overall Study|Reason not specified|1|||
157108649|NCT00545402|567152221|FG001|Overall Study|Reason not specified|1|||
157108650|NCT01984164|567152222|FG000|Overall Study|Withdrawal by Subject|4|||
157108651|NCT01984164|567152223|FG001|Overall Study|Withdrawal by Subject|3|||
157108652|NCT01984164|567152222|FG000|Overall Study|Adverse Event|5|||
157108653|NCT01984164|567152223|FG001|Overall Study|Adverse Event|19|||
157108654|NCT01984164|567152222|FG000|Overall Study|Lost to Follow-up|1|||
157108655|NCT01984164|567152223|FG001|Overall Study|Lost to Follow-up|3|||
157108656|NCT00427349|567152224|FG000|Overall Study|Lack of Efficacy|23|||
157108657|NCT00427349|567152224|FG000|Overall Study|Adverse Event|14|||
157108658|NCT00427349|567152224|FG000|Overall Study|Death|1|||
157108659|NCT00427349|567152224|FG000|Overall Study|Withdrawal by Subject|3|||
157108660|NCT00427349|567152224|FG000|Overall Study|Alternative therapy|1|||
157108661|NCT00427349|567152224|FG000|Overall Study|Other|2|||
157108662|NCT00427349|567152224|FG000|Overall Study|Ineligible|1|||
157108663|NCT00427349|567152224|FG000|Overall Study|Never started therapy|1|||
157108664|NCT05082376|567152227|FG000|Overall Study|Lost to Follow-up|2|||
157108665|NCT00493220|567152228|FG000|Third Intervention|Withdrawal by Subject|1|||
157108666|NCT00493220|567152229|FG001|Third Intervention|Withdrawal by Subject|0|||
157108667|NCT00493220|567152230|FG002|Third Intervention|Withdrawal by Subject|0|||
157108668|NCT00493220|567152231|FG003|Third Intervention|Withdrawal by Subject|0|||
157108669|NCT00493220|567152232|FG004|Third Intervention|Withdrawal by Subject|0|||
157108670|NCT00493220|567152233|FG005|Third Intervention|Withdrawal by Subject|0|||
157108671|NCT00916279|567152234|FG000|Overall Study|Death|2|||
157108672|NCT00916279|567152234|FG000|Overall Study|Lost to Follow-up|2|||
157108673|NCT02064920|567152235|FG000|Overall Study|Adverse Event|0|||
157108674|NCT02064920|567152236|FG001|Overall Study|Adverse Event|4|||
157108675|NCT02064920|567152235|FG000|Overall Study|Physician Decision|0|||
157108676|NCT02064920|567152236|FG001|Overall Study|Physician Decision|1|||
157108677|NCT02064920|567152235|FG000|Overall Study|Technical Problems|0|||
157108678|NCT02064920|567152236|FG001|Overall Study|Technical Problems|1|||
157108679|NCT02064920|567152235|FG000|Overall Study|Withdrawal by Subject|1|||
157108680|NCT02064920|567152236|FG001|Overall Study|Withdrawal by Subject|3|||
157108681|NCT00310804|567152237|FG000|Overall Study|Lost to Follow-up|2|||
157108682|NCT00310804|567152238|FG001|Overall Study|Lost to Follow-up|0|||
157108683|NCT00310804|567152237|FG000|Overall Study|Withdrawal by Subject|3|||
157108684|NCT00310804|567152238|FG001|Overall Study|Withdrawal by Subject|0|||
157108685|NCT00445224|567152239|FG000|Specific Exercises|Withdrawal by Subject|3|||
157108686|NCT00445224|567152240|FG001|Specific Exercises|Withdrawal by Subject|3|||
157108687|NCT00445224|567152239|FG000|Specific Exercises|Withdrawal by Subject|1|||
157108688|NCT00445224|567152240|FG001|Specific Exercises|Withdrawal by Subject|0|||
157108689|NCT04360551|567153472|FG000|Overall Study|Withdrawal by Subject|1|||
157108690|NCT04360551|567153473|FG001|Overall Study|Withdrawal by Subject|0|||
157108691|NCT02053168|567153481|FG000|Overall Study|Withdrawal by Subject|1|||
157108692|NCT02053168|567153481|FG000|Overall Study|Physician Decision|1|||
157108693|NCT02053168|567153481|FG000|Overall Study|Lost to Follow-up|1|||
157108694|NCT00636675|567153482|FG000|Overall Study|Lost to Follow-up|121|||
157108695|NCT00636675|567153483|FG001|Overall Study|Lost to Follow-up|31|||
157108696|NCT00636675|567153482|FG000|Overall Study|Withdrawal by Subject|19|||
157108697|NCT00636675|567153483|FG001|Overall Study|Withdrawal by Subject|10|||
157108698|NCT02318667|567153488|FG000|Overall Study|Adverse Event|1|||
157108699|NCT02318667|567153488|FG000|Overall Study|Lack of Efficacy|6|||
157108700|NCT02318667|567153488|FG000|Overall Study|Protocol Violation|2|||
157108701|NCT02161575|567153497|FG000|Overall Study|Protocol Violation|8|||
157108702|NCT02161575|567153497|FG000|Overall Study|Lack of Efficacy|1|||
157108703|NCT02161575|567153497|FG000|Overall Study|Adverse Event|2|||
157108704|NCT00714285|567153498|FG000|Overall Study|Lost to Follow-up|0|||
157108705|NCT00714285|567153499|FG001|Overall Study|Lost to Follow-up|2|||
157108706|NCT00714285|567153500|FG002|Overall Study|Lost to Follow-up|0|||
157108707|NCT00714285|567153501|FG003|Overall Study|Lost to Follow-up|1|||
157108708|NCT00714285|567153498|FG000|Overall Study|Migrated/moved from study area|0|||
157108709|NCT00714285|567153499|FG001|Overall Study|Migrated/moved from study area|1|||
157108710|NCT00714285|567153500|FG002|Overall Study|Migrated/moved from study area|0|||
157108711|NCT00714285|567153501|FG003|Overall Study|Migrated/moved from study area|0|||
157108712|NCT02577406|567153502|FG000|Randomized Period|Death|1|||
157108713|NCT02577406|567153503|FG001|Randomized Period|Death|0|||
157108714|NCT02577406|567153502|FG000|Randomized Period|Other reasons|0|||
157108715|NCT02577406|567153503|FG001|Randomized Period|Other reasons|20|||
157108716|NCT02577406|567153502|FG000|Treatment Period|Death|38|||
157108717|NCT02577406|567153503|FG001|Treatment Period|Death|23|||
157108718|NCT02577406|567153502|FG000|Treatment Period|Adverse Event|17|||
157108719|NCT02577406|567153503|FG001|Treatment Period|Adverse Event|12|||
157108720|NCT02577406|567153502|FG000|Treatment Period|Progressive Disease|53|||
157108721|NCT02577406|567153503|FG001|Treatment Period|Progressive Disease|37|||
157108722|NCT02577406|567153502|FG000|Treatment Period|Withdrawal by Subject|10|||
157108723|NCT02577406|567153503|FG001|Treatment Period|Withdrawal by Subject|24|||
157108724|NCT02577406|567153502|FG000|Treatment Period|Lost to Follow-up|0|||
157108725|NCT02577406|567153503|FG001|Treatment Period|Lost to Follow-up|1|||
157108726|NCT02577406|567153502|FG000|Treatment Period|Transition to commercially available treatment|1|||
157108727|NCT02577406|567153503|FG001|Treatment Period|Transition to commercially available treatment|1|||
157108728|NCT02577406|567153502|FG000|Treatment Period|Physician Decision|1|||
157108729|NCT02577406|567153503|FG001|Treatment Period|Physician Decision|0|||
157108730|NCT02577406|567153502|FG000|Treatment Period|Disease Relapse|28|||
157108731|NCT02577406|567153503|FG001|Treatment Period|Disease Relapse|1|||
157108732|NCT02577406|567153502|FG000|Treatment Period|Protocol Violation|0|||
157108733|NCT02577406|567153503|FG001|Treatment Period|Protocol Violation|1|||
157108734|NCT02577406|567153502|FG000|Treatment Period|Other Reasons|3|||
157108735|NCT02577406|567153503|FG001|Treatment Period|Other Reasons|39|||
157108736|NCT02577406|567153502|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
157108737|NCT02577406|567153503|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
157108738|NCT02138617|567153504|FG000|Overall Study|Death|1|||
157108739|NCT02138617|567153505|FG001|Overall Study|Death|2|||
157108740|NCT02138617|567153506|FG002|Overall Study|Death|2|||
157108741|NCT02138617|567153504|FG000|Overall Study|Adverse Event|8|||
157108742|NCT02138617|567153505|FG001|Overall Study|Adverse Event|5|||
157108743|NCT02138617|567153506|FG002|Overall Study|Adverse Event|2|||
157108744|NCT02138617|567153504|FG000|Overall Study|Disease Progression|20|||
157108745|NCT02138617|567153505|FG001|Overall Study|Disease Progression|13|||
157108746|NCT02138617|567153506|FG002|Overall Study|Disease Progression|4|||
157108747|NCT02138617|567153504|FG000|Overall Study|Withdrawal by Subject|7|||
157108748|NCT02138617|567153505|FG001|Overall Study|Withdrawal by Subject|10|||
157108749|NCT02138617|567153506|FG002|Overall Study|Withdrawal by Subject|2|||
157108750|NCT02138617|567153504|FG000|Overall Study|other complicating disease|0|||
157108751|NCT02138617|567153505|FG001|Overall Study|other complicating disease|2|||
157108752|NCT02138617|567153506|FG002|Overall Study|other complicating disease|0|||
157108753|NCT02138617|567153504|FG000|Overall Study|Protocol Violation|1|||
157108754|NCT02138617|567153505|FG001|Overall Study|Protocol Violation|0|||
157108755|NCT02138617|567153506|FG002|Overall Study|Protocol Violation|0|||
157108756|NCT02138617|567153504|FG000|Overall Study|Physician Decision|7|||
157108757|NCT02138617|567153505|FG001|Overall Study|Physician Decision|6|||
157108758|NCT02138617|567153506|FG002|Overall Study|Physician Decision|0|||
157108759|NCT02138617|567153504|FG000|Overall Study|financial reason|0|||
157108760|NCT02138617|567153505|FG001|Overall Study|financial reason|1|||
157108761|NCT02138617|567153506|FG002|Overall Study|financial reason|0|||
157108762|NCT02138617|567153504|FG000|Overall Study|other therapy|3|||
157108763|NCT02138617|567153505|FG001|Overall Study|other therapy|4|||
157108764|NCT02138617|567153506|FG002|Overall Study|other therapy|0|||
157108765|NCT01970488|567153508|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
157108766|NCT01970488|567153509|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
157108767|NCT01970488|567153510|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
157108768|NCT01970488|567153511|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
157108769|NCT01970488|567153512|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
157108770|NCT01970488|567153508|FG000|Part 1: Through Week 16|Protocol Violation|1|||
157108771|NCT01970488|567153509|FG001|Part 1: Through Week 16|Protocol Violation|2|||
157108772|NCT01970488|567153510|FG002|Part 1: Through Week 16|Protocol Violation|0|||
157108773|NCT01970488|567153511|FG003|Part 1: Through Week 16|Protocol Violation|0|||
157108774|NCT01970488|567153512|FG004|Part 1: Through Week 16|Protocol Violation|0|||
157108775|NCT01970488|567153508|FG000|Part 1: Through Week 16|Adverse Event|6|||
157108776|NCT01970488|567153509|FG001|Part 1: Through Week 16|Adverse Event|5|||
157108777|NCT01970488|567153510|FG002|Part 1: Through Week 16|Adverse Event|0|||
157108778|NCT01970488|567153511|FG003|Part 1: Through Week 16|Adverse Event|0|||
157108779|NCT01970488|567153512|FG004|Part 1: Through Week 16|Adverse Event|0|||
157108780|NCT01970488|567153508|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
157108781|NCT01970488|567153509|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
157108782|NCT01970488|567153510|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
157108783|NCT01970488|567153511|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
157108784|NCT01970488|567153512|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
157108785|NCT01970488|567153508|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
157108786|NCT01970488|567153509|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
157108787|NCT01970488|567153510|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
157108788|NCT01970488|567153511|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
157108789|NCT01970488|567153512|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
157108790|NCT01970488|567153508|FG000|Part 2: Post Week 16|Physician Decision|0|||
157108791|NCT01970488|567153509|FG001|Part 2: Post Week 16|Physician Decision|0|||
157108792|NCT01970488|567153510|FG002|Part 2: Post Week 16|Physician Decision|0|||
157108793|NCT01970488|567153511|FG003|Part 2: Post Week 16|Physician Decision|0|||
157108794|NCT01970488|567153512|FG004|Part 2: Post Week 16|Physician Decision|1|||
157108795|NCT01970488|567153508|FG000|Part 2: Post Week 16|Non-compliance|0|||
157108796|NCT01970488|567153509|FG001|Part 2: Post Week 16|Non-compliance|0|||
157108797|NCT01970488|567153510|FG002|Part 2: Post Week 16|Non-compliance|1|||
157108798|NCT01970488|567153511|FG003|Part 2: Post Week 16|Non-compliance|0|||
157108799|NCT01970488|567153512|FG004|Part 2: Post Week 16|Non-compliance|0|||
157108800|NCT01970488|567153508|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
157108801|NCT01970488|567153509|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
157108802|NCT01970488|567153510|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
157108803|NCT01970488|567153511|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
157108804|NCT01970488|567153512|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
157108805|NCT01970488|567153508|FG000|Part 2: Post Week 16|Adverse Event|0|||
157108806|NCT01970488|567153509|FG001|Part 2: Post Week 16|Adverse Event|0|||
157108807|NCT01970488|567153510|FG002|Part 2: Post Week 16|Adverse Event|5|||
157108808|NCT01970488|567153511|FG003|Part 2: Post Week 16|Adverse Event|1|||
157108809|NCT01970488|567153512|FG004|Part 2: Post Week 16|Adverse Event|1|||
157108810|NCT01970488|567153508|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
157108811|NCT01970488|567153509|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
157108812|NCT01970488|567153510|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
157108813|NCT01970488|567153511|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
157108814|NCT01970488|567153512|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
157108815|NCT01970488|567153508|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
157108816|NCT01970488|567153509|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
157108817|NCT01970488|567153510|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
157108818|NCT01970488|567153511|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
157108819|NCT01970488|567153512|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
157108820|NCT01816061|567153513|FG000|Overall Study|Lost to Follow-up|13|||
157108821|NCT01816061|567153514|FG001|Overall Study|Lost to Follow-up|24|||
157108822|NCT01961349|567153515|FG000|Overall Study|Withdrawal by Subject|1|||
157108823|NCT01961349|567153516|FG001|Overall Study|Withdrawal by Subject|4|||
157108824|NCT01961349|567153517|FG002|Overall Study|Withdrawal by Subject|0|||
157108825|NCT01961349|567153515|FG000|Overall Study|Adverse Event|0|||
157108826|NCT01961349|567153516|FG001|Overall Study|Adverse Event|0|||
157108827|NCT01961349|567153517|FG002|Overall Study|Adverse Event|1|||
157108828|NCT01961349|567153515|FG000|Overall Study|registration error, personal reason etc|2|||
157108829|NCT01961349|567153516|FG001|Overall Study|registration error, personal reason etc|2|||
157108830|NCT01961349|567153517|FG002|Overall Study|registration error, personal reason etc|1|||
157108831|NCT05525689|567153519|FG000|Overall Study|Lost to Follow-up|1|||
157108832|NCT05525689|567153520|FG001|Overall Study|Lost to Follow-up|0|||
157108833|NCT01671111|567153525|FG000|Overall Study|Adverse Event|2|||
157108834|NCT01671111|567153525|FG000|Overall Study|Lack of Efficacy|1|||
157108835|NCT01671111|567153525|FG000|Overall Study|Withdrawal by Subject|2|||
157108836|NCT01671111|567153525|FG000|Overall Study|Physician Decision|1|||
157108837|NCT01671111|567153525|FG000|Overall Study|Other|24|||
157108838|NCT01231659|567153526|FG000|Overall Study|Adverse Event|9|||
157108839|NCT01231659|567153526|FG000|Overall Study|Disease Progression|48|||
157108840|NCT01231659|567153526|FG000|Overall Study|Death|2|||
157108841|NCT01231659|567153526|FG000|Overall Study|Patient refused to complete study visit|1|||
157108842|NCT01231659|567153526|FG000|Overall Study|Other protocol defined criteria|12|||
157108843|NCT01075412|567153531|FG000|Overall Study|Withdrawal by Subject|0|||
157108844|NCT01075412|567153532|FG001|Overall Study|Withdrawal by Subject|1|||
157108845|NCT00509067|567153533|FG000|Overall Study|Lost to Follow-up|1|||
157108846|NCT00509067|567153534|FG001|Overall Study|Lost to Follow-up|1|||
157108847|NCT00509067|567153533|FG000|Overall Study|Adverse Event|3|||
157108848|NCT00509067|567153534|FG001|Overall Study|Adverse Event|1|||
157108849|NCT00509067|567153533|FG000|Overall Study|Protocol Violation|0|||
157108850|NCT00509067|567153534|FG001|Overall Study|Protocol Violation|3|||
157108851|NCT00702325|567153548|FG000|Overall Study|Adverse Event|1|||
157108852|NCT00702325|567153549|FG001|Overall Study|Adverse Event|0|||
157108853|NCT00702325|567153548|FG000|Overall Study|Withdrawal by Subject|7|||
157108854|NCT00702325|567153549|FG001|Overall Study|Withdrawal by Subject|7|||
157108855|NCT00702325|567153548|FG000|Overall Study|Lost to Follow-up|3|||
157108856|NCT00702325|567153549|FG001|Overall Study|Lost to Follow-up|4|||
157108857|NCT00702325|567153548|FG000|Overall Study|Incorrect enrollment|5|||
157108858|NCT00702325|567153549|FG001|Overall Study|Incorrect enrollment|7|||
157108859|NCT00702325|567153548|FG000|Overall Study|Developed study discontinuation criteria|18|||
157108860|NCT00702325|567153549|FG001|Overall Study|Developed study discontinuation criteria|28|||
157108861|NCT00702325|567153548|FG000|Overall Study|Severe noncompliance to protocol|3|||
157108862|NCT00702325|567153549|FG001|Overall Study|Severe noncompliance to protocol|3|||
157108863|NCT00702325|567153548|FG000|Overall Study|Termination due to lab results|1|||
157108864|NCT00702325|567153549|FG001|Overall Study|Termination due to lab results|0|||
157108865|NCT00702325|567153548|FG000|Overall Study|Didn't follow study medication dosage|0|||
157108866|NCT00702325|567153549|FG001|Overall Study|Didn't follow study medication dosage|2|||
157108867|NCT00702325|567153548|FG000|Overall Study|Withdrew consent|0|||
157108868|NCT00702325|567153549|FG001|Overall Study|Withdrew consent|1|||
157108869|NCT00702325|567153548|FG000|Overall Study|Incorrectly Discontinued|0|||
157108870|NCT00702325|567153549|FG001|Overall Study|Incorrectly Discontinued|1|||
157108871|NCT04556136|567153553|FG000|Overall Study|Lost to Follow-up|6|||
157108872|NCT04556136|567153554|FG001|Overall Study|Lost to Follow-up|6|||
157108873|NCT04556136|567153553|FG000|Overall Study|Physician Decision|2|||
157108874|NCT04556136|567153554|FG001|Overall Study|Physician Decision|1|||
157108875|NCT04556136|567153553|FG000|Overall Study|Withdrawal by Subject|2|||
157108876|NCT04556136|567153554|FG001|Overall Study|Withdrawal by Subject|1|||
157108877|NCT01022502|567153557|FG000|Overall Study|Adverse Event|1|||
157108878|NCT01022502|567153557|FG000|Overall Study|employment related reasons|1|||
157108879|NCT01022502|567153557|FG000|Overall Study|Withdrawal by Subject|1|||
157108880|NCT03199040|567153565|FG000|Overall Study|Lack of Efficacy|2|||
157108881|NCT03199040|567153566|FG001|Overall Study|Lack of Efficacy|0|||
157108882|NCT03199040|567153565|FG000|Overall Study|Withdrawal by Subject|2|||
157108883|NCT03199040|567153566|FG001|Overall Study|Withdrawal by Subject|0|||
157108884|NCT03199040|567153565|FG000|Overall Study|Adverse Event|0|||
157108885|NCT03199040|567153566|FG001|Overall Study|Adverse Event|1|||
157108886|NCT03199040|567153565|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
157108887|NCT03199040|567153566|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
157108888|NCT01786603|567153567|FG000|Overall Study|Death|5|||
157108889|NCT01786603|567153568|FG001|Overall Study|Death|1|||
157108890|NCT01786603|567153567|FG000|Overall Study|Adverse Event|6|||
157108891|NCT01786603|567153568|FG001|Overall Study|Adverse Event|2|||
157108892|NCT01786603|567153567|FG000|Overall Study|Physician decision to withdraw|6|||
157108893|NCT01786603|567153568|FG001|Overall Study|Physician decision to withdraw|7|||
157108894|NCT01786603|567153567|FG000|Overall Study|Lost to Follow-up|1|||
157108895|NCT01786603|567153568|FG001|Overall Study|Lost to Follow-up|2|||
157108896|NCT01226459|567153569|FG000|Overall Study|Adverse Event|2|||
157108897|NCT01226459|567153570|FG001|Overall Study|Adverse Event|8|||
156761966|NCT05616013|565879944|FG000|Overall Study|Withdrawal by Subject|11|||
156761967|NCT05616013|565879945|FG001|Overall Study|Withdrawal by Subject|9|||
156761968|NCT05616013|565879946|FG002|Overall Study|Withdrawal by Subject|8|||
157108898|NCT01226459|567153569|FG000|Overall Study|Protocol Violation|4|||
157108899|NCT01226459|567153570|FG001|Overall Study|Protocol Violation|3|||
157108900|NCT01226459|567153569|FG000|Overall Study|Withdrawal by Subject|10|||
157108901|NCT01226459|567153570|FG001|Overall Study|Withdrawal by Subject|13|||
157108902|NCT01226459|567153569|FG000|Overall Study|Lost to Follow-up|4|||
157108903|NCT01226459|567153570|FG001|Overall Study|Lost to Follow-up|8|||
157108904|NCT01226459|567153569|FG000|Overall Study|Pregnancy|1|||
157108905|NCT01226459|567153570|FG001|Overall Study|Pregnancy|0|||
157108906|NCT01092143|567153571|FG000|Overall Study|Adverse Event|10|||
157108907|NCT01092143|567153572|FG001|Overall Study|Adverse Event|5|||
157108908|NCT01092143|567153573|FG002|Overall Study|Adverse Event|1|||
157108909|NCT01092143|567153574|FG003|Overall Study|Adverse Event|4|||
157108910|NCT01092143|567153575|FG004|Overall Study|Adverse Event|3|||
157108911|NCT01092143|567153571|FG000|Overall Study|Lost to Follow-up|1|||
157108912|NCT01092143|567153572|FG001|Overall Study|Lost to Follow-up|0|||
157108913|NCT01092143|567153573|FG002|Overall Study|Lost to Follow-up|1|||
157108914|NCT01092143|567153574|FG003|Overall Study|Lost to Follow-up|0|||
157108915|NCT01092143|567153575|FG004|Overall Study|Lost to Follow-up|0|||
157108916|NCT01092143|567153571|FG000|Overall Study|Consent withdrawn|2|||
157108917|NCT01092143|567153572|FG001|Overall Study|Consent withdrawn|1|||
157108918|NCT01092143|567153573|FG002|Overall Study|Consent withdrawn|0|||
157108919|NCT01092143|567153574|FG003|Overall Study|Consent withdrawn|1|||
157108920|NCT01092143|567153575|FG004|Overall Study|Consent withdrawn|3|||
157108921|NCT01092143|567153571|FG000|Overall Study|Not treated|0|||
157108922|NCT01092143|567153572|FG001|Overall Study|Not treated|0|||
157108923|NCT01092143|567153573|FG002|Overall Study|Not treated|1|||
157108924|NCT01092143|567153574|FG003|Overall Study|Not treated|0|||
157108925|NCT01092143|567153575|FG004|Overall Study|Not treated|0|||
157108926|NCT01092143|567153571|FG000|Overall Study|did not reversibility criteria|0|||
157108927|NCT01092143|567153572|FG001|Overall Study|did not reversibility criteria|0|||
157108928|NCT01092143|567153573|FG002|Overall Study|did not reversibility criteria|1|||
157108929|NCT01092143|567153574|FG003|Overall Study|did not reversibility criteria|0|||
157108930|NCT01092143|567153575|FG004|Overall Study|did not reversibility criteria|0|||
157108931|NCT01092143|567153571|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
157108932|NCT01092143|567153572|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
157108933|NCT01092143|567153573|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
157108934|NCT01092143|567153574|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
157108935|NCT01092143|567153575|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
157108936|NCT01092143|567153571|FG000|Overall Study|Ineligible patient|1|||
157108937|NCT01092143|567153572|FG001|Overall Study|Ineligible patient|0|||
157108938|NCT01092143|567153573|FG002|Overall Study|Ineligible patient|0|||
157108939|NCT01092143|567153574|FG003|Overall Study|Ineligible patient|0|||
157108940|NCT01092143|567153575|FG004|Overall Study|Ineligible patient|0|||
157108941|NCT01092143|567153571|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
157108942|NCT01092143|567153572|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
157108943|NCT01092143|567153573|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
157108944|NCT01092143|567153574|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
157108945|NCT01092143|567153575|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
157108946|NCT01092143|567153571|FG000|Overall Study|Patient travel|0|||
157108947|NCT01092143|567153572|FG001|Overall Study|Patient travel|0|||
157108948|NCT01092143|567153573|FG002|Overall Study|Patient travel|0|||
157108949|NCT01092143|567153574|FG003|Overall Study|Patient travel|0|||
157108950|NCT01092143|567153575|FG004|Overall Study|Patient travel|1|||
156761969|NCT05616013|565879947|FG003|Overall Study|Withdrawal by Subject|6|||
156761970|NCT05616013|565879948|FG004|Overall Study|Withdrawal by Subject|3|||
157108951|NCT01092143|567153571|FG000|Overall Study|Non compliance with study medication|0|||
157108952|NCT01092143|567153572|FG001|Overall Study|Non compliance with study medication|0|||
156761971|NCT05616013|565879949|FG005|Overall Study|Withdrawal by Subject|4|||
156761972|NCT05616013|565879950|FG006|Overall Study|Withdrawal by Subject|6|||
156761973|NCT05616013|565879951|FG007|Overall Study|Withdrawal by Subject|5|||
156761974|NCT05616013|565879952|FG008|Overall Study|Withdrawal by Subject|4|||
156761975|NCT05616013|565879944|FG000|Overall Study|Physician Decision|0|||
156761976|NCT05616013|565879945|FG001|Overall Study|Physician Decision|0|||
156761977|NCT05616013|565879946|FG002|Overall Study|Physician Decision|1|||
156761978|NCT05616013|565879947|FG003|Overall Study|Physician Decision|0|||
156761979|NCT05616013|565879948|FG004|Overall Study|Physician Decision|0|||
157108953|NCT01092143|567153573|FG002|Overall Study|Non compliance with study medication|0|||
157108954|NCT01092143|567153574|FG003|Overall Study|Non compliance with study medication|0|||
157108955|NCT01092143|567153575|FG004|Overall Study|Non compliance with study medication|1|||
157108956|NCT01092143|567153571|FG000|Overall Study|Randomized by mistake|0|||
157108957|NCT01092143|567153572|FG001|Overall Study|Randomized by mistake|0|||
157108958|NCT01092143|567153573|FG002|Overall Study|Randomized by mistake|0|||
157108959|NCT01092143|567153574|FG003|Overall Study|Randomized by mistake|1|||
157108960|NCT01092143|567153575|FG004|Overall Study|Randomized by mistake|0|||
157108961|NCT01092143|567153571|FG000|Overall Study|Pregnancy|0|||
157108962|NCT01092143|567153572|FG001|Overall Study|Pregnancy|0|||
157108963|NCT01092143|567153573|FG002|Overall Study|Pregnancy|0|||
157108964|NCT01092143|567153574|FG003|Overall Study|Pregnancy|1|||
157108965|NCT01092143|567153575|FG004|Overall Study|Pregnancy|0|||
157108966|NCT00117598|567153576|FG000|Prior to Treatment Cross Over|Death|40|||
157108967|NCT00117598|567153577|FG001|Prior to Treatment Cross Over|Death|41|||
157108968|NCT00117598|567153578|FG002|Prior to Treatment Cross Over|Death|37|||
157108969|NCT00117598|567153579|FG003|Prior to Treatment Cross Over|Death|0|||
157108970|NCT00117598|567153580|FG004|Prior to Treatment Cross Over|Death|0|||
157108971|NCT00117598|567153576|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
157108972|NCT00117598|567153577|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
157108973|NCT00117598|567153578|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
157108974|NCT00117598|567153579|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
157108975|NCT00117598|567153580|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
157108976|NCT00117598|567153576|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
157108977|NCT00117598|567153577|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
157108978|NCT00117598|567153578|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
157108979|NCT00117598|567153579|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
157108980|NCT00117598|567153580|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
157108981|NCT00117598|567153576|FG000|Prior to Treatment Cross Over|Other|15|||
157108982|NCT00117598|567153577|FG001|Prior to Treatment Cross Over|Other|9|||
157108983|NCT00117598|567153578|FG002|Prior to Treatment Cross Over|Other|9|||
157108984|NCT00117598|567153579|FG003|Prior to Treatment Cross Over|Other|0|||
157108985|NCT00117598|567153580|FG004|Prior to Treatment Cross Over|Other|0|||
157108986|NCT00117598|567153576|FG000|After Treament Cross Over|Death|0|||
157108987|NCT00117598|567153577|FG001|After Treament Cross Over|Death|0|||
157108988|NCT00117598|567153578|FG002|After Treament Cross Over|Death|0|||
157108989|NCT00117598|567153579|FG003|After Treament Cross Over|Death|1|||
157108990|NCT00117598|567153580|FG004|After Treament Cross Over|Death|2|||
157108991|NCT00117598|567153576|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
157108992|NCT00117598|567153577|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
157108993|NCT00117598|567153578|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
157108994|NCT00117598|567153579|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
157108995|NCT00117598|567153580|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
157108996|NCT00117598|567153576|FG000|After Treament Cross Over|Other|0|||
157108997|NCT00117598|567153577|FG001|After Treament Cross Over|Other|0|||
157108998|NCT00117598|567153578|FG002|After Treament Cross Over|Other|0|||
157108999|NCT00117598|567153579|FG003|After Treament Cross Over|Other|1|||
157109000|NCT00117598|567153580|FG004|After Treament Cross Over|Other|2|||
157109001|NCT04688775|567153583|FG000|Placebo-controlled Period|Randomized, not treated|1|||
157109002|NCT04688775|567153584|FG001|Placebo-controlled Period|Randomized, not treated|1|||
157109003|NCT04688775|567153585|FG002|Placebo-controlled Period|Randomized, not treated|0|||
157109004|NCT04688775|567153586|FG003|Placebo-controlled Period|Randomized, not treated|0|||
157109005|NCT04688775|567153583|FG000|Placebo-controlled Period|Adverse Event|2|||
157109006|NCT04688775|567153584|FG001|Placebo-controlled Period|Adverse Event|0|||
157109007|NCT04688775|567153585|FG002|Placebo-controlled Period|Adverse Event|0|||
157109008|NCT04688775|567153586|FG003|Placebo-controlled Period|Adverse Event|0|||
157109009|NCT04688775|567153583|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
157109010|NCT04688775|567153584|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
157109011|NCT04688775|567153585|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
157109012|NCT04688775|567153586|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
157109013|NCT04688775|567153583|FG000|Placebo-controlled Period|Protocol Violation|0|||
157109014|NCT04688775|567153584|FG001|Placebo-controlled Period|Protocol Violation|1|||
156761980|NCT05616013|565879949|FG005|Overall Study|Physician Decision|1|||
156761981|NCT05616013|565879950|FG006|Overall Study|Physician Decision|3|||
156761982|NCT05616013|565879951|FG007|Overall Study|Physician Decision|0|||
157109015|NCT04688775|567153585|FG002|Placebo-controlled Period|Protocol Violation|0|||
157109016|NCT04688775|567153586|FG003|Placebo-controlled Period|Protocol Violation|0|||
157109017|NCT04688775|567153583|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
157109018|NCT04688775|567153584|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
157109019|NCT04688775|567153585|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
156761983|NCT05616013|565879952|FG008|Overall Study|Physician Decision|0|||
156761984|NCT05616013|565879944|FG000|Overall Study|Protocol Violation|0|||
157109020|NCT04688775|567153586|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
157109021|NCT04688775|567153583|FG000|Placebo-controlled Period|Other reasons|0|||
157109022|NCT04688775|567153584|FG001|Placebo-controlled Period|Other reasons|1|||
157109023|NCT04688775|567153585|FG002|Placebo-controlled Period|Other reasons|0|||
157109024|NCT04688775|567153586|FG003|Placebo-controlled Period|Other reasons|0|||
157109025|NCT04688775|567153583|FG000|Delayed Start Period|Adverse Event|0|||
157109026|NCT04688775|567153584|FG001|Delayed Start Period|Adverse Event|0|||
157109027|NCT04688775|567153585|FG002|Delayed Start Period|Adverse Event|1|||
157109028|NCT04688775|567153586|FG003|Delayed Start Period|Adverse Event|0|||
157109029|NCT04688775|567153583|FG000|Delayed Start Period|Lack of Efficacy|0|||
157109030|NCT04688775|567153584|FG001|Delayed Start Period|Lack of Efficacy|0|||
157109031|NCT04688775|567153585|FG002|Delayed Start Period|Lack of Efficacy|0|||
157109032|NCT04688775|567153586|FG003|Delayed Start Period|Lack of Efficacy|3|||
157109033|NCT04688775|567153583|FG000|Delayed Start Period|Withdrawal by Subject|0|||
157109034|NCT04688775|567153584|FG001|Delayed Start Period|Withdrawal by Subject|0|||
157109035|NCT04688775|567153585|FG002|Delayed Start Period|Withdrawal by Subject|2|||
157109036|NCT04688775|567153586|FG003|Delayed Start Period|Withdrawal by Subject|4|||
157109037|NCT04688775|567153583|FG000|Delayed Start Period|Lost to Follow-up|0|||
157109038|NCT04688775|567153584|FG001|Delayed Start Period|Lost to Follow-up|0|||
157109039|NCT04688775|567153585|FG002|Delayed Start Period|Lost to Follow-up|2|||
157109040|NCT04688775|567153586|FG003|Delayed Start Period|Lost to Follow-up|1|||
157109041|NCT04688775|567153583|FG000|Delayed Start Period|other reasons|0|||
157109042|NCT04688775|567153584|FG001|Delayed Start Period|other reasons|0|||
157109043|NCT04688775|567153585|FG002|Delayed Start Period|other reasons|1|||
157109044|NCT04688775|567153586|FG003|Delayed Start Period|other reasons|0|||
157109045|NCT01854645|567153590|FG000|Overall Study|Protocol-Specified Criteria|13|||
157109046|NCT01854645|567153591|FG001|Overall Study|Protocol-Specified Criteria|10|||
157109047|NCT01854645|567153592|FG002|Overall Study|Protocol-Specified Criteria|8|||
157109048|NCT01854645|567153593|FG003|Overall Study|Protocol-Specified Criteria|5|||
157109049|NCT01854645|567153594|FG004|Overall Study|Protocol-Specified Criteria|7|||
157109050|NCT01854645|567153590|FG000|Overall Study|Administrative Reasons / Missing|0|||
157109051|NCT01854645|567153591|FG001|Overall Study|Administrative Reasons / Missing|0|||
157109052|NCT01854645|567153592|FG002|Overall Study|Administrative Reasons / Missing|0|||
157109053|NCT01854645|567153593|FG003|Overall Study|Administrative Reasons / Missing|1|||
157109054|NCT01854645|567153594|FG004|Overall Study|Administrative Reasons / Missing|1|||
157109055|NCT01854645|567153590|FG000|Overall Study|Protocol Violation|3|||
157109056|NCT01854645|567153591|FG001|Overall Study|Protocol Violation|0|||
157109057|NCT01854645|567153592|FG002|Overall Study|Protocol Violation|5|||
157109058|NCT01854645|567153593|FG003|Overall Study|Protocol Violation|4|||
157109059|NCT01854645|567153594|FG004|Overall Study|Protocol Violation|1|||
157109060|NCT01854645|567153590|FG000|Overall Study|Lost to Follow-up|10|||
157109061|NCT01854645|567153591|FG001|Overall Study|Lost to Follow-up|7|||
157109062|NCT01854645|567153592|FG002|Overall Study|Lost to Follow-up|8|||
157109063|NCT01854645|567153593|FG003|Overall Study|Lost to Follow-up|5|||
157109064|NCT01854645|567153594|FG004|Overall Study|Lost to Follow-up|0|||
157109065|NCT01854645|567153590|FG000|Overall Study|Physician Decision|1|||
157109066|NCT01854645|567153591|FG001|Overall Study|Physician Decision|5|||
157109067|NCT01854645|567153592|FG002|Overall Study|Physician Decision|3|||
157109068|NCT01854645|567153593|FG003|Overall Study|Physician Decision|3|||
157109069|NCT01854645|567153594|FG004|Overall Study|Physician Decision|7|||
157109070|NCT01854645|567153590|FG000|Overall Study|Withdrawal by Subject|31|||
157109071|NCT01854645|567153591|FG001|Overall Study|Withdrawal by Subject|41|||
157109072|NCT01854645|567153592|FG002|Overall Study|Withdrawal by Subject|30|||
157109073|NCT01854645|567153593|FG003|Overall Study|Withdrawal by Subject|21|||
157109074|NCT01854645|567153594|FG004|Overall Study|Withdrawal by Subject|24|||
157109075|NCT01854645|567153590|FG000|Overall Study|Lack of Efficacy|7|||
157109076|NCT01854645|567153591|FG001|Overall Study|Lack of Efficacy|12|||
157109077|NCT01854645|567153592|FG002|Overall Study|Lack of Efficacy|9|||
157109078|NCT01854645|567153593|FG003|Overall Study|Lack of Efficacy|3|||
157109079|NCT01854645|567153594|FG004|Overall Study|Lack of Efficacy|9|||
157109080|NCT01854645|567153590|FG000|Overall Study|Adverse Event|33|||
157109081|NCT01854645|567153591|FG001|Overall Study|Adverse Event|31|||
157109082|NCT01854645|567153592|FG002|Overall Study|Adverse Event|19|||
157109083|NCT01854645|567153593|FG003|Overall Study|Adverse Event|20|||
157109084|NCT01854645|567153594|FG004|Overall Study|Adverse Event|11|||
157109085|NCT01817751|567153598|FG000|Overall Study|Physician Decision|1|||
157109086|NCT00382018|567153599|FG000|Overall Study|Progression|0|||
157109087|NCT00382018|567153600|FG001|Overall Study|Progression|136|||
157109088|NCT00382018|567153601|FG002|Overall Study|Progression|51|||
157109089|NCT00382018|567153602|FG003|Overall Study|Progression|43|||
157109090|NCT00382018|567153599|FG000|Overall Study|Death|0|||
157109091|NCT00382018|567153600|FG001|Overall Study|Death|9|||
157109092|NCT00382018|567153601|FG002|Overall Study|Death|7|||
157109093|NCT00382018|567153602|FG003|Overall Study|Death|11|||
157109094|NCT00382018|567153599|FG000|Overall Study|Withdrawal by Subject|0|||
157109095|NCT00382018|567153600|FG001|Overall Study|Withdrawal by Subject|4|||
157109096|NCT00382018|567153601|FG002|Overall Study|Withdrawal by Subject|3|||
157109097|NCT00382018|567153602|FG003|Overall Study|Withdrawal by Subject|4|||
157109098|NCT00382018|567153599|FG000|Overall Study|Other, not protocol specified|0|||
157109099|NCT00382018|567153600|FG001|Overall Study|Other, not protocol specified|16|||
157109100|NCT00382018|567153601|FG002|Overall Study|Other, not protocol specified|3|||
157109101|NCT00382018|567153602|FG003|Overall Study|Other, not protocol specified|1|||
157109102|NCT02109562|567153610|FG000|Overall Study|Insufficient clinical response|2|||
157109103|NCT02109562|567153611|FG001|Overall Study|Insufficient clinical response|0|||
157109104|NCT02109562|567153612|FG002|Overall Study|Insufficient clinical response|4|||
157109105|NCT02109562|567153610|FG000|Overall Study|Adverse Event|0|||
157109106|NCT02109562|567153611|FG001|Overall Study|Adverse Event|2|||
157109107|NCT02109562|567153612|FG002|Overall Study|Adverse Event|3|||
157109108|NCT02109562|567153610|FG000|Overall Study|Lost to Follow-up|1|||
157109109|NCT02109562|567153611|FG001|Overall Study|Lost to Follow-up|0|||
157109110|NCT02109562|567153612|FG002|Overall Study|Lost to Follow-up|1|||
157109111|NCT02109562|567153610|FG000|Overall Study|Protocol Violation|0|||
157109112|NCT02109562|567153611|FG001|Overall Study|Protocol Violation|3|||
157109113|NCT02109562|567153612|FG002|Overall Study|Protocol Violation|1|||
156761985|NCT05616013|565879945|FG001|Overall Study|Protocol Violation|0|||
156761986|NCT05616013|565879946|FG002|Overall Study|Protocol Violation|0|||
156761987|NCT05616013|565879947|FG003|Overall Study|Protocol Violation|0|||
157109114|NCT02109562|567153610|FG000|Overall Study|Withdrawal by Subject|20|||
157109115|NCT02109562|567153611|FG001|Overall Study|Withdrawal by Subject|25|||
157109116|NCT02109562|567153612|FG002|Overall Study|Withdrawal by Subject|21|||
157109117|NCT02109562|567153610|FG000|Overall Study|Physician Decision|3|||
157109118|NCT02109562|567153611|FG001|Overall Study|Physician Decision|4|||
157109119|NCT02109562|567153612|FG002|Overall Study|Physician Decision|5|||
157109120|NCT00574145|567155316|FG000|Overall Study|Withdrawal by Subject|2|||
157109121|NCT00574145|567155317|FG001|Overall Study|Withdrawal by Subject|1|||
157109122|NCT03227471|567155318|FG000|Overall Study|Withdrawal by Subject|0|||
157109123|NCT03227471|567155319|FG001|Overall Study|Withdrawal by Subject|0|||
157109124|NCT03227471|567155320|FG002|Overall Study|Withdrawal by Subject|0|||
157109125|NCT03227471|567155321|FG003|Overall Study|Withdrawal by Subject|0|||
157109126|NCT03227471|567155322|FG004|Overall Study|Withdrawal by Subject|1|||
157109127|NCT03227471|567155323|FG005|Overall Study|Withdrawal by Subject|0|||
157109128|NCT03227471|567155324|FG006|Overall Study|Withdrawal by Subject|0|||
157109129|NCT03227471|567155325|FG007|Overall Study|Withdrawal by Subject|0|||
157109130|NCT03227471|567155326|FG008|Overall Study|Withdrawal by Subject|0|||
157109131|NCT03227471|567155327|FG009|Overall Study|Withdrawal by Subject|0|||
157109132|NCT03227471|567155328|FG010|Overall Study|Withdrawal by Subject|0|||
157109133|NCT03227471|567155329|FG011|Overall Study|Withdrawal by Subject|0|||
157109134|NCT03227471|567155330|FG012|Overall Study|Withdrawal by Subject|1|||
157109135|NCT03227471|567155331|FG013|Overall Study|Withdrawal by Subject|0|||
157109136|NCT03227471|567155332|FG014|Overall Study|Withdrawal by Subject|0|||
157109137|NCT03227471|567155318|FG000|Overall Study|Randomized, Never Dosed|0|||
157109138|NCT03227471|567155319|FG001|Overall Study|Randomized, Never Dosed|0|||
157109139|NCT03227471|567155320|FG002|Overall Study|Randomized, Never Dosed|0|||
157109140|NCT03227471|567155321|FG003|Overall Study|Randomized, Never Dosed|0|||
157109141|NCT03227471|567155322|FG004|Overall Study|Randomized, Never Dosed|0|||
157109142|NCT03227471|567155323|FG005|Overall Study|Randomized, Never Dosed|0|||
157109143|NCT03227471|567155324|FG006|Overall Study|Randomized, Never Dosed|0|||
157109144|NCT03227471|567155325|FG007|Overall Study|Randomized, Never Dosed|0|||
157109145|NCT03227471|567155326|FG008|Overall Study|Randomized, Never Dosed|0|||
157109146|NCT03227471|567155327|FG009|Overall Study|Randomized, Never Dosed|0|||
156761988|NCT05616013|565879948|FG004|Overall Study|Protocol Violation|0|||
156761989|NCT05616013|565879949|FG005|Overall Study|Protocol Violation|0|||
156761990|NCT05616013|565879950|FG006|Overall Study|Protocol Violation|1|||
157109147|NCT03227471|567155328|FG010|Overall Study|Randomized, Never Dosed|0|||
157109148|NCT03227471|567155329|FG011|Overall Study|Randomized, Never Dosed|0|||
157109149|NCT03227471|567155330|FG012|Overall Study|Randomized, Never Dosed|0|||
157109150|NCT03227471|567155331|FG013|Overall Study|Randomized, Never Dosed|0|||
157109151|NCT03227471|567155332|FG014|Overall Study|Randomized, Never Dosed|1|||
156761991|NCT05616013|565879951|FG007|Overall Study|Protocol Violation|0|||
156761992|NCT05616013|565879952|FG008|Overall Study|Protocol Violation|2|||
157109152|NCT00176605|567155345|FG000|Overall Study|Withdrawal by Subject|2|||
157109153|NCT01566773|567155348|FG000|Overall Study|Protocol specified criteria|4|||
157109154|NCT01566773|567155348|FG000|Overall Study|Protocol Violation|4|||
157109155|NCT01566773|567155348|FG000|Overall Study|Withdrawal by Subject|9|||
157109156|NCT01566773|567155348|FG000|Overall Study|Administrative reason|1|||
157109157|NCT01566773|567155348|FG000|Overall Study|Adverse Event|10|||
157109158|NCT01566773|567155348|FG000|Overall Study|Physician Decision|2|||
157004269|NCT03478696|566764199|FG000|Overall Study|Lost to Follow-up|1|||
157004270|NCT03478696|566764200|FG001|Overall Study|Lost to Follow-up|0|||
157004271|NCT03478696|566764199|FG000|Overall Study|Physician Decision|6|||
157004272|NCT03478696|566764200|FG001|Overall Study|Physician Decision|3|||
157004273|NCT03478696|566764199|FG000|Overall Study|Withdrawal by Subject|9|||
157004274|NCT03478696|566764200|FG001|Overall Study|Withdrawal by Subject|4|||
157004275|NCT04246762|566764201|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
157004276|NCT02878330|566764202|FG000|Overall Study|Death|3|||
157004277|NCT02878330|566764203|FG001|Overall Study|Death|2|||
157004278|NCT02878330|566764202|FG000|Overall Study|Lost to Follow-up|11|||
157004279|NCT02878330|566764203|FG001|Overall Study|Lost to Follow-up|26|||
157004280|NCT02878330|566764202|FG000|Overall Study|Withdrawal by Subject|11|||
157004281|NCT02878330|566764203|FG001|Overall Study|Withdrawal by Subject|21|||
157004282|NCT02878330|566764202|FG000|Overall Study|Other|4|||
157004283|NCT02878330|566764203|FG001|Overall Study|Other|7|||
157004284|NCT03615924|566764208|FG000|Overall Study|Withdrawal by Subject|2|||
157004285|NCT03615924|566764209|FG001|Overall Study|Withdrawal by Subject|5|||
157004286|NCT03615924|566764208|FG000|Overall Study|Death|3|||
157004287|NCT03615924|566764209|FG001|Overall Study|Death|1|||
157004288|NCT03615924|566764208|FG000|Overall Study|Lost to Follow-up|1|||
157004289|NCT03615924|566764209|FG001|Overall Study|Lost to Follow-up|0|||
157004290|NCT03615924|566764208|FG000|Overall Study|Randomized in error|1|||
157004291|NCT03615924|566764209|FG001|Overall Study|Randomized in error|0|||
157004292|NCT03615924|566764208|FG000|Overall Study|Study termination by Sponsor|94|||
157004293|NCT03615924|566764209|FG001|Overall Study|Study termination by Sponsor|86|||
157004294|NCT00880048|566764217|FG000|Overall Study|Adverse Event|2|||
157004295|NCT00880048|566764218|FG001|Overall Study|Adverse Event|3|||
157004296|NCT00880048|566764219|FG002|Overall Study|Adverse Event|5|||
157004297|NCT00880048|566764217|FG000|Overall Study|Lack of Efficacy|1|||
157004298|NCT00880048|566764218|FG001|Overall Study|Lack of Efficacy|2|||
157004299|NCT00880048|566764219|FG002|Overall Study|Lack of Efficacy|2|||
157004300|NCT00880048|566764217|FG000|Overall Study|Protocol Violation|4|||
157004301|NCT00880048|566764218|FG001|Overall Study|Protocol Violation|6|||
157004302|NCT00880048|566764219|FG002|Overall Study|Protocol Violation|5|||
157004303|NCT00880048|566764217|FG000|Overall Study|Lost to Follow-up|6|||
157004304|NCT00880048|566764218|FG001|Overall Study|Lost to Follow-up|6|||
157004305|NCT00880048|566764219|FG002|Overall Study|Lost to Follow-up|5|||
157004306|NCT00880048|566764217|FG000|Overall Study|Physician Decision|1|||
157004307|NCT00880048|566764218|FG001|Overall Study|Physician Decision|1|||
157004308|NCT00880048|566764219|FG002|Overall Study|Physician Decision|7|||
157004309|NCT00880048|566764217|FG000|Overall Study|Withdrawal by Subject|5|||
157004310|NCT00880048|566764218|FG001|Overall Study|Withdrawal by Subject|8|||
157004311|NCT00880048|566764219|FG002|Overall Study|Withdrawal by Subject|5|||
157004312|NCT00880048|566764217|FG000|Overall Study|Study closed/terminated|9|||
157004313|NCT00880048|566764218|FG001|Overall Study|Study closed/terminated|7|||
157004314|NCT00880048|566764219|FG002|Overall Study|Study closed/terminated|6|||
157004315|NCT01069341|566764220|FG000|Overall Study|Lost to Follow-up|1|||
157004316|NCT03299816|566764221|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
157004317|NCT03299816|566764222|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
157004318|NCT03299816|566764221|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
157004319|NCT03299816|566764222|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
157004320|NCT03299816|566764221|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
157004321|NCT03299816|566764222|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
157004322|NCT00082810|566764223|FG000|Overall Study|Adverse Event|3|||
157004323|NCT00082810|566764223|FG000|Overall Study|Progressive disease|24|||
157004324|NCT00082810|566764223|FG000|Overall Study|Withdrawal by Subject|4|||
157004325|NCT02194933|566764227|FG000|Overall Study|Lost to Follow-up|1|||
157004326|NCT02194933|566764228|FG001|Overall Study|Lost to Follow-up|2|||
157004327|NCT02194933|566764227|FG000|Overall Study|Participant met withdrawal criteria|1|||
157004328|NCT02194933|566764228|FG001|Overall Study|Participant met withdrawal criteria|3|||
157004329|NCT02194933|566764227|FG000|Overall Study|Withdrawal by Subject|0|||
157004330|NCT02194933|566764228|FG001|Overall Study|Withdrawal by Subject|2|||
157004331|NCT02194933|566764227|FG000|Overall Study|Lack of Efficacy|1|||
157004332|NCT02194933|566764228|FG001|Overall Study|Lack of Efficacy|2|||
157004333|NCT05382104|566764230|FG000|Period 2 (2 Days)|Adverse Event|0|||
157004334|NCT05382104|566764231|FG001|Period 2 (2 Days)|Adverse Event|1|||
157004335|NCT05382104|566764232|FG002|Period 2 (2 Days)|Adverse Event|0|||
157004336|NCT05382104|566764233|FG003|Period 2 (2 Days)|Adverse Event|0|||
157004337|NCT05382104|566764234|FG004|Period 2 (2 Days)|Adverse Event|0|||
157004338|NCT05382104|566764235|FG005|Period 2 (2 Days)|Adverse Event|0|||
157004339|NCT05190419|566764237|FG000|Overall Study|Lack of Efficacy|8|||
157004340|NCT05190419|566764238|FG001|Overall Study|Lack of Efficacy|0|||
157004341|NCT05190419|566764239|FG002|Overall Study|Lack of Efficacy|1|||
157004342|NCT05190419|566764240|FG003|Overall Study|Lack of Efficacy|0|||
157004343|NCT05190419|566764237|FG000|Overall Study|Withdrawal by Subject|7|||
157004344|NCT05190419|566764238|FG001|Overall Study|Withdrawal by Subject|1|||
157004345|NCT05190419|566764239|FG002|Overall Study|Withdrawal by Subject|2|||
157004346|NCT05190419|566764240|FG003|Overall Study|Withdrawal by Subject|2|||
157004347|NCT05190419|566764237|FG000|Overall Study|Adverse Event|2|||
157004348|NCT05190419|566764238|FG001|Overall Study|Adverse Event|10|||
157004349|NCT05190419|566764239|FG002|Overall Study|Adverse Event|11|||
157004350|NCT05190419|566764240|FG003|Overall Study|Adverse Event|21|||
157004351|NCT05190419|566764237|FG000|Overall Study|Lost to Follow-up|1|||
157004352|NCT05190419|566764238|FG001|Overall Study|Lost to Follow-up|2|||
157004353|NCT05190419|566764239|FG002|Overall Study|Lost to Follow-up|3|||
157004354|NCT05190419|566764240|FG003|Overall Study|Lost to Follow-up|1|||
157004355|NCT05190419|566764237|FG000|Overall Study|Other|1|||
157004356|NCT05190419|566764238|FG001|Overall Study|Other|1|||
157004357|NCT05190419|566764239|FG002|Overall Study|Other|0|||
157004358|NCT05190419|566764240|FG003|Overall Study|Other|3|||
157004359|NCT03523091|566764241|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
157004360|NCT03523091|566764242|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
157004361|NCT03523091|566764241|FG000|Overall Study|Withdrawal by Subject|0|||
157004362|NCT03523091|566764242|FG001|Overall Study|Withdrawal by Subject|3|||
157004363|NCT03523091|566764241|FG000|Overall Study|Increase Botox dose|0|||
157004364|NCT03523091|566764242|FG001|Overall Study|Increase Botox dose|1|||
157004365|NCT00811057|566764243|FG000|Overall Study|Protocol Violation|5|||
157004366|NCT00811057|566764244|FG001|Overall Study|Protocol Violation|10|||
157004367|NCT00811057|566764245|FG002|Overall Study|Protocol Violation|10|||
157004368|NCT01769391|566764246|FG000|Overall Study|Death|10|||
157004369|NCT01769391|566764247|FG001|Overall Study|Death|1|||
157004370|NCT01769391|566764246|FG000|Overall Study|Adverse Event|0|||
157004371|NCT01769391|566764247|FG001|Overall Study|Adverse Event|3|||
157004372|NCT01769391|566764246|FG000|Overall Study|Progressive Disease|1|||
157004373|NCT01769391|566764247|FG001|Overall Study|Progressive Disease|2|||
157004374|NCT01769391|566764246|FG000|Overall Study|Withdrawal by Subject|4|||
157004375|NCT01769391|566764247|FG001|Overall Study|Withdrawal by Subject|3|||
157004376|NCT01769391|566764246|FG000|Overall Study|Investigator Decision|2|||
157004377|NCT01769391|566764247|FG001|Overall Study|Investigator Decision|0|||
157004378|NCT03538054|566764248|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
157004379|NCT03538054|566764248|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
157004380|NCT03538054|566764248|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
157004381|NCT02351180|566764249|FG000|Overall Study|Withdrawal by Subject|1|||
157004382|NCT02351180|566764250|FG001|Overall Study|Withdrawal by Subject|0|||
157004383|NCT00208767|566764251|FG000|Overall Study|Adverse Event|9|||
157004384|NCT00208767|566764252|FG001|Overall Study|Adverse Event|1|||
157004385|NCT00208767|566764251|FG000|Overall Study|Withdrawal by Subject|14|||
157004386|NCT00208767|566764252|FG001|Overall Study|Withdrawal by Subject|3|||
157004387|NCT00208767|566764251|FG000|Overall Study|Death|1|||
157004388|NCT00208767|566764252|FG001|Overall Study|Death|0|||
157004389|NCT00208767|566764251|FG000|Overall Study|Lost to Follow-up|3|||
157004390|NCT00208767|566764252|FG001|Overall Study|Lost to Follow-up|3|||
157004391|NCT00605033|566764253|FG000|Overall Study|Adverse Event|2|||
157004392|NCT00605033|566764254|FG001|Overall Study|Adverse Event|2|||
157004393|NCT00605033|566764253|FG000|Overall Study|Lost to Follow-up|1|||
157004394|NCT00605033|566764254|FG001|Overall Study|Lost to Follow-up|1|||
157004395|NCT00605033|566764253|FG000|Overall Study|Withdrawal by Subject|3|||
157004396|NCT00605033|566764254|FG001|Overall Study|Withdrawal by Subject|4|||
157004397|NCT00605033|566764253|FG000|Overall Study|Protocol Violation|1|||
157004398|NCT00605033|566764254|FG001|Overall Study|Protocol Violation|1|||
157004399|NCT02754479|566764255|FG000|Overall Study|Lost to Follow-up|1|||
157004400|NCT03183518|566764256|FG000|Overall Study|Other (Not specified)|2|||
157004401|NCT03183518|566764256|FG000|Overall Study|Other (Withdrawal of consent)|1|||
157004402|NCT00849147|566764259|FG000|Overall Study|Withdrawal by Subject|1|||
157004403|NCT00849147|566764259|FG000|Overall Study|Protocol Violation|2|||
157004404|NCT00849147|566764259|FG000|Overall Study|Disease Relapse/Progression|2|||
157004405|NCT03284957|566766744|FG000|Overall Study|Adverse Event|0|||
157004406|NCT03284957|566766745|FG001|Overall Study|Adverse Event|0|||
157004407|NCT03284957|566766746|FG002|Overall Study|Adverse Event|0|||
157004408|NCT03284957|566766747|FG003|Overall Study|Adverse Event|0|||
157004409|NCT03284957|566766748|FG004|Overall Study|Adverse Event|0|||
157004410|NCT03284957|566766749|FG005|Overall Study|Adverse Event|1|||
157004411|NCT03284957|566766750|FG006|Overall Study|Adverse Event|1|||
157004412|NCT03284957|566766751|FG007|Overall Study|Adverse Event|1|||
157004413|NCT03284957|566766752|FG008|Overall Study|Adverse Event|0|||
157004414|NCT03284957|566766753|FG009|Overall Study|Adverse Event|4|||
157004415|NCT03284957|566766754|FG010|Overall Study|Adverse Event|1|||
157004416|NCT03284957|566766755|FG011|Overall Study|Adverse Event|1|||
157004417|NCT03284957|566766756|FG012|Overall Study|Adverse Event|0|||
157004418|NCT03284957|566766757|FG013|Overall Study|Adverse Event|0|||
157004419|NCT03284957|566766758|FG014|Overall Study|Adverse Event|0|||
157004420|NCT03284957|566766759|FG015|Overall Study|Adverse Event|0|||
157004421|NCT03284957|566766744|FG000|Overall Study|Progressive Disease|3|||
157004422|NCT03284957|566766745|FG001|Overall Study|Progressive Disease|3|||
157004423|NCT03284957|566766746|FG002|Overall Study|Progressive Disease|4|||
157004424|NCT03284957|566766747|FG003|Overall Study|Progressive Disease|3|||
157004425|NCT03284957|566766748|FG004|Overall Study|Progressive Disease|3|||
157004426|NCT03284957|566766749|FG005|Overall Study|Progressive Disease|5|||
157004427|NCT03284957|566766750|FG006|Overall Study|Progressive Disease|45|||
157004428|NCT03284957|566766751|FG007|Overall Study|Progressive Disease|8|||
157004429|NCT03284957|566766752|FG008|Overall Study|Progressive Disease|5|||
157004430|NCT03284957|566766753|FG009|Overall Study|Progressive Disease|18|||
157004431|NCT03284957|566766754|FG010|Overall Study|Progressive Disease|7|||
157004432|NCT03284957|566766755|FG011|Overall Study|Progressive Disease|2|||
157004433|NCT03284957|566766756|FG012|Overall Study|Progressive Disease|3|||
157004434|NCT03284957|566766757|FG013|Overall Study|Progressive Disease|1|||
157004435|NCT03284957|566766758|FG014|Overall Study|Progressive Disease|1|||
157004436|NCT03284957|566766759|FG015|Overall Study|Progressive Disease|2|||
157004437|NCT03284957|566766744|FG000|Overall Study|Withdrawal by Subject|0|||
157004438|NCT03284957|566766745|FG001|Overall Study|Withdrawal by Subject|0|||
157004439|NCT03284957|566766746|FG002|Overall Study|Withdrawal by Subject|0|||
157004440|NCT03284957|566766747|FG003|Overall Study|Withdrawal by Subject|0|||
157004441|NCT03284957|566766748|FG004|Overall Study|Withdrawal by Subject|0|||
157004442|NCT03284957|566766749|FG005|Overall Study|Withdrawal by Subject|0|||
157004443|NCT03284957|566766750|FG006|Overall Study|Withdrawal by Subject|0|||
157004444|NCT03284957|566766751|FG007|Overall Study|Withdrawal by Subject|0|||
157004445|NCT03284957|566766752|FG008|Overall Study|Withdrawal by Subject|0|||
157004446|NCT03284957|566766753|FG009|Overall Study|Withdrawal by Subject|2|||
157004447|NCT03284957|566766754|FG010|Overall Study|Withdrawal by Subject|0|||
157004448|NCT03284957|566766755|FG011|Overall Study|Withdrawal by Subject|0|||
157004449|NCT03284957|566766756|FG012|Overall Study|Withdrawal by Subject|0|||
157004450|NCT03284957|566766757|FG013|Overall Study|Withdrawal by Subject|0|||
157004451|NCT03284957|566766758|FG014|Overall Study|Withdrawal by Subject|0|||
157004452|NCT03284957|566766759|FG015|Overall Study|Withdrawal by Subject|0|||
157004453|NCT03284957|566766744|FG000|Overall Study|Other|0|||
157004454|NCT03284957|566766745|FG001|Overall Study|Other|0|||
157004455|NCT03284957|566766746|FG002|Overall Study|Other|0|||
157004456|NCT03284957|566766747|FG003|Overall Study|Other|0|||
157004457|NCT03284957|566766748|FG004|Overall Study|Other|0|||
157004458|NCT03284957|566766749|FG005|Overall Study|Other|0|||
157004459|NCT03284957|566766750|FG006|Overall Study|Other|3|||
157004460|NCT03284957|566766751|FG007|Overall Study|Other|0|||
157004461|NCT03284957|566766752|FG008|Overall Study|Other|1|||
157004462|NCT03284957|566766753|FG009|Overall Study|Other|6|||
157004463|NCT03284957|566766754|FG010|Overall Study|Other|0|||
157004464|NCT03284957|566766755|FG011|Overall Study|Other|0|||
157004465|NCT03284957|566766756|FG012|Overall Study|Other|0|||
157004466|NCT03284957|566766757|FG013|Overall Study|Other|0|||
157004467|NCT03284957|566766758|FG014|Overall Study|Other|2|||
157004468|NCT03284957|566766759|FG015|Overall Study|Other|0|||
157004469|NCT04517864|566766760|FG000|Placebo-Controlled Phase|Adverse Event|1|||
157004470|NCT04517864|566766761|FG001|Placebo-Controlled Phase|Adverse Event|0|||
157004471|NCT04517864|566766762|FG002|Placebo-Controlled Phase|Adverse Event|0|||
157004472|NCT04517864|566766760|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
157004473|NCT04517864|566766761|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
157004474|NCT04517864|566766762|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
157004475|NCT04517864|566766760|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
157004476|NCT04517864|566766761|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
157004477|NCT04517864|566766762|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
157004478|NCT04517864|566766760|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
157004479|NCT04517864|566766761|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
157004480|NCT04517864|566766762|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
157004481|NCT04517864|566766760|FG000|Active Therapy Extension Phase|Adverse Event|1|||
157004482|NCT04517864|566766761|FG001|Active Therapy Extension Phase|Adverse Event|0|||
157004483|NCT04517864|566766762|FG002|Active Therapy Extension Phase|Adverse Event|0|||
157004484|NCT04517864|566766760|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
157004485|NCT04517864|566766761|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
157004486|NCT04517864|566766762|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
157004487|NCT04517864|566766760|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
157004488|NCT04517864|566766761|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
157004489|NCT04517864|566766762|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
157004490|NCT04517864|566766760|FG000|Active Therapy Extension Phase|Physician Decision|1|||
157004491|NCT04517864|566766761|FG001|Active Therapy Extension Phase|Physician Decision|0|||
157109159|NCT00833053|567155349|FG000|Overall Study|Adverse Event|4|||
157109160|NCT00833053|567155350|FG001|Overall Study|Adverse Event|0|||
157109161|NCT00833053|567155349|FG000|Overall Study|Treatment Failure|3|||
157109162|NCT00833053|567155350|FG001|Overall Study|Treatment Failure|1|||
157109163|NCT00833053|567155349|FG000|Overall Study|Withdrawal by Subject|0|||
157109164|NCT00833053|567155350|FG001|Overall Study|Withdrawal by Subject|1|||
156761993|NCT05616013|565879944|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
156761994|NCT05616013|565879945|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
157109165|NCT00833053|567155349|FG000|Overall Study|Protocol Violation|2|||
157109166|NCT00833053|567155350|FG001|Overall Study|Protocol Violation|1|||
157109167|NCT02187471|567155351|FG000|Overall Study|Protocol Violation|4|||
157109168|NCT02187471|567155352|FG001|Overall Study|Protocol Violation|5|||
157109169|NCT02187471|567155353|FG002|Overall Study|Protocol Violation|4|||
157109170|NCT02187471|567155354|FG003|Overall Study|Protocol Violation|4|||
157109171|NCT02187471|567155351|FG000|Overall Study|Missing|0|||
157109172|NCT02187471|567155352|FG001|Overall Study|Missing|0|||
157109173|NCT02187471|567155353|FG002|Overall Study|Missing|0|||
157109174|NCT02187471|567155354|FG003|Overall Study|Missing|1|||
157109175|NCT02187471|567155351|FG000|Overall Study|Lack of Efficacy|18|||
157004492|NCT04517864|566766762|FG002|Active Therapy Extension Phase|Physician Decision|0|||
157004493|NCT04517864|566766760|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
157004494|NCT04517864|566766761|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
157004495|NCT04517864|566766762|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
157004496|NCT04517864|566766760|FG000|Extension Phase|Adverse Event|0|||
157004497|NCT04517864|566766761|FG001|Extension Phase|Adverse Event|0|||
157004498|NCT04517864|566766762|FG002|Extension Phase|Adverse Event|1|||
157004499|NCT04517864|566766760|FG000|Extension Phase|Lack of Efficacy|0|||
157004500|NCT04517864|566766761|FG001|Extension Phase|Lack of Efficacy|0|||
157004501|NCT04517864|566766762|FG002|Extension Phase|Lack of Efficacy|2|||
157004502|NCT04517864|566766760|FG000|Extension Phase|Study Terminated By Sponsor|0|||
157004503|NCT04517864|566766761|FG001|Extension Phase|Study Terminated By Sponsor|0|||
157004504|NCT04517864|566766762|FG002|Extension Phase|Study Terminated By Sponsor|32|||
157004505|NCT04517864|566766760|FG000|Extension Phase|Withdrawal by Subject|0|||
157004506|NCT04517864|566766761|FG001|Extension Phase|Withdrawal by Subject|0|||
157004507|NCT04517864|566766762|FG002|Extension Phase|Withdrawal by Subject|3|||
157004508|NCT04517864|566766760|FG000|Extension Phase|Approved Drug Available for Indication|0|||
157004509|NCT04517864|566766761|FG001|Extension Phase|Approved Drug Available for Indication|0|||
157004510|NCT04517864|566766762|FG002|Extension Phase|Approved Drug Available for Indication|7|||
157004511|NCT04722003|566766765|FG000|Overall Study|Lost to Follow-up|2|||
157004512|NCT04722003|566766766|FG001|Overall Study|Lost to Follow-up|0|||
157004513|NCT04722003|566766765|FG000|Overall Study|Physician Decision|1|||
157004514|NCT04722003|566766766|FG001|Overall Study|Physician Decision|0|||
157004515|NCT00708032|566766767|FG000|Overall Study|Adverse Event|0|||
157004516|NCT00708032|566766768|FG001|Overall Study|Adverse Event|2|||
157004517|NCT00708032|566766767|FG000|Overall Study|Lost to Follow-up|1|||
157004518|NCT00708032|566766768|FG001|Overall Study|Lost to Follow-up|2|||
157004519|NCT00708032|566766767|FG000|Overall Study|Pregnancy|0|||
157004520|NCT00708032|566766768|FG001|Overall Study|Pregnancy|1|||
157004521|NCT00708032|566766767|FG000|Overall Study|Poor vision|0|||
157004522|NCT00708032|566766768|FG001|Overall Study|Poor vision|6|||
157004523|NCT00708032|566766767|FG000|Overall Study|Visit out of range at month 12|4|||
157004524|NCT00708032|566766768|FG001|Overall Study|Visit out of range at month 12|1|||
157004525|NCT00708032|566766767|FG000|Overall Study|Did not meet protocol criteria|1|||
157004526|NCT00708032|566766768|FG001|Overall Study|Did not meet protocol criteria|2|||
157004527|NCT00708032|566766767|FG000|Overall Study|Protocol Violation|4|||
157004528|NCT00708032|566766768|FG001|Overall Study|Protocol Violation|1|||
157004529|NCT00708032|566766767|FG000|Overall Study|Withdrawal by Subject|0|||
157004530|NCT00708032|566766768|FG001|Overall Study|Withdrawal by Subject|1|||
157004531|NCT00446550|566766773|FG000|Overall Study|Adverse Event|1|||
157004532|NCT00446550|566766774|FG001|Overall Study|Adverse Event|0|||
157004533|NCT01759264|566766775|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
157004534|NCT01759264|566766775|FG000|Overall Study|Adverse Event|1|||
157004535|NCT01759264|566766775|FG000|Overall Study|Other|2|||
157004536|NCT01759264|566766775|FG000|Overall Study|Lost to Follow-up|2|||
157004537|NCT01759264|566766775|FG000|Overall Study|Withdrawal by Subject|3|||
157004538|NCT01759264|566766775|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
157004539|NCT02027558|566766776|FG000|Overall Study|Death|0|||
157004540|NCT02027558|566766777|FG001|Overall Study|Death|1|||
157004541|NCT02027558|566766776|FG000|Overall Study|Withdrawal by Subject|2|||
157004542|NCT02027558|566766777|FG001|Overall Study|Withdrawal by Subject|0|||
157004543|NCT02027558|566766776|FG000|Overall Study|Lost to Follow-up|4|||
157004544|NCT02027558|566766777|FG001|Overall Study|Lost to Follow-up|1|||
157109176|NCT02187471|567155352|FG001|Overall Study|Lack of Efficacy|9|||
157109177|NCT02187471|567155353|FG002|Overall Study|Lack of Efficacy|13|||
157109178|NCT02187471|567155354|FG003|Overall Study|Lack of Efficacy|11|||
157109179|NCT02187471|567155351|FG000|Overall Study|Adverse Event|24|||
157109180|NCT02187471|567155352|FG001|Overall Study|Adverse Event|34|||
157109181|NCT02187471|567155353|FG002|Overall Study|Adverse Event|44|||
157109182|NCT02187471|567155354|FG003|Overall Study|Adverse Event|36|||
157109183|NCT02187471|567155351|FG000|Overall Study|Withdrawal by Subject|23|||
157109184|NCT02187471|567155352|FG001|Overall Study|Withdrawal by Subject|29|||
157109185|NCT02187471|567155353|FG002|Overall Study|Withdrawal by Subject|22|||
157109186|NCT02187471|567155354|FG003|Overall Study|Withdrawal by Subject|24|||
157109187|NCT02187471|567155351|FG000|Overall Study|Other|7|||
157109188|NCT02187471|567155352|FG001|Overall Study|Other|5|||
157109189|NCT02187471|567155353|FG002|Overall Study|Other|3|||
157109190|NCT02187471|567155354|FG003|Overall Study|Other|4|||
157109191|NCT01033734|567155355|FG000|Overall Study|Withdrawal by Subject|1|||
157109192|NCT02289742|567155358|FG000|First Wear Period|Adverse event prior to treatment|0|||
157109193|NCT02289742|567155359|FG001|First Wear Period|Adverse event prior to treatment|1|||
157109194|NCT02289742|567155360|FG002|First Wear Period|Adverse event prior to treatment|0|||
156761995|NCT05616013|565879946|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761996|NCT05616013|565879947|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761997|NCT05616013|565879948|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761998|NCT05616013|565879949|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
156761999|NCT05616013|565879950|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762000|NCT05616013|565879951|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762001|NCT05616013|565879952|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
156762002|NCT05616013|565879944|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
157109195|NCT02289742|567155361|FG003|First Wear Period|Adverse event prior to treatment|0|||
157109196|NCT02289742|567155358|FG000|First Wear Period|Adverse Event|0|||
157109197|NCT02289742|567155359|FG001|First Wear Period|Adverse Event|0|||
157109198|NCT02289742|567155360|FG002|First Wear Period|Adverse Event|1|||
157109199|NCT02289742|567155361|FG003|First Wear Period|Adverse Event|0|||
157109200|NCT02289742|567155358|FG000|First Wear Period|Other prior to treatment|0|||
157109201|NCT02289742|567155359|FG001|First Wear Period|Other prior to treatment|0|||
157109202|NCT02289742|567155360|FG002|First Wear Period|Other prior to treatment|0|||
157109203|NCT02289742|567155361|FG003|First Wear Period|Other prior to treatment|1|||
157109204|NCT02289742|567155358|FG000|Third Wear Period|Adverse Event|0|||
157109205|NCT02289742|567155359|FG001|Third Wear Period|Adverse Event|1|||
157109206|NCT02289742|567155360|FG002|Third Wear Period|Adverse Event|0|||
157109207|NCT02289742|567155361|FG003|Third Wear Period|Adverse Event|0|||
157109208|NCT02289742|567155358|FG000|Third Wear Period|Reason not given|0|||
157109209|NCT02289742|567155359|FG001|Third Wear Period|Reason not given|0|||
157109210|NCT02289742|567155360|FG002|Third Wear Period|Reason not given|0|||
157109211|NCT02289742|567155361|FG003|Third Wear Period|Reason not given|1|||
157109212|NCT02865018|567155362|FG000|Overall Study|Withdrawal by Subject|1|||
157109213|NCT01365039|567155363|FG000|Overall Study|Study related symptoms and complaints|1|||
157109214|NCT01365039|567155364|FG001|Overall Study|Study related symptoms and complaints|0|||
157109215|NCT00294060|567155367|FG000|Overall Study|Death|225|||
157109216|NCT00294060|567155367|FG000|Overall Study|Other|59|||
157109217|NCT00294060|567155367|FG000|Overall Study|Lost to Follow-up|55|||
157109218|NCT00294060|567155367|FG000|Overall Study|Withdrawal by Subject|11|||
157109219|NCT00294060|567155367|FG000|Overall Study|Physician Decision|797|||
157109220|NCT00294060|567155367|FG000|Overall Study|Medical condition|3|||
157109221|NCT00294060|567155367|FG000|Overall Study|Device explanted/not replaced|23|||
157109222|NCT00139776|567155368|FG000|Period I|Did not enter Period II|575|||
157109223|NCT00139776|567155369|FG001|Period I|Did not enter Period II|0|||
157109224|NCT00139776|567155370|FG002|Period I|Did not enter Period II|0|||
157109225|NCT00139776|567155371|FG003|Period I|Did not enter Period II|0|||
157109226|NCT00139776|567155368|FG000|Period II|Not Randomized into Period III|0|||
157109227|NCT00139776|567155369|FG001|Period II|Not Randomized into Period III|322|||
157109228|NCT00139776|567155370|FG002|Period II|Not Randomized into Period III|0|||
157109229|NCT00139776|567155371|FG003|Period II|Not Randomized into Period III|0|||
157109230|NCT00139776|567155368|FG000|Period III|Adverse Event|0|||
157109231|NCT00139776|567155369|FG001|Period III|Adverse Event|0|||
157109232|NCT00139776|567155370|FG002|Period III|Adverse Event|22|||
157109233|NCT00139776|567155371|FG003|Period III|Adverse Event|23|||
157109234|NCT00139776|567155368|FG000|Period III|Other|0|||
157109235|NCT00139776|567155369|FG001|Period III|Other|0|||
157109236|NCT00139776|567155370|FG002|Period III|Other|23|||
157109237|NCT00139776|567155371|FG003|Period III|Other|34|||
157109238|NCT00139776|567155368|FG000|Period III|Lack of Efficacy|0|||
157109239|NCT00139776|567155369|FG001|Period III|Lack of Efficacy|0|||
157109240|NCT00139776|567155370|FG002|Period III|Lack of Efficacy|10|||
157109241|NCT00139776|567155371|FG003|Period III|Lack of Efficacy|24|||
157109242|NCT00139776|567155368|FG000|Period III|Lost to Follow-up|0|||
157109243|NCT00139776|567155369|FG001|Period III|Lost to Follow-up|0|||
157109244|NCT00139776|567155370|FG002|Period III|Lost to Follow-up|5|||
157109245|NCT00139776|567155371|FG003|Period III|Lost to Follow-up|4|||
157109246|NCT00139776|567155368|FG000|Period III|Withdrawal by Subject|0|||
157109247|NCT00139776|567155369|FG001|Period III|Withdrawal by Subject|0|||
157109248|NCT00139776|567155370|FG002|Period III|Withdrawal by Subject|16|||
157109249|NCT00139776|567155371|FG003|Period III|Withdrawal by Subject|21|||
157109250|NCT01360554|567155372|FG000|Overall Study|Death|359|||
157109251|NCT01360554|567155373|FG001|Overall Study|Death|371|||
157109252|NCT01360554|567155372|FG000|Overall Study|Lost to Follow-up|4|||
157109253|NCT01360554|567155373|FG001|Overall Study|Lost to Follow-up|4|||
157109254|NCT01360554|567155372|FG000|Overall Study|Withdrawal by Subject|23|||
157109255|NCT01360554|567155373|FG001|Overall Study|Withdrawal by Subject|24|||
157004545|NCT02027558|566766776|FG000|Overall Study|Refused assessment|3|||
157004546|NCT02027558|566766777|FG001|Overall Study|Refused assessment|0|||
157004547|NCT00114244|566766778|FG000|Overall Study|Adverse Event|2|||
157004548|NCT00114244|566766779|FG001|Overall Study|Adverse Event|5|||
157004549|NCT00114244|566766778|FG000|Overall Study|Withdrawal by Subject|0|||
157004550|NCT00114244|566766779|FG001|Overall Study|Withdrawal by Subject|2|||
157004551|NCT00393848|566766780|FG000|Overall Study|Surgical schedule|0|||
157004552|NCT00393848|566766781|FG001|Overall Study|Surgical schedule|0|||
157004553|NCT00393848|566766782|FG002|Overall Study|Surgical schedule|0|||
157004554|NCT00393848|566766783|FG003|Overall Study|Surgical schedule|1|||
157004555|NCT00393848|566766780|FG000|Overall Study|Personal reasons|0|||
157004556|NCT00393848|566766781|FG001|Overall Study|Personal reasons|0|||
157004557|NCT00393848|566766782|FG002|Overall Study|Personal reasons|2|||
157004558|NCT00393848|566766783|FG003|Overall Study|Personal reasons|0|||
157004559|NCT02694978|566766790|FG000|Overall Study|Adverse Event|10|||
157004560|NCT02694978|566766791|FG001|Overall Study|Adverse Event|9|||
157004561|NCT02694978|566766790|FG000|Overall Study|Withdrawal by Subject|22|||
157004562|NCT02694978|566766791|FG001|Overall Study|Withdrawal by Subject|19|||
157004563|NCT02694978|566766790|FG000|Overall Study|Lost to Follow-up|14|||
157004564|NCT02694978|566766791|FG001|Overall Study|Lost to Follow-up|17|||
157004565|NCT02694978|566766790|FG000|Overall Study|Death|4|||
157004566|NCT02694978|566766791|FG001|Overall Study|Death|1|||
157004567|NCT02694978|566766790|FG000|Overall Study|Other-Decision of Participant|6|||
157004568|NCT02694978|566766791|FG001|Overall Study|Other-Decision of Participant|1|||
157004569|NCT02694978|566766790|FG000|Overall Study|Other-Investigator's decision|1|||
157004570|NCT02694978|566766791|FG001|Overall Study|Other-Investigator's decision|0|||
157004571|NCT02694978|566766790|FG000|Overall Study|Other-Unable to be reached|0|||
157004572|NCT02694978|566766791|FG001|Overall Study|Other-Unable to be reached|1|||
157004573|NCT02694978|566766790|FG000|Overall Study|Other-Protocol noncompliant|2|||
157004574|NCT02694978|566766791|FG001|Overall Study|Other-Protocol noncompliant|1|||
157004575|NCT02694978|566766790|FG000|Overall Study|Other-Personal reasons|3|||
157004576|NCT02694978|566766791|FG001|Overall Study|Other-Personal reasons|3|||
157004577|NCT02694978|566766790|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
157004578|NCT02694978|566766791|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
157004579|NCT01613716|566766794|FG000|Overall Study|screen failures|3|||
157004580|NCT01613716|566766794|FG000|Overall Study|Lost to Follow-up|4|||
157004581|NCT01458210|566766802|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
157004582|NCT01458210|566766802|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
157004583|NCT01458210|566766802|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
157004584|NCT01458210|566766802|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
157004585|NCT03020745|566766803|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004586|NCT03020745|566766804|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004587|NCT03020745|566766805|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004588|NCT03020745|566766806|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004589|NCT03020745|566766807|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004590|NCT03020745|566766808|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004591|NCT03020745|566766809|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004592|NCT03020745|566766810|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004593|NCT03020745|566766811|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
157004594|NCT03020745|566766812|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
157004595|NCT03020745|566766803|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004596|NCT03020745|566766804|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004597|NCT03020745|566766805|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004598|NCT03020745|566766806|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004599|NCT03020745|566766807|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004600|NCT03020745|566766808|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004601|NCT03020745|566766809|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004602|NCT03020745|566766810|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
157004603|NCT03020745|566766811|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004604|NCT03020745|566766812|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
157004605|NCT03020745|566766803|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004606|NCT03020745|566766804|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004607|NCT03020745|566766805|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004608|NCT03020745|566766806|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004609|NCT03020745|566766807|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004610|NCT03020745|566766808|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
157004611|NCT03020745|566766809|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004612|NCT03020745|566766810|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004613|NCT03020745|566766811|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
157109256|NCT01360554|567155372|FG000|Overall Study|Study terminated by sponsor|49|||
157109257|NCT01360554|567155373|FG001|Overall Study|Study terminated by sponsor|37|||
157109258|NCT01360554|567155372|FG000|Overall Study|Other, not specified|1|||
157109259|NCT01360554|567155373|FG001|Overall Study|Other, not specified|0|||
157109260|NCT01360554|567155372|FG000|Overall Study|Randomized but not treated.|3|||
157109261|NCT01360554|567155373|FG001|Overall Study|Randomized but not treated.|3|||
157109262|NCT00187096|567155374|FG000|Overall Study|unacceptable toxicity|0|||
157109263|NCT00187096|567155375|FG001|Overall Study|unacceptable toxicity|0|||
157109264|NCT00187096|567155376|FG002|Overall Study|unacceptable toxicity|1|||
157109265|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
157109266|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
157109267|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
157109268|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
157109269|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
157109270|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
157109271|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
157109272|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
157109273|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
157109274|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
157109275|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
157109276|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
157109277|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
157109278|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
157109279|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
157109280|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
157109281|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
157109282|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
157109283|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
157109284|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
157109285|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
157109286|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
157109287|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
157109288|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
157109289|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
157109290|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
157109291|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
157109292|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
157109293|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
157109294|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
157109295|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109296|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
157109297|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
157109298|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
157109299|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109300|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
157109301|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
157109302|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
157109303|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
157109304|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
157109305|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
157109306|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
157109307|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
157109308|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
157109309|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
157109310|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
157109311|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
157109312|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
157109313|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
157109314|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
157109315|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
157109316|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
157109317|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
157109318|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
157109319|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
157109320|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
157109321|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
157109322|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
157109323|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
157109324|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
157109325|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
157109326|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
157109327|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
157109328|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
157109329|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
157109330|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
157109331|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
157109332|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
157109333|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
157109334|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
157109335|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
157109336|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
157109337|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
157109338|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
157109339|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
157109340|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
157109341|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
157109342|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
157109343|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
157109344|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
157109345|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
157109346|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
157109347|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
157109348|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
157109349|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
157109350|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
157109351|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
157109352|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
156762003|NCT05616013|565879945|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762004|NCT05616013|565879946|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
157004614|NCT03020745|566766812|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
157004615|NCT03020745|566766803|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004616|NCT03020745|566766804|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004617|NCT03020745|566766805|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004618|NCT03020745|566766806|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004619|NCT03020745|566766807|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004620|NCT03020745|566766808|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004621|NCT03020745|566766809|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004622|NCT03020745|566766810|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004623|NCT03020745|566766811|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
157004624|NCT03020745|566766812|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
157004625|NCT00743444|566766813|FG000|First Intervention|Catheter placement problems|0|||
157004626|NCT00743444|566766814|FG001|First Intervention|Catheter placement problems|1|||
157004627|NCT00743444|566766813|FG000|Washout Period|Adverse Event|0|||
157004628|NCT00743444|566766814|FG001|Washout Period|Adverse Event|1|||
157004629|NCT02567656|566766820|FG000|Overall Study|Premature discontinuation due to PD|1|||
157004630|NCT02567656|566766821|FG001|Overall Study|Premature discontinuation due to PD|1|||
157004631|NCT02567656|566766822|FG002|Overall Study|Premature discontinuation due to PD|2|||
157004632|NCT02567656|566766823|FG003|Overall Study|Premature discontinuation due to PD|0|||
157004633|NCT02567656|566766824|FG004|Overall Study|Premature discontinuation due to PD|0|||
157004634|NCT02567656|566766825|FG005|Overall Study|Premature discontinuation due to PD|0|||
157004635|NCT03287622|566766827|FG000|Overall Study|Withdrawal by Subject|1|||
157004636|NCT03287622|566766828|FG001|Overall Study|Withdrawal by Subject|0|||
157004637|NCT03287622|566766827|FG000|Overall Study|Lost to Follow-up|27|||
157004638|NCT03287622|566766828|FG001|Overall Study|Lost to Follow-up|15|||
157004639|NCT03287622|566766827|FG000|Overall Study|No prescripion after surgery|28|||
157004640|NCT03287622|566766828|FG001|Overall Study|No prescripion after surgery|31|||
157004641|NCT03287622|566766827|FG000|Overall Study|prolonged Length of stay|2|||
157004642|NCT03287622|566766828|FG001|Overall Study|prolonged Length of stay|0|||
157004643|NCT03287622|566766827|FG000|Overall Study|surgery related|0|||
157004644|NCT03287622|566766828|FG001|Overall Study|surgery related|2|||
157109353|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
157109354|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
157109355|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
157109356|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
157109357|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
157109358|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
157109359|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
157109360|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
157109361|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
157109362|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
157109363|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
157109364|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
157109365|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
157109366|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
157109367|NCT00111800|567155383|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
157109368|NCT00111800|567155384|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
157109369|NCT00111800|567155385|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
157109370|NCT00111800|567155386|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
157109371|NCT00111800|567155387|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
157109372|NCT00111800|567155388|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
157109373|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
157109374|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
157109375|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
157109376|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
157109377|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
157109378|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
157109379|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
157109380|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
157109381|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
157109382|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
157109383|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
157109384|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
157109385|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
157109386|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
157109387|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
157109388|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
157109389|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
157109390|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
157109391|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
157109392|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
157109393|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
157109394|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
157109395|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
157109396|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
157109397|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109398|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109399|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
157109400|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109401|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109402|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
157109403|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
157109404|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
157109405|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
157109406|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
157109407|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
157109408|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
157109409|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
157109410|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
157109411|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
157109412|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
157109413|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
157109414|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
156762005|NCT05616013|565879947|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762006|NCT05616013|565879948|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762007|NCT05616013|565879949|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762008|NCT05616013|565879950|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762009|NCT05616013|565879951|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
157004645|NCT01616654|566766832|FG000|Overall Study|Lack of Efficacy|1|||
157004646|NCT01616654|566766833|FG001|Overall Study|Lack of Efficacy|0|||
157004647|NCT01616654|566766834|FG002|Overall Study|Lack of Efficacy|0|||
157004648|NCT01616654|566766835|FG003|Overall Study|Lack of Efficacy|0|||
157004649|NCT01616654|566766836|FG004|Overall Study|Lack of Efficacy|1|||
157004650|NCT01616654|566766832|FG000|Overall Study|Adverse Event|0|||
157004651|NCT01616654|566766833|FG001|Overall Study|Adverse Event|1|||
157004652|NCT01616654|566766834|FG002|Overall Study|Adverse Event|2|||
157004653|NCT01616654|566766835|FG003|Overall Study|Adverse Event|1|||
157004654|NCT01616654|566766836|FG004|Overall Study|Adverse Event|0|||
157004655|NCT01616654|566766832|FG000|Overall Study|Withdrawal by Subject|2|||
157004656|NCT01616654|566766833|FG001|Overall Study|Withdrawal by Subject|2|||
157004657|NCT01616654|566766834|FG002|Overall Study|Withdrawal by Subject|3|||
157004658|NCT01616654|566766835|FG003|Overall Study|Withdrawal by Subject|1|||
157004659|NCT01616654|566766836|FG004|Overall Study|Withdrawal by Subject|5|||
157004660|NCT01616654|566766832|FG000|Overall Study|Protocol Violation|0|||
157004661|NCT01616654|566766833|FG001|Overall Study|Protocol Violation|5|||
157004662|NCT01616654|566766834|FG002|Overall Study|Protocol Violation|2|||
157004663|NCT01616654|566766835|FG003|Overall Study|Protocol Violation|4|||
157004664|NCT01616654|566766836|FG004|Overall Study|Protocol Violation|4|||
157004665|NCT01616654|566766832|FG000|Overall Study|Lost to Follow-up|1|||
157004666|NCT01616654|566766833|FG001|Overall Study|Lost to Follow-up|0|||
157004667|NCT01616654|566766834|FG002|Overall Study|Lost to Follow-up|3|||
157004668|NCT01616654|566766835|FG003|Overall Study|Lost to Follow-up|2|||
157004669|NCT01616654|566766836|FG004|Overall Study|Lost to Follow-up|1|||
157004670|NCT01616654|566766832|FG000|Overall Study|Pregnancy|1|||
157004671|NCT01616654|566766833|FG001|Overall Study|Pregnancy|0|||
157004672|NCT01616654|566766834|FG002|Overall Study|Pregnancy|0|||
157004673|NCT01616654|566766835|FG003|Overall Study|Pregnancy|0|||
157004674|NCT01616654|566766836|FG004|Overall Study|Pregnancy|1|||
157004675|NCT01087762|566766837|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
157004676|NCT01087762|566766838|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
157004677|NCT01087762|566766839|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
157004678|NCT01087762|566766840|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
157004679|NCT01087762|566766841|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
157004680|NCT01087762|566766837|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
157004681|NCT01087762|566766838|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
157004682|NCT01087762|566766839|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
157004683|NCT01087762|566766840|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
157004684|NCT01087762|566766841|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
157004685|NCT01087762|566766837|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
157004686|NCT01087762|566766838|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
157004687|NCT01087762|566766839|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
157004688|NCT01087762|566766840|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
157004689|NCT01087762|566766841|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
157004690|NCT01087762|566766837|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
157004691|NCT01087762|566766838|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
157004692|NCT01087762|566766839|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
157004693|NCT01087762|566766840|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
157004694|NCT01087762|566766841|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
157004695|NCT01087762|566766837|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
157004696|NCT01087762|566766838|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
157004697|NCT01087762|566766839|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
157004698|NCT01087762|566766840|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
157004699|NCT01087762|566766841|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
157004700|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
157004701|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
157004702|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
157004703|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
157004704|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
157004705|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
157004706|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
157004707|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
157004708|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
157004709|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
156762010|NCT05616013|565879952|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
156762011|NCT05616013|565879944|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
156762012|NCT05616013|565879945|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762013|NCT05616013|565879946|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762014|NCT05616013|565879947|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762015|NCT05616013|565879948|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
157004710|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
157004711|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
157004712|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
157004713|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
157004714|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
157004715|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
157004716|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
157004717|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
157004718|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
157004719|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
157004720|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
157004721|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
157004722|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
157004723|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
157004724|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
157004725|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
157004726|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
157004727|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
157004728|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
157004729|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
157004730|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
157004731|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
157004732|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
157004733|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
157004734|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
157004735|NCT01087762|566766837|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
157004736|NCT01087762|566766838|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
157004737|NCT01087762|566766839|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
157004738|NCT01087762|566766840|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
157004739|NCT01087762|566766841|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
157004740|NCT01329328|566766842|FG000|Overall Study|Withdrawal by Subject|2|||
157004741|NCT01329328|566766843|FG001|Overall Study|Withdrawal by Subject|4|||
157004742|NCT01329328|566766844|FG002|Overall Study|Withdrawal by Subject|3|||
157004743|NCT03987451|566766845|FG000|Overall Study|Lost to Follow-up|1|||
157004744|NCT03987451|566766846|FG001|Overall Study|Lost to Follow-up|0|||
157004745|NCT03987451|566766845|FG000|Overall Study|Withdrawal by Subject|1|||
157004746|NCT03987451|566766846|FG001|Overall Study|Withdrawal by Subject|1|||
157004747|NCT00612586|566766847|FG000|Overall Study|Adverse Event|6|||
157004748|NCT00612586|566766848|FG001|Overall Study|Adverse Event|2|||
157004749|NCT00612586|566766847|FG000|Overall Study|Death|1|||
157004750|NCT00612586|566766848|FG001|Overall Study|Death|0|||
157004751|NCT00612586|566766847|FG000|Overall Study|Entry Criteria Not Met|0|||
157004752|NCT00612586|566766848|FG001|Overall Study|Entry Criteria Not Met|2|||
157004753|NCT00612586|566766847|FG000|Overall Study|Withdrawal by Subject|7|||
157004754|NCT00612586|566766848|FG001|Overall Study|Withdrawal by Subject|9|||
157004755|NCT00612586|566766847|FG000|Overall Study|Physician Decision|1|||
157004756|NCT00612586|566766848|FG001|Overall Study|Physician Decision|2|||
157004757|NCT00612586|566766847|FG000|Overall Study|Sponsor Decision|1|||
157004758|NCT00612586|566766848|FG001|Overall Study|Sponsor Decision|1|||
157004759|NCT00612586|566766847|FG000|Overall Study|Progressive Disease|26|||
157004760|NCT00612586|566766848|FG001|Overall Study|Progressive Disease|24|||
157004761|NCT00612586|566766847|FG000|Overall Study|Randomized and Not Treated|1|||
157004762|NCT00612586|566766848|FG001|Overall Study|Randomized and Not Treated|1|||
157004763|NCT03192046|566766849|FG000|Overall Study|Withdrawal by Subject|1|||
157004764|NCT03192046|566766850|FG001|Overall Study|Withdrawal by Subject|1|||
157004765|NCT01505881|566766851|FG000|Overall Study|Adverse Event|0|||
157004766|NCT01505881|566766852|FG001|Overall Study|Adverse Event|1|||
157004767|NCT01505881|566766851|FG000|Overall Study|Lost to Follow-up|2|||
157004768|NCT01505881|566766852|FG001|Overall Study|Lost to Follow-up|0|||
157004769|NCT01505881|566766851|FG000|Overall Study|Withdrawal by Subject|2|||
157004770|NCT01505881|566766852|FG001|Overall Study|Withdrawal by Subject|0|||
157004771|NCT01194154|566766853|FG000|Overall Study|Adverse Event|12|||
157004772|NCT01194154|566766854|FG001|Overall Study|Adverse Event|7|||
157004773|NCT01194154|566766853|FG000|Overall Study|Lost to Follow-up|2|||
156762016|NCT05616013|565879949|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762017|NCT05616013|565879950|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762018|NCT05616013|565879951|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762019|NCT05616013|565879952|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
156762020|NCT05616013|565879944|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
157004774|NCT01194154|566766854|FG001|Overall Study|Lost to Follow-up|3|||
157004775|NCT01194154|566766853|FG000|Overall Study|Protocol Violation|0|||
157004776|NCT01194154|566766854|FG001|Overall Study|Protocol Violation|1|||
157004777|NCT01194154|566766853|FG000|Overall Study|Withdrawal by Subject|5|||
157004778|NCT01194154|566766854|FG001|Overall Study|Withdrawal by Subject|6|||
157004779|NCT01194154|566766853|FG000|Overall Study|Blood pressure increase|5|||
157004780|NCT01194154|566766854|FG001|Overall Study|Blood pressure increase|3|||
157004781|NCT01194154|566766853|FG000|Overall Study|Hemoglobin decrease|0|||
157004782|NCT01194154|566766854|FG001|Overall Study|Hemoglobin decrease|1|||
157004783|NCT01194154|566766853|FG000|Overall Study|Hemoglobin increase|12|||
157004784|NCT01194154|566766854|FG001|Overall Study|Hemoglobin increase|3|||
157004785|NCT01194154|566766853|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
157004786|NCT01194154|566766854|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
157004787|NCT01194154|566766853|FG000|Overall Study|Treatment with prohibited medication|4|||
157004788|NCT01194154|566766854|FG001|Overall Study|Treatment with prohibited medication|5|||
157004789|NCT01194154|566766853|FG000|Overall Study|Other|4|||
157004790|NCT01194154|566766854|FG001|Overall Study|Other|0|||
157004791|NCT01194154|566766853|FG000|Overall Study|Did not receive study medication|2|||
157004792|NCT01194154|566766854|FG001|Overall Study|Did not receive study medication|4|||
157004793|NCT01147341|566766855|FG000|Double Blind Period|Lack of Efficacy|1|||
157004794|NCT01147341|566766856|FG001|Double Blind Period|Lack of Efficacy|1|||
157004795|NCT01147341|566766855|FG000|Double Blind Period|Withdrawal by Subject|0|||
157004796|NCT01147341|566766856|FG001|Double Blind Period|Withdrawal by Subject|1|||
157004797|NCT01147341|566766855|FG000|Open Label Period|Lack of Efficacy|3|||
157004798|NCT01147341|566766856|FG001|Open Label Period|Lack of Efficacy|0|||
157004799|NCT01147341|566766855|FG000|Open Label Period|Subject moved|1|||
157004800|NCT01147341|566766856|FG001|Open Label Period|Subject moved|0|||
157004801|NCT01901276|566766857|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
157004802|NCT01901276|566766858|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
157004803|NCT02314117|566766859|FG000|Overall Study|Lost to Follow-up|9|||
157004804|NCT02314117|566766860|FG001|Overall Study|Lost to Follow-up|14|||
157004805|NCT02314117|566766859|FG000|Overall Study|Withdrawal by Subject|3|||
157004806|NCT02314117|566766860|FG001|Overall Study|Withdrawal by Subject|2|||
157004807|NCT01184508|566766874|FG000|Overall Study|Adverse Event|4|||
157004808|NCT01184508|566766875|FG001|Overall Study|Adverse Event|6|||
157004809|NCT01184508|566766874|FG000|Overall Study|Lack of Efficacy|1|||
157004810|NCT01184508|566766875|FG001|Overall Study|Lack of Efficacy|1|||
157004811|NCT01184508|566766874|FG000|Overall Study|Lost to Follow-up|1|||
157004812|NCT01184508|566766875|FG001|Overall Study|Lost to Follow-up|1|||
157004813|NCT01184508|566766874|FG000|Overall Study|Physician Decision|1|||
157004814|NCT01184508|566766875|FG001|Overall Study|Physician Decision|0|||
157004815|NCT01184508|566766874|FG000|Overall Study|Protocol Violation|3|||
157004816|NCT01184508|566766875|FG001|Overall Study|Protocol Violation|1|||
157004817|NCT01184508|566766874|FG000|Overall Study|Sponsor Decision|5|||
157004818|NCT01184508|566766875|FG001|Overall Study|Sponsor Decision|2|||
157004819|NCT01184508|566766874|FG000|Overall Study|Withdrawal by Subject|1|||
157004820|NCT01184508|566766875|FG001|Overall Study|Withdrawal by Subject|3|||
157004821|NCT01184508|566766874|FG000|Overall Study|Randomized, Not Treated|0|||
157004822|NCT01184508|566766875|FG001|Overall Study|Randomized, Not Treated|1|||
157004823|NCT00790790|566766878|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
157004824|NCT00790790|566766879|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
157004825|NCT00790790|566766880|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
157004826|NCT00790790|566766878|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
157004827|NCT00790790|566766879|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
157004828|NCT00790790|566766880|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
157004829|NCT00790790|566766878|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
157004830|NCT00790790|566766879|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
157004831|NCT00790790|566766880|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
157004832|NCT00790790|566766878|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
157004833|NCT00790790|566766879|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
157004834|NCT00790790|566766880|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
157004835|NCT00790790|566766878|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
157004836|NCT00790790|566766879|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
157004837|NCT00790790|566766880|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
157004838|NCT02808338|566766882|FG000|Screening|Screen Failure|10|||
157004839|NCT02808338|566766882|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
157004840|NCT02808338|566766882|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
157004841|NCT00756730|566766885|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
157109415|NCT00111800|567155383|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
157109416|NCT00111800|567155384|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
157109417|NCT00111800|567155385|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
157109418|NCT00111800|567155386|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
157109419|NCT00111800|567155387|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
157109420|NCT00111800|567155388|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
157109421|NCT01131676|567155395|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
157109422|NCT01131676|567155396|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
157109423|NCT01131676|567155397|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
157109424|NCT01131676|567155395|FG000|Discontinuation From Treatment|Not treated|4|||
157109425|NCT01131676|567155396|FG001|Discontinuation From Treatment|Not treated|2|||
157109426|NCT01131676|567155397|FG002|Discontinuation From Treatment|Not treated|2|||
157109427|NCT01131676|567155395|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
157109428|NCT01131676|567155396|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
157109429|NCT01131676|567155397|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
157109430|NCT01131676|567155395|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
157109431|NCT01131676|567155396|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
157109432|NCT01131676|567155397|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
157109433|NCT01131676|567155395|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
157109434|NCT01131676|567155396|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
157109435|NCT01131676|567155397|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
157109436|NCT01131676|567155395|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
157109437|NCT01131676|567155396|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
156762021|NCT05616013|565879945|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
156762022|NCT05616013|565879946|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762023|NCT05616013|565879947|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762024|NCT05616013|565879948|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762025|NCT05616013|565879949|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762026|NCT05616013|565879950|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762027|NCT05616013|565879951|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
156762028|NCT05616013|565879952|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
157109438|NCT01131676|567155397|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
157109439|NCT01131676|567155395|FG000|Discontinuation From Treatment|Other than those specified|162|||
157109440|NCT01131676|567155396|FG001|Discontinuation From Treatment|Other than those specified|142|||
157109441|NCT01131676|567155397|FG002|Discontinuation From Treatment|Other than those specified|125|||
157109442|NCT01131676|567155395|FG000|Discontinuation From Treatment|Adverse Event|303|||
157109443|NCT01131676|567155396|FG001|Discontinuation From Treatment|Adverse Event|267|||
157109444|NCT01131676|567155397|FG002|Discontinuation From Treatment|Adverse Event|273|||
157109445|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
157109446|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
157109447|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
156762029|NCT05616013|565879944|FG000|Overall Study|Participant Decision, Time Constraints|0|||
156762030|NCT05616013|565879945|FG001|Overall Study|Participant Decision, Time Constraints|1|||
156762031|NCT05616013|565879946|FG002|Overall Study|Participant Decision, Time Constraints|0|||
156762032|NCT05616013|565879947|FG003|Overall Study|Participant Decision, Time Constraints|0|||
156762033|NCT05616013|565879948|FG004|Overall Study|Participant Decision, Time Constraints|0|||
156762034|NCT05616013|565879949|FG005|Overall Study|Participant Decision, Time Constraints|0|||
156762035|NCT05616013|565879950|FG006|Overall Study|Participant Decision, Time Constraints|0|||
157109448|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
157109449|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
157109450|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
157109451|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
157109452|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
157109453|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
157109454|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
157109455|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
157109456|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
157109457|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
157109458|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
157109459|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
157109460|NCT01131676|567155395|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
157109461|NCT01131676|567155396|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
157109462|NCT01131676|567155397|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
157109463|NCT04109222|567155398|FG000|Overall Study|Adverse Event|1|||
157109464|NCT04109222|567155399|FG001|Overall Study|Adverse Event|0|||
157109465|NCT04109222|567155400|FG002|Overall Study|Adverse Event|0|||
157109466|NCT01111851|567155401|FG000|Overall Study|All planned PET scans were not obtained.|2|||
157109467|NCT01111851|567155402|FG001|Overall Study|All planned PET scans were not obtained.|0|||
157109468|NCT03519867|567155406|FG000|Overall Study|Adverse Event|1|||
157109469|NCT03519867|567155407|FG001|Overall Study|Adverse Event|1|||
157004842|NCT00756730|566766886|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
157109470|NCT03519867|567155408|FG002|Overall Study|Adverse Event|0|||
157109471|NCT03519867|567155409|FG003|Overall Study|Adverse Event|0|||
157109472|NCT03519867|567155410|FG004|Overall Study|Adverse Event|0|||
157109473|NCT03519867|567155411|FG005|Overall Study|Adverse Event|0|||
157109474|NCT03519867|567155412|FG006|Overall Study|Adverse Event|0|||
157109475|NCT03519867|567155413|FG007|Overall Study|Adverse Event|0|||
157109476|NCT03519867|567155414|FG008|Overall Study|Adverse Event|0|||
157109477|NCT03519867|567155415|FG009|Overall Study|Adverse Event|0|||
157109478|NCT03519867|567155406|FG000|Overall Study|Protocol Violation|0|||
157109479|NCT03519867|567155407|FG001|Overall Study|Protocol Violation|0|||
157109480|NCT03519867|567155408|FG002|Overall Study|Protocol Violation|0|||
157109481|NCT03519867|567155409|FG003|Overall Study|Protocol Violation|0|||
157109482|NCT03519867|567155410|FG004|Overall Study|Protocol Violation|0|||
157109483|NCT03519867|567155411|FG005|Overall Study|Protocol Violation|1|||
157109484|NCT03519867|567155412|FG006|Overall Study|Protocol Violation|0|||
157109485|NCT03519867|567155413|FG007|Overall Study|Protocol Violation|0|||
157109486|NCT03519867|567155414|FG008|Overall Study|Protocol Violation|0|||
157109487|NCT03519867|567155415|FG009|Overall Study|Protocol Violation|0|||
157109488|NCT03519867|567155406|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109489|NCT03519867|567155407|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109490|NCT03519867|567155408|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109491|NCT03519867|567155409|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157004843|NCT00756730|566766885|FG000|Overall Study|persistent low-level viremmia|0|||
157004844|NCT00756730|566766886|FG001|Overall Study|persistent low-level viremmia|1|||
157004845|NCT01493778|566766889|FG000|Overall Study|Withdrawal by Subject|8|||
157004846|NCT04210180|566766890|FG000|Overall Study|Withdrawal by Subject|2|||
157004847|NCT03210402|566766891|FG000|Overall Study|Withdrawal by Subject|0|||
157004848|NCT03210402|566766892|FG001|Overall Study|Withdrawal by Subject|1|||
157004849|NCT02517307|566766907|FG000|Overall Study|Withdrawal by Subject|1|||
157004850|NCT02517307|566766908|FG001|Overall Study|Withdrawal by Subject|0|||
157004851|NCT02517307|566766909|FG002|Overall Study|Withdrawal by Subject|1|||
157004852|NCT02517307|566766910|FG003|Overall Study|Withdrawal by Subject|0|||
157004853|NCT02517307|566766907|FG000|Overall Study|Protocol Violation|0|||
157004854|NCT02517307|566766908|FG001|Overall Study|Protocol Violation|0|||
157004855|NCT02517307|566766909|FG002|Overall Study|Protocol Violation|1|||
157004856|NCT02517307|566766910|FG003|Overall Study|Protocol Violation|1|||
157004857|NCT03863834|566766920|FG000|Overall Study|Lost to Follow-up|3|||
157004858|NCT02685488|566766921|FG000|Overall Study|Withdrawal by Subject|0|||
157004859|NCT02685488|566766922|FG001|Overall Study|Withdrawal by Subject|1|||
157004860|NCT02020616|566766923|FG000|Overall Study|Adverse Event|0|||
157004861|NCT02020616|566766924|FG001|Overall Study|Adverse Event|0|||
157004862|NCT02020616|566766925|FG002|Overall Study|Adverse Event|0|||
157004863|NCT02020616|566766926|FG003|Overall Study|Adverse Event|0|||
157004864|NCT02020616|566766927|FG004|Overall Study|Adverse Event|0|||
157004865|NCT02020616|566766928|FG005|Overall Study|Adverse Event|1|||
157004866|NCT02020616|566766929|FG006|Overall Study|Adverse Event|1|||
157004867|NCT02020616|566766923|FG000|Overall Study|Physician Decision|0|||
157004868|NCT02020616|566766924|FG001|Overall Study|Physician Decision|0|||
157004869|NCT02020616|566766925|FG002|Overall Study|Physician Decision|0|||
157004870|NCT02020616|566766926|FG003|Overall Study|Physician Decision|0|||
157004871|NCT02020616|566766927|FG004|Overall Study|Physician Decision|0|||
157004872|NCT02020616|566766928|FG005|Overall Study|Physician Decision|1|||
157004873|NCT02020616|566766929|FG006|Overall Study|Physician Decision|2|||
157004874|NCT02020616|566766923|FG000|Overall Study|Withdrawal by Subject|0|||
157004875|NCT02020616|566766924|FG001|Overall Study|Withdrawal by Subject|0|||
157004876|NCT02020616|566766925|FG002|Overall Study|Withdrawal by Subject|1|||
157004877|NCT02020616|566766926|FG003|Overall Study|Withdrawal by Subject|0|||
157004878|NCT02020616|566766927|FG004|Overall Study|Withdrawal by Subject|0|||
157109492|NCT03519867|567155410|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109493|NCT03519867|567155411|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109494|NCT03519867|567155412|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
157004879|NCT02020616|566766928|FG005|Overall Study|Withdrawal by Subject|1|||
157004880|NCT02020616|566766929|FG006|Overall Study|Withdrawal by Subject|1|||
157004881|NCT02020616|566766923|FG000|Overall Study|Lost to Follow-up|0|||
157004882|NCT02020616|566766924|FG001|Overall Study|Lost to Follow-up|1|||
157004883|NCT02020616|566766925|FG002|Overall Study|Lost to Follow-up|0|||
157109495|NCT03519867|567155413|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109496|NCT03519867|567155414|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109497|NCT03519867|567155415|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
157109498|NCT03519867|567155406|FG000|Overall Study|Admin. of other reversal agent|1|||
157109499|NCT03519867|567155407|FG001|Overall Study|Admin. of other reversal agent|1|||
157109500|NCT03519867|567155408|FG002|Overall Study|Admin. of other reversal agent|0|||
157109501|NCT03519867|567155409|FG003|Overall Study|Admin. of other reversal agent|0|||
157109502|NCT03519867|567155410|FG004|Overall Study|Admin. of other reversal agent|0|||
157109503|NCT03519867|567155411|FG005|Overall Study|Admin. of other reversal agent|1|||
157109504|NCT03519867|567155412|FG006|Overall Study|Admin. of other reversal agent|0|||
157109505|NCT03519867|567155413|FG007|Overall Study|Admin. of other reversal agent|0|||
157109506|NCT03519867|567155414|FG008|Overall Study|Admin. of other reversal agent|0|||
157109507|NCT03519867|567155415|FG009|Overall Study|Admin. of other reversal agent|0|||
157109508|NCT03519867|567155406|FG000|Overall Study|Reason not provided|1|||
157109509|NCT03519867|567155407|FG001|Overall Study|Reason not provided|1|||
157109510|NCT03519867|567155408|FG002|Overall Study|Reason not provided|1|||
157109511|NCT03519867|567155409|FG003|Overall Study|Reason not provided|1|||
157109512|NCT03519867|567155410|FG004|Overall Study|Reason not provided|0|||
157109513|NCT03519867|567155411|FG005|Overall Study|Reason not provided|1|||
156762036|NCT05616013|565879951|FG007|Overall Study|Participant Decision, Time Constraints|0|||
156762037|NCT05616013|565879952|FG008|Overall Study|Participant Decision, Time Constraints|0|||
156762038|NCT05616013|565879944|FG000|Overall Study|Prohibited Concomitant Medication|0|||
156762039|NCT05616013|565879945|FG001|Overall Study|Prohibited Concomitant Medication|0|||
157109514|NCT03519867|567155412|FG006|Overall Study|Reason not provided|0|||
157109515|NCT03519867|567155413|FG007|Overall Study|Reason not provided|1|||
157109516|NCT03519867|567155414|FG008|Overall Study|Reason not provided|1|||
157109517|NCT03519867|567155415|FG009|Overall Study|Reason not provided|0|||
157109518|NCT01846624|567155416|FG000|Overall Study|Died during induction, no midostaurin|1|||
157109519|NCT01721057|567155417|FG000|Treatment Period|Withdrawal by Subject|11|||
157109520|NCT01721057|567155418|FG001|Treatment Period|Withdrawal by Subject|5|||
157109521|NCT01721057|567155419|FG002|Treatment Period|Withdrawal by Subject|8|||
157109522|NCT01721057|567155420|FG003|Treatment Period|Withdrawal by Subject|0|||
157109523|NCT01721057|567155421|FG004|Treatment Period|Withdrawal by Subject|0|||
157109524|NCT01721057|567155422|FG005|Treatment Period|Withdrawal by Subject|0|||
157109525|NCT01721057|567155423|FG006|Treatment Period|Withdrawal by Subject|0|||
157109526|NCT01721057|567155417|FG000|Treatment Period|Adverse Event|7|||
157109527|NCT01721057|567155418|FG001|Treatment Period|Adverse Event|10|||
157109528|NCT01721057|567155419|FG002|Treatment Period|Adverse Event|12|||
157109529|NCT01721057|567155420|FG003|Treatment Period|Adverse Event|0|||
157109530|NCT01721057|567155421|FG004|Treatment Period|Adverse Event|0|||
157109531|NCT01721057|567155422|FG005|Treatment Period|Adverse Event|0|||
157109532|NCT01721057|567155423|FG006|Treatment Period|Adverse Event|0|||
157109533|NCT01721057|567155417|FG000|Treatment Period|Lack of Efficacy|7|||
157109534|NCT01721057|567155418|FG001|Treatment Period|Lack of Efficacy|3|||
157109535|NCT01721057|567155419|FG002|Treatment Period|Lack of Efficacy|0|||
157109536|NCT01721057|567155420|FG003|Treatment Period|Lack of Efficacy|0|||
157109537|NCT01721057|567155421|FG004|Treatment Period|Lack of Efficacy|0|||
157109538|NCT01721057|567155422|FG005|Treatment Period|Lack of Efficacy|0|||
157109539|NCT01721057|567155423|FG006|Treatment Period|Lack of Efficacy|0|||
157109540|NCT01721057|567155417|FG000|Treatment Period|Lost to Follow-up|1|||
157109541|NCT01721057|567155418|FG001|Treatment Period|Lost to Follow-up|0|||
156762040|NCT05616013|565879946|FG002|Overall Study|Prohibited Concomitant Medication|1|||
156762041|NCT05616013|565879947|FG003|Overall Study|Prohibited Concomitant Medication|0|||
156762042|NCT05616013|565879948|FG004|Overall Study|Prohibited Concomitant Medication|0|||
157109542|NCT01721057|567155419|FG002|Treatment Period|Lost to Follow-up|0|||
157109543|NCT01721057|567155420|FG003|Treatment Period|Lost to Follow-up|0|||
157109544|NCT01721057|567155421|FG004|Treatment Period|Lost to Follow-up|0|||
157109545|NCT01721057|567155422|FG005|Treatment Period|Lost to Follow-up|0|||
157109546|NCT01721057|567155423|FG006|Treatment Period|Lost to Follow-up|0|||
157109547|NCT01721057|567155417|FG000|Treatment Period|Physician Decision|0|||
157109548|NCT01721057|567155418|FG001|Treatment Period|Physician Decision|1|||
157109549|NCT01721057|567155419|FG002|Treatment Period|Physician Decision|3|||
157109550|NCT01721057|567155420|FG003|Treatment Period|Physician Decision|0|||
157109551|NCT01721057|567155421|FG004|Treatment Period|Physician Decision|0|||
157109552|NCT01721057|567155422|FG005|Treatment Period|Physician Decision|0|||
157109553|NCT01721057|567155423|FG006|Treatment Period|Physician Decision|0|||
157109554|NCT01721057|567155417|FG000|Treatment Period|Death|2|||
157109555|NCT01721057|567155418|FG001|Treatment Period|Death|0|||
157109556|NCT01721057|567155419|FG002|Treatment Period|Death|0|||
157109557|NCT01721057|567155420|FG003|Treatment Period|Death|0|||
157109558|NCT01721057|567155421|FG004|Treatment Period|Death|0|||
157109559|NCT01721057|567155422|FG005|Treatment Period|Death|0|||
157109560|NCT01721057|567155423|FG006|Treatment Period|Death|0|||
157109561|NCT01721057|567155417|FG000|Rescue Period|Adverse Event|0|||
157109562|NCT01721057|567155418|FG001|Rescue Period|Adverse Event|0|||
157109563|NCT01721057|567155419|FG002|Rescue Period|Adverse Event|0|||
157109564|NCT01721057|567155420|FG003|Rescue Period|Adverse Event|1|||
157109565|NCT01721057|567155421|FG004|Rescue Period|Adverse Event|0|||
157109566|NCT01721057|567155422|FG005|Rescue Period|Adverse Event|0|||
157109567|NCT01721057|567155423|FG006|Rescue Period|Adverse Event|0|||
157109568|NCT01721057|567155417|FG000|Rescue Period|Lack of Efficacy|0|||
157109569|NCT01721057|567155418|FG001|Rescue Period|Lack of Efficacy|0|||
157109570|NCT01721057|567155419|FG002|Rescue Period|Lack of Efficacy|0|||
157109571|NCT01721057|567155420|FG003|Rescue Period|Lack of Efficacy|2|||
157109572|NCT01721057|567155421|FG004|Rescue Period|Lack of Efficacy|0|||
157109573|NCT01721057|567155422|FG005|Rescue Period|Lack of Efficacy|0|||
157109574|NCT01721057|567155423|FG006|Rescue Period|Lack of Efficacy|0|||
157109575|NCT01202279|567155424|FG000|Overall Study|Adverse Event|8|||
157109576|NCT01202279|567155425|FG001|Overall Study|Adverse Event|6|||
157109577|NCT01202279|567155424|FG000|Overall Study|Withdrawal by Subject|13|||
157109578|NCT01202279|567155425|FG001|Overall Study|Withdrawal by Subject|10|||
157109579|NCT01202279|567155424|FG000|Overall Study|Physician Decision|0|||
157109580|NCT01202279|567155425|FG001|Overall Study|Physician Decision|1|||
157109581|NCT01202279|567155424|FG000|Overall Study|Lost to Follow-up|10|||
157109582|NCT01202279|567155425|FG001|Overall Study|Lost to Follow-up|7|||
157109583|NCT01202279|567155424|FG000|Overall Study|Protocol Violation|1|||
157109584|NCT01202279|567155425|FG001|Overall Study|Protocol Violation|1|||
157109585|NCT01202279|567155424|FG000|Overall Study|study compliance|5|||
157109586|NCT01202279|567155425|FG001|Overall Study|study compliance|2|||
157109587|NCT03574753|567155426|FG000|Overall Study|Adverse Event|3|||
157109588|NCT03574753|567155426|FG000|Overall Study|Progression/relapse|19|||
157109589|NCT03574753|567155426|FG000|Overall Study|Death|1|||
157109590|NCT01177683|567155427|FG000|Study Treatment|Disease Progressions during treatment|2|||
157109591|NCT01177683|567155428|FG001|Study Treatment|Disease Progressions during treatment|0|||
157109592|NCT01177683|567155429|FG002|Study Treatment|Disease Progressions during treatment|3|||
157109593|NCT01177683|567155427|FG000|Study Treatment|Adverse Event|0|||
157109594|NCT01177683|567155428|FG001|Study Treatment|Adverse Event|1|||
157109595|NCT01177683|567155429|FG002|Study Treatment|Adverse Event|12|||
157109596|NCT01177683|567155427|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
157109597|NCT01177683|567155428|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
157109598|NCT01177683|567155429|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
157109599|NCT01177683|567155427|FG000|Study Treatment|Alternative therapy|0|||
157109600|NCT01177683|567155428|FG001|Study Treatment|Alternative therapy|0|||
157109601|NCT01177683|567155429|FG002|Study Treatment|Alternative therapy|4|||
157109602|NCT01177683|567155427|FG000|Study Treatment|Physician Decision|1|||
157109603|NCT01177683|567155428|FG001|Study Treatment|Physician Decision|0|||
157109604|NCT01177683|567155429|FG002|Study Treatment|Physician Decision|1|||
157109605|NCT01177683|567155427|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
157109606|NCT01177683|567155428|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
157109607|NCT01177683|567155429|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
157109608|NCT01177683|567155427|FG000|Study Treatment|Symptomatic Deterioration|0|||
157109609|NCT01177683|567155428|FG001|Study Treatment|Symptomatic Deterioration|0|||
157109610|NCT01177683|567155429|FG002|Study Treatment|Symptomatic Deterioration|1|||
157109611|NCT01177683|567155427|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
157109612|NCT01177683|567155428|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
157109613|NCT01177683|567155429|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
157109614|NCT01177683|567155427|FG000|Follow up|Patient lost to follow up|0|||
157109615|NCT01177683|567155428|FG001|Follow up|Patient lost to follow up|0|||
157109616|NCT01177683|567155429|FG002|Follow up|Patient lost to follow up|2|||
157109617|NCT01177683|567155427|FG000|Follow up|Death|2|||
157109618|NCT01177683|567155428|FG001|Follow up|Death|1|||
157109619|NCT01177683|567155429|FG002|Follow up|Death|7|||
157109620|NCT01177683|567155427|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
157109621|NCT01177683|567155428|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
157109622|NCT01177683|567155429|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
156762043|NCT05616013|565879949|FG005|Overall Study|Prohibited Concomitant Medication|0|||
156762044|NCT05616013|565879950|FG006|Overall Study|Prohibited Concomitant Medication|0|||
156762045|NCT05616013|565879951|FG007|Overall Study|Prohibited Concomitant Medication|0|||
157109623|NCT02546765|567155432|FG000|Overall Study|Withdrawal by Subject|0|||
157109624|NCT02546765|567155433|FG001|Overall Study|Withdrawal by Subject|1|||
157109625|NCT02546765|567155434|FG002|Overall Study|Withdrawal by Subject|0|||
157109626|NCT02546765|567155435|FG003|Overall Study|Withdrawal by Subject|0|||
157109627|NCT01977820|567155436|FG000|Overall Study|Sponsor terminated the study|1|||
157109628|NCT01977820|567155437|FG001|Overall Study|Sponsor terminated the study|1|||
157109629|NCT00475722|567155438|FG000|Overall Study|Withdrawal by Subject|12|||
157109630|NCT00475722|567155439|FG001|Overall Study|Withdrawal by Subject|12|||
157109631|NCT00475722|567155438|FG000|Overall Study|Protocol Violation|3|||
157109632|NCT00475722|567155439|FG001|Overall Study|Protocol Violation|0|||
157109633|NCT00698997|567155440|FG000|Overall Study|Lost to Follow-up|3|||
157109634|NCT00698997|567155441|FG001|Overall Study|Lost to Follow-up|0|||
157109635|NCT00698997|567155440|FG000|Overall Study|Withdrawal by Subject|7|||
157109636|NCT00698997|567155441|FG001|Overall Study|Withdrawal by Subject|27|||
157109637|NCT02568475|567155442|FG000|Overall Study|Lost to Follow-up|40|||
157109638|NCT02568475|567155443|FG001|Overall Study|Lost to Follow-up|39|||
157109639|NCT02568475|567155442|FG000|Overall Study|Withdrawal by Subject|2|||
157109640|NCT02568475|567155443|FG001|Overall Study|Withdrawal by Subject|0|||
157109641|NCT02568475|567155442|FG000|Overall Study|Discharged home|4|||
157109642|NCT02568475|567155443|FG001|Overall Study|Discharged home|4|||
157109643|NCT02568475|567155442|FG000|Overall Study|Short-term: Discharge location unknown|4|||
157109644|NCT02568475|567155443|FG001|Overall Study|Short-term: Discharge location unknown|0|||
157109645|NCT02568475|567155442|FG000|Overall Study|Transferred to another facility|1|||
157109646|NCT02568475|567155443|FG001|Overall Study|Transferred to another facility|0|||
157109647|NCT02625233|567155444|FG000|Overall Study|Adverse Event|2|||
157109648|NCT02625233|567155445|FG001|Overall Study|Adverse Event|0|||
157109649|NCT04425720|567155446|FG000|Overall Study|Withdrawal by Subject|0|||
157109650|NCT04425720|567155447|FG001|Overall Study|Withdrawal by Subject|20|||
157109651|NCT00290186|567155448|FG000|Overall Study|Adverse Event|1|||
157004884|NCT02020616|566766926|FG003|Overall Study|Lost to Follow-up|1|||
157004885|NCT02020616|566766927|FG004|Overall Study|Lost to Follow-up|1|||
157004886|NCT02020616|566766928|FG005|Overall Study|Lost to Follow-up|1|||
157004887|NCT02020616|566766929|FG006|Overall Study|Lost to Follow-up|0|||
157004888|NCT02020616|566766923|FG000|Overall Study|Early Termination Criteria Met|0|||
157004889|NCT02020616|566766924|FG001|Overall Study|Early Termination Criteria Met|0|||
157004890|NCT02020616|566766925|FG002|Overall Study|Early Termination Criteria Met|1|||
157004891|NCT02020616|566766926|FG003|Overall Study|Early Termination Criteria Met|0|||
157004892|NCT02020616|566766927|FG004|Overall Study|Early Termination Criteria Met|0|||
157004893|NCT02020616|566766928|FG005|Overall Study|Early Termination Criteria Met|1|||
157004894|NCT02020616|566766929|FG006|Overall Study|Early Termination Criteria Met|0|||
157004895|NCT02020616|566766923|FG000|Overall Study|Randomized in Error|0|||
157004896|NCT02020616|566766924|FG001|Overall Study|Randomized in Error|0|||
157004897|NCT02020616|566766925|FG002|Overall Study|Randomized in Error|0|||
157004898|NCT02020616|566766926|FG003|Overall Study|Randomized in Error|1|||
157004899|NCT02020616|566766927|FG004|Overall Study|Randomized in Error|0|||
157004900|NCT02020616|566766928|FG005|Overall Study|Randomized in Error|0|||
157004901|NCT02020616|566766929|FG006|Overall Study|Randomized in Error|0|||
157004902|NCT02020616|566766923|FG000|Overall Study|Lack of Efficacy|0|||
157004903|NCT02020616|566766924|FG001|Overall Study|Lack of Efficacy|0|||
157004904|NCT02020616|566766925|FG002|Overall Study|Lack of Efficacy|0|||
157004905|NCT02020616|566766926|FG003|Overall Study|Lack of Efficacy|0|||
157004906|NCT02020616|566766927|FG004|Overall Study|Lack of Efficacy|1|||
157004907|NCT02020616|566766928|FG005|Overall Study|Lack of Efficacy|0|||
157004908|NCT02020616|566766929|FG006|Overall Study|Lack of Efficacy|0|||
157004909|NCT05019729|566766930|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
157004910|NCT05019729|566766931|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
157004911|NCT05019729|566766932|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
157004912|NCT05019729|566766933|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
157004913|NCT05019729|566766934|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
157004914|NCT05019729|566766935|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
157004915|NCT04493242|566766946|FG000|Overall Study|Death|10|||
157004916|NCT04493242|566766947|FG001|Overall Study|Death|14|||
157004917|NCT04493242|566766948|FG002|Overall Study|Death|16|||
157004918|NCT04493242|566766946|FG000|Overall Study|Lost to Follow-up|1|||
157004919|NCT04493242|566766947|FG001|Overall Study|Lost to Follow-up|1|||
157004920|NCT04493242|566766948|FG002|Overall Study|Lost to Follow-up|0|||
157004921|NCT04493242|566766946|FG000|Overall Study|Withdrawal by Subject|1|||
157004922|NCT04493242|566766947|FG001|Overall Study|Withdrawal by Subject|0|||
157004923|NCT04493242|566766948|FG002|Overall Study|Withdrawal by Subject|0|||
157004924|NCT04493242|566766946|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
157004925|NCT04493242|566766947|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
157004926|NCT04493242|566766948|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
157004927|NCT04493242|566766946|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
157004928|NCT04493242|566766947|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
157004929|NCT04493242|566766948|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
157004930|NCT04513522|566768526|FG000|Overall Study|Other reasons|1|||
157004931|NCT04513522|566768526|FG000|Overall Study|Adverse event unrelated to study drug|9|||
157004932|NCT04513522|566768526|FG000|Overall Study|Study drug toxicity|14|||
157004933|NCT04513522|566768526|FG000|Overall Study|Disease progression|39|||
157004934|NCT04513522|566768526|FG000|Overall Study|Participants withdrew consent|2|||
157004935|NCT03351075|566768529|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
157004936|NCT03351075|566768530|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
157004937|NCT03351075|566768529|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
157004938|NCT03351075|566768530|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
157109652|NCT00290186|567155449|FG001|Overall Study|Adverse Event|1|||
157109653|NCT00290186|567155448|FG000|Overall Study|Lost to Follow-up|3|||
157109654|NCT00290186|567155449|FG001|Overall Study|Lost to Follow-up|2|||
157109655|NCT00290186|567155448|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
157109656|NCT00290186|567155449|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
157109657|NCT00290186|567155448|FG000|Overall Study|Withdrawal by Subject|0|||
157109658|NCT00290186|567155449|FG001|Overall Study|Withdrawal by Subject|1|||
157109659|NCT00262522|567155452|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
157109660|NCT00262522|567155453|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
157109661|NCT00262522|567155454|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
157109662|NCT00262522|567155455|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
157109663|NCT00262522|567155452|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
157109664|NCT00262522|567155453|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
157109665|NCT00262522|567155454|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
157109666|NCT00262522|567155455|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
157109667|NCT00262522|567155452|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
157109668|NCT00262522|567155453|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
157109669|NCT00262522|567155454|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
157109670|NCT00262522|567155455|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
157109671|NCT00262522|567155452|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
157109672|NCT00262522|567155453|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
157109673|NCT00262522|567155454|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
157109674|NCT00262522|567155455|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
157109675|NCT00262522|567155452|FG000|Study Start Through 8 Weeks|Death|1|||
157109676|NCT00262522|567155453|FG001|Study Start Through 8 Weeks|Death|0|||
157109677|NCT00262522|567155454|FG002|Study Start Through 8 Weeks|Death|0|||
157109678|NCT00262522|567155455|FG003|Study Start Through 8 Weeks|Death|0|||
157109679|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
157109680|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
157109681|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
157109682|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
157109683|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
157109684|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
157109685|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
157109686|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
157109687|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
157109688|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
157109689|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
157109690|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
157109691|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
157109692|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
157109693|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
157109694|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
157109695|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Death|2|||
157109696|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Death|0|||
157109697|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Death|1|||
157109698|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Death|0|||
157109699|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
157109700|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
157109701|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
157109702|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
157109703|NCT00262522|567155452|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
157109704|NCT00262522|567155453|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
157109705|NCT00262522|567155454|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
157109706|NCT00262522|567155455|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
157109707|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
157109708|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
157004939|NCT03351075|566768529|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
157004940|NCT03351075|566768530|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
157004941|NCT03351075|566768529|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
157004942|NCT03351075|566768530|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
157004943|NCT05219253|566768535|FG000|Overall Study|Withdrawal by Subject|1|||
157004944|NCT05219253|566768536|FG001|Overall Study|Withdrawal by Subject|2|||
157004945|NCT03086369|566768537|FG000|Overall Study|Lost to Follow-up|1|||
157004946|NCT03086369|566768538|FG001|Overall Study|Lost to Follow-up|0|||
157004947|NCT03086369|566768539|FG002|Overall Study|Lost to Follow-up|0|||
157004948|NCT03086369|566768540|FG003|Overall Study|Lost to Follow-up|2|||
157004949|NCT03086369|566768541|FG004|Overall Study|Lost to Follow-up|1|||
157109709|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
157004950|NCT03086369|566768537|FG000|Overall Study|Physician Decision|0|||
157004951|NCT03086369|566768538|FG001|Overall Study|Physician Decision|0|||
157109710|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
157109711|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
157109712|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
157109713|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
157109714|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
157109715|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
157109716|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
157109717|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
157109718|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
157109719|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
157109720|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
157109721|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
157109722|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
157109723|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Death|2|||
157109724|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Death|0|||
157109725|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Death|2|||
157109726|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Death|0|||
157109727|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
157109728|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
157109729|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
157109730|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
157109731|NCT00262522|567155452|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
157109732|NCT00262522|567155453|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
157109733|NCT00262522|567155454|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
157109734|NCT00262522|567155455|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
157109735|NCT05314517|567155467|FG000|Double-blind Period|Adverse Event|4|||
157109736|NCT05314517|567155468|FG001|Double-blind Period|Adverse Event|0|||
157109737|NCT05314517|567155469|FG002|Double-blind Period|Adverse Event|0|||
157109738|NCT05314517|567155470|FG003|Double-blind Period|Adverse Event|0|||
157109739|NCT05314517|567155467|FG000|Double-blind Period|Noncompliance|0|||
157109740|NCT05314517|567155468|FG001|Double-blind Period|Noncompliance|1|||
157109741|NCT05314517|567155469|FG002|Double-blind Period|Noncompliance|0|||
157109742|NCT05314517|567155470|FG003|Double-blind Period|Noncompliance|0|||
157109743|NCT05314517|567155467|FG000|Double-blind Period|Randomized, not treated|1|||
157109744|NCT05314517|567155468|FG001|Double-blind Period|Randomized, not treated|0|||
157109745|NCT05314517|567155469|FG002|Double-blind Period|Randomized, not treated|0|||
157109746|NCT05314517|567155470|FG003|Double-blind Period|Randomized, not treated|0|||
157109747|NCT05314517|567155467|FG000|Open-label Extension|Adverse Event|0|||
157109748|NCT05314517|567155468|FG001|Open-label Extension|Adverse Event|0|||
157109749|NCT05314517|567155469|FG002|Open-label Extension|Adverse Event|1|||
157109750|NCT05314517|567155470|FG003|Open-label Extension|Adverse Event|2|||
157109751|NCT05314517|567155467|FG000|Open-label Extension|Investigator decision|0|||
157109752|NCT05314517|567155468|FG001|Open-label Extension|Investigator decision|0|||
157109753|NCT05314517|567155469|FG002|Open-label Extension|Investigator decision|1|||
157109754|NCT05314517|567155470|FG003|Open-label Extension|Investigator decision|0|||
157109755|NCT05314517|567155467|FG000|Open-label Extension|Lost to Follow-up|0|||
157109756|NCT05314517|567155468|FG001|Open-label Extension|Lost to Follow-up|0|||
157109757|NCT05314517|567155469|FG002|Open-label Extension|Lost to Follow-up|0|||
157109758|NCT05314517|567155470|FG003|Open-label Extension|Lost to Follow-up|1|||
157109759|NCT05314517|567155467|FG000|Open-label Extension|Withdrawal by Subject|0|||
157109760|NCT05314517|567155468|FG001|Open-label Extension|Withdrawal by Subject|0|||
157109761|NCT05314517|567155469|FG002|Open-label Extension|Withdrawal by Subject|1|||
157109762|NCT05314517|567155470|FG003|Open-label Extension|Withdrawal by Subject|2|||
157109763|NCT05314517|567155467|FG000|Open-label Extension|Use of prohibited medication|0|||
157109764|NCT05314517|567155468|FG001|Open-label Extension|Use of prohibited medication|0|||
157109765|NCT05314517|567155469|FG002|Open-label Extension|Use of prohibited medication|1|||
157109766|NCT05314517|567155470|FG003|Open-label Extension|Use of prohibited medication|0|||
157109767|NCT05314517|567155467|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
157109768|NCT05314517|567155468|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
157109769|NCT05314517|567155469|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
157109770|NCT05314517|567155470|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
157109771|NCT02710136|567155473|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
157109772|NCT02710136|567155474|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
157109773|NCT02269787|567155475|FG000|Overall Study|Lost to Follow-up|20|||
157109774|NCT02269787|567155476|FG001|Overall Study|Lost to Follow-up|6|||
157109775|NCT02269787|567155475|FG000|Overall Study|Death|2|||
157109776|NCT02269787|567155476|FG001|Overall Study|Death|3|||
157109777|NCT02269787|567155475|FG000|Overall Study|Incapacitated|0|||
157109778|NCT02269787|567155476|FG001|Overall Study|Incapacitated|1|||
157109779|NCT00798135|567155477|FG000|Overall Study|Disease progression, relapse|11|||
157109780|NCT00798135|567155477|FG000|Overall Study|Disease progression, refractory|1|||
157109781|NCT00798135|567155477|FG000|Overall Study|Physician Decision|1|||
157109782|NCT02228720|567155478|FG000|Open Label - Day 30|Lost to Follow-up|1|||
157109783|NCT03337542|567155479|FG000|Overall Study|Withdrew Consent|17|||
157109784|NCT03337542|567155479|FG000|Overall Study|Allergic Adverse Event|1|||
157109785|NCT03337542|567155479|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
157109786|NCT03337542|567155479|FG000|Overall Study|Lost to Follow-up|1|||
157109787|NCT03337542|567155479|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
157109788|NCT00282295|567155480|FG000|Overall Study|Adverse Event|0|||
157109789|NCT00282295|567155481|FG001|Overall Study|Adverse Event|1|||
157109790|NCT00282295|567155482|FG002|Overall Study|Adverse Event|0|||
157109791|NCT00282295|567155480|FG000|Overall Study|Serious Adverse Events|0|||
157109792|NCT00282295|567155481|FG001|Overall Study|Serious Adverse Events|0|||
157109793|NCT00282295|567155482|FG002|Overall Study|Serious Adverse Events|1|||
157109794|NCT00282295|567155480|FG000|Overall Study|Protocol Violation|0|||
157109795|NCT00282295|567155481|FG001|Overall Study|Protocol Violation|2|||
157109796|NCT00282295|567155482|FG002|Overall Study|Protocol Violation|1|||
157109797|NCT00282295|567155480|FG000|Overall Study|Withdrawal by Subject|2|||
157109798|NCT00282295|567155481|FG001|Overall Study|Withdrawal by Subject|6|||
157109799|NCT00282295|567155482|FG002|Overall Study|Withdrawal by Subject|4|||
157109800|NCT00282295|567155480|FG000|Overall Study|Lost to Follow-up|1|||
157109801|NCT00282295|567155481|FG001|Overall Study|Lost to Follow-up|7|||
157109802|NCT00282295|567155482|FG002|Overall Study|Lost to Follow-up|2|||
157109803|NCT00282295|567155480|FG000|Overall Study|Other|0|||
157109804|NCT00282295|567155481|FG001|Overall Study|Other|1|||
157109805|NCT00282295|567155482|FG002|Overall Study|Other|0|||
157109806|NCT01401842|567155485|FG000|Overall Study|Withdrawal by Subject|3|||
157109807|NCT01401842|567155486|FG001|Overall Study|Withdrawal by Subject|2|||
157109808|NCT01401842|567155485|FG000|Overall Study|academic reason|4|||
157109809|NCT01401842|567155486|FG001|Overall Study|academic reason|1|||
157109810|NCT01401842|567155485|FG000|Overall Study|changed companies|20|||
157109811|NCT01401842|567155486|FG001|Overall Study|changed companies|34|||
157109812|NCT01401842|567155485|FG000|Overall Study|discharged from US Army|3|||
157109813|NCT01401842|567155486|FG001|Overall Study|discharged from US Army|4|||
157109814|NCT01401842|567155485|FG000|Overall Study|invalid follow-up strength data|1|||
157109815|NCT01401842|567155486|FG001|Overall Study|invalid follow-up strength data|4|||
157109816|NCT01401842|567155485|FG000|Overall Study|on profile|9|||
157109817|NCT01401842|567155486|FG001|Overall Study|on profile|5|||
157109818|NCT01401842|567155485|FG000|Overall Study|other/unknown|28|||
157109819|NCT01401842|567155486|FG001|Overall Study|other/unknown|17|||
157109820|NCT04198623|567157110|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
157109821|NCT05050318|567157118|FG000|Overall Study|Protocol Deviation|1|||
157109822|NCT05050318|567157119|FG001|Overall Study|Protocol Deviation|0|||
157109823|NCT05050318|567157120|FG002|Overall Study|Protocol Deviation|0|||
157109824|NCT04259411|567157121|FG000|Overall Study|Death|1|||
157109825|NCT04259411|567157121|FG000|Overall Study|Missed visit|2|||
157109826|NCT00736255|567157122|FG000|Overall Study|Adverse Event|1|||
157109827|NCT00736255|567157123|FG001|Overall Study|Adverse Event|0|||
157109828|NCT00736255|567157122|FG000|Overall Study|Physician Decision|1|||
157109829|NCT00736255|567157123|FG001|Overall Study|Physician Decision|0|||
157109830|NCT00736255|567157122|FG000|Overall Study|Non-compliance|1|||
157109831|NCT00736255|567157123|FG001|Overall Study|Non-compliance|1|||
157109832|NCT00766038|567157126|FG000|Overall Study|Lost to Follow-up|15|||
157109833|NCT00766038|567157127|FG001|Overall Study|Lost to Follow-up|14|||
157109834|NCT00449670|567157128|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
157109835|NCT00449670|567157129|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
157109836|NCT00449670|567157128|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
157109837|NCT00449670|567157129|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
157109838|NCT00449670|567157128|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
157109839|NCT00449670|567157129|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
157109840|NCT00449670|567157128|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
157109841|NCT00449670|567157129|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
157109842|NCT00449670|567157128|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
157109843|NCT00449670|567157129|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
157109844|NCT00449670|567157128|FG000|Booster Phase (Study no.109873)|Other|0|||
157109845|NCT00449670|567157129|FG001|Booster Phase (Study no.109873)|Other|2|||
157109846|NCT00847145|567157133|FG000|Overall Study|AE or Death|0|||
157109847|NCT00847145|567157134|FG001|Overall Study|AE or Death|1|||
157109848|NCT00847145|567157135|FG002|Overall Study|AE or Death|1|||
157109849|NCT00847145|567157136|FG003|Overall Study|AE or Death|0|||
157109850|NCT00847145|567157137|FG004|Overall Study|AE or Death|0|||
157109851|NCT00847145|567157138|FG005|Overall Study|AE or Death|0|||
157109852|NCT00847145|567157139|FG006|Overall Study|AE or Death|0|||
157109853|NCT00847145|567157140|FG007|Overall Study|AE or Death|0|||
157109854|NCT00847145|567157133|FG000|Overall Study|Withdrawal by Subject|3|||
157109855|NCT00847145|567157134|FG001|Overall Study|Withdrawal by Subject|4|||
157109856|NCT00847145|567157135|FG002|Overall Study|Withdrawal by Subject|6|||
157109857|NCT00847145|567157136|FG003|Overall Study|Withdrawal by Subject|1|||
157109858|NCT00847145|567157137|FG004|Overall Study|Withdrawal by Subject|0|||
157109859|NCT00847145|567157138|FG005|Overall Study|Withdrawal by Subject|0|||
157109860|NCT00847145|567157139|FG006|Overall Study|Withdrawal by Subject|1|||
157109861|NCT00847145|567157140|FG007|Overall Study|Withdrawal by Subject|1|||
157109862|NCT00847145|567157133|FG000|Overall Study|Lost to Follow-up|3|||
157109863|NCT00847145|567157134|FG001|Overall Study|Lost to Follow-up|1|||
157109864|NCT00847145|567157135|FG002|Overall Study|Lost to Follow-up|1|||
157109865|NCT00847145|567157136|FG003|Overall Study|Lost to Follow-up|0|||
157109866|NCT00847145|567157137|FG004|Overall Study|Lost to Follow-up|4|||
157109867|NCT00847145|567157138|FG005|Overall Study|Lost to Follow-up|4|||
157109868|NCT00847145|567157139|FG006|Overall Study|Lost to Follow-up|8|||
157109869|NCT00847145|567157140|FG007|Overall Study|Lost to Follow-up|2|||
157109870|NCT00847145|567157133|FG000|Overall Study|Inappropriate enrollment|0|||
157109871|NCT00847145|567157134|FG001|Overall Study|Inappropriate enrollment|0|||
157109872|NCT00847145|567157135|FG002|Overall Study|Inappropriate enrollment|0|||
157109873|NCT00847145|567157136|FG003|Overall Study|Inappropriate enrollment|0|||
157109874|NCT00847145|567157137|FG004|Overall Study|Inappropriate enrollment|1|||
157109875|NCT00847145|567157138|FG005|Overall Study|Inappropriate enrollment|0|||
157109876|NCT00847145|567157139|FG006|Overall Study|Inappropriate enrollment|0|||
157109877|NCT00847145|567157140|FG007|Overall Study|Inappropriate enrollment|0|||
157109878|NCT00847145|567157133|FG000|Overall Study|Protocol Violation|0|||
157109879|NCT00847145|567157134|FG001|Overall Study|Protocol Violation|0|||
157109880|NCT00847145|567157135|FG002|Overall Study|Protocol Violation|3|||
157109881|NCT00847145|567157136|FG003|Overall Study|Protocol Violation|0|||
157109882|NCT00847145|567157137|FG004|Overall Study|Protocol Violation|1|||
157109883|NCT00847145|567157138|FG005|Overall Study|Protocol Violation|0|||
157109884|NCT00847145|567157139|FG006|Overall Study|Protocol Violation|0|||
157109885|NCT00847145|567157140|FG007|Overall Study|Protocol Violation|1|||
157109886|NCT02833974|567157141|FG000|Overall Study|Lost to Follow-up|1|||
157109887|NCT02833974|567157142|FG001|Overall Study|Lost to Follow-up|0|||
157109888|NCT02833974|567157141|FG000|Overall Study|Adverse Event|0|||
157109889|NCT02833974|567157142|FG001|Overall Study|Adverse Event|3|||
157109890|NCT01502709|567157144|FG000|Overall Study|Lost to Follow-up|4|||
157109891|NCT01502709|567157145|FG001|Overall Study|Lost to Follow-up|0|||
157109892|NCT00346073|567157147|FG000|Overall Study|Serious Adverse Event|2|||
157109893|NCT00346073|567157148|FG001|Overall Study|Serious Adverse Event|0|||
157109894|NCT00346073|567157147|FG000|Overall Study|Lost to Follow-up|39|||
157109895|NCT00346073|567157148|FG001|Overall Study|Lost to Follow-up|24|||
157109896|NCT00980200|567157150|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
157109897|NCT00980200|567157151|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
157109898|NCT00980200|567157152|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
157109899|NCT00980200|567157153|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
157109900|NCT00980200|567157154|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
157109901|NCT00980200|567157150|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
157109902|NCT00980200|567157151|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
157109903|NCT00980200|567157152|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
157109904|NCT00980200|567157153|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
157109905|NCT00980200|567157154|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
157109906|NCT01617460|567157155|FG000|Overall Study|Adverse Event|10|||
157109907|NCT01617460|567157155|FG000|Overall Study|Physician Decision|16|||
157109908|NCT01617460|567157155|FG000|Overall Study|Protocol Violation|5|||
157109909|NCT01617460|567157155|FG000|Overall Study|Withdrawal by Subject|9|||
157109910|NCT00457015|567157157|FG000|Overall Study|Left study site against medical advice|0|||
157109911|NCT00457015|567157158|FG001|Overall Study|Left study site against medical advice|1|||
157109912|NCT03670953|567157159|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
157109913|NCT03670953|567157160|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
157109914|NCT03670953|567157161|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
157109915|NCT03670953|567157162|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
157109916|NCT03670953|567157159|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
157109917|NCT03670953|567157160|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
157109918|NCT03670953|567157161|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
157109919|NCT03670953|567157162|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
157109920|NCT03670953|567157159|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
157109921|NCT03670953|567157160|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
157109922|NCT03670953|567157161|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
157109923|NCT03670953|567157162|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
157109924|NCT03670953|567157159|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
157109925|NCT03670953|567157160|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
157109926|NCT03670953|567157161|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
157109927|NCT03670953|567157162|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
157109928|NCT03670953|567157159|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
157109929|NCT03670953|567157160|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
157109930|NCT03670953|567157161|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
157109931|NCT03670953|567157162|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
157109932|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
157109933|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
157109934|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
157109935|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
157109936|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
157109937|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
157109938|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
157109939|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
157109940|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
157109941|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
157109942|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
157109943|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
157109944|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
157109945|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
157109946|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
157109947|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
157109948|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
157109949|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
157109950|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
157109951|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
157109952|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
157109953|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
157109954|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
157109955|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
157109956|NCT03670953|567157159|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
157109957|NCT03670953|567157160|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
157109958|NCT03670953|567157161|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
157109959|NCT03670953|567157162|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
157109960|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
157109961|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
157109962|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
157109963|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
156762046|NCT05616013|565879952|FG008|Overall Study|Prohibited Concomitant Medication|0|||
156762047|NCT05616013|565879944|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762048|NCT05616013|565879945|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762049|NCT05616013|565879946|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
156762050|NCT05616013|565879947|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762051|NCT05616013|565879948|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762052|NCT05616013|565879949|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762053|NCT05616013|565879950|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762054|NCT05616013|565879951|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
156808567|NCT01070979|566052716|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
157109964|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
157109965|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
157109966|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
157109967|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
157109968|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
157109969|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
157109970|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
157109971|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
157109972|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
157109973|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
157109974|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
157109975|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
157109976|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
157109977|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
157109978|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
157109979|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
157109980|NCT03670953|567157159|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
157109981|NCT03670953|567157160|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
157109982|NCT03670953|567157161|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
157109983|NCT03670953|567157162|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
157109984|NCT00937937|567157163|FG000|Overall Study|Adverse Event|6|||
157109985|NCT00937937|567157163|FG000|Overall Study|Withdrawal by Subject|2|||
157109986|NCT00937937|567157163|FG000|Overall Study|Progression/relapse|61|||
157109987|NCT00937937|567157163|FG000|Overall Study|Death|1|||
157109988|NCT00937937|567157163|FG000|Overall Study|Other|2|||
157109989|NCT03197493|567157165|FG000|Overall Study|Withdrawal by Subject|5|||
157109990|NCT00054704|567157166|FG000|Overall Study|Lack of Efficacy|2|||
157109991|NCT00054704|567157167|FG001|Overall Study|Lack of Efficacy|3|||
157109992|NCT00054704|567157166|FG000|Overall Study|Adverse Event|3|||
157109993|NCT00054704|567157167|FG001|Overall Study|Adverse Event|1|||
157109994|NCT00054704|567157166|FG000|Overall Study|Lost to Follow-up|0|||
157109995|NCT00054704|567157167|FG001|Overall Study|Lost to Follow-up|1|||
157109996|NCT00362414|567157170|FG000|Overall Study|Death|2|||
157109997|NCT00362414|567157170|FG000|Overall Study|Adverse Event|1|||
157109998|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
157109999|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
157110000|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
157110001|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
157110002|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
157110003|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
157110004|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Death|2|||
157110005|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Death|0|||
157110006|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
157110007|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
157110008|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
157110009|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
157110010|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
157110011|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
157110012|NCT02603120|567157171|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
157110013|NCT02603120|567157172|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
157110014|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
157110015|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
157110016|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
157110017|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
157110018|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
157110019|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
157110020|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
157110021|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
157110022|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
157110023|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
157110024|NCT02603120|567157171|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
157110025|NCT02603120|567157172|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
157110026|NCT01469182|567157175|FG000|Overall Study|Adverse Event|21|||
157110027|NCT01469182|567157176|FG001|Overall Study|Adverse Event|3|||
157110028|NCT01469182|567157175|FG000|Overall Study|Lost to Follow-up|3|||
157110029|NCT01469182|567157176|FG001|Overall Study|Lost to Follow-up|0|||
157110030|NCT01469182|567157175|FG000|Overall Study|Withdrawal by Subject|4|||
157110031|NCT01469182|567157176|FG001|Overall Study|Withdrawal by Subject|1|||
157110032|NCT01469182|567157175|FG000|Overall Study|Protocol Violation|4|||
157110033|NCT01469182|567157176|FG001|Overall Study|Protocol Violation|2|||
157110034|NCT01469182|567157175|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
157110035|NCT01469182|567157176|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
157110036|NCT01785160|567157178|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
157110037|NCT01785160|567157178|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
157110038|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
157110039|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
157110040|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
157110041|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
157110042|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
157110043|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
157110044|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
157110045|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
157110046|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
157110047|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
157110048|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
157110049|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
157110050|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
157110051|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
157110052|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
157110053|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
157110054|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
157110055|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
157110056|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
157110057|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
157110058|NCT02752035|567157179|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
157110059|NCT02752035|567157180|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
157110060|NCT02752035|567157181|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
157110061|NCT02752035|567157182|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
157110062|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
157110063|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
157110064|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
157110065|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
157110066|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
157110067|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
157110068|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
157110069|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
157110070|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
157110071|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
157110072|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
157110073|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
157110074|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
157110075|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
157110076|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
157110077|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
157110078|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
157110079|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
157110080|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
156762055|NCT05616013|565879952|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
156762056|NCT05616013|565879944|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762057|NCT05616013|565879945|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762058|NCT05616013|565879946|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762059|NCT05616013|565879947|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
156762060|NCT05616013|565879948|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762061|NCT05616013|565879949|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762062|NCT05616013|565879950|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762063|NCT05616013|565879951|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762064|NCT05616013|565879952|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
156762065|NCT05616013|565879944|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762066|NCT05616013|565879945|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762067|NCT05616013|565879946|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762068|NCT05616013|565879947|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762069|NCT05616013|565879948|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762070|NCT05616013|565879949|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762071|NCT05616013|565879950|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
156762072|NCT05616013|565879951|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762073|NCT05616013|565879952|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
156762074|NCT05616013|565879944|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762075|NCT05616013|565879945|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762076|NCT05616013|565879946|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762077|NCT05616013|565879947|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762078|NCT05616013|565879948|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762079|NCT05616013|565879949|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762080|NCT05616013|565879950|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762081|NCT05616013|565879951|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
156762082|NCT05616013|565879952|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
156762083|NCT05616013|565879944|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762084|NCT05616013|565879945|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762085|NCT05616013|565879946|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762086|NCT05616013|565879947|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762087|NCT05616013|565879948|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762088|NCT05616013|565879949|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762089|NCT05616013|565879950|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762090|NCT05616013|565879951|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
156762091|NCT05616013|565879952|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
156762092|NCT04391842|565879953|FG000|Overall Study|Withdrawal by Subject|2|||
156762093|NCT00810199|565879954|FG000|Overall Study|Adverse Event|24|||
156762094|NCT00810199|565879955|FG001|Overall Study|Adverse Event|26|||
156762095|NCT00810199|565879954|FG000|Overall Study|Death|4|||
156762096|NCT00810199|565879955|FG001|Overall Study|Death|6|||
156762097|NCT00810199|565879954|FG000|Overall Study|Withdrew consent|9|||
156762098|NCT00810199|565879955|FG001|Overall Study|Withdrew consent|12|||
156762099|NCT00810199|565879954|FG000|Overall Study|Insufficient therapeutic response|5|||
156762100|NCT00810199|565879955|FG001|Overall Study|Insufficient therapeutic response|14|||
156762101|NCT00810199|565879954|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
157004952|NCT03086369|566768539|FG002|Overall Study|Physician Decision|0|||
157004953|NCT03086369|566768540|FG003|Overall Study|Physician Decision|1|||
157004954|NCT03086369|566768541|FG004|Overall Study|Physician Decision|2|||
157004955|NCT03086369|566768537|FG000|Overall Study|Withdrawal by Subject|0|||
157004956|NCT03086369|566768538|FG001|Overall Study|Withdrawal by Subject|0|||
157004957|NCT03086369|566768539|FG002|Overall Study|Withdrawal by Subject|0|||
157004958|NCT03086369|566768540|FG003|Overall Study|Withdrawal by Subject|5|||
157004959|NCT03086369|566768541|FG004|Overall Study|Withdrawal by Subject|3|||
157004960|NCT03086369|566768537|FG000|Overall Study|Progressive Disease|0|||
157004961|NCT03086369|566768538|FG001|Overall Study|Progressive Disease|0|||
157004962|NCT03086369|566768539|FG002|Overall Study|Progressive Disease|0|||
157004963|NCT03086369|566768540|FG003|Overall Study|Progressive Disease|1|||
157004964|NCT03086369|566768541|FG004|Overall Study|Progressive Disease|1|||
157004965|NCT00941655|566768548|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
157004966|NCT00941655|566768549|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
157004967|NCT00941655|566768548|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
156762102|NCT00810199|565879955|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
156762103|NCT00810199|565879954|FG000|Overall Study|Administrative/Other|5|||
156762104|NCT00810199|565879955|FG001|Overall Study|Administrative/Other|6|||
156762105|NCT00810199|565879954|FG000|Overall Study|Protocol Violation|2|||
156762106|NCT00810199|565879955|FG001|Overall Study|Protocol Violation|6|||
156762107|NCT00810199|565879954|FG000|Overall Study|Failure to return|1|||
156762108|NCT00810199|565879955|FG001|Overall Study|Failure to return|4|||
156762109|NCT00810199|565879954|FG000|Overall Study|Did not receive study drug|2|||
156762110|NCT00810199|565879955|FG001|Overall Study|Did not receive study drug|1|||
156762111|NCT00992017|565879957|FG000|Overall Study|Lost to Follow-up|2|||
156762112|NCT00992017|565879957|FG000|Overall Study|Withdrawal by Subject|2|||
156762113|NCT00992017|565879957|FG000|Overall Study|Unable to get to clinic|5|||
156762114|NCT00992017|565879957|FG000|Overall Study|Not adhere to study requirements|1|||
157110081|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
157110082|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Death|0|||
157110083|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Death|25|||
156762115|NCT02864407|565879958|FG000|Overall Study|Protocol Violation|3|||
156762116|NCT02864407|565879958|FG000|Overall Study|Lost to Follow-up|115|||
157110084|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Death|13|||
157110085|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Death|4|||
157110086|NCT02752035|567157179|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
157110087|NCT02752035|567157180|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
157110088|NCT02752035|567157181|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
157110089|NCT02752035|567157182|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
157110090|NCT02752035|567157179|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
157110091|NCT02752035|567157180|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
157110092|NCT02752035|567157181|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
156762117|NCT02864407|565879958|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
156762118|NCT02864407|565879958|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
156762119|NCT02864407|565879958|FG000|Overall Study|Consent prior to the contract date|1|||
156762120|NCT02686164|565879966|FG000|Overall Study|Adverse Event|1|||
156762121|NCT02686164|565879966|FG000|Overall Study|Withdrawal of consent|1|||
156762122|NCT02686164|565879966|FG000|Overall Study|Clinical progression|1|||
156762123|NCT01691378|565879967|FG000|Overall Study|Withdrawal by Subject|2|||
156762124|NCT01691378|565879968|FG001|Overall Study|Withdrawal by Subject|0|||
156762125|NCT01691378|565879967|FG000|Overall Study|Lost to Follow-up|5|||
156762126|NCT01691378|565879968|FG001|Overall Study|Lost to Follow-up|2|||
156762127|NCT01827592|565879971|FG000|Overall Study|Adverse Event|11|||
156762128|NCT01827592|565879972|FG001|Overall Study|Adverse Event|9|||
156762129|NCT01827592|565879973|FG002|Overall Study|Adverse Event|2|||
156762130|NCT01827592|565879971|FG000|Overall Study|Physician Decision|0|||
156762131|NCT01827592|565879972|FG001|Overall Study|Physician Decision|2|||
156762132|NCT01827592|565879973|FG002|Overall Study|Physician Decision|1|||
157110093|NCT02752035|567157182|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
157110094|NCT02752035|567157179|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
157110095|NCT02752035|567157180|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
157110096|NCT02752035|567157181|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
157110097|NCT02752035|567157182|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
157110098|NCT02752035|567157179|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
157110099|NCT02752035|567157180|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
157110100|NCT02752035|567157181|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
157110101|NCT02752035|567157182|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
157110102|NCT02752035|567157179|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
157110103|NCT02752035|567157180|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
157110104|NCT02752035|567157181|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
157110105|NCT02752035|567157182|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
157110106|NCT03668600|567157183|FG000|Overall Study|Study Terminated by the Sponsor|157|||
157110107|NCT03668600|567157183|FG000|Overall Study|Protocol Violation|1|||
157110108|NCT03668600|567157183|FG000|Overall Study|Pregnancy|1|||
157110109|NCT03668600|567157183|FG000|Overall Study|Lost to Follow-up|7|||
157110110|NCT03668600|567157183|FG000|Overall Study|Withdrawal by Subject|56|||
157110111|NCT03668600|567157183|FG000|Overall Study|Lack of Efficacy|7|||
157110112|NCT03668600|567157183|FG000|Overall Study|Adverse Event|1|||
157110113|NCT00424749|567157185|FG000|Overall Study|Withdrawal by Subject|1|||
157110114|NCT05500274|567157191|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
157110115|NCT05500274|567157192|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
157110116|NCT05500274|567157191|FG000|Overall Study|Lost to Follow-up|76|||
157110117|NCT05500274|567157192|FG001|Overall Study|Lost to Follow-up|51|||
156762133|NCT01827592|565879971|FG000|Overall Study|Protocol Violation|2|||
156762134|NCT01827592|565879972|FG001|Overall Study|Protocol Violation|1|||
157110118|NCT05807464|567157195|FG000|Overall Study|Adverse Event|1|||
157110119|NCT01555151|567157196|FG000|Overall Study|Withdrawal by Subject|6|||
157110120|NCT01555151|567157197|FG001|Overall Study|Withdrawal by Subject|2|||
157110121|NCT01555151|567157198|FG002|Overall Study|Withdrawal by Subject|0|||
157110122|NCT01555151|567157199|FG003|Overall Study|Withdrawal by Subject|2|||
157110123|NCT01555151|567157196|FG000|Overall Study|Administrative|3|||
157110124|NCT01555151|567157197|FG001|Overall Study|Administrative|1|||
157110125|NCT01555151|567157198|FG002|Overall Study|Administrative|2|||
157110126|NCT01555151|567157199|FG003|Overall Study|Administrative|0|||
157110127|NCT01555151|567157196|FG000|Overall Study|Protocol Violation|3|||
157110128|NCT01555151|567157197|FG001|Overall Study|Protocol Violation|3|||
157110129|NCT01555151|567157198|FG002|Overall Study|Protocol Violation|3|||
157110130|NCT01555151|567157199|FG003|Overall Study|Protocol Violation|5|||
157110131|NCT01555151|567157196|FG000|Overall Study|Adverse Event|1|||
157110132|NCT01555151|567157197|FG001|Overall Study|Adverse Event|2|||
157110133|NCT01555151|567157198|FG002|Overall Study|Adverse Event|1|||
157110134|NCT01555151|567157199|FG003|Overall Study|Adverse Event|2|||
157110135|NCT01555151|567157196|FG000|Overall Study|Lost to Follow-up|0|||
157110136|NCT01555151|567157197|FG001|Overall Study|Lost to Follow-up|0|||
157110137|NCT01555151|567157198|FG002|Overall Study|Lost to Follow-up|0|||
157110138|NCT01555151|567157199|FG003|Overall Study|Lost to Follow-up|1|||
157110139|NCT03596866|567157200|FG000|Overall Study|Site terminated by Sponsor|64|||
157110140|NCT03596866|567157201|FG001|Overall Study|Site terminated by Sponsor|65|||
157110141|NCT03596866|567157200|FG000|Overall Study|Death|37|||
157110142|NCT03596866|567157201|FG001|Overall Study|Death|24|||
157110143|NCT03596866|567157200|FG000|Overall Study|Withdrawal by Subject|4|||
157110144|NCT03596866|567157201|FG001|Overall Study|Withdrawal by Subject|6|||
157110145|NCT03596866|567157200|FG000|Overall Study|Missing|0|||
157110146|NCT03596866|567157201|FG001|Overall Study|Missing|6|||
157110147|NCT03596866|567157200|FG000|Overall Study|Lost to Follow-up|2|||
156762135|NCT01827592|565879973|FG002|Overall Study|Protocol Violation|0|||
157110148|NCT03596866|567157201|FG001|Overall Study|Lost to Follow-up|3|||
157110149|NCT03596866|567157200|FG000|Overall Study|Protocol Violation|1|||
157110150|NCT03596866|567157201|FG001|Overall Study|Protocol Violation|0|||
157110151|NCT03596866|567157200|FG000|Overall Study|Reason Not Specified|14|||
157110152|NCT03596866|567157201|FG001|Overall Study|Reason Not Specified|13|||
157110153|NCT02343159|567157203|FG000|Overall Study|Early Study Termination|16|||
157110154|NCT02343159|567157204|FG001|Overall Study|Early Study Termination|19|||
157110155|NCT02343159|567157205|FG002|Overall Study|Early Study Termination|23|||
157110156|NCT02343159|567157203|FG000|Overall Study|Physician Decision|2|||
157110157|NCT02343159|567157204|FG001|Overall Study|Physician Decision|0|||
157110158|NCT02343159|567157205|FG002|Overall Study|Physician Decision|1|||
157110159|NCT02343159|567157203|FG000|Overall Study|Withdrawal by Subject|3|||
157110160|NCT02343159|567157204|FG001|Overall Study|Withdrawal by Subject|0|||
157110161|NCT02343159|567157205|FG002|Overall Study|Withdrawal by Subject|2|||
157110162|NCT02343159|567157203|FG000|Overall Study|Lost to Follow-up|0|||
156762136|NCT01827592|565879971|FG000|Overall Study|Lost to Follow-up|1|||
156762137|NCT01827592|565879972|FG001|Overall Study|Lost to Follow-up|2|||
156762138|NCT01827592|565879973|FG002|Overall Study|Lost to Follow-up|2|||
156762139|NCT01827592|565879971|FG000|Overall Study|Withdrawal by Subject|12|||
156762140|NCT01827592|565879972|FG001|Overall Study|Withdrawal by Subject|11|||
156762141|NCT01827592|565879973|FG002|Overall Study|Withdrawal by Subject|11|||
156762142|NCT01827592|565879971|FG000|Overall Study|Patient's substantial non-compliance|1|||
156762143|NCT01827592|565879972|FG001|Overall Study|Patient's substantial non-compliance|1|||
156762144|NCT01827592|565879973|FG002|Overall Study|Patient's substantial non-compliance|6|||
156762145|NCT01827592|565879971|FG000|Overall Study|Trial terminated by Sponsor|47|||
156762146|NCT01827592|565879972|FG001|Overall Study|Trial terminated by Sponsor|53|||
156762147|NCT01827592|565879973|FG002|Overall Study|Trial terminated by Sponsor|51|||
156762148|NCT01827592|565879971|FG000|Overall Study|Others|0|||
156762149|NCT01827592|565879972|FG001|Overall Study|Others|1|||
156762150|NCT01827592|565879973|FG002|Overall Study|Others|3|||
156762151|NCT04888494|565879979|FG000|Overall Study|Lost to Follow-up|2|||
156762152|NCT04888494|565879980|FG001|Overall Study|Lost to Follow-up|3|||
156762153|NCT04888494|565879979|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
156762154|NCT04888494|565879980|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
156762155|NCT02357459|565882412|FG000|Overall Study|Adverse Event|0|||
156762156|NCT02357459|565882413|FG001|Overall Study|Adverse Event|1|||
156762157|NCT02357459|565882414|FG002|Overall Study|Adverse Event|1|||
156762158|NCT02357459|565882412|FG000|Overall Study|Withdrawal by Subject|5|||
157110163|NCT02343159|567157204|FG001|Overall Study|Lost to Follow-up|2|||
157110164|NCT02343159|567157205|FG002|Overall Study|Lost to Follow-up|2|||
157110165|NCT02343159|567157203|FG000|Overall Study|Adverse Event|4|||
157110166|NCT02343159|567157204|FG001|Overall Study|Adverse Event|4|||
157110167|NCT02343159|567157205|FG002|Overall Study|Adverse Event|2|||
157110168|NCT02343159|567157203|FG000|Overall Study|Sponsor Decision|0|||
157110169|NCT02343159|567157204|FG001|Overall Study|Sponsor Decision|1|||
157110170|NCT02343159|567157205|FG002|Overall Study|Sponsor Decision|0|||
157110171|NCT02343159|567157203|FG000|Overall Study|Enrollment Error|1|||
157110172|NCT02343159|567157204|FG001|Overall Study|Enrollment Error|0|||
157110173|NCT02343159|567157205|FG002|Overall Study|Enrollment Error|0|||
157110174|NCT02114268|567157208|FG000|Overall Study|Lost to Follow-up|4|||
156762159|NCT02357459|565882413|FG001|Overall Study|Withdrawal by Subject|3|||
156762160|NCT02357459|565882414|FG002|Overall Study|Withdrawal by Subject|3|||
156762161|NCT02357459|565882412|FG000|Overall Study|Physician Decision|0|||
156762162|NCT02357459|565882413|FG001|Overall Study|Physician Decision|2|||
156762163|NCT02357459|565882414|FG002|Overall Study|Physician Decision|0|||
156762164|NCT02357459|565882412|FG000|Overall Study|Protocol Violation|1|||
156762165|NCT02357459|565882413|FG001|Overall Study|Protocol Violation|1|||
156762166|NCT02357459|565882414|FG002|Overall Study|Protocol Violation|0|||
156762167|NCT02357459|565882412|FG000|Overall Study|Lost to Follow-up|1|||
156762168|NCT02357459|565882413|FG001|Overall Study|Lost to Follow-up|3|||
156762169|NCT02357459|565882414|FG002|Overall Study|Lost to Follow-up|0|||
156762170|NCT02357459|565882412|FG000|Overall Study|Lack of Efficacy|7|||
156762171|NCT02357459|565882413|FG001|Overall Study|Lack of Efficacy|4|||
156762172|NCT02357459|565882414|FG002|Overall Study|Lack of Efficacy|4|||
156762173|NCT02357459|565882412|FG000|Overall Study|Patient Relocated|2|||
156762174|NCT02357459|565882413|FG001|Overall Study|Patient Relocated|0|||
156762175|NCT02357459|565882414|FG002|Overall Study|Patient Relocated|0|||
156762176|NCT02357459|565882412|FG000|Overall Study|Instruction from PCP|1|||
156762177|NCT02357459|565882413|FG001|Overall Study|Instruction from PCP|0|||
156762178|NCT02357459|565882414|FG002|Overall Study|Instruction from PCP|0|||
156762179|NCT02357459|565882412|FG000|Overall Study|Incarceration|0|||
156762180|NCT02357459|565882413|FG001|Overall Study|Incarceration|0|||
156762181|NCT02357459|565882414|FG002|Overall Study|Incarceration|1|||
156762182|NCT02357459|565882412|FG000|Overall Study|Pre-planned Knee surgery|0|||
156762183|NCT02357459|565882413|FG001|Overall Study|Pre-planned Knee surgery|0|||
156762184|NCT02357459|565882414|FG002|Overall Study|Pre-planned Knee surgery|2|||
156762185|NCT02357459|565882412|FG000|Overall Study|Job Commitments|0|||
156762186|NCT02357459|565882413|FG001|Overall Study|Job Commitments|0|||
156762187|NCT02357459|565882414|FG002|Overall Study|Job Commitments|1|||
156762188|NCT03246347|565882415|FG000|Overall Study|On Study|23|||
156762189|NCT02188160|565882416|FG000|Overall Study|Adverse Event|1|||
156762190|NCT02188160|565882417|FG001|Overall Study|Adverse Event|0|||
156762191|NCT02188160|565882416|FG000|Overall Study|Use of an excluded medication|0|||
156762192|NCT02188160|565882417|FG001|Overall Study|Use of an excluded medication|1|||
156762193|NCT04113694|565882418|FG000|Overall Study|Adverse Event|2|||
156762194|NCT04113694|565882418|FG000|Overall Study|Lost to Follow-up|2|||
156762195|NCT04113694|565882418|FG000|Overall Study|Withdrawal by Subject|6|||
156762196|NCT04113694|565882418|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
156762197|NCT05630196|565882421|FG000|Overall Study|Adverse Event|2|||
156762198|NCT05630196|565882422|FG001|Overall Study|Adverse Event|1|||
156762199|NCT05630196|565882421|FG000|Overall Study|Lost to Follow-up|1|||
156762200|NCT05630196|565882422|FG001|Overall Study|Lost to Follow-up|1|||
156762201|NCT05630196|565882421|FG000|Overall Study|Protocol Violation|2|||
156762202|NCT05630196|565882422|FG001|Overall Study|Protocol Violation|3|||
156762203|NCT05630196|565882421|FG000|Overall Study|Physician Decision|1|||
156762204|NCT05630196|565882422|FG001|Overall Study|Physician Decision|0|||
156762205|NCT05630196|565882421|FG000|Overall Study|Withdrawal by Subject|3|||
156762206|NCT05630196|565882422|FG001|Overall Study|Withdrawal by Subject|4|||
156762207|NCT00916578|565882423|FG000|Overall Study|Physician Decision|2|||
156762208|NCT00916578|565882423|FG000|Overall Study|Withdrawal by Subject|3|||
156762209|NCT00916578|565882423|FG000|Overall Study|Insurance Denial|2|||
156762210|NCT01022203|565882429|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
156762211|NCT01022203|565882430|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
156762212|NCT01022203|565882429|FG000|Post Treatment Assessment|Physician Decision|2|||
156762213|NCT01022203|565882430|FG001|Post Treatment Assessment|Physician Decision|0|||
156762214|NCT01022203|565882429|FG000|Post Treatment Assessment|Adverse Event|0|||
156762215|NCT01022203|565882430|FG001|Post Treatment Assessment|Adverse Event|2|||
156762216|NCT01022203|565882429|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
156762217|NCT01022203|565882430|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
156762218|NCT03163446|565882433|FG000|Overall Study|Unable to return for Day 180 visit|2|||
156762219|NCT03163446|565882434|FG001|Overall Study|Unable to return for Day 180 visit|0|||
156762220|NCT03163446|565882433|FG000|Overall Study|Withdrawal by Subject|2|||
156762221|NCT03163446|565882434|FG001|Overall Study|Withdrawal by Subject|6|||
156762222|NCT03163446|565882433|FG000|Overall Study|Death|16|||
156762223|NCT03163446|565882434|FG001|Overall Study|Death|5|||
156762224|NCT03163446|565882433|FG000|Overall Study|Lost to Follow-up|6|||
156762225|NCT03163446|565882434|FG001|Overall Study|Lost to Follow-up|5|||
156762226|NCT03163446|565882433|FG000|Overall Study|Physician Decision|1|||
156762227|NCT03163446|565882434|FG001|Overall Study|Physician Decision|1|||
156762228|NCT03163446|565882433|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
156762229|NCT03163446|565882434|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
156762230|NCT00903201|565882435|FG000|Overall Study|Adverse Event|1|||
156762231|NCT00903201|565882436|FG001|Overall Study|Adverse Event|4|||
156762232|NCT00903201|565882437|FG002|Overall Study|Adverse Event|0|||
156762233|NCT00903201|565882435|FG000|Overall Study|Protocol Violation|2|||
156762234|NCT00903201|565882436|FG001|Overall Study|Protocol Violation|1|||
156762235|NCT00903201|565882437|FG002|Overall Study|Protocol Violation|0|||
156762236|NCT00903201|565882435|FG000|Overall Study|Lost to Follow-up|0|||
156762237|NCT00903201|565882436|FG001|Overall Study|Lost to Follow-up|1|||
156762238|NCT00903201|565882437|FG002|Overall Study|Lost to Follow-up|0|||
156762239|NCT00903201|565882435|FG000|Overall Study|Physician Decision|1|||
156762240|NCT00903201|565882436|FG001|Overall Study|Physician Decision|0|||
156762241|NCT00903201|565882437|FG002|Overall Study|Physician Decision|1|||
156762242|NCT00903201|565882435|FG000|Overall Study|Withdrawal by Subject|1|||
156762243|NCT00903201|565882436|FG001|Overall Study|Withdrawal by Subject|0|||
156762244|NCT00903201|565882437|FG002|Overall Study|Withdrawal by Subject|1|||
156762245|NCT01094288|565882440|FG000|Overall Study|Adverse Event|0|||
156762246|NCT01094288|565882441|FG001|Overall Study|Adverse Event|3|||
156762247|NCT01094288|565882442|FG002|Overall Study|Adverse Event|1|||
156762248|NCT01094288|565882443|FG003|Overall Study|Adverse Event|1|||
156762249|NCT01094288|565882444|FG004|Overall Study|Adverse Event|0|||
156762250|NCT01094288|565882445|FG005|Overall Study|Adverse Event|0|||
156762251|NCT01094288|565882446|FG006|Overall Study|Adverse Event|0|||
156762252|NCT01094288|565882447|FG007|Overall Study|Adverse Event|0|||
156762253|NCT01094288|565882440|FG000|Overall Study|Withdrawal by Subject|0|||
156762254|NCT01094288|565882441|FG001|Overall Study|Withdrawal by Subject|1|||
156762255|NCT01094288|565882442|FG002|Overall Study|Withdrawal by Subject|2|||
156762256|NCT01094288|565882443|FG003|Overall Study|Withdrawal by Subject|0|||
156762257|NCT01094288|565882444|FG004|Overall Study|Withdrawal by Subject|0|||
156762258|NCT01094288|565882445|FG005|Overall Study|Withdrawal by Subject|0|||
156762259|NCT01094288|565882446|FG006|Overall Study|Withdrawal by Subject|0|||
156762260|NCT01094288|565882447|FG007|Overall Study|Withdrawal by Subject|2|||
156762261|NCT01094288|565882440|FG000|Overall Study|Initiation of Alternative Therapy|0|||
156762262|NCT01094288|565882441|FG001|Overall Study|Initiation of Alternative Therapy|0|||
156762263|NCT01094288|565882442|FG002|Overall Study|Initiation of Alternative Therapy|1|||
156762264|NCT01094288|565882443|FG003|Overall Study|Initiation of Alternative Therapy|0|||
156762265|NCT01094288|565882444|FG004|Overall Study|Initiation of Alternative Therapy|0|||
156762266|NCT01094288|565882445|FG005|Overall Study|Initiation of Alternative Therapy|0|||
156762267|NCT01094288|565882446|FG006|Overall Study|Initiation of Alternative Therapy|0|||
156762268|NCT01094288|565882447|FG007|Overall Study|Initiation of Alternative Therapy|0|||
156762269|NCT01094288|565882440|FG000|Overall Study|Reason not Specified|2|||
156762270|NCT01094288|565882441|FG001|Overall Study|Reason not Specified|3|||
156762271|NCT01094288|565882442|FG002|Overall Study|Reason not Specified|0|||
156762272|NCT01094288|565882443|FG003|Overall Study|Reason not Specified|1|||
156762273|NCT01094288|565882444|FG004|Overall Study|Reason not Specified|0|||
156762274|NCT01094288|565882445|FG005|Overall Study|Reason not Specified|0|||
156762275|NCT01094288|565882446|FG006|Overall Study|Reason not Specified|0|||
156762276|NCT01094288|565882447|FG007|Overall Study|Reason not Specified|0|||
156762277|NCT01094288|565882440|FG000|Overall Study|Ongoing Participants|0|||
156762278|NCT01094288|565882441|FG001|Overall Study|Ongoing Participants|3|||
156762279|NCT01094288|565882442|FG002|Overall Study|Ongoing Participants|0|||
156762280|NCT01094288|565882443|FG003|Overall Study|Ongoing Participants|0|||
156762281|NCT01094288|565882444|FG004|Overall Study|Ongoing Participants|0|||
156762282|NCT01094288|565882445|FG005|Overall Study|Ongoing Participants|0|||
156762283|NCT01094288|565882446|FG006|Overall Study|Ongoing Participants|0|||
156762284|NCT01094288|565882447|FG007|Overall Study|Ongoing Participants|0|||
156762285|NCT02611882|565882448|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
156762286|NCT02611882|565882449|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
156762287|NCT02611882|565882450|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
156762288|NCT01228591|565882451|FG000|Baseline|Lack of Efficacy|1|||
156762289|NCT01228591|565882452|FG001|Baseline|Lack of Efficacy|2|||
156762290|NCT01389232|565882453|FG000|Overall Study|Had scaffold removed|15|||
156762291|NCT01389232|565882453|FG000|Overall Study|Personal reasons|2|||
156762292|NCT01389232|565882453|FG000|Overall Study|Adverse Event|1|||
156762293|NCT01389232|565882453|FG000|Overall Study|Death|1|||
156762294|NCT01317940|565882454|FG000|Overall Study|Death|1|||
156762295|NCT01317940|565882455|FG001|Overall Study|Death|0|||
156762296|NCT01317940|565882456|FG002|Overall Study|Death|1|||
156762297|NCT01317940|565882457|FG003|Overall Study|Death|0|||
156762298|NCT01317940|565882458|FG004|Overall Study|Death|0|||
156762299|NCT01317940|565882459|FG005|Overall Study|Death|0|||
156762300|NCT01317940|565882454|FG000|Overall Study|Lost to Follow-up|0|||
156762301|NCT01317940|565882455|FG001|Overall Study|Lost to Follow-up|0|||
156762302|NCT01317940|565882456|FG002|Overall Study|Lost to Follow-up|1|||
156762303|NCT01317940|565882457|FG003|Overall Study|Lost to Follow-up|1|||
156762304|NCT01317940|565882458|FG004|Overall Study|Lost to Follow-up|1|||
156762305|NCT01317940|565882459|FG005|Overall Study|Lost to Follow-up|0|||
156762306|NCT01317940|565882454|FG000|Overall Study|Change in therapy plan|0|||
156762307|NCT01317940|565882455|FG001|Overall Study|Change in therapy plan|0|||
156762308|NCT01317940|565882456|FG002|Overall Study|Change in therapy plan|3|||
156762309|NCT01317940|565882457|FG003|Overall Study|Change in therapy plan|0|||
156762310|NCT01317940|565882458|FG004|Overall Study|Change in therapy plan|0|||
156762311|NCT01317940|565882459|FG005|Overall Study|Change in therapy plan|0|||
157110175|NCT02114268|567157209|FG001|Overall Study|Lost to Follow-up|1|||
157110176|NCT02114268|567157210|FG002|Overall Study|Lost to Follow-up|1|||
157110177|NCT02114268|567157211|FG003|Overall Study|Lost to Follow-up|0|||
157110178|NCT02114268|567157212|FG004|Overall Study|Lost to Follow-up|0|||
157110179|NCT02114268|567157213|FG005|Overall Study|Lost to Follow-up|2|||
157110180|NCT02114268|567157208|FG000|Overall Study|Withdrawal by Subject|1|||
157110181|NCT02114268|567157209|FG001|Overall Study|Withdrawal by Subject|0|||
157110182|NCT02114268|567157210|FG002|Overall Study|Withdrawal by Subject|0|||
157110183|NCT02114268|567157211|FG003|Overall Study|Withdrawal by Subject|0|||
157110184|NCT02114268|567157212|FG004|Overall Study|Withdrawal by Subject|0|||
157110185|NCT02114268|567157213|FG005|Overall Study|Withdrawal by Subject|1|||
157110186|NCT02114268|567157208|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
157110187|NCT02114268|567157209|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
157110188|NCT02114268|567157210|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
157110189|NCT02114268|567157211|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
157110190|NCT02114268|567157212|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
157110191|NCT02114268|567157213|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
157110192|NCT01431274|567157218|FG000|Overall Study|Adverse Event|51|||
157110193|NCT01431274|567157219|FG001|Overall Study|Adverse Event|37|||
157110194|NCT01431274|567157220|FG002|Overall Study|Adverse Event|43|||
157110195|NCT01431274|567157221|FG003|Overall Study|Adverse Event|30|||
157110196|NCT01431274|567157222|FG004|Overall Study|Adverse Event|37|||
157110197|NCT01431274|567157218|FG000|Overall Study|Consent withdrawn not due to AE|29|||
157110198|NCT01431274|567157219|FG001|Overall Study|Consent withdrawn not due to AE|20|||
157110199|NCT01431274|567157220|FG002|Overall Study|Consent withdrawn not due to AE|17|||
157110200|NCT01431274|567157221|FG003|Overall Study|Consent withdrawn not due to AE|20|||
157110201|NCT01431274|567157222|FG004|Overall Study|Consent withdrawn not due to AE|11|||
157110202|NCT01431274|567157218|FG000|Overall Study|Non compliant with protocol|5|||
157110203|NCT01431274|567157219|FG001|Overall Study|Non compliant with protocol|8|||
157110204|NCT01431274|567157220|FG002|Overall Study|Non compliant with protocol|4|||
157110205|NCT01431274|567157221|FG003|Overall Study|Non compliant with protocol|4|||
157110206|NCT01431274|567157222|FG004|Overall Study|Non compliant with protocol|4|||
157110207|NCT01431274|567157218|FG000|Overall Study|Lost to Follow-up|6|||
157110208|NCT01431274|567157219|FG001|Overall Study|Lost to Follow-up|7|||
157110209|NCT01431274|567157220|FG002|Overall Study|Lost to Follow-up|1|||
157110210|NCT01431274|567157221|FG003|Overall Study|Lost to Follow-up|4|||
157110211|NCT01431274|567157222|FG004|Overall Study|Lost to Follow-up|0|||
157110212|NCT01431274|567157218|FG000|Overall Study|Other reason not stated above|6|||
157110213|NCT01431274|567157219|FG001|Overall Study|Other reason not stated above|5|||
157110214|NCT01431274|567157220|FG002|Overall Study|Other reason not stated above|7|||
157110215|NCT01431274|567157221|FG003|Overall Study|Other reason not stated above|2|||
157110216|NCT01431274|567157222|FG004|Overall Study|Other reason not stated above|4|||
157110217|NCT02790138|567157223|FG000|Overall Study|Adverse Event|5|||
157110218|NCT02790138|567157224|FG001|Overall Study|Adverse Event|2|||
157110219|NCT02790138|567157223|FG000|Overall Study|Significant Protocol Deviation|0|||
157110220|NCT02790138|567157224|FG001|Overall Study|Significant Protocol Deviation|1|||
157110221|NCT02790138|567157223|FG000|Overall Study|Lost to Follow-up|1|||
157110222|NCT02790138|567157224|FG001|Overall Study|Lost to Follow-up|0|||
157110223|NCT02790138|567157223|FG000|Overall Study|Voluntary Withdrawal|8|||
157110224|NCT02790138|567157224|FG001|Overall Study|Voluntary Withdrawal|9|||
157110225|NCT02790138|567157223|FG000|Overall Study|Lack of Efficacy|6|||
157110226|NCT02790138|567157224|FG001|Overall Study|Lack of Efficacy|7|||
157110227|NCT02790138|567157223|FG000|Overall Study|Reason not Specified|1|||
157110228|NCT02790138|567157224|FG001|Overall Study|Reason not Specified|0|||
157004968|NCT00941655|566768549|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
157004969|NCT00941655|566768548|FG000|Overall Study|progressed while on chemo|0|||
157004970|NCT00941655|566768549|FG001|Overall Study|progressed while on chemo|2|||
157004971|NCT00941655|566768548|FG000|Overall Study|refused further treatment|0|||
157004972|NCT00941655|566768549|FG001|Overall Study|refused further treatment|1|||
157004973|NCT00941655|566768548|FG000|Overall Study|withdrew consent|0|||
157004974|NCT00941655|566768549|FG001|Overall Study|withdrew consent|1|||
157004975|NCT00941655|566768548|FG000|Overall Study|non-compliant|0|||
157004976|NCT00941655|566768549|FG001|Overall Study|non-compliant|1|||
157004977|NCT03262935|566768550|FG000|Overall Study|Withdrawal by Subject|6|||
157110229|NCT04037748|567157225|FG000|Treatment Period 1|Withdrawal by Subject|3|||
157110230|NCT04037748|567157226|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157110231|NCT04037748|567157225|FG000|Treatment Period 1|Adverse Event|1|||
157110232|NCT04037748|567157226|FG001|Treatment Period 1|Adverse Event|1|||
157110233|NCT04037748|567157225|FG000|Treatment Period 1|Protocol Violation|4|||
157110234|NCT04037748|567157226|FG001|Treatment Period 1|Protocol Violation|5|||
157004978|NCT03262935|566768551|FG001|Overall Study|Withdrawal by Subject|7|||
157110235|NCT04037748|567157225|FG000|Treatment Period 2|Adverse Event|0|||
157110236|NCT04037748|567157226|FG001|Treatment Period 2|Adverse Event|1|||
157110237|NCT04037748|567157225|FG000|Treatment Period 2|Protocol Violation|2|||
157110238|NCT04037748|567157226|FG001|Treatment Period 2|Protocol Violation|0|||
157110239|NCT00555477|567157229|FG000|Overall Study|Adverse Event|0|||
157110240|NCT00555477|567157230|FG001|Overall Study|Adverse Event|9|||
157110241|NCT00555477|567157229|FG000|Overall Study|Withdrawal by Subject|1|||
157110242|NCT00555477|567157230|FG001|Overall Study|Withdrawal by Subject|2|||
156762312|NCT00945243|565882461|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
156762313|NCT03256578|565882462|FG000|Overall Study|Excluded Post Randomization|66|||
156762314|NCT03256578|565882463|FG001|Overall Study|Excluded Post Randomization|56|||
156762315|NCT02371616|565882464|FG000|Overall Study|Protocol Violation|2|||
156762316|NCT02371616|565882465|FG001|Overall Study|Protocol Violation|1|||
156762317|NCT02371616|565882464|FG000|Overall Study|Adverse Event|0|||
156762318|NCT02371616|565882465|FG001|Overall Study|Adverse Event|1|||
156762319|NCT02371616|565882464|FG000|Overall Study|Withdrawal of Consent|1|||
156762320|NCT02371616|565882465|FG001|Overall Study|Withdrawal of Consent|0|||
156762321|NCT02371616|565882464|FG000|Overall Study|Other (Not specified)|1|||
157110243|NCT00555477|567157229|FG000|Overall Study|Physician Decision|1|||
157110244|NCT00555477|567157230|FG001|Overall Study|Physician Decision|2|||
157110245|NCT00397033|567157231|FG000|Overall Study|Adverse Event|7|||
157110246|NCT00397033|567157232|FG001|Overall Study|Adverse Event|10|||
157110247|NCT00397033|567157233|FG002|Overall Study|Adverse Event|4|||
157110248|NCT00397033|567157231|FG000|Overall Study|Lack of Efficacy|22|||
157110249|NCT00397033|567157232|FG001|Overall Study|Lack of Efficacy|12|||
157110250|NCT00397033|567157233|FG002|Overall Study|Lack of Efficacy|9|||
157110251|NCT00397033|567157231|FG000|Overall Study|Lost to Follow-up|3|||
157110252|NCT00397033|567157232|FG001|Overall Study|Lost to Follow-up|3|||
157110253|NCT00397033|567157233|FG002|Overall Study|Lost to Follow-up|3|||
157110254|NCT00397033|567157231|FG000|Overall Study|Withdrawal by Subject|12|||
157110255|NCT00397033|567157232|FG001|Overall Study|Withdrawal by Subject|7|||
157110256|NCT00397033|567157233|FG002|Overall Study|Withdrawal by Subject|5|||
157110257|NCT00397033|567157231|FG000|Overall Study|Other|0|||
157110258|NCT00397033|567157232|FG001|Overall Study|Other|5|||
157110259|NCT00397033|567157233|FG002|Overall Study|Other|2|||
157110260|NCT04702737|567157234|FG000|Overall Study|Decision by Sponsor|1|||
157110261|NCT04702737|567157234|FG000|Overall Study|Withdrawal of Consent from Study|3|||
157110262|NCT04702737|567157234|FG000|Overall Study|Lost to Follow-up|1|||
157110263|NCT04702737|567157234|FG000|Overall Study|Death|35|||
157110264|NCT02047253|567157235|FG000|Overall Study|Lost to Follow-up|8|||
157110265|NCT03472924|567157237|FG000|Overall Study|Adverse Event|1|||
157110266|NCT03472924|567157238|FG001|Overall Study|Adverse Event|0|||
157110267|NCT00807742|567157245|FG000|Overall Study|Death|9|||
157110268|NCT00807742|567157246|FG001|Overall Study|Death|2|||
157110269|NCT00807742|567157245|FG000|Overall Study|Withdrawal by Subject|2|||
157110270|NCT00807742|567157246|FG001|Overall Study|Withdrawal by Subject|1|||
157110271|NCT00807742|567157245|FG000|Overall Study|Lost to Follow-up|35|||
157110272|NCT00807742|567157246|FG001|Overall Study|Lost to Follow-up|51|||
157110273|NCT04814823|567157248|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
157110274|NCT05318937|567157249|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157110275|NCT05318937|567157250|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157110276|NCT05318937|567157249|FG000|Overall Study|Lost to Follow-up|0|||
157110277|NCT05318937|567157250|FG001|Overall Study|Lost to Follow-up|1|||
157110278|NCT05318937|567157249|FG000|Overall Study|Withdrawal by Subject|0|||
157110279|NCT05318937|567157250|FG001|Overall Study|Withdrawal by Subject|2|||
157110280|NCT05318937|567157249|FG000|Overall Study|Protocol Violation|0|||
157110281|NCT05318937|567157250|FG001|Overall Study|Protocol Violation|1|||
157110282|NCT01877915|567157251|FG000|Overall Study|Lost to Follow-up|10|||
157110283|NCT01877915|567157252|FG001|Overall Study|Lost to Follow-up|9|||
157110284|NCT01877915|567157251|FG000|Overall Study|Withdrawal by Subject|42|||
157110285|NCT01877915|567157252|FG001|Overall Study|Withdrawal by Subject|55|||
157110286|NCT01877915|567157251|FG000|Overall Study|Other|2|||
156762322|NCT02371616|565882465|FG001|Overall Study|Other (Not specified)|5|||
156762323|NCT02699996|565882468|FG000|Overall Study|Withdrawal by Subject|5|||
156762324|NCT02699996|565882469|FG001|Overall Study|Withdrawal by Subject|2|||
157110287|NCT01877915|567157252|FG001|Overall Study|Other|4|||
157110288|NCT05678257|567157257|FG000|Overall Study|Withdrawal by Subject|2|||
157110289|NCT05678257|567157258|FG001|Overall Study|Withdrawal by Subject|0|||
157110290|NCT05678257|567157259|FG002|Overall Study|Withdrawal by Subject|5|||
157110291|NCT05678257|567157257|FG000|Overall Study|Physician Decision|1|||
156762325|NCT03205150|565882470|FG000|Overall Study|Protocol deviation|1|||
157110292|NCT05678257|567157258|FG001|Overall Study|Physician Decision|0|||
157110293|NCT05678257|567157259|FG002|Overall Study|Physician Decision|1|||
157110294|NCT05678257|567157257|FG000|Overall Study|Adverse Event|1|||
156762326|NCT03205150|565882471|FG001|Overall Study|Protocol deviation|3|||
156762327|NCT03205150|565882472|FG002|Overall Study|Protocol deviation|0|||
156762328|NCT03205150|565882470|FG000|Overall Study|Patient/guardian decision|0|||
157110295|NCT05678257|567157258|FG001|Overall Study|Adverse Event|3|||
157110296|NCT05678257|567157259|FG002|Overall Study|Adverse Event|1|||
157110297|NCT05678257|567157257|FG000|Overall Study|Progressive disease|11|||
157110298|NCT05678257|567157258|FG001|Overall Study|Progressive disease|18|||
157110299|NCT05678257|567157259|FG002|Overall Study|Progressive disease|7|||
157110300|NCT05678257|567157257|FG000|Overall Study|No longer clinically benefitting|2|||
156762329|NCT03205150|565882471|FG001|Overall Study|Patient/guardian decision|3|||
157004979|NCT03262935|566768550|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
157004980|NCT03262935|566768551|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
157004981|NCT03262935|566768550|FG000|Overall Study|Death|181|||
157004982|NCT03262935|566768551|FG001|Overall Study|Death|94|||
157004983|NCT03262935|566768550|FG000|Overall Study|Lost to Follow-up|9|||
157004984|NCT03262935|566768551|FG001|Overall Study|Lost to Follow-up|4|||
157004985|NCT03262935|566768550|FG000|Overall Study|Other reason|5|||
157004986|NCT03262935|566768551|FG001|Overall Study|Other reason|0|||
157004987|NCT00419094|566768552|FG000|Overall Study|Adverse Event|3|||
157004988|NCT00419094|566768553|FG001|Overall Study|Adverse Event|7|||
157004989|NCT00419094|566768552|FG000|Overall Study|Lack of Efficacy|1|||
157004990|NCT00419094|566768553|FG001|Overall Study|Lack of Efficacy|0|||
157004991|NCT00419094|566768552|FG000|Overall Study|Lost to Follow-up|0|||
157004992|NCT00419094|566768553|FG001|Overall Study|Lost to Follow-up|2|||
157004993|NCT00419094|566768552|FG000|Overall Study|Protocol Violation|1|||
157004994|NCT00419094|566768553|FG001|Overall Study|Protocol Violation|14|||
157004995|NCT00419094|566768552|FG000|Overall Study|Withdrawal of consent|1|||
157004996|NCT00419094|566768553|FG001|Overall Study|Withdrawal of consent|5|||
157004997|NCT00419094|566768552|FG000|Overall Study|Other: Error determining exit criteria|1|||
157004998|NCT00419094|566768553|FG001|Overall Study|Other: Error determining exit criteria|0|||
157004999|NCT00419094|566768552|FG000|Overall Study|Other: Patient non-compliant|0|||
157005000|NCT00419094|566768553|FG001|Overall Study|Other: Patient non-compliant|1|||
157005001|NCT00419094|566768552|FG000|Overall Study|Other: No contact for extended period|0|||
157005002|NCT00419094|566768553|FG001|Overall Study|Other: No contact for extended period|1|||
157005003|NCT03557008|566768554|FG000|Overall Study|Withdrawal by Subject|2|||
157005004|NCT03557008|566768555|FG001|Overall Study|Withdrawal by Subject|2|||
157005005|NCT03557008|566768554|FG000|Overall Study|Early termination from study|3|||
157005006|NCT03557008|566768555|FG001|Overall Study|Early termination from study|1|||
157005007|NCT01811706|566768556|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
157005008|NCT01811706|566768557|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
157005009|NCT00186186|566768560|FG000|Overall Study|Lack of Efficacy|3|||
157005010|NCT00186186|566768560|FG000|Overall Study|Withdrawal by Subject|3|||
157005011|NCT00186186|566768560|FG000|Overall Study|Not reported as to reason|2|||
157005012|NCT00807144|566768561|FG000|Overall Study|Lost to Follow-up|0|||
157005013|NCT00807144|566768562|FG001|Overall Study|Lost to Follow-up|1|||
157005014|NCT02057692|566768568|FG000|Overall Study|Adverse Event|1|||
157005015|NCT02057692|566768569|FG001|Overall Study|Adverse Event|0|||
157005016|NCT02057692|566768570|FG002|Overall Study|Adverse Event|0|||
157005017|NCT02057692|566768571|FG003|Overall Study|Adverse Event|0|||
157005018|NCT02057692|566768568|FG000|Overall Study|Lost to Follow-up|0|||
157005019|NCT02057692|566768569|FG001|Overall Study|Lost to Follow-up|0|||
157005020|NCT02057692|566768570|FG002|Overall Study|Lost to Follow-up|0|||
157005021|NCT02057692|566768571|FG003|Overall Study|Lost to Follow-up|1|||
157005022|NCT00943735|566768576|FG000|Overall Study|Adverse Event|12|||
157005023|NCT00943735|566768576|FG000|Overall Study|Withdrawal by Subject|8|||
157005024|NCT00943735|566768576|FG000|Overall Study|Death|1|||
157005025|NCT00943735|566768576|FG000|Overall Study|Other|8|||
157005026|NCT00943735|566768576|FG000|Overall Study|Other|3|||
157005027|NCT00486330|566768577|FG000|Overall Study|Adverse Event|2|||
157005028|NCT01027286|566768578|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
157005029|NCT01027286|566768579|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
156762330|NCT03205150|565882472|FG002|Overall Study|Patient/guardian decision|0|||
156762331|NCT03205150|565882470|FG000|Overall Study|Adverse Event|1|||
156762332|NCT03205150|565882471|FG001|Overall Study|Adverse Event|1|||
156762333|NCT03205150|565882472|FG002|Overall Study|Adverse Event|1|||
156762334|NCT03205150|565882470|FG000|Overall Study|Lost to Follow-up|0|||
156762335|NCT03205150|565882471|FG001|Overall Study|Lost to Follow-up|0|||
156762336|NCT03205150|565882472|FG002|Overall Study|Lost to Follow-up|1|||
156762337|NCT01095835|565882473|FG000|Overall Study|Adverse Event|8|||
156762338|NCT01095835|565882474|FG001|Overall Study|Adverse Event|6|||
156762339|NCT01095835|565882475|FG002|Overall Study|Adverse Event|6|||
156762340|NCT01095835|565882473|FG000|Overall Study|Lack of Efficacy|0|||
156762341|NCT01095835|565882474|FG001|Overall Study|Lack of Efficacy|1|||
156762342|NCT01095835|565882475|FG002|Overall Study|Lack of Efficacy|0|||
156762343|NCT01095835|565882473|FG000|Overall Study|Physician Decision|0|||
156762344|NCT01095835|565882474|FG001|Overall Study|Physician Decision|0|||
156762345|NCT01095835|565882475|FG002|Overall Study|Physician Decision|1|||
156762346|NCT01095835|565882473|FG000|Overall Study|Withdrawal by Subject|1|||
157005030|NCT01027286|566768578|FG000|Overall Study|Lost to Follow-up|0|||
157005031|NCT01027286|566768579|FG001|Overall Study|Lost to Follow-up|1|||
157005032|NCT03804918|566768580|FG000|Overall Study|Participant did not use the app|1|||
157005033|NCT00813904|566768581|FG000|Overall Study|Death|1|||
157005034|NCT01405924|566768584|FG000|Overall Study|Protocol Violation|8|||
157005035|NCT01405924|566768584|FG000|Overall Study|Missing/Incomplete Data|2|||
157005036|NCT02393716|566768585|FG000|Overall Study|Death|29|||
157005037|NCT02393716|566768585|FG000|Overall Study|Withdrawal by Subject|8|||
156762347|NCT01095835|565882474|FG001|Overall Study|Withdrawal by Subject|3|||
157005038|NCT02393716|566768585|FG000|Overall Study|Device Explanted|8|||
157005039|NCT02393716|566768585|FG000|Overall Study|Missed visit|16|||
157005040|NCT01924767|566768586|FG000|Overall Study|Adverse Event|1|||
157005041|NCT01924767|566768587|FG001|Overall Study|Adverse Event|0|||
157005042|NCT01924767|566768588|FG002|Overall Study|Adverse Event|1|||
157005043|NCT01924767|566768589|FG003|Overall Study|Adverse Event|0|||
157005044|NCT01924767|566768590|FG004|Overall Study|Adverse Event|0|||
157005045|NCT01648140|566768591|FG000|Overall Study|Physician Decision|1|||
157110301|NCT05678257|567157258|FG001|Overall Study|No longer clinically benefitting|1|||
157005046|NCT01648140|566768592|FG001|Overall Study|Physician Decision|0|||
157110302|NCT05678257|567157259|FG002|Overall Study|No longer clinically benefitting|0|||
157110303|NCT05678257|567157257|FG000|Overall Study|Sponsor decision|5|||
157110304|NCT05678257|567157258|FG001|Overall Study|Sponsor decision|9|||
157110305|NCT05678257|567157259|FG002|Overall Study|Sponsor decision|8|||
157110306|NCT05678257|567157257|FG000|Overall Study|Protocol Violation|0|||
157110307|NCT05678257|567157258|FG001|Overall Study|Protocol Violation|0|||
157110308|NCT05678257|567157259|FG002|Overall Study|Protocol Violation|1|||
157110309|NCT05678257|567157257|FG000|Overall Study|Patient non-compliance|0|||
157110310|NCT05678257|567157258|FG001|Overall Study|Patient non-compliance|0|||
157110311|NCT05678257|567157259|FG002|Overall Study|Patient non-compliance|3|||
157110312|NCT01045798|567157260|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
157110313|NCT01045798|567157261|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
157110314|NCT01045798|567157260|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
157110315|NCT01045798|567157261|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
157110316|NCT01045798|567157260|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
157110317|NCT01045798|567157261|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
157110318|NCT01045798|567157260|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
156762348|NCT01095835|565882475|FG002|Overall Study|Withdrawal by Subject|0|||
156762349|NCT01095835|565882473|FG000|Overall Study|Non study compliance|0|||
156762350|NCT01095835|565882474|FG001|Overall Study|Non study compliance|0|||
156762351|NCT01095835|565882475|FG002|Overall Study|Non study compliance|1|||
156762352|NCT01095835|565882473|FG000|Overall Study|Protocol Violation|1|||
156762353|NCT01095835|565882474|FG001|Overall Study|Protocol Violation|2|||
156762354|NCT01095835|565882475|FG002|Overall Study|Protocol Violation|0|||
156762355|NCT03028142|565882478|FG000|Overall Study|Adverse Event|1|||
156762356|NCT03028142|565882479|FG001|Overall Study|Adverse Event|1|||
156762357|NCT03028142|565882480|FG002|Overall Study|Adverse Event|0|||
156762358|NCT03028142|565882481|FG003|Overall Study|Adverse Event|0|||
156762359|NCT03028142|565882482|FG004|Overall Study|Adverse Event|0|||
156762360|NCT03028142|565882483|FG005|Overall Study|Adverse Event|1|||
156762361|NCT03028142|565882478|FG000|Overall Study|Withdrawal by Subject|0|||
156762362|NCT03028142|565882479|FG001|Overall Study|Withdrawal by Subject|0|||
156762363|NCT03028142|565882480|FG002|Overall Study|Withdrawal by Subject|0|||
156762364|NCT03028142|565882481|FG003|Overall Study|Withdrawal by Subject|0|||
156762365|NCT03028142|565882482|FG004|Overall Study|Withdrawal by Subject|1|||
156762366|NCT03028142|565882483|FG005|Overall Study|Withdrawal by Subject|0|||
156762367|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
156762368|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
156762369|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
156762370|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
156762371|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
156762372|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
156762373|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
156762374|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
156762375|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
156762376|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
156762377|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
156762378|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
156762379|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
156762380|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
156762381|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
156762382|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
156762383|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
156762384|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
156762385|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
156762386|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
156762387|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
156762388|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
156762389|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
156762390|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
156762391|NCT01198002|565882488|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
156762392|NCT01198002|565882489|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
156762393|NCT01198002|565882490|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
156762394|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
156762395|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
157110319|NCT01045798|567157261|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
157110320|NCT01449461|567157262|FG000|Overall Study|Adverse Event|0|||
156762396|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
156762397|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
156762398|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
156762399|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
156762400|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
156762401|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
156762402|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
156762403|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
156762404|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
156762405|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
156762406|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
156762407|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
156762408|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
156762409|NCT01198002|565882488|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
156762410|NCT01198002|565882489|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
156762411|NCT01198002|565882490|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
156762412|NCT02812186|565882493|FG000|Period 1|Post randomization screen failure|5|||
156762413|NCT02812186|565882494|FG001|Period 1|Post randomization screen failure|9|||
156762414|NCT02812186|565882493|FG000|Period 1|nonevaluable data sets|6|||
156762415|NCT02812186|565882494|FG001|Period 1|nonevaluable data sets|6|||
156762416|NCT01162343|565882495|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
156762417|NCT01162343|565882495|FG000|Overall Study|Refused psychiatrist assessment|12|||
157110321|NCT01449461|567157263|FG001|Overall Study|Adverse Event|3|||
157110322|NCT01449461|567157264|FG002|Overall Study|Adverse Event|2|||
157110323|NCT01449461|567157265|FG003|Overall Study|Adverse Event|3|||
157110324|NCT01449461|567157266|FG004|Overall Study|Adverse Event|4|||
157110325|NCT01449461|567157267|FG005|Overall Study|Adverse Event|4|||
157110326|NCT01449461|567157262|FG000|Overall Study|Death|0|||
157110327|NCT01449461|567157263|FG001|Overall Study|Death|2|||
157110328|NCT01449461|567157264|FG002|Overall Study|Death|0|||
157110329|NCT01449461|567157265|FG003|Overall Study|Death|0|||
157110330|NCT01449461|567157266|FG004|Overall Study|Death|7|||
157110331|NCT01449461|567157267|FG005|Overall Study|Death|1|||
157110332|NCT01449461|567157262|FG000|Overall Study|Physician Decision|0|||
157110333|NCT01449461|567157263|FG001|Overall Study|Physician Decision|1|||
157110334|NCT01449461|567157264|FG002|Overall Study|Physician Decision|0|||
157110335|NCT01449461|567157265|FG003|Overall Study|Physician Decision|4|||
157110336|NCT01449461|567157266|FG004|Overall Study|Physician Decision|1|||
157110337|NCT01449461|567157267|FG005|Overall Study|Physician Decision|0|||
157110338|NCT01449461|567157262|FG000|Overall Study|Documented Progressive Disease|4|||
156762418|NCT01130272|565882496|FG000|Overall Study|Adverse Event|2|||
156762419|NCT01130272|565882497|FG001|Overall Study|Adverse Event|5|||
156762420|NCT01130272|565882498|FG002|Overall Study|Adverse Event|6|||
156762421|NCT01130272|565882499|FG003|Overall Study|Adverse Event|22|||
156762422|NCT01130272|565882500|FG004|Overall Study|Adverse Event|7|||
156762423|NCT01130272|565882496|FG000|Overall Study|IVRS-confirmed constipation|0|||
156762424|NCT01130272|565882497|FG001|Overall Study|IVRS-confirmed constipation|1|||
156762425|NCT01130272|565882498|FG002|Overall Study|IVRS-confirmed constipation|1|||
156762426|NCT01130272|565882499|FG003|Overall Study|IVRS-confirmed constipation|2|||
156762427|NCT01130272|565882500|FG004|Overall Study|IVRS-confirmed constipation|0|||
156762428|NCT01130272|565882496|FG000|Overall Study|Rescue medications due to diarrhea|3|||
156762429|NCT01130272|565882497|FG001|Overall Study|Rescue medications due to diarrhea|5|||
156762430|NCT01130272|565882498|FG002|Overall Study|Rescue medications due to diarrhea|8|||
157110339|NCT01449461|567157263|FG001|Overall Study|Documented Progressive Disease|7|||
157110340|NCT01449461|567157264|FG002|Overall Study|Documented Progressive Disease|14|||
157110341|NCT01449461|567157265|FG003|Overall Study|Documented Progressive Disease|15|||
157110342|NCT01449461|567157266|FG004|Overall Study|Documented Progressive Disease|24|||
157110343|NCT01449461|567157267|FG005|Overall Study|Documented Progressive Disease|5|||
157110344|NCT01449461|567157262|FG000|Overall Study|Clinical Progressive Disease|2|||
156762431|NCT01130272|565882499|FG003|Overall Study|Rescue medications due to diarrhea|8|||
156762432|NCT01130272|565882500|FG004|Overall Study|Rescue medications due to diarrhea|6|||
156762433|NCT01130272|565882496|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
156762434|NCT01130272|565882497|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
156762435|NCT01130272|565882498|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
156762436|NCT01130272|565882499|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
156762437|NCT01130272|565882500|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
157110345|NCT01449461|567157263|FG001|Overall Study|Clinical Progressive Disease|2|||
157110346|NCT01449461|567157264|FG002|Overall Study|Clinical Progressive Disease|0|||
157110347|NCT01449461|567157265|FG003|Overall Study|Clinical Progressive Disease|3|||
157110348|NCT01449461|567157266|FG004|Overall Study|Clinical Progressive Disease|4|||
157110349|NCT01449461|567157267|FG005|Overall Study|Clinical Progressive Disease|2|||
157110350|NCT01449461|567157262|FG000|Overall Study|Protocol Violation|0|||
157110351|NCT01449461|567157263|FG001|Overall Study|Protocol Violation|0|||
157110352|NCT01449461|567157264|FG002|Overall Study|Protocol Violation|0|||
157110353|NCT01449461|567157265|FG003|Overall Study|Protocol Violation|1|||
157110354|NCT01449461|567157266|FG004|Overall Study|Protocol Violation|0|||
156762438|NCT01130272|565882496|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762439|NCT01130272|565882497|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
157110355|NCT01449461|567157267|FG005|Overall Study|Protocol Violation|0|||
157110356|NCT01449461|567157262|FG000|Overall Study|Site Terminated by Sponsor|0|||
157110357|NCT01449461|567157263|FG001|Overall Study|Site Terminated by Sponsor|1|||
156762440|NCT01130272|565882498|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762441|NCT01130272|565882499|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
156762442|NCT01130272|565882500|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
156762443|NCT01130272|565882496|FG000|Overall Study|Protocol Violation|0|||
156762444|NCT01130272|565882497|FG001|Overall Study|Protocol Violation|0|||
156762445|NCT01130272|565882498|FG002|Overall Study|Protocol Violation|3|||
156762446|NCT01130272|565882499|FG003|Overall Study|Protocol Violation|5|||
156762447|NCT01130272|565882500|FG004|Overall Study|Protocol Violation|5|||
156762448|NCT01130272|565882496|FG000|Overall Study|Lost to Follow-up|4|||
156762449|NCT01130272|565882497|FG001|Overall Study|Lost to Follow-up|3|||
156762450|NCT01130272|565882498|FG002|Overall Study|Lost to Follow-up|4|||
156762451|NCT01130272|565882499|FG003|Overall Study|Lost to Follow-up|7|||
156762452|NCT01130272|565882500|FG004|Overall Study|Lost to Follow-up|6|||
156762453|NCT01130272|565882496|FG000|Overall Study|Withdrawal by Subject|4|||
156762454|NCT01130272|565882497|FG001|Overall Study|Withdrawal by Subject|11|||
156762455|NCT01130272|565882498|FG002|Overall Study|Withdrawal by Subject|10|||
156762456|NCT01130272|565882499|FG003|Overall Study|Withdrawal by Subject|9|||
156762457|NCT01130272|565882500|FG004|Overall Study|Withdrawal by Subject|8|||
156762458|NCT01130272|565882496|FG000|Overall Study|Physician Decision|1|||
156762459|NCT01130272|565882497|FG001|Overall Study|Physician Decision|1|||
156762460|NCT01130272|565882498|FG002|Overall Study|Physician Decision|0|||
156762461|NCT01130272|565882499|FG003|Overall Study|Physician Decision|1|||
156762462|NCT01130272|565882500|FG004|Overall Study|Physician Decision|2|||
156762463|NCT01130272|565882496|FG000|Overall Study|Sponsor decision|6|||
156762464|NCT01130272|565882497|FG001|Overall Study|Sponsor decision|15|||
156762465|NCT01130272|565882498|FG002|Overall Study|Sponsor decision|16|||
156762466|NCT01130272|565882499|FG003|Overall Study|Sponsor decision|13|||
156762467|NCT01130272|565882500|FG004|Overall Study|Sponsor decision|16|||
156762468|NCT01130272|565882496|FG000|Overall Study|Study arm discontinued|38|||
156762469|NCT01130272|565882497|FG001|Overall Study|Study arm discontinued|0|||
156762470|NCT01130272|565882498|FG002|Overall Study|Study arm discontinued|0|||
156762471|NCT01130272|565882499|FG003|Overall Study|Study arm discontinued|0|||
156762472|NCT01130272|565882500|FG004|Overall Study|Study arm discontinued|0|||
156762473|NCT01405560|565882505|FG000|Overall Study|Physician Decision|1|||
156762474|NCT01699750|565882508|FG000|Overall Study|Withdrew Consent|0|||
157110358|NCT01449461|567157264|FG002|Overall Study|Site Terminated by Sponsor|2|||
157110359|NCT01449461|567157265|FG003|Overall Study|Site Terminated by Sponsor|3|||
157110360|NCT01449461|567157266|FG004|Overall Study|Site Terminated by Sponsor|4|||
157110361|NCT01449461|567157267|FG005|Overall Study|Site Terminated by Sponsor|1|||
157110362|NCT01449461|567157262|FG000|Overall Study|Withdrawal by Subject|0|||
157110363|NCT01449461|567157263|FG001|Overall Study|Withdrawal by Subject|1|||
157110364|NCT01449461|567157264|FG002|Overall Study|Withdrawal by Subject|0|||
157110365|NCT01449461|567157265|FG003|Overall Study|Withdrawal by Subject|0|||
157110366|NCT01449461|567157266|FG004|Overall Study|Withdrawal by Subject|2|||
157110367|NCT01449461|567157267|FG005|Overall Study|Withdrawal by Subject|1|||
157110368|NCT01449461|567157262|FG000|Overall Study|Reason not Specified|0|||
157110369|NCT01449461|567157263|FG001|Overall Study|Reason not Specified|1|||
157110370|NCT01449461|567157264|FG002|Overall Study|Reason not Specified|0|||
157110371|NCT01449461|567157265|FG003|Overall Study|Reason not Specified|3|||
157110372|NCT01449461|567157266|FG004|Overall Study|Reason not Specified|2|||
157110373|NCT01449461|567157267|FG005|Overall Study|Reason not Specified|1|||
157110374|NCT00430482|567157270|FG000|Completed Treatment|Insufficient Treatment|7|||
157110375|NCT00430482|567157271|FG001|Completed Treatment|Insufficient Treatment|11|||
157110376|NCT00583024|567157272|FG000|Overall Study|Lost to Follow-up|4|||
157110377|NCT04183790|567158368|FG000|Overall Study|Participants did not rollover to Part B|12|||
157110378|NCT04183790|567158369|FG001|Overall Study|Participants did not rollover to Part B|0|||
157110379|NCT04183790|567158368|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
157110380|NCT04183790|567158369|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
157110381|NCT04183790|567158368|FG000|Overall Study|Commercial drug is available for participant|6|||
157110382|NCT04183790|567158369|FG001|Overall Study|Commercial drug is available for participant|0|||
157110383|NCT04183790|567158368|FG000|Overall Study|Adverse Event|1|||
156762475|NCT01699750|565882509|FG001|Overall Study|Withdrew Consent|1|||
156762476|NCT01699750|565882508|FG000|Overall Study|Other|0|||
156762477|NCT01699750|565882509|FG001|Overall Study|Other|2|||
156762478|NCT01484951|565882510|FG000|Overall Study|Adverse Event|3|||
156762479|NCT01484951|565882510|FG000|Overall Study|Personal Reasons|1|||
156762480|NCT01484951|565882510|FG000|Overall Study|Non-Compliance|1|||
156762481|NCT02452047|565882512|FG000|Overall Study|Adverse Event|0|||
156762482|NCT02452047|565882513|FG001|Overall Study|Adverse Event|1|||
156762483|NCT02452047|565882514|FG002|Overall Study|Adverse Event|1|||
157110384|NCT04183790|567158369|FG001|Overall Study|Adverse Event|0|||
157110385|NCT04183790|567158368|FG000|Overall Study|Not enrolled in 107 study|0|||
156762484|NCT02452047|565882512|FG000|Overall Study|Death|1|||
156762485|NCT02452047|565882513|FG001|Overall Study|Death|3|||
156762486|NCT02452047|565882514|FG002|Overall Study|Death|1|||
156762487|NCT02452047|565882512|FG000|Overall Study|Physician Decision|1|||
156762488|NCT02452047|565882513|FG001|Overall Study|Physician Decision|0|||
156762489|NCT02452047|565882514|FG002|Overall Study|Physician Decision|0|||
156762490|NCT02452047|565882512|FG000|Overall Study|Lost to Follow-up|1|||
156762491|NCT02452047|565882513|FG001|Overall Study|Lost to Follow-up|1|||
156762492|NCT02452047|565882514|FG002|Overall Study|Lost to Follow-up|0|||
156762493|NCT02452047|565882512|FG000|Overall Study|Withdrawal by Subject|1|||
156762494|NCT02452047|565882513|FG001|Overall Study|Withdrawal by Subject|0|||
156762495|NCT02452047|565882514|FG002|Overall Study|Withdrawal by Subject|0|||
156762496|NCT02169505|565882515|FG000|Overall Study|Withdrawal by Subject|1|||
157005047|NCT01648140|566768593|FG002|Overall Study|Physician Decision|0|||
157005048|NCT01648140|566768594|FG003|Overall Study|Physician Decision|0|||
157005049|NCT01648140|566768591|FG000|Overall Study|Lack of Efficacy|4|||
157005050|NCT01648140|566768592|FG001|Overall Study|Lack of Efficacy|7|||
157005051|NCT01648140|566768593|FG002|Overall Study|Lack of Efficacy|1|||
157005052|NCT01648140|566768594|FG003|Overall Study|Lack of Efficacy|0|||
157005053|NCT01648140|566768591|FG000|Overall Study|Adverse Event|3|||
157005054|NCT01648140|566768592|FG001|Overall Study|Adverse Event|1|||
157005055|NCT01648140|566768593|FG002|Overall Study|Adverse Event|2|||
157005056|NCT01648140|566768594|FG003|Overall Study|Adverse Event|0|||
157005057|NCT01648140|566768591|FG000|Overall Study|Withdrawal by Subject|2|||
157005058|NCT01648140|566768592|FG001|Overall Study|Withdrawal by Subject|3|||
157005059|NCT01648140|566768593|FG002|Overall Study|Withdrawal by Subject|3|||
157005060|NCT01648140|566768594|FG003|Overall Study|Withdrawal by Subject|2|||
157005061|NCT01648140|566768591|FG000|Overall Study|Lost to Follow-up|2|||
157005062|NCT01648140|566768592|FG001|Overall Study|Lost to Follow-up|1|||
157005063|NCT01648140|566768593|FG002|Overall Study|Lost to Follow-up|2|||
157005064|NCT01648140|566768594|FG003|Overall Study|Lost to Follow-up|0|||
157005065|NCT04347954|566768595|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
157005066|NCT04347954|566768596|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
157005067|NCT04347954|566768597|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
157005068|NCT04347954|566768595|FG000|Overall Study|Lost to Follow-up|0|||
157005069|NCT04347954|566768596|FG001|Overall Study|Lost to Follow-up|1|||
157005070|NCT04347954|566768597|FG002|Overall Study|Lost to Follow-up|0|||
157005071|NCT05641311|566768598|FG000|Dosing Period 1|Adverse Event|1|||
157005072|NCT05641311|566768599|FG001|Dosing Period 1|Adverse Event|0|||
157005073|NCT02954848|566768600|FG000|Overall Study|Randomized but Not Treated|0|||
157005074|NCT02954848|566768601|FG001|Overall Study|Randomized but Not Treated|1|||
157005075|NCT02954848|566768600|FG000|Overall Study|Adverse Event|2|||
157005076|NCT02954848|566768601|FG001|Overall Study|Adverse Event|3|||
157005077|NCT02954848|566768600|FG000|Overall Study|Withdrawal by Participant|0|||
157005078|NCT02954848|566768601|FG001|Overall Study|Withdrawal by Participant|1|||
157005079|NCT01802632|566768602|FG000|Overall Study|Death|28|||
157005080|NCT01802632|566768603|FG001|Overall Study|Death|1|||
157005081|NCT01802632|566768604|FG002|Overall Study|Death|38|||
157005082|NCT01802632|566768605|FG003|Overall Study|Death|0|||
157005083|NCT01802632|566768606|FG004|Overall Study|Death|2|||
157005084|NCT01802632|566768607|FG005|Overall Study|Death|0|||
157005085|NCT01802632|566768602|FG000|Overall Study|Withdrawal by Subject|4|||
157005086|NCT01802632|566768603|FG001|Overall Study|Withdrawal by Subject|2|||
157005087|NCT01802632|566768604|FG002|Overall Study|Withdrawal by Subject|7|||
157005088|NCT01802632|566768605|FG003|Overall Study|Withdrawal by Subject|3|||
157005089|NCT01802632|566768606|FG004|Overall Study|Withdrawal by Subject|0|||
157005090|NCT01802632|566768607|FG005|Overall Study|Withdrawal by Subject|1|||
157005091|NCT01802632|566768602|FG000|Overall Study|Objective Disease Progression|1|||
157005092|NCT01802632|566768603|FG001|Overall Study|Objective Disease Progression|12|||
157005093|NCT01802632|566768604|FG002|Overall Study|Objective Disease Progression|104|||
157005094|NCT01802632|566768605|FG003|Overall Study|Objective Disease Progression|6|||
157005095|NCT01802632|566768606|FG004|Overall Study|Objective Disease Progression|4|||
157005096|NCT01802632|566768607|FG005|Overall Study|Objective Disease Progression|4|||
157005097|NCT01802632|566768602|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
157005098|NCT01802632|566768603|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
157005099|NCT01802632|566768604|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
157005100|NCT01802632|566768605|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
157005101|NCT01802632|566768606|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
157005102|NCT01802632|566768607|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
157005103|NCT01802632|566768602|FG000|Overall Study|Other (not specified)|0|||
156762497|NCT00917124|565882519|FG000|Overall Study|Protocol Violation|4|||
156762498|NCT00917124|565882520|FG001|Overall Study|Protocol Violation|6|||
157005104|NCT01802632|566768603|FG001|Overall Study|Other (not specified)|0|||
157005105|NCT01802632|566768604|FG002|Overall Study|Other (not specified)|7|||
157005106|NCT01802632|566768605|FG003|Overall Study|Other (not specified)|1|||
157005107|NCT01802632|566768606|FG004|Overall Study|Other (not specified)|0|||
157005108|NCT01802632|566768607|FG005|Overall Study|Other (not specified)|1|||
157005109|NCT00539292|566768608|FG000|Overall Study|Physician Decision|1|||
157005110|NCT00539292|566768609|FG001|Overall Study|Physician Decision|0|||
157005111|NCT00324038|566768619|FG000|Overall Study|Adverse Event|38|||
156762499|NCT01783743|565882521|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
156762500|NCT01783743|565882522|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
156762501|NCT01783743|565882521|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
156762502|NCT01783743|565882522|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
156762503|NCT01783743|565882521|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
156762504|NCT01783743|565882522|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
156762505|NCT02631941|565882538|FG000|Overall Study|Physician Decision|0|||
156762506|NCT02631941|565882539|FG001|Overall Study|Physician Decision|1|||
156762507|NCT02631941|565882540|FG002|Overall Study|Physician Decision|0|||
156762508|NCT02631941|565882541|FG003|Overall Study|Physician Decision|0|||
156762509|NCT02631941|565882542|FG004|Overall Study|Physician Decision|0|||
156762510|NCT02631941|565882543|FG005|Overall Study|Physician Decision|0|||
156762511|NCT02631941|565882544|FG006|Overall Study|Physician Decision|0|||
156762512|NCT02631941|565882545|FG007|Overall Study|Physician Decision|0|||
156762513|NCT02631941|565882546|FG008|Overall Study|Physician Decision|0|||
156762514|NCT02631941|565882547|FG009|Overall Study|Physician Decision|0|||
156762515|NCT02631941|565882538|FG000|Overall Study|Adverse Event|0|||
156762516|NCT02631941|565882539|FG001|Overall Study|Adverse Event|1|||
156762517|NCT02631941|565882540|FG002|Overall Study|Adverse Event|0|||
156762518|NCT02631941|565882541|FG003|Overall Study|Adverse Event|0|||
156762519|NCT02631941|565882542|FG004|Overall Study|Adverse Event|0|||
157110386|NCT04183790|567158369|FG001|Overall Study|Not enrolled in 107 study|2|||
157110387|NCT01251653|567158370|FG000|Overall Study|Progressive Disease|1|||
156762520|NCT02631941|565882543|FG005|Overall Study|Adverse Event|0|||
156762521|NCT02631941|565882544|FG006|Overall Study|Adverse Event|0|||
156762522|NCT02631941|565882545|FG007|Overall Study|Adverse Event|0|||
156762523|NCT02631941|565882546|FG008|Overall Study|Adverse Event|0|||
156762524|NCT02631941|565882547|FG009|Overall Study|Adverse Event|0|||
156762525|NCT02631941|565882538|FG000|Overall Study|Withdrawal by Subject|0|||
156762526|NCT02631941|565882539|FG001|Overall Study|Withdrawal by Subject|0|||
156762527|NCT02631941|565882540|FG002|Overall Study|Withdrawal by Subject|0|||
156762528|NCT02631941|565882541|FG003|Overall Study|Withdrawal by Subject|0|||
156762529|NCT02631941|565882542|FG004|Overall Study|Withdrawal by Subject|1|||
156762530|NCT02631941|565882543|FG005|Overall Study|Withdrawal by Subject|0|||
156762531|NCT02631941|565882544|FG006|Overall Study|Withdrawal by Subject|0|||
156762532|NCT02631941|565882545|FG007|Overall Study|Withdrawal by Subject|1|||
156762533|NCT02631941|565882546|FG008|Overall Study|Withdrawal by Subject|0|||
156762534|NCT02631941|565882547|FG009|Overall Study|Withdrawal by Subject|0|||
156762535|NCT02631941|565882538|FG000|Overall Study|Lost to Follow-up|0|||
156762536|NCT02631941|565882539|FG001|Overall Study|Lost to Follow-up|0|||
156762537|NCT02631941|565882540|FG002|Overall Study|Lost to Follow-up|0|||
156762538|NCT02631941|565882541|FG003|Overall Study|Lost to Follow-up|0|||
156762539|NCT02631941|565882542|FG004|Overall Study|Lost to Follow-up|0|||
156762540|NCT02631941|565882543|FG005|Overall Study|Lost to Follow-up|0|||
156762541|NCT02631941|565882544|FG006|Overall Study|Lost to Follow-up|0|||
156762542|NCT02631941|565882545|FG007|Overall Study|Lost to Follow-up|0|||
156762543|NCT02631941|565882546|FG008|Overall Study|Lost to Follow-up|1|||
156762544|NCT02631941|565882547|FG009|Overall Study|Lost to Follow-up|0|||
156762545|NCT03933449|565882548|FG000|Overall Study|Adverse Event|6|||
156762546|NCT03933449|565882549|FG001|Overall Study|Adverse Event|4|||
156762547|NCT03933449|565882548|FG000|Overall Study|Death|55|||
156762548|NCT03933449|565882549|FG001|Overall Study|Death|57|||
156762549|NCT03933449|565882548|FG000|Overall Study|Sponsor Decision|1|||
156762550|NCT03933449|565882549|FG001|Overall Study|Sponsor Decision|0|||
157110388|NCT01251653|567158371|FG001|Overall Study|Progressive Disease|7|||
157110389|NCT01251653|567158372|FG002|Overall Study|Progressive Disease|16|||
157110390|NCT01251653|567158373|FG003|Overall Study|Progressive Disease|4|||
156762551|NCT02087774|565882552|FG000|Overall Study|Were absent day of data collection|8|||
156762552|NCT02087774|565882553|FG001|Overall Study|Were absent day of data collection|20|||
157110391|NCT01251653|567158374|FG004|Overall Study|Progressive Disease|0|||
156762553|NCT00719901|565882554|FG000|Overall Study|Adverse Event|5|||
156762554|NCT00719901|565882554|FG000|Overall Study|Withdrawal by Subject|1|||
156762555|NCT00719901|565882554|FG000|Overall Study|Alternate Treatment|1|||
156762556|NCT00719901|565882554|FG000|Overall Study|Disease Progression|3|||
156762557|NCT00719901|565882554|FG000|Overall Study|Availability of Study Drug|1|||
157110392|NCT01251653|567158375|FG005|Overall Study|Progressive Disease|17|||
157110393|NCT01251653|567158376|FG006|Overall Study|Progressive Disease|14|||
156762558|NCT04456686|565882555|FG000|Overall Study|Adverse Event|2|||
156762559|NCT04456686|565882556|FG001|Overall Study|Adverse Event|1|||
156762560|NCT04456686|565882555|FG000|Overall Study|Lack of Efficacy|3|||
156762561|NCT04456686|565882556|FG001|Overall Study|Lack of Efficacy|1|||
156762562|NCT04456686|565882555|FG000|Overall Study|Withdrew consent|3|||
156762563|NCT04456686|565882556|FG001|Overall Study|Withdrew consent|1|||
156762564|NCT04456686|565882555|FG000|Overall Study|Physician Decision|2|||
156762565|NCT04456686|565882556|FG001|Overall Study|Physician Decision|2|||
156762566|NCT04456686|565882555|FG000|Overall Study|Withdrawal by Subject|5|||
156762567|NCT04456686|565882556|FG001|Overall Study|Withdrawal by Subject|1|||
156762568|NCT04456686|565882555|FG000|Overall Study|Protocol Violation|0|||
156762569|NCT04456686|565882556|FG001|Overall Study|Protocol Violation|1|||
156762570|NCT02858401|565882561|FG000|Overall Study|Withdrew Consent|0|||
156762571|NCT02858401|565882562|FG001|Overall Study|Withdrew Consent|0|||
156762572|NCT02858401|565882563|FG002|Overall Study|Withdrew Consent|0|||
156762573|NCT02858401|565882564|FG003|Overall Study|Withdrew Consent|0|||
156762574|NCT02858401|565882565|FG004|Overall Study|Withdrew Consent|0|||
156762575|NCT02858401|565882566|FG005|Overall Study|Withdrew Consent|1|||
156762576|NCT02858401|565882567|FG006|Overall Study|Withdrew Consent|0|||
156762577|NCT02858401|565882561|FG000|Overall Study|Lost to Follow-up|0|||
156762578|NCT02858401|565882562|FG001|Overall Study|Lost to Follow-up|1|||
156762579|NCT02858401|565882563|FG002|Overall Study|Lost to Follow-up|0|||
156762580|NCT02858401|565882564|FG003|Overall Study|Lost to Follow-up|0|||
156762581|NCT02858401|565882565|FG004|Overall Study|Lost to Follow-up|0|||
156762582|NCT02858401|565882566|FG005|Overall Study|Lost to Follow-up|0|||
156762583|NCT02858401|565882567|FG006|Overall Study|Lost to Follow-up|0|||
156762584|NCT02869789|565882573|FG000|Overall Study|Disease progression|184|||
156762585|NCT02869789|565882574|FG001|Overall Study|Disease progression|109|||
156762586|NCT02869789|565882575|FG002|Overall Study|Disease progression|260|||
156762587|NCT02869789|565882576|FG003|Overall Study|Disease progression|19|||
156762588|NCT02869789|565882573|FG000|Overall Study|Study drug toxicity|90|||
156762589|NCT02869789|565882574|FG001|Overall Study|Study drug toxicity|32|||
156762590|NCT02869789|565882575|FG002|Overall Study|Study drug toxicity|55|||
156762591|NCT02869789|565882576|FG003|Overall Study|Study drug toxicity|14|||
156762592|NCT02869789|565882573|FG000|Overall Study|Death|7|||
156762593|NCT02869789|565882574|FG001|Overall Study|Death|3|||
156762594|NCT02869789|565882575|FG002|Overall Study|Death|5|||
156762595|NCT02869789|565882576|FG003|Overall Study|Death|1|||
156762596|NCT02869789|565882573|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
156762597|NCT02869789|565882574|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
156762598|NCT02869789|565882575|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
156762599|NCT02869789|565882576|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
156762600|NCT02869789|565882573|FG000|Overall Study|Participant request to discontinue study treatment|10|||
156762601|NCT02869789|565882574|FG001|Overall Study|Participant request to discontinue study treatment|5|||
156762602|NCT02869789|565882575|FG002|Overall Study|Participant request to discontinue study treatment|5|||
156762603|NCT02869789|565882576|FG003|Overall Study|Participant request to discontinue study treatment|3|||
156762604|NCT02869789|565882573|FG000|Overall Study|Withdrawal by Subject|5|||
156762605|NCT02869789|565882574|FG001|Overall Study|Withdrawal by Subject|2|||
156762606|NCT02869789|565882575|FG002|Overall Study|Withdrawal by Subject|7|||
156762607|NCT02869789|565882576|FG003|Overall Study|Withdrawal by Subject|2|||
156762608|NCT02869789|565882573|FG000|Overall Study|Lost to Follow-up|0|||
156762609|NCT02869789|565882574|FG001|Overall Study|Lost to Follow-up|0|||
156762610|NCT02869789|565882575|FG002|Overall Study|Lost to Follow-up|2|||
156762611|NCT02869789|565882576|FG003|Overall Study|Lost to Follow-up|0|||
156762612|NCT02869789|565882573|FG000|Overall Study|Maximum clinical benefit|5|||
156762613|NCT02869789|565882574|FG001|Overall Study|Maximum clinical benefit|2|||
157005112|NCT00324038|566768620|FG001|Overall Study|Adverse Event|23|||
157005113|NCT00324038|566768619|FG000|Overall Study|Lack of Efficacy|5|||
157005114|NCT00324038|566768620|FG001|Overall Study|Lack of Efficacy|13|||
157005115|NCT00324038|566768619|FG000|Overall Study|Lost to Follow-up|0|||
157005116|NCT00324038|566768620|FG001|Overall Study|Lost to Follow-up|2|||
157005117|NCT00324038|566768619|FG000|Overall Study|Other|6|||
157005118|NCT00324038|566768620|FG001|Overall Study|Other|13|||
157005119|NCT02770248|566768621|FG000|Overall Study|Adverse Event|0|||
157005120|NCT02770248|566768622|FG001|Overall Study|Adverse Event|1|||
156762614|NCT02869789|565882575|FG002|Overall Study|Maximum clinical benefit|1|||
156762615|NCT02869789|565882576|FG003|Overall Study|Maximum clinical benefit|0|||
156762616|NCT02869789|565882573|FG000|Overall Study|Poor/Non-compliance|0|||
156762617|NCT02869789|565882574|FG001|Overall Study|Poor/Non-compliance|2|||
156762618|NCT02869789|565882575|FG002|Overall Study|Poor/Non-compliance|1|||
156762619|NCT02869789|565882576|FG003|Overall Study|Poor/Non-compliance|0|||
156762620|NCT02869789|565882573|FG000|Overall Study|Participant no longer meets study criteria|0|||
156762621|NCT02869789|565882574|FG001|Overall Study|Participant no longer meets study criteria|1|||
156762622|NCT02869789|565882575|FG002|Overall Study|Participant no longer meets study criteria|1|||
156762623|NCT02869789|565882576|FG003|Overall Study|Participant no longer meets study criteria|0|||
156762624|NCT02869789|565882573|FG000|Overall Study|Administrative reason by sponsor|0|||
156762625|NCT02869789|565882574|FG001|Overall Study|Administrative reason by sponsor|0|||
156762626|NCT02869789|565882575|FG002|Overall Study|Administrative reason by sponsor|1|||
157110394|NCT01251653|567158377|FG007|Overall Study|Progressive Disease|7|||
157110395|NCT01251653|567158378|FG008|Overall Study|Progressive Disease|5|||
157110396|NCT01251653|567158370|FG000|Overall Study|Dose-limiting toxicity|0|||
157110397|NCT01251653|567158371|FG001|Overall Study|Dose-limiting toxicity|1|||
157110398|NCT01251653|567158372|FG002|Overall Study|Dose-limiting toxicity|1|||
157110399|NCT01251653|567158373|FG003|Overall Study|Dose-limiting toxicity|1|||
157110400|NCT01251653|567158374|FG004|Overall Study|Dose-limiting toxicity|0|||
157110401|NCT01251653|567158375|FG005|Overall Study|Dose-limiting toxicity|0|||
157110402|NCT01251653|567158376|FG006|Overall Study|Dose-limiting toxicity|2|||
157110403|NCT01251653|567158377|FG007|Overall Study|Dose-limiting toxicity|0|||
157110404|NCT01251653|567158378|FG008|Overall Study|Dose-limiting toxicity|0|||
157110405|NCT01251653|567158370|FG000|Overall Study|Adverse Event|1|||
157110406|NCT01251653|567158371|FG001|Overall Study|Adverse Event|0|||
157110407|NCT01251653|567158372|FG002|Overall Study|Adverse Event|2|||
157110408|NCT01251653|567158373|FG003|Overall Study|Adverse Event|1|||
157110409|NCT01251653|567158374|FG004|Overall Study|Adverse Event|1|||
157110410|NCT01251653|567158375|FG005|Overall Study|Adverse Event|0|||
157110411|NCT01251653|567158376|FG006|Overall Study|Adverse Event|2|||
157110412|NCT01251653|567158377|FG007|Overall Study|Adverse Event|2|||
157110413|NCT01251653|567158378|FG008|Overall Study|Adverse Event|1|||
157110414|NCT01251653|567158370|FG000|Overall Study|Withdrawal by Subject|1|||
157110415|NCT01251653|567158371|FG001|Overall Study|Withdrawal by Subject|0|||
157110416|NCT01251653|567158372|FG002|Overall Study|Withdrawal by Subject|1|||
157110417|NCT01251653|567158373|FG003|Overall Study|Withdrawal by Subject|0|||
157110418|NCT01251653|567158374|FG004|Overall Study|Withdrawal by Subject|1|||
157110419|NCT01251653|567158375|FG005|Overall Study|Withdrawal by Subject|1|||
157110420|NCT01251653|567158376|FG006|Overall Study|Withdrawal by Subject|0|||
157110421|NCT01251653|567158377|FG007|Overall Study|Withdrawal by Subject|1|||
157110422|NCT01251653|567158378|FG008|Overall Study|Withdrawal by Subject|0|||
157110423|NCT01251653|567158370|FG000|Overall Study|Other reason not mentioned above|0|||
157110424|NCT01251653|567158371|FG001|Overall Study|Other reason not mentioned above|0|||
157110425|NCT01251653|567158372|FG002|Overall Study|Other reason not mentioned above|0|||
157110426|NCT01251653|567158373|FG003|Overall Study|Other reason not mentioned above|0|||
157110427|NCT01251653|567158374|FG004|Overall Study|Other reason not mentioned above|0|||
157110428|NCT01251653|567158375|FG005|Overall Study|Other reason not mentioned above|0|||
157110429|NCT01251653|567158376|FG006|Overall Study|Other reason not mentioned above|0|||
157110430|NCT01251653|567158377|FG007|Overall Study|Other reason not mentioned above|2|||
157110431|NCT01251653|567158378|FG008|Overall Study|Other reason not mentioned above|0|||
157110432|NCT04179734|567158379|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
157110433|NCT04179734|567158380|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
157110434|NCT04179734|567158379|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
157110435|NCT04179734|567158380|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
157110436|NCT02236520|567158382|FG000|Overall Study|Physician Decision|0|||
157110437|NCT02236520|567158383|FG001|Overall Study|Physician Decision|5|||
157110438|NCT02236520|567158384|FG002|Overall Study|Physician Decision|0|||
157110439|NCT02236520|567158385|FG003|Overall Study|Physician Decision|0|||
156762627|NCT02869789|565882576|FG003|Overall Study|Administrative reason by sponsor|0|||
156762628|NCT02869789|565882573|FG000|Overall Study|Other reasons|4|||
156762629|NCT02869789|565882574|FG001|Overall Study|Other reasons|8|||
157110440|NCT02236520|567158382|FG000|Overall Study|Withdrawal by Subject|1|||
157110441|NCT02236520|567158383|FG001|Overall Study|Withdrawal by Subject|0|||
156762630|NCT02869789|565882575|FG002|Overall Study|Other reasons|6|||
157110442|NCT02236520|567158384|FG002|Overall Study|Withdrawal by Subject|0|||
157110443|NCT02236520|567158385|FG003|Overall Study|Withdrawal by Subject|1|||
157110444|NCT02236520|567158382|FG000|Overall Study|Pregnancy|1|||
157110445|NCT02236520|567158383|FG001|Overall Study|Pregnancy|0|||
157110446|NCT02236520|567158384|FG002|Overall Study|Pregnancy|0|||
156762631|NCT02869789|565882576|FG003|Overall Study|Other reasons|0|||
156762632|NCT00297648|565882578|FG000|Overall Study|Adverse Event|13|||
156762633|NCT00297648|565882578|FG000|Overall Study|Lack of Efficacy|18|||
156762634|NCT00297648|565882578|FG000|Overall Study|Lost to Follow-up|1|||
156762635|NCT00297648|565882578|FG000|Overall Study|Withdrawal by Subject|3|||
157110447|NCT02236520|567158385|FG003|Overall Study|Pregnancy|0|||
157110448|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
157110449|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
157110450|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
157110451|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
157110452|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
157110453|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
157110454|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
157110455|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
157110456|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
157110457|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
157110458|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
157110459|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
157110460|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
157110461|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
157110462|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
157110463|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
157110464|NCT00094770|567158386|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
157110465|NCT00094770|567158387|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
157110466|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
157110467|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
157110468|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
157110469|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
157110470|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
157110471|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
157110472|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
157110473|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
157110474|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
157110475|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
157110476|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
157110477|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
157110478|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
157110479|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
157005121|NCT02770248|566768621|FG000|Overall Study|Randomized in error, prior to treatment|0|||
157005122|NCT02770248|566768622|FG001|Overall Study|Randomized in error, prior to treatment|1|||
157005123|NCT00361283|566768624|FG000|Overall Study|Lost to Follow-up|27|||
157005124|NCT01579916|566768625|FG000|Overall Study|Lost to Follow-up|6|||
157005125|NCT01579916|566768626|FG001|Overall Study|Lost to Follow-up|1|||
157005126|NCT01579916|566768625|FG000|Overall Study|Withdrawal by Subject|1|||
157005127|NCT01579916|566768626|FG001|Overall Study|Withdrawal by Subject|1|||
157005128|NCT01579916|566768625|FG000|Overall Study|Death|1|||
157005129|NCT01579916|566768626|FG001|Overall Study|Death|0|||
157005130|NCT03264456|566768629|FG000|Overall Study|Withdrawal by Subject|3|||
157005131|NCT03264456|566768629|FG000|Overall Study|Lost to Follow-up|1|||
157005132|NCT01123083|566768630|FG000|Overall Study|Investigator recommendation|1|||
157005133|NCT01123083|566768631|FG001|Overall Study|Investigator recommendation|1|||
157005134|NCT01123083|566768630|FG000|Overall Study|Administrative reasons|0|||
157005135|NCT01123083|566768631|FG001|Overall Study|Administrative reasons|4|||
157005136|NCT01123083|566768630|FG000|Overall Study|Lost to Follow-up|2|||
157005137|NCT01123083|566768631|FG001|Overall Study|Lost to Follow-up|6|||
157005138|NCT01123083|566768630|FG000|Overall Study|Adverse Event|1|||
157005139|NCT01123083|566768631|FG001|Overall Study|Adverse Event|0|||
157005140|NCT01123083|566768630|FG000|Overall Study|Withdrew for another reason not covered|0|||
157005141|NCT01123083|566768631|FG001|Overall Study|Withdrew for another reason not covered|1|||
157005142|NCT01123083|566768630|FG000|Overall Study|Participant/legal representative request|7|||
157005143|NCT01123083|566768631|FG001|Overall Study|Participant/legal representative request|3|||
157005144|NCT00961636|566768632|FG000|Overall Study|Adverse Event|35|||
157005145|NCT00961636|566768633|FG001|Overall Study|Adverse Event|54|||
157005146|NCT00961636|566768634|FG002|Overall Study|Adverse Event|13|||
157005147|NCT00961636|566768632|FG000|Overall Study|Flushing Symptoms|29|||
157005148|NCT00961636|566768633|FG001|Overall Study|Flushing Symptoms|46|||
157005149|NCT00961636|566768634|FG002|Overall Study|Flushing Symptoms|3|||
157005150|NCT00961636|566768632|FG000|Overall Study|Lost to Follow-up|2|||
157005151|NCT00961636|566768633|FG001|Overall Study|Lost to Follow-up|3|||
157005152|NCT00961636|566768634|FG002|Overall Study|Lost to Follow-up|1|||
157005153|NCT00961636|566768632|FG000|Overall Study|Physician Decision|3|||
157005154|NCT00961636|566768633|FG001|Overall Study|Physician Decision|1|||
157005155|NCT00961636|566768634|FG002|Overall Study|Physician Decision|1|||
157005156|NCT00961636|566768632|FG000|Overall Study|Protocol Violation|9|||
157005157|NCT00961636|566768633|FG001|Overall Study|Protocol Violation|5|||
157005158|NCT00961636|566768634|FG002|Overall Study|Protocol Violation|1|||
157005159|NCT00961636|566768632|FG000|Overall Study|Withdrawal by Subject|29|||
157005160|NCT00961636|566768633|FG001|Overall Study|Withdrawal by Subject|22|||
157005161|NCT00961636|566768634|FG002|Overall Study|Withdrawal by Subject|13|||
156762636|NCT00297648|565882578|FG000|Overall Study|Other: Incompliance|1|||
156762637|NCT02048722|565882579|FG000|2 Cycles of Treatment|Adverse Event|2|||
156762638|NCT02048722|565882579|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
156762639|NCT02048722|565882579|FG000|2 Cycles of Treatment|Progressive Disease|2|||
156762640|NCT02048722|565882579|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
156762641|NCT02048722|565882579|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
156762642|NCT02048722|565882579|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
156762643|NCT01529606|565882581|FG000|Overall Study|Lost to Follow-up|21|||
156762644|NCT01529606|565882582|FG001|Overall Study|Lost to Follow-up|18|||
156762645|NCT01746862|565882583|FG000|Overall Study|Withdrawal by Subject|1|||
156762646|NCT01746862|565882584|FG001|Overall Study|Withdrawal by Subject|1|||
156762647|NCT01746862|565882583|FG000|Overall Study|Protocol Violation|1|||
156762648|NCT01746862|565882584|FG001|Overall Study|Protocol Violation|0|||
156762649|NCT01746862|565882583|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
156762650|NCT01746862|565882584|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
156762651|NCT01746862|565882583|FG000|Overall Study|Entered puberty during the study|1|||
156762652|NCT01746862|565882584|FG001|Overall Study|Entered puberty during the study|0|||
156762653|NCT05209880|565882589|FG000|1-Month Follow-up|Spoke with Doctor|5|||
156762654|NCT05209880|565882590|FG001|1-Month Follow-up|Spoke with Doctor|5|||
157110480|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
157110481|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
157110482|NCT00094770|567158386|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
157110483|NCT00094770|567158387|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
157110484|NCT01911442|567158388|FG000|Overall Study|Adverse Event|2|||
157110485|NCT01911442|567158389|FG001|Overall Study|Adverse Event|2|||
157110486|NCT01911442|567158390|FG002|Overall Study|Adverse Event|4|||
157110487|NCT01911442|567158388|FG000|Overall Study|Lack of Efficacy|1|||
157110488|NCT01911442|567158389|FG001|Overall Study|Lack of Efficacy|1|||
157110489|NCT01911442|567158390|FG002|Overall Study|Lack of Efficacy|1|||
157110490|NCT01911442|567158388|FG000|Overall Study|Lost to Follow-up|2|||
157110491|NCT01911442|567158389|FG001|Overall Study|Lost to Follow-up|0|||
157110492|NCT01911442|567158390|FG002|Overall Study|Lost to Follow-up|1|||
157110493|NCT01911442|567158388|FG000|Overall Study|Withdrawal by Subject|1|||
157110494|NCT01911442|567158389|FG001|Overall Study|Withdrawal by Subject|0|||
157110495|NCT01911442|567158390|FG002|Overall Study|Withdrawal by Subject|6|||
157110496|NCT01911442|567158388|FG000|Overall Study|Mother's Work Schedule|0|||
157110497|NCT01911442|567158389|FG001|Overall Study|Mother's Work Schedule|1|||
156762655|NCT05209880|565882589|FG000|1-Month Follow-up|Lost to Follow-up|7|||
157110498|NCT01911442|567158390|FG002|Overall Study|Mother's Work Schedule|0|||
156762656|NCT05209880|565882590|FG001|1-Month Follow-up|Lost to Follow-up|9|||
157110499|NCT00253643|567158391|FG000|Overall Study|Withdrawal by Subject|0|||
157110500|NCT00253643|567158392|FG001|Overall Study|Withdrawal by Subject|0|||
157110501|NCT00253643|567158393|FG002|Overall Study|Withdrawal by Subject|1|||
157110502|NCT00253643|567158394|FG003|Overall Study|Withdrawal by Subject|1|||
157110503|NCT00253643|567158391|FG000|Overall Study|Non-Compliance|0|||
156762657|NCT05209880|565882589|FG000|1-Month Follow-up|Discontinued|0|||
156762658|NCT05209880|565882590|FG001|1-Month Follow-up|Discontinued|1|||
157110504|NCT00253643|567158392|FG001|Overall Study|Non-Compliance|0|||
157110505|NCT00253643|567158393|FG002|Overall Study|Non-Compliance|0|||
157110506|NCT00253643|567158394|FG003|Overall Study|Non-Compliance|2|||
156762659|NCT05209880|565882589|FG000|3-Month Follow-up|Spoke with Doctor|17|||
156762660|NCT05209880|565882590|FG001|3-Month Follow-up|Spoke with Doctor|7|||
156762661|NCT05209880|565882589|FG000|3-Month Follow-up|Lost to Follow-up|8|||
156762662|NCT05209880|565882590|FG001|3-Month Follow-up|Lost to Follow-up|10|||
156762663|NCT05209880|565882589|FG000|3-Month Follow-up|Discontinued|1|||
156762664|NCT05209880|565882590|FG001|3-Month Follow-up|Discontinued|3|||
156762665|NCT05209880|565882589|FG000|6-Month Follow-up|Spoke with Doctor|25|||
156762666|NCT05209880|565882590|FG001|6-Month Follow-up|Spoke with Doctor|14|||
156762667|NCT05209880|565882589|FG000|6-Month Follow-up|Lost to Follow-up|9|||
156762668|NCT05209880|565882590|FG001|6-Month Follow-up|Lost to Follow-up|14|||
156762669|NCT05209880|565882589|FG000|6-Month Follow-up|Discontinued|1|||
156762670|NCT05209880|565882590|FG001|6-Month Follow-up|Discontinued|3|||
156762671|NCT03143101|565882598|FG000|Overall Study|Withdrawal by Subject|0|||
156762672|NCT03143101|565882599|FG001|Overall Study|Withdrawal by Subject|1|||
156762673|NCT03143101|565882600|FG002|Overall Study|Withdrawal by Subject|0|||
156762674|NCT03143101|565882598|FG000|Overall Study|Lost to Follow-up|2|||
156762675|NCT03143101|565882599|FG001|Overall Study|Lost to Follow-up|2|||
156762676|NCT03143101|565882600|FG002|Overall Study|Lost to Follow-up|0|||
156762677|NCT03973996|565884599|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762678|NCT03973996|565884600|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762679|NCT03973996|565884601|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156762680|NCT03973996|565884602|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
156762681|NCT02026141|565884603|FG000|Overall Study|Protocol Violation|0|||
156762682|NCT02026141|565884604|FG001|Overall Study|Protocol Violation|1|||
156762683|NCT02735980|565884605|FG000|Overall Study|Adverse Event|0|||
156762684|NCT02735980|565884606|FG001|Overall Study|Adverse Event|4|||
156762685|NCT02735980|565884607|FG002|Overall Study|Adverse Event|1|||
156762686|NCT02735980|565884605|FG000|Overall Study|Death|5|||
156762687|NCT02735980|565884606|FG001|Overall Study|Death|4|||
157110507|NCT01263483|567158398|FG000|Overall Study|Adverse Event|4|||
157110508|NCT01263483|567158399|FG001|Overall Study|Adverse Event|0|||
157110509|NCT01263483|567158400|FG002|Overall Study|Adverse Event|3|||
157110510|NCT01263483|567158398|FG000|Overall Study|Withdrawal by Subject|1|||
157110511|NCT01263483|567158399|FG001|Overall Study|Withdrawal by Subject|0|||
157110512|NCT01263483|567158400|FG002|Overall Study|Withdrawal by Subject|0|||
157110513|NCT01263483|567158398|FG000|Overall Study|Lack of Efficacy|2|||
157110514|NCT01263483|567158399|FG001|Overall Study|Lack of Efficacy|0|||
157110515|NCT01263483|567158400|FG002|Overall Study|Lack of Efficacy|0|||
157110516|NCT01263483|567158398|FG000|Overall Study|Protocol Violation|0|||
157110517|NCT01263483|567158399|FG001|Overall Study|Protocol Violation|1|||
157110518|NCT01263483|567158400|FG002|Overall Study|Protocol Violation|1|||
157110519|NCT01263483|567158398|FG000|Overall Study|Participant Unavailability|0|||
157110520|NCT01263483|567158399|FG001|Overall Study|Participant Unavailability|1|||
157110521|NCT01263483|567158400|FG002|Overall Study|Participant Unavailability|1|||
157110522|NCT04451161|567158401|FG000|Overall Study|Lost to Follow-up|28|||
157110523|NCT04451161|567158402|FG001|Overall Study|Lost to Follow-up|37|||
157110524|NCT04451161|567158403|FG002|Overall Study|Lost to Follow-up|22|||
157110525|NCT04451161|567158404|FG003|Overall Study|Lost to Follow-up|13|||
157110526|NCT04451161|567158405|FG004|Overall Study|Lost to Follow-up|11|||
157110527|NCT04451161|567158406|FG005|Overall Study|Lost to Follow-up|14|||
157110528|NCT04451161|567158401|FG000|Overall Study|Withdrawal by Subject|3|||
157110529|NCT04451161|567158402|FG001|Overall Study|Withdrawal by Subject|0|||
157110530|NCT04451161|567158403|FG002|Overall Study|Withdrawal by Subject|0|||
157110531|NCT04451161|567158404|FG003|Overall Study|Withdrawal by Subject|0|||
157110532|NCT04451161|567158405|FG004|Overall Study|Withdrawal by Subject|2|||
157110533|NCT04451161|567158406|FG005|Overall Study|Withdrawal by Subject|4|||
157110534|NCT00454857|567158410|FG000|Overall Study|Withdrawal by Subject|15|||
156762688|NCT02735980|565884607|FG002|Overall Study|Death|0|||
157110535|NCT00454857|567158410|FG000|Overall Study|Lost to Follow-up|16|||
157110536|NCT00454857|567158410|FG000|Overall Study|Noncompliance|6|||
156762689|NCT02735980|565884605|FG000|Overall Study|Physician Decision|3|||
157110537|NCT00454857|567158410|FG000|Overall Study|Death|5|||
157110538|NCT00454857|567158410|FG000|Overall Study|Other|11|||
157110539|NCT00454857|567158410|FG000|Overall Study|Reason unknown|1|||
157110540|NCT00596947|567158411|FG000|Overall Study|study halted due to low enrollment|5|||
157110541|NCT00596947|567158412|FG001|Overall Study|study halted due to low enrollment|3|||
157110542|NCT00596947|567158411|FG000|Overall Study|Lost to Follow-up|1|||
157110543|NCT00596947|567158412|FG001|Overall Study|Lost to Follow-up|0|||
157110544|NCT00829179|567158413|FG000|Overall Study|Withdrawal by Subject|1|||
157110545|NCT03000179|567158414|FG000|Overall Study|Lost to Follow-up|2|||
157110546|NCT00003702|567158416|FG000|Overall Study|Ineligible cell types|2|||
157110547|NCT00003702|567158417|FG001|Overall Study|Ineligible cell types|2|||
157110548|NCT00003702|567158416|FG000|Overall Study|Did not meet criteria for persistence|8|||
157110549|NCT00003702|567158417|FG001|Overall Study|Did not meet criteria for persistence|5|||
157110550|NCT00003702|567158416|FG000|Overall Study|WHO score > 6|2|||
157110551|NCT00003702|567158417|FG001|Overall Study|WHO score > 6|1|||
157110552|NCT00003702|567158416|FG000|Overall Study|Inadequate documentation of disease|1|||
157110553|NCT00003702|567158417|FG001|Overall Study|Inadequate documentation of disease|3|||
157110554|NCT00827606|567158418|FG000|Overall Study|Protocol Violation|4|||
157110555|NCT00827606|567158419|FG001|Overall Study|Protocol Violation|3|||
157110556|NCT00827606|567158418|FG000|Overall Study|Lost to Follow-up|3|||
157110557|NCT00827606|567158419|FG001|Overall Study|Lost to Follow-up|1|||
157110558|NCT00827606|567158418|FG000|Overall Study|Withdrawal by Subject|7|||
157110559|NCT00827606|567158419|FG001|Overall Study|Withdrawal by Subject|6|||
157110560|NCT00827606|567158418|FG000|Overall Study|Pregnancy|0|||
157110561|NCT00827606|567158419|FG001|Overall Study|Pregnancy|1|||
157110562|NCT00827606|567158418|FG000|Overall Study|Other|5|||
157110563|NCT00827606|567158419|FG001|Overall Study|Other|13|||
156762690|NCT02735980|565884606|FG001|Overall Study|Physician Decision|1|||
156762691|NCT02735980|565884607|FG002|Overall Study|Physician Decision|0|||
156762692|NCT02735980|565884605|FG000|Overall Study|Screen failure|1|||
156762693|NCT02735980|565884606|FG001|Overall Study|Screen failure|0|||
156762694|NCT02735980|565884607|FG002|Overall Study|Screen failure|0|||
156762695|NCT02735980|565884605|FG000|Overall Study|Withdrawal by Subject|1|||
156762696|NCT02735980|565884606|FG001|Overall Study|Withdrawal by Subject|2|||
157110564|NCT00827606|567158418|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
157110565|NCT00827606|567158419|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
157110566|NCT00827606|567158418|FG000|Overall Study|Adverse Event|4|||
157110567|NCT00827606|567158419|FG001|Overall Study|Adverse Event|2|||
157110568|NCT00243386|567158424|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
157110569|NCT00243386|567158425|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
157110570|NCT00243386|567158426|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
157110571|NCT00243386|567158424|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
157110572|NCT00243386|567158425|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
157110573|NCT00243386|567158426|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
157110574|NCT00243386|567158424|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
157110575|NCT00243386|567158425|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
157110576|NCT00243386|567158426|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
157110577|NCT00243386|567158424|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
157110578|NCT00243386|567158425|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
157110579|NCT00243386|567158426|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
157110580|NCT00243386|567158424|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
157110581|NCT00243386|567158425|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
157110582|NCT00243386|567158426|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
157110583|NCT00243386|567158424|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
157110584|NCT00243386|567158425|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
157110585|NCT00243386|567158426|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
157110586|NCT00243386|567158424|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
157110587|NCT00243386|567158425|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
157110588|NCT00243386|567158426|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
157110589|NCT00243386|567158424|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
156762697|NCT02735980|565884607|FG002|Overall Study|Withdrawal by Subject|0|||
157110590|NCT00243386|567158425|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
157110591|NCT00243386|567158426|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
156762698|NCT00126594|565884608|FG000|Overall Study|Ineligible|2|||
156762699|NCT00126594|565884609|FG001|Overall Study|Ineligible|0|||
157110592|NCT04995055|567158427|FG000|Period 1|COVID-19 Related|1|||
157110593|NCT04995055|567158428|FG001|Period 1|COVID-19 Related|0|||
156762700|NCT00126594|565884608|FG000|Overall Study|Withdrawal by Subject|0|||
156762701|NCT00126594|565884609|FG001|Overall Study|Withdrawal by Subject|4|||
157005162|NCT00290706|566768635|FG000|Overall Study|Withdrawal by Subject|2|||
157005163|NCT00290706|566768636|FG001|Overall Study|Withdrawal by Subject|0|||
157005164|NCT00290706|566768637|FG002|Overall Study|Withdrawal by Subject|0|||
157005165|NCT00290706|566768638|FG003|Overall Study|Withdrawal by Subject|0|||
157005166|NCT00290706|566768635|FG000|Overall Study|Progressive Disease|3|||
157005167|NCT00290706|566768636|FG001|Overall Study|Progressive Disease|5|||
157005168|NCT00290706|566768637|FG002|Overall Study|Progressive Disease|4|||
157005169|NCT00290706|566768638|FG003|Overall Study|Progressive Disease|10|||
157005170|NCT00290706|566768635|FG000|Overall Study|Adverse Event|0|||
157005171|NCT00290706|566768636|FG001|Overall Study|Adverse Event|1|||
157005172|NCT00290706|566768637|FG002|Overall Study|Adverse Event|2|||
157005173|NCT00290706|566768638|FG003|Overall Study|Adverse Event|0|||
157005174|NCT00290706|566768635|FG000|Overall Study|Receive auto transplant or radiation|0|||
157005175|NCT00290706|566768636|FG001|Overall Study|Receive auto transplant or radiation|0|||
157005176|NCT00290706|566768637|FG002|Overall Study|Receive auto transplant or radiation|0|||
157005177|NCT00290706|566768638|FG003|Overall Study|Receive auto transplant or radiation|1|||
157005178|NCT00290706|566768635|FG000|Overall Study|Physician Decision|0|||
157005179|NCT00290706|566768636|FG001|Overall Study|Physician Decision|0|||
157005180|NCT00290706|566768637|FG002|Overall Study|Physician Decision|0|||
157005181|NCT00290706|566768638|FG003|Overall Study|Physician Decision|1|||
157005182|NCT01196429|566768642|FG000|Overall Study|Ineligible - inadequate pathology|1|||
157005183|NCT01196429|566768643|FG001|Overall Study|Ineligible - inadequate pathology|0|||
157005184|NCT01196429|566768642|FG000|Overall Study|Ineligible - wrong cell type|1|||
157005185|NCT01196429|566768643|FG001|Overall Study|Ineligible - wrong cell type|0|||
157005186|NCT01196429|566768642|FG000|Overall Study|Refused - Never Treated|1|||
157110594|NCT04995055|567158427|FG000|Period 1|Withdrawal by Subject|0|||
157005187|NCT01196429|566768643|FG001|Overall Study|Refused - Never Treated|0|||
157005188|NCT00688519|566768644|FG000|Overall Study|Adverse Event|2|||
157005189|NCT00688519|566768645|FG001|Overall Study|Adverse Event|3|||
157005190|NCT00688519|566768644|FG000|Overall Study|Lost to Follow-up|3|||
157005191|NCT00688519|566768645|FG001|Overall Study|Lost to Follow-up|3|||
157005192|NCT00688519|566768644|FG000|Overall Study|Lack of Efficacy|3|||
157005193|NCT00688519|566768645|FG001|Overall Study|Lack of Efficacy|1|||
157005194|NCT00688519|566768644|FG000|Overall Study|Withdrawal by Subject|7|||
157005195|NCT00688519|566768645|FG001|Overall Study|Withdrawal by Subject|6|||
157005196|NCT00688519|566768644|FG000|Overall Study|Prohibited medication|1|||
157005197|NCT00688519|566768645|FG001|Overall Study|Prohibited medication|0|||
157005198|NCT00688519|566768644|FG000|Overall Study|Non-compliance|0|||
157005199|NCT00688519|566768645|FG001|Overall Study|Non-compliance|1|||
157005200|NCT00688519|566768644|FG000|Overall Study|Subject moved out of state|1|||
157005201|NCT00688519|566768645|FG001|Overall Study|Subject moved out of state|0|||
157005202|NCT00688519|566768644|FG000|Overall Study|Investigator decision|1|||
157005203|NCT00688519|566768645|FG001|Overall Study|Investigator decision|0|||
157005204|NCT00688519|566768644|FG000|Overall Study|Subject moved out of area|1|||
157005205|NCT00688519|566768645|FG001|Overall Study|Subject moved out of area|0|||
157005206|NCT00688519|566768644|FG000|Overall Study|Pregnancy|0|||
157005207|NCT00688519|566768645|FG001|Overall Study|Pregnancy|1|||
157005208|NCT03768206|566768646|FG000|Overall Study|Lost to Follow-up|2|||
157005209|NCT03768206|566768647|FG001|Overall Study|Lost to Follow-up|1|||
157005210|NCT03768206|566768646|FG000|Overall Study|Withdrawal by Subject|0|||
157110595|NCT04995055|567158428|FG001|Period 1|Withdrawal by Subject|1|||
157110596|NCT04995055|567158427|FG000|Period 1|Subject discontinued due to timing|4|||
157110597|NCT04995055|567158428|FG001|Period 1|Subject discontinued due to timing|4|||
157110598|NCT01358760|567158430|FG000|Overall Study|Adverse Event|3|||
157005211|NCT03768206|566768647|FG001|Overall Study|Withdrawal by Subject|1|||
157005212|NCT02486588|566768648|FG000|Overall Study|Randomized in error- ineligible|738|||
157005213|NCT02486588|566768649|FG001|Overall Study|Randomized in error- ineligible|750|||
157005214|NCT02486588|566768650|FG002|Overall Study|Randomized in error- ineligible|755|||
157005215|NCT02486588|566768651|FG003|Overall Study|Randomized in error- ineligible|738|||
157005216|NCT02486588|566768652|FG004|Overall Study|Randomized in error- ineligible|746|||
157005217|NCT02486588|566768653|FG005|Overall Study|Randomized in error- ineligible|746|||
157005218|NCT02551055|566768656|FG000|Overall Study|Death|2|||
157005219|NCT02551055|566768657|FG001|Overall Study|Death|4|||
157005220|NCT02551055|566768658|FG002|Overall Study|Death|2|||
157005221|NCT02551055|566768659|FG003|Overall Study|Death|2|||
157005222|NCT02551055|566768660|FG004|Overall Study|Death|2|||
157005223|NCT02551055|566768661|FG005|Overall Study|Death|1|||
157005224|NCT02551055|566768662|FG006|Overall Study|Death|2|||
157005225|NCT02551055|566768663|FG007|Overall Study|Death|0|||
157005226|NCT02551055|566768656|FG000|Overall Study|Study Terminated by Sponsor|1|||
157005227|NCT02551055|566768657|FG001|Overall Study|Study Terminated by Sponsor|1|||
157005228|NCT02551055|566768658|FG002|Overall Study|Study Terminated by Sponsor|0|||
157005229|NCT02551055|566768659|FG003|Overall Study|Study Terminated by Sponsor|2|||
157005230|NCT02551055|566768660|FG004|Overall Study|Study Terminated by Sponsor|2|||
157005231|NCT02551055|566768661|FG005|Overall Study|Study Terminated by Sponsor|0|||
157005232|NCT02551055|566768662|FG006|Overall Study|Study Terminated by Sponsor|0|||
157005233|NCT02551055|566768663|FG007|Overall Study|Study Terminated by Sponsor|0|||
157005234|NCT02551055|566768656|FG000|Overall Study|Withdrawal by Subject|1|||
157005235|NCT02551055|566768657|FG001|Overall Study|Withdrawal by Subject|1|||
157005236|NCT02551055|566768658|FG002|Overall Study|Withdrawal by Subject|0|||
157005237|NCT02551055|566768659|FG003|Overall Study|Withdrawal by Subject|1|||
157005238|NCT02551055|566768660|FG004|Overall Study|Withdrawal by Subject|2|||
157005239|NCT02551055|566768661|FG005|Overall Study|Withdrawal by Subject|0|||
157005240|NCT02551055|566768662|FG006|Overall Study|Withdrawal by Subject|0|||
157110599|NCT01358760|567158431|FG001|Overall Study|Adverse Event|4|||
156762702|NCT00126594|565884608|FG000|Overall Study|Physician Decision|1|||
156762703|NCT00126594|565884609|FG001|Overall Study|Physician Decision|3|||
156762704|NCT00126594|565884608|FG000|Overall Study|Adverse Event|7|||
156762705|NCT00126594|565884609|FG001|Overall Study|Adverse Event|5|||
156762706|NCT00126594|565884608|FG000|Overall Study|Non-compliance|0|||
156762707|NCT00126594|565884609|FG001|Overall Study|Non-compliance|1|||
156762708|NCT00126594|565884608|FG000|Overall Study|Disease Progression|29|||
156762709|NCT00126594|565884609|FG001|Overall Study|Disease Progression|24|||
156762710|NCT01232790|565884612|FG000|Randomization|Withdrawal by Subject|2|||
156762711|NCT01232790|565884613|FG001|Randomization|Withdrawal by Subject|0|||
156762712|NCT01232790|565884612|FG000|Randomization|Protocol Violation|0|||
156762713|NCT01232790|565884613|FG001|Randomization|Protocol Violation|1|||
156762714|NCT01232790|565884612|FG000|Randomization|Physician Decision|0|||
156762715|NCT01232790|565884613|FG001|Randomization|Physician Decision|1|||
156762716|NCT01232790|565884612|FG000|Initial Assessment|Withdrawal by Subject|0|||
156762717|NCT01232790|565884613|FG001|Initial Assessment|Withdrawal by Subject|1|||
156762718|NCT01232790|565884612|FG000|First Crossover|Withdrawal by Subject|1|||
156762719|NCT01232790|565884613|FG001|First Crossover|Withdrawal by Subject|0|||
156762720|NCT01232790|565884612|FG000|Second Crossover|Withdrawal by Subject|1|||
156762721|NCT01232790|565884613|FG001|Second Crossover|Withdrawal by Subject|2|||
156762722|NCT01239797|565884616|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
156762723|NCT01239797|565884617|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
156762724|NCT01239797|565884616|FG000|Randomized Participants|Participant withdrew consent|1|||
156762725|NCT01239797|565884617|FG001|Randomized Participants|Participant withdrew consent|7|||
156762726|NCT01239797|565884616|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
156762727|NCT01239797|565884617|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
156762728|NCT01239797|565884616|FG000|Treated Participants|Disease progression|185|||
156762729|NCT01239797|565884617|FG001|Treated Participants|Disease progression|185|||
156762730|NCT01239797|565884616|FG000|Treated Participants|Study drug toxicity|39|||
156762731|NCT01239797|565884617|FG001|Treated Participants|Study drug toxicity|45|||
156762732|NCT01239797|565884616|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
156762733|NCT01239797|565884617|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
157005241|NCT02551055|566768663|FG007|Overall Study|Withdrawal by Subject|0|||
157110600|NCT01358760|567158432|FG002|Overall Study|Adverse Event|3|||
156762734|NCT01239797|565884616|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
156762735|NCT01239797|565884617|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
156762736|NCT01239797|565884616|FG000|Treated Participants|Administrative reason by sponsor|13|||
157005242|NCT02551055|566768656|FG000|Overall Study|Reason not specified|0|||
157005243|NCT02551055|566768657|FG001|Overall Study|Reason not specified|0|||
157110601|NCT01358760|567158430|FG000|Overall Study|Lost to Follow-up|1|||
156762737|NCT01239797|565884617|FG001|Treated Participants|Administrative reason by sponsor|4|||
156762738|NCT01239797|565884616|FG000|Treated Participants|Other reasons|14|||
156762739|NCT01239797|565884617|FG001|Treated Participants|Other reasons|14|||
156762740|NCT01239797|565884616|FG000|Treated Participants|Participant withdrew consent|6|||
156762741|NCT01239797|565884617|FG001|Treated Participants|Participant withdrew consent|11|||
156762742|NCT01239797|565884616|FG000|Treated Participants|Death|1|||
156762743|NCT01239797|565884617|FG001|Treated Participants|Death|1|||
156762744|NCT01239797|565884616|FG000|Treated Participants|Participant no longer meets study criteria|1|||
156762745|NCT01239797|565884617|FG001|Treated Participants|Participant no longer meets study criteria|1|||
156762746|NCT01239797|565884616|FG000|Treated Participants|Poor/non-compliance|0|||
156762747|NCT01239797|565884617|FG001|Treated Participants|Poor/non-compliance|1|||
156762748|NCT00853762|565884618|FG000|Overall Study|Premature Termination|16|||
156762749|NCT00853762|565884619|FG001|Overall Study|Premature Termination|15|||
156762750|NCT00853762|565884620|FG002|Overall Study|Premature Termination|14|||
156762751|NCT00853762|565884621|FG003|Overall Study|Premature Termination|21|||
156762752|NCT00853762|565884618|FG000|Overall Study|Protocol Violation|0|||
156762753|NCT00853762|565884619|FG001|Overall Study|Protocol Violation|0|||
156762754|NCT00853762|565884620|FG002|Overall Study|Protocol Violation|0|||
156762755|NCT00853762|565884621|FG003|Overall Study|Protocol Violation|1|||
156762756|NCT00853762|565884618|FG000|Overall Study|Withdrawal by Subject|0|||
156762757|NCT00853762|565884619|FG001|Overall Study|Withdrawal by Subject|0|||
156762758|NCT00853762|565884620|FG002|Overall Study|Withdrawal by Subject|1|||
156762759|NCT00853762|565884621|FG003|Overall Study|Withdrawal by Subject|0|||
156762760|NCT00853762|565884618|FG000|Overall Study|Other|0|||
156762761|NCT00853762|565884619|FG001|Overall Study|Other|2|||
156762762|NCT00853762|565884620|FG002|Overall Study|Other|0|||
156762763|NCT00853762|565884621|FG003|Overall Study|Other|0|||
156762764|NCT00853762|565884618|FG000|Overall Study|Randomised but not Treated|0|||
156762765|NCT00853762|565884619|FG001|Overall Study|Randomised but not Treated|2|||
156762766|NCT00853762|565884620|FG002|Overall Study|Randomised but not Treated|2|||
156762767|NCT00853762|565884621|FG003|Overall Study|Randomised but not Treated|0|||
156762768|NCT02059239|565884628|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
156762769|NCT02059239|565884629|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
156762770|NCT02059239|565884628|FG000|Overall Study|Physician Decision|1|||
156762771|NCT02059239|565884629|FG001|Overall Study|Physician Decision|0|||
156762772|NCT01408706|565884631|FG000|Overall Study|Physician Decision|1|||
156762773|NCT01408706|565884632|FG001|Overall Study|Physician Decision|0|||
156762774|NCT01222104|565884633|FG000|Overall Study|Lost to Follow-up|37|||
156762775|NCT01222104|565884633|FG000|Overall Study|Death|10|||
156762776|NCT00888654|565884635|FG000|Overall Study|Problems swallowing oral meds.|1|||
156762777|NCT00888654|565884635|FG000|Overall Study|Not enough oral meds before surgery|3|||
156762778|NCT00888654|565884635|FG000|Overall Study|Surgery aborted|2|||
156762779|NCT00888654|565884635|FG000|Overall Study|Withdrawal by Subject|1|||
156762780|NCT00888654|565884635|FG000|Overall Study|Inelig. due to contraindication of med|1|||
156762781|NCT00888654|565884635|FG000|Overall Study|Change in surg date|1|||
156762782|NCT00888654|565884635|FG000|Overall Study|Stopped meds due to headaches|1|||
157005244|NCT02551055|566768658|FG002|Overall Study|Reason not specified|0|||
156762783|NCT01418339|565884636|FG000|Overall Study|Adverse Event|5|||
156762784|NCT01418339|565884637|FG001|Overall Study|Adverse Event|2|||
156762785|NCT01418339|565884636|FG000|Overall Study|Subject Withdrew Consent|1|||
157110602|NCT01358760|567158431|FG001|Overall Study|Lost to Follow-up|1|||
157110603|NCT01358760|567158432|FG002|Overall Study|Lost to Follow-up|3|||
157110604|NCT01358760|567158430|FG000|Overall Study|Withdrawal by Subject|5|||
157110605|NCT01358760|567158431|FG001|Overall Study|Withdrawal by Subject|3|||
157110606|NCT01358760|567158432|FG002|Overall Study|Withdrawal by Subject|2|||
157110607|NCT01358760|567158430|FG000|Overall Study|Physician Decision|1|||
157110608|NCT01358760|567158431|FG001|Overall Study|Physician Decision|0|||
157110609|NCT01358760|567158432|FG002|Overall Study|Physician Decision|1|||
157110610|NCT01358760|567158430|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
157110611|NCT01358760|567158431|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
157110612|NCT01358760|567158432|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
157110613|NCT04695392|567158433|FG000|Overall Study|Withdrawn by parent/guardian|0|||
157110614|NCT04695392|567158434|FG001|Overall Study|Withdrawn by parent/guardian|1|||
157110615|NCT04695392|567158433|FG000|Overall Study|Withdrawn by physician|0|||
157110616|NCT04695392|567158434|FG001|Overall Study|Withdrawn by physician|1|||
157110617|NCT01506960|567158435|FG000|Overall Study|Did not meet angiographic criteria|47|||
157110618|NCT01987960|567158437|FG000|Period 1|Adverse Event|24|||
157110619|NCT01987960|567158438|FG001|Period 1|Adverse Event|0|||
157110620|NCT01987960|567158439|FG002|Period 1|Adverse Event|0|||
157110621|NCT01987960|567158440|FG003|Period 1|Adverse Event|0|||
157110622|NCT01987960|567158437|FG000|Period 1|Lack of Efficacy|4|||
157110623|NCT01987960|567158438|FG001|Period 1|Lack of Efficacy|0|||
157110624|NCT01987960|567158439|FG002|Period 1|Lack of Efficacy|0|||
157110625|NCT01987960|567158440|FG003|Period 1|Lack of Efficacy|0|||
157110626|NCT01987960|567158437|FG000|Period 1|Non-compliance with IMP|6|||
157110627|NCT01987960|567158438|FG001|Period 1|Non-compliance with IMP|0|||
157110628|NCT01987960|567158439|FG002|Period 1|Non-compliance with IMP|0|||
157110629|NCT01987960|567158440|FG003|Period 1|Non-compliance with IMP|0|||
157110630|NCT01987960|567158437|FG000|Period 1|Protocol Violation|12|||
157110631|NCT01987960|567158438|FG001|Period 1|Protocol Violation|0|||
157110632|NCT01987960|567158439|FG002|Period 1|Protocol Violation|0|||
157110633|NCT01987960|567158440|FG003|Period 1|Protocol Violation|0|||
157110634|NCT01987960|567158437|FG000|Period 1|Withdrawal by Subject|21|||
157110635|NCT01987960|567158438|FG001|Period 1|Withdrawal by Subject|0|||
157110636|NCT01987960|567158439|FG002|Period 1|Withdrawal by Subject|0|||
157110637|NCT01987960|567158440|FG003|Period 1|Withdrawal by Subject|0|||
157110638|NCT01987960|567158437|FG000|Period 1|Lost to Follow-up|40|||
157110639|NCT01987960|567158438|FG001|Period 1|Lost to Follow-up|0|||
157110640|NCT01987960|567158439|FG002|Period 1|Lost to Follow-up|0|||
157110641|NCT01987960|567158440|FG003|Period 1|Lost to Follow-up|0|||
157110642|NCT01987960|567158437|FG000|Period 1|administrative or other reason|75|||
157110643|NCT01987960|567158438|FG001|Period 1|administrative or other reason|0|||
157110644|NCT01987960|567158439|FG002|Period 1|administrative or other reason|0|||
157110645|NCT01987960|567158440|FG003|Period 1|administrative or other reason|0|||
157110646|NCT01987960|567158437|FG000|Period 1|Withdrawal of consent before treatment|4|||
157110647|NCT01987960|567158438|FG001|Period 1|Withdrawal of consent before treatment|0|||
157110648|NCT01987960|567158439|FG002|Period 1|Withdrawal of consent before treatment|0|||
157110649|NCT01987960|567158440|FG003|Period 1|Withdrawal of consent before treatment|0|||
157110650|NCT01987960|567158437|FG000|Period 2|Adverse Event|0|||
157110651|NCT01987960|567158438|FG001|Period 2|Adverse Event|0|||
157110652|NCT01987960|567158439|FG002|Period 2|Adverse Event|1|||
156762786|NCT01418339|565884637|FG001|Overall Study|Subject Withdrew Consent|2|||
156762787|NCT01418339|565884636|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
156762788|NCT01418339|565884637|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
156762789|NCT02204917|565884640|FG000|Overall Study|Protocol Violation|1|||
156762790|NCT02219685|565884641|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
156762791|NCT02219685|565884642|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
156762792|NCT02219685|565884641|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
156762793|NCT02219685|565884642|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
156762794|NCT00698815|565884643|FG000|Overall Study|Death|1|||
156762795|NCT00698815|565884644|FG001|Overall Study|Death|2|||
156762796|NCT00698815|565884645|FG002|Overall Study|Death|4|||
156762797|NCT00698815|565884643|FG000|Overall Study|Withdrawal by Subject|6|||
156762798|NCT00698815|565884644|FG001|Overall Study|Withdrawal by Subject|3|||
156762799|NCT00698815|565884645|FG002|Overall Study|Withdrawal by Subject|2|||
156762800|NCT00698815|565884643|FG000|Overall Study|MD discretion|2|||
156762801|NCT00698815|565884644|FG001|Overall Study|MD discretion|7|||
156762802|NCT00698815|565884645|FG002|Overall Study|MD discretion|2|||
156762803|NCT00698815|565884643|FG000|Overall Study|Did not receive protocol treatment|1|||
157005245|NCT02551055|566768659|FG003|Overall Study|Reason not specified|0|||
157005246|NCT02551055|566768660|FG004|Overall Study|Reason not specified|1|||
157005247|NCT02551055|566768661|FG005|Overall Study|Reason not specified|0|||
157005248|NCT02551055|566768662|FG006|Overall Study|Reason not specified|1|||
157005249|NCT02551055|566768663|FG007|Overall Study|Reason not specified|0|||
157005250|NCT00430300|566768664|FG000|Overall Study|Adverse Event|0|||
157005251|NCT00430300|566768665|FG001|Overall Study|Adverse Event|2|||
157005252|NCT00430300|566768666|FG002|Overall Study|Adverse Event|1|||
157005253|NCT00430300|566768667|FG003|Overall Study|Adverse Event|1|||
157005254|NCT00430300|566768664|FG000|Overall Study|Withdrawal by Subject|1|||
157005255|NCT00430300|566768665|FG001|Overall Study|Withdrawal by Subject|0|||
157005256|NCT00430300|566768666|FG002|Overall Study|Withdrawal by Subject|5|||
157005257|NCT00430300|566768667|FG003|Overall Study|Withdrawal by Subject|0|||
157005258|NCT00430300|566768664|FG000|Overall Study|Laboratory abnormality|1|||
157005259|NCT00430300|566768665|FG001|Overall Study|Laboratory abnormality|0|||
157005260|NCT00430300|566768666|FG002|Overall Study|Laboratory abnormality|0|||
157005261|NCT00430300|566768667|FG003|Overall Study|Laboratory abnormality|0|||
157005262|NCT00430300|566768664|FG000|Overall Study|Other|0|||
157005263|NCT00430300|566768665|FG001|Overall Study|Other|0|||
157005264|NCT00430300|566768666|FG002|Overall Study|Other|0|||
157005265|NCT00430300|566768667|FG003|Overall Study|Other|1|||
157005266|NCT02041104|566768672|FG000|Overall Study|Lost to Follow-up|1|||
157005267|NCT02041104|566768673|FG001|Overall Study|Lost to Follow-up|4|||
157005268|NCT02041104|566768672|FG000|Overall Study|discomfort during OGTT|0|||
157005269|NCT02041104|566768673|FG001|Overall Study|discomfort during OGTT|3|||
157005270|NCT01063517|566768674|FG000|Overall Study|Consent withdrawal|1|||
157005271|NCT01063517|566768675|FG001|Overall Study|Consent withdrawal|0|||
157005272|NCT01063517|566768674|FG000|Overall Study|Study reached data cut-off|19|||
157005273|NCT01063517|566768675|FG001|Overall Study|Study reached data cut-off|7|||
157005274|NCT01063517|566768674|FG000|Overall Study|Lost to Follow-up|4|||
157005275|NCT01063517|566768675|FG001|Overall Study|Lost to Follow-up|3|||
157005276|NCT01063517|566768674|FG000|Overall Study|Withdrawal by Subject|1|||
157005277|NCT01063517|566768675|FG001|Overall Study|Withdrawal by Subject|2|||
157005278|NCT01063517|566768674|FG000|Overall Study|Death|33|||
157005279|NCT01063517|566768675|FG001|Overall Study|Death|48|||
157005280|NCT05328297|566770070|FG000|Overall Study|Adverse Event|5|||
157005281|NCT05328297|566770071|FG001|Overall Study|Adverse Event|7|||
157005282|NCT05328297|566770070|FG000|Overall Study|Withdrawal by Subject|4|||
157005283|NCT05328297|566770071|FG001|Overall Study|Withdrawal by Subject|3|||
157005284|NCT05328297|566770070|FG000|Overall Study|Lack of Efficacy|1|||
157005285|NCT05328297|566770071|FG001|Overall Study|Lack of Efficacy|0|||
157005286|NCT05328297|566770070|FG000|Overall Study|Lost to Follow-up|1|||
157005287|NCT05328297|566770071|FG001|Overall Study|Lost to Follow-up|0|||
157005288|NCT05328297|566770070|FG000|Overall Study|Protocol Violation|1|||
157005289|NCT05328297|566770071|FG001|Overall Study|Protocol Violation|0|||
157005290|NCT05328297|566770070|FG000|Overall Study|Randomized but not treated|1|||
157005291|NCT05328297|566770071|FG001|Overall Study|Randomized but not treated|1|||
157005292|NCT05147233|566770072|FG000|Overall Study|Adverse Event|0|||
157005293|NCT05147233|566770073|FG001|Overall Study|Adverse Event|1|||
157005294|NCT05147233|566770072|FG000|Overall Study|Lost to Follow-up|1|||
157005295|NCT05147233|566770073|FG001|Overall Study|Lost to Follow-up|1|||
157005296|NCT05147233|566770072|FG000|Overall Study|Protocol Violation|0|||
157005297|NCT05147233|566770073|FG001|Overall Study|Protocol Violation|1|||
157005298|NCT05147233|566770072|FG000|Overall Study|Withdrawal by Subject|2|||
157005299|NCT05147233|566770073|FG001|Overall Study|Withdrawal by Subject|1|||
157005300|NCT04860258|566770074|FG000|Overall Study|Withdrawal by Subject|0|||
157005301|NCT04860258|566770075|FG001|Overall Study|Withdrawal by Subject|0|||
156762804|NCT00698815|565884644|FG001|Overall Study|Did not receive protocol treatment|2|||
156762805|NCT00698815|565884645|FG002|Overall Study|Did not receive protocol treatment|2|||
156762806|NCT00731822|565884653|FG000|Overall Study|Adverse Event|2|||
156762807|NCT00731822|565884654|FG001|Overall Study|Adverse Event|1|||
156762808|NCT00731822|565884653|FG000|Overall Study|Protocol Violation|1|||
156762809|NCT00731822|565884654|FG001|Overall Study|Protocol Violation|0|||
156762810|NCT00731822|565884653|FG000|Overall Study|Lost to Follow-up|1|||
156762811|NCT00731822|565884654|FG001|Overall Study|Lost to Follow-up|0|||
156762812|NCT02127658|565884658|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
156762813|NCT02127658|565884659|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
156762814|NCT02127658|565884658|FG000|Overall Study|Withdrawal by Subject|0|||
156762815|NCT02127658|565884659|FG001|Overall Study|Withdrawal by Subject|2|||
156762816|NCT02127658|565884658|FG000|Overall Study|Physician Decision|0|||
156762817|NCT02127658|565884659|FG001|Overall Study|Physician Decision|1|||
156762818|NCT03834493|565884660|FG000|Overall Study|Participants Ongoing|311|||
156762819|NCT03834493|565884661|FG001|Overall Study|Participants Ongoing|324|||
156762820|NCT03834493|565884660|FG000|Overall Study|Withdrawal by Subject|20|||
156762821|NCT03834493|565884661|FG001|Overall Study|Withdrawal by Subject|17|||
156762822|NCT03834493|565884660|FG000|Overall Study|Physician Decision|1|||
156762823|NCT03834493|565884661|FG001|Overall Study|Physician Decision|0|||
156762824|NCT03834493|565884660|FG000|Overall Study|Death|289|||
156762825|NCT03834493|565884661|FG001|Overall Study|Death|282|||
156762826|NCT04003103|565884662|FG000|Overall Study|Death|1|||
156762827|NCT04003103|565884663|FG001|Overall Study|Death|0|||
156762828|NCT04003103|565884664|FG002|Overall Study|Death|0|||
156762829|NCT04003103|565884662|FG000|Overall Study|Lost to Follow-up|4|||
156762830|NCT04003103|565884663|FG001|Overall Study|Lost to Follow-up|3|||
156762831|NCT04003103|565884664|FG002|Overall Study|Lost to Follow-up|2|||
156762832|NCT04003103|565884662|FG000|Overall Study|Withdrawal by Subject|10|||
156762833|NCT04003103|565884663|FG001|Overall Study|Withdrawal by Subject|1|||
156762834|NCT04003103|565884664|FG002|Overall Study|Withdrawal by Subject|1|||
156762835|NCT04003103|565884662|FG000|Overall Study|Status not recorded|0|||
156762836|NCT04003103|565884663|FG001|Overall Study|Status not recorded|2|||
156762837|NCT04003103|565884664|FG002|Overall Study|Status not recorded|0|||
156762838|NCT04144322|565884668|FG000|Overall Study|Lack of Efficacy|2|||
156762839|NCT04144322|565884669|FG001|Overall Study|Lack of Efficacy|2|||
156762840|NCT02277028|565884670|FG000|Overall Study|Lost to Follow-up|1|||
156762841|NCT02277028|565884671|FG001|Overall Study|Lost to Follow-up|0|||
156762842|NCT02277028|565884670|FG000|Overall Study|Withdrawal by Subject|0|||
156762843|NCT02277028|565884671|FG001|Overall Study|Withdrawal by Subject|1|||
156762844|NCT02718911|565884672|FG000|Overall Study|Adverse Event|0|||
156762845|NCT02718911|565884673|FG001|Overall Study|Adverse Event|0|||
156762846|NCT02718911|565884674|FG002|Overall Study|Adverse Event|0|||
156762847|NCT02718911|565884675|FG003|Overall Study|Adverse Event|0|||
156762848|NCT02718911|565884676|FG004|Overall Study|Adverse Event|0|||
156762849|NCT02718911|565884677|FG005|Overall Study|Adverse Event|0|||
156762850|NCT02718911|565884678|FG006|Overall Study|Adverse Event|0|||
156762851|NCT02718911|565884679|FG007|Overall Study|Adverse Event|0|||
156762852|NCT02718911|565884680|FG008|Overall Study|Adverse Event|0|||
156762853|NCT02718911|565884681|FG009|Overall Study|Adverse Event|2|||
156762854|NCT02718911|565884672|FG000|Overall Study|Death|2|||
156762855|NCT02718911|565884673|FG001|Overall Study|Death|3|||
156762856|NCT02718911|565884674|FG002|Overall Study|Death|1|||
156762857|NCT02718911|565884675|FG003|Overall Study|Death|0|||
156762858|NCT02718911|565884676|FG004|Overall Study|Death|1|||
156762859|NCT02718911|565884677|FG005|Overall Study|Death|3|||
156762860|NCT02718911|565884678|FG006|Overall Study|Death|1|||
156762861|NCT02718911|565884679|FG007|Overall Study|Death|1|||
156762862|NCT02718911|565884680|FG008|Overall Study|Death|4|||
156762863|NCT02718911|565884681|FG009|Overall Study|Death|3|||
156762864|NCT02718911|565884672|FG000|Overall Study|Lost to Follow-up|0|||
156762865|NCT02718911|565884673|FG001|Overall Study|Lost to Follow-up|0|||
156762866|NCT02718911|565884674|FG002|Overall Study|Lost to Follow-up|0|||
156762867|NCT02718911|565884675|FG003|Overall Study|Lost to Follow-up|0|||
156762868|NCT02718911|565884676|FG004|Overall Study|Lost to Follow-up|0|||
156762869|NCT02718911|565884677|FG005|Overall Study|Lost to Follow-up|0|||
156762870|NCT02718911|565884678|FG006|Overall Study|Lost to Follow-up|0|||
156762871|NCT02718911|565884679|FG007|Overall Study|Lost to Follow-up|0|||
156762872|NCT02718911|565884680|FG008|Overall Study|Lost to Follow-up|1|||
156762873|NCT02718911|565884681|FG009|Overall Study|Lost to Follow-up|0|||
156762874|NCT02718911|565884672|FG000|Overall Study|Physician Decision|2|||
156762875|NCT02718911|565884673|FG001|Overall Study|Physician Decision|0|||
156762876|NCT02718911|565884674|FG002|Overall Study|Physician Decision|1|||
156762877|NCT02718911|565884675|FG003|Overall Study|Physician Decision|1|||
156762878|NCT02718911|565884676|FG004|Overall Study|Physician Decision|0|||
156762879|NCT02718911|565884677|FG005|Overall Study|Physician Decision|0|||
156762880|NCT02718911|565884678|FG006|Overall Study|Physician Decision|0|||
156762881|NCT02718911|565884679|FG007|Overall Study|Physician Decision|1|||
156762882|NCT02718911|565884680|FG008|Overall Study|Physician Decision|2|||
156762883|NCT02718911|565884681|FG009|Overall Study|Physician Decision|1|||
156762884|NCT02718911|565884672|FG000|Overall Study|Withdrawal by Subject|0|||
156762885|NCT02718911|565884673|FG001|Overall Study|Withdrawal by Subject|0|||
156762886|NCT02718911|565884674|FG002|Overall Study|Withdrawal by Subject|0|||
156762887|NCT02718911|565884675|FG003|Overall Study|Withdrawal by Subject|0|||
157110653|NCT01987960|567158440|FG003|Period 2|Adverse Event|0|||
157110654|NCT01987960|567158437|FG000|Period 2|Withdrawal by Subject|0|||
157110655|NCT01987960|567158438|FG001|Period 2|Withdrawal by Subject|0|||
156762888|NCT02718911|565884676|FG004|Overall Study|Withdrawal by Subject|1|||
156762889|NCT02718911|565884677|FG005|Overall Study|Withdrawal by Subject|0|||
156762890|NCT02718911|565884678|FG006|Overall Study|Withdrawal by Subject|0|||
156762891|NCT02718911|565884679|FG007|Overall Study|Withdrawal by Subject|0|||
156762892|NCT02718911|565884680|FG008|Overall Study|Withdrawal by Subject|1|||
156762893|NCT02718911|565884681|FG009|Overall Study|Withdrawal by Subject|4|||
156762894|NCT02718911|565884672|FG000|Overall Study|Reason Not Collected|0|||
156762895|NCT02718911|565884673|FG001|Overall Study|Reason Not Collected|0|||
156762896|NCT02718911|565884674|FG002|Overall Study|Reason Not Collected|1|||
156762897|NCT02718911|565884675|FG003|Overall Study|Reason Not Collected|0|||
156762898|NCT02718911|565884676|FG004|Overall Study|Reason Not Collected|0|||
156762899|NCT02718911|565884677|FG005|Overall Study|Reason Not Collected|0|||
156762900|NCT02718911|565884678|FG006|Overall Study|Reason Not Collected|2|||
156762901|NCT02718911|565884679|FG007|Overall Study|Reason Not Collected|1|||
156762902|NCT02718911|565884680|FG008|Overall Study|Reason Not Collected|4|||
156762903|NCT02718911|565884681|FG009|Overall Study|Reason Not Collected|9|||
156762904|NCT04817332|565884682|FG000|Overall Study|Lost to Follow-up|3|||
156762905|NCT04817332|565884683|FG001|Overall Study|Lost to Follow-up|3|||
156762906|NCT04817332|565884682|FG000|Overall Study|Protocol Violation|2|||
156762907|NCT04817332|565884683|FG001|Overall Study|Protocol Violation|0|||
156762908|NCT01867008|565884684|FG000|Overall Study|Withdrawal by Subject|1|||
156762909|NCT00983372|565884685|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
156762910|NCT00983372|565884685|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
156762911|NCT00983372|565884685|FG000|Diltiazem ER Alone|Adverse Event|1|||
156762912|NCT05635045|565884686|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762913|NCT05635045|565884687|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762914|NCT05635045|565884688|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
156762915|NCT05635045|565884689|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
156762916|NCT00570401|565884704|FG000|Overall Study|Adverse Event|2|||
156762917|NCT00871234|565884705|FG000|Overall Study|Adverse Event|2|||
156762918|NCT00871234|565884705|FG000|Overall Study|Lost to Follow-up|3|||
156762919|NCT00427908|565884706|FG000|Primary Phase|Lost to Follow-up|4|||
156762920|NCT00427908|565884707|FG001|Primary Phase|Lost to Follow-up|0|||
156762921|NCT00427908|565884708|FG002|Primary Phase|Lost to Follow-up|2|||
156762922|NCT00427908|565884709|FG003|Primary Phase|Lost to Follow-up|0|||
156762923|NCT00427908|565884706|FG000|Primary Phase|Withdrawal by Subject|1|||
156762924|NCT00427908|565884707|FG001|Primary Phase|Withdrawal by Subject|2|||
156762925|NCT00427908|565884708|FG002|Primary Phase|Withdrawal by Subject|1|||
156762926|NCT00427908|565884709|FG003|Primary Phase|Withdrawal by Subject|0|||
156762927|NCT00427908|565884706|FG000|Primary Phase|Adverse Event|0|||
156762928|NCT00427908|565884707|FG001|Primary Phase|Adverse Event|1|||
156762929|NCT00427908|565884708|FG002|Primary Phase|Adverse Event|0|||
156762930|NCT00427908|565884709|FG003|Primary Phase|Adverse Event|0|||
156762931|NCT01710020|565884710|FG000|Period 1|Protocol Violation|1|||
156762932|NCT01764841|565884711|FG000|Overall Study|Logistical Difficulties|0|||
156762933|NCT01764841|565884712|FG001|Overall Study|Logistical Difficulties|1|||
156762934|NCT01764841|565884713|FG002|Overall Study|Logistical Difficulties|0|||
156762935|NCT01764841|565884714|FG003|Overall Study|Logistical Difficulties|0|||
156762936|NCT01764841|565884711|FG000|Overall Study|Death|3|||
156762937|NCT01764841|565884712|FG001|Overall Study|Death|0|||
156762938|NCT01764841|565884713|FG002|Overall Study|Death|1|||
156762939|NCT01764841|565884714|FG003|Overall Study|Death|4|||
156762940|NCT01764841|565884711|FG000|Overall Study|No Follow Up|1|||
156762941|NCT01764841|565884712|FG001|Overall Study|No Follow Up|0|||
156762942|NCT01764841|565884713|FG002|Overall Study|No Follow Up|1|||
156762943|NCT01764841|565884714|FG003|Overall Study|No Follow Up|0|||
156762944|NCT01764841|565884711|FG000|Overall Study|Protocol Violation|0|||
157005302|NCT04860258|566770076|FG002|Overall Study|Withdrawal by Subject|4|||
157005303|NCT04860258|566770077|FG003|Overall Study|Withdrawal by Subject|1|||
157005304|NCT04860258|566770078|FG004|Overall Study|Withdrawal by Subject|4|||
157005305|NCT04860258|566770079|FG005|Overall Study|Withdrawal by Subject|1|||
157005306|NCT04860258|566770080|FG006|Overall Study|Withdrawal by Subject|0|||
157005307|NCT00028769|566770081|FG000|Overall Study|Adverse Event|2|||
157005308|NCT00028769|566770081|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
157005309|NCT00028769|566770081|FG000|Overall Study|Progression or Death|31|||
157005310|NCT00028769|566770081|FG000|Overall Study|Other - Not Protocol Specified|1|||
156762945|NCT01764841|565884712|FG001|Overall Study|Protocol Violation|1|||
156762946|NCT01764841|565884713|FG002|Overall Study|Protocol Violation|0|||
156762947|NCT01764841|565884714|FG003|Overall Study|Protocol Violation|0|||
156762948|NCT01764841|565884711|FG000|Overall Study|Withdrawal by Subject|16|||
156762949|NCT01764841|565884712|FG001|Overall Study|Withdrawal by Subject|24|||
156762950|NCT01764841|565884713|FG002|Overall Study|Withdrawal by Subject|11|||
156762951|NCT01764841|565884714|FG003|Overall Study|Withdrawal by Subject|15|||
156762952|NCT01764841|565884711|FG000|Overall Study|Lost to Follow-up|3|||
156762953|NCT01764841|565884712|FG001|Overall Study|Lost to Follow-up|0|||
156762954|NCT01764841|565884713|FG002|Overall Study|Lost to Follow-up|1|||
156762955|NCT01764841|565884714|FG003|Overall Study|Lost to Follow-up|0|||
156762956|NCT02573259|565884720|FG000|Overall Study|Death|1|||
156762957|NCT02573259|565884721|FG001|Overall Study|Death|6|||
156762958|NCT02573259|565884722|FG002|Overall Study|Death|5|||
156762959|NCT02573259|565884723|FG003|Overall Study|Death|6|||
156762960|NCT02573259|565884724|FG004|Overall Study|Death|9|||
156762961|NCT02573259|565884725|FG005|Overall Study|Death|32|||
156762962|NCT02573259|565884726|FG006|Overall Study|Death|21|||
156762963|NCT02573259|565884720|FG000|Overall Study|Lost to Follow-up|0|||
156762964|NCT02573259|565884721|FG001|Overall Study|Lost to Follow-up|0|||
156762965|NCT02573259|565884722|FG002|Overall Study|Lost to Follow-up|0|||
156762966|NCT02573259|565884723|FG003|Overall Study|Lost to Follow-up|0|||
156762967|NCT02573259|565884724|FG004|Overall Study|Lost to Follow-up|0|||
156762968|NCT02573259|565884725|FG005|Overall Study|Lost to Follow-up|2|||
156762969|NCT02573259|565884726|FG006|Overall Study|Lost to Follow-up|1|||
156762970|NCT02573259|565884720|FG000|Overall Study|Participant refused further follow-up|0|||
156762971|NCT02573259|565884721|FG001|Overall Study|Participant refused further follow-up|2|||
156762972|NCT02573259|565884722|FG002|Overall Study|Participant refused further follow-up|1|||
156762973|NCT02573259|565884723|FG003|Overall Study|Participant refused further follow-up|0|||
156762974|NCT02573259|565884724|FG004|Overall Study|Participant refused further follow-up|3|||
156762975|NCT02573259|565884725|FG005|Overall Study|Participant refused further follow-up|20|||
156762976|NCT02573259|565884726|FG006|Overall Study|Participant refused further follow-up|7|||
156762977|NCT02573259|565884720|FG000|Overall Study|Other|0|||
156762978|NCT02573259|565884721|FG001|Overall Study|Other|0|||
156762979|NCT02573259|565884722|FG002|Overall Study|Other|0|||
156762980|NCT02573259|565884723|FG003|Overall Study|Other|0|||
156762981|NCT02573259|565884724|FG004|Overall Study|Other|1|||
156762982|NCT02573259|565884725|FG005|Overall Study|Other|4|||
156762983|NCT02573259|565884726|FG006|Overall Study|Other|5|||
156762984|NCT00751140|565884730|FG000|Overall Study|benign angioma excluded from analysis|1|||
156762985|NCT03160716|565884731|FG000|Overall Study|Lost to Follow-up|1|||
156762986|NCT01628848|565884732|FG000|Overall Study|Adverse Event|9|||
156762987|NCT01628848|565884733|FG001|Overall Study|Adverse Event|7|||
156762988|NCT01628848|565884732|FG000|Overall Study|Lack of Efficacy|0|||
156762989|NCT01628848|565884733|FG001|Overall Study|Lack of Efficacy|4|||
156762990|NCT01628848|565884732|FG000|Overall Study|Withdrawal by Subject|0|||
156762991|NCT01628848|565884733|FG001|Overall Study|Withdrawal by Subject|2|||
156762992|NCT01628848|565884732|FG000|Overall Study|Physician Decision|3|||
156762993|NCT01628848|565884733|FG001|Overall Study|Physician Decision|1|||
156762994|NCT00689338|565884735|FG000|Overall Study|Death|65|||
156762995|NCT00689338|565884735|FG000|Overall Study|Adverse Event|13|||
156762996|NCT00689338|565884735|FG000|Overall Study|Insufficient Clinical Response|1|||
156762997|NCT00689338|565884735|FG000|Overall Study|Lack of Efficacy|6|||
156762998|NCT00689338|565884735|FG000|Overall Study|Other|8|||
156762999|NCT00689338|565884735|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
156763000|NCT00689338|565884735|FG000|Overall Study|Lost to Follow-up|5|||
156763001|NCT00689338|565884735|FG000|Overall Study|Withdrawal by Subject|3|||
156763002|NCT00689338|565884735|FG000|Overall Study|Protocol Violation|15|||
156763003|NCT00808067|565884736|FG000|Overall Study|Major/minor bleed|30|||
156763004|NCT00808067|565884737|FG001|Overall Study|Major/minor bleed|44|||
156763005|NCT00808067|565884736|FG000|Overall Study|Outcome event - other|33|||
156763006|NCT00808067|565884737|FG001|Overall Study|Outcome event - other|25|||
156763007|NCT00808067|565884736|FG000|Overall Study|Adverse Event|111|||
156763008|NCT00808067|565884737|FG001|Overall Study|Adverse Event|121|||
156763009|NCT00808067|565884736|FG000|Overall Study|Hospitalization (not including surgery)|18|||
156763010|NCT00808067|565884737|FG001|Overall Study|Hospitalization (not including surgery)|17|||
156763011|NCT00808067|565884736|FG000|Overall Study|Hospitalization due to surgery|37|||
156763012|NCT00808067|565884737|FG001|Overall Study|Hospitalization due to surgery|40|||
156763013|NCT00808067|565884736|FG000|Overall Study|Reduced creatinine clearance|53|||
156763014|NCT00808067|565884737|FG001|Overall Study|Reduced creatinine clearance|55|||
156763015|NCT00808067|565884736|FG000|Overall Study|Elevated LFT results|7|||
156763016|NCT00808067|565884737|FG001|Overall Study|Elevated LFT results|3|||
156763017|NCT00808067|565884736|FG000|Overall Study|Patient refused to take study medication|65|||
156763018|NCT00808067|565884737|FG001|Overall Study|Patient refused to take study medication|76|||
156763019|NCT00808067|565884736|FG000|Overall Study|Missing|1|||
156763020|NCT00808067|565884737|FG001|Overall Study|Missing|0|||
156763021|NCT00808067|565884736|FG000|Overall Study|Death|1|||
156763022|NCT00808067|565884737|FG001|Overall Study|Death|1|||
156763023|NCT00808067|565884736|FG000|Overall Study|Procedure|6|||
156763024|NCT00808067|565884737|FG001|Overall Study|Procedure|7|||
156763025|NCT00808067|565884736|FG000|Overall Study|Withdrawal by Subject|21|||
156763026|NCT00808067|565884737|FG001|Overall Study|Withdrawal by Subject|25|||
156763027|NCT00808067|565884736|FG000|Overall Study|Site closed|4|||
156763028|NCT00808067|565884737|FG001|Overall Study|Site closed|3|||
156763029|NCT00808067|565884736|FG000|Overall Study|Physician Decision|47|||
156763030|NCT00808067|565884737|FG001|Overall Study|Physician Decision|38|||
156763031|NCT00808067|565884736|FG000|Overall Study|Protocol Violation|3|||
156763032|NCT00808067|565884737|FG001|Overall Study|Protocol Violation|11|||
156763033|NCT00808067|565884736|FG000|Overall Study|Patient elected|7|||
156763034|NCT00808067|565884737|FG001|Overall Study|Patient elected|9|||
156763035|NCT00808067|565884736|FG000|Overall Study|Site closed for cause|19|||
156763036|NCT00808067|565884737|FG001|Overall Study|Site closed for cause|19|||
156763037|NCT00808067|565884736|FG000|Overall Study|Other reason not defined above|5|||
156763038|NCT00808067|565884737|FG001|Overall Study|Other reason not defined above|5|||
156763039|NCT00808067|565884736|FG000|Overall Study|Excluded from analysis|13|||
156763040|NCT00808067|565884737|FG001|Overall Study|Excluded from analysis|19|||
156763041|NCT01939314|565884738|FG000|Overall Study|Withdrawal by Subject|3|||
156763042|NCT01939314|565884739|FG001|Overall Study|Withdrawal by Subject|1|||
156763043|NCT01939314|565884738|FG000|Overall Study|Protocol Violation|1|||
156763044|NCT01939314|565884739|FG001|Overall Study|Protocol Violation|0|||
156763045|NCT01939314|565884738|FG000|Overall Study|Pregnancy|0|||
156763046|NCT01939314|565884739|FG001|Overall Study|Pregnancy|1|||
156763047|NCT01939314|565884738|FG000|Overall Study|Lost to Follow-up|5|||
156763048|NCT01939314|565884739|FG001|Overall Study|Lost to Follow-up|6|||
156763049|NCT02104895|565884742|FG000|Overall Study|Withdrawal by Subject|0|||
156763050|NCT02104895|565884743|FG001|Overall Study|Withdrawal by Subject|14|||
156763051|NCT00969228|565884744|FG000|Overall Study|Adverse Event|1|||
156763052|NCT00969228|565884745|FG001|Overall Study|Adverse Event|0|||
156763053|NCT00969228|565884744|FG000|Overall Study|Withdrawal by Subject|4|||
156763054|NCT00969228|565884745|FG001|Overall Study|Withdrawal by Subject|0|||
156763055|NCT00969228|565884744|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
156763056|NCT00969228|565884745|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
156763057|NCT03311945|565884754|FG000|Overall Study|Adverse Event|2|||
156763058|NCT03311945|565884754|FG000|Overall Study|Lack of Efficacy|1|||
156763059|NCT01107925|565884755|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
156763060|NCT01107925|565884756|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763061|NCT01107925|565884757|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763062|NCT01107925|565884758|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763063|NCT01107925|565884759|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
156763064|NCT01107925|565884760|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
156763065|NCT01107925|565884755|FG000|Period 2|Withdrawal by Subject|0|||
156763066|NCT01107925|565884756|FG001|Period 2|Withdrawal by Subject|1|||
156763067|NCT01107925|565884757|FG002|Period 2|Withdrawal by Subject|0|||
156763068|NCT01107925|565884758|FG003|Period 2|Withdrawal by Subject|0|||
156763069|NCT01107925|565884759|FG004|Period 2|Withdrawal by Subject|0|||
156763070|NCT01107925|565884760|FG005|Period 2|Withdrawal by Subject|1|||
156763071|NCT04877990|565884761|FG000|Treatment|Other reasons|3|||
156763072|NCT04877990|565884762|FG001|Treatment|Other reasons|1|||
156763073|NCT04877990|565884761|FG000|Treatment|Administrative reasons by sponsor|17|||
156763074|NCT04877990|565884762|FG001|Treatment|Administrative reasons by sponsor|33|||
156763075|NCT04877990|565884761|FG000|Treatment|Withdrawal by Subject|2|||
156763076|NCT04877990|565884762|FG001|Treatment|Withdrawal by Subject|6|||
156763077|NCT04877990|565884761|FG000|Treatment|Adverse Event|2|||
156763078|NCT04877990|565884762|FG001|Treatment|Adverse Event|1|||
156763079|NCT04235504|565884763|FG000|Study Phase|Withdrawal by Subject|5|||
156763080|NCT04235504|565884764|FG001|Study Phase|Withdrawal by Subject|2|||
156763081|NCT04235504|565884765|FG002|Study Phase|Withdrawal by Subject|0|||
156763082|NCT04235504|565884766|FG003|Study Phase|Withdrawal by Subject|0|||
156763083|NCT04235504|565884763|FG000|Continuation Phase|Withdrawal by Subject|0|||
156763084|NCT04235504|565884764|FG001|Continuation Phase|Withdrawal by Subject|4|||
156763085|NCT04235504|565884765|FG002|Continuation Phase|Withdrawal by Subject|0|||
156763086|NCT04235504|565884766|FG003|Continuation Phase|Withdrawal by Subject|0|||
156763087|NCT04235504|565884763|FG000|Continuation Phase|Adverse Event|0|||
156763088|NCT04235504|565884764|FG001|Continuation Phase|Adverse Event|1|||
156763089|NCT04235504|565884765|FG002|Continuation Phase|Adverse Event|0|||
156763090|NCT04235504|565884766|FG003|Continuation Phase|Adverse Event|0|||
156763091|NCT04235504|565884763|FG000|Continuation Phase|Physician Decision|1|||
156763092|NCT04235504|565884764|FG001|Continuation Phase|Physician Decision|2|||
156763093|NCT04235504|565884765|FG002|Continuation Phase|Physician Decision|1|||
156763094|NCT04235504|565884766|FG003|Continuation Phase|Physician Decision|0|||
156763095|NCT02532283|565884770|FG000|Overall Study|Adverse Event|0|||
156763096|NCT02532283|565884771|FG001|Overall Study|Adverse Event|1|||
156763097|NCT02532283|565884770|FG000|Overall Study|Death|1|||
156763098|NCT02532283|565884771|FG001|Overall Study|Death|0|||
156763099|NCT02532283|565884770|FG000|Overall Study|Lost to Follow-up|0|||
156763100|NCT02532283|565884771|FG001|Overall Study|Lost to Follow-up|1|||
156763101|NCT02532283|565884770|FG000|Overall Study|Withdrawal by Subject|8|||
156763102|NCT02532283|565884771|FG001|Overall Study|Withdrawal by Subject|3|||
156763103|NCT01945944|565884772|FG000|Overall Study|Adverse Event|0|||
156763104|NCT01945944|565884773|FG001|Overall Study|Adverse Event|2|||
156763105|NCT01945944|565884772|FG000|Overall Study|Physician Decision|1|||
156763106|NCT01945944|565884773|FG001|Overall Study|Physician Decision|0|||
156763107|NCT01945944|565884772|FG000|Overall Study|Withdrawal by Subject|0|||
156763108|NCT01945944|565884773|FG001|Overall Study|Withdrawal by Subject|1|||
156763109|NCT01817075|565884774|FG000|Overall Study|Adverse Event|7|||
156763110|NCT01817075|565884775|FG001|Overall Study|Adverse Event|5|||
156763111|NCT01817075|565884774|FG000|Overall Study|Physician Decision|9|||
156763112|NCT01817075|565884775|FG001|Overall Study|Physician Decision|12|||
156763113|NCT01817075|565884774|FG000|Overall Study|Withdrawal by Subject|31|||
156763114|NCT01817075|565884775|FG001|Overall Study|Withdrawal by Subject|15|||
156763115|NCT01817075|565884774|FG000|Overall Study|Received Sorafenib after enrollment|0|||
156763116|NCT01817075|565884775|FG001|Overall Study|Received Sorafenib after enrollment|1|||
156763117|NCT01817075|565884774|FG000|Overall Study|Ineligible|0|||
156763118|NCT01817075|565884775|FG001|Overall Study|Ineligible|2|||
156763119|NCT04376515|565884778|FG000|Overall Study|Found to have been vaccinated before study start|6|||
156763120|NCT04376515|565884779|FG001|Overall Study|Found to have been vaccinated before study start|6|||
156763121|NCT03811821|565884780|FG000|Overall Study|Adverse Event|1|||
156763122|NCT03811821|565884781|FG001|Overall Study|Adverse Event|1|||
156763123|NCT03811821|565884780|FG000|Overall Study|Withdrawal by Subject|5|||
156763124|NCT03811821|565884781|FG001|Overall Study|Withdrawal by Subject|4|||
156763125|NCT03811821|565884780|FG000|Overall Study|Lost to Follow-up|2|||
156763126|NCT03811821|565884781|FG001|Overall Study|Lost to Follow-up|2|||
156763127|NCT03811821|565884780|FG000|Overall Study|Contraindication for treatment|0|||
156763128|NCT03811821|565884781|FG001|Overall Study|Contraindication for treatment|1|||
156763129|NCT03811821|565884780|FG000|Overall Study|Tolerability|0|||
156763130|NCT03811821|565884781|FG001|Overall Study|Tolerability|3|||
156763131|NCT03811821|565884780|FG000|Overall Study|Comorbidities|0|||
156763132|NCT03811821|565884781|FG001|Overall Study|Comorbidities|2|||
156763133|NCT01395810|565884784|FG000|Overall Study|Adverse Event|0|||
156763134|NCT01395810|565884785|FG001|Overall Study|Adverse Event|1|||
156763135|NCT01395810|565884786|FG002|Overall Study|Adverse Event|0|||
156763136|NCT01395810|565884787|FG003|Overall Study|Adverse Event|0|||
156763137|NCT01395810|565884784|FG000|Overall Study|Lack of Efficacy|0|||
156763138|NCT01395810|565884785|FG001|Overall Study|Lack of Efficacy|1|||
156763139|NCT01395810|565884786|FG002|Overall Study|Lack of Efficacy|0|||
156763140|NCT01395810|565884787|FG003|Overall Study|Lack of Efficacy|0|||
156763141|NCT01395810|565884784|FG000|Overall Study|Withdrawal criteria|0|||
156763142|NCT01395810|565884785|FG001|Overall Study|Withdrawal criteria|2|||
156763143|NCT01395810|565884786|FG002|Overall Study|Withdrawal criteria|0|||
156763144|NCT01395810|565884787|FG003|Overall Study|Withdrawal criteria|0|||
156763145|NCT01395810|565884784|FG000|Overall Study|Unclassified|2|||
156763146|NCT01395810|565884785|FG001|Overall Study|Unclassified|0|||
156763147|NCT01395810|565884786|FG002|Overall Study|Unclassified|0|||
156763148|NCT01395810|565884787|FG003|Overall Study|Unclassified|0|||
156763149|NCT01496976|565886291|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
156763150|NCT04579380|565886292|FG000|Overall Study|Death|9|||
156763151|NCT04579380|565886293|FG001|Overall Study|Death|22|||
156763152|NCT04579380|565886294|FG002|Overall Study|Death|22|||
156763153|NCT04579380|565886295|FG003|Overall Study|Death|17|||
156763154|NCT04579380|565886296|FG004|Overall Study|Death|6|||
156763155|NCT04579380|565886297|FG005|Overall Study|Death|21|||
156763156|NCT04579380|565886298|FG006|Overall Study|Death|10|||
156763157|NCT04579380|565886299|FG007|Overall Study|Death|11|||
156763158|NCT04579380|565886300|FG008|Overall Study|Death|25|||
156763159|NCT04579380|565886292|FG000|Overall Study|Withdrawal by Subject|0|||
156763160|NCT04579380|565886293|FG001|Overall Study|Withdrawal by Subject|3|||
156763161|NCT04579380|565886294|FG002|Overall Study|Withdrawal by Subject|4|||
156763162|NCT04579380|565886295|FG003|Overall Study|Withdrawal by Subject|0|||
156763163|NCT04579380|565886296|FG004|Overall Study|Withdrawal by Subject|1|||
156763164|NCT04579380|565886297|FG005|Overall Study|Withdrawal by Subject|2|||
156763165|NCT04579380|565886298|FG006|Overall Study|Withdrawal by Subject|0|||
156763166|NCT04579380|565886299|FG007|Overall Study|Withdrawal by Subject|1|||
156763167|NCT04579380|565886300|FG008|Overall Study|Withdrawal by Subject|2|||
156763168|NCT04579380|565886292|FG000|Overall Study|Ongoing|2|||
156763169|NCT04579380|565886293|FG001|Overall Study|Ongoing|6|||
156763170|NCT04579380|565886294|FG002|Overall Study|Ongoing|4|||
156763171|NCT04579380|565886295|FG003|Overall Study|Ongoing|8|||
156763172|NCT04579380|565886296|FG004|Overall Study|Ongoing|5|||
156763173|NCT04579380|565886297|FG005|Overall Study|Ongoing|8|||
156763174|NCT04579380|565886298|FG006|Overall Study|Ongoing|3|||
156763175|NCT04579380|565886299|FG007|Overall Study|Ongoing|19|||
156763176|NCT04579380|565886300|FG008|Overall Study|Ongoing|6|||
156763177|NCT04070989|565886302|FG000|Overall Study|Death|1|||
156763178|NCT04070989|565886303|FG001|Overall Study|Death|0|||
156763179|NCT04070989|565886304|FG002|Overall Study|Death|0|||
156763180|NCT04070989|565886302|FG000|Overall Study|Study Terminated by Sponsor|7|||
156763181|NCT04070989|565886303|FG001|Overall Study|Study Terminated by Sponsor|8|||
156763182|NCT04070989|565886304|FG002|Overall Study|Study Terminated by Sponsor|23|||
156763183|NCT04070989|565886302|FG000|Overall Study|Withdrawal by Subject|0|||
156763184|NCT04070989|565886303|FG001|Overall Study|Withdrawal by Subject|1|||
156763185|NCT04070989|565886304|FG002|Overall Study|Withdrawal by Subject|0|||
156763186|NCT04070989|565886302|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
156763187|NCT04070989|565886303|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
156763188|NCT04070989|565886304|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
156763189|NCT04070989|565886302|FG000|Overall Study|Other|1|||
156763190|NCT04070989|565886303|FG001|Overall Study|Other|1|||
156763191|NCT04070989|565886304|FG002|Overall Study|Other|0|||
156763192|NCT06088784|565886305|FG000|Overall Study|Adverse Event|0|||
156763193|NCT06088784|565886306|FG001|Overall Study|Adverse Event|0|||
156763194|NCT06088784|565886307|FG002|Overall Study|Adverse Event|0|||
156763195|NCT06088784|565886308|FG003|Overall Study|Adverse Event|0|||
156763196|NCT06088784|565886309|FG004|Overall Study|Adverse Event|0|||
156763197|NCT06088784|565886310|FG005|Overall Study|Adverse Event|0|||
156763198|NCT06088784|565886311|FG006|Overall Study|Adverse Event|3|||
156763199|NCT06088784|565886312|FG007|Overall Study|Adverse Event|0|||
156763200|NCT06088784|565886313|FG008|Overall Study|Adverse Event|0|||
156763201|NCT06088784|565886314|FG009|Overall Study|Adverse Event|0|||
156763202|NCT06088784|565886315|FG010|Overall Study|Adverse Event|0|||
156763203|NCT06088784|565886316|FG011|Overall Study|Adverse Event|0|||
156763204|NCT06088784|565886305|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763205|NCT06088784|565886306|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763206|NCT06088784|565886307|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763207|NCT06088784|565886308|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763208|NCT06088784|565886309|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763209|NCT06088784|565886310|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763210|NCT06088784|565886311|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
156763211|NCT06088784|565886312|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763212|NCT06088784|565886313|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763213|NCT06088784|565886314|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763214|NCT06088784|565886315|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763215|NCT06088784|565886316|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
156763216|NCT05556616|565886319|FG000|Overall Study|Withdrawal by Subject|1|||
156763217|NCT05556616|565886320|FG001|Overall Study|Withdrawal by Subject|0|||
156763218|NCT05556616|565886321|FG002|Overall Study|Withdrawal by Subject|0|||
156763219|NCT05556616|565886322|FG003|Overall Study|Withdrawal by Subject|0|||
156763220|NCT05556616|565886323|FG004|Overall Study|Withdrawal by Subject|0|||
156763221|NCT05556616|565886324|FG005|Overall Study|Withdrawal by Subject|0|||
156763222|NCT05556616|565886325|FG006|Overall Study|Withdrawal by Subject|0|||
156763223|NCT05556616|565886319|FG000|Overall Study|Death|0|||
156763224|NCT05556616|565886320|FG001|Overall Study|Death|0|||
156763225|NCT05556616|565886321|FG002|Overall Study|Death|2|||
156763226|NCT05556616|565886322|FG003|Overall Study|Death|1|||
156763227|NCT05556616|565886323|FG004|Overall Study|Death|0|||
156763228|NCT05556616|565886324|FG005|Overall Study|Death|0|||
156763229|NCT05556616|565886325|FG006|Overall Study|Death|0|||
156763230|NCT05556616|565886319|FG000|Overall Study|Study Terminated by Sponsor|0|||
156763231|NCT05556616|565886320|FG001|Overall Study|Study Terminated by Sponsor|3|||
156763232|NCT05556616|565886321|FG002|Overall Study|Study Terminated by Sponsor|0|||
156763233|NCT05556616|565886322|FG003|Overall Study|Study Terminated by Sponsor|0|||
156763234|NCT05556616|565886323|FG004|Overall Study|Study Terminated by Sponsor|0|||
156763235|NCT05556616|565886324|FG005|Overall Study|Study Terminated by Sponsor|0|||
156763236|NCT05556616|565886325|FG006|Overall Study|Study Terminated by Sponsor|0|||
156763237|NCT05428436|565886326|FG000|Period 1 - 2 washout|Adverse Event|1|||
156763238|NCT05428436|565886327|FG001|Period 1 - 2 washout|Adverse Event|0|||
156763239|NCT05428436|565886328|FG002|Period 1 - 2 washout|Adverse Event|0|||
156763240|NCT03964207|565886329|FG000|First Treatment|Withdrawal by Subject|1|||
156763241|NCT03964207|565886330|FG001|First Treatment|Withdrawal by Subject|2|||
156763242|NCT03964207|565886329|FG000|First Treatment|Protocol Violation|1|||
157005311|NCT00028769|566770081|FG000|Overall Study|Ineligible|5|||
157005312|NCT00028769|566770081|FG000|Overall Study|Not Analyzable|1|||
157005313|NCT02496702|566770082|FG000|Overall Study|Lost to Follow-up|8|||
157005314|NCT02496702|566770083|FG001|Overall Study|Lost to Follow-up|6|||
157005315|NCT02496702|566770082|FG000|Overall Study|Only partially tested|0|||
157005316|NCT02496702|566770083|FG001|Overall Study|Only partially tested|2|||
157005317|NCT01499134|566770086|FG000|Overall Study|Withdrawal by Subject|0|||
157005318|NCT01499134|566770087|FG001|Overall Study|Withdrawal by Subject|1|||
157005319|NCT02983617|566770099|FG000|Overall Study|Adverse Event|0|||
157005320|NCT02983617|566770100|FG001|Overall Study|Adverse Event|7|||
157005321|NCT02983617|566770099|FG000|Overall Study|Death|0|||
157005322|NCT02983617|566770100|FG001|Overall Study|Death|1|||
157005323|NCT02983617|566770099|FG000|Overall Study|Investigator's Discretion|0|||
157005324|NCT02983617|566770100|FG001|Overall Study|Investigator's Discretion|1|||
157005325|NCT00516386|566770103|FG000|Overall Study|not interested in the study|4|||
157005326|NCT00516386|566770103|FG000|Overall Study|Lost to Follow-up|2|||
157005327|NCT02698891|566770104|FG000|Overall Study|Withdrawal by Subject|2|||
157005328|NCT02698891|566770104|FG000|Overall Study|deemed ineligible|1|||
156763243|NCT03964207|565886330|FG001|First Treatment|Protocol Violation|0|||
156763244|NCT03964207|565886329|FG000|First Treatment|Lost to Follow-up|1|||
156763245|NCT03964207|565886330|FG001|First Treatment|Lost to Follow-up|0|||
156763246|NCT03964207|565886329|FG000|Second Treatment|Lost to Follow-up|0|||
156763247|NCT03964207|565886330|FG001|Second Treatment|Lost to Follow-up|1|||
156763248|NCT03964207|565886329|FG000|Second Treatment|Adverse Event|1|||
157005329|NCT02698891|566770104|FG000|Overall Study|Adverse Event|9|||
156763249|NCT03964207|565886330|FG001|Second Treatment|Adverse Event|2|||
156763250|NCT00830219|565886333|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156763251|NCT00830219|565886334|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
156763252|NCT00641056|565886335|FG000|Overall Study|Adverse Event|12|||
156763253|NCT00641056|565886336|FG001|Overall Study|Adverse Event|2|||
156763254|NCT00641056|565886335|FG000|Overall Study|Lost to Follow-up|2|||
156763255|NCT00641056|565886336|FG001|Overall Study|Lost to Follow-up|1|||
156763256|NCT00641056|565886335|FG000|Overall Study|Physician Decision|3|||
156763257|NCT00641056|565886336|FG001|Overall Study|Physician Decision|1|||
156763258|NCT00641056|565886335|FG000|Overall Study|Protocol Violation|2|||
156763259|NCT00641056|565886336|FG001|Overall Study|Protocol Violation|0|||
156763260|NCT00641056|565886335|FG000|Overall Study|Entry Criteria Not Met|3|||
156763261|NCT00641056|565886336|FG001|Overall Study|Entry Criteria Not Met|0|||
156763262|NCT00641056|565886335|FG000|Overall Study|Subject Decision|6|||
156763263|NCT00641056|565886336|FG001|Overall Study|Subject Decision|19|||
156763264|NCT00641056|565886335|FG000|Overall Study|Sponsor Decision|1|||
156763265|NCT00641056|565886336|FG001|Overall Study|Sponsor Decision|2|||
156763266|NCT00239720|565886338|FG000|Overall Study|Adverse Event|1|||
156763267|NCT00239720|565886339|FG001|Overall Study|Adverse Event|0|||
156763268|NCT00239720|565886338|FG000|Overall Study|Lost to Follow-up|0|||
156763269|NCT00239720|565886339|FG001|Overall Study|Lost to Follow-up|1|||
156763270|NCT01811732|565886342|FG000|Overall Study|Lost to Follow-up|24|||
156763271|NCT01811732|565886343|FG001|Overall Study|Lost to Follow-up|30|||
156763272|NCT01811732|565886342|FG000|Overall Study|Withdrawal by Subject|16|||
156763273|NCT01811732|565886343|FG001|Overall Study|Withdrawal by Subject|10|||
156763274|NCT01811732|565886342|FG000|Overall Study|Adverse Event|3|||
156763275|NCT01811732|565886343|FG001|Overall Study|Adverse Event|9|||
156763276|NCT01811732|565886342|FG000|Overall Study|Lack of Efficacy|3|||
156763277|NCT01811732|565886343|FG001|Overall Study|Lack of Efficacy|1|||
156763278|NCT01811732|565886342|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
156763279|NCT01811732|565886343|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
156763280|NCT01811732|565886342|FG000|Overall Study|Physician Decision|2|||
156763281|NCT01811732|565886343|FG001|Overall Study|Physician Decision|0|||
156763282|NCT01811732|565886342|FG000|Overall Study|Death|1|||
156763283|NCT01811732|565886343|FG001|Overall Study|Death|1|||
156763284|NCT01811732|565886342|FG000|Overall Study|Insufficient venous access|0|||
156763285|NCT01811732|565886343|FG001|Overall Study|Insufficient venous access|1|||
156763286|NCT01811732|565886342|FG000|Overall Study|Protocol Violation|0|||
156763287|NCT01811732|565886343|FG001|Overall Study|Protocol Violation|1|||
156763288|NCT01811732|565886342|FG000|Overall Study|Subject incarcerated|1|||
156763289|NCT01811732|565886343|FG001|Overall Study|Subject incarcerated|2|||
156763290|NCT01811732|565886342|FG000|Overall Study|Admitted to another facility|1|||
156763291|NCT01811732|565886343|FG001|Overall Study|Admitted to another facility|0|||
156763292|NCT01811732|565886342|FG000|Overall Study|Correct study drug not available on site|1|||
156763293|NCT01811732|565886343|FG001|Overall Study|Correct study drug not available on site|0|||
156763294|NCT00896493|565886344|FG000|Overall Study|Early disease relapse|3|||
156763295|NCT01868646|565886347|FG000|Overall Study|Do not meet inclusion criteria|3|||
156763296|NCT01868646|565886348|FG001|Overall Study|Do not meet inclusion criteria|5|||
156763297|NCT01831427|565886349|FG000|Overall Study|Adverse Event|0|||
156763298|NCT01831427|565886350|FG001|Overall Study|Adverse Event|1|||
156763299|NCT01831427|565886351|FG002|Overall Study|Adverse Event|0|||
156763300|NCT01831427|565886352|FG003|Overall Study|Adverse Event|0|||
156763301|NCT01831427|565886353|FG004|Overall Study|Adverse Event|0|||
156763302|NCT01831427|565886354|FG005|Overall Study|Adverse Event|1|||
156763303|NCT01831427|565886355|FG006|Overall Study|Adverse Event|0|||
157005330|NCT04218110|566770105|FG000|Overall Study|Withdrawal by Subject|0|||
157005331|NCT04218110|566770106|FG001|Overall Study|Withdrawal by Subject|0|||
157005332|NCT04218110|566770107|FG002|Overall Study|Withdrawal by Subject|0|||
157005333|NCT04218110|566770108|FG003|Overall Study|Withdrawal by Subject|1|||
157005334|NCT00002842|566770109|FG000|Overall Study|ineligible for surgical resection|27|||
157005335|NCT01867216|566770112|FG000|Overall Study|Withdrawal by Subject|2|||
157005336|NCT01867216|566770113|FG001|Overall Study|Withdrawal by Subject|0|||
157005337|NCT01867216|566770114|FG002|Overall Study|Withdrawal by Subject|0|||
157005338|NCT01867216|566770115|FG003|Overall Study|Withdrawal by Subject|0|||
157005339|NCT01867216|566770116|FG004|Overall Study|Withdrawal by Subject|1|||
157005340|NCT01867216|566770117|FG005|Overall Study|Withdrawal by Subject|0|||
156763304|NCT01831427|565886356|FG007|Overall Study|Adverse Event|1|||
156763305|NCT01831427|565886357|FG008|Overall Study|Adverse Event|0|||
156763306|NCT01831427|565886358|FG009|Overall Study|Adverse Event|0|||
156763307|NCT01831427|565886359|FG010|Overall Study|Adverse Event|2|||
156763308|NCT01831427|565886349|FG000|Overall Study|Investigator's Discretion|0|||
156763309|NCT01831427|565886350|FG001|Overall Study|Investigator's Discretion|0|||
156763310|NCT01831427|565886351|FG002|Overall Study|Investigator's Discretion|0|||
156763311|NCT01831427|565886352|FG003|Overall Study|Investigator's Discretion|1|||
156763312|NCT01831427|565886353|FG004|Overall Study|Investigator's Discretion|0|||
156763313|NCT01831427|565886354|FG005|Overall Study|Investigator's Discretion|0|||
156763314|NCT01831427|565886355|FG006|Overall Study|Investigator's Discretion|0|||
157110656|NCT01987960|567158439|FG002|Period 2|Withdrawal by Subject|1|||
157110657|NCT01987960|567158440|FG003|Period 2|Withdrawal by Subject|0|||
157110658|NCT01987960|567158437|FG000|Period 2|Administrative or other reason|0|||
157110659|NCT01987960|567158438|FG001|Period 2|Administrative or other reason|5|||
157110660|NCT01987960|567158439|FG002|Period 2|Administrative or other reason|7|||
157110661|NCT01987960|567158440|FG003|Period 2|Administrative or other reason|0|||
157110662|NCT01987960|567158437|FG000|Period 3|Adverse Event|0|||
157110663|NCT01987960|567158438|FG001|Period 3|Adverse Event|0|||
157110664|NCT01987960|567158439|FG002|Period 3|Adverse Event|0|||
156763315|NCT01831427|565886356|FG007|Overall Study|Investigator's Discretion|0|||
156763316|NCT01831427|565886357|FG008|Overall Study|Investigator's Discretion|0|||
156763317|NCT01831427|565886358|FG009|Overall Study|Investigator's Discretion|0|||
156763318|NCT01831427|565886359|FG010|Overall Study|Investigator's Discretion|0|||
156763319|NCT01831427|565886349|FG000|Overall Study|Withdrew Consent|0|||
156763320|NCT01831427|565886350|FG001|Overall Study|Withdrew Consent|0|||
156763321|NCT01831427|565886351|FG002|Overall Study|Withdrew Consent|0|||
156763322|NCT01831427|565886352|FG003|Overall Study|Withdrew Consent|0|||
156763323|NCT01831427|565886353|FG004|Overall Study|Withdrew Consent|0|||
156763324|NCT01831427|565886354|FG005|Overall Study|Withdrew Consent|0|||
156763325|NCT01831427|565886355|FG006|Overall Study|Withdrew Consent|2|||
156763326|NCT01831427|565886356|FG007|Overall Study|Withdrew Consent|0|||
156763327|NCT01831427|565886357|FG008|Overall Study|Withdrew Consent|0|||
156763328|NCT01831427|565886358|FG009|Overall Study|Withdrew Consent|1|||
156763329|NCT01831427|565886359|FG010|Overall Study|Withdrew Consent|1|||
156763330|NCT01249417|565886362|FG000|Randomised Population|Study treatment not received|0|||
156763331|NCT01249417|565886363|FG001|Randomised Population|Study treatment not received|0|||
156763332|NCT01249417|565886364|FG002|Randomised Population|Study treatment not received|2|||
156763333|NCT01249417|565886362|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
156763334|NCT01249417|565886363|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
156763335|NCT01249417|565886364|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
156763336|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Other|0|||
156763337|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Other|0|||
156763338|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Other|1|||
156763339|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
156763340|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
156763341|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
156763342|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
156763343|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
156763344|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
156763345|NCT01249417|565886362|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
156763346|NCT01249417|565886363|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
156763347|NCT01249417|565886364|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
156763348|NCT01248455|565886365|FG000|Overall Study|switched to alternate treatment|1|||
156763349|NCT02035553|565886366|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
156763350|NCT02035553|565886367|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
156763351|NCT02035553|565886366|FG000|Overall Study|Adverse Event|10|||
156763352|NCT02035553|565886367|FG001|Overall Study|Adverse Event|6|||
156763353|NCT02035553|565886366|FG000|Overall Study|Physician Decision|3|||
156763354|NCT02035553|565886367|FG001|Overall Study|Physician Decision|2|||
156763355|NCT02035553|565886366|FG000|Overall Study|Lack of Efficacy|1|||
156763356|NCT02035553|565886367|FG001|Overall Study|Lack of Efficacy|1|||
156763357|NCT02035553|565886366|FG000|Overall Study|Withdrawal by Subject|4|||
156763358|NCT02035553|565886367|FG001|Overall Study|Withdrawal by Subject|7|||
156763359|NCT02035553|565886366|FG000|Overall Study|Non-compliance with Study Drug|0|||
156763360|NCT02035553|565886367|FG001|Overall Study|Non-compliance with Study Drug|1|||
156763361|NCT02035553|565886366|FG000|Overall Study|Lost to Follow-up|0|||
156763362|NCT02035553|565886367|FG001|Overall Study|Lost to Follow-up|1|||
156763363|NCT02035553|565886366|FG000|Overall Study|Other Reason|0|||
156763364|NCT02035553|565886367|FG001|Overall Study|Other Reason|4|||
156763365|NCT04539964|565886368|FG000|Overall Study|device malfunction|1|||
156763366|NCT04539964|565886369|FG001|Overall Study|device malfunction|0|||
156763367|NCT04539964|565886368|FG000|Overall Study|Withdrawal by Subject|1|||
156763368|NCT04539964|565886369|FG001|Overall Study|Withdrawal by Subject|2|||
156763369|NCT04539964|565886368|FG000|Overall Study|Adverse Event|0|||
156763370|NCT04539964|565886369|FG001|Overall Study|Adverse Event|2|||
156763371|NCT01854697|565886370|FG000|Overall Study|Adverse Event|1|||
157110665|NCT01987960|567158440|FG003|Period 3|Adverse Event|7|||
156763372|NCT01854697|565886371|FG001|Overall Study|Adverse Event|0|||
156763373|NCT01854697|565886372|FG002|Overall Study|Adverse Event|0|||
156763374|NCT01854697|565886373|FG003|Overall Study|Adverse Event|0|||
156763375|NCT01854697|565886374|FG004|Overall Study|Adverse Event|1|||
156763376|NCT01854697|565886370|FG000|Overall Study|Lost to Follow-up|4|||
157110666|NCT01987960|567158437|FG000|Period 3|Non-compliance with IMP|0|||
157110667|NCT01987960|567158438|FG001|Period 3|Non-compliance with IMP|0|||
157110668|NCT01987960|567158439|FG002|Period 3|Non-compliance with IMP|0|||
157110669|NCT01987960|567158440|FG003|Period 3|Non-compliance with IMP|1|||
156763377|NCT01854697|565886371|FG001|Overall Study|Lost to Follow-up|1|||
156763378|NCT01854697|565886372|FG002|Overall Study|Lost to Follow-up|1|||
156763379|NCT01854697|565886373|FG003|Overall Study|Lost to Follow-up|2|||
156763380|NCT01854697|565886374|FG004|Overall Study|Lost to Follow-up|0|||
156763381|NCT01854697|565886370|FG000|Overall Study|To enter another AbbVie study|1|||
156763382|NCT01854697|565886371|FG001|Overall Study|To enter another AbbVie study|0|||
156763383|NCT01854697|565886372|FG002|Overall Study|To enter another AbbVie study|0|||
156763384|NCT01854697|565886373|FG003|Overall Study|To enter another AbbVie study|0|||
156763385|NCT01854697|565886374|FG004|Overall Study|To enter another AbbVie study|1|||
156763386|NCT01854697|565886370|FG000|Overall Study|Withdrew Consent|0|||
156763387|NCT01854697|565886371|FG001|Overall Study|Withdrew Consent|1|||
156763388|NCT01854697|565886372|FG002|Overall Study|Withdrew Consent|0|||
156763389|NCT01854697|565886373|FG003|Overall Study|Withdrew Consent|1|||
156763390|NCT01854697|565886374|FG004|Overall Study|Withdrew Consent|0|||
156763391|NCT01854697|565886370|FG000|Overall Study|Other|0|||
156763392|NCT01854697|565886371|FG001|Overall Study|Other|1|||
156763393|NCT01854697|565886372|FG002|Overall Study|Other|1|||
156763394|NCT01854697|565886373|FG003|Overall Study|Other|0|||
156763395|NCT01854697|565886374|FG004|Overall Study|Other|0|||
156763396|NCT02771275|565886379|FG000|Overall Study|Reoperation|3|||
156763397|NCT02771275|565886379|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
156763398|NCT05556148|565886380|FG000|Overall Study|Early Termination|29|||
156763399|NCT05556148|565886380|FG000|Overall Study|Baseline Tasks Expired|4|||
156763400|NCT05556148|565886380|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
156763401|NCT05556148|565886380|FG000|Overall Study|No Longer Wished to Participate|1|||
156763402|NCT05556148|565886380|FG000|Overall Study|Bacterial Conjunctivitis|1|||
156763403|NCT01171898|565886381|FG000|Overall Study|Death|0|||
156763404|NCT01171898|565886382|FG001|Overall Study|Death|0|||
156763405|NCT01171898|565886383|FG002|Overall Study|Death|2|||
156763406|NCT01171898|565886384|FG003|Overall Study|Death|0|||
156763407|NCT01171898|565886381|FG000|Overall Study|Lost to Follow-up|0|||
156763408|NCT01171898|565886382|FG001|Overall Study|Lost to Follow-up|1|||
156763409|NCT01171898|565886383|FG002|Overall Study|Lost to Follow-up|1|||
156763410|NCT01171898|565886384|FG003|Overall Study|Lost to Follow-up|1|||
156763411|NCT01171898|565886381|FG000|Overall Study|Withdrawal by Subject|1|||
156763412|NCT01171898|565886382|FG001|Overall Study|Withdrawal by Subject|4|||
156763413|NCT01171898|565886383|FG002|Overall Study|Withdrawal by Subject|6|||
156763414|NCT01171898|565886384|FG003|Overall Study|Withdrawal by Subject|3|||
156763415|NCT01171898|565886381|FG000|Overall Study|Terminated by Sponsor|1|||
156763416|NCT01171898|565886382|FG001|Overall Study|Terminated by Sponsor|0|||
156763417|NCT01171898|565886383|FG002|Overall Study|Terminated by Sponsor|0|||
156763418|NCT01171898|565886384|FG003|Overall Study|Terminated by Sponsor|0|||
156763419|NCT01171898|565886381|FG000|Overall Study|Ongoing|1|||
156763420|NCT01171898|565886382|FG001|Overall Study|Ongoing|9|||
156763421|NCT01171898|565886383|FG002|Overall Study|Ongoing|3|||
156763422|NCT01171898|565886384|FG003|Overall Study|Ongoing|0|||
156763423|NCT01171898|565886381|FG000|Overall Study|Other|1|||
156763424|NCT01171898|565886382|FG001|Overall Study|Other|5|||
156763425|NCT01171898|565886383|FG002|Overall Study|Other|0|||
156763426|NCT01171898|565886384|FG003|Overall Study|Other|2|||
156763427|NCT03191799|565886385|FG000|Overall Study|Withdrawal by Subject|4|||
156763428|NCT03191799|565886385|FG000|Overall Study|Physician Decision|2|||
156763429|NCT03191799|565886385|FG000|Overall Study|Lost to Follow-up|1|||
156763430|NCT03191799|565886385|FG000|Overall Study|Death|2|||
156763431|NCT00902577|565886389|FG000|Overall Study|Withdrawal by Subject|6|||
156763432|NCT00902577|565886389|FG000|Overall Study|FMISO production failure|2|||
156763433|NCT00468585|565886390|FG000|Overall Study|Patient not treated|1|||
156763434|NCT00468585|565886391|FG001|Overall Study|Patient not treated|0|||
156763435|NCT00468585|565886392|FG002|Overall Study|Patient not treated|1|||
156763436|NCT00468585|565886393|FG003|Overall Study|Patient not treated|0|||
156763437|NCT00468585|565886390|FG000|Overall Study|Patient found to be ineligible|0|||
156763438|NCT00468585|565886391|FG001|Overall Study|Patient found to be ineligible|0|||
156763439|NCT00468585|565886392|FG002|Overall Study|Patient found to be ineligible|1|||
156763440|NCT00468585|565886393|FG003|Overall Study|Patient found to be ineligible|0|||
156763441|NCT00468585|565886390|FG000|Overall Study|Adverse Event|0|||
156763442|NCT00468585|565886391|FG001|Overall Study|Adverse Event|0|||
157005341|NCT01867216|566770118|FG006|Overall Study|Withdrawal by Subject|1|||
157005342|NCT01867216|566770112|FG000|Overall Study|Physician Decision|1|||
157005343|NCT01867216|566770113|FG001|Overall Study|Physician Decision|0|||
157005344|NCT01867216|566770114|FG002|Overall Study|Physician Decision|0|||
157005345|NCT01867216|566770115|FG003|Overall Study|Physician Decision|0|||
157005346|NCT01867216|566770116|FG004|Overall Study|Physician Decision|0|||
157005347|NCT01867216|566770117|FG005|Overall Study|Physician Decision|0|||
156763443|NCT00468585|565886392|FG002|Overall Study|Adverse Event|1|||
156763444|NCT00468585|565886393|FG003|Overall Study|Adverse Event|0|||
156763445|NCT00468585|565886390|FG000|Overall Study|Withdrawal by Subject|0|||
156763446|NCT00468585|565886391|FG001|Overall Study|Withdrawal by Subject|0|||
156763447|NCT00468585|565886392|FG002|Overall Study|Withdrawal by Subject|2|||
157005348|NCT01867216|566770118|FG006|Overall Study|Physician Decision|0|||
156763448|NCT00468585|565886393|FG003|Overall Study|Withdrawal by Subject|1|||
156763449|NCT03769649|565886394|FG000|Overall Study|Lost to Follow-up|4|||
156763450|NCT03322293|565886395|FG000|Overall Study|Lost to Follow-up|0|||
156763451|NCT03322293|565886396|FG001|Overall Study|Lost to Follow-up|0|||
156763452|NCT03322293|565886397|FG002|Overall Study|Lost to Follow-up|1|||
156763453|NCT00083915|565886398|FG000|Overall Study|Death|6|||
156763454|NCT00083915|565886399|FG001|Overall Study|Death|3|||
156763455|NCT00083915|565886398|FG000|Overall Study|Physician Decision|11|||
156763456|NCT00083915|565886399|FG001|Overall Study|Physician Decision|6|||
156763457|NCT00083915|565886398|FG000|Overall Study|Withdrawal by Subject|8|||
156763458|NCT00083915|565886399|FG001|Overall Study|Withdrawal by Subject|3|||
156763459|NCT00083915|565886398|FG000|Overall Study|disease progression|18|||
156763460|NCT00083915|565886399|FG001|Overall Study|disease progression|23|||
156763461|NCT00083915|565886398|FG000|Overall Study|Failure to collect|3|||
156763462|NCT00083915|565886399|FG001|Overall Study|Failure to collect|0|||
156763463|NCT00083915|565886398|FG000|Overall Study|No response|3|||
156763464|NCT00083915|565886399|FG001|Overall Study|No response|1|||
156763465|NCT00083915|565886398|FG000|Overall Study|Insurance issues|1|||
156763466|NCT00083915|565886399|FG001|Overall Study|Insurance issues|1|||
156763467|NCT02000921|565886401|FG000|Overall Study|Withdrawal by Subject|3|||
156763468|NCT02000921|565886402|FG001|Overall Study|Withdrawal by Subject|10|||
156763469|NCT02000921|565886403|FG002|Overall Study|Withdrawal by Subject|5|||
156763470|NCT02000921|565886401|FG000|Overall Study|Lost to Follow-up|2|||
156763471|NCT02000921|565886402|FG001|Overall Study|Lost to Follow-up|4|||
156763472|NCT02000921|565886403|FG002|Overall Study|Lost to Follow-up|5|||
156763473|NCT02000921|565886401|FG000|Overall Study|Physician Decision|0|||
156763474|NCT02000921|565886402|FG001|Overall Study|Physician Decision|2|||
156763475|NCT02000921|565886403|FG002|Overall Study|Physician Decision|0|||
156763476|NCT01290718|565886404|FG000|Overall Study|Early termination of the study|4|||
156763477|NCT03722576|565886408|FG000|Overall Study|Withdrawal by Subject|3|||
156763478|NCT03722576|565886408|FG000|Overall Study|Adverse Event|2|||
156763479|NCT03722576|565886408|FG000|Overall Study|Physician Decision|1|||
156763480|NCT03722576|565886408|FG000|Overall Study|Lost to Follow-up|1|||
156763481|NCT01240382|565886409|FG000|Overall Study|Adverse Event|2|||
156763482|NCT01240382|565886410|FG001|Overall Study|Adverse Event|1|||
156763483|NCT01240382|565886409|FG000|Overall Study|Lack of Efficacy|0|||
156763484|NCT01240382|565886410|FG001|Overall Study|Lack of Efficacy|2|||
156763485|NCT01240382|565886409|FG000|Overall Study|Fear of adverse events|0|||
156763486|NCT01240382|565886410|FG001|Overall Study|Fear of adverse events|1|||
156763487|NCT02643693|565886411|FG000|Overall Study|Physician Decision|0|||
156763488|NCT02643693|565886412|FG001|Overall Study|Physician Decision|1|||
156763489|NCT02643693|565886413|FG002|Overall Study|Physician Decision|0|||
156763490|NCT02643693|565886414|FG003|Overall Study|Physician Decision|0|||
156763491|NCT02643693|565886415|FG004|Overall Study|Physician Decision|0|||
156763492|NCT02643693|565886416|FG005|Overall Study|Physician Decision|0|||
156763493|NCT02643693|565886411|FG000|Overall Study|Withdrawal by Subject|0|||
156763494|NCT02643693|565886412|FG001|Overall Study|Withdrawal by Subject|1|||
156763495|NCT02643693|565886413|FG002|Overall Study|Withdrawal by Subject|0|||
156763496|NCT02643693|565886414|FG003|Overall Study|Withdrawal by Subject|0|||
156763497|NCT02643693|565886415|FG004|Overall Study|Withdrawal by Subject|0|||
156763498|NCT02643693|565886416|FG005|Overall Study|Withdrawal by Subject|0|||
156763499|NCT02643693|565886411|FG000|Overall Study|Protocol Adherence Issues|2|||
156763500|NCT02643693|565886412|FG001|Overall Study|Protocol Adherence Issues|0|||
156763501|NCT02643693|565886413|FG002|Overall Study|Protocol Adherence Issues|1|||
156763502|NCT02643693|565886414|FG003|Overall Study|Protocol Adherence Issues|0|||
156763503|NCT02643693|565886415|FG004|Overall Study|Protocol Adherence Issues|0|||
156763504|NCT02643693|565886416|FG005|Overall Study|Protocol Adherence Issues|1|||
157110670|NCT01987960|567158437|FG000|Period 3|Protocol Violation|0|||
157110671|NCT01987960|567158438|FG001|Period 3|Protocol Violation|0|||
157110672|NCT01987960|567158439|FG002|Period 3|Protocol Violation|0|||
156763505|NCT01319565|565886417|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
156763506|NCT01319565|565886418|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
156763507|NCT01319565|565886419|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
156763508|NCT01268267|565886420|FG000|Overall Study|Protocol Violation|1|||
156763509|NCT02131064|565886422|FG000|Overall Study|Death|5|||
156763510|NCT02131064|565886423|FG001|Overall Study|Death|6|||
156763511|NCT02131064|565886422|FG000|Overall Study|Lost to Follow-up|4|||
156763512|NCT02131064|565886423|FG001|Overall Study|Lost to Follow-up|8|||
156763513|NCT02131064|565886422|FG000|Overall Study|Withdrawal by Subject|14|||
156763514|NCT02131064|565886423|FG001|Overall Study|Withdrawal by Subject|18|||
156763515|NCT02131064|565886422|FG000|Overall Study|Other|2|||
156763516|NCT02131064|565886423|FG001|Overall Study|Other|2|||
156763517|NCT04831138|565886426|FG000|Overall Study|Lost to Follow-up|2|||
156763518|NCT04831138|565886427|FG001|Overall Study|Lost to Follow-up|0|||
156763519|NCT00593918|565886428|FG000|Overall Study|Withdrawal by Subject|5|||
156763520|NCT00593918|565886429|FG001|Overall Study|Withdrawal by Subject|24|||
156763521|NCT04414787|565886437|FG000|Overall Study|Patient Death|18|||
157110673|NCT01987960|567158440|FG003|Period 3|Protocol Violation|6|||
156763522|NCT04414787|565886438|FG001|Overall Study|Patient Death|18|||
156763523|NCT04414787|565886439|FG002|Overall Study|Patient Death|15|||
156763524|NCT04414787|565886440|FG003|Overall Study|Patient Death|15|||
156763525|NCT04414787|565886437|FG000|Overall Study|Patient Hospitalization|1|||
156763526|NCT04414787|565886438|FG001|Overall Study|Patient Hospitalization|1|||
156763527|NCT04414787|565886439|FG002|Overall Study|Patient Hospitalization|2|||
156763528|NCT04414787|565886440|FG003|Overall Study|Patient Hospitalization|2|||
156763529|NCT04414787|565886437|FG000|Overall Study|Lost to Follow-up|7|||
156763530|NCT04414787|565886438|FG001|Overall Study|Lost to Follow-up|7|||
156763531|NCT04414787|565886439|FG002|Overall Study|Lost to Follow-up|5|||
156763532|NCT04414787|565886440|FG003|Overall Study|Lost to Follow-up|5|||
156763533|NCT04414787|565886437|FG000|Overall Study|Residence in post-acute care facility|3|||
156763534|NCT04414787|565886438|FG001|Overall Study|Residence in post-acute care facility|3|||
156763535|NCT04414787|565886439|FG002|Overall Study|Residence in post-acute care facility|5|||
156763536|NCT04414787|565886440|FG003|Overall Study|Residence in post-acute care facility|5|||
156763537|NCT00536510|565887912|FG000|Overall Study|Adverse Event|27|||
156763538|NCT00536510|565887913|FG001|Overall Study|Adverse Event|4|||
156763539|NCT00536510|565887912|FG000|Overall Study|Lost to Follow-up|11|||
156763540|NCT00536510|565887913|FG001|Overall Study|Lost to Follow-up|8|||
156763541|NCT00536510|565887912|FG000|Overall Study|Protocol Violation|4|||
156763542|NCT00536510|565887913|FG001|Overall Study|Protocol Violation|5|||
156763543|NCT00536510|565887912|FG000|Overall Study|Withdrawal by Subject|16|||
156763544|NCT00536510|565887913|FG001|Overall Study|Withdrawal by Subject|9|||
156763545|NCT00536510|565887912|FG000|Overall Study|Flushing with Product|20|||
156763546|NCT00536510|565887913|FG001|Overall Study|Flushing with Product|0|||
156763547|NCT00536510|565887912|FG000|Overall Study|Laboratory Adverse Event|2|||
156763548|NCT00536510|565887913|FG001|Overall Study|Laboratory Adverse Event|1|||
156763549|NCT00536510|565887912|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
156763550|NCT00536510|565887913|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
156763551|NCT02062437|565887914|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
156763552|NCT02062437|565887914|FG000|Overall Study|Patient not available for the 2y visit|18|||
156763553|NCT02062437|565887914|FG000|Overall Study|Death|2|||
156763554|NCT02062437|565887914|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
156763555|NCT01674725|565887915|FG000|Overall Study|Adverse Event|1|||
156763556|NCT01674725|565887916|FG001|Overall Study|Adverse Event|0|||
156763557|NCT01674725|565887915|FG000|Overall Study|Did not receive study drug|1|||
156763558|NCT01674725|565887916|FG001|Overall Study|Did not receive study drug|0|||
156763559|NCT01674725|565887915|FG000|Overall Study|Withdrawal by Subject|1|||
156763560|NCT01674725|565887916|FG001|Overall Study|Withdrawal by Subject|0|||
156763561|NCT01674725|565887915|FG000|Overall Study|Lost to Follow-up|0|||
156763562|NCT01674725|565887916|FG001|Overall Study|Lost to Follow-up|1|||
156763563|NCT03102762|565887917|FG000|Overall Study|Lost to Follow-up|1|||
156763564|NCT03102762|565887918|FG001|Overall Study|Lost to Follow-up|0|||
156763565|NCT03074695|565887923|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
156763566|NCT03074695|565887924|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
156763567|NCT03074695|565887923|FG000|Overall Study|Research staff not available|1|||
156763568|NCT03074695|565887924|FG001|Overall Study|Research staff not available|2|||
156763569|NCT03074695|565887923|FG000|Overall Study|Did not receive neuraxial block|2|||
156763570|NCT03074695|565887924|FG001|Overall Study|Did not receive neuraxial block|2|||
156763571|NCT04464707|565887926|FG000|Overall Study|Adverse Event|1|||
156763572|NCT04464707|565887927|FG001|Overall Study|Adverse Event|0|||
156763573|NCT04464707|565887928|FG002|Overall Study|Adverse Event|0|||
156763574|NCT04464707|565887926|FG000|Overall Study|Withdrawal by Subject|0|||
156763575|NCT04464707|565887927|FG001|Overall Study|Withdrawal by Subject|0|||
156763576|NCT04464707|565887928|FG002|Overall Study|Withdrawal by Subject|2|||
156763577|NCT04464707|565887926|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156763578|NCT04464707|565887927|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156763579|NCT04464707|565887928|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156763580|NCT04464707|565887926|FG000|Overall Study|Protocol Deviation|1|||
156763581|NCT04464707|565887927|FG001|Overall Study|Protocol Deviation|0|||
156763582|NCT04464707|565887928|FG002|Overall Study|Protocol Deviation|0|||
156763583|NCT04464707|565887926|FG000|Overall Study|Lost to Follow-up|2|||
156763584|NCT04464707|565887927|FG001|Overall Study|Lost to Follow-up|0|||
156763585|NCT04464707|565887928|FG002|Overall Study|Lost to Follow-up|1|||
156763586|NCT04202497|565887933|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
156763587|NCT04202497|565887934|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
156763588|NCT04202497|565887935|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
156763589|NCT04202497|565887936|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
157005349|NCT01867216|566770112|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
157005350|NCT01867216|566770113|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
157005351|NCT01867216|566770114|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
156763590|NCT04344301|565887937|FG000|Overall Study|Withdrawal by Subject|1|||
156763591|NCT04344301|565887938|FG001|Overall Study|Withdrawal by Subject|0|||
156763592|NCT04344301|565887937|FG000|Overall Study|Death|0|||
156763593|NCT04344301|565887938|FG001|Overall Study|Death|1|||
156763594|NCT00072410|565887939|FG000|Overall Study|Progressive disease|0|||
156763595|NCT00072410|565887940|FG001|Overall Study|Progressive disease|3|||
156763596|NCT05590377|565887943|FG000|Overall Study|Death|1|||
156763597|NCT05590377|565887944|FG001|Overall Study|Death|1|||
156763598|NCT05590377|565887945|FG002|Overall Study|Death|2|||
156763599|NCT05590377|565887946|FG003|Overall Study|Death|0|||
156763600|NCT05590377|565887947|FG004|Overall Study|Death|0|||
156763601|NCT05590377|565887943|FG000|Overall Study|Study Terminated by Sponsor|1|||
156763602|NCT05590377|565887944|FG001|Overall Study|Study Terminated by Sponsor|5|||
156763603|NCT05590377|565887945|FG002|Overall Study|Study Terminated by Sponsor|4|||
156763604|NCT05590377|565887946|FG003|Overall Study|Study Terminated by Sponsor|0|||
156763605|NCT05590377|565887947|FG004|Overall Study|Study Terminated by Sponsor|0|||
156763606|NCT05590377|565887943|FG000|Overall Study|Withdrawal by Subject|1|||
156763607|NCT05590377|565887944|FG001|Overall Study|Withdrawal by Subject|0|||
156763608|NCT05590377|565887945|FG002|Overall Study|Withdrawal by Subject|0|||
156763609|NCT05590377|565887946|FG003|Overall Study|Withdrawal by Subject|0|||
156763610|NCT05590377|565887947|FG004|Overall Study|Withdrawal by Subject|0|||
156763611|NCT03389620|565887948|FG000|Overall Study|Lost to Follow-up|5|||
156763612|NCT03389620|565887949|FG001|Overall Study|Lost to Follow-up|1|||
156763613|NCT00549549|565887950|FG000|Overall Study|Adverse Event|5|||
156763614|NCT00549549|565887951|FG001|Overall Study|Adverse Event|3|||
156763615|NCT00549549|565887952|FG002|Overall Study|Adverse Event|1|||
156763616|NCT00549549|565887953|FG003|Overall Study|Adverse Event|9|||
156763617|NCT00549549|565887950|FG000|Overall Study|Lack of Efficacy|9|||
156763618|NCT00549549|565887951|FG001|Overall Study|Lack of Efficacy|6|||
156763619|NCT00549549|565887952|FG002|Overall Study|Lack of Efficacy|4|||
156763620|NCT00549549|565887953|FG003|Overall Study|Lack of Efficacy|2|||
156763621|NCT00549549|565887950|FG000|Overall Study|Lost to Follow-up|1|||
156763622|NCT00549549|565887951|FG001|Overall Study|Lost to Follow-up|0|||
156763623|NCT00549549|565887952|FG002|Overall Study|Lost to Follow-up|1|||
156763624|NCT00549549|565887953|FG003|Overall Study|Lost to Follow-up|2|||
156763625|NCT00549549|565887950|FG000|Overall Study|Withdrawal by Subject|0|||
156763626|NCT00549549|565887951|FG001|Overall Study|Withdrawal by Subject|4|||
156763627|NCT00549549|565887952|FG002|Overall Study|Withdrawal by Subject|1|||
156763628|NCT00549549|565887953|FG003|Overall Study|Withdrawal by Subject|0|||
156763629|NCT00549549|565887950|FG000|Overall Study|Other|9|||
156763630|NCT00549549|565887951|FG001|Overall Study|Other|9|||
156763631|NCT00549549|565887952|FG002|Overall Study|Other|9|||
156763632|NCT00549549|565887953|FG003|Overall Study|Other|11|||
156763633|NCT00549549|565887950|FG000|Overall Study|Randomized but not treated|0|||
156763634|NCT00549549|565887951|FG001|Overall Study|Randomized but not treated|0|||
156763635|NCT00549549|565887952|FG002|Overall Study|Randomized but not treated|1|||
156763636|NCT00549549|565887953|FG003|Overall Study|Randomized but not treated|1|||
156763637|NCT02155699|565887954|FG000|Overall Study|Withdrawal by Subject|0|||
156763638|NCT02155699|565887955|FG001|Overall Study|Withdrawal by Subject|3|||
156763639|NCT02155699|565887956|FG002|Overall Study|Withdrawal by Subject|6|||
156763640|NCT02155699|565887957|FG003|Overall Study|Withdrawal by Subject|1|||
156763641|NCT02155699|565887954|FG000|Overall Study|Lost to Follow-up|0|||
156763642|NCT02155699|565887955|FG001|Overall Study|Lost to Follow-up|0|||
156763643|NCT02155699|565887956|FG002|Overall Study|Lost to Follow-up|0|||
156763644|NCT02155699|565887957|FG003|Overall Study|Lost to Follow-up|3|||
156763645|NCT02155699|565887954|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
156763646|NCT02155699|565887955|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
156763647|NCT02155699|565887956|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
156763648|NCT02155699|565887957|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
156763649|NCT05547386|565887958|FG000|Overall Study|Withdrawal by Subject|7|||
156763650|NCT05852353|565887959|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
156763651|NCT05852353|565887959|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
156763652|NCT05852353|565887959|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
156763653|NCT05852353|565887959|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
156763654|NCT03509467|565887960|FG000|Overall Study|Withdrawal by Subject|5|||
156763655|NCT03509467|565887961|FG001|Overall Study|Withdrawal by Subject|1|||
156763656|NCT03509467|565887962|FG002|Overall Study|Withdrawal by Subject|6|||
156763657|NCT03509467|565887963|FG003|Overall Study|Withdrawal by Subject|7|||
156763658|NCT03509467|565887964|FG004|Overall Study|Withdrawal by Subject|10|||
156763659|NCT03509467|565887965|FG005|Overall Study|Withdrawal by Subject|10|||
156763660|NCT03509467|565887966|FG006|Overall Study|Withdrawal by Subject|10|||
156763661|NCT03509467|565887967|FG007|Overall Study|Withdrawal by Subject|10|||
156763662|NCT03509467|565887960|FG000|Overall Study|Death|0|||
156763663|NCT03509467|565887961|FG001|Overall Study|Death|0|||
156763664|NCT03509467|565887962|FG002|Overall Study|Death|2|||
156763665|NCT03509467|565887963|FG003|Overall Study|Death|2|||
156763666|NCT03509467|565887964|FG004|Overall Study|Death|1|||
156763667|NCT03509467|565887965|FG005|Overall Study|Death|0|||
156763668|NCT03509467|565887966|FG006|Overall Study|Death|1|||
157005352|NCT01867216|566770115|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
157005353|NCT01867216|566770116|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
157005354|NCT01867216|566770117|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
157005355|NCT01867216|566770118|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
157005356|NCT00831415|566770119|FG000|Overall Study|Adverse Event|14|||
157005357|NCT00831415|566770119|FG000|Overall Study|Failed to return|3|||
157005358|NCT00831415|566770119|FG000|Overall Study|Physician Decision|6|||
157005359|NCT00831415|566770119|FG000|Overall Study|Lost to Follow-up|9|||
157005360|NCT00831415|566770119|FG000|Overall Study|Protocol Violation|3|||
156763669|NCT03509467|565887967|FG007|Overall Study|Death|0|||
156763670|NCT03509467|565887960|FG000|Overall Study|Proxy Withdrawal|0|||
156763671|NCT03509467|565887961|FG001|Overall Study|Proxy Withdrawal|0|||
156763672|NCT03509467|565887962|FG002|Overall Study|Proxy Withdrawal|0|||
156763673|NCT03509467|565887963|FG003|Overall Study|Proxy Withdrawal|0|||
156763674|NCT03509467|565887964|FG004|Overall Study|Proxy Withdrawal|0|||
156763675|NCT03509467|565887965|FG005|Overall Study|Proxy Withdrawal|0|||
156763676|NCT03509467|565887966|FG006|Overall Study|Proxy Withdrawal|0|||
156763677|NCT03509467|565887967|FG007|Overall Study|Proxy Withdrawal|1|||
156763678|NCT01005745|565887968|FG000|Overall Study|No TIL growth|1|||
156763679|NCT01005745|565887968|FG000|Overall Study|Disease progressed during TIL growth|3|||
156763680|NCT01005745|565887968|FG000|Overall Study|Death prior to treatment|1|||
156763681|NCT01005745|565887968|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
156763682|NCT03834506|565887969|FG000|Overall Study|Death|336|||
156763683|NCT03834506|565887970|FG001|Overall Study|Death|326|||
156763684|NCT03834506|565887969|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156763685|NCT03834506|565887970|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156763686|NCT03834506|565887969|FG000|Overall Study|Withdrawal by Subject|10|||
156763687|NCT03834506|565887970|FG001|Overall Study|Withdrawal by Subject|8|||
156763688|NCT03834506|565887969|FG000|Overall Study|Sponsor decision|165|||
156763689|NCT03834506|565887970|FG001|Overall Study|Sponsor decision|178|||
156763690|NCT03834506|565887969|FG000|Overall Study|Physician Decision|3|||
156763691|NCT03834506|565887970|FG001|Overall Study|Physician Decision|1|||
156763692|NCT03834506|565887969|FG000|Overall Study|Lost to Follow-up|0|||
156763693|NCT03834506|565887970|FG001|Overall Study|Lost to Follow-up|1|||
156763694|NCT02287038|565887973|FG000|Overall Study|Stopped attending appointments|3|||
156763695|NCT02287038|565887974|FG001|Overall Study|Stopped attending appointments|2|||
156763696|NCT02287038|565887973|FG000|Overall Study|Anxiety after starting medication|0|||
156763697|NCT02287038|565887974|FG001|Overall Study|Anxiety after starting medication|1|||
156763698|NCT02287038|565887973|FG000|Overall Study|Nausea after starting medication|1|||
156763699|NCT02287038|565887974|FG001|Overall Study|Nausea after starting medication|0|||
156763700|NCT02287038|565887973|FG000|Overall Study|Abnormal ECG after starting medication|1|||
156763701|NCT02287038|565887974|FG001|Overall Study|Abnormal ECG after starting medication|0|||
156763702|NCT05502302|565887980|FG000|Overall Study|Lost to Follow-up|6|||
156763703|NCT05502302|565887980|FG000|Overall Study|Death|2|||
156763704|NCT02998151|565887981|FG000|Overall Study|Withdrawal by Subject|3|||
156763705|NCT02998151|565887981|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
156763706|NCT02998151|565887981|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
156763707|NCT02667301|565887982|FG000|Overall Study|Adverse Event|1|||
156763708|NCT02667301|565887982|FG000|Overall Study|Lack of Efficacy|1|||
156763709|NCT01619878|565887984|FG000|6 Week Follow-up Phase|Adverse Event|1|||
156763710|NCT01619878|565887984|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
156763711|NCT01619878|565887984|FG000|Follow-up at 12 Months of Age|Death|2|||
156763712|NCT02895295|565887985|FG000|Overall Study|Survey Non-response|71|||
156763713|NCT02895295|565887986|FG001|Overall Study|Survey Non-response|94|||
156763714|NCT02895295|565887987|FG002|Overall Study|Survey Non-response|92|||
156763715|NCT05093933|565887988|FG000|Overall Study|Death|372|||
156763716|NCT05093933|565887989|FG001|Overall Study|Death|434|||
156763717|NCT05093933|565887988|FG000|Overall Study|Lost to Follow-up|13|||
156763718|NCT05093933|565887989|FG001|Overall Study|Lost to Follow-up|16|||
156763719|NCT05093933|565887988|FG000|Overall Study|Physician Decision|0|||
156763720|NCT05093933|565887989|FG001|Overall Study|Physician Decision|2|||
156763721|NCT05093933|565887988|FG000|Overall Study|Sponsor Decision|1|||
156763722|NCT05093933|565887989|FG001|Overall Study|Sponsor Decision|3|||
156763723|NCT05093933|565887988|FG000|Overall Study|Withdrawal by Guardian|1|||
156763724|NCT05093933|565887989|FG001|Overall Study|Withdrawal by Guardian|1|||
157005361|NCT00831415|566770119|FG000|Overall Study|Withdrawal by Subject|35|||
157005362|NCT00831415|566770119|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
157005363|NCT00831415|566770119|FG000|Overall Study|Death|1|||
157005364|NCT01290224|566770120|FG000|Overall Study|Adverse Event|1|||
157005365|NCT01290224|566770120|FG000|Overall Study|Refused Further Treatment|4|||
157005366|NCT05694065|566770121|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
157005367|NCT05694065|566770121|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
157005368|NCT05694065|566770121|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
157005369|NCT00424762|566770122|FG000|Overall Study|Withdrawal by Subject|18|||
157005370|NCT00424762|566770123|FG001|Overall Study|Withdrawal by Subject|19|||
157005371|NCT00424762|566770122|FG000|Overall Study|Lost to Follow-up|2|||
157005372|NCT00424762|566770123|FG001|Overall Study|Lost to Follow-up|3|||
157005373|NCT00842257|566770130|FG000|Overall Study|Adverse Event|1|||
157005374|NCT00909363|566770134|FG000|Overall Study|Withdrawal by Subject|1|||
157005375|NCT00909363|566770135|FG001|Overall Study|Withdrawal by Subject|0|||
157005376|NCT00909363|566770136|FG002|Overall Study|Withdrawal by Subject|0|||
156763725|NCT05093933|565887988|FG000|Overall Study|Withdrawal by Subject|18|||
156763726|NCT05093933|565887989|FG001|Overall Study|Withdrawal by Subject|25|||
156763727|NCT04037358|565887990|FG000|Overall Study|Patient withdrew before intervention|1|||
156763728|NCT04037358|565887991|FG001|Overall Study|Patient withdrew before intervention|0|||
156763729|NCT04157517|565887994|FG000|Overall Study|Death|1|||
156763730|NCT04157517|565887995|FG001|Overall Study|Death|2|||
156763731|NCT04157517|565887996|FG002|Overall Study|Death|2|||
156763732|NCT04157517|565887997|FG003|Overall Study|Death|3|||
156763733|NCT04157517|565887998|FG004|Overall Study|Death|3|||
156763734|NCT04157517|565887999|FG005|Overall Study|Death|4|||
156763735|NCT04157517|565888000|FG006|Overall Study|Death|1|||
157005377|NCT00909363|566770134|FG000|Overall Study|Lack of Efficacy|1|||
157005378|NCT00909363|566770135|FG001|Overall Study|Lack of Efficacy|0|||
157005379|NCT00909363|566770136|FG002|Overall Study|Lack of Efficacy|0|||
157005380|NCT00922207|566770137|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
157005381|NCT00922207|566770138|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
157005382|NCT00922207|566770139|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
157005383|NCT00922207|566770137|FG000|Overall Study|Insufficient Therapeutic Response|0|||
157005384|NCT00922207|566770138|FG001|Overall Study|Insufficient Therapeutic Response|0|||
157005385|NCT00922207|566770139|FG002|Overall Study|Insufficient Therapeutic Response|1|||
157005386|NCT00922207|566770137|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
157005387|NCT00922207|566770138|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
157005388|NCT00922207|566770139|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
157005389|NCT00922207|566770137|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
157005390|NCT00922207|566770138|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
157005391|NCT00922207|566770139|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
157005392|NCT00922207|566770137|FG000|Overall Study|Withdrew Consent|2|||
157005393|NCT00922207|566770138|FG001|Overall Study|Withdrew Consent|5|||
157005394|NCT00922207|566770139|FG002|Overall Study|Withdrew Consent|2|||
157005395|NCT00922207|566770137|FG000|Overall Study|Abnormality of Laboratory Test|0|||
157005396|NCT00922207|566770138|FG001|Overall Study|Abnormality of Laboratory Test|1|||
157005397|NCT00922207|566770139|FG002|Overall Study|Abnormality of Laboratory Test|1|||
157005398|NCT00367991|566770141|FG000|Overall Study|Withdrawal by Subject|1|||
157005399|NCT00367991|566770142|FG001|Overall Study|Withdrawal by Subject|1|||
157005400|NCT00367991|566770141|FG000|Overall Study|Adverse Event|1|||
157005401|NCT00367991|566770142|FG001|Overall Study|Adverse Event|1|||
157005402|NCT03515304|566770143|FG000|Overall Study|Lost to Follow-up|0|||
157005403|NCT03515304|566770144|FG001|Overall Study|Lost to Follow-up|3|||
157005404|NCT02969863|566770149|FG000|Overall Study|Physician Decision|1|||
157005405|NCT02969863|566770150|FG001|Overall Study|Physician Decision|0|||
157005406|NCT02969863|566770151|FG002|Overall Study|Physician Decision|0|||
157005407|NCT02969863|566770152|FG003|Overall Study|Physician Decision|0|||
157005408|NCT02969863|566770153|FG004|Overall Study|Physician Decision|0|||
157005409|NCT02969863|566770154|FG005|Overall Study|Physician Decision|0|||
157005410|NCT02705586|566770155|FG000|Overall Study|Health Issues|2|||
157005411|NCT02705586|566770155|FG000|Overall Study|Transportation Difficulties|5|||
157005412|NCT02705586|566770155|FG000|Overall Study|Vacation/Planned Absence|1|||
157005413|NCT02045836|566770156|FG000|Overall Study|Adverse Event|4|||
157005414|NCT02045836|566770157|FG001|Overall Study|Adverse Event|4|||
157005415|NCT02045836|566770156|FG000|Overall Study|Withdrawal by Subject|1|||
157005416|NCT02045836|566770157|FG001|Overall Study|Withdrawal by Subject|1|||
157005417|NCT02045836|566770156|FG000|Overall Study|Lost to Follow-up|4|||
157005418|NCT02045836|566770157|FG001|Overall Study|Lost to Follow-up|7|||
157005419|NCT02045836|566770156|FG000|Overall Study|Migrated from study area|0|||
157005420|NCT02045836|566770157|FG001|Overall Study|Migrated from study area|2|||
157005421|NCT00057837|566770158|FG000|Overall Study|Progression/relapse|12|||
157005422|NCT00057837|566770159|FG001|Overall Study|Progression/relapse|14|||
157005423|NCT00057837|566770158|FG000|Overall Study|Adverse Event|2|||
157005424|NCT00057837|566770159|FG001|Overall Study|Adverse Event|12|||
157005425|NCT00057837|566770158|FG000|Overall Study|Death|5|||
157005426|NCT00057837|566770159|FG001|Overall Study|Death|4|||
157005427|NCT00057837|566770158|FG000|Overall Study|Withdrawal by Subject|5|||
157005428|NCT00057837|566770159|FG001|Overall Study|Withdrawal by Subject|3|||
157005429|NCT00057837|566770158|FG000|Overall Study|Alternative therapy|0|||
157005430|NCT00057837|566770159|FG001|Overall Study|Alternative therapy|1|||
157005431|NCT00057837|566770158|FG000|Overall Study|Other complicating disease|2|||
157005432|NCT00057837|566770159|FG001|Overall Study|Other complicating disease|1|||
157005433|NCT00057837|566770158|FG000|Overall Study|Physician Decision|1|||
157005434|NCT00057837|566770159|FG001|Overall Study|Physician Decision|0|||
157005435|NCT00057837|566770158|FG000|Overall Study|Ineligible|3|||
157005436|NCT00057837|566770159|FG001|Overall Study|Ineligible|3|||
157005437|NCT00057837|566770158|FG000|Overall Study|Never started treatment|1|||
157005438|NCT00057837|566770159|FG001|Overall Study|Never started treatment|1|||
157005439|NCT02000817|566770160|FG000|Overall Study|Withdrawal by Subject|2|||
157005440|NCT02000817|566770161|FG001|Overall Study|Withdrawal by Subject|0|||
157005441|NCT02000817|566770162|FG002|Overall Study|Withdrawal by Subject|0|||
156763736|NCT04157517|565888001|FG007|Overall Study|Death|2|||
156763737|NCT04157517|565888002|FG008|Overall Study|Death|4|||
156763738|NCT04157517|565888003|FG009|Overall Study|Death|0|||
156763739|NCT04157517|565887994|FG000|Overall Study|Withdrawal by Subject|1|||
157005442|NCT02000817|566770163|FG003|Overall Study|Withdrawal by Subject|0|||
157005443|NCT02000817|566770160|FG000|Overall Study|Adverse Event|0|||
157005444|NCT02000817|566770161|FG001|Overall Study|Adverse Event|1|||
157005445|NCT02000817|566770162|FG002|Overall Study|Adverse Event|0|||
157005446|NCT02000817|566770163|FG003|Overall Study|Adverse Event|0|||
157005447|NCT02000817|566770160|FG000|Overall Study|Lost to Follow-up|0|||
157005448|NCT02000817|566770161|FG001|Overall Study|Lost to Follow-up|0|||
157005449|NCT02000817|566770162|FG002|Overall Study|Lost to Follow-up|1|||
157005450|NCT02000817|566770163|FG003|Overall Study|Lost to Follow-up|0|||
157005451|NCT03383146|566770164|FG000|Overall Study|Screen Failure|1|||
157005452|NCT03383146|566770165|FG001|Overall Study|Screen Failure|0|||
157005453|NCT03383146|566770164|FG000|Overall Study|Adverse Event|6|||
157005454|NCT03383146|566770165|FG001|Overall Study|Adverse Event|18|||
157005455|NCT03383146|566770164|FG000|Overall Study|Lack of Efficacy|0|||
157005456|NCT03383146|566770165|FG001|Overall Study|Lack of Efficacy|3|||
157005457|NCT03383146|566770164|FG000|Overall Study|Withdrawal by Subject|20|||
157005458|NCT03383146|566770165|FG001|Overall Study|Withdrawal by Subject|36|||
157005459|NCT03383146|566770164|FG000|Overall Study|Lost to Follow-up|5|||
157005460|NCT03383146|566770165|FG001|Overall Study|Lost to Follow-up|15|||
157005461|NCT03383146|566770164|FG000|Overall Study|Death|0|||
157005462|NCT03383146|566770165|FG001|Overall Study|Death|2|||
157005463|NCT03383146|566770164|FG000|Overall Study|Physician Decision|0|||
157005464|NCT03383146|566770165|FG001|Overall Study|Physician Decision|1|||
157005465|NCT03383146|566770164|FG000|Overall Study|Protocol Deviation|1|||
157005466|NCT03383146|566770165|FG001|Overall Study|Protocol Deviation|8|||
157005467|NCT03383146|566770164|FG000|Overall Study|Study Terminated by the Sponsor|48|||
157005468|NCT03383146|566770165|FG001|Overall Study|Study Terminated by the Sponsor|95|||
157005469|NCT03383146|566770164|FG000|Overall Study|Reason not Specified|4|||
157005470|NCT03383146|566770165|FG001|Overall Study|Reason not Specified|6|||
157005471|NCT01317420|566770166|FG000|Overall Study|Progressive disease according to RECIST|2|||
157005472|NCT01317420|566770167|FG001|Overall Study|Progressive disease according to RECIST|3|||
157005473|NCT01317420|566770168|FG002|Overall Study|Progressive disease according to RECIST|3|||
157005474|NCT01317420|566770169|FG003|Overall Study|Progressive disease according to RECIST|3|||
157005475|NCT01317420|566770170|FG004|Overall Study|Progressive disease according to RECIST|3|||
157005476|NCT01317420|566770171|FG005|Overall Study|Progressive disease according to RECIST|3|||
157005477|NCT01317420|566770172|FG006|Overall Study|Progressive disease according to RECIST|3|||
157005478|NCT01317420|566770173|FG007|Overall Study|Progressive disease according to RECIST|3|||
157005479|NCT01317420|566770174|FG008|Overall Study|Progressive disease according to RECIST|3|||
157005480|NCT01317420|566770175|FG009|Overall Study|Progressive disease according to RECIST|2|||
157005481|NCT01317420|566770176|FG010|Overall Study|Progressive disease according to RECIST|3|||
157005482|NCT01317420|566770177|FG011|Overall Study|Progressive disease according to RECIST|11|||
157005483|NCT01317420|566770178|FG012|Overall Study|Progressive disease according to RECIST|16|||
157005484|NCT01317420|566770166|FG000|Overall Study|Other adverse event|1|||
157005485|NCT01317420|566770167|FG001|Overall Study|Other adverse event|0|||
157005486|NCT01317420|566770168|FG002|Overall Study|Other adverse event|0|||
157005487|NCT01317420|566770169|FG003|Overall Study|Other adverse event|0|||
157005488|NCT01317420|566770170|FG004|Overall Study|Other adverse event|0|||
156763740|NCT04157517|565887995|FG001|Overall Study|Withdrawal by Subject|1|||
156763741|NCT04157517|565887996|FG002|Overall Study|Withdrawal by Subject|1|||
156763742|NCT04157517|565887997|FG003|Overall Study|Withdrawal by Subject|0|||
156763743|NCT04157517|565887998|FG004|Overall Study|Withdrawal by Subject|0|||
156763744|NCT04157517|565887999|FG005|Overall Study|Withdrawal by Subject|1|||
156763745|NCT04157517|565888000|FG006|Overall Study|Withdrawal by Subject|0|||
156763746|NCT04157517|565888001|FG007|Overall Study|Withdrawal by Subject|0|||
156763747|NCT04157517|565888002|FG008|Overall Study|Withdrawal by Subject|1|||
156763748|NCT04157517|565888003|FG009|Overall Study|Withdrawal by Subject|0|||
156763749|NCT04157517|565887994|FG000|Overall Study|Other|1|||
156763750|NCT04157517|565887995|FG001|Overall Study|Other|0|||
156763751|NCT04157517|565887996|FG002|Overall Study|Other|0|||
156763752|NCT04157517|565887997|FG003|Overall Study|Other|0|||
156763753|NCT04157517|565887998|FG004|Overall Study|Other|0|||
156763754|NCT04157517|565887999|FG005|Overall Study|Other|1|||
156763755|NCT04157517|565888000|FG006|Overall Study|Other|2|||
156763756|NCT04157517|565888001|FG007|Overall Study|Other|7|||
156763757|NCT04157517|565888002|FG008|Overall Study|Other|7|||
156763758|NCT04157517|565888003|FG009|Overall Study|Other|0|||
156763759|NCT03433898|565888006|FG000|Overall Study|Progressive disease|6|||
156763760|NCT03433898|565888007|FG001|Overall Study|Progressive disease|3|||
156763761|NCT03433898|565888008|FG002|Overall Study|Progressive disease|3|||
156763762|NCT03433898|565888009|FG003|Overall Study|Progressive disease|2|||
156763763|NCT03433898|565888010|FG004|Overall Study|Progressive disease|30|||
156763764|NCT03433898|565888011|FG005|Overall Study|Progressive disease|29|||
156763765|NCT03433898|565888012|FG006|Overall Study|Progressive disease|17|||
156763766|NCT03433898|565888013|FG007|Overall Study|Progressive disease|30|||
156763767|NCT03433898|565888006|FG000|Overall Study|Not treated|1|||
156763768|NCT03433898|565888007|FG001|Overall Study|Not treated|0|||
156763769|NCT03433898|565888008|FG002|Overall Study|Not treated|0|||
156763770|NCT03433898|565888009|FG003|Overall Study|Not treated|0|||
156763771|NCT03433898|565888010|FG004|Overall Study|Not treated|1|||
156763772|NCT03433898|565888011|FG005|Overall Study|Not treated|0|||
156763773|NCT03433898|565888012|FG006|Overall Study|Not treated|0|||
156763774|NCT03433898|565888013|FG007|Overall Study|Not treated|0|||
156763775|NCT03433898|565888006|FG000|Overall Study|Death|0|||
156763776|NCT03433898|565888007|FG001|Overall Study|Death|0|||
156763777|NCT03433898|565888008|FG002|Overall Study|Death|0|||
156763778|NCT03433898|565888009|FG003|Overall Study|Death|0|||
156763779|NCT03433898|565888010|FG004|Overall Study|Death|0|||
156763780|NCT03433898|565888011|FG005|Overall Study|Death|0|||
156763781|NCT03433898|565888012|FG006|Overall Study|Death|1|||
157005489|NCT01317420|566770171|FG005|Overall Study|Other adverse event|0|||
157005490|NCT01317420|566770172|FG006|Overall Study|Other adverse event|0|||
157005491|NCT01317420|566770173|FG007|Overall Study|Other adverse event|0|||
157005492|NCT01317420|566770174|FG008|Overall Study|Other adverse event|0|||
157005493|NCT01317420|566770175|FG009|Overall Study|Other adverse event|0|||
157005494|NCT01317420|566770176|FG010|Overall Study|Other adverse event|0|||
157005495|NCT01317420|566770177|FG011|Overall Study|Other adverse event|0|||
157005496|NCT01317420|566770178|FG012|Overall Study|Other adverse event|2|||
157005497|NCT01317420|566770166|FG000|Overall Study|Non-compliant with protocol|0|||
157005498|NCT01317420|566770167|FG001|Overall Study|Non-compliant with protocol|0|||
157005499|NCT01317420|566770168|FG002|Overall Study|Non-compliant with protocol|0|||
157005500|NCT01317420|566770169|FG003|Overall Study|Non-compliant with protocol|0|||
157005501|NCT01317420|566770170|FG004|Overall Study|Non-compliant with protocol|0|||
157005502|NCT01317420|566770171|FG005|Overall Study|Non-compliant with protocol|0|||
157005503|NCT01317420|566770172|FG006|Overall Study|Non-compliant with protocol|0|||
157005504|NCT01317420|566770173|FG007|Overall Study|Non-compliant with protocol|0|||
157005505|NCT01317420|566770174|FG008|Overall Study|Non-compliant with protocol|0|||
157005506|NCT01317420|566770175|FG009|Overall Study|Non-compliant with protocol|0|||
157005507|NCT01317420|566770176|FG010|Overall Study|Non-compliant with protocol|0|||
157005508|NCT01317420|566770177|FG011|Overall Study|Non-compliant with protocol|0|||
156763782|NCT03433898|565888013|FG007|Overall Study|Death|1|||
156763783|NCT03433898|565888006|FG000|Overall Study|Withdrawal by Subject|0|||
156763784|NCT03433898|565888007|FG001|Overall Study|Withdrawal by Subject|0|||
156763785|NCT03433898|565888008|FG002|Overall Study|Withdrawal by Subject|0|||
156763786|NCT03433898|565888009|FG003|Overall Study|Withdrawal by Subject|0|||
156763787|NCT03433898|565888010|FG004|Overall Study|Withdrawal by Subject|2|||
156763788|NCT03433898|565888011|FG005|Overall Study|Withdrawal by Subject|0|||
156763789|NCT03433898|565888012|FG006|Overall Study|Withdrawal by Subject|0|||
156763790|NCT03433898|565888013|FG007|Overall Study|Withdrawal by Subject|0|||
156763791|NCT03433898|565888006|FG000|Overall Study|Adverse Event|0|||
156763792|NCT03433898|565888007|FG001|Overall Study|Adverse Event|0|||
156763793|NCT03433898|565888008|FG002|Overall Study|Adverse Event|0|||
156763794|NCT03433898|565888009|FG003|Overall Study|Adverse Event|0|||
156763795|NCT03433898|565888010|FG004|Overall Study|Adverse Event|0|||
156763796|NCT03433898|565888011|FG005|Overall Study|Adverse Event|5|||
156763797|NCT03433898|565888012|FG006|Overall Study|Adverse Event|2|||
156763798|NCT03433898|565888013|FG007|Overall Study|Adverse Event|2|||
156763799|NCT03433898|565888006|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763800|NCT03433898|565888007|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763801|NCT03433898|565888008|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763802|NCT03433898|565888009|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763803|NCT03433898|565888010|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
156763804|NCT03433898|565888011|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763805|NCT03433898|565888012|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763806|NCT03433898|565888013|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
156763807|NCT05027815|565888016|FG000|Overall Study|Death|2|||
156763808|NCT05027815|565888017|FG001|Overall Study|Death|1|||
156763809|NCT05069259|565888021|FG000|Overall Study|Withdrawal by Subject|1|||
156763810|NCT05069259|565888021|FG000|Overall Study|Sponsor decision|1|||
156763811|NCT00447902|565888023|FG000|Overall Study|Adverse Event|0|||
156763812|NCT00447902|565888024|FG001|Overall Study|Adverse Event|3|||
156763813|NCT00447902|565888023|FG000|Overall Study|Protocol Violation|1|||
156763814|NCT00447902|565888024|FG001|Overall Study|Protocol Violation|0|||
156763815|NCT00447902|565888023|FG000|Overall Study|Withdrawal by Subject|0|||
156763816|NCT00447902|565888024|FG001|Overall Study|Withdrawal by Subject|1|||
156763817|NCT00447902|565888023|FG000|Overall Study|included patients who discontinued|1|||
156763818|NCT00447902|565888024|FG001|Overall Study|included patients who discontinued|1|||
156763819|NCT00447902|565888023|FG000|Overall Study|Lack of Efficacy|2|||
156763820|NCT00447902|565888024|FG001|Overall Study|Lack of Efficacy|1|||
156763821|NCT00870727|565889503|FG000|Overall Study|Lost to Follow-up|0|||
156763822|NCT00870727|565889504|FG001|Overall Study|Lost to Follow-up|1|||
156763823|NCT00870727|565889503|FG000|Overall Study|Lack of Efficacy|1|||
156763824|NCT00870727|565889504|FG001|Overall Study|Lack of Efficacy|3|||
156763825|NCT00870727|565889503|FG000|Overall Study|Adverse Event|0|||
156763826|NCT00870727|565889504|FG001|Overall Study|Adverse Event|1|||
156763827|NCT01712516|565889505|FG000|Overall Study|Technical problems|0|||
156763828|NCT01712516|565889506|FG001|Overall Study|Technical problems|0|||
156763829|NCT01712516|565889507|FG002|Overall Study|Technical problems|0|||
156763830|NCT01712516|565889508|FG003|Overall Study|Technical problems|2|||
156763831|NCT01712516|565889505|FG000|Overall Study|Lost to Follow-up|0|||
156763832|NCT01712516|565889506|FG001|Overall Study|Lost to Follow-up|0|||
156763833|NCT01712516|565889507|FG002|Overall Study|Lost to Follow-up|2|||
156763834|NCT01712516|565889508|FG003|Overall Study|Lost to Follow-up|1|||
156763835|NCT01712516|565889505|FG000|Overall Study|Death|0|||
156763836|NCT01712516|565889506|FG001|Overall Study|Death|1|||
156763837|NCT01712516|565889507|FG002|Overall Study|Death|0|||
156763838|NCT01712516|565889508|FG003|Overall Study|Death|0|||
156763839|NCT01712516|565889505|FG000|Overall Study|Protocol deviation|1|||
156763840|NCT01712516|565889506|FG001|Overall Study|Protocol deviation|0|||
156763841|NCT01712516|565889507|FG002|Overall Study|Protocol deviation|1|||
156763842|NCT01712516|565889508|FG003|Overall Study|Protocol deviation|0|||
156763843|NCT01712516|565889505|FG000|Overall Study|Physician Decision|2|||
156763844|NCT01712516|565889506|FG001|Overall Study|Physician Decision|0|||
156763845|NCT01712516|565889507|FG002|Overall Study|Physician Decision|0|||
156763846|NCT01712516|565889508|FG003|Overall Study|Physician Decision|1|||
156763847|NCT01712516|565889505|FG000|Overall Study|Withdrawal by Subject|3|||
156763848|NCT01712516|565889506|FG001|Overall Study|Withdrawal by Subject|9|||
156763849|NCT01712516|565889507|FG002|Overall Study|Withdrawal by Subject|3|||
156763850|NCT01712516|565889508|FG003|Overall Study|Withdrawal by Subject|9|||
156763851|NCT01251952|565889509|FG000|Overall Study|Adverse Event|1|||
156763852|NCT00496769|565889510|FG000|Double Blind|>=1 reason assigned per patient|558|||
156763853|NCT00496769|565889511|FG001|Double Blind|>=1 reason assigned per patient|649|||
156763854|NCT00496769|565889512|FG002|Double Blind|>=1 reason assigned per patient|0|||
156763855|NCT00496769|565889510|FG000|Open Label|>=1 reason assigned per patient|0|||
156763856|NCT00496769|565889511|FG001|Open Label|>=1 reason assigned per patient|0|||
156763857|NCT00496769|565889512|FG002|Open Label|>=1 reason assigned per patient|1011|||
156763858|NCT02224625|565889518|FG000|Irritation|Adverse Event|6|||
156763859|NCT02224625|565889518|FG000|Sensitization|Adverse Event|55|||
156763860|NCT01433159|565889522|FG000|Overall Study|Adverse Event|1|||
156763861|NCT01433159|565889523|FG001|Overall Study|Adverse Event|0|||
156763862|NCT01433159|565889522|FG000|Overall Study|Physician Decision|1|||
157005509|NCT01317420|566770178|FG012|Overall Study|Non-compliant with protocol|1|||
157005510|NCT01317420|566770166|FG000|Overall Study|Refused to cont. taking trial medication|0|||
157005511|NCT01317420|566770167|FG001|Overall Study|Refused to cont. taking trial medication|0|||
157005512|NCT01317420|566770168|FG002|Overall Study|Refused to cont. taking trial medication|0|||
157005513|NCT01317420|566770169|FG003|Overall Study|Refused to cont. taking trial medication|0|||
157005514|NCT01317420|566770170|FG004|Overall Study|Refused to cont. taking trial medication|0|||
157005515|NCT01317420|566770171|FG005|Overall Study|Refused to cont. taking trial medication|0|||
157005516|NCT01317420|566770172|FG006|Overall Study|Refused to cont. taking trial medication|0|||
157005517|NCT01317420|566770173|FG007|Overall Study|Refused to cont. taking trial medication|0|||
157005518|NCT01317420|566770174|FG008|Overall Study|Refused to cont. taking trial medication|0|||
157110674|NCT01987960|567158437|FG000|Period 3|Withdrawal by Subject|0|||
157110675|NCT01987960|567158438|FG001|Period 3|Withdrawal by Subject|0|||
157110676|NCT01987960|567158439|FG002|Period 3|Withdrawal by Subject|0|||
157110677|NCT01987960|567158440|FG003|Period 3|Withdrawal by Subject|9|||
157110678|NCT01987960|567158437|FG000|Period 3|Lost to Follow-up|0|||
157110679|NCT01987960|567158438|FG001|Period 3|Lost to Follow-up|0|||
157005519|NCT01317420|566770175|FG009|Overall Study|Refused to cont. taking trial medication|0|||
157005520|NCT01317420|566770176|FG010|Overall Study|Refused to cont. taking trial medication|0|||
157005521|NCT01317420|566770177|FG011|Overall Study|Refused to cont. taking trial medication|0|||
157005522|NCT01317420|566770178|FG012|Overall Study|Refused to cont. taking trial medication|1|||
157005523|NCT01317420|566770166|FG000|Overall Study|Reason other than those specified|0|||
157005524|NCT01317420|566770167|FG001|Overall Study|Reason other than those specified|0|||
157005525|NCT01317420|566770168|FG002|Overall Study|Reason other than those specified|0|||
157005526|NCT01317420|566770169|FG003|Overall Study|Reason other than those specified|0|||
157005527|NCT01317420|566770170|FG004|Overall Study|Reason other than those specified|0|||
157005528|NCT01317420|566770171|FG005|Overall Study|Reason other than those specified|0|||
157005529|NCT01317420|566770172|FG006|Overall Study|Reason other than those specified|0|||
157005530|NCT01317420|566770173|FG007|Overall Study|Reason other than those specified|0|||
157005531|NCT01317420|566770174|FG008|Overall Study|Reason other than those specified|0|||
157005532|NCT01317420|566770175|FG009|Overall Study|Reason other than those specified|1|||
157005533|NCT01317420|566770176|FG010|Overall Study|Reason other than those specified|0|||
157005534|NCT01317420|566770177|FG011|Overall Study|Reason other than those specified|0|||
157005535|NCT01317420|566770178|FG012|Overall Study|Reason other than those specified|0|||
157005536|NCT05686421|566770179|FG000|Overall Study|Screen failure|22|||
157005537|NCT05686421|566770180|FG001|Overall Study|Screen failure|0|||
157005538|NCT05686421|566770181|FG002|Overall Study|Screen failure|0|||
157005539|NCT05686421|566770182|FG003|Overall Study|Screen failure|0|||
157005540|NCT00367055|566770184|FG000|Overall Study|Adverse Event|6|||
157005541|NCT00367055|566770185|FG001|Overall Study|Adverse Event|3|||
157005542|NCT00367055|566770184|FG000|Overall Study|Patient's Willing|3|||
157005543|NCT00367055|566770185|FG001|Overall Study|Patient's Willing|2|||
157005544|NCT00367055|566770184|FG000|Overall Study|Lack of Efficacy|1|||
157005545|NCT00367055|566770185|FG001|Overall Study|Lack of Efficacy|2|||
157005546|NCT00367055|566770184|FG000|Overall Study|Lost to Follow-up|1|||
157005547|NCT00367055|566770185|FG001|Overall Study|Lost to Follow-up|1|||
157005548|NCT00367055|566770184|FG000|Overall Study|Protocol Violation|0|||
157005549|NCT00367055|566770185|FG001|Overall Study|Protocol Violation|1|||
157005550|NCT00367055|566770184|FG000|Overall Study|Stopping Criterion Met|0|||
157005551|NCT00367055|566770185|FG001|Overall Study|Stopping Criterion Met|1|||
157005552|NCT00367055|566770184|FG000|Overall Study|Participant Living too Far from Hospital|0|||
157005553|NCT00367055|566770185|FG001|Overall Study|Participant Living too Far from Hospital|1|||
157005554|NCT04221438|566770186|FG000|Overall Study|Adverse Event|1|||
157110680|NCT01987960|567158439|FG002|Period 3|Lost to Follow-up|0|||
157110681|NCT01987960|567158440|FG003|Period 3|Lost to Follow-up|5|||
156763863|NCT01433159|565889523|FG001|Overall Study|Physician Decision|0|||
156763864|NCT01433159|565889522|FG000|Overall Study|Protocol Violation|0|||
156763865|NCT01433159|565889523|FG001|Overall Study|Protocol Violation|1|||
156763866|NCT01100853|565889524|FG000|Overall Study|Lost to Follow-up|11|||
156763867|NCT01100853|565889525|FG001|Overall Study|Lost to Follow-up|6|||
156763868|NCT01100853|565889524|FG000|Overall Study|Received <4 study injections|10|||
156763869|NCT01100853|565889525|FG001|Overall Study|Received <4 study injections|13|||
156763870|NCT01100853|565889524|FG000|Overall Study|Withdrawal by Subject|6|||
156763871|NCT01100853|565889525|FG001|Overall Study|Withdrawal by Subject|4|||
156763872|NCT01384877|565889526|FG000|Treatment 2|Lost to Follow-up|2|||
156763873|NCT01384877|565889527|FG001|Treatment 2|Lost to Follow-up|2|||
156763874|NCT01548404|565889528|FG000|Overall Study|Adverse Event|3|||
156763875|NCT01548404|565889529|FG001|Overall Study|Adverse Event|1|||
156763876|NCT01548404|565889528|FG000|Overall Study|Physician Decision|2|||
157005555|NCT04221438|566770186|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
157005556|NCT03586544|566770189|FG000|First Intervention|Adverse Event|0|||
156763877|NCT01548404|565889529|FG001|Overall Study|Physician Decision|1|||
156763878|NCT01548404|565889528|FG000|Overall Study|Inadequate response to study treatment|23|||
156763879|NCT01548404|565889529|FG001|Overall Study|Inadequate response to study treatment|7|||
156763880|NCT01548404|565889528|FG000|Overall Study|Lost to Follow-up|2|||
156763881|NCT01548404|565889529|FG001|Overall Study|Lost to Follow-up|0|||
156763882|NCT01548404|565889528|FG000|Overall Study|Withdrawal by Subject|0|||
156763883|NCT01548404|565889529|FG001|Overall Study|Withdrawal by Subject|3|||
156763884|NCT01548404|565889528|FG000|Overall Study|Other than specified above|0|||
156763885|NCT01548404|565889529|FG001|Overall Study|Other than specified above|2|||
156763886|NCT00426270|565889530|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
156763887|NCT00426270|565889530|FG000|Overall Study|Adverse Event|5|||
156763888|NCT01117870|565889531|FG000|Overall Study|Inability to place needle|1|||
156763889|NCT01117870|565889532|FG001|Overall Study|Inability to place needle|0|||
156763890|NCT01774981|565889535|FG000|Overall Study|Adverse Event|0|||
156763891|NCT01774981|565889536|FG001|Overall Study|Adverse Event|0|||
156763892|NCT01774981|565889537|FG002|Overall Study|Adverse Event|0|||
156763893|NCT01774981|565889538|FG003|Overall Study|Adverse Event|0|||
156763894|NCT01774981|565889539|FG004|Overall Study|Adverse Event|0|||
156763895|NCT01774981|565889540|FG005|Overall Study|Adverse Event|1|||
156763896|NCT01774981|565889541|FG006|Overall Study|Adverse Event|0|||
156763897|NCT01774981|565889542|FG007|Overall Study|Adverse Event|0|||
156763898|NCT01774981|565889535|FG000|Overall Study|Withdrawal by Subject|0|||
156763899|NCT01774981|565889536|FG001|Overall Study|Withdrawal by Subject|0|||
156763900|NCT01774981|565889537|FG002|Overall Study|Withdrawal by Subject|0|||
156763901|NCT01774981|565889538|FG003|Overall Study|Withdrawal by Subject|0|||
156763902|NCT01774981|565889539|FG004|Overall Study|Withdrawal by Subject|0|||
156763903|NCT01774981|565889540|FG005|Overall Study|Withdrawal by Subject|0|||
156763904|NCT01774981|565889541|FG006|Overall Study|Withdrawal by Subject|0|||
156763905|NCT01774981|565889542|FG007|Overall Study|Withdrawal by Subject|1|||
156763906|NCT01774981|565889535|FG000|Overall Study|Death|0|||
156763907|NCT01774981|565889536|FG001|Overall Study|Death|0|||
156763908|NCT01774981|565889537|FG002|Overall Study|Death|0|||
156763909|NCT01774981|565889538|FG003|Overall Study|Death|0|||
156763910|NCT01774981|565889539|FG004|Overall Study|Death|1|||
156763911|NCT01774981|565889540|FG005|Overall Study|Death|0|||
157005557|NCT03586544|566770190|FG001|First Intervention|Adverse Event|1|||
156763912|NCT01774981|565889541|FG006|Overall Study|Death|0|||
156763913|NCT01774981|565889542|FG007|Overall Study|Death|0|||
156763914|NCT00960193|565889543|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
156763915|NCT01324102|565889546|FG000|Overall Study|illness|1|||
156763916|NCT01324102|565889547|FG001|Overall Study|illness|6|||
156763917|NCT00728494|565889548|FG000|Overall Study|Adverse Event|7|||
156763918|NCT00728494|565889549|FG001|Overall Study|Adverse Event|0|||
156763919|NCT00728494|565889548|FG000|Overall Study|Withdrawal by Subject|0|||
156763920|NCT00728494|565889549|FG001|Overall Study|Withdrawal by Subject|2|||
156763921|NCT00728494|565889548|FG000|Overall Study|Lack of Efficacy|2|||
156763922|NCT00728494|565889549|FG001|Overall Study|Lack of Efficacy|4|||
156763923|NCT00728494|565889548|FG000|Overall Study|No data available|0|||
156763924|NCT00728494|565889549|FG001|Overall Study|No data available|1|||
156763925|NCT00001566|565889550|FG000|Overall Study|patients' choice to discontinue protocol|3|||
156763926|NCT00001566|565889550|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
156763927|NCT00001566|565889550|FG000|Overall Study|Death|13|||
156763928|NCT00001566|565889550|FG000|Overall Study|Lost to Follow-up|1|||
157005558|NCT03586544|566770189|FG000|Second Intervention|Withdrawal by Subject|0|||
156763929|NCT00001566|565889550|FG000|Overall Study|unable to complete initial apheresis|1|||
156763930|NCT00433836|565889551|FG000|Overall Study|Adverse Event|7|||
156763931|NCT00433836|565889552|FG001|Overall Study|Adverse Event|0|||
156763932|NCT00433836|565889551|FG000|Overall Study|Lost to Follow-up|3|||
156763933|NCT00433836|565889552|FG001|Overall Study|Lost to Follow-up|0|||
157005559|NCT03586544|566770190|FG001|Second Intervention|Withdrawal by Subject|1|||
156763934|NCT00433836|565889551|FG000|Overall Study|Withdrawal by Subject|2|||
156763935|NCT00433836|565889552|FG001|Overall Study|Withdrawal by Subject|1|||
156763936|NCT00433836|565889551|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156763937|NCT00433836|565889552|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156763938|NCT00433836|565889551|FG000|Overall Study|Protocol Violation|0|||
156763939|NCT00433836|565889552|FG001|Overall Study|Protocol Violation|2|||
156763940|NCT00433836|565889551|FG000|Overall Study|Condition no longer requires study drug|0|||
156763941|NCT00433836|565889552|FG001|Overall Study|Condition no longer requires study drug|1|||
156763942|NCT00433836|565889551|FG000|Overall Study|Abnormal laboratory values|0|||
156763943|NCT00433836|565889552|FG001|Overall Study|Abnormal laboratory values|1|||
156763944|NCT00748241|565889553|FG000|Overall Study|Implant failure|1|||
156763945|NCT00748241|565889553|FG000|Overall Study|Lost to Follow-up|5|||
156763946|NCT00748241|565889553|FG000|Overall Study|Death|2|||
156763947|NCT02456727|565889554|FG000|Overall Study|Lost to Follow-up|63|||
156763948|NCT02456727|565889555|FG001|Overall Study|Lost to Follow-up|65|||
156763949|NCT02456727|565889554|FG000|Overall Study|Death|2|||
156763950|NCT02456727|565889555|FG001|Overall Study|Death|1|||
156763951|NCT02456727|565889554|FG000|Overall Study|Withdrawal by Subject|1|||
156763952|NCT02456727|565889555|FG001|Overall Study|Withdrawal by Subject|10|||
156763953|NCT02456727|565889554|FG000|Overall Study|Never Initiated Treatment|43|||
156763954|NCT02456727|565889555|FG001|Overall Study|Never Initiated Treatment|30|||
156763955|NCT00492297|565889556|FG000|Treatment|Death|2|||
156763956|NCT00492297|565889556|FG000|Treatment|Study terminated by sponsor|3|||
156763957|NCT00492297|565889556|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
156763958|NCT00492297|565889556|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
156763959|NCT00492297|565889556|FG000|Survival Only Follow-up|Death|46|||
156763960|NCT00492297|565889556|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
156763961|NCT00492297|565889556|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
156763962|NCT00113607|565889557|FG000|Overall Study|Adverse Event|40|||
156763963|NCT00113607|565889558|FG001|Overall Study|Adverse Event|71|||
156763964|NCT00113607|565889557|FG000|Overall Study|Death|8|||
156763965|NCT00113607|565889558|FG001|Overall Study|Death|8|||
156763966|NCT00113607|565889557|FG000|Overall Study|Withdrawal by Subject|50|||
156763967|NCT00113607|565889558|FG001|Overall Study|Withdrawal by Subject|58|||
156763968|NCT00113607|565889557|FG000|Overall Study|Lost to Follow-up|0|||
156763969|NCT00113607|565889558|FG001|Overall Study|Lost to Follow-up|2|||
156763970|NCT00113607|565889557|FG000|Overall Study|Disease Progression|180|||
156763971|NCT00113607|565889558|FG001|Overall Study|Disease Progression|142|||
156763972|NCT00113607|565889557|FG000|Overall Study|Complete Response (Confirmed)|14|||
156763973|NCT00113607|565889558|FG001|Overall Study|Complete Response (Confirmed)|24|||
156763974|NCT00113607|565889557|FG000|Overall Study|Other|43|||
156763975|NCT00113607|565889558|FG001|Overall Study|Other|32|||
156763976|NCT03669549|565889559|FG000|Overall Study|Adverse Event|4|||
156763977|NCT03669549|565889559|FG000|Overall Study|Withdrawal by Subject|1|||
156763978|NCT03669549|565889559|FG000|Overall Study|Study terminated by the Sponsor|1|||
156763979|NCT00909844|565889560|FG000|Overall Study|Adverse Event|1|||
156763980|NCT00909844|565889560|FG000|Overall Study|Withdrawal by Subject|1|||
156763981|NCT00909844|565889560|FG000|Overall Study|Lost to Follow-up|2|||
156763982|NCT02974868|565889562|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
156763983|NCT02974868|565889563|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
156763984|NCT02974868|565889564|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
156763985|NCT02974868|565889565|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
156763986|NCT02974868|565889562|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
156763987|NCT02974868|565889563|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
156763988|NCT02974868|565889564|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
156763989|NCT02974868|565889565|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
156763990|NCT02974868|565889562|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
156763991|NCT02974868|565889563|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
156763992|NCT02974868|565889564|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
156763993|NCT02974868|565889565|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
156763994|NCT02974868|565889562|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
156763995|NCT02974868|565889563|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
156763996|NCT02974868|565889564|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
156763997|NCT02974868|565889565|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
156763998|NCT00706004|565889566|FG000|Overall Study|Did not meet eligibility criteria|2|||
156763999|NCT02674516|565889567|FG000|Overall Study|Lost to Follow-up|3|||
156764000|NCT02674516|565889568|FG001|Overall Study|Lost to Follow-up|0|||
156764001|NCT02674516|565889567|FG000|Overall Study|Protocol Violation|0|||
156764002|NCT02674516|565889568|FG001|Overall Study|Protocol Violation|4|||
156764003|NCT02674516|565889567|FG000|Overall Study|Knowledge of study hypothesis|1|||
156764004|NCT02674516|565889568|FG001|Overall Study|Knowledge of study hypothesis|0|||
156764005|NCT01064479|565889569|FG000|Overall Study|Death|10|||
156764006|NCT01064479|565889570|FG001|Overall Study|Death|11|||
156764007|NCT01064479|565889569|FG000|Overall Study|Withdrawal by Subject|2|||
156764008|NCT01064479|565889570|FG001|Overall Study|Withdrawal by Subject|2|||
157005560|NCT01837641|566770196|FG000|Overall Study|Sponsor decision|1|||
157005561|NCT01837641|566770197|FG001|Overall Study|Sponsor decision|0|||
157005562|NCT01837641|566770198|FG002|Overall Study|Sponsor decision|0|||
157005563|NCT01837641|566770199|FG003|Overall Study|Sponsor decision|0|||
157005564|NCT01837641|566770200|FG004|Overall Study|Sponsor decision|0|||
157005565|NCT01837641|566770201|FG005|Overall Study|Sponsor decision|1|||
157005566|NCT01837641|566770202|FG006|Overall Study|Sponsor decision|0|||
157005567|NCT01837641|566770203|FG007|Overall Study|Sponsor decision|0|||
157005568|NCT01837641|566770196|FG000|Overall Study|Adverse Event|0|||
157005569|NCT01837641|566770197|FG001|Overall Study|Adverse Event|0|||
157005570|NCT01837641|566770198|FG002|Overall Study|Adverse Event|0|||
157005571|NCT01837641|566770199|FG003|Overall Study|Adverse Event|0|||
157005572|NCT01837641|566770200|FG004|Overall Study|Adverse Event|0|||
157005573|NCT01837641|566770201|FG005|Overall Study|Adverse Event|1|||
157005574|NCT01837641|566770202|FG006|Overall Study|Adverse Event|0|||
157110682|NCT01987960|567158437|FG000|Period 3|Administrative or other reason|0|||
156764009|NCT01064479|565889569|FG000|Overall Study|Disease progression|1|||
156764010|NCT01064479|565889570|FG001|Overall Study|Disease progression|1|||
156764011|NCT01064479|565889569|FG000|Overall Study|Toxicity|1|||
157005575|NCT01837641|566770203|FG007|Overall Study|Adverse Event|0|||
157005576|NCT01837641|566770196|FG000|Overall Study|Withdrawal by Subject|0|||
156764012|NCT01064479|565889570|FG001|Overall Study|Toxicity|1|||
156764013|NCT01064479|565889569|FG000|Overall Study|Other|1|||
156764014|NCT01064479|565889570|FG001|Overall Study|Other|2|||
156764015|NCT00749398|565889571|FG000|Overall Study|Lack of Efficacy|7|||
156764016|NCT00749398|565889571|FG000|Overall Study|Adverse Event|4|||
156764017|NCT00749398|565889571|FG000|Overall Study|Serious adverse event|11|||
156764018|NCT00749398|565889571|FG000|Overall Study|Withdrawal by Subject|17|||
157005577|NCT01837641|566770197|FG001|Overall Study|Withdrawal by Subject|0|||
156764019|NCT00749398|565889571|FG000|Overall Study|Lost to Follow-up|11|||
156764020|NCT00749398|565889571|FG000|Overall Study|Reason not specified|2|||
156764021|NCT00749398|565889571|FG000|Overall Study|Unknown reason|1|||
156764022|NCT01663402|565889577|FG000|Overall Study|Randomized but not treated|19|||
156764023|NCT01663402|565889578|FG001|Overall Study|Randomized but not treated|11|||
156764024|NCT01663402|565889577|FG000|Overall Study|Adverse Event|347|||
156764025|NCT01663402|565889578|FG001|Overall Study|Adverse Event|362|||
156764026|NCT01663402|565889577|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
156764027|NCT01663402|565889578|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
156764028|NCT01663402|565889577|FG000|Overall Study|Poor compliance to protocol|529|||
156764029|NCT01663402|565889578|FG001|Overall Study|Poor compliance to protocol|454|||
156764030|NCT01663402|565889577|FG000|Overall Study|Physician Decision|77|||
156764031|NCT01663402|565889578|FG001|Overall Study|Physician Decision|62|||
156764032|NCT01663402|565889577|FG000|Overall Study|Site terminated by sponsor|1|||
156764033|NCT01663402|565889578|FG001|Overall Study|Site terminated by sponsor|3|||
156764034|NCT01663402|565889577|FG000|Overall Study|Participant moved|139|||
156764035|NCT01663402|565889578|FG001|Overall Study|Participant moved|104|||
156764036|NCT01663402|565889577|FG000|Overall Study|Withdrawal by Subject|118|||
156764037|NCT01663402|565889578|FG001|Overall Study|Withdrawal by Subject|91|||
156764038|NCT01663402|565889577|FG000|Overall Study|Related to study drug administration|96|||
156764039|NCT01663402|565889578|FG001|Overall Study|Related to study drug administration|105|||
156764040|NCT01663402|565889577|FG000|Overall Study|Lost to Follow-up|17|||
156764041|NCT01663402|565889578|FG001|Overall Study|Lost to Follow-up|15|||
156764042|NCT01663402|565889577|FG000|Overall Study|Other than specified above|172|||
156764043|NCT01663402|565889578|FG001|Overall Study|Other than specified above|147|||
156764044|NCT03575702|565889581|FG000|Overall Study|Withdrawal by Subject|1|||
156764045|NCT03575702|565889582|FG001|Overall Study|Withdrawal by Subject|1|||
156764046|NCT03575702|565889581|FG000|Overall Study|Lost to Follow-up|1|||
156764047|NCT03575702|565889582|FG001|Overall Study|Lost to Follow-up|2|||
156764048|NCT03575702|565889581|FG000|Overall Study|Protocol Violation|0|||
156764049|NCT03575702|565889582|FG001|Overall Study|Protocol Violation|1|||
156764050|NCT03575702|565889581|FG000|Overall Study|Patient non compliance|4|||
156764051|NCT03575702|565889582|FG001|Overall Study|Patient non compliance|0|||
156764052|NCT01900444|565889583|FG000|Overall Study|Protocol Violation|2|||
156764053|NCT01900444|565889583|FG000|Overall Study|Lost to Follow-up|1|||
156764054|NCT00072384|565889584|FG000|Overall Study|Physician Decision|1|||
156764055|NCT00072384|565889584|FG000|Overall Study|Ineligible|8|||
156764056|NCT01825200|565889589|FG000|Overall Study|Lost to Follow-up|5|||
156764057|NCT01825200|565889590|FG001|Overall Study|Lost to Follow-up|6|||
156764058|NCT01825200|565889589|FG000|Overall Study|Withdrawal by Subject|0|||
156764059|NCT01825200|565889590|FG001|Overall Study|Withdrawal by Subject|1|||
156764060|NCT00490035|565889591|FG000|Overall Study|AE, non-serious non-fatal|3|||
156764061|NCT00490035|565889592|FG001|Overall Study|AE, non-serious non-fatal|4|||
156764062|NCT00490035|565889593|FG002|Overall Study|AE, non-serious non-fatal|4|||
156764063|NCT00490035|565889594|FG003|Overall Study|AE, non-serious non-fatal|5|||
156764064|NCT00490035|565889591|FG000|Overall Study|Lost to Follow-up|2|||
156764065|NCT00490035|565889592|FG001|Overall Study|Lost to Follow-up|0|||
156764066|NCT00490035|565889593|FG002|Overall Study|Lost to Follow-up|1|||
156764067|NCT00490035|565889594|FG003|Overall Study|Lost to Follow-up|0|||
156764068|NCT00490035|565889591|FG000|Overall Study|Withdrawal by Subject|2|||
156764069|NCT00490035|565889592|FG001|Overall Study|Withdrawal by Subject|1|||
156764070|NCT00490035|565889593|FG002|Overall Study|Withdrawal by Subject|1|||
156764071|NCT00490035|565889594|FG003|Overall Study|Withdrawal by Subject|0|||
156764072|NCT00490035|565889591|FG000|Overall Study|Other reason|0|||
156764073|NCT00490035|565889592|FG001|Overall Study|Other reason|1|||
156764074|NCT00490035|565889593|FG002|Overall Study|Other reason|3|||
156764075|NCT00490035|565889594|FG003|Overall Study|Other reason|1|||
156764076|NCT00490035|565889591|FG000|Overall Study|AE, serious fatal|1|||
156764077|NCT00490035|565889592|FG001|Overall Study|AE, serious fatal|0|||
156764078|NCT00490035|565889593|FG002|Overall Study|AE, serious fatal|0|||
156764079|NCT00490035|565889594|FG003|Overall Study|AE, serious fatal|0|||
156764080|NCT00490035|565889591|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764081|NCT00490035|565889592|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764082|NCT00490035|565889593|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
156764083|NCT00490035|565889594|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
156764084|NCT00490035|565889591|FG000|Overall Study|AE of unknown type|0|||
156764085|NCT00490035|565889592|FG001|Overall Study|AE of unknown type|0|||
156764086|NCT00490035|565889593|FG002|Overall Study|AE of unknown type|2|||
156764087|NCT00490035|565889594|FG003|Overall Study|AE of unknown type|0|||
156764088|NCT06058390|565889595|FG000|Overall Study|Lost to Follow-up|0|||
156764089|NCT06058390|565889596|FG001|Overall Study|Lost to Follow-up|0|||
156764090|NCT06058390|565889597|FG002|Overall Study|Lost to Follow-up|2|||
156764091|NCT06058390|565889598|FG003|Overall Study|Lost to Follow-up|1|||
156764092|NCT06058390|565889595|FG000|Overall Study|Physician Decision|0|||
156764093|NCT06058390|565889596|FG001|Overall Study|Physician Decision|0|||
156764094|NCT06058390|565889597|FG002|Overall Study|Physician Decision|0|||
156764095|NCT06058390|565889598|FG003|Overall Study|Physician Decision|1|||
156764096|NCT06058390|565889595|FG000|Overall Study|Participants did not receive any study intervention|0|||
156764097|NCT06058390|565889596|FG001|Overall Study|Participants did not receive any study intervention|0|||
156764098|NCT06058390|565889597|FG002|Overall Study|Participants did not receive any study intervention|0|||
156764099|NCT06058390|565889598|FG003|Overall Study|Participants did not receive any study intervention|1|||
156764100|NCT03585270|565889601|FG000|Overall Study|Withdrawal by Subject|2|||
156764101|NCT03585270|565889602|FG001|Overall Study|Withdrawal by Subject|6|||
156764102|NCT03585270|565889601|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
156764103|NCT03585270|565889602|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
156764104|NCT03585270|565889601|FG000|Overall Study|Adverse Event|5|||
156764105|NCT03585270|565889602|FG001|Overall Study|Adverse Event|2|||
156764106|NCT03585270|565889601|FG000|Overall Study|Lost to Follow-up|1|||
156764107|NCT03585270|565889602|FG001|Overall Study|Lost to Follow-up|4|||
156764108|NCT03585270|565889601|FG000|Overall Study|Death|5|||
156764109|NCT03585270|565889602|FG001|Overall Study|Death|3|||
156764110|NCT03585270|565889601|FG000|Overall Study|Other reasons|2|||
156764111|NCT03585270|565889602|FG001|Overall Study|Other reasons|2|||
156764112|NCT05953363|565889603|FG000|Overall Study|Screen Failure|2|||
156764113|NCT05953363|565889603|FG000|Overall Study|Withdrawal by Subject|3|||
156764114|NCT05953363|565889603|FG000|Overall Study|Surgery cancelled|2|||
156764115|NCT05953363|565889603|FG000|Overall Study|Adverse Event|1|||
156764116|NCT05559905|565889604|FG000|Overall Study|Withdrawal by Subject|1|||
156764117|NCT05559905|565889605|FG001|Overall Study|Withdrawal by Subject|0|||
156764118|NCT05559905|565889606|FG002|Overall Study|Withdrawal by Subject|0|||
156764119|NCT05559905|565889604|FG000|Overall Study|Not Reported|1|||
156764120|NCT05559905|565889605|FG001|Overall Study|Not Reported|0|||
156764121|NCT05559905|565889606|FG002|Overall Study|Not Reported|0|||
156764122|NCT01701674|565889607|FG000|Overall Study|Unable to safely complete treatment|1|||
156764123|NCT05696392|565889609|FG000|Overall Study|Lost to Follow-up|3|||
156764124|NCT05696392|565889609|FG000|Overall Study|Protocol Violation|1|||
156764125|NCT05696392|565889609|FG000|Overall Study|Withdrawal by Subject|1|||
156764126|NCT05276973|565889610|FG000|Overall Study|Treated and DLT unevaluable|1|||
156764127|NCT05276973|565889611|FG001|Overall Study|Treated and DLT unevaluable|1|||
156764128|NCT05276973|565889612|FG002|Overall Study|Treated and DLT unevaluable|0|||
156764129|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764130|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764131|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
156764132|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764133|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764134|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
156764135|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764136|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764137|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
156764138|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764139|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764140|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
156764141|NCT03904693|565889613|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764142|NCT03904693|565889614|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
156764143|NCT03904693|565889615|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
156764144|NCT03904693|565889616|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764145|NCT03904693|565889617|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764146|NCT03904693|565889618|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
156764147|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764148|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764149|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
156764150|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
156764151|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
156764152|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
156764153|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764154|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764155|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764156|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764157|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
156764158|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
156764159|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764160|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764161|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764162|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
156764163|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764164|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
156764165|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764166|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764167|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764168|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
156764169|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764170|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
156764171|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764172|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764173|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764174|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764175|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
156764176|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
156764177|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764178|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764179|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764180|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764181|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
156764182|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
156764183|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764184|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764185|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764186|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764187|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
156764188|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
156764189|NCT03904693|565889613|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764190|NCT03904693|565889614|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764191|NCT03904693|565889615|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764192|NCT03904693|565889616|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764193|NCT03904693|565889617|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
156764194|NCT03904693|565889618|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
157005578|NCT01837641|566770198|FG002|Overall Study|Withdrawal by Subject|0|||
157005579|NCT01837641|566770199|FG003|Overall Study|Withdrawal by Subject|0|||
157005580|NCT01837641|566770200|FG004|Overall Study|Withdrawal by Subject|1|||
157005581|NCT01837641|566770201|FG005|Overall Study|Withdrawal by Subject|0|||
157005582|NCT01837641|566770202|FG006|Overall Study|Withdrawal by Subject|1|||
157005583|NCT01837641|566770203|FG007|Overall Study|Withdrawal by Subject|0|||
157005584|NCT00546871|566770206|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
157005585|NCT00546871|566770207|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
157005586|NCT00546871|566770206|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
157005587|NCT00546871|566770207|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
157005588|NCT00546871|566770206|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
157005589|NCT00546871|566770207|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
157005590|NCT00546871|566770206|FG000|Study Extension Period|Protocol Violation|1|||
157005591|NCT00546871|566770207|FG001|Study Extension Period|Protocol Violation|0|||
157005592|NCT00546871|566770206|FG000|Study Extension Period|Withdrawal by Subject|0|||
157005593|NCT00546871|566770207|FG001|Study Extension Period|Withdrawal by Subject|1|||
157110683|NCT01987960|567158438|FG001|Period 3|Administrative or other reason|0|||
157110684|NCT01987960|567158439|FG002|Period 3|Administrative or other reason|0|||
157110685|NCT01987960|567158440|FG003|Period 3|Administrative or other reason|43|||
156764195|NCT03180736|565889619|FG000|Overall Study|Adverse Event|3|||
156764196|NCT03180736|565889620|FG001|Overall Study|Adverse Event|4|||
156764197|NCT03180736|565889619|FG000|Overall Study|Death|10|||
156764198|NCT03180736|565889620|FG001|Overall Study|Death|7|||
157005594|NCT02106442|566770209|FG000|Overall Study|Case Report Forms Uncollected|7|||
157005595|NCT02106442|566770209|FG000|Overall Study|Protocol Deviation|30|||
157005596|NCT03516942|566770211|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
157005597|NCT03516942|566770211|FG000|Registration through baseline survey com|Death|8|||
157005598|NCT03516942|566770211|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
157005599|NCT03516942|566770211|FG000|T0: Baseline|LOST|13|||
157005600|NCT03516942|566770211|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
157005601|NCT03516942|566770211|FG000|T1: 3 Months Survey|Death|10|||
157005602|NCT03516942|566770211|FG000|T1: 3 Months Survey|Lost|163|||
157005603|NCT03516942|566770211|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
157005604|NCT03516942|566770211|FG000|T2: 6 Month Survey|Death|14|||
157005605|NCT03516942|566770211|FG000|T2: 6 Month Survey|Lost|180|||
157005606|NCT03516942|566770211|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
157005607|NCT03516942|566770211|FG000|T3: 12 Month Survey|Death|19|||
157005608|NCT03516942|566770211|FG000|T3: 12 Month Survey|Lost|209|||
157005609|NCT03215927|566771544|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
157005610|NCT03215927|566771545|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
157005611|NCT03215927|566771544|FG000|Open Label Extension|Adverse Event|1|||
157005612|NCT03215927|566771545|FG001|Open Label Extension|Adverse Event|0|||
157005613|NCT03215927|566771544|FG000|Open Label Extension|Lack of Efficacy|1|||
157005614|NCT03215927|566771545|FG001|Open Label Extension|Lack of Efficacy|0|||
157005615|NCT03215927|566771544|FG000|Open Label Extension|Death|0|||
157005616|NCT03215927|566771545|FG001|Open Label Extension|Death|1|||
157005617|NCT03779048|566771546|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
157005618|NCT03779048|566771547|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
157005619|NCT03779048|566771548|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
157005620|NCT03779048|566771546|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
157005621|NCT03779048|566771547|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
157005622|NCT03779048|566771548|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
157005623|NCT03779048|566771546|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
157005624|NCT03779048|566771547|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
157005625|NCT03779048|566771548|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
157005626|NCT01286272|566771549|FG000|Overall Study|Ineligible after beginning treatment|1|||
157005627|NCT01286272|566771550|FG001|Overall Study|Ineligible after beginning treatment|3|||
157005628|NCT04001829|566771553|FG000|Overall Study|Never start protocol therapy|5|||
157005629|NCT04001829|566771554|FG001|Overall Study|Never start protocol therapy|5|||
157005630|NCT04001829|566771553|FG000|Overall Study|Adverse Event|11|||
157005631|NCT04001829|566771554|FG001|Overall Study|Adverse Event|7|||
157005632|NCT04001829|566771553|FG000|Overall Study|Alternative therapy|1|||
157005633|NCT04001829|566771554|FG001|Overall Study|Alternative therapy|2|||
157005634|NCT04001829|566771553|FG000|Overall Study|Disease progression/relapse|2|||
157005635|NCT04001829|566771554|FG001|Overall Study|Disease progression/relapse|1|||
157005636|NCT04001829|566771553|FG000|Overall Study|Other complicating disease|1|||
157005637|NCT04001829|566771554|FG001|Overall Study|Other complicating disease|0|||
157005638|NCT04001829|566771553|FG000|Overall Study|Withdrawal by Subject|1|||
157005639|NCT04001829|566771554|FG001|Overall Study|Withdrawal by Subject|4|||
157005640|NCT04001829|566771553|FG000|Overall Study|Ineligible|2|||
157005641|NCT04001829|566771554|FG001|Overall Study|Ineligible|2|||
157005642|NCT04001829|566771553|FG000|Overall Study|Reason missing due to delinquent data|1|||
157005643|NCT04001829|566771554|FG001|Overall Study|Reason missing due to delinquent data|0|||
157005644|NCT04496960|566771555|FG000|Overall Study|Physician Decision|0|||
157005645|NCT04496960|566771556|FG001|Overall Study|Physician Decision|1|||
157005646|NCT03175172|566771557|FG000|Overall Study|Death|3|||
157005647|NCT03175172|566771557|FG000|Overall Study|Withdrawal by Subject|3|||
157005648|NCT03175172|566771557|FG000|Overall Study|Lost to Follow-up|1|||
157005649|NCT03175172|566771557|FG000|Overall Study|Study Terminated by Sponsor|3|||
157005650|NCT02974634|566771558|FG000|Overall Study|Advanced disease|12|||
157110686|NCT04085523|567158446|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
157110687|NCT04085523|567158447|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
157005651|NCT02974634|566771559|FG001|Overall Study|Advanced disease|3|||
157005652|NCT02974634|566771558|FG000|Overall Study|Noncompliance|3|||
157005653|NCT02974634|566771559|FG001|Overall Study|Noncompliance|7|||
157005654|NCT02974634|566771558|FG000|Overall Study|intervention technology related issues|5|||
157005655|NCT02974634|566771559|FG001|Overall Study|intervention technology related issues|0|||
157005656|NCT02974634|566771558|FG000|Overall Study|Death|8|||
157005657|NCT02974634|566771559|FG001|Overall Study|Death|11|||
157005658|NCT02932410|566771560|FG000|Overall Study|Death|7|||
157005659|NCT02932410|566771561|FG001|Overall Study|Death|6|||
157005660|NCT02932410|566771562|FG002|Overall Study|Death|0|||
157005661|NCT02932410|566771563|FG003|Overall Study|Death|0|||
157005662|NCT02932410|566771560|FG000|Overall Study|Lost to Follow-up|1|||
156764199|NCT03180736|565889619|FG000|Overall Study|Withdrawal by Subject|5|||
156764200|NCT03180736|565889620|FG001|Overall Study|Withdrawal by Subject|12|||
156764201|NCT03180736|565889619|FG000|Overall Study|Lost to Follow-up|1|||
156764202|NCT03180736|565889620|FG001|Overall Study|Lost to Follow-up|0|||
156764203|NCT03180736|565889619|FG000|Overall Study|Lack of Efficacy|66|||
156764204|NCT03180736|565889620|FG001|Overall Study|Lack of Efficacy|87|||
156764205|NCT03180736|565889619|FG000|Overall Study|Physician Decision|4|||
156764206|NCT03180736|565889620|FG001|Overall Study|Physician Decision|7|||
156764207|NCT03180736|565889619|FG000|Overall Study|randomized but not treated|2|||
156764208|NCT03180736|565889620|FG001|Overall Study|randomized but not treated|3|||
156764209|NCT03258593|565889621|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
156764210|NCT03258593|565889622|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
156764211|NCT03258593|565889623|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
156764212|NCT03258593|565889624|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
156764213|NCT03258593|565889621|FG000|Run-In Maintenance Phase|Disease progression|3|||
156764214|NCT03258593|565889622|FG001|Run-In Maintenance Phase|Disease progression|0|||
156764215|NCT03258593|565889623|FG002|Run-In Maintenance Phase|Disease progression|0|||
156764216|NCT03258593|565889624|FG003|Run-In Maintenance Phase|Disease progression|0|||
156764217|NCT03258593|565889621|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764218|NCT03258593|565889622|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
156764219|NCT03258593|565889623|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764220|NCT03258593|565889624|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
156764221|NCT03258593|565889621|FG000|Expansion Maintenance Phase|Physician Decision|0|||
156764222|NCT03258593|565889622|FG001|Expansion Maintenance Phase|Physician Decision|1|||
156764223|NCT03258593|565889623|FG002|Expansion Maintenance Phase|Physician Decision|0|||
156764224|NCT03258593|565889624|FG003|Expansion Maintenance Phase|Physician Decision|0|||
156764225|NCT05457257|565889629|FG000|Overall Study|Withdrawal by Subject|0|||
156764226|NCT05457257|565889630|FG001|Overall Study|Withdrawal by Subject|2|||
156764227|NCT05457257|565889629|FG000|Overall Study|Death|10|||
156764228|NCT05457257|565889630|FG001|Overall Study|Death|3|||
156764229|NCT05457257|565889629|FG000|Overall Study|Ongoing|19|||
156764230|NCT05457257|565889630|FG001|Overall Study|Ongoing|9|||
156764231|NCT06077773|565889635|FG000|Overall Study|Withdrawal by Subject|1|||
156764232|NCT06077773|565889636|FG001|Overall Study|Withdrawal by Subject|0|||
156764233|NCT06077773|565889637|FG002|Overall Study|Withdrawal by Subject|1|||
156764234|NCT06077773|565889635|FG000|Overall Study|Lost to Follow-up|0|||
156764235|NCT06077773|565889636|FG001|Overall Study|Lost to Follow-up|1|||
156764236|NCT06077773|565889637|FG002|Overall Study|Lost to Follow-up|0|||
156764237|NCT06077773|565889635|FG000|Overall Study|Adverse Event|0|||
156764238|NCT06077773|565889636|FG001|Overall Study|Adverse Event|0|||
156764239|NCT06077773|565889637|FG002|Overall Study|Adverse Event|2|||
156764240|NCT04275973|565889638|FG000|Overall Study|Withdrawal by Subject|2|||
156764241|NCT04275973|565889639|FG001|Overall Study|Withdrawal by Subject|1|||
156764242|NCT02499146|565889642|FG000|Overall Study|Global deterioration of health status|1|||
156764243|NCT02499146|565889642|FG000|Overall Study|Objective progression or relapse|20|||
156764244|NCT02499146|565889642|FG000|Overall Study|Other|2|||
156764245|NCT02499146|565889642|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
156764246|NCT04325828|565889643|FG000|Overall Study|Ongoing|26|||
156764247|NCT05115630|565889644|FG000|Overall Study|Due to COVID19|1|||
156764248|NCT05115630|565889644|FG000|Overall Study|Due to Bacteremia|1|||
156764249|NCT05115630|565889644|FG000|Overall Study|Due to viral infection|1|||
156764250|NCT01655901|565890828|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764251|NCT01655901|565890829|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764252|NCT01655901|565890830|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764253|NCT01655901|565890831|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
156764254|NCT01655901|565890832|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
156764255|NCT01655901|565890833|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
156764256|NCT00352118|565890834|FG000|Overall Study|Physician Decision|4|||
156764257|NCT02997163|565890835|FG000|Overall Study|Adverse Event|1|||
156764258|NCT02997163|565890836|FG001|Overall Study|Adverse Event|0|||
156764259|NCT02997163|565890837|FG002|Overall Study|Adverse Event|0|||
157005663|NCT02932410|566771561|FG001|Overall Study|Lost to Follow-up|2|||
156764260|NCT02997163|565890838|FG003|Overall Study|Adverse Event|1|||
156764261|NCT00922636|565890839|FG000|Overall Study|Adverse Event|3|||
156764262|NCT00922636|565890840|FG001|Overall Study|Adverse Event|3|||
156764263|NCT00922636|565890841|FG002|Overall Study|Adverse Event|2|||
157005664|NCT02932410|566771562|FG002|Overall Study|Lost to Follow-up|0|||
157005665|NCT02932410|566771563|FG003|Overall Study|Lost to Follow-up|0|||
156764264|NCT00922636|565890842|FG003|Overall Study|Adverse Event|3|||
156764265|NCT00922636|565890843|FG004|Overall Study|Adverse Event|2|||
156764266|NCT00922636|565890839|FG000|Overall Study|Lack of Efficacy|1|||
156764267|NCT00922636|565890840|FG001|Overall Study|Lack of Efficacy|7|||
156764268|NCT00922636|565890841|FG002|Overall Study|Lack of Efficacy|3|||
156764269|NCT00922636|565890842|FG003|Overall Study|Lack of Efficacy|2|||
156764270|NCT00922636|565890843|FG004|Overall Study|Lack of Efficacy|4|||
157005666|NCT02932410|566771560|FG000|Overall Study|Parent/Subjects decision|6|||
156764271|NCT00922636|565890839|FG000|Overall Study|Sponsor Decision|0|||
156764272|NCT00922636|565890840|FG001|Overall Study|Sponsor Decision|0|||
156764273|NCT00922636|565890841|FG002|Overall Study|Sponsor Decision|2|||
156764274|NCT00922636|565890842|FG003|Overall Study|Sponsor Decision|0|||
156764275|NCT00922636|565890843|FG004|Overall Study|Sponsor Decision|0|||
156764276|NCT00922636|565890839|FG000|Overall Study|Withdrawal by Subject|0|||
156764277|NCT00922636|565890840|FG001|Overall Study|Withdrawal by Subject|0|||
156764278|NCT00922636|565890841|FG002|Overall Study|Withdrawal by Subject|5|||
156764279|NCT00922636|565890842|FG003|Overall Study|Withdrawal by Subject|2|||
156764280|NCT00922636|565890843|FG004|Overall Study|Withdrawal by Subject|4|||
156764281|NCT00922636|565890839|FG000|Overall Study|Protocol Violation|0|||
156764282|NCT00922636|565890840|FG001|Overall Study|Protocol Violation|0|||
157110688|NCT04085523|567158448|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
157110689|NCT04085523|567158449|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
157110690|NCT04085523|567158450|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
157110691|NCT04085523|567158451|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
156764283|NCT00922636|565890841|FG002|Overall Study|Protocol Violation|2|||
156764284|NCT00922636|565890842|FG003|Overall Study|Protocol Violation|2|||
156764285|NCT00922636|565890843|FG004|Overall Study|Protocol Violation|0|||
156764286|NCT00922636|565890839|FG000|Overall Study|Entry Criteria Not Met|0|||
156764287|NCT00922636|565890840|FG001|Overall Study|Entry Criteria Not Met|0|||
156764288|NCT00922636|565890841|FG002|Overall Study|Entry Criteria Not Met|1|||
156764289|NCT00922636|565890842|FG003|Overall Study|Entry Criteria Not Met|1|||
156764290|NCT00922636|565890843|FG004|Overall Study|Entry Criteria Not Met|0|||
156764291|NCT00922636|565890839|FG000|Overall Study|Parent/Caregiver Decision|2|||
156764292|NCT00922636|565890840|FG001|Overall Study|Parent/Caregiver Decision|4|||
156764293|NCT00922636|565890841|FG002|Overall Study|Parent/Caregiver Decision|3|||
156764294|NCT00922636|565890842|FG003|Overall Study|Parent/Caregiver Decision|5|||
156764295|NCT00922636|565890843|FG004|Overall Study|Parent/Caregiver Decision|2|||
156764296|NCT00922636|565890839|FG000|Overall Study|Lost to Follow-up|1|||
156764297|NCT00922636|565890840|FG001|Overall Study|Lost to Follow-up|2|||
156764298|NCT00922636|565890841|FG002|Overall Study|Lost to Follow-up|2|||
156764299|NCT00922636|565890842|FG003|Overall Study|Lost to Follow-up|2|||
156764300|NCT00922636|565890843|FG004|Overall Study|Lost to Follow-up|4|||
156764301|NCT02308046|565890844|FG000|Overall Study|Negative yeast culture at Baseline|32|||
156764302|NCT02308046|565890845|FG001|Overall Study|Negative yeast culture at Baseline|33|||
156764303|NCT02308046|565890844|FG000|Overall Study|Positive for STD at Baseline|1|||
156764304|NCT02308046|565890845|FG001|Overall Study|Positive for STD at Baseline|2|||
156764305|NCT02308046|565890844|FG000|Overall Study|Lost to Follow-up|1|||
156764306|NCT02308046|565890845|FG001|Overall Study|Lost to Follow-up|3|||
156764307|NCT01181167|565890846|FG000|Overall Study|Adverse Event|11|||
156764308|NCT01181167|565890847|FG001|Overall Study|Adverse Event|21|||
156764309|NCT01181167|565890846|FG000|Overall Study|Lost to Follow-up|1|||
156764310|NCT01181167|565890847|FG001|Overall Study|Lost to Follow-up|0|||
156764311|NCT01181167|565890846|FG000|Overall Study|Physician Decision|2|||
156764312|NCT01181167|565890847|FG001|Overall Study|Physician Decision|3|||
156764313|NCT01181167|565890846|FG000|Overall Study|Protocol Violation|3|||
156764314|NCT01181167|565890847|FG001|Overall Study|Protocol Violation|0|||
156764315|NCT01181167|565890846|FG000|Overall Study|Withdrawal by Subject|6|||
156764316|NCT01181167|565890847|FG001|Overall Study|Withdrawal by Subject|8|||
156764317|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
156764318|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
156764319|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
156764320|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
156764321|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
156764322|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
156764323|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
156764324|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
156764325|NCT01573000|565890848|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
156764326|NCT01573000|565890849|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
156764327|NCT01573000|565890848|FG000|Crossover Phase|Lack of Efficacy|0|||
156764328|NCT01573000|565890849|FG001|Crossover Phase|Lack of Efficacy|13|||
156764329|NCT01573000|565890848|FG000|Crossover Phase|Lost to Follow-up|0|||
156764330|NCT01573000|565890849|FG001|Crossover Phase|Lost to Follow-up|2|||
156764331|NCT01573000|565890848|FG000|Crossover Phase|Death|0|||
156764332|NCT01573000|565890849|FG001|Crossover Phase|Death|3|||
156764333|NCT01573000|565890848|FG000|Long-Term Follow-Up|Death|3|||
156764334|NCT01573000|565890849|FG001|Long-Term Follow-Up|Death|0|||
156764335|NCT01573000|565890848|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
156764336|NCT01573000|565890849|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
156764337|NCT03885908|565890855|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
157110692|NCT04722042|567158452|FG000|Overall Study|Withdrawal by Subject|2|||
156764338|NCT03885908|565890856|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
156764339|NCT03885908|565890855|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
156764340|NCT03885908|565890856|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
156764341|NCT03885908|565890855|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
156764342|NCT03885908|565890856|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
156764343|NCT03885908|565890855|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
156764344|NCT03885908|565890856|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
156764345|NCT03903172|565890861|FG000|Overall Study|screen fail|4|||
156764346|NCT03903172|565890862|FG001|Overall Study|screen fail|1|||
156764347|NCT01545388|565890863|FG000|Overall Study|Adverse Event|2|||
156764348|NCT01545388|565890864|FG001|Overall Study|Adverse Event|4|||
156764349|NCT01545388|565890865|FG002|Overall Study|Adverse Event|1|||
156764350|NCT01545388|565890863|FG000|Overall Study|Lack of Efficacy|3|||
156764351|NCT01545388|565890864|FG001|Overall Study|Lack of Efficacy|2|||
156764352|NCT01545388|565890865|FG002|Overall Study|Lack of Efficacy|5|||
156764353|NCT01545388|565890863|FG000|Overall Study|Participant moved or relocated|1|||
156764354|NCT01545388|565890864|FG001|Overall Study|Participant moved or relocated|0|||
156764355|NCT01545388|565890865|FG002|Overall Study|Participant moved or relocated|0|||
156764356|NCT01545388|565890863|FG000|Overall Study|Withdrawal by Subject|1|||
156764357|NCT01545388|565890864|FG001|Overall Study|Withdrawal by Subject|4|||
156764358|NCT01545388|565890865|FG002|Overall Study|Withdrawal by Subject|2|||
156764359|NCT01545388|565890863|FG000|Overall Study|Other|1|||
156764360|NCT01545388|565890864|FG001|Overall Study|Other|1|||
156764361|NCT01545388|565890865|FG002|Overall Study|Other|0|||
156764362|NCT05002972|565890867|FG000|Overall Study|Withdrawal by Subject|2|||
156764363|NCT01664091|565890868|FG000|Overall Study|Death|1|||
156764364|NCT01664091|565890868|FG000|Overall Study|Disease Progression|2|||
156764365|NCT01664091|565890868|FG000|Overall Study|Lost to Follow-up|2|||
156764366|NCT01664091|565890868|FG000|Overall Study|Withdrawal by Subject|1|||
156764367|NCT01946204|565890880|FG000|Overall Study|Death|38|||
156764368|NCT01946204|565890881|FG001|Overall Study|Death|59|||
156764369|NCT01946204|565890880|FG000|Overall Study|Withdrawal by Subject|37|||
156764370|NCT01946204|565890881|FG001|Overall Study|Withdrawal by Subject|50|||
156764371|NCT01946204|565890880|FG000|Overall Study|Lost to Follow-up|3|||
156764372|NCT01946204|565890881|FG001|Overall Study|Lost to Follow-up|7|||
156764373|NCT01946204|565890880|FG000|Overall Study|Ongoing|316|||
156764374|NCT01946204|565890881|FG001|Overall Study|Ongoing|687|||
156764375|NCT01946204|565890880|FG000|Overall Study|Other|7|||
156764376|NCT01946204|565890881|FG001|Overall Study|Other|3|||
156764377|NCT04782180|565890882|FG000|Overall Study|Withdrawal by Subject|2|||
156764378|NCT04782180|565890882|FG000|Overall Study|Lost to Follow-up|2|||
156764379|NCT00249834|565890883|FG000|Overall Study|Ovarian stimulation failed|1|||
156764380|NCT00249834|565890884|FG001|Overall Study|Ovarian stimulation failed|0|||
156764381|NCT00249834|565890885|FG002|Overall Study|Ovarian stimulation failed|0|||
156764382|NCT00249834|565890886|FG003|Overall Study|Ovarian stimulation failed|0|||
156764383|NCT00249834|565890887|FG004|Overall Study|Ovarian stimulation failed|0|||
156764384|NCT00249834|565890888|FG005|Overall Study|Ovarian stimulation failed|0|||
156764385|NCT00249834|565890889|FG006|Overall Study|Ovarian stimulation failed|0|||
156764386|NCT00249834|565890890|FG007|Overall Study|Ovarian stimulation failed|0|||
156764387|NCT00249834|565890883|FG000|Overall Study|Failure of down-regulation|0|||
156764388|NCT00249834|565890884|FG001|Overall Study|Failure of down-regulation|0|||
156764389|NCT00249834|565890885|FG002|Overall Study|Failure of down-regulation|0|||
156764390|NCT00249834|565890886|FG003|Overall Study|Failure of down-regulation|0|||
156764391|NCT00249834|565890887|FG004|Overall Study|Failure of down-regulation|0|||
156764392|NCT00249834|565890888|FG005|Overall Study|Failure of down-regulation|0|||
156764393|NCT00249834|565890889|FG006|Overall Study|Failure of down-regulation|1|||
156764394|NCT00249834|565890890|FG007|Overall Study|Failure of down-regulation|0|||
156764395|NCT00249834|565890883|FG000|Overall Study|Protocol Violation|0|||
156764396|NCT00249834|565890884|FG001|Overall Study|Protocol Violation|19|||
156764397|NCT00249834|565890885|FG002|Overall Study|Protocol Violation|14|||
156764398|NCT00249834|565890886|FG003|Overall Study|Protocol Violation|8|||
156764399|NCT00249834|565890887|FG004|Overall Study|Protocol Violation|5|||
156764400|NCT00249834|565890888|FG005|Overall Study|Protocol Violation|2|||
156764401|NCT00249834|565890889|FG006|Overall Study|Protocol Violation|0|||
156764402|NCT00249834|565890890|FG007|Overall Study|Protocol Violation|0|||
156764403|NCT06110754|565890891|FG000|Overall Study|Withdrawal by Subject|0|||
156764404|NCT06110754|565890892|FG001|Overall Study|Withdrawal by Subject|0|||
156764405|NCT06110754|565890893|FG002|Overall Study|Withdrawal by Subject|1|||
156764406|NCT06110754|565890894|FG003|Overall Study|Withdrawal by Subject|0|||
156764407|NCT00846586|565890900|FG000|Overall Study|Adverse Event|20|||
156764408|NCT00846586|565890901|FG001|Overall Study|Adverse Event|10|||
156764409|NCT00846586|565890900|FG000|Overall Study|Subject withdrew consent|8|||
156764410|NCT00846586|565890901|FG001|Overall Study|Subject withdrew consent|10|||
156764411|NCT00846586|565890900|FG000|Overall Study|Administrative problems|5|||
156764412|NCT00846586|565890901|FG001|Overall Study|Administrative problems|4|||
156764413|NCT00846586|565890900|FG000|Overall Study|Death|2|||
156764414|NCT00846586|565890901|FG001|Overall Study|Death|0|||
156764415|NCT00846586|565890900|FG000|Overall Study|Protocol deviation|2|||
156764416|NCT00846586|565890901|FG001|Overall Study|Protocol deviation|6|||
156764417|NCT00846586|565890900|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156764418|NCT00846586|565890901|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156764419|NCT00846586|565890900|FG000|Overall Study|Lost to Follow-up|1|||
156764420|NCT00846586|565890901|FG001|Overall Study|Lost to Follow-up|4|||
156764421|NCT00846586|565890900|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156764422|NCT00846586|565890901|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156764423|NCT01949142|565890914|FG000|Overall Study|Withdrawal of consent|1|||
156764424|NCT01949142|565890915|FG001|Overall Study|Withdrawal of consent|0|||
156764425|NCT01949142|565890914|FG000|Overall Study|Lost to Follow-up|1|||
156764426|NCT01949142|565890915|FG001|Overall Study|Lost to Follow-up|1|||
156764427|NCT01949142|565890914|FG000|Overall Study|Parent changed their mind|1|||
156764428|NCT01949142|565890915|FG001|Overall Study|Parent changed their mind|0|||
156764429|NCT04802161|565890916|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
156764430|NCT04802161|565890917|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
156764431|NCT04802161|565890918|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
156764432|NCT04802161|565890919|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
156764433|NCT04802161|565890916|FG000|Overall Study|Clinical Instability|0|||
156764434|NCT04802161|565890917|FG001|Overall Study|Clinical Instability|0|||
156764435|NCT04802161|565890918|FG002|Overall Study|Clinical Instability|1|||
156764436|NCT04802161|565890919|FG003|Overall Study|Clinical Instability|0|||
156764437|NCT04802161|565890916|FG000|Overall Study|Adverse Event|0|||
156764438|NCT04802161|565890917|FG001|Overall Study|Adverse Event|0|||
156764439|NCT04802161|565890918|FG002|Overall Study|Adverse Event|1|||
156764440|NCT04802161|565890919|FG003|Overall Study|Adverse Event|0|||
156764441|NCT04802161|565890916|FG000|Overall Study|Death|0|||
156764442|NCT04802161|565890917|FG001|Overall Study|Death|0|||
156764443|NCT04802161|565890918|FG002|Overall Study|Death|1|||
156764444|NCT04802161|565890919|FG003|Overall Study|Death|0|||
156764445|NCT01249131|565892904|FG000|Washout Period of 10 Days|Adverse Event|0|||
156764446|NCT01249131|565892905|FG001|Washout Period of 10 Days|Adverse Event|0|||
156764447|NCT01249131|565892906|FG002|Washout Period of 10 Days|Adverse Event|0|||
156764448|NCT01249131|565892907|FG003|Washout Period of 10 Days|Adverse Event|0|||
156764449|NCT01249131|565892908|FG004|Washout Period of 10 Days|Adverse Event|1|||
156764450|NCT01249131|565892909|FG005|Washout Period of 10 Days|Adverse Event|0|||
156764451|NCT02915835|565892910|FG000|Overall Study|Physician Decision|1|||
156764452|NCT02915835|565892911|FG001|Overall Study|Physician Decision|0|||
156764453|NCT02915835|565892910|FG000|Overall Study|Withdrawal by Subject|0|||
156764454|NCT02915835|565892911|FG001|Overall Study|Withdrawal by Subject|1|||
156764455|NCT03426345|565892912|FG000|Overall Study|Adverse Event|4|||
156764456|NCT03426345|565892913|FG001|Overall Study|Adverse Event|4|||
156764457|NCT03426345|565892912|FG000|Overall Study|Lack of Efficacy|1|||
156764458|NCT03426345|565892913|FG001|Overall Study|Lack of Efficacy|0|||
156764459|NCT03426345|565892912|FG000|Overall Study|Withdrawal by Subject|5|||
156764460|NCT03426345|565892913|FG001|Overall Study|Withdrawal by Subject|6|||
156764461|NCT03426345|565892912|FG000|Overall Study|Lost to Follow-up|3|||
156764462|NCT03426345|565892913|FG001|Overall Study|Lost to Follow-up|1|||
156764463|NCT03426345|565892912|FG000|Overall Study|Protocol Deviation|3|||
156764464|NCT03426345|565892913|FG001|Overall Study|Protocol Deviation|4|||
156764465|NCT03426345|565892912|FG000|Overall Study|Reason Not Specified|1|||
156764466|NCT03426345|565892913|FG001|Overall Study|Reason Not Specified|2|||
156764467|NCT03426345|565892912|FG000|Overall Study|Missing Completion Status|1|||
156764468|NCT03426345|565892913|FG001|Overall Study|Missing Completion Status|0|||
156764469|NCT02446691|565892920|FG000|Overall Study|Withdrawal by Subject|2|||
156764470|NCT02446691|565892920|FG000|Overall Study|Lost to Follow-up|8|||
156764471|NCT02446691|565892920|FG000|Overall Study|Protocol Violation|1|||
156764472|NCT00192114|565892921|FG000|Overall Study|Objective Tumor Progression|19|||
156764473|NCT00192114|565892921|FG000|Overall Study|Adverse Event|2|||
156764474|NCT00192114|565892921|FG000|Overall Study|Clinical Progression|2|||
156764475|NCT00192114|565892921|FG000|Overall Study|Death|1|||
156764476|NCT01172873|565892925|FG000|Overall Study|Withdrawal by Subject|3|||
156764477|NCT01172873|565892926|FG001|Overall Study|Withdrawal by Subject|2|||
156764478|NCT05518539|565892930|FG000|Overall Study|Lost to Follow-up|6|||
156764479|NCT02053493|565892931|FG000|Overall Study|Withdrawal by Subject|1|||
156764480|NCT02053493|565892932|FG001|Overall Study|Withdrawal by Subject|1|||
156764481|NCT01909804|565892933|FG000|Overall Study|Randomized but Never Treated|0|||
156764482|NCT01909804|565892934|FG001|Overall Study|Randomized but Never Treated|0|||
156764483|NCT01909804|565892935|FG002|Overall Study|Randomized but Never Treated|0|||
156764484|NCT01909804|565892936|FG003|Overall Study|Randomized but Never Treated|0|||
156764485|NCT01909804|565892937|FG004|Overall Study|Randomized but Never Treated|0|||
156764486|NCT01909804|565892938|FG005|Overall Study|Randomized but Never Treated|0|||
156764487|NCT01909804|565892939|FG006|Overall Study|Randomized but Never Treated|1|||
156764488|NCT01909804|565892940|FG007|Overall Study|Randomized but Never Treated|0|||
156764489|NCT01909804|565892941|FG008|Overall Study|Randomized but Never Treated|0|||
156764490|NCT01909804|565892942|FG009|Overall Study|Randomized but Never Treated|0|||
156764491|NCT01909804|565892943|FG010|Overall Study|Randomized but Never Treated|0|||
156764492|NCT01909804|565892944|FG011|Overall Study|Randomized but Never Treated|1|||
156764493|NCT01909804|565892933|FG000|Overall Study|Death|0|||
156764494|NCT01909804|565892934|FG001|Overall Study|Death|0|||
156764495|NCT01909804|565892935|FG002|Overall Study|Death|0|||
156764496|NCT01909804|565892936|FG003|Overall Study|Death|0|||
156764497|NCT01909804|565892937|FG004|Overall Study|Death|0|||
156764498|NCT01909804|565892938|FG005|Overall Study|Death|0|||
156764499|NCT01909804|565892939|FG006|Overall Study|Death|0|||
156764500|NCT01909804|565892940|FG007|Overall Study|Death|0|||
156764501|NCT01909804|565892941|FG008|Overall Study|Death|0|||
156764502|NCT01909804|565892942|FG009|Overall Study|Death|0|||
156764503|NCT01909804|565892943|FG010|Overall Study|Death|1|||
156764504|NCT01909804|565892944|FG011|Overall Study|Death|0|||
156764505|NCT01909804|565892933|FG000|Overall Study|Lack of Efficacy|4|||
156764506|NCT01909804|565892934|FG001|Overall Study|Lack of Efficacy|1|||
156764507|NCT01909804|565892935|FG002|Overall Study|Lack of Efficacy|0|||
156764508|NCT01909804|565892936|FG003|Overall Study|Lack of Efficacy|0|||
156764509|NCT01909804|565892937|FG004|Overall Study|Lack of Efficacy|7|||
156764510|NCT01909804|565892938|FG005|Overall Study|Lack of Efficacy|3|||
156764511|NCT01909804|565892939|FG006|Overall Study|Lack of Efficacy|1|||
156764512|NCT01909804|565892940|FG007|Overall Study|Lack of Efficacy|1|||
156764513|NCT01909804|565892941|FG008|Overall Study|Lack of Efficacy|0|||
156764514|NCT01909804|565892942|FG009|Overall Study|Lack of Efficacy|1|||
156764515|NCT01909804|565892943|FG010|Overall Study|Lack of Efficacy|0|||
156764516|NCT01909804|565892944|FG011|Overall Study|Lack of Efficacy|1|||
156764517|NCT01909804|565892933|FG000|Overall Study|Withdrew Consent|0|||
156764518|NCT01909804|565892934|FG001|Overall Study|Withdrew Consent|0|||
156764519|NCT01909804|565892935|FG002|Overall Study|Withdrew Consent|0|||
156764520|NCT01909804|565892936|FG003|Overall Study|Withdrew Consent|0|||
156764521|NCT01909804|565892937|FG004|Overall Study|Withdrew Consent|1|||
156764522|NCT01909804|565892938|FG005|Overall Study|Withdrew Consent|1|||
156764523|NCT01909804|565892939|FG006|Overall Study|Withdrew Consent|0|||
156764524|NCT01909804|565892940|FG007|Overall Study|Withdrew Consent|0|||
156764525|NCT01909804|565892941|FG008|Overall Study|Withdrew Consent|0|||
156764526|NCT01909804|565892942|FG009|Overall Study|Withdrew Consent|0|||
156764527|NCT01909804|565892943|FG010|Overall Study|Withdrew Consent|0|||
156764528|NCT01909804|565892944|FG011|Overall Study|Withdrew Consent|0|||
156764529|NCT01909804|565892933|FG000|Overall Study|Protocol Violation|0|||
156764530|NCT01909804|565892934|FG001|Overall Study|Protocol Violation|0|||
156764531|NCT01909804|565892935|FG002|Overall Study|Protocol Violation|0|||
156764532|NCT01909804|565892936|FG003|Overall Study|Protocol Violation|0|||
156764533|NCT01909804|565892937|FG004|Overall Study|Protocol Violation|0|||
156764534|NCT01909804|565892938|FG005|Overall Study|Protocol Violation|0|||
156764535|NCT01909804|565892939|FG006|Overall Study|Protocol Violation|0|||
156764536|NCT01909804|565892940|FG007|Overall Study|Protocol Violation|0|||
156764537|NCT01909804|565892941|FG008|Overall Study|Protocol Violation|0|||
156764538|NCT01909804|565892942|FG009|Overall Study|Protocol Violation|0|||
156764539|NCT01909804|565892943|FG010|Overall Study|Protocol Violation|0|||
156764540|NCT01909804|565892944|FG011|Overall Study|Protocol Violation|1|||
156764541|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
156764542|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156764543|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
156764544|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Adverse Event|2|||
156764545|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156764546|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Adverse Event|1|||
156764547|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
156764548|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
156764549|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
156764550|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
156764551|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
157005667|NCT02932410|566771561|FG001|Overall Study|Parent/Subjects decision|6|||
157005668|NCT02932410|566771562|FG002|Overall Study|Parent/Subjects decision|1|||
157005669|NCT02932410|566771563|FG003|Overall Study|Parent/Subjects decision|0|||
157005670|NCT02932410|566771560|FG000|Overall Study|Physician Decision|0|||
157005671|NCT02932410|566771561|FG001|Overall Study|Physician Decision|1|||
157005672|NCT02932410|566771562|FG002|Overall Study|Physician Decision|0|||
157005673|NCT02932410|566771563|FG003|Overall Study|Physician Decision|0|||
157005674|NCT05011396|566771566|FG000|Overall Study|Lost to Follow-up|3|||
157005675|NCT05011396|566771567|FG001|Overall Study|Lost to Follow-up|1|||
157005676|NCT05011396|566771566|FG000|Overall Study|Withdrawal by Subject|0|||
156764552|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
157005677|NCT05011396|566771567|FG001|Overall Study|Withdrawal by Subject|1|||
157005678|NCT05011396|566771566|FG000|Overall Study|Positive Drug Screen|0|||
157005679|NCT05011396|566771567|FG001|Overall Study|Positive Drug Screen|1|||
156764553|NCT04613518|565892947|FG000|Double-Blind Treatment Period|Other Reasons|2|||
156764554|NCT04613518|565892948|FG001|Double-Blind Treatment Period|Other Reasons|0|||
156764555|NCT04613518|565892949|FG002|Double-Blind Treatment Period|Other Reasons|0|||
156764556|NCT04613518|565892947|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
157005680|NCT04668339|566771568|FG000|Overall Study|Physician Decision|1|||
157110693|NCT04722042|567158453|FG001|Overall Study|Withdrawal by Subject|1|||
157110694|NCT04722042|567158454|FG002|Overall Study|Withdrawal by Subject|0|||
157110695|NCT02046096|567158455|FG000|Overall Study|Death|28|||
156764557|NCT04613518|565892948|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
156764558|NCT04613518|565892949|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156764559|NCT04613518|565892947|FG000|Open-Label Treatment Period|Adverse Event|1|||
156764560|NCT04613518|565892948|FG001|Open-Label Treatment Period|Adverse Event|0|||
156764561|NCT04613518|565892949|FG002|Open-Label Treatment Period|Adverse Event|3|||
156764562|NCT04613518|565892947|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
156764563|NCT04613518|565892948|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
156764564|NCT04613518|565892949|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
156764565|NCT04613518|565892947|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
156764566|NCT04613518|565892948|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
156764567|NCT04613518|565892949|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
156764568|NCT04613518|565892947|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
156764569|NCT04613518|565892948|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
156764570|NCT04613518|565892949|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
156764571|NCT04613518|565892947|FG000|Open-Label Treatment Period|Other reasons|1|||
156764572|NCT04613518|565892948|FG001|Open-Label Treatment Period|Other reasons|0|||
156764573|NCT04613518|565892949|FG002|Open-Label Treatment Period|Other reasons|0|||
156764574|NCT03589807|565892950|FG000|Overall Study|Lost to Follow-up|0|||
156764575|NCT03589807|565892951|FG001|Overall Study|Lost to Follow-up|2|||
156764576|NCT03589807|565892952|FG002|Overall Study|Lost to Follow-up|2|||
156764577|NCT03589807|565892953|FG003|Overall Study|Lost to Follow-up|3|||
156764578|NCT03589807|565892954|FG004|Overall Study|Lost to Follow-up|1|||
156764579|NCT03589807|565892955|FG005|Overall Study|Lost to Follow-up|1|||
156764580|NCT03589807|565892950|FG000|Overall Study|Withdrawal by Subject|0|||
156764581|NCT03589807|565892951|FG001|Overall Study|Withdrawal by Subject|5|||
156764582|NCT03589807|565892952|FG002|Overall Study|Withdrawal by Subject|0|||
156764583|NCT03589807|565892953|FG003|Overall Study|Withdrawal by Subject|0|||
156764584|NCT03589807|565892954|FG004|Overall Study|Withdrawal by Subject|0|||
156764585|NCT03589807|565892955|FG005|Overall Study|Withdrawal by Subject|0|||
156764586|NCT03589807|565892950|FG000|Overall Study|Protocol Violation|0|||
156764587|NCT03589807|565892951|FG001|Overall Study|Protocol Violation|0|||
156764588|NCT03589807|565892952|FG002|Overall Study|Protocol Violation|0|||
156764589|NCT03589807|565892953|FG003|Overall Study|Protocol Violation|1|||
156764590|NCT03589807|565892954|FG004|Overall Study|Protocol Violation|0|||
156764591|NCT03589807|565892955|FG005|Overall Study|Protocol Violation|0|||
156764592|NCT03589807|565892950|FG000|Overall Study|Enrolled but treatment not administered|0|||
156764593|NCT03589807|565892951|FG001|Overall Study|Enrolled but treatment not administered|0|||
156764594|NCT03589807|565892952|FG002|Overall Study|Enrolled but treatment not administered|0|||
156764595|NCT03589807|565892953|FG003|Overall Study|Enrolled but treatment not administered|0|||
156764596|NCT03589807|565892954|FG004|Overall Study|Enrolled but treatment not administered|1|||
156764597|NCT03589807|565892955|FG005|Overall Study|Enrolled but treatment not administered|0|||
156764598|NCT01076543|565892957|FG000|Overall Study|Withdrawal by Subject|2|||
156764599|NCT01076543|565892958|FG001|Overall Study|Withdrawal by Subject|0|||
156764600|NCT01076543|565892959|FG002|Overall Study|Withdrawal by Subject|0|||
156764601|NCT01076543|565892960|FG003|Overall Study|Withdrawal by Subject|0|||
156764602|NCT01076543|565892961|FG004|Overall Study|Withdrawal by Subject|0|||
156764603|NCT01076543|565892962|FG005|Overall Study|Withdrawal by Subject|0|||
156764604|NCT00338741|565892963|FG000|Overall Study|Lost to Follow-up|2|||
156764605|NCT00338741|565892964|FG001|Overall Study|Lost to Follow-up|0|||
156764606|NCT01534273|565892965|FG000|Period 1|Physician Decision|0|||
156764607|NCT01534273|565892966|FG001|Period 1|Physician Decision|0|||
156764608|NCT01534273|565892967|FG002|Period 1|Physician Decision|0|||
156764609|NCT01534273|565892968|FG003|Period 1|Physician Decision|1|||
156764610|NCT01534273|565892969|FG004|Period 1|Physician Decision|0|||
156764611|NCT01534273|565892970|FG005|Period 1|Physician Decision|0|||
156764612|NCT01534273|565892971|FG006|Period 1|Physician Decision|0|||
156764613|NCT01619865|565892972|FG000|Overall Study|Adverse Event|1|||
156764614|NCT01619865|565892972|FG000|Overall Study|Death|2|||
156764615|NCT01619865|565892972|FG000|Overall Study|subject not able to comply|1|||
156764616|NCT03586050|565892973|FG000|Overall Study|Death|3|||
156764617|NCT03586050|565892973|FG000|Overall Study|Withdrawal by Subject|2|||
156764618|NCT01494818|565892974|FG000|Overall Study|Relocation|1|||
156764619|NCT01494818|565892975|FG001|Overall Study|Relocation|2|||
156764620|NCT01494818|565892974|FG000|Overall Study|Lost to Follow-up|1|||
156764621|NCT01494818|565892975|FG001|Overall Study|Lost to Follow-up|0|||
156764622|NCT01211145|565892976|FG000|Overall Study|Reason not specified|3|||
156764623|NCT01211145|565892977|FG001|Overall Study|Reason not specified|2|||
156764624|NCT01211145|565892978|FG002|Overall Study|Reason not specified|2|||
156764625|NCT01211145|565892979|FG003|Overall Study|Reason not specified|1|||
156764626|NCT01211145|565892976|FG000|Overall Study|Lost to Follow-up|3|||
156764627|NCT01211145|565892977|FG001|Overall Study|Lost to Follow-up|2|||
156764628|NCT01211145|565892978|FG002|Overall Study|Lost to Follow-up|1|||
156764629|NCT01211145|565892979|FG003|Overall Study|Lost to Follow-up|2|||
156764630|NCT01211145|565892976|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156764631|NCT01211145|565892977|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156764632|NCT01211145|565892978|FG002|Overall Study|Study-specific withdrawal criteria|0|||
156764633|NCT01211145|565892979|FG003|Overall Study|Study-specific withdrawal criteria|0|||
156764634|NCT01211145|565892976|FG000|Overall Study|Severe noncompliance to protocol|1|||
156764635|NCT01211145|565892977|FG001|Overall Study|Severe noncompliance to protocol|0|||
156764636|NCT01211145|565892978|FG002|Overall Study|Severe noncompliance to protocol|0|||
156764637|NCT01211145|565892979|FG003|Overall Study|Severe noncompliance to protocol|0|||
156764638|NCT01211145|565892976|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
156764639|NCT01211145|565892977|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
156764640|NCT01211145|565892978|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
156764641|NCT01211145|565892979|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
156764642|NCT01211145|565892976|FG000|Overall Study|Patient decision|2|||
156764643|NCT01211145|565892977|FG001|Overall Study|Patient decision|1|||
156764644|NCT01211145|565892978|FG002|Overall Study|Patient decision|0|||
156764645|NCT01211145|565892979|FG003|Overall Study|Patient decision|2|||
156764646|NCT00791999|565892980|FG000|Overall Study|Protocol planed withdrawal|14|||
156764647|NCT00791999|565892981|FG001|Overall Study|Protocol planed withdrawal|11|||
156764648|NCT00791999|565892982|FG002|Overall Study|Protocol planed withdrawal|11|||
156764649|NCT00791999|565892983|FG003|Overall Study|Protocol planed withdrawal|45|||
156764650|NCT00791999|565892980|FG000|Overall Study|Withdrawal by Subject|0|||
156764651|NCT00791999|565892981|FG001|Overall Study|Withdrawal by Subject|1|||
156764652|NCT00791999|565892982|FG002|Overall Study|Withdrawal by Subject|0|||
156764653|NCT00791999|565892983|FG003|Overall Study|Withdrawal by Subject|2|||
156764654|NCT00791999|565892980|FG000|Overall Study|Protocol Violation|3|||
156764655|NCT00791999|565892981|FG001|Overall Study|Protocol Violation|0|||
156764656|NCT00791999|565892982|FG002|Overall Study|Protocol Violation|1|||
156764657|NCT00791999|565892983|FG003|Overall Study|Protocol Violation|0|||
156764658|NCT00791999|565892980|FG000|Overall Study|Adverse Event|3|||
156764659|NCT00791999|565892981|FG001|Overall Study|Adverse Event|3|||
156764660|NCT00791999|565892982|FG002|Overall Study|Adverse Event|7|||
156764661|NCT00791999|565892983|FG003|Overall Study|Adverse Event|3|||
156764662|NCT00791999|565892980|FG000|Overall Study|Lack of Efficacy|0|||
156764663|NCT00791999|565892981|FG001|Overall Study|Lack of Efficacy|1|||
156764664|NCT00791999|565892982|FG002|Overall Study|Lack of Efficacy|0|||
156764665|NCT00791999|565892983|FG003|Overall Study|Lack of Efficacy|2|||
156764666|NCT00791999|565892980|FG000|Overall Study|Reason other than those above|1|||
156764667|NCT00791999|565892981|FG001|Overall Study|Reason other than those above|0|||
156764668|NCT00791999|565892982|FG002|Overall Study|Reason other than those above|1|||
156764669|NCT00791999|565892983|FG003|Overall Study|Reason other than those above|0|||
156764670|NCT00617357|565892986|FG000|Overall Study|Lost to Follow-up|7|||
156764671|NCT00617357|565892986|FG000|Overall Study|Death|5|||
156764672|NCT00617357|565892986|FG000|Overall Study|insurance concerns|2|||
156764673|NCT00617357|565892986|FG000|Overall Study|Withdrawal by Subject|1|||
156764674|NCT00617357|565892986|FG000|Overall Study|Physician Decision|1|||
156764675|NCT01791985|565892991|FG000|Overall Study|Adverse Event|7|||
156764676|NCT01791985|565892991|FG000|Overall Study|Withdrawal by Subject|1|||
156764677|NCT00485069|565892996|FG000|Overall Study|Adverse Event|10|||
156764678|NCT00485069|565892997|FG001|Overall Study|Adverse Event|4|||
156764679|NCT00485069|565892996|FG000|Overall Study|Lack of Efficacy|2|||
156764680|NCT00485069|565892997|FG001|Overall Study|Lack of Efficacy|1|||
156764681|NCT00485069|565892996|FG000|Overall Study|Protocol Violation|0|||
156764682|NCT00485069|565892997|FG001|Overall Study|Protocol Violation|1|||
156764683|NCT00485069|565892996|FG000|Overall Study|Withdrawal by Subject|6|||
156764684|NCT00485069|565892997|FG001|Overall Study|Withdrawal by Subject|6|||
156764685|NCT00086190|565892998|FG000|Overall Study|Adverse Event|6|||
156764686|NCT00086190|565892999|FG001|Overall Study|Adverse Event|2|||
156764687|NCT00086190|565893000|FG002|Overall Study|Adverse Event|2|||
156764688|NCT00086190|565892998|FG000|Overall Study|Withdrawal by Subject|0|||
156764689|NCT00086190|565892999|FG001|Overall Study|Withdrawal by Subject|2|||
156764690|NCT00086190|565893000|FG002|Overall Study|Withdrawal by Subject|2|||
156764691|NCT00086190|565892998|FG000|Overall Study|Protocol Violation|1|||
156764692|NCT00086190|565892999|FG001|Overall Study|Protocol Violation|0|||
156764693|NCT00086190|565893000|FG002|Overall Study|Protocol Violation|0|||
156764694|NCT00086190|565892998|FG000|Overall Study|Moved|1|||
156764695|NCT00086190|565892999|FG001|Overall Study|Moved|0|||
156764696|NCT00086190|565893000|FG002|Overall Study|Moved|0|||
156764697|NCT00086190|565892998|FG000|Overall Study|Worsening depression|0|||
157005681|NCT04668339|566771569|FG001|Overall Study|Physician Decision|0|||
157005682|NCT04668339|566771570|FG002|Overall Study|Physician Decision|1|||
157005683|NCT04668339|566771571|FG003|Overall Study|Physician Decision|1|||
156764698|NCT00086190|565892999|FG001|Overall Study|Worsening depression|0|||
156764699|NCT00086190|565893000|FG002|Overall Study|Worsening depression|2|||
156764700|NCT02688933|565893003|FG000|Overall Study|Adverse Event|3|||
156764701|NCT02688933|565893004|FG001|Overall Study|Adverse Event|1|||
156764702|NCT02688933|565893003|FG000|Overall Study|Lack of Efficacy|2|||
156764703|NCT02688933|565893004|FG001|Overall Study|Lack of Efficacy|2|||
156764704|NCT02688933|565893003|FG000|Overall Study|Poor compliance to protocol|7|||
157005684|NCT04668339|566771568|FG000|Overall Study|Lost to Follow-up|14|||
156764705|NCT02688933|565893004|FG001|Overall Study|Poor compliance to protocol|4|||
156764706|NCT02688933|565893003|FG000|Overall Study|Hypoglycemia|2|||
156764707|NCT02688933|565893004|FG001|Overall Study|Hypoglycemia|0|||
156764708|NCT02688933|565893003|FG000|Overall Study|Other than Specified|14|||
156764709|NCT02688933|565893004|FG001|Overall Study|Other than Specified|25|||
156764710|NCT02688933|565893003|FG000|Overall Study|Lost to Follow-up|1|||
156764711|NCT02688933|565893004|FG001|Overall Study|Lost to Follow-up|5|||
156764712|NCT03902613|565893005|FG000|Overall Study|Physician Decision|1|||
156764713|NCT04622969|565893009|FG000|Overall Study|Withdrawal by Subject|2|||
156764714|NCT04622969|565893010|FG001|Overall Study|Withdrawal by Subject|3|||
156764715|NCT04467515|565893011|FG000|Overall Study|Lost to Follow-up|1|||
156764716|NCT04467515|565893012|FG001|Overall Study|Lost to Follow-up|0|||
156764717|NCT04467515|565893013|FG002|Overall Study|Lost to Follow-up|0|||
156764718|NCT04467515|565893011|FG000|Overall Study|Withdrawal by Subject|1|||
156764719|NCT04467515|565893012|FG001|Overall Study|Withdrawal by Subject|0|||
156764720|NCT04467515|565893013|FG002|Overall Study|Withdrawal by Subject|1|||
156764721|NCT04467515|565893011|FG000|Overall Study|Progressive Disease|0|||
156764722|NCT04467515|565893012|FG001|Overall Study|Progressive Disease|1|||
156764723|NCT04467515|565893013|FG002|Overall Study|Progressive Disease|3|||
156764724|NCT04467515|565893011|FG000|Overall Study|Death|0|||
156764725|NCT04467515|565893012|FG001|Overall Study|Death|1|||
156764726|NCT04467515|565893013|FG002|Overall Study|Death|0|||
156764727|NCT01091246|565893016|FG000|Overall Study|Lost to Follow-up|23|||
156764728|NCT01091246|565893017|FG001|Overall Study|Lost to Follow-up|11|||
156764729|NCT01091246|565893018|FG002|Overall Study|Lost to Follow-up|7|||
156764730|NCT01091246|565893016|FG000|Overall Study|Adverse Event|1|||
156764731|NCT01091246|565893017|FG001|Overall Study|Adverse Event|0|||
156764732|NCT01091246|565893018|FG002|Overall Study|Adverse Event|1|||
156764733|NCT01091246|565893016|FG000|Overall Study|Withdrawal by Subject|9|||
156764734|NCT01091246|565893017|FG001|Overall Study|Withdrawal by Subject|5|||
156764735|NCT01091246|565893018|FG002|Overall Study|Withdrawal by Subject|4|||
156764736|NCT01091246|565893016|FG000|Overall Study|Subject not dosed|2|||
156764737|NCT01091246|565893017|FG001|Overall Study|Subject not dosed|0|||
156764738|NCT01091246|565893018|FG002|Overall Study|Subject not dosed|1|||
156764739|NCT04577794|565893019|FG000|Overall Study|Adverse Event|1|||
156764740|NCT04577794|565893020|FG001|Overall Study|Adverse Event|1|||
156764741|NCT01676012|565893021|FG000|Overall Study|Adverse Event|2|||
156764742|NCT01676012|565893021|FG000|Overall Study|incomplete set of videos|1|||
156764743|NCT02155985|565893031|FG000|Overall Study|Withdrawal by Subject|0|||
156764744|NCT02155985|565893032|FG001|Overall Study|Withdrawal by Subject|0|||
156764745|NCT02155985|565893033|FG002|Overall Study|Withdrawal by Subject|1|||
156764746|NCT02155985|565893031|FG000|Overall Study|Lost to Follow-up|1|||
156764747|NCT02155985|565893032|FG001|Overall Study|Lost to Follow-up|0|||
156764748|NCT02155985|565893033|FG002|Overall Study|Lost to Follow-up|0|||
156764749|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Early discharge|5|||
156764750|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Early discharge|5|||
156764751|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
156764752|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
156764753|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
156764754|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
156764755|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
156764756|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
156764757|NCT04460326|565893038|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
156764758|NCT04460326|565893039|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
156764759|NCT04460326|565893038|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
156764760|NCT04460326|565893039|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
156764761|NCT03372798|565893040|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
156764762|NCT03372798|565893041|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
156764763|NCT03372798|565893040|FG000|Overall Study|Failure of imaging probe|0|||
156764764|NCT03372798|565893041|FG001|Overall Study|Failure of imaging probe|1|||
156764765|NCT04794751|565893043|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
156764766|NCT04794751|565893044|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
156764767|NCT04794751|565893043|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
156764768|NCT04794751|565893044|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
156764769|NCT04794751|565893043|FG000|Period 1|Protocol Violation|0|||
156764770|NCT04794751|565893044|FG001|Period 1|Protocol Violation|2|||
156764771|NCT04794751|565893043|FG000|Period 1|Withdrawal by Subject|0|||
156764772|NCT04794751|565893044|FG001|Period 1|Withdrawal by Subject|1|||
156764773|NCT04794751|565893043|FG000|Period 2|Withdrawal by Subject|0|||
156764774|NCT04794751|565893044|FG001|Period 2|Withdrawal by Subject|1|||
156764775|NCT04794751|565893043|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
156764776|NCT04794751|565893044|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
156764777|NCT04794751|565893043|FG000|Period 2|Protocol Violation|1|||
156764778|NCT04794751|565893044|FG001|Period 2|Protocol Violation|0|||
156764779|NCT01405898|565893045|FG000|Overall Study|Withdrawal by Subject|2|||
156764780|NCT01405898|565893046|FG001|Overall Study|Withdrawal by Subject|2|||
156764781|NCT01687218|565893047|FG000|Overall Study|Withdrawal by Subject|2|||
156764782|NCT01687218|565893048|FG001|Overall Study|Withdrawal by Subject|3|||
156764783|NCT01687218|565893049|FG002|Overall Study|Withdrawal by Subject|0|||
156764784|NCT01687218|565893050|FG003|Overall Study|Withdrawal by Subject|1|||
156764785|NCT01687218|565893051|FG004|Overall Study|Withdrawal by Subject|1|||
156764786|NCT01687218|565893052|FG005|Overall Study|Withdrawal by Subject|0|||
156764787|NCT01687218|565893047|FG000|Overall Study|Relocated, no follow-up planned|1|||
156764788|NCT01687218|565893048|FG001|Overall Study|Relocated, no follow-up planned|0|||
156764789|NCT01687218|565893049|FG002|Overall Study|Relocated, no follow-up planned|1|||
156764790|NCT01687218|565893050|FG003|Overall Study|Relocated, no follow-up planned|1|||
156764791|NCT01687218|565893051|FG004|Overall Study|Relocated, no follow-up planned|0|||
156764792|NCT01687218|565893052|FG005|Overall Study|Relocated, no follow-up planned|0|||
156764793|NCT03528551|565893057|FG000|Overall Study|Lost to Follow-up|0|||
156764794|NCT03528551|565893058|FG001|Overall Study|Lost to Follow-up|1|||
156764795|NCT03528551|565893059|FG002|Overall Study|Lost to Follow-up|0|||
156764796|NCT03528551|565893057|FG000|Overall Study|Transferred to other arm/group|2|||
156764797|NCT03528551|565893058|FG001|Overall Study|Transferred to other arm/group|3|||
156764798|NCT03528551|565893059|FG002|Overall Study|Transferred to other arm/group|0|||
156764799|NCT03528551|565893057|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156764800|NCT03528551|565893058|FG001|Overall Study|Withdrawal by parent/guardian|5|||
156764801|NCT03528551|565893059|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156764802|NCT03528551|565893057|FG000|Overall Study|Protocol Violation|0|||
156764803|NCT03528551|565893058|FG001|Overall Study|Protocol Violation|3|||
156764804|NCT03528551|565893059|FG002|Overall Study|Protocol Violation|0|||
156764805|NCT03528551|565893057|FG000|Overall Study|Withdrawal by Subject|0|||
156764806|NCT03528551|565893058|FG001|Overall Study|Withdrawal by Subject|7|||
156764807|NCT03528551|565893059|FG002|Overall Study|Withdrawal by Subject|0|||
156764808|NCT01789047|565893060|FG000|Overall Study|Adverse Event|3|||
156764809|NCT01789047|565893061|FG001|Overall Study|Adverse Event|2|||
156764810|NCT01789047|565893060|FG000|Overall Study|Withdrawal by Subject|1|||
156764811|NCT01789047|565893061|FG001|Overall Study|Withdrawal by Subject|2|||
156764812|NCT03644017|565893062|FG000|Overall Study|Access Abandonment|5|||
156764813|NCT03644017|565893062|FG000|Overall Study|Kidney Transplant|2|||
156764814|NCT01204671|565893063|FG000|Overall Study|Adverse Event|4|||
156764815|NCT01204671|565893064|FG001|Overall Study|Adverse Event|3|||
156764816|NCT01204671|565893065|FG002|Overall Study|Adverse Event|3|||
156764817|NCT01204671|565893066|FG003|Overall Study|Adverse Event|3|||
156764818|NCT01204671|565893067|FG004|Overall Study|Adverse Event|1|||
156764819|NCT01204671|565893063|FG000|Overall Study|Withdrawal by Subject|2|||
156764820|NCT01204671|565893064|FG001|Overall Study|Withdrawal by Subject|3|||
156764821|NCT01204671|565893065|FG002|Overall Study|Withdrawal by Subject|4|||
156764822|NCT01204671|565893066|FG003|Overall Study|Withdrawal by Subject|5|||
156764823|NCT01204671|565893067|FG004|Overall Study|Withdrawal by Subject|3|||
156764824|NCT01204671|565893063|FG000|Overall Study|Lost to Follow-up|7|||
156764825|NCT01204671|565893064|FG001|Overall Study|Lost to Follow-up|8|||
156764826|NCT01204671|565893065|FG002|Overall Study|Lost to Follow-up|6|||
156764827|NCT01204671|565893066|FG003|Overall Study|Lost to Follow-up|4|||
156764828|NCT01204671|565893067|FG004|Overall Study|Lost to Follow-up|0|||
156764829|NCT01204671|565893063|FG000|Overall Study|Unknown Completion Status|1|||
156764830|NCT01204671|565893064|FG001|Overall Study|Unknown Completion Status|1|||
156764831|NCT01204671|565893065|FG002|Overall Study|Unknown Completion Status|0|||
156764832|NCT01204671|565893066|FG003|Overall Study|Unknown Completion Status|0|||
156764833|NCT01204671|565893067|FG004|Overall Study|Unknown Completion Status|0|||
156764834|NCT01204671|565893063|FG000|Overall Study|Physician Decision|0|||
156764835|NCT01204671|565893064|FG001|Overall Study|Physician Decision|0|||
156764836|NCT01204671|565893065|FG002|Overall Study|Physician Decision|0|||
156764837|NCT01204671|565893066|FG003|Overall Study|Physician Decision|1|||
156764838|NCT01204671|565893067|FG004|Overall Study|Physician Decision|0|||
156764839|NCT02700048|565893068|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
156764840|NCT02700048|565893069|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
157005685|NCT04668339|566771569|FG001|Overall Study|Lost to Follow-up|12|||
157005686|NCT04668339|566771570|FG002|Overall Study|Lost to Follow-up|8|||
157005687|NCT04668339|566771571|FG003|Overall Study|Lost to Follow-up|5|||
157005688|NCT04668339|566771568|FG000|Overall Study|Adverse Event|0|||
157005689|NCT04668339|566771569|FG001|Overall Study|Adverse Event|0|||
157110696|NCT02046096|567158456|FG001|Overall Study|Death|45|||
156764841|NCT02175225|565893070|FG000|Overall Study|Withdrawal by Subject|1|||
156764842|NCT02175225|565893071|FG001|Overall Study|Withdrawal by Subject|2|||
156764843|NCT02175225|565893070|FG000|Overall Study|Lost to Follow-up|6|||
156764844|NCT02175225|565893071|FG001|Overall Study|Lost to Follow-up|7|||
156764845|NCT02175225|565893070|FG000|Overall Study|Study drug not administered|1|||
156764846|NCT02175225|565893071|FG001|Overall Study|Study drug not administered|2|||
157005690|NCT04668339|566771570|FG002|Overall Study|Adverse Event|1|||
157005691|NCT04668339|566771571|FG003|Overall Study|Adverse Event|0|||
157005692|NCT04668339|566771568|FG000|Overall Study|Other than specified|3|||
157005693|NCT04668339|566771569|FG001|Overall Study|Other than specified|0|||
156764847|NCT02340000|565893072|FG000|Time Period 1|Withdrawal by Subject|6|||
156764848|NCT02340000|565893073|FG001|Time Period 1|Withdrawal by Subject|8|||
156764849|NCT02340000|565893072|FG000|Time Period 1|Lost to Follow-up|6|||
156764850|NCT02340000|565893073|FG001|Time Period 1|Lost to Follow-up|7|||
156764851|NCT02340000|565893072|FG000|Time Period 2|Withdrawal by Subject|9|||
156764852|NCT02340000|565893073|FG001|Time Period 2|Withdrawal by Subject|7|||
156764853|NCT02340000|565893072|FG000|Time Period 2|Lost to Follow-up|10|||
156764854|NCT02340000|565893073|FG001|Time Period 2|Lost to Follow-up|8|||
156764855|NCT02668640|565893074|FG000|Overall Study|Lost to Follow-up|13|||
156764856|NCT02668640|565893074|FG000|Overall Study|Other, not specified|1|||
156764857|NCT01883895|565893076|FG000|Overall Study|Lost to Follow-up|2|||
156764858|NCT07116759|565893084|FG000|Overall Study|Incompatibility with the RHMC device|2|||
156764859|NCT03342001|565894435|FG000|Overall Study|Adverse Event|1|||
156764860|NCT03342001|565894435|FG000|Overall Study|Lost to Follow-up|1|||
156764861|NCT01930539|565894450|FG000|Overall Study|Withdrawal by Subject|2|||
156764862|NCT01930539|565894451|FG001|Overall Study|Withdrawal by Subject|2|||
156764863|NCT00883181|565894452|FG000|Overall Study|Hematological Adverse Event|26|||
156764864|NCT00883181|565894452|FG000|Overall Study|Non-hematological Adverse Event|55|||
156764865|NCT00883181|565894452|FG000|Overall Study|Disease Progression|94|||
156764866|NCT00883181|565894452|FG000|Overall Study|Administrative Reason|24|||
156764867|NCT00883181|565894452|FG000|Overall Study|Withdrawal by Subject|4|||
156764868|NCT00883181|565894452|FG000|Overall Study|Death|31|||
156764869|NCT00883181|565894452|FG000|Overall Study|Other|38|||
156764870|NCT00883181|565894452|FG000|Overall Study|Protocol Deviation|3|||
156764871|NCT00883181|565894452|FG000|Overall Study|Noncompliance|3|||
156764872|NCT04040439|565894453|FG000|Overall Study|Invalid registration|11|||
156764873|NCT04040439|565894453|FG000|Overall Study|No IC* on publication of study results|2|||
156764874|NCT01450813|565894458|FG000|Overall Study|Physician Decision|1|||
156764875|NCT01450813|565894459|FG001|Overall Study|Physician Decision|1|||
156764876|NCT01450813|565894460|FG002|Overall Study|Physician Decision|0|||
156764877|NCT01450813|565894461|FG003|Overall Study|Physician Decision|3|||
156764878|NCT01309386|565894462|FG000|Overall Study|Other|2|||
156764879|NCT01309386|565894463|FG001|Overall Study|Other|0|||
156764880|NCT01309386|565894462|FG000|Overall Study|Withdrawal by Subject|2|||
156764881|NCT01309386|565894463|FG001|Overall Study|Withdrawal by Subject|0|||
156764882|NCT01309386|565894462|FG000|Overall Study|Progressive disease|9|||
156764883|NCT01309386|565894463|FG001|Overall Study|Progressive disease|11|||
156764884|NCT01309386|565894462|FG000|Overall Study|Physician Decision|1|||
156764885|NCT01309386|565894463|FG001|Overall Study|Physician Decision|1|||
156764886|NCT01309386|565894462|FG000|Overall Study|Lack of Efficacy|3|||
156764887|NCT01309386|565894463|FG001|Overall Study|Lack of Efficacy|1|||
156764888|NCT01309386|565894462|FG000|Overall Study|Adverse Event|5|||
156764889|NCT01309386|565894463|FG001|Overall Study|Adverse Event|8|||
156764890|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
156764891|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764892|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764893|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764894|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
156764895|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
156764896|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764897|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764898|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764899|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
156764900|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
156764901|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764902|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764903|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764904|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
156764905|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
156764906|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764907|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764908|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764909|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
156764910|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
156764911|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764912|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764913|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764914|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
156764915|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
156764916|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764917|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
157110697|NCT02046096|567158455|FG000|Overall Study|Lost to Follow-up|9|||
156764918|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764919|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
156764920|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
156764921|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764922|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764923|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764924|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
156764925|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
156764926|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764927|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764928|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764929|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
156764930|NCT02709746|565894464|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
156764931|NCT02709746|565894465|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764932|NCT02709746|565894466|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764933|NCT02709746|565894467|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764934|NCT02709746|565894468|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
156764935|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764936|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
156764937|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764938|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
156764939|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
156764940|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
156764941|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
156764942|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
156764943|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
156764944|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
156764945|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
156764946|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
156764947|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
156764948|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
156764949|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
156764950|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
156764951|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
156764952|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
156764953|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
156764954|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
156764955|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
156764956|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
156764957|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
156764958|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
156764959|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
156764960|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
156764961|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764962|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764963|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
156764964|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
156764965|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764966|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764967|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
156764968|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764969|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
156764970|NCT02709746|565894464|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
156764971|NCT02709746|565894465|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
156764972|NCT02709746|565894466|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
156764973|NCT02709746|565894467|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
156764974|NCT02709746|565894468|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
156764975|NCT00752089|565894469|FG000|Overall Study|Adverse Event|1|||
156764976|NCT00752089|565894469|FG000|Overall Study|Protocol Deviation|2|||
156764977|NCT00752089|565894469|FG000|Overall Study|Could not attend visit 9|1|||
156764978|NCT00752089|565894469|FG000|Overall Study|Not capable of wearing partial denture|1|||
156764979|NCT00752089|565894469|FG000|Overall Study|Cannot continue the study|1|||
156764980|NCT02089347|565894470|FG000|Overall Study|Protocol Violation|1|||
156764981|NCT02089347|565894471|FG001|Overall Study|Protocol Violation|0|||
156764982|NCT02914834|565894475|FG000|Overall Study|Study halted due to COVID|1|||
156764983|NCT02914834|565894476|FG001|Overall Study|Study halted due to COVID|1|||
156764984|NCT02914834|565894475|FG000|Overall Study|1 subject withdrew|0|||
156764985|NCT02914834|565894476|FG001|Overall Study|1 subject withdrew|1|||
156764986|NCT00975416|565894483|FG000|Overall Study|early discharge from tx|3|||
156764987|NCT00975416|565894484|FG001|Overall Study|early discharge from tx|5|||
156764988|NCT01245101|565894485|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
156764989|NCT01245101|565894486|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
156764990|NCT01245101|565894485|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
156764991|NCT01245101|565894486|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
156764992|NCT01245101|565894485|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
156764993|NCT01245101|565894486|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
156764994|NCT01225549|565894487|FG000|Period 4 - Washout|Disallowed medication|0|||
156764995|NCT01225549|565894488|FG001|Period 4 - Washout|Disallowed medication|1|||
156764996|NCT01225549|565894489|FG002|Period 4 - Washout|Disallowed medication|0|||
156764997|NCT01225549|565894490|FG003|Period 4 - Washout|Disallowed medication|0|||
156764998|NCT01225549|565894491|FG004|Period 4 - Washout|Disallowed medication|0|||
156764999|NCT01225549|565894492|FG005|Period 4 - Washout|Disallowed medication|0|||
156765000|NCT01225549|565894493|FG006|Period 4 - Washout|Disallowed medication|0|||
156765001|NCT01225549|565894494|FG007|Period 4 - Washout|Disallowed medication|0|||
156765002|NCT01225549|565894495|FG008|Period 4 - Washout|Disallowed medication|0|||
156765003|NCT01225549|565894496|FG009|Period 4 - Washout|Disallowed medication|0|||
156765004|NCT01225549|565894487|FG000|Period 6 - Washout|Disallowed medication|0|||
156765005|NCT01225549|565894488|FG001|Period 6 - Washout|Disallowed medication|0|||
156765006|NCT01225549|565894489|FG002|Period 6 - Washout|Disallowed medication|0|||
156765007|NCT01225549|565894490|FG003|Period 6 - Washout|Disallowed medication|1|||
156765008|NCT01225549|565894491|FG004|Period 6 - Washout|Disallowed medication|0|||
156765009|NCT01225549|565894492|FG005|Period 6 - Washout|Disallowed medication|0|||
156765010|NCT01225549|565894493|FG006|Period 6 - Washout|Disallowed medication|0|||
156765011|NCT01225549|565894494|FG007|Period 6 - Washout|Disallowed medication|0|||
156765012|NCT01225549|565894495|FG008|Period 6 - Washout|Disallowed medication|0|||
156765013|NCT01225549|565894496|FG009|Period 6 - Washout|Disallowed medication|0|||
156765014|NCT00473083|565894499|FG000|Overall Study|Adverse Event|1|||
156765015|NCT00473083|565894500|FG001|Overall Study|Adverse Event|0|||
156765016|NCT00473083|565894501|FG002|Overall Study|Adverse Event|0|||
156765017|NCT01184872|565894502|FG000|Overall Study|Adverse Event|3|||
156765018|NCT01184872|565894503|FG001|Overall Study|Adverse Event|4|||
156765019|NCT01184872|565894502|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156765020|NCT01184872|565894503|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156765021|NCT01184872|565894502|FG000|Overall Study|Withdrawal by Subject|2|||
156765022|NCT01184872|565894503|FG001|Overall Study|Withdrawal by Subject|0|||
156765023|NCT01184872|565894502|FG000|Overall Study|Lost to Follow-up|0|||
156765024|NCT01184872|565894503|FG001|Overall Study|Lost to Follow-up|1|||
156765025|NCT01184872|565894502|FG000|Overall Study|Administrative problems|1|||
156765026|NCT01184872|565894503|FG001|Overall Study|Administrative problems|1|||
156765027|NCT01184872|565894502|FG000|Overall Study|Protocol deviation|1|||
156765028|NCT01184872|565894503|FG001|Overall Study|Protocol deviation|0|||
156765029|NCT02283658|565894507|FG000|Overall Study|Withdrawal by Subject|1|||
156765030|NCT03608826|565894509|FG000|Overall Study|Death|3|||
156765031|NCT03608826|565894509|FG000|Overall Study|Heart Transplant|3|||
156765032|NCT03608826|565894509|FG000|Overall Study|Physician Decision|4|||
156765033|NCT00875810|565894510|FG000|Overall Study|Withdrawal by Subject|1|||
156765034|NCT00875810|565894510|FG000|Overall Study|Physician Decision|3|||
156765035|NCT00875810|565894510|FG000|Overall Study|Lost to Follow-up|39|||
156765036|NCT00875810|565894510|FG000|Overall Study|Patient enroled but not implanted|2|||
156765037|NCT00875810|565894510|FG000|Overall Study|Device explanted|1|||
156765038|NCT00780975|565894511|FG000|Overall Study|Progressive disease|3|||
156765039|NCT00780975|565894511|FG000|Overall Study|Toxicity|5|||
156765040|NCT01061606|565894512|FG000|Overall Study|Adverse Event|1|||
156765041|NCT01061606|565894512|FG000|Overall Study|Death|1|||
156765042|NCT01061606|565894512|FG000|Overall Study|Disease Progression|4|||
156765043|NCT01061606|565894512|FG000|Overall Study|alternative therapy|2|||
156765044|NCT01305564|565894513|FG000|Overall Study|Death|21|||
156765045|NCT01305564|565894513|FG000|Overall Study|Lost to Follow-up|12|||
156765046|NCT01305564|565894513|FG000|Overall Study|Withdrawal by Subject|1|||
156765047|NCT01305564|565894513|FG000|Overall Study|Physician Decision|3|||
156765048|NCT02322749|565894515|FG000|Period 2|Adverse Event|0|||
156765049|NCT02322749|565894516|FG001|Period 2|Adverse Event|0|||
156765050|NCT02322749|565894517|FG002|Period 2|Adverse Event|0|||
156765051|NCT02322749|565894518|FG003|Period 2|Adverse Event|1|||
156765052|NCT02322749|565894519|FG004|Period 2|Adverse Event|0|||
156765053|NCT02322749|565894520|FG005|Period 2|Adverse Event|0|||
156765054|NCT02322749|565894515|FG000|Period 2|Withdrawal by Subject|0|||
156765055|NCT02322749|565894516|FG001|Period 2|Withdrawal by Subject|0|||
156765056|NCT02322749|565894517|FG002|Period 2|Withdrawal by Subject|0|||
156765057|NCT02322749|565894518|FG003|Period 2|Withdrawal by Subject|1|||
156765058|NCT02322749|565894519|FG004|Period 2|Withdrawal by Subject|0|||
156765059|NCT02322749|565894520|FG005|Period 2|Withdrawal by Subject|0|||
156765060|NCT02322749|565894515|FG000|Period 3|Withdrawal by Subject|0|||
156765061|NCT02322749|565894516|FG001|Period 3|Withdrawal by Subject|0|||
156765062|NCT02322749|565894517|FG002|Period 3|Withdrawal by Subject|1|||
156765063|NCT02322749|565894518|FG003|Period 3|Withdrawal by Subject|0|||
156765064|NCT02322749|565894519|FG004|Period 3|Withdrawal by Subject|0|||
156765065|NCT02322749|565894520|FG005|Period 3|Withdrawal by Subject|0|||
156765066|NCT00073918|565894525|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
156765067|NCT00073918|565894525|FG000|Overall Study|Rapid disease progression|2|||
156765068|NCT00073918|565894525|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
156765069|NCT01190813|565894528|FG000|Overall Study|Lost to Follow-up|1|||
156765070|NCT01190813|565894529|FG001|Overall Study|Lost to Follow-up|2|||
156765071|NCT01190813|565894528|FG000|Overall Study|Withdrawal by Subject|2|||
156765072|NCT01190813|565894529|FG001|Overall Study|Withdrawal by Subject|1|||
156765073|NCT01190813|565894528|FG000|Overall Study|Refused study treatment after randomized|1|||
156765074|NCT01190813|565894529|FG001|Overall Study|Refused study treatment after randomized|0|||
156765075|NCT01190813|565894528|FG000|Overall Study|Adverse Event|0|||
156765076|NCT01190813|565894529|FG001|Overall Study|Adverse Event|1|||
156765077|NCT02033759|565894531|FG000|Overall Study|Withdrawal by Subject|2|||
156765078|NCT02033759|565894532|FG001|Overall Study|Withdrawal by Subject|1|||
156765079|NCT02033759|565894531|FG000|Overall Study|Protocol Violation|1|||
156765080|NCT02033759|565894532|FG001|Overall Study|Protocol Violation|1|||
156765081|NCT00807365|565894536|FG000|Overall Study|Study Terminated|5|||
156765082|NCT04821830|565894539|FG000|Overall Study|Withdrawal by Subject|1|||
156765083|NCT04821830|565894540|FG001|Overall Study|Withdrawal by Subject|0|||
156765084|NCT00919633|565894542|FG000|Overall Study|Adverse Event|1|||
156765085|NCT00919633|565894543|FG001|Overall Study|Adverse Event|9|||
156765086|NCT00919633|565894544|FG002|Overall Study|Adverse Event|12|||
156765087|NCT00919633|565894545|FG003|Overall Study|Adverse Event|10|||
156765088|NCT00919633|565894542|FG000|Overall Study|Death|0|||
156765089|NCT00919633|565894543|FG001|Overall Study|Death|0|||
156765090|NCT00919633|565894544|FG002|Overall Study|Death|2|||
156765091|NCT00919633|565894545|FG003|Overall Study|Death|0|||
156765092|NCT00919633|565894542|FG000|Overall Study|Lack of Efficacy|17|||
156765093|NCT00919633|565894543|FG001|Overall Study|Lack of Efficacy|3|||
156765094|NCT00919633|565894544|FG002|Overall Study|Lack of Efficacy|2|||
156765095|NCT00919633|565894545|FG003|Overall Study|Lack of Efficacy|3|||
156765096|NCT00919633|565894542|FG000|Overall Study|Withdrawal by Subject|1|||
156765097|NCT00919633|565894543|FG001|Overall Study|Withdrawal by Subject|2|||
156765098|NCT00919633|565894544|FG002|Overall Study|Withdrawal by Subject|4|||
156765099|NCT00919633|565894545|FG003|Overall Study|Withdrawal by Subject|3|||
156765100|NCT00919633|565894542|FG000|Overall Study|Lost to Follow-up|3|||
156765101|NCT00919633|565894543|FG001|Overall Study|Lost to Follow-up|1|||
156765102|NCT00919633|565894544|FG002|Overall Study|Lost to Follow-up|0|||
156765103|NCT00919633|565894545|FG003|Overall Study|Lost to Follow-up|2|||
156765104|NCT00919633|565894542|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
156765105|NCT00919633|565894543|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
156765106|NCT00919633|565894544|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
156765107|NCT00919633|565894545|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
156765108|NCT00919633|565894542|FG000|Overall Study|Protocol Violation|0|||
156765109|NCT00919633|565894543|FG001|Overall Study|Protocol Violation|0|||
156765110|NCT00919633|565894544|FG002|Overall Study|Protocol Violation|0|||
156765111|NCT00919633|565894545|FG003|Overall Study|Protocol Violation|1|||
156765112|NCT00919633|565894542|FG000|Overall Study|Physician Decision|0|||
156765113|NCT00919633|565894543|FG001|Overall Study|Physician Decision|0|||
156765114|NCT00919633|565894544|FG002|Overall Study|Physician Decision|0|||
156765115|NCT00919633|565894545|FG003|Overall Study|Physician Decision|1|||
156765116|NCT00919633|565894542|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
156765117|NCT00919633|565894543|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
156765118|NCT00919633|565894544|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
156765119|NCT00919633|565894545|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
156765120|NCT00919633|565894542|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
157110698|NCT02046096|567158456|FG001|Overall Study|Lost to Follow-up|20|||
157110699|NCT02046096|567158455|FG000|Overall Study|Withdrawal by Subject|5|||
157110700|NCT02046096|567158456|FG001|Overall Study|Withdrawal by Subject|17|||
157110701|NCT02046096|567158455|FG000|Overall Study|Other endpoint|2|||
157110702|NCT02046096|567158456|FG001|Overall Study|Other endpoint|19|||
157110703|NCT03520959|567158457|FG000|Overall Study|Study terminated by Sponsor|0|||
157110704|NCT03520959|567158458|FG001|Overall Study|Study terminated by Sponsor|1|||
157110705|NCT04969276|567158460|FG000|Overall Study|Protocol Deviation|0|||
156765121|NCT00919633|565894543|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
156765122|NCT00919633|565894544|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
156765123|NCT00919633|565894545|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
156765124|NCT01526785|565894546|FG000|Overall Study|Study Terminated by Sponsor|8|||
156765125|NCT01526785|565894546|FG000|Overall Study|Death|2|||
157110706|NCT04969276|567158461|FG001|Overall Study|Protocol Deviation|1|||
157110707|NCT04969276|567158462|FG002|Overall Study|Protocol Deviation|0|||
157110708|NCT04969276|567158460|FG000|Overall Study|Withdrawal by Subject|1|||
157110709|NCT04969276|567158461|FG001|Overall Study|Withdrawal by Subject|10|||
157110710|NCT04969276|567158462|FG002|Overall Study|Withdrawal by Subject|0|||
156765126|NCT01526785|565894546|FG000|Overall Study|Physician Decision|1|||
157110711|NCT04969276|567158460|FG000|Overall Study|Lost to Follow-up|0|||
157110712|NCT04969276|567158461|FG001|Overall Study|Lost to Follow-up|1|||
157110713|NCT04969276|567158462|FG002|Overall Study|Lost to Follow-up|0|||
157110714|NCT01538628|567158471|FG000|Overall Study|Withdrawal by Subject|1|||
157110715|NCT01538628|567158472|FG001|Overall Study|Withdrawal by Subject|1|||
157110716|NCT01538628|567158471|FG000|Overall Study|Lost to Follow-up|0|||
157110717|NCT01538628|567158472|FG001|Overall Study|Lost to Follow-up|1|||
157110718|NCT01357577|567158473|FG000|Overall Study|Lost to Follow-up|20|||
157110719|NCT01357577|567158474|FG001|Overall Study|Lost to Follow-up|16|||
157110720|NCT01357577|567158473|FG000|Overall Study|Withdrawal by Subject|16|||
157110721|NCT01357577|567158474|FG001|Overall Study|Withdrawal by Subject|8|||
157110722|NCT01357577|567158473|FG000|Overall Study|look at data in database?|1|||
157110723|NCT01357577|567158474|FG001|Overall Study|look at data in database?|2|||
157110724|NCT01439282|567159334|FG000|Overall Study|Adverse Event|5|||
157110725|NCT01439282|567159335|FG001|Overall Study|Adverse Event|0|||
157110726|NCT01439282|567159334|FG000|Overall Study|Withdrawal by Subject|2|||
156765127|NCT01526785|565894546|FG000|Overall Study|Withdrawal by Subject|2|||
156765128|NCT01121263|565894549|FG000|Overall Study|Death|3|||
156765129|NCT01121263|565894550|FG001|Overall Study|Death|2|||
156765130|NCT01121263|565894549|FG000|Overall Study|Lost to Follow-up|22|||
156765131|NCT01121263|565894550|FG001|Overall Study|Lost to Follow-up|12|||
156765132|NCT01121263|565894549|FG000|Overall Study|Withdrawal by Subject|0|||
156765133|NCT01121263|565894550|FG001|Overall Study|Withdrawal by Subject|1|||
156765134|NCT02007720|565894551|FG000|Overall Study|Withdrawal by Subject|9|||
156765135|NCT02007720|565894552|FG001|Overall Study|Withdrawal by Subject|11|||
156765136|NCT02007720|565894551|FG000|Overall Study|study terminated by sponsor|58|||
156765137|NCT02007720|565894552|FG001|Overall Study|study terminated by sponsor|54|||
156765138|NCT02007720|565894551|FG000|Overall Study|technical problem|4|||
156765139|NCT02007720|565894552|FG001|Overall Study|technical problem|2|||
156765140|NCT02007720|565894551|FG000|Overall Study|patient followd less than 165 days|11|||
156765141|NCT02007720|565894552|FG001|Overall Study|patient followd less than 165 days|5|||
156765142|NCT03810456|565894554|FG000|Treatment|Urgent Family Matters|3|||
156765143|NCT03810456|565894555|FG001|Treatment|Urgent Family Matters|0|||
156765144|NCT03810456|565894556|FG002|Treatment|Urgent Family Matters|0|||
156765145|NCT03810456|565894554|FG000|Treatment|Scheduling Conflicts|0|||
156765146|NCT03810456|565894555|FG001|Treatment|Scheduling Conflicts|11|||
156765147|NCT03810456|565894556|FG002|Treatment|Scheduling Conflicts|0|||
156765148|NCT03810456|565894554|FG000|Treatment|No Longer Interested|0|||
156765149|NCT03810456|565894555|FG001|Treatment|No Longer Interested|12|||
156765150|NCT03810456|565894556|FG002|Treatment|No Longer Interested|0|||
156765151|NCT03810456|565894554|FG000|Treatment|Transportation Issues|0|||
156765152|NCT03810456|565894555|FG001|Treatment|Transportation Issues|1|||
156765153|NCT03810456|565894556|FG002|Treatment|Transportation Issues|0|||
156765154|NCT03810456|565894554|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
156765155|NCT03810456|565894555|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
156765156|NCT03810456|565894556|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
157110727|NCT01439282|567159335|FG001|Overall Study|Withdrawal by Subject|0|||
157110728|NCT01439282|567159334|FG000|Overall Study|Other|1|||
157110729|NCT01439282|567159335|FG001|Overall Study|Other|1|||
157110730|NCT04419610|567159336|FG000|Overall Study|Withdrawal by Subject|3|||
157110731|NCT04419610|567159337|FG001|Overall Study|Withdrawal by Subject|1|||
157110732|NCT04419610|567159336|FG000|Overall Study|Adverse Event|1|||
157110733|NCT04419610|567159337|FG001|Overall Study|Adverse Event|0|||
157110734|NCT04419610|567159336|FG000|Overall Study|discharged early|1|||
157110735|NCT04419610|567159337|FG001|Overall Study|discharged early|1|||
157110736|NCT00307151|567159340|FG000|Overall Study|Death|4|||
157110737|NCT00307151|567159341|FG001|Overall Study|Death|3|||
156765157|NCT03810456|565894554|FG000|1 Month Follow-Up|Relocated to Different State|1|||
156765158|NCT03810456|565894555|FG001|1 Month Follow-Up|Relocated to Different State|0|||
156765159|NCT03810456|565894556|FG002|1 Month Follow-Up|Relocated to Different State|1|||
157110738|NCT00307151|567159342|FG002|Overall Study|Death|10|||
157110739|NCT00307151|567159343|FG003|Overall Study|Death|3|||
157110740|NCT00307151|567159340|FG000|Overall Study|Severe debilitation, unable to continue|1|||
157110741|NCT00307151|567159341|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156765160|NCT03810456|565894554|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
156765161|NCT03810456|565894555|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
156765162|NCT03810456|565894556|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
156765163|NCT03810456|565894554|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
156765164|NCT03810456|565894555|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
157110742|NCT00307151|567159342|FG002|Overall Study|Severe debilitation, unable to continue|0|||
157110743|NCT00307151|567159343|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156765165|NCT03810456|565894556|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
156765166|NCT03810456|565894554|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
157110744|NCT00307151|567159340|FG000|Overall Study|Subject unable to get to clinic|1|||
157110745|NCT00307151|567159341|FG001|Overall Study|Subject unable to get to clinic|0|||
157110746|NCT00307151|567159342|FG002|Overall Study|Subject unable to get to clinic|6|||
157110747|NCT00307151|567159343|FG003|Overall Study|Subject unable to get to clinic|2|||
157110748|NCT00307151|567159340|FG000|Overall Study|Withdrew consent|0|||
157110749|NCT00307151|567159341|FG001|Overall Study|Withdrew consent|1|||
157110750|NCT00307151|567159342|FG002|Overall Study|Withdrew consent|1|||
157110751|NCT00307151|567159343|FG003|Overall Study|Withdrew consent|3|||
157110752|NCT00307151|567159340|FG000|Overall Study|Not willing to adhere to study reqs|2|||
157110753|NCT00307151|567159341|FG001|Overall Study|Not willing to adhere to study reqs|0|||
157110754|NCT00307151|567159342|FG002|Overall Study|Not willing to adhere to study reqs|2|||
157110755|NCT00307151|567159343|FG003|Overall Study|Not willing to adhere to study reqs|2|||
157110756|NCT00307151|567159340|FG000|Overall Study|Clinic unable to contact subject|3|||
157110757|NCT00307151|567159341|FG001|Overall Study|Clinic unable to contact subject|3|||
157110758|NCT00307151|567159342|FG002|Overall Study|Clinic unable to contact subject|1|||
157110759|NCT00307151|567159343|FG003|Overall Study|Clinic unable to contact subject|1|||
157110760|NCT02966509|567159344|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
157110761|NCT02966509|567159345|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
157110762|NCT02966509|567159344|FG000|Baseline Satisfaction Survey|Death|0|||
157110763|NCT02966509|567159345|FG001|Baseline Satisfaction Survey|Death|1|||
157110764|NCT02966509|567159344|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
157110765|NCT02966509|567159345|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
157110766|NCT02966509|567159344|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
157110767|NCT02966509|567159345|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
157110768|NCT02966509|567159344|FG000|6 Month Satisfaction Decision Survey|Death|22|||
157110769|NCT02966509|567159345|FG001|6 Month Satisfaction Decision Survey|Death|25|||
157110770|NCT02966509|567159344|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
157110771|NCT02966509|567159345|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
157110772|NCT02966509|567159344|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
157110773|NCT02966509|567159345|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
157110774|NCT02966509|567159344|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
157110775|NCT02966509|567159345|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
157110776|NCT02966509|567159344|FG000|6 Month Satisfaction Survey|Death|36|||
157110777|NCT02966509|567159345|FG001|6 Month Satisfaction Survey|Death|33|||
157110778|NCT02966509|567159344|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
157110779|NCT02966509|567159345|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
157110780|NCT02966509|567159344|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
157110781|NCT02966509|567159345|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
157110782|NCT02966509|567159344|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
157110783|NCT02966509|567159345|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
157110784|NCT02966509|567159344|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
157110785|NCT02966509|567159345|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
157110786|NCT02966509|567159344|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
157110787|NCT02966509|567159345|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
157110788|NCT01761292|567159346|FG000|Part 1|Adverse Event|1|||
157110789|NCT01761292|567159346|FG000|Part 1|not receiving treatment in Part 1|1|||
157110790|NCT01761292|567159346|FG000|Extension 1|Withdrawal by Subject|1|||
157110791|NCT03332498|567159348|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
157110792|NCT03332498|567159349|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
157110793|NCT03332498|567159350|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
157110794|NCT00916357|567159351|FG000|Period 1|Withdrawal by Subject|1|||
157110795|NCT00916357|567159352|FG001|Period 1|Withdrawal by Subject|0|||
157110796|NCT00916357|567159353|FG002|Period 1|Withdrawal by Subject|0|||
157110797|NCT00916357|567159354|FG003|Period 1|Withdrawal by Subject|0|||
157110798|NCT00916357|567159355|FG004|Period 1|Withdrawal by Subject|0|||
157005694|NCT04668339|566771570|FG002|Overall Study|Other than specified|1|||
157110799|NCT00916357|567159356|FG005|Period 1|Withdrawal by Subject|0|||
157110800|NCT00916357|567159351|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
157005695|NCT04668339|566771571|FG003|Overall Study|Other than specified|0|||
157005696|NCT04668339|566771568|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
157005697|NCT04668339|566771569|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
157005698|NCT04668339|566771570|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
157005699|NCT04668339|566771571|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
157005700|NCT04668339|566771568|FG000|Overall Study|Vaccine not Administered|0|||
157005701|NCT04668339|566771569|FG001|Overall Study|Vaccine not Administered|0|||
157005702|NCT04668339|566771570|FG002|Overall Study|Vaccine not Administered|1|||
157005703|NCT04668339|566771571|FG003|Overall Study|Vaccine not Administered|0|||
157005704|NCT04668339|566771568|FG000|Overall Study|Protocol Violation|18|||
157005705|NCT04668339|566771569|FG001|Overall Study|Protocol Violation|23|||
157005706|NCT04668339|566771570|FG002|Overall Study|Protocol Violation|12|||
157005707|NCT04668339|566771571|FG003|Overall Study|Protocol Violation|20|||
157110801|NCT00916357|567159352|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
157110802|NCT00916357|567159353|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
157110803|NCT00916357|567159354|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
157110804|NCT00916357|567159355|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
157110805|NCT00916357|567159356|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
157110806|NCT03807349|567159359|FG000|Overall Study|Early Study Termination|9|||
157110807|NCT05611671|567159361|FG000|Overall Study|Adverse Event|1|||
157110808|NCT05611671|567159362|FG001|Overall Study|Adverse Event|1|||
157110809|NCT05611671|567159363|FG002|Overall Study|Adverse Event|0|||
157110810|NCT05611671|567159364|FG003|Overall Study|Adverse Event|1|||
157110811|NCT05611671|567159361|FG000|Overall Study|Lack of Efficacy|1|||
157110812|NCT05611671|567159362|FG001|Overall Study|Lack of Efficacy|0|||
157110813|NCT05611671|567159363|FG002|Overall Study|Lack of Efficacy|1|||
157110814|NCT05611671|567159364|FG003|Overall Study|Lack of Efficacy|2|||
157110815|NCT05611671|567159361|FG000|Overall Study|Lost to Follow-up|0|||
156765167|NCT03810456|565894555|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
156765168|NCT03810456|565894556|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
156765169|NCT03810456|565894554|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
156765170|NCT03810456|565894555|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
156765171|NCT03810456|565894556|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
156765172|NCT03810456|565894554|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
156765173|NCT03810456|565894555|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
156765174|NCT03810456|565894556|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
156765175|NCT00490919|565894559|FG000|Open-label Run-in Period|Adverse Event|239|||
156765176|NCT00490919|565894560|FG001|Open-label Run-in Period|Adverse Event|0|||
156765177|NCT00490919|565894561|FG002|Open-label Run-in Period|Adverse Event|0|||
156765178|NCT00490919|565894559|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
156765179|NCT00490919|565894560|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
156765180|NCT00490919|565894561|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
156765181|NCT00490919|565894559|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
156765182|NCT00490919|565894560|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
156765183|NCT00490919|565894561|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
156765184|NCT00490919|565894559|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
156765185|NCT00490919|565894560|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
156765186|NCT00490919|565894561|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
156765187|NCT00490919|565894559|FG000|Open-label Run-in Period|Administrative|40|||
156765188|NCT00490919|565894560|FG001|Open-label Run-in Period|Administrative|0|||
156765189|NCT00490919|565894561|FG002|Open-label Run-in Period|Administrative|0|||
156765190|NCT00490919|565894559|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
156765191|NCT00490919|565894560|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
156765192|NCT00490919|565894561|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
156765193|NCT00490919|565894559|FG000|Double-blind Phase|Adverse Event|0|||
156765194|NCT00490919|565894560|FG001|Double-blind Phase|Adverse Event|40|||
156765195|NCT00490919|565894561|FG002|Double-blind Phase|Adverse Event|20|||
156765196|NCT00490919|565894559|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156765197|NCT00490919|565894560|FG001|Double-blind Phase|Withdrawal by Subject|10|||
156765198|NCT00490919|565894561|FG002|Double-blind Phase|Withdrawal by Subject|11|||
156765199|NCT00490919|565894559|FG000|Double-blind Phase|Lost to Follow-up|0|||
156765200|NCT00490919|565894560|FG001|Double-blind Phase|Lost to Follow-up|8|||
156765201|NCT00490919|565894561|FG002|Double-blind Phase|Lost to Follow-up|11|||
156765202|NCT00490919|565894559|FG000|Double-blind Phase|Lack of Efficacy|0|||
156765203|NCT00490919|565894560|FG001|Double-blind Phase|Lack of Efficacy|22|||
156765204|NCT00490919|565894561|FG002|Double-blind Phase|Lack of Efficacy|36|||
156765205|NCT00490919|565894559|FG000|Double-blind Phase|Administrative|0|||
156765206|NCT00490919|565894560|FG001|Double-blind Phase|Administrative|6|||
156765207|NCT00490919|565894561|FG002|Double-blind Phase|Administrative|6|||
156765208|NCT02100124|565894568|FG000|Overall Study|Lost to Follow-up|5|||
156765209|NCT02100124|565894569|FG001|Overall Study|Lost to Follow-up|11|||
156765210|NCT02100124|565894570|FG002|Overall Study|Lost to Follow-up|3|||
156765211|NCT02100124|565894568|FG000|Overall Study|Withdrawal by Subject|1|||
156765212|NCT02100124|565894569|FG001|Overall Study|Withdrawal by Subject|0|||
156765213|NCT02100124|565894570|FG002|Overall Study|Withdrawal by Subject|0|||
156765214|NCT04350827|565894571|FG000|Overall Study|Lost to Follow-up|1|||
156765215|NCT04350827|565894572|FG001|Overall Study|Lost to Follow-up|2|||
156765216|NCT04265261|565894573|FG000|Overall Study|Adverse Event|2|||
156765217|NCT04265261|565894574|FG001|Overall Study|Adverse Event|0|||
156765218|NCT04265261|565894575|FG002|Overall Study|Adverse Event|0|||
156765219|NCT04265261|565894573|FG000|Overall Study|Death|1|||
156765220|NCT04265261|565894574|FG001|Overall Study|Death|0|||
156765221|NCT04265261|565894575|FG002|Overall Study|Death|0|||
156765222|NCT04265261|565894573|FG000|Overall Study|Lost to Follow-up|4|||
156765223|NCT04265261|565894574|FG001|Overall Study|Lost to Follow-up|1|||
156765224|NCT04265261|565894575|FG002|Overall Study|Lost to Follow-up|3|||
156765225|NCT04265261|565894573|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156765226|NCT04265261|565894574|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156765227|NCT04265261|565894575|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156765228|NCT04265261|565894573|FG000|Overall Study|Physician Decision|0|||
156765229|NCT04265261|565894574|FG001|Overall Study|Physician Decision|0|||
156765230|NCT04265261|565894575|FG002|Overall Study|Physician Decision|1|||
156765231|NCT04265261|565894573|FG000|Overall Study|Protocol Deviation|0|||
156765232|NCT04265261|565894574|FG001|Overall Study|Protocol Deviation|2|||
156765233|NCT04265261|565894575|FG002|Overall Study|Protocol Deviation|0|||
156765234|NCT04265261|565894573|FG000|Overall Study|Withdrawal by Subject|2|||
156765235|NCT04265261|565894574|FG001|Overall Study|Withdrawal by Subject|1|||
156765236|NCT04265261|565894575|FG002|Overall Study|Withdrawal by Subject|4|||
156765237|NCT02337764|565896475|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
156765238|NCT02337764|565896475|FG000|Overall Study|Voluntary Withdrawal|12|||
156765239|NCT02337764|565896475|FG000|Overall Study|Lack of Efficacy|2|||
156765240|NCT02990000|565896476|FG000|Overall Study|Failed to provide data beyond baseline|36|||
156765241|NCT02990000|565896477|FG001|Overall Study|Failed to provide data beyond baseline|34|||
156765242|NCT00557466|565896481|FG000|Overall Study|Adverse Event|3|||
156765243|NCT00557466|565896482|FG001|Overall Study|Adverse Event|1|||
156765244|NCT00557466|565896483|FG002|Overall Study|Adverse Event|4|||
156765245|NCT00557466|565896484|FG003|Overall Study|Adverse Event|1|||
156765246|NCT00557466|565896485|FG004|Overall Study|Adverse Event|2|||
156765247|NCT00557466|565896486|FG005|Overall Study|Adverse Event|4|||
156765248|NCT00557466|565896481|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156765249|NCT00557466|565896482|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156765250|NCT00557466|565896483|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156765251|NCT00557466|565896484|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156765252|NCT00557466|565896485|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156765253|NCT00557466|565896486|FG005|Overall Study|Abnormal laboratory value(s)|0|||
156765254|NCT00557466|565896481|FG000|Overall Study|Protocol deviation|0|||
156765255|NCT00557466|565896482|FG001|Overall Study|Protocol deviation|1|||
156765256|NCT00557466|565896483|FG002|Overall Study|Protocol deviation|0|||
156765257|NCT00557466|565896484|FG003|Overall Study|Protocol deviation|2|||
156765258|NCT00557466|565896485|FG004|Overall Study|Protocol deviation|0|||
156765259|NCT00557466|565896486|FG005|Overall Study|Protocol deviation|0|||
156765260|NCT00557466|565896481|FG000|Overall Study|Subject withdrew consent|0|||
156765261|NCT00557466|565896482|FG001|Overall Study|Subject withdrew consent|0|||
156765262|NCT00557466|565896483|FG002|Overall Study|Subject withdrew consent|0|||
156765263|NCT00557466|565896484|FG003|Overall Study|Subject withdrew consent|0|||
156765264|NCT00557466|565896485|FG004|Overall Study|Subject withdrew consent|1|||
156765265|NCT00557466|565896486|FG005|Overall Study|Subject withdrew consent|2|||
156765266|NCT00557466|565896481|FG000|Overall Study|Administrative problems|0|||
156765267|NCT00557466|565896482|FG001|Overall Study|Administrative problems|1|||
156765268|NCT00557466|565896483|FG002|Overall Study|Administrative problems|1|||
156765269|NCT00557466|565896484|FG003|Overall Study|Administrative problems|0|||
156765270|NCT00557466|565896485|FG004|Overall Study|Administrative problems|0|||
156765271|NCT00557466|565896486|FG005|Overall Study|Administrative problems|0|||
156765272|NCT00557466|565896481|FG000|Overall Study|Abnormal test procedure results|0|||
156765273|NCT00557466|565896482|FG001|Overall Study|Abnormal test procedure results|0|||
156765274|NCT00557466|565896483|FG002|Overall Study|Abnormal test procedure results|1|||
156765275|NCT00557466|565896484|FG003|Overall Study|Abnormal test procedure results|0|||
156765276|NCT00557466|565896485|FG004|Overall Study|Abnormal test procedure results|0|||
156765277|NCT00557466|565896486|FG005|Overall Study|Abnormal test procedure results|0|||
156765278|NCT00557466|565896481|FG000|Overall Study|Lost to Follow-up|0|||
156765279|NCT00557466|565896482|FG001|Overall Study|Lost to Follow-up|0|||
156765280|NCT00557466|565896483|FG002|Overall Study|Lost to Follow-up|0|||
156765281|NCT00557466|565896484|FG003|Overall Study|Lost to Follow-up|1|||
156765282|NCT00557466|565896485|FG004|Overall Study|Lost to Follow-up|0|||
156765283|NCT00557466|565896486|FG005|Overall Study|Lost to Follow-up|0|||
156765284|NCT02810418|565896497|FG000|Arm A Dose Escalation|Adverse Event|2|||
156765285|NCT02810418|565896498|FG001|Arm A Dose Escalation|Adverse Event|1|||
156765286|NCT02810418|565896499|FG002|Arm A Dose Escalation|Adverse Event|0|||
156765287|NCT02810418|565896500|FG003|Arm A Dose Escalation|Adverse Event|0|||
156765288|NCT02810418|565896501|FG004|Arm A Dose Escalation|Adverse Event|0|||
156765289|NCT02810418|565896502|FG005|Arm A Dose Escalation|Adverse Event|0|||
156765290|NCT02810418|565896503|FG006|Arm A Dose Escalation|Adverse Event|0|||
156765291|NCT02810418|565896497|FG000|Dose Expansion|Adverse Event|0|||
156765292|NCT02810418|565896498|FG001|Dose Expansion|Adverse Event|1|||
156765293|NCT02810418|565896499|FG002|Dose Expansion|Adverse Event|1|||
156765294|NCT02810418|565896500|FG003|Dose Expansion|Adverse Event|0|||
156765295|NCT02810418|565896501|FG004|Dose Expansion|Adverse Event|0|||
156765296|NCT02810418|565896502|FG005|Dose Expansion|Adverse Event|0|||
156765297|NCT02810418|565896503|FG006|Dose Expansion|Adverse Event|0|||
156765298|NCT02810418|565896497|FG000|Dose Expansion|Physician Decision|0|||
156765299|NCT02810418|565896498|FG001|Dose Expansion|Physician Decision|0|||
156765300|NCT02810418|565896499|FG002|Dose Expansion|Physician Decision|2|||
156765301|NCT02810418|565896500|FG003|Dose Expansion|Physician Decision|0|||
156765302|NCT02810418|565896501|FG004|Dose Expansion|Physician Decision|0|||
156765303|NCT02810418|565896502|FG005|Dose Expansion|Physician Decision|0|||
156765304|NCT02810418|565896503|FG006|Dose Expansion|Physician Decision|0|||
156765305|NCT02810418|565896497|FG000|Arm B Dose Escalation|Adverse Event|0|||
156765306|NCT02810418|565896498|FG001|Arm B Dose Escalation|Adverse Event|0|||
156765307|NCT02810418|565896499|FG002|Arm B Dose Escalation|Adverse Event|0|||
156765308|NCT02810418|565896500|FG003|Arm B Dose Escalation|Adverse Event|0|||
156765309|NCT02810418|565896501|FG004|Arm B Dose Escalation|Adverse Event|1|||
156765310|NCT02810418|565896502|FG005|Arm B Dose Escalation|Adverse Event|2|||
156765311|NCT02810418|565896503|FG006|Arm B Dose Escalation|Adverse Event|0|||
156765312|NCT04161391|565896504|FG000|Overall Study|Adverse Event|0|||
156765313|NCT04161391|565896505|FG001|Overall Study|Adverse Event|1|||
156765314|NCT04161391|565896506|FG002|Overall Study|Adverse Event|0|||
156765315|NCT04161391|565896507|FG003|Overall Study|Adverse Event|1|||
156765316|NCT04161391|565896508|FG004|Overall Study|Adverse Event|0|||
156765317|NCT04161391|565896509|FG005|Overall Study|Adverse Event|0|||
156765318|NCT04161391|565896510|FG006|Overall Study|Adverse Event|0|||
156765319|NCT04161391|565896511|FG007|Overall Study|Adverse Event|3|||
156765320|NCT04161391|565896512|FG008|Overall Study|Adverse Event|0|||
156765321|NCT04161391|565896504|FG000|Overall Study|Death|0|||
156765322|NCT04161391|565896505|FG001|Overall Study|Death|0|||
156765323|NCT04161391|565896506|FG002|Overall Study|Death|0|||
156765324|NCT04161391|565896507|FG003|Overall Study|Death|0|||
156765325|NCT04161391|565896508|FG004|Overall Study|Death|0|||
156765326|NCT04161391|565896509|FG005|Overall Study|Death|0|||
156765327|NCT04161391|565896510|FG006|Overall Study|Death|0|||
156765328|NCT04161391|565896511|FG007|Overall Study|Death|1|||
156765329|NCT04161391|565896512|FG008|Overall Study|Death|0|||
156765330|NCT04161391|565896504|FG000|Overall Study|Physician Decision|0|||
156765331|NCT04161391|565896505|FG001|Overall Study|Physician Decision|0|||
156765332|NCT04161391|565896506|FG002|Overall Study|Physician Decision|1|||
156765333|NCT04161391|565896507|FG003|Overall Study|Physician Decision|2|||
156765334|NCT04161391|565896508|FG004|Overall Study|Physician Decision|0|||
156765335|NCT04161391|565896509|FG005|Overall Study|Physician Decision|0|||
156765336|NCT04161391|565896510|FG006|Overall Study|Physician Decision|2|||
156765337|NCT04161391|565896511|FG007|Overall Study|Physician Decision|0|||
156765338|NCT04161391|565896512|FG008|Overall Study|Physician Decision|0|||
156765339|NCT04161391|565896504|FG000|Overall Study|Progressive Disease|4|||
156765340|NCT04161391|565896505|FG001|Overall Study|Progressive Disease|3|||
156765341|NCT04161391|565896506|FG002|Overall Study|Progressive Disease|3|||
156765342|NCT04161391|565896507|FG003|Overall Study|Progressive Disease|5|||
156765343|NCT04161391|565896508|FG004|Overall Study|Progressive Disease|3|||
156765344|NCT04161391|565896509|FG005|Overall Study|Progressive Disease|3|||
156765345|NCT04161391|565896510|FG006|Overall Study|Progressive Disease|5|||
156765346|NCT04161391|565896511|FG007|Overall Study|Progressive Disease|2|||
156765347|NCT04161391|565896512|FG008|Overall Study|Progressive Disease|2|||
156765348|NCT02579629|565896516|FG000|Overall Study|Withdrawal by Subject|0|||
156765349|NCT02579629|565896517|FG001|Overall Study|Withdrawal by Subject|1|||
156765350|NCT02579629|565896518|FG002|Overall Study|Withdrawal by Subject|0|||
156765351|NCT02579629|565896516|FG000|Overall Study|Screen Failure|2|||
156765352|NCT02579629|565896517|FG001|Overall Study|Screen Failure|0|||
156765353|NCT02579629|565896518|FG002|Overall Study|Screen Failure|2|||
156765354|NCT02666222|565896525|FG000|Overall Study|Death|2|||
156765355|NCT01474486|565896526|FG000|Overall Study|Death|2|||
156765356|NCT01474486|565896526|FG000|Overall Study|Withdrawal by Subject|4|||
156765357|NCT01474486|565896526|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
156765358|NCT01255163|565896527|FG000|Overall Study|Withdrawal by Subject|1|||
156765359|NCT01255163|565896528|FG001|Overall Study|Withdrawal by Subject|0|||
156765360|NCT01255163|565896527|FG000|Overall Study|Lost to Follow-up|2|||
156765361|NCT01255163|565896528|FG001|Overall Study|Lost to Follow-up|0|||
156765362|NCT01255163|565896527|FG000|Overall Study|Adverse Event|0|||
156765363|NCT01255163|565896528|FG001|Overall Study|Adverse Event|2|||
156765364|NCT01255163|565896527|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
156765365|NCT01255163|565896528|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
156765366|NCT03504917|565896532|FG000|Blinded Treatment Period|Protocol Violation|1|||
156765367|NCT03504917|565896533|FG001|Blinded Treatment Period|Protocol Violation|0|||
156765368|NCT03504917|565896532|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
156765369|NCT03504917|565896533|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
156765370|NCT03504917|565896532|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
156765371|NCT03504917|565896533|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
156765372|NCT03504917|565896532|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
156765373|NCT03504917|565896533|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
156765374|NCT03504917|565896532|FG000|Blinded Treatment Period|Adverse Event|4|||
156765375|NCT03504917|565896533|FG001|Blinded Treatment Period|Adverse Event|4|||
156765376|NCT03504917|565896532|FG000|Blinded Treatment Period|Physician Decision|1|||
156765377|NCT03504917|565896533|FG001|Blinded Treatment Period|Physician Decision|0|||
156765378|NCT03504917|565896532|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
156765379|NCT03504917|565896533|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
156765380|NCT03504917|565896532|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
156765381|NCT03504917|565896533|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
156765382|NCT03504917|565896532|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
156765383|NCT03504917|565896533|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
156765384|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
156765385|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
156765386|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
156765387|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
156765388|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
156765389|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
156765390|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
156765391|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
156765392|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
157110816|NCT05611671|567159362|FG001|Overall Study|Lost to Follow-up|0|||
156765393|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
156765394|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
156765395|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
156765396|NCT03504917|565896532|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
156765397|NCT03504917|565896533|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
156765398|NCT04219189|565896534|FG000|Overall Study|Withdrawal by Subject|1|||
156765399|NCT04219189|565896535|FG001|Overall Study|Withdrawal by Subject|2|||
156765400|NCT04219189|565896534|FG000|Overall Study|Protocol Violation|0|||
156765401|NCT04219189|565896535|FG001|Overall Study|Protocol Violation|1|||
156765402|NCT04219189|565896534|FG000|Overall Study|Lost to Follow-up|0|||
156765403|NCT04219189|565896535|FG001|Overall Study|Lost to Follow-up|1|||
156765404|NCT04219189|565896534|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
156765405|NCT04219189|565896535|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
156765406|NCT03863353|565896536|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
156765407|NCT03863353|565896537|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
157110817|NCT05611671|567159363|FG002|Overall Study|Lost to Follow-up|0|||
157110818|NCT05611671|567159364|FG003|Overall Study|Lost to Follow-up|1|||
157110819|NCT05611671|567159361|FG000|Overall Study|Protocol Violation|0|||
157110820|NCT05611671|567159362|FG001|Overall Study|Protocol Violation|1|||
157110821|NCT05611671|567159363|FG002|Overall Study|Protocol Violation|0|||
157110822|NCT05611671|567159364|FG003|Overall Study|Protocol Violation|0|||
157110823|NCT05611671|567159361|FG000|Overall Study|Withdrawal by Subject|2|||
157110824|NCT05611671|567159362|FG001|Overall Study|Withdrawal by Subject|1|||
157110825|NCT05611671|567159363|FG002|Overall Study|Withdrawal by Subject|2|||
157110826|NCT05611671|567159364|FG003|Overall Study|Withdrawal by Subject|1|||
157110827|NCT01368536|567159365|FG000|Overall Study|Adverse Event|5|||
157110828|NCT01368536|567159366|FG001|Overall Study|Adverse Event|6|||
157110829|NCT01368536|567159367|FG002|Overall Study|Adverse Event|8|||
157110830|NCT01368536|567159365|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157110831|NCT01368536|567159366|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157110832|NCT01368536|567159367|FG002|Overall Study|Abnormal laboratory value(s)|2|||
157110833|NCT01368536|567159365|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157110834|NCT01368536|567159366|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157110835|NCT01368536|567159367|FG002|Overall Study|Abnormal test procedure result(s)|1|||
157110836|NCT01368536|567159365|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
157110837|NCT01368536|567159366|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157110838|NCT01368536|567159367|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
157110839|NCT01368536|567159365|FG000|Overall Study|No longer required study medication|0|||
157110840|NCT01368536|567159366|FG001|Overall Study|No longer required study medication|0|||
157110841|NCT01368536|567159367|FG002|Overall Study|No longer required study medication|1|||
157110842|NCT01368536|567159365|FG000|Overall Study|Withdrawal by Subject|2|||
157110843|NCT01368536|567159366|FG001|Overall Study|Withdrawal by Subject|5|||
157110844|NCT01368536|567159367|FG002|Overall Study|Withdrawal by Subject|4|||
157110845|NCT01368536|567159365|FG000|Overall Study|Lost to Follow-up|3|||
157110846|NCT01368536|567159366|FG001|Overall Study|Lost to Follow-up|3|||
157110847|NCT01368536|567159367|FG002|Overall Study|Lost to Follow-up|5|||
157110848|NCT01368536|567159365|FG000|Overall Study|Administrative problems|34|||
157110849|NCT01368536|567159366|FG001|Overall Study|Administrative problems|39|||
157110850|NCT01368536|567159367|FG002|Overall Study|Administrative problems|35|||
157110851|NCT01368536|567159365|FG000|Overall Study|Protocol deviation|0|||
157110852|NCT01368536|567159366|FG001|Overall Study|Protocol deviation|3|||
157110853|NCT01368536|567159367|FG002|Overall Study|Protocol deviation|1|||
157110854|NCT01486927|567159370|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
157110855|NCT01486927|567159370|FG000|Overall Study|Physician Decision|1|||
157110856|NCT01486927|567159370|FG000|Overall Study|50 Exposure days not reached|2|||
157110857|NCT01486927|567159370|FG000|Overall Study|Withdrawal by Subject|8|||
157110858|NCT01486927|567159370|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
157110859|NCT02159729|567159371|FG000|Overall Study|Adverse Event|0|||
157110860|NCT02159729|567159372|FG001|Overall Study|Adverse Event|1|||
157110861|NCT02159729|567159371|FG000|Overall Study|Subject's Request|13|||
157110862|NCT02159729|567159372|FG001|Overall Study|Subject's Request|10|||
157110863|NCT02159729|567159371|FG000|Overall Study|Lost to Follow-up|24|||
157110864|NCT02159729|567159372|FG001|Overall Study|Lost to Follow-up|9|||
157110865|NCT02159729|567159371|FG000|Overall Study|Non compliance|2|||
157110866|NCT02159729|567159372|FG001|Overall Study|Non compliance|0|||
157110867|NCT02159729|567159371|FG000|Overall Study|Other Unspecified|3|||
157110868|NCT02159729|567159372|FG001|Overall Study|Other Unspecified|1|||
157110869|NCT02636582|567159373|FG000|Overall Study|Surgical Pathology|1|||
157110870|NCT02636582|567159374|FG001|Overall Study|Surgical Pathology|0|||
157110871|NCT00573430|567159375|FG000|Overall Study|Incorrect enrollment of randomization|0|||
157110872|NCT00573430|567159376|FG001|Overall Study|Incorrect enrollment of randomization|4|||
157110873|NCT00573430|567159377|FG002|Overall Study|Incorrect enrollment of randomization|3|||
157110874|NCT00573430|567159375|FG000|Overall Study|Adverse Event|0|||
156765408|NCT02495389|565896538|FG000|Overall Study|Withdrawal by Subject|40|||
156765409|NCT04079790|565896542|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
156765410|NCT04079790|565896543|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765411|NCT04079790|565896544|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765412|NCT04079790|565896545|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
156765413|NCT04079790|565896542|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765414|NCT04079790|565896543|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765415|NCT04079790|565896544|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
156765416|NCT04079790|565896545|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
156765417|NCT04079790|565896542|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765418|NCT04079790|565896543|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765419|NCT04079790|565896544|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
156765420|NCT04079790|565896545|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
156765421|NCT01924533|565896547|FG000|Overall Study|Death|181|||
156765422|NCT01924533|565896548|FG001|Overall Study|Death|200|||
156765423|NCT01924533|565896547|FG000|Overall Study|Lost to Follow-up|0|||
156765424|NCT01924533|565896548|FG001|Overall Study|Lost to Follow-up|1|||
156765425|NCT01924533|565896547|FG000|Overall Study|Withdrawal by Subject|7|||
156765426|NCT01924533|565896548|FG001|Overall Study|Withdrawal by Subject|3|||
156765427|NCT01924533|565896547|FG000|Overall Study|Other Eligibility criteria|1|||
156765428|NCT01924533|565896548|FG001|Overall Study|Other Eligibility criteria|1|||
156765429|NCT05817669|565896549|FG000|Overall Study|Prohibited medication used|1|||
156765430|NCT05817669|565896550|FG001|Overall Study|Prohibited medication used|2|||
156765431|NCT05817669|565896549|FG000|Overall Study|Adverse Event|1|||
156765432|NCT05817669|565896550|FG001|Overall Study|Adverse Event|0|||
156765433|NCT05817669|565896549|FG000|Overall Study|Withdrawal by Subject|1|||
156765434|NCT05817669|565896550|FG001|Overall Study|Withdrawal by Subject|2|||
156765435|NCT04233879|565896551|FG000|Overall Study|Death|2|||
156765436|NCT04233879|565896552|FG001|Overall Study|Death|0|||
156765437|NCT04233879|565896551|FG000|Overall Study|Lost to Follow-up|3|||
156765438|NCT04233879|565896552|FG001|Overall Study|Lost to Follow-up|8|||
156765439|NCT04233879|565896551|FG000|Overall Study|Physician Decision|4|||
156765440|NCT04233879|565896552|FG001|Overall Study|Physician Decision|4|||
156765441|NCT04233879|565896551|FG000|Overall Study|Withdrawal by Subject|7|||
156765442|NCT04233879|565896552|FG001|Overall Study|Withdrawal by Subject|10|||
156765443|NCT04233879|565896551|FG000|Overall Study|Other|281|||
156765444|NCT04233879|565896552|FG001|Overall Study|Other|279|||
156765445|NCT03292016|565896555|FG000|Second Washout|Adverse Event|0|||
156765446|NCT03292016|565896556|FG001|Second Washout|Adverse Event|1|||
156765447|NCT03292016|565896557|FG002|Second Washout|Adverse Event|0|||
156765448|NCT03292016|565896558|FG003|Second Washout|Adverse Event|0|||
156765449|NCT03292016|565896559|FG004|Second Washout|Adverse Event|0|||
156765450|NCT03292016|565896560|FG005|Second Washout|Adverse Event|0|||
156765451|NCT01802385|565896562|FG000|Overall Study|Death|106|||
156765452|NCT01802385|565896563|FG001|Overall Study|Death|120|||
156765453|NCT03810183|565896564|FG000|Overall Study|Study terminated by Sponsor|2|||
156765454|NCT03810183|565896565|FG001|Overall Study|Study terminated by Sponsor|1|||
156765455|NCT00323063|565896567|FG000|Overall Study|Adverse Event|1|||
156765456|NCT00323063|565896568|FG001|Overall Study|Adverse Event|0|||
156765457|NCT00323063|565896567|FG000|Overall Study|brain mets discovered prior to treatment|1|||
156765458|NCT00323063|565896568|FG001|Overall Study|brain mets discovered prior to treatment|0|||
156765459|NCT04275336|565896571|FG000|Overall Study|First venipuncture failed|4|||
156765460|NCT04275336|565896572|FG001|Overall Study|First venipuncture failed|6|||
156765461|NCT04275336|565896573|FG002|Overall Study|First venipuncture failed|5|||
156765462|NCT04275336|565896571|FG000|Overall Study|Unscheduled venipuncture|9|||
156765463|NCT04275336|565896572|FG001|Overall Study|Unscheduled venipuncture|13|||
157110875|NCT00573430|567159376|FG001|Overall Study|Adverse Event|0|||
156765464|NCT04275336|565896573|FG002|Overall Study|Unscheduled venipuncture|7|||
156765465|NCT04275336|565896571|FG000|Overall Study|Failed specimen of saliva|4|||
156765466|NCT04275336|565896572|FG001|Overall Study|Failed specimen of saliva|3|||
156765467|NCT04275336|565896573|FG002|Overall Study|Failed specimen of saliva|4|||
156765468|NCT03055936|565896574|FG000|Overall Study|Adverse Event|0|||
156765469|NCT03055936|565896575|FG001|Overall Study|Adverse Event|1|||
156765470|NCT03055936|565896576|FG002|Overall Study|Adverse Event|1|||
156765471|NCT03055936|565896577|FG003|Overall Study|Adverse Event|1|||
156765472|NCT03055936|565896574|FG000|Overall Study|Personal reason|2|||
157110876|NCT00573430|567159377|FG002|Overall Study|Adverse Event|2|||
157110877|NCT00573430|567159375|FG000|Overall Study|Withdrawal by Subject|1|||
157110878|NCT00573430|567159376|FG001|Overall Study|Withdrawal by Subject|0|||
157110879|NCT00573430|567159377|FG002|Overall Study|Withdrawal by Subject|1|||
156765473|NCT03055936|565896575|FG001|Overall Study|Personal reason|0|||
156765474|NCT03055936|565896576|FG002|Overall Study|Personal reason|1|||
156765475|NCT03055936|565896577|FG003|Overall Study|Personal reason|0|||
156765476|NCT05222880|565896583|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156765477|NCT05222880|565896583|FG000|Overall Study|Withdrew Consent during Study|1|||
157110880|NCT00573430|567159375|FG000|Overall Study|Protocol Violation|0|||
156765478|NCT05222880|565896583|FG000|Overall Study|COVID-19 Related|1|||
156765479|NCT01077323|565896586|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
156765480|NCT01077323|565896587|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
156765481|NCT01077323|565896588|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
156765482|NCT01077323|565896586|FG000|Overall Study|Dispensing of drug in baseline period|0|||
156765483|NCT01077323|565896587|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
156765484|NCT01077323|565896588|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
156765485|NCT01077323|565896586|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
156765486|NCT01077323|565896587|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
156765487|NCT01077323|565896588|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
156765488|NCT02153918|565896589|FG000|Overall Study|Refused further treatment|1|||
156765489|NCT02144701|565896590|FG000|Overall Study|development of relapse, GVHD or death|9|||
156765490|NCT02144701|565896591|FG001|Overall Study|development of relapse, GVHD or death|3|||
156765491|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765492|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765493|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765494|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765495|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765496|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
156765497|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Refused|0|||
156765498|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Refused|0|||
156765499|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Refused|0|||
156765500|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Refused|0|||
156765501|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Refused|1|||
156765502|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Refused|0|||
156765503|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765504|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
156765505|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765506|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765507|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765508|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
156765509|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|Death|0|||
156765510|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|Death|0|||
156765511|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|Death|0|||
156765512|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|Death|0|||
156765513|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|Death|1|||
156765514|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|Death|0|||
156765515|NCT03327324|565896592|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765516|NCT03327324|565896593|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765517|NCT03327324|565896594|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765518|NCT03327324|565896595|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765519|NCT03327324|565896596|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765520|NCT03327324|565896597|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
156765521|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765522|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765523|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
156765524|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765525|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765526|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765527|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
156765528|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765529|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765530|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
156765531|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
156765532|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
156765533|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
156765534|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765535|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765536|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
157005708|NCT04668339|566771568|FG000|Overall Study|Withdrawal by Subject|45|||
157005709|NCT04668339|566771569|FG001|Overall Study|Withdrawal by Subject|46|||
157005710|NCT04668339|566771570|FG002|Overall Study|Withdrawal by Subject|46|||
157005711|NCT04668339|566771571|FG003|Overall Study|Withdrawal by Subject|27|||
157005712|NCT04668339|566771568|FG000|Overall Study|Study Terminated by Sponsor|59|||
157005713|NCT04668339|566771569|FG001|Overall Study|Study Terminated by Sponsor|59|||
157005714|NCT04668339|566771570|FG002|Overall Study|Study Terminated by Sponsor|71|||
157005715|NCT04668339|566771571|FG003|Overall Study|Study Terminated by Sponsor|1|||
157005716|NCT03253848|566771575|FG000|Overall Study|Adverse Event|7|||
157005717|NCT03253848|566771575|FG000|Overall Study|Death|5|||
157005718|NCT03253848|566771575|FG000|Overall Study|initiation of other treatments|3|||
157005719|NCT03253848|566771575|FG000|Overall Study|Other complicating disease|1|||
157005720|NCT03253848|566771575|FG000|Overall Study|Withdrawal by Subject|1|||
157005721|NCT03253848|566771575|FG000|Overall Study|Declining health|1|||
157005722|NCT05758415|566771576|FG000|Overall Study|Subject Decision|2|||
157005723|NCT05758415|566771577|FG001|Overall Study|Subject Decision|5|||
157005724|NCT05758415|566771576|FG000|Overall Study|Lost to Follow-up|0|||
157005725|NCT05758415|566771577|FG001|Overall Study|Lost to Follow-up|1|||
157005726|NCT03622593|566771578|FG000|Overall Study|Withdrawal by Subject|11|||
157005727|NCT03622593|566771579|FG001|Overall Study|Withdrawal by Subject|9|||
157005728|NCT03622593|566771580|FG002|Overall Study|Withdrawal by Subject|13|||
157005729|NCT03622593|566771578|FG000|Overall Study|Death|12|||
157005730|NCT03622593|566771579|FG001|Overall Study|Death|9|||
157005731|NCT03622593|566771580|FG002|Overall Study|Death|10|||
157005732|NCT03622593|566771578|FG000|Overall Study|Lost to Follow-up|11|||
157005733|NCT03622593|566771579|FG001|Overall Study|Lost to Follow-up|5|||
157005734|NCT03622593|566771580|FG002|Overall Study|Lost to Follow-up|8|||
157005735|NCT03622593|566771578|FG000|Overall Study|Adverse Event|4|||
157005736|NCT03622593|566771579|FG001|Overall Study|Adverse Event|5|||
157005737|NCT03622593|566771580|FG002|Overall Study|Adverse Event|6|||
157005738|NCT03622593|566771578|FG000|Overall Study|Physician Decision|2|||
157005739|NCT03622593|566771579|FG001|Overall Study|Physician Decision|1|||
157005740|NCT03622593|566771580|FG002|Overall Study|Physician Decision|6|||
157005741|NCT03622593|566771578|FG000|Overall Study|Other|2|||
157005742|NCT03622593|566771579|FG001|Overall Study|Other|2|||
157005743|NCT03622593|566771580|FG002|Overall Study|Other|3|||
157005744|NCT03622593|566771578|FG000|Overall Study|Protocol Violation|0|||
157005745|NCT03622593|566771579|FG001|Overall Study|Protocol Violation|0|||
157005746|NCT03622593|566771580|FG002|Overall Study|Protocol Violation|1|||
157005747|NCT03622593|566771578|FG000|Overall Study|Pregnancy|0|||
157005748|NCT03622593|566771579|FG001|Overall Study|Pregnancy|0|||
157005749|NCT03622593|566771580|FG002|Overall Study|Pregnancy|1|||
157005750|NCT01393119|566771583|FG000|Overall Study|Adverse Event|1|||
157005751|NCT01393119|566771584|FG001|Overall Study|Adverse Event|1|||
157005752|NCT01393119|566771585|FG002|Overall Study|Adverse Event|0|||
157005753|NCT01393119|566771586|FG003|Overall Study|Adverse Event|1|||
157005754|NCT01393119|566771583|FG000|Overall Study|Withdrawal by Subject|0|||
157005755|NCT01393119|566771584|FG001|Overall Study|Withdrawal by Subject|1|||
157005756|NCT01393119|566771585|FG002|Overall Study|Withdrawal by Subject|1|||
157005757|NCT01393119|566771586|FG003|Overall Study|Withdrawal by Subject|0|||
157005758|NCT01393119|566771583|FG000|Overall Study|Lack of Efficacy|1|||
157005759|NCT01393119|566771584|FG001|Overall Study|Lack of Efficacy|0|||
157005760|NCT01393119|566771585|FG002|Overall Study|Lack of Efficacy|2|||
157005761|NCT01393119|566771586|FG003|Overall Study|Lack of Efficacy|1|||
157005762|NCT01393119|566771583|FG000|Overall Study|Protocol Violation|0|||
157005763|NCT01393119|566771584|FG001|Overall Study|Protocol Violation|0|||
157005764|NCT01393119|566771585|FG002|Overall Study|Protocol Violation|1|||
157005765|NCT01393119|566771586|FG003|Overall Study|Protocol Violation|0|||
157005766|NCT01393119|566771583|FG000|Overall Study|Death|0|||
157110881|NCT00573430|567159376|FG001|Overall Study|Protocol Violation|1|||
157110882|NCT00573430|567159377|FG002|Overall Study|Protocol Violation|1|||
157005767|NCT01393119|566771584|FG001|Overall Study|Death|0|||
157005768|NCT01393119|566771585|FG002|Overall Study|Death|0|||
157005769|NCT01393119|566771586|FG003|Overall Study|Death|1|||
157005770|NCT01393119|566771583|FG000|Overall Study|Randomized but Not treated|1|||
157005771|NCT01393119|566771584|FG001|Overall Study|Randomized but Not treated|0|||
157005772|NCT01393119|566771585|FG002|Overall Study|Randomized but Not treated|1|||
157005773|NCT01393119|566771586|FG003|Overall Study|Randomized but Not treated|1|||
157005774|NCT01393119|566771583|FG000|Overall Study|Sponsor Termination of Study|11|||
157005775|NCT01393119|566771584|FG001|Overall Study|Sponsor Termination of Study|12|||
157005776|NCT01393119|566771585|FG002|Overall Study|Sponsor Termination of Study|9|||
157005777|NCT01393119|566771586|FG003|Overall Study|Sponsor Termination of Study|12|||
157005778|NCT01400776|566771587|FG000|Overall Study|Adverse Event|7|||
157005779|NCT01400776|566771588|FG001|Overall Study|Adverse Event|2|||
157005780|NCT01400776|566771589|FG002|Overall Study|Adverse Event|9|||
157005781|NCT01400776|566771590|FG003|Overall Study|Adverse Event|2|||
157005782|NCT01400776|566771587|FG000|Overall Study|Lost to Follow-up|1|||
157005783|NCT01400776|566771588|FG001|Overall Study|Lost to Follow-up|0|||
157005784|NCT01400776|566771589|FG002|Overall Study|Lost to Follow-up|4|||
157005785|NCT01400776|566771590|FG003|Overall Study|Lost to Follow-up|1|||
157110883|NCT00573430|567159375|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157110884|NCT00573430|567159376|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
157110885|NCT00573430|567159377|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
157110886|NCT02953340|567159378|FG000|Overall Study|Death|0|||
157110887|NCT02953340|567159379|FG001|Overall Study|Death|1|||
157110888|NCT02953340|567159378|FG000|Overall Study|Investigator Decision|3|||
157110889|NCT02953340|567159379|FG001|Overall Study|Investigator Decision|3|||
157110890|NCT02953340|567159378|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
157110891|NCT02953340|567159379|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
157110892|NCT02953340|567159378|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
157110893|NCT02953340|567159379|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
157110894|NCT02953340|567159378|FG000|Overall Study|Withdrawal by Subject|9|||
157110895|NCT02953340|567159379|FG001|Overall Study|Withdrawal by Subject|9|||
157110896|NCT02953340|567159378|FG000|Overall Study|Sponsor decision|0|||
157110897|NCT02953340|567159379|FG001|Overall Study|Sponsor decision|2|||
157110898|NCT02953340|567159378|FG000|Overall Study|Lost to Follow-up|3|||
157110899|NCT02953340|567159379|FG001|Overall Study|Lost to Follow-up|2|||
157110900|NCT02953340|567159378|FG000|Overall Study|Reason not specified|2|||
157110901|NCT02953340|567159379|FG001|Overall Study|Reason not specified|2|||
157110902|NCT04707157|567159380|FG000|Overall Study|Adverse Event|12|||
157110903|NCT04707157|567159381|FG001|Overall Study|Adverse Event|3|||
157110904|NCT04707157|567159380|FG000|Overall Study|Lost to Follow-up|2|||
157110905|NCT04707157|567159381|FG001|Overall Study|Lost to Follow-up|0|||
157110906|NCT04707157|567159380|FG000|Overall Study|Sponsor's decision|1|||
157110907|NCT04707157|567159381|FG001|Overall Study|Sponsor's decision|0|||
157110908|NCT04707157|567159380|FG000|Overall Study|Physician Decision|8|||
157110909|NCT04707157|567159381|FG001|Overall Study|Physician Decision|5|||
157110910|NCT04707157|567159380|FG000|Overall Study|Protocol Deviation|1|||
157110911|NCT04707157|567159381|FG001|Overall Study|Protocol Deviation|0|||
157110912|NCT04707157|567159380|FG000|Overall Study|Withdrawal by Subject|1|||
157110913|NCT04707157|567159381|FG001|Overall Study|Withdrawal by Subject|1|||
157110914|NCT02969915|567159382|FG000|Overall Study|Death|104|||
157110915|NCT02969915|567159383|FG001|Overall Study|Death|125|||
157110916|NCT02969915|567159382|FG000|Overall Study|Lost to Follow-up|108|||
157110917|NCT02969915|567159383|FG001|Overall Study|Lost to Follow-up|112|||
157110918|NCT02969915|567159382|FG000|Overall Study|Censored due to COVID-19|481|||
157110919|NCT02969915|567159383|FG001|Overall Study|Censored due to COVID-19|471|||
157110920|NCT01378858|567159386|FG000|Overall Study|Withdrawal by Subject|4|||
157110921|NCT01378858|567159387|FG001|Overall Study|Withdrawal by Subject|4|||
157110922|NCT03073980|567159388|FG000|Overall Study|Lost to Follow-up|10|||
157110923|NCT03073980|567159389|FG001|Overall Study|Lost to Follow-up|2|||
157110924|NCT03073980|567159390|FG002|Overall Study|Lost to Follow-up|9|||
157110925|NCT03073980|567159388|FG000|Overall Study|No post-procedure data|0|||
157110926|NCT03073980|567159389|FG001|Overall Study|No post-procedure data|0|||
157110927|NCT03073980|567159390|FG002|Overall Study|No post-procedure data|2|||
157110928|NCT04810689|567159391|FG000|Overall Study|Withdrawal by Subject|0|||
157110929|NCT04810689|567159392|FG001|Overall Study|Withdrawal by Subject|1|||
157110930|NCT00450723|567159396|FG000|Overall Study|Physician Decision|5|||
157110931|NCT00789880|567159399|FG000|Overall Study|Adverse Event|0|||
157110932|NCT00789880|567159400|FG001|Overall Study|Adverse Event|0|||
157110933|NCT00789880|567159401|FG002|Overall Study|Adverse Event|0|||
157110934|NCT00789880|567159402|FG003|Overall Study|Adverse Event|0|||
157110935|NCT00789880|567159403|FG004|Overall Study|Adverse Event|1|||
157110936|NCT00789880|567159404|FG005|Overall Study|Adverse Event|0|||
157110937|NCT00789880|567159399|FG000|Overall Study|Protocol Violation|0|||
157110938|NCT00789880|567159400|FG001|Overall Study|Protocol Violation|1|||
157110939|NCT00789880|567159401|FG002|Overall Study|Protocol Violation|0|||
157110940|NCT00789880|567159402|FG003|Overall Study|Protocol Violation|1|||
157110941|NCT00789880|567159403|FG004|Overall Study|Protocol Violation|0|||
157110942|NCT00789880|567159404|FG005|Overall Study|Protocol Violation|0|||
157110943|NCT00789880|567159399|FG000|Overall Study|Withdrawal by Subject|1|||
157110944|NCT00789880|567159400|FG001|Overall Study|Withdrawal by Subject|0|||
157110945|NCT00789880|567159401|FG002|Overall Study|Withdrawal by Subject|0|||
157110946|NCT00789880|567159402|FG003|Overall Study|Withdrawal by Subject|0|||
157110947|NCT00789880|567159403|FG004|Overall Study|Withdrawal by Subject|2|||
157110948|NCT00789880|567159404|FG005|Overall Study|Withdrawal by Subject|0|||
157110949|NCT06347731|567159405|FG000|Overall Study|Death|1|||
157110950|NCT06347731|567159405|FG000|Overall Study|Protocol Violation|1|||
157110951|NCT06347731|567159405|FG000|Overall Study|Withdrawal by Subject|2|||
157110952|NCT00609986|567159406|FG000|Overall Study|Did not receive transplant or treatment|8|||
156765537|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765538|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
156765539|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|Death|1|||
156765540|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|Death|0|||
156765541|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|Death|1|||
156765542|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|Death|1|||
156765543|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|Death|1|||
156765544|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|Death|0|||
156765545|NCT03327324|565896592|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765546|NCT03327324|565896593|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765547|NCT03327324|565896594|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765548|NCT03327324|565896595|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765549|NCT03327324|565896596|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765550|NCT03327324|565896597|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
156765551|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
157005786|NCT01400776|566771587|FG000|Overall Study|Withdrew Consent|4|||
157005787|NCT01400776|566771588|FG001|Overall Study|Withdrew Consent|2|||
157005788|NCT01400776|566771589|FG002|Overall Study|Withdrew Consent|6|||
157005789|NCT01400776|566771590|FG003|Overall Study|Withdrew Consent|1|||
157005790|NCT01400776|566771587|FG000|Overall Study|Protocol Deviation|6|||
157005791|NCT01400776|566771588|FG001|Overall Study|Protocol Deviation|1|||
157005792|NCT01400776|566771589|FG002|Overall Study|Protocol Deviation|5|||
157005793|NCT01400776|566771590|FG003|Overall Study|Protocol Deviation|2|||
157005794|NCT01400776|566771587|FG000|Overall Study|Reason not Specified|3|||
157005795|NCT01400776|566771588|FG001|Overall Study|Reason not Specified|0|||
157005796|NCT01400776|566771589|FG002|Overall Study|Reason not Specified|4|||
157005797|NCT01400776|566771590|FG003|Overall Study|Reason not Specified|3|||
157005798|NCT00423098|566771591|FG000|Overall Study|Adverse Event|1|||
157005799|NCT00423098|566771592|FG001|Overall Study|Adverse Event|2|||
157005800|NCT00423098|566771591|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157005801|NCT00423098|566771592|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
157005802|NCT00423098|566771591|FG000|Overall Study|Administrative problems|0|||
157005803|NCT00423098|566771592|FG001|Overall Study|Administrative problems|1|||
157005804|NCT00423098|566771591|FG000|Overall Study|Death|2|||
157005805|NCT00423098|566771592|FG001|Overall Study|Death|0|||
157005806|NCT01111526|566771594|FG000|Overall Study|GVHD Disease Progression|0|||
157005807|NCT01111526|566771595|FG001|Overall Study|GVHD Disease Progression|1|||
157005808|NCT01111526|566771596|FG002|Overall Study|GVHD Disease Progression|2|||
157005809|NCT02013830|566771597|FG000|Overall Study|Adverse Event|3|||
157005810|NCT02013830|566771597|FG000|Overall Study|Death|1|||
157005811|NCT02013830|566771597|FG000|Overall Study|Insufficient therapeutic response|25|||
157005812|NCT02013830|566771597|FG000|Overall Study|Refused treatment|1|||
157005813|NCT04424641|566771598|FG000|Overall Study|Death|1|||
157005814|NCT04424641|566771599|FG001|Overall Study|Death|2|||
157005815|NCT04424641|566771600|FG002|Overall Study|Death|3|||
157005816|NCT04424641|566771601|FG003|Overall Study|Death|0|||
157005817|NCT04424641|566771602|FG004|Overall Study|Death|3|||
157005818|NCT04424641|566771603|FG005|Overall Study|Death|0|||
157005819|NCT04424641|566771604|FG006|Overall Study|Death|1|||
157005820|NCT04424641|566771605|FG007|Overall Study|Death|2|||
157005821|NCT04424641|566771598|FG000|Overall Study|Sponsor decision|0|||
156765552|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765553|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765554|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765555|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765556|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
156765557|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
156765558|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
156765559|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765560|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765561|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
156765562|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
157110953|NCT00609986|567159407|FG001|Overall Study|Did not receive transplant or treatment|3|||
157110954|NCT03159091|567159408|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
157110955|NCT03159091|567159409|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
157110956|NCT03159091|567159408|FG000|Overall Study|Patient has taken no dose of study drug|0|||
157110957|NCT03159091|567159409|FG001|Overall Study|Patient has taken no dose of study drug|1|||
157110958|NCT05998148|567159410|FG000|Allocation|Did not attend any appointments|1|||
157110959|NCT05998148|567159411|FG001|Allocation|Did not attend any appointments|4|||
157110960|NCT05998148|567159410|FG000|Follow-Up|Lost to Follow-up|1|||
157110961|NCT05998148|567159411|FG001|Follow-Up|Lost to Follow-up|2|||
156765563|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
157110962|NCT05998148|567159410|FG000|Follow-Up|Change in insurance|1|||
157110963|NCT05998148|567159411|FG001|Follow-Up|Change in insurance|1|||
157110964|NCT02044133|567159412|FG000|Overall Study|Lost to Follow-up|1|||
157110965|NCT02044133|567159413|FG001|Overall Study|Lost to Follow-up|1|||
157110966|NCT02044133|567159412|FG000|Overall Study|Death|1|||
157110967|NCT02044133|567159413|FG001|Overall Study|Death|0|||
157110968|NCT02044133|567159412|FG000|Overall Study|Release|3|||
157110969|NCT02044133|567159413|FG001|Overall Study|Release|4|||
157110970|NCT02044133|567159412|FG000|Overall Study|Transfer|1|||
157110971|NCT02044133|567159413|FG001|Overall Study|Transfer|0|||
157110972|NCT02044133|567159412|FG000|Overall Study|refusal of blood sampling|0|||
157110973|NCT02044133|567159413|FG001|Overall Study|refusal of blood sampling|1|||
157110974|NCT03834519|567159414|FG000|Overall Study|Lost to Follow-up|2|||
157110975|NCT03834519|567159415|FG001|Overall Study|Lost to Follow-up|1|||
157110976|NCT03834519|567159414|FG000|Overall Study|Withdrawal by Subject|5|||
157110977|NCT03834519|567159415|FG001|Overall Study|Withdrawal by Subject|8|||
157110978|NCT03834519|567159414|FG000|Overall Study|Death|368|||
157110979|NCT03834519|567159415|FG001|Overall Study|Death|174|||
157110980|NCT03834519|567159414|FG000|Overall Study|Physician Decision|5|||
157110981|NCT03834519|567159415|FG001|Overall Study|Physician Decision|1|||
157110982|NCT03834519|567159414|FG000|Overall Study|Sponsor decision|149|||
157110983|NCT03834519|567159415|FG001|Overall Study|Sponsor decision|80|||
157110984|NCT04655144|567159419|FG000|Overall Study|Consumed THC|1|||
157110985|NCT04655144|567159420|FG001|Overall Study|Consumed THC|0|||
157110986|NCT04655144|567159419|FG000|Overall Study|Unilateral embolization|0|||
157110987|NCT04655144|567159420|FG001|Overall Study|Unilateral embolization|1|||
157110988|NCT00943579|567159426|FG000|Overall Study|Adverse Event|4|||
157110989|NCT00943579|567159427|FG001|Overall Study|Adverse Event|3|||
157110990|NCT00943579|567159426|FG000|Overall Study|Lack of Efficacy|2|||
157110991|NCT00943579|567159427|FG001|Overall Study|Lack of Efficacy|2|||
157110992|NCT00418665|567159430|FG000|Treatment Period|Ineligibility determined|1|||
157110993|NCT00418665|567159431|FG001|Treatment Period|Ineligibility determined|1|||
157110994|NCT00418665|567159432|FG002|Treatment Period|Ineligibility determined|0|||
157110995|NCT00418665|567159430|FG000|Treatment Period|Adverse Event|2|||
156765564|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
156765565|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
156765566|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765567|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765568|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
156765569|NCT03327324|565896592|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
157110996|NCT00418665|567159431|FG001|Treatment Period|Adverse Event|2|||
157110997|NCT00418665|567159432|FG002|Treatment Period|Adverse Event|0|||
157110998|NCT00418665|567159430|FG000|Treatment Period|Withdrawal by Subject|0|||
157110999|NCT00418665|567159431|FG001|Treatment Period|Withdrawal by Subject|3|||
157111000|NCT00418665|567159432|FG002|Treatment Period|Withdrawal by Subject|1|||
157111001|NCT00418665|567159430|FG000|Treatment Period|Requirement for alternative therapy|1|||
157111002|NCT00418665|567159431|FG001|Treatment Period|Requirement for alternative therapy|0|||
157111003|NCT00418665|567159432|FG002|Treatment Period|Requirement for alternative therapy|0|||
157111004|NCT00418665|567159430|FG000|Treatment Period|Physician Decision|1|||
156765570|NCT03327324|565896593|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765571|NCT03327324|565896594|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765572|NCT03327324|565896595|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
156765573|NCT03327324|565896596|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
156765574|NCT03327324|565896597|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
156765575|NCT03327324|565896592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
156765576|NCT03327324|565896593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765577|NCT03327324|565896594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765578|NCT03327324|565896595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765579|NCT03327324|565896596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765580|NCT03327324|565896597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
156765581|NCT03327324|565896592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
156765582|NCT03327324|565896593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765583|NCT03327324|565896594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765584|NCT03327324|565896595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765585|NCT03327324|565896596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765586|NCT03327324|565896597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
156765587|NCT03886272|565896599|FG000|Period 1|Withdrawal by Subject|0|||
156765588|NCT03886272|565896600|FG001|Period 1|Withdrawal by Subject|0|||
156765589|NCT03886272|565896601|FG002|Period 1|Withdrawal by Subject|0|||
156765590|NCT03886272|565896602|FG003|Period 1|Withdrawal by Subject|0|||
156765591|NCT03886272|565896603|FG004|Period 1|Withdrawal by Subject|0|||
156765592|NCT03886272|565896604|FG005|Period 1|Withdrawal by Subject|1|||
156765593|NCT03886272|565896605|FG006|Period 1|Withdrawal by Subject|0|||
156765594|NCT03014206|565896606|FG000|Overall Study|Registration Violation|12|||
156765595|NCT02895347|565896609|FG000|Overall Study|Withdrawal by Subject|3|||
156765596|NCT02895347|565896610|FG001|Overall Study|Withdrawal by Subject|1|||
156765597|NCT01673178|565896614|FG000|Overall Study|Lost to Follow-up|0|||
156765598|NCT01673178|565896615|FG001|Overall Study|Lost to Follow-up|1|||
156765599|NCT01673178|565896616|FG002|Overall Study|Lost to Follow-up|0|||
156765600|NCT01673178|565896617|FG003|Overall Study|Lost to Follow-up|0|||
156765601|NCT01673178|565896618|FG004|Overall Study|Lost to Follow-up|0|||
156765602|NCT01673178|565896614|FG000|Overall Study|Withdrawal by Subject|0|||
156765603|NCT01673178|565896615|FG001|Overall Study|Withdrawal by Subject|0|||
156765604|NCT01673178|565896616|FG002|Overall Study|Withdrawal by Subject|1|||
156765605|NCT01673178|565896617|FG003|Overall Study|Withdrawal by Subject|4|||
156765606|NCT01673178|565896618|FG004|Overall Study|Withdrawal by Subject|2|||
156765607|NCT01673178|565896614|FG000|Overall Study|Protocol Violation|1|||
156765608|NCT01673178|565896615|FG001|Overall Study|Protocol Violation|1|||
156765609|NCT01673178|565896616|FG002|Overall Study|Protocol Violation|0|||
156765610|NCT01673178|565896617|FG003|Overall Study|Protocol Violation|1|||
156765611|NCT01673178|565896618|FG004|Overall Study|Protocol Violation|0|||
156765612|NCT01673178|565896614|FG000|Overall Study|Adverse Event|1|||
156765613|NCT01673178|565896615|FG001|Overall Study|Adverse Event|0|||
156765614|NCT01673178|565896616|FG002|Overall Study|Adverse Event|0|||
156765615|NCT01673178|565896617|FG003|Overall Study|Adverse Event|2|||
156765616|NCT01673178|565896618|FG004|Overall Study|Adverse Event|0|||
156765617|NCT01673178|565896614|FG000|Overall Study|Other|1|||
156765618|NCT01673178|565896615|FG001|Overall Study|Other|0|||
156765619|NCT01673178|565896616|FG002|Overall Study|Other|2|||
156765620|NCT01673178|565896617|FG003|Overall Study|Other|1|||
156765621|NCT01673178|565896618|FG004|Overall Study|Other|0|||
156765622|NCT03177148|565896619|FG000|Overall Study|Lost to Follow-up|50|||
156765623|NCT03177148|565896620|FG001|Overall Study|Lost to Follow-up|1|||
156765624|NCT03177148|565896619|FG000|Overall Study|Death|1|||
156765625|NCT03177148|565896620|FG001|Overall Study|Death|0|||
156765626|NCT02848664|565896624|FG000|Overall Study|Withdrawal by Subject|2|||
157111005|NCT00418665|567159431|FG001|Treatment Period|Physician Decision|0|||
157111006|NCT00418665|567159432|FG002|Treatment Period|Physician Decision|3|||
157111007|NCT00418665|567159430|FG000|Treatment Extension|Adverse Event|1|||
157111008|NCT00418665|567159431|FG001|Treatment Extension|Adverse Event|0|||
157111009|NCT00418665|567159432|FG002|Treatment Extension|Adverse Event|0|||
157111010|NCT00418665|567159430|FG000|Treatment Extension|Withdrawal by Subject|1|||
156765627|NCT02848664|565896624|FG000|Overall Study|Adverse Event|1|||
157111011|NCT00418665|567159431|FG001|Treatment Extension|Withdrawal by Subject|0|||
157111012|NCT00418665|567159432|FG002|Treatment Extension|Withdrawal by Subject|0|||
157111013|NCT00418665|567159430|FG000|Treatment Extension|Requirement for alternative therapy|2|||
156765628|NCT02848664|565896624|FG000|Overall Study|no assistance for device training|1|||
156765629|NCT01819727|565896627|FG000|Overall Study|Adverse Event|8|||
156765630|NCT01819727|565896628|FG001|Overall Study|Adverse Event|9|||
156765631|NCT01819727|565896627|FG000|Overall Study|Death|1|||
157111014|NCT00418665|567159431|FG001|Treatment Extension|Requirement for alternative therapy|2|||
157111015|NCT00418665|567159432|FG002|Treatment Extension|Requirement for alternative therapy|0|||
156765632|NCT01819727|565896628|FG001|Overall Study|Death|0|||
156765633|NCT01819727|565896627|FG000|Overall Study|Lost to Follow-up|1|||
156765634|NCT01819727|565896628|FG001|Overall Study|Lost to Follow-up|1|||
156765635|NCT01819727|565896627|FG000|Overall Study|Physician Decision|3|||
156765636|NCT01819727|565896628|FG001|Overall Study|Physician Decision|2|||
156765637|NCT01819727|565896627|FG000|Overall Study|Pregnancy|1|||
156765638|NCT01819727|565896628|FG001|Overall Study|Pregnancy|0|||
156765639|NCT01819727|565896627|FG000|Overall Study|Protocol Violation|0|||
156765640|NCT01819727|565896628|FG001|Overall Study|Protocol Violation|2|||
156765641|NCT01819727|565896627|FG000|Overall Study|Study Terminated by Sponsor|0|||
156765642|NCT01819727|565896628|FG001|Overall Study|Study Terminated by Sponsor|1|||
156765643|NCT01819727|565896627|FG000|Overall Study|Withdrawal by Subject|6|||
156765644|NCT01819727|565896628|FG001|Overall Study|Withdrawal by Subject|11|||
156765645|NCT01819727|565896627|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
156765646|NCT01819727|565896628|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
156765647|NCT01819727|565896627|FG000|Overall Study|Quit due to lack of health benifits|0|||
156765648|NCT01819727|565896628|FG001|Overall Study|Quit due to lack of health benifits|1|||
156765649|NCT00402727|565896631|FG000|Overall Study|Adverse Event|10|||
156765650|NCT00402727|565896632|FG001|Overall Study|Adverse Event|6|||
156765651|NCT00402727|565896631|FG000|Overall Study|Death|1|||
156765652|NCT00402727|565896632|FG001|Overall Study|Death|0|||
156765653|NCT00402727|565896631|FG000|Overall Study|Lack of Efficacy|1|||
156765654|NCT00402727|565896632|FG001|Overall Study|Lack of Efficacy|3|||
156765655|NCT00402727|565896631|FG000|Overall Study|Lost to Follow-up|24|||
156765656|NCT00402727|565896632|FG001|Overall Study|Lost to Follow-up|11|||
156765657|NCT00402727|565896631|FG000|Overall Study|Physician Decision|1|||
157111016|NCT00418665|567159430|FG000|Treatment Extension|Physician Decision|2|||
157111017|NCT00418665|567159431|FG001|Treatment Extension|Physician Decision|2|||
157111018|NCT00418665|567159432|FG002|Treatment Extension|Physician Decision|1|||
157111019|NCT00418665|567159430|FG000|Treatment Extension|Death|0|||
157111020|NCT00418665|567159431|FG001|Treatment Extension|Death|0|||
157111021|NCT00418665|567159432|FG002|Treatment Extension|Death|1|||
157111022|NCT00853749|567159433|FG000|Overall Study|Lost to Follow-up|0|||
157111023|NCT00853749|567159434|FG001|Overall Study|Lost to Follow-up|1|||
157111024|NCT00687440|567159437|FG000|Overall Study|Adverse Event|3|||
157111025|NCT00687440|567159437|FG000|Overall Study|Lost to Follow-up|3|||
157111026|NCT00687440|567159437|FG000|Overall Study|Lack of Efficacy|2|||
157111027|NCT00687440|567159437|FG000|Overall Study|Death|2|||
157111028|NCT00687440|567159437|FG000|Overall Study|Other|1|||
157111029|NCT00687440|567159437|FG000|Overall Study|Missing|1|||
157111030|NCT03703882|567160452|FG000|Overall Study|Adverse Event|1|||
157111031|NCT03703882|567160453|FG001|Overall Study|Adverse Event|0|||
157111032|NCT03703882|567160452|FG000|Overall Study|Lost to Follow-up|0|||
157111033|NCT03703882|567160453|FG001|Overall Study|Lost to Follow-up|2|||
157111034|NCT03703882|567160452|FG000|Overall Study|Non-compliance with study drug|0|||
157111035|NCT03703882|567160453|FG001|Overall Study|Non-compliance with study drug|1|||
157111036|NCT03703882|567160452|FG000|Overall Study|Physician Decision|0|||
157111037|NCT03703882|567160453|FG001|Overall Study|Physician Decision|1|||
157111038|NCT03703882|567160452|FG000|Overall Study|Progressive disease|1|||
157111039|NCT03703882|567160453|FG001|Overall Study|Progressive disease|0|||
157111040|NCT03703882|567160452|FG000|Overall Study|Withdrawal by parent/guardian|1|||
157111041|NCT03703882|567160453|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157111042|NCT03703882|567160452|FG000|Overall Study|Starting another treatment|0|||
157111043|NCT03703882|567160453|FG001|Overall Study|Starting another treatment|1|||
157111044|NCT03703882|567160452|FG000|Overall Study|noncompliance with study procedures|0|||
157111045|NCT03703882|567160453|FG001|Overall Study|noncompliance with study procedures|1|||
157111046|NCT02263079|567160460|FG000|Overall Study|Physician Decision|1|||
157111047|NCT02263079|567160461|FG001|Overall Study|Physician Decision|0|||
157111048|NCT02263079|567160462|FG002|Overall Study|Physician Decision|0|||
157111049|NCT02263079|567160460|FG000|Overall Study|Withdrawal by Subject|2|||
157111050|NCT02263079|567160461|FG001|Overall Study|Withdrawal by Subject|8|||
157111051|NCT02263079|567160462|FG002|Overall Study|Withdrawal by Subject|0|||
157111052|NCT01321710|567160468|FG000|Overall Study|Lost to Follow-up|4|||
157111053|NCT01321710|567160469|FG001|Overall Study|Lost to Follow-up|5|||
157111054|NCT01321710|567160470|FG002|Overall Study|Lost to Follow-up|0|||
156765658|NCT00402727|565896632|FG001|Overall Study|Physician Decision|1|||
156765659|NCT00402727|565896631|FG000|Overall Study|Protocol Violation|0|||
156765660|NCT00402727|565896632|FG001|Overall Study|Protocol Violation|4|||
156765661|NCT00402727|565896631|FG000|Overall Study|Withdrawal by Subject|3|||
156765662|NCT00402727|565896632|FG001|Overall Study|Withdrawal by Subject|7|||
156765663|NCT00402727|565896631|FG000|Overall Study|supply problems|2|||
156765664|NCT00402727|565896632|FG001|Overall Study|supply problems|1|||
156765665|NCT00402727|565896631|FG000|Overall Study|non-compliance|0|||
157111055|NCT03577730|567160471|FG000|Overall Study|Physician Decision|3|||
157111056|NCT03577730|567160472|FG001|Overall Study|Physician Decision|1|||
157111057|NCT03577730|567160471|FG000|Overall Study|Did not receive allocated intervention|1|||
157111058|NCT03577730|567160472|FG001|Overall Study|Did not receive allocated intervention|0|||
157111059|NCT03810781|567160474|FG000|Overall Study|COVID shut down|2|||
157111060|NCT02349048|567160477|FG000|Overall Study|Withdrawal by Subject|4|||
156765666|NCT00402727|565896632|FG001|Overall Study|non-compliance|1|||
156765667|NCT00732069|565896633|FG000|Washout After First Study Drug|Adverse Event|1|||
156765668|NCT00732069|565896634|FG001|Washout After First Study Drug|Adverse Event|0|||
156765669|NCT00732069|565896635|FG002|Washout After First Study Drug|Adverse Event|0|||
156765670|NCT00732069|565896636|FG003|Washout After First Study Drug|Adverse Event|0|||
156765671|NCT00732069|565896637|FG004|Washout After First Study Drug|Adverse Event|0|||
156765672|NCT00732069|565896638|FG005|Washout After First Study Drug|Adverse Event|0|||
156765673|NCT00577317|565896639|FG000|Overall Study|Study Terminated|0|||
157111061|NCT02349048|567160478|FG001|Overall Study|Withdrawal by Subject|0|||
157111062|NCT02349048|567160477|FG000|Overall Study|Lost to Follow-up|1|||
157111063|NCT02349048|567160478|FG001|Overall Study|Lost to Follow-up|0|||
157111064|NCT00383084|567160485|FG000|Overall Study|Withdrawal by Subject|12|||
157111065|NCT00383084|567160486|FG001|Overall Study|Withdrawal by Subject|10|||
157111066|NCT01648790|567160487|FG000|Treatment 3|Withdrawal by Subject|0|||
157111067|NCT01648790|567160488|FG001|Treatment 3|Withdrawal by Subject|0|||
157111068|NCT01648790|567160489|FG002|Treatment 3|Withdrawal by Subject|0|||
157111069|NCT01648790|567160490|FG003|Treatment 3|Withdrawal by Subject|1|||
157111070|NCT01648790|567160491|FG004|Treatment 3|Withdrawal by Subject|0|||
157111071|NCT05895552|567160492|FG000|Overall Study|Adverse Event|2|||
157111072|NCT05895552|567160493|FG001|Overall Study|Adverse Event|2|||
157111073|NCT05895552|567160494|FG002|Overall Study|Adverse Event|1|||
157111074|NCT05895552|567160492|FG000|Overall Study|Lost to Follow-up|0|||
156765674|NCT00577317|565896640|FG001|Overall Study|Study Terminated|2|||
156765675|NCT03106077|565896660|FG000|Overall Study|Screen Failure|94|||
156765676|NCT03106077|565896661|FG001|Overall Study|Screen Failure|0|||
156765677|NCT00606307|565896662|FG000|Overall Study|Adverse Event|2|||
156765678|NCT00606307|565896662|FG000|Overall Study|Withdrawal by Subject|2|||
156765679|NCT00606307|565896662|FG000|Overall Study|Disease progression|6|||
156765680|NCT00606307|565896662|FG000|Overall Study|QTc prolongation|1|||
156765681|NCT01274533|565896663|FG000|Overall Study|Withdrawal by Subject|1|||
156765682|NCT01274533|565896663|FG000|Overall Study|Non-compliance|1|||
156765683|NCT01274533|565896663|FG000|Overall Study|Disease progression|2|||
156765684|NCT02563899|565896664|FG000|Overall Study|Protocol Violation|1|||
156765685|NCT02563899|565896665|FG001|Overall Study|Protocol Violation|0|||
156765686|NCT02563899|565896666|FG002|Overall Study|Protocol Violation|0|||
156765687|NCT02563899|565896667|FG003|Overall Study|Protocol Violation|0|||
156765688|NCT02563899|565896664|FG000|Overall Study|Withdrawal by Subject|0|||
156765689|NCT02563899|565896665|FG001|Overall Study|Withdrawal by Subject|0|||
156765690|NCT02563899|565896666|FG002|Overall Study|Withdrawal by Subject|1|||
156765691|NCT02563899|565896667|FG003|Overall Study|Withdrawal by Subject|0|||
156765692|NCT03669588|565896669|FG000|Overall Study|Adverse Event|1|||
156765693|NCT03669588|565896670|FG001|Overall Study|Adverse Event|0|||
156765694|NCT03669588|565896669|FG000|Overall Study|Physician Decision|0|||
156765695|NCT03669588|565896670|FG001|Overall Study|Physician Decision|1|||
156765696|NCT03669588|565896669|FG000|Overall Study|Protocol Violation|1|||
156765697|NCT03669588|565896670|FG001|Overall Study|Protocol Violation|0|||
156765698|NCT03669588|565896669|FG000|Overall Study|Sponsor Decision|1|||
156765699|NCT03669588|565896670|FG001|Overall Study|Sponsor Decision|1|||
156765700|NCT03669588|565896669|FG000|Overall Study|Withdrawal by Subject|1|||
156765701|NCT03669588|565896670|FG001|Overall Study|Withdrawal by Subject|4|||
156765702|NCT03669588|565896669|FG000|Overall Study|Rescue Therapy Needed|0|||
156765703|NCT03669588|565896670|FG001|Overall Study|Rescue Therapy Needed|1|||
156765704|NCT02008526|565896671|FG000|Overall Study|Death|0|||
156765705|NCT02008526|565896672|FG001|Overall Study|Death|2|||
156765706|NCT02008526|565896673|FG002|Overall Study|Death|1|||
156765707|NCT02008526|565896671|FG000|Overall Study|Withdrawal by Subject|3|||
156765708|NCT02008526|565896672|FG001|Overall Study|Withdrawal by Subject|3|||
156765709|NCT02008526|565896673|FG002|Overall Study|Withdrawal by Subject|2|||
156765710|NCT02008526|565896671|FG000|Overall Study|Lost to Follow-up|5|||
156765711|NCT02008526|565896672|FG001|Overall Study|Lost to Follow-up|9|||
156765712|NCT02008526|565896673|FG002|Overall Study|Lost to Follow-up|6|||
156765713|NCT00161213|565898493|FG000|Overall Study|Withdrawal by Subject|1|||
156765714|NCT00161213|565898493|FG000|Overall Study|Evaluable for toxicity but not response|1|||
156765715|NCT03103503|565898494|FG000|Overall Study|Death|64|||
156765716|NCT03103503|565898494|FG000|Overall Study|Physician Decision|57|||
156765717|NCT03103503|565898494|FG000|Overall Study|Withdrawal by Subject|10|||
156765718|NCT03103503|565898494|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
156765719|NCT03103503|565898494|FG000|Overall Study|Lost to Follow-up|3|||
157111075|NCT05895552|567160493|FG001|Overall Study|Lost to Follow-up|1|||
157111076|NCT05895552|567160494|FG002|Overall Study|Lost to Follow-up|0|||
156765720|NCT03103503|565898494|FG000|Overall Study|Study Closure|757|||
156765721|NCT00737048|565898501|FG000|Overall Study|Physician Decision|0|||
156765722|NCT00737048|565898502|FG001|Overall Study|Physician Decision|0|||
156765723|NCT00737048|565898503|FG002|Overall Study|Physician Decision|1|||
156765724|NCT00737048|565898501|FG000|Overall Study|Adverse Event|0|||
157111077|NCT05895552|567160492|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157111078|NCT05895552|567160493|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157111079|NCT05895552|567160494|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157111080|NCT05895552|567160492|FG000|Overall Study|Protocol Deviation|0|||
157111081|NCT05895552|567160493|FG001|Overall Study|Protocol Deviation|0|||
157111082|NCT05895552|567160494|FG002|Overall Study|Protocol Deviation|2|||
157111083|NCT05895552|567160492|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
157111084|NCT05895552|567160493|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156765725|NCT00737048|565898502|FG001|Overall Study|Adverse Event|1|||
156765726|NCT00737048|565898503|FG002|Overall Study|Adverse Event|0|||
156765727|NCT00737048|565898501|FG000|Overall Study|Worsening of the symptoms|3|||
156765728|NCT00737048|565898502|FG001|Overall Study|Worsening of the symptoms|5|||
156765729|NCT00737048|565898503|FG002|Overall Study|Worsening of the symptoms|3|||
156765730|NCT00301834|565898504|FG000|Overall Study|Death|1|||
156765731|NCT02737358|565898505|FG000|Overall Study|Withdrawal by Subject|7|||
156765732|NCT02737358|565898506|FG001|Overall Study|Withdrawal by Subject|12|||
156765733|NCT02737358|565898505|FG000|Overall Study|Lost to Follow-up|2|||
156765734|NCT02737358|565898506|FG001|Overall Study|Lost to Follow-up|3|||
156765735|NCT02870868|565898507|FG000|Overall Study|Withdrawal by Subject|2|||
156765736|NCT02870868|565898508|FG001|Overall Study|Withdrawal by Subject|1|||
156765737|NCT00744939|565898509|FG000|Overall Study|Withdrawal by Subject|9|||
156765738|NCT00744939|565898509|FG000|Overall Study|Protocol Violation|13|||
157005822|NCT04424641|566771599|FG001|Overall Study|Sponsor decision|2|||
157005823|NCT04424641|566771600|FG002|Overall Study|Sponsor decision|3|||
157005824|NCT04424641|566771601|FG003|Overall Study|Sponsor decision|7|||
157005825|NCT04424641|566771602|FG004|Overall Study|Sponsor decision|2|||
157005826|NCT04424641|566771603|FG005|Overall Study|Sponsor decision|2|||
157005827|NCT04424641|566771604|FG006|Overall Study|Sponsor decision|3|||
157005828|NCT04424641|566771605|FG007|Overall Study|Sponsor decision|4|||
157005829|NCT04424641|566771598|FG000|Overall Study|Withdrawal by Subject|0|||
157005830|NCT04424641|566771599|FG001|Overall Study|Withdrawal by Subject|0|||
157005831|NCT04424641|566771600|FG002|Overall Study|Withdrawal by Subject|0|||
157005832|NCT04424641|566771601|FG003|Overall Study|Withdrawal by Subject|0|||
157005833|NCT04424641|566771602|FG004|Overall Study|Withdrawal by Subject|1|||
157005834|NCT04424641|566771603|FG005|Overall Study|Withdrawal by Subject|0|||
157005835|NCT04424641|566771604|FG006|Overall Study|Withdrawal by Subject|0|||
157005836|NCT04424641|566771605|FG007|Overall Study|Withdrawal by Subject|0|||
157005837|NCT04424641|566771598|FG000|Overall Study|Other|0|||
157005838|NCT04424641|566771599|FG001|Overall Study|Other|0|||
157005839|NCT04424641|566771600|FG002|Overall Study|Other|1|||
157005840|NCT04424641|566771601|FG003|Overall Study|Other|0|||
157005841|NCT04424641|566771602|FG004|Overall Study|Other|0|||
157005842|NCT04424641|566771603|FG005|Overall Study|Other|0|||
157005843|NCT04424641|566771604|FG006|Overall Study|Other|0|||
157005844|NCT04424641|566771605|FG007|Overall Study|Other|0|||
157005845|NCT05855655|566771608|FG000|Overall Study|Withdrawal by Subject|0|||
157005846|NCT05855655|566771609|FG001|Overall Study|Withdrawal by Subject|1|||
157005847|NCT05855655|566771608|FG000|Overall Study|Lost to Follow-up|4|||
157005848|NCT05855655|566771609|FG001|Overall Study|Lost to Follow-up|0|||
157005849|NCT01426269|566771610|FG000|Period 1: 12 Weeks|Adverse Event|5|||
157005850|NCT01426269|566771611|FG001|Period 1: 12 Weeks|Adverse Event|0|||
157005851|NCT01426269|566771612|FG002|Period 1: 12 Weeks|Adverse Event|0|||
157005852|NCT01426269|566771610|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
157111085|NCT05895552|567160494|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
157111086|NCT05895552|567160492|FG000|Overall Study|Withdrawal by Subject|2|||
157111087|NCT05895552|567160493|FG001|Overall Study|Withdrawal by Subject|2|||
157111088|NCT05895552|567160494|FG002|Overall Study|Withdrawal by Subject|4|||
157111089|NCT03810911|567160495|FG000|Overall Study|Death|1|||
157111090|NCT03810911|567160496|FG001|Overall Study|Death|1|||
157111091|NCT03810911|567160495|FG000|Overall Study|Withdrawal by Subject|1|||
157111092|NCT03810911|567160496|FG001|Overall Study|Withdrawal by Subject|1|||
157111093|NCT04770532|567160497|FG000|Overall Study|Withdrawal by Subject|0|||
157111094|NCT04770532|567160498|FG001|Overall Study|Withdrawal by Subject|3|||
157111095|NCT04770532|567160497|FG000|Overall Study|Physician Decision|1|||
157111096|NCT04770532|567160498|FG001|Overall Study|Physician Decision|0|||
157111097|NCT04770532|567160497|FG000|Overall Study|Death|2|||
157111098|NCT04770532|567160498|FG001|Overall Study|Death|2|||
157111099|NCT04232553|567160502|FG000|Overall Study|Adverse Event|3|||
157111100|NCT04232553|567160503|FG001|Overall Study|Adverse Event|2|||
157111101|NCT04232553|567160504|FG002|Overall Study|Adverse Event|1|||
157111102|NCT04232553|567160505|FG003|Overall Study|Adverse Event|2|||
157111103|NCT04232553|567160506|FG004|Overall Study|Adverse Event|1|||
157111104|NCT04232553|567160507|FG005|Overall Study|Adverse Event|1|||
157111105|NCT04232553|567160508|FG006|Overall Study|Adverse Event|0|||
157111106|NCT04232553|567160509|FG007|Overall Study|Adverse Event|0|||
157111107|NCT04232553|567160510|FG008|Overall Study|Adverse Event|0|||
157111108|NCT04232553|567160502|FG000|Overall Study|Death|0|||
157111109|NCT04232553|567160503|FG001|Overall Study|Death|1|||
157111110|NCT04232553|567160504|FG002|Overall Study|Death|0|||
157111111|NCT04232553|567160505|FG003|Overall Study|Death|1|||
157111112|NCT04232553|567160506|FG004|Overall Study|Death|0|||
157111113|NCT04232553|567160507|FG005|Overall Study|Death|0|||
157111114|NCT04232553|567160508|FG006|Overall Study|Death|0|||
157005853|NCT01426269|566771611|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
157005854|NCT01426269|566771612|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
157005855|NCT01426269|566771610|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
157005856|NCT01426269|566771611|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
157005857|NCT01426269|566771612|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
157005858|NCT01426269|566771610|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
157005859|NCT01426269|566771611|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
157005860|NCT01426269|566771612|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
157005861|NCT01426269|566771610|FG000|Period 1: 12 Weeks|Pregnancy|1|||
157005862|NCT01426269|566771611|FG001|Period 1: 12 Weeks|Pregnancy|0|||
157005863|NCT01426269|566771612|FG002|Period 1: 12 Weeks|Pregnancy|0|||
157005864|NCT01426269|566771610|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
157005865|NCT01426269|566771611|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
157005866|NCT01426269|566771612|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
157005867|NCT01426269|566771610|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
157005868|NCT01426269|566771611|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
157005869|NCT01426269|566771612|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
157005870|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Adverse Event|0|||
157005871|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Adverse Event|1|||
157005872|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Adverse Event|2|||
157005873|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
157005874|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
157005875|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
157005876|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
157005877|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
157005878|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
157005879|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
157005880|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
157005881|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
157005882|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Site closed|0|||
157005883|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Site closed|6|||
157005884|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Site closed|5|||
157005885|NCT01426269|566771610|FG000|Period 2: 40 Weeks|Relapsed|0|||
157005886|NCT01426269|566771611|FG001|Period 2: 40 Weeks|Relapsed|9|||
157005887|NCT01426269|566771612|FG002|Period 2: 40 Weeks|Relapsed|18|||
157005888|NCT01171625|566771613|FG000|Overall Study|On-Protocol|67|||
157005889|NCT01171625|566771613|FG000|Overall Study|Death|38|||
157005890|NCT01171625|566771613|FG000|Overall Study|Withdrawal by Subject|31|||
157005891|NCT01171625|566771613|FG000|Overall Study|Explanted|10|||
157005892|NCT01171625|566771613|FG000|Overall Study|Lost to Follow-up|5|||
157005893|NCT01171625|566771613|FG000|Overall Study|Patient received valve-in-valve|3|||
157005894|NCT01171625|566771613|FG000|Overall Study|Other|1|||
157005895|NCT01171625|566771613|FG000|Overall Study|Consented but did not receive device|25|||
157005896|NCT02296424|566771616|FG000|Part 1|New therapy for study indication|0|||
157005897|NCT02296424|566771617|FG001|Part 1|New therapy for study indication|1|||
157005898|NCT02296424|566771618|FG002|Part 1|New therapy for study indication|0|||
157005899|NCT02296424|566771619|FG003|Part 1|New therapy for study indication|0|||
157005900|NCT02296424|566771616|FG000|Part 1|Protocol Violation|0|||
157005901|NCT02296424|566771617|FG001|Part 1|Protocol Violation|1|||
157005902|NCT02296424|566771618|FG002|Part 1|Protocol Violation|0|||
157005903|NCT02296424|566771619|FG003|Part 1|Protocol Violation|0|||
157005904|NCT02296424|566771616|FG000|Part 1|Withdrawal by Subject|0|||
157005905|NCT02296424|566771617|FG001|Part 1|Withdrawal by Subject|2|||
157005906|NCT02296424|566771618|FG002|Part 1|Withdrawal by Subject|0|||
157005907|NCT02296424|566771619|FG003|Part 1|Withdrawal by Subject|0|||
157005908|NCT02296424|566771616|FG000|Part 1|Study terminated by sponsor|0|||
157005909|NCT02296424|566771617|FG001|Part 1|Study terminated by sponsor|1|||
157005910|NCT02296424|566771618|FG002|Part 1|Study terminated by sponsor|0|||
157005911|NCT02296424|566771619|FG003|Part 1|Study terminated by sponsor|0|||
157005912|NCT02296424|566771616|FG000|Part 1|Adverse Event|2|||
157005913|NCT02296424|566771617|FG001|Part 1|Adverse Event|11|||
157005914|NCT02296424|566771618|FG002|Part 1|Adverse Event|0|||
157005915|NCT02296424|566771619|FG003|Part 1|Adverse Event|0|||
157005916|NCT02296424|566771616|FG000|Part 1|Lack of Efficacy|5|||
157005917|NCT02296424|566771617|FG001|Part 1|Lack of Efficacy|17|||
157005918|NCT02296424|566771618|FG002|Part 1|Lack of Efficacy|0|||
157005919|NCT02296424|566771619|FG003|Part 1|Lack of Efficacy|0|||
157005920|NCT02296424|566771616|FG000|Part 1|16 directly started part II|16|||
157005921|NCT02296424|566771617|FG001|Part 1|16 directly started part II|0|||
157005922|NCT02296424|566771618|FG002|Part 1|16 directly started part II|0|||
157005923|NCT02296424|566771619|FG003|Part 1|16 directly started part II|0|||
157005924|NCT02296424|566771616|FG000|Part 2|Lack of Efficacy|0|||
157005925|NCT02296424|566771617|FG001|Part 2|Lack of Efficacy|0|||
157005926|NCT02296424|566771618|FG002|Part 2|Lack of Efficacy|1|||
157005927|NCT02296424|566771619|FG003|Part 2|Lack of Efficacy|0|||
157005928|NCT02296424|566771616|FG000|Part 2|Adverse Event|0|||
157005929|NCT02296424|566771617|FG001|Part 2|Adverse Event|0|||
157005930|NCT02296424|566771618|FG002|Part 2|Adverse Event|1|||
157005931|NCT02296424|566771619|FG003|Part 2|Adverse Event|0|||
156765739|NCT00744939|565898509|FG000|Overall Study|Death|24|||
156765740|NCT00744939|565898509|FG000|Overall Study|distance|4|||
156765741|NCT00744939|565898509|FG000|Overall Study|Lost to Follow-up|12|||
156765742|NCT00744939|565898509|FG000|Overall Study|Medical history exclusionary|1|||
156765743|NCT00744939|565898509|FG000|Overall Study|Did not receive Magnevist|7|||
156765744|NCT00744939|565898509|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
156765745|NCT00744939|565898509|FG000|Overall Study|coma|1|||
156765746|NCT00744939|565898509|FG000|Overall Study|incorrect race|1|||
156765747|NCT01739335|565898510|FG000|Overall Study|Lost to Follow-up|7|||
156765748|NCT01739335|565898511|FG001|Overall Study|Lost to Follow-up|4|||
156765749|NCT01739335|565898510|FG000|Overall Study|Ineligible patient randomized|0|||
156765750|NCT01739335|565898511|FG001|Overall Study|Ineligible patient randomized|1|||
156765751|NCT00288912|565898512|FG000|Overall Study|Developed exclusion criterion|4|||
156765752|NCT00288912|565898513|FG001|Overall Study|Developed exclusion criterion|6|||
156765753|NCT00288912|565898514|FG002|Overall Study|Developed exclusion criterion|7|||
156765754|NCT00288912|565898512|FG000|Overall Study|Lost to Follow-up|9|||
156765755|NCT00288912|565898513|FG001|Overall Study|Lost to Follow-up|6|||
156765756|NCT00288912|565898514|FG002|Overall Study|Lost to Follow-up|9|||
156765757|NCT00288912|565898512|FG000|Overall Study|Withdrawal by Subject|4|||
156765758|NCT00288912|565898513|FG001|Overall Study|Withdrawal by Subject|5|||
156765759|NCT00288912|565898514|FG002|Overall Study|Withdrawal by Subject|12|||
156765760|NCT00183430|565898517|FG000|Overall Study|Adverse Event|1|||
156765761|NCT00183430|565898518|FG001|Overall Study|Adverse Event|0|||
156765762|NCT00183430|565898517|FG000|Overall Study|Lost to Follow-up|3|||
156765763|NCT00183430|565898518|FG001|Overall Study|Lost to Follow-up|0|||
156765764|NCT00183430|565898517|FG000|Overall Study|did not meet inclusion criteria|1|||
156765765|NCT00183430|565898518|FG001|Overall Study|did not meet inclusion criteria|0|||
156765766|NCT00183430|565898517|FG000|Overall Study|Withdrawal by Subject|1|||
156765767|NCT00183430|565898518|FG001|Overall Study|Withdrawal by Subject|0|||
156765768|NCT01863771|565898527|FG000|Induction Phase|Adverse Event|9|||
156765769|NCT01863771|565898528|FG001|Induction Phase|Adverse Event|0|||
156765770|NCT01863771|565898529|FG002|Induction Phase|Adverse Event|0|||
156765771|NCT01863771|565898530|FG003|Induction Phase|Adverse Event|0|||
156765772|NCT01863771|565898527|FG000|Induction Phase|Lack of Efficacy|10|||
156765773|NCT01863771|565898528|FG001|Induction Phase|Lack of Efficacy|0|||
156765774|NCT01863771|565898529|FG002|Induction Phase|Lack of Efficacy|0|||
156765775|NCT01863771|565898530|FG003|Induction Phase|Lack of Efficacy|0|||
156765776|NCT01863771|565898527|FG000|Induction Phase|Withdrawal by Subject|2|||
156765777|NCT01863771|565898528|FG001|Induction Phase|Withdrawal by Subject|0|||
156765778|NCT01863771|565898529|FG002|Induction Phase|Withdrawal by Subject|0|||
156765779|NCT01863771|565898530|FG003|Induction Phase|Withdrawal by Subject|0|||
156765780|NCT01863771|565898527|FG000|Maintenance Phase|Adverse Event|0|||
156765781|NCT01863771|565898528|FG001|Maintenance Phase|Adverse Event|0|||
156765782|NCT01863771|565898529|FG002|Maintenance Phase|Adverse Event|1|||
156765783|NCT01863771|565898530|FG003|Maintenance Phase|Adverse Event|1|||
156765784|NCT01863771|565898527|FG000|Maintenance Phase|Lack of Efficacy|0|||
156765785|NCT01863771|565898528|FG001|Maintenance Phase|Lack of Efficacy|3|||
156765786|NCT01863771|565898529|FG002|Maintenance Phase|Lack of Efficacy|7|||
156765787|NCT01863771|565898530|FG003|Maintenance Phase|Lack of Efficacy|38|||
156765788|NCT01863771|565898527|FG000|Maintenance Phase|Physician Decision|0|||
156765789|NCT01863771|565898528|FG001|Maintenance Phase|Physician Decision|0|||
156765790|NCT01863771|565898529|FG002|Maintenance Phase|Physician Decision|2|||
156765791|NCT01863771|565898530|FG003|Maintenance Phase|Physician Decision|1|||
156765792|NCT01863771|565898527|FG000|Maintenance Phase|Pregnancy|0|||
156765793|NCT01863771|565898528|FG001|Maintenance Phase|Pregnancy|1|||
156765794|NCT01863771|565898529|FG002|Maintenance Phase|Pregnancy|0|||
156765795|NCT01863771|565898530|FG003|Maintenance Phase|Pregnancy|0|||
156765796|NCT01863771|565898527|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156765797|NCT01863771|565898528|FG001|Maintenance Phase|Withdrawal by Subject|1|||
156765798|NCT01863771|565898529|FG002|Maintenance Phase|Withdrawal by Subject|2|||
156765799|NCT01863771|565898530|FG003|Maintenance Phase|Withdrawal by Subject|3|||
156765800|NCT03636256|565898531|FG000|Overall Study|Lost to Follow-up|3|||
156765801|NCT03636256|565898532|FG001|Overall Study|Lost to Follow-up|0|||
156765802|NCT03636256|565898533|FG002|Overall Study|Lost to Follow-up|2|||
156765803|NCT03636256|565898534|FG003|Overall Study|Lost to Follow-up|1|||
156765804|NCT03636256|565898535|FG004|Overall Study|Lost to Follow-up|0|||
156765805|NCT03636256|565898536|FG005|Overall Study|Lost to Follow-up|4|||
156765806|NCT03636256|565898537|FG006|Overall Study|Lost to Follow-up|2|||
156765807|NCT03636256|565898538|FG007|Overall Study|Lost to Follow-up|0|||
156765808|NCT03636256|565898539|FG008|Overall Study|Lost to Follow-up|4|||
156765809|NCT03636256|565898531|FG000|Overall Study|Withdrawal by Subject|0|||
156765810|NCT03636256|565898532|FG001|Overall Study|Withdrawal by Subject|0|||
156765811|NCT03636256|565898533|FG002|Overall Study|Withdrawal by Subject|0|||
156765812|NCT03636256|565898534|FG003|Overall Study|Withdrawal by Subject|0|||
156765813|NCT03636256|565898535|FG004|Overall Study|Withdrawal by Subject|0|||
156765814|NCT03636256|565898536|FG005|Overall Study|Withdrawal by Subject|0|||
156765815|NCT03636256|565898537|FG006|Overall Study|Withdrawal by Subject|0|||
156765816|NCT03636256|565898538|FG007|Overall Study|Withdrawal by Subject|0|||
156765817|NCT03636256|565898539|FG008|Overall Study|Withdrawal by Subject|1|||
156765818|NCT01218308|565898540|FG000|Overall Study|Adverse Event|1|||
156765819|NCT01218308|565898541|FG001|Overall Study|Adverse Event|2|||
156765820|NCT01218308|565898540|FG000|Overall Study|Protocol Violation|0|||
156765821|NCT01218308|565898541|FG001|Overall Study|Protocol Violation|2|||
156765822|NCT01218308|565898540|FG000|Overall Study|Withdrawal by Subject|61|||
156765823|NCT01218308|565898541|FG001|Overall Study|Withdrawal by Subject|64|||
156765824|NCT01218308|565898540|FG000|Overall Study|Lost to Follow-up|27|||
156765825|NCT01218308|565898541|FG001|Overall Study|Lost to Follow-up|31|||
156765826|NCT01218308|565898540|FG000|Overall Study|Other|14|||
156765827|NCT01218308|565898541|FG001|Overall Study|Other|21|||
156765828|NCT00723229|565898542|FG000|First Intervention|Lost to Follow-up|7|||
156765829|NCT00723229|565898543|FG001|First Intervention|Lost to Follow-up|3|||
156765830|NCT02900352|565898544|FG000|Overall Study|Lost to Follow-up|28|||
156765831|NCT02900352|565898545|FG001|Overall Study|Lost to Follow-up|17|||
156765832|NCT00386334|565898548|FG000|Double Blind Period|Adverse Event|9|||
156765833|NCT00386334|565898549|FG001|Double Blind Period|Adverse Event|14|||
156765834|NCT00386334|565898548|FG000|Double Blind Period|Protocol Violation|1|||
156765835|NCT00386334|565898549|FG001|Double Blind Period|Protocol Violation|1|||
156765836|NCT00386334|565898548|FG000|Double Blind Period|Withdrawal by Subject|9|||
156765837|NCT00386334|565898549|FG001|Double Blind Period|Withdrawal by Subject|13|||
156765838|NCT00386334|565898548|FG000|Double Blind Period|Lack of Efficacy|20|||
156765839|NCT00386334|565898549|FG001|Double Blind Period|Lack of Efficacy|11|||
156765840|NCT00386334|565898548|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
156765841|NCT00386334|565898549|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
156765842|NCT00386334|565898548|FG000|Double Blind Period|Other|3|||
156765843|NCT00386334|565898549|FG001|Double Blind Period|Other|3|||
156765844|NCT00386334|565898548|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
156765845|NCT00386334|565898549|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
156765846|NCT00785356|565898550|FG000|Overall Study|Study prematurely terminated|8|||
156765847|NCT03238417|565898551|FG000|Overall|non-response|955|||
156765848|NCT03238417|565898552|FG001|Overall|non-response|1920|||
156765849|NCT03238417|565898551|FG000|Overall|partial completion|48|||
156765850|NCT03238417|565898552|FG001|Overall|partial completion|68|||
156765851|NCT03238417|565898551|FG000|Baseline|Partial completion|17|||
156765852|NCT03238417|565898552|FG001|Baseline|Partial completion|48|||
156765853|NCT03238417|565898551|FG000|Baseline|non-response|372|||
156765854|NCT03238417|565898552|FG001|Baseline|non-response|669|||
156765855|NCT03238417|565898551|FG000|12-month|non-response|296|||
156765856|NCT03238417|565898552|FG001|12-month|non-response|669|||
156765857|NCT03238417|565898551|FG000|12-month|partial completion|23|||
156765858|NCT03238417|565898552|FG001|12-month|partial completion|37|||
156765859|NCT03238417|565898551|FG000|24-month|non-response|287|||
156765860|NCT03238417|565898552|FG001|24-month|non-response|594|||
156765861|NCT03238417|565898551|FG000|24-month|partial completion|8|||
156765862|NCT03238417|565898552|FG001|24-month|partial completion|31|||
156765863|NCT00106002|565898553|FG000|Overall Study|Did not take any study drug|1|||
156765864|NCT00106002|565898553|FG000|Overall Study|Ineligible after Registration|1|||
156765865|NCT01122173|565898558|FG000|Overall Study|Lost to Follow-up|3|||
156765866|NCT01122173|565898558|FG000|Overall Study|Withdrawal by Subject|3|||
156765867|NCT01122173|565898558|FG000|Overall Study|Left study for other reasons|3|||
156765868|NCT04210986|565898560|FG000|Overall Study|Lost to Follow-up|5|||
156765869|NCT04210986|565898561|FG001|Overall Study|Lost to Follow-up|2|||
156765870|NCT04210986|565898560|FG000|Overall Study|Withdrawal by Subject|3|||
156765871|NCT04210986|565898561|FG001|Overall Study|Withdrawal by Subject|1|||
156765872|NCT04210986|565898560|FG000|Overall Study|Protocol Violation|1|||
156765873|NCT04210986|565898561|FG001|Overall Study|Protocol Violation|1|||
156765874|NCT04210986|565898560|FG000|Overall Study|Physician Decision|0|||
156765875|NCT04210986|565898561|FG001|Overall Study|Physician Decision|1|||
156765876|NCT02378662|565898562|FG000|Overall Study|Early Discontinuation|2|||
156765877|NCT02378662|565898563|FG001|Overall Study|Early Discontinuation|0|||
156765878|NCT02295644|565898564|FG000|Overall Study|Did not meet inclusion criterion|0|||
156765879|NCT02295644|565898565|FG001|Overall Study|Did not meet inclusion criterion|0|||
156765880|NCT02295644|565898566|FG002|Overall Study|Did not meet inclusion criterion|1|||
156765881|NCT02295644|565898567|FG003|Overall Study|Did not meet inclusion criterion|2|||
156765882|NCT03101020|565898568|FG000|Overall Study|Lack of time to participate|1|||
156765883|NCT03101020|565898569|FG001|Overall Study|Lack of time to participate|0|||
156765884|NCT03101020|565898568|FG000|Overall Study|Ran over by a car|0|||
156765885|NCT03101020|565898569|FG001|Overall Study|Ran over by a car|1|||
156765886|NCT03101020|565898568|FG000|Overall Study|Withdrawal by Subject|0|||
156765887|NCT03101020|565898569|FG001|Overall Study|Withdrawal by Subject|2|||
156765888|NCT02616783|565898570|FG000|Overall Study|Randomized but Not Treated|1|||
156765889|NCT02616783|565898571|FG001|Overall Study|Randomized but Not Treated|0|||
156765890|NCT02616783|565898570|FG000|Overall Study|Adverse Event|1|||
156765891|NCT02616783|565898571|FG001|Overall Study|Adverse Event|0|||
156765892|NCT02616783|565898570|FG000|Overall Study|Death|1|||
156765893|NCT02616783|565898571|FG001|Overall Study|Death|0|||
156765894|NCT02616783|565898570|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156765895|NCT02616783|565898571|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156765896|NCT02616783|565898570|FG000|Overall Study|Protocol Violation|1|||
156765897|NCT02616783|565898571|FG001|Overall Study|Protocol Violation|1|||
156765898|NCT02616783|565898570|FG000|Overall Study|Withdrew Consent|1|||
156765899|NCT02616783|565898571|FG001|Overall Study|Withdrew Consent|1|||
156765900|NCT01103323|565898572|FG000|Without/Before Drug Switch|Adverse Event|50|||
156765901|NCT01103323|565898573|FG001|Without/Before Drug Switch|Adverse Event|7|||
156765902|NCT01103323|565898572|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
156765903|NCT01103323|565898573|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
156765904|NCT01103323|565898572|FG000|Without/Before Drug Switch|Protocol Violation|2|||
156765905|NCT01103323|565898573|FG001|Without/Before Drug Switch|Protocol Violation|0|||
156765906|NCT01103323|565898572|FG000|Without/Before Drug Switch|Physician Decision|2|||
156765907|NCT01103323|565898573|FG001|Without/Before Drug Switch|Physician Decision|0|||
156765908|NCT01103323|565898572|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
156765909|NCT01103323|565898573|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
156765910|NCT01103323|565898572|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
156765911|NCT01103323|565898573|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
156765912|NCT01103323|565898572|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
156765913|NCT01103323|565898573|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
156765914|NCT00372424|565898574|FG000|Overall Study|Adverse Event|2|||
156765915|NCT00372424|565898574|FG000|Overall Study|Withdrawal by Subject|1|||
156765916|NCT00372424|565898574|FG000|Overall Study|Death|1|||
156765917|NCT00372424|565898574|FG000|Overall Study|Objective Progression or Relapse|14|||
156765918|NCT00372424|565898574|FG000|Overall Study|Other|7|||
156765919|NCT00372424|565898574|FG000|Overall Study|Enrolled, Not Treated|1|||
156765920|NCT05214118|565898583|FG000|Overall Study|Lost to Follow-up|0|||
156765921|NCT05214118|565898584|FG001|Overall Study|Lost to Follow-up|2|||
156765922|NCT05214118|565898583|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
156765923|NCT05214118|565898584|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
156765924|NCT05214118|565898583|FG000|Overall Study|moved|1|||
156765925|NCT05214118|565898584|FG001|Overall Study|moved|0|||
156765926|NCT03797898|565898587|FG000|Overall Study|Lost to Follow-up|60|||
156765927|NCT03797898|565898588|FG001|Overall Study|Lost to Follow-up|69|||
156765928|NCT03797898|565898587|FG000|Overall Study|Withdrawal by Subject|9|||
156765929|NCT03797898|565898588|FG001|Overall Study|Withdrawal by Subject|7|||
156765930|NCT03797898|565898587|FG000|Overall Study|Became ineligible|5|||
156765931|NCT03797898|565898588|FG001|Overall Study|Became ineligible|2|||
156765932|NCT02314728|565898589|FG000|Overall Study|Protocol Violation|1|||
156765933|NCT02314728|565898590|FG001|Overall Study|Protocol Violation|0|||
156765934|NCT02314728|565898589|FG000|Overall Study|Lost to Follow-up|0|||
156765935|NCT02314728|565898590|FG001|Overall Study|Lost to Follow-up|1|||
156765936|NCT03080935|565898591|FG000|Overall Study|Death|34|||
156765937|NCT03080935|565898592|FG001|Overall Study|Death|50|||
156765938|NCT03080935|565898591|FG000|Overall Study|Lost to Follow-up|5|||
156765939|NCT03080935|565898592|FG001|Overall Study|Lost to Follow-up|4|||
156765940|NCT03080935|565898591|FG000|Overall Study|Withdrawal by Subject|11|||
156765941|NCT03080935|565898592|FG001|Overall Study|Withdrawal by Subject|15|||
156765942|NCT03118934|565898593|FG000|Overall Study|Adverse Event|0|||
156765943|NCT03118934|565898594|FG001|Overall Study|Adverse Event|0|||
156765944|NCT03118934|565898595|FG002|Overall Study|Adverse Event|0|||
156765945|NCT03118934|565898596|FG003|Overall Study|Adverse Event|0|||
156765946|NCT03118934|565898597|FG004|Overall Study|Adverse Event|0|||
156765947|NCT03118934|565898598|FG005|Overall Study|Adverse Event|1|||
156765948|NCT03118934|565898593|FG000|Overall Study|Physician Decision|0|||
156765949|NCT03118934|565898594|FG001|Overall Study|Physician Decision|0|||
156765950|NCT03118934|565898595|FG002|Overall Study|Physician Decision|0|||
156765951|NCT03118934|565898596|FG003|Overall Study|Physician Decision|0|||
156765952|NCT03118934|565898597|FG004|Overall Study|Physician Decision|0|||
156765953|NCT03118934|565898598|FG005|Overall Study|Physician Decision|1|||
156765954|NCT03118934|565898593|FG000|Overall Study|Discontinued prior to exposure|0|||
156765955|NCT03118934|565898594|FG001|Overall Study|Discontinued prior to exposure|1|||
156765956|NCT03118934|565898595|FG002|Overall Study|Discontinued prior to exposure|1|||
156765957|NCT03118934|565898596|FG003|Overall Study|Discontinued prior to exposure|1|||
156765958|NCT03118934|565898597|FG004|Overall Study|Discontinued prior to exposure|2|||
156765959|NCT03118934|565898598|FG005|Overall Study|Discontinued prior to exposure|0|||
156765960|NCT01614470|565898599|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
156765961|NCT01614470|565898600|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156765962|NCT01614470|565898601|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
156765963|NCT01614470|565898599|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
156765964|NCT01614470|565898600|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
156765965|NCT01614470|565898601|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
156765966|NCT03217591|565898602|FG000|Overall Study|Adverse Event|1|||
156765967|NCT03217591|565898603|FG001|Overall Study|Adverse Event|2|||
156765968|NCT03217591|565898604|FG002|Overall Study|Adverse Event|6|||
156765969|NCT03217591|565898602|FG000|Overall Study|Withdrawal by Subject|0|||
156765970|NCT03217591|565898603|FG001|Overall Study|Withdrawal by Subject|1|||
156765971|NCT03217591|565898604|FG002|Overall Study|Withdrawal by Subject|3|||
156765972|NCT03217591|565898602|FG000|Overall Study|Lost to Follow-up|1|||
156765973|NCT03217591|565898603|FG001|Overall Study|Lost to Follow-up|0|||
156765974|NCT03217591|565898604|FG002|Overall Study|Lost to Follow-up|0|||
156765975|NCT03217591|565898602|FG000|Overall Study|Protocol Violation|1|||
156765976|NCT03217591|565898603|FG001|Overall Study|Protocol Violation|0|||
156765977|NCT03217591|565898604|FG002|Overall Study|Protocol Violation|1|||
156765978|NCT00069264|565898619|FG000|Overall Study|Adverse Event|3|||
156765979|NCT00069264|565898619|FG000|Overall Study|Progressive Disease|23|||
156765980|NCT00069264|565898619|FG000|Overall Study|Withdrawal by Subject|3|||
156765981|NCT00069264|565898619|FG000|Overall Study|Discon Therapy|3|||
156765982|NCT04249427|565898622|FG000|Overall Study|Adverse Event|3|||
156765983|NCT04249427|565898623|FG001|Overall Study|Adverse Event|1|||
156765984|NCT04249427|565898622|FG000|Overall Study|Lack of Efficacy|0|||
156765985|NCT04249427|565898623|FG001|Overall Study|Lack of Efficacy|1|||
156765986|NCT04249427|565898622|FG000|Overall Study|Withdrawal by Subject|1|||
156765987|NCT04249427|565898623|FG001|Overall Study|Withdrawal by Subject|2|||
156765988|NCT02557399|565898624|FG000|Overall Study|Adverse Event|6|||
156765989|NCT02557399|565898625|FG001|Overall Study|Adverse Event|5|||
156765990|NCT02557399|565898624|FG000|Overall Study|Protocol Violation|0|||
156765991|NCT02557399|565898625|FG001|Overall Study|Protocol Violation|1|||
157111115|NCT04232553|567160509|FG007|Overall Study|Death|0|||
157111116|NCT04232553|567160510|FG008|Overall Study|Death|0|||
157111117|NCT04232553|567160502|FG000|Overall Study|Lack of Efficacy|0|||
157111118|NCT04232553|567160503|FG001|Overall Study|Lack of Efficacy|2|||
157111119|NCT04232553|567160504|FG002|Overall Study|Lack of Efficacy|0|||
157111120|NCT04232553|567160505|FG003|Overall Study|Lack of Efficacy|0|||
157111121|NCT04232553|567160506|FG004|Overall Study|Lack of Efficacy|0|||
157111122|NCT04232553|567160507|FG005|Overall Study|Lack of Efficacy|0|||
157111123|NCT04232553|567160508|FG006|Overall Study|Lack of Efficacy|0|||
157111124|NCT04232553|567160509|FG007|Overall Study|Lack of Efficacy|0|||
157111125|NCT04232553|567160510|FG008|Overall Study|Lack of Efficacy|1|||
157111126|NCT04232553|567160502|FG000|Overall Study|Lost to Follow-up|0|||
157111127|NCT04232553|567160503|FG001|Overall Study|Lost to Follow-up|1|||
157111128|NCT04232553|567160504|FG002|Overall Study|Lost to Follow-up|0|||
157111129|NCT04232553|567160505|FG003|Overall Study|Lost to Follow-up|0|||
157111130|NCT04232553|567160506|FG004|Overall Study|Lost to Follow-up|1|||
157111131|NCT04232553|567160507|FG005|Overall Study|Lost to Follow-up|0|||
157111132|NCT04232553|567160508|FG006|Overall Study|Lost to Follow-up|0|||
157111133|NCT04232553|567160509|FG007|Overall Study|Lost to Follow-up|0|||
157111134|NCT04232553|567160510|FG008|Overall Study|Lost to Follow-up|1|||
157111135|NCT04232553|567160502|FG000|Overall Study|Other - As reported by the investigator|0|||
157111136|NCT04232553|567160503|FG001|Overall Study|Other - As reported by the investigator|1|||
157111137|NCT04232553|567160504|FG002|Overall Study|Other - As reported by the investigator|0|||
157111138|NCT04232553|567160505|FG003|Overall Study|Other - As reported by the investigator|0|||
157111139|NCT04232553|567160506|FG004|Overall Study|Other - As reported by the investigator|0|||
157111140|NCT04232553|567160507|FG005|Overall Study|Other - As reported by the investigator|0|||
157111141|NCT04232553|567160508|FG006|Overall Study|Other - As reported by the investigator|0|||
157111142|NCT04232553|567160509|FG007|Overall Study|Other - As reported by the investigator|0|||
157111143|NCT04232553|567160510|FG008|Overall Study|Other - As reported by the investigator|0|||
157111144|NCT04232553|567160502|FG000|Overall Study|Physician Decision|1|||
157111145|NCT04232553|567160503|FG001|Overall Study|Physician Decision|1|||
157111146|NCT04232553|567160504|FG002|Overall Study|Physician Decision|0|||
157111147|NCT04232553|567160505|FG003|Overall Study|Physician Decision|0|||
157111148|NCT04232553|567160506|FG004|Overall Study|Physician Decision|1|||
157111149|NCT04232553|567160507|FG005|Overall Study|Physician Decision|0|||
157005932|NCT02296424|566771616|FG000|Part 2|Lost to Follow-up|0|||
157005933|NCT02296424|566771617|FG001|Part 2|Lost to Follow-up|0|||
157005934|NCT02296424|566771618|FG002|Part 2|Lost to Follow-up|1|||
157005935|NCT02296424|566771619|FG003|Part 2|Lost to Follow-up|0|||
157005936|NCT01337635|566771626|FG000|Overall Study|Lost to Follow-up|0|||
157005937|NCT01337635|566771627|FG001|Overall Study|Lost to Follow-up|1|||
157111150|NCT04232553|567160508|FG006|Overall Study|Physician Decision|0|||
156765992|NCT02557399|565898624|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156765993|NCT02557399|565898625|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156765994|NCT02557399|565898624|FG000|Overall Study|Withdrawal by Subject|1|||
156765995|NCT02557399|565898625|FG001|Overall Study|Withdrawal by Subject|1|||
156765996|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
156765997|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
157005938|NCT02950558|566771628|FG000|Overall Study|Lost to Follow-up|2|||
157005939|NCT02950558|566771629|FG001|Overall Study|Lost to Follow-up|0|||
157005940|NCT02537522|566771635|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
157005941|NCT02537522|566771636|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
157111151|NCT04232553|567160509|FG007|Overall Study|Physician Decision|0|||
157111152|NCT04232553|567160510|FG008|Overall Study|Physician Decision|0|||
157111153|NCT04232553|567160502|FG000|Overall Study|Pregnancy|1|||
157111154|NCT04232553|567160503|FG001|Overall Study|Pregnancy|0|||
157111155|NCT04232553|567160504|FG002|Overall Study|Pregnancy|0|||
157111156|NCT04232553|567160505|FG003|Overall Study|Pregnancy|0|||
157111157|NCT04232553|567160506|FG004|Overall Study|Pregnancy|0|||
156765998|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
156765999|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
156766000|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
156766001|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
156766002|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
156766003|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
157111158|NCT04232553|567160507|FG005|Overall Study|Pregnancy|0|||
157111159|NCT04232553|567160508|FG006|Overall Study|Pregnancy|0|||
157111160|NCT04232553|567160509|FG007|Overall Study|Pregnancy|0|||
157111161|NCT04232553|567160510|FG008|Overall Study|Pregnancy|0|||
157111162|NCT04232553|567160502|FG000|Overall Study|Withdrawal by Subject|7|||
157111163|NCT04232553|567160503|FG001|Overall Study|Withdrawal by Subject|5|||
157111164|NCT04232553|567160504|FG002|Overall Study|Withdrawal by Subject|0|||
157111165|NCT04232553|567160505|FG003|Overall Study|Withdrawal by Subject|0|||
157111166|NCT04232553|567160506|FG004|Overall Study|Withdrawal by Subject|2|||
157111167|NCT04232553|567160507|FG005|Overall Study|Withdrawal by Subject|2|||
157111168|NCT04232553|567160508|FG006|Overall Study|Withdrawal by Subject|0|||
157111169|NCT04232553|567160509|FG007|Overall Study|Withdrawal by Subject|2|||
157111170|NCT04232553|567160510|FG008|Overall Study|Withdrawal by Subject|0|||
157111171|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
157111172|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
157111173|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Death|0|||
157111174|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Death|1|||
157111175|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
157111176|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
157111177|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
157111178|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
157111179|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
157111180|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
157111181|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
157111182|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
157111183|NCT00843518|567160513|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
157111184|NCT00843518|567160514|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
157111185|NCT00133991|567160515|FG000|Overall Study|Death|4|||
157111186|NCT02664272|567160516|FG000|Overall Study|Fluoroscopic images not made available|2|||
156766004|NCT02849080|565898627|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
156766005|NCT02849080|565898628|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
157111187|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
157111188|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
157111189|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
157111190|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
157111191|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
157111192|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
157111193|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
157111194|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156766006|NCT02849080|565898629|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
156766007|NCT02849080|565898630|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
156766008|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
156766009|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766010|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766011|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
156766012|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
156766013|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
156766014|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
156766015|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
156766016|NCT02849080|565898627|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
156766017|NCT02849080|565898628|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766018|NCT02849080|565898629|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766019|NCT02849080|565898630|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
156766020|NCT00449163|565898633|FG000|Overall Study|Physician Decision|3|||
157111195|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
157111196|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
156766021|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
156766022|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
157111197|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
157111198|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
156766023|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
156766024|NCT03368807|565898646|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
157111199|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
156766025|NCT00369343|565898661|FG000|Double-blind Phase|Adverse Event|19|||
156766026|NCT00369343|565898662|FG001|Double-blind Phase|Adverse Event|4|||
156766027|NCT00369343|565898661|FG000|Double-blind Phase|Failed to return|2|||
156766028|NCT00369343|565898662|FG001|Double-blind Phase|Failed to return|0|||
156766029|NCT00369343|565898661|FG000|Double-blind Phase|Lost to Follow-up|9|||
156766030|NCT00369343|565898662|FG001|Double-blind Phase|Lost to Follow-up|2|||
156766031|NCT00369343|565898661|FG000|Double-blind Phase|Protocol Violation|2|||
156766032|NCT00369343|565898662|FG001|Double-blind Phase|Protocol Violation|0|||
156766033|NCT00369343|565898661|FG000|Double-blind Phase|Withdrawal by Subject|8|||
156766034|NCT00369343|565898662|FG001|Double-blind Phase|Withdrawal by Subject|6|||
156766035|NCT00369343|565898661|FG000|Double-blind Phase|Lack of Efficacy|0|||
156766036|NCT00369343|565898662|FG001|Double-blind Phase|Lack of Efficacy|4|||
156766037|NCT00369343|565898661|FG000|Double-blind Phase|Protocol deviation|4|||
156766038|NCT00369343|565898662|FG001|Double-blind Phase|Protocol deviation|0|||
156766039|NCT00369343|565898661|FG000|Open-label Phase|Adverse Event|19|||
156766040|NCT00369343|565898662|FG001|Open-label Phase|Adverse Event|7|||
156766041|NCT00369343|565898661|FG000|Open-label Phase|Failed to return|4|||
156766042|NCT00369343|565898662|FG001|Open-label Phase|Failed to return|0|||
156766043|NCT00369343|565898661|FG000|Open-label Phase|Physician Decision|2|||
156766044|NCT00369343|565898662|FG001|Open-label Phase|Physician Decision|0|||
156766045|NCT00369343|565898661|FG000|Open-label Phase|Lost to Follow-up|5|||
156766046|NCT00369343|565898662|FG001|Open-label Phase|Lost to Follow-up|3|||
156766047|NCT00369343|565898661|FG000|Open-label Phase|inadvertently reported study completers|3|||
156766048|NCT00369343|565898662|FG001|Open-label Phase|inadvertently reported study completers|2|||
156766049|NCT00369343|565898661|FG000|Open-label Phase|Protocol Violation|1|||
156766050|NCT00369343|565898662|FG001|Open-label Phase|Protocol Violation|3|||
156766051|NCT00369343|565898661|FG000|Open-label Phase|Withdrawal by Subject|15|||
156766052|NCT00369343|565898662|FG001|Open-label Phase|Withdrawal by Subject|6|||
156766053|NCT00369343|565898661|FG000|Open-label Phase|Lack of Efficacy|4|||
156766054|NCT00369343|565898662|FG001|Open-label Phase|Lack of Efficacy|3|||
156766055|NCT00369343|565898661|FG000|Open-label Phase|Lack of continuance tolerability|3|||
157111200|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
157111201|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
157111202|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
157111203|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
157111204|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
157111205|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
157111206|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
157111207|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
156766056|NCT00369343|565898662|FG001|Open-label Phase|Lack of continuance tolerability|4|||
156766057|NCT00369343|565898661|FG000|Open-label Phase|did not take study drug|1|||
156766058|NCT00369343|565898662|FG001|Open-label Phase|did not take study drug|2|||
156766059|NCT02949947|565898663|FG000|Overall Study|Non Compliance|0|||
156766060|NCT02949947|565898664|FG001|Overall Study|Non Compliance|1|||
156766061|NCT02949947|565898663|FG000|Overall Study|Insurance change|1|||
156766062|NCT02949947|565898664|FG001|Overall Study|Insurance change|0|||
156766063|NCT01973218|565898667|FG000|Overall Study|Adverse Event|1|||
156766064|NCT01973218|565898668|FG001|Overall Study|Adverse Event|0|||
156766065|NCT01973218|565898667|FG000|Overall Study|Withdrawal by Subject|1|||
156766066|NCT01973218|565898668|FG001|Overall Study|Withdrawal by Subject|0|||
156766067|NCT02247466|565898669|FG000|Overall Study|Procedure changed to open surgery|0|||
156766068|NCT02247466|565898670|FG001|Overall Study|Procedure changed to open surgery|3|||
157111208|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
156766069|NCT00492726|565898671|FG000|Overall Study|Adverse Event|10|||
156766070|NCT00492726|565898672|FG001|Overall Study|Adverse Event|6|||
156766071|NCT00492726|565898671|FG000|Overall Study|Death|7|||
156766072|NCT00492726|565898672|FG001|Overall Study|Death|2|||
156766073|NCT00492726|565898671|FG000|Overall Study|Lack of Efficacy|0|||
156766074|NCT00492726|565898672|FG001|Overall Study|Lack of Efficacy|2|||
156766075|NCT00492726|565898671|FG000|Overall Study|Lost to Follow-up|27|||
156766076|NCT00492726|565898672|FG001|Overall Study|Lost to Follow-up|19|||
156766077|NCT00492726|565898671|FG000|Overall Study|Physician Decision|0|||
156766078|NCT00492726|565898672|FG001|Overall Study|Physician Decision|1|||
156766079|NCT00492726|565898671|FG000|Overall Study|Withdrawal by Subject|6|||
156766080|NCT00492726|565898672|FG001|Overall Study|Withdrawal by Subject|3|||
156766081|NCT00492726|565898671|FG000|Overall Study|Non compliant with study medication|0|||
156766082|NCT00492726|565898672|FG001|Overall Study|Non compliant with study medication|3|||
156766083|NCT04386902|565898673|FG000|Overall Study|Withdrawal by Subject|5|||
156766084|NCT04386902|565898673|FG000|Overall Study|Technical problems in the recording|5|||
156766085|NCT01100502|565898674|FG000|Overall Study|Withdrawal by Subject|18|||
156766086|NCT01100502|565898675|FG001|Overall Study|Withdrawal by Subject|25|||
156766087|NCT01100502|565898674|FG000|Overall Study|Lost to Follow-up|13|||
156766088|NCT01100502|565898675|FG001|Overall Study|Lost to Follow-up|28|||
156766089|NCT01100502|565898674|FG000|Overall Study|Site request to end participation in study|0|||
156766090|NCT01100502|565898675|FG001|Overall Study|Site request to end participation in study|1|||
156766091|NCT01100502|565898674|FG000|Overall Study|Death|45|||
156766092|NCT01100502|565898675|FG001|Overall Study|Death|40|||
156766093|NCT04356937|565898678|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
156766094|NCT04356937|565898679|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
156766095|NCT00960804|565898680|FG000|Overall Study|Adverse Event|1|||
156766096|NCT00960804|565898681|FG001|Overall Study|Adverse Event|0|||
156766097|NCT00960804|565898682|FG002|Overall Study|Adverse Event|0|||
156766098|NCT00960804|565898680|FG000|Overall Study|Withdrawal by Subject|1|||
156766099|NCT00960804|565898681|FG001|Overall Study|Withdrawal by Subject|0|||
156766100|NCT00960804|565898682|FG002|Overall Study|Withdrawal by Subject|0|||
156766101|NCT00960804|565898680|FG000|Overall Study|Study terminated by the sponsor|5|||
157111209|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
157111210|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
157111211|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Death|2|||
157111212|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Death|1|||
157111213|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Death|0|||
157111214|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Death|0|||
157111215|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
157111216|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
156766102|NCT00960804|565898681|FG001|Overall Study|Study terminated by the sponsor|4|||
157111217|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
157111218|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
157111219|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
157111220|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
157111221|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
157111222|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
157111223|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
157111224|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
157111225|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
157111226|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
157111227|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
156766103|NCT00960804|565898682|FG002|Overall Study|Study terminated by the sponsor|10|||
156766104|NCT01190891|565900382|FG000|Overall Study|Protocol Violation|1|||
156766105|NCT01190891|565900383|FG001|Overall Study|Protocol Violation|0|||
156766106|NCT01190891|565900382|FG000|Overall Study|Withdrawal by Subject|5|||
156766107|NCT01190891|565900383|FG001|Overall Study|Withdrawal by Subject|0|||
156766108|NCT01926028|565900384|FG000|Overall Study|Lost to Follow-up|7|||
157005942|NCT02537522|566771637|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
157005943|NCT02537522|566771638|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
157005944|NCT02537522|566771635|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
157005945|NCT02537522|566771636|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
157005946|NCT02537522|566771637|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
157005947|NCT02537522|566771638|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
157005948|NCT02537522|566771635|FG000|Phase I - Contralateral|incorrect randomization|0|||
156766109|NCT01926028|565900385|FG001|Overall Study|Lost to Follow-up|6|||
156766110|NCT01926028|565900386|FG002|Overall Study|Lost to Follow-up|0|||
156766111|NCT01926028|565900384|FG000|Overall Study|Physician Decision|1|||
156766112|NCT01926028|565900385|FG001|Overall Study|Physician Decision|5|||
157005949|NCT02537522|566771636|FG001|Phase I - Contralateral|incorrect randomization|1|||
157005950|NCT02537522|566771637|FG002|Phase I - Contralateral|incorrect randomization|0|||
157005951|NCT02537522|566771638|FG003|Phase I - Contralateral|incorrect randomization|0|||
156766113|NCT01926028|565900386|FG002|Overall Study|Physician Decision|0|||
156766114|NCT01926028|565900384|FG000|Overall Study|Withdrawal by Subject|9|||
156766115|NCT01926028|565900385|FG001|Overall Study|Withdrawal by Subject|9|||
156766116|NCT01926028|565900386|FG002|Overall Study|Withdrawal by Subject|2|||
156766117|NCT01926028|565900384|FG000|Overall Study|Non compliance or other reasons|4|||
156766118|NCT01926028|565900385|FG001|Overall Study|Non compliance or other reasons|2|||
157111228|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
157111229|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
157111230|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
157111231|NCT01940471|567160517|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
157111232|NCT01940471|567160518|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
157111233|NCT01940471|567160519|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
157111234|NCT01940471|567160520|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
157111235|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
157111236|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
157111237|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
157111238|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
157111239|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
157111240|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
157111241|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
157111242|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
157111243|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
157111244|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
157111245|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
157111246|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
157111247|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
157111248|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
157111249|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
157111250|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
157111251|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
157111252|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
157111253|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
157111254|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
156766119|NCT01926028|565900386|FG002|Overall Study|Non compliance or other reasons|0|||
156766120|NCT04635839|565900387|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
156766121|NCT04635839|565900388|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
156766122|NCT02669849|565900394|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156766123|NCT02669849|565900395|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
156766124|NCT02669849|565900396|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
157111255|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
157111256|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
157111257|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
157111258|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
157111259|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157111260|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157111261|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
157111262|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157111263|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
157111264|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
157111265|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
157111266|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
157111267|NCT01940471|567160517|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157111268|NCT01940471|567160518|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157111269|NCT01940471|567160519|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
157111270|NCT01940471|567160520|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157111271|NCT01131520|567160521|FG000|Overall Study|Computer problem|1|||
157111272|NCT01131520|567160522|FG001|Overall Study|Computer problem|0|||
157111273|NCT01131520|567160521|FG000|Overall Study|Counselor not available|0|||
157111274|NCT01131520|567160522|FG001|Overall Study|Counselor not available|3|||
157111275|NCT01131520|567160521|FG000|Overall Study|Subject changed history after enrollment|0|||
157111276|NCT01131520|567160522|FG001|Overall Study|Subject changed history after enrollment|1|||
157111277|NCT04857996|567160529|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
157111278|NCT04857996|567160530|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
156766125|NCT02669849|565900394|FG000|Overall Study|Lost to Follow-up|1|||
156766126|NCT02669849|565900395|FG001|Overall Study|Lost to Follow-up|0|||
156766127|NCT02669849|565900396|FG002|Overall Study|Lost to Follow-up|3|||
156766128|NCT02669849|565900394|FG000|Overall Study|Death|1|||
156766129|NCT02669849|565900395|FG001|Overall Study|Death|1|||
156766130|NCT02669849|565900396|FG002|Overall Study|Death|2|||
156766131|NCT02669849|565900394|FG000|Overall Study|Study terminated by sponsor|16|||
156766132|NCT02669849|565900395|FG001|Overall Study|Study terminated by sponsor|1|||
156766133|NCT02669849|565900396|FG002|Overall Study|Study terminated by sponsor|14|||
156766134|NCT02669849|565900394|FG000|Overall Study|Other|0|||
156766135|NCT02669849|565900395|FG001|Overall Study|Other|0|||
156766136|NCT02669849|565900396|FG002|Overall Study|Other|2|||
156766137|NCT03408899|565900397|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
156766138|NCT00606008|565900398|FG000|Overall Study|Adverse Event|1|||
156766139|NCT00606008|565900398|FG000|Overall Study|Withdrawal by Subject|4|||
156766140|NCT04745351|565900399|FG000|Overall Study|Death|51|||
156766141|NCT04745351|565900400|FG001|Overall Study|Death|25|||
156766142|NCT04745351|565900399|FG000|Overall Study|Lost to Follow-up|9|||
156766143|NCT04745351|565900400|FG001|Overall Study|Lost to Follow-up|3|||
156766144|NCT04745351|565900399|FG000|Overall Study|Randomized but Never Treated|3|||
156766145|NCT04745351|565900400|FG001|Overall Study|Randomized but Never Treated|3|||
156766146|NCT04745351|565900399|FG000|Overall Study|Adverse Event|4|||
156766147|NCT04745351|565900400|FG001|Overall Study|Adverse Event|0|||
156766148|NCT04745351|565900399|FG000|Overall Study|Withdrew Consent|1|||
156766149|NCT04745351|565900400|FG001|Overall Study|Withdrew Consent|2|||
156766150|NCT04745351|565900399|FG000|Overall Study|Investigator's Discretion|2|||
156766151|NCT04745351|565900400|FG001|Overall Study|Investigator's Discretion|0|||
156766152|NCT04745351|565900399|FG000|Overall Study|Protocol Violation|1|||
156766153|NCT04745351|565900400|FG001|Overall Study|Protocol Violation|0|||
156766154|NCT02426684|565900401|FG000|Overall Study|Physician Decision|1|||
156766155|NCT01587885|565900404|FG000|Treatment Period 1|Failure to Return|0|||
156766156|NCT01587885|565900405|FG001|Treatment Period 1|Failure to Return|1|||
156766157|NCT01587885|565900404|FG000|Treatment Period 1|Protocol Violation|0|||
156766158|NCT01587885|565900405|FG001|Treatment Period 1|Protocol Violation|2|||
156766159|NCT00977197|565900406|FG000|Overall Study|Withdrawal by Subject|3|||
156766160|NCT00977197|565900407|FG001|Overall Study|Withdrawal by Subject|4|||
156766161|NCT00977197|565900406|FG000|Overall Study|Adverse Event|3|||
156766162|NCT00977197|565900407|FG001|Overall Study|Adverse Event|1|||
156766163|NCT00977197|565900406|FG000|Overall Study|Lack of Efficacy|1|||
156766164|NCT00977197|565900407|FG001|Overall Study|Lack of Efficacy|0|||
156766165|NCT00977197|565900406|FG000|Overall Study|Lost to Follow-up|1|||
156766166|NCT00977197|565900407|FG001|Overall Study|Lost to Follow-up|3|||
156766167|NCT00977197|565900406|FG000|Overall Study|Nonadherence|1|||
156766168|NCT00977197|565900407|FG001|Overall Study|Nonadherence|1|||
156766169|NCT02265510|565900408|FG000|Overall Study|Withdrawal by Subject|1|||
156766170|NCT02265510|565900409|FG001|Overall Study|Withdrawal by Subject|1|||
156766171|NCT02265510|565900410|FG002|Overall Study|Withdrawal by Subject|2|||
156766172|NCT02265510|565900411|FG003|Overall Study|Withdrawal by Subject|1|||
156766173|NCT02265510|565900412|FG004|Overall Study|Withdrawal by Subject|0|||
156766174|NCT02265510|565900413|FG005|Overall Study|Withdrawal by Subject|2|||
156766175|NCT02265510|565900414|FG006|Overall Study|Withdrawal by Subject|0|||
156766176|NCT02265510|565900415|FG007|Overall Study|Withdrawal by Subject|2|||
156766177|NCT02265510|565900416|FG008|Overall Study|Withdrawal by Subject|0|||
156766178|NCT02265510|565900417|FG009|Overall Study|Withdrawal by Subject|0|||
157111279|NCT04857996|567160529|FG000|Overall Study|Lost to Follow-up|1|||
156766179|NCT02265510|565900418|FG010|Overall Study|Withdrawal by Subject|0|||
156766180|NCT02265510|565900419|FG011|Overall Study|Withdrawal by Subject|0|||
156766181|NCT02265510|565900420|FG012|Overall Study|Withdrawal by Subject|1|||
156766182|NCT02265510|565900421|FG013|Overall Study|Withdrawal by Subject|0|||
156766183|NCT02265510|565900408|FG000|Overall Study|Disease Progression|0|||
156766184|NCT02265510|565900409|FG001|Overall Study|Disease Progression|1|||
156766185|NCT02265510|565900410|FG002|Overall Study|Disease Progression|2|||
157111280|NCT04857996|567160530|FG001|Overall Study|Lost to Follow-up|3|||
156766186|NCT02265510|565900411|FG003|Overall Study|Disease Progression|1|||
156766187|NCT02265510|565900412|FG004|Overall Study|Disease Progression|1|||
156766188|NCT02265510|565900413|FG005|Overall Study|Disease Progression|0|||
156766189|NCT02265510|565900414|FG006|Overall Study|Disease Progression|0|||
156766190|NCT02265510|565900415|FG007|Overall Study|Disease Progression|0|||
156766191|NCT02265510|565900416|FG008|Overall Study|Disease Progression|0|||
156766192|NCT02265510|565900417|FG009|Overall Study|Disease Progression|0|||
156766193|NCT02265510|565900418|FG010|Overall Study|Disease Progression|0|||
156766194|NCT02265510|565900419|FG011|Overall Study|Disease Progression|0|||
156766195|NCT02265510|565900420|FG012|Overall Study|Disease Progression|0|||
156766196|NCT02265510|565900421|FG013|Overall Study|Disease Progression|0|||
156766197|NCT02265510|565900408|FG000|Overall Study|Death|2|||
156766198|NCT02265510|565900409|FG001|Overall Study|Death|0|||
156766199|NCT02265510|565900410|FG002|Overall Study|Death|2|||
156766200|NCT02265510|565900411|FG003|Overall Study|Death|2|||
156766201|NCT02265510|565900412|FG004|Overall Study|Death|1|||
156766202|NCT02265510|565900413|FG005|Overall Study|Death|3|||
156766203|NCT02265510|565900414|FG006|Overall Study|Death|2|||
156766204|NCT02265510|565900415|FG007|Overall Study|Death|1|||
156766205|NCT02265510|565900416|FG008|Overall Study|Death|3|||
156766206|NCT02265510|565900417|FG009|Overall Study|Death|3|||
156766207|NCT02265510|565900418|FG010|Overall Study|Death|4|||
156766208|NCT02265510|565900419|FG011|Overall Study|Death|12|||
156766209|NCT02265510|565900420|FG012|Overall Study|Death|7|||
157111281|NCT04857996|567160529|FG000|Overall Study|Site Closure|1|||
157111282|NCT04857996|567160530|FG001|Overall Study|Site Closure|0|||
157111283|NCT04857996|567160529|FG000|Overall Study|Withdrawal by Subject|1|||
157111284|NCT04857996|567160530|FG001|Overall Study|Withdrawal by Subject|0|||
157111285|NCT01129921|567160531|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
157111286|NCT01129921|567160532|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
157111287|NCT01129921|567160531|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
157111288|NCT01129921|567160532|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
157111289|NCT01129921|567160531|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
157111290|NCT01129921|567160532|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
157111291|NCT01129921|567160531|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
157111292|NCT01129921|567160532|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
157111293|NCT02988661|567160533|FG000|Overall Study|Death|2|||
157111294|NCT02988661|567160534|FG001|Overall Study|Death|18|||
157111295|NCT02988661|567160533|FG000|Overall Study|Lost to Follow-up|0|||
157111296|NCT02988661|567160534|FG001|Overall Study|Lost to Follow-up|33|||
157111297|NCT02988661|567160533|FG000|Overall Study|Withdrawal by Subject|0|||
157111298|NCT02988661|567160534|FG001|Overall Study|Withdrawal by Subject|6|||
157111299|NCT02988661|567160533|FG000|Overall Study|Unable to complete the 18-month survey|1|||
157111300|NCT02988661|567160534|FG001|Overall Study|Unable to complete the 18-month survey|27|||
157111301|NCT01392677|567160535|FG000|Overall Study|Adverse Event|3|||
157111302|NCT01392677|567160536|FG001|Overall Study|Adverse Event|1|||
157111303|NCT01392677|567160535|FG000|Overall Study|Withdrawal by Subject|0|||
157111304|NCT01392677|567160536|FG001|Overall Study|Withdrawal by Subject|2|||
157111305|NCT01392677|567160535|FG000|Overall Study|Incorrect enrollment|2|||
157111306|NCT01392677|567160536|FG001|Overall Study|Incorrect enrollment|3|||
157111307|NCT01392677|567160535|FG000|Overall Study|Other reason|3|||
157111308|NCT01392677|567160536|FG001|Overall Study|Other reason|2|||
157111309|NCT01380379|567160537|FG000|Overall Study|Pregnancy|1|||
157111310|NCT05937165|567160540|FG000|Overall Study|Withdrawal by Subject|0|||
157111311|NCT05937165|567160541|FG001|Overall Study|Withdrawal by Subject|1|||
157111312|NCT05493280|567160542|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
157111313|NCT05493280|567160543|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
157111314|NCT06608368|567160544|FG000|Overall Study|Family Emergency|0|||
157111315|NCT06608368|567160545|FG001|Overall Study|Family Emergency|1|||
157111316|NCT06608368|567160546|FG002|Overall Study|Family Emergency|0|||
157111317|NCT06608368|567160544|FG000|Overall Study|Scheduling Issues|0|||
157111318|NCT06608368|567160545|FG001|Overall Study|Scheduling Issues|1|||
157111319|NCT06608368|567160546|FG002|Overall Study|Scheduling Issues|0|||
157111320|NCT03977974|567160547|FG000|Period 2|Adverse Event|0|||
157111321|NCT03977974|567160548|FG001|Period 2|Adverse Event|0|||
157111322|NCT03977974|567160549|FG002|Period 2|Adverse Event|0|||
157111323|NCT03977974|567160550|FG003|Period 2|Adverse Event|0|||
157111324|NCT03977974|567160551|FG004|Period 2|Adverse Event|1|||
157111325|NCT03977974|567160552|FG005|Period 2|Adverse Event|0|||
157111326|NCT03977974|567160553|FG006|Period 2|Adverse Event|0|||
157111327|NCT03977974|567160554|FG007|Period 2|Adverse Event|0|||
157111328|NCT03977974|567160555|FG008|Period 2|Adverse Event|0|||
157111329|NCT03977974|567160556|FG009|Period 2|Adverse Event|0|||
157111330|NCT03977974|567160557|FG010|Period 2|Adverse Event|0|||
157111331|NCT03977974|567160558|FG011|Period 2|Adverse Event|0|||
157111332|NCT03977974|567160559|FG012|Period 2|Adverse Event|0|||
157111333|NCT04526899|567160561|FG000|Overall Study|Withdrawal by Subject|3|||
157111334|NCT04526899|567160562|FG001|Overall Study|Withdrawal by Subject|2|||
157111335|NCT04526899|567160563|FG002|Overall Study|Withdrawal by Subject|2|||
157111336|NCT04526899|567160561|FG000|Overall Study|Lost to Follow-up|3|||
157111337|NCT04526899|567160562|FG001|Overall Study|Lost to Follow-up|3|||
157111338|NCT04526899|567160563|FG002|Overall Study|Lost to Follow-up|1|||
157111339|NCT04526899|567160561|FG000|Overall Study|Investigator's decision|1|||
157111340|NCT04526899|567160562|FG001|Overall Study|Investigator's decision|0|||
156766210|NCT02265510|565900421|FG013|Overall Study|Death|6|||
156766211|NCT02265510|565900408|FG000|Overall Study|Lost to Follow-up|0|||
156766212|NCT02265510|565900409|FG001|Overall Study|Lost to Follow-up|0|||
156766213|NCT02265510|565900410|FG002|Overall Study|Lost to Follow-up|0|||
157111341|NCT04526899|567160563|FG002|Overall Study|Investigator's decision|0|||
156766214|NCT02265510|565900411|FG003|Overall Study|Lost to Follow-up|0|||
156766215|NCT02265510|565900412|FG004|Overall Study|Lost to Follow-up|1|||
156766216|NCT02265510|565900413|FG005|Overall Study|Lost to Follow-up|0|||
157111342|NCT04526899|567160561|FG000|Overall Study|Death|33|||
157111343|NCT04526899|567160562|FG001|Overall Study|Death|17|||
157111344|NCT04526899|567160563|FG002|Overall Study|Death|13|||
156766217|NCT02265510|565900414|FG006|Overall Study|Lost to Follow-up|0|||
157111345|NCT04526899|567160561|FG000|Overall Study|Other|1|||
156766218|NCT02265510|565900415|FG007|Overall Study|Lost to Follow-up|0|||
156766219|NCT02265510|565900416|FG008|Overall Study|Lost to Follow-up|0|||
156766220|NCT02265510|565900417|FG009|Overall Study|Lost to Follow-up|2|||
156766221|NCT02265510|565900418|FG010|Overall Study|Lost to Follow-up|0|||
156766222|NCT02265510|565900419|FG011|Overall Study|Lost to Follow-up|0|||
156766223|NCT02265510|565900420|FG012|Overall Study|Lost to Follow-up|0|||
156766224|NCT02265510|565900421|FG013|Overall Study|Lost to Follow-up|2|||
156766225|NCT02265510|565900408|FG000|Overall Study|Other|0|||
156766226|NCT02265510|565900409|FG001|Overall Study|Other|1|||
156766227|NCT02265510|565900410|FG002|Overall Study|Other|0|||
156766228|NCT02265510|565900411|FG003|Overall Study|Other|0|||
156766229|NCT02265510|565900412|FG004|Overall Study|Other|0|||
156766230|NCT02265510|565900413|FG005|Overall Study|Other|0|||
156766231|NCT02265510|565900414|FG006|Overall Study|Other|0|||
156766232|NCT02265510|565900415|FG007|Overall Study|Other|0|||
156766233|NCT02265510|565900416|FG008|Overall Study|Other|0|||
156766234|NCT02265510|565900417|FG009|Overall Study|Other|0|||
156766235|NCT02265510|565900418|FG010|Overall Study|Other|0|||
156766236|NCT02265510|565900419|FG011|Overall Study|Other|0|||
156766237|NCT02265510|565900420|FG012|Overall Study|Other|0|||
156766238|NCT02265510|565900421|FG013|Overall Study|Other|0|||
156766239|NCT02265510|565900408|FG000|Overall Study|Study Terminated by Sponsor|0|||
156766240|NCT02265510|565900409|FG001|Overall Study|Study Terminated by Sponsor|0|||
156766241|NCT02265510|565900410|FG002|Overall Study|Study Terminated by Sponsor|0|||
156766242|NCT02265510|565900411|FG003|Overall Study|Study Terminated by Sponsor|0|||
156766243|NCT02265510|565900412|FG004|Overall Study|Study Terminated by Sponsor|0|||
156766244|NCT02265510|565900413|FG005|Overall Study|Study Terminated by Sponsor|1|||
156766245|NCT02265510|565900414|FG006|Overall Study|Study Terminated by Sponsor|1|||
156766246|NCT02265510|565900415|FG007|Overall Study|Study Terminated by Sponsor|1|||
156766247|NCT02265510|565900416|FG008|Overall Study|Study Terminated by Sponsor|1|||
156766248|NCT02265510|565900417|FG009|Overall Study|Study Terminated by Sponsor|2|||
156766249|NCT02265510|565900418|FG010|Overall Study|Study Terminated by Sponsor|1|||
156766250|NCT02265510|565900419|FG011|Overall Study|Study Terminated by Sponsor|4|||
156766251|NCT02265510|565900420|FG012|Overall Study|Study Terminated by Sponsor|1|||
156766252|NCT02265510|565900421|FG013|Overall Study|Study Terminated by Sponsor|2|||
156766253|NCT02530385|565900422|FG000|Overall Study|Withdrawal by Subject|0|||
156766254|NCT02530385|565900423|FG001|Overall Study|Withdrawal by Subject|1|||
156766255|NCT00116142|565900424|FG000|Overall Study|Adverse Event|8|||
156766256|NCT00116142|565900425|FG001|Overall Study|Adverse Event|7|||
156766257|NCT00116142|565900424|FG000|Overall Study|Protocol Violation|2|||
156766258|NCT00116142|565900425|FG001|Overall Study|Protocol Violation|1|||
156766259|NCT00116142|565900424|FG000|Overall Study|Withdrawal by Subject|5|||
156766260|NCT00116142|565900425|FG001|Overall Study|Withdrawal by Subject|5|||
156766261|NCT00116142|565900424|FG000|Overall Study|Physician Decision|3|||
156766262|NCT00116142|565900425|FG001|Overall Study|Physician Decision|1|||
156766263|NCT00116142|565900424|FG000|Overall Study|Delayed Radiation Therapy|1|||
156766264|NCT00116142|565900425|FG001|Overall Study|Delayed Radiation Therapy|0|||
156766265|NCT00116142|565900424|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
156766266|NCT00116142|565900425|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
157111346|NCT04526899|567160562|FG001|Overall Study|Other|0|||
156766267|NCT00116142|565900424|FG000|Overall Study|Patient stopped due to depression|0|||
156766268|NCT00116142|565900425|FG001|Overall Study|Patient stopped due to depression|1|||
156766269|NCT00116142|565900424|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
156766270|NCT00116142|565900425|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
156766271|NCT00116142|565900424|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
156766272|NCT00116142|565900425|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
156766273|NCT00116142|565900424|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
156766274|NCT00116142|565900425|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
156766275|NCT02133508|565900426|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
156766276|NCT02133508|565900426|FG000|Overall Study|Death|12|||
156766277|NCT02133508|565900426|FG000|Overall Study|Lost to Follow-up|2|||
156766278|NCT01026493|565900427|FG000|Overall Study|Protocol Violation|0|||
156766279|NCT01026493|565900428|FG001|Overall Study|Protocol Violation|1|||
157111347|NCT04526899|567160563|FG002|Overall Study|Other|0|||
157111348|NCT04526899|567160561|FG000|Overall Study|On-Treatment|19|||
157111349|NCT04526899|567160562|FG001|Overall Study|On-Treatment|10|||
157111350|NCT04526899|567160563|FG002|Overall Study|On-Treatment|12|||
157111351|NCT04526899|567160561|FG000|Overall Study|Survival Follow-up|34|||
157111352|NCT04526899|567160562|FG001|Overall Study|Survival Follow-up|14|||
157111353|NCT04526899|567160563|FG002|Overall Study|Survival Follow-up|16|||
157111354|NCT00075400|567161718|FG000|Overall Study|Ineligible: wrong primary|1|||
157111355|NCT00075400|567161718|FG000|Overall Study|Never treated|2|||
157111356|NCT00666458|567161725|FG000|Overall Study|Adverse Event|8|||
157111357|NCT00666458|567161726|FG001|Overall Study|Adverse Event|7|||
157111358|NCT00666458|567161725|FG000|Overall Study|Withdrawal by Subject|5|||
157111359|NCT00666458|567161726|FG001|Overall Study|Withdrawal by Subject|4|||
157111360|NCT00666458|567161725|FG000|Overall Study|Lost to Follow-up|0|||
157111361|NCT00666458|567161726|FG001|Overall Study|Lost to Follow-up|3|||
157111362|NCT00666458|567161725|FG000|Overall Study|Administrative reason by sponsor|1|||
157111363|NCT00666458|567161726|FG001|Overall Study|Administrative reason by sponsor|1|||
157111364|NCT00666458|567161725|FG000|Overall Study|Incorrect enrollment|7|||
157111365|NCT00666458|567161726|FG001|Overall Study|Incorrect enrollment|1|||
157111366|NCT00666458|567161725|FG000|Overall Study|Study specific discontinuation criteria|14|||
157111367|NCT00666458|567161726|FG001|Overall Study|Study specific discontinuation criteria|7|||
157111368|NCT00666458|567161725|FG000|Overall Study|Severe non-compliance to the protocol|1|||
157111369|NCT00666458|567161726|FG001|Overall Study|Severe non-compliance to the protocol|1|||
157111370|NCT00666458|567161725|FG000|Overall Study|Safety reasons|1|||
157111371|NCT00666458|567161726|FG001|Overall Study|Safety reasons|0|||
157111372|NCT00666458|567161725|FG000|Overall Study|Medical history of anemia|1|||
157111373|NCT00666458|567161726|FG001|Overall Study|Medical history of anemia|0|||
157111374|NCT02982954|567161727|FG000|Overall Study|Death|55|||
157111375|NCT02982954|567161728|FG001|Overall Study|Death|29|||
157111376|NCT02982954|567161729|FG002|Overall Study|Death|15|||
157111377|NCT02982954|567161730|FG003|Overall Study|Death|20|||
157111378|NCT02982954|567161727|FG000|Overall Study|Lost to Follow-up|2|||
157111379|NCT02982954|567161728|FG001|Overall Study|Lost to Follow-up|1|||
157111380|NCT02982954|567161729|FG002|Overall Study|Lost to Follow-up|0|||
157111381|NCT02982954|567161730|FG003|Overall Study|Lost to Follow-up|0|||
157111382|NCT02982954|567161727|FG000|Overall Study|Participant withdrew consent|7|||
157111383|NCT02982954|567161728|FG001|Overall Study|Participant withdrew consent|5|||
157111384|NCT02982954|567161729|FG002|Overall Study|Participant withdrew consent|1|||
157111385|NCT02982954|567161730|FG003|Overall Study|Participant withdrew consent|1|||
157111386|NCT02982954|567161727|FG000|Overall Study|Other reasons|42|||
157111387|NCT02982954|567161728|FG001|Overall Study|Other reasons|17|||
157111388|NCT02982954|567161729|FG002|Overall Study|Other reasons|12|||
157111389|NCT02982954|567161730|FG003|Overall Study|Other reasons|3|||
157111390|NCT02982954|567161727|FG000|Overall Study|Premature site closure|0|||
157111391|NCT02982954|567161728|FG001|Overall Study|Premature site closure|0|||
157111392|NCT02982954|567161729|FG002|Overall Study|Premature site closure|0|||
157111393|NCT02982954|567161730|FG003|Overall Study|Premature site closure|1|||
157111394|NCT00516048|567161731|FG000|Overall Study|Death|0|||
157111395|NCT00516048|567161732|FG001|Overall Study|Death|0|||
157111396|NCT00516048|567161733|FG002|Overall Study|Death|1|||
157111397|NCT00516048|567161731|FG000|Overall Study|Subject Decision|0|||
157111398|NCT00516048|567161732|FG001|Overall Study|Subject Decision|2|||
157111399|NCT00516048|567161733|FG002|Overall Study|Subject Decision|0|||
157111400|NCT00402649|567161734|FG000|Overall Study|Lost to Follow-up|1|||
157111401|NCT00402649|567161734|FG000|Overall Study|Withdrawal by Subject|1|||
156766280|NCT01026493|565900429|FG002|Overall Study|Protocol Violation|0|||
156766281|NCT01026493|565900430|FG003|Overall Study|Protocol Violation|0|||
157111402|NCT00840086|567161735|FG000|Overall Study|Adverse Event|1|||
157111403|NCT00840086|567161735|FG000|Overall Study|Protocol Violation|2|||
157111404|NCT00840086|567161735|FG000|Overall Study|Lost to Follow-up|1|||
157111405|NCT02554019|567161736|FG000|Overall Study|Withdrawal by Subject|1|||
157111406|NCT02554019|567161737|FG001|Overall Study|Withdrawal by Subject|0|||
157111407|NCT02554019|567161738|FG002|Overall Study|Withdrawal by Subject|2|||
157111408|NCT02554019|567161736|FG000|Overall Study|Adverse Event|1|||
157111409|NCT02554019|567161737|FG001|Overall Study|Adverse Event|0|||
157111410|NCT02554019|567161738|FG002|Overall Study|Adverse Event|0|||
157111411|NCT02463409|567161739|FG000|Overall Study|Withdrawal by Subject|1|||
157111412|NCT02463409|567161739|FG000|Overall Study|Screen failure|1|||
157111413|NCT02347098|567161740|FG000|Overall Study|Death|1|||
157111414|NCT02347098|567161741|FG001|Overall Study|Death|0|||
157111415|NCT02347098|567161740|FG000|Overall Study|Withdrawal by Subject|1|||
157111416|NCT02347098|567161741|FG001|Overall Study|Withdrawal by Subject|0|||
157111417|NCT02347098|567161740|FG000|Overall Study|Lost to Follow-up|2|||
157111418|NCT02347098|567161741|FG001|Overall Study|Lost to Follow-up|2|||
157111419|NCT02347098|567161740|FG000|Overall Study|Refuse Follow-up Visit|1|||
157111420|NCT02347098|567161741|FG001|Overall Study|Refuse Follow-up Visit|5|||
157111421|NCT02347098|567161740|FG000|Overall Study|no visit due to illness|2|||
157111422|NCT02347098|567161741|FG001|Overall Study|no visit due to illness|1|||
157111423|NCT01444742|567161742|FG000|Overall Study|Death|1|||
157111424|NCT02181816|567161743|FG000|Overall Study|Case Report Forms Uncollected|38|||
157111425|NCT02181816|567161743|FG000|Overall Study|Protocol Deviation|21|||
157111426|NCT00909181|567161744|FG000|Overall Study|Lost to Follow-up|39|||
157111427|NCT00909181|567161745|FG001|Overall Study|Lost to Follow-up|18|||
157111428|NCT00909181|567161746|FG002|Overall Study|Lost to Follow-up|33|||
157111429|NCT02830880|567161748|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
157111430|NCT02830880|567161748|FG000|Overall Study|Death|1|||
157111431|NCT02830880|567161748|FG000|Overall Study|Physician Decision|1|||
157111432|NCT03179891|567161757|FG000|First Intervention|Withdrawal by Subject|1|||
157111433|NCT03179891|567161758|FG001|First Intervention|Withdrawal by Subject|1|||
157111434|NCT03179891|567161757|FG000|First Intervention|Unspecified reason|1|||
157111435|NCT03179891|567161758|FG001|First Intervention|Unspecified reason|0|||
157111436|NCT03179891|567161757|FG000|First Intervention|Protocol Violation|0|||
157111437|NCT03179891|567161758|FG001|First Intervention|Protocol Violation|1|||
157111438|NCT02113436|567161759|FG000|Period 1: 8 Weeks|Adverse Event|1|||
157111439|NCT02113436|567161760|FG001|Period 1: 8 Weeks|Adverse Event|0|||
157111440|NCT02113436|567161761|FG002|Period 1: 8 Weeks|Adverse Event|0|||
157111441|NCT02113436|567161762|FG003|Period 1: 8 Weeks|Adverse Event|0|||
157111442|NCT02113436|567161759|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
157111443|NCT02113436|567161760|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
157111444|NCT02113436|567161761|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
157111445|NCT02113436|567161762|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
157111446|NCT02113436|567161759|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
157111447|NCT02113436|567161760|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
157111448|NCT02113436|567161761|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
157111449|NCT02113436|567161762|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
157111450|NCT02113436|567161759|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
157111451|NCT02113436|567161760|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
157111452|NCT02113436|567161761|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
157111453|NCT02113436|567161762|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
157111454|NCT02113436|567161759|FG000|Period 2: 16 Weeks|Adverse Event|0|||
157111455|NCT02113436|567161760|FG001|Period 2: 16 Weeks|Adverse Event|0|||
157111456|NCT02113436|567161761|FG002|Period 2: 16 Weeks|Adverse Event|4|||
157111457|NCT02113436|567161762|FG003|Period 2: 16 Weeks|Adverse Event|5|||
157111458|NCT02113436|567161759|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
157111459|NCT02113436|567161760|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
157111460|NCT02113436|567161761|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
157005952|NCT02537522|566771635|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
157005953|NCT02537522|566771636|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
157005954|NCT02537522|566771637|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
157005955|NCT02537522|566771638|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
157005956|NCT02537522|566771635|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
157005957|NCT02537522|566771636|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
157005958|NCT02537522|566771637|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
157005959|NCT02537522|566771638|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
157111461|NCT02113436|567161762|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
157111462|NCT02113436|567161759|FG000|Period 2: 16 Weeks|Physician Decision|0|||
157111463|NCT02113436|567161760|FG001|Period 2: 16 Weeks|Physician Decision|0|||
157111464|NCT02113436|567161761|FG002|Period 2: 16 Weeks|Physician Decision|2|||
157111465|NCT02113436|567161762|FG003|Period 2: 16 Weeks|Physician Decision|0|||
157111466|NCT02113436|567161759|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
157111467|NCT02113436|567161760|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
157111468|NCT02113436|567161761|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
157111469|NCT02113436|567161762|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
157111470|NCT01278745|567161768|FG000|Overall Study|Death|2|||
157111471|NCT01278745|567161769|FG001|Overall Study|Death|5|||
157111472|NCT01278745|567161770|FG002|Overall Study|Death|7|||
157111473|NCT01278745|567161771|FG003|Overall Study|Death|0|||
157111474|NCT01278745|567161768|FG000|Overall Study|Physician Decision|1|||
157111475|NCT01278745|567161769|FG001|Overall Study|Physician Decision|0|||
156766282|NCT01026493|565900431|FG004|Overall Study|Protocol Violation|2|||
156766283|NCT01026493|565900432|FG005|Overall Study|Protocol Violation|3|||
156766284|NCT01026493|565900433|FG006|Overall Study|Protocol Violation|4|||
157111476|NCT01278745|567161770|FG002|Overall Study|Physician Decision|0|||
157111477|NCT01278745|567161771|FG003|Overall Study|Physician Decision|9|||
157111478|NCT01278745|567161768|FG000|Overall Study|Withdrawal by Subject|1|||
157111479|NCT01278745|567161769|FG001|Overall Study|Withdrawal by Subject|1|||
157111480|NCT01278745|567161770|FG002|Overall Study|Withdrawal by Subject|5|||
157111481|NCT01278745|567161771|FG003|Overall Study|Withdrawal by Subject|1|||
157111482|NCT01278745|567161768|FG000|Overall Study|Sponsor Decision|1|||
157111483|NCT01278745|567161769|FG001|Overall Study|Sponsor Decision|0|||
157111484|NCT01278745|567161770|FG002|Overall Study|Sponsor Decision|62|||
157111485|NCT01278745|567161771|FG003|Overall Study|Sponsor Decision|6|||
157111486|NCT01278745|567161768|FG000|Overall Study|Ineligible|0|||
157111487|NCT01278745|567161769|FG001|Overall Study|Ineligible|0|||
157111488|NCT01278745|567161770|FG002|Overall Study|Ineligible|42|||
157111489|NCT01278745|567161771|FG003|Overall Study|Ineligible|61|||
157111490|NCT01278745|567161768|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
157111491|NCT01278745|567161769|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
157111492|NCT01278745|567161770|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
157111493|NCT01278745|567161771|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
157111494|NCT01148537|567161772|FG000|Overall Study|Withdrawal by Subject|1|||
157111495|NCT01148537|567161773|FG001|Overall Study|Withdrawal by Subject|0|||
157111496|NCT01148537|567161774|FG002|Overall Study|Withdrawal by Subject|2|||
157111497|NCT01148537|567161772|FG000|Overall Study|Adverse Event|2|||
157111498|NCT01148537|567161773|FG001|Overall Study|Adverse Event|0|||
157111499|NCT01148537|567161774|FG002|Overall Study|Adverse Event|1|||
157111500|NCT05630001|567161775|FG000|Overall Study|Adverse Event|1|||
157111501|NCT05374525|567161777|FG000|Overall Study|Adverse Event|5|||
157111502|NCT05374525|567161778|FG001|Overall Study|Adverse Event|6|||
157111503|NCT05374525|567161777|FG000|Overall Study|Lost to Follow-up|3|||
157111504|NCT05374525|567161778|FG001|Overall Study|Lost to Follow-up|3|||
157111505|NCT05374525|567161777|FG000|Overall Study|Physician Decision|2|||
157111506|NCT05374525|567161778|FG001|Overall Study|Physician Decision|2|||
157111507|NCT05374525|567161777|FG000|Overall Study|Withdrawal by Subject|26|||
157111508|NCT05374525|567161778|FG001|Overall Study|Withdrawal by Subject|8|||
157111509|NCT01349101|567161781|FG000|Overall Study|Disease Progression|1|||
157111510|NCT01349101|567161782|FG001|Overall Study|Disease Progression|1|||
157111511|NCT01349101|567161781|FG000|Overall Study|Death|3|||
157111512|NCT01349101|567161782|FG001|Overall Study|Death|8|||
157111513|NCT01843842|567161785|FG000|Overall Study|Do not meet inclusion criteria|1|||
157111514|NCT01843842|567161786|FG001|Overall Study|Do not meet inclusion criteria|1|||
157111515|NCT01376778|567161787|FG000|Overall Study|Lost to Follow-up|3|||
157111516|NCT01376778|567161788|FG001|Overall Study|Lost to Follow-up|2|||
157111517|NCT00632099|567161789|FG000|Overall Study|Lost to Follow-up|3|||
157111518|NCT00632099|567161790|FG001|Overall Study|Lost to Follow-up|3|||
157111519|NCT03374189|567161793|FG000|Overall Study|Lost to Follow-up|1|||
157111520|NCT03374189|567161794|FG001|Overall Study|Lost to Follow-up|0|||
157111521|NCT01517893|567161795|FG000|Overall Study|Withdrawal by Subject|3|||
157111522|NCT01517893|567161796|FG001|Overall Study|Withdrawal by Subject|0|||
157111523|NCT03462576|567161797|FG000|Overall Study|Protocol Violation|5|||
157111524|NCT03462576|567161798|FG001|Overall Study|Protocol Violation|11|||
157111525|NCT03462576|567161799|FG002|Overall Study|Protocol Violation|7|||
157111526|NCT03462576|567161797|FG000|Overall Study|Device Malfunction|0|||
157111527|NCT03462576|567161798|FG001|Overall Study|Device Malfunction|0|||
157111528|NCT03462576|567161799|FG002|Overall Study|Device Malfunction|1|||
157111529|NCT00750737|567161809|FG000|Overall Study|Withdrawal by Subject|3|||
157111530|NCT00750737|567161810|FG001|Overall Study|Withdrawal by Subject|3|||
157111531|NCT00271596|567161811|FG000|Overall Study|Protocol Violation|1|||
157111532|NCT00271596|567161812|FG001|Overall Study|Protocol Violation|0|||
157111533|NCT00271596|567161811|FG000|Overall Study|Withdrawal by Subject|0|||
156766285|NCT01026493|565900434|FG007|Overall Study|Protocol Violation|1|||
156766286|NCT03093181|565900435|FG000|Overall Study|Withdrawal by Subject|2|||
156766287|NCT03093181|565900436|FG001|Overall Study|Withdrawal by Subject|1|||
156766288|NCT03093181|565900437|FG002|Overall Study|Withdrawal by Subject|2|||
157111534|NCT00271596|567161812|FG001|Overall Study|Withdrawal by Subject|1|||
157111535|NCT00865904|567161816|FG000|Overall Study|Randomized but not Treated|2|||
157111536|NCT00865904|567161817|FG001|Overall Study|Randomized but not Treated|0|||
157111537|NCT00865904|567161818|FG002|Overall Study|Randomized but not Treated|0|||
157111538|NCT00865904|567161819|FG003|Overall Study|Randomized but not Treated|1|||
156766289|NCT03093181|565900435|FG000|Overall Study|Other (Not specified)|1|||
156766290|NCT03093181|565900436|FG001|Overall Study|Other (Not specified)|0|||
156766291|NCT03093181|565900437|FG002|Overall Study|Other (Not specified)|0|||
156766292|NCT03093181|565900435|FG000|Overall Study|Adverse Event|0|||
157111539|NCT00865904|567161820|FG004|Overall Study|Randomized but not Treated|1|||
157111540|NCT04206605|567161821|FG000|Overall Study|Adverse Event|0|||
157111541|NCT04206605|567161822|FG001|Overall Study|Adverse Event|1|||
157111542|NCT04206605|567161821|FG000|Overall Study|Withdrawal by Subject|1|||
156766293|NCT03093181|565900436|FG001|Overall Study|Adverse Event|1|||
156766294|NCT03093181|565900437|FG002|Overall Study|Adverse Event|0|||
156766295|NCT03093181|565900435|FG000|Overall Study|Other (Protocol violation)|0|||
156766296|NCT03093181|565900436|FG001|Overall Study|Other (Protocol violation)|0|||
156766297|NCT03093181|565900437|FG002|Overall Study|Other (Protocol violation)|1|||
156766298|NCT04076917|565900440|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
156766299|NCT04076917|565900440|FG000|Overall Study|Study closure|13|||
156766300|NCT04076917|565900440|FG000|Overall Study|Physician Decision|3|||
156766301|NCT04076917|565900440|FG000|Overall Study|Death|1|||
156766302|NCT04076917|565900440|FG000|Overall Study|Lost to Follow-up|1|||
156766303|NCT04076917|565900440|FG000|Overall Study|Withdrawal by Subject|1|||
156766304|NCT04076917|565900440|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
156766305|NCT01774591|565900443|FG000|Overall Study|Physician Decision|1|||
156766306|NCT01774591|565900444|FG001|Overall Study|Physician Decision|1|||
156766307|NCT01774591|565900443|FG000|Overall Study|Withdrawal by Subject|0|||
156766308|NCT01774591|565900444|FG001|Overall Study|Withdrawal by Subject|1|||
156766309|NCT01774591|565900443|FG000|Overall Study|Adverse Event|0|||
156766310|NCT01774591|565900444|FG001|Overall Study|Adverse Event|2|||
156766311|NCT01701245|565900445|FG000|Overall Study|Protocol Violation|1|||
156766312|NCT01701245|565900446|FG001|Overall Study|Protocol Violation|3|||
156766313|NCT01701245|565900445|FG000|Overall Study|Did not complete the open label period|11|||
156766314|NCT01701245|565900446|FG001|Overall Study|Did not complete the open label period|12|||
156766315|NCT01159574|565900447|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
156766316|NCT01159574|565900447|FG000|Treatment Phase|Adverse Event|3|||
156766317|NCT01159574|565900447|FG000|Treatment Phase|Death|6|||
156766318|NCT01159574|565900447|FG000|Treatment Phase|Physician Decision|2|||
156766319|NCT01159574|565900447|FG000|Treatment Phase|Withdrawal by Subject|7|||
156766320|NCT01159574|565900447|FG000|Treatment Phase|still on treatment|2|||
156766321|NCT01159574|565900447|FG000|Follow Up Phase|Lost to Follow-up|2|||
156766322|NCT01159574|565900447|FG000|Follow Up Phase|still being followed for overall surviva|18|||
156766323|NCT01787552|565900450|FG000|Overall Study|Withdrawal by Subject|2|||
156766324|NCT01787552|565900451|FG001|Overall Study|Withdrawal by Subject|0|||
156766325|NCT01787552|565900452|FG002|Overall Study|Withdrawal by Subject|0|||
156766326|NCT01787552|565900453|FG003|Overall Study|Withdrawal by Subject|4|||
156766327|NCT01787552|565900450|FG000|Overall Study|Physician Decision|2|||
156766328|NCT01787552|565900451|FG001|Overall Study|Physician Decision|2|||
156766329|NCT01787552|565900452|FG002|Overall Study|Physician Decision|1|||
156766330|NCT01787552|565900453|FG003|Overall Study|Physician Decision|2|||
156766331|NCT01787552|565900450|FG000|Overall Study|Death|0|||
156766332|NCT01787552|565900451|FG001|Overall Study|Death|0|||
156766333|NCT01787552|565900452|FG002|Overall Study|Death|0|||
156766334|NCT01787552|565900453|FG003|Overall Study|Death|1|||
156766335|NCT01787552|565900450|FG000|Overall Study|Adverse Event|2|||
156766336|NCT01787552|565900451|FG001|Overall Study|Adverse Event|5|||
156766337|NCT01787552|565900452|FG002|Overall Study|Adverse Event|2|||
156766338|NCT01787552|565900453|FG003|Overall Study|Adverse Event|16|||
156766339|NCT01787552|565900450|FG000|Overall Study|Study terminated by Sponsor|0|||
156766340|NCT01787552|565900451|FG001|Overall Study|Study terminated by Sponsor|0|||
156766341|NCT01787552|565900452|FG002|Overall Study|Study terminated by Sponsor|1|||
156766342|NCT01787552|565900453|FG003|Overall Study|Study terminated by Sponsor|3|||
156766343|NCT01787552|565900450|FG000|Overall Study|Progressive Disease|2|||
156766344|NCT01787552|565900451|FG001|Overall Study|Progressive Disease|2|||
156766345|NCT01787552|565900452|FG002|Overall Study|Progressive Disease|1|||
156766346|NCT01787552|565900453|FG003|Overall Study|Progressive Disease|1|||
156766347|NCT00630916|565900454|FG000|Overall Study|Death|110|||
156766348|NCT00630916|565900454|FG000|Overall Study|Explant|8|||
156766349|NCT00630916|565900454|FG000|Overall Study|Lost to Follow-up|5|||
156766350|NCT00630916|565900454|FG000|Overall Study|Withdrawal by Subject|30|||
156766351|NCT00630916|565900454|FG000|Overall Study|Protocol Violation|7|||
156766352|NCT00630916|565900454|FG000|Overall Study|Physician Decision|47|||
156766353|NCT00630916|565900454|FG000|Overall Study|Lack of Efficacy|3|||
156766354|NCT02147626|565900458|FG000|Overall Study|Lost to Follow-up|4|||
156766355|NCT02147626|565900459|FG001|Overall Study|Lost to Follow-up|4|||
156766356|NCT02147626|565900458|FG000|Overall Study|Pregnancy|1|||
156766357|NCT02147626|565900459|FG001|Overall Study|Pregnancy|2|||
156766358|NCT02147626|565900458|FG000|Overall Study|Withdrawal by Subject|0|||
156766359|NCT02147626|565900459|FG001|Overall Study|Withdrawal by Subject|1|||
156766360|NCT03167242|565900462|FG000|Overall Study|Patient/Guardian Decision|0|||
156766361|NCT03167242|565900463|FG001|Overall Study|Patient/Guardian Decision|1|||
156766362|NCT03167242|565900464|FG002|Overall Study|Patient/Guardian Decision|2|||
156766363|NCT03167242|565900465|FG003|Overall Study|Patient/Guardian Decision|1|||
156766364|NCT03167242|565900466|FG004|Overall Study|Patient/Guardian Decision|1|||
156766365|NCT03167242|565900467|FG005|Overall Study|Patient/Guardian Decision|1|||
156766366|NCT03167242|565900468|FG006|Overall Study|Patient/Guardian Decision|0|||
156766367|NCT03167242|565900469|FG007|Overall Study|Patient/Guardian Decision|0|||
156766368|NCT03167242|565900470|FG008|Overall Study|Patient/Guardian Decision|0|||
156766369|NCT03167242|565900471|FG009|Overall Study|Patient/Guardian Decision|0|||
157111543|NCT04206605|567161822|FG001|Overall Study|Withdrawal by Subject|0|||
157111544|NCT00589420|567161826|FG000|Overall Study|screen failure|1|||
157111545|NCT03418129|567161832|FG000|Overall Study|Lost to Follow-up|11|||
157111546|NCT03418129|567161833|FG001|Overall Study|Lost to Follow-up|20|||
157111547|NCT03418129|567161834|FG002|Overall Study|Lost to Follow-up|15|||
157111548|NCT03418129|567161832|FG000|Overall Study|Withdrawal by Subject|3|||
157111549|NCT03418129|567161833|FG001|Overall Study|Withdrawal by Subject|6|||
157111550|NCT03418129|567161834|FG002|Overall Study|Withdrawal by Subject|4|||
157111551|NCT03302975|567161837|FG000|Overall Study|Lost to Follow-up|4|||
157111552|NCT01436084|567161838|FG000|Overall Study|Disease Progression|2|||
157111553|NCT01436084|567161838|FG000|Overall Study|Withdrawal by Subject|1|||
157111554|NCT01436084|567161838|FG000|Overall Study|Early Closure of Study|1|||
157111555|NCT00388973|567163304|FG000|Overall Study|Adverse Event|16|||
157111556|NCT00388973|567163305|FG001|Overall Study|Adverse Event|6|||
157111557|NCT00388973|567163304|FG000|Overall Study|Lack of Efficacy|1|||
157111558|NCT00388973|567163305|FG001|Overall Study|Lack of Efficacy|12|||
157111559|NCT00388973|567163304|FG000|Overall Study|Protocol Violation|3|||
157111560|NCT00388973|567163305|FG001|Overall Study|Protocol Violation|0|||
157111561|NCT00388973|567163304|FG000|Overall Study|Withdrawal by Subject|14|||
157111562|NCT00388973|567163305|FG001|Overall Study|Withdrawal by Subject|17|||
157111563|NCT00388973|567163304|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
157111564|NCT00388973|567163305|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
157111565|NCT00388973|567163304|FG000|Overall Study|Did not complete 61 days of treatment|5|||
157111566|NCT00388973|567163305|FG001|Overall Study|Did not complete 61 days of treatment|4|||
157111567|NCT00388973|567163304|FG000|Overall Study|Left region|0|||
157111568|NCT00388973|567163305|FG001|Overall Study|Left region|1|||
157111569|NCT00388973|567163304|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
157111570|NCT00388973|567163305|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
157111571|NCT01652885|567163306|FG000|Overall Study|Adverse Event|1|||
157111572|NCT00075023|567163307|FG000|Pilot Study|Physician Decision|1|||
157111573|NCT00075023|567163308|FG001|Pilot Study|Physician Decision|2|||
157111574|NCT00075023|567163307|FG000|Pilot Study|Withdrawal by Subject|1|||
157111575|NCT00075023|567163308|FG001|Pilot Study|Withdrawal by Subject|0|||
157111576|NCT04342871|567163309|FG000|Overall Study|Death|4|||
157111577|NCT04342871|567163309|FG000|Overall Study|Clinical deterioration/illness progression|2|||
157111578|NCT04342871|567163309|FG000|Overall Study|Did not complete baseline assessments|5|||
157111579|NCT04342871|567163309|FG000|Overall Study|Lost to Follow-up|13|||
157111580|NCT01429584|567163314|FG000|Overall Study|Withdrawal by Subject|1|||
157111581|NCT01429584|567163315|FG001|Overall Study|Withdrawal by Subject|0|||
157111582|NCT01429584|567163314|FG000|Overall Study|Protocol Violation|0|||
157111583|NCT01429584|567163315|FG001|Overall Study|Protocol Violation|1|||
157111584|NCT02634151|567163316|FG000|Overall Study|Withdrawal by Subject|1|||
157111585|NCT02634151|567163317|FG001|Overall Study|Withdrawal by Subject|0|||
157111586|NCT02634151|567163316|FG000|Overall Study|Non-Compliance|0|||
157111587|NCT02634151|567163317|FG001|Overall Study|Non-Compliance|1|||
157111588|NCT02634151|567163316|FG000|Overall Study|Other|0|||
157111589|NCT02634151|567163317|FG001|Overall Study|Other|1|||
157111590|NCT00003535|567163318|FG000|Overall Study|Not evaluable|5|||
157111591|NCT02018822|567163319|FG000|Overall Study|filling replaced by crown|0|||
156766370|NCT03167242|565900472|FG010|Overall Study|Patient/Guardian Decision|1|||
156766371|NCT03167242|565900473|FG011|Overall Study|Patient/Guardian Decision|0|||
156766372|NCT03167242|565900462|FG000|Overall Study|Lost to Follow-up|0|||
156766373|NCT03167242|565900463|FG001|Overall Study|Lost to Follow-up|0|||
156766374|NCT03167242|565900464|FG002|Overall Study|Lost to Follow-up|1|||
156766375|NCT03167242|565900465|FG003|Overall Study|Lost to Follow-up|0|||
156766376|NCT03167242|565900466|FG004|Overall Study|Lost to Follow-up|0|||
156766377|NCT03167242|565900467|FG005|Overall Study|Lost to Follow-up|1|||
156766378|NCT03167242|565900468|FG006|Overall Study|Lost to Follow-up|2|||
156766379|NCT03167242|565900469|FG007|Overall Study|Lost to Follow-up|1|||
156766380|NCT03167242|565900470|FG008|Overall Study|Lost to Follow-up|0|||
156766381|NCT03167242|565900471|FG009|Overall Study|Lost to Follow-up|0|||
156766382|NCT03167242|565900472|FG010|Overall Study|Lost to Follow-up|1|||
156766383|NCT03167242|565900473|FG011|Overall Study|Lost to Follow-up|1|||
156766384|NCT03167242|565900462|FG000|Overall Study|Reason not provided|0|||
156766385|NCT03167242|565900463|FG001|Overall Study|Reason not provided|0|||
157111592|NCT02018822|567163320|FG001|Overall Study|filling replaced by crown|1|||
157111593|NCT02018822|567163321|FG002|Overall Study|filling replaced by crown|0|||
157111594|NCT02018822|567163319|FG000|Overall Study|Physician Decision|0|||
157111595|NCT02018822|567163320|FG001|Overall Study|Physician Decision|1|||
157111596|NCT02018822|567163321|FG002|Overall Study|Physician Decision|1|||
157111597|NCT02018822|567163319|FG000|Overall Study|Lost to Follow-up|6|||
157111598|NCT02018822|567163320|FG001|Overall Study|Lost to Follow-up|6|||
157111599|NCT02018822|567163321|FG002|Overall Study|Lost to Follow-up|5|||
157111600|NCT03201458|567163322|FG000|Overall Study|No longer eligible|2|||
157111601|NCT03201458|567163323|FG001|Overall Study|No longer eligible|5|||
157111602|NCT03201458|567163322|FG000|Overall Study|Health event before starting|1|||
157111603|NCT03201458|567163323|FG001|Overall Study|Health event before starting|0|||
157111604|NCT03201458|567163322|FG000|Overall Study|Physician Decision|1|||
157111605|NCT03201458|567163323|FG001|Overall Study|Physician Decision|0|||
157111606|NCT00715026|567163324|FG000|Overall Study|Withdrawal by Subject|5|||
157111607|NCT00715026|567163324|FG000|Overall Study|Lost to Follow-up|3|||
157111608|NCT00715026|567163324|FG000|Overall Study|Protocol Violation|1|||
157111609|NCT00715026|567163324|FG000|Overall Study|Surgery done on non-study consented hip|1|||
157111610|NCT03625687|567163331|FG000|Overall Study|Death|1|||
157111611|NCT01543828|567163332|FG000|Treatment 2|Lost to Follow-up|1|||
157111612|NCT01543828|567163333|FG001|Treatment 2|Lost to Follow-up|0|||
157111613|NCT01069172|567163334|FG000|Overall Study|Withdrawal by Subject|1|||
157111614|NCT01069172|567163335|FG001|Overall Study|Withdrawal by Subject|0|||
157111615|NCT00711425|567163340|FG000|Overall Study|Protocol Violation|1|||
157111616|NCT00711425|567163340|FG000|Overall Study|Death|2|||
157111617|NCT00711425|567163340|FG000|Overall Study|Lost to Follow-up|1|||
157111618|NCT05879107|567163341|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
157111619|NCT05879107|567163342|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
157111620|NCT05879107|567163341|FG000|Overall Study|Migrated / moved from the study area|1|||
157111621|NCT05879107|567163342|FG001|Overall Study|Migrated / moved from the study area|1|||
157111622|NCT05879107|567163341|FG000|Overall Study|Lost to Follow-up|8|||
157111623|NCT05879107|567163342|FG001|Overall Study|Lost to Follow-up|13|||
157111624|NCT05879107|567163341|FG000|Overall Study|Death|0|||
156766386|NCT03167242|565900464|FG002|Overall Study|Reason not provided|0|||
156766387|NCT03167242|565900465|FG003|Overall Study|Reason not provided|0|||
157111625|NCT05879107|567163342|FG001|Overall Study|Death|2|||
157111626|NCT05879107|567163341|FG000|Overall Study|Other|0|||
157111627|NCT05879107|567163342|FG001|Overall Study|Other|3|||
157111628|NCT03901079|567163343|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
157111629|NCT00841568|567163344|FG000|Overall Study|Adverse Event|1|||
157111630|NCT00841568|567163344|FG000|Overall Study|Death|1|||
156766388|NCT03167242|565900466|FG004|Overall Study|Reason not provided|0|||
156766389|NCT03167242|565900467|FG005|Overall Study|Reason not provided|0|||
156766390|NCT03167242|565900468|FG006|Overall Study|Reason not provided|0|||
156766391|NCT03167242|565900469|FG007|Overall Study|Reason not provided|0|||
156766392|NCT03167242|565900470|FG008|Overall Study|Reason not provided|1|||
156766393|NCT03167242|565900471|FG009|Overall Study|Reason not provided|0|||
157111631|NCT00841568|567163344|FG000|Overall Study|Withdrawal by Subject|2|||
157111632|NCT00841568|567163344|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
157111633|NCT03002155|567163345|FG000|Overall Study|Lost to Follow-up|1|||
157111634|NCT03002155|567163346|FG001|Overall Study|Lost to Follow-up|2|||
157111635|NCT03002155|567163345|FG000|Overall Study|Withdrawal by Subject|1|||
157111636|NCT03002155|567163346|FG001|Overall Study|Withdrawal by Subject|0|||
157111637|NCT03002155|567163345|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
157111638|NCT03002155|567163346|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
157111639|NCT01087775|567163347|FG000|Overall Study|failed inclusion criteria|2|||
156766394|NCT03167242|565900472|FG010|Overall Study|Reason not provided|0|||
156766395|NCT03167242|565900473|FG011|Overall Study|Reason not provided|0|||
156766396|NCT03786380|565900474|FG000|Overall Study|Adverse Event|1|||
156766397|NCT03786380|565900475|FG001|Overall Study|Adverse Event|0|||
156766398|NCT03786380|565900476|FG002|Overall Study|Adverse Event|0|||
156766399|NCT03786380|565900477|FG003|Overall Study|Adverse Event|3|||
156766400|NCT03786380|565900478|FG004|Overall Study|Adverse Event|1|||
156766401|NCT03786380|565900474|FG000|Overall Study|Lack of Efficacy|0|||
156766402|NCT03786380|565900475|FG001|Overall Study|Lack of Efficacy|0|||
156766403|NCT03786380|565900476|FG002|Overall Study|Lack of Efficacy|0|||
156766404|NCT03786380|565900477|FG003|Overall Study|Lack of Efficacy|0|||
156766405|NCT03786380|565900478|FG004|Overall Study|Lack of Efficacy|1|||
156766406|NCT03786380|565900474|FG000|Overall Study|Withdrawal by Subject|1|||
156766407|NCT03786380|565900475|FG001|Overall Study|Withdrawal by Subject|2|||
156766408|NCT03786380|565900476|FG002|Overall Study|Withdrawal by Subject|2|||
156766409|NCT03786380|565900477|FG003|Overall Study|Withdrawal by Subject|1|||
156766410|NCT03786380|565900478|FG004|Overall Study|Withdrawal by Subject|2|||
156766411|NCT03786380|565900474|FG000|Overall Study|Lost to Follow-up|3|||
156766412|NCT03786380|565900475|FG001|Overall Study|Lost to Follow-up|0|||
156766413|NCT03786380|565900476|FG002|Overall Study|Lost to Follow-up|1|||
156766414|NCT03786380|565900477|FG003|Overall Study|Lost to Follow-up|2|||
156766415|NCT03786380|565900478|FG004|Overall Study|Lost to Follow-up|0|||
156766416|NCT03786380|565900474|FG000|Overall Study|Physician Decision|0|||
156766417|NCT03786380|565900475|FG001|Overall Study|Physician Decision|0|||
156766418|NCT03786380|565900476|FG002|Overall Study|Physician Decision|1|||
156766419|NCT03786380|565900477|FG003|Overall Study|Physician Decision|0|||
156766420|NCT03786380|565900478|FG004|Overall Study|Physician Decision|0|||
156766421|NCT03786380|565900474|FG000|Overall Study|Study Terminated by the Sponsor|30|||
156766422|NCT03786380|565900475|FG001|Overall Study|Study Terminated by the Sponsor|20|||
156766423|NCT03786380|565900476|FG002|Overall Study|Study Terminated by the Sponsor|50|||
156766424|NCT03786380|565900477|FG003|Overall Study|Study Terminated by the Sponsor|57|||
156766425|NCT03786380|565900478|FG004|Overall Study|Study Terminated by the Sponsor|23|||
156766426|NCT03786380|565900474|FG000|Overall Study|Reason Not Specified|0|||
156766427|NCT03786380|565900475|FG001|Overall Study|Reason Not Specified|0|||
156766428|NCT03786380|565900476|FG002|Overall Study|Reason Not Specified|0|||
156766429|NCT03786380|565900477|FG003|Overall Study|Reason Not Specified|0|||
156766430|NCT03786380|565900478|FG004|Overall Study|Reason Not Specified|1|||
156766431|NCT01038687|565900481|FG000|Overall Study|Adverse Event|0|||
156766432|NCT01038687|565900482|FG001|Overall Study|Adverse Event|2|||
156766433|NCT01038687|565900483|FG002|Overall Study|Adverse Event|1|||
156766434|NCT05401565|565900484|FG000|Overall Study|Lost to Follow-up|1|||
156766435|NCT05401565|565900485|FG001|Overall Study|Lost to Follow-up|0|||
156766436|NCT05401565|565900484|FG000|Overall Study|Adverse Event|2|||
156766437|NCT05401565|565900485|FG001|Overall Study|Adverse Event|0|||
156766438|NCT02984982|565900486|FG000|Overall Study|Adverse Event|2|||
156766439|NCT02984982|565900487|FG001|Overall Study|Adverse Event|5|||
156766440|NCT02984982|565900486|FG000|Overall Study|Poor Compliance to Protocol|4|||
156766441|NCT02984982|565900487|FG001|Overall Study|Poor Compliance to Protocol|4|||
156766442|NCT02984982|565900486|FG000|Overall Study|Withdrawal by Subject|2|||
156766443|NCT02984982|565900487|FG001|Overall Study|Withdrawal by Subject|0|||
157111640|NCT00974675|567163350|FG000|Overall Study|Adverse Event|2|||
157111641|NCT00974675|567163351|FG001|Overall Study|Adverse Event|1|||
157111642|NCT00974675|567163352|FG002|Overall Study|Adverse Event|1|||
157111643|NCT00974675|567163353|FG003|Overall Study|Adverse Event|1|||
157111644|NCT00974675|567163350|FG000|Overall Study|Physician Decision|0|||
157111645|NCT00974675|567163351|FG001|Overall Study|Physician Decision|0|||
157111646|NCT00974675|567163352|FG002|Overall Study|Physician Decision|1|||
157111647|NCT00974675|567163353|FG003|Overall Study|Physician Decision|0|||
157111648|NCT00974675|567163350|FG000|Overall Study|Participant on holiday; unable to attend|0|||
157111649|NCT00974675|567163351|FG001|Overall Study|Participant on holiday; unable to attend|0|||
157111650|NCT00974675|567163352|FG002|Overall Study|Participant on holiday; unable to attend|0|||
157111651|NCT00974675|567163353|FG003|Overall Study|Participant on holiday; unable to attend|1|||
157111652|NCT02973087|567163362|FG000|Overall Study|Withdrawal by Subject|2|||
157111653|NCT02973087|567163363|FG001|Overall Study|Withdrawal by Subject|1|||
157111654|NCT02973087|567163362|FG000|Overall Study|Adverse Event|1|||
157111655|NCT02973087|567163363|FG001|Overall Study|Adverse Event|0|||
157111656|NCT02973087|567163362|FG000|Overall Study|other|1|||
157111657|NCT02973087|567163363|FG001|Overall Study|other|1|||
156766444|NCT02984982|565900486|FG000|Overall Study|Randomized but not treated|0|||
156766445|NCT02984982|565900487|FG001|Overall Study|Randomized but not treated|1|||
156766446|NCT02175121|565900489|FG000|Overall Study|Lack of Efficacy|1|||
157111658|NCT03710486|567163364|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
156766447|NCT02175121|565900490|FG001|Overall Study|Lack of Efficacy|0|||
156766448|NCT02175121|565900491|FG002|Overall Study|Lack of Efficacy|0|||
156766449|NCT02175121|565900492|FG003|Overall Study|Lack of Efficacy|0|||
156766450|NCT02175121|565900493|FG004|Overall Study|Lack of Efficacy|0|||
157111659|NCT03710486|567163365|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
157111660|NCT03710486|567163364|FG000|Overall Study|Missing|0|||
157111661|NCT03710486|567163365|FG001|Overall Study|Missing|2|||
156766451|NCT02175121|565900489|FG000|Overall Study|Lost to Follow-up|0|||
156766452|NCT02175121|565900490|FG001|Overall Study|Lost to Follow-up|1|||
156766453|NCT02175121|565900491|FG002|Overall Study|Lost to Follow-up|0|||
157111662|NCT01147744|567163370|FG000|Overall Study|Protocol Violation|1|||
156766454|NCT02175121|565900492|FG003|Overall Study|Lost to Follow-up|1|||
156766455|NCT02175121|565900493|FG004|Overall Study|Lost to Follow-up|0|||
156766456|NCT02175121|565900489|FG000|Overall Study|Personal emergency|0|||
156766457|NCT02175121|565900490|FG001|Overall Study|Personal emergency|0|||
156766458|NCT02175121|565900491|FG002|Overall Study|Personal emergency|0|||
156766459|NCT02175121|565900492|FG003|Overall Study|Personal emergency|0|||
156766460|NCT02175121|565900493|FG004|Overall Study|Personal emergency|1|||
156766461|NCT02175121|565900489|FG000|Overall Study|Schedule conflict|0|||
156766462|NCT02175121|565900490|FG001|Overall Study|Schedule conflict|0|||
156766463|NCT02175121|565900491|FG002|Overall Study|Schedule conflict|1|||
156766464|NCT02175121|565900492|FG003|Overall Study|Schedule conflict|0|||
156766465|NCT02175121|565900493|FG004|Overall Study|Schedule conflict|0|||
156766466|NCT02175121|565900489|FG000|Overall Study|Time issues|0|||
156766467|NCT02175121|565900490|FG001|Overall Study|Time issues|0|||
156766468|NCT02175121|565900491|FG002|Overall Study|Time issues|1|||
156766469|NCT02175121|565900492|FG003|Overall Study|Time issues|0|||
156766470|NCT02175121|565900493|FG004|Overall Study|Time issues|0|||
156766471|NCT00931632|565900498|FG000|Overall Study|Withdrawal by Subject|2|||
156766472|NCT00931632|565900499|FG001|Overall Study|Withdrawal by Subject|3|||
156766473|NCT00931632|565900498|FG000|Overall Study|Adverse Event|19|||
156766474|NCT00931632|565900499|FG001|Overall Study|Adverse Event|15|||
156766475|NCT01419314|565900500|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
156766476|NCT01419314|565900501|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
156766477|NCT01419314|565900500|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
157111663|NCT01147744|567163371|FG001|Overall Study|Protocol Violation|0|||
157111664|NCT01147744|567163372|FG002|Overall Study|Protocol Violation|1|||
156766478|NCT01419314|565900501|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
156766479|NCT01419314|565900500|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
156766480|NCT01419314|565900501|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
156766481|NCT03139552|565900510|FG000|Overall Study|unable to attend tasting due to schedule|3|||
156766482|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
156766483|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
156766484|NCT00887484|565900519|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
156766485|NCT03122171|565900521|FG000|Overall Study|Withdrawal by Subject|1|||
156766486|NCT03044314|565900522|FG000|Overall Study|Physician Decision|2|||
156766487|NCT03044314|565900522|FG000|Overall Study|Withdrawal by Subject|1|||
156766488|NCT03044314|565900522|FG000|Overall Study|Connector tubing not available|1|||
156766489|NCT01316224|565900523|FG000|Overall Study|Protocol Violation|3|||
156766490|NCT01316224|565900523|FG000|Overall Study|Adverse Event|3|||
156766491|NCT01316224|565900523|FG000|Overall Study|Lack of Efficacy|1|||
156766492|NCT01316224|565900523|FG000|Overall Study|Withdrawal by Subject|1|||
156766493|NCT01316224|565900523|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
156766494|NCT01316224|565900523|FG000|Overall Study|Other|1|||
156766495|NCT00264147|565900524|FG000|Treatment I Period|Adverse Event|3|||
156766496|NCT00264147|565900525|FG001|Treatment I Period|Adverse Event|6|||
156766497|NCT00264147|565900526|FG002|Treatment I Period|Adverse Event|3|||
156766498|NCT00264147|565900527|FG003|Treatment I Period|Adverse Event|5|||
156766499|NCT00264147|565900528|FG004|Treatment I Period|Adverse Event|7|||
156766500|NCT00264147|565900529|FG005|Treatment I Period|Adverse Event|0|||
156766501|NCT00264147|565900524|FG000|Treatment I Period|Laboratory Adverse Event|0|||
156766502|NCT00264147|565900525|FG001|Treatment I Period|Laboratory Adverse Event|0|||
156766503|NCT00264147|565900526|FG002|Treatment I Period|Laboratory Adverse Event|0|||
156766504|NCT00264147|565900527|FG003|Treatment I Period|Laboratory Adverse Event|1|||
156766505|NCT00264147|565900528|FG004|Treatment I Period|Laboratory Adverse Event|0|||
156766506|NCT00264147|565900529|FG005|Treatment I Period|Laboratory Adverse Event|0|||
156766507|NCT00264147|565900524|FG000|Treatment I Period|Lack of Efficacy|6|||
156766508|NCT00264147|565900525|FG001|Treatment I Period|Lack of Efficacy|2|||
156766509|NCT00264147|565900526|FG002|Treatment I Period|Lack of Efficacy|8|||
156766510|NCT00264147|565900527|FG003|Treatment I Period|Lack of Efficacy|0|||
156766511|NCT00264147|565900528|FG004|Treatment I Period|Lack of Efficacy|1|||
156766512|NCT00264147|565900529|FG005|Treatment I Period|Lack of Efficacy|0|||
156766513|NCT00264147|565900524|FG000|Treatment I Period|Lost to Follow-up|1|||
156766514|NCT00264147|565900525|FG001|Treatment I Period|Lost to Follow-up|0|||
156766515|NCT00264147|565900526|FG002|Treatment I Period|Lost to Follow-up|0|||
156766516|NCT00264147|565900527|FG003|Treatment I Period|Lost to Follow-up|1|||
156766517|NCT00264147|565900528|FG004|Treatment I Period|Lost to Follow-up|1|||
156766518|NCT00264147|565900529|FG005|Treatment I Period|Lost to Follow-up|0|||
156766519|NCT00264147|565900524|FG000|Treatment I Period|Protocol Violation|2|||
156766520|NCT00264147|565900525|FG001|Treatment I Period|Protocol Violation|2|||
156766521|NCT00264147|565900526|FG002|Treatment I Period|Protocol Violation|0|||
156766522|NCT00264147|565900527|FG003|Treatment I Period|Protocol Violation|0|||
157111665|NCT01147744|567163373|FG003|Overall Study|Protocol Violation|0|||
156766523|NCT00264147|565900528|FG004|Treatment I Period|Protocol Violation|0|||
156766524|NCT00264147|565900529|FG005|Treatment I Period|Protocol Violation|0|||
156766525|NCT00264147|565900524|FG000|Treatment I Period|Withdrawal by Subject|2|||
157111666|NCT01147744|567163374|FG004|Overall Study|Protocol Violation|1|||
156766526|NCT00264147|565900525|FG001|Treatment I Period|Withdrawal by Subject|0|||
156766527|NCT00264147|565900526|FG002|Treatment I Period|Withdrawal by Subject|0|||
156766528|NCT00264147|565900527|FG003|Treatment I Period|Withdrawal by Subject|2|||
156766529|NCT00264147|565900528|FG004|Treatment I Period|Withdrawal by Subject|2|||
156766530|NCT00264147|565900529|FG005|Treatment I Period|Withdrawal by Subject|0|||
156766531|NCT00264147|565900524|FG000|Treatment I Period|Patient out of town for an extended time|0|||
156766532|NCT00264147|565900525|FG001|Treatment I Period|Patient out of town for an extended time|1|||
156766533|NCT00264147|565900526|FG002|Treatment I Period|Patient out of town for an extended time|0|||
156766534|NCT00264147|565900527|FG003|Treatment I Period|Patient out of town for an extended time|0|||
156766535|NCT00264147|565900528|FG004|Treatment I Period|Patient out of town for an extended time|0|||
156766536|NCT00264147|565900529|FG005|Treatment I Period|Patient out of town for an extended time|0|||
156766537|NCT00264147|565900524|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766538|NCT00264147|565900525|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766539|NCT00264147|565900526|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
156766540|NCT00264147|565900527|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766541|NCT00264147|565900528|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766542|NCT00264147|565900529|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
156766543|NCT00264147|565900524|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
156766544|NCT00264147|565900525|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
156766545|NCT00264147|565900526|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
156766546|NCT00264147|565900527|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
156766547|NCT00264147|565900528|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
156766548|NCT00264147|565900529|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
156766549|NCT00264147|565900524|FG000|Treatment II Period|Adverse Event|0|||
156766550|NCT00264147|565900525|FG001|Treatment II Period|Adverse Event|0|||
156766551|NCT00264147|565900526|FG002|Treatment II Period|Adverse Event|0|||
156766552|NCT00264147|565900527|FG003|Treatment II Period|Adverse Event|0|||
156766553|NCT00264147|565900528|FG004|Treatment II Period|Adverse Event|9|||
156766554|NCT00264147|565900529|FG005|Treatment II Period|Adverse Event|9|||
156766555|NCT00264147|565900524|FG000|Treatment II Period|Laboratory Adverse Event|0|||
156766556|NCT00264147|565900525|FG001|Treatment II Period|Laboratory Adverse Event|0|||
156766557|NCT00264147|565900526|FG002|Treatment II Period|Laboratory Adverse Event|0|||
156766558|NCT00264147|565900527|FG003|Treatment II Period|Laboratory Adverse Event|0|||
156766559|NCT00264147|565900528|FG004|Treatment II Period|Laboratory Adverse Event|0|||
156766560|NCT00264147|565900529|FG005|Treatment II Period|Laboratory Adverse Event|1|||
156766561|NCT00264147|565900524|FG000|Treatment II Period|Lack of Efficacy|0|||
156766562|NCT00264147|565900525|FG001|Treatment II Period|Lack of Efficacy|0|||
156766563|NCT00264147|565900526|FG002|Treatment II Period|Lack of Efficacy|0|||
156766564|NCT00264147|565900527|FG003|Treatment II Period|Lack of Efficacy|0|||
156766565|NCT00264147|565900528|FG004|Treatment II Period|Lack of Efficacy|20|||
156766566|NCT00264147|565900529|FG005|Treatment II Period|Lack of Efficacy|19|||
156766567|NCT00264147|565900524|FG000|Treatment II Period|Lost to Follow-up|0|||
156766568|NCT00264147|565900525|FG001|Treatment II Period|Lost to Follow-up|0|||
156766569|NCT00264147|565900526|FG002|Treatment II Period|Lost to Follow-up|0|||
156766570|NCT00264147|565900527|FG003|Treatment II Period|Lost to Follow-up|0|||
156766571|NCT00264147|565900528|FG004|Treatment II Period|Lost to Follow-up|1|||
156766572|NCT00264147|565900529|FG005|Treatment II Period|Lost to Follow-up|1|||
156766573|NCT00264147|565900524|FG000|Treatment II Period|Withdrawal by Subject|0|||
156766574|NCT00264147|565900525|FG001|Treatment II Period|Withdrawal by Subject|0|||
156766575|NCT00264147|565900526|FG002|Treatment II Period|Withdrawal by Subject|0|||
156766576|NCT00264147|565900527|FG003|Treatment II Period|Withdrawal by Subject|0|||
156766577|NCT00264147|565900528|FG004|Treatment II Period|Withdrawal by Subject|3|||
156766578|NCT00264147|565900529|FG005|Treatment II Period|Withdrawal by Subject|2|||
156766579|NCT00264147|565900524|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766580|NCT00264147|565900525|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766581|NCT00264147|565900526|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766582|NCT00264147|565900527|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766583|NCT00264147|565900528|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
156766584|NCT00264147|565900529|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
156766585|NCT03234465|565900530|FG000|Overall Study|Adverse Event|4|||
156766586|NCT03234465|565900531|FG001|Overall Study|Adverse Event|2|||
156766587|NCT03234465|565900530|FG000|Overall Study|Death|0|||
156766588|NCT03234465|565900531|FG001|Overall Study|Death|1|||
156766589|NCT03234465|565900530|FG000|Overall Study|Lost to Follow-up|1|||
156766590|NCT03234465|565900531|FG001|Overall Study|Lost to Follow-up|1|||
156766591|NCT03234465|565900530|FG000|Overall Study|Withdrawal by Subject|12|||
156766592|NCT03234465|565900531|FG001|Overall Study|Withdrawal by Subject|27|||
156766593|NCT03234465|565900530|FG000|Overall Study|Symptomatic deterioration|0|||
156766594|NCT03234465|565900531|FG001|Overall Study|Symptomatic deterioration|1|||
156766595|NCT03234465|565900530|FG000|Overall Study|Non-compliance|2|||
156766596|NCT03234465|565900531|FG001|Overall Study|Non-compliance|0|||
156766597|NCT03234465|565900530|FG000|Overall Study|Other|14|||
156766598|NCT03234465|565900531|FG001|Overall Study|Other|8|||
156766599|NCT00720499|565900532|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
156766600|NCT00720499|565900533|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
156766601|NCT00720499|565900532|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
156766602|NCT00720499|565900533|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
156766603|NCT00720499|565900532|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
156766604|NCT00720499|565900533|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
156766605|NCT00721799|565900538|FG000|Overall Study|Withdrawal by Subject|7|||
156766606|NCT00721799|565900538|FG000|Overall Study|withdraw by subject after scan 1|1|||
156766607|NCT01441973|565900539|FG000|Overall Study|Disease progression|8|||
156766608|NCT01441973|565900540|FG001|Overall Study|Disease progression|6|||
156766609|NCT01441973|565900539|FG000|Overall Study|Adverse event unrelated to study drug|3|||
156766610|NCT01441973|565900540|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156766611|NCT01441973|565900539|FG000|Overall Study|Participant request to discontinue|1|||
156766612|NCT01441973|565900540|FG001|Overall Study|Participant request to discontinue|1|||
156766613|NCT01441973|565900539|FG000|Overall Study|Poor compliance/noncompliance|0|||
156766614|NCT01441973|565900540|FG001|Overall Study|Poor compliance/noncompliance|1|||
156766615|NCT01441973|565900539|FG000|Overall Study|Administrative reason by sponsor|3|||
156766616|NCT01441973|565900540|FG001|Overall Study|Administrative reason by sponsor|5|||
156766617|NCT01441973|565900539|FG000|Overall Study|Participant withdrew consent|0|||
156766618|NCT01441973|565900540|FG001|Overall Study|Participant withdrew consent|1|||
156766619|NCT00617279|565900541|FG000|Overall Study|Study terminated by Sponsor|10|||
156766620|NCT00617279|565900542|FG001|Overall Study|Study terminated by Sponsor|15|||
156766621|NCT00617279|565900541|FG000|Overall Study|Graft abandonment|2|||
156766622|NCT00617279|565900542|FG001|Overall Study|Graft abandonment|0|||
156766623|NCT00617279|565900541|FG000|Overall Study|Lost to Follow-up|1|||
156766624|NCT00617279|565900542|FG001|Overall Study|Lost to Follow-up|0|||
156766625|NCT00617279|565900541|FG000|Overall Study|Death|1|||
156766626|NCT00617279|565900542|FG001|Overall Study|Death|2|||
156766627|NCT02351934|565903013|FG000|Allocation|POD weight<pre-op weight|3|||
156766628|NCT02351934|565903014|FG001|Allocation|POD weight<pre-op weight|0|||
156766629|NCT02351934|565903013|FG000|Allocation|Hypotension preventing administration|2|||
156766630|NCT02351934|565903014|FG001|Allocation|Hypotension preventing administration|0|||
156766631|NCT02351934|565903013|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
156766632|NCT02351934|565903014|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
156766633|NCT02351934|565903013|FG000|Follow-Up|POD weight<pre-op weight|3|||
156766634|NCT02351934|565903014|FG001|Follow-Up|POD weight<pre-op weight|0|||
156766635|NCT02351934|565903013|FG000|Follow-Up|Acute Kidney Injury|1|||
156766636|NCT02351934|565903014|FG001|Follow-Up|Acute Kidney Injury|0|||
156766637|NCT02351934|565903013|FG000|Follow-Up|Early dismissal|3|||
156766638|NCT02351934|565903014|FG001|Follow-Up|Early dismissal|0|||
156766639|NCT02351934|565903013|FG000|Follow-Up|Hypotension|3|||
156766640|NCT02351934|565903014|FG001|Follow-Up|Hypotension|0|||
156766641|NCT02351934|565903013|FG000|Follow-Up|No documentation|2|||
156766642|NCT02351934|565903014|FG001|Follow-Up|No documentation|0|||
156766643|NCT02351934|565903013|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
156766644|NCT02351934|565903014|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
156766645|NCT02351934|565903013|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
156766646|NCT02351934|565903014|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
156766647|NCT02014272|565903018|FG000|Intervention Period 1|Withdrawal by Subject|1|||
156766648|NCT02014272|565903019|FG001|Intervention Period 1|Withdrawal by Subject|0|||
156766649|NCT02014272|565903018|FG000|Intervention Period 1|Adverse Event|0|||
156766650|NCT02014272|565903019|FG001|Intervention Period 1|Adverse Event|1|||
156766651|NCT03499795|565903020|FG000|Overall Study|Adverse Event|1|||
156766652|NCT03499795|565903020|FG000|Overall Study|Lost to Follow-up|1|||
156766653|NCT00547339|565903021|FG000|Overall Study|Physician Decision|0|||
156766654|NCT00547339|565903022|FG001|Overall Study|Physician Decision|0|||
156766655|NCT00547339|565903023|FG002|Overall Study|Physician Decision|1|||
156766656|NCT00547339|565903024|FG003|Overall Study|Physician Decision|0|||
156766657|NCT03736967|565903025|FG000|Overall Study|Withdrawal by Subject|26|||
156766658|NCT03736967|565903026|FG001|Overall Study|Withdrawal by Subject|25|||
156766659|NCT03736967|565903027|FG002|Overall Study|Withdrawal by Subject|23|||
156766660|NCT03736967|565903028|FG003|Overall Study|Withdrawal by Subject|26|||
157111667|NCT01147744|567163375|FG005|Overall Study|Protocol Violation|3|||
157111668|NCT01147744|567163376|FG006|Overall Study|Protocol Violation|1|||
156766661|NCT03736967|565903025|FG000|Overall Study|Lost to Follow-up|3|||
156766662|NCT03736967|565903026|FG001|Overall Study|Lost to Follow-up|2|||
156766663|NCT03736967|565903027|FG002|Overall Study|Lost to Follow-up|1|||
156766664|NCT03736967|565903028|FG003|Overall Study|Lost to Follow-up|1|||
156766665|NCT03736967|565903025|FG000|Overall Study|Physician Decision|1|||
156766666|NCT03736967|565903026|FG001|Overall Study|Physician Decision|0|||
156766667|NCT03736967|565903027|FG002|Overall Study|Physician Decision|0|||
156766668|NCT03736967|565903028|FG003|Overall Study|Physician Decision|1|||
156766669|NCT03736967|565903025|FG000|Overall Study|Adverse Event|0|||
156766670|NCT03736967|565903026|FG001|Overall Study|Adverse Event|1|||
157111669|NCT01147744|567163370|FG000|Overall Study|Physician Decision|0|||
157111670|NCT01147744|567163371|FG001|Overall Study|Physician Decision|1|||
156766671|NCT03736967|565903027|FG002|Overall Study|Adverse Event|0|||
156766672|NCT03736967|565903028|FG003|Overall Study|Adverse Event|1|||
156766673|NCT03736967|565903025|FG000|Overall Study|Death|0|||
156766674|NCT03736967|565903026|FG001|Overall Study|Death|0|||
156766675|NCT03736967|565903027|FG002|Overall Study|Death|0|||
156766676|NCT03736967|565903028|FG003|Overall Study|Death|1|||
156766677|NCT03736967|565903025|FG000|Overall Study|Randomized but never treated|1|||
156766678|NCT03736967|565903026|FG001|Overall Study|Randomized but never treated|0|||
156766679|NCT03736967|565903027|FG002|Overall Study|Randomized but never treated|0|||
156766680|NCT03736967|565903028|FG003|Overall Study|Randomized but never treated|0|||
156766681|NCT02369653|565903029|FG000|Overall Study|Lost to Follow-up|0|||
156766682|NCT02369653|565903030|FG001|Overall Study|Lost to Follow-up|1|||
156766683|NCT02369653|565903029|FG000|Overall Study|Administrative reason by sponsor|0|||
156766684|NCT02369653|565903030|FG001|Overall Study|Administrative reason by sponsor|1|||
156766685|NCT02369653|565903029|FG000|Overall Study|Death|1|||
156766686|NCT02369653|565903030|FG001|Overall Study|Death|2|||
156766687|NCT02369653|565903029|FG000|Overall Study|Participant withdrew consent|13|||
156766688|NCT02369653|565903030|FG001|Overall Study|Participant withdrew consent|3|||
156766689|NCT03587636|565903031|FG000|Overall Study|Lost to Follow-up|2|||
156766690|NCT03587636|565903032|FG001|Overall Study|Lost to Follow-up|5|||
156766691|NCT01458587|565903033|FG000|Overall Study|Withdrawal by Subject|1|||
156766692|NCT01458587|565903034|FG001|Overall Study|Withdrawal by Subject|0|||
156766693|NCT01603602|565903035|FG000|Overall Study|Adverse Event|1|||
156766694|NCT01603602|565903036|FG001|Overall Study|Adverse Event|0|||
156766695|NCT01603602|565903037|FG002|Overall Study|Adverse Event|0|||
156766696|NCT01603602|565903035|FG000|Overall Study|Personal Reasons|1|||
156766697|NCT01603602|565903036|FG001|Overall Study|Personal Reasons|0|||
156766698|NCT01603602|565903037|FG002|Overall Study|Personal Reasons|1|||
156766699|NCT04748718|565903041|FG000|Overall Study|Lost to Follow-up|50|||
156766700|NCT00316004|565903042|FG000|Overall Study|Subject was not given study fluid.|14|||
156766701|NCT00316004|565903043|FG001|Overall Study|Subject was not given study fluid.|14|||
156766702|NCT00316004|565903044|FG002|Overall Study|Subject was not given study fluid.|21|||
156766703|NCT01118299|565903046|FG000|Overall Study|Death|7|||
156766704|NCT01118299|565903047|FG001|Overall Study|Death|5|||
156766705|NCT01118299|565903046|FG000|Overall Study|Withdrawal by Subject|8|||
157111671|NCT01147744|567163372|FG002|Overall Study|Physician Decision|1|||
157111672|NCT01147744|567163373|FG003|Overall Study|Physician Decision|0|||
156766706|NCT01118299|565903047|FG001|Overall Study|Withdrawal by Subject|8|||
156766707|NCT01118299|565903046|FG000|Overall Study|Lost to Follow-up|2|||
156766708|NCT01118299|565903047|FG001|Overall Study|Lost to Follow-up|1|||
156766709|NCT01118299|565903046|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
156766710|NCT01118299|565903047|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
156766711|NCT01935089|565903048|FG000|Overall Study|Adverse Event|2|||
156766712|NCT01935089|565903048|FG000|Overall Study|Withdrawal by Subject|1|||
156766713|NCT02932943|565903049|FG000|Overall Study|Lost to Follow-up|0|||
156766714|NCT02932943|565903050|FG001|Overall Study|Lost to Follow-up|2|||
156766715|NCT02932943|565903049|FG000|Overall Study|Adverse Event|2|||
156766716|NCT02932943|565903050|FG001|Overall Study|Adverse Event|2|||
156766717|NCT02932943|565903049|FG000|Overall Study|Withdrawal by Subject|3|||
156766718|NCT02932943|565903050|FG001|Overall Study|Withdrawal by Subject|3|||
157111673|NCT01147744|567163374|FG004|Overall Study|Physician Decision|0|||
156766719|NCT02665117|565903053|FG000|Overall Study|Physician Decision|1|||
156766720|NCT02665117|565903054|FG001|Overall Study|Physician Decision|0|||
156766721|NCT02337491|565903057|FG000|Overall Study|Death|1|||
156766722|NCT02337491|565903058|FG001|Overall Study|Death|1|||
156766723|NCT02337491|565903057|FG000|Overall Study|Adverse Event|0|||
156766724|NCT02337491|565903058|FG001|Overall Study|Adverse Event|1|||
156766725|NCT02337491|565903057|FG000|Overall Study|Withdrawal by Subject|3|||
156766726|NCT02337491|565903058|FG001|Overall Study|Withdrawal by Subject|0|||
156766727|NCT02337491|565903057|FG000|Overall Study|Progressive Disease|44|||
157111674|NCT01147744|567163375|FG005|Overall Study|Physician Decision|0|||
157111675|NCT01147744|567163376|FG006|Overall Study|Physician Decision|1|||
156766728|NCT02337491|565903058|FG001|Overall Study|Progressive Disease|28|||
156766729|NCT02337491|565903057|FG000|Overall Study|On Treatment|2|||
156766730|NCT02337491|565903058|FG001|Overall Study|On Treatment|0|||
156766731|NCT01432951|565903059|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
156766732|NCT03712280|565903069|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
156766733|NCT03712280|565903070|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
156766734|NCT03712280|565903071|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
156766735|NCT03712280|565903072|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
156766736|NCT03712280|565903069|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
156766737|NCT03712280|565903070|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766738|NCT03712280|565903071|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766739|NCT03712280|565903072|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
156766740|NCT03712280|565903069|FG000|Overall Study|Adverse Event|0|||
156766741|NCT03712280|565903070|FG001|Overall Study|Adverse Event|0|||
156766742|NCT03712280|565903071|FG002|Overall Study|Adverse Event|1|||
156766743|NCT03712280|565903072|FG003|Overall Study|Adverse Event|0|||
156766744|NCT00551369|565903073|FG000|Overall Study|Protocol Violation|5|||
156766745|NCT00551369|565903073|FG000|Overall Study|Withdrawal by Subject|1|||
156766746|NCT00551369|565903073|FG000|Overall Study|Not treated per protocol and re|1|||
156766747|NCT03439137|565903076|FG000|Overall Study|Adverse Event|16|||
156766748|NCT03439137|565903077|FG001|Overall Study|Adverse Event|12|||
156766749|NCT03439137|565903076|FG000|Overall Study|Physician Decision|0|||
156766750|NCT03439137|565903077|FG001|Overall Study|Physician Decision|5|||
156766751|NCT03439137|565903076|FG000|Overall Study|Withdrawal by Subject|14|||
156766752|NCT03439137|565903077|FG001|Overall Study|Withdrawal by Subject|4|||
156766753|NCT03439137|565903076|FG000|Overall Study|Conducting rescue therapy|2|||
156766754|NCT03439137|565903077|FG001|Overall Study|Conducting rescue therapy|1|||
156766755|NCT03439137|565903076|FG000|Overall Study|Difficult to control Hb|10|||
156766756|NCT03439137|565903077|FG001|Overall Study|Difficult to control Hb|2|||
156766757|NCT03439137|565903076|FG000|Overall Study|Initiation of a renal transplant|0|||
156766758|NCT03439137|565903077|FG001|Overall Study|Initiation of a renal transplant|2|||
156766759|NCT01569022|565903081|FG000|First Intervention|Lost to Follow-up|2|||
156766760|NCT01569022|565903082|FG001|First Intervention|Lost to Follow-up|1|||
156766761|NCT01569022|565903081|FG000|Second Intervention|Lost to Follow-up|2|||
156766762|NCT01569022|565903082|FG001|Second Intervention|Lost to Follow-up|2|||
156766763|NCT00644059|565903087|FG000|Overall Study|Lost to Follow-up|37|||
156766764|NCT00644059|565903088|FG001|Overall Study|Lost to Follow-up|34|||
156766765|NCT00644059|565903089|FG002|Overall Study|Lost to Follow-up|16|||
156766766|NCT00644059|565903087|FG000|Overall Study|Withdrawal by Subject|52|||
156766767|NCT00644059|565903088|FG001|Overall Study|Withdrawal by Subject|60|||
156766768|NCT00644059|565903089|FG002|Overall Study|Withdrawal by Subject|30|||
156766769|NCT00644059|565903087|FG000|Overall Study|Adverse Event|8|||
156766770|NCT00644059|565903088|FG001|Overall Study|Adverse Event|5|||
156766771|NCT00644059|565903089|FG002|Overall Study|Adverse Event|1|||
156766772|NCT00644059|565903087|FG000|Overall Study|Inappropriate Enrollment|1|||
156766773|NCT00644059|565903088|FG001|Overall Study|Inappropriate Enrollment|3|||
156766774|NCT00644059|565903089|FG002|Overall Study|Inappropriate Enrollment|0|||
156766775|NCT00644059|565903087|FG000|Overall Study|Protocol Deviation/violation|20|||
156766776|NCT00644059|565903088|FG001|Overall Study|Protocol Deviation/violation|19|||
156766777|NCT00644059|565903089|FG002|Overall Study|Protocol Deviation/violation|15|||
156766778|NCT00644059|565903087|FG000|Overall Study|Unable to classify|6|||
156766779|NCT00644059|565903088|FG001|Overall Study|Unable to classify|2|||
156766780|NCT00644059|565903089|FG002|Overall Study|Unable to classify|3|||
156766781|NCT01302899|565903090|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
156766782|NCT01302899|565903091|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
156766783|NCT01302899|565903090|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
156766784|NCT01302899|565903091|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
156766785|NCT02834975|565903092|FG000|Overall Study|Physician Decision|2|||
156766786|NCT02834975|565903092|FG000|Overall Study|Adverse Event|1|||
156766787|NCT02834975|565903092|FG000|Overall Study|Withdrawal by Subject|1|||
156766788|NCT02834975|565903092|FG000|Overall Study|Lack of Efficacy|1|||
156766789|NCT03482024|565903094|FG000|Overall Study|Physician Decision|1|||
156766790|NCT03482024|565903095|FG001|Overall Study|Physician Decision|0|||
156766791|NCT03482024|565903096|FG002|Overall Study|Physician Decision|0|||
156766792|NCT03482024|565903097|FG003|Overall Study|Physician Decision|0|||
156766793|NCT03482024|565903098|FG004|Overall Study|Physician Decision|0|||
156766794|NCT00472420|565903099|FG000|Induction Treatment Period|Physician Decision|9|||
156766795|NCT00472420|565903099|FG000|Induction Treatment Period|Adverse Event|3|||
156766796|NCT00472420|565903099|FG000|Induction Treatment Period|Non-compliance|1|||
156766797|NCT00472420|565903099|FG000|Induction Treatment Period|Death|3|||
156766798|NCT00472420|565903099|FG000|Follow-up Period|Death|5|||
156766799|NCT00472420|565903099|FG000|Follow-up Period|Physician Decision|9|||
156766800|NCT00472420|565903099|FG000|Follow-up Period|Lost to Follow-up|2|||
156766801|NCT00472420|565903099|FG000|Follow-up Period|Protocol Violation|1|||
157005960|NCT02425111|566771641|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
156766802|NCT00686972|565903101|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
156766803|NCT02065557|565903102|FG000|Induction Period|Withdrawal by Subject|2|||
156766804|NCT02065557|565903103|FG001|Induction Period|Withdrawal by Subject|1|||
156766805|NCT02065557|565903104|FG002|Induction Period|Withdrawal by Subject|0|||
156766806|NCT02065557|565903105|FG003|Induction Period|Withdrawal by Subject|0|||
156766807|NCT02065557|565903106|FG004|Induction Period|Withdrawal by Subject|0|||
156766808|NCT02065557|565903107|FG005|Induction Period|Withdrawal by Subject|0|||
156766809|NCT02065557|565903102|FG000|Induction Period|Lack of Efficacy|2|||
156766810|NCT02065557|565903103|FG001|Induction Period|Lack of Efficacy|1|||
156766811|NCT02065557|565903104|FG002|Induction Period|Lack of Efficacy|1|||
156766812|NCT02065557|565903105|FG003|Induction Period|Lack of Efficacy|0|||
156766813|NCT02065557|565903106|FG004|Induction Period|Lack of Efficacy|0|||
156766814|NCT02065557|565903107|FG005|Induction Period|Lack of Efficacy|0|||
156766815|NCT02065557|565903102|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766816|NCT02065557|565903103|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766817|NCT02065557|565903104|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
156766818|NCT02065557|565903105|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766819|NCT02065557|565903106|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766820|NCT02065557|565903107|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
156766821|NCT02065557|565903102|FG000|Induction Period|Non-Responder at Week 8|4|||
156766822|NCT02065557|565903103|FG001|Induction Period|Non-Responder at Week 8|4|||
156766823|NCT02065557|565903104|FG002|Induction Period|Non-Responder at Week 8|0|||
156766824|NCT02065557|565903105|FG003|Induction Period|Non-Responder at Week 8|0|||
156766825|NCT02065557|565903106|FG004|Induction Period|Non-Responder at Week 8|0|||
156766826|NCT02065557|565903107|FG005|Induction Period|Non-Responder at Week 8|0|||
156766827|NCT02065557|565903102|FG000|Induction Period|Adverse Event|1|||
156766828|NCT02065557|565903103|FG001|Induction Period|Adverse Event|1|||
156766829|NCT02065557|565903104|FG002|Induction Period|Adverse Event|0|||
156766830|NCT02065557|565903105|FG003|Induction Period|Adverse Event|0|||
156766831|NCT02065557|565903106|FG004|Induction Period|Adverse Event|0|||
156766832|NCT02065557|565903107|FG005|Induction Period|Adverse Event|0|||
156766833|NCT02065557|565903102|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766834|NCT02065557|565903103|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766835|NCT02065557|565903104|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766836|NCT02065557|565903105|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
156766837|NCT02065557|565903106|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
156766838|NCT02065557|565903107|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
156766839|NCT02065557|565903102|FG000|Maintenance Period|Withdrawal by Subject|0|||
156766840|NCT02065557|565903103|FG001|Maintenance Period|Withdrawal by Subject|0|||
156766841|NCT02065557|565903104|FG002|Maintenance Period|Withdrawal by Subject|0|||
156766842|NCT02065557|565903105|FG003|Maintenance Period|Withdrawal by Subject|0|||
156766843|NCT02065557|565903106|FG004|Maintenance Period|Withdrawal by Subject|2|||
156766844|NCT02065557|565903107|FG005|Maintenance Period|Withdrawal by Subject|1|||
156766845|NCT02065557|565903102|FG000|Maintenance Period|Lack of Efficacy|0|||
156766846|NCT02065557|565903103|FG001|Maintenance Period|Lack of Efficacy|0|||
156766847|NCT02065557|565903104|FG002|Maintenance Period|Lack of Efficacy|0|||
156766848|NCT02065557|565903105|FG003|Maintenance Period|Lack of Efficacy|0|||
156766849|NCT02065557|565903106|FG004|Maintenance Period|Lack of Efficacy|5|||
156766850|NCT02065557|565903107|FG005|Maintenance Period|Lack of Efficacy|2|||
156766851|NCT02065557|565903102|FG000|Maintenance Period|Subject Non-Compliance|0|||
156766852|NCT02065557|565903103|FG001|Maintenance Period|Subject Non-Compliance|0|||
156766853|NCT02065557|565903104|FG002|Maintenance Period|Subject Non-Compliance|0|||
157111676|NCT01147744|567163370|FG000|Overall Study|Lack of Efficacy|11|||
157111677|NCT01147744|567163371|FG001|Overall Study|Lack of Efficacy|11|||
157111678|NCT01147744|567163372|FG002|Overall Study|Lack of Efficacy|9|||
157111679|NCT01147744|567163373|FG003|Overall Study|Lack of Efficacy|11|||
157111680|NCT01147744|567163374|FG004|Overall Study|Lack of Efficacy|13|||
157111681|NCT01147744|567163375|FG005|Overall Study|Lack of Efficacy|8|||
157111682|NCT01147744|567163376|FG006|Overall Study|Lack of Efficacy|7|||
157111683|NCT01147744|567163370|FG000|Overall Study|Adverse Event|1|||
157111684|NCT01147744|567163371|FG001|Overall Study|Adverse Event|2|||
157111685|NCT01147744|567163372|FG002|Overall Study|Adverse Event|3|||
156766854|NCT02065557|565903105|FG003|Maintenance Period|Subject Non-Compliance|0|||
156766855|NCT02065557|565903106|FG004|Maintenance Period|Subject Non-Compliance|0|||
156766856|NCT02065557|565903107|FG005|Maintenance Period|Subject Non-Compliance|1|||
156766857|NCT01462942|565903111|FG000|Overall Study|Adverse Event|7|||
156766858|NCT01462942|565903112|FG001|Overall Study|Adverse Event|12|||
156766859|NCT01462942|565903113|FG002|Overall Study|Adverse Event|10|||
156766860|NCT01462942|565903114|FG003|Overall Study|Adverse Event|11|||
156766861|NCT01462942|565903115|FG004|Overall Study|Adverse Event|11|||
156766862|NCT01462942|565903111|FG000|Overall Study|Other, including COPD exacerbation|3|||
156766863|NCT01462942|565903112|FG001|Overall Study|Other, including COPD exacerbation|5|||
156766864|NCT01462942|565903113|FG002|Overall Study|Other, including COPD exacerbation|2|||
157111686|NCT01147744|567163373|FG003|Overall Study|Adverse Event|0|||
157111687|NCT01147744|567163374|FG004|Overall Study|Adverse Event|2|||
157005961|NCT02425111|566771641|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
157005962|NCT02425111|566771641|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
157005963|NCT02425111|566771641|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
157005964|NCT02425111|566771641|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
157005965|NCT02425111|566771641|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
157005966|NCT00585533|566771642|FG000|Overall Study|objective or symptomatic progression|9|||
157005967|NCT02798835|566771643|FG000|Overall Study|Protocol Violation|0|||
157005968|NCT02798835|566771644|FG001|Overall Study|Protocol Violation|0|||
157005969|NCT02798835|566771645|FG002|Overall Study|Protocol Violation|3|||
157005970|NCT03024606|566771650|FG000|Overall Study|Withdrawal by Subject|9|||
157111688|NCT01147744|567163375|FG005|Overall Study|Adverse Event|1|||
157111689|NCT01147744|567163376|FG006|Overall Study|Adverse Event|2|||
157111690|NCT01147744|567163370|FG000|Overall Study|Withdrawal by Subject|8|||
157111691|NCT01147744|567163371|FG001|Overall Study|Withdrawal by Subject|4|||
157111692|NCT01147744|567163372|FG002|Overall Study|Withdrawal by Subject|2|||
157111693|NCT01147744|567163373|FG003|Overall Study|Withdrawal by Subject|2|||
157111694|NCT01147744|567163374|FG004|Overall Study|Withdrawal by Subject|2|||
157111695|NCT01147744|567163375|FG005|Overall Study|Withdrawal by Subject|5|||
157111696|NCT01147744|567163376|FG006|Overall Study|Withdrawal by Subject|2|||
157111697|NCT01147744|567163370|FG000|Overall Study|Lost to Follow-up|0|||
157111698|NCT01147744|567163371|FG001|Overall Study|Lost to Follow-up|1|||
157111699|NCT01147744|567163372|FG002|Overall Study|Lost to Follow-up|0|||
157111700|NCT01147744|567163373|FG003|Overall Study|Lost to Follow-up|0|||
157111701|NCT01147744|567163374|FG004|Overall Study|Lost to Follow-up|0|||
157111702|NCT01147744|567163375|FG005|Overall Study|Lost to Follow-up|0|||
157005971|NCT03024606|566771651|FG001|Overall Study|Withdrawal by Subject|10|||
157005972|NCT03482011|566771662|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
157005973|NCT03482011|566771663|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
157005974|NCT03482011|566771664|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
157005975|NCT03482011|566771665|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
157005976|NCT03482011|566771666|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
157005977|NCT03482011|566771667|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
157005978|NCT03482011|566771668|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
157005979|NCT03482011|566771669|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
157005980|NCT03482011|566771662|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
157111703|NCT01147744|567163376|FG006|Overall Study|Lost to Follow-up|0|||
157111704|NCT01147744|567163370|FG000|Overall Study|Sponsor decision to amend protocol|7|||
157111705|NCT01147744|567163371|FG001|Overall Study|Sponsor decision to amend protocol|4|||
157111706|NCT01147744|567163372|FG002|Overall Study|Sponsor decision to amend protocol|2|||
157111707|NCT01147744|567163373|FG003|Overall Study|Sponsor decision to amend protocol|5|||
157005981|NCT03482011|566771663|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
157005982|NCT03482011|566771664|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157005983|NCT03482011|566771665|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157111708|NCT01147744|567163374|FG004|Overall Study|Sponsor decision to amend protocol|7|||
157111709|NCT01147744|567163375|FG005|Overall Study|Sponsor decision to amend protocol|2|||
157111710|NCT01147744|567163376|FG006|Overall Study|Sponsor decision to amend protocol|6|||
157111711|NCT01147744|567163370|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157111712|NCT01147744|567163371|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157111713|NCT01147744|567163372|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157111714|NCT01147744|567163373|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157111715|NCT01147744|567163374|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157111716|NCT01147744|567163375|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157111717|NCT01147744|567163376|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157111718|NCT01342484|567163377|FG000|Overall Study|Other Reasons|1|||
157111719|NCT01342484|567163378|FG001|Overall Study|Other Reasons|0|||
157111720|NCT01342484|567163379|FG002|Overall Study|Other Reasons|0|||
157111721|NCT01342484|567163377|FG000|Overall Study|Protocol Violation|0|||
157111722|NCT01342484|567163378|FG001|Overall Study|Protocol Violation|0|||
157111723|NCT01342484|567163379|FG002|Overall Study|Protocol Violation|1|||
157111724|NCT01342484|567163377|FG000|Overall Study|Withdrawal by Subject|1|||
157111725|NCT01342484|567163378|FG001|Overall Study|Withdrawal by Subject|0|||
157111726|NCT01342484|567163379|FG002|Overall Study|Withdrawal by Subject|0|||
157111727|NCT01840579|567163380|FG000|Overall Study|Status not recorded|0|||
157111728|NCT01840579|567163381|FG001|Overall Study|Status not recorded|0|||
157111729|NCT01840579|567163382|FG002|Overall Study|Status not recorded|2|||
157111730|NCT01840579|567163383|FG003|Overall Study|Status not recorded|3|||
157111731|NCT01840579|567163384|FG004|Overall Study|Status not recorded|4|||
157111732|NCT01840579|567163385|FG005|Overall Study|Status not recorded|3|||
156766865|NCT01462942|565903114|FG003|Overall Study|Other, including COPD exacerbation|8|||
156766866|NCT01462942|565903115|FG004|Overall Study|Other, including COPD exacerbation|5|||
156766867|NCT01462942|565903111|FG000|Overall Study|Withdrawal by Subject|14|||
156766868|NCT01462942|565903112|FG001|Overall Study|Withdrawal by Subject|10|||
156766869|NCT01462942|565903113|FG002|Overall Study|Withdrawal by Subject|14|||
156766870|NCT01462942|565903114|FG003|Overall Study|Withdrawal by Subject|16|||
156766871|NCT01462942|565903115|FG004|Overall Study|Withdrawal by Subject|19|||
156766872|NCT01462942|565903111|FG000|Overall Study|Lack of Efficacy|6|||
156766873|NCT01462942|565903112|FG001|Overall Study|Lack of Efficacy|0|||
156766874|NCT01462942|565903113|FG002|Overall Study|Lack of Efficacy|4|||
156766875|NCT01462942|565903114|FG003|Overall Study|Lack of Efficacy|5|||
156766876|NCT01462942|565903115|FG004|Overall Study|Lack of Efficacy|3|||
156766877|NCT01462942|565903111|FG000|Overall Study|Lost to Follow-up|0|||
156766878|NCT01462942|565903112|FG001|Overall Study|Lost to Follow-up|1|||
156766879|NCT01462942|565903113|FG002|Overall Study|Lost to Follow-up|1|||
156766880|NCT01462942|565903114|FG003|Overall Study|Lost to Follow-up|1|||
156766881|NCT01462942|565903115|FG004|Overall Study|Lost to Follow-up|1|||
156766882|NCT01462942|565903111|FG000|Overall Study|Protocol Violation|4|||
156766883|NCT01462942|565903112|FG001|Overall Study|Protocol Violation|6|||
156766884|NCT01462942|565903113|FG002|Overall Study|Protocol Violation|9|||
156766885|NCT01462942|565903114|FG003|Overall Study|Protocol Violation|9|||
156766886|NCT01462942|565903115|FG004|Overall Study|Protocol Violation|6|||
156766887|NCT02737722|565903118|FG000|Overall Study|Physician Decision|0|||
156766888|NCT02737722|565903119|FG001|Overall Study|Physician Decision|0|||
156766889|NCT02737722|565903120|FG002|Overall Study|Physician Decision|1|||
156766890|NCT02737722|565903121|FG003|Overall Study|Physician Decision|0|||
156766891|NCT02662569|565903122|FG000|Overall Study|Withdrawal by Subject|6|||
156766892|NCT02662569|565903123|FG001|Overall Study|Withdrawal by Subject|1|||
156766893|NCT02662569|565903124|FG002|Overall Study|Withdrawal by Subject|6|||
156766894|NCT02662569|565903125|FG003|Overall Study|Withdrawal by Subject|4|||
156766895|NCT02662569|565903122|FG000|Overall Study|Lost to Follow-up|1|||
156766896|NCT02662569|565903123|FG001|Overall Study|Lost to Follow-up|0|||
156766897|NCT02662569|565903124|FG002|Overall Study|Lost to Follow-up|0|||
156766898|NCT02662569|565903125|FG003|Overall Study|Lost to Follow-up|0|||
156766899|NCT03154086|565903126|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766900|NCT03154086|565903127|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766901|NCT03154086|565903128|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766902|NCT03154086|565903129|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
156766903|NCT03154086|565903130|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766904|NCT03154086|565903131|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766905|NCT03154086|565903132|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766906|NCT03154086|565903133|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766907|NCT03154086|565903134|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766908|NCT03154086|565903135|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766909|NCT03154086|565903136|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766910|NCT03154086|565903137|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766911|NCT03154086|565903138|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766912|NCT03154086|565903139|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
157111733|NCT01840579|567163386|FG006|Overall Study|Status not recorded|0|||
157111734|NCT01840579|567163387|FG007|Overall Study|Status not recorded|3|||
157111735|NCT01840579|567163388|FG008|Overall Study|Status not recorded|3|||
157111736|NCT01840579|567163389|FG009|Overall Study|Status not recorded|3|||
157111737|NCT01840579|567163380|FG000|Overall Study|Progressive disease|3|||
157111738|NCT01840579|567163381|FG001|Overall Study|Progressive disease|5|||
157111739|NCT01840579|567163382|FG002|Overall Study|Progressive disease|0|||
157111740|NCT01840579|567163383|FG003|Overall Study|Progressive disease|0|||
157111741|NCT01840579|567163384|FG004|Overall Study|Progressive disease|0|||
157111742|NCT01840579|567163385|FG005|Overall Study|Progressive disease|0|||
157111743|NCT01840579|567163386|FG006|Overall Study|Progressive disease|0|||
157111744|NCT01840579|567163387|FG007|Overall Study|Progressive disease|0|||
157111745|NCT01840579|567163388|FG008|Overall Study|Progressive disease|0|||
157111746|NCT01840579|567163389|FG009|Overall Study|Progressive disease|0|||
157111747|NCT01840579|567163380|FG000|Overall Study|Ongoing in study|0|||
157111748|NCT01840579|567163381|FG001|Overall Study|Ongoing in study|1|||
157111749|NCT01840579|567163382|FG002|Overall Study|Ongoing in study|0|||
157111750|NCT01840579|567163383|FG003|Overall Study|Ongoing in study|0|||
156766913|NCT03154086|565903140|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
156766914|NCT03154086|565903126|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766915|NCT03154086|565903127|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
156766916|NCT03154086|565903128|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766917|NCT03154086|565903129|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766918|NCT03154086|565903130|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766919|NCT03154086|565903131|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766920|NCT03154086|565903132|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766921|NCT03154086|565903133|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766922|NCT03154086|565903134|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766923|NCT03154086|565903135|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766924|NCT03154086|565903136|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766925|NCT03154086|565903137|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766926|NCT03154086|565903138|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
157111751|NCT01840579|567163384|FG004|Overall Study|Ongoing in study|0|||
156766927|NCT03154086|565903139|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766928|NCT03154086|565903140|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
156766929|NCT03154086|565903126|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766930|NCT03154086|565903127|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766931|NCT03154086|565903128|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
156766932|NCT03154086|565903129|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766933|NCT03154086|565903130|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766934|NCT03154086|565903131|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766935|NCT03154086|565903132|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766936|NCT03154086|565903133|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766937|NCT03154086|565903134|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766938|NCT03154086|565903135|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766939|NCT03154086|565903136|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766940|NCT03154086|565903137|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766941|NCT03154086|565903138|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766942|NCT03154086|565903139|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766943|NCT03154086|565903140|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
156766944|NCT03154086|565903126|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
156766945|NCT03154086|565903127|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766946|NCT03154086|565903128|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766947|NCT03154086|565903129|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766948|NCT03154086|565903130|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766949|NCT03154086|565903131|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766950|NCT03154086|565903132|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766951|NCT03154086|565903133|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766952|NCT03154086|565903134|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766953|NCT03154086|565903135|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766954|NCT03154086|565903136|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766955|NCT03154086|565903137|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766956|NCT03154086|565903138|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766957|NCT03154086|565903139|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766958|NCT03154086|565903140|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
156766959|NCT03154086|565903126|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766960|NCT03154086|565903127|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766961|NCT03154086|565903128|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766962|NCT03154086|565903129|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766963|NCT03154086|565903130|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766964|NCT03154086|565903131|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766965|NCT03154086|565903132|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766966|NCT03154086|565903133|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766967|NCT03154086|565903134|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
156766968|NCT03154086|565903135|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766969|NCT03154086|565903136|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766970|NCT03154086|565903137|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
157111752|NCT01840579|567163385|FG005|Overall Study|Ongoing in study|0|||
157111753|NCT01840579|567163386|FG006|Overall Study|Ongoing in study|0|||
157111754|NCT01840579|567163387|FG007|Overall Study|Ongoing in study|0|||
156766971|NCT03154086|565903138|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766972|NCT03154086|565903139|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766973|NCT03154086|565903140|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
156766974|NCT03154086|565903126|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766975|NCT03154086|565903127|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766976|NCT03154086|565903128|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766977|NCT03154086|565903129|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766978|NCT03154086|565903130|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766979|NCT03154086|565903131|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766980|NCT03154086|565903132|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766981|NCT03154086|565903133|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
156766982|NCT03154086|565903134|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766983|NCT03154086|565903135|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766984|NCT03154086|565903136|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766985|NCT03154086|565903137|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766986|NCT03154086|565903138|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766987|NCT03154086|565903139|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766988|NCT03154086|565903140|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
156766989|NCT03154086|565903126|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
156766990|NCT03154086|565903127|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
156766991|NCT03154086|565903128|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
156766992|NCT03154086|565903129|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
156766993|NCT03154086|565903130|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
156766994|NCT03154086|565903131|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
156766995|NCT03154086|565903132|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
156766996|NCT03154086|565903133|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
156766997|NCT03154086|565903134|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
156766998|NCT03154086|565903135|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
156766999|NCT03154086|565903136|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
156767000|NCT03154086|565903137|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
156767001|NCT03154086|565903138|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
156767002|NCT03154086|565903139|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
156767003|NCT03154086|565903140|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
156767004|NCT03555149|565903148|FG000|Overall Study|Death|18|||
156767005|NCT03555149|565903149|FG001|Overall Study|Death|15|||
156767006|NCT03555149|565903150|FG002|Overall Study|Death|15|||
156767007|NCT03555149|565903151|FG003|Overall Study|Death|4|||
156767008|NCT03555149|565903152|FG004|Overall Study|Death|4|||
156767009|NCT03555149|565903153|FG005|Overall Study|Death|11|||
156767010|NCT03555149|565903154|FG006|Overall Study|Death|12|||
156767011|NCT03555149|565903155|FG007|Overall Study|Death|1|||
156767012|NCT03555149|565903148|FG000|Overall Study|Lost to Follow-up|1|||
156767013|NCT03555149|565903149|FG001|Overall Study|Lost to Follow-up|0|||
156767014|NCT03555149|565903150|FG002|Overall Study|Lost to Follow-up|0|||
156767015|NCT03555149|565903151|FG003|Overall Study|Lost to Follow-up|0|||
156767016|NCT03555149|565903152|FG004|Overall Study|Lost to Follow-up|0|||
156767017|NCT03555149|565903153|FG005|Overall Study|Lost to Follow-up|1|||
156767018|NCT03555149|565903154|FG006|Overall Study|Lost to Follow-up|0|||
156767019|NCT03555149|565903155|FG007|Overall Study|Lost to Follow-up|0|||
156767020|NCT03555149|565903148|FG000|Overall Study|Physician Decision|1|||
156767021|NCT03555149|565903149|FG001|Overall Study|Physician Decision|0|||
156767022|NCT03555149|565903150|FG002|Overall Study|Physician Decision|0|||
156767023|NCT03555149|565903151|FG003|Overall Study|Physician Decision|0|||
156767024|NCT03555149|565903152|FG004|Overall Study|Physician Decision|0|||
156767025|NCT03555149|565903153|FG005|Overall Study|Physician Decision|0|||
156767026|NCT03555149|565903154|FG006|Overall Study|Physician Decision|0|||
156767027|NCT03555149|565903155|FG007|Overall Study|Physician Decision|0|||
156767028|NCT03555149|565903148|FG000|Overall Study|Study Terminated By Sponsor|1|||
157111755|NCT01840579|567163388|FG008|Overall Study|Ongoing in study|0|||
157111756|NCT01840579|567163389|FG009|Overall Study|Ongoing in study|0|||
156767029|NCT03555149|565903149|FG001|Overall Study|Study Terminated By Sponsor|0|||
156767030|NCT03555149|565903150|FG002|Overall Study|Study Terminated By Sponsor|0|||
156767031|NCT03555149|565903151|FG003|Overall Study|Study Terminated By Sponsor|0|||
156767032|NCT03555149|565903152|FG004|Overall Study|Study Terminated By Sponsor|0|||
156767033|NCT03555149|565903153|FG005|Overall Study|Study Terminated By Sponsor|2|||
156767034|NCT03555149|565903154|FG006|Overall Study|Study Terminated By Sponsor|3|||
156767035|NCT03555149|565903155|FG007|Overall Study|Study Terminated By Sponsor|1|||
156767036|NCT03555149|565903148|FG000|Overall Study|Withdrawal by Subject|3|||
156767037|NCT03555149|565903149|FG001|Overall Study|Withdrawal by Subject|0|||
156767038|NCT03555149|565903150|FG002|Overall Study|Withdrawal by Subject|0|||
156767039|NCT03555149|565903151|FG003|Overall Study|Withdrawal by Subject|2|||
156767040|NCT03555149|565903152|FG004|Overall Study|Withdrawal by Subject|0|||
156767041|NCT03555149|565903153|FG005|Overall Study|Withdrawal by Subject|1|||
156767042|NCT03555149|565903154|FG006|Overall Study|Withdrawal by Subject|0|||
156767043|NCT03555149|565903155|FG007|Overall Study|Withdrawal by Subject|0|||
157111757|NCT01840579|567163380|FG000|Overall Study|Death|0|||
157111758|NCT01840579|567163381|FG001|Overall Study|Death|0|||
157111759|NCT01840579|567163382|FG002|Overall Study|Death|0|||
157111760|NCT01840579|567163383|FG003|Overall Study|Death|0|||
157111761|NCT01840579|567163384|FG004|Overall Study|Death|0|||
157111762|NCT01840579|567163385|FG005|Overall Study|Death|1|||
157111763|NCT01840579|567163386|FG006|Overall Study|Death|0|||
157005984|NCT03482011|566771666|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157005985|NCT03482011|566771667|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157005986|NCT03482011|566771668|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157005987|NCT03482011|566771669|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
157005988|NCT03482011|566771662|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005989|NCT03482011|566771663|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
157005990|NCT03482011|566771664|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005991|NCT03482011|566771665|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005992|NCT03482011|566771666|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005993|NCT03482011|566771667|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005994|NCT03482011|566771668|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005995|NCT03482011|566771669|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
157005996|NCT03482011|566771662|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
157005997|NCT03482011|566771663|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
157005998|NCT03482011|566771664|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
157005999|NCT03482011|566771665|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
157006000|NCT03482011|566771666|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
157006001|NCT03482011|566771667|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
157006002|NCT03482011|566771668|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
157006003|NCT03482011|566771669|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
157006004|NCT03482011|566771662|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
157111764|NCT01840579|567163387|FG007|Overall Study|Death|0|||
157111765|NCT01840579|567163388|FG008|Overall Study|Death|0|||
156767044|NCT02785939|565903169|FG000|Overall Study|Progression|25|||
157111766|NCT01840579|567163389|FG009|Overall Study|Death|0|||
157111767|NCT01840579|567163380|FG000|Overall Study|Adverse Event|0|||
157111768|NCT01840579|567163381|FG001|Overall Study|Adverse Event|1|||
157111769|NCT01840579|567163382|FG002|Overall Study|Adverse Event|0|||
157111770|NCT01840579|567163383|FG003|Overall Study|Adverse Event|0|||
157111771|NCT01840579|567163384|FG004|Overall Study|Adverse Event|0|||
157111772|NCT01840579|567163385|FG005|Overall Study|Adverse Event|0|||
156767045|NCT02785939|565903170|FG001|Overall Study|Progression|8|||
156767046|NCT02785939|565903169|FG000|Overall Study|Adverse Event|3|||
156767047|NCT02785939|565903170|FG001|Overall Study|Adverse Event|1|||
156767048|NCT02785939|565903169|FG000|Overall Study|Death|1|||
156767049|NCT02785939|565903170|FG001|Overall Study|Death|0|||
156767050|NCT02785939|565903169|FG000|Overall Study|Refusal|1|||
156767051|NCT02785939|565903170|FG001|Overall Study|Refusal|0|||
156767052|NCT02785939|565903169|FG000|Overall Study|Deteriorating health|1|||
156767053|NCT02785939|565903170|FG001|Overall Study|Deteriorating health|0|||
156767054|NCT02785939|565903169|FG000|Overall Study|Not protocol specified|0|||
156767055|NCT02785939|565903170|FG001|Overall Study|Not protocol specified|1|||
156767056|NCT04465422|565903171|FG000|Overall Study|Lost to Follow-up|0|||
156767057|NCT04465422|565903172|FG001|Overall Study|Lost to Follow-up|2|||
156767058|NCT00572832|565903178|FG000|Overall Study|Lost to Follow-up|0|||
156767059|NCT00572832|565903179|FG001|Overall Study|Lost to Follow-up|11|||
157111773|NCT01840579|567163386|FG006|Overall Study|Adverse Event|0|||
156767060|NCT00572832|565903178|FG000|Overall Study|Pregnancy|0|||
156767061|NCT00572832|565903179|FG001|Overall Study|Pregnancy|1|||
156767062|NCT00324155|565903180|FG000|Enrolled and Randomized|No longer met study criteria|3|||
156767063|NCT00324155|565903181|FG001|Enrolled and Randomized|No longer met study criteria|0|||
156767064|NCT00324155|565903180|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
156767065|NCT00324155|565903181|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
156767066|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
156767067|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
156767068|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
156767069|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
156767070|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Death|8|||
156767071|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Death|15|||
156767072|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
156767073|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
156767074|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
156767075|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
156767076|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
156767077|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
156767078|NCT00324155|565903180|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
156767079|NCT00324155|565903181|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
156767080|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
156767081|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
156767082|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
156767083|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
156767084|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
156767085|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
156767086|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
156767087|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
156767088|NCT00324155|565903180|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
156767089|NCT00324155|565903181|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
156767090|NCT00324155|565903180|FG000|Follow-up Phase|On-going participants still on drug|11|||
156767091|NCT00324155|565903181|FG001|Follow-up Phase|On-going participants still on drug|6|||
156767092|NCT00390689|565903182|FG000|Overall Study|Adverse Event|2|||
156767093|NCT00390689|565903183|FG001|Overall Study|Adverse Event|5|||
156767094|NCT00390689|565903184|FG002|Overall Study|Adverse Event|2|||
156767095|NCT00390689|565903182|FG000|Overall Study|Lack of Efficacy|0|||
156767096|NCT00390689|565903183|FG001|Overall Study|Lack of Efficacy|0|||
156767097|NCT00390689|565903184|FG002|Overall Study|Lack of Efficacy|1|||
156767098|NCT00390689|565903182|FG000|Overall Study|Protocol Violation|1|||
156767099|NCT00390689|565903183|FG001|Overall Study|Protocol Violation|0|||
156767100|NCT00390689|565903184|FG002|Overall Study|Protocol Violation|0|||
156767101|NCT00390689|565903182|FG000|Overall Study|Investigator's judgement|2|||
157111774|NCT01840579|567163387|FG007|Overall Study|Adverse Event|0|||
157111775|NCT01840579|567163388|FG008|Overall Study|Adverse Event|0|||
156767102|NCT00390689|565903183|FG001|Overall Study|Investigator's judgement|0|||
156767103|NCT00390689|565903184|FG002|Overall Study|Investigator's judgement|0|||
156767104|NCT01253161|565903185|FG000|Overall Study|Adverse Event|1|||
157111776|NCT01840579|567163389|FG009|Overall Study|Adverse Event|0|||
157111777|NCT01840579|567163380|FG000|Overall Study|Follow-up ended by Sponsor|0|||
156767105|NCT05412134|565903187|FG000|Overall Study|Lost to Follow-up|2|||
157111778|NCT01840579|567163381|FG001|Overall Study|Follow-up ended by Sponsor|0|||
157111779|NCT01840579|567163382|FG002|Overall Study|Follow-up ended by Sponsor|0|||
156767106|NCT05412134|565903188|FG001|Overall Study|Lost to Follow-up|0|||
156767107|NCT03444584|565903191|FG000|Overall Study|Withdrawal by Subject|0|||
156767108|NCT03444584|565903192|FG001|Overall Study|Withdrawal by Subject|1|||
156767109|NCT03444584|565903191|FG000|Overall Study|Other|0|||
156767110|NCT03444584|565903192|FG001|Overall Study|Other|1|||
156767111|NCT00423046|565903193|FG000|Overall Study|Other|340|||
156767112|NCT00423046|565903194|FG001|Overall Study|Other|345|||
156767113|NCT01604785|565903195|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
156767114|NCT01604785|565903196|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
156767115|NCT02783911|565903197|FG000|Overall Study|Lost to Follow-up|3|||
156767116|NCT02783911|565903198|FG001|Overall Study|Lost to Follow-up|32|||
156767117|NCT00467519|565903199|FG000|Overall Study|Protocol Violation|8|||
156767118|NCT00467519|565903200|FG001|Overall Study|Protocol Violation|4|||
156767119|NCT00467519|565903199|FG000|Overall Study|Lost to Follow-up|2|||
156767120|NCT00467519|565903200|FG001|Overall Study|Lost to Follow-up|9|||
156767121|NCT00467519|565903199|FG000|Overall Study|Withdrawal by Subject|4|||
156767122|NCT00467519|565903200|FG001|Overall Study|Withdrawal by Subject|10|||
156767123|NCT01118052|565903201|FG000|Overall Study|Never treated|2|||
156767124|NCT00843492|565903206|FG000|Overall Study|Adverse Event|0|||
156767125|NCT00843492|565903207|FG001|Overall Study|Adverse Event|3|||
156767126|NCT00843492|565903206|FG000|Overall Study|Lost to Follow-up|4|||
156767127|NCT00843492|565903207|FG001|Overall Study|Lost to Follow-up|4|||
156767128|NCT00843492|565903206|FG000|Overall Study|Withdrawal by Subject|0|||
156767129|NCT00843492|565903207|FG001|Overall Study|Withdrawal by Subject|4|||
156767130|NCT00843492|565903206|FG000|Overall Study|Immobilization Stopped|1|||
156767131|NCT00843492|565903207|FG001|Overall Study|Immobilization Stopped|0|||
156767132|NCT00843492|565903206|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
157111780|NCT01840579|567163383|FG003|Overall Study|Follow-up ended by Sponsor|0|||
157111781|NCT01840579|567163384|FG004|Overall Study|Follow-up ended by Sponsor|0|||
156767133|NCT00843492|565903207|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
156767134|NCT00843492|565903206|FG000|Overall Study|Orthopedic Surgery|0|||
156767135|NCT00843492|565903207|FG001|Overall Study|Orthopedic Surgery|2|||
156767136|NCT00843492|565903206|FG000|Overall Study|Visit Not Performed|1|||
156767137|NCT00843492|565903207|FG001|Overall Study|Visit Not Performed|0|||
156767138|NCT00843492|565903206|FG000|Overall Study|Deep-vein Thrombosis|1|||
156767139|NCT00843492|565903207|FG001|Overall Study|Deep-vein Thrombosis|0|||
156767140|NCT00794664|565903208|FG000|Treatment Period|Withdrawal by Subject|0|||
156767141|NCT00794664|565903209|FG001|Treatment Period|Withdrawal by Subject|2|||
156767142|NCT00794664|565903208|FG000|Treatment Period|Protocol non-compliance|0|||
156767143|NCT00794664|565903209|FG001|Treatment Period|Protocol non-compliance|1|||
156767144|NCT00794664|565903208|FG000|Treatment Period|Other|0|||
156767145|NCT00794664|565903209|FG001|Treatment Period|Other|1|||
156767146|NCT00794664|565903208|FG000|Treatment Period|Adverse Event|1|||
156767147|NCT00794664|565903209|FG001|Treatment Period|Adverse Event|8|||
156767148|NCT00794664|565903208|FG000|Follow-up Period|Other|1|||
156767149|NCT00794664|565903209|FG001|Follow-up Period|Other|2|||
156767150|NCT00794664|565903208|FG000|Follow-up Period|Withdrawal by Subject|0|||
156767151|NCT00794664|565903209|FG001|Follow-up Period|Withdrawal by Subject|2|||
156767152|NCT00794664|565903208|FG000|Follow-up Period|Protocol non-compliance|0|||
156767153|NCT00794664|565903209|FG001|Follow-up Period|Protocol non-compliance|1|||
156767154|NCT01677741|565903210|FG000|Overall Study|Death|0|||
156767155|NCT01677741|565903211|FG001|Overall Study|Death|0|||
156767156|NCT01677741|565903212|FG002|Overall Study|Death|0|||
156767157|NCT01677741|565903213|FG003|Overall Study|Death|1|||
156767158|NCT01677741|565903214|FG004|Overall Study|Death|0|||
156767159|NCT01677741|565903215|FG005|Overall Study|Death|1|||
156767160|NCT01677741|565903216|FG006|Overall Study|Death|0|||
156767161|NCT01677741|565903217|FG007|Overall Study|Death|0|||
156767162|NCT01677741|565903210|FG000|Overall Study|Withdrawal by Subject|2|||
156767163|NCT01677741|565903211|FG001|Overall Study|Withdrawal by Subject|7|||
156767164|NCT01677741|565903212|FG002|Overall Study|Withdrawal by Subject|5|||
156767165|NCT01677741|565903213|FG003|Overall Study|Withdrawal by Subject|4|||
156767166|NCT01677741|565903214|FG004|Overall Study|Withdrawal by Subject|11|||
156767167|NCT01677741|565903215|FG005|Overall Study|Withdrawal by Subject|20|||
156767168|NCT01677741|565903216|FG006|Overall Study|Withdrawal by Subject|4|||
156767169|NCT01677741|565903217|FG007|Overall Study|Withdrawal by Subject|2|||
156767170|NCT01677741|565903210|FG000|Overall Study|Enrolled in a rollover study|0|||
156767171|NCT01677741|565903211|FG001|Overall Study|Enrolled in a rollover study|3|||
156767172|NCT01677741|565903212|FG002|Overall Study|Enrolled in a rollover study|2|||
156767173|NCT01677741|565903213|FG003|Overall Study|Enrolled in a rollover study|1|||
156767174|NCT01677741|565903214|FG004|Overall Study|Enrolled in a rollover study|6|||
156767175|NCT01677741|565903215|FG005|Overall Study|Enrolled in a rollover study|6|||
156767176|NCT01677741|565903216|FG006|Overall Study|Enrolled in a rollover study|7|||
156767177|NCT01677741|565903217|FG007|Overall Study|Enrolled in a rollover study|0|||
156767178|NCT01677741|565903210|FG000|Overall Study|Progressive disease|1|||
156767179|NCT01677741|565903211|FG001|Overall Study|Progressive disease|0|||
156767180|NCT01677741|565903212|FG002|Overall Study|Progressive disease|1|||
156767181|NCT01677741|565903213|FG003|Overall Study|Progressive disease|0|||
157006005|NCT03482011|566771663|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
157006006|NCT03482011|566771664|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006007|NCT03482011|566771665|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006008|NCT03482011|566771666|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006009|NCT03482011|566771667|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006010|NCT03482011|566771668|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006011|NCT03482011|566771669|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157006012|NCT03482011|566771662|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
157006013|NCT03482011|566771663|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
157006014|NCT03482011|566771664|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
157006015|NCT03482011|566771665|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
157006016|NCT03482011|566771666|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
157006017|NCT03482011|566771667|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
157006018|NCT03482011|566771668|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
157006019|NCT03482011|566771669|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
156767182|NCT01677741|565903214|FG004|Overall Study|Progressive disease|0|||
156767183|NCT01677741|565903215|FG005|Overall Study|Progressive disease|1|||
156767184|NCT01677741|565903216|FG006|Overall Study|Progressive disease|0|||
156767185|NCT01677741|565903217|FG007|Overall Study|Progressive disease|0|||
156767186|NCT02873689|565904599|FG000|Overall Study|Lack of Efficacy|1|||
156767187|NCT02873689|565904600|FG001|Overall Study|Lack of Efficacy|0|||
157006020|NCT03482011|566771662|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156767188|NCT02873689|565904599|FG000|Overall Study|Withdrawal by Subject|2|||
156767189|NCT02873689|565904600|FG001|Overall Study|Withdrawal by Subject|2|||
157006021|NCT03482011|566771663|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
157111782|NCT01840579|567163385|FG005|Overall Study|Follow-up ended by Sponsor|0|||
157111783|NCT01840579|567163386|FG006|Overall Study|Follow-up ended by Sponsor|2|||
157006022|NCT03482011|566771664|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
157006023|NCT03482011|566771665|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
157006024|NCT03482011|566771666|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
157006025|NCT03482011|566771667|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
157006026|NCT03482011|566771668|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
157006027|NCT03482011|566771669|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
157006028|NCT03482011|566771662|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006029|NCT03482011|566771663|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006030|NCT03482011|566771664|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006031|NCT03482011|566771665|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006032|NCT03482011|566771666|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
157006033|NCT03482011|566771667|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006034|NCT03482011|566771668|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157006035|NCT03482011|566771669|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
157006036|NCT03482011|566771662|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
157006037|NCT03482011|566771663|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
157006038|NCT03482011|566771664|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
157006039|NCT03482011|566771665|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
157006040|NCT03482011|566771666|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
157006041|NCT03482011|566771667|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
157006042|NCT03482011|566771668|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
157006043|NCT03482011|566771669|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
157006044|NCT03482011|566771662|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
157006045|NCT03482011|566771663|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
157006046|NCT03482011|566771664|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
157006047|NCT03482011|566771665|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
157006048|NCT03482011|566771666|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
157006049|NCT03482011|566771667|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
157006050|NCT03482011|566771668|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
157006051|NCT03482011|566771669|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
157006052|NCT03482011|566771662|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157006053|NCT03482011|566771663|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157006054|NCT03482011|566771664|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157006055|NCT03482011|566771665|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
157006056|NCT03482011|566771666|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157006057|NCT03482011|566771667|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
157006058|NCT03482011|566771668|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
157006059|NCT03482011|566771669|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
157006060|NCT03482011|566771662|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006061|NCT03482011|566771663|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006062|NCT03482011|566771664|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006063|NCT03482011|566771665|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006064|NCT03482011|566771666|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006065|NCT03482011|566771667|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
157006066|NCT03482011|566771668|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
157006067|NCT03482011|566771669|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
157006068|NCT03482011|566771662|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
157006069|NCT03482011|566771663|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
157006070|NCT03482011|566771664|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
157006071|NCT03482011|566771665|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
157006072|NCT03482011|566771666|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
157006073|NCT03482011|566771667|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
157006074|NCT03482011|566771668|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
157006075|NCT03482011|566771669|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
157006076|NCT03482011|566771662|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006077|NCT03482011|566771663|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006078|NCT03482011|566771664|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006079|NCT03482011|566771665|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006080|NCT03482011|566771666|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006081|NCT03482011|566771667|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006082|NCT03482011|566771668|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
157006083|NCT03482011|566771669|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
157006084|NCT03482011|566771662|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006085|NCT03482011|566771663|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006086|NCT03482011|566771664|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006087|NCT03482011|566771665|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006088|NCT03482011|566771666|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157111784|NCT01840579|567163387|FG007|Overall Study|Follow-up ended by Sponsor|0|||
157006089|NCT03482011|566771667|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006090|NCT03482011|566771668|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157006091|NCT03482011|566771669|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
157006092|NCT00940992|566771670|FG000|Overall Study|Adverse Event|2|||
157006093|NCT00940992|566771671|FG001|Overall Study|Adverse Event|0|||
157006094|NCT00940992|566771672|FG002|Overall Study|Adverse Event|1|||
157006095|NCT00940992|566771670|FG000|Overall Study|subject request|2|||
157006096|NCT00940992|566771671|FG001|Overall Study|subject request|1|||
157006097|NCT00940992|566771672|FG002|Overall Study|subject request|0|||
157006098|NCT00940992|566771670|FG000|Overall Study|Lost to Follow-up|0|||
156767190|NCT02873689|565904599|FG000|Overall Study|Protocol Violation|1|||
156767191|NCT02873689|565904600|FG001|Overall Study|Protocol Violation|0|||
156767192|NCT02873689|565904599|FG000|Overall Study|Adverse Event|2|||
156767193|NCT02873689|565904600|FG001|Overall Study|Adverse Event|2|||
156767194|NCT02873689|565904599|FG000|Overall Study|Randomized but not Treated|1|||
156767195|NCT02873689|565904600|FG001|Overall Study|Randomized but not Treated|1|||
156767196|NCT00350545|565904601|FG000|Overall Study|Withdrawal by Subject|2|||
156767197|NCT00434252|565904602|FG000|Overall Study|Lack of Efficacy|50|||
156767198|NCT00434252|565904603|FG001|Overall Study|Lack of Efficacy|100|||
157111785|NCT01840579|567163388|FG008|Overall Study|Follow-up ended by Sponsor|0|||
157111786|NCT01840579|567163389|FG009|Overall Study|Follow-up ended by Sponsor|0|||
156767199|NCT00434252|565904602|FG000|Overall Study|Adverse Event|6|||
156767200|NCT00434252|565904603|FG001|Overall Study|Adverse Event|13|||
156767201|NCT00434252|565904602|FG000|Overall Study|Death|1|||
156767202|NCT00434252|565904603|FG001|Overall Study|Death|2|||
156767203|NCT00434252|565904602|FG000|Overall Study|Lost to Follow-up|0|||
156767204|NCT00434252|565904603|FG001|Overall Study|Lost to Follow-up|1|||
156767205|NCT00434252|565904602|FG000|Overall Study|Physician Decision|4|||
156767206|NCT00434252|565904603|FG001|Overall Study|Physician Decision|8|||
156767207|NCT00434252|565904602|FG000|Overall Study|Withdrawal by Subject|3|||
156767208|NCT00434252|565904603|FG001|Overall Study|Withdrawal by Subject|7|||
156767209|NCT00750269|565904622|FG000|Overall Study|Protocol Violation|0|||
156767210|NCT00750269|565904623|FG001|Overall Study|Protocol Violation|1|||
156767211|NCT00750269|565904624|FG002|Overall Study|Protocol Violation|1|||
156767212|NCT00750269|565904625|FG003|Overall Study|Protocol Violation|2|||
156767213|NCT00750269|565904626|FG004|Overall Study|Protocol Violation|4|||
156767214|NCT00750269|565904622|FG000|Overall Study|Withdrawal by Subject|0|||
156767215|NCT00750269|565904623|FG001|Overall Study|Withdrawal by Subject|0|||
156767216|NCT00750269|565904624|FG002|Overall Study|Withdrawal by Subject|2|||
156767217|NCT00750269|565904625|FG003|Overall Study|Withdrawal by Subject|2|||
156767218|NCT00750269|565904626|FG004|Overall Study|Withdrawal by Subject|2|||
156767219|NCT00750269|565904622|FG000|Overall Study|Physician Decision|0|||
156767220|NCT00750269|565904623|FG001|Overall Study|Physician Decision|0|||
156767221|NCT00750269|565904624|FG002|Overall Study|Physician Decision|0|||
156767222|NCT00750269|565904625|FG003|Overall Study|Physician Decision|0|||
156767223|NCT00750269|565904626|FG004|Overall Study|Physician Decision|2|||
156767224|NCT00750269|565904622|FG000|Overall Study|Patient too large for positioning|0|||
156767225|NCT00750269|565904623|FG001|Overall Study|Patient too large for positioning|0|||
156767226|NCT00750269|565904624|FG002|Overall Study|Patient too large for positioning|1|||
156767227|NCT00750269|565904625|FG003|Overall Study|Patient too large for positioning|0|||
156767228|NCT00750269|565904626|FG004|Overall Study|Patient too large for positioning|0|||
156767229|NCT00750269|565904622|FG000|Overall Study|Site error|0|||
156767230|NCT00750269|565904623|FG001|Overall Study|Site error|0|||
156767231|NCT00750269|565904624|FG002|Overall Study|Site error|0|||
156767232|NCT00750269|565904625|FG003|Overall Study|Site error|1|||
156767233|NCT00750269|565904626|FG004|Overall Study|Site error|0|||
156767234|NCT00750269|565904622|FG000|Overall Study|SBRT plan could not be drawn|0|||
156767235|NCT00750269|565904623|FG001|Overall Study|SBRT plan could not be drawn|0|||
156767236|NCT00750269|565904624|FG002|Overall Study|SBRT plan could not be drawn|0|||
156767237|NCT00750269|565904625|FG003|Overall Study|SBRT plan could not be drawn|0|||
156767238|NCT00750269|565904626|FG004|Overall Study|SBRT plan could not be drawn|1|||
156767239|NCT00750269|565904622|FG000|Overall Study|Fiducials could not be placed|0|||
156767240|NCT00750269|565904623|FG001|Overall Study|Fiducials could not be placed|0|||
156767241|NCT00750269|565904624|FG002|Overall Study|Fiducials could not be placed|0|||
156767242|NCT00750269|565904625|FG003|Overall Study|Fiducials could not be placed|0|||
156767243|NCT00750269|565904626|FG004|Overall Study|Fiducials could not be placed|1|||
156767244|NCT01898078|565904627|FG000|Overall Study|Progressive Disease|1|||
156767245|NCT01898078|565904628|FG001|Overall Study|Progressive Disease|5|||
156767246|NCT01898078|565904627|FG000|Overall Study|Adverse Event|2|||
156767247|NCT01898078|565904628|FG001|Overall Study|Adverse Event|1|||
156767248|NCT01898078|565904627|FG000|Overall Study|Withdrawal by Subject|1|||
156767249|NCT01898078|565904628|FG001|Overall Study|Withdrawal by Subject|1|||
156767250|NCT01898078|565904627|FG000|Overall Study|Symptomatic Deterioration|2|||
156767251|NCT01898078|565904628|FG001|Overall Study|Symptomatic Deterioration|0|||
156767252|NCT01898078|565904627|FG000|Overall Study|Reason not Specified|0|||
156767253|NCT01898078|565904628|FG001|Overall Study|Reason not Specified|1|||
156767254|NCT00720278|565904635|FG000|Overall Study|Adverse Event|5|||
156767255|NCT00720278|565904636|FG001|Overall Study|Adverse Event|3|||
156767256|NCT00720278|565904637|FG002|Overall Study|Adverse Event|4|||
156767257|NCT00720278|565904635|FG000|Overall Study|Withdrawal by Subject|0|||
156767258|NCT00720278|565904636|FG001|Overall Study|Withdrawal by Subject|1|||
156767259|NCT00720278|565904637|FG002|Overall Study|Withdrawal by Subject|0|||
156767260|NCT00720278|565904635|FG000|Overall Study|Lost to Follow-up|0|||
156767261|NCT00720278|565904636|FG001|Overall Study|Lost to Follow-up|0|||
157111787|NCT03803059|567163390|FG000|Overall Study|Protocol Violation|2|||
157111788|NCT03803059|567163390|FG000|Overall Study|Lost to Follow-up|1|||
157111789|NCT02090413|567163394|FG000|Overall Study|Adverse Event|11|||
157111790|NCT02090413|567163395|FG001|Overall Study|Adverse Event|15|||
157111791|NCT02090413|567163396|FG002|Overall Study|Adverse Event|20|||
157111792|NCT02090413|567163394|FG000|Overall Study|Flushing event|2|||
157111793|NCT02090413|567163395|FG001|Overall Study|Flushing event|0|||
157111794|NCT02090413|567163396|FG002|Overall Study|Flushing event|1|||
157111795|NCT02090413|567163394|FG000|Overall Study|Withdrawal by Subject|2|||
157111796|NCT02090413|567163395|FG001|Overall Study|Withdrawal by Subject|2|||
157111797|NCT02090413|567163396|FG002|Overall Study|Withdrawal by Subject|2|||
157111798|NCT02090413|567163394|FG000|Overall Study|Investigator Decision|1|||
157111799|NCT02090413|567163395|FG001|Overall Study|Investigator Decision|1|||
156767262|NCT00720278|565904637|FG002|Overall Study|Lost to Follow-up|1|||
156767263|NCT00720278|565904635|FG000|Overall Study|Non-compliance|1|||
156767264|NCT00720278|565904636|FG001|Overall Study|Non-compliance|0|||
156767265|NCT00720278|565904637|FG002|Overall Study|Non-compliance|0|||
156767266|NCT00720278|565904635|FG000|Overall Study|eligibility criteria violation|1|||
156767267|NCT00720278|565904636|FG001|Overall Study|eligibility criteria violation|0|||
156767268|NCT00720278|565904637|FG002|Overall Study|eligibility criteria violation|1|||
156767269|NCT03630393|565904639|FG000|Overall Study|Death|1|||
156767270|NCT03630393|565904640|FG001|Overall Study|Death|0|||
156767271|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767272|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767273|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
156767274|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767275|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
156767276|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
156767277|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
156767278|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767279|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767280|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
156767281|NCT00408499|565904641|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
156767282|NCT00408499|565904642|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
156767283|NCT00408499|565904643|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767284|NCT00408499|565904644|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767285|NCT00408499|565904645|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
156767286|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Adverse Event|0|||
156767287|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Adverse Event|0|||
156767288|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Adverse Event|0|||
156767289|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Adverse Event|0|||
156767290|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Adverse Event|9|||
156767291|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Death|0|||
156767292|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Death|0|||
156767293|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Death|0|||
156767294|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Death|0|||
156767295|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Death|2|||
156767296|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Physician Decision|0|||
156767297|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Physician Decision|0|||
156767298|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Physician Decision|0|||
156767299|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Physician Decision|0|||
156767300|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Physician Decision|1|||
156767301|NCT00408499|565904641|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767302|NCT00408499|565904642|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767303|NCT00408499|565904643|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
157111800|NCT02090413|567163396|FG002|Overall Study|Investigator Decision|0|||
156767304|NCT00408499|565904644|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
156767305|NCT00408499|565904645|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
156767306|NCT00408499|565904641|FG000|Phase II- MTD Expansion|treatment delay|0|||
156767307|NCT00408499|565904642|FG001|Phase II- MTD Expansion|treatment delay|0|||
156767308|NCT00408499|565904643|FG002|Phase II- MTD Expansion|treatment delay|0|||
156767309|NCT00408499|565904644|FG003|Phase II- MTD Expansion|treatment delay|0|||
156767310|NCT00408499|565904645|FG004|Phase II- MTD Expansion|treatment delay|3|||
156767311|NCT00997334|565904647|FG000|Overall Study|still on therapy|12|||
156767312|NCT00997334|565904647|FG000|Overall Study|Adverse Event|3|||
156767313|NCT00997334|565904647|FG000|Overall Study|Patient non-compliance|1|||
156767314|NCT00997334|565904647|FG000|Overall Study|Withdrawal by Subject|3|||
156767315|NCT00997334|565904647|FG000|Overall Study|Death|2|||
156767316|NCT00997334|565904647|FG000|Overall Study|Urgent Palliative Care|2|||
156767317|NCT00997334|565904647|FG000|Overall Study|No lesion amenable|1|||
156767318|NCT00997334|565904647|FG000|Overall Study|Ineligible|1|||
156767319|NCT01586195|565904648|FG000|Overall Study|Death|11|||
156767320|NCT01586195|565904648|FG000|Overall Study|Withdrawal of Consent|5|||
156767321|NCT01586195|565904648|FG000|Overall Study|Started new anti-melanoma therapy|1|||
156767322|NCT01586195|565904648|FG000|Overall Study|Reason not specified|9|||
156767323|NCT01855958|565904649|FG000|Overall Study|Withdrawal by Subject|1|||
156767324|NCT01855958|565904650|FG001|Overall Study|Withdrawal by Subject|0|||
156767325|NCT00266708|565904656|FG000|Overall Study|No renal function|1|||
156767326|NCT00266708|565904657|FG001|Overall Study|No renal function|1|||
156767327|NCT00266708|565904656|FG000|Overall Study|Refused biopsy|3|||
156767328|NCT00266708|565904657|FG001|Overall Study|Refused biopsy|6|||
156767329|NCT00266708|565904656|FG000|Overall Study|Asthma|0|||
156767330|NCT00266708|565904657|FG001|Overall Study|Asthma|2|||
156767331|NCT02791269|565904658|FG000|Overall Study|Lost to Follow-up|0|||
156767332|NCT02791269|565904659|FG001|Overall Study|Lost to Follow-up|1|||
156767333|NCT02683109|565904660|FG000|Overall Study|Adverse Event|1|||
156767334|NCT02683109|565904661|FG001|Overall Study|Adverse Event|0|||
156767335|NCT00368251|565904662|FG000|Overall Study|SAE, non-fatal|1|||
156767336|NCT00368251|565904663|FG001|Overall Study|SAE, non-fatal|0|||
156767337|NCT00368251|565904664|FG002|Overall Study|SAE, non-fatal|0|||
156767338|NCT00368251|565904662|FG000|Overall Study|AE, non-serious non-fatal|0|||
156767339|NCT00368251|565904663|FG001|Overall Study|AE, non-serious non-fatal|0|||
156767340|NCT00368251|565904664|FG002|Overall Study|AE, non-serious non-fatal|1|||
156767341|NCT00499122|565904666|FG000|Overall Study|Withdrawal by Subject|2|||
156767342|NCT03312738|565904667|FG000|Overall Study|Progressive disease|58|||
156767343|NCT03312738|565904668|FG001|Overall Study|Progressive disease|67|||
156767344|NCT03312738|565904667|FG000|Overall Study|Patient/guardian decision|13|||
156767345|NCT03312738|565904668|FG001|Overall Study|Patient/guardian decision|5|||
156767346|NCT03312738|565904667|FG000|Overall Study|Adverse Event|5|||
157111801|NCT02090413|567163394|FG000|Overall Study|Other|2|||
156767347|NCT03312738|565904668|FG001|Overall Study|Adverse Event|3|||
156767348|NCT03312738|565904667|FG000|Overall Study|Protocol deviation|2|||
156767349|NCT03312738|565904668|FG001|Overall Study|Protocol deviation|0|||
156767350|NCT03312738|565904667|FG000|Overall Study|Technical problems|0|||
156767351|NCT03312738|565904668|FG001|Overall Study|Technical problems|1|||
156767352|NCT03312738|565904667|FG000|Overall Study|Physician Decision|2|||
156767353|NCT03312738|565904668|FG001|Overall Study|Physician Decision|3|||
156767354|NCT02466399|565904677|FG000|Overall Study|Adverse Event|1|||
156767355|NCT02466399|565904678|FG001|Overall Study|Adverse Event|0|||
156767356|NCT02466399|565904677|FG000|Overall Study|Early exit due to family emergency|1|||
156767357|NCT02466399|565904678|FG001|Overall Study|Early exit due to family emergency|0|||
156767358|NCT04539275|565904679|FG000|Overall Study|Death|2|||
156767359|NCT04539275|565904680|FG001|Overall Study|Death|4|||
156767360|NCT04539275|565904679|FG000|Overall Study|Lost to Follow-up|1|||
156767361|NCT04539275|565904680|FG001|Overall Study|Lost to Follow-up|1|||
156767362|NCT04539275|565904679|FG000|Overall Study|Withdrawal by Subject|3|||
156767363|NCT04539275|565904680|FG001|Overall Study|Withdrawal by Subject|0|||
156767364|NCT01715831|565904683|FG000|Overall Study|Adverse Event|1|||
156767365|NCT00900562|565904684|FG000|Overall Study|Progressive disease|9|||
156767366|NCT00900562|565904685|FG001|Overall Study|Progressive disease|5|||
156767367|NCT00900562|565904684|FG000|Overall Study|Toxicity|1|||
156767368|NCT00900562|565904685|FG001|Overall Study|Toxicity|0|||
156767369|NCT00900562|565904684|FG000|Overall Study|Death|1|||
156767370|NCT00900562|565904685|FG001|Overall Study|Death|1|||
156767371|NCT00900562|565904684|FG000|Overall Study|Withdrawal by Subject|0|||
156767372|NCT00900562|565904685|FG001|Overall Study|Withdrawal by Subject|1|||
156767373|NCT00900562|565904684|FG000|Overall Study|Unrelated adverse event|1|||
156767374|NCT00900562|565904685|FG001|Overall Study|Unrelated adverse event|0|||
156767375|NCT01516216|565904688|FG000|Overall Study|Adverse Event|2|||
156767376|NCT01516216|565904689|FG001|Overall Study|Adverse Event|4|||
156767377|NCT01516216|565904688|FG000|Overall Study|Disease Progression|38|||
156767378|NCT01516216|565904689|FG001|Overall Study|Disease Progression|34|||
156767379|NCT01516216|565904688|FG000|Overall Study|Withdrawal by Subject|9|||
156767380|NCT01516216|565904689|FG001|Overall Study|Withdrawal by Subject|11|||
156767381|NCT01516216|565904688|FG000|Overall Study|Potentially Curative Resection|6|||
156767382|NCT01516216|565904689|FG001|Overall Study|Potentially Curative Resection|12|||
156767383|NCT01516216|565904688|FG000|Overall Study|Nonadherence|2|||
156767384|NCT01516216|565904689|FG001|Overall Study|Nonadherence|3|||
156767385|NCT01516216|565904688|FG000|Overall Study|Physician Decision|6|||
156767386|NCT01516216|565904689|FG001|Overall Study|Physician Decision|3|||
156767387|NCT01516216|565904688|FG000|Overall Study|Prolonged Treatment Delay|5|||
156767388|NCT01516216|565904689|FG001|Overall Study|Prolonged Treatment Delay|1|||
156767389|NCT01516216|565904688|FG000|Overall Study|Intercurrent Illness|1|||
156767390|NCT01516216|565904689|FG001|Overall Study|Intercurrent Illness|0|||
156767391|NCT01516216|565904688|FG000|Overall Study|Death|1|||
156767392|NCT01516216|565904689|FG001|Overall Study|Death|1|||
156767393|NCT03098979|565904690|FG000|Overall Study|Adverse Event|1|||
156767394|NCT03098979|565904691|FG001|Overall Study|Adverse Event|0|||
156767395|NCT03098979|565904692|FG002|Overall Study|Adverse Event|1|||
156767396|NCT03098979|565904693|FG003|Overall Study|Adverse Event|4|||
156767397|NCT03098979|565904694|FG004|Overall Study|Adverse Event|6|||
156767398|NCT03098979|565904695|FG005|Overall Study|Adverse Event|1|||
156767399|NCT03098979|565904690|FG000|Overall Study|Withdrawal by Subject|2|||
156767400|NCT03098979|565904691|FG001|Overall Study|Withdrawal by Subject|1|||
156767401|NCT03098979|565904692|FG002|Overall Study|Withdrawal by Subject|1|||
156767402|NCT03098979|565904693|FG003|Overall Study|Withdrawal by Subject|1|||
156767403|NCT03098979|565904694|FG004|Overall Study|Withdrawal by Subject|2|||
156767404|NCT03098979|565904695|FG005|Overall Study|Withdrawal by Subject|1|||
156767405|NCT03098979|565904690|FG000|Overall Study|Death|1|||
156767406|NCT03098979|565904691|FG001|Overall Study|Death|0|||
156767407|NCT03098979|565904692|FG002|Overall Study|Death|2|||
156767408|NCT03098979|565904693|FG003|Overall Study|Death|0|||
156767409|NCT03098979|565904694|FG004|Overall Study|Death|1|||
156767410|NCT03098979|565904695|FG005|Overall Study|Death|0|||
156767411|NCT03098979|565904690|FG000|Overall Study|Physician Decision|2|||
156767412|NCT03098979|565904691|FG001|Overall Study|Physician Decision|1|||
156767413|NCT03098979|565904692|FG002|Overall Study|Physician Decision|0|||
156767414|NCT03098979|565904693|FG003|Overall Study|Physician Decision|0|||
156767415|NCT03098979|565904694|FG004|Overall Study|Physician Decision|0|||
156767416|NCT03098979|565904695|FG005|Overall Study|Physician Decision|0|||
156767417|NCT03098979|565904690|FG000|Overall Study|Non-compliance|0|||
156767418|NCT03098979|565904691|FG001|Overall Study|Non-compliance|0|||
156767419|NCT03098979|565904692|FG002|Overall Study|Non-compliance|0|||
156767420|NCT03098979|565904693|FG003|Overall Study|Non-compliance|0|||
156767421|NCT03098979|565904694|FG004|Overall Study|Non-compliance|0|||
156767422|NCT03098979|565904695|FG005|Overall Study|Non-compliance|1|||
156767423|NCT03098979|565904690|FG000|Overall Study|Protocol Violation|0|||
156767424|NCT03098979|565904691|FG001|Overall Study|Protocol Violation|0|||
156767425|NCT03098979|565904692|FG002|Overall Study|Protocol Violation|0|||
156767426|NCT03098979|565904693|FG003|Overall Study|Protocol Violation|0|||
156767427|NCT03098979|565904694|FG004|Overall Study|Protocol Violation|0|||
156767428|NCT03098979|565904695|FG005|Overall Study|Protocol Violation|1|||
156767429|NCT01483118|565904699|FG000|Overall Study|Lost to Follow-up|12|||
156767430|NCT01483118|565904700|FG001|Overall Study|Lost to Follow-up|16|||
156767431|NCT01079780|565904701|FG000|Overall Study|Disease progression|43|||
156767432|NCT01079780|565904702|FG001|Overall Study|Disease progression|7|||
156767433|NCT01079780|565904703|FG002|Overall Study|Disease progression|31|||
156767434|NCT01079780|565904701|FG000|Overall Study|Adverse Event|13|||
156767435|NCT01079780|565904702|FG001|Overall Study|Adverse Event|5|||
156767436|NCT01079780|565904703|FG002|Overall Study|Adverse Event|7|||
156767437|NCT01079780|565904701|FG000|Overall Study|Death|2|||
156767438|NCT01079780|565904702|FG001|Overall Study|Death|0|||
156767439|NCT01079780|565904703|FG002|Overall Study|Death|2|||
156767440|NCT01079780|565904701|FG000|Overall Study|Withdrawal by Subject|6|||
156767441|NCT01079780|565904702|FG001|Overall Study|Withdrawal by Subject|4|||
156767442|NCT01079780|565904703|FG002|Overall Study|Withdrawal by Subject|4|||
156767443|NCT01079780|565904701|FG000|Overall Study|Alternative therapy|2|||
156767444|NCT01079780|565904702|FG001|Overall Study|Alternative therapy|0|||
156767445|NCT01079780|565904703|FG002|Overall Study|Alternative therapy|2|||
156767446|NCT01079780|565904701|FG000|Overall Study|Physician Decision|1|||
156767447|NCT01079780|565904702|FG001|Overall Study|Physician Decision|0|||
156767448|NCT01079780|565904703|FG002|Overall Study|Physician Decision|1|||
156767449|NCT01079780|565904701|FG000|Overall Study|Error made in lesion measurement|1|||
156767450|NCT01079780|565904702|FG001|Overall Study|Error made in lesion measurement|0|||
156767451|NCT01079780|565904703|FG002|Overall Study|Error made in lesion measurement|0|||
156767452|NCT01079780|565904701|FG000|Overall Study|Patient had surgery|1|||
156767453|NCT01079780|565904702|FG001|Overall Study|Patient had surgery|0|||
156767454|NCT01079780|565904703|FG002|Overall Study|Patient had surgery|0|||
156767455|NCT01079780|565904701|FG000|Overall Study|Treatment cycle delay|0|||
156767456|NCT01079780|565904702|FG001|Overall Study|Treatment cycle delay|0|||
156767457|NCT01079780|565904703|FG002|Overall Study|Treatment cycle delay|1|||
156767458|NCT01079780|565904701|FG000|Overall Study|Never started treatment|1|||
156767459|NCT01079780|565904702|FG001|Overall Study|Never started treatment|0|||
156767460|NCT01079780|565904703|FG002|Overall Study|Never started treatment|2|||
156767461|NCT01178294|565904704|FG000|Overall Study|Adverse Event|4|||
156767462|NCT01178294|565904704|FG000|Overall Study|Lost to Follow-up|2|||
156767463|NCT01178294|565904704|FG000|Overall Study|Lack of Efficacy|1|||
156767464|NCT01178294|565904704|FG000|Overall Study|Death|1|||
156767465|NCT01178294|565904704|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
156767466|NCT01178294|565904704|FG000|Overall Study|Subject status is terminal|1|||
156767467|NCT01178294|565904704|FG000|Overall Study|Completion status could not be verified|1|||
156767468|NCT02783066|565904705|FG000|Overall Study|Withdrawal by Subject|13|||
156767469|NCT05379920|565904706|FG000|Overall Study|Lost to Follow-up|0|||
156767470|NCT05379920|565904707|FG001|Overall Study|Lost to Follow-up|5|||
156767471|NCT05379920|565904708|FG002|Overall Study|Lost to Follow-up|0|||
156767472|NCT05379920|565904709|FG003|Overall Study|Lost to Follow-up|0|||
156767473|NCT03530293|565904712|FG000|Pre-randomization|Adverse Event|12|||
156767474|NCT03530293|565904713|FG001|Pre-randomization|Adverse Event|0|||
156767475|NCT03530293|565904714|FG002|Pre-randomization|Adverse Event|0|||
156767476|NCT03530293|565904712|FG000|Pre-randomization|Protocol Violation|2|||
156767477|NCT03530293|565904713|FG001|Pre-randomization|Protocol Violation|0|||
156767478|NCT03530293|565904714|FG002|Pre-randomization|Protocol Violation|0|||
157006099|NCT00940992|566771671|FG001|Overall Study|Lost to Follow-up|1|||
156767479|NCT03530293|565904712|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
156767480|NCT03530293|565904713|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
156767481|NCT03530293|565904714|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
156767482|NCT03530293|565904712|FG000|Pre-randomization|Withdrawal by Subject|5|||
157006100|NCT00940992|566771672|FG002|Overall Study|Lost to Follow-up|1|||
156767483|NCT03530293|565904713|FG001|Pre-randomization|Withdrawal by Subject|0|||
156767484|NCT03530293|565904714|FG002|Pre-randomization|Withdrawal by Subject|0|||
157006101|NCT01713946|566771673|FG000|Overall Study|Death|0|||
157006102|NCT01713946|566771674|FG001|Overall Study|Death|2|||
157006103|NCT01713946|566771675|FG002|Overall Study|Death|2|||
157006104|NCT01713946|566771673|FG000|Overall Study|Adverse Event|19|||
157006105|NCT01713946|566771674|FG001|Overall Study|Adverse Event|14|||
157006106|NCT01713946|566771675|FG002|Overall Study|Adverse Event|13|||
157006107|NCT01713946|566771673|FG000|Overall Study|Withdrawal by Subject|12|||
157006108|NCT01713946|566771674|FG001|Overall Study|Withdrawal by Subject|12|||
157006109|NCT01713946|566771675|FG002|Overall Study|Withdrawal by Subject|8|||
157006110|NCT01713946|566771673|FG000|Overall Study|Lack of Efficacy|8|||
157006111|NCT01713946|566771674|FG001|Overall Study|Lack of Efficacy|8|||
157006112|NCT01713946|566771675|FG002|Overall Study|Lack of Efficacy|14|||
157006113|NCT01713946|566771673|FG000|Overall Study|Protocol Violation|2|||
157006114|NCT01713946|566771674|FG001|Overall Study|Protocol Violation|4|||
157006115|NCT01713946|566771675|FG002|Overall Study|Protocol Violation|1|||
157006116|NCT01713946|566771673|FG000|Overall Study|Lost to Follow-up|0|||
157006117|NCT01713946|566771674|FG001|Overall Study|Lost to Follow-up|0|||
157006118|NCT01713946|566771675|FG002|Overall Study|Lost to Follow-up|1|||
157006119|NCT01713946|566771673|FG000|Overall Study|Administrative problems|1|||
157006120|NCT01713946|566771674|FG001|Overall Study|Administrative problems|0|||
157006121|NCT01713946|566771675|FG002|Overall Study|Administrative problems|0|||
157006122|NCT01713946|566771673|FG000|Overall Study|Did not continue in Ext|0|||
157006123|NCT01713946|566771674|FG001|Overall Study|Did not continue in Ext|3|||
157006124|NCT01713946|566771675|FG002|Overall Study|Did not continue in Ext|0|||
157006125|NCT01713946|566771673|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
157006126|NCT01713946|566771674|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
157006127|NCT01713946|566771675|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
157006128|NCT01713946|566771673|FG000|Overall Study|Patients never switched to everolimus|0|||
157006129|NCT01713946|566771674|FG001|Overall Study|Patients never switched to everolimus|0|||
157006130|NCT01713946|566771675|FG002|Overall Study|Patients never switched to everolimus|5|||
157006131|NCT06269640|566773250|FG000|Overall Study|Death|1|||
157006132|NCT03979365|566773251|FG000|Overall Study|Death|1|||
157006133|NCT03979365|566773252|FG001|Overall Study|Death|3|||
157006134|NCT03979365|566773251|FG000|Overall Study|Withdrawal by Subject|0|||
157006135|NCT03979365|566773252|FG001|Overall Study|Withdrawal by Subject|1|||
157006136|NCT03979365|566773251|FG000|Overall Study|Drug Conversion|0|||
157006137|NCT03979365|566773252|FG001|Overall Study|Drug Conversion|3|||
157006138|NCT01266265|566773254|FG000|Overall Study|Death|95|||
157006139|NCT01266265|566773255|FG001|Overall Study|Death|73|||
157006140|NCT01266265|566773254|FG000|Overall Study|Lost to Follow-up|23|||
157006141|NCT01266265|566773255|FG001|Overall Study|Lost to Follow-up|28|||
157006142|NCT01266265|566773254|FG000|Overall Study|Withdrawal by Subject|13|||
157006143|NCT01266265|566773255|FG001|Overall Study|Withdrawal by Subject|11|||
157006144|NCT01266265|566773254|FG000|Overall Study|Respiratory-related adverse event|2|||
157006145|NCT01266265|566773255|FG001|Overall Study|Respiratory-related adverse event|1|||
157006146|NCT01266265|566773254|FG000|Overall Study|Transferred care to another provider|22|||
157006147|NCT01266265|566773255|FG001|Overall Study|Transferred care to another provider|28|||
157006148|NCT01266265|566773254|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
157006149|NCT01266265|566773255|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
157006150|NCT01266265|566773254|FG000|Overall Study|Enrolled in another clinical study|15|||
157006151|NCT01266265|566773255|FG001|Overall Study|Enrolled in another clinical study|26|||
157006152|NCT01266265|566773254|FG000|Overall Study|Non-compliance|8|||
157006153|NCT01266265|566773255|FG001|Overall Study|Non-compliance|5|||
157111802|NCT02090413|567163395|FG001|Overall Study|Other|1|||
157111803|NCT02090413|567163396|FG002|Overall Study|Other|0|||
157111804|NCT02090413|567163394|FG000|Overall Study|Lost to Follow-up|1|||
157111805|NCT02090413|567163395|FG001|Overall Study|Lost to Follow-up|1|||
157111806|NCT02090413|567163396|FG002|Overall Study|Lost to Follow-up|0|||
157111807|NCT05248295|567163397|FG000|Overall Study|found ineligible|4|||
157111808|NCT05248295|567163398|FG001|Overall Study|found ineligible|1|||
157111809|NCT05248295|567163397|FG000|Overall Study|Withdrawal by Subject|0|||
156767485|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
157006154|NCT01266265|566773254|FG000|Overall Study|Lung transplant|6|||
157006155|NCT01266265|566773255|FG001|Overall Study|Lung transplant|5|||
157006156|NCT01266265|566773254|FG000|Overall Study|Site closed early|4|||
157006157|NCT01266265|566773255|FG001|Overall Study|Site closed early|3|||
157006158|NCT01266265|566773254|FG000|Overall Study|Clinical worsening|1|||
157006159|NCT01266265|566773255|FG001|Overall Study|Clinical worsening|1|||
157006160|NCT01580293|566773256|FG000|Part A_Main Trial|Adverse Event|0|||
157006161|NCT01580293|566773257|FG001|Part A_Main Trial|Adverse Event|2|||
157006162|NCT01580293|566773258|FG002|Part A_Main Trial|Adverse Event|0|||
157006163|NCT01580293|566773256|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
157006164|NCT01580293|566773257|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
157006165|NCT01580293|566773258|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
157006166|NCT01580293|566773256|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
157006167|NCT01580293|566773257|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
157006168|NCT01580293|566773258|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
157006169|NCT01580293|566773256|FG000|Part A_Extension|Adverse Event|0|||
157006170|NCT01580293|566773257|FG001|Part A_Extension|Adverse Event|2|||
157006171|NCT01580293|566773258|FG002|Part A_Extension|Adverse Event|0|||
157006172|NCT01580293|566773256|FG000|Part A_Extension|Withdrawal by Subject|0|||
157006173|NCT01580293|566773257|FG001|Part A_Extension|Withdrawal by Subject|3|||
157006174|NCT01580293|566773258|FG002|Part A_Extension|Withdrawal by Subject|0|||
157006175|NCT01580293|566773256|FG000|Part A_Extension|Lost to Follow-up|0|||
157006176|NCT01580293|566773257|FG001|Part A_Extension|Lost to Follow-up|1|||
157006177|NCT01580293|566773258|FG002|Part A_Extension|Lost to Follow-up|0|||
157006178|NCT01580293|566773256|FG000|Part A_Extension|Other Reason|0|||
157006179|NCT01580293|566773257|FG001|Part A_Extension|Other Reason|1|||
157006180|NCT01580293|566773258|FG002|Part A_Extension|Other Reason|0|||
157006181|NCT01580293|566773256|FG000|Part A_Extension|Completed Japan only|0|||
157006182|NCT01580293|566773257|FG001|Part A_Extension|Completed Japan only|5|||
157006183|NCT01580293|566773258|FG002|Part A_Extension|Completed Japan only|0|||
157006184|NCT01580293|566773256|FG000|Part B|Withdrawal by Subject|0|||
157006185|NCT01580293|566773257|FG001|Part B|Withdrawal by Subject|0|||
157006186|NCT01580293|566773258|FG002|Part B|Withdrawal by Subject|1|||
157006187|NCT01580293|566773256|FG000|Part B|Other reason|0|||
157006188|NCT01580293|566773257|FG001|Part B|Other reason|0|||
157006189|NCT01580293|566773258|FG002|Part B|Other reason|1|||
157006190|NCT00711958|566773259|FG000|Overall Study|Withdrawal by Subject|6|||
157006191|NCT00711958|566773260|FG001|Overall Study|Withdrawal by Subject|8|||
157006192|NCT00711958|566773259|FG000|Overall Study|Lack of Efficacy|3|||
157006193|NCT00711958|566773260|FG001|Overall Study|Lack of Efficacy|1|||
157006194|NCT00711958|566773259|FG000|Overall Study|Clinical deterioration|1|||
157006195|NCT00711958|566773260|FG001|Overall Study|Clinical deterioration|0|||
157006196|NCT00711958|566773259|FG000|Overall Study|Adverse Event|9|||
157006197|NCT00711958|566773260|FG001|Overall Study|Adverse Event|7|||
157006198|NCT00711958|566773259|FG000|Overall Study|Protocol Violation|1|||
157006199|NCT00711958|566773260|FG001|Overall Study|Protocol Violation|0|||
157006200|NCT00711958|566773259|FG000|Overall Study|Lost to Follow-up|2|||
157006201|NCT00711958|566773260|FG001|Overall Study|Lost to Follow-up|2|||
157006202|NCT00711958|566773259|FG000|Overall Study|Death|10|||
157006203|NCT00711958|566773260|FG001|Overall Study|Death|5|||
157006204|NCT00711958|566773259|FG000|Overall Study|Progression of disease|1|||
157006205|NCT00711958|566773260|FG001|Overall Study|Progression of disease|0|||
157006206|NCT02015546|566773261|FG000|Overall Study|Withdrawal by Subject|1|||
157006207|NCT02015546|566773262|FG001|Overall Study|Withdrawal by Subject|1|||
157006208|NCT02015546|566773263|FG002|Overall Study|Withdrawal by Subject|1|||
157006209|NCT02015546|566773261|FG000|Overall Study|Screem Failure|2|||
157006210|NCT02015546|566773262|FG001|Overall Study|Screem Failure|1|||
157006211|NCT02015546|566773263|FG002|Overall Study|Screem Failure|3|||
156767486|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
156767487|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
156767488|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
156767489|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
157006212|NCT01113931|566773264|FG000|Overall Study|Adverse Event|2|||
157006213|NCT01113931|566773265|FG001|Overall Study|Adverse Event|2|||
156767490|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
156767491|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
156767492|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
156767493|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
156767494|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
156767495|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
156767496|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
156767497|NCT03530293|565904712|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
156767498|NCT03530293|565904713|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
156767499|NCT03530293|565904714|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
156767500|NCT01663623|565904715|FG000|Overall Study|Adverse Event|3|||
156767501|NCT01663623|565904716|FG001|Overall Study|Adverse Event|7|||
156767502|NCT01663623|565904715|FG000|Overall Study|Lack of Efficacy|5|||
156767503|NCT01663623|565904716|FG001|Overall Study|Lack of Efficacy|6|||
156767504|NCT01663623|565904715|FG000|Overall Study|Protocol Violation|0|||
156767505|NCT01663623|565904716|FG001|Overall Study|Protocol Violation|1|||
156767506|NCT01663623|565904715|FG000|Overall Study|Other-Study closed/terminated|1|||
156767507|NCT01663623|565904716|FG001|Overall Study|Other-Study closed/terminated|1|||
156767508|NCT01663623|565904715|FG000|Overall Study|Physician Decision|1|||
156767509|NCT01663623|565904716|FG001|Overall Study|Physician Decision|4|||
156767510|NCT01663623|565904715|FG000|Overall Study|Withdrawal by Subject|2|||
156767511|NCT01663623|565904716|FG001|Overall Study|Withdrawal by Subject|1|||
156767512|NCT02251275|565904717|FG000|Overall Study|Adverse Event|23|||
156767513|NCT02251275|565904718|FG001|Overall Study|Adverse Event|60|||
156767514|NCT02251275|565904719|FG002|Overall Study|Adverse Event|28|||
157006214|NCT01113931|566773264|FG000|Overall Study|Physician Decision|0|||
157006215|NCT01113931|566773265|FG001|Overall Study|Physician Decision|2|||
157006216|NCT01113931|566773264|FG000|Overall Study|Lost to Follow-up|12|||
157006217|NCT01113931|566773265|FG001|Overall Study|Lost to Follow-up|9|||
157006218|NCT01113931|566773264|FG000|Overall Study|Various|2|||
157006219|NCT01113931|566773265|FG001|Overall Study|Various|4|||
157006220|NCT01113931|566773264|FG000|Overall Study|Withdrawal by Subject|3|||
157006221|NCT01113931|566773265|FG001|Overall Study|Withdrawal by Subject|0|||
157006222|NCT00507689|566773268|FG000|Pre-Randomization Period|Adverse Event|1|||
157006223|NCT00507689|566773269|FG001|Pre-Randomization Period|Adverse Event|0|||
157006224|NCT00507689|566773268|FG000|Pre-Randomization Period|Physician Decision|1|||
157006225|NCT00507689|566773269|FG001|Pre-Randomization Period|Physician Decision|0|||
157006226|NCT00507689|566773268|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
157006227|NCT00507689|566773269|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
157006228|NCT00507689|566773268|FG000|Randomized Period|Adverse Event|1|||
157006229|NCT00507689|566773269|FG001|Randomized Period|Adverse Event|1|||
157006230|NCT00507689|566773268|FG000|Randomized Period|Withdrawal by Subject|0|||
157006231|NCT00507689|566773269|FG001|Randomized Period|Withdrawal by Subject|1|||
157006232|NCT01145885|566773270|FG000|Overall Study|Progressive Disease|7|||
157006233|NCT05299606|566773271|FG000|Overall Study|Death|1|||
157006234|NCT03460756|566773273|FG000|Overall Study|Adverse Event|0|||
157006235|NCT03460756|566773274|FG001|Overall Study|Adverse Event|0|||
156767515|NCT02251275|565904720|FG003|Overall Study|Adverse Event|0|||
157006236|NCT03460756|566773275|FG002|Overall Study|Adverse Event|0|||
157006237|NCT03460756|566773276|FG003|Overall Study|Adverse Event|1|||
157006238|NCT03460756|566773273|FG000|Overall Study|Lack of Efficacy|0|||
157111810|NCT05248295|567163398|FG001|Overall Study|Withdrawal by Subject|1|||
157006239|NCT03460756|566773274|FG001|Overall Study|Lack of Efficacy|0|||
157006240|NCT03460756|566773275|FG002|Overall Study|Lack of Efficacy|0|||
157006241|NCT03460756|566773276|FG003|Overall Study|Lack of Efficacy|2|||
157006242|NCT03460756|566773273|FG000|Overall Study|Lost to Follow-up|0|||
157006243|NCT03460756|566773274|FG001|Overall Study|Lost to Follow-up|1|||
157006244|NCT03460756|566773275|FG002|Overall Study|Lost to Follow-up|2|||
157006245|NCT03460756|566773276|FG003|Overall Study|Lost to Follow-up|1|||
157006246|NCT03460756|566773273|FG000|Overall Study|Pregnancy|0|||
157006247|NCT03460756|566773274|FG001|Overall Study|Pregnancy|0|||
157006248|NCT03460756|566773275|FG002|Overall Study|Pregnancy|0|||
157006249|NCT03460756|566773276|FG003|Overall Study|Pregnancy|1|||
157006250|NCT03460756|566773273|FG000|Overall Study|Protocol Violation|0|||
157006251|NCT03460756|566773274|FG001|Overall Study|Protocol Violation|0|||
157006252|NCT03460756|566773275|FG002|Overall Study|Protocol Violation|0|||
157111811|NCT05248295|567163397|FG000|Overall Study|Data loss: audio recording error|1|||
157111812|NCT05248295|567163398|FG001|Overall Study|Data loss: audio recording error|1|||
157111813|NCT04066491|567163399|FG000|Overall Study|Randomized, not treated|0|||
157111814|NCT04066491|567163400|FG001|Overall Study|Randomized, not treated|0|||
157111815|NCT04066491|567163401|FG002|Overall Study|Randomized, not treated|2|||
157111816|NCT04506086|567163402|FG000|Overall Study|Withdrawal by Subject|2|||
157111817|NCT04490018|567163403|FG000|Overall Study|Protocol Violation|0|||
157111818|NCT04490018|567163404|FG001|Overall Study|Protocol Violation|2|||
157111819|NCT04490018|567163405|FG002|Overall Study|Protocol Violation|1|||
157111820|NCT04490018|567163403|FG000|Overall Study|Lost to Follow-up|2|||
157111821|NCT04490018|567163404|FG001|Overall Study|Lost to Follow-up|2|||
157111822|NCT04490018|567163405|FG002|Overall Study|Lost to Follow-up|0|||
157111823|NCT04490018|567163403|FG000|Overall Study|Withdrawal by Subject|2|||
157111824|NCT04490018|567163404|FG001|Overall Study|Withdrawal by Subject|1|||
157111825|NCT04490018|567163405|FG002|Overall Study|Withdrawal by Subject|0|||
157111826|NCT04490018|567163403|FG000|Overall Study|Withdrawal by parent/guardian|2|||
157111827|NCT04490018|567163404|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156767516|NCT02251275|565904721|FG004|Overall Study|Adverse Event|0|||
156767517|NCT02251275|565904717|FG000|Overall Study|Lost to Follow-up|5|||
156767518|NCT02251275|565904718|FG001|Overall Study|Lost to Follow-up|6|||
156767519|NCT02251275|565904719|FG002|Overall Study|Lost to Follow-up|4|||
156767520|NCT02251275|565904720|FG003|Overall Study|Lost to Follow-up|0|||
156767521|NCT02251275|565904721|FG004|Overall Study|Lost to Follow-up|0|||
156767522|NCT02251275|565904717|FG000|Overall Study|Physician Decision|19|||
156767523|NCT02251275|565904718|FG001|Overall Study|Physician Decision|30|||
156767524|NCT02251275|565904719|FG002|Overall Study|Physician Decision|26|||
156767525|NCT02251275|565904720|FG003|Overall Study|Physician Decision|0|||
156767526|NCT02251275|565904721|FG004|Overall Study|Physician Decision|1|||
156767527|NCT02251275|565904717|FG000|Overall Study|Protocol Deviation|0|||
156767528|NCT02251275|565904718|FG001|Overall Study|Protocol Deviation|0|||
156767529|NCT02251275|565904719|FG002|Overall Study|Protocol Deviation|1|||
156767530|NCT02251275|565904720|FG003|Overall Study|Protocol Deviation|0|||
156767531|NCT02251275|565904721|FG004|Overall Study|Protocol Deviation|0|||
156767532|NCT02251275|565904717|FG000|Overall Study|Withdrawal by Subject|25|||
156767533|NCT02251275|565904718|FG001|Overall Study|Withdrawal by Subject|51|||
156767534|NCT02251275|565904719|FG002|Overall Study|Withdrawal by Subject|35|||
156767535|NCT02251275|565904720|FG003|Overall Study|Withdrawal by Subject|1|||
156767536|NCT02251275|565904721|FG004|Overall Study|Withdrawal by Subject|0|||
156767537|NCT01004614|565904723|FG000|Washout|Withdrawal by Subject|0|||
156767538|NCT01004614|565904724|FG001|Washout|Withdrawal by Subject|1|||
156767539|NCT01004614|565904725|FG002|Washout|Withdrawal by Subject|0|||
157111828|NCT04490018|567163405|FG002|Overall Study|Withdrawal by parent/guardian|0|||
157111829|NCT02321930|567163408|FG000|Overall Study|Lost to Follow-up|1|||
157111830|NCT01293968|567163409|FG000|Overall Study|non-cooperation|3|||
156767540|NCT01004614|565904726|FG003|Washout|Withdrawal by Subject|0|||
157111831|NCT01293968|567163410|FG001|Overall Study|non-cooperation|3|||
157111832|NCT01484977|567163411|FG000|Overall Study|Adverse Event|8|||
157111833|NCT01484977|567163411|FG000|Overall Study|Lack of Efficacy|4|||
157111834|NCT01484977|567163411|FG000|Overall Study|Protocol Violation|6|||
157111835|NCT01484977|567163411|FG000|Overall Study|Lost to Follow-up|1|||
157111836|NCT01484977|567163411|FG000|Overall Study|Withdrawal by Subject|4|||
156767541|NCT02111083|565904728|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
156767542|NCT02111083|565904729|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
156767543|NCT02152007|565904730|FG000|Overall Study|Withdrawal by Subject|1|||
156767544|NCT02497469|565904735|FG000|Overall Study|Randomized but not Treated|0|||
156767545|NCT02497469|565904736|FG001|Overall Study|Randomized but not Treated|2|||
156767546|NCT02497469|565904735|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
157006253|NCT03460756|566773276|FG003|Overall Study|Protocol Violation|1|||
157111837|NCT01484977|567163411|FG000|Overall Study|Subject Protocol Non-compliant|1|||
157111838|NCT01484977|567163411|FG000|Overall Study|Moving Overseas|1|||
157111839|NCT01484977|567163411|FG000|Overall Study|Low White Blood Cell Count|1|||
157111840|NCT01484977|567163411|FG000|Overall Study|Lack of Compliance|1|||
157111841|NCT01133379|567163412|FG000|Overall Study|Withdrawal by Subject|0|||
156767547|NCT02497469|565904736|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
156767548|NCT02497469|565904735|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
157006254|NCT03460756|566773273|FG000|Overall Study|Withdrawal by Subject|0|||
157006255|NCT03460756|566773274|FG001|Overall Study|Withdrawal by Subject|4|||
157006256|NCT03460756|566773275|FG002|Overall Study|Withdrawal by Subject|7|||
157006257|NCT03460756|566773276|FG003|Overall Study|Withdrawal by Subject|3|||
157006258|NCT00723450|566773278|FG000|Open-Label Phase|Adverse Event|26|||
157006259|NCT00723450|566773279|FG001|Open-Label Phase|Adverse Event|0|||
157006260|NCT00723450|566773280|FG002|Open-Label Phase|Adverse Event|0|||
157006261|NCT00723450|566773278|FG000|Open-Label Phase|Lack of Efficacy|18|||
157006262|NCT00723450|566773279|FG001|Open-Label Phase|Lack of Efficacy|0|||
157006263|NCT00723450|566773280|FG002|Open-Label Phase|Lack of Efficacy|0|||
157006264|NCT00723450|566773278|FG000|Open-Label Phase|Protocol Violation|35|||
157006265|NCT00723450|566773279|FG001|Open-Label Phase|Protocol Violation|0|||
157006266|NCT00723450|566773280|FG002|Open-Label Phase|Protocol Violation|0|||
157006267|NCT00723450|566773278|FG000|Open-Label Phase|Lost to Follow-up|7|||
157006268|NCT00723450|566773279|FG001|Open-Label Phase|Lost to Follow-up|0|||
157006269|NCT00723450|566773280|FG002|Open-Label Phase|Lost to Follow-up|0|||
157006270|NCT00723450|566773278|FG000|Open-Label Phase|Physician Decision|2|||
157006271|NCT00723450|566773279|FG001|Open-Label Phase|Physician Decision|0|||
157006272|NCT00723450|566773280|FG002|Open-Label Phase|Physician Decision|0|||
157006273|NCT00723450|566773278|FG000|Open-Label Phase|Withdrawal by Subject|37|||
157006274|NCT00723450|566773279|FG001|Open-Label Phase|Withdrawal by Subject|0|||
157006275|NCT00723450|566773280|FG002|Open-Label Phase|Withdrawal by Subject|0|||
157006276|NCT00723450|566773278|FG000|Randomized Phase|Adverse Event|0|||
157006277|NCT00723450|566773279|FG001|Randomized Phase|Adverse Event|26|||
157006278|NCT00723450|566773280|FG002|Randomized Phase|Adverse Event|17|||
157006279|NCT00723450|566773278|FG000|Randomized Phase|Lack of Efficacy|0|||
157006280|NCT00723450|566773279|FG001|Randomized Phase|Lack of Efficacy|11|||
157006281|NCT00723450|566773280|FG002|Randomized Phase|Lack of Efficacy|11|||
157006282|NCT00723450|566773278|FG000|Randomized Phase|Protocol Violation|0|||
157006283|NCT00723450|566773279|FG001|Randomized Phase|Protocol Violation|9|||
157006284|NCT00723450|566773280|FG002|Randomized Phase|Protocol Violation|13|||
157006285|NCT00723450|566773278|FG000|Randomized Phase|Lost to Follow-up|0|||
157006286|NCT00723450|566773279|FG001|Randomized Phase|Lost to Follow-up|2|||
157006287|NCT00723450|566773280|FG002|Randomized Phase|Lost to Follow-up|3|||
157006288|NCT00723450|566773278|FG000|Randomized Phase|Physician Decision|0|||
157006289|NCT00723450|566773279|FG001|Randomized Phase|Physician Decision|3|||
157006290|NCT00723450|566773280|FG002|Randomized Phase|Physician Decision|1|||
157006291|NCT00723450|566773278|FG000|Randomized Phase|Withdrawal by Subject|0|||
157006292|NCT00723450|566773279|FG001|Randomized Phase|Withdrawal by Subject|14|||
157006293|NCT00723450|566773280|FG002|Randomized Phase|Withdrawal by Subject|22|||
157006294|NCT03946670|566773286|FG000|Overall Study|Progressive Disease|34|||
157006295|NCT03946670|566773287|FG001|Overall Study|Progressive Disease|27|||
157006296|NCT03946670|566773286|FG000|Overall Study|Adverse Event|7|||
157006297|NCT03946670|566773287|FG001|Overall Study|Adverse Event|10|||
157006298|NCT03946670|566773286|FG000|Overall Study|Physician Decision|6|||
157006299|NCT03946670|566773287|FG001|Overall Study|Physician Decision|5|||
157006300|NCT03946670|566773286|FG000|Overall Study|Death|5|||
157006301|NCT03946670|566773287|FG001|Overall Study|Death|8|||
157006302|NCT03946670|566773286|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
157006303|NCT03946670|566773287|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
157006304|NCT03946670|566773286|FG000|Overall Study|Subject Decision|4|||
156767549|NCT02497469|565904736|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
156767550|NCT02497469|565904735|FG000|Overall Study|Significant Protocol Deviation|4|||
156767551|NCT02497469|565904736|FG001|Overall Study|Significant Protocol Deviation|5|||
156767552|NCT02497469|565904735|FG000|Overall Study|Lost to Follow-up|14|||
156767553|NCT02497469|565904736|FG001|Overall Study|Lost to Follow-up|4|||
156767554|NCT02497469|565904735|FG000|Overall Study|Voluntary Withdrawal|39|||
156767555|NCT02497469|565904736|FG001|Overall Study|Voluntary Withdrawal|41|||
156767556|NCT02497469|565904735|FG000|Overall Study|Pregnancy|1|||
156767557|NCT02497469|565904736|FG001|Overall Study|Pregnancy|1|||
156767558|NCT02497469|565904735|FG000|Overall Study|Lack of Efficacy|86|||
156767559|NCT02497469|565904736|FG001|Overall Study|Lack of Efficacy|40|||
156767560|NCT02497469|565904735|FG000|Overall Study|Reason not Specified|6|||
156767561|NCT02497469|565904736|FG001|Overall Study|Reason not Specified|6|||
156767562|NCT03558516|565904737|FG000|Overall Study|Protocol Violation|2|||
156767563|NCT03558516|565904738|FG001|Overall Study|Protocol Violation|2|||
156767564|NCT02714153|565904739|FG000|Overall Study|Death|1|||
156767565|NCT01901185|565904740|FG000|Overall Study|Withdrawal by Subject|2|||
156767566|NCT00828711|565904743|FG000|Overall Study|Lost to Follow-up|1|||
156767567|NCT00828711|565904744|FG001|Overall Study|Lost to Follow-up|0|||
156767568|NCT00828711|565904745|FG002|Overall Study|Lost to Follow-up|0|||
156767569|NCT01618968|565904746|FG000|Overall Study|Adverse Event|1|||
156767570|NCT01618968|565904747|FG001|Overall Study|Adverse Event|0|||
156767571|NCT01618968|565904748|FG002|Overall Study|Adverse Event|0|||
156767572|NCT01618968|565904749|FG003|Overall Study|Adverse Event|0|||
156767573|NCT01618968|565904746|FG000|Overall Study|Death|0|||
156767574|NCT01618968|565904747|FG001|Overall Study|Death|0|||
156767575|NCT01618968|565904748|FG002|Overall Study|Death|0|||
156767576|NCT01618968|565904749|FG003|Overall Study|Death|1|||
156767577|NCT03087058|565904752|FG000|Overall Study|Withdrawal by Subject|2|||
156767578|NCT03087058|565904753|FG001|Overall Study|Withdrawal by Subject|0|||
156767579|NCT03087058|565904754|FG002|Overall Study|Withdrawal by Subject|0|||
156767580|NCT05158140|565904755|FG000|Overall Study|Death|0|||
156767581|NCT05158140|565904756|FG001|Overall Study|Death|0|||
156767582|NCT05158140|565904757|FG002|Overall Study|Death|0|||
156767583|NCT05158140|565904758|FG003|Overall Study|Death|1|||
156767584|NCT05158140|565904755|FG000|Overall Study|Lost to Follow-up|3|||
156767585|NCT05158140|565904756|FG001|Overall Study|Lost to Follow-up|6|||
156767586|NCT05158140|565904757|FG002|Overall Study|Lost to Follow-up|4|||
156767587|NCT05158140|565904758|FG003|Overall Study|Lost to Follow-up|3|||
156767588|NCT05158140|565904755|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156767589|NCT05158140|565904756|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156767590|NCT05158140|565904757|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
156767591|NCT05158140|565904758|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156767592|NCT05158140|565904755|FG000|Overall Study|Withdrawal by Subject|3|||
156767593|NCT05158140|565904756|FG001|Overall Study|Withdrawal by Subject|7|||
156767594|NCT05158140|565904757|FG002|Overall Study|Withdrawal by Subject|3|||
156767595|NCT05158140|565904758|FG003|Overall Study|Withdrawal by Subject|7|||
156767596|NCT01113749|565906313|FG000|Overall Study|Lost to Follow-up|1|||
156767597|NCT01113749|565906314|FG001|Overall Study|Lost to Follow-up|2|||
156767598|NCT02034006|565906315|FG000|Overall Study|Withdrawal by Subject|7|||
156767599|NCT02034006|565906315|FG000|Overall Study|Lost to Follow-up|5|||
156767600|NCT02034006|565906315|FG000|Overall Study|Death|1|||
156767601|NCT02034006|565906315|FG000|Overall Study|Pregnancy|1|||
156767602|NCT02934178|565906316|FG000|Received Vaccination 2|Death|0|||
156767603|NCT02934178|565906317|FG001|Received Vaccination 2|Death|1|||
156767604|NCT02934178|565906316|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
156767605|NCT02934178|565906317|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
156767606|NCT03944616|565906318|FG000|Overall Study|Lost to Follow-up|0|||
156767607|NCT03944616|565906319|FG001|Overall Study|Lost to Follow-up|2|||
156767608|NCT01373164|565906320|FG000|Overall Study|Lost to Follow-up|0|||
156767609|NCT01373164|565906321|FG001|Overall Study|Lost to Follow-up|0|||
156767610|NCT01373164|565906322|FG002|Overall Study|Lost to Follow-up|1|||
156767611|NCT01373164|565906323|FG003|Overall Study|Lost to Follow-up|2|||
156767612|NCT01373164|565906324|FG004|Overall Study|Lost to Follow-up|0|||
156767613|NCT01373164|565906320|FG000|Overall Study|Withdrawal by Subject|0|||
156767614|NCT01373164|565906321|FG001|Overall Study|Withdrawal by Subject|1|||
156767615|NCT01373164|565906322|FG002|Overall Study|Withdrawal by Subject|0|||
156767616|NCT01373164|565906323|FG003|Overall Study|Withdrawal by Subject|10|||
156767617|NCT01373164|565906324|FG004|Overall Study|Withdrawal by Subject|2|||
156767618|NCT00607893|565906325|FG000|Overall Study|Lost to Follow-up|4|||
156767619|NCT00607893|565906326|FG001|Overall Study|Lost to Follow-up|0|||
156767620|NCT00607893|565906325|FG000|Overall Study|withdrew due to loss of interest|0|||
156767621|NCT00607893|565906326|FG001|Overall Study|withdrew due to loss of interest|1|||
156767622|NCT00607893|565906325|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
156767623|NCT00607893|565906326|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
156767624|NCT00607893|565906325|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
156767625|NCT00607893|565906326|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
156767626|NCT00607893|565906325|FG000|Overall Study|Declined to be treated|1|||
157111842|NCT01133379|567163413|FG001|Overall Study|Withdrawal by Subject|1|||
157111843|NCT01133379|567163414|FG002|Overall Study|Withdrawal by Subject|1|||
157111844|NCT01133379|567163412|FG000|Overall Study|Lost to Follow-up|1|||
157111845|NCT01133379|567163413|FG001|Overall Study|Lost to Follow-up|1|||
157111846|NCT01133379|567163414|FG002|Overall Study|Lost to Follow-up|1|||
157111847|NCT00591214|567163415|FG000|Overall Study|Physician Decision|7|||
157111848|NCT00591214|567163415|FG000|Overall Study|Withdrawal by Subject|1|||
157111849|NCT00121108|567163418|FG000|Overall Study|Lost to Follow-up|10|||
157111850|NCT00121108|567163419|FG001|Overall Study|Lost to Follow-up|22|||
157111851|NCT00121108|567163418|FG000|Overall Study|Withdrawal by Subject|106|||
157111852|NCT00121108|567163419|FG001|Overall Study|Withdrawal by Subject|195|||
157111853|NCT00121108|567163418|FG000|Overall Study|Death|5|||
157111854|NCT00121108|567163419|FG001|Overall Study|Death|8|||
157111855|NCT03996876|567163420|FG000|Overall Study|Incomplete Data|2|||
157111856|NCT03996876|567163421|FG001|Overall Study|Incomplete Data|4|||
157006305|NCT03946670|566773287|FG001|Overall Study|Subject Decision|5|||
157006306|NCT03946670|566773286|FG000|Overall Study|Study Terminated By Sponsor|2|||
157006307|NCT03946670|566773287|FG001|Overall Study|Study Terminated By Sponsor|0|||
157006308|NCT03946670|566773286|FG000|Overall Study|New Therapy For Study Indication|1|||
157006309|NCT03946670|566773287|FG001|Overall Study|New Therapy For Study Indication|0|||
157006310|NCT03946670|566773286|FG000|Overall Study|Not Treated|1|||
157006311|NCT03946670|566773287|FG001|Overall Study|Not Treated|1|||
157006312|NCT01135511|566773291|FG000|Overall Study|Adverse Event|0|||
157006313|NCT01135511|566773292|FG001|Overall Study|Adverse Event|1|||
157006314|NCT01135511|566773293|FG002|Overall Study|Adverse Event|2|||
157006315|NCT01135511|566773294|FG003|Overall Study|Adverse Event|0|||
157111857|NCT00597753|567163426|FG000|Overall Study|Adverse Event|6|||
157111858|NCT00597753|567163427|FG001|Overall Study|Adverse Event|2|||
156767627|NCT00607893|565906326|FG001|Overall Study|Declined to be treated|0|||
156767628|NCT00607893|565906325|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
156767629|NCT00607893|565906326|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
156767630|NCT01799941|565906327|FG000|Overall Study|Adverse Event|34|||
156767631|NCT01799941|565906327|FG000|Overall Study|Withdrawal by Subject|21|||
156767632|NCT01799941|565906327|FG000|Overall Study|Death|2|||
156767633|NCT01799941|565906327|FG000|Overall Study|Investigator Decision|4|||
156767634|NCT01799941|565906327|FG000|Overall Study|Lack of Efficacy|3|||
156767635|NCT01799941|565906327|FG000|Overall Study|Lost to Follow-up|17|||
156767636|NCT01799941|565906327|FG000|Overall Study|Other|15|||
156767637|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
156767638|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
156767639|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
156767640|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
156767641|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
156767642|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767643|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
156767644|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767645|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767646|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
156767647|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
157111859|NCT00597753|567163426|FG000|Overall Study|Death|55|||
157111860|NCT00597753|567163427|FG001|Overall Study|Death|29|||
157111861|NCT00597753|567163426|FG000|Overall Study|Lack of Efficacy|2|||
156767648|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
157006316|NCT01135511|566773295|FG004|Overall Study|Adverse Event|0|||
157006317|NCT01135511|566773296|FG005|Overall Study|Adverse Event|1|||
157006318|NCT01135511|566773297|FG006|Overall Study|Adverse Event|0|||
156767649|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
156767650|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
156767651|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
156767652|NCT03176771|565906345|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767653|NCT03176771|565906346|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767654|NCT03176771|565906347|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
156767655|NCT03176771|565906348|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767656|NCT03176771|565906349|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
156767657|NCT03176771|565906345|FG000|Double-Blind Extension Period|Adverse Event|0|||
156767658|NCT03176771|565906346|FG001|Double-Blind Extension Period|Adverse Event|0|||
156767659|NCT03176771|565906347|FG002|Double-Blind Extension Period|Adverse Event|0|||
156767660|NCT03176771|565906348|FG003|Double-Blind Extension Period|Adverse Event|15|||
156767661|NCT03176771|565906349|FG004|Double-Blind Extension Period|Adverse Event|18|||
156767662|NCT03176771|565906345|FG000|Double-Blind Extension Period|Death|0|||
156767663|NCT03176771|565906346|FG001|Double-Blind Extension Period|Death|0|||
156767664|NCT03176771|565906347|FG002|Double-Blind Extension Period|Death|0|||
156767665|NCT03176771|565906348|FG003|Double-Blind Extension Period|Death|3|||
156767666|NCT03176771|565906349|FG004|Double-Blind Extension Period|Death|4|||
156767667|NCT03176771|565906345|FG000|Double-Blind Extension Period|Physician Decision|0|||
156767668|NCT03176771|565906346|FG001|Double-Blind Extension Period|Physician Decision|0|||
156767669|NCT03176771|565906347|FG002|Double-Blind Extension Period|Physician Decision|0|||
156767670|NCT03176771|565906348|FG003|Double-Blind Extension Period|Physician Decision|3|||
156767671|NCT03176771|565906349|FG004|Double-Blind Extension Period|Physician Decision|1|||
156767672|NCT03176771|565906345|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767673|NCT03176771|565906346|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767674|NCT03176771|565906347|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
156767675|NCT03176771|565906348|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
156767676|NCT03176771|565906349|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
156767677|NCT03363906|565906350|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
156767678|NCT03363906|565906351|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
156767679|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
156767680|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
156767681|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
156767682|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
156767683|NCT03363906|565906350|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
156767684|NCT03363906|565906351|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
156767685|NCT00676143|565906352|FG000|Overall Study|Adverse Event|34|||
156767686|NCT00676143|565906353|FG001|Overall Study|Adverse Event|60|||
156767687|NCT00676143|565906352|FG000|Overall Study|Death|4|||
156767688|NCT00676143|565906353|FG001|Overall Study|Death|4|||
156767689|NCT00676143|565906352|FG000|Overall Study|Lack of Efficacy|0|||
156767690|NCT00676143|565906353|FG001|Overall Study|Lack of Efficacy|6|||
156767691|NCT00676143|565906352|FG000|Overall Study|Lost to Follow-up|0|||
156767692|NCT00676143|565906353|FG001|Overall Study|Lost to Follow-up|13|||
156767693|NCT00676143|565906352|FG000|Overall Study|Physician Decision|5|||
156767694|NCT00676143|565906353|FG001|Overall Study|Physician Decision|8|||
156767695|NCT00676143|565906352|FG000|Overall Study|Protocol Violation|4|||
156767696|NCT00676143|565906353|FG001|Overall Study|Protocol Violation|8|||
156767697|NCT00676143|565906352|FG000|Overall Study|Withdrawal by Subject|24|||
156767698|NCT00676143|565906353|FG001|Overall Study|Withdrawal by Subject|42|||
156767699|NCT00676143|565906352|FG000|Overall Study|Discontinuation of study by sponsor|65|||
156767700|NCT00676143|565906353|FG001|Overall Study|Discontinuation of study by sponsor|88|||
156767701|NCT00676143|565906352|FG000|Overall Study|Failed to return|2|||
156767702|NCT00676143|565906353|FG001|Overall Study|Failed to return|1|||
156767703|NCT00676143|565906352|FG000|Overall Study|Loss of caregiver|5|||
156767704|NCT00676143|565906353|FG001|Overall Study|Loss of caregiver|3|||
156767705|NCT00676143|565906352|FG000|Overall Study|Other|11|||
156767706|NCT00676143|565906353|FG001|Overall Study|Other|20|||
156767707|NCT00676143|565906352|FG000|Overall Study|Participant participation unknown|1|||
156767708|NCT00676143|565906353|FG001|Overall Study|Participant participation unknown|4|||
156767709|NCT00676143|565906352|FG000|Overall Study|Vasogenic edema recurrence|1|||
156767710|NCT00676143|565906353|FG001|Overall Study|Vasogenic edema recurrence|3|||
157111862|NCT00597753|567163427|FG001|Overall Study|Lack of Efficacy|0|||
156767711|NCT00929669|565906354|FG000|Overall Study|elevated glucose levels|1|||
156767712|NCT00250588|565906355|FG000|Overall Study|Withdrawal by Subject|3|||
156767713|NCT00250588|565906356|FG001|Overall Study|Withdrawal by Subject|6|||
156767714|NCT00250588|565906357|FG002|Overall Study|Withdrawal by Subject|0|||
156767715|NCT00250588|565906355|FG000|Overall Study|Lost to Follow-up|6|||
156767716|NCT00250588|565906356|FG001|Overall Study|Lost to Follow-up|13|||
157006319|NCT01135511|566773298|FG007|Overall Study|Adverse Event|1|||
157006320|NCT01135511|566773299|FG008|Overall Study|Adverse Event|0|||
156767717|NCT00250588|565906357|FG002|Overall Study|Lost to Follow-up|13|||
157006321|NCT01135511|566773291|FG000|Overall Study|Lack of Efficacy|0|||
157006322|NCT01135511|566773292|FG001|Overall Study|Lack of Efficacy|1|||
157006323|NCT01135511|566773293|FG002|Overall Study|Lack of Efficacy|1|||
157006324|NCT01135511|566773294|FG003|Overall Study|Lack of Efficacy|2|||
157006325|NCT01135511|566773295|FG004|Overall Study|Lack of Efficacy|0|||
157006326|NCT01135511|566773296|FG005|Overall Study|Lack of Efficacy|0|||
157006327|NCT01135511|566773297|FG006|Overall Study|Lack of Efficacy|0|||
156767718|NCT00706797|565906358|FG000|Overall Study|Lack of Efficacy|3|||
157006328|NCT01135511|566773298|FG007|Overall Study|Lack of Efficacy|0|||
157006329|NCT01135511|566773299|FG008|Overall Study|Lack of Efficacy|0|||
157006330|NCT01135511|566773291|FG000|Overall Study|Protocol Violation|0|||
157006331|NCT01135511|566773292|FG001|Overall Study|Protocol Violation|0|||
157006332|NCT01135511|566773293|FG002|Overall Study|Protocol Violation|3|||
157006333|NCT01135511|566773294|FG003|Overall Study|Protocol Violation|0|||
156767719|NCT00706797|565906359|FG001|Overall Study|Lack of Efficacy|0|||
156767720|NCT00706797|565906358|FG000|Overall Study|Adverse Event|0|||
156767721|NCT00706797|565906359|FG001|Overall Study|Adverse Event|3|||
156767722|NCT00706797|565906358|FG000|Overall Study|Withdrawal by Subject|8|||
156767723|NCT00706797|565906359|FG001|Overall Study|Withdrawal by Subject|1|||
156767724|NCT00706797|565906358|FG000|Overall Study|Death|1|||
156767725|NCT00706797|565906359|FG001|Overall Study|Death|0|||
156767726|NCT00706797|565906358|FG000|Overall Study|Discontinuation of study by sponsor|52|||
156767727|NCT00706797|565906359|FG001|Overall Study|Discontinuation of study by sponsor|63|||
156767728|NCT00706797|565906358|FG000|Overall Study|Protocol Violation|3|||
156767729|NCT00706797|565906359|FG001|Overall Study|Protocol Violation|2|||
156767730|NCT00706797|565906358|FG000|Overall Study|Lost to Follow-up|1|||
157006334|NCT01135511|566773295|FG004|Overall Study|Protocol Violation|0|||
157006335|NCT01135511|566773296|FG005|Overall Study|Protocol Violation|0|||
156767731|NCT00706797|565906359|FG001|Overall Study|Lost to Follow-up|2|||
156767732|NCT00706797|565906358|FG000|Overall Study|Other|1|||
156767733|NCT00706797|565906359|FG001|Overall Study|Other|0|||
156767734|NCT03502798|565906362|FG000|Overall Study|equipment failure|0|||
156767735|NCT03502798|565906363|FG001|Overall Study|equipment failure|7|||
156767736|NCT01603277|565906367|FG000|Overall Study|Adverse Event|1|||
156767737|NCT01603277|565906368|FG001|Overall Study|Adverse Event|2|||
156767738|NCT01603277|565906367|FG000|Overall Study|Physician Decision|0|||
156767739|NCT01603277|565906368|FG001|Overall Study|Physician Decision|1|||
156767740|NCT01603277|565906367|FG000|Overall Study|Protocol Violation|6|||
156767741|NCT01603277|565906368|FG001|Overall Study|Protocol Violation|10|||
156767742|NCT01603277|565906367|FG000|Overall Study|Withdrawal by Subject|5|||
156767743|NCT01603277|565906368|FG001|Overall Study|Withdrawal by Subject|4|||
156767744|NCT01603277|565906367|FG000|Overall Study|Non-Compliance|2|||
156767745|NCT01603277|565906368|FG001|Overall Study|Non-Compliance|1|||
156767746|NCT00087178|565906369|FG000|Overall Study|No follow up data|5|||
156767747|NCT00087178|565906370|FG001|Overall Study|No follow up data|15|||
156767748|NCT00087178|565906369|FG000|Overall Study|No clinical assessment|1|||
156767749|NCT00087178|565906370|FG001|Overall Study|No clinical assessment|2|||
156767750|NCT00087178|565906369|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
156767751|NCT00087178|565906370|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
156767752|NCT01692119|565906373|FG000|Overall Study|Protocol Violation|3|||
156767753|NCT01692119|565906374|FG001|Overall Study|Protocol Violation|1|||
156767754|NCT01692119|565906373|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
156767755|NCT01692119|565906374|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
156767756|NCT01299584|565906381|FG000|Overall Study|Protocol Violation|9|||
156767757|NCT05063448|565906394|FG000|Overall Study|Withdrawal by Subject|1|||
156767758|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
156767759|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767760|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767761|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767762|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767763|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767764|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
156767765|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
156767766|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767767|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767768|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767769|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767770|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767771|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
156767772|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767773|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
156767774|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767775|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767776|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767777|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767778|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
156767779|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767780|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767781|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
156767782|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767783|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767784|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767785|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
156767786|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767787|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767788|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
156767789|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767790|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767791|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767792|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
156767793|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767794|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767795|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
156767796|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767797|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
156767798|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
157006336|NCT01135511|566773297|FG006|Overall Study|Protocol Violation|0|||
157006337|NCT01135511|566773298|FG007|Overall Study|Protocol Violation|0|||
157006338|NCT01135511|566773299|FG008|Overall Study|Protocol Violation|0|||
157006339|NCT01135511|566773291|FG000|Overall Study|Pregnancy|0|||
157006340|NCT01135511|566773292|FG001|Overall Study|Pregnancy|0|||
157006341|NCT01135511|566773293|FG002|Overall Study|Pregnancy|0|||
157006342|NCT01135511|566773294|FG003|Overall Study|Pregnancy|1|||
157006343|NCT01135511|566773295|FG004|Overall Study|Pregnancy|0|||
157006344|NCT01135511|566773296|FG005|Overall Study|Pregnancy|0|||
157006345|NCT01135511|566773297|FG006|Overall Study|Pregnancy|0|||
157006346|NCT01135511|566773298|FG007|Overall Study|Pregnancy|0|||
157006347|NCT01135511|566773299|FG008|Overall Study|Pregnancy|0|||
157006348|NCT01135511|566773291|FG000|Overall Study|could not visit the clinic|0|||
157006349|NCT01135511|566773292|FG001|Overall Study|could not visit the clinic|1|||
156767799|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
157006350|NCT01135511|566773293|FG002|Overall Study|could not visit the clinic|2|||
157006351|NCT01135511|566773294|FG003|Overall Study|could not visit the clinic|0|||
157006352|NCT01135511|566773295|FG004|Overall Study|could not visit the clinic|0|||
156767800|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767801|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767802|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767803|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
156767804|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767805|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767806|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
156767807|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767808|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767809|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767810|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
156767811|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767812|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767813|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
156767814|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
157006353|NCT01135511|566773296|FG005|Overall Study|could not visit the clinic|0|||
157006354|NCT01135511|566773297|FG006|Overall Study|could not visit the clinic|0|||
157006355|NCT01135511|566773298|FG007|Overall Study|could not visit the clinic|0|||
157006356|NCT01135511|566773299|FG008|Overall Study|could not visit the clinic|0|||
157006357|NCT01135511|566773291|FG000|Overall Study|noncompliance with study drug taken|0|||
157006358|NCT01135511|566773292|FG001|Overall Study|noncompliance with study drug taken|0|||
157006359|NCT01135511|566773293|FG002|Overall Study|noncompliance with study drug taken|0|||
157006360|NCT01135511|566773294|FG003|Overall Study|noncompliance with study drug taken|0|||
157006361|NCT01135511|566773295|FG004|Overall Study|noncompliance with study drug taken|1|||
157006362|NCT01135511|566773296|FG005|Overall Study|noncompliance with study drug taken|0|||
157006363|NCT01135511|566773297|FG006|Overall Study|noncompliance with study drug taken|0|||
157006364|NCT01135511|566773298|FG007|Overall Study|noncompliance with study drug taken|0|||
157006365|NCT01135511|566773299|FG008|Overall Study|noncompliance with study drug taken|0|||
157006366|NCT01135511|566773291|FG000|Overall Study|Withdrawal by Subject|0|||
157006367|NCT01135511|566773292|FG001|Overall Study|Withdrawal by Subject|0|||
157006368|NCT01135511|566773293|FG002|Overall Study|Withdrawal by Subject|0|||
157006369|NCT01135511|566773294|FG003|Overall Study|Withdrawal by Subject|0|||
157006370|NCT01135511|566773295|FG004|Overall Study|Withdrawal by Subject|0|||
157006371|NCT01135511|566773296|FG005|Overall Study|Withdrawal by Subject|0|||
157006372|NCT01135511|566773297|FG006|Overall Study|Withdrawal by Subject|1|||
157006373|NCT01135511|566773298|FG007|Overall Study|Withdrawal by Subject|0|||
157006374|NCT01135511|566773299|FG008|Overall Study|Withdrawal by Subject|1|||
157006375|NCT03920215|566773305|FG000|Overall Study|Lost to Follow-up|1|||
157006376|NCT03920215|566773306|FG001|Overall Study|Lost to Follow-up|2|||
157006377|NCT03920215|566773307|FG002|Overall Study|Lost to Follow-up|0|||
157006378|NCT03920215|566773308|FG003|Overall Study|Lost to Follow-up|0|||
157006379|NCT03920215|566773305|FG000|Overall Study|Death|0|||
157006380|NCT03920215|566773306|FG001|Overall Study|Death|0|||
157006381|NCT03920215|566773307|FG002|Overall Study|Death|0|||
157006382|NCT03920215|566773308|FG003|Overall Study|Death|1|||
157006383|NCT02547922|566773312|FG000|Overall Study|Withdrawal by Subject|9|||
157006384|NCT02547922|566773313|FG001|Overall Study|Withdrawal by Subject|6|||
157006385|NCT02547922|566773314|FG002|Overall Study|Withdrawal by Subject|10|||
157006386|NCT02547922|566773312|FG000|Overall Study|Adverse Event|3|||
157006387|NCT02547922|566773313|FG001|Overall Study|Adverse Event|1|||
157006388|NCT02547922|566773314|FG002|Overall Study|Adverse Event|2|||
157006389|NCT02547922|566773312|FG000|Overall Study|Lost to Follow-up|1|||
157006390|NCT02547922|566773313|FG001|Overall Study|Lost to Follow-up|0|||
157006391|NCT02547922|566773314|FG002|Overall Study|Lost to Follow-up|0|||
157006392|NCT02547922|566773312|FG000|Overall Study|Lack of Efficacy|5|||
157006393|NCT02547922|566773313|FG001|Overall Study|Lack of Efficacy|7|||
157006394|NCT02547922|566773314|FG002|Overall Study|Lack of Efficacy|4|||
157006395|NCT02547922|566773312|FG000|Overall Study|Death|1|||
157006396|NCT02547922|566773313|FG001|Overall Study|Death|0|||
157006397|NCT02547922|566773314|FG002|Overall Study|Death|0|||
157006398|NCT02547922|566773312|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
157006399|NCT02547922|566773313|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
157006400|NCT02547922|566773314|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
157006401|NCT02547922|566773312|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
157006402|NCT02547922|566773313|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
157006403|NCT02547922|566773314|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
156767815|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
157111863|NCT00597753|567163426|FG000|Overall Study|Lost to Follow-up|10|||
157006404|NCT02547922|566773312|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
157006405|NCT02547922|566773313|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
157006406|NCT02547922|566773314|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
157111864|NCT00597753|567163427|FG001|Overall Study|Lost to Follow-up|3|||
156767816|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767817|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767818|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
156767819|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767820|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
156767821|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767822|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767823|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767824|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767825|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
156767826|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767827|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
156767828|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767829|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767830|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767831|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767832|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
156767833|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767834|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
156767835|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767836|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767837|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767838|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767839|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
156767840|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767841|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
156767842|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767843|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767844|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767845|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767846|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767847|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
156767848|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
156767849|NCT01791595|565906398|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767850|NCT01791595|565906399|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767851|NCT01791595|565906400|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767852|NCT01791595|565906401|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767853|NCT01791595|565906402|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767854|NCT01791595|565906403|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
156767855|NCT01791595|565906404|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
156767856|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767857|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767858|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767859|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767860|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767861|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
156767862|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
156767863|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767864|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767865|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767866|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767867|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767868|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
156767869|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
156767870|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767871|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767872|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767873|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767874|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767875|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
156767876|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
156767877|NCT01791595|565906398|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767878|NCT01791595|565906399|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767879|NCT01791595|565906400|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767880|NCT01791595|565906401|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767881|NCT01791595|565906402|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767882|NCT01791595|565906403|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
156767883|NCT01791595|565906404|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
157111865|NCT00597753|567163426|FG000|Overall Study|Physician Decision|5|||
156767884|NCT01776554|565906405|FG000|Overall Study|Adverse Event|1|||
156767885|NCT01776554|565906406|FG001|Overall Study|Adverse Event|0|||
156767886|NCT01776554|565906405|FG000|Overall Study|Withdrawal by Subject|3|||
156767887|NCT01776554|565906406|FG001|Overall Study|Withdrawal by Subject|8|||
156767888|NCT01776554|565906405|FG000|Overall Study|Lost to Follow-up|6|||
156767889|NCT01776554|565906406|FG001|Overall Study|Lost to Follow-up|9|||
156767890|NCT01776554|565906405|FG000|Overall Study|Administrative Reason|2|||
156767891|NCT01776554|565906406|FG001|Overall Study|Administrative Reason|5|||
156767892|NCT01776554|565906405|FG000|Overall Study|Protocol Violation|1|||
156767893|NCT01776554|565906406|FG001|Overall Study|Protocol Violation|0|||
156767894|NCT01776554|565906405|FG000|Overall Study|Unclassified|4|||
156767895|NCT01776554|565906406|FG001|Overall Study|Unclassified|1|||
156767896|NCT01041859|565906407|FG000|Open-Label Titration|Adverse Event|69|||
156767897|NCT01041859|565906408|FG001|Open-Label Titration|Adverse Event|0|||
156767898|NCT01041859|565906409|FG002|Open-Label Titration|Adverse Event|0|||
156767899|NCT01041859|565906407|FG000|Open-Label Titration|Lack of Efficacy|3|||
156767900|NCT01041859|565906408|FG001|Open-Label Titration|Lack of Efficacy|0|||
156767901|NCT01041859|565906409|FG002|Open-Label Titration|Lack of Efficacy|0|||
156767902|NCT01041859|565906407|FG000|Open-Label Titration|Lost to Follow-up|1|||
156767903|NCT01041859|565906408|FG001|Open-Label Titration|Lost to Follow-up|0|||
156767904|NCT01041859|565906409|FG002|Open-Label Titration|Lost to Follow-up|0|||
156767905|NCT01041859|565906407|FG000|Open-Label Titration|Physician Decision|1|||
156767906|NCT01041859|565906408|FG001|Open-Label Titration|Physician Decision|0|||
156767907|NCT01041859|565906409|FG002|Open-Label Titration|Physician Decision|0|||
156767908|NCT01041859|565906407|FG000|Open-Label Titration|Protocol Violation|1|||
156767909|NCT01041859|565906408|FG001|Open-Label Titration|Protocol Violation|0|||
156767910|NCT01041859|565906409|FG002|Open-Label Titration|Protocol Violation|0|||
156767911|NCT01041859|565906407|FG000|Open-Label Titration|Other|7|||
156767912|NCT01041859|565906408|FG001|Open-Label Titration|Other|0|||
156767913|NCT01041859|565906409|FG002|Open-Label Titration|Other|0|||
156767914|NCT01041859|565906407|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
156767915|NCT01041859|565906408|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
156767916|NCT01041859|565906409|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
156767917|NCT01041859|565906407|FG000|Open-Label Titration|Withdrawal by Subject|11|||
156767918|NCT01041859|565906408|FG001|Open-Label Titration|Withdrawal by Subject|0|||
157006407|NCT02547922|566773312|FG000|Overall Study|Physician Decision|2|||
157006408|NCT02547922|566773313|FG001|Overall Study|Physician Decision|1|||
157006409|NCT02547922|566773314|FG002|Overall Study|Physician Decision|2|||
157006410|NCT02547922|566773312|FG000|Overall Study|Patients did not receive IP|1|||
157006411|NCT02547922|566773313|FG001|Overall Study|Patients did not receive IP|1|||
157006412|NCT02547922|566773314|FG002|Overall Study|Patients did not receive IP|0|||
157006413|NCT00468052|566773315|FG000|Overall Study|Protocol Violation|7|||
157006414|NCT00468052|566773316|FG001|Overall Study|Protocol Violation|8|||
157006415|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
157006416|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
157006417|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
157006418|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
157006419|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
157006420|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
157006421|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
157006422|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
157006423|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
157006424|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
157006425|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
157006426|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
157006427|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
157006428|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
157006429|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
157006430|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
157006431|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
157006432|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
157006433|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
157006434|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
157006435|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
157006436|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
157006437|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
157006438|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
157006439|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
157006440|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
157006441|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
157006442|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
157006443|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
157006444|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
157006445|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
157006446|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
157006447|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
157006448|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
157006449|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
157006450|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
157006451|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
157006452|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
157006453|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
157006454|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
157006455|NCT02709655|566773317|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
157006456|NCT02709655|566773318|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
157006457|NCT02709655|566773319|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
157006458|NCT02709655|566773320|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
157006459|NCT02709655|566773321|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
157111866|NCT00597753|567163427|FG001|Overall Study|Physician Decision|1|||
156767919|NCT01041859|565906409|FG002|Open-Label Titration|Withdrawal by Subject|0|||
156767920|NCT01041859|565906407|FG000|Double-Blind Maintenance|Adverse Event|0|||
156767921|NCT01041859|565906408|FG001|Double-Blind Maintenance|Adverse Event|23|||
156767922|NCT01041859|565906409|FG002|Double-Blind Maintenance|Adverse Event|13|||
156767923|NCT01041859|565906407|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
156767924|NCT01041859|565906408|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
156767925|NCT01041859|565906409|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
156767926|NCT01041859|565906407|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
156767927|NCT01041859|565906408|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
156767928|NCT01041859|565906409|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
156767929|NCT01041859|565906407|FG000|Double-Blind Maintenance|Physician Decision|0|||
156767930|NCT01041859|565906408|FG001|Double-Blind Maintenance|Physician Decision|2|||
156767931|NCT01041859|565906409|FG002|Double-Blind Maintenance|Physician Decision|1|||
156767932|NCT01041859|565906407|FG000|Double-Blind Maintenance|Protocol Violation|0|||
156767933|NCT01041859|565906408|FG001|Double-Blind Maintenance|Protocol Violation|1|||
156767934|NCT01041859|565906409|FG002|Double-Blind Maintenance|Protocol Violation|3|||
156767935|NCT01041859|565906407|FG000|Double-Blind Maintenance|Other|0|||
156767936|NCT01041859|565906408|FG001|Double-Blind Maintenance|Other|6|||
156767937|NCT01041859|565906409|FG002|Double-Blind Maintenance|Other|2|||
156767938|NCT01041859|565906407|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
156767939|NCT01041859|565906408|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
156767940|NCT01041859|565906409|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
156767941|NCT01041859|565906407|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
156767942|NCT01041859|565906408|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
156767943|NCT01041859|565906409|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
156767944|NCT03329885|565906410|FG000|Overall Study|Sponsor discontinued the study early|0|||
156767945|NCT03329885|565906411|FG001|Overall Study|Sponsor discontinued the study early|0|||
156767946|NCT03329885|565906412|FG002|Overall Study|Sponsor discontinued the study early|0|||
156767947|NCT03329885|565906413|FG003|Overall Study|Sponsor discontinued the study early|0|||
156767948|NCT03329885|565906414|FG004|Overall Study|Sponsor discontinued the study early|0|||
156767949|NCT03329885|565906415|FG005|Overall Study|Sponsor discontinued the study early|0|||
156767950|NCT03329885|565906416|FG006|Overall Study|Sponsor discontinued the study early|1|||
156767951|NCT03329885|565906417|FG007|Overall Study|Sponsor discontinued the study early|1|||
156767952|NCT03329885|565906418|FG008|Overall Study|Sponsor discontinued the study early|0|||
156767953|NCT01991795|565906419|FG000|Overall Study|Lost to Follow-up|6|||
156767954|NCT01991795|565906420|FG001|Overall Study|Lost to Follow-up|4|||
156767955|NCT01991795|565906419|FG000|Overall Study|Withdrawal by Subject|117|||
156767956|NCT01991795|565906420|FG001|Overall Study|Withdrawal by Subject|94|||
156767957|NCT01991795|565906419|FG000|Overall Study|Site prematurely closed by sponsor|26|||
156767958|NCT01991795|565906420|FG001|Overall Study|Site prematurely closed by sponsor|25|||
156767959|NCT02027025|565906421|FG000|Overall Study|Adverse Event|0|||
156767960|NCT02027025|565906422|FG001|Overall Study|Adverse Event|1|||
156767961|NCT02027025|565906423|FG002|Overall Study|Adverse Event|1|||
156767962|NCT02027025|565906421|FG000|Overall Study|Protocol Violation|1|||
156767963|NCT02027025|565906422|FG001|Overall Study|Protocol Violation|0|||
156767964|NCT02027025|565906423|FG002|Overall Study|Protocol Violation|0|||
156767965|NCT02027025|565906421|FG000|Overall Study|Lost to Follow-up|0|||
156767966|NCT02027025|565906422|FG001|Overall Study|Lost to Follow-up|2|||
156767967|NCT02027025|565906423|FG002|Overall Study|Lost to Follow-up|0|||
156767968|NCT02027025|565906421|FG000|Overall Study|Withdrawal by Subject|0|||
156767969|NCT02027025|565906422|FG001|Overall Study|Withdrawal by Subject|1|||
156767970|NCT02027025|565906423|FG002|Overall Study|Withdrawal by Subject|0|||
156767971|NCT02027025|565906421|FG000|Overall Study|Sponsor's decision|0|||
156767972|NCT02027025|565906422|FG001|Overall Study|Sponsor's decision|1|||
156767973|NCT02027025|565906423|FG002|Overall Study|Sponsor's decision|0|||
156767974|NCT03883386|565906426|FG000|First Assignment|Lost to Follow-up|1|||
156767975|NCT03883386|565906427|FG001|First Assignment|Lost to Follow-up|0|||
156767976|NCT03883386|565906426|FG000|First Assignment|Withdrawal by Subject|1|||
156767977|NCT03883386|565906427|FG001|First Assignment|Withdrawal by Subject|1|||
156767978|NCT01326871|565906428|FG000|Overall Study|Major surgery|0|||
156767979|NCT01326871|565906429|FG001|Overall Study|Major surgery|1|||
156767980|NCT01326871|565906430|FG002|Overall Study|Major surgery|0|||
156767981|NCT01326871|565906428|FG000|Overall Study|SAE and death|0|||
156767982|NCT01326871|565906429|FG001|Overall Study|SAE and death|2|||
156767983|NCT01326871|565906430|FG002|Overall Study|SAE and death|0|||
156767984|NCT01326871|565906428|FG000|Overall Study|Physician decision and decreased performance status|0|||
156767985|NCT01326871|565906429|FG001|Overall Study|Physician decision and decreased performance status|1|||
156767986|NCT01326871|565906430|FG002|Overall Study|Physician decision and decreased performance status|0|||
156767987|NCT01326871|565906428|FG000|Overall Study|Disease progression|0|||
156767988|NCT01326871|565906429|FG001|Overall Study|Disease progression|11|||
156767989|NCT01326871|565906430|FG002|Overall Study|Disease progression|5|||
156767990|NCT01326871|565906428|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
157111867|NCT00597753|567163426|FG000|Overall Study|Pregnancy|1|||
157111868|NCT00597753|567163427|FG001|Overall Study|Pregnancy|0|||
156767991|NCT01326871|565906429|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
156767992|NCT01326871|565906430|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
157006460|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
157006461|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
157006462|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
157006463|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
157006464|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
157006465|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
157006466|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
157006467|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
157006468|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
157006469|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
157006470|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
157006471|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
157006472|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
157006473|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
157006474|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
157006475|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
157006476|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
157006477|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
157006478|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
157006479|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
157006480|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
157006481|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
157006482|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
157006483|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
157006484|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
157006485|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
157006486|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
157006487|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
157006488|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
157006489|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
157006490|NCT02709655|566773317|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
157006491|NCT02709655|566773318|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
157006492|NCT02709655|566773319|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
157006493|NCT02709655|566773320|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
157006494|NCT02709655|566773321|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
157006495|NCT00102063|566773322|FG000|Overall Study|Lack of Efficacy|5|||
157006496|NCT00102063|566773323|FG001|Overall Study|Lack of Efficacy|1|||
157006497|NCT00102063|566773324|FG002|Overall Study|Lack of Efficacy|1|||
157006498|NCT00102063|566773322|FG000|Overall Study|Adverse Event|7|||
157006499|NCT00102063|566773323|FG001|Overall Study|Adverse Event|4|||
157006500|NCT00102063|566773324|FG002|Overall Study|Adverse Event|2|||
157006501|NCT00102063|566773322|FG000|Overall Study|Withdrawal by Subject|4|||
157006502|NCT00102063|566773323|FG001|Overall Study|Withdrawal by Subject|12|||
156767993|NCT01326871|565906428|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
156767994|NCT01326871|565906429|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
156767995|NCT01326871|565906430|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
156767996|NCT01326871|565906428|FG000|Overall Study|Withdrawal by Subject|0|||
156767997|NCT01326871|565906429|FG001|Overall Study|Withdrawal by Subject|1|||
156767998|NCT01326871|565906430|FG002|Overall Study|Withdrawal by Subject|0|||
156767999|NCT01326871|565906428|FG000|Overall Study|DLT|0|||
156768000|NCT01326871|565906429|FG001|Overall Study|DLT|2|||
157006503|NCT00102063|566773324|FG002|Overall Study|Withdrawal by Subject|5|||
157006504|NCT00102063|566773322|FG000|Overall Study|Lost to Follow-up|0|||
157006505|NCT00102063|566773323|FG001|Overall Study|Lost to Follow-up|0|||
157006506|NCT00102063|566773324|FG002|Overall Study|Lost to Follow-up|1|||
157006507|NCT00102063|566773322|FG000|Overall Study|Protocol Violation|0|||
157006508|NCT00102063|566773323|FG001|Overall Study|Protocol Violation|1|||
157006509|NCT00102063|566773324|FG002|Overall Study|Protocol Violation|1|||
157006510|NCT00857649|566773325|FG000|Overall Study|Adverse Event|15|||
157006511|NCT00857649|566773326|FG001|Overall Study|Adverse Event|10|||
157006512|NCT00857649|566773325|FG000|Overall Study|Non-compliance|1|||
157006513|NCT00857649|566773326|FG001|Overall Study|Non-compliance|1|||
157006514|NCT00857649|566773325|FG000|Overall Study|Protocol Violation|2|||
157006515|NCT00857649|566773326|FG001|Overall Study|Protocol Violation|2|||
157006516|NCT00857649|566773325|FG000|Overall Study|Withdrawal of Consent|10|||
157006517|NCT00857649|566773326|FG001|Overall Study|Withdrawal of Consent|7|||
157006518|NCT00857649|566773325|FG000|Overall Study|Nursing Home Placement|2|||
157006519|NCT00857649|566773326|FG001|Overall Study|Nursing Home Placement|9|||
157006520|NCT00857649|566773325|FG000|Overall Study|Other Reasons|1|||
157006521|NCT00857649|566773326|FG001|Overall Study|Other Reasons|3|||
157006522|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
157006523|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
157006524|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
157006525|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
157006526|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
157006527|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
157006528|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
157006529|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
157006530|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
157006531|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
157006532|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
157006533|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
157006534|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
157006535|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
157006536|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
157006537|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156768001|NCT01326871|565906430|FG002|Overall Study|DLT|0|||
157006538|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006539|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
157006540|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
156768002|NCT01326871|565906428|FG000|Overall Study|SAE, disease progression and subject decision|0|||
156768003|NCT01326871|565906429|FG001|Overall Study|SAE, disease progression and subject decision|1|||
156768004|NCT01326871|565906430|FG002|Overall Study|SAE, disease progression and subject decision|0|||
156768005|NCT01326871|565906428|FG000|Overall Study|Death|0|||
156768006|NCT01326871|565906429|FG001|Overall Study|Death|1|||
156768007|NCT01326871|565906430|FG002|Overall Study|Death|0|||
156768008|NCT01326871|565906428|FG000|Overall Study|Other|0|||
156768009|NCT01326871|565906429|FG001|Overall Study|Other|3|||
156768010|NCT01326871|565906430|FG002|Overall Study|Other|0|||
156768011|NCT01326871|565906428|FG000|Overall Study|SAE and disease progression|0|||
156768012|NCT01326871|565906429|FG001|Overall Study|SAE and disease progression|0|||
156768013|NCT01326871|565906430|FG002|Overall Study|SAE and disease progression|1|||
156768014|NCT01326871|565906428|FG000|Overall Study|SAE and physician decision|0|||
156768015|NCT01326871|565906429|FG001|Overall Study|SAE and physician decision|0|||
156768016|NCT01326871|565906430|FG002|Overall Study|SAE and physician decision|1|||
156768017|NCT01326871|565906428|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
156768018|NCT01326871|565906429|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
156768019|NCT01326871|565906430|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
156768020|NCT01326871|565906428|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
156768021|NCT01326871|565906429|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
156768022|NCT01326871|565906430|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
156768023|NCT01326871|565906428|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
156768024|NCT01326871|565906429|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
156768025|NCT01326871|565906430|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
156768026|NCT01326871|565906428|FG000|Overall Study|Physician Decision|0|||
156768027|NCT01326871|565906429|FG001|Overall Study|Physician Decision|0|||
156768028|NCT01326871|565906430|FG002|Overall Study|Physician Decision|1|||
156768029|NCT01326871|565906428|FG000|Overall Study|SAE|0|||
156768030|NCT01326871|565906429|FG001|Overall Study|SAE|0|||
156768031|NCT01326871|565906430|FG002|Overall Study|SAE|1|||
156768032|NCT01326871|565906428|FG000|Overall Study|Disease progression and death|0|||
156768033|NCT01326871|565906429|FG001|Overall Study|Disease progression and death|0|||
156768034|NCT01326871|565906430|FG002|Overall Study|Disease progression and death|1|||
156768035|NCT01326871|565906428|FG000|Overall Study|Subject decision|0|||
156768036|NCT01326871|565906429|FG001|Overall Study|Subject decision|0|||
156768037|NCT01326871|565906430|FG002|Overall Study|Subject decision|1|||
156768038|NCT01387269|565906434|FG000|Overall Study|Death|38|||
156768039|NCT01387269|565906435|FG001|Overall Study|Death|20|||
156768040|NCT01387269|565906434|FG000|Overall Study|Other|8|||
156768041|NCT01387269|565906435|FG001|Overall Study|Other|7|||
156768042|NCT01387269|565906434|FG000|Overall Study|Unrelated AE|12|||
156768043|NCT01387269|565906435|FG001|Overall Study|Unrelated AE|3|||
156768044|NCT01387269|565906434|FG000|Overall Study|Withdrawal by patient|32|||
156768045|NCT01387269|565906435|FG001|Overall Study|Withdrawal by patient|10|||
156768046|NCT01387269|565906434|FG000|Overall Study|Study drug-related AE|1|||
156768047|NCT01387269|565906435|FG001|Overall Study|Study drug-related AE|0|||
156768048|NCT01387269|565906434|FG000|Overall Study|Lost to Follow-up|1|||
156768049|NCT01387269|565906435|FG001|Overall Study|Lost to Follow-up|0|||
157006541|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006542|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006543|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006544|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006545|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006546|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006547|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
157006548|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
157006549|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
157006550|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
157006551|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
157006552|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
157006553|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
157006554|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
157111869|NCT00597753|567163426|FG000|Overall Study|Withdrawal by Subject|35|||
156768050|NCT01200329|565906436|FG000|Overall Study|Lack of financial coverage|2|||
156768051|NCT01200329|565906436|FG000|Overall Study|Progressive disease|1|||
156768052|NCT02230891|565906441|FG000|Baseline|Did not meet inclusion|0|||
156768053|NCT02230891|565906442|FG001|Baseline|Did not meet inclusion|1|||
156768054|NCT02230891|565906443|FG002|Baseline|Did not meet inclusion|1|||
156768055|NCT02230891|565906441|FG000|2 Week|Withdrawal by Subject|2|||
156768056|NCT02230891|565906442|FG001|2 Week|Withdrawal by Subject|2|||
156768057|NCT02230891|565906443|FG002|2 Week|Withdrawal by Subject|0|||
156768058|NCT02230891|565906441|FG000|2 Week|Consent withdrawn|1|||
156768059|NCT02230891|565906442|FG001|2 Week|Consent withdrawn|0|||
156768060|NCT02230891|565906443|FG002|2 Week|Consent withdrawn|0|||
156768061|NCT02230891|565906441|FG000|6 Month|Withdrawal by Subject|1|||
156768062|NCT02230891|565906442|FG001|6 Month|Withdrawal by Subject|1|||
156768063|NCT02230891|565906443|FG002|6 Month|Withdrawal by Subject|1|||
156768064|NCT02230891|565906441|FG000|6 Month|Physician Decision|0|||
156768065|NCT02230891|565906442|FG001|6 Month|Physician Decision|2|||
156768066|NCT02230891|565906443|FG002|6 Month|Physician Decision|0|||
156768067|NCT02230891|565906441|FG000|12 Month|Death|1|||
156768068|NCT02230891|565906442|FG001|12 Month|Death|0|||
156768069|NCT02230891|565906443|FG002|12 Month|Death|0|||
156768070|NCT02230891|565906441|FG000|12 Month|Lost to Follow-up|0|||
156768071|NCT02230891|565906442|FG001|12 Month|Lost to Follow-up|1|||
156768072|NCT02230891|565906443|FG002|12 Month|Lost to Follow-up|0|||
156768073|NCT02230891|565906441|FG000|12 Month|Withdrawal by Subject|0|||
156768074|NCT02230891|565906442|FG001|12 Month|Withdrawal by Subject|2|||
156768075|NCT02230891|565906443|FG002|12 Month|Withdrawal by Subject|0|||
156768076|NCT02230891|565906441|FG000|18 Month End of Study|Death|0|||
156768077|NCT02230891|565906442|FG001|18 Month End of Study|Death|0|||
156768078|NCT02230891|565906443|FG002|18 Month End of Study|Death|1|||
156768079|NCT02230891|565906441|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
156768080|NCT02230891|565906442|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
156768081|NCT02230891|565906443|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
156768082|NCT00921024|565906448|FG000|Overall Study|Lost to Follow-up|2|||
156768083|NCT00921024|565906449|FG001|Overall Study|Lost to Follow-up|0|||
156768084|NCT00921024|565906448|FG000|Overall Study|Received concomittant therapy|2|||
156768085|NCT00921024|565906449|FG001|Overall Study|Received concomittant therapy|0|||
156768086|NCT00921024|565906448|FG000|Overall Study|Withdrawal by Subject|0|||
156768087|NCT00921024|565906449|FG001|Overall Study|Withdrawal by Subject|3|||
156768088|NCT04158219|565906454|FG000|Overall Study|Lost to Follow-up|1|||
156768089|NCT01814007|565906455|FG000|Overall Study|Withdrawal by Subject|1|||
156768090|NCT01324947|565906457|FG000|Overall Study|Adverse Event|7|||
156768091|NCT01324947|565906457|FG000|Overall Study|Death|10|||
156768092|NCT01324947|565906457|FG000|Overall Study|Other|3|||
156768093|NCT01324947|565906457|FG000|Overall Study|Progressive Disease|50|||
156768094|NCT01324947|565906457|FG000|Overall Study|Withdrawal by Subject|3|||
157111870|NCT00597753|567163427|FG001|Overall Study|Withdrawal by Subject|12|||
156768095|NCT01324947|565906457|FG000|Overall Study|1 discontinued before starting drug|1|||
156768096|NCT01274351|565906458|FG000|Overall Study|Lost to Follow-up|1|||
156768097|NCT01274351|565906458|FG000|Overall Study|patient not compliant with the protocol|1|||
156768098|NCT01274351|565906458|FG000|Overall Study|Pregnancy|1|||
156768099|NCT01274351|565906458|FG000|Overall Study|Death|2|||
156768100|NCT01274351|565906458|FG000|Overall Study|Withdrawal by Subject|3|||
156768101|NCT01274351|565906458|FG000|Overall Study|Adverse Event|8|||
156768102|NCT01274351|565906458|FG000|Overall Study|progression of disease|3|||
156768103|NCT01274351|565906458|FG000|Overall Study|hospitalization|1|||
156768104|NCT01296412|565906461|FG000|Overall Study|Adverse Event|8|||
156768105|NCT01296412|565906462|FG001|Overall Study|Adverse Event|29|||
156768106|NCT01296412|565906461|FG000|Overall Study|Lack of Efficacy|1|||
156768107|NCT01296412|565906462|FG001|Overall Study|Lack of Efficacy|0|||
156768108|NCT01296412|565906461|FG000|Overall Study|Lost to Follow-up|10|||
156768109|NCT01296412|565906462|FG001|Overall Study|Lost to Follow-up|7|||
156768110|NCT01296412|565906461|FG000|Overall Study|Non-compliance with study drug|1|||
156768111|NCT01296412|565906462|FG001|Overall Study|Non-compliance with study drug|2|||
156768112|NCT01296412|565906461|FG000|Overall Study|Other reason not specified|20|||
156768113|NCT01296412|565906462|FG001|Overall Study|Other reason not specified|15|||
156768114|NCT01296412|565906461|FG000|Overall Study|Physician Decision|1|||
156768115|NCT01296412|565906462|FG001|Overall Study|Physician Decision|3|||
156768116|NCT01296412|565906461|FG000|Overall Study|Pregnancy|0|||
156768117|NCT01296412|565906462|FG001|Overall Study|Pregnancy|1|||
156768118|NCT01296412|565906461|FG000|Overall Study|Withdrawal by Subject|10|||
156768119|NCT01296412|565906462|FG001|Overall Study|Withdrawal by Subject|13|||
156768120|NCT02160626|565906463|FG000|Overall Study|Adverse Event|1|||
156768121|NCT02160626|565906464|FG001|Overall Study|Adverse Event|0|||
156768122|NCT02160626|565906465|FG002|Overall Study|Adverse Event|0|||
156768123|NCT02160626|565906463|FG000|Overall Study|Schedule not conducive to study visits|0|||
156768124|NCT02160626|565906464|FG001|Overall Study|Schedule not conducive to study visits|0|||
156768125|NCT02160626|565906465|FG002|Overall Study|Schedule not conducive to study visits|1|||
156768126|NCT02160626|565906463|FG000|Overall Study|Withdrawal by Subject|0|||
156768127|NCT02160626|565906464|FG001|Overall Study|Withdrawal by Subject|1|||
156768128|NCT02160626|565906465|FG002|Overall Study|Withdrawal by Subject|0|||
156768129|NCT04194814|565906469|FG000|Overall Study|Physician Decision|3|||
156768130|NCT04194814|565906470|FG001|Overall Study|Physician Decision|0|||
156768131|NCT04194814|565906469|FG000|Overall Study|Withdrawal by Subject|0|||
157111871|NCT00597753|567163426|FG000|Overall Study|Discontinued Dialysis|0|||
156768132|NCT04194814|565906470|FG001|Overall Study|Withdrawal by Subject|2|||
156768133|NCT00959751|565908376|FG000|Overall Study|Lost to Follow-up|2|||
156768134|NCT00959751|565908377|FG001|Overall Study|Lost to Follow-up|3|||
156768135|NCT00959751|565908376|FG000|Overall Study|Consent Withdrawn|0|||
156768136|NCT00959751|565908377|FG001|Overall Study|Consent Withdrawn|1|||
156768137|NCT00959751|565908376|FG000|Overall Study|Non-compliance to Study Procedures|0|||
156768138|NCT00959751|565908377|FG001|Overall Study|Non-compliance to Study Procedures|1|||
156768139|NCT00959751|565908376|FG000|Overall Study|No migraine headache without aura|7|||
156768140|NCT00959751|565908377|FG001|Overall Study|No migraine headache without aura|7|||
156768141|NCT03737994|565908378|FG000|Overall Study|Withdrawal by Subject|0|||
156768142|NCT03737994|565908379|FG001|Overall Study|Withdrawal by Subject|0|||
156768143|NCT03737994|565908380|FG002|Overall Study|Withdrawal by Subject|0|||
156768144|NCT03737994|565908381|FG003|Overall Study|Withdrawal by Subject|0|||
156768145|NCT03737994|565908382|FG004|Overall Study|Withdrawal by Subject|0|||
156768146|NCT03737994|565908383|FG005|Overall Study|Withdrawal by Subject|0|||
156768147|NCT03737994|565908384|FG006|Overall Study|Withdrawal by Subject|1|||
156768148|NCT03861039|565908387|FG000|Overall Study|Adverse Event|2|||
156768149|NCT03861039|565908388|FG001|Overall Study|Adverse Event|5|||
156768150|NCT03861039|565908389|FG002|Overall Study|Adverse Event|11|||
156768151|NCT03861039|565908387|FG000|Overall Study|Withdrawal by Subject|1|||
156768152|NCT03861039|565908388|FG001|Overall Study|Withdrawal by Subject|3|||
156768153|NCT03861039|565908389|FG002|Overall Study|Withdrawal by Subject|4|||
156768154|NCT03427892|565908390|FG000|Overall Study|Lost to Follow-up|2|||
156768155|NCT03255187|565908391|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
156768156|NCT03255187|565908392|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
156768157|NCT03255187|565908391|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
156768158|NCT03255187|565908392|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
156768159|NCT03617588|565908399|FG000|Overall Study|Withdrawal by Subject|1|||
156768160|NCT03617588|565908400|FG001|Overall Study|Withdrawal by Subject|0|||
156768161|NCT02419807|565908401|FG000|Overall Study|Withdrawal by Subject|4|||
156768162|NCT02419807|565908401|FG000|Overall Study|Physician Decision|1|||
156768163|NCT02419807|565908401|FG000|Overall Study|Protocol Violation|5|||
156768164|NCT01006629|565908402|FG000|Overall Study|Adverse Event|1|||
156768165|NCT01006629|565908402|FG000|Overall Study|Parent refused to continue participation|1|||
156768166|NCT01006629|565908402|FG000|Overall Study|Parent unable to perform site visit|4|||
156768167|NCT01499511|565908403|FG000|Overall Study|Death|1|||
156768168|NCT01499511|565908404|FG001|Overall Study|Death|0|||
156768169|NCT01065818|565908406|FG000|Overall Study|Withdrawal by Subject|1|||
156768170|NCT01065818|565908406|FG000|Overall Study|Not a candidate for surgery|1|||
156768171|NCT04459338|565908409|FG000|Overall Study|Loss of IV during study|1|||
156768172|NCT04459338|565908410|FG001|Overall Study|Loss of IV during study|0|||
156768173|NCT03157089|565908411|FG000|Overall Study|Treated only with pembrolizumab|1|||
156768174|NCT03157089|565908412|FG001|Overall Study|Treated only with pembrolizumab|0|||
156768175|NCT03157089|565908411|FG000|Overall Study|Adverse Event|5|||
156768176|NCT03157089|565908412|FG001|Overall Study|Adverse Event|4|||
156768177|NCT03157089|565908411|FG000|Overall Study|Progressive disease|6|||
156768178|NCT03157089|565908412|FG001|Overall Study|Progressive disease|8|||
156768179|NCT00784875|565908413|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
156768180|NCT00784875|565908414|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
156768181|NCT00784875|565908415|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
156768182|NCT00784875|565908416|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
156768183|NCT00784875|565908413|FG000|Period A - Baseline|Adverse Event|0|||
156768184|NCT00784875|565908414|FG001|Period A - Baseline|Adverse Event|0|||
156768185|NCT00784875|565908415|FG002|Period A - Baseline|Adverse Event|0|||
156768186|NCT00784875|565908416|FG003|Period A - Baseline|Adverse Event|8|||
156768187|NCT00784875|565908413|FG000|Period A - Baseline|Protocol Violation|0|||
156768188|NCT00784875|565908414|FG001|Period A - Baseline|Protocol Violation|0|||
156768189|NCT00784875|565908415|FG002|Period A - Baseline|Protocol Violation|0|||
156768190|NCT00784875|565908416|FG003|Period A - Baseline|Protocol Violation|25|||
156768191|NCT00784875|565908413|FG000|Period A - Baseline|Withdrawal by Subject|0|||
156768192|NCT00784875|565908414|FG001|Period A - Baseline|Withdrawal by Subject|0|||
156768193|NCT00784875|565908415|FG002|Period A - Baseline|Withdrawal by Subject|0|||
156768194|NCT00784875|565908416|FG003|Period A - Baseline|Withdrawal by Subject|27|||
156768195|NCT00784875|565908413|FG000|Period A - Baseline|Physician Decision|0|||
156768196|NCT00784875|565908414|FG001|Period A - Baseline|Physician Decision|0|||
156768197|NCT00784875|565908415|FG002|Period A - Baseline|Physician Decision|0|||
156768198|NCT00784875|565908416|FG003|Period A - Baseline|Physician Decision|2|||
156768199|NCT00784875|565908413|FG000|Period A - Baseline|Sponsor Decision|0|||
156768200|NCT00784875|565908414|FG001|Period A - Baseline|Sponsor Decision|0|||
156768201|NCT00784875|565908415|FG002|Period A - Baseline|Sponsor Decision|0|||
156768202|NCT00784875|565908416|FG003|Period A - Baseline|Sponsor Decision|113|||
156768203|NCT00784875|565908413|FG000|Period A - Baseline|Lost to Follow-up|0|||
156768204|NCT00784875|565908414|FG001|Period A - Baseline|Lost to Follow-up|0|||
157111872|NCT00597753|567163427|FG001|Overall Study|Discontinued Dialysis|1|||
156768205|NCT00784875|565908415|FG002|Period A - Baseline|Lost to Follow-up|0|||
156768206|NCT00784875|565908416|FG003|Period A - Baseline|Lost to Follow-up|2|||
156768207|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
157111873|NCT00597753|567163426|FG000|Overall Study|Never dosed|2|||
156768208|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
156768209|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
156768210|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
156768211|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
156768212|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
156768213|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
156768214|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
156768215|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
156768216|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
156768217|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
157006555|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
157006556|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
157006557|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
157006558|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
157006559|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
157006560|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
157006561|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006562|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
157006563|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
157006564|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006565|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
157006566|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006567|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006568|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006569|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006570|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006571|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006572|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006573|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
157006574|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
157006575|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
157006576|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
157006577|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
157006578|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
157006579|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006580|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006581|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006582|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
157006583|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006584|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006585|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006586|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
157006587|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
157006588|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006589|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006590|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006591|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006592|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
157006593|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
157006594|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
157006595|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006596|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006597|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006598|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006599|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
157006600|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
157006601|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
157006602|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
157006603|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
157006604|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
157006605|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
157006606|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
157006607|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
157006608|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
157006609|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
156768218|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
156768219|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
157006610|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
157006611|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
157006612|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
157006613|NCT04707313|566773330|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006614|NCT04707313|566773331|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006615|NCT04707313|566773332|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
157006616|NCT04707313|566773333|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006617|NCT04707313|566773334|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006618|NCT04707313|566773335|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006619|NCT04707313|566773336|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006620|NCT04707313|566773337|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
157006621|NCT04707313|566773338|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006622|NCT04707313|566773339|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006623|NCT04707313|566773340|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006624|NCT04707313|566773341|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006625|NCT04707313|566773342|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
157006626|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006627|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006628|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006629|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006630|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006631|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006632|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006633|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006634|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006635|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
157006636|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
157006637|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
157006638|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
157006639|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006640|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006641|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006642|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006643|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006644|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006645|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006646|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006647|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006648|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
157006649|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
157006650|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
157006651|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
157006652|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006653|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006654|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006655|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006656|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006657|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006658|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006659|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006660|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
157006661|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
157006662|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
157006663|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
157006664|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
157006665|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006666|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006667|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006668|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006669|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006670|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006671|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006672|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006673|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006674|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006675|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
157006676|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
157006677|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
157006678|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006679|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006680|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006681|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
156768220|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
156768221|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
156768222|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
156768223|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
156768224|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
156768225|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
156768226|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
156768227|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
156768228|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
156768229|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
156768230|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
156768231|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
156768232|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
156768233|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
156768234|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
156768235|NCT00784875|565908413|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768236|NCT00784875|565908414|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768237|NCT00784875|565908415|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
156768238|NCT00784875|565908416|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
156768239|NCT00784875|565908413|FG000|Period C|Adverse Event|1|||
156768240|NCT00784875|565908414|FG001|Period C|Adverse Event|0|||
156768241|NCT00784875|565908415|FG002|Period C|Adverse Event|4|||
156768242|NCT00784875|565908416|FG003|Period C|Adverse Event|2|||
156768243|NCT00784875|565908413|FG000|Period C|Protocol Violation|0|||
156768244|NCT00784875|565908414|FG001|Period C|Protocol Violation|0|||
156768245|NCT00784875|565908415|FG002|Period C|Protocol Violation|1|||
156768246|NCT00784875|565908416|FG003|Period C|Protocol Violation|2|||
156768247|NCT00784875|565908413|FG000|Period C|Lack of Efficacy|0|||
156768248|NCT00784875|565908414|FG001|Period C|Lack of Efficacy|0|||
156768249|NCT00784875|565908415|FG002|Period C|Lack of Efficacy|1|||
156768250|NCT00784875|565908416|FG003|Period C|Lack of Efficacy|0|||
156768251|NCT00784875|565908413|FG000|Period C|Withdrawal by Subject|1|||
156768252|NCT00784875|565908414|FG001|Period C|Withdrawal by Subject|1|||
156768253|NCT00784875|565908415|FG002|Period C|Withdrawal by Subject|2|||
156768254|NCT00784875|565908416|FG003|Period C|Withdrawal by Subject|0|||
156768255|NCT00784875|565908413|FG000|Period C|Physician Decision|0|||
156768256|NCT00784875|565908414|FG001|Period C|Physician Decision|0|||
156768257|NCT00784875|565908415|FG002|Period C|Physician Decision|1|||
156768258|NCT00784875|565908416|FG003|Period C|Physician Decision|1|||
156768259|NCT00784875|565908413|FG000|Period C|Sponsor Decision|5|||
156768260|NCT00784875|565908414|FG001|Period C|Sponsor Decision|5|||
156768261|NCT00784875|565908415|FG002|Period C|Sponsor Decision|4|||
156768262|NCT00784875|565908416|FG003|Period C|Sponsor Decision|2|||
156768263|NCT00784875|565908413|FG000|Period D|Adverse Event|0|||
156768264|NCT00784875|565908414|FG001|Period D|Adverse Event|2|||
156768265|NCT00784875|565908415|FG002|Period D|Adverse Event|2|||
156768266|NCT00784875|565908416|FG003|Period D|Adverse Event|0|||
156768267|NCT00784875|565908413|FG000|Period D|Protocol Violation|1|||
156768268|NCT00784875|565908414|FG001|Period D|Protocol Violation|0|||
156768269|NCT00784875|565908415|FG002|Period D|Protocol Violation|0|||
156768270|NCT00784875|565908416|FG003|Period D|Protocol Violation|0|||
157006682|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006683|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006684|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006685|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006686|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006687|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
157006688|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
157006689|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006690|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
157006691|NCT04707313|566773330|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156768271|NCT00784875|565908413|FG000|Period D|Withdrawal by Subject|2|||
156768272|NCT00784875|565908414|FG001|Period D|Withdrawal by Subject|0|||
156768273|NCT00784875|565908415|FG002|Period D|Withdrawal by Subject|2|||
156768274|NCT00784875|565908416|FG003|Period D|Withdrawal by Subject|0|||
156768275|NCT00784875|565908413|FG000|Period D|Physician Decision|0|||
156768276|NCT00784875|565908414|FG001|Period D|Physician Decision|1|||
156768277|NCT00784875|565908415|FG002|Period D|Physician Decision|0|||
156768278|NCT00784875|565908416|FG003|Period D|Physician Decision|0|||
156768279|NCT00784875|565908413|FG000|Period D|Sponsor Decision|1|||
156768280|NCT00784875|565908414|FG001|Period D|Sponsor Decision|1|||
156768281|NCT00784875|565908415|FG002|Period D|Sponsor Decision|1|||
156768282|NCT00784875|565908416|FG003|Period D|Sponsor Decision|0|||
156768283|NCT00784875|565908413|FG000|Period D|Lost to Follow-up|1|||
156768284|NCT00784875|565908414|FG001|Period D|Lost to Follow-up|0|||
156768285|NCT00784875|565908415|FG002|Period D|Lost to Follow-up|1|||
156768286|NCT00784875|565908416|FG003|Period D|Lost to Follow-up|1|||
156768287|NCT00958074|565908417|FG000|Overall Study|Withdrawal by Subject|0|||
156768288|NCT00958074|565908418|FG001|Overall Study|Withdrawal by Subject|1|||
156768289|NCT00853385|565908419|FG000|Overall Study|Death|0|||
156768290|NCT00853385|565908420|FG001|Overall Study|Death|0|||
156768291|NCT00853385|565908421|FG002|Overall Study|Death|0|||
156768292|NCT00853385|565908422|FG003|Overall Study|Death|0|||
156768293|NCT00853385|565908423|FG004|Overall Study|Death|1|||
156768294|NCT00853385|565908419|FG000|Overall Study|Adverse Event|24|||
156768295|NCT00853385|565908420|FG001|Overall Study|Adverse Event|24|||
156768296|NCT00853385|565908421|FG002|Overall Study|Adverse Event|2|||
156768297|NCT00853385|565908422|FG003|Overall Study|Adverse Event|5|||
156768298|NCT00853385|565908423|FG004|Overall Study|Adverse Event|22|||
156768299|NCT00853385|565908419|FG000|Overall Study|Lack of Efficacy|6|||
156768300|NCT00853385|565908420|FG001|Overall Study|Lack of Efficacy|7|||
156768301|NCT00853385|565908421|FG002|Overall Study|Lack of Efficacy|3|||
156768302|NCT00853385|565908422|FG003|Overall Study|Lack of Efficacy|3|||
156768303|NCT00853385|565908423|FG004|Overall Study|Lack of Efficacy|6|||
156768304|NCT00853385|565908419|FG000|Overall Study|Lost to Follow-up|2|||
156768305|NCT00853385|565908420|FG001|Overall Study|Lost to Follow-up|1|||
156768306|NCT00853385|565908421|FG002|Overall Study|Lost to Follow-up|0|||
156768307|NCT00853385|565908422|FG003|Overall Study|Lost to Follow-up|0|||
156768308|NCT00853385|565908423|FG004|Overall Study|Lost to Follow-up|0|||
156768309|NCT00853385|565908419|FG000|Overall Study|Withdrawal by Subject|4|||
156768310|NCT00853385|565908420|FG001|Overall Study|Withdrawal by Subject|2|||
156768311|NCT00853385|565908421|FG002|Overall Study|Withdrawal by Subject|0|||
156768312|NCT00853385|565908422|FG003|Overall Study|Withdrawal by Subject|1|||
156768313|NCT00853385|565908423|FG004|Overall Study|Withdrawal by Subject|1|||
156768314|NCT00853385|565908419|FG000|Overall Study|Other|18|||
156768315|NCT00853385|565908420|FG001|Overall Study|Other|9|||
156768316|NCT00853385|565908421|FG002|Overall Study|Other|4|||
156768317|NCT00853385|565908422|FG003|Overall Study|Other|4|||
156768318|NCT00853385|565908423|FG004|Overall Study|Other|12|||
156768319|NCT00941928|565908424|FG000|Overall Study|Withdrawal by Subject|1|||
156768320|NCT00941928|565908424|FG000|Overall Study|Disease Progression|1|||
156768321|NCT02300610|565908429|FG000|Overall Study|Withdrawal by Subject|1|||
156768322|NCT02300610|565908430|FG001|Overall Study|Withdrawal by Subject|0|||
156768323|NCT02300610|565908431|FG002|Overall Study|Withdrawal by Subject|1|||
156768324|NCT00095979|565908432|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
156768325|NCT01829347|565908433|FG000|VTI-210|Death|5|||
156768326|NCT01829347|565908434|FG001|VTI-210|Death|3|||
156768327|NCT01829347|565908433|FG000|VTI-210|Withdrawal by Subject|1|||
156768328|NCT01829347|565908434|FG001|VTI-210|Withdrawal by Subject|0|||
156768329|NCT01829347|565908433|FG000|VTI-210E|Death|2|||
156768330|NCT01829347|565908434|FG001|VTI-210E|Death|1|||
156768331|NCT01829347|565908433|FG000|VTI-210E|Study terminated prematurely|1|||
156768332|NCT01829347|565908434|FG001|VTI-210E|Study terminated prematurely|5|||
156768333|NCT02051296|565908437|FG000|Overall Study|Lost to Follow-up|1|||
156768334|NCT02051296|565908438|FG001|Overall Study|Lost to Follow-up|2|||
156768335|NCT02051296|565908437|FG000|Overall Study|withdraw prior to treatment|7|||
156768336|NCT02051296|565908438|FG001|Overall Study|withdraw prior to treatment|7|||
156768337|NCT02515227|565908439|FG000|Overall Study|Adverse Event|0|||
156768338|NCT02515227|565908440|FG001|Overall Study|Adverse Event|2|||
156768339|NCT02515227|565908439|FG000|Overall Study|Progressive disease|2|||
156768340|NCT02515227|565908440|FG001|Overall Study|Progressive disease|9|||
156768341|NCT03451071|565908447|FG000|First Vaccine|Withdrawal by Subject|1|||
156768342|NCT03451071|565908447|FG000|Second Vaccine|Lost to Follow-up|19|||
156768343|NCT03451071|565908447|FG000|Third Vaccine|Lost to Follow-up|22|||
156768344|NCT03451071|565908447|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
156768345|NCT01027845|565908452|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
156768346|NCT01027845|565908453|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
156768347|NCT01027845|565908454|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
156768348|NCT01027845|565908455|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
156768349|NCT01027845|565908452|FG000|Primary Vaccination Phase|Adverse Event|1|||
156768350|NCT01027845|565908453|FG001|Primary Vaccination Phase|Adverse Event|0|||
156768351|NCT01027845|565908454|FG002|Primary Vaccination Phase|Adverse Event|0|||
156768352|NCT01027845|565908455|FG003|Primary Vaccination Phase|Adverse Event|0|||
156768353|NCT01027845|565908452|FG000|Primary Vaccination Phase|Protocol Violation|1|||
156768354|NCT01027845|565908453|FG001|Primary Vaccination Phase|Protocol Violation|0|||
156768355|NCT01027845|565908454|FG002|Primary Vaccination Phase|Protocol Violation|0|||
156768356|NCT01027845|565908455|FG003|Primary Vaccination Phase|Protocol Violation|0|||
156768357|NCT01027845|565908452|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768358|NCT01027845|565908453|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
156768359|NCT01027845|565908454|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768360|NCT01027845|565908455|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
156768361|NCT01027845|565908452|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
156768362|NCT01027845|565908453|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768363|NCT01027845|565908454|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768364|NCT01027845|565908455|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
156768365|NCT01027845|565908452|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
156768366|NCT01027845|565908453|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768367|NCT01027845|565908454|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768368|NCT01027845|565908455|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
156768369|NCT01670292|565908456|FG000|Overall Study|Lost to Follow-up|14|||
156768370|NCT04142242|565908458|FG000|Stage I|Non-compliance with the protocol|1|||
156768371|NCT04142242|565908459|FG001|Stage I|Non-compliance with the protocol|0|||
156768372|NCT04142242|565908460|FG002|Stage I|Non-compliance with the protocol|0|||
156768373|NCT04142242|565908461|FG003|Stage I|Non-compliance with the protocol|0|||
156768374|NCT04142242|565908462|FG004|Stage I|Non-compliance with the protocol|0|||
156768375|NCT04142242|565908463|FG005|Stage I|Non-compliance with the protocol|1|||
156768376|NCT04142242|565908458|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768377|NCT04142242|565908459|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
156768378|NCT04142242|565908460|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768379|NCT04142242|565908461|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768380|NCT04142242|565908462|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768381|NCT04142242|565908463|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
156768382|NCT04142242|565908458|FG000|Stage II|Non-compliance with the protocol|0|||
156768383|NCT04142242|565908459|FG001|Stage II|Non-compliance with the protocol|0|||
156768384|NCT04142242|565908460|FG002|Stage II|Non-compliance with the protocol|0|||
156768385|NCT04142242|565908461|FG003|Stage II|Non-compliance with the protocol|2|||
156768386|NCT04142242|565908462|FG004|Stage II|Non-compliance with the protocol|0|||
156768387|NCT04142242|565908463|FG005|Stage II|Non-compliance with the protocol|0|||
156768388|NCT04142242|565908458|FG000|Stage II|Lost to Follow-up|0|||
156768389|NCT04142242|565908459|FG001|Stage II|Lost to Follow-up|0|||
156768390|NCT04142242|565908460|FG002|Stage II|Lost to Follow-up|1|||
156768391|NCT04142242|565908461|FG003|Stage II|Lost to Follow-up|2|||
156768392|NCT04142242|565908462|FG004|Stage II|Lost to Follow-up|0|||
156768393|NCT04142242|565908463|FG005|Stage II|Lost to Follow-up|0|||
156768394|NCT04142242|565908458|FG000|Stage II|Withdrawal by Subject|0|||
156768395|NCT04142242|565908459|FG001|Stage II|Withdrawal by Subject|0|||
156768396|NCT04142242|565908460|FG002|Stage II|Withdrawal by Subject|5|||
156768397|NCT04142242|565908461|FG003|Stage II|Withdrawal by Subject|9|||
156768398|NCT04142242|565908462|FG004|Stage II|Withdrawal by Subject|0|||
156768399|NCT04142242|565908463|FG005|Stage II|Withdrawal by Subject|0|||
156768400|NCT00846053|565908466|FG000|Overall Study|Physician Decision|3|||
156768401|NCT00846053|565908467|FG001|Overall Study|Physician Decision|0|||
156768402|NCT02475369|565908474|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
156768403|NCT02475369|565908475|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
156768404|NCT04798027|565908484|FG000|Overall Study|Protocol Violation|0|||
156768405|NCT04798027|565908485|FG001|Overall Study|Protocol Violation|0|||
156768406|NCT04798027|565908486|FG002|Overall Study|Protocol Violation|0|||
156768407|NCT04798027|565908487|FG003|Overall Study|Protocol Violation|0|||
156768408|NCT04798027|565908488|FG004|Overall Study|Protocol Violation|1|||
156768409|NCT04798027|565908489|FG005|Overall Study|Protocol Violation|0|||
156768410|NCT04798027|565908490|FG006|Overall Study|Protocol Violation|0|||
156768411|NCT04798027|565908491|FG007|Overall Study|Protocol Violation|1|||
156768412|NCT04798027|565908492|FG008|Overall Study|Protocol Violation|0|||
156768413|NCT04798027|565908484|FG000|Overall Study|Withdrawal by Subject|1|||
156768414|NCT04798027|565908485|FG001|Overall Study|Withdrawal by Subject|0|||
156768415|NCT04798027|565908486|FG002|Overall Study|Withdrawal by Subject|1|||
156768416|NCT04798027|565908487|FG003|Overall Study|Withdrawal by Subject|1|||
156768417|NCT04798027|565908488|FG004|Overall Study|Withdrawal by Subject|1|||
156768418|NCT04798027|565908489|FG005|Overall Study|Withdrawal by Subject|1|||
156768419|NCT04798027|565908490|FG006|Overall Study|Withdrawal by Subject|3|||
156768420|NCT04798027|565908491|FG007|Overall Study|Withdrawal by Subject|2|||
156768421|NCT04798027|565908492|FG008|Overall Study|Withdrawal by Subject|2|||
156768422|NCT04798027|565908484|FG000|Overall Study|Lost to Follow-up|1|||
156768423|NCT04798027|565908485|FG001|Overall Study|Lost to Follow-up|3|||
156768424|NCT04798027|565908486|FG002|Overall Study|Lost to Follow-up|0|||
156768425|NCT04798027|565908487|FG003|Overall Study|Lost to Follow-up|0|||
156768426|NCT04798027|565908488|FG004|Overall Study|Lost to Follow-up|0|||
156768427|NCT04798027|565908489|FG005|Overall Study|Lost to Follow-up|1|||
156768428|NCT04798027|565908490|FG006|Overall Study|Lost to Follow-up|0|||
156768429|NCT04798027|565908491|FG007|Overall Study|Lost to Follow-up|0|||
156768430|NCT04798027|565908492|FG008|Overall Study|Lost to Follow-up|1|||
156768431|NCT04798027|565908484|FG000|Overall Study|Withdrawal by Sponsor|8|||
156768432|NCT04798027|565908485|FG001|Overall Study|Withdrawal by Sponsor|22|||
156768433|NCT04798027|565908486|FG002|Overall Study|Withdrawal by Sponsor|9|||
156768434|NCT04798027|565908487|FG003|Overall Study|Withdrawal by Sponsor|26|||
156768435|NCT04798027|565908488|FG004|Overall Study|Withdrawal by Sponsor|24|||
157006692|NCT04707313|566773331|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006693|NCT04707313|566773332|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
156768436|NCT04798027|565908489|FG005|Overall Study|Withdrawal by Sponsor|11|||
156768437|NCT04798027|565908490|FG006|Overall Study|Withdrawal by Sponsor|25|||
156768438|NCT04798027|565908491|FG007|Overall Study|Withdrawal by Sponsor|26|||
156768439|NCT04798027|565908492|FG008|Overall Study|Withdrawal by Sponsor|11|||
156768440|NCT03210714|565908493|FG000|Overall Study|Adverse Event|6|||
156768441|NCT03210714|565908493|FG000|Overall Study|Physician Decision|1|||
156768442|NCT03210714|565908493|FG000|Overall Study|Progressive disease|11|||
156768443|NCT03210714|565908493|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
156768444|NCT00803179|565908494|FG000|Overall Study|Lost to Follow-up|3|||
156768445|NCT04158648|565908495|FG000|Overall Study|Ongoing in the Study|69|||
156768446|NCT04158648|565908495|FG000|Overall Study|Withdrawal by Subject|4|||
156768447|NCT02121210|565908496|FG000|Overall Study|Adverse Event|5|||
156768448|NCT02121210|565908497|FG001|Overall Study|Adverse Event|7|||
156768449|NCT02121210|565908496|FG000|Overall Study|Lack of Efficacy|2|||
156768450|NCT02121210|565908497|FG001|Overall Study|Lack of Efficacy|0|||
156768451|NCT02121210|565908496|FG000|Overall Study|Other than specified above|0|||
156768452|NCT02121210|565908497|FG001|Overall Study|Other than specified above|2|||
156768453|NCT04609514|565908498|FG000|Overall Study|Lost to Follow-up|5|||
156768454|NCT04609514|565908499|FG001|Overall Study|Lost to Follow-up|4|||
156768455|NCT04609514|565908498|FG000|Overall Study|Withdrawal by PI|0|||
156768456|NCT04609514|565908499|FG001|Overall Study|Withdrawal by PI|2|||
156768457|NCT00885118|565908500|FG000|Overall Study|Adverse Event|1|||
156768458|NCT00885118|565908501|FG001|Overall Study|Adverse Event|0|||
156768459|NCT00885118|565908502|FG002|Overall Study|Adverse Event|0|||
156768460|NCT00885118|565908503|FG003|Overall Study|Adverse Event|0|||
156768461|NCT00885118|565908504|FG004|Overall Study|Adverse Event|0|||
156768462|NCT00885118|565908500|FG000|Overall Study|Withdrawal by Subject|0|||
156768463|NCT00885118|565908501|FG001|Overall Study|Withdrawal by Subject|0|||
156768464|NCT00885118|565908502|FG002|Overall Study|Withdrawal by Subject|0|||
156768465|NCT00885118|565908503|FG003|Overall Study|Withdrawal by Subject|0|||
156768466|NCT00885118|565908504|FG004|Overall Study|Withdrawal by Subject|1|||
156768467|NCT00885118|565908500|FG000|Overall Study|Other reason not defined above|0|||
156768468|NCT00885118|565908501|FG001|Overall Study|Other reason not defined above|0|||
156768469|NCT00885118|565908502|FG002|Overall Study|Other reason not defined above|1|||
156768470|NCT00885118|565908503|FG003|Overall Study|Other reason not defined above|0|||
156768471|NCT00885118|565908504|FG004|Overall Study|Other reason not defined above|0|||
156768472|NCT03642990|565908511|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
156768473|NCT03642990|565908511|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
156768474|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
156768475|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
156768476|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768477|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768478|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
156768479|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
156768480|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
156768481|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768482|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768483|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
156768484|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
156768485|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
156768486|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768487|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768488|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
156768489|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
156768490|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
156768491|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768492|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768493|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
156768494|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
156768495|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
156768496|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768497|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768498|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
156768499|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
156768500|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
156768501|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768502|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768503|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
156768504|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
156768505|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
156768506|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768507|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768508|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
156768509|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
156768510|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
156768511|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768512|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768513|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
156768514|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
156768515|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768516|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768517|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768518|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
156768519|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
156768520|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
156768521|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
156768522|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
156768523|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
156768524|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
156768525|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
156768526|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
156768527|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
156768528|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
156768529|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
156768530|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768531|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768532|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
157111874|NCT00597753|567163427|FG001|Overall Study|Never dosed|0|||
157111875|NCT00597753|567163426|FG000|Overall Study|Noncompliance|2|||
157111876|NCT00597753|567163427|FG001|Overall Study|Noncompliance|1|||
157111877|NCT00597753|567163426|FG000|Overall Study|Relocation|17|||
157111878|NCT00597753|567163427|FG001|Overall Study|Relocation|6|||
157111879|NCT00597753|567163426|FG000|Overall Study|Renal transplant|10|||
157111880|NCT00597753|567163427|FG001|Overall Study|Renal transplant|3|||
157111881|NCT00597753|567163426|FG000|Overall Study|Site closed by sponsor|19|||
156768533|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
156768534|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
156768535|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768536|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768537|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768538|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
156768539|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768540|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
156768541|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768542|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768543|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
156768544|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
156768545|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
156768546|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768547|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768548|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
156768549|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768550|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
156768551|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
157111882|NCT00597753|567163427|FG001|Overall Study|Site closed by sponsor|7|||
157111883|NCT00597753|567163426|FG000|Overall Study|Site elected to close|2|||
157111884|NCT00597753|567163427|FG001|Overall Study|Site elected to close|4|||
157111885|NCT03080883|567163428|FG000|Overall Study|Withdrawal by Subject|11|||
157111886|NCT03080883|567163429|FG001|Overall Study|Withdrawal by Subject|15|||
157111887|NCT03080883|567163428|FG000|Overall Study|Adverse Event|22|||
157111888|NCT03080883|567163429|FG001|Overall Study|Adverse Event|22|||
157111889|NCT03080883|567163428|FG000|Overall Study|Alternative Therapy|0|||
157111890|NCT03080883|567163429|FG001|Overall Study|Alternative Therapy|3|||
157111891|NCT03080883|567163428|FG000|Overall Study|Other Complicating Disease|9|||
157111892|NCT03080883|567163429|FG001|Overall Study|Other Complicating Disease|5|||
157111893|NCT03080883|567163428|FG000|Overall Study|Death|21|||
157111894|NCT03080883|567163429|FG001|Overall Study|Death|16|||
157111895|NCT03080883|567163428|FG000|Overall Study|Physician Decision|2|||
157111896|NCT03080883|567163429|FG001|Overall Study|Physician Decision|2|||
157111897|NCT03080883|567163428|FG000|Overall Study|Disease Progression|2|||
157111898|NCT03080883|567163429|FG001|Overall Study|Disease Progression|8|||
157111899|NCT03080883|567163428|FG000|Overall Study|Lost to Follow-up|1|||
157111900|NCT03080883|567163429|FG001|Overall Study|Lost to Follow-up|1|||
157111901|NCT03723707|567165047|FG000|Overall Study|Death|32|||
157111902|NCT03723707|567165048|FG001|Overall Study|Death|32|||
157111903|NCT03723707|567165047|FG000|Overall Study|Admitted to long term care|12|||
157111904|NCT03723707|567165048|FG001|Overall Study|Admitted to long term care|12|||
157111905|NCT03723707|567165047|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
157111906|NCT03723707|567165048|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
157111907|NCT03723707|567165047|FG000|Overall Study|Lost to Follow-up|40|||
157111908|NCT03723707|567165048|FG001|Overall Study|Lost to Follow-up|22|||
157111909|NCT03723707|567165047|FG000|Overall Study|Discontinued after study closure|24|||
157111910|NCT03723707|567165048|FG001|Overall Study|Discontinued after study closure|12|||
157111911|NCT00750698|567165049|FG000|Overall Study|Withdrawal by Subject|1|||
157111912|NCT00750698|567165050|FG001|Overall Study|Withdrawal by Subject|0|||
157111913|NCT00750698|567165049|FG000|Overall Study|Progressive disease|5|||
157111914|NCT00750698|567165050|FG001|Overall Study|Progressive disease|2|||
157111915|NCT01999465|567165051|FG000|Overall Study|Lost to Follow-up|0|||
157111916|NCT01999465|567165052|FG001|Overall Study|Lost to Follow-up|2|||
157111917|NCT01999465|567165051|FG000|Overall Study|Protocol Violation|0|||
157111918|NCT01999465|567165052|FG001|Overall Study|Protocol Violation|1|||
157111919|NCT00390546|567165053|FG000|Overall Study|Renal impairment|1|||
157111920|NCT00390546|567165054|FG001|Overall Study|Renal impairment|0|||
157111921|NCT00390546|567165053|FG000|Overall Study|Physician Decision|5|||
157111922|NCT00390546|567165054|FG001|Overall Study|Physician Decision|5|||
157111923|NCT01308008|567165055|FG000|4 Weeks|Illness, disinterest, time|9|||
157111924|NCT01308008|567165056|FG001|4 Weeks|Illness, disinterest, time|2|||
157111925|NCT02325219|567165057|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
157111926|NCT02325219|567165058|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
157111927|NCT02325219|567165059|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
157111928|NCT02325219|567165060|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
157111929|NCT02325219|567165061|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
157111930|NCT02325219|567165057|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
157111931|NCT02325219|567165058|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
157111932|NCT02325219|567165059|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157111933|NCT02325219|567165060|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157111934|NCT02325219|567165061|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157111935|NCT02325219|567165057|FG000|Controlled Period (Week 0 - 16)|Other|0|||
157111936|NCT02325219|567165058|FG001|Controlled Period (Week 0 - 16)|Other|0|||
157111937|NCT02325219|567165059|FG002|Controlled Period (Week 0 - 16)|Other|1|||
157111938|NCT02325219|567165060|FG003|Controlled Period (Week 0 - 16)|Other|0|||
157111939|NCT02325219|567165061|FG004|Controlled Period (Week 0 - 16)|Other|0|||
157111940|NCT02325219|567165057|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
157111941|NCT02325219|567165058|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
157111942|NCT02325219|567165059|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
157111943|NCT02325219|567165060|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
157111944|NCT02325219|567165061|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
157111945|NCT02325219|567165057|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
157111946|NCT02325219|567165058|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
157111947|NCT02325219|567165059|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
157111948|NCT02325219|567165060|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
157111949|NCT02325219|567165061|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
157111950|NCT02325219|567165057|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157111951|NCT02325219|567165058|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
157111952|NCT02325219|567165059|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157111953|NCT02325219|567165060|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157111954|NCT02325219|567165061|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157111955|NCT02257372|567165062|FG000|Overall Study|Adverse Event|3|||
157111956|NCT02257372|567165063|FG001|Overall Study|Adverse Event|7|||
157111957|NCT02257372|567165062|FG000|Overall Study|Lack of Efficacy|2|||
157111958|NCT02257372|567165063|FG001|Overall Study|Lack of Efficacy|1|||
157111959|NCT02257372|567165062|FG000|Overall Study|Protocol Violation|1|||
157111960|NCT02257372|567165063|FG001|Overall Study|Protocol Violation|1|||
157111961|NCT02257372|567165062|FG000|Overall Study|Lost to Follow-up|0|||
157111962|NCT02257372|567165063|FG001|Overall Study|Lost to Follow-up|1|||
157111963|NCT02257372|567165062|FG000|Overall Study|Withdrew consent|1|||
157111964|NCT02257372|567165063|FG001|Overall Study|Withdrew consent|0|||
157111965|NCT02187172|567165065|FG000|Overall Study|Lost to Follow-up|1|||
156808568|NCT01070979|566052717|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
156768552|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768553|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
156768554|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
156768555|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768556|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768557|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768558|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
156768559|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768560|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
156768561|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768562|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768563|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
156768564|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
156768565|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768566|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768567|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768568|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
156768569|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768570|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
156768571|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768572|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768573|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
156768574|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
156768575|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768576|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768577|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768578|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
156768579|NCT02717195|565908512|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
156768580|NCT02717195|565908513|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768581|NCT02717195|565908514|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768582|NCT02717195|565908515|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768583|NCT02717195|565908516|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
156768584|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
156768585|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
156768586|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
156768587|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
156768588|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
156768589|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
156768590|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
156768591|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
156768592|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
156768593|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
156768594|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
156768595|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
156768596|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
156768597|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
156768598|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
156768599|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768600|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768601|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
156768602|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
156768603|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
156768604|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
156768605|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
157006694|NCT04707313|566773333|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006695|NCT04707313|566773334|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006696|NCT04707313|566773335|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006697|NCT04707313|566773336|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006698|NCT04707313|566773337|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157111966|NCT02187172|567165066|FG001|Overall Study|Lost to Follow-up|2|||
157006699|NCT04707313|566773338|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
157006700|NCT04707313|566773339|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
157006701|NCT04707313|566773340|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
157111967|NCT02187172|567165065|FG000|Overall Study|Lack of Efficacy|1|||
157111968|NCT02187172|567165066|FG001|Overall Study|Lack of Efficacy|2|||
157111969|NCT02187172|567165065|FG000|Overall Study|Adverse Event|0|||
157111970|NCT02187172|567165066|FG001|Overall Study|Adverse Event|1|||
157111971|NCT02187172|567165065|FG000|Overall Study|Physician Decision|1|||
157111972|NCT02187172|567165066|FG001|Overall Study|Physician Decision|1|||
157111973|NCT00880399|567165067|FG000|Overall Study|Adverse Event|4|||
157111974|NCT00880399|567165068|FG001|Overall Study|Adverse Event|6|||
157111975|NCT00880399|567165069|FG002|Overall Study|Adverse Event|5|||
157111976|NCT00880399|567165067|FG000|Overall Study|Lack of Efficacy|1|||
157111977|NCT00880399|567165068|FG001|Overall Study|Lack of Efficacy|4|||
157111978|NCT00880399|567165069|FG002|Overall Study|Lack of Efficacy|2|||
157111979|NCT00880399|567165067|FG000|Overall Study|Protocol Violation|4|||
157111980|NCT00880399|567165068|FG001|Overall Study|Protocol Violation|4|||
157111981|NCT00880399|567165069|FG002|Overall Study|Protocol Violation|6|||
157111982|NCT00880399|567165067|FG000|Overall Study|Study closed/terminated|3|||
157111983|NCT00880399|567165068|FG001|Overall Study|Study closed/terminated|7|||
157111984|NCT00880399|567165069|FG002|Overall Study|Study closed/terminated|4|||
157111985|NCT00880399|567165067|FG000|Overall Study|Lost to Follow-up|8|||
157111986|NCT00880399|567165068|FG001|Overall Study|Lost to Follow-up|5|||
157111987|NCT00880399|567165069|FG002|Overall Study|Lost to Follow-up|3|||
157111988|NCT00880399|567165067|FG000|Overall Study|Physician Decision|5|||
157111989|NCT00880399|567165068|FG001|Overall Study|Physician Decision|0|||
157111990|NCT00880399|567165069|FG002|Overall Study|Physician Decision|3|||
157111991|NCT00880399|567165067|FG000|Overall Study|Withdrawal by Subject|6|||
157111992|NCT00880399|567165068|FG001|Overall Study|Withdrawal by Subject|3|||
157111993|NCT00880399|567165069|FG002|Overall Study|Withdrawal by Subject|3|||
157111994|NCT02969187|567165081|FG000|Overall Study|Physician Decision|12|||
157111995|NCT02969187|567165082|FG001|Overall Study|Physician Decision|13|||
157111996|NCT00766532|567165083|FG000|Overall Study|Protocol Violation|2|||
157111997|NCT01372384|567165086|FG000|Overall Study|Progression of disease|3|||
157111998|NCT02576444|567165093|FG000|Overall Study|Death|1|||
157111999|NCT02576444|567165094|FG001|Overall Study|Death|1|||
157112000|NCT02576444|567165095|FG002|Overall Study|Death|0|||
157112001|NCT02576444|567165096|FG003|Overall Study|Death|0|||
157112002|NCT02576444|567165093|FG000|Overall Study|Withdrawal by Subject|0|||
157112003|NCT02576444|567165094|FG001|Overall Study|Withdrawal by Subject|0|||
157112004|NCT02576444|567165095|FG002|Overall Study|Withdrawal by Subject|2|||
156768606|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
156768607|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
156768608|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
157112005|NCT02576444|567165096|FG003|Overall Study|Withdrawal by Subject|0|||
157112006|NCT02576444|567165093|FG000|Overall Study|Adverse Event|0|||
157112007|NCT02576444|567165094|FG001|Overall Study|Adverse Event|0|||
157112008|NCT02576444|567165095|FG002|Overall Study|Adverse Event|1|||
157112009|NCT02576444|567165096|FG003|Overall Study|Adverse Event|0|||
157112010|NCT02576444|567165093|FG000|Overall Study|Physician Decision|0|||
157112011|NCT02576444|567165094|FG001|Overall Study|Physician Decision|0|||
157112012|NCT02576444|567165095|FG002|Overall Study|Physician Decision|1|||
157112013|NCT02576444|567165096|FG003|Overall Study|Physician Decision|0|||
157112014|NCT02700412|567165104|FG000|Overall Study|Adverse Event|6|||
157112015|NCT02700412|567165104|FG000|Overall Study|Death|1|||
157112016|NCT02700412|567165104|FG000|Overall Study|Lack of Efficacy|19|||
157112017|NCT02700412|567165104|FG000|Overall Study|Protocol Violation|5|||
157112018|NCT02700412|567165104|FG000|Overall Study|Withdrawal by Subject|2|||
157112019|NCT00530270|567165109|FG000|Overall Study|Protocol Violation|1|||
157112020|NCT00530270|567165110|FG001|Overall Study|Protocol Violation|0|||
157112021|NCT01923285|567165119|FG000|Overall Study|Withdrawal by Subject|7|||
157112022|NCT01923285|567165120|FG001|Overall Study|Withdrawal by Subject|6|||
157112023|NCT02375724|567165122|FG000|Overall Study|Lack of Efficacy|1|||
157112024|NCT02375724|567165123|FG001|Overall Study|Lack of Efficacy|1|||
157112025|NCT02375724|567165122|FG000|Overall Study|Withdrawal by Subject|1|||
157112026|NCT02375724|567165123|FG001|Overall Study|Withdrawal by Subject|1|||
157112027|NCT02375724|567165122|FG000|Overall Study|Lost to Follow-up|1|||
157112028|NCT02375724|567165123|FG001|Overall Study|Lost to Follow-up|0|||
157112029|NCT02375724|567165122|FG000|Overall Study|Protocol Violation|1|||
157112030|NCT02375724|567165123|FG001|Overall Study|Protocol Violation|0|||
157112031|NCT02375724|567165122|FG000|Overall Study|Adverse Event|2|||
156768609|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
157112032|NCT02375724|567165123|FG001|Overall Study|Adverse Event|4|||
157112033|NCT04712110|567165126|FG000|Overall Study|Lost to Follow-up|0|||
157112034|NCT04712110|567165127|FG001|Overall Study|Lost to Follow-up|1|||
157112035|NCT04712110|567165126|FG000|Overall Study|Withdrawal by Subject|0|||
157112036|NCT04712110|567165127|FG001|Overall Study|Withdrawal by Subject|4|||
157112037|NCT04712110|567165126|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
157112038|NCT04712110|567165127|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
157112039|NCT01197521|567165128|FG000|Overall Study|Not reported|24|||
157112040|NCT01197521|567165129|FG001|Overall Study|Not reported|25|||
157112041|NCT01197521|567165130|FG002|Overall Study|Not reported|21|||
157112042|NCT01197521|567165128|FG000|Overall Study|Enrolment in long term extension|42|||
156768610|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
156768611|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
156768612|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
156768613|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
156768614|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768615|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768616|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
156768617|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768618|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
156768619|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768620|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768621|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
156768622|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
156768623|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
156768624|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768625|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768626|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
156768627|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
156768628|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
156768629|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768630|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768631|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768632|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
156768633|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
156768634|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768635|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768636|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
156768637|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
156768638|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
156768639|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768640|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
157006702|NCT04707313|566773341|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
157006703|NCT04707313|566773342|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
157006704|NCT02459899|566773343|FG000|Overall Study|Adverse Event|1|||
157006705|NCT02459899|566773344|FG001|Overall Study|Adverse Event|1|||
157006706|NCT02459899|566773345|FG002|Overall Study|Adverse Event|0|||
157006707|NCT02459899|566773346|FG003|Overall Study|Adverse Event|0|||
157006708|NCT02459899|566773343|FG000|Overall Study|Lost to Follow-up|1|||
157006709|NCT02459899|566773344|FG001|Overall Study|Lost to Follow-up|2|||
157006710|NCT02459899|566773345|FG002|Overall Study|Lost to Follow-up|0|||
157006711|NCT02459899|566773346|FG003|Overall Study|Lost to Follow-up|1|||
157006712|NCT02459899|566773343|FG000|Overall Study|Non-compliance with the treatment|0|||
157006713|NCT02459899|566773344|FG001|Overall Study|Non-compliance with the treatment|0|||
157006714|NCT02459899|566773345|FG002|Overall Study|Non-compliance with the treatment|0|||
157006715|NCT02459899|566773346|FG003|Overall Study|Non-compliance with the treatment|1|||
157006716|NCT02459899|566773343|FG000|Overall Study|Withdrawal by Subject|1|||
157006717|NCT02459899|566773344|FG001|Overall Study|Withdrawal by Subject|3|||
157006718|NCT02459899|566773345|FG002|Overall Study|Withdrawal by Subject|0|||
157006719|NCT02459899|566773346|FG003|Overall Study|Withdrawal by Subject|0|||
157006720|NCT02739035|566773349|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
157006721|NCT02739035|566773350|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
157006722|NCT02739035|566773349|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
157006723|NCT02739035|566773350|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
157006724|NCT02739035|566773349|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
157006725|NCT02739035|566773350|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
157006726|NCT02739035|566773349|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
157006727|NCT02739035|566773350|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
157006728|NCT00843882|566773358|FG000|Step 1|Lack of Efficacy|14|||
157006729|NCT00843882|566773359|FG001|Step 1|Lack of Efficacy|10|||
157006730|NCT00843882|566773360|FG002|Step 1|Lack of Efficacy|21|||
157006731|NCT00843882|566773358|FG000|Step 1|Adverse Event|8|||
157006732|NCT00843882|566773359|FG001|Step 1|Adverse Event|17|||
157006733|NCT00843882|566773360|FG002|Step 1|Adverse Event|20|||
157006734|NCT00843882|566773358|FG000|Step 1|Death|1|||
157006735|NCT00843882|566773359|FG001|Step 1|Death|2|||
157006736|NCT00843882|566773360|FG002|Step 1|Death|4|||
157006737|NCT00843882|566773358|FG000|Step 1|Withdrawal by Subject|6|||
157006738|NCT00843882|566773359|FG001|Step 1|Withdrawal by Subject|12|||
157006739|NCT00843882|566773360|FG002|Step 1|Withdrawal by Subject|9|||
157006740|NCT00843882|566773358|FG000|Step 1|Physician Decision|0|||
157112043|NCT01197521|567165129|FG001|Overall Study|Enrolment in long term extension|36|||
157006741|NCT00843882|566773359|FG001|Step 1|Physician Decision|5|||
157112044|NCT01197521|567165130|FG002|Overall Study|Enrolment in long term extension|87|||
157112045|NCT01197521|567165128|FG000|Overall Study|Severe non-compliance to protocol|1|||
157112046|NCT01197521|567165129|FG001|Overall Study|Severe non-compliance to protocol|3|||
157112047|NCT01197521|567165130|FG002|Overall Study|Severe non-compliance to protocol|3|||
157112048|NCT01197521|567165128|FG000|Overall Study|Lack of therapeutic response|2|||
157112049|NCT01197521|567165129|FG001|Overall Study|Lack of therapeutic response|3|||
157112050|NCT01197521|567165130|FG002|Overall Study|Lack of therapeutic response|4|||
157112051|NCT01197521|567165128|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
157112052|NCT01197521|567165129|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
157112053|NCT01197521|567165130|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
157112054|NCT01197521|567165128|FG000|Overall Study|Lost to Follow-up|3|||
157112055|NCT01197521|567165129|FG001|Overall Study|Lost to Follow-up|2|||
157112056|NCT01197521|567165130|FG002|Overall Study|Lost to Follow-up|2|||
157112057|NCT01197521|567165128|FG000|Overall Study|Adverse Event|25|||
157112058|NCT01197521|567165129|FG001|Overall Study|Adverse Event|28|||
157112059|NCT01197521|567165130|FG002|Overall Study|Adverse Event|24|||
157112060|NCT01309659|567165131|FG000|Overall Study|Protocol Violation|0|||
157112061|NCT01309659|567165132|FG001|Overall Study|Protocol Violation|1|||
157112062|NCT02285777|567165133|FG000|Overall Study|Withdrawal by Subject|1|||
157112063|NCT02285777|567165134|FG001|Overall Study|Withdrawal by Subject|1|||
157112064|NCT02285777|567165133|FG000|Overall Study|Lost to Follow-up|4|||
157112065|NCT02285777|567165134|FG001|Overall Study|Lost to Follow-up|2|||
157112066|NCT02184195|567165136|FG000|Overall Study|Patient decision|5|||
157112067|NCT02184195|567165137|FG001|Overall Study|Patient decision|2|||
157112068|NCT02184195|567165136|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157112069|NCT02184195|567165137|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
157112070|NCT02184195|567165136|FG000|Overall Study|Death|67|||
157112071|NCT02184195|567165137|FG001|Overall Study|Death|44|||
157112072|NCT02184195|567165136|FG000|Overall Study|Lost to Follow-up|1|||
157112073|NCT02184195|567165137|FG001|Overall Study|Lost to Follow-up|5|||
157112074|NCT02184195|567165136|FG000|Overall Study|Other|0|||
157112075|NCT02184195|567165137|FG001|Overall Study|Other|3|||
157112076|NCT00916149|567165138|FG000|Overall Study|Lost to Follow-up|3|||
157112077|NCT00916149|567165139|FG001|Overall Study|Lost to Follow-up|2|||
157112078|NCT00916149|567165140|FG002|Overall Study|Lost to Follow-up|0|||
157112079|NCT00916149|567165138|FG000|Overall Study|Unable to place scalp EEG leads|1|||
157112080|NCT00916149|567165139|FG001|Overall Study|Unable to place scalp EEG leads|0|||
157112081|NCT00916149|567165140|FG002|Overall Study|Unable to place scalp EEG leads|0|||
157112082|NCT00912028|567165143|FG000|Overall Study|Lost to Follow-up|2|||
157112083|NCT00912028|567165144|FG001|Overall Study|Lost to Follow-up|3|||
157112084|NCT00912028|567165145|FG002|Overall Study|Lost to Follow-up|0|||
157112085|NCT00912028|567165146|FG003|Overall Study|Lost to Follow-up|1|||
157112086|NCT00912028|567165147|FG004|Overall Study|Lost to Follow-up|3|||
157112087|NCT00912028|567165143|FG000|Overall Study|Withdrawal by Subject|3|||
157112088|NCT00912028|567165144|FG001|Overall Study|Withdrawal by Subject|0|||
157112089|NCT00912028|567165145|FG002|Overall Study|Withdrawal by Subject|0|||
157112090|NCT00912028|567165146|FG003|Overall Study|Withdrawal by Subject|0|||
157112091|NCT00912028|567165147|FG004|Overall Study|Withdrawal by Subject|0|||
157112092|NCT00978029|567165148|FG000|Overall Study|Adverse Event|1|||
157112093|NCT00978029|567165149|FG001|Overall Study|Adverse Event|2|||
157112094|NCT00978029|567165150|FG002|Overall Study|Adverse Event|5|||
157112095|NCT00978029|567165148|FG000|Overall Study|Withdrawal by Subject|0|||
157112096|NCT00978029|567165149|FG001|Overall Study|Withdrawal by Subject|0|||
157112097|NCT00978029|567165150|FG002|Overall Study|Withdrawal by Subject|1|||
157112098|NCT00978029|567165148|FG000|Overall Study|Protocol Violation|0|||
157112099|NCT00978029|567165149|FG001|Overall Study|Protocol Violation|1|||
157112100|NCT00978029|567165150|FG002|Overall Study|Protocol Violation|0|||
157112101|NCT00545298|567165151|FG000|Overall Study|Issues with Standard of Care|2|||
157112102|NCT00545298|567165152|FG001|Overall Study|Issues with Standard of Care|0|||
157112103|NCT00545298|567165153|FG002|Overall Study|Issues with Standard of Care|1|||
157112104|NCT01820364|567165154|FG000|Part I: LGX818|Death|1|||
156768641|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768642|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
156768643|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
157112105|NCT01820364|567165155|FG001|Part I: LGX818|Death|0|||
157112106|NCT01820364|567165154|FG000|Part I: LGX818|Administrative Problems|3|||
157112107|NCT01820364|567165155|FG001|Part I: LGX818|Administrative Problems|0|||
157112108|NCT01820364|567165154|FG000|Part I: LGX818|Adverse Event|6|||
157112109|NCT01820364|567165155|FG001|Part I: LGX818|Adverse Event|0|||
157112110|NCT01820364|567165154|FG000|Part I: LGX818|Disease Progression|4|||
157112111|NCT01820364|567165155|FG001|Part I: LGX818|Disease Progression|0|||
157112112|NCT01820364|567165154|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
157112113|NCT01820364|567165155|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
157112114|NCT01793142|567165156|FG000|Overall Study|Randomized not treated|7|||
157112115|NCT04744207|567165157|FG000|Treatment|Withdrawal by Subject|2|||
157112116|NCT04744207|567165158|FG001|Treatment|Withdrawal by Subject|0|||
156768644|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768645|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768646|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
156768647|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768648|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
156768649|NCT02717195|565908512|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768650|NCT02717195|565908513|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768651|NCT02717195|565908514|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
156768652|NCT02717195|565908515|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
156768653|NCT02717195|565908516|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
156768654|NCT02577029|565908519|FG000|Overall Study|Adverse Event|1|||
156768655|NCT02577029|565908520|FG001|Overall Study|Adverse Event|0|||
156768656|NCT02577029|565908521|FG002|Overall Study|Adverse Event|2|||
156768657|NCT02577029|565908522|FG003|Overall Study|Adverse Event|0|||
156768658|NCT02577029|565908523|FG004|Overall Study|Adverse Event|1|||
156768659|NCT02577029|565908524|FG005|Overall Study|Adverse Event|0|||
156768660|NCT02577029|565908525|FG006|Overall Study|Adverse Event|0|||
156768661|NCT02577029|565908526|FG007|Overall Study|Adverse Event|0|||
156768662|NCT02577029|565908519|FG000|Overall Study|Withdrawal by Subject|0|||
156768663|NCT02577029|565908520|FG001|Overall Study|Withdrawal by Subject|0|||
156768664|NCT02577029|565908521|FG002|Overall Study|Withdrawal by Subject|0|||
156768665|NCT02577029|565908522|FG003|Overall Study|Withdrawal by Subject|0|||
156768666|NCT02577029|565908523|FG004|Overall Study|Withdrawal by Subject|0|||
156768667|NCT02577029|565908524|FG005|Overall Study|Withdrawal by Subject|1|||
156768668|NCT02577029|565908525|FG006|Overall Study|Withdrawal by Subject|0|||
156768669|NCT02577029|565908526|FG007|Overall Study|Withdrawal by Subject|0|||
156768670|NCT02577029|565908519|FG000|Overall Study|Sponsor Termination of the Study|9|||
156768671|NCT02577029|565908520|FG001|Overall Study|Sponsor Termination of the Study|2|||
156768672|NCT02577029|565908521|FG002|Overall Study|Sponsor Termination of the Study|5|||
156768673|NCT02577029|565908522|FG003|Overall Study|Sponsor Termination of the Study|12|||
156768674|NCT02577029|565908523|FG004|Overall Study|Sponsor Termination of the Study|10|||
156768675|NCT02577029|565908524|FG005|Overall Study|Sponsor Termination of the Study|12|||
156768676|NCT02577029|565908525|FG006|Overall Study|Sponsor Termination of the Study|12|||
156768677|NCT02577029|565908526|FG007|Overall Study|Sponsor Termination of the Study|12|||
156768678|NCT02078817|565908527|FG000|Overall Study|Withdrawal by Subject|1|||
156768679|NCT00769561|565908528|FG000|Overall Study|Withdrawal by Subject|2|||
156768680|NCT00769561|565908529|FG001|Overall Study|Withdrawal by Subject|2|||
156768681|NCT00769561|565908528|FG000|Overall Study|Lost to Follow-up|1|||
156768682|NCT00769561|565908529|FG001|Overall Study|Lost to Follow-up|3|||
156768683|NCT02370511|565908537|FG000|Overall Study|Death|10|||
156768684|NCT02370511|565908538|FG001|Overall Study|Death|7|||
156768685|NCT02370511|565908539|FG002|Overall Study|Death|1|||
157006742|NCT00843882|566773360|FG002|Step 1|Physician Decision|1|||
157006743|NCT00843882|566773358|FG000|Step 1|Patient and physician's decision|0|||
157006744|NCT00843882|566773359|FG001|Step 1|Patient and physician's decision|0|||
157006745|NCT00843882|566773360|FG002|Step 1|Patient and physician's decision|1|||
157006746|NCT00843882|566773358|FG000|Step 1|Other complicating disease|1|||
157006747|NCT00843882|566773359|FG001|Step 1|Other complicating disease|3|||
157006748|NCT00843882|566773360|FG002|Step 1|Other complicating disease|4|||
157006749|NCT00843882|566773358|FG000|Step 1|Alternative therapy|0|||
157006750|NCT00843882|566773359|FG001|Step 1|Alternative therapy|1|||
157006751|NCT00843882|566773360|FG002|Step 1|Alternative therapy|1|||
157006752|NCT00843882|566773358|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
157006753|NCT00843882|566773359|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
157006754|NCT00843882|566773360|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
157006755|NCT00843882|566773358|FG000|Step 1|Off treatment reason unknown|0|||
157006756|NCT00843882|566773359|FG001|Step 1|Off treatment reason unknown|1|||
157006757|NCT00843882|566773360|FG002|Step 1|Off treatment reason unknown|4|||
157006758|NCT00843882|566773358|FG000|Step 1|Never started treatment|2|||
157006759|NCT00843882|566773359|FG001|Step 1|Never started treatment|0|||
157006760|NCT00843882|566773360|FG002|Step 1|Never started treatment|0|||
157006761|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
157006762|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
157006763|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
157006764|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
157006765|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
157112117|NCT04744207|567165157|FG000|Treatment|Adverse Event|1|||
156768686|NCT02370511|565908537|FG000|Overall Study|Withdrawal by Subject|2|||
156768687|NCT02370511|565908538|FG001|Overall Study|Withdrawal by Subject|0|||
156768688|NCT02370511|565908539|FG002|Overall Study|Withdrawal by Subject|0|||
156768689|NCT02370511|565908537|FG000|Overall Study|Lost to Follow-up|0|||
156768690|NCT02370511|565908538|FG001|Overall Study|Lost to Follow-up|4|||
157006766|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
157112118|NCT04744207|567165158|FG001|Treatment|Adverse Event|2|||
157006767|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
157006768|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
157006769|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
157006770|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
157006771|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
157006772|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
157006773|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
157006774|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
157006775|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
157006776|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
157006777|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
157006778|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
157006779|NCT00843882|566773358|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
157006780|NCT00843882|566773359|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
157006781|NCT00843882|566773360|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
157006782|NCT02248480|566773361|FG000|Overall Study|Lack of Efficacy|4|||
157006783|NCT02248480|566773362|FG001|Overall Study|Lack of Efficacy|6|||
157006784|NCT02248480|566773361|FG000|Overall Study|Adverse Event|11|||
157006785|NCT02248480|566773362|FG001|Overall Study|Adverse Event|2|||
157006786|NCT02248480|566773361|FG000|Overall Study|Withdrawal by Subject|2|||
157006787|NCT02248480|566773362|FG001|Overall Study|Withdrawal by Subject|4|||
157006788|NCT02248480|566773361|FG000|Overall Study|Entry Criteria Not Met|0|||
157006789|NCT02248480|566773362|FG001|Overall Study|Entry Criteria Not Met|1|||
157006790|NCT02248480|566773361|FG000|Overall Study|Other:Physician Decision|0|||
157006791|NCT02248480|566773362|FG001|Overall Study|Other:Physician Decision|1|||
157006792|NCT00630786|566773363|FG000|Overall Study|Physician Decision|0|||
157006793|NCT00630786|566773364|FG001|Overall Study|Physician Decision|0|||
157006794|NCT00630786|566773365|FG002|Overall Study|Physician Decision|1|||
157006795|NCT00630786|566773363|FG000|Overall Study|Withdrawal by Subject|0|||
157006796|NCT00630786|566773364|FG001|Overall Study|Withdrawal by Subject|1|||
157006797|NCT00630786|566773365|FG002|Overall Study|Withdrawal by Subject|1|||
157006798|NCT00630786|566773363|FG000|Overall Study|Lost to Follow-up|0|||
157006799|NCT00630786|566773364|FG001|Overall Study|Lost to Follow-up|1|||
157006800|NCT00630786|566773365|FG002|Overall Study|Lost to Follow-up|0|||
157006801|NCT00630786|566773363|FG000|Overall Study|Other|1|||
157006802|NCT00630786|566773364|FG001|Overall Study|Other|0|||
157006803|NCT00630786|566773365|FG002|Overall Study|Other|0|||
157006804|NCT01582269|566773366|FG000|Overall Study|Withdrawal by Subject|1|||
157006805|NCT01582269|566773367|FG001|Overall Study|Withdrawal by Subject|0|||
157006806|NCT01582269|566773368|FG002|Overall Study|Withdrawal by Subject|0|||
157006807|NCT06218251|566773369|FG000|Overall Study|Lost to Follow-up|4|||
157006808|NCT03070483|566773372|FG000|Overall Study|Lost to Follow-up|2|||
157006809|NCT02031471|566773373|FG000|24 Week Treatment Period|Adverse Event|6|||
157006810|NCT02031471|566773373|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
157006811|NCT02031471|566773373|FG000|24 Week Treatment Period|Protocol Violation|1|||
157006812|NCT02031471|566773373|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
157006813|NCT02031471|566773373|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
157006814|NCT02031471|566773373|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
157006815|NCT02031471|566773373|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
157006816|NCT05797155|566773374|FG000|Overall Study|Lost to Follow-up|33|||
157006817|NCT05797155|566773375|FG001|Overall Study|Lost to Follow-up|12|||
157112119|NCT02230384|567165160|FG000|Phase 1|Lost to Follow-up|1|||
157112120|NCT02230384|567165161|FG001|Phase 1|Lost to Follow-up|0|||
157112121|NCT02230384|567165160|FG000|Phase 1|Physician Decision|0|||
157112122|NCT02230384|567165161|FG001|Phase 1|Physician Decision|1|||
157112123|NCT02230384|567165160|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
157112124|NCT02230384|567165161|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
157112125|NCT02230384|567165160|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
157112126|NCT02230384|567165161|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
157112127|NCT02230384|567165160|FG000|Phase 2 - Switch|Adverse Event|2|||
157112128|NCT02230384|567165161|FG001|Phase 2 - Switch|Adverse Event|0|||
157112129|NCT00961220|567165162|FG000|Overall Study|Adverse Event|3|||
157112130|NCT00961220|567165162|FG000|Overall Study|Lack of Efficacy|1|||
157112131|NCT00961220|567165162|FG000|Overall Study|No IV access for O6BG|1|||
157112132|NCT00961220|567165162|FG000|Overall Study|O6BG no longer supplied|1|||
157112133|NCT00961220|567165162|FG000|Overall Study|Complete Response prior to 12 courses|1|||
157112134|NCT00942175|567165163|FG000|Overall Study|Adverse Event|2|||
157112135|NCT00942175|567165164|FG001|Overall Study|Adverse Event|1|||
157112136|NCT00942175|567165165|FG002|Overall Study|Adverse Event|0|||
157112137|NCT00942175|567165166|FG003|Overall Study|Adverse Event|0|||
157112138|NCT00942175|567165163|FG000|Overall Study|Protocol Violation|0|||
157112139|NCT00942175|567165164|FG001|Overall Study|Protocol Violation|1|||
157112140|NCT00942175|567165165|FG002|Overall Study|Protocol Violation|2|||
157112141|NCT00942175|567165166|FG003|Overall Study|Protocol Violation|0|||
157112142|NCT00942175|567165163|FG000|Overall Study|Pregnancy|0|||
157112143|NCT00942175|567165164|FG001|Overall Study|Pregnancy|0|||
157112144|NCT00942175|567165165|FG002|Overall Study|Pregnancy|0|||
157112145|NCT00942175|567165166|FG003|Overall Study|Pregnancy|1|||
157112146|NCT00942175|567165163|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
157112147|NCT00942175|567165164|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
157112148|NCT00942175|567165165|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
157112149|NCT00942175|567165166|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
157112150|NCT00942175|567165163|FG000|Overall Study|Low Platelet Count|0|||
157112151|NCT00942175|567165164|FG001|Overall Study|Low Platelet Count|2|||
157112152|NCT00942175|567165165|FG002|Overall Study|Low Platelet Count|0|||
156768691|NCT02370511|565908539|FG002|Overall Study|Lost to Follow-up|0|||
156768692|NCT03092752|565908540|FG000|Overall Study|Aged <40 years|14209|||
156768693|NCT03092752|565908540|FG000|Overall Study|At least one claim with T2DM|61299|||
156768694|NCT03092752|565908540|FG000|Overall Study|Having no claim of study drugs|29282|||
156768695|NCT03092752|565908540|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
156768696|NCT03092752|565908540|FG000|Overall Study|<6 month history|245900|||
156768697|NCT03882918|565908543|FG000|Overall Study|Study terminated by sponsor|98|||
156768698|NCT03882918|565908543|FG000|Overall Study|Protocol Violation|1|||
156768699|NCT03882918|565908543|FG000|Overall Study|Other|9|||
156768700|NCT03882918|565908543|FG000|Overall Study|Lack of Efficacy|14|||
156768701|NCT03882918|565908543|FG000|Overall Study|Adverse Event|13|||
156768702|NCT03882918|565908543|FG000|Overall Study|Withdrawal by Subject|5|||
156768703|NCT01075048|565909979|FG000|Overall Study|Death|4|||
156768704|NCT01075048|565909980|FG001|Overall Study|Death|17|||
156768705|NCT01075048|565909981|FG002|Overall Study|Death|12|||
156768706|NCT01075048|565909979|FG000|Overall Study|Start of other or new therapy|4|||
156768707|NCT01075048|565909980|FG001|Overall Study|Start of other or new therapy|36|||
156768708|NCT01075048|565909981|FG002|Overall Study|Start of other or new therapy|46|||
156768709|NCT01075048|565909979|FG000|Overall Study|Withdrawal by Subject|1|||
156768710|NCT01075048|565909980|FG001|Overall Study|Withdrawal by Subject|6|||
156768711|NCT01075048|565909981|FG002|Overall Study|Withdrawal by Subject|3|||
156768712|NCT01075048|565909979|FG000|Overall Study|Lost to Follow-up|0|||
156768713|NCT01075048|565909980|FG001|Overall Study|Lost to Follow-up|1|||
156768714|NCT01075048|565909981|FG002|Overall Study|Lost to Follow-up|1|||
156768715|NCT01287936|565909986|FG000|Overall Study|Lost to Follow-up|0|||
157112153|NCT00942175|567165166|FG003|Overall Study|Low Platelet Count|0|||
157112154|NCT00825162|567165167|FG000|Overall Study|Withdrawal by Subject|11|||
157112155|NCT00825162|567165168|FG001|Overall Study|Withdrawal by Subject|13|||
157112156|NCT00825162|567165169|FG002|Overall Study|Withdrawal by Subject|3|||
157112157|NCT00825162|567165167|FG000|Overall Study|Lost to Follow-up|9|||
157112158|NCT00825162|567165168|FG001|Overall Study|Lost to Follow-up|6|||
157112159|NCT00825162|567165169|FG002|Overall Study|Lost to Follow-up|3|||
156768716|NCT01287936|565909987|FG001|Overall Study|Lost to Follow-up|1|||
156768717|NCT01287936|565909988|FG002|Overall Study|Lost to Follow-up|1|||
157112160|NCT00825162|567165167|FG000|Overall Study|Physician Decision|2|||
157112161|NCT00825162|567165168|FG001|Overall Study|Physician Decision|0|||
157112162|NCT00825162|567165169|FG002|Overall Study|Physician Decision|0|||
157112163|NCT00825162|567165167|FG000|Overall Study|Move away from the study area|1|||
156768718|NCT00296244|565909989|FG000|Overall Study|Underwent retransplant|0|||
156768719|NCT00296244|565909990|FG001|Overall Study|Underwent retransplant|1|||
156768720|NCT00427934|565909991|FG000|Overall Study|Adverse Event|1|||
156768721|NCT00427934|565909992|FG001|Overall Study|Adverse Event|0|||
156768722|NCT00427934|565909993|FG002|Overall Study|Adverse Event|5|||
156768723|NCT00427934|565909994|FG003|Overall Study|Adverse Event|4|||
157112164|NCT00825162|567165168|FG001|Overall Study|Move away from the study area|0|||
157112165|NCT00825162|567165169|FG002|Overall Study|Move away from the study area|0|||
157112166|NCT00825162|567165167|FG000|Overall Study|Unable to attend the study visit|5|||
157112167|NCT00825162|567165168|FG001|Overall Study|Unable to attend the study visit|2|||
157112168|NCT00825162|567165169|FG002|Overall Study|Unable to attend the study visit|0|||
157112169|NCT01279850|567165176|FG000|Overall Study|Protocol Violation|50|||
157112170|NCT01279850|567165176|FG000|Overall Study|No Drug Administration Information|7|||
157112171|NCT01279850|567165176|FG000|Overall Study|No Visit After Treatment|34|||
157112172|NCT00432042|567165184|FG000|Overall Study|Protocol Violation|2|||
157112173|NCT00432042|567165185|FG001|Overall Study|Protocol Violation|0|||
157112174|NCT00432042|567165186|FG002|Overall Study|Protocol Violation|0|||
157112175|NCT00432042|567165184|FG000|Overall Study|Withdrawal by Subject|0|||
157112176|NCT00432042|567165185|FG001|Overall Study|Withdrawal by Subject|0|||
157112177|NCT00432042|567165186|FG002|Overall Study|Withdrawal by Subject|2|||
157112178|NCT00432042|567165184|FG000|Overall Study|Lost to Follow-up|5|||
157112179|NCT00432042|567165185|FG001|Overall Study|Lost to Follow-up|1|||
157112180|NCT00432042|567165186|FG002|Overall Study|Lost to Follow-up|0|||
156768724|NCT00427934|565909991|FG000|Overall Study|Lack of Efficacy|0|||
156768725|NCT00427934|565909992|FG001|Overall Study|Lack of Efficacy|0|||
156768726|NCT00427934|565909993|FG002|Overall Study|Lack of Efficacy|5|||
156768727|NCT00427934|565909994|FG003|Overall Study|Lack of Efficacy|2|||
156768728|NCT00427934|565909991|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
156768729|NCT00427934|565909992|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
156768730|NCT00427934|565909993|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
156768731|NCT00427934|565909994|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
156768732|NCT00427934|565909991|FG000|Overall Study|Other|0|||
156768733|NCT00427934|565909992|FG001|Overall Study|Other|0|||
156768734|NCT00427934|565909993|FG002|Overall Study|Other|11|||
156768735|NCT00427934|565909994|FG003|Overall Study|Other|5|||
156768736|NCT00427934|565909991|FG000|Overall Study|Withdrawal by Subject|0|||
157112181|NCT05419128|567165189|FG000|Overall Study|Withdrawal by Subject|1|||
157112182|NCT05419128|567165190|FG001|Overall Study|Withdrawal by Subject|1|||
157112183|NCT05419128|567165191|FG002|Overall Study|Withdrawal by Subject|0|||
157112184|NCT05419128|567165192|FG003|Overall Study|Withdrawal by Subject|1|||
157112185|NCT05419128|567165193|FG004|Overall Study|Withdrawal by Subject|1|||
157112186|NCT05419128|567165194|FG005|Overall Study|Withdrawal by Subject|0|||
157112187|NCT05419128|567165189|FG000|Overall Study|Lost to Follow-up|0|||
157112188|NCT05419128|567165190|FG001|Overall Study|Lost to Follow-up|0|||
157112189|NCT05419128|567165191|FG002|Overall Study|Lost to Follow-up|1|||
157112190|NCT05419128|567165192|FG003|Overall Study|Lost to Follow-up|0|||
157112191|NCT05419128|567165193|FG004|Overall Study|Lost to Follow-up|0|||
157112192|NCT05419128|567165194|FG005|Overall Study|Lost to Follow-up|1|||
157112193|NCT00747643|567166625|FG000|Overall Study|Withdrawal by Subject|36|||
157112194|NCT00747643|567166626|FG001|Overall Study|Withdrawal by Subject|27|||
157112195|NCT01417195|567166629|FG000|Overall Study|Stimulation failure|1|||
157112196|NCT01417195|567166630|FG001|Overall Study|Stimulation failure|0|||
157112197|NCT01417195|567166629|FG000|Overall Study|No embryos for transfer|0|||
157112198|NCT01417195|567166630|FG001|Overall Study|No embryos for transfer|1|||
157112199|NCT01417195|567166629|FG000|Overall Study|No transfer due to risk of OHSS|1|||
157112200|NCT01417195|567166630|FG001|Overall Study|No transfer due to risk of OHSS|0|||
157112201|NCT01417195|567166629|FG000|Overall Study|No transfer due to elevated progesterone|1|||
157112202|NCT01417195|567166630|FG001|Overall Study|No transfer due to elevated progesterone|0|||
157112203|NCT01239342|567166631|FG000|Overall Study|Adverse Event|1|||
157112204|NCT01239342|567166632|FG001|Overall Study|Adverse Event|0|||
157112205|NCT01239342|567166631|FG000|Overall Study|Withdrawal by Subject|1|||
157112206|NCT01239342|567166632|FG001|Overall Study|Withdrawal by Subject|5|||
157112207|NCT01239342|567166631|FG000|Overall Study|Reason Unknown|1|||
157112208|NCT01239342|567166632|FG001|Overall Study|Reason Unknown|1|||
157112209|NCT02918864|567166633|FG000|Overall Study|Withdrawal by Subject|1|||
157112210|NCT02918864|567166634|FG001|Overall Study|Withdrawal by Subject|1|||
157112211|NCT02918864|567166633|FG000|Overall Study|Lost to Follow-up|3|||
157112212|NCT02918864|567166634|FG001|Overall Study|Lost to Follow-up|2|||
157112213|NCT04766021|567166635|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
156768737|NCT00427934|565909992|FG001|Overall Study|Withdrawal by Subject|0|||
156768738|NCT00427934|565909993|FG002|Overall Study|Withdrawal by Subject|1|||
156768739|NCT00427934|565909994|FG003|Overall Study|Withdrawal by Subject|3|||
156768740|NCT00761319|565909995|FG000|Overall Study|Protocol Violation|21|||
156768741|NCT00761319|565909996|FG001|Overall Study|Protocol Violation|14|||
156768742|NCT00761319|565909995|FG000|Overall Study|Adverse Event|11|||
156768743|NCT00761319|565909996|FG001|Overall Study|Adverse Event|7|||
156768744|NCT00761319|565909995|FG000|Overall Study|Withdrawal by Subject|8|||
157112214|NCT04766021|567166635|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
157112215|NCT01849874|567166642|FG000|Overall Study|Death|89|||
157112216|NCT01849874|567166643|FG001|Overall Study|Death|42|||
157112217|NCT01849874|567166642|FG000|Overall Study|Withdrawal by Subject|17|||
157112218|NCT01849874|567166643|FG001|Overall Study|Withdrawal by Subject|16|||
156768745|NCT00761319|565909996|FG001|Overall Study|Withdrawal by Subject|7|||
156768746|NCT00761319|565909995|FG000|Overall Study|Noncompliance|4|||
156768747|NCT00761319|565909996|FG001|Overall Study|Noncompliance|3|||
156768748|NCT00761319|565909995|FG000|Overall Study|Lost to Follow-up|1|||
156768749|NCT00761319|565909996|FG001|Overall Study|Lost to Follow-up|1|||
156768750|NCT00761319|565909995|FG000|Overall Study|Nonspecified|2|||
156768751|NCT00761319|565909996|FG001|Overall Study|Nonspecified|2|||
156768752|NCT00761319|565909995|FG000|Overall Study|Missing|1|||
156768753|NCT00761319|565909996|FG001|Overall Study|Missing|0|||
156768754|NCT03261401|565909999|FG000|Overall Study|Withdrawal by Subject|0|||
156768755|NCT03261401|565910000|FG001|Overall Study|Withdrawal by Subject|0|||
156768756|NCT03261401|565910001|FG002|Overall Study|Withdrawal by Subject|0|||
156768757|NCT03261401|565910002|FG003|Overall Study|Withdrawal by Subject|0|||
156768758|NCT03261401|565910003|FG004|Overall Study|Withdrawal by Subject|0|||
156768759|NCT03261401|565910004|FG005|Overall Study|Withdrawal by Subject|1|||
156768760|NCT03261401|565910005|FG006|Overall Study|Withdrawal by Subject|0|||
156768761|NCT03261401|565910006|FG007|Overall Study|Withdrawal by Subject|0|||
156768762|NCT03261401|565910007|FG008|Overall Study|Withdrawal by Subject|0|||
156768763|NCT03261401|565910008|FG009|Overall Study|Withdrawal by Subject|0|||
156768764|NCT03261401|565910009|FG010|Overall Study|Withdrawal by Subject|0|||
156768765|NCT03261401|565910010|FG011|Overall Study|Withdrawal by Subject|0|||
156768766|NCT03261401|565910011|FG012|Overall Study|Withdrawal by Subject|0|||
156768767|NCT03261401|565909999|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
156768768|NCT03261401|565910000|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
156768769|NCT03261401|565910001|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
156768770|NCT03261401|565910002|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
156768771|NCT03261401|565910003|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
156768772|NCT03261401|565910004|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
156768773|NCT03261401|565910005|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
156768774|NCT03261401|565910006|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
156768775|NCT03261401|565910007|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
156768776|NCT03261401|565910008|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
156768777|NCT03261401|565910009|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
156768778|NCT03261401|565910010|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
156768779|NCT03261401|565910011|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
156768780|NCT00915525|565910015|FG000|Overall Study|Protocol Violation|9|||
156768781|NCT00915525|565910016|FG001|Overall Study|Protocol Violation|4|||
156768782|NCT00915525|565910015|FG000|Overall Study|Withdrawal by Subject|59|||
156768783|NCT00915525|565910016|FG001|Overall Study|Withdrawal by Subject|21|||
156768784|NCT00915525|565910015|FG000|Overall Study|Lost to Follow-up|27|||
156768785|NCT00915525|565910016|FG001|Overall Study|Lost to Follow-up|16|||
156768786|NCT00915525|565910015|FG000|Overall Study|Pregnancy|2|||
156768787|NCT00915525|565910016|FG001|Overall Study|Pregnancy|0|||
156768788|NCT00915525|565910015|FG000|Overall Study|Lack of Efficacy|15|||
156768789|NCT00915525|565910016|FG001|Overall Study|Lack of Efficacy|32|||
156768790|NCT00915525|565910015|FG000|Overall Study|Adverse Event|29|||
156768791|NCT00915525|565910016|FG001|Overall Study|Adverse Event|13|||
156768792|NCT00915525|565910015|FG000|Overall Study|Missing|12|||
156768793|NCT00915525|565910016|FG001|Overall Study|Missing|1|||
157112219|NCT01849874|567166642|FG000|Overall Study|Lost to Follow-up|3|||
156768794|NCT00915525|565910015|FG000|Overall Study|Other Reason|35|||
156768795|NCT00915525|565910016|FG001|Overall Study|Other Reason|12|||
156768796|NCT00915525|565910015|FG000|Overall Study|Site Closed|27|||
156768797|NCT00915525|565910016|FG001|Overall Study|Site Closed|9|||
157112220|NCT01849874|567166643|FG001|Overall Study|Lost to Follow-up|2|||
157112221|NCT01849874|567166642|FG000|Overall Study|Study Termination By Sponsor|93|||
157112222|NCT01849874|567166643|FG001|Overall Study|Study Termination By Sponsor|48|||
157112223|NCT01849874|567166642|FG000|Overall Study|Completed as per protocol amendment 6|3|||
157112224|NCT01849874|567166643|FG001|Overall Study|Completed as per protocol amendment 6|0|||
157112225|NCT01849874|567166642|FG000|Overall Study|Physician Decision|7|||
157112226|NCT01849874|567166643|FG001|Overall Study|Physician Decision|1|||
157112227|NCT01849874|567166642|FG000|Overall Study|Other|16|||
157112228|NCT01849874|567166643|FG001|Overall Study|Other|4|||
157112229|NCT02104583|567166644|FG000|Overall Study|New ICD or CRT-D implanted|2|||
156768798|NCT00915525|565910015|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
156768799|NCT00915525|565910016|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
156768800|NCT00915525|565910015|FG000|Overall Study|Study Burden|28|||
156768801|NCT00915525|565910016|FG001|Overall Study|Study Burden|12|||
156768802|NCT00915525|565910015|FG000|Overall Study|Non-Compliance|3|||
156768803|NCT00915525|565910016|FG001|Overall Study|Non-Compliance|1|||
156768804|NCT00915525|565910015|FG000|Overall Study|Patient Moved|15|||
156768805|NCT00915525|565910016|FG001|Overall Study|Patient Moved|9|||
156768806|NCT00577408|565910017|FG000|Overall Study|Stopped attending study visits|9|||
157006818|NCT00617201|566773376|FG000|Overall Study|Lost to Follow-up|9|||
157006819|NCT00617201|566773377|FG001|Overall Study|Lost to Follow-up|13|||
157112230|NCT02104583|567166645|FG001|Overall Study|New ICD or CRT-D implanted|0|||
156768807|NCT00577408|565910018|FG001|Overall Study|Stopped attending study visits|11|||
156768808|NCT00577408|565910017|FG000|Overall Study|Continued opioid use|3|||
156768809|NCT00577408|565910018|FG001|Overall Study|Continued opioid use|2|||
156768810|NCT00577408|565910017|FG000|Overall Study|Non-compliance with study meds|0|||
156768811|NCT00577408|565910018|FG001|Overall Study|Non-compliance with study meds|3|||
156768812|NCT00577408|565910017|FG000|Overall Study|Refused Oral Naltrexone|0|||
156768813|NCT00577408|565910018|FG001|Overall Study|Refused Oral Naltrexone|1|||
156768814|NCT00577408|565910017|FG000|Overall Study|Moved out of state|0|||
156768815|NCT00577408|565910018|FG001|Overall Study|Moved out of state|1|||
156768816|NCT00577408|565910017|FG000|Overall Study|Scheduling Issues|0|||
156768817|NCT00577408|565910018|FG001|Overall Study|Scheduling Issues|3|||
156768818|NCT00577408|565910017|FG000|Overall Study|Death|0|||
156768819|NCT00577408|565910018|FG001|Overall Study|Death|1|||
156768820|NCT00577408|565910017|FG000|Overall Study|Psychiatric hospitalization|0|||
156768821|NCT00577408|565910018|FG001|Overall Study|Psychiatric hospitalization|1|||
156768822|NCT02765035|565910024|FG000|First Intervention (90 Days)|Adverse Event|1|||
156768823|NCT02765035|565910025|FG001|First Intervention (90 Days)|Adverse Event|1|||
156768824|NCT02765035|565910024|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
157006820|NCT01134562|566775021|FG000|Overall Study|Adverse Event|0|||
157006821|NCT01134562|566775022|FG001|Overall Study|Adverse Event|1|||
157006822|NCT01134562|566775023|FG002|Overall Study|Adverse Event|0|||
157006823|NCT01134562|566775024|FG003|Overall Study|Adverse Event|0|||
157006824|NCT01134562|566775025|FG004|Overall Study|Adverse Event|0|||
157006825|NCT02383472|566775026|FG000|Overall Study|Withdrawal by Subject|1|||
157006826|NCT02383472|566775027|FG001|Overall Study|Withdrawal by Subject|1|||
157006827|NCT00799396|566775028|FG000|Clopidogrel Treatment|Adverse Event|6|||
157006828|NCT00799396|566775028|FG000|Clopidogrel Treatment|Physician Decision|5|||
157006829|NCT00799396|566775028|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
157006830|NCT00799396|566775028|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
157006831|NCT00799396|566775028|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
157006832|NCT01307267|566775029|FG000|Overall Study|Death|4|||
157006833|NCT01307267|566775030|FG001|Overall Study|Death|3|||
157006834|NCT01307267|566775031|FG002|Overall Study|Death|5|||
157006835|NCT01307267|566775032|FG003|Overall Study|Death|3|||
157006836|NCT01307267|566775033|FG004|Overall Study|Death|1|||
157006837|NCT01307267|566775034|FG005|Overall Study|Death|26|||
157006838|NCT01307267|566775035|FG006|Overall Study|Death|2|||
157006839|NCT01307267|566775036|FG007|Overall Study|Death|2|||
157006840|NCT01307267|566775037|FG008|Overall Study|Death|21|||
157006841|NCT01307267|566775038|FG009|Overall Study|Death|2|||
157006842|NCT01307267|566775039|FG010|Overall Study|Death|3|||
157006843|NCT01307267|566775040|FG011|Overall Study|Death|9|||
157006844|NCT01307267|566775041|FG012|Overall Study|Death|0|||
157006845|NCT01307267|566775042|FG013|Overall Study|Death|0|||
157006846|NCT01307267|566775043|FG014|Overall Study|Death|0|||
157006847|NCT01307267|566775044|FG015|Overall Study|Death|0|||
157006848|NCT01307267|566775045|FG016|Overall Study|Death|1|||
157006849|NCT01307267|566775046|FG017|Overall Study|Death|1|||
157006850|NCT01307267|566775047|FG018|Overall Study|Death|2|||
157006851|NCT01307267|566775048|FG019|Overall Study|Death|8|||
157006852|NCT01307267|566775049|FG020|Overall Study|Death|1|||
157006853|NCT01307267|566775050|FG021|Overall Study|Death|2|||
157006854|NCT01307267|566775051|FG022|Overall Study|Death|2|||
157006855|NCT01307267|566775029|FG000|Overall Study|Lost to Follow-up|0|||
157006856|NCT01307267|566775030|FG001|Overall Study|Lost to Follow-up|0|||
157006857|NCT01307267|566775031|FG002|Overall Study|Lost to Follow-up|0|||
157006858|NCT01307267|566775032|FG003|Overall Study|Lost to Follow-up|0|||
157006859|NCT01307267|566775033|FG004|Overall Study|Lost to Follow-up|0|||
157006860|NCT01307267|566775034|FG005|Overall Study|Lost to Follow-up|7|||
157006861|NCT01307267|566775035|FG006|Overall Study|Lost to Follow-up|0|||
157006862|NCT01307267|566775036|FG007|Overall Study|Lost to Follow-up|0|||
157006863|NCT01307267|566775037|FG008|Overall Study|Lost to Follow-up|1|||
157006864|NCT01307267|566775038|FG009|Overall Study|Lost to Follow-up|2|||
157006865|NCT01307267|566775039|FG010|Overall Study|Lost to Follow-up|1|||
157006866|NCT01307267|566775040|FG011|Overall Study|Lost to Follow-up|0|||
157006867|NCT01307267|566775041|FG012|Overall Study|Lost to Follow-up|0|||
157006868|NCT01307267|566775042|FG013|Overall Study|Lost to Follow-up|0|||
157006869|NCT01307267|566775043|FG014|Overall Study|Lost to Follow-up|0|||
157006870|NCT01307267|566775044|FG015|Overall Study|Lost to Follow-up|0|||
157006871|NCT01307267|566775045|FG016|Overall Study|Lost to Follow-up|0|||
157112231|NCT02104583|567166646|FG002|Overall Study|New ICD or CRT-D implanted|1|||
157006872|NCT01307267|566775046|FG017|Overall Study|Lost to Follow-up|0|||
157112232|NCT02104583|567166647|FG003|Overall Study|New ICD or CRT-D implanted|0|||
156768825|NCT02765035|565910025|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
156768826|NCT02732639|565910031|FG000|Overall Study|Lost to Follow-up|1|||
156768827|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
156768828|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
157006873|NCT01307267|566775047|FG018|Overall Study|Lost to Follow-up|0|||
157006874|NCT01307267|566775048|FG019|Overall Study|Lost to Follow-up|2|||
157006875|NCT01307267|566775049|FG020|Overall Study|Lost to Follow-up|0|||
156768829|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
156768830|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
156768831|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
156768832|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768833|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768834|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
156768835|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
156768836|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
156768837|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
156768838|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
156768839|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
156768840|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768841|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768842|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
156768843|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
156768844|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
156768845|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
156768846|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
156768847|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
156768848|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768849|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768850|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
156768851|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
156768852|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768853|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768854|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
156768855|NCT01668797|565910032|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
156768856|NCT01668797|565910033|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768857|NCT01668797|565910034|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768858|NCT01668797|565910035|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
156768859|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768860|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
156768861|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768862|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
156768863|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768864|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
156768865|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768866|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
156768867|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
156768868|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
156768869|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
156768870|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
156768871|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768872|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
156768873|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768874|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
156768875|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768876|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
156768877|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768878|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
156768879|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768880|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
156768881|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768882|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
156768883|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768884|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
156768885|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768886|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
156768887|NCT01668797|565910032|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
156768888|NCT01668797|565910033|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
157006876|NCT01307267|566775050|FG021|Overall Study|Lost to Follow-up|0|||
157006877|NCT01307267|566775051|FG022|Overall Study|Lost to Follow-up|0|||
157006878|NCT01307267|566775029|FG000|Overall Study|Withdrawal by Subject|0|||
157006879|NCT01307267|566775030|FG001|Overall Study|Withdrawal by Subject|0|||
156768889|NCT01668797|565910034|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
157006880|NCT01307267|566775031|FG002|Overall Study|Withdrawal by Subject|0|||
157006881|NCT01307267|566775032|FG003|Overall Study|Withdrawal by Subject|0|||
156768890|NCT01668797|565910035|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
156768891|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
156768892|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
156768893|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
156768894|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
156768895|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
156768896|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
156768897|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
156768898|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
156768899|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
156768900|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
156768901|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
156768902|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
156768903|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
156768904|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
156768905|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
156768906|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
157112233|NCT02104583|567166648|FG004|Overall Study|New ICD or CRT-D implanted|0|||
157112234|NCT02104583|567166644|FG000|Overall Study|Death|2|||
157112235|NCT02104583|567166645|FG001|Overall Study|Death|1|||
156768907|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768908|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768909|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
156768910|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
156768911|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
156768912|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
156768913|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
156768914|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
156768915|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
156768916|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
156768917|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
156768918|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
156768919|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
156768920|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
156768921|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
156768922|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
156768923|NCT01668797|565910032|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
156768924|NCT01668797|565910033|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
156768925|NCT01668797|565910034|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
156768926|NCT01668797|565910035|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
156768927|NCT00827567|565910036|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
156768928|NCT01259245|565910039|FG000|Overall Study|Withdrawal by Subject|27|||
156768929|NCT01259245|565910040|FG001|Overall Study|Withdrawal by Subject|24|||
156768930|NCT01259245|565910039|FG000|Overall Study|Death|1|||
156768931|NCT01259245|565910040|FG001|Overall Study|Death|2|||
156768932|NCT00296335|565910048|FG000|Overall Study|Recurrence|3|||
156768933|NCT00296335|565910049|FG001|Overall Study|Recurrence|51|||
156768934|NCT00296335|565910048|FG000|Overall Study|Adverse Event|17|||
156768935|NCT00296335|565910049|FG001|Overall Study|Adverse Event|27|||
156768936|NCT00296335|565910048|FG000|Overall Study|Lost to Follow-up|7|||
156768937|NCT00296335|565910049|FG001|Overall Study|Lost to Follow-up|33|||
156768938|NCT00296335|565910048|FG000|Overall Study|Physician Decision|3|||
156768939|NCT00296335|565910049|FG001|Overall Study|Physician Decision|11|||
156768940|NCT03895086|565910056|FG000|Overall Study|Early termination study|1|||
156768941|NCT03895086|565910057|FG001|Overall Study|Early termination study|0|||
156768942|NCT04656652|565910058|FG000|Overall Study|Lost to Follow-up|2|||
157112236|NCT02104583|567166646|FG002|Overall Study|Death|3|||
157112237|NCT02104583|567166647|FG003|Overall Study|Death|3|||
157112238|NCT02104583|567166648|FG004|Overall Study|Death|5|||
157112239|NCT02104583|567166644|FG000|Overall Study|Subject required cardiac ablation|6|||
157112240|NCT02104583|567166645|FG001|Overall Study|Subject required cardiac ablation|4|||
156768943|NCT04656652|565910059|FG001|Overall Study|Lost to Follow-up|2|||
156768944|NCT04656652|565910058|FG000|Overall Study|Death|213|||
157112241|NCT02104583|567166646|FG002|Overall Study|Subject required cardiac ablation|4|||
156768945|NCT04656652|565910059|FG001|Overall Study|Death|212|||
156768946|NCT04656652|565910058|FG000|Overall Study|Other|1|||
156768947|NCT04656652|565910059|FG001|Overall Study|Other|0|||
157112242|NCT02104583|567166647|FG003|Overall Study|Subject required cardiac ablation|5|||
157112243|NCT02104583|567166648|FG004|Overall Study|Subject required cardiac ablation|4|||
156768948|NCT04656652|565910058|FG000|Overall Study|Withdrawal by Subject|15|||
156768949|NCT04656652|565910059|FG001|Overall Study|Withdrawal by Subject|29|||
156768950|NCT01192815|565910060|FG000|Overall Study|Withdrawal by Subject|1|||
157006882|NCT01307267|566775033|FG004|Overall Study|Withdrawal by Subject|0|||
157006883|NCT01307267|566775034|FG005|Overall Study|Withdrawal by Subject|1|||
157006884|NCT01307267|566775035|FG006|Overall Study|Withdrawal by Subject|0|||
157006885|NCT01307267|566775036|FG007|Overall Study|Withdrawal by Subject|1|||
157006886|NCT01307267|566775037|FG008|Overall Study|Withdrawal by Subject|5|||
157006887|NCT01307267|566775038|FG009|Overall Study|Withdrawal by Subject|1|||
157006888|NCT01307267|566775039|FG010|Overall Study|Withdrawal by Subject|1|||
157006889|NCT01307267|566775040|FG011|Overall Study|Withdrawal by Subject|1|||
157006890|NCT01307267|566775041|FG012|Overall Study|Withdrawal by Subject|0|||
157006891|NCT01307267|566775042|FG013|Overall Study|Withdrawal by Subject|0|||
157006892|NCT01307267|566775043|FG014|Overall Study|Withdrawal by Subject|0|||
157006893|NCT01307267|566775044|FG015|Overall Study|Withdrawal by Subject|0|||
157006894|NCT01307267|566775045|FG016|Overall Study|Withdrawal by Subject|0|||
157006895|NCT01307267|566775046|FG017|Overall Study|Withdrawal by Subject|0|||
157006896|NCT01307267|566775047|FG018|Overall Study|Withdrawal by Subject|0|||
157006897|NCT01307267|566775048|FG019|Overall Study|Withdrawal by Subject|3|||
157006898|NCT01307267|566775049|FG020|Overall Study|Withdrawal by Subject|0|||
157006899|NCT01307267|566775050|FG021|Overall Study|Withdrawal by Subject|0|||
157006900|NCT01307267|566775051|FG022|Overall Study|Withdrawal by Subject|0|||
157006901|NCT01307267|566775029|FG000|Overall Study|Other|0|||
157006902|NCT01307267|566775030|FG001|Overall Study|Other|0|||
157006903|NCT01307267|566775031|FG002|Overall Study|Other|0|||
157006904|NCT01307267|566775032|FG003|Overall Study|Other|0|||
157006905|NCT01307267|566775033|FG004|Overall Study|Other|0|||
157006906|NCT01307267|566775034|FG005|Overall Study|Other|7|||
157006907|NCT01307267|566775035|FG006|Overall Study|Other|0|||
157006908|NCT01307267|566775036|FG007|Overall Study|Other|1|||
157006909|NCT01307267|566775037|FG008|Overall Study|Other|3|||
157006910|NCT01307267|566775038|FG009|Overall Study|Other|0|||
157006911|NCT01307267|566775039|FG010|Overall Study|Other|1|||
157006912|NCT01307267|566775040|FG011|Overall Study|Other|1|||
157006913|NCT01307267|566775041|FG012|Overall Study|Other|1|||
157006914|NCT01307267|566775042|FG013|Overall Study|Other|0|||
157006915|NCT01307267|566775043|FG014|Overall Study|Other|2|||
157006916|NCT01307267|566775044|FG015|Overall Study|Other|1|||
157006917|NCT01307267|566775045|FG016|Overall Study|Other|0|||
157006918|NCT01307267|566775046|FG017|Overall Study|Other|0|||
157006919|NCT01307267|566775047|FG018|Overall Study|Other|0|||
157006920|NCT01307267|566775048|FG019|Overall Study|Other|19|||
157006921|NCT01307267|566775049|FG020|Overall Study|Other|2|||
157006922|NCT01307267|566775050|FG021|Overall Study|Other|3|||
157006923|NCT01307267|566775051|FG022|Overall Study|Other|2|||
157006924|NCT04956575|566775052|FG000|Overall Study|Death|1|||
157006925|NCT04956575|566775053|FG001|Overall Study|Death|0|||
157006926|NCT04956575|566775054|FG002|Overall Study|Death|0|||
157006927|NCT04956575|566775055|FG003|Overall Study|Death|0|||
157006928|NCT04956575|566775056|FG004|Overall Study|Death|0|||
157006929|NCT04956575|566775057|FG005|Overall Study|Death|0|||
157006930|NCT04956575|566775058|FG006|Overall Study|Death|0|||
157006931|NCT04956575|566775059|FG007|Overall Study|Death|1|||
157006932|NCT04956575|566775060|FG008|Overall Study|Death|0|||
157006933|NCT04956575|566775061|FG009|Overall Study|Death|1|||
157006934|NCT04956575|566775062|FG010|Overall Study|Death|0|||
157006935|NCT04956575|566775063|FG011|Overall Study|Death|0|||
157006936|NCT04956575|566775052|FG000|Overall Study|Lost to Follow-up|3|||
157006937|NCT04956575|566775053|FG001|Overall Study|Lost to Follow-up|4|||
157006938|NCT04956575|566775054|FG002|Overall Study|Lost to Follow-up|2|||
157006939|NCT04956575|566775055|FG003|Overall Study|Lost to Follow-up|3|||
157006940|NCT04956575|566775056|FG004|Overall Study|Lost to Follow-up|1|||
157006941|NCT04956575|566775057|FG005|Overall Study|Lost to Follow-up|10|||
157006942|NCT04956575|566775058|FG006|Overall Study|Lost to Follow-up|11|||
157006943|NCT04956575|566775059|FG007|Overall Study|Lost to Follow-up|7|||
157006944|NCT04956575|566775060|FG008|Overall Study|Lost to Follow-up|4|||
157112244|NCT02104583|567166644|FG000|Overall Study|Subject required prohibited medication|0|||
157006945|NCT04956575|566775061|FG009|Overall Study|Lost to Follow-up|2|||
157006946|NCT04956575|566775062|FG010|Overall Study|Lost to Follow-up|3|||
157006947|NCT04956575|566775063|FG011|Overall Study|Lost to Follow-up|8|||
157006948|NCT04956575|566775052|FG000|Overall Study|Withdrawal by Subject|1|||
157006949|NCT04956575|566775053|FG001|Overall Study|Withdrawal by Subject|2|||
156768951|NCT01192815|565910060|FG000|Overall Study|Lack of Efficacy|1|||
157006950|NCT04956575|566775054|FG002|Overall Study|Withdrawal by Subject|1|||
157006951|NCT04956575|566775055|FG003|Overall Study|Withdrawal by Subject|4|||
157006952|NCT04956575|566775056|FG004|Overall Study|Withdrawal by Subject|2|||
157006953|NCT04956575|566775057|FG005|Overall Study|Withdrawal by Subject|8|||
157006954|NCT04956575|566775058|FG006|Overall Study|Withdrawal by Subject|5|||
157006955|NCT04956575|566775059|FG007|Overall Study|Withdrawal by Subject|1|||
157006956|NCT04956575|566775060|FG008|Overall Study|Withdrawal by Subject|1|||
156768952|NCT03451045|565910061|FG000|Overall Study|Lack of Efficacy|3|||
156768953|NCT03451045|565910062|FG001|Overall Study|Lack of Efficacy|2|||
156768954|NCT03451045|565910063|FG002|Overall Study|Lack of Efficacy|2|||
156768955|NCT03451045|565910061|FG000|Overall Study|Physician Decision|1|||
156768956|NCT03451045|565910062|FG001|Overall Study|Physician Decision|1|||
156768957|NCT03451045|565910063|FG002|Overall Study|Physician Decision|1|||
156768958|NCT03451045|565910061|FG000|Overall Study|Withdrawal by Subject|4|||
156768959|NCT03451045|565910062|FG001|Overall Study|Withdrawal by Subject|0|||
156768960|NCT03451045|565910063|FG002|Overall Study|Withdrawal by Subject|5|||
156768961|NCT03451045|565910061|FG000|Overall Study|Pregnancy|0|||
156768962|NCT03451045|565910062|FG001|Overall Study|Pregnancy|0|||
156768963|NCT03451045|565910063|FG002|Overall Study|Pregnancy|2|||
156768964|NCT03451045|565910061|FG000|Overall Study|Adverse Event|7|||
156768965|NCT03451045|565910062|FG001|Overall Study|Adverse Event|1|||
156768966|NCT03451045|565910063|FG002|Overall Study|Adverse Event|3|||
156768967|NCT03451045|565910061|FG000|Overall Study|Non-compliance with study|2|||
156768968|NCT03451045|565910062|FG001|Overall Study|Non-compliance with study|0|||
156768969|NCT03451045|565910063|FG002|Overall Study|Non-compliance with study|1|||
156768970|NCT03451045|565910061|FG000|Overall Study|any other reason|10|||
156768971|NCT03451045|565910062|FG001|Overall Study|any other reason|2|||
156768972|NCT03451045|565910063|FG002|Overall Study|any other reason|13|||
156768973|NCT01142336|565910064|FG000|Overall Study|Adverse Event|1|||
156768974|NCT01142336|565910065|FG001|Overall Study|Adverse Event|1|||
156768975|NCT01142336|565910064|FG000|Overall Study|Lost to Follow-up|0|||
156768976|NCT01142336|565910065|FG001|Overall Study|Lost to Follow-up|1|||
156768977|NCT02722967|565910066|FG000|Overall Study|Adverse Event|1|||
156768978|NCT02722967|565910067|FG001|Overall Study|Adverse Event|0|||
156768979|NCT02722967|565910068|FG002|Overall Study|Adverse Event|0|||
156768980|NCT02722967|565910066|FG000|Overall Study|Lost to Follow-up|0|||
156768981|NCT02722967|565910067|FG001|Overall Study|Lost to Follow-up|1|||
156768982|NCT02722967|565910068|FG002|Overall Study|Lost to Follow-up|0|||
156768983|NCT02722967|565910066|FG000|Overall Study|Non-compliance with patch wearing|2|||
156768984|NCT02722967|565910067|FG001|Overall Study|Non-compliance with patch wearing|1|||
156768985|NCT02722967|565910068|FG002|Overall Study|Non-compliance with patch wearing|1|||
156768986|NCT02722967|565910066|FG000|Overall Study|Withdrawal by Subject|1|||
156768987|NCT02722967|565910067|FG001|Overall Study|Withdrawal by Subject|0|||
156768988|NCT02722967|565910068|FG002|Overall Study|Withdrawal by Subject|1|||
156768989|NCT02722967|565910066|FG000|Overall Study|Physician Decision|1|||
156768990|NCT02722967|565910067|FG001|Overall Study|Physician Decision|0|||
156768991|NCT02722967|565910068|FG002|Overall Study|Physician Decision|0|||
156768992|NCT02722967|565910066|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
156768993|NCT02722967|565910067|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
156768994|NCT02722967|565910068|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
156768995|NCT01123655|565910071|FG000|Overall Study|Medication for RA had to be changed|1|||
156768996|NCT01123655|565910072|FG001|Overall Study|Medication for RA had to be changed|0|||
156768997|NCT01123655|565910073|FG002|Overall Study|Medication for RA had to be changed|0|||
156768998|NCT01123655|565910071|FG000|Overall Study|new illness|0|||
156768999|NCT01123655|565910072|FG001|Overall Study|new illness|1|||
156769000|NCT01123655|565910073|FG002|Overall Study|new illness|0|||
156769001|NCT01123655|565910071|FG000|Overall Study|began prohibitive drug|0|||
156769002|NCT01123655|565910072|FG001|Overall Study|began prohibitive drug|0|||
156769003|NCT01123655|565910073|FG002|Overall Study|began prohibitive drug|1|||
156769004|NCT00062166|565910074|FG000|Overall Study|Withdrawal by Subject|6|||
156769005|NCT06996301|565910076|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
156769006|NCT06996301|565910077|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
156769007|NCT06996301|565910076|FG000|Overall Study|Patients with discordant diagnostic results|107|||
156769008|NCT06996301|565910077|FG001|Overall Study|Patients with discordant diagnostic results|90|||
156769009|NCT06996301|565910076|FG000|Overall Study|Lost to Follow-up|31|||
156769010|NCT06996301|565910077|FG001|Overall Study|Lost to Follow-up|56|||
156769011|NCT06996301|565910076|FG000|Overall Study|Withdrawal by Subject|12|||
156769012|NCT06996301|565910077|FG001|Overall Study|Withdrawal by Subject|7|||
156769013|NCT04030598|565910078|FG000|Overall Study|Voluntary Withdrawal|0|||
156769014|NCT04030598|565910079|FG001|Overall Study|Voluntary Withdrawal|1|||
157112245|NCT02104583|567166645|FG001|Overall Study|Subject required prohibited medication|1|||
156769015|NCT04030598|565910080|FG002|Overall Study|Voluntary Withdrawal|0|||
156769016|NCT05117060|565910083|FG000|Overall Study|Adverse Event|3|||
156769017|NCT05117060|565910084|FG001|Overall Study|Adverse Event|5|||
156769018|NCT05117060|565910085|FG002|Overall Study|Adverse Event|6|||
156769019|NCT05117060|565910086|FG003|Overall Study|Adverse Event|1|||
156769020|NCT05117060|565910083|FG000|Overall Study|Lost to Follow-up|0|||
156769021|NCT05117060|565910084|FG001|Overall Study|Lost to Follow-up|0|||
156769022|NCT05117060|565910085|FG002|Overall Study|Lost to Follow-up|0|||
156769023|NCT05117060|565910086|FG003|Overall Study|Lost to Follow-up|1|||
156769024|NCT05117060|565910083|FG000|Overall Study|Lack of Efficacy|4|||
156769025|NCT05117060|565910084|FG001|Overall Study|Lack of Efficacy|5|||
156769026|NCT05117060|565910085|FG002|Overall Study|Lack of Efficacy|2|||
156769027|NCT05117060|565910086|FG003|Overall Study|Lack of Efficacy|6|||
156769028|NCT05117060|565910083|FG000|Overall Study|Withdrawal by Subject|8|||
156769029|NCT05117060|565910084|FG001|Overall Study|Withdrawal by Subject|5|||
156769030|NCT05117060|565910085|FG002|Overall Study|Withdrawal by Subject|5|||
156769031|NCT05117060|565910086|FG003|Overall Study|Withdrawal by Subject|6|||
157112246|NCT02104583|567166646|FG002|Overall Study|Subject required prohibited medication|1|||
157112247|NCT02104583|567166647|FG003|Overall Study|Subject required prohibited medication|0|||
157112248|NCT02104583|567166648|FG004|Overall Study|Subject required prohibited medication|1|||
157112249|NCT02104583|567166644|FG000|Overall Study|Withdrew Consent|3|||
157112250|NCT02104583|567166645|FG001|Overall Study|Withdrew Consent|2|||
157112251|NCT02104583|567166646|FG002|Overall Study|Withdrew Consent|0|||
157112252|NCT02104583|567166647|FG003|Overall Study|Withdrew Consent|2|||
157112253|NCT02104583|567166648|FG004|Overall Study|Withdrew Consent|1|||
157112254|NCT02104583|567166644|FG000|Overall Study|Investigator's Discretion|1|||
157112255|NCT02104583|567166645|FG001|Overall Study|Investigator's Discretion|0|||
157112256|NCT02104583|567166646|FG002|Overall Study|Investigator's Discretion|0|||
157112257|NCT02104583|567166647|FG003|Overall Study|Investigator's Discretion|0|||
157112258|NCT02104583|567166648|FG004|Overall Study|Investigator's Discretion|0|||
157112259|NCT02104583|567166644|FG000|Overall Study|Protocol Violation|0|||
157112260|NCT02104583|567166645|FG001|Overall Study|Protocol Violation|0|||
157112261|NCT02104583|567166646|FG002|Overall Study|Protocol Violation|1|||
157112262|NCT02104583|567166647|FG003|Overall Study|Protocol Violation|0|||
157112263|NCT02104583|567166648|FG004|Overall Study|Protocol Violation|0|||
157112264|NCT02104583|567166644|FG000|Overall Study|Adverse Event|3|||
157112265|NCT02104583|567166645|FG001|Overall Study|Adverse Event|3|||
157112266|NCT02104583|567166646|FG002|Overall Study|Adverse Event|6|||
157112267|NCT02104583|567166647|FG003|Overall Study|Adverse Event|6|||
157112268|NCT02104583|567166648|FG004|Overall Study|Adverse Event|1|||
157112269|NCT02104583|567166644|FG000|Overall Study|Lost to Follow-up|1|||
157112270|NCT02104583|567166645|FG001|Overall Study|Lost to Follow-up|0|||
157112271|NCT02104583|567166646|FG002|Overall Study|Lost to Follow-up|0|||
157112272|NCT02104583|567166647|FG003|Overall Study|Lost to Follow-up|0|||
157112273|NCT02104583|567166648|FG004|Overall Study|Lost to Follow-up|0|||
157112274|NCT02104583|567166644|FG000|Overall Study|Randomized but Never Treated|0|||
157112275|NCT02104583|567166645|FG001|Overall Study|Randomized but Never Treated|0|||
157112276|NCT02104583|567166646|FG002|Overall Study|Randomized but Never Treated|0|||
157112277|NCT02104583|567166647|FG003|Overall Study|Randomized but Never Treated|1|||
157112278|NCT02104583|567166648|FG004|Overall Study|Randomized but Never Treated|0|||
157112279|NCT04640272|567166650|FG000|Overall Study|Subject moved out of area|1|||
157112280|NCT02535715|567166654|FG000|Overall Study|Withdrawal by Subject|0|||
157112281|NCT02535715|567166655|FG001|Overall Study|Withdrawal by Subject|0|||
157112282|NCT02535715|567166656|FG002|Overall Study|Withdrawal by Subject|1|||
157112283|NCT04353284|567166657|FG000|Overall Study|Adverse Event|1|||
157112284|NCT04353284|567166658|FG001|Overall Study|Adverse Event|1|||
157112285|NCT04353284|567166657|FG000|Overall Study|Lost to Follow-up|1|||
157112286|NCT04353284|567166658|FG001|Overall Study|Lost to Follow-up|0|||
157112287|NCT03709654|567166664|FG000|Overall Study|Lost to Follow-up|1|||
157112288|NCT03709654|567166665|FG001|Overall Study|Lost to Follow-up|1|||
157112289|NCT03709654|567166664|FG000|Overall Study|Withdrawal by Subject|1|||
157112290|NCT03709654|567166665|FG001|Overall Study|Withdrawal by Subject|1|||
157112291|NCT03709654|567166664|FG000|Overall Study|Adverse Event|1|||
157112292|NCT03709654|567166665|FG001|Overall Study|Adverse Event|0|||
157112293|NCT01902966|567166666|FG000|Overall Study|Death|1|||
157112294|NCT01902966|567166666|FG000|Overall Study|Physician Decision|1|||
157112295|NCT01902966|567166666|FG000|Overall Study|Withdrawal by Subject|1|||
157112296|NCT01549275|567166667|FG000|Overall Study|Lost to Follow-up|1|||
157112297|NCT01549275|567166668|FG001|Overall Study|Lost to Follow-up|0|||
157112298|NCT01040351|567166669|FG000|Overall Study|poor ovarian response|1|||
157112299|NCT01040351|567166670|FG001|Overall Study|poor ovarian response|2|||
157112300|NCT00530894|567166675|FG000|Overall Study|Death|84|||
157112301|NCT00530894|567166676|FG001|Overall Study|Death|89|||
157112302|NCT00530894|567166677|FG002|Overall Study|Death|55|||
156769032|NCT05117060|565910083|FG000|Overall Study|Other|2|||
157112303|NCT00530894|567166678|FG003|Overall Study|Death|89|||
157112304|NCT00530894|567166675|FG000|Overall Study|Lost to Follow-up|1|||
157112305|NCT00530894|567166676|FG001|Overall Study|Lost to Follow-up|3|||
157112306|NCT00530894|567166677|FG002|Overall Study|Lost to Follow-up|0|||
157112307|NCT00530894|567166678|FG003|Overall Study|Lost to Follow-up|0|||
157112308|NCT00530894|567166675|FG000|Overall Study|Withdrawal by Subject|1|||
157112309|NCT00530894|567166676|FG001|Overall Study|Withdrawal by Subject|23|||
157112310|NCT00530894|567166677|FG002|Overall Study|Withdrawal by Subject|0|||
157112311|NCT00530894|567166678|FG003|Overall Study|Withdrawal by Subject|5|||
157112312|NCT00530894|567166675|FG000|Overall Study|Alive and censored prior to 1 year|2|||
157112313|NCT00530894|567166676|FG001|Overall Study|Alive and censored prior to 1 year|0|||
157112314|NCT00530894|567166677|FG002|Overall Study|Alive and censored prior to 1 year|0|||
157112315|NCT00530894|567166678|FG003|Overall Study|Alive and censored prior to 1 year|0|||
157112316|NCT02256540|567166679|FG000|Overall Study|Withdrawal by Subject|0|||
157112317|NCT02256540|567166680|FG001|Overall Study|Withdrawal by Subject|1|||
157112318|NCT02256540|567166681|FG002|Overall Study|Withdrawal by Subject|1|||
156769033|NCT05117060|565910084|FG001|Overall Study|Other|1|||
157112319|NCT02256540|567166679|FG000|Overall Study|Back pain preventing exercise|0|||
157112320|NCT02256540|567166680|FG001|Overall Study|Back pain preventing exercise|0|||
157112321|NCT02256540|567166681|FG002|Overall Study|Back pain preventing exercise|1|||
156769034|NCT05117060|565910085|FG002|Overall Study|Other|3|||
156769035|NCT05117060|565910086|FG003|Overall Study|Other|1|||
156769036|NCT03141359|565910087|FG000|Overall Study|Death|32|||
156769037|NCT03141359|565910087|FG000|Overall Study|Still On Study (in follow up)|29|||
156769038|NCT05079321|565910088|FG000|Overall Study|Withdrawal by Subject|2|||
156769039|NCT05079321|565910089|FG001|Overall Study|Withdrawal by Subject|2|||
156769040|NCT05079321|565910088|FG000|Overall Study|Lost to Follow-up|0|||
156769041|NCT05079321|565910089|FG001|Overall Study|Lost to Follow-up|1|||
156769042|NCT02097823|565910090|FG000|Overall Study|Withdrawal by Subject|1|||
156769043|NCT02097823|565910091|FG001|Overall Study|Withdrawal by Subject|1|||
156769044|NCT01081626|565910092|FG000|Overall Study|Dosing error|1|||
156769045|NCT01081626|565910093|FG001|Overall Study|Dosing error|1|||
156769046|NCT01081626|565910092|FG000|Overall Study|Missing Estradiol|25|||
156769047|NCT01081626|565910093|FG001|Overall Study|Missing Estradiol|28|||
156769048|NCT01081626|565910092|FG000|Overall Study|Low antral follicle count|1|||
156769049|NCT01081626|565910093|FG001|Overall Study|Low antral follicle count|0|||
156769050|NCT01081626|565910092|FG000|Overall Study|Overstimulation|0|||
156769051|NCT01081626|565910093|FG001|Overall Study|Overstimulation|1|||
156769052|NCT01081626|565910092|FG000|Overall Study|Lost to Follow-up|0|||
156769053|NCT01081626|565910093|FG001|Overall Study|Lost to Follow-up|1|||
156769054|NCT01081626|565910092|FG000|Overall Study|Other|33|||
156769055|NCT01081626|565910093|FG001|Overall Study|Other|30|||
156769056|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Other than specified|2|||
156769057|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Other than specified|4|||
156769058|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
156769059|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
156769060|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Pregnancy|0|||
156769061|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Pregnancy|2|||
156769062|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Physician Decision|1|||
156769063|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Physician Decision|1|||
156769064|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
156769065|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
156769066|NCT02003144|565910094|FG000|Open Label Maintenance Phase|Adverse Event|2|||
156769067|NCT02003144|565910095|FG001|Open Label Maintenance Phase|Adverse Event|1|||
156769068|NCT01419535|565910097|FG000|Overall Study|could not maintain iv line|1|||
156769069|NCT01419535|565910098|FG001|Overall Study|could not maintain iv line|1|||
156769070|NCT01419535|565910097|FG000|Overall Study|Withdrawal by Subject|0|||
156769071|NCT01419535|565910098|FG001|Overall Study|Withdrawal by Subject|1|||
156769072|NCT04239924|565910103|FG000|Overall Study|Lost to Follow-up|2|||
156769073|NCT03759379|565911728|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
156769074|NCT03759379|565911729|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
156769075|NCT03759379|565911728|FG000|Treatment Period|Death|2|||
156769076|NCT03759379|565911729|FG001|Treatment Period|Death|3|||
156769077|NCT03759379|565911728|FG000|Treatment Period|Lost to Follow-up|1|||
156769078|NCT03759379|565911729|FG001|Treatment Period|Lost to Follow-up|0|||
156769079|NCT03759379|565911728|FG000|Treatment Period|Physician Decision|0|||
156769080|NCT03759379|565911729|FG001|Treatment Period|Physician Decision|1|||
157112322|NCT01230242|567166682|FG000|Overall Study|Physician Decision|2|||
157112323|NCT01230242|567166682|FG000|Overall Study|Withdrawal by Subject|1|||
157112324|NCT04329702|567166683|FG000|Overall Study|illness|3|||
157112325|NCT04329702|567166684|FG001|Overall Study|illness|4|||
157112326|NCT04329702|567166685|FG002|Overall Study|illness|0|||
157112327|NCT04329702|567166683|FG000|Overall Study|Lost to Follow-up|0|||
157112328|NCT04329702|567166684|FG001|Overall Study|Lost to Follow-up|0|||
156769081|NCT05399680|565911730|FG000|Overall Study|Lost to Follow-up|1|||
157112329|NCT04329702|567166685|FG002|Overall Study|Lost to Follow-up|2|||
156769082|NCT05399680|565911731|FG001|Overall Study|Lost to Follow-up|0|||
156769083|NCT05399680|565911730|FG000|Overall Study|Death|0|||
156769084|NCT05399680|565911731|FG001|Overall Study|Death|1|||
157112330|NCT04329702|567166683|FG000|Overall Study|Death|0|||
156769085|NCT02659865|565911732|FG000|Period 1|Withdrawal by Subject|1|||
156769086|NCT02659865|565911733|FG001|Period 1|Withdrawal by Subject|0|||
156769087|NCT02659865|565911734|FG002|Period 1|Withdrawal by Subject|0|||
157112331|NCT04329702|567166684|FG001|Overall Study|Death|2|||
156769088|NCT02659865|565911735|FG003|Period 1|Withdrawal by Subject|0|||
157112332|NCT04329702|567166685|FG002|Overall Study|Death|0|||
156769089|NCT02659865|565911736|FG004|Period 1|Withdrawal by Subject|0|||
156769090|NCT02659865|565911732|FG000|Period 1|Adverse Event|0|||
156769091|NCT02659865|565911733|FG001|Period 1|Adverse Event|0|||
156769092|NCT02659865|565911734|FG002|Period 1|Adverse Event|0|||
156769093|NCT02659865|565911735|FG003|Period 1|Adverse Event|0|||
157112333|NCT01438489|567166686|FG000|Overall Study|Lost to Follow-up|4|||
157112334|NCT01438489|567166687|FG001|Overall Study|Lost to Follow-up|2|||
157112335|NCT01438489|567166688|FG002|Overall Study|Lost to Follow-up|2|||
157112336|NCT01438489|567166686|FG000|Overall Study|Withdrawal by Subject|11|||
157112337|NCT01438489|567166687|FG001|Overall Study|Withdrawal by Subject|3|||
157112338|NCT01438489|567166688|FG002|Overall Study|Withdrawal by Subject|8|||
157112339|NCT01438489|567166686|FG000|Overall Study|Death|0|||
157112340|NCT01438489|567166687|FG001|Overall Study|Death|0|||
157112341|NCT01438489|567166688|FG002|Overall Study|Death|1|||
157112342|NCT01438489|567166686|FG000|Overall Study|Sponsor decision|4|||
157112343|NCT01438489|567166687|FG001|Overall Study|Sponsor decision|1|||
157112344|NCT01438489|567166688|FG002|Overall Study|Sponsor decision|4|||
157112345|NCT01438489|567166686|FG000|Overall Study|Subject choice/Subject moved|2|||
157112346|NCT01438489|567166687|FG001|Overall Study|Subject choice/Subject moved|1|||
157112347|NCT01438489|567166688|FG002|Overall Study|Subject choice/Subject moved|1|||
157112348|NCT01438489|567166686|FG000|Overall Study|Investigator decision|0|||
157112349|NCT01438489|567166687|FG001|Overall Study|Investigator decision|1|||
157112350|NCT01438489|567166688|FG002|Overall Study|Investigator decision|0|||
157112351|NCT01438489|567166686|FG000|Overall Study|AE/SAEs|2|||
157112352|NCT01438489|567166687|FG001|Overall Study|AE/SAEs|1|||
157112353|NCT01438489|567166688|FG002|Overall Study|AE/SAEs|1|||
157112354|NCT01438489|567166686|FG000|Overall Study|Received prohibited medication|1|||
157112355|NCT01438489|567166687|FG001|Overall Study|Received prohibited medication|0|||
157112356|NCT01438489|567166688|FG002|Overall Study|Received prohibited medication|0|||
157112357|NCT01438489|567166686|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
157112358|NCT01438489|567166687|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
157112359|NCT01438489|567166688|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
157112360|NCT01438489|567166686|FG000|Overall Study|Inadequate venous access|0|||
157112361|NCT01438489|567166687|FG001|Overall Study|Inadequate venous access|2|||
157112362|NCT01438489|567166688|FG002|Overall Study|Inadequate venous access|0|||
157112363|NCT03923426|567166689|FG000|Overall Study|Other|19|||
157112364|NCT03923426|567166689|FG000|Overall Study|Lost to Follow-up|16|||
157112365|NCT03923426|567166689|FG000|Overall Study|Death|107|||
157112366|NCT03923426|567166689|FG000|Overall Study|Incomplete response to question|13|||
157112367|NCT03719690|567166691|FG000|Overall Study|Withdrawal by Subject|5|||
157112368|NCT03719690|567166692|FG001|Overall Study|Withdrawal by Subject|10|||
157112369|NCT03719690|567166691|FG000|Overall Study|Death|40|||
157112370|NCT03719690|567166692|FG001|Overall Study|Death|149|||
157112371|NCT03719690|567166691|FG000|Overall Study|Miscellaneous|12|||
157112372|NCT03719690|567166692|FG001|Overall Study|Miscellaneous|56|||
157112373|NCT03719690|567166691|FG000|Overall Study|Lost to Follow-up|2|||
157112374|NCT03719690|567166692|FG001|Overall Study|Lost to Follow-up|18|||
157112375|NCT03719690|567166691|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
157112376|NCT03719690|567166692|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
157112377|NCT00751400|567166694|FG000|Overall Study|Lost to Follow-up|10|||
157112378|NCT03370120|567166698|FG000|Overall Study|Adverse event, non-fatal|24|||
157112379|NCT03370120|567166698|FG000|Overall Study|Withdrawal by Subject|6|||
157112380|NCT03370120|567166698|FG000|Overall Study|Lost to Follow-up|1|||
157112381|NCT03370120|567166698|FG000|Overall Study|Lack of Efficacy|37|||
157112382|NCT03370120|567166698|FG000|Overall Study|Per sponsor's instructions|1|||
157112383|NCT03370120|567166698|FG000|Overall Study|Study was terminated by parent company UCB|2|||
157112384|NCT03370120|567166698|FG000|Overall Study|The study was ended by the promoter|3|||
157112385|NCT03370120|567166698|FG000|Overall Study|Discontinuation of drug development|3|||
157112386|NCT03370120|567166698|FG000|Overall Study|End of project|2|||
157112387|NCT03370120|567166698|FG000|Overall Study|Premature study closure|2|||
157112388|NCT03370120|567166698|FG000|Overall Study|Premature program termination|1|||
157112389|NCT03370120|567166698|FG000|Overall Study|Premature study termination|7|||
157112390|NCT03370120|567166698|FG000|Overall Study|Trial terminated by sponsor|2|||
157112391|NCT03370120|567166698|FG000|Overall Study|Trial discontinued by sponsor|2|||
157112392|NCT03370120|567166698|FG000|Overall Study|Study ended|15|||
157112393|NCT03370120|567166698|FG000|Overall Study|Clinical trial has been cancelled|1|||
157112394|NCT03370120|567166698|FG000|Overall Study|End of study per sponsor decision|2|||
157112395|NCT03370120|567166698|FG000|Overall Study|Promoter's decision|2|||
157112396|NCT03370120|567166698|FG000|Overall Study|The trial has been suspended|3|||
157112397|NCT03370120|567166698|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
157112398|NCT03370120|567166698|FG000|Overall Study|Early termination by order of sponsor|2|||
157112399|NCT03370120|567166698|FG000|Overall Study|Discontinuation of the study|5|||
157112400|NCT03370120|567166698|FG000|Overall Study|End of clinical trial discontinuation|1|||
157112401|NCT03370120|567166698|FG000|Overall Study|Because the clinical trial ended halfway|4|||
157112402|NCT03370120|567166698|FG000|Overall Study|Development discontinued|5|||
157112403|NCT03370120|567166698|FG000|Overall Study|Padsenovil program closed|3|||
157112404|NCT03370120|567166698|FG000|Overall Study|End of project|2|||
157112405|NCT03370120|567166698|FG000|Overall Study|Termination of project|1|||
157112406|NCT03370120|567166698|FG000|Overall Study|The study was interrupted by sponsor|4|||
157112407|NCT03370120|567166698|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
157112408|NCT03370120|567166698|FG000|Overall Study|End of sponsor decision|1|||
157112409|NCT03370120|567166698|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
157112410|NCT03370120|567166698|FG000|Overall Study|Early termination of studies|5|||
157112411|NCT03370120|567166698|FG000|Overall Study|This study is ended early|1|||
157112412|NCT03370120|567166698|FG000|Overall Study|End of padsevonil program|2|||
157112413|NCT03370120|567166698|FG000|Overall Study|Decision of sponsor|6|||
157112414|NCT03370120|567166698|FG000|Overall Study|Asked by the sponsor|3|||
157112415|NCT03370120|567166698|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
157112416|NCT03370120|567166698|FG000|Overall Study|PI decision poor compliance from participant|1|||
157112417|NCT03370120|567166698|FG000|Overall Study|Promoter ended the study|3|||
157112418|NCT03370120|567166698|FG000|Overall Study|Premature study close by sponsor's decision|4|||
157112419|NCT03370120|567166698|FG000|Overall Study|Study terminated by sponsor|33|||
157112420|NCT03370120|567166698|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
157112421|NCT03370120|567166698|FG000|Overall Study|Sponsor decision to terminate study|63|||
157112422|NCT03370120|567166698|FG000|Overall Study|Program closure|3|||
157112423|NCT03370120|567166698|FG000|Overall Study|Study ended prematurely|1|||
157112424|NCT03370120|567166698|FG000|Overall Study|Study stopped by sponsor|2|||
157112425|NCT03370120|567166698|FG000|Overall Study|Program termination|55|||
157112426|NCT03370120|567166698|FG000|Overall Study|Sponsor decision|62|||
157112427|NCT03370120|567166698|FG000|Overall Study|Sponsor study closure|10|||
157112428|NCT04206020|567166699|FG000|Overall Study|Adverse Event|1|||
157112429|NCT04206020|567166700|FG001|Overall Study|Adverse Event|4|||
157112430|NCT04206020|567166699|FG000|Overall Study|Protocol Violation|2|||
157112431|NCT04206020|567166700|FG001|Overall Study|Protocol Violation|0|||
157112432|NCT04206020|567166699|FG000|Overall Study|Withdrawal by Subject|2|||
157112433|NCT04206020|567166700|FG001|Overall Study|Withdrawal by Subject|0|||
157112434|NCT04206020|567166699|FG000|Overall Study|Lost to Follow-up|2|||
157112435|NCT04206020|567166700|FG001|Overall Study|Lost to Follow-up|0|||
157112436|NCT04206020|567166699|FG000|Overall Study|Pregnancy|0|||
157112437|NCT04206020|567166700|FG001|Overall Study|Pregnancy|1|||
157112438|NCT04206020|567166699|FG000|Overall Study|Unable to attend visits|1|||
157112439|NCT04206020|567166700|FG001|Overall Study|Unable to attend visits|2|||
157112440|NCT00928889|567166701|FG000|Overall Study|Lost to Follow-up|3|||
157112441|NCT00928889|567166702|FG001|Overall Study|Lost to Follow-up|1|||
157112442|NCT00928889|567166701|FG000|Overall Study|Protocol Violation|0|||
157112443|NCT00928889|567166702|FG001|Overall Study|Protocol Violation|1|||
157112444|NCT00928889|567166701|FG000|Overall Study|Adverse Event|1|||
157112445|NCT00928889|567166702|FG001|Overall Study|Adverse Event|0|||
157112446|NCT00928889|567166701|FG000|Overall Study|Other|1|||
157112447|NCT00928889|567166702|FG001|Overall Study|Other|0|||
157112448|NCT04416555|567166704|FG000|Overall Study|Withdrawal by Subject|0|||
157112449|NCT04416555|567166705|FG001|Overall Study|Withdrawal by Subject|3|||
157112450|NCT01356407|567166706|FG000|Overall Study|Lost to Follow-up|2|||
157112451|NCT01356407|567166707|FG001|Overall Study|Lost to Follow-up|0|||
157112452|NCT01356407|567166706|FG000|Overall Study|Patient Withdrew Consent|2|||
157112453|NCT01356407|567166707|FG001|Overall Study|Patient Withdrew Consent|1|||
157112454|NCT01356407|567166706|FG000|Overall Study|Could not afford IMP administration|0|||
157112455|NCT01356407|567166707|FG001|Overall Study|Could not afford IMP administration|1|||
157112456|NCT01356407|567166706|FG000|Overall Study|Not complete Endoscopy|2|||
157112457|NCT01356407|567166707|FG001|Overall Study|Not complete Endoscopy|2|||
157112458|NCT02716987|567166712|FG000|Overall Study|Ligand synthesis failure|0|||
157112459|NCT02716987|567166713|FG001|Overall Study|Ligand synthesis failure|0|||
157112460|NCT02716987|567166714|FG002|Overall Study|Ligand synthesis failure|1|||
157112461|NCT02716987|567166715|FG003|Overall Study|Ligand synthesis failure|0|||
157112462|NCT02716987|567166716|FG004|Overall Study|Ligand synthesis failure|0|||
157112463|NCT02716987|567166717|FG005|Overall Study|Ligand synthesis failure|0|||
157112464|NCT02716987|567166712|FG000|Overall Study|Withdrawal by Subject|0|||
156769094|NCT02659865|565911736|FG004|Period 1|Adverse Event|1|||
156769095|NCT03675308|565911737|FG000|Overall Study|Adverse Event|3|||
157112465|NCT02716987|567166713|FG001|Overall Study|Withdrawal by Subject|0|||
157112466|NCT02716987|567166714|FG002|Overall Study|Withdrawal by Subject|0|||
157112467|NCT02716987|567166715|FG003|Overall Study|Withdrawal by Subject|0|||
157112468|NCT02716987|567166716|FG004|Overall Study|Withdrawal by Subject|1|||
157112469|NCT02716987|567166717|FG005|Overall Study|Withdrawal by Subject|1|||
157112470|NCT02829138|567166718|FG000|Overall Study|Withdrawal by Subject|1|||
157112471|NCT02829138|567166719|FG001|Overall Study|Withdrawal by Subject|0|||
157112472|NCT01394627|567166720|FG000|First Intervention (1 Day)|poor intravenous access|0|||
157112473|NCT01394627|567166721|FG001|First Intervention (1 Day)|poor intravenous access|1|||
157112474|NCT01394627|567166720|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
157112475|NCT01394627|567166721|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
157112476|NCT03223428|567166722|FG000|Overall Study|No longer taking Xermelo|27|||
157006957|NCT04956575|566775061|FG009|Overall Study|Withdrawal by Subject|0|||
157006958|NCT04956575|566775062|FG010|Overall Study|Withdrawal by Subject|3|||
157006959|NCT04956575|566775063|FG011|Overall Study|Withdrawal by Subject|1|||
157006960|NCT06119113|566775066|FG000|Overall Study|Lost to Follow-up|15|||
157006961|NCT06119113|566775067|FG001|Overall Study|Lost to Follow-up|13|||
157006962|NCT06119113|566775068|FG002|Overall Study|Lost to Follow-up|21|||
157006963|NCT00854906|566775069|FG000|Overall Study|One person had no ocular history|1|||
157006964|NCT00071799|566775070|FG000|Overall Study|Adverse Event|19|||
157006965|NCT00071799|566775071|FG001|Overall Study|Adverse Event|10|||
157006966|NCT00071799|566775070|FG000|Overall Study|Protocol Violation|1|||
157006967|NCT00071799|566775071|FG001|Overall Study|Protocol Violation|7|||
157006968|NCT00071799|566775070|FG000|Overall Study|Lost to Follow-up|1|||
157006969|NCT00071799|566775071|FG001|Overall Study|Lost to Follow-up|1|||
157006970|NCT00071799|566775070|FG000|Overall Study|Withdrawal by Subject|15|||
157006971|NCT00071799|566775071|FG001|Overall Study|Withdrawal by Subject|37|||
157006972|NCT00071799|566775070|FG000|Overall Study|Physician Decision|0|||
157006973|NCT00071799|566775071|FG001|Overall Study|Physician Decision|2|||
157006974|NCT00071799|566775070|FG000|Overall Study|Lack of Efficacy|11|||
157006975|NCT00071799|566775071|FG001|Overall Study|Lack of Efficacy|18|||
157006976|NCT00071799|566775070|FG000|Overall Study|Disease Progression|23|||
157006977|NCT00071799|566775071|FG001|Overall Study|Disease Progression|20|||
157006978|NCT00071799|566775070|FG000|Overall Study|Different Central+Local Pathology Review|0|||
157006979|NCT00071799|566775071|FG001|Overall Study|Different Central+Local Pathology Review|1|||
157006980|NCT00071799|566775070|FG000|Overall Study|Not Documented|0|||
157006981|NCT00071799|566775071|FG001|Overall Study|Not Documented|2|||
157112477|NCT03223428|567166722|FG000|Overall Study|Declined Consent|1|||
157112478|NCT03223428|567166722|FG000|Overall Study|Non-responders|56|||
157112479|NCT03223428|567166722|FG000|Overall Study|Withdrawal by Subject|14|||
156769096|NCT03675308|565911738|FG001|Overall Study|Adverse Event|2|||
156769097|NCT03675308|565911737|FG000|Overall Study|Withdrawal by Subject|6|||
156769098|NCT03675308|565911738|FG001|Overall Study|Withdrawal by Subject|4|||
156769099|NCT03675308|565911737|FG000|Overall Study|Lost to Follow-up|3|||
156769100|NCT03675308|565911738|FG001|Overall Study|Lost to Follow-up|0|||
156769101|NCT03675308|565911737|FG000|Overall Study|Lack of Efficacy|1|||
156769102|NCT03675308|565911738|FG001|Overall Study|Lack of Efficacy|1|||
156769103|NCT03675308|565911737|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
156769104|NCT03675308|565911738|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
156769105|NCT03675308|565911737|FG000|Overall Study|Other|0|||
156769106|NCT03675308|565911738|FG001|Overall Study|Other|1|||
156769107|NCT02325414|565911739|FG000|Overall Study|Withdrawal by Subject|3|||
156769108|NCT02325414|565911740|FG001|Overall Study|Withdrawal by Subject|1|||
156769109|NCT02325414|565911739|FG000|Overall Study|Lost to Follow-up|5|||
156769110|NCT02325414|565911740|FG001|Overall Study|Lost to Follow-up|5|||
156769111|NCT05722522|565911741|FG000|Overall Study|Adverse Event|0|||
156769112|NCT05722522|565911742|FG001|Overall Study|Adverse Event|1|||
156769113|NCT02775851|565911746|FG000|Overall Study|Adverse Event|1|||
156769114|NCT02775851|565911747|FG001|Overall Study|Adverse Event|10|||
156769115|NCT02775851|565911746|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
156769116|NCT02775851|565911747|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
156769117|NCT02775851|565911746|FG000|Overall Study|Progression/Relapse|0|||
156769118|NCT02775851|565911747|FG001|Overall Study|Progression/Relapse|4|||
156769119|NCT02775851|565911746|FG000|Overall Study|Other - Not Protocol Specified|0|||
156769120|NCT02775851|565911747|FG001|Overall Study|Other - Not Protocol Specified|7|||
156769121|NCT02775851|565911746|FG000|Overall Study|Withdrawal by Subject|1|||
156769122|NCT02775851|565911747|FG001|Overall Study|Withdrawal by Subject|0|||
156769123|NCT00703534|565911748|FG000|Overall Study|Adverse Event|14|||
156769124|NCT00703534|565911749|FG001|Overall Study|Adverse Event|3|||
156769125|NCT00703534|565911748|FG000|Overall Study|Withdrawal by Subject|8|||
156769126|NCT00703534|565911749|FG001|Overall Study|Withdrawal by Subject|7|||
156769127|NCT00703534|565911748|FG000|Overall Study|Incorrect Enrollment|6|||
156769128|NCT00703534|565911749|FG001|Overall Study|Incorrect Enrollment|6|||
156769129|NCT00703534|565911748|FG000|Overall Study|Lost to Follow-up|1|||
156769130|NCT00703534|565911749|FG001|Overall Study|Lost to Follow-up|4|||
156769131|NCT00703534|565911748|FG000|Overall Study|Severe Non Compliance|1|||
156769132|NCT00703534|565911749|FG001|Overall Study|Severe Non Compliance|5|||
156769133|NCT02194465|565911750|FG000|Overall Study|Adverse Event|6|||
156769134|NCT02194465|565911751|FG001|Overall Study|Adverse Event|1|||
156769135|NCT02194465|565911752|FG002|Overall Study|Adverse Event|4|||
156769136|NCT02194465|565911753|FG003|Overall Study|Adverse Event|4|||
156769137|NCT02194465|565911754|FG004|Overall Study|Adverse Event|4|||
156769138|NCT02194465|565911755|FG005|Overall Study|Adverse Event|2|||
156769139|NCT02194465|565911756|FG006|Overall Study|Adverse Event|0|||
156769140|NCT02194465|565911750|FG000|Overall Study|Lost to Follow-up|0|||
156769141|NCT02194465|565911751|FG001|Overall Study|Lost to Follow-up|0|||
156769142|NCT02194465|565911752|FG002|Overall Study|Lost to Follow-up|0|||
156769143|NCT02194465|565911753|FG003|Overall Study|Lost to Follow-up|1|||
156769144|NCT02194465|565911754|FG004|Overall Study|Lost to Follow-up|0|||
156769145|NCT02194465|565911755|FG005|Overall Study|Lost to Follow-up|1|||
156769146|NCT02194465|565911756|FG006|Overall Study|Lost to Follow-up|0|||
156769147|NCT02194465|565911750|FG000|Overall Study|Physician Decision|1|||
156769148|NCT02194465|565911751|FG001|Overall Study|Physician Decision|0|||
156769149|NCT02194465|565911752|FG002|Overall Study|Physician Decision|0|||
156769150|NCT02194465|565911753|FG003|Overall Study|Physician Decision|0|||
156769151|NCT02194465|565911754|FG004|Overall Study|Physician Decision|0|||
156769152|NCT02194465|565911755|FG005|Overall Study|Physician Decision|0|||
156769153|NCT02194465|565911756|FG006|Overall Study|Physician Decision|0|||
156769154|NCT02194465|565911750|FG000|Overall Study|Protocol Violation|1|||
156769155|NCT02194465|565911751|FG001|Overall Study|Protocol Violation|1|||
156769156|NCT02194465|565911752|FG002|Overall Study|Protocol Violation|2|||
156769157|NCT02194465|565911753|FG003|Overall Study|Protocol Violation|1|||
156769158|NCT02194465|565911754|FG004|Overall Study|Protocol Violation|1|||
156769159|NCT02194465|565911755|FG005|Overall Study|Protocol Violation|0|||
156769160|NCT02194465|565911756|FG006|Overall Study|Protocol Violation|0|||
156769161|NCT02194465|565911750|FG000|Overall Study|Withdrawal by Subject|1|||
156769162|NCT02194465|565911751|FG001|Overall Study|Withdrawal by Subject|3|||
156769163|NCT02194465|565911752|FG002|Overall Study|Withdrawal by Subject|1|||
156769164|NCT02194465|565911753|FG003|Overall Study|Withdrawal by Subject|2|||
156769165|NCT02194465|565911754|FG004|Overall Study|Withdrawal by Subject|2|||
156769166|NCT02194465|565911755|FG005|Overall Study|Withdrawal by Subject|1|||
156769167|NCT02194465|565911756|FG006|Overall Study|Withdrawal by Subject|2|||
156769168|NCT02194465|565911750|FG000|Overall Study|Discontinued follow-up period|0|||
156769169|NCT02194465|565911751|FG001|Overall Study|Discontinued follow-up period|2|||
157112480|NCT00808236|567166723|FG000|Overall Study|Was not resuscitated|50|||
156769170|NCT02194465|565911752|FG002|Overall Study|Discontinued follow-up period|1|||
156769171|NCT02194465|565911753|FG003|Overall Study|Discontinued follow-up period|0|||
156769172|NCT02194465|565911754|FG004|Overall Study|Discontinued follow-up period|2|||
156769173|NCT02194465|565911755|FG005|Overall Study|Discontinued follow-up period|0|||
156769174|NCT02194465|565911756|FG006|Overall Study|Discontinued follow-up period|0|||
156769175|NCT01125930|565911757|FG000|Overall Study|Adverse Event|0|||
156769176|NCT01125930|565911758|FG001|Overall Study|Adverse Event|1|||
156769177|NCT01125930|565911757|FG000|Overall Study|Withdrawal by Subject|1|||
156769178|NCT01125930|565911758|FG001|Overall Study|Withdrawal by Subject|6|||
156769179|NCT01125930|565911757|FG000|Overall Study|Protocol Violation|0|||
156769180|NCT01125930|565911758|FG001|Overall Study|Protocol Violation|1|||
156769181|NCT01125930|565911757|FG000|Overall Study|Lost to Follow-up|0|||
156769182|NCT01125930|565911758|FG001|Overall Study|Lost to Follow-up|2|||
156769183|NCT01715298|565911759|FG000|Overall Study|Lost to Follow-up|0|||
156769184|NCT01715298|565911760|FG001|Overall Study|Lost to Follow-up|2|||
156769185|NCT01715298|565911759|FG000|Overall Study|Patient/guardian decision|7|||
156769186|NCT01715298|565911760|FG001|Overall Study|Patient/guardian decision|9|||
156769187|NCT02058095|565911761|FG000|Overall Study|Adverse Event|1|||
156769188|NCT02058095|565911762|FG001|Overall Study|Adverse Event|0|||
156769189|NCT00998946|565911765|FG000|Overall Study|Lost to Follow-up|1|||
156769190|NCT00998946|565911765|FG000|Overall Study|Withdrawal by Subject|1|||
156769191|NCT00998946|565911765|FG000|Overall Study|Death|2|||
156769192|NCT00998946|565911765|FG000|Overall Study|Reason Unspecified|3|||
156769193|NCT00998946|565911765|FG000|Overall Study|Enrolled but not Dosed|2|||
156769194|NCT01454284|565911768|FG000|Overall Study|Adverse Event|20|||
156769195|NCT01454284|565911769|FG001|Overall Study|Adverse Event|7|||
156769196|NCT01454284|565911768|FG000|Overall Study|Death|0|||
156769197|NCT01454284|565911769|FG001|Overall Study|Death|3|||
156769198|NCT01454284|565911768|FG000|Overall Study|Lost to Follow-up|13|||
156769199|NCT01454284|565911769|FG001|Overall Study|Lost to Follow-up|8|||
156769200|NCT01454284|565911768|FG000|Overall Study|Protocol Violation|9|||
156769201|NCT01454284|565911769|FG001|Overall Study|Protocol Violation|6|||
156769202|NCT01454284|565911768|FG000|Overall Study|Withdrawal by Subject|58|||
156769203|NCT01454284|565911769|FG001|Overall Study|Withdrawal by Subject|36|||
156769204|NCT01454284|565911768|FG000|Overall Study|Physician Decision|16|||
156769205|NCT01454284|565911769|FG001|Overall Study|Physician Decision|11|||
156769206|NCT01454284|565911768|FG000|Overall Study|Sponsor Decision|0|||
156769207|NCT01454284|565911769|FG001|Overall Study|Sponsor Decision|2|||
156769208|NCT02842866|565911770|FG000|Overall Study|Serious Adverse Event|0|||
156769209|NCT02842866|565911771|FG001|Overall Study|Serious Adverse Event|1|||
156769210|NCT02842866|565911770|FG000|Overall Study|Protocol Violation|4|||
156769211|NCT02842866|565911771|FG001|Overall Study|Protocol Violation|2|||
156769212|NCT02842866|565911770|FG000|Overall Study|Lost to Follow-up|2|||
156769213|NCT02842866|565911771|FG001|Overall Study|Lost to Follow-up|0|||
156769214|NCT02842866|565911770|FG000|Overall Study|Withdrawal by Subject|1|||
156769215|NCT02842866|565911771|FG001|Overall Study|Withdrawal by Subject|0|||
156769216|NCT01432327|565911772|FG000|Posttest 3 Months|depression|3|||
156769217|NCT01432327|565911773|FG001|Posttest 3 Months|depression|0|||
156769218|NCT01432327|565911774|FG002|Posttest 3 Months|depression|0|||
156769219|NCT01432327|565911775|FG003|Posttest 3 Months|depression|0|||
156769220|NCT01432327|565911772|FG000|Posttest 3 Months|Lost to Follow-up|1|||
156769221|NCT01432327|565911773|FG001|Posttest 3 Months|Lost to Follow-up|0|||
156769222|NCT01432327|565911774|FG002|Posttest 3 Months|Lost to Follow-up|2|||
156769223|NCT01432327|565911775|FG003|Posttest 3 Months|Lost to Follow-up|1|||
156769224|NCT01432327|565911772|FG000|Posttest 3 Months|Allergic reaction|0|||
156769225|NCT01432327|565911773|FG001|Posttest 3 Months|Allergic reaction|2|||
156769226|NCT01432327|565911774|FG002|Posttest 3 Months|Allergic reaction|0|||
156769227|NCT01432327|565911775|FG003|Posttest 3 Months|Allergic reaction|0|||
156769228|NCT01432327|565911772|FG000|Posttest 6 Months|Lost to Follow-up|0|||
156769229|NCT01432327|565911773|FG001|Posttest 6 Months|Lost to Follow-up|0|||
156769230|NCT01432327|565911774|FG002|Posttest 6 Months|Lost to Follow-up|3|||
156769231|NCT01432327|565911775|FG003|Posttest 6 Months|Lost to Follow-up|2|||
156769232|NCT01432327|565911772|FG000|Posttest 6 Months|Allergic reaction|0|||
156769233|NCT01432327|565911773|FG001|Posttest 6 Months|Allergic reaction|0|||
156769234|NCT01432327|565911774|FG002|Posttest 6 Months|Allergic reaction|1|||
156769235|NCT01432327|565911775|FG003|Posttest 6 Months|Allergic reaction|0|||
156769236|NCT01432327|565911772|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
156769237|NCT01432327|565911773|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
156769238|NCT01432327|565911774|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
156769239|NCT01432327|565911775|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
156769240|NCT01432327|565911772|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
156769241|NCT01432327|565911773|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
156769242|NCT01432327|565911774|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
156769243|NCT01432327|565911775|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
156769244|NCT01432327|565911772|FG000|Posttest 1 Year|Lost to Follow-up|0|||
156769245|NCT01432327|565911773|FG001|Posttest 1 Year|Lost to Follow-up|0|||
157112481|NCT00808236|567166724|FG001|Overall Study|Was not resuscitated|56|||
156769246|NCT01432327|565911774|FG002|Posttest 1 Year|Lost to Follow-up|4|||
156769247|NCT01432327|565911775|FG003|Posttest 1 Year|Lost to Follow-up|2|||
156769248|NCT01432327|565911772|FG000|Posttest 1 Year|Allergic reaction|0|||
156769249|NCT01432327|565911773|FG001|Posttest 1 Year|Allergic reaction|0|||
156769250|NCT01432327|565911774|FG002|Posttest 1 Year|Allergic reaction|1|||
156769251|NCT01432327|565911775|FG003|Posttest 1 Year|Allergic reaction|1|||
156769252|NCT03248037|565911776|FG000|Overall Study|Withdrawal by Subject|6|||
156769253|NCT03248037|565911777|FG001|Overall Study|Withdrawal by Subject|9|||
156769254|NCT03248037|565911776|FG000|Overall Study|Adverse Event|15|||
156769255|NCT03248037|565911777|FG001|Overall Study|Adverse Event|0|||
156769256|NCT03055013|565911779|FG000|Overall Study|Adverse Event|78|||
156769257|NCT03055013|565911780|FG001|Overall Study|Adverse Event|0|||
156769258|NCT03055013|565911779|FG000|Overall Study|Death|6|||
156769259|NCT03055013|565911780|FG001|Overall Study|Death|0|||
156769260|NCT03055013|565911779|FG000|Overall Study|Disease relapse|33|||
156769261|NCT03055013|565911780|FG001|Overall Study|Disease relapse|0|||
156769262|NCT03055013|565911779|FG000|Overall Study|Withdrawal by Subject|28|||
156769263|NCT03055013|565911780|FG001|Overall Study|Withdrawal by Subject|0|||
156769264|NCT03055013|565911779|FG000|Overall Study|Other complicating disease|5|||
156769265|NCT03055013|565911780|FG001|Overall Study|Other complicating disease|0|||
156769266|NCT03055013|565911779|FG000|Overall Study|Physician Decision|1|||
156769267|NCT03055013|565911780|FG001|Overall Study|Physician Decision|0|||
156769268|NCT03055013|565911779|FG000|Overall Study|Benign mass/non-RCC|4|||
156769269|NCT03055013|565911780|FG001|Overall Study|Benign mass/non-RCC|0|||
156769270|NCT03055013|565911779|FG000|Overall Study|Enrolled in another trial|1|||
156769271|NCT03055013|565911780|FG001|Overall Study|Enrolled in another trial|0|||
156769272|NCT03055013|565911779|FG000|Overall Study|Non-protocol therapy|1|||
156769273|NCT03055013|565911780|FG001|Overall Study|Non-protocol therapy|0|||
156769274|NCT03055013|565911779|FG000|Overall Study|Incompliance|1|||
156769275|NCT03055013|565911780|FG001|Overall Study|Incompliance|0|||
156769276|NCT03055013|565911779|FG000|Overall Study|Insurance issues|1|||
156769277|NCT03055013|565911780|FG001|Overall Study|Insurance issues|0|||
156769278|NCT03055013|565911779|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
156769279|NCT03055013|565911780|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
156769280|NCT03055013|565911779|FG000|Overall Study|Did not receive nivolumab|10|||
156769281|NCT03055013|565911780|FG001|Overall Study|Did not receive nivolumab|0|||
156769282|NCT03055013|565911779|FG000|Overall Study|Did not receive surgery|0|||
156769283|NCT03055013|565911780|FG001|Overall Study|Did not receive surgery|28|||
156769284|NCT03435055|565911781|FG000|Screening|Physician Decision|2|||
156769285|NCT03435055|565911781|FG000|Received Intervention|Did not complete nitrous administration|3|||
156769286|NCT03817528|565911782|FG000|Overall Study|Withdrawal by Subject|1|||
156769287|NCT03817528|565911782|FG000|Overall Study|Adverse Event|2|||
156769288|NCT00671749|565911788|FG000|Overall Study|Adverse Event|2|||
156769289|NCT00671749|565911788|FG000|Overall Study|Withdrawal by Subject|4|||
156769290|NCT00671749|565911788|FG000|Overall Study|Protocol Violation|1|||
156769291|NCT00671749|565911788|FG000|Overall Study|Lost to Follow-up|1|||
156769292|NCT03937778|565911794|FG000|Overall Study|Withdrawal by Subject|1|||
156769293|NCT03937778|565911794|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
156769294|NCT01200355|565911795|FG000|Overall Study|Death|7|||
156769295|NCT01200355|565911796|FG001|Overall Study|Death|2|||
156769296|NCT00485303|565911797|FG000|Overall Study|Adverse Event|5|||
156769297|NCT00485303|565911797|FG000|Overall Study|Progressive Disease|44|||
156769298|NCT00485303|565911797|FG000|Overall Study|Other|3|||
156769299|NCT00485303|565911797|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
156769300|NCT00485303|565911797|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
156769301|NCT03307174|565911798|FG000|Overall Study|Unplanned ICU Administrion|5|||
156769302|NCT03307174|565911799|FG001|Overall Study|Unplanned ICU Administrion|3|||
156769303|NCT03307174|565911798|FG000|Overall Study|Aborted Surgery|1|||
156769304|NCT03307174|565911799|FG001|Overall Study|Aborted Surgery|2|||
156769305|NCT03307174|565911798|FG000|Overall Study|Hypotension|6|||
156769306|NCT03307174|565911799|FG001|Overall Study|Hypotension|0|||
156769307|NCT03307174|565911798|FG000|Overall Study|Nonfunctional epidural|1|||
157112482|NCT00808236|567166723|FG000|Overall Study|Pre-defined exclusion|13|||
156769308|NCT03307174|565911799|FG001|Overall Study|Nonfunctional epidural|1|||
156769309|NCT03307174|565911798|FG000|Overall Study|Planned epidural removal|1|||
156769310|NCT03307174|565911799|FG001|Overall Study|Planned epidural removal|0|||
156769311|NCT03307174|565911798|FG000|Overall Study|Intrathecal catheter placement|0|||
156769312|NCT03307174|565911799|FG001|Overall Study|Intrathecal catheter placement|1|||
156769313|NCT00863707|565911800|FG000|Overall Study|Randomized, but drug not received|4|||
156769314|NCT00863707|565911801|FG001|Overall Study|Randomized, but drug not received|3|||
156769315|NCT01704261|565911802|FG000|Overall Study|Withdrawal by Subject|12|||
156769316|NCT01704261|565911803|FG001|Overall Study|Withdrawal by Subject|15|||
156769317|NCT01704261|565911802|FG000|Overall Study|Lost to Follow-up|1|||
156769318|NCT01704261|565911803|FG001|Overall Study|Lost to Follow-up|0|||
156769319|NCT02391337|565911804|FG000|6 Months Follow-up|Death|5|||
156769320|NCT02391337|565911805|FG001|6 Months Follow-up|Death|4|||
156769321|NCT02391337|565911804|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
156769322|NCT02391337|565911805|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
156769323|NCT02391337|565911804|FG000|12 Months Follow-up|Death|2|||
156769324|NCT02391337|565911805|FG001|12 Months Follow-up|Death|0|||
156769325|NCT02391337|565911804|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
156769326|NCT02391337|565911805|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
156769327|NCT02391337|565911804|FG000|12 Months Follow-up|Lost to Follow-up|0|||
156769328|NCT02391337|565911805|FG001|12 Months Follow-up|Lost to Follow-up|2|||
156769329|NCT03704064|565911809|FG000|Overall Study|Lost to Follow-up|8|||
156769330|NCT03704064|565911810|FG001|Overall Study|Lost to Follow-up|4|||
156769331|NCT03704064|565911809|FG000|Overall Study|Withdrawal by Subject|1|||
156769332|NCT03704064|565911810|FG001|Overall Study|Withdrawal by Subject|1|||
156769333|NCT03704064|565911809|FG000|Overall Study|No longer available for study visits|0|||
156769334|NCT03704064|565911810|FG001|Overall Study|No longer available for study visits|1|||
156769335|NCT03704064|565911809|FG000|Overall Study|Censoring event|1|||
156769336|NCT03704064|565911810|FG001|Overall Study|Censoring event|0|||
156769337|NCT01286129|565911811|FG000|Overall Study|Withdrawal by Subject|4|||
156769338|NCT01286129|565911812|FG001|Overall Study|Withdrawal by Subject|1|||
156769339|NCT01286129|565911811|FG000|Overall Study|Could not comply with study requirements|4|||
156769340|NCT01286129|565911812|FG001|Overall Study|Could not comply with study requirements|4|||
156769341|NCT00830128|565911813|FG000|Overall Study|Adverse Event|5|||
156769342|NCT00830128|565911813|FG000|Overall Study|Lack of Efficacy|7|||
156769343|NCT00830128|565911813|FG000|Overall Study|Protocol Violation|1|||
156769344|NCT00830128|565911813|FG000|Overall Study|Withdrawal by Subject|2|||
156769345|NCT00830128|565911813|FG000|Overall Study|Family obligation|1|||
156769346|NCT00830128|565911813|FG000|Overall Study|Relocation|1|||
156769347|NCT00830128|565911813|FG000|Overall Study|Work obligation|1|||
156769348|NCT00830128|565911813|FG000|Overall Study|Operating a vehicle|1|||
156769349|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
156769350|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
156769351|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
156769352|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
156769353|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
156769354|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
156769355|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
156769356|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
156769357|NCT03040726|565911820|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
156769358|NCT03040726|565911821|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
156769359|NCT03025035|565911822|FG000|Overall Study|Death|2|||
156769360|NCT03025035|565911822|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
156769361|NCT01218802|565911823|FG000|Overall Study|Lost to Follow-up|5|||
156769362|NCT01218802|565911824|FG001|Overall Study|Lost to Follow-up|6|||
156769363|NCT01218802|565911823|FG000|Overall Study|Withdrawal by Subject|3|||
156769364|NCT01218802|565911824|FG001|Overall Study|Withdrawal by Subject|10|||
156769365|NCT01218802|565911823|FG000|Overall Study|Adverse Event|0|||
156769366|NCT01218802|565911824|FG001|Overall Study|Adverse Event|2|||
156769367|NCT01218802|565911823|FG000|Overall Study|Incarcerated|2|||
156769368|NCT01218802|565911824|FG001|Overall Study|Incarcerated|0|||
156769369|NCT03104374|565911827|FG000|Period 1|Adverse Event|7|||
156769370|NCT03104374|565911828|FG001|Period 1|Adverse Event|7|||
156769371|NCT03104374|565911829|FG002|Period 1|Adverse Event|12|||
156769372|NCT03104374|565911830|FG003|Period 1|Adverse Event|14|||
156769373|NCT03104374|565911827|FG000|Period 1|Withdrawal by Subject|18|||
156769374|NCT03104374|565911828|FG001|Period 1|Withdrawal by Subject|9|||
156769375|NCT03104374|565911829|FG002|Period 1|Withdrawal by Subject|10|||
157006982|NCT05526248|566775074|FG000|Overall Study|Lost to Follow-up|1|||
157006983|NCT05526248|566775074|FG000|Overall Study|Adverse Event|2|||
157006984|NCT05526248|566775074|FG000|Overall Study|Withdrawal by Subject|1|||
157006985|NCT04527549|566775075|FG000|Overall Study|Withdrawal by Subject|1|||
157006986|NCT04527549|566775076|FG001|Overall Study|Withdrawal by Subject|1|||
157006987|NCT00814346|566775079|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
157006988|NCT00814346|566775080|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
157006989|NCT00814346|566775079|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
157006990|NCT00814346|566775080|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
157006991|NCT00814346|566775079|FG000|Open Phase (17 Months)|Adverse Event|5|||
157112483|NCT00808236|567166724|FG001|Overall Study|Pre-defined exclusion|3|||
157112484|NCT00808236|567166723|FG000|Overall Study|Lost to Follow-up|1|||
157112485|NCT00808236|567166724|FG001|Overall Study|Lost to Follow-up|1|||
156769376|NCT03104374|565911830|FG003|Period 1|Withdrawal by Subject|17|||
156769377|NCT03104374|565911827|FG000|Period 1|Lost to Follow-up|4|||
156769378|NCT03104374|565911828|FG001|Period 1|Lost to Follow-up|4|||
156769379|NCT03104374|565911829|FG002|Period 1|Lost to Follow-up|6|||
156769380|NCT03104374|565911830|FG003|Period 1|Lost to Follow-up|8|||
157112486|NCT00808236|567166723|FG000|Overall Study|Physician Decision|0|||
156769381|NCT03104374|565911827|FG000|Period 1|Lack of Efficacy|6|||
156769382|NCT03104374|565911828|FG001|Period 1|Lack of Efficacy|7|||
156769383|NCT03104374|565911829|FG002|Period 1|Lack of Efficacy|12|||
156769384|NCT03104374|565911830|FG003|Period 1|Lack of Efficacy|6|||
156769385|NCT03104374|565911827|FG000|Period 1|Other|2|||
156769386|NCT03104374|565911828|FG001|Period 1|Other|2|||
156769387|NCT03104374|565911829|FG002|Period 1|Other|4|||
156769388|NCT03104374|565911830|FG003|Period 1|Other|7|||
156769389|NCT03104374|565911827|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769390|NCT03104374|565911828|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769391|NCT03104374|565911829|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
156769392|NCT03104374|565911830|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
156769393|NCT03104374|565911827|FG000|Period 2|Adverse Event|4|||
156769394|NCT03104374|565911828|FG001|Period 2|Adverse Event|7|||
156769395|NCT03104374|565911829|FG002|Period 2|Adverse Event|10|||
156769396|NCT03104374|565911830|FG003|Period 2|Adverse Event|10|||
156769397|NCT03104374|565911827|FG000|Period 2|Withdrawal by Subject|3|||
156769398|NCT03104374|565911828|FG001|Period 2|Withdrawal by Subject|7|||
156769399|NCT03104374|565911829|FG002|Period 2|Withdrawal by Subject|13|||
156769400|NCT03104374|565911830|FG003|Period 2|Withdrawal by Subject|16|||
156769401|NCT03104374|565911827|FG000|Period 2|Lost to Follow-up|2|||
156769402|NCT03104374|565911828|FG001|Period 2|Lost to Follow-up|2|||
156769403|NCT03104374|565911829|FG002|Period 2|Lost to Follow-up|3|||
156769404|NCT03104374|565911830|FG003|Period 2|Lost to Follow-up|5|||
156769405|NCT03104374|565911827|FG000|Period 2|Lack of Efficacy|2|||
156769406|NCT03104374|565911828|FG001|Period 2|Lack of Efficacy|4|||
156769407|NCT03104374|565911829|FG002|Period 2|Lack of Efficacy|7|||
156769408|NCT03104374|565911830|FG003|Period 2|Lack of Efficacy|4|||
156769409|NCT03104374|565911827|FG000|Period 2|COVID-19 Infection|0|||
156769410|NCT03104374|565911828|FG001|Period 2|COVID-19 Infection|0|||
156769411|NCT03104374|565911829|FG002|Period 2|COVID-19 Infection|1|||
156769412|NCT03104374|565911830|FG003|Period 2|COVID-19 Infection|0|||
156769413|NCT03104374|565911827|FG000|Period 2|Other|3|||
156769414|NCT03104374|565911828|FG001|Period 2|Other|2|||
156769415|NCT03104374|565911829|FG002|Period 2|Other|2|||
156769416|NCT03104374|565911830|FG003|Period 2|Other|4|||
156769417|NCT00251758|565911832|FG000|Overall Study|Adverse Event|7|||
156769418|NCT00251758|565911833|FG001|Overall Study|Adverse Event|9|||
156769419|NCT00251758|565911834|FG002|Overall Study|Adverse Event|11|||
156769420|NCT00251758|565911832|FG000|Overall Study|Lost to Follow-up|4|||
156769421|NCT00251758|565911833|FG001|Overall Study|Lost to Follow-up|2|||
156769422|NCT00251758|565911834|FG002|Overall Study|Lost to Follow-up|5|||
156769423|NCT00251758|565911832|FG000|Overall Study|Withdrawal by Subject|13|||
156769424|NCT00251758|565911833|FG001|Overall Study|Withdrawal by Subject|7|||
156769425|NCT00251758|565911834|FG002|Overall Study|Withdrawal by Subject|3|||
156769426|NCT00251758|565911832|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156769427|NCT00251758|565911833|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
156769428|NCT00251758|565911834|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
156769429|NCT00251758|565911832|FG000|Overall Study|Lack of Efficacy|3|||
156769430|NCT00251758|565911833|FG001|Overall Study|Lack of Efficacy|0|||
156769431|NCT00251758|565911834|FG002|Overall Study|Lack of Efficacy|0|||
156769432|NCT00251758|565911832|FG000|Overall Study|Noncompliant|0|||
156769433|NCT00251758|565911833|FG001|Overall Study|Noncompliant|2|||
156769434|NCT00251758|565911834|FG002|Overall Study|Noncompliant|2|||
156769435|NCT00251758|565911832|FG000|Overall Study|Pregnancy|0|||
157006992|NCT00814346|566775080|FG001|Open Phase (17 Months)|Adverse Event|0|||
157006993|NCT00814346|566775079|FG000|Open Phase (17 Months)|Consent|2|||
157006994|NCT00814346|566775080|FG001|Open Phase (17 Months)|Consent|0|||
157006995|NCT00814346|566775079|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
157006996|NCT00814346|566775080|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
157006997|NCT00814346|566775079|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
157006998|NCT00814346|566775080|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
157006999|NCT05136443|566775082|FG000|Overall Study|Lost to Follow-up|2|||
157007000|NCT05136443|566775082|FG000|Overall Study|Adverse Event|2|||
157007001|NCT05764161|566775083|FG000|12-week DBVC Period|Lack of Efficacy|2|||
157112487|NCT00808236|567166724|FG001|Overall Study|Physician Decision|1|||
157112488|NCT00808236|567166723|FG000|Overall Study|Death|18|||
156769436|NCT00251758|565911833|FG001|Overall Study|Pregnancy|1|||
156769437|NCT00251758|565911834|FG002|Overall Study|Pregnancy|0|||
156769438|NCT00251758|565911832|FG000|Overall Study|Per Subject Request|0|||
156769439|NCT00251758|565911833|FG001|Overall Study|Per Subject Request|0|||
156769440|NCT00251758|565911834|FG002|Overall Study|Per Subject Request|1|||
156769441|NCT00251758|565911832|FG000|Overall Study|Per Investigator Request|1|||
156769442|NCT00251758|565911833|FG001|Overall Study|Per Investigator Request|0|||
156769443|NCT00251758|565911834|FG002|Overall Study|Per Investigator Request|0|||
156769444|NCT01981616|565911837|FG000|Overall Study|Adverse Event|0|||
156769445|NCT01981616|565911838|FG001|Overall Study|Adverse Event|1|||
156769446|NCT01981616|565911837|FG000|Overall Study|Protocol Violation|1|||
157007002|NCT05764161|566775084|FG001|12-week DBVC Period|Lack of Efficacy|1|||
156769447|NCT01981616|565911838|FG001|Overall Study|Protocol Violation|0|||
156769448|NCT02404545|565911839|FG000|Overall Study|Sponsor Termination|6|||
156769449|NCT02404545|565911840|FG001|Overall Study|Sponsor Termination|6|||
156769450|NCT03641508|565911841|FG000|First Injection|Lost to Follow-up|2|||
156769451|NCT03641508|565911842|FG001|First Injection|Lost to Follow-up|0|||
156769452|NCT00094445|565911843|FG000|Overall Study|Withdrawal by Subject|3|||
156769453|NCT00094445|565911843|FG000|Overall Study|Lost to Follow-up|1|||
156769454|NCT00094445|565911843|FG000|Overall Study|Progressive Disease|2|||
156769455|NCT00855218|565911844|FG000|Overall Study|Adverse Event|43|||
156769456|NCT00855218|565911845|FG001|Overall Study|Adverse Event|27|||
156769457|NCT00855218|565911844|FG000|Overall Study|Withdrawal by Subject|10|||
156769458|NCT00855218|565911845|FG001|Overall Study|Withdrawal by Subject|6|||
156769459|NCT00855218|565911844|FG000|Overall Study|Physician Decision|18|||
156769460|NCT00855218|565911845|FG001|Overall Study|Physician Decision|11|||
156769461|NCT00855218|565911844|FG000|Overall Study|Lost to Follow-up|0|||
156769462|NCT00855218|565911845|FG001|Overall Study|Lost to Follow-up|1|||
156769463|NCT00855218|565911844|FG000|Overall Study|Protocol Violation|5|||
156769464|NCT00855218|565911845|FG001|Overall Study|Protocol Violation|9|||
156769465|NCT00855218|565911844|FG000|Overall Study|non-compliant with study drug|3|||
156769466|NCT00855218|565911845|FG001|Overall Study|non-compliant with study drug|1|||
156769467|NCT00855218|565911844|FG000|Overall Study|patient convenience|2|||
156769468|NCT00855218|565911845|FG001|Overall Study|patient convenience|0|||
156769469|NCT00855218|565911844|FG000|Overall Study|technical problems|2|||
156769470|NCT00855218|565911845|FG001|Overall Study|technical problems|1|||
156769471|NCT00855218|565911844|FG000|Overall Study|Still treated with study medication|0|||
156769472|NCT00855218|565911845|FG001|Overall Study|Still treated with study medication|1|||
156769473|NCT00855218|565911844|FG000|Overall Study|Untreatable disease progression|54|||
156769474|NCT00855218|565911845|FG001|Overall Study|Untreatable disease progression|67|||
156769475|NCT00855218|565911844|FG000|Overall Study|Second malignancy|0|||
156769476|NCT00855218|565911845|FG001|Overall Study|Second malignancy|1|||
156769477|NCT00855218|565911844|FG000|Overall Study|Progression measurement proven|7|||
156769478|NCT00855218|565911845|FG001|Overall Study|Progression measurement proven|15|||
156769479|NCT00855218|565911844|FG000|Overall Study|Clinical endpoint reached|10|||
156769480|NCT00855218|565911845|FG001|Overall Study|Clinical endpoint reached|13|||
156769481|NCT03191552|565911853|FG000|Overall Study|Lost to Follow-up|1|||
156769482|NCT03191552|565911854|FG001|Overall Study|Lost to Follow-up|0|||
156769483|NCT03191552|565911855|FG002|Overall Study|Lost to Follow-up|0|||
156769484|NCT03191552|565911853|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
156769485|NCT03191552|565911854|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
156769486|NCT03191552|565911855|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
156769487|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
156769488|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769489|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769490|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
156769491|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
156769492|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769493|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769494|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
156769495|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
156769496|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769497|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769498|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
156769499|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
156769500|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
156769501|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
156769502|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
156769503|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
156769504|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769505|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769506|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
156769507|NCT01149655|565911856|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
156769508|NCT01149655|565911857|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769509|NCT01149655|565911858|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769510|NCT01149655|565911859|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
156769511|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
157112489|NCT00808236|567166724|FG001|Overall Study|Death|30|||
157112490|NCT01301950|567166727|FG000|Overall Study|Surgery was cancelled by patient|0|||
156769512|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
156769513|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
156769514|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
157112491|NCT01301950|567166728|FG001|Overall Study|Surgery was cancelled by patient|1|||
157112492|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
157112493|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
157112494|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
156769515|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769516|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
156769517|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769518|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
156769519|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
156769520|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
156769521|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
156769522|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
157007003|NCT05764161|566775083|FG000|12-week DBVC Period|Lost to Follow-up|0|||
157007004|NCT05764161|566775084|FG001|12-week DBVC Period|Lost to Follow-up|2|||
157007005|NCT05764161|566775083|FG000|12-week DBVC Period|Protocol Violation|2|||
157007006|NCT05764161|566775084|FG001|12-week DBVC Period|Protocol Violation|4|||
157007007|NCT05764161|566775083|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
157007008|NCT05764161|566775084|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
157007009|NCT05764161|566775083|FG000|40-week OLE Period|Lack of Efficacy|0|||
157007010|NCT05764161|566775084|FG001|40-week OLE Period|Lack of Efficacy|1|||
157007011|NCT05764161|566775083|FG000|40-week OLE Period|Lost to Follow-up|1|||
157007012|NCT05764161|566775084|FG001|40-week OLE Period|Lost to Follow-up|4|||
157007013|NCT05764161|566775083|FG000|40-week OLE Period|Withdrawal by Subject|2|||
157007014|NCT05764161|566775084|FG001|40-week OLE Period|Withdrawal by Subject|7|||
157007015|NCT05764161|566775083|FG000|40-week OLE Period|Extended Travel|0|||
157007016|NCT05764161|566775084|FG001|40-week OLE Period|Extended Travel|1|||
157007017|NCT05764161|566775083|FG000|40-week OLE Period|Ongoing|66|||
157007018|NCT05764161|566775084|FG001|40-week OLE Period|Ongoing|59|||
157007019|NCT03861767|566775093|FG000|Overall Study|Withdrawal by Subject|2|||
157007020|NCT03861767|566775094|FG001|Overall Study|Withdrawal by Subject|1|||
157007021|NCT03861767|566775095|FG002|Overall Study|Withdrawal by Subject|0|||
157007022|NCT03861767|566775096|FG003|Overall Study|Withdrawal by Subject|5|||
157007023|NCT03861767|566775097|FG004|Overall Study|Withdrawal by Subject|2|||
157007024|NCT03861767|566775098|FG005|Overall Study|Withdrawal by Subject|1|||
157007025|NCT03861767|566775099|FG006|Overall Study|Withdrawal by Subject|3|||
157007026|NCT03861767|566775100|FG007|Overall Study|Withdrawal by Subject|1|||
157007027|NCT03861767|566775101|FG008|Overall Study|Withdrawal by Subject|0|||
157007028|NCT03861767|566775102|FG009|Overall Study|Withdrawal by Subject|5|||
157007029|NCT00346333|566775103|FG000|Overall Study|Death|1|||
157007030|NCT00346333|566775104|FG001|Overall Study|Death|0|||
157007031|NCT00346333|566775103|FG000|Overall Study|unwilling or unable to continue|4|||
157007032|NCT00346333|566775104|FG001|Overall Study|unwilling or unable to continue|8|||
157007033|NCT00117286|566775110|FG000|Overall Study|Adverse Event|12|||
157007034|NCT00117286|566775111|FG001|Overall Study|Adverse Event|6|||
157007035|NCT00117286|566775110|FG000|Overall Study|Lost to Follow-up|2|||
157007036|NCT00117286|566775111|FG001|Overall Study|Lost to Follow-up|0|||
157007037|NCT00117286|566775110|FG000|Overall Study|Protocol Violation|3|||
157007038|NCT00117286|566775111|FG001|Overall Study|Protocol Violation|3|||
157007039|NCT00117286|566775110|FG000|Overall Study|Withdrawal by Subject|6|||
157007040|NCT00117286|566775111|FG001|Overall Study|Withdrawal by Subject|2|||
157007041|NCT00117286|566775110|FG000|Overall Study|Physician Decision|3|||
157007042|NCT00117286|566775111|FG001|Overall Study|Physician Decision|7|||
157007043|NCT00117286|566775110|FG000|Overall Study|Lack of Efficacy|2|||
157007044|NCT00117286|566775111|FG001|Overall Study|Lack of Efficacy|1|||
157007045|NCT00117286|566775110|FG000|Overall Study|Research site closing|0|||
157007046|NCT00117286|566775111|FG001|Overall Study|Research site closing|2|||
157007047|NCT00189202|566775112|FG000|Overall Study|Physician Decision|5|||
157007048|NCT04446117|566775115|FG000|Overall Study|No Study Treatment Given|4|||
157007049|NCT04446117|566775116|FG001|Overall Study|No Study Treatment Given|3|||
157007050|NCT04446117|566775115|FG000|Overall Study|Radiographic Disease Progression|132|||
157007051|NCT04446117|566775116|FG001|Overall Study|Radiographic Disease Progression|158|||
157007052|NCT04446117|566775115|FG000|Overall Study|Adverse Event|79|||
157007053|NCT04446117|566775116|FG001|Overall Study|Adverse Event|43|||
157007054|NCT04446117|566775115|FG000|Overall Study|Lack of Clinical Benefit|1|||
157007055|NCT04446117|566775116|FG001|Overall Study|Lack of Clinical Benefit|1|||
157007056|NCT04446117|566775115|FG000|Overall Study|Withdrawal by Subject|24|||
157007057|NCT04446117|566775116|FG001|Overall Study|Withdrawal by Subject|22|||
157007058|NCT04446117|566775115|FG000|Overall Study|Lost to Follow-up|0|||
157007059|NCT04446117|566775116|FG001|Overall Study|Lost to Follow-up|3|||
157007060|NCT04446117|566775115|FG000|Overall Study|Miscellaneous|26|||
157007061|NCT04446117|566775116|FG001|Overall Study|Miscellaneous|36|||
157007062|NCT04446117|566775115|FG000|Overall Study|Missing Data/Data not yet Received|1|||
157007063|NCT04446117|566775116|FG001|Overall Study|Missing Data/Data not yet Received|0|||
157007064|NCT03654768|566775119|FG000|Overall Study|Adverse Event|1|||
157007065|NCT03654768|566775120|FG001|Overall Study|Adverse Event|6|||
157007066|NCT03654768|566775119|FG000|Overall Study|Loss of response|2|||
157007067|NCT03654768|566775120|FG001|Overall Study|Loss of response|2|||
157007068|NCT03654768|566775119|FG000|Overall Study|Non-compliance|0|||
157007069|NCT03654768|566775120|FG001|Overall Study|Non-compliance|1|||
157112495|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
157112496|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
157112497|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
157112498|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
156769523|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769524|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
156769525|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769526|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
156769527|NCT01149655|565911856|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769528|NCT01149655|565911857|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
156769529|NCT01149655|565911858|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769530|NCT01149655|565911859|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
156769531|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
156769532|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
156769533|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
156769534|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
156769535|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769536|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769537|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
156769538|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
156769539|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
156769540|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
156769541|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
156769542|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
156769543|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
156769544|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
156769545|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
156769546|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
156769547|NCT01149655|565911856|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
156769548|NCT01149655|565911857|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
156769549|NCT01149655|565911858|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
156769550|NCT01149655|565911859|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
156769551|NCT01265498|565911862|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
156769552|NCT01265498|565911863|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
156769553|NCT01884597|565911864|FG000|Overall Study|Adverse Event|0|||
156769554|NCT01884597|565911865|FG001|Overall Study|Adverse Event|0|||
156769555|NCT01884597|565911866|FG002|Overall Study|Adverse Event|1|||
156769556|NCT01884597|565911864|FG000|Overall Study|Lack of Efficacy|1|||
156769557|NCT01884597|565911865|FG001|Overall Study|Lack of Efficacy|0|||
156769558|NCT01884597|565911866|FG002|Overall Study|Lack of Efficacy|0|||
156769559|NCT01884597|565911864|FG000|Overall Study|Death|0|||
156769560|NCT01884597|565911865|FG001|Overall Study|Death|1|||
156769561|NCT01884597|565911866|FG002|Overall Study|Death|0|||
156769562|NCT05965752|565911869|FG000|Overall Study|Adverse Event|0|||
156769563|NCT05965752|565911870|FG001|Overall Study|Adverse Event|1|||
156769564|NCT05965752|565911871|FG002|Overall Study|Adverse Event|0|||
156769565|NCT05965752|565911872|FG003|Overall Study|Adverse Event|1|||
156769566|NCT05965752|565911873|FG004|Overall Study|Adverse Event|3|||
156769567|NCT05965752|565911869|FG000|Overall Study|Lost to Follow-up|2|||
156769568|NCT05965752|565911870|FG001|Overall Study|Lost to Follow-up|0|||
156769569|NCT05965752|565911871|FG002|Overall Study|Lost to Follow-up|1|||
156769570|NCT05965752|565911872|FG003|Overall Study|Lost to Follow-up|1|||
156769571|NCT05965752|565911873|FG004|Overall Study|Lost to Follow-up|1|||
156769572|NCT05965752|565911869|FG000|Overall Study|Withdrawal by Subject|2|||
156769573|NCT05965752|565911870|FG001|Overall Study|Withdrawal by Subject|2|||
156769574|NCT05965752|565911871|FG002|Overall Study|Withdrawal by Subject|1|||
156769575|NCT05965752|565911872|FG003|Overall Study|Withdrawal by Subject|5|||
156769576|NCT05965752|565911873|FG004|Overall Study|Withdrawal by Subject|0|||
156769577|NCT05965752|565911869|FG000|Overall Study|Disease Relapse|1|||
156769578|NCT05965752|565911870|FG001|Overall Study|Disease Relapse|0|||
157112499|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
157112500|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
157112501|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
156769579|NCT05965752|565911871|FG002|Overall Study|Disease Relapse|1|||
156769580|NCT05965752|565911872|FG003|Overall Study|Disease Relapse|0|||
156769581|NCT05965752|565911873|FG004|Overall Study|Disease Relapse|0|||
156769582|NCT05965752|565911869|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156769583|NCT05965752|565911870|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156769584|NCT05965752|565911871|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156769585|NCT05965752|565911872|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
156769586|NCT05965752|565911873|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
157112502|NCT04041284|567166731|FG000|DB Phase (12 Weeks)|Other than specified|1|||
156769587|NCT05965752|565911869|FG000|Overall Study|Unable to Return for Study Visits|0|||
156769588|NCT05965752|565911870|FG001|Overall Study|Unable to Return for Study Visits|1|||
156769589|NCT05965752|565911871|FG002|Overall Study|Unable to Return for Study Visits|0|||
156769590|NCT05965752|565911872|FG003|Overall Study|Unable to Return for Study Visits|3|||
156769591|NCT05965752|565911873|FG004|Overall Study|Unable to Return for Study Visits|1|||
156769592|NCT05965752|565911869|FG000|Overall Study|Early Termination|0|||
156769593|NCT05965752|565911870|FG001|Overall Study|Early Termination|0|||
156769594|NCT05965752|565911871|FG002|Overall Study|Early Termination|1|||
156769595|NCT05965752|565911872|FG003|Overall Study|Early Termination|0|||
156769596|NCT05965752|565911873|FG004|Overall Study|Early Termination|0|||
156769597|NCT05965752|565911869|FG000|Overall Study|Reported Unwanted Symptoms|0|||
157112503|NCT04041284|567166732|FG001|DB Phase (12 Weeks)|Other than specified|0|||
157112504|NCT04041284|567166731|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
157112505|NCT04041284|567166732|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
157112506|NCT04041284|567166731|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
156769598|NCT05965752|565911870|FG001|Overall Study|Reported Unwanted Symptoms|0|||
156769599|NCT05965752|565911871|FG002|Overall Study|Reported Unwanted Symptoms|0|||
156769600|NCT05965752|565911872|FG003|Overall Study|Reported Unwanted Symptoms|0|||
156769601|NCT05965752|565911873|FG004|Overall Study|Reported Unwanted Symptoms|1|||
156769602|NCT05965752|565911869|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769603|NCT05965752|565911870|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769604|NCT05965752|565911871|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769605|NCT05965752|565911872|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
156769606|NCT05965752|565911873|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
156769607|NCT02074514|565911875|FG000|Overall Study|Lack of Efficacy|3|||
156769608|NCT02074514|565911876|FG001|Overall Study|Lack of Efficacy|2|||
156769609|NCT02074514|565911875|FG000|Overall Study|Lost to Follow-up|0|||
156769610|NCT02074514|565911876|FG001|Overall Study|Lost to Follow-up|1|||
156769611|NCT02074514|565911875|FG000|Overall Study|Withdrew Consent|0|||
156769612|NCT02074514|565911876|FG001|Overall Study|Withdrew Consent|1|||
156769613|NCT00666237|565911879|FG000|Overall Study|Death|5|||
156769614|NCT00666237|565911880|FG001|Overall Study|Death|5|||
156769615|NCT00666237|565911879|FG000|Overall Study|Lost to Follow-up|29|||
156769616|NCT00666237|565911880|FG001|Overall Study|Lost to Follow-up|25|||
156769617|NCT02839707|565911882|FG000|Phase I|Not eligible for analysis|9|||
156769618|NCT02839707|565911883|FG001|Phase I|Not eligible for analysis|0|||
156769619|NCT02839707|565911884|FG002|Phase I|Not eligible for analysis|0|||
156769620|NCT02839707|565911882|FG000|Phase II|Not treated according to protocol|4|||
156769621|NCT02839707|565911883|FG001|Phase II|Not treated according to protocol|0|||
156769622|NCT02839707|565911884|FG002|Phase II|Not treated according to protocol|2|||
156769623|NCT02839707|565911882|FG000|Phase III|Not treated according to protocol|0|||
156769624|NCT02839707|565911883|FG001|Phase III|Not treated according to protocol|0|||
156769625|NCT02839707|565911884|FG002|Phase III|Not treated according to protocol|4|||
156769626|NCT03834961|565913004|FG000|Overall Study|Lack of Efficacy|1|||
156769627|NCT03834961|565913005|FG001|Overall Study|Lack of Efficacy|1|||
156769628|NCT03834961|565913006|FG002|Overall Study|Lack of Efficacy|0|||
156769629|NCT03834961|565913004|FG000|Overall Study|Physician Decision|0|||
156769630|NCT03834961|565913005|FG001|Overall Study|Physician Decision|1|||
156769631|NCT03834961|565913006|FG002|Overall Study|Physician Decision|0|||
156769632|NCT03370172|565913007|FG000|Overall Study|Withdrawal by Subject|0|||
156769633|NCT03370172|565913008|FG001|Overall Study|Withdrawal by Subject|1|||
156769634|NCT05610605|565913009|FG000|6-month Assessment|Death|1|||
156769635|NCT05610605|565913010|FG001|6-month Assessment|Death|1|||
156769636|NCT05610605|565913009|FG000|6-month Assessment|Lost to Follow-up|20|||
156769637|NCT05610605|565913010|FG001|6-month Assessment|Lost to Follow-up|0|||
156769638|NCT05610605|565913009|FG000|6-month Assessment|Institutionalized|1|||
156769639|NCT05610605|565913010|FG001|6-month Assessment|Institutionalized|2|||
156769640|NCT05610605|565913009|FG000|12-month Assessment|Death|2|||
156769641|NCT05610605|565913010|FG001|12-month Assessment|Death|1|||
156769642|NCT05610605|565913009|FG000|12-month Assessment|Lost to Follow-up|1|||
156769643|NCT05610605|565913010|FG001|12-month Assessment|Lost to Follow-up|4|||
156769644|NCT05610605|565913009|FG000|12-month Assessment|Institutionalized|2|||
156769645|NCT05610605|565913010|FG001|12-month Assessment|Institutionalized|1|||
156769646|NCT00753519|565913011|FG000|Overall Study|Withdrawal by Subject|0|||
156769647|NCT00753519|565913012|FG001|Overall Study|Withdrawal by Subject|2|||
156769648|NCT01171534|565913013|FG000|Overall Study|Lost to Follow-up|0|||
156769649|NCT01171534|565913014|FG001|Overall Study|Lost to Follow-up|2|||
156769650|NCT01171534|565913013|FG000|Overall Study|screen failure|0|||
156769651|NCT01171534|565913014|FG001|Overall Study|screen failure|1|||
156769652|NCT00548327|565913015|FG000|Overall Study|Adverse Event|0|||
156769653|NCT00548327|565913016|FG001|Overall Study|Adverse Event|1|||
157112507|NCT04041284|567166732|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
157112508|NCT04041284|567166731|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
156769654|NCT02100631|565913017|FG000|Overall Study|Withdrawal by Subject|1|||
156769655|NCT02100631|565913018|FG001|Overall Study|Withdrawal by Subject|0|||
157112509|NCT04041284|567166732|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
157112510|NCT04041284|567166731|FG000|OL Phase (12 Weeks)|Other than specified|6|||
157112511|NCT04041284|567166732|FG001|OL Phase (12 Weeks)|Other than specified|2|||
157112512|NCT00258674|567166735|FG000|Overall Study|Death|32|||
157112513|NCT00258674|567166736|FG001|Overall Study|Death|53|||
157112514|NCT00258674|567166737|FG002|Overall Study|Death|34|||
157112515|NCT01744665|567166739|FG000|Monitoring Phase|Adverse Event|4|||
157112516|NCT01744665|567166739|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
157112517|NCT01744665|567166739|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
157112518|NCT01744665|567166739|FG000|Monitoring Phase|Withdrawal by Subject|5|||
157112519|NCT01744665|567166739|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
157112520|NCT01744665|567166739|FG000|Consolidation Phase|Adverse Event|2|||
157112521|NCT01744665|567166739|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
157112522|NCT01744665|567166739|FG000|Consolidation Phase|Withdrawal by Subject|4|||
157112523|NCT01744665|567166739|FG000|Consolidation Phase|Administrative problems|9|||
157112524|NCT01744665|567166739|FG000|Re-initiation Phase|Administrative problems|10|||
157112525|NCT01744665|567166739|FG000|Re-initiation Phase|Adverse Event|1|||
157112526|NCT01744665|567166739|FG000|Re-initiation Phase|No longer required treatment|1|||
157112527|NCT01744665|567166739|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
157112528|NCT00492752|567166740|FG000|Double Blind Treatment|Death|13|||
157112529|NCT00492752|567166741|FG001|Double Blind Treatment|Death|0|||
157112530|NCT00492752|567166742|FG002|Double Blind Treatment|Death|2|||
157112531|NCT00492752|567166743|FG003|Double Blind Treatment|Death|0|||
157112532|NCT00492752|567166740|FG000|Double Blind Treatment|Adverse Event|1|||
157112533|NCT00492752|567166741|FG001|Double Blind Treatment|Adverse Event|0|||
157112534|NCT00492752|567166742|FG002|Double Blind Treatment|Adverse Event|0|||
157112535|NCT00492752|567166743|FG003|Double Blind Treatment|Adverse Event|0|||
157112536|NCT00492752|567166740|FG000|Double Blind Treatment|Protocol Violation|0|||
157112537|NCT00492752|567166741|FG001|Double Blind Treatment|Protocol Violation|0|||
157112538|NCT00492752|567166742|FG002|Double Blind Treatment|Protocol Violation|1|||
157112539|NCT00492752|567166743|FG003|Double Blind Treatment|Protocol Violation|0|||
157112540|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
157112541|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
157112542|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
157112543|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
157112544|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
157112545|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
156769656|NCT02100631|565913019|FG002|Overall Study|Withdrawal by Subject|0|||
156769657|NCT02100631|565913017|FG000|Overall Study|Lost to Follow-up|3|||
156769658|NCT02100631|565913018|FG001|Overall Study|Lost to Follow-up|4|||
156769659|NCT02100631|565913019|FG002|Overall Study|Lost to Follow-up|0|||
156769660|NCT02100631|565913017|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
156769661|NCT02100631|565913018|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
156769662|NCT02100631|565913019|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
156769663|NCT01316614|565913020|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
156769664|NCT01316614|565913020|FG000|Overall Study|Cytology slides not available for review|4|||
156769665|NCT01316614|565913020|FG000|Overall Study|Cystic lesion|5|||
156769666|NCT01316614|565913020|FG000|Overall Study|Inadequate number of passes|2|||
156769667|NCT01316614|565913020|FG000|Overall Study|Medically unstable|1|||
156769668|NCT00089648|565913021|FG000|Overall Study|Adverse Event|7|||
156769669|NCT00089648|565913021|FG000|Overall Study|Withdrawal by Subject|1|||
156769670|NCT00089648|565913021|FG000|Overall Study|Lack of Efficacy|33|||
156769671|NCT00420745|565913022|FG000|Overall Study|Adverse Event|2|||
156769672|NCT00420745|565913023|FG001|Overall Study|Adverse Event|2|||
156769673|NCT00420745|565913022|FG000|Overall Study|Lost to Follow-up|10|||
156769674|NCT00420745|565913023|FG001|Overall Study|Lost to Follow-up|2|||
156769675|NCT00420745|565913022|FG000|Overall Study|Protocol Violation|1|||
156769676|NCT00420745|565913023|FG001|Overall Study|Protocol Violation|0|||
156769677|NCT00420745|565913022|FG000|Overall Study|Physician Decision|1|||
156769678|NCT00420745|565913023|FG001|Overall Study|Physician Decision|1|||
157112546|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
157112547|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
157112548|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
157112549|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
157112550|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
157112551|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
156769679|NCT00420745|565913022|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
156769680|NCT00420745|565913023|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
156769681|NCT00420745|565913022|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
156769682|NCT00420745|565913023|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
156769683|NCT00423605|565913024|FG000|Overall Study|Adverse Event|129|||
157112552|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
157112553|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
156769684|NCT00423605|565913024|FG000|Overall Study|Withdrawal by Subject|36|||
156769685|NCT00423605|565913024|FG000|Overall Study|Lost to Follow-up|15|||
156769686|NCT00423605|565913024|FG000|Overall Study|Lack of Efficacy|38|||
156769687|NCT00423605|565913024|FG000|Overall Study|Sponsor Decision|3|||
156769688|NCT00423605|565913024|FG000|Overall Study|Physician Decision|8|||
156769689|NCT00423605|565913024|FG000|Overall Study|Protocol Violation|7|||
156769690|NCT00423605|565913024|FG000|Overall Study|Not one of the pre-specified options|5|||
156769691|NCT00726453|565913026|FG000|Primary Enrollment Group|Death|18|||
156769692|NCT00726453|565913027|FG001|Primary Enrollment Group|Death|0|||
156769693|NCT00726453|565913026|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
156769694|NCT00726453|565913027|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
156769695|NCT00726453|565913026|FG000|38 mm Length Group|Death|0|||
156769696|NCT00726453|565913027|FG001|38 mm Length Group|Death|3|||
156769697|NCT01588509|565913029|FG000|Overall Study|Lost to Follow-up|1|||
156769698|NCT01588509|565913030|FG001|Overall Study|Lost to Follow-up|0|||
156769699|NCT02897349|565913034|FG000|Overall Study|Lost to Follow-up|2|||
156769700|NCT02897349|565913035|FG001|Overall Study|Lost to Follow-up|2|||
156769701|NCT02897349|565913034|FG000|Overall Study|Adverse Event|3|||
156769702|NCT02897349|565913035|FG001|Overall Study|Adverse Event|3|||
156769703|NCT02897349|565913034|FG000|Overall Study|Other than listed above|0|||
156769704|NCT02897349|565913035|FG001|Overall Study|Other than listed above|1|||
156769705|NCT01281306|565913043|FG000|Overall Study|Lack of Efficacy|0|||
156769706|NCT01281306|565913044|FG001|Overall Study|Lack of Efficacy|1|||
156769707|NCT01281306|565913045|FG002|Overall Study|Lack of Efficacy|3|||
156769708|NCT01281306|565913046|FG003|Overall Study|Lack of Efficacy|0|||
156769709|NCT01281306|565913047|FG004|Overall Study|Lack of Efficacy|2|||
156769710|NCT01281306|565913048|FG005|Overall Study|Lack of Efficacy|0|||
156769711|NCT01281306|565913049|FG006|Overall Study|Lack of Efficacy|1|||
156769712|NCT01281306|565913043|FG000|Overall Study|Withdrawal by Subject|1|||
156769713|NCT01281306|565913044|FG001|Overall Study|Withdrawal by Subject|0|||
156769714|NCT01281306|565913045|FG002|Overall Study|Withdrawal by Subject|2|||
156769715|NCT01281306|565913046|FG003|Overall Study|Withdrawal by Subject|4|||
156769716|NCT01281306|565913047|FG004|Overall Study|Withdrawal by Subject|1|||
156769717|NCT01281306|565913048|FG005|Overall Study|Withdrawal by Subject|3|||
156769718|NCT01281306|565913049|FG006|Overall Study|Withdrawal by Subject|1|||
156769719|NCT01281306|565913043|FG000|Overall Study|Protocol deviation|0|||
156769720|NCT01281306|565913044|FG001|Overall Study|Protocol deviation|1|||
156769721|NCT01281306|565913045|FG002|Overall Study|Protocol deviation|1|||
156769722|NCT01281306|565913046|FG003|Overall Study|Protocol deviation|1|||
156769723|NCT01281306|565913047|FG004|Overall Study|Protocol deviation|1|||
156769724|NCT01281306|565913048|FG005|Overall Study|Protocol deviation|0|||
156769725|NCT01281306|565913049|FG006|Overall Study|Protocol deviation|0|||
156769726|NCT01281306|565913043|FG000|Overall Study|Condition no longer requires study drug|1|||
156769727|NCT01281306|565913044|FG001|Overall Study|Condition no longer requires study drug|0|||
156769728|NCT01281306|565913045|FG002|Overall Study|Condition no longer requires study drug|0|||
156769729|NCT01281306|565913046|FG003|Overall Study|Condition no longer requires study drug|0|||
156769730|NCT01281306|565913047|FG004|Overall Study|Condition no longer requires study drug|0|||
156769731|NCT01281306|565913048|FG005|Overall Study|Condition no longer requires study drug|1|||
156769732|NCT01281306|565913049|FG006|Overall Study|Condition no longer requires study drug|1|||
156769733|NCT01281306|565913043|FG000|Overall Study|Lost to Follow-up|1|||
156769734|NCT01281306|565913044|FG001|Overall Study|Lost to Follow-up|0|||
156769735|NCT01281306|565913045|FG002|Overall Study|Lost to Follow-up|0|||
156769736|NCT01281306|565913046|FG003|Overall Study|Lost to Follow-up|2|||
156769737|NCT01281306|565913047|FG004|Overall Study|Lost to Follow-up|0|||
156769738|NCT01281306|565913048|FG005|Overall Study|Lost to Follow-up|0|||
156769739|NCT01281306|565913049|FG006|Overall Study|Lost to Follow-up|1|||
156769740|NCT01281306|565913043|FG000|Overall Study|Death|1|||
156769741|NCT01281306|565913044|FG001|Overall Study|Death|0|||
156769742|NCT01281306|565913045|FG002|Overall Study|Death|0|||
156769743|NCT01281306|565913046|FG003|Overall Study|Death|0|||
156769744|NCT01281306|565913047|FG004|Overall Study|Death|0|||
156769745|NCT01281306|565913048|FG005|Overall Study|Death|0|||
156769746|NCT01281306|565913049|FG006|Overall Study|Death|0|||
156769747|NCT01281306|565913043|FG000|Overall Study|Adverse Event|3|||
156769748|NCT01281306|565913044|FG001|Overall Study|Adverse Event|2|||
156769749|NCT01281306|565913045|FG002|Overall Study|Adverse Event|2|||
156769750|NCT01281306|565913046|FG003|Overall Study|Adverse Event|3|||
156769751|NCT01281306|565913047|FG004|Overall Study|Adverse Event|5|||
156769752|NCT01281306|565913048|FG005|Overall Study|Adverse Event|3|||
156769753|NCT01281306|565913049|FG006|Overall Study|Adverse Event|3|||
156769754|NCT01281306|565913043|FG000|Overall Study|Randomized in error|1|||
156769755|NCT01281306|565913044|FG001|Overall Study|Randomized in error|0|||
156769756|NCT01281306|565913045|FG002|Overall Study|Randomized in error|0|||
156769757|NCT01281306|565913046|FG003|Overall Study|Randomized in error|1|||
156769758|NCT01281306|565913047|FG004|Overall Study|Randomized in error|0|||
156769759|NCT01281306|565913048|FG005|Overall Study|Randomized in error|0|||
156769760|NCT01281306|565913049|FG006|Overall Study|Randomized in error|0|||
156769761|NCT00368550|565913050|FG000|Overall Study|Adverse Event|7|||
156769762|NCT00368550|565913051|FG001|Overall Study|Adverse Event|4|||
156769763|NCT00368550|565913050|FG000|Overall Study|Lack of Efficacy|4|||
156769764|NCT00368550|565913051|FG001|Overall Study|Lack of Efficacy|9|||
156769765|NCT00368550|565913050|FG000|Overall Study|Withdrawal by Subject|17|||
156769766|NCT00368550|565913051|FG001|Overall Study|Withdrawal by Subject|10|||
156769767|NCT01401322|565913052|FG000|Overall Study|Withdrawal by Subject|1|||
156769768|NCT01401322|565913052|FG000|Overall Study|Physician Decision|1|||
156769769|NCT02410629|565913054|FG000|Overall Study|Family cannot commit to the study|2|||
156769770|NCT02410629|565913055|FG001|Overall Study|Family cannot commit to the study|1|||
156769771|NCT02410629|565913054|FG000|Overall Study|Subject returned to work|1|||
156769772|NCT02410629|565913055|FG001|Overall Study|Subject returned to work|0|||
156769773|NCT02410629|565913054|FG000|Overall Study|Subject moved back to home country|0|||
156769774|NCT02410629|565913055|FG001|Overall Study|Subject moved back to home country|1|||
156769775|NCT02410629|565913054|FG000|Overall Study|Subject underwent heart surgery|0|||
156769776|NCT02410629|565913055|FG001|Overall Study|Subject underwent heart surgery|1|||
156769777|NCT01206764|565913056|FG000|Overall Study|Adverse Event|20|||
156769778|NCT01206764|565913056|FG000|Overall Study|Abnormal laboratory value|2|||
156769779|NCT01206764|565913056|FG000|Overall Study|Abnormal test procedure result|1|||
156769780|NCT01206764|565913056|FG000|Overall Study|Patient withdrew consent|5|||
156769781|NCT01206764|565913056|FG000|Overall Study|Lost to Follow-up|6|||
156769782|NCT01206764|565913056|FG000|Overall Study|Death|11|||
156769783|NCT01206764|565913056|FG000|Overall Study|New cancer therapy|2|||
156769784|NCT01206764|565913056|FG000|Overall Study|Disease progression|88|||
156769785|NCT01206764|565913056|FG000|Overall Study|Protocol deviation|3|||
156769786|NCT04494646|565913057|FG000|Overall Study|Adverse Event|0|||
156769787|NCT04494646|565913058|FG001|Overall Study|Adverse Event|1|||
156769788|NCT04494646|565913057|FG000|Overall Study|Withdrawal by Subject|0|||
156769789|NCT04494646|565913058|FG001|Overall Study|Withdrawal by Subject|1|||
156769790|NCT05282823|565913061|FG000|Overall Study|Withdrawal by Subject|9|||
156769791|NCT05282823|565913061|FG000|Overall Study|Adverse Event|1|||
156769792|NCT05282823|565913061|FG000|Overall Study|did not meet protocol criteria|2|||
156769793|NCT05282823|565913061|FG000|Overall Study|Withdrawal by Subject|7|||
156769794|NCT00997893|565913062|FG000|Overall Study|Adverse Event|1|||
156769795|NCT00997893|565913063|FG001|Overall Study|Adverse Event|0|||
156769796|NCT00997893|565913064|FG002|Overall Study|Adverse Event|0|||
156769797|NCT00997893|565913062|FG000|Overall Study|Unable to meet study timelines|1|||
156769798|NCT00997893|565913063|FG001|Overall Study|Unable to meet study timelines|0|||
156769799|NCT00997893|565913064|FG002|Overall Study|Unable to meet study timelines|0|||
156769800|NCT00997893|565913062|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
156769801|NCT00997893|565913063|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
156769802|NCT00997893|565913064|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
156769803|NCT05569174|565913065|FG000|Overall Study|Adverse Event|0|||
156769804|NCT05569174|565913066|FG001|Overall Study|Adverse Event|1|||
156769805|NCT05569174|565913065|FG000|Overall Study|Lack of compliance|0|||
156769806|NCT05569174|565913066|FG001|Overall Study|Lack of compliance|1|||
156769807|NCT05569174|565913065|FG000|Overall Study|Withdrawal of consent|0|||
156769808|NCT05569174|565913066|FG001|Overall Study|Withdrawal of consent|1|||
156769809|NCT05569174|565913065|FG000|Overall Study|Participant wish|0|||
156769810|NCT05569174|565913066|FG001|Overall Study|Participant wish|1|||
156769811|NCT05569174|565913065|FG000|Overall Study|Lost to Follow-up|0|||
156769812|NCT05569174|565913066|FG001|Overall Study|Lost to Follow-up|1|||
156769813|NCT00112957|565913067|FG000|Overall Study|Progressive disease|18|||
156769814|NCT00112957|565913067|FG000|Overall Study|Physician Decision|1|||
156769815|NCT00961415|565913068|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
156769816|NCT00961415|565913069|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
156769817|NCT00961415|565913070|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
156769818|NCT00961415|565913068|FG000|Induction Treatment Phase|Death|77|||
156769819|NCT00961415|565913069|FG001|Induction Treatment Phase|Death|0|||
156769820|NCT00961415|565913070|FG002|Induction Treatment Phase|Death|0|||
156769821|NCT00961415|565913068|FG000|Induction Treatment Phase|Protocol Violation|1|||
156769822|NCT00961415|565913069|FG001|Induction Treatment Phase|Protocol Violation|0|||
156769823|NCT00961415|565913070|FG002|Induction Treatment Phase|Protocol Violation|0|||
156769824|NCT00961415|565913068|FG000|Induction Treatment Phase|Physician Decision|2|||
156769825|NCT00961415|565913069|FG001|Induction Treatment Phase|Physician Decision|0|||
156769826|NCT00961415|565913070|FG002|Induction Treatment Phase|Physician Decision|0|||
156769827|NCT00961415|565913068|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
156769828|NCT00961415|565913069|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
156769829|NCT00961415|565913070|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
156769830|NCT00961415|565913068|FG000|Induction Treatment Phase|Other Reason|5|||
156769831|NCT00961415|565913069|FG001|Induction Treatment Phase|Other Reason|0|||
156769832|NCT00961415|565913070|FG002|Induction Treatment Phase|Other Reason|0|||
156769833|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Death|0|||
156769834|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Death|42|||
156769835|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Death|34|||
156769836|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Investigators decision|0|||
156769837|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Investigators decision|2|||
156769838|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Investigators decision|0|||
156769839|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156769840|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
156769841|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
156769842|NCT00961415|565913068|FG000|Maintenance Treatment Phase|Other reason|0|||
156769843|NCT00961415|565913069|FG001|Maintenance Treatment Phase|Other reason|1|||
156769844|NCT00961415|565913070|FG002|Maintenance Treatment Phase|Other reason|3|||
156769845|NCT02309359|565913071|FG000|Overall Study|Adverse Event|4|||
156769846|NCT02309359|565913072|FG001|Overall Study|Adverse Event|5|||
156769847|NCT02309359|565913073|FG002|Overall Study|Adverse Event|5|||
156769848|NCT02309359|565913074|FG003|Overall Study|Adverse Event|4|||
156769849|NCT02309359|565913075|FG004|Overall Study|Adverse Event|4|||
156769850|NCT02309359|565913071|FG000|Overall Study|Death|1|||
156769851|NCT02309359|565913072|FG001|Overall Study|Death|0|||
156769852|NCT02309359|565913073|FG002|Overall Study|Death|0|||
156769853|NCT02309359|565913074|FG003|Overall Study|Death|0|||
156769854|NCT02309359|565913075|FG004|Overall Study|Death|0|||
156769855|NCT02309359|565913071|FG000|Overall Study|Withdrawal by Subject|2|||
156769856|NCT02309359|565913072|FG001|Overall Study|Withdrawal by Subject|2|||
156769857|NCT02309359|565913073|FG002|Overall Study|Withdrawal by Subject|4|||
156769858|NCT02309359|565913074|FG003|Overall Study|Withdrawal by Subject|4|||
156769859|NCT02309359|565913075|FG004|Overall Study|Withdrawal by Subject|0|||
156769860|NCT02309359|565913071|FG000|Overall Study|Lack of Efficacy|3|||
156769861|NCT02309359|565913072|FG001|Overall Study|Lack of Efficacy|1|||
156769862|NCT02309359|565913073|FG002|Overall Study|Lack of Efficacy|0|||
156769863|NCT02309359|565913074|FG003|Overall Study|Lack of Efficacy|0|||
156769864|NCT02309359|565913075|FG004|Overall Study|Lack of Efficacy|3|||
156769865|NCT02309359|565913071|FG000|Overall Study|Lost to Follow-up|0|||
156769866|NCT02309359|565913072|FG001|Overall Study|Lost to Follow-up|0|||
156769867|NCT02309359|565913073|FG002|Overall Study|Lost to Follow-up|0|||
156769868|NCT02309359|565913074|FG003|Overall Study|Lost to Follow-up|1|||
156769869|NCT02309359|565913075|FG004|Overall Study|Lost to Follow-up|0|||
156769870|NCT02309359|565913071|FG000|Overall Study|Other|2|||
156769871|NCT02309359|565913072|FG001|Overall Study|Other|0|||
156769872|NCT02309359|565913073|FG002|Overall Study|Other|2|||
156769873|NCT02309359|565913074|FG003|Overall Study|Other|3|||
156769874|NCT02309359|565913075|FG004|Overall Study|Other|2|||
156769875|NCT06129149|565913078|FG000|Overall Study|Death|1|||
156769876|NCT04649359|565913079|FG000|Overall Study|Withdrawal by Subject|7|||
156769877|NCT04649359|565913080|FG001|Overall Study|Withdrawal by Subject|7|||
156769878|NCT04649359|565913079|FG000|Overall Study|Death|41|||
156769879|NCT04649359|565913080|FG001|Overall Study|Death|26|||
156769880|NCT04649359|565913079|FG000|Overall Study|Ongoing in the study|75|||
156769881|NCT04649359|565913080|FG001|Overall Study|Ongoing in the study|31|||
156769882|NCT05595369|565913081|FG000|Overall Study|Adverse Event|2|||
156769883|NCT05595369|565913082|FG001|Overall Study|Adverse Event|0|||
156769884|NCT05595369|565913083|FG002|Overall Study|Adverse Event|0|||
156769885|NCT05595369|565913081|FG000|Overall Study|Lost to Follow-up|11|||
156769886|NCT05595369|565913082|FG001|Overall Study|Lost to Follow-up|10|||
156769887|NCT05595369|565913083|FG002|Overall Study|Lost to Follow-up|10|||
156769888|NCT05595369|565913081|FG000|Overall Study|Physician Decision|1|||
156769889|NCT05595369|565913082|FG001|Overall Study|Physician Decision|0|||
156769890|NCT05595369|565913083|FG002|Overall Study|Physician Decision|0|||
156769891|NCT05595369|565913081|FG000|Overall Study|Withdrawal by Subject|5|||
156769892|NCT05595369|565913082|FG001|Overall Study|Withdrawal by Subject|7|||
156769893|NCT05595369|565913083|FG002|Overall Study|Withdrawal by Subject|6|||
156769894|NCT05595369|565913081|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156769895|NCT05595369|565913082|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
156769896|NCT05595369|565913083|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
156769897|NCT05595369|565913081|FG000|Overall Study|Study Drug Non-compliance|0|||
156769898|NCT05595369|565913082|FG001|Overall Study|Study Drug Non-compliance|1|||
156769899|NCT05595369|565913083|FG002|Overall Study|Study Drug Non-compliance|0|||
156769900|NCT05595369|565913081|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
156769901|NCT05595369|565913082|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
156769902|NCT05595369|565913083|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
156769903|NCT06494761|565913084|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
156769904|NCT06494761|565913084|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
156769905|NCT04865289|565913086|FG000|Overall Study|Death|34|||
156769906|NCT04865289|565913087|FG001|Overall Study|Death|25|||
156769907|NCT04865289|565913086|FG000|Overall Study|Physician Decision|27|||
156769908|NCT04865289|565913087|FG001|Overall Study|Physician Decision|27|||
156769909|NCT04865289|565913086|FG000|Overall Study|Sponsor Decision|11|||
156769910|NCT04865289|565913087|FG001|Overall Study|Sponsor Decision|1|||
156769911|NCT04865289|565913086|FG000|Overall Study|Withdrawal by Subject|2|||
156769912|NCT04865289|565913087|FG001|Overall Study|Withdrawal by Subject|3|||
156769913|NCT02867592|565913088|FG000|Overall Study|Adverse Event|3|||
156769914|NCT02867592|565913089|FG001|Overall Study|Adverse Event|0|||
156769915|NCT02867592|565913090|FG002|Overall Study|Adverse Event|2|||
156769916|NCT02867592|565913091|FG003|Overall Study|Adverse Event|1|||
156769917|NCT02867592|565913092|FG004|Overall Study|Adverse Event|1|||
156769918|NCT02867592|565913093|FG005|Overall Study|Adverse Event|5|||
156769919|NCT02867592|565913088|FG000|Overall Study|Death|0|||
156769920|NCT02867592|565913089|FG001|Overall Study|Death|0|||
156769921|NCT02867592|565913090|FG002|Overall Study|Death|0|||
156769922|NCT02867592|565913091|FG003|Overall Study|Death|1|||
156769923|NCT02867592|565913092|FG004|Overall Study|Death|0|||
156769924|NCT02867592|565913093|FG005|Overall Study|Death|1|||
156769925|NCT02867592|565913088|FG000|Overall Study|Lack of Efficacy|8|||
156769926|NCT02867592|565913089|FG001|Overall Study|Lack of Efficacy|10|||
156769927|NCT02867592|565913090|FG002|Overall Study|Lack of Efficacy|8|||
156769928|NCT02867592|565913091|FG003|Overall Study|Lack of Efficacy|8|||
156769929|NCT02867592|565913092|FG004|Overall Study|Lack of Efficacy|12|||
156769930|NCT02867592|565913093|FG005|Overall Study|Lack of Efficacy|17|||
156769931|NCT02867592|565913088|FG000|Overall Study|Physician Decision|1|||
156769932|NCT02867592|565913089|FG001|Overall Study|Physician Decision|2|||
156769933|NCT02867592|565913090|FG002|Overall Study|Physician Decision|2|||
156769934|NCT02867592|565913091|FG003|Overall Study|Physician Decision|0|||
156769935|NCT02867592|565913092|FG004|Overall Study|Physician Decision|5|||
156769936|NCT02867592|565913093|FG005|Overall Study|Physician Decision|1|||
156769937|NCT02867592|565913088|FG000|Overall Study|Protocol Violation|0|||
156769938|NCT02867592|565913089|FG001|Overall Study|Protocol Violation|0|||
156769939|NCT02867592|565913090|FG002|Overall Study|Protocol Violation|0|||
156769940|NCT02867592|565913091|FG003|Overall Study|Protocol Violation|0|||
156769941|NCT02867592|565913092|FG004|Overall Study|Protocol Violation|1|||
156769942|NCT02867592|565913093|FG005|Overall Study|Protocol Violation|1|||
156769943|NCT02867592|565913088|FG000|Overall Study|Withdrawal by Subject|0|||
156769944|NCT02867592|565913089|FG001|Overall Study|Withdrawal by Subject|1|||
156769945|NCT02867592|565913090|FG002|Overall Study|Withdrawal by Subject|0|||
156769946|NCT02867592|565913091|FG003|Overall Study|Withdrawal by Subject|1|||
156769947|NCT02867592|565913092|FG004|Overall Study|Withdrawal by Subject|3|||
156769948|NCT02867592|565913093|FG005|Overall Study|Withdrawal by Subject|3|||
156769949|NCT02867592|565913088|FG000|Overall Study|Ineligible|1|||
156769950|NCT02867592|565913089|FG001|Overall Study|Ineligible|1|||
156769951|NCT02867592|565913090|FG002|Overall Study|Ineligible|0|||
156769952|NCT02867592|565913091|FG003|Overall Study|Ineligible|0|||
156769953|NCT02867592|565913092|FG004|Overall Study|Ineligible|2|||
156769954|NCT02867592|565913093|FG005|Overall Study|Ineligible|0|||
156769955|NCT02867592|565913088|FG000|Overall Study|No Treatment|1|||
156769956|NCT02867592|565913089|FG001|Overall Study|No Treatment|0|||
156769957|NCT02867592|565913090|FG002|Overall Study|No Treatment|0|||
156769958|NCT02867592|565913091|FG003|Overall Study|No Treatment|0|||
156769959|NCT02867592|565913092|FG004|Overall Study|No Treatment|0|||
156769960|NCT02867592|565913093|FG005|Overall Study|No Treatment|0|||
156769961|NCT02867592|565913088|FG000|Overall Study|Still on Therapy|0|||
156769962|NCT02867592|565913089|FG001|Overall Study|Still on Therapy|0|||
156769963|NCT02867592|565913090|FG002|Overall Study|Still on Therapy|0|||
156769964|NCT02867592|565913091|FG003|Overall Study|Still on Therapy|0|||
156769965|NCT02867592|565913092|FG004|Overall Study|Still on Therapy|1|||
156769966|NCT02867592|565913093|FG005|Overall Study|Still on Therapy|0|||
156769967|NCT02867592|565913088|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769968|NCT02867592|565913089|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769969|NCT02867592|565913090|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769970|NCT02867592|565913091|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769971|NCT02867592|565913092|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
156769972|NCT02867592|565913093|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
156769973|NCT02867592|565913088|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
156769974|NCT02867592|565913089|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769975|NCT02867592|565913090|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
156769976|NCT02867592|565913091|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
156769977|NCT02867592|565913092|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769978|NCT02867592|565913093|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
156769979|NCT00909870|565913094|FG000|Overall Study|Adverse Event|13|||
156769980|NCT00909870|565913095|FG001|Overall Study|Adverse Event|7|||
156769981|NCT00909870|565913094|FG000|Overall Study|Protocol Violation|1|||
156769982|NCT00909870|565913095|FG001|Overall Study|Protocol Violation|2|||
156769983|NCT00909870|565913094|FG000|Overall Study|Withdrawal by Subject|5|||
156769984|NCT00909870|565913095|FG001|Overall Study|Withdrawal by Subject|8|||
156769985|NCT00909870|565913094|FG000|Overall Study|Lost to Follow-up|3|||
156769986|NCT00909870|565913095|FG001|Overall Study|Lost to Follow-up|3|||
156769987|NCT00909870|565913094|FG000|Overall Study|Physician Decision|0|||
156769988|NCT00909870|565913095|FG001|Overall Study|Physician Decision|2|||
156769989|NCT00909870|565913094|FG000|Overall Study|Other|1|||
156769990|NCT00909870|565913095|FG001|Overall Study|Other|5|||
156769991|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
156769992|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
156769993|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769994|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769995|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769996|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769997|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769998|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156769999|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156770000|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
156770001|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
156770002|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
156770003|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770004|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770005|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770006|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770007|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770008|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770009|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770010|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
156770011|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
156770012|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770013|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
157007070|NCT03654768|566775119|FG000|Overall Study|Refusal not related to toxicity|1|||
157007071|NCT03654768|566775120|FG001|Overall Study|Refusal not related to toxicity|5|||
156770014|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770015|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770016|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770017|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770018|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770019|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770020|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
156770021|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
156770022|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
156770023|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770024|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770025|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770026|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770027|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770028|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770029|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
157007072|NCT03654768|566775119|FG000|Overall Study|Did not receive protocol therapy|1|||
157007073|NCT03654768|566775120|FG001|Overall Study|Did not receive protocol therapy|1|||
157007074|NCT00588770|566775121|FG000|Overall Study|Disease progression|85|||
157007075|NCT00588770|566775122|FG001|Overall Study|Disease progression|68|||
157007076|NCT00588770|566775121|FG000|Overall Study|Adverse Event|29|||
156770030|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
156770031|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
156770032|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
156770033|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770034|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770035|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770036|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770037|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770038|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770039|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770040|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
156770041|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
156770042|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
156770043|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770044|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770045|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770046|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770047|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770048|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770049|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770050|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
156770051|NCT01232283|565913098|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
156770052|NCT01232283|565913099|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
156770053|NCT01232283|565913100|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770054|NCT01232283|565913101|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770055|NCT01232283|565913102|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770056|NCT01232283|565913103|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770057|NCT01232283|565913104|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770058|NCT01232283|565913105|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770059|NCT01232283|565913106|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770060|NCT01232283|565913107|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
156770061|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770062|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770063|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
156770064|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
156770065|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770066|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770067|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770068|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770069|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770070|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
156770071|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770072|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770073|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
156770074|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
156770075|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770076|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770077|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770078|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770079|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770080|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
156770081|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770082|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770083|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
156770084|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770085|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770086|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770087|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770088|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770089|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770090|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
156770091|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770092|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770093|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
156770094|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
156770095|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770096|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770097|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770098|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770099|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770100|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
156770101|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770102|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770103|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
156770104|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
156770105|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770106|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770107|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770108|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770109|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770110|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
156770111|NCT01232283|565913098|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
156770112|NCT01232283|565913099|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
156770113|NCT01232283|565913100|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
156770114|NCT01232283|565913101|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
156770115|NCT01232283|565913102|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
156770116|NCT01232283|565913103|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
156770117|NCT01232283|565913104|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
156770118|NCT01232283|565913105|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
156770119|NCT01232283|565913106|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
156770120|NCT01232283|565913107|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
156770121|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770122|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770123|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770124|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770125|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
156770126|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
156770127|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770128|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
156770129|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770130|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
156770131|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770132|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770133|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770134|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770135|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
156770136|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770137|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
156770138|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
156770139|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770140|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
156770141|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770142|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770143|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770144|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770145|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770146|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770147|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
156770148|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
156770149|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770150|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
156770151|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770152|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770153|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770154|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770155|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
156770156|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770157|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770158|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770159|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770160|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
156770161|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770162|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770163|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770164|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770165|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
156770166|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770167|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
156770168|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
156770169|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770170|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
156770171|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770172|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770173|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770174|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770175|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770176|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770177|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770178|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
156770179|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770180|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
156770181|NCT01232283|565913098|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770182|NCT01232283|565913099|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770183|NCT01232283|565913100|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770184|NCT01232283|565913101|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770185|NCT01232283|565913102|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770186|NCT01232283|565913103|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
156770187|NCT01232283|565913104|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770188|NCT01232283|565913105|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770189|NCT01232283|565913106|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770190|NCT01232283|565913107|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
156770191|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770192|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770193|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770194|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770195|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770196|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770197|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770198|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
156770199|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
156770200|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
156770201|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770202|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
157007077|NCT00588770|566775122|FG001|Overall Study|Adverse Event|58|||
156770203|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770204|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770205|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770206|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770207|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770208|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
156770209|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
156770210|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
156770211|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770212|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770213|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770214|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770215|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770216|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770217|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770218|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
156770219|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
156770220|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
156770221|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770222|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770223|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770224|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770225|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770226|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770227|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770228|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
156770229|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
156770230|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
156770231|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770232|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770233|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770234|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770235|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770236|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770237|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770238|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
156770239|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
156770240|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
156770241|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770242|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770243|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770244|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770245|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770246|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
157112554|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
156770247|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770248|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770249|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
156770250|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
156770251|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770252|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770253|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770254|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770255|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770256|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770257|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770258|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770259|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
156770260|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
156770261|NCT01232283|565913098|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770262|NCT01232283|565913099|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770263|NCT01232283|565913100|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
157112555|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
157112556|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
156770264|NCT01232283|565913101|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770265|NCT01232283|565913102|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770266|NCT01232283|565913103|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770267|NCT01232283|565913104|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770268|NCT01232283|565913105|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
156770269|NCT01232283|565913106|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
156770270|NCT01232283|565913107|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
156770271|NCT03824561|565913108|FG000|Overall Study|Protocol Violation|19|||
156770272|NCT01773928|565913110|FG000|Overall Study|Adverse Event|0|||
156770273|NCT01773928|565913111|FG001|Overall Study|Adverse Event|0|||
156770274|NCT01773928|565913112|FG002|Overall Study|Adverse Event|0|||
156770275|NCT01773928|565913113|FG003|Overall Study|Adverse Event|0|||
156770276|NCT01773928|565913114|FG004|Overall Study|Adverse Event|0|||
156770277|NCT01773928|565913115|FG005|Overall Study|Adverse Event|0|||
156770278|NCT01773928|565913116|FG006|Overall Study|Adverse Event|0|||
156770279|NCT01773928|565913117|FG007|Overall Study|Adverse Event|1|||
156770280|NCT01773928|565913118|FG008|Overall Study|Adverse Event|0|||
156770281|NCT01773928|565913110|FG000|Overall Study|Physician Decision|0|||
156770282|NCT01773928|565913111|FG001|Overall Study|Physician Decision|0|||
156770283|NCT01773928|565913112|FG002|Overall Study|Physician Decision|0|||
156770284|NCT01773928|565913113|FG003|Overall Study|Physician Decision|1|||
156770285|NCT01773928|565913114|FG004|Overall Study|Physician Decision|0|||
156770286|NCT01773928|565913115|FG005|Overall Study|Physician Decision|0|||
156770287|NCT01773928|565913116|FG006|Overall Study|Physician Decision|0|||
156770288|NCT01773928|565913117|FG007|Overall Study|Physician Decision|0|||
156770289|NCT01773928|565913118|FG008|Overall Study|Physician Decision|0|||
156770290|NCT01773928|565913110|FG000|Overall Study|Withdrawal by Subject|5|||
156770291|NCT01773928|565913111|FG001|Overall Study|Withdrawal by Subject|4|||
156770292|NCT01773928|565913112|FG002|Overall Study|Withdrawal by Subject|4|||
156770293|NCT01773928|565913113|FG003|Overall Study|Withdrawal by Subject|4|||
156770294|NCT01773928|565913114|FG004|Overall Study|Withdrawal by Subject|7|||
156770295|NCT01773928|565913115|FG005|Overall Study|Withdrawal by Subject|1|||
156770296|NCT01773928|565913116|FG006|Overall Study|Withdrawal by Subject|0|||
156770297|NCT01773928|565913117|FG007|Overall Study|Withdrawal by Subject|0|||
156770298|NCT01773928|565913118|FG008|Overall Study|Withdrawal by Subject|1|||
156770299|NCT01773928|565913110|FG000|Overall Study|Lost to Follow-up|0|||
156770300|NCT01773928|565913111|FG001|Overall Study|Lost to Follow-up|0|||
157007078|NCT00588770|566775121|FG000|Overall Study|Death|13|||
157112557|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
157112558|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
157112559|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
157112560|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
157112561|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
157112562|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
157112563|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
157112564|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
157112565|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
157112566|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
157112567|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
157112568|NCT00492752|567166740|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
157112569|NCT00492752|567166741|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
157112570|NCT00492752|567166742|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
157112571|NCT00492752|567166743|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
157112572|NCT02581202|567166749|FG000|Overall Study|Lack of Efficacy|2|||
157112573|NCT02581202|567166749|FG000|Overall Study|Withdrawal by Subject|4|||
157112574|NCT02581202|567166749|FG000|Overall Study|Lost to Follow-up|5|||
157112575|NCT02581202|567166749|FG000|Overall Study|Pregnancy|3|||
157112576|NCT04050982|567166750|FG000|Overall Study|Did not meet eligibility criteria|0|||
157112577|NCT04050982|567166751|FG001|Overall Study|Did not meet eligibility criteria|1|||
157112578|NCT04050982|567166752|FG002|Overall Study|Did not meet eligibility criteria|0|||
157112579|NCT04050982|567166750|FG000|Overall Study|Withdrawal by Subject|1|||
157206888|NCT00440193|567501235|FG001|Observational Period|Clinical endpoint reached|0|||
157206889|NCT00440193|567501234|FG000|Observational Period|Participant convenience|2|||
157206890|NCT00440193|567501235|FG001|Observational Period|Participant convenience|0|||
157206891|NCT00834366|567501236|FG000|Treatment Period 1|Adverse Event|1|||
157206892|NCT00834366|567501237|FG001|Treatment Period 1|Adverse Event|1|||
157206893|NCT03014570|567501238|FG000|Overall Study|COVID-19 Restrictions|38|||
157206894|NCT03014570|567501239|FG001|Overall Study|COVID-19 Restrictions|24|||
157206895|NCT03014570|567501238|FG000|Overall Study|Death|70|||
157206896|NCT03014570|567501239|FG001|Overall Study|Death|79|||
157206897|NCT03014570|567501238|FG000|Overall Study|Transfer from facility|11|||
157206898|NCT03014570|567501239|FG001|Overall Study|Transfer from facility|14|||
157206899|NCT03014570|567501238|FG000|Overall Study|Hospitalized|5|||
157206900|NCT03014570|567501239|FG001|Overall Study|Hospitalized|3|||
157206901|NCT03014570|567501238|FG000|Overall Study|Transfer within facility|1|||
157206902|NCT03014570|567501239|FG001|Overall Study|Transfer within facility|0|||
157206903|NCT03014570|567501238|FG000|Overall Study|Site refusal|0|||
157206904|NCT03014570|567501239|FG001|Overall Study|Site refusal|11|||
157206905|NCT01154673|567501245|FG000|Overall Study|Lost to Follow-up|1|||
157112580|NCT04050982|567166751|FG001|Overall Study|Withdrawal by Subject|0|||
157206906|NCT01154673|567501246|FG001|Overall Study|Lost to Follow-up|0|||
157206907|NCT01154673|567501245|FG000|Overall Study|moved out of province|1|||
157206908|NCT01154673|567501246|FG001|Overall Study|moved out of province|0|||
157206909|NCT01216319|567501249|FG000|Overall Study|Lost to Follow-up|2|||
157206910|NCT01216319|567501249|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
157206911|NCT02666768|567501250|FG000|Overall Study|Withdrawal by Subject|4|||
157206912|NCT01023022|567501253|FG000|Overall Study|Death|5|||
157206913|NCT01023022|567501253|FG000|Overall Study|Lost to Follow-up|7|||
157206914|NCT01023022|567501253|FG000|Overall Study|due to technical issues|2|||
157206915|NCT03728257|567501254|FG000|Overall Study|Death|3|||
157206916|NCT03728257|567501255|FG001|Overall Study|Death|0|||
157206917|NCT00905437|567501257|FG000|Overall Study|Adverse Event|3|||
157206918|NCT00905437|567501258|FG001|Overall Study|Adverse Event|2|||
157206919|NCT00905437|567501257|FG000|Overall Study|Lost to Follow-up|0|||
157206920|NCT00905437|567501258|FG001|Overall Study|Lost to Follow-up|1|||
157206921|NCT00905437|567501257|FG000|Overall Study|Withdrawal by Subject|0|||
157206922|NCT00905437|567501258|FG001|Overall Study|Withdrawal by Subject|1|||
157206923|NCT00905437|567501257|FG000|Overall Study|Other|5|||
157206924|NCT00905437|567501258|FG001|Overall Study|Other|6|||
157206925|NCT01306968|567501259|FG000|Overall Study|Lost to Follow-up|1|||
157206926|NCT01306968|567501260|FG001|Overall Study|Lost to Follow-up|1|||
157206927|NCT01306968|567501261|FG002|Overall Study|Lost to Follow-up|0|||
157206928|NCT01306968|567501262|FG003|Overall Study|Lost to Follow-up|0|||
157206929|NCT01306968|567501259|FG000|Overall Study|Physician Decision|0|||
157206930|NCT01306968|567501260|FG001|Overall Study|Physician Decision|1|||
157206931|NCT01306968|567501261|FG002|Overall Study|Physician Decision|0|||
157206932|NCT01306968|567501262|FG003|Overall Study|Physician Decision|0|||
157206933|NCT01306968|567501259|FG000|Overall Study|Relocated and left active duty|0|||
157206934|NCT01306968|567501260|FG001|Overall Study|Relocated and left active duty|1|||
157007079|NCT00588770|566775122|FG001|Overall Study|Death|22|||
157206935|NCT01306968|567501261|FG002|Overall Study|Relocated and left active duty|1|||
157206936|NCT01306968|567501262|FG003|Overall Study|Relocated and left active duty|1|||
157206937|NCT01306968|567501259|FG000|Overall Study|Withdrew - time commitment|0|||
156770301|NCT01773928|565913112|FG002|Overall Study|Lost to Follow-up|0|||
157007080|NCT00588770|566775121|FG000|Overall Study|Withdrawal by Subject|15|||
157206938|NCT01306968|567501260|FG001|Overall Study|Withdrew - time commitment|0|||
157206939|NCT01306968|567501261|FG002|Overall Study|Withdrew - time commitment|0|||
157206940|NCT01306968|567501262|FG003|Overall Study|Withdrew - time commitment|2|||
157206941|NCT01306968|567501259|FG000|Overall Study|Withdrew over privacy concerns|0|||
157206942|NCT01306968|567501260|FG001|Overall Study|Withdrew over privacy concerns|0|||
157206943|NCT01306968|567501261|FG002|Overall Study|Withdrew over privacy concerns|0|||
157206944|NCT01306968|567501262|FG003|Overall Study|Withdrew over privacy concerns|1|||
157206945|NCT03128931|567501265|FG000|Overall Study|Physician Decision|1|||
157206946|NCT03128931|567501265|FG000|Overall Study|Equipment Issues|3|||
157206947|NCT03252015|567501266|FG000|Overall Study|Withdrawal by Subject|0|||
157206948|NCT03252015|567501267|FG001|Overall Study|Withdrawal by Subject|1|||
157206949|NCT03252015|567501268|FG002|Overall Study|Withdrawal by Subject|1|||
157206950|NCT03252015|567501269|FG003|Overall Study|Withdrawal by Subject|0|||
157206951|NCT03252015|567501266|FG000|Overall Study|Adverse Event|1|||
157112581|NCT04050982|567166752|FG002|Overall Study|Withdrawal by Subject|0|||
157112582|NCT04050982|567166750|FG000|Overall Study|Unable to enroll on platform|1|||
157112583|NCT04050982|567166751|FG001|Overall Study|Unable to enroll on platform|0|||
157112584|NCT04050982|567166752|FG002|Overall Study|Unable to enroll on platform|0|||
157112585|NCT04218201|567168368|FG000|Overall Study|Death|0|||
157112586|NCT04218201|567168369|FG001|Overall Study|Death|0|||
157112587|NCT04218201|567168370|FG002|Overall Study|Death|2|||
157112588|NCT04218201|567168371|FG003|Overall Study|Death|0|||
157007081|NCT00588770|566775122|FG001|Overall Study|Withdrawal by Subject|25|||
157112589|NCT04218201|567168368|FG000|Overall Study|Unable to contact participant|4|||
157112590|NCT04218201|567168369|FG001|Overall Study|Unable to contact participant|0|||
157112591|NCT04218201|567168370|FG002|Overall Study|Unable to contact participant|3|||
157112592|NCT04218201|567168371|FG003|Overall Study|Unable to contact participant|0|||
157112593|NCT04218201|567168368|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
157112594|NCT04218201|567168369|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
157112595|NCT04218201|567168370|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
157112596|NCT04218201|567168371|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
157112597|NCT04218201|567168368|FG000|Overall Study|Withdrawal by Subject|2|||
157112598|NCT04218201|567168369|FG001|Overall Study|Withdrawal by Subject|0|||
157112599|NCT04218201|567168370|FG002|Overall Study|Withdrawal by Subject|0|||
157112600|NCT04218201|567168371|FG003|Overall Study|Withdrawal by Subject|0|||
157112601|NCT04218201|567168368|FG000|Overall Study|PCP plans to leave practice|0|||
157112602|NCT04218201|567168369|FG001|Overall Study|PCP plans to leave practice|8|||
157112603|NCT04218201|567168370|FG002|Overall Study|PCP plans to leave practice|0|||
157112604|NCT04218201|567168371|FG003|Overall Study|PCP plans to leave practice|5|||
157112605|NCT04218201|567168368|FG000|Overall Study|Reduced panel|0|||
157112606|NCT04218201|567168369|FG001|Overall Study|Reduced panel|0|||
157112607|NCT04218201|567168370|FG002|Overall Study|Reduced panel|0|||
157112608|NCT04218201|567168371|FG003|Overall Study|Reduced panel|1|||
157112609|NCT04218201|567168368|FG000|Overall Study|No longer interested in participating|0|||
157112610|NCT04218201|567168369|FG001|Overall Study|No longer interested in participating|1|||
157112611|NCT04218201|567168370|FG002|Overall Study|No longer interested in participating|0|||
157112612|NCT04218201|567168371|FG003|Overall Study|No longer interested in participating|0|||
157112613|NCT04649255|567168372|FG000|Overall Study|Death|9|||
157112614|NCT04649255|567168372|FG000|Overall Study|Withdrawal by Subject|1|||
157112615|NCT02222207|567168373|FG000|Overall Study|Death|1|||
157112616|NCT02222207|567168373|FG000|Overall Study|Other reasons|2|||
157112617|NCT02222207|567168373|FG000|Overall Study|Adverse Event|1|||
157112618|NCT04682405|567168374|FG000|Overall Study|Adverse Event|0|||
157112619|NCT04682405|567168375|FG001|Overall Study|Adverse Event|1|||
157112620|NCT03557281|567168376|FG000|Overall Study|Investigator discretion|0|||
157112621|NCT03557281|567168377|FG001|Overall Study|Investigator discretion|0|||
157112622|NCT03557281|567168378|FG002|Overall Study|Investigator discretion|1|||
157112623|NCT03557281|567168379|FG003|Overall Study|Investigator discretion|0|||
157112624|NCT03557281|567168380|FG004|Overall Study|Investigator discretion|0|||
157112625|NCT03557281|567168376|FG000|Overall Study|Withdrawal by Subject|0|||
157112626|NCT03557281|567168377|FG001|Overall Study|Withdrawal by Subject|1|||
157112627|NCT03557281|567168378|FG002|Overall Study|Withdrawal by Subject|1|||
157112628|NCT03557281|567168379|FG003|Overall Study|Withdrawal by Subject|1|||
157112629|NCT03557281|567168380|FG004|Overall Study|Withdrawal by Subject|2|||
157112630|NCT03557281|567168376|FG000|Overall Study|Randomized, but did not receive treatment|0|||
157112631|NCT03557281|567168377|FG001|Overall Study|Randomized, but did not receive treatment|0|||
157112632|NCT03557281|567168378|FG002|Overall Study|Randomized, but did not receive treatment|0|||
157112633|NCT03557281|567168379|FG003|Overall Study|Randomized, but did not receive treatment|0|||
157112634|NCT03557281|567168380|FG004|Overall Study|Randomized, but did not receive treatment|1|||
157112635|NCT01199042|567168381|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
157112636|NCT01199042|567168381|FG000|At Home (3 Months)|Lost to Follow-up|1|||
157112637|NCT03357731|567168384|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
157112638|NCT03357731|567168385|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
157112639|NCT03357731|567168386|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
157112640|NCT03357731|567168387|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
157112641|NCT03357731|567168388|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
157112642|NCT03357731|567168389|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
157112643|NCT03357731|567168384|FG000|Overall Study|Acute bradycardia and hypotension|0|||
157112644|NCT03357731|567168385|FG001|Overall Study|Acute bradycardia and hypotension|0|||
157112645|NCT03357731|567168386|FG002|Overall Study|Acute bradycardia and hypotension|0|||
157112646|NCT03357731|567168387|FG003|Overall Study|Acute bradycardia and hypotension|1|||
157112647|NCT03357731|567168388|FG004|Overall Study|Acute bradycardia and hypotension|0|||
157112648|NCT03357731|567168389|FG005|Overall Study|Acute bradycardia and hypotension|0|||
157112649|NCT03357731|567168384|FG000|Overall Study|Adverse Event|0|||
157112650|NCT03357731|567168385|FG001|Overall Study|Adverse Event|0|||
157112651|NCT03357731|567168386|FG002|Overall Study|Adverse Event|0|||
157112652|NCT03357731|567168387|FG003|Overall Study|Adverse Event|0|||
157112653|NCT03357731|567168388|FG004|Overall Study|Adverse Event|0|||
157112654|NCT03357731|567168389|FG005|Overall Study|Adverse Event|1|||
157112655|NCT03357731|567168384|FG000|Overall Study|Hypotension|0|||
157112656|NCT03357731|567168385|FG001|Overall Study|Hypotension|0|||
157112657|NCT03357731|567168386|FG002|Overall Study|Hypotension|1|||
157112658|NCT03357731|567168387|FG003|Overall Study|Hypotension|1|||
157112659|NCT03357731|567168388|FG004|Overall Study|Hypotension|0|||
157112660|NCT03357731|567168389|FG005|Overall Study|Hypotension|0|||
157112661|NCT03357731|567168384|FG000|Overall Study|Lost to Follow-up|0|||
157112662|NCT03357731|567168385|FG001|Overall Study|Lost to Follow-up|0|||
157112663|NCT03357731|567168386|FG002|Overall Study|Lost to Follow-up|0|||
157112664|NCT03357731|567168387|FG003|Overall Study|Lost to Follow-up|1|||
157112665|NCT03357731|567168388|FG004|Overall Study|Lost to Follow-up|0|||
157112666|NCT03357731|567168389|FG005|Overall Study|Lost to Follow-up|0|||
157112667|NCT01773109|567168390|FG000|Overall Study|Symptomatic Progression|2|||
157112668|NCT01773109|567168390|FG000|Overall Study|Death|1|||
157112669|NCT04036708|567168393|FG000|Overall Study|Lost to Follow-up|14|||
157112670|NCT04036708|567168394|FG001|Overall Study|Lost to Follow-up|4|||
157112671|NCT04036708|567168395|FG002|Overall Study|Lost to Follow-up|14|||
157112672|NCT04036708|567168396|FG003|Overall Study|Lost to Follow-up|4|||
157112673|NCT01230307|567168397|FG000|Overall Study|LVAD Placement|0|||
157112674|NCT01230307|567168398|FG001|Overall Study|LVAD Placement|2|||
157112675|NCT04773106|567168399|FG000|Overall Study|Withdrawal by Subject|3|||
157112676|NCT04773106|567168399|FG000|Overall Study|Death|1|||
157112677|NCT01349465|567168401|FG000|Overall Study|Adverse Event|1|||
157112678|NCT01349465|567168402|FG001|Overall Study|Adverse Event|0|||
157112679|NCT01349465|567168401|FG000|Overall Study|Death|3|||
157112680|NCT01349465|567168402|FG001|Overall Study|Death|0|||
157112681|NCT01349465|567168401|FG000|Overall Study|Lost to Follow-up|10|||
157112682|NCT01349465|567168402|FG001|Overall Study|Lost to Follow-up|1|||
157112683|NCT01349465|567168401|FG000|Overall Study|Withdrawal by Subject|4|||
157112684|NCT01349465|567168402|FG001|Overall Study|Withdrawal by Subject|2|||
157112685|NCT01349465|567168401|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
157112686|NCT01349465|567168402|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
157112687|NCT01918007|567168407|FG000|Overall Study|Baseline oximetry not acceptable|11|||
157112688|NCT01918007|567168408|FG001|Overall Study|Baseline oximetry not acceptable|7|||
157112689|NCT01918007|567168407|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
157112690|NCT01918007|567168408|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
157112691|NCT01918007|567168407|FG000|Overall Study|Lost to Follow-up|4|||
157112692|NCT01918007|567168408|FG001|Overall Study|Lost to Follow-up|7|||
157112693|NCT01471015|567168415|FG000|Overall Study|Death|0|||
157112694|NCT01471015|567168416|FG001|Overall Study|Death|1|||
157112695|NCT01471015|567168417|FG002|Overall Study|Death|1|||
157112696|NCT04962022|567168418|FG000|Period 1|Withdrawal by Subject|1|||
157112697|NCT04962022|567168419|FG001|Period 1|Withdrawal by Subject|0|||
157112698|NCT02055820|567168422|FG000|Phase I: Dose-Finding|Death|1|||
157112699|NCT02055820|567168423|FG001|Phase I: Dose-Finding|Death|0|||
157112700|NCT02055820|567168424|FG002|Phase I: Dose-Finding|Death|1|||
157112701|NCT02055820|567168425|FG003|Phase I: Dose-Finding|Death|2|||
157112702|NCT02055820|567168426|FG004|Phase I: Dose-Finding|Death|0|||
157112703|NCT02055820|567168427|FG005|Phase I: Dose-Finding|Death|1|||
157112704|NCT02055820|567168428|FG006|Phase I: Dose-Finding|Death|1|||
157112705|NCT02055820|567168429|FG007|Phase I: Dose-Finding|Death|0|||
157112706|NCT02055820|567168430|FG008|Phase I: Dose-Finding|Death|0|||
157112707|NCT02055820|567168431|FG009|Phase I: Dose-Finding|Death|0|||
157112708|NCT02055820|567168422|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112709|NCT02055820|567168423|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112710|NCT02055820|567168424|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112711|NCT02055820|567168425|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112712|NCT02055820|567168426|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112713|NCT02055820|567168427|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
157112714|NCT02055820|567168428|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112715|NCT02055820|567168429|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112716|NCT02055820|567168430|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112717|NCT02055820|567168431|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
157112718|NCT02055820|567168422|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112719|NCT02055820|567168423|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112720|NCT02055820|567168424|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112721|NCT02055820|567168425|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
157112722|NCT02055820|567168426|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112723|NCT02055820|567168427|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112724|NCT02055820|567168428|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
157112725|NCT02055820|567168429|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112726|NCT02055820|567168430|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
157112727|NCT02055820|567168431|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
157206952|NCT03252015|567501267|FG001|Overall Study|Adverse Event|0|||
157206953|NCT03252015|567501268|FG002|Overall Study|Adverse Event|0|||
157112728|NCT02055820|567168422|FG000|Phase II: Expansion|Death|0|||
157112729|NCT02055820|567168423|FG001|Phase II: Expansion|Death|0|||
157206954|NCT03252015|567501269|FG003|Overall Study|Adverse Event|1|||
157206955|NCT04993339|567501270|FG000|Overall Study|Lost to Follow-up|0|||
157206956|NCT04993339|567501271|FG001|Overall Study|Lost to Follow-up|1|||
157112730|NCT02055820|567168424|FG002|Phase II: Expansion|Death|0|||
157112731|NCT02055820|567168425|FG003|Phase II: Expansion|Death|0|||
157112732|NCT02055820|567168426|FG004|Phase II: Expansion|Death|33|||
157112733|NCT02055820|567168427|FG005|Phase II: Expansion|Death|0|||
157112734|NCT02055820|567168428|FG006|Phase II: Expansion|Death|0|||
157112735|NCT02055820|567168429|FG007|Phase II: Expansion|Death|0|||
157112736|NCT02055820|567168430|FG008|Phase II: Expansion|Death|0|||
157112737|NCT02055820|567168431|FG009|Phase II: Expansion|Death|0|||
157112738|NCT02055820|567168422|FG000|Phase II: Expansion|Lost to Follow-up|0|||
157112739|NCT02055820|567168423|FG001|Phase II: Expansion|Lost to Follow-up|0|||
157112740|NCT02055820|567168424|FG002|Phase II: Expansion|Lost to Follow-up|0|||
157112741|NCT02055820|567168425|FG003|Phase II: Expansion|Lost to Follow-up|0|||
157112742|NCT02055820|567168426|FG004|Phase II: Expansion|Lost to Follow-up|4|||
157112743|NCT02055820|567168427|FG005|Phase II: Expansion|Lost to Follow-up|0|||
157112744|NCT02055820|567168428|FG006|Phase II: Expansion|Lost to Follow-up|0|||
157112745|NCT02055820|567168429|FG007|Phase II: Expansion|Lost to Follow-up|0|||
157112746|NCT02055820|567168430|FG008|Phase II: Expansion|Lost to Follow-up|0|||
157112747|NCT02055820|567168431|FG009|Phase II: Expansion|Lost to Follow-up|0|||
157112748|NCT02055820|567168422|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
156770302|NCT01773928|565913113|FG003|Overall Study|Lost to Follow-up|0|||
156770303|NCT01773928|565913114|FG004|Overall Study|Lost to Follow-up|0|||
156770304|NCT01773928|565913115|FG005|Overall Study|Lost to Follow-up|1|||
157112749|NCT02055820|567168423|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
157112750|NCT02055820|567168424|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
157112751|NCT02055820|567168425|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
157112752|NCT02055820|567168426|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
157112753|NCT02055820|567168427|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
157112754|NCT02055820|567168428|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
157112755|NCT02055820|567168429|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
157112756|NCT02055820|567168430|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
157112757|NCT02055820|567168431|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
157112758|NCT03962101|567168432|FG000|Overall Study|Adverse Event|1|||
157112759|NCT03962101|567168432|FG000|Overall Study|Physician Decision|2|||
157112760|NCT03962101|567168432|FG000|Overall Study|Not related to medical events|1|||
157112761|NCT00552175|567168433|FG000|Overall Study|Lack of Efficacy|2|||
157112762|NCT00552175|567168434|FG001|Overall Study|Lack of Efficacy|0|||
157112763|NCT00552175|567168435|FG002|Overall Study|Lack of Efficacy|1|||
157112764|NCT00552175|567168433|FG000|Overall Study|Adverse Event|9|||
157112765|NCT00552175|567168434|FG001|Overall Study|Adverse Event|9|||
157112766|NCT00552175|567168435|FG002|Overall Study|Adverse Event|10|||
157112767|NCT00552175|567168433|FG000|Overall Study|Withdrawal by Subject|2|||
157112768|NCT00552175|567168434|FG001|Overall Study|Withdrawal by Subject|2|||
157112769|NCT00552175|567168435|FG002|Overall Study|Withdrawal by Subject|1|||
157112770|NCT00552175|567168433|FG000|Overall Study|Lost to Follow-up|0|||
157112771|NCT00552175|567168434|FG001|Overall Study|Lost to Follow-up|0|||
157112772|NCT00552175|567168435|FG002|Overall Study|Lost to Follow-up|1|||
157112773|NCT00552175|567168433|FG000|Overall Study|Entry Criteria Not Met|1|||
157112774|NCT00552175|567168434|FG001|Overall Study|Entry Criteria Not Met|1|||
157112775|NCT00552175|567168435|FG002|Overall Study|Entry Criteria Not Met|0|||
157112776|NCT00552175|567168433|FG000|Overall Study|Reason Not Specified|3|||
157112777|NCT00552175|567168434|FG001|Overall Study|Reason Not Specified|1|||
157112778|NCT00552175|567168435|FG002|Overall Study|Reason Not Specified|1|||
157112779|NCT03548935|567168436|FG000|Overall Study|Withdrawal by Subject|26|||
157112780|NCT03548935|567168437|FG001|Overall Study|Withdrawal by Subject|17|||
157112781|NCT03548935|567168436|FG000|Overall Study|Lost to Follow-up|39|||
157112782|NCT03548935|567168437|FG001|Overall Study|Lost to Follow-up|28|||
156770305|NCT01773928|565913116|FG006|Overall Study|Lost to Follow-up|0|||
156770306|NCT01773928|565913117|FG007|Overall Study|Lost to Follow-up|0|||
156770307|NCT01773928|565913118|FG008|Overall Study|Lost to Follow-up|0|||
156770308|NCT01773928|565913110|FG000|Overall Study|Subject misrepresented age|0|||
156770309|NCT01773928|565913111|FG001|Overall Study|Subject misrepresented age|1|||
157112783|NCT03548935|567168436|FG000|Overall Study|Death|1|||
157112784|NCT03548935|567168437|FG001|Overall Study|Death|1|||
157112785|NCT01074190|567168438|FG000|Overall Study|Emergency Cesarean Delivery|1|||
157112786|NCT01074190|567168439|FG001|Overall Study|Emergency Cesarean Delivery|2|||
157112787|NCT01074190|567168440|FG002|Overall Study|Emergency Cesarean Delivery|1|||
157112788|NCT01074190|567168438|FG000|Overall Study|Protocol Violation|2|||
157112789|NCT01074190|567168439|FG001|Overall Study|Protocol Violation|1|||
157112790|NCT01074190|567168440|FG002|Overall Study|Protocol Violation|0|||
157112791|NCT01074190|567168438|FG000|Overall Study|Delivered in under 90 minutes|0|||
157112792|NCT01074190|567168439|FG001|Overall Study|Delivered in under 90 minutes|2|||
157112793|NCT01074190|567168440|FG002|Overall Study|Delivered in under 90 minutes|1|||
157112794|NCT01074190|567168438|FG000|Overall Study|Subject withdrew consent|1|||
157112795|NCT01074190|567168439|FG001|Overall Study|Subject withdrew consent|1|||
157112796|NCT01074190|567168440|FG002|Overall Study|Subject withdrew consent|1|||
157112797|NCT04607148|567168443|FG000|Overall Study|Withdrawal by Subject|0|||
157112798|NCT04607148|567168444|FG001|Overall Study|Withdrawal by Subject|4|||
157112799|NCT04607148|567168445|FG002|Overall Study|Withdrawal by Subject|2|||
157112800|NCT04607148|567168446|FG003|Overall Study|Withdrawal by Subject|8|||
157112801|NCT04607148|567168443|FG000|Overall Study|Study Terminated by Sponsor|14|||
157112802|NCT04607148|567168444|FG001|Overall Study|Study Terminated by Sponsor|59|||
157112803|NCT04607148|567168445|FG002|Overall Study|Study Terminated by Sponsor|9|||
157112804|NCT04607148|567168446|FG003|Overall Study|Study Terminated by Sponsor|39|||
157112805|NCT04607148|567168443|FG000|Overall Study|Sponsor Decision|0|||
157112806|NCT04607148|567168444|FG001|Overall Study|Sponsor Decision|0|||
157112807|NCT04607148|567168445|FG002|Overall Study|Sponsor Decision|1|||
157112808|NCT04607148|567168446|FG003|Overall Study|Sponsor Decision|0|||
157112809|NCT04607148|567168443|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157112810|NCT04607148|567168444|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157112811|NCT04607148|567168445|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157112812|NCT04607148|567168446|FG003|Overall Study|Non-Compliance With Study Drug|0|||
157112813|NCT04607148|567168443|FG000|Overall Study|Lost to Follow-up|0|||
157112814|NCT04607148|567168444|FG001|Overall Study|Lost to Follow-up|2|||
157112815|NCT04607148|567168445|FG002|Overall Study|Lost to Follow-up|0|||
157112816|NCT04607148|567168446|FG003|Overall Study|Lost to Follow-up|0|||
157112817|NCT04607148|567168443|FG000|Overall Study|Death|0|||
157112818|NCT04607148|567168444|FG001|Overall Study|Death|3|||
157112819|NCT04607148|567168445|FG002|Overall Study|Death|0|||
157112820|NCT04607148|567168446|FG003|Overall Study|Death|1|||
157112821|NCT04607148|567168443|FG000|Overall Study|Adverse Event|0|||
157112822|NCT04607148|567168444|FG001|Overall Study|Adverse Event|1|||
157112823|NCT04607148|567168445|FG002|Overall Study|Adverse Event|0|||
157112824|NCT04607148|567168446|FG003|Overall Study|Adverse Event|0|||
157112825|NCT00804570|567168447|FG000|Overall Study|Adverse Event|14|||
157112826|NCT00804570|567168448|FG001|Overall Study|Adverse Event|7|||
157112827|NCT00804570|567168447|FG000|Overall Study|Lack of Efficacy|0|||
157112828|NCT00804570|567168448|FG001|Overall Study|Lack of Efficacy|1|||
157112829|NCT00804570|567168447|FG000|Overall Study|Lost to Follow-up|18|||
157112830|NCT00804570|567168448|FG001|Overall Study|Lost to Follow-up|21|||
157112831|NCT00804570|567168447|FG000|Overall Study|Entry criteria not met|5|||
157112832|NCT00804570|567168448|FG001|Overall Study|Entry criteria not met|5|||
157112833|NCT00804570|567168447|FG000|Overall Study|Protocol Violation|12|||
157112834|NCT00804570|567168448|FG001|Overall Study|Protocol Violation|16|||
157112835|NCT00804570|567168447|FG000|Overall Study|Physician Decision|1|||
157112836|NCT00804570|567168448|FG001|Overall Study|Physician Decision|2|||
157112837|NCT00804570|567168447|FG000|Overall Study|Sponsor decision|1|||
157112838|NCT00804570|567168448|FG001|Overall Study|Sponsor decision|4|||
157206957|NCT04993339|567501270|FG000|Overall Study|no MRI scan|3|||
157206958|NCT04993339|567501271|FG001|Overall Study|no MRI scan|1|||
157206959|NCT03151226|567501272|FG000|Overall Study|Withdrawal by Subject|2|||
157206960|NCT03151226|567501272|FG000|Overall Study|not wear device correctly|1|||
157206961|NCT00903409|567501273|FG000|Overall Study|Adverse Event|11|||
157206962|NCT00903409|567501274|FG001|Overall Study|Adverse Event|9|||
157206963|NCT00903409|567501273|FG000|Overall Study|Non-compliance with Protocol|1|||
157206964|NCT00903409|567501274|FG001|Overall Study|Non-compliance with Protocol|1|||
157206965|NCT00903409|567501273|FG000|Overall Study|Laboratory Abnormality|2|||
157206966|NCT00903409|567501274|FG001|Overall Study|Laboratory Abnormality|0|||
157206967|NCT00903409|567501273|FG000|Overall Study|Withdrawal by Subject|8|||
157206968|NCT00903409|567501274|FG001|Overall Study|Withdrawal by Subject|8|||
157206969|NCT00903409|567501273|FG000|Overall Study|Other|2|||
157206970|NCT00903409|567501274|FG001|Overall Study|Other|3|||
157206971|NCT00903409|567501273|FG000|Overall Study|Lost to Follow-up|2|||
157206972|NCT00903409|567501274|FG001|Overall Study|Lost to Follow-up|6|||
157206973|NCT00797316|567501275|FG000|Overall Study|Administrative problems|1|||
157112839|NCT00804570|567168447|FG000|Overall Study|Withdrawal by Subject|21|||
157112840|NCT00804570|567168448|FG001|Overall Study|Withdrawal by Subject|38|||
157112841|NCT00290342|567168449|FG000|Overall Study|Other|0|||
157112842|NCT00290342|567168450|FG001|Overall Study|Other|1|||
157112843|NCT00290342|567168449|FG000|Overall Study|Withdrawal by Subject|6|||
157007082|NCT00588770|566775121|FG000|Overall Study|Alternative therapy|2|||
157112844|NCT00290342|567168450|FG001|Overall Study|Withdrawal by Subject|4|||
157112845|NCT00290342|567168449|FG000|Overall Study|Lost to Follow-up|1|||
157112846|NCT00290342|567168450|FG001|Overall Study|Lost to Follow-up|0|||
157112847|NCT01056510|567168453|FG000|Overall Study|Dropout Before Start of Treatment|1|||
157112848|NCT01056510|567168454|FG001|Overall Study|Dropout Before Start of Treatment|1|||
157112849|NCT01056510|567168453|FG000|Overall Study|Withdrawal by Subject|4|||
157112850|NCT01056510|567168454|FG001|Overall Study|Withdrawal by Subject|2|||
157112851|NCT01056510|567168453|FG000|Overall Study|Death|29|||
157112852|NCT01056510|567168454|FG001|Overall Study|Death|34|||
157112853|NCT01056510|567168453|FG000|Overall Study|Noncompliance|1|||
157112854|NCT01056510|567168454|FG001|Overall Study|Noncompliance|3|||
157112855|NCT01056510|567168453|FG000|Overall Study|Physician Decision|4|||
157112856|NCT01056510|567168454|FG001|Overall Study|Physician Decision|5|||
157112857|NCT01056510|567168453|FG000|Overall Study|Lost to Follow-up|5|||
157112858|NCT01056510|567168454|FG001|Overall Study|Lost to Follow-up|6|||
157112859|NCT01056510|567168453|FG000|Overall Study|Other|10|||
157112860|NCT01056510|567168454|FG001|Overall Study|Other|12|||
157112861|NCT01056510|567168453|FG000|Overall Study|Missing|0|||
157112862|NCT01056510|567168454|FG001|Overall Study|Missing|1|||
157112863|NCT02285998|567168455|FG000|Overall Study|Adverse Event|9|||
157112864|NCT02285998|567168456|FG001|Overall Study|Adverse Event|8|||
157112865|NCT02285998|567168455|FG000|Overall Study|Physician Decision|1|||
157112866|NCT02285998|567168456|FG001|Overall Study|Physician Decision|2|||
157112867|NCT02285998|567168455|FG000|Overall Study|Lost to Follow-up|176|||
157112868|NCT02285998|567168456|FG001|Overall Study|Lost to Follow-up|172|||
157112869|NCT02285998|567168455|FG000|Overall Study|Withdrawal by Subject|53|||
157112870|NCT02285998|567168456|FG001|Overall Study|Withdrawal by Subject|61|||
157112871|NCT02285998|567168455|FG000|Overall Study|Other Reasons|7|||
157112872|NCT02285998|567168456|FG001|Overall Study|Other Reasons|10|||
157112873|NCT03451084|567168457|FG000|Overall Study|Withdrawal by Subject|2|||
157112874|NCT03451084|567168458|FG001|Overall Study|Withdrawal by Subject|1|||
157112875|NCT03451084|567168459|FG002|Overall Study|Withdrawal by Subject|2|||
157112876|NCT03451084|567168460|FG003|Overall Study|Withdrawal by Subject|1|||
157112877|NCT03451084|567168457|FG000|Overall Study|Disease recurrence|0|||
157112878|NCT03451084|567168458|FG001|Overall Study|Disease recurrence|2|||
157112879|NCT03451084|567168459|FG002|Overall Study|Disease recurrence|0|||
157112880|NCT03451084|567168460|FG003|Overall Study|Disease recurrence|0|||
157112881|NCT03451084|567168457|FG000|Overall Study|Lack of Efficacy|0|||
157112882|NCT03451084|567168458|FG001|Overall Study|Lack of Efficacy|3|||
157112883|NCT03451084|567168459|FG002|Overall Study|Lack of Efficacy|0|||
157112884|NCT03451084|567168460|FG003|Overall Study|Lack of Efficacy|1|||
157112885|NCT03451084|567168457|FG000|Overall Study|Death|1|||
157112886|NCT03451084|567168458|FG001|Overall Study|Death|0|||
157112887|NCT03451084|567168459|FG002|Overall Study|Death|2|||
157112888|NCT03451084|567168460|FG003|Overall Study|Death|0|||
157112889|NCT03451084|567168457|FG000|Overall Study|Physician Decision|0|||
157112890|NCT03451084|567168458|FG001|Overall Study|Physician Decision|0|||
157112891|NCT03451084|567168459|FG002|Overall Study|Physician Decision|2|||
157112892|NCT03451084|567168460|FG003|Overall Study|Physician Decision|2|||
157112893|NCT03451084|567168457|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
157112894|NCT03451084|567168458|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
157112895|NCT03451084|567168459|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
157112896|NCT03451084|567168460|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
157112897|NCT03029143|567168461|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
157206974|NCT00797316|567501276|FG001|Overall Study|Administrative problems|0|||
157206975|NCT00797316|567501275|FG000|Overall Study|Adverse Event|5|||
157206976|NCT00797316|567501276|FG001|Overall Study|Adverse Event|3|||
157206977|NCT00797316|567501275|FG000|Overall Study|Lost to Follow-up|4|||
157112898|NCT03029143|567168462|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
157112899|NCT03029143|567168463|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
157112900|NCT03029143|567168461|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
157112901|NCT03029143|567168462|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
157112902|NCT03029143|567168463|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
157112903|NCT03029143|567168461|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
157112904|NCT03029143|567168462|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
157112905|NCT03029143|567168463|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
157112906|NCT03029143|567168461|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
157112907|NCT03029143|567168462|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
157112908|NCT03029143|567168463|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
157112909|NCT03029143|567168461|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
157112910|NCT03029143|567168462|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
157112911|NCT03029143|567168463|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
157112912|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
157112913|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
157112914|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
157112915|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
157112916|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
157112917|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
157112918|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157112919|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157112920|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
157112921|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
156770310|NCT01773928|565913112|FG002|Overall Study|Subject misrepresented age|0|||
156770311|NCT01773928|565913113|FG003|Overall Study|Subject misrepresented age|0|||
157112922|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
157112923|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
157112924|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157112925|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
157112926|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
157112927|NCT03029143|567168461|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
157112928|NCT03029143|567168462|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
157112929|NCT03029143|567168463|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
157112930|NCT02121262|567168464|FG000|Overall Study|Adverse Event|6|||
157112931|NCT02121262|567168465|FG001|Overall Study|Adverse Event|3|||
157112932|NCT02121262|567168464|FG000|Overall Study|Lack of Efficacy|3|||
157112933|NCT02121262|567168465|FG001|Overall Study|Lack of Efficacy|0|||
157112934|NCT02121262|567168464|FG000|Overall Study|Personal Reasons|19|||
157112935|NCT02121262|567168465|FG001|Overall Study|Personal Reasons|5|||
157112936|NCT02121262|567168464|FG000|Overall Study|Protocol Violation|1|||
157112937|NCT02121262|567168465|FG001|Overall Study|Protocol Violation|1|||
157112938|NCT02121262|567168464|FG000|Overall Study|Participant Dropped-out|0|||
157112939|NCT02121262|567168465|FG001|Overall Study|Participant Dropped-out|1|||
157112940|NCT02121262|567168464|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
157112941|NCT02121262|567168465|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
157112942|NCT02121262|567168464|FG000|Overall Study|Consent Withdrawn|1|||
157112943|NCT02121262|567168465|FG001|Overall Study|Consent Withdrawn|0|||
157112944|NCT01617070|567168466|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
157112945|NCT00777101|567168468|FG000|Overall Study|Death|48|||
157112946|NCT00777101|567168469|FG001|Overall Study|Death|43|||
157112947|NCT00777101|567168468|FG000|Overall Study|Withdrawal by Subject|11|||
157112948|NCT00777101|567168469|FG001|Overall Study|Withdrawal by Subject|6|||
157112949|NCT00777101|567168468|FG000|Overall Study|Lost to Follow-up|2|||
157112950|NCT00777101|567168469|FG001|Overall Study|Lost to Follow-up|1|||
157112951|NCT00777101|567168468|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
157206978|NCT00797316|567501276|FG001|Overall Study|Lost to Follow-up|8|||
157206979|NCT00797316|567501275|FG000|Overall Study|Protocol Deviation|1|||
157206980|NCT00797316|567501276|FG001|Overall Study|Protocol Deviation|2|||
157206981|NCT00797316|567501275|FG000|Overall Study|Patient withdrew consent|12|||
157206982|NCT00797316|567501276|FG001|Overall Study|Patient withdrew consent|6|||
157206983|NCT00797316|567501275|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157206984|NCT00797316|567501276|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
157206985|NCT00402779|567501279|FG000|Overall Study|Screen Failure|77|||
157206986|NCT00402779|567501280|FG001|Overall Study|Screen Failure|76|||
157206987|NCT03239340|567501281|FG000|Overall Study|Other|26|||
157206988|NCT03239340|567501281|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
157206989|NCT03239340|567501281|FG000|Overall Study|Death|40|||
157206990|NCT03239340|567501281|FG000|Overall Study|Lost to Follow-up|2|||
157206991|NCT03239340|567501281|FG000|Overall Study|Physician Decision|16|||
157206992|NCT03239340|567501281|FG000|Overall Study|Withdrawal by Subject|27|||
157206993|NCT02332655|567501285|FG000|Overall Study|Lack of Efficacy|1|||
157206994|NCT01843660|567501286|FG000|Overall Study|Other|30|||
157206995|NCT01977482|567501287|FG000|Overall Study|Adverse Event|0|||
157206996|NCT01977482|567501288|FG001|Overall Study|Adverse Event|1|||
157206997|NCT01977482|567501289|FG002|Overall Study|Adverse Event|1|||
157206998|NCT01977482|567501290|FG003|Overall Study|Adverse Event|0|||
157206999|NCT01977482|567501291|FG004|Overall Study|Adverse Event|2|||
157207000|NCT01977482|567501292|FG005|Overall Study|Adverse Event|0|||
157207001|NCT01977482|567501287|FG000|Overall Study|Lost to Follow-up|1|||
157207002|NCT01977482|567501288|FG001|Overall Study|Lost to Follow-up|0|||
157207003|NCT01977482|567501289|FG002|Overall Study|Lost to Follow-up|0|||
157207004|NCT01977482|567501290|FG003|Overall Study|Lost to Follow-up|0|||
157207005|NCT01977482|567501291|FG004|Overall Study|Lost to Follow-up|0|||
157207006|NCT01977482|567501292|FG005|Overall Study|Lost to Follow-up|0|||
157207007|NCT01977482|567501287|FG000|Overall Study|Physician Decision|0|||
157207008|NCT01977482|567501288|FG001|Overall Study|Physician Decision|1|||
157207009|NCT01977482|567501289|FG002|Overall Study|Physician Decision|0|||
157207010|NCT01977482|567501290|FG003|Overall Study|Physician Decision|0|||
157207011|NCT01977482|567501291|FG004|Overall Study|Physician Decision|0|||
157207012|NCT01977482|567501292|FG005|Overall Study|Physician Decision|0|||
157207013|NCT01977482|567501287|FG000|Overall Study|Protocol Violation|0|||
157207014|NCT01977482|567501288|FG001|Overall Study|Protocol Violation|0|||
157207015|NCT01977482|567501289|FG002|Overall Study|Protocol Violation|1|||
157207016|NCT01977482|567501290|FG003|Overall Study|Protocol Violation|0|||
157207017|NCT01977482|567501291|FG004|Overall Study|Protocol Violation|0|||
157207018|NCT01977482|567501292|FG005|Overall Study|Protocol Violation|0|||
157207019|NCT01977482|567501287|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
157207020|NCT01977482|567501288|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
157207021|NCT01977482|567501289|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
157207022|NCT01977482|567501290|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
157207023|NCT01977482|567501291|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
157112952|NCT00777101|567168469|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
157112953|NCT00777101|567168468|FG000|Overall Study|Failed to Return|0|||
157112954|NCT00777101|567168469|FG001|Overall Study|Failed to Return|1|||
157112955|NCT05376215|567168470|FG000|Overall Study|Withdrawal by Subject|2|||
157112956|NCT05376215|567168471|FG001|Overall Study|Withdrawal by Subject|1|||
157112957|NCT05376215|567168470|FG000|Overall Study|Lost to Follow-up|0|||
157112958|NCT05376215|567168471|FG001|Overall Study|Lost to Follow-up|1|||
157112959|NCT00282334|567168473|FG000|Overall Study|Withdrawal by Subject|8|||
157112960|NCT00282334|567168474|FG001|Overall Study|Withdrawal by Subject|5|||
157112961|NCT01066585|567168478|FG000|Overall Study|Protocol Violation|1|||
157112962|NCT01066585|567168479|FG001|Overall Study|Protocol Violation|0|||
157112963|NCT01066585|567168478|FG000|Overall Study|Withdrawal by Subject|0|||
157112964|NCT01066585|567168479|FG001|Overall Study|Withdrawal by Subject|3|||
157112965|NCT00964743|567168481|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
157112966|NCT03317795|567168484|FG000|Overall Study|IUD Expulsion|1|||
157112967|NCT03317795|567168485|FG001|Overall Study|IUD Expulsion|0|||
157112968|NCT03317795|567168484|FG000|Overall Study|Lost to Follow-up|1|||
157112969|NCT03317795|567168485|FG001|Overall Study|Lost to Follow-up|3|||
157112970|NCT03317795|567168484|FG000|Overall Study|Treatment change|0|||
157112971|NCT03317795|567168485|FG001|Overall Study|Treatment change|3|||
157112972|NCT03317795|567168484|FG000|Overall Study|Intolerance of medication|0|||
157112973|NCT03317795|567168485|FG001|Overall Study|Intolerance of medication|1|||
157112974|NCT00886600|567168486|FG000|Double-blind Monotherapy|Adverse Event|1|||
157112975|NCT00886600|567168487|FG001|Double-blind Monotherapy|Adverse Event|1|||
157112976|NCT00886600|567168488|FG002|Double-blind Monotherapy|Adverse Event|1|||
157112977|NCT00886600|567168489|FG003|Double-blind Monotherapy|Adverse Event|1|||
157112978|NCT00886600|567168486|FG000|Double-blind Monotherapy|Protocol Violation|0|||
157112979|NCT00886600|567168487|FG001|Double-blind Monotherapy|Protocol Violation|0|||
157112980|NCT00886600|567168488|FG002|Double-blind Monotherapy|Protocol Violation|0|||
157112981|NCT00886600|567168489|FG003|Double-blind Monotherapy|Protocol Violation|1|||
157112982|NCT00886600|567168486|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
157112983|NCT00886600|567168487|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
157112984|NCT00886600|567168488|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
157112985|NCT00886600|567168489|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
157112986|NCT00886600|567168486|FG000|Combination Therapy Period|Adverse Event|0|||
157112987|NCT00886600|567168487|FG001|Combination Therapy Period|Adverse Event|0|||
157112988|NCT00886600|567168488|FG002|Combination Therapy Period|Adverse Event|1|||
157112989|NCT00886600|567168489|FG003|Combination Therapy Period|Adverse Event|0|||
157112990|NCT00886600|567168486|FG000|Combination Therapy Period|Protocol Violation|0|||
157112991|NCT00886600|567168487|FG001|Combination Therapy Period|Protocol Violation|0|||
157112992|NCT00886600|567168488|FG002|Combination Therapy Period|Protocol Violation|1|||
157112993|NCT00886600|567168489|FG003|Combination Therapy Period|Protocol Violation|0|||
157112994|NCT00501007|567168490|FG000|Overall Study|Inclusion criteria not met.|29|||
157112995|NCT00501007|567168491|FG001|Overall Study|Inclusion criteria not met.|25|||
157112996|NCT03917823|567168493|FG000|Overall Study|Lost to Follow-up|1|||
157112997|NCT03917823|567168494|FG001|Overall Study|Lost to Follow-up|1|||
157112998|NCT03917823|567168493|FG000|Overall Study|Withdrawal by Subject|0|||
157112999|NCT03917823|567168494|FG001|Overall Study|Withdrawal by Subject|1|||
157113000|NCT02016820|567168495|FG000|Overall Study|Lost to Follow-up|2|||
157113001|NCT02016820|567168496|FG001|Overall Study|Lost to Follow-up|4|||
157113002|NCT02424253|567168499|FG000|Overall Study|Other, unspecified|1|||
157113003|NCT02424253|567168500|FG001|Overall Study|Other, unspecified|0|||
157113004|NCT02424253|567168499|FG000|Overall Study|Compliance problems|1|||
157207024|NCT01977482|567501292|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
157207025|NCT01977482|567501287|FG000|Overall Study|Withdrawal by Subject|2|||
157207026|NCT01977482|567501288|FG001|Overall Study|Withdrawal by Subject|4|||
157207027|NCT01977482|567501289|FG002|Overall Study|Withdrawal by Subject|1|||
157207028|NCT01977482|567501290|FG003|Overall Study|Withdrawal by Subject|3|||
157207029|NCT01977482|567501291|FG004|Overall Study|Withdrawal by Subject|1|||
157113005|NCT02424253|567168500|FG001|Overall Study|Compliance problems|0|||
157207030|NCT01977482|567501292|FG005|Overall Study|Withdrawal by Subject|5|||
157207031|NCT00209560|567501293|FG000|Overall Study|Lack of Efficacy|1|||
157113006|NCT02424253|567168499|FG000|Overall Study|Physician Decision|2|||
157113007|NCT02424253|567168500|FG001|Overall Study|Physician Decision|0|||
157113008|NCT02424253|567168499|FG000|Overall Study|Lack of Efficacy|0|||
157113009|NCT02424253|567168500|FG001|Overall Study|Lack of Efficacy|7|||
157113010|NCT02424253|567168499|FG000|Overall Study|Adverse Event|2|||
157113011|NCT02424253|567168500|FG001|Overall Study|Adverse Event|0|||
157113012|NCT02424253|567168499|FG000|Overall Study|Consent withdrawn by subject|4|||
157113013|NCT02424253|567168500|FG001|Overall Study|Consent withdrawn by subject|1|||
157113014|NCT02424253|567168499|FG000|Overall Study|Lost to Follow-up|1|||
157113015|NCT02424253|567168500|FG001|Overall Study|Lost to Follow-up|1|||
157113016|NCT00884273|567168501|FG000|Overall Study|Adverse Event|0|||
157113017|NCT00884273|567168502|FG001|Overall Study|Adverse Event|2|||
157113018|NCT00884273|567168501|FG000|Overall Study|Protocol Violation|1|||
157113019|NCT00884273|567168502|FG001|Overall Study|Protocol Violation|3|||
157113020|NCT00884273|567168501|FG000|Overall Study|Practical reasons|1|||
157113021|NCT00884273|567168502|FG001|Overall Study|Practical reasons|0|||
157113022|NCT00473343|567168503|FG000|Overall Study|Adverse Event|9|||
157113023|NCT00473343|567168503|FG000|Overall Study|Lost to Follow-up|8|||
157113024|NCT00473343|567168503|FG000|Overall Study|Treatment failure|27|||
157113025|NCT00473343|567168503|FG000|Overall Study|Withdrew consent|3|||
157113026|NCT00473343|567168503|FG000|Overall Study|Other un-specified reason|3|||
157113027|NCT02290873|567168504|FG000|Overall Study|Withdrawal by Subject|0|||
157113028|NCT02290873|567168505|FG001|Overall Study|Withdrawal by Subject|1|||
157113029|NCT02290873|567168506|FG002|Overall Study|Withdrawal by Subject|1|||
157113030|NCT02290873|567168504|FG000|Overall Study|Nellcor device error|1|||
157113031|NCT02290873|567168505|FG001|Overall Study|Nellcor device error|0|||
157113032|NCT02290873|567168506|FG002|Overall Study|Nellcor device error|0|||
157113033|NCT02290873|567168504|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
157113034|NCT02290873|567168505|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
157113035|NCT02290873|567168506|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
157113036|NCT02290873|567168504|FG000|Overall Study|Protocol Violation|0|||
157113037|NCT02290873|567168505|FG001|Overall Study|Protocol Violation|0|||
157113038|NCT02290873|567168506|FG002|Overall Study|Protocol Violation|1|||
157113039|NCT03715153|567168507|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
157113040|NCT03715153|567168508|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
157113041|NCT03715153|567168507|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
157113042|NCT03715153|567168508|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
157113043|NCT03715153|567168507|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
157113044|NCT03715153|567168508|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
157113045|NCT03715153|567168507|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
157113046|NCT03715153|567168508|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
157113047|NCT03715153|567168507|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
157113048|NCT03715153|567168508|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
157113049|NCT03715153|567168507|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
157113050|NCT03715153|567168508|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
157113051|NCT01519765|567168513|FG000|Overall Study|Adverse Event|0|||
157113052|NCT01519765|567168514|FG001|Overall Study|Adverse Event|1|||
157113053|NCT01519765|567168513|FG000|Overall Study|Lack of Efficacy|2|||
157113054|NCT01519765|567168514|FG001|Overall Study|Lack of Efficacy|0|||
157113055|NCT01519765|567168513|FG000|Overall Study|Protocol Violation|1|||
157113056|NCT01519765|567168514|FG001|Overall Study|Protocol Violation|0|||
157207032|NCT00209560|567501294|FG001|Overall Study|Lack of Efficacy|0|||
157113057|NCT01519765|567168513|FG000|Overall Study|Withdrawal by Subject|0|||
157207033|NCT01721369|567501301|FG000|Overall Study|Not initial etiological diagnosis|12|||
157207034|NCT00359073|567502646|FG000|Overall Study|Withdrawal by Subject|1|||
157113058|NCT01519765|567168514|FG001|Overall Study|Withdrawal by Subject|1|||
157113059|NCT00578136|567168515|FG000|Overall Study|Not given intervention|1|||
156770312|NCT01773928|565913114|FG004|Overall Study|Subject misrepresented age|0|||
157113060|NCT00578136|567168516|FG001|Overall Study|Not given intervention|1|||
157113061|NCT02437864|567168523|FG000|Overall Study|Protocol Violation|4|||
157113062|NCT02437864|567168524|FG001|Overall Study|Protocol Violation|0|||
157113063|NCT01585272|567168526|FG000|Overall Study|Adverse Event|22|||
157207035|NCT00359073|567502647|FG001|Overall Study|Withdrawal by Subject|1|||
156770313|NCT01773928|565913115|FG005|Overall Study|Subject misrepresented age|0|||
157207036|NCT00359073|567502646|FG000|Overall Study|Eligibility criteria no longer met|3|||
157207037|NCT00359073|567502647|FG001|Overall Study|Eligibility criteria no longer met|0|||
157113064|NCT01585272|567168526|FG000|Overall Study|Protocol Violation|7|||
157113065|NCT01585272|567168526|FG000|Overall Study|Withdrawal by Subject|10|||
157113066|NCT00645593|567168527|FG000|Overall Study|Later found to be ineligible|1|||
157113067|NCT00645593|567168528|FG001|Overall Study|Later found to be ineligible|0|||
157113068|NCT00781911|567168529|FG000|Overall Study|Adverse Event|4|||
157113069|NCT00781911|567168530|FG001|Overall Study|Adverse Event|4|||
157113070|NCT00781911|567168529|FG000|Overall Study|Withdrawal by Subject|1|||
157113071|NCT00781911|567168530|FG001|Overall Study|Withdrawal by Subject|2|||
157113072|NCT00781911|567168529|FG000|Overall Study|Physician Decision|0|||
157113073|NCT00781911|567168530|FG001|Overall Study|Physician Decision|2|||
157113074|NCT00781911|567168529|FG000|Overall Study|Sponsor Decision|1|||
157113075|NCT00781911|567168530|FG001|Overall Study|Sponsor Decision|0|||
157113076|NCT00609791|567170146|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
157113077|NCT00129766|567170148|FG000|Overall Study|Death|3|||
157113078|NCT00129766|567170149|FG001|Overall Study|Death|8|||
157113079|NCT00129766|567170148|FG000|Overall Study|Withdrawal of consent|31|||
157113080|NCT00129766|567170149|FG001|Overall Study|Withdrawal of consent|30|||
157113081|NCT00129766|567170148|FG000|Overall Study|Lost to Follow-up|26|||
157113082|NCT00129766|567170149|FG001|Overall Study|Lost to Follow-up|21|||
157113083|NCT00122681|567170157|FG000|Overall Study|Adverse Event|20|||
157113084|NCT00122681|567170158|FG001|Overall Study|Adverse Event|16|||
157113085|NCT00122681|567170157|FG000|Overall Study|Lost to Follow-up|1080|||
157113086|NCT00122681|567170158|FG001|Overall Study|Lost to Follow-up|1097|||
157113087|NCT00122681|567170157|FG000|Overall Study|Protocol Violation|7|||
157113088|NCT00122681|567170158|FG001|Overall Study|Protocol Violation|10|||
157113089|NCT00122681|567170157|FG000|Overall Study|Withdrawal by Subject|257|||
157113090|NCT00122681|567170158|FG001|Overall Study|Withdrawal by Subject|251|||
157113091|NCT00122681|567170157|FG000|Overall Study|Personal reasons|150|||
157113092|NCT00122681|567170158|FG001|Overall Study|Personal reasons|147|||
157113093|NCT02819635|567170159|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
157113094|NCT02819635|567170160|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
157113095|NCT02819635|567170161|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
157113096|NCT02819635|567170162|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
157113097|NCT02819635|567170163|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
157113098|NCT02819635|567170164|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
157113099|NCT02819635|567170165|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
157113100|NCT02819635|567170166|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
157113101|NCT02819635|567170167|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
157113102|NCT02819635|567170168|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
157113103|NCT02819635|567170169|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
157113104|NCT02819635|567170170|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
157113105|NCT02819635|567170159|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113106|NCT02819635|567170160|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113107|NCT02819635|567170161|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113108|NCT02819635|567170162|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113109|NCT02819635|567170163|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
157113110|NCT02819635|567170164|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
157113111|NCT02819635|567170165|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
157113112|NCT02819635|567170166|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113113|NCT02819635|567170167|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113114|NCT02819635|567170168|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113115|NCT02819635|567170169|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113116|NCT02819635|567170170|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
157113117|NCT02819635|567170159|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113118|NCT02819635|567170160|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113119|NCT02819635|567170161|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113120|NCT02819635|567170162|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113121|NCT02819635|567170163|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113122|NCT02819635|567170164|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
157113123|NCT02819635|567170165|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
157113124|NCT02819635|567170166|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113125|NCT02819635|567170167|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113126|NCT02819635|567170168|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113127|NCT02819635|567170169|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113128|NCT02819635|567170170|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
157113129|NCT02819635|567170159|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113130|NCT02819635|567170160|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113131|NCT02819635|567170161|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113132|NCT02819635|567170162|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113133|NCT02819635|567170163|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157207038|NCT00359073|567502646|FG000|Overall Study|developed RV16 antibody|0|||
157207039|NCT00359073|567502647|FG001|Overall Study|developed RV16 antibody|1|||
157207040|NCT01371006|567502648|FG000|Overall Study|Adverse Event|1|||
157207041|NCT01371006|567502649|FG001|Overall Study|Adverse Event|0|||
157207042|NCT00684645|567502650|FG000|Overall Study|Death|2|||
157207043|NCT00684645|567502650|FG000|Overall Study|Progressive disease|67|||
157207044|NCT00684645|567502650|FG000|Overall Study|Adverse Event|27|||
157207045|NCT00684645|567502650|FG000|Overall Study|Lost to Follow-up|3|||
157207046|NCT00684645|567502650|FG000|Overall Study|Other|15|||
157207047|NCT03256526|567502651|FG000|Overall Study|Adverse Event|1|||
157207048|NCT03256526|567502652|FG001|Overall Study|Adverse Event|0|||
157207049|NCT03256526|567502653|FG002|Overall Study|Adverse Event|1|||
157207050|NCT03256526|567502651|FG000|Overall Study|Lost to Follow-up|1|||
157207051|NCT03256526|567502652|FG001|Overall Study|Lost to Follow-up|0|||
157207052|NCT03256526|567502653|FG002|Overall Study|Lost to Follow-up|2|||
157207053|NCT03515837|567502654|FG000|Overall Study|Death|219|||
157207054|NCT03515837|567502655|FG001|Overall Study|Death|227|||
157207055|NCT03515837|567502654|FG000|Overall Study|Lost to Follow-up|0|||
157207056|NCT03515837|567502655|FG001|Overall Study|Lost to Follow-up|1|||
157207057|NCT03515837|567502654|FG000|Overall Study|Withdrawal by Subject|0|||
157207058|NCT03515837|567502655|FG001|Overall Study|Withdrawal by Subject|4|||
157207059|NCT03515837|567502654|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
157207060|NCT03515837|567502655|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
157207061|NCT01964898|567502656|FG000|Overall Study|ineligible post-randomization|1|||
157207062|NCT01964898|567502657|FG001|Overall Study|ineligible post-randomization|1|||
157207063|NCT01964898|567502656|FG000|Overall Study|did not receive the allocated interventi|2|||
157207064|NCT01964898|567502657|FG001|Overall Study|did not receive the allocated interventi|1|||
157207065|NCT01964898|567502656|FG000|Overall Study|Lost to Follow-up|3|||
157207066|NCT01964898|567502657|FG001|Overall Study|Lost to Follow-up|5|||
157207067|NCT01964898|567502656|FG000|Overall Study|Withdrawal by Subject|1|||
157207068|NCT01964898|567502657|FG001|Overall Study|Withdrawal by Subject|0|||
157207069|NCT02325401|567502658|FG000|Overall Study|Withdrawal by Subject|0|||
157207070|NCT02325401|567502659|FG001|Overall Study|Withdrawal by Subject|1|||
157207071|NCT02325401|567502660|FG002|Overall Study|Withdrawal by Subject|1|||
157207072|NCT00391092|567502661|FG000|Overall Study|Death|78|||
157207073|NCT00391092|567502662|FG001|Overall Study|Death|81|||
157207074|NCT00391092|567502661|FG000|Overall Study|Lost to Follow-up|13|||
157207075|NCT00391092|567502662|FG001|Overall Study|Lost to Follow-up|18|||
157207076|NCT00391092|567502661|FG000|Overall Study|Alive on treatment|29|||
157207077|NCT00391092|567502662|FG001|Overall Study|Alive on treatment|33|||
157207078|NCT00391092|567502661|FG000|Overall Study|Alive in follow-up|88|||
157207079|NCT00391092|567502662|FG001|Overall Study|Alive in follow-up|84|||
157207080|NCT00602979|567502665|FG000|Overall Study|Lost to Follow-up|3|||
157207081|NCT00602979|567502666|FG001|Overall Study|Lost to Follow-up|2|||
157207082|NCT00602979|567502667|FG002|Overall Study|Lost to Follow-up|3|||
157207083|NCT00602979|567502668|FG003|Overall Study|Lost to Follow-up|2|||
157207084|NCT00602979|567502669|FG004|Overall Study|Lost to Follow-up|3|||
157207085|NCT00602979|567502665|FG000|Overall Study|Failed Intubation|0|||
157207086|NCT00602979|567502666|FG001|Overall Study|Failed Intubation|1|||
157207087|NCT00602979|567502667|FG002|Overall Study|Failed Intubation|0|||
157207088|NCT00602979|567502668|FG003|Overall Study|Failed Intubation|1|||
157207089|NCT00602979|567502669|FG004|Overall Study|Failed Intubation|0|||
157207090|NCT02367729|567502672|FG000|Overall Study|Organic disorder diagnosed|2|||
157207091|NCT02367729|567502673|FG001|Overall Study|Organic disorder diagnosed|1|||
157207092|NCT02367729|567502672|FG000|Overall Study|Adverse Event|1|||
157007083|NCT00588770|566775122|FG001|Overall Study|Alternative therapy|4|||
157007084|NCT00588770|566775121|FG000|Overall Study|Other complicating disease|3|||
157007085|NCT00588770|566775122|FG001|Overall Study|Other complicating disease|2|||
157007086|NCT00588770|566775121|FG000|Overall Study|Not start protocol therapy|0|||
157007087|NCT00588770|566775122|FG001|Overall Study|Not start protocol therapy|9|||
157007088|NCT00588770|566775121|FG000|Overall Study|Lack of Efficacy|8|||
157007089|NCT00588770|566775122|FG001|Overall Study|Lack of Efficacy|10|||
157007090|NCT00588770|566775121|FG000|Overall Study|Physician discretion|2|||
157007091|NCT00588770|566775122|FG001|Overall Study|Physician discretion|0|||
157007092|NCT00588770|566775121|FG000|Overall Study|Patient non-compliance|2|||
157007093|NCT00588770|566775122|FG001|Overall Study|Patient non-compliance|2|||
157207093|NCT02367729|567502673|FG001|Overall Study|Adverse Event|2|||
157007094|NCT04697628|566775123|FG000|Overall Study|Withdrawal by Subject|17|||
157007095|NCT04697628|566775124|FG001|Overall Study|Withdrawal by Subject|23|||
157207094|NCT02367729|567502672|FG000|Overall Study|Withdrawal by Subject|0|||
157007096|NCT04697628|566775123|FG000|Overall Study|Lost to Follow-up|0|||
157007097|NCT04697628|566775124|FG001|Overall Study|Lost to Follow-up|4|||
157007098|NCT04697628|566775123|FG000|Overall Study|On-going in study|122|||
157207095|NCT02367729|567502673|FG001|Overall Study|Withdrawal by Subject|5|||
157207096|NCT03359473|567502682|FG000|Overall Study|Adverse Event|0|||
157207097|NCT03359473|567502683|FG001|Overall Study|Adverse Event|2|||
157207098|NCT03359473|567502684|FG002|Overall Study|Adverse Event|5|||
157207099|NCT03359473|567502685|FG003|Overall Study|Adverse Event|3|||
157207100|NCT03359473|567502682|FG000|Overall Study|Lost to Follow-up|0|||
157207101|NCT03359473|567502683|FG001|Overall Study|Lost to Follow-up|1|||
157207102|NCT03359473|567502684|FG002|Overall Study|Lost to Follow-up|0|||
157207103|NCT03359473|567502685|FG003|Overall Study|Lost to Follow-up|0|||
157207104|NCT03359473|567502682|FG000|Overall Study|Physician Decision|0|||
157207105|NCT03359473|567502683|FG001|Overall Study|Physician Decision|1|||
157207106|NCT03359473|567502684|FG002|Overall Study|Physician Decision|0|||
157207107|NCT03359473|567502685|FG003|Overall Study|Physician Decision|1|||
157207108|NCT03359473|567502682|FG000|Overall Study|Withdrawal by Subject|1|||
157207109|NCT03359473|567502683|FG001|Overall Study|Withdrawal by Subject|2|||
157207110|NCT03359473|567502684|FG002|Overall Study|Withdrawal by Subject|1|||
157207111|NCT03359473|567502685|FG003|Overall Study|Withdrawal by Subject|0|||
157207112|NCT03359473|567502682|FG000|Overall Study|Protocol-defined stopping criteria|1|||
157207113|NCT03359473|567502683|FG001|Overall Study|Protocol-defined stopping criteria|0|||
157207114|NCT03359473|567502684|FG002|Overall Study|Protocol-defined stopping criteria|0|||
157207115|NCT03359473|567502685|FG003|Overall Study|Protocol-defined stopping criteria|1|||
157207116|NCT04101721|567502687|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
157207117|NCT04101721|567502688|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
157207118|NCT04101721|567502687|FG000|Overall Study|Death|0|||
157207119|NCT04101721|567502688|FG001|Overall Study|Death|1|||
157207120|NCT04101721|567502687|FG000|Overall Study|Lost to Follow-up|0|||
157207121|NCT04101721|567502688|FG001|Overall Study|Lost to Follow-up|3|||
157207122|NCT01215955|567502689|FG000|Overall Study|Adverse Event|1|||
157207123|NCT01215955|567502690|FG001|Overall Study|Adverse Event|4|||
157207124|NCT01215955|567502691|FG002|Overall Study|Adverse Event|2|||
157207125|NCT01215955|567502692|FG003|Overall Study|Adverse Event|3|||
157207126|NCT01215955|567502689|FG000|Overall Study|Death|2|||
157207127|NCT01215955|567502690|FG001|Overall Study|Death|0|||
157207128|NCT01215955|567502691|FG002|Overall Study|Death|1|||
157207129|NCT01215955|567502692|FG003|Overall Study|Death|3|||
157207130|NCT01215955|567502689|FG000|Overall Study|Entry Criteria Not Met|1|||
157207131|NCT01215955|567502690|FG001|Overall Study|Entry Criteria Not Met|3|||
157207132|NCT01215955|567502691|FG002|Overall Study|Entry Criteria Not Met|4|||
157207133|NCT01215955|567502692|FG003|Overall Study|Entry Criteria Not Met|7|||
157207134|NCT01215955|567502689|FG000|Overall Study|Lack of Efficacy|1|||
157207135|NCT01215955|567502690|FG001|Overall Study|Lack of Efficacy|2|||
157207136|NCT01215955|567502691|FG002|Overall Study|Lack of Efficacy|1|||
157207137|NCT01215955|567502692|FG003|Overall Study|Lack of Efficacy|0|||
157207138|NCT01215955|567502689|FG000|Overall Study|Lost to Follow-up|4|||
157207139|NCT01215955|567502690|FG001|Overall Study|Lost to Follow-up|4|||
157207140|NCT01215955|567502691|FG002|Overall Study|Lost to Follow-up|8|||
157207141|NCT01215955|567502692|FG003|Overall Study|Lost to Follow-up|9|||
157207142|NCT01215955|567502689|FG000|Overall Study|Physician Decision|4|||
157207143|NCT01215955|567502690|FG001|Overall Study|Physician Decision|10|||
157207144|NCT01215955|567502691|FG002|Overall Study|Physician Decision|8|||
157207145|NCT01215955|567502692|FG003|Overall Study|Physician Decision|11|||
157207146|NCT01215955|567502689|FG000|Overall Study|Protocol Violation|17|||
157207147|NCT01215955|567502690|FG001|Overall Study|Protocol Violation|13|||
157207148|NCT01215955|567502691|FG002|Overall Study|Protocol Violation|8|||
157207149|NCT01215955|567502692|FG003|Overall Study|Protocol Violation|8|||
157207150|NCT01215955|567502689|FG000|Overall Study|Sponsor Decision|1|||
157207151|NCT01215955|567502690|FG001|Overall Study|Sponsor Decision|2|||
157207152|NCT01215955|567502691|FG002|Overall Study|Sponsor Decision|0|||
157207153|NCT01215955|567502692|FG003|Overall Study|Sponsor Decision|1|||
157207154|NCT01215955|567502689|FG000|Overall Study|Withdrawal by Subject|14|||
157207155|NCT01215955|567502690|FG001|Overall Study|Withdrawal by Subject|15|||
157207156|NCT01215955|567502691|FG002|Overall Study|Withdrawal by Subject|13|||
157207157|NCT01215955|567502692|FG003|Overall Study|Withdrawal by Subject|9|||
157207158|NCT01215955|567502689|FG000|Overall Study|Quality Issues|0|||
157207159|NCT01215955|567502690|FG001|Overall Study|Quality Issues|0|||
157207160|NCT01215955|567502691|FG002|Overall Study|Quality Issues|3|||
157207161|NCT01215955|567502692|FG003|Overall Study|Quality Issues|2|||
157207162|NCT05013749|567502694|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
157207163|NCT05013749|567502695|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
157207164|NCT05013749|567502694|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
157207165|NCT05013749|567502695|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
156770314|NCT01773928|565913116|FG006|Overall Study|Subject misrepresented age|0|||
156770315|NCT01773928|565913117|FG007|Overall Study|Subject misrepresented age|0|||
156770316|NCT01773928|565913118|FG008|Overall Study|Subject misrepresented age|0|||
156770317|NCT01773928|565913110|FG000|Overall Study|Subject met exclusion criteria|0|||
156770318|NCT01773928|565913111|FG001|Overall Study|Subject met exclusion criteria|0|||
156770319|NCT01773928|565913112|FG002|Overall Study|Subject met exclusion criteria|0|||
156770320|NCT01773928|565913113|FG003|Overall Study|Subject met exclusion criteria|0|||
156770321|NCT01773928|565913114|FG004|Overall Study|Subject met exclusion criteria|0|||
156770322|NCT01773928|565913115|FG005|Overall Study|Subject met exclusion criteria|0|||
156770323|NCT01773928|565913116|FG006|Overall Study|Subject met exclusion criteria|0|||
156770324|NCT01773928|565913117|FG007|Overall Study|Subject met exclusion criteria|0|||
156770325|NCT01773928|565913118|FG008|Overall Study|Subject met exclusion criteria|1|||
156770326|NCT01773928|565913110|FG000|Overall Study|Randomized, had to leave, never returned|0|||
156770327|NCT01773928|565913111|FG001|Overall Study|Randomized, had to leave, never returned|0|||
156770328|NCT01773928|565913112|FG002|Overall Study|Randomized, had to leave, never returned|0|||
156770329|NCT01773928|565913113|FG003|Overall Study|Randomized, had to leave, never returned|1|||
156770330|NCT01773928|565913114|FG004|Overall Study|Randomized, had to leave, never returned|0|||
156770331|NCT01773928|565913115|FG005|Overall Study|Randomized, had to leave, never returned|0|||
156770332|NCT01773928|565913116|FG006|Overall Study|Randomized, had to leave, never returned|0|||
156770333|NCT01773928|565913117|FG007|Overall Study|Randomized, had to leave, never returned|0|||
156770334|NCT01773928|565913118|FG008|Overall Study|Randomized, had to leave, never returned|0|||
156770335|NCT01773928|565913110|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
156770336|NCT01773928|565913111|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
156770337|NCT01773928|565913112|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
156770338|NCT01773928|565913113|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
156770339|NCT01773928|565913114|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
156770340|NCT01773928|565913115|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
156770341|NCT01773928|565913116|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
156770342|NCT01773928|565913117|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
157007099|NCT04697628|566775124|FG001|Overall Study|On-going in study|91|||
157007100|NCT04108208|566775125|FG000|Overall Study|Withdrawal by Subject|2|||
157207166|NCT01393626|567502698|FG000|Overall Study|Adverse Event|2|||
157207167|NCT01393626|567502699|FG001|Overall Study|Adverse Event|1|||
157207168|NCT01393626|567502700|FG002|Overall Study|Adverse Event|5|||
157207169|NCT01393626|567502701|FG003|Overall Study|Adverse Event|0|||
157207170|NCT01393626|567502698|FG000|Overall Study|Did not meet entrance criteria|1|||
156770343|NCT01773928|565913118|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
156770344|NCT06125964|565914573|FG000|Overall Study|Lost to Follow-up|0|||
156770345|NCT06125964|565914574|FG001|Overall Study|Lost to Follow-up|1|||
157007101|NCT04108208|566775126|FG001|Overall Study|Withdrawal by Subject|6|||
157007102|NCT04108208|566775125|FG000|Overall Study|other-ongoing|20|||
157007103|NCT04108208|566775126|FG001|Overall Study|other-ongoing|40|||
157207171|NCT01393626|567502699|FG001|Overall Study|Did not meet entrance criteria|0|||
157207172|NCT01393626|567502700|FG002|Overall Study|Did not meet entrance criteria|0|||
157207173|NCT01393626|567502701|FG003|Overall Study|Did not meet entrance criteria|0|||
156770346|NCT06125964|565914575|FG002|Overall Study|Lost to Follow-up|0|||
156770347|NCT06125964|565914576|FG003|Overall Study|Lost to Follow-up|0|||
156770348|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
156770349|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
156770350|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
156770351|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Death|1|||
156770352|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Death|1|||
156770353|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Death|0|||
156770354|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
156770355|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
156770356|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
156770357|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
156770358|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
156770359|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
156770360|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
156770361|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
156770362|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
156770363|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
156770364|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
156770365|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
156770366|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
156770367|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
156770368|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
156770369|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
156770370|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
156770371|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
156770372|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
156770373|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
156770374|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
156770375|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
156770376|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
156770377|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
156770378|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Other|10|||
156770379|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Other|4|||
156770380|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Other|0|||
156770381|NCT04006457|565914577|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
156770382|NCT04006457|565914578|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
156770383|NCT04006457|565914579|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
156770384|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
156770385|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
156770386|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
156770387|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
156770388|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
156770389|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
156770390|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
156770391|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
156770392|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
156770393|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
156770394|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
156770395|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
156770396|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
156770397|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
156770398|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
156770399|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Other|2|||
156770400|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Other|3|||
156770401|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Other|0|||
156770402|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
156770403|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
156770404|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
156770405|NCT04006457|565914577|FG000|Main Study: Treatment Period 2|Ongoing|86|||
156770406|NCT04006457|565914578|FG001|Main Study: Treatment Period 2|Ongoing|96|||
156770407|NCT04006457|565914579|FG002|Main Study: Treatment Period 2|Ongoing|0|||
156770408|NCT04006457|565914577|FG000|Main Study Observation Period|Adverse Event|1|||
156770409|NCT04006457|565914578|FG001|Main Study Observation Period|Adverse Event|1|||
156770410|NCT04006457|565914579|FG002|Main Study Observation Period|Adverse Event|0|||
156770411|NCT04006457|565914577|FG000|Main Study Observation Period|Lost to Follow-up|0|||
156770412|NCT04006457|565914578|FG001|Main Study Observation Period|Lost to Follow-up|1|||
156770413|NCT04006457|565914579|FG002|Main Study Observation Period|Lost to Follow-up|0|||
156770414|NCT04006457|565914577|FG000|Main Study Observation Period|Pregnancy|1|||
156770415|NCT04006457|565914578|FG001|Main Study Observation Period|Pregnancy|0|||
156770416|NCT04006457|565914579|FG002|Main Study Observation Period|Pregnancy|0|||
156770417|NCT04006457|565914577|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
156770418|NCT04006457|565914578|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
157207174|NCT01393626|567502698|FG000|Overall Study|Lack of Efficacy|6|||
157207175|NCT01393626|567502699|FG001|Overall Study|Lack of Efficacy|6|||
156770419|NCT04006457|565914579|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
156770420|NCT04006457|565914577|FG000|Main Study Observation Period|Other|8|||
156770421|NCT04006457|565914578|FG001|Main Study Observation Period|Other|16|||
156770422|NCT04006457|565914579|FG002|Main Study Observation Period|Other|0|||
156770423|NCT04006457|565914577|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
156770424|NCT04006457|565914578|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
156770425|NCT04006457|565914579|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
156770426|NCT04006457|565914577|FG000|Main Study Observation Period|Ongoing|2|||
156770427|NCT04006457|565914578|FG001|Main Study Observation Period|Ongoing|1|||
156770428|NCT04006457|565914579|FG002|Main Study Observation Period|Ongoing|0|||
156770429|NCT04006457|565914577|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
156770430|NCT04006457|565914578|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
156770431|NCT04006457|565914579|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
156770432|NCT05918055|565914580|FG000|Phase I - Dose Level 1|Ineligible|0|||
156770433|NCT05918055|565914581|FG001|Phase I - Dose Level 1|Ineligible|0|||
156770434|NCT05918055|565914582|FG002|Phase I - Dose Level 1|Ineligible|1|||
156770435|NCT05918055|565914580|FG000|Phase I - Dose Level -1|Physician Decision|1|||
156770436|NCT05918055|565914581|FG001|Phase I - Dose Level -1|Physician Decision|0|||
156770437|NCT05918055|565914582|FG002|Phase I - Dose Level -1|Physician Decision|0|||
156770438|NCT00109343|565914585|FG000|Overall Study|Adverse Event|1|||
156770439|NCT00109343|565914586|FG001|Overall Study|Adverse Event|0|||
156770440|NCT00109343|565914587|FG002|Overall Study|Adverse Event|2|||
156770441|NCT00109343|565914585|FG000|Overall Study|Lack of Efficacy|1|||
156770442|NCT00109343|565914586|FG001|Overall Study|Lack of Efficacy|0|||
156770443|NCT00109343|565914587|FG002|Overall Study|Lack of Efficacy|0|||
156770444|NCT00109343|565914585|FG000|Overall Study|Lost to Follow-up|35|||
156770445|NCT00109343|565914586|FG001|Overall Study|Lost to Follow-up|20|||
156770446|NCT00109343|565914587|FG002|Overall Study|Lost to Follow-up|14|||
156770447|NCT00109343|565914585|FG000|Overall Study|Protocol Violation|1|||
156770448|NCT00109343|565914586|FG001|Overall Study|Protocol Violation|2|||
156770449|NCT00109343|565914587|FG002|Overall Study|Protocol Violation|2|||
156770450|NCT00109343|565914585|FG000|Overall Study|Withdrawal by Subject|15|||
156770451|NCT00109343|565914586|FG001|Overall Study|Withdrawal by Subject|11|||
156770452|NCT00109343|565914587|FG002|Overall Study|Withdrawal by Subject|10|||
156770453|NCT00109343|565914585|FG000|Overall Study|Subject Moved|6|||
156770454|NCT00109343|565914586|FG001|Overall Study|Subject Moved|2|||
156770455|NCT00109343|565914587|FG002|Overall Study|Subject Moved|1|||
156770456|NCT00109343|565914585|FG000|Overall Study|Other|5|||
156770457|NCT00109343|565914586|FG001|Overall Study|Other|2|||
156770458|NCT00109343|565914587|FG002|Overall Study|Other|1|||
157007104|NCT04108208|566775125|FG000|Overall Study|Death|1|||
157207176|NCT01393626|567502700|FG002|Overall Study|Lack of Efficacy|4|||
157207177|NCT01393626|567502701|FG003|Overall Study|Lack of Efficacy|1|||
157207178|NCT01393626|567502698|FG000|Overall Study|Lost to Follow-up|1|||
157207179|NCT01393626|567502699|FG001|Overall Study|Lost to Follow-up|1|||
157207180|NCT01393626|567502700|FG002|Overall Study|Lost to Follow-up|1|||
156770459|NCT01721798|565914590|FG000|Overall Study|Death|0|||
156770460|NCT01721798|565914591|FG001|Overall Study|Death|0|||
156770461|NCT01721798|565914592|FG002|Overall Study|Death|1|||
156770462|NCT01721798|565914593|FG003|Overall Study|Death|1|||
156770463|NCT01721798|565914590|FG000|Overall Study|Lost to Follow-up|2|||
156770464|NCT01721798|565914591|FG001|Overall Study|Lost to Follow-up|2|||
156770465|NCT01721798|565914592|FG002|Overall Study|Lost to Follow-up|9|||
156770466|NCT01721798|565914593|FG003|Overall Study|Lost to Follow-up|9|||
156770467|NCT01721798|565914590|FG000|Overall Study|Pregnancy|0|||
156770468|NCT01721798|565914591|FG001|Overall Study|Pregnancy|0|||
156770469|NCT01721798|565914592|FG002|Overall Study|Pregnancy|1|||
156770470|NCT01721798|565914593|FG003|Overall Study|Pregnancy|1|||
156770471|NCT01721798|565914590|FG000|Overall Study|Withdrawal by Subject|1|||
156770472|NCT01721798|565914591|FG001|Overall Study|Withdrawal by Subject|0|||
156770473|NCT01721798|565914592|FG002|Overall Study|Withdrawal by Subject|2|||
156770474|NCT01721798|565914593|FG003|Overall Study|Withdrawal by Subject|1|||
156770475|NCT01721798|565914590|FG000|Overall Study|Not eligible for 24 month visit|1|||
156770476|NCT01721798|565914591|FG001|Overall Study|Not eligible for 24 month visit|0|||
156770477|NCT01721798|565914592|FG002|Overall Study|Not eligible for 24 month visit|8|||
156770478|NCT01721798|565914593|FG003|Overall Study|Not eligible for 24 month visit|7|||
156770479|NCT01983930|565914597|FG000|Overall Study|Withdrawal by Subject|9|||
157007105|NCT04108208|566775126|FG001|Overall Study|Death|4|||
157207181|NCT01393626|567502701|FG003|Overall Study|Lost to Follow-up|0|||
157207182|NCT01393626|567502698|FG000|Overall Study|Withdrawal by Subject|6|||
157207183|NCT01393626|567502699|FG001|Overall Study|Withdrawal by Subject|4|||
157007106|NCT04108208|566775125|FG000|Overall Study|Lost to Follow-up|2|||
157007107|NCT04108208|566775126|FG001|Overall Study|Lost to Follow-up|0|||
157207184|NCT01393626|567502700|FG002|Overall Study|Withdrawal by Subject|0|||
157207185|NCT01393626|567502701|FG003|Overall Study|Withdrawal by Subject|0|||
157207186|NCT01393626|567502698|FG000|Overall Study|Other|1|||
157207187|NCT01393626|567502699|FG001|Overall Study|Other|0|||
157207188|NCT01393626|567502700|FG002|Overall Study|Other|0|||
157207189|NCT01393626|567502701|FG003|Overall Study|Other|0|||
157207190|NCT01393626|567502698|FG000|Overall Study|Protocol Violation|1|||
156770480|NCT01983930|565914598|FG001|Overall Study|Withdrawal by Subject|8|||
156770481|NCT01983930|565914597|FG000|Overall Study|Adverse Event|0|||
157207191|NCT01393626|567502699|FG001|Overall Study|Protocol Violation|0|||
157207192|NCT01393626|567502700|FG002|Overall Study|Protocol Violation|2|||
157007108|NCT04177394|566775127|FG000|Overall Study|Death|16|||
157207193|NCT01393626|567502701|FG003|Overall Study|Protocol Violation|0|||
157207194|NCT02426125|567502702|FG000|Overall Study|Lost to Follow-up|14|||
157207195|NCT02426125|567502703|FG001|Overall Study|Lost to Follow-up|12|||
157007109|NCT04177394|566775127|FG000|Overall Study|Withdrawal by Subject|19|||
157207196|NCT02426125|567502702|FG000|Overall Study|Withdrawal by Subject|13|||
157207197|NCT02426125|567502703|FG001|Overall Study|Withdrawal by Subject|14|||
157207198|NCT02426125|567502702|FG000|Overall Study|Death|185|||
157207199|NCT02426125|567502703|FG001|Overall Study|Death|200|||
157207200|NCT02426125|567502702|FG000|Overall Study|Randomized, But Never Treated|5|||
157207201|NCT02426125|567502703|FG001|Overall Study|Randomized, But Never Treated|2|||
157207202|NCT02858076|567502704|FG000|Overall Study|Death|6|||
157207203|NCT02858076|567502705|FG001|Overall Study|Death|3|||
157207204|NCT02858076|567502704|FG000|Overall Study|Withdrawal by Subject|1|||
157207205|NCT02858076|567502705|FG001|Overall Study|Withdrawal by Subject|5|||
157207206|NCT02858076|567502704|FG000|Overall Study|Lost to Follow-up|2|||
157207207|NCT02858076|567502705|FG001|Overall Study|Lost to Follow-up|7|||
157207208|NCT02858076|567502704|FG000|Overall Study|Completed Out of Window|1|||
157207209|NCT02858076|567502705|FG001|Overall Study|Completed Out of Window|3|||
157207210|NCT00938015|567502710|FG000|Overall Study|Death|2|||
157207211|NCT00938015|567502710|FG000|Overall Study|Lost to Follow-up|32|||
156770482|NCT01983930|565914598|FG001|Overall Study|Adverse Event|1|||
156770483|NCT00486044|565914599|FG000|Overall Study|Withdrawal by Subject|2|||
156770484|NCT00486044|565914600|FG001|Overall Study|Withdrawal by Subject|1|||
156770485|NCT00486044|565914599|FG000|Overall Study|Adverse Event|0|||
156770486|NCT00486044|565914600|FG001|Overall Study|Adverse Event|1|||
156770487|NCT00486044|565914599|FG000|Overall Study|Lost to Follow-up|0|||
156770488|NCT00486044|565914600|FG001|Overall Study|Lost to Follow-up|1|||
156770489|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770490|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
156770491|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770492|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770493|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
156770494|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
156770495|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
156770496|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770497|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770498|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
156770499|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
156770500|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
156770501|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770502|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770503|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
156770504|NCT03466346|565914603|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
156770505|NCT03466346|565914604|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
156770506|NCT03466346|565914605|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770507|NCT03466346|565914606|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770508|NCT03466346|565914607|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
156770509|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
156770510|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
156770511|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
156770512|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
156770513|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
156770514|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770515|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770516|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
156770517|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
156770518|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
156770519|NCT03466346|565914603|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
156770520|NCT03466346|565914604|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
156770521|NCT03466346|565914605|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
156770522|NCT03466346|565914606|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
156770523|NCT03466346|565914607|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
156770524|NCT02701634|565914612|FG000|Overall Study|Adverse Event|2|||
157007110|NCT04177394|566775127|FG000|Overall Study|Missed visits|61|||
157207212|NCT00938015|567502710|FG000|Overall Study|Adverse Event|32|||
157207213|NCT00938015|567502710|FG000|Overall Study|Non-responder|52|||
157207214|NCT00938015|567502710|FG000|Overall Study|Reason not related to Etanercept|29|||
157207215|NCT02341482|567502711|FG000|Overall Study|Adverse Event|1|||
157207216|NCT03186794|567502712|FG000|Overall Study|Physician Decision|2|||
156770525|NCT02701634|565914613|FG001|Overall Study|Adverse Event|3|||
156770526|NCT02701634|565914612|FG000|Overall Study|Death|1|||
156770527|NCT02701634|565914613|FG001|Overall Study|Death|0|||
156770528|NCT02701634|565914612|FG000|Overall Study|Investigator's Discretion|7|||
156770529|NCT02701634|565914613|FG001|Overall Study|Investigator's Discretion|4|||
156770530|NCT02701634|565914612|FG000|Overall Study|Study terminated by Sponsor|15|||
156770531|NCT02701634|565914613|FG001|Overall Study|Study terminated by Sponsor|17|||
156770532|NCT02701634|565914612|FG000|Overall Study|Withdrew Consent|6|||
156770533|NCT02701634|565914613|FG001|Overall Study|Withdrew Consent|7|||
156770534|NCT02701634|565914612|FG000|Overall Study|Randomized but not treated|1|||
156770535|NCT02701634|565914613|FG001|Overall Study|Randomized but not treated|0|||
156770536|NCT00537277|565914614|FG000|Overall Study|Adverse Event|1|||
156770537|NCT00537277|565914614|FG000|Overall Study|Lack of Efficacy|2|||
156770538|NCT00537277|565914614|FG000|Overall Study|Lost to Follow-up|12|||
156770539|NCT00537277|565914614|FG000|Overall Study|Protocol Violation|11|||
156770540|NCT00537277|565914614|FG000|Overall Study|Unclassified|4|||
156770541|NCT00537277|565914614|FG000|Overall Study|Inability to tolerate trial medication|4|||
156770542|NCT00537277|565914614|FG000|Overall Study|Non-compliance with trial procedures|15|||
156770543|NCT05911841|565914615|FG000|Induction Period|Study Terminated by Sponsor|2|||
156770544|NCT05911841|565914616|FG001|Induction Period|Study Terminated by Sponsor|0|||
156770545|NCT05911841|565914617|FG002|Induction Period|Study Terminated by Sponsor|14|||
156770546|NCT05911841|565914618|FG003|Induction Period|Study Terminated by Sponsor|6|||
156770547|NCT05911841|565914619|FG004|Induction Period|Study Terminated by Sponsor|0|||
156770548|NCT05911841|565914620|FG005|Induction Period|Study Terminated by Sponsor|0|||
156770549|NCT05911841|565914621|FG006|Induction Period|Study Terminated by Sponsor|0|||
156770550|NCT05911841|565914622|FG007|Induction Period|Study Terminated by Sponsor|0|||
156770551|NCT05911841|565914623|FG008|Induction Period|Study Terminated by Sponsor|0|||
156770552|NCT05911841|565914624|FG009|Induction Period|Study Terminated by Sponsor|0|||
156770553|NCT05911841|565914615|FG000|Induction Period|Withdrawal by Subject|4|||
156770554|NCT05911841|565914616|FG001|Induction Period|Withdrawal by Subject|3|||
156770555|NCT05911841|565914617|FG002|Induction Period|Withdrawal by Subject|4|||
156770556|NCT05911841|565914618|FG003|Induction Period|Withdrawal by Subject|6|||
156770557|NCT05911841|565914619|FG004|Induction Period|Withdrawal by Subject|0|||
156770558|NCT05911841|565914620|FG005|Induction Period|Withdrawal by Subject|0|||
156770559|NCT05911841|565914621|FG006|Induction Period|Withdrawal by Subject|0|||
156770560|NCT05911841|565914622|FG007|Induction Period|Withdrawal by Subject|0|||
156770561|NCT05911841|565914623|FG008|Induction Period|Withdrawal by Subject|0|||
156770562|NCT05911841|565914624|FG009|Induction Period|Withdrawal by Subject|0|||
156770563|NCT05911841|565914615|FG000|Induction Period|Lack of Efficacy|3|||
156770564|NCT05911841|565914616|FG001|Induction Period|Lack of Efficacy|0|||
156770565|NCT05911841|565914617|FG002|Induction Period|Lack of Efficacy|3|||
156770566|NCT05911841|565914618|FG003|Induction Period|Lack of Efficacy|3|||
156770567|NCT05911841|565914619|FG004|Induction Period|Lack of Efficacy|0|||
156770568|NCT05911841|565914620|FG005|Induction Period|Lack of Efficacy|0|||
156770569|NCT05911841|565914621|FG006|Induction Period|Lack of Efficacy|0|||
156770570|NCT05911841|565914622|FG007|Induction Period|Lack of Efficacy|0|||
156770571|NCT05911841|565914623|FG008|Induction Period|Lack of Efficacy|0|||
156770572|NCT05911841|565914624|FG009|Induction Period|Lack of Efficacy|0|||
156770573|NCT05911841|565914615|FG000|Induction Period|Adverse Event|3|||
156770574|NCT05911841|565914616|FG001|Induction Period|Adverse Event|1|||
156770575|NCT05911841|565914617|FG002|Induction Period|Adverse Event|2|||
156770576|NCT05911841|565914618|FG003|Induction Period|Adverse Event|0|||
156770577|NCT05911841|565914619|FG004|Induction Period|Adverse Event|0|||
156770578|NCT05911841|565914620|FG005|Induction Period|Adverse Event|0|||
156770579|NCT05911841|565914621|FG006|Induction Period|Adverse Event|0|||
156770580|NCT05911841|565914622|FG007|Induction Period|Adverse Event|0|||
156770581|NCT05911841|565914623|FG008|Induction Period|Adverse Event|0|||
156770582|NCT05911841|565914624|FG009|Induction Period|Adverse Event|0|||
156770583|NCT05911841|565914615|FG000|Induction Period|Assigned Treatment by Mistake|0|||
157007111|NCT04177394|566775127|FG000|Overall Study|Expected Visits|15|||
157007112|NCT05076266|566775128|FG000|Overall Study|Survey not complete - Participant refusal|2|||
157007113|NCT05076266|566775129|FG001|Overall Study|Survey not complete - Participant refusal|0|||
156770584|NCT05911841|565914616|FG001|Induction Period|Assigned Treatment by Mistake|1|||
156770585|NCT05911841|565914617|FG002|Induction Period|Assigned Treatment by Mistake|0|||
156770586|NCT05911841|565914618|FG003|Induction Period|Assigned Treatment by Mistake|1|||
156770587|NCT05911841|565914619|FG004|Induction Period|Assigned Treatment by Mistake|0|||
156770588|NCT05911841|565914620|FG005|Induction Period|Assigned Treatment by Mistake|0|||
156770589|NCT05911841|565914621|FG006|Induction Period|Assigned Treatment by Mistake|0|||
156770590|NCT05911841|565914622|FG007|Induction Period|Assigned Treatment by Mistake|0|||
156770591|NCT05911841|565914623|FG008|Induction Period|Assigned Treatment by Mistake|0|||
156770592|NCT05911841|565914624|FG009|Induction Period|Assigned Treatment by Mistake|0|||
156770593|NCT05911841|565914615|FG000|Induction Period|Lost to Follow-up|0|||
156770594|NCT05911841|565914616|FG001|Induction Period|Lost to Follow-up|0|||
156770595|NCT05911841|565914617|FG002|Induction Period|Lost to Follow-up|1|||
156770596|NCT05911841|565914618|FG003|Induction Period|Lost to Follow-up|1|||
156770597|NCT05911841|565914619|FG004|Induction Period|Lost to Follow-up|0|||
156770598|NCT05911841|565914620|FG005|Induction Period|Lost to Follow-up|0|||
156770599|NCT05911841|565914621|FG006|Induction Period|Lost to Follow-up|0|||
156770600|NCT05911841|565914622|FG007|Induction Period|Lost to Follow-up|0|||
156770601|NCT05911841|565914623|FG008|Induction Period|Lost to Follow-up|0|||
156770602|NCT05911841|565914624|FG009|Induction Period|Lost to Follow-up|0|||
156770603|NCT05911841|565914615|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
156770604|NCT05911841|565914616|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
156770605|NCT05911841|565914617|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
156770606|NCT05911841|565914618|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
156770607|NCT05911841|565914619|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
156770608|NCT05911841|565914620|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
156770609|NCT05911841|565914621|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
156770610|NCT05911841|565914622|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
156770611|NCT05911841|565914623|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
156770612|NCT05911841|565914624|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
156770613|NCT05911841|565914615|FG000|Maintenance Period|Lack of Efficacy|0|||
156770614|NCT05911841|565914616|FG001|Maintenance Period|Lack of Efficacy|0|||
156770615|NCT05911841|565914617|FG002|Maintenance Period|Lack of Efficacy|0|||
156770616|NCT05911841|565914618|FG003|Maintenance Period|Lack of Efficacy|0|||
156770617|NCT05911841|565914619|FG004|Maintenance Period|Lack of Efficacy|1|||
156770618|NCT05911841|565914620|FG005|Maintenance Period|Lack of Efficacy|0|||
156770619|NCT05911841|565914621|FG006|Maintenance Period|Lack of Efficacy|1|||
156770620|NCT05911841|565914622|FG007|Maintenance Period|Lack of Efficacy|0|||
156770621|NCT05911841|565914623|FG008|Maintenance Period|Lack of Efficacy|0|||
156770622|NCT05911841|565914624|FG009|Maintenance Period|Lack of Efficacy|0|||
156770623|NCT05911841|565914615|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
156770624|NCT05911841|565914616|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
156770625|NCT05911841|565914617|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
156770626|NCT05911841|565914618|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
156770627|NCT05911841|565914619|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
156770628|NCT05911841|565914620|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
156770629|NCT05911841|565914621|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
156770630|NCT05911841|565914622|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
156770631|NCT05911841|565914623|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
156770632|NCT05911841|565914624|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
156770633|NCT05911841|565914615|FG000|Maintenance Period|Withdrawal by Subject|0|||
156770634|NCT05911841|565914616|FG001|Maintenance Period|Withdrawal by Subject|0|||
156770635|NCT05911841|565914617|FG002|Maintenance Period|Withdrawal by Subject|0|||
156770636|NCT05911841|565914618|FG003|Maintenance Period|Withdrawal by Subject|0|||
156770637|NCT05911841|565914619|FG004|Maintenance Period|Withdrawal by Subject|0|||
156770638|NCT05911841|565914620|FG005|Maintenance Period|Withdrawal by Subject|1|||
156770639|NCT05911841|565914621|FG006|Maintenance Period|Withdrawal by Subject|0|||
156770640|NCT05911841|565914622|FG007|Maintenance Period|Withdrawal by Subject|1|||
156770641|NCT05911841|565914623|FG008|Maintenance Period|Withdrawal by Subject|0|||
156770642|NCT05911841|565914624|FG009|Maintenance Period|Withdrawal by Subject|0|||
156770643|NCT05911841|565914615|FG000|Maintenance Period|Adverse Event|0|||
156770644|NCT05911841|565914616|FG001|Maintenance Period|Adverse Event|0|||
156770645|NCT05911841|565914617|FG002|Maintenance Period|Adverse Event|0|||
156770646|NCT05911841|565914618|FG003|Maintenance Period|Adverse Event|0|||
156770647|NCT05911841|565914619|FG004|Maintenance Period|Adverse Event|0|||
156770648|NCT05911841|565914620|FG005|Maintenance Period|Adverse Event|0|||
156770649|NCT05911841|565914621|FG006|Maintenance Period|Adverse Event|0|||
156770650|NCT05911841|565914622|FG007|Maintenance Period|Adverse Event|1|||
156770651|NCT05911841|565914623|FG008|Maintenance Period|Adverse Event|0|||
156770652|NCT05911841|565914624|FG009|Maintenance Period|Adverse Event|0|||
156770653|NCT05911841|565914615|FG000|Escape Period|Adverse Event|0|||
156770654|NCT05911841|565914616|FG001|Escape Period|Adverse Event|0|||
156770655|NCT05911841|565914617|FG002|Escape Period|Adverse Event|0|||
156770656|NCT05911841|565914618|FG003|Escape Period|Adverse Event|0|||
156770657|NCT05911841|565914619|FG004|Escape Period|Adverse Event|0|||
156770658|NCT05911841|565914620|FG005|Escape Period|Adverse Event|0|||
156770659|NCT05911841|565914621|FG006|Escape Period|Adverse Event|0|||
157007114|NCT00997386|566775130|FG000|Overall Study|Death|7|||
157007115|NCT01350804|566775131|FG000|Core Study|Withdrawal by Subject|11|||
157007116|NCT01350804|566775132|FG001|Core Study|Withdrawal by Subject|17|||
156770660|NCT05911841|565914622|FG007|Escape Period|Adverse Event|0|||
156770661|NCT05911841|565914623|FG008|Escape Period|Adverse Event|0|||
156770662|NCT05911841|565914624|FG009|Escape Period|Adverse Event|1|||
156770663|NCT05911841|565914615|FG000|Escape Period|Lack of Efficacy|0|||
156770664|NCT05911841|565914616|FG001|Escape Period|Lack of Efficacy|0|||
156770665|NCT05911841|565914617|FG002|Escape Period|Lack of Efficacy|0|||
156770666|NCT05911841|565914618|FG003|Escape Period|Lack of Efficacy|0|||
156770667|NCT05911841|565914619|FG004|Escape Period|Lack of Efficacy|0|||
156770668|NCT05911841|565914620|FG005|Escape Period|Lack of Efficacy|0|||
156770669|NCT05911841|565914621|FG006|Escape Period|Lack of Efficacy|0|||
157007117|NCT01350804|566775133|FG002|Core Study|Withdrawal by Subject|16|||
156770670|NCT05911841|565914622|FG007|Escape Period|Lack of Efficacy|0|||
156770671|NCT05911841|565914623|FG008|Escape Period|Lack of Efficacy|0|||
156770672|NCT05911841|565914624|FG009|Escape Period|Lack of Efficacy|31|||
156770673|NCT05911841|565914615|FG000|Escape Period|Lost to Follow-up|0|||
156770674|NCT05911841|565914616|FG001|Escape Period|Lost to Follow-up|0|||
156770675|NCT05911841|565914617|FG002|Escape Period|Lost to Follow-up|0|||
156770676|NCT05911841|565914618|FG003|Escape Period|Lost to Follow-up|0|||
156770677|NCT05911841|565914619|FG004|Escape Period|Lost to Follow-up|0|||
156770678|NCT05911841|565914620|FG005|Escape Period|Lost to Follow-up|0|||
156770679|NCT05911841|565914621|FG006|Escape Period|Lost to Follow-up|0|||
156770680|NCT05911841|565914622|FG007|Escape Period|Lost to Follow-up|0|||
156770681|NCT05911841|565914623|FG008|Escape Period|Lost to Follow-up|0|||
156770682|NCT05911841|565914624|FG009|Escape Period|Lost to Follow-up|1|||
156770683|NCT05911841|565914615|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770684|NCT05911841|565914616|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
157207217|NCT03186794|567502712|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
157207218|NCT00664066|567502714|FG000|Overall Study|Study terminated|3|||
157207219|NCT02575807|567502715|FG000|Overall Study|Death|8|||
157207220|NCT02575807|567502716|FG001|Overall Study|Death|3|||
157207221|NCT02575807|567502717|FG002|Overall Study|Death|7|||
157207222|NCT02575807|567502718|FG003|Overall Study|Death|0|||
157207223|NCT02575807|567502719|FG004|Overall Study|Death|1|||
157207224|NCT02575807|567502715|FG000|Overall Study|Study terminated by Sponsor|0|||
157207225|NCT02575807|567502716|FG001|Overall Study|Study terminated by Sponsor|1|||
157207226|NCT02575807|567502717|FG002|Overall Study|Study terminated by Sponsor|7|||
157207227|NCT02575807|567502718|FG003|Overall Study|Study terminated by Sponsor|0|||
157207228|NCT02575807|567502719|FG004|Overall Study|Study terminated by Sponsor|1|||
157207229|NCT02575807|567502715|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
157207230|NCT02575807|567502716|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
157207231|NCT02575807|567502717|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
157207232|NCT02575807|567502718|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
157207233|NCT02575807|567502719|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
157207234|NCT02575807|567502715|FG000|Overall Study|Terminated due to physician decision|0|||
157207235|NCT02575807|567502716|FG001|Overall Study|Terminated due to physician decision|0|||
157207236|NCT02575807|567502717|FG002|Overall Study|Terminated due to physician decision|1|||
157207237|NCT02575807|567502718|FG003|Overall Study|Terminated due to physician decision|0|||
157207238|NCT02575807|567502719|FG004|Overall Study|Terminated due to physician decision|0|||
157207239|NCT02575807|567502715|FG000|Overall Study|Subject ineligible - medical implant|0|||
157207240|NCT02575807|567502716|FG001|Overall Study|Subject ineligible - medical implant|0|||
157207241|NCT02575807|567502717|FG002|Overall Study|Subject ineligible - medical implant|0|||
157207242|NCT02575807|567502718|FG003|Overall Study|Subject ineligible - medical implant|1|||
157207243|NCT02575807|567502719|FG004|Overall Study|Subject ineligible - medical implant|0|||
157207244|NCT02575807|567502715|FG000|Overall Study|Withdrawal by Subject|0|||
157207245|NCT02575807|567502716|FG001|Overall Study|Withdrawal by Subject|0|||
157207246|NCT02575807|567502717|FG002|Overall Study|Withdrawal by Subject|1|||
157207247|NCT02575807|567502718|FG003|Overall Study|Withdrawal by Subject|1|||
157207248|NCT02575807|567502719|FG004|Overall Study|Withdrawal by Subject|2|||
157207249|NCT03000075|567502720|FG000|Part A|Adverse Event|4|||
156770685|NCT05911841|565914617|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770686|NCT05911841|565914618|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770687|NCT05911841|565914619|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770688|NCT05911841|565914620|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770689|NCT05911841|565914621|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770690|NCT05911841|565914622|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770691|NCT05911841|565914623|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
156770692|NCT05911841|565914624|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
156770693|NCT05911841|565914615|FG000|Escape Period|Site Terminated by Sponsor|0|||
156770694|NCT05911841|565914616|FG001|Escape Period|Site Terminated by Sponsor|0|||
156770695|NCT05911841|565914617|FG002|Escape Period|Site Terminated by Sponsor|0|||
156770696|NCT05911841|565914618|FG003|Escape Period|Site Terminated by Sponsor|0|||
156770697|NCT05911841|565914619|FG004|Escape Period|Site Terminated by Sponsor|0|||
156770698|NCT05911841|565914620|FG005|Escape Period|Site Terminated by Sponsor|0|||
156770699|NCT05911841|565914621|FG006|Escape Period|Site Terminated by Sponsor|0|||
156770700|NCT05911841|565914622|FG007|Escape Period|Site Terminated by Sponsor|0|||
156770701|NCT05911841|565914623|FG008|Escape Period|Site Terminated by Sponsor|0|||
156770702|NCT05911841|565914624|FG009|Escape Period|Site Terminated by Sponsor|1|||
156770703|NCT05911841|565914615|FG000|Escape Period|Study Terminated by Sponsor|0|||
157207250|NCT03000075|567502721|FG001|Part A|Adverse Event|0|||
157207251|NCT03000075|567502722|FG002|Part A|Adverse Event|0|||
157207252|NCT03000075|567502723|FG003|Part A|Adverse Event|0|||
157207253|NCT03000075|567502724|FG004|Part A|Adverse Event|0|||
157207254|NCT03000075|567502725|FG005|Part A|Adverse Event|0|||
157007118|NCT01350804|566775134|FG003|Core Study|Withdrawal by Subject|7|||
156770704|NCT05911841|565914616|FG001|Escape Period|Study Terminated by Sponsor|0|||
156770705|NCT05911841|565914617|FG002|Escape Period|Study Terminated by Sponsor|0|||
156770706|NCT05911841|565914618|FG003|Escape Period|Study Terminated by Sponsor|0|||
156770707|NCT05911841|565914619|FG004|Escape Period|Study Terminated by Sponsor|0|||
156770708|NCT05911841|565914620|FG005|Escape Period|Study Terminated by Sponsor|0|||
156770709|NCT05911841|565914621|FG006|Escape Period|Study Terminated by Sponsor|0|||
156770710|NCT05911841|565914622|FG007|Escape Period|Study Terminated by Sponsor|0|||
156770711|NCT05911841|565914623|FG008|Escape Period|Study Terminated by Sponsor|0|||
156770712|NCT05911841|565914624|FG009|Escape Period|Study Terminated by Sponsor|34|||
156770713|NCT05911841|565914615|FG000|Escape Period|Withdrawal by Subject|0|||
156770714|NCT05911841|565914616|FG001|Escape Period|Withdrawal by Subject|0|||
156770715|NCT05911841|565914617|FG002|Escape Period|Withdrawal by Subject|0|||
156770716|NCT05911841|565914618|FG003|Escape Period|Withdrawal by Subject|0|||
156770717|NCT05911841|565914619|FG004|Escape Period|Withdrawal by Subject|0|||
156770718|NCT05911841|565914620|FG005|Escape Period|Withdrawal by Subject|0|||
156770719|NCT05911841|565914621|FG006|Escape Period|Withdrawal by Subject|0|||
156770720|NCT05911841|565914622|FG007|Escape Period|Withdrawal by Subject|0|||
156770721|NCT05911841|565914623|FG008|Escape Period|Withdrawal by Subject|0|||
156770722|NCT05911841|565914624|FG009|Escape Period|Withdrawal by Subject|10|||
157007119|NCT01350804|566775131|FG000|Core Study|Study terminated by Sponsor|0|||
156770723|NCT00111761|565914631|FG000|Part 1|Physician Decision|0|||
156770724|NCT00111761|565914632|FG001|Part 1|Physician Decision|1|||
156770725|NCT00111761|565914631|FG000|Part 1|Death|0|||
156770726|NCT00111761|565914632|FG001|Part 1|Death|2|||
156770727|NCT00111761|565914631|FG000|Part 1|Other|0|||
156770728|NCT00111761|565914632|FG001|Part 1|Other|1|||
156770729|NCT00111761|565914631|FG000|Part 1|Withdrawal by Subject|0|||
156770730|NCT00111761|565914632|FG001|Part 1|Withdrawal by Subject|1|||
156770731|NCT00111761|565914631|FG000|Part 2|Adverse Event|1|||
156770732|NCT00111761|565914632|FG001|Part 2|Adverse Event|0|||
156770733|NCT00111761|565914631|FG000|Part 2|Physician Decision|1|||
156770734|NCT00111761|565914632|FG001|Part 2|Physician Decision|0|||
156770735|NCT00111761|565914631|FG000|Part 2|Death|1|||
156770736|NCT00111761|565914632|FG001|Part 2|Death|0|||
156770737|NCT00111761|565914631|FG000|Part 2|Disease progression|3|||
156770738|NCT00111761|565914632|FG001|Part 2|Disease progression|0|||
156770739|NCT00111761|565914631|FG000|Part 2|Protocol-specified criteria|1|||
156770740|NCT00111761|565914632|FG001|Part 2|Protocol-specified criteria|0|||
156770741|NCT00111761|565914631|FG000|Part 2|Other|1|||
156770742|NCT00111761|565914632|FG001|Part 2|Other|0|||
156770743|NCT04108468|565914636|FG000|Overall Study|Physician Decision|0|||
156770744|NCT04108468|565914637|FG001|Overall Study|Physician Decision|1|||
156770745|NCT04108468|565914636|FG000|Overall Study|Lost to Follow-up|0|||
156770746|NCT04108468|565914637|FG001|Overall Study|Lost to Follow-up|1|||
156770747|NCT04108468|565914636|FG000|Overall Study|Non-compliance|1|||
156770748|NCT04108468|565914637|FG001|Overall Study|Non-compliance|1|||
156770749|NCT04108468|565914636|FG000|Overall Study|Unable to attend final visit|2|||
156770750|NCT04108468|565914637|FG001|Overall Study|Unable to attend final visit|0|||
156770751|NCT04108468|565914636|FG000|Overall Study|Missed study medication|0|||
156770752|NCT04108468|565914637|FG001|Overall Study|Missed study medication|1|||
156770753|NCT00471497|565914638|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
156770754|NCT00471497|565914639|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
156770755|NCT00471497|565914640|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
156770756|NCT00471497|565914638|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
156770757|NCT00471497|565914639|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
156770758|NCT00471497|565914640|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
156770759|NCT00471497|565914638|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
156770760|NCT00471497|565914639|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
156770761|NCT00471497|565914640|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
156770762|NCT00471497|565914638|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
156770763|NCT00471497|565914639|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
156770764|NCT00471497|565914640|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
156770765|NCT00471497|565914638|FG000|Core Treatment Phase|Lost to Follow-up|6|||
156770766|NCT00471497|565914639|FG001|Core Treatment Phase|Lost to Follow-up|6|||
156770767|NCT00471497|565914640|FG002|Core Treatment Phase|Lost to Follow-up|3|||
156770768|NCT00471497|565914638|FG000|Core Treatment Phase|Death|3|||
156770769|NCT00471497|565914639|FG001|Core Treatment Phase|Death|9|||
156770770|NCT00471497|565914640|FG002|Core Treatment Phase|Death|3|||
156770771|NCT00471497|565914638|FG000|Core Treatment Phase|Disease Progression|10|||
157007120|NCT01350804|566775132|FG001|Core Study|Study terminated by Sponsor|0|||
157007121|NCT01350804|566775133|FG002|Core Study|Study terminated by Sponsor|0|||
156770772|NCT00471497|565914639|FG001|Core Treatment Phase|Disease Progression|2|||
156770773|NCT00471497|565914640|FG002|Core Treatment Phase|Disease Progression|4|||
156770774|NCT00471497|565914638|FG000|Core Treatment Phase|Protocol Violation|6|||
156770775|NCT00471497|565914639|FG001|Core Treatment Phase|Protocol Violation|15|||
156770776|NCT00471497|565914640|FG002|Core Treatment Phase|Protocol Violation|11|||
157007122|NCT01350804|566775134|FG003|Core Study|Study terminated by Sponsor|2|||
157007123|NCT01350804|566775131|FG000|Core Study|Protocol deviation|1|||
157007124|NCT01350804|566775132|FG001|Core Study|Protocol deviation|0|||
157007125|NCT01350804|566775133|FG002|Core Study|Protocol deviation|1|||
157007126|NCT01350804|566775134|FG003|Core Study|Protocol deviation|0|||
157007127|NCT01350804|566775131|FG000|Core Study|Physician Decision|1|||
157007128|NCT01350804|566775132|FG001|Core Study|Physician Decision|0|||
157007129|NCT01350804|566775133|FG002|Core Study|Physician Decision|1|||
157007130|NCT01350804|566775134|FG003|Core Study|Physician Decision|3|||
157007131|NCT01350804|566775131|FG000|Core Study|Lost to Follow-up|3|||
157007132|NCT01350804|566775132|FG001|Core Study|Lost to Follow-up|0|||
157007133|NCT01350804|566775133|FG002|Core Study|Lost to Follow-up|2|||
157007134|NCT01350804|566775134|FG003|Core Study|Lost to Follow-up|1|||
157007135|NCT01350804|566775131|FG000|Core Study|Lack of Efficacy|16|||
157007136|NCT01350804|566775132|FG001|Core Study|Lack of Efficacy|19|||
157007137|NCT01350804|566775133|FG002|Core Study|Lack of Efficacy|18|||
157007138|NCT01350804|566775134|FG003|Core Study|Lack of Efficacy|5|||
157007139|NCT01350804|566775131|FG000|Core Study|Death|1|||
157007140|NCT01350804|566775132|FG001|Core Study|Death|1|||
157007141|NCT01350804|566775133|FG002|Core Study|Death|1|||
157007142|NCT01350804|566775134|FG003|Core Study|Death|0|||
157007143|NCT01350804|566775131|FG000|Core Study|Adverse Event|8|||
157007144|NCT01350804|566775132|FG001|Core Study|Adverse Event|10|||
157007145|NCT01350804|566775133|FG002|Core Study|Adverse Event|8|||
157007146|NCT01350804|566775134|FG003|Core Study|Adverse Event|8|||
157007147|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
157007148|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
157007149|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
157007150|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
157007151|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
157007152|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
157007153|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
157007154|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
157007155|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
157007156|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
157007157|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
157007158|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
157007159|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
157007160|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
157007161|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
157007162|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
157007163|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
157007164|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
157007165|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
157007166|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
157007167|NCT01350804|566775131|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
157007168|NCT01350804|566775132|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
157207255|NCT03000075|567502726|FG006|Part A|Adverse Event|0|||
157207256|NCT03000075|567502720|FG000|Part B|Not dosed due to AE|0|||
157207257|NCT03000075|567502721|FG001|Part B|Not dosed due to AE|0|||
157207258|NCT03000075|567502722|FG002|Part B|Not dosed due to AE|0|||
157207259|NCT03000075|567502723|FG003|Part B|Not dosed due to AE|0|||
157207260|NCT03000075|567502724|FG004|Part B|Not dosed due to AE|0|||
157207261|NCT03000075|567502725|FG005|Part B|Not dosed due to AE|2|||
157207262|NCT03000075|567502726|FG006|Part B|Not dosed due to AE|1|||
157207263|NCT03000075|567502720|FG000|Part B|Adverse Event|0|||
157207264|NCT03000075|567502721|FG001|Part B|Adverse Event|0|||
156770777|NCT00471497|565914638|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
156770778|NCT00471497|565914639|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
156770779|NCT00471497|565914640|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
156770780|NCT00471497|565914638|FG000|Core Treatment Phase|Administrative problems|14|||
156770781|NCT00471497|565914639|FG001|Core Treatment Phase|Administrative problems|14|||
156770782|NCT00471497|565914640|FG002|Core Treatment Phase|Administrative problems|12|||
156770783|NCT00471497|565914638|FG000|Core Treatment Phase|Adverse Event|43|||
156770784|NCT00471497|565914639|FG001|Core Treatment Phase|Adverse Event|53|||
156770785|NCT00471497|565914640|FG002|Core Treatment Phase|Adverse Event|89|||
156770786|NCT00471497|565914638|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
156770787|NCT00471497|565914639|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
156770788|NCT00471497|565914640|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
156770789|NCT00471497|565914638|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
156770790|NCT00471497|565914639|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
156770791|NCT00471497|565914640|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
156770792|NCT00471497|565914638|FG000|Extension Phase|Adverse Event|9|||
156770793|NCT00471497|565914639|FG001|Extension Phase|Adverse Event|5|||
156770794|NCT00471497|565914640|FG002|Extension Phase|Adverse Event|1|||
156770795|NCT00471497|565914638|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
156770796|NCT00471497|565914639|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
156770797|NCT00471497|565914640|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
156770798|NCT00471497|565914638|FG000|Extension Phase|Withdrawal by Subject|3|||
156770799|NCT00471497|565914639|FG001|Extension Phase|Withdrawal by Subject|1|||
156770800|NCT00471497|565914640|FG002|Extension Phase|Withdrawal by Subject|0|||
156770801|NCT00471497|565914638|FG000|Extension Phase|Lost to Follow-up|2|||
156770802|NCT00471497|565914639|FG001|Extension Phase|Lost to Follow-up|0|||
156770803|NCT00471497|565914640|FG002|Extension Phase|Lost to Follow-up|0|||
156770804|NCT00471497|565914638|FG000|Extension Phase|Death|1|||
156770805|NCT00471497|565914639|FG001|Extension Phase|Death|0|||
156770806|NCT00471497|565914640|FG002|Extension Phase|Death|0|||
156770807|NCT00471497|565914638|FG000|Extension Phase|Disease progression|2|||
156770808|NCT00471497|565914639|FG001|Extension Phase|Disease progression|0|||
156770809|NCT00471497|565914640|FG002|Extension Phase|Disease progression|0|||
156770810|NCT00471497|565914638|FG000|Extension Phase|Protocol Violation|2|||
156770811|NCT00471497|565914639|FG001|Extension Phase|Protocol Violation|2|||
156770812|NCT00471497|565914640|FG002|Extension Phase|Protocol Violation|0|||
156770813|NCT04004000|565914644|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
156770814|NCT06121609|565914645|FG000|Overall Study|Lack of Efficacy|0|||
156770815|NCT06121609|565914646|FG001|Overall Study|Lack of Efficacy|0|||
156770816|NCT06121609|565914647|FG002|Overall Study|Lack of Efficacy|45|||
156770817|NCT00848497|565914648|FG000|Overall Study|Screen failure|2|||
156770818|NCT00848497|565914649|FG001|Overall Study|Screen failure|0|||
156770819|NCT00848497|565914648|FG000|Overall Study|Withdrawal by Subject|0|||
156770820|NCT00848497|565914649|FG001|Overall Study|Withdrawal by Subject|1|||
156770821|NCT01420536|565914659|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
156770822|NCT01420536|565914660|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
156770823|NCT04711005|565914661|FG000|Overall Study|Withdrawal by Subject|0|||
156770824|NCT04711005|565914662|FG001|Overall Study|Withdrawal by Subject|0|||
156770825|NCT04711005|565914663|FG002|Overall Study|Withdrawal by Subject|0|||
156770826|NCT04711005|565914664|FG003|Overall Study|Withdrawal by Subject|0|||
156770827|NCT04711005|565914665|FG004|Overall Study|Withdrawal by Subject|0|||
156770828|NCT04711005|565914666|FG005|Overall Study|Withdrawal by Subject|0|||
156770829|NCT04711005|565914667|FG006|Overall Study|Withdrawal by Subject|0|||
156770830|NCT04711005|565914668|FG007|Overall Study|Withdrawal by Subject|1|||
156770831|NCT04711005|565914669|FG008|Overall Study|Withdrawal by Subject|0|||
156770832|NCT04711005|565914670|FG009|Overall Study|Withdrawal by Subject|0|||
156770833|NCT04711005|565914661|FG000|Overall Study|Physician Decision|0|||
156770834|NCT04711005|565914662|FG001|Overall Study|Physician Decision|0|||
156770835|NCT04711005|565914663|FG002|Overall Study|Physician Decision|0|||
156770836|NCT04711005|565914664|FG003|Overall Study|Physician Decision|0|||
156770837|NCT04711005|565914665|FG004|Overall Study|Physician Decision|0|||
156770838|NCT04711005|565914666|FG005|Overall Study|Physician Decision|0|||
156770839|NCT04711005|565914667|FG006|Overall Study|Physician Decision|0|||
156770840|NCT04711005|565914668|FG007|Overall Study|Physician Decision|2|||
156770841|NCT04711005|565914669|FG008|Overall Study|Physician Decision|1|||
156770842|NCT04711005|565914670|FG009|Overall Study|Physician Decision|0|||
156770843|NCT04935879|565914671|FG000|Overall Study|Adverse Event|2|||
156770844|NCT04935879|565914672|FG001|Overall Study|Adverse Event|1|||
157207265|NCT03000075|567502722|FG002|Part B|Adverse Event|0|||
156770845|NCT04935879|565914671|FG000|Overall Study|Lost to Follow-up|1|||
156770846|NCT04935879|565914672|FG001|Overall Study|Lost to Follow-up|1|||
156770847|NCT04935879|565914671|FG000|Overall Study|Pregnancy|2|||
157207266|NCT03000075|567502723|FG003|Part B|Adverse Event|0|||
156770848|NCT04935879|565914672|FG001|Overall Study|Pregnancy|3|||
156770849|NCT04935879|565914671|FG000|Overall Study|Withdrawal by Subject|8|||
156770850|NCT04935879|565914672|FG001|Overall Study|Withdrawal by Subject|6|||
156770851|NCT04935879|565914671|FG000|Overall Study|Other|3|||
156770852|NCT04935879|565914672|FG001|Overall Study|Other|3|||
156770853|NCT03054428|565914673|FG000|Overall Study|Physician Decision|0|||
156770854|NCT03054428|565914674|FG001|Overall Study|Physician Decision|1|||
156770855|NCT03054428|565914675|FG002|Overall Study|Physician Decision|1|||
156770856|NCT03054428|565914673|FG000|Overall Study|Lack of Efficacy|3|||
156770857|NCT03054428|565914674|FG001|Overall Study|Lack of Efficacy|1|||
157207267|NCT03000075|567502724|FG004|Part B|Adverse Event|1|||
157207268|NCT03000075|567502725|FG005|Part B|Adverse Event|0|||
157207269|NCT03000075|567502726|FG006|Part B|Adverse Event|0|||
157207270|NCT02180659|567502727|FG000|Overall Study|Adverse Event|1|||
157207271|NCT02180659|567502728|FG001|Overall Study|Adverse Event|0|||
157207272|NCT02180659|567502727|FG000|Overall Study|Lost to Follow-up|4|||
157207273|NCT02180659|567502728|FG001|Overall Study|Lost to Follow-up|2|||
157207274|NCT02180659|567502727|FG000|Overall Study|Subject incarcerated during conduct|1|||
157207275|NCT02180659|567502728|FG001|Overall Study|Subject incarcerated during conduct|0|||
157207276|NCT02180659|567502727|FG000|Overall Study|Withdrawal by Subject|0|||
157207277|NCT02180659|567502728|FG001|Overall Study|Withdrawal by Subject|2|||
157207278|NCT02180659|567502727|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
157207279|NCT02180659|567502728|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
157207280|NCT00518011|567502729|FG000|Overall Study|Death|1|||
157207281|NCT00518011|567502730|FG001|Overall Study|Death|1|||
157207282|NCT00518011|567502729|FG000|Overall Study|Adverse Event|2|||
157207283|NCT00518011|567502730|FG001|Overall Study|Adverse Event|3|||
157207284|NCT00518011|567502729|FG000|Overall Study|Disease Progression|2|||
157207285|NCT00518011|567502730|FG001|Overall Study|Disease Progression|2|||
157207286|NCT00518011|567502729|FG000|Overall Study|Other Reasons|3|||
157207287|NCT00518011|567502730|FG001|Overall Study|Other Reasons|2|||
157207288|NCT00518011|567502729|FG000|Overall Study|Withdrawal by Subject|1|||
157207289|NCT00518011|567502730|FG001|Overall Study|Withdrawal by Subject|0|||
157207290|NCT00090259|567502731|FG000|Overall Study|Lost to Follow-up|30|||
157207291|NCT00090259|567502732|FG001|Overall Study|Lost to Follow-up|26|||
157207292|NCT00090259|567502731|FG000|Overall Study|Withdrawal by Subject|21|||
157207293|NCT00090259|567502732|FG001|Overall Study|Withdrawal by Subject|15|||
157207294|NCT00090259|567502731|FG000|Overall Study|Investigator site closed|11|||
157207295|NCT00090259|567502732|FG001|Overall Study|Investigator site closed|7|||
157207296|NCT04797637|567502734|FG000|Overall Study|Lost to Follow-up|23|||
157207297|NCT04797637|567502735|FG001|Overall Study|Lost to Follow-up|32|||
157207298|NCT04797637|567502734|FG000|Overall Study|Withdrawal by Subject|0|||
157207299|NCT04797637|567502735|FG001|Overall Study|Withdrawal by Subject|1|||
157207300|NCT03083639|567502736|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
157207301|NCT03083639|567502737|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
157207302|NCT03083639|567502736|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
157207303|NCT03083639|567502737|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
157207304|NCT00960687|567502741|FG000|Washout Period of 7 Days|Adverse Event|3|||
156770858|NCT03054428|565914675|FG002|Overall Study|Lack of Efficacy|0|||
156770859|NCT03054428|565914673|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
156770860|NCT03054428|565914674|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
156770861|NCT03054428|565914675|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
156770862|NCT03054428|565914673|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
156770863|NCT03054428|565914674|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
156770864|NCT03054428|565914675|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
156770865|NCT03054428|565914673|FG000|Overall Study|Transitioned to OLE study|76|||
156770866|NCT03054428|565914674|FG001|Overall Study|Transitioned to OLE study|76|||
156770867|NCT03054428|565914675|FG002|Overall Study|Transitioned to OLE study|73|||
156770868|NCT03054428|565914673|FG000|Overall Study|Withdrawal by Subject|3|||
156770869|NCT03054428|565914674|FG001|Overall Study|Withdrawal by Subject|2|||
156770870|NCT03054428|565914675|FG002|Overall Study|Withdrawal by Subject|3|||
156770871|NCT03054428|565914673|FG000|Overall Study|Lost to Follow-up|0|||
156770872|NCT03054428|565914674|FG001|Overall Study|Lost to Follow-up|0|||
156770873|NCT03054428|565914675|FG002|Overall Study|Lost to Follow-up|1|||
156770874|NCT01652690|565914676|FG000|Overall Study|Withdrawal by Subject|16|||
156770875|NCT01652690|565914677|FG001|Overall Study|Withdrawal by Subject|4|||
156770876|NCT01652690|565914676|FG000|Overall Study|Other|8|||
156770877|NCT01652690|565914677|FG001|Overall Study|Other|9|||
156770878|NCT01652690|565914676|FG000|Overall Study|Lost to Follow-up|6|||
156770879|NCT01652690|565914677|FG001|Overall Study|Lost to Follow-up|6|||
156770880|NCT01652690|565914676|FG000|Overall Study|Death|5|||
156770881|NCT01652690|565914677|FG001|Overall Study|Death|2|||
156770882|NCT03533751|565914678|FG000|Overall Study|Withdrawal by Subject|12|||
156770883|NCT03533751|565914679|FG001|Overall Study|Withdrawal by Subject|6|||
157207305|NCT00960687|567502742|FG001|Washout Period of 7 Days|Adverse Event|2|||
157207306|NCT00960687|567502741|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156770884|NCT03533751|565914680|FG002|Overall Study|Withdrawal by Subject|11|||
156770885|NCT03533751|565914681|FG003|Overall Study|Withdrawal by Subject|9|||
156770886|NCT03533751|565914682|FG004|Overall Study|Withdrawal by Subject|10|||
156770887|NCT03533751|565914678|FG000|Overall Study|Adverse Event|4|||
156770888|NCT03533751|565914679|FG001|Overall Study|Adverse Event|7|||
156770889|NCT03533751|565914680|FG002|Overall Study|Adverse Event|2|||
156770890|NCT03533751|565914681|FG003|Overall Study|Adverse Event|4|||
156770891|NCT03533751|565914682|FG004|Overall Study|Adverse Event|5|||
156770892|NCT03533751|565914678|FG000|Overall Study|Physician Decision|0|||
157207307|NCT00960687|567502742|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
157207308|NCT01381068|567502746|FG000|Overall Study|Death|1|||
157207309|NCT01381068|567502747|FG001|Overall Study|Death|0|||
157207310|NCT01525407|567502755|FG000|Overall Study|Change in recipient treatment plan|2|||
157207311|NCT01525407|567502756|FG001|Overall Study|Change in recipient treatment plan|2|||
157207312|NCT01525407|567502755|FG000|Overall Study|Withdrawal by Subject|0|||
157207313|NCT01525407|567502756|FG001|Overall Study|Withdrawal by Subject|1|||
157207314|NCT01525407|567502755|FG000|Overall Study|Transplant was delayed|0|||
157207315|NCT01525407|567502756|FG001|Overall Study|Transplant was delayed|1|||
157207316|NCT01525407|567502755|FG000|Overall Study|Delay in Transplant|1|||
157207317|NCT01525407|567502756|FG001|Overall Study|Delay in Transplant|0|||
157221631|NCT01644890|567558453|FG000|Overall Study|Withdrawal by Subject|19|||
157221632|NCT01644890|567558454|FG001|Overall Study|Withdrawal by Subject|27|||
157221633|NCT01644890|567558453|FG000|Overall Study|Progression Disease|160|||
157221634|NCT01644890|567558454|FG001|Overall Study|Progression Disease|131|||
157221635|NCT01644890|567558453|FG000|Overall Study|Clinical Progression|6|||
157221636|NCT01644890|567558454|FG001|Overall Study|Clinical Progression|6|||
157221637|NCT01644890|567558453|FG000|Overall Study|> 28 days since last dose of study drug|6|||
156770893|NCT03533751|565914679|FG001|Overall Study|Physician Decision|2|||
156770894|NCT03533751|565914680|FG002|Overall Study|Physician Decision|1|||
156770895|NCT03533751|565914681|FG003|Overall Study|Physician Decision|2|||
156770896|NCT03533751|565914682|FG004|Overall Study|Physician Decision|1|||
156770897|NCT03533751|565914678|FG000|Overall Study|Sponsor Decision|0|||
156770898|NCT03533751|565914679|FG001|Overall Study|Sponsor Decision|0|||
156770899|NCT03533751|565914680|FG002|Overall Study|Sponsor Decision|1|||
156770900|NCT03533751|565914681|FG003|Overall Study|Sponsor Decision|1|||
156770901|NCT03533751|565914682|FG004|Overall Study|Sponsor Decision|0|||
156770902|NCT03533751|565914678|FG000|Overall Study|Lost to Follow-up|3|||
156770903|NCT03533751|565914679|FG001|Overall Study|Lost to Follow-up|7|||
156770904|NCT03533751|565914680|FG002|Overall Study|Lost to Follow-up|6|||
156770905|NCT03533751|565914681|FG003|Overall Study|Lost to Follow-up|4|||
156770906|NCT03533751|565914682|FG004|Overall Study|Lost to Follow-up|3|||
156770907|NCT03533751|565914678|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
156770908|NCT03533751|565914679|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
156770909|NCT03533751|565914680|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
156770910|NCT03533751|565914681|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
156770911|NCT03533751|565914682|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
156770912|NCT03533751|565914678|FG000|Overall Study|Other|0|||
156770913|NCT03533751|565914679|FG001|Overall Study|Other|2|||
156770914|NCT03533751|565914680|FG002|Overall Study|Other|1|||
156770915|NCT03533751|565914681|FG003|Overall Study|Other|0|||
156770916|NCT03533751|565914682|FG004|Overall Study|Other|3|||
156770917|NCT03225287|565914683|FG000|Overall Study|Adverse Event|0|||
156770918|NCT03225287|565914684|FG001|Overall Study|Adverse Event|0|||
156770919|NCT03225287|565914685|FG002|Overall Study|Adverse Event|1|||
156770920|NCT03225287|565914683|FG000|Overall Study|Protocol non-compliance|0|||
156770921|NCT03225287|565914684|FG001|Overall Study|Protocol non-compliance|0|||
156770922|NCT03225287|565914685|FG002|Overall Study|Protocol non-compliance|1|||
156770923|NCT03225287|565914683|FG000|Overall Study|Subject withdraws consent|3|||
156770924|NCT03225287|565914684|FG001|Overall Study|Subject withdraws consent|0|||
156770925|NCT03225287|565914685|FG002|Overall Study|Subject withdraws consent|0|||
156770926|NCT03225287|565914683|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
156770927|NCT03225287|565914684|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
156770928|NCT03225287|565914685|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
157221638|NCT01644890|567558454|FG001|Overall Study|> 28 days since last dose of study drug|3|||
157221639|NCT01644890|567558453|FG000|Overall Study|Other|8|||
157221640|NCT01644890|567558454|FG001|Overall Study|Other|9|||
157221641|NCT00313703|567558456|FG000|Overall Study|Lost to Follow-up|11|||
157221642|NCT00313703|567558457|FG001|Overall Study|Lost to Follow-up|2|||
157221643|NCT00313703|567558458|FG002|Overall Study|Lost to Follow-up|5|||
157221644|NCT00313703|567558459|FG003|Overall Study|Lost to Follow-up|12|||
157221645|NCT03031899|567558462|FG000|Overall Study|Protocol Violation|1|||
157221646|NCT03031899|567558462|FG000|Overall Study|lesion disappeared after stopping habit|1|||
157221647|NCT01060670|567558463|FG000|Run In|screen failure|0|||
157221648|NCT01060670|567558464|FG001|Run In|screen failure|238|||
156770929|NCT03225287|565914683|FG000|Overall Study|Trial drug not effective|0|||
157221649|NCT00094302|567558465|FG000|Overall Study|Lost to Follow-up|43|||
157221650|NCT00094302|567558466|FG001|Overall Study|Lost to Follow-up|41|||
157221651|NCT00094302|567558465|FG000|Overall Study|Physician Decision|5|||
157221652|NCT00094302|567558466|FG001|Overall Study|Physician Decision|8|||
157207318|NCT05378269|567504428|FG000|Overall Study|Protocol Violation|1|||
157207319|NCT05378269|567504429|FG001|Overall Study|Protocol Violation|0|||
157207320|NCT05378269|567504430|FG002|Overall Study|Protocol Violation|2|||
157207321|NCT05378269|567504431|FG003|Overall Study|Protocol Violation|0|||
157207322|NCT05378269|567504432|FG004|Overall Study|Protocol Violation|0|||
157207323|NCT00891527|567504433|FG000|Overall Study|Withdrawal by Subject|2|||
157207324|NCT01186744|567504434|FG000|Overall Study|Lack of Efficacy|156|||
157207325|NCT01186744|567504435|FG001|Overall Study|Lack of Efficacy|99|||
157207326|NCT01186744|567504436|FG002|Overall Study|Lack of Efficacy|0|||
157207327|NCT01186744|567504437|FG003|Overall Study|Lack of Efficacy|2|||
157207328|NCT01186744|567504438|FG004|Overall Study|Lack of Efficacy|2|||
157207329|NCT01186744|567504439|FG005|Overall Study|Lack of Efficacy|5|||
157207330|NCT01186744|567504434|FG000|Overall Study|Protocol Violation|1|||
157207331|NCT01186744|567504435|FG001|Overall Study|Protocol Violation|2|||
157207332|NCT01186744|567504436|FG002|Overall Study|Protocol Violation|0|||
157207333|NCT01186744|567504437|FG003|Overall Study|Protocol Violation|1|||
157207334|NCT01186744|567504438|FG004|Overall Study|Protocol Violation|1|||
157207335|NCT01186744|567504439|FG005|Overall Study|Protocol Violation|2|||
157207336|NCT01186744|567504434|FG000|Overall Study|Lost to Follow-up|15|||
157207337|NCT01186744|567504435|FG001|Overall Study|Lost to Follow-up|16|||
157207338|NCT01186744|567504436|FG002|Overall Study|Lost to Follow-up|2|||
157207339|NCT01186744|567504437|FG003|Overall Study|Lost to Follow-up|1|||
157207340|NCT01186744|567504438|FG004|Overall Study|Lost to Follow-up|1|||
157207341|NCT01186744|567504439|FG005|Overall Study|Lost to Follow-up|4|||
157207342|NCT01186744|567504434|FG000|Overall Study|Screen failure|1|||
157207343|NCT01186744|567504435|FG001|Overall Study|Screen failure|1|||
157207344|NCT01186744|567504436|FG002|Overall Study|Screen failure|0|||
157207345|NCT01186744|567504437|FG003|Overall Study|Screen failure|1|||
157207346|NCT01186744|567504438|FG004|Overall Study|Screen failure|0|||
157207347|NCT01186744|567504439|FG005|Overall Study|Screen failure|0|||
157207348|NCT01186744|567504434|FG000|Overall Study|Withdrawal by Subject|14|||
157207349|NCT01186744|567504435|FG001|Overall Study|Withdrawal by Subject|10|||
157207350|NCT01186744|567504436|FG002|Overall Study|Withdrawal by Subject|2|||
157207351|NCT01186744|567504437|FG003|Overall Study|Withdrawal by Subject|5|||
157207352|NCT01186744|567504438|FG004|Overall Study|Withdrawal by Subject|0|||
157207353|NCT01186744|567504439|FG005|Overall Study|Withdrawal by Subject|6|||
157207354|NCT01186744|567504434|FG000|Overall Study|Study terminated by Sponsor|1|||
157207355|NCT01186744|567504435|FG001|Overall Study|Study terminated by Sponsor|0|||
157207356|NCT01186744|567504436|FG002|Overall Study|Study terminated by Sponsor|0|||
157207357|NCT01186744|567504437|FG003|Overall Study|Study terminated by Sponsor|0|||
157207358|NCT01186744|567504438|FG004|Overall Study|Study terminated by Sponsor|0|||
157207359|NCT01186744|567504439|FG005|Overall Study|Study terminated by Sponsor|0|||
157207360|NCT01186744|567504434|FG000|Overall Study|Other|9|||
156770930|NCT03225287|565914684|FG001|Overall Study|Trial drug not effective|1|||
156770931|NCT03225287|565914685|FG002|Overall Study|Trial drug not effective|0|||
156770932|NCT03225287|565914683|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
156770933|NCT03225287|565914684|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
156770934|NCT03225287|565914685|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
156770935|NCT03225287|565914683|FG000|Overall Study|Stem cell transplantation|0|||
156770936|NCT03225287|565914684|FG001|Overall Study|Stem cell transplantation|1|||
156770937|NCT03225287|565914685|FG002|Overall Study|Stem cell transplantation|0|||
156770938|NCT06070610|565914690|FG000|Washout period|Adverse Event|1|||
156770939|NCT06070610|565914690|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
156770940|NCT01499810|565914691|FG000|Overall Study|Lost to Follow-up|10|||
156770941|NCT01499810|565914691|FG000|Overall Study|Protocol Violation|1|||
156770942|NCT01499810|565914691|FG000|Overall Study|Withdrawal by Subject|1|||
156770943|NCT04530630|565916132|FG000|Overall Study|Physician Decision|1|||
156770944|NCT04736199|565916135|FG000|Overall Study|Adverse Event|28|||
157207361|NCT01186744|567504435|FG001|Overall Study|Other|10|||
157207362|NCT01186744|567504436|FG002|Overall Study|Other|1|||
157207363|NCT01186744|567504437|FG003|Overall Study|Other|2|||
157207364|NCT01186744|567504438|FG004|Overall Study|Other|1|||
156770945|NCT04736199|565916136|FG001|Overall Study|Adverse Event|22|||
156770946|NCT04736199|565916135|FG000|Overall Study|Death|9|||
156770947|NCT04736199|565916136|FG001|Overall Study|Death|3|||
156770948|NCT04736199|565916135|FG000|Overall Study|Lost to Follow-up|4|||
156770949|NCT04736199|565916136|FG001|Overall Study|Lost to Follow-up|1|||
156770950|NCT04736199|565916135|FG000|Overall Study|Physician Decision|5|||
156770951|NCT04736199|565916136|FG001|Overall Study|Physician Decision|9|||
156770952|NCT04736199|565916135|FG000|Overall Study|Withdrawal by Subject|21|||
156770953|NCT04736199|565916136|FG001|Overall Study|Withdrawal by Subject|9|||
156770954|NCT04736199|565916135|FG000|Overall Study|Progressive disease|120|||
156770955|NCT04736199|565916136|FG001|Overall Study|Progressive disease|101|||
156770956|NCT04736199|565916135|FG000|Overall Study|Subject decision|13|||
156770957|NCT04736199|565916136|FG001|Overall Study|Subject decision|13|||
156770958|NCT04736199|565916135|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
156770959|NCT04736199|565916136|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
156770960|NCT04736199|565916135|FG000|Overall Study|Additional primary malignancy|1|||
156770961|NCT04736199|565916136|FG001|Overall Study|Additional primary malignancy|0|||
156770962|NCT04736199|565916135|FG000|Overall Study|Non-compliance with study drug|0|||
156770963|NCT04736199|565916136|FG001|Overall Study|Non-compliance with study drug|1|||
156770964|NCT04736199|565916135|FG000|Overall Study|Other reason|0|||
156770965|NCT04736199|565916136|FG001|Overall Study|Other reason|1|||
156770966|NCT04736199|565916135|FG000|Overall Study|Ongoing with study drug|240|||
156770967|NCT04736199|565916136|FG001|Overall Study|Ongoing with study drug|63|||
156770968|NCT04736199|565916135|FG000|Overall Study|Study drug never administered|3|||
156770969|NCT04736199|565916136|FG001|Overall Study|Study drug never administered|0|||
156770970|NCT05172609|565916137|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
156770971|NCT05172609|565916138|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
156770972|NCT05172609|565916137|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
156770973|NCT05172609|565916138|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
156770974|NCT05172609|565916137|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
156770975|NCT05172609|565916138|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
156770976|NCT00336544|565916144|FG000|Overall Study|Lack of Efficacy|8|||
157207365|NCT01186744|567504439|FG005|Overall Study|Other|5|||
157207366|NCT01186744|567504434|FG000|Overall Study|Adverse Event|10|||
157207367|NCT01186744|567504435|FG001|Overall Study|Adverse Event|14|||
157207368|NCT01186744|567504436|FG002|Overall Study|Adverse Event|1|||
157207369|NCT01186744|567504437|FG003|Overall Study|Adverse Event|0|||
157207370|NCT01186744|567504438|FG004|Overall Study|Adverse Event|1|||
157207371|NCT01186744|567504439|FG005|Overall Study|Adverse Event|4|||
157207372|NCT01186744|567504434|FG000|Overall Study|Death|1|||
156770977|NCT00336544|565916145|FG001|Overall Study|Lack of Efficacy|5|||
156770978|NCT00336544|565916144|FG000|Overall Study|Adverse Event|4|||
156770979|NCT00336544|565916145|FG001|Overall Study|Adverse Event|9|||
156770980|NCT00336544|565916144|FG000|Overall Study|Withdrawal by Subject|4|||
156770981|NCT00336544|565916145|FG001|Overall Study|Withdrawal by Subject|3|||
156770982|NCT00336544|565916144|FG000|Overall Study|Other|3|||
156770983|NCT00336544|565916145|FG001|Overall Study|Other|5|||
156770984|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
157207373|NCT01186744|567504435|FG001|Overall Study|Death|0|||
157207374|NCT01186744|567504436|FG002|Overall Study|Death|0|||
157207375|NCT01186744|567504437|FG003|Overall Study|Death|0|||
157207376|NCT01186744|567504438|FG004|Overall Study|Death|0|||
157207377|NCT01186744|567504439|FG005|Overall Study|Death|0|||
157207378|NCT02428231|567504445|FG000|Overall Study|Other|10|||
157207379|NCT02428231|567504446|FG001|Overall Study|Other|16|||
157207380|NCT02428231|567504445|FG000|Overall Study|Required Symptomatic Therapy|0|||
157207381|NCT02428231|567504446|FG001|Overall Study|Required Symptomatic Therapy|1|||
157207382|NCT02428231|567504445|FG000|Overall Study|Adverse Event|3|||
157207383|NCT02428231|567504446|FG001|Overall Study|Adverse Event|0|||
157207384|NCT03976076|567504449|FG000|Overall Study|Withdrawal by Subject|2|||
157207385|NCT02406742|567504450|FG000|Overall Study|Progression of Disease|5|||
157207386|NCT02406742|567504451|FG001|Overall Study|Progression of Disease|1|||
157207387|NCT02406742|567504452|FG002|Overall Study|Progression of Disease|6|||
157207388|NCT02406742|567504450|FG000|Overall Study|Adverse Event|3|||
157207389|NCT02406742|567504451|FG001|Overall Study|Adverse Event|0|||
157207390|NCT02406742|567504452|FG002|Overall Study|Adverse Event|2|||
156770985|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
157207391|NCT02406742|567504450|FG000|Overall Study|Death|1|||
156770986|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
156770987|NCT00961064|565916146|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
156770988|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
156770989|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
156770990|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
157207392|NCT02406742|567504451|FG001|Overall Study|Death|0|||
157207393|NCT02406742|567504452|FG002|Overall Study|Death|0|||
157207394|NCT02406742|567504450|FG000|Overall Study|Lack of Efficacy|0|||
156770991|NCT00961064|565916146|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
156770992|NCT01408641|565916147|FG000|Overall Study|Physician Decision|1|||
156770993|NCT01408641|565916148|FG001|Overall Study|Physician Decision|0|||
156770994|NCT00576758|565916149|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
156770995|NCT00576758|565916150|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
156770996|NCT00576758|565916149|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
156770997|NCT00576758|565916150|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
156770998|NCT00576758|565916149|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
156770999|NCT00576758|565916150|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
157113134|NCT02819635|567170164|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113135|NCT02819635|567170165|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
157113136|NCT02819635|567170166|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113137|NCT02819635|567170167|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113138|NCT02819635|567170168|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113139|NCT02819635|567170169|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113140|NCT02819635|567170170|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
157113141|NCT02819635|567170159|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
157113142|NCT02819635|567170160|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
157113143|NCT02819635|567170161|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
157113144|NCT02819635|567170162|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
157113145|NCT02819635|567170163|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
157113146|NCT02819635|567170164|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
157113147|NCT02819635|567170165|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
157113148|NCT02819635|567170166|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
157113149|NCT02819635|567170167|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
157113150|NCT02819635|567170168|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
157113151|NCT02819635|567170169|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
157113152|NCT02819635|567170170|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
157113153|NCT02819635|567170159|FG000|Substudy 2, Part 2|Adverse Event|0|||
157113154|NCT02819635|567170160|FG001|Substudy 2, Part 2|Adverse Event|0|||
157113155|NCT02819635|567170161|FG002|Substudy 2, Part 2|Adverse Event|0|||
157113156|NCT02819635|567170162|FG003|Substudy 2, Part 2|Adverse Event|0|||
157113157|NCT02819635|567170163|FG004|Substudy 2, Part 2|Adverse Event|0|||
157113158|NCT02819635|567170164|FG005|Substudy 2, Part 2|Adverse Event|4|||
157113159|NCT02819635|567170165|FG006|Substudy 2, Part 2|Adverse Event|0|||
157113160|NCT02819635|567170166|FG007|Substudy 2, Part 2|Adverse Event|0|||
157113161|NCT02819635|567170167|FG008|Substudy 2, Part 2|Adverse Event|0|||
157113162|NCT02819635|567170168|FG009|Substudy 2, Part 2|Adverse Event|0|||
157113163|NCT02819635|567170169|FG010|Substudy 2, Part 2|Adverse Event|0|||
157113164|NCT02819635|567170170|FG011|Substudy 2, Part 2|Adverse Event|0|||
157113165|NCT02819635|567170159|FG000|Substudy 2, Part 2|Withdrew consent|0|||
157113166|NCT02819635|567170160|FG001|Substudy 2, Part 2|Withdrew consent|0|||
157113167|NCT02819635|567170161|FG002|Substudy 2, Part 2|Withdrew consent|0|||
157113168|NCT02819635|567170162|FG003|Substudy 2, Part 2|Withdrew consent|0|||
157113169|NCT02819635|567170163|FG004|Substudy 2, Part 2|Withdrew consent|0|||
157113170|NCT02819635|567170164|FG005|Substudy 2, Part 2|Withdrew consent|3|||
157113171|NCT02819635|567170165|FG006|Substudy 2, Part 2|Withdrew consent|1|||
157113172|NCT02819635|567170166|FG007|Substudy 2, Part 2|Withdrew consent|0|||
157113173|NCT02819635|567170167|FG008|Substudy 2, Part 2|Withdrew consent|0|||
157113174|NCT02819635|567170168|FG009|Substudy 2, Part 2|Withdrew consent|0|||
157113175|NCT02819635|567170169|FG010|Substudy 2, Part 2|Withdrew consent|0|||
157113176|NCT02819635|567170170|FG011|Substudy 2, Part 2|Withdrew consent|0|||
157113177|NCT02819635|567170159|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
157113178|NCT02819635|567170160|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
157113179|NCT02819635|567170161|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
157113180|NCT02819635|567170162|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
157113181|NCT02819635|567170163|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
157113182|NCT02819635|567170164|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
157113183|NCT02819635|567170165|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
157113184|NCT02819635|567170166|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
157113185|NCT02819635|567170167|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
157113186|NCT02819635|567170168|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
157113187|NCT02819635|567170169|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
157113188|NCT02819635|567170170|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
157113189|NCT02819635|567170159|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113190|NCT02819635|567170160|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113191|NCT02819635|567170161|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113192|NCT02819635|567170162|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113193|NCT02819635|567170163|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113194|NCT02819635|567170164|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157207395|NCT02406742|567504451|FG001|Overall Study|Lack of Efficacy|0|||
156771000|NCT00576758|565916149|FG000|Induction Treatment Period|Death|1|||
156771001|NCT00576758|565916150|FG001|Induction Treatment Period|Death|0|||
156771002|NCT00576758|565916149|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
156771003|NCT00576758|565916150|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
156771004|NCT00576758|565916149|FG000|Induction Treatment Period|Withdrew consent|1|||
156771005|NCT00576758|565916150|FG001|Induction Treatment Period|Withdrew consent|0|||
156771006|NCT00576758|565916149|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
156771007|NCT00576758|565916150|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
156771008|NCT00576758|565916149|FG000|Extension Treatment Period|Death|1|||
156771009|NCT00576758|565916150|FG001|Extension Treatment Period|Death|1|||
156771010|NCT00576758|565916149|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
156771011|NCT00576758|565916150|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
156771012|NCT00576758|565916149|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
156771013|NCT00576758|565916150|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
156771014|NCT00576758|565916149|FG000|Extension Treatment Period|Administrative/Other|3|||
156771015|NCT00576758|565916150|FG001|Extension Treatment Period|Administrative/Other|1|||
156771016|NCT00576758|565916149|FG000|Follow-up Period|Administrative/Other|6|||
156771017|NCT00576758|565916150|FG001|Follow-up Period|Administrative/Other|8|||
156771018|NCT00576758|565916149|FG000|Follow-up Period|Death|3|||
156771019|NCT00576758|565916150|FG001|Follow-up Period|Death|3|||
156771020|NCT00576758|565916149|FG000|Follow-up Period|Insufficient therapeutic response|16|||
156771021|NCT00576758|565916150|FG001|Follow-up Period|Insufficient therapeutic response|5|||
156771022|NCT00576758|565916149|FG000|Follow-up Period|Withdrew consent|2|||
156771023|NCT00576758|565916150|FG001|Follow-up Period|Withdrew consent|1|||
156771024|NCT00715208|565916151|FG000|Overall Study|Withdrawal by Subject|1|||
156771025|NCT00715208|565916152|FG001|Overall Study|Withdrawal by Subject|1|||
156771026|NCT00715208|565916151|FG000|Overall Study|Adverse Event|0|||
156771027|NCT00715208|565916152|FG001|Overall Study|Adverse Event|6|||
156771028|NCT00715208|565916151|FG000|Overall Study|Lack of Efficacy|0|||
156771029|NCT00715208|565916152|FG001|Overall Study|Lack of Efficacy|2|||
156771030|NCT00076570|565916153|FG000|Overall Study|Drug intolerance|8|||
156771031|NCT00076570|565916154|FG001|Overall Study|Drug intolerance|8|||
156771032|NCT03427411|565916155|FG000|Overall Study|Screen failure - platelets too low|0|||
156771033|NCT03427411|565916156|FG001|Overall Study|Screen failure - platelets too low|1|||
156771034|NCT00903968|565916157|FG000|Overall Study|Adverse Event|0|||
156771035|NCT00903968|565916158|FG001|Overall Study|Adverse Event|0|||
156771036|NCT00903968|565916159|FG002|Overall Study|Adverse Event|0|||
156771037|NCT00903968|565916160|FG003|Overall Study|Adverse Event|0|||
156771038|NCT00903968|565916161|FG004|Overall Study|Adverse Event|0|||
156771039|NCT00903968|565916162|FG005|Overall Study|Adverse Event|0|||
156771040|NCT00903968|565916163|FG006|Overall Study|Adverse Event|1|||
156771041|NCT00903968|565916164|FG007|Overall Study|Adverse Event|8|||
156771042|NCT00903968|565916157|FG000|Overall Study|DLT|0|||
156771043|NCT00903968|565916158|FG001|Overall Study|DLT|0|||
156771044|NCT00903968|565916159|FG002|Overall Study|DLT|0|||
156771045|NCT00903968|565916160|FG003|Overall Study|DLT|0|||
156771046|NCT00903968|565916161|FG004|Overall Study|DLT|0|||
156771047|NCT00903968|565916162|FG005|Overall Study|DLT|0|||
156771048|NCT00903968|565916163|FG006|Overall Study|DLT|2|||
156771049|NCT00903968|565916164|FG007|Overall Study|DLT|0|||
156771050|NCT00903968|565916157|FG000|Overall Study|Withdrawal by Subject|1|||
156771051|NCT00903968|565916158|FG001|Overall Study|Withdrawal by Subject|0|||
156771052|NCT00903968|565916159|FG002|Overall Study|Withdrawal by Subject|1|||
156771053|NCT00903968|565916160|FG003|Overall Study|Withdrawal by Subject|0|||
156771054|NCT00903968|565916161|FG004|Overall Study|Withdrawal by Subject|1|||
156771055|NCT00903968|565916162|FG005|Overall Study|Withdrawal by Subject|1|||
156771056|NCT00903968|565916163|FG006|Overall Study|Withdrawal by Subject|0|||
156771057|NCT00903968|565916164|FG007|Overall Study|Withdrawal by Subject|4|||
156771058|NCT00903968|565916157|FG000|Overall Study|Non-Compliance|0|||
156771059|NCT00903968|565916158|FG001|Overall Study|Non-Compliance|0|||
156771060|NCT00903968|565916159|FG002|Overall Study|Non-Compliance|0|||
156771061|NCT00903968|565916160|FG003|Overall Study|Non-Compliance|0|||
156771062|NCT00903968|565916161|FG004|Overall Study|Non-Compliance|0|||
156771063|NCT00903968|565916162|FG005|Overall Study|Non-Compliance|1|||
156771064|NCT00903968|565916163|FG006|Overall Study|Non-Compliance|0|||
156771065|NCT00903968|565916164|FG007|Overall Study|Non-Compliance|0|||
156771066|NCT00903968|565916157|FG000|Overall Study|Physician Decision|0|||
156771067|NCT00903968|565916158|FG001|Overall Study|Physician Decision|0|||
156771068|NCT00903968|565916159|FG002|Overall Study|Physician Decision|0|||
156771069|NCT00903968|565916160|FG003|Overall Study|Physician Decision|0|||
156771070|NCT00903968|565916161|FG004|Overall Study|Physician Decision|0|||
157207396|NCT02406742|567504452|FG002|Overall Study|Lack of Efficacy|1|||
156771071|NCT00903968|565916162|FG005|Overall Study|Physician Decision|1|||
156771072|NCT00903968|565916163|FG006|Overall Study|Physician Decision|0|||
156771073|NCT00903968|565916164|FG007|Overall Study|Physician Decision|0|||
156771074|NCT00903968|565916157|FG000|Overall Study|Progressive Disease|2|||
156771075|NCT00903968|565916158|FG001|Overall Study|Progressive Disease|3|||
156771076|NCT00903968|565916159|FG002|Overall Study|Progressive Disease|2|||
156771077|NCT00903968|565916160|FG003|Overall Study|Progressive Disease|3|||
156771078|NCT00903968|565916161|FG004|Overall Study|Progressive Disease|3|||
156771079|NCT00903968|565916162|FG005|Overall Study|Progressive Disease|3|||
156771080|NCT00903968|565916163|FG006|Overall Study|Progressive Disease|0|||
156771081|NCT00903968|565916164|FG007|Overall Study|Progressive Disease|18|||
156771082|NCT00903968|565916157|FG000|Overall Study|Lack of Efficacy|0|||
156771083|NCT00903968|565916158|FG001|Overall Study|Lack of Efficacy|0|||
157207397|NCT02406742|567504450|FG000|Overall Study|Withdrawal by Participant|1|||
157207398|NCT02406742|567504451|FG001|Overall Study|Withdrawal by Participant|2|||
157207399|NCT02406742|567504452|FG002|Overall Study|Withdrawal by Participant|0|||
157207400|NCT02406742|567504450|FG000|Overall Study|Physician Decision|1|||
157207401|NCT02406742|567504451|FG001|Overall Study|Physician Decision|2|||
157207402|NCT02406742|567504452|FG002|Overall Study|Physician Decision|1|||
157207403|NCT02406742|567504450|FG000|Overall Study|Transition to other treatment|2|||
157207404|NCT02406742|567504451|FG001|Overall Study|Transition to other treatment|0|||
157207405|NCT02406742|567504452|FG002|Overall Study|Transition to other treatment|1|||
157207406|NCT02406742|567504450|FG000|Overall Study|Other Reasons|1|||
157207407|NCT02406742|567504451|FG001|Overall Study|Other Reasons|11|||
157207408|NCT02406742|567504452|FG002|Overall Study|Other Reasons|5|||
157207409|NCT00765999|567504453|FG000|Overall Study|Adverse Event|203|||
157207410|NCT00765999|567504453|FG000|Overall Study|Insufficient Therapeutic Response|100|||
157207411|NCT00765999|567504453|FG000|Overall Study|Protocol Violation|95|||
157207412|NCT00765999|567504453|FG000|Overall Study|Consent Withdrawn|202|||
157207413|NCT00765999|567504453|FG000|Overall Study|Lost to Follow-up|131|||
157207414|NCT00765999|567504453|FG000|Overall Study|Study Terminated by Sponsor|2|||
157207415|NCT00765999|567504453|FG000|Overall Study|Other Miscellaneous Reasons|51|||
157207416|NCT00759174|567504456|FG000|Overall Study|Other|0|||
157207417|NCT00759174|567504457|FG001|Overall Study|Other|2|||
157207418|NCT01890109|567504458|FG000|Overall Study|Withdrawal by Subject|0|||
157207419|NCT01890109|567504459|FG001|Overall Study|Withdrawal by Subject|3|||
156771084|NCT00903968|565916159|FG002|Overall Study|Lack of Efficacy|0|||
156771085|NCT00903968|565916160|FG003|Overall Study|Lack of Efficacy|0|||
156771086|NCT00903968|565916161|FG004|Overall Study|Lack of Efficacy|0|||
156771087|NCT00903968|565916162|FG005|Overall Study|Lack of Efficacy|0|||
156771088|NCT00903968|565916163|FG006|Overall Study|Lack of Efficacy|0|||
156771089|NCT00903968|565916164|FG007|Overall Study|Lack of Efficacy|3|||
156771090|NCT01294046|565916165|FG000|Overall Study|Infection and surgical explant|1|||
156771091|NCT01294046|565916165|FG000|Overall Study|Eligibility criteria expanded|1|||
156771092|NCT01294046|565916165|FG000|Overall Study|Stimulation response inadqequate|1|||
156771093|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
156771094|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
156771095|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
156771096|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
156771097|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
156771098|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
156771099|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
156771100|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
156771101|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
156771102|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
156771103|NCT03979313|565916166|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
156771104|NCT03979313|565916167|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
156771105|NCT03979313|565916166|FG000|All Subjects|Any Other Reason|16|||
156771106|NCT03979313|565916167|FG001|All Subjects|Any Other Reason|23|||
156771107|NCT03979313|565916166|FG000|All Subjects|Covid-19|1|||
156771108|NCT03979313|565916167|FG001|All Subjects|Covid-19|3|||
156771109|NCT03979313|565916166|FG000|All Subjects|Withdrawal by Subject|35|||
156771110|NCT03979313|565916167|FG001|All Subjects|Withdrawal by Subject|44|||
156771111|NCT03979313|565916166|FG000|All Subjects|Death|0|||
156771112|NCT03979313|565916167|FG001|All Subjects|Death|5|||
156771113|NCT03979313|565916166|FG000|All Subjects|Lost to Follow-up|28|||
157007169|NCT01350804|566775133|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
157007170|NCT01350804|566775134|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
156771114|NCT03979313|565916167|FG001|All Subjects|Lost to Follow-up|61|||
156771115|NCT03183908|565916168|FG000|Overall Study|Missing Symptom Diary Data|0|||
156771116|NCT03183908|565916169|FG001|Overall Study|Missing Symptom Diary Data|2|||
156771117|NCT00393367|565916174|FG000|Overall Study|Protocol Violation|2|||
156771118|NCT00393367|565916175|FG001|Overall Study|Protocol Violation|5|||
156771119|NCT00393367|565916174|FG000|Overall Study|Withdrawal by Subject|0|||
156771120|NCT00393367|565916175|FG001|Overall Study|Withdrawal by Subject|2|||
156771121|NCT01027949|565916176|FG000|Overall Study|Death|174|||
156771122|NCT01027949|565916176|FG000|Overall Study|Progressive Disease|163|||
156771123|NCT01027949|565916176|FG000|Overall Study|Adverse Event|172|||
156771124|NCT01027949|565916176|FG000|Overall Study|Withdrawal by Subject|113|||
156771125|NCT01027949|565916176|FG000|Overall Study|Lost to Follow-up|17|||
156771126|NCT01027949|565916176|FG000|Overall Study|Protocol Violation|13|||
156771127|NCT01027949|565916176|FG000|Overall Study|PI Decision|8|||
156771128|NCT01027949|565916176|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
156771129|NCT01027949|565916176|FG000|Overall Study|Non-compliance with Study Procedures|7|||
156771130|NCT01027949|565916176|FG000|Overall Study|Lung Transplant|5|||
156771131|NCT01027949|565916176|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
156771132|NCT01027949|565916176|FG000|Overall Study|Use of Excluded Medication|2|||
156771133|NCT01027949|565916176|FG000|Overall Study|Patient Self-discontinuation|1|||
156771134|NCT01027949|565916176|FG000|Overall Study|Pregnancy|1|||
156771135|NCT01027949|565916176|FG000|Overall Study|Surgery|1|||
156771136|NCT00091819|565916181|FG000|Overall Study|Adverse Event|1|||
156771137|NCT00091819|565916182|FG001|Overall Study|Adverse Event|1|||
156771138|NCT00091819|565916181|FG000|Overall Study|Death|4|||
156771139|NCT00091819|565916182|FG001|Overall Study|Death|5|||
156771140|NCT00091819|565916181|FG000|Overall Study|Lost to Follow-up|26|||
156771141|NCT00091819|565916182|FG001|Overall Study|Lost to Follow-up|23|||
156771142|NCT00091819|565916181|FG000|Overall Study|Withdrawal by Subject|5|||
156771143|NCT00091819|565916182|FG001|Overall Study|Withdrawal by Subject|8|||
156771144|NCT00091819|565916181|FG000|Overall Study|Protocol Violation|1|||
156771145|NCT00091819|565916182|FG001|Overall Study|Protocol Violation|2|||
156771146|NCT00091819|565916181|FG000|Overall Study|Other|2|||
156771147|NCT00091819|565916182|FG001|Overall Study|Other|3|||
156771148|NCT00091819|565916181|FG000|Overall Study|Never received study treatment|3|||
156771149|NCT00091819|565916182|FG001|Overall Study|Never received study treatment|4|||
156771150|NCT00856180|565916183|FG000|Overall Study|Adverse Event|4|||
156771151|NCT00856180|565916183|FG000|Overall Study|Progressive Disease|16|||
156771152|NCT00481676|565916184|FG000|Overall Study|Adverse Event|0|||
156771153|NCT00481676|565916185|FG001|Overall Study|Adverse Event|1|||
156771154|NCT00481676|565916184|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156771155|NCT00481676|565916185|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156771156|NCT00481676|565916184|FG000|Overall Study|Administrative problem|1|||
156771157|NCT00481676|565916185|FG001|Overall Study|Administrative problem|0|||
156771158|NCT02911116|565916186|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156771159|NCT02911116|565916187|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156771160|NCT02911116|565916186|FG000|Overall Study|Lost to Follow-up|0|||
156771161|NCT02911116|565916187|FG001|Overall Study|Lost to Follow-up|1|||
156771162|NCT04796415|565916188|FG000|Overall Study|not interested|12|||
156771163|NCT04796415|565916188|FG000|Overall Study|health issue|8|||
156771164|NCT04796415|565916188|FG000|Overall Study|Other|4|||
156771165|NCT04796415|565916188|FG000|Overall Study|discharged from home health service|3|||
156771166|NCT04796415|565916188|FG000|Overall Study|re-hospitalization|2|||
156771167|NCT04796415|565916188|FG000|Overall Study|moving to nursing home|1|||
156771168|NCT04796415|565916188|FG000|Overall Study|lost contact|1|||
156771169|NCT01513590|565916189|FG000|Overall Study|Adverse Event|2|||
156771170|NCT01513590|565916190|FG001|Overall Study|Adverse Event|3|||
156771171|NCT01513590|565916189|FG000|Overall Study|Withdrawal Criteria|3|||
156771172|NCT01513590|565916190|FG001|Overall Study|Withdrawal Criteria|0|||
156771173|NCT01513590|565916189|FG000|Overall Study|Unclassified|5|||
156771174|NCT01513590|565916190|FG001|Overall Study|Unclassified|10|||
156771175|NCT04810962|565916191|FG000|Overall Study|Adverse Event|0|||
156771176|NCT04810962|565916192|FG001|Overall Study|Adverse Event|1|||
156771177|NCT04810962|565916191|FG000|Overall Study|Lost to Follow-up|2|||
156771178|NCT04810962|565916192|FG001|Overall Study|Lost to Follow-up|1|||
156771179|NCT04810962|565916191|FG000|Overall Study|Physician Decision|1|||
156771180|NCT04810962|565916192|FG001|Overall Study|Physician Decision|0|||
156771181|NCT04810962|565916191|FG000|Overall Study|Withdrawal by Subject|1|||
156771182|NCT04810962|565916192|FG001|Overall Study|Withdrawal by Subject|3|||
156771183|NCT04810962|565916191|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
156771184|NCT04810962|565916192|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
156771185|NCT03620162|565916193|FG000|Overall Study|Physician Decision|4|||
156771186|NCT03620162|565916194|FG001|Overall Study|Physician Decision|0|||
156771187|NCT03620162|565916195|FG002|Overall Study|Physician Decision|1|||
156771188|NCT03620162|565916196|FG003|Overall Study|Physician Decision|0|||
156771189|NCT03620162|565916197|FG004|Overall Study|Physician Decision|2|||
156771190|NCT03620162|565916193|FG000|Overall Study|Lost to Follow-up|2|||
156771191|NCT03620162|565916194|FG001|Overall Study|Lost to Follow-up|6|||
156771192|NCT03620162|565916195|FG002|Overall Study|Lost to Follow-up|7|||
156771193|NCT03620162|565916196|FG003|Overall Study|Lost to Follow-up|3|||
156771194|NCT03620162|565916197|FG004|Overall Study|Lost to Follow-up|2|||
156771195|NCT03620162|565916193|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
156771196|NCT03620162|565916194|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
156771197|NCT03620162|565916195|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
156771198|NCT03620162|565916196|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
156771199|NCT03620162|565916197|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
156771200|NCT04009837|565916201|FG000|Overall Study|Withdrawal by Subject|5|||
156771201|NCT04009837|565916202|FG001|Overall Study|Withdrawal by Subject|4|||
156771202|NCT04009837|565916201|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
156771203|NCT04009837|565916202|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
156771204|NCT05352815|565916204|FG000|Overall Study|Withdrawal by Subject|28|||
156771205|NCT05352815|565916205|FG001|Overall Study|Withdrawal by Subject|24|||
156771206|NCT05352815|565916204|FG000|Overall Study|Lost to Follow-up|4|||
156771207|NCT05352815|565916205|FG001|Overall Study|Lost to Follow-up|7|||
156771208|NCT05352815|565916204|FG000|Overall Study|Death|2|||
156771209|NCT05352815|565916205|FG001|Overall Study|Death|3|||
156771210|NCT05352815|565916204|FG000|Overall Study|Site closure|1|||
156771211|NCT05352815|565916205|FG001|Overall Study|Site closure|0|||
156771212|NCT00226655|565916206|FG000|Overall Study|Death|13|||
156771213|NCT00226655|565916206|FG000|Overall Study|Withdrawal by Subject|15|||
156771214|NCT00226655|565916206|FG000|Overall Study|Adverse Event|35|||
156771215|NCT00226655|565916206|FG000|Overall Study|Physician Decision|6|||
156771216|NCT00226655|565916206|FG000|Overall Study|Clinical deterioration|10|||
156771217|NCT05144945|565916207|FG000|Overall Study|Withdrawal by Subject|1|||
156771218|NCT05144945|565916208|FG001|Overall Study|Withdrawal by Subject|0|||
156771219|NCT04530552|565916212|FG000|Overall Study|Physician Decision|0|||
156771220|NCT04530552|565916213|FG001|Overall Study|Physician Decision|1|||
156771221|NCT04530552|565916212|FG000|Overall Study|Withdrawal by Subject|0|||
156771222|NCT04530552|565916213|FG001|Overall Study|Withdrawal by Subject|1|||
156771223|NCT04530552|565916212|FG000|Overall Study|Adverse Event|0|||
156771224|NCT04530552|565916213|FG001|Overall Study|Adverse Event|1|||
156771225|NCT04530552|565916212|FG000|Overall Study|No surgery|0|||
156771226|NCT04530552|565916213|FG001|Overall Study|No surgery|1|||
156771227|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
156771228|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
156771229|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
156771230|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
156771231|NCT02855268|565916214|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
156771232|NCT02855268|565916215|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
156771233|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
156771234|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
156771235|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
156771236|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
156771237|NCT02855268|565916214|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
156771238|NCT02855268|565916215|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
156771239|NCT00465517|565916216|FG000|Overall Study|Adverse Event|7|||
156771240|NCT00465517|565916217|FG001|Overall Study|Adverse Event|3|||
156771241|NCT00465517|565916216|FG000|Overall Study|Lost to Follow-up|1|||
156771242|NCT00465517|565916217|FG001|Overall Study|Lost to Follow-up|0|||
156771243|NCT00465517|565916216|FG000|Overall Study|Withdrawal by Subject|4|||
156771244|NCT00465517|565916217|FG001|Overall Study|Withdrawal by Subject|1|||
156771245|NCT00726609|565916228|FG000|Overall Study|Adverse Event|10|||
156771246|NCT00726609|565916228|FG000|Overall Study|Withdrawal by Subject|2|||
156771247|NCT00726609|565916228|FG000|Overall Study|Lack of Efficacy|25|||
156771248|NCT00726609|565916228|FG000|Overall Study|Other|16|||
156771249|NCT00726609|565916228|FG000|Overall Study|Missing|42|||
156771250|NCT00726609|565916228|FG000|Overall Study|Other|3|||
156771251|NCT02029417|565916231|FG000|Overall Study|Death|1|||
156771252|NCT02029417|565916231|FG000|Overall Study|Adverse Event|1|||
156771253|NCT00071981|565916232|FG000|Overall Study|Lack of Efficacy|37|||
156771254|NCT00071981|565916233|FG001|Overall Study|Lack of Efficacy|29|||
156771255|NCT00071981|565916234|FG002|Overall Study|Lack of Efficacy|30|||
156771256|NCT00071981|565916235|FG003|Overall Study|Lack of Efficacy|43|||
156771257|NCT00071981|565916232|FG000|Overall Study|Adverse Event|4|||
156771258|NCT00071981|565916233|FG001|Overall Study|Adverse Event|4|||
156771259|NCT00071981|565916234|FG002|Overall Study|Adverse Event|3|||
156771260|NCT00071981|565916235|FG003|Overall Study|Adverse Event|1|||
156771261|NCT00071981|565916232|FG000|Overall Study|Death|0|||
156771262|NCT00071981|565916233|FG001|Overall Study|Death|0|||
156771263|NCT00071981|565916234|FG002|Overall Study|Death|1|||
156771264|NCT00071981|565916235|FG003|Overall Study|Death|1|||
156771265|NCT00071981|565916232|FG000|Overall Study|Withdrawal by Subject|3|||
156771266|NCT00071981|565916233|FG001|Overall Study|Withdrawal by Subject|1|||
156771267|NCT00071981|565916234|FG002|Overall Study|Withdrawal by Subject|0|||
156771268|NCT00071981|565916235|FG003|Overall Study|Withdrawal by Subject|0|||
156771269|NCT00071981|565916232|FG000|Overall Study|No protocol therapy|2|||
156771270|NCT00071981|565916233|FG001|Overall Study|No protocol therapy|5|||
156771271|NCT00071981|565916234|FG002|Overall Study|No protocol therapy|1|||
156771272|NCT00071981|565916235|FG003|Overall Study|No protocol therapy|0|||
156771273|NCT00071981|565916232|FG000|Overall Study|others (not specified in the study)|0|||
156771274|NCT00071981|565916233|FG001|Overall Study|others (not specified in the study)|2|||
156771275|NCT00071981|565916234|FG002|Overall Study|others (not specified in the study)|2|||
156771276|NCT00071981|565916235|FG003|Overall Study|others (not specified in the study)|0|||
156771277|NCT00465179|565916238|FG000|Overall Study|Adverse Event|4|||
156771278|NCT00465179|565916238|FG000|Overall Study|Withdrawal by Subject|2|||
156771279|NCT00465179|565916238|FG000|Overall Study|Progression of Disease|47|||
156771280|NCT00833755|565916242|FG000|Overall Study|Physician Decision|4|||
156771281|NCT00833755|565916243|FG001|Overall Study|Physician Decision|4|||
156771282|NCT00833755|565916244|FG002|Overall Study|Physician Decision|2|||
156771283|NCT00833755|565916245|FG003|Overall Study|Physician Decision|6|||
156771284|NCT00833755|565916242|FG000|Overall Study|Subject had scheduling issues|0|||
156771285|NCT00833755|565916243|FG001|Overall Study|Subject had scheduling issues|1|||
156771286|NCT00833755|565916244|FG002|Overall Study|Subject had scheduling issues|0|||
156771287|NCT00833755|565916245|FG003|Overall Study|Subject had scheduling issues|0|||
156771288|NCT00262925|565916246|FG000|Overall Study|Lack of Efficacy|3|||
156771289|NCT00262925|565916246|FG000|Overall Study|Adverse Event|4|||
156771290|NCT00262925|565916246|FG000|Overall Study|Death|2|||
156771291|NCT00262925|565916246|FG000|Overall Study|alternative therapy|1|||
156771292|NCT00262925|565916246|FG000|Overall Study|Other|1|||
156771293|NCT00560404|565916248|FG000|Overall Study|Adverse Event|2|||
156771294|NCT00560404|565916249|FG001|Overall Study|Adverse Event|3|||
156771295|NCT00560404|565916248|FG000|Overall Study|Death|3|||
156771296|NCT00560404|565916249|FG001|Overall Study|Death|3|||
156771297|NCT00560404|565916248|FG000|Overall Study|Protocol Violation|12|||
156771298|NCT00560404|565916249|FG001|Overall Study|Protocol Violation|7|||
156771299|NCT00560404|565916248|FG000|Overall Study|Administrative Reasons|1|||
156771300|NCT00560404|565916249|FG001|Overall Study|Administrative Reasons|1|||
156771301|NCT00560404|565916248|FG000|Overall Study|Withdrew Consent|4|||
156771302|NCT00560404|565916249|FG001|Overall Study|Withdrew Consent|0|||
156771303|NCT00560404|565916248|FG000|Overall Study|Failure to return|1|||
156771304|NCT00560404|565916249|FG001|Overall Study|Failure to return|2|||
156771305|NCT00560404|565916248|FG000|Overall Study|Other withdrawal reason|13|||
156771306|NCT00560404|565916249|FG001|Overall Study|Other withdrawal reason|5|||
156771307|NCT02642042|565916250|FG000|Overall Study|Adverse Event|22|||
156771308|NCT02642042|565916250|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156771309|NCT02642042|565916250|FG000|Overall Study|Progression/Relapse|28|||
156771310|NCT02642042|565916250|FG000|Overall Study|Death|1|||
156771311|NCT02642042|565916250|FG000|Overall Study|Not Protocol Specified|2|||
156771312|NCT03260023|565916251|FG000|Overall Study|Adverse Event|0|||
156771313|NCT03260023|565916252|FG001|Overall Study|Adverse Event|0|||
156771314|NCT03260023|565916253|FG002|Overall Study|Adverse Event|4|||
156771315|NCT03260023|565916254|FG003|Overall Study|Adverse Event|4|||
156771316|NCT03260023|565916255|FG004|Overall Study|Adverse Event|4|||
156771317|NCT03260023|565916256|FG005|Overall Study|Adverse Event|1|||
156771318|NCT03260023|565916257|FG006|Overall Study|Adverse Event|2|||
156771319|NCT03260023|565916251|FG000|Overall Study|Clinical Progression|0|||
156771320|NCT03260023|565916252|FG001|Overall Study|Clinical Progression|1|||
156771321|NCT03260023|565916253|FG002|Overall Study|Clinical Progression|3|||
156771322|NCT03260023|565916254|FG003|Overall Study|Clinical Progression|1|||
156771323|NCT03260023|565916255|FG004|Overall Study|Clinical Progression|0|||
156771324|NCT03260023|565916256|FG005|Overall Study|Clinical Progression|0|||
156771325|NCT03260023|565916257|FG006|Overall Study|Clinical Progression|0|||
156771326|NCT03260023|565916251|FG000|Overall Study|Physician Decision|0|||
156771327|NCT03260023|565916252|FG001|Overall Study|Physician Decision|0|||
156771328|NCT03260023|565916253|FG002|Overall Study|Physician Decision|0|||
156771329|NCT03260023|565916254|FG003|Overall Study|Physician Decision|1|||
156771330|NCT03260023|565916255|FG004|Overall Study|Physician Decision|1|||
156771331|NCT03260023|565916256|FG005|Overall Study|Physician Decision|0|||
156771332|NCT03260023|565916257|FG006|Overall Study|Physician Decision|0|||
156771333|NCT03260023|565916251|FG000|Overall Study|Withdrawal by Subject|0|||
156771334|NCT03260023|565916252|FG001|Overall Study|Withdrawal by Subject|0|||
156771335|NCT03260023|565916253|FG002|Overall Study|Withdrawal by Subject|0|||
156771336|NCT03260023|565916254|FG003|Overall Study|Withdrawal by Subject|0|||
156771337|NCT03260023|565916255|FG004|Overall Study|Withdrawal by Subject|3|||
156771338|NCT03260023|565916256|FG005|Overall Study|Withdrawal by Subject|0|||
156771339|NCT03260023|565916257|FG006|Overall Study|Withdrawal by Subject|0|||
156771340|NCT03260023|565916251|FG000|Overall Study|Under trial intervention|0|||
156771341|NCT03260023|565916252|FG001|Overall Study|Under trial intervention|0|||
156771342|NCT03260023|565916253|FG002|Overall Study|Under trial intervention|2|||
156771343|NCT03260023|565916254|FG003|Overall Study|Under trial intervention|5|||
156771344|NCT03260023|565916255|FG004|Overall Study|Under trial intervention|3|||
156771345|NCT03260023|565916256|FG005|Overall Study|Under trial intervention|0|||
156771346|NCT03260023|565916257|FG006|Overall Study|Under trial intervention|0|||
156771347|NCT05035407|565916260|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
156771348|NCT05035407|565916261|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771349|NCT05035407|565916262|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771350|NCT05035407|565916263|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771351|NCT05035407|565916264|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771352|NCT05035407|565916265|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
156771353|NCT04220021|565916266|FG000|Overall Study|Withdrawal by Subject|11|||
156771354|NCT04220021|565916266|FG000|Overall Study|Physician Decision|2|||
156771355|NCT04220021|565916266|FG000|Overall Study|Non-study related illness|5|||
156771356|NCT04513366|565916267|FG000|Treatment Phase|Withdrawal by Subject|6|||
156771357|NCT04513366|565916268|FG001|Treatment Phase|Withdrawal by Subject|8|||
156771358|NCT04513366|565916269|FG002|Treatment Phase|Withdrawal by Subject|3|||
156771359|NCT04513366|565916267|FG000|Treatment Phase|Lost to Follow-up|1|||
156771360|NCT04513366|565916268|FG001|Treatment Phase|Lost to Follow-up|2|||
156771361|NCT04513366|565916269|FG002|Treatment Phase|Lost to Follow-up|5|||
156771362|NCT04513366|565916267|FG000|Treatment Phase|Other than Specified|1|||
156771363|NCT04513366|565916268|FG001|Treatment Phase|Other than Specified|0|||
156771364|NCT04513366|565916269|FG002|Treatment Phase|Other than Specified|2|||
156771365|NCT04513366|565916267|FG000|Treatment Phase|Physician Decision|2|||
156771366|NCT04513366|565916268|FG001|Treatment Phase|Physician Decision|0|||
156771367|NCT04513366|565916269|FG002|Treatment Phase|Physician Decision|0|||
156771368|NCT04513366|565916267|FG000|Treatment Phase|Adverse Event|0|||
156771369|NCT04513366|565916268|FG001|Treatment Phase|Adverse Event|1|||
156771370|NCT04513366|565916269|FG002|Treatment Phase|Adverse Event|1|||
156771371|NCT04513366|565916267|FG000|Extension Phase|Withdrawal by Subject|3|||
156771372|NCT04513366|565916268|FG001|Extension Phase|Withdrawal by Subject|1|||
156771373|NCT04513366|565916269|FG002|Extension Phase|Withdrawal by Subject|1|||
156771374|NCT04513366|565916267|FG000|Extension Phase|Other than Specified|4|||
156771375|NCT04513366|565916268|FG001|Extension Phase|Other than Specified|0|||
156771376|NCT04513366|565916269|FG002|Extension Phase|Other than Specified|1|||
156771377|NCT04513366|565916267|FG000|Extension Phase|Lost to Follow-up|1|||
156771378|NCT04513366|565916268|FG001|Extension Phase|Lost to Follow-up|1|||
156771379|NCT04513366|565916269|FG002|Extension Phase|Lost to Follow-up|1|||
156771380|NCT04513366|565916267|FG000|Extension Phase|Sponsor Decision|0|||
156771381|NCT04513366|565916268|FG001|Extension Phase|Sponsor Decision|1|||
156771382|NCT04513366|565916269|FG002|Extension Phase|Sponsor Decision|0|||
156771383|NCT04513366|565916267|FG000|Extension Phase|Death|0|||
156771384|NCT04513366|565916268|FG001|Extension Phase|Death|1|||
156771385|NCT04513366|565916269|FG002|Extension Phase|Death|0|||
156771386|NCT04513366|565916267|FG000|Extension Phase|Adverse Event|0|||
156771387|NCT04513366|565916268|FG001|Extension Phase|Adverse Event|0|||
156771388|NCT04513366|565916269|FG002|Extension Phase|Adverse Event|1|||
156771389|NCT02187783|565916270|FG000|Overall Study|Adverse Event|8|||
156771390|NCT02187783|565916270|FG000|Overall Study|Death|3|||
156771391|NCT02187783|565916270|FG000|Overall Study|Progressive disease|80|||
156771392|NCT02187783|565916270|FG000|Overall Study|Protocol Violation|3|||
156771393|NCT02187783|565916270|FG000|Overall Study|Physician Decision|2|||
156771394|NCT02187783|565916270|FG000|Overall Study|Withdrawal by Subject|9|||
156771395|NCT02187783|565916270|FG000|Overall Study|Study terminated by sponsor|1|||
156771396|NCT00171249|565916271|FG000|Overall Study|Withdrawal by Subject|2|||
156771397|NCT00171249|565916272|FG001|Overall Study|Withdrawal by Subject|0|||
156771398|NCT00171249|565916273|FG002|Overall Study|Withdrawal by Subject|0|||
156771399|NCT00171249|565916274|FG003|Overall Study|Withdrawal by Subject|6|||
156771400|NCT00171249|565916275|FG004|Overall Study|Withdrawal by Subject|0|||
156771401|NCT00171249|565916276|FG005|Overall Study|Withdrawal by Subject|0|||
156771402|NCT00171249|565916277|FG006|Overall Study|Withdrawal by Subject|0|||
156771403|NCT00171249|565916271|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
156771404|NCT00171249|565916272|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156771405|NCT00171249|565916273|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
156771406|NCT00171249|565916274|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
156771407|NCT00171249|565916275|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156771408|NCT00171249|565916276|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
156771409|NCT00171249|565916277|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156771410|NCT00171249|565916271|FG000|Overall Study|Death|7|||
156771411|NCT00171249|565916272|FG001|Overall Study|Death|1|||
156771412|NCT00171249|565916273|FG002|Overall Study|Death|0|||
156771413|NCT00171249|565916274|FG003|Overall Study|Death|4|||
156771414|NCT00171249|565916275|FG004|Overall Study|Death|0|||
156771415|NCT00171249|565916276|FG005|Overall Study|Death|3|||
156771416|NCT00171249|565916277|FG006|Overall Study|Death|1|||
157207420|NCT01890109|567504458|FG000|Overall Study|Lost to Follow-up|1|||
156771417|NCT00171249|565916271|FG000|Overall Study|Other|10|||
156771418|NCT00171249|565916272|FG001|Overall Study|Other|0|||
156771419|NCT00171249|565916273|FG002|Overall Study|Other|0|||
156771420|NCT00171249|565916274|FG003|Overall Study|Other|43|||
156771421|NCT00171249|565916275|FG004|Overall Study|Other|0|||
156771422|NCT00171249|565916276|FG005|Overall Study|Other|2|||
156771423|NCT00171249|565916277|FG006|Overall Study|Other|0|||
156771424|NCT00171249|565916271|FG000|Overall Study|No Longer Requires Study Drug|4|||
156771425|NCT00171249|565916272|FG001|Overall Study|No Longer Requires Study Drug|0|||
156771426|NCT00171249|565916273|FG002|Overall Study|No Longer Requires Study Drug|0|||
156771427|NCT00171249|565916274|FG003|Overall Study|No Longer Requires Study Drug|3|||
156771428|NCT00171249|565916275|FG004|Overall Study|No Longer Requires Study Drug|0|||
156771429|NCT00171249|565916276|FG005|Overall Study|No Longer Requires Study Drug|5|||
156771430|NCT00171249|565916277|FG006|Overall Study|No Longer Requires Study Drug|0|||
156771431|NCT00171249|565916271|FG000|Overall Study|Administrative Problems|1|||
156771432|NCT00171249|565916272|FG001|Overall Study|Administrative Problems|0|||
156771433|NCT00171249|565916273|FG002|Overall Study|Administrative Problems|0|||
156771434|NCT00171249|565916274|FG003|Overall Study|Administrative Problems|2|||
156771435|NCT00171249|565916275|FG004|Overall Study|Administrative Problems|0|||
156771436|NCT00171249|565916276|FG005|Overall Study|Administrative Problems|0|||
156771437|NCT00171249|565916277|FG006|Overall Study|Administrative Problems|0|||
156771438|NCT00171249|565916271|FG000|Overall Study|Adverse Event|3|||
156771439|NCT00171249|565916272|FG001|Overall Study|Adverse Event|1|||
156771440|NCT00171249|565916273|FG002|Overall Study|Adverse Event|0|||
156771441|NCT00171249|565916274|FG003|Overall Study|Adverse Event|15|||
156771442|NCT00171249|565916275|FG004|Overall Study|Adverse Event|0|||
156771443|NCT00171249|565916276|FG005|Overall Study|Adverse Event|2|||
156771444|NCT00171249|565916277|FG006|Overall Study|Adverse Event|0|||
156771445|NCT00171249|565916271|FG000|Overall Study|Lost to Follow-up|5|||
156771446|NCT00171249|565916272|FG001|Overall Study|Lost to Follow-up|0|||
156771447|NCT00171249|565916273|FG002|Overall Study|Lost to Follow-up|0|||
156771448|NCT00171249|565916274|FG003|Overall Study|Lost to Follow-up|9|||
156771449|NCT00171249|565916275|FG004|Overall Study|Lost to Follow-up|0|||
156771450|NCT00171249|565916276|FG005|Overall Study|Lost to Follow-up|0|||
156771451|NCT00171249|565916277|FG006|Overall Study|Lost to Follow-up|0|||
156771452|NCT02908347|565916278|FG000|Overall Study|Adverse Event|0|||
156771453|NCT02908347|565916279|FG001|Overall Study|Adverse Event|1|||
156771454|NCT02908347|565916278|FG000|Overall Study|Lost to Follow-up|1|||
156771455|NCT02908347|565916279|FG001|Overall Study|Lost to Follow-up|0|||
156771456|NCT03344757|565916280|FG000|Overall Study|Withdrawal by Subject|18|||
156771457|NCT03344757|565916281|FG001|Overall Study|Withdrawal by Subject|16|||
156771458|NCT03344757|565916280|FG000|Overall Study|Lost to Follow-up|0|||
156771459|NCT03344757|565916281|FG001|Overall Study|Lost to Follow-up|2|||
156771460|NCT01832766|565916282|FG000|Washout|Lost to Follow-up|0|||
156771461|NCT01832766|565916283|FG001|Washout|Lost to Follow-up|1|||
156771462|NCT00764790|565916286|FG000|Overall Study|Protocol Violation|0|||
156771463|NCT00764790|565916287|FG001|Overall Study|Protocol Violation|0|||
156771464|NCT00764790|565916288|FG002|Overall Study|Protocol Violation|1|||
156771465|NCT00764790|565916286|FG000|Overall Study|Withdrawal by Subject|10|||
156771466|NCT00764790|565916287|FG001|Overall Study|Withdrawal by Subject|12|||
156771467|NCT00764790|565916288|FG002|Overall Study|Withdrawal by Subject|6|||
156771468|NCT00764790|565916286|FG000|Overall Study|Lost to Follow-up|28|||
156771469|NCT00764790|565916287|FG001|Overall Study|Lost to Follow-up|29|||
156771470|NCT00764790|565916288|FG002|Overall Study|Lost to Follow-up|23|||
156771471|NCT02634710|565916293|FG000|Overall Study|Death|4|||
156771472|NCT04780659|565918095|FG000|Overall Study|Adverse event, serious fatal|3|||
156771473|NCT04780659|565918096|FG001|Overall Study|Adverse event, serious fatal|0|||
156771474|NCT04780659|565918095|FG000|Overall Study|Withdrawal by Subject|3|||
156771475|NCT04780659|565918096|FG001|Overall Study|Withdrawal by Subject|0|||
156771476|NCT04780659|565918095|FG000|Overall Study|Physician Decision|1|||
156771477|NCT04780659|565918096|FG001|Overall Study|Physician Decision|0|||
156771478|NCT04780659|565918095|FG000|Overall Study|Died in original disease|2|||
156771479|NCT04780659|565918096|FG001|Overall Study|Died in original disease|0|||
156771480|NCT04780659|565918095|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
156771481|NCT04780659|565918096|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
156771482|NCT05507437|565918097|FG000|Overall Study|Withdrawal by Subject|1|||
156771483|NCT05507437|565918098|FG001|Overall Study|Withdrawal by Subject|1|||
156771484|NCT05507437|565918097|FG000|Overall Study|Death|3|||
156771485|NCT05507437|565918098|FG001|Overall Study|Death|0|||
156771486|NCT06583096|565918099|FG000|Overall Study|Lost to Follow-up|4|||
156771487|NCT06583096|565918100|FG001|Overall Study|Lost to Follow-up|10|||
156771488|NCT06583096|565918099|FG000|Overall Study|Withdrawal by Subject|0|||
156771489|NCT06583096|565918100|FG001|Overall Study|Withdrawal by Subject|2|||
156771490|NCT03729362|565918101|FG000|Overall Study|Withdrawal by Subject|2|||
156771491|NCT03729362|565918102|FG001|Overall Study|Withdrawal by Subject|0|||
156771492|NCT03729362|565918101|FG000|Overall Study|Physician Decision|1|||
157207421|NCT01890109|567504459|FG001|Overall Study|Lost to Follow-up|2|||
156771493|NCT03729362|565918102|FG001|Overall Study|Physician Decision|0|||
156771494|NCT03729362|565918101|FG000|Overall Study|COVID-19 Pandemic|1|||
156771495|NCT03729362|565918102|FG001|Overall Study|COVID-19 Pandemic|0|||
156771496|NCT03729362|565918101|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
156771497|NCT03729362|565918102|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
156771498|NCT03729362|565918101|FG000|Overall Study|Adverse Event|0|||
156771499|NCT03729362|565918102|FG001|Overall Study|Adverse Event|1|||
156771500|NCT03729362|565918101|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
156771501|NCT03729362|565918102|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
156771502|NCT03405870|565918103|FG000|Overall Study|Withdrawal|1|||
156771503|NCT03405870|565918104|FG001|Overall Study|Withdrawal|0|||
156771504|NCT03405870|565918105|FG002|Overall Study|Withdrawal|1|||
156771505|NCT03405870|565918106|FG003|Overall Study|Withdrawal|0|||
156771506|NCT03405870|565918107|FG004|Overall Study|Withdrawal|0|||
156771507|NCT03405870|565918108|FG005|Overall Study|Withdrawal|0|||
156771508|NCT03405870|565918109|FG006|Overall Study|Withdrawal|1|||
156771509|NCT03405870|565918110|FG007|Overall Study|Withdrawal|0|||
156771510|NCT00042289|565918111|FG000|Overall Study|Lost to Follow-up|3|||
156771511|NCT00042289|565918112|FG001|Overall Study|Lost to Follow-up|0|||
156771512|NCT00042289|565918113|FG002|Overall Study|Lost to Follow-up|0|||
156771513|NCT00042289|565918114|FG003|Overall Study|Lost to Follow-up|1|||
156771514|NCT00042289|565918115|FG004|Overall Study|Lost to Follow-up|3|||
156771515|NCT00042289|565918116|FG005|Overall Study|Lost to Follow-up|3|||
156771516|NCT00042289|565918117|FG006|Overall Study|Lost to Follow-up|6|||
156771517|NCT00042289|565918118|FG007|Overall Study|Lost to Follow-up|1|||
156771518|NCT00042289|565918119|FG008|Overall Study|Lost to Follow-up|1|||
156771519|NCT00042289|565918120|FG009|Overall Study|Lost to Follow-up|0|||
156771520|NCT00042289|565918121|FG010|Overall Study|Lost to Follow-up|0|||
156771521|NCT00042289|565918122|FG011|Overall Study|Lost to Follow-up|0|||
156771522|NCT00042289|565918123|FG012|Overall Study|Lost to Follow-up|0|||
156771523|NCT00042289|565918124|FG013|Overall Study|Lost to Follow-up|0|||
156771524|NCT00042289|565918125|FG014|Overall Study|Lost to Follow-up|0|||
156771525|NCT00042289|565918126|FG015|Overall Study|Lost to Follow-up|1|||
156771526|NCT00042289|565918127|FG016|Overall Study|Lost to Follow-up|1|||
156771527|NCT00042289|565918128|FG017|Overall Study|Lost to Follow-up|0|||
156771528|NCT00042289|565918129|FG018|Overall Study|Lost to Follow-up|3|||
156771529|NCT00042289|565918130|FG019|Overall Study|Lost to Follow-up|2|||
156771530|NCT00042289|565918131|FG020|Overall Study|Lost to Follow-up|0|||
156771531|NCT00042289|565918132|FG021|Overall Study|Lost to Follow-up|0|||
156771532|NCT00042289|565918133|FG022|Overall Study|Lost to Follow-up|0|||
156771533|NCT00042289|565918134|FG023|Overall Study|Lost to Follow-up|0|||
156771534|NCT00042289|565918135|FG024|Overall Study|Lost to Follow-up|0|||
156771535|NCT00042289|565918136|FG025|Overall Study|Lost to Follow-up|0|||
156771536|NCT00042289|565918137|FG026|Overall Study|Lost to Follow-up|2|||
156771537|NCT00042289|565918138|FG027|Overall Study|Lost to Follow-up|2|||
156771538|NCT00042289|565918139|FG028|Overall Study|Lost to Follow-up|2|||
156771539|NCT00042289|565918140|FG029|Overall Study|Lost to Follow-up|0|||
156771540|NCT00042289|565918141|FG030|Overall Study|Lost to Follow-up|0|||
156771541|NCT00042289|565918142|FG031|Overall Study|Lost to Follow-up|2|||
156771542|NCT00042289|565918143|FG032|Overall Study|Lost to Follow-up|1|||
156771543|NCT00042289|565918144|FG033|Overall Study|Lost to Follow-up|1|||
156771544|NCT00042289|565918145|FG034|Overall Study|Lost to Follow-up|1|||
156771545|NCT00042289|565918146|FG035|Overall Study|Lost to Follow-up|2|||
156771546|NCT00042289|565918147|FG036|Overall Study|Lost to Follow-up|1|||
156771547|NCT00042289|565918148|FG037|Overall Study|Lost to Follow-up|1|||
156771548|NCT00042289|565918149|FG038|Overall Study|Lost to Follow-up|0|||
156771549|NCT00042289|565918150|FG039|Overall Study|Lost to Follow-up|5|||
156771550|NCT00042289|565918151|FG040|Overall Study|Lost to Follow-up|0|||
156771551|NCT00042289|565918152|FG041|Overall Study|Lost to Follow-up|2|||
156771552|NCT00042289|565918153|FG042|Overall Study|Lost to Follow-up|2|||
156771553|NCT00042289|565918154|FG043|Overall Study|Lost to Follow-up|0|||
156771554|NCT00042289|565918155|FG044|Overall Study|Lost to Follow-up|0|||
156771555|NCT00042289|565918156|FG045|Overall Study|Lost to Follow-up|1|||
156771556|NCT00042289|565918157|FG046|Overall Study|Lost to Follow-up|0|||
156771557|NCT00042289|565918111|FG000|Overall Study|Other reason|0|||
156771558|NCT00042289|565918112|FG001|Overall Study|Other reason|0|||
156771559|NCT00042289|565918113|FG002|Overall Study|Other reason|0|||
156771560|NCT00042289|565918114|FG003|Overall Study|Other reason|2|||
156771561|NCT00042289|565918115|FG004|Overall Study|Other reason|0|||
156771562|NCT00042289|565918116|FG005|Overall Study|Other reason|0|||
156771563|NCT00042289|565918117|FG006|Overall Study|Other reason|0|||
156771564|NCT00042289|565918118|FG007|Overall Study|Other reason|0|||
156771565|NCT00042289|565918119|FG008|Overall Study|Other reason|0|||
156771566|NCT00042289|565918120|FG009|Overall Study|Other reason|0|||
156771567|NCT00042289|565918121|FG010|Overall Study|Other reason|0|||
156771568|NCT00042289|565918122|FG011|Overall Study|Other reason|0|||
156771569|NCT00042289|565918123|FG012|Overall Study|Other reason|0|||
156771570|NCT00042289|565918124|FG013|Overall Study|Other reason|0|||
156771571|NCT00042289|565918125|FG014|Overall Study|Other reason|0|||
156771572|NCT00042289|565918126|FG015|Overall Study|Other reason|0|||
156771573|NCT00042289|565918127|FG016|Overall Study|Other reason|0|||
156771574|NCT00042289|565918128|FG017|Overall Study|Other reason|0|||
156771575|NCT00042289|565918129|FG018|Overall Study|Other reason|1|||
156771576|NCT00042289|565918130|FG019|Overall Study|Other reason|0|||
156771577|NCT00042289|565918131|FG020|Overall Study|Other reason|0|||
156771578|NCT00042289|565918132|FG021|Overall Study|Other reason|0|||
156771579|NCT00042289|565918133|FG022|Overall Study|Other reason|0|||
156771580|NCT00042289|565918134|FG023|Overall Study|Other reason|1|||
157207422|NCT01643928|567504460|FG000|Overall Study|Lost to Follow-up|1|||
156771581|NCT00042289|565918135|FG024|Overall Study|Other reason|0|||
156771582|NCT00042289|565918136|FG025|Overall Study|Other reason|0|||
156771583|NCT00042289|565918137|FG026|Overall Study|Other reason|1|||
156771584|NCT00042289|565918138|FG027|Overall Study|Other reason|0|||
156771585|NCT00042289|565918139|FG028|Overall Study|Other reason|3|||
156771586|NCT00042289|565918140|FG029|Overall Study|Other reason|0|||
156771587|NCT00042289|565918141|FG030|Overall Study|Other reason|0|||
156771588|NCT00042289|565918142|FG031|Overall Study|Other reason|1|||
157207423|NCT01643928|567504461|FG001|Overall Study|Lost to Follow-up|0|||
157207424|NCT01643928|567504462|FG002|Overall Study|Lost to Follow-up|2|||
157207425|NCT01643928|567504463|FG003|Overall Study|Lost to Follow-up|0|||
157207426|NCT01643928|567504464|FG004|Overall Study|Lost to Follow-up|0|||
157207427|NCT01643928|567504460|FG000|Overall Study|Withdrawal by Subject|2|||
156771589|NCT00042289|565918143|FG032|Overall Study|Other reason|0|||
156771590|NCT00042289|565918144|FG033|Overall Study|Other reason|1|||
156771591|NCT00042289|565918145|FG034|Overall Study|Other reason|0|||
156771592|NCT00042289|565918146|FG035|Overall Study|Other reason|2|||
156771593|NCT00042289|565918147|FG036|Overall Study|Other reason|0|||
156771594|NCT00042289|565918148|FG037|Overall Study|Other reason|0|||
156771595|NCT00042289|565918149|FG038|Overall Study|Other reason|0|||
156771596|NCT00042289|565918150|FG039|Overall Study|Other reason|0|||
156771597|NCT00042289|565918151|FG040|Overall Study|Other reason|0|||
156771598|NCT00042289|565918152|FG041|Overall Study|Other reason|0|||
156771599|NCT00042289|565918153|FG042|Overall Study|Other reason|0|||
156771600|NCT00042289|565918154|FG043|Overall Study|Other reason|1|||
156771601|NCT00042289|565918155|FG044|Overall Study|Other reason|0|||
156771602|NCT00042289|565918156|FG045|Overall Study|Other reason|0|||
156771603|NCT00042289|565918157|FG046|Overall Study|Other reason|0|||
156771604|NCT00042289|565918111|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156771605|NCT00042289|565918112|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156771606|NCT00042289|565918113|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156771607|NCT00042289|565918114|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156771608|NCT00042289|565918115|FG004|Overall Study|Severe debilitation, unable to continue|0|||
156771609|NCT00042289|565918116|FG005|Overall Study|Severe debilitation, unable to continue|0|||
156771610|NCT00042289|565918117|FG006|Overall Study|Severe debilitation, unable to continue|0|||
156771611|NCT00042289|565918118|FG007|Overall Study|Severe debilitation, unable to continue|0|||
156771612|NCT00042289|565918119|FG008|Overall Study|Severe debilitation, unable to continue|0|||
156771613|NCT00042289|565918120|FG009|Overall Study|Severe debilitation, unable to continue|0|||
156771614|NCT00042289|565918121|FG010|Overall Study|Severe debilitation, unable to continue|0|||
156771615|NCT00042289|565918122|FG011|Overall Study|Severe debilitation, unable to continue|0|||
156771616|NCT00042289|565918123|FG012|Overall Study|Severe debilitation, unable to continue|0|||
156771617|NCT00042289|565918124|FG013|Overall Study|Severe debilitation, unable to continue|0|||
156771618|NCT00042289|565918125|FG014|Overall Study|Severe debilitation, unable to continue|0|||
156771619|NCT00042289|565918126|FG015|Overall Study|Severe debilitation, unable to continue|0|||
156771620|NCT00042289|565918127|FG016|Overall Study|Severe debilitation, unable to continue|0|||
156771621|NCT00042289|565918128|FG017|Overall Study|Severe debilitation, unable to continue|0|||
156771622|NCT00042289|565918129|FG018|Overall Study|Severe debilitation, unable to continue|0|||
156771623|NCT00042289|565918130|FG019|Overall Study|Severe debilitation, unable to continue|0|||
156771624|NCT00042289|565918131|FG020|Overall Study|Severe debilitation, unable to continue|0|||
156771625|NCT00042289|565918132|FG021|Overall Study|Severe debilitation, unable to continue|1|||
156771626|NCT00042289|565918133|FG022|Overall Study|Severe debilitation, unable to continue|0|||
156771627|NCT00042289|565918134|FG023|Overall Study|Severe debilitation, unable to continue|1|||
156771628|NCT00042289|565918135|FG024|Overall Study|Severe debilitation, unable to continue|0|||
156771629|NCT00042289|565918136|FG025|Overall Study|Severe debilitation, unable to continue|0|||
156771630|NCT00042289|565918137|FG026|Overall Study|Severe debilitation, unable to continue|0|||
156771631|NCT00042289|565918138|FG027|Overall Study|Severe debilitation, unable to continue|1|||
156771632|NCT00042289|565918139|FG028|Overall Study|Severe debilitation, unable to continue|0|||
156771633|NCT00042289|565918140|FG029|Overall Study|Severe debilitation, unable to continue|0|||
156771634|NCT00042289|565918141|FG030|Overall Study|Severe debilitation, unable to continue|0|||
156771635|NCT00042289|565918142|FG031|Overall Study|Severe debilitation, unable to continue|1|||
156771636|NCT00042289|565918143|FG032|Overall Study|Severe debilitation, unable to continue|1|||
156771637|NCT00042289|565918144|FG033|Overall Study|Severe debilitation, unable to continue|0|||
156771638|NCT00042289|565918145|FG034|Overall Study|Severe debilitation, unable to continue|0|||
156771639|NCT00042289|565918146|FG035|Overall Study|Severe debilitation, unable to continue|0|||
156771640|NCT00042289|565918147|FG036|Overall Study|Severe debilitation, unable to continue|0|||
156771641|NCT00042289|565918148|FG037|Overall Study|Severe debilitation, unable to continue|0|||
156771642|NCT00042289|565918149|FG038|Overall Study|Severe debilitation, unable to continue|0|||
156771643|NCT00042289|565918150|FG039|Overall Study|Severe debilitation, unable to continue|0|||
156771644|NCT00042289|565918151|FG040|Overall Study|Severe debilitation, unable to continue|0|||
156771645|NCT00042289|565918152|FG041|Overall Study|Severe debilitation, unable to continue|0|||
156771646|NCT00042289|565918153|FG042|Overall Study|Severe debilitation, unable to continue|0|||
156771647|NCT00042289|565918154|FG043|Overall Study|Severe debilitation, unable to continue|0|||
156771648|NCT00042289|565918155|FG044|Overall Study|Severe debilitation, unable to continue|0|||
156771649|NCT00042289|565918156|FG045|Overall Study|Severe debilitation, unable to continue|0|||
156771650|NCT00042289|565918157|FG046|Overall Study|Severe debilitation, unable to continue|0|||
156771651|NCT00042289|565918111|FG000|Overall Study|Site closed|0|||
156771652|NCT00042289|565918112|FG001|Overall Study|Site closed|0|||
156771653|NCT00042289|565918113|FG002|Overall Study|Site closed|0|||
156771654|NCT00042289|565918114|FG003|Overall Study|Site closed|0|||
156771655|NCT00042289|565918115|FG004|Overall Study|Site closed|0|||
156771656|NCT00042289|565918116|FG005|Overall Study|Site closed|0|||
156771657|NCT00042289|565918117|FG006|Overall Study|Site closed|0|||
156771658|NCT00042289|565918118|FG007|Overall Study|Site closed|0|||
156771659|NCT00042289|565918119|FG008|Overall Study|Site closed|0|||
156771660|NCT00042289|565918120|FG009|Overall Study|Site closed|0|||
156771661|NCT00042289|565918121|FG010|Overall Study|Site closed|0|||
156771662|NCT00042289|565918122|FG011|Overall Study|Site closed|0|||
156771663|NCT00042289|565918123|FG012|Overall Study|Site closed|0|||
156771664|NCT00042289|565918124|FG013|Overall Study|Site closed|0|||
156771665|NCT00042289|565918125|FG014|Overall Study|Site closed|0|||
156771666|NCT00042289|565918126|FG015|Overall Study|Site closed|0|||
156771667|NCT00042289|565918127|FG016|Overall Study|Site closed|0|||
156771668|NCT00042289|565918128|FG017|Overall Study|Site closed|0|||
156771669|NCT00042289|565918129|FG018|Overall Study|Site closed|0|||
156771670|NCT00042289|565918130|FG019|Overall Study|Site closed|0|||
156771671|NCT00042289|565918131|FG020|Overall Study|Site closed|0|||
156771672|NCT00042289|565918132|FG021|Overall Study|Site closed|0|||
156771673|NCT00042289|565918133|FG022|Overall Study|Site closed|0|||
156771674|NCT00042289|565918134|FG023|Overall Study|Site closed|0|||
156771675|NCT00042289|565918135|FG024|Overall Study|Site closed|0|||
156771676|NCT00042289|565918136|FG025|Overall Study|Site closed|0|||
156771677|NCT00042289|565918137|FG026|Overall Study|Site closed|0|||
156771678|NCT00042289|565918138|FG027|Overall Study|Site closed|0|||
156771679|NCT00042289|565918139|FG028|Overall Study|Site closed|0|||
156771680|NCT00042289|565918140|FG029|Overall Study|Site closed|0|||
156771681|NCT00042289|565918141|FG030|Overall Study|Site closed|0|||
156771682|NCT00042289|565918142|FG031|Overall Study|Site closed|3|||
156771683|NCT00042289|565918143|FG032|Overall Study|Site closed|0|||
156771684|NCT00042289|565918144|FG033|Overall Study|Site closed|0|||
156771685|NCT00042289|565918145|FG034|Overall Study|Site closed|0|||
157207428|NCT01643928|567504461|FG001|Overall Study|Withdrawal by Subject|0|||
157207429|NCT01643928|567504462|FG002|Overall Study|Withdrawal by Subject|0|||
156771686|NCT00042289|565918146|FG035|Overall Study|Site closed|0|||
156771687|NCT00042289|565918147|FG036|Overall Study|Site closed|1|||
156771688|NCT00042289|565918148|FG037|Overall Study|Site closed|0|||
156771689|NCT00042289|565918149|FG038|Overall Study|Site closed|0|||
156771690|NCT00042289|565918150|FG039|Overall Study|Site closed|0|||
156771691|NCT00042289|565918151|FG040|Overall Study|Site closed|0|||
156771692|NCT00042289|565918152|FG041|Overall Study|Site closed|0|||
156771693|NCT00042289|565918153|FG042|Overall Study|Site closed|1|||
156771694|NCT00042289|565918154|FG043|Overall Study|Site closed|0|||
156771695|NCT00042289|565918155|FG044|Overall Study|Site closed|0|||
156771696|NCT00042289|565918156|FG045|Overall Study|Site closed|0|||
156771697|NCT00042289|565918157|FG046|Overall Study|Site closed|0|||
157207430|NCT01643928|567504463|FG003|Overall Study|Withdrawal by Subject|1|||
157207431|NCT01643928|567504464|FG004|Overall Study|Withdrawal by Subject|0|||
157207432|NCT01643928|567504460|FG000|Overall Study|Pregnancy|0|||
157207433|NCT01643928|567504461|FG001|Overall Study|Pregnancy|0|||
157207434|NCT01643928|567504462|FG002|Overall Study|Pregnancy|0|||
157207435|NCT01643928|567504463|FG003|Overall Study|Pregnancy|1|||
157207436|NCT01643928|567504464|FG004|Overall Study|Pregnancy|0|||
157207437|NCT01643928|567504460|FG000|Overall Study|Other|5|||
157207438|NCT01643928|567504461|FG001|Overall Study|Other|1|||
157207439|NCT01643928|567504462|FG002|Overall Study|Other|1|||
157207440|NCT01643928|567504463|FG003|Overall Study|Other|0|||
157207441|NCT01643928|567504464|FG004|Overall Study|Other|0|||
157207442|NCT01643928|567504460|FG000|Overall Study|Adverse Event|2|||
157207443|NCT01643928|567504461|FG001|Overall Study|Adverse Event|1|||
157207444|NCT01643928|567504462|FG002|Overall Study|Adverse Event|0|||
157207445|NCT01643928|567504463|FG003|Overall Study|Adverse Event|1|||
157207446|NCT01643928|567504464|FG004|Overall Study|Adverse Event|2|||
157207447|NCT01615822|567504467|FG000|Period 1|Withdrawal by Subject|0|||
157207448|NCT01615822|567504468|FG001|Period 1|Withdrawal by Subject|1|||
157207449|NCT01615822|567504469|FG002|Period 1|Withdrawal by Subject|0|||
157207450|NCT01615822|567504467|FG000|Period 1|Adverse Event|1|||
157207451|NCT01615822|567504468|FG001|Period 1|Adverse Event|1|||
157207452|NCT01615822|567504469|FG002|Period 1|Adverse Event|0|||
157207453|NCT01615822|567504467|FG000|Period 2|Lost to Follow-up|0|||
156771698|NCT00042289|565918111|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
156771699|NCT00042289|565918112|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
156771700|NCT00042289|565918113|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
156771701|NCT00042289|565918114|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
156771702|NCT00042289|565918115|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
156771703|NCT00042289|565918116|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
156771704|NCT00042289|565918117|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
156771705|NCT00042289|565918118|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
156771706|NCT00042289|565918119|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
156771707|NCT00042289|565918120|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
157207454|NCT01615822|567504468|FG001|Period 2|Lost to Follow-up|1|||
157207455|NCT01615822|567504469|FG002|Period 2|Lost to Follow-up|2|||
157207456|NCT01988337|567504470|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
157207457|NCT02742818|567504471|FG000|Overall Study|Adverse Event|0|||
157207458|NCT02742818|567504472|FG001|Overall Study|Adverse Event|1|||
157207459|NCT02742818|567504471|FG000|Overall Study|Protocol Violation|0|||
157207460|NCT02742818|567504472|FG001|Overall Study|Protocol Violation|1|||
157207461|NCT04701658|567504473|FG000|Overall Study|Lost to Follow-up|6|||
157207462|NCT00457418|567504474|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
157207463|NCT00457418|567504474|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
157207464|NCT00457418|567504474|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
157207465|NCT00457418|567504474|FG000|Post PK Maintenance|Adverse Event|10|||
157207466|NCT00457418|567504474|FG000|Post PK Maintenance|Progression of Disease|6|||
157207467|NCT00457418|567504474|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
157207468|NCT00457418|567504474|FG000|Post PK Maintenance|Lost to Follow-up|1|||
157207469|NCT00756652|567504481|FG000|Original Phase|Withdrawal by Subject|864|||
157207470|NCT00756652|567504482|FG001|Original Phase|Withdrawal by Subject|23|||
157207471|NCT00756652|567504481|FG000|Original Phase|Lost to Follow-up|601|||
157207472|NCT00756652|567504482|FG001|Original Phase|Lost to Follow-up|0|||
157207473|NCT00756652|567504481|FG000|Original Phase|Other Discontinuation|797|||
157207474|NCT00756652|567504482|FG001|Original Phase|Other Discontinuation|5|||
157207475|NCT00756652|567504481|FG000|Original Phase|Participant Noncompliance|18622|||
157207476|NCT00756652|567504482|FG001|Original Phase|Participant Noncompliance|424|||
157207477|NCT00756652|567504481|FG000|Original Phase|Unknown Discontinuation Reason|2|||
157207478|NCT00756652|567504482|FG001|Original Phase|Unknown Discontinuation Reason|0|||
157207479|NCT00756652|567504481|FG000|Original Phase|Participants without data|3259|||
157207480|NCT00756652|567504482|FG001|Original Phase|Participants without data|466|||
157207481|NCT00756652|567504481|FG000|Original Phase|Death|168|||
157207482|NCT00756652|567504482|FG001|Original Phase|Death|1|||
157207483|NCT00756652|567504481|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
157207484|NCT00756652|567504482|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
157207485|NCT00756652|567504481|FG000|Re-Op Phase|Withdrawal by Subject|62|||
157207486|NCT00756652|567504482|FG001|Re-Op Phase|Withdrawal by Subject|0|||
157207487|NCT00756652|567504481|FG000|Re-Op Phase|Death|6|||
157207488|NCT00756652|567504482|FG001|Re-Op Phase|Death|0|||
157207489|NCT00756652|567504481|FG000|Re-Op Phase|Lost to Follow-up|340|||
157207490|NCT00756652|567504482|FG001|Re-Op Phase|Lost to Follow-up|0|||
157207491|NCT00756652|567504481|FG000|Re-Op Phase|Site Closed|2454|||
157207492|NCT00756652|567504482|FG001|Re-Op Phase|Site Closed|0|||
157207493|NCT00756652|567504481|FG000|Re-Op Phase|Withdrawn after explant|14|||
157207494|NCT00756652|567504482|FG001|Re-Op Phase|Withdrawn after explant|0|||
157207495|NCT02564952|567504483|FG000|Overall Study|Adverse Event|6|||
157207496|NCT02564952|567504483|FG000|Overall Study|Lost to Follow-up|1|||
157207497|NCT02564952|567504483|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
157207498|NCT02564952|567504483|FG000|Overall Study|Withdrawal by Subject|1|||
157207499|NCT02564952|567504483|FG000|Overall Study|Low Efficacy|1|||
157207500|NCT02564952|567504483|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
157207501|NCT00728988|567504493|FG000|Overall Study|Not Treated|2|||
157207502|NCT00728988|567504494|FG001|Overall Study|Not Treated|2|||
157207503|NCT00728988|567504493|FG000|Overall Study|Death|1|||
157207504|NCT00728988|567504494|FG001|Overall Study|Death|1|||
157207505|NCT00728988|567504493|FG000|Overall Study|Adverse Event|3|||
157207506|NCT00728988|567504494|FG001|Overall Study|Adverse Event|2|||
157207507|NCT00728988|567504493|FG000|Overall Study|Other|85|||
157207508|NCT00728988|567504494|FG001|Overall Study|Other|77|||
157207509|NCT00728988|567504493|FG000|Overall Study|Withdrawal by Subject|2|||
157207510|NCT00728988|567504494|FG001|Overall Study|Withdrawal by Subject|6|||
157207511|NCT02643394|567504495|FG000|Overall Study|Protocol Violation|4|||
157207512|NCT02643394|567504496|FG001|Overall Study|Protocol Violation|5|||
157207513|NCT00943384|567504497|FG000|Overall Study|Dispositioned prior to treatment|23|||
157207514|NCT00943384|567504497|FG000|Overall Study|Treated off protocol-protocol violation|5|||
157207515|NCT00943384|567504497|FG000|Overall Study|Lost to Follow-up|16|||
156771708|NCT00042289|565918121|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
156771709|NCT00042289|565918122|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
156771710|NCT00042289|565918123|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
156771711|NCT00042289|565918124|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
156771712|NCT00042289|565918125|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
157007171|NCT03723616|566776077|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
157007172|NCT03723616|566776078|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
157007173|NCT03723616|566776079|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
157021617|NCT03519581|566830928|FG001|Overall Study|Withdrawal by Subject|0|||
157207516|NCT00943384|567504497|FG000|Overall Study|Withdrawal by Subject|5|||
157207517|NCT00096200|567504498|FG000|Overall Study|Adverse Event|0|||
157207518|NCT00096200|567504499|FG001|Overall Study|Adverse Event|4|||
157207519|NCT00096200|567504500|FG002|Overall Study|Adverse Event|0|||
157207520|NCT00096200|567504498|FG000|Overall Study|Withdrawal by Subject|1|||
156771713|NCT00042289|565918126|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
156771714|NCT00042289|565918127|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
156771715|NCT00042289|565918128|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
156771716|NCT00042289|565918129|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
156771717|NCT00042289|565918130|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
156771718|NCT00042289|565918131|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
156771719|NCT00042289|565918132|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
156771720|NCT00042289|565918133|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
156771721|NCT00042289|565918134|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
156771722|NCT00042289|565918135|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
156771723|NCT00042289|565918136|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
156771724|NCT00042289|565918137|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
156771725|NCT00042289|565918138|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
156771726|NCT00042289|565918139|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
156771727|NCT00042289|565918140|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
156771728|NCT00042289|565918141|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
156771729|NCT00042289|565918142|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
156771730|NCT00042289|565918143|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
156771731|NCT00042289|565918144|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
156771732|NCT00042289|565918145|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
156771733|NCT00042289|565918146|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
156771734|NCT00042289|565918147|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
156771735|NCT00042289|565918148|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
156771736|NCT00042289|565918149|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
156771737|NCT00042289|565918150|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
156771738|NCT00042289|565918151|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
156771739|NCT00042289|565918152|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
156771740|NCT00042289|565918153|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
156771741|NCT00042289|565918154|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
156771742|NCT00042289|565918155|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
156771743|NCT00042289|565918156|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
156771744|NCT00042289|565918157|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
156771745|NCT00042289|565918111|FG000|Overall Study|Protocol Violation|0|||
156771746|NCT00042289|565918112|FG001|Overall Study|Protocol Violation|0|||
156771747|NCT00042289|565918113|FG002|Overall Study|Protocol Violation|0|||
156771748|NCT00042289|565918114|FG003|Overall Study|Protocol Violation|0|||
156771749|NCT00042289|565918115|FG004|Overall Study|Protocol Violation|0|||
156771750|NCT00042289|565918116|FG005|Overall Study|Protocol Violation|1|||
156771751|NCT00042289|565918117|FG006|Overall Study|Protocol Violation|0|||
156771752|NCT00042289|565918118|FG007|Overall Study|Protocol Violation|1|||
156771753|NCT00042289|565918119|FG008|Overall Study|Protocol Violation|0|||
157007174|NCT03723616|566776080|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
157007175|NCT03723616|566776081|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
157007176|NCT03723616|566776082|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
157007177|NCT06001177|566776085|FG000|Treatment Phase|Adverse Event|1|||
157007178|NCT06001177|566776086|FG001|Treatment Phase|Adverse Event|0|||
157007179|NCT06001177|566776085|FG000|Treatment Phase|Withdrawal by Subject|1|||
157007180|NCT06001177|566776086|FG001|Treatment Phase|Withdrawal by Subject|0|||
157007181|NCT06001177|566776085|FG000|Observation Phase|Adverse Event|1|||
157007182|NCT06001177|566776086|FG001|Observation Phase|Adverse Event|1|||
157007183|NCT06001177|566776085|FG000|Observation Phase|Withdrawal by Subject|0|||
157007184|NCT06001177|566776086|FG001|Observation Phase|Withdrawal by Subject|1|||
157007185|NCT03593876|566776089|FG000|Overall Study|Withdrawal by Subject|1|||
157007186|NCT03593876|566776089|FG000|Overall Study|Discharged home before intervention completion|2|||
157007187|NCT05309668|566776090|FG000|Overall Study|Ongoing at data cut-off|14|||
157007188|NCT05309668|566776091|FG001|Overall Study|Ongoing at data cut-off|17|||
157007189|NCT05309668|566776092|FG002|Overall Study|Ongoing at data cut-off|4|||
157007190|NCT02696707|566776093|FG000|Per Protocol Population|Physician Decision|2|||
157007191|NCT02696707|566776094|FG001|Per Protocol Population|Physician Decision|1|||
157007192|NCT02696707|566776093|FG000|Per Protocol Population|Participant Decision|0|||
157007193|NCT02696707|566776094|FG001|Per Protocol Population|Participant Decision|2|||
156771754|NCT00042289|565918120|FG009|Overall Study|Protocol Violation|0|||
156771755|NCT00042289|565918121|FG010|Overall Study|Protocol Violation|0|||
156771756|NCT00042289|565918122|FG011|Overall Study|Protocol Violation|0|||
156771757|NCT00042289|565918123|FG012|Overall Study|Protocol Violation|0|||
156771758|NCT00042289|565918124|FG013|Overall Study|Protocol Violation|0|||
157007194|NCT02696707|566776093|FG000|Completed Study as Planned|Reason = LVEF|2|||
157007195|NCT02696707|566776094|FG001|Completed Study as Planned|Reason = LVEF|2|||
156771759|NCT00042289|565918125|FG014|Overall Study|Protocol Violation|0|||
156771760|NCT00042289|565918126|FG015|Overall Study|Protocol Violation|0|||
156771761|NCT00042289|565918127|FG016|Overall Study|Protocol Violation|0|||
156771762|NCT00042289|565918128|FG017|Overall Study|Protocol Violation|0|||
156771763|NCT00042289|565918129|FG018|Overall Study|Protocol Violation|0|||
156771764|NCT00042289|565918130|FG019|Overall Study|Protocol Violation|0|||
156771765|NCT00042289|565918131|FG020|Overall Study|Protocol Violation|0|||
156771766|NCT00042289|565918132|FG021|Overall Study|Protocol Violation|0|||
156771767|NCT00042289|565918133|FG022|Overall Study|Protocol Violation|0|||
156771768|NCT00042289|565918134|FG023|Overall Study|Protocol Violation|1|||
156771769|NCT00042289|565918135|FG024|Overall Study|Protocol Violation|1|||
156771770|NCT00042289|565918136|FG025|Overall Study|Protocol Violation|0|||
156771771|NCT00042289|565918137|FG026|Overall Study|Protocol Violation|2|||
156771772|NCT00042289|565918138|FG027|Overall Study|Protocol Violation|0|||
156771773|NCT00042289|565918139|FG028|Overall Study|Protocol Violation|0|||
156771774|NCT00042289|565918140|FG029|Overall Study|Protocol Violation|0|||
156771775|NCT00042289|565918141|FG030|Overall Study|Protocol Violation|1|||
156771776|NCT00042289|565918142|FG031|Overall Study|Protocol Violation|0|||
156771777|NCT00042289|565918143|FG032|Overall Study|Protocol Violation|0|||
156771778|NCT00042289|565918144|FG033|Overall Study|Protocol Violation|0|||
156771779|NCT00042289|565918145|FG034|Overall Study|Protocol Violation|0|||
156771780|NCT00042289|565918146|FG035|Overall Study|Protocol Violation|0|||
156771781|NCT00042289|565918147|FG036|Overall Study|Protocol Violation|0|||
156771782|NCT00042289|565918148|FG037|Overall Study|Protocol Violation|0|||
156771783|NCT00042289|565918149|FG038|Overall Study|Protocol Violation|0|||
156771784|NCT00042289|565918150|FG039|Overall Study|Protocol Violation|0|||
156771785|NCT00042289|565918151|FG040|Overall Study|Protocol Violation|0|||
156771786|NCT00042289|565918152|FG041|Overall Study|Protocol Violation|1|||
156771787|NCT00042289|565918153|FG042|Overall Study|Protocol Violation|1|||
156771788|NCT00042289|565918154|FG043|Overall Study|Protocol Violation|1|||
156771789|NCT00042289|565918155|FG044|Overall Study|Protocol Violation|0|||
156771790|NCT00042289|565918156|FG045|Overall Study|Protocol Violation|0|||
156771791|NCT00042289|565918157|FG046|Overall Study|Protocol Violation|0|||
156771792|NCT00042289|565918111|FG000|Overall Study|Withdrawal by Subject|4|||
156771793|NCT00042289|565918112|FG001|Overall Study|Withdrawal by Subject|1|||
156771794|NCT00042289|565918113|FG002|Overall Study|Withdrawal by Subject|0|||
156771795|NCT00042289|565918114|FG003|Overall Study|Withdrawal by Subject|2|||
156771796|NCT00042289|565918115|FG004|Overall Study|Withdrawal by Subject|0|||
156771797|NCT00042289|565918116|FG005|Overall Study|Withdrawal by Subject|2|||
156771798|NCT00042289|565918117|FG006|Overall Study|Withdrawal by Subject|0|||
156771799|NCT00042289|565918118|FG007|Overall Study|Withdrawal by Subject|0|||
156771800|NCT00042289|565918119|FG008|Overall Study|Withdrawal by Subject|0|||
156771801|NCT00042289|565918120|FG009|Overall Study|Withdrawal by Subject|1|||
156771802|NCT00042289|565918121|FG010|Overall Study|Withdrawal by Subject|0|||
156771803|NCT00042289|565918122|FG011|Overall Study|Withdrawal by Subject|0|||
156771804|NCT00042289|565918123|FG012|Overall Study|Withdrawal by Subject|2|||
156771805|NCT00042289|565918124|FG013|Overall Study|Withdrawal by Subject|0|||
156771806|NCT00042289|565918125|FG014|Overall Study|Withdrawal by Subject|0|||
157113195|NCT02819635|567170165|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
156771807|NCT00042289|565918126|FG015|Overall Study|Withdrawal by Subject|0|||
156771808|NCT00042289|565918127|FG016|Overall Study|Withdrawal by Subject|0|||
156771809|NCT00042289|565918128|FG017|Overall Study|Withdrawal by Subject|0|||
156771810|NCT00042289|565918129|FG018|Overall Study|Withdrawal by Subject|0|||
156771811|NCT00042289|565918130|FG019|Overall Study|Withdrawal by Subject|0|||
156771812|NCT00042289|565918131|FG020|Overall Study|Withdrawal by Subject|0|||
156771813|NCT00042289|565918132|FG021|Overall Study|Withdrawal by Subject|1|||
156771814|NCT00042289|565918133|FG022|Overall Study|Withdrawal by Subject|1|||
156771815|NCT00042289|565918134|FG023|Overall Study|Withdrawal by Subject|1|||
156771816|NCT00042289|565918135|FG024|Overall Study|Withdrawal by Subject|0|||
156771817|NCT00042289|565918136|FG025|Overall Study|Withdrawal by Subject|0|||
156771818|NCT00042289|565918137|FG026|Overall Study|Withdrawal by Subject|1|||
156771819|NCT00042289|565918138|FG027|Overall Study|Withdrawal by Subject|0|||
156771820|NCT00042289|565918139|FG028|Overall Study|Withdrawal by Subject|2|||
156771821|NCT00042289|565918140|FG029|Overall Study|Withdrawal by Subject|0|||
157113196|NCT02819635|567170166|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156771822|NCT00042289|565918141|FG030|Overall Study|Withdrawal by Subject|0|||
156771823|NCT00042289|565918142|FG031|Overall Study|Withdrawal by Subject|1|||
156771824|NCT00042289|565918143|FG032|Overall Study|Withdrawal by Subject|2|||
156771825|NCT00042289|565918144|FG033|Overall Study|Withdrawal by Subject|1|||
156771826|NCT00042289|565918145|FG034|Overall Study|Withdrawal by Subject|0|||
156771827|NCT00042289|565918146|FG035|Overall Study|Withdrawal by Subject|0|||
156771828|NCT00042289|565918147|FG036|Overall Study|Withdrawal by Subject|0|||
156771829|NCT00042289|565918148|FG037|Overall Study|Withdrawal by Subject|1|||
156771830|NCT00042289|565918149|FG038|Overall Study|Withdrawal by Subject|0|||
156771831|NCT00042289|565918150|FG039|Overall Study|Withdrawal by Subject|0|||
156771832|NCT00042289|565918151|FG040|Overall Study|Withdrawal by Subject|0|||
156771833|NCT00042289|565918152|FG041|Overall Study|Withdrawal by Subject|0|||
156771834|NCT00042289|565918153|FG042|Overall Study|Withdrawal by Subject|1|||
156771835|NCT00042289|565918154|FG043|Overall Study|Withdrawal by Subject|0|||
156771836|NCT00042289|565918155|FG044|Overall Study|Withdrawal by Subject|0|||
156771837|NCT00042289|565918156|FG045|Overall Study|Withdrawal by Subject|0|||
156771838|NCT00042289|565918157|FG046|Overall Study|Withdrawal by Subject|0|||
156771839|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
156771840|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
156771841|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
156771842|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
156771843|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
156771844|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
156771845|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
156771846|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
156771847|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
156771848|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
156771849|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
156771850|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
156771851|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
156771852|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
156771853|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
156771854|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
156771855|NCT00849056|565918159|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156771856|NCT00849056|565918160|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
156771857|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156771858|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
156771859|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
156771860|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
156771861|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
156771862|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
156771863|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
156771864|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
156771865|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156771866|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156771867|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
156771868|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
156771869|NCT00849056|565918159|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
156771870|NCT00849056|565918160|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
156771871|NCT04588259|565918161|FG000|Run-in period|Run-in failure|0|||
156771872|NCT04588259|565918162|FG001|Run-in period|Run-in failure|23|||
156771873|NCT04588259|565918161|FG000|Run-in period|Withdrawn before randomisation|0|||
156771874|NCT04588259|565918162|FG001|Run-in period|Withdrawn before randomisation|8|||
156771875|NCT04588259|565918161|FG000|Treatment period|Withdrawal by Subject|6|||
156771876|NCT04588259|565918162|FG001|Treatment period|Withdrawal by Subject|6|||
156771877|NCT01673386|565918163|FG000|Overall Study|Study terminated by sponsor|16|||
156771878|NCT01673386|565918164|FG001|Overall Study|Study terminated by sponsor|22|||
156771879|NCT01673386|565918163|FG000|Overall Study|Adverse Event|5|||
156771880|NCT01673386|565918164|FG001|Overall Study|Adverse Event|2|||
156771881|NCT01673386|565918163|FG000|Overall Study|Progressive disease|4|||
156771882|NCT01673386|565918164|FG001|Overall Study|Progressive disease|1|||
156771883|NCT01673386|565918163|FG000|Overall Study|Withdrawal by Subject|0|||
156771884|NCT01673386|565918164|FG001|Overall Study|Withdrawal by Subject|2|||
156771885|NCT00274456|565918165|FG000|Overall Study|Still on treatment|2|||
156771886|NCT00274456|565918166|FG001|Overall Study|Still on treatment|3|||
156771887|NCT00274456|565918167|FG002|Overall Study|Still on treatment|5|||
156771888|NCT00274456|565918168|FG003|Overall Study|Still on treatment|1|||
156771889|NCT00274456|565918165|FG000|Overall Study|Unacceptable toxicity|10|||
156771890|NCT00274456|565918166|FG001|Overall Study|Unacceptable toxicity|5|||
156771891|NCT00274456|565918167|FG002|Overall Study|Unacceptable toxicity|12|||
156771892|NCT00274456|565918168|FG003|Overall Study|Unacceptable toxicity|16|||
156771893|NCT00274456|565918165|FG000|Overall Study|Adverse Event|0|||
156771894|NCT00274456|565918166|FG001|Overall Study|Adverse Event|1|||
156771895|NCT00274456|565918167|FG002|Overall Study|Adverse Event|2|||
156771896|NCT00274456|565918168|FG003|Overall Study|Adverse Event|2|||
156771897|NCT00274456|565918165|FG000|Overall Study|Physician Decision|7|||
156771898|NCT00274456|565918166|FG001|Overall Study|Physician Decision|5|||
156771899|NCT00274456|565918167|FG002|Overall Study|Physician Decision|6|||
156771900|NCT00274456|565918168|FG003|Overall Study|Physician Decision|13|||
156771901|NCT00274456|565918165|FG000|Overall Study|Lost to Follow-up|0|||
156771902|NCT00274456|565918166|FG001|Overall Study|Lost to Follow-up|0|||
156771903|NCT00274456|565918167|FG002|Overall Study|Lost to Follow-up|1|||
156771904|NCT00274456|565918168|FG003|Overall Study|Lost to Follow-up|0|||
156771905|NCT00274456|565918165|FG000|Overall Study|Withdrawal by Subject|18|||
156771906|NCT00274456|565918166|FG001|Overall Study|Withdrawal by Subject|13|||
156771907|NCT00274456|565918167|FG002|Overall Study|Withdrawal by Subject|9|||
156771908|NCT00274456|565918168|FG003|Overall Study|Withdrawal by Subject|13|||
156771909|NCT03738696|565918175|FG000|Overall Study|Withdrawal by Subject|0|||
156771910|NCT03738696|565918176|FG001|Overall Study|Withdrawal by Subject|1|||
156771911|NCT03738696|565918175|FG000|Overall Study|Lost to Follow-up|8|||
156771912|NCT03738696|565918176|FG001|Overall Study|Lost to Follow-up|14|||
156771913|NCT02030600|565918177|FG000|Treatment Period 1|Adverse Event|5|||
156771914|NCT02030600|565918178|FG001|Treatment Period 1|Adverse Event|7|||
156771915|NCT02030600|565918177|FG000|Treatment Period 1|Lack of Efficacy|0|||
156771916|NCT02030600|565918178|FG001|Treatment Period 1|Lack of Efficacy|1|||
156771917|NCT02030600|565918177|FG000|Treatment Period 1|Lost to Follow-up|11|||
156771918|NCT02030600|565918178|FG001|Treatment Period 1|Lost to Follow-up|3|||
156771919|NCT02030600|565918177|FG000|Treatment Period 1|Protocol Violation|22|||
156771920|NCT02030600|565918178|FG001|Treatment Period 1|Protocol Violation|17|||
156771921|NCT02030600|565918177|FG000|Treatment Period 1|Withdrawal by Subject|13|||
156771922|NCT02030600|565918178|FG001|Treatment Period 1|Withdrawal by Subject|17|||
156771923|NCT02030600|565918177|FG000|Treatment Period 1|Casebook Unsigned|1|||
156771924|NCT02030600|565918178|FG001|Treatment Period 1|Casebook Unsigned|0|||
156771925|NCT02030600|565918177|FG000|Treatment Period 1|Unclassified|1|||
156771926|NCT02030600|565918178|FG001|Treatment Period 1|Unclassified|0|||
156771927|NCT02030600|565918177|FG000|Treatment Period 2|Adverse Event|4|||
156771928|NCT02030600|565918178|FG001|Treatment Period 2|Adverse Event|4|||
156771929|NCT02030600|565918177|FG000|Treatment Period 2|Lack of Efficacy|2|||
156771930|NCT02030600|565918178|FG001|Treatment Period 2|Lack of Efficacy|1|||
156771931|NCT02030600|565918177|FG000|Treatment Period 2|Lost to Follow-up|4|||
156771932|NCT02030600|565918178|FG001|Treatment Period 2|Lost to Follow-up|2|||
156771933|NCT02030600|565918177|FG000|Treatment Period 2|Protocol Violation|1|||
156771934|NCT02030600|565918178|FG001|Treatment Period 2|Protocol Violation|2|||
156771935|NCT02030600|565918177|FG000|Treatment Period 2|Withdrawal by Subject|13|||
156771936|NCT02030600|565918178|FG001|Treatment Period 2|Withdrawal by Subject|9|||
156771937|NCT02030600|565918177|FG000|Treatment Period 2|Unclassified|1|||
156771938|NCT02030600|565918178|FG001|Treatment Period 2|Unclassified|0|||
156771939|NCT01712178|565918179|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
156771940|NCT01712178|565918180|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
156771941|NCT01712178|565918179|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
156771942|NCT01712178|565918180|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
156771943|NCT01712178|565918179|FG000|Overall Study|Lost to Follow-up|0|||
156771944|NCT01712178|565918180|FG001|Overall Study|Lost to Follow-up|1|||
156771945|NCT05001620|565918181|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
156771946|NCT05001620|565918182|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
156771947|NCT00819039|565918183|FG000|Overall Study|Physician Decision|1|||
156771948|NCT00819039|565918184|FG001|Overall Study|Physician Decision|0|||
156771949|NCT00819039|565918185|FG002|Overall Study|Physician Decision|1|||
156771950|NCT00819039|565918183|FG000|Overall Study|Protocol Violation|1|||
156771951|NCT00819039|565918184|FG001|Overall Study|Protocol Violation|0|||
156771952|NCT00819039|565918185|FG002|Overall Study|Protocol Violation|0|||
156771953|NCT01240694|565918186|FG000|Overall Study|Adverse Event|9|||
156771954|NCT01240694|565918186|FG000|Overall Study|Lack of Efficacy|6|||
156771955|NCT01240694|565918186|FG000|Overall Study|Withdrawal by Subject|6|||
156771956|NCT01240694|565918186|FG000|Overall Study|Protocol Violation|2|||
156771957|NCT01240694|565918186|FG000|Overall Study|Lost to Follow-up|2|||
156771958|NCT01240694|565918186|FG000|Overall Study|Other than specified|3|||
156771959|NCT01240694|565918186|FG000|Overall Study|Withdrawn due to early study termination|107|||
156771960|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
156771961|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
156771962|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
156771963|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
156771964|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
156771965|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
157207521|NCT00096200|567504499|FG001|Overall Study|Withdrawal by Subject|2|||
156771966|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
157007196|NCT02696707|566776093|FG000|Completed Study as Planned|Protocol Violation|2|||
157007197|NCT02696707|566776094|FG001|Completed Study as Planned|Protocol Violation|6|||
157207522|NCT00096200|567504500|FG002|Overall Study|Withdrawal by Subject|0|||
156771967|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
156771968|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
156771969|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
157007198|NCT02696707|566776093|FG000|Completed Study as Planned|Metastatic disease|3|||
156771970|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Death|3|||
156771971|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Death|1|||
156771972|NCT01056276|565918187|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
156771973|NCT01056276|565918188|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
157207523|NCT00096200|567504498|FG000|Overall Study|Ineligible pathology|0|||
156771974|NCT01056276|565918187|FG000|Maintenance Therapy|Toxicity|0|||
156771975|NCT01056276|565918188|FG001|Maintenance Therapy|Toxicity|2|||
156771976|NCT01056276|565918187|FG000|Maintenance Therapy|Progressive Disease|0|||
156771977|NCT01056276|565918188|FG001|Maintenance Therapy|Progressive Disease|9|||
156771978|NCT01056276|565918187|FG000|Maintenance Therapy|Physician Decision|0|||
156771979|NCT01056276|565918188|FG001|Maintenance Therapy|Physician Decision|1|||
156771980|NCT01056276|565918187|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
156771981|NCT01056276|565918188|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
156771982|NCT01056276|565918187|FG000|Maintenance Therapy|Intercurrent Illness|0|||
156771983|NCT01056276|565918188|FG001|Maintenance Therapy|Intercurrent Illness|1|||
156771984|NCT01056276|565918187|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
156771985|NCT01056276|565918188|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
156771986|NCT01881425|565918189|FG000|Overall Study|Death|5|||
156771987|NCT01881425|565918190|FG001|Overall Study|Death|1|||
156771988|NCT01881425|565918189|FG000|Overall Study|Withdrawal by Subject|8|||
156771989|NCT01881425|565918190|FG001|Overall Study|Withdrawal by Subject|3|||
156771990|NCT01881425|565918189|FG000|Overall Study|Physician Decision|2|||
156771991|NCT01881425|565918190|FG001|Overall Study|Physician Decision|1|||
156771992|NCT01881425|565918189|FG000|Overall Study|Adverse Event|3|||
156771993|NCT01881425|565918190|FG001|Overall Study|Adverse Event|0|||
156771994|NCT01881425|565918189|FG000|Overall Study|General Anesthesia panic attack|0|||
156771995|NCT01881425|565918190|FG001|Overall Study|General Anesthesia panic attack|1|||
156771996|NCT01881425|565918189|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
156771997|NCT01881425|565918190|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
156771998|NCT01881425|565918189|FG000|Overall Study|Lost to Follow-up|7|||
156771999|NCT01881425|565918190|FG001|Overall Study|Lost to Follow-up|2|||
156772000|NCT04154956|565918195|FG000|Overall Study|Death|109|||
156772001|NCT04154956|565918196|FG001|Overall Study|Death|110|||
156772002|NCT04154956|565918195|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
156772003|NCT04154956|565918196|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
156772004|NCT04154956|565918195|FG000|Overall Study|Withdrawal by Subject|1|||
156772005|NCT04154956|565918196|FG001|Overall Study|Withdrawal by Subject|7|||
156772006|NCT04154956|565918195|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
156772007|NCT04154956|565918196|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
156772008|NCT00147238|565918197|FG000|Overall Study|Inevaluable|8|||
156772009|NCT04424901|565918198|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
156772010|NCT04424901|565918199|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
156772011|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
156772012|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
156772013|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
156772014|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
156772015|NCT01348269|565918200|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
156772016|NCT01348269|565918201|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
156772017|NCT00805532|565918202|FG000|Overall Study|invalid data|0|||
156772018|NCT00805532|565918203|FG001|Overall Study|invalid data|1|||
156772019|NCT01859741|565918204|FG000|Overall Study|Death|3|||
156772020|NCT01859741|565918205|FG001|Overall Study|Death|2|||
156772021|NCT01859741|565918206|FG002|Overall Study|Death|4|||
156772022|NCT01859741|565918207|FG003|Overall Study|Death|3|||
156772023|NCT01859741|565918208|FG004|Overall Study|Death|5|||
156772024|NCT01859741|565918209|FG005|Overall Study|Death|4|||
156772025|NCT01859741|565918210|FG006|Overall Study|Death|51|||
156772026|NCT01859741|565918211|FG007|Overall Study|Death|51|||
156772027|NCT01859741|565918204|FG000|Overall Study|Lost to Follow-up|0|||
156772028|NCT01859741|565918205|FG001|Overall Study|Lost to Follow-up|0|||
156772029|NCT01859741|565918206|FG002|Overall Study|Lost to Follow-up|0|||
156772030|NCT01859741|565918207|FG003|Overall Study|Lost to Follow-up|0|||
156772031|NCT01859741|565918208|FG004|Overall Study|Lost to Follow-up|0|||
156772032|NCT01859741|565918209|FG005|Overall Study|Lost to Follow-up|1|||
156772033|NCT01859741|565918210|FG006|Overall Study|Lost to Follow-up|0|||
156772034|NCT01859741|565918211|FG007|Overall Study|Lost to Follow-up|4|||
156772035|NCT01859741|565918204|FG000|Overall Study|Withdrawal by Subject|0|||
156772036|NCT01859741|565918205|FG001|Overall Study|Withdrawal by Subject|1|||
156772037|NCT01859741|565918206|FG002|Overall Study|Withdrawal by Subject|2|||
156772038|NCT01859741|565918207|FG003|Overall Study|Withdrawal by Subject|0|||
156772039|NCT01859741|565918208|FG004|Overall Study|Withdrawal by Subject|0|||
157113197|NCT02819635|567170167|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156772040|NCT01859741|565918209|FG005|Overall Study|Withdrawal by Subject|1|||
156772041|NCT01859741|565918210|FG006|Overall Study|Withdrawal by Subject|1|||
156772042|NCT01859741|565918211|FG007|Overall Study|Withdrawal by Subject|1|||
156772043|NCT01859741|565918204|FG000|Overall Study|Study Terminated by Sponsor|0|||
156772044|NCT01859741|565918205|FG001|Overall Study|Study Terminated by Sponsor|0|||
156772045|NCT01859741|565918206|FG002|Overall Study|Study Terminated by Sponsor|0|||
156772046|NCT01859741|565918207|FG003|Overall Study|Study Terminated by Sponsor|0|||
157113198|NCT02819635|567170168|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
156772047|NCT01859741|565918208|FG004|Overall Study|Study Terminated by Sponsor|1|||
156772048|NCT01859741|565918209|FG005|Overall Study|Study Terminated by Sponsor|0|||
156772049|NCT01859741|565918210|FG006|Overall Study|Study Terminated by Sponsor|16|||
156772050|NCT01859741|565918211|FG007|Overall Study|Study Terminated by Sponsor|14|||
156772051|NCT01859741|565918204|FG000|Overall Study|Other|0|||
156772052|NCT01859741|565918205|FG001|Overall Study|Other|0|||
156772053|NCT01859741|565918206|FG002|Overall Study|Other|0|||
156772054|NCT01859741|565918207|FG003|Overall Study|Other|0|||
156772055|NCT01859741|565918208|FG004|Overall Study|Other|0|||
156772056|NCT01859741|565918209|FG005|Overall Study|Other|0|||
156772057|NCT01859741|565918210|FG006|Overall Study|Other|2|||
156772058|NCT01859741|565918211|FG007|Overall Study|Other|0|||
156772059|NCT02412657|565918212|FG000|Overall Study|Lost to Follow-up|1|||
156772060|NCT02412657|565918213|FG001|Overall Study|Lost to Follow-up|0|||
156772061|NCT02412657|565918214|FG002|Overall Study|Lost to Follow-up|0|||
156772062|NCT02412657|565918212|FG000|Overall Study|Protocol Violation|0|||
156772063|NCT02412657|565918213|FG001|Overall Study|Protocol Violation|2|||
156772064|NCT02412657|565918214|FG002|Overall Study|Protocol Violation|3|||
156772065|NCT03185208|565918218|FG000|Overall Study|Did not start study medication|0|||
156772066|NCT03185208|565918219|FG001|Overall Study|Did not start study medication|3|||
156772067|NCT03834350|565918220|FG000|Overall Study|Withdrawal by Subject|1|||
156772068|NCT00701363|565918221|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
156772069|NCT00701363|565918222|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772070|NCT00701363|565918223|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772071|NCT00701363|565918224|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
156772072|NCT00701363|565918221|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
156772073|NCT00701363|565918222|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
156772074|NCT00701363|565918223|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
156772075|NCT00701363|565918224|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
156772076|NCT00701363|565918221|FG000|Treatment Phase 1|Adverse Event|7|||
156772077|NCT00701363|565918222|FG001|Treatment Phase 1|Adverse Event|0|||
156772078|NCT00701363|565918223|FG002|Treatment Phase 1|Adverse Event|0|||
156772079|NCT00701363|565918224|FG003|Treatment Phase 1|Adverse Event|0|||
156772080|NCT00701363|565918221|FG000|Treatment Phase 1|Protocol Violation|1|||
156772081|NCT00701363|565918222|FG001|Treatment Phase 1|Protocol Violation|0|||
156772082|NCT00701363|565918223|FG002|Treatment Phase 1|Protocol Violation|0|||
156772083|NCT00701363|565918224|FG003|Treatment Phase 1|Protocol Violation|0|||
156772084|NCT00701363|565918221|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
156772085|NCT00701363|565918222|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
156772086|NCT00701363|565918223|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
156772087|NCT00701363|565918224|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
156772088|NCT00701363|565918221|FG000|Treatment Phase 1|Lack of Efficacy|1|||
156772089|NCT00701363|565918222|FG001|Treatment Phase 1|Lack of Efficacy|0|||
156772090|NCT00701363|565918223|FG002|Treatment Phase 1|Lack of Efficacy|0|||
156772091|NCT00701363|565918224|FG003|Treatment Phase 1|Lack of Efficacy|0|||
156772092|NCT00701363|565918221|FG000|Treatment Phase 2|Adverse Event|0|||
156772093|NCT00701363|565918222|FG001|Treatment Phase 2|Adverse Event|0|||
156772094|NCT00701363|565918223|FG002|Treatment Phase 2|Adverse Event|1|||
156772095|NCT00701363|565918224|FG003|Treatment Phase 2|Adverse Event|0|||
156772096|NCT00701363|565918221|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
156772097|NCT00701363|565918222|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
156772098|NCT00701363|565918223|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
156772099|NCT00701363|565918224|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
156772100|NCT04759131|565918225|FG000|Overall Study|Investigator's discretion|1|||
156772101|NCT04759131|565918226|FG001|Overall Study|Investigator's discretion|0|||
156772102|NCT04759131|565918225|FG000|Overall Study|Subject withdrawal|1|||
156772103|NCT04759131|565918226|FG001|Overall Study|Subject withdrawal|0|||
156772104|NCT02592824|565918231|FG000|Overall Study|Protocol Violation|5|||
156772105|NCT02592824|565918232|FG001|Overall Study|Protocol Violation|3|||
156772106|NCT02592824|565918231|FG000|Overall Study|Lost to Follow-up|2|||
156772107|NCT02592824|565918232|FG001|Overall Study|Lost to Follow-up|1|||
156772108|NCT00289276|565918233|FG000|Second Part of FAST Study (Expansion)|Death|0|||
156772109|NCT00289276|565918234|FG001|Second Part of FAST Study (Expansion)|Death|2|||
156772110|NCT00289276|565918233|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
156772111|NCT00289276|565918234|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
156772112|NCT04458922|565918237|FG000|Overall Study|Withdrawal by Subject|1|||
156772113|NCT04458922|565918238|FG001|Overall Study|Withdrawal by Subject|0|||
156772114|NCT04458922|565918239|FG002|Overall Study|Withdrawal by Subject|2|||
156772115|NCT04458922|565918237|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
156772116|NCT04458922|565918238|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
156772117|NCT04458922|565918239|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
156772118|NCT04458922|565918237|FG000|Overall Study|Adverse Event|1|||
156772119|NCT04458922|565918238|FG001|Overall Study|Adverse Event|0|||
156772120|NCT04458922|565918239|FG002|Overall Study|Adverse Event|0|||
156772121|NCT04458922|565918237|FG000|Overall Study|Started new study|0|||
156772122|NCT04458922|565918238|FG001|Overall Study|Started new study|0|||
156772123|NCT04458922|565918239|FG002|Overall Study|Started new study|1|||
156772124|NCT04458922|565918237|FG000|Overall Study|Progressive disease|6|||
156772125|NCT04458922|565918238|FG001|Overall Study|Progressive disease|8|||
156772126|NCT04458922|565918239|FG002|Overall Study|Progressive disease|2|||
156772127|NCT04458922|565918237|FG000|Overall Study|Death|1|||
156772128|NCT04458922|565918238|FG001|Overall Study|Death|0|||
156772129|NCT04458922|565918239|FG002|Overall Study|Death|2|||
156772130|NCT04458922|565918237|FG000|Overall Study|Participant started chemotherapy|0|||
156772131|NCT04458922|565918238|FG001|Overall Study|Participant started chemotherapy|1|||
156772132|NCT04458922|565918239|FG002|Overall Study|Participant started chemotherapy|0|||
156772133|NCT04682301|565918240|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
156772134|NCT04682301|565918240|FG000|Overall Study|Death|2|||
156772135|NCT05219162|565918241|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
156772136|NCT05219162|565918241|FG000|Overall Study|Withdrawal by Subject|23|||
156772137|NCT00392223|565918248|FG000|Overall Study|Adverse Event|5|||
156772138|NCT00392223|565918249|FG001|Overall Study|Adverse Event|4|||
156772139|NCT00392223|565918248|FG000|Overall Study|Lost to Follow-up|1|||
156772140|NCT00392223|565918249|FG001|Overall Study|Lost to Follow-up|4|||
156772141|NCT00392223|565918248|FG000|Overall Study|Protocol Violation|0|||
156772142|NCT00392223|565918249|FG001|Overall Study|Protocol Violation|3|||
156772143|NCT00392223|565918248|FG000|Overall Study|Withdrawal by Subject|3|||
156772144|NCT00392223|565918249|FG001|Overall Study|Withdrawal by Subject|2|||
156772145|NCT00269152|565918250|FG000|Overall Study|Adverse Event|9|||
156772146|NCT00269152|565918251|FG001|Overall Study|Adverse Event|3|||
156772147|NCT00269152|565918250|FG000|Overall Study|Withdrawal by Subject|7|||
156772148|NCT00269152|565918251|FG001|Overall Study|Withdrawal by Subject|3|||
156772149|NCT00269152|565918250|FG000|Overall Study|Physician Decision|2|||
156772150|NCT00269152|565918251|FG001|Overall Study|Physician Decision|3|||
156772151|NCT00269152|565918250|FG000|Overall Study|Protocol Violation|0|||
156772152|NCT00269152|565918251|FG001|Overall Study|Protocol Violation|1|||
156772153|NCT05516758|565918252|FG000|Overall Study|Adverse Event|5|||
156772154|NCT05516758|565918253|FG001|Overall Study|Adverse Event|1|||
157113199|NCT02819635|567170169|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113200|NCT02819635|567170170|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
157113201|NCT02819635|567170159|FG000|Substudy 2, Part 2|Other, not specified|0|||
157113202|NCT02819635|567170160|FG001|Substudy 2, Part 2|Other, not specified|0|||
157113203|NCT02819635|567170161|FG002|Substudy 2, Part 2|Other, not specified|0|||
157113204|NCT02819635|567170162|FG003|Substudy 2, Part 2|Other, not specified|0|||
157113205|NCT02819635|567170163|FG004|Substudy 2, Part 2|Other, not specified|0|||
157113206|NCT02819635|567170164|FG005|Substudy 2, Part 2|Other, not specified|4|||
157113207|NCT02819635|567170165|FG006|Substudy 2, Part 2|Other, not specified|8|||
157113208|NCT02819635|567170166|FG007|Substudy 2, Part 2|Other, not specified|0|||
157113209|NCT02819635|567170167|FG008|Substudy 2, Part 2|Other, not specified|0|||
157113210|NCT02819635|567170168|FG009|Substudy 2, Part 2|Other, not specified|0|||
157113211|NCT02819635|567170169|FG010|Substudy 2, Part 2|Other, not specified|0|||
157113212|NCT02819635|567170170|FG011|Substudy 2, Part 2|Other, not specified|0|||
157113213|NCT02819635|567170159|FG000|Substudy 3|Adverse Event|0|||
157113214|NCT02819635|567170160|FG001|Substudy 3|Adverse Event|0|||
157113215|NCT02819635|567170161|FG002|Substudy 3|Adverse Event|0|||
157113216|NCT02819635|567170162|FG003|Substudy 3|Adverse Event|0|||
157113217|NCT02819635|567170163|FG004|Substudy 3|Adverse Event|0|||
157113218|NCT02819635|567170164|FG005|Substudy 3|Adverse Event|0|||
157113219|NCT02819635|567170165|FG006|Substudy 3|Adverse Event|0|||
156772155|NCT05516758|565918254|FG002|Overall Study|Adverse Event|3|||
156772156|NCT05516758|565918255|FG003|Overall Study|Adverse Event|0|||
156772157|NCT05516758|565918256|FG004|Overall Study|Adverse Event|1|||
156772158|NCT05516758|565918257|FG005|Overall Study|Adverse Event|3|||
156772159|NCT05516758|565918258|FG006|Overall Study|Adverse Event|5|||
156772160|NCT05516758|565918252|FG000|Overall Study|Assigned treatment by mistake|1|||
156772161|NCT05516758|565918253|FG001|Overall Study|Assigned treatment by mistake|0|||
156772162|NCT05516758|565918254|FG002|Overall Study|Assigned treatment by mistake|0|||
156772163|NCT05516758|565918255|FG003|Overall Study|Assigned treatment by mistake|0|||
156772164|NCT05516758|565918256|FG004|Overall Study|Assigned treatment by mistake|1|||
156772165|NCT05516758|565918257|FG005|Overall Study|Assigned treatment by mistake|0|||
157207524|NCT00096200|567504499|FG001|Overall Study|Ineligible pathology|1|||
157207525|NCT00096200|567504500|FG002|Overall Study|Ineligible pathology|0|||
157207526|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
156772166|NCT05516758|565918258|FG006|Overall Study|Assigned treatment by mistake|0|||
156772167|NCT05516758|565918252|FG000|Overall Study|Lack of Efficacy|6|||
156772168|NCT05516758|565918253|FG001|Overall Study|Lack of Efficacy|0|||
156772169|NCT05516758|565918254|FG002|Overall Study|Lack of Efficacy|2|||
156772170|NCT05516758|565918255|FG003|Overall Study|Lack of Efficacy|0|||
156772171|NCT05516758|565918256|FG004|Overall Study|Lack of Efficacy|3|||
156772172|NCT05516758|565918257|FG005|Overall Study|Lack of Efficacy|6|||
156772173|NCT05516758|565918258|FG006|Overall Study|Lack of Efficacy|3|||
157113220|NCT02819635|567170166|FG007|Substudy 3|Adverse Event|0|||
157113221|NCT02819635|567170167|FG008|Substudy 3|Adverse Event|32|||
157113222|NCT02819635|567170168|FG009|Substudy 3|Adverse Event|3|||
156772174|NCT05516758|565918252|FG000|Overall Study|Lost to Follow-up|2|||
156772175|NCT05516758|565918253|FG001|Overall Study|Lost to Follow-up|0|||
156772176|NCT05516758|565918254|FG002|Overall Study|Lost to Follow-up|2|||
156772177|NCT05516758|565918255|FG003|Overall Study|Lost to Follow-up|0|||
156772178|NCT05516758|565918256|FG004|Overall Study|Lost to Follow-up|3|||
156772179|NCT05516758|565918257|FG005|Overall Study|Lost to Follow-up|2|||
156772180|NCT05516758|565918258|FG006|Overall Study|Lost to Follow-up|1|||
156772181|NCT05516758|565918252|FG000|Overall Study|Other- As reported by the site|2|||
156772182|NCT05516758|565918253|FG001|Overall Study|Other- As reported by the site|1|||
156772183|NCT05516758|565918254|FG002|Overall Study|Other- As reported by the site|8|||
156772184|NCT05516758|565918255|FG003|Overall Study|Other- As reported by the site|1|||
156772185|NCT05516758|565918256|FG004|Overall Study|Other- As reported by the site|2|||
156772186|NCT05516758|565918257|FG005|Overall Study|Other- As reported by the site|3|||
156772187|NCT05516758|565918258|FG006|Overall Study|Other- As reported by the site|8|||
156772188|NCT05516758|565918252|FG000|Overall Study|Physician Decision|1|||
156772189|NCT05516758|565918253|FG001|Overall Study|Physician Decision|0|||
156772190|NCT05516758|565918254|FG002|Overall Study|Physician Decision|7|||
156772191|NCT05516758|565918255|FG003|Overall Study|Physician Decision|0|||
156772192|NCT05516758|565918256|FG004|Overall Study|Physician Decision|1|||
156772193|NCT05516758|565918257|FG005|Overall Study|Physician Decision|1|||
156772194|NCT05516758|565918258|FG006|Overall Study|Physician Decision|2|||
156772195|NCT05516758|565918252|FG000|Overall Study|Protocol Deviation|1|||
156772196|NCT05516758|565918253|FG001|Overall Study|Protocol Deviation|0|||
156772197|NCT05516758|565918254|FG002|Overall Study|Protocol Deviation|0|||
156772198|NCT05516758|565918255|FG003|Overall Study|Protocol Deviation|0|||
156772199|NCT05516758|565918256|FG004|Overall Study|Protocol Deviation|0|||
156772200|NCT05516758|565918257|FG005|Overall Study|Protocol Deviation|1|||
156772201|NCT05516758|565918258|FG006|Overall Study|Protocol Deviation|5|||
156772202|NCT05516758|565918252|FG000|Overall Study|Withdrawal by Subject|11|||
156772203|NCT05516758|565918253|FG001|Overall Study|Withdrawal by Subject|1|||
156772204|NCT05516758|565918254|FG002|Overall Study|Withdrawal by Subject|15|||
156772205|NCT05516758|565918255|FG003|Overall Study|Withdrawal by Subject|2|||
156772206|NCT05516758|565918256|FG004|Overall Study|Withdrawal by Subject|7|||
156772207|NCT05516758|565918257|FG005|Overall Study|Withdrawal by Subject|7|||
156772208|NCT05516758|565918258|FG006|Overall Study|Withdrawal by Subject|6|||
156772209|NCT05516758|565918252|FG000|Overall Study|Death|1|||
156772210|NCT05516758|565918253|FG001|Overall Study|Death|0|||
156772211|NCT05516758|565918254|FG002|Overall Study|Death|0|||
156772212|NCT05516758|565918255|FG003|Overall Study|Death|0|||
156772213|NCT05516758|565918256|FG004|Overall Study|Death|0|||
156772214|NCT05516758|565918257|FG005|Overall Study|Death|0|||
156772215|NCT05516758|565918258|FG006|Overall Study|Death|0|||
156772216|NCT05516758|565918252|FG000|Overall Study|Non-compliance With Study Drug|0|||
156772217|NCT05516758|565918253|FG001|Overall Study|Non-compliance With Study Drug|0|||
156772218|NCT05516758|565918254|FG002|Overall Study|Non-compliance With Study Drug|1|||
156772219|NCT05516758|565918255|FG003|Overall Study|Non-compliance With Study Drug|0|||
156772220|NCT05516758|565918256|FG004|Overall Study|Non-compliance With Study Drug|0|||
156772221|NCT05516758|565918257|FG005|Overall Study|Non-compliance With Study Drug|0|||
156772222|NCT05516758|565918258|FG006|Overall Study|Non-compliance With Study Drug|0|||
156772223|NCT05516758|565918252|FG000|Overall Study|Site Terminated by Sponsor|2|||
156772224|NCT05516758|565918253|FG001|Overall Study|Site Terminated by Sponsor|0|||
156772225|NCT05516758|565918254|FG002|Overall Study|Site Terminated by Sponsor|0|||
156772226|NCT05516758|565918255|FG003|Overall Study|Site Terminated by Sponsor|0|||
156772227|NCT05516758|565918256|FG004|Overall Study|Site Terminated by Sponsor|0|||
156772228|NCT05516758|565918257|FG005|Overall Study|Site Terminated by Sponsor|0|||
156772229|NCT05516758|565918258|FG006|Overall Study|Site Terminated by Sponsor|0|||
156772230|NCT05516758|565918252|FG000|Overall Study|Study Terminated by Sponsor|4|||
156772231|NCT05516758|565918253|FG001|Overall Study|Study Terminated by Sponsor|0|||
156772232|NCT05516758|565918254|FG002|Overall Study|Study Terminated by Sponsor|3|||
156772233|NCT05516758|565918255|FG003|Overall Study|Study Terminated by Sponsor|0|||
156772234|NCT05516758|565918256|FG004|Overall Study|Study Terminated by Sponsor|2|||
156772235|NCT05516758|565918257|FG005|Overall Study|Study Terminated by Sponsor|3|||
156772236|NCT05516758|565918258|FG006|Overall Study|Study Terminated by Sponsor|0|||
156772237|NCT05516758|565918252|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
156772238|NCT05516758|565918253|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
157007199|NCT02696707|566776094|FG001|Completed Study as Planned|Metastatic disease|0|||
156772239|NCT05516758|565918254|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
157007200|NCT02696707|566776093|FG000|Completed Study as Planned|Location|1|||
156772240|NCT05516758|565918255|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
157007201|NCT02696707|566776094|FG001|Completed Study as Planned|Location|1|||
157007202|NCT01786564|566776099|FG000|Overall Study|Lost to Follow-up|47|||
156772241|NCT05516758|565918256|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
156772242|NCT05516758|565918257|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
156772243|NCT05516758|565918258|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
157007203|NCT01786564|566776099|FG000|Overall Study|Ineligible|17|||
156772244|NCT05516758|565918252|FG000|Overall Study|Other|0|||
156772245|NCT05516758|565918253|FG001|Overall Study|Other|0|||
156772246|NCT05516758|565918254|FG002|Overall Study|Other|0|||
156772247|NCT05516758|565918255|FG003|Overall Study|Other|0|||
156772248|NCT05516758|565918256|FG004|Overall Study|Other|0|||
156772249|NCT05516758|565918257|FG005|Overall Study|Other|0|||
156772250|NCT05516758|565918258|FG006|Overall Study|Other|1|||
156772251|NCT01316575|565918259|FG000|Overall Study|Withdrawal by Subject|2|||
156772252|NCT01316575|565918260|FG001|Overall Study|Withdrawal by Subject|0|||
156772253|NCT01316575|565918259|FG000|Overall Study|Required alternate treatment|0|||
156772254|NCT01316575|565918260|FG001|Overall Study|Required alternate treatment|1|||
156772255|NCT00402831|565918261|FG000|Overall Study|Lost to Follow-up|1|||
156772256|NCT00402831|565918262|FG001|Overall Study|Lost to Follow-up|2|||
156772257|NCT00402831|565918261|FG000|Overall Study|Non-compliance with protocol|0|||
156772258|NCT00402831|565918262|FG001|Overall Study|Non-compliance with protocol|1|||
156772259|NCT02792504|565918265|FG000|Overall Study|Lost to Follow-up|24|||
156772260|NCT02792504|565918265|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
156772261|NCT02814526|565918272|FG000|Overall Study|Adverse Event|4|||
156772262|NCT02814526|565918273|FG001|Overall Study|Adverse Event|3|||
156772263|NCT02814526|565918272|FG000|Overall Study|Death|1|||
156772264|NCT02814526|565918273|FG001|Overall Study|Death|1|||
156772265|NCT02814526|565918272|FG000|Overall Study|Lost to Follow-up|3|||
156772266|NCT02814526|565918273|FG001|Overall Study|Lost to Follow-up|4|||
156772267|NCT02814526|565918272|FG000|Overall Study|non site physician decision|1|||
156772268|NCT02814526|565918273|FG001|Overall Study|non site physician decision|0|||
156772269|NCT02814526|565918272|FG000|Overall Study|participant noncompliance|1|||
156772270|NCT02814526|565918273|FG001|Overall Study|participant noncompliance|1|||
156772271|NCT02814526|565918272|FG000|Overall Study|Withdrawal by Subject|20|||
156772272|NCT02814526|565918273|FG001|Overall Study|Withdrawal by Subject|14|||
156772273|NCT02814526|565918272|FG000|Overall Study|safety risk|2|||
156772274|NCT02814526|565918273|FG001|Overall Study|safety risk|1|||
156772275|NCT02814526|565918272|FG000|Overall Study|early termination-study terminated|1|||
156772276|NCT02814526|565918273|FG001|Overall Study|early termination-study terminated|2|||
156772277|NCT02814526|565918272|FG000|Overall Study|Other|0|||
156772278|NCT02814526|565918273|FG001|Overall Study|Other|4|||
156772279|NCT04585893|565918274|FG000|Overall Study|Death|1|||
156772280|NCT04585893|565918275|FG001|Overall Study|Death|0|||
156772281|NCT06178991|565918280|FG000|Overall Study|Withdrawal by Subject|2|||
156772282|NCT06178991|565918281|FG001|Overall Study|Withdrawal by Subject|6|||
156772283|NCT06178991|565918282|FG002|Overall Study|Withdrawal by Subject|44|||
156772284|NCT06178991|565918283|FG003|Overall Study|Withdrawal by Subject|23|||
156772285|NCT06178991|565918284|FG004|Overall Study|Withdrawal by Subject|7|||
156772286|NCT06178991|565918285|FG005|Overall Study|Withdrawal by Subject|7|||
156772287|NCT06178991|565918286|FG006|Overall Study|Withdrawal by Subject|7|||
156772288|NCT06178991|565918287|FG007|Overall Study|Withdrawal by Subject|5|||
156772289|NCT06178991|565918280|FG000|Overall Study|Lost to Follow-up|2|||
156772290|NCT06178991|565918281|FG001|Overall Study|Lost to Follow-up|4|||
156772291|NCT06178991|565918282|FG002|Overall Study|Lost to Follow-up|133|||
156772292|NCT06178991|565918283|FG003|Overall Study|Lost to Follow-up|65|||
156772293|NCT06178991|565918284|FG004|Overall Study|Lost to Follow-up|68|||
156772294|NCT06178991|565918285|FG005|Overall Study|Lost to Follow-up|57|||
156772295|NCT06178991|565918286|FG006|Overall Study|Lost to Follow-up|25|||
156772296|NCT06178991|565918287|FG007|Overall Study|Lost to Follow-up|18|||
156772297|NCT06178991|565918280|FG000|Overall Study|Death|1|||
156772298|NCT06178991|565918281|FG001|Overall Study|Death|0|||
156772299|NCT06178991|565918282|FG002|Overall Study|Death|2|||
156772300|NCT06178991|565918283|FG003|Overall Study|Death|1|||
156772301|NCT06178991|565918284|FG004|Overall Study|Death|1|||
156772302|NCT06178991|565918285|FG005|Overall Study|Death|0|||
156772303|NCT06178991|565918286|FG006|Overall Study|Death|1|||
156772304|NCT06178991|565918287|FG007|Overall Study|Death|1|||
156772305|NCT06178991|565918280|FG000|Overall Study|Randomized but not Vaccinated|4|||
156772306|NCT06178991|565918281|FG001|Overall Study|Randomized but not Vaccinated|1|||
156772307|NCT06178991|565918282|FG002|Overall Study|Randomized but not Vaccinated|15|||
156772308|NCT06178991|565918283|FG003|Overall Study|Randomized but not Vaccinated|9|||
156772309|NCT06178991|565918284|FG004|Overall Study|Randomized but not Vaccinated|8|||
156772310|NCT06178991|565918285|FG005|Overall Study|Randomized but not Vaccinated|4|||
156772311|NCT06178991|565918286|FG006|Overall Study|Randomized but not Vaccinated|2|||
156772312|NCT06178991|565918287|FG007|Overall Study|Randomized but not Vaccinated|2|||
156772313|NCT06178991|565918280|FG000|Overall Study|Other: Unspecified|0|||
156772314|NCT06178991|565918281|FG001|Overall Study|Other: Unspecified|1|||
156772315|NCT06178991|565918282|FG002|Overall Study|Other: Unspecified|7|||
156772316|NCT06178991|565918283|FG003|Overall Study|Other: Unspecified|6|||
156772317|NCT06178991|565918284|FG004|Overall Study|Other: Unspecified|1|||
156772318|NCT06178991|565918285|FG005|Overall Study|Other: Unspecified|1|||
156772319|NCT06178991|565918286|FG006|Overall Study|Other: Unspecified|1|||
156772320|NCT06178991|565918287|FG007|Overall Study|Other: Unspecified|0|||
156772321|NCT06178991|565918280|FG000|Overall Study|Physician Decision|0|||
156772322|NCT06178991|565918281|FG001|Overall Study|Physician Decision|0|||
156772323|NCT06178991|565918282|FG002|Overall Study|Physician Decision|2|||
156772324|NCT06178991|565918283|FG003|Overall Study|Physician Decision|0|||
156772325|NCT06178991|565918284|FG004|Overall Study|Physician Decision|2|||
156772326|NCT06178991|565918285|FG005|Overall Study|Physician Decision|1|||
156772327|NCT06178991|565918286|FG006|Overall Study|Physician Decision|0|||
156772328|NCT06178991|565918287|FG007|Overall Study|Physician Decision|0|||
156772329|NCT06178991|565918280|FG000|Overall Study|Protocol Violation|0|||
156772330|NCT06178991|565918281|FG001|Overall Study|Protocol Violation|0|||
156772331|NCT06178991|565918282|FG002|Overall Study|Protocol Violation|1|||
156772332|NCT06178991|565918283|FG003|Overall Study|Protocol Violation|0|||
156772333|NCT06178991|565918284|FG004|Overall Study|Protocol Violation|0|||
156772334|NCT06178991|565918285|FG005|Overall Study|Protocol Violation|0|||
156772335|NCT06178991|565918286|FG006|Overall Study|Protocol Violation|0|||
156772336|NCT06178991|565918287|FG007|Overall Study|Protocol Violation|0|||
156772337|NCT02485860|565918291|FG000|Overall Study|Lost to Follow-up|4|||
156772338|NCT02485860|565918292|FG001|Overall Study|Lost to Follow-up|1|||
156772339|NCT02485860|565918291|FG000|Overall Study|Physician Decision|1|||
156772340|NCT02485860|565918292|FG001|Overall Study|Physician Decision|2|||
156772341|NCT02485860|565918291|FG000|Overall Study|Health context (COVID-19)|1|||
156772342|NCT02485860|565918292|FG001|Overall Study|Health context (COVID-19)|0|||
156772343|NCT01366092|565918293|FG000|Overall Study|Progressive cGVHD|2|||
156772344|NCT01366092|565918293|FG000|Overall Study|Physician Decision|1|||
156772345|NCT01366092|565918293|FG000|Overall Study|Withdrawal by Subject|1|||
156772346|NCT03082729|565918297|FG000|Overall Study|Lost to Follow-up|7|||
156772347|NCT03082729|565918297|FG000|Overall Study|Physician Decision|2|||
156772348|NCT03082729|565918297|FG000|Overall Study|Withdrawal by Subject|1|||
156772349|NCT03082729|565918297|FG000|Overall Study|Lack of Efficacy|9|||
156772350|NCT03082729|565918297|FG000|Overall Study|Adverse Event|4|||
156772351|NCT03082729|565918297|FG000|Overall Study|Protocol Violation|6|||
156772352|NCT03082729|565918297|FG000|Overall Study|Fear of study procedure|1|||
156772353|NCT03082729|565918297|FG000|Overall Study|Scheduling conflict|1|||
156772354|NCT03608163|565918302|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
156772355|NCT03608163|565918303|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
156772356|NCT03454555|565919838|FG000|Overall Study|Death|6|||
156772357|NCT03454555|565919839|FG001|Overall Study|Death|6|||
156772358|NCT03454555|565919838|FG000|Overall Study|Lost to Follow-up|31|||
156772359|NCT03454555|565919839|FG001|Overall Study|Lost to Follow-up|12|||
156772360|NCT03454555|565919838|FG000|Overall Study|Physician Decision|2|||
156772361|NCT03454555|565919839|FG001|Overall Study|Physician Decision|6|||
156772362|NCT03454555|565919838|FG000|Overall Study|Withdrawal by Subject|34|||
156772363|NCT03454555|565919839|FG001|Overall Study|Withdrawal by Subject|5|||
156772364|NCT03454555|565919838|FG000|Overall Study|Ineligible|1|||
156772365|NCT03454555|565919839|FG001|Overall Study|Ineligible|5|||
156772366|NCT04770753|565919846|FG000|Overall Study|Randomized, never treated|1|||
156772367|NCT04770753|565919847|FG001|Overall Study|Randomized, never treated|1|||
156772368|NCT04770753|565919846|FG000|Overall Study|Withdrawal by Subject|3|||
156772369|NCT04770753|565919847|FG001|Overall Study|Withdrawal by Subject|1|||
156772370|NCT04770753|565919846|FG000|Overall Study|Adverse Event|2|||
156772371|NCT04770753|565919847|FG001|Overall Study|Adverse Event|0|||
156772372|NCT04770753|565919846|FG000|Overall Study|Pregnancy|1|||
156772373|NCT04770753|565919847|FG001|Overall Study|Pregnancy|0|||
156772374|NCT04770753|565919846|FG000|Overall Study|Other un-specified|1|||
156772375|NCT04770753|565919847|FG001|Overall Study|Other un-specified|0|||
156772376|NCT00788671|565919848|FG000|Overall Study|Death|2|||
156772377|NCT00788671|565919848|FG000|Overall Study|Unable to biopsy|1|||
156772378|NCT00788671|565919848|FG000|Overall Study|Withdrawal by Subject|4|||
156772379|NCT00788671|565919848|FG000|Overall Study|IUD expulsed|1|||
156772380|NCT00788671|565919848|FG000|Overall Study|Lost to follow up|2|||
156772381|NCT00375752|565919851|FG000|Overall Study|Lack of Efficacy|4|||
156772382|NCT00375752|565919852|FG001|Overall Study|Lack of Efficacy|4|||
156772383|NCT00375752|565919851|FG000|Overall Study|Adverse Event|1|||
156772384|NCT00375752|565919852|FG001|Overall Study|Adverse Event|6|||
156772385|NCT00375752|565919851|FG000|Overall Study|Withdrawal by Subject|6|||
156772386|NCT00375752|565919852|FG001|Overall Study|Withdrawal by Subject|1|||
156772387|NCT00375752|565919851|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156772388|NCT00375752|565919852|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156772389|NCT00375752|565919851|FG000|Overall Study|Protocol Violation|0|||
156772390|NCT00375752|565919852|FG001|Overall Study|Protocol Violation|2|||
156772391|NCT00375752|565919851|FG000|Overall Study|Administrative Problems|0|||
156772392|NCT00375752|565919852|FG001|Overall Study|Administrative Problems|1|||
157007204|NCT03034915|566776102|FG000|Overall Study|Adverse Event|29|||
156772393|NCT04460885|565919854|FG000|Overall Study|Withdrawal by Subject|6|||
156772394|NCT04460885|565919855|FG001|Overall Study|Withdrawal by Subject|8|||
156772395|NCT04460885|565919854|FG000|Overall Study|Site closure|1|||
156772396|NCT04460885|565919855|FG001|Overall Study|Site closure|0|||
156772397|NCT04460885|565919854|FG000|Overall Study|Death|5|||
156772398|NCT04460885|565919855|FG001|Overall Study|Death|4|||
156772399|NCT04460885|565919854|FG000|Overall Study|Physician Decision|2|||
156772400|NCT04460885|565919855|FG001|Overall Study|Physician Decision|1|||
156772401|NCT04460885|565919854|FG000|Overall Study|Lost to Follow-up|4|||
156772402|NCT04460885|565919855|FG001|Overall Study|Lost to Follow-up|4|||
156772403|NCT01140906|565919859|FG000|Overall Study|Adverse Event|7|||
156772404|NCT01140906|565919860|FG001|Overall Study|Adverse Event|10|||
156772405|NCT01140906|565919861|FG002|Overall Study|Adverse Event|17|||
156772406|NCT01140906|565919862|FG003|Overall Study|Adverse Event|7|||
156772407|NCT01140906|565919859|FG000|Overall Study|Lack of Efficacy|6|||
156772408|NCT01140906|565919860|FG001|Overall Study|Lack of Efficacy|8|||
156772409|NCT01140906|565919861|FG002|Overall Study|Lack of Efficacy|2|||
156772410|NCT01140906|565919862|FG003|Overall Study|Lack of Efficacy|1|||
156772411|NCT01140906|565919859|FG000|Overall Study|Non-compliance|0|||
156772412|NCT01140906|565919860|FG001|Overall Study|Non-compliance|1|||
156772413|NCT01140906|565919861|FG002|Overall Study|Non-compliance|0|||
156772414|NCT01140906|565919862|FG003|Overall Study|Non-compliance|1|||
156772415|NCT01140906|565919859|FG000|Overall Study|Protocol Violation|5|||
156772416|NCT01140906|565919860|FG001|Overall Study|Protocol Violation|3|||
156772417|NCT01140906|565919861|FG002|Overall Study|Protocol Violation|2|||
156772418|NCT01140906|565919862|FG003|Overall Study|Protocol Violation|1|||
156772419|NCT01140906|565919859|FG000|Overall Study|Withdrawal of consent|6|||
156772420|NCT01140906|565919860|FG001|Overall Study|Withdrawal of consent|6|||
156772421|NCT01140906|565919861|FG002|Overall Study|Withdrawal of consent|2|||
156772422|NCT01140906|565919862|FG003|Overall Study|Withdrawal of consent|2|||
156772423|NCT01140906|565919859|FG000|Overall Study|Lost to Follow-up|1|||
156772424|NCT01140906|565919860|FG001|Overall Study|Lost to Follow-up|1|||
156772425|NCT01140906|565919861|FG002|Overall Study|Lost to Follow-up|0|||
156772426|NCT01140906|565919862|FG003|Overall Study|Lost to Follow-up|2|||
156772427|NCT01140906|565919859|FG000|Overall Study|Administrative or other reason|0|||
156772428|NCT01140906|565919860|FG001|Overall Study|Administrative or other reason|5|||
156772429|NCT01140906|565919861|FG002|Overall Study|Administrative or other reason|3|||
156772430|NCT01140906|565919862|FG003|Overall Study|Administrative or other reason|2|||
156772431|NCT01649765|565919863|FG000|Overall Study|Adverse Event|5|||
156772432|NCT01649765|565919864|FG001|Overall Study|Adverse Event|3|||
156772433|NCT01649765|565919863|FG000|Overall Study|Lack of Efficacy|1|||
156772434|NCT01649765|565919864|FG001|Overall Study|Lack of Efficacy|1|||
156772435|NCT01649765|565919863|FG000|Overall Study|Physician Decision|0|||
156772436|NCT01649765|565919864|FG001|Overall Study|Physician Decision|3|||
156772437|NCT01649765|565919863|FG000|Overall Study|Protocol Violation|1|||
156772438|NCT01649765|565919864|FG001|Overall Study|Protocol Violation|0|||
156772439|NCT01649765|565919863|FG000|Overall Study|Withdrawal by Subject|2|||
156772440|NCT01649765|565919864|FG001|Overall Study|Withdrawal by Subject|1|||
156772441|NCT02469233|565919865|FG000|Overall Study|Death|1|||
156772442|NCT02469233|565919866|FG001|Overall Study|Death|1|||
156772443|NCT02469233|565919865|FG000|Overall Study|Lost to post or 6 month follow up|7|||
156772444|NCT02469233|565919866|FG001|Overall Study|Lost to post or 6 month follow up|2|||
156772445|NCT01648764|565919867|FG000|Overall Study|Progressive Disease|0|||
156772446|NCT01648764|565919868|FG001|Overall Study|Progressive Disease|1|||
156772447|NCT01648764|565919869|FG002|Overall Study|Progressive Disease|0|||
156772448|NCT01648764|565919870|FG003|Overall Study|Progressive Disease|0|||
156772449|NCT01648764|565919871|FG004|Overall Study|Progressive Disease|0|||
156772450|NCT01648764|565919872|FG005|Overall Study|Progressive Disease|1|||
156772451|NCT01648764|565919873|FG006|Overall Study|Progressive Disease|1|||
156772452|NCT01648764|565919874|FG007|Overall Study|Progressive Disease|0|||
156772453|NCT01648764|565919875|FG008|Overall Study|Progressive Disease|0|||
156772454|NCT01648764|565919876|FG009|Overall Study|Progressive Disease|2|||
156772455|NCT01648764|565919877|FG010|Overall Study|Progressive Disease|0|||
156772456|NCT01648764|565919878|FG011|Overall Study|Progressive Disease|1|||
156772457|NCT01648764|565919879|FG012|Overall Study|Progressive Disease|2|||
156772458|NCT01648764|565919880|FG013|Overall Study|Progressive Disease|1|||
156772459|NCT01648764|565919867|FG000|Overall Study|Adverse Event|0|||
156772460|NCT01648764|565919868|FG001|Overall Study|Adverse Event|0|||
156772461|NCT01648764|565919869|FG002|Overall Study|Adverse Event|0|||
156772462|NCT01648764|565919870|FG003|Overall Study|Adverse Event|0|||
156772463|NCT01648764|565919871|FG004|Overall Study|Adverse Event|0|||
156772464|NCT01648764|565919872|FG005|Overall Study|Adverse Event|1|||
156772465|NCT01648764|565919873|FG006|Overall Study|Adverse Event|0|||
156772466|NCT01648764|565919874|FG007|Overall Study|Adverse Event|0|||
156772467|NCT01648764|565919875|FG008|Overall Study|Adverse Event|0|||
156772468|NCT01648764|565919876|FG009|Overall Study|Adverse Event|1|||
156772469|NCT01648764|565919877|FG010|Overall Study|Adverse Event|0|||
156772470|NCT01648764|565919878|FG011|Overall Study|Adverse Event|3|||
156772471|NCT01648764|565919879|FG012|Overall Study|Adverse Event|1|||
156772472|NCT01648764|565919880|FG013|Overall Study|Adverse Event|1|||
156772473|NCT01648764|565919867|FG000|Overall Study|Death|0|||
156772474|NCT01648764|565919868|FG001|Overall Study|Death|0|||
156772475|NCT01648764|565919869|FG002|Overall Study|Death|0|||
156772476|NCT01648764|565919870|FG003|Overall Study|Death|0|||
156772477|NCT01648764|565919871|FG004|Overall Study|Death|0|||
156772478|NCT01648764|565919872|FG005|Overall Study|Death|0|||
156772479|NCT01648764|565919873|FG006|Overall Study|Death|1|||
156772480|NCT01648764|565919874|FG007|Overall Study|Death|0|||
156772481|NCT01648764|565919875|FG008|Overall Study|Death|0|||
156772482|NCT01648764|565919876|FG009|Overall Study|Death|0|||
156772483|NCT01648764|565919877|FG010|Overall Study|Death|0|||
156772484|NCT01648764|565919878|FG011|Overall Study|Death|0|||
156772485|NCT01648764|565919879|FG012|Overall Study|Death|0|||
156772486|NCT01648764|565919880|FG013|Overall Study|Death|1|||
156772487|NCT01648764|565919867|FG000|Overall Study|Withdrawal by Subject|0|||
156772488|NCT01648764|565919868|FG001|Overall Study|Withdrawal by Subject|0|||
156772489|NCT01648764|565919869|FG002|Overall Study|Withdrawal by Subject|0|||
156772490|NCT01648764|565919870|FG003|Overall Study|Withdrawal by Subject|0|||
156772491|NCT01648764|565919871|FG004|Overall Study|Withdrawal by Subject|0|||
156772492|NCT01648764|565919872|FG005|Overall Study|Withdrawal by Subject|0|||
156772493|NCT01648764|565919873|FG006|Overall Study|Withdrawal by Subject|2|||
156772494|NCT01648764|565919874|FG007|Overall Study|Withdrawal by Subject|0|||
156772495|NCT01648764|565919875|FG008|Overall Study|Withdrawal by Subject|0|||
156772496|NCT01648764|565919876|FG009|Overall Study|Withdrawal by Subject|0|||
156772497|NCT01648764|565919877|FG010|Overall Study|Withdrawal by Subject|0|||
156772498|NCT01648764|565919878|FG011|Overall Study|Withdrawal by Subject|0|||
156772499|NCT01648764|565919879|FG012|Overall Study|Withdrawal by Subject|1|||
156772500|NCT01648764|565919880|FG013|Overall Study|Withdrawal by Subject|0|||
156772501|NCT01648764|565919867|FG000|Overall Study|Investigator Decision|0|||
156772502|NCT01648764|565919868|FG001|Overall Study|Investigator Decision|0|||
156772503|NCT01648764|565919869|FG002|Overall Study|Investigator Decision|0|||
156772504|NCT01648764|565919870|FG003|Overall Study|Investigator Decision|0|||
156772505|NCT01648764|565919871|FG004|Overall Study|Investigator Decision|0|||
156772506|NCT01648764|565919872|FG005|Overall Study|Investigator Decision|0|||
156772507|NCT01648764|565919873|FG006|Overall Study|Investigator Decision|1|||
156772508|NCT01648764|565919874|FG007|Overall Study|Investigator Decision|0|||
156772509|NCT01648764|565919875|FG008|Overall Study|Investigator Decision|0|||
156772510|NCT01648764|565919876|FG009|Overall Study|Investigator Decision|0|||
156772511|NCT01648764|565919877|FG010|Overall Study|Investigator Decision|0|||
156772512|NCT01648764|565919878|FG011|Overall Study|Investigator Decision|1|||
156772513|NCT01648764|565919879|FG012|Overall Study|Investigator Decision|0|||
156772514|NCT01648764|565919880|FG013|Overall Study|Investigator Decision|0|||
156772515|NCT04889040|565919883|FG000|Overall Study|Withdrawal by Subject|3|||
156772516|NCT04889040|565919884|FG001|Overall Study|Withdrawal by Subject|3|||
156772517|NCT04889040|565919883|FG000|Overall Study|Lost to Follow-up|0|||
156772518|NCT04889040|565919884|FG001|Overall Study|Lost to Follow-up|1|||
156772519|NCT04889040|565919883|FG000|Overall Study|Adverse Event|2|||
156772520|NCT04889040|565919884|FG001|Overall Study|Adverse Event|1|||
156772521|NCT03801252|565919887|FG000|Overall Study|Protocol Violation|1|||
156772522|NCT03801252|565919888|FG001|Overall Study|Protocol Violation|2|||
156772523|NCT02690727|565919889|FG000|Overall Study|Adverse Event|2|||
156772524|NCT02690727|565919890|FG001|Overall Study|Adverse Event|2|||
156772525|NCT00855582|565919893|FG000|Overall Study|Adverse Event|2|||
156772526|NCT00855582|565919894|FG001|Overall Study|Adverse Event|6|||
156772527|NCT00855582|565919895|FG002|Overall Study|Adverse Event|3|||
156772528|NCT00855582|565919893|FG000|Overall Study|Death|1|||
156772529|NCT00855582|565919894|FG001|Overall Study|Death|0|||
156772530|NCT00855582|565919895|FG002|Overall Study|Death|0|||
156772531|NCT00855582|565919893|FG000|Overall Study|Lack of Efficacy|1|||
156772532|NCT00855582|565919894|FG001|Overall Study|Lack of Efficacy|3|||
156772533|NCT00855582|565919895|FG002|Overall Study|Lack of Efficacy|8|||
156772534|NCT00855582|565919893|FG000|Overall Study|Lost to Follow-up|1|||
156772535|NCT00855582|565919894|FG001|Overall Study|Lost to Follow-up|3|||
156772536|NCT00855582|565919895|FG002|Overall Study|Lost to Follow-up|1|||
156772537|NCT00855582|565919893|FG000|Overall Study|Physician Decision|0|||
156772538|NCT00855582|565919894|FG001|Overall Study|Physician Decision|0|||
156772539|NCT00855582|565919895|FG002|Overall Study|Physician Decision|1|||
156772540|NCT00855582|565919893|FG000|Overall Study|Protocol Violation|6|||
156772541|NCT00855582|565919894|FG001|Overall Study|Protocol Violation|2|||
156772542|NCT00855582|565919895|FG002|Overall Study|Protocol Violation|6|||
156772543|NCT00855582|565919893|FG000|Overall Study|Entry Criteria Not Met|8|||
156772544|NCT00855582|565919894|FG001|Overall Study|Entry Criteria Not Met|6|||
156772545|NCT00855582|565919895|FG002|Overall Study|Entry Criteria Not Met|3|||
156772546|NCT00855582|565919893|FG000|Overall Study|Withdrawal by Subject|7|||
157007205|NCT03034915|566776103|FG001|Overall Study|Adverse Event|32|||
156772547|NCT00855582|565919894|FG001|Overall Study|Withdrawal by Subject|4|||
156772548|NCT00855582|565919895|FG002|Overall Study|Withdrawal by Subject|8|||
156772549|NCT04757636|565919899|FG000|Overall Study|Adverse Event|25|||
156772550|NCT04757636|565919900|FG001|Overall Study|Adverse Event|8|||
156772551|NCT04757636|565919901|FG002|Overall Study|Adverse Event|11|||
156772552|NCT04757636|565919899|FG000|Overall Study|Death|9|||
156772553|NCT04757636|565919900|FG001|Overall Study|Death|12|||
156772554|NCT04757636|565919901|FG002|Overall Study|Death|6|||
156772555|NCT04757636|565919899|FG000|Overall Study|Lack of Efficacy|2|||
156772556|NCT04757636|565919900|FG001|Overall Study|Lack of Efficacy|0|||
156772557|NCT04757636|565919901|FG002|Overall Study|Lack of Efficacy|0|||
156772558|NCT04757636|565919899|FG000|Overall Study|Lost to Follow-up|1|||
156772559|NCT04757636|565919900|FG001|Overall Study|Lost to Follow-up|6|||
156772560|NCT04757636|565919901|FG002|Overall Study|Lost to Follow-up|7|||
156772561|NCT04757636|565919899|FG000|Overall Study|Physician Decision|1|||
156772562|NCT04757636|565919900|FG001|Overall Study|Physician Decision|3|||
156772563|NCT04757636|565919901|FG002|Overall Study|Physician Decision|4|||
156772564|NCT04757636|565919899|FG000|Overall Study|Withdrawal by Subject|20|||
156772565|NCT04757636|565919900|FG001|Overall Study|Withdrawal by Subject|23|||
156772566|NCT04757636|565919901|FG002|Overall Study|Withdrawal by Subject|18|||
156772567|NCT04757636|565919899|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
156772568|NCT04757636|565919900|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
156772569|NCT04757636|565919901|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
156772570|NCT04757636|565919899|FG000|Overall Study|Study Terminated by Sponsor|103|||
156772571|NCT04757636|565919900|FG001|Overall Study|Study Terminated by Sponsor|104|||
156772572|NCT04757636|565919901|FG002|Overall Study|Study Terminated by Sponsor|114|||
156772573|NCT04757636|565919899|FG000|Overall Study|Sponsor Decision|0|||
156772574|NCT04757636|565919900|FG001|Overall Study|Sponsor Decision|0|||
156772575|NCT04757636|565919901|FG002|Overall Study|Sponsor Decision|1|||
156772576|NCT04757636|565919899|FG000|Overall Study|Randomized in Error|0|||
156772577|NCT04757636|565919900|FG001|Overall Study|Randomized in Error|0|||
156772578|NCT04757636|565919901|FG002|Overall Study|Randomized in Error|2|||
156772579|NCT01732692|565919905|FG000|Overall Study|Adverse Event|0|||
156772580|NCT01732692|565919906|FG001|Overall Study|Adverse Event|1|||
156772581|NCT00656617|565919907|FG000|Overall Study|Adverse Event|1|||
156772582|NCT00656617|565919907|FG000|Overall Study|Death|2|||
156772583|NCT00656617|565919907|FG000|Overall Study|Insurance Issues|2|||
156772584|NCT00656617|565919907|FG000|Overall Study|Move to different clinical trial|2|||
156772585|NCT01155323|565919914|FG000|First Intervention|exclusion criteria|1|||
156772586|NCT01155323|565919915|FG001|First Intervention|exclusion criteria|1|||
156772587|NCT01155323|565919914|FG000|Second Intervention|Lost to Follow-up|1|||
156772588|NCT01155323|565919915|FG001|Second Intervention|Lost to Follow-up|1|||
156772589|NCT01208051|565919916|FG000|Total Enrollment|Withdrawal by Subject|0|||
156772590|NCT01208051|565919917|FG001|Total Enrollment|Withdrawal by Subject|1|||
156772591|NCT01208051|565919918|FG002|Total Enrollment|Withdrawal by Subject|0|||
156772592|NCT01208051|565919919|FG003|Total Enrollment|Withdrawal by Subject|0|||
156772593|NCT01208051|565919920|FG004|Total Enrollment|Withdrawal by Subject|2|||
156772594|NCT01208051|565919916|FG000|Total Enrollment|Brain metastases|0|||
156772595|NCT01208051|565919917|FG001|Total Enrollment|Brain metastases|0|||
156772596|NCT01208051|565919918|FG002|Total Enrollment|Brain metastases|1|||
156772597|NCT01208051|565919919|FG003|Total Enrollment|Brain metastases|0|||
156772598|NCT01208051|565919920|FG004|Total Enrollment|Brain metastases|0|||
156772599|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
156772600|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
156772601|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
156772602|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
156772603|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
156772604|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
156772605|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
156772606|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
156772607|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
156772608|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
156772609|NCT00973973|565919921|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
156772610|NCT00973973|565919922|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
156772611|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
156772612|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
156772613|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
156772614|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
156772615|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
156772616|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
156772617|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
156772618|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
156772619|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
156772620|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
156772621|NCT00973973|565919921|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
156772622|NCT00973973|565919922|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
156772623|NCT02471339|565919923|FG000|Overall Study|Did not provide follow-up data|2|||
156772624|NCT02471339|565919924|FG001|Overall Study|Did not provide follow-up data|0|||
156772625|NCT06057064|565919925|FG000|Overall Study|Death|2|||
156772626|NCT06057064|565919926|FG001|Overall Study|Death|0|||
156772627|NCT06057064|565919925|FG000|Overall Study|Physician Decision|1|||
156772628|NCT06057064|565919926|FG001|Overall Study|Physician Decision|0|||
156772629|NCT06057064|565919925|FG000|Overall Study|Withdrawal by Subject|1|||
156772630|NCT06057064|565919926|FG001|Overall Study|Withdrawal by Subject|1|||
156772631|NCT00851591|565919928|FG000|Overall Study|Withdrawal by Subject|2|||
156772632|NCT00851591|565919929|FG001|Overall Study|Withdrawal by Subject|0|||
156772633|NCT00746551|565919939|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
156772634|NCT00746551|565919940|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
156772635|NCT00746551|565919939|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
156772636|NCT00746551|565919940|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
156772637|NCT00746551|565919939|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
156772638|NCT00746551|565919940|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
156772639|NCT01114724|565919945|FG000|Overall Study|Death|8|||
156772640|NCT01114724|565919945|FG000|Overall Study|Lost to Follow-up|1|||
156772641|NCT01114724|565919945|FG000|Overall Study|Withdrawal by Subject|1|||
156772642|NCT02273167|565919948|FG000|Overall Study|Adverse Event|1|||
156772643|NCT02273167|565919949|FG001|Overall Study|Adverse Event|0|||
156772644|NCT02273167|565919950|FG002|Overall Study|Adverse Event|0|||
156772645|NCT02273167|565919948|FG000|Overall Study|Protocol Violation|3|||
156772646|NCT02273167|565919949|FG001|Overall Study|Protocol Violation|1|||
156772647|NCT02273167|565919950|FG002|Overall Study|Protocol Violation|1|||
156772648|NCT02273167|565919948|FG000|Overall Study|Lost to Follow-up|0|||
156772649|NCT02273167|565919949|FG001|Overall Study|Lost to Follow-up|1|||
156772650|NCT02273167|565919950|FG002|Overall Study|Lost to Follow-up|1|||
156772651|NCT02273167|565919948|FG000|Overall Study|Withdrawal by Subject|10|||
156772652|NCT02273167|565919949|FG001|Overall Study|Withdrawal by Subject|12|||
156772653|NCT02273167|565919950|FG002|Overall Study|Withdrawal by Subject|11|||
156772654|NCT02273167|565919948|FG000|Overall Study|Various|10|||
156772655|NCT02273167|565919949|FG001|Overall Study|Various|9|||
156772656|NCT02273167|565919950|FG002|Overall Study|Various|8|||
156772657|NCT00834041|565919954|FG000|Overall Study|Withdrawal by Subject|1|||
156772658|NCT00834041|565919955|FG001|Overall Study|Withdrawal by Subject|0|||
156772659|NCT00834041|565919954|FG000|Overall Study|Lost to Follow-up|0|||
156772660|NCT00834041|565919955|FG001|Overall Study|Lost to Follow-up|1|||
156772661|NCT03074500|565919956|FG000|Overall Study|Lost to Follow-up|1|||
156772662|NCT03074500|565919957|FG001|Overall Study|Lost to Follow-up|0|||
156772663|NCT03074500|565919958|FG002|Overall Study|Lost to Follow-up|0|||
156772664|NCT03074500|565919956|FG000|Overall Study|Lack of Efficacy|0|||
156772665|NCT03074500|565919957|FG001|Overall Study|Lack of Efficacy|1|||
156772666|NCT03074500|565919958|FG002|Overall Study|Lack of Efficacy|0|||
156772667|NCT03074500|565919956|FG000|Overall Study|Adverse Event|0|||
156772668|NCT03074500|565919957|FG001|Overall Study|Adverse Event|0|||
156772669|NCT03074500|565919958|FG002|Overall Study|Adverse Event|1|||
156772670|NCT01416571|565919959|FG000|Overall Study|Lost to Follow-up|2|||
156772671|NCT03353220|565919965|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
156772672|NCT03353220|565919966|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
156772673|NCT03586479|565919967|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
156772674|NCT03586479|565919968|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
156772675|NCT03586479|565919969|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
156772676|NCT03586479|565919967|FG000|Overall Study|Protocol Violation|2|||
156772677|NCT03586479|565919968|FG001|Overall Study|Protocol Violation|0|||
156772678|NCT03586479|565919969|FG002|Overall Study|Protocol Violation|0|||
156772679|NCT03586479|565919967|FG000|Overall Study|Lost to Follow-up|1|||
156772680|NCT03586479|565919968|FG001|Overall Study|Lost to Follow-up|1|||
156772681|NCT03586479|565919969|FG002|Overall Study|Lost to Follow-up|2|||
156772682|NCT03586479|565919967|FG000|Overall Study|Behavioral Issues|1|||
156772683|NCT03586479|565919968|FG001|Overall Study|Behavioral Issues|0|||
156772684|NCT03586479|565919969|FG002|Overall Study|Behavioral Issues|0|||
156772685|NCT01288430|565921118|FG000|Part 1|Progressive disease|2|||
156772686|NCT01288430|565921119|FG001|Part 1|Progressive disease|1|||
156772687|NCT01288430|565921120|FG002|Part 1|Progressive disease|1|||
156772688|NCT01288430|565921121|FG003|Part 1|Progressive disease|6|||
156772689|NCT01288430|565921122|FG004|Part 1|Progressive disease|2|||
156772690|NCT01288430|565921123|FG005|Part 1|Progressive disease|4|||
156772691|NCT01288430|565921124|FG006|Part 1|Progressive disease|2|||
156772692|NCT01288430|565921125|FG007|Part 1|Progressive disease|0|||
156772693|NCT01288430|565921126|FG008|Part 1|Progressive disease|0|||
156772694|NCT01288430|565921127|FG009|Part 1|Progressive disease|0|||
156772695|NCT01288430|565921118|FG000|Part 1|Clinical disease progression|0|||
156772696|NCT01288430|565921119|FG001|Part 1|Clinical disease progression|0|||
156772697|NCT01288430|565921120|FG002|Part 1|Clinical disease progression|1|||
156772698|NCT01288430|565921121|FG003|Part 1|Clinical disease progression|0|||
156772699|NCT01288430|565921122|FG004|Part 1|Clinical disease progression|0|||
156772700|NCT01288430|565921123|FG005|Part 1|Clinical disease progression|2|||
156772701|NCT01288430|565921124|FG006|Part 1|Clinical disease progression|2|||
157113223|NCT02819635|567170169|FG010|Substudy 3|Adverse Event|12|||
157113224|NCT02819635|567170170|FG011|Substudy 3|Adverse Event|18|||
156772702|NCT01288430|565921125|FG007|Part 1|Clinical disease progression|0|||
156772703|NCT01288430|565921126|FG008|Part 1|Clinical disease progression|0|||
156772704|NCT01288430|565921127|FG009|Part 1|Clinical disease progression|0|||
156772705|NCT01288430|565921118|FG000|Part 1|Death due to disease progression|0|||
156772706|NCT01288430|565921119|FG001|Part 1|Death due to disease progression|0|||
156772707|NCT01288430|565921120|FG002|Part 1|Death due to disease progression|0|||
156772708|NCT01288430|565921121|FG003|Part 1|Death due to disease progression|0|||
156772709|NCT01288430|565921122|FG004|Part 1|Death due to disease progression|1|||
156772710|NCT01288430|565921123|FG005|Part 1|Death due to disease progression|0|||
156772711|NCT01288430|565921124|FG006|Part 1|Death due to disease progression|0|||
156772712|NCT01288430|565921125|FG007|Part 1|Death due to disease progression|0|||
156772713|NCT01288430|565921126|FG008|Part 1|Death due to disease progression|0|||
156772714|NCT01288430|565921127|FG009|Part 1|Death due to disease progression|0|||
156772715|NCT01288430|565921118|FG000|Part 1|Adverse Event|0|||
156772716|NCT01288430|565921119|FG001|Part 1|Adverse Event|0|||
156772717|NCT01288430|565921120|FG002|Part 1|Adverse Event|3|||
156772718|NCT01288430|565921121|FG003|Part 1|Adverse Event|1|||
156772719|NCT01288430|565921122|FG004|Part 1|Adverse Event|0|||
156772720|NCT01288430|565921123|FG005|Part 1|Adverse Event|0|||
156772721|NCT01288430|565921124|FG006|Part 1|Adverse Event|2|||
156772722|NCT01288430|565921125|FG007|Part 1|Adverse Event|0|||
156772723|NCT01288430|565921126|FG008|Part 1|Adverse Event|0|||
156772724|NCT01288430|565921127|FG009|Part 1|Adverse Event|0|||
156772725|NCT01288430|565921118|FG000|Part 1|Other|0|||
156772726|NCT01288430|565921119|FG001|Part 1|Other|2|||
156772727|NCT01288430|565921120|FG002|Part 1|Other|0|||
156772728|NCT01288430|565921121|FG003|Part 1|Other|0|||
156772729|NCT01288430|565921122|FG004|Part 1|Other|0|||
156772730|NCT01288430|565921123|FG005|Part 1|Other|0|||
156772731|NCT01288430|565921124|FG006|Part 1|Other|1|||
156772732|NCT01288430|565921125|FG007|Part 1|Other|0|||
156772733|NCT01288430|565921126|FG008|Part 1|Other|0|||
156772734|NCT01288430|565921127|FG009|Part 1|Other|0|||
156772735|NCT01288430|565921118|FG000|Part 2|Progressive disease|0|||
156772736|NCT01288430|565921119|FG001|Part 2|Progressive disease|0|||
156772737|NCT01288430|565921120|FG002|Part 2|Progressive disease|0|||
156772738|NCT01288430|565921121|FG003|Part 2|Progressive disease|0|||
156772739|NCT01288430|565921122|FG004|Part 2|Progressive disease|0|||
156772740|NCT01288430|565921123|FG005|Part 2|Progressive disease|0|||
156772741|NCT01288430|565921124|FG006|Part 2|Progressive disease|0|||
156772742|NCT01288430|565921125|FG007|Part 2|Progressive disease|8|||
156772743|NCT01288430|565921126|FG008|Part 2|Progressive disease|7|||
156772744|NCT01288430|565921127|FG009|Part 2|Progressive disease|2|||
156772745|NCT01288430|565921118|FG000|Part 2|Clinical disease progression|0|||
156772746|NCT01288430|565921119|FG001|Part 2|Clinical disease progression|0|||
156772747|NCT01288430|565921120|FG002|Part 2|Clinical disease progression|0|||
156772748|NCT01288430|565921121|FG003|Part 2|Clinical disease progression|0|||
156772749|NCT01288430|565921122|FG004|Part 2|Clinical disease progression|0|||
156772750|NCT01288430|565921123|FG005|Part 2|Clinical disease progression|0|||
156772751|NCT01288430|565921124|FG006|Part 2|Clinical disease progression|0|||
156772752|NCT01288430|565921125|FG007|Part 2|Clinical disease progression|2|||
156772753|NCT01288430|565921126|FG008|Part 2|Clinical disease progression|0|||
156772754|NCT01288430|565921127|FG009|Part 2|Clinical disease progression|0|||
156772755|NCT01288430|565921118|FG000|Part 2|Withdrawal by Subject|0|||
156772756|NCT01288430|565921119|FG001|Part 2|Withdrawal by Subject|0|||
156772757|NCT01288430|565921120|FG002|Part 2|Withdrawal by Subject|0|||
156772758|NCT01288430|565921121|FG003|Part 2|Withdrawal by Subject|0|||
156772759|NCT01288430|565921122|FG004|Part 2|Withdrawal by Subject|0|||
156772760|NCT01288430|565921123|FG005|Part 2|Withdrawal by Subject|0|||
157113225|NCT02819635|567170159|FG000|Substudy 3|Withdrew consent|0|||
156772761|NCT01288430|565921124|FG006|Part 2|Withdrawal by Subject|0|||
156772762|NCT01288430|565921125|FG007|Part 2|Withdrawal by Subject|1|||
156772763|NCT01288430|565921126|FG008|Part 2|Withdrawal by Subject|4|||
156772764|NCT01288430|565921127|FG009|Part 2|Withdrawal by Subject|0|||
156772765|NCT01288430|565921118|FG000|Part 2|Adverse Event|0|||
156772766|NCT01288430|565921119|FG001|Part 2|Adverse Event|0|||
156772767|NCT01288430|565921120|FG002|Part 2|Adverse Event|0|||
156772768|NCT01288430|565921121|FG003|Part 2|Adverse Event|0|||
156772769|NCT01288430|565921122|FG004|Part 2|Adverse Event|0|||
156772770|NCT01288430|565921123|FG005|Part 2|Adverse Event|0|||
156772771|NCT01288430|565921124|FG006|Part 2|Adverse Event|0|||
156772772|NCT01288430|565921125|FG007|Part 2|Adverse Event|1|||
157113226|NCT02819635|567170160|FG001|Substudy 3|Withdrew consent|0|||
157113227|NCT02819635|567170161|FG002|Substudy 3|Withdrew consent|0|||
156772773|NCT01288430|565921126|FG008|Part 2|Adverse Event|1|||
156772774|NCT01288430|565921127|FG009|Part 2|Adverse Event|0|||
156772775|NCT01288430|565921118|FG000|Part 2|Other|0|||
156772776|NCT01288430|565921119|FG001|Part 2|Other|0|||
156772777|NCT01288430|565921120|FG002|Part 2|Other|0|||
156772778|NCT01288430|565921121|FG003|Part 2|Other|0|||
156772779|NCT01288430|565921122|FG004|Part 2|Other|0|||
156772780|NCT01288430|565921123|FG005|Part 2|Other|0|||
156772781|NCT01288430|565921124|FG006|Part 2|Other|0|||
156772782|NCT01288430|565921125|FG007|Part 2|Other|0|||
156772783|NCT01288430|565921126|FG008|Part 2|Other|0|||
156772784|NCT01288430|565921127|FG009|Part 2|Other|1|||
156772785|NCT05493111|565921128|FG000|Overall Study|Adverse Event|3|||
156772786|NCT05493111|565921129|FG001|Overall Study|Adverse Event|4|||
156772787|NCT05493111|565921128|FG000|Overall Study|Withdrawal of Consent|19|||
156772788|NCT05493111|565921129|FG001|Overall Study|Withdrawal of Consent|10|||
156772789|NCT05493111|565921128|FG000|Overall Study|Non-compliance|1|||
156772790|NCT05493111|565921129|FG001|Overall Study|Non-compliance|1|||
156772791|NCT05493111|565921128|FG000|Overall Study|Lost to Follow-up|8|||
156772792|NCT05493111|565921129|FG001|Overall Study|Lost to Follow-up|1|||
156772793|NCT05493111|565921128|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
156772794|NCT05493111|565921129|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
156772795|NCT05493111|565921128|FG000|Overall Study|Withdrawal by Subject|1|||
156772796|NCT05493111|565921129|FG001|Overall Study|Withdrawal by Subject|1|||
156772797|NCT03836053|565921132|FG000|Overall Study|Protocol-specified criteria|0|||
157007206|NCT03034915|566776104|FG002|Overall Study|Adverse Event|22|||
156772798|NCT03836053|565921133|FG001|Overall Study|Protocol-specified criteria|2|||
156772799|NCT03836053|565921134|FG002|Overall Study|Protocol-specified criteria|1|||
156772800|NCT03836053|565921132|FG000|Overall Study|Death|1|||
156772801|NCT03836053|565921133|FG001|Overall Study|Death|6|||
156772802|NCT03836053|565921134|FG002|Overall Study|Death|4|||
156772803|NCT03836053|565921132|FG000|Overall Study|Withdrawal of consent from study|0|||
156772804|NCT03836053|565921133|FG001|Overall Study|Withdrawal of consent from study|0|||
156772805|NCT03836053|565921134|FG002|Overall Study|Withdrawal of consent from study|1|||
156772806|NCT03836053|565921132|FG000|Overall Study|Decision by sponsor|0|||
156772807|NCT03836053|565921133|FG001|Overall Study|Decision by sponsor|2|||
156772808|NCT03836053|565921134|FG002|Overall Study|Decision by sponsor|4|||
156772809|NCT04486716|565921135|FG000|Core Phase|Subject decision|6|||
156772810|NCT04486716|565921135|FG000|Core Phase|Adverse Event|5|||
156772811|NCT04486716|565921135|FG000|Core Phase|Lost to Follow-up|1|||
156772812|NCT04486716|565921135|FG000|Core Phase|Physician Decision|1|||
156772813|NCT04486716|565921135|FG000|Core Phase|Enrolled subjects not treated|9|||
156772814|NCT02807259|565921136|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
156772815|NCT02807259|565921137|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
156772816|NCT02807259|565921136|FG000|Midline (3 Months)|migration, refusal, not available|30|||
156772817|NCT02807259|565921137|FG001|Midline (3 Months)|migration, refusal, not available|34|||
156772818|NCT02807259|565921136|FG000|Endline (3 Months)|migration, refusal, not available|35|||
156772819|NCT02807259|565921137|FG001|Endline (3 Months)|migration, refusal, not available|87|||
156772820|NCT04761822|565921140|FG000|Overall Study|Adverse Event|3|||
156772821|NCT04761822|565921141|FG001|Overall Study|Adverse Event|1|||
156772822|NCT04761822|565921142|FG002|Overall Study|Adverse Event|1|||
156772823|NCT04761822|565921143|FG003|Overall Study|Adverse Event|3|||
156772824|NCT04761822|565921140|FG000|Overall Study|Lost to Follow-up|1|||
156772825|NCT04761822|565921141|FG001|Overall Study|Lost to Follow-up|0|||
156772826|NCT04761822|565921142|FG002|Overall Study|Lost to Follow-up|2|||
156772827|NCT04761822|565921143|FG003|Overall Study|Lost to Follow-up|3|||
156772828|NCT04761822|565921140|FG000|Overall Study|Physician Decision|0|||
156772829|NCT04761822|565921141|FG001|Overall Study|Physician Decision|1|||
156772830|NCT04761822|565921142|FG002|Overall Study|Physician Decision|0|||
156772831|NCT04761822|565921143|FG003|Overall Study|Physician Decision|0|||
156772832|NCT04761822|565921140|FG000|Overall Study|Withdrawal by Subject|3|||
156772833|NCT04761822|565921141|FG001|Overall Study|Withdrawal by Subject|8|||
156772834|NCT04761822|565921142|FG002|Overall Study|Withdrawal by Subject|1|||
156772835|NCT04761822|565921143|FG003|Overall Study|Withdrawal by Subject|11|||
156772836|NCT04761822|565921140|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
156772837|NCT04761822|565921141|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772838|NCT04761822|565921142|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772839|NCT04761822|565921143|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
156772840|NCT04761822|565921140|FG000|Overall Study|Participant requested unblinding|0|||
156772841|NCT04761822|565921141|FG001|Overall Study|Participant requested unblinding|0|||
156772842|NCT04761822|565921142|FG002|Overall Study|Participant requested unblinding|0|||
156772843|NCT04761822|565921143|FG003|Overall Study|Participant requested unblinding|1|||
156772844|NCT02233413|565921144|FG000|Overall Study|Lost to Follow-up|7|||
156772845|NCT02233413|565921145|FG001|Overall Study|Lost to Follow-up|9|||
156772846|NCT02233413|565921144|FG000|Overall Study|Withdrawal by Subject|4|||
156772847|NCT02233413|565921145|FG001|Overall Study|Withdrawal by Subject|5|||
157007207|NCT03034915|566776102|FG000|Overall Study|Lost to Follow-up|5|||
156772848|NCT04476043|565921150|FG000|Overall Study|Withdrawal by Subject|1|||
156772849|NCT04476043|565921151|FG001|Overall Study|Withdrawal by Subject|3|||
156772850|NCT04476043|565921152|FG002|Overall Study|Withdrawal by Subject|4|||
156772851|NCT04476043|565921153|FG003|Overall Study|Withdrawal by Subject|1|||
157007208|NCT03034915|566776103|FG001|Overall Study|Lost to Follow-up|13|||
157007209|NCT03034915|566776104|FG002|Overall Study|Lost to Follow-up|3|||
156772852|NCT04476043|565921150|FG000|Overall Study|Lost to Follow-up|1|||
156772853|NCT04476043|565921151|FG001|Overall Study|Lost to Follow-up|1|||
156772854|NCT04476043|565921152|FG002|Overall Study|Lost to Follow-up|2|||
156772855|NCT04476043|565921153|FG003|Overall Study|Lost to Follow-up|1|||
156772856|NCT04476043|565921150|FG000|Overall Study|Adverse Event|2|||
156772857|NCT04476043|565921151|FG001|Overall Study|Adverse Event|0|||
156772858|NCT04476043|565921152|FG002|Overall Study|Adverse Event|1|||
156772859|NCT04476043|565921153|FG003|Overall Study|Adverse Event|0|||
156772860|NCT04476043|565921150|FG000|Overall Study|Protocol Violation|0|||
156772861|NCT04476043|565921151|FG001|Overall Study|Protocol Violation|1|||
156772862|NCT04476043|565921152|FG002|Overall Study|Protocol Violation|0|||
156772863|NCT04476043|565921153|FG003|Overall Study|Protocol Violation|0|||
156772864|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
156772865|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
156772866|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
156772867|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
156772868|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
156772869|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
156772870|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
156772871|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
156772872|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772873|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772874|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
156772875|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
156772876|NCT02349386|565921154|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772877|NCT02349386|565921155|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772878|NCT02349386|565921156|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
156772879|NCT02349386|565921157|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
156772880|NCT02349386|565921154|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
156772881|NCT02349386|565921155|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
156772882|NCT02349386|565921156|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
156772883|NCT02349386|565921157|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
156772884|NCT02349386|565921154|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772885|NCT02349386|565921155|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772886|NCT02349386|565921156|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
156772887|NCT02349386|565921157|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
156772888|NCT02736617|565921158|FG000|Treatment|Adverse Event|1|||
156772889|NCT02736617|565921158|FG000|Treatment|Lack of Efficacy|1|||
156772890|NCT02736617|565921158|FG000|Treatment|Withdrawal by Subject|1|||
156772891|NCT02736617|565921158|FG000|Maintenance|Lack of Efficacy|4|||
156772892|NCT02736617|565921158|FG000|Maintenance|Physician Decision|1|||
156772893|NCT02110693|565921159|FG000|Overall Study|Withdrawal by Subject|6|||
156772894|NCT02110693|565921160|FG001|Overall Study|Withdrawal by Subject|7|||
156772895|NCT02110693|565921159|FG000|Overall Study|skipped assessment|15|||
156772896|NCT02110693|565921160|FG001|Overall Study|skipped assessment|18|||
156772897|NCT02110693|565921159|FG000|Overall Study|technical difficulties|6|||
156772898|NCT02110693|565921160|FG001|Overall Study|technical difficulties|4|||
156772899|NCT02110693|565921159|FG000|Overall Study|Other|1|||
156772900|NCT02110693|565921160|FG001|Overall Study|Other|0|||
156772901|NCT00920816|565921161|FG000|Overall Study|Death|116|||
156772902|NCT00920816|565921162|FG001|Overall Study|Death|63|||
156772903|NCT00920816|565921163|FG002|Overall Study|Death|8|||
156772904|NCT00920816|565921164|FG003|Overall Study|Death|3|||
156772905|NCT00920816|565921161|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
156772906|NCT00920816|565921162|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
156772907|NCT00920816|565921163|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
156772908|NCT00920816|565921164|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
156772909|NCT00920816|565921161|FG000|Overall Study|Global deterioration of health status|2|||
156772910|NCT00920816|565921162|FG001|Overall Study|Global deterioration of health status|0|||
156772911|NCT00920816|565921163|FG002|Overall Study|Global deterioration of health status|0|||
156772912|NCT00920816|565921164|FG003|Overall Study|Global deterioration of health status|0|||
156772913|NCT00920816|565921161|FG000|Overall Study|Objective progression or relapse|6|||
156772914|NCT00920816|565921162|FG001|Overall Study|Objective progression or relapse|2|||
156772915|NCT00920816|565921163|FG002|Overall Study|Objective progression or relapse|0|||
156772916|NCT00920816|565921164|FG003|Overall Study|Objective progression or relapse|0|||
156772917|NCT00920816|565921161|FG000|Overall Study|Other|26|||
156772918|NCT00920816|565921162|FG001|Overall Study|Other|15|||
156772919|NCT00920816|565921163|FG002|Overall Study|Other|1|||
156772920|NCT00920816|565921164|FG003|Overall Study|Other|2|||
156772921|NCT00920816|565921161|FG000|Overall Study|Lost to Follow-up|11|||
156772922|NCT00920816|565921162|FG001|Overall Study|Lost to Follow-up|2|||
156772923|NCT00920816|565921163|FG002|Overall Study|Lost to Follow-up|0|||
156772924|NCT00920816|565921164|FG003|Overall Study|Lost to Follow-up|0|||
156772925|NCT00920816|565921161|FG000|Overall Study|Adverse Event|1|||
156772926|NCT00920816|565921162|FG001|Overall Study|Adverse Event|1|||
156772927|NCT00920816|565921163|FG002|Overall Study|Adverse Event|1|||
156772928|NCT00920816|565921164|FG003|Overall Study|Adverse Event|0|||
156772929|NCT00920816|565921161|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
156772930|NCT00920816|565921162|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
156772931|NCT00920816|565921163|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
156772932|NCT00920816|565921164|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
156772933|NCT00920816|565921161|FG000|Overall Study|Randomized but not treated|3|||
156772934|NCT00920816|565921162|FG001|Overall Study|Randomized but not treated|0|||
156772935|NCT00920816|565921163|FG002|Overall Study|Randomized but not treated|0|||
156772936|NCT00920816|565921164|FG003|Overall Study|Randomized but not treated|0|||
156772937|NCT01180777|565921165|FG000|Overall Study|Protocol Violation|6|||
156772938|NCT01180777|565921165|FG000|Overall Study|Poor lens fit|4|||
156772939|NCT01180777|565921165|FG000|Overall Study|Lost to Follow-up|1|||
156772940|NCT01180777|565921165|FG000|Overall Study|Adverse Event|1|||
156772941|NCT02606253|565921166|FG000|Overall Study|Adverse Event|2|||
156772942|NCT02606253|565921167|FG001|Overall Study|Adverse Event|0|||
156772943|NCT02606253|565921168|FG002|Overall Study|Adverse Event|0|||
156772944|NCT02606253|565921166|FG000|Overall Study|Protocol Violation|2|||
156772945|NCT02606253|565921167|FG001|Overall Study|Protocol Violation|1|||
156772946|NCT02606253|565921168|FG002|Overall Study|Protocol Violation|0|||
156772947|NCT02606253|565921166|FG000|Overall Study|Physician Decision|1|||
156772948|NCT02606253|565921167|FG001|Overall Study|Physician Decision|1|||
156772949|NCT02606253|565921168|FG002|Overall Study|Physician Decision|0|||
156772950|NCT01311661|565921169|FG000|Overall Study|Adverse Event|2|||
156772951|NCT01311661|565921169|FG000|Overall Study|Protocol Violation|3|||
156772952|NCT01311661|565921169|FG000|Overall Study|Withdrawal by Subject|2|||
156772953|NCT00284856|565921170|FG000|Overall Study|Adverse Event|3|||
156772954|NCT00284856|565921171|FG001|Overall Study|Adverse Event|3|||
156772955|NCT00284856|565921172|FG002|Overall Study|Adverse Event|3|||
156772956|NCT00284856|565921170|FG000|Overall Study|Lack of Efficacy|2|||
156772957|NCT00284856|565921171|FG001|Overall Study|Lack of Efficacy|1|||
156772958|NCT00284856|565921172|FG002|Overall Study|Lack of Efficacy|8|||
156772959|NCT00284856|565921170|FG000|Overall Study|Lost to Follow-up|25|||
156772960|NCT00284856|565921171|FG001|Overall Study|Lost to Follow-up|21|||
156772961|NCT00284856|565921172|FG002|Overall Study|Lost to Follow-up|22|||
156772962|NCT00284856|565921170|FG000|Overall Study|Protocol Violation|5|||
156772963|NCT00284856|565921171|FG001|Overall Study|Protocol Violation|4|||
156772964|NCT00284856|565921172|FG002|Overall Study|Protocol Violation|5|||
156772965|NCT00284856|565921170|FG000|Overall Study|Withdrawal by Subject|12|||
156772966|NCT00284856|565921171|FG001|Overall Study|Withdrawal by Subject|16|||
156772967|NCT00284856|565921172|FG002|Overall Study|Withdrawal by Subject|18|||
156772968|NCT00284856|565921170|FG000|Overall Study|Other|4|||
156772969|NCT00284856|565921171|FG001|Overall Study|Other|5|||
156772970|NCT00284856|565921172|FG002|Overall Study|Other|4|||
156772971|NCT03426878|565921173|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
156772972|NCT03426878|565921173|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
156772973|NCT03426878|565921173|FG000|Overall Study|Declined to receive results|3|||
156772974|NCT03426878|565921173|FG000|Overall Study|Received negative results by mailed letter|65|||
156772975|NCT03426878|565921173|FG000|Overall Study|Lost to Follow-up|177|||
156772976|NCT05082025|565921175|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
156772977|NCT00869960|565921176|FG000|Overall Study|Lost to Follow-up|2|||
156772978|NCT04428151|565921177|FG000|Overall Study|Death|100|||
156772979|NCT04428151|565921178|FG001|Overall Study|Death|86|||
156772980|NCT04428151|565921179|FG002|Overall Study|Death|57|||
156772981|NCT04428151|565921177|FG000|Overall Study|Lost to Follow-up|1|||
156772982|NCT04428151|565921178|FG001|Overall Study|Lost to Follow-up|1|||
156772983|NCT04428151|565921179|FG002|Overall Study|Lost to Follow-up|0|||
156772984|NCT04428151|565921177|FG000|Overall Study|Withdrawal by Subject|2|||
156772985|NCT04428151|565921178|FG001|Overall Study|Withdrawal by Subject|2|||
156772986|NCT04428151|565921179|FG002|Overall Study|Withdrawal by Subject|3|||
156772987|NCT04428151|565921177|FG000|Overall Study|Participant Ongoing in Study|41|||
156772988|NCT04428151|565921178|FG001|Overall Study|Participant Ongoing in Study|53|||
156772989|NCT04428151|565921179|FG002|Overall Study|Participant Ongoing in Study|28|||
156772990|NCT00671788|565921180|FG000|Overall Study|Adverse Event|8|||
156772991|NCT00671788|565921180|FG000|Overall Study|Refused further treatment|3|||
156772992|NCT00671788|565921180|FG000|Overall Study|Ineligible|1|||
156772993|NCT00671788|565921180|FG000|Overall Study|MD Decision|1|||
156772994|NCT00671788|565921180|FG000|Overall Study|Other|1|||
156772995|NCT04739800|565921181|FG000|Overall Study|Adverse Event|2|||
156772996|NCT04739800|565921182|FG001|Overall Study|Adverse Event|1|||
156772997|NCT04739800|565921183|FG002|Overall Study|Adverse Event|4|||
156772998|NCT04739800|565921184|FG003|Overall Study|Adverse Event|5|||
156772999|NCT04739800|565921181|FG000|Overall Study|Never Treated|2|||
156773000|NCT04739800|565921182|FG001|Overall Study|Never Treated|0|||
156773001|NCT04739800|565921183|FG002|Overall Study|Never Treated|1|||
156773002|NCT04739800|565921184|FG003|Overall Study|Never Treated|1|||
156773003|NCT04739800|565921181|FG000|Overall Study|On Treatment|5|||
156773004|NCT04739800|565921182|FG001|Overall Study|On Treatment|9|||
156773005|NCT04739800|565921183|FG002|Overall Study|On Treatment|9|||
156773006|NCT04739800|565921184|FG003|Overall Study|On Treatment|9|||
156773007|NCT04739800|565921181|FG000|Overall Study|Symptomatic Deterioration|1|||
156773008|NCT04739800|565921182|FG001|Overall Study|Symptomatic Deterioration|1|||
156773009|NCT04739800|565921183|FG002|Overall Study|Symptomatic Deterioration|3|||
156773010|NCT04739800|565921184|FG003|Overall Study|Symptomatic Deterioration|0|||
156773011|NCT04739800|565921181|FG000|Overall Study|Withdrawal by Subject|1|||
156773012|NCT04739800|565921182|FG001|Overall Study|Withdrawal by Subject|2|||
156773013|NCT04739800|565921183|FG002|Overall Study|Withdrawal by Subject|1|||
156773014|NCT04739800|565921184|FG003|Overall Study|Withdrawal by Subject|3|||
156773015|NCT04739800|565921181|FG000|Overall Study|Other Reason|1|||
156773016|NCT04739800|565921182|FG001|Overall Study|Other Reason|3|||
156773017|NCT04739800|565921183|FG002|Overall Study|Other Reason|5|||
156773018|NCT04739800|565921184|FG003|Overall Study|Other Reason|4|||
156773019|NCT03415178|565921185|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
156773020|NCT03415178|565921186|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
156773021|NCT03415178|565921185|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
156773022|NCT03415178|565921186|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
156773023|NCT04880850|565921187|FG000|Overall Study|Death|2|||
156773024|NCT04880850|565921188|FG001|Overall Study|Death|1|||
156773025|NCT04880850|565921187|FG000|Overall Study|Lost to Follow-up|3|||
156773026|NCT04880850|565921188|FG001|Overall Study|Lost to Follow-up|6|||
156773027|NCT04880850|565921187|FG000|Overall Study|Physician Decision|2|||
156773028|NCT04880850|565921188|FG001|Overall Study|Physician Decision|1|||
156773029|NCT04880850|565921187|FG000|Overall Study|Withdrawal by Subject|9|||
156773030|NCT04880850|565921188|FG001|Overall Study|Withdrawal by Subject|10|||
156773031|NCT03907488|565921189|FG000|Overall Study|Adverse Event|20|||
156773032|NCT03907488|565921190|FG001|Overall Study|Adverse Event|20|||
156773033|NCT03907488|565921189|FG000|Overall Study|Withdrawal by Subject|9|||
156773034|NCT03907488|565921190|FG001|Overall Study|Withdrawal by Subject|13|||
156773035|NCT03907488|565921189|FG000|Overall Study|Lack of Efficacy|0|||
156773036|NCT03907488|565921190|FG001|Overall Study|Lack of Efficacy|9|||
156773037|NCT03907488|565921189|FG000|Overall Study|Death|3|||
156773038|NCT03907488|565921190|FG001|Overall Study|Death|8|||
156773039|NCT03907488|565921189|FG000|Overall Study|not protocol specified|5|||
156773040|NCT03907488|565921190|FG001|Overall Study|not protocol specified|8|||
156773041|NCT03907488|565921189|FG000|Overall Study|Ineligible|9|||
156773042|NCT03907488|565921190|FG001|Overall Study|Ineligible|15|||
156773043|NCT01093846|565921192|FG000|Overall Study|Adverse Event|0|||
156773044|NCT01093846|565921193|FG001|Overall Study|Adverse Event|0|||
156773045|NCT01093846|565921194|FG002|Overall Study|Adverse Event|1|||
156773046|NCT01093846|565921192|FG000|Overall Study|Lack of Efficacy|0|||
156773047|NCT01093846|565921193|FG001|Overall Study|Lack of Efficacy|0|||
156773048|NCT01093846|565921194|FG002|Overall Study|Lack of Efficacy|4|||
156773049|NCT01093846|565921192|FG000|Overall Study|Condition no longer required study drug|1|||
156773050|NCT01093846|565921193|FG001|Overall Study|Condition no longer required study drug|1|||
156773051|NCT01093846|565921194|FG002|Overall Study|Condition no longer required study drug|1|||
156773052|NCT01093846|565921192|FG000|Overall Study|Administrative Problems|18|||
156773053|NCT01093846|565921193|FG001|Overall Study|Administrative Problems|17|||
156773054|NCT01093846|565921194|FG002|Overall Study|Administrative Problems|15|||
156773055|NCT03321721|565921195|FG000|Overall Study|Lost to Follow-up|4|||
156773056|NCT03321721|565921196|FG001|Overall Study|Lost to Follow-up|8|||
156773057|NCT03321721|565921197|FG002|Overall Study|Lost to Follow-up|11|||
156773058|NCT00661388|565921201|FG000|Overall Study|Adverse Event|14|||
156773059|NCT00661388|565921201|FG000|Overall Study|Protocol Violation|7|||
156773060|NCT00661388|565921201|FG000|Overall Study|Renal transplantation|1|||
156773061|NCT00661388|565921201|FG000|Overall Study|Dialysis initiation|1|||
156773062|NCT00661388|565921201|FG000|Overall Study|Administrative reasons|1|||
156773063|NCT02332707|565922650|FG000|Overall Study|Adverse Event|0|||
156773064|NCT02332707|565922651|FG001|Overall Study|Adverse Event|0|||
156773065|NCT02332707|565922652|FG002|Overall Study|Adverse Event|0|||
156773066|NCT02332707|565922653|FG003|Overall Study|Adverse Event|0|||
156773067|NCT02332707|565922654|FG004|Overall Study|Adverse Event|0|||
156773068|NCT02332707|565922655|FG005|Overall Study|Adverse Event|0|||
156773069|NCT02332707|565922656|FG006|Overall Study|Adverse Event|0|||
156773070|NCT02332707|565922657|FG007|Overall Study|Adverse Event|0|||
156773071|NCT02332707|565922658|FG008|Overall Study|Adverse Event|0|||
156773072|NCT02332707|565922659|FG009|Overall Study|Adverse Event|0|||
156773073|NCT02332707|565922660|FG010|Overall Study|Adverse Event|0|||
156773074|NCT02332707|565922661|FG011|Overall Study|Adverse Event|0|||
156773075|NCT02332707|565922662|FG012|Overall Study|Adverse Event|1|||
156773076|NCT02332707|565922663|FG013|Overall Study|Adverse Event|0|||
156773077|NCT02332707|565922664|FG014|Overall Study|Adverse Event|0|||
156773078|NCT02332707|565922665|FG015|Overall Study|Adverse Event|0|||
156773079|NCT02332707|565922666|FG016|Overall Study|Adverse Event|0|||
156773080|NCT02332707|565922667|FG017|Overall Study|Adverse Event|0|||
156773081|NCT02332707|565922650|FG000|Overall Study|Lost to Follow-up|0|||
156773082|NCT02332707|565922651|FG001|Overall Study|Lost to Follow-up|0|||
156773083|NCT02332707|565922652|FG002|Overall Study|Lost to Follow-up|0|||
156773084|NCT02332707|565922653|FG003|Overall Study|Lost to Follow-up|0|||
156773085|NCT02332707|565922654|FG004|Overall Study|Lost to Follow-up|0|||
156773086|NCT02332707|565922655|FG005|Overall Study|Lost to Follow-up|1|||
156773087|NCT02332707|565922656|FG006|Overall Study|Lost to Follow-up|0|||
156773088|NCT02332707|565922657|FG007|Overall Study|Lost to Follow-up|0|||
156773089|NCT02332707|565922658|FG008|Overall Study|Lost to Follow-up|0|||
156773090|NCT02332707|565922659|FG009|Overall Study|Lost to Follow-up|0|||
156773091|NCT02332707|565922660|FG010|Overall Study|Lost to Follow-up|2|||
156773092|NCT02332707|565922661|FG011|Overall Study|Lost to Follow-up|0|||
156773093|NCT02332707|565922662|FG012|Overall Study|Lost to Follow-up|3|||
156773094|NCT02332707|565922663|FG013|Overall Study|Lost to Follow-up|0|||
156773095|NCT02332707|565922664|FG014|Overall Study|Lost to Follow-up|0|||
156773096|NCT02332707|565922665|FG015|Overall Study|Lost to Follow-up|0|||
156773097|NCT02332707|565922666|FG016|Overall Study|Lost to Follow-up|0|||
156773098|NCT02332707|565922667|FG017|Overall Study|Lost to Follow-up|0|||
156773099|NCT02332707|565922650|FG000|Overall Study|Physician Decision|0|||
156773100|NCT02332707|565922651|FG001|Overall Study|Physician Decision|0|||
156773101|NCT02332707|565922652|FG002|Overall Study|Physician Decision|0|||
156773102|NCT02332707|565922653|FG003|Overall Study|Physician Decision|1|||
156773103|NCT02332707|565922654|FG004|Overall Study|Physician Decision|0|||
156773104|NCT02332707|565922655|FG005|Overall Study|Physician Decision|0|||
156773105|NCT02332707|565922656|FG006|Overall Study|Physician Decision|0|||
156773106|NCT02332707|565922657|FG007|Overall Study|Physician Decision|0|||
156773107|NCT02332707|565922658|FG008|Overall Study|Physician Decision|0|||
156773108|NCT02332707|565922659|FG009|Overall Study|Physician Decision|0|||
156773109|NCT02332707|565922660|FG010|Overall Study|Physician Decision|0|||
156773110|NCT02332707|565922661|FG011|Overall Study|Physician Decision|0|||
156773111|NCT02332707|565922662|FG012|Overall Study|Physician Decision|1|||
156773112|NCT02332707|565922663|FG013|Overall Study|Physician Decision|0|||
156773113|NCT02332707|565922664|FG014|Overall Study|Physician Decision|0|||
156773114|NCT02332707|565922665|FG015|Overall Study|Physician Decision|0|||
156773115|NCT02332707|565922666|FG016|Overall Study|Physician Decision|0|||
156773116|NCT02332707|565922667|FG017|Overall Study|Physician Decision|0|||
156773117|NCT02332707|565922650|FG000|Overall Study|Withdrawal by Subject|0|||
156773118|NCT02332707|565922651|FG001|Overall Study|Withdrawal by Subject|0|||
156773119|NCT02332707|565922652|FG002|Overall Study|Withdrawal by Subject|1|||
156773120|NCT02332707|565922653|FG003|Overall Study|Withdrawal by Subject|0|||
156773121|NCT02332707|565922654|FG004|Overall Study|Withdrawal by Subject|0|||
156773122|NCT02332707|565922655|FG005|Overall Study|Withdrawal by Subject|0|||
156773123|NCT02332707|565922656|FG006|Overall Study|Withdrawal by Subject|0|||
156773124|NCT02332707|565922657|FG007|Overall Study|Withdrawal by Subject|0|||
156773125|NCT02332707|565922658|FG008|Overall Study|Withdrawal by Subject|0|||
156773126|NCT02332707|565922659|FG009|Overall Study|Withdrawal by Subject|3|||
156773127|NCT02332707|565922660|FG010|Overall Study|Withdrawal by Subject|0|||
156773128|NCT02332707|565922661|FG011|Overall Study|Withdrawal by Subject|0|||
156773129|NCT02332707|565922662|FG012|Overall Study|Withdrawal by Subject|0|||
156773130|NCT02332707|565922663|FG013|Overall Study|Withdrawal by Subject|0|||
156773131|NCT02332707|565922664|FG014|Overall Study|Withdrawal by Subject|0|||
156773132|NCT02332707|565922665|FG015|Overall Study|Withdrawal by Subject|0|||
156773133|NCT02332707|565922666|FG016|Overall Study|Withdrawal by Subject|0|||
156773134|NCT02332707|565922667|FG017|Overall Study|Withdrawal by Subject|0|||
156773135|NCT01473134|565922668|FG000|Overall Study|Lost to Follow-up|21|||
156773136|NCT01473134|565922669|FG001|Overall Study|Lost to Follow-up|13|||
156773137|NCT01473134|565922668|FG000|Overall Study|Protocol Violation|32|||
156773138|NCT01473134|565922669|FG001|Overall Study|Protocol Violation|19|||
156773139|NCT01473134|565922668|FG000|Overall Study|Withdrawal by Subject|1|||
156773140|NCT01473134|565922669|FG001|Overall Study|Withdrawal by Subject|2|||
156773141|NCT01473134|565922668|FG000|Overall Study|Death|0|||
156773142|NCT01473134|565922669|FG001|Overall Study|Death|1|||
156773143|NCT01473134|565922668|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
156773144|NCT01473134|565922669|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
156773145|NCT03286504|565922673|FG000|Overall Study|Lost to Follow-up|19|||
156773146|NCT03286504|565922674|FG001|Overall Study|Lost to Follow-up|16|||
156773147|NCT02832037|565922676|FG000|Overall Study|Administrative reasons|0|||
156773148|NCT02832037|565922677|FG001|Overall Study|Administrative reasons|0|||
156773149|NCT02832037|565922678|FG002|Overall Study|Administrative reasons|1|||
156773150|NCT02832037|565922679|FG003|Overall Study|Administrative reasons|0|||
156773151|NCT02832037|565922680|FG004|Overall Study|Administrative reasons|0|||
156773152|NCT02832037|565922676|FG000|Overall Study|Protocol Violation|3|||
156773153|NCT02832037|565922677|FG001|Overall Study|Protocol Violation|0|||
156773154|NCT02832037|565922678|FG002|Overall Study|Protocol Violation|4|||
156773155|NCT02832037|565922679|FG003|Overall Study|Protocol Violation|1|||
156773156|NCT02832037|565922680|FG004|Overall Study|Protocol Violation|2|||
156773157|NCT02832037|565922676|FG000|Overall Study|Lost to Follow-up|2|||
156773158|NCT02832037|565922677|FG001|Overall Study|Lost to Follow-up|0|||
156773159|NCT02832037|565922678|FG002|Overall Study|Lost to Follow-up|3|||
156773160|NCT02832037|565922679|FG003|Overall Study|Lost to Follow-up|0|||
156773161|NCT02832037|565922680|FG004|Overall Study|Lost to Follow-up|5|||
156773162|NCT02832037|565922676|FG000|Overall Study|Withdrawal by Subject|9|||
156773163|NCT02832037|565922677|FG001|Overall Study|Withdrawal by Subject|8|||
156773164|NCT02832037|565922678|FG002|Overall Study|Withdrawal by Subject|0|||
156773165|NCT02832037|565922679|FG003|Overall Study|Withdrawal by Subject|4|||
156773166|NCT02832037|565922680|FG004|Overall Study|Withdrawal by Subject|8|||
156773167|NCT02832037|565922676|FG000|Overall Study|Adverse Event|5|||
156773168|NCT02832037|565922677|FG001|Overall Study|Adverse Event|4|||
156773169|NCT02832037|565922678|FG002|Overall Study|Adverse Event|0|||
156773170|NCT02832037|565922679|FG003|Overall Study|Adverse Event|2|||
156773171|NCT02832037|565922680|FG004|Overall Study|Adverse Event|4|||
156773172|NCT04167462|565922689|FG000|Overall Study|Other reasons|3|||
156773173|NCT04167462|565922690|FG001|Overall Study|Other reasons|2|||
156773174|NCT04167462|565922689|FG000|Overall Study|Withdrawal by Subject|6|||
156773175|NCT04167462|565922690|FG001|Overall Study|Withdrawal by Subject|7|||
156773176|NCT04167462|565922689|FG000|Overall Study|Adverse Event|4|||
156773177|NCT04167462|565922690|FG001|Overall Study|Adverse Event|0|||
156773178|NCT04167462|565922689|FG000|Overall Study|Pregnancy|1|||
156773179|NCT04167462|565922690|FG001|Overall Study|Pregnancy|0|||
156773180|NCT04167462|565922689|FG000|Overall Study|Lack of Efficacy|0|||
156773181|NCT04167462|565922690|FG001|Overall Study|Lack of Efficacy|1|||
156773182|NCT02765165|565922691|FG000|Treatment Period|Progressive disease|3|||
156773183|NCT02765165|565922692|FG001|Treatment Period|Progressive disease|2|||
156773184|NCT02765165|565922693|FG002|Treatment Period|Progressive disease|3|||
156773185|NCT02765165|565922694|FG003|Treatment Period|Progressive disease|3|||
156773186|NCT02765165|565922695|FG004|Treatment Period|Progressive disease|4|||
156773187|NCT02765165|565922696|FG005|Treatment Period|Progressive disease|2|||
156773188|NCT02765165|565922697|FG006|Treatment Period|Progressive disease|2|||
156773189|NCT02765165|565922691|FG000|Treatment Period|Physician Decision|0|||
156773190|NCT02765165|565922692|FG001|Treatment Period|Physician Decision|1|||
156773191|NCT02765165|565922693|FG002|Treatment Period|Physician Decision|0|||
156773192|NCT02765165|565922694|FG003|Treatment Period|Physician Decision|0|||
156773193|NCT02765165|565922695|FG004|Treatment Period|Physician Decision|0|||
156773194|NCT02765165|565922696|FG005|Treatment Period|Physician Decision|0|||
156773195|NCT02765165|565922697|FG006|Treatment Period|Physician Decision|0|||
156773196|NCT02765165|565922691|FG000|Treatment Period|Adverse Event|0|||
156773197|NCT02765165|565922692|FG001|Treatment Period|Adverse Event|1|||
156773198|NCT02765165|565922693|FG002|Treatment Period|Adverse Event|0|||
156773199|NCT02765165|565922694|FG003|Treatment Period|Adverse Event|0|||
156773200|NCT02765165|565922695|FG004|Treatment Period|Adverse Event|0|||
156773201|NCT02765165|565922696|FG005|Treatment Period|Adverse Event|0|||
156773202|NCT02765165|565922697|FG006|Treatment Period|Adverse Event|0|||
156773203|NCT02765165|565922691|FG000|Treatment Period|Withdrawal by Subject|0|||
156773204|NCT02765165|565922692|FG001|Treatment Period|Withdrawal by Subject|0|||
156773205|NCT02765165|565922693|FG002|Treatment Period|Withdrawal by Subject|0|||
156773206|NCT02765165|565922694|FG003|Treatment Period|Withdrawal by Subject|0|||
156773207|NCT02765165|565922695|FG004|Treatment Period|Withdrawal by Subject|2|||
156773208|NCT02765165|565922696|FG005|Treatment Period|Withdrawal by Subject|0|||
156773209|NCT02765165|565922697|FG006|Treatment Period|Withdrawal by Subject|0|||
156773210|NCT02765165|565922691|FG000|Treatment Period|Study terminated|0|||
156773211|NCT02765165|565922692|FG001|Treatment Period|Study terminated|0|||
156773212|NCT02765165|565922693|FG002|Treatment Period|Study terminated|0|||
156773213|NCT02765165|565922694|FG003|Treatment Period|Study terminated|0|||
156773214|NCT02765165|565922695|FG004|Treatment Period|Study terminated|0|||
156773215|NCT02765165|565922696|FG005|Treatment Period|Study terminated|1|||
156773216|NCT02765165|565922697|FG006|Treatment Period|Study terminated|2|||
156773217|NCT02765165|565922691|FG000|Post-treatment Follow-up|Death|1|||
156773218|NCT02765165|565922692|FG001|Post-treatment Follow-up|Death|2|||
156773219|NCT02765165|565922693|FG002|Post-treatment Follow-up|Death|1|||
156773220|NCT02765165|565922694|FG003|Post-treatment Follow-up|Death|1|||
156773221|NCT02765165|565922695|FG004|Post-treatment Follow-up|Death|1|||
156773222|NCT02765165|565922696|FG005|Post-treatment Follow-up|Death|1|||
156773223|NCT02765165|565922697|FG006|Post-treatment Follow-up|Death|0|||
156773224|NCT02765165|565922691|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
156773225|NCT02765165|565922692|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
156773226|NCT02765165|565922693|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
156773227|NCT02765165|565922694|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
156773228|NCT02765165|565922695|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
156773229|NCT02765165|565922696|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
156773230|NCT02765165|565922697|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
156773231|NCT02765165|565922691|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773232|NCT02765165|565922692|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773233|NCT02765165|565922693|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
156773234|NCT02765165|565922694|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773235|NCT02765165|565922695|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773236|NCT02765165|565922696|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773237|NCT02765165|565922697|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
156773238|NCT02765165|565922691|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773239|NCT02765165|565922692|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773240|NCT02765165|565922693|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
156773241|NCT02765165|565922694|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
156773242|NCT02765165|565922695|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773243|NCT02765165|565922696|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773244|NCT02765165|565922697|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
156773245|NCT02765165|565922691|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773246|NCT02765165|565922692|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
156773247|NCT02765165|565922693|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773248|NCT02765165|565922694|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773249|NCT02765165|565922695|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773250|NCT02765165|565922696|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773251|NCT02765165|565922697|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
156773252|NCT02765165|565922691|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773253|NCT02765165|565922692|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773254|NCT02765165|565922693|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773255|NCT02765165|565922694|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
156773256|NCT02765165|565922695|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
156773257|NCT02765165|565922696|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
156773258|NCT02765165|565922697|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
156773259|NCT02382939|565922700|FG000|Overall Study|Adverse Event|1|||
156773260|NCT02382939|565922701|FG001|Overall Study|Adverse Event|1|||
156773261|NCT02382939|565922700|FG000|Overall Study|Withdrawal by Subject|2|||
156773262|NCT02382939|565922701|FG001|Overall Study|Withdrawal by Subject|2|||
156773263|NCT00142415|565922702|FG000|Overall Study|Physician Decision|0|||
156773264|NCT00142415|565922703|FG001|Overall Study|Physician Decision|0|||
156773265|NCT00142415|565922704|FG002|Overall Study|Physician Decision|0|||
156773266|NCT00142415|565922705|FG003|Overall Study|Physician Decision|0|||
156773267|NCT00142415|565922706|FG004|Overall Study|Physician Decision|1|||
156773268|NCT00142415|565922707|FG005|Overall Study|Physician Decision|2|||
156773269|NCT01189266|565922712|FG000|Overall Study|Adverse Event|1|||
156773270|NCT01189266|565922713|FG001|Overall Study|Adverse Event|0|||
156773271|NCT01189266|565922714|FG002|Overall Study|Adverse Event|5|||
156773272|NCT01189266|565922712|FG000|Overall Study|Death|0|||
156773273|NCT01189266|565922713|FG001|Overall Study|Death|0|||
156773274|NCT01189266|565922714|FG002|Overall Study|Death|5|||
156773275|NCT01189266|565922712|FG000|Overall Study|Lack of Efficacy|4|||
156773276|NCT01189266|565922713|FG001|Overall Study|Lack of Efficacy|5|||
156773277|NCT01189266|565922714|FG002|Overall Study|Lack of Efficacy|44|||
156773278|NCT01189266|565922712|FG000|Overall Study|Physician Decision|0|||
156773279|NCT01189266|565922713|FG001|Overall Study|Physician Decision|0|||
156773280|NCT01189266|565922714|FG002|Overall Study|Physician Decision|1|||
156773281|NCT01189266|565922712|FG000|Overall Study|Protocol Violation|0|||
156773282|NCT01189266|565922713|FG001|Overall Study|Protocol Violation|1|||
156773283|NCT01189266|565922714|FG002|Overall Study|Protocol Violation|1|||
156773284|NCT01189266|565922712|FG000|Overall Study|Withdrawal by Subject|0|||
156773285|NCT01189266|565922713|FG001|Overall Study|Withdrawal by Subject|0|||
156773286|NCT01189266|565922714|FG002|Overall Study|Withdrawal by Subject|1|||
156773287|NCT01189266|565922712|FG000|Overall Study|Patient refuses further therapy|1|||
156773288|NCT01189266|565922713|FG001|Overall Study|Patient refuses further therapy|0|||
156773289|NCT01189266|565922714|FG002|Overall Study|Patient refuses further therapy|7|||
156773290|NCT01189266|565922712|FG000|Overall Study|No treatment|0|||
156773291|NCT01189266|565922713|FG001|Overall Study|No treatment|0|||
156773292|NCT01189266|565922714|FG002|Overall Study|No treatment|1|||
156773293|NCT00321763|565922715|FG000|Overall Study|Adverse Event|1|||
156773294|NCT00321763|565922716|FG001|Overall Study|Adverse Event|1|||
156773295|NCT00321763|565922717|FG002|Overall Study|Adverse Event|0|||
156773296|NCT00321763|565922718|FG003|Overall Study|Adverse Event|1|||
156773297|NCT00321763|565922715|FG000|Overall Study|Withdrawal by Subject|2|||
156773298|NCT00321763|565922716|FG001|Overall Study|Withdrawal by Subject|0|||
156773299|NCT00321763|565922717|FG002|Overall Study|Withdrawal by Subject|1|||
156773300|NCT00321763|565922718|FG003|Overall Study|Withdrawal by Subject|0|||
156773301|NCT00321763|565922715|FG000|Overall Study|Lost to Follow-up|3|||
156773302|NCT00321763|565922716|FG001|Overall Study|Lost to Follow-up|1|||
156773303|NCT00321763|565922717|FG002|Overall Study|Lost to Follow-up|5|||
156773304|NCT00321763|565922718|FG003|Overall Study|Lost to Follow-up|4|||
156773305|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
156773306|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
156773307|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
156773308|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
156773309|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
156773310|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
156773311|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
156773312|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
156773313|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
156773314|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
156773315|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
156773316|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
156773317|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
156773318|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
156773319|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
156773320|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
156773321|NCT00410163|565922719|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
156773322|NCT00410163|565922720|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
156773323|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
156773324|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
156773325|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
157113228|NCT02819635|567170162|FG003|Substudy 3|Withdrew consent|0|||
156773326|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
156773327|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
156773328|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
156773329|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
156773330|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
156773331|NCT00410163|565922719|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
156773332|NCT00410163|565922720|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
156773333|NCT01572792|565922723|FG000|Lead-in Study|Lost to Follow-up|5|||
156773334|NCT01572792|565922724|FG001|Lead-in Study|Lost to Follow-up|9|||
156773335|NCT01572792|565922725|FG002|Lead-in Study|Lost to Follow-up|4|||
156773336|NCT01572792|565922726|FG003|Lead-in Study|Lost to Follow-up|2|||
156773337|NCT01572792|565922727|FG004|Lead-in Study|Lost to Follow-up|4|||
156773338|NCT01572792|565922723|FG000|Lead-in Study|Withdrawal by Subject|22|||
156773339|NCT01572792|565922724|FG001|Lead-in Study|Withdrawal by Subject|11|||
156773340|NCT01572792|565922725|FG002|Lead-in Study|Withdrawal by Subject|12|||
156773341|NCT01572792|565922726|FG003|Lead-in Study|Withdrawal by Subject|24|||
156773342|NCT01572792|565922727|FG004|Lead-in Study|Withdrawal by Subject|11|||
156773343|NCT01572792|565922723|FG000|Lead-in Study|Protocol Violation|19|||
156773344|NCT01572792|565922724|FG001|Lead-in Study|Protocol Violation|10|||
156773345|NCT01572792|565922725|FG002|Lead-in Study|Protocol Violation|12|||
156773346|NCT01572792|565922726|FG003|Lead-in Study|Protocol Violation|13|||
156773347|NCT01572792|565922727|FG004|Lead-in Study|Protocol Violation|21|||
156773348|NCT01572792|565922723|FG000|Lead-in Study|Lack of Efficacy|20|||
156773349|NCT01572792|565922724|FG001|Lead-in Study|Lack of Efficacy|5|||
156773350|NCT01572792|565922725|FG002|Lead-in Study|Lack of Efficacy|4|||
156773351|NCT01572792|565922726|FG003|Lead-in Study|Lack of Efficacy|8|||
156773352|NCT01572792|565922727|FG004|Lead-in Study|Lack of Efficacy|10|||
156773353|NCT01572792|565922723|FG000|Lead-in Study|Adverse Event|21|||
156773354|NCT01572792|565922724|FG001|Lead-in Study|Adverse Event|21|||
156773355|NCT01572792|565922725|FG002|Lead-in Study|Adverse Event|22|||
156773356|NCT01572792|565922726|FG003|Lead-in Study|Adverse Event|16|||
156773357|NCT01572792|565922727|FG004|Lead-in Study|Adverse Event|14|||
156773358|NCT01572792|565922723|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
156773359|NCT01572792|565922724|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
156773360|NCT01572792|565922725|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
156773361|NCT01572792|565922726|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
156773362|NCT01572792|565922727|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
156773363|NCT01572792|565922723|FG000|Extension Study|Lost to Follow-up|6|||
156773364|NCT01572792|565922724|FG001|Extension Study|Lost to Follow-up|2|||
156773365|NCT01572792|565922725|FG002|Extension Study|Lost to Follow-up|0|||
156773366|NCT01572792|565922726|FG003|Extension Study|Lost to Follow-up|3|||
157113229|NCT02819635|567170163|FG004|Substudy 3|Withdrew consent|0|||
157113230|NCT02819635|567170164|FG005|Substudy 3|Withdrew consent|0|||
156773367|NCT01572792|565922727|FG004|Extension Study|Lost to Follow-up|3|||
156773368|NCT01572792|565922723|FG000|Extension Study|Withdrawal by Subject|7|||
156773369|NCT01572792|565922724|FG001|Extension Study|Withdrawal by Subject|6|||
157113231|NCT02819635|567170165|FG006|Substudy 3|Withdrew consent|0|||
157113232|NCT02819635|567170166|FG007|Substudy 3|Withdrew consent|0|||
156773370|NCT01572792|565922725|FG002|Extension Study|Withdrawal by Subject|11|||
156773371|NCT01572792|565922726|FG003|Extension Study|Withdrawal by Subject|8|||
156773372|NCT01572792|565922727|FG004|Extension Study|Withdrawal by Subject|14|||
156773373|NCT01572792|565922723|FG000|Extension Study|Protocol Violation|0|||
157113233|NCT02819635|567170167|FG008|Substudy 3|Withdrew consent|11|||
156773374|NCT01572792|565922724|FG001|Extension Study|Protocol Violation|4|||
156773375|NCT01572792|565922725|FG002|Extension Study|Protocol Violation|3|||
156773376|NCT01572792|565922726|FG003|Extension Study|Protocol Violation|4|||
156773377|NCT01572792|565922727|FG004|Extension Study|Protocol Violation|3|||
156773378|NCT01572792|565922723|FG000|Extension Study|Lack of Efficacy|2|||
156773379|NCT01572792|565922724|FG001|Extension Study|Lack of Efficacy|3|||
156773380|NCT01572792|565922725|FG002|Extension Study|Lack of Efficacy|3|||
156773381|NCT01572792|565922726|FG003|Extension Study|Lack of Efficacy|2|||
156773382|NCT01572792|565922727|FG004|Extension Study|Lack of Efficacy|2|||
156773383|NCT01572792|565922723|FG000|Extension Study|Adverse Event|7|||
156773384|NCT01572792|565922724|FG001|Extension Study|Adverse Event|6|||
156773385|NCT01572792|565922725|FG002|Extension Study|Adverse Event|5|||
156773386|NCT01572792|565922726|FG003|Extension Study|Adverse Event|6|||
156773387|NCT01572792|565922727|FG004|Extension Study|Adverse Event|4|||
156773388|NCT01572792|565922723|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
156773389|NCT01572792|565922724|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
156773390|NCT01572792|565922725|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
156773391|NCT01572792|565922726|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
156773392|NCT01572792|565922727|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
156773393|NCT03530696|565922730|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
156773394|NCT03530696|565922731|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
156773395|NCT01129128|565922732|FG000|Overall Study|Lost to Follow-up|2|||
156773396|NCT01129128|565922733|FG001|Overall Study|Lost to Follow-up|2|||
156773397|NCT01129128|565922734|FG002|Overall Study|Lost to Follow-up|1|||
156773398|NCT01129128|565922732|FG000|Overall Study|Protocol Violation|0|||
156773399|NCT01129128|565922733|FG001|Overall Study|Protocol Violation|1|||
156773400|NCT01129128|565922734|FG002|Overall Study|Protocol Violation|0|||
156773401|NCT01129128|565922732|FG000|Overall Study|Withdrawal by Subject|0|||
156773402|NCT01129128|565922733|FG001|Overall Study|Withdrawal by Subject|1|||
156773403|NCT01129128|565922734|FG002|Overall Study|Withdrawal by Subject|3|||
156773404|NCT01129128|565922732|FG000|Overall Study|Physician Decision|1|||
156773405|NCT01129128|565922733|FG001|Overall Study|Physician Decision|0|||
156773406|NCT01129128|565922734|FG002|Overall Study|Physician Decision|0|||
156773407|NCT01900314|565922737|FG000|Overall Study|Lost to Follow-up|1|||
156773408|NCT01900314|565922738|FG001|Overall Study|Lost to Follow-up|0|||
156773409|NCT01900314|565922737|FG000|Overall Study|Protocol Violation|0|||
156773410|NCT01900314|565922738|FG001|Overall Study|Protocol Violation|1|||
156773411|NCT01900314|565922737|FG000|Overall Study|Withdrawal by Subject|3|||
156773412|NCT01900314|565922738|FG001|Overall Study|Withdrawal by Subject|3|||
156773413|NCT05452239|565922740|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
156773414|NCT05452239|565922741|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
156773415|NCT05452239|565922740|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
156773416|NCT05452239|565922741|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
156773417|NCT05452239|565922740|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
156773418|NCT05452239|565922741|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
156773419|NCT05452239|565922740|FG000|Placebo-controlled Period|Randomized but not treated|2|||
156773420|NCT05452239|565922741|FG001|Placebo-controlled Period|Randomized but not treated|2|||
156773421|NCT05452239|565922740|FG000|Placebo-controlled Period|Other than specified|1|||
156773422|NCT05452239|565922741|FG001|Placebo-controlled Period|Other than specified|1|||
156773423|NCT05452239|565922740|FG000|Open-label Period|Withdrawal by Subject|2|||
156773424|NCT05452239|565922741|FG001|Open-label Period|Withdrawal by Subject|1|||
156773425|NCT05452239|565922740|FG000|Open-label Period|Lost to Follow-up|3|||
156773426|NCT05452239|565922741|FG001|Open-label Period|Lost to Follow-up|0|||
156773427|NCT05452239|565922740|FG000|Open-label Period|Other than specified|1|||
156773428|NCT05452239|565922741|FG001|Open-label Period|Other than specified|2|||
156773429|NCT01385176|565922742|FG000|Randomization Phase|Death|1|||
156773430|NCT01385176|565922743|FG001|Randomization Phase|Death|2|||
156773431|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Death|1|||
156773432|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Death|2|||
156773433|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Physician Decision|0|||
156773434|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Physician Decision|1|||
156773435|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
156773436|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
156773437|NCT01385176|565922742|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
156773438|NCT01385176|565922743|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
156773439|NCT01056536|565922744|FG000|Overall Study|Lost to Follow-up|202|||
156773440|NCT01056536|565922745|FG001|Overall Study|Lost to Follow-up|116|||
156773441|NCT01056536|565922746|FG002|Overall Study|Lost to Follow-up|248|||
157113234|NCT02819635|567170168|FG009|Substudy 3|Withdrew consent|1|||
156773442|NCT05853120|565922747|FG000|Overall Study|Lost to Follow-up|4|||
156773443|NCT05853120|565922748|FG001|Overall Study|Lost to Follow-up|4|||
156773444|NCT05853120|565922747|FG000|Overall Study|Physician Decision|3|||
156773445|NCT05853120|565922748|FG001|Overall Study|Physician Decision|0|||
156773446|NCT05853120|565922747|FG000|Overall Study|Withdrawal by Subject|5|||
156773447|NCT05853120|565922748|FG001|Overall Study|Withdrawal by Subject|2|||
156773448|NCT03692949|565922753|FG000|Overall Study|Lost to Follow-up|0|||
156773449|NCT03692949|565922754|FG001|Overall Study|Lost to Follow-up|0|||
156773450|NCT03692949|565922755|FG002|Overall Study|Lost to Follow-up|0|||
156773451|NCT03692949|565922756|FG003|Overall Study|Lost to Follow-up|0|||
156773452|NCT03692949|565922757|FG004|Overall Study|Lost to Follow-up|0|||
156773453|NCT03692949|565922758|FG005|Overall Study|Lost to Follow-up|0|||
156773454|NCT03692949|565922759|FG006|Overall Study|Lost to Follow-up|0|||
156773455|NCT03692949|565922760|FG007|Overall Study|Lost to Follow-up|1|||
156773456|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Adverse Event|6|||
156773457|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Adverse Event|15|||
156773458|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Adverse Event|0|||
156773459|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Death|0|||
156773460|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Death|2|||
156773461|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Death|0|||
156773462|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
156773463|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
156773464|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
156773465|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
156773466|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
156773467|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
156773468|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Physician Decision|1|||
156773469|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Physician Decision|1|||
156773470|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Physician Decision|0|||
156773471|NCT02921256|565922766|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
156773472|NCT02921256|565922767|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
156773473|NCT02921256|565922768|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
156773474|NCT02921256|565922766|FG000|Arm Ib v Arm III|Adverse Event|9|||
156773475|NCT02921256|565922767|FG001|Arm Ib v Arm III|Adverse Event|0|||
156773476|NCT02921256|565922768|FG002|Arm Ib v Arm III|Adverse Event|4|||
156773477|NCT02921256|565922766|FG000|Arm Ib v Arm III|Death|1|||
156773478|NCT02921256|565922767|FG001|Arm Ib v Arm III|Death|0|||
156773479|NCT02921256|565922768|FG002|Arm Ib v Arm III|Death|1|||
156773480|NCT02921256|565922766|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
156773481|NCT02921256|565922767|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
156773482|NCT02921256|565922768|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
156773483|NCT02921256|565922766|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
156773484|NCT02921256|565922767|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
156773485|NCT02921256|565922768|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
156773486|NCT02921256|565922766|FG000|Arm Ib v Arm III|Physician Decision|4|||
156773487|NCT02921256|565922767|FG001|Arm Ib v Arm III|Physician Decision|0|||
156773488|NCT02921256|565922768|FG002|Arm Ib v Arm III|Physician Decision|1|||
156773489|NCT02921256|565922766|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
156773490|NCT02921256|565922767|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
156773491|NCT02921256|565922768|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
156773492|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Death|1|||
156773493|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Death|0|||
156773494|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
156773495|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
156773496|NCT04848480|565922769|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
156773497|NCT04848480|565922770|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
156773498|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
156773499|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
156773500|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
156773501|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
156773502|NCT04848480|565922769|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
156773503|NCT04848480|565922770|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
156773504|NCT02783690|565922773|FG000|Overall Study|Withdrawal by Subject|3|||
156773505|NCT02783690|565922774|FG001|Overall Study|Withdrawal by Subject|3|||
156773506|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
156773507|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
156773508|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
156773509|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
156773510|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Death|38|||
156773511|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Death|10|||
156773512|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
157113235|NCT02819635|567170169|FG010|Substudy 3|Withdrew consent|4|||
156773513|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
156773514|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
156773515|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
156773516|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
156773517|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
156773518|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
156773519|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
156773520|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
156773521|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
157113236|NCT02819635|567170170|FG011|Substudy 3|Withdrew consent|9|||
157113237|NCT02819635|567170159|FG000|Substudy 3|Lost to Follow-up|0|||
157113238|NCT02819635|567170160|FG001|Substudy 3|Lost to Follow-up|0|||
157113239|NCT02819635|567170161|FG002|Substudy 3|Lost to Follow-up|0|||
157113240|NCT02819635|567170162|FG003|Substudy 3|Lost to Follow-up|0|||
157113241|NCT02819635|567170163|FG004|Substudy 3|Lost to Follow-up|0|||
157113242|NCT02819635|567170164|FG005|Substudy 3|Lost to Follow-up|0|||
157113243|NCT02819635|567170165|FG006|Substudy 3|Lost to Follow-up|0|||
157113244|NCT02819635|567170166|FG007|Substudy 3|Lost to Follow-up|0|||
157113245|NCT02819635|567170167|FG008|Substudy 3|Lost to Follow-up|1|||
157113246|NCT02819635|567170168|FG009|Substudy 3|Lost to Follow-up|0|||
157113247|NCT02819635|567170169|FG010|Substudy 3|Lost to Follow-up|1|||
157113248|NCT02819635|567170170|FG011|Substudy 3|Lost to Follow-up|1|||
157113249|NCT02819635|567170159|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113250|NCT02819635|567170160|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113251|NCT02819635|567170161|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113252|NCT02819635|567170162|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113253|NCT02819635|567170163|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113254|NCT02819635|567170164|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113255|NCT02819635|567170165|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113256|NCT02819635|567170166|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113257|NCT02819635|567170167|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113258|NCT02819635|567170168|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113259|NCT02819635|567170169|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
157113260|NCT02819635|567170170|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
157113261|NCT02819635|567170159|FG000|Substudy 3|Other, not specified|0|||
157113262|NCT02819635|567170160|FG001|Substudy 3|Other, not specified|0|||
157113263|NCT02819635|567170161|FG002|Substudy 3|Other, not specified|0|||
157113264|NCT02819635|567170162|FG003|Substudy 3|Other, not specified|0|||
157113265|NCT02819635|567170163|FG004|Substudy 3|Other, not specified|0|||
157113266|NCT02819635|567170164|FG005|Substudy 3|Other, not specified|0|||
157113267|NCT02819635|567170165|FG006|Substudy 3|Other, not specified|0|||
157113268|NCT02819635|567170166|FG007|Substudy 3|Other, not specified|0|||
157113269|NCT02819635|567170167|FG008|Substudy 3|Other, not specified|202|||
157113270|NCT02819635|567170168|FG009|Substudy 3|Other, not specified|5|||
157113271|NCT02819635|567170169|FG010|Substudy 3|Other, not specified|89|||
157113272|NCT02819635|567170170|FG011|Substudy 3|Other, not specified|39|||
157113273|NCT01476475|567170171|FG000|Overall Study|Adverse Event|6|||
157113274|NCT01476475|567170172|FG001|Overall Study|Adverse Event|0|||
157113275|NCT01476475|567170171|FG000|Overall Study|Poor compliance to protocol|1|||
157113276|NCT01476475|567170172|FG001|Overall Study|Poor compliance to protocol|1|||
157113277|NCT01476475|567170171|FG000|Overall Study|Other reasons|4|||
157113278|NCT01476475|567170172|FG001|Overall Study|Other reasons|2|||
157113279|NCT00441974|567170173|FG000|Overall Study|Adverse Event|6|||
157113280|NCT00441974|567170173|FG000|Overall Study|Consent Withdrawn|35|||
157113281|NCT00441974|567170173|FG000|Overall Study|Lost to Follow-up|80|||
156773522|NCT02421939|565922775|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
156773523|NCT02421939|565922776|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
156773524|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
157113282|NCT00441974|567170173|FG000|Overall Study|Protocol Violation|7|||
157113283|NCT01146873|567170181|FG000|Overall Study|Transfer out|0|||
157113284|NCT01146873|567170182|FG001|Overall Study|Transfer out|6|||
157113285|NCT00631020|567170188|FG000|Overall Study|Lost to Follow-up|7|||
157113286|NCT00631020|567170188|FG000|Overall Study|Incarcerated|1|||
157113287|NCT02614859|567170190|FG000|Overall Study|Physician Decision|0|||
157113288|NCT02614859|567170191|FG001|Overall Study|Physician Decision|1|||
157113289|NCT03972969|567170193|FG000|3-month Follow-up|Death|1|||
157113290|NCT03972969|567170194|FG001|3-month Follow-up|Death|1|||
157113291|NCT03972969|567170195|FG002|3-month Follow-up|Death|0|||
157113292|NCT03972969|567170193|FG000|6-month Follow-up|Death|1|||
157113293|NCT03972969|567170194|FG001|6-month Follow-up|Death|1|||
157113294|NCT03972969|567170195|FG002|6-month Follow-up|Death|1|||
157113295|NCT03972969|567170193|FG000|6-month Follow-up|Lost to Follow-up|2|||
156773525|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
156773526|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
157113296|NCT03972969|567170194|FG001|6-month Follow-up|Lost to Follow-up|2|||
157113297|NCT03972969|567170195|FG002|6-month Follow-up|Lost to Follow-up|2|||
156773527|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
157113298|NCT04677959|567170196|FG000|Overall Study|Adverse Event|1|||
157113299|NCT04677959|567170197|FG001|Overall Study|Adverse Event|9|||
157113300|NCT04677959|567170196|FG000|Overall Study|Withdrawal by Subject|2|||
157113301|NCT04677959|567170197|FG001|Overall Study|Withdrawal by Subject|15|||
157113302|NCT04677959|567170196|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157113303|NCT04677959|567170197|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157113304|NCT04677959|567170196|FG000|Overall Study|Non-compliance with study drug|0|||
157113305|NCT04677959|567170197|FG001|Overall Study|Non-compliance with study drug|2|||
156773528|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Death|118|||
157113306|NCT04677959|567170196|FG000|Overall Study|Protocol deviation|0|||
157113307|NCT04677959|567170197|FG001|Overall Study|Protocol deviation|11|||
157113308|NCT04677959|567170196|FG000|Overall Study|Lost to Follow-up|9|||
157113309|NCT04677959|567170197|FG001|Overall Study|Lost to Follow-up|13|||
157113310|NCT04677959|567170196|FG000|Overall Study|Other than specified|0|||
157113311|NCT04677959|567170197|FG001|Overall Study|Other than specified|8|||
157113312|NCT00732303|567170198|FG000|Overall Study|Study Terminated|2|||
157113313|NCT01399788|567170205|FG000|First Intervention Period|Adverse Event|1|||
157113314|NCT01399788|567170206|FG001|First Intervention Period|Adverse Event|0|||
156773529|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Death|65|||
156773530|NCT02421939|565922775|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
157113315|NCT02919436|567170207|FG000|Overall Study|Did not undergo surgery|16|||
157113316|NCT02919436|567170208|FG001|Overall Study|Did not undergo surgery|20|||
157113317|NCT02919436|567170207|FG000|Overall Study|Enrolled before trial registration|44|||
157113318|NCT02919436|567170208|FG001|Overall Study|Enrolled before trial registration|33|||
157113319|NCT00283595|567170209|FG000|Overall Study|Withdrawal by Subject|1|||
157113320|NCT00283595|567170210|FG001|Overall Study|Withdrawal by Subject|2|||
157113321|NCT03699007|567170214|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
157113322|NCT03699007|567170215|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
157113323|NCT03699007|567170214|FG000|6-month Follow Up|Lost to Follow-up|2|||
157113324|NCT03699007|567170215|FG001|6-month Follow Up|Lost to Follow-up|3|||
157113325|NCT04718974|567170216|FG000|Overall Study|Death|0|||
157113326|NCT04718974|567170217|FG001|Overall Study|Death|2|||
157113327|NCT04718974|567170216|FG000|Overall Study|Lost to Follow-up|10|||
157113328|NCT04718974|567170217|FG001|Overall Study|Lost to Follow-up|20|||
157113329|NCT04718974|567170216|FG000|Overall Study|Transferred out|2|||
157113330|NCT04718974|567170217|FG001|Overall Study|Transferred out|4|||
156773531|NCT02421939|565922776|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
156773532|NCT01035138|565922780|FG000|Overall Study|Adverse Event|4|||
156773533|NCT01035138|565922781|FG001|Overall Study|Adverse Event|0|||
156773534|NCT01035138|565922782|FG002|Overall Study|Adverse Event|2|||
156773535|NCT01035138|565922780|FG000|Overall Study|Caregiver Decision|2|||
156773536|NCT01035138|565922781|FG001|Overall Study|Caregiver Decision|0|||
156773537|NCT01035138|565922782|FG002|Overall Study|Caregiver Decision|1|||
156773538|NCT01035138|565922780|FG000|Overall Study|Withdrawal by Subject|1|||
156773539|NCT01035138|565922781|FG001|Overall Study|Withdrawal by Subject|0|||
157007210|NCT03034915|566776102|FG000|Overall Study|Withdrawal by Subject|29|||
157113331|NCT00845728|567170218|FG000|Overall Study|Abnormal laboratory value (s)|2|||
157113332|NCT00845728|567170219|FG001|Overall Study|Abnormal laboratory value (s)|2|||
157113333|NCT00845728|567170218|FG000|Overall Study|Patient's inability to use the device|4|||
157007211|NCT03034915|566776103|FG001|Overall Study|Withdrawal by Subject|46|||
157007212|NCT03034915|566776104|FG002|Overall Study|Withdrawal by Subject|41|||
157007213|NCT03034915|566776102|FG000|Overall Study|Protocol Deviation|2|||
157007214|NCT03034915|566776103|FG001|Overall Study|Protocol Deviation|14|||
157007215|NCT03034915|566776104|FG002|Overall Study|Protocol Deviation|7|||
157007216|NCT03034915|566776102|FG000|Overall Study|Lack of Efficacy|8|||
157007217|NCT03034915|566776103|FG001|Overall Study|Lack of Efficacy|16|||
157007218|NCT03034915|566776104|FG002|Overall Study|Lack of Efficacy|18|||
157007219|NCT03034915|566776102|FG000|Overall Study|Site closed|2|||
157007220|NCT03034915|566776103|FG001|Overall Study|Site closed|2|||
157007221|NCT03034915|566776104|FG002|Overall Study|Site closed|4|||
157007222|NCT03034915|566776102|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
157007223|NCT03034915|566776103|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
157007224|NCT03034915|566776104|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
157007225|NCT03034915|566776102|FG000|Overall Study|Physician Decision|1|||
157007226|NCT03034915|566776103|FG001|Overall Study|Physician Decision|5|||
157007227|NCT03034915|566776104|FG002|Overall Study|Physician Decision|2|||
157007228|NCT03388632|566776105|FG000|Triplet C|Clinical progression|0|||
157007229|NCT03388632|566776106|FG001|Triplet C|Clinical progression|0|||
157007230|NCT03388632|566776107|FG002|Triplet C|Clinical progression|0|||
157007231|NCT03388632|566776108|FG003|Triplet C|Clinical progression|0|||
157007232|NCT03388632|566776109|FG004|Triplet C|Clinical progression|1|||
157007233|NCT03388632|566776110|FG005|Triplet C|Clinical progression|0|||
157007234|NCT03388632|566776111|FG006|Triplet C|Clinical progression|0|||
157007235|NCT03388632|566776112|FG007|Triplet C|Clinical progression|0|||
157007236|NCT03388632|566776113|FG008|Triplet C|Clinical progression|0|||
157007237|NCT03388632|566776105|FG000|Triplet C|42-day lapse in tx|0|||
157007238|NCT03388632|566776106|FG001|Triplet C|42-day lapse in tx|0|||
157007239|NCT03388632|566776107|FG002|Triplet C|42-day lapse in tx|0|||
157007240|NCT03388632|566776108|FG003|Triplet C|42-day lapse in tx|0|||
157007241|NCT03388632|566776109|FG004|Triplet C|42-day lapse in tx|1|||
156773540|NCT01035138|565922782|FG002|Overall Study|Withdrawal by Subject|0|||
157007242|NCT03388632|566776110|FG005|Triplet C|42-day lapse in tx|0|||
156773541|NCT01035138|565922780|FG000|Overall Study|Physician Decision|0|||
156773542|NCT01035138|565922781|FG001|Overall Study|Physician Decision|0|||
156773543|NCT01035138|565922782|FG002|Overall Study|Physician Decision|1|||
157007243|NCT03388632|566776111|FG006|Triplet C|42-day lapse in tx|0|||
156773544|NCT01035138|565922780|FG000|Overall Study|Sponsor Decision|66|||
157007244|NCT03388632|566776112|FG007|Triplet C|42-day lapse in tx|0|||
157007245|NCT03388632|566776113|FG008|Triplet C|42-day lapse in tx|0|||
157007246|NCT03388632|566776105|FG000|Triplet C|Adverse Event|0|||
157007247|NCT03388632|566776106|FG001|Triplet C|Adverse Event|0|||
157007248|NCT03388632|566776107|FG002|Triplet C|Adverse Event|0|||
157007249|NCT03388632|566776108|FG003|Triplet C|Adverse Event|0|||
157007250|NCT03388632|566776109|FG004|Triplet C|Adverse Event|0|||
157007251|NCT03388632|566776110|FG005|Triplet C|Adverse Event|0|||
157007252|NCT03388632|566776111|FG006|Triplet C|Adverse Event|0|||
157007253|NCT03388632|566776112|FG007|Triplet C|Adverse Event|0|||
157007254|NCT03388632|566776113|FG008|Triplet C|Adverse Event|1|||
157007255|NCT03388632|566776105|FG000|Triplet C|Switched to alternative treatment|0|||
157007256|NCT03388632|566776106|FG001|Triplet C|Switched to alternative treatment|0|||
157007257|NCT03388632|566776107|FG002|Triplet C|Switched to alternative treatment|0|||
157007258|NCT03388632|566776108|FG003|Triplet C|Switched to alternative treatment|0|||
157007259|NCT03388632|566776109|FG004|Triplet C|Switched to alternative treatment|0|||
157007260|NCT03388632|566776110|FG005|Triplet C|Switched to alternative treatment|0|||
157007261|NCT03388632|566776111|FG006|Triplet C|Switched to alternative treatment|0|||
157007262|NCT03388632|566776112|FG007|Triplet C|Switched to alternative treatment|1|||
157007263|NCT03388632|566776113|FG008|Triplet C|Switched to alternative treatment|0|||
157007264|NCT03388632|566776105|FG000|Triplet C|Participant choice|0|||
157007265|NCT03388632|566776106|FG001|Triplet C|Participant choice|0|||
157007266|NCT03388632|566776107|FG002|Triplet C|Participant choice|0|||
157007267|NCT03388632|566776108|FG003|Triplet C|Participant choice|0|||
157007268|NCT03388632|566776109|FG004|Triplet C|Participant choice|0|||
157007269|NCT03388632|566776110|FG005|Triplet C|Participant choice|1|||
157007270|NCT03388632|566776111|FG006|Triplet C|Participant choice|0|||
157007271|NCT03388632|566776112|FG007|Triplet C|Participant choice|0|||
157007272|NCT03388632|566776113|FG008|Triplet C|Participant choice|0|||
157007273|NCT02115282|566776114|FG000|Overall Study|Disease progression during treatment|216|||
157007274|NCT02115282|566776115|FG001|Overall Study|Disease progression during treatment|229|||
157007275|NCT02115282|566776114|FG000|Overall Study|Adverse Event|49|||
157007276|NCT02115282|566776115|FG001|Overall Study|Adverse Event|23|||
157007277|NCT02115282|566776114|FG000|Overall Study|Death|1|||
157007278|NCT02115282|566776115|FG001|Overall Study|Death|3|||
157007279|NCT02115282|566776114|FG000|Overall Study|Alternative therapy|1|||
157007280|NCT02115282|566776115|FG001|Overall Study|Alternative therapy|1|||
157007281|NCT02115282|566776114|FG000|Overall Study|Complicating disease|0|||
157007282|NCT02115282|566776115|FG001|Overall Study|Complicating disease|3|||
157007283|NCT02115282|566776114|FG000|Overall Study|Withdrawal by Subject|12|||
157007284|NCT02115282|566776115|FG001|Overall Study|Withdrawal by Subject|10|||
157007285|NCT02115282|566776114|FG000|Overall Study|Symptomatic progression/deterioration|7|||
157007286|NCT02115282|566776115|FG001|Overall Study|Symptomatic progression/deterioration|18|||
157007287|NCT02115282|566776114|FG000|Overall Study|Non-compliance|5|||
157007288|NCT02115282|566776115|FG001|Overall Study|Non-compliance|1|||
157007289|NCT02115282|566776114|FG000|Overall Study|Protocol Violation|2|||
157007290|NCT02115282|566776115|FG001|Overall Study|Protocol Violation|2|||
157007291|NCT02115282|566776114|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
157007292|NCT02115282|566776115|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
157007293|NCT02115282|566776114|FG000|Overall Study|Not start protocol therapy|9|||
157007294|NCT02115282|566776115|FG001|Overall Study|Not start protocol therapy|10|||
157007295|NCT04795752|566776117|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
157007296|NCT04795752|566776118|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
157007297|NCT04795752|566776117|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
157007298|NCT04795752|566776118|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
157007299|NCT04795752|566776117|FG000|Primary Endpoint Phase|Physician Decision|2|||
157007300|NCT04795752|566776118|FG001|Primary Endpoint Phase|Physician Decision|0|||
157007301|NCT04795752|566776117|FG000|Primary Endpoint Phase|Other|4|||
157007302|NCT04795752|566776118|FG001|Primary Endpoint Phase|Other|1|||
157007303|NCT04795752|566776117|FG000|Primary Endpoint Phase|Protocol Violation|1|||
157007304|NCT04795752|566776118|FG001|Primary Endpoint Phase|Protocol Violation|0|||
157007305|NCT04795752|566776117|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
157007306|NCT04795752|566776118|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
157007307|NCT04795752|566776117|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
157007308|NCT04795752|566776118|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
157007309|NCT04795752|566776117|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
157007310|NCT04795752|566776118|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
157007311|NCT04795752|566776117|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
157007312|NCT04795752|566776118|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
157007313|NCT04795752|566776117|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
157007314|NCT04795752|566776118|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
157007315|NCT00792948|566776119|FG000|Overall Study|Adverse Event|6|||
157007316|NCT00792948|566776119|FG000|Overall Study|Death|4|||
157007317|NCT00792948|566776119|FG000|Overall Study|Withdrawal by Subject|3|||
156773545|NCT01035138|565922781|FG001|Overall Study|Sponsor Decision|60|||
156773546|NCT01035138|565922782|FG002|Overall Study|Sponsor Decision|42|||
156773547|NCT01035138|565922780|FG000|Overall Study|Lost to Follow-up|0|||
156773548|NCT01035138|565922781|FG001|Overall Study|Lost to Follow-up|0|||
156773549|NCT01035138|565922782|FG002|Overall Study|Lost to Follow-up|1|||
157113334|NCT00845728|567170219|FG001|Overall Study|Patient's inability to use the device|6|||
157113335|NCT00845728|567170218|FG000|Overall Study|Abnormal test procedure result (s)|7|||
157113336|NCT00845728|567170219|FG001|Overall Study|Abnormal test procedure result (s)|2|||
156773550|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773551|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773552|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773553|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773554|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
156773555|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
156773556|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
156773557|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773558|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773559|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773560|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773561|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156773562|NCT02966834|565922783|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773563|NCT02966834|565922784|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773564|NCT02966834|565922785|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
156773565|NCT02966834|565922786|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
156773566|NCT02966834|565922787|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
156773567|NCT02966834|565922788|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
156773568|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773569|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773570|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
156773571|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
156773572|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
156773573|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
156773574|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773575|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773576|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773577|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
156773578|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773579|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156773580|NCT02966834|565922783|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773581|NCT02966834|565922784|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773582|NCT02966834|565922785|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773583|NCT02966834|565922786|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
156773584|NCT02966834|565922787|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773585|NCT02966834|565922788|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
156773586|NCT00655889|565922789|FG000|Overall Study|Inadequate cell growth|1|||
156773587|NCT00655889|565922789|FG000|Overall Study|Protocol Violation|1|||
156773588|NCT03573297|565922792|FG000|Open Label Treatment Period|Adverse Event|67|||
156773589|NCT03573297|565922793|FG001|Open Label Treatment Period|Adverse Event|0|||
156773590|NCT03573297|565922794|FG002|Open Label Treatment Period|Adverse Event|0|||
156773591|NCT03573297|565922795|FG003|Open Label Treatment Period|Adverse Event|0|||
156773592|NCT03573297|565922792|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
156773593|NCT03573297|565922793|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
156773594|NCT03573297|565922794|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
156773595|NCT03573297|565922795|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
156773596|NCT03573297|565922792|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
156773597|NCT03573297|565922793|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
156773598|NCT03573297|565922794|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
156773599|NCT03573297|565922795|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
156773600|NCT03573297|565922792|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
156773601|NCT03573297|565922793|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
156773602|NCT03573297|565922794|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
156773603|NCT03573297|565922795|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
156773604|NCT03573297|565922792|FG000|Open Label Treatment Period|Pregnancy|1|||
156773605|NCT03573297|565922793|FG001|Open Label Treatment Period|Pregnancy|0|||
156773606|NCT03573297|565922794|FG002|Open Label Treatment Period|Pregnancy|0|||
156773607|NCT03573297|565922795|FG003|Open Label Treatment Period|Pregnancy|0|||
156773608|NCT03573297|565922792|FG000|Open Label Treatment Period|Protocol Violation|17|||
156773609|NCT03573297|565922793|FG001|Open Label Treatment Period|Protocol Violation|0|||
156773610|NCT03573297|565922794|FG002|Open Label Treatment Period|Protocol Violation|0|||
156773611|NCT03573297|565922795|FG003|Open Label Treatment Period|Protocol Violation|0|||
156773612|NCT03573297|565922792|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
156773613|NCT03573297|565922793|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773614|NCT03573297|565922794|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773615|NCT03573297|565922795|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
156773616|NCT03573297|565922792|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
156773617|NCT03573297|565922793|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773618|NCT03573297|565922794|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773619|NCT03573297|565922795|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
156773620|NCT03573297|565922792|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
156773621|NCT03573297|565922793|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773622|NCT03573297|565922794|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773623|NCT03573297|565922795|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
156773624|NCT03573297|565922792|FG000|Open Label Treatment Period|Other, Not Specified|7|||
156773625|NCT03573297|565922793|FG001|Open Label Treatment Period|Other, Not Specified|0|||
156773626|NCT03573297|565922794|FG002|Open Label Treatment Period|Other, Not Specified|0|||
156773627|NCT03573297|565922795|FG003|Open Label Treatment Period|Other, Not Specified|0|||
156773628|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
156773629|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
156773630|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
156773631|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
156773632|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156773633|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156773634|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Adverse Event|5|||
156773635|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Adverse Event|1|||
156773636|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773637|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
156773638|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773639|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
156773640|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156773641|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
156773642|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
156773643|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
156773644|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156773645|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
156773646|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
157207527|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
157207528|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Death|5|||
157207529|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Death|2|||
157207530|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
157207531|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
156773647|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
157007318|NCT00792948|566776119|FG000|Overall Study|Ineligible|2|||
157207532|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
157207533|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
157207534|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
157207535|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
157207536|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Relapse|1|||
157207537|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Relapse|0|||
157207538|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
157207539|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
157207540|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
157207541|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
157207542|NCT00111007|567504508|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
156773648|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156773649|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
156773650|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
156773651|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
156773652|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
156773653|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
156773654|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
156773655|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
156773656|NCT03573297|565922792|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
156773657|NCT03573297|565922793|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
157007319|NCT00792948|566776119|FG000|Overall Study|Insurance denial - not treated|1|||
157007320|NCT00792948|566776119|FG000|Overall Study|Physician Decision|11|||
157007321|NCT00792948|566776119|FG000|Overall Study|Protocol Violation|1|||
157007322|NCT06129045|566776120|FG000|Overall Study|Lost to Follow-up|1|||
157007323|NCT06129045|566776121|FG001|Overall Study|Lost to Follow-up|1|||
157007324|NCT06129045|566776122|FG002|Overall Study|Lost to Follow-up|4|||
157007325|NCT01390402|566776129|FG000|Overall Study|Death|1|||
157007326|NCT01390402|566776129|FG000|Overall Study|Disease Progression|4|||
157007327|NCT03492177|566776130|FG000|Overall Study|Adverse Event|1|||
157007328|NCT03492177|566776131|FG001|Overall Study|Adverse Event|0|||
157007329|NCT03492177|566776132|FG002|Overall Study|Adverse Event|0|||
157007330|NCT03492177|566776130|FG000|Overall Study|Death|3|||
157007331|NCT03492177|566776131|FG001|Overall Study|Death|0|||
157007332|NCT03492177|566776132|FG002|Overall Study|Death|3|||
157007333|NCT03492177|566776130|FG000|Overall Study|Lack of Efficacy|1|||
157007334|NCT03492177|566776131|FG001|Overall Study|Lack of Efficacy|2|||
157007335|NCT03492177|566776132|FG002|Overall Study|Lack of Efficacy|0|||
157007336|NCT03492177|566776130|FG000|Overall Study|Other|1|||
157007337|NCT03492177|566776131|FG001|Overall Study|Other|0|||
157007338|NCT03492177|566776132|FG002|Overall Study|Other|0|||
157007339|NCT03492177|566776130|FG000|Overall Study|Ongoing|16|||
157007340|NCT03492177|566776131|FG001|Overall Study|Ongoing|19|||
157007341|NCT03492177|566776132|FG002|Overall Study|Ongoing|17|||
157007342|NCT02445391|566776136|FG000|Overall Study|No active protocol treatment|3|||
157007343|NCT02445391|566776137|FG001|Overall Study|No active protocol treatment|0|||
157007344|NCT02445391|566776138|FG002|Overall Study|No active protocol treatment|0|||
157007345|NCT02445391|566776136|FG000|Overall Study|Adverse Event|0|||
157007346|NCT02445391|566776137|FG001|Overall Study|Adverse Event|21|||
157007347|NCT02445391|566776138|FG002|Overall Study|Adverse Event|12|||
157007348|NCT02445391|566776136|FG000|Overall Study|Alternative therapy|0|||
157007349|NCT02445391|566776137|FG001|Overall Study|Alternative therapy|0|||
157007350|NCT02445391|566776138|FG002|Overall Study|Alternative therapy|1|||
157007351|NCT02445391|566776136|FG000|Overall Study|Disease progression|0|||
157007352|NCT02445391|566776137|FG001|Overall Study|Disease progression|7|||
157007353|NCT02445391|566776138|FG002|Overall Study|Disease progression|22|||
157007354|NCT02445391|566776136|FG000|Overall Study|Complicating disease|0|||
157007355|NCT02445391|566776137|FG001|Overall Study|Complicating disease|2|||
157007356|NCT02445391|566776138|FG002|Overall Study|Complicating disease|1|||
157207543|NCT00111007|567504509|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
157007357|NCT02445391|566776136|FG000|Overall Study|Withdrawal by Subject|0|||
157007358|NCT02445391|566776137|FG001|Overall Study|Withdrawal by Subject|4|||
157007359|NCT02445391|566776138|FG002|Overall Study|Withdrawal by Subject|9|||
157007360|NCT02445391|566776136|FG000|Overall Study|Financial issue|0|||
157007361|NCT02445391|566776137|FG001|Overall Study|Financial issue|0|||
157007362|NCT02445391|566776138|FG002|Overall Study|Financial issue|2|||
157007363|NCT02445391|566776136|FG000|Overall Study|Still on treatment|0|||
157007364|NCT02445391|566776137|FG001|Overall Study|Still on treatment|7|||
157007365|NCT02445391|566776138|FG002|Overall Study|Still on treatment|16|||
157007366|NCT02445391|566776136|FG000|Overall Study|Not start protocol therapy|0|||
157007367|NCT02445391|566776137|FG001|Overall Study|Not start protocol therapy|12|||
157007368|NCT02445391|566776138|FG002|Overall Study|Not start protocol therapy|9|||
157007369|NCT05850520|566776141|FG000|Overall Study|Withdrawal by Subject|8|||
157007370|NCT05850520|566776142|FG001|Overall Study|Withdrawal by Subject|8|||
157007371|NCT05850520|566776143|FG002|Overall Study|Withdrawal by Subject|16|||
157207544|NCT00111007|567504508|FG000|Active Follow-up|Adverse Event|1|||
156773658|NCT03573297|565922794|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
156773659|NCT03573297|565922795|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
156773660|NCT02781324|565922797|FG000|Overall Study|Withdrawal by Subject|1|||
156773661|NCT02781324|565922798|FG001|Overall Study|Withdrawal by Subject|0|||
156773662|NCT02781324|565922797|FG000|Overall Study|Physician Decision|1|||
156773663|NCT02781324|565922798|FG001|Overall Study|Physician Decision|2|||
156773664|NCT03846479|565924688|FG000|Overall Study|Death|8|||
156773665|NCT03846479|565924688|FG000|Overall Study|Lost to Follow-up|1|||
156773666|NCT00300053|565924693|FG000|Overall Study|Patient/Caregiver Preference|2|||
156773667|NCT00300053|565924694|FG001|Overall Study|Patient/Caregiver Preference|2|||
156773668|NCT00300053|565924695|FG002|Overall Study|Patient/Caregiver Preference|3|||
156773669|NCT00300053|565924693|FG000|Overall Study|Death|0|||
156773670|NCT00300053|565924694|FG001|Overall Study|Death|0|||
156773671|NCT00300053|565924695|FG002|Overall Study|Death|3|||
156773672|NCT00300053|565924693|FG000|Overall Study|Lost to Follow-up|0|||
156773673|NCT00300053|565924694|FG001|Overall Study|Lost to Follow-up|1|||
156773674|NCT00300053|565924695|FG002|Overall Study|Lost to Follow-up|0|||
156773675|NCT03095287|565924699|FG000|Overall Study|Treatment Failure|1|||
156773676|NCT03095287|565924699|FG000|Overall Study|Adverse Event|1|||
156773677|NCT01294514|565924702|FG000|Overall Study|Excluded due to Arrhythmia|1|||
156773678|NCT01963611|565924703|FG000|Overall Study|Adverse Event|1|||
156773679|NCT01963611|565924704|FG001|Overall Study|Adverse Event|1|||
156773680|NCT01963611|565924705|FG002|Overall Study|Adverse Event|3|||
156773681|NCT01963611|565924706|FG003|Overall Study|Adverse Event|4|||
156773682|NCT01963611|565924707|FG004|Overall Study|Adverse Event|3|||
156773683|NCT01963611|565924703|FG000|Overall Study|Protocol Violation|0|||
156773684|NCT01963611|565924704|FG001|Overall Study|Protocol Violation|0|||
156773685|NCT01963611|565924705|FG002|Overall Study|Protocol Violation|0|||
156773686|NCT01963611|565924706|FG003|Overall Study|Protocol Violation|1|||
156773687|NCT01963611|565924707|FG004|Overall Study|Protocol Violation|0|||
156773688|NCT01963611|565924703|FG000|Overall Study|Lack of Efficacy|0|||
156773689|NCT01963611|565924704|FG001|Overall Study|Lack of Efficacy|0|||
156773690|NCT01963611|565924705|FG002|Overall Study|Lack of Efficacy|0|||
156773691|NCT01963611|565924706|FG003|Overall Study|Lack of Efficacy|1|||
156773692|NCT01963611|565924707|FG004|Overall Study|Lack of Efficacy|0|||
156773693|NCT01963611|565924703|FG000|Overall Study|Withdrawal by Subject|3|||
156773694|NCT01963611|565924704|FG001|Overall Study|Withdrawal by Subject|2|||
156773695|NCT01963611|565924705|FG002|Overall Study|Withdrawal by Subject|1|||
156773696|NCT01963611|565924706|FG003|Overall Study|Withdrawal by Subject|1|||
156773697|NCT01963611|565924707|FG004|Overall Study|Withdrawal by Subject|3|||
156773698|NCT01963611|565924703|FG000|Overall Study|Other|47|||
156773699|NCT01963611|565924704|FG001|Overall Study|Other|46|||
156773700|NCT01963611|565924705|FG002|Overall Study|Other|48|||
156773701|NCT01963611|565924706|FG003|Overall Study|Other|45|||
156773702|NCT01963611|565924707|FG004|Overall Study|Other|45|||
156773703|NCT01126424|565924709|FG000|Overall Study|Adverse Event|0|||
156773704|NCT01126424|565924710|FG001|Overall Study|Adverse Event|0|||
157007372|NCT05850520|566776141|FG000|Overall Study|Lost to Follow-up|2|||
157007373|NCT05850520|566776142|FG001|Overall Study|Lost to Follow-up|2|||
157007374|NCT05850520|566776143|FG002|Overall Study|Lost to Follow-up|2|||
157007375|NCT05850520|566776141|FG000|Overall Study|Death|2|||
157007376|NCT05850520|566776142|FG001|Overall Study|Death|2|||
157007377|NCT05850520|566776143|FG002|Overall Study|Death|3|||
157007378|NCT05850520|566776141|FG000|Overall Study|Adverse Event|2|||
157007379|NCT05850520|566776142|FG001|Overall Study|Adverse Event|0|||
157007380|NCT05850520|566776143|FG002|Overall Study|Adverse Event|1|||
157007381|NCT05850520|566776141|FG000|Overall Study|Physician Decision|0|||
157007382|NCT05850520|566776142|FG001|Overall Study|Physician Decision|1|||
157007383|NCT05850520|566776143|FG002|Overall Study|Physician Decision|0|||
157007384|NCT05850520|566776141|FG000|Overall Study|Protocol deviation|0|||
157007385|NCT05850520|566776142|FG001|Overall Study|Protocol deviation|0|||
157007386|NCT05850520|566776143|FG002|Overall Study|Protocol deviation|1|||
157007387|NCT05850520|566776141|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
156773705|NCT01126424|565924711|FG002|Overall Study|Adverse Event|0|||
156773706|NCT01126424|565924712|FG003|Overall Study|Adverse Event|0|||
156773707|NCT01126424|565924713|FG004|Overall Study|Adverse Event|1|||
156773708|NCT01126424|565924714|FG005|Overall Study|Adverse Event|0|||
156773709|NCT01126424|565924709|FG000|Overall Study|Withdrawal by Subject|0|||
156773710|NCT01126424|565924710|FG001|Overall Study|Withdrawal by Subject|0|||
156773711|NCT01126424|565924711|FG002|Overall Study|Withdrawal by Subject|1|||
157007388|NCT05850520|566776142|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
157007389|NCT05850520|566776143|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
157007390|NCT01241292|566776713|FG000|Overall Study|Administrative Reason by Sponsor|1|||
157007391|NCT01241292|566776714|FG001|Overall Study|Administrative Reason by Sponsor|0|||
157007392|NCT01241292|566776713|FG000|Overall Study|Disease Progression|2|||
157007393|NCT01241292|566776714|FG001|Overall Study|Disease Progression|0|||
157007394|NCT01241292|566776713|FG000|Overall Study|Study Drug Toxicity|0|||
157007395|NCT01241292|566776714|FG001|Overall Study|Study Drug Toxicity|1|||
157113337|NCT00845728|567170218|FG000|Overall Study|Lost to Follow-up|22|||
157113338|NCT00845728|567170219|FG001|Overall Study|Lost to Follow-up|13|||
157113339|NCT00845728|567170218|FG000|Overall Study|Death|24|||
157113340|NCT00845728|567170219|FG001|Overall Study|Death|26|||
157113341|NCT00845728|567170218|FG000|Overall Study|Administrative Problems|34|||
157113342|NCT00845728|567170219|FG001|Overall Study|Administrative Problems|26|||
157113343|NCT00845728|567170218|FG000|Overall Study|Protocol Violation|36|||
157113344|NCT00845728|567170219|FG001|Overall Study|Protocol Violation|24|||
157113345|NCT00845728|567170218|FG000|Overall Study|Lack of Efficacy|51|||
157113346|NCT00845728|567170219|FG001|Overall Study|Lack of Efficacy|39|||
157113347|NCT00845728|567170218|FG000|Overall Study|Adverse Event|101|||
157113348|NCT00845728|567170219|FG001|Overall Study|Adverse Event|96|||
157113349|NCT00845728|567170218|FG000|Overall Study|Withdrawal by Subject|105|||
157113350|NCT00845728|567170219|FG001|Overall Study|Withdrawal by Subject|108|||
157113351|NCT01389752|567170220|FG000|Study Period 1|Sponsor decision|0|||
156773712|NCT01126424|565924712|FG003|Overall Study|Withdrawal by Subject|3|||
156773713|NCT01126424|565924713|FG004|Overall Study|Withdrawal by Subject|1|||
157113352|NCT01389752|567170221|FG001|Study Period 1|Sponsor decision|2|||
157113353|NCT01389752|567170220|FG000|Study Period 2|Sponsor decision|1|||
157113354|NCT01389752|567170221|FG001|Study Period 2|Sponsor decision|0|||
157113355|NCT03259074|567170222|FG000|Overall Study|Adverse Event|9|||
157113356|NCT03259074|567170223|FG001|Overall Study|Adverse Event|12|||
157113357|NCT03259074|567170224|FG002|Overall Study|Adverse Event|8|||
157113358|NCT03259074|567170222|FG000|Overall Study|Death|1|||
156773714|NCT01126424|565924714|FG005|Overall Study|Withdrawal by Subject|0|||
157113359|NCT03259074|567170223|FG001|Overall Study|Death|1|||
157113360|NCT03259074|567170224|FG002|Overall Study|Death|3|||
157113361|NCT03259074|567170222|FG000|Overall Study|Lost to Follow-up|2|||
157113362|NCT03259074|567170223|FG001|Overall Study|Lost to Follow-up|4|||
157113363|NCT03259074|567170224|FG002|Overall Study|Lost to Follow-up|3|||
157113364|NCT03259074|567170222|FG000|Overall Study|New Therapy For Study Indication|1|||
157113365|NCT03259074|567170223|FG001|Overall Study|New Therapy For Study Indication|2|||
157113366|NCT03259074|567170224|FG002|Overall Study|New Therapy For Study Indication|2|||
157113367|NCT03259074|567170222|FG000|Overall Study|Physician Decision|4|||
157113368|NCT03259074|567170223|FG001|Overall Study|Physician Decision|12|||
157113369|NCT03259074|567170224|FG002|Overall Study|Physician Decision|10|||
157113370|NCT03259074|567170222|FG000|Overall Study|Pregnancy|1|||
157113371|NCT03259074|567170223|FG001|Overall Study|Pregnancy|1|||
157113372|NCT03259074|567170224|FG002|Overall Study|Pregnancy|0|||
157113373|NCT03259074|567170222|FG000|Overall Study|Progressive Disease|1|||
157113374|NCT03259074|567170223|FG001|Overall Study|Progressive Disease|0|||
157113375|NCT03259074|567170224|FG002|Overall Study|Progressive Disease|0|||
157113376|NCT03259074|567170222|FG000|Overall Study|Protocol Deviation|1|||
157113377|NCT03259074|567170223|FG001|Overall Study|Protocol Deviation|1|||
157113378|NCT03259074|567170224|FG002|Overall Study|Protocol Deviation|3|||
157113379|NCT03259074|567170222|FG000|Overall Study|Subject/Guardian Decision|13|||
157113380|NCT03259074|567170223|FG001|Overall Study|Subject/Guardian Decision|16|||
157113381|NCT03259074|567170224|FG002|Overall Study|Subject/Guardian Decision|14|||
157113382|NCT00053417|567170235|FG000|Overall Study|Adverse Event|1|||
157113383|NCT00053417|567170236|FG001|Overall Study|Adverse Event|0|||
157113384|NCT00053417|567170237|FG002|Overall Study|Adverse Event|1|||
157113385|NCT00053417|567170238|FG003|Overall Study|Adverse Event|5|||
157113386|NCT00053417|567170235|FG000|Overall Study|Non-Compliance|0|||
157113387|NCT00053417|567170236|FG001|Overall Study|Non-Compliance|0|||
157113388|NCT00053417|567170237|FG002|Overall Study|Non-Compliance|0|||
157113389|NCT00053417|567170238|FG003|Overall Study|Non-Compliance|1|||
157113390|NCT00053417|567170235|FG000|Overall Study|Withdrawal by Subject|0|||
157207545|NCT00111007|567504509|FG001|Active Follow-up|Adverse Event|0|||
156773715|NCT02127671|565924715|FG000|Overall Study|Death|2|||
157113391|NCT00053417|567170236|FG001|Overall Study|Withdrawal by Subject|1|||
157113392|NCT00053417|567170237|FG002|Overall Study|Withdrawal by Subject|0|||
157113393|NCT00053417|567170238|FG003|Overall Study|Withdrawal by Subject|0|||
157113394|NCT00053417|567170235|FG000|Overall Study|Lost to Follow-up|1|||
157207546|NCT00111007|567504508|FG000|Active Follow-up|Death|2|||
157207547|NCT00111007|567504509|FG001|Active Follow-up|Death|0|||
157207548|NCT00111007|567504508|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
157207549|NCT00111007|567504509|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
157207550|NCT00111007|567504508|FG000|Long Term Follow-up|Death|34|||
157207551|NCT00111007|567504509|FG001|Long Term Follow-up|Death|39|||
157207552|NCT00111007|567504508|FG000|Long Term Follow-up|Lost to Follow-up|1|||
157207553|NCT00111007|567504509|FG001|Long Term Follow-up|Lost to Follow-up|1|||
157207554|NCT00111007|567504508|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
157207555|NCT00111007|567504509|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
157207556|NCT00111007|567504508|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
157207557|NCT00111007|567504509|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
157207558|NCT00111007|567504508|FG000|Long Term Follow-up|Missing|10|||
157207559|NCT00111007|567504509|FG001|Long Term Follow-up|Missing|3|||
157207560|NCT01495793|567504510|FG000|Overall Study|Lost to Follow-up|1|||
157207561|NCT01495793|567504510|FG000|Overall Study|Violation of inclusion criteria|1|||
157207562|NCT02362646|567504514|FG000|Overall Study|Death|15|||
156773716|NCT02127671|565924716|FG001|Overall Study|Death|2|||
156773717|NCT02127671|565924715|FG000|Overall Study|Lost to Follow-up|4|||
156773718|NCT02127671|565924716|FG001|Overall Study|Lost to Follow-up|2|||
156773719|NCT02127671|565924715|FG000|Overall Study|Physician Decision|1|||
157113395|NCT00053417|567170236|FG001|Overall Study|Lost to Follow-up|1|||
157113396|NCT00053417|567170237|FG002|Overall Study|Lost to Follow-up|0|||
157113397|NCT00053417|567170238|FG003|Overall Study|Lost to Follow-up|0|||
157113398|NCT02409290|567170239|FG000|Overall Study|Protocol Violation|3|||
157113399|NCT02409290|567170240|FG001|Overall Study|Protocol Violation|6|||
157113400|NCT02409290|567170241|FG002|Overall Study|Protocol Violation|9|||
157113401|NCT02409290|567170242|FG003|Overall Study|Protocol Violation|4|||
157113402|NCT02409290|567170239|FG000|Overall Study|No positive culture/no baseline sample|3|||
157113403|NCT02409290|567170240|FG001|Overall Study|No positive culture/no baseline sample|9|||
157113404|NCT02409290|567170241|FG002|Overall Study|No positive culture/no baseline sample|6|||
157113405|NCT02409290|567170242|FG003|Overall Study|No positive culture/no baseline sample|5|||
157113406|NCT02409290|567170239|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
157113407|NCT02409290|567170240|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
157113408|NCT02409290|567170241|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
157113409|NCT02409290|567170242|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
157113410|NCT04251910|567170248|FG000|Overall Study|Covid 19 lockdown|0|||
157113411|NCT04251910|567170249|FG001|Overall Study|Covid 19 lockdown|5|||
157113412|NCT04251910|567170250|FG002|Overall Study|Covid 19 lockdown|0|||
157113413|NCT04251910|567170251|FG003|Overall Study|Covid 19 lockdown|4|||
157113414|NCT04251910|567170252|FG004|Overall Study|Covid 19 lockdown|0|||
157113415|NCT04251910|567170253|FG005|Overall Study|Covid 19 lockdown|0|||
157113416|NCT04251910|567170248|FG000|Overall Study|Assisted living facility was closed|0|||
157113417|NCT04251910|567170249|FG001|Overall Study|Assisted living facility was closed|0|||
157113418|NCT04251910|567170250|FG002|Overall Study|Assisted living facility was closed|0|||
157113419|NCT04251910|567170251|FG003|Overall Study|Assisted living facility was closed|0|||
157113420|NCT04251910|567170252|FG004|Overall Study|Assisted living facility was closed|1|||
157113421|NCT04251910|567170253|FG005|Overall Study|Assisted living facility was closed|0|||
157113422|NCT02830776|567170256|FG000|Overall Study|Lost to Follow-up|1|||
157113423|NCT01553188|567170266|FG000|Overall Study|Patient choice|1|||
157113424|NCT01553188|567170267|FG001|Overall Study|Patient choice|0|||
157113425|NCT01553188|567170268|FG002|Overall Study|Patient choice|0|||
157113426|NCT01553188|567170269|FG003|Overall Study|Patient choice|0|||
157113427|NCT01553188|567170266|FG000|Overall Study|Intercurrent illness and adverse event|0|||
157113428|NCT01553188|567170267|FG001|Overall Study|Intercurrent illness and adverse event|1|||
157113429|NCT01553188|567170268|FG002|Overall Study|Intercurrent illness and adverse event|2|||
157113430|NCT01553188|567170269|FG003|Overall Study|Intercurrent illness and adverse event|0|||
157113431|NCT05289570|567170271|FG000|Overall Study|Physician Decision|1|||
157113432|NCT04544475|567170276|FG000|Overall Study|Withdrawal by Subject|1|||
157113433|NCT04544475|567170277|FG001|Overall Study|Withdrawal by Subject|3|||
157113434|NCT00135668|567170282|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
157113435|NCT00135668|567170283|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
156773720|NCT02127671|565924716|FG001|Overall Study|Physician Decision|0|||
157113436|NCT00135668|567170284|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
157113437|NCT00135668|567170285|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
157113438|NCT04126083|567170286|FG000|Overall Study|Withdrawal by Subject|1|||
157207563|NCT02362646|567504515|FG001|Overall Study|Death|8|||
156773721|NCT02127671|565924715|FG000|Overall Study|incarceration|0|||
157207564|NCT02362646|567504514|FG000|Overall Study|Withdrawal by Subject|2|||
157207565|NCT02362646|567504515|FG001|Overall Study|Withdrawal by Subject|2|||
157207566|NCT02362646|567504514|FG000|Overall Study|received transplant|21|||
157207567|NCT02362646|567504515|FG001|Overall Study|received transplant|14|||
157113439|NCT00932360|567170287|FG000|Washout (One Week)|Withdrawal by Subject|0|||
157113440|NCT00932360|567170288|FG001|Washout (One Week)|Withdrawal by Subject|0|||
157113441|NCT00932360|567170289|FG002|Washout (One Week)|Withdrawal by Subject|0|||
157113442|NCT00932360|567170290|FG003|Washout (One Week)|Withdrawal by Subject|0|||
157113443|NCT00932360|567170291|FG004|Washout (One Week)|Withdrawal by Subject|2|||
157113444|NCT00932360|567170292|FG005|Washout (One Week)|Withdrawal by Subject|0|||
157113445|NCT01892163|567170295|FG000|Overall Study|Death|1|||
157113446|NCT01892163|567170296|FG001|Overall Study|Death|1|||
157113447|NCT01892163|567170295|FG000|Overall Study|Lost to Follow-up|1|||
157113448|NCT01892163|567170296|FG001|Overall Study|Lost to Follow-up|0|||
156773722|NCT02127671|565924716|FG001|Overall Study|incarceration|1|||
156773723|NCT02127671|565924715|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
156773724|NCT02127671|565924716|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
156773725|NCT02394275|565924717|FG000|Overall Study|Adverse Event|22|||
156773726|NCT02394275|565924717|FG000|Overall Study|Lost to Follow-up|7|||
156773727|NCT00782067|565924719|FG000|Overall Study|Adverse Event|35|||
157007396|NCT01241292|566776713|FG000|Overall Study|Participant Discontinued Treatment|0|||
157007397|NCT01241292|566776714|FG001|Overall Study|Participant Discontinued Treatment|2|||
157007398|NCT01595061|566776715|FG000|Overall Study|Never Treated|3|||
157007399|NCT01595061|566776715|FG000|Overall Study|Inadequate Pathology|1|||
156773728|NCT00782067|565924719|FG000|Overall Study|Subject withdrew consent|11|||
157007400|NCT03194958|566776718|FG000|Overall Study|Death|0|||
157007401|NCT03194958|566776719|FG001|Overall Study|Death|1|||
157007402|NCT03194958|566776720|FG002|Overall Study|Death|1|||
157007403|NCT03194958|566776721|FG003|Overall Study|Death|1|||
157007404|NCT03194958|566776718|FG000|Overall Study|Withdrawal by Subject|24|||
157007405|NCT03194958|566776719|FG001|Overall Study|Withdrawal by Subject|27|||
157007406|NCT03194958|566776720|FG002|Overall Study|Withdrawal by Subject|7|||
157007407|NCT03194958|566776721|FG003|Overall Study|Withdrawal by Subject|22|||
157007408|NCT03194958|566776718|FG000|Overall Study|Lost to Follow-up|168|||
157007409|NCT03194958|566776719|FG001|Overall Study|Lost to Follow-up|196|||
157007410|NCT03194958|566776720|FG002|Overall Study|Lost to Follow-up|174|||
157007411|NCT03194958|566776721|FG003|Overall Study|Lost to Follow-up|186|||
157007412|NCT01179334|566776724|FG000|Treatment Period|Adverse Event|1|||
157007413|NCT01179334|566776725|FG001|Treatment Period|Adverse Event|0|||
157007414|NCT01179334|566776724|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
157007415|NCT01179334|566776725|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
157007416|NCT01179334|566776724|FG000|Long-term Extension (LTE) Period|Death|3|||
157007417|NCT01179334|566776725|FG001|Long-term Extension (LTE) Period|Death|0|||
157007418|NCT01179334|566776724|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
157007419|NCT01179334|566776725|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
157007420|NCT00256243|566776728|FG000|Overall Study|Lost to Follow-up|2|||
157007421|NCT00256243|566776728|FG000|Overall Study|Death|7|||
157007422|NCT00256243|566776728|FG000|Overall Study|Not treated|1|||
157007423|NCT01152190|566776729|FG000|Overall Study|Adverse Event|2|||
157007424|NCT01152190|566776730|FG001|Overall Study|Adverse Event|4|||
157007425|NCT01152190|566776729|FG000|Overall Study|Death|1|||
157007426|NCT01152190|566776730|FG001|Overall Study|Death|0|||
157007427|NCT01152190|566776729|FG000|Overall Study|Protocol Violation|1|||
157007428|NCT01152190|566776730|FG001|Overall Study|Protocol Violation|1|||
157007429|NCT01152190|566776729|FG000|Overall Study|Withdrawal by Subject|1|||
157007430|NCT01152190|566776730|FG001|Overall Study|Withdrawal by Subject|3|||
157007431|NCT00373529|566776733|FG000|Overall Study|Physician Decision|19|||
157007432|NCT00373529|566776733|FG000|Overall Study|Withdrawal by Subject|7|||
157007433|NCT00373529|566776733|FG000|Overall Study|Adverse Event|7|||
157007434|NCT00373529|566776733|FG000|Overall Study|Treatment failure|36|||
157007435|NCT00373529|566776733|FG000|Overall Study|Disease recurrence|10|||
157007436|NCT00373529|566776733|FG000|Overall Study|Death|16|||
157007437|NCT00373529|566776733|FG000|Overall Study|Need for treatment prohibited by study|1|||
157007438|NCT00373529|566776733|FG000|Overall Study|Other|8|||
157007439|NCT00373529|566776733|FG000|Overall Study|Failed independent confirmation of AML|3|||
157007440|NCT00373529|566776733|FG000|Overall Study|Consent violation|1|||
157007441|NCT01585558|566776742|FG000|Overall Study|Withdrawal by Subject|4|||
157007442|NCT01585558|566776743|FG001|Overall Study|Withdrawal by Subject|5|||
157007443|NCT01585558|566776744|FG002|Overall Study|Withdrawal by Subject|8|||
157007444|NCT01585558|566776742|FG000|Overall Study|Lost to Follow-up|2|||
157007445|NCT01585558|566776743|FG001|Overall Study|Lost to Follow-up|0|||
157007446|NCT01585558|566776744|FG002|Overall Study|Lost to Follow-up|3|||
157007447|NCT01585558|566776742|FG000|Overall Study|Adverse Event|3|||
157007448|NCT01585558|566776743|FG001|Overall Study|Adverse Event|4|||
157007449|NCT01585558|566776744|FG002|Overall Study|Adverse Event|1|||
157007450|NCT01585558|566776742|FG000|Overall Study|Protocol Violation|4|||
157007451|NCT01585558|566776743|FG001|Overall Study|Protocol Violation|3|||
157007452|NCT01585558|566776744|FG002|Overall Study|Protocol Violation|2|||
157007453|NCT01585558|566776742|FG000|Overall Study|Lack of Efficacy|0|||
157007454|NCT01585558|566776743|FG001|Overall Study|Lack of Efficacy|0|||
157007455|NCT01585558|566776744|FG002|Overall Study|Lack of Efficacy|1|||
157007456|NCT00026312|566776754|FG000|Overall Study|Adverse Event|0|||
156773729|NCT00782067|565924719|FG000|Overall Study|Lost to Follow-up|2|||
157007457|NCT00026312|566776755|FG001|Overall Study|Adverse Event|32|||
157007458|NCT00026312|566776754|FG000|Overall Study|Death|1|||
157007459|NCT00026312|566776755|FG001|Overall Study|Death|7|||
157007460|NCT00026312|566776754|FG000|Overall Study|Lack of Efficacy|19|||
157007461|NCT00026312|566776755|FG001|Overall Study|Lack of Efficacy|114|||
157007462|NCT00026312|566776754|FG000|Overall Study|Lost to Follow-up|0|||
157207568|NCT03611751|567504517|FG000|Pre-treatment|Randomized but not treated|1|||
157207569|NCT03611751|567504518|FG001|Pre-treatment|Randomized but not treated|1|||
157207570|NCT03611751|567504519|FG002|Pre-treatment|Randomized but not treated|0|||
157207571|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
157207572|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
157007463|NCT00026312|566776755|FG001|Overall Study|Lost to Follow-up|5|||
157007464|NCT00026312|566776754|FG000|Overall Study|Physician Decision|1|||
157007465|NCT00026312|566776755|FG001|Overall Study|Physician Decision|37|||
157007466|NCT00026312|566776754|FG000|Overall Study|Protocol Violation|0|||
157007467|NCT00026312|566776755|FG001|Overall Study|Protocol Violation|3|||
157007468|NCT00026312|566776754|FG000|Overall Study|Withdrawal by Subject|1|||
157007469|NCT00026312|566776755|FG001|Overall Study|Withdrawal by Subject|6|||
157007470|NCT00026312|566776754|FG000|Overall Study|Ineligible|4|||
157007471|NCT00026312|566776755|FG001|Overall Study|Ineligible|5|||
157007472|NCT00026312|566776754|FG000|Overall Study|Entry onto another COG study|0|||
157007473|NCT00026312|566776755|FG001|Overall Study|Entry onto another COG study|1|||
157007474|NCT00026312|566776754|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
157007475|NCT00026312|566776755|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
157007476|NCT02611037|566776756|FG000|Overall Study|Withdrawal prior to treatment|2|||
157007477|NCT02611037|566776757|FG001|Overall Study|Withdrawal prior to treatment|0|||
157007478|NCT03785782|566777702|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
157007479|NCT03785782|566777703|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
157007480|NCT03785782|566777702|FG000|Overall Study|Withdrawal by Subject|1|||
157007481|NCT03785782|566777703|FG001|Overall Study|Withdrawal by Subject|1|||
157007482|NCT03785782|566777702|FG000|Overall Study|insufficient image quality.|3|||
157007483|NCT03785782|566777703|FG001|Overall Study|insufficient image quality.|0|||
157007484|NCT03889925|566777704|FG000|Overall Study|Lost to Follow-up|11|||
157007485|NCT03889925|566777705|FG001|Overall Study|Lost to Follow-up|10|||
157007486|NCT05777785|566777706|FG000|Overall Study|Withdrawal by Subject|5|||
157007487|NCT05777785|566777706|FG000|Overall Study|Lost to Follow-up|1|||
157207573|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
157207574|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
156773730|NCT00782067|565924719|FG000|Overall Study|Administrative problems|14|||
157007488|NCT05644444|566777711|FG000|Tolerance Phase|Adverse Event|0|||
157007489|NCT05644444|566777712|FG001|Tolerance Phase|Adverse Event|2|||
157007490|NCT05644444|566777711|FG000|Treatment Phase|Adverse Event|0|||
157007491|NCT05644444|566777712|FG001|Treatment Phase|Adverse Event|2|||
157007492|NCT00493649|566777714|FG000|Overall Study|Adverse Event|44|||
157007493|NCT00493649|566777714|FG000|Overall Study|Patient Request|21|||
157007494|NCT00493649|566777714|FG000|Overall Study|Investigator Request|2|||
157007495|NCT00493649|566777714|FG000|Overall Study|Disease Progression|1|||
157007496|NCT00493649|566777714|FG000|Overall Study|Lost to Follow-up|1|||
157007497|NCT00493649|566777714|FG000|Overall Study|Other|13|||
157007498|NCT00925899|566777717|FG000|Part 1|Death|1|||
157007499|NCT00925899|566777718|FG001|Part 1|Death|2|||
157007500|NCT00925899|566777717|FG000|Part 1|Withdrawal by Subject|10|||
157007501|NCT00925899|566777718|FG001|Part 1|Withdrawal by Subject|9|||
157007502|NCT01823536|566777721|FG000|Overall Study|Lost to Follow-up|1|||
157007503|NCT01823536|566777722|FG001|Overall Study|Lost to Follow-up|0|||
157007504|NCT01823536|566777723|FG002|Overall Study|Lost to Follow-up|0|||
157007505|NCT01823536|566777724|FG003|Overall Study|Lost to Follow-up|1|||
157007506|NCT01823536|566777725|FG004|Overall Study|Lost to Follow-up|1|||
157007507|NCT01823536|566777726|FG005|Overall Study|Lost to Follow-up|0|||
157007508|NCT01823536|566777721|FG000|Overall Study|Protocol Violation|0|||
157007509|NCT01823536|566777722|FG001|Overall Study|Protocol Violation|1|||
157007510|NCT01823536|566777723|FG002|Overall Study|Protocol Violation|0|||
157007511|NCT01823536|566777724|FG003|Overall Study|Protocol Violation|0|||
157007512|NCT01823536|566777725|FG004|Overall Study|Protocol Violation|0|||
157007513|NCT01823536|566777726|FG005|Overall Study|Protocol Violation|0|||
157007514|NCT01823536|566777721|FG000|Overall Study|Withdrawal by Subject|1|||
157007515|NCT01823536|566777722|FG001|Overall Study|Withdrawal by Subject|1|||
157007516|NCT01823536|566777723|FG002|Overall Study|Withdrawal by Subject|0|||
157007517|NCT01823536|566777724|FG003|Overall Study|Withdrawal by Subject|0|||
157007518|NCT01823536|566777725|FG004|Overall Study|Withdrawal by Subject|0|||
157007519|NCT01823536|566777726|FG005|Overall Study|Withdrawal by Subject|0|||
157007520|NCT01823536|566777721|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
157007521|NCT01823536|566777722|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
157007522|NCT01823536|566777723|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
156773731|NCT00782067|565924719|FG000|Overall Study|Death|9|||
156773732|NCT00782067|565924719|FG000|Overall Study|Disease progression|43|||
156773733|NCT00782067|565924719|FG000|Overall Study|Protocol deviation|2|||
157007523|NCT01823536|566777724|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
157007524|NCT01823536|566777725|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
157007525|NCT01823536|566777726|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
157007526|NCT01823536|566777721|FG000|Overall Study|Met exclusion criterion No 6|0|||
157021618|NCT03519581|566830927|FG000|Overall Study|Change to insurance|2|||
157021619|NCT03519581|566830928|FG001|Overall Study|Change to insurance|1|||
157021620|NCT03519581|566830927|FG000|Overall Study|Other|2|||
157021621|NCT03519581|566830928|FG001|Overall Study|Other|4|||
157021622|NCT05177848|566830929|FG000|Overall Study|Lost to Follow-up|1|||
157021623|NCT05177848|566830930|FG001|Overall Study|Lost to Follow-up|4|||
157021624|NCT05177848|566830929|FG000|Overall Study|Discontinued|2|||
157021625|NCT05177848|566830930|FG001|Overall Study|Discontinued|1|||
157021626|NCT06414213|566830931|FG000|Overall Study|Lost to Follow-up|1|||
157021627|NCT06414213|566830932|FG001|Overall Study|Lost to Follow-up|1|||
157021628|NCT06414213|566830933|FG002|Overall Study|Lost to Follow-up|3|||
157021629|NCT05134233|566830942|FG000|Overall Study|Pregnancy|1|||
157021630|NCT05134233|566830942|FG000|Overall Study|MEP value too low|2|||
157021631|NCT05134233|566830942|FG000|Overall Study|Lost to Follow-up|1|||
157021632|NCT01573442|566830943|FG000|Overall Study|Cancels|9|||
157021633|NCT01573442|566830944|FG001|Overall Study|Cancels|10|||
157021634|NCT04763265|566830950|FG000|Overall Study|Adverse Event|1|||
157021635|NCT04763265|566830951|FG001|Overall Study|Adverse Event|0|||
157021636|NCT04763265|566830950|FG000|Overall Study|Lost to Follow-up|2|||
157021637|NCT04763265|566830951|FG001|Overall Study|Lost to Follow-up|4|||
157021638|NCT04763265|566830950|FG000|Overall Study|Withdrawal by Subject|0|||
157021639|NCT04763265|566830951|FG001|Overall Study|Withdrawal by Subject|1|||
157021640|NCT02908477|566830952|FG000|Overall Study|Withdrawal by Subject|8|||
157021641|NCT02908477|566830953|FG001|Overall Study|Withdrawal by Subject|28|||
157021642|NCT05071807|566830960|FG000|Overall Study|Withdrawal by Subject|4|||
157021643|NCT05071807|566830961|FG001|Overall Study|Withdrawal by Subject|0|||
157021644|NCT05071807|566830960|FG000|Overall Study|Unrelated medical issues|3|||
157021645|NCT05071807|566830961|FG001|Overall Study|Unrelated medical issues|0|||
157021646|NCT05071807|566830960|FG000|Overall Study|Relocated|0|||
157021647|NCT05071807|566830961|FG001|Overall Study|Relocated|1|||
157021648|NCT04552223|566830963|FG000|Overall Study|Withdrawal by Subject|1|||
157021649|NCT00881621|566830966|FG000|Overall Study|Physician Decision|34|||
157021650|NCT04072380|566830971|FG000|Overall Study|Adverse Event|4|||
157021651|NCT04072380|566830972|FG001|Overall Study|Adverse Event|6|||
157021652|NCT04072380|566830973|FG002|Overall Study|Adverse Event|0|||
156773734|NCT02471183|565924720|FG000|Main Treatment Period|Adverse Event|1|||
156773735|NCT02471183|565924720|FG000|Main Treatment Period|Withdrawal by Subject|1|||
156773736|NCT02471183|565924720|FG000|Extended Treatment Period|Lack of Efficacy|1|||
156773737|NCT02328105|565924722|FG000|Overall Study|Death|6|||
156773738|NCT02328105|565924722|FG000|Overall Study|Withdrawal by Subject|1|||
156773739|NCT02328105|565924722|FG000|Overall Study|Still On Study in Follow-Up|4|||
156773740|NCT00614393|565924723|FG000|Overall Study|Adverse Event|20|||
156773741|NCT00614393|565924724|FG001|Overall Study|Adverse Event|2|||
156773742|NCT00614393|565924725|FG002|Overall Study|Adverse Event|3|||
156773743|NCT00614393|565924726|FG003|Overall Study|Adverse Event|13|||
156773744|NCT00614393|565924727|FG004|Overall Study|Adverse Event|21|||
156773745|NCT00614393|565924723|FG000|Overall Study|Lost to Follow-up|0|||
156773746|NCT00614393|565924724|FG001|Overall Study|Lost to Follow-up|0|||
156773747|NCT00614393|565924725|FG002|Overall Study|Lost to Follow-up|0|||
156773748|NCT00614393|565924726|FG003|Overall Study|Lost to Follow-up|1|||
157007527|NCT01823536|566777722|FG001|Overall Study|Met exclusion criterion No 6|0|||
156773749|NCT00614393|565924727|FG004|Overall Study|Lost to Follow-up|2|||
157007528|NCT01823536|566777723|FG002|Overall Study|Met exclusion criterion No 6|0|||
157007529|NCT01823536|566777724|FG003|Overall Study|Met exclusion criterion No 6|1|||
157007530|NCT01823536|566777725|FG004|Overall Study|Met exclusion criterion No 6|0|||
157007531|NCT01823536|566777726|FG005|Overall Study|Met exclusion criterion No 6|0|||
157007532|NCT01823536|566777721|FG000|Overall Study|Subject moved out of the state|0|||
157007533|NCT01823536|566777722|FG001|Overall Study|Subject moved out of the state|0|||
157007534|NCT01823536|566777723|FG002|Overall Study|Subject moved out of the state|0|||
157007535|NCT01823536|566777724|FG003|Overall Study|Subject moved out of the state|0|||
157007536|NCT01823536|566777725|FG004|Overall Study|Subject moved out of the state|1|||
157007537|NCT01823536|566777726|FG005|Overall Study|Subject moved out of the state|0|||
157007538|NCT03648762|566777727|FG000|Overall Study|Lost to Follow-up|1|||
157007539|NCT03648762|566777728|FG001|Overall Study|Lost to Follow-up|2|||
157007540|NCT03648762|566777729|FG002|Overall Study|Lost to Follow-up|0|||
157007541|NCT03648762|566777727|FG000|Overall Study|Withdrawal by Subject|5|||
157007542|NCT03648762|566777728|FG001|Overall Study|Withdrawal by Subject|2|||
157007543|NCT03648762|566777729|FG002|Overall Study|Withdrawal by Subject|1|||
157007544|NCT00768664|566777737|FG000|Overall Study|Death|57|||
157007545|NCT00768664|566777737|FG000|Overall Study|Lost to Follow-up|2|||
157007546|NCT00768664|566777737|FG000|Overall Study|Other|9|||
157007547|NCT00768664|566777737|FG000|Overall Study|Participant refused|1|||
157007548|NCT02544152|566777738|FG000|Overall Study|Adverse Event|0|||
157007549|NCT02544152|566777739|FG001|Overall Study|Adverse Event|4|||
157007550|NCT02544152|566777738|FG000|Overall Study|Withdrawal by Subject|0|||
157007551|NCT02544152|566777739|FG001|Overall Study|Withdrawal by Subject|3|||
157007552|NCT02544152|566777738|FG000|Overall Study|Other|1|||
157007553|NCT02544152|566777739|FG001|Overall Study|Other|0|||
157007554|NCT02320123|566777740|FG000|Overall Study|Lost to Follow-up|4|||
157007555|NCT02320123|566777741|FG001|Overall Study|Lost to Follow-up|6|||
157007556|NCT02320123|566777740|FG000|Overall Study|Death|6|||
157007557|NCT02320123|566777741|FG001|Overall Study|Death|5|||
157007558|NCT02139046|566777742|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
157007559|NCT02139046|566777743|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
157007560|NCT02139046|566777744|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
157007561|NCT02139046|566777745|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
157007562|NCT02139046|566777746|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
157007563|NCT02139046|566777742|FG000|Overall Study|Major Protocol Deviation|9|||
157007564|NCT02139046|566777743|FG001|Overall Study|Major Protocol Deviation|10|||
157007565|NCT02139046|566777744|FG002|Overall Study|Major Protocol Deviation|16|||
157007566|NCT02139046|566777745|FG003|Overall Study|Major Protocol Deviation|12|||
157007567|NCT02139046|566777746|FG004|Overall Study|Major Protocol Deviation|6|||
157007568|NCT02139046|566777742|FG000|Overall Study|Lost to Follow-up|13|||
157007569|NCT02139046|566777743|FG001|Overall Study|Lost to Follow-up|16|||
157007570|NCT02139046|566777744|FG002|Overall Study|Lost to Follow-up|16|||
157007571|NCT02139046|566777745|FG003|Overall Study|Lost to Follow-up|18|||
157113449|NCT04143009|567170298|FG000|Pilot Trial|Lost to Follow-up|0|||
156773750|NCT00614393|565924723|FG000|Overall Study|Physician Decision|17|||
156773751|NCT00614393|565924724|FG001|Overall Study|Physician Decision|0|||
156773752|NCT00614393|565924725|FG002|Overall Study|Physician Decision|1|||
156773753|NCT00614393|565924726|FG003|Overall Study|Physician Decision|8|||
156773754|NCT00614393|565924727|FG004|Overall Study|Physician Decision|9|||
156773755|NCT00614393|565924723|FG000|Overall Study|Progressive Disease|118|||
157007572|NCT02139046|566777746|FG004|Overall Study|Lost to Follow-up|13|||
157007573|NCT02139046|566777742|FG000|Overall Study|Voluntary Withdrawal|20|||
157007574|NCT02139046|566777743|FG001|Overall Study|Voluntary Withdrawal|8|||
157007575|NCT02139046|566777744|FG002|Overall Study|Voluntary Withdrawal|10|||
157007576|NCT02139046|566777745|FG003|Overall Study|Voluntary Withdrawal|15|||
157007577|NCT02139046|566777746|FG004|Overall Study|Voluntary Withdrawal|16|||
157007578|NCT02139046|566777742|FG000|Overall Study|Lack of Efficacy|0|||
156773756|NCT00614393|565924724|FG001|Overall Study|Progressive Disease|5|||
156773757|NCT00614393|565924725|FG002|Overall Study|Progressive Disease|5|||
157007579|NCT02139046|566777743|FG001|Overall Study|Lack of Efficacy|1|||
157007580|NCT02139046|566777744|FG002|Overall Study|Lack of Efficacy|2|||
157007581|NCT02139046|566777745|FG003|Overall Study|Lack of Efficacy|1|||
157007582|NCT02139046|566777746|FG004|Overall Study|Lack of Efficacy|2|||
157007583|NCT02139046|566777742|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
157007584|NCT02139046|566777743|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
157007585|NCT02139046|566777744|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
156773758|NCT00614393|565924726|FG003|Overall Study|Progressive Disease|138|||
156773759|NCT00614393|565924727|FG004|Overall Study|Progressive Disease|130|||
156773760|NCT00614393|565924723|FG000|Overall Study|Protocol Violation|1|||
156773761|NCT00614393|565924724|FG001|Overall Study|Protocol Violation|0|||
156773762|NCT00614393|565924725|FG002|Overall Study|Protocol Violation|0|||
156773763|NCT00614393|565924726|FG003|Overall Study|Protocol Violation|0|||
156773764|NCT00614393|565924727|FG004|Overall Study|Protocol Violation|0|||
156773765|NCT00614393|565924723|FG000|Overall Study|Terminated by Sponsor|0|||
156773766|NCT00614393|565924724|FG001|Overall Study|Terminated by Sponsor|0|||
156773767|NCT00614393|565924725|FG002|Overall Study|Terminated by Sponsor|0|||
157113450|NCT04143009|567170299|FG001|Pilot Trial|Lost to Follow-up|1|||
157113451|NCT04143009|567170300|FG002|Pilot Trial|Lost to Follow-up|1|||
157113452|NCT02577146|567170305|FG000|Overall Study|Lost to Follow-up|8|||
157113453|NCT02577146|567170305|FG000|Overall Study|Physician Decision|3|||
157113454|NCT02577146|567170305|FG000|Overall Study|Screen Failure|17|||
157113455|NCT01357655|567170306|FG000|Overall Study|Administrative Reason by Sponsor|45|||
157113456|NCT01357655|567170307|FG001|Overall Study|Administrative Reason by Sponsor|0|||
157113457|NCT01357655|567170306|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
157113458|NCT01357655|567170307|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
157113459|NCT01357655|567170306|FG000|Overall Study|Disease Progression|1|||
157113460|NCT01357655|567170307|FG001|Overall Study|Disease Progression|0|||
157007586|NCT02139046|566777745|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
157007587|NCT02139046|566777746|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
157007588|NCT02139046|566777742|FG000|Overall Study|Other Miscellaneous Reasons|10|||
157007589|NCT02139046|566777743|FG001|Overall Study|Other Miscellaneous Reasons|9|||
157007590|NCT02139046|566777744|FG002|Overall Study|Other Miscellaneous Reasons|4|||
157007591|NCT02139046|566777745|FG003|Overall Study|Other Miscellaneous Reasons|9|||
157007592|NCT02139046|566777746|FG004|Overall Study|Other Miscellaneous Reasons|12|||
157007593|NCT01765543|566777751|FG000|Overall Study|Death|1|||
157007594|NCT01765543|566777751|FG000|Overall Study|Withdrawal by Subject|2|||
157007595|NCT01190007|566777756|FG000|Overall Study|Withdrawal by Subject|4|||
157007596|NCT01190007|566777756|FG000|Overall Study|Adverse Event|8|||
157007597|NCT01190007|566777756|FG000|Overall Study|Difficulty of visit for complications|1|||
157007598|NCT01190007|566777756|FG000|Overall Study|Participant was arrested|1|||
157007599|NCT01254019|566777758|FG000|Overall Study|Adverse Event|0|||
157007600|NCT01254019|566777759|FG001|Overall Study|Adverse Event|2|||
157007601|NCT01254019|566777758|FG000|Overall Study|Protocol Violation|1|||
157113461|NCT01357655|567170306|FG000|Overall Study|Lost to Follow-up|2|||
156773768|NCT00614393|565924726|FG003|Overall Study|Terminated by Sponsor|0|||
156773769|NCT00614393|565924727|FG004|Overall Study|Terminated by Sponsor|1|||
157007602|NCT01254019|566777759|FG001|Overall Study|Protocol Violation|0|||
157207575|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
156773770|NCT00614393|565924723|FG000|Overall Study|Withdrawal by Subject|20|||
157007603|NCT01254019|566777758|FG000|Overall Study|Withdrawal by Subject|0|||
157007604|NCT01254019|566777759|FG001|Overall Study|Withdrawal by Subject|2|||
157007605|NCT03061474|566777760|FG000|Overall Study|Adverse Event|2|||
157007606|NCT03061474|566777761|FG001|Overall Study|Adverse Event|0|||
157007607|NCT03061474|566777760|FG000|Overall Study|Safety Risk|0|||
157007608|NCT03061474|566777761|FG001|Overall Study|Safety Risk|1|||
157007609|NCT03061474|566777760|FG000|Overall Study|Participant unwilling or unable to participate|0|||
157007610|NCT03061474|566777761|FG001|Overall Study|Participant unwilling or unable to participate|2|||
157007611|NCT03061474|566777760|FG000|Overall Study|Lost to Follow-up|0|||
157007612|NCT03061474|566777761|FG001|Overall Study|Lost to Follow-up|1|||
157007613|NCT03520413|566777770|FG000|Overall Study|Lost to Follow-up|1|||
157007614|NCT03520413|566777771|FG001|Overall Study|Lost to Follow-up|1|||
157007615|NCT03520413|566777770|FG000|Overall Study|Withdrawal by Subject|1|||
157007616|NCT03520413|566777771|FG001|Overall Study|Withdrawal by Subject|2|||
156773771|NCT00614393|565924724|FG001|Overall Study|Withdrawal by Subject|1|||
157207576|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
157207577|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
157207578|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
157207579|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
157207580|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
157207581|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
157207582|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
157207583|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
157207584|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
157207585|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
157207586|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
157207587|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
157207588|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
157207589|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
157207590|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
157207591|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
157207592|NCT03611751|567504517|FG000|Treatment Week 0 - Week 16|Death|0|||
157207593|NCT03611751|567504518|FG001|Treatment Week 0 - Week 16|Death|0|||
157207594|NCT03611751|567504519|FG002|Treatment Week 0 - Week 16|Death|1|||
157207595|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
157207596|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
157207597|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
157207598|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
157207599|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
157207600|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
157207601|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
157207602|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
157207603|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
157207604|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
157207605|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
157207606|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
157207607|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
157207608|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
157207609|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
157207610|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
157207611|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
157207612|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
157207613|NCT03611751|567504517|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
157207614|NCT03611751|567504518|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
157207615|NCT03611751|567504519|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
157207616|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
157207617|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
157207618|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
157207619|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
157207620|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
157207621|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
157207622|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
157207623|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
157207624|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
157207625|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
157207626|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
157207627|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
157207628|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
157207629|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
157207630|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
157207631|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
157207632|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
157207633|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
157207634|NCT03611751|567504517|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
157207635|NCT03611751|567504518|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
157207636|NCT03611751|567504519|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
157207637|NCT03940742|567504522|FG000|Overall Study|Lost to Follow-up|0|||
157207638|NCT03940742|567504523|FG001|Overall Study|Lost to Follow-up|0|||
157207639|NCT03940742|567504524|FG002|Overall Study|Lost to Follow-up|0|||
157207640|NCT03940742|567504525|FG003|Overall Study|Lost to Follow-up|1|||
157207641|NCT03428217|567504527|FG000|Overall Study|Death|89|||
157207642|NCT03428217|567504528|FG001|Overall Study|Death|93|||
157207643|NCT03428217|567504527|FG000|Overall Study|Withdrawal by Subject|8|||
157207644|NCT03428217|567504528|FG001|Overall Study|Withdrawal by Subject|7|||
157207645|NCT03428217|567504527|FG000|Overall Study|Lost to Follow-up|1|||
157207646|NCT03428217|567504528|FG001|Overall Study|Lost to Follow-up|3|||
157207647|NCT03428217|567504527|FG000|Overall Study|Study terminated by sponsor|124|||
157207648|NCT03428217|567504528|FG001|Overall Study|Study terminated by sponsor|118|||
157113462|NCT01357655|567170307|FG001|Overall Study|Lost to Follow-up|0|||
157113463|NCT01357655|567170306|FG000|Overall Study|Maximum Clinical Benefit|2|||
157113464|NCT01357655|567170307|FG001|Overall Study|Maximum Clinical Benefit|0|||
157113465|NCT01357655|567170306|FG000|Overall Study|Reason Unspecified|1|||
157113466|NCT01357655|567170307|FG001|Overall Study|Reason Unspecified|0|||
157207649|NCT03428217|567504527|FG000|Overall Study|Other, Not Specified|1|||
157207650|NCT03428217|567504528|FG001|Overall Study|Other, Not Specified|0|||
157207651|NCT00621309|567504529|FG000|Overall Study|Withdrawal by Subject|2|||
157207652|NCT00621309|567504530|FG001|Overall Study|Withdrawal by Subject|0|||
157207653|NCT00621309|567504531|FG002|Overall Study|Withdrawal by Subject|1|||
157207654|NCT00621309|567504532|FG003|Overall Study|Withdrawal by Subject|1|||
157207655|NCT00621309|567504533|FG004|Overall Study|Withdrawal by Subject|1|||
157207656|NCT00621309|567504534|FG005|Overall Study|Withdrawal by Subject|1|||
157207657|NCT05246111|567504535|FG000|Period 01|NOT ELIGIBLE IC5|1|||
157207658|NCT05246111|567504536|FG001|Period 01|NOT ELIGIBLE IC5|0|||
157207659|NCT01329562|567504537|FG000|Overall Study|Protocol Violation|5|||
157207660|NCT01329562|567504538|FG001|Overall Study|Protocol Violation|3|||
157207661|NCT01329562|567504537|FG000|Overall Study|Lost to Follow-up|1|||
157207662|NCT01329562|567504538|FG001|Overall Study|Lost to Follow-up|1|||
157207663|NCT01329562|567504537|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
157207664|NCT01329562|567504538|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
157207665|NCT01329562|567504537|FG000|Overall Study|Physician Decision|0|||
157207666|NCT01329562|567504538|FG001|Overall Study|Physician Decision|1|||
157207667|NCT00061568|567504539|FG000|Overall Study|Lost to Follow-up|12|||
157207668|NCT00061568|567504540|FG001|Overall Study|Lost to Follow-up|0|||
157207669|NCT00061568|567504539|FG000|Overall Study|Death|6|||
157207670|NCT00061568|567504540|FG001|Overall Study|Death|0|||
157207671|NCT00061568|567504539|FG000|Overall Study|Withdrawal by Subject|1|||
157207672|NCT00061568|567504540|FG001|Overall Study|Withdrawal by Subject|0|||
157207673|NCT00690573|567504547|FG000|Overall Study|Lack of Efficacy|8|||
157207674|NCT00690573|567504547|FG000|Overall Study|Withdrawal by Subject|1|||
157207675|NCT00777920|567504548|FG000|Overall Study|Adverse Event|39|||
157207676|NCT00777920|567504548|FG000|Overall Study|Withdrawal of Consent|4|||
157207677|NCT00777920|567504548|FG000|Overall Study|Lost to Follow-up|1|||
157207678|NCT00777920|567504548|FG000|Overall Study|Investigator's discretion|1|||
157207679|NCT00777920|567504548|FG000|Overall Study|Clinical status did not improve|1|||
157207680|NCT00777920|567504548|FG000|Overall Study|Other, not specified|4|||
157207681|NCT02392377|567504549|FG000|Overall Study|Withdrawal by Subject|0|||
157207682|NCT02392377|567504550|FG001|Overall Study|Withdrawal by Subject|1|||
157207683|NCT01126359|567504553|FG000|First Intervention (20-minutes)|Physician Decision|0|||
157207684|NCT01126359|567504554|FG001|First Intervention (20-minutes)|Physician Decision|1|||
157207685|NCT00902486|567504555|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
157207686|NCT00902486|567504556|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
157207687|NCT00902486|567504557|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
157207688|NCT00902486|567504558|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
157207689|NCT00902486|567504559|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
157207690|NCT00902486|567504560|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
156773772|NCT00614393|565924725|FG002|Overall Study|Withdrawal by Subject|1|||
157007617|NCT03520413|566777770|FG000|Overall Study|Death|0|||
157207691|NCT00902486|567504555|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
157207692|NCT00902486|567504556|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
157207693|NCT00902486|567504557|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
157207694|NCT00902486|567504558|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
157207695|NCT00902486|567504559|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
157207696|NCT00902486|567504560|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
157207697|NCT00902486|567504555|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
157207698|NCT00902486|567504556|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
157207699|NCT00902486|567504557|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
157207700|NCT00902486|567504558|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
157207701|NCT00902486|567504559|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
157207702|NCT00902486|567504560|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
157207703|NCT00902486|567504555|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
157207704|NCT00902486|567504556|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
157207705|NCT00902486|567504557|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
156773773|NCT00614393|565924726|FG003|Overall Study|Withdrawal by Subject|16|||
156773774|NCT00614393|565924727|FG004|Overall Study|Withdrawal by Subject|13|||
156773775|NCT00614393|565924723|FG000|Overall Study|Other|4|||
156773776|NCT00614393|565924724|FG001|Overall Study|Other|0|||
156773777|NCT00614393|565924725|FG002|Overall Study|Other|0|||
156773778|NCT00614393|565924726|FG003|Overall Study|Other|4|||
156773779|NCT00614393|565924727|FG004|Overall Study|Other|2|||
156773780|NCT00614393|565924723|FG000|Overall Study|Not Treated|0|||
156773781|NCT00614393|565924724|FG001|Overall Study|Not Treated|0|||
156773782|NCT00614393|565924725|FG002|Overall Study|Not Treated|0|||
156773783|NCT00614393|565924726|FG003|Overall Study|Not Treated|0|||
156773784|NCT00614393|565924727|FG004|Overall Study|Not Treated|2|||
156773785|NCT05350423|565924731|FG000|Overall Study|Lost to Follow-up|3|||
156773786|NCT05350423|565924732|FG001|Overall Study|Lost to Follow-up|3|||
156773787|NCT05350423|565924731|FG000|Overall Study|screen failure|5|||
156773788|NCT05350423|565924732|FG001|Overall Study|screen failure|6|||
156773789|NCT02097277|565924734|FG000|Overall Study|Subject no longer meets study criteria|0|||
156773790|NCT02097277|565924735|FG001|Overall Study|Subject no longer meets study criteria|1|||
156773791|NCT02097277|565924736|FG002|Overall Study|Subject no longer meets study criteria|0|||
156773792|NCT02097277|565924737|FG003|Overall Study|Subject no longer meets study criteria|1|||
156773793|NCT02097277|565924738|FG004|Overall Study|Subject no longer meets study criteria|0|||
156773794|NCT02097277|565924734|FG000|Overall Study|Subject request to discontinue treatment|0|||
156773795|NCT02097277|565924735|FG001|Overall Study|Subject request to discontinue treatment|0|||
156773796|NCT02097277|565924736|FG002|Overall Study|Subject request to discontinue treatment|0|||
156773797|NCT02097277|565924737|FG003|Overall Study|Subject request to discontinue treatment|0|||
156773798|NCT02097277|565924738|FG004|Overall Study|Subject request to discontinue treatment|1|||
156773799|NCT02097277|565924734|FG000|Overall Study|Lost to Follow-up|0|||
156773800|NCT02097277|565924735|FG001|Overall Study|Lost to Follow-up|1|||
156773801|NCT02097277|565924736|FG002|Overall Study|Lost to Follow-up|1|||
156773802|NCT02097277|565924737|FG003|Overall Study|Lost to Follow-up|0|||
156773803|NCT02097277|565924738|FG004|Overall Study|Lost to Follow-up|0|||
156773804|NCT02097277|565924734|FG000|Overall Study|Withdrawal by Subject|2|||
156773805|NCT02097277|565924735|FG001|Overall Study|Withdrawal by Subject|1|||
156773806|NCT02097277|565924736|FG002|Overall Study|Withdrawal by Subject|0|||
156773807|NCT02097277|565924737|FG003|Overall Study|Withdrawal by Subject|1|||
156773808|NCT02097277|565924738|FG004|Overall Study|Withdrawal by Subject|0|||
156773809|NCT02097277|565924734|FG000|Overall Study|Adverse Event|0|||
156773810|NCT02097277|565924735|FG001|Overall Study|Adverse Event|0|||
156773811|NCT02097277|565924736|FG002|Overall Study|Adverse Event|1|||
156773812|NCT02097277|565924737|FG003|Overall Study|Adverse Event|2|||
156773813|NCT02097277|565924738|FG004|Overall Study|Adverse Event|0|||
156773814|NCT00141921|565924740|FG000|Overall Study|Remain on Study|28|||
156773815|NCT00141921|565924740|FG000|Overall Study|Withdrawal by Subject|42|||
156773816|NCT00141921|565924740|FG000|Overall Study|Lost to Follow-up|19|||
156773817|NCT00141921|565924740|FG000|Overall Study|Noncompliance|17|||
156773818|NCT00141921|565924740|FG000|Overall Study|Disease Progression|7|||
156773819|NCT00141921|565924740|FG000|Overall Study|Protocol Deviation|7|||
156773820|NCT00141921|565924740|FG000|Overall Study|Adverse Event|5|||
156773821|NCT00141921|565924740|FG000|Overall Study|Administrative Decision|2|||
156773822|NCT00141921|565924740|FG000|Overall Study|Pregnancy|4|||
156773823|NCT00141921|565924740|FG000|Overall Study|Ineligibility Determined|2|||
156773824|NCT00141921|565924740|FG000|Overall Study|Other|8|||
156773825|NCT03320369|565924741|FG000|Overall Study|Adverse Event|1|||
156773826|NCT03320369|565924741|FG000|Overall Study|Withdrawal by Subject|2|||
156773827|NCT03813654|565924744|FG000|Overall Study|Protocol Violation|0|||
157007618|NCT03520413|566777771|FG001|Overall Study|Death|1|||
157007619|NCT03520413|566777770|FG000|Overall Study|Physician Decision|3|||
157007620|NCT03520413|566777771|FG001|Overall Study|Physician Decision|3|||
157007621|NCT03520413|566777770|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
157007622|NCT03520413|566777771|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
157007623|NCT00638963|566777772|FG000|Overall Study|Withdrawal by Subject|1|||
157007624|NCT00638963|566777773|FG001|Overall Study|Withdrawal by Subject|0|||
157007625|NCT02755116|566777782|FG000|Overall Study|surgery converted to open, pt admitted|3|||
157007626|NCT02755116|566777783|FG001|Overall Study|surgery converted to open, pt admitted|1|||
157113467|NCT01357655|567170306|FG000|Overall Study|Study Drug Toxicity|11|||
157113468|NCT01357655|567170307|FG001|Overall Study|Study Drug Toxicity|0|||
156773828|NCT03813654|565924745|FG001|Overall Study|Protocol Violation|1|||
156773829|NCT03813654|565924746|FG002|Overall Study|Protocol Violation|2|||
156773830|NCT03813654|565924744|FG000|Overall Study|Withdrawal by Subject|1|||
156773831|NCT03813654|565924745|FG001|Overall Study|Withdrawal by Subject|0|||
156773832|NCT03813654|565924746|FG002|Overall Study|Withdrawal by Subject|0|||
156773833|NCT03473197|565924770|FG000|Overall Study|Adverse Event|4|||
156773834|NCT03473197|565924770|FG000|Overall Study|Lost to Follow-up|1|||
156773835|NCT03473197|565924770|FG000|Overall Study|Withdrawal by Subject|5|||
156773836|NCT02326883|565924771|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
156773837|NCT02326883|565924772|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
156808569|NCT01070979|566052715|FG000|Overall Study|Withdrawal by Subject|3|||
156773838|NCT02326883|565924773|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
156773839|NCT00435942|565924777|FG000|Overall Study|Death|17|||
156773840|NCT00435942|565924778|FG001|Overall Study|Death|10|||
156773841|NCT00435942|565924777|FG000|Overall Study|Withdrawal by Subject|2|||
156773842|NCT00435942|565924778|FG001|Overall Study|Withdrawal by Subject|0|||
156773843|NCT00435942|565924777|FG000|Overall Study|Lost to Follow-up|0|||
156773844|NCT00435942|565924778|FG001|Overall Study|Lost to Follow-up|16|||
157113469|NCT01357655|567170306|FG000|Overall Study|Subject Withdrew Consent|1|||
157113470|NCT01357655|567170307|FG001|Overall Study|Subject Withdrew Consent|0|||
157113471|NCT00361270|567170309|FG000|Overall Study|Death|0|||
157113472|NCT00361270|567170310|FG001|Overall Study|Death|0|||
157113473|NCT00361270|567170311|FG002|Overall Study|Death|0|||
157113474|NCT00361270|567170312|FG003|Overall Study|Death|2|||
157113475|NCT00361270|567170309|FG000|Overall Study|Lost to Follow-up|4|||
157113476|NCT00361270|567170310|FG001|Overall Study|Lost to Follow-up|1|||
157113477|NCT00361270|567170311|FG002|Overall Study|Lost to Follow-up|0|||
157113478|NCT00361270|567170312|FG003|Overall Study|Lost to Follow-up|0|||
157113479|NCT00361270|567170309|FG000|Overall Study|Physician Decision|0|||
157113480|NCT00361270|567170310|FG001|Overall Study|Physician Decision|0|||
157113481|NCT00361270|567170311|FG002|Overall Study|Physician Decision|1|||
157113482|NCT00361270|567170312|FG003|Overall Study|Physician Decision|0|||
157113483|NCT00361270|567170309|FG000|Overall Study|Protocol Violation|9|||
157113484|NCT00361270|567170310|FG001|Overall Study|Protocol Violation|4|||
157113485|NCT00361270|567170311|FG002|Overall Study|Protocol Violation|5|||
157113486|NCT00361270|567170312|FG003|Overall Study|Protocol Violation|4|||
157113487|NCT00361270|567170309|FG000|Overall Study|Withdrawal by Subject|6|||
157113488|NCT00361270|567170310|FG001|Overall Study|Withdrawal by Subject|6|||
157113489|NCT00361270|567170311|FG002|Overall Study|Withdrawal by Subject|3|||
157113490|NCT00361270|567170312|FG003|Overall Study|Withdrawal by Subject|7|||
157113491|NCT00361270|567170309|FG000|Overall Study|Afraid of Hypnosis|1|||
157113492|NCT00361270|567170310|FG001|Overall Study|Afraid of Hypnosis|2|||
157113493|NCT00361270|567170311|FG002|Overall Study|Afraid of Hypnosis|0|||
157113494|NCT00361270|567170312|FG003|Overall Study|Afraid of Hypnosis|0|||
157113495|NCT00361270|567170309|FG000|Overall Study|Problems with Transportation|4|||
157113496|NCT00361270|567170310|FG001|Overall Study|Problems with Transportation|0|||
157113497|NCT00361270|567170311|FG002|Overall Study|Problems with Transportation|0|||
157113498|NCT00361270|567170312|FG003|Overall Study|Problems with Transportation|0|||
157113499|NCT00361270|567170309|FG000|Overall Study|Adverse Event|0|||
157113500|NCT00361270|567170310|FG001|Overall Study|Adverse Event|1|||
156773845|NCT00435942|565924777|FG000|Overall Study|Conversion to Open Repair|1|||
156773846|NCT00435942|565924778|FG001|Overall Study|Conversion to Open Repair|0|||
156773847|NCT00435942|565924777|FG000|Overall Study|Technical Failure|3|||
156773848|NCT00435942|565924778|FG001|Overall Study|Technical Failure|0|||
156773849|NCT00435942|565924777|FG000|Overall Study|Other|0|||
156773850|NCT00435942|565924778|FG001|Overall Study|Other|1|||
156773851|NCT00297167|565924780|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
156773852|NCT00297167|565924781|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
156773853|NCT00297167|565924782|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
156773854|NCT00297167|565924780|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
156773855|NCT00297167|565924781|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
156773856|NCT00297167|565924782|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
156773857|NCT02320396|565924783|FG000|Overall Study|Adverse Event|2|||
156773858|NCT02320396|565924784|FG001|Overall Study|Adverse Event|2|||
157113501|NCT00361270|567170311|FG002|Overall Study|Adverse Event|1|||
157113502|NCT00361270|567170312|FG003|Overall Study|Adverse Event|0|||
157113503|NCT04013529|567170315|FG000|Overall Study|Withdrawal by Subject|1|||
156773859|NCT02320396|565924783|FG000|Overall Study|Pregnancy|0|||
157113504|NCT04013529|567170316|FG001|Overall Study|Withdrawal by Subject|1|||
157113505|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
157113506|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
157113507|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
157113508|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
157113509|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
157113510|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
157113511|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
157113512|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
157113513|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to death|4|||
156773860|NCT02320396|565924784|FG001|Overall Study|Pregnancy|1|||
156773861|NCT02320396|565924783|FG000|Overall Study|Protocol Violation|0|||
156773862|NCT02320396|565924784|FG001|Overall Study|Protocol Violation|1|||
156773863|NCT02320396|565924783|FG000|Overall Study|Withdrawal by Subject|2|||
156773864|NCT02320396|565924784|FG001|Overall Study|Withdrawal by Subject|0|||
156773865|NCT02441283|565924785|FG000|Overall Study|Withdrew consent|15|||
156773866|NCT02441283|565924785|FG000|Overall Study|Lost to Follow-up|42|||
156773867|NCT02441283|565924785|FG000|Overall Study|Death|1|||
156773868|NCT02441283|565924785|FG000|Overall Study|Other, not specified|32|||
156773869|NCT06438601|565924786|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
156773870|NCT06438601|565924787|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
156773871|NCT06438601|565924786|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
156773872|NCT06438601|565924787|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
156773873|NCT03282097|565924788|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
156773874|NCT03282097|565924789|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
156773875|NCT03282097|565924788|FG000|Intervention Visit Complete|Patient Death|13|||
156773876|NCT03282097|565924789|FG001|Intervention Visit Complete|Patient Death|15|||
156773877|NCT03282097|565924788|FG000|Intervention Visit Complete|Caregiver Death|0|||
156773878|NCT03282097|565924789|FG001|Intervention Visit Complete|Caregiver Death|3|||
156773879|NCT03282097|565924788|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
156773880|NCT03282097|565924789|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
156773881|NCT03282097|565924788|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
156773882|NCT03282097|565924789|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
156773883|NCT03282097|565924788|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
156773884|NCT03282097|565924789|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
156773885|NCT03282097|565924788|FG000|Primary Outcome Data Collection Complete|Missing|2|||
156773886|NCT03282097|565924789|FG001|Primary Outcome Data Collection Complete|Missing|3|||
156773887|NCT03282097|565924788|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
156773888|NCT03282097|565924789|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
156773889|NCT03282097|565924788|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
156773890|NCT03282097|565924789|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
156773891|NCT03282097|565924788|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
156773892|NCT03282097|565924789|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
156773893|NCT03034967|565924792|FG000|Overall Study|Withdrawal by Subject|9|||
156773894|NCT03034967|565924793|FG001|Overall Study|Withdrawal by Subject|2|||
156773895|NCT03034967|565924794|FG002|Overall Study|Withdrawal by Subject|6|||
156773896|NCT03034967|565924795|FG003|Overall Study|Withdrawal by Subject|6|||
156773897|NCT03034967|565924796|FG004|Overall Study|Withdrawal by Subject|9|||
156773898|NCT03034967|565924797|FG005|Overall Study|Withdrawal by Subject|2|||
156773899|NCT03034967|565924792|FG000|Overall Study|Physician Decision|1|||
156773900|NCT03034967|565924793|FG001|Overall Study|Physician Decision|0|||
156773901|NCT03034967|565924794|FG002|Overall Study|Physician Decision|1|||
156773902|NCT03034967|565924795|FG003|Overall Study|Physician Decision|1|||
156773903|NCT03034967|565924796|FG004|Overall Study|Physician Decision|1|||
157007627|NCT02200770|566777784|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
157007628|NCT02200770|566777785|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
157007629|NCT02200770|566777784|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
157007630|NCT02200770|566777785|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
157007631|NCT02200770|566777784|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
157007632|NCT02200770|566777785|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
157007633|NCT02200770|566777784|FG000|Randomized-controlled Period (RCP)|Other|1|||
157007634|NCT02200770|566777785|FG001|Randomized-controlled Period (RCP)|Other|2|||
157007635|NCT02200770|566777784|FG000|Open-label Period (OLP)|Adverse Event|1|||
157007636|NCT02200770|566777785|FG001|Open-label Period (OLP)|Adverse Event|2|||
157007637|NCT02200770|566777784|FG000|Open-label Period (OLP)|Death|1|||
157007638|NCT02200770|566777785|FG001|Open-label Period (OLP)|Death|2|||
157007639|NCT02200770|566777784|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
157007640|NCT02200770|566777785|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
157007641|NCT02200770|566777784|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
157007642|NCT02200770|566777785|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
157007643|NCT02200770|566777784|FG000|Open-label Period (OLP)|Other|6|||
157007644|NCT02200770|566777785|FG001|Open-label Period (OLP)|Other|15|||
157007645|NCT05283395|566777787|FG000|Overall Study|Adverse Event|4|||
157007646|NCT05283395|566777788|FG001|Overall Study|Adverse Event|4|||
157007647|NCT05283395|566777789|FG002|Overall Study|Adverse Event|0|||
157007648|NCT05283395|566777787|FG000|Overall Study|Patient Lost to Follow-Up|0|||
157113514|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to death|3|||
156773904|NCT03034967|565924797|FG005|Overall Study|Physician Decision|0|||
156773905|NCT03034967|565924792|FG000|Overall Study|Lost to Follow-up|0|||
156773906|NCT03034967|565924793|FG001|Overall Study|Lost to Follow-up|0|||
157207706|NCT00902486|567504558|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
157207707|NCT00902486|567504559|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
157207708|NCT00902486|567504560|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
157207709|NCT00902486|567504555|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
157207710|NCT00902486|567504556|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
157207711|NCT00902486|567504557|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
157207712|NCT00902486|567504558|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
157207713|NCT00902486|567504559|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
157207714|NCT00902486|567504560|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
157207715|NCT00902486|567504555|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
157207716|NCT00902486|567504556|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
157207717|NCT00902486|567504557|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
157207718|NCT00902486|567504558|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
157207719|NCT00902486|567504559|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
157207720|NCT00902486|567504560|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
157207721|NCT00902486|567504555|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
157207722|NCT00902486|567504556|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
157207723|NCT00902486|567504557|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
157207724|NCT00902486|567504558|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
157207725|NCT00902486|567504559|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
157207726|NCT00902486|567504560|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
157207727|NCT00902486|567504555|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
157207728|NCT00902486|567504556|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
157207729|NCT00902486|567504557|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
157207730|NCT00902486|567504558|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
157207731|NCT00902486|567504559|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
157207732|NCT00902486|567504560|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
157207733|NCT00902486|567504555|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
156773907|NCT03034967|565924794|FG002|Overall Study|Lost to Follow-up|0|||
157207734|NCT00902486|567504556|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
157207735|NCT00902486|567504557|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
157207736|NCT00902486|567504558|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
157007649|NCT05283395|566777788|FG001|Overall Study|Patient Lost to Follow-Up|0|||
157007650|NCT05283395|566777789|FG002|Overall Study|Patient Lost to Follow-Up|1|||
157007651|NCT05283395|566777787|FG000|Overall Study|Patient Withdrawal|2|||
157007652|NCT05283395|566777788|FG001|Overall Study|Patient Withdrawal|4|||
157007653|NCT05283395|566777789|FG002|Overall Study|Patient Withdrawal|2|||
157007654|NCT05283395|566777787|FG000|Overall Study|Investigator Decision|1|||
157007655|NCT05283395|566777788|FG001|Overall Study|Investigator Decision|0|||
157007656|NCT05283395|566777789|FG002|Overall Study|Investigator Decision|1|||
157007657|NCT05283395|566777787|FG000|Overall Study|Enrolled in error|0|||
157007658|NCT05283395|566777788|FG001|Overall Study|Enrolled in error|0|||
157007659|NCT05283395|566777789|FG002|Overall Study|Enrolled in error|1|||
157007660|NCT03401112|566777791|FG000|Overall Study|Adverse Event|1|||
157007661|NCT03401112|566777792|FG001|Overall Study|Adverse Event|2|||
157007662|NCT03401112|566777793|FG002|Overall Study|Adverse Event|3|||
157007663|NCT03401112|566777794|FG003|Overall Study|Adverse Event|2|||
157007664|NCT03401112|566777795|FG004|Overall Study|Adverse Event|0|||
157007665|NCT03401112|566777791|FG000|Overall Study|Lost to Follow-up|1|||
157007666|NCT03401112|566777792|FG001|Overall Study|Lost to Follow-up|0|||
156773908|NCT03034967|565924795|FG003|Overall Study|Lost to Follow-up|1|||
157113515|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
157113516|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
157113517|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
157113518|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
157113519|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
157113520|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
157113521|NCT02258451|567170317|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
157113522|NCT02258451|567170318|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
157113523|NCT02258451|567170317|FG000|Overall Study|Other reason|1|||
157113524|NCT02258451|567170318|FG001|Overall Study|Other reason|1|||
157113525|NCT02258451|567170317|FG000|Overall Study|Never treated|2|||
157113526|NCT02258451|567170318|FG001|Overall Study|Never treated|3|||
157113527|NCT00517751|567170321|FG000|Overall Study|Death|3|||
157113528|NCT00517751|567170321|FG000|Overall Study|Withdrawal by Subject|37|||
157113529|NCT00517751|567170321|FG000|Overall Study|Lost to Follow-up|4|||
157113530|NCT00517751|567170321|FG000|Overall Study|patient not over due|6|||
157113531|NCT00517751|567170321|FG000|Overall Study|Patient not due for visit|76|||
157113532|NCT00517751|567170321|FG000|Overall Study|Missing|3|||
157113533|NCT03021499|567170324|FG000|Overall Study|Adverse Event|1|||
157113534|NCT03021499|567170325|FG001|Overall Study|Adverse Event|0|||
157113535|NCT03021499|567170324|FG000|Overall Study|Death|1|||
157113536|NCT03021499|567170325|FG001|Overall Study|Death|5|||
157113537|NCT03021499|567170324|FG000|Overall Study|Lack of Efficacy|0|||
157207737|NCT00902486|567504559|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
157207738|NCT00902486|567504560|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
157207739|NCT00902486|567504555|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
157207740|NCT00902486|567504556|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
157207741|NCT00902486|567504557|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
157207742|NCT00902486|567504558|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
157207743|NCT00902486|567504559|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
157207744|NCT00902486|567504560|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
157207745|NCT00902486|567504555|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
157207746|NCT00902486|567504556|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
157207747|NCT00902486|567504557|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
157207748|NCT00902486|567504558|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
157207749|NCT00902486|567504559|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
157207750|NCT00902486|567504560|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
157207751|NCT01607398|567506237|FG000|Overall Study|Adverse Event|0|||
157207752|NCT01607398|567506238|FG001|Overall Study|Adverse Event|2|||
157207753|NCT01607398|567506237|FG000|Overall Study|Severe COPD|2|||
157207754|NCT01607398|567506238|FG001|Overall Study|Severe COPD|0|||
157207755|NCT00858234|567506239|FG000|Overall Study|Adverse Event|6|||
157207756|NCT00858234|567506239|FG000|Overall Study|Progressive disease|2|||
157207757|NCT00858234|567506239|FG000|Overall Study|Status unknown|1|||
157207758|NCT02957682|567506242|FG000|Overall Study|Adverse Event|64|||
157207759|NCT02957682|567506243|FG001|Overall Study|Adverse Event|67|||
157207760|NCT02957682|567506242|FG000|Overall Study|Poor Compliance to Protocol|30|||
157207761|NCT02957682|567506243|FG001|Overall Study|Poor Compliance to Protocol|26|||
157207762|NCT02957682|567506242|FG000|Overall Study|Physician Decision|4|||
157207763|NCT02957682|567506243|FG001|Overall Study|Physician Decision|4|||
157207764|NCT02957682|567506242|FG000|Overall Study|Study Terminated by Sponsor|4|||
157207765|NCT02957682|567506243|FG001|Overall Study|Study Terminated by Sponsor|3|||
157207766|NCT02957682|567506242|FG000|Overall Study|Subject Moved|10|||
157207767|NCT02957682|567506243|FG001|Overall Study|Subject Moved|16|||
157207768|NCT02957682|567506242|FG000|Overall Study|Withdrawal by Subject|64|||
157207769|NCT02957682|567506243|FG001|Overall Study|Withdrawal by Subject|33|||
157207770|NCT02957682|567506242|FG000|Overall Study|Related to IMP Administration|3|||
157207771|NCT02957682|567506243|FG001|Overall Study|Related to IMP Administration|6|||
157207772|NCT02957682|567506242|FG000|Overall Study|Non-disclosed|16|||
157207773|NCT02957682|567506243|FG001|Overall Study|Non-disclosed|12|||
156773909|NCT03034967|565924796|FG004|Overall Study|Lost to Follow-up|0|||
157113538|NCT03021499|567170325|FG001|Overall Study|Lack of Efficacy|1|||
157113539|NCT03021499|567170324|FG000|Overall Study|Lost to Follow-up|1|||
157113540|NCT03021499|567170325|FG001|Overall Study|Lost to Follow-up|3|||
157207774|NCT02957682|567506242|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
157207775|NCT02957682|567506243|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
157207776|NCT02953262|567506251|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
157207777|NCT02953262|567506252|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
156773910|NCT03034967|565924797|FG005|Overall Study|Lost to Follow-up|2|||
156773911|NCT03034967|565924792|FG000|Overall Study|Liver function test abnormality|0|||
156773912|NCT03034967|565924793|FG001|Overall Study|Liver function test abnormality|0|||
156773913|NCT03034967|565924794|FG002|Overall Study|Liver function test abnormality|1|||
156773914|NCT03034967|565924795|FG003|Overall Study|Liver function test abnormality|0|||
156773915|NCT03034967|565924796|FG004|Overall Study|Liver function test abnormality|0|||
156773916|NCT03034967|565924797|FG005|Overall Study|Liver function test abnormality|0|||
156773917|NCT03034967|565924792|FG000|Overall Study|Protocol Violation|1|||
156773918|NCT03034967|565924793|FG001|Overall Study|Protocol Violation|0|||
157007667|NCT03401112|566777793|FG002|Overall Study|Lost to Follow-up|0|||
157007668|NCT03401112|566777794|FG003|Overall Study|Lost to Follow-up|0|||
157007669|NCT03401112|566777795|FG004|Overall Study|Lost to Follow-up|0|||
157007670|NCT03401112|566777791|FG000|Overall Study|Noncompliance|1|||
157007671|NCT03401112|566777792|FG001|Overall Study|Noncompliance|2|||
157007672|NCT03401112|566777793|FG002|Overall Study|Noncompliance|3|||
157007673|NCT03401112|566777794|FG003|Overall Study|Noncompliance|0|||
157007674|NCT03401112|566777795|FG004|Overall Study|Noncompliance|0|||
157007675|NCT03401112|566777791|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
157007676|NCT03401112|566777792|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
157007677|NCT03401112|566777793|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
157207778|NCT02953262|567506253|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
157207779|NCT02953262|567506254|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
157207780|NCT01652573|567506255|FG000|Overall Study|Adverse Event|0|||
157207781|NCT01652573|567506256|FG001|Overall Study|Adverse Event|1|||
157207782|NCT00934622|567506257|FG000|Overall Study|Lost to Follow-up|7|||
157207783|NCT00934622|567506257|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
157207784|NCT03284424|567506258|FG000|Overall Study|Death|70|||
157207785|NCT03284424|567506259|FG001|Overall Study|Death|24|||
157207786|NCT03284424|567506258|FG000|Overall Study|Lost to Follow-up|3|||
157207787|NCT03284424|567506259|FG001|Overall Study|Lost to Follow-up|1|||
157207788|NCT03284424|567506258|FG000|Overall Study|Physician Decision|1|||
157207789|NCT03284424|567506259|FG001|Overall Study|Physician Decision|2|||
157207790|NCT03284424|567506258|FG000|Overall Study|Withdrawal by Subject|4|||
157207791|NCT03284424|567506259|FG001|Overall Study|Withdrawal by Subject|5|||
157207792|NCT03284424|567506258|FG000|Overall Study|Sponsor's decision|27|||
157207793|NCT03284424|567506259|FG001|Overall Study|Sponsor's decision|22|||
157207794|NCT00468312|567506260|FG000|Overall Study|Adverse Event|2|||
157207795|NCT00468312|567506261|FG001|Overall Study|Adverse Event|1|||
157207796|NCT00468312|567506260|FG000|Overall Study|Lack of Efficacy|0|||
157207797|NCT00468312|567506261|FG001|Overall Study|Lack of Efficacy|1|||
157207798|NCT00468312|567506260|FG000|Overall Study|Withdrawal by Subject|0|||
157207799|NCT00468312|567506261|FG001|Overall Study|Withdrawal by Subject|1|||
157207800|NCT00468312|567506260|FG000|Overall Study|Protocol Violation|2|||
157207801|NCT00468312|567506261|FG001|Overall Study|Protocol Violation|1|||
157207802|NCT00468312|567506260|FG000|Overall Study|Did not meet protocol eligibility|0|||
157207803|NCT00468312|567506261|FG001|Overall Study|Did not meet protocol eligibility|1|||
157207804|NCT01052038|567506262|FG000|Overall Study|Lost to Follow-up|2|||
157207805|NCT01052038|567506263|FG001|Overall Study|Lost to Follow-up|3|||
157207806|NCT01052038|567506264|FG002|Overall Study|Lost to Follow-up|1|||
157207807|NCT01052038|567506262|FG000|Overall Study|Protocol Violation|2|||
157207808|NCT01052038|567506263|FG001|Overall Study|Protocol Violation|3|||
157207809|NCT01052038|567506264|FG002|Overall Study|Protocol Violation|3|||
157207810|NCT03349437|567506265|FG000|Screening|Screen Fail|4|||
157207811|NCT03349437|567506266|FG001|Screening|Screen Fail|0|||
157207812|NCT03349437|567506267|FG002|Screening|Screen Fail|0|||
157207813|NCT03349437|567506265|FG000|Screening|Withdrawn|1|||
157207814|NCT03349437|567506266|FG001|Screening|Withdrawn|0|||
157207815|NCT03349437|567506267|FG002|Screening|Withdrawn|0|||
157007678|NCT03401112|566777794|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
157007679|NCT03401112|566777795|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
157007680|NCT03401112|566777791|FG000|Overall Study|Withdrawal by Subject|0|||
157007681|NCT03401112|566777792|FG001|Overall Study|Withdrawal by Subject|3|||
157007682|NCT03401112|566777793|FG002|Overall Study|Withdrawal by Subject|2|||
157007683|NCT03401112|566777794|FG003|Overall Study|Withdrawal by Subject|1|||
157007684|NCT03401112|566777795|FG004|Overall Study|Withdrawal by Subject|0|||
157007685|NCT03401112|566777791|FG000|Overall Study|Physician Decision|0|||
157007686|NCT03401112|566777792|FG001|Overall Study|Physician Decision|0|||
157007687|NCT03401112|566777793|FG002|Overall Study|Physician Decision|0|||
157007688|NCT03401112|566777794|FG003|Overall Study|Physician Decision|2|||
157007689|NCT03401112|566777795|FG004|Overall Study|Physician Decision|0|||
157007690|NCT03401112|566777791|FG000|Overall Study|Study was Terminated by Sponsor|0|||
157007691|NCT03401112|566777792|FG001|Overall Study|Study was Terminated by Sponsor|0|||
157007692|NCT03401112|566777793|FG002|Overall Study|Study was Terminated by Sponsor|0|||
157007693|NCT03401112|566777794|FG003|Overall Study|Study was Terminated by Sponsor|1|||
157007694|NCT03401112|566777795|FG004|Overall Study|Study was Terminated by Sponsor|0|||
157007695|NCT03401112|566777791|FG000|Overall Study|Day 1 Assessment not Done|1|||
157007696|NCT03401112|566777792|FG001|Overall Study|Day 1 Assessment not Done|0|||
157007697|NCT03401112|566777793|FG002|Overall Study|Day 1 Assessment not Done|0|||
157007698|NCT03401112|566777794|FG003|Overall Study|Day 1 Assessment not Done|0|||
157007699|NCT03401112|566777795|FG004|Overall Study|Day 1 Assessment not Done|0|||
157007700|NCT03401112|566777791|FG000|Overall Study|Not Dosed|0|||
157007701|NCT03401112|566777792|FG001|Overall Study|Not Dosed|0|||
157207816|NCT05723835|567506275|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
157207817|NCT05723835|567506276|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
157207818|NCT05723835|567506277|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
156773919|NCT03034967|565924794|FG002|Overall Study|Protocol Violation|0|||
156773920|NCT03034967|565924795|FG003|Overall Study|Protocol Violation|0|||
156773921|NCT03034967|565924796|FG004|Overall Study|Protocol Violation|0|||
156773922|NCT03034967|565924797|FG005|Overall Study|Protocol Violation|2|||
156773923|NCT03034967|565924792|FG000|Overall Study|Lack of Efficacy|0|||
156773924|NCT03034967|565924793|FG001|Overall Study|Lack of Efficacy|1|||
157207819|NCT05723835|567506278|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
157207820|NCT05723835|567506279|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
157207821|NCT05723835|567506280|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
157207822|NCT05723835|567506281|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
157207823|NCT05723835|567506282|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
157207824|NCT05226286|567506283|FG000|Overall Study|Screen failures prior to implant|62|||
157207825|NCT05226286|567506283|FG000|Overall Study|Withdrawal by Subject|13|||
157207826|NCT05226286|567506283|FG000|Overall Study|Lost to Follow-up|3|||
157207827|NCT05226286|567506283|FG000|Overall Study|Physician Decision|1|||
157207828|NCT05226286|567506283|FG000|Overall Study|Adverse Event|1|||
157207829|NCT05226286|567506283|FG000|Overall Study|Death|1|||
157207830|NCT05226286|567506283|FG000|Overall Study|Device explant with no planned replacement|1|||
157207831|NCT05226286|567506283|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
157207832|NCT05226286|567506283|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
157207833|NCT00602641|567506284|FG000|Overall Study|Never started protocol therapy|6|||
157207834|NCT00602641|567506285|FG001|Overall Study|Never started protocol therapy|2|||
157207835|NCT00602641|567506284|FG000|Overall Study|Still on treatment at time of analysis|8|||
157207836|NCT00602641|567506285|FG001|Overall Study|Still on treatment at time of analysis|15|||
157207837|NCT00602641|567506284|FG000|Overall Study|Adverse Event|62|||
157207838|NCT00602641|567506285|FG001|Overall Study|Adverse Event|53|||
157207839|NCT00602641|567506284|FG000|Overall Study|Disease progression|38|||
157207840|NCT00602641|567506285|FG001|Overall Study|Disease progression|55|||
157207841|NCT00602641|567506284|FG000|Overall Study|Death|6|||
157207842|NCT00602641|567506285|FG001|Overall Study|Death|5|||
157207843|NCT00602641|567506284|FG000|Overall Study|Withdrawal by Subject|15|||
157207844|NCT00602641|567506285|FG001|Overall Study|Withdrawal by Subject|12|||
157207845|NCT00602641|567506284|FG000|Overall Study|Alternative therapy|5|||
157207846|NCT00602641|567506285|FG001|Overall Study|Alternative therapy|2|||
156773925|NCT03034967|565924794|FG002|Overall Study|Lack of Efficacy|2|||
157207847|NCT00602641|567506284|FG000|Overall Study|Other Complicating Disease|5|||
157207848|NCT00602641|567506285|FG001|Overall Study|Other Complicating Disease|2|||
157207849|NCT00602641|567506284|FG000|Overall Study|Physician Decision|5|||
157207850|NCT00602641|567506285|FG001|Overall Study|Physician Decision|4|||
157207851|NCT00602641|567506284|FG000|Overall Study|Administrative Closure|1|||
157207852|NCT00602641|567506285|FG001|Overall Study|Administrative Closure|1|||
157207853|NCT00602641|567506284|FG000|Overall Study|Other|3|||
157207854|NCT00602641|567506285|FG001|Overall Study|Other|1|||
157207855|NCT01826201|567506288|FG000|Overall Study|Non compliance with protocol|4|||
157207856|NCT03387735|567506291|FG000|Overall Study|Lost to Follow-up|4|||
157207857|NCT03387735|567506292|FG001|Overall Study|Lost to Follow-up|8|||
157207858|NCT03387735|567506291|FG000|Overall Study|Death|4|||
157207859|NCT03387735|567506292|FG001|Overall Study|Death|8|||
157207860|NCT03099161|567506293|FG000|Overall Study|Adverse Event|0|||
157207861|NCT03099161|567506294|FG001|Overall Study|Adverse Event|0|||
157207862|NCT03099161|567506295|FG002|Overall Study|Adverse Event|2|||
157207863|NCT03099161|567506293|FG000|Overall Study|Physician Decision|2|||
157207864|NCT03099161|567506294|FG001|Overall Study|Physician Decision|0|||
157207865|NCT03099161|567506295|FG002|Overall Study|Physician Decision|0|||
157207866|NCT03099161|567506293|FG000|Overall Study|Progressive Disease|1|||
157207867|NCT03099161|567506294|FG001|Overall Study|Progressive Disease|4|||
157207868|NCT03099161|567506295|FG002|Overall Study|Progressive Disease|1|||
157207869|NCT00110084|567506296|FG000|Overall Study|Adverse Event|9|||
156773926|NCT03034967|565924795|FG003|Overall Study|Lack of Efficacy|1|||
157207870|NCT00110084|567506296|FG000|Overall Study|Death|1|||
157207871|NCT00110084|567506296|FG000|Overall Study|Patient Refusal|10|||
157207872|NCT00110084|567506296|FG000|Overall Study|Alternate Therapy|5|||
157207873|NCT00110084|567506296|FG000|Overall Study|Intercurrent Illness|1|||
157207874|NCT00110084|567506296|FG000|Overall Study|Other|2|||
157207875|NCT04854707|567506297|FG000|Overall Study|Lack of Efficacy|78|||
157207876|NCT04854707|567506298|FG001|Overall Study|Lack of Efficacy|59|||
157207877|NCT04854707|567506299|FG002|Overall Study|Lack of Efficacy|30|||
157207878|NCT05302414|567506301|FG000|Pretest to Posttest|Lost to Follow-up|12|||
156773927|NCT03034967|565924796|FG004|Overall Study|Lack of Efficacy|1|||
156773928|NCT03034967|565924797|FG005|Overall Study|Lack of Efficacy|0|||
157113541|NCT03021499|567170324|FG000|Overall Study|Physician Decision|2|||
157113542|NCT03021499|567170325|FG001|Overall Study|Physician Decision|3|||
157113543|NCT03021499|567170324|FG000|Overall Study|Pregnancy|1|||
157113544|NCT03021499|567170325|FG001|Overall Study|Pregnancy|0|||
157113545|NCT03021499|567170324|FG000|Overall Study|Withdrawal by Subject|7|||
157113546|NCT03021499|567170325|FG001|Overall Study|Withdrawal by Subject|14|||
157113547|NCT03021499|567170324|FG000|Overall Study|Prohibited medication required|1|||
157113548|NCT03021499|567170325|FG001|Overall Study|Prohibited medication required|0|||
157113549|NCT03021499|567170324|FG000|Overall Study|Protocol non-compliance|1|||
157113550|NCT03021499|567170325|FG001|Overall Study|Protocol non-compliance|1|||
157113551|NCT03021499|567170324|FG000|Overall Study|None of the above|0|||
157113552|NCT03021499|567170325|FG001|Overall Study|None of the above|4|||
157113553|NCT03021499|567170324|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
157113554|NCT03021499|567170325|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
157113555|NCT00495820|567170326|FG000|Overall Study|Adverse Event|1|||
157113556|NCT00495820|567170327|FG001|Overall Study|Adverse Event|1|||
157113557|NCT00820950|567170328|FG000|Overall Study|Scheduling Conflict|0|||
157113558|NCT00820950|567170329|FG001|Overall Study|Scheduling Conflict|0|||
157113559|NCT00820950|567170330|FG002|Overall Study|Scheduling Conflict|0|||
157113560|NCT00820950|567170331|FG003|Overall Study|Scheduling Conflict|0|||
157113561|NCT00820950|567170332|FG004|Overall Study|Scheduling Conflict|0|||
157113562|NCT00820950|567170333|FG005|Overall Study|Scheduling Conflict|0|||
157113563|NCT00820950|567170334|FG006|Overall Study|Scheduling Conflict|1|||
157113564|NCT00820950|567170335|FG007|Overall Study|Scheduling Conflict|1|||
157113565|NCT00820950|567170336|FG008|Overall Study|Scheduling Conflict|0|||
157113566|NCT00820950|567170337|FG009|Overall Study|Scheduling Conflict|0|||
157113567|NCT00820950|567170328|FG000|Overall Study|Protocol Violation|1|||
157113568|NCT00820950|567170329|FG001|Overall Study|Protocol Violation|1|||
157113569|NCT00820950|567170330|FG002|Overall Study|Protocol Violation|0|||
157113570|NCT00820950|567170331|FG003|Overall Study|Protocol Violation|0|||
157113571|NCT00820950|567170332|FG004|Overall Study|Protocol Violation|0|||
157113572|NCT00820950|567170333|FG005|Overall Study|Protocol Violation|0|||
157113573|NCT00820950|567170334|FG006|Overall Study|Protocol Violation|0|||
157113574|NCT00820950|567170335|FG007|Overall Study|Protocol Violation|0|||
157113575|NCT00820950|567170336|FG008|Overall Study|Protocol Violation|0|||
157113576|NCT00820950|567170337|FG009|Overall Study|Protocol Violation|0|||
157113577|NCT02484911|567171711|FG000|Overall Study|Withdrawal by Subject|2|||
157113578|NCT02484911|567171712|FG001|Overall Study|Withdrawal by Subject|1|||
157113579|NCT02484911|567171711|FG000|Overall Study|Protocol Violation|2|||
157113580|NCT02484911|567171712|FG001|Overall Study|Protocol Violation|1|||
157113581|NCT04129528|567171713|FG000|Overall Study|Adverse Event|1|||
157113582|NCT04129528|567171714|FG001|Overall Study|Adverse Event|0|||
157113583|NCT04129528|567171713|FG000|Overall Study|Physician Decision|1|||
157113584|NCT04129528|567171714|FG001|Overall Study|Physician Decision|1|||
157113585|NCT04129528|567171713|FG000|Overall Study|Withdrawal by Subject|1|||
157113586|NCT04129528|567171714|FG001|Overall Study|Withdrawal by Subject|1|||
157113587|NCT00490568|567171723|FG000|Overall Study|Adverse Event|116|||
157113588|NCT00490568|567171723|FG000|Overall Study|Lost to Follow-up|13|||
157113589|NCT00490568|567171723|FG000|Overall Study|Protocol Violation|45|||
157113590|NCT00490568|567171723|FG000|Overall Study|Withdrawal by Subject|135|||
157113591|NCT00490568|567171723|FG000|Overall Study|Still in the study at termination|974|||
157113592|NCT00490568|567171723|FG000|Overall Study|Other|1|||
157113593|NCT00490568|567171723|FG000|Overall Study|Exclusion criteria met|1|||
157113594|NCT00490568|567171723|FG000|Overall Study|Caregiver related|20|||
157113595|NCT00490568|567171723|FG000|Overall Study|Abnormal ECG|25|||
157113596|NCT00490568|567171723|FG000|Overall Study|Participant refused follow-up|9|||
157113597|NCT00490568|567171723|FG000|Overall Study|Legal representative withdrew consent|1|||
157113598|NCT00490568|567171723|FG000|Overall Study|Disease progression|4|||
157113599|NCT00490568|567171723|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
157207879|NCT05302414|567506302|FG001|Pretest to Posttest|Lost to Follow-up|8|||
157113600|NCT00490568|567171723|FG000|Overall Study|Investigator decision|3|||
157113601|NCT00490568|567171723|FG000|Overall Study|Non-Compliance|7|||
157007702|NCT03401112|566777793|FG002|Overall Study|Not Dosed|1|||
157007703|NCT03401112|566777794|FG003|Overall Study|Not Dosed|0|||
157007704|NCT03401112|566777795|FG004|Overall Study|Not Dosed|0|||
157007705|NCT03401112|566777791|FG000|Overall Study|Missed Clinical Visit|0|||
157007706|NCT03401112|566777792|FG001|Overall Study|Missed Clinical Visit|0|||
157207880|NCT05302414|567506303|FG002|Pretest to Posttest|Lost to Follow-up|8|||
157007707|NCT03401112|566777793|FG002|Overall Study|Missed Clinical Visit|1|||
157207881|NCT05302414|567506301|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
157207882|NCT05302414|567506302|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
157207883|NCT05302414|567506303|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
157207884|NCT00742859|567506304|FG000|Overall Study|Adverse Event|5|||
157207885|NCT00742859|567506305|FG001|Overall Study|Adverse Event|6|||
157207886|NCT00742859|567506306|FG002|Overall Study|Adverse Event|3|||
157207887|NCT00742859|567506307|FG003|Overall Study|Adverse Event|1|||
157207888|NCT00742859|567506304|FG000|Overall Study|Death|1|||
157207889|NCT00742859|567506305|FG001|Overall Study|Death|0|||
157207890|NCT00742859|567506306|FG002|Overall Study|Death|0|||
157207891|NCT00742859|567506307|FG003|Overall Study|Death|1|||
157207892|NCT00742859|567506304|FG000|Overall Study|Physician Decision|1|||
157207893|NCT00742859|567506305|FG001|Overall Study|Physician Decision|2|||
157207894|NCT00742859|567506306|FG002|Overall Study|Physician Decision|0|||
157207895|NCT00742859|567506307|FG003|Overall Study|Physician Decision|0|||
157207896|NCT00742859|567506304|FG000|Overall Study|Withdrawal by Subject|4|||
157207897|NCT00742859|567506305|FG001|Overall Study|Withdrawal by Subject|2|||
157207898|NCT00742859|567506306|FG002|Overall Study|Withdrawal by Subject|4|||
157207899|NCT00742859|567506307|FG003|Overall Study|Withdrawal by Subject|1|||
157207900|NCT00742859|567506304|FG000|Overall Study|Endpoint|0|||
157207901|NCT00742859|567506305|FG001|Overall Study|Endpoint|1|||
157207902|NCT00742859|567506306|FG002|Overall Study|Endpoint|1|||
157207903|NCT00742859|567506307|FG003|Overall Study|Endpoint|2|||
157207904|NCT00742859|567506304|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
157207905|NCT00742859|567506305|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
157207906|NCT00742859|567506306|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
157207907|NCT00742859|567506307|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
157207908|NCT00742859|567506304|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
157207909|NCT00742859|567506305|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
157207910|NCT00742859|567506306|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
157207911|NCT00742859|567506307|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
157207912|NCT00742859|567506304|FG000|Overall Study|Sponsor request patient out of town|0|||
157207913|NCT00742859|567506305|FG001|Overall Study|Sponsor request patient out of town|0|||
157207914|NCT00742859|567506306|FG002|Overall Study|Sponsor request patient out of town|1|||
157207915|NCT00742859|567506307|FG003|Overall Study|Sponsor request patient out of town|1|||
157207916|NCT00742859|567506304|FG000|Overall Study|Site error|0|||
157207917|NCT00742859|567506305|FG001|Overall Study|Site error|0|||
157207918|NCT00742859|567506306|FG002|Overall Study|Site error|1|||
157207919|NCT00742859|567506307|FG003|Overall Study|Site error|1|||
157207920|NCT01346501|567506308|FG000|Overall Study|Initiated Other Biological Agents|3|||
157207921|NCT01346501|567506309|FG001|Overall Study|Initiated Other Biological Agents|1|||
157207922|NCT01346501|567506308|FG000|Overall Study|Other|8|||
157207923|NCT01346501|567506309|FG001|Overall Study|Other|12|||
157207924|NCT03972709|567506315|FG000|Overall Study|Withdrawal by Subject|18|||
157207925|NCT03972709|567506316|FG001|Overall Study|Withdrawal by Subject|7|||
157207926|NCT03972709|567506317|FG002|Overall Study|Withdrawal by Subject|14|||
156773929|NCT03034967|565924792|FG000|Overall Study|Adverse Event, non-fatal|3|||
156773930|NCT03034967|565924793|FG001|Overall Study|Adverse Event, non-fatal|1|||
156773931|NCT03034967|565924794|FG002|Overall Study|Adverse Event, non-fatal|2|||
156773932|NCT03034967|565924795|FG003|Overall Study|Adverse Event, non-fatal|0|||
156773933|NCT03034967|565924796|FG004|Overall Study|Adverse Event, non-fatal|2|||
156773934|NCT03034967|565924797|FG005|Overall Study|Adverse Event, non-fatal|8|||
156773935|NCT03034967|565924792|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
156773936|NCT03034967|565924793|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
156773937|NCT03034967|565924794|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
156773938|NCT03034967|565924795|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
156773939|NCT03034967|565924796|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
156773940|NCT03034967|565924797|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
156773941|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
156773942|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
156773943|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
156773944|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
156773945|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
156773946|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
156773947|NCT03806296|565924798|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
156773948|NCT03806296|565924799|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
156773949|NCT03806296|565924800|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
156773950|NCT00879658|565924803|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156773951|NCT00879658|565924804|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156773952|NCT00879658|565924805|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156773953|NCT00879658|565924806|FG003|Overall Study|Abnormal laboratory value(s)|1|||
156773954|NCT00879658|565924807|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156773955|NCT00879658|565924808|FG005|Overall Study|Abnormal laboratory value(s)|0|||
156773956|NCT00879658|565924809|FG006|Overall Study|Abnormal laboratory value(s)|0|||
156773957|NCT00879658|565924803|FG000|Overall Study|Administrative problems|2|||
156773958|NCT00879658|565924804|FG001|Overall Study|Administrative problems|1|||
156773959|NCT00879658|565924805|FG002|Overall Study|Administrative problems|0|||
156773960|NCT00879658|565924806|FG003|Overall Study|Administrative problems|1|||
156773961|NCT00879658|565924807|FG004|Overall Study|Administrative problems|0|||
156773962|NCT00879658|565924808|FG005|Overall Study|Administrative problems|0|||
156773963|NCT00879658|565924809|FG006|Overall Study|Administrative problems|0|||
156773964|NCT00879658|565924803|FG000|Overall Study|Adverse Event|6|||
156773965|NCT00879658|565924804|FG001|Overall Study|Adverse Event|4|||
156773966|NCT00879658|565924805|FG002|Overall Study|Adverse Event|3|||
156773967|NCT00879658|565924806|FG003|Overall Study|Adverse Event|1|||
156773968|NCT00879658|565924807|FG004|Overall Study|Adverse Event|2|||
156773969|NCT00879658|565924808|FG005|Overall Study|Adverse Event|0|||
156773970|NCT00879658|565924809|FG006|Overall Study|Adverse Event|0|||
156773971|NCT00879658|565924803|FG000|Overall Study|Protocol Violation|1|||
156773972|NCT00879658|565924804|FG001|Overall Study|Protocol Violation|0|||
156773973|NCT00879658|565924805|FG002|Overall Study|Protocol Violation|0|||
156773974|NCT00879658|565924806|FG003|Overall Study|Protocol Violation|0|||
156773975|NCT00879658|565924807|FG004|Overall Study|Protocol Violation|0|||
157007708|NCT03401112|566777794|FG003|Overall Study|Missed Clinical Visit|0|||
157007709|NCT03401112|566777795|FG004|Overall Study|Missed Clinical Visit|0|||
157007710|NCT03401112|566777791|FG000|Overall Study|Missed Doses|0|||
157007711|NCT03401112|566777792|FG001|Overall Study|Missed Doses|0|||
157007712|NCT03401112|566777793|FG002|Overall Study|Missed Doses|1|||
157007713|NCT03401112|566777794|FG003|Overall Study|Missed Doses|0|||
157007714|NCT03401112|566777795|FG004|Overall Study|Missed Doses|0|||
157007715|NCT01264679|566777796|FG000|Overall Study|Participation in Another Clinical Trial|1|||
157113602|NCT00490568|567171723|FG000|Overall Study|Efficacy related|3|||
156773976|NCT00879658|565924808|FG005|Overall Study|Protocol Violation|0|||
156773977|NCT00879658|565924809|FG006|Overall Study|Protocol Violation|0|||
156773978|NCT00879658|565924803|FG000|Overall Study|Withdrawal by Subject|3|||
156773979|NCT00879658|565924804|FG001|Overall Study|Withdrawal by Subject|0|||
156773980|NCT00879658|565924805|FG002|Overall Study|Withdrawal by Subject|2|||
156773981|NCT00879658|565924806|FG003|Overall Study|Withdrawal by Subject|0|||
156773982|NCT00879658|565924807|FG004|Overall Study|Withdrawal by Subject|0|||
156773983|NCT00879658|565924808|FG005|Overall Study|Withdrawal by Subject|1|||
157007716|NCT01264679|566777796|FG000|Overall Study|Physician Decision|1|||
157113603|NCT00490568|567171723|FG000|Overall Study|Participant died|1|||
156773984|NCT00879658|565924809|FG006|Overall Study|Withdrawal by Subject|0|||
156773985|NCT00879658|565924803|FG000|Overall Study|Lack of Efficacy|0|||
156773986|NCT00879658|565924804|FG001|Overall Study|Lack of Efficacy|0|||
157113604|NCT00490568|567171723|FG000|Overall Study|Participant withdrawal due to surgery|1|||
157113605|NCT03927105|567171726|FG000|Overall Study|Death|1|||
157113606|NCT03927105|567171726|FG000|Overall Study|In observation for potential re-treatment|2|||
157113607|NCT03927105|567171726|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
157113608|NCT01351389|567171728|FG000|Overall Study|Withdrawal by Subject|7|||
157113609|NCT01351389|567171729|FG001|Overall Study|Withdrawal by Subject|0|||
157113610|NCT01351389|567171728|FG000|Overall Study|did not complete intervention|23|||
157113611|NCT01351389|567171729|FG001|Overall Study|did not complete intervention|15|||
157113612|NCT01081912|567171730|FG000|Conversion/Titration|Adverse Event|47|||
157113613|NCT01081912|567171731|FG001|Conversion/Titration|Adverse Event|0|||
156773987|NCT00879658|565924805|FG002|Overall Study|Lack of Efficacy|2|||
156773988|NCT00879658|565924806|FG003|Overall Study|Lack of Efficacy|0|||
156773989|NCT00879658|565924807|FG004|Overall Study|Lack of Efficacy|0|||
157007717|NCT01264679|566777796|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
157007718|NCT01264679|566777796|FG000|Overall Study|Withdrawal by Subject|1|||
157007719|NCT03475316|566777797|FG000|6 Month Intervention|Adverse Event|2|||
157007720|NCT03475316|566777798|FG001|6 Month Intervention|Adverse Event|1|||
157007721|NCT03475316|566777797|FG000|6 Month Intervention|Withdrawal by Subject|2|||
157007722|NCT03475316|566777798|FG001|6 Month Intervention|Withdrawal by Subject|0|||
157007723|NCT03475316|566777797|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
157007724|NCT03475316|566777798|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
157007725|NCT03475316|566777797|FG000|9 Months|Study stopped due to COVID pandemic|3|||
157007726|NCT03475316|566777798|FG001|9 Months|Study stopped due to COVID pandemic|4|||
157207927|NCT03972709|567506315|FG000|Overall Study|Study Terminated by Sponsor|48|||
157207928|NCT03972709|567506316|FG001|Overall Study|Study Terminated by Sponsor|25|||
157207929|NCT03972709|567506317|FG002|Overall Study|Study Terminated by Sponsor|50|||
157207930|NCT03972709|567506315|FG000|Overall Study|Physician Decision|1|||
157207931|NCT03972709|567506316|FG001|Overall Study|Physician Decision|0|||
157207932|NCT03972709|567506317|FG002|Overall Study|Physician Decision|0|||
157207933|NCT03972709|567506315|FG000|Overall Study|COVID-19|0|||
157207934|NCT03972709|567506316|FG001|Overall Study|COVID-19|1|||
157207935|NCT03972709|567506317|FG002|Overall Study|COVID-19|1|||
157207936|NCT03972709|567506315|FG000|Overall Study|Lost to Follow-up|6|||
157207937|NCT03972709|567506316|FG001|Overall Study|Lost to Follow-up|1|||
157207938|NCT03972709|567506317|FG002|Overall Study|Lost to Follow-up|2|||
157207939|NCT03972709|567506315|FG000|Overall Study|Death|5|||
157207940|NCT03972709|567506316|FG001|Overall Study|Death|1|||
157207941|NCT03972709|567506317|FG002|Overall Study|Death|4|||
157207942|NCT03972709|567506315|FG000|Overall Study|Adverse Event|3|||
157207943|NCT03972709|567506316|FG001|Overall Study|Adverse Event|1|||
157207944|NCT03972709|567506317|FG002|Overall Study|Adverse Event|4|||
157207945|NCT03972709|567506315|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
157207946|NCT03972709|567506316|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
157207947|NCT03972709|567506317|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
157207948|NCT03972709|567506315|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
157207949|NCT03972709|567506316|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
157207950|NCT03972709|567506317|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
157207951|NCT03972709|567506315|FG000|Overall Study|Subject Unable to be Contacted|0|||
157207952|NCT03972709|567506316|FG001|Overall Study|Subject Unable to be Contacted|1|||
157207953|NCT03972709|567506317|FG002|Overall Study|Subject Unable to be Contacted|0|||
157207954|NCT03972709|567506315|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
157207955|NCT03972709|567506316|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
157207956|NCT03972709|567506317|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
157207957|NCT03972709|567506315|FG000|Overall Study|Subject Moved|0|||
157207958|NCT03972709|567506316|FG001|Overall Study|Subject Moved|1|||
157207959|NCT03972709|567506317|FG002|Overall Study|Subject Moved|0|||
157207960|NCT03972709|567506315|FG000|Overall Study|Missed Study Visits|1|||
157207961|NCT03972709|567506316|FG001|Overall Study|Missed Study Visits|0|||
157207962|NCT03972709|567506317|FG002|Overall Study|Missed Study Visits|0|||
157207963|NCT01523301|567506318|FG000|Overall Study|Adverse Event|25|||
157207964|NCT01523301|567506319|FG001|Overall Study|Adverse Event|16|||
157207965|NCT01523301|567506318|FG000|Overall Study|Lack of Efficacy|0|||
157207966|NCT01523301|567506319|FG001|Overall Study|Lack of Efficacy|2|||
157207967|NCT01523301|567506318|FG000|Overall Study|Protocol Violation|3|||
157207968|NCT01523301|567506319|FG001|Overall Study|Protocol Violation|4|||
157207969|NCT01523301|567506318|FG000|Overall Study|Lost to Follow-up|1|||
157207970|NCT01523301|567506319|FG001|Overall Study|Lost to Follow-up|0|||
157207971|NCT01523301|567506318|FG000|Overall Study|Withdrawal by Subject|6|||
157207972|NCT01523301|567506319|FG001|Overall Study|Withdrawal by Subject|8|||
157207973|NCT01523301|567506318|FG000|Overall Study|Other Reason|0|||
157207974|NCT01523301|567506319|FG001|Overall Study|Other Reason|2|||
157207975|NCT00929864|567506322|FG000|Overall Study|Death|1|||
157207976|NCT00929864|567506323|FG001|Overall Study|Death|1|||
157207977|NCT00929864|567506322|FG000|Overall Study|Adverse Event|11|||
157207978|NCT00929864|567506323|FG001|Overall Study|Adverse Event|30|||
157207979|NCT00929864|567506322|FG000|Overall Study|Lack of Efficacy|19|||
157207980|NCT00929864|567506323|FG001|Overall Study|Lack of Efficacy|16|||
157207981|NCT00929864|567506322|FG000|Overall Study|Lost to Follow-up|7|||
156773990|NCT00879658|565924808|FG005|Overall Study|Lack of Efficacy|0|||
157007727|NCT00356265|566777800|FG000|Overall Study|Withdrawal by Subject|0|||
157007728|NCT00356265|566777801|FG001|Overall Study|Withdrawal by Subject|0|||
157207982|NCT00929864|567506323|FG001|Overall Study|Lost to Follow-up|12|||
157207983|NCT00929864|567506322|FG000|Overall Study|Withdrawal by Subject|20|||
157207984|NCT00929864|567506323|FG001|Overall Study|Withdrawal by Subject|9|||
157207985|NCT00929864|567506322|FG000|Overall Study|No longer met criteria|2|||
157113614|NCT01081912|567171732|FG002|Conversion/Titration|Adverse Event|0|||
156773991|NCT00879658|565924809|FG006|Overall Study|Lack of Efficacy|0|||
156773992|NCT00879658|565924803|FG000|Overall Study|misrandomized (never received study med)|0|||
157113615|NCT01081912|567171730|FG000|Conversion/Titration|Lack of Efficacy|17|||
157113616|NCT01081912|567171731|FG001|Conversion/Titration|Lack of Efficacy|0|||
157113617|NCT01081912|567171732|FG002|Conversion/Titration|Lack of Efficacy|0|||
157113618|NCT01081912|567171730|FG000|Conversion/Titration|Lost to Follow-up|5|||
157113619|NCT01081912|567171731|FG001|Conversion/Titration|Lost to Follow-up|0|||
157113620|NCT01081912|567171732|FG002|Conversion/Titration|Lost to Follow-up|0|||
157113621|NCT01081912|567171730|FG000|Conversion/Titration|Physician Decision|2|||
157113622|NCT01081912|567171731|FG001|Conversion/Titration|Physician Decision|0|||
157113623|NCT01081912|567171732|FG002|Conversion/Titration|Physician Decision|0|||
157207986|NCT00929864|567506323|FG001|Overall Study|No longer met criteria|1|||
157207987|NCT00929864|567506322|FG000|Overall Study|Poor or non-compliance|3|||
157207988|NCT00929864|567506323|FG001|Overall Study|Poor or non-compliance|3|||
156773993|NCT00879658|565924804|FG001|Overall Study|misrandomized (never received study med)|0|||
156773994|NCT00879658|565924805|FG002|Overall Study|misrandomized (never received study med)|0|||
156773995|NCT00879658|565924806|FG003|Overall Study|misrandomized (never received study med)|1|||
156773996|NCT00879658|565924807|FG004|Overall Study|misrandomized (never received study med)|0|||
156773997|NCT00879658|565924808|FG005|Overall Study|misrandomized (never received study med)|0|||
156773998|NCT00879658|565924809|FG006|Overall Study|misrandomized (never received study med)|0|||
156773999|NCT01925417|565924819|FG000|Overall Study|Withdrawal by Subject|2|||
156774000|NCT01925417|565924819|FG000|Overall Study|Death|1|||
156774001|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
156774002|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
156774003|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
156774004|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Death|0|||
156774005|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Death|0|||
156774006|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Death|1|||
156774007|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
156774008|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
156774009|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
157207989|NCT00929864|567506322|FG000|Overall Study|Pregnancy|0|||
157207990|NCT00929864|567506323|FG001|Overall Study|Pregnancy|3|||
157207991|NCT00929864|567506322|FG000|Overall Study|Administrative reason by Sponsor|1|||
157207992|NCT00929864|567506323|FG001|Overall Study|Administrative reason by Sponsor|1|||
157207993|NCT00929864|567506322|FG000|Overall Study|Non-specified|2|||
157207994|NCT00929864|567506323|FG001|Overall Study|Non-specified|7|||
157207995|NCT03889197|567506324|FG000|Overall Study|Withdrawal by Subject|1|||
157207996|NCT03889197|567506325|FG001|Overall Study|Withdrawal by Subject|0|||
156774010|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
156774011|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
156774012|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
156774013|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
156774014|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
156774015|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
156774016|NCT02696798|565924820|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
156774017|NCT02696798|565924821|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
156774018|NCT02696798|565924822|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
156774019|NCT02696798|565924820|FG000|Extended Treatment Period|Adverse Event|1|||
156774020|NCT02696798|565924821|FG001|Extended Treatment Period|Adverse Event|4|||
156774021|NCT02696798|565924822|FG002|Extended Treatment Period|Adverse Event|5|||
156774022|NCT02696798|565924820|FG000|Extended Treatment Period|Lack of Efficacy|7|||
156774023|NCT02696798|565924821|FG001|Extended Treatment Period|Lack of Efficacy|2|||
156774024|NCT02696798|565924822|FG002|Extended Treatment Period|Lack of Efficacy|2|||
156774025|NCT02696798|565924820|FG000|Extended Treatment Period|Lost to Follow-up|1|||
156774026|NCT02696798|565924821|FG001|Extended Treatment Period|Lost to Follow-up|0|||
156774027|NCT02696798|565924822|FG002|Extended Treatment Period|Lost to Follow-up|0|||
156774028|NCT02696798|565924820|FG000|Extended Treatment Period|Physician Decision|0|||
156774029|NCT02696798|565924821|FG001|Extended Treatment Period|Physician Decision|1|||
156774030|NCT02696798|565924822|FG002|Extended Treatment Period|Physician Decision|0|||
156774031|NCT02696798|565924820|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
156774032|NCT02696798|565924821|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
156774033|NCT02696798|565924822|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
156774034|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
156774035|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
156774036|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
156774037|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
157113624|NCT01081912|567171730|FG000|Conversion/Titration|Protocol Violation|67|||
157113625|NCT01081912|567171731|FG001|Conversion/Titration|Protocol Violation|0|||
157207997|NCT03889197|567506324|FG000|Overall Study|Physician Decision|0|||
157207998|NCT03889197|567506325|FG001|Overall Study|Physician Decision|1|||
156774038|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
156774039|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
156774040|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
156774041|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
157113626|NCT01081912|567171732|FG002|Conversion/Titration|Protocol Violation|0|||
157113627|NCT01081912|567171730|FG000|Conversion/Titration|Withdrawal by Subject|23|||
157113628|NCT01081912|567171731|FG001|Conversion/Titration|Withdrawal by Subject|0|||
157113629|NCT01081912|567171732|FG002|Conversion/Titration|Withdrawal by Subject|0|||
157113630|NCT01081912|567171730|FG000|Conversion/Titration|Non-Compliance|47|||
157113631|NCT01081912|567171731|FG001|Conversion/Titration|Non-Compliance|0|||
157113632|NCT01081912|567171732|FG002|Conversion/Titration|Non-Compliance|0|||
157113633|NCT01081912|567171730|FG000|Maintenance Treatment|Adverse Event|0|||
157113634|NCT01081912|567171731|FG001|Maintenance Treatment|Adverse Event|2|||
157113635|NCT01081912|567171732|FG002|Maintenance Treatment|Adverse Event|12|||
157113636|NCT01081912|567171730|FG000|Maintenance Treatment|Lack of Efficacy|0|||
157113637|NCT01081912|567171731|FG001|Maintenance Treatment|Lack of Efficacy|14|||
157113638|NCT01081912|567171732|FG002|Maintenance Treatment|Lack of Efficacy|64|||
157113639|NCT01081912|567171730|FG000|Maintenance Treatment|Lost to Follow-up|0|||
157113640|NCT01081912|567171731|FG001|Maintenance Treatment|Lost to Follow-up|1|||
157113641|NCT01081912|567171732|FG002|Maintenance Treatment|Lost to Follow-up|0|||
157113642|NCT01081912|567171730|FG000|Maintenance Treatment|Physician Decision|0|||
157113643|NCT01081912|567171731|FG001|Maintenance Treatment|Physician Decision|0|||
157113644|NCT01081912|567171732|FG002|Maintenance Treatment|Physician Decision|1|||
157113645|NCT01081912|567171730|FG000|Maintenance Treatment|Protocol Violation|0|||
157113646|NCT01081912|567171731|FG001|Maintenance Treatment|Protocol Violation|1|||
157113647|NCT01081912|567171732|FG002|Maintenance Treatment|Protocol Violation|2|||
157113648|NCT01081912|567171730|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
157113649|NCT01081912|567171731|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
157113650|NCT01081912|567171732|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
157113651|NCT01081912|567171730|FG000|Maintenance Treatment|Non-Compliance|0|||
157007729|NCT00356265|566777802|FG002|Overall Study|Withdrawal by Subject|1|||
157007730|NCT01595321|566777804|FG000|Overall Study|Adverse Event|1|||
157007731|NCT01595321|566777805|FG001|Overall Study|Adverse Event|1|||
157007732|NCT01595321|566777806|FG002|Overall Study|Adverse Event|1|||
157007733|NCT01595321|566777804|FG000|Overall Study|Lack of Efficacy|0|||
157007734|NCT01595321|566777805|FG001|Overall Study|Lack of Efficacy|0|||
157007735|NCT01595321|566777806|FG002|Overall Study|Lack of Efficacy|4|||
157007736|NCT00834834|566777807|FG000|Overall Study|Withdrawal by Subject|4|||
157007737|NCT00834834|566777808|FG001|Overall Study|Withdrawal by Subject|3|||
157007738|NCT01810263|566777813|FG000|Overall Study|Lost to Follow-up|8|||
157007739|NCT01810263|566777814|FG001|Overall Study|Lost to Follow-up|7|||
157007740|NCT01170026|566778863|FG000|Overall Study|Lost to Follow-up|4|||
157007741|NCT01170026|566778864|FG001|Overall Study|Lost to Follow-up|2|||
157007742|NCT04817670|566778865|FG000|Overall Study|Withdrawal by Subject|1|||
157007743|NCT04817670|566778866|FG001|Overall Study|Withdrawal by Subject|0|||
157007744|NCT04817670|566778867|FG002|Overall Study|Withdrawal by Subject|0|||
157007745|NCT04817670|566778868|FG003|Overall Study|Withdrawal by Subject|0|||
157007746|NCT04817670|566778869|FG004|Overall Study|Withdrawal by Subject|0|||
157007747|NCT04817670|566778865|FG000|Overall Study|Lost to Follow-up|0|||
157007748|NCT04817670|566778866|FG001|Overall Study|Lost to Follow-up|0|||
157007749|NCT04817670|566778867|FG002|Overall Study|Lost to Follow-up|1|||
157007750|NCT04817670|566778868|FG003|Overall Study|Lost to Follow-up|0|||
157007751|NCT04817670|566778869|FG004|Overall Study|Lost to Follow-up|0|||
157007752|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
157007753|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
157007754|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
157007755|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
157007756|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
157007757|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
157007758|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
157007759|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
157007760|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
157007761|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
157007762|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
157007763|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
157007764|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
156774042|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
157007765|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
157007766|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
157007767|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
157113652|NCT01081912|567171731|FG001|Maintenance Treatment|Non-Compliance|4|||
157007768|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
157007769|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
157007770|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
157007771|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
157007772|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
157007773|NCT00304031|566778870|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
157007774|NCT00304031|566778871|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
157007775|NCT00304031|566778872|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
156774043|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
156774044|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
156774045|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
157007776|NCT00304031|566778870|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
157007777|NCT00304031|566778871|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
156774046|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
157207999|NCT03889197|567506324|FG000|Overall Study|met exclusion criteria|0|||
157208000|NCT03889197|567506325|FG001|Overall Study|met exclusion criteria|1|||
157208001|NCT03889197|567506324|FG000|Overall Study|Protocol Violation|1|||
157208002|NCT03889197|567506325|FG001|Overall Study|Protocol Violation|0|||
157208003|NCT05004181|567506328|FG000|Overall Study|Withdrawal of consent|0|||
157208004|NCT05004181|567506329|FG001|Overall Study|Withdrawal of consent|0|||
157208005|NCT05004181|567506330|FG002|Overall Study|Withdrawal of consent|1|||
156774047|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
156774048|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
156774049|NCT02696798|565924820|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
156774050|NCT02696798|565924821|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
156774051|NCT02696798|565924822|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
156774052|NCT04091451|565924823|FG000|Overall Study|Adverse Event|15|||
156774053|NCT04091451|565924824|FG001|Overall Study|Adverse Event|10|||
156774054|NCT04091451|565924823|FG000|Overall Study|Lost to Follow-up|8|||
156774055|NCT04091451|565924824|FG001|Overall Study|Lost to Follow-up|8|||
156774056|NCT04091451|565924823|FG000|Overall Study|Protocol Violation|5|||
156774057|NCT04091451|565924824|FG001|Overall Study|Protocol Violation|4|||
156774058|NCT04091451|565924823|FG000|Overall Study|Withdrawal by Subject|21|||
156774059|NCT04091451|565924824|FG001|Overall Study|Withdrawal by Subject|27|||
156774060|NCT04091451|565924823|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
157208006|NCT05004181|567506331|FG003|Overall Study|Withdrawal of consent|3|||
157208007|NCT05004181|567506332|FG004|Overall Study|Withdrawal of consent|3|||
156774061|NCT04091451|565924824|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
156774062|NCT04091451|565924823|FG000|Overall Study|Migrated/moved from the study area|3|||
157113653|NCT01081912|567171732|FG002|Maintenance Treatment|Non-Compliance|7|||
157113654|NCT01081912|567171730|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
157113655|NCT01081912|567171731|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
156774063|NCT04091451|565924824|FG001|Overall Study|Migrated/moved from the study area|5|||
156774064|NCT04091451|565924823|FG000|Overall Study|Suspected HZ episode|1|||
156774065|NCT04091451|565924824|FG001|Overall Study|Suspected HZ episode|0|||
156774066|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
156774067|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
156774068|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Death|1|||
156774069|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Death|3|||
156774070|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
156774071|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
156774072|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
156774073|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
156774074|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
156774075|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
156774076|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
156774077|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
156774078|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
156774079|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
156774080|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
156774081|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
156774082|NCT00362232|565926634|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
156774083|NCT00362232|565926635|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
156774084|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
156774085|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
156774086|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
156774087|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
157007778|NCT00304031|566778872|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
157007779|NCT01188655|566778873|FG000|Overall Study|Lack of Efficacy|1|||
157007780|NCT01188655|566778873|FG000|Overall Study|Lost to Follow-up|1|||
157007781|NCT01188655|566778873|FG000|Overall Study|Other|11|||
157007782|NCT00683696|566778874|FG000|Overall Study|Withdrawn due to study closure|337|||
157007783|NCT00683696|566778875|FG001|Overall Study|Withdrawn due to study closure|338|||
157007784|NCT00683696|566778874|FG000|Overall Study|Withdrawn prior to study closure|13|||
157007785|NCT00683696|566778875|FG001|Overall Study|Withdrawn prior to study closure|28|||
156774088|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
157007786|NCT00683696|566778874|FG000|Overall Study|Lost to Follow-up|5|||
157007787|NCT00683696|566778875|FG001|Overall Study|Lost to Follow-up|6|||
156774089|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
156774090|NCT00362232|565926634|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
156774091|NCT00362232|565926635|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
156774092|NCT05020015|565926640|FG000|Overall Study|Ongoing on study|1|||
156774093|NCT05020015|565926641|FG001|Overall Study|Ongoing on study|3|||
156774094|NCT05020015|565926642|FG002|Overall Study|Ongoing on study|4|||
156774095|NCT05020015|565926643|FG003|Overall Study|Ongoing on study|7|||
156774096|NCT05020015|565926640|FG000|Overall Study|Death|2|||
156774097|NCT05020015|565926641|FG001|Overall Study|Death|3|||
156774098|NCT05020015|565926642|FG002|Overall Study|Death|4|||
156774099|NCT05020015|565926643|FG003|Overall Study|Death|0|||
156774100|NCT05020015|565926640|FG000|Overall Study|Withdrawal by Subject|0|||
156774101|NCT05020015|565926641|FG001|Overall Study|Withdrawal by Subject|0|||
156774102|NCT05020015|565926642|FG002|Overall Study|Withdrawal by Subject|1|||
156774103|NCT05020015|565926643|FG003|Overall Study|Withdrawal by Subject|0|||
156774104|NCT05020015|565926640|FG000|Overall Study|Reason Not Specified|0|||
156774105|NCT05020015|565926641|FG001|Overall Study|Reason Not Specified|0|||
156774106|NCT05020015|565926642|FG002|Overall Study|Reason Not Specified|2|||
156774107|NCT05020015|565926643|FG003|Overall Study|Reason Not Specified|0|||
156774108|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
156774109|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
156774110|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
156774111|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
156774112|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
156774113|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
156774114|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
156774115|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
156774116|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
156774117|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
156774118|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
156774119|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
156774120|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
156774121|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
156774122|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
156774123|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
157007788|NCT00683696|566778874|FG000|Overall Study|Vital status follow-up only|3|||
156774124|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
156774125|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
156774126|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
156774127|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
156774128|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
157007789|NCT00683696|566778875|FG001|Overall Study|Vital status follow-up only|3|||
157007790|NCT00683696|566778874|FG000|Overall Study|Death|46|||
157007791|NCT00683696|566778875|FG001|Overall Study|Death|30|||
157007792|NCT00089544|566778876|FG000|Overall Study|Ineligible|1|||
157007793|NCT00089544|566778877|FG001|Overall Study|Ineligible|0|||
157007794|NCT02396316|566778878|FG000|Overall Study|Physician Decision|1|||
156774129|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
157007795|NCT02396316|566778879|FG001|Overall Study|Physician Decision|0|||
156774130|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
156774131|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
156774132|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
156774133|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
156774134|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
156774135|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
156774136|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
156774137|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
156774138|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
156774139|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
156774140|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
156774141|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
156774142|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
156774143|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
156774144|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
156774145|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
156774146|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
156774147|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
156774148|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
156774149|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
157007796|NCT02396316|566778878|FG000|Overall Study|Progressive disease|6|||
157007797|NCT02396316|566778879|FG001|Overall Study|Progressive disease|3|||
157007798|NCT02396316|566778878|FG000|Overall Study|Protocol Violation|0|||
157007799|NCT02396316|566778879|FG001|Overall Study|Protocol Violation|1|||
157007800|NCT02396316|566778878|FG000|Overall Study|Treatment unblinded|0|||
157007801|NCT02396316|566778879|FG001|Overall Study|Treatment unblinded|1|||
156774150|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
156774151|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
157113656|NCT01081912|567171732|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
157113657|NCT01140451|567171734|FG000|Overall Study|Withdrawal by Subject|26|||
157113658|NCT01140451|567171735|FG001|Overall Study|Withdrawal by Subject|33|||
157113659|NCT01140451|567171734|FG000|Overall Study|Adverse Event|2|||
157113660|NCT01140451|567171735|FG001|Overall Study|Adverse Event|6|||
157113661|NCT01140451|567171734|FG000|Overall Study|Physician Decision|5|||
157113662|NCT01140451|567171735|FG001|Overall Study|Physician Decision|3|||
157113663|NCT01140451|567171734|FG000|Overall Study|Lost to Follow-up|2|||
157113664|NCT01140451|567171735|FG001|Overall Study|Lost to Follow-up|0|||
156774152|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
156774153|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
156774154|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
157113665|NCT01140451|567171734|FG000|Overall Study|Participants Planning Pregnancy|3|||
157113666|NCT01140451|567171735|FG001|Overall Study|Participants Planning Pregnancy|0|||
157113667|NCT03200366|567171739|FG000|Patient Navigation Intervention Given|Death|0|||
157113668|NCT03200366|567171740|FG001|Patient Navigation Intervention Given|Death|2|||
157113669|NCT03200366|567171741|FG002|Patient Navigation Intervention Given|Death|0|||
157113670|NCT03200366|567171739|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
157113671|NCT03200366|567171740|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
156774155|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
157113672|NCT03200366|567171741|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
157113673|NCT03200366|567171739|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
157113674|NCT03200366|567171740|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
156774156|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
156774157|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
156774158|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
156774159|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
156774160|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
156774161|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
156774162|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
156774163|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
156774164|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
156774165|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
156774166|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
156774167|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
156774168|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
156774169|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
156774170|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
156774171|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
156774172|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
156774173|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
156774174|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
156774175|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
156774176|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
156774177|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
156774178|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
156774179|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
156774180|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
156774181|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
156774182|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
156774183|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
156774184|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
156774185|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
156774186|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
156774187|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
156774188|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
156774189|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
156774190|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
156774191|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
156774192|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
156774193|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
156774194|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
156774195|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
156774196|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
156774197|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
156774198|NCT00090103|565926644|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
156774199|NCT00090103|565926645|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
156774200|NCT00090103|565926646|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
156774201|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
156774202|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
156774203|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
156774204|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
156774205|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
156774206|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
156774207|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
156774208|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
156774209|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
156774210|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
156774211|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
156774212|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
156774213|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
157113675|NCT03200366|567171741|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
157113676|NCT03200366|567171739|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
157113677|NCT03200366|567171740|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
157113678|NCT03200366|567171741|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
156774214|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
156774215|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
156774216|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
156774217|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
156774218|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
156774219|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
156774220|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
156774221|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
156774222|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
156774223|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
156774224|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
156774225|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
156774226|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
156774227|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
156774228|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
156774229|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
156774230|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
156774231|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
156774232|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
156774233|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
156774234|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
156774235|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
156774236|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
156774237|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
156774238|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
156774239|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
156774240|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
156774241|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
156774242|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
156774243|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
156774244|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
156774245|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
156774246|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
156774247|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
156774248|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
156774249|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Death|1|||
156774250|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Death|0|||
156774251|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Death|1|||
156774252|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
156774253|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
156774254|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
156774255|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
156774256|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
156774257|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
156774258|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
156774259|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
156774260|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
156774261|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
156774262|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
156774263|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
156774264|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
156774265|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
156774266|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
156774267|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
156774268|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
156774269|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
156774270|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
156774271|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
156774272|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
156774273|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Depression|0|||
156774274|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Depression|1|||
156774275|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Depression|0|||
156774276|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
156774277|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
156774278|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
156774279|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Jailed|0|||
156774280|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Jailed|1|||
156774281|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Jailed|0|||
156774282|NCT00090103|565926644|FG000|16-Week Safety Follow-up Period|Other|0|||
156774283|NCT00090103|565926645|FG001|16-Week Safety Follow-up Period|Other|1|||
156774284|NCT00090103|565926646|FG002|16-Week Safety Follow-up Period|Other|0|||
156774285|NCT01799889|565926649|FG000|Overall Study|Adverse Event|4|||
156774286|NCT01799889|565926650|FG001|Overall Study|Adverse Event|4|||
156774287|NCT01799889|565926651|FG002|Overall Study|Adverse Event|5|||
156774288|NCT01799889|565926652|FG003|Overall Study|Adverse Event|1|||
156774289|NCT01799889|565926653|FG004|Overall Study|Adverse Event|11|||
156774290|NCT01799889|565926654|FG005|Overall Study|Adverse Event|1|||
156774291|NCT01799889|565926655|FG006|Overall Study|Adverse Event|5|||
156774292|NCT01799889|565926656|FG007|Overall Study|Adverse Event|2|||
156774293|NCT01799889|565926657|FG008|Overall Study|Adverse Event|3|||
156774294|NCT01799889|565926658|FG009|Overall Study|Adverse Event|1|||
156774295|NCT01799889|565926659|FG010|Overall Study|Adverse Event|1|||
156774296|NCT01799889|565926660|FG011|Overall Study|Adverse Event|0|||
156774297|NCT01799889|565926649|FG000|Overall Study|Death|1|||
156774298|NCT01799889|565926650|FG001|Overall Study|Death|0|||
156774299|NCT01799889|565926651|FG002|Overall Study|Death|5|||
156774300|NCT01799889|565926652|FG003|Overall Study|Death|3|||
156774301|NCT01799889|565926653|FG004|Overall Study|Death|1|||
156774302|NCT01799889|565926654|FG005|Overall Study|Death|0|||
156774303|NCT01799889|565926655|FG006|Overall Study|Death|0|||
156774304|NCT01799889|565926656|FG007|Overall Study|Death|0|||
156774305|NCT01799889|565926657|FG008|Overall Study|Death|1|||
156774306|NCT01799889|565926658|FG009|Overall Study|Death|0|||
156774307|NCT01799889|565926659|FG010|Overall Study|Death|1|||
156774308|NCT01799889|565926660|FG011|Overall Study|Death|0|||
156774309|NCT01799889|565926649|FG000|Overall Study|Lack of Efficacy|1|||
156774310|NCT01799889|565926650|FG001|Overall Study|Lack of Efficacy|1|||
156774311|NCT01799889|565926651|FG002|Overall Study|Lack of Efficacy|0|||
156774312|NCT01799889|565926652|FG003|Overall Study|Lack of Efficacy|1|||
156774313|NCT01799889|565926653|FG004|Overall Study|Lack of Efficacy|2|||
156774314|NCT01799889|565926654|FG005|Overall Study|Lack of Efficacy|2|||
156774315|NCT01799889|565926655|FG006|Overall Study|Lack of Efficacy|0|||
156774316|NCT01799889|565926656|FG007|Overall Study|Lack of Efficacy|0|||
156774317|NCT01799889|565926657|FG008|Overall Study|Lack of Efficacy|2|||
156774318|NCT01799889|565926658|FG009|Overall Study|Lack of Efficacy|0|||
156774319|NCT01799889|565926659|FG010|Overall Study|Lack of Efficacy|1|||
156774320|NCT01799889|565926660|FG011|Overall Study|Lack of Efficacy|0|||
156774321|NCT01799889|565926649|FG000|Overall Study|Lost to Follow-up|0|||
157113679|NCT03200366|567171739|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
156774322|NCT01799889|565926650|FG001|Overall Study|Lost to Follow-up|1|||
156774323|NCT01799889|565926651|FG002|Overall Study|Lost to Follow-up|0|||
156774324|NCT01799889|565926652|FG003|Overall Study|Lost to Follow-up|0|||
157113680|NCT03200366|567171740|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
157113681|NCT03200366|567171741|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
157113682|NCT03200366|567171739|FG000|6 Month Post-Baseline Interview|Death|1|||
157113683|NCT03200366|567171740|FG001|6 Month Post-Baseline Interview|Death|1|||
157113684|NCT03200366|567171741|FG002|6 Month Post-Baseline Interview|Death|1|||
157113685|NCT03200366|567171739|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
157113686|NCT03200366|567171740|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
157113687|NCT03200366|567171741|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
157113688|NCT03200366|567171739|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
157113689|NCT03200366|567171740|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
157113690|NCT03200366|567171741|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
157113691|NCT03200366|567171739|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
157113692|NCT03200366|567171740|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
157113693|NCT03200366|567171741|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
157113694|NCT03200366|567171739|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
157113695|NCT03200366|567171740|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
157113696|NCT03200366|567171741|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
157113697|NCT03200366|567171739|FG000|9 Month Post-Baseline Interview|Death|1|||
157113698|NCT03200366|567171740|FG001|9 Month Post-Baseline Interview|Death|1|||
157113699|NCT03200366|567171741|FG002|9 Month Post-Baseline Interview|Death|1|||
157113700|NCT03200366|567171739|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
157113701|NCT03200366|567171740|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
156774325|NCT01799889|565926653|FG004|Overall Study|Lost to Follow-up|0|||
156774326|NCT01799889|565926654|FG005|Overall Study|Lost to Follow-up|0|||
156774327|NCT01799889|565926655|FG006|Overall Study|Lost to Follow-up|0|||
156774328|NCT01799889|565926656|FG007|Overall Study|Lost to Follow-up|0|||
156774329|NCT01799889|565926657|FG008|Overall Study|Lost to Follow-up|0|||
156774330|NCT01799889|565926658|FG009|Overall Study|Lost to Follow-up|0|||
156774331|NCT01799889|565926659|FG010|Overall Study|Lost to Follow-up|0|||
156774332|NCT01799889|565926660|FG011|Overall Study|Lost to Follow-up|0|||
156774333|NCT01799889|565926649|FG000|Overall Study|Physician Decision|3|||
156774334|NCT01799889|565926650|FG001|Overall Study|Physician Decision|2|||
156774335|NCT01799889|565926651|FG002|Overall Study|Physician Decision|4|||
156774336|NCT01799889|565926652|FG003|Overall Study|Physician Decision|4|||
156774337|NCT01799889|565926653|FG004|Overall Study|Physician Decision|5|||
156774338|NCT01799889|565926654|FG005|Overall Study|Physician Decision|5|||
156774339|NCT01799889|565926655|FG006|Overall Study|Physician Decision|5|||
156774340|NCT01799889|565926656|FG007|Overall Study|Physician Decision|2|||
156774341|NCT01799889|565926657|FG008|Overall Study|Physician Decision|6|||
156774342|NCT01799889|565926658|FG009|Overall Study|Physician Decision|0|||
156774343|NCT01799889|565926659|FG010|Overall Study|Physician Decision|0|||
156774344|NCT01799889|565926660|FG011|Overall Study|Physician Decision|1|||
156774345|NCT01799889|565926649|FG000|Overall Study|Progressive Disease|30|||
156774346|NCT01799889|565926650|FG001|Overall Study|Progressive Disease|26|||
156774347|NCT01799889|565926651|FG002|Overall Study|Progressive Disease|25|||
156774348|NCT01799889|565926652|FG003|Overall Study|Progressive Disease|30|||
156774349|NCT01799889|565926653|FG004|Overall Study|Progressive Disease|23|||
156774350|NCT01799889|565926654|FG005|Overall Study|Progressive Disease|9|||
156774351|NCT01799889|565926655|FG006|Overall Study|Progressive Disease|8|||
156774352|NCT01799889|565926656|FG007|Overall Study|Progressive Disease|13|||
156774353|NCT01799889|565926657|FG008|Overall Study|Progressive Disease|18|||
156774354|NCT01799889|565926658|FG009|Overall Study|Progressive Disease|5|||
156774355|NCT01799889|565926659|FG010|Overall Study|Progressive Disease|3|||
156774356|NCT01799889|565926660|FG011|Overall Study|Progressive Disease|1|||
156774357|NCT01799889|565926649|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
156774358|NCT01799889|565926650|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
156774359|NCT01799889|565926651|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
156774360|NCT01799889|565926652|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
156774361|NCT01799889|565926653|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
156774362|NCT01799889|565926654|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
156774363|NCT01799889|565926655|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
156774364|NCT01799889|565926656|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
156774365|NCT01799889|565926657|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
156774366|NCT01799889|565926658|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
156774367|NCT01799889|565926659|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
156774368|NCT01799889|565926660|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
156774369|NCT01799889|565926649|FG000|Overall Study|Study Terminated By Sponsor|1|||
156774370|NCT01799889|565926650|FG001|Overall Study|Study Terminated By Sponsor|0|||
156774371|NCT01799889|565926651|FG002|Overall Study|Study Terminated By Sponsor|0|||
156774372|NCT01799889|565926652|FG003|Overall Study|Study Terminated By Sponsor|0|||
156774373|NCT01799889|565926653|FG004|Overall Study|Study Terminated By Sponsor|2|||
156774374|NCT01799889|565926654|FG005|Overall Study|Study Terminated By Sponsor|1|||
156774375|NCT01799889|565926655|FG006|Overall Study|Study Terminated By Sponsor|0|||
156774376|NCT01799889|565926656|FG007|Overall Study|Study Terminated By Sponsor|2|||
156774377|NCT01799889|565926657|FG008|Overall Study|Study Terminated By Sponsor|1|||
156774378|NCT01799889|565926658|FG009|Overall Study|Study Terminated By Sponsor|1|||
156774379|NCT01799889|565926659|FG010|Overall Study|Study Terminated By Sponsor|0|||
156774380|NCT01799889|565926660|FG011|Overall Study|Study Terminated By Sponsor|0|||
156774381|NCT01799889|565926649|FG000|Overall Study|Withdrawal by Subject|1|||
156774382|NCT01799889|565926650|FG001|Overall Study|Withdrawal by Subject|6|||
156774383|NCT01799889|565926651|FG002|Overall Study|Withdrawal by Subject|4|||
156774384|NCT01799889|565926652|FG003|Overall Study|Withdrawal by Subject|0|||
156774385|NCT01799889|565926653|FG004|Overall Study|Withdrawal by Subject|5|||
156774386|NCT01799889|565926654|FG005|Overall Study|Withdrawal by Subject|1|||
156774387|NCT01799889|565926655|FG006|Overall Study|Withdrawal by Subject|3|||
156774388|NCT01799889|565926656|FG007|Overall Study|Withdrawal by Subject|1|||
156774389|NCT01799889|565926657|FG008|Overall Study|Withdrawal by Subject|2|||
156774390|NCT01799889|565926658|FG009|Overall Study|Withdrawal by Subject|1|||
156774391|NCT01799889|565926659|FG010|Overall Study|Withdrawal by Subject|1|||
156774392|NCT01799889|565926660|FG011|Overall Study|Withdrawal by Subject|1|||
156774393|NCT01799889|565926649|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156774394|NCT01799889|565926650|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156774395|NCT01799889|565926651|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156774396|NCT01799889|565926652|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156774397|NCT01799889|565926653|FG004|Overall Study|Non-Compliance With Study Drug|0|||
157208008|NCT05004181|567506333|FG005|Overall Study|Withdrawal of consent|0|||
156774398|NCT01799889|565926654|FG005|Overall Study|Non-Compliance With Study Drug|1|||
156774399|NCT01799889|565926655|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156774400|NCT01799889|565926656|FG007|Overall Study|Non-Compliance With Study Drug|0|||
156774401|NCT01799889|565926657|FG008|Overall Study|Non-Compliance With Study Drug|0|||
156774402|NCT01799889|565926658|FG009|Overall Study|Non-Compliance With Study Drug|0|||
156774403|NCT01799889|565926659|FG010|Overall Study|Non-Compliance With Study Drug|0|||
156774404|NCT01799889|565926660|FG011|Overall Study|Non-Compliance With Study Drug|0|||
156808570|NCT01070979|566052716|FG001|Overall Study|Withdrawal by Subject|1|||
156774405|NCT06217380|565926661|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
156774406|NCT06217380|565926661|FG000|Overall Study|Physician Decision|1|||
156774407|NCT06217380|565926661|FG000|Overall Study|Withdrawal by Subject|2|||
156774408|NCT06633965|565926662|FG000|Overall Study|Withdrawal by Subject|0|||
156774409|NCT06633965|565926663|FG001|Overall Study|Withdrawal by Subject|1|||
156774410|NCT00947544|565926668|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
156774411|NCT00947544|565926669|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
156774412|NCT02566005|565926670|FG000|Overall Study|vaginal bleeding|0|||
156774413|NCT02566005|565926671|FG001|Overall Study|vaginal bleeding|1|||
156774414|NCT02566005|565926670|FG000|Overall Study|received foley|8|||
157208009|NCT05004181|567506334|FG006|Overall Study|Withdrawal of consent|30|||
157208010|NCT05004181|567506335|FG007|Overall Study|Withdrawal of consent|9|||
157208011|NCT05004181|567506336|FG008|Overall Study|Withdrawal of consent|3|||
157208012|NCT05004181|567506337|FG009|Overall Study|Withdrawal of consent|2|||
157208013|NCT05004181|567506338|FG010|Overall Study|Withdrawal of consent|5|||
157208014|NCT05004181|567506339|FG011|Overall Study|Withdrawal of consent|1|||
157208015|NCT05004181|567506328|FG000|Overall Study|Lost to Follow-up|2|||
157208016|NCT05004181|567506329|FG001|Overall Study|Lost to Follow-up|4|||
157208017|NCT05004181|567506330|FG002|Overall Study|Lost to Follow-up|2|||
157208018|NCT05004181|567506331|FG003|Overall Study|Lost to Follow-up|3|||
157208019|NCT05004181|567506332|FG004|Overall Study|Lost to Follow-up|5|||
157208020|NCT05004181|567506333|FG005|Overall Study|Lost to Follow-up|2|||
157208021|NCT05004181|567506334|FG006|Overall Study|Lost to Follow-up|15|||
157208022|NCT05004181|567506335|FG007|Overall Study|Lost to Follow-up|12|||
156774415|NCT02566005|565926671|FG001|Overall Study|received foley|0|||
156774416|NCT02566005|565926670|FG000|Overall Study|did not receive foley|0|||
156774417|NCT02566005|565926671|FG001|Overall Study|did not receive foley|1|||
156774418|NCT02566005|565926670|FG000|Overall Study|labor after randomization|0|||
156774419|NCT02566005|565926671|FG001|Overall Study|labor after randomization|4|||
156774420|NCT00984867|565926674|FG000|Overall Study|Adverse Event|3|||
156774421|NCT00984867|565926675|FG001|Overall Study|Adverse Event|7|||
156774422|NCT00984867|565926674|FG000|Overall Study|Death|1|||
156774423|NCT00984867|565926675|FG001|Overall Study|Death|0|||
156774424|NCT00984867|565926674|FG000|Overall Study|Withdrawal by Subject|13|||
156774425|NCT00984867|565926675|FG001|Overall Study|Withdrawal by Subject|4|||
156774426|NCT00984867|565926674|FG000|Overall Study|Lost to Follow-up|3|||
156774427|NCT00984867|565926675|FG001|Overall Study|Lost to Follow-up|4|||
157208023|NCT05004181|567506336|FG008|Overall Study|Lost to Follow-up|38|||
157208024|NCT05004181|567506337|FG009|Overall Study|Lost to Follow-up|6|||
157208025|NCT05004181|567506338|FG010|Overall Study|Lost to Follow-up|6|||
157208026|NCT05004181|567506339|FG011|Overall Study|Lost to Follow-up|0|||
157208027|NCT05004181|567506328|FG000|Overall Study|Death|0|||
157208028|NCT05004181|567506329|FG001|Overall Study|Death|0|||
157208029|NCT05004181|567506330|FG002|Overall Study|Death|0|||
157208030|NCT05004181|567506331|FG003|Overall Study|Death|0|||
157208031|NCT05004181|567506332|FG004|Overall Study|Death|0|||
157208032|NCT05004181|567506333|FG005|Overall Study|Death|0|||
157208033|NCT05004181|567506334|FG006|Overall Study|Death|1|||
157208034|NCT05004181|567506335|FG007|Overall Study|Death|0|||
157208035|NCT05004181|567506336|FG008|Overall Study|Death|2|||
157208036|NCT05004181|567506337|FG009|Overall Study|Death|0|||
157208037|NCT05004181|567506338|FG010|Overall Study|Death|0|||
156774428|NCT00984867|565926674|FG000|Overall Study|Poor/non-compliance|0|||
156774429|NCT00984867|565926675|FG001|Overall Study|Poor/non-compliance|1|||
156774430|NCT00984867|565926674|FG000|Overall Study|Subject no longer meets study criteria|1|||
156774431|NCT00984867|565926675|FG001|Overall Study|Subject no longer meets study criteria|1|||
156774432|NCT00984867|565926674|FG000|Overall Study|site closing|1|||
156774433|NCT00984867|565926675|FG001|Overall Study|site closing|0|||
156774434|NCT00984867|565926674|FG000|Overall Study|lack of efficacy and subject compliance|1|||
156774435|NCT00984867|565926675|FG001|Overall Study|lack of efficacy and subject compliance|0|||
156774436|NCT00671060|565926676|FG000|Overall Study|Protocol Violation|1|||
156774437|NCT00671060|565926677|FG001|Overall Study|Protocol Violation|0|||
156774438|NCT00671060|565926676|FG000|Overall Study|Physician Decision|0|||
156774439|NCT00671060|565926677|FG001|Overall Study|Physician Decision|1|||
156774440|NCT00626639|565926678|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
156774441|NCT00626639|565926679|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
156774442|NCT01461551|565926680|FG000|Overall Study|Physician Decision|2|||
156774443|NCT01461551|565926681|FG001|Overall Study|Physician Decision|1|||
156774444|NCT01461551|565926682|FG002|Overall Study|Physician Decision|2|||
157208038|NCT05004181|567506339|FG011|Overall Study|Death|0|||
157208039|NCT05004181|567506328|FG000|Overall Study|Physician Decision|0|||
157208040|NCT05004181|567506329|FG001|Overall Study|Physician Decision|0|||
157208041|NCT05004181|567506330|FG002|Overall Study|Physician Decision|0|||
157208042|NCT05004181|567506331|FG003|Overall Study|Physician Decision|0|||
157208043|NCT05004181|567506332|FG004|Overall Study|Physician Decision|0|||
157208044|NCT05004181|567506333|FG005|Overall Study|Physician Decision|0|||
157208045|NCT05004181|567506334|FG006|Overall Study|Physician Decision|2|||
157208046|NCT05004181|567506335|FG007|Overall Study|Physician Decision|0|||
157208047|NCT05004181|567506336|FG008|Overall Study|Physician Decision|7|||
157208048|NCT05004181|567506337|FG009|Overall Study|Physician Decision|0|||
157208049|NCT05004181|567506338|FG010|Overall Study|Physician Decision|0|||
157208050|NCT05004181|567506339|FG011|Overall Study|Physician Decision|0|||
157208051|NCT05004181|567506328|FG000|Overall Study|Withdrawal by Subject|2|||
156774445|NCT01155141|565926683|FG000|Overall Study|Withdrawal by Subject|1|||
156774446|NCT01155141|565926683|FG000|Overall Study|Screen Failure|1|||
156774447|NCT00303186|565926684|FG000|Overall Study|Other|52|||
156774448|NCT00785629|565926687|FG000|Overall Study|Adverse Event|2|||
157208052|NCT05004181|567506329|FG001|Overall Study|Withdrawal by Subject|3|||
157208053|NCT05004181|567506330|FG002|Overall Study|Withdrawal by Subject|2|||
157208054|NCT05004181|567506331|FG003|Overall Study|Withdrawal by Subject|2|||
157208055|NCT05004181|567506332|FG004|Overall Study|Withdrawal by Subject|4|||
157208056|NCT05004181|567506333|FG005|Overall Study|Withdrawal by Subject|2|||
157208057|NCT05004181|567506334|FG006|Overall Study|Withdrawal by Subject|4|||
157208058|NCT05004181|567506335|FG007|Overall Study|Withdrawal by Subject|22|||
157208059|NCT05004181|567506336|FG008|Overall Study|Withdrawal by Subject|8|||
157208060|NCT05004181|567506337|FG009|Overall Study|Withdrawal by Subject|1|||
157208061|NCT05004181|567506338|FG010|Overall Study|Withdrawal by Subject|3|||
157208062|NCT05004181|567506339|FG011|Overall Study|Withdrawal by Subject|2|||
157208063|NCT05004181|567506328|FG000|Overall Study|Protocol Violation|2|||
157208064|NCT05004181|567506329|FG001|Overall Study|Protocol Violation|3|||
157208065|NCT05004181|567506330|FG002|Overall Study|Protocol Violation|0|||
157208066|NCT05004181|567506331|FG003|Overall Study|Protocol Violation|0|||
157208067|NCT05004181|567506332|FG004|Overall Study|Protocol Violation|1|||
156774449|NCT00785629|565926688|FG001|Overall Study|Adverse Event|1|||
156774450|NCT00785629|565926689|FG002|Overall Study|Adverse Event|1|||
156774451|NCT00785629|565926690|FG003|Overall Study|Adverse Event|5|||
156774452|NCT00785629|565926687|FG000|Overall Study|Protocol Violation|1|||
156774453|NCT00785629|565926688|FG001|Overall Study|Protocol Violation|2|||
156774454|NCT00785629|565926689|FG002|Overall Study|Protocol Violation|4|||
156774455|NCT00785629|565926690|FG003|Overall Study|Protocol Violation|5|||
156774456|NCT00785629|565926687|FG000|Overall Study|administrative decision|5|||
156774457|NCT00785629|565926688|FG001|Overall Study|administrative decision|1|||
156774458|NCT00785629|565926689|FG002|Overall Study|administrative decision|3|||
156774459|NCT00785629|565926690|FG003|Overall Study|administrative decision|4|||
156774460|NCT00785629|565926687|FG000|Overall Study|Withdrawal by Subject|0|||
156774461|NCT00785629|565926688|FG001|Overall Study|Withdrawal by Subject|1|||
156774462|NCT00785629|565926689|FG002|Overall Study|Withdrawal by Subject|2|||
156774463|NCT00785629|565926690|FG003|Overall Study|Withdrawal by Subject|2|||
156774464|NCT02020941|565926691|FG000|Overall Study|Adverse Event|1|||
156774465|NCT02020941|565926691|FG000|Overall Study|Physician Decision|2|||
156774466|NCT02020941|565926691|FG000|Overall Study|Withdrawal by Subject|1|||
156774467|NCT02020941|565926691|FG000|Overall Study|Disease Progression|4|||
156774468|NCT02107898|565926693|FG000|Overall Study|Adverse Event|4|||
156774469|NCT02107898|565926694|FG001|Overall Study|Adverse Event|7|||
156774470|NCT02107898|565926693|FG000|Overall Study|Poor compliance to protocol|0|||
156774471|NCT02107898|565926694|FG001|Overall Study|Poor compliance to protocol|1|||
156774472|NCT02107898|565926693|FG000|Overall Study|Participant moved|0|||
156774473|NCT02107898|565926694|FG001|Overall Study|Participant moved|2|||
156774474|NCT02107898|565926693|FG000|Overall Study|Consent withdrawn by participant|2|||
156774475|NCT02107898|565926694|FG001|Overall Study|Consent withdrawn by participant|1|||
156774476|NCT02107898|565926693|FG000|Overall Study|Randomized but not treated|0|||
156774477|NCT02107898|565926694|FG001|Overall Study|Randomized but not treated|1|||
157208068|NCT05004181|567506333|FG005|Overall Study|Protocol Violation|0|||
157208069|NCT05004181|567506334|FG006|Overall Study|Protocol Violation|16|||
157208070|NCT05004181|567506335|FG007|Overall Study|Protocol Violation|18|||
157208071|NCT05004181|567506336|FG008|Overall Study|Protocol Violation|2|||
156774478|NCT03329989|565926695|FG000|Overall Study|Withdrawal by Subject|9|||
156774479|NCT03329989|565926695|FG000|Overall Study|Lost to Follow-up|8|||
156774480|NCT03329989|565926695|FG000|Overall Study|Adverse Event|5|||
156774481|NCT03329989|565926695|FG000|Overall Study|Protocol Violation|1|||
156774482|NCT00634504|565926696|FG000|Overall Study|Protocol Violation|1|||
156774483|NCT00634504|565926697|FG001|Overall Study|Protocol Violation|0|||
156774484|NCT02469857|565926698|FG000|Overall Study|Death|24|||
156774485|NCT02469857|565926699|FG001|Overall Study|Death|29|||
156774486|NCT02469857|565926698|FG000|Overall Study|Discontinuation|1|||
156774487|NCT02469857|565926699|FG001|Overall Study|Discontinuation|3|||
157208072|NCT05004181|567506337|FG009|Overall Study|Protocol Violation|2|||
157208073|NCT05004181|567506338|FG010|Overall Study|Protocol Violation|2|||
157208074|NCT05004181|567506339|FG011|Overall Study|Protocol Violation|1|||
157208075|NCT05004181|567506328|FG000|Overall Study|Not further specified|1|||
157208076|NCT05004181|567506329|FG001|Overall Study|Not further specified|0|||
156774488|NCT00937950|565926700|FG000|Overall Study|Withdrawal by Subject|23|||
156774489|NCT00937950|565926700|FG000|Overall Study|Migrated/moved from study area|27|||
156774490|NCT00937950|565926700|FG000|Overall Study|Lost to Follow-up|144|||
157208077|NCT05004181|567506330|FG002|Overall Study|Not further specified|0|||
157208078|NCT05004181|567506331|FG003|Overall Study|Not further specified|0|||
156774491|NCT00937950|565926700|FG000|Overall Study|Missing confirmed|4|||
156774492|NCT00937950|565926700|FG000|Overall Study|Other|18|||
156774493|NCT01531153|565926703|FG000|Overall Study|Withdrawal by Subject|10|||
156774494|NCT01531153|565926704|FG001|Overall Study|Withdrawal by Subject|9|||
157113702|NCT03200366|567171741|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
157113703|NCT03200366|567171739|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
157113704|NCT03200366|567171740|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
157113705|NCT03200366|567171741|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
157113706|NCT03200366|567171739|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
157113707|NCT03200366|567171740|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
157113708|NCT03200366|567171741|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
157113709|NCT00405067|567171742|FG000|Overall Study|Adverse Event|4|||
157113710|NCT00405067|567171743|FG001|Overall Study|Adverse Event|9|||
157113711|NCT00405067|567171744|FG002|Overall Study|Adverse Event|4|||
157113712|NCT00405067|567171742|FG000|Overall Study|Lost to Follow-up|0|||
157113713|NCT00405067|567171743|FG001|Overall Study|Lost to Follow-up|0|||
157113714|NCT00405067|567171744|FG002|Overall Study|Lost to Follow-up|1|||
157113715|NCT03287219|567171745|FG000|Overall Study|Protocol Violation|0|||
157113716|NCT03287219|567171746|FG001|Overall Study|Protocol Violation|2|||
157113717|NCT00930761|567171747|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
157113718|NCT00930761|567171748|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
157113719|NCT00930761|567171747|FG000|Overall Study|less than 3 music therapy sessions|0|||
157113720|NCT00930761|567171748|FG001|Overall Study|less than 3 music therapy sessions|3|||
157113721|NCT03571646|567171749|FG000|Overall Study|Adverse Event|1|||
157113722|NCT03571646|567171750|FG001|Overall Study|Adverse Event|0|||
157113723|NCT03571646|567171749|FG000|Overall Study|Withdrawal by Subject|1|||
157113724|NCT03571646|567171750|FG001|Overall Study|Withdrawal by Subject|1|||
157113725|NCT01576549|567171751|FG000|Overall Study|Sponsor Decision|2|||
157113726|NCT04081363|567171752|FG000|Overall Study|Withdrawal by Subject|1|||
157113727|NCT04081363|567171753|FG001|Overall Study|Withdrawal by Subject|0|||
157113728|NCT00705783|567171754|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
157113729|NCT00705783|567171755|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
157113730|NCT00705783|567171756|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
157113731|NCT00705783|567171754|FG000|Conversion Phase|Lost to Follow-up|13|||
157113732|NCT00705783|567171755|FG001|Conversion Phase|Lost to Follow-up|0|||
157113733|NCT00705783|567171756|FG002|Conversion Phase|Lost to Follow-up|0|||
157113734|NCT00705783|567171754|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
157113735|NCT00705783|567171755|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
157113736|NCT00705783|567171756|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
157113737|NCT00705783|567171754|FG000|Conversion Phase|Withdrawn by Investigator|4|||
157113738|NCT00705783|567171755|FG001|Conversion Phase|Withdrawn by Investigator|0|||
157113739|NCT00705783|567171756|FG002|Conversion Phase|Withdrawn by Investigator|0|||
157113740|NCT00705783|567171754|FG000|Conversion Phase|Withdrew Consent|24|||
157113741|NCT00705783|567171755|FG001|Conversion Phase|Withdrew Consent|0|||
157113742|NCT00705783|567171756|FG002|Conversion Phase|Withdrew Consent|0|||
157113743|NCT00705783|567171754|FG000|Conversion Phase|Protocol Deviation|2|||
157113744|NCT00705783|567171755|FG001|Conversion Phase|Protocol Deviation|0|||
157113745|NCT00705783|567171756|FG002|Conversion Phase|Protocol Deviation|0|||
157113746|NCT00705783|567171754|FG000|Conversion Phase|Adverse Event|11|||
157113747|NCT00705783|567171755|FG001|Conversion Phase|Adverse Event|0|||
157113748|NCT00705783|567171756|FG002|Conversion Phase|Adverse Event|0|||
157113749|NCT00705783|567171754|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
157113750|NCT00705783|567171755|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
157113751|NCT00705783|567171756|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
157113752|NCT00705783|567171754|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
157113753|NCT00705783|567171755|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
157113754|NCT00705783|567171756|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
157113755|NCT00705783|567171754|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
157113756|NCT00705783|567171755|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
157113757|NCT00705783|567171756|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
157113758|NCT00705783|567171754|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
157113759|NCT00705783|567171755|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
157113760|NCT00705783|567171756|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
157113761|NCT00705783|567171754|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
157113762|NCT00705783|567171755|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
157113763|NCT00705783|567171756|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
157113764|NCT00705783|567171754|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
157113765|NCT00705783|567171755|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
157113766|NCT00705783|567171756|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
157113767|NCT00705783|567171754|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
157113768|NCT00705783|567171755|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
157113769|NCT00705783|567171756|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
157113770|NCT00705783|567171754|FG000|Oral Stabilization Phase|Adverse Event|14|||
157113771|NCT00705783|567171755|FG001|Oral Stabilization Phase|Adverse Event|0|||
157113772|NCT00705783|567171756|FG002|Oral Stabilization Phase|Adverse Event|0|||
157113773|NCT00705783|567171754|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
157113774|NCT00705783|567171755|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157113775|NCT00705783|567171756|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157113776|NCT00705783|567171754|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
157113777|NCT00705783|567171755|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157113778|NCT00705783|567171756|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157113779|NCT00705783|567171754|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
157113780|NCT00705783|567171755|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
157113781|NCT00705783|567171756|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
157113782|NCT00705783|567171754|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
157113783|NCT00705783|567171755|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
157113784|NCT00705783|567171756|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
157113785|NCT00705783|567171754|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
157113786|NCT00705783|567171755|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
157113787|NCT00705783|567171756|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
157113788|NCT00705783|567171754|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
157208079|NCT05004181|567506332|FG004|Overall Study|Not further specified|0|||
157208080|NCT05004181|567506333|FG005|Overall Study|Not further specified|0|||
157208081|NCT05004181|567506334|FG006|Overall Study|Not further specified|1|||
157208082|NCT05004181|567506335|FG007|Overall Study|Not further specified|0|||
157208083|NCT05004181|567506336|FG008|Overall Study|Not further specified|2|||
157208084|NCT05004181|567506337|FG009|Overall Study|Not further specified|1|||
157208085|NCT05004181|567506338|FG010|Overall Study|Not further specified|0|||
157208086|NCT05004181|567506339|FG011|Overall Study|Not further specified|1|||
157208087|NCT03353415|567506348|FG000|Masked CGM Wear|Lost to Follow-up|2|||
157208088|NCT03353415|567506348|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
157208089|NCT00975000|567506349|FG000|Overall Study|Other|1|||
157208090|NCT00975000|567506350|FG001|Overall Study|Other|0|||
157208091|NCT00975000|567506349|FG000|Overall Study|Adverse Event|1|||
157208092|NCT00975000|567506350|FG001|Overall Study|Adverse Event|1|||
157208093|NCT00975000|567506349|FG000|Overall Study|Withdrawal by Subject|2|||
157208094|NCT00975000|567506350|FG001|Overall Study|Withdrawal by Subject|2|||
157208095|NCT00975000|567506349|FG000|Overall Study|Lost to Follow-up|0|||
157208096|NCT00975000|567506350|FG001|Overall Study|Lost to Follow-up|1|||
157208097|NCT00975000|567506349|FG000|Overall Study|Protocol-specified Criteria|1|||
157208098|NCT00975000|567506350|FG001|Overall Study|Protocol-specified Criteria|0|||
157208099|NCT00975000|567506349|FG000|Overall Study|Non-compliance|0|||
157208100|NCT00975000|567506350|FG001|Overall Study|Non-compliance|1|||
157208101|NCT03205163|567506351|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
157208102|NCT03205163|567506352|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
157208103|NCT01238172|567506353|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
157208104|NCT01238172|567506354|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
157208105|NCT01238172|567506353|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
157208106|NCT01238172|567506354|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
157208107|NCT05022121|567506355|FG000|Overall Study|Lack of Efficacy|1|||
157208108|NCT05022121|567506356|FG001|Overall Study|Lack of Efficacy|0|||
157208109|NCT05022121|567506355|FG000|Overall Study|Lost to Follow-up|0|||
157208110|NCT05022121|567506356|FG001|Overall Study|Lost to Follow-up|2|||
157208111|NCT04439110|567506357|FG000|Overall Study|Ineligible|2|||
157208112|NCT04439110|567506357|FG000|Overall Study|Adverse Event|4|||
157208113|NCT04439110|567506357|FG000|Overall Study|Death|2|||
157208114|NCT04439110|567506357|FG000|Overall Study|Disease proression|25|||
157208115|NCT04439110|567506357|FG000|Overall Study|Withdrawal by Subject|1|||
157208116|NCT04439110|567506357|FG000|Overall Study|Alternative therapy|1|||
157208117|NCT04439110|567506357|FG000|Overall Study|Other complicating disease|1|||
157208118|NCT04439110|567506357|FG000|Overall Study|Personal reasons|1|||
157208119|NCT04439110|567506357|FG000|Overall Study|Still on treatment|1|||
157208120|NCT01298661|567506358|FG000|Overall Study|Withdrawal by Subject|2|||
157208121|NCT01298661|567506359|FG001|Overall Study|Withdrawal by Subject|0|||
157208122|NCT01298661|567506360|FG002|Overall Study|Withdrawal by Subject|2|||
157208123|NCT00526227|567506363|FG000|Overall Study|Device not implanted|1|||
157113789|NCT00705783|567171755|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
157208124|NCT00526227|567506363|FG000|Overall Study|Death|1|||
157208125|NCT01678924|567507961|FG000|Overall Study|Adverse Event|1|||
157208126|NCT01678924|567507962|FG001|Overall Study|Adverse Event|1|||
157208127|NCT01678924|567507963|FG002|Overall Study|Adverse Event|0|||
157208128|NCT01678924|567507964|FG003|Overall Study|Adverse Event|1|||
157208129|NCT01678924|567507961|FG000|Overall Study|Lack of Efficacy|7|||
157208130|NCT01678924|567507962|FG001|Overall Study|Lack of Efficacy|2|||
157113790|NCT00705783|567171756|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
157208131|NCT01678924|567507963|FG002|Overall Study|Lack of Efficacy|0|||
157208132|NCT01678924|567507964|FG003|Overall Study|Lack of Efficacy|5|||
156774495|NCT01531153|565926705|FG002|Overall Study|Withdrawal by Subject|15|||
156774496|NCT03483103|565926706|FG000|Pre-Treatment Phase|Other reasons|1|||
156774497|NCT03483103|565926706|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
156774498|NCT03483103|565926706|FG000|Pre-Treatment Phase|Disease-related complications|1|||
156774499|NCT03483103|565926706|FG000|Pre-Treatment Phase|Death|5|||
156774500|NCT03483103|565926706|FG000|Treatment Phase|Withdrawal by Subject|7|||
156774501|NCT03483103|565926706|FG000|Treatment Phase|Other reasons|1|||
156774502|NCT03483103|565926706|FG000|Treatment Phase|Death|23|||
156774503|NCT03483103|565926706|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
156774504|NCT03483103|565926706|FG000|Treatment Phase|Received nonconforming product|1|||
156774505|NCT04727749|565926707|FG000|Overall Study|Lost to Follow-up|10|||
156774506|NCT04727749|565926708|FG001|Overall Study|Lost to Follow-up|3|||
156774507|NCT02378181|565926709|FG000|Overall Study|Lost to Follow-up|2|||
156774508|NCT02378181|565926710|FG001|Overall Study|Lost to Follow-up|5|||
156774509|NCT02378181|565926709|FG000|Overall Study|Withdrawal by Subject|1|||
156774510|NCT02378181|565926710|FG001|Overall Study|Withdrawal by Subject|1|||
156774511|NCT02378181|565926709|FG000|Overall Study|Incarcerated|0|||
156774512|NCT02378181|565926710|FG001|Overall Study|Incarcerated|1|||
156774513|NCT02475213|565926713|FG000|Overall Study|Adverse Event|2|||
156774514|NCT02475213|565926714|FG001|Overall Study|Adverse Event|0|||
156774515|NCT02475213|565926715|FG002|Overall Study|Adverse Event|0|||
156774516|NCT02475213|565926716|FG003|Overall Study|Adverse Event|1|||
156774517|NCT02475213|565926717|FG004|Overall Study|Adverse Event|1|||
156774518|NCT02475213|565926718|FG005|Overall Study|Adverse Event|4|||
156774519|NCT02475213|565926719|FG006|Overall Study|Adverse Event|6|||
156774520|NCT02475213|565926720|FG007|Overall Study|Adverse Event|2|||
156774521|NCT02475213|565926713|FG000|Overall Study|Physician Decision|1|||
156774522|NCT02475213|565926714|FG001|Overall Study|Physician Decision|1|||
156774523|NCT02475213|565926715|FG002|Overall Study|Physician Decision|1|||
156774524|NCT02475213|565926716|FG003|Overall Study|Physician Decision|0|||
156774525|NCT02475213|565926717|FG004|Overall Study|Physician Decision|0|||
156774526|NCT02475213|565926718|FG005|Overall Study|Physician Decision|1|||
156774527|NCT02475213|565926719|FG006|Overall Study|Physician Decision|4|||
156774528|NCT02475213|565926720|FG007|Overall Study|Physician Decision|0|||
156774529|NCT02475213|565926713|FG000|Overall Study|Progressive Disease|3|||
156774530|NCT02475213|565926714|FG001|Overall Study|Progressive Disease|2|||
156774531|NCT02475213|565926715|FG002|Overall Study|Progressive Disease|2|||
156774532|NCT02475213|565926716|FG003|Overall Study|Progressive Disease|13|||
156774533|NCT02475213|565926717|FG004|Overall Study|Progressive Disease|15|||
156774534|NCT02475213|565926718|FG005|Overall Study|Progressive Disease|25|||
156774535|NCT02475213|565926719|FG006|Overall Study|Progressive Disease|30|||
156774536|NCT02475213|565926720|FG007|Overall Study|Progressive Disease|10|||
156774537|NCT02475213|565926713|FG000|Overall Study|Death|0|||
156774538|NCT02475213|565926714|FG001|Overall Study|Death|0|||
156774539|NCT02475213|565926715|FG002|Overall Study|Death|0|||
156774540|NCT02475213|565926716|FG003|Overall Study|Death|0|||
156774541|NCT02475213|565926717|FG004|Overall Study|Death|0|||
156774542|NCT02475213|565926718|FG005|Overall Study|Death|4|||
156774543|NCT02475213|565926719|FG006|Overall Study|Death|1|||
156774544|NCT02475213|565926720|FG007|Overall Study|Death|0|||
156774545|NCT02475213|565926713|FG000|Overall Study|Protocol Violation|0|||
156774546|NCT02475213|565926714|FG001|Overall Study|Protocol Violation|0|||
156774547|NCT02475213|565926715|FG002|Overall Study|Protocol Violation|0|||
156774548|NCT02475213|565926716|FG003|Overall Study|Protocol Violation|0|||
156774549|NCT02475213|565926717|FG004|Overall Study|Protocol Violation|1|||
156774550|NCT02475213|565926718|FG005|Overall Study|Protocol Violation|0|||
156774551|NCT02475213|565926719|FG006|Overall Study|Protocol Violation|0|||
156774552|NCT02475213|565926720|FG007|Overall Study|Protocol Violation|0|||
156774553|NCT02475213|565926713|FG000|Overall Study|Withdrawal by Subject|0|||
156774554|NCT02475213|565926714|FG001|Overall Study|Withdrawal by Subject|0|||
156774555|NCT02475213|565926715|FG002|Overall Study|Withdrawal by Subject|0|||
157007802|NCT01662336|566778885|FG000|Overall Study|Adverse Event|1|||
156774556|NCT02475213|565926716|FG003|Overall Study|Withdrawal by Subject|1|||
157007803|NCT01662336|566778885|FG000|Overall Study|No longer on LPV/r|30|||
157007804|NCT01662336|566778885|FG000|Overall Study|Other|29|||
157007805|NCT01662336|566778885|FG000|Overall Study|Withdrawal by Subject|6|||
156774557|NCT02475213|565926717|FG004|Overall Study|Withdrawal by Subject|0|||
156774558|NCT02475213|565926718|FG005|Overall Study|Withdrawal by Subject|2|||
156774559|NCT02475213|565926719|FG006|Overall Study|Withdrawal by Subject|2|||
156774560|NCT02475213|565926720|FG007|Overall Study|Withdrawal by Subject|0|||
156774561|NCT02475213|565926713|FG000|Overall Study|Other|0|||
156774562|NCT02475213|565926714|FG001|Overall Study|Other|0|||
156774563|NCT02475213|565926715|FG002|Overall Study|Other|0|||
156774564|NCT02475213|565926716|FG003|Overall Study|Other|1|||
156774565|NCT02475213|565926717|FG004|Overall Study|Other|3|||
157007806|NCT02189252|566778886|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
156774566|NCT02475213|565926718|FG005|Overall Study|Other|1|||
156774567|NCT02475213|565926719|FG006|Overall Study|Other|0|||
156774568|NCT02475213|565926720|FG007|Overall Study|Other|0|||
156774569|NCT01186770|565926721|FG000|Overall Study|Ineligibility|0|||
156774570|NCT01186770|565926722|FG001|Overall Study|Ineligibility|0|||
157113791|NCT00705783|567171754|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
157113792|NCT00705783|567171755|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
157113793|NCT00705783|567171756|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
157113794|NCT00705783|567171754|FG000|Depot Stabilization Phase|Adverse Event|17|||
157113795|NCT00705783|567171755|FG001|Depot Stabilization Phase|Adverse Event|0|||
157113796|NCT00705783|567171756|FG002|Depot Stabilization Phase|Adverse Event|0|||
157113797|NCT00705783|567171754|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
157113798|NCT00705783|567171755|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157113799|NCT00705783|567171756|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157113800|NCT00705783|567171754|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
157113801|NCT00705783|567171755|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157113802|NCT00705783|567171756|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157113803|NCT00705783|567171754|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
157113804|NCT00705783|567171755|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
157113805|NCT00705783|567171756|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
157113806|NCT00705783|567171754|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
157113807|NCT00705783|567171755|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
157113808|NCT00705783|567171756|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
157113809|NCT00705783|567171754|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
157113810|NCT00705783|567171755|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
157113811|NCT00705783|567171756|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
157113812|NCT00705783|567171754|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
157113813|NCT00705783|567171755|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
157113814|NCT00705783|567171756|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
157113815|NCT00705783|567171754|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
157113816|NCT00705783|567171755|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
157113817|NCT00705783|567171756|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
157113818|NCT00705783|567171754|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
157113819|NCT00705783|567171755|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
157113820|NCT00705783|567171756|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
157113821|NCT00705783|567171754|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
157113822|NCT00705783|567171755|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
157113823|NCT00705783|567171756|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
157113824|NCT00705783|567171754|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
157113825|NCT00705783|567171755|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
157113826|NCT00705783|567171756|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
157113827|NCT00705783|567171754|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
157113828|NCT00705783|567171755|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
157113829|NCT00705783|567171756|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
157113830|NCT02182687|567171757|FG000|Overall Study|Withdrawal by Subject|4|||
157113831|NCT02182687|567171758|FG001|Overall Study|Withdrawal by Subject|0|||
157113832|NCT02182687|567171757|FG000|Overall Study|Adverse Event|1|||
157113833|NCT02182687|567171758|FG001|Overall Study|Adverse Event|0|||
157113834|NCT02182687|567171757|FG000|Overall Study|Lost to Follow-up|0|||
157113835|NCT02182687|567171758|FG001|Overall Study|Lost to Follow-up|1|||
157113836|NCT01765920|567171764|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
157113837|NCT01765920|567171765|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
157113838|NCT01765920|567171764|FG000|Overall Study|Patient code disclosure|0|||
157113839|NCT01765920|567171765|FG001|Overall Study|Patient code disclosure|1|||
157113840|NCT02025907|567171766|FG000|Overall Study|Lack of Efficacy|1|||
157113841|NCT02025907|567171767|FG001|Overall Study|Lack of Efficacy|0|||
157113842|NCT02025907|567171766|FG000|Overall Study|Withdrawal by Subject|15|||
157113843|NCT02025907|567171767|FG001|Overall Study|Withdrawal by Subject|8|||
157113844|NCT02025907|567171766|FG000|Overall Study|Protocol Violation|2|||
157113845|NCT02025907|567171767|FG001|Overall Study|Protocol Violation|0|||
157113846|NCT02025907|567171766|FG000|Overall Study|Physician Decision|2|||
157113847|NCT02025907|567171767|FG001|Overall Study|Physician Decision|0|||
157113848|NCT02025907|567171766|FG000|Overall Study|Lost to Follow-up|2|||
157113849|NCT02025907|567171767|FG001|Overall Study|Lost to Follow-up|2|||
157113850|NCT02025907|567171766|FG000|Overall Study|Adverse Event|3|||
157208133|NCT01678924|567507961|FG000|Overall Study|Lost to Follow-up|0|||
157208134|NCT01678924|567507962|FG001|Overall Study|Lost to Follow-up|4|||
157208135|NCT01678924|567507963|FG002|Overall Study|Lost to Follow-up|0|||
157208136|NCT01678924|567507964|FG003|Overall Study|Lost to Follow-up|2|||
157113851|NCT02025907|567171767|FG001|Overall Study|Adverse Event|1|||
157113852|NCT02025907|567171766|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
157113853|NCT02025907|567171767|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
157113854|NCT01549002|567171774|FG000|Overall Study|Excessive pain|0|||
157113855|NCT01549002|567171775|FG001|Overall Study|Excessive pain|2|||
157113856|NCT01549002|567171774|FG000|Overall Study|Moderate sedation required|0|||
157113857|NCT01549002|567171775|FG001|Overall Study|Moderate sedation required|2|||
156774571|NCT01186770|565926723|FG002|Overall Study|Ineligibility|2|||
156774572|NCT01186770|565926724|FG003|Overall Study|Ineligibility|0|||
156774573|NCT01186770|565926721|FG000|Overall Study|Protocol Violation|7|||
156774574|NCT01186770|565926722|FG001|Overall Study|Protocol Violation|9|||
156774575|NCT01186770|565926723|FG002|Overall Study|Protocol Violation|12|||
156774576|NCT01186770|565926724|FG003|Overall Study|Protocol Violation|14|||
156774577|NCT01186770|565926721|FG000|Overall Study|Adverse Event|2|||
156774578|NCT01186770|565926722|FG001|Overall Study|Adverse Event|9|||
156774579|NCT01186770|565926723|FG002|Overall Study|Adverse Event|7|||
156774580|NCT01186770|565926724|FG003|Overall Study|Adverse Event|9|||
156774581|NCT01186770|565926721|FG000|Overall Study|Withdrawal by Subject|15|||
157113858|NCT01251367|567171776|FG000|Overall Study|Protocol Violation|1|||
157113859|NCT01251367|567171776|FG000|Overall Study|Lack of Efficacy|2|||
157113860|NCT01251367|567171776|FG000|Overall Study|Adverse Event|19|||
157113861|NCT01251367|567171776|FG000|Overall Study|Withdrawal by Subject|36|||
157113862|NCT01251367|567171776|FG000|Overall Study|Lost to Follow-up|5|||
157113863|NCT01251367|567171776|FG000|Overall Study|Subject Required Alternative Treatment|7|||
156774582|NCT01186770|565926722|FG001|Overall Study|Withdrawal by Subject|13|||
156774583|NCT01186770|565926723|FG002|Overall Study|Withdrawal by Subject|11|||
156774584|NCT01186770|565926724|FG003|Overall Study|Withdrawal by Subject|17|||
156774585|NCT01186770|565926721|FG000|Overall Study|Lost to Follow-up|10|||
156774586|NCT01186770|565926722|FG001|Overall Study|Lost to Follow-up|6|||
156774587|NCT01186770|565926723|FG002|Overall Study|Lost to Follow-up|14|||
156774588|NCT01186770|565926724|FG003|Overall Study|Lost to Follow-up|9|||
156774589|NCT01186770|565926721|FG000|Overall Study|Insufficient response to treatment|7|||
156774590|NCT01186770|565926722|FG001|Overall Study|Insufficient response to treatment|8|||
156774591|NCT01186770|565926723|FG002|Overall Study|Insufficient response to treatment|5|||
156774592|NCT01186770|565926724|FG003|Overall Study|Insufficient response to treatment|7|||
156774593|NCT01186770|565926721|FG000|Overall Study|Other than specified|0|||
156774594|NCT01186770|565926722|FG001|Overall Study|Other than specified|1|||
156774595|NCT01186770|565926723|FG002|Overall Study|Other than specified|1|||
156774596|NCT01186770|565926724|FG003|Overall Study|Other than specified|2|||
156774597|NCT00505921|565926725|FG000|Overall Study|Ineligible|1|||
156774598|NCT00505921|565926725|FG000|Overall Study|Failed to Mobilize|8|||
156774599|NCT00630292|565926726|FG000|Overall Study|Withdrawal by Subject|1|||
156774600|NCT00797563|565926728|FG000|Overall Study|Adverse Event|1|||
156774601|NCT03416179|565926729|FG000|Overall Study|Death|90|||
156774602|NCT03416179|565926730|FG001|Overall Study|Death|87|||
156774603|NCT03416179|565926731|FG002|Overall Study|Death|117|||
156774604|NCT03416179|565926732|FG003|Overall Study|Death|113|||
156774605|NCT03416179|565926729|FG000|Overall Study|Withdrawal by Subject|15|||
156774606|NCT03416179|565926730|FG001|Overall Study|Withdrawal by Subject|20|||
156774607|NCT03416179|565926731|FG002|Overall Study|Withdrawal by Subject|6|||
156774608|NCT03416179|565926732|FG003|Overall Study|Withdrawal by Subject|9|||
156774609|NCT03416179|565926729|FG000|Overall Study|Lost to Follow-up|1|||
156774610|NCT03416179|565926730|FG001|Overall Study|Lost to Follow-up|1|||
156774611|NCT03416179|565926731|FG002|Overall Study|Lost to Follow-up|0|||
156774612|NCT03416179|565926732|FG003|Overall Study|Lost to Follow-up|3|||
156774613|NCT03416179|565926729|FG000|Overall Study|Study participation terminated by Sponsor|93|||
157113864|NCT01251367|567171776|FG000|Overall Study|No Study Drug Available|1|||
157113865|NCT01251367|567171776|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
157113866|NCT01251367|567171776|FG000|Overall Study|End of Study Visit Performed in Error|1|||
157113867|NCT02370615|567171781|FG000|Overall Study|Adverse Event|1|||
157113868|NCT02370615|567171782|FG001|Overall Study|Adverse Event|0|||
156774614|NCT03416179|565926730|FG001|Overall Study|Study participation terminated by Sponsor|91|||
156774615|NCT03416179|565926731|FG002|Overall Study|Study participation terminated by Sponsor|26|||
156774616|NCT03416179|565926732|FG003|Overall Study|Study participation terminated by Sponsor|31|||
156774617|NCT03416179|565926729|FG000|Overall Study|Other|2|||
156774618|NCT03416179|565926730|FG001|Overall Study|Other|3|||
156774619|NCT03416179|565926731|FG002|Overall Study|Other|1|||
156774620|NCT03416179|565926732|FG003|Overall Study|Other|0|||
156774621|NCT00790036|565926738|FG000|Overall Study|Abnormal lab values|3|||
156774622|NCT00790036|565926739|FG001|Overall Study|Abnormal lab values|2|||
156774623|NCT00790036|565926738|FG000|Overall Study|Administrative problems|5|||
156774624|NCT00790036|565926739|FG001|Overall Study|Administrative problems|9|||
156774625|NCT00790036|565926738|FG000|Overall Study|Adverse Event|113|||
156774626|NCT00790036|565926739|FG001|Overall Study|Adverse Event|44|||
156774627|NCT00790036|565926738|FG000|Overall Study|Death|1|||
156774628|NCT00790036|565926739|FG001|Overall Study|Death|0|||
156774629|NCT00790036|565926738|FG000|Overall Study|Disease progression|24|||
156774630|NCT00790036|565926739|FG001|Overall Study|Disease progression|48|||
156774631|NCT00790036|565926738|FG000|Overall Study|Lost to Follow-up|1|||
157113869|NCT00506883|567171785|FG000|Overall Study|Lost to Follow-up|1|||
156774632|NCT00790036|565926739|FG001|Overall Study|Lost to Follow-up|2|||
156774633|NCT00790036|565926738|FG000|Overall Study|Protocol Violation|10|||
156774634|NCT00790036|565926739|FG001|Overall Study|Protocol Violation|2|||
156774635|NCT00790036|565926738|FG000|Overall Study|Withdrawal by Subject|18|||
157113870|NCT00506883|567171786|FG001|Overall Study|Lost to Follow-up|1|||
156774636|NCT00790036|565926739|FG001|Overall Study|Withdrawal by Subject|7|||
156774637|NCT00790036|565926738|FG000|Overall Study|Subject/guardian decision|20|||
156774638|NCT00790036|565926739|FG001|Overall Study|Subject/guardian decision|7|||
156774639|NCT03197129|565926740|FG000|Overall Study|did not answer the VPT: shyness|4|||
156774640|NCT03197129|565926741|FG001|Overall Study|did not answer the VPT: shyness|5|||
156774641|NCT05233761|565926742|FG000|Treatment Period A|Withdrawal by Subject|12|||
156774642|NCT05233761|565926743|FG001|Treatment Period A|Withdrawal by Subject|10|||
156774643|NCT05233761|565926742|FG000|Treatment Period A|Lost to Follow-up|6|||
156774644|NCT05233761|565926743|FG001|Treatment Period A|Lost to Follow-up|12|||
156774645|NCT05233761|565926742|FG000|Treatment Period A|Protocol Violation|8|||
156774646|NCT05233761|565926743|FG001|Treatment Period A|Protocol Violation|15|||
156774647|NCT02442349|565926744|FG000|Overall Study|Death|95|||
156774648|NCT02442349|565926744|FG000|Overall Study|Withdrawal by Subject|27|||
156774649|NCT02442349|565926744|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
156774650|NCT02442349|565926744|FG000|Overall Study|Lost to Follow-up|1|||
156774651|NCT01285518|565926745|FG000|Overall Study|Lost to Follow-up|0|||
156774652|NCT01285518|565926746|FG001|Overall Study|Lost to Follow-up|0|||
156774653|NCT01285518|565926747|FG002|Overall Study|Lost to Follow-up|0|||
156774654|NCT01285518|565926748|FG003|Overall Study|Lost to Follow-up|0|||
156774655|NCT01285518|565926749|FG004|Overall Study|Lost to Follow-up|0|||
156774656|NCT01285518|565926750|FG005|Overall Study|Lost to Follow-up|1|||
156774657|NCT01285518|565926751|FG006|Overall Study|Lost to Follow-up|0|||
156774658|NCT01285518|565926752|FG007|Overall Study|Lost to Follow-up|0|||
156774659|NCT00639509|565926759|FG000|Overall Study|Death|1|||
156774660|NCT01551173|565926760|FG000|Overall Study|Withdrawal by Subject|11|||
156774661|NCT01551173|565926761|FG001|Overall Study|Withdrawal by Subject|16|||
156774662|NCT01551173|565926760|FG000|Overall Study|Adverse Event|7|||
156774663|NCT01551173|565926761|FG001|Overall Study|Adverse Event|6|||
156774664|NCT01551173|565926760|FG000|Overall Study|Lost to Follow-up|5|||
156774665|NCT01551173|565926761|FG001|Overall Study|Lost to Follow-up|7|||
156774666|NCT01551173|565926760|FG000|Overall Study|Other|5|||
156774667|NCT01551173|565926761|FG001|Overall Study|Other|3|||
156774668|NCT01394276|565926762|FG000|Overall Study|Related Adverse event (AEs)|15|||
156774669|NCT01394276|565926762|FG000|Overall Study|Not related AEs|9|||
156774670|NCT01394276|565926762|FG000|Overall Study|Remission of disease|2|||
156774671|NCT01394276|565926762|FG000|Overall Study|Insufficient therapeutic effect|17|||
156774672|NCT01394276|565926762|FG000|Overall Study|Insufficient compliance|9|||
156774673|NCT01394276|565926762|FG000|Overall Study|Lost to Follow-up|5|||
156774674|NCT01394276|565926762|FG000|Overall Study|Participant moved to another site|1|||
156774675|NCT01394276|565926762|FG000|Overall Study|Pregnancy|1|||
156774676|NCT01394276|565926762|FG000|Overall Study|unavailability of drug at the Hospital|2|||
156774677|NCT01394276|565926762|FG000|Overall Study|Symptoms of concurrent diseases|1|||
156774678|NCT03507790|565926763|FG000|Overall Study|Adverse Event|0|||
156774679|NCT03507790|565926764|FG001|Overall Study|Adverse Event|11|||
156774680|NCT03507790|565926765|FG002|Overall Study|Adverse Event|3|||
156774681|NCT03507790|565926763|FG000|Overall Study|Withdrawal by Subject|2|||
156774682|NCT03507790|565926764|FG001|Overall Study|Withdrawal by Subject|0|||
156774683|NCT03507790|565926765|FG002|Overall Study|Withdrawal by Subject|0|||
156774684|NCT03507790|565926763|FG000|Overall Study|Subject moved to another location|1|||
156774685|NCT03507790|565926764|FG001|Overall Study|Subject moved to another location|2|||
156774686|NCT03507790|565926765|FG002|Overall Study|Subject moved to another location|0|||
156774687|NCT03507790|565926763|FG000|Overall Study|Non-compliance with study drug|0|||
156774688|NCT03507790|565926764|FG001|Overall Study|Non-compliance with study drug|0|||
156774689|NCT03507790|565926765|FG002|Overall Study|Non-compliance with study drug|1|||
156774690|NCT03507790|565926763|FG000|Overall Study|COVID 19 Pandemic|0|||
156774691|NCT03507790|565926764|FG001|Overall Study|COVID 19 Pandemic|1|||
156774692|NCT03507790|565926765|FG002|Overall Study|COVID 19 Pandemic|0|||
157007807|NCT02189252|566778887|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
157007808|NCT02189252|566778888|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
157007809|NCT02189252|566778889|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
157007810|NCT02189252|566778886|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
157007811|NCT02189252|566778887|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
156774693|NCT03507790|565926763|FG000|Overall Study|Lost to Follow-up|0|||
156774694|NCT03507790|565926764|FG001|Overall Study|Lost to Follow-up|1|||
156774695|NCT03507790|565926765|FG002|Overall Study|Lost to Follow-up|0|||
156774696|NCT03507790|565926763|FG000|Overall Study|Discontinuation of the trial at the site|1|||
156774697|NCT03507790|565926764|FG001|Overall Study|Discontinuation of the trial at the site|1|||
156774698|NCT03507790|565926765|FG002|Overall Study|Discontinuation of the trial at the site|0|||
157007812|NCT02189252|566778888|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
156774699|NCT03507790|565926763|FG000|Overall Study|Randomized in error|0|||
156774700|NCT03507790|565926764|FG001|Overall Study|Randomized in error|0|||
156774701|NCT03507790|565926765|FG002|Overall Study|Randomized in error|1|||
156774702|NCT00157755|565926767|FG000|Overall Study|Death|2|||
156774703|NCT00157755|565926768|FG001|Overall Study|Death|3|||
156774704|NCT00157755|565926769|FG002|Overall Study|Death|3|||
156774705|NCT00157755|565926770|FG003|Overall Study|Death|2|||
156774706|NCT00157755|565926771|FG004|Overall Study|Death|0|||
157208137|NCT01678924|567507961|FG000|Overall Study|Personal Reasons|2|||
157208138|NCT01678924|567507962|FG001|Overall Study|Personal Reasons|2|||
157208139|NCT01678924|567507963|FG002|Overall Study|Personal Reasons|2|||
157208140|NCT01678924|567507964|FG003|Overall Study|Personal Reasons|7|||
157208141|NCT01678924|567507961|FG000|Overall Study|Withdrawal by Subject|0|||
157208142|NCT01678924|567507962|FG001|Overall Study|Withdrawal by Subject|3|||
157208143|NCT01678924|567507963|FG002|Overall Study|Withdrawal by Subject|0|||
157208144|NCT01678924|567507964|FG003|Overall Study|Withdrawal by Subject|2|||
157208145|NCT01678924|567507961|FG000|Overall Study|Unable to attend scheduled visits|0|||
157208146|NCT01678924|567507962|FG001|Overall Study|Unable to attend scheduled visits|0|||
157208147|NCT01678924|567507963|FG002|Overall Study|Unable to attend scheduled visits|0|||
157208148|NCT01678924|567507964|FG003|Overall Study|Unable to attend scheduled visits|1|||
157208149|NCT02576054|567507965|FG000|Overall Study|Withdrawal by Subject|1|||
157208150|NCT00981409|567507972|FG000|Overall Study|Adverse Event|4|||
157208151|NCT00981409|567507973|FG001|Overall Study|Adverse Event|0|||
157208152|NCT00981409|567507972|FG000|Overall Study|Protocol Violation|0|||
157208153|NCT00981409|567507973|FG001|Overall Study|Protocol Violation|1|||
157208154|NCT00981409|567507972|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
157208155|NCT00981409|567507973|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
157208156|NCT03901339|567507976|FG000|Overall Study|Death|220|||
157208157|NCT03901339|567507977|FG001|Overall Study|Death|192|||
157208158|NCT03901339|567507976|FG000|Overall Study|Informed consent withdrawn|13|||
157208159|NCT03901339|567507977|FG001|Overall Study|Informed consent withdrawn|40|||
157208160|NCT03901339|567507976|FG000|Overall Study|Sponsor request|30|||
157208161|NCT03901339|567507977|FG001|Overall Study|Sponsor request|23|||
157208162|NCT03901339|567507976|FG000|Overall Study|Reason not specified|5|||
157208163|NCT03901339|567507977|FG001|Overall Study|Reason not specified|7|||
157208164|NCT03901339|567507976|FG000|Overall Study|Lost to Follow-up|4|||
157208165|NCT03901339|567507977|FG001|Overall Study|Lost to Follow-up|7|||
157208166|NCT03901339|567507976|FG000|Overall Study|Covid19|0|||
157208167|NCT03901339|567507977|FG001|Overall Study|Covid19|2|||
157208168|NCT01071083|567507984|FG000|Overall Study|Adverse Event|1|||
157208169|NCT01071083|567507985|FG001|Overall Study|Adverse Event|0|||
157208170|NCT01071083|567507986|FG002|Overall Study|Adverse Event|1|||
157208171|NCT01071083|567507987|FG003|Overall Study|Adverse Event|0|||
157208172|NCT01071083|567507988|FG004|Overall Study|Adverse Event|1|||
157208173|NCT01071083|567507984|FG000|Overall Study|Withdrawal by Subject|3|||
157208174|NCT01071083|567507985|FG001|Overall Study|Withdrawal by Subject|0|||
157208175|NCT01071083|567507986|FG002|Overall Study|Withdrawal by Subject|2|||
157208176|NCT01071083|567507987|FG003|Overall Study|Withdrawal by Subject|0|||
157208177|NCT01071083|567507988|FG004|Overall Study|Withdrawal by Subject|3|||
157208178|NCT01071083|567507984|FG000|Overall Study|Physician Decision|1|||
157208179|NCT01071083|567507985|FG001|Overall Study|Physician Decision|0|||
157208180|NCT01071083|567507986|FG002|Overall Study|Physician Decision|0|||
157208181|NCT01071083|567507987|FG003|Overall Study|Physician Decision|1|||
157208182|NCT01071083|567507988|FG004|Overall Study|Physician Decision|1|||
157208183|NCT01071083|567507984|FG000|Overall Study|Early Rescue|1|||
157208184|NCT01071083|567507985|FG001|Overall Study|Early Rescue|0|||
157208185|NCT01071083|567507986|FG002|Overall Study|Early Rescue|0|||
157208186|NCT01071083|567507987|FG003|Overall Study|Early Rescue|0|||
157208187|NCT01071083|567507988|FG004|Overall Study|Early Rescue|1|||
157208188|NCT01071083|567507984|FG000|Overall Study|Subject Moved|0|||
157208189|NCT01071083|567507985|FG001|Overall Study|Subject Moved|1|||
157208190|NCT01071083|567507986|FG002|Overall Study|Subject Moved|0|||
157208191|NCT01071083|567507987|FG003|Overall Study|Subject Moved|0|||
157208192|NCT01071083|567507988|FG004|Overall Study|Subject Moved|0|||
157208193|NCT01071083|567507984|FG000|Overall Study|Images Not Usable (Motion)|0|||
157208194|NCT01071083|567507985|FG001|Overall Study|Images Not Usable (Motion)|1|||
156774707|NCT00157755|565926772|FG005|Overall Study|Death|0|||
156774708|NCT00157755|565926767|FG000|Overall Study|Lost to Follow-up|0|||
156774709|NCT00157755|565926768|FG001|Overall Study|Lost to Follow-up|0|||
156774710|NCT00157755|565926769|FG002|Overall Study|Lost to Follow-up|1|||
156774711|NCT00157755|565926770|FG003|Overall Study|Lost to Follow-up|0|||
156774712|NCT00157755|565926771|FG004|Overall Study|Lost to Follow-up|0|||
157208195|NCT01071083|567507986|FG002|Overall Study|Images Not Usable (Motion)|0|||
157208196|NCT01071083|567507987|FG003|Overall Study|Images Not Usable (Motion)|0|||
157208197|NCT01071083|567507988|FG004|Overall Study|Images Not Usable (Motion)|0|||
157208198|NCT01071083|567507984|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
157208199|NCT01071083|567507985|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
157208200|NCT01071083|567507986|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
156774713|NCT00157755|565926772|FG005|Overall Study|Lost to Follow-up|0|||
157208201|NCT01071083|567507987|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
157208202|NCT01071083|567507988|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
156774714|NCT00157755|565926767|FG000|Overall Study|Withdrawal by Subject|0|||
156774715|NCT00157755|565926768|FG001|Overall Study|Withdrawal by Subject|0|||
157208203|NCT01071083|567507984|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
157208204|NCT01071083|567507985|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
157208205|NCT01071083|567507986|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
157113871|NCT00506883|567171787|FG002|Overall Study|Lost to Follow-up|1|||
157113872|NCT00506883|567171785|FG000|Overall Study|Withdrawal by Subject|1|||
157113873|NCT00506883|567171786|FG001|Overall Study|Withdrawal by Subject|0|||
157113874|NCT00506883|567171787|FG002|Overall Study|Withdrawal by Subject|1|||
157113875|NCT00506883|567171785|FG000|Overall Study|Lack of Efficacy|0|||
157113876|NCT00506883|567171786|FG001|Overall Study|Lack of Efficacy|1|||
157113877|NCT00506883|567171787|FG002|Overall Study|Lack of Efficacy|1|||
157113878|NCT00506883|567171785|FG000|Overall Study|Other|5|||
157113879|NCT00506883|567171786|FG001|Overall Study|Other|1|||
157113880|NCT00506883|567171787|FG002|Overall Study|Other|1|||
157113881|NCT00455013|567171788|FG000|Short Term Period|Adverse Event|2|||
157113882|NCT00455013|567171789|FG001|Short Term Period|Adverse Event|5|||
157113883|NCT00455013|567171790|FG002|Short Term Period|Adverse Event|0|||
157113884|NCT00455013|567171788|FG000|Short Term Period|Withdrawal by Subject|0|||
157113885|NCT00455013|567171789|FG001|Short Term Period|Withdrawal by Subject|0|||
157113886|NCT00455013|567171790|FG002|Short Term Period|Withdrawal by Subject|1|||
157113887|NCT00455013|567171788|FG000|Short Term Period|Lack of Efficacy|4|||
157113888|NCT00455013|567171789|FG001|Short Term Period|Lack of Efficacy|0|||
157113889|NCT00455013|567171790|FG002|Short Term Period|Lack of Efficacy|0|||
157113890|NCT00455013|567171788|FG000|Short Term Period|Other|0|||
157113891|NCT00455013|567171789|FG001|Short Term Period|Other|0|||
157113892|NCT00455013|567171790|FG002|Short Term Period|Other|1|||
157113893|NCT00455013|567171788|FG000|Long Term Extension (LTE)|Adverse Event|0|||
157113894|NCT00455013|567171789|FG001|Long Term Extension (LTE)|Adverse Event|1|||
157113895|NCT00455013|567171790|FG002|Long Term Extension (LTE)|Adverse Event|1|||
157113896|NCT00455013|567171788|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
157113897|NCT00455013|567171789|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
157113898|NCT00455013|567171790|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
157113899|NCT00455013|567171788|FG000|Long Term Extension (LTE)|Death|1|||
156774716|NCT00157755|565926769|FG002|Overall Study|Withdrawal by Subject|1|||
156774717|NCT00157755|565926770|FG003|Overall Study|Withdrawal by Subject|1|||
156774718|NCT00157755|565926771|FG004|Overall Study|Withdrawal by Subject|1|||
156774719|NCT00157755|565926772|FG005|Overall Study|Withdrawal by Subject|2|||
156774720|NCT00157755|565926767|FG000|Overall Study|Explant due to infection|0|||
156774721|NCT00157755|565926768|FG001|Overall Study|Explant due to infection|0|||
156774722|NCT00157755|565926769|FG002|Overall Study|Explant due to infection|1|||
156774723|NCT00157755|565926770|FG003|Overall Study|Explant due to infection|0|||
156774724|NCT00157755|565926771|FG004|Overall Study|Explant due to infection|0|||
156774725|NCT00157755|565926772|FG005|Overall Study|Explant due to infection|0|||
156774726|NCT00157755|565926767|FG000|Overall Study|Medical reason|0|||
156774727|NCT00157755|565926768|FG001|Overall Study|Medical reason|0|||
156774728|NCT00157755|565926769|FG002|Overall Study|Medical reason|1|||
156774729|NCT00157755|565926770|FG003|Overall Study|Medical reason|1|||
156774730|NCT00157755|565926771|FG004|Overall Study|Medical reason|0|||
156774731|NCT00157755|565926772|FG005|Overall Study|Medical reason|0|||
156774732|NCT00157755|565926767|FG000|Overall Study|Study site closure|0|||
157007813|NCT02189252|566778889|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
157007814|NCT00566735|566778890|FG000|Overall Study|Withdrawal by Subject|0|||
157007815|NCT00566735|566778891|FG001|Overall Study|Withdrawal by Subject|1|||
157007816|NCT00566735|566778890|FG000|Overall Study|Refused neuropsychological testing|2|||
157007817|NCT00566735|566778891|FG001|Overall Study|Refused neuropsychological testing|5|||
157007818|NCT00566735|566778890|FG000|Overall Study|Switched into a manic episode|0|||
157007819|NCT00566735|566778891|FG001|Overall Study|Switched into a manic episode|1|||
157007820|NCT00465816|566778892|FG000|Overall Study|Lost to Follow-up|0|||
157007821|NCT00465816|566778893|FG001|Overall Study|Lost to Follow-up|0|||
157007822|NCT00465816|566778894|FG002|Overall Study|Lost to Follow-up|2|||
157007823|NCT04480827|566778895|FG000|Overall Study|Adverse Event|0|||
157007824|NCT04480827|566778896|FG001|Overall Study|Adverse Event|0|||
157007825|NCT04480827|566778897|FG002|Overall Study|Adverse Event|0|||
157007826|NCT04480827|566778898|FG003|Overall Study|Adverse Event|0|||
157007827|NCT04480827|566778899|FG004|Overall Study|Adverse Event|0|||
157007828|NCT04480827|566778900|FG005|Overall Study|Adverse Event|1|||
157007829|NCT04480827|566778901|FG006|Overall Study|Adverse Event|0|||
157007830|NCT00818454|566778904|FG000|Treatment Period 1|Adverse Event|0|||
157007831|NCT00818454|566778905|FG001|Treatment Period 1|Adverse Event|1|||
157007832|NCT00818454|566778906|FG002|Treatment Period 1|Adverse Event|0|||
157007833|NCT00818454|566778907|FG003|Treatment Period 1|Adverse Event|0|||
157007834|NCT00818454|566778904|FG000|Treatment Period 1|Other|3|||
157007835|NCT00818454|566778905|FG001|Treatment Period 1|Other|0|||
157007836|NCT00818454|566778906|FG002|Treatment Period 1|Other|0|||
157007837|NCT00818454|566778907|FG003|Treatment Period 1|Other|0|||
157007838|NCT00818454|566778904|FG000|Washout Period of 1 Week|Adverse Event|1|||
157007839|NCT00818454|566778905|FG001|Washout Period of 1 Week|Adverse Event|1|||
157007840|NCT00818454|566778906|FG002|Washout Period of 1 Week|Adverse Event|0|||
157007841|NCT00818454|566778907|FG003|Washout Period of 1 Week|Adverse Event|0|||
157007842|NCT00818454|566778904|FG000|Washout Period of 1 Week|Protocol Violation|2|||
157007843|NCT00818454|566778905|FG001|Washout Period of 1 Week|Protocol Violation|0|||
157007844|NCT00818454|566778906|FG002|Washout Period of 1 Week|Protocol Violation|0|||
157007845|NCT00818454|566778907|FG003|Washout Period of 1 Week|Protocol Violation|0|||
157007846|NCT00818454|566778904|FG000|Washout Period of 1 Week|Other|1|||
157007847|NCT00818454|566778905|FG001|Washout Period of 1 Week|Other|2|||
157007848|NCT00818454|566778906|FG002|Washout Period of 1 Week|Other|0|||
157007849|NCT00818454|566778907|FG003|Washout Period of 1 Week|Other|0|||
157007850|NCT00818454|566778904|FG000|Treatment Period 2|Other|2|||
157007851|NCT00818454|566778905|FG001|Treatment Period 2|Other|1|||
157007852|NCT00818454|566778906|FG002|Treatment Period 2|Other|0|||
157007853|NCT00818454|566778907|FG003|Treatment Period 2|Other|0|||
157007854|NCT00818454|566778904|FG000|Treatment Period 3|Adverse Event|0|||
157007855|NCT00818454|566778905|FG001|Treatment Period 3|Adverse Event|0|||
157007856|NCT00818454|566778906|FG002|Treatment Period 3|Adverse Event|0|||
157007857|NCT00818454|566778907|FG003|Treatment Period 3|Adverse Event|1|||
157007858|NCT03454529|566778910|FG000|Overall Study|Did not receive treatment|6|||
157007859|NCT03454529|566778910|FG000|Overall Study|Received < 80% doses|1|||
157007860|NCT01582100|566778914|FG000|Overall Study|Adverse Event|1|||
157007861|NCT01582100|566778914|FG000|Overall Study|Withdrawal by Subject|1|||
157007862|NCT01040689|566778916|FG000|Overall Study|Adverse Event|0|||
157007863|NCT01040689|566778917|FG001|Overall Study|Adverse Event|0|||
157007864|NCT01040689|566778918|FG002|Overall Study|Adverse Event|2|||
157007865|NCT01040689|566778919|FG003|Overall Study|Adverse Event|4|||
156774733|NCT00157755|565926768|FG001|Overall Study|Study site closure|1|||
156774734|NCT00157755|565926769|FG002|Overall Study|Study site closure|0|||
156774735|NCT00157755|565926770|FG003|Overall Study|Study site closure|0|||
156774736|NCT00157755|565926771|FG004|Overall Study|Study site closure|0|||
156774737|NCT00157755|565926772|FG005|Overall Study|Study site closure|0|||
156774738|NCT00157755|565926767|FG000|Overall Study|Subject non-compliance|0|||
156774739|NCT00157755|565926768|FG001|Overall Study|Subject non-compliance|0|||
156774740|NCT00157755|565926769|FG002|Overall Study|Subject non-compliance|0|||
156774741|NCT00157755|565926770|FG003|Overall Study|Subject non-compliance|0|||
156774742|NCT00157755|565926771|FG004|Overall Study|Subject non-compliance|0|||
156774743|NCT00157755|565926772|FG005|Overall Study|Subject non-compliance|1|||
156774744|NCT00157755|565926767|FG000|Overall Study|Study completion|0|||
156774745|NCT00157755|565926768|FG001|Overall Study|Study completion|0|||
156774746|NCT00157755|565926769|FG002|Overall Study|Study completion|0|||
156774747|NCT00157755|565926770|FG003|Overall Study|Study completion|0|||
156774748|NCT00157755|565926771|FG004|Overall Study|Study completion|1|||
156774749|NCT00157755|565926772|FG005|Overall Study|Study completion|2|||
156774750|NCT01933594|565926773|FG000|Overall Study|Lost to Follow-up|1|||
156774751|NCT01933594|565926774|FG001|Overall Study|Lost to Follow-up|0|||
156774752|NCT01933594|565926775|FG002|Overall Study|Lost to Follow-up|0|||
156774753|NCT01933594|565926776|FG003|Overall Study|Lost to Follow-up|0|||
156774754|NCT01933594|565926777|FG004|Overall Study|Lost to Follow-up|1|||
156774755|NCT01933594|565926778|FG005|Overall Study|Lost to Follow-up|0|||
156774756|NCT01933594|565926773|FG000|Overall Study|Ineligible for subsequent study step|0|||
156774757|NCT01933594|565926774|FG001|Overall Study|Ineligible for subsequent study step|0|||
156774758|NCT01933594|565926775|FG002|Overall Study|Ineligible for subsequent study step|0|||
156774759|NCT01933594|565926776|FG003|Overall Study|Ineligible for subsequent study step|0|||
156774760|NCT01933594|565926777|FG004|Overall Study|Ineligible for subsequent study step|1|||
156774761|NCT01933594|565926778|FG005|Overall Study|Ineligible for subsequent study step|0|||
156774762|NCT03570892|565926789|FG000|Overall Study|Death|51|||
156774763|NCT03570892|565926790|FG001|Overall Study|Death|45|||
156774764|NCT03570892|565926789|FG000|Overall Study|Subject decision|5|||
156774765|NCT03570892|565926790|FG001|Overall Study|Subject decision|3|||
156774766|NCT03570892|565926789|FG000|Overall Study|Protocol Violation|1|||
156774767|NCT03570892|565926790|FG001|Overall Study|Protocol Violation|4|||
156774768|NCT03570892|565926789|FG000|Overall Study|Physician Decision|0|||
156774769|NCT03570892|565926790|FG001|Overall Study|Physician Decision|2|||
156774770|NCT02472405|565928328|FG000|Overall Study|Lost to Follow-up|9|||
156774771|NCT02472405|565928328|FG000|Overall Study|Adverse Event|1|||
156774772|NCT01431976|565928329|FG000|Overall Study|Adverse Event|6|||
156774773|NCT01431976|565928329|FG000|Overall Study|Lack of Efficacy|2|||
156774774|NCT01431976|565928329|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156774775|NCT01431976|565928329|FG000|Overall Study|Physician Decision|1|||
156774776|NCT01431976|565928329|FG000|Overall Study|Withdrawal by Subject|1|||
156774777|NCT01134042|565928336|FG000|Overall Study|Adverse Event|3|||
156774778|NCT01134042|565928337|FG001|Overall Study|Adverse Event|7|||
156774779|NCT01134042|565928338|FG002|Overall Study|Adverse Event|2|||
156774780|NCT01134042|565928336|FG000|Overall Study|Lack of Efficacy|21|||
156774781|NCT01134042|565928337|FG001|Overall Study|Lack of Efficacy|6|||
156774782|NCT01134042|565928338|FG002|Overall Study|Lack of Efficacy|18|||
157113900|NCT00455013|567171789|FG001|Long Term Extension (LTE)|Death|1|||
157113901|NCT00455013|567171790|FG002|Long Term Extension (LTE)|Death|0|||
157113902|NCT00455013|567171788|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
157113903|NCT00455013|567171789|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
157113904|NCT00455013|567171790|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
157113905|NCT00455013|567171788|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
157113906|NCT00455013|567171789|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
157113907|NCT00455013|567171790|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
157113908|NCT00455013|567171788|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
157113909|NCT00455013|567171789|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
156774783|NCT01134042|565928336|FG000|Overall Study|Protocol Violation|5|||
156774784|NCT01134042|565928337|FG001|Overall Study|Protocol Violation|3|||
156774785|NCT01134042|565928338|FG002|Overall Study|Protocol Violation|5|||
156774786|NCT01134042|565928336|FG000|Overall Study|Lost to Follow-up|2|||
157113910|NCT00455013|567171790|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
156774787|NCT01134042|565928337|FG001|Overall Study|Lost to Follow-up|0|||
156774788|NCT01134042|565928338|FG002|Overall Study|Lost to Follow-up|1|||
156774789|NCT01134042|565928336|FG000|Overall Study|Physician Decision|4|||
156774790|NCT01134042|565928337|FG001|Overall Study|Physician Decision|8|||
156774791|NCT01134042|565928338|FG002|Overall Study|Physician Decision|1|||
156774792|NCT01134042|565928336|FG000|Overall Study|Withdrawal by Subject|13|||
156774793|NCT01134042|565928337|FG001|Overall Study|Withdrawal by Subject|4|||
156774794|NCT01134042|565928338|FG002|Overall Study|Withdrawal by Subject|7|||
156774795|NCT03345004|565928339|FG000|Overall Study|Physician Decision|1|||
157113911|NCT00455013|567171788|FG000|Long Term Extension (LTE)|non-specified|0|||
157113912|NCT00455013|567171789|FG001|Long Term Extension (LTE)|non-specified|0|||
156774796|NCT03345004|565928340|FG001|Overall Study|Physician Decision|0|||
156774797|NCT03345004|565928339|FG000|Overall Study|Withdrawal by Subject|0|||
156774798|NCT03345004|565928340|FG001|Overall Study|Withdrawal by Subject|1|||
156774799|NCT01013753|565928343|FG000|Overall Study|Adverse Event|8|||
156774800|NCT01013753|565928343|FG000|Overall Study|Protocol Violation|3|||
156774801|NCT01013753|565928343|FG000|Overall Study|Lost to Follow-up|1|||
156774802|NCT01013753|565928343|FG000|Overall Study|Withdrawal by Subject|2|||
156774803|NCT01013753|565928343|FG000|Overall Study|Other|2|||
156774804|NCT01091259|565928346|FG000|Overall Study|Adverse Event|3|||
156774805|NCT01091259|565928346|FG000|Overall Study|Lack of Efficacy|2|||
156774806|NCT01541748|565928347|FG000|Overall Study|Lost to Follow-up|17|||
156774807|NCT01541748|565928347|FG000|Overall Study|Moved out of state|1|||
156774808|NCT01541748|565928347|FG000|Overall Study|Withdrawal by Subject|7|||
156774809|NCT01541748|565928347|FG000|Overall Study|Screen failure|5|||
156774810|NCT01541748|565928347|FG000|Overall Study|Did not receive study device|1|||
156774811|NCT01283386|565928348|FG000|Overall Study|Death|2|||
156774812|NCT01283386|565928349|FG001|Overall Study|Death|0|||
156774813|NCT01283386|565928348|FG000|Overall Study|Withdrawal by Subject|2|||
156774814|NCT01283386|565928349|FG001|Overall Study|Withdrawal by Subject|1|||
156774815|NCT01283386|565928348|FG000|Overall Study|Relapse of underlying disease|1|||
156774816|NCT01283386|565928349|FG001|Overall Study|Relapse of underlying disease|3|||
156774817|NCT01283386|565928348|FG000|Overall Study|Progression of underlying disease|2|||
156774818|NCT01283386|565928349|FG001|Overall Study|Progression of underlying disease|7|||
157113913|NCT00455013|567171790|FG002|Long Term Extension (LTE)|non-specified|1|||
157113914|NCT00078325|567171791|FG000|Overall Study|Adverse Event|15|||
157113915|NCT00078325|567171792|FG001|Overall Study|Adverse Event|10|||
157113916|NCT00078325|567171793|FG002|Overall Study|Adverse Event|5|||
157113917|NCT00078325|567171791|FG000|Overall Study|Protocol Violation|2|||
157113918|NCT00078325|567171792|FG001|Overall Study|Protocol Violation|2|||
157113919|NCT00078325|567171793|FG002|Overall Study|Protocol Violation|0|||
157113920|NCT00078325|567171791|FG000|Overall Study|Withdrawal by Subject|1|||
157113921|NCT00078325|567171792|FG001|Overall Study|Withdrawal by Subject|5|||
157113922|NCT00078325|567171793|FG002|Overall Study|Withdrawal by Subject|3|||
157113923|NCT00078325|567171791|FG000|Overall Study|Lost to Follow-up|0|||
157113924|NCT00078325|567171792|FG001|Overall Study|Lost to Follow-up|1|||
157113925|NCT00078325|567171793|FG002|Overall Study|Lost to Follow-up|1|||
157113926|NCT00078325|567171791|FG000|Overall Study|Physician Decision|2|||
157113927|NCT00078325|567171792|FG001|Overall Study|Physician Decision|0|||
157113928|NCT00078325|567171793|FG002|Overall Study|Physician Decision|1|||
157113929|NCT00078325|567171791|FG000|Overall Study|Miscellaneous|1|||
157113930|NCT00078325|567171792|FG001|Overall Study|Miscellaneous|1|||
157113931|NCT00078325|567171793|FG002|Overall Study|Miscellaneous|1|||
157113932|NCT00754793|567171797|FG000|Overall Study|voluntary withdrawn from study|0|||
157113933|NCT00754793|567171798|FG001|Overall Study|voluntary withdrawn from study|1|||
157113934|NCT00993265|567171800|FG000|Overall Study|Adverse Event|1|||
157113935|NCT00993265|567171801|FG001|Overall Study|Adverse Event|0|||
157113936|NCT00993265|567171800|FG000|Overall Study|Changed dose of concomitant drug|2|||
157113937|NCT00993265|567171801|FG001|Overall Study|Changed dose of concomitant drug|0|||
157113938|NCT00993265|567171800|FG000|Overall Study|Non-compliant with study medication|1|||
157113939|NCT00993265|567171801|FG001|Overall Study|Non-compliant with study medication|0|||
157113940|NCT05003622|567171802|FG000|Overall Study|Progressive disease|2|||
157113941|NCT05003622|567171802|FG000|Overall Study|Withdrawal by Subject|1|||
157113942|NCT01624662|567171806|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
157113943|NCT01624662|567171807|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
157113944|NCT01624662|567171808|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
157113945|NCT01624662|567171809|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
157113946|NCT01624662|567171806|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
157113947|NCT01624662|567171807|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
157113948|NCT01624662|567171808|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
157113949|NCT01624662|567171809|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
157113950|NCT01624662|567171806|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
157113951|NCT01624662|567171807|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
157113952|NCT01624662|567171808|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
157113953|NCT01624662|567171809|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
157113954|NCT01624662|567171806|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
157113955|NCT01624662|567171807|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
157113956|NCT01624662|567171808|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
157113957|NCT01624662|567171809|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
157113958|NCT01624662|567171806|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
157113959|NCT01624662|567171807|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
156774819|NCT01283386|565928348|FG000|Overall Study|Reason not specified|1|||
156774820|NCT01283386|565928349|FG001|Overall Study|Reason not specified|0|||
156774821|NCT01283386|565928348|FG000|Overall Study|Protocol Violation|0|||
157208206|NCT01071083|567507987|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
157208207|NCT01071083|567507988|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
157208208|NCT01071083|567507984|FG000|Overall Study|Subject Refused to Continue|1|||
157208209|NCT01071083|567507985|FG001|Overall Study|Subject Refused to Continue|0|||
157208210|NCT01071083|567507986|FG002|Overall Study|Subject Refused to Continue|0|||
157208211|NCT01071083|567507987|FG003|Overall Study|Subject Refused to Continue|0|||
157208212|NCT01071083|567507988|FG004|Overall Study|Subject Refused to Continue|0|||
157208213|NCT00038467|567507989|FG000|Overall Study|Adverse Event|170|||
157208214|NCT00038467|567507990|FG001|Overall Study|Adverse Event|145|||
157208215|NCT00038467|567507989|FG000|Overall Study|Withdrawal by Subject|150|||
157208216|NCT00038467|567507990|FG001|Overall Study|Withdrawal by Subject|107|||
157208217|NCT00038467|567507989|FG000|Overall Study|Protocol Violation|19|||
157208218|NCT00038467|567507990|FG001|Overall Study|Protocol Violation|22|||
157208219|NCT00038467|567507989|FG000|Overall Study|Death|22|||
157208220|NCT00038467|567507990|FG001|Overall Study|Death|16|||
157208221|NCT00038467|567507989|FG000|Overall Study|Lost to Follow-up|15|||
157208222|NCT00038467|567507990|FG001|Overall Study|Lost to Follow-up|10|||
157208223|NCT00038467|567507989|FG000|Overall Study|Recurrence|109|||
157208224|NCT00038467|567507990|FG001|Overall Study|Recurrence|179|||
157208225|NCT00038467|567507989|FG000|Overall Study|Randomized, but not treated|31|||
157208226|NCT00038467|567507990|FG001|Overall Study|Randomized, but not treated|35|||
157208227|NCT00038467|567507989|FG000|Overall Study|Other|26|||
157208228|NCT00038467|567507990|FG001|Overall Study|Other|28|||
157208229|NCT04732728|567507991|FG000|Overall Study|Death|12|||
157208230|NCT04732728|567507991|FG000|Overall Study|Withdrawn|136|||
157208231|NCT01339000|567507992|FG000|Overall Study|study closed due to lack of drug supply|1|||
157208232|NCT01339000|567507993|FG001|Overall Study|study closed due to lack of drug supply|0|||
157208233|NCT02017535|567507994|FG000|Overall Study|Withdrawal by Subject|1|||
157208234|NCT02017535|567507995|FG001|Overall Study|Withdrawal by Subject|0|||
157208235|NCT02017535|567507996|FG002|Overall Study|Withdrawal by Subject|0|||
157208236|NCT02017535|567507997|FG003|Overall Study|Withdrawal by Subject|0|||
157208237|NCT05511428|567507998|FG000|Overall Study|Withdrawal by Subject|1|||
157208238|NCT05511428|567507998|FG000|Overall Study|Adverse Event|1|||
157208239|NCT04088734|567507999|FG000|Overall Study|Other, Not Specified|5|||
157208240|NCT03829462|567508000|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
157208241|NCT03829462|567508001|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
157208242|NCT03829462|567508000|FG000|Overall Study|No treatment due to progression disease|0|||
157208243|NCT03829462|567508001|FG001|Overall Study|No treatment due to progression disease|1|||
157208244|NCT03332212|567508006|FG000|Overall Study|Not treated|0|||
157208245|NCT03332212|567508007|FG001|Overall Study|Not treated|1|||
157208246|NCT03332212|567508008|FG002|Overall Study|Not treated|0|||
157208247|NCT03332212|567508009|FG003|Overall Study|Not treated|0|||
157208248|NCT03332212|567508006|FG000|Overall Study|Adverse Event|0|||
157208249|NCT03332212|567508007|FG001|Overall Study|Adverse Event|0|||
157208250|NCT03332212|567508008|FG002|Overall Study|Adverse Event|0|||
157208251|NCT03332212|567508009|FG003|Overall Study|Adverse Event|1|||
157208252|NCT03332212|567508006|FG000|Overall Study|worsening of disease under study|1|||
157208253|NCT03332212|567508007|FG001|Overall Study|worsening of disease under study|1|||
157208254|NCT03332212|567508008|FG002|Overall Study|worsening of disease under study|0|||
157208255|NCT03332212|567508009|FG003|Overall Study|worsening of disease under study|0|||
157208256|NCT02736695|567508011|FG000|Overall Study|Ineligible|6|||
157208257|NCT02736695|567508012|FG001|Overall Study|Ineligible|0|||
157208258|NCT04223193|567508015|FG000|Overall Study|Adverse Event|6|||
157208259|NCT04223193|567508016|FG001|Overall Study|Adverse Event|36|||
157208260|NCT04223193|567508015|FG000|Overall Study|Lack of Efficacy|2|||
157208261|NCT04223193|567508016|FG001|Overall Study|Lack of Efficacy|2|||
157208262|NCT04223193|567508015|FG000|Overall Study|Lost to Follow-up|1|||
157208263|NCT04223193|567508016|FG001|Overall Study|Lost to Follow-up|1|||
157007866|NCT01040689|566778916|FG000|Overall Study|Lack of Efficacy|0|||
157007867|NCT01040689|566778917|FG001|Overall Study|Lack of Efficacy|0|||
157208264|NCT04223193|567508015|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
157208265|NCT04223193|567508016|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
157208266|NCT04223193|567508015|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
157208267|NCT04223193|567508016|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
157208268|NCT04223193|567508015|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157208269|NCT04223193|567508016|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157208270|NCT04223193|567508015|FG000|Overall Study|Physician Decision|0|||
157208271|NCT04223193|567508016|FG001|Overall Study|Physician Decision|1|||
157208272|NCT04223193|567508015|FG000|Overall Study|Protocol Violation|1|||
157208273|NCT04223193|567508016|FG001|Overall Study|Protocol Violation|1|||
157208274|NCT04223193|567508015|FG000|Overall Study|Site Terminated by Sponsor|1|||
157208275|NCT04223193|567508016|FG001|Overall Study|Site Terminated by Sponsor|3|||
157208276|NCT04223193|567508015|FG000|Overall Study|Withdrawal by Subject|5|||
157208277|NCT04223193|567508016|FG001|Overall Study|Withdrawal by Subject|6|||
157208278|NCT04223193|567508015|FG000|Overall Study|Other|3|||
157208279|NCT04223193|567508016|FG001|Overall Study|Other|6|||
157208280|NCT03193190|567508022|FG000|Stage 1|Arm Terminated by Sponsor|0|||
156774822|NCT01283386|565928349|FG001|Overall Study|Protocol Violation|1|||
156774823|NCT00770367|565928350|FG000|First Intervention|Withdrawal by Subject|0|||
156774824|NCT00770367|565928351|FG001|First Intervention|Withdrawal by Subject|2|||
156774825|NCT00770367|565928350|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
156774826|NCT00770367|565928351|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
156774827|NCT00770367|565928350|FG000|Second Intervention|Lost to Follow-up|2|||
156774828|NCT00770367|565928351|FG001|Second Intervention|Lost to Follow-up|0|||
156774829|NCT01898130|565928352|FG000|Treatment|Withdrawal by Subject|2|||
156774830|NCT01898130|565928352|FG000|Treatment|Progressive Disease|4|||
156774831|NCT01898130|565928352|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
156774832|NCT04115059|565928356|FG000|Overall Study|Withdrawal by Subject|1|||
156774833|NCT04115059|565928356|FG000|Overall Study|Lack of Efficacy|2|||
156774834|NCT04491994|565928357|FG000|Overall Study|Withdrawal by Subject|10|||
156774835|NCT04491994|565928358|FG001|Overall Study|Withdrawal by Subject|5|||
156774836|NCT04491994|565928357|FG000|Overall Study|developed fever > 3 days|4|||
156774837|NCT04491994|565928358|FG001|Overall Study|developed fever > 3 days|1|||
156774838|NCT04491994|565928357|FG000|Overall Study|Protocol Violation|11|||
156774839|NCT04491994|565928358|FG001|Overall Study|Protocol Violation|2|||
156774840|NCT04491994|565928357|FG000|Overall Study|Lost to Follow-up|4|||
156774841|NCT04491994|565928358|FG001|Overall Study|Lost to Follow-up|3|||
156774842|NCT02567188|565928364|FG000|Overall Study|Death|10|||
156774843|NCT02567188|565928364|FG000|Overall Study|Terminated Mircera Treatment|9|||
156774844|NCT02567188|565928364|FG000|Overall Study|Lost to Follow-up|5|||
156774845|NCT02567188|565928364|FG000|Overall Study|Adverse Event|1|||
156774846|NCT02567188|565928364|FG000|Overall Study|Withdrawal by Subject|1|||
156774847|NCT02567188|565928364|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
156774848|NCT02567188|565928364|FG000|Overall Study|Moved and Changed Clinic|1|||
156774849|NCT02567188|565928364|FG000|Overall Study|Started Hemodialysis|2|||
156774850|NCT02567188|565928364|FG000|Overall Study|Protocol Violation|5|||
156774851|NCT01033136|565928365|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
156774852|NCT01033136|565928366|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
156774853|NCT05383209|565928367|FG000|Overall Study|Adverse Event: Non-ocular|0|||
156774854|NCT05383209|565928368|FG001|Overall Study|Adverse Event: Non-ocular|1|||
156774855|NCT05383209|565928369|FG002|Overall Study|Adverse Event: Non-ocular|0|||
156774856|NCT05383209|565928367|FG000|Overall Study|Lost to Follow-up|2|||
156774857|NCT05383209|565928368|FG001|Overall Study|Lost to Follow-up|1|||
156774858|NCT05383209|565928369|FG002|Overall Study|Lost to Follow-up|4|||
156774859|NCT05383209|565928367|FG000|Overall Study|Withdrawal by Subject|2|||
156774860|NCT05383209|565928368|FG001|Overall Study|Withdrawal by Subject|0|||
157007868|NCT01040689|566778918|FG002|Overall Study|Lack of Efficacy|1|||
157007869|NCT01040689|566778919|FG003|Overall Study|Lack of Efficacy|0|||
157007870|NCT01040689|566778916|FG000|Overall Study|Lost to Follow-up|1|||
157007871|NCT01040689|566778917|FG001|Overall Study|Lost to Follow-up|0|||
157007872|NCT01040689|566778918|FG002|Overall Study|Lost to Follow-up|0|||
157007873|NCT01040689|566778919|FG003|Overall Study|Lost to Follow-up|0|||
157007874|NCT01040689|566778916|FG000|Overall Study|Withdrawal by Subject|2|||
157007875|NCT01040689|566778917|FG001|Overall Study|Withdrawal by Subject|1|||
157007876|NCT01040689|566778918|FG002|Overall Study|Withdrawal by Subject|1|||
157007877|NCT01040689|566778919|FG003|Overall Study|Withdrawal by Subject|0|||
157007878|NCT01040689|566778916|FG000|Overall Study|Other reasons not listed above|0|||
157007879|NCT01040689|566778917|FG001|Overall Study|Other reasons not listed above|1|||
157007880|NCT01040689|566778918|FG002|Overall Study|Other reasons not listed above|0|||
157007881|NCT01040689|566778919|FG003|Overall Study|Other reasons not listed above|0|||
157007882|NCT05876949|566778920|FG000|Overall Study|Withdrawal by Subject|1|||
157007883|NCT05876949|566778921|FG001|Overall Study|Withdrawal by Subject|3|||
157007884|NCT05876949|566778920|FG000|Overall Study|Physician Decision|0|||
157007885|NCT05876949|566778921|FG001|Overall Study|Physician Decision|2|||
157007886|NCT05876949|566778920|FG000|Overall Study|Death|0|||
157007887|NCT05876949|566778921|FG001|Overall Study|Death|1|||
157007888|NCT00508924|566778922|FG000|Overall Study|Protocol Violation|0|||
157007889|NCT00508924|566778923|FG001|Overall Study|Protocol Violation|0|||
157007890|NCT00508924|566778924|FG002|Overall Study|Protocol Violation|1|||
157007891|NCT00508924|566778925|FG003|Overall Study|Protocol Violation|1|||
157007892|NCT02755805|566778926|FG000|Overall Study|Lost to Follow-up|1|||
157007893|NCT02755805|566778927|FG001|Overall Study|Lost to Follow-up|2|||
157007894|NCT02755805|566778926|FG000|Overall Study|Refused assessments|1|||
157007895|NCT02755805|566778927|FG001|Overall Study|Refused assessments|0|||
157007896|NCT02755805|566778926|FG000|Overall Study|Withdrawal by Subject|0|||
157007897|NCT02755805|566778927|FG001|Overall Study|Withdrawal by Subject|2|||
157007898|NCT03718767|566778933|FG000|Overall Study|Declined to participate (before treatment started)|0|||
157007899|NCT03718767|566778934|FG001|Overall Study|Declined to participate (before treatment started)|0|||
157007900|NCT03718767|566778935|FG002|Overall Study|Declined to participate (before treatment started)|7|||
157007901|NCT03718767|566778933|FG000|Overall Study|Ineligible|0|||
157007902|NCT03718767|566778934|FG001|Overall Study|Ineligible|0|||
156774861|NCT05383209|565928369|FG002|Overall Study|Withdrawal by Subject|1|||
156774862|NCT05383209|565928367|FG000|Overall Study|Death|1|||
156774863|NCT05383209|565928368|FG001|Overall Study|Death|0|||
156774864|NCT05383209|565928369|FG002|Overall Study|Death|0|||
156774865|NCT05383209|565928367|FG000|Overall Study|Other|0|||
156774866|NCT05383209|565928368|FG001|Overall Study|Other|1|||
156774867|NCT05383209|565928369|FG002|Overall Study|Other|0|||
156774868|NCT00717886|565928370|FG000|Overall Study|Withdrawal by Subject|3|||
156774869|NCT00717886|565928370|FG000|Overall Study|Treatment Failure|1|||
156774870|NCT01553851|565928371|FG000|Overall Study|Adverse Event|2|||
156774871|NCT01553851|565928371|FG000|Overall Study|constipation|1|||
156774872|NCT02472353|565928374|FG000|Overall Study|Lost to Follow-up|1|||
156774873|NCT02472353|565928375|FG001|Overall Study|Lost to Follow-up|1|||
156774874|NCT02472353|565928374|FG000|Overall Study|Withdrawal by Subject|2|||
156774875|NCT02472353|565928375|FG001|Overall Study|Withdrawal by Subject|1|||
156774876|NCT02472353|565928374|FG000|Overall Study|Study Termination|1|||
156774877|NCT02472353|565928375|FG001|Overall Study|Study Termination|4|||
156774878|NCT02101294|565928376|FG000|Overall Study|Withdrawal by Subject|5|||
156774879|NCT02101294|565928376|FG000|Overall Study|Lost to Follow-up|6|||
156774880|NCT02313155|565928381|FG000|Overall Study|Lost to Follow-up|0|||
156774881|NCT02313155|565928382|FG001|Overall Study|Lost to Follow-up|1|||
156774882|NCT00688597|565928386|FG000|Overall Study|Adverse Event|2|||
156774883|NCT00688597|565928387|FG001|Overall Study|Adverse Event|0|||
156774884|NCT00688597|565928388|FG002|Overall Study|Adverse Event|0|||
156774885|NCT00688597|565928386|FG000|Overall Study|Physician Decision|1|||
156774886|NCT00688597|565928387|FG001|Overall Study|Physician Decision|0|||
156774887|NCT00688597|565928388|FG002|Overall Study|Physician Decision|0|||
156774888|NCT02709369|565928389|FG000|Overall Study|Lost to Follow-up|15|||
156774889|NCT02709369|565928389|FG000|Overall Study|Withdrawal by Subject|10|||
156774890|NCT02709369|565928389|FG000|Overall Study|Did not received intervention|2|||
156774891|NCT02755090|565928390|FG000|Overall Study|equipment malfunction|1|||
156774892|NCT02755090|565928391|FG001|Overall Study|equipment malfunction|0|||
156774893|NCT00207740|565928392|FG000|Overall Study|Adverse Event|4|||
156774894|NCT00207740|565928393|FG001|Overall Study|Adverse Event|14|||
156774895|NCT00207740|565928394|FG002|Overall Study|Adverse Event|14|||
156774896|NCT00207740|565928395|FG003|Overall Study|Adverse Event|11|||
156774897|NCT00207740|565928392|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156774898|NCT00207740|565928393|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156774899|NCT00207740|565928394|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156774900|NCT00207740|565928395|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
156774901|NCT00207740|565928392|FG000|Overall Study|Lost to Follow-up|0|||
156774902|NCT00207740|565928393|FG001|Overall Study|Lost to Follow-up|2|||
156774903|NCT00207740|565928394|FG002|Overall Study|Lost to Follow-up|1|||
156774904|NCT00207740|565928395|FG003|Overall Study|Lost to Follow-up|1|||
156774905|NCT00207740|565928392|FG000|Overall Study|Death|0|||
156774906|NCT00207740|565928393|FG001|Overall Study|Death|0|||
156774907|NCT00207740|565928394|FG002|Overall Study|Death|0|||
156774908|NCT00207740|565928395|FG003|Overall Study|Death|1|||
156774909|NCT00207740|565928392|FG000|Overall Study|Sponsor Directive|22|||
156774910|NCT00207740|565928393|FG001|Overall Study|Sponsor Directive|15|||
156774911|NCT00207740|565928394|FG002|Overall Study|Sponsor Directive|16|||
156774912|NCT00207740|565928395|FG003|Overall Study|Sponsor Directive|21|||
156774913|NCT00207740|565928392|FG000|Overall Study|Other|2|||
156774914|NCT00207740|565928393|FG001|Overall Study|Other|10|||
156774915|NCT00207740|565928394|FG002|Overall Study|Other|7|||
156774916|NCT00207740|565928395|FG003|Overall Study|Other|5|||
156774917|NCT04797169|565928396|FG000|Overall Study|Lost to Follow-up|84|||
156774918|NCT04797169|565928397|FG001|Overall Study|Lost to Follow-up|67|||
156774919|NCT04797169|565928396|FG000|Overall Study|Pregnancy|1|||
156774920|NCT04797169|565928397|FG001|Overall Study|Pregnancy|3|||
156774921|NCT04797169|565928396|FG000|Overall Study|Withdrawal by Subject|27|||
156774922|NCT04797169|565928397|FG001|Overall Study|Withdrawal by Subject|35|||
157007903|NCT03718767|566778935|FG002|Overall Study|Ineligible|17|||
156774923|NCT03916926|565928398|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
156774924|NCT03916926|565928399|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
156774925|NCT03916926|565928398|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
156774926|NCT03916926|565928399|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
156774927|NCT03916926|565928398|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
156774928|NCT03916926|565928399|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
156774929|NCT03916926|565928398|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
156774930|NCT03916926|565928399|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
156774931|NCT02763566|565928400|FG000|Overall Study|Lost to Follow-up|1|||
156774932|NCT02763566|565928401|FG001|Overall Study|Lost to Follow-up|4|||
156774933|NCT02763566|565928402|FG002|Overall Study|Lost to Follow-up|0|||
156774934|NCT02763566|565928403|FG003|Overall Study|Lost to Follow-up|1|||
156774935|NCT02763566|565928400|FG000|Overall Study|On study treatment at study conclusion|114|||
156774936|NCT02763566|565928401|FG001|Overall Study|On study treatment at study conclusion|34|||
156774937|NCT02763566|565928402|FG002|Overall Study|On study treatment at study conclusion|54|||
156774938|NCT02763566|565928403|FG003|Overall Study|On study treatment at study conclusion|13|||
156774939|NCT02763566|565928400|FG000|Overall Study|Withdrawal by Subject|3|||
156774940|NCT02763566|565928401|FG001|Overall Study|Withdrawal by Subject|1|||
156774941|NCT02763566|565928402|FG002|Overall Study|Withdrawal by Subject|0|||
156774942|NCT02763566|565928403|FG003|Overall Study|Withdrawal by Subject|0|||
156774943|NCT04530344|565928404|FG000|Overall Study|Lost to Follow-up|3|||
156774944|NCT04530344|565928405|FG001|Overall Study|Lost to Follow-up|3|||
156774945|NCT04530344|565928406|FG002|Overall Study|Lost to Follow-up|3|||
156774946|NCT04530344|565928407|FG003|Overall Study|Lost to Follow-up|10|||
156774947|NCT04530344|565928404|FG000|Overall Study|Withdrawal by Subject|14|||
156774948|NCT04530344|565928405|FG001|Overall Study|Withdrawal by Subject|5|||
156774949|NCT04530344|565928406|FG002|Overall Study|Withdrawal by Subject|18|||
156774950|NCT04530344|565928407|FG003|Overall Study|Withdrawal by Subject|33|||
156774951|NCT04530344|565928404|FG000|Overall Study|Adverse Event|0|||
156774952|NCT04530344|565928405|FG001|Overall Study|Adverse Event|0|||
156774953|NCT04530344|565928406|FG002|Overall Study|Adverse Event|0|||
156774954|NCT04530344|565928407|FG003|Overall Study|Adverse Event|1|||
156774955|NCT04530344|565928404|FG000|Overall Study|Lack of Efficacy|0|||
156774956|NCT04530344|565928405|FG001|Overall Study|Lack of Efficacy|0|||
156774957|NCT04530344|565928406|FG002|Overall Study|Lack of Efficacy|0|||
156774958|NCT04530344|565928407|FG003|Overall Study|Lack of Efficacy|1|||
156774959|NCT04530344|565928404|FG000|Overall Study|Physician Decision|0|||
156774960|NCT04530344|565928405|FG001|Overall Study|Physician Decision|0|||
156774961|NCT04530344|565928406|FG002|Overall Study|Physician Decision|1|||
156774962|NCT04530344|565928407|FG003|Overall Study|Physician Decision|1|||
156774963|NCT04530344|565928404|FG000|Overall Study|Pregnancy|0|||
156774964|NCT04530344|565928405|FG001|Overall Study|Pregnancy|0|||
156774965|NCT04530344|565928406|FG002|Overall Study|Pregnancy|2|||
156774966|NCT04530344|565928407|FG003|Overall Study|Pregnancy|1|||
156774967|NCT04530344|565928404|FG000|Overall Study|Protocol Violation|0|||
156774968|NCT04530344|565928405|FG001|Overall Study|Protocol Violation|0|||
156774969|NCT04530344|565928406|FG002|Overall Study|Protocol Violation|0|||
156774970|NCT04530344|565928407|FG003|Overall Study|Protocol Violation|1|||
156774971|NCT04530344|565928404|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
157113960|NCT01624662|567171808|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
157113961|NCT01624662|567171809|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
157113962|NCT01624662|567171806|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156774972|NCT04530344|565928405|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
156774973|NCT04530344|565928406|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
156774974|NCT04530344|565928407|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
156774975|NCT04530344|565928404|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774976|NCT04530344|565928405|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774977|NCT04530344|565928406|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
157113963|NCT01624662|567171807|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
156774978|NCT04530344|565928407|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
156774979|NCT04530344|565928404|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
156774980|NCT04530344|565928405|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
156774981|NCT04530344|565928406|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
156774982|NCT04530344|565928407|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
156774983|NCT04530344|565928404|FG000|Overall Study|Personal Reasons|0|||
156774984|NCT04530344|565928405|FG001|Overall Study|Personal Reasons|0|||
156774985|NCT04530344|565928406|FG002|Overall Study|Personal Reasons|0|||
156774986|NCT04530344|565928407|FG003|Overall Study|Personal Reasons|1|||
156774987|NCT04530344|565928404|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774988|NCT04530344|565928405|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774989|NCT04530344|565928406|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
156774990|NCT04530344|565928407|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
156774991|NCT01402700|565928408|FG000|Overall Study|Death|3|||
156774992|NCT01402700|565928408|FG000|Overall Study|Withdrawal by Subject|3|||
156774993|NCT01402700|565928408|FG000|Overall Study|Missed Visit|1|||
156774994|NCT05352399|565928420|FG000|Overall Study|Discontinued intervention|6|||
156774995|NCT02657551|565928421|FG000|Overall Study|Adverse Event|2|||
156774996|NCT02657551|565928421|FG000|Overall Study|Withdrawal by Subject|1|||
156774997|NCT02657551|565928421|FG000|Overall Study|Non-Compliance|1|||
156774998|NCT02657551|565928421|FG000|Overall Study|Progression / Relapse|4|||
156774999|NCT04058717|565928422|FG000|Randomization Period|Lost to Follow-up|2|||
156775000|NCT04058717|565928423|FG001|Randomization Period|Lost to Follow-up|3|||
156775001|NCT04058717|565928424|FG002|Randomization Period|Lost to Follow-up|4|||
156775002|NCT04058717|565928425|FG003|Randomization Period|Lost to Follow-up|4|||
156775003|NCT04058717|565928422|FG000|Randomization Period|Withdrawal by Subject|1|||
156775004|NCT04058717|565928423|FG001|Randomization Period|Withdrawal by Subject|3|||
156775005|NCT04058717|565928424|FG002|Randomization Period|Withdrawal by Subject|3|||
156775006|NCT04058717|565928425|FG003|Randomization Period|Withdrawal by Subject|3|||
156775007|NCT04058717|565928422|FG000|Randomization Period|PI decision|0|||
156775008|NCT04058717|565928423|FG001|Randomization Period|PI decision|1|||
156775009|NCT04058717|565928424|FG002|Randomization Period|PI decision|0|||
156775010|NCT04058717|565928425|FG003|Randomization Period|PI decision|0|||
156775011|NCT04770779|565928427|FG000|Overall Study|Randomized, never treated|0|||
156775012|NCT04770779|565928428|FG001|Overall Study|Randomized, never treated|1|||
156775013|NCT04770779|565928427|FG000|Overall Study|Adverse Event|9|||
156775014|NCT04770779|565928428|FG001|Overall Study|Adverse Event|1|||
156775015|NCT04770779|565928427|FG000|Overall Study|Withdrawal by Subject|7|||
156775016|NCT04770779|565928428|FG001|Overall Study|Withdrawal by Subject|1|||
156775017|NCT04770779|565928427|FG000|Overall Study|Pregnancy|0|||
156775018|NCT04770779|565928428|FG001|Overall Study|Pregnancy|1|||
156775019|NCT02799602|565928429|FG000|Overall Study|Protocol Violation|1|||
156775020|NCT02799602|565928430|FG001|Overall Study|Protocol Violation|0|||
156775021|NCT02799602|565928429|FG000|Overall Study|Physician Decision|5|||
156775022|NCT02799602|565928430|FG001|Overall Study|Physician Decision|6|||
156775023|NCT02799602|565928429|FG000|Overall Study|Lost to Follow-up|4|||
156775024|NCT02799602|565928430|FG001|Overall Study|Lost to Follow-up|2|||
156775025|NCT02799602|565928429|FG000|Overall Study|Additional primary malignancy|11|||
156775026|NCT02799602|565928430|FG001|Overall Study|Additional primary malignancy|6|||
156775027|NCT02799602|565928429|FG000|Overall Study|Non-compliance with study drug|14|||
156775028|NCT02799602|565928430|FG001|Overall Study|Non-compliance with study drug|12|||
156775029|NCT02799602|565928429|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
156775030|NCT02799602|565928430|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
156775031|NCT02799602|565928429|FG000|Overall Study|Withdrawal by Subject|26|||
156775032|NCT02799602|565928430|FG001|Overall Study|Withdrawal by Subject|40|||
156775033|NCT02799602|565928429|FG000|Overall Study|Progressive disease - clinical progression|131|||
156775034|NCT02799602|565928430|FG001|Overall Study|Progressive disease - clinical progression|276|||
156775035|NCT02799602|565928429|FG000|Overall Study|Progressive disease - radiological progression|90|||
156775036|NCT02799602|565928430|FG001|Overall Study|Progressive disease - radiological progression|133|||
156775037|NCT02799602|565928429|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
156775038|NCT02799602|565928430|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
156775039|NCT02799602|565928429|FG000|Overall Study|Death|9|||
156775040|NCT02799602|565928430|FG001|Overall Study|Death|5|||
156775041|NCT02799602|565928429|FG000|Overall Study|Other|287|||
157007904|NCT00494442|566778936|FG000|Overall Study|Death|1|||
156775042|NCT02799602|565928430|FG001|Overall Study|Other|118|||
156775043|NCT02799602|565928429|FG000|Overall Study|Study drug never administered|0|||
156775044|NCT02799602|565928430|FG001|Overall Study|Study drug never administered|3|||
156775045|NCT00596635|565928439|FG000|Overall Study|Lost to Follow-up|0|||
156775046|NCT00596635|565928440|FG001|Overall Study|Lost to Follow-up|2|||
156775047|NCT00596635|565928441|FG002|Overall Study|Lost to Follow-up|0|||
156775048|NCT00596635|565928439|FG000|Overall Study|Treatment for symptomatic UTI|4|||
156775049|NCT00596635|565928440|FG001|Overall Study|Treatment for symptomatic UTI|6|||
157007905|NCT00494442|566778937|FG001|Overall Study|Death|1|||
157007906|NCT00494442|566778936|FG000|Overall Study|Lack of Efficacy|16|||
156775050|NCT00596635|565928441|FG002|Overall Study|Treatment for symptomatic UTI|3|||
156775051|NCT00596635|565928439|FG000|Overall Study|Hip fracture|2|||
157007907|NCT00494442|566778937|FG001|Overall Study|Lack of Efficacy|10|||
157007908|NCT00494442|566778936|FG000|Overall Study|Adverse Event|0|||
157007909|NCT00494442|566778937|FG001|Overall Study|Adverse Event|2|||
156775052|NCT00596635|565928440|FG001|Overall Study|Hip fracture|3|||
156775053|NCT00596635|565928441|FG002|Overall Study|Hip fracture|3|||
156775054|NCT00596635|565928439|FG000|Overall Study|Could not provide urine specimen|1|||
156775055|NCT00596635|565928440|FG001|Overall Study|Could not provide urine specimen|2|||
156775056|NCT00596635|565928441|FG002|Overall Study|Could not provide urine specimen|2|||
156775057|NCT01850641|565928444|FG000|Overall Study|Physician Decision|1|||
156775058|NCT01850641|565928444|FG000|Overall Study|Decrease in serum phosphorus|1|||
156775059|NCT01850641|565928444|FG000|Overall Study|Decrease in serum calcium|2|||
156775060|NCT01850641|565928444|FG000|Overall Study|Increase in serum ferritin|1|||
156775061|NCT00846365|565928445|FG000|Overall Study|Adverse Event|20|||
156775062|NCT00846365|565928446|FG001|Overall Study|Adverse Event|30|||
156775063|NCT00846365|565928447|FG002|Overall Study|Adverse Event|11|||
156775064|NCT00846365|565928445|FG000|Overall Study|Protocol Violation|5|||
156775065|NCT00846365|565928446|FG001|Overall Study|Protocol Violation|4|||
156775066|NCT00846365|565928447|FG002|Overall Study|Protocol Violation|0|||
156775067|NCT00846365|565928445|FG000|Overall Study|Lost to Follow-up|8|||
156775068|NCT00846365|565928446|FG001|Overall Study|Lost to Follow-up|2|||
156775069|NCT00846365|565928447|FG002|Overall Study|Lost to Follow-up|5|||
156775070|NCT00846365|565928445|FG000|Overall Study|Withdrawal by Subject|11|||
156775071|NCT00846365|565928446|FG001|Overall Study|Withdrawal by Subject|11|||
156775072|NCT00846365|565928447|FG002|Overall Study|Withdrawal by Subject|9|||
156775073|NCT00846365|565928445|FG000|Overall Study|Pregnancy|1|||
156775074|NCT00846365|565928446|FG001|Overall Study|Pregnancy|0|||
156775075|NCT00846365|565928447|FG002|Overall Study|Pregnancy|0|||
156775076|NCT00846365|565928445|FG000|Overall Study|Lack of Efficacy|1|||
156775077|NCT00846365|565928446|FG001|Overall Study|Lack of Efficacy|1|||
156775078|NCT00846365|565928447|FG002|Overall Study|Lack of Efficacy|2|||
156775079|NCT00846365|565928445|FG000|Overall Study|Other|9|||
156775080|NCT00846365|565928446|FG001|Overall Study|Other|1|||
156775081|NCT00846365|565928447|FG002|Overall Study|Other|6|||
156775082|NCT05032196|565928449|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775083|NCT05032196|565928450|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
156775084|NCT05032196|565928451|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775085|NCT05032196|565928452|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775086|NCT05032196|565928453|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775087|NCT05032196|565928454|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
156775088|NCT05032196|565928449|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775089|NCT05032196|565928450|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775090|NCT05032196|565928451|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775091|NCT05032196|565928452|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
156775092|NCT05032196|565928453|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775093|NCT05032196|565928454|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
156775094|NCT05032196|565928449|FG000|Period 2 (Multidose)|Physician Decision|0|||
156775095|NCT05032196|565928450|FG001|Period 2 (Multidose)|Physician Decision|0|||
156775096|NCT05032196|565928451|FG002|Period 2 (Multidose)|Physician Decision|0|||
156775097|NCT05032196|565928452|FG003|Period 2 (Multidose)|Physician Decision|0|||
156775098|NCT05032196|565928453|FG004|Period 2 (Multidose)|Physician Decision|1|||
156775099|NCT05032196|565928454|FG005|Period 2 (Multidose)|Physician Decision|0|||
156775100|NCT05260008|565928455|FG000|Overall Study|Physician Decision|0|||
156775101|NCT05260008|565928456|FG001|Overall Study|Physician Decision|1|||
156775102|NCT05260008|565928457|FG002|Overall Study|Physician Decision|0|||
156775103|NCT05260008|565928458|FG003|Overall Study|Physician Decision|0|||
156775104|NCT04817410|565929820|FG000|Overall Study|Withdrawal by Subject|5|||
156775105|NCT04817410|565929820|FG000|Overall Study|Physician Decision|3|||
156775106|NCT03595748|565929821|FG000|Overall Study|Death|11|||
156775107|NCT03595748|565929822|FG001|Overall Study|Death|12|||
156775108|NCT03595748|565929821|FG000|Overall Study|Withdrawal by Subject|28|||
156775109|NCT03595748|565929822|FG001|Overall Study|Withdrawal by Subject|29|||
156775110|NCT03595748|565929821|FG000|Overall Study|Protocol Violation|0|||
156775111|NCT03595748|565929822|FG001|Overall Study|Protocol Violation|1|||
156775112|NCT04809974|565929823|FG000|Lead-in Phase|Withdrawal by Subject|3|||
156775113|NCT04809974|565929824|FG001|Lead-in Phase|Withdrawal by Subject|0|||
156775114|NCT04809974|565929825|FG002|Lead-in Phase|Withdrawal by Subject|0|||
156775115|NCT04809974|565929823|FG000|Lead-in Phase|No longer eligible|11|||
156775116|NCT04809974|565929824|FG001|Lead-in Phase|No longer eligible|0|||
156775117|NCT04809974|565929825|FG002|Lead-in Phase|No longer eligible|0|||
156775118|NCT04809974|565929823|FG000|Randomized Phase|Lost to Follow-up|0|||
156775119|NCT04809974|565929824|FG001|Randomized Phase|Lost to Follow-up|1|||
156775120|NCT04809974|565929825|FG002|Randomized Phase|Lost to Follow-up|5|||
156775121|NCT04809974|565929823|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
156775122|NCT04809974|565929824|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
156775123|NCT04809974|565929825|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
156775124|NCT04809974|565929823|FG000|Randomized Phase|Adverse Event|0|||
156775125|NCT04809974|565929824|FG001|Randomized Phase|Adverse Event|1|||
156775126|NCT04809974|565929825|FG002|Randomized Phase|Adverse Event|4|||
156775127|NCT04809974|565929823|FG000|Randomized Phase|Withdrawal by Subject|0|||
156775128|NCT04809974|565929824|FG001|Randomized Phase|Withdrawal by Subject|0|||
156775129|NCT04809974|565929825|FG002|Randomized Phase|Withdrawal by Subject|5|||
156775130|NCT00549055|565929834|FG000|Overall Study|Adverse Event|4|||
156775131|NCT00549055|565929834|FG000|Overall Study|Lack of Efficacy|18|||
156775132|NCT00549055|565929834|FG000|Overall Study|Stabilization|5|||
156775133|NCT00549055|565929834|FG000|Overall Study|Progression to fibrosis|2|||
156775134|NCT00549055|565929834|FG000|Overall Study|Decrease of size|1|||
156775135|NCT00549055|565929834|FG000|Overall Study|Active choroidal neovascula increased|1|||
156775136|NCT00549055|565929834|FG000|Overall Study|Vitreous hemorrhage|1|||
156775137|NCT00549055|565929834|FG000|Overall Study|Growth choroidal neovascularisation|1|||
156775138|NCT00549055|565929834|FG000|Overall Study|Choroidal neovascularization|1|||
156775139|NCT00549055|565929834|FG000|Overall Study|Very low visual acuity (VA)|1|||
156775140|NCT01240746|565929835|FG000|Overall Study|Adverse Event|2|||
156775141|NCT01240746|565929836|FG001|Overall Study|Adverse Event|0|||
156775142|NCT01240746|565929837|FG002|Overall Study|Adverse Event|10|||
156775143|NCT01240746|565929835|FG000|Overall Study|Lost to Follow-up|23|||
156775144|NCT01240746|565929836|FG001|Overall Study|Lost to Follow-up|20|||
156775145|NCT01240746|565929837|FG002|Overall Study|Lost to Follow-up|102|||
156775146|NCT01240746|565929835|FG000|Overall Study|Protocol Violation|24|||
156775147|NCT01240746|565929836|FG001|Overall Study|Protocol Violation|15|||
156775148|NCT01240746|565929837|FG002|Overall Study|Protocol Violation|72|||
156775149|NCT01240746|565929835|FG000|Overall Study|Withdrawal by Subject|10|||
156775150|NCT01240746|565929836|FG001|Overall Study|Withdrawal by Subject|13|||
156775151|NCT01240746|565929837|FG002|Overall Study|Withdrawal by Subject|59|||
156775152|NCT00764517|565929842|FG000|Overall Study|Adverse Event|9|||
156775153|NCT00764517|565929843|FG001|Overall Study|Adverse Event|3|||
156775154|NCT00764517|565929842|FG000|Overall Study|Death|3|||
156775155|NCT00764517|565929843|FG001|Overall Study|Death|11|||
156775156|NCT00764517|565929842|FG000|Overall Study|Physician Decision|3|||
156775157|NCT00764517|565929843|FG001|Overall Study|Physician Decision|0|||
156775158|NCT01137786|565929851|FG000|Overall Study|Lost to Follow-up|0|||
156775159|NCT01137786|565929852|FG001|Overall Study|Lost to Follow-up|2|||
156775160|NCT01137786|565929851|FG000|Overall Study|Withdrawal by Subject|1|||
156775161|NCT01137786|565929852|FG001|Overall Study|Withdrawal by Subject|1|||
156775162|NCT03331562|565929853|FG000|Overall Study|Adverse Event|2|||
156775163|NCT03331562|565929854|FG001|Overall Study|Adverse Event|0|||
156775164|NCT03331562|565929853|FG000|Overall Study|Death|1|||
156775165|NCT03331562|565929854|FG001|Overall Study|Death|0|||
156775166|NCT03718000|565929862|FG000|Overall Study|Relocation|2|||
156775167|NCT03718000|565929863|FG001|Overall Study|Relocation|4|||
156775168|NCT03718000|565929862|FG000|Overall Study|Pregnancy|0|||
156775169|NCT03718000|565929863|FG001|Overall Study|Pregnancy|1|||
156775170|NCT03517137|565929864|FG000|Overall Study|Lack of Efficacy|1|||
156775171|NCT03517137|565929864|FG000|Overall Study|Adverse Event|2|||
156775172|NCT03517137|565929864|FG000|Overall Study|Withdrawal by Subject|2|||
156775173|NCT03517137|565929864|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
156775174|NCT03575364|565929865|FG000|Overall Study|Death|45|||
156775175|NCT03575364|565929865|FG000|Overall Study|Lost to Follow-up|114|||
156775176|NCT03575364|565929865|FG000|Overall Study|Withdrawal by Subject|21|||
156775177|NCT03575364|565929865|FG000|Overall Study|Physician Decision|11|||
156775178|NCT03575364|565929865|FG000|Overall Study|Subject Refused Follow-up|13|||
156775179|NCT03575364|565929865|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
156775180|NCT03575364|565929865|FG000|Overall Study|Patient moved out of the state|1|||
156775181|NCT03575364|565929865|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
156775182|NCT03575364|565929865|FG000|Overall Study|Patient is lost to follow up|1|||
156775183|NCT03575364|565929865|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
156775184|NCT00716417|565929866|FG000|Overall Study|Adverse Event|0|||
156775185|NCT00716417|565929867|FG001|Overall Study|Adverse Event|0|||
156775186|NCT00716417|565929868|FG002|Overall Study|Adverse Event|2|||
156775187|NCT00716417|565929869|FG003|Overall Study|Adverse Event|1|||
156775188|NCT00716417|565929870|FG004|Overall Study|Adverse Event|0|||
156775189|NCT00716417|565929871|FG005|Overall Study|Adverse Event|0|||
156775190|NCT00716417|565929872|FG006|Overall Study|Adverse Event|3|||
156775191|NCT00716417|565929873|FG007|Overall Study|Adverse Event|1|||
156775192|NCT00716417|565929874|FG008|Overall Study|Adverse Event|0|||
156775193|NCT00716417|565929875|FG009|Overall Study|Adverse Event|3|||
156775194|NCT00716417|565929866|FG000|Overall Study|Withdrawal by Subject|0|||
156775195|NCT00716417|565929867|FG001|Overall Study|Withdrawal by Subject|1|||
156775196|NCT00716417|565929868|FG002|Overall Study|Withdrawal by Subject|0|||
156775197|NCT00716417|565929869|FG003|Overall Study|Withdrawal by Subject|2|||
156775198|NCT00716417|565929870|FG004|Overall Study|Withdrawal by Subject|0|||
156775199|NCT00716417|565929871|FG005|Overall Study|Withdrawal by Subject|0|||
156775200|NCT00716417|565929872|FG006|Overall Study|Withdrawal by Subject|1|||
156775201|NCT00716417|565929873|FG007|Overall Study|Withdrawal by Subject|0|||
156775202|NCT00716417|565929874|FG008|Overall Study|Withdrawal by Subject|0|||
157007910|NCT00494442|566778936|FG000|Overall Study|Physician Decision|0|||
157007911|NCT00494442|566778937|FG001|Overall Study|Physician Decision|1|||
157007912|NCT00494442|566778936|FG000|Overall Study|Non-compliance|0|||
156775203|NCT00716417|565929875|FG009|Overall Study|Withdrawal by Subject|0|||
156775204|NCT00716417|565929866|FG000|Overall Study|Progressive disease|3|||
157007913|NCT00494442|566778937|FG001|Overall Study|Non-compliance|1|||
156775205|NCT00716417|565929867|FG001|Overall Study|Progressive disease|5|||
156775206|NCT00716417|565929868|FG002|Overall Study|Progressive disease|3|||
156775207|NCT00716417|565929869|FG003|Overall Study|Progressive disease|8|||
156775208|NCT00716417|565929870|FG004|Overall Study|Progressive disease|0|||
156775209|NCT00716417|565929871|FG005|Overall Study|Progressive disease|3|||
156775210|NCT00716417|565929872|FG006|Overall Study|Progressive disease|3|||
156775211|NCT00716417|565929873|FG007|Overall Study|Progressive disease|1|||
156775212|NCT00716417|565929874|FG008|Overall Study|Progressive disease|5|||
156775213|NCT00716417|565929875|FG009|Overall Study|Progressive disease|0|||
156775214|NCT00716417|565929866|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156775215|NCT00716417|565929867|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
156775216|NCT00716417|565929868|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156775217|NCT00716417|565929869|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
156775218|NCT00716417|565929870|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
156775219|NCT00716417|565929871|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
156775220|NCT00716417|565929872|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156775221|NCT00716417|565929873|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156775222|NCT00716417|565929874|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
156775223|NCT00716417|565929875|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
156775224|NCT00716417|565929866|FG000|Overall Study|On patient request due to toxicities|0|||
156775225|NCT00716417|565929867|FG001|Overall Study|On patient request due to toxicities|0|||
156775226|NCT00716417|565929868|FG002|Overall Study|On patient request due to toxicities|0|||
156775227|NCT00716417|565929869|FG003|Overall Study|On patient request due to toxicities|0|||
156775228|NCT00716417|565929870|FG004|Overall Study|On patient request due to toxicities|0|||
156775229|NCT00716417|565929871|FG005|Overall Study|On patient request due to toxicities|0|||
156775230|NCT00716417|565929872|FG006|Overall Study|On patient request due to toxicities|0|||
156775231|NCT00716417|565929873|FG007|Overall Study|On patient request due to toxicities|1|||
156775232|NCT00716417|565929874|FG008|Overall Study|On patient request due to toxicities|0|||
156775233|NCT00716417|565929875|FG009|Overall Study|On patient request due to toxicities|0|||
156775234|NCT01369433|565929876|FG000|Overall Study|Adverse Event|31|||
156775235|NCT01369433|565929877|FG001|Overall Study|Adverse Event|1|||
156775236|NCT01369433|565929876|FG000|Overall Study|Required significant surgical procedure|1|||
156775237|NCT01369433|565929877|FG001|Overall Study|Required significant surgical procedure|0|||
156775238|NCT01369433|565929876|FG000|Overall Study|Non-compliance|1|||
156775239|NCT01369433|565929877|FG001|Overall Study|Non-compliance|0|||
156775240|NCT01369433|565929876|FG000|Overall Study|Withdrawal by Subject|5|||
156775241|NCT01369433|565929877|FG001|Overall Study|Withdrawal by Subject|2|||
156775242|NCT01369433|565929876|FG000|Overall Study|Study terminated by Sponsor|67|||
156775243|NCT01369433|565929877|FG001|Overall Study|Study terminated by Sponsor|0|||
156775244|NCT01369433|565929876|FG000|Overall Study|Lost to Follow-up|1|||
156775245|NCT01369433|565929877|FG001|Overall Study|Lost to Follow-up|0|||
156775246|NCT01369433|565929876|FG000|Overall Study|Death|5|||
156775247|NCT01369433|565929877|FG001|Overall Study|Death|0|||
156775248|NCT01369433|565929876|FG000|Overall Study|Investigator discretion|6|||
156775249|NCT01369433|565929877|FG001|Overall Study|Investigator discretion|1|||
156775250|NCT01369433|565929876|FG000|Overall Study|Progressive Disease|92|||
156775251|NCT01369433|565929877|FG001|Overall Study|Progressive Disease|12|||
156775252|NCT03822416|565929879|FG000|Overall Study|Lost to Follow-up|1|||
156775253|NCT03822416|565929880|FG001|Overall Study|Lost to Follow-up|0|||
156775254|NCT03822416|565929879|FG000|Overall Study|Withdrawal by Subject|0|||
156775255|NCT03822416|565929880|FG001|Overall Study|Withdrawal by Subject|1|||
156775256|NCT04666298|565929883|FG000|Overall Study|Subject decision|1|||
156775257|NCT04666298|565929884|FG001|Overall Study|Subject decision|0|||
156775258|NCT04666298|565929885|FG002|Overall Study|Subject decision|0|||
156775259|NCT04666298|565929886|FG003|Overall Study|Subject decision|2|||
156775260|NCT04666298|565929883|FG000|Overall Study|Death|1|||
156775261|NCT04666298|565929884|FG001|Overall Study|Death|0|||
156775262|NCT04666298|565929885|FG002|Overall Study|Death|0|||
156775263|NCT04666298|565929886|FG003|Overall Study|Death|0|||
156775264|NCT04666298|565929883|FG000|Overall Study|Lost to Follow-up|0|||
156775265|NCT04666298|565929884|FG001|Overall Study|Lost to Follow-up|0|||
156775266|NCT04666298|565929885|FG002|Overall Study|Lost to Follow-up|0|||
156775267|NCT04666298|565929886|FG003|Overall Study|Lost to Follow-up|1|||
156775268|NCT04666298|565929883|FG000|Overall Study|Physician Decision|0|||
156775269|NCT04666298|565929884|FG001|Overall Study|Physician Decision|0|||
156775270|NCT04666298|565929885|FG002|Overall Study|Physician Decision|0|||
156775271|NCT04666298|565929886|FG003|Overall Study|Physician Decision|1|||
156775272|NCT04666298|565929883|FG000|Overall Study|Protocol deviation|0|||
156775273|NCT04666298|565929884|FG001|Overall Study|Protocol deviation|0|||
156775274|NCT04666298|565929885|FG002|Overall Study|Protocol deviation|1|||
156775275|NCT04666298|565929886|FG003|Overall Study|Protocol deviation|0|||
156775276|NCT00844519|565929887|FG000|Overall Study|Withdrawal by Subject|1|||
157007914|NCT00494442|566778936|FG000|Overall Study|Intercurrent illness|0|||
157007915|NCT00494442|566778937|FG001|Overall Study|Intercurrent illness|1|||
157007916|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
157007917|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
157007918|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
157007919|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
156775277|NCT00844519|565929888|FG001|Overall Study|Withdrawal by Subject|1|||
156775278|NCT00844519|565929887|FG000|Overall Study|Adverse Event|1|||
157007920|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
156775279|NCT00844519|565929888|FG001|Overall Study|Adverse Event|0|||
156775280|NCT01303419|565929891|FG000|Overall Study|Discontinuation of study|60|||
156775281|NCT01303419|565929891|FG000|Overall Study|Did not complete both imaging methods|5|||
156775282|NCT01303419|565929891|FG000|Overall Study|Did not meet all I/E after screening|31|||
156775283|NCT01995201|565929892|FG000|From Baseline Until Week 24|Adverse Event|4|||
156775284|NCT01995201|565929893|FG001|From Baseline Until Week 24|Adverse Event|15|||
156775285|NCT01995201|565929894|FG002|From Baseline Until Week 24|Adverse Event|0|||
156775286|NCT01995201|565929895|FG003|From Baseline Until Week 24|Adverse Event|0|||
156775287|NCT01995201|565929896|FG004|From Baseline Until Week 24|Adverse Event|0|||
156775288|NCT01995201|565929897|FG005|From Baseline Until Week 24|Adverse Event|0|||
156775289|NCT01995201|565929898|FG006|From Baseline Until Week 24|Adverse Event|0|||
156775290|NCT01995201|565929892|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
157208281|NCT03193190|567508023|FG001|Stage 1|Arm Terminated by Sponsor|0|||
157208282|NCT03193190|567508024|FG002|Stage 1|Arm Terminated by Sponsor|0|||
157208283|NCT03193190|567508025|FG003|Stage 1|Arm Terminated by Sponsor|1|||
157208284|NCT03193190|567508026|FG004|Stage 1|Arm Terminated by Sponsor|0|||
157208285|NCT03193190|567508027|FG005|Stage 1|Arm Terminated by Sponsor|2|||
157208286|NCT03193190|567508028|FG006|Stage 1|Arm Terminated by Sponsor|0|||
157208287|NCT03193190|567508029|FG007|Stage 1|Arm Terminated by Sponsor|0|||
157208288|NCT03193190|567508030|FG008|Stage 1|Arm Terminated by Sponsor|0|||
157208289|NCT03193190|567508031|FG009|Stage 1|Arm Terminated by Sponsor|0|||
157208290|NCT03193190|567508032|FG010|Stage 1|Arm Terminated by Sponsor|0|||
157208291|NCT03193190|567508033|FG011|Stage 1|Arm Terminated by Sponsor|0|||
157208292|NCT03193190|567508034|FG012|Stage 1|Arm Terminated by Sponsor|0|||
157208293|NCT03193190|567508035|FG013|Stage 1|Arm Terminated by Sponsor|0|||
157208294|NCT03193190|567508036|FG014|Stage 1|Arm Terminated by Sponsor|0|||
157208295|NCT03193190|567508037|FG015|Stage 1|Arm Terminated by Sponsor|0|||
157208296|NCT03193190|567508022|FG000|Stage 1|Death|22|||
157208297|NCT03193190|567508023|FG001|Stage 1|Death|8|||
156775291|NCT01995201|565929893|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
156775292|NCT01995201|565929894|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775293|NCT01995201|565929895|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775294|NCT01995201|565929896|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775295|NCT01995201|565929897|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775296|NCT01995201|565929898|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
156775297|NCT01995201|565929892|FG000|From Baseline Until Week 24|Death|0|||
156775298|NCT01995201|565929893|FG001|From Baseline Until Week 24|Death|1|||
156775299|NCT01995201|565929894|FG002|From Baseline Until Week 24|Death|0|||
156775300|NCT01995201|565929895|FG003|From Baseline Until Week 24|Death|0|||
156775301|NCT01995201|565929896|FG004|From Baseline Until Week 24|Death|0|||
156775302|NCT01995201|565929897|FG005|From Baseline Until Week 24|Death|0|||
156775303|NCT01995201|565929898|FG006|From Baseline Until Week 24|Death|0|||
156775304|NCT01995201|565929892|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
156775305|NCT01995201|565929893|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
156775306|NCT01995201|565929894|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
156775307|NCT01995201|565929895|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
156775308|NCT01995201|565929896|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
156775309|NCT01995201|565929897|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
156775310|NCT01995201|565929898|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
156775311|NCT01995201|565929892|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
156775312|NCT01995201|565929893|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
156775313|NCT01995201|565929894|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
156775314|NCT01995201|565929895|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
156775315|NCT01995201|565929896|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
156775316|NCT01995201|565929897|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
156775317|NCT01995201|565929898|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
156775318|NCT01995201|565929892|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
156775319|NCT01995201|565929893|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
156775320|NCT01995201|565929894|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775321|NCT01995201|565929895|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775322|NCT01995201|565929896|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775323|NCT01995201|565929897|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775324|NCT01995201|565929898|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
156775325|NCT01995201|565929892|FG000|From Baseline Until Week 24|Physician Decision|0|||
156775326|NCT01995201|565929893|FG001|From Baseline Until Week 24|Physician Decision|2|||
156775327|NCT01995201|565929894|FG002|From Baseline Until Week 24|Physician Decision|0|||
156775328|NCT01995201|565929895|FG003|From Baseline Until Week 24|Physician Decision|0|||
156775329|NCT01995201|565929896|FG004|From Baseline Until Week 24|Physician Decision|0|||
156775330|NCT01995201|565929897|FG005|From Baseline Until Week 24|Physician Decision|0|||
157007921|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
157208298|NCT03193190|567508024|FG002|Stage 1|Death|23|||
157208299|NCT03193190|567508025|FG003|Stage 1|Death|14|||
157208300|NCT03193190|567508026|FG004|Stage 1|Death|34|||
157208301|NCT03193190|567508027|FG005|Stage 1|Death|28|||
157007922|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
157007923|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
157007924|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
157007925|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
157007926|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
157007927|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
157007928|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
157007929|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
157007930|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
157208302|NCT03193190|567508028|FG006|Stage 1|Death|19|||
157208303|NCT03193190|567508029|FG007|Stage 1|Death|21|||
157208304|NCT03193190|567508030|FG008|Stage 1|Death|14|||
157208305|NCT03193190|567508031|FG009|Stage 1|Death|10|||
157208306|NCT03193190|567508032|FG010|Stage 1|Death|59|||
157208307|NCT03193190|567508033|FG011|Stage 1|Death|14|||
157208308|NCT03193190|567508034|FG012|Stage 1|Death|14|||
157208309|NCT03193190|567508035|FG013|Stage 1|Death|0|||
157208310|NCT03193190|567508036|FG014|Stage 1|Death|0|||
157208311|NCT03193190|567508037|FG015|Stage 1|Death|0|||
157208312|NCT03193190|567508022|FG000|Stage 1|Lost to Follow-up|2|||
157208313|NCT03193190|567508023|FG001|Stage 1|Lost to Follow-up|1|||
157208314|NCT03193190|567508024|FG002|Stage 1|Lost to Follow-up|1|||
157208315|NCT03193190|567508025|FG003|Stage 1|Lost to Follow-up|0|||
157208316|NCT03193190|567508026|FG004|Stage 1|Lost to Follow-up|0|||
157208317|NCT03193190|567508027|FG005|Stage 1|Lost to Follow-up|0|||
157208318|NCT03193190|567508028|FG006|Stage 1|Lost to Follow-up|1|||
157208319|NCT03193190|567508029|FG007|Stage 1|Lost to Follow-up|0|||
157208320|NCT03193190|567508030|FG008|Stage 1|Lost to Follow-up|0|||
157208321|NCT03193190|567508031|FG009|Stage 1|Lost to Follow-up|0|||
157208322|NCT03193190|567508032|FG010|Stage 1|Lost to Follow-up|0|||
157208323|NCT03193190|567508033|FG011|Stage 1|Lost to Follow-up|0|||
157208324|NCT03193190|567508034|FG012|Stage 1|Lost to Follow-up|0|||
157208325|NCT03193190|567508035|FG013|Stage 1|Lost to Follow-up|0|||
157208326|NCT03193190|567508036|FG014|Stage 1|Lost to Follow-up|0|||
157208327|NCT03193190|567508037|FG015|Stage 1|Lost to Follow-up|0|||
157208328|NCT03193190|567508022|FG000|Stage 1|Reason not Specified|1|||
157208329|NCT03193190|567508023|FG001|Stage 1|Reason not Specified|0|||
157208330|NCT03193190|567508024|FG002|Stage 1|Reason not Specified|0|||
157208331|NCT03193190|567508025|FG003|Stage 1|Reason not Specified|1|||
157208332|NCT03193190|567508026|FG004|Stage 1|Reason not Specified|0|||
157208333|NCT03193190|567508027|FG005|Stage 1|Reason not Specified|1|||
157208334|NCT03193190|567508028|FG006|Stage 1|Reason not Specified|2|||
157208335|NCT03193190|567508029|FG007|Stage 1|Reason not Specified|2|||
157208336|NCT03193190|567508030|FG008|Stage 1|Reason not Specified|0|||
157208337|NCT03193190|567508031|FG009|Stage 1|Reason not Specified|1|||
157208338|NCT03193190|567508032|FG010|Stage 1|Reason not Specified|3|||
157208339|NCT03193190|567508033|FG011|Stage 1|Reason not Specified|0|||
157208340|NCT03193190|567508034|FG012|Stage 1|Reason not Specified|1|||
157208341|NCT03193190|567508035|FG013|Stage 1|Reason not Specified|0|||
157208342|NCT03193190|567508036|FG014|Stage 1|Reason not Specified|0|||
157208343|NCT03193190|567508037|FG015|Stage 1|Reason not Specified|0|||
157208344|NCT03193190|567508022|FG000|Stage 1|Physician Decision|0|||
157208345|NCT03193190|567508023|FG001|Stage 1|Physician Decision|0|||
157208346|NCT03193190|567508024|FG002|Stage 1|Physician Decision|0|||
157208347|NCT03193190|567508025|FG003|Stage 1|Physician Decision|0|||
157208348|NCT03193190|567508026|FG004|Stage 1|Physician Decision|0|||
157208349|NCT03193190|567508027|FG005|Stage 1|Physician Decision|0|||
157208350|NCT03193190|567508028|FG006|Stage 1|Physician Decision|0|||
157208351|NCT03193190|567508029|FG007|Stage 1|Physician Decision|0|||
157208352|NCT03193190|567508030|FG008|Stage 1|Physician Decision|0|||
157208353|NCT03193190|567508031|FG009|Stage 1|Physician Decision|0|||
157208354|NCT03193190|567508032|FG010|Stage 1|Physician Decision|0|||
157208355|NCT03193190|567508033|FG011|Stage 1|Physician Decision|1|||
156775331|NCT01995201|565929898|FG006|From Baseline Until Week 24|Physician Decision|0|||
156775332|NCT01995201|565929892|FG000|From Baseline Until Week 24|Protocol Violation|0|||
156775333|NCT01995201|565929893|FG001|From Baseline Until Week 24|Protocol Violation|9|||
156775334|NCT01995201|565929894|FG002|From Baseline Until Week 24|Protocol Violation|0|||
156775335|NCT01995201|565929895|FG003|From Baseline Until Week 24|Protocol Violation|0|||
156775336|NCT01995201|565929896|FG004|From Baseline Until Week 24|Protocol Violation|0|||
156775337|NCT01995201|565929897|FG005|From Baseline Until Week 24|Protocol Violation|0|||
156775338|NCT01995201|565929898|FG006|From Baseline Until Week 24|Protocol Violation|0|||
156775339|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Adverse Event|0|||
156775340|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Adverse Event|0|||
156775341|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Adverse Event|2|||
156775342|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Adverse Event|1|||
156775343|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Adverse Event|1|||
156775344|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Adverse Event|3|||
156775345|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Adverse Event|1|||
156775346|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Death|0|||
156775347|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Death|0|||
156775348|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Death|0|||
156775349|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Death|0|||
156775350|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Death|0|||
156775351|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Death|2|||
156775352|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Death|0|||
156775353|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775354|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775355|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
156775356|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775357|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
156775358|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
157007931|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
157007932|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
156775359|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
156775360|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775361|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775362|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
157007933|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
157208356|NCT03193190|567508034|FG012|Stage 1|Physician Decision|0|||
157208357|NCT03193190|567508035|FG013|Stage 1|Physician Decision|0|||
156775363|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775364|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
156775365|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
156775366|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
156775367|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775368|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775369|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
156775370|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775371|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
156775372|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775373|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
156775374|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Physician Decision|0|||
156775375|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Physician Decision|0|||
156775376|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Physician Decision|0|||
156775377|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Physician Decision|0|||
156775378|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Physician Decision|1|||
156775379|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Physician Decision|0|||
156775380|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Physician Decision|0|||
156775381|NCT01995201|565929892|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
157208358|NCT03193190|567508036|FG014|Stage 1|Physician Decision|0|||
156775382|NCT01995201|565929893|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
157007934|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
157007935|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
157007936|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
157007937|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
156775383|NCT01995201|565929894|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
156775384|NCT01995201|565929895|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
156775385|NCT01995201|565929896|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
156775386|NCT01995201|565929897|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
156775387|NCT01995201|565929898|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
156775388|NCT01138046|565929899|FG000|Overall Study|Withdrawal due to death|6|||
156775389|NCT02178956|565929900|FG000|Overall Study|Lost to Follow-up|4|||
156775390|NCT02178956|565929901|FG001|Overall Study|Lost to Follow-up|4|||
156775391|NCT02178956|565929900|FG000|Overall Study|Sponsor terminated study|49|||
156775392|NCT02178956|565929901|FG001|Overall Study|Sponsor terminated study|58|||
156775393|NCT02178956|565929900|FG000|Overall Study|Withdrawal by Subject|15|||
156775394|NCT02178956|565929901|FG001|Overall Study|Withdrawal by Subject|11|||
156775395|NCT02178956|565929900|FG000|Overall Study|Various Reasons|3|||
156775396|NCT02178956|565929901|FG001|Overall Study|Various Reasons|5|||
156775397|NCT01341470|565929903|FG000|Overall Study|Sponsor decision|0|||
156775398|NCT01341470|565929904|FG001|Overall Study|Sponsor decision|0|||
156775399|NCT01341470|565929905|FG002|Overall Study|Sponsor decision|1|||
156775400|NCT01341470|565929906|FG003|Overall Study|Sponsor decision|1|||
156775401|NCT01341470|565929907|FG004|Overall Study|Sponsor decision|0|||
156775402|NCT01341470|565929908|FG005|Overall Study|Sponsor decision|1|||
156775403|NCT02337829|565929911|FG000|Overall Study|Death|0|||
156775404|NCT02337829|565929912|FG001|Overall Study|Death|1|||
156775405|NCT02337829|565929913|FG002|Overall Study|Death|0|||
156775406|NCT02337829|565929914|FG003|Overall Study|Death|0|||
156775407|NCT02337829|565929911|FG000|Overall Study|Study terminated by sponsor|12|||
156775408|NCT02337829|565929912|FG001|Overall Study|Study terminated by sponsor|10|||
156775409|NCT02337829|565929913|FG002|Overall Study|Study terminated by sponsor|5|||
156775410|NCT02337829|565929914|FG003|Overall Study|Study terminated by sponsor|6|||
156775411|NCT02337829|565929911|FG000|Overall Study|discontinued for other reasons|6|||
156775412|NCT02337829|565929912|FG001|Overall Study|discontinued for other reasons|3|||
156775413|NCT02337829|565929913|FG002|Overall Study|discontinued for other reasons|1|||
156775414|NCT02337829|565929914|FG003|Overall Study|discontinued for other reasons|4|||
156775415|NCT03188822|565929918|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
156775416|NCT03188822|565929918|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
156775417|NCT01654276|565929927|FG000|Overall Study|Lack of Efficacy|1|||
156775418|NCT01654276|565929927|FG000|Overall Study|Lost to Follow-up|4|||
156775419|NCT01654276|565929927|FG000|Overall Study|Withdrawal by Subject|1|||
156775420|NCT04478266|565929928|FG000|Overall Study|Adverse Event|20|||
156775421|NCT04478266|565929929|FG001|Overall Study|Adverse Event|21|||
156775422|NCT04478266|565929928|FG000|Overall Study|Progressive disease|146|||
156775423|NCT04478266|565929929|FG001|Overall Study|Progressive disease|168|||
156775424|NCT04478266|565929928|FG000|Overall Study|Poor compliance to protocol|1|||
156775425|NCT04478266|565929929|FG001|Overall Study|Poor compliance to protocol|0|||
156775426|NCT04478266|565929928|FG000|Overall Study|Withdrawal by Subject|19|||
156775427|NCT04478266|565929929|FG001|Overall Study|Withdrawal by Subject|16|||
156775428|NCT04478266|565929928|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
156775429|NCT04478266|565929929|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
156775430|NCT04478266|565929928|FG000|Overall Study|Study terminated by sponsor|33|||
156775431|NCT04478266|565929929|FG001|Overall Study|Study terminated by sponsor|35|||
156775432|NCT04478266|565929928|FG000|Overall Study|Other: unspecified|5|||
156775433|NCT04478266|565929929|FG001|Overall Study|Other: unspecified|7|||
156775434|NCT04478266|565929928|FG000|Overall Study|Randomized but not treated|1|||
156775435|NCT04478266|565929929|FG001|Overall Study|Randomized but not treated|1|||
156775436|NCT02340949|565929930|FG000|Overall Study|Adverse Event|4|||
156775437|NCT02340949|565929931|FG001|Overall Study|Adverse Event|2|||
156775438|NCT02340949|565929930|FG000|Overall Study|Withdrawal by Subject|2|||
156775439|NCT02340949|565929931|FG001|Overall Study|Withdrawal by Subject|0|||
156775440|NCT02340949|565929930|FG000|Overall Study|Progression disease|6|||
156775441|NCT02340949|565929931|FG001|Overall Study|Progression disease|2|||
156775442|NCT02340949|565929930|FG000|Overall Study|Death|3|||
156775443|NCT02340949|565929931|FG001|Overall Study|Death|0|||
156775444|NCT02340949|565929930|FG000|Overall Study|Physician Decision|1|||
156775445|NCT02340949|565929931|FG001|Overall Study|Physician Decision|0|||
156775446|NCT01192178|565929932|FG000|Overall Study|Withdrawal by Subject|6|||
156775447|NCT01192178|565929933|FG001|Overall Study|Withdrawal by Subject|10|||
156775448|NCT01192178|565929932|FG000|Overall Study|Protocol Violation|10|||
156775449|NCT01192178|565929933|FG001|Overall Study|Protocol Violation|3|||
156775450|NCT01192178|565929932|FG000|Overall Study|Physician Decision|2|||
156775451|NCT01192178|565929933|FG001|Overall Study|Physician Decision|4|||
156775452|NCT01192178|565929932|FG000|Overall Study|Lost to Follow-up|3|||
156775453|NCT01192178|565929933|FG001|Overall Study|Lost to Follow-up|3|||
156775454|NCT01192178|565929932|FG000|Overall Study|Adverse Event|2|||
156775455|NCT01192178|565929933|FG001|Overall Study|Adverse Event|1|||
156775456|NCT01192178|565929932|FG000|Overall Study|Lack of Efficacy|1|||
156775457|NCT01192178|565929933|FG001|Overall Study|Lack of Efficacy|2|||
156775458|NCT00296517|565929936|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
156775459|NCT00296517|565929937|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
157007938|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
157007939|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
157007940|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
157208359|NCT03193190|567508037|FG015|Stage 1|Physician Decision|0|||
156775460|NCT00296517|565929936|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
157208360|NCT03193190|567508022|FG000|Stage 1|Progressive Disease|1|||
157113964|NCT01624662|567171808|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
157113965|NCT01624662|567171809|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
157113966|NCT01624662|567171806|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
157113967|NCT01624662|567171807|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
157113968|NCT01624662|567171808|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
157113969|NCT01624662|567171809|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
157113970|NCT03116698|567171813|FG000|Overall Study|Adverse Event|1|||
157113971|NCT03116698|567171814|FG001|Overall Study|Adverse Event|1|||
157113972|NCT03116698|567171815|FG002|Overall Study|Adverse Event|1|||
157113973|NCT03116698|567171816|FG003|Overall Study|Adverse Event|0|||
157113974|NCT03116698|567171813|FG000|Overall Study|Withdrawal by Subject|1|||
157113975|NCT03116698|567171814|FG001|Overall Study|Withdrawal by Subject|4|||
157113976|NCT03116698|567171815|FG002|Overall Study|Withdrawal by Subject|5|||
157113977|NCT03116698|567171816|FG003|Overall Study|Withdrawal by Subject|2|||
157113978|NCT03116698|567171813|FG000|Overall Study|Lost to Follow-up|2|||
157113979|NCT03116698|567171814|FG001|Overall Study|Lost to Follow-up|0|||
157113980|NCT03116698|567171815|FG002|Overall Study|Lost to Follow-up|0|||
157113981|NCT03116698|567171816|FG003|Overall Study|Lost to Follow-up|0|||
157113982|NCT03116698|567171813|FG000|Overall Study|Physician Decision|1|||
157113983|NCT03116698|567171814|FG001|Overall Study|Physician Decision|1|||
157113984|NCT03116698|567171815|FG002|Overall Study|Physician Decision|0|||
157113985|NCT03116698|567171816|FG003|Overall Study|Physician Decision|0|||
157113986|NCT03116698|567171813|FG000|Overall Study|Protocol Violation|1|||
157113987|NCT03116698|567171814|FG001|Overall Study|Protocol Violation|0|||
157113988|NCT03116698|567171815|FG002|Overall Study|Protocol Violation|0|||
157113989|NCT03116698|567171816|FG003|Overall Study|Protocol Violation|0|||
157113990|NCT03116698|567171813|FG000|Overall Study|Death|0|||
157113991|NCT03116698|567171814|FG001|Overall Study|Death|0|||
157113992|NCT03116698|567171815|FG002|Overall Study|Death|2|||
157113993|NCT03116698|567171816|FG003|Overall Study|Death|0|||
157113994|NCT01246583|567171822|FG000|Overall Study|Lost to Follow-up|0|||
157113995|NCT01246583|567171823|FG001|Overall Study|Lost to Follow-up|0|||
157113996|NCT01246583|567171824|FG002|Overall Study|Lost to Follow-up|0|||
157113997|NCT01246583|567171825|FG003|Overall Study|Lost to Follow-up|1|||
157113998|NCT01246583|567171822|FG000|Overall Study|Protocol Violation|0|||
157113999|NCT01246583|567171823|FG001|Overall Study|Protocol Violation|0|||
157114000|NCT01246583|567171824|FG002|Overall Study|Protocol Violation|1|||
157114001|NCT01246583|567171825|FG003|Overall Study|Protocol Violation|0|||
157114002|NCT01246583|567171822|FG000|Overall Study|Withdrawal by Subject|1|||
157114003|NCT01246583|567171823|FG001|Overall Study|Withdrawal by Subject|0|||
157114004|NCT01246583|567171824|FG002|Overall Study|Withdrawal by Subject|0|||
157114005|NCT01246583|567171825|FG003|Overall Study|Withdrawal by Subject|0|||
157114006|NCT05264740|567171826|FG000|Baseline|Withdrawal by Subject|0|||
157114007|NCT05264740|567171827|FG001|Baseline|Withdrawal by Subject|1|||
157114008|NCT05264740|567171826|FG000|Follow Up 1|Lost to Follow-up|1|||
157114009|NCT05264740|567171827|FG001|Follow Up 1|Lost to Follow-up|1|||
157114010|NCT05264740|567171826|FG000|Follow Up 1|Withdrawal by Subject|0|||
157114011|NCT05264740|567171827|FG001|Follow Up 1|Withdrawal by Subject|1|||
157114012|NCT05264740|567171826|FG000|Follow Up 2|Lost to Follow-up|1|||
157114013|NCT05264740|567171827|FG001|Follow Up 2|Lost to Follow-up|4|||
157114014|NCT05264740|567171826|FG000|Follow Up 3|Lost to Follow-up|7|||
157114015|NCT05264740|567171827|FG001|Follow Up 3|Lost to Follow-up|4|||
157114016|NCT01423851|567171828|FG000|Whole Study|Disease progression|2|||
157114017|NCT01423851|567171829|FG001|Whole Study|Disease progression|1|||
157114018|NCT01423851|567171830|FG002|Whole Study|Disease progression|1|||
157114019|NCT01423851|567171831|FG003|Whole Study|Disease progression|4|||
157114020|NCT01423851|567171832|FG004|Whole Study|Disease progression|1|||
157114021|NCT01423851|567171833|FG005|Whole Study|Disease progression|3|||
157114022|NCT01423851|567171834|FG006|Whole Study|Disease progression|1|||
157114023|NCT01423851|567171835|FG007|Whole Study|Disease progression|4|||
157114024|NCT01423851|567171836|FG008|Whole Study|Disease progression|0|||
157114025|NCT01423851|567171837|FG009|Whole Study|Disease progression|2|||
157114026|NCT01423851|567171838|FG010|Whole Study|Disease progression|10|||
157114027|NCT01423851|567171828|FG000|Whole Study|Physician Decision|0|||
157114028|NCT01423851|567171829|FG001|Whole Study|Physician Decision|1|||
157114029|NCT01423851|567171830|FG002|Whole Study|Physician Decision|2|||
157114030|NCT01423851|567171831|FG003|Whole Study|Physician Decision|0|||
157114031|NCT01423851|567171832|FG004|Whole Study|Physician Decision|2|||
157114032|NCT01423851|567171833|FG005|Whole Study|Physician Decision|0|||
157114033|NCT01423851|567171834|FG006|Whole Study|Physician Decision|2|||
157114034|NCT01423851|567171835|FG007|Whole Study|Physician Decision|1|||
157114035|NCT01423851|567171836|FG008|Whole Study|Physician Decision|3|||
157114036|NCT01423851|567171837|FG009|Whole Study|Physician Decision|4|||
157114037|NCT01423851|567171838|FG010|Whole Study|Physician Decision|12|||
157114038|NCT01423851|567171828|FG000|Whole Study|Withdrawal by Subject|1|||
157114039|NCT01423851|567171829|FG001|Whole Study|Withdrawal by Subject|1|||
157114040|NCT01423851|567171830|FG002|Whole Study|Withdrawal by Subject|0|||
157114041|NCT01423851|567171831|FG003|Whole Study|Withdrawal by Subject|0|||
156775461|NCT00296517|565929937|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
156775462|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
156775463|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
156775464|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
156775465|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
156775466|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
156775467|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
156775468|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
156775469|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
156775470|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
156775471|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
156775472|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
156775473|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
156775474|NCT00296517|565929936|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
156775475|NCT00296517|565929937|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
156775476|NCT02164916|565929938|FG000|Overall Study|Adverse Event|3|||
156775477|NCT02164916|565929939|FG001|Overall Study|Adverse Event|8|||
156775478|NCT02164916|565929938|FG000|Overall Study|Death|1|||
156775479|NCT02164916|565929939|FG001|Overall Study|Death|1|||
156775480|NCT02164916|565929938|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156775481|NCT02164916|565929939|FG001|Overall Study|Refusal unrelated to adverse event|7|||
156775482|NCT02164916|565929938|FG000|Overall Study|Progression|37|||
156775483|NCT02164916|565929939|FG001|Overall Study|Progression|26|||
156775484|NCT02164916|565929938|FG000|Overall Study|Not protocol specified|5|||
156775485|NCT02164916|565929939|FG001|Overall Study|Not protocol specified|1|||
156775486|NCT02164916|565929938|FG000|Overall Study|Reason under review|1|||
156775487|NCT02164916|565929939|FG001|Overall Study|Reason under review|6|||
156775488|NCT02164916|565929938|FG000|Overall Study|Not eligible|2|||
156775489|NCT02164916|565929939|FG001|Overall Study|Not eligible|5|||
156775490|NCT00964782|565929942|FG000|Overall Study|Lost to Follow-up|1|||
156775491|NCT00964782|565929943|FG001|Overall Study|Lost to Follow-up|0|||
156775492|NCT01143324|565929944|FG000|Overall Study|Lost to Follow-up|11|||
156775493|NCT01143324|565929944|FG000|Overall Study|Withdrawal by Subject|4|||
156775494|NCT01143324|565929944|FG000|Overall Study|Explant of the device|4|||
156775495|NCT01101178|565929948|FG000|Period 1|Withdrawal by Subject|1|||
156775496|NCT01101178|565929949|FG001|Period 1|Withdrawal by Subject|2|||
156775497|NCT01101178|565929948|FG000|Period 1|Positive drug screen|1|||
156775498|NCT01101178|565929949|FG001|Period 1|Positive drug screen|1|||
156775499|NCT01101178|565929948|FG000|Period 1|Adverse Event|2|||
156775500|NCT01101178|565929949|FG001|Period 1|Adverse Event|1|||
156775501|NCT01101178|565929948|FG000|Period 2|Withdrawal by Subject|0|||
156775502|NCT01101178|565929949|FG001|Period 2|Withdrawal by Subject|1|||
156775503|NCT00141817|565929950|FG000|Overall Study|Protocol Violation|0|||
156775504|NCT00141817|565929951|FG001|Overall Study|Protocol Violation|0|||
156775505|NCT00141817|565929952|FG002|Overall Study|Protocol Violation|1|||
156775506|NCT00141817|565929953|FG003|Overall Study|Protocol Violation|0|||
156775507|NCT00141817|565929950|FG000|Overall Study|Parent request|1|||
156775508|NCT00141817|565929951|FG001|Overall Study|Parent request|0|||
156775509|NCT00141817|565929952|FG002|Overall Study|Parent request|0|||
156775510|NCT00141817|565929953|FG003|Overall Study|Parent request|0|||
156775511|NCT00127803|565929956|FG000|Overall Study|Adverse Event|2|||
156775512|NCT00127803|565929957|FG001|Overall Study|Adverse Event|0|||
156775513|NCT00127803|565929958|FG002|Overall Study|Adverse Event|0|||
156775514|NCT00127803|565929959|FG003|Overall Study|Adverse Event|0|||
156775515|NCT00127803|565929956|FG000|Overall Study|Withdrawal by Subject|1|||
156775516|NCT00127803|565929957|FG001|Overall Study|Withdrawal by Subject|0|||
156775517|NCT00127803|565929958|FG002|Overall Study|Withdrawal by Subject|0|||
156775518|NCT00127803|565929959|FG003|Overall Study|Withdrawal by Subject|0|||
156775519|NCT00127803|565929956|FG000|Overall Study|Lost to Follow-up|0|||
156775520|NCT00127803|565929957|FG001|Overall Study|Lost to Follow-up|0|||
156775521|NCT00127803|565929958|FG002|Overall Study|Lost to Follow-up|0|||
156775522|NCT00127803|565929959|FG003|Overall Study|Lost to Follow-up|1|||
156775523|NCT02318940|565929960|FG000|Overall Study|lost the record|1|||
156775524|NCT02318940|565929961|FG001|Overall Study|lost the record|0|||
156775525|NCT01277861|565929967|FG000|Overall Study|Physician Decision|2|||
156775526|NCT01277861|565929968|FG001|Overall Study|Physician Decision|2|||
156775527|NCT00857389|565929969|FG000|Overall Study|Did not proceed to transplant|2|||
156775528|NCT04584788|565929970|FG000|Overall Study|Physician Decision|8|||
156775529|NCT04584788|565929970|FG000|Overall Study|Withdrawal by Subject|1|||
156775530|NCT04584788|565929970|FG000|Overall Study|Adverse Event|3|||
156775531|NCT04284774|565929972|FG000|Overall Study|Progressive disease|5|||
156775532|NCT03329001|565931298|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775533|NCT03329001|565931299|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775534|NCT03329001|565931300|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
156775535|NCT03329001|565931301|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
156775536|NCT03329001|565931302|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775537|NCT03329001|565931303|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775538|NCT03329001|565931304|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775539|NCT03329001|565931305|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
156775540|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775541|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775542|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775543|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
157007941|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
157007942|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
157007943|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
157007944|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
157208361|NCT03193190|567508023|FG001|Stage 1|Progressive Disease|0|||
156775544|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775545|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775546|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775547|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
156775548|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775549|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775550|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775551|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
156775552|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775553|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775554|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775555|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
156775556|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775557|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775558|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775559|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
156775560|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775561|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775562|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775563|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
156775564|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775565|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775566|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
156775567|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775568|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775569|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775570|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775571|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
156775572|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775573|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775574|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
156775575|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775576|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775577|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775578|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775579|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
156775580|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775581|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775582|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
156775583|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775584|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
157007945|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
157007946|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
157007947|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
157007948|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
157007949|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
157007950|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
157007951|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
157007952|NCT03593213|566778940|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
157007953|NCT03593213|566778941|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
157007954|NCT03593213|566778942|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
157007955|NCT03593213|566778943|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
157007956|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
156775585|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775586|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775587|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
156775588|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775589|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775590|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
156775591|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775592|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775593|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775594|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775595|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
156775596|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775597|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775598|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
157208362|NCT03193190|567508024|FG002|Stage 1|Progressive Disease|0|||
157208363|NCT03193190|567508025|FG003|Stage 1|Progressive Disease|0|||
157114042|NCT01423851|567171832|FG004|Whole Study|Withdrawal by Subject|0|||
157114043|NCT01423851|567171833|FG005|Whole Study|Withdrawal by Subject|0|||
157114044|NCT01423851|567171834|FG006|Whole Study|Withdrawal by Subject|0|||
157114045|NCT01423851|567171835|FG007|Whole Study|Withdrawal by Subject|0|||
157114046|NCT01423851|567171836|FG008|Whole Study|Withdrawal by Subject|2|||
157114047|NCT01423851|567171837|FG009|Whole Study|Withdrawal by Subject|0|||
157114048|NCT01423851|567171838|FG010|Whole Study|Withdrawal by Subject|4|||
156775599|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
156775600|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775601|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775602|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775603|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
156775604|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775605|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775606|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
156775607|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775608|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775609|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775610|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775611|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
156775612|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775613|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775614|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
156775615|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
156775616|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775617|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775618|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775619|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
156775620|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775621|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775622|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
156775623|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
156775624|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775625|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775626|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775627|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
156775628|NCT03329001|565931298|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775629|NCT03329001|565931299|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775630|NCT03329001|565931300|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
157114049|NCT01423851|567171828|FG000|Whole Study|Adverse Event|0|||
157114050|NCT01423851|567171829|FG001|Whole Study|Adverse Event|0|||
157114051|NCT01423851|567171830|FG002|Whole Study|Adverse Event|0|||
156775631|NCT03329001|565931301|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
156775632|NCT03329001|565931302|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775633|NCT03329001|565931303|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775634|NCT03329001|565931304|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775635|NCT03329001|565931305|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
156775636|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775637|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775638|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775639|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
156775640|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775641|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775642|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775643|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
156775644|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775645|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775646|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775647|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
156775648|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775649|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775650|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775651|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
156775652|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775653|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775654|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
156775655|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775656|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775657|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775658|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775659|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
156775660|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775661|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775662|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
156775663|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
156775664|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775665|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775666|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775667|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
156775668|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775669|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775670|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
156775671|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775672|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775673|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775674|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775675|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
156775676|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775677|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775678|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
156775679|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775680|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775681|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775682|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775683|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
156775684|NCT03329001|565931298|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
157007957|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
156775685|NCT03329001|565931299|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775686|NCT03329001|565931300|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775687|NCT03329001|565931301|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
156775688|NCT03329001|565931302|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775689|NCT03329001|565931303|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775690|NCT03329001|565931304|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775691|NCT03329001|565931305|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
156775692|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775693|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775694|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775695|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775696|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775697|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
156775698|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775699|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
156775700|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775701|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775702|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775703|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775704|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
156775705|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775706|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775707|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
156775708|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775709|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775710|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775711|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775712|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
156775713|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
156775714|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775715|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
156775716|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775717|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775718|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775719|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775720|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
156775721|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775722|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775723|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
156775724|NCT03329001|565931298|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775725|NCT03329001|565931299|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775726|NCT03329001|565931300|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775727|NCT03329001|565931301|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775728|NCT03329001|565931302|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
156775729|NCT03329001|565931303|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
156775730|NCT03329001|565931304|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775731|NCT03329001|565931305|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
156775732|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775733|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775734|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775735|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775736|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775737|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
156775738|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
156775739|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
156775740|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775741|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775742|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775743|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775744|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775745|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
157114052|NCT01423851|567171831|FG003|Whole Study|Adverse Event|2|||
157114053|NCT01423851|567171832|FG004|Whole Study|Adverse Event|0|||
157114054|NCT01423851|567171833|FG005|Whole Study|Adverse Event|0|||
157114055|NCT01423851|567171834|FG006|Whole Study|Adverse Event|0|||
156775746|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
157114056|NCT01423851|567171835|FG007|Whole Study|Adverse Event|3|||
157114057|NCT01423851|567171836|FG008|Whole Study|Adverse Event|3|||
157114058|NCT01423851|567171837|FG009|Whole Study|Adverse Event|2|||
157114059|NCT01423851|567171838|FG010|Whole Study|Adverse Event|3|||
157114060|NCT05885737|567171842|FG000|DB Period|Adverse Event|4|||
157114061|NCT05885737|567171843|FG001|DB Period|Adverse Event|4|||
157114062|NCT05885737|567171842|FG000|DB Period|Lost to Follow-up|0|||
157114063|NCT05885737|567171843|FG001|DB Period|Lost to Follow-up|1|||
157114064|NCT05885737|567171842|FG000|DB Period|Physician Decision|2|||
157114065|NCT05885737|567171843|FG001|DB Period|Physician Decision|0|||
157114066|NCT05885737|567171842|FG000|DB Period|Withdrawal by Subject|12|||
157114067|NCT05885737|567171843|FG001|DB Period|Withdrawal by Subject|6|||
157114068|NCT05885737|567171842|FG000|DB Period|Other: Unspecified|2|||
157114069|NCT05885737|567171843|FG001|DB Period|Other: Unspecified|2|||
157114070|NCT05885737|567171842|FG000|OLE Period|Adverse Event|3|||
157114071|NCT05885737|567171843|FG001|OLE Period|Adverse Event|2|||
157114072|NCT05885737|567171842|FG000|OLE Period|Physician Decision|1|||
157114073|NCT05885737|567171843|FG001|OLE Period|Physician Decision|0|||
157114074|NCT05885737|567171842|FG000|OLE Period|Withdrawal by Subject|5|||
156775747|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
156775748|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775749|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775750|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
157114075|NCT05885737|567171843|FG001|OLE Period|Withdrawal by Subject|5|||
157114076|NCT05885737|567171842|FG000|OLE Period|Other: Unspecified|2|||
157114077|NCT05885737|567171843|FG001|OLE Period|Other: Unspecified|1|||
157114078|NCT02037295|567173246|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
157114079|NCT02037295|567173247|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
157114080|NCT02037295|567173248|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
157114081|NCT02037295|567173249|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
157114082|NCT02770547|567173252|FG000|Overall Study|Patient non-compliant|1|||
157114083|NCT02770547|567173253|FG001|Overall Study|Patient non-compliant|0|||
157114084|NCT02770547|567173252|FG000|Overall Study|Adverse Event|0|||
157114085|NCT02770547|567173253|FG001|Overall Study|Adverse Event|1|||
157114086|NCT01324232|567173254|FG000|Overall Study|Protocol Violation|0|||
157114087|NCT01324232|567173255|FG001|Overall Study|Protocol Violation|0|||
157114088|NCT01324232|567173256|FG002|Overall Study|Protocol Violation|0|||
157114089|NCT01324232|567173257|FG003|Overall Study|Protocol Violation|2|||
157114090|NCT01324232|567173254|FG000|Overall Study|Missing|0|||
157114091|NCT01324232|567173255|FG001|Overall Study|Missing|0|||
157114092|NCT01324232|567173256|FG002|Overall Study|Missing|1|||
157114093|NCT01324232|567173257|FG003|Overall Study|Missing|0|||
157114094|NCT01324232|567173254|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
157114095|NCT01324232|567173255|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
157114096|NCT01324232|567173256|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
157114097|NCT01324232|567173257|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
157114098|NCT01324232|567173254|FG000|Overall Study|Lack of Efficacy|2|||
157114099|NCT01324232|567173255|FG001|Overall Study|Lack of Efficacy|1|||
157114100|NCT01324232|567173256|FG002|Overall Study|Lack of Efficacy|2|||
157114101|NCT01324232|567173257|FG003|Overall Study|Lack of Efficacy|2|||
157114102|NCT01324232|567173254|FG000|Overall Study|Participant Refused Medication|0|||
157114103|NCT01324232|567173255|FG001|Overall Study|Participant Refused Medication|1|||
157114104|NCT01324232|567173256|FG002|Overall Study|Participant Refused Medication|0|||
157114105|NCT01324232|567173257|FG003|Overall Study|Participant Refused Medication|0|||
157114106|NCT01324232|567173254|FG000|Overall Study|Intercurrent illness|0|||
157114107|NCT01324232|567173255|FG001|Overall Study|Intercurrent illness|0|||
157114108|NCT01324232|567173256|FG002|Overall Study|Intercurrent illness|0|||
157114109|NCT01324232|567173257|FG003|Overall Study|Intercurrent illness|1|||
157114110|NCT01324232|567173254|FG000|Overall Study|Adverse Event|2|||
157114111|NCT01324232|567173255|FG001|Overall Study|Adverse Event|5|||
157114112|NCT01324232|567173256|FG002|Overall Study|Adverse Event|6|||
157114113|NCT01324232|567173257|FG003|Overall Study|Adverse Event|6|||
157114114|NCT01324232|567173254|FG000|Overall Study|Withdrawal by Subject|0|||
157114115|NCT01324232|567173255|FG001|Overall Study|Withdrawal by Subject|3|||
157114116|NCT01324232|567173256|FG002|Overall Study|Withdrawal by Subject|4|||
157114117|NCT01324232|567173257|FG003|Overall Study|Withdrawal by Subject|0|||
157114118|NCT01324232|567173254|FG000|Overall Study|Lost to Follow-up|1|||
157114119|NCT01324232|567173255|FG001|Overall Study|Lost to Follow-up|0|||
157114120|NCT01324232|567173256|FG002|Overall Study|Lost to Follow-up|0|||
157114121|NCT01324232|567173257|FG003|Overall Study|Lost to Follow-up|0|||
157114122|NCT00661531|567173258|FG000|Overall Study|Withdrawal by Subject|3|||
157114123|NCT03134599|567173259|FG000|Week 1|Lost to Follow-up|0|||
157114124|NCT03134599|567173260|FG001|Week 1|Lost to Follow-up|0|||
157114125|NCT03134599|567173261|FG002|Week 1|Lost to Follow-up|0|||
157114126|NCT03134599|567173262|FG003|Week 1|Lost to Follow-up|0|||
157114127|NCT03134599|567173263|FG004|Week 1|Lost to Follow-up|1|||
157114128|NCT03134599|567173264|FG005|Week 1|Lost to Follow-up|0|||
157114129|NCT03134599|567173259|FG000|Week 2|Lost to Follow-up|1|||
157114130|NCT03134599|567173260|FG001|Week 2|Lost to Follow-up|0|||
157114131|NCT03134599|567173261|FG002|Week 2|Lost to Follow-up|0|||
157114132|NCT03134599|567173262|FG003|Week 2|Lost to Follow-up|1|||
157114133|NCT03134599|567173263|FG004|Week 2|Lost to Follow-up|1|||
157114134|NCT03134599|567173264|FG005|Week 2|Lost to Follow-up|0|||
157114135|NCT03134599|567173259|FG000|Week 3|Lost to Follow-up|0|||
157114136|NCT03134599|567173260|FG001|Week 3|Lost to Follow-up|0|||
157114137|NCT03134599|567173261|FG002|Week 3|Lost to Follow-up|0|||
157114138|NCT03134599|567173262|FG003|Week 3|Lost to Follow-up|1|||
157114139|NCT03134599|567173263|FG004|Week 3|Lost to Follow-up|0|||
157114140|NCT03134599|567173264|FG005|Week 3|Lost to Follow-up|1|||
157114141|NCT00393887|567173265|FG000|Overall Study|Physician Decision|5|||
157114142|NCT00393887|567173266|FG001|Overall Study|Physician Decision|0|||
157114143|NCT00393887|567173265|FG000|Overall Study|Lost to Follow-up|11|||
157114144|NCT00393887|567173266|FG001|Overall Study|Lost to Follow-up|9|||
157114145|NCT01265615|567173267|FG000|Overall Study|Protocol Violation|2|||
157114146|NCT01265615|567173268|FG001|Overall Study|Protocol Violation|2|||
157114147|NCT01265615|567173269|FG002|Overall Study|Protocol Violation|4|||
157114148|NCT01265615|567173270|FG003|Overall Study|Protocol Violation|3|||
157114149|NCT01732796|567173271|FG000|Overall Study|Adverse Event|16|||
157114150|NCT01732796|567173272|FG001|Overall Study|Adverse Event|16|||
156775751|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775752|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775753|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
156775754|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
156775755|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
156775756|NCT03329001|565931298|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775757|NCT03329001|565931299|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775758|NCT03329001|565931300|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775759|NCT03329001|565931301|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775760|NCT03329001|565931302|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775761|NCT03329001|565931303|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
156775762|NCT03329001|565931304|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
157114151|NCT01732796|567173273|FG002|Overall Study|Adverse Event|4|||
156775763|NCT03329001|565931305|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
156775764|NCT00963235|565931311|FG000|Overall Study|Withdrawal by Subject|22|||
156775765|NCT00963235|565931311|FG000|Overall Study|Lost to Follow-up|14|||
156775766|NCT00963235|565931311|FG000|Overall Study|Failed to return|9|||
157007958|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
157007959|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
157007960|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
157007961|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
157007962|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
157007963|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
156775767|NCT00963235|565931311|FG000|Overall Study|Protocol Violation|7|||
156775768|NCT00963235|565931311|FG000|Overall Study|Adverse Event|5|||
156775769|NCT00963235|565931311|FG000|Overall Study|Physician Decision|2|||
156775770|NCT00963235|565931311|FG000|Overall Study|Other|1|||
156775771|NCT01136915|565931313|FG000|Overall Study|Lost to Follow-up|2|||
156775772|NCT01136915|565931314|FG001|Overall Study|Lost to Follow-up|0|||
156775773|NCT01136915|565931313|FG000|Overall Study|Exclusion criterion met|0|||
156775774|NCT01136915|565931314|FG001|Overall Study|Exclusion criterion met|1|||
156775775|NCT03965923|565931319|FG000|Overall Study|Withdrawal by Subject|1|||
156775776|NCT03965923|565931320|FG001|Overall Study|Withdrawal by Subject|2|||
156775777|NCT03965923|565931321|FG002|Overall Study|Withdrawal by Subject|3|||
156775778|NCT03965923|565931322|FG003|Overall Study|Withdrawal by Subject|1|||
156775779|NCT03965923|565931323|FG004|Overall Study|Withdrawal by Subject|2|||
156775780|NCT03965923|565931324|FG005|Overall Study|Withdrawal by Subject|0|||
156775781|NCT03965923|565931325|FG006|Overall Study|Withdrawal by Subject|4|||
156775782|NCT03965923|565931326|FG007|Overall Study|Withdrawal by Subject|3|||
156775783|NCT03965923|565931327|FG008|Overall Study|Withdrawal by Subject|4|||
156775784|NCT03965923|565931328|FG009|Overall Study|Withdrawal by Subject|0|||
156775785|NCT03965923|565931329|FG010|Overall Study|Withdrawal by Subject|2|||
156775786|NCT03965923|565931330|FG011|Overall Study|Withdrawal by Subject|0|||
156775787|NCT03965923|565931319|FG000|Overall Study|Lost to Follow-up|2|||
156775788|NCT03965923|565931320|FG001|Overall Study|Lost to Follow-up|1|||
156775789|NCT03965923|565931321|FG002|Overall Study|Lost to Follow-up|1|||
156775790|NCT03965923|565931322|FG003|Overall Study|Lost to Follow-up|0|||
156775791|NCT03965923|565931323|FG004|Overall Study|Lost to Follow-up|2|||
156775792|NCT03965923|565931324|FG005|Overall Study|Lost to Follow-up|1|||
156775793|NCT03965923|565931325|FG006|Overall Study|Lost to Follow-up|2|||
156775794|NCT03965923|565931326|FG007|Overall Study|Lost to Follow-up|1|||
156775795|NCT03965923|565931327|FG008|Overall Study|Lost to Follow-up|0|||
156775796|NCT03965923|565931328|FG009|Overall Study|Lost to Follow-up|2|||
156775797|NCT03965923|565931329|FG010|Overall Study|Lost to Follow-up|0|||
156775798|NCT03965923|565931330|FG011|Overall Study|Lost to Follow-up|0|||
156775799|NCT03965923|565931319|FG000|Overall Study|Death|0|||
156775800|NCT03965923|565931320|FG001|Overall Study|Death|0|||
156775801|NCT03965923|565931321|FG002|Overall Study|Death|0|||
156775802|NCT03965923|565931322|FG003|Overall Study|Death|0|||
156775803|NCT03965923|565931323|FG004|Overall Study|Death|0|||
156775804|NCT03965923|565931324|FG005|Overall Study|Death|0|||
156775805|NCT03965923|565931325|FG006|Overall Study|Death|0|||
156775806|NCT03965923|565931326|FG007|Overall Study|Death|1|||
156775807|NCT03965923|565931327|FG008|Overall Study|Death|4|||
156775808|NCT03965923|565931328|FG009|Overall Study|Death|0|||
157007964|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
157007965|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
157114152|NCT01732796|567173271|FG000|Overall Study|Lack of Efficacy|21|||
156775809|NCT03965923|565931329|FG010|Overall Study|Death|4|||
156775810|NCT03965923|565931330|FG011|Overall Study|Death|0|||
156775811|NCT03965923|565931319|FG000|Overall Study|Other reason|0|||
156775812|NCT03965923|565931320|FG001|Overall Study|Other reason|0|||
156775813|NCT03965923|565931321|FG002|Overall Study|Other reason|0|||
156775814|NCT03965923|565931322|FG003|Overall Study|Other reason|1|||
156775815|NCT03965923|565931323|FG004|Overall Study|Other reason|0|||
156775816|NCT03965923|565931324|FG005|Overall Study|Other reason|0|||
156775817|NCT03965923|565931325|FG006|Overall Study|Other reason|0|||
156775818|NCT03965923|565931326|FG007|Overall Study|Other reason|0|||
156775819|NCT03965923|565931327|FG008|Overall Study|Other reason|0|||
156775820|NCT03965923|565931328|FG009|Overall Study|Other reason|0|||
156775821|NCT03965923|565931329|FG010|Overall Study|Other reason|2|||
156775822|NCT03965923|565931330|FG011|Overall Study|Other reason|0|||
156775823|NCT02452190|565931331|FG000|Overall Study|Withdrawal by Sponsor|1|||
156775824|NCT02452190|565931332|FG001|Overall Study|Withdrawal by Sponsor|3|||
156775825|NCT02452190|565931331|FG000|Overall Study|Pregnancy|1|||
156775826|NCT02452190|565931332|FG001|Overall Study|Pregnancy|0|||
156775827|NCT02452190|565931331|FG000|Overall Study|Investigator's Decision|2|||
156775828|NCT02452190|565931332|FG001|Overall Study|Investigator's Decision|0|||
156775829|NCT02452190|565931331|FG000|Overall Study|Lack of Efficacy|3|||
156775830|NCT02452190|565931332|FG001|Overall Study|Lack of Efficacy|1|||
156775831|NCT02452190|565931331|FG000|Overall Study|Lost to Follow-up|4|||
156775832|NCT02452190|565931332|FG001|Overall Study|Lost to Follow-up|3|||
156775833|NCT02452190|565931331|FG000|Overall Study|Adverse Event|2|||
156775834|NCT02452190|565931332|FG001|Overall Study|Adverse Event|5|||
156775835|NCT02452190|565931331|FG000|Overall Study|Withdrawal by Subject|20|||
156775836|NCT02452190|565931332|FG001|Overall Study|Withdrawal by Subject|11|||
156775837|NCT02452190|565931331|FG000|Overall Study|Noncompliance with study drug|1|||
157007966|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
157007967|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
157114153|NCT01732796|567173272|FG001|Overall Study|Lack of Efficacy|18|||
156775838|NCT02452190|565931332|FG001|Overall Study|Noncompliance with study drug|0|||
156775839|NCT02452190|565931331|FG000|Overall Study|Participant traveled abroad|1|||
156775840|NCT02452190|565931332|FG001|Overall Study|Participant traveled abroad|0|||
156775841|NCT02452190|565931331|FG000|Overall Study|Death|0|||
156775842|NCT02452190|565931332|FG001|Overall Study|Death|1|||
156775843|NCT02327078|565931337|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775844|NCT02327078|565931338|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775845|NCT02327078|565931339|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
156775846|NCT02327078|565931340|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775847|NCT02327078|565931341|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
156775848|NCT02327078|565931342|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775849|NCT02327078|565931343|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
156775850|NCT02327078|565931344|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
156775851|NCT02327078|565931345|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
156775852|NCT02327078|565931337|FG000|Overall Study|Death|2|||
156775853|NCT02327078|565931338|FG001|Overall Study|Death|4|||
156775854|NCT02327078|565931339|FG002|Overall Study|Death|10|||
156775855|NCT02327078|565931340|FG003|Overall Study|Death|6|||
156775856|NCT02327078|565931341|FG004|Overall Study|Death|4|||
156775857|NCT02327078|565931342|FG005|Overall Study|Death|3|||
156775858|NCT02327078|565931343|FG006|Overall Study|Death|2|||
156775859|NCT02327078|565931344|FG007|Overall Study|Death|51|||
156775860|NCT02327078|565931345|FG008|Overall Study|Death|97|||
156775861|NCT02327078|565931337|FG000|Overall Study|Lost to Follow-up|0|||
156775862|NCT02327078|565931338|FG001|Overall Study|Lost to Follow-up|1|||
156775863|NCT02327078|565931339|FG002|Overall Study|Lost to Follow-up|1|||
156775864|NCT02327078|565931340|FG003|Overall Study|Lost to Follow-up|0|||
156775865|NCT02327078|565931341|FG004|Overall Study|Lost to Follow-up|0|||
156775866|NCT02327078|565931342|FG005|Overall Study|Lost to Follow-up|0|||
156775867|NCT02327078|565931343|FG006|Overall Study|Lost to Follow-up|0|||
156775868|NCT02327078|565931344|FG007|Overall Study|Lost to Follow-up|2|||
156775869|NCT02327078|565931345|FG008|Overall Study|Lost to Follow-up|5|||
156775870|NCT02327078|565931337|FG000|Overall Study|Site Terminated by Sponsor|1|||
156775871|NCT02327078|565931338|FG001|Overall Study|Site Terminated by Sponsor|0|||
156775872|NCT02327078|565931339|FG002|Overall Study|Site Terminated by Sponsor|1|||
156775873|NCT02327078|565931340|FG003|Overall Study|Site Terminated by Sponsor|4|||
156775874|NCT02327078|565931341|FG004|Overall Study|Site Terminated by Sponsor|0|||
156775875|NCT02327078|565931342|FG005|Overall Study|Site Terminated by Sponsor|0|||
156775876|NCT02327078|565931343|FG006|Overall Study|Site Terminated by Sponsor|0|||
156775877|NCT02327078|565931344|FG007|Overall Study|Site Terminated by Sponsor|11|||
156775878|NCT02327078|565931345|FG008|Overall Study|Site Terminated by Sponsor|25|||
156775879|NCT02327078|565931337|FG000|Overall Study|Physician Decision|0|||
156775880|NCT02327078|565931338|FG001|Overall Study|Physician Decision|0|||
156775881|NCT02327078|565931339|FG002|Overall Study|Physician Decision|0|||
156775882|NCT02327078|565931340|FG003|Overall Study|Physician Decision|1|||
156775883|NCT02327078|565931341|FG004|Overall Study|Physician Decision|0|||
156775884|NCT02327078|565931342|FG005|Overall Study|Physician Decision|0|||
156775885|NCT02327078|565931343|FG006|Overall Study|Physician Decision|0|||
156775886|NCT02327078|565931344|FG007|Overall Study|Physician Decision|0|||
156775887|NCT02327078|565931345|FG008|Overall Study|Physician Decision|1|||
156775888|NCT02327078|565931337|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775889|NCT02327078|565931338|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775890|NCT02327078|565931339|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775891|NCT02327078|565931340|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775892|NCT02327078|565931341|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775893|NCT02327078|565931342|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
156775894|NCT02327078|565931343|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
156775895|NCT02327078|565931344|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
156775896|NCT02327078|565931345|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
156775897|NCT02327078|565931337|FG000|Overall Study|Reason not Specified|0|||
156775898|NCT02327078|565931338|FG001|Overall Study|Reason not Specified|0|||
156775899|NCT02327078|565931339|FG002|Overall Study|Reason not Specified|0|||
156775900|NCT02327078|565931340|FG003|Overall Study|Reason not Specified|0|||
156775901|NCT02327078|565931341|FG004|Overall Study|Reason not Specified|0|||
156775902|NCT02327078|565931342|FG005|Overall Study|Reason not Specified|0|||
156775903|NCT02327078|565931343|FG006|Overall Study|Reason not Specified|0|||
156775904|NCT02327078|565931344|FG007|Overall Study|Reason not Specified|5|||
156775905|NCT02327078|565931345|FG008|Overall Study|Reason not Specified|12|||
156775906|NCT06001866|565931350|FG000|Overall Study|Withdrawal by Subject|0|||
156775907|NCT06001866|565931351|FG001|Overall Study|Withdrawal by Subject|2|||
156775908|NCT06001866|565931350|FG000|Overall Study|Protocol Violation|0|||
156775909|NCT06001866|565931351|FG001|Overall Study|Protocol Violation|2|||
156775910|NCT03112603|565931354|FG000|End of Randomization Period|Lost to Follow-up|3|||
156775911|NCT03112603|565931355|FG001|End of Randomization Period|Lost to Follow-up|0|||
156775912|NCT03112603|565931356|FG002|End of Randomization Period|Lost to Follow-up|0|||
156775913|NCT03112603|565931354|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
156775914|NCT03112603|565931355|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
156775915|NCT03112603|565931356|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
156775916|NCT03112603|565931354|FG000|End of Randomization Period|Physician Decision|43|||
156775917|NCT03112603|565931355|FG001|End of Randomization Period|Physician Decision|18|||
156775918|NCT03112603|565931356|FG002|End of Randomization Period|Physician Decision|0|||
157114154|NCT01732796|567173273|FG002|Overall Study|Lack of Efficacy|5|||
156775919|NCT03112603|565931354|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
156775920|NCT03112603|565931355|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
156775921|NCT03112603|565931356|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
156775922|NCT03112603|565931354|FG000|End of Randomization Period|Death|10|||
156775923|NCT03112603|565931355|FG001|End of Randomization Period|Death|7|||
157007968|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
157007969|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
157007970|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
157007971|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
157007972|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
157007973|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
157007974|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
157007975|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
157007976|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
157007977|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
157007978|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
157007979|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
157007980|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
157007981|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
157007982|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
157007983|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
157007984|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
157007985|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
157007986|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
157007987|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
157007988|NCT03593213|566778940|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
157007989|NCT03593213|566778941|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
157007990|NCT03593213|566778942|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
157007991|NCT03593213|566778943|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
157007992|NCT03184558|566778946|FG000|Overall Study|Withdrawal by Subject|2|||
157007993|NCT03184558|566778946|FG000|Overall Study|Death|16|||
157007994|NCT03184558|566778946|FG000|Overall Study|Lost to Follow-up|2|||
157007995|NCT03184558|566778946|FG000|Overall Study|Other|9|||
157007996|NCT01831791|566778947|FG000|Overall Study|Withdrawal by Subject|10|||
156775924|NCT03112603|565931356|FG002|End of Randomization Period|Death|0|||
157007997|NCT00494780|566778948|FG000|Overall Study|Adverse Event|1|||
156775925|NCT03112603|565931354|FG000|End of Randomization Period|Disease Relapse|12|||
156775926|NCT03112603|565931355|FG001|End of Randomization Period|Disease Relapse|7|||
157007998|NCT00494780|566778949|FG001|Overall Study|Adverse Event|0|||
156775927|NCT03112603|565931356|FG002|End of Randomization Period|Disease Relapse|0|||
156775928|NCT03112603|565931354|FG000|End of Randomization Period|Lack of Efficacy|25|||
156775929|NCT03112603|565931355|FG001|End of Randomization Period|Lack of Efficacy|77|||
156775930|NCT03112603|565931356|FG002|End of Randomization Period|Lack of Efficacy|0|||
156775931|NCT03112603|565931354|FG000|End of Randomization Period|Adverse Event|32|||
156775932|NCT03112603|565931355|FG001|End of Randomization Period|Adverse Event|12|||
156775933|NCT03112603|565931356|FG002|End of Randomization Period|Adverse Event|0|||
156775934|NCT03112603|565931354|FG000|End of Cross Over Period|Death|0|||
156775935|NCT03112603|565931355|FG001|End of Cross Over Period|Death|0|||
156775936|NCT03112603|565931356|FG002|End of Cross Over Period|Death|2|||
156775937|NCT03112603|565931354|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
156775938|NCT03112603|565931355|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
156775939|NCT03112603|565931356|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
156775940|NCT03112603|565931354|FG000|End of Cross Over Period|Physician Decision|0|||
156775941|NCT03112603|565931355|FG001|End of Cross Over Period|Physician Decision|0|||
156775942|NCT03112603|565931356|FG002|End of Cross Over Period|Physician Decision|29|||
156775943|NCT03112603|565931354|FG000|End of Cross Over Period|Lack of Efficacy|0|||
156775944|NCT03112603|565931355|FG001|End of Cross Over Period|Lack of Efficacy|0|||
156775945|NCT03112603|565931356|FG002|End of Cross Over Period|Lack of Efficacy|8|||
156775946|NCT03112603|565931354|FG000|End of Cross Over Period|Adverse Event|0|||
156775947|NCT03112603|565931355|FG001|End of Cross Over Period|Adverse Event|0|||
156775948|NCT03112603|565931356|FG002|End of Cross Over Period|Adverse Event|6|||
156775949|NCT03112603|565931354|FG000|End of Cross Over Period|Disease Relapse|0|||
156775950|NCT03112603|565931355|FG001|End of Cross Over Period|Disease Relapse|0|||
156775951|NCT03112603|565931356|FG002|End of Cross Over Period|Disease Relapse|2|||
156775952|NCT04725188|565931357|FG000|Overall Study|Death|72|||
156775953|NCT04725188|565931358|FG001|Overall Study|Death|69|||
156775954|NCT04725188|565931359|FG002|Overall Study|Death|76|||
156775955|NCT04725188|565931357|FG000|Overall Study|Lost to Follow-up|1|||
157114155|NCT01732796|567173271|FG000|Overall Study|Lost to Follow-up|2|||
157114156|NCT01732796|567173272|FG001|Overall Study|Lost to Follow-up|0|||
157007999|NCT00494780|566778948|FG000|Overall Study|Withdrew before Dosed|0|||
157008000|NCT00494780|566778949|FG001|Overall Study|Withdrew before Dosed|1|||
157008001|NCT00494780|566778948|FG000|Overall Study|Progression of Study Disease|7|||
157008002|NCT00494780|566778949|FG001|Overall Study|Progression of Study Disease|8|||
157008003|NCT00494780|566778948|FG000|Overall Study|New Treatment|2|||
157008004|NCT00494780|566778949|FG001|Overall Study|New Treatment|2|||
157008005|NCT00494780|566778948|FG000|Overall Study|Non-compliance|1|||
157008006|NCT00494780|566778949|FG001|Overall Study|Non-compliance|0|||
157008007|NCT00494780|566778948|FG000|Overall Study|Residual Tumour Mass|0|||
157008008|NCT00494780|566778949|FG001|Overall Study|Residual Tumour Mass|1|||
157008009|NCT00494780|566778948|FG000|Overall Study|Insurance Issues|0|||
157008010|NCT00494780|566778949|FG001|Overall Study|Insurance Issues|1|||
157008011|NCT01391130|566778956|FG000|Overall Study|Withdrawal by Subject|3|||
157008012|NCT01391130|566778957|FG001|Overall Study|Withdrawal by Subject|2|||
157008013|NCT01391130|566778956|FG000|Overall Study|Physician Decision|2|||
157008014|NCT01391130|566778957|FG001|Overall Study|Physician Decision|3|||
157008015|NCT01391130|566778956|FG000|Overall Study|Did not Receive Drug|1|||
157008016|NCT01391130|566778957|FG001|Overall Study|Did not Receive Drug|1|||
157008017|NCT03260140|566778958|FG000|Overall Study|Death|4|||
157008018|NCT03260140|566778959|FG001|Overall Study|Death|1|||
157008019|NCT03260140|566778958|FG000|Overall Study|Withdrawal by Subject|1|||
157008020|NCT03260140|566778959|FG001|Overall Study|Withdrawal by Subject|4|||
157008021|NCT00463788|566778960|FG000|Overall Study|Progressive Disease|86|||
157008022|NCT00463788|566778961|FG001|Overall Study|Progressive Disease|42|||
157008023|NCT00463788|566778960|FG000|Overall Study|Adverse Event|6|||
157008024|NCT00463788|566778961|FG001|Overall Study|Adverse Event|2|||
157008025|NCT00463788|566778960|FG000|Overall Study|Withdrawal by Subject|6|||
157008026|NCT00463788|566778961|FG001|Overall Study|Withdrawal by Subject|2|||
157008027|NCT00463788|566778960|FG000|Overall Study|Death|4|||
157008028|NCT00463788|566778961|FG001|Overall Study|Death|3|||
157008029|NCT00463788|566778960|FG000|Overall Study|Symptomatic Deterioration|2|||
157008030|NCT00463788|566778961|FG001|Overall Study|Symptomatic Deterioration|3|||
157008031|NCT00463788|566778960|FG000|Overall Study|Lost to Follow-up|1|||
157008032|NCT00463788|566778961|FG001|Overall Study|Lost to Follow-up|0|||
157008033|NCT00463788|566778960|FG000|Overall Study|Protocol Violation|0|||
157008034|NCT00463788|566778961|FG001|Overall Study|Protocol Violation|1|||
157008035|NCT00463788|566778960|FG000|Overall Study|Other|3|||
157008036|NCT00463788|566778961|FG001|Overall Study|Other|0|||
157114157|NCT01732796|567173273|FG002|Overall Study|Lost to Follow-up|0|||
157114158|NCT01732796|567173271|FG000|Overall Study|Withdrawal by Subject|6|||
157114159|NCT01732796|567173272|FG001|Overall Study|Withdrawal by Subject|8|||
157114160|NCT01732796|567173273|FG002|Overall Study|Withdrawal by Subject|2|||
157114161|NCT01732796|567173271|FG000|Overall Study|Other reason not defined above|1|||
157114162|NCT01732796|567173272|FG001|Overall Study|Other reason not defined above|0|||
157114163|NCT01732796|567173273|FG002|Overall Study|Other reason not defined above|2|||
157114164|NCT00876187|567173275|FG000|Overall Study|Adverse Event|14|||
157114165|NCT00876187|567173276|FG001|Overall Study|Adverse Event|12|||
157114166|NCT00876187|567173277|FG002|Overall Study|Adverse Event|19|||
157114167|NCT00876187|567173278|FG003|Overall Study|Adverse Event|29|||
157114168|NCT00876187|567173279|FG004|Overall Study|Adverse Event|10|||
157114169|NCT00876187|567173275|FG000|Overall Study|Lack of Efficacy|59|||
157114170|NCT00876187|567173276|FG001|Overall Study|Lack of Efficacy|34|||
157114171|NCT00876187|567173277|FG002|Overall Study|Lack of Efficacy|45|||
157114172|NCT00876187|567173278|FG003|Overall Study|Lack of Efficacy|34|||
157114173|NCT00876187|567173279|FG004|Overall Study|Lack of Efficacy|59|||
157114174|NCT00876187|567173275|FG000|Overall Study|Lost to Follow-up|9|||
157114175|NCT00876187|567173276|FG001|Overall Study|Lost to Follow-up|10|||
157114176|NCT00876187|567173277|FG002|Overall Study|Lost to Follow-up|8|||
157114177|NCT00876187|567173278|FG003|Overall Study|Lost to Follow-up|8|||
157114178|NCT00876187|567173279|FG004|Overall Study|Lost to Follow-up|11|||
157114179|NCT00876187|567173275|FG000|Overall Study|Protocol Violation|6|||
157114180|NCT00876187|567173276|FG001|Overall Study|Protocol Violation|7|||
157114181|NCT00876187|567173277|FG002|Overall Study|Protocol Violation|7|||
157114182|NCT00876187|567173278|FG003|Overall Study|Protocol Violation|6|||
157114183|NCT00876187|567173279|FG004|Overall Study|Protocol Violation|3|||
157114184|NCT00876187|567173275|FG000|Overall Study|Withdrawal by Subject|16|||
157114185|NCT00876187|567173276|FG001|Overall Study|Withdrawal by Subject|26|||
157114186|NCT00876187|567173277|FG002|Overall Study|Withdrawal by Subject|32|||
157114187|NCT00876187|567173278|FG003|Overall Study|Withdrawal by Subject|38|||
157114188|NCT00876187|567173279|FG004|Overall Study|Withdrawal by Subject|37|||
157114189|NCT00876187|567173275|FG000|Overall Study|Entered extension study|101|||
157114190|NCT00876187|567173276|FG001|Overall Study|Entered extension study|120|||
157114191|NCT00876187|567173277|FG002|Overall Study|Entered extension study|156|||
157114192|NCT00876187|567173278|FG003|Overall Study|Entered extension study|151|||
157114193|NCT00876187|567173279|FG004|Overall Study|Entered extension study|144|||
157114194|NCT00876187|567173275|FG000|Overall Study|Randomized but not treated|3|||
157114195|NCT00876187|567173276|FG001|Overall Study|Randomized but not treated|1|||
157114196|NCT00876187|567173277|FG002|Overall Study|Randomized but not treated|3|||
156775956|NCT04725188|565931358|FG001|Overall Study|Lost to Follow-up|0|||
157114197|NCT00876187|567173278|FG003|Overall Study|Randomized but not treated|2|||
157114198|NCT00876187|567173279|FG004|Overall Study|Randomized but not treated|3|||
157114199|NCT00876187|567173275|FG000|Overall Study|Other|2|||
157114200|NCT00876187|567173276|FG001|Overall Study|Other|5|||
157114201|NCT00876187|567173277|FG002|Overall Study|Other|9|||
157114202|NCT00876187|567173278|FG003|Overall Study|Other|7|||
157114203|NCT00876187|567173279|FG004|Overall Study|Other|4|||
157114204|NCT00838331|567173280|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
157114205|NCT01379274|567173281|FG000|Overall Study|funding withdrawn|1|||
157114206|NCT00957008|567173282|FG000|Overall Study|Withdrawal by Subject|13|||
157008037|NCT00463788|566778960|FG000|Overall Study|Randomized but not treated|1|||
157008038|NCT00463788|566778961|FG001|Overall Study|Randomized but not treated|1|||
157008039|NCT00360698|566778962|FG000|Run-In|Physician Decision|0|||
157008040|NCT00360698|566778963|FG001|Run-In|Physician Decision|1|||
157008041|NCT00360698|566778962|FG000|Run-In|Withdrawal by Subject|0|||
157008042|NCT00360698|566778963|FG001|Run-In|Withdrawal by Subject|2|||
157008043|NCT00360698|566778962|FG000|Run-In|Non compliance with treatment procedure|0|||
157008044|NCT00360698|566778963|FG001|Run-In|Non compliance with treatment procedure|1|||
157008045|NCT00360698|566778962|FG000|Run-In|Sponsor request|0|||
157008046|NCT00360698|566778963|FG001|Run-In|Sponsor request|2|||
157008047|NCT00360698|566778962|FG000|Run-In|Patient did not meet inclusion criteria|0|||
157008048|NCT00360698|566778963|FG001|Run-In|Patient did not meet inclusion criteria|1|||
157008049|NCT00360698|566778962|FG000|Run-In|Patient personal reasons|0|||
157008050|NCT00360698|566778963|FG001|Run-In|Patient personal reasons|2|||
157008051|NCT00360698|566778962|FG000|Run-In|Need of insulin with meals|0|||
157008052|NCT00360698|566778963|FG001|Run-In|Need of insulin with meals|1|||
157008053|NCT00360698|566778962|FG000|Treatment Period|Non compliance with treatment procedure|1|||
157008054|NCT00360698|566778963|FG001|Treatment Period|Non compliance with treatment procedure|0|||
157008055|NCT00360698|566778962|FG000|Treatment Period|Early termination by error|0|||
157008056|NCT00360698|566778963|FG001|Treatment Period|Early termination by error|1|||
157008057|NCT01692938|566778964|FG000|Overall Study|Protocol Deviation|1|||
157008058|NCT01692938|566778965|FG001|Overall Study|Protocol Deviation|1|||
157008059|NCT01692938|566778964|FG000|Overall Study|Study completed prior to site completion|3|||
157008060|NCT01692938|566778965|FG001|Overall Study|Study completed prior to site completion|3|||
156775957|NCT04725188|565931359|FG002|Overall Study|Lost to Follow-up|1|||
157008061|NCT02423291|566778969|FG000|Overall Study|Lack of Efficacy|14|||
157008062|NCT02423291|566778969|FG000|Overall Study|Adverse Event|1|||
157114207|NCT00957008|567173283|FG001|Overall Study|Withdrawal by Subject|10|||
157114208|NCT00957008|567173284|FG002|Overall Study|Withdrawal by Subject|12|||
157114209|NCT00957008|567173285|FG003|Overall Study|Withdrawal by Subject|16|||
157114210|NCT00957008|567173282|FG000|Overall Study|Lost to Follow-up|3|||
157114211|NCT00957008|567173283|FG001|Overall Study|Lost to Follow-up|1|||
157114212|NCT00957008|567173284|FG002|Overall Study|Lost to Follow-up|3|||
157114213|NCT00957008|567173285|FG003|Overall Study|Lost to Follow-up|4|||
157114214|NCT00957008|567173282|FG000|Overall Study|Physician Decision|1|||
157114215|NCT00957008|567173283|FG001|Overall Study|Physician Decision|0|||
157114216|NCT00957008|567173284|FG002|Overall Study|Physician Decision|1|||
157114217|NCT00957008|567173285|FG003|Overall Study|Physician Decision|1|||
157114218|NCT00957008|567173282|FG000|Overall Study|Relocated; Family conflict|4|||
157114219|NCT00957008|567173283|FG001|Overall Study|Relocated; Family conflict|1|||
157114220|NCT00957008|567173284|FG002|Overall Study|Relocated; Family conflict|1|||
157114221|NCT00957008|567173285|FG003|Overall Study|Relocated; Family conflict|3|||
157114222|NCT02411539|567173293|FG000|Overall Study|Lost to Follow-up|2|||
157114223|NCT02411539|567173294|FG001|Overall Study|Lost to Follow-up|0|||
157114224|NCT02411539|567173293|FG000|Overall Study|Confounding medical condition|0|||
157114225|NCT02411539|567173294|FG001|Overall Study|Confounding medical condition|1|||
157114226|NCT01422915|567173297|FG000|Overall Study|Adverse Event|1|||
157114227|NCT01265797|567173298|FG000|Run-in Month|Withdrawal by Subject|0|||
157114228|NCT01265797|567173299|FG001|Run-in Month|Withdrawal by Subject|4|||
157114229|NCT01265797|567173298|FG000|Run-in Month|1st seizure during run-in month|0|||
157114230|NCT01265797|567173299|FG001|Run-in Month|1st seizure during run-in month|1|||
157114231|NCT01265797|567173298|FG000|Blinded Month|Lack of Efficacy|5|||
157114232|NCT01265797|567173299|FG001|Blinded Month|Lack of Efficacy|0|||
157114233|NCT01265797|567173298|FG000|Blinded Month|Lost to Follow-up|1|||
157114234|NCT01265797|567173299|FG001|Blinded Month|Lost to Follow-up|0|||
157114235|NCT01265797|567173298|FG000|Blinded Month|Protocol Violation|2|||
157114236|NCT01265797|567173299|FG001|Blinded Month|Protocol Violation|1|||
157114237|NCT01265797|567173298|FG000|Blinded Month|Adverse Event|2|||
157114238|NCT01265797|567173299|FG001|Blinded Month|Adverse Event|0|||
157114239|NCT01265797|567173298|FG000|Blinded Month|Diary data incomplete|0|||
157114240|NCT01265797|567173299|FG001|Blinded Month|Diary data incomplete|1|||
157114241|NCT01265797|567173298|FG000|Open Label Month|Lost to Follow-up|0|||
157114242|NCT01265797|567173299|FG001|Open Label Month|Lost to Follow-up|1|||
157114243|NCT00939783|567173301|FG000|Overall Study|Death|6|||
157114244|NCT00939783|567173301|FG000|Overall Study|Adverse Event|39|||
157114245|NCT00939783|567173301|FG000|Overall Study|Study Terminated by Sponsor|498|||
157114246|NCT00939783|567173301|FG000|Overall Study|Withdrawal by Subject|78|||
157114247|NCT00939783|567173301|FG000|Overall Study|Other|16|||
157114248|NCT00939783|567173301|FG000|Overall Study|Lost to Follow-up|8|||
157114249|NCT00939783|567173301|FG000|Overall Study|Protocol Violation|3|||
157114250|NCT00939783|567173301|FG000|Overall Study|Enrolled but not treated|1|||
157114251|NCT03631732|567173308|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
157114252|NCT03631732|567173309|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
157114253|NCT03631732|567173308|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
157114254|NCT03631732|567173309|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
157114255|NCT03631732|567173308|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
157114256|NCT03631732|567173309|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
157114257|NCT03631732|567173308|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
157114258|NCT03631732|567173309|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
157114259|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
157114260|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
157114261|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
157208364|NCT03193190|567508026|FG004|Stage 1|Progressive Disease|0|||
157114262|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
157114263|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
157114264|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
157114265|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
157114266|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
157114267|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
157114268|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
157114269|NCT03631732|567173308|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
157114270|NCT03631732|567173309|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
157114271|NCT01439204|567173310|FG000|Overall Study|Withdrawal by Subject|0|||
157114272|NCT01439204|567173311|FG001|Overall Study|Withdrawal by Subject|1|||
157114273|NCT01439204|567173310|FG000|Overall Study|Lost to Follow-up|0|||
157114274|NCT01439204|567173311|FG001|Overall Study|Lost to Follow-up|2|||
157114275|NCT01439204|567173310|FG000|Overall Study|No longer meets study criteria|1|||
157114276|NCT01439204|567173311|FG001|Overall Study|No longer meets study criteria|0|||
157114277|NCT01439204|567173310|FG000|Overall Study|poor/non-compliance|3|||
157114278|NCT01439204|567173311|FG001|Overall Study|poor/non-compliance|0|||
156775958|NCT04725188|565931357|FG000|Overall Study|Withdrawal by Subject|2|||
156775959|NCT04725188|565931358|FG001|Overall Study|Withdrawal by Subject|2|||
156775960|NCT04725188|565931359|FG002|Overall Study|Withdrawal by Subject|1|||
156775961|NCT04725188|565931357|FG000|Overall Study|Sponsor Decision|12|||
156775962|NCT04725188|565931358|FG001|Overall Study|Sponsor Decision|12|||
156775963|NCT04725188|565931359|FG002|Overall Study|Sponsor Decision|7|||
157114279|NCT02255409|567173312|FG000|Overall Study|Administrative Reason|3|||
157114280|NCT02255409|567173313|FG001|Overall Study|Administrative Reason|7|||
157114281|NCT02255409|567173312|FG000|Overall Study|Withdrawal by Subject|1|||
157114282|NCT02255409|567173313|FG001|Overall Study|Withdrawal by Subject|5|||
157114283|NCT02255409|567173312|FG000|Overall Study|Lost to Follow-up|10|||
156775964|NCT00390013|565931361|FG000|Phase 1|tired|0|||
157114284|NCT02255409|567173313|FG001|Overall Study|Lost to Follow-up|19|||
157114285|NCT03775421|567173315|FG000|Overall Study|Lost to Follow-up|2|||
156775965|NCT00390013|565931362|FG001|Phase 1|tired|0|||
156775966|NCT00390013|565931363|FG002|Phase 1|tired|0|||
157114286|NCT03775421|567173315|FG000|Overall Study|Withdrawal by Subject|10|||
157008063|NCT00712335|566778973|FG000|Overall Study|Withdrawal by Subject|0|||
157008064|NCT00712335|566778974|FG001|Overall Study|Withdrawal by Subject|7|||
157008065|NCT00712335|566778975|FG002|Overall Study|Withdrawal by Subject|2|||
157008066|NCT00712335|566778976|FG003|Overall Study|Withdrawal by Subject|3|||
157008067|NCT00712335|566778977|FG004|Overall Study|Withdrawal by Subject|0|||
157114287|NCT03775421|567173315|FG000|Overall Study|Physician Decision|3|||
157114288|NCT03775421|567173315|FG000|Overall Study|Death|1|||
157114289|NCT03775421|567173315|FG000|Overall Study|Study Terminated by Sponsor|94|||
157114290|NCT02287623|567173323|FG000|Overall Study|Protocol Violation|0|||
157114291|NCT02287623|567173324|FG001|Overall Study|Protocol Violation|1|||
157114292|NCT02700997|567173325|FG000|Overall Study|Did not undergo CT imaging|1|||
157114293|NCT02700997|567173325|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
157114294|NCT01445951|567173329|FG000|Overall Study|Adverse Event|16|||
157114295|NCT01445951|567173330|FG001|Overall Study|Adverse Event|9|||
157114296|NCT01445951|567173331|FG002|Overall Study|Adverse Event|0|||
157114297|NCT01445951|567173329|FG000|Overall Study|Protocol Violation|2|||
157114298|NCT01445951|567173330|FG001|Overall Study|Protocol Violation|2|||
157114299|NCT01445951|567173331|FG002|Overall Study|Protocol Violation|2|||
157114300|NCT01445951|567173329|FG000|Overall Study|Withdrawal by Subject|21|||
157114301|NCT01445951|567173330|FG001|Overall Study|Withdrawal by Subject|16|||
157114302|NCT01445951|567173331|FG002|Overall Study|Withdrawal by Subject|8|||
157114303|NCT01445951|567173329|FG000|Overall Study|Physician Decision|3|||
157114304|NCT01445951|567173330|FG001|Overall Study|Physician Decision|1|||
157114305|NCT01445951|567173331|FG002|Overall Study|Physician Decision|0|||
157114306|NCT01445951|567173329|FG000|Overall Study|Lost to Follow-up|1|||
157114307|NCT01445951|567173330|FG001|Overall Study|Lost to Follow-up|2|||
157114308|NCT01445951|567173331|FG002|Overall Study|Lost to Follow-up|4|||
157114309|NCT01445951|567173329|FG000|Overall Study|Pregnancy|0|||
157114310|NCT01445951|567173330|FG001|Overall Study|Pregnancy|1|||
157114311|NCT01445951|567173331|FG002|Overall Study|Pregnancy|4|||
157114312|NCT01445951|567173329|FG000|Overall Study|Death|0|||
157114313|NCT01445951|567173330|FG001|Overall Study|Death|0|||
157114314|NCT01445951|567173331|FG002|Overall Study|Death|1|||
157114315|NCT01445951|567173329|FG000|Overall Study|Non-compliance with study drug|1|||
157114316|NCT01445951|567173330|FG001|Overall Study|Non-compliance with study drug|2|||
157114317|NCT01445951|567173331|FG002|Overall Study|Non-compliance with study drug|0|||
157114318|NCT01445951|567173329|FG000|Overall Study|Non-compliance with protocol|0|||
157114319|NCT01445951|567173330|FG001|Overall Study|Non-compliance with protocol|1|||
157114320|NCT01445951|567173331|FG002|Overall Study|Non-compliance with protocol|0|||
157114321|NCT01445951|567173329|FG000|Overall Study|Sponsor decision - subject travel|0|||
157114322|NCT01445951|567173330|FG001|Overall Study|Sponsor decision - subject travel|1|||
157114323|NCT01445951|567173331|FG002|Overall Study|Sponsor decision - subject travel|0|||
157114324|NCT01445951|567173329|FG000|Overall Study|Cough|0|||
157114325|NCT01445951|567173330|FG001|Overall Study|Cough|1|||
157114326|NCT01445951|567173331|FG002|Overall Study|Cough|0|||
157114327|NCT01473563|567173332|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
157114328|NCT03610724|567173333|FG000|Overall Study|Death|17|||
157114329|NCT03610724|567173333|FG000|Overall Study|Lost to Follow-up|1|||
157114330|NCT03610724|567173333|FG000|Overall Study|Physician Decision|1|||
157008068|NCT00712335|566778973|FG000|Overall Study|Lost to Follow-up|2|||
157008069|NCT00712335|566778974|FG001|Overall Study|Lost to Follow-up|5|||
157008070|NCT00712335|566778975|FG002|Overall Study|Lost to Follow-up|0|||
157114331|NCT03610724|567173333|FG000|Overall Study|Died prior to infusion|1|||
157114332|NCT02739620|567173334|FG000|Overall Study|Lost to Follow-up|3|||
157114333|NCT02739620|567173335|FG001|Overall Study|Lost to Follow-up|1|||
157114334|NCT02739620|567173334|FG000|Overall Study|Adverse Event|0|||
157114335|NCT02739620|567173335|FG001|Overall Study|Adverse Event|1|||
157114336|NCT00786565|567173339|FG000|Enrollment Prior to Surgery|Site Closed|3|||
157114337|NCT00786565|567173339|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
157114338|NCT00786565|567173339|FG000|Post Surgery|Abnormal macular pucker|1|||
157114339|NCT00786565|567173339|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
157114340|NCT05513625|567173340|FG000|Overall Study|Withdrawal by Subject|1|||
157114341|NCT02943564|567173342|FG000|Overall Study|Miscellaneous Reasons|0|||
157114342|NCT02943564|567173343|FG001|Overall Study|Miscellaneous Reasons|0|||
157114343|NCT02943564|567173344|FG002|Overall Study|Miscellaneous Reasons|3|||
157114344|NCT02943564|567173342|FG000|Overall Study|Site terminated by sponsor|0|||
157114345|NCT02943564|567173343|FG001|Overall Study|Site terminated by sponsor|1|||
157208365|NCT03193190|567508027|FG005|Stage 1|Progressive Disease|0|||
157114346|NCT02943564|567173344|FG002|Overall Study|Site terminated by sponsor|0|||
157114347|NCT02943564|567173342|FG000|Overall Study|Non-compliance with study drug|0|||
157208366|NCT03193190|567508028|FG006|Stage 1|Progressive Disease|0|||
157114348|NCT02943564|567173343|FG001|Overall Study|Non-compliance with study drug|1|||
157114349|NCT02943564|567173344|FG002|Overall Study|Non-compliance with study drug|0|||
157114350|NCT02943564|567173342|FG000|Overall Study|Pregnancy|0|||
157208367|NCT03193190|567508029|FG007|Stage 1|Progressive Disease|0|||
157008071|NCT00712335|566778976|FG003|Overall Study|Lost to Follow-up|1|||
157008072|NCT00712335|566778977|FG004|Overall Study|Lost to Follow-up|0|||
157114351|NCT02943564|567173343|FG001|Overall Study|Pregnancy|1|||
157114352|NCT02943564|567173344|FG002|Overall Study|Pregnancy|1|||
157114353|NCT02943564|567173342|FG000|Overall Study|Protocol Violation|2|||
157114354|NCT02943564|567173343|FG001|Overall Study|Protocol Violation|2|||
157114355|NCT02943564|567173344|FG002|Overall Study|Protocol Violation|2|||
157114356|NCT02943564|567173342|FG000|Overall Study|Lost to Follow-up|1|||
157114357|NCT02943564|567173343|FG001|Overall Study|Lost to Follow-up|0|||
157114358|NCT02943564|567173344|FG002|Overall Study|Lost to Follow-up|0|||
157114359|NCT02943564|567173342|FG000|Overall Study|Withdrawal by Subject|6|||
157114360|NCT02943564|567173343|FG001|Overall Study|Withdrawal by Subject|5|||
157114361|NCT02943564|567173344|FG002|Overall Study|Withdrawal by Subject|2|||
157114362|NCT02943564|567173342|FG000|Overall Study|Adverse Event|1|||
157114363|NCT02943564|567173343|FG001|Overall Study|Adverse Event|2|||
156775967|NCT00390013|565931364|FG003|Phase 1|tired|1|||
156775968|NCT00390013|565931361|FG000|Phase 2 First Treatment|tired|1|||
157114364|NCT02943564|567173344|FG002|Overall Study|Adverse Event|1|||
157114365|NCT02943564|567173342|FG000|Overall Study|Lack of Efficacy|0|||
157114366|NCT02943564|567173343|FG001|Overall Study|Lack of Efficacy|1|||
157114367|NCT02943564|567173344|FG002|Overall Study|Lack of Efficacy|0|||
157114368|NCT02536313|567173345|FG000|Overall Study|Lack of Efficacy|0|||
157114369|NCT02536313|567173346|FG001|Overall Study|Lack of Efficacy|1|||
157208368|NCT03193190|567508030|FG008|Stage 1|Progressive Disease|0|||
157114370|NCT01924182|567173347|FG000|Overall Study|Withdrawal by Subject|1|||
157114371|NCT01924182|567173348|FG001|Overall Study|Withdrawal by Subject|0|||
157114372|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
157008073|NCT00712335|566778973|FG000|Overall Study|Protocol Violation|1|||
157008074|NCT00712335|566778974|FG001|Overall Study|Protocol Violation|2|||
157008075|NCT00712335|566778975|FG002|Overall Study|Protocol Violation|1|||
157008076|NCT00712335|566778976|FG003|Overall Study|Protocol Violation|0|||
157008077|NCT00712335|566778977|FG004|Overall Study|Protocol Violation|0|||
157008078|NCT00712335|566778973|FG000|Overall Study|Lack of Efficacy|0|||
156775969|NCT00390013|565931362|FG001|Phase 2 First Treatment|tired|0|||
156775970|NCT00390013|565931363|FG002|Phase 2 First Treatment|tired|0|||
156775971|NCT00390013|565931364|FG003|Phase 2 First Treatment|tired|0|||
156775972|NCT00390013|565931361|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775973|NCT00390013|565931362|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
156775974|NCT00390013|565931363|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775975|NCT00390013|565931364|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
156775976|NCT03839641|565931365|FG000|Overall Study|Withdrawal by Subject|1|||
156775977|NCT03839641|565931366|FG001|Overall Study|Withdrawal by Subject|1|||
156775978|NCT04221490|565931370|FG000|At 30 Days Follow-up|Death|7|||
156775979|NCT04221490|565931370|FG000|At 30 Days Follow-up|Missed Visit|4|||
156775980|NCT04221490|565931370|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
156775981|NCT04221490|565931370|FG000|At 6 Months Follow-up|Death|9|||
156775982|NCT04221490|565931370|FG000|At 6 Months Follow-up|Physician Decision|1|||
156775983|NCT04221490|565931370|FG000|At 6 Months Follow-up|Missed Visit|8|||
156775984|NCT04221490|565931370|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
156775985|NCT04896385|565931383|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
156775986|NCT04896385|565931384|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
156775987|NCT04896385|565931385|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
156775988|NCT04896385|565931386|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
156775989|NCT04896385|565931383|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
156775990|NCT04896385|565931384|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
157008079|NCT00712335|566778974|FG001|Overall Study|Lack of Efficacy|0|||
157008080|NCT00712335|566778975|FG002|Overall Study|Lack of Efficacy|1|||
157008081|NCT00712335|566778976|FG003|Overall Study|Lack of Efficacy|1|||
157008082|NCT00712335|566778977|FG004|Overall Study|Lack of Efficacy|0|||
157008083|NCT00712335|566778973|FG000|Overall Study|Other Reason|0|||
157008084|NCT00712335|566778974|FG001|Overall Study|Other Reason|3|||
157008085|NCT00712335|566778975|FG002|Overall Study|Other Reason|1|||
157008086|NCT00712335|566778976|FG003|Overall Study|Other Reason|0|||
157008087|NCT00712335|566778977|FG004|Overall Study|Other Reason|0|||
157008088|NCT00424645|566778978|FG000|Overall Study|Death|1|||
157008089|NCT00424645|566778979|FG001|Overall Study|Death|0|||
157008090|NCT02994654|566778980|FG000|Overall Study|Lost to Follow-up|1|||
157008091|NCT03603717|566778985|FG000|Overall Study|Lost to Follow-up|20|||
157008092|NCT03603717|566778986|FG001|Overall Study|Lost to Follow-up|20|||
157008093|NCT03603717|566778985|FG000|Overall Study|Withdrawal by Subject|16|||
157008094|NCT03603717|566778986|FG001|Overall Study|Withdrawal by Subject|10|||
157008095|NCT00732381|566778987|FG000|Overall Study|Adverse Event|1|||
157008096|NCT00732381|566778988|FG001|Overall Study|Adverse Event|0|||
157008097|NCT00732381|566778987|FG000|Overall Study|Treatment Failure|1|||
157008098|NCT00732381|566778988|FG001|Overall Study|Treatment Failure|1|||
157008099|NCT04603924|566780098|FG000|Overall Study|Not Dosed|2|||
157008100|NCT04603924|566780099|FG001|Overall Study|Not Dosed|1|||
157008101|NCT04603924|566780098|FG000|Overall Study|Withdrawal by Subject|6|||
157008102|NCT04603924|566780099|FG001|Overall Study|Withdrawal by Subject|6|||
157008103|NCT04603924|566780098|FG000|Overall Study|Adverse Event|2|||
157008104|NCT04603924|566780099|FG001|Overall Study|Adverse Event|2|||
157008105|NCT03762668|566780102|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
157008106|NCT03762668|566780103|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
157008107|NCT00686855|566780107|FG000|Overall Study|Lost to Follow-up|1|||
157008108|NCT00686855|566780108|FG001|Overall Study|Lost to Follow-up|0|||
157008109|NCT00686855|566780107|FG000|Overall Study|Progressive GVHD|0|||
157008110|NCT00686855|566780108|FG001|Overall Study|Progressive GVHD|1|||
157008111|NCT02731755|566780111|FG000|First Intervention|Withdrawal by Subject|0|||
157008112|NCT02731755|566780112|FG001|First Intervention|Withdrawal by Subject|2|||
156775991|NCT04896385|565931385|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156775992|NCT04896385|565931386|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
156775993|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156775994|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
156775995|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
156775996|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
156775997|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156775998|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
156775999|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
156776000|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
156776001|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
156776002|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
156776003|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
156776004|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
157114373|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
157114374|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
157114375|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
157114376|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
157114377|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
157114378|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
157114379|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
157114380|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
157114381|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
157114382|NCT00219284|567173349|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
157114383|NCT00219284|567173350|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
157114384|NCT00219284|567173349|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
157114385|NCT00219284|567173350|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
157114386|NCT00219284|567173349|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
157114387|NCT00219284|567173350|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
157114388|NCT00219284|567173349|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
157114389|NCT00219284|567173350|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
157114390|NCT00788372|567173352|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
156776005|NCT04896385|565931383|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
157114391|NCT00788372|567173352|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
157114392|NCT00788372|567173352|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
157114393|NCT00788372|567173352|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
157208369|NCT03193190|567508031|FG009|Stage 1|Progressive Disease|0|||
157208370|NCT03193190|567508032|FG010|Stage 1|Progressive Disease|0|||
157114394|NCT00788372|567173352|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
157114395|NCT00788372|567173352|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
157114396|NCT00788372|567173352|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
157114397|NCT03099187|567173361|FG000|Double-blind Treatment|Adverse Event|19|||
157114398|NCT03099187|567173362|FG001|Double-blind Treatment|Adverse Event|1|||
157114399|NCT03099187|567173363|FG002|Double-blind Treatment|Adverse Event|0|||
157114400|NCT03099187|567173364|FG003|Double-blind Treatment|Adverse Event|0|||
157114401|NCT03099187|567173361|FG000|Double-blind Treatment|Death|1|||
157114402|NCT03099187|567173362|FG001|Double-blind Treatment|Death|3|||
157114403|NCT03099187|567173363|FG002|Double-blind Treatment|Death|0|||
157114404|NCT03099187|567173364|FG003|Double-blind Treatment|Death|0|||
157114405|NCT03099187|567173361|FG000|Double-blind Treatment|Lack of Efficacy|1|||
157114406|NCT03099187|567173362|FG001|Double-blind Treatment|Lack of Efficacy|0|||
157114407|NCT03099187|567173363|FG002|Double-blind Treatment|Lack of Efficacy|0|||
157114408|NCT03099187|567173364|FG003|Double-blind Treatment|Lack of Efficacy|0|||
157114409|NCT03099187|567173361|FG000|Double-blind Treatment|Physician Decision|2|||
157114410|NCT03099187|567173362|FG001|Double-blind Treatment|Physician Decision|1|||
157114411|NCT03099187|567173363|FG002|Double-blind Treatment|Physician Decision|0|||
157114412|NCT03099187|567173364|FG003|Double-blind Treatment|Physician Decision|0|||
157114413|NCT03099187|567173361|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
157114414|NCT03099187|567173362|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
157114415|NCT03099187|567173363|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
157114416|NCT03099187|567173364|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
157114417|NCT03099187|567173361|FG000|Double-blind Treatment|Lung transplantation|0|||
157114418|NCT03099187|567173362|FG001|Double-blind Treatment|Lung transplantation|1|||
157114419|NCT03099187|567173363|FG002|Double-blind Treatment|Lung transplantation|0|||
157114420|NCT03099187|567173364|FG003|Double-blind Treatment|Lung transplantation|0|||
157114421|NCT03099187|567173361|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
157114422|NCT03099187|567173362|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
157114423|NCT03099187|567173363|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
157114424|NCT03099187|567173364|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
157114425|NCT03099187|567173361|FG000|Double-blind Treatment|Disease progression|0|||
157114426|NCT03099187|567173362|FG001|Double-blind Treatment|Disease progression|1|||
157114427|NCT03099187|567173363|FG002|Double-blind Treatment|Disease progression|0|||
157114428|NCT03099187|567173364|FG003|Double-blind Treatment|Disease progression|0|||
157114429|NCT03099187|567173361|FG000|Double-blind Treatment|Randomization error|0|||
157114430|NCT03099187|567173362|FG001|Double-blind Treatment|Randomization error|2|||
157114431|NCT03099187|567173363|FG002|Double-blind Treatment|Randomization error|0|||
157114432|NCT03099187|567173364|FG003|Double-blind Treatment|Randomization error|0|||
157114433|NCT03099187|567173361|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
157114434|NCT03099187|567173362|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
157114435|NCT03099187|567173363|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
157114436|NCT03099187|567173364|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
157114437|NCT03099187|567173361|FG000|12-month Safety Follow-up|Adverse Event|0|||
157114438|NCT03099187|567173362|FG001|12-month Safety Follow-up|Adverse Event|0|||
157114439|NCT03099187|567173363|FG002|12-month Safety Follow-up|Adverse Event|5|||
157114440|NCT03099187|567173364|FG003|12-month Safety Follow-up|Adverse Event|12|||
157114441|NCT03099187|567173361|FG000|12-month Safety Follow-up|Death|0|||
157114442|NCT03099187|567173362|FG001|12-month Safety Follow-up|Death|0|||
157114443|NCT03099187|567173363|FG002|12-month Safety Follow-up|Death|7|||
157114444|NCT03099187|567173364|FG003|12-month Safety Follow-up|Death|9|||
157114445|NCT03099187|567173361|FG000|12-month Safety Follow-up|Lung transplantation|0|||
157114446|NCT03099187|567173362|FG001|12-month Safety Follow-up|Lung transplantation|0|||
157114447|NCT03099187|567173363|FG002|12-month Safety Follow-up|Lung transplantation|2|||
157114448|NCT03099187|567173364|FG003|12-month Safety Follow-up|Lung transplantation|1|||
157114449|NCT03099187|567173361|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
156776006|NCT04896385|565931384|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
156776007|NCT04896385|565931385|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
157114450|NCT03099187|567173362|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
157208371|NCT03193190|567508033|FG011|Stage 1|Progressive Disease|0|||
156776008|NCT04896385|565931386|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
156776009|NCT05291689|565931390|FG000|Overall Study|Adverse Event|3|||
156776010|NCT05291689|565931390|FG000|Overall Study|Lack of Efficacy|10|||
156776011|NCT05291689|565931390|FG000|Overall Study|Withdrawal by Subject|4|||
156776012|NCT01931098|565931391|FG000|Overall Study|Withdrawal by Subject|0|||
156776013|NCT01931098|565931392|FG001|Overall Study|Withdrawal by Subject|1|||
156776014|NCT01931098|565931391|FG000|Overall Study|Enrolled in different protocol|0|||
156776015|NCT01931098|565931392|FG001|Overall Study|Enrolled in different protocol|1|||
156776016|NCT01931098|565931391|FG000|Overall Study|Unable to begin trmt:active infection|0|||
156776017|NCT01931098|565931392|FG001|Overall Study|Unable to begin trmt:active infection|1|||
156776018|NCT01931098|565931391|FG000|Overall Study|Refused further treatment|0|||
157208372|NCT03193190|567508034|FG012|Stage 1|Progressive Disease|0|||
156776019|NCT01931098|565931392|FG001|Overall Study|Refused further treatment|1|||
156776020|NCT04235374|565931393|FG000|Overall Study|Death|91|||
156776021|NCT04235374|565931394|FG001|Overall Study|Death|91|||
157208373|NCT03193190|567508035|FG013|Stage 1|Progressive Disease|0|||
157208374|NCT03193190|567508036|FG014|Stage 1|Progressive Disease|0|||
157208375|NCT03193190|567508037|FG015|Stage 1|Progressive Disease|0|||
157208376|NCT03193190|567508022|FG000|Stage 1|Study Terminated By Sponsor|3|||
157208377|NCT03193190|567508023|FG001|Stage 1|Study Terminated By Sponsor|0|||
157208378|NCT03193190|567508024|FG002|Stage 1|Study Terminated By Sponsor|0|||
157208379|NCT03193190|567508025|FG003|Stage 1|Study Terminated By Sponsor|0|||
157208380|NCT03193190|567508026|FG004|Stage 1|Study Terminated By Sponsor|6|||
157208381|NCT03193190|567508027|FG005|Stage 1|Study Terminated By Sponsor|0|||
157208382|NCT03193190|567508028|FG006|Stage 1|Study Terminated By Sponsor|0|||
157208383|NCT03193190|567508029|FG007|Stage 1|Study Terminated By Sponsor|0|||
157208384|NCT03193190|567508030|FG008|Stage 1|Study Terminated By Sponsor|0|||
156776022|NCT04235374|565931393|FG000|Overall Study|Refused|2|||
156776023|NCT04235374|565931394|FG001|Overall Study|Refused|2|||
157208385|NCT03193190|567508031|FG009|Stage 1|Study Terminated By Sponsor|0|||
157114451|NCT03099187|567173363|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
157114452|NCT03099187|567173364|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
157114453|NCT03099187|567173361|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
157114454|NCT03099187|567173362|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
157114455|NCT03099187|567173363|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
156776024|NCT04235374|565931393|FG000|Overall Study|Unavailable|12|||
156776025|NCT04235374|565931394|FG001|Overall Study|Unavailable|3|||
156776026|NCT04235374|565931393|FG000|Overall Study|Withdrawal by Subject|0|||
156776027|NCT04235374|565931394|FG001|Overall Study|Withdrawal by Subject|1|||
156776028|NCT04235374|565931393|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
156776029|NCT04235374|565931394|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
156776030|NCT00314145|565931395|FG000|Overall Study|Withdrawal by Subject|8|||
156776031|NCT00314145|565931396|FG001|Overall Study|Withdrawal by Subject|10|||
156776032|NCT00314145|565931395|FG000|Overall Study|Lost to Follow-up|5|||
156776033|NCT00314145|565931396|FG001|Overall Study|Lost to Follow-up|12|||
156776034|NCT00314145|565931395|FG000|Overall Study|Physician Decision|3|||
156776035|NCT00314145|565931396|FG001|Overall Study|Physician Decision|4|||
156776036|NCT00314145|565931395|FG000|Overall Study|Adverse Event|0|||
156776037|NCT00314145|565931396|FG001|Overall Study|Adverse Event|3|||
156776038|NCT00314145|565931395|FG000|Overall Study|Protocol Violation|3|||
156776039|NCT00314145|565931396|FG001|Overall Study|Protocol Violation|0|||
156776040|NCT00314145|565931395|FG000|Overall Study|Sponsor Decision|2|||
156776041|NCT00314145|565931396|FG001|Overall Study|Sponsor Decision|0|||
156776042|NCT00294658|565931397|FG000|Overall Study|Death|0|||
156776043|NCT00294658|565931398|FG001|Overall Study|Death|1|||
156776044|NCT00294658|565931397|FG000|Overall Study|Lost to Follow-up|4|||
156776045|NCT00294658|565931398|FG001|Overall Study|Lost to Follow-up|0|||
156776046|NCT00294658|565931397|FG000|Overall Study|Physician Decision|1|||
156776047|NCT00294658|565931398|FG001|Overall Study|Physician Decision|2|||
156776048|NCT00294658|565931397|FG000|Overall Study|Pregnancy|0|||
156776049|NCT00294658|565931398|FG001|Overall Study|Pregnancy|1|||
156776050|NCT00294658|565931397|FG000|Overall Study|Withdrawal by Subject|0|||
156776051|NCT00294658|565931398|FG001|Overall Study|Withdrawal by Subject|4|||
156776052|NCT00294658|565931397|FG000|Overall Study|Found to have invasive thymoma|1|||
156776053|NCT00294658|565931398|FG001|Overall Study|Found to have invasive thymoma|0|||
156776054|NCT00294658|565931397|FG000|Overall Study|Patient and family were not satisfied|0|||
156776055|NCT00294658|565931398|FG001|Overall Study|Patient and family were not satisfied|1|||
156776056|NCT04717557|565931399|FG000|Overall Study|Withdrawal by Subject|2|||
156776057|NCT04717557|565931400|FG001|Overall Study|Withdrawal by Subject|0|||
156776058|NCT04717557|565931399|FG000|Overall Study|Death|1|||
156776059|NCT04717557|565931400|FG001|Overall Study|Death|0|||
156776060|NCT00858988|565931401|FG000|Analysis|Lactulose unable to be detected in urine|2|||
156776061|NCT00858988|565931402|FG001|Analysis|Lactulose unable to be detected in urine|1|||
156776062|NCT01020123|565931407|FG000|Main Period|Withdrawal by Subject|6|||
156776063|NCT01020123|565931408|FG001|Main Period|Withdrawal by Subject|5|||
156776064|NCT01020123|565931409|FG002|Main Period|Withdrawal by Subject|3|||
156776065|NCT01020123|565931410|FG003|Main Period|Withdrawal by Subject|1|||
156776066|NCT01020123|565931411|FG004|Main Period|Withdrawal by Subject|6|||
156776067|NCT01020123|565931412|FG005|Main Period|Withdrawal by Subject|3|||
156776068|NCT01020123|565931413|FG006|Main Period|Withdrawal by Subject|2|||
156776069|NCT01020123|565931407|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
156776070|NCT01020123|565931408|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
156776071|NCT01020123|565931409|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
156776072|NCT01020123|565931410|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
156776073|NCT01020123|565931411|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
156776074|NCT01020123|565931412|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
156776075|NCT01020123|565931413|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
156776076|NCT01020123|565931407|FG000|Main Period|Adverse Event|5|||
156776077|NCT01020123|565931408|FG001|Main Period|Adverse Event|2|||
156776078|NCT01020123|565931409|FG002|Main Period|Adverse Event|2|||
156776079|NCT01020123|565931410|FG003|Main Period|Adverse Event|1|||
156776080|NCT01020123|565931411|FG004|Main Period|Adverse Event|1|||
157008113|NCT01460446|566780113|FG000|Overall Study|Non-compliance|2|||
157008114|NCT01460446|566780114|FG001|Overall Study|Non-compliance|9|||
157008115|NCT01460446|566780113|FG000|Overall Study|Consent Withdrawn|0|||
157008116|NCT01460446|566780114|FG001|Overall Study|Consent Withdrawn|4|||
157008117|NCT01460446|566780113|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
157008118|NCT01460446|566780114|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
157008119|NCT01460446|566780113|FG000|Overall Study|Surgery/Illness|1|||
157008120|NCT01460446|566780114|FG001|Overall Study|Surgery/Illness|1|||
157008121|NCT01460446|566780113|FG000|Overall Study|Pregnancy|1|||
157008122|NCT01460446|566780114|FG001|Overall Study|Pregnancy|0|||
157008123|NCT01460446|566780113|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
157008124|NCT01460446|566780114|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
157008125|NCT00714714|566780115|FG000|Overall Study|Adverse Event|1|||
157008126|NCT02616900|566780116|FG000|Overall Study|Lack of Efficacy|7|||
157008127|NCT02616900|566780116|FG000|Overall Study|Lost to Follow-up|2|||
157008128|NCT02616900|566780116|FG000|Overall Study|Protocol Violation|5|||
157008129|NCT02616900|566780116|FG000|Overall Study|Withdrawal by Subject|3|||
157008130|NCT02616900|566780116|FG000|Overall Study|Incomplete data|6|||
156776081|NCT01020123|565931412|FG005|Main Period|Adverse Event|2|||
156776082|NCT01020123|565931413|FG006|Main Period|Adverse Event|1|||
156776083|NCT01020123|565931407|FG000|Main Period|Protocol Violation|4|||
157008131|NCT02613871|566780119|FG000|Overall Study|Death|2|||
156776084|NCT01020123|565931408|FG001|Main Period|Protocol Violation|4|||
156776085|NCT01020123|565931409|FG002|Main Period|Protocol Violation|2|||
156776086|NCT01020123|565931410|FG003|Main Period|Protocol Violation|5|||
156776087|NCT01020123|565931411|FG004|Main Period|Protocol Violation|2|||
157008132|NCT02613871|566780119|FG000|Overall Study|Withdrew Consent|1|||
157008133|NCT00845832|566780120|FG000|Treatment Period|Adverse Event|0|||
157008134|NCT00845832|566780121|FG001|Treatment Period|Adverse Event|2|||
157008135|NCT00845832|566780122|FG002|Treatment Period|Adverse Event|0|||
157008136|NCT00845832|566780120|FG000|Treatment Period|Protocol Violation|1|||
157008137|NCT00845832|566780121|FG001|Treatment Period|Protocol Violation|1|||
157008138|NCT00845832|566780122|FG002|Treatment Period|Protocol Violation|0|||
157008139|NCT00845832|566780120|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
157008140|NCT00845832|566780121|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
156776088|NCT01020123|565931412|FG005|Main Period|Protocol Violation|3|||
156776089|NCT01020123|565931413|FG006|Main Period|Protocol Violation|2|||
156776090|NCT01020123|565931407|FG000|Main Period|Lost to Follow-up|0|||
156776091|NCT01020123|565931408|FG001|Main Period|Lost to Follow-up|2|||
156776092|NCT01020123|565931409|FG002|Main Period|Lost to Follow-up|0|||
157208386|NCT03193190|567508032|FG010|Stage 1|Study Terminated By Sponsor|0|||
157208387|NCT03193190|567508033|FG011|Stage 1|Study Terminated By Sponsor|0|||
157208388|NCT03193190|567508034|FG012|Stage 1|Study Terminated By Sponsor|0|||
157114456|NCT03099187|567173364|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
156776093|NCT01020123|565931410|FG003|Main Period|Lost to Follow-up|0|||
157114457|NCT03099187|567173361|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
156776094|NCT01020123|565931411|FG004|Main Period|Lost to Follow-up|0|||
156776095|NCT01020123|565931412|FG005|Main Period|Lost to Follow-up|0|||
156776096|NCT01020123|565931413|FG006|Main Period|Lost to Follow-up|0|||
156776097|NCT01020123|565931407|FG000|Main Period|Unclasified|2|||
156776098|NCT01020123|565931408|FG001|Main Period|Unclasified|0|||
156776099|NCT01020123|565931409|FG002|Main Period|Unclasified|1|||
156776100|NCT01020123|565931410|FG003|Main Period|Unclasified|0|||
156776101|NCT01020123|565931411|FG004|Main Period|Unclasified|1|||
156776102|NCT01020123|565931412|FG005|Main Period|Unclasified|3|||
156776103|NCT01020123|565931413|FG006|Main Period|Unclasified|6|||
156776104|NCT01020123|565931407|FG000|Extention Period|Withdrawal by Subject|2|||
156776105|NCT01020123|565931408|FG001|Extention Period|Withdrawal by Subject|1|||
156776106|NCT01020123|565931409|FG002|Extention Period|Withdrawal by Subject|1|||
156776107|NCT01020123|565931410|FG003|Extention Period|Withdrawal by Subject|0|||
156776108|NCT01020123|565931411|FG004|Extention Period|Withdrawal by Subject|0|||
156776109|NCT01020123|565931412|FG005|Extention Period|Withdrawal by Subject|0|||
156776110|NCT01020123|565931413|FG006|Extention Period|Withdrawal by Subject|0|||
156776111|NCT01020123|565931407|FG000|Extention Period|Adverse Event|0|||
156776112|NCT01020123|565931408|FG001|Extention Period|Adverse Event|0|||
156776113|NCT01020123|565931409|FG002|Extention Period|Adverse Event|0|||
156776114|NCT01020123|565931410|FG003|Extention Period|Adverse Event|1|||
156776115|NCT01020123|565931411|FG004|Extention Period|Adverse Event|0|||
156776116|NCT01020123|565931412|FG005|Extention Period|Adverse Event|0|||
156776117|NCT01020123|565931413|FG006|Extention Period|Adverse Event|0|||
156776118|NCT01020123|565931407|FG000|Extention Period|Protocol Violation|1|||
156776119|NCT01020123|565931408|FG001|Extention Period|Protocol Violation|1|||
156776120|NCT01020123|565931409|FG002|Extention Period|Protocol Violation|1|||
156776121|NCT01020123|565931410|FG003|Extention Period|Protocol Violation|0|||
156776122|NCT01020123|565931411|FG004|Extention Period|Protocol Violation|0|||
157208389|NCT03193190|567508035|FG013|Stage 1|Study Terminated By Sponsor|0|||
157208390|NCT03193190|567508036|FG014|Stage 1|Study Terminated By Sponsor|0|||
157208391|NCT03193190|567508037|FG015|Stage 1|Study Terminated By Sponsor|0|||
157208392|NCT03193190|567508022|FG000|Stage 1|Withdrawal by Subject|6|||
157208393|NCT03193190|567508023|FG001|Stage 1|Withdrawal by Subject|0|||
157208394|NCT03193190|567508024|FG002|Stage 1|Withdrawal by Subject|1|||
157208395|NCT03193190|567508025|FG003|Stage 1|Withdrawal by Subject|0|||
157208396|NCT03193190|567508026|FG004|Stage 1|Withdrawal by Subject|2|||
157208397|NCT03193190|567508027|FG005|Stage 1|Withdrawal by Subject|0|||
157208398|NCT03193190|567508028|FG006|Stage 1|Withdrawal by Subject|3|||
157208399|NCT03193190|567508029|FG007|Stage 1|Withdrawal by Subject|2|||
157208400|NCT03193190|567508030|FG008|Stage 1|Withdrawal by Subject|2|||
157208401|NCT03193190|567508031|FG009|Stage 1|Withdrawal by Subject|4|||
157208402|NCT03193190|567508032|FG010|Stage 1|Withdrawal by Subject|9|||
157208403|NCT03193190|567508033|FG011|Stage 1|Withdrawal by Subject|1|||
157208404|NCT03193190|567508034|FG012|Stage 1|Withdrawal by Subject|0|||
157208405|NCT03193190|567508035|FG013|Stage 1|Withdrawal by Subject|0|||
157208406|NCT03193190|567508036|FG014|Stage 1|Withdrawal by Subject|0|||
157208407|NCT03193190|567508037|FG015|Stage 1|Withdrawal by Subject|0|||
157208408|NCT03193190|567508022|FG000|Stage 2|Death|0|||
157208409|NCT03193190|567508023|FG001|Stage 2|Death|0|||
157208410|NCT03193190|567508024|FG002|Stage 2|Death|0|||
157208411|NCT03193190|567508025|FG003|Stage 2|Death|0|||
157208412|NCT03193190|567508026|FG004|Stage 2|Death|0|||
157208413|NCT03193190|567508027|FG005|Stage 2|Death|0|||
157208414|NCT03193190|567508028|FG006|Stage 2|Death|0|||
157208415|NCT03193190|567508029|FG007|Stage 2|Death|0|||
157208416|NCT03193190|567508030|FG008|Stage 2|Death|0|||
157208417|NCT03193190|567508031|FG009|Stage 2|Death|0|||
157208418|NCT03193190|567508032|FG010|Stage 2|Death|0|||
157208419|NCT03193190|567508033|FG011|Stage 2|Death|0|||
157208420|NCT03193190|567508034|FG012|Stage 2|Death|0|||
157208421|NCT03193190|567508035|FG013|Stage 2|Death|14|||
157208422|NCT03193190|567508036|FG014|Stage 2|Death|4|||
157208423|NCT03193190|567508037|FG015|Stage 2|Death|1|||
156776123|NCT01020123|565931412|FG005|Extention Period|Protocol Violation|0|||
156776124|NCT01020123|565931413|FG006|Extention Period|Protocol Violation|1|||
156776125|NCT01020123|565931407|FG000|Extention Period|Lost to Follow-up|0|||
156776126|NCT01020123|565931408|FG001|Extention Period|Lost to Follow-up|0|||
156776127|NCT01020123|565931409|FG002|Extention Period|Lost to Follow-up|0|||
157208424|NCT03193190|567508022|FG000|Stage 2|Lost to Follow-up|0|||
157208425|NCT03193190|567508023|FG001|Stage 2|Lost to Follow-up|0|||
156776128|NCT01020123|565931410|FG003|Extention Period|Lost to Follow-up|0|||
156776129|NCT01020123|565931411|FG004|Extention Period|Lost to Follow-up|0|||
157208426|NCT03193190|567508024|FG002|Stage 2|Lost to Follow-up|0|||
157208427|NCT03193190|567508025|FG003|Stage 2|Lost to Follow-up|0|||
157208428|NCT03193190|567508026|FG004|Stage 2|Lost to Follow-up|0|||
157208429|NCT03193190|567508027|FG005|Stage 2|Lost to Follow-up|0|||
157208430|NCT03193190|567508028|FG006|Stage 2|Lost to Follow-up|0|||
157208431|NCT03193190|567508029|FG007|Stage 2|Lost to Follow-up|0|||
157208432|NCT03193190|567508030|FG008|Stage 2|Lost to Follow-up|0|||
157208433|NCT03193190|567508031|FG009|Stage 2|Lost to Follow-up|0|||
157208434|NCT03193190|567508032|FG010|Stage 2|Lost to Follow-up|0|||
157208435|NCT03193190|567508033|FG011|Stage 2|Lost to Follow-up|0|||
157208436|NCT03193190|567508034|FG012|Stage 2|Lost to Follow-up|0|||
157008141|NCT00845832|566780122|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
157008142|NCT00845832|566780120|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
157008143|NCT00845832|566780121|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
157008144|NCT00845832|566780122|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
157008145|NCT00869323|566780123|FG000|Maintenance Therapy|concurrent illness|1|||
157008146|NCT02880241|566780124|FG000|Overall Study|Lack of Efficacy|1|||
157008147|NCT02880241|566780125|FG001|Overall Study|Lack of Efficacy|0|||
157008148|NCT02880241|566780126|FG002|Overall Study|Lack of Efficacy|0|||
157008149|NCT02880241|566780127|FG003|Overall Study|Lack of Efficacy|0|||
157008150|NCT02880241|566780128|FG004|Overall Study|Lack of Efficacy|0|||
157008151|NCT02880241|566780129|FG005|Overall Study|Lack of Efficacy|0|||
157008152|NCT00891930|566780130|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
157008153|NCT00891930|566780130|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
157008154|NCT00891930|566780130|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
157008155|NCT00891930|566780130|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
157008156|NCT00891930|566780130|FG000|Part 2 Panitumumab + AMG479|Death|30|||
157008157|NCT02448446|566780133|FG000|Overall Study|Withdrawal by Subject|1|||
157008158|NCT02448446|566780134|FG001|Overall Study|Withdrawal by Subject|0|||
157008159|NCT01510717|566780139|FG000|Overall Study|Adverse Event|1|||
157008160|NCT01510717|566780140|FG001|Overall Study|Adverse Event|2|||
157008161|NCT01510717|566780139|FG000|Overall Study|Death|1|||
157008162|NCT01510717|566780140|FG001|Overall Study|Death|0|||
157008163|NCT01510717|566780139|FG000|Overall Study|Lost to Follow-up|0|||
157008164|NCT01510717|566780140|FG001|Overall Study|Lost to Follow-up|1|||
157008165|NCT01510717|566780139|FG000|Overall Study|Withdrawal by Subject|0|||
157008166|NCT01510717|566780140|FG001|Overall Study|Withdrawal by Subject|2|||
157008167|NCT02555215|566780146|FG000|Overall Study|Other|1|||
157008168|NCT02555215|566780146|FG000|Overall Study|Investigator Decision|2|||
157008169|NCT00529789|566780147|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
157008170|NCT00529789|566780147|FG000|Study Period II/III|Adverse Event|3|||
157008171|NCT00529789|566780147|FG000|Study Period II/III|Lack of Efficacy|2|||
157008172|NCT00529789|566780147|FG000|Study Period II/III|Withdrawal by Subject|1|||
157008173|NCT00529789|566780147|FG000|Study Period II/III|Protocol Violation|3|||
157008174|NCT00529789|566780147|FG000|Study Period II/III|Physician Decision|3|||
157008175|NCT00529789|566780147|FG000|Study Period II/III|Lost to Follow-up|3|||
157008176|NCT00529789|566780147|FG000|Study Period IV|Parent/Caregiver Decision|1|||
157008177|NCT00529789|566780147|FG000|Study Period IV|Adverse Event|1|||
157208437|NCT03193190|567508035|FG013|Stage 2|Lost to Follow-up|0|||
157208438|NCT03193190|567508036|FG014|Stage 2|Lost to Follow-up|1|||
157208439|NCT03193190|567508037|FG015|Stage 2|Lost to Follow-up|0|||
157208440|NCT03193190|567508022|FG000|Stage 2|Withdrawal by Subject|0|||
157208441|NCT03193190|567508023|FG001|Stage 2|Withdrawal by Subject|0|||
157208442|NCT03193190|567508024|FG002|Stage 2|Withdrawal by Subject|0|||
157208443|NCT03193190|567508025|FG003|Stage 2|Withdrawal by Subject|0|||
157208444|NCT03193190|567508026|FG004|Stage 2|Withdrawal by Subject|0|||
157208445|NCT03193190|567508027|FG005|Stage 2|Withdrawal by Subject|0|||
157208446|NCT03193190|567508028|FG006|Stage 2|Withdrawal by Subject|0|||
157208447|NCT03193190|567508029|FG007|Stage 2|Withdrawal by Subject|0|||
157208448|NCT03193190|567508030|FG008|Stage 2|Withdrawal by Subject|0|||
157208449|NCT03193190|567508031|FG009|Stage 2|Withdrawal by Subject|0|||
157208450|NCT03193190|567508032|FG010|Stage 2|Withdrawal by Subject|0|||
157208451|NCT03193190|567508033|FG011|Stage 2|Withdrawal by Subject|0|||
157208452|NCT03193190|567508034|FG012|Stage 2|Withdrawal by Subject|0|||
157208453|NCT03193190|567508035|FG013|Stage 2|Withdrawal by Subject|1|||
157208454|NCT03193190|567508036|FG014|Stage 2|Withdrawal by Subject|1|||
157208455|NCT03193190|567508037|FG015|Stage 2|Withdrawal by Subject|0|||
157208456|NCT03532295|567508038|FG000|Overall Study|Did not start treatment|0|||
157208457|NCT03532295|567508039|FG001|Overall Study|Did not start treatment|2|||
157208458|NCT01907516|567508040|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
157208459|NCT01907516|567508041|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
157208460|NCT01907516|567508040|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
157208461|NCT01907516|567508041|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
157208462|NCT01907516|567508040|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
157208463|NCT01907516|567508041|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
157008178|NCT00529789|566780147|FG000|Study Period IV|Lack of Efficacy|1|||
157008179|NCT00529789|566780147|FG000|Study Period IV|Lost to Follow-up|3|||
157008180|NCT01968226|566780148|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
157008181|NCT00457743|566780152|FG000|Overall Study|Adverse Event|0|||
157208464|NCT01907516|567508040|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
157208465|NCT01907516|567508041|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
157208466|NCT04644237|567508045|FG000|Overall Study|Death|4|||
157208467|NCT04644237|567508046|FG001|Overall Study|Death|2|||
157208468|NCT04644237|567508045|FG000|Overall Study|Adverse Event|18|||
157208469|NCT04644237|567508046|FG001|Overall Study|Adverse Event|19|||
157208470|NCT04644237|567508045|FG000|Overall Study|Progressive Disease|61|||
157208471|NCT04644237|567508046|FG001|Overall Study|Progressive Disease|23|||
157208472|NCT04644237|567508045|FG000|Overall Study|Clinical Progression|4|||
156776130|NCT01020123|565931412|FG005|Extention Period|Lost to Follow-up|2|||
156776131|NCT01020123|565931413|FG006|Extention Period|Lost to Follow-up|0|||
156776132|NCT01349595|565931414|FG000|Overall Study|Lack of funding|2|||
156776133|NCT01349595|565931415|FG001|Overall Study|Lack of funding|2|||
156776134|NCT03479905|565931418|FG000|Overall Study|Other airway method used|4|||
156776135|NCT03479905|565931419|FG001|Overall Study|Other airway method used|5|||
156776136|NCT03479905|565931420|FG002|Overall Study|Other airway method used|5|||
156776137|NCT00862992|565931425|FG000|Overall Study|Adverse Event|2|||
156776138|NCT00862992|565931426|FG001|Overall Study|Adverse Event|1|||
156776139|NCT00862992|565931427|FG002|Overall Study|Adverse Event|1|||
156776140|NCT00862992|565931425|FG000|Overall Study|Physician Decision|1|||
156776141|NCT00862992|565931426|FG001|Overall Study|Physician Decision|0|||
156776142|NCT00862992|565931427|FG002|Overall Study|Physician Decision|0|||
156776143|NCT00862992|565931425|FG000|Overall Study|Withdrawal by Subject|0|||
156776144|NCT00862992|565931426|FG001|Overall Study|Withdrawal by Subject|0|||
156776145|NCT00862992|565931427|FG002|Overall Study|Withdrawal by Subject|2|||
156776146|NCT00720759|565931428|FG000|Overall Study|Lost to Follow-up|0|||
156776147|NCT00720759|565931429|FG001|Overall Study|Lost to Follow-up|1|||
156776148|NCT00720759|565931430|FG002|Overall Study|Lost to Follow-up|1|||
156776149|NCT00720759|565931431|FG003|Overall Study|Lost to Follow-up|0|||
156776150|NCT01706328|565931432|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
156776151|NCT01706328|565931433|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156776152|NCT01706328|565931434|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156776153|NCT01706328|565931432|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
156776154|NCT01706328|565931433|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156776155|NCT01706328|565931434|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156776156|NCT01706328|565931432|FG000|2-week Run-in Period|Physician Decision|4|||
156776157|NCT01706328|565931433|FG001|2-week Run-in Period|Physician Decision|0|||
156776158|NCT01706328|565931434|FG002|2-week Run-in Period|Physician Decision|0|||
156776159|NCT01706328|565931432|FG000|2-week Run-in Period|Adverse Event|4|||
156776160|NCT01706328|565931433|FG001|2-week Run-in Period|Adverse Event|0|||
156776161|NCT01706328|565931434|FG002|2-week Run-in Period|Adverse Event|0|||
156776162|NCT01706328|565931432|FG000|2-week Run-in Period|Lost to Follow-up|2|||
156776163|NCT01706328|565931433|FG001|2-week Run-in Period|Lost to Follow-up|0|||
157008182|NCT00457743|566780153|FG001|Overall Study|Adverse Event|4|||
157008183|NCT00457743|566780154|FG002|Overall Study|Adverse Event|0|||
157008184|NCT00457743|566780152|FG000|Overall Study|Lack of Efficacy|3|||
157008185|NCT00457743|566780153|FG001|Overall Study|Lack of Efficacy|23|||
157114458|NCT03099187|567173362|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
157114459|NCT03099187|567173363|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
156776164|NCT01706328|565931434|FG002|2-week Run-in Period|Lost to Follow-up|0|||
157114460|NCT03099187|567173364|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
156776165|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
157114461|NCT03099187|567173361|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
157114462|NCT03099187|567173362|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
157114463|NCT03099187|567173363|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
157114464|NCT03099187|567173364|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
157114465|NCT01210690|567173367|FG000|Overall Study|Adverse Event|7|||
157114466|NCT01210690|567173367|FG000|Overall Study|Lack of Efficacy|12|||
157114467|NCT01210690|567173367|FG000|Overall Study|Lost to Follow-up|3|||
157114468|NCT01210690|567173367|FG000|Overall Study|Disease Remission|1|||
157114469|NCT01210690|567173367|FG000|Overall Study|Withdrawal by Subject|1|||
157114470|NCT01210690|567173367|FG000|Overall Study|Patient refused to swallow|1|||
157114471|NCT01210690|567173367|FG000|Overall Study|Patient could not take glucose|1|||
157114472|NCT00470054|567173368|FG000|Overall Study|Ineligible|1|||
157114473|NCT04869345|567173369|FG000|Overall Study|Lost to Follow-up|8|||
157114474|NCT04869345|567173370|FG001|Overall Study|Lost to Follow-up|3|||
157114475|NCT04194528|567173376|FG000|Overall Study|Adverse Event|1|||
157114476|NCT00528021|567173377|FG000|Overall Study|Lack of Efficacy|17|||
157114477|NCT00528021|567173378|FG001|Overall Study|Lack of Efficacy|13|||
157114478|NCT00528021|567173379|FG002|Overall Study|Lack of Efficacy|7|||
157114479|NCT00528021|567173380|FG003|Overall Study|Lack of Efficacy|9|||
157114480|NCT00102960|567173391|FG000|Overall Study|Death|23|||
157114481|NCT00102960|567173392|FG001|Overall Study|Death|11|||
157114482|NCT00102960|567173393|FG002|Overall Study|Death|11|||
157114483|NCT00102960|567173391|FG000|Overall Study|Lost to Follow-up|6|||
157114484|NCT00102960|567173392|FG001|Overall Study|Lost to Follow-up|12|||
157114485|NCT00102960|567173393|FG002|Overall Study|Lost to Follow-up|16|||
157114486|NCT00102960|567173391|FG000|Overall Study|Withdrawal by Subject|1|||
157114487|NCT00102960|567173392|FG001|Overall Study|Withdrawal by Subject|0|||
157114488|NCT00102960|567173393|FG002|Overall Study|Withdrawal by Subject|1|||
157114489|NCT01395394|567175582|FG000|Baseline Study Visit|Protocol Violation|1|||
157114490|NCT01395394|567175583|FG001|Baseline Study Visit|Protocol Violation|0|||
157114491|NCT01395394|567175584|FG002|Baseline Study Visit|Protocol Violation|0|||
157114492|NCT05121480|567175585|FG000|Overall Study|Lack of Efficacy|2|||
157114493|NCT05121480|567175586|FG001|Overall Study|Lack of Efficacy|2|||
157114494|NCT05121480|567175587|FG002|Overall Study|Lack of Efficacy|1|||
157114495|NCT05121480|567175588|FG003|Overall Study|Lack of Efficacy|4|||
157114496|NCT05121480|567175589|FG004|Overall Study|Lack of Efficacy|0|||
157114497|NCT05121480|567175590|FG005|Overall Study|Lack of Efficacy|1|||
157114498|NCT05121480|567175591|FG006|Overall Study|Lack of Efficacy|0|||
157114499|NCT05121480|567175592|FG007|Overall Study|Lack of Efficacy|2|||
157114500|NCT05121480|567175585|FG000|Overall Study|Treatment Failure|0|||
157114501|NCT05121480|567175586|FG001|Overall Study|Treatment Failure|2|||
157114502|NCT05121480|567175587|FG002|Overall Study|Treatment Failure|0|||
157114503|NCT05121480|567175588|FG003|Overall Study|Treatment Failure|1|||
157114504|NCT05121480|567175589|FG004|Overall Study|Treatment Failure|0|||
157114505|NCT05121480|567175590|FG005|Overall Study|Treatment Failure|0|||
157114506|NCT05121480|567175591|FG006|Overall Study|Treatment Failure|0|||
157114507|NCT05121480|567175592|FG007|Overall Study|Treatment Failure|0|||
157114508|NCT05121480|567175585|FG000|Overall Study|Adverse Event|0|||
157114509|NCT05121480|567175586|FG001|Overall Study|Adverse Event|1|||
157114510|NCT05121480|567175587|FG002|Overall Study|Adverse Event|0|||
157114511|NCT05121480|567175588|FG003|Overall Study|Adverse Event|5|||
157114512|NCT05121480|567175589|FG004|Overall Study|Adverse Event|3|||
157114513|NCT05121480|567175590|FG005|Overall Study|Adverse Event|2|||
157114514|NCT05121480|567175591|FG006|Overall Study|Adverse Event|0|||
157114515|NCT05121480|567175592|FG007|Overall Study|Adverse Event|4|||
157114516|NCT05121480|567175585|FG000|Overall Study|Withdrawal by Subject|4|||
157114517|NCT05121480|567175586|FG001|Overall Study|Withdrawal by Subject|9|||
157114518|NCT05121480|567175587|FG002|Overall Study|Withdrawal by Subject|1|||
157114519|NCT05121480|567175588|FG003|Overall Study|Withdrawal by Subject|8|||
157114520|NCT05121480|567175589|FG004|Overall Study|Withdrawal by Subject|0|||
157114521|NCT05121480|567175590|FG005|Overall Study|Withdrawal by Subject|9|||
157114522|NCT05121480|567175591|FG006|Overall Study|Withdrawal by Subject|0|||
157114523|NCT05121480|567175592|FG007|Overall Study|Withdrawal by Subject|4|||
157114524|NCT05121480|567175585|FG000|Overall Study|Non-compliance with the protocol|0|||
157114525|NCT05121480|567175586|FG001|Overall Study|Non-compliance with the protocol|0|||
157114526|NCT05121480|567175587|FG002|Overall Study|Non-compliance with the protocol|0|||
157114527|NCT05121480|567175588|FG003|Overall Study|Non-compliance with the protocol|0|||
157114528|NCT05121480|567175589|FG004|Overall Study|Non-compliance with the protocol|1|||
157114529|NCT05121480|567175590|FG005|Overall Study|Non-compliance with the protocol|6|||
157114530|NCT05121480|567175591|FG006|Overall Study|Non-compliance with the protocol|0|||
157114531|NCT05121480|567175592|FG007|Overall Study|Non-compliance with the protocol|1|||
157114532|NCT05121480|567175585|FG000|Overall Study|Lost to Follow-up|0|||
157114533|NCT05121480|567175586|FG001|Overall Study|Lost to Follow-up|4|||
157114534|NCT05121480|567175587|FG002|Overall Study|Lost to Follow-up|1|||
157114535|NCT05121480|567175588|FG003|Overall Study|Lost to Follow-up|3|||
157114536|NCT05121480|567175589|FG004|Overall Study|Lost to Follow-up|1|||
157114537|NCT05121480|567175590|FG005|Overall Study|Lost to Follow-up|1|||
157114538|NCT05121480|567175591|FG006|Overall Study|Lost to Follow-up|1|||
157114539|NCT05121480|567175592|FG007|Overall Study|Lost to Follow-up|4|||
157114540|NCT05121480|567175585|FG000|Overall Study|Physician Decision|0|||
157114541|NCT05121480|567175586|FG001|Overall Study|Physician Decision|0|||
157114542|NCT05121480|567175587|FG002|Overall Study|Physician Decision|0|||
157114543|NCT05121480|567175588|FG003|Overall Study|Physician Decision|0|||
157114544|NCT05121480|567175589|FG004|Overall Study|Physician Decision|0|||
157114545|NCT05121480|567175590|FG005|Overall Study|Physician Decision|1|||
157114546|NCT05121480|567175591|FG006|Overall Study|Physician Decision|0|||
157114547|NCT05121480|567175592|FG007|Overall Study|Physician Decision|1|||
157114548|NCT05121480|567175585|FG000|Overall Study|Other Reason|0|||
157114549|NCT05121480|567175586|FG001|Overall Study|Other Reason|0|||
157114550|NCT05121480|567175587|FG002|Overall Study|Other Reason|0|||
157114551|NCT05121480|567175588|FG003|Overall Study|Other Reason|0|||
157114552|NCT05121480|567175589|FG004|Overall Study|Other Reason|0|||
157114553|NCT05121480|567175590|FG005|Overall Study|Other Reason|1|||
157114554|NCT05121480|567175591|FG006|Overall Study|Other Reason|1|||
157114555|NCT05121480|567175592|FG007|Overall Study|Other Reason|1|||
157114556|NCT02356562|567175593|FG000|Overall Study|Withdrawal by Subject|0|||
157114557|NCT02356562|567175594|FG001|Overall Study|Withdrawal by Subject|1|||
157114558|NCT02356562|567175593|FG000|Overall Study|Re-entered treatment in a previous study|1|||
157114559|NCT02356562|567175594|FG001|Overall Study|Re-entered treatment in a previous study|0|||
157114560|NCT02356562|567175593|FG000|Overall Study|site closure|1|||
157114561|NCT02356562|567175594|FG001|Overall Study|site closure|0|||
157114562|NCT00412750|567175595|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157114563|NCT00412750|567175596|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157114564|NCT00412750|567175597|FG002|Overall Study|Abnormal laboratory value(s)|0|||
157114565|NCT00412750|567175595|FG000|Overall Study|Administrative problems|21|||
157114566|NCT00412750|567175596|FG001|Overall Study|Administrative problems|17|||
157114567|NCT00412750|567175597|FG002|Overall Study|Administrative problems|14|||
157114568|NCT00412750|567175595|FG000|Overall Study|Adverse Event|8|||
157114569|NCT00412750|567175596|FG001|Overall Study|Adverse Event|3|||
157114570|NCT00412750|567175597|FG002|Overall Study|Adverse Event|3|||
157114571|NCT00412750|567175595|FG000|Overall Study|Lost to Follow-up|1|||
157114572|NCT00412750|567175596|FG001|Overall Study|Lost to Follow-up|0|||
157114573|NCT00412750|567175597|FG002|Overall Study|Lost to Follow-up|1|||
157114574|NCT00412750|567175595|FG000|Overall Study|Withdrawal by Subject|0|||
157114575|NCT00412750|567175596|FG001|Overall Study|Withdrawal by Subject|1|||
157114576|NCT00412750|567175597|FG002|Overall Study|Withdrawal by Subject|2|||
157114577|NCT00412750|567175595|FG000|Overall Study|Lack of Efficacy|0|||
157114578|NCT00412750|567175596|FG001|Overall Study|Lack of Efficacy|0|||
157114579|NCT00412750|567175597|FG002|Overall Study|Lack of Efficacy|3|||
157114580|NCT00874120|567175598|FG000|First Intervention|Adverse Event|0|||
157114581|NCT00874120|567175599|FG001|First Intervention|Adverse Event|1|||
157114582|NCT00874120|567175598|FG000|First Intervention|Withdrawal by Subject|2|||
157114583|NCT00874120|567175599|FG001|First Intervention|Withdrawal by Subject|0|||
157114584|NCT00874120|567175598|FG000|First Intervention|Lost to Follow-up|0|||
157114585|NCT00874120|567175599|FG001|First Intervention|Lost to Follow-up|1|||
157114586|NCT00874120|567175598|FG000|First Intervention|Protocol Violation|3|||
157114587|NCT00874120|567175599|FG001|First Intervention|Protocol Violation|0|||
157114588|NCT00874120|567175598|FG000|First Intervention|positive drug test|1|||
157114589|NCT00874120|567175599|FG001|First Intervention|positive drug test|0|||
157114590|NCT00874120|567175598|FG000|Second Intervention|Withdrawal by Subject|1|||
157114591|NCT00874120|567175599|FG001|Second Intervention|Withdrawal by Subject|0|||
157114592|NCT00874120|567175598|FG000|Second Intervention|Protocol Violation|1|||
157114593|NCT00874120|567175599|FG001|Second Intervention|Protocol Violation|0|||
157114594|NCT01823679|567175600|FG000|Overall Study|Death|1|||
157114595|NCT01157078|567175604|FG000|Overall Study|Withdrawal by Subject|12|||
157114596|NCT01157078|567175605|FG001|Overall Study|Withdrawal by Subject|14|||
157114597|NCT01157078|567175604|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
157114598|NCT01157078|567175605|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
157114599|NCT01157078|567175604|FG000|Overall Study|Adverse Event|6|||
157114600|NCT01157078|567175605|FG001|Overall Study|Adverse Event|6|||
157114601|NCT01157078|567175604|FG000|Overall Study|Severe non-compliance to protocol|2|||
157114602|NCT01157078|567175605|FG001|Overall Study|Severe non-compliance to protocol|4|||
157114603|NCT01157078|567175604|FG000|Overall Study|Condition under investigation worsened|0|||
157114604|NCT01157078|567175605|FG001|Overall Study|Condition under investigation worsened|1|||
157114605|NCT01157078|567175604|FG000|Overall Study|Lack of Efficacy|2|||
157114606|NCT01157078|567175605|FG001|Overall Study|Lack of Efficacy|0|||
157114607|NCT01157078|567175604|FG000|Overall Study|Study-specific withdrawal criteria|2|||
157114608|NCT01157078|567175605|FG001|Overall Study|Study-specific withdrawal criteria|2|||
157114609|NCT01157078|567175604|FG000|Overall Study|Lost to Follow-up|7|||
157114610|NCT01157078|567175605|FG001|Overall Study|Lost to Follow-up|5|||
157114611|NCT01157078|567175604|FG000|Overall Study|Other|2|||
157114612|NCT01157078|567175605|FG001|Overall Study|Other|4|||
157114613|NCT01623271|567175608|FG000|Overall Study|Withdrawal by Subject|2|||
157114614|NCT01611974|567175609|FG000|Overall Study|Death|10|||
156776166|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
156776167|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
156776168|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
156776169|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
156776170|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
156776171|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
156776172|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
156776173|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
156776174|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
156776175|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
156776176|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
156776177|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
156776178|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
156776179|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
156776180|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
156776181|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
156776182|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
156776183|NCT01706328|565931432|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156776184|NCT01706328|565931433|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
156776185|NCT01706328|565931434|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
156776186|NCT06481579|565931443|FG000|Overall Study|Death|1|||
156776187|NCT06481579|565931444|FG001|Overall Study|Death|0|||
156776188|NCT06481579|565931443|FG000|Overall Study|Withdrawal by Subject|3|||
156776189|NCT06481579|565931444|FG001|Overall Study|Withdrawal by Subject|0|||
157114615|NCT01611974|567175610|FG001|Overall Study|Death|12|||
157114616|NCT01611974|567175611|FG002|Overall Study|Death|10|||
157114617|NCT01611974|567175609|FG000|Overall Study|Lost to Follow-up|0|||
157114618|NCT01611974|567175610|FG001|Overall Study|Lost to Follow-up|1|||
157208473|NCT04644237|567508046|FG001|Overall Study|Clinical Progression|1|||
157208474|NCT04644237|567508045|FG000|Overall Study|Withdrawal by Subject|4|||
157208475|NCT04644237|567508046|FG001|Overall Study|Withdrawal by Subject|2|||
157208476|NCT04644237|567508045|FG000|Overall Study|Physician Decision|4|||
157208477|NCT04644237|567508046|FG001|Overall Study|Physician Decision|0|||
157208478|NCT04644237|567508045|FG000|Overall Study|Other|6|||
157208479|NCT04644237|567508046|FG001|Overall Study|Other|3|||
157208480|NCT04644237|567508045|FG000|Overall Study|Randomized but not Treated|1|||
157208481|NCT04644237|567508046|FG001|Overall Study|Randomized but not Treated|0|||
157208482|NCT03131817|567508047|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
157208483|NCT03868059|567508049|FG000|Overall Study|Adverse Event|3|||
157208484|NCT03868059|567508049|FG000|Overall Study|Lost to Follow-up|3|||
157208485|NCT03868059|567508049|FG000|Overall Study|Withdrawal by Subject|6|||
157208486|NCT02061293|567508050|FG000|Overall Study|Elevated Blood Pressure|1|||
157208487|NCT02061293|567508051|FG001|Overall Study|Elevated Blood Pressure|1|||
157208488|NCT04066894|567508053|FG000|Overall Study|Lack of Efficacy|1|||
157208489|NCT04066894|567508053|FG000|Overall Study|Screen Failure|1|||
157208490|NCT02949219|567508060|FG000|Overall Study|Withdrawal by Subject|1|||
157208491|NCT04278872|567508061|FG000|Overall Study|Adverse Event|1|||
157208492|NCT04278872|567508062|FG001|Overall Study|Adverse Event|0|||
157208493|NCT04278872|567508061|FG000|Overall Study|Protocol Violation|0|||
157208494|NCT04278872|567508062|FG001|Overall Study|Protocol Violation|1|||
157208495|NCT04278872|567508061|FG000|Overall Study|Study Termination|2|||
157208496|NCT04278872|567508062|FG001|Overall Study|Study Termination|0|||
157208497|NCT05838755|567508068|FG000|Overall Study|Adverse Event|1|||
157208498|NCT05838755|567508069|FG001|Overall Study|Adverse Event|0|||
157208499|NCT05838755|567508070|FG002|Overall Study|Adverse Event|0|||
157208500|NCT05838755|567508068|FG000|Overall Study|Lack of Efficacy|1|||
157208501|NCT05838755|567508069|FG001|Overall Study|Lack of Efficacy|0|||
157208502|NCT05838755|567508070|FG002|Overall Study|Lack of Efficacy|1|||
157208503|NCT05838755|567508068|FG000|Overall Study|Lost to Follow-up|0|||
157208504|NCT05838755|567508069|FG001|Overall Study|Lost to Follow-up|1|||
157208505|NCT05838755|567508070|FG002|Overall Study|Lost to Follow-up|4|||
157208506|NCT05838755|567508068|FG000|Overall Study|Withdrawal by Subject|0|||
157208507|NCT05838755|567508069|FG001|Overall Study|Withdrawal by Subject|2|||
157208508|NCT05838755|567508070|FG002|Overall Study|Withdrawal by Subject|0|||
157208509|NCT05838755|567508068|FG000|Overall Study|Study terminated by sponsor|26|||
157208510|NCT05838755|567508069|FG001|Overall Study|Study terminated by sponsor|27|||
157208511|NCT05838755|567508070|FG002|Overall Study|Study terminated by sponsor|26|||
157208512|NCT05838755|567508068|FG000|Overall Study|Randomized, not treated|2|||
157208513|NCT05838755|567508069|FG001|Overall Study|Randomized, not treated|0|||
157208514|NCT05838755|567508070|FG002|Overall Study|Randomized, not treated|1|||
157208515|NCT05838755|567508068|FG000|Overall Study|Pregnancy|0|||
157208516|NCT05838755|567508069|FG001|Overall Study|Pregnancy|1|||
157208517|NCT05838755|567508070|FG002|Overall Study|Pregnancy|0|||
157208518|NCT00096031|567508071|FG000|Overall Study|Adverse Event|3|||
157208519|NCT00096031|567508071|FG000|Overall Study|Lack of Efficacy|42|||
157208520|NCT00096031|567508071|FG000|Overall Study|Death|4|||
157208521|NCT00096031|567508071|FG000|Overall Study|Withdrawal by Subject|1|||
157208522|NCT00096031|567508071|FG000|Overall Study|Ineligible|8|||
157208523|NCT00096031|567508071|FG000|Overall Study|Not protocol specified|5|||
157208524|NCT01283282|567508072|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
157208525|NCT01283282|567508073|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
157208526|NCT01283282|567508072|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
157208527|NCT01283282|567508073|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
157208528|NCT01283282|567508072|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
157208529|NCT01283282|567508073|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
157208530|NCT00483717|567508074|FG000|Overall Study|Protocol Violation|5|||
157208531|NCT00483717|567508075|FG001|Overall Study|Protocol Violation|7|||
157208532|NCT00483717|567508074|FG000|Overall Study|Time of dosing missing|1|||
157208533|NCT00483717|567508075|FG001|Overall Study|Time of dosing missing|1|||
157208534|NCT00483717|567508074|FG000|Overall Study|No treatment for migraine|16|||
157208535|NCT00483717|567508075|FG001|Overall Study|No treatment for migraine|13|||
157208536|NCT00483717|567508074|FG000|Overall Study|Lost to Follow-up|1|||
157208537|NCT00483717|567508075|FG001|Overall Study|Lost to Follow-up|0|||
157208538|NCT00483717|567508074|FG000|Overall Study|Withdrawal by Subject|1|||
157208539|NCT00483717|567508075|FG001|Overall Study|Withdrawal by Subject|0|||
157208540|NCT00083226|567508076|FG000|Overall Study|Lack of Efficacy|19|||
157208541|NCT00083226|567508076|FG000|Overall Study|Adverse Event|9|||
157208542|NCT00083226|567508076|FG000|Overall Study|Death|4|||
157208543|NCT00083226|567508076|FG000|Overall Study|Withdrawal by Subject|4|||
157208544|NCT00083226|567508076|FG000|Overall Study|Other|2|||
157208545|NCT00083226|567508076|FG000|Overall Study|ineligible or not receiving treatment|4|||
157208546|NCT00909857|567508077|FG000|Overall Study|Withdrawal by Subject|6|||
157208547|NCT00909857|567508078|FG001|Overall Study|Withdrawal by Subject|10|||
157208548|NCT00909857|567508077|FG000|Overall Study|Adverse Event|5|||
157208549|NCT00909857|567508078|FG001|Overall Study|Adverse Event|5|||
157208550|NCT00909857|567508077|FG000|Overall Study|Lost to Follow-up|2|||
157208551|NCT00909857|567508078|FG001|Overall Study|Lost to Follow-up|5|||
157208552|NCT00909857|567508077|FG000|Overall Study|Protocol Violation|2|||
157208553|NCT00909857|567508078|FG001|Overall Study|Protocol Violation|1|||
157208554|NCT00909857|567508077|FG000|Overall Study|Pregnancy|1|||
157208555|NCT00909857|567508078|FG001|Overall Study|Pregnancy|0|||
157208556|NCT00909857|567508077|FG000|Overall Study|Other|1|||
157208557|NCT00909857|567508078|FG001|Overall Study|Other|0|||
157208558|NCT00909857|567508077|FG000|Overall Study|Did not receive study medication|19|||
157208559|NCT00909857|567508078|FG001|Overall Study|Did not receive study medication|24|||
157208560|NCT03878108|567508079|FG000|Overall Study|Adverse Event|1|||
157208561|NCT03878108|567508080|FG001|Overall Study|Adverse Event|0|||
157208562|NCT00604175|567508087|FG000|Entry Through Week 28|Death|2|||
157208563|NCT00604175|567508088|FG001|Entry Through Week 28|Death|0|||
157208564|NCT00604175|567508089|FG002|Entry Through Week 28|Death|0|||
157208565|NCT00604175|567508087|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
157208566|NCT00604175|567508088|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
157208567|NCT00604175|567508089|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
157208568|NCT00604175|567508087|FG000|Entry Through Week 28|Lost to Follow-up|4|||
157208569|NCT00604175|567508088|FG001|Entry Through Week 28|Lost to Follow-up|3|||
157208570|NCT00604175|567508089|FG002|Entry Through Week 28|Lost to Follow-up|0|||
157208571|NCT00604175|567508087|FG000|Entry Through Week 28|Ineligible|1|||
157208572|NCT00604175|567508088|FG001|Entry Through Week 28|Ineligible|0|||
157208573|NCT00604175|567508089|FG002|Entry Through Week 28|Ineligible|0|||
157208574|NCT00604175|567508087|FG000|Entry Through Week 28|Did not start intervention|2|||
157208575|NCT00604175|567508088|FG001|Entry Through Week 28|Did not start intervention|0|||
157208576|NCT00604175|567508089|FG002|Entry Through Week 28|Did not start intervention|1|||
157208577|NCT00604175|567508087|FG000|Week 29 Through Week 72|Death|0|||
157208578|NCT00604175|567508088|FG001|Week 29 Through Week 72|Death|0|||
157208579|NCT00604175|567508089|FG002|Week 29 Through Week 72|Death|1|||
157208580|NCT00604175|567508087|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
157208581|NCT00604175|567508088|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
157208582|NCT00604175|567508089|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
157208583|NCT00604175|567508087|FG000|Week 29 Through Week 72|Site closure|0|||
157208584|NCT00604175|567508088|FG001|Week 29 Through Week 72|Site closure|1|||
157208585|NCT00604175|567508089|FG002|Week 29 Through Week 72|Site closure|0|||
157208586|NCT00604175|567508087|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
157208587|NCT00604175|567508088|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
157208588|NCT00604175|567508089|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
157208589|NCT01682681|567508090|FG000|Overall Study|Lack of Efficacy|62|||
157208590|NCT01682681|567508090|FG000|Overall Study|Withdrawal by Subject|1|||
157208591|NCT01682681|567508090|FG000|Overall Study|Moved to other hospital|10|||
157208592|NCT01682681|567508090|FG000|Overall Study|Lost to Follow-up|174|||
157208593|NCT01682681|567508090|FG000|Overall Study|Adverse Event|46|||
157208594|NCT01682681|567508090|FG000|Overall Study|tapering of topiramate|5|||
157208595|NCT01682681|567508090|FG000|Overall Study|Other|21|||
157208596|NCT01682681|567508090|FG000|Overall Study|Low compliance|13|||
157208597|NCT02044094|567508091|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
157208598|NCT02044094|567508091|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
157208599|NCT02044094|567508091|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
157208600|NCT02044094|567508091|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
157208601|NCT02044094|567508091|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
157208602|NCT02044094|567508091|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
157208603|NCT02044094|567508091|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
157208604|NCT02044094|567508091|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
157208605|NCT00005879|567508094|FG000|Overall Study|Withdrawal by Subject|8|||
157208606|NCT00005879|567508095|FG001|Overall Study|Withdrawal by Subject|10|||
157208607|NCT00131937|567508096|FG000|Overall Study|Adverse Event|3|||
157208608|NCT00131937|567508096|FG000|Overall Study|Withdrawal by Subject|2|||
157208609|NCT00131937|567508096|FG000|Overall Study|Physician Decision|1|||
157208610|NCT00131937|567508096|FG000|Overall Study|Disease Progression|7|||
157208611|NCT00131937|567508096|FG000|Overall Study|Alternative therapy|1|||
157208612|NCT04647253|567508103|FG000|Overall Study|Death ≤ 365 Days|16|||
157208613|NCT04647253|567508104|FG001|Overall Study|Death ≤ 365 Days|7|||
157208614|NCT04647253|567508103|FG000|Overall Study|Physician Decision|0|||
157208615|NCT04647253|567508104|FG001|Overall Study|Physician Decision|1|||
157208616|NCT04647253|567508103|FG000|Overall Study|Withdrawal by Subject|7|||
157208617|NCT04647253|567508104|FG001|Overall Study|Withdrawal by Subject|2|||
157208618|NCT04647253|567508103|FG000|Overall Study|Missed 12-Month Visit|9|||
157208619|NCT04647253|567508104|FG001|Overall Study|Missed 12-Month Visit|7|||
157208620|NCT04647253|567508103|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
157208621|NCT04647253|567508104|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
157114619|NCT01611974|567175611|FG002|Overall Study|Lost to Follow-up|0|||
157114620|NCT01611974|567175609|FG000|Overall Study|Physician Decision|5|||
157114621|NCT01611974|567175610|FG001|Overall Study|Physician Decision|1|||
156776190|NCT06481579|565931443|FG000|Overall Study|Other|1|||
157114622|NCT01611974|567175611|FG002|Overall Study|Physician Decision|2|||
156776191|NCT06481579|565931444|FG001|Overall Study|Other|1|||
156776192|NCT01157845|565931445|FG000|Overall Study|Lost to Follow-up|5|||
157114623|NCT01611974|567175609|FG000|Overall Study|Withdrawal by Subject|0|||
157114624|NCT01611974|567175610|FG001|Overall Study|Withdrawal by Subject|1|||
156776193|NCT01157845|565931445|FG000|Overall Study|Withdrawal by Subject|12|||
156776194|NCT01157845|565931445|FG000|Overall Study|Physician Decision|3|||
156776195|NCT01157845|565931445|FG000|Overall Study|Protocol Violation|13|||
156776196|NCT01157845|565931445|FG000|Overall Study|Study was ended|1|||
156776197|NCT01157845|565931445|FG000|Overall Study|Device malfunction|1|||
156776198|NCT03311555|565931446|FG000|Overall Study|Adverse Event|1|||
156776199|NCT04338581|565933390|FG000|Overall Study|Lack of Efficacy|1|||
156776200|NCT04338581|565933391|FG001|Overall Study|Lack of Efficacy|0|||
156776201|NCT04338581|565933390|FG000|Overall Study|Withdrawal by Subject|4|||
156776202|NCT04338581|565933391|FG001|Overall Study|Withdrawal by Subject|4|||
156776203|NCT04338581|565933390|FG000|Overall Study|Prohibited Medication|1|||
156776204|NCT04338581|565933391|FG001|Overall Study|Prohibited Medication|0|||
156776205|NCT04609553|565933392|FG000|Overall Study|Lost to Follow-up|27|||
156776206|NCT04609553|565933393|FG001|Overall Study|Lost to Follow-up|31|||
156776207|NCT04609553|565933394|FG002|Overall Study|Lost to Follow-up|24|||
156776208|NCT04609553|565933392|FG000|Overall Study|Discontinued|12|||
156776209|NCT04609553|565933393|FG001|Overall Study|Discontinued|10|||
156776210|NCT04609553|565933394|FG002|Overall Study|Discontinued|9|||
156776211|NCT02239328|565933395|FG000|Overall Study|Benign disease noted at time of surgery|6|||
157008186|NCT00457743|566780154|FG002|Overall Study|Lack of Efficacy|3|||
157008187|NCT00566527|566780155|FG000|Overall Study|Reason not provided|3|||
157008188|NCT00566527|566780156|FG001|Overall Study|Reason not provided|11|||
157008189|NCT00566527|566780157|FG002|Overall Study|Reason not provided|10|||
156776212|NCT02239328|565933395|FG000|Overall Study|Equipment or website malfunction|2|||
157114625|NCT01611974|567175611|FG002|Overall Study|Withdrawal by Subject|4|||
157114626|NCT00522431|567175612|FG000|Overall Study|Adverse Event|5|||
156776213|NCT00460798|565933397|FG000|Overall Study|Death|59|||
156776214|NCT00460798|565933397|FG000|Overall Study|Adverse Event|27|||
156776215|NCT00460798|565933397|FG000|Overall Study|Lost to Follow-up|19|||
157114627|NCT00522431|567175612|FG000|Overall Study|Protocol Violation|2|||
157114628|NCT00522431|567175612|FG000|Overall Study|Withdrawal by Subject|2|||
157114629|NCT00522431|567175612|FG000|Overall Study|Subject non-compliance|1|||
157114630|NCT00522431|567175612|FG000|Overall Study|Other/unknown|1|||
157114631|NCT00789529|567175615|FG000|Overall Study|Withdrawal by Subject|0|||
157114632|NCT00789529|567175616|FG001|Overall Study|Withdrawal by Subject|1|||
157114633|NCT00789529|567175615|FG000|Overall Study|Other Reason|1|||
157114634|NCT00789529|567175616|FG001|Overall Study|Other Reason|0|||
157114635|NCT01870401|567175617|FG000|Overall Study|Death|48|||
157114636|NCT01870401|567175618|FG001|Overall Study|Death|24|||
157114637|NCT01870401|567175617|FG000|Overall Study|Withdrawal by Subject|39|||
157114638|NCT01870401|567175618|FG001|Overall Study|Withdrawal by Subject|26|||
157114639|NCT01870401|567175617|FG000|Overall Study|Lost to Follow-up|19|||
157114640|NCT01870401|567175618|FG001|Overall Study|Lost to Follow-up|14|||
157114641|NCT01870401|567175617|FG000|Overall Study|Other|9|||
157114642|NCT01870401|567175618|FG001|Overall Study|Other|7|||
157114643|NCT01870401|567175617|FG000|Overall Study|On-going in the Study|35|||
157114644|NCT01870401|567175618|FG001|Overall Study|On-going in the Study|25|||
157114645|NCT01135498|567175619|FG000|Overall Study|Adverse Event|20|||
157114646|NCT01135498|567175619|FG000|Overall Study|Progressive disease|38|||
157114647|NCT01135498|567175619|FG000|Overall Study|Investigator judgement|25|||
157114648|NCT01135498|567175619|FG000|Overall Study|Withdrawal by Subject|4|||
156776216|NCT00460798|565933397|FG000|Overall Study|Progressive Disease|99|||
157114649|NCT01135498|567175619|FG000|Overall Study|Death|1|||
157114650|NCT01135498|567175619|FG000|Overall Study|Ongoing at time of analysis|2|||
157114651|NCT01192022|567175620|FG000|Overall Study|Withdrawal of Consent|3|||
157114652|NCT01192022|567175621|FG001|Overall Study|Withdrawal of Consent|1|||
156776217|NCT00460798|565933397|FG000|Overall Study|Other|27|||
156776218|NCT00460798|565933397|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
156776219|NCT00460798|565933397|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
156776220|NCT00933933|565933400|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
156776221|NCT00933933|565933401|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
156776222|NCT00933933|565933402|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
156776223|NCT00933933|565933400|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
156776224|NCT00933933|565933401|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
156776225|NCT00933933|565933402|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
156776226|NCT01104766|565933403|FG000|Overall Study|Did not meet inc/exc criteria|1|||
156776227|NCT01104766|565933404|FG001|Overall Study|Did not meet inc/exc criteria|0|||
157008190|NCT00566527|566780155|FG000|Overall Study|Adverse Event|2|||
157008191|NCT00566527|566780156|FG001|Overall Study|Adverse Event|0|||
157008192|NCT00566527|566780157|FG002|Overall Study|Adverse Event|1|||
157008193|NCT00566527|566780155|FG000|Overall Study|Physician Decision|3|||
157008194|NCT00566527|566780156|FG001|Overall Study|Physician Decision|8|||
157008195|NCT00566527|566780157|FG002|Overall Study|Physician Decision|20|||
157008196|NCT00566527|566780155|FG000|Overall Study|Lost to Follow-up|3|||
157008197|NCT00566527|566780156|FG001|Overall Study|Lost to Follow-up|4|||
157008198|NCT00566527|566780157|FG002|Overall Study|Lost to Follow-up|4|||
157008199|NCT00566527|566780155|FG000|Overall Study|Withdrawal by Subject|6|||
157008200|NCT00566527|566780156|FG001|Overall Study|Withdrawal by Subject|43|||
157008201|NCT00566527|566780157|FG002|Overall Study|Withdrawal by Subject|43|||
157008202|NCT00959946|566780158|FG000|Overall Study|Adverse Event|0|||
156776228|NCT01104766|565933405|FG002|Overall Study|Did not meet inc/exc criteria|0|||
157008203|NCT00959946|566780159|FG001|Overall Study|Adverse Event|0|||
157008204|NCT00959946|566780160|FG002|Overall Study|Adverse Event|2|||
157008205|NCT00959946|566780161|FG003|Overall Study|Adverse Event|1|||
157008206|NCT00959946|566780162|FG004|Overall Study|Adverse Event|0|||
157008207|NCT00959946|566780163|FG005|Overall Study|Adverse Event|1|||
157008208|NCT00959946|566780164|FG006|Overall Study|Adverse Event|0|||
157008209|NCT00959946|566780165|FG007|Overall Study|Adverse Event|0|||
157008210|NCT00959946|566780158|FG000|Overall Study|Death|0|||
157008211|NCT00959946|566780159|FG001|Overall Study|Death|0|||
157008212|NCT00959946|566780160|FG002|Overall Study|Death|0|||
157008213|NCT00959946|566780161|FG003|Overall Study|Death|0|||
157008214|NCT00959946|566780162|FG004|Overall Study|Death|0|||
157008215|NCT00959946|566780163|FG005|Overall Study|Death|1|||
157008216|NCT00959946|566780164|FG006|Overall Study|Death|0|||
157008217|NCT00959946|566780165|FG007|Overall Study|Death|0|||
157008218|NCT00959946|566780158|FG000|Overall Study|Disease Progression|2|||
157008219|NCT00959946|566780159|FG001|Overall Study|Disease Progression|4|||
157008220|NCT00959946|566780160|FG002|Overall Study|Disease Progression|2|||
157008221|NCT00959946|566780161|FG003|Overall Study|Disease Progression|4|||
157008222|NCT00959946|566780162|FG004|Overall Study|Disease Progression|4|||
157008223|NCT00959946|566780163|FG005|Overall Study|Disease Progression|6|||
157008224|NCT00959946|566780164|FG006|Overall Study|Disease Progression|2|||
157008225|NCT00959946|566780165|FG007|Overall Study|Disease Progression|2|||
157008226|NCT00959946|566780158|FG000|Overall Study|Withdrawal by Subject|0|||
157008227|NCT00959946|566780159|FG001|Overall Study|Withdrawal by Subject|0|||
157008228|NCT00959946|566780160|FG002|Overall Study|Withdrawal by Subject|0|||
157008229|NCT00959946|566780161|FG003|Overall Study|Withdrawal by Subject|0|||
157008230|NCT00959946|566780162|FG004|Overall Study|Withdrawal by Subject|0|||
157008231|NCT00959946|566780163|FG005|Overall Study|Withdrawal by Subject|1|||
157008232|NCT00959946|566780164|FG006|Overall Study|Withdrawal by Subject|0|||
157008233|NCT00959946|566780165|FG007|Overall Study|Withdrawal by Subject|0|||
157008234|NCT01837966|566780166|FG000|Overall Study|Withdrawal by Subject|2|||
157008235|NCT01837966|566780167|FG001|Overall Study|Withdrawal by Subject|1|||
157008236|NCT04975308|566780171|FG000|Overall Study|Withdrawal by Subject|6|||
157008237|NCT04975308|566780172|FG001|Overall Study|Withdrawal by Subject|16|||
157008238|NCT04975308|566780173|FG002|Overall Study|Withdrawal by Subject|6|||
157008239|NCT04975308|566780171|FG000|Overall Study|Physician Decision|0|||
157008240|NCT04975308|566780172|FG001|Overall Study|Physician Decision|3|||
157008241|NCT04975308|566780173|FG002|Overall Study|Physician Decision|1|||
157008242|NCT04975308|566780171|FG000|Overall Study|Adverse Event|10|||
157008243|NCT04975308|566780172|FG001|Overall Study|Adverse Event|1|||
157008244|NCT04975308|566780173|FG002|Overall Study|Adverse Event|12|||
157008245|NCT04975308|566780171|FG000|Overall Study|On study treatment (Ongoing)|65|||
157008246|NCT04975308|566780172|FG001|Overall Study|On study treatment (Ongoing)|43|||
157008247|NCT04975308|566780173|FG002|Overall Study|On study treatment (Ongoing)|75|||
157008248|NCT04975308|566780171|FG000|Overall Study|Protocol Deviation|4|||
157008249|NCT04975308|566780172|FG001|Overall Study|Protocol Deviation|3|||
157008250|NCT04975308|566780173|FG002|Overall Study|Protocol Deviation|2|||
157008251|NCT02115139|566780176|FG000|Overall Study|Protocol Violation|1|||
157008252|NCT02115139|566780176|FG000|Overall Study|treatment discontinuation|6|||
157008253|NCT00468910|566780177|FG000|Overall Study|Lost to Follow-up|2|||
157008254|NCT00468910|566780178|FG001|Overall Study|Lost to Follow-up|1|||
157008255|NCT00468910|566780177|FG000|Overall Study|Withdrawal by Subject|2|||
157008256|NCT00468910|566780178|FG001|Overall Study|Withdrawal by Subject|1|||
157008257|NCT00468910|566780177|FG000|Overall Study|Medical Contraindication|0|||
157008258|NCT00468910|566780178|FG001|Overall Study|Medical Contraindication|1|||
157008259|NCT01909778|566780179|FG000|Overall Study|failed screening|1|||
157008260|NCT00258895|566780181|FG000|Overall Study|Lost to Follow-up|3|||
156776229|NCT01104766|565933406|FG003|Overall Study|Did not meet inc/exc criteria|0|||
157008261|NCT00258895|566780182|FG001|Overall Study|Lost to Follow-up|1|||
157008262|NCT00258895|566780181|FG000|Overall Study|Protocol Violation|6|||
157008263|NCT00258895|566780182|FG001|Overall Study|Protocol Violation|2|||
156776230|NCT01104766|565933403|FG000|Overall Study|Adverse Event|17|||
156776231|NCT01104766|565933404|FG001|Overall Study|Adverse Event|15|||
156776232|NCT01104766|565933405|FG002|Overall Study|Adverse Event|20|||
156776233|NCT01104766|565933406|FG003|Overall Study|Adverse Event|14|||
156776234|NCT01104766|565933403|FG000|Overall Study|Lack of Efficacy|20|||
156776235|NCT01104766|565933404|FG001|Overall Study|Lack of Efficacy|15|||
156776236|NCT01104766|565933405|FG002|Overall Study|Lack of Efficacy|14|||
156776237|NCT01104766|565933406|FG003|Overall Study|Lack of Efficacy|8|||
156776238|NCT01104766|565933403|FG000|Overall Study|Protocol Violation|2|||
156776239|NCT01104766|565933404|FG001|Overall Study|Protocol Violation|0|||
156776240|NCT01104766|565933405|FG002|Overall Study|Protocol Violation|0|||
156776241|NCT01104766|565933406|FG003|Overall Study|Protocol Violation|0|||
156776242|NCT01104766|565933403|FG000|Overall Study|Withdrawal by Subject|17|||
156776243|NCT01104766|565933404|FG001|Overall Study|Withdrawal by Subject|19|||
157008264|NCT00258895|566780181|FG000|Overall Study|Withdrawal by Subject|1|||
157008265|NCT00258895|566780182|FG001|Overall Study|Withdrawal by Subject|0|||
156776244|NCT01104766|565933405|FG002|Overall Study|Withdrawal by Subject|25|||
156776245|NCT01104766|565933406|FG003|Overall Study|Withdrawal by Subject|15|||
156776246|NCT01104766|565933403|FG000|Overall Study|Lost to Follow-up|1|||
157114653|NCT01192022|567175622|FG002|Overall Study|Withdrawal of Consent|0|||
157114654|NCT01192022|567175623|FG003|Overall Study|Withdrawal of Consent|0|||
157114655|NCT01192022|567175624|FG004|Overall Study|Withdrawal of Consent|0|||
157114656|NCT01192022|567175620|FG000|Overall Study|Lost to Follow-up|4|||
157114657|NCT01192022|567175621|FG001|Overall Study|Lost to Follow-up|2|||
157114658|NCT01192022|567175622|FG002|Overall Study|Lost to Follow-up|1|||
157114659|NCT01192022|567175623|FG003|Overall Study|Lost to Follow-up|1|||
157114660|NCT01192022|567175624|FG004|Overall Study|Lost to Follow-up|0|||
157114661|NCT01192022|567175620|FG000|Overall Study|Adverse Event|1|||
157114662|NCT01192022|567175621|FG001|Overall Study|Adverse Event|0|||
157114663|NCT01192022|567175622|FG002|Overall Study|Adverse Event|0|||
157114664|NCT01192022|567175623|FG003|Overall Study|Adverse Event|0|||
157114665|NCT01192022|567175624|FG004|Overall Study|Adverse Event|0|||
157114666|NCT01192022|567175620|FG000|Overall Study|Fatal Adverse Event|4|||
157114667|NCT01192022|567175621|FG001|Overall Study|Fatal Adverse Event|6|||
157114668|NCT01192022|567175622|FG002|Overall Study|Fatal Adverse Event|0|||
157114669|NCT01192022|567175623|FG003|Overall Study|Fatal Adverse Event|0|||
157114670|NCT01192022|567175624|FG004|Overall Study|Fatal Adverse Event|1|||
157114671|NCT01192022|567175620|FG000|Overall Study|Physician withdrew-patient hardship|1|||
157114672|NCT01192022|567175621|FG001|Overall Study|Physician withdrew-patient hardship|0|||
157114673|NCT01192022|567175622|FG002|Overall Study|Physician withdrew-patient hardship|0|||
157114674|NCT01192022|567175623|FG003|Overall Study|Physician withdrew-patient hardship|0|||
157114675|NCT01192022|567175624|FG004|Overall Study|Physician withdrew-patient hardship|0|||
157114676|NCT01192022|567175620|FG000|Overall Study|Patient too sick from chemotherapy|0|||
157114677|NCT01192022|567175621|FG001|Overall Study|Patient too sick from chemotherapy|1|||
157114678|NCT01192022|567175622|FG002|Overall Study|Patient too sick from chemotherapy|0|||
157114679|NCT01192022|567175623|FG003|Overall Study|Patient too sick from chemotherapy|0|||
156776247|NCT01104766|565933404|FG001|Overall Study|Lost to Follow-up|2|||
156776248|NCT01104766|565933405|FG002|Overall Study|Lost to Follow-up|1|||
157114680|NCT01192022|567175624|FG004|Overall Study|Patient too sick from chemotherapy|0|||
157114681|NCT01192022|567175620|FG000|Overall Study|Patient needed surgery|0|||
157114682|NCT01192022|567175621|FG001|Overall Study|Patient needed surgery|1|||
157114683|NCT01192022|567175622|FG002|Overall Study|Patient needed surgery|0|||
157114684|NCT01192022|567175623|FG003|Overall Study|Patient needed surgery|0|||
157114685|NCT01192022|567175624|FG004|Overall Study|Patient needed surgery|0|||
157114686|NCT01192022|567175620|FG000|Overall Study|Parents did not allow all follow up|0|||
157114687|NCT01192022|567175621|FG001|Overall Study|Parents did not allow all follow up|0|||
157114688|NCT01192022|567175622|FG002|Overall Study|Parents did not allow all follow up|0|||
157114689|NCT01192022|567175623|FG003|Overall Study|Parents did not allow all follow up|1|||
157114690|NCT01192022|567175624|FG004|Overall Study|Parents did not allow all follow up|0|||
157114691|NCT04839978|567175625|FG000|Overall Study|Lost to Follow-up|135|||
157114692|NCT04839978|567175626|FG001|Overall Study|Lost to Follow-up|147|||
157114693|NCT03551509|567175627|FG000|Overall Study|Lost to Follow-up|0|||
157114694|NCT03551509|567175628|FG001|Overall Study|Lost to Follow-up|1|||
157114695|NCT03551509|567175629|FG002|Overall Study|Lost to Follow-up|0|||
157114696|NCT03776175|567175630|FG000|Treatment Period (42 Days)|Adverse Event|0|||
157114697|NCT03776175|567175631|FG001|Treatment Period (42 Days)|Adverse Event|1|||
157114698|NCT03776175|567175632|FG002|Treatment Period (42 Days)|Adverse Event|1|||
157114699|NCT03776175|567175633|FG003|Treatment Period (42 Days)|Adverse Event|0|||
157114700|NCT03776175|567175630|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
157114701|NCT03776175|567175631|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
157114702|NCT03776175|567175632|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
157114703|NCT03776175|567175633|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
157114704|NCT03776175|567175630|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
157114705|NCT03776175|567175631|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
156776249|NCT01104766|565933406|FG003|Overall Study|Lost to Follow-up|1|||
156776250|NCT01756235|565933407|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
156776251|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
156776252|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
156776253|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
156776254|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
157114706|NCT03776175|567175632|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
157114707|NCT03776175|567175633|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
157114708|NCT03776175|567175630|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
157114709|NCT03776175|567175631|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
157114710|NCT03776175|567175632|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
157114711|NCT03776175|567175633|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
157114712|NCT03776175|567175630|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
157114713|NCT03776175|567175631|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
157114714|NCT03776175|567175632|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
156776255|NCT05376358|565933408|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
156776256|NCT05376358|565933409|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
156776257|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
156776258|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
156776259|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
156776260|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
156776261|NCT05376358|565933408|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
156776262|NCT05376358|565933409|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
156776263|NCT04225832|565933410|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
156776264|NCT04225832|565933411|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
156776265|NCT04225832|565933410|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
156776266|NCT04225832|565933411|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
156776267|NCT00311168|565933412|FG000|First Intervention|Withdrawal by Subject|2|||
156776268|NCT00311168|565933413|FG001|First Intervention|Withdrawal by Subject|2|||
156776269|NCT00311168|565933412|FG000|First Intervention|Lost to Follow-up|1|||
156776270|NCT00311168|565933413|FG001|First Intervention|Lost to Follow-up|1|||
156776271|NCT00311168|565933412|FG000|First Intervention|Protocol Violation|1|||
156776272|NCT00311168|565933413|FG001|First Intervention|Protocol Violation|1|||
156776273|NCT00311168|565933412|FG000|First Intervention|Adverse Event|1|||
156776274|NCT00311168|565933413|FG001|First Intervention|Adverse Event|0|||
157114715|NCT03776175|567175633|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
157114716|NCT03776175|567175630|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
156776275|NCT00311168|565933412|FG000|First Intervention|Other|2|||
157114717|NCT03776175|567175631|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
156776276|NCT00311168|565933413|FG001|First Intervention|Other|2|||
156776277|NCT00311168|565933412|FG000|Second Intervention|Lost to Follow-up|9|||
156776278|NCT00311168|565933413|FG001|Second Intervention|Lost to Follow-up|2|||
156776279|NCT00311168|565933412|FG000|Second Intervention|Withdrawal by Subject|0|||
156776280|NCT00311168|565933413|FG001|Second Intervention|Withdrawal by Subject|1|||
156776281|NCT00311168|565933412|FG000|Second Intervention|Other|1|||
156776282|NCT00311168|565933413|FG001|Second Intervention|Other|1|||
156776283|NCT06001021|565933416|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
156776284|NCT06001021|565933417|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776285|NCT06001021|565933418|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776286|NCT06001021|565933419|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
156776287|NCT06001021|565933420|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
156776288|NCT06001021|565933421|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
156776289|NCT06001021|565933422|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
156776290|NCT06001021|565933416|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
156776291|NCT06001021|565933417|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776292|NCT06001021|565933418|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776293|NCT06001021|565933419|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
156776294|NCT06001021|565933420|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
156776295|NCT06001021|565933421|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776296|NCT06001021|565933422|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
156776297|NCT04703192|565933424|FG000|Overall Study|Withdrawal by Subject|2|||
156776298|NCT04703192|565933425|FG001|Overall Study|Withdrawal by Subject|0|||
156776299|NCT04703192|565933424|FG000|Overall Study|Death|3|||
156776300|NCT04703192|565933425|FG001|Overall Study|Death|1|||
156776301|NCT04703192|565933424|FG000|Overall Study|Adverse Event|13|||
156776302|NCT04703192|565933425|FG001|Overall Study|Adverse Event|2|||
156776303|NCT04703192|565933424|FG000|Overall Study|Progressive or Relapsed Disease|46|||
156776304|NCT04703192|565933425|FG001|Overall Study|Progressive or Relapsed Disease|7|||
157114718|NCT03776175|567175632|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
157114719|NCT03776175|567175633|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
157114720|NCT00783094|567175642|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
157114721|NCT00783094|567175643|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
157114722|NCT00783094|567175644|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
157114723|NCT00783094|567175642|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
157114724|NCT00783094|567175643|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
157114725|NCT00783094|567175644|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
157114726|NCT00783094|567175642|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
157114727|NCT00783094|567175643|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
157114728|NCT00783094|567175644|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
157114729|NCT00783094|567175642|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
157114730|NCT00783094|567175643|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
157114731|NCT00783094|567175644|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
157114732|NCT00783094|567175642|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
157114733|NCT00783094|567175643|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
156776305|NCT04703192|565933424|FG000|Overall Study|Clinical Progression|19|||
156776306|NCT04703192|565933425|FG001|Overall Study|Clinical Progression|8|||
156776307|NCT04703192|565933424|FG000|Overall Study|Lost to Follow-up|1|||
156776308|NCT04703192|565933425|FG001|Overall Study|Lost to Follow-up|0|||
156776309|NCT04703192|565933424|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
156776310|NCT04703192|565933425|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
156776311|NCT04703192|565933424|FG000|Overall Study|Other|5|||
156776312|NCT04703192|565933425|FG001|Overall Study|Other|1|||
157114734|NCT00783094|567175644|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
157114735|NCT00783094|567175642|FG000|Open-Label Extension Period|Adverse Event|12|||
156776313|NCT04537299|565933428|FG000|Overall Study|Withdrawal by Subject|2|||
157114736|NCT00783094|567175643|FG001|Open-Label Extension Period|Adverse Event|7|||
157114737|NCT00783094|567175644|FG002|Open-Label Extension Period|Adverse Event|16|||
157114738|NCT00783094|567175642|FG000|Open-Label Extension Period|Death|0|||
157114739|NCT00783094|567175643|FG001|Open-Label Extension Period|Death|0|||
157114740|NCT00783094|567175644|FG002|Open-Label Extension Period|Death|1|||
157114741|NCT00783094|567175642|FG000|Open-Label Extension Period|Protocol Violation|4|||
157114742|NCT00783094|567175643|FG001|Open-Label Extension Period|Protocol Violation|5|||
157114743|NCT00783094|567175644|FG002|Open-Label Extension Period|Protocol Violation|7|||
157114744|NCT00783094|567175642|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
156776314|NCT04537299|565933429|FG001|Overall Study|Withdrawal by Subject|0|||
156776315|NCT04537299|565933428|FG000|Overall Study|Protocol Violation|1|||
156776316|NCT04537299|565933429|FG001|Overall Study|Protocol Violation|1|||
156776317|NCT00876343|565933430|FG000|Overall Study|Adverse Event|7|||
156776318|NCT00876343|565933431|FG001|Overall Study|Adverse Event|8|||
156776319|NCT00876343|565933432|FG002|Overall Study|Adverse Event|2|||
156776320|NCT00876343|565933430|FG000|Overall Study|Withdrawal by Subject|4|||
156776321|NCT00876343|565933431|FG001|Overall Study|Withdrawal by Subject|4|||
156776322|NCT00876343|565933432|FG002|Overall Study|Withdrawal by Subject|3|||
156776323|NCT00876343|565933430|FG000|Overall Study|Lack of Efficacy|0|||
156776324|NCT00876343|565933431|FG001|Overall Study|Lack of Efficacy|0|||
156776325|NCT00876343|565933432|FG002|Overall Study|Lack of Efficacy|1|||
156776326|NCT00876343|565933430|FG000|Overall Study|Protocol Violation|4|||
156776327|NCT00876343|565933431|FG001|Overall Study|Protocol Violation|1|||
156776328|NCT00876343|565933432|FG002|Overall Study|Protocol Violation|1|||
156776329|NCT00876343|565933430|FG000|Overall Study|Physician Decision|0|||
156776330|NCT00876343|565933431|FG001|Overall Study|Physician Decision|1|||
156776331|NCT00876343|565933432|FG002|Overall Study|Physician Decision|1|||
156776332|NCT00876343|565933430|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
156776333|NCT00876343|565933431|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
156776334|NCT00876343|565933432|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
156776335|NCT00876343|565933430|FG000|Overall Study|Change of residence or other commitments|2|||
156776336|NCT00876343|565933431|FG001|Overall Study|Change of residence or other commitments|2|||
156776337|NCT00876343|565933432|FG002|Overall Study|Change of residence or other commitments|3|||
156776338|NCT02802228|565933436|FG000|Overall Study|Withdrawal by Subject|2|||
156776339|NCT02802228|565933437|FG001|Overall Study|Withdrawal by Subject|0|||
156776340|NCT02802228|565933436|FG000|Overall Study|Lost to Follow-up|1|||
156776341|NCT02802228|565933437|FG001|Overall Study|Lost to Follow-up|0|||
156776342|NCT02802228|565933436|FG000|Overall Study|Adverse Event|1|||
156776343|NCT02802228|565933437|FG001|Overall Study|Adverse Event|0|||
156776344|NCT02802228|565933436|FG000|Overall Study|Physician Decision|1|||
156776345|NCT02802228|565933437|FG001|Overall Study|Physician Decision|0|||
156776346|NCT00695019|565933440|FG000|Overall Study|Withdrawal by Subject|8|||
156776347|NCT00695019|565933441|FG001|Overall Study|Withdrawal by Subject|6|||
156776348|NCT00695019|565933442|FG002|Overall Study|Withdrawal by Subject|4|||
156776349|NCT00695019|565933440|FG000|Overall Study|Protocol Violation|1|||
156776350|NCT00695019|565933441|FG001|Overall Study|Protocol Violation|3|||
156776351|NCT00695019|565933442|FG002|Overall Study|Protocol Violation|1|||
156776352|NCT00695019|565933440|FG000|Overall Study|Lack of Efficacy|0|||
157114745|NCT00783094|567175643|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
157114746|NCT00783094|567175644|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
157114747|NCT00783094|567175642|FG000|Open-Label Extension Period|Physician Decision|4|||
157114748|NCT00783094|567175643|FG001|Open-Label Extension Period|Physician Decision|2|||
156776353|NCT00695019|565933441|FG001|Overall Study|Lack of Efficacy|0|||
156776354|NCT00695019|565933442|FG002|Overall Study|Lack of Efficacy|1|||
156776355|NCT00695019|565933440|FG000|Overall Study|Various|4|||
156776356|NCT00695019|565933441|FG001|Overall Study|Various|5|||
156776357|NCT00695019|565933442|FG002|Overall Study|Various|4|||
156776358|NCT00924898|565933443|FG000|Overall Study|Withdrawal by Subject|2|||
156776359|NCT02278354|565933447|FG000|Overall Study|Lost to Follow-up|2|||
156776360|NCT02278354|565933448|FG001|Overall Study|Lost to Follow-up|2|||
157114749|NCT00783094|567175644|FG002|Open-Label Extension Period|Physician Decision|3|||
157114750|NCT00783094|567175642|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
157114751|NCT00783094|567175643|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
156776361|NCT02278354|565933447|FG000|Overall Study|Withdrawal by Subject|0|||
156776362|NCT02278354|565933448|FG001|Overall Study|Withdrawal by Subject|1|||
157114752|NCT00783094|567175644|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
156776363|NCT02278354|565933447|FG000|Overall Study|<10 professional fights|2|||
156776364|NCT02278354|565933448|FG001|Overall Study|<10 professional fights|0|||
156776365|NCT01901562|565933453|FG000|Overall Study|Protocol Violation|5|||
156776366|NCT01901562|565933453|FG000|Overall Study|Excluded intraoperatively|4|||
156776367|NCT01925794|565933454|FG000|180 Days|Death|2|||
156776368|NCT01925794|565933454|FG000|180 Days|Withdrawal by Subject|2|||
156776369|NCT01925794|565933454|FG000|270 Days|Death|2|||
156776370|NCT01925794|565933454|FG000|270 Days|Protocol Violation|3|||
156776371|NCT02612155|565933455|FG000|Overall Study|Death|1|||
156776372|NCT02612155|565933456|FG001|Overall Study|Death|1|||
156776373|NCT02612155|565933455|FG000|Overall Study|Lost to Follow-up|2|||
156776374|NCT02612155|565933456|FG001|Overall Study|Lost to Follow-up|2|||
156776375|NCT03126110|565933466|FG000|Phase 1|Death|2|||
156776376|NCT03126110|565933467|FG001|Phase 1|Death|2|||
156776377|NCT03126110|565933468|FG002|Phase 1|Death|4|||
156776378|NCT03126110|565933469|FG003|Phase 1|Death|3|||
156776379|NCT03126110|565933470|FG004|Phase 1|Death|4|||
156776380|NCT03126110|565933471|FG005|Phase 1|Death|4|||
156776381|NCT03126110|565933472|FG006|Phase 1|Death|3|||
156776382|NCT03126110|565933473|FG007|Phase 1|Death|4|||
156776383|NCT03126110|565933474|FG008|Phase 1|Death|5|||
156776384|NCT03126110|565933475|FG009|Phase 1|Death|2|||
156776385|NCT03126110|565933476|FG010|Phase 1|Death|6|||
156776386|NCT03126110|565933477|FG011|Phase 1|Death|0|||
156776387|NCT03126110|565933478|FG012|Phase 1|Death|0|||
156776388|NCT03126110|565933479|FG013|Phase 1|Death|0|||
156776389|NCT03126110|565933480|FG014|Phase 1|Death|0|||
156776390|NCT03126110|565933481|FG015|Phase 1|Death|0|||
156776391|NCT03126110|565933482|FG016|Phase 1|Death|0|||
156776392|NCT03126110|565933466|FG000|Phase 1|Lost to Follow-up|0|||
156776393|NCT03126110|565933467|FG001|Phase 1|Lost to Follow-up|1|||
156776394|NCT03126110|565933468|FG002|Phase 1|Lost to Follow-up|0|||
156776395|NCT03126110|565933469|FG003|Phase 1|Lost to Follow-up|0|||
156776396|NCT03126110|565933470|FG004|Phase 1|Lost to Follow-up|0|||
156776397|NCT03126110|565933471|FG005|Phase 1|Lost to Follow-up|0|||
156776398|NCT03126110|565933472|FG006|Phase 1|Lost to Follow-up|0|||
156776399|NCT03126110|565933473|FG007|Phase 1|Lost to Follow-up|0|||
156776400|NCT03126110|565933474|FG008|Phase 1|Lost to Follow-up|1|||
156776401|NCT03126110|565933475|FG009|Phase 1|Lost to Follow-up|0|||
156776402|NCT03126110|565933476|FG010|Phase 1|Lost to Follow-up|0|||
156776403|NCT03126110|565933477|FG011|Phase 1|Lost to Follow-up|0|||
156776404|NCT03126110|565933478|FG012|Phase 1|Lost to Follow-up|0|||
156776405|NCT03126110|565933479|FG013|Phase 1|Lost to Follow-up|0|||
156776406|NCT03126110|565933480|FG014|Phase 1|Lost to Follow-up|0|||
156776407|NCT03126110|565933481|FG015|Phase 1|Lost to Follow-up|0|||
156776408|NCT03126110|565933482|FG016|Phase 1|Lost to Follow-up|0|||
156776409|NCT03126110|565933466|FG000|Phase 1|Withdrawal by Subject|1|||
156776410|NCT03126110|565933467|FG001|Phase 1|Withdrawal by Subject|0|||
156776411|NCT03126110|565933468|FG002|Phase 1|Withdrawal by Subject|0|||
156776412|NCT03126110|565933469|FG003|Phase 1|Withdrawal by Subject|1|||
156776413|NCT03126110|565933470|FG004|Phase 1|Withdrawal by Subject|1|||
156776414|NCT03126110|565933471|FG005|Phase 1|Withdrawal by Subject|0|||
156776415|NCT03126110|565933472|FG006|Phase 1|Withdrawal by Subject|0|||
156776416|NCT03126110|565933473|FG007|Phase 1|Withdrawal by Subject|0|||
156776417|NCT03126110|565933474|FG008|Phase 1|Withdrawal by Subject|2|||
156776418|NCT03126110|565933475|FG009|Phase 1|Withdrawal by Subject|1|||
156776419|NCT03126110|565933476|FG010|Phase 1|Withdrawal by Subject|0|||
156776420|NCT03126110|565933477|FG011|Phase 1|Withdrawal by Subject|0|||
156776421|NCT03126110|565933478|FG012|Phase 1|Withdrawal by Subject|0|||
156776422|NCT03126110|565933479|FG013|Phase 1|Withdrawal by Subject|0|||
156776423|NCT03126110|565933480|FG014|Phase 1|Withdrawal by Subject|0|||
156776424|NCT03126110|565933481|FG015|Phase 1|Withdrawal by Subject|0|||
156776425|NCT03126110|565933482|FG016|Phase 1|Withdrawal by Subject|0|||
156776426|NCT03126110|565933466|FG000|Phase 1|Safety follow-up no longer necessary|1|||
156776427|NCT03126110|565933467|FG001|Phase 1|Safety follow-up no longer necessary|0|||
156776428|NCT03126110|565933468|FG002|Phase 1|Safety follow-up no longer necessary|0|||
156776429|NCT03126110|565933469|FG003|Phase 1|Safety follow-up no longer necessary|0|||
156776430|NCT03126110|565933470|FG004|Phase 1|Safety follow-up no longer necessary|0|||
156776431|NCT03126110|565933471|FG005|Phase 1|Safety follow-up no longer necessary|0|||
156776432|NCT03126110|565933472|FG006|Phase 1|Safety follow-up no longer necessary|0|||
156776433|NCT03126110|565933473|FG007|Phase 1|Safety follow-up no longer necessary|0|||
156776434|NCT03126110|565933474|FG008|Phase 1|Safety follow-up no longer necessary|0|||
156776435|NCT03126110|565933475|FG009|Phase 1|Safety follow-up no longer necessary|0|||
156776436|NCT03126110|565933476|FG010|Phase 1|Safety follow-up no longer necessary|0|||
156776437|NCT03126110|565933477|FG011|Phase 1|Safety follow-up no longer necessary|0|||
156776438|NCT03126110|565933478|FG012|Phase 1|Safety follow-up no longer necessary|0|||
156776439|NCT03126110|565933479|FG013|Phase 1|Safety follow-up no longer necessary|0|||
156776440|NCT03126110|565933480|FG014|Phase 1|Safety follow-up no longer necessary|0|||
156776441|NCT03126110|565933481|FG015|Phase 1|Safety follow-up no longer necessary|0|||
156776442|NCT03126110|565933482|FG016|Phase 1|Safety follow-up no longer necessary|0|||
156776443|NCT03126110|565933466|FG000|Phase 1|Survival follow-up no longer necessary|0|||
156776444|NCT03126110|565933467|FG001|Phase 1|Survival follow-up no longer necessary|0|||
156776445|NCT03126110|565933468|FG002|Phase 1|Survival follow-up no longer necessary|1|||
156776446|NCT03126110|565933469|FG003|Phase 1|Survival follow-up no longer necessary|0|||
156776447|NCT03126110|565933470|FG004|Phase 1|Survival follow-up no longer necessary|0|||
156776448|NCT03126110|565933471|FG005|Phase 1|Survival follow-up no longer necessary|0|||
156776449|NCT03126110|565933472|FG006|Phase 1|Survival follow-up no longer necessary|0|||
156776450|NCT03126110|565933473|FG007|Phase 1|Survival follow-up no longer necessary|0|||
156776451|NCT03126110|565933474|FG008|Phase 1|Survival follow-up no longer necessary|0|||
156776452|NCT03126110|565933475|FG009|Phase 1|Survival follow-up no longer necessary|0|||
156776453|NCT03126110|565933476|FG010|Phase 1|Survival follow-up no longer necessary|0|||
156776454|NCT03126110|565933477|FG011|Phase 1|Survival follow-up no longer necessary|0|||
156776455|NCT03126110|565933478|FG012|Phase 1|Survival follow-up no longer necessary|0|||
156776456|NCT03126110|565933479|FG013|Phase 1|Survival follow-up no longer necessary|0|||
156776457|NCT03126110|565933480|FG014|Phase 1|Survival follow-up no longer necessary|0|||
156776458|NCT03126110|565933481|FG015|Phase 1|Survival follow-up no longer necessary|0|||
156776459|NCT03126110|565933482|FG016|Phase 1|Survival follow-up no longer necessary|0|||
156776460|NCT03126110|565933466|FG000|Phase 2|Study terminated by the sponsor|0|||
156776461|NCT03126110|565933467|FG001|Phase 2|Study terminated by the sponsor|0|||
156776462|NCT03126110|565933468|FG002|Phase 2|Study terminated by the sponsor|0|||
156776463|NCT03126110|565933469|FG003|Phase 2|Study terminated by the sponsor|0|||
156776464|NCT03126110|565933470|FG004|Phase 2|Study terminated by the sponsor|0|||
156776465|NCT03126110|565933471|FG005|Phase 2|Study terminated by the sponsor|0|||
156776466|NCT03126110|565933472|FG006|Phase 2|Study terminated by the sponsor|0|||
156776467|NCT03126110|565933473|FG007|Phase 2|Study terminated by the sponsor|0|||
156776468|NCT03126110|565933474|FG008|Phase 2|Study terminated by the sponsor|0|||
156776469|NCT03126110|565933475|FG009|Phase 2|Study terminated by the sponsor|0|||
156776470|NCT03126110|565933476|FG010|Phase 2|Study terminated by the sponsor|0|||
156776471|NCT03126110|565933477|FG011|Phase 2|Study terminated by the sponsor|0|||
156776472|NCT03126110|565933478|FG012|Phase 2|Study terminated by the sponsor|0|||
156776473|NCT03126110|565933479|FG013|Phase 2|Study terminated by the sponsor|4|||
156776474|NCT03126110|565933480|FG014|Phase 2|Study terminated by the sponsor|0|||
156776475|NCT03126110|565933481|FG015|Phase 2|Study terminated by the sponsor|0|||
156776476|NCT03126110|565933482|FG016|Phase 2|Study terminated by the sponsor|0|||
156776477|NCT03126110|565933466|FG000|Phase 2|Withdrawal by Subject|0|||
156776478|NCT03126110|565933467|FG001|Phase 2|Withdrawal by Subject|0|||
156776479|NCT03126110|565933468|FG002|Phase 2|Withdrawal by Subject|0|||
156776480|NCT03126110|565933469|FG003|Phase 2|Withdrawal by Subject|0|||
156776481|NCT03126110|565933470|FG004|Phase 2|Withdrawal by Subject|0|||
156776482|NCT03126110|565933471|FG005|Phase 2|Withdrawal by Subject|0|||
156776483|NCT03126110|565933472|FG006|Phase 2|Withdrawal by Subject|0|||
156776484|NCT03126110|565933473|FG007|Phase 2|Withdrawal by Subject|0|||
156776485|NCT03126110|565933474|FG008|Phase 2|Withdrawal by Subject|0|||
156776486|NCT03126110|565933475|FG009|Phase 2|Withdrawal by Subject|0|||
156776487|NCT03126110|565933476|FG010|Phase 2|Withdrawal by Subject|0|||
156776488|NCT03126110|565933477|FG011|Phase 2|Withdrawal by Subject|1|||
156776489|NCT03126110|565933478|FG012|Phase 2|Withdrawal by Subject|3|||
156776490|NCT03126110|565933479|FG013|Phase 2|Withdrawal by Subject|3|||
156776491|NCT03126110|565933480|FG014|Phase 2|Withdrawal by Subject|2|||
156776492|NCT03126110|565933481|FG015|Phase 2|Withdrawal by Subject|1|||
156776493|NCT03126110|565933482|FG016|Phase 2|Withdrawal by Subject|0|||
156776494|NCT03126110|565933466|FG000|Phase 2|Lost to Follow-up|0|||
156776495|NCT03126110|565933467|FG001|Phase 2|Lost to Follow-up|0|||
156776496|NCT03126110|565933468|FG002|Phase 2|Lost to Follow-up|0|||
156776497|NCT03126110|565933469|FG003|Phase 2|Lost to Follow-up|0|||
156776498|NCT03126110|565933470|FG004|Phase 2|Lost to Follow-up|0|||
156776499|NCT03126110|565933471|FG005|Phase 2|Lost to Follow-up|0|||
156776500|NCT03126110|565933472|FG006|Phase 2|Lost to Follow-up|0|||
156776501|NCT03126110|565933473|FG007|Phase 2|Lost to Follow-up|0|||
156776502|NCT03126110|565933474|FG008|Phase 2|Lost to Follow-up|0|||
156776503|NCT03126110|565933475|FG009|Phase 2|Lost to Follow-up|0|||
156776504|NCT03126110|565933476|FG010|Phase 2|Lost to Follow-up|0|||
156776505|NCT03126110|565933477|FG011|Phase 2|Lost to Follow-up|1|||
156776506|NCT03126110|565933478|FG012|Phase 2|Lost to Follow-up|1|||
156776507|NCT03126110|565933479|FG013|Phase 2|Lost to Follow-up|1|||
157008266|NCT00547118|566780183|FG000|Overall Study|Did not qualify prior to starting drug|1|||
157008267|NCT00547118|566780184|FG001|Overall Study|Did not qualify prior to starting drug|1|||
157008268|NCT00547118|566780183|FG000|Overall Study|Study suspended|7|||
157008269|NCT00547118|566780184|FG001|Overall Study|Study suspended|8|||
157008270|NCT00841035|566780192|FG000|Phase 1 Overall Study|Physician Decision|13|||
157008271|NCT00433199|566780197|FG000|Double-Blind Period|Adverse Event|0|||
157008272|NCT00433199|566780198|FG001|Double-Blind Period|Adverse Event|25|||
157008273|NCT00433199|566780197|FG000|Double-Blind Period|Lack of Efficacy|0|||
157008274|NCT00433199|566780198|FG001|Double-Blind Period|Lack of Efficacy|2|||
157008275|NCT00433199|566780197|FG000|Double-Blind Period|Lost to Follow-up|2|||
157008276|NCT00433199|566780198|FG001|Double-Blind Period|Lost to Follow-up|5|||
157008277|NCT00433199|566780197|FG000|Double-Blind Period|Withdrawal by Subject|8|||
157008278|NCT00433199|566780198|FG001|Double-Blind Period|Withdrawal by Subject|19|||
157114753|NCT02513329|567175645|FG000|Overall Study|Lost to Follow-up|5|||
157114754|NCT02513329|567175646|FG001|Overall Study|Lost to Follow-up|2|||
157114755|NCT05440539|567175648|FG000|Overall Study|Lost to Follow-up|4|||
157114756|NCT05440539|567175649|FG001|Overall Study|Lost to Follow-up|4|||
157114757|NCT05440539|567175648|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
157114758|NCT05440539|567175649|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
157114759|NCT03808077|567175650|FG000|Overall Study|Physician Decision|2|||
157114760|NCT03808077|567175651|FG001|Overall Study|Physician Decision|3|||
157114761|NCT03808077|567175650|FG000|Overall Study|Withdrawal by Subject|1|||
157114762|NCT03808077|567175651|FG001|Overall Study|Withdrawal by Subject|0|||
157114763|NCT03808077|567175650|FG000|Overall Study|Equipment Issues|2|||
157114764|NCT03808077|567175651|FG001|Overall Study|Equipment Issues|1|||
157114765|NCT02004262|567175656|FG000|Overall Study|Death|67|||
157114766|NCT02004262|567175657|FG001|Overall Study|Death|64|||
157114767|NCT02004262|567175658|FG002|Overall Study|Death|66|||
157114768|NCT02004262|567175659|FG003|Overall Study|Death|28|||
157114769|NCT02004262|567175660|FG004|Overall Study|Death|29|||
157114770|NCT02004262|567175661|FG005|Overall Study|Death|22|||
157114771|NCT02004262|567175656|FG000|Overall Study|Withdrawal by Subject|1|||
157114772|NCT02004262|567175657|FG001|Overall Study|Withdrawal by Subject|0|||
157114773|NCT02004262|567175658|FG002|Overall Study|Withdrawal by Subject|4|||
157114774|NCT02004262|567175659|FG003|Overall Study|Withdrawal by Subject|0|||
157114775|NCT02004262|567175660|FG004|Overall Study|Withdrawal by Subject|1|||
157114776|NCT02004262|567175661|FG005|Overall Study|Withdrawal by Subject|3|||
157114777|NCT02004262|567175656|FG000|Overall Study|Lost to Follow-up|1|||
157114778|NCT02004262|567175657|FG001|Overall Study|Lost to Follow-up|1|||
157114779|NCT02004262|567175658|FG002|Overall Study|Lost to Follow-up|0|||
157114780|NCT02004262|567175659|FG003|Overall Study|Lost to Follow-up|0|||
157114781|NCT02004262|567175660|FG004|Overall Study|Lost to Follow-up|0|||
157114782|NCT02004262|567175661|FG005|Overall Study|Lost to Follow-up|0|||
157114783|NCT02004262|567175656|FG000|Overall Study|Study Terminated by Sponsor|4|||
157114784|NCT02004262|567175657|FG001|Overall Study|Study Terminated by Sponsor|3|||
157114785|NCT02004262|567175658|FG002|Overall Study|Study Terminated by Sponsor|2|||
157114786|NCT02004262|567175659|FG003|Overall Study|Study Terminated by Sponsor|1|||
157114787|NCT02004262|567175660|FG004|Overall Study|Study Terminated by Sponsor|1|||
157114788|NCT02004262|567175661|FG005|Overall Study|Study Terminated by Sponsor|5|||
157114789|NCT03703102|567175662|FG000|Overall Study|Adverse Event|4|||
157114790|NCT03703102|567175663|FG001|Overall Study|Adverse Event|3|||
157114791|NCT03703102|567175664|FG002|Overall Study|Adverse Event|7|||
157114792|NCT03703102|567175665|FG003|Overall Study|Adverse Event|3|||
157114793|NCT03703102|567175666|FG004|Overall Study|Adverse Event|13|||
157114794|NCT03703102|567175662|FG000|Overall Study|Lack of Efficacy|4|||
157114795|NCT03703102|567175663|FG001|Overall Study|Lack of Efficacy|0|||
157114796|NCT03703102|567175664|FG002|Overall Study|Lack of Efficacy|1|||
157114797|NCT03703102|567175665|FG003|Overall Study|Lack of Efficacy|4|||
157114798|NCT03703102|567175666|FG004|Overall Study|Lack of Efficacy|1|||
157008279|NCT00433199|566780197|FG000|Double-Blind Period|Protocol Violation|1|||
157008280|NCT00433199|566780198|FG001|Double-Blind Period|Protocol Violation|10|||
157008281|NCT00433199|566780197|FG000|Double-Blind Period|Administrative|1|||
157008282|NCT00433199|566780198|FG001|Double-Blind Period|Administrative|5|||
157008283|NCT00433199|566780197|FG000|Open-Label Period|Adverse Event|0|||
157114799|NCT03703102|567175662|FG000|Overall Study|Lost to Follow-up|0|||
157114800|NCT03703102|567175663|FG001|Overall Study|Lost to Follow-up|0|||
157114801|NCT03703102|567175664|FG002|Overall Study|Lost to Follow-up|1|||
157114802|NCT03703102|567175665|FG003|Overall Study|Lost to Follow-up|2|||
157114803|NCT03703102|567175666|FG004|Overall Study|Lost to Follow-up|2|||
157114804|NCT03703102|567175662|FG000|Overall Study|Physician Decision|2|||
157114805|NCT03703102|567175663|FG001|Overall Study|Physician Decision|2|||
157114806|NCT03703102|567175664|FG002|Overall Study|Physician Decision|2|||
157114807|NCT03703102|567175665|FG003|Overall Study|Physician Decision|2|||
157114808|NCT03703102|567175666|FG004|Overall Study|Physician Decision|4|||
157114809|NCT03703102|567175662|FG000|Overall Study|Withdrawal by Subject|7|||
157114810|NCT03703102|567175663|FG001|Overall Study|Withdrawal by Subject|5|||
157114811|NCT03703102|567175664|FG002|Overall Study|Withdrawal by Subject|5|||
157114812|NCT03703102|567175665|FG003|Overall Study|Withdrawal by Subject|5|||
157008284|NCT00433199|566780198|FG001|Open-Label Period|Adverse Event|19|||
157008285|NCT00433199|566780197|FG000|Open-Label Period|Lack of Efficacy|0|||
156776508|NCT03126110|565933480|FG014|Phase 2|Lost to Follow-up|2|||
156776509|NCT03126110|565933481|FG015|Phase 2|Lost to Follow-up|0|||
156776510|NCT03126110|565933482|FG016|Phase 2|Lost to Follow-up|0|||
156776511|NCT03126110|565933466|FG000|Phase 2|Death|0|||
156776512|NCT03126110|565933467|FG001|Phase 2|Death|0|||
156776513|NCT03126110|565933468|FG002|Phase 2|Death|0|||
156776514|NCT03126110|565933469|FG003|Phase 2|Death|0|||
156776515|NCT03126110|565933470|FG004|Phase 2|Death|0|||
156776516|NCT03126110|565933471|FG005|Phase 2|Death|0|||
156776517|NCT03126110|565933472|FG006|Phase 2|Death|0|||
156776518|NCT03126110|565933473|FG007|Phase 2|Death|0|||
156776519|NCT03126110|565933474|FG008|Phase 2|Death|0|||
156776520|NCT03126110|565933475|FG009|Phase 2|Death|0|||
156776521|NCT03126110|565933476|FG010|Phase 2|Death|0|||
156776522|NCT03126110|565933477|FG011|Phase 2|Death|6|||
156776523|NCT03126110|565933478|FG012|Phase 2|Death|12|||
156776524|NCT03126110|565933479|FG013|Phase 2|Death|25|||
156776525|NCT03126110|565933480|FG014|Phase 2|Death|11|||
156776526|NCT03126110|565933481|FG015|Phase 2|Death|3|||
156776527|NCT03126110|565933482|FG016|Phase 2|Death|2|||
156776528|NCT03126110|565933466|FG000|Phase 2|Progressive Disease|0|||
156776529|NCT03126110|565933467|FG001|Phase 2|Progressive Disease|0|||
156776530|NCT03126110|565933468|FG002|Phase 2|Progressive Disease|0|||
156776531|NCT03126110|565933469|FG003|Phase 2|Progressive Disease|0|||
156776532|NCT03126110|565933470|FG004|Phase 2|Progressive Disease|0|||
156776533|NCT03126110|565933471|FG005|Phase 2|Progressive Disease|0|||
156776534|NCT03126110|565933472|FG006|Phase 2|Progressive Disease|0|||
156776535|NCT03126110|565933473|FG007|Phase 2|Progressive Disease|0|||
156776536|NCT03126110|565933474|FG008|Phase 2|Progressive Disease|0|||
156776537|NCT03126110|565933475|FG009|Phase 2|Progressive Disease|0|||
156776538|NCT03126110|565933476|FG010|Phase 2|Progressive Disease|0|||
156776539|NCT03126110|565933477|FG011|Phase 2|Progressive Disease|0|||
156776540|NCT03126110|565933478|FG012|Phase 2|Progressive Disease|0|||
156776541|NCT03126110|565933479|FG013|Phase 2|Progressive Disease|1|||
156776542|NCT03126110|565933480|FG014|Phase 2|Progressive Disease|0|||
156776543|NCT03126110|565933481|FG015|Phase 2|Progressive Disease|0|||
156776544|NCT03126110|565933482|FG016|Phase 2|Progressive Disease|0|||
156776545|NCT03126110|565933466|FG000|Phase 2|Started new treatment|0|||
156776546|NCT03126110|565933467|FG001|Phase 2|Started new treatment|0|||
156776547|NCT03126110|565933468|FG002|Phase 2|Started new treatment|0|||
156776548|NCT03126110|565933469|FG003|Phase 2|Started new treatment|0|||
156776549|NCT03126110|565933470|FG004|Phase 2|Started new treatment|0|||
156776550|NCT03126110|565933471|FG005|Phase 2|Started new treatment|0|||
156776551|NCT03126110|565933472|FG006|Phase 2|Started new treatment|0|||
156776552|NCT03126110|565933473|FG007|Phase 2|Started new treatment|0|||
156776553|NCT03126110|565933474|FG008|Phase 2|Started new treatment|0|||
156776554|NCT03126110|565933475|FG009|Phase 2|Started new treatment|0|||
156776555|NCT03126110|565933476|FG010|Phase 2|Started new treatment|0|||
156776556|NCT03126110|565933477|FG011|Phase 2|Started new treatment|0|||
157008286|NCT00433199|566780198|FG001|Open-Label Period|Lack of Efficacy|2|||
157008287|NCT00433199|566780197|FG000|Open-Label Period|Lost to Follow-up|0|||
157008288|NCT00433199|566780198|FG001|Open-Label Period|Lost to Follow-up|3|||
157008289|NCT00433199|566780197|FG000|Open-Label Period|Withdrawal by Subject|0|||
157008290|NCT00433199|566780198|FG001|Open-Label Period|Withdrawal by Subject|7|||
156776557|NCT03126110|565933478|FG012|Phase 2|Started new treatment|0|||
156776558|NCT03126110|565933479|FG013|Phase 2|Started new treatment|0|||
156776559|NCT03126110|565933480|FG014|Phase 2|Started new treatment|1|||
156776560|NCT03126110|565933481|FG015|Phase 2|Started new treatment|0|||
156776561|NCT03126110|565933482|FG016|Phase 2|Started new treatment|0|||
156776562|NCT04435626|565933486|FG000|Overall Study|Lost to Follow-up|1|||
156776563|NCT04435626|565933487|FG001|Overall Study|Lost to Follow-up|5|||
156776564|NCT04435626|565933486|FG000|Overall Study|Withdrawal by Subject|6|||
156776565|NCT04435626|565933487|FG001|Overall Study|Withdrawal by Subject|7|||
156776566|NCT04435626|565933486|FG000|Overall Study|major GCP violations|8|||
156776567|NCT04435626|565933487|FG001|Overall Study|major GCP violations|7|||
156776568|NCT05049122|565933493|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
156776569|NCT05049122|565933493|FG000|Overall Study|Participant moved|1|||
156776570|NCT05049122|565933493|FG000|Overall Study|At the direction of the doctor|1|||
156776571|NCT03314935|565933494|FG000|Phase 1|Death|4|||
156776572|NCT03314935|565933495|FG001|Phase 1|Death|2|||
156776573|NCT03314935|565933496|FG002|Phase 1|Death|5|||
156776574|NCT03314935|565933497|FG003|Phase 1|Death|4|||
156776575|NCT03314935|565933498|FG004|Phase 1|Death|3|||
156776576|NCT03314935|565933499|FG005|Phase 1|Death|4|||
156776577|NCT03314935|565933500|FG006|Phase 1|Death|5|||
156776578|NCT03314935|565933501|FG007|Phase 1|Death|4|||
156776579|NCT03314935|565933502|FG008|Phase 1|Death|3|||
156776580|NCT03314935|565933503|FG009|Phase 1|Death|0|||
156776581|NCT03314935|565933504|FG010|Phase 1|Death|0|||
156776582|NCT03314935|565933505|FG011|Phase 1|Death|0|||
156776583|NCT03314935|565933506|FG012|Phase 1|Death|0|||
156776584|NCT03314935|565933507|FG013|Phase 1|Death|0|||
156776585|NCT03314935|565933508|FG014|Phase 1|Death|0|||
156776586|NCT03314935|565933494|FG000|Phase 1|Withdrawal by Subject|2|||
156776587|NCT03314935|565933495|FG001|Phase 1|Withdrawal by Subject|1|||
156776588|NCT03314935|565933496|FG002|Phase 1|Withdrawal by Subject|1|||
156776589|NCT03314935|565933497|FG003|Phase 1|Withdrawal by Subject|2|||
156776590|NCT03314935|565933498|FG004|Phase 1|Withdrawal by Subject|1|||
156776591|NCT03314935|565933499|FG005|Phase 1|Withdrawal by Subject|0|||
156776592|NCT03314935|565933500|FG006|Phase 1|Withdrawal by Subject|1|||
156776593|NCT03314935|565933501|FG007|Phase 1|Withdrawal by Subject|0|||
156776594|NCT03314935|565933502|FG008|Phase 1|Withdrawal by Subject|1|||
156776595|NCT03314935|565933503|FG009|Phase 1|Withdrawal by Subject|0|||
156776596|NCT03314935|565933504|FG010|Phase 1|Withdrawal by Subject|0|||
156776597|NCT03314935|565933505|FG011|Phase 1|Withdrawal by Subject|0|||
156776598|NCT03314935|565933506|FG012|Phase 1|Withdrawal by Subject|0|||
156776599|NCT03314935|565933507|FG013|Phase 1|Withdrawal by Subject|0|||
156776600|NCT03314935|565933508|FG014|Phase 1|Withdrawal by Subject|0|||
156776601|NCT03314935|565933494|FG000|Phase 1|Progressive Disease|2|||
156776602|NCT03314935|565933495|FG001|Phase 1|Progressive Disease|0|||
156776603|NCT03314935|565933496|FG002|Phase 1|Progressive Disease|0|||
156776604|NCT03314935|565933497|FG003|Phase 1|Progressive Disease|1|||
156776605|NCT03314935|565933498|FG004|Phase 1|Progressive Disease|0|||
156776606|NCT03314935|565933499|FG005|Phase 1|Progressive Disease|0|||
156776607|NCT03314935|565933500|FG006|Phase 1|Progressive Disease|0|||
156776608|NCT03314935|565933501|FG007|Phase 1|Progressive Disease|0|||
156776609|NCT03314935|565933502|FG008|Phase 1|Progressive Disease|0|||
156776610|NCT03314935|565933503|FG009|Phase 1|Progressive Disease|0|||
156776611|NCT03314935|565933504|FG010|Phase 1|Progressive Disease|0|||
156776612|NCT03314935|565933505|FG011|Phase 1|Progressive Disease|0|||
156776613|NCT03314935|565933506|FG012|Phase 1|Progressive Disease|0|||
156776614|NCT03314935|565933507|FG013|Phase 1|Progressive Disease|0|||
156776615|NCT03314935|565933508|FG014|Phase 1|Progressive Disease|0|||
156776616|NCT03314935|565933494|FG000|Phase 1|Study Terminated by Sponsor|0|||
156776617|NCT03314935|565933495|FG001|Phase 1|Study Terminated by Sponsor|1|||
156776618|NCT03314935|565933496|FG002|Phase 1|Study Terminated by Sponsor|0|||
156776619|NCT03314935|565933497|FG003|Phase 1|Study Terminated by Sponsor|0|||
156776620|NCT03314935|565933498|FG004|Phase 1|Study Terminated by Sponsor|0|||
156776621|NCT03314935|565933499|FG005|Phase 1|Study Terminated by Sponsor|0|||
156776622|NCT03314935|565933500|FG006|Phase 1|Study Terminated by Sponsor|0|||
156776623|NCT03314935|565933501|FG007|Phase 1|Study Terminated by Sponsor|0|||
156776624|NCT03314935|565933502|FG008|Phase 1|Study Terminated by Sponsor|1|||
156776625|NCT03314935|565933503|FG009|Phase 1|Study Terminated by Sponsor|0|||
156776626|NCT03314935|565933504|FG010|Phase 1|Study Terminated by Sponsor|0|||
156776627|NCT03314935|565933505|FG011|Phase 1|Study Terminated by Sponsor|0|||
156776628|NCT03314935|565933506|FG012|Phase 1|Study Terminated by Sponsor|0|||
156776629|NCT03314935|565933507|FG013|Phase 1|Study Terminated by Sponsor|0|||
156776630|NCT03314935|565933508|FG014|Phase 1|Study Terminated by Sponsor|0|||
156776631|NCT03314935|565933494|FG000|Phase 1|"Captured as Other in Database"|0|||
156776632|NCT03314935|565933495|FG001|Phase 1|"Captured as Other in Database"|2|||
156776633|NCT03314935|565933496|FG002|Phase 1|"Captured as Other in Database"|0|||
156776634|NCT03314935|565933497|FG003|Phase 1|"Captured as Other in Database"|0|||
156776635|NCT03314935|565933498|FG004|Phase 1|"Captured as Other in Database"|0|||
156776636|NCT03314935|565933499|FG005|Phase 1|"Captured as Other in Database"|0|||
156776637|NCT03314935|565933500|FG006|Phase 1|"Captured as Other in Database"|1|||
156776638|NCT03314935|565933501|FG007|Phase 1|"Captured as Other in Database"|1|||
156776639|NCT03314935|565933502|FG008|Phase 1|"Captured as Other in Database"|1|||
156776640|NCT03314935|565933503|FG009|Phase 1|"Captured as Other in Database"|0|||
156776641|NCT03314935|565933504|FG010|Phase 1|"Captured as Other in Database"|0|||
156776642|NCT03314935|565933505|FG011|Phase 1|"Captured as Other in Database"|0|||
156776643|NCT03314935|565933506|FG012|Phase 1|"Captured as Other in Database"|0|||
156776644|NCT03314935|565933507|FG013|Phase 1|"Captured as Other in Database"|0|||
156776645|NCT03314935|565933508|FG014|Phase 1|"Captured as Other in Database"|0|||
156776646|NCT03314935|565933494|FG000|Phase 1|Lost to Follow-up|0|||
156776647|NCT03314935|565933495|FG001|Phase 1|Lost to Follow-up|0|||
156776648|NCT03314935|565933496|FG002|Phase 1|Lost to Follow-up|0|||
156776649|NCT03314935|565933497|FG003|Phase 1|Lost to Follow-up|0|||
156776650|NCT03314935|565933498|FG004|Phase 1|Lost to Follow-up|0|||
156776651|NCT03314935|565933499|FG005|Phase 1|Lost to Follow-up|0|||
156776652|NCT03314935|565933500|FG006|Phase 1|Lost to Follow-up|0|||
156776653|NCT03314935|565933501|FG007|Phase 1|Lost to Follow-up|0|||
156776654|NCT03314935|565933502|FG008|Phase 1|Lost to Follow-up|1|||
156776655|NCT03314935|565933503|FG009|Phase 1|Lost to Follow-up|0|||
156776656|NCT03314935|565933504|FG010|Phase 1|Lost to Follow-up|0|||
156776657|NCT03314935|565933505|FG011|Phase 1|Lost to Follow-up|0|||
157114813|NCT03703102|567175666|FG004|Overall Study|Withdrawal by Subject|9|||
156776658|NCT03314935|565933506|FG012|Phase 1|Lost to Follow-up|0|||
156776659|NCT03314935|565933507|FG013|Phase 1|Lost to Follow-up|0|||
156776660|NCT03314935|565933508|FG014|Phase 1|Lost to Follow-up|0|||
157114814|NCT03703102|567175662|FG000|Overall Study|Ineligibility|0|||
157114815|NCT03703102|567175663|FG001|Overall Study|Ineligibility|0|||
157114816|NCT03703102|567175664|FG002|Overall Study|Ineligibility|1|||
157114817|NCT03703102|567175665|FG003|Overall Study|Ineligibility|0|||
157114818|NCT03703102|567175666|FG004|Overall Study|Ineligibility|0|||
157114819|NCT03703102|567175662|FG000|Overall Study|Protocol Deviation|4|||
156776661|NCT03314935|565933494|FG000|Phase 2|Death|0|||
156776662|NCT03314935|565933495|FG001|Phase 2|Death|0|||
156776663|NCT03314935|565933496|FG002|Phase 2|Death|0|||
156776664|NCT03314935|565933497|FG003|Phase 2|Death|0|||
156776665|NCT03314935|565933498|FG004|Phase 2|Death|0|||
156776666|NCT03314935|565933499|FG005|Phase 2|Death|0|||
156776667|NCT03314935|565933500|FG006|Phase 2|Death|0|||
156776668|NCT03314935|565933501|FG007|Phase 2|Death|0|||
156776669|NCT03314935|565933502|FG008|Phase 2|Death|0|||
156776670|NCT03314935|565933503|FG009|Phase 2|Death|5|||
156776671|NCT03314935|565933504|FG010|Phase 2|Death|20|||
156776672|NCT03314935|565933505|FG011|Phase 2|Death|6|||
156776673|NCT03314935|565933506|FG012|Phase 2|Death|7|||
156776674|NCT03314935|565933507|FG013|Phase 2|Death|6|||
156776675|NCT03314935|565933508|FG014|Phase 2|Death|17|||
156776676|NCT03314935|565933494|FG000|Phase 2|Withdrawal by Subject|0|||
156776677|NCT03314935|565933495|FG001|Phase 2|Withdrawal by Subject|0|||
156776678|NCT03314935|565933496|FG002|Phase 2|Withdrawal by Subject|0|||
156776679|NCT03314935|565933497|FG003|Phase 2|Withdrawal by Subject|0|||
156776680|NCT03314935|565933498|FG004|Phase 2|Withdrawal by Subject|0|||
156776681|NCT03314935|565933499|FG005|Phase 2|Withdrawal by Subject|0|||
156776682|NCT03314935|565933500|FG006|Phase 2|Withdrawal by Subject|0|||
156776683|NCT03314935|565933501|FG007|Phase 2|Withdrawal by Subject|0|||
156776684|NCT03314935|565933502|FG008|Phase 2|Withdrawal by Subject|0|||
156776685|NCT03314935|565933503|FG009|Phase 2|Withdrawal by Subject|1|||
156776686|NCT03314935|565933504|FG010|Phase 2|Withdrawal by Subject|4|||
156776687|NCT03314935|565933505|FG011|Phase 2|Withdrawal by Subject|0|||
156776688|NCT03314935|565933506|FG012|Phase 2|Withdrawal by Subject|1|||
156776689|NCT03314935|565933507|FG013|Phase 2|Withdrawal by Subject|0|||
156776690|NCT03314935|565933508|FG014|Phase 2|Withdrawal by Subject|1|||
156776691|NCT03314935|565933494|FG000|Phase 2|Progressive Disease|0|||
156776692|NCT03314935|565933495|FG001|Phase 2|Progressive Disease|0|||
156776693|NCT03314935|565933496|FG002|Phase 2|Progressive Disease|0|||
156776694|NCT03314935|565933497|FG003|Phase 2|Progressive Disease|0|||
156776695|NCT03314935|565933498|FG004|Phase 2|Progressive Disease|0|||
156776696|NCT03314935|565933499|FG005|Phase 2|Progressive Disease|0|||
156776697|NCT03314935|565933500|FG006|Phase 2|Progressive Disease|0|||
156776698|NCT03314935|565933501|FG007|Phase 2|Progressive Disease|0|||
156776699|NCT03314935|565933502|FG008|Phase 2|Progressive Disease|0|||
156776700|NCT03314935|565933503|FG009|Phase 2|Progressive Disease|1|||
156776701|NCT03314935|565933504|FG010|Phase 2|Progressive Disease|1|||
156776702|NCT03314935|565933505|FG011|Phase 2|Progressive Disease|1|||
156776703|NCT03314935|565933506|FG012|Phase 2|Progressive Disease|2|||
156776704|NCT03314935|565933507|FG013|Phase 2|Progressive Disease|0|||
156776705|NCT03314935|565933508|FG014|Phase 2|Progressive Disease|1|||
156776706|NCT03314935|565933494|FG000|Phase 2|Study Terminated by Sponsor|0|||
156776707|NCT03314935|565933495|FG001|Phase 2|Study Terminated by Sponsor|0|||
156776708|NCT03314935|565933496|FG002|Phase 2|Study Terminated by Sponsor|0|||
156776709|NCT03314935|565933497|FG003|Phase 2|Study Terminated by Sponsor|0|||
156776710|NCT03314935|565933498|FG004|Phase 2|Study Terminated by Sponsor|0|||
156776711|NCT03314935|565933499|FG005|Phase 2|Study Terminated by Sponsor|0|||
156776712|NCT03314935|565933500|FG006|Phase 2|Study Terminated by Sponsor|0|||
156776713|NCT03314935|565933501|FG007|Phase 2|Study Terminated by Sponsor|0|||
156776714|NCT03314935|565933502|FG008|Phase 2|Study Terminated by Sponsor|0|||
156776715|NCT03314935|565933503|FG009|Phase 2|Study Terminated by Sponsor|0|||
156776716|NCT03314935|565933504|FG010|Phase 2|Study Terminated by Sponsor|7|||
156776717|NCT03314935|565933505|FG011|Phase 2|Study Terminated by Sponsor|2|||
156776718|NCT03314935|565933506|FG012|Phase 2|Study Terminated by Sponsor|1|||
156776719|NCT03314935|565933507|FG013|Phase 2|Study Terminated by Sponsor|4|||
156776720|NCT03314935|565933508|FG014|Phase 2|Study Terminated by Sponsor|4|||
156776721|NCT03314935|565933494|FG000|Phase 2|Lost to Follow-up|0|||
156776722|NCT03314935|565933495|FG001|Phase 2|Lost to Follow-up|0|||
156776723|NCT03314935|565933496|FG002|Phase 2|Lost to Follow-up|0|||
156776724|NCT03314935|565933497|FG003|Phase 2|Lost to Follow-up|0|||
156776725|NCT03314935|565933498|FG004|Phase 2|Lost to Follow-up|0|||
156776726|NCT03314935|565933499|FG005|Phase 2|Lost to Follow-up|0|||
156776727|NCT03314935|565933500|FG006|Phase 2|Lost to Follow-up|0|||
156776728|NCT03314935|565933501|FG007|Phase 2|Lost to Follow-up|0|||
156776729|NCT03314935|565933502|FG008|Phase 2|Lost to Follow-up|0|||
156776730|NCT03314935|565933503|FG009|Phase 2|Lost to Follow-up|1|||
156776731|NCT03314935|565933504|FG010|Phase 2|Lost to Follow-up|0|||
156776732|NCT03314935|565933505|FG011|Phase 2|Lost to Follow-up|0|||
156776733|NCT03314935|565933506|FG012|Phase 2|Lost to Follow-up|0|||
157114820|NCT03703102|567175663|FG001|Overall Study|Protocol Deviation|4|||
156776734|NCT03314935|565933507|FG013|Phase 2|Lost to Follow-up|0|||
156776735|NCT03314935|565933508|FG014|Phase 2|Lost to Follow-up|1|||
156776736|NCT03314935|565933494|FG000|Phase 2|Physician Decision|0|||
156776737|NCT03314935|565933495|FG001|Phase 2|Physician Decision|0|||
156776738|NCT03314935|565933496|FG002|Phase 2|Physician Decision|0|||
156776739|NCT03314935|565933497|FG003|Phase 2|Physician Decision|0|||
156776740|NCT03314935|565933498|FG004|Phase 2|Physician Decision|0|||
156776741|NCT03314935|565933499|FG005|Phase 2|Physician Decision|0|||
156776742|NCT03314935|565933500|FG006|Phase 2|Physician Decision|0|||
156776743|NCT03314935|565933501|FG007|Phase 2|Physician Decision|0|||
156776744|NCT03314935|565933502|FG008|Phase 2|Physician Decision|0|||
156776745|NCT03314935|565933503|FG009|Phase 2|Physician Decision|0|||
156776746|NCT03314935|565933504|FG010|Phase 2|Physician Decision|1|||
156776747|NCT03314935|565933505|FG011|Phase 2|Physician Decision|0|||
156776748|NCT03314935|565933506|FG012|Phase 2|Physician Decision|0|||
156776749|NCT03314935|565933507|FG013|Phase 2|Physician Decision|0|||
156776750|NCT03314935|565933508|FG014|Phase 2|Physician Decision|0|||
156776751|NCT05845619|565933509|FG000|Overall Study|duplicate enrollment|2|||
156776752|NCT05845619|565933510|FG001|Overall Study|duplicate enrollment|2|||
156776753|NCT05845619|565933511|FG002|Overall Study|duplicate enrollment|1|||
156776754|NCT05168800|565933512|FG000|Time 1 Survey|Did not start T1 survey|182|||
156776755|NCT05168800|565933513|FG001|Time 1 Survey|Did not start T1 survey|150|||
156776756|NCT05168800|565933514|FG002|Time 1 Survey|Did not start T1 survey|140|||
156776757|NCT05168800|565933512|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
156776758|NCT05168800|565933513|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
156776759|NCT05168800|565933514|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
156776760|NCT05168800|565933512|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
156776761|NCT05168800|565933513|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
156776762|NCT05168800|565933514|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
156776763|NCT05168800|565933512|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
156776764|NCT05168800|565933513|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
156776765|NCT05168800|565933514|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
156776766|NCT05168800|565933512|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
156776767|NCT05168800|565933513|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
156776768|NCT05168800|565933514|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
156776769|NCT05168800|565933512|FG000|Time 1 Survey|Withdrawal by Subject|6|||
156776770|NCT05168800|565933513|FG001|Time 1 Survey|Withdrawal by Subject|3|||
156776771|NCT05168800|565933514|FG002|Time 1 Survey|Withdrawal by Subject|2|||
156776772|NCT05168800|565933512|FG000|Time 2 Survey|Already excluded at Time 1|228|||
156776773|NCT05168800|565933513|FG001|Time 2 Survey|Already excluded at Time 1|202|||
156776774|NCT05168800|565933514|FG002|Time 2 Survey|Already excluded at Time 1|173|||
156776775|NCT05168800|565933512|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
156776776|NCT05168800|565933513|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
156776777|NCT05168800|565933514|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
156776778|NCT05168800|565933512|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
156776779|NCT05168800|565933513|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
156776780|NCT05168800|565933514|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
156776781|NCT05168800|565933512|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
156776782|NCT05168800|565933513|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
156776783|NCT05168800|565933514|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
156776784|NCT05168800|565933512|FG000|Time 2 Survey|Withdrawal by Subject|1|||
156776785|NCT05168800|565933513|FG001|Time 2 Survey|Withdrawal by Subject|0|||
156776786|NCT05168800|565933514|FG002|Time 2 Survey|Withdrawal by Subject|1|||
156776787|NCT05168800|565933512|FG000|Time 3 Survey|Already excluded at Time 1|228|||
156776788|NCT05168800|565933513|FG001|Time 3 Survey|Already excluded at Time 1|200|||
156776789|NCT05168800|565933514|FG002|Time 3 Survey|Already excluded at Time 1|173|||
156776790|NCT05168800|565933512|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
156776791|NCT05168800|565933513|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
156776792|NCT05168800|565933514|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
156776793|NCT05168800|565933512|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
156776794|NCT05168800|565933513|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
156776795|NCT05168800|565933514|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
156776796|NCT05168800|565933512|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
156776797|NCT05168800|565933513|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
156776798|NCT05168800|565933514|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
156776799|NCT05252702|565933515|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
157008291|NCT00433199|566780197|FG000|Open-Label Period|Protocol Violation|0|||
156776800|NCT05252702|565933515|FG000|Overall Study|Death|16|||
156776801|NCT05252702|565933515|FG000|Overall Study|System explant|5|||
156776802|NCT05252702|565933515|FG000|Overall Study|Lost to Follow-up|1|||
156776803|NCT05252702|565933515|FG000|Overall Study|Withdrawn by investigator|1|||
157008292|NCT00433199|566780198|FG001|Open-Label Period|Protocol Violation|2|||
156776804|NCT05252702|565933515|FG000|Overall Study|Visit not due|306|||
157208622|NCT05257109|567508107|FG000|Overall Study|Withdrawal by Subject|1|||
157208623|NCT05257109|567508108|FG001|Overall Study|Withdrawal by Subject|0|||
156776805|NCT05252702|565933515|FG000|Overall Study|Visit within window but not completed|92|||
156776806|NCT05252702|565933515|FG000|Overall Study|Unsuccessful implant|1|||
156776807|NCT04153864|565933516|FG000|Overall Study|Withdrawal by Subject|21|||
156776808|NCT04153864|565933517|FG001|Overall Study|Withdrawal by Subject|7|||
156776809|NCT04153864|565933518|FG002|Overall Study|Withdrawal by Subject|23|||
156776810|NCT04153864|565933519|FG003|Overall Study|Withdrawal by Subject|2|||
156776811|NCT04153864|565933516|FG000|Overall Study|Lost to Follow-up|4|||
156776812|NCT04153864|565933517|FG001|Overall Study|Lost to Follow-up|0|||
156776813|NCT04153864|565933518|FG002|Overall Study|Lost to Follow-up|3|||
156776814|NCT04153864|565933519|FG003|Overall Study|Lost to Follow-up|0|||
156776815|NCT04153864|565933516|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
156776816|NCT04153864|565933517|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
156776817|NCT04153864|565933518|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
156776818|NCT04153864|565933519|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
156776819|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
156776820|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
156776821|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
156776822|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
156776823|NCT04279522|565933521|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
156776824|NCT04279522|565933522|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
156776825|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
156776826|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
156776827|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
156776828|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
156776829|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Physician Decision|0|||
156776830|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Physician Decision|3|||
156776831|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Adverse Event|0|||
156776832|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Adverse Event|1|||
156776833|NCT04279522|565933521|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
156776834|NCT04279522|565933522|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
156776835|NCT06354257|565933527|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156776836|NCT06354257|565933527|FG000|Treatment Period 2|Adverse Event|1|||
156776837|NCT02685735|565933528|FG000|Overall Study|Surgery Cancelled|4|||
156776838|NCT02685735|565933529|FG001|Overall Study|Surgery Cancelled|9|||
156776839|NCT02685735|565933528|FG000|Overall Study|Adverse Event|10|||
156776840|NCT02685735|565933529|FG001|Overall Study|Adverse Event|3|||
156776841|NCT02685735|565933528|FG000|Overall Study|Preop testing found to be incomplete|2|||
156776842|NCT02685735|565933529|FG001|Overall Study|Preop testing found to be incomplete|2|||
156776843|NCT02685735|565933528|FG000|Overall Study|Withdrawal by Subject|1|||
156776844|NCT02685735|565933529|FG001|Overall Study|Withdrawal by Subject|2|||
156776845|NCT02685735|565933528|FG000|Overall Study|Death|1|||
156776846|NCT02685735|565933529|FG001|Overall Study|Death|0|||
156776847|NCT02401230|565933530|FG000|Overall Study|Adverse Event|3|||
156776848|NCT02401230|565933531|FG001|Overall Study|Adverse Event|2|||
156776849|NCT02401230|565933532|FG002|Overall Study|Adverse Event|0|||
156776850|NCT02401230|565933530|FG000|Overall Study|Withdrawal by Subject|2|||
156776851|NCT02401230|565933531|FG001|Overall Study|Withdrawal by Subject|1|||
156776852|NCT02401230|565933532|FG002|Overall Study|Withdrawal by Subject|1|||
156776853|NCT02401230|565933530|FG000|Overall Study|Lost to Follow-up|1|||
156776854|NCT02401230|565933531|FG001|Overall Study|Lost to Follow-up|3|||
156776855|NCT02401230|565933532|FG002|Overall Study|Lost to Follow-up|3|||
156776856|NCT00831844|565933540|FG000|Overall Study|Adverse Event|2|||
156776857|NCT00831844|565933541|FG001|Overall Study|Adverse Event|0|||
156776858|NCT00831844|565933542|FG002|Overall Study|Adverse Event|0|||
157008293|NCT00433199|566780197|FG000|Open-Label Period|Administrative|0|||
157008294|NCT00433199|566780198|FG001|Open-Label Period|Administrative|1|||
157008295|NCT00357097|566780199|FG000|Overall Study|Did not meet inclusion criteria|5|||
157008296|NCT00357097|566780200|FG001|Overall Study|Did not meet inclusion criteria|3|||
157008297|NCT00357097|566780199|FG000|Overall Study|Adverse Event|34|||
157008298|NCT00357097|566780200|FG001|Overall Study|Adverse Event|6|||
157008299|NCT00357097|566780199|FG000|Overall Study|Withdrawal by Subject|8|||
157008300|NCT00357097|566780200|FG001|Overall Study|Withdrawal by Subject|7|||
157008301|NCT00357097|566780199|FG000|Overall Study|Non-compliance|1|||
157008302|NCT00357097|566780200|FG001|Overall Study|Non-compliance|2|||
157008303|NCT00357097|566780199|FG000|Overall Study|Lack of Efficacy|2|||
157008304|NCT00357097|566780200|FG001|Overall Study|Lack of Efficacy|8|||
157008305|NCT00357097|566780199|FG000|Overall Study|Met Exclusion Criteria|3|||
157008306|NCT00357097|566780200|FG001|Overall Study|Met Exclusion Criteria|1|||
157008307|NCT00357097|566780199|FG000|Overall Study|Other|1|||
157008308|NCT00357097|566780200|FG001|Overall Study|Other|1|||
156776859|NCT00831844|565933543|FG003|Overall Study|Adverse Event|0|||
157008309|NCT00357097|566780199|FG000|Overall Study|Increase of RLS Symptoms|0|||
156776860|NCT00831844|565933544|FG004|Overall Study|Adverse Event|1|||
156776861|NCT00831844|565933545|FG005|Overall Study|Adverse Event|1|||
156776862|NCT00831844|565933546|FG006|Overall Study|Adverse Event|2|||
156776863|NCT00831844|565933547|FG007|Overall Study|Adverse Event|0|||
156776864|NCT00831844|565933548|FG008|Overall Study|Adverse Event|0|||
156776865|NCT00831844|565933549|FG009|Overall Study|Adverse Event|0|||
156776866|NCT00831844|565933540|FG000|Overall Study|Death|0|||
156776867|NCT00831844|565933541|FG001|Overall Study|Death|0|||
156776868|NCT00831844|565933542|FG002|Overall Study|Death|0|||
156776869|NCT00831844|565933543|FG003|Overall Study|Death|1|||
156776870|NCT00831844|565933544|FG004|Overall Study|Death|0|||
156776871|NCT00831844|565933545|FG005|Overall Study|Death|0|||
156776872|NCT00831844|565933546|FG006|Overall Study|Death|0|||
156776873|NCT00831844|565933547|FG007|Overall Study|Death|0|||
156776874|NCT00831844|565933548|FG008|Overall Study|Death|0|||
156776875|NCT00831844|565933549|FG009|Overall Study|Death|0|||
156776876|NCT00831844|565933540|FG000|Overall Study|Lack of Efficacy|8|||
156776877|NCT00831844|565933541|FG001|Overall Study|Lack of Efficacy|10|||
156776878|NCT00831844|565933542|FG002|Overall Study|Lack of Efficacy|15|||
156776879|NCT00831844|565933543|FG003|Overall Study|Lack of Efficacy|8|||
156776880|NCT00831844|565933544|FG004|Overall Study|Lack of Efficacy|11|||
156776881|NCT00831844|565933545|FG005|Overall Study|Lack of Efficacy|17|||
156776882|NCT00831844|565933546|FG006|Overall Study|Lack of Efficacy|8|||
156776883|NCT00831844|565933547|FG007|Overall Study|Lack of Efficacy|9|||
156776884|NCT00831844|565933548|FG008|Overall Study|Lack of Efficacy|7|||
156776885|NCT00831844|565933549|FG009|Overall Study|Lack of Efficacy|0|||
157008310|NCT00357097|566780200|FG001|Overall Study|Increase of RLS Symptoms|1|||
157008311|NCT00658996|566780201|FG000|First Intervention|Positive slit lamp finding|1|||
157008312|NCT00658996|566780202|FG001|First Intervention|Positive slit lamp finding|0|||
157008313|NCT00658996|566780201|FG000|First Intervention|Lack of lenses|0|||
157008314|NCT00658996|566780202|FG001|First Intervention|Lack of lenses|1|||
157008315|NCT00658996|566780201|FG000|Crossover Period|Physician Decision|1|||
157008316|NCT00658996|566780202|FG001|Crossover Period|Physician Decision|0|||
157008317|NCT00658996|566780201|FG000|Crossover Period|Ineligible|1|||
157008318|NCT00658996|566780202|FG001|Crossover Period|Ineligible|1|||
157008319|NCT00658996|566780201|FG000|Second Intervention|Developed a stye on upper lid|1|||
157008320|NCT00658996|566780202|FG001|Second Intervention|Developed a stye on upper lid|0|||
157008321|NCT00658996|566780201|FG000|Second Intervention|Positive slit lamp finding|0|||
157008322|NCT00658996|566780202|FG001|Second Intervention|Positive slit lamp finding|1|||
157008323|NCT03073941|566781786|FG000|Overall Study|Received non-study device intraoperatively|0|||
157008324|NCT03073941|566781787|FG001|Overall Study|Received non-study device intraoperatively|2|||
157008325|NCT03073941|566781786|FG000|Overall Study|Death|1|||
157008326|NCT03073941|566781787|FG001|Overall Study|Death|0|||
157008327|NCT03073941|566781786|FG000|Overall Study|Withdrawal by Subject|1|||
157008328|NCT03073941|566781787|FG001|Overall Study|Withdrawal by Subject|3|||
157008329|NCT03073941|566781786|FG000|Overall Study|Lost to Follow-up|5|||
157008330|NCT03073941|566781787|FG001|Overall Study|Lost to Follow-up|4|||
157008331|NCT03073941|566781786|FG000|Overall Study|Adverse Event|4|||
157008332|NCT03073941|566781787|FG001|Overall Study|Adverse Event|2|||
157008333|NCT03073941|566781786|FG000|Overall Study|Met an exclusion criterion|0|||
157008334|NCT03073941|566781787|FG001|Overall Study|Met an exclusion criterion|1|||
157008335|NCT04250883|566781788|FG000|Overall Study|Lost to Follow-up|1|||
157008336|NCT04250883|566781789|FG001|Overall Study|Lost to Follow-up|0|||
157008337|NCT03936660|566781791|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
157008338|NCT03936660|566781792|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
157008339|NCT01391832|566781793|FG000|Overall Study|Withdrawal by Subject|21|||
157008340|NCT01391832|566781794|FG001|Overall Study|Withdrawal by Subject|22|||
157008341|NCT01391832|566781793|FG000|Overall Study|Lost to Follow-up|0|||
157008342|NCT01391832|566781794|FG001|Overall Study|Lost to Follow-up|1|||
157008343|NCT00722046|566781797|FG000|Overall Study|Adverse Event|0|||
157008344|NCT00722046|566781798|FG001|Overall Study|Adverse Event|1|||
157008345|NCT00722046|566781799|FG002|Overall Study|Adverse Event|2|||
157008346|NCT00722046|566781800|FG003|Overall Study|Adverse Event|1|||
157008347|NCT00722046|566781801|FG004|Overall Study|Adverse Event|2|||
157008348|NCT00722046|566781802|FG005|Overall Study|Adverse Event|1|||
157008349|NCT00722046|566781803|FG006|Overall Study|Adverse Event|0|||
157008350|NCT00722046|566781797|FG000|Overall Study|Death|0|||
157008351|NCT00722046|566781798|FG001|Overall Study|Death|1|||
157008352|NCT00722046|566781799|FG002|Overall Study|Death|0|||
157008353|NCT00722046|566781800|FG003|Overall Study|Death|0|||
156776886|NCT00831844|565933540|FG000|Overall Study|Physician Decision|0|||
156776887|NCT00831844|565933541|FG001|Overall Study|Physician Decision|1|||
156776888|NCT00831844|565933542|FG002|Overall Study|Physician Decision|3|||
156776889|NCT00831844|565933543|FG003|Overall Study|Physician Decision|1|||
157008354|NCT00722046|566781801|FG004|Overall Study|Death|0|||
157008355|NCT00722046|566781802|FG005|Overall Study|Death|0|||
157008356|NCT00722046|566781803|FG006|Overall Study|Death|2|||
157008357|NCT00722046|566781797|FG000|Overall Study|Protocol Violation|1|||
157008358|NCT00722046|566781798|FG001|Overall Study|Protocol Violation|0|||
157008359|NCT00722046|566781799|FG002|Overall Study|Protocol Violation|0|||
157008360|NCT00722046|566781800|FG003|Overall Study|Protocol Violation|0|||
157008361|NCT00722046|566781801|FG004|Overall Study|Protocol Violation|0|||
156776890|NCT00831844|565933544|FG004|Overall Study|Physician Decision|1|||
156776891|NCT00831844|565933545|FG005|Overall Study|Physician Decision|1|||
157008362|NCT00722046|566781802|FG005|Overall Study|Protocol Violation|1|||
156776892|NCT00831844|565933546|FG006|Overall Study|Physician Decision|0|||
156776893|NCT00831844|565933547|FG007|Overall Study|Physician Decision|0|||
156776894|NCT00831844|565933548|FG008|Overall Study|Physician Decision|1|||
156776895|NCT00831844|565933549|FG009|Overall Study|Physician Decision|0|||
156776896|NCT00831844|565933540|FG000|Overall Study|Withdrawal by Subject|0|||
156776897|NCT00831844|565933541|FG001|Overall Study|Withdrawal by Subject|0|||
156776898|NCT00831844|565933542|FG002|Overall Study|Withdrawal by Subject|1|||
156776899|NCT00831844|565933543|FG003|Overall Study|Withdrawal by Subject|0|||
156776900|NCT00831844|565933544|FG004|Overall Study|Withdrawal by Subject|0|||
156776901|NCT00831844|565933545|FG005|Overall Study|Withdrawal by Subject|0|||
156776902|NCT00831844|565933546|FG006|Overall Study|Withdrawal by Subject|0|||
156776903|NCT00831844|565933547|FG007|Overall Study|Withdrawal by Subject|1|||
156776904|NCT00831844|565933548|FG008|Overall Study|Withdrawal by Subject|1|||
156776905|NCT00831844|565933549|FG009|Overall Study|Withdrawal by Subject|0|||
156776906|NCT00831844|565933540|FG000|Overall Study|Ineligible|0|||
156776907|NCT00831844|565933541|FG001|Overall Study|Ineligible|1|||
156776908|NCT00831844|565933542|FG002|Overall Study|Ineligible|1|||
157008363|NCT00722046|566781803|FG006|Overall Study|Protocol Violation|0|||
157008364|NCT00722046|566781797|FG000|Overall Study|Withdrawal by Subject|3|||
156776909|NCT00831844|565933543|FG003|Overall Study|Ineligible|0|||
156776910|NCT00831844|565933544|FG004|Overall Study|Ineligible|1|||
156776911|NCT00831844|565933545|FG005|Overall Study|Ineligible|0|||
156776912|NCT00831844|565933546|FG006|Overall Study|Ineligible|0|||
156776913|NCT00831844|565933547|FG007|Overall Study|Ineligible|0|||
156776914|NCT00831844|565933548|FG008|Overall Study|Ineligible|0|||
156776915|NCT00831844|565933549|FG009|Overall Study|Ineligible|0|||
156776916|NCT04133909|565933550|FG000|Overall Study|Death|11|||
156776917|NCT04133909|565933551|FG001|Overall Study|Death|11|||
156776918|NCT04133909|565933550|FG000|Overall Study|Adverse Event|4|||
156776919|NCT04133909|565933551|FG001|Overall Study|Adverse Event|5|||
156776920|NCT04133909|565933550|FG000|Overall Study|Lost to Follow-up|3|||
156776921|NCT04133909|565933551|FG001|Overall Study|Lost to Follow-up|5|||
156776922|NCT04133909|565933550|FG000|Overall Study|Physician Decision|4|||
156776923|NCT04133909|565933551|FG001|Overall Study|Physician Decision|7|||
156776924|NCT04133909|565933550|FG000|Overall Study|Withdrawal by Subject|40|||
156776925|NCT04133909|565933551|FG001|Overall Study|Withdrawal by Subject|35|||
156776926|NCT04133909|565933550|FG000|Overall Study|Lack of Efficacy|2|||
156776927|NCT04133909|565933551|FG001|Overall Study|Lack of Efficacy|7|||
156776928|NCT04133909|565933550|FG000|Overall Study|Randomized in error|1|||
156776929|NCT04133909|565933551|FG001|Overall Study|Randomized in error|1|||
156776930|NCT00315445|565933556|FG000|Overall Study|Adverse Event|7|||
156776931|NCT00315445|565933557|FG001|Overall Study|Adverse Event|12|||
156776932|NCT00315445|565933558|FG002|Overall Study|Adverse Event|15|||
156776933|NCT00315445|565933556|FG000|Overall Study|Lack of Efficacy|16|||
156776934|NCT00315445|565933557|FG001|Overall Study|Lack of Efficacy|1|||
156776935|NCT00315445|565933558|FG002|Overall Study|Lack of Efficacy|7|||
156776936|NCT00315445|565933556|FG000|Overall Study|Lost to Follow-up|1|||
156776937|NCT00315445|565933557|FG001|Overall Study|Lost to Follow-up|0|||
156776938|NCT00315445|565933558|FG002|Overall Study|Lost to Follow-up|1|||
156776939|NCT00315445|565933556|FG000|Overall Study|Protocol Violation|2|||
156776940|NCT00315445|565933557|FG001|Overall Study|Protocol Violation|0|||
156776941|NCT00315445|565933558|FG002|Overall Study|Protocol Violation|1|||
156776942|NCT00315445|565933556|FG000|Overall Study|Other|1|||
156776943|NCT00315445|565933557|FG001|Overall Study|Other|3|||
156776944|NCT00315445|565933558|FG002|Overall Study|Other|0|||
156776945|NCT03980223|565933559|FG000|Overall Study|Lost to Follow-up|3|||
156776946|NCT03980223|565933560|FG001|Overall Study|Lost to Follow-up|7|||
156776947|NCT03980223|565933561|FG002|Overall Study|Lost to Follow-up|10|||
156776948|NCT03980223|565933562|FG003|Overall Study|Lost to Follow-up|8|||
156776949|NCT03980223|565933559|FG000|Overall Study|Withdrawal by Subject|0|||
156776950|NCT03980223|565933560|FG001|Overall Study|Withdrawal by Subject|0|||
156776951|NCT03980223|565933561|FG002|Overall Study|Withdrawal by Subject|1|||
156776952|NCT03980223|565933562|FG003|Overall Study|Withdrawal by Subject|2|||
156776953|NCT03980223|565933559|FG000|Overall Study|Physician Decision|0|||
156776954|NCT03980223|565933560|FG001|Overall Study|Physician Decision|0|||
156776955|NCT03980223|565933561|FG002|Overall Study|Physician Decision|1|||
156776956|NCT03980223|565933562|FG003|Overall Study|Physician Decision|0|||
156776957|NCT03980223|565933559|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
156776958|NCT03980223|565933560|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
156776959|NCT03980223|565933561|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
156776960|NCT03980223|565933562|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
156776961|NCT02460289|565933566|FG000|Overall Study|Adverse Event|1|||
156776962|NCT02460289|565933566|FG000|Overall Study|Withdrawal by Subject|8|||
156776963|NCT02460289|565933566|FG000|Overall Study|Lost to Follow-up|1|||
156776964|NCT01977846|565933567|FG000|Total Study - Prospective|Death|0|||
156776965|NCT01977846|565933568|FG001|Total Study - Prospective|Death|1|||
156776966|NCT01977846|565933567|FG000|Total Study - Prospective|Lost to Follow-up|0|||
156776967|NCT01977846|565933568|FG001|Total Study - Prospective|Lost to Follow-up|8|||
156776968|NCT01977846|565933567|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
156776969|NCT01977846|565933568|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
156776970|NCT01977846|565933567|FG000|Total Study - Prospective|Not available at time of visit|0|||
157008365|NCT00722046|566781798|FG001|Overall Study|Withdrawal by Subject|3|||
157008366|NCT00722046|566781799|FG002|Overall Study|Withdrawal by Subject|4|||
157008367|NCT00722046|566781800|FG003|Overall Study|Withdrawal by Subject|4|||
157008368|NCT00722046|566781801|FG004|Overall Study|Withdrawal by Subject|4|||
157008369|NCT00722046|566781802|FG005|Overall Study|Withdrawal by Subject|7|||
157008370|NCT00722046|566781803|FG006|Overall Study|Withdrawal by Subject|3|||
157008371|NCT00722046|566781797|FG000|Overall Study|Randomized, but not treated|1|||
157008372|NCT00722046|566781798|FG001|Overall Study|Randomized, but not treated|1|||
157008373|NCT00722046|566781799|FG002|Overall Study|Randomized, but not treated|0|||
156776971|NCT01977846|565933568|FG001|Total Study - Prospective|Not available at time of visit|5|||
157008374|NCT00722046|566781800|FG003|Overall Study|Randomized, but not treated|2|||
157008375|NCT00722046|566781801|FG004|Overall Study|Randomized, but not treated|0|||
157008376|NCT00722046|566781802|FG005|Overall Study|Randomized, but not treated|0|||
157008377|NCT00722046|566781803|FG006|Overall Study|Randomized, but not treated|0|||
156776972|NCT01977846|565933567|FG000|Total Study - Prospective|No show|0|||
157008378|NCT00722046|566781797|FG000|Overall Study|Other|0|||
157008379|NCT00722046|566781798|FG001|Overall Study|Other|0|||
157008380|NCT00722046|566781799|FG002|Overall Study|Other|1|||
157008381|NCT00722046|566781800|FG003|Overall Study|Other|1|||
157008382|NCT00722046|566781801|FG004|Overall Study|Other|3|||
157008383|NCT00722046|566781802|FG005|Overall Study|Other|2|||
157008384|NCT00722046|566781803|FG006|Overall Study|Other|1|||
157008385|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
157008386|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
157008387|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
157008388|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
157008389|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
157008390|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
157008391|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
157008392|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
157008393|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
157008394|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
157008395|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
157008396|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
157008397|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
156776973|NCT01977846|565933568|FG001|Total Study - Prospective|No show|1|||
157208624|NCT05257109|567508109|FG002|Overall Study|Withdrawal by Subject|0|||
157208625|NCT05257109|567508110|FG003|Overall Study|Withdrawal by Subject|0|||
157208626|NCT02239692|567509387|FG000|Overall Study|Incomplete colonoscopy|1|||
157208627|NCT02239692|567509388|FG001|Overall Study|Incomplete colonoscopy|2|||
157208628|NCT02239692|567509387|FG000|Overall Study|Adverse Event|0|||
157208629|NCT02239692|567509388|FG001|Overall Study|Adverse Event|1|||
157208630|NCT02239692|567509387|FG000|Overall Study|Physician Decision|0|||
157208631|NCT02239692|567509388|FG001|Overall Study|Physician Decision|1|||
157208632|NCT02239692|567509387|FG000|Overall Study|Lost to Follow-up|1|||
157208633|NCT02239692|567509388|FG001|Overall Study|Lost to Follow-up|4|||
157208634|NCT02239692|567509387|FG000|Overall Study|Withdrawal by Subject|3|||
157208635|NCT02239692|567509388|FG001|Overall Study|Withdrawal by Subject|5|||
157208636|NCT02239692|567509387|FG000|Overall Study|Other reason|1|||
157208637|NCT02239692|567509388|FG001|Overall Study|Other reason|0|||
157208638|NCT02156466|567509394|FG000|Overall Study|Adverse Event|0|||
157208639|NCT02156466|567509395|FG001|Overall Study|Adverse Event|0|||
157208640|NCT02156466|567509396|FG002|Overall Study|Adverse Event|1|||
157208641|NCT02156466|567509397|FG003|Overall Study|Adverse Event|1|||
157208642|NCT02156466|567509398|FG004|Overall Study|Adverse Event|0|||
157208643|NCT02156466|567509394|FG000|Overall Study|Quantiferon Positivity|0|||
157208644|NCT02156466|567509395|FG001|Overall Study|Quantiferon Positivity|0|||
157208645|NCT02156466|567509396|FG002|Overall Study|Quantiferon Positivity|0|||
157208646|NCT02156466|567509397|FG003|Overall Study|Quantiferon Positivity|1|||
157208647|NCT02156466|567509398|FG004|Overall Study|Quantiferon Positivity|0|||
157208648|NCT01784419|567509399|FG000|Overall Study|Adverse Event|3|||
157208649|NCT00080288|567509400|FG000|Overall Study|Adverse Event|7|||
157208650|NCT00080288|567509401|FG001|Overall Study|Adverse Event|4|||
157208651|NCT00080288|567509400|FG000|Overall Study|Lost to Follow-up|3|||
157208652|NCT00080288|567509401|FG001|Overall Study|Lost to Follow-up|5|||
157208653|NCT00080288|567509400|FG000|Overall Study|Physician Decision|6|||
157208654|NCT00080288|567509401|FG001|Overall Study|Physician Decision|2|||
157208655|NCT00080288|567509400|FG000|Overall Study|Withdrawal by Subject|3|||
157208656|NCT00080288|567509401|FG001|Overall Study|Withdrawal by Subject|16|||
157208657|NCT00080288|567509400|FG000|Overall Study|Miscellaneous|11|||
157208658|NCT00080288|567509401|FG001|Overall Study|Miscellaneous|11|||
157208659|NCT02253654|567509402|FG000|Overall Study|Withdrawal by Subject|12|||
157208660|NCT02253654|567509403|FG001|Overall Study|Withdrawal by Subject|4|||
157208661|NCT02253654|567509402|FG000|Overall Study|Decision by Sponsor|1|||
157208662|NCT02253654|567509403|FG001|Overall Study|Decision by Sponsor|1|||
157208663|NCT02253654|567509402|FG000|Overall Study|Lost to Follow-up|2|||
157208664|NCT02253654|567509403|FG001|Overall Study|Lost to Follow-up|5|||
157208665|NCT02253654|567509402|FG000|Overall Study|Death|4|||
157208666|NCT02253654|567509403|FG001|Overall Study|Death|7|||
157208667|NCT02253654|567509402|FG000|Overall Study|Did Not Receive Study Treatment|4|||
157208668|NCT02253654|567509403|FG001|Overall Study|Did Not Receive Study Treatment|1|||
157208669|NCT03044431|567509406|FG000|Overall Study|Lost to Follow-up|59|||
157008398|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
157008399|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
157008400|NCT00516321|566781811|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
157008401|NCT00516321|566781812|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
157008402|NCT00516321|566781813|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
157008403|NCT00516321|566781811|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
157008404|NCT00516321|566781812|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
157008405|NCT00516321|566781813|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
157008406|NCT00516321|566781811|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
157008407|NCT00516321|566781812|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
157008408|NCT00516321|566781813|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
157008409|NCT00516321|566781811|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
157008410|NCT00516321|566781812|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
157008411|NCT00516321|566781813|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
157008412|NCT00516321|566781811|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
157008413|NCT00516321|566781812|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
157008414|NCT00516321|566781813|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
157008415|NCT00516321|566781811|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
157008416|NCT00516321|566781812|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
157008417|NCT00516321|566781813|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
157008418|NCT01599104|566781818|FG000|Overall Study|Withdrawal by Subject|1|||
157008419|NCT01599104|566781819|FG001|Overall Study|Withdrawal by Subject|1|||
157008420|NCT01599104|566781820|FG002|Overall Study|Withdrawal by Subject|2|||
157008421|NCT01599104|566781818|FG000|Overall Study|Technical Problems|1|||
157008422|NCT01599104|566781819|FG001|Overall Study|Technical Problems|0|||
157008423|NCT01599104|566781820|FG002|Overall Study|Technical Problems|0|||
157208670|NCT00569231|567509407|FG000|Overall Study|Study unrelated surgery|1|||
157208671|NCT00569231|567509407|FG000|Overall Study|Airfare expense|2|||
157008424|NCT01599104|566781818|FG000|Overall Study|Physician Decision|3|||
157008425|NCT01599104|566781819|FG001|Overall Study|Physician Decision|2|||
157008426|NCT01599104|566781820|FG002|Overall Study|Physician Decision|2|||
157008427|NCT01599104|566781818|FG000|Overall Study|Non-compliance with study treatment|0|||
157008428|NCT01599104|566781819|FG001|Overall Study|Non-compliance with study treatment|1|||
157008429|NCT01599104|566781820|FG002|Overall Study|Non-compliance with study treatment|0|||
156776974|NCT01977846|565933567|FG000|Total Study - Prospective|Protocol Violation|0|||
156776975|NCT01977846|565933568|FG001|Total Study - Prospective|Protocol Violation|1|||
157008430|NCT01599104|566781818|FG000|Overall Study|Lack of Efficacy|4|||
157008431|NCT01599104|566781819|FG001|Overall Study|Lack of Efficacy|4|||
157008432|NCT01599104|566781820|FG002|Overall Study|Lack of Efficacy|10|||
157008433|NCT01599104|566781818|FG000|Overall Study|Adverse Event|7|||
157008434|NCT01599104|566781819|FG001|Overall Study|Adverse Event|6|||
156776976|NCT01155570|565933569|FG000|Overall Study|Adverse Event|39|||
156776977|NCT01155570|565933569|FG000|Overall Study|Lack of Efficacy|46|||
156776978|NCT01155570|565933569|FG000|Overall Study|Participant's Economic Reasons|17|||
156776979|NCT01155570|565933569|FG000|Overall Study|No Hospital Visits|7|||
156776980|NCT01155570|565933569|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
156776981|NCT01155570|565933569|FG000|Overall Study|Adverse Event + Other Reasons|7|||
156776982|NCT01155570|565933569|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
156776983|NCT01155570|565933569|FG000|Overall Study|Other Reasons|23|||
157114821|NCT03703102|567175664|FG002|Overall Study|Protocol Deviation|3|||
157114822|NCT03703102|567175665|FG003|Overall Study|Protocol Deviation|0|||
156776984|NCT02916927|565933570|FG000|Overall Study|Discharged prior to study drug receipt|0|||
156776985|NCT02916927|565933571|FG001|Overall Study|Discharged prior to study drug receipt|2|||
156776986|NCT02916927|565933570|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
156776987|NCT02916927|565933571|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
156776988|NCT02916927|565933570|FG000|Overall Study|Withdrawal before first time point|1|||
156776989|NCT02916927|565933571|FG001|Overall Study|Withdrawal before first time point|0|||
156776990|NCT02774889|565933572|FG000|Overall Study|Lost to Follow-up|2|||
156776991|NCT02774889|565933573|FG001|Overall Study|Lost to Follow-up|1|||
156776992|NCT01047319|565933574|FG000|Overall Study|Teva requested participant withdrawal|3|||
156776993|NCT01047319|565933575|FG001|Overall Study|Teva requested participant withdrawal|0|||
156776994|NCT01047319|565933576|FG002|Overall Study|Teva requested participant withdrawal|1|||
156776995|NCT01047319|565933574|FG000|Overall Study|Protocol Violation|3|||
156776996|NCT01047319|565933575|FG001|Overall Study|Protocol Violation|2|||
156776997|NCT01047319|565933576|FG002|Overall Study|Protocol Violation|4|||
156776998|NCT01047319|565933574|FG000|Overall Study|Lack of Efficacy|4|||
156776999|NCT01047319|565933575|FG001|Overall Study|Lack of Efficacy|3|||
156777000|NCT01047319|565933576|FG002|Overall Study|Lack of Efficacy|3|||
156777001|NCT01047319|565933574|FG000|Overall Study|Death|5|||
156777002|NCT01047319|565933575|FG001|Overall Study|Death|1|||
156777003|NCT01047319|565933576|FG002|Overall Study|Death|5|||
156777004|NCT01047319|565933574|FG000|Overall Study|Pregnancy|13|||
156777005|NCT01047319|565933575|FG001|Overall Study|Pregnancy|8|||
156777006|NCT01047319|565933576|FG002|Overall Study|Pregnancy|8|||
156777007|NCT01047319|565933574|FG000|Overall Study|Physician Decision|12|||
156777008|NCT01047319|565933575|FG001|Overall Study|Physician Decision|9|||
156777009|NCT01047319|565933576|FG002|Overall Study|Physician Decision|10|||
156777010|NCT01047319|565933574|FG000|Overall Study|Lost to Follow-up|14|||
156777011|NCT01047319|565933575|FG001|Overall Study|Lost to Follow-up|10|||
156777012|NCT01047319|565933576|FG002|Overall Study|Lost to Follow-up|10|||
156777013|NCT01047319|565933574|FG000|Overall Study|Adverse Event|16|||
156777014|NCT01047319|565933575|FG001|Overall Study|Adverse Event|27|||
156777015|NCT01047319|565933576|FG002|Overall Study|Adverse Event|21|||
156777016|NCT01047319|565933574|FG000|Overall Study|Withdrawal by Subject|77|||
156777017|NCT01047319|565933575|FG001|Overall Study|Withdrawal by Subject|75|||
156777018|NCT01047319|565933576|FG002|Overall Study|Withdrawal by Subject|87|||
156777019|NCT01047319|565933574|FG000|Overall Study|Study terminated by Sponsor|198|||
156777020|NCT01047319|565933575|FG001|Overall Study|Study terminated by Sponsor|215|||
156777021|NCT01047319|565933576|FG002|Overall Study|Study terminated by Sponsor|203|||
156777022|NCT00770809|565935203|FG000|Overall Study|Adverse Event|9|||
156777023|NCT00770809|565935204|FG001|Overall Study|Adverse Event|1|||
156777024|NCT00770809|565935205|FG002|Overall Study|Adverse Event|12|||
156777025|NCT00770809|565935203|FG000|Overall Study|Death|1|||
156777026|NCT00770809|565935204|FG001|Overall Study|Death|0|||
156777027|NCT00770809|565935205|FG002|Overall Study|Death|0|||
156777028|NCT00770809|565935203|FG000|Overall Study|Withdrawal by Subject|3|||
156777029|NCT00770809|565935204|FG001|Overall Study|Withdrawal by Subject|3|||
156777030|NCT00770809|565935205|FG002|Overall Study|Withdrawal by Subject|7|||
156777031|NCT00770809|565935203|FG000|Overall Study|Progression|2|||
156777032|NCT00770809|565935204|FG001|Overall Study|Progression|2|||
156777033|NCT00770809|565935205|FG002|Overall Study|Progression|0|||
156777034|NCT00770809|565935203|FG000|Overall Study|Complicating illness|0|||
156777035|NCT00770809|565935204|FG001|Overall Study|Complicating illness|0|||
156777036|NCT00770809|565935205|FG002|Overall Study|Complicating illness|1|||
156777037|NCT00770809|565935203|FG000|Overall Study|Other Medical Reasons|2|||
157114823|NCT03703102|567175666|FG004|Overall Study|Protocol Deviation|0|||
156777038|NCT00770809|565935204|FG001|Overall Study|Other Medical Reasons|4|||
156777039|NCT00770809|565935205|FG002|Overall Study|Other Medical Reasons|3|||
156777040|NCT05028569|565935206|FG000|Double-Blind Phase|Death|0|||
156777041|NCT05028569|565935207|FG001|Double-Blind Phase|Death|0|||
156777042|NCT05028569|565935208|FG002|Double-Blind Phase|Death|0|||
156777043|NCT05028569|565935209|FG003|Double-Blind Phase|Death|1|||
156777044|NCT05028569|565935210|FG004|Double-Blind Phase|Death|0|||
156777045|NCT05028569|565935211|FG005|Double-Blind Phase|Death|0|||
156777046|NCT05028569|565935212|FG006|Double-Blind Phase|Death|0|||
157114824|NCT03703102|567175662|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156777047|NCT05028569|565935206|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156777048|NCT05028569|565935207|FG001|Double-Blind Phase|Lost to Follow-up|6|||
156777049|NCT05028569|565935208|FG002|Double-Blind Phase|Lost to Follow-up|3|||
156777050|NCT05028569|565935209|FG003|Double-Blind Phase|Lost to Follow-up|9|||
156777051|NCT05028569|565935210|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156777052|NCT05028569|565935211|FG005|Double-Blind Phase|Lost to Follow-up|0|||
157008435|NCT01599104|566781820|FG002|Overall Study|Adverse Event|12|||
157008436|NCT03691428|566781828|FG000|Overall Study|Withdrawal by Subject|6|||
156777053|NCT05028569|565935212|FG006|Double-Blind Phase|Lost to Follow-up|0|||
156777054|NCT05028569|565935206|FG000|Double-Blind Phase|Protocol Deviation|0|||
156777055|NCT05028569|565935207|FG001|Double-Blind Phase|Protocol Deviation|2|||
156777056|NCT05028569|565935208|FG002|Double-Blind Phase|Protocol Deviation|0|||
156777057|NCT05028569|565935209|FG003|Double-Blind Phase|Protocol Deviation|0|||
156777058|NCT05028569|565935210|FG004|Double-Blind Phase|Protocol Deviation|0|||
156777059|NCT05028569|565935211|FG005|Double-Blind Phase|Protocol Deviation|0|||
156777060|NCT05028569|565935212|FG006|Double-Blind Phase|Protocol Deviation|0|||
156777061|NCT05028569|565935206|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156777062|NCT05028569|565935207|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
156777063|NCT05028569|565935208|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
156777064|NCT05028569|565935209|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
156777065|NCT05028569|565935210|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156777066|NCT05028569|565935211|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
156777067|NCT05028569|565935212|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
156777068|NCT05028569|565935206|FG000|Double-Blind Phase|Other, not specified|0|||
156777069|NCT05028569|565935207|FG001|Double-Blind Phase|Other, not specified|5|||
156777070|NCT05028569|565935208|FG002|Double-Blind Phase|Other, not specified|4|||
156777071|NCT05028569|565935209|FG003|Double-Blind Phase|Other, not specified|6|||
156777072|NCT05028569|565935210|FG004|Double-Blind Phase|Other, not specified|0|||
157008437|NCT03691428|566781829|FG001|Overall Study|Withdrawal by Subject|8|||
157008438|NCT01460290|566781830|FG000|Overall Study|Adverse Event|3|||
157008439|NCT01460290|566781830|FG000|Overall Study|Elevated liver function|1|||
157008440|NCT02527148|566781831|FG000|Overall Study|Did not receive study intervention|1|||
157008441|NCT02527148|566781832|FG001|Overall Study|Did not receive study intervention|0|||
157208672|NCT00569231|567509407|FG000|Overall Study|Withdrawal by Subject|1|||
156777073|NCT05028569|565935211|FG005|Double-Blind Phase|Other, not specified|0|||
156777074|NCT05028569|565935212|FG006|Double-Blind Phase|Other, not specified|0|||
156777075|NCT05028569|565935206|FG000|Open-Label Phase|Death|0|||
156777076|NCT05028569|565935207|FG001|Open-Label Phase|Death|0|||
156777077|NCT05028569|565935208|FG002|Open-Label Phase|Death|0|||
156777078|NCT05028569|565935209|FG003|Open-Label Phase|Death|0|||
156777079|NCT05028569|565935210|FG004|Open-Label Phase|Death|0|||
156777080|NCT05028569|565935211|FG005|Open-Label Phase|Death|0|||
156777081|NCT05028569|565935212|FG006|Open-Label Phase|Death|1|||
156777082|NCT05028569|565935206|FG000|Open-Label Phase|Lost to Follow-up|0|||
156777083|NCT05028569|565935207|FG001|Open-Label Phase|Lost to Follow-up|0|||
156777084|NCT05028569|565935208|FG002|Open-Label Phase|Lost to Follow-up|0|||
156777085|NCT05028569|565935209|FG003|Open-Label Phase|Lost to Follow-up|0|||
156777086|NCT05028569|565935210|FG004|Open-Label Phase|Lost to Follow-up|5|||
156777087|NCT05028569|565935211|FG005|Open-Label Phase|Lost to Follow-up|5|||
156777088|NCT05028569|565935212|FG006|Open-Label Phase|Lost to Follow-up|4|||
156777089|NCT05028569|565935206|FG000|Open-Label Phase|Protocol Deviation|0|||
156777090|NCT05028569|565935207|FG001|Open-Label Phase|Protocol Deviation|0|||
156777091|NCT05028569|565935208|FG002|Open-Label Phase|Protocol Deviation|0|||
156777092|NCT05028569|565935209|FG003|Open-Label Phase|Protocol Deviation|0|||
156777093|NCT05028569|565935210|FG004|Open-Label Phase|Protocol Deviation|1|||
156777094|NCT05028569|565935211|FG005|Open-Label Phase|Protocol Deviation|0|||
156777095|NCT05028569|565935212|FG006|Open-Label Phase|Protocol Deviation|0|||
156777096|NCT05028569|565935206|FG000|Open-Label Phase|Pregnancy|0|||
156777097|NCT05028569|565935207|FG001|Open-Label Phase|Pregnancy|0|||
156777098|NCT05028569|565935208|FG002|Open-Label Phase|Pregnancy|0|||
156777099|NCT05028569|565935209|FG003|Open-Label Phase|Pregnancy|0|||
156777100|NCT05028569|565935210|FG004|Open-Label Phase|Pregnancy|0|||
156777101|NCT05028569|565935211|FG005|Open-Label Phase|Pregnancy|1|||
156777102|NCT05028569|565935212|FG006|Open-Label Phase|Pregnancy|0|||
156777103|NCT05028569|565935206|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156777104|NCT05028569|565935207|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156777105|NCT05028569|565935208|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156777106|NCT05028569|565935209|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156777107|NCT05028569|565935210|FG004|Open-Label Phase|Withdrawal by Subject|15|||
156777108|NCT05028569|565935211|FG005|Open-Label Phase|Withdrawal by Subject|8|||
156777109|NCT05028569|565935212|FG006|Open-Label Phase|Withdrawal by Subject|13|||
156777110|NCT05028569|565935206|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
156777111|NCT05028569|565935207|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
156777112|NCT05028569|565935208|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
156777113|NCT05028569|565935209|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
156777114|NCT05028569|565935210|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
156777115|NCT05028569|565935211|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
156777116|NCT05028569|565935212|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
156777117|NCT05028569|565935206|FG000|Open-Label Phase|Other, not specified|0|||
156777118|NCT05028569|565935207|FG001|Open-Label Phase|Other, not specified|0|||
156777119|NCT05028569|565935208|FG002|Open-Label Phase|Other, not specified|0|||
156777120|NCT05028569|565935209|FG003|Open-Label Phase|Other, not specified|0|||
156777121|NCT05028569|565935210|FG004|Open-Label Phase|Other, not specified|6|||
156777122|NCT05028569|565935211|FG005|Open-Label Phase|Other, not specified|5|||
156777123|NCT05028569|565935212|FG006|Open-Label Phase|Other, not specified|7|||
156777124|NCT05028569|565935206|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777125|NCT05028569|565935207|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777126|NCT05028569|565935208|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777127|NCT05028569|565935209|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777128|NCT05028569|565935210|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777129|NCT05028569|565935211|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
156777130|NCT05028569|565935212|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
156777131|NCT05028569|565935206|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777132|NCT05028569|565935207|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777133|NCT05028569|565935208|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
157008442|NCT00309907|566781833|FG000|Overall Study|Death|4|||
156777134|NCT05028569|565935209|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777135|NCT05028569|565935210|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777136|NCT05028569|565935211|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
156777137|NCT05028569|565935212|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
156777138|NCT01136954|565935216|FG000|Overall Study|Adverse Event|3|||
156777139|NCT01136954|565935217|FG001|Overall Study|Adverse Event|2|||
156777140|NCT01136954|565935216|FG000|Overall Study|Withdrawal by Subject|6|||
156777141|NCT01136954|565935217|FG001|Overall Study|Withdrawal by Subject|2|||
156777142|NCT01136954|565935216|FG000|Overall Study|Lack of Efficacy|14|||
156777143|NCT01136954|565935217|FG001|Overall Study|Lack of Efficacy|13|||
156777144|NCT01136954|565935216|FG000|Overall Study|Physician Decision|0|||
156777145|NCT01136954|565935217|FG001|Overall Study|Physician Decision|1|||
156777146|NCT01136954|565935216|FG000|Overall Study|Other|1|||
156777147|NCT01136954|565935217|FG001|Overall Study|Other|3|||
156777148|NCT04190225|565935228|FG000|Overall Study|Lost to Follow-up|2|||
156777149|NCT04190225|565935229|FG001|Overall Study|Lost to Follow-up|3|||
156777150|NCT04190225|565935228|FG000|Overall Study|Withdrawal by Subject|3|||
156777151|NCT04190225|565935229|FG001|Overall Study|Withdrawal by Subject|2|||
156777152|NCT04190225|565935228|FG000|Overall Study|Unrelated health condition|2|||
156777153|NCT04190225|565935229|FG001|Overall Study|Unrelated health condition|0|||
156777154|NCT02362451|565935230|FG000|Overall Study|Withdrawal by Subject|0|||
156777155|NCT02362451|565935231|FG001|Overall Study|Withdrawal by Subject|1|||
156777156|NCT02362451|565935230|FG000|Overall Study|Lack of Efficacy|2|||
156777157|NCT02362451|565935231|FG001|Overall Study|Lack of Efficacy|0|||
156777158|NCT02362451|565935230|FG000|Overall Study|Progression|1|||
156777159|NCT02362451|565935231|FG001|Overall Study|Progression|0|||
156777160|NCT02362451|565935230|FG000|Overall Study|Participant chose other therapy.|1|||
156777161|NCT02362451|565935231|FG001|Overall Study|Participant chose other therapy.|0|||
156777162|NCT01732783|565935234|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
156777163|NCT01732783|565935235|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
156777164|NCT01732783|565935236|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
156777165|NCT01732783|565935234|FG000|Overall Study|Death|13|||
156777166|NCT01732783|565935235|FG001|Overall Study|Death|4|||
156777167|NCT01732783|565935236|FG002|Overall Study|Death|1|||
156777168|NCT01732783|565935234|FG000|Overall Study|Lost to Follow-up|7|||
156777169|NCT01732783|565935235|FG001|Overall Study|Lost to Follow-up|1|||
156777170|NCT01732783|565935236|FG002|Overall Study|Lost to Follow-up|1|||
156777171|NCT01732783|565935234|FG000|Overall Study|Administrative Decision|8|||
156777172|NCT01732783|565935235|FG001|Overall Study|Administrative Decision|2|||
156777173|NCT01732783|565935236|FG002|Overall Study|Administrative Decision|1|||
156777174|NCT01732783|565935234|FG000|Overall Study|Withdrawal by Subject|1|||
156777175|NCT01732783|565935235|FG001|Overall Study|Withdrawal by Subject|0|||
156777176|NCT01732783|565935236|FG002|Overall Study|Withdrawal by Subject|0|||
156777177|NCT01838876|565935237|FG000|Overall Study|Adverse Event|49|||
156777178|NCT01838876|565935237|FG000|Overall Study|Insufficient Therapeutic Response|10|||
156777179|NCT01838876|565935237|FG000|Overall Study|Protocol Violation|34|||
156777180|NCT01838876|565935237|FG000|Overall Study|Withdrawal of Consent|33|||
156777181|NCT01838876|565935237|FG000|Overall Study|Lost to Follow-up|21|||
156777182|NCT01838876|565935237|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
156777183|NCT01838876|565935237|FG000|Overall Study|Reason not Specified|7|||
156777184|NCT01838876|565935237|FG000|Overall Study|Did not meet eligibility criteria|78|||
156777185|NCT00689936|565935238|FG000|Active Treatment Phase|Adverse Event|68|||
156777186|NCT00689936|565935239|FG001|Active Treatment Phase|Adverse Event|71|||
156777187|NCT00689936|565935240|FG002|Active Treatment Phase|Adverse Event|76|||
157008443|NCT00309907|566781833|FG000|Overall Study|Physician Decision|1|||
156777188|NCT00689936|565935238|FG000|Active Treatment Phase|Disease Progression|273|||
156777189|NCT00689936|565935239|FG001|Active Treatment Phase|Disease Progression|362|||
156777190|NCT00689936|565935240|FG002|Active Treatment Phase|Disease Progression|339|||
156777191|NCT00689936|565935238|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
156777192|NCT00689936|565935239|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
156777193|NCT00689936|565935240|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
156777194|NCT00689936|565935238|FG000|Active Treatment Phase|Death|60|||
156777195|NCT00689936|565935239|FG001|Active Treatment Phase|Death|28|||
157008444|NCT00309907|566781833|FG000|Overall Study|Ineligible|11|||
156777196|NCT00689936|565935240|FG002|Active Treatment Phase|Death|37|||
156777197|NCT00689936|565935238|FG000|Active Treatment Phase|Lost to Follow-up|0|||
156777198|NCT00689936|565935239|FG001|Active Treatment Phase|Lost to Follow-up|2|||
156777199|NCT00689936|565935240|FG002|Active Treatment Phase|Lost to Follow-up|2|||
156777200|NCT00689936|565935238|FG000|Active Treatment Phase|Protocol Violation|2|||
156777201|NCT00689936|565935239|FG001|Active Treatment Phase|Protocol Violation|2|||
156777202|NCT00689936|565935240|FG002|Active Treatment Phase|Protocol Violation|4|||
156777203|NCT00689936|565935238|FG000|Active Treatment Phase|Study Close Out|64|||
156777204|NCT00689936|565935239|FG001|Active Treatment Phase|Study Close Out|26|||
156777205|NCT00689936|565935240|FG002|Active Treatment Phase|Study Close Out|21|||
156777206|NCT00689936|565935238|FG000|Active Treatment Phase|Miscellaneous|52|||
156777207|NCT00689936|565935239|FG001|Active Treatment Phase|Miscellaneous|34|||
156777208|NCT00689936|565935240|FG002|Active Treatment Phase|Miscellaneous|47|||
157114825|NCT03703102|567175663|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157114826|NCT03703102|567175664|FG002|Overall Study|Non-Compliance with Study Drug|2|||
157114827|NCT03703102|567175665|FG003|Overall Study|Non-Compliance with Study Drug|1|||
157114828|NCT03703102|567175666|FG004|Overall Study|Non-Compliance with Study Drug|4|||
157114829|NCT02311153|567175667|FG000|Overall Study|Lost to Follow-up|5|||
157114830|NCT02311153|567175668|FG001|Overall Study|Lost to Follow-up|7|||
157114831|NCT01967628|567175669|FG000|Overall Study|Withdrawal by Subject|2|||
157114832|NCT01967628|567175670|FG001|Overall Study|Withdrawal by Subject|0|||
157114833|NCT01967628|567175669|FG000|Overall Study|Unable to complete bronchoscopy|4|||
157114834|NCT01967628|567175670|FG001|Overall Study|Unable to complete bronchoscopy|6|||
157114835|NCT01967628|567175669|FG000|Overall Study|Lost to Follow-up|1|||
157114836|NCT01967628|567175670|FG001|Overall Study|Lost to Follow-up|0|||
157114837|NCT01967628|567175669|FG000|Overall Study|Low protein concentration in sample|20|||
157114838|NCT01967628|567175670|FG001|Overall Study|Low protein concentration in sample|25|||
157114839|NCT01650636|567175675|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
157114840|NCT01650636|567175676|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
157114841|NCT01650636|567175675|FG000|Washout up to 5 Months|Physician Decision|2|||
157114842|NCT01650636|567175676|FG001|Washout up to 5 Months|Physician Decision|2|||
157114843|NCT01650636|567175675|FG000|Washout up to 5 Months|Death|1|||
157114844|NCT01650636|567175676|FG001|Washout up to 5 Months|Death|0|||
157114845|NCT01650636|567175675|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
157114846|NCT01650636|567175676|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
157114847|NCT01650636|567175675|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
157114848|NCT01650636|567175676|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
157114849|NCT01650636|567175675|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
157114850|NCT01650636|567175676|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
157114851|NCT01560780|567175677|FG000|Overall Study|Death|2|||
157114852|NCT01560780|567175678|FG001|Overall Study|Death|1|||
157114853|NCT01560780|567175677|FG000|Overall Study|Patient Preference|11|||
157114854|NCT01560780|567175678|FG001|Overall Study|Patient Preference|11|||
157114855|NCT02192827|567175679|FG000|Overall Study|Lost to Follow-up|25|||
157114856|NCT02192827|567175680|FG001|Overall Study|Lost to Follow-up|27|||
157114857|NCT02192827|567175679|FG000|Overall Study|Given additional steroids with admission|13|||
156777209|NCT00689936|565935238|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
156777210|NCT00689936|565935239|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
156777211|NCT00689936|565935240|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
156777212|NCT01682031|565935241|FG000|Overall Study|Withdrawal by Subject|0|||
156777213|NCT01682031|565935242|FG001|Overall Study|Withdrawal by Subject|1|||
156777214|NCT01682031|565935241|FG000|Overall Study|Adverse Event|0|||
156777215|NCT01682031|565935242|FG001|Overall Study|Adverse Event|2|||
156777216|NCT01682031|565935241|FG000|Overall Study|MRI results indicate increased nodul|0|||
156777217|NCT01682031|565935242|FG001|Overall Study|MRI results indicate increased nodul|1|||
156777218|NCT01682031|565935241|FG000|Overall Study|Patient could not swallow tablets|1|||
156777219|NCT01682031|565935242|FG001|Overall Study|Patient could not swallow tablets|0|||
156777220|NCT01682031|565935241|FG000|Overall Study|Patient stopped selenium on his own|0|||
156777221|NCT01682031|565935242|FG001|Overall Study|Patient stopped selenium on his own|1|||
156777222|NCT03881371|565935247|FG000|Overall Study|Adverse Event|8|||
156777223|NCT03881371|565935248|FG001|Overall Study|Adverse Event|9|||
156777224|NCT03881371|565935247|FG000|Overall Study|Death|1|||
156777225|NCT03881371|565935248|FG001|Overall Study|Death|0|||
156777226|NCT03881371|565935247|FG000|Overall Study|Lost to Follow-up|1|||
156777227|NCT03881371|565935248|FG001|Overall Study|Lost to Follow-up|0|||
156777228|NCT03881371|565935247|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156777229|NCT03881371|565935248|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156777230|NCT03881371|565935247|FG000|Overall Study|Physician Decision|3|||
157114858|NCT02192827|567175680|FG001|Overall Study|Given additional steroids with admission|11|||
157114859|NCT01970995|567175682|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
157114860|NCT01970995|567175683|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
157114861|NCT01970995|567175684|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
156777231|NCT03881371|565935248|FG001|Overall Study|Physician Decision|3|||
156777232|NCT03881371|565935247|FG000|Overall Study|Withdrawal by Subject|2|||
156777233|NCT03881371|565935248|FG001|Overall Study|Withdrawal by Subject|10|||
156777234|NCT03881371|565935247|FG000|Overall Study|Discontinuation from Study|1|||
156777235|NCT03881371|565935248|FG001|Overall Study|Discontinuation from Study|0|||
156777236|NCT03330197|565935254|FG000|Overall Study|Adverse Event|0|||
156777237|NCT03330197|565935255|FG001|Overall Study|Adverse Event|1|||
156777238|NCT03330197|565935254|FG000|Overall Study|Withdrawal by Subject|0|||
156777239|NCT03330197|565935255|FG001|Overall Study|Withdrawal by Subject|1|||
156777240|NCT01564407|565935259|FG000|Overall Study|Lost to Follow-up|0|||
156777241|NCT01564407|565935260|FG001|Overall Study|Lost to Follow-up|1|||
157114862|NCT01970995|567175682|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
157114863|NCT01970995|567175683|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
157114864|NCT01970995|567175684|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
157114865|NCT01157364|567175685|FG000|Overall Study|Other Reasons|1|||
156777242|NCT01564407|565935261|FG002|Overall Study|Lost to Follow-up|0|||
156777243|NCT01564407|565935262|FG003|Overall Study|Lost to Follow-up|0|||
156777244|NCT01564407|565935263|FG004|Overall Study|Lost to Follow-up|0|||
156777245|NCT01564407|565935259|FG000|Overall Study|Withdrawal by Subject|0|||
156777246|NCT01564407|565935260|FG001|Overall Study|Withdrawal by Subject|1|||
156777247|NCT01564407|565935261|FG002|Overall Study|Withdrawal by Subject|0|||
156777248|NCT01564407|565935262|FG003|Overall Study|Withdrawal by Subject|0|||
156777249|NCT01564407|565935263|FG004|Overall Study|Withdrawal by Subject|0|||
156777250|NCT01564407|565935259|FG000|Overall Study|funding lost, study ended|0|||
156777251|NCT01564407|565935260|FG001|Overall Study|funding lost, study ended|0|||
156777252|NCT01564407|565935261|FG002|Overall Study|funding lost, study ended|0|||
156777253|NCT01564407|565935262|FG003|Overall Study|funding lost, study ended|1|||
156777254|NCT01564407|565935263|FG004|Overall Study|funding lost, study ended|0|||
156777255|NCT02879695|565935267|FG000|Overall Study|Did not start study treatment|2|||
156777256|NCT02879695|565935268|FG001|Overall Study|Did not start study treatment|0|||
156777257|NCT02879695|565935269|FG002|Overall Study|Did not start study treatment|3|||
156777258|NCT02879695|565935270|FG003|Overall Study|Did not start study treatment|0|||
156777259|NCT00976027|565935271|FG000|Overall Study|Serious Adverse Event|36|||
156777260|NCT00976027|565935272|FG001|Overall Study|Serious Adverse Event|17|||
156777261|NCT00976027|565935271|FG000|Overall Study|Adverse Event|0|||
156777262|NCT00976027|565935272|FG001|Overall Study|Adverse Event|2|||
156777263|NCT00976027|565935271|FG000|Overall Study|Protocol Violation|60|||
156777264|NCT00976027|565935272|FG001|Overall Study|Protocol Violation|27|||
156777265|NCT00976027|565935271|FG000|Overall Study|Lost to Follow-up|208|||
156777266|NCT00976027|565935272|FG001|Overall Study|Lost to Follow-up|103|||
156777267|NCT00976027|565935271|FG000|Overall Study|Withdrawal by Subject|107|||
156777268|NCT00976027|565935272|FG001|Overall Study|Withdrawal by Subject|66|||
156777269|NCT01771107|565935277|FG000|Overall Study|Adverse Event|1|||
156777270|NCT01771107|565935278|FG001|Overall Study|Adverse Event|3|||
156777271|NCT01771107|565935277|FG000|Overall Study|Withdrawal by Subject|0|||
156777272|NCT01771107|565935278|FG001|Overall Study|Withdrawal by Subject|2|||
156777273|NCT01771107|565935277|FG000|Overall Study|Lost to Follow-up|0|||
156777274|NCT01771107|565935278|FG001|Overall Study|Lost to Follow-up|1|||
156777275|NCT01771107|565935277|FG000|Overall Study|participant moved|0|||
156777276|NCT01771107|565935278|FG001|Overall Study|participant moved|1|||
156777277|NCT01771107|565935277|FG000|Overall Study|Other|0|||
156777278|NCT01771107|565935278|FG001|Overall Study|Other|1|||
156777279|NCT01160614|565935279|FG000|Overall Study|Withdrawal by Subject|0|||
156777280|NCT01160614|565935280|FG001|Overall Study|Withdrawal by Subject|2|||
156777281|NCT03805841|565935281|FG000|Overall Study|Clinical Progression|2|||
156777282|NCT03805841|565935282|FG001|Overall Study|Clinical Progression|0|||
156777283|NCT03805841|565935283|FG002|Overall Study|Clinical Progression|0|||
156777284|NCT03805841|565935281|FG000|Overall Study|Death|0|||
156777285|NCT03805841|565935282|FG001|Overall Study|Death|3|||
156777286|NCT03805841|565935283|FG002|Overall Study|Death|1|||
156777287|NCT03805841|565935281|FG000|Overall Study|Lost to Follow-up|0|||
157008445|NCT00309907|566781833|FG000|Overall Study|Major infectious event|4|||
157008446|NCT00980330|566781834|FG000|Overall Study|Adverse Event|0|||
157008447|NCT00980330|566781835|FG001|Overall Study|Adverse Event|0|||
157008448|NCT00980330|566781836|FG002|Overall Study|Adverse Event|0|||
156777288|NCT03805841|565935282|FG001|Overall Study|Lost to Follow-up|0|||
156777289|NCT03805841|565935283|FG002|Overall Study|Lost to Follow-up|1|||
156777290|NCT03805841|565935281|FG000|Overall Study|Withdrawal by Subject|2|||
156777291|NCT03805841|565935282|FG001|Overall Study|Withdrawal by Subject|3|||
156777292|NCT03805841|565935283|FG002|Overall Study|Withdrawal by Subject|0|||
156777293|NCT03805841|565935281|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
156777294|NCT03805841|565935282|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
156777295|NCT03805841|565935283|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
156777296|NCT05248386|565935284|FG000|Overall Study|Technical problems|0|||
156777297|NCT05248386|565935285|FG001|Overall Study|Technical problems|1|||
157114866|NCT01157364|567175686|FG001|Overall Study|Other Reasons|1|||
157114867|NCT01157364|567175687|FG002|Overall Study|Other Reasons|2|||
157114868|NCT01157364|567175688|FG003|Overall Study|Other Reasons|1|||
157114869|NCT01157364|567175689|FG004|Overall Study|Other Reasons|0|||
157114870|NCT01157364|567175690|FG005|Overall Study|Other Reasons|0|||
157114871|NCT01157364|567175685|FG000|Overall Study|Personal Reasons|0|||
157114872|NCT01157364|567175686|FG001|Overall Study|Personal Reasons|2|||
157114873|NCT01157364|567175687|FG002|Overall Study|Personal Reasons|0|||
157114874|NCT01157364|567175688|FG003|Overall Study|Personal Reasons|0|||
157114875|NCT01157364|567175689|FG004|Overall Study|Personal Reasons|1|||
157114876|NCT01157364|567175690|FG005|Overall Study|Personal Reasons|1|||
157114877|NCT01157364|567175685|FG000|Overall Study|Lost to Follow-up|1|||
157114878|NCT01157364|567175686|FG001|Overall Study|Lost to Follow-up|0|||
157114879|NCT01157364|567175687|FG002|Overall Study|Lost to Follow-up|1|||
157114880|NCT01157364|567175688|FG003|Overall Study|Lost to Follow-up|0|||
157114881|NCT01157364|567175689|FG004|Overall Study|Lost to Follow-up|0|||
157114882|NCT01157364|567175690|FG005|Overall Study|Lost to Follow-up|0|||
157114883|NCT01157364|567175685|FG000|Overall Study|Lack of Efficacy|0|||
157114884|NCT01157364|567175686|FG001|Overall Study|Lack of Efficacy|0|||
157114885|NCT01157364|567175687|FG002|Overall Study|Lack of Efficacy|0|||
156777298|NCT05248386|565935284|FG000|Overall Study|Withdrawal by Subject|15|||
156777299|NCT05248386|565935285|FG001|Overall Study|Withdrawal by Subject|10|||
156777300|NCT05248386|565935284|FG000|Overall Study|Physician Decision|0|||
156777301|NCT05248386|565935285|FG001|Overall Study|Physician Decision|1|||
156777302|NCT05248386|565935284|FG000|Overall Study|Adverse Event|2|||
156777303|NCT05248386|565935285|FG001|Overall Study|Adverse Event|4|||
156777304|NCT05248386|565935284|FG000|Overall Study|Other|1|||
156777305|NCT05248386|565935285|FG001|Overall Study|Other|0|||
156777306|NCT05248386|565935284|FG000|Overall Study|Lack of Efficacy|14|||
156777307|NCT05248386|565935285|FG001|Overall Study|Lack of Efficacy|12|||
156777308|NCT01723774|565935286|FG000|Neoadjuvant|Ki67 > 10%|4|||
156777309|NCT01723774|565935287|FG001|Neoadjuvant|Ki67 > 10%|0|||
156777310|NCT01723774|565935288|FG002|Neoadjuvant|Ki67 > 10%|10|||
156777311|NCT01723774|565935289|FG003|Neoadjuvant|Ki67 > 10%|0|||
156777312|NCT01723774|565935286|FG000|Neoadjuvant|Withdrawal by Subject|3|||
156777313|NCT01723774|565935287|FG001|Neoadjuvant|Withdrawal by Subject|1|||
156777314|NCT01723774|565935288|FG002|Neoadjuvant|Withdrawal by Subject|0|||
156777315|NCT01723774|565935289|FG003|Neoadjuvant|Withdrawal by Subject|0|||
156777316|NCT01723774|565935286|FG000|Neoadjuvant|Disease progression|0|||
156777317|NCT01723774|565935287|FG001|Neoadjuvant|Disease progression|1|||
156777318|NCT01723774|565935288|FG002|Neoadjuvant|Disease progression|1|||
156777319|NCT01723774|565935289|FG003|Neoadjuvant|Disease progression|0|||
156777320|NCT01723774|565935286|FG000|Neoadjuvant|Adverse Event|0|||
156777321|NCT01723774|565935287|FG001|Neoadjuvant|Adverse Event|1|||
156777322|NCT01723774|565935288|FG002|Neoadjuvant|Adverse Event|2|||
156777323|NCT01723774|565935289|FG003|Neoadjuvant|Adverse Event|0|||
156777324|NCT01723774|565935286|FG000|Neoadjuvant|High estradiol|0|||
156777325|NCT01723774|565935287|FG001|Neoadjuvant|High estradiol|1|||
156777326|NCT01723774|565935288|FG002|Neoadjuvant|High estradiol|0|||
156777327|NCT01723774|565935289|FG003|Neoadjuvant|High estradiol|0|||
156777328|NCT01910441|565935290|FG000|Overall Study|Sponsor decision|0|||
156777329|NCT01910441|565935291|FG001|Overall Study|Sponsor decision|2|||
156777330|NCT01910441|565935290|FG000|Overall Study|Lost to Follow-up|6|||
156777331|NCT01910441|565935291|FG001|Overall Study|Lost to Follow-up|5|||
156777332|NCT01910441|565935290|FG000|Overall Study|Withdrawal by Subject|0|||
156777333|NCT01910441|565935291|FG001|Overall Study|Withdrawal by Subject|1|||
156777334|NCT01910441|565935290|FG000|Overall Study|Non-compliance|0|||
156777335|NCT01910441|565935291|FG001|Overall Study|Non-compliance|1|||
156777336|NCT01910441|565935290|FG000|Overall Study|Adverse Event|1|||
156777337|NCT01910441|565935291|FG001|Overall Study|Adverse Event|0|||
156777338|NCT01910441|565935290|FG000|Overall Study|Physician Decision|0|||
156777339|NCT01910441|565935291|FG001|Overall Study|Physician Decision|1|||
156777340|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777341|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
156777342|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777343|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777344|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777345|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
156777346|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777347|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
156777348|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
157114886|NCT01157364|567175688|FG003|Overall Study|Lack of Efficacy|1|||
157114887|NCT01157364|567175689|FG004|Overall Study|Lack of Efficacy|0|||
157114888|NCT01157364|567175690|FG005|Overall Study|Lack of Efficacy|0|||
157114889|NCT01157364|567175685|FG000|Overall Study|Adverse Event|0|||
157114890|NCT01157364|567175686|FG001|Overall Study|Adverse Event|1|||
156777349|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777350|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777351|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777352|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777353|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
156777354|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777355|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
156777356|NCT02964182|565935292|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777357|NCT02964182|565935293|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
156777358|NCT02964182|565935294|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777359|NCT02964182|565935295|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777360|NCT02964182|565935296|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777361|NCT02964182|565935297|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
156777362|NCT02964182|565935298|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777363|NCT02964182|565935299|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
156777364|NCT02964182|565935292|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777365|NCT02964182|565935293|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777366|NCT02964182|565935294|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
156777367|NCT02964182|565935295|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
156777368|NCT02964182|565935296|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777369|NCT02964182|565935297|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777370|NCT02964182|565935298|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
156777371|NCT02964182|565935299|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
156777372|NCT02964182|565935292|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777373|NCT02964182|565935293|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777374|NCT02964182|565935294|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
156777375|NCT02964182|565935295|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
156777376|NCT02964182|565935296|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777377|NCT02964182|565935297|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777378|NCT02964182|565935298|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
156777379|NCT02964182|565935299|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
156777380|NCT02964182|565935292|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777381|NCT02964182|565935293|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777382|NCT02964182|565935294|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
157008449|NCT00980330|566781837|FG003|Overall Study|Adverse Event|1|||
157008450|NCT00980330|566781838|FG004|Overall Study|Adverse Event|0|||
157008451|NCT00980330|566781839|FG005|Overall Study|Adverse Event|0|||
156777383|NCT02964182|565935295|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
156777384|NCT02964182|565935296|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777385|NCT02964182|565935297|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777386|NCT02964182|565935298|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
156777387|NCT02964182|565935299|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
157008452|NCT00980330|566781840|FG006|Overall Study|Adverse Event|0|||
157008453|NCT00980330|566781834|FG000|Overall Study|Lost to Follow-up|1|||
157114891|NCT01157364|567175687|FG002|Overall Study|Adverse Event|1|||
157114892|NCT01157364|567175688|FG003|Overall Study|Adverse Event|0|||
157114893|NCT01157364|567175689|FG004|Overall Study|Adverse Event|1|||
157114894|NCT01157364|567175690|FG005|Overall Study|Adverse Event|0|||
157114895|NCT01709435|567175691|FG000|Overall Study|Adverse Event|1|||
157114896|NCT01709435|567175692|FG001|Overall Study|Adverse Event|1|||
157114897|NCT01709435|567175693|FG002|Overall Study|Adverse Event|1|||
156777388|NCT02964182|565935292|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777389|NCT02964182|565935293|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777390|NCT02964182|565935294|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
156777391|NCT02964182|565935295|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
156777392|NCT02964182|565935296|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777393|NCT02964182|565935297|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777394|NCT02964182|565935298|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
156777395|NCT02964182|565935299|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
156777396|NCT03621592|565935302|FG000|Overall Study|Lost to Follow-up|1|||
156777397|NCT03621592|565935303|FG001|Overall Study|Lost to Follow-up|0|||
156777398|NCT03621592|565935302|FG000|Overall Study|Lack of Improvement|1|||
156777399|NCT03621592|565935303|FG001|Overall Study|Lack of Improvement|0|||
156777400|NCT03621592|565935302|FG000|Overall Study|Preference to receive wound care closer to home|1|||
156777401|NCT03621592|565935303|FG001|Overall Study|Preference to receive wound care closer to home|0|||
156777402|NCT03621592|565935302|FG000|Overall Study|Lack of healing|0|||
156777403|NCT03621592|565935303|FG001|Overall Study|Lack of healing|2|||
156777404|NCT04967222|565935304|FG000|Randomized|Lost to Follow-up|0|||
156777405|NCT04967222|565935305|FG001|Randomized|Lost to Follow-up|1|||
156777406|NCT04967222|565935306|FG002|Randomized|Lost to Follow-up|1|||
156777407|NCT04967222|565935304|FG000|Randomized|Physician Decision|0|||
156777408|NCT04967222|565935305|FG001|Randomized|Physician Decision|0|||
156777409|NCT04967222|565935306|FG002|Randomized|Physician Decision|1|||
156777410|NCT04967222|565935304|FG000|Randomized|Withdrawal by Subject|0|||
156777411|NCT04967222|565935305|FG001|Randomized|Withdrawal by Subject|0|||
156777412|NCT04967222|565935306|FG002|Randomized|Withdrawal by Subject|2|||
156777413|NCT04967222|565935304|FG000|Randomized|abnormal finding in MRI|0|||
156777414|NCT04967222|565935305|FG001|Randomized|abnormal finding in MRI|2|||
156777415|NCT04967222|565935306|FG002|Randomized|abnormal finding in MRI|0|||
156777416|NCT04958707|565935314|FG000|Post Intervention|Withdrawal by Subject|1|||
156777417|NCT04958707|565935315|FG001|Post Intervention|Withdrawal by Subject|0|||
156777418|NCT04958707|565935316|FG002|Post Intervention|Withdrawal by Subject|0|||
156777419|NCT04958707|565935314|FG000|3 Months Follow- up|Lost to Follow-up|0|||
156777420|NCT04958707|565935315|FG001|3 Months Follow- up|Lost to Follow-up|3|||
156777421|NCT04958707|565935316|FG002|3 Months Follow- up|Lost to Follow-up|0|||
156777422|NCT04958707|565935314|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
156777423|NCT04958707|565935315|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
156777424|NCT04958707|565935316|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
156777425|NCT02629159|565935319|FG000|Overall Study|Adverse Event|17|||
156777426|NCT02629159|565935320|FG001|Overall Study|Adverse Event|20|||
156777427|NCT02629159|565935321|FG002|Overall Study|Adverse Event|22|||
156777428|NCT02629159|565935319|FG000|Overall Study|Withdrawal by Subject|22|||
156777429|NCT02629159|565935320|FG001|Overall Study|Withdrawal by Subject|11|||
156777430|NCT02629159|565935321|FG002|Overall Study|Withdrawal by Subject|15|||
156777431|NCT02629159|565935319|FG000|Overall Study|Lost to Follow-up|7|||
156777432|NCT02629159|565935320|FG001|Overall Study|Lost to Follow-up|4|||
156777433|NCT02629159|565935321|FG002|Overall Study|Lost to Follow-up|5|||
156777434|NCT02629159|565935319|FG000|Overall Study|Lack of Efficacy|4|||
156777435|NCT02629159|565935320|FG001|Overall Study|Lack of Efficacy|0|||
156777436|NCT02629159|565935321|FG002|Overall Study|Lack of Efficacy|1|||
157114898|NCT01709435|567175694|FG003|Overall Study|Adverse Event|0|||
156777437|NCT02629159|565935319|FG000|Overall Study|Other|6|||
156777438|NCT02629159|565935320|FG001|Overall Study|Other|4|||
156777439|NCT02629159|565935321|FG002|Overall Study|Other|8|||
156777440|NCT05523297|565935331|FG000|Overall Study|Death|7|||
156777441|NCT05523297|565935332|FG001|Overall Study|Death|8|||
156777442|NCT05523297|565935331|FG000|Overall Study|Lost to Follow-up|2|||
156777443|NCT05523297|565935332|FG001|Overall Study|Lost to Follow-up|1|||
156777444|NCT00830765|565935333|FG000|Overall Study|Protocol Violation|3|||
156777445|NCT00830765|565935334|FG001|Overall Study|Protocol Violation|2|||
156777446|NCT02390284|565935335|FG000|Overall Study|Physician Decision|0|||
156777447|NCT02390284|565935336|FG001|Overall Study|Physician Decision|0|||
156777448|NCT02390284|565935337|FG002|Overall Study|Physician Decision|9|||
156777449|NCT00724945|565935340|FG000|Period 1|non-compliance|1|||
156777450|NCT00724945|565935341|FG001|Period 1|non-compliance|0|||
156777451|NCT00724945|565935340|FG000|Period 1|Adverse Event|1|||
156777452|NCT00724945|565935341|FG001|Period 1|Adverse Event|1|||
156777453|NCT00724945|565935340|FG000|Period 1|Lost to Follow-up|1|||
156777454|NCT00724945|565935341|FG001|Period 1|Lost to Follow-up|0|||
156777455|NCT00724945|565935340|FG000|Period 2|lens comfort issue|3|||
156777456|NCT00724945|565935341|FG001|Period 2|lens comfort issue|0|||
156777457|NCT00724945|565935340|FG000|Period 2|lens physiology issue|1|||
156777458|NCT00724945|565935341|FG001|Period 2|lens physiology issue|0|||
156777459|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
156777460|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
156777461|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
156777462|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
156777463|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
156777464|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
156777465|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
156777466|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
156777467|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
156777468|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
156777469|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
156777470|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
156777471|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
156777472|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
156777473|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
156777474|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
156777475|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
156777476|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
156777477|NCT01069939|565935342|FG000|Randomised and Included in the Analyses|Removal|1|||
156777478|NCT01069939|565935343|FG001|Randomised and Included in the Analyses|Removal|0|||
156777479|NCT05166876|565935344|FG000|Overall Study|Withdrawal by Subject|1|||
156777480|NCT05166876|565935345|FG001|Overall Study|Withdrawal by Subject|0|||
156777481|NCT05166876|565935346|FG002|Overall Study|Withdrawal by Subject|0|||
156777482|NCT00658528|565935347|FG000|Overall Study|Adverse Event|5|||
156777483|NCT00658528|565935348|FG001|Overall Study|Adverse Event|7|||
156777484|NCT00658528|565935347|FG000|Overall Study|Lost to Follow-up|14|||
156777485|NCT00658528|565935348|FG001|Overall Study|Lost to Follow-up|22|||
156777486|NCT00658528|565935347|FG000|Overall Study|Withdrawal by Subject|8|||
156777487|NCT00658528|565935348|FG001|Overall Study|Withdrawal by Subject|6|||
156777488|NCT00658528|565935347|FG000|Overall Study|Withdrawal of consent|5|||
156777489|NCT00658528|565935348|FG001|Overall Study|Withdrawal of consent|6|||
156777490|NCT00658528|565935347|FG000|Overall Study|Other|8|||
156777491|NCT00658528|565935348|FG001|Overall Study|Other|4|||
156777492|NCT02811159|565935354|FG000|Treatment Course 1|Lost to Follow-up|1|||
156777493|NCT05759338|565935355|FG000|Overall Study|Withdrawal by Subject|3|||
156777494|NCT04409002|565935356|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
156777495|NCT04611126|565935358|FG000|Overall Study|TIL expansion unsuccessful|1|||
156777496|NCT04611126|565935359|FG001|Overall Study|TIL expansion unsuccessful|0|||
156777497|NCT02328014|565936930|FG000|Overall Study|Adverse Event|1|||
156777498|NCT02328014|565936931|FG001|Overall Study|Adverse Event|0|||
156777499|NCT02328014|565936932|FG002|Overall Study|Adverse Event|0|||
156777500|NCT02328014|565936933|FG003|Overall Study|Adverse Event|1|||
156777501|NCT02328014|565936930|FG000|Overall Study|Death|0|||
156777502|NCT02328014|565936931|FG001|Overall Study|Death|0|||
156777503|NCT02328014|565936932|FG002|Overall Study|Death|0|||
156777504|NCT02328014|565936933|FG003|Overall Study|Death|4|||
156777505|NCT02328014|565936930|FG000|Overall Study|Physician Decision|0|||
156777506|NCT02328014|565936931|FG001|Overall Study|Physician Decision|0|||
156777507|NCT02328014|565936932|FG002|Overall Study|Physician Decision|0|||
156777508|NCT02328014|565936933|FG003|Overall Study|Physician Decision|1|||
156777509|NCT02328014|565936930|FG000|Overall Study|Disease Progression|1|||
156777510|NCT02328014|565936931|FG001|Overall Study|Disease Progression|0|||
156777511|NCT02328014|565936932|FG002|Overall Study|Disease Progression|1|||
156777512|NCT02328014|565936933|FG003|Overall Study|Disease Progression|3|||
156777513|NCT02328014|565936930|FG000|Overall Study|Study Terminated by Sponsor|4|||
156777514|NCT02328014|565936931|FG001|Overall Study|Study Terminated by Sponsor|1|||
156777515|NCT02328014|565936932|FG002|Overall Study|Study Terminated by Sponsor|1|||
156777516|NCT02328014|565936933|FG003|Overall Study|Study Terminated by Sponsor|0|||
156777517|NCT02328014|565936930|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
156777518|NCT02328014|565936931|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
156777519|NCT02328014|565936932|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
156777520|NCT02328014|565936933|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
156777521|NCT02328014|565936930|FG000|Overall Study|Withdrawal by Subject|0|||
156777522|NCT02328014|565936931|FG001|Overall Study|Withdrawal by Subject|0|||
156777523|NCT02328014|565936932|FG002|Overall Study|Withdrawal by Subject|0|||
156777524|NCT02328014|565936933|FG003|Overall Study|Withdrawal by Subject|1|||
156777525|NCT04429971|565936942|FG000|Overall Study|Lost to Follow-up|7|||
156777526|NCT04429971|565936943|FG001|Overall Study|Lost to Follow-up|8|||
156777527|NCT05522751|565936949|FG000|Overall Study|Adverse Event|1|||
156777528|NCT04044690|565936951|FG000|Period 1|Lack of Efficacy|1|||
156777529|NCT04044690|565936952|FG001|Period 1|Lack of Efficacy|1|||
156777530|NCT04044690|565936951|FG000|Period 1|Adverse Event|4|||
156777531|NCT04044690|565936952|FG001|Period 1|Adverse Event|2|||
156777532|NCT04044690|565936951|FG000|Period 1|Physician Decision|0|||
156777533|NCT04044690|565936952|FG001|Period 1|Physician Decision|1|||
156777534|NCT04044690|565936951|FG000|Period 1|Withdrawal by Subject|2|||
156777535|NCT04044690|565936952|FG001|Period 1|Withdrawal by Subject|5|||
156777536|NCT04044690|565936951|FG000|Period 1|Protocol Deviation|2|||
156777537|NCT04044690|565936952|FG001|Period 1|Protocol Deviation|0|||
156777538|NCT04044690|565936951|FG000|Period 1|Site Terminated by Sponsor|0|||
156777539|NCT04044690|565936952|FG001|Period 1|Site Terminated by Sponsor|1|||
156777540|NCT04044690|565936951|FG000|Period 1|Study Terminated by Sponsor|0|||
156777541|NCT04044690|565936952|FG001|Period 1|Study Terminated by Sponsor|1|||
156777542|NCT04044690|565936951|FG000|Period 1|Death|1|||
156777543|NCT04044690|565936952|FG001|Period 1|Death|1|||
156777544|NCT04044690|565936951|FG000|Period 1|Other: Unspecified|1|||
156777545|NCT04044690|565936952|FG001|Period 1|Other: Unspecified|0|||
156777546|NCT04044690|565936951|FG000|Period 2|Lack of Efficacy|0|||
156777547|NCT04044690|565936952|FG001|Period 2|Lack of Efficacy|1|||
156777548|NCT04044690|565936951|FG000|Period 2|Adverse Event|0|||
156777549|NCT04044690|565936952|FG001|Period 2|Adverse Event|1|||
156777550|NCT04044690|565936951|FG000|Period 2|Physician Decision|0|||
156777551|NCT04044690|565936952|FG001|Period 2|Physician Decision|2|||
156777552|NCT04044690|565936951|FG000|Period 2|Withdrawal by Subject|5|||
156777553|NCT04044690|565936952|FG001|Period 2|Withdrawal by Subject|5|||
156777554|NCT04044690|565936951|FG000|Period 2|Lost to Follow-up|0|||
156777555|NCT04044690|565936952|FG001|Period 2|Lost to Follow-up|1|||
156777556|NCT04044690|565936951|FG000|Period 2|Site Terminated by Sponsor|1|||
156777557|NCT04044690|565936952|FG001|Period 2|Site Terminated by Sponsor|3|||
156777558|NCT04044690|565936951|FG000|Period 2|Study Terminated by Sponsor|8|||
156777559|NCT04044690|565936952|FG001|Period 2|Study Terminated by Sponsor|3|||
156777560|NCT04044690|565936951|FG000|Period 2|Death|1|||
156777561|NCT04044690|565936952|FG001|Period 2|Death|0|||
156777562|NCT04044690|565936951|FG000|Period 2|Other: Unspecified|1|||
156777563|NCT04044690|565936952|FG001|Period 2|Other: Unspecified|1|||
156777564|NCT04044690|565936951|FG000|Period 3|Site Terminated by Sponsor|1|||
157114899|NCT01709435|567175695|FG004|Overall Study|Adverse Event|0|||
156777565|NCT04044690|565936952|FG001|Period 3|Site Terminated by Sponsor|2|||
156777566|NCT04044690|565936951|FG000|Period 3|Study Terminated by Sponsor|24|||
156777567|NCT04044690|565936952|FG001|Period 3|Study Terminated by Sponsor|18|||
156777568|NCT04044690|565936951|FG000|Period 3|Missing|0|||
156777569|NCT04044690|565936952|FG001|Period 3|Missing|2|||
156777570|NCT01582451|565936958|FG000|Overall Study|Adverse Event|1|||
156777571|NCT01582451|565936959|FG001|Overall Study|Adverse Event|3|||
156777572|NCT01582451|565936958|FG000|Overall Study|Death|3|||
156777573|NCT01582451|565936959|FG001|Overall Study|Death|3|||
156777574|NCT01582451|565936958|FG000|Overall Study|Lost to Follow-up|0|||
156777575|NCT01582451|565936959|FG001|Overall Study|Lost to Follow-up|2|||
156777576|NCT01582451|565936958|FG000|Overall Study|Protocol Violation|11|||
156777577|NCT01582451|565936959|FG001|Overall Study|Protocol Violation|3|||
157008454|NCT00980330|566781835|FG001|Overall Study|Lost to Follow-up|1|||
157008455|NCT00980330|566781836|FG002|Overall Study|Lost to Follow-up|4|||
157008456|NCT00980330|566781837|FG003|Overall Study|Lost to Follow-up|2|||
157008457|NCT00980330|566781838|FG004|Overall Study|Lost to Follow-up|1|||
157008458|NCT00980330|566781839|FG005|Overall Study|Lost to Follow-up|1|||
157008459|NCT00980330|566781840|FG006|Overall Study|Lost to Follow-up|2|||
157008460|NCT00980330|566781834|FG000|Overall Study|Withdrawal by Subject|2|||
157008461|NCT00980330|566781835|FG001|Overall Study|Withdrawal by Subject|4|||
157008462|NCT00980330|566781836|FG002|Overall Study|Withdrawal by Subject|4|||
157008463|NCT00980330|566781837|FG003|Overall Study|Withdrawal by Subject|1|||
157008464|NCT00980330|566781838|FG004|Overall Study|Withdrawal by Subject|3|||
157008465|NCT00980330|566781839|FG005|Overall Study|Withdrawal by Subject|2|||
157008466|NCT00980330|566781840|FG006|Overall Study|Withdrawal by Subject|5|||
157008467|NCT00980330|566781834|FG000|Overall Study|(not specified)|2|||
157008468|NCT00980330|566781835|FG001|Overall Study|(not specified)|0|||
157008469|NCT00980330|566781836|FG002|Overall Study|(not specified)|0|||
157008470|NCT00980330|566781837|FG003|Overall Study|(not specified)|1|||
157008471|NCT00980330|566781838|FG004|Overall Study|(not specified)|1|||
157008472|NCT00980330|566781839|FG005|Overall Study|(not specified)|1|||
157008473|NCT00980330|566781840|FG006|Overall Study|(not specified)|0|||
157008474|NCT01039688|566781841|FG000|Overall Study|Adverse Event|38|||
156777578|NCT01582451|565936958|FG000|Overall Study|Withdrawal by Subject|13|||
156777579|NCT01582451|565936959|FG001|Overall Study|Withdrawal by Subject|9|||
156777580|NCT01582451|565936958|FG000|Overall Study|Physician Decision|3|||
156777581|NCT01582451|565936959|FG001|Overall Study|Physician Decision|0|||
156777582|NCT01582451|565936958|FG000|Overall Study|Sponsor Decision|1|||
156777583|NCT01582451|565936959|FG001|Overall Study|Sponsor Decision|0|||
156777584|NCT05472142|565936962|FG000|Total Participants|Lost to Follow-up|312|||
156777585|NCT05472142|565936963|FG001|Total Participants|Lost to Follow-up|0|||
156777586|NCT05472142|565936962|FG000|Clinic Patients|Lost to Follow-up|312|||
156777587|NCT05472142|565936963|FG001|Clinic Patients|Lost to Follow-up|0|||
156777588|NCT04092777|565936964|FG000|Overall Study|Lost to Follow-up|28|||
156777589|NCT04092777|565936965|FG001|Overall Study|Lost to Follow-up|46|||
156777590|NCT04092777|565936964|FG000|Overall Study|Withdrawal by Subject|8|||
156777591|NCT04092777|565936965|FG001|Overall Study|Withdrawal by Subject|5|||
156777592|NCT03765073|565936966|FG000|Stage 1|Lost to Follow-up|1|||
156777593|NCT03765073|565936967|FG001|Stage 1|Lost to Follow-up|0|||
156777594|NCT03765073|565936968|FG002|Stage 1|Lost to Follow-up|0|||
156777595|NCT03765073|565936969|FG003|Stage 1|Lost to Follow-up|0|||
156777596|NCT03765073|565936970|FG004|Stage 1|Lost to Follow-up|0|||
156777597|NCT03765073|565936971|FG005|Stage 1|Lost to Follow-up|0|||
156777598|NCT03765073|565936972|FG006|Stage 1|Lost to Follow-up|0|||
156777599|NCT03765073|565936973|FG007|Stage 1|Lost to Follow-up|0|||
156777600|NCT03765073|565936974|FG008|Stage 1|Lost to Follow-up|0|||
156777601|NCT03765073|565936975|FG009|Stage 1|Lost to Follow-up|0|||
156777602|NCT03765073|565936976|FG010|Stage 1|Lost to Follow-up|0|||
156777603|NCT03765073|565936977|FG011|Stage 1|Lost to Follow-up|0|||
156777604|NCT03765073|565936978|FG012|Stage 1|Lost to Follow-up|0|||
156777605|NCT03765073|565936979|FG013|Stage 1|Lost to Follow-up|0|||
156777606|NCT03765073|565936980|FG014|Stage 1|Lost to Follow-up|0|||
156777607|NCT03765073|565936981|FG015|Stage 1|Lost to Follow-up|0|||
156777608|NCT03765073|565936982|FG016|Stage 1|Lost to Follow-up|0|||
156777609|NCT03765073|565936983|FG017|Stage 1|Lost to Follow-up|0|||
156777610|NCT03765073|565936984|FG018|Stage 1|Lost to Follow-up|0|||
156777611|NCT03765073|565936985|FG019|Stage 1|Lost to Follow-up|0|||
156777612|NCT03765073|565936986|FG020|Stage 1|Lost to Follow-up|0|||
156777613|NCT03765073|565936966|FG000|Stage 1|Withdrawal by participant|0|||
156777614|NCT03765073|565936967|FG001|Stage 1|Withdrawal by participant|1|||
156777615|NCT03765073|565936968|FG002|Stage 1|Withdrawal by participant|0|||
156777616|NCT03765073|565936969|FG003|Stage 1|Withdrawal by participant|0|||
157008475|NCT01039688|566781842|FG001|Overall Study|Adverse Event|39|||
157008476|NCT01039688|566781843|FG002|Overall Study|Adverse Event|24|||
156777617|NCT03765073|565936970|FG004|Stage 1|Withdrawal by participant|0|||
156777618|NCT03765073|565936971|FG005|Stage 1|Withdrawal by participant|0|||
156777619|NCT03765073|565936972|FG006|Stage 1|Withdrawal by participant|0|||
156777620|NCT03765073|565936973|FG007|Stage 1|Withdrawal by participant|0|||
156777621|NCT03765073|565936974|FG008|Stage 1|Withdrawal by participant|0|||
156777622|NCT03765073|565936975|FG009|Stage 1|Withdrawal by participant|0|||
156777623|NCT03765073|565936976|FG010|Stage 1|Withdrawal by participant|0|||
157008477|NCT01039688|566781841|FG000|Overall Study|Lack of Efficacy|20|||
156777624|NCT03765073|565936977|FG011|Stage 1|Withdrawal by participant|0|||
156777625|NCT03765073|565936978|FG012|Stage 1|Withdrawal by participant|0|||
156777626|NCT03765073|565936979|FG013|Stage 1|Withdrawal by participant|0|||
156777627|NCT03765073|565936980|FG014|Stage 1|Withdrawal by participant|0|||
156777628|NCT03765073|565936981|FG015|Stage 1|Withdrawal by participant|0|||
156777629|NCT03765073|565936982|FG016|Stage 1|Withdrawal by participant|0|||
156777630|NCT03765073|565936983|FG017|Stage 1|Withdrawal by participant|0|||
156777631|NCT03765073|565936984|FG018|Stage 1|Withdrawal by participant|0|||
156777632|NCT03765073|565936985|FG019|Stage 1|Withdrawal by participant|0|||
156777633|NCT03765073|565936986|FG020|Stage 1|Withdrawal by participant|0|||
156777634|NCT03765073|565936966|FG000|Stage 2|Death|0|||
156777635|NCT03765073|565936967|FG001|Stage 2|Death|0|||
156777636|NCT03765073|565936968|FG002|Stage 2|Death|0|||
156777637|NCT03765073|565936969|FG003|Stage 2|Death|0|||
156777638|NCT03765073|565936970|FG004|Stage 2|Death|0|||
156777639|NCT03765073|565936971|FG005|Stage 2|Death|0|||
156777640|NCT03765073|565936972|FG006|Stage 2|Death|0|||
156777641|NCT03765073|565936973|FG007|Stage 2|Death|0|||
156777642|NCT03765073|565936974|FG008|Stage 2|Death|0|||
156777643|NCT03765073|565936975|FG009|Stage 2|Death|1|||
156777644|NCT03765073|565936976|FG010|Stage 2|Death|0|||
156777645|NCT03765073|565936977|FG011|Stage 2|Death|1|||
156777646|NCT03765073|565936978|FG012|Stage 2|Death|0|||
156777647|NCT03765073|565936979|FG013|Stage 2|Death|0|||
156777648|NCT03765073|565936980|FG014|Stage 2|Death|0|||
156777649|NCT03765073|565936981|FG015|Stage 2|Death|0|||
156777650|NCT03765073|565936982|FG016|Stage 2|Death|2|||
156777651|NCT03765073|565936983|FG017|Stage 2|Death|0|||
156777652|NCT03765073|565936984|FG018|Stage 2|Death|0|||
156777653|NCT03765073|565936985|FG019|Stage 2|Death|0|||
156777654|NCT03765073|565936986|FG020|Stage 2|Death|0|||
156777655|NCT03765073|565936966|FG000|Stage 2|Lost to Follow-up|0|||
156777656|NCT03765073|565936967|FG001|Stage 2|Lost to Follow-up|0|||
156777657|NCT03765073|565936968|FG002|Stage 2|Lost to Follow-up|0|||
156777658|NCT03765073|565936969|FG003|Stage 2|Lost to Follow-up|5|||
156777659|NCT03765073|565936970|FG004|Stage 2|Lost to Follow-up|1|||
156777660|NCT03765073|565936971|FG005|Stage 2|Lost to Follow-up|0|||
156777661|NCT03765073|565936972|FG006|Stage 2|Lost to Follow-up|3|||
156777662|NCT03765073|565936973|FG007|Stage 2|Lost to Follow-up|3|||
156777663|NCT03765073|565936974|FG008|Stage 2|Lost to Follow-up|1|||
156777664|NCT03765073|565936975|FG009|Stage 2|Lost to Follow-up|6|||
156777665|NCT03765073|565936976|FG010|Stage 2|Lost to Follow-up|5|||
156777666|NCT03765073|565936977|FG011|Stage 2|Lost to Follow-up|1|||
156777667|NCT03765073|565936978|FG012|Stage 2|Lost to Follow-up|1|||
156777668|NCT03765073|565936979|FG013|Stage 2|Lost to Follow-up|3|||
156777669|NCT03765073|565936980|FG014|Stage 2|Lost to Follow-up|3|||
156777670|NCT03765073|565936981|FG015|Stage 2|Lost to Follow-up|1|||
156777671|NCT03765073|565936982|FG016|Stage 2|Lost to Follow-up|6|||
156777672|NCT03765073|565936983|FG017|Stage 2|Lost to Follow-up|0|||
156777673|NCT03765073|565936984|FG018|Stage 2|Lost to Follow-up|0|||
156777674|NCT03765073|565936985|FG019|Stage 2|Lost to Follow-up|0|||
156777675|NCT03765073|565936986|FG020|Stage 2|Lost to Follow-up|0|||
156777676|NCT03765073|565936966|FG000|Stage 2|Other|0|||
156777677|NCT03765073|565936967|FG001|Stage 2|Other|0|||
156777678|NCT03765073|565936968|FG002|Stage 2|Other|0|||
156777679|NCT03765073|565936969|FG003|Stage 2|Other|0|||
156777680|NCT03765073|565936970|FG004|Stage 2|Other|0|||
157114900|NCT01709435|567175696|FG005|Overall Study|Adverse Event|1|||
157114901|NCT01709435|567175691|FG000|Overall Study|Lack of Efficacy|5|||
157114902|NCT01709435|567175692|FG001|Overall Study|Lack of Efficacy|7|||
156777681|NCT03765073|565936971|FG005|Stage 2|Other|0|||
156777682|NCT03765073|565936972|FG006|Stage 2|Other|0|||
156777683|NCT03765073|565936973|FG007|Stage 2|Other|1|||
156777684|NCT03765073|565936974|FG008|Stage 2|Other|1|||
156777685|NCT03765073|565936975|FG009|Stage 2|Other|3|||
156777686|NCT03765073|565936976|FG010|Stage 2|Other|0|||
156777687|NCT03765073|565936977|FG011|Stage 2|Other|0|||
156777688|NCT03765073|565936978|FG012|Stage 2|Other|0|||
156777689|NCT03765073|565936979|FG013|Stage 2|Other|0|||
156777690|NCT03765073|565936980|FG014|Stage 2|Other|0|||
156777691|NCT03765073|565936981|FG015|Stage 2|Other|1|||
156777692|NCT03765073|565936982|FG016|Stage 2|Other|2|||
156777693|NCT03765073|565936983|FG017|Stage 2|Other|0|||
156777694|NCT03765073|565936984|FG018|Stage 2|Other|0|||
156777695|NCT03765073|565936985|FG019|Stage 2|Other|0|||
156777696|NCT03765073|565936986|FG020|Stage 2|Other|0|||
156777697|NCT03765073|565936966|FG000|Stage 2|Withdrawal by parent/guardian|0|||
156777698|NCT03765073|565936967|FG001|Stage 2|Withdrawal by parent/guardian|0|||
156777699|NCT03765073|565936968|FG002|Stage 2|Withdrawal by parent/guardian|0|||
156777700|NCT03765073|565936969|FG003|Stage 2|Withdrawal by parent/guardian|0|||
156777701|NCT03765073|565936970|FG004|Stage 2|Withdrawal by parent/guardian|0|||
156777702|NCT03765073|565936971|FG005|Stage 2|Withdrawal by parent/guardian|0|||
156777703|NCT03765073|565936972|FG006|Stage 2|Withdrawal by parent/guardian|0|||
156777704|NCT03765073|565936973|FG007|Stage 2|Withdrawal by parent/guardian|0|||
156777705|NCT03765073|565936974|FG008|Stage 2|Withdrawal by parent/guardian|0|||
156777706|NCT03765073|565936975|FG009|Stage 2|Withdrawal by parent/guardian|0|||
156777707|NCT03765073|565936976|FG010|Stage 2|Withdrawal by parent/guardian|3|||
157114903|NCT01709435|567175693|FG002|Overall Study|Lack of Efficacy|2|||
157114904|NCT01709435|567175694|FG003|Overall Study|Lack of Efficacy|2|||
157114905|NCT01709435|567175695|FG004|Overall Study|Lack of Efficacy|6|||
157114906|NCT01709435|567175696|FG005|Overall Study|Lack of Efficacy|3|||
157114907|NCT01709435|567175691|FG000|Overall Study|Physician Decision|0|||
157114908|NCT01709435|567175692|FG001|Overall Study|Physician Decision|1|||
157114909|NCT01709435|567175693|FG002|Overall Study|Physician Decision|0|||
157114910|NCT01709435|567175694|FG003|Overall Study|Physician Decision|1|||
157114911|NCT01709435|567175695|FG004|Overall Study|Physician Decision|2|||
156777708|NCT03765073|565936977|FG011|Stage 2|Withdrawal by parent/guardian|3|||
156777709|NCT03765073|565936978|FG012|Stage 2|Withdrawal by parent/guardian|3|||
156777710|NCT03765073|565936979|FG013|Stage 2|Withdrawal by parent/guardian|1|||
156777711|NCT03765073|565936980|FG014|Stage 2|Withdrawal by parent/guardian|1|||
156777712|NCT03765073|565936981|FG015|Stage 2|Withdrawal by parent/guardian|0|||
156777713|NCT03765073|565936982|FG016|Stage 2|Withdrawal by parent/guardian|3|||
156777714|NCT03765073|565936983|FG017|Stage 2|Withdrawal by parent/guardian|0|||
156777715|NCT03765073|565936984|FG018|Stage 2|Withdrawal by parent/guardian|0|||
156777716|NCT03765073|565936985|FG019|Stage 2|Withdrawal by parent/guardian|0|||
156777717|NCT03765073|565936986|FG020|Stage 2|Withdrawal by parent/guardian|0|||
156777718|NCT03765073|565936966|FG000|Stage 2|Withdrawal by Subject|0|||
156777719|NCT03765073|565936967|FG001|Stage 2|Withdrawal by Subject|0|||
156777720|NCT03765073|565936968|FG002|Stage 2|Withdrawal by Subject|0|||
156777721|NCT03765073|565936969|FG003|Stage 2|Withdrawal by Subject|3|||
156777722|NCT03765073|565936970|FG004|Stage 2|Withdrawal by Subject|3|||
156777723|NCT03765073|565936971|FG005|Stage 2|Withdrawal by Subject|3|||
156777724|NCT03765073|565936972|FG006|Stage 2|Withdrawal by Subject|0|||
156777725|NCT03765073|565936973|FG007|Stage 2|Withdrawal by Subject|1|||
156777726|NCT03765073|565936974|FG008|Stage 2|Withdrawal by Subject|0|||
156777727|NCT03765073|565936975|FG009|Stage 2|Withdrawal by Subject|5|||
156777728|NCT03765073|565936976|FG010|Stage 2|Withdrawal by Subject|0|||
156777729|NCT03765073|565936977|FG011|Stage 2|Withdrawal by Subject|0|||
156777730|NCT03765073|565936978|FG012|Stage 2|Withdrawal by Subject|0|||
156777731|NCT03765073|565936979|FG013|Stage 2|Withdrawal by Subject|0|||
156777732|NCT03765073|565936980|FG014|Stage 2|Withdrawal by Subject|0|||
156777733|NCT03765073|565936981|FG015|Stage 2|Withdrawal by Subject|0|||
156777734|NCT03765073|565936982|FG016|Stage 2|Withdrawal by Subject|0|||
156777735|NCT03765073|565936983|FG017|Stage 2|Withdrawal by Subject|0|||
156777736|NCT03765073|565936984|FG018|Stage 2|Withdrawal by Subject|0|||
156777737|NCT03765073|565936985|FG019|Stage 2|Withdrawal by Subject|0|||
156777738|NCT03765073|565936986|FG020|Stage 2|Withdrawal by Subject|0|||
156777739|NCT03765073|565936966|FG000|Stage 3|Adverse Event|0|||
156777740|NCT03765073|565936967|FG001|Stage 3|Adverse Event|0|||
156777741|NCT03765073|565936968|FG002|Stage 3|Adverse Event|0|||
156777742|NCT03765073|565936969|FG003|Stage 3|Adverse Event|0|||
156777743|NCT03765073|565936970|FG004|Stage 3|Adverse Event|0|||
156777744|NCT03765073|565936971|FG005|Stage 3|Adverse Event|0|||
156777745|NCT03765073|565936972|FG006|Stage 3|Adverse Event|0|||
156777746|NCT03765073|565936973|FG007|Stage 3|Adverse Event|0|||
156777747|NCT03765073|565936974|FG008|Stage 3|Adverse Event|0|||
156777748|NCT03765073|565936975|FG009|Stage 3|Adverse Event|0|||
156777749|NCT03765073|565936976|FG010|Stage 3|Adverse Event|0|||
156777750|NCT03765073|565936977|FG011|Stage 3|Adverse Event|0|||
156777751|NCT03765073|565936978|FG012|Stage 3|Adverse Event|0|||
156777752|NCT03765073|565936979|FG013|Stage 3|Adverse Event|0|||
156777753|NCT03765073|565936980|FG014|Stage 3|Adverse Event|0|||
156777754|NCT03765073|565936981|FG015|Stage 3|Adverse Event|0|||
156777755|NCT03765073|565936982|FG016|Stage 3|Adverse Event|0|||
156777756|NCT03765073|565936983|FG017|Stage 3|Adverse Event|0|||
156777757|NCT03765073|565936984|FG018|Stage 3|Adverse Event|1|||
156777758|NCT03765073|565936985|FG019|Stage 3|Adverse Event|0|||
156777759|NCT03765073|565936986|FG020|Stage 3|Adverse Event|0|||
156777760|NCT03765073|565936966|FG000|Stage 3|Death|0|||
156777761|NCT03765073|565936967|FG001|Stage 3|Death|0|||
156777762|NCT03765073|565936968|FG002|Stage 3|Death|0|||
156777763|NCT03765073|565936969|FG003|Stage 3|Death|0|||
156777764|NCT03765073|565936970|FG004|Stage 3|Death|0|||
156777765|NCT03765073|565936971|FG005|Stage 3|Death|0|||
156777766|NCT03765073|565936972|FG006|Stage 3|Death|0|||
156777767|NCT03765073|565936973|FG007|Stage 3|Death|0|||
156777768|NCT03765073|565936974|FG008|Stage 3|Death|0|||
156777769|NCT03765073|565936975|FG009|Stage 3|Death|0|||
156777770|NCT03765073|565936976|FG010|Stage 3|Death|0|||
156777771|NCT03765073|565936977|FG011|Stage 3|Death|0|||
156777772|NCT03765073|565936978|FG012|Stage 3|Death|0|||
156777773|NCT03765073|565936979|FG013|Stage 3|Death|0|||
156777774|NCT03765073|565936980|FG014|Stage 3|Death|0|||
156777775|NCT03765073|565936981|FG015|Stage 3|Death|0|||
156777776|NCT03765073|565936982|FG016|Stage 3|Death|0|||
156777777|NCT03765073|565936983|FG017|Stage 3|Death|0|||
156777778|NCT03765073|565936984|FG018|Stage 3|Death|0|||
156777779|NCT03765073|565936985|FG019|Stage 3|Death|3|||
156777780|NCT03765073|565936986|FG020|Stage 3|Death|2|||
156777781|NCT03765073|565936966|FG000|Stage 3|Lost to Follow-up|0|||
156777782|NCT03765073|565936967|FG001|Stage 3|Lost to Follow-up|0|||
157114912|NCT01709435|567175696|FG005|Overall Study|Physician Decision|0|||
157114913|NCT01709435|567175691|FG000|Overall Study|Withdrawal by Subject|0|||
157114914|NCT01709435|567175692|FG001|Overall Study|Withdrawal by Subject|0|||
156777783|NCT03765073|565936968|FG002|Stage 3|Lost to Follow-up|0|||
156777784|NCT03765073|565936969|FG003|Stage 3|Lost to Follow-up|0|||
156777785|NCT03765073|565936970|FG004|Stage 3|Lost to Follow-up|0|||
156777786|NCT03765073|565936971|FG005|Stage 3|Lost to Follow-up|0|||
156777787|NCT03765073|565936972|FG006|Stage 3|Lost to Follow-up|0|||
156777788|NCT03765073|565936973|FG007|Stage 3|Lost to Follow-up|0|||
156777789|NCT03765073|565936974|FG008|Stage 3|Lost to Follow-up|0|||
156777790|NCT03765073|565936975|FG009|Stage 3|Lost to Follow-up|0|||
156777791|NCT03765073|565936976|FG010|Stage 3|Lost to Follow-up|0|||
156777792|NCT03765073|565936977|FG011|Stage 3|Lost to Follow-up|0|||
156777793|NCT03765073|565936978|FG012|Stage 3|Lost to Follow-up|0|||
156777794|NCT03765073|565936979|FG013|Stage 3|Lost to Follow-up|0|||
156777795|NCT03765073|565936980|FG014|Stage 3|Lost to Follow-up|0|||
156777796|NCT03765073|565936981|FG015|Stage 3|Lost to Follow-up|0|||
156777797|NCT03765073|565936982|FG016|Stage 3|Lost to Follow-up|0|||
156777798|NCT03765073|565936983|FG017|Stage 3|Lost to Follow-up|8|||
156777799|NCT03765073|565936984|FG018|Stage 3|Lost to Follow-up|5|||
156777800|NCT03765073|565936985|FG019|Stage 3|Lost to Follow-up|7|||
156777801|NCT03765073|565936986|FG020|Stage 3|Lost to Follow-up|4|||
156777802|NCT03765073|565936966|FG000|Stage 3|No longer meets eligibility criteria|0|||
156777803|NCT03765073|565936967|FG001|Stage 3|No longer meets eligibility criteria|0|||
156777804|NCT03765073|565936968|FG002|Stage 3|No longer meets eligibility criteria|0|||
156777805|NCT03765073|565936969|FG003|Stage 3|No longer meets eligibility criteria|0|||
156777806|NCT03765073|565936970|FG004|Stage 3|No longer meets eligibility criteria|0|||
156777807|NCT03765073|565936971|FG005|Stage 3|No longer meets eligibility criteria|0|||
156777808|NCT03765073|565936972|FG006|Stage 3|No longer meets eligibility criteria|0|||
156777809|NCT03765073|565936973|FG007|Stage 3|No longer meets eligibility criteria|0|||
156777810|NCT03765073|565936974|FG008|Stage 3|No longer meets eligibility criteria|0|||
156777811|NCT03765073|565936975|FG009|Stage 3|No longer meets eligibility criteria|0|||
156777812|NCT03765073|565936976|FG010|Stage 3|No longer meets eligibility criteria|0|||
157208673|NCT00569231|567509407|FG000|Overall Study|Car accident injury|1|||
157208674|NCT00569231|567509407|FG000|Overall Study|Non-compliance|2|||
157208675|NCT03456726|567509408|FG000|Overall Study|Disease Progression|6|||
157208676|NCT03456726|567509409|FG001|Overall Study|Disease Progression|1|||
157208677|NCT03456726|567509408|FG000|Overall Study|Adverse Event|4|||
157208678|NCT03456726|567509409|FG001|Overall Study|Adverse Event|2|||
157208679|NCT03456726|567509408|FG000|Overall Study|Withdrawal by Subject|1|||
157208680|NCT03456726|567509409|FG001|Overall Study|Withdrawal by Subject|0|||
157208681|NCT03456726|567509408|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
157208682|NCT03456726|567509409|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
157208683|NCT01614925|567509410|FG000|Overall Study|Withdrawal by Subject|1|||
157208684|NCT01614925|567509411|FG001|Overall Study|Withdrawal by Subject|0|||
157208685|NCT01614925|567509410|FG000|Overall Study|Protocol Violation|3|||
157208686|NCT01614925|567509411|FG001|Overall Study|Protocol Violation|2|||
156777813|NCT03765073|565936977|FG011|Stage 3|No longer meets eligibility criteria|0|||
156777814|NCT03765073|565936978|FG012|Stage 3|No longer meets eligibility criteria|0|||
156777815|NCT03765073|565936979|FG013|Stage 3|No longer meets eligibility criteria|0|||
156777816|NCT03765073|565936980|FG014|Stage 3|No longer meets eligibility criteria|0|||
157008478|NCT01039688|566781842|FG001|Overall Study|Lack of Efficacy|11|||
156777817|NCT03765073|565936981|FG015|Stage 3|No longer meets eligibility criteria|0|||
156777818|NCT03765073|565936982|FG016|Stage 3|No longer meets eligibility criteria|0|||
156777819|NCT03765073|565936983|FG017|Stage 3|No longer meets eligibility criteria|0|||
156777820|NCT03765073|565936984|FG018|Stage 3|No longer meets eligibility criteria|1|||
156777821|NCT03765073|565936985|FG019|Stage 3|No longer meets eligibility criteria|0|||
156777822|NCT03765073|565936986|FG020|Stage 3|No longer meets eligibility criteria|1|||
156777823|NCT03765073|565936966|FG000|Stage 3|Other|0|||
156777824|NCT03765073|565936967|FG001|Stage 3|Other|0|||
156777825|NCT03765073|565936968|FG002|Stage 3|Other|0|||
156777826|NCT03765073|565936969|FG003|Stage 3|Other|0|||
156777827|NCT03765073|565936970|FG004|Stage 3|Other|0|||
156777828|NCT03765073|565936971|FG005|Stage 3|Other|0|||
156777829|NCT03765073|565936972|FG006|Stage 3|Other|0|||
156777830|NCT03765073|565936973|FG007|Stage 3|Other|0|||
156777831|NCT03765073|565936974|FG008|Stage 3|Other|0|||
156777832|NCT03765073|565936975|FG009|Stage 3|Other|0|||
156777833|NCT03765073|565936976|FG010|Stage 3|Other|0|||
156777834|NCT03765073|565936977|FG011|Stage 3|Other|0|||
156777835|NCT03765073|565936978|FG012|Stage 3|Other|0|||
156777836|NCT03765073|565936979|FG013|Stage 3|Other|0|||
156777837|NCT03765073|565936980|FG014|Stage 3|Other|0|||
156777838|NCT03765073|565936981|FG015|Stage 3|Other|0|||
156777839|NCT03765073|565936982|FG016|Stage 3|Other|0|||
156777840|NCT03765073|565936983|FG017|Stage 3|Other|1|||
156777841|NCT03765073|565936984|FG018|Stage 3|Other|2|||
156777842|NCT03765073|565936985|FG019|Stage 3|Other|2|||
156777843|NCT03765073|565936986|FG020|Stage 3|Other|2|||
156777844|NCT03765073|565936966|FG000|Stage 3|Withdrawal by parent/guardian|0|||
156777845|NCT03765073|565936967|FG001|Stage 3|Withdrawal by parent/guardian|0|||
157208687|NCT04470622|567509412|FG000|Overall Study|Withdrawal by Subject|0|||
157208688|NCT04470622|567509413|FG001|Overall Study|Withdrawal by Subject|1|||
156777846|NCT03765073|565936968|FG002|Stage 3|Withdrawal by parent/guardian|0|||
156777847|NCT03765073|565936969|FG003|Stage 3|Withdrawal by parent/guardian|0|||
156777848|NCT03765073|565936970|FG004|Stage 3|Withdrawal by parent/guardian|0|||
156777849|NCT03765073|565936971|FG005|Stage 3|Withdrawal by parent/guardian|0|||
157208689|NCT04470622|567509412|FG000|Overall Study|Screen Failure|0|||
156777850|NCT03765073|565936972|FG006|Stage 3|Withdrawal by parent/guardian|0|||
156777851|NCT03765073|565936973|FG007|Stage 3|Withdrawal by parent/guardian|0|||
156777852|NCT03765073|565936974|FG008|Stage 3|Withdrawal by parent/guardian|0|||
156777853|NCT03765073|565936975|FG009|Stage 3|Withdrawal by parent/guardian|0|||
156777854|NCT03765073|565936976|FG010|Stage 3|Withdrawal by parent/guardian|0|||
156777855|NCT03765073|565936977|FG011|Stage 3|Withdrawal by parent/guardian|0|||
156777856|NCT03765073|565936978|FG012|Stage 3|Withdrawal by parent/guardian|0|||
156777857|NCT03765073|565936979|FG013|Stage 3|Withdrawal by parent/guardian|0|||
156777858|NCT03765073|565936980|FG014|Stage 3|Withdrawal by parent/guardian|0|||
156777859|NCT03765073|565936981|FG015|Stage 3|Withdrawal by parent/guardian|0|||
156777860|NCT03765073|565936982|FG016|Stage 3|Withdrawal by parent/guardian|0|||
156777861|NCT03765073|565936983|FG017|Stage 3|Withdrawal by parent/guardian|0|||
156777862|NCT03765073|565936984|FG018|Stage 3|Withdrawal by parent/guardian|0|||
156777863|NCT03765073|565936985|FG019|Stage 3|Withdrawal by parent/guardian|6|||
156777864|NCT03765073|565936986|FG020|Stage 3|Withdrawal by parent/guardian|9|||
156777865|NCT03765073|565936966|FG000|Stage 3|Withdrawal by Subject|0|||
156777866|NCT03765073|565936967|FG001|Stage 3|Withdrawal by Subject|0|||
156777867|NCT03765073|565936968|FG002|Stage 3|Withdrawal by Subject|0|||
156777868|NCT03765073|565936969|FG003|Stage 3|Withdrawal by Subject|0|||
156777869|NCT03765073|565936970|FG004|Stage 3|Withdrawal by Subject|0|||
156777870|NCT03765073|565936971|FG005|Stage 3|Withdrawal by Subject|0|||
156777871|NCT03765073|565936972|FG006|Stage 3|Withdrawal by Subject|0|||
156777872|NCT03765073|565936973|FG007|Stage 3|Withdrawal by Subject|0|||
156777873|NCT03765073|565936974|FG008|Stage 3|Withdrawal by Subject|0|||
156777874|NCT03765073|565936975|FG009|Stage 3|Withdrawal by Subject|0|||
156777875|NCT03765073|565936976|FG010|Stage 3|Withdrawal by Subject|0|||
156777876|NCT03765073|565936977|FG011|Stage 3|Withdrawal by Subject|0|||
156777877|NCT03765073|565936978|FG012|Stage 3|Withdrawal by Subject|0|||
157208690|NCT04470622|567509413|FG001|Overall Study|Screen Failure|1|||
157208691|NCT04470622|567509412|FG000|Overall Study|Death|0|||
157208692|NCT04470622|567509413|FG001|Overall Study|Death|1|||
157208693|NCT00399490|567509416|FG000|Overall Study|Adverse Event|19|||
157208694|NCT00399490|567509416|FG000|Overall Study|Lack of Efficacy|31|||
157208695|NCT00399490|567509416|FG000|Overall Study|Lost to Follow-up|5|||
157208696|NCT00399490|567509416|FG000|Overall Study|Withdrawal by Subject|18|||
157208697|NCT00399490|567509416|FG000|Overall Study|Other|25|||
157208698|NCT00791154|567509421|FG000|Overall Study|Noncompliance|0|||
157208699|NCT00791154|567509422|FG001|Overall Study|Noncompliance|1|||
157208700|NCT00791154|567509423|FG002|Overall Study|Noncompliance|0|||
157208701|NCT00791154|567509424|FG003|Overall Study|Noncompliance|0|||
157208702|NCT00791154|567509425|FG004|Overall Study|Noncompliance|1|||
157208703|NCT00791154|567509426|FG005|Overall Study|Noncompliance|1|||
157208704|NCT00791154|567509427|FG006|Overall Study|Noncompliance|1|||
157208705|NCT00791154|567509421|FG000|Overall Study|Adverse Event|0|||
157208706|NCT00791154|567509422|FG001|Overall Study|Adverse Event|0|||
157208707|NCT00791154|567509423|FG002|Overall Study|Adverse Event|0|||
157208708|NCT00791154|567509424|FG003|Overall Study|Adverse Event|0|||
157208709|NCT00791154|567509425|FG004|Overall Study|Adverse Event|2|||
157208710|NCT00791154|567509426|FG005|Overall Study|Adverse Event|0|||
157208711|NCT00791154|567509427|FG006|Overall Study|Adverse Event|1|||
157208712|NCT00791154|567509421|FG000|Overall Study|Full Consent withdrawn|1|||
157208713|NCT00791154|567509422|FG001|Overall Study|Full Consent withdrawn|3|||
157208714|NCT00791154|567509423|FG002|Overall Study|Full Consent withdrawn|0|||
157208715|NCT00791154|567509424|FG003|Overall Study|Full Consent withdrawn|0|||
157208716|NCT00791154|567509425|FG004|Overall Study|Full Consent withdrawn|1|||
157208717|NCT00791154|567509426|FG005|Overall Study|Full Consent withdrawn|3|||
157208718|NCT00791154|567509427|FG006|Overall Study|Full Consent withdrawn|1|||
157208719|NCT00791154|567509421|FG000|Overall Study|Lost to Follow-up|0|||
157208720|NCT00791154|567509422|FG001|Overall Study|Lost to Follow-up|0|||
157208721|NCT00791154|567509423|FG002|Overall Study|Lost to Follow-up|0|||
157208722|NCT00791154|567509424|FG003|Overall Study|Lost to Follow-up|1|||
157208723|NCT00791154|567509425|FG004|Overall Study|Lost to Follow-up|2|||
157208724|NCT00791154|567509426|FG005|Overall Study|Lost to Follow-up|0|||
157208725|NCT00791154|567509427|FG006|Overall Study|Lost to Follow-up|4|||
157208726|NCT00791154|567509421|FG000|Overall Study|Death|5|||
157208727|NCT00791154|567509422|FG001|Overall Study|Death|4|||
157208728|NCT00791154|567509423|FG002|Overall Study|Death|4|||
157208729|NCT00791154|567509424|FG003|Overall Study|Death|7|||
157208730|NCT00791154|567509425|FG004|Overall Study|Death|54|||
157208731|NCT00791154|567509426|FG005|Overall Study|Death|54|||
157208732|NCT00791154|567509427|FG006|Overall Study|Death|52|||
157208733|NCT00791154|567509421|FG000|Overall Study|Other event|0|||
157208734|NCT00791154|567509422|FG001|Overall Study|Other event|0|||
157208735|NCT00791154|567509423|FG002|Overall Study|Other event|2|||
157208736|NCT00791154|567509424|FG003|Overall Study|Other event|0|||
157208737|NCT00791154|567509425|FG004|Overall Study|Other event|2|||
157208738|NCT00791154|567509426|FG005|Overall Study|Other event|4|||
157208739|NCT00791154|567509427|FG006|Overall Study|Other event|2|||
156777878|NCT03765073|565936979|FG013|Stage 3|Withdrawal by Subject|0|||
156777879|NCT03765073|565936980|FG014|Stage 3|Withdrawal by Subject|0|||
157208740|NCT00953927|567509428|FG000|Overall Study|Lost to Follow-up|61|||
157208741|NCT00953927|567509429|FG001|Overall Study|Lost to Follow-up|65|||
157208742|NCT00953927|567509428|FG000|Overall Study|Withdrawal by Subject|36|||
157208743|NCT00953927|567509429|FG001|Overall Study|Withdrawal by Subject|25|||
157208744|NCT00953927|567509428|FG000|Overall Study|Death|7|||
157208745|NCT00953927|567509429|FG001|Overall Study|Death|4|||
157208746|NCT00953927|567509428|FG000|Overall Study|Other study discontinuation|1|||
156777880|NCT03765073|565936981|FG015|Stage 3|Withdrawal by Subject|0|||
156777881|NCT03765073|565936982|FG016|Stage 3|Withdrawal by Subject|0|||
156777882|NCT03765073|565936983|FG017|Stage 3|Withdrawal by Subject|8|||
156777883|NCT03765073|565936984|FG018|Stage 3|Withdrawal by Subject|11|||
157208747|NCT00953927|567509429|FG001|Overall Study|Other study discontinuation|1|||
156777884|NCT03765073|565936985|FG019|Stage 3|Withdrawal by Subject|0|||
156777885|NCT03765073|565936986|FG020|Stage 3|Withdrawal by Subject|0|||
156777886|NCT02550795|565936987|FG000|Overall Study|Physician Decision|0|||
156777887|NCT02550795|565936988|FG001|Overall Study|Physician Decision|1|||
156777888|NCT02550795|565936989|FG002|Overall Study|Physician Decision|0|||
156777889|NCT02225587|565936990|FG000|Overall Study|Adverse Event|5|||
156777890|NCT02225587|565936991|FG001|Overall Study|Adverse Event|5|||
156777891|NCT02225587|565936990|FG000|Overall Study|Lost to Follow-up|5|||
156777892|NCT02225587|565936991|FG001|Overall Study|Lost to Follow-up|5|||
157208748|NCT01396161|567509431|FG000|Overall Study|Withdrawal by Subject|0|||
157208749|NCT01396161|567509432|FG001|Overall Study|Withdrawal by Subject|0|||
157208750|NCT01396161|567509433|FG002|Overall Study|Withdrawal by Subject|0|||
157208751|NCT01396161|567509434|FG003|Overall Study|Withdrawal by Subject|0|||
157208752|NCT01396161|567509435|FG004|Overall Study|Withdrawal by Subject|1|||
156777893|NCT02225587|565936990|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156777894|NCT02225587|565936991|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157208753|NCT01396161|567509436|FG005|Overall Study|Withdrawal by Subject|0|||
156777895|NCT02225587|565936990|FG000|Overall Study|Physician Decision|2|||
156777896|NCT02225587|565936991|FG001|Overall Study|Physician Decision|0|||
156777897|NCT02225587|565936990|FG000|Overall Study|Protocol Violation|1|||
156777898|NCT02225587|565936991|FG001|Overall Study|Protocol Violation|0|||
156777899|NCT02225587|565936990|FG000|Overall Study|Participant Moved|1|||
156777900|NCT02225587|565936991|FG001|Overall Study|Participant Moved|0|||
156777901|NCT02225587|565936990|FG000|Overall Study|Withdrawal by Subject|13|||
156777902|NCT02225587|565936991|FG001|Overall Study|Withdrawal by Subject|28|||
156777903|NCT04063163|565936992|FG000|Overall Study|Death|281|||
157208754|NCT01396161|567509437|FG006|Overall Study|Withdrawal by Subject|0|||
157208755|NCT01396161|567509431|FG000|Overall Study|Other|0|||
157208756|NCT01396161|567509432|FG001|Overall Study|Other|0|||
157208757|NCT01396161|567509433|FG002|Overall Study|Other|0|||
156777904|NCT04063163|565936993|FG001|Overall Study|Death|166|||
157208758|NCT01396161|567509434|FG003|Overall Study|Other|0|||
157208759|NCT01396161|567509435|FG004|Overall Study|Other|0|||
157208760|NCT01396161|567509436|FG005|Overall Study|Other|0|||
157208761|NCT01396161|567509437|FG006|Overall Study|Other|1|||
157208762|NCT00450177|567509438|FG000|Overall Study|Adverse Event|7|||
157208763|NCT00450177|567509439|FG001|Overall Study|Adverse Event|4|||
157208764|NCT00450177|567509438|FG000|Overall Study|Withdrawal by Subject|1|||
157208765|NCT00450177|567509439|FG001|Overall Study|Withdrawal by Subject|6|||
157208766|NCT00450177|567509438|FG000|Overall Study|Withdrawal by Primary Team|1|||
156777905|NCT04063163|565936992|FG000|Overall Study|Lost to Follow-up|12|||
156777906|NCT04063163|565936993|FG001|Overall Study|Lost to Follow-up|8|||
156777907|NCT04063163|565936992|FG000|Overall Study|Withdrawal by Subject|19|||
156777908|NCT04063163|565936993|FG001|Overall Study|Withdrawal by Subject|10|||
156777909|NCT02572167|565936996|FG000|Overall Study|Withdrawal by Subject|0|||
156777910|NCT02572167|565936997|FG001|Overall Study|Withdrawal by Subject|3|||
156777911|NCT02572167|565936998|FG002|Overall Study|Withdrawal by Subject|0|||
156777912|NCT02572167|565936996|FG000|Overall Study|Lost to Follow-up|2|||
156777913|NCT02572167|565936997|FG001|Overall Study|Lost to Follow-up|5|||
156777914|NCT02572167|565936998|FG002|Overall Study|Lost to Follow-up|3|||
156777915|NCT02572167|565936996|FG000|Overall Study|Death|0|||
156777916|NCT02572167|565936997|FG001|Overall Study|Death|8|||
156777917|NCT02572167|565936998|FG002|Overall Study|Death|3|||
156777918|NCT02572167|565936996|FG000|Overall Study|Did not meet inclusion criteria|0|||
157208767|NCT00450177|567509439|FG001|Overall Study|Withdrawal by Primary Team|1|||
157208768|NCT03869684|567509442|FG000|Overall Study|Adverse Event|0|||
157208769|NCT03869684|567509443|FG001|Overall Study|Adverse Event|3|||
157208770|NCT03869684|567509444|FG002|Overall Study|Adverse Event|1|||
157208771|NCT03869684|567509442|FG000|Overall Study|Withdrawal by Subject|1|||
157208772|NCT03869684|567509443|FG001|Overall Study|Withdrawal by Subject|0|||
157208773|NCT03869684|567509444|FG002|Overall Study|Withdrawal by Subject|0|||
157208774|NCT03869684|567509442|FG000|Overall Study|Lost to Follow-up|1|||
157208775|NCT03869684|567509443|FG001|Overall Study|Lost to Follow-up|0|||
157208776|NCT03869684|567509444|FG002|Overall Study|Lost to Follow-up|0|||
157208777|NCT03869684|567509442|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
157208778|NCT03869684|567509443|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
157208779|NCT03869684|567509444|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
157208780|NCT04056299|567509445|FG000|Overall Study|Sponsor discontinued study|3|||
157208781|NCT04056299|567509446|FG001|Overall Study|Sponsor discontinued study|3|||
156777919|NCT02572167|565936997|FG001|Overall Study|Did not meet inclusion criteria|0|||
156777920|NCT02572167|565936998|FG002|Overall Study|Did not meet inclusion criteria|1|||
156777921|NCT02572167|565936996|FG000|Overall Study|Study closure by Sponsor|4|||
156777922|NCT02572167|565936997|FG001|Overall Study|Study closure by Sponsor|40|||
156777923|NCT02572167|565936998|FG002|Overall Study|Study closure by Sponsor|24|||
156777924|NCT00580840|565936999|FG000|Run-in|Adverse Event|17|||
156777925|NCT00580840|565937000|FG001|Run-in|Adverse Event|0|||
157208782|NCT01227954|567509451|FG000|Overall Study|Protocol Violation|6|||
156777926|NCT00580840|565937001|FG002|Run-in|Adverse Event|0|||
156777927|NCT00580840|565937002|FG003|Run-in|Adverse Event|0|||
156777928|NCT00580840|565936999|FG000|Run-in|Lack of Efficacy|93|||
156777929|NCT00580840|565937000|FG001|Run-in|Lack of Efficacy|0|||
156777930|NCT00580840|565937001|FG002|Run-in|Lack of Efficacy|0|||
156777931|NCT00580840|565937002|FG003|Run-in|Lack of Efficacy|0|||
156777932|NCT00580840|565936999|FG000|Run-in|Loss of Efficacy|1|||
156777933|NCT00580840|565937000|FG001|Run-in|Loss of Efficacy|0|||
156777934|NCT00580840|565937001|FG002|Run-in|Loss of Efficacy|0|||
156777935|NCT00580840|565937002|FG003|Run-in|Loss of Efficacy|0|||
156777936|NCT00580840|565936999|FG000|Run-in|Lost to Follow-up|4|||
156777937|NCT00580840|565937000|FG001|Run-in|Lost to Follow-up|0|||
156777938|NCT00580840|565937001|FG002|Run-in|Lost to Follow-up|0|||
156777939|NCT00580840|565937002|FG003|Run-in|Lost to Follow-up|0|||
156777940|NCT00580840|565936999|FG000|Run-in|Withdrawal by Subject|5|||
156777941|NCT00580840|565937000|FG001|Run-in|Withdrawal by Subject|0|||
156777942|NCT00580840|565937001|FG002|Run-in|Withdrawal by Subject|0|||
156777943|NCT00580840|565937002|FG003|Run-in|Withdrawal by Subject|0|||
156777944|NCT00580840|565936999|FG000|Run-in|Other: Per Sponsor Request|2|||
156777945|NCT00580840|565937000|FG001|Run-in|Other: Per Sponsor Request|0|||
156777946|NCT00580840|565937001|FG002|Run-in|Other: Per Sponsor Request|0|||
156777947|NCT00580840|565937002|FG003|Run-in|Other: Per Sponsor Request|0|||
156777948|NCT00580840|565936999|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
156777949|NCT00580840|565937000|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777950|NCT00580840|565937001|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777951|NCT00580840|565937002|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
156777952|NCT00580840|565936999|FG000|Run-in|Other: Exclusionary Lab Value|1|||
156777953|NCT00580840|565937000|FG001|Run-in|Other: Exclusionary Lab Value|0|||
156777954|NCT00580840|565937001|FG002|Run-in|Other: Exclusionary Lab Value|0|||
156777955|NCT00580840|565937002|FG003|Run-in|Other: Exclusionary Lab Value|0|||
156777956|NCT00580840|565936999|FG000|Double-Blind|Adverse Event|0|||
156777957|NCT00580840|565937000|FG001|Double-Blind|Adverse Event|3|||
156777958|NCT00580840|565937001|FG002|Double-Blind|Adverse Event|4|||
156777959|NCT00580840|565937002|FG003|Double-Blind|Adverse Event|1|||
156777960|NCT00580840|565936999|FG000|Double-Blind|Loss of Efficacy|0|||
156777961|NCT00580840|565937000|FG001|Double-Blind|Loss of Efficacy|1|||
156777962|NCT00580840|565937001|FG002|Double-Blind|Loss of Efficacy|2|||
156777963|NCT00580840|565937002|FG003|Double-Blind|Loss of Efficacy|10|||
156777964|NCT00580840|565936999|FG000|Double-Blind|Lost to Follow-up|0|||
156777965|NCT00580840|565937000|FG001|Double-Blind|Lost to Follow-up|1|||
156777966|NCT00580840|565937001|FG002|Double-Blind|Lost to Follow-up|0|||
156777967|NCT00580840|565937002|FG003|Double-Blind|Lost to Follow-up|2|||
156777968|NCT00580840|565936999|FG000|Double-Blind|Withdrawal by Subject|0|||
156777969|NCT00580840|565937000|FG001|Double-Blind|Withdrawal by Subject|1|||
156777970|NCT00580840|565937001|FG002|Double-Blind|Withdrawal by Subject|2|||
156777971|NCT00580840|565937002|FG003|Double-Blind|Withdrawal by Subject|2|||
156777972|NCT00580840|565936999|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
156777973|NCT00580840|565937000|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
156777974|NCT00580840|565937001|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
156777975|NCT00580840|565937002|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
156777976|NCT00580840|565936999|FG000|Double-Blind|Other: Forbidden Medication|0|||
156777977|NCT00580840|565937000|FG001|Double-Blind|Other: Forbidden Medication|0|||
156777978|NCT00580840|565937001|FG002|Double-Blind|Other: Forbidden Medication|1|||
156777979|NCT00580840|565937002|FG003|Double-Blind|Other: Forbidden Medication|0|||
156777980|NCT02296125|565937004|FG000|Overall Study|Withdrawal by Subject|18|||
156777981|NCT02296125|565937005|FG001|Overall Study|Withdrawal by Subject|8|||
156777982|NCT02296125|565937006|FG002|Overall Study|Withdrawal by Subject|6|||
156777983|NCT02296125|565937007|FG003|Overall Study|Withdrawal by Subject|2|||
156777984|NCT02296125|565937004|FG000|Overall Study|Adverse Event|41|||
156777985|NCT02296125|565937005|FG001|Overall Study|Adverse Event|52|||
156777986|NCT02296125|565937006|FG002|Overall Study|Adverse Event|9|||
156777987|NCT02296125|565937007|FG003|Overall Study|Adverse Event|4|||
156777988|NCT02296125|565937004|FG000|Overall Study|Severe non-compliance to protocol|0|||
156777989|NCT02296125|565937005|FG001|Overall Study|Severe non-compliance to protocol|1|||
156777990|NCT02296125|565937006|FG002|Overall Study|Severe non-compliance to protocol|0|||
156777991|NCT02296125|565937007|FG003|Overall Study|Severe non-compliance to protocol|0|||
156777992|NCT02296125|565937004|FG000|Overall Study|Condition under investigation worsened|153|||
156777993|NCT02296125|565937005|FG001|Overall Study|Condition under investigation worsened|199|||
156777994|NCT02296125|565937006|FG002|Overall Study|Condition under investigation worsened|39|||
156777995|NCT02296125|565937007|FG003|Overall Study|Condition under investigation worsened|56|||
156777996|NCT02296125|565937004|FG000|Overall Study|Any reason not specifically recorded|6|||
156777997|NCT02296125|565937005|FG001|Overall Study|Any reason not specifically recorded|4|||
156777998|NCT02296125|565937006|FG002|Overall Study|Any reason not specifically recorded|2|||
156777999|NCT02296125|565937007|FG003|Overall Study|Any reason not specifically recorded|0|||
156778000|NCT00984399|565937008|FG000|Overall Study|Adverse Event|0|||
156778001|NCT00984399|565937009|FG001|Overall Study|Adverse Event|1|||
156778002|NCT00984399|565937008|FG000|Overall Study|Physician Decision|1|||
157208783|NCT01227954|567509451|FG000|Overall Study|No protocol treatment|7|||
157208784|NCT00078312|567509452|FG000|Overall Study|Adverse Event|43|||
157208785|NCT00078312|567509452|FG000|Overall Study|Lack of Efficacy|15|||
157208786|NCT00078312|567509452|FG000|Overall Study|Lost to Follow-up|41|||
157208787|NCT00078312|567509452|FG000|Overall Study|Physician Decision|9|||
157208788|NCT00078312|567509452|FG000|Overall Study|Protocol Violation|3|||
157208789|NCT00078312|567509452|FG000|Overall Study|Withdrawal by Subject|33|||
157208790|NCT00078312|567509452|FG000|Overall Study|Miscellaneous|33|||
157208791|NCT01296152|567509455|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
157208792|NCT03901352|567509456|FG000|Double-blind Phase|Adverse Event|6|||
157208793|NCT03901352|567509457|FG001|Double-blind Phase|Adverse Event|4|||
157208794|NCT03901352|567509456|FG000|Double-blind Phase|Death|1|||
157208795|NCT03901352|567509457|FG001|Double-blind Phase|Death|0|||
157008479|NCT01039688|566781843|FG002|Overall Study|Lack of Efficacy|26|||
157008480|NCT01039688|566781841|FG000|Overall Study|Lost to Follow-up|11|||
157008481|NCT01039688|566781842|FG001|Overall Study|Lost to Follow-up|9|||
157008482|NCT01039688|566781843|FG002|Overall Study|Lost to Follow-up|5|||
157008483|NCT01039688|566781841|FG000|Overall Study|Other|13|||
157008484|NCT01039688|566781842|FG001|Overall Study|Other|25|||
157008485|NCT01039688|566781843|FG002|Overall Study|Other|12|||
157008486|NCT01039688|566781841|FG000|Overall Study|Withdrawal by Subject|23|||
157008487|NCT01039688|566781842|FG001|Overall Study|Withdrawal by Subject|27|||
157008488|NCT01039688|566781843|FG002|Overall Study|Withdrawal by Subject|13|||
157008489|NCT01039688|566781841|FG000|Overall Study|Death|2|||
157008490|NCT01039688|566781842|FG001|Overall Study|Death|0|||
157008491|NCT01039688|566781843|FG002|Overall Study|Death|0|||
157208796|NCT03901352|567509456|FG000|Double-blind Phase|Lack of Efficacy|0|||
157208797|NCT03901352|567509457|FG001|Double-blind Phase|Lack of Efficacy|1|||
157208798|NCT03901352|567509456|FG000|Double-blind Phase|Protocol Violation|0|||
157208799|NCT03901352|567509457|FG001|Double-blind Phase|Protocol Violation|1|||
157208800|NCT03901352|567509456|FG000|Double-blind Phase|Withdrawal by Subject|10|||
156778003|NCT00984399|565937009|FG001|Overall Study|Physician Decision|0|||
157208801|NCT03901352|567509457|FG001|Double-blind Phase|Withdrawal by Subject|8|||
156778004|NCT00984399|565937008|FG000|Overall Study|Withdrawal by Subject|1|||
156778005|NCT00984399|565937009|FG001|Overall Study|Withdrawal by Subject|1|||
157208802|NCT03901352|567509456|FG000|Open-label Extension Phase|Adverse Event|24|||
156778006|NCT00984399|565937008|FG000|Overall Study|Protocol Violation|0|||
156778007|NCT00984399|565937009|FG001|Overall Study|Protocol Violation|1|||
156778008|NCT00984399|565937008|FG000|Overall Study|Pts did not start treatment|2|||
156778009|NCT00984399|565937009|FG001|Overall Study|Pts did not start treatment|2|||
156778010|NCT03636477|565937012|FG000|Overall Study|Adverse Event|0|||
156778011|NCT03636477|565937013|FG001|Overall Study|Adverse Event|0|||
156778012|NCT03636477|565937014|FG002|Overall Study|Adverse Event|1|||
156778013|NCT02382380|565937016|FG000|Overall Study|Withdrawal by Subject|2|||
156778014|NCT02382380|565937017|FG001|Overall Study|Withdrawal by Subject|2|||
156778015|NCT02382380|565937016|FG000|Overall Study|Lost to Follow-up|0|||
156778016|NCT02382380|565937017|FG001|Overall Study|Lost to Follow-up|1|||
156778017|NCT01295944|565937018|FG000|Overall Study|Switched to alternative treatment|1|||
156778018|NCT01295944|565937018|FG000|Overall Study|Ineligible|9|||
156778019|NCT01295944|565937018|FG000|Overall Study|Withdrawal by Subject|1|||
156778020|NCT01295944|565937018|FG000|Overall Study|Participant chose to be treated in Peru|1|||
156778021|NCT01295944|565937018|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
157208803|NCT03901352|567509457|FG001|Open-label Extension Phase|Adverse Event|0|||
157208804|NCT03901352|567509456|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
157208805|NCT03901352|567509457|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156778022|NCT01295944|565937018|FG000|Overall Study|Physician Decision|1|||
156778023|NCT01295944|565937018|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
156778024|NCT01295944|565937018|FG000|Overall Study|Disease progression|4|||
156778025|NCT01295944|565937018|FG000|Overall Study|Transferred care before starting new treatment|1|||
156778026|NCT03785366|565937019|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
156778027|NCT03785366|565937020|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
156778028|NCT03785366|565937019|FG000|Overall Study|Lost to Follow-up|1|||
156778029|NCT03785366|565937020|FG001|Overall Study|Lost to Follow-up|0|||
156778030|NCT03785366|565937019|FG000|Overall Study|Partial IUD Expulsion|0|||
156778031|NCT03785366|565937020|FG001|Overall Study|Partial IUD Expulsion|2|||
156778032|NCT03785366|565937019|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
156778033|NCT03785366|565937020|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
156778034|NCT03036254|565937027|FG000|Overall Study|Adverse Event|6|||
156778035|NCT03036254|565937028|FG001|Overall Study|Adverse Event|4|||
156778036|NCT03036254|565937027|FG000|Overall Study|Death|3|||
156778037|NCT03036254|565937028|FG001|Overall Study|Death|1|||
156778038|NCT03036254|565937027|FG000|Overall Study|Lack of Efficacy|5|||
156778039|NCT03036254|565937028|FG001|Overall Study|Lack of Efficacy|1|||
156778040|NCT03036254|565937027|FG000|Overall Study|Withdrawal by Subject|3|||
156778041|NCT03036254|565937028|FG001|Overall Study|Withdrawal by Subject|5|||
156778042|NCT02783274|565937029|FG000|Overall Study|Withdrawal by Subject|16|||
156778043|NCT02783274|565937029|FG000|Overall Study|Physician Decision|6|||
156778044|NCT02783274|565937029|FG000|Overall Study|Death|9|||
156778045|NCT02783274|565937029|FG000|Overall Study|Lost to Follow-up|22|||
156778046|NCT02783274|565937029|FG000|Overall Study|Other|22|||
156778047|NCT05722015|565937033|FG000|Overall Study|Death|57|||
156778048|NCT05722015|565937034|FG001|Overall Study|Death|37|||
156778049|NCT05722015|565937033|FG000|Overall Study|Lost to Follow-up|1|||
156778050|NCT05722015|565937034|FG001|Overall Study|Lost to Follow-up|0|||
156778051|NCT05722015|565937033|FG000|Overall Study|Withdrawal by Subject|5|||
156778052|NCT05722015|565937034|FG001|Overall Study|Withdrawal by Subject|1|||
157208806|NCT03901352|567509456|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
157208807|NCT03901352|567509457|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
157208808|NCT03901352|567509456|FG000|Open-label Extension Phase|Other|1|||
157208809|NCT03901352|567509457|FG001|Open-label Extension Phase|Other|0|||
157208810|NCT03981614|567509458|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
157208811|NCT03981614|567509459|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
157208812|NCT03981614|567509460|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
157208813|NCT05349188|567509461|FG000|Overall Study|Withdrawal by Subject|1|||
157208814|NCT05349188|567509462|FG001|Overall Study|Withdrawal by Subject|0|||
157208815|NCT04971226|567509463|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
157208816|NCT04971226|567509464|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156778053|NCT05722015|565937033|FG000|Overall Study|Participants Ongoing|188|||
156778054|NCT05722015|565937034|FG001|Overall Study|Participants Ongoing|88|||
156778055|NCT01802281|565937035|FG000|Overall Study|Death|1|||
156778056|NCT01802281|565937036|FG001|Overall Study|Death|2|||
156778057|NCT01802281|565937035|FG000|Overall Study|Withdrawal by Subject|2|||
156778058|NCT01802281|565937036|FG001|Overall Study|Withdrawal by Subject|1|||
156778059|NCT01802281|565937035|FG000|Overall Study|Ineligible|5|||
156778060|NCT01802281|565937036|FG001|Overall Study|Ineligible|3|||
156778061|NCT00927472|565937037|FG000|Overall Study|Withdrawal by Subject|10|||
156778062|NCT00927472|565937038|FG001|Overall Study|Withdrawal by Subject|11|||
156778063|NCT00927472|565937037|FG000|Overall Study|Lost to Follow-up|1|||
156778064|NCT00927472|565937038|FG001|Overall Study|Lost to Follow-up|6|||
156778065|NCT00927472|565937037|FG000|Overall Study|Protocol Violation|0|||
156778066|NCT00927472|565937038|FG001|Overall Study|Protocol Violation|1|||
156778067|NCT00927472|565937037|FG000|Overall Study|Post treatment Assessment out of window|0|||
157208817|NCT04971226|567509465|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
156778068|NCT00927472|565937038|FG001|Overall Study|Post treatment Assessment out of window|4|||
156778069|NCT05317546|565937041|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
156778070|NCT05317546|565937042|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
156778071|NCT05020743|565937047|FG000|Overall Study|Enrollment in Interventional Study|2|||
156778072|NCT05020743|565937048|FG001|Overall Study|Enrollment in Interventional Study|9|||
156778073|NCT05020743|565937049|FG002|Overall Study|Enrollment in Interventional Study|0|||
156778074|NCT05020743|565937047|FG000|Overall Study|Withdrawal by Subject|0|||
156778075|NCT05020743|565937048|FG001|Overall Study|Withdrawal by Subject|3|||
156778076|NCT05020743|565937049|FG002|Overall Study|Withdrawal by Subject|1|||
156778077|NCT05020743|565937047|FG000|Overall Study|Lost to Follow-up|1|||
156778078|NCT05020743|565937048|FG001|Overall Study|Lost to Follow-up|0|||
156778079|NCT05020743|565937049|FG002|Overall Study|Lost to Follow-up|0|||
156778080|NCT05020743|565937047|FG000|Overall Study|Study Termination by Sponsor|10|||
156778081|NCT05020743|565937048|FG001|Overall Study|Study Termination by Sponsor|11|||
156778082|NCT05020743|565937049|FG002|Overall Study|Study Termination by Sponsor|10|||
156778083|NCT03488524|565937050|FG000|Overall Study|Withdrawal by Subject|51|||
156778084|NCT03488524|565937050|FG000|Overall Study|Death|19|||
156778085|NCT03488524|565937050|FG000|Overall Study|Study Sponsor|11|||
156778086|NCT03488524|565937050|FG000|Overall Study|Physician Decision|4|||
156778087|NCT03488524|565937050|FG000|Overall Study|Lost to Follow-up|3|||
156778088|NCT01299909|565937051|FG000|Overall Study|Lost to Follow-up|22|||
156778089|NCT01299909|565937052|FG001|Overall Study|Lost to Follow-up|18|||
156778090|NCT01299909|565937053|FG002|Overall Study|Lost to Follow-up|17|||
156778091|NCT01811238|565937054|FG000|Overall Study|Withdrawal by Subject|42|||
156778092|NCT01811238|565937054|FG000|Overall Study|Adverse Event|25|||
156778093|NCT01811238|565937054|FG000|Overall Study|Protocol Violation|4|||
156778094|NCT01811238|565937054|FG000|Overall Study|Lack of Efficacy|4|||
157114915|NCT01709435|567175693|FG002|Overall Study|Withdrawal by Subject|3|||
157114916|NCT01709435|567175694|FG003|Overall Study|Withdrawal by Subject|0|||
157114917|NCT01709435|567175695|FG004|Overall Study|Withdrawal by Subject|2|||
157114918|NCT01709435|567175696|FG005|Overall Study|Withdrawal by Subject|2|||
157114919|NCT01263639|567175697|FG000|Overall Study|Lost to Follow-up|66|||
157114920|NCT01263639|567175698|FG001|Overall Study|Lost to Follow-up|70|||
157114921|NCT01263639|567175697|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
157114922|NCT01263639|567175698|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
157114923|NCT01780662|567175699|FG000|Overall Study|Adverse Event|1|||
157114924|NCT01780662|567175700|FG001|Overall Study|Adverse Event|0|||
157114925|NCT01780662|567175701|FG002|Overall Study|Adverse Event|2|||
157114926|NCT01780662|567175699|FG000|Overall Study|Physician Decision|0|||
157114927|NCT01780662|567175700|FG001|Overall Study|Physician Decision|5|||
157114928|NCT01780662|567175701|FG002|Overall Study|Physician Decision|7|||
157114929|NCT01780662|567175699|FG000|Overall Study|Protocol Violation|0|||
157114930|NCT01780662|567175700|FG001|Overall Study|Protocol Violation|1|||
157114931|NCT01780662|567175701|FG002|Overall Study|Protocol Violation|0|||
157114932|NCT01780662|567175699|FG000|Overall Study|Ineligible|0|||
157114933|NCT01780662|567175700|FG001|Overall Study|Ineligible|0|||
157114934|NCT01780662|567175701|FG002|Overall Study|Ineligible|1|||
157114935|NCT03975920|567175703|FG000|Overall Study|Lost to Follow-up|1|||
157114936|NCT03975920|567175704|FG001|Overall Study|Lost to Follow-up|2|||
157114937|NCT03975920|567175703|FG000|Overall Study|Protocol Violation|1|||
157114938|NCT03975920|567175704|FG001|Overall Study|Protocol Violation|1|||
157114939|NCT03975920|567175703|FG000|Overall Study|Did not complete survey|2|||
157208818|NCT04971226|567509466|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
157208819|NCT04971226|567509463|FG000|Overall Study|Adverse Event|6|||
156778095|NCT01811238|565937054|FG000|Overall Study|subject refused study medication|6|||
156778096|NCT01922934|565937058|FG000|Eligible Patients|Death|0|||
156778097|NCT01922934|565937059|FG001|Eligible Patients|Death|7|||
156778098|NCT01922934|565937058|FG000|Eligible Patients|Physician Decision|17|||
156778099|NCT01922934|565937059|FG001|Eligible Patients|Physician Decision|0|||
156778100|NCT01922934|565937058|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
156778101|NCT01922934|565937059|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
156778102|NCT01922934|565937058|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
156778103|NCT01922934|565937059|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
156778104|NCT01922934|565937058|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
156778105|NCT01922934|565937059|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
156778106|NCT01922934|565937058|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
156778107|NCT01922934|565937059|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
156778108|NCT01147458|565937062|FG000|First Intervention|Study terminated by sponsor|8|||
156778109|NCT01147458|565937063|FG001|First Intervention|Study terminated by sponsor|8|||
156778110|NCT01147458|565937064|FG002|First Intervention|Study terminated by sponsor|7|||
156778111|NCT01147458|565937065|FG003|First Intervention|Study terminated by sponsor|8|||
157114940|NCT03975920|567175704|FG001|Overall Study|Did not complete survey|1|||
157114941|NCT01081249|567175705|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
157114942|NCT01081249|567175706|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
157208820|NCT04971226|567509464|FG001|Overall Study|Adverse Event|5|||
156778112|NCT01147458|565937062|FG000|First Intervention|Protocol Violation|2|||
156778113|NCT01147458|565937063|FG001|First Intervention|Protocol Violation|3|||
156778114|NCT01147458|565937064|FG002|First Intervention|Protocol Violation|2|||
156778115|NCT01147458|565937065|FG003|First Intervention|Protocol Violation|3|||
156778116|NCT01147458|565937062|FG000|First Intervention|Withdrawal by Subject|3|||
156778117|NCT01147458|565937063|FG001|First Intervention|Withdrawal by Subject|0|||
156778118|NCT01147458|565937064|FG002|First Intervention|Withdrawal by Subject|1|||
156778119|NCT01147458|565937065|FG003|First Intervention|Withdrawal by Subject|0|||
156778120|NCT01147458|565937062|FG000|First Intervention|Adverse Event|0|||
156778121|NCT01147458|565937063|FG001|First Intervention|Adverse Event|3|||
156778122|NCT01147458|565937064|FG002|First Intervention|Adverse Event|2|||
156778123|NCT01147458|565937065|FG003|First Intervention|Adverse Event|3|||
156778124|NCT01147458|565937062|FG000|First Intervention|Other|1|||
156778125|NCT01147458|565937063|FG001|First Intervention|Other|2|||
156778126|NCT01147458|565937064|FG002|First Intervention|Other|0|||
156778127|NCT01147458|565937065|FG003|First Intervention|Other|0|||
156778128|NCT01147458|565937062|FG000|Second Intervention|Study terminated by sponsor|7|||
156778129|NCT01147458|565937063|FG001|Second Intervention|Study terminated by sponsor|5|||
156778130|NCT01147458|565937064|FG002|Second Intervention|Study terminated by sponsor|5|||
156778131|NCT01147458|565937065|FG003|Second Intervention|Study terminated by sponsor|3|||
156778132|NCT01147458|565937062|FG000|Second Intervention|Protocol Violation|0|||
156778133|NCT01147458|565937063|FG001|Second Intervention|Protocol Violation|1|||
156778134|NCT01147458|565937064|FG002|Second Intervention|Protocol Violation|1|||
156778135|NCT01147458|565937065|FG003|Second Intervention|Protocol Violation|0|||
156778136|NCT01147458|565937062|FG000|Second Intervention|Withdrawal by Subject|0|||
156778137|NCT01147458|565937063|FG001|Second Intervention|Withdrawal by Subject|1|||
156778138|NCT01147458|565937064|FG002|Second Intervention|Withdrawal by Subject|0|||
156778139|NCT01147458|565937065|FG003|Second Intervention|Withdrawal by Subject|0|||
156778140|NCT01147458|565937062|FG000|Second Intervention|Adverse Event|2|||
156778141|NCT01147458|565937063|FG001|Second Intervention|Adverse Event|0|||
156778142|NCT01147458|565937064|FG002|Second Intervention|Adverse Event|1|||
156778143|NCT01147458|565937065|FG003|Second Intervention|Adverse Event|1|||
156778144|NCT01147458|565937062|FG000|Second Intervention|Other|0|||
156778145|NCT01147458|565937063|FG001|Second Intervention|Other|0|||
156778146|NCT01147458|565937064|FG002|Second Intervention|Other|1|||
156778147|NCT01147458|565937065|FG003|Second Intervention|Other|0|||
156778148|NCT04603066|565937077|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
156778149|NCT04603066|565937078|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
156778150|NCT00487188|565938104|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
156778151|NCT00487188|565938105|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
156778152|NCT00487188|565938106|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
156778153|NCT00487188|565938104|FG000|Induction Phase|Adverse Event|5|||
156778154|NCT00487188|565938105|FG001|Induction Phase|Adverse Event|0|||
156778155|NCT00487188|565938106|FG002|Induction Phase|Adverse Event|0|||
156778156|NCT00487188|565938104|FG000|Induction Phase|Lack of Efficacy|0|||
156778157|NCT00487188|565938105|FG001|Induction Phase|Lack of Efficacy|1|||
156778158|NCT00487188|565938106|FG002|Induction Phase|Lack of Efficacy|0|||
156778159|NCT00487188|565938104|FG000|Induction Phase|Protocol Violation|1|||
156778160|NCT00487188|565938105|FG001|Induction Phase|Protocol Violation|0|||
156778161|NCT00487188|565938106|FG002|Induction Phase|Protocol Violation|0|||
157208821|NCT04971226|567509465|FG002|Overall Study|Adverse Event|11|||
157208822|NCT04971226|567509466|FG003|Overall Study|Adverse Event|10|||
157208823|NCT04971226|567509463|FG000|Overall Study|Progressive disease|2|||
157208824|NCT04971226|567509464|FG001|Overall Study|Progressive disease|0|||
157208825|NCT04971226|567509465|FG002|Overall Study|Progressive disease|3|||
157208826|NCT04971226|567509466|FG003|Overall Study|Progressive disease|1|||
157208827|NCT04971226|567509463|FG000|Overall Study|Protocol Deviation|1|||
157208828|NCT04971226|567509464|FG001|Overall Study|Protocol Deviation|0|||
157208829|NCT04971226|567509465|FG002|Overall Study|Protocol Deviation|1|||
157208830|NCT04971226|567509466|FG003|Overall Study|Protocol Deviation|1|||
157208831|NCT04971226|567509463|FG000|Overall Study|Subject Decision|0|||
157208832|NCT04971226|567509464|FG001|Overall Study|Subject Decision|1|||
157208833|NCT04971226|567509465|FG002|Overall Study|Subject Decision|1|||
156778162|NCT00487188|565938104|FG000|Induction Phase|Refused Treatment|1|||
156778163|NCT00487188|565938105|FG001|Induction Phase|Refused Treatment|2|||
156778164|NCT00487188|565938106|FG002|Induction Phase|Refused Treatment|0|||
156778165|NCT00487188|565938104|FG000|Induction Phase|Lost to Follow-up|2|||
156778166|NCT00487188|565938105|FG001|Induction Phase|Lost to Follow-up|2|||
156778167|NCT00487188|565938106|FG002|Induction Phase|Lost to Follow-up|0|||
156778168|NCT00487188|565938104|FG000|Induction Phase|Administrative|0|||
156778169|NCT00487188|565938105|FG001|Induction Phase|Administrative|1|||
157208834|NCT04971226|567509466|FG003|Overall Study|Subject Decision|1|||
157208835|NCT04971226|567509463|FG000|Overall Study|Pregnancy|0|||
156778170|NCT00487188|565938106|FG002|Induction Phase|Administrative|0|||
156778171|NCT00487188|565938104|FG000|Maintenance Phase|Adverse Event|1|||
156778172|NCT00487188|565938105|FG001|Maintenance Phase|Adverse Event|0|||
156778173|NCT00487188|565938106|FG002|Maintenance Phase|Adverse Event|0|||
157208836|NCT04971226|567509464|FG001|Overall Study|Pregnancy|0|||
157208837|NCT04971226|567509465|FG002|Overall Study|Pregnancy|0|||
157008492|NCT00346151|566781844|FG000|Overall Study|Withdrawal by Subject|3|||
157008493|NCT03737240|566781847|FG000|Overall Study|Lost to Follow-up|16|||
157008494|NCT03737240|566781848|FG001|Overall Study|Lost to Follow-up|15|||
157008495|NCT02570711|566781852|FG000|Overall Study|Death|1|||
157008496|NCT02570711|566781853|FG001|Overall Study|Death|0|||
157008497|NCT02570711|566781852|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
157008498|NCT02570711|566781853|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
157008499|NCT05001945|566781854|FG000|Overall Study|Adverse Event|0|||
157008500|NCT05001945|566781855|FG001|Overall Study|Adverse Event|0|||
157008501|NCT05001945|566781856|FG002|Overall Study|Adverse Event|0|||
157008502|NCT05001945|566781857|FG003|Overall Study|Adverse Event|1|||
157008503|NCT05001945|566781858|FG004|Overall Study|Adverse Event|0|||
157008504|NCT05001945|566781859|FG005|Overall Study|Adverse Event|0|||
157008505|NCT05001945|566781860|FG006|Overall Study|Adverse Event|0|||
157008506|NCT05001945|566781861|FG007|Overall Study|Adverse Event|0|||
157008507|NCT05001945|566781854|FG000|Overall Study|Lost to Follow-up|0|||
157008508|NCT05001945|566781855|FG001|Overall Study|Lost to Follow-up|1|||
157008509|NCT05001945|566781856|FG002|Overall Study|Lost to Follow-up|1|||
157008510|NCT05001945|566781857|FG003|Overall Study|Lost to Follow-up|2|||
157008511|NCT05001945|566781858|FG004|Overall Study|Lost to Follow-up|0|||
157008512|NCT05001945|566781859|FG005|Overall Study|Lost to Follow-up|1|||
157008513|NCT05001945|566781860|FG006|Overall Study|Lost to Follow-up|0|||
157008514|NCT05001945|566781861|FG007|Overall Study|Lost to Follow-up|0|||
157008515|NCT05001945|566781854|FG000|Overall Study|Protocol Violation|1|||
157008516|NCT05001945|566781855|FG001|Overall Study|Protocol Violation|0|||
157008517|NCT05001945|566781856|FG002|Overall Study|Protocol Violation|1|||
157008518|NCT05001945|566781857|FG003|Overall Study|Protocol Violation|1|||
157008519|NCT05001945|566781858|FG004|Overall Study|Protocol Violation|0|||
157008520|NCT05001945|566781859|FG005|Overall Study|Protocol Violation|1|||
157008521|NCT05001945|566781860|FG006|Overall Study|Protocol Violation|0|||
157008522|NCT05001945|566781861|FG007|Overall Study|Protocol Violation|0|||
157008523|NCT05001945|566781854|FG000|Overall Study|Withdrawal by Subject|0|||
157008524|NCT05001945|566781855|FG001|Overall Study|Withdrawal by Subject|0|||
157008525|NCT05001945|566781856|FG002|Overall Study|Withdrawal by Subject|0|||
157008526|NCT05001945|566781857|FG003|Overall Study|Withdrawal by Subject|1|||
157008527|NCT05001945|566781858|FG004|Overall Study|Withdrawal by Subject|1|||
157008528|NCT05001945|566781859|FG005|Overall Study|Withdrawal by Subject|1|||
157008529|NCT05001945|566781860|FG006|Overall Study|Withdrawal by Subject|0|||
157008530|NCT05001945|566781861|FG007|Overall Study|Withdrawal by Subject|1|||
157008531|NCT05001945|566781854|FG000|Overall Study|Not specified by Investigator|0|||
157008532|NCT05001945|566781855|FG001|Overall Study|Not specified by Investigator|3|||
157008533|NCT05001945|566781856|FG002|Overall Study|Not specified by Investigator|0|||
157008534|NCT05001945|566781857|FG003|Overall Study|Not specified by Investigator|0|||
157008535|NCT05001945|566781858|FG004|Overall Study|Not specified by Investigator|1|||
157008536|NCT05001945|566781859|FG005|Overall Study|Not specified by Investigator|0|||
157008537|NCT05001945|566781860|FG006|Overall Study|Not specified by Investigator|0|||
157008538|NCT05001945|566781861|FG007|Overall Study|Not specified by Investigator|0|||
157008539|NCT00545077|566781863|FG000|Overall Study|Treatment not received|5|||
157008540|NCT00545077|566781864|FG001|Overall Study|Treatment not received|1|||
157008541|NCT00545077|566781863|FG000|Overall Study|Disease Progression|131|||
157008542|NCT00545077|566781864|FG001|Overall Study|Disease Progression|98|||
157008543|NCT00545077|566781863|FG000|Overall Study|Withdrawal by Subject|3|||
157008544|NCT00545077|566781864|FG001|Overall Study|Withdrawal by Subject|14|||
157008545|NCT00545077|566781863|FG000|Overall Study|Physician Decision|6|||
157008546|NCT00545077|566781864|FG001|Overall Study|Physician Decision|3|||
157008547|NCT00545077|566781863|FG000|Overall Study|Lost to Follow-up|2|||
157008548|NCT00545077|566781864|FG001|Overall Study|Lost to Follow-up|0|||
157008549|NCT00545077|566781863|FG000|Overall Study|Protocol Violation|1|||
157008550|NCT00545077|566781864|FG001|Overall Study|Protocol Violation|0|||
157008551|NCT00545077|566781863|FG000|Overall Study|Adverse Event|0|||
157008552|NCT00545077|566781864|FG001|Overall Study|Adverse Event|31|||
157008553|NCT00545077|566781863|FG000|Overall Study|Death|0|||
157008554|NCT00545077|566781864|FG001|Overall Study|Death|8|||
157008555|NCT00535145|566781865|FG000|Phase I|Adverse Event|3|||
157008556|NCT00535145|566781865|FG000|Phase I|Lost to Follow-up|7|||
157008557|NCT00535145|566781865|FG000|Phase I|Withdrawal by Subject|6|||
157008558|NCT00535145|566781865|FG000|Phase I|(eligibility)|8|||
157008559|NCT00535145|566781865|FG000|Phase I|(protocol violation)|1|||
157008560|NCT00535145|566781865|FG000|Phase I|(PI decision)|1|||
157008561|NCT00535145|566781865|FG000|Phase I|(diagnosis)|3|||
157008562|NCT00535145|566781865|FG000|Phase II|Adverse Event|2|||
157008563|NCT00535145|566781865|FG000|Phase II|Lack of Efficacy|1|||
157008564|NCT00535145|566781865|FG000|Phase II|Lost to Follow-up|5|||
157008565|NCT00535145|566781865|FG000|Phase II|Withdrawal by Subject|5|||
157008566|NCT00535145|566781865|FG000|Phase II|Subject non-compliance|2|||
157008567|NCT02957136|566781866|FG000|Overall Study|Withdrawal by Subject|2|||
157008568|NCT02957136|566781867|FG001|Overall Study|Withdrawal by Subject|1|||
157008569|NCT02214160|566781868|FG000|Overall Study|Withdrawal by Subject|1|||
157008570|NCT02214160|566781869|FG001|Overall Study|Withdrawal by Subject|0|||
157008571|NCT02214160|566781870|FG002|Overall Study|Withdrawal by Subject|6|||
157008572|NCT02214160|566781868|FG000|Overall Study|Death|2|||
157008573|NCT02214160|566781869|FG001|Overall Study|Death|2|||
157008574|NCT02214160|566781870|FG002|Overall Study|Death|1|||
157008575|NCT02214160|566781868|FG000|Overall Study|Subject Non-Compliance|0|||
157008576|NCT02214160|566781869|FG001|Overall Study|Subject Non-Compliance|3|||
157008577|NCT02214160|566781870|FG002|Overall Study|Subject Non-Compliance|1|||
157008578|NCT02214160|566781868|FG000|Overall Study|Adverse Event|0|||
157008579|NCT02214160|566781869|FG001|Overall Study|Adverse Event|1|||
157008580|NCT02214160|566781870|FG002|Overall Study|Adverse Event|1|||
157008581|NCT02214160|566781868|FG000|Overall Study|Sponsor Decision|0|||
157008582|NCT02214160|566781869|FG001|Overall Study|Sponsor Decision|2|||
157008583|NCT02214160|566781870|FG002|Overall Study|Sponsor Decision|0|||
157008584|NCT02214160|566781868|FG000|Overall Study|Protocol Violation|1|||
157008585|NCT02214160|566781869|FG001|Overall Study|Protocol Violation|0|||
157008586|NCT02214160|566781870|FG002|Overall Study|Protocol Violation|0|||
157008587|NCT02214160|566781868|FG000|Overall Study|Physician Decision|0|||
157008588|NCT02214160|566781869|FG001|Overall Study|Physician Decision|0|||
157008589|NCT02214160|566781870|FG002|Overall Study|Physician Decision|1|||
157008590|NCT02423798|566781871|FG000|Overall Study|Withdrawal by Subject|3|||
157008591|NCT01063972|566781872|FG000|Overall Study|Death|12|||
157008592|NCT01063972|566781873|FG001|Overall Study|Death|11|||
157008593|NCT01063972|566781872|FG000|Overall Study|Incarcerated|2|||
157008594|NCT01063972|566781873|FG001|Overall Study|Incarcerated|1|||
157008595|NCT01430611|566781874|FG000|Overall Study|Adverse Event|0|||
157008596|NCT01430611|566781875|FG001|Overall Study|Adverse Event|1|||
157008597|NCT01430611|566781874|FG000|Overall Study|Protocol Violation|1|||
157008598|NCT01430611|566781875|FG001|Overall Study|Protocol Violation|0|||
157008599|NCT01430611|566781874|FG000|Overall Study|Lost to Follow-up|1|||
157008600|NCT01430611|566781875|FG001|Overall Study|Lost to Follow-up|0|||
157008601|NCT01430611|566781874|FG000|Overall Study|Withdrawal by Subject|15|||
157008602|NCT01430611|566781875|FG001|Overall Study|Withdrawal by Subject|14|||
157008603|NCT01943916|566781876|FG000|Overall Study|Technically invalid images|10|||
157008604|NCT01943916|566781876|FG000|Overall Study|Enrollment Failure|23|||
157008605|NCT01943916|566781876|FG000|Overall Study|Pilot Phase exclusion|100|||
157008606|NCT01943916|566781876|FG000|Overall Study|Quality Assurance Reader Fail|130|||
157008607|NCT01943916|566781876|FG000|Overall Study|Technical Failure|39|||
157008608|NCT01943916|566781876|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
157008609|NCT01943916|566781876|FG000|Overall Study|No Truth Panel Review|38|||
157008610|NCT01943916|566781876|FG000|Overall Study|Protocol Deviation|1|||
157008611|NCT00919763|566781877|FG000|Overall Study|Adverse Event|7|||
157008612|NCT00919763|566781878|FG001|Overall Study|Adverse Event|1|||
157008613|NCT00919763|566781877|FG000|Overall Study|Lost to Follow-up|1|||
157008614|NCT00919763|566781878|FG001|Overall Study|Lost to Follow-up|0|||
157008615|NCT00919763|566781877|FG000|Overall Study|Protocol Violation|1|||
157008616|NCT00919763|566781878|FG001|Overall Study|Protocol Violation|1|||
157008617|NCT00919763|566781877|FG000|Overall Study|Withdrawal by Subject|3|||
157008618|NCT00919763|566781878|FG001|Overall Study|Withdrawal by Subject|1|||
157008619|NCT00919763|566781877|FG000|Overall Study|Non-compliance|0|||
157008620|NCT00919763|566781878|FG001|Overall Study|Non-compliance|1|||
157008621|NCT04740164|566781879|FG000|Overall Study|Lack of Efficacy|4|||
156778174|NCT00487188|565938104|FG000|Maintenance Phase|Death|1|||
157008622|NCT04740164|566781880|FG001|Overall Study|Lack of Efficacy|0|||
157008623|NCT04740164|566781879|FG000|Overall Study|Physician Decision|3|||
157208838|NCT04971226|567509466|FG003|Overall Study|Pregnancy|1|||
157008624|NCT04740164|566781880|FG001|Overall Study|Physician Decision|3|||
157008625|NCT05323734|566781884|FG000|Overall Study|Adverse Event|5|||
157008626|NCT05323734|566781885|FG001|Overall Study|Adverse Event|2|||
157208839|NCT04971226|567509463|FG000|Overall Study|Participants not treated|1|||
157008627|NCT05323734|566781884|FG000|Overall Study|Physician Decision|1|||
157008628|NCT05323734|566781885|FG001|Overall Study|Physician Decision|0|||
157008629|NCT05323734|566781884|FG000|Overall Study|Lack of Efficacy|1|||
157008630|NCT05323734|566781885|FG001|Overall Study|Lack of Efficacy|2|||
157008631|NCT05323734|566781884|FG000|Overall Study|Withdrawal by Subject|2|||
157008632|NCT05323734|566781885|FG001|Overall Study|Withdrawal by Subject|0|||
157008633|NCT05323734|566781884|FG000|Overall Study|Participant Withdrawn Due|0|||
157008634|NCT05323734|566781885|FG001|Overall Study|Participant Withdrawn Due|1|||
157008635|NCT00442117|566781886|FG000|Overall Study|Adverse Event|3|||
157208840|NCT04971226|567509464|FG001|Overall Study|Participants not treated|0|||
156778175|NCT00487188|565938105|FG001|Maintenance Phase|Death|0|||
156778176|NCT00487188|565938106|FG002|Maintenance Phase|Death|0|||
156778177|NCT00487188|565938104|FG000|Maintenance Phase|Lost to Follow-up|1|||
156778178|NCT00487188|565938105|FG001|Maintenance Phase|Lost to Follow-up|0|||
156778179|NCT00487188|565938106|FG002|Maintenance Phase|Lost to Follow-up|0|||
156778180|NCT00487188|565938104|FG000|Maintenance Phase|Administrative|0|||
156778181|NCT00487188|565938105|FG001|Maintenance Phase|Administrative|0|||
156778182|NCT00487188|565938106|FG002|Maintenance Phase|Administrative|1|||
156778183|NCT03483584|565938111|FG000|Overall Study|Lost to Follow-up|40|||
156778184|NCT03483584|565938112|FG001|Overall Study|Lost to Follow-up|7|||
156778185|NCT03483584|565938111|FG000|Overall Study|Withdrawal by Subject|4|||
156778186|NCT03483584|565938112|FG001|Overall Study|Withdrawal by Subject|1|||
156778187|NCT00005047|565938113|FG000|Overall Study|Withdrawal by Subject|12|||
156778188|NCT00005047|565938114|FG001|Overall Study|Withdrawal by Subject|0|||
156778189|NCT00005047|565938115|FG002|Overall Study|Withdrawal by Subject|0|||
156778190|NCT00005047|565938116|FG003|Overall Study|Withdrawal by Subject|0|||
156778191|NCT00005047|565938113|FG000|Overall Study|Adverse Event|5|||
156778192|NCT00005047|565938114|FG001|Overall Study|Adverse Event|0|||
156778193|NCT00005047|565938115|FG002|Overall Study|Adverse Event|0|||
156778194|NCT00005047|565938116|FG003|Overall Study|Adverse Event|0|||
156778195|NCT00005047|565938113|FG000|Overall Study|Lost to Follow-up|1|||
156778196|NCT00005047|565938114|FG001|Overall Study|Lost to Follow-up|0|||
156778197|NCT00005047|565938115|FG002|Overall Study|Lost to Follow-up|0|||
156778198|NCT00005047|565938116|FG003|Overall Study|Lost to Follow-up|0|||
156778199|NCT00005047|565938113|FG000|Overall Study|Lack of Efficacy|1|||
156778200|NCT00005047|565938114|FG001|Overall Study|Lack of Efficacy|0|||
156778201|NCT00005047|565938115|FG002|Overall Study|Lack of Efficacy|0|||
156778202|NCT00005047|565938116|FG003|Overall Study|Lack of Efficacy|0|||
156778203|NCT03240874|565938123|FG000|Overall Study|Lost to Follow-up|0|||
156778204|NCT03240874|565938124|FG001|Overall Study|Lost to Follow-up|2|||
156778205|NCT03240874|565938125|FG002|Overall Study|Lost to Follow-up|4|||
156778206|NCT03240874|565938126|FG003|Overall Study|Lost to Follow-up|1|||
156778207|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
156778208|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
156778209|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
156778210|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
156778211|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
156778212|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
156778213|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
156778214|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
156778215|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
156778216|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
156778217|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
156778218|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
156778219|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778220|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778221|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778222|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778223|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778224|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778225|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778226|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778227|NCT01964404|565938127|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
156778228|NCT01964404|565938128|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
156778229|NCT01964404|565938129|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778230|NCT01964404|565938130|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
156778231|NCT01964404|565938131|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778232|NCT01964404|565938132|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
157208841|NCT04971226|567509465|FG002|Overall Study|Participants not treated|2|||
157208842|NCT04971226|567509466|FG003|Overall Study|Participants not treated|1|||
157208843|NCT00481871|567509467|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
157208844|NCT00481871|567509468|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
157208845|NCT00481871|567509469|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
157208846|NCT00481871|567509470|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
157208847|NCT00481871|567509471|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
157208848|NCT04439149|567509475|FG000|Overall Study|Ineligible|1|||
157208849|NCT04439149|567509475|FG000|Overall Study|Never start protocol therapy|1|||
157208850|NCT04439149|567509475|FG000|Overall Study|Adverse Event|4|||
156778233|NCT01964404|565938133|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778234|NCT01964404|565938134|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778235|NCT01964404|565938135|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
157208851|NCT04439149|567509475|FG000|Overall Study|Disease Progression|14|||
156778236|NCT01964404|565938136|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
156778237|NCT05528510|565938137|FG000|Overall Study|Death|1|||
156778238|NCT05528510|565938138|FG001|Overall Study|Death|0|||
156778239|NCT05528510|565938139|FG002|Overall Study|Death|0|||
157008636|NCT00442117|566781887|FG001|Overall Study|Adverse Event|2|||
157008637|NCT00442117|566781886|FG000|Overall Study|Lack of Efficacy|2|||
157008638|NCT00442117|566781887|FG001|Overall Study|Lack of Efficacy|6|||
157008639|NCT00442117|566781886|FG000|Overall Study|Lost to Follow-up|1|||
157008640|NCT00442117|566781887|FG001|Overall Study|Lost to Follow-up|2|||
157008641|NCT00442117|566781886|FG000|Overall Study|Withdrawal by Subject|2|||
157008642|NCT00442117|566781887|FG001|Overall Study|Withdrawal by Subject|2|||
157008643|NCT00442117|566781886|FG000|Overall Study|Major Deviation|25|||
157008644|NCT00442117|566781887|FG001|Overall Study|Major Deviation|20|||
157008645|NCT00442117|566781886|FG000|Overall Study|Non compliance with protocol|3|||
157008646|NCT00442117|566781887|FG001|Overall Study|Non compliance with protocol|5|||
157008647|NCT00442117|566781886|FG000|Overall Study|Met Withdrawal Criteria|2|||
157008648|NCT00442117|566781887|FG001|Overall Study|Met Withdrawal Criteria|1|||
157008649|NCT00457691|566781895|FG000|Overall Study|Adverse Event|4|||
157008650|NCT00457691|566781896|FG001|Overall Study|Adverse Event|1|||
157008651|NCT00457691|566781895|FG000|Overall Study|Death|163|||
157008652|NCT00457691|566781896|FG001|Overall Study|Death|148|||
157008653|NCT00457691|566781895|FG000|Overall Study|Protocol Violation|1|||
156778240|NCT05528510|565938137|FG000|Overall Study|Lost to Follow-up|1|||
156778241|NCT05528510|565938138|FG001|Overall Study|Lost to Follow-up|0|||
156778242|NCT05528510|565938139|FG002|Overall Study|Lost to Follow-up|0|||
156778243|NCT05528510|565938137|FG000|Overall Study|Withdrawal by Subject|4|||
156778244|NCT05528510|565938138|FG001|Overall Study|Withdrawal by Subject|1|||
156778245|NCT05528510|565938139|FG002|Overall Study|Withdrawal by Subject|3|||
156778246|NCT05528510|565938137|FG000|Overall Study|Other|2|||
156778247|NCT05528510|565938138|FG001|Overall Study|Other|2|||
156778248|NCT05528510|565938139|FG002|Overall Study|Other|1|||
156778249|NCT05350202|565938140|FG000|Visit 1 - Baseline|Not-treated|18|||
156778250|NCT05350202|565938141|FG001|Visit 1 - Baseline|Not-treated|0|||
156778251|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
156778252|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
156778253|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
156778254|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
156778255|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
156778256|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
156778257|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
156778258|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
156778259|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
156778260|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
156778261|NCT05350202|565938140|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
156778262|NCT05350202|565938141|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
156778263|NCT04707469|565938142|FG000|Overall Study|Site closure|0|||
156778264|NCT04707469|565938143|FG001|Overall Study|Site closure|2|||
156778265|NCT04707469|565938144|FG002|Overall Study|Site closure|0|||
156778266|NCT04707469|565938142|FG000|Overall Study|Physician Decision|2|||
156778267|NCT04707469|565938143|FG001|Overall Study|Physician Decision|2|||
156778268|NCT04707469|565938144|FG002|Overall Study|Physician Decision|2|||
157008654|NCT00457691|566781896|FG001|Overall Study|Protocol Violation|3|||
157008655|NCT00457691|566781895|FG000|Overall Study|Lost to Follow-up|23|||
157008656|NCT00457691|566781896|FG001|Overall Study|Lost to Follow-up|14|||
157008657|NCT00457691|566781895|FG000|Overall Study|Study terminated by Sponsor|1|||
157008658|NCT00457691|566781896|FG001|Overall Study|Study terminated by Sponsor|1|||
157008659|NCT00457691|566781895|FG000|Overall Study|Subject refused (reason other than AE)|14|||
157008660|NCT00457691|566781896|FG001|Overall Study|Subject refused (reason other than AE)|19|||
157008661|NCT00457691|566781895|FG000|Overall Study|Disease progression, study terminated|180|||
157008662|NCT00457691|566781896|FG001|Overall Study|Disease progression, study terminated|196|||
157008663|NCT01121549|566781897|FG000|Overall Study|Adverse Event|10|||
157008664|NCT01121549|566781897|FG000|Overall Study|Lack of Efficacy|11|||
157008665|NCT01121549|566781897|FG000|Overall Study|Lost to Follow-up|12|||
157008666|NCT01121549|566781897|FG000|Overall Study|Did not meet entrance criteria|9|||
157008667|NCT01121549|566781897|FG000|Overall Study|Study terminated by sponsor|197|||
157008668|NCT01121549|566781897|FG000|Overall Study|Pregnancy|1|||
157008669|NCT01121549|566781897|FG000|Overall Study|Protocol Violation|33|||
157008670|NCT01121549|566781897|FG000|Overall Study|Withdrawal by Subject|16|||
157008671|NCT01121549|566781897|FG000|Overall Study|Other|58|||
157008672|NCT04789408|566781898|FG000|Overall Study|Death|4|||
157008673|NCT04789408|566781899|FG001|Overall Study|Death|3|||
157008674|NCT04789408|566781900|FG002|Overall Study|Death|6|||
157008675|NCT04789408|566781898|FG000|Overall Study|Did not meet eligibility criteria|1|||
157008676|NCT04789408|566781899|FG001|Overall Study|Did not meet eligibility criteria|0|||
157008677|NCT04789408|566781900|FG002|Overall Study|Did not meet eligibility criteria|0|||
157008678|NCT04789408|566781898|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
157008679|NCT04789408|566781899|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
157008680|NCT04789408|566781900|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
157008681|NCT00414544|566783413|FG000|Overall Study|Lost to Follow-up|14|||
157008682|NCT01318382|566783415|FG000|Overall Study|Physician Decision|2|||
157008683|NCT01318382|566783415|FG000|Overall Study|Device Malfunction|10|||
157008684|NCT01318382|566783415|FG000|Overall Study|Protocol Violation|1|||
157008685|NCT02271854|566783418|FG000|Overall Study|Withdrawal by Subject|2|||
157008686|NCT02271854|566783418|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
157008687|NCT02271854|566783418|FG000|Overall Study|Lost to Follow-up|1|||
157008688|NCT01308567|566783419|FG000|Overall Study|Lost to Follow-up|2|||
157008689|NCT01308567|566783420|FG001|Overall Study|Lost to Follow-up|4|||
157008690|NCT01308567|566783421|FG002|Overall Study|Lost to Follow-up|4|||
157008691|NCT01571596|566783424|FG000|Overall Study|Adverse Event|2|||
157008692|NCT01571596|566783425|FG001|Overall Study|Adverse Event|0|||
157008693|NCT01571596|566783426|FG002|Overall Study|Adverse Event|0|||
157008694|NCT01571596|566783424|FG000|Overall Study|Study Terminated by the Sponsor|0|||
157008695|NCT01571596|566783425|FG001|Overall Study|Study Terminated by the Sponsor|1|||
157008696|NCT01571596|566783426|FG002|Overall Study|Study Terminated by the Sponsor|1|||
157008697|NCT01185561|566783431|FG000|Overall Study|Lost to Follow-up|0|||
157008698|NCT01185561|566783432|FG001|Overall Study|Lost to Follow-up|4|||
157008699|NCT01185561|566783431|FG000|Overall Study|Withdrawal by Subject|2|||
157008700|NCT01185561|566783432|FG001|Overall Study|Withdrawal by Subject|8|||
157008701|NCT01078116|566783435|FG000|Overall Study|Lost to Follow-up|17|||
157008702|NCT01078116|566783435|FG000|Overall Study|Adverse Event|5|||
157008703|NCT01078116|566783435|FG000|Overall Study|Withdrawal by Subject|8|||
157008704|NCT01078116|566783435|FG000|Overall Study|Lack of effectiveness|15|||
157008705|NCT01078116|566783435|FG000|Overall Study|Case report form not completed|3|||
157008706|NCT00585052|566783436|FG000|Overall Study|Withdrawal by Subject|1|||
157008707|NCT02499159|566783437|FG000|Randomization|Protocol Violation|1|||
157008708|NCT02499159|566783438|FG001|Randomization|Protocol Violation|1|||
157008709|NCT02499159|566783437|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
157008710|NCT02499159|566783438|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
157008711|NCT02499159|566783437|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
157008712|NCT02499159|566783438|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
157008713|NCT02499159|566783437|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
157008714|NCT02499159|566783438|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
157008715|NCT02499159|566783437|FG000|30-Day Follow-Up Phone Call|Other|1|||
157008716|NCT02499159|566783438|FG001|30-Day Follow-Up Phone Call|Other|0|||
157008717|NCT04425863|566783439|FG000|Overall Study|Death|0|||
157008718|NCT04425863|566783440|FG001|Overall Study|Death|0|||
157008719|NCT04425863|566783441|FG002|Overall Study|Death|1|||
157008720|NCT02242487|566783442|FG000|Overall Study|Adverse Event|13|||
157008721|NCT02242487|566783443|FG001|Overall Study|Adverse Event|15|||
157008722|NCT02242487|566783442|FG000|Overall Study|Lack of Efficacy|4|||
157008723|NCT02242487|566783443|FG001|Overall Study|Lack of Efficacy|6|||
157008724|NCT02242487|566783442|FG000|Overall Study|Protocol Violation|2|||
157008725|NCT02242487|566783443|FG001|Overall Study|Protocol Violation|0|||
157008726|NCT02242487|566783442|FG000|Overall Study|Lost to Follow-up|2|||
157008727|NCT02242487|566783443|FG001|Overall Study|Lost to Follow-up|1|||
156778269|NCT04707469|565938142|FG000|Overall Study|Death|1|||
157008728|NCT02242487|566783442|FG000|Overall Study|Other - Miscellaneous|4|||
157008729|NCT02242487|566783443|FG001|Overall Study|Other - Miscellaneous|6|||
157008730|NCT02242487|566783442|FG000|Overall Study|Withdrawal by Subject|37|||
157008731|NCT02242487|566783443|FG001|Overall Study|Withdrawal by Subject|19|||
157008732|NCT03644849|566783444|FG000|Overall Study|Lost to Follow-up|1|||
156778270|NCT04707469|565938143|FG001|Overall Study|Death|6|||
156778271|NCT04707469|565938144|FG002|Overall Study|Death|2|||
157008733|NCT03644849|566783445|FG001|Overall Study|Lost to Follow-up|3|||
157008734|NCT02564744|566783447|FG000|Overall Study|Investigator decision|0|||
157008735|NCT02564744|566783448|FG001|Overall Study|Investigator decision|0|||
157008736|NCT02564744|566783449|FG002|Overall Study|Investigator decision|0|||
157008737|NCT02564744|566783450|FG003|Overall Study|Investigator decision|0|||
157208852|NCT04439149|567509475|FG000|Overall Study|Complicating disease|1|||
157208853|NCT04439149|567509475|FG000|Overall Study|Withdrawal by Subject|3|||
157208854|NCT05264506|567509478|FG000|Overall Study|Adverse Event|59|||
157208855|NCT05264506|567509478|FG000|Overall Study|Lost to Follow-up|204|||
157208856|NCT05264506|567509478|FG000|Overall Study|Protocol Violation|185|||
157208857|NCT05264506|567509478|FG000|Overall Study|Pregnancy|60|||
157208858|NCT05264506|567509478|FG000|Overall Study|Physician Decision|6|||
157208859|NCT05264506|567509478|FG000|Overall Study|Non-compliance with Study Drug|29|||
157208860|NCT05264506|567509478|FG000|Overall Study|Study termination|677|||
157208861|NCT05264506|567509478|FG000|Overall Study|Withdrawal by Subject|208|||
157208862|NCT05264506|567509478|FG000|Overall Study|Discontinued prior treatment|89|||
157208863|NCT02032823|567509485|FG000|Overall Study|Death|75|||
157208864|NCT02032823|567509486|FG001|Overall Study|Death|109|||
157208865|NCT02032823|567509485|FG000|Overall Study|Lost to Follow-up|18|||
157208866|NCT02032823|567509486|FG001|Overall Study|Lost to Follow-up|17|||
157208867|NCT02032823|567509485|FG000|Overall Study|Withdrawal by Subject|70|||
157208868|NCT02032823|567509486|FG001|Overall Study|Withdrawal by Subject|53|||
157208869|NCT02032823|567509485|FG000|Overall Study|Ongoing study at data cut-off|755|||
157208870|NCT02032823|567509486|FG001|Overall Study|Ongoing study at data cut-off|731|||
157208871|NCT02032823|567509485|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
157208872|NCT02032823|567509486|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
157208873|NCT04521608|567509487|FG000|Overall Study|Death|8|||
157208874|NCT04521608|567509488|FG001|Overall Study|Death|9|||
157208875|NCT04521608|567509487|FG000|Overall Study|Withdrawal by Subject|25|||
157208876|NCT04521608|567509488|FG001|Overall Study|Withdrawal by Subject|18|||
157208877|NCT04521608|567509487|FG000|Overall Study|Disease Progression|3|||
157208878|NCT04521608|567509488|FG001|Overall Study|Disease Progression|10|||
157208879|NCT04521608|567509487|FG000|Overall Study|Complicating Disease|6|||
157208880|NCT04521608|567509488|FG001|Overall Study|Complicating Disease|3|||
157208881|NCT04521608|567509487|FG000|Overall Study|Lost Contact|25|||
157208882|NCT04521608|567509488|FG001|Overall Study|Lost Contact|27|||
157208883|NCT04521608|567509487|FG000|Overall Study|Ineligible|1|||
157008738|NCT02564744|566783451|FG004|Overall Study|Investigator decision|1|||
157008739|NCT02564744|566783447|FG000|Overall Study|Death|10|||
157008740|NCT02564744|566783448|FG001|Overall Study|Death|5|||
157008741|NCT02564744|566783449|FG002|Overall Study|Death|4|||
157008742|NCT02564744|566783450|FG003|Overall Study|Death|16|||
157008743|NCT02564744|566783451|FG004|Overall Study|Death|16|||
157008744|NCT02564744|566783447|FG000|Overall Study|End of study Page Missing|0|||
157008745|NCT02564744|566783448|FG001|Overall Study|End of study Page Missing|0|||
157008746|NCT02564744|566783449|FG002|Overall Study|End of study Page Missing|3|||
157008747|NCT02564744|566783450|FG003|Overall Study|End of study Page Missing|3|||
157008748|NCT02564744|566783451|FG004|Overall Study|End of study Page Missing|0|||
157008749|NCT02564744|566783447|FG000|Overall Study|Subject Withdrew Consent|1|||
157008750|NCT02564744|566783448|FG001|Overall Study|Subject Withdrew Consent|1|||
157008751|NCT02564744|566783449|FG002|Overall Study|Subject Withdrew Consent|1|||
157008752|NCT02564744|566783450|FG003|Overall Study|Subject Withdrew Consent|0|||
157008753|NCT02564744|566783451|FG004|Overall Study|Subject Withdrew Consent|2|||
157008754|NCT02564744|566783447|FG000|Overall Study|Lost to Follow-up|0|||
157208884|NCT04521608|567509488|FG001|Overall Study|Ineligible|0|||
157208885|NCT04521608|567509487|FG000|Overall Study|Refused Further Study Participation|13|||
157208886|NCT04521608|567509488|FG001|Overall Study|Refused Further Study Participation|7|||
157208887|NCT04083378|567509489|FG000|Overall Study|Death|18|||
157208888|NCT04083378|567509490|FG001|Overall Study|Death|4|||
157208889|NCT04083378|567509489|FG000|Overall Study|Lost to Follow-up|4|||
157208890|NCT04083378|567509490|FG001|Overall Study|Lost to Follow-up|0|||
157208891|NCT00644228|567509491|FG000|Randomization & Eligibility|Ineligible|31|||
157208892|NCT00644228|567509492|FG001|Randomization & Eligibility|Ineligible|21|||
157208893|NCT00644228|567509491|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
157208894|NCT00644228|567509492|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
157208895|NCT00644228|567509491|FG000|Randomization & Eligibility|Invalid Consent|0|||
157008755|NCT02564744|566783448|FG001|Overall Study|Lost to Follow-up|1|||
157008756|NCT02564744|566783449|FG002|Overall Study|Lost to Follow-up|0|||
157008757|NCT02564744|566783450|FG003|Overall Study|Lost to Follow-up|0|||
157008758|NCT02564744|566783451|FG004|Overall Study|Lost to Follow-up|1|||
157008759|NCT02564744|566783447|FG000|Overall Study|Reason not specified|1|||
157008760|NCT02564744|566783448|FG001|Overall Study|Reason not specified|0|||
157008761|NCT02564744|566783449|FG002|Overall Study|Reason not specified|0|||
157008762|NCT02564744|566783450|FG003|Overall Study|Reason not specified|0|||
157008763|NCT02564744|566783451|FG004|Overall Study|Reason not specified|0|||
157008764|NCT02252042|566783452|FG000|Overall Study|Adverse Event|9|||
157008765|NCT02252042|566783453|FG001|Overall Study|Adverse Event|6|||
157008766|NCT02252042|566783452|FG000|Overall Study|Death|209|||
157008767|NCT02252042|566783453|FG001|Overall Study|Death|217|||
157208896|NCT00644228|567509492|FG001|Randomization & Eligibility|Invalid Consent|1|||
157208897|NCT00644228|567509491|FG000|Induction Therapy|Adverse Event|22|||
157208898|NCT00644228|567509492|FG001|Induction Therapy|Adverse Event|55|||
157208899|NCT00644228|567509491|FG000|Induction Therapy|Withdrawal by Subject|10|||
157208900|NCT00644228|567509492|FG001|Induction Therapy|Withdrawal by Subject|3|||
157208901|NCT00644228|567509491|FG000|Induction Therapy|Progression/Relapse|24|||
157208902|NCT00644228|567509492|FG001|Induction Therapy|Progression/Relapse|12|||
157208903|NCT00644228|567509491|FG000|Induction Therapy|Death|3|||
157208904|NCT00644228|567509492|FG001|Induction Therapy|Death|7|||
157008768|NCT02252042|566783452|FG000|Overall Study|Physician Decision|0|||
157008769|NCT02252042|566783453|FG001|Overall Study|Physician Decision|2|||
157008770|NCT02252042|566783452|FG000|Overall Study|Transferred to Extension Study|7|||
157008771|NCT02252042|566783453|FG001|Overall Study|Transferred to Extension Study|1|||
157008772|NCT02252042|566783452|FG000|Overall Study|Did Not Continue on Extension Study|7|||
157008773|NCT02252042|566783453|FG001|Overall Study|Did Not Continue on Extension Study|2|||
157008774|NCT02252042|566783452|FG000|Overall Study|Withdrawal by Subject|15|||
157008775|NCT02252042|566783453|FG001|Overall Study|Withdrawal by Subject|20|||
157208905|NCT00644228|567509491|FG000|Induction Therapy|Not Protocol-Specified|24|||
157208906|NCT00644228|567509492|FG001|Induction Therapy|Not Protocol-Specified|28|||
157208907|NCT00644228|567509491|FG000|Maintenance|Adverse Event|27|||
157208908|NCT00644228|567509492|FG001|Maintenance|Adverse Event|31|||
157208909|NCT00644228|567509491|FG000|Maintenance|Withdrawal by Subject|6|||
157208910|NCT00644228|567509492|FG001|Maintenance|Withdrawal by Subject|4|||
157208911|NCT00644228|567509491|FG000|Maintenance|Progression/Relapse|67|||
157208912|NCT00644228|567509492|FG001|Maintenance|Progression/Relapse|42|||
157208913|NCT00644228|567509491|FG000|Maintenance|Death|3|||
157208914|NCT00644228|567509492|FG001|Maintenance|Death|3|||
157208915|NCT00644228|567509491|FG000|Maintenance|Not Protocol-Specified|14|||
157208916|NCT00644228|567509492|FG001|Maintenance|Not Protocol-Specified|15|||
157208917|NCT00644228|567509491|FG000|Maintenance|On Treatment|26|||
157208918|NCT00644228|567509492|FG001|Maintenance|On Treatment|40|||
157208919|NCT06078124|567509493|FG000|Overall Study|Lost to Follow-up|14|||
157208920|NCT06078124|567509494|FG001|Overall Study|Lost to Follow-up|14|||
157208921|NCT05824273|567509495|FG000|Overall Study|Lost to Follow-up|16|||
157208922|NCT05824273|567509496|FG001|Overall Study|Lost to Follow-up|13|||
157208923|NCT00285012|567509497|FG000|Assigned to Study Treatment (Tx)|Other|2|||
157208924|NCT00285012|567509498|FG001|Assigned to Study Treatment (Tx)|Other|3|||
157208925|NCT00285012|567509497|FG000|Received Study Tx|Death|2|||
157208926|NCT00285012|567509498|FG001|Received Study Tx|Death|1|||
157208927|NCT00285012|567509497|FG000|Received Study Tx|Adverse Event|5|||
157208928|NCT00285012|567509498|FG001|Received Study Tx|Adverse Event|11|||
157208929|NCT00285012|567509497|FG000|Received Study Tx|Lack of Efficacy|0|||
157208930|NCT00285012|567509498|FG001|Received Study Tx|Lack of Efficacy|3|||
157208931|NCT00285012|567509497|FG000|Received Study Tx|Lost to Follow-up|29|||
157208932|NCT00285012|567509498|FG001|Received Study Tx|Lost to Follow-up|31|||
157208933|NCT00285012|567509497|FG000|Received Study Tx|Withdrawal by Subject|31|||
157208934|NCT00285012|567509498|FG001|Received Study Tx|Withdrawal by Subject|43|||
157208935|NCT00285012|567509497|FG000|Received Study Tx|Other|5|||
157208936|NCT00285012|567509498|FG001|Received Study Tx|Other|5|||
157208937|NCT04050293|567509500|FG000|Overall Study|Lost to Follow-up|1|||
157208938|NCT04050293|567509501|FG001|Overall Study|Lost to Follow-up|2|||
157208939|NCT04050293|567509500|FG000|Overall Study|Withdrawal by Subject|2|||
156778272|NCT04707469|565938142|FG000|Overall Study|Lost to Follow-up|9|||
156778273|NCT04707469|565938143|FG001|Overall Study|Lost to Follow-up|19|||
156778274|NCT04707469|565938144|FG002|Overall Study|Lost to Follow-up|14|||
156778275|NCT04707469|565938142|FG000|Overall Study|Withdrawal by Subject|17|||
157208940|NCT04050293|567509501|FG001|Overall Study|Withdrawal by Subject|0|||
156778276|NCT04707469|565938143|FG001|Overall Study|Withdrawal by Subject|16|||
156778277|NCT04707469|565938144|FG002|Overall Study|Withdrawal by Subject|12|||
156778278|NCT05556057|565938145|FG000|Overall Study|Lost to Follow-up|5|||
156778279|NCT05556057|565938146|FG001|Overall Study|Lost to Follow-up|4|||
156778280|NCT05556057|565938145|FG000|Overall Study|Withdrawal by Subject|0|||
156778281|NCT05556057|565938146|FG001|Overall Study|Withdrawal by Subject|2|||
156778282|NCT02003924|565938149|FG000|Double-blind Phase|Lost to Follow-up|2|||
156778283|NCT02003924|565938150|FG001|Double-blind Phase|Lost to Follow-up|1|||
156778284|NCT02003924|565938151|FG002|Double-blind Phase|Lost to Follow-up|0|||
156778285|NCT02003924|565938149|FG000|Double-blind Phase|Protocol Violation|1|||
156778286|NCT02003924|565938150|FG001|Double-blind Phase|Protocol Violation|2|||
156778287|NCT02003924|565938151|FG002|Double-blind Phase|Protocol Violation|0|||
156778288|NCT02003924|565938149|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
156778289|NCT02003924|565938150|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
156778290|NCT02003924|565938151|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
156778291|NCT02003924|565938149|FG000|Double-blind Phase|Disease Progression|229|||
156778292|NCT02003924|565938150|FG001|Double-blind Phase|Disease Progression|247|||
156778293|NCT02003924|565938151|FG002|Double-blind Phase|Disease Progression|0|||
156778294|NCT02003924|565938149|FG000|Double-blind Phase|Adverse Event|120|||
156778295|NCT02003924|565938150|FG001|Double-blind Phase|Adverse Event|31|||
156778296|NCT02003924|565938151|FG002|Double-blind Phase|Adverse Event|0|||
156778297|NCT02003924|565938149|FG000|Double-blind Phase|Randomized But not Treated|3|||
156778298|NCT02003924|565938150|FG001|Double-blind Phase|Randomized But not Treated|3|||
156778299|NCT02003924|565938151|FG002|Double-blind Phase|Randomized But not Treated|0|||
156778300|NCT02003924|565938149|FG000|Double-blind Phase|Other|29|||
156778301|NCT02003924|565938150|FG001|Double-blind Phase|Other|50|||
156778302|NCT02003924|565938151|FG002|Double-blind Phase|Other|0|||
156778303|NCT02003924|565938149|FG000|Open-label Phase|Lost to Follow-up|0|||
156778304|NCT02003924|565938150|FG001|Open-label Phase|Lost to Follow-up|0|||
156778305|NCT02003924|565938151|FG002|Open-label Phase|Lost to Follow-up|1|||
156778306|NCT02003924|565938149|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
156778307|NCT02003924|565938150|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
156778308|NCT02003924|565938151|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
156778309|NCT02003924|565938149|FG000|Open-label Phase|Disease Progression|59|||
156778310|NCT02003924|565938150|FG001|Open-label Phase|Disease Progression|0|||
156778311|NCT02003924|565938151|FG002|Open-label Phase|Disease Progression|5|||
156778312|NCT02003924|565938149|FG000|Open-label Phase|Adverse Event|25|||
156778313|NCT02003924|565938150|FG001|Open-label Phase|Adverse Event|0|||
156778314|NCT02003924|565938151|FG002|Open-label Phase|Adverse Event|10|||
156778315|NCT02003924|565938149|FG000|Open-label Phase|Other|7|||
156778316|NCT02003924|565938150|FG001|Open-label Phase|Other|0|||
156778317|NCT02003924|565938151|FG002|Open-label Phase|Other|0|||
156778318|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Death|288|||
156778319|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Death|174|||
157114943|NCT04839380|567175707|FG000|Overall Study|Withdrawal by Subject|2|||
157114944|NCT04839380|567175707|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
157114945|NCT01378104|567175710|FG000|Overall Study|Adverse Event|8|||
157114946|NCT01378104|567175711|FG001|Overall Study|Adverse Event|8|||
157114947|NCT01378104|567175710|FG000|Overall Study|Lack of Efficacy|7|||
157114948|NCT01378104|567175711|FG001|Overall Study|Lack of Efficacy|5|||
157114949|NCT01378104|567175710|FG000|Overall Study|Withdrawal by Subject|12|||
157114950|NCT01378104|567175711|FG001|Overall Study|Withdrawal by Subject|13|||
157114951|NCT00205855|567175720|FG000|Overall Study|Only received temporary implants|16|||
157114952|NCT00205855|567175720|FG000|Overall Study|Withdrawal by Subject|5|||
157114953|NCT02354222|567175723|FG000|Overall Study|Adverse Event|0|||
157114954|NCT02354222|567175724|FG001|Overall Study|Adverse Event|3|||
157114955|NCT02354222|567175723|FG000|Overall Study|Physician Decision|1|||
157114956|NCT02354222|567175724|FG001|Overall Study|Physician Decision|1|||
157114957|NCT02354222|567175723|FG000|Overall Study|Pregnancy|1|||
157114958|NCT02354222|567175724|FG001|Overall Study|Pregnancy|0|||
157114959|NCT02354222|567175723|FG000|Overall Study|Withdrawal by Subject|2|||
157114960|NCT02354222|567175724|FG001|Overall Study|Withdrawal by Subject|3|||
157114961|NCT02354222|567175723|FG000|Overall Study|Conflict with the stopping criteria|0|||
156778320|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Death|4|||
156778321|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
156778322|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
156778323|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
156778324|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
156778325|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
156778326|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
156778327|NCT02003924|565938149|FG000|Long-term Follow-up Phase|Other|5|||
156778328|NCT02003924|565938150|FG001|Long-term Follow-up Phase|Other|2|||
157114962|NCT02354222|567175724|FG001|Overall Study|Conflict with the stopping criteria|4|||
157114963|NCT00917150|567175725|FG000|Overall Study|Adverse Event|12|||
157114964|NCT00917150|567175726|FG001|Overall Study|Adverse Event|7|||
157114965|NCT00917150|567175727|FG002|Overall Study|Adverse Event|12|||
156778329|NCT02003924|565938151|FG002|Long-term Follow-up Phase|Other|1|||
157208941|NCT04502862|567509509|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
157208942|NCT04502862|567509510|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
157208943|NCT04502862|567509509|FG000|Overall Study|Withdrawal by Subject|1|||
157208944|NCT04502862|567509510|FG001|Overall Study|Withdrawal by Subject|0|||
157208945|NCT04502862|567509509|FG000|Overall Study|Adverse Event|1|||
157208946|NCT04502862|567509510|FG001|Overall Study|Adverse Event|1|||
157208947|NCT01211613|567510972|FG000|Overall Study|Lost to Follow-up|2|||
157208948|NCT01211613|567510973|FG001|Overall Study|Lost to Follow-up|2|||
157208949|NCT01211613|567510974|FG002|Overall Study|Lost to Follow-up|2|||
157208950|NCT01211613|567510972|FG000|Overall Study|Withdrawal by Subject|1|||
157208951|NCT01211613|567510973|FG001|Overall Study|Withdrawal by Subject|0|||
157008776|NCT01177670|566783455|FG000|Overall Study|Study Terminated|115|||
157008777|NCT01177670|566783455|FG000|Overall Study|Physician Decision|50|||
157008778|NCT01177670|566783455|FG000|Overall Study|Withdrawal by Subject|4|||
157008779|NCT00979992|566783456|FG000|Overall Study|Ineligible - inadequate pathology|1|||
157008780|NCT00979992|566783456|FG000|Overall Study|Ineligible - wrong cell type|2|||
157008781|NCT00979992|566783456|FG000|Overall Study|Refused - Never Treated|2|||
157008782|NCT02918279|566783463|FG000|Overall Study|Lost to Follow-up|3|||
157008783|NCT02918279|566783464|FG001|Overall Study|Lost to Follow-up|6|||
157008784|NCT02918279|566783463|FG000|Overall Study|Withdrawal by Subject|5|||
157008785|NCT02918279|566783464|FG001|Overall Study|Withdrawal by Subject|15|||
157008786|NCT02918279|566783463|FG000|Overall Study|Withdrawal by parent/guardian|2|||
157008787|NCT02918279|566783464|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157008788|NCT02918279|566783463|FG000|Overall Study|Other|3|||
157008789|NCT02918279|566783464|FG001|Overall Study|Other|1|||
157008790|NCT00869258|566783465|FG000|Overall Study|Physician Decision|1|||
157008791|NCT02888080|566783466|FG000|Overall Study|Subject / Guardian decision|1|||
157008792|NCT02888080|566783467|FG001|Overall Study|Subject / Guardian decision|3|||
157008793|NCT02888080|566783466|FG000|Overall Study|New Therapy for study indication|1|||
157008794|NCT02888080|566783467|FG001|Overall Study|New Therapy for study indication|0|||
157008795|NCT02888080|566783466|FG000|Overall Study|Lack of Efficacy|0|||
157008796|NCT02888080|566783467|FG001|Overall Study|Lack of Efficacy|1|||
157008797|NCT02888080|566783466|FG000|Overall Study|Adverse Event|0|||
157008798|NCT02888080|566783467|FG001|Overall Study|Adverse Event|1|||
157008799|NCT01641198|566783468|FG000|After 12 Months of Function|Lost to Follow-up|3|||
157008800|NCT01641198|566783469|FG001|After 12 Months of Function|Lost to Follow-up|2|||
157008801|NCT01641198|566783470|FG002|After 12 Months of Function|Lost to Follow-up|2|||
157008802|NCT01641198|566783468|FG000|After 12 Months of Function|Protocol Violation|1|||
157008803|NCT01641198|566783469|FG001|After 12 Months of Function|Protocol Violation|0|||
157008804|NCT01641198|566783470|FG002|After 12 Months of Function|Protocol Violation|0|||
157008805|NCT01641198|566783468|FG000|After 12 Months of Function|Adverse Event|0|||
157008806|NCT01641198|566783469|FG001|After 12 Months of Function|Adverse Event|1|||
157008807|NCT01641198|566783470|FG002|After 12 Months of Function|Adverse Event|0|||
157008808|NCT01641198|566783468|FG000|After 24 Months of Function|Lost to Follow-up|4|||
157008809|NCT01641198|566783469|FG001|After 24 Months of Function|Lost to Follow-up|9|||
157008810|NCT01641198|566783470|FG002|After 24 Months of Function|Lost to Follow-up|6|||
157008811|NCT01641198|566783468|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
157008812|NCT01641198|566783469|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
157008813|NCT01641198|566783470|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
157008814|NCT01641198|566783468|FG000|At 15-20 Years of Function|Death|1|||
157008815|NCT01641198|566783469|FG001|At 15-20 Years of Function|Death|0|||
157008816|NCT01641198|566783470|FG002|At 15-20 Years of Function|Death|1|||
157008817|NCT03844269|566783477|FG000|Overall Study|Withdrawal pre-intervention|1|||
157008818|NCT03844269|566783477|FG000|Overall Study|Did not complete the intervention|2|||
157008819|NCT01075217|566783483|FG000|Overall Study|Adverse Event|1|||
157008820|NCT01075217|566783484|FG001|Overall Study|Adverse Event|1|||
157008821|NCT01075217|566783483|FG000|Overall Study|Physician Decision|1|||
157008822|NCT01075217|566783484|FG001|Overall Study|Physician Decision|0|||
157008823|NCT04054635|566783487|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
157008824|NCT04054635|566783488|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
157008825|NCT04054635|566783489|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
157008826|NCT04054635|566783487|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
157008827|NCT04054635|566783488|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
157008828|NCT04054635|566783489|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
157008829|NCT02512965|566783493|FG000|Overall Study|Withdrawal by Subject|0|||
157208952|NCT01211613|567510974|FG002|Overall Study|Withdrawal by Subject|0|||
157208953|NCT01020773|567510975|FG000|Overall Study|Withdrawal by Subject|4|||
157208954|NCT01020773|567510976|FG001|Overall Study|Withdrawal by Subject|3|||
157208955|NCT03853213|567510977|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
157008830|NCT02512965|566783494|FG001|Overall Study|Withdrawal by Subject|4|||
157008831|NCT00835770|566783495|FG000|Overall Study|MS Relapse|17|||
157008832|NCT00835770|566783496|FG001|Overall Study|MS Relapse|23|||
157008833|NCT00835770|566783495|FG000|Overall Study|MS Progression|14|||
157008834|NCT00835770|566783496|FG001|Overall Study|MS Progression|9|||
156778330|NCT00832975|565938164|FG000|Overall Study|Lost to Follow-up|7|||
156778331|NCT00832975|565938164|FG000|Overall Study|Protocol Violation|6|||
156778332|NCT00832975|565938164|FG000|Overall Study|Death|5|||
156778333|NCT00832975|565938164|FG000|Overall Study|Physician Decision|4|||
156778334|NCT00832975|565938164|FG000|Overall Study|Withdrawal by Subject|3|||
156778335|NCT00832975|565938164|FG000|Overall Study|Other reasons|14|||
156778336|NCT06081829|565938165|FG000|Overall Study|Participants still on-study|8|||
156778337|NCT06081829|565938165|FG000|Overall Study|Death|4|||
156778338|NCT01525589|565938166|FG000|Overall Study|Non-treatment-related AE|1|||
156778339|NCT01525589|565938167|FG001|Overall Study|Non-treatment-related AE|0|||
156778340|NCT01525589|565938168|FG002|Overall Study|Non-treatment-related AE|0|||
156778341|NCT01525589|565938166|FG000|Overall Study|Progressive disease|48|||
156778342|NCT01525589|565938167|FG001|Overall Study|Progressive disease|15|||
156778343|NCT01525589|565938168|FG002|Overall Study|Progressive disease|29|||
156778344|NCT01525589|565938166|FG000|Overall Study|Never treated|2|||
156778345|NCT01525589|565938167|FG001|Overall Study|Never treated|0|||
156778346|NCT01525589|565938168|FG002|Overall Study|Never treated|0|||
156778347|NCT01525589|565938166|FG000|Overall Study|Physician Decision|4|||
156778348|NCT01525589|565938167|FG001|Overall Study|Physician Decision|2|||
157208956|NCT03853213|567510978|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
157208957|NCT03853213|567510977|FG000|Overall Study|Other (e.g., too busy)|0|||
157208958|NCT03853213|567510978|FG001|Overall Study|Other (e.g., too busy)|2|||
157208959|NCT03302299|567510979|FG000|Overall Study|Protocol Violation|1|||
157208960|NCT01458132|567510980|FG000|Overall Study|Other|15|||
157208961|NCT01458132|567510981|FG001|Overall Study|Other|3|||
157208962|NCT02038959|567510986|FG000|Overall Study|Withdrawal by Subject|6|||
157208963|NCT02038959|567510987|FG001|Overall Study|Withdrawal by Subject|8|||
157208964|NCT00819091|567510993|FG000|Overall Study|Adverse Event|3|||
157208965|NCT00819091|567510994|FG001|Overall Study|Adverse Event|5|||
157208966|NCT00819091|567510993|FG000|Overall Study|Protocol Violation|0|||
157208967|NCT00819091|567510994|FG001|Overall Study|Protocol Violation|1|||
157208968|NCT00819091|567510993|FG000|Overall Study|Lost to Follow-up|2|||
157208969|NCT00819091|567510994|FG001|Overall Study|Lost to Follow-up|0|||
157208970|NCT00819091|567510993|FG000|Overall Study|Withdrawal by Subject|1|||
157208971|NCT00819091|567510994|FG001|Overall Study|Withdrawal by Subject|2|||
157208972|NCT00819091|567510993|FG000|Overall Study|Other|1|||
157208973|NCT00819091|567510994|FG001|Overall Study|Other|2|||
157208974|NCT01788163|567510996|FG000|Overall Study|Other|53|||
157208975|NCT01788163|567510997|FG001|Overall Study|Other|0|||
157208976|NCT01788163|567510998|FG002|Overall Study|Other|0|||
157208977|NCT01788163|567510999|FG003|Overall Study|Other|0|||
157208978|NCT01788163|567511000|FG004|Overall Study|Other|0|||
157208979|NCT01788163|567511001|FG005|Overall Study|Other|7|||
157208980|NCT01788163|567511002|FG006|Overall Study|Other|1|||
157208981|NCT01788163|567511003|FG007|Overall Study|Other|48|||
157208982|NCT01788163|567511004|FG008|Overall Study|Other|15|||
157208983|NCT01788163|567510996|FG000|Overall Study|Withdrawal by Subject|2|||
157208984|NCT01788163|567510997|FG001|Overall Study|Withdrawal by Subject|0|||
157208985|NCT01788163|567510998|FG002|Overall Study|Withdrawal by Subject|0|||
157208986|NCT01788163|567510999|FG003|Overall Study|Withdrawal by Subject|0|||
157208987|NCT01788163|567511000|FG004|Overall Study|Withdrawal by Subject|0|||
157208988|NCT01788163|567511001|FG005|Overall Study|Withdrawal by Subject|0|||
157208989|NCT01788163|567511002|FG006|Overall Study|Withdrawal by Subject|0|||
157208990|NCT01788163|567511003|FG007|Overall Study|Withdrawal by Subject|0|||
157208991|NCT01788163|567511004|FG008|Overall Study|Withdrawal by Subject|1|||
157208992|NCT00545441|567511005|FG000|Overall Study|Fistula draining at 6 months|2|||
157208993|NCT00545441|567511006|FG001|Overall Study|Fistula draining at 6 months|4|||
157208994|NCT00545441|567511005|FG000|Overall Study|Lost to Follow-up|9|||
157208995|NCT00545441|567511006|FG001|Overall Study|Lost to Follow-up|5|||
157208996|NCT00545441|567511005|FG000|Overall Study|Technical failure|0|||
157208997|NCT00545441|567511006|FG001|Overall Study|Technical failure|1|||
157208998|NCT00545441|567511005|FG000|Overall Study|Withdrawal by Subject|1|||
157208999|NCT00545441|567511006|FG001|Overall Study|Withdrawal by Subject|1|||
157209000|NCT00545441|567511005|FG000|Overall Study|Persistence or recurrence of fistula|5|||
157209001|NCT00545441|567511006|FG001|Overall Study|Persistence or recurrence of fistula|2|||
157209002|NCT00545441|567511005|FG000|Overall Study|Patients were not treated|1|||
157209003|NCT00545441|567511006|FG001|Overall Study|Patients were not treated|3|||
157209004|NCT03911960|567511007|FG000|Overall Study|Lost to Follow-up|5|||
157209005|NCT03911960|567511008|FG001|Overall Study|Lost to Follow-up|3|||
157209006|NCT00265239|567511009|FG000|Overall Study|Adverse Event|2|||
157209007|NCT00265239|567511010|FG001|Overall Study|Adverse Event|1|||
157209008|NCT02803138|567511013|FG000|Overall Study|Failure to return|38|||
156778349|NCT01525589|565938168|FG002|Overall Study|Physician Decision|2|||
156778350|NCT01525589|565938166|FG000|Overall Study|Death|0|||
156778351|NCT01525589|565938167|FG001|Overall Study|Death|0|||
156778352|NCT01525589|565938168|FG002|Overall Study|Death|2|||
156778353|NCT01525589|565938166|FG000|Overall Study|Treatment-related AE|1|||
156778354|NCT01525589|565938167|FG001|Overall Study|Treatment-related AE|1|||
157008835|NCT00835770|566783495|FG000|Overall Study|Adverse Event|113|||
157008836|NCT00835770|566783496|FG001|Overall Study|Adverse Event|124|||
157008837|NCT00835770|566783495|FG000|Overall Study|Lost to Follow-up|22|||
157008838|NCT00835770|566783496|FG001|Overall Study|Lost to Follow-up|19|||
157008839|NCT00835770|566783495|FG000|Overall Study|Consent Withdrawn|144|||
157008840|NCT00835770|566783496|FG001|Overall Study|Consent Withdrawn|156|||
157008841|NCT00835770|566783495|FG000|Overall Study|Investigator Decision|42|||
157008842|NCT00835770|566783496|FG001|Overall Study|Investigator Decision|42|||
157008843|NCT00835770|566783495|FG000|Overall Study|Participant Non-Compliance|11|||
157008844|NCT00835770|566783496|FG001|Overall Study|Participant Non-Compliance|9|||
157008845|NCT00835770|566783495|FG000|Overall Study|Death|4|||
157008846|NCT00835770|566783496|FG001|Overall Study|Death|6|||
157008847|NCT00835770|566783495|FG000|Overall Study|Other|115|||
157008848|NCT00835770|566783496|FG001|Overall Study|Other|104|||
157008849|NCT00835770|566783495|FG000|Overall Study|Other|2|||
157008850|NCT00835770|566783496|FG001|Overall Study|Other|1|||
157008851|NCT01254188|566783497|FG000|Overall Study|Disease Progression|6|||
157008852|NCT01254188|566783497|FG000|Overall Study|Protocol Violation|6|||
157008853|NCT01254188|566783497|FG000|Overall Study|Pregnancy|2|||
157008854|NCT01254188|566783497|FG000|Overall Study|Death|4|||
157008855|NCT01254188|566783497|FG000|Overall Study|Lost to Follow-up|5|||
157008856|NCT01254188|566783497|FG000|Overall Study|Withdrawal by Subject|7|||
157008857|NCT01254188|566783497|FG000|Overall Study|Adverse Event|43|||
157008858|NCT01254188|566783497|FG000|Overall Study|per investigator discretion|20|||
157008859|NCT01369498|566783498|FG000|Overall Study|Lack of Efficacy|9|||
157008860|NCT01369498|566783499|FG001|Overall Study|Lack of Efficacy|9|||
157008861|NCT01369498|566783500|FG002|Overall Study|Lack of Efficacy|1|||
157008862|NCT01369498|566783501|FG003|Overall Study|Lack of Efficacy|3|||
157008863|NCT01369498|566783498|FG000|Overall Study|Adverse Event|1|||
157008864|NCT01369498|566783499|FG001|Overall Study|Adverse Event|2|||
157008865|NCT01369498|566783500|FG002|Overall Study|Adverse Event|0|||
157008866|NCT01369498|566783501|FG003|Overall Study|Adverse Event|1|||
157008867|NCT01369498|566783498|FG000|Overall Study|Withdrawal of Consent|0|||
157008868|NCT01369498|566783499|FG001|Overall Study|Withdrawal of Consent|1|||
157008869|NCT01369498|566783500|FG002|Overall Study|Withdrawal of Consent|1|||
157008870|NCT01369498|566783501|FG003|Overall Study|Withdrawal of Consent|1|||
157008871|NCT01369498|566783498|FG000|Overall Study|Death|0|||
157008872|NCT01369498|566783499|FG001|Overall Study|Death|0|||
157008873|NCT01369498|566783500|FG002|Overall Study|Death|1|||
157008874|NCT01369498|566783501|FG003|Overall Study|Death|0|||
157008875|NCT01369498|566783498|FG000|Overall Study|Investigator's Discretion|1|||
157008876|NCT01369498|566783499|FG001|Overall Study|Investigator's Discretion|0|||
157008877|NCT01369498|566783500|FG002|Overall Study|Investigator's Discretion|1|||
157008878|NCT01369498|566783501|FG003|Overall Study|Investigator's Discretion|3|||
157008879|NCT01369498|566783498|FG000|Overall Study|Unknown Reason|1|||
157008880|NCT01369498|566783499|FG001|Overall Study|Unknown Reason|0|||
157008881|NCT01369498|566783500|FG002|Overall Study|Unknown Reason|11|||
157008882|NCT01369498|566783501|FG003|Overall Study|Unknown Reason|6|||
157008883|NCT01369498|566783498|FG000|Overall Study|Disease Progression|0|||
157008884|NCT01369498|566783499|FG001|Overall Study|Disease Progression|0|||
157008885|NCT01369498|566783500|FG002|Overall Study|Disease Progression|0|||
157008886|NCT01369498|566783501|FG003|Overall Study|Disease Progression|1|||
157008887|NCT02202499|566783505|FG000|Overall Study|Cancer diagnosis|0|||
157008888|NCT02202499|566783506|FG001|Overall Study|Cancer diagnosis|0|||
157008889|NCT02202499|566783507|FG002|Overall Study|Cancer diagnosis|1|||
157008890|NCT02202499|566783505|FG000|Overall Study|Moved from area|0|||
157008891|NCT02202499|566783506|FG001|Overall Study|Moved from area|0|||
157008892|NCT02202499|566783507|FG002|Overall Study|Moved from area|1|||
157008893|NCT02202499|566783505|FG000|Overall Study|Declined before randomization|1|||
157008894|NCT02202499|566783506|FG001|Overall Study|Declined before randomization|0|||
156778355|NCT01525589|565938168|FG002|Overall Study|Treatment-related AE|2|||
157008895|NCT02202499|566783507|FG002|Overall Study|Declined before randomization|0|||
157008896|NCT02202499|566783505|FG000|Overall Study|Auto accident|1|||
157008897|NCT02202499|566783506|FG001|Overall Study|Auto accident|0|||
157008898|NCT02202499|566783507|FG002|Overall Study|Auto accident|0|||
157008899|NCT00439569|566783514|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
157008900|NCT00439569|566783514|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
157008901|NCT00439569|566783514|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
157008902|NCT01124734|566783515|FG000|Overall Study|Disease progression|13|||
157008903|NCT01124734|566783515|FG000|Overall Study|Adverse Event|1|||
157008904|NCT01124734|566783515|FG000|Overall Study|Withdrawal by Subject|1|||
157008905|NCT01124734|566783515|FG000|Overall Study|Elected for alternative treatment|2|||
157008906|NCT02204982|566783519|FG000|Overall Study|Patient ineligible-medical monitor|1|||
157008907|NCT02204982|566783520|FG001|Overall Study|Patient ineligible-medical monitor|0|||
157008908|NCT02204982|566783519|FG000|Overall Study|Withdrawal by Subject|1|||
157008909|NCT02204982|566783520|FG001|Overall Study|Withdrawal by Subject|0|||
157008910|NCT02204982|566783519|FG000|Overall Study|Adverse Event|1|||
157008911|NCT02204982|566783520|FG001|Overall Study|Adverse Event|0|||
157008912|NCT02204982|566783519|FG000|Overall Study|Adverse Event and Investigator decision|1|||
157114966|NCT00917150|567175728|FG003|Overall Study|Adverse Event|11|||
156778356|NCT01525589|565938166|FG000|Overall Study|Other reasons|0|||
156778357|NCT01525589|565938167|FG001|Overall Study|Other reasons|1|||
156778358|NCT01525589|565938168|FG002|Overall Study|Other reasons|0|||
156778359|NCT01525589|565938166|FG000|Overall Study|Withdrawal by Subject|0|||
156778360|NCT01525589|565938167|FG001|Overall Study|Withdrawal by Subject|1|||
156778361|NCT01525589|565938168|FG002|Overall Study|Withdrawal by Subject|0|||
156778362|NCT02924376|565938169|FG000|Overall Study|Progressive Disease|4|||
156778363|NCT02924376|565938170|FG001|Overall Study|Progressive Disease|0|||
156778364|NCT02924376|565938171|FG002|Overall Study|Progressive Disease|1|||
156778365|NCT02924376|565938172|FG003|Overall Study|Progressive Disease|0|||
156778366|NCT02924376|565938169|FG000|Overall Study|Death|73|||
156778367|NCT02924376|565938170|FG001|Overall Study|Death|18|||
156778368|NCT02924376|565938171|FG002|Overall Study|Death|15|||
156778369|NCT02924376|565938172|FG003|Overall Study|Death|2|||
156778370|NCT02924376|565938169|FG000|Overall Study|Lost to Follow-up|3|||
156778371|NCT02924376|565938170|FG001|Overall Study|Lost to Follow-up|0|||
156778372|NCT02924376|565938171|FG002|Overall Study|Lost to Follow-up|0|||
156778373|NCT02924376|565938172|FG003|Overall Study|Lost to Follow-up|0|||
156778374|NCT02924376|565938169|FG000|Overall Study|Study Terminated by Sponsor|19|||
156778375|NCT02924376|565938170|FG001|Overall Study|Study Terminated by Sponsor|0|||
156778376|NCT02924376|565938171|FG002|Overall Study|Study Terminated by Sponsor|0|||
156778377|NCT02924376|565938172|FG003|Overall Study|Study Terminated by Sponsor|0|||
156778378|NCT02924376|565938169|FG000|Overall Study|Physician Decision|1|||
156778379|NCT02924376|565938170|FG001|Overall Study|Physician Decision|0|||
156778380|NCT02924376|565938171|FG002|Overall Study|Physician Decision|0|||
156778381|NCT02924376|565938172|FG003|Overall Study|Physician Decision|0|||
156778382|NCT02924376|565938169|FG000|Overall Study|Withdrawal by Subject|7|||
156778383|NCT02924376|565938170|FG001|Overall Study|Withdrawal by Subject|2|||
156778384|NCT02924376|565938171|FG002|Overall Study|Withdrawal by Subject|1|||
156778385|NCT02924376|565938172|FG003|Overall Study|Withdrawal by Subject|0|||
156778386|NCT02924376|565938169|FG000|Overall Study|Rolled Over to Another Study|1|||
156778387|NCT02924376|565938170|FG001|Overall Study|Rolled Over to Another Study|0|||
157209009|NCT02803138|567511013|FG000|Overall Study|Insufficient virological response|2|||
157209010|NCT02803138|567511013|FG000|Overall Study|Withdrawn consent|1|||
157209011|NCT02803138|567511013|FG000|Overall Study|Death|1|||
157209012|NCT02803138|567511013|FG000|Overall Study|Other, not specified|28|||
157209013|NCT00424515|567511014|FG000|Overall Study|Progressive Disease|10|||
156778388|NCT02924376|565938171|FG002|Overall Study|Rolled Over to Another Study|0|||
156778389|NCT02924376|565938172|FG003|Overall Study|Rolled Over to Another Study|0|||
156778390|NCT04835441|565938173|FG000|Overall Study|Physician Decision|4|||
156778391|NCT04835441|565938174|FG001|Overall Study|Physician Decision|4|||
156778392|NCT04835441|565938173|FG000|Overall Study|Other|1|||
156778393|NCT04835441|565938174|FG001|Overall Study|Other|1|||
156778394|NCT04835441|565938173|FG000|Overall Study|Lost to Follow-up|0|||
156778395|NCT04835441|565938174|FG001|Overall Study|Lost to Follow-up|1|||
156778396|NCT03069989|565938175|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
156778397|NCT03069989|565938176|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
156778398|NCT02145390|565938180|FG000|Overall Study|Withdrawal by Subject|1|||
156778399|NCT00177671|565939224|FG000|Overall Study|Withdrawal by Subject|5|||
156778400|NCT00177671|565939225|FG001|Overall Study|Withdrawal by Subject|6|||
156778401|NCT00177671|565939224|FG000|Overall Study|medical complications|2|||
156778402|NCT00177671|565939225|FG001|Overall Study|medical complications|0|||
156778403|NCT00177671|565939224|FG000|Overall Study|Adverse Event|6|||
156778404|NCT00177671|565939225|FG001|Overall Study|Adverse Event|0|||
156778405|NCT00177671|565939224|FG000|Overall Study|Physician Decision|12|||
156778406|NCT00177671|565939225|FG001|Overall Study|Physician Decision|8|||
156778407|NCT02293499|565939226|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
156778408|NCT02293499|565939227|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
156778409|NCT02293499|565939228|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
157008913|NCT02204982|566783520|FG001|Overall Study|Adverse Event and Investigator decision|0|||
157008914|NCT02204982|566783519|FG000|Overall Study|Physician Decision|0|||
157008915|NCT02204982|566783520|FG001|Overall Study|Physician Decision|2|||
157008916|NCT02204982|566783519|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
157008917|NCT02204982|566783520|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
157008918|NCT02204982|566783519|FG000|Overall Study|Termination of Study bySponsor|0|||
157008919|NCT02204982|566783520|FG001|Overall Study|Termination of Study bySponsor|1|||
157008920|NCT01202955|566783521|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
157008921|NCT01202955|566783522|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
157008922|NCT00159783|566783527|FG000|Overall Study|Adverse Event|5|||
157008923|NCT00159783|566783528|FG001|Overall Study|Adverse Event|7|||
157008924|NCT00159783|566783529|FG002|Overall Study|Adverse Event|9|||
157008925|NCT00159783|566783527|FG000|Overall Study|Lack of Efficacy|1|||
157008926|NCT00159783|566783528|FG001|Overall Study|Lack of Efficacy|2|||
157008927|NCT00159783|566783529|FG002|Overall Study|Lack of Efficacy|3|||
157008928|NCT00159783|566783527|FG000|Overall Study|Withdrawal by Subject|7|||
157209014|NCT00424515|567511015|FG001|Overall Study|Progressive Disease|11|||
157209015|NCT00424515|567511014|FG000|Overall Study|Adverse Event|0|||
157209016|NCT00424515|567511015|FG001|Overall Study|Adverse Event|1|||
157209017|NCT00424515|567511014|FG000|Overall Study|Intercurrent Illness|0|||
157209018|NCT00424515|567511015|FG001|Overall Study|Intercurrent Illness|1|||
157209019|NCT00424515|567511014|FG000|Overall Study|Withdrawal by Subject|1|||
157209020|NCT00424515|567511015|FG001|Overall Study|Withdrawal by Subject|0|||
157209021|NCT04071366|567511016|FG000|Part 1: Open-label (29 Days)|Death|4|||
157209022|NCT04071366|567511017|FG001|Part 1: Open-label (29 Days)|Death|2|||
157209023|NCT04071366|567511018|FG002|Part 1: Open-label (29 Days)|Death|8|||
157209024|NCT04071366|567511019|FG003|Part 1: Open-label (29 Days)|Death|0|||
157209025|NCT04071366|567511020|FG004|Part 1: Open-label (29 Days)|Death|0|||
157209026|NCT04071366|567511016|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
157209027|NCT04071366|567511017|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
157209028|NCT04071366|567511018|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
157209029|NCT04071366|567511019|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
157209030|NCT04071366|567511020|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
157209031|NCT04071366|567511016|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
157209032|NCT04071366|567511017|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
157209033|NCT04071366|567511018|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
157209034|NCT04071366|567511019|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
157209035|NCT04071366|567511020|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
157209036|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Death|0|||
157209037|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Death|0|||
157209038|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Death|0|||
157209039|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Death|2|||
157209040|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Death|2|||
157209041|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
157209042|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
157209043|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
157209044|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
157209045|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
157209046|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
157209047|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
157209048|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
157209049|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
157209050|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
157209051|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
157209052|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
157209053|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
157209054|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
157209055|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
157209056|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
157209057|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
157209058|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
157209059|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
157209060|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
157209061|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
157209062|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
157209063|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
157209064|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
157008929|NCT00159783|566783528|FG001|Overall Study|Withdrawal by Subject|11|||
157008930|NCT00159783|566783529|FG002|Overall Study|Withdrawal by Subject|12|||
157008931|NCT00159783|566783527|FG000|Overall Study|Lost to Follow-up|6|||
157008932|NCT00159783|566783528|FG001|Overall Study|Lost to Follow-up|5|||
157008933|NCT00159783|566783529|FG002|Overall Study|Lost to Follow-up|11|||
157008934|NCT00159783|566783527|FG000|Overall Study|Other|0|||
157008935|NCT00159783|566783528|FG001|Overall Study|Other|2|||
157008936|NCT00159783|566783529|FG002|Overall Study|Other|4|||
157008937|NCT02928224|566783530|FG000|Overall Study|Lost to Follow-up|1|||
157008938|NCT02928224|566783531|FG001|Overall Study|Lost to Follow-up|1|||
157008939|NCT02928224|566783532|FG002|Overall Study|Lost to Follow-up|3|||
157008940|NCT02928224|566783533|FG003|Overall Study|Lost to Follow-up|0|||
157008941|NCT02928224|566783530|FG000|Overall Study|Death|30|||
157008942|NCT02928224|566783531|FG001|Overall Study|Death|209|||
157008943|NCT02928224|566783532|FG002|Overall Study|Death|193|||
157008944|NCT02928224|566783533|FG003|Overall Study|Death|198|||
157008945|NCT02928224|566783530|FG000|Overall Study|Withdrawal by Subject|0|||
157008946|NCT02928224|566783531|FG001|Overall Study|Withdrawal by Subject|3|||
157008947|NCT02928224|566783532|FG002|Overall Study|Withdrawal by Subject|7|||
157008948|NCT02928224|566783533|FG003|Overall Study|Withdrawal by Subject|20|||
157008949|NCT02928224|566783530|FG000|Overall Study|Study participation terminated by sponsor|3|||
157008950|NCT02928224|566783531|FG001|Overall Study|Study participation terminated by sponsor|8|||
157209065|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
157209066|NCT04071366|567511016|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
157209067|NCT04071366|567511017|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
157209068|NCT04071366|567511018|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
157209069|NCT04071366|567511019|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
157209070|NCT04071366|567511020|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
157209071|NCT04318535|567511021|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
157209072|NCT04318535|567511022|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
157209073|NCT04318535|567511023|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
157209074|NCT00021229|567511025|FG000|Overall Study|Adverse Event|10|||
157209075|NCT00021229|567511026|FG001|Overall Study|Adverse Event|5|||
157209076|NCT00021229|567511027|FG002|Overall Study|Adverse Event|2|||
157209077|NCT00021229|567511025|FG000|Overall Study|Death|0|||
157209078|NCT00021229|567511026|FG001|Overall Study|Death|1|||
157209079|NCT00021229|567511027|FG002|Overall Study|Death|0|||
157209080|NCT00021229|567511025|FG000|Overall Study|Withdrawal by Subject|7|||
157209081|NCT00021229|567511026|FG001|Overall Study|Withdrawal by Subject|7|||
157209082|NCT00021229|567511027|FG002|Overall Study|Withdrawal by Subject|1|||
157209083|NCT00021229|567511025|FG000|Overall Study|Progressive Disease|15|||
157209084|NCT00021229|567511026|FG001|Overall Study|Progressive Disease|19|||
157209085|NCT00021229|567511027|FG002|Overall Study|Progressive Disease|12|||
157209086|NCT00021229|567511025|FG000|Overall Study|Protocol Violation|1|||
157209087|NCT00021229|567511026|FG001|Overall Study|Protocol Violation|1|||
157209088|NCT00021229|567511027|FG002|Overall Study|Protocol Violation|0|||
157209089|NCT00021229|567511025|FG000|Overall Study|Physician Decision|0|||
157209090|NCT00021229|567511026|FG001|Overall Study|Physician Decision|0|||
157209091|NCT00021229|567511027|FG002|Overall Study|Physician Decision|1|||
157209092|NCT00021229|567511025|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
157209093|NCT00021229|567511026|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
157209094|NCT00021229|567511027|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
157209095|NCT01901146|567511028|FG000|Neoadjuvant Phase|Death|1|||
157209096|NCT01901146|567511029|FG001|Neoadjuvant Phase|Death|2|||
157209097|NCT01901146|567511030|FG002|Neoadjuvant Phase|Death|0|||
157209098|NCT01901146|567511031|FG003|Neoadjuvant Phase|Death|0|||
157209099|NCT01901146|567511032|FG004|Neoadjuvant Phase|Death|0|||
157209100|NCT01901146|567511028|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
157209101|NCT01901146|567511029|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
157209102|NCT01901146|567511030|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
157209103|NCT01901146|567511031|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
157209104|NCT01901146|567511032|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
157209105|NCT01901146|567511028|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
157209106|NCT01901146|567511029|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
157209107|NCT01901146|567511030|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
157209108|NCT01901146|567511031|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
157209109|NCT01901146|567511032|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
157209110|NCT01901146|567511028|FG000|Neoadjuvant Phase|Physician Decision|1|||
157209111|NCT01901146|567511029|FG001|Neoadjuvant Phase|Physician Decision|2|||
157209112|NCT01901146|567511030|FG002|Neoadjuvant Phase|Physician Decision|0|||
157209113|NCT01901146|567511031|FG003|Neoadjuvant Phase|Physician Decision|0|||
157209114|NCT01901146|567511032|FG004|Neoadjuvant Phase|Physician Decision|0|||
157209115|NCT01901146|567511028|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
157209116|NCT01901146|567511029|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
157209117|NCT01901146|567511030|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
157209118|NCT01901146|567511031|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
157209119|NCT01901146|567511032|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
157209120|NCT01901146|567511028|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
157209121|NCT01901146|567511029|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
157209122|NCT01901146|567511030|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
157209123|NCT01901146|567511031|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
157209124|NCT01901146|567511032|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
157209125|NCT01901146|567511028|FG000|Adjuvant Phase|Other|0|||
157209126|NCT01901146|567511029|FG001|Adjuvant Phase|Other|0|||
157209127|NCT01901146|567511030|FG002|Adjuvant Phase|Other|1|||
157209128|NCT01901146|567511031|FG003|Adjuvant Phase|Other|0|||
157209129|NCT01901146|567511032|FG004|Adjuvant Phase|Other|0|||
157209130|NCT01901146|567511028|FG000|Adjuvant Phase|Death|0|||
157209131|NCT01901146|567511029|FG001|Adjuvant Phase|Death|0|||
157209132|NCT01901146|567511030|FG002|Adjuvant Phase|Death|0|||
157209133|NCT01901146|567511031|FG003|Adjuvant Phase|Death|0|||
157209134|NCT01901146|567511032|FG004|Adjuvant Phase|Death|3|||
157209135|NCT01901146|567511028|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
157209136|NCT01901146|567511029|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
157209137|NCT01901146|567511030|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
157209138|NCT01901146|567511031|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
157008951|NCT02928224|566783532|FG002|Overall Study|Study participation terminated by sponsor|12|||
157008952|NCT02928224|566783533|FG003|Overall Study|Study participation terminated by sponsor|3|||
157008953|NCT02928224|566783530|FG000|Overall Study|Other|3|||
157008954|NCT02928224|566783531|FG001|Overall Study|Other|3|||
157008955|NCT02928224|566783532|FG002|Overall Study|Other|5|||
157008956|NCT02928224|566783533|FG003|Overall Study|Other|0|||
157008957|NCT02538107|566783534|FG000|Overall Study|Did not receive any Mircera dose|11|||
157008958|NCT02538107|566783534|FG000|Overall Study|Missing|5|||
157008959|NCT02538107|566783534|FG000|Overall Study|Necessity of dialysis|20|||
157008960|NCT02538107|566783534|FG000|Overall Study|Administration of other ESA|11|||
157008961|NCT02538107|566783534|FG000|Overall Study|No further treatment necessary|18|||
157008962|NCT02538107|566783534|FG000|Overall Study|Withdrawal by Subject|17|||
157008963|NCT02538107|566783534|FG000|Overall Study|Death|4|||
157008964|NCT02538107|566783534|FG000|Overall Study|Administrative reason|5|||
157008965|NCT02538107|566783534|FG000|Overall Study|Adverse Event|4|||
157008966|NCT02538107|566783534|FG000|Overall Study|Surgery|1|||
157008967|NCT02538107|566783534|FG000|Overall Study|Other|7|||
157008968|NCT02538107|566783534|FG000|Overall Study|Not recorded|7|||
157008969|NCT01278394|566783535|FG000|Overall Study|Lost to Follow-up|1|||
157008970|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
157008971|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
157008972|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
157008973|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
157008974|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
157008975|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
157008976|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
157008977|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
157008978|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
157008979|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
157008980|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
157008981|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
157008982|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
157008983|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
157008984|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
157008985|NCT00958633|566783536|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
157008986|NCT00958633|566783537|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
157008987|NCT00958633|566783538|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
157008988|NCT00958633|566783536|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
157008989|NCT00958633|566783537|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
157008990|NCT00958633|566783538|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
157008991|NCT00094575|566783542|FG000|Overall Study|Death|146|||
157008992|NCT00094575|566783543|FG001|Overall Study|Death|146|||
157008993|NCT00794118|566783544|FG000|Overall Study|Lost to Follow-up|16|||
157008994|NCT00794118|566783544|FG000|Overall Study|Withdrawal by Subject|9|||
157008995|NCT00794118|566783544|FG000|Overall Study|Changed hospital center|2|||
157008996|NCT00206375|566783545|FG000|Overall Study|Lost to Follow-up|1|||
157008997|NCT00206375|566783546|FG001|Overall Study|Lost to Follow-up|0|||
157008998|NCT00206375|566783547|FG002|Overall Study|Lost to Follow-up|0|||
157008999|NCT00206375|566783545|FG000|Overall Study|Withdrawal by Subject|2|||
157009000|NCT00206375|566783546|FG001|Overall Study|Withdrawal by Subject|1|||
157009001|NCT00206375|566783547|FG002|Overall Study|Withdrawal by Subject|3|||
157114967|NCT00917150|567175725|FG000|Overall Study|Death|1|||
157114968|NCT00917150|567175726|FG001|Overall Study|Death|4|||
157114969|NCT00917150|567175727|FG002|Overall Study|Death|3|||
157114970|NCT00917150|567175728|FG003|Overall Study|Death|2|||
157114971|NCT00917150|567175725|FG000|Overall Study|Lost to Follow-up|1|||
157114972|NCT00917150|567175726|FG001|Overall Study|Lost to Follow-up|0|||
157114973|NCT00917150|567175727|FG002|Overall Study|Lost to Follow-up|4|||
157114974|NCT00917150|567175728|FG003|Overall Study|Lost to Follow-up|2|||
157114975|NCT00917150|567175725|FG000|Overall Study|Physician Decision|0|||
157114976|NCT00917150|567175726|FG001|Overall Study|Physician Decision|2|||
157114977|NCT00917150|567175727|FG002|Overall Study|Physician Decision|0|||
157114978|NCT00917150|567175728|FG003|Overall Study|Physician Decision|1|||
157114979|NCT00917150|567175725|FG000|Overall Study|Protocol Violation|5|||
157114980|NCT00917150|567175726|FG001|Overall Study|Protocol Violation|5|||
157114981|NCT00917150|567175727|FG002|Overall Study|Protocol Violation|3|||
157114982|NCT00917150|567175728|FG003|Overall Study|Protocol Violation|5|||
157114983|NCT00917150|567175725|FG000|Overall Study|Withdrawal by Subject|15|||
157114984|NCT00917150|567175726|FG001|Overall Study|Withdrawal by Subject|16|||
157114985|NCT00917150|567175727|FG002|Overall Study|Withdrawal by Subject|18|||
157114986|NCT00917150|567175728|FG003|Overall Study|Withdrawal by Subject|11|||
157114987|NCT00917150|567175725|FG000|Overall Study|Other than specified|3|||
157114988|NCT00917150|567175726|FG001|Overall Study|Other than specified|3|||
157114989|NCT00917150|567175727|FG002|Overall Study|Other than specified|2|||
157114990|NCT00917150|567175728|FG003|Overall Study|Other than specified|2|||
156778410|NCT02293499|565939226|FG000|Intervention - Camp|Withdrawal by Subject|3|||
156778411|NCT02293499|565939227|FG001|Intervention - Camp|Withdrawal by Subject|6|||
156778412|NCT02293499|565939228|FG002|Intervention - Camp|Withdrawal by Subject|2|||
156778413|NCT02293499|565939226|FG000|Intervention - Camp|these are those not showing up at camp|24|||
156778414|NCT02293499|565939227|FG001|Intervention - Camp|these are those not showing up at camp|28|||
156778415|NCT02293499|565939228|FG002|Intervention - Camp|these are those not showing up at camp|4|||
156778416|NCT02293499|565939226|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
156778417|NCT02293499|565939227|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
156778418|NCT02293499|565939228|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
156778419|NCT02293499|565939226|FG000|3 Month Follow Up|Lost to Follow-up|14|||
156778420|NCT02293499|565939227|FG001|3 Month Follow Up|Lost to Follow-up|15|||
156778421|NCT02293499|565939228|FG002|3 Month Follow Up|Lost to Follow-up|6|||
156778422|NCT02293499|565939226|FG000|6 Month Follow Up|Lost to Follow-up|17|||
156778423|NCT02293499|565939227|FG001|6 Month Follow Up|Lost to Follow-up|27|||
156778424|NCT02293499|565939228|FG002|6 Month Follow Up|Lost to Follow-up|6|||
156778425|NCT02293499|565939226|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
156778426|NCT02293499|565939227|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
156778427|NCT02293499|565939228|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
156778428|NCT02293499|565939226|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
156778429|NCT02293499|565939227|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
156778430|NCT02293499|565939228|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
156778431|NCT02293499|565939226|FG000|9 Month Follow Up|Lost to Follow-up|24|||
156778432|NCT02293499|565939227|FG001|9 Month Follow Up|Lost to Follow-up|28|||
156778433|NCT02293499|565939228|FG002|9 Month Follow Up|Lost to Follow-up|4|||
156778434|NCT02293499|565939226|FG000|12 Month Follow Up|Lost to Follow-up|26|||
156778435|NCT02293499|565939227|FG001|12 Month Follow Up|Lost to Follow-up|25|||
156778436|NCT02293499|565939228|FG002|12 Month Follow Up|Lost to Follow-up|6|||
156778437|NCT02293499|565939226|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
156778438|NCT02293499|565939227|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
156778439|NCT02293499|565939228|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
156778440|NCT02293499|565939226|FG000|15 Month Follow Up|Lost to Follow-up|22|||
156778441|NCT02293499|565939227|FG001|15 Month Follow Up|Lost to Follow-up|22|||
156778442|NCT02293499|565939228|FG002|15 Month Follow Up|Lost to Follow-up|7|||
156778443|NCT01787838|565939233|FG000|Overall Study|refused|1413|||
156778444|NCT01991314|565939237|FG000|Overall Study|Adverse Event|5|||
156778445|NCT01991314|565939238|FG001|Overall Study|Adverse Event|1|||
156778446|NCT01991314|565939237|FG000|Overall Study|Lost to Follow-up|6|||
156778447|NCT01991314|565939238|FG001|Overall Study|Lost to Follow-up|10|||
156778448|NCT01750346|565939239|FG000|Overall Study|Adverse Event|1|||
156778449|NCT01750346|565939240|FG001|Overall Study|Adverse Event|0|||
156778450|NCT01750346|565939241|FG002|Overall Study|Adverse Event|0|||
156778451|NCT01001104|565939242|FG000|Overall Study|Adverse Event|2|||
156778452|NCT01001104|565939243|FG001|Overall Study|Adverse Event|1|||
156778453|NCT01001104|565939244|FG002|Overall Study|Adverse Event|0|||
156778454|NCT01001104|565939245|FG003|Overall Study|Adverse Event|0|||
156778455|NCT01001104|565939242|FG000|Overall Study|Lost to Follow-up|0|||
156778456|NCT01001104|565939243|FG001|Overall Study|Lost to Follow-up|0|||
156778457|NCT01001104|565939244|FG002|Overall Study|Lost to Follow-up|1|||
156778458|NCT01001104|565939245|FG003|Overall Study|Lost to Follow-up|0|||
156778459|NCT01001104|565939242|FG000|Overall Study|Entry Criteria Not Met|0|||
156778460|NCT01001104|565939243|FG001|Overall Study|Entry Criteria Not Met|0|||
156778461|NCT01001104|565939244|FG002|Overall Study|Entry Criteria Not Met|0|||
156778462|NCT01001104|565939245|FG003|Overall Study|Entry Criteria Not Met|1|||
156778463|NCT01001104|565939242|FG000|Overall Study|Withdrawal by Subject|0|||
156778464|NCT01001104|565939243|FG001|Overall Study|Withdrawal by Subject|0|||
156778465|NCT01001104|565939244|FG002|Overall Study|Withdrawal by Subject|0|||
156778466|NCT01001104|565939245|FG003|Overall Study|Withdrawal by Subject|2|||
156778467|NCT02034591|565939246|FG000|Overall Study|Withdrawal by Subject|0|||
156778468|NCT02034591|565939247|FG001|Overall Study|Withdrawal by Subject|0|||
156778469|NCT02034591|565939248|FG002|Overall Study|Withdrawal by Subject|0|||
156778470|NCT02034591|565939249|FG003|Overall Study|Withdrawal by Subject|0|||
156778471|NCT02034591|565939250|FG004|Overall Study|Withdrawal by Subject|1|||
156778472|NCT02034591|565939251|FG005|Overall Study|Withdrawal by Subject|0|||
156778473|NCT00599313|565939252|FG000|Overall Study|Adverse Event|19|||
156778474|NCT00599313|565939252|FG000|Overall Study|Disease Progression|12|||
156778475|NCT00599313|565939252|FG000|Overall Study|Patient Request|4|||
156778476|NCT00599313|565939252|FG000|Overall Study|Ineligible|1|||
156778477|NCT00356590|565939253|FG000|Overall Study|Adverse Event|54|||
156778478|NCT00356590|565939253|FG000|Overall Study|Death|10|||
156778479|NCT00356590|565939253|FG000|Overall Study|Lost to Follow-up|35|||
156778480|NCT00356590|565939253|FG000|Overall Study|Physician Decision|46|||
156778481|NCT00356590|565939253|FG000|Overall Study|Withdrawal by Subject|41|||
156778482|NCT00356590|565939253|FG000|Overall Study|Completed month 12 only|2|||
156778483|NCT00356590|565939253|FG000|Overall Study|Protocol issues|6|||
156778484|NCT00356590|565939253|FG000|Overall Study|Response status|28|||
156778485|NCT00356590|565939253|FG000|Overall Study|Other|52|||
156778486|NCT00712920|565939254|FG000|Overall Study|Adverse Event|3|||
156778487|NCT00712920|565939255|FG001|Overall Study|Adverse Event|4|||
156778488|NCT00712920|565939256|FG002|Overall Study|Adverse Event|7|||
156778489|NCT00712920|565939254|FG000|Overall Study|Withdrawal by Subject|4|||
156778490|NCT00712920|565939255|FG001|Overall Study|Withdrawal by Subject|2|||
156778491|NCT00712920|565939256|FG002|Overall Study|Withdrawal by Subject|1|||
156778492|NCT00712920|565939254|FG000|Overall Study|Lost to Follow-up|1|||
156778493|NCT00712920|565939255|FG001|Overall Study|Lost to Follow-up|4|||
156778494|NCT00712920|565939256|FG002|Overall Study|Lost to Follow-up|0|||
156778495|NCT00712920|565939254|FG000|Overall Study|Lack of Efficacy|1|||
156778496|NCT00712920|565939255|FG001|Overall Study|Lack of Efficacy|0|||
156778497|NCT00712920|565939256|FG002|Overall Study|Lack of Efficacy|1|||
156778498|NCT00712920|565939254|FG000|Overall Study|Other|5|||
156778499|NCT00712920|565939255|FG001|Overall Study|Other|7|||
156778500|NCT00712920|565939256|FG002|Overall Study|Other|3|||
156778501|NCT00712920|565939254|FG000|Overall Study|Non-compliance|3|||
156778502|NCT00712920|565939255|FG001|Overall Study|Non-compliance|0|||
156778503|NCT00712920|565939256|FG002|Overall Study|Non-compliance|0|||
156778504|NCT02489773|565939257|FG000|Overall Study|Lost to Follow-up|4|||
156778505|NCT02489773|565939258|FG001|Overall Study|Lost to Follow-up|1|||
156778506|NCT02489773|565939257|FG000|Overall Study|Physician Decision|1|||
156778507|NCT02489773|565939258|FG001|Overall Study|Physician Decision|0|||
156778508|NCT02489773|565939257|FG000|Overall Study|Withdrawal by Subject|1|||
156778509|NCT02489773|565939258|FG001|Overall Study|Withdrawal by Subject|0|||
156778510|NCT02489773|565939257|FG000|Overall Study|Leave the country or the state|1|||
156778511|NCT02489773|565939258|FG001|Overall Study|Leave the country or the state|1|||
156778512|NCT02696616|565939260|FG000|Overall Study|Adverse Event|0|||
156778513|NCT02696616|565939261|FG001|Overall Study|Adverse Event|1|||
156778514|NCT02696616|565939262|FG002|Overall Study|Adverse Event|0|||
156778515|NCT02696616|565939263|FG003|Overall Study|Adverse Event|0|||
156778516|NCT02696616|565939264|FG004|Overall Study|Adverse Event|0|||
156778517|NCT02696616|565939265|FG005|Overall Study|Adverse Event|0|||
156778518|NCT02696616|565939266|FG006|Overall Study|Adverse Event|0|||
156778519|NCT01970371|565939267|FG000|Overall Study|Death|8|||
156778520|NCT01970371|565939268|FG001|Overall Study|Death|13|||
156778521|NCT01970371|565939269|FG002|Overall Study|Death|12|||
156778522|NCT01970371|565939267|FG000|Overall Study|Lost to Follow-up|0|||
156778523|NCT01970371|565939268|FG001|Overall Study|Lost to Follow-up|0|||
156778524|NCT01970371|565939269|FG002|Overall Study|Lost to Follow-up|1|||
156778525|NCT01481779|565939270|FG000|Overall Study|Adverse Event|23|||
156778526|NCT01481779|565939271|FG001|Overall Study|Adverse Event|5|||
156778527|NCT01481779|565939270|FG000|Overall Study|Lost to Follow-up|3|||
156778528|NCT01481779|565939271|FG001|Overall Study|Lost to Follow-up|2|||
156778529|NCT01481779|565939270|FG000|Overall Study|Protocol Violation|2|||
156778530|NCT01481779|565939271|FG001|Overall Study|Protocol Violation|3|||
156778531|NCT01481779|565939270|FG000|Overall Study|Withdrawal by Subject|26|||
156778532|NCT01481779|565939271|FG001|Overall Study|Withdrawal by Subject|13|||
156778533|NCT01481779|565939270|FG000|Overall Study|Physician Decision|13|||
156778534|NCT01481779|565939271|FG001|Overall Study|Physician Decision|4|||
156778535|NCT01481779|565939270|FG000|Overall Study|Sponsor Decision|3|||
156778536|NCT01481779|565939271|FG001|Overall Study|Sponsor Decision|1|||
156778537|NCT06420232|565939277|FG000|Overall Study|Withdrawal by Subject|3|||
156778538|NCT01697579|565939278|FG000|Base Study-Cycle 1|Adverse Event|1|||
156778539|NCT01697579|565939279|FG001|Base Study-Cycle 1|Adverse Event|0|||
156778540|NCT01697579|565939280|FG002|Base Study-Cycle 1|Adverse Event|0|||
156778541|NCT01697579|565939281|FG003|Base Study-Cycle 1|Adverse Event|0|||
156778542|NCT01697579|565939282|FG004|Base Study-Cycle 1|Adverse Event|0|||
156778543|NCT01697579|565939283|FG005|Base Study-Cycle 1|Adverse Event|0|||
156778544|NCT01697579|565939284|FG006|Base Study-Cycle 1|Adverse Event|0|||
156778545|NCT01697579|565939278|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
156778546|NCT01697579|565939279|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778547|NCT01697579|565939280|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778548|NCT01697579|565939281|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778549|NCT01697579|565939282|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778550|NCT01697579|565939283|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778551|NCT01697579|565939284|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
156778552|NCT01697579|565939278|FG000|Base Study-Cycle 1|Protocol Violation|0|||
156778553|NCT01697579|565939279|FG001|Base Study-Cycle 1|Protocol Violation|0|||
156778554|NCT01697579|565939280|FG002|Base Study-Cycle 1|Protocol Violation|0|||
156778555|NCT01697579|565939281|FG003|Base Study-Cycle 1|Protocol Violation|0|||
156778556|NCT01697579|565939282|FG004|Base Study-Cycle 1|Protocol Violation|3|||
156778557|NCT01697579|565939283|FG005|Base Study-Cycle 1|Protocol Violation|0|||
156778558|NCT01697579|565939284|FG006|Base Study-Cycle 1|Protocol Violation|0|||
156778559|NCT01697579|565939278|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778560|NCT01697579|565939279|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
156778561|NCT01697579|565939280|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778562|NCT01697579|565939281|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778563|NCT01697579|565939282|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778564|NCT01697579|565939283|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778565|NCT01697579|565939284|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
156778566|NCT01697579|565939278|FG000|Base Study-Cycle 1|Technical Problems|0|||
156778567|NCT01697579|565939279|FG001|Base Study-Cycle 1|Technical Problems|0|||
156778568|NCT01697579|565939280|FG002|Base Study-Cycle 1|Technical Problems|1|||
156778569|NCT01697579|565939281|FG003|Base Study-Cycle 1|Technical Problems|1|||
156778570|NCT01697579|565939282|FG004|Base Study-Cycle 1|Technical Problems|0|||
156778571|NCT01697579|565939283|FG005|Base Study-Cycle 1|Technical Problems|0|||
156778572|NCT01697579|565939284|FG006|Base Study-Cycle 1|Technical Problems|0|||
156778573|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Death|0|||
156778574|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Death|0|||
156778575|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Death|0|||
156778576|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Death|0|||
156778577|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Death|0|||
156778578|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Death|0|||
156778579|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Death|2|||
156778580|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778581|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778582|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
157114991|NCT02039375|567175729|FG000|Overall Study|Lost to Follow-up|2|||
157114992|NCT03891264|567175731|FG000|Overall Study|Adverse Event|1|||
157114993|NCT03891264|567175731|FG000|Overall Study|Withdrawal by Subject|2|||
157114994|NCT03891264|567175731|FG000|Overall Study|Physician Decision|2|||
157114995|NCT01692275|567175732|FG000|Overall Study|Lost to Follow-up|57|||
157114996|NCT01692275|567175733|FG001|Overall Study|Lost to Follow-up|48|||
156778583|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778584|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156778585|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
156778586|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
156778587|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778588|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778589|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778590|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778591|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
156778592|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
156778593|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
156778594|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778595|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778596|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778597|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778598|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778599|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
156778600|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
156778601|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778602|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778603|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778604|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
156778605|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
157114997|NCT01692275|567175732|FG000|Overall Study|Withdrawal by Subject|9|||
157114998|NCT01692275|567175733|FG001|Overall Study|Withdrawal by Subject|11|||
157114999|NCT00640328|567175734|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
157115000|NCT00640328|567175735|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
157115001|NCT00640328|567175736|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
157115002|NCT00640328|567175737|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
157115003|NCT00640328|567175738|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
156778606|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
156778607|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
156778608|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778609|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778610|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778611|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
157209139|NCT01901146|567511032|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
157209140|NCT01901146|567511028|FG000|Adjuvant Phase|Physician Decision|0|||
157209141|NCT01901146|567511029|FG001|Adjuvant Phase|Physician Decision|0|||
157209142|NCT01901146|567511030|FG002|Adjuvant Phase|Physician Decision|9|||
157209143|NCT01901146|567511031|FG003|Adjuvant Phase|Physician Decision|2|||
157209144|NCT01901146|567511032|FG004|Adjuvant Phase|Physician Decision|4|||
156778612|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778613|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
156778614|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
156778615|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778616|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778617|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778618|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778619|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
156778620|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
156778621|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
156778622|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778623|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778624|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778625|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778626|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
156778627|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
156778628|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
156778629|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778630|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778631|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778632|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
157209145|NCT01901146|567511028|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
157209146|NCT01901146|567511029|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
157209147|NCT01901146|567511030|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
157209148|NCT01901146|567511031|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
157209149|NCT01901146|567511032|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
157209150|NCT00297492|567511033|FG000|Set Quit Date|Lost to Follow-up|7|||
157209151|NCT00297492|567511034|FG001|Set Quit Date|Lost to Follow-up|13|||
157209152|NCT00297492|567511035|FG002|Set Quit Date|Lost to Follow-up|5|||
157209153|NCT00297492|567511033|FG000|6 Month Follow-up|Lost to Follow-up|63|||
157209154|NCT00297492|567511034|FG001|6 Month Follow-up|Lost to Follow-up|49|||
157209155|NCT00297492|567511035|FG002|6 Month Follow-up|Lost to Follow-up|27|||
157209156|NCT02675426|567511036|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
157209157|NCT02675426|567511037|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
157209158|NCT02675426|567511038|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
157209159|NCT02675426|567511039|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
157209160|NCT02675426|567511036|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
157209161|NCT02675426|567511037|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
157209162|NCT02675426|567511038|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
157209163|NCT02675426|567511039|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
157209164|NCT02675426|567511036|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
157209165|NCT02675426|567511037|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
156778633|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
156778634|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
157209166|NCT02675426|567511038|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
157209167|NCT02675426|567511039|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
157209168|NCT02675426|567511036|FG000|Period 1: Week 1 to Week 12|Other|2|||
157209169|NCT02675426|567511037|FG001|Period 1: Week 1 to Week 12|Other|1|||
157209170|NCT02675426|567511038|FG002|Period 1: Week 1 to Week 12|Other|0|||
157209171|NCT02675426|567511039|FG003|Period 1: Week 1 to Week 12|Other|2|||
157209172|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
157209173|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
157209174|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
157209175|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
157209176|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
157209177|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
157209178|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
157209179|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
157209180|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
157209181|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
157209182|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
157209183|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
157209184|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
157209185|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
157209186|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
157209187|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
157209188|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
157209189|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
157209190|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
157209191|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
157209192|NCT02675426|567511036|FG000|Period 2: Week 12 to Week 260|Other|8|||
157209193|NCT02675426|567511037|FG001|Period 2: Week 12 to Week 260|Other|12|||
157209194|NCT02675426|567511038|FG002|Period 2: Week 12 to Week 260|Other|23|||
157209195|NCT02675426|567511039|FG003|Period 2: Week 12 to Week 260|Other|15|||
157209196|NCT02237118|567511040|FG000|Overall Study|Protocol Violation|0|||
157209197|NCT02237118|567511041|FG001|Overall Study|Protocol Violation|1|||
157209198|NCT02237118|567511040|FG000|Overall Study|consent withdrawn|1|||
157209199|NCT02237118|567511041|FG001|Overall Study|consent withdrawn|0|||
157209200|NCT03978117|567511042|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
157209201|NCT03978117|567511043|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
157209202|NCT03978117|567511042|FG000|Overall Study|Lost to Follow-up|4|||
157209203|NCT03978117|567511043|FG001|Overall Study|Lost to Follow-up|4|||
157209204|NCT04723173|567511044|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
157209205|NCT02962739|567511049|FG000|Overall Study|Withdrawal by Subject|0|||
157209206|NCT02962739|567511050|FG001|Overall Study|Withdrawal by Subject|1|||
157209207|NCT02962739|567511051|FG002|Overall Study|Withdrawal by Subject|0|||
157209208|NCT02962739|567511052|FG003|Overall Study|Withdrawal by Subject|0|||
157209209|NCT02962739|567511053|FG004|Overall Study|Withdrawal by Subject|0|||
157209210|NCT02962739|567511054|FG005|Overall Study|Withdrawal by Subject|0|||
157209211|NCT02962739|567511049|FG000|Overall Study|Protocol Violation|0|||
157209212|NCT02962739|567511050|FG001|Overall Study|Protocol Violation|0|||
157209213|NCT02962739|567511051|FG002|Overall Study|Protocol Violation|1|||
157209214|NCT02962739|567511052|FG003|Overall Study|Protocol Violation|0|||
157209215|NCT02962739|567511053|FG004|Overall Study|Protocol Violation|1|||
157209216|NCT02962739|567511054|FG005|Overall Study|Protocol Violation|0|||
157209217|NCT00414011|567511055|FG000|Overall Study|Physician Decision|3|||
157209218|NCT00414011|567511055|FG000|Overall Study|Withdrawal by Subject|2|||
157209219|NCT00306852|567511056|FG000|Overall Study|Death|14|||
157209220|NCT00306852|567511057|FG001|Overall Study|Death|14|||
157209221|NCT00306852|567511056|FG000|Overall Study|Lost to Follow-up|15|||
157209222|NCT00306852|567511057|FG001|Overall Study|Lost to Follow-up|24|||
157209223|NCT00817778|567511059|FG000|Overall Study|Adverse Event|1|||
157209224|NCT00817778|567511060|FG001|Overall Study|Adverse Event|0|||
157209225|NCT00817778|567511059|FG000|Overall Study|Withdrawal by Subject|1|||
157209226|NCT00817778|567511060|FG001|Overall Study|Withdrawal by Subject|1|||
157209227|NCT00817778|567511059|FG000|Overall Study|Protocol Violation|0|||
157209228|NCT00817778|567511060|FG001|Overall Study|Protocol Violation|1|||
157209229|NCT00817778|567511059|FG000|Overall Study|Study-specific discontinuation criteria|0|||
157209230|NCT00817778|567511060|FG001|Overall Study|Study-specific discontinuation criteria|1|||
157209231|NCT00817778|567511059|FG000|Overall Study|Poor venous access|1|||
157209232|NCT00817778|567511060|FG001|Overall Study|Poor venous access|0|||
157209233|NCT03343054|567511061|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
157209234|NCT03343054|567511062|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
157209235|NCT03343054|567511063|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
156778635|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
156778636|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778637|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778638|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778639|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778640|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778641|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
156778642|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
156778643|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778644|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778645|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778646|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778647|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778648|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
156778649|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
156778650|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778651|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778652|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778653|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778654|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
156778655|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
156778656|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
156778657|NCT01697579|565939278|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778658|NCT01697579|565939279|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778659|NCT01697579|565939280|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778660|NCT01697579|565939281|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778661|NCT01697579|565939282|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778662|NCT01697579|565939283|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
156778663|NCT01697579|565939284|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
156778664|NCT04225039|565939287|FG000|Overall Study|Withdrawal by Subject|1|||
156778665|NCT04225039|565939288|FG001|Overall Study|Withdrawal by Subject|0|||
156778666|NCT04225039|565939289|FG002|Overall Study|Withdrawal by Subject|0|||
156778667|NCT04225039|565939290|FG003|Overall Study|Withdrawal by Subject|1|||
156778668|NCT04225039|565939287|FG000|Overall Study|Currently active on study treatment|0|||
156778669|NCT04225039|565939288|FG001|Overall Study|Currently active on study treatment|1|||
156778670|NCT04225039|565939289|FG002|Overall Study|Currently active on study treatment|0|||
156778671|NCT04225039|565939290|FG003|Overall Study|Currently active on study treatment|0|||
156778672|NCT04225039|565939287|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
156778673|NCT04225039|565939288|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778674|NCT04225039|565939289|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778675|NCT04225039|565939290|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
156778676|NCT04225039|565939287|FG000|Overall Study|Ineligible for treatment|0|||
156778677|NCT04225039|565939288|FG001|Overall Study|Ineligible for treatment|0|||
156778678|NCT04225039|565939289|FG002|Overall Study|Ineligible for treatment|0|||
156778679|NCT04225039|565939290|FG003|Overall Study|Ineligible for treatment|4|||
156778680|NCT00975923|565939291|FG000|Overall Study|Withdrawal by Subject|0|||
156778681|NCT00975923|565939292|FG001|Overall Study|Withdrawal by Subject|1|||
156778682|NCT05567172|565939293|FG000|Overall Study|Death|3|||
156778683|NCT03168672|565939296|FG000|Overall Study|Withdrawal by Subject|13|||
156778684|NCT03168672|565939296|FG000|Overall Study|Death|3|||
156778685|NCT03168672|565939296|FG000|Overall Study|Investigator's Decision|137|||
156778686|NCT03168672|565939296|FG000|Overall Study|Adverse Event|1|||
156778687|NCT03168672|565939296|FG000|Overall Study|Other|2|||
156778688|NCT03168672|565939296|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
156778689|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
156778690|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
156778691|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
156778692|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
156778693|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
157209236|NCT03343054|567511061|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
157209237|NCT03343054|567511062|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
157209238|NCT03343054|567511063|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
157209239|NCT03343054|567511061|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
157209240|NCT03343054|567511062|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
157209241|NCT03343054|567511063|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
156778694|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
156778695|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
157209242|NCT03343054|567511061|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
156778696|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
156778697|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
156778698|NCT00433537|565939297|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
156778699|NCT00433537|565939298|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
156778700|NCT00433537|565939299|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
156778701|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
156778702|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
156778703|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
156778704|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
156778705|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
156778706|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
156778707|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
156778708|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
156778709|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
156778710|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
156778711|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
156778712|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
156778713|NCT00433537|565939297|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
156778714|NCT00433537|565939298|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
156778715|NCT00433537|565939299|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
156778716|NCT04635423|565939312|FG000|Overall Study|Ongoing|493|||
156778717|NCT04635423|565939313|FG001|Overall Study|Ongoing|501|||
156778718|NCT04635423|565939312|FG000|Overall Study|Withdrawal by Subject|36|||
156778719|NCT04635423|565939313|FG001|Overall Study|Withdrawal by Subject|29|||
156778720|NCT04364646|565939318|FG000|Overall Study|Lost to Follow-up|1|||
156778721|NCT04364646|565939319|FG001|Overall Study|Lost to Follow-up|0|||
156778722|NCT04364646|565939318|FG000|Overall Study|Withdrawal by Subject|7|||
156778723|NCT04364646|565939319|FG001|Overall Study|Withdrawal by Subject|14|||
156778724|NCT04364646|565939318|FG000|Overall Study|Protocol Violation|4|||
156778725|NCT04364646|565939319|FG001|Overall Study|Protocol Violation|5|||
156778726|NCT02555878|565939321|FG000|Overall Study|Lost to Follow-up|2|||
156778727|NCT02555878|565939322|FG001|Overall Study|Lost to Follow-up|3|||
156778728|NCT02555878|565939321|FG000|Overall Study|Withdrawal by Subject|48|||
156778729|NCT02555878|565939322|FG001|Overall Study|Withdrawal by Subject|48|||
156778730|NCT02555878|565939321|FG000|Overall Study|Adverse Event|12|||
156778731|NCT02555878|565939322|FG001|Overall Study|Adverse Event|8|||
156778732|NCT02555878|565939321|FG000|Overall Study|Death|74|||
156778733|NCT02555878|565939322|FG001|Overall Study|Death|59|||
156778734|NCT02555878|565939321|FG000|Overall Study|Protocol Violation|1|||
156778735|NCT02555878|565939322|FG001|Overall Study|Protocol Violation|2|||
156778736|NCT02555878|565939321|FG000|Overall Study|Physician Decision|12|||
156778737|NCT02555878|565939322|FG001|Overall Study|Physician Decision|13|||
156778738|NCT02555878|565939321|FG000|Overall Study|Other|17|||
156778739|NCT02555878|565939322|FG001|Overall Study|Other|17|||
156778740|NCT03608033|565939325|FG000|Treatment Period|Death|0|||
156778741|NCT03608033|565939326|FG001|Treatment Period|Death|1|||
156778742|NCT03608033|565939325|FG000|Treatment Period|Adverse Event|1|||
156778743|NCT03608033|565939326|FG001|Treatment Period|Adverse Event|5|||
156778744|NCT03608033|565939325|FG000|Treatment Period|Lack of Efficacy|4|||
156778745|NCT03608033|565939326|FG001|Treatment Period|Lack of Efficacy|3|||
156778746|NCT03608033|565939325|FG000|Treatment Period|Lost to Follow-up|2|||
156778747|NCT03608033|565939326|FG001|Treatment Period|Lost to Follow-up|6|||
156778748|NCT03608033|565939325|FG000|Treatment Period|Physician Decision|6|||
156778749|NCT03608033|565939326|FG001|Treatment Period|Physician Decision|10|||
156778750|NCT03608033|565939325|FG000|Treatment Period|Pregnancy|1|||
156778751|NCT03608033|565939326|FG001|Treatment Period|Pregnancy|0|||
156778752|NCT03608033|565939325|FG000|Treatment Period|Protocol Violation|1|||
156778753|NCT03608033|565939326|FG001|Treatment Period|Protocol Violation|2|||
156778754|NCT03608033|565939325|FG000|Treatment Period|Withdrawal by Subject|46|||
157209243|NCT03343054|567511062|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
157209244|NCT03343054|567511063|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
156778755|NCT03608033|565939326|FG001|Treatment Period|Withdrawal by Subject|45|||
156778756|NCT03608033|565939325|FG000|Treatment Period|Study terminated by sponsor|82|||
156778757|NCT03608033|565939326|FG001|Treatment Period|Study terminated by sponsor|68|||
156778758|NCT03608033|565939325|FG000|Treatment Period|Site Terminated by Sponsor|1|||
156778759|NCT03608033|565939326|FG001|Treatment Period|Site Terminated by Sponsor|0|||
156778760|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Adverse Event|1|||
156778761|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Adverse Event|0|||
156778762|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
156778763|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
156778764|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
156778765|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
156778766|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
156778767|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
157209245|NCT01537549|567511064|FG000|Overall Study|Lost to Follow-up|1|||
157209246|NCT01537549|567511064|FG000|Overall Study|Withdrawal by Subject|2|||
157209247|NCT00883740|567511065|FG000|First Intervention|Lost to Follow-up|1|||
157209248|NCT00883740|567511066|FG001|First Intervention|Lost to Follow-up|0|||
157209249|NCT00883740|567511065|FG000|First Intervention|No longer willing to participate|2|||
157209250|NCT00883740|567511066|FG001|First Intervention|No longer willing to participate|0|||
157209251|NCT00883740|567511065|FG000|First Intervention|Protocol Violation|3|||
157209252|NCT00883740|567511066|FG001|First Intervention|Protocol Violation|6|||
157209253|NCT00883740|567511065|FG000|First Intervention|Adverse Event|1|||
157209254|NCT00883740|567511066|FG001|First Intervention|Adverse Event|2|||
157209255|NCT00883740|567511065|FG000|Second Intervention|Protocol Violation|1|||
157209256|NCT00883740|567511066|FG001|Second Intervention|Protocol Violation|0|||
157209257|NCT00883740|567511065|FG000|Second Intervention|No longer willing to participate|0|||
157209258|NCT00883740|567511066|FG001|Second Intervention|No longer willing to participate|1|||
157209259|NCT01286207|567511067|FG000|Overall Study|Adverse Event|27|||
157209260|NCT01286207|567511068|FG001|Overall Study|Adverse Event|41|||
157209261|NCT01286207|567511069|FG002|Overall Study|Adverse Event|8|||
157209262|NCT01286207|567511067|FG000|Overall Study|Lost to Follow-up|49|||
157209263|NCT01286207|567511068|FG001|Overall Study|Lost to Follow-up|43|||
157209264|NCT01286207|567511069|FG002|Overall Study|Lost to Follow-up|20|||
157209265|NCT01286207|567511067|FG000|Overall Study|Withdrawal by Subject|93|||
157209266|NCT01286207|567511068|FG001|Overall Study|Withdrawal by Subject|79|||
157209267|NCT01286207|567511069|FG002|Overall Study|Withdrawal by Subject|41|||
157209268|NCT01286207|567511067|FG000|Overall Study|Lack of Response|92|||
157209269|NCT01286207|567511068|FG001|Overall Study|Lack of Response|38|||
157209270|NCT01286207|567511069|FG002|Overall Study|Lack of Response|8|||
157209271|NCT01286207|567511067|FG000|Overall Study|Other|37|||
157009002|NCT00206375|566783545|FG000|Overall Study|Study terminated due to lack of funds|0|||
157009003|NCT00206375|566783546|FG001|Overall Study|Study terminated due to lack of funds|1|||
157009004|NCT00206375|566783547|FG002|Overall Study|Study terminated due to lack of funds|1|||
157009005|NCT01353963|566783548|FG000|Overall Study|Adverse Event|2|||
157009006|NCT01420549|566783549|FG000|Overall Study|Adverse Event|1|||
157009007|NCT01420549|566783550|FG001|Overall Study|Adverse Event|1|||
157009008|NCT01420549|566783549|FG000|Overall Study|Lost to Follow-up|2|||
157009009|NCT01420549|566783550|FG001|Overall Study|Lost to Follow-up|2|||
157009010|NCT01420549|566783549|FG000|Overall Study|Protocol Violation|0|||
157009011|NCT01420549|566783550|FG001|Overall Study|Protocol Violation|1|||
157009012|NCT01420549|566783549|FG000|Overall Study|Non-adherence to medication|4|||
157009013|NCT01420549|566783550|FG001|Overall Study|Non-adherence to medication|1|||
157009014|NCT02763319|566784936|FG000|Overall Study|Adverse Event|12|||
157009015|NCT02763319|566784937|FG001|Overall Study|Adverse Event|3|||
157009016|NCT02763319|566784936|FG000|Overall Study|Death|123|||
157009017|NCT02763319|566784937|FG001|Overall Study|Death|123|||
157009018|NCT02763319|566784936|FG000|Overall Study|Lost to Follow-up|6|||
157009019|NCT02763319|566784937|FG001|Overall Study|Lost to Follow-up|7|||
157009020|NCT02763319|566784936|FG000|Overall Study|Noncompliance with Study Drug|2|||
157009021|NCT02763319|566784937|FG001|Overall Study|Noncompliance with Study Drug|0|||
157009022|NCT02763319|566784936|FG000|Overall Study|"Captured as Other in Database"|29|||
157009023|NCT02763319|566784937|FG001|Overall Study|"Captured as Other in Database"|34|||
157009024|NCT02763319|566784936|FG000|Overall Study|Physician Decision|1|||
157009025|NCT02763319|566784937|FG001|Overall Study|Physician Decision|7|||
157009026|NCT02763319|566784936|FG000|Overall Study|Progressive Disease|24|||
157009027|NCT02763319|566784937|FG001|Overall Study|Progressive Disease|27|||
157009028|NCT02763319|566784936|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
157009029|NCT02763319|566784937|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
157009030|NCT02763319|566784936|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
157009031|NCT02763319|566784937|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
157009032|NCT02763319|566784936|FG000|Overall Study|Withdrawal by Subject|26|||
157009033|NCT02763319|566784937|FG001|Overall Study|Withdrawal by Subject|25|||
157009034|NCT00840177|566784941|FG000|Overall Study|Adverse Event|5|||
157009035|NCT00840177|566784942|FG001|Overall Study|Adverse Event|1|||
157009036|NCT00840177|566784943|FG002|Overall Study|Adverse Event|1|||
157009037|NCT00840177|566784941|FG000|Overall Study|Refusal unrelated to adverse events|1|||
157009038|NCT00840177|566784942|FG001|Overall Study|Refusal unrelated to adverse events|0|||
157009039|NCT00840177|566784943|FG002|Overall Study|Refusal unrelated to adverse events|1|||
157009040|NCT00840177|566784941|FG000|Overall Study|Progression/relapse|2|||
157009041|NCT00840177|566784942|FG001|Overall Study|Progression/relapse|0|||
157009042|NCT00840177|566784943|FG002|Overall Study|Progression/relapse|0|||
157009043|NCT00840177|566784941|FG000|Overall Study|Death|4|||
157209272|NCT01286207|567511068|FG001|Overall Study|Other|47|||
157209273|NCT01286207|567511069|FG002|Overall Study|Other|13|||
157209274|NCT02923115|567511070|FG000|Overall Study|Lost to Follow-up|0|||
157209275|NCT02923115|567511071|FG001|Overall Study|Lost to Follow-up|0|||
157209276|NCT02923115|567511072|FG002|Overall Study|Lost to Follow-up|0|||
157209277|NCT02923115|567511073|FG003|Overall Study|Lost to Follow-up|1|||
157209278|NCT02923115|567511074|FG004|Overall Study|Lost to Follow-up|0|||
156778768|NCT03608033|565939325|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
156778769|NCT03608033|565939326|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
156778770|NCT03483012|565939327|FG000|Overall Study|Lack of Efficacy|6|||
156778771|NCT05253807|565939328|FG000|Overall Study|Death|1|||
156778772|NCT05253807|565939329|FG001|Overall Study|Death|4|||
156778773|NCT05253807|565939328|FG000|Overall Study|Withdrawal by Subject|1|||
156778774|NCT05253807|565939329|FG001|Overall Study|Withdrawal by Subject|0|||
156778775|NCT05253807|565939328|FG000|Overall Study|Study Terminated by Sponsor|1|||
156778776|NCT05253807|565939329|FG001|Overall Study|Study Terminated by Sponsor|1|||
156778777|NCT02360579|565939330|FG000|Initial|Death|16|||
156778778|NCT02360579|565939331|FG001|Initial|Death|49|||
156778779|NCT02360579|565939332|FG002|Initial|Death|0|||
156778780|NCT02360579|565939333|FG003|Initial|Death|71|||
156778781|NCT02360579|565939330|FG000|Initial|Lost to Follow-up|0|||
157209279|NCT02923115|567511075|FG005|Overall Study|Lost to Follow-up|0|||
157209280|NCT02923115|567511070|FG000|Overall Study|Withdrawal by Subject|0|||
157209281|NCT02923115|567511071|FG001|Overall Study|Withdrawal by Subject|1|||
157209282|NCT02923115|567511072|FG002|Overall Study|Withdrawal by Subject|0|||
157209283|NCT02923115|567511073|FG003|Overall Study|Withdrawal by Subject|0|||
157209284|NCT02923115|567511074|FG004|Overall Study|Withdrawal by Subject|0|||
157209285|NCT02923115|567511075|FG005|Overall Study|Withdrawal by Subject|0|||
157209286|NCT02923115|567511070|FG000|Overall Study|Randomized, but not dosed|0|||
157209287|NCT02923115|567511071|FG001|Overall Study|Randomized, but not dosed|0|||
157209288|NCT02923115|567511072|FG002|Overall Study|Randomized, but not dosed|3|||
157209289|NCT02923115|567511073|FG003|Overall Study|Randomized, but not dosed|1|||
157209290|NCT02923115|567511074|FG004|Overall Study|Randomized, but not dosed|5|||
157209291|NCT02923115|567511075|FG005|Overall Study|Randomized, but not dosed|0|||
157209292|NCT01875991|567511080|FG000|Overall Study|Withdrawal by Subject|6|||
157209293|NCT01875991|567511081|FG001|Overall Study|Withdrawal by Subject|6|||
157209294|NCT01875991|567511080|FG000|Overall Study|Sponsor Decision|1|||
157209295|NCT01875991|567511081|FG001|Overall Study|Sponsor Decision|0|||
157209296|NCT00103259|567511082|FG000|Overall Study|Death|3|||
157209297|NCT00103259|567511083|FG001|Overall Study|Death|2|||
157209298|NCT00103259|567511082|FG000|Overall Study|Withdrawal by Subject|2|||
157209299|NCT00103259|567511083|FG001|Overall Study|Withdrawal by Subject|3|||
157209300|NCT00103259|567511082|FG000|Overall Study|alternative therapy|1|||
157209301|NCT00103259|567511083|FG001|Overall Study|alternative therapy|0|||
157209302|NCT00103259|567511082|FG000|Overall Study|other (reasons were not specified)|2|||
157209303|NCT00103259|567511083|FG001|Overall Study|other (reasons were not specified)|1|||
157209304|NCT00103259|567511082|FG000|Overall Study|ineligible/no protocol therapy|4|||
157209305|NCT00103259|567511083|FG001|Overall Study|ineligible/no protocol therapy|6|||
157209306|NCT03224234|567511084|FG000|Main Study|Lost to Follow-up|5|||
157209307|NCT03224234|567511085|FG001|Main Study|Lost to Follow-up|5|||
157209308|NCT00835068|567511086|FG000|Overall Study|Death|1|||
157209309|NCT00835068|567511087|FG001|Overall Study|Death|0|||
157209310|NCT00835068|567511086|FG000|Overall Study|Adverse Event|0|||
157209311|NCT00835068|567511087|FG001|Overall Study|Adverse Event|1|||
157209312|NCT00835068|567511086|FG000|Overall Study|Other|8|||
157209313|NCT00835068|567511087|FG001|Overall Study|Other|0|||
157209314|NCT00835068|567511086|FG000|Overall Study|Withdrawal by Subject|1|||
157209315|NCT00835068|567511087|FG001|Overall Study|Withdrawal by Subject|0|||
157209316|NCT05631093|567511092|FG000|Overall Study|Death|0|||
157209317|NCT05631093|567511093|FG001|Overall Study|Death|1|||
157009044|NCT00840177|566784942|FG001|Overall Study|Death|5|||
157009045|NCT00840177|566784943|FG002|Overall Study|Death|5|||
157009046|NCT00840177|566784941|FG000|Overall Study|not protocol specified|6|||
157009047|NCT00840177|566784942|FG001|Overall Study|not protocol specified|3|||
157009048|NCT00840177|566784943|FG002|Overall Study|not protocol specified|0|||
157009049|NCT00840177|566784941|FG000|Overall Study|Ineligible|0|||
157009050|NCT00840177|566784942|FG001|Overall Study|Ineligible|0|||
157009051|NCT00840177|566784943|FG002|Overall Study|Ineligible|3|||
157009052|NCT00840177|566784941|FG000|Overall Study|Did not start treatment|0|||
157009053|NCT00840177|566784942|FG001|Overall Study|Did not start treatment|0|||
157009054|NCT00840177|566784943|FG002|Overall Study|Did not start treatment|1|||
157009055|NCT03345901|566784947|FG000|Overall Study|The study was terminated|18|||
157009056|NCT00925587|566784948|FG000|Overall Study|Protocol Specified Criteria|6|||
157009057|NCT00925587|566784949|FG001|Overall Study|Protocol Specified Criteria|6|||
157009058|NCT00925587|566784948|FG000|Overall Study|Physician Decision|4|||
157009059|NCT00925587|566784949|FG001|Overall Study|Physician Decision|1|||
157009060|NCT00925587|566784948|FG000|Overall Study|Protocol Violation|6|||
157009061|NCT00925587|566784949|FG001|Overall Study|Protocol Violation|4|||
157009062|NCT00925587|566784948|FG000|Overall Study|Withdrawal by Subject|9|||
157009063|NCT00925587|566784949|FG001|Overall Study|Withdrawal by Subject|6|||
157009064|NCT00925587|566784948|FG000|Overall Study|Death|5|||
157009065|NCT00925587|566784949|FG001|Overall Study|Death|5|||
157009066|NCT00925587|566784948|FG000|Overall Study|Adverse Event|6|||
157009067|NCT00925587|566784949|FG001|Overall Study|Adverse Event|2|||
157009068|NCT00925587|566784948|FG000|Overall Study|Lost to Follow-up|0|||
157009069|NCT00925587|566784949|FG001|Overall Study|Lost to Follow-up|1|||
157009070|NCT01149369|566784950|FG000|Overall Study|Adverse Event|6|||
157009071|NCT01149369|566784951|FG001|Overall Study|Adverse Event|3|||
157009072|NCT02767765|566784952|FG000|Overall Study|Adverse Event|4|||
157009073|NCT02767765|566784952|FG000|Overall Study|Death|1|||
157009074|NCT02767765|566784952|FG000|Overall Study|Insufficient response|1|||
157009075|NCT02767765|566784952|FG000|Overall Study|Lost to Follow-up|2|||
157009076|NCT02767765|566784952|FG000|Overall Study|Investigator decision|1|||
157009077|NCT02767765|566784952|FG000|Overall Study|Non-Compliance|1|||
157009078|NCT02767765|566784952|FG000|Overall Study|Withdrawal by Subject|1|||
157009079|NCT04723394|566784953|FG000|Overall Study|Adverse Event|0|||
157009080|NCT04723394|566784954|FG001|Overall Study|Adverse Event|3|||
157009081|NCT04723394|566784953|FG000|Overall Study|Death|8|||
157009082|NCT04723394|566784954|FG001|Overall Study|Death|8|||
157009083|NCT04723394|566784953|FG000|Overall Study|Lost to Follow-up|20|||
157009084|NCT04723394|566784954|FG001|Overall Study|Lost to Follow-up|17|||
157009085|NCT04723394|566784953|FG000|Overall Study|Physician Decision|1|||
157209318|NCT05631093|567511092|FG000|Overall Study|Lost to Follow-up|1|||
157009086|NCT04723394|566784954|FG001|Overall Study|Physician Decision|0|||
157209319|NCT05631093|567511093|FG001|Overall Study|Lost to Follow-up|2|||
157209320|NCT05631093|567511092|FG000|Overall Study|Physician Decision|1|||
157209321|NCT05631093|567511093|FG001|Overall Study|Physician Decision|0|||
157009087|NCT04723394|566784953|FG000|Overall Study|Withdrawal by Subject|20|||
157209322|NCT05631093|567511092|FG000|Overall Study|Withdrawal by Subject|4|||
157209323|NCT05631093|567511093|FG001|Overall Study|Withdrawal by Subject|1|||
157209324|NCT05631093|567511092|FG000|Overall Study|Ongoing|353|||
157209325|NCT05631093|567511093|FG001|Overall Study|Ongoing|177|||
157209326|NCT05631093|567511092|FG000|Overall Study|Adverse Event|0|||
157209327|NCT05631093|567511093|FG001|Overall Study|Adverse Event|1|||
157209328|NCT03252756|567511094|FG000|Overall Study|Protocol Violation|2|||
157209329|NCT03252756|567511095|FG001|Overall Study|Protocol Violation|4|||
157209330|NCT03252756|567511094|FG000|Overall Study|COVID-19 Pandemic|1|||
157209331|NCT03252756|567511095|FG001|Overall Study|COVID-19 Pandemic|1|||
157209332|NCT03252756|567511094|FG000|Overall Study|Study Drug Expiration|0|||
157209333|NCT03252756|567511095|FG001|Overall Study|Study Drug Expiration|1|||
157209334|NCT03594175|567511096|FG000|Overall Study|Not treated|8|||
157209335|NCT03594175|567511097|FG001|Overall Study|Not treated|1|||
157009088|NCT04723394|566784954|FG001|Overall Study|Withdrawal by Subject|34|||
157009089|NCT04723394|566784953|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
157009090|NCT04723394|566784954|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
157009091|NCT00774397|566784955|FG000|Overall Study|Adverse Event|1|||
157009092|NCT00774397|566784956|FG001|Overall Study|Adverse Event|3|||
157009093|NCT00774397|566784957|FG002|Overall Study|Adverse Event|16|||
157009094|NCT00774397|566784958|FG003|Overall Study|Adverse Event|8|||
157009095|NCT00774397|566784959|FG004|Overall Study|Adverse Event|8|||
157009096|NCT00774397|566784960|FG005|Overall Study|Adverse Event|3|||
157009097|NCT00774397|566784961|FG006|Overall Study|Adverse Event|16|||
157009098|NCT00774397|566784955|FG000|Overall Study|Lack of Efficacy|11|||
157009099|NCT00774397|566784956|FG001|Overall Study|Lack of Efficacy|4|||
157009100|NCT00774397|566784957|FG002|Overall Study|Lack of Efficacy|5|||
157009101|NCT00774397|566784958|FG003|Overall Study|Lack of Efficacy|3|||
157009102|NCT00774397|566784959|FG004|Overall Study|Lack of Efficacy|27|||
157009103|NCT00774397|566784960|FG005|Overall Study|Lack of Efficacy|15|||
157009104|NCT00774397|566784961|FG006|Overall Study|Lack of Efficacy|9|||
157009105|NCT00774397|566784955|FG000|Overall Study|Protocol Violation|0|||
157009106|NCT00774397|566784956|FG001|Overall Study|Protocol Violation|1|||
157009107|NCT00774397|566784957|FG002|Overall Study|Protocol Violation|3|||
157009108|NCT00774397|566784958|FG003|Overall Study|Protocol Violation|1|||
157009109|NCT00774397|566784959|FG004|Overall Study|Protocol Violation|2|||
157009110|NCT00774397|566784960|FG005|Overall Study|Protocol Violation|1|||
157009111|NCT00774397|566784961|FG006|Overall Study|Protocol Violation|0|||
157009112|NCT00774397|566784955|FG000|Overall Study|Lost to Follow-up|0|||
157009113|NCT00774397|566784956|FG001|Overall Study|Lost to Follow-up|1|||
157009114|NCT00774397|566784957|FG002|Overall Study|Lost to Follow-up|1|||
157009115|NCT00774397|566784958|FG003|Overall Study|Lost to Follow-up|1|||
157009116|NCT00774397|566784959|FG004|Overall Study|Lost to Follow-up|0|||
157009117|NCT00774397|566784960|FG005|Overall Study|Lost to Follow-up|1|||
157009118|NCT00774397|566784961|FG006|Overall Study|Lost to Follow-up|0|||
157009119|NCT00774397|566784955|FG000|Overall Study|Refused to continue trial medication|1|||
157009120|NCT00774397|566784956|FG001|Overall Study|Refused to continue trial medication|3|||
157009121|NCT00774397|566784957|FG002|Overall Study|Refused to continue trial medication|2|||
157009122|NCT00774397|566784958|FG003|Overall Study|Refused to continue trial medication|2|||
157009123|NCT00774397|566784959|FG004|Overall Study|Refused to continue trial medication|6|||
157009124|NCT00774397|566784960|FG005|Overall Study|Refused to continue trial medication|2|||
157009125|NCT00774397|566784961|FG006|Overall Study|Refused to continue trial medication|3|||
157009126|NCT00774397|566784955|FG000|Overall Study|Not treated|0|||
157009127|NCT00774397|566784956|FG001|Overall Study|Not treated|0|||
157009128|NCT00774397|566784957|FG002|Overall Study|Not treated|0|||
157009129|NCT00774397|566784958|FG003|Overall Study|Not treated|0|||
157009130|NCT00774397|566784959|FG004|Overall Study|Not treated|1|||
157009131|NCT00774397|566784960|FG005|Overall Study|Not treated|0|||
157009132|NCT00774397|566784961|FG006|Overall Study|Not treated|1|||
157009133|NCT00774397|566784955|FG000|Overall Study|Other than those stated above|1|||
157009134|NCT00774397|566784956|FG001|Overall Study|Other than those stated above|1|||
157009135|NCT00774397|566784957|FG002|Overall Study|Other than those stated above|3|||
157009136|NCT00774397|566784958|FG003|Overall Study|Other than those stated above|2|||
157009137|NCT00774397|566784959|FG004|Overall Study|Other than those stated above|2|||
157009138|NCT00774397|566784960|FG005|Overall Study|Other than those stated above|0|||
157009139|NCT00774397|566784961|FG006|Overall Study|Other than those stated above|1|||
157009140|NCT00277355|566784968|FG000|Overall Study|Withdrawal by Subject|3|||
157209336|NCT03594175|567511098|FG002|Overall Study|Not treated|5|||
157209337|NCT03594175|567511096|FG000|Overall Study|Adverse Event|3|||
157209338|NCT03594175|567511097|FG001|Overall Study|Adverse Event|0|||
157209339|NCT03594175|567511098|FG002|Overall Study|Adverse Event|0|||
157009141|NCT00277355|566784969|FG001|Overall Study|Withdrawal by Subject|3|||
157009142|NCT00277355|566784968|FG000|Overall Study|Lost to Follow-up|2|||
157209340|NCT03594175|567511096|FG000|Overall Study|Withdrawal by Subject|3|||
156778782|NCT02360579|565939331|FG001|Initial|Lost to Follow-up|4|||
156778783|NCT02360579|565939332|FG002|Initial|Lost to Follow-up|0|||
156778784|NCT02360579|565939333|FG003|Initial|Lost to Follow-up|1|||
156778785|NCT02360579|565939330|FG000|Initial|Withdrawal by Subject|0|||
156778786|NCT02360579|565939331|FG001|Initial|Withdrawal by Subject|0|||
156778787|NCT02360579|565939332|FG002|Initial|Withdrawal by Subject|0|||
156778788|NCT02360579|565939333|FG003|Initial|Withdrawal by Subject|3|||
156778789|NCT02360579|565939330|FG000|Initial|Other|7|||
156778790|NCT02360579|565939331|FG001|Initial|Other|0|||
156778791|NCT02360579|565939332|FG002|Initial|Other|0|||
156778792|NCT02360579|565939333|FG003|Initial|Other|0|||
156778793|NCT02360579|565939330|FG000|Initial|Did not receive TIL|8|||
156778794|NCT02360579|565939331|FG001|Initial|Did not receive TIL|11|||
156778795|NCT02360579|565939332|FG002|Initial|Did not receive TIL|0|||
156778796|NCT02360579|565939333|FG003|Initial|Did not receive TIL|22|||
156778797|NCT02360579|565939330|FG000|Retreatment|Death|0|||
156778798|NCT02360579|565939331|FG001|Retreatment|Death|0|||
156778799|NCT02360579|565939332|FG002|Retreatment|Death|11|||
156778800|NCT02360579|565939333|FG003|Retreatment|Death|0|||
156778801|NCT03682848|565939336|FG000|Overall Study|Withdrawal by Subject|3|||
156778802|NCT03682848|565939336|FG000|Overall Study|Site closed|5|||
156778803|NCT03682848|565939336|FG000|Overall Study|Protocol Deviation|1|||
156778804|NCT03682848|565939336|FG000|Overall Study|Adverse Event|2|||
156778805|NCT03682848|565939336|FG000|Overall Study|Lack of Efficacy|1|||
156808571|NCT01070979|566052717|FG002|Overall Study|Withdrawal by Subject|1|||
156808572|NCT01070979|566052715|FG000|Overall Study|No study drug taken|0|||
156808573|NCT01070979|566052716|FG001|Overall Study|No study drug taken|1|||
156808574|NCT01070979|566052717|FG002|Overall Study|No study drug taken|0|||
156808575|NCT00142792|566052718|FG000|Overall Study|Death|0|||
156808576|NCT00142792|566052719|FG001|Overall Study|Death|0|||
156808577|NCT00142792|566052720|FG002|Overall Study|Death|1|||
156808578|NCT00142792|566052718|FG000|Overall Study|Withdrawal by Subject|3|||
156808579|NCT00142792|566052719|FG001|Overall Study|Withdrawal by Subject|2|||
156808580|NCT00142792|566052720|FG002|Overall Study|Withdrawal by Subject|3|||
156808581|NCT00142792|566052718|FG000|Overall Study|Lost to Follow-up|8|||
156808582|NCT00142792|566052719|FG001|Overall Study|Lost to Follow-up|11|||
156808583|NCT00142792|566052720|FG002|Overall Study|Lost to Follow-up|7|||
156808584|NCT00142792|566052718|FG000|Overall Study|No category|1|||
156808585|NCT00142792|566052719|FG001|Overall Study|No category|2|||
156808586|NCT00142792|566052720|FG002|Overall Study|No category|1|||
156808587|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
156808588|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
156808589|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
156808590|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
156808591|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
156808592|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
156808593|NCT03069716|566052721|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
156808594|NCT03069716|566052722|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
156808595|NCT03069716|566052723|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
157209341|NCT03594175|567511097|FG001|Overall Study|Withdrawal by Subject|0|||
157209342|NCT03594175|567511098|FG002|Overall Study|Withdrawal by Subject|0|||
157209343|NCT03594175|567511096|FG000|Overall Study|Protocol Violation|2|||
156808596|NCT03069716|566052721|FG000|Randomized Treatment|Withdrawal by Subject|0|||
156808597|NCT03069716|566052722|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156808598|NCT03069716|566052723|FG002|Randomized Treatment|Withdrawal by Subject|0|||
156808599|NCT01673126|566052724|FG000|Overall Study|change of diagnosis|4|||
156808600|NCT01673126|566052725|FG001|Overall Study|change of diagnosis|3|||
156808601|NCT00237042|566052728|FG000|Treatment|Became ineligible post-randomization|0|||
156808602|NCT00237042|566052729|FG001|Treatment|Became ineligible post-randomization|1|||
156808603|NCT00237042|566052730|FG002|Treatment|Became ineligible post-randomization|16|||
156808604|NCT00237042|566052728|FG000|Treatment|Moved out of state|1|||
156808605|NCT00237042|566052729|FG001|Treatment|Moved out of state|1|||
156808606|NCT00237042|566052730|FG002|Treatment|Moved out of state|1|||
156808607|NCT00237042|566052728|FG000|Treatment|Completed no treatment|5|||
156808608|NCT00237042|566052729|FG001|Treatment|Completed no treatment|5|||
157209344|NCT03594175|567511097|FG001|Overall Study|Protocol Violation|2|||
157209345|NCT03594175|567511098|FG002|Overall Study|Protocol Violation|2|||
157209346|NCT03732677|567511099|FG000|Overall Study|Terminated the study|154|||
157209347|NCT03732677|567511100|FG001|Overall Study|Terminated the study|197|||
157209348|NCT03732677|567511099|FG000|Overall Study|Continuing study off treatment|379|||
157209349|NCT03732677|567511100|FG001|Overall Study|Continuing study off treatment|333|||
157209350|NCT03494816|567511101|FG000|Overall Study|Protocol Violation|2|||
157209351|NCT03494816|567511101|FG000|Overall Study|Physician Decision|2|||
157209352|NCT03494816|567511101|FG000|Overall Study|Did not start trial treatment|1|||
157209353|NCT03494816|567511101|FG000|Overall Study|Adverse Event|1|||
157209354|NCT01500434|567511102|FG000|Overall Study|Death|1|||
157209355|NCT01500434|567511102|FG000|Overall Study|Withdrawal by Subject|1|||
157209356|NCT01500434|567511102|FG000|Overall Study|Missed 12-month follow-up|5|||
157209357|NCT00633217|567511103|FG000|Overall Study|Adverse Event|5|||
157209358|NCT00633217|567511104|FG001|Overall Study|Adverse Event|9|||
157209359|NCT00633217|567511103|FG000|Overall Study|Lack of Efficacy|0|||
157209360|NCT00633217|567511104|FG001|Overall Study|Lack of Efficacy|2|||
157209361|NCT00633217|567511103|FG000|Overall Study|Protocol Violation|3|||
157209362|NCT00633217|567511104|FG001|Overall Study|Protocol Violation|7|||
157209363|NCT00633217|567511103|FG000|Overall Study|Lost to Follow-up|2|||
157209364|NCT00633217|567511104|FG001|Overall Study|Lost to Follow-up|2|||
157209365|NCT00633217|567511103|FG000|Overall Study|Investigator Discretion|2|||
157209366|NCT00633217|567511104|FG001|Overall Study|Investigator Discretion|0|||
157209367|NCT00633217|567511103|FG000|Overall Study|Withdrew Consent|3|||
157209368|NCT00633217|567511104|FG001|Overall Study|Withdrew Consent|3|||
157209369|NCT04822701|567511105|FG000|Overall Study|Not treated|2|||
157209370|NCT04822701|567511106|FG001|Overall Study|Not treated|0|||
157209371|NCT04822701|567511105|FG000|Overall Study|Lost to Follow-up|1|||
157209372|NCT04822701|567511106|FG001|Overall Study|Lost to Follow-up|0|||
157209373|NCT04822701|567511105|FG000|Overall Study|Withdrawal by Subject|1|||
157209374|NCT04822701|567511106|FG001|Overall Study|Withdrawal by Subject|0|||
157209375|NCT02706353|567511107|FG000|Dose Level 1|Disease Progression|1|||
157209376|NCT02706353|567511108|FG001|Dose Level 1|Disease Progression|0|||
157209377|NCT02706353|567511109|FG002|Dose Level 1|Disease Progression|0|||
157209378|NCT02706353|567511110|FG003|Dose Level 1|Disease Progression|0|||
157209379|NCT02706353|567511111|FG004|Dose Level 1|Disease Progression|0|||
157209380|NCT02706353|567511112|FG005|Dose Level 1|Disease Progression|0|||
157209381|NCT02706353|567511107|FG000|Dose Level 3|Disease Progression|0|||
157209382|NCT02706353|567511108|FG001|Dose Level 3|Disease Progression|0|||
157209383|NCT02706353|567511109|FG002|Dose Level 3|Disease Progression|2|||
157209384|NCT02706353|567511110|FG003|Dose Level 3|Disease Progression|0|||
157209385|NCT02706353|567511111|FG004|Dose Level 3|Disease Progression|0|||
157209386|NCT02706353|567511112|FG005|Dose Level 3|Disease Progression|0|||
157209387|NCT02706353|567511107|FG000|Dose Level 4|Disease Progression|0|||
157209388|NCT02706353|567511108|FG001|Dose Level 4|Disease Progression|0|||
157209389|NCT02706353|567511109|FG002|Dose Level 4|Disease Progression|0|||
157209390|NCT02706353|567511110|FG003|Dose Level 4|Disease Progression|1|||
157209391|NCT02706353|567511111|FG004|Dose Level 4|Disease Progression|0|||
157209392|NCT02706353|567511112|FG005|Dose Level 4|Disease Progression|0|||
157209393|NCT02706353|567511107|FG000|Dose Level 4|Toxicity|0|||
157209394|NCT02706353|567511108|FG001|Dose Level 4|Toxicity|0|||
157209395|NCT02706353|567511109|FG002|Dose Level 4|Toxicity|0|||
157209396|NCT02706353|567511110|FG003|Dose Level 4|Toxicity|1|||
157209397|NCT02706353|567511111|FG004|Dose Level 4|Toxicity|0|||
157209398|NCT02706353|567511112|FG005|Dose Level 4|Toxicity|0|||
157209399|NCT02706353|567511107|FG000|Dose Level 4|Death|0|||
157209400|NCT02706353|567511108|FG001|Dose Level 4|Death|0|||
157009143|NCT00277355|566784969|FG001|Overall Study|Lost to Follow-up|2|||
157009144|NCT00277355|566784968|FG000|Overall Study|Adverse Event|5|||
157009145|NCT00277355|566784969|FG001|Overall Study|Adverse Event|0|||
157009146|NCT00277355|566784968|FG000|Overall Study|Death|3|||
157009147|NCT00277355|566784969|FG001|Overall Study|Death|0|||
157009148|NCT00277355|566784968|FG000|Overall Study|Physician Decision|1|||
157009149|NCT00277355|566784969|FG001|Overall Study|Physician Decision|0|||
157009150|NCT01140048|566784978|FG000|Overall Study|Physician Decision|1|||
157009151|NCT01140048|566784978|FG000|Overall Study|Withdrawal by Subject|13|||
157009152|NCT01140048|566784978|FG000|Overall Study|Lost to Follow-up|31|||
157009153|NCT01068743|566784983|FG000|Period 3|Adverse Event|0|||
157209401|NCT02706353|567511109|FG002|Dose Level 4|Death|0|||
157209402|NCT02706353|567511110|FG003|Dose Level 4|Death|1|||
157209403|NCT02706353|567511111|FG004|Dose Level 4|Death|0|||
157209404|NCT02706353|567511112|FG005|Dose Level 4|Death|0|||
157209405|NCT02706353|567511107|FG000|Dose Level 5|Toxicity|0|||
157209406|NCT02706353|567511108|FG001|Dose Level 5|Toxicity|0|||
157209407|NCT02706353|567511109|FG002|Dose Level 5|Toxicity|0|||
157009154|NCT01068743|566784984|FG001|Period 3|Adverse Event|1|||
157009155|NCT01068743|566784985|FG002|Period 3|Adverse Event|0|||
157009156|NCT01068743|566784986|FG003|Period 3|Adverse Event|0|||
157209408|NCT02706353|567511110|FG003|Dose Level 5|Toxicity|0|||
157209409|NCT02706353|567511111|FG004|Dose Level 5|Toxicity|1|||
157209410|NCT02706353|567511112|FG005|Dose Level 5|Toxicity|0|||
157209411|NCT02706353|567511107|FG000|Dose Level 5|Disease Progression|0|||
157209412|NCT02706353|567511108|FG001|Dose Level 5|Disease Progression|0|||
156778806|NCT00143507|565940583|FG000|Overall Study|Death|572|||
156778807|NCT00143507|565940584|FG001|Overall Study|Death|547|||
156778808|NCT00143507|565940583|FG000|Overall Study|Withdrawal by Subject|114|||
156778809|NCT00143507|565940584|FG001|Overall Study|Withdrawal by Subject|102|||
156778810|NCT00143507|565940583|FG000|Overall Study|Lost to Follow-up|1|||
156778811|NCT00143507|565940584|FG001|Overall Study|Lost to Follow-up|0|||
156778812|NCT00143507|565940583|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
156778813|NCT00143507|565940584|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
156778814|NCT00690898|565940585|FG000|SCREENING|Screen failure|18|||
156778815|NCT00690898|565940585|FG000|TREATMENT|Adverse Event|3|||
156778816|NCT00690898|565940585|FG000|TREATMENT|Lack of Efficacy|18|||
156778817|NCT00690898|565940585|FG000|TREATMENT|Withdrawal by Subject|4|||
156778818|NCT00690898|565940585|FG000|TREATMENT|Other (not otherwise specified)|1|||
156778819|NCT05977868|565940586|FG000|Overall Study|Withdrawal by Subject|1|||
156778820|NCT05977868|565940587|FG001|Overall Study|Withdrawal by Subject|2|||
156778821|NCT05977868|565940586|FG000|Overall Study|Transitioned to comfort care|1|||
156778822|NCT05977868|565940587|FG001|Overall Study|Transitioned to comfort care|0|||
156778823|NCT00970944|565940589|FG000|Overall Study|Death|1|||
156778824|NCT00970944|565940590|FG001|Overall Study|Death|0|||
156778825|NCT00970944|565940589|FG000|Overall Study|Physician Decision|0|||
156778826|NCT00970944|565940590|FG001|Overall Study|Physician Decision|2|||
156778827|NCT02008370|565940591|FG000|Overall Study|Lost to Follow-up|7|||
156778828|NCT00662259|565940592|FG000|Overall Study|Adverse Event|2|||
156778829|NCT00662259|565940593|FG001|Overall Study|Adverse Event|0|||
156778830|NCT00972738|565940594|FG000|Overall Study|Adverse Event|7|||
156778831|NCT00972738|565940595|FG001|Overall Study|Adverse Event|1|||
156778832|NCT00972738|565940596|FG002|Overall Study|Adverse Event|8|||
156778833|NCT00972738|565940594|FG000|Overall Study|Protocol Violation|2|||
156778834|NCT00972738|565940595|FG001|Overall Study|Protocol Violation|1|||
156778835|NCT00972738|565940596|FG002|Overall Study|Protocol Violation|3|||
156778836|NCT00972738|565940594|FG000|Overall Study|Lost to Follow-up|1|||
156778837|NCT00972738|565940595|FG001|Overall Study|Lost to Follow-up|0|||
156778838|NCT00972738|565940596|FG002|Overall Study|Lost to Follow-up|1|||
156778839|NCT00972738|565940594|FG000|Overall Study|Lack of Efficacy|5|||
157209413|NCT02706353|567511109|FG002|Dose Level 5|Disease Progression|0|||
157209414|NCT02706353|567511110|FG003|Dose Level 5|Disease Progression|0|||
157209415|NCT02706353|567511111|FG004|Dose Level 5|Disease Progression|3|||
157209416|NCT02706353|567511112|FG005|Dose Level 5|Disease Progression|2|||
157209417|NCT02706353|567511107|FG000|Dose Level 5|Death|0|||
157209418|NCT02706353|567511108|FG001|Dose Level 5|Death|0|||
157209419|NCT02706353|567511109|FG002|Dose Level 5|Death|0|||
157209420|NCT02706353|567511110|FG003|Dose Level 5|Death|0|||
157209421|NCT02706353|567511111|FG004|Dose Level 5|Death|1|||
157209422|NCT02706353|567511112|FG005|Dose Level 5|Death|6|||
157209423|NCT02706353|567511107|FG000|Dose Level 5|Withdrawal by Subject|0|||
157209424|NCT02706353|567511108|FG001|Dose Level 5|Withdrawal by Subject|0|||
157209425|NCT02706353|567511109|FG002|Dose Level 5|Withdrawal by Subject|0|||
157209426|NCT02706353|567511110|FG003|Dose Level 5|Withdrawal by Subject|0|||
157209427|NCT02706353|567511111|FG004|Dose Level 5|Withdrawal by Subject|0|||
157209428|NCT02706353|567511112|FG005|Dose Level 5|Withdrawal by Subject|2|||
157209429|NCT03724968|567512244|FG000|Overall Study|Insurance issues|0|||
157209430|NCT03724968|567512245|FG001|Overall Study|Insurance issues|1|||
157209431|NCT03724968|567512244|FG000|Overall Study|Study closed|0|||
157209432|NCT03724968|567512245|FG001|Overall Study|Study closed|1|||
157209433|NCT01858558|567512246|FG000|Overall Study|Death|1|||
157209434|NCT01858558|567512247|FG001|Overall Study|Death|1|||
157209435|NCT01858558|567512246|FG000|Overall Study|Lost to Follow-up|1|||
157209436|NCT01858558|567512247|FG001|Overall Study|Lost to Follow-up|0|||
157209437|NCT01858558|567512246|FG000|Overall Study|Disease progression|3|||
157209438|NCT01858558|567512247|FG001|Overall Study|Disease progression|1|||
156778840|NCT00972738|565940595|FG001|Overall Study|Lack of Efficacy|1|||
156778841|NCT00972738|565940596|FG002|Overall Study|Lack of Efficacy|11|||
156778842|NCT00972738|565940594|FG000|Overall Study|Withdrawal by Subject|5|||
156778843|NCT00972738|565940595|FG001|Overall Study|Withdrawal by Subject|1|||
156778844|NCT00972738|565940596|FG002|Overall Study|Withdrawal by Subject|4|||
156778845|NCT00972738|565940594|FG000|Overall Study|Moved|0|||
156778846|NCT00972738|565940595|FG001|Overall Study|Moved|0|||
156778847|NCT00972738|565940596|FG002|Overall Study|Moved|1|||
156778848|NCT00972738|565940594|FG000|Overall Study|Other|1|||
157209439|NCT01858558|567512246|FG000|Overall Study|Product contamination|2|||
157209440|NCT01858558|567512247|FG001|Overall Study|Product contamination|0|||
157209441|NCT01858558|567512246|FG000|Overall Study|Failed expansion of cell product|2|||
156778849|NCT00972738|565940595|FG001|Overall Study|Other|2|||
157209442|NCT01858558|567512247|FG001|Overall Study|Failed expansion of cell product|0|||
157209443|NCT01336608|567512248|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
157209444|NCT01336608|567512249|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
157209445|NCT01336608|567512250|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
157209446|NCT01336608|567512251|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
157209447|NCT01336608|567512248|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
157209448|NCT01336608|567512249|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
157209449|NCT01336608|567512250|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
157209450|NCT01336608|567512251|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
157209451|NCT01336608|567512248|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
157209452|NCT01336608|567512249|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
157209453|NCT01336608|567512250|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
157209454|NCT01336608|567512251|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
157209455|NCT01336608|567512248|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
157209456|NCT01336608|567512249|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
157209457|NCT01336608|567512250|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
157209458|NCT01336608|567512251|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
157209459|NCT01336608|567512248|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
157209460|NCT01336608|567512249|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
157209461|NCT01336608|567512250|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
157209462|NCT01336608|567512251|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
157209463|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
157209464|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
157209465|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
157209466|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
157209467|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
157209468|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
157209469|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
157209470|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
157209471|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
157209472|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
157209473|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
157209474|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
156778850|NCT00972738|565940596|FG002|Overall Study|Other|1|||
156778851|NCT03915067|565940598|FG000|Overall Study|Adverse Event|0|||
156778852|NCT03915067|565940599|FG001|Overall Study|Adverse Event|0|||
156778853|NCT03915067|565940600|FG002|Overall Study|Adverse Event|1|||
156778854|NCT03915067|565940598|FG000|Overall Study|Withdrawal by Subject|4|||
156778855|NCT03915067|565940599|FG001|Overall Study|Withdrawal by Subject|3|||
156778856|NCT03915067|565940600|FG002|Overall Study|Withdrawal by Subject|0|||
156778857|NCT03915067|565940598|FG000|Overall Study|Lost to Follow-up|3|||
156778858|NCT03915067|565940599|FG001|Overall Study|Lost to Follow-up|2|||
156778859|NCT03915067|565940600|FG002|Overall Study|Lost to Follow-up|0|||
156778860|NCT03915067|565940598|FG000|Overall Study|Protocol Deviation|0|||
156778861|NCT03915067|565940599|FG001|Overall Study|Protocol Deviation|0|||
156778862|NCT03915067|565940600|FG002|Overall Study|Protocol Deviation|1|||
156778863|NCT03915067|565940598|FG000|Overall Study|Covid-19 Related Issues|2|||
156778864|NCT03915067|565940599|FG001|Overall Study|Covid-19 Related Issues|4|||
156778865|NCT03915067|565940600|FG002|Overall Study|Covid-19 Related Issues|4|||
156778866|NCT03915067|565940598|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
156778867|NCT03915067|565940599|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
156778868|NCT03915067|565940600|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
156778869|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
156778870|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
156778871|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
156778872|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
156778873|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
156778874|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778875|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
156778876|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778877|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778878|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
156778879|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Death|0|||
156778880|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Death|0|||
156778881|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Death|1|||
156778882|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Death|0|||
156778883|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Death|0|||
156778884|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
156778885|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
156778886|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
156778887|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
156778888|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
156778889|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Other|2|||
156778890|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Other|1|||
156778891|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Other|0|||
156778892|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Other|0|||
156778893|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Other|0|||
156778894|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778895|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778896|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
156778897|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778898|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
156778899|NCT03317496|565940601|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778900|NCT03317496|565940602|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
156778901|NCT03317496|565940603|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778902|NCT03317496|565940604|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
156778903|NCT03317496|565940605|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
156778904|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
156778905|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
156778906|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
156778907|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
156778908|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
156778909|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
156778910|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778911|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778912|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778913|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
156778914|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778915|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778916|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
156778917|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778918|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
156778919|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
156778920|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
156778921|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
156778922|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
156778923|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
156778924|NCT03317496|565940601|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
156778925|NCT03317496|565940602|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
156778926|NCT03317496|565940603|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
156778927|NCT03317496|565940604|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
156778928|NCT03317496|565940605|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
156778929|NCT03317496|565940601|FG000|Phase 2: Treatment|Adverse Event|0|||
156778930|NCT03317496|565940602|FG001|Phase 2: Treatment|Adverse Event|0|||
156778931|NCT03317496|565940603|FG002|Phase 2: Treatment|Adverse Event|0|||
156778932|NCT03317496|565940604|FG003|Phase 2: Treatment|Adverse Event|0|||
156778933|NCT03317496|565940605|FG004|Phase 2: Treatment|Adverse Event|6|||
156778934|NCT03317496|565940601|FG000|Phase 2: Treatment|Progressive disease|0|||
156778935|NCT03317496|565940602|FG001|Phase 2: Treatment|Progressive disease|0|||
156778936|NCT03317496|565940603|FG002|Phase 2: Treatment|Progressive disease|0|||
156778937|NCT03317496|565940604|FG003|Phase 2: Treatment|Progressive disease|0|||
156778938|NCT03317496|565940605|FG004|Phase 2: Treatment|Progressive disease|22|||
156778939|NCT03317496|565940601|FG000|Phase 2: Treatment|Other|0|||
156778940|NCT03317496|565940602|FG001|Phase 2: Treatment|Other|0|||
156778941|NCT03317496|565940603|FG002|Phase 2: Treatment|Other|0|||
156778942|NCT03317496|565940604|FG003|Phase 2: Treatment|Other|0|||
156778943|NCT03317496|565940605|FG004|Phase 2: Treatment|Other|4|||
156778944|NCT03317496|565940601|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
156778945|NCT03317496|565940602|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
156778946|NCT03317496|565940603|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
157115004|NCT00640328|567175739|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
157115005|NCT00640328|567175734|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
157115006|NCT00640328|567175735|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
157115007|NCT00640328|567175736|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
157115008|NCT00640328|567175737|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
157115009|NCT00640328|567175738|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
157115010|NCT00640328|567175739|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
157115011|NCT00640328|567175734|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
157115012|NCT00640328|567175735|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
157115013|NCT00640328|567175736|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
156778947|NCT03317496|565940604|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
156778948|NCT03317496|565940605|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
156778949|NCT03317496|565940601|FG000|Phase 2: Treatment|Physician Decision|0|||
156778950|NCT03317496|565940602|FG001|Phase 2: Treatment|Physician Decision|0|||
156778951|NCT03317496|565940603|FG002|Phase 2: Treatment|Physician Decision|0|||
156778952|NCT03317496|565940604|FG003|Phase 2: Treatment|Physician Decision|0|||
156778953|NCT03317496|565940605|FG004|Phase 2: Treatment|Physician Decision|1|||
156778954|NCT03317496|565940601|FG000|Phase 2: Treatment|Death|0|||
156778955|NCT03317496|565940602|FG001|Phase 2: Treatment|Death|0|||
156778956|NCT03317496|565940603|FG002|Phase 2: Treatment|Death|0|||
156778957|NCT03317496|565940604|FG003|Phase 2: Treatment|Death|0|||
156778958|NCT03317496|565940605|FG004|Phase 2: Treatment|Death|1|||
156778959|NCT03317496|565940601|FG000|Phase 2: Follow-up|Death|0|||
156778960|NCT03317496|565940602|FG001|Phase 2: Follow-up|Death|0|||
157115014|NCT00640328|567175737|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
157115015|NCT00640328|567175738|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
157115016|NCT00640328|567175739|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
157115017|NCT00640328|567175734|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
157115018|NCT00640328|567175735|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
157115019|NCT00640328|567175736|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
156778961|NCT03317496|565940603|FG002|Phase 2: Follow-up|Death|0|||
156778962|NCT03317496|565940604|FG003|Phase 2: Follow-up|Death|0|||
156778963|NCT03317496|565940605|FG004|Phase 2: Follow-up|Death|24|||
156778964|NCT03317496|565940601|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
157115020|NCT00640328|567175737|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
157115021|NCT00640328|567175738|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
157115022|NCT00640328|567175739|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
157115023|NCT02374099|567175740|FG000|Overall Study|Adverse Event|1|||
157115024|NCT02374099|567175741|FG001|Overall Study|Adverse Event|0|||
157115025|NCT02374099|567175740|FG000|Overall Study|Progressive Disease|35|||
157115026|NCT02374099|567175741|FG001|Overall Study|Progressive Disease|40|||
157115027|NCT02374099|567175740|FG000|Overall Study|Withdrawal by Subject|5|||
156778965|NCT03317496|565940602|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
156778966|NCT03317496|565940603|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
156778967|NCT03317496|565940604|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
156778968|NCT03317496|565940605|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
156778969|NCT03317496|565940601|FG000|Phase 2: Follow-up|Other|0|||
156778970|NCT03317496|565940602|FG001|Phase 2: Follow-up|Other|0|||
156778971|NCT03317496|565940603|FG002|Phase 2: Follow-up|Other|0|||
156778972|NCT03317496|565940604|FG003|Phase 2: Follow-up|Other|0|||
156778973|NCT03317496|565940605|FG004|Phase 2: Follow-up|Other|1|||
156778974|NCT03317496|565940601|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778975|NCT03317496|565940602|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778976|NCT03317496|565940603|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778977|NCT03317496|565940604|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
156778978|NCT03317496|565940605|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
156778979|NCT02693418|565940606|FG000|Overall Study|Lost to Follow-up|1|||
156778980|NCT02693418|565940607|FG001|Overall Study|Lost to Follow-up|2|||
156778981|NCT02693418|565940608|FG002|Overall Study|Lost to Follow-up|0|||
156778982|NCT02693418|565940609|FG003|Overall Study|Lost to Follow-up|0|||
156778983|NCT02693418|565940610|FG004|Overall Study|Lost to Follow-up|0|||
156778984|NCT02693418|565940606|FG000|Overall Study|Menses during study period|0|||
156778985|NCT02693418|565940607|FG001|Overall Study|Menses during study period|0|||
156778986|NCT02693418|565940608|FG002|Overall Study|Menses during study period|2|||
156778987|NCT02693418|565940609|FG003|Overall Study|Menses during study period|0|||
157209475|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
157209476|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
157209477|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
157209478|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
157209479|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
157209480|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
157209481|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
157209482|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
157209483|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157209484|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
157209485|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156778988|NCT02693418|565940610|FG004|Overall Study|Menses during study period|0|||
156778989|NCT01793935|565940617|FG000|Overall Study|Pregnancy|1|||
157115028|NCT02374099|567175741|FG001|Overall Study|Withdrawal by Subject|1|||
157115029|NCT02374099|567175740|FG000|Overall Study|Miscellaneous|2|||
157115030|NCT02374099|567175741|FG001|Overall Study|Miscellaneous|3|||
157115031|NCT02374099|567175740|FG000|Overall Study|Randomized, but not treated|2|||
157115032|NCT02374099|567175741|FG001|Overall Study|Randomized, but not treated|1|||
156778990|NCT01793935|565940618|FG001|Overall Study|Pregnancy|0|||
156778991|NCT01793935|565940617|FG000|Overall Study|Protocol Violation|2|||
157115033|NCT02374099|567175740|FG000|Overall Study|Study Terminated by Sponsor|3|||
157115034|NCT02374099|567175741|FG001|Overall Study|Study Terminated by Sponsor|4|||
157115035|NCT01033825|567175742|FG000|Overall Study|Withdrawal by Subject|2|||
157115036|NCT01033825|567175743|FG001|Overall Study|Withdrawal by Subject|3|||
157115037|NCT01033825|567175744|FG002|Overall Study|Withdrawal by Subject|2|||
157115038|NCT01033825|567175745|FG003|Overall Study|Withdrawal by Subject|1|||
157115039|NCT01033825|567175746|FG004|Overall Study|Withdrawal by Subject|1|||
157115040|NCT01033825|567175747|FG005|Overall Study|Withdrawal by Subject|0|||
157115041|NCT01033825|567175748|FG006|Overall Study|Withdrawal by Subject|0|||
157115042|NCT01033825|567175742|FG000|Overall Study|Adverse Event|0|||
157115043|NCT01033825|567175743|FG001|Overall Study|Adverse Event|0|||
157115044|NCT01033825|567175744|FG002|Overall Study|Adverse Event|0|||
157115045|NCT01033825|567175745|FG003|Overall Study|Adverse Event|1|||
157115046|NCT01033825|567175746|FG004|Overall Study|Adverse Event|0|||
157115047|NCT01033825|567175747|FG005|Overall Study|Adverse Event|0|||
157115048|NCT01033825|567175748|FG006|Overall Study|Adverse Event|0|||
157115049|NCT01033825|567175742|FG000|Overall Study|Protocol Violation|1|||
157115050|NCT01033825|567175743|FG001|Overall Study|Protocol Violation|0|||
157115051|NCT01033825|567175744|FG002|Overall Study|Protocol Violation|0|||
157115052|NCT01033825|567175745|FG003|Overall Study|Protocol Violation|0|||
157115053|NCT01033825|567175746|FG004|Overall Study|Protocol Violation|0|||
157115054|NCT01033825|567175747|FG005|Overall Study|Protocol Violation|0|||
157115055|NCT01033825|567175748|FG006|Overall Study|Protocol Violation|0|||
157115056|NCT01033825|567175742|FG000|Overall Study|Other|0|||
157115057|NCT01033825|567175743|FG001|Overall Study|Other|0|||
157115058|NCT01033825|567175744|FG002|Overall Study|Other|0|||
157115059|NCT01033825|567175745|FG003|Overall Study|Other|0|||
157115060|NCT01033825|567175746|FG004|Overall Study|Other|1|||
157115061|NCT01033825|567175747|FG005|Overall Study|Other|0|||
157115062|NCT01033825|567175748|FG006|Overall Study|Other|0|||
157115063|NCT01714687|567175749|FG000|Overall Study|Withdrawal by Subject|1|||
157115064|NCT01714687|567175750|FG001|Overall Study|Withdrawal by Subject|0|||
157115065|NCT01714687|567175749|FG000|Overall Study|Lost to Follow-up|2|||
157115066|NCT01714687|567175750|FG001|Overall Study|Lost to Follow-up|4|||
157115067|NCT03885089|567175751|FG000|Overall Study|No informed consent for publication of study results|2|||
157115068|NCT03349099|567175752|FG000|Overall Study|Physician Decision|3|||
157115069|NCT03349099|567175753|FG001|Overall Study|Physician Decision|4|||
157115070|NCT03349099|567175752|FG000|Overall Study|Stone migrated from the kidney|1|||
157115071|NCT03349099|567175753|FG001|Overall Study|Stone migrated from the kidney|0|||
157115072|NCT00278993|567175754|FG000|Overall Study|Adverse Event|24|||
157115073|NCT00278993|567175754|FG000|Overall Study|Withdrawal by Subject|5|||
157115074|NCT00278993|567175754|FG000|Overall Study|Progressive Disease|65|||
157115075|NCT00278993|567175754|FG000|Overall Study|Physician Decision|9|||
157115076|NCT00278993|567175754|FG000|Overall Study|Not Otherwise Specified|4|||
157115077|NCT01439555|567175756|FG000|Overall Study|Protocol Violation|1|||
157115078|NCT01979536|567175765|FG000|Overall Study|Physician Decision|2|||
157115079|NCT01979536|567175766|FG001|Overall Study|Physician Decision|3|||
157115080|NCT01979536|567175765|FG000|Overall Study|Withdrawal by Subject|0|||
157115081|NCT01979536|567175766|FG001|Overall Study|Withdrawal by Subject|1|||
157115082|NCT01979536|567175765|FG000|Overall Study|Refusal|0|||
157115083|NCT01979536|567175766|FG001|Overall Study|Refusal|1|||
157115084|NCT01979536|567175765|FG000|Overall Study|Relapse|0|||
157115085|NCT01979536|567175766|FG001|Overall Study|Relapse|1|||
157115086|NCT01979536|567175765|FG000|Overall Study|Study terminated by Sponsor|0|||
157115087|NCT01979536|567175766|FG001|Overall Study|Study terminated by Sponsor|1|||
157115088|NCT01979536|567175765|FG000|Overall Study|Did not start treatment|0|||
157115089|NCT01979536|567175766|FG001|Overall Study|Did not start treatment|1|||
157115090|NCT03077685|567175769|FG000|Overall Study|Lost to Follow-up|0|||
157115091|NCT03077685|567175770|FG001|Overall Study|Lost to Follow-up|0|||
157115092|NCT03077685|567175771|FG002|Overall Study|Lost to Follow-up|0|||
157115093|NCT03077685|567175772|FG003|Overall Study|Lost to Follow-up|0|||
157115094|NCT03077685|567175773|FG004|Overall Study|Lost to Follow-up|1|||
157115095|NCT03077685|567175769|FG000|Overall Study|Death|0|||
157209486|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157209487|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
157115096|NCT03077685|567175770|FG001|Overall Study|Death|0|||
157115097|NCT03077685|567175771|FG002|Overall Study|Death|1|||
157115098|NCT03077685|567175772|FG003|Overall Study|Death|1|||
157115099|NCT03077685|567175773|FG004|Overall Study|Death|3|||
157115100|NCT03077685|567175769|FG000|Overall Study|Withdrawal by Subject|0|||
157115101|NCT03077685|567175770|FG001|Overall Study|Withdrawal by Subject|0|||
157115102|NCT03077685|567175771|FG002|Overall Study|Withdrawal by Subject|0|||
157115103|NCT03077685|567175772|FG003|Overall Study|Withdrawal by Subject|2|||
157115104|NCT03077685|567175773|FG004|Overall Study|Withdrawal by Subject|1|||
157209488|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
157115105|NCT03077685|567175769|FG000|Overall Study|Physician Decision|0|||
157115106|NCT03077685|567175770|FG001|Overall Study|Physician Decision|0|||
157115107|NCT03077685|567175771|FG002|Overall Study|Physician Decision|1|||
157115108|NCT03077685|567175772|FG003|Overall Study|Physician Decision|0|||
157115109|NCT03077685|567175773|FG004|Overall Study|Physician Decision|3|||
157115110|NCT03077685|567175769|FG000|Overall Study|Disease Progression|1|||
157115111|NCT03077685|567175770|FG001|Overall Study|Disease Progression|0|||
157115112|NCT03077685|567175771|FG002|Overall Study|Disease Progression|0|||
157115113|NCT03077685|567175772|FG003|Overall Study|Disease Progression|2|||
157115114|NCT03077685|567175773|FG004|Overall Study|Disease Progression|1|||
157115115|NCT03077685|567175769|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
157115116|NCT03077685|567175770|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
157115117|NCT03077685|567175771|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
157115118|NCT03077685|567175772|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
157115119|NCT03077685|567175773|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
157115120|NCT03077685|567175769|FG000|Overall Study|Subject entered hospice care|0|||
157115121|NCT03077685|567175770|FG001|Overall Study|Subject entered hospice care|0|||
157115122|NCT03077685|567175771|FG002|Overall Study|Subject entered hospice care|0|||
157115123|NCT03077685|567175772|FG003|Overall Study|Subject entered hospice care|0|||
157115124|NCT03077685|567175773|FG004|Overall Study|Subject entered hospice care|1|||
157115125|NCT02116777|567175774|FG000|Overall Study|Adverse Event|0|||
157115126|NCT02116777|567175775|FG001|Overall Study|Adverse Event|0|||
157115127|NCT02116777|567175776|FG002|Overall Study|Adverse Event|0|||
157115128|NCT02116777|567175777|FG003|Overall Study|Adverse Event|0|||
157115129|NCT02116777|567175778|FG004|Overall Study|Adverse Event|2|||
157115130|NCT02116777|567175779|FG005|Overall Study|Adverse Event|2|||
157115131|NCT02116777|567175780|FG006|Overall Study|Adverse Event|0|||
157115132|NCT02116777|567175774|FG000|Overall Study|Death|0|||
157115133|NCT02116777|567175775|FG001|Overall Study|Death|0|||
157115134|NCT02116777|567175776|FG002|Overall Study|Death|0|||
157115135|NCT02116777|567175777|FG003|Overall Study|Death|1|||
157115136|NCT02116777|567175778|FG004|Overall Study|Death|0|||
157115137|NCT02116777|567175779|FG005|Overall Study|Death|0|||
157115138|NCT02116777|567175780|FG006|Overall Study|Death|0|||
157115139|NCT02116777|567175774|FG000|Overall Study|Lack of Efficacy|3|||
157115140|NCT02116777|567175775|FG001|Overall Study|Lack of Efficacy|3|||
157115141|NCT02116777|567175776|FG002|Overall Study|Lack of Efficacy|3|||
157115142|NCT02116777|567175777|FG003|Overall Study|Lack of Efficacy|8|||
157115143|NCT02116777|567175778|FG004|Overall Study|Lack of Efficacy|4|||
157115144|NCT02116777|567175779|FG005|Overall Study|Lack of Efficacy|1|||
157115145|NCT02116777|567175780|FG006|Overall Study|Lack of Efficacy|9|||
157115146|NCT02116777|567175774|FG000|Overall Study|Physician Decision|0|||
157115147|NCT02116777|567175775|FG001|Overall Study|Physician Decision|0|||
157115148|NCT02116777|567175776|FG002|Overall Study|Physician Decision|0|||
157115149|NCT02116777|567175777|FG003|Overall Study|Physician Decision|2|||
157115150|NCT02116777|567175778|FG004|Overall Study|Physician Decision|0|||
157115151|NCT02116777|567175779|FG005|Overall Study|Physician Decision|0|||
157115152|NCT02116777|567175780|FG006|Overall Study|Physician Decision|0|||
157115153|NCT02116777|567175774|FG000|Overall Study|Protocol Violation|0|||
157115154|NCT02116777|567175775|FG001|Overall Study|Protocol Violation|0|||
157115155|NCT02116777|567175776|FG002|Overall Study|Protocol Violation|0|||
157115156|NCT02116777|567175777|FG003|Overall Study|Protocol Violation|1|||
157115157|NCT02116777|567175778|FG004|Overall Study|Protocol Violation|0|||
157115158|NCT02116777|567175779|FG005|Overall Study|Protocol Violation|0|||
157115159|NCT02116777|567175780|FG006|Overall Study|Protocol Violation|0|||
157115160|NCT02116777|567175774|FG000|Overall Study|Withdrawal by Subject|0|||
157115161|NCT02116777|567175775|FG001|Overall Study|Withdrawal by Subject|0|||
157115162|NCT02116777|567175776|FG002|Overall Study|Withdrawal by Subject|0|||
157115163|NCT02116777|567175777|FG003|Overall Study|Withdrawal by Subject|1|||
157115164|NCT02116777|567175778|FG004|Overall Study|Withdrawal by Subject|0|||
157115165|NCT02116777|567175779|FG005|Overall Study|Withdrawal by Subject|0|||
157115166|NCT02116777|567175780|FG006|Overall Study|Withdrawal by Subject|0|||
157115167|NCT01964352|567177338|FG000|Overall Study|Adverse Event|13|||
157115168|NCT01964352|567177339|FG001|Overall Study|Adverse Event|3|||
157115169|NCT01964352|567177340|FG002|Overall Study|Adverse Event|4|||
157115170|NCT01964352|567177341|FG003|Overall Study|Adverse Event|3|||
157115171|NCT01964352|567177338|FG000|Overall Study|Lack of Efficacy|6|||
157115172|NCT01964352|567177339|FG001|Overall Study|Lack of Efficacy|0|||
157115173|NCT01964352|567177340|FG002|Overall Study|Lack of Efficacy|0|||
157115174|NCT01964352|567177341|FG003|Overall Study|Lack of Efficacy|0|||
157115175|NCT01964352|567177338|FG000|Overall Study|Protocol Violation|2|||
157115176|NCT01964352|567177339|FG001|Overall Study|Protocol Violation|4|||
157115177|NCT01964352|567177340|FG002|Overall Study|Protocol Violation|0|||
157115178|NCT01964352|567177341|FG003|Overall Study|Protocol Violation|2|||
157115179|NCT01964352|567177338|FG000|Overall Study|Lost to Follow-up|1|||
157115180|NCT01964352|567177339|FG001|Overall Study|Lost to Follow-up|0|||
157115181|NCT01964352|567177340|FG002|Overall Study|Lost to Follow-up|0|||
157115182|NCT01964352|567177341|FG003|Overall Study|Lost to Follow-up|1|||
157115183|NCT01964352|567177338|FG000|Overall Study|Withdrawal by Subject|4|||
157115184|NCT01964352|567177339|FG001|Overall Study|Withdrawal by Subject|2|||
157115185|NCT01964352|567177340|FG002|Overall Study|Withdrawal by Subject|1|||
157115186|NCT01964352|567177341|FG003|Overall Study|Withdrawal by Subject|0|||
157115187|NCT01964352|567177338|FG000|Overall Study|Other than stated above|0|||
157115188|NCT01964352|567177339|FG001|Overall Study|Other than stated above|2|||
157115189|NCT01964352|567177340|FG002|Overall Study|Other than stated above|1|||
157115190|NCT01964352|567177341|FG003|Overall Study|Other than stated above|2|||
157115191|NCT01394939|567177342|FG000|Overall Study|Adverse Event|1|||
157115192|NCT01394939|567177343|FG001|Overall Study|Adverse Event|3|||
157115193|NCT01394939|567177344|FG002|Overall Study|Adverse Event|0|||
157115194|NCT01394939|567177345|FG003|Overall Study|Adverse Event|2|||
157115195|NCT01394939|567177342|FG000|Overall Study|Death|0|||
157115196|NCT01394939|567177343|FG001|Overall Study|Death|2|||
157115197|NCT01394939|567177344|FG002|Overall Study|Death|0|||
157115198|NCT01394939|567177345|FG003|Overall Study|Death|0|||
157115199|NCT01394939|567177342|FG000|Overall Study|Physician Decision|0|||
157115200|NCT01394939|567177343|FG001|Overall Study|Physician Decision|1|||
157115201|NCT01394939|567177344|FG002|Overall Study|Physician Decision|0|||
157115202|NCT01394939|567177345|FG003|Overall Study|Physician Decision|0|||
157115203|NCT01394939|567177342|FG000|Overall Study|Withdrawal by Subject|0|||
157115204|NCT01394939|567177343|FG001|Overall Study|Withdrawal by Subject|2|||
157115205|NCT01394939|567177344|FG002|Overall Study|Withdrawal by Subject|0|||
157115206|NCT01394939|567177345|FG003|Overall Study|Withdrawal by Subject|2|||
157115207|NCT01394939|567177342|FG000|Overall Study|Others|0|||
157115208|NCT01394939|567177343|FG001|Overall Study|Others|2|||
157115209|NCT01394939|567177344|FG002|Overall Study|Others|0|||
157115210|NCT01394939|567177345|FG003|Overall Study|Others|3|||
157115211|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
157115212|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
157115213|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
157115214|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
157115215|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
157115216|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
157115217|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
157115218|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
157115219|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
157115220|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
157115221|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
157115222|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
157115223|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
157115224|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
157115225|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
157115226|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
157115227|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
157115228|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
157115229|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
157115230|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
157115231|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
157115232|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
157115233|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
157115234|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
157115235|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
157115236|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
157115237|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
157115238|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
157115239|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
157115240|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
157115241|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
157115242|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
157115243|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
157115244|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
157115245|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
157209489|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
157209490|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
157115246|NCT02831673|567177348|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
157115247|NCT02831673|567177349|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
157209491|NCT01336608|567512248|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
157209492|NCT01336608|567512249|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
157115248|NCT02831673|567177350|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
157115249|NCT02831673|567177351|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
157115250|NCT02831673|567177352|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
157209493|NCT01336608|567512250|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
157009157|NCT00293293|566784987|FG000|Overall Study|Withdrawal by Subject|1|||
157009158|NCT00293293|566784988|FG001|Overall Study|Withdrawal by Subject|1|||
157009159|NCT00293293|566784987|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
157009160|NCT00293293|566784988|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
157009161|NCT00293293|566784987|FG000|Overall Study|Patient discontinued chemotherapy|0|||
157009162|NCT00293293|566784988|FG001|Overall Study|Patient discontinued chemotherapy|1|||
157009163|NCT01185782|566784989|FG000|Overall Study|Adverse Event|0|||
157009164|NCT01185782|566784990|FG001|Overall Study|Adverse Event|1|||
157009165|NCT01185782|566784989|FG000|Overall Study|Protocol Violation|1|||
157009166|NCT01185782|566784990|FG001|Overall Study|Protocol Violation|0|||
157115251|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
157115252|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
157115253|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
157115254|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
157115255|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
157115256|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
157115257|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
157115258|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
157115259|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
157115260|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
157115261|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
157115262|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
157115263|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
157115264|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
157115265|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
157115266|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
157115267|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
157115268|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
157115269|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
157115270|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
157115271|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
157115272|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
157115273|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
157115274|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
157209494|NCT01336608|567512251|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
157209495|NCT02328547|567512258|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
157209496|NCT02328547|567512259|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
157209497|NCT02328547|567512258|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
157209498|NCT02328547|567512259|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
157009167|NCT01185782|566784989|FG000|Overall Study|Poor Response to Treatment|3|||
157009168|NCT01185782|566784990|FG001|Overall Study|Poor Response to Treatment|1|||
157009169|NCT01185782|566784989|FG000|Overall Study|Other|2|||
157009170|NCT01185782|566784990|FG001|Overall Study|Other|5|||
157009171|NCT01185782|566784989|FG000|Overall Study|Randomized but not treated|0|||
157009172|NCT01185782|566784990|FG001|Overall Study|Randomized but not treated|4|||
157009173|NCT05082935|566784993|FG000|Overall Study|Lost to Follow-up|549|||
157009174|NCT05082935|566784994|FG001|Overall Study|Lost to Follow-up|631|||
157009175|NCT05082935|566784993|FG000|Overall Study|Withdrawal by Subject|27|||
157009176|NCT05082935|566784994|FG001|Overall Study|Withdrawal by Subject|58|||
157009177|NCT01444417|566784996|FG000|Overall Study|Ineligibility Determined|0|||
157009178|NCT01444417|566784997|FG001|Overall Study|Ineligibility Determined|1|||
157009179|NCT01444417|566784996|FG000|Overall Study|Withdrawal by Subject|2|||
157009180|NCT01444417|566784997|FG001|Overall Study|Withdrawal by Subject|0|||
157009181|NCT03531840|566785000|FG000|Overall Study|Death on study|3|||
157009182|NCT03531840|566785001|FG001|Overall Study|Death on study|2|||
157009183|NCT03531840|566785002|FG002|Overall Study|Death on study|1|||
157009184|NCT03531840|566785003|FG003|Overall Study|Death on study|2|||
157009185|NCT03531840|566785000|FG000|Overall Study|Death during follow up|2|||
157009186|NCT03531840|566785001|FG001|Overall Study|Death during follow up|3|||
157009187|NCT03531840|566785002|FG002|Overall Study|Death during follow up|4|||
157009188|NCT03531840|566785003|FG003|Overall Study|Death during follow up|1|||
157009189|NCT01546753|566785004|FG000|Overall Study|anxiety|1|||
157009190|NCT01546753|566785005|FG001|Overall Study|anxiety|1|||
157009191|NCT01546753|566785004|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
157009192|NCT01546753|566785005|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
157009193|NCT00939510|566785006|FG000|Overall Study|Withdrawal by Subject|1|||
157009194|NCT01236560|566785007|FG000|Overall Study|Adverse Event|0|||
157009195|NCT01236560|566785008|FG001|Overall Study|Adverse Event|2|||
157009196|NCT01236560|566785009|FG002|Overall Study|Adverse Event|1|||
157009197|NCT01236560|566785010|FG003|Overall Study|Adverse Event|3|||
157115275|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
157115276|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
157115277|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
157115278|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
157115279|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
157115280|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
157115281|NCT02831673|567177348|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
157115282|NCT02831673|567177349|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
157115283|NCT02831673|567177350|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
157115284|NCT02831673|567177351|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
157115285|NCT02831673|567177352|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
157115286|NCT02831673|567177348|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
157115287|NCT02831673|567177349|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
157115288|NCT02831673|567177350|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
157009198|NCT01236560|566785011|FG004|Overall Study|Adverse Event|0|||
157009199|NCT01236560|566785012|FG005|Overall Study|Adverse Event|0|||
157009200|NCT01236560|566785007|FG000|Overall Study|Death|0|||
157009201|NCT01236560|566785008|FG001|Overall Study|Death|1|||
157009202|NCT01236560|566785009|FG002|Overall Study|Death|0|||
157009203|NCT01236560|566785010|FG003|Overall Study|Death|1|||
157009204|NCT01236560|566785011|FG004|Overall Study|Death|0|||
157009205|NCT01236560|566785012|FG005|Overall Study|Death|0|||
157009206|NCT01236560|566785007|FG000|Overall Study|Lost to Follow-up|0|||
157009207|NCT01236560|566785008|FG001|Overall Study|Lost to Follow-up|1|||
157009208|NCT01236560|566785009|FG002|Overall Study|Lost to Follow-up|1|||
157009209|NCT01236560|566785010|FG003|Overall Study|Lost to Follow-up|0|||
157009210|NCT01236560|566785011|FG004|Overall Study|Lost to Follow-up|0|||
157009211|NCT01236560|566785012|FG005|Overall Study|Lost to Follow-up|0|||
157009212|NCT01236560|566785007|FG000|Overall Study|Physician Decision|0|||
157009213|NCT01236560|566785008|FG001|Overall Study|Physician Decision|1|||
157009214|NCT01236560|566785009|FG002|Overall Study|Physician Decision|8|||
157009215|NCT01236560|566785010|FG003|Overall Study|Physician Decision|0|||
157009216|NCT01236560|566785011|FG004|Overall Study|Physician Decision|0|||
157009217|NCT01236560|566785012|FG005|Overall Study|Physician Decision|0|||
157009218|NCT01236560|566785007|FG000|Overall Study|Withdrawal by Subject|0|||
157009219|NCT01236560|566785008|FG001|Overall Study|Withdrawal by Subject|0|||
157009220|NCT01236560|566785009|FG002|Overall Study|Withdrawal by Subject|1|||
157009221|NCT01236560|566785010|FG003|Overall Study|Withdrawal by Subject|2|||
157009222|NCT01236560|566785011|FG004|Overall Study|Withdrawal by Subject|0|||
157009223|NCT01236560|566785012|FG005|Overall Study|Withdrawal by Subject|0|||
157009224|NCT01236560|566785007|FG000|Overall Study|Progressive disease|5|||
157009225|NCT01236560|566785008|FG001|Overall Study|Progressive disease|19|||
157009226|NCT01236560|566785009|FG002|Overall Study|Progressive disease|9|||
157009227|NCT01236560|566785010|FG003|Overall Study|Progressive disease|16|||
157009228|NCT01236560|566785011|FG004|Overall Study|Progressive disease|0|||
157009229|NCT01236560|566785012|FG005|Overall Study|Progressive disease|0|||
157009230|NCT02471755|566785013|FG000|Overall Study|Withdrawal by Subject|1|||
157009231|NCT02471755|566785014|FG001|Overall Study|Withdrawal by Subject|0|||
157009232|NCT02471755|566785013|FG000|Overall Study|Lost to Follow-up|0|||
157009233|NCT02471755|566785014|FG001|Overall Study|Lost to Follow-up|1|||
157009234|NCT01576484|566785015|FG000|Overall Study|Adverse Event|1|||
157009235|NCT01576484|566785016|FG001|Overall Study|Adverse Event|1|||
157009236|NCT01576484|566785015|FG000|Overall Study|Protocol Violation|0|||
157009237|NCT01576484|566785016|FG001|Overall Study|Protocol Violation|2|||
157009238|NCT01576484|566785015|FG000|Overall Study|Sponsor Decision|2|||
157009239|NCT01576484|566785016|FG001|Overall Study|Sponsor Decision|8|||
157009240|NCT01576484|566785015|FG000|Overall Study|Withdrawal by Subject|0|||
157009241|NCT01576484|566785016|FG001|Overall Study|Withdrawal by Subject|3|||
157009242|NCT01576484|566785015|FG000|Overall Study|Other|2|||
157009243|NCT01576484|566785016|FG001|Overall Study|Other|5|||
157009244|NCT00305695|566785022|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
157009245|NCT00305695|566785023|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
157009246|NCT00305695|566785022|FG000|Overall Study|Did not have baseline scan|1|||
157009247|NCT00305695|566785023|FG001|Overall Study|Did not have baseline scan|1|||
157009248|NCT04305405|566785026|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157009249|NCT04305405|566785027|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157009250|NCT02674750|566785029|FG000|Overall Study|Death|4|||
157009251|NCT02674750|566785030|FG001|Overall Study|Death|5|||
157009252|NCT02674750|566785031|FG002|Overall Study|Death|8|||
157009253|NCT02674750|566785029|FG000|Overall Study|Lost to Follow-up|0|||
157009254|NCT02674750|566785030|FG001|Overall Study|Lost to Follow-up|8|||
157009255|NCT02674750|566785031|FG002|Overall Study|Lost to Follow-up|0|||
157009256|NCT02674750|566785029|FG000|Overall Study|Lack of Efficacy|1|||
157009257|NCT02674750|566785030|FG001|Overall Study|Lack of Efficacy|17|||
157009258|NCT02674750|566785031|FG002|Overall Study|Lack of Efficacy|3|||
157009259|NCT02674750|566785029|FG000|Overall Study|Withdrawal by Subject|0|||
157009260|NCT02674750|566785030|FG001|Overall Study|Withdrawal by Subject|7|||
157009261|NCT02674750|566785031|FG002|Overall Study|Withdrawal by Subject|1|||
157009262|NCT02674750|566785029|FG000|Overall Study|Other|0|||
157009263|NCT02674750|566785030|FG001|Overall Study|Other|8|||
157009264|NCT02674750|566785031|FG002|Overall Study|Other|0|||
157009265|NCT01685606|566785036|FG000|Overall Study|Withdrawal by Subject|1|||
157009266|NCT01787760|566785039|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
157009267|NCT01787760|566785040|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
157009268|NCT01787760|566785041|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
157009269|NCT01787760|566785039|FG000|Overall Study|Decompensated on left exotropia|0|||
157009270|NCT01787760|566785040|FG001|Overall Study|Decompensated on left exotropia|0|||
157009271|NCT01787760|566785041|FG002|Overall Study|Decompensated on left exotropia|1|||
157009272|NCT01787760|566785039|FG000|Overall Study|Dryness|0|||
157009273|NCT01787760|566785040|FG001|Overall Study|Dryness|1|||
157009274|NCT01787760|566785041|FG002|Overall Study|Dryness|0|||
157009275|NCT01787760|566785039|FG000|Overall Study|Relocation|1|||
157009276|NCT01787760|566785040|FG001|Overall Study|Relocation|1|||
157009277|NCT01787760|566785041|FG002|Overall Study|Relocation|0|||
157009278|NCT01787760|566785039|FG000|Overall Study|Lens discomfort|3|||
157009279|NCT01787760|566785040|FG001|Overall Study|Lens discomfort|0|||
157009280|NCT01787760|566785041|FG002|Overall Study|Lens discomfort|0|||
157009281|NCT01787760|566785039|FG000|Overall Study|Lens handling difficulty|1|||
157009282|NCT01787760|566785040|FG001|Overall Study|Lens handling difficulty|2|||
157009283|NCT01787760|566785041|FG002|Overall Study|Lens handling difficulty|0|||
157009284|NCT01787760|566785039|FG000|Overall Study|Protocol Violation|6|||
157009285|NCT01787760|566785040|FG001|Overall Study|Protocol Violation|0|||
157009286|NCT01787760|566785041|FG002|Overall Study|Protocol Violation|1|||
157009287|NCT01787760|566785039|FG000|Overall Study|Withdrawal by Subject|5|||
157009288|NCT01787760|566785040|FG001|Overall Study|Withdrawal by Subject|1|||
157009289|NCT01787760|566785041|FG002|Overall Study|Withdrawal by Subject|2|||
157009290|NCT01787760|566785039|FG000|Overall Study|Lost to Follow-up|1|||
157009291|NCT01787760|566785040|FG001|Overall Study|Lost to Follow-up|0|||
157009292|NCT01787760|566785041|FG002|Overall Study|Lost to Follow-up|1|||
157009293|NCT01787760|566785039|FG000|Overall Study|Stroke|1|||
157009294|NCT01787760|566785040|FG001|Overall Study|Stroke|0|||
157009295|NCT01787760|566785041|FG002|Overall Study|Stroke|0|||
157009296|NCT01787760|566785039|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
157009297|NCT01787760|566785040|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
157009298|NCT01787760|566785041|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
157009299|NCT01787760|566785039|FG000|Overall Study|Unsatisfactory physiological response|2|||
157009300|NCT01787760|566785040|FG001|Overall Study|Unsatisfactory physiological response|4|||
157009301|NCT01787760|566785041|FG002|Overall Study|Unsatisfactory physiological response|0|||
157009302|NCT01787760|566785039|FG000|Overall Study|Unsatisfactory visual response|1|||
157009303|NCT01787760|566785040|FG001|Overall Study|Unsatisfactory visual response|1|||
157009304|NCT01787760|566785041|FG002|Overall Study|Unsatisfactory visual response|0|||
157009305|NCT01787760|566785039|FG000|Overall Study|Near vision blur|1|||
157009306|NCT01787760|566785040|FG001|Overall Study|Near vision blur|0|||
157009307|NCT01787760|566785041|FG002|Overall Study|Near vision blur|0|||
157009308|NCT03512756|566785042|FG000|Part 1|Death|23|||
157009309|NCT03512756|566785043|FG001|Part 1|Death|18|||
157009310|NCT03512756|566785044|FG002|Part 1|Death|0|||
157009311|NCT03512756|566785045|FG003|Part 1|Death|0|||
157009312|NCT03512756|566785042|FG000|Part 1|Lost to Follow-up|0|||
157009313|NCT03512756|566785043|FG001|Part 1|Lost to Follow-up|3|||
157009314|NCT03512756|566785044|FG002|Part 1|Lost to Follow-up|0|||
157009315|NCT03512756|566785045|FG003|Part 1|Lost to Follow-up|0|||
157009316|NCT03512756|566785042|FG000|Part 1|Physician Decision|0|||
157009317|NCT03512756|566785043|FG001|Part 1|Physician Decision|1|||
157009318|NCT03512756|566785044|FG002|Part 1|Physician Decision|0|||
157009319|NCT03512756|566785045|FG003|Part 1|Physician Decision|0|||
157009320|NCT03512756|566785042|FG000|Part 1|Withdrawal by Subject|2|||
157009321|NCT03512756|566785043|FG001|Part 1|Withdrawal by Subject|2|||
157009322|NCT03512756|566785044|FG002|Part 1|Withdrawal by Subject|0|||
157009323|NCT03512756|566785045|FG003|Part 1|Withdrawal by Subject|0|||
157009324|NCT03512756|566785042|FG000|Part 2|Death|0|||
157009325|NCT03512756|566785043|FG001|Part 2|Death|0|||
157115289|NCT02831673|567177351|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
157115290|NCT02831673|567177352|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
157009326|NCT03512756|566785044|FG002|Part 2|Death|32|||
157009327|NCT03512756|566785045|FG003|Part 2|Death|21|||
157009328|NCT03512756|566785042|FG000|Part 2|Lost to Follow-up|0|||
157009329|NCT03512756|566785043|FG001|Part 2|Lost to Follow-up|0|||
157009330|NCT03512756|566785044|FG002|Part 2|Lost to Follow-up|1|||
157009331|NCT03512756|566785045|FG003|Part 2|Lost to Follow-up|0|||
157115291|NCT02831673|567177348|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
157115292|NCT02831673|567177349|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
157009332|NCT03512756|566785042|FG000|Part 2|Physician Decision|0|||
157009333|NCT03512756|566785043|FG001|Part 2|Physician Decision|0|||
157009334|NCT03512756|566785044|FG002|Part 2|Physician Decision|2|||
157009335|NCT03512756|566785045|FG003|Part 2|Physician Decision|4|||
157115293|NCT02831673|567177350|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
157115294|NCT02831673|567177351|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
157115295|NCT02831673|567177352|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
157115296|NCT02831673|567177348|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
157115297|NCT02831673|567177349|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
157115298|NCT02831673|567177350|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
157115299|NCT02831673|567177351|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
157115300|NCT02831673|567177352|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
157115301|NCT02831673|567177348|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
157115302|NCT02831673|567177349|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
157115303|NCT02831673|567177350|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
157115304|NCT02831673|567177351|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
157115305|NCT02831673|567177352|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
157115306|NCT02831673|567177348|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
157115307|NCT02831673|567177349|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
157115308|NCT02831673|567177350|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
157115309|NCT02831673|567177351|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
157115310|NCT02831673|567177352|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
157115311|NCT00150592|567177353|FG000|Overall Study|Adverse Event|4|||
157115312|NCT00150592|567177354|FG001|Overall Study|Adverse Event|1|||
157115313|NCT00150592|567177353|FG000|Overall Study|Protocol Violation|1|||
157115314|NCT00150592|567177354|FG001|Overall Study|Protocol Violation|0|||
157115315|NCT00150592|567177353|FG000|Overall Study|Withdrawal by Subject|1|||
157115316|NCT00150592|567177354|FG001|Overall Study|Withdrawal by Subject|2|||
157115317|NCT00150592|567177353|FG000|Overall Study|Non-compliance|1|||
157115318|NCT00150592|567177354|FG001|Overall Study|Non-compliance|0|||
157115319|NCT00477165|567177362|FG000|Overall Study|Adverse Event|7|||
157115320|NCT00477165|567177363|FG001|Overall Study|Adverse Event|2|||
157115321|NCT00105443|567177369|FG000|Double-Blind Treatment|Adverse Event|1|||
157115322|NCT00105443|567177370|FG001|Double-Blind Treatment|Adverse Event|0|||
157115323|NCT00105443|567177371|FG002|Double-Blind Treatment|Adverse Event|0|||
157115324|NCT00105443|567177372|FG003|Double-Blind Treatment|Adverse Event|0|||
157115325|NCT00105443|567177369|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
157115326|NCT00105443|567177370|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
157115327|NCT00105443|567177371|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
157115328|NCT00105443|567177372|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
157115329|NCT00105443|567177369|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
157115330|NCT00105443|567177370|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
157115331|NCT00105443|567177371|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
157115332|NCT00105443|567177372|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
157115333|NCT00105443|567177369|FG000|Double-Blind Treatment|Physician Decision|1|||
157115334|NCT00105443|567177370|FG001|Double-Blind Treatment|Physician Decision|0|||
157115335|NCT00105443|567177371|FG002|Double-Blind Treatment|Physician Decision|2|||
157115336|NCT00105443|567177372|FG003|Double-Blind Treatment|Physician Decision|0|||
157115337|NCT00105443|567177369|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
157115338|NCT00105443|567177370|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
157115339|NCT00105443|567177371|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
157115340|NCT00105443|567177372|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
157115341|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
157115342|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
157115343|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
157115344|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
157115345|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
157115346|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
157115347|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
157115348|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
157115349|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
157115350|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
157115351|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
157115352|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
157115353|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
157115354|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
157115355|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
157115356|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
157209499|NCT00344305|567512260|FG000|Overall Study|Lost to Follow-up|2|||
157115357|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
157115358|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
157115359|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
157115360|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
157115361|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
157115362|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
157115363|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
157115364|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
157115365|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
157115366|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
157209500|NCT00344305|567512261|FG001|Overall Study|Lost to Follow-up|0|||
157209501|NCT00344305|567512260|FG000|Overall Study|Participant was not contacted in window|0|||
157209502|NCT00344305|567512261|FG001|Overall Study|Participant was not contacted in window|1|||
157209503|NCT02996448|567512262|FG000|Overall Study|Study terminated due to adverse effects|3|||
157209504|NCT02360397|567512266|FG000|Overall Study|Incomplete screening|3|||
157209505|NCT02360397|567512266|FG000|Overall Study|Adverse Event|1|||
157209506|NCT04840901|567512267|FG000|Overall Study|Lost to Follow-up|3|||
157209507|NCT04840901|567512268|FG001|Overall Study|Lost to Follow-up|1|||
157209508|NCT04840901|567512267|FG000|Overall Study|Moved|1|||
157209509|NCT04840901|567512268|FG001|Overall Study|Moved|0|||
157209510|NCT04840901|567512267|FG000|Overall Study|Unable to comply with study schedule|0|||
157209511|NCT04840901|567512268|FG001|Overall Study|Unable to comply with study schedule|1|||
157209512|NCT04840901|567512267|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
157209513|NCT04840901|567512268|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
157209514|NCT01268683|567512269|FG000|Overall Study|Lost to Follow-up|1|||
157209515|NCT01268683|567512269|FG000|Overall Study|Death|1|||
157209516|NCT04256759|567512270|FG000|Overall Study|Physician Decision|1|||
157209517|NCT04256759|567512270|FG000|Overall Study|Lack of Efficacy|1|||
157209518|NCT02610842|567512276|FG000|Overall Study|Lost to Follow-up|5|||
157209519|NCT01783483|567512283|FG000|Overall Study|Death|3|||
157209520|NCT01783483|567512284|FG001|Overall Study|Death|3|||
157209521|NCT01783483|567512283|FG000|Overall Study|Lost to Follow-up|14|||
157209522|NCT01783483|567512284|FG001|Overall Study|Lost to Follow-up|10|||
157209523|NCT01783483|567512283|FG000|Overall Study|Withdrawal by Subject|2|||
157209524|NCT01783483|567512284|FG001|Overall Study|Withdrawal by Subject|1|||
157209525|NCT01783483|567512283|FG000|Overall Study|Physician Decision|1|||
157209526|NCT01783483|567512284|FG001|Overall Study|Physician Decision|1|||
157209527|NCT02268045|567512285|FG000|Overall Study|Death|4|||
157209528|NCT02268045|567512286|FG001|Overall Study|Death|4|||
157209529|NCT02268045|567512285|FG000|Overall Study|Disease Progression|2|||
157209530|NCT02268045|567512286|FG001|Overall Study|Disease Progression|1|||
157209531|NCT02268045|567512285|FG000|Overall Study|Adverse Event|7|||
157209532|NCT02268045|567512286|FG001|Overall Study|Adverse Event|7|||
157209533|NCT02268045|567512285|FG000|Overall Study|Withdrawal by Subject|2|||
157209534|NCT02268045|567512286|FG001|Overall Study|Withdrawal by Subject|6|||
157209535|NCT02268045|567512285|FG000|Overall Study|Physician Decision|0|||
157209536|NCT02268045|567512286|FG001|Overall Study|Physician Decision|1|||
157209537|NCT02268045|567512285|FG000|Overall Study|Protocol Violation|1|||
157209538|NCT02268045|567512286|FG001|Overall Study|Protocol Violation|1|||
157209539|NCT03151707|567512289|FG000|Overall Study|Lost to Follow-up|6|||
157209540|NCT02125734|567512291|FG000|Period 2|Adverse Event|0|||
157209541|NCT02125734|567512292|FG001|Period 2|Adverse Event|1|||
157209542|NCT01308762|567512293|FG000|Overall Study|Protocol Violation|0|||
157209543|NCT01308762|567512294|FG001|Overall Study|Protocol Violation|1|||
157209544|NCT01308762|567512295|FG002|Overall Study|Protocol Violation|0|||
157209545|NCT02617446|567512296|FG000|Overall Study|Withdrawal by Subject|0|||
157209546|NCT02617446|567512297|FG001|Overall Study|Withdrawal by Subject|2|||
157209547|NCT02617446|567512298|FG002|Overall Study|Withdrawal by Subject|0|||
157209548|NCT02617446|567512296|FG000|Overall Study|Adverse Event|1|||
157209549|NCT02617446|567512297|FG001|Overall Study|Adverse Event|0|||
157209550|NCT02617446|567512298|FG002|Overall Study|Adverse Event|5|||
157209551|NCT02617446|567512296|FG000|Overall Study|Lost to Follow-up|3|||
157209552|NCT02617446|567512297|FG001|Overall Study|Lost to Follow-up|0|||
157209553|NCT02617446|567512298|FG002|Overall Study|Lost to Follow-up|0|||
157209554|NCT02617446|567512296|FG000|Overall Study|Death|0|||
157209555|NCT02617446|567512297|FG001|Overall Study|Death|0|||
157209556|NCT02617446|567512298|FG002|Overall Study|Death|2|||
157209557|NCT01556490|567512307|FG000|Randomized Patients Summary|Protocol Violation|22|||
157209558|NCT01556490|567512308|FG001|Randomized Patients Summary|Protocol Violation|23|||
157209559|NCT01556490|567512307|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
157209560|NCT01556490|567512308|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
156778992|NCT01793935|565940618|FG001|Overall Study|Protocol Violation|1|||
157115367|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
157115368|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
157115369|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
157115370|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
157115371|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
157115372|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
157115373|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
157115374|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
157115375|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
157115376|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
157115377|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
157115378|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
157115379|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
157115380|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
157115381|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
157115382|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
156778993|NCT01793935|565940617|FG000|Overall Study|Adverse Event|2|||
156778994|NCT01793935|565940618|FG001|Overall Study|Adverse Event|0|||
156778995|NCT01793935|565940617|FG000|Overall Study|Patient did not take study medication|1|||
156778996|NCT01793935|565940618|FG001|Overall Study|Patient did not take study medication|1|||
156778997|NCT01793935|565940617|FG000|Overall Study|Lost to Follow-up|0|||
156778998|NCT01793935|565940618|FG001|Overall Study|Lost to Follow-up|1|||
156778999|NCT01121926|565940619|FG000|First Intervention Period|Adverse Event|1|||
156779000|NCT01121926|565940620|FG001|First Intervention Period|Adverse Event|0|||
156779001|NCT01121926|565940619|FG000|Washout Period|Adverse Event|0|||
156779002|NCT01121926|565940620|FG001|Washout Period|Adverse Event|1|||
157115383|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
157115384|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
157115385|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
157115386|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
157115387|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
157115388|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
157115389|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
157115390|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
157115391|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
157115392|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
157115393|NCT00105443|567177369|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
157115394|NCT00105443|567177370|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
157115395|NCT00105443|567177371|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
157115396|NCT00105443|567177372|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
157115397|NCT02135692|567177373|FG000|Overall Study|Adverse Event|3|||
157115398|NCT02135692|567177373|FG000|Overall Study|Lack of Efficacy|2|||
157115399|NCT02135692|567177373|FG000|Overall Study|Protocol Violation|2|||
157115400|NCT02135692|567177373|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
157115401|NCT02135692|567177373|FG000|Overall Study|Product commercially available|159|||
157115402|NCT02135692|567177373|FG000|Overall Study|Study closed/terminated|153|||
157115403|NCT02135692|567177373|FG000|Overall Study|Lost to Follow-up|4|||
157115404|NCT02135692|567177373|FG000|Overall Study|Withdrawal by Subject|15|||
157115405|NCT01097746|567177375|FG000|Overall Study|Adverse Event|4|||
157115406|NCT01097746|567177375|FG000|Overall Study|taken off study before any treatment given|1|||
157115407|NCT02495844|567177380|FG000|Overall Study|Lack of Efficacy|1|||
157115408|NCT02495844|567177381|FG001|Overall Study|Lack of Efficacy|2|||
157115409|NCT02495844|567177380|FG000|Overall Study|AE, non-fatal|0|||
157115410|NCT02495844|567177381|FG001|Overall Study|AE, non-fatal|1|||
157115411|NCT02495844|567177380|FG000|Overall Study|Hepatitis Positivity|0|||
157115412|NCT02495844|567177381|FG001|Overall Study|Hepatitis Positivity|1|||
157209561|NCT01652872|567512309|FG000|Overall Study|Death|36|||
157115413|NCT01514682|567177382|FG000|Overall Study|Withdrawal by Subject|2|||
157115414|NCT01514682|567177383|FG001|Overall Study|Withdrawal by Subject|3|||
157115415|NCT01514682|567177382|FG000|Overall Study|Physician Decision|4|||
157115416|NCT01514682|567177383|FG001|Overall Study|Physician Decision|3|||
157115417|NCT02145741|567177384|FG000|Overall Study|Progressive disease|3|||
157115418|NCT02145741|567177385|FG001|Overall Study|Progressive disease|6|||
157115419|NCT02145741|567177386|FG002|Overall Study|Progressive disease|6|||
157115420|NCT02145741|567177384|FG000|Overall Study|quality issue with the administered drug|3|||
157115421|NCT02145741|567177385|FG001|Overall Study|quality issue with the administered drug|0|||
156779003|NCT01121926|565940619|FG000|Washout Period|Positive pregnancy test|0|||
157009336|NCT03512756|566785042|FG000|Part 2|Study Terminated by Sponsor|0|||
157009337|NCT03512756|566785043|FG001|Part 2|Study Terminated by Sponsor|0|||
157009338|NCT03512756|566785044|FG002|Part 2|Study Terminated by Sponsor|2|||
157009339|NCT03512756|566785045|FG003|Part 2|Study Terminated by Sponsor|6|||
157009340|NCT03512756|566785042|FG000|Part 2|Protocol Violation|0|||
157009341|NCT03512756|566785043|FG001|Part 2|Protocol Violation|0|||
157009342|NCT03512756|566785044|FG002|Part 2|Protocol Violation|1|||
157009343|NCT03512756|566785045|FG003|Part 2|Protocol Violation|0|||
157009344|NCT03512756|566785042|FG000|Part 2|Withdrawal by Subject|0|||
157009345|NCT03512756|566785043|FG001|Part 2|Withdrawal by Subject|0|||
157009346|NCT03512756|566785044|FG002|Part 2|Withdrawal by Subject|3|||
157009347|NCT03512756|566785045|FG003|Part 2|Withdrawal by Subject|9|||
157009348|NCT03312907|566786627|FG000|Overall Study|Adverse Event|1|||
157009349|NCT03312907|566786628|FG001|Overall Study|Adverse Event|6|||
157009350|NCT03312907|566786629|FG002|Overall Study|Adverse Event|1|||
157009351|NCT03312907|566786627|FG000|Overall Study|Protocol Violation|2|||
157009352|NCT03312907|566786628|FG001|Overall Study|Protocol Violation|3|||
157009353|NCT03312907|566786629|FG002|Overall Study|Protocol Violation|4|||
157009354|NCT03312907|566786627|FG000|Overall Study|Lost to Follow-up|2|||
157009355|NCT03312907|566786628|FG001|Overall Study|Lost to Follow-up|3|||
157009356|NCT03312907|566786629|FG002|Overall Study|Lost to Follow-up|2|||
157009357|NCT03312907|566786627|FG000|Overall Study|Physician Decision|3|||
157009358|NCT03312907|566786628|FG001|Overall Study|Physician Decision|4|||
157009359|NCT03312907|566786629|FG002|Overall Study|Physician Decision|2|||
157009360|NCT03312907|566786627|FG000|Overall Study|Withdrawal by Subject|9|||
157009361|NCT03312907|566786628|FG001|Overall Study|Withdrawal by Subject|14|||
157009362|NCT03312907|566786629|FG002|Overall Study|Withdrawal by Subject|10|||
157009363|NCT04688450|566786630|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
157009364|NCT04688450|566786630|FG000|Overall Study|Withdrawal by Subject|1|||
157009365|NCT03481777|566786635|FG000|Overall Study|Withdrawal by Subject|36|||
157009366|NCT03481777|566786636|FG001|Overall Study|Withdrawal by Subject|31|||
157009367|NCT03481777|566786635|FG000|Overall Study|Non stroke = non target population|277|||
157009368|NCT03481777|566786636|FG001|Overall Study|Non stroke = non target population|254|||
157009369|NCT03189524|566786637|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
157009370|NCT03189524|566786638|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
157009371|NCT03189524|566786639|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
157009372|NCT03189524|566786637|FG000|Overall Study|Death|2|||
157009373|NCT03189524|566786638|FG001|Overall Study|Death|2|||
157009374|NCT03189524|566786639|FG002|Overall Study|Death|1|||
157009375|NCT03189524|566786637|FG000|Overall Study|Lost to Follow-up|1|||
157009376|NCT03189524|566786638|FG001|Overall Study|Lost to Follow-up|0|||
157009377|NCT03189524|566786639|FG002|Overall Study|Lost to Follow-up|8|||
157009378|NCT03189524|566786637|FG000|Overall Study|Withdrawal by Subject|1|||
157009379|NCT03189524|566786638|FG001|Overall Study|Withdrawal by Subject|1|||
157009380|NCT03189524|566786639|FG002|Overall Study|Withdrawal by Subject|3|||
157009381|NCT03189524|566786637|FG000|Overall Study|Progressive Disease|0|||
157009382|NCT03189524|566786638|FG001|Overall Study|Progressive Disease|2|||
157009383|NCT03189524|566786639|FG002|Overall Study|Progressive Disease|0|||
157009384|NCT01780298|566786641|FG000|Overall Study|Physician Decision|1|||
157009385|NCT01780298|566786642|FG001|Overall Study|Physician Decision|5|||
157009386|NCT01780298|566786643|FG002|Overall Study|Physician Decision|1|||
157009387|NCT01780298|566786644|FG003|Overall Study|Physician Decision|1|||
157009388|NCT01780298|566786641|FG000|Overall Study|Subject not matched|1|||
157009389|NCT01780298|566786642|FG001|Overall Study|Subject not matched|0|||
157009390|NCT01780298|566786643|FG002|Overall Study|Subject not matched|1|||
157009391|NCT01780298|566786644|FG003|Overall Study|Subject not matched|0|||
157009392|NCT01780298|566786641|FG000|Overall Study|Adverse Event|0|||
157009393|NCT01780298|566786642|FG001|Overall Study|Adverse Event|0|||
157009394|NCT01780298|566786643|FG002|Overall Study|Adverse Event|2|||
157009395|NCT01780298|566786644|FG003|Overall Study|Adverse Event|0|||
157009396|NCT03613740|566786656|FG000|Overall Study|Lost to Follow-up|1|||
157009397|NCT03613740|566786657|FG001|Overall Study|Lost to Follow-up|1|||
157009398|NCT02407249|566786658|FG000|Overall Study|Did not complete 12-month follow-up|13|||
157009399|NCT02407249|566786658|FG000|Overall Study|Not treated|13|||
157009400|NCT02374463|566786661|FG000|Overall Study|Withdrawal by Subject|3|||
157009401|NCT02374463|566786662|FG001|Overall Study|Withdrawal by Subject|3|||
157009402|NCT00077675|566786663|FG000|Overall Study|Adverse Event|1|||
157009403|NCT00077675|566786664|FG001|Overall Study|Adverse Event|2|||
157009404|NCT00077675|566786663|FG000|Overall Study|Lost to Follow-up|6|||
157009405|NCT00077675|566786664|FG001|Overall Study|Lost to Follow-up|3|||
157009406|NCT00077675|566786663|FG000|Overall Study|Withdrawal by Subject|1|||
157209562|NCT01652872|567512310|FG001|Overall Study|Death|39|||
157009407|NCT00077675|566786664|FG001|Overall Study|Withdrawal by Subject|0|||
157009408|NCT00077675|566786663|FG000|Overall Study|Other|0|||
157009409|NCT00077675|566786664|FG001|Overall Study|Other|1|||
157009410|NCT00077675|566786663|FG000|Overall Study|Never received study treatment|3|||
157009411|NCT00077675|566786664|FG001|Overall Study|Never received study treatment|3|||
157115422|NCT02145741|567177386|FG002|Overall Study|quality issue with the administered drug|0|||
157115423|NCT00623480|567177387|FG000|Overall Study|Lost to Follow-up|0|||
157115424|NCT00623480|567177388|FG001|Overall Study|Lost to Follow-up|1|||
157115425|NCT00623480|567177387|FG000|Overall Study|Withdrawal by Subject|2|||
157115426|NCT00623480|567177388|FG001|Overall Study|Withdrawal by Subject|4|||
157115427|NCT00623480|567177387|FG000|Overall Study|Lack of Efficacy|1|||
157115428|NCT00623480|567177388|FG001|Overall Study|Lack of Efficacy|0|||
157115429|NCT00623480|567177387|FG000|Overall Study|Non-compliant with study medication|4|||
157115430|NCT00623480|567177388|FG001|Overall Study|Non-compliant with study medication|0|||
157115431|NCT00623480|567177387|FG000|Overall Study|Protocol Violation|0|||
157115432|NCT00623480|567177388|FG001|Overall Study|Protocol Violation|1|||
157115433|NCT00623480|567177387|FG000|Overall Study|Site closed by sponsor|0|||
157115434|NCT00623480|567177388|FG001|Overall Study|Site closed by sponsor|1|||
157115435|NCT01594853|567177389|FG000|Overall Study|Withdrawal by Subject|1|||
157115436|NCT01594853|567177390|FG001|Overall Study|Withdrawal by Subject|1|||
157115437|NCT01594853|567177389|FG000|Overall Study|Lost to Follow-up|1|||
157115438|NCT01594853|567177390|FG001|Overall Study|Lost to Follow-up|1|||
157115439|NCT01594853|567177389|FG000|Overall Study|noncompliance with exercise|0|||
157115440|NCT01594853|567177390|FG001|Overall Study|noncompliance with exercise|1|||
157115441|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
157115442|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
157115443|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
157115444|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
157115445|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
157115446|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
157115447|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
157115448|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
157115449|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
157115450|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
157115451|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
157115452|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
157115453|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
157115454|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
157115455|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
157115456|NCT00960661|567177391|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
157115457|NCT00960661|567177392|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
157115458|NCT00960661|567177393|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
157115459|NCT00960661|567177391|FG000|Interventional Phase|Adverse Event|0|||
157115460|NCT00960661|567177392|FG001|Interventional Phase|Adverse Event|17|||
157115461|NCT00960661|567177393|FG002|Interventional Phase|Adverse Event|8|||
157115462|NCT00960661|567177391|FG000|Interventional Phase|Death|0|||
157115463|NCT00960661|567177392|FG001|Interventional Phase|Death|1|||
157115464|NCT00960661|567177393|FG002|Interventional Phase|Death|0|||
157115465|NCT00960661|567177391|FG000|Interventional Phase|Lost to Follow-up|0|||
157115466|NCT00960661|567177392|FG001|Interventional Phase|Lost to Follow-up|0|||
157115467|NCT00960661|567177393|FG002|Interventional Phase|Lost to Follow-up|2|||
157115468|NCT00960661|567177391|FG000|Interventional Phase|entry criteria not met|0|||
157115469|NCT00960661|567177392|FG001|Interventional Phase|entry criteria not met|3|||
157115470|NCT00960661|567177393|FG002|Interventional Phase|entry criteria not met|0|||
157115471|NCT00960661|567177391|FG000|Interventional Phase|Protocol Violation|0|||
157115472|NCT00960661|567177392|FG001|Interventional Phase|Protocol Violation|7|||
157115473|NCT00960661|567177393|FG002|Interventional Phase|Protocol Violation|2|||
157115474|NCT00960661|567177391|FG000|Interventional Phase|Withdrawal by Subject|0|||
157115475|NCT00960661|567177392|FG001|Interventional Phase|Withdrawal by Subject|18|||
157115476|NCT00960661|567177393|FG002|Interventional Phase|Withdrawal by Subject|29|||
157115477|NCT00960661|567177391|FG000|Interventional Phase|Physician Decision|0|||
157115478|NCT00960661|567177392|FG001|Interventional Phase|Physician Decision|3|||
157115479|NCT00960661|567177393|FG002|Interventional Phase|Physician Decision|5|||
157115480|NCT00960661|567177391|FG000|Interventional Phase|sponsor decision|0|||
157115481|NCT00960661|567177392|FG001|Interventional Phase|sponsor decision|1|||
157115482|NCT00960661|567177393|FG002|Interventional Phase|sponsor decision|0|||
157115483|NCT00960661|567177391|FG000|Interventional Phase|Lack of Efficacy|0|||
157115484|NCT00960661|567177392|FG001|Interventional Phase|Lack of Efficacy|2|||
157115485|NCT00960661|567177393|FG002|Interventional Phase|Lack of Efficacy|0|||
157115486|NCT02699892|567177394|FG000|Overall Study|Other|36|||
157115487|NCT00711100|567177395|FG000|Overall Study|Lack of Efficacy|5|||
157115488|NCT00711100|567177395|FG000|Overall Study|Withdrawal by Subject|8|||
157115489|NCT02412787|567177396|FG000|Overall Study|Withdrawal by Subject|9|||
157115490|NCT02412787|567177396|FG000|Overall Study|Participation Terminated by Investigator|1|||
157115491|NCT02412787|567177396|FG000|Overall Study|Site Terminated by Sponsor|21|||
157115492|NCT02412787|567177396|FG000|Overall Study|Technical Problems|1|||
157115493|NCT02412787|567177396|FG000|Overall Study|Reason Not Specified|1|||
157115494|NCT00001379|567177397|FG000|Initial Treatment|Disease progression|21|||
157115495|NCT00001379|567177398|FG001|Initial Treatment|Disease progression|3|||
157115496|NCT00001379|567177399|FG002|Initial Treatment|Disease progression|0|||
157115497|NCT00001379|567177400|FG003|Initial Treatment|Disease progression|0|||
157115498|NCT00001379|567177397|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
157115499|NCT00001379|567177398|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
157115500|NCT00001379|567177399|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
157115501|NCT00001379|567177400|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
157115502|NCT00001379|567177397|FG000|Initial Treatment|Received alternative treatment|2|||
157115503|NCT00001379|567177398|FG001|Initial Treatment|Received alternative treatment|1|||
157115504|NCT00001379|567177399|FG002|Initial Treatment|Received alternative treatment|0|||
157115505|NCT00001379|567177400|FG003|Initial Treatment|Received alternative treatment|0|||
157115506|NCT00001379|567177397|FG000|Initial Treatment|Refused further treatment|2|||
156779004|NCT01121926|565940620|FG001|Washout Period|Positive pregnancy test|1|||
156779005|NCT02782468|565940621|FG000|Overall Study|Progressive Disease|2|||
156779006|NCT02782468|565940622|FG001|Overall Study|Progressive Disease|5|||
156779007|NCT02782468|565940623|FG002|Overall Study|Progressive Disease|0|||
156779008|NCT02782468|565940624|FG003|Overall Study|Progressive Disease|4|||
156779009|NCT02782468|565940621|FG000|Overall Study|Adverse Event|0|||
156779010|NCT02782468|565940622|FG001|Overall Study|Adverse Event|2|||
156779011|NCT02782468|565940623|FG002|Overall Study|Adverse Event|2|||
156779012|NCT02782468|565940624|FG003|Overall Study|Adverse Event|3|||
156779013|NCT02782468|565940621|FG000|Overall Study|Other|0|||
156779014|NCT02782468|565940622|FG001|Overall Study|Other|0|||
156779015|NCT02782468|565940623|FG002|Overall Study|Other|1|||
156779016|NCT02782468|565940624|FG003|Overall Study|Other|1|||
156779017|NCT02782468|565940621|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779018|NCT02782468|565940622|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779019|NCT02782468|565940623|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
156779020|NCT02782468|565940624|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
156779021|NCT02782468|565940621|FG000|Overall Study|Symptomatic Deterioration|0|||
156779022|NCT02782468|565940622|FG001|Overall Study|Symptomatic Deterioration|0|||
156779023|NCT02782468|565940623|FG002|Overall Study|Symptomatic Deterioration|0|||
157115507|NCT00001379|567177398|FG001|Initial Treatment|Refused further treatment|0|||
157115508|NCT00001379|567177399|FG002|Initial Treatment|Refused further treatment|0|||
157115509|NCT00001379|567177400|FG003|Initial Treatment|Refused further treatment|0|||
157115510|NCT00001379|567177397|FG000|Initial Treatment|Did not receive protocol treatment|0|||
157115511|NCT00001379|567177398|FG001|Initial Treatment|Did not receive protocol treatment|0|||
157115512|NCT00001379|567177399|FG002|Initial Treatment|Did not receive protocol treatment|5|||
157115513|NCT00001379|567177400|FG003|Initial Treatment|Did not receive protocol treatment|0|||
157115514|NCT00001379|567177397|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
157115515|NCT00001379|567177398|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
157115516|NCT00001379|567177399|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
157115517|NCT00001379|567177400|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
157115518|NCT00001379|567177397|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
157115519|NCT00001379|567177398|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
157115520|NCT00001379|567177399|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
157115521|NCT00001379|567177400|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
157115522|NCT00001379|567177397|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
157115523|NCT00001379|567177398|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
157115524|NCT00001379|567177399|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
157115525|NCT00001379|567177400|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
157115526|NCT00001379|567177397|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
157115527|NCT00001379|567177398|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
157209563|NCT01652872|567512309|FG000|Overall Study|Lost to Follow-up|28|||
157209564|NCT01652872|567512310|FG001|Overall Study|Lost to Follow-up|23|||
157209565|NCT01652872|567512309|FG000|Overall Study|Decision by sponsor|5|||
156779024|NCT02782468|565940624|FG003|Overall Study|Symptomatic Deterioration|1|||
156779025|NCT02782468|565940621|FG000|Overall Study|Withdrawal by Subject|1|||
156779026|NCT02782468|565940622|FG001|Overall Study|Withdrawal by Subject|0|||
156779027|NCT02782468|565940623|FG002|Overall Study|Withdrawal by Subject|0|||
156779028|NCT02782468|565940624|FG003|Overall Study|Withdrawal by Subject|0|||
156779029|NCT00817063|565940631|FG000|Overall Study|Adverse Event|32|||
156779030|NCT00817063|565940632|FG001|Overall Study|Adverse Event|13|||
156779031|NCT00817063|565940631|FG000|Overall Study|Death|1|||
156779032|NCT00817063|565940632|FG001|Overall Study|Death|1|||
156779033|NCT00817063|565940631|FG000|Overall Study|Lack of Efficacy|33|||
156779034|NCT00817063|565940632|FG001|Overall Study|Lack of Efficacy|86|||
156779035|NCT00817063|565940631|FG000|Overall Study|Failure to Return|13|||
157115528|NCT00001379|567177399|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
157115529|NCT00001379|567177400|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
157115530|NCT00001379|567177397|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
157115531|NCT00001379|567177398|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
157115532|NCT00001379|567177399|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
157115533|NCT00001379|567177400|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
157115534|NCT03246958|567177401|FG000|Overall Study|Withdrawal by Subject|0|||
157115535|NCT03246958|567177402|FG001|Overall Study|Withdrawal by Subject|1|||
157115536|NCT03246958|567177403|FG002|Overall Study|Withdrawal by Subject|0|||
157115537|NCT03246958|567177404|FG003|Overall Study|Withdrawal by Subject|0|||
157115538|NCT03246958|567177405|FG004|Overall Study|Withdrawal by Subject|0|||
157115539|NCT03246958|567177406|FG005|Overall Study|Withdrawal by Subject|1|||
157115540|NCT03246958|567177407|FG006|Overall Study|Withdrawal by Subject|0|||
157115541|NCT03246958|567177401|FG000|Overall Study|Progression|13|||
157115542|NCT03246958|567177402|FG001|Overall Study|Progression|9|||
157115543|NCT03246958|567177403|FG002|Overall Study|Progression|3|||
157115544|NCT03246958|567177404|FG003|Overall Study|Progression|2|||
157115545|NCT03246958|567177405|FG004|Overall Study|Progression|1|||
157115546|NCT03246958|567177406|FG005|Overall Study|Progression|2|||
156779036|NCT00817063|565940632|FG001|Overall Study|Failure to Return|12|||
156779037|NCT00817063|565940631|FG000|Overall Study|Violation of Selection at Entry|7|||
156779038|NCT00817063|565940632|FG001|Overall Study|Violation of Selection at Entry|4|||
156779039|NCT00817063|565940631|FG000|Overall Study|Protocol Violation|3|||
156779040|NCT00817063|565940632|FG001|Overall Study|Protocol Violation|8|||
156779041|NCT00817063|565940631|FG000|Overall Study|Withdrawal by Subject|17|||
156779042|NCT00817063|565940632|FG001|Overall Study|Withdrawal by Subject|37|||
156779043|NCT00817063|565940631|FG000|Overall Study|Early Improvement|19|||
156779044|NCT00817063|565940632|FG001|Overall Study|Early Improvement|4|||
156779045|NCT00817063|565940631|FG000|Overall Study|Administrative|10|||
156779046|NCT00817063|565940632|FG001|Overall Study|Administrative|4|||
156779047|NCT00817063|565940631|FG000|Overall Study|Abnormality of Laboratory Test|2|||
156779048|NCT00817063|565940632|FG001|Overall Study|Abnormality of Laboratory Test|1|||
156779049|NCT01496456|565940633|FG000|Overall Study|Protocol Violation|1|||
156779050|NCT01496456|565940633|FG000|Overall Study|Lost to Follow-up|7|||
156779051|NCT04919161|565940634|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
156779052|NCT04919161|565940635|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
156779053|NCT04919161|565940634|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
156779054|NCT04919161|565940635|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
156779055|NCT04919161|565940634|FG000|Overall Study|Acute ankle sprain after session 1|0|||
156779056|NCT04919161|565940635|FG001|Overall Study|Acute ankle sprain after session 1|1|||
156779057|NCT01044498|565940639|FG000|Overall Study|Withdrew consent|1|||
156779058|NCT01044498|565940640|FG001|Overall Study|Withdrew consent|1|||
156779059|NCT01044498|565940639|FG000|Overall Study|Adverse Event|1|||
156779060|NCT01044498|565940640|FG001|Overall Study|Adverse Event|1|||
156779061|NCT01044498|565940639|FG000|Overall Study|Other|1|||
156779062|NCT01044498|565940640|FG001|Overall Study|Other|0|||
156779063|NCT03487445|565940643|FG000|Randomization|Not treated for administrative reasons|1|||
156779064|NCT03487445|565940644|FG001|Randomization|Not treated for administrative reasons|0|||
156779065|NCT04132050|565940649|FG000|Period I (Double-blind Period)|Adverse Event|3|||
156779066|NCT04132050|565940650|FG001|Period I (Double-blind Period)|Adverse Event|0|||
156779067|NCT04132050|565940649|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
156779068|NCT04132050|565940650|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
156779069|NCT04132050|565940649|FG000|R788 Treatment Period|Adverse Event|5|||
156779070|NCT04132050|565940650|FG001|R788 Treatment Period|Adverse Event|0|||
156779071|NCT04132050|565940649|FG000|R788 Treatment Period|Lack of Efficacy|5|||
156779072|NCT04132050|565940650|FG001|R788 Treatment Period|Lack of Efficacy|0|||
156779073|NCT04132050|565940649|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
156779074|NCT04132050|565940650|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
156779075|NCT02246777|565940651|FG000|Overall Study|Adverse Event|2|||
156779076|NCT02246777|565940651|FG000|Overall Study|Change of residence|1|||
156779077|NCT04556097|565940652|FG000|Overall Study|Death|0|||
156779078|NCT04556097|565940653|FG001|Overall Study|Death|5|||
156779079|NCT04556097|565940654|FG002|Overall Study|Death|0|||
156779080|NCT04556097|565940655|FG003|Overall Study|Death|0|||
156779081|NCT04556097|565940652|FG000|Overall Study|No caregiver|43|||
156779082|NCT04556097|565940653|FG001|Overall Study|No caregiver|53|||
156779083|NCT04556097|565940654|FG002|Overall Study|No caregiver|0|||
156779084|NCT04556097|565940655|FG003|Overall Study|No caregiver|0|||
156779085|NCT04556097|565940652|FG000|Overall Study|Ineligible, SNF|2|||
156779086|NCT04556097|565940653|FG001|Overall Study|Ineligible, SNF|2|||
156779087|NCT04556097|565940654|FG002|Overall Study|Ineligible, SNF|0|||
156779088|NCT04556097|565940655|FG003|Overall Study|Ineligible, SNF|0|||
156779089|NCT04556097|565940652|FG000|Overall Study|Ineligible, health|3|||
156779090|NCT04556097|565940653|FG001|Overall Study|Ineligible, health|4|||
156779091|NCT04556097|565940654|FG002|Overall Study|Ineligible, health|0|||
157115547|NCT03246958|567177407|FG006|Overall Study|Progression|1|||
157115548|NCT03246958|567177401|FG000|Overall Study|Adverse Event|2|||
157115549|NCT03246958|567177402|FG001|Overall Study|Adverse Event|2|||
157115550|NCT03246958|567177403|FG002|Overall Study|Adverse Event|0|||
157115551|NCT03246958|567177404|FG003|Overall Study|Adverse Event|1|||
157115552|NCT03246958|567177405|FG004|Overall Study|Adverse Event|1|||
157115553|NCT03246958|567177406|FG005|Overall Study|Adverse Event|0|||
157115554|NCT03246958|567177407|FG006|Overall Study|Adverse Event|2|||
157115555|NCT03246958|567177401|FG000|Overall Study|Death|0|||
157115556|NCT03246958|567177402|FG001|Overall Study|Death|1|||
157115557|NCT03246958|567177403|FG002|Overall Study|Death|0|||
157115558|NCT03246958|567177404|FG003|Overall Study|Death|0|||
157115559|NCT03246958|567177405|FG004|Overall Study|Death|0|||
157115560|NCT03246958|567177406|FG005|Overall Study|Death|0|||
157115561|NCT03246958|567177407|FG006|Overall Study|Death|0|||
157115562|NCT03246958|567177401|FG000|Overall Study|Physician Decision|0|||
157115563|NCT03246958|567177402|FG001|Overall Study|Physician Decision|0|||
156779092|NCT04556097|565940655|FG003|Overall Study|Ineligible, health|0|||
156779093|NCT04556097|565940652|FG000|Overall Study|Ineligible, language|0|||
156779094|NCT04556097|565940653|FG001|Overall Study|Ineligible, language|1|||
156779095|NCT04556097|565940654|FG002|Overall Study|Ineligible, language|0|||
157115564|NCT03246958|567177403|FG002|Overall Study|Physician Decision|0|||
157115565|NCT03246958|567177404|FG003|Overall Study|Physician Decision|1|||
157115566|NCT03246958|567177405|FG004|Overall Study|Physician Decision|0|||
157115567|NCT03246958|567177406|FG005|Overall Study|Physician Decision|0|||
157115568|NCT03246958|567177407|FG006|Overall Study|Physician Decision|0|||
157115569|NCT03246958|567177401|FG000|Overall Study|Never start treatment|1|||
157115570|NCT03246958|567177402|FG001|Overall Study|Never start treatment|0|||
157115571|NCT03246958|567177403|FG002|Overall Study|Never start treatment|0|||
157115572|NCT03246958|567177404|FG003|Overall Study|Never start treatment|0|||
157115573|NCT03246958|567177405|FG004|Overall Study|Never start treatment|0|||
157115574|NCT03246958|567177406|FG005|Overall Study|Never start treatment|0|||
157115575|NCT03246958|567177407|FG006|Overall Study|Never start treatment|0|||
157115576|NCT03246958|567177401|FG000|Overall Study|Over enrollment|0|||
157115577|NCT03246958|567177402|FG001|Overall Study|Over enrollment|2|||
157115578|NCT03246958|567177403|FG002|Overall Study|Over enrollment|0|||
157115579|NCT03246958|567177404|FG003|Overall Study|Over enrollment|0|||
157115580|NCT03246958|567177405|FG004|Overall Study|Over enrollment|0|||
157115581|NCT03246958|567177406|FG005|Overall Study|Over enrollment|0|||
157115582|NCT03246958|567177407|FG006|Overall Study|Over enrollment|0|||
157115583|NCT00811135|567177411|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
157115584|NCT00811135|567177411|FG000|Overall Study|Death|3|||
157115585|NCT00811135|567177411|FG000|Overall Study|Protocol Violation|2|||
157115586|NCT00811135|567177411|FG000|Overall Study|Violation of Selection Criteria|1|||
157115587|NCT00811135|567177411|FG000|Overall Study|Refused Treatment|1|||
157115588|NCT00811135|567177411|FG000|Overall Study|Withdrawal by Subject|3|||
157115589|NCT00811135|567177411|FG000|Overall Study|Administrative/Other Unspecified|11|||
157115590|NCT00811135|567177411|FG000|Overall Study|Ongoing|59|||
157209566|NCT01652872|567512310|FG001|Overall Study|Decision by sponsor|7|||
157009412|NCT01599793|566786666|FG000|Overall Study|Adverse Event|2|||
157009413|NCT02652442|566786672|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
157009414|NCT02593149|566786673|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
157009415|NCT02593149|566786674|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
157009416|NCT02593149|566786673|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
157009417|NCT02593149|566786674|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
157009418|NCT04532528|566786675|FG000|Overall Study|Adverse Event|12|||
157009419|NCT04532528|566786676|FG001|Overall Study|Adverse Event|17|||
157009420|NCT04532528|566786675|FG000|Overall Study|Withdrawal of consent|16|||
157009421|NCT04532528|566786676|FG001|Overall Study|Withdrawal of consent|17|||
157009422|NCT04532528|566786675|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
157009423|NCT04532528|566786676|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
157009424|NCT04532528|566786675|FG000|Overall Study|Lost to Follow-up|69|||
157009425|NCT04532528|566786676|FG001|Overall Study|Lost to Follow-up|68|||
157009426|NCT04532528|566786675|FG000|Overall Study|Administrative problems|12|||
157009427|NCT04532528|566786676|FG001|Overall Study|Administrative problems|14|||
157009428|NCT04532528|566786675|FG000|Overall Study|Death|3|||
157009429|NCT04532528|566786676|FG001|Overall Study|Death|3|||
157009430|NCT04532528|566786675|FG000|Overall Study|Other|38|||
157009431|NCT04532528|566786676|FG001|Overall Study|Other|46|||
157009432|NCT01636687|566786677|FG000|Induction Period|Withdrawal by Subject|1|||
157009433|NCT01636687|566786678|FG001|Induction Period|Withdrawal by Subject|0|||
157009434|NCT01636687|566786679|FG002|Induction Period|Withdrawal by Subject|0|||
157009435|NCT01636687|566786680|FG003|Induction Period|Withdrawal by Subject|0|||
157009436|NCT01636687|566786681|FG004|Induction Period|Withdrawal by Subject|0|||
157009437|NCT01636687|566786677|FG000|Induction Period|Adverse Event|1|||
157009438|NCT01636687|566786678|FG001|Induction Period|Adverse Event|0|||
157009439|NCT01636687|566786679|FG002|Induction Period|Adverse Event|0|||
157009440|NCT01636687|566786680|FG003|Induction Period|Adverse Event|0|||
157009441|NCT01636687|566786681|FG004|Induction Period|Adverse Event|1|||
157009442|NCT01636687|566786677|FG000|Induction Period|Lack of Efficacy|0|||
157009443|NCT01636687|566786678|FG001|Induction Period|Lack of Efficacy|0|||
157009444|NCT01636687|566786679|FG002|Induction Period|Lack of Efficacy|0|||
157009445|NCT01636687|566786680|FG003|Induction Period|Lack of Efficacy|0|||
157009446|NCT01636687|566786681|FG004|Induction Period|Lack of Efficacy|1|||
157009447|NCT01636687|566786677|FG000|Induction Period|Physician Decision|1|||
157009448|NCT01636687|566786678|FG001|Induction Period|Physician Decision|0|||
157009449|NCT01636687|566786679|FG002|Induction Period|Physician Decision|0|||
157009450|NCT01636687|566786680|FG003|Induction Period|Physician Decision|0|||
157009451|NCT01636687|566786681|FG004|Induction Period|Physician Decision|0|||
157009452|NCT01636687|566786677|FG000|Maintenance Period|Withdrawal by Subject|2|||
157009453|NCT01636687|566786678|FG001|Maintenance Period|Withdrawal by Subject|0|||
157009454|NCT01636687|566786679|FG002|Maintenance Period|Withdrawal by Subject|2|||
157009455|NCT01636687|566786680|FG003|Maintenance Period|Withdrawal by Subject|0|||
157009456|NCT01636687|566786681|FG004|Maintenance Period|Withdrawal by Subject|0|||
157009457|NCT01636687|566786677|FG000|Maintenance Period|Adverse Event|1|||
157009458|NCT01636687|566786678|FG001|Maintenance Period|Adverse Event|0|||
157115591|NCT01118351|567177412|FG000|Overall Study|Adverse Event|3|||
157115592|NCT01118351|567177412|FG000|Overall Study|Withdrawal by Subject|1|||
157115593|NCT02797808|567177414|FG000|Overall Study|Withdrawal by Subject|1|||
157115594|NCT02797808|567177415|FG001|Overall Study|Withdrawal by Subject|1|||
157115595|NCT02797808|567177414|FG000|Overall Study|Physician Decision|6|||
157115596|NCT02797808|567177415|FG001|Overall Study|Physician Decision|2|||
157115597|NCT00535132|567177419|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
157115598|NCT00535132|567177420|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
157115599|NCT00535132|567177419|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
157115600|NCT00535132|567177420|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
157115601|NCT00264875|567177421|FG000|Overall Study|Adverse Event|6|||
157115602|NCT00264875|567177421|FG000|Overall Study|Lost to Follow-up|6|||
157115603|NCT00264875|567177421|FG000|Overall Study|Protocol Violation|11|||
157115604|NCT00264875|567177421|FG000|Overall Study|Withdrawal by Subject|7|||
157115605|NCT01500278|567177422|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
157115606|NCT01500278|567177423|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
157115607|NCT01500278|567177422|FG000|Week 0 - Week 12|Protocol Violation|10|||
157115608|NCT01500278|567177423|FG001|Week 0 - Week 12|Protocol Violation|16|||
157115609|NCT01500278|567177422|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
157115610|NCT01500278|567177423|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
157115611|NCT01500278|567177422|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
157115612|NCT01500278|567177423|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
157115613|NCT01500278|567177422|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
157115614|NCT01500278|567177423|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
157009459|NCT01636687|566786679|FG002|Maintenance Period|Adverse Event|0|||
157009460|NCT01636687|566786680|FG003|Maintenance Period|Adverse Event|0|||
157009461|NCT01636687|566786681|FG004|Maintenance Period|Adverse Event|0|||
157009462|NCT01636687|566786677|FG000|Maintenance Period|Lack of Efficacy|4|||
156779096|NCT04556097|565940655|FG003|Overall Study|Ineligible, language|0|||
156779097|NCT04556097|565940652|FG000|Overall Study|Ineligible, no longer in care management|0|||
156779098|NCT04556097|565940653|FG001|Overall Study|Ineligible, no longer in care management|2|||
156779099|NCT04556097|565940654|FG002|Overall Study|Ineligible, no longer in care management|1|||
156779100|NCT04556097|565940655|FG003|Overall Study|Ineligible, no longer in care management|0|||
156779101|NCT04556097|565940652|FG000|Overall Study|No dementia|13|||
156779102|NCT04556097|565940653|FG001|Overall Study|No dementia|3|||
156779103|NCT04556097|565940654|FG002|Overall Study|No dementia|0|||
156779104|NCT04556097|565940655|FG003|Overall Study|No dementia|0|||
156779105|NCT04556097|565940652|FG000|Overall Study|Missing identifier|2|||
156779106|NCT04556097|565940653|FG001|Overall Study|Missing identifier|4|||
156779107|NCT04556097|565940654|FG002|Overall Study|Missing identifier|0|||
156779108|NCT04556097|565940655|FG003|Overall Study|Missing identifier|0|||
156779109|NCT04556097|565940652|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
156779110|NCT04556097|565940653|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
156779111|NCT04556097|565940654|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
156779112|NCT04556097|565940655|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
156779113|NCT05436613|565940656|FG000|Overall Study|Lost to Follow-up|9|||
156779114|NCT05436613|565940656|FG000|Overall Study|Withdrawal by Subject|3|||
156779115|NCT06239610|565940661|FG000|Overall Study|no usable migration data for minimum of one day|11|||
156779116|NCT00765076|565940662|FG000|Overall Study|Adverse Event|1|||
156779117|NCT00765076|565940663|FG001|Overall Study|Adverse Event|0|||
156779118|NCT00765076|565940664|FG002|Overall Study|Adverse Event|0|||
156779119|NCT00765076|565940662|FG000|Overall Study|Withdrawal by Subject|0|||
156779120|NCT00765076|565940663|FG001|Overall Study|Withdrawal by Subject|0|||
156779121|NCT00765076|565940664|FG002|Overall Study|Withdrawal by Subject|1|||
156779122|NCT01164475|565940665|FG000|Overall Study|Lack of Efficacy|1|||
156779123|NCT01164475|565940666|FG001|Overall Study|Lack of Efficacy|0|||
156779124|NCT01164475|565940665|FG000|Overall Study|Other|0|||
156779125|NCT01164475|565940666|FG001|Overall Study|Other|1|||
156779126|NCT01164475|565940665|FG000|Overall Study|Progressive disease|0|||
156779127|NCT01164475|565940666|FG001|Overall Study|Progressive disease|1|||
156779128|NCT01164475|565940665|FG000|Overall Study|Protocol Violation|1|||
156779129|NCT01164475|565940666|FG001|Overall Study|Protocol Violation|0|||
156779130|NCT02335944|565940667|FG000|Treatment Phase|Progressive Disease|2|||
156779131|NCT02335944|565940668|FG001|Treatment Phase|Progressive Disease|5|||
156779132|NCT02335944|565940669|FG002|Treatment Phase|Progressive Disease|2|||
156779133|NCT02335944|565940670|FG003|Treatment Phase|Progressive Disease|11|||
156779134|NCT02335944|565940671|FG004|Treatment Phase|Progressive Disease|4|||
156779135|NCT02335944|565940672|FG005|Treatment Phase|Progressive Disease|25|||
156779136|NCT02335944|565940673|FG006|Treatment Phase|Progressive Disease|2|||
156779137|NCT02335944|565940674|FG007|Treatment Phase|Progressive Disease|30|||
156866137|NCT01342211|566269177|FG002|Overall Study|Withdrawal by Subject|0|||
157115615|NCT01500278|567177422|FG000|Week 0 - Week 12|Patient decision|1|||
157209567|NCT01652872|567512309|FG000|Overall Study|Withdrawal by Subject|76|||
157209568|NCT01652872|567512310|FG001|Overall Study|Withdrawal by Subject|84|||
157209569|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
157209570|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
157209571|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
157209572|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
157209573|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
157209574|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
157209575|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
157209576|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
157209577|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
157209578|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
157209579|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
157209580|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
157209581|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
157209582|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
157209583|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
157209584|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
157209585|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
157209586|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
157209587|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
157209588|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
157209589|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
157209590|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
157209591|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
157209592|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
157209593|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
157209594|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
157209595|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
157209596|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
157209597|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
157209598|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
157209599|NCT03985293|567512312|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
157209600|NCT03985293|567512313|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
157209601|NCT03985293|567512314|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
157209602|NCT03985293|567512315|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
157209603|NCT03985293|567512316|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
157209604|NCT03985293|567512317|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
157209605|NCT03985293|567512312|FG000|FOLLOW-UP|Lost to Follow-up|0|||
157209606|NCT03985293|567512313|FG001|FOLLOW-UP|Lost to Follow-up|0|||
157209607|NCT03985293|567512314|FG002|FOLLOW-UP|Lost to Follow-up|1|||
157209608|NCT03985293|567512315|FG003|FOLLOW-UP|Lost to Follow-up|0|||
157209609|NCT03985293|567512316|FG004|FOLLOW-UP|Lost to Follow-up|0|||
157209610|NCT03985293|567512317|FG005|FOLLOW-UP|Lost to Follow-up|0|||
157209611|NCT06065176|567512318|FG000|Overall Study|Lost to Follow-up|11|||
157209612|NCT06065176|567512319|FG001|Overall Study|Lost to Follow-up|11|||
157209613|NCT06065176|567512320|FG002|Overall Study|Lost to Follow-up|10|||
157209614|NCT06065176|567512318|FG000|Overall Study|Withdrawal by Subject|1|||
157209615|NCT06065176|567512319|FG001|Overall Study|Withdrawal by Subject|1|||
157209616|NCT06065176|567512320|FG002|Overall Study|Withdrawal by Subject|2|||
157209617|NCT06065176|567512318|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
156779138|NCT02335944|565940675|FG008|Treatment Phase|Progressive Disease|27|||
156779139|NCT02335944|565940676|FG009|Treatment Phase|Progressive Disease|0|||
156779140|NCT02335944|565940667|FG000|Treatment Phase|Adverse Event|2|||
156779141|NCT02335944|565940668|FG001|Treatment Phase|Adverse Event|0|||
156779142|NCT02335944|565940669|FG002|Treatment Phase|Adverse Event|0|||
157209618|NCT06065176|567512319|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
157209619|NCT06065176|567512320|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
157209620|NCT02588651|567512321|FG000|Overall Study|Adverse Event|1|||
157209621|NCT02588651|567512321|FG000|Overall Study|Withdrawal by Subject|2|||
157209622|NCT02588651|567512321|FG000|Overall Study|Death|1|||
157209623|NCT02588651|567512321|FG000|Overall Study|Lack of Efficacy|13|||
157209624|NCT02588651|567512321|FG000|Overall Study|Lost to Follow-up|1|||
156779143|NCT02335944|565940670|FG003|Treatment Phase|Adverse Event|2|||
157209625|NCT02588651|567512321|FG000|Overall Study|Physician Decision|1|||
156779144|NCT02335944|565940671|FG004|Treatment Phase|Adverse Event|1|||
157209626|NCT02588651|567512321|FG000|Overall Study|Disease progression|2|||
157209627|NCT03078192|567512329|FG000|Overall Study|Withdrawal by Subject|2|||
157209628|NCT03078192|567512330|FG001|Overall Study|Withdrawal by Subject|1|||
157209629|NCT03078192|567512329|FG000|Overall Study|screen failure|0|||
157209630|NCT03078192|567512330|FG001|Overall Study|screen failure|3|||
157209631|NCT02873195|567512331|FG000|Overall Study|Ineligible|5|||
156779145|NCT02335944|565940672|FG005|Treatment Phase|Adverse Event|15|||
156779146|NCT02335944|565940673|FG006|Treatment Phase|Adverse Event|0|||
157209632|NCT02873195|567512332|FG001|Overall Study|Ineligible|0|||
156779147|NCT02335944|565940674|FG007|Treatment Phase|Adverse Event|5|||
156779148|NCT02335944|565940675|FG008|Treatment Phase|Adverse Event|7|||
156779149|NCT02335944|565940676|FG009|Treatment Phase|Adverse Event|0|||
156779150|NCT02335944|565940667|FG000|Treatment Phase|Physician Decision|0|||
156779151|NCT02335944|565940668|FG001|Treatment Phase|Physician Decision|0|||
156779152|NCT02335944|565940669|FG002|Treatment Phase|Physician Decision|0|||
156779153|NCT02335944|565940670|FG003|Treatment Phase|Physician Decision|1|||
156779154|NCT02335944|565940671|FG004|Treatment Phase|Physician Decision|0|||
156779155|NCT02335944|565940672|FG005|Treatment Phase|Physician Decision|6|||
156779156|NCT02335944|565940673|FG006|Treatment Phase|Physician Decision|1|||
156779157|NCT02335944|565940674|FG007|Treatment Phase|Physician Decision|2|||
156779158|NCT02335944|565940675|FG008|Treatment Phase|Physician Decision|1|||
156779159|NCT02335944|565940676|FG009|Treatment Phase|Physician Decision|0|||
156779160|NCT02335944|565940667|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
156779161|NCT02335944|565940668|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
156779162|NCT02335944|565940669|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
156779163|NCT02335944|565940670|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
156779164|NCT02335944|565940671|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
156779165|NCT02335944|565940672|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
156779166|NCT02335944|565940673|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
156779167|NCT02335944|565940674|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
156779168|NCT02335944|565940675|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
156779169|NCT02335944|565940676|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
156779170|NCT02335944|565940667|FG000|Treatment Phase|Subject/Guardian Decision|0|||
156779171|NCT02335944|565940668|FG001|Treatment Phase|Subject/Guardian Decision|0|||
156779172|NCT02335944|565940669|FG002|Treatment Phase|Subject/Guardian Decision|1|||
156779173|NCT02335944|565940670|FG003|Treatment Phase|Subject/Guardian Decision|0|||
156779174|NCT02335944|565940671|FG004|Treatment Phase|Subject/Guardian Decision|0|||
156779175|NCT02335944|565940672|FG005|Treatment Phase|Subject/Guardian Decision|1|||
156779176|NCT02335944|565940673|FG006|Treatment Phase|Subject/Guardian Decision|0|||
156779177|NCT02335944|565940674|FG007|Treatment Phase|Subject/Guardian Decision|4|||
156779178|NCT02335944|565940675|FG008|Treatment Phase|Subject/Guardian Decision|0|||
156779179|NCT02335944|565940676|FG009|Treatment Phase|Subject/Guardian Decision|0|||
156779180|NCT02335944|565940667|FG000|Post-treatment Follow-up|Progressive Disease|0|||
156779181|NCT02335944|565940668|FG001|Post-treatment Follow-up|Progressive Disease|0|||
156779182|NCT02335944|565940669|FG002|Post-treatment Follow-up|Progressive Disease|0|||
156779183|NCT02335944|565940670|FG003|Post-treatment Follow-up|Progressive Disease|1|||
156779184|NCT02335944|565940671|FG004|Post-treatment Follow-up|Progressive Disease|0|||
156779185|NCT02335944|565940672|FG005|Post-treatment Follow-up|Progressive Disease|9|||
156779186|NCT02335944|565940673|FG006|Post-treatment Follow-up|Progressive Disease|0|||
156779187|NCT02335944|565940674|FG007|Post-treatment Follow-up|Progressive Disease|2|||
156779188|NCT02335944|565940675|FG008|Post-treatment Follow-up|Progressive Disease|3|||
156779189|NCT02335944|565940676|FG009|Post-treatment Follow-up|Progressive Disease|0|||
156779190|NCT02335944|565940667|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779191|NCT02335944|565940668|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779192|NCT02335944|565940669|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779193|NCT02335944|565940670|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779194|NCT02335944|565940671|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779195|NCT02335944|565940672|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
156779196|NCT02335944|565940673|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779197|NCT02335944|565940674|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779198|NCT02335944|565940675|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779199|NCT02335944|565940676|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
156779200|NCT02335944|565940667|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779201|NCT02335944|565940668|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779202|NCT02335944|565940669|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779203|NCT02335944|565940670|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779204|NCT02335944|565940671|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779205|NCT02335944|565940672|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779206|NCT02335944|565940673|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779207|NCT02335944|565940674|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
156779208|NCT02335944|565940675|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779209|NCT02335944|565940676|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
156779210|NCT02335944|565940667|FG000|Post-treatment Follow-up|Adverse Event|0|||
156779211|NCT02335944|565940668|FG001|Post-treatment Follow-up|Adverse Event|0|||
156779212|NCT02335944|565940669|FG002|Post-treatment Follow-up|Adverse Event|0|||
156779213|NCT02335944|565940670|FG003|Post-treatment Follow-up|Adverse Event|0|||
156779214|NCT02335944|565940671|FG004|Post-treatment Follow-up|Adverse Event|0|||
156779215|NCT02335944|565940672|FG005|Post-treatment Follow-up|Adverse Event|1|||
156779216|NCT02335944|565940673|FG006|Post-treatment Follow-up|Adverse Event|0|||
156779217|NCT02335944|565940674|FG007|Post-treatment Follow-up|Adverse Event|0|||
157009463|NCT01636687|566786678|FG001|Maintenance Period|Lack of Efficacy|1|||
157009464|NCT01636687|566786679|FG002|Maintenance Period|Lack of Efficacy|0|||
156779218|NCT02335944|565940675|FG008|Post-treatment Follow-up|Adverse Event|0|||
156779219|NCT02335944|565940676|FG009|Post-treatment Follow-up|Adverse Event|0|||
156779220|NCT02335944|565940667|FG000|Post-treatment Follow-up|Death|0|||
156779221|NCT02335944|565940668|FG001|Post-treatment Follow-up|Death|0|||
156779222|NCT02335944|565940669|FG002|Post-treatment Follow-up|Death|0|||
156779223|NCT02335944|565940670|FG003|Post-treatment Follow-up|Death|1|||
156779224|NCT02335944|565940671|FG004|Post-treatment Follow-up|Death|0|||
156779225|NCT02335944|565940672|FG005|Post-treatment Follow-up|Death|1|||
156779226|NCT02335944|565940673|FG006|Post-treatment Follow-up|Death|0|||
156779227|NCT02335944|565940674|FG007|Post-treatment Follow-up|Death|0|||
156779228|NCT02335944|565940675|FG008|Post-treatment Follow-up|Death|0|||
156779229|NCT02335944|565940676|FG009|Post-treatment Follow-up|Death|0|||
156779230|NCT02335944|565940667|FG000|Post-treatment Follow-up|Physician Decision|1|||
156779231|NCT02335944|565940668|FG001|Post-treatment Follow-up|Physician Decision|0|||
156779232|NCT02335944|565940669|FG002|Post-treatment Follow-up|Physician Decision|0|||
156779233|NCT02335944|565940670|FG003|Post-treatment Follow-up|Physician Decision|0|||
156779234|NCT02335944|565940671|FG004|Post-treatment Follow-up|Physician Decision|0|||
156779235|NCT02335944|565940672|FG005|Post-treatment Follow-up|Physician Decision|0|||
156779236|NCT02335944|565940673|FG006|Post-treatment Follow-up|Physician Decision|0|||
156779237|NCT02335944|565940674|FG007|Post-treatment Follow-up|Physician Decision|1|||
156779238|NCT02335944|565940675|FG008|Post-treatment Follow-up|Physician Decision|0|||
156779239|NCT02335944|565940676|FG009|Post-treatment Follow-up|Physician Decision|0|||
156779240|NCT02406612|565940677|FG000|Overall Study|Screening Failure|3|||
156779241|NCT02406612|565940678|FG001|Overall Study|Screening Failure|0|||
156779242|NCT02406612|565940677|FG000|Overall Study|Intra-procedural Exclusion|1|||
156779243|NCT02406612|565940678|FG001|Overall Study|Intra-procedural Exclusion|3|||
156779244|NCT02406612|565940677|FG000|Overall Study|Guidewire Failure|0|||
156779245|NCT02406612|565940678|FG001|Overall Study|Guidewire Failure|1|||
156779246|NCT02900976|565940685|FG000|Overall Study|Adverse Event|0|||
156779247|NCT02900976|565940686|FG001|Overall Study|Adverse Event|1|||
156779248|NCT02900976|565940685|FG000|Overall Study|Physician Decision|0|||
156779249|NCT02900976|565940686|FG001|Overall Study|Physician Decision|2|||
156779250|NCT02900976|565940685|FG000|Overall Study|Progressive disease|0|||
156779251|NCT02900976|565940686|FG001|Overall Study|Progressive disease|6|||
156779252|NCT02337686|565940699|FG000|Overall Study|Adverse Event|1|||
157115616|NCT01500278|567177423|FG001|Week 0 - Week 12|Patient decision|0|||
157115617|NCT01500278|567177422|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
157115618|NCT01500278|567177423|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
157115619|NCT01500278|567177422|FG000|Week 0 - Week 12|Investigator decision|1|||
157115620|NCT01500278|567177423|FG001|Week 0 - Week 12|Investigator decision|0|||
157115621|NCT01500278|567177422|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
157115622|NCT01500278|567177423|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
157115623|NCT01500278|567177422|FG000|Week 0 - Week 12|Sponsor decision|1|||
157115624|NCT01500278|567177423|FG001|Week 0 - Week 12|Sponsor decision|0|||
157115625|NCT01500278|567177422|FG000|Week 0 - Week 12|Personal reason|0|||
157115626|NCT01500278|567177423|FG001|Week 0 - Week 12|Personal reason|1|||
157115627|NCT01500278|567177422|FG000|Week 0 - Week 12|Other serious disease|0|||
157115628|NCT01500278|567177423|FG001|Week 0 - Week 12|Other serious disease|1|||
157115629|NCT01500278|567177422|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
157115630|NCT01500278|567177423|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
157115631|NCT01500278|567177422|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
157115632|NCT01500278|567177423|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
157115633|NCT01500278|567177422|FG000|Week 13 - Week 104|Protocol Violation|6|||
157115634|NCT01500278|567177423|FG001|Week 13 - Week 104|Protocol Violation|6|||
157115635|NCT01500278|567177422|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
157209633|NCT03107715|567512334|FG000|Overall Study|did not deliver at the home hospital|4|||
157209634|NCT03107715|567512335|FG001|Overall Study|did not deliver at the home hospital|6|||
157009465|NCT01636687|566786680|FG003|Maintenance Period|Lack of Efficacy|0|||
157009466|NCT01636687|566786681|FG004|Maintenance Period|Lack of Efficacy|0|||
157009467|NCT01636687|566786677|FG000|Maintenance Period|Lost to Follow-up|1|||
157009468|NCT01636687|566786678|FG001|Maintenance Period|Lost to Follow-up|1|||
157009469|NCT01636687|566786679|FG002|Maintenance Period|Lost to Follow-up|0|||
157009470|NCT01636687|566786680|FG003|Maintenance Period|Lost to Follow-up|0|||
157009471|NCT01636687|566786681|FG004|Maintenance Period|Lost to Follow-up|1|||
157115636|NCT01500278|567177423|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
157115637|NCT01500278|567177422|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
157115638|NCT01500278|567177423|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
157115639|NCT01500278|567177422|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
157115640|NCT01500278|567177423|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
157115641|NCT01500278|567177422|FG000|Week 13 - Week 104|Non/bad compliance|7|||
156779253|NCT00876395|565942525|FG000|Overall Study|Untreated|8|||
156779254|NCT00876395|565942526|FG001|Overall Study|Untreated|1|||
157009472|NCT01636687|566786677|FG000|Maintenance Period|Physician Decision|0|||
157115642|NCT01500278|567177423|FG001|Week 13 - Week 104|Non/bad compliance|5|||
156779255|NCT00876395|565942525|FG000|Overall Study|Adverse Event|63|||
156779256|NCT00876395|565942526|FG001|Overall Study|Adverse Event|11|||
156779257|NCT00876395|565942525|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156779258|NCT00876395|565942526|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156779259|NCT00876395|565942525|FG000|Overall Study|Disease progression|259|||
157009473|NCT01636687|566786678|FG001|Maintenance Period|Physician Decision|0|||
157009474|NCT01636687|566786679|FG002|Maintenance Period|Physician Decision|0|||
157009475|NCT01636687|566786680|FG003|Maintenance Period|Physician Decision|0|||
157009476|NCT01636687|566786681|FG004|Maintenance Period|Physician Decision|1|||
157009477|NCT01636687|566786677|FG000|Extension Period|technical problems|0|||
157009478|NCT01636687|566786678|FG001|Extension Period|technical problems|1|||
157009479|NCT01636687|566786679|FG002|Extension Period|technical problems|2|||
157009480|NCT01636687|566786680|FG003|Extension Period|technical problems|1|||
157009481|NCT01636687|566786681|FG004|Extension Period|technical problems|0|||
157009482|NCT01636687|566786677|FG000|Extension Period|Adverse Event|4|||
157009483|NCT01636687|566786678|FG001|Extension Period|Adverse Event|3|||
157009484|NCT01636687|566786679|FG002|Extension Period|Adverse Event|2|||
157009485|NCT01636687|566786680|FG003|Extension Period|Adverse Event|1|||
157009486|NCT01636687|566786681|FG004|Extension Period|Adverse Event|0|||
157009487|NCT01636687|566786677|FG000|Extension Period|Lack of Efficacy|7|||
157009488|NCT01636687|566786678|FG001|Extension Period|Lack of Efficacy|0|||
157009489|NCT01636687|566786679|FG002|Extension Period|Lack of Efficacy|2|||
157009490|NCT01636687|566786680|FG003|Extension Period|Lack of Efficacy|1|||
157009491|NCT01636687|566786681|FG004|Extension Period|Lack of Efficacy|0|||
157009492|NCT01636687|566786677|FG000|Extension Period|Lost to Follow-up|1|||
156779260|NCT00876395|565942526|FG001|Overall Study|Disease progression|162|||
157009493|NCT01636687|566786678|FG001|Extension Period|Lost to Follow-up|0|||
157009494|NCT01636687|566786679|FG002|Extension Period|Lost to Follow-up|1|||
157009495|NCT01636687|566786680|FG003|Extension Period|Lost to Follow-up|0|||
157009496|NCT01636687|566786681|FG004|Extension Period|Lost to Follow-up|0|||
157009497|NCT01636687|566786677|FG000|Extension Period|Physician Decision|1|||
157009498|NCT01636687|566786678|FG001|Extension Period|Physician Decision|0|||
157209635|NCT03107715|567512334|FG000|Overall Study|infant stillborn|0|||
157209636|NCT03107715|567512335|FG001|Overall Study|infant stillborn|1|||
157209637|NCT03560466|567512337|FG000|Overall Study|Adverse Event|1|||
157209638|NCT03560466|567512338|FG001|Overall Study|Adverse Event|2|||
157209639|NCT03560466|567512339|FG002|Overall Study|Adverse Event|0|||
157209640|NCT03560466|567512337|FG000|Overall Study|Poor Compliance to Protocol|0|||
157209641|NCT03560466|567512338|FG001|Overall Study|Poor Compliance to Protocol|2|||
157209642|NCT03560466|567512339|FG002|Overall Study|Poor Compliance to Protocol|0|||
157209643|NCT03560466|567512337|FG000|Overall Study|Other|6|||
157209644|NCT03560466|567512338|FG001|Overall Study|Other|8|||
157209645|NCT03560466|567512339|FG002|Overall Study|Other|1|||
157209646|NCT02437890|567513984|FG000|Overall Study|Non-compliance to study drug|0|||
157209647|NCT02437890|567513985|FG001|Overall Study|Non-compliance to study drug|1|||
157209648|NCT02437890|567513986|FG002|Overall Study|Non-compliance to study drug|0|||
157209649|NCT02437890|567513987|FG003|Overall Study|Non-compliance to study drug|0|||
157209650|NCT02437890|567513988|FG004|Overall Study|Non-compliance to study drug|1|||
157209651|NCT02437890|567513984|FG000|Overall Study|Sponsor's decision|1|||
157209652|NCT02437890|567513985|FG001|Overall Study|Sponsor's decision|1|||
157209653|NCT02437890|567513986|FG002|Overall Study|Sponsor's decision|4|||
157209654|NCT02437890|567513987|FG003|Overall Study|Sponsor's decision|0|||
157209655|NCT02437890|567513988|FG004|Overall Study|Sponsor's decision|2|||
157209656|NCT02437890|567513984|FG000|Overall Study|Physician Decision|0|||
157209657|NCT02437890|567513985|FG001|Overall Study|Physician Decision|0|||
157209658|NCT02437890|567513986|FG002|Overall Study|Physician Decision|0|||
157209659|NCT02437890|567513987|FG003|Overall Study|Physician Decision|1|||
157209660|NCT02437890|567513988|FG004|Overall Study|Physician Decision|0|||
157209661|NCT02437890|567513984|FG000|Overall Study|Unable to attend visit(s)|1|||
157209662|NCT02437890|567513985|FG001|Overall Study|Unable to attend visit(s)|0|||
157209663|NCT02437890|567513986|FG002|Overall Study|Unable to attend visit(s)|0|||
157209664|NCT02437890|567513987|FG003|Overall Study|Unable to attend visit(s)|0|||
157209665|NCT02437890|567513988|FG004|Overall Study|Unable to attend visit(s)|0|||
157209666|NCT02437890|567513984|FG000|Overall Study|Lack of Efficacy|1|||
157209667|NCT02437890|567513985|FG001|Overall Study|Lack of Efficacy|3|||
157209668|NCT02437890|567513986|FG002|Overall Study|Lack of Efficacy|0|||
157209669|NCT02437890|567513987|FG003|Overall Study|Lack of Efficacy|3|||
157209670|NCT02437890|567513988|FG004|Overall Study|Lack of Efficacy|1|||
157209671|NCT02437890|567513984|FG000|Overall Study|Adverse Event|4|||
157209672|NCT02437890|567513985|FG001|Overall Study|Adverse Event|9|||
157209673|NCT02437890|567513986|FG002|Overall Study|Adverse Event|5|||
157209674|NCT02437890|567513987|FG003|Overall Study|Adverse Event|11|||
157209675|NCT02437890|567513988|FG004|Overall Study|Adverse Event|7|||
157209676|NCT02437890|567513984|FG000|Overall Study|Withdrawal by Subject|1|||
157209677|NCT02437890|567513985|FG001|Overall Study|Withdrawal by Subject|2|||
157209678|NCT02437890|567513986|FG002|Overall Study|Withdrawal by Subject|6|||
157209679|NCT02437890|567513987|FG003|Overall Study|Withdrawal by Subject|5|||
157209680|NCT02437890|567513988|FG004|Overall Study|Withdrawal by Subject|5|||
157209681|NCT02437890|567513984|FG000|Overall Study|Death|0|||
157209682|NCT02437890|567513985|FG001|Overall Study|Death|0|||
157209683|NCT02437890|567513986|FG002|Overall Study|Death|0|||
157209684|NCT02437890|567513987|FG003|Overall Study|Death|2|||
157209685|NCT02437890|567513988|FG004|Overall Study|Death|0|||
156779261|NCT00876395|565942525|FG000|Overall Study|New cancer therapy|25|||
156779262|NCT00876395|565942526|FG001|Overall Study|New cancer therapy|7|||
156779263|NCT00876395|565942525|FG000|Overall Study|Protocol Violation|5|||
156779264|NCT00876395|565942526|FG001|Overall Study|Protocol Violation|2|||
156779265|NCT00876395|565942525|FG000|Overall Study|Withdrawal by Subject|66|||
156779266|NCT00876395|565942526|FG001|Overall Study|Withdrawal by Subject|33|||
156779267|NCT00876395|565942525|FG000|Overall Study|Lost to Follow-up|2|||
156779268|NCT00876395|565942526|FG001|Overall Study|Lost to Follow-up|0|||
156779269|NCT00876395|565942525|FG000|Overall Study|Administrative problems|39|||
156779270|NCT00876395|565942526|FG001|Overall Study|Administrative problems|23|||
156779271|NCT00876395|565942525|FG000|Overall Study|Death|12|||
156779272|NCT00876395|565942526|FG001|Overall Study|Death|0|||
156779273|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Other|4|||
156779274|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Other|1|||
156779275|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
156779276|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156779277|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
156779278|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
156779279|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
156779280|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156779281|NCT03439514|565942546|FG000|Double-Blind Treatment Period|Death|1|||
156779282|NCT03439514|565942547|FG001|Double-Blind Treatment Period|Death|2|||
156779283|NCT02175758|565942548|FG000|Treatment Phase|Lost to Follow-up|0|||
156779284|NCT02175758|565942549|FG001|Treatment Phase|Lost to Follow-up|1|||
156779285|NCT02175758|565942550|FG002|Treatment Phase|Lost to Follow-up|0|||
156779286|NCT02175758|565942551|FG003|Treatment Phase|Lost to Follow-up|0|||
157209686|NCT01190098|567513989|FG000|Overall Study|Adverse Event|2|||
157209687|NCT01190098|567513990|FG001|Overall Study|Adverse Event|0|||
157009499|NCT01636687|566786679|FG002|Extension Period|Physician Decision|0|||
157009500|NCT01636687|566786680|FG003|Extension Period|Physician Decision|1|||
157009501|NCT01636687|566786681|FG004|Extension Period|Physician Decision|0|||
157009502|NCT01636687|566786677|FG000|Extension Period|study terminated by sponsor|33|||
157209688|NCT01190098|567513989|FG000|Overall Study|Patient coomorbidity|0|||
157209689|NCT01190098|567513990|FG001|Overall Study|Patient coomorbidity|1|||
157209690|NCT01190098|567513989|FG000|Overall Study|Lack of transportation|1|||
157209691|NCT01190098|567513990|FG001|Overall Study|Lack of transportation|0|||
157209692|NCT01190098|567513989|FG000|Overall Study|Other|0|||
157209693|NCT01190098|567513990|FG001|Overall Study|Other|1|||
157209694|NCT01586624|567513999|FG000|Overall Study|Adverse Event|3|||
157209695|NCT01586624|567514000|FG001|Overall Study|Adverse Event|0|||
157209696|NCT01586624|567514001|FG002|Overall Study|Adverse Event|2|||
157209697|NCT01586624|567514002|FG003|Overall Study|Adverse Event|1|||
157209698|NCT01586624|567514003|FG004|Overall Study|Adverse Event|3|||
157209699|NCT01586624|567514004|FG005|Overall Study|Adverse Event|3|||
157209700|NCT01586624|567514005|FG006|Overall Study|Adverse Event|2|||
157209701|NCT01586624|567514006|FG007|Overall Study|Adverse Event|3|||
157209702|NCT01586624|567513999|FG000|Overall Study|Physician Decision|0|||
157209703|NCT01586624|567514000|FG001|Overall Study|Physician Decision|1|||
157209704|NCT01586624|567514001|FG002|Overall Study|Physician Decision|1|||
157209705|NCT01586624|567514002|FG003|Overall Study|Physician Decision|0|||
157009503|NCT01636687|566786678|FG001|Extension Period|study terminated by sponsor|50|||
157009504|NCT01636687|566786679|FG002|Extension Period|study terminated by sponsor|17|||
157009505|NCT01636687|566786680|FG003|Extension Period|study terminated by sponsor|23|||
157009506|NCT01636687|566786681|FG004|Extension Period|study terminated by sponsor|0|||
157209706|NCT01586624|567514003|FG004|Overall Study|Physician Decision|2|||
157209707|NCT01586624|567514004|FG005|Overall Study|Physician Decision|0|||
157209708|NCT01586624|567514005|FG006|Overall Study|Physician Decision|1|||
157209709|NCT01586624|567514006|FG007|Overall Study|Physician Decision|1|||
157209710|NCT01586624|567513999|FG000|Overall Study|Withdrawal by Subject|0|||
156779287|NCT02175758|565942552|FG004|Treatment Phase|Lost to Follow-up|0|||
157009507|NCT01636687|566786677|FG000|Extension Period|Withdrawal by Subject|1|||
157009508|NCT01636687|566786678|FG001|Extension Period|Withdrawal by Subject|0|||
157009509|NCT01636687|566786679|FG002|Extension Period|Withdrawal by Subject|1|||
157009510|NCT01636687|566786680|FG003|Extension Period|Withdrawal by Subject|1|||
156779288|NCT02175758|565942553|FG005|Treatment Phase|Lost to Follow-up|0|||
156779289|NCT02175758|565942548|FG000|Treatment Phase|Adverse Event|0|||
156779290|NCT02175758|565942549|FG001|Treatment Phase|Adverse Event|0|||
156779291|NCT02175758|565942550|FG002|Treatment Phase|Adverse Event|0|||
156779292|NCT02175758|565942551|FG003|Treatment Phase|Adverse Event|0|||
156779293|NCT02175758|565942552|FG004|Treatment Phase|Adverse Event|1|||
156779294|NCT02175758|565942553|FG005|Treatment Phase|Adverse Event|0|||
156779295|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
156779296|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
156779297|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
156779298|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
156779299|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
156779300|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
156779301|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779302|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779303|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
156779304|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
156779305|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
156779306|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
156779307|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
156779308|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
156779309|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
156779310|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
156779311|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779312|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
156779313|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779314|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
156779315|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156779316|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
156779317|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156779318|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
156779319|NCT00620542|565942556|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
156779320|NCT00620542|565942557|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
156779321|NCT00620542|565942558|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
156779322|NCT00620542|565942559|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
156779323|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
156779324|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
156779325|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
156779326|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
156779327|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
156779328|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
156779329|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
156779330|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
156779331|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
156779332|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
156779333|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
156779334|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
156779335|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
156779336|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
156779337|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
156779338|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
156779339|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
156779340|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
156779341|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
156779342|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
156779343|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
156779344|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
156779345|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
156779346|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
156779347|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
156779348|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
156779349|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
156779350|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
156779351|NCT00620542|565942556|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
156779352|NCT00620542|565942557|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
156779353|NCT00620542|565942558|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
156779354|NCT00620542|565942559|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
156779355|NCT01500083|565942560|FG000|Overall Study|Adverse Event|4|||
156779356|NCT01500083|565942561|FG001|Overall Study|Adverse Event|17|||
156779357|NCT01500083|565942560|FG000|Overall Study|Death|0|||
156779358|NCT01500083|565942561|FG001|Overall Study|Death|2|||
156779359|NCT01500083|565942560|FG000|Overall Study|Lost to Follow-up|1|||
156779360|NCT01500083|565942561|FG001|Overall Study|Lost to Follow-up|0|||
156779361|NCT01500083|565942560|FG000|Overall Study|Withdrawal of Consent|0|||
156779362|NCT01500083|565942561|FG001|Overall Study|Withdrawal of Consent|1|||
156779363|NCT01500083|565942560|FG000|Overall Study|Disease Progression|2|||
156779364|NCT01500083|565942561|FG001|Overall Study|Disease Progression|10|||
156779365|NCT01500083|565942560|FG000|Overall Study|Investigator Discretion|3|||
156779366|NCT01500083|565942561|FG001|Overall Study|Investigator Discretion|8|||
156779367|NCT01500083|565942560|FG000|Overall Study|Other Reasons|2|||
156779368|NCT01500083|565942561|FG001|Overall Study|Other Reasons|5|||
156779369|NCT00741611|565942562|FG000|Overall Study|Death|0|||
156779370|NCT00741611|565942563|FG001|Overall Study|Death|0|||
156779371|NCT00741611|565942564|FG002|Overall Study|Death|1|||
156779372|NCT00741611|565942562|FG000|Overall Study|Withdrawal by Subject|0|||
156779373|NCT00741611|565942563|FG001|Overall Study|Withdrawal by Subject|2|||
156779374|NCT00741611|565942564|FG002|Overall Study|Withdrawal by Subject|2|||
156779375|NCT01555931|565942567|FG000|Overall Study|Lost to Follow-up|2|||
156779376|NCT01555931|565942568|FG001|Overall Study|Lost to Follow-up|5|||
156779377|NCT01510756|565942569|FG000|Overall Study|Death|1|||
156779378|NCT01510756|565942569|FG000|Overall Study|Lack of Efficacy|2|||
156779379|NCT01510756|565942569|FG000|Overall Study|Physician Decision|1|||
157115643|NCT01500278|567177422|FG000|Week 13 - Week 104|Recurrent infections|1|||
157115644|NCT01500278|567177423|FG001|Week 13 - Week 104|Recurrent infections|0|||
157115645|NCT01500278|567177422|FG000|Week 13 - Week 104|False positive test|1|||
157115646|NCT01500278|567177423|FG001|Week 13 - Week 104|False positive test|2|||
157115647|NCT01500278|567177422|FG000|Week 13 - Week 104|Sponsor request|4|||
157115648|NCT01500278|567177423|FG001|Week 13 - Week 104|Sponsor request|0|||
157115649|NCT01500278|567177422|FG000|Week 13 - Week 104|Withdrawn in error|1|||
157115650|NCT01500278|567177423|FG001|Week 13 - Week 104|Withdrawn in error|0|||
157115651|NCT01500278|567177422|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
156779380|NCT01922011|565942570|FG000|Overall Study|Protocol Violation|0|||
156779381|NCT01922011|565942571|FG001|Overall Study|Protocol Violation|1|||
156779382|NCT01922011|565942570|FG000|Overall Study|Physician Decision|0|||
156779383|NCT01922011|565942571|FG001|Overall Study|Physician Decision|1|||
156779384|NCT01922011|565942570|FG000|Overall Study|Parent/Guardian Decision|3|||
156779385|NCT01922011|565942571|FG001|Overall Study|Parent/Guardian Decision|0|||
156779386|NCT01922011|565942570|FG000|Overall Study|Lost to Follow-up|0|||
156779387|NCT01922011|565942571|FG001|Overall Study|Lost to Follow-up|1|||
156779388|NCT01922011|565942570|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
156779389|NCT01922011|565942571|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
156779390|NCT01922011|565942570|FG000|Overall Study|Not Treated|1|||
156779391|NCT01922011|565942571|FG001|Overall Study|Not Treated|0|||
156779392|NCT01922011|565942570|FG000|Overall Study|Lack of willing home health agency|1|||
156779393|NCT01922011|565942571|FG001|Overall Study|Lack of willing home health agency|0|||
156779394|NCT01922011|565942570|FG000|Overall Study|Randomized in error|1|||
156779395|NCT01922011|565942571|FG001|Overall Study|Randomized in error|0|||
156779396|NCT02299167|565942572|FG000|Overall Study|patients were excluded from the study|11|||
156779397|NCT05696847|565942579|FG000|Overall Study|Withdrawal by Subject|1|||
156779398|NCT05696847|565942580|FG001|Overall Study|Withdrawal by Subject|0|||
156779399|NCT05696847|565942581|FG002|Overall Study|Withdrawal by Subject|0|||
156779400|NCT05696847|565942582|FG003|Overall Study|Withdrawal by Subject|0|||
156779401|NCT05696847|565942583|FG004|Overall Study|Withdrawal by Subject|0|||
156779402|NCT05696847|565942584|FG005|Overall Study|Withdrawal by Subject|0|||
156779403|NCT05696847|565942579|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156779404|NCT05696847|565942580|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156779405|NCT05696847|565942581|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156779406|NCT05696847|565942582|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156779407|NCT05696847|565942583|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156779408|NCT05696847|565942584|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156779409|NCT05696847|565942579|FG000|Overall Study|Adverse Event|0|||
156779410|NCT05696847|565942580|FG001|Overall Study|Adverse Event|0|||
156779411|NCT05696847|565942581|FG002|Overall Study|Adverse Event|0|||
156779412|NCT05696847|565942582|FG003|Overall Study|Adverse Event|0|||
156779413|NCT05696847|565942583|FG004|Overall Study|Adverse Event|0|||
156779414|NCT05696847|565942584|FG005|Overall Study|Adverse Event|1|||
156779415|NCT05696847|565942579|FG000|Overall Study|Sponsor Decision|0|||
156779416|NCT05696847|565942580|FG001|Overall Study|Sponsor Decision|0|||
156779417|NCT05696847|565942581|FG002|Overall Study|Sponsor Decision|0|||
156779418|NCT05696847|565942582|FG003|Overall Study|Sponsor Decision|1|||
156779419|NCT05696847|565942583|FG004|Overall Study|Sponsor Decision|0|||
156779420|NCT05696847|565942584|FG005|Overall Study|Sponsor Decision|0|||
156779421|NCT02903914|565942585|FG000|Overall Study|Adverse Event|0|||
156779422|NCT02903914|565942586|FG001|Overall Study|Adverse Event|0|||
156779423|NCT02903914|565942587|FG002|Overall Study|Adverse Event|1|||
156779424|NCT02903914|565942588|FG003|Overall Study|Adverse Event|0|||
156779425|NCT02903914|565942589|FG004|Overall Study|Adverse Event|0|||
156779426|NCT02903914|565942590|FG005|Overall Study|Adverse Event|0|||
156779427|NCT02903914|565942591|FG006|Overall Study|Adverse Event|2|||
156779428|NCT02903914|565942592|FG007|Overall Study|Adverse Event|0|||
156779429|NCT02903914|565942585|FG000|Overall Study|Withdrawal by Subject|3|||
156779430|NCT02903914|565942586|FG001|Overall Study|Withdrawal by Subject|1|||
156779431|NCT02903914|565942587|FG002|Overall Study|Withdrawal by Subject|28|||
156779432|NCT02903914|565942588|FG003|Overall Study|Withdrawal by Subject|0|||
156779433|NCT02903914|565942589|FG004|Overall Study|Withdrawal by Subject|1|||
156779434|NCT02903914|565942590|FG005|Overall Study|Withdrawal by Subject|2|||
156779435|NCT02903914|565942591|FG006|Overall Study|Withdrawal by Subject|12|||
156779436|NCT02903914|565942592|FG007|Overall Study|Withdrawal by Subject|0|||
157209711|NCT01586624|567514000|FG001|Overall Study|Withdrawal by Subject|0|||
157209712|NCT01586624|567514001|FG002|Overall Study|Withdrawal by Subject|0|||
157209713|NCT01586624|567514002|FG003|Overall Study|Withdrawal by Subject|1|||
157209714|NCT01586624|567514003|FG004|Overall Study|Withdrawal by Subject|0|||
157209715|NCT01586624|567514004|FG005|Overall Study|Withdrawal by Subject|0|||
157209716|NCT01586624|567514005|FG006|Overall Study|Withdrawal by Subject|0|||
157209717|NCT01586624|567514006|FG007|Overall Study|Withdrawal by Subject|0|||
157209718|NCT01586624|567513999|FG000|Overall Study|Evidence of disease progression|1|||
157209719|NCT01586624|567514000|FG001|Overall Study|Evidence of disease progression|3|||
157209720|NCT01586624|567514001|FG002|Overall Study|Evidence of disease progression|2|||
157209721|NCT01586624|567514002|FG003|Overall Study|Evidence of disease progression|5|||
157209722|NCT01586624|567514003|FG004|Overall Study|Evidence of disease progression|3|||
157209723|NCT01586624|567514004|FG005|Overall Study|Evidence of disease progression|5|||
157209724|NCT01586624|567514005|FG006|Overall Study|Evidence of disease progression|4|||
157209725|NCT01586624|567514006|FG007|Overall Study|Evidence of disease progression|6|||
157209726|NCT01586624|567513999|FG000|Overall Study|Screen failure (no treatment received)|0|||
157209727|NCT01586624|567514000|FG001|Overall Study|Screen failure (no treatment received)|0|||
157209728|NCT01586624|567514001|FG002|Overall Study|Screen failure (no treatment received)|0|||
157209729|NCT01586624|567514002|FG003|Overall Study|Screen failure (no treatment received)|0|||
157209730|NCT01586624|567514003|FG004|Overall Study|Screen failure (no treatment received)|0|||
157209731|NCT01586624|567514004|FG005|Overall Study|Screen failure (no treatment received)|0|||
157209732|NCT01586624|567514005|FG006|Overall Study|Screen failure (no treatment received)|1|||
157209733|NCT01586624|567514006|FG007|Overall Study|Screen failure (no treatment received)|0|||
157209734|NCT01160198|567514011|FG000|Overall Study|Withdrawal by Subject|2|||
157209735|NCT01160198|567514012|FG001|Overall Study|Withdrawal by Subject|1|||
157209736|NCT01160198|567514013|FG002|Overall Study|Withdrawal by Subject|0|||
157209737|NCT01160198|567514011|FG000|Overall Study|Adverse Event|0|||
157209738|NCT01160198|567514012|FG001|Overall Study|Adverse Event|1|||
157209739|NCT01160198|567514013|FG002|Overall Study|Adverse Event|0|||
157209740|NCT01160198|567514011|FG000|Overall Study|Lost to Follow-up|0|||
157209741|NCT01160198|567514012|FG001|Overall Study|Lost to Follow-up|1|||
157209742|NCT01160198|567514013|FG002|Overall Study|Lost to Follow-up|0|||
156779437|NCT02903914|565942585|FG000|Overall Study|Progressive Disease|1|||
156779438|NCT02903914|565942586|FG001|Overall Study|Progressive Disease|0|||
157009511|NCT01636687|566786681|FG004|Extension Period|Withdrawal by Subject|0|||
157009512|NCT01636687|566786677|FG000|Follow-up Period|Withdrawal by Subject|1|||
157009513|NCT01636687|566786678|FG001|Follow-up Period|Withdrawal by Subject|0|||
157009514|NCT01636687|566786679|FG002|Follow-up Period|Withdrawal by Subject|0|||
157009515|NCT01636687|566786680|FG003|Follow-up Period|Withdrawal by Subject|0|||
157009516|NCT01636687|566786681|FG004|Follow-up Period|Withdrawal by Subject|1|||
157009517|NCT00244855|566786682|FG000|Overall Study|Withdrawal by Subject|0|||
157009518|NCT00244855|566786683|FG001|Overall Study|Withdrawal by Subject|1|||
157009519|NCT00636207|566786684|FG000|Overall Study|Adverse Event|1|||
157009520|NCT00636207|566786685|FG001|Overall Study|Adverse Event|0|||
157009521|NCT00636207|566786686|FG002|Overall Study|Adverse Event|0|||
157009522|NCT00636207|566786687|FG003|Overall Study|Adverse Event|0|||
157009523|NCT00636207|566786688|FG004|Overall Study|Adverse Event|0|||
157009524|NCT00636207|566786689|FG005|Overall Study|Adverse Event|0|||
157009525|NCT00636207|566786690|FG006|Overall Study|Adverse Event|0|||
157009526|NCT00636207|566786684|FG000|Overall Study|Withdrawal by Subject|0|||
157009527|NCT00636207|566786685|FG001|Overall Study|Withdrawal by Subject|1|||
157009528|NCT00636207|566786686|FG002|Overall Study|Withdrawal by Subject|0|||
157009529|NCT00636207|566786687|FG003|Overall Study|Withdrawal by Subject|0|||
157009530|NCT00636207|566786688|FG004|Overall Study|Withdrawal by Subject|1|||
157009531|NCT00636207|566786689|FG005|Overall Study|Withdrawal by Subject|0|||
157009532|NCT00636207|566786690|FG006|Overall Study|Withdrawal by Subject|0|||
157009533|NCT00666276|566786693|FG000|Overall Study|Protocol Violation|34|||
157009534|NCT02594735|566786694|FG000|Overall Study|Adverse Event|1|||
157009535|NCT00668863|566786695|FG000|Overall Study|Objective Progression or Relapse|42|||
157009536|NCT00668863|566786695|FG000|Overall Study|Adverse Event|13|||
157009537|NCT00668863|566786695|FG000|Overall Study|Study Terminated by Sponsor|8|||
157009538|NCT00668863|566786695|FG000|Overall Study|Global Deterioration of Health Status|4|||
157009539|NCT00668863|566786695|FG000|Overall Study|Withdrawal by Subject|1|||
157009540|NCT00668863|566786695|FG000|Overall Study|Surgery|1|||
157009541|NCT00668863|566786695|FG000|Overall Study|Subject's work scheduling problem|1|||
157009542|NCT00668863|566786695|FG000|Overall Study|Physician Decision|1|||
157009543|NCT00665444|566786696|FG000|Overall Study|Physician Decision|1|||
157009544|NCT00665444|566786696|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
156779439|NCT02903914|565942587|FG002|Overall Study|Progressive Disease|4|||
156779440|NCT02903914|565942588|FG003|Overall Study|Progressive Disease|0|||
157009545|NCT00101010|566786697|FG000|Overall Study|Physician Decision|1|||
157009546|NCT00364013|566786700|FG000|Overall Study|Ineligibility determined|4|||
157009547|NCT00364013|566786701|FG001|Overall Study|Ineligibility determined|2|||
157009548|NCT00364013|566786700|FG000|Overall Study|Adverse Event|4|||
157009549|NCT00364013|566786701|FG001|Overall Study|Adverse Event|3|||
157209743|NCT01160198|567514011|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
157209744|NCT01160198|567514012|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
157209745|NCT01160198|567514013|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
156779441|NCT02903914|565942589|FG004|Overall Study|Progressive Disease|0|||
156779442|NCT02903914|565942590|FG005|Overall Study|Progressive Disease|0|||
156779443|NCT02903914|565942591|FG006|Overall Study|Progressive Disease|2|||
156779444|NCT02903914|565942592|FG007|Overall Study|Progressive Disease|0|||
156779445|NCT02903914|565942585|FG000|Overall Study|Death|0|||
156779446|NCT02903914|565942586|FG001|Overall Study|Death|0|||
156779447|NCT02903914|565942587|FG002|Overall Study|Death|9|||
156779448|NCT02903914|565942588|FG003|Overall Study|Death|0|||
156779449|NCT02903914|565942589|FG004|Overall Study|Death|1|||
156779450|NCT02903914|565942590|FG005|Overall Study|Death|3|||
156779451|NCT02903914|565942591|FG006|Overall Study|Death|24|||
156779452|NCT02903914|565942592|FG007|Overall Study|Death|2|||
156779453|NCT02903914|565942585|FG000|Overall Study|Lost to Follow-up|0|||
156779454|NCT02903914|565942586|FG001|Overall Study|Lost to Follow-up|1|||
156779455|NCT02903914|565942587|FG002|Overall Study|Lost to Follow-up|0|||
156779456|NCT02903914|565942588|FG003|Overall Study|Lost to Follow-up|0|||
156779457|NCT02903914|565942589|FG004|Overall Study|Lost to Follow-up|2|||
156779458|NCT02903914|565942590|FG005|Overall Study|Lost to Follow-up|0|||
156779459|NCT02903914|565942591|FG006|Overall Study|Lost to Follow-up|1|||
156779460|NCT02903914|565942592|FG007|Overall Study|Lost to Follow-up|0|||
156779461|NCT02903914|565942585|FG000|Overall Study|Physician Decision|0|||
156779462|NCT02903914|565942586|FG001|Overall Study|Physician Decision|0|||
156779463|NCT02903914|565942587|FG002|Overall Study|Physician Decision|1|||
156779464|NCT02903914|565942588|FG003|Overall Study|Physician Decision|0|||
156779465|NCT02903914|565942589|FG004|Overall Study|Physician Decision|0|||
156779466|NCT02903914|565942590|FG005|Overall Study|Physician Decision|0|||
156779467|NCT02903914|565942591|FG006|Overall Study|Physician Decision|1|||
156779468|NCT02903914|565942592|FG007|Overall Study|Physician Decision|0|||
156779469|NCT02903914|565942585|FG000|Overall Study|Symptomatic Deterioration|0|||
156779470|NCT02903914|565942586|FG001|Overall Study|Symptomatic Deterioration|0|||
156779471|NCT02903914|565942587|FG002|Overall Study|Symptomatic Deterioration|1|||
157115652|NCT01500278|567177423|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
157115653|NCT01500278|567177422|FG000|Week 13 - Week 104|Protocol deviation|1|||
157115654|NCT01500278|567177423|FG001|Week 13 - Week 104|Protocol deviation|0|||
157115655|NCT01500278|567177422|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
157115656|NCT01500278|567177423|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
157115657|NCT01500278|567177422|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
157115658|NCT01500278|567177423|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
157115659|NCT01500278|567177422|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
157115660|NCT01500278|567177423|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
157115661|NCT01500278|567177422|FG000|Week 13 - Week 104|Relocation|0|||
157115662|NCT01500278|567177423|FG001|Week 13 - Week 104|Relocation|1|||
157115663|NCT01500278|567177422|FG000|Week 13 - Week 104|Sponsor decision|0|||
157115664|NCT01500278|567177423|FG001|Week 13 - Week 104|Sponsor decision|2|||
157115665|NCT01500278|567177422|FG000|Week 13 - Week 104|Medical monitor decision|0|||
157209746|NCT01796860|567514014|FG000|Overall Study|Withdrawal by Subject|3|||
157209747|NCT01408576|567514015|FG000|Overall Study|Lack of Efficacy|17|||
157209748|NCT01408576|567514016|FG001|Overall Study|Lack of Efficacy|30|||
157209749|NCT01408576|567514017|FG002|Overall Study|Lack of Efficacy|48|||
156779472|NCT02903914|565942588|FG003|Overall Study|Symptomatic Deterioration|0|||
156779473|NCT02903914|565942589|FG004|Overall Study|Symptomatic Deterioration|0|||
156779474|NCT02903914|565942590|FG005|Overall Study|Symptomatic Deterioration|0|||
157209750|NCT01408576|567514015|FG000|Overall Study|Protocol Violation|1|||
157209751|NCT01408576|567514016|FG001|Overall Study|Protocol Violation|2|||
157209752|NCT01408576|567514017|FG002|Overall Study|Protocol Violation|2|||
157209753|NCT01408576|567514015|FG000|Overall Study|Lost to Follow-up|10|||
157209754|NCT01408576|567514016|FG001|Overall Study|Lost to Follow-up|9|||
157209755|NCT01408576|567514017|FG002|Overall Study|Lost to Follow-up|17|||
157209756|NCT01408576|567514015|FG000|Overall Study|Withdrawal by Subject|34|||
157209757|NCT01408576|567514016|FG001|Overall Study|Withdrawal by Subject|60|||
157209758|NCT01408576|567514017|FG002|Overall Study|Withdrawal by Subject|66|||
157209759|NCT01408576|567514015|FG000|Overall Study|Sponsor terminated study|89|||
157209760|NCT01408576|567514016|FG001|Overall Study|Sponsor terminated study|333|||
157209761|NCT01408576|567514017|FG002|Overall Study|Sponsor terminated study|330|||
157209762|NCT01408576|567514015|FG000|Overall Study|AE, serious fatal|4|||
157209763|NCT01408576|567514016|FG001|Overall Study|AE, serious fatal|4|||
157209764|NCT01408576|567514017|FG002|Overall Study|AE, serious fatal|1|||
157209765|NCT01408576|567514015|FG000|Overall Study|SAE, non-fatal|11|||
156779475|NCT02903914|565942591|FG006|Overall Study|Symptomatic Deterioration|0|||
156779476|NCT02903914|565942592|FG007|Overall Study|Symptomatic Deterioration|0|||
156779477|NCT02903914|565942585|FG000|Overall Study|New Cancer Therapy|2|||
156779478|NCT02903914|565942586|FG001|Overall Study|New Cancer Therapy|2|||
157115666|NCT01500278|567177423|FG001|Week 13 - Week 104|Medical monitor decision|2|||
157115667|NCT01500278|567177422|FG000|Week 13 - Week 104|Personal reason|0|||
157209766|NCT01408576|567514016|FG001|Overall Study|SAE, non-fatal|23|||
157209767|NCT01408576|567514017|FG002|Overall Study|SAE, non-fatal|14|||
156779479|NCT02903914|565942587|FG002|Overall Study|New Cancer Therapy|21|||
156779480|NCT02903914|565942588|FG003|Overall Study|New Cancer Therapy|4|||
156779481|NCT02903914|565942589|FG004|Overall Study|New Cancer Therapy|3|||
156779482|NCT02903914|565942590|FG005|Overall Study|New Cancer Therapy|6|||
156779483|NCT02903914|565942591|FG006|Overall Study|New Cancer Therapy|56|||
156779484|NCT02903914|565942592|FG007|Overall Study|New Cancer Therapy|3|||
156779485|NCT02903914|565942585|FG000|Overall Study|Didn't Return to Site|1|||
156779486|NCT02903914|565942586|FG001|Overall Study|Didn't Return to Site|0|||
156779487|NCT02903914|565942587|FG002|Overall Study|Didn't Return to Site|1|||
156779488|NCT02903914|565942588|FG003|Overall Study|Didn't Return to Site|1|||
156779489|NCT02903914|565942589|FG004|Overall Study|Didn't Return to Site|0|||
156779490|NCT02903914|565942590|FG005|Overall Study|Didn't Return to Site|0|||
156779491|NCT02903914|565942591|FG006|Overall Study|Didn't Return to Site|2|||
156779492|NCT02903914|565942592|FG007|Overall Study|Didn't Return to Site|0|||
156779493|NCT02903914|565942585|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
156779494|NCT02903914|565942586|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
156779495|NCT02903914|565942587|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
156779496|NCT02903914|565942588|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
156779497|NCT02903914|565942589|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
157209768|NCT01408576|567514015|FG000|Overall Study|AE, non-serious non-fatal|12|||
157209769|NCT01408576|567514016|FG001|Overall Study|AE, non-serious non-fatal|19|||
157209770|NCT01408576|567514017|FG002|Overall Study|AE, non-serious non-fatal|11|||
157209771|NCT01408576|567514015|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
157209772|NCT01408576|567514016|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
157209773|NCT01408576|567514017|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
157209774|NCT01408576|567514015|FG000|Overall Study|AE, unknown type|0|||
157209775|NCT01408576|567514016|FG001|Overall Study|AE, unknown type|1|||
157209776|NCT01408576|567514017|FG002|Overall Study|AE, unknown type|0|||
157209777|NCT01408576|567514015|FG000|Overall Study|Other|10|||
157209778|NCT01408576|567514016|FG001|Overall Study|Other|16|||
157209779|NCT01408576|567514017|FG002|Overall Study|Other|18|||
157209780|NCT00802529|567514018|FG000|Overall Study|Lost to Follow-up|0|||
157209781|NCT00802529|567514019|FG001|Overall Study|Lost to Follow-up|1|||
157209782|NCT02476851|567514020|FG000|Overall Study|Protocol Violation|1|||
157209783|NCT02476851|567514021|FG001|Overall Study|Protocol Violation|1|||
157209784|NCT00337129|567514022|FG000|Overall Study|Adverse Event|4|||
157209785|NCT00337129|567514022|FG000|Overall Study|Withdrawal by Subject|1|||
157209786|NCT00337129|567514022|FG000|Overall Study|Lack of Efficacy|32|||
157209787|NCT00337129|567514022|FG000|Overall Study|Death|2|||
157209788|NCT00337129|567514022|FG000|Overall Study|not protocol specified|1|||
157209789|NCT00647426|567514023|FG000|Overall Study|Withdrawal by Subject|2|||
157209790|NCT03578276|567514027|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
157209791|NCT03578276|567514028|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
157209792|NCT01508325|567514031|FG000|Overall Study|Withdrawal by Subject|8|||
157209793|NCT01508325|567514032|FG001|Overall Study|Withdrawal by Subject|9|||
157209794|NCT01508325|567514031|FG000|Overall Study|Protocol Violation|0|||
157209795|NCT01508325|567514032|FG001|Overall Study|Protocol Violation|3|||
157209796|NCT01508325|567514031|FG000|Overall Study|Physician Decision|2|||
157209797|NCT01508325|567514032|FG001|Overall Study|Physician Decision|1|||
157209798|NCT01508325|567514031|FG000|Overall Study|Adverse Event|1|||
157209799|NCT01508325|567514032|FG001|Overall Study|Adverse Event|0|||
157209800|NCT01508325|567514031|FG000|Overall Study|Lost to Follow-up|5|||
157209801|NCT01508325|567514032|FG001|Overall Study|Lost to Follow-up|6|||
157209802|NCT01508325|567514031|FG000|Overall Study|Other|2|||
157209803|NCT01508325|567514032|FG001|Overall Study|Other|2|||
157209804|NCT03543046|567514038|FG000|Overall Study|Adverse Event|1|||
157209805|NCT03543046|567514039|FG001|Overall Study|Adverse Event|1|||
157209806|NCT03543046|567514038|FG000|Overall Study|Physician Decision|1|||
157209807|NCT03543046|567514039|FG001|Overall Study|Physician Decision|1|||
157209808|NCT03543046|567514038|FG000|Overall Study|Protocol Violation|1|||
157209809|NCT03543046|567514039|FG001|Overall Study|Protocol Violation|0|||
157209810|NCT00520494|567514045|FG000|Overall Study|Withdrawal by Subject|1|||
157209811|NCT02018042|567514046|FG000|Overall Study|Withdrawal by Subject|1|||
157209812|NCT00589693|567514047|FG000|Overall Study|randomized in error|12|||
157209813|NCT00589693|567514048|FG001|Overall Study|randomized in error|6|||
157209814|NCT00589693|567514047|FG000|Overall Study|Adverse Event|4|||
157209815|NCT00589693|567514048|FG001|Overall Study|Adverse Event|4|||
157209816|NCT00589693|567514047|FG000|Overall Study|Death|26|||
157209817|NCT00589693|567514048|FG001|Overall Study|Death|16|||
157209818|NCT00589693|567514047|FG000|Overall Study|Lack of Efficacy|0|||
157209819|NCT00589693|567514048|FG001|Overall Study|Lack of Efficacy|1|||
156779498|NCT02903914|565942590|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
156779499|NCT02903914|565942591|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
157209820|NCT00589693|567514047|FG000|Overall Study|Lost to Follow-up|1|||
157209821|NCT00589693|567514048|FG001|Overall Study|Lost to Follow-up|0|||
157209822|NCT00589693|567514047|FG000|Overall Study|Physician Decision|0|||
157209823|NCT00589693|567514048|FG001|Overall Study|Physician Decision|1|||
157209824|NCT00589693|567514047|FG000|Overall Study|Protocol Violation|1|||
157209825|NCT00589693|567514048|FG001|Overall Study|Protocol Violation|1|||
157209826|NCT02419469|567514049|FG000|Overall Study|Withdrawal by Subject|1|||
157209827|NCT01414062|567514050|FG000|Overall Study|Lost to Follow-up|3|||
157209828|NCT01414062|567514051|FG001|Overall Study|Lost to Follow-up|2|||
157209829|NCT01414062|567514050|FG000|Overall Study|Left Country|1|||
157209830|NCT01414062|567514051|FG001|Overall Study|Left Country|1|||
157209831|NCT01414062|567514050|FG000|Overall Study|Family Disapproval|1|||
157209832|NCT01414062|567514051|FG001|Overall Study|Family Disapproval|0|||
157209833|NCT01414062|567514050|FG000|Overall Study|Withdrawal by Subject|0|||
157209834|NCT01414062|567514051|FG001|Overall Study|Withdrawal by Subject|1|||
157209835|NCT04285983|567514052|FG000|Overall Study|Protocol Violation|6|||
157209836|NCT00902265|567514055|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
157209837|NCT00902265|567514055|FG000|Overall Study|Adverse Event|2|||
157209838|NCT00902265|567514055|FG000|Overall Study|Lack of Efficacy|2|||
157209839|NCT00902265|567514055|FG000|Overall Study|Protocol Violation|1|||
157209840|NCT02866695|567514056|FG000|Overall Study|Adverse Event|1|||
157209841|NCT02866695|567514056|FG000|Overall Study|Lost to Follow-up|1|||
157209842|NCT05016765|567514057|FG000|Overall Study|Lost to Follow-up|4|||
157209843|NCT00185731|567514060|FG000|Overall Study|Withdrawal by Subject|1|||
157209844|NCT00185731|567514060|FG000|Overall Study|Not Eligible|1|||
157009550|NCT00364013|566786700|FG000|Overall Study|Withdrawal by Subject|13|||
157009551|NCT00364013|566786701|FG001|Overall Study|Withdrawal by Subject|18|||
157209845|NCT02494583|567514063|FG000|Overall Study|Death|224|||
157209846|NCT02494583|567514064|FG001|Overall Study|Death|214|||
157209847|NCT02494583|567514065|FG002|Overall Study|Death|225|||
157209848|NCT02494583|567514063|FG000|Overall Study|Lost to Follow-up|1|||
157209849|NCT02494583|567514064|FG001|Overall Study|Lost to Follow-up|0|||
157209850|NCT02494583|567514065|FG002|Overall Study|Lost to Follow-up|0|||
157209851|NCT02494583|567514063|FG000|Overall Study|Protocol Violation|1|||
157209852|NCT02494583|567514064|FG001|Overall Study|Protocol Violation|2|||
157209853|NCT02494583|567514065|FG002|Overall Study|Protocol Violation|0|||
157209854|NCT02494583|567514063|FG000|Overall Study|Screen Failure|0|||
157209855|NCT02494583|567514064|FG001|Overall Study|Screen Failure|1|||
157209856|NCT02494583|567514065|FG002|Overall Study|Screen Failure|0|||
157209857|NCT02494583|567514063|FG000|Overall Study|Transferred to Extension Study|15|||
157209858|NCT02494583|567514064|FG001|Overall Study|Transferred to Extension Study|15|||
157009552|NCT00364013|566786700|FG000|Overall Study|Physician Decision|3|||
157009553|NCT00364013|566786701|FG001|Overall Study|Physician Decision|3|||
157009554|NCT00364013|566786700|FG000|Overall Study|Lost to Follow-up|10|||
157009555|NCT00364013|566786701|FG001|Overall Study|Lost to Follow-up|3|||
157009556|NCT00364013|566786700|FG000|Overall Study|Protocol-specified criteria|6|||
157009557|NCT00364013|566786701|FG001|Overall Study|Protocol-specified criteria|6|||
157009558|NCT00364013|566786700|FG000|Overall Study|Other|41|||
157009559|NCT00364013|566786701|FG001|Overall Study|Other|47|||
157009560|NCT00364013|566786700|FG000|Overall Study|Ongoing|20|||
157209859|NCT02494583|567514065|FG002|Overall Study|Transferred to Extension Study|6|||
157209860|NCT02494583|567514063|FG000|Overall Study|Did Not Continue on Extension Study|8|||
157009561|NCT00364013|566786701|FG001|Overall Study|Ongoing|13|||
157009562|NCT02507752|566786705|FG000|Overall Study|Adverse Event|1|||
157209861|NCT02494583|567514064|FG001|Overall Study|Did Not Continue on Extension Study|10|||
157209862|NCT02494583|567514065|FG002|Overall Study|Did Not Continue on Extension Study|4|||
156779500|NCT02903914|565942592|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
156779501|NCT02903914|565942585|FG000|Overall Study|Follow-up Did Not Occur|0|||
156779502|NCT02903914|565942586|FG001|Overall Study|Follow-up Did Not Occur|1|||
156779503|NCT02903914|565942587|FG002|Overall Study|Follow-up Did Not Occur|1|||
156779504|NCT02903914|565942588|FG003|Overall Study|Follow-up Did Not Occur|0|||
156779505|NCT02903914|565942589|FG004|Overall Study|Follow-up Did Not Occur|2|||
156779506|NCT02903914|565942590|FG005|Overall Study|Follow-up Did Not Occur|0|||
156779507|NCT02903914|565942591|FG006|Overall Study|Follow-up Did Not Occur|8|||
156779508|NCT02903914|565942592|FG007|Overall Study|Follow-up Did Not Occur|0|||
156779509|NCT02903914|565942585|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
156779510|NCT02903914|565942586|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
156779511|NCT02903914|565942587|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
156779512|NCT02903914|565942588|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
156779513|NCT02903914|565942589|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
156779514|NCT02903914|565942590|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
156779515|NCT02903914|565942591|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
156779516|NCT02903914|565942592|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
156779517|NCT02903914|565942585|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779518|NCT02903914|565942586|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779519|NCT02903914|565942587|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
156779520|NCT02903914|565942588|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779521|NCT02903914|565942589|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779522|NCT02903914|565942590|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
156779523|NCT02903914|565942591|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779524|NCT02903914|565942592|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
156779525|NCT02903914|565942585|FG000|Overall Study|Clinical Disease Progression|0|||
156779526|NCT02903914|565942586|FG001|Overall Study|Clinical Disease Progression|0|||
156779527|NCT02903914|565942587|FG002|Overall Study|Clinical Disease Progression|2|||
156779528|NCT02903914|565942588|FG003|Overall Study|Clinical Disease Progression|0|||
156779529|NCT02903914|565942589|FG004|Overall Study|Clinical Disease Progression|0|||
156779530|NCT02903914|565942590|FG005|Overall Study|Clinical Disease Progression|0|||
156779531|NCT02903914|565942591|FG006|Overall Study|Clinical Disease Progression|0|||
156779532|NCT02903914|565942592|FG007|Overall Study|Clinical Disease Progression|0|||
156779533|NCT02903914|565942585|FG000|Overall Study|Completed Follow-up Period|0|||
156779534|NCT02903914|565942586|FG001|Overall Study|Completed Follow-up Period|0|||
156779535|NCT02903914|565942587|FG002|Overall Study|Completed Follow-up Period|6|||
156779536|NCT02903914|565942588|FG003|Overall Study|Completed Follow-up Period|2|||
156779537|NCT02903914|565942589|FG004|Overall Study|Completed Follow-up Period|1|||
156779538|NCT02903914|565942590|FG005|Overall Study|Completed Follow-up Period|0|||
156779539|NCT02903914|565942591|FG006|Overall Study|Completed Follow-up Period|9|||
156779540|NCT02903914|565942592|FG007|Overall Study|Completed Follow-up Period|1|||
156779541|NCT02903914|565942585|FG000|Overall Study|Taken off Treatment per Protocol|0|||
156779542|NCT02903914|565942586|FG001|Overall Study|Taken off Treatment per Protocol|0|||
156779543|NCT02903914|565942587|FG002|Overall Study|Taken off Treatment per Protocol|0|||
156779544|NCT02903914|565942588|FG003|Overall Study|Taken off Treatment per Protocol|0|||
156779545|NCT02903914|565942589|FG004|Overall Study|Taken off Treatment per Protocol|0|||
156779546|NCT02903914|565942590|FG005|Overall Study|Taken off Treatment per Protocol|1|||
156779547|NCT02903914|565942591|FG006|Overall Study|Taken off Treatment per Protocol|0|||
156779548|NCT02903914|565942592|FG007|Overall Study|Taken off Treatment per Protocol|0|||
157115668|NCT01500278|567177423|FG001|Week 13 - Week 104|Personal reason|1|||
157115669|NCT01500278|567177422|FG000|Week 13 - Week 104|Not completed|0|||
157115670|NCT01500278|567177423|FG001|Week 13 - Week 104|Not completed|1|||
157115671|NCT01500278|567177422|FG000|Week 13 - Week 104|Death|2|||
157115672|NCT01500278|567177423|FG001|Week 13 - Week 104|Death|4|||
157115673|NCT01500278|567177422|FG000|Week 13 - Week 104|Adverse Event|54|||
157115674|NCT01500278|567177423|FG001|Week 13 - Week 104|Adverse Event|54|||
157115675|NCT00414453|567177426|FG000|Overall Study|Abnormal lab work|16|||
157115676|NCT00183274|567177429|FG000|Phase 1: Open-Label|Adverse Event|31|||
157115677|NCT00183274|567177430|FG001|Phase 1: Open-Label|Adverse Event|0|||
157115678|NCT00183274|567177431|FG002|Phase 1: Open-Label|Adverse Event|0|||
157115679|NCT00183274|567177432|FG003|Phase 1: Open-Label|Adverse Event|0|||
157115680|NCT00183274|567177433|FG004|Phase 1: Open-Label|Adverse Event|0|||
157115681|NCT00183274|567177434|FG005|Phase 1: Open-Label|Adverse Event|0|||
157115682|NCT00183274|567177429|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
157115683|NCT00183274|567177430|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
157115684|NCT00183274|567177431|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
157115685|NCT00183274|567177432|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
157115686|NCT00183274|567177433|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
157115687|NCT00183274|567177434|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
157115688|NCT00183274|567177429|FG000|Phase 1: Open-Label|Protocol Violation|11|||
157009563|NCT02507752|566786705|FG000|Overall Study|Protocol Violation|6|||
157009564|NCT02507752|566786705|FG000|Overall Study|Lost to Follow-up|7|||
157209863|NCT02494583|567514063|FG000|Overall Study|Withdrawal by Subject|7|||
157209864|NCT02494583|567514064|FG001|Overall Study|Withdrawal by Subject|15|||
157009565|NCT02507752|566786705|FG000|Overall Study|Infusion reaction at first infusion|1|||
157009566|NCT02507752|566786705|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
157009567|NCT02507752|566786705|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
157009568|NCT03740009|566786710|FG000|Overall Study|Physician Decision|9|||
157009569|NCT03740009|566786710|FG000|Overall Study|Lost to Follow-up|1|||
157009570|NCT01236001|566786714|FG000|Overall Study|Adverse Event|5|||
157009571|NCT01236001|566786715|FG001|Overall Study|Adverse Event|14|||
157009572|NCT01236001|566786714|FG000|Overall Study|Lack of Efficacy|6|||
157009573|NCT01236001|566786715|FG001|Overall Study|Lack of Efficacy|6|||
157009574|NCT01236001|566786714|FG000|Overall Study|Lost to Follow-up|6|||
157009575|NCT01236001|566786715|FG001|Overall Study|Lost to Follow-up|1|||
157009576|NCT01236001|566786714|FG000|Overall Study|Incompliance|1|||
157009577|NCT01236001|566786715|FG001|Overall Study|Incompliance|0|||
157009578|NCT01236001|566786714|FG000|Overall Study|Planned Visit After End of Study|0|||
157009579|NCT01236001|566786715|FG001|Overall Study|Planned Visit After End of Study|1|||
157009580|NCT04530747|566786717|FG000|Overall Study|Withdrawal by Subject|1|||
157009581|NCT04530747|566786718|FG001|Overall Study|Withdrawal by Subject|0|||
157009582|NCT03950622|566786719|FG000|Overall Study|Withdrawal by Subject|1|||
157009583|NCT03950622|566786720|FG001|Overall Study|Withdrawal by Subject|0|||
157009584|NCT03950622|566786719|FG000|Overall Study|Protocol Deviation|0|||
157009585|NCT03950622|566786720|FG001|Overall Study|Protocol Deviation|1|||
157009586|NCT03950622|566786719|FG000|Overall Study|Physician Decision|1|||
157009587|NCT03950622|566786720|FG001|Overall Study|Physician Decision|0|||
157009588|NCT03950622|566786719|FG000|Overall Study|Lost to Follow-up|5|||
157009589|NCT03950622|566786720|FG001|Overall Study|Lost to Follow-up|5|||
157009590|NCT03950622|566786719|FG000|Overall Study|Death|1|||
157009591|NCT03950622|566786720|FG001|Overall Study|Death|1|||
157009592|NCT02092116|566786723|FG000|Overall Study|Withdrawal by Subject|0|||
157009593|NCT02092116|566786724|FG001|Overall Study|Withdrawal by Subject|3|||
157009594|NCT02092116|566786723|FG000|Overall Study|Adverse Event|0|||
157009595|NCT02092116|566786724|FG001|Overall Study|Adverse Event|1|||
157009596|NCT02267824|566786726|FG000|Overall Study|Pregnancy|1|||
157009597|NCT02267824|566786727|FG001|Overall Study|Pregnancy|1|||
157009598|NCT02267824|566786726|FG000|Overall Study|Lost to Follow-up|4|||
157009599|NCT02267824|566786727|FG001|Overall Study|Lost to Follow-up|0|||
157009600|NCT02267824|566786726|FG000|Overall Study|Protocol Violation|3|||
157009601|NCT02267824|566786727|FG001|Overall Study|Protocol Violation|0|||
157009602|NCT02267824|566786726|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
157009603|NCT02267824|566786727|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
157009604|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
157009605|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
157009606|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
157009607|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009608|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009609|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009610|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009611|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009612|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009613|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009614|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009615|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
157009616|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
157009617|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
157009618|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
157009619|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
157009620|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
157009621|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
157009622|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
157009623|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
157009624|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
157009625|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
157009626|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
157009627|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
157009628|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
157009629|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009630|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009631|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157209865|NCT02494583|567514065|FG002|Overall Study|Withdrawal by Subject|15|||
157009632|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009633|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157209866|NCT05144477|567514066|FG000|Overall Study|Withdrawal by Subject|1|||
156779549|NCT02903914|565942585|FG000|Overall Study|Refused Further Treatment/Contact|0|||
156779550|NCT02903914|565942586|FG001|Overall Study|Refused Further Treatment/Contact|0|||
156779551|NCT02903914|565942587|FG002|Overall Study|Refused Further Treatment/Contact|0|||
156779552|NCT02903914|565942588|FG003|Overall Study|Refused Further Treatment/Contact|0|||
156779553|NCT02903914|565942589|FG004|Overall Study|Refused Further Treatment/Contact|0|||
156779554|NCT02903914|565942590|FG005|Overall Study|Refused Further Treatment/Contact|0|||
157115689|NCT00183274|567177430|FG001|Phase 1: Open-Label|Protocol Violation|0|||
157115690|NCT00183274|567177431|FG002|Phase 1: Open-Label|Protocol Violation|0|||
157115691|NCT00183274|567177432|FG003|Phase 1: Open-Label|Protocol Violation|0|||
157115692|NCT00183274|567177433|FG004|Phase 1: Open-Label|Protocol Violation|0|||
157115693|NCT00183274|567177434|FG005|Phase 1: Open-Label|Protocol Violation|0|||
156779555|NCT02903914|565942591|FG006|Overall Study|Refused Further Treatment/Contact|1|||
156779556|NCT02903914|565942592|FG007|Overall Study|Refused Further Treatment/Contact|0|||
156779557|NCT02903914|565942585|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779558|NCT02903914|565942586|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779559|NCT02903914|565942587|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779560|NCT02903914|565942588|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779561|NCT02903914|565942589|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779562|NCT02903914|565942590|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779563|NCT02903914|565942591|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
156779564|NCT02903914|565942592|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
156779565|NCT02989389|565942595|FG000|Period 1|Lost to Follow-up|0|||
156779566|NCT02989389|565942596|FG001|Period 1|Lost to Follow-up|1|||
156779567|NCT02989389|565942597|FG002|Period 1|Lost to Follow-up|0|||
156779568|NCT02989389|565942598|FG003|Period 1|Lost to Follow-up|0|||
156779569|NCT02989389|565942599|FG004|Period 1|Lost to Follow-up|0|||
156779570|NCT02989389|565942600|FG005|Period 1|Lost to Follow-up|0|||
156779571|NCT02989389|565942601|FG006|Period 1|Lost to Follow-up|0|||
156779572|NCT02989389|565942602|FG007|Period 1|Lost to Follow-up|0|||
156779573|NCT02989389|565942603|FG008|Period 1|Lost to Follow-up|0|||
156779574|NCT02989389|565942604|FG009|Period 1|Lost to Follow-up|0|||
156779575|NCT02989389|565942595|FG000|Period 1|Physician Decision|0|||
156779576|NCT02989389|565942596|FG001|Period 1|Physician Decision|0|||
156779577|NCT02989389|565942597|FG002|Period 1|Physician Decision|0|||
156779578|NCT02989389|565942598|FG003|Period 1|Physician Decision|0|||
156779579|NCT02989389|565942599|FG004|Period 1|Physician Decision|0|||
156779580|NCT02989389|565942600|FG005|Period 1|Physician Decision|0|||
156779581|NCT02989389|565942601|FG006|Period 1|Physician Decision|0|||
156779582|NCT02989389|565942602|FG007|Period 1|Physician Decision|0|||
156779583|NCT02989389|565942603|FG008|Period 1|Physician Decision|1|||
156779584|NCT02989389|565942604|FG009|Period 1|Physician Decision|0|||
156779585|NCT01018979|565942605|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
156779586|NCT01018979|565942606|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
156779587|NCT01018979|565942605|FG000|Overall Study|Not received at least one dose|0|||
156779588|NCT01018979|565942606|FG001|Overall Study|Not received at least one dose|1|||
156779589|NCT03506477|565942607|FG000|Overall Study|Withdrawal by Subject|1|||
156779590|NCT03506477|565942608|FG001|Overall Study|Withdrawal by Subject|0|||
156779591|NCT03462680|565942609|FG000|Overall Study|Withdrawal by Subject|3|||
156779592|NCT03462680|565942610|FG001|Overall Study|Withdrawal by Subject|5|||
156779593|NCT02516241|565942616|FG000|Overall Study|Death|255|||
156779594|NCT02516241|565942617|FG001|Overall Study|Death|262|||
156779595|NCT02516241|565942618|FG002|Overall Study|Death|270|||
156779596|NCT02516241|565942616|FG000|Overall Study|Lost to Follow-up|1|||
156779597|NCT02516241|565942617|FG001|Overall Study|Lost to Follow-up|1|||
156779598|NCT02516241|565942618|FG002|Overall Study|Lost to Follow-up|3|||
156779599|NCT02516241|565942616|FG000|Overall Study|Withdrawal by Subject|2|||
156779600|NCT02516241|565942617|FG001|Overall Study|Withdrawal by Subject|7|||
156779601|NCT02516241|565942618|FG002|Overall Study|Withdrawal by Subject|12|||
156779602|NCT02516241|565942616|FG000|Overall Study|participants ongoing at data cut-off|84|||
156779603|NCT02516241|565942617|FG001|Overall Study|participants ongoing at data cut-off|76|||
156779604|NCT02516241|565942618|FG002|Overall Study|participants ongoing at data cut-off|59|||
156779605|NCT01063114|565942619|FG000|Overall Study|Lost to Follow-up|1|||
156779606|NCT00462462|565942624|FG000|Overall Study|Physician Decision|0|||
156779607|NCT00462462|565942625|FG001|Overall Study|Physician Decision|1|||
156779608|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779609|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
156779610|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779611|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779612|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779613|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779614|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779615|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
156779616|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779617|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
156779618|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779619|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779620|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779621|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779622|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779623|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
156779624|NCT01163617|565942626|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779625|NCT01163617|565942627|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779626|NCT01163617|565942628|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
156779627|NCT01163617|565942629|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779628|NCT01163617|565942630|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779629|NCT01163617|565942631|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779630|NCT01163617|565942632|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779631|NCT01163617|565942633|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
156779632|NCT02875080|565942634|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
156779633|NCT02875080|565942635|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
156779634|NCT02875080|565942636|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
156779635|NCT02394756|565942637|FG000|Period 1|Lens Discomfort|0|||
156779636|NCT02394756|565942638|FG001|Period 1|Lens Discomfort|0|||
156779637|NCT02394756|565942639|FG002|Period 1|Lens Discomfort|0|||
156779638|NCT02394756|565942640|FG003|Period 1|Lens Discomfort|0|||
156779639|NCT02394756|565942641|FG004|Period 1|Lens Discomfort|0|||
156779640|NCT02394756|565942642|FG005|Period 1|Lens Discomfort|1|||
156866138|NCT01342211|566269178|FG003|Overall Study|Withdrawal by Subject|1|||
156866139|NCT01342211|566269179|FG004|Overall Study|Withdrawal by Subject|0|||
156866140|NCT01342211|566269175|FG000|Overall Study|Randomized, but not Treated|0|||
156866141|NCT01342211|566269176|FG001|Overall Study|Randomized, but not Treated|2|||
156866142|NCT01342211|566269177|FG002|Overall Study|Randomized, but not Treated|0|||
157209867|NCT05144477|567514067|FG001|Overall Study|Withdrawal by Subject|1|||
157209868|NCT03891875|567514070|FG000|Overall Study|Withdrawal by Subject|20|||
157209869|NCT03891875|567514071|FG001|Overall Study|Withdrawal by Subject|3|||
157209870|NCT03891875|567514070|FG000|Overall Study|Adverse Event|10|||
156779641|NCT02394756|565942637|FG000|Period 1|Withdrawal by Subject|0|||
156779642|NCT02394756|565942638|FG001|Period 1|Withdrawal by Subject|1|||
156779643|NCT02394756|565942639|FG002|Period 1|Withdrawal by Subject|1|||
156779644|NCT02394756|565942640|FG003|Period 1|Withdrawal by Subject|1|||
157209871|NCT03891875|567514071|FG001|Overall Study|Adverse Event|4|||
156779645|NCT02394756|565942641|FG004|Period 1|Withdrawal by Subject|0|||
156779646|NCT02394756|565942642|FG005|Period 1|Withdrawal by Subject|0|||
157209872|NCT03891875|567514070|FG000|Overall Study|Physician Decision|1|||
157209873|NCT03891875|567514071|FG001|Overall Study|Physician Decision|1|||
157209874|NCT03891875|567514070|FG000|Overall Study|Protocol Violation|1|||
157209875|NCT03891875|567514071|FG001|Overall Study|Protocol Violation|0|||
157209876|NCT03891875|567514070|FG000|Overall Study|Lost to Follow-up|1|||
157209877|NCT03891875|567514071|FG001|Overall Study|Lost to Follow-up|0|||
157209878|NCT03891875|567514070|FG000|Overall Study|COVID-19 infection|1|||
157209879|NCT03891875|567514071|FG001|Overall Study|COVID-19 infection|0|||
157209880|NCT01787188|567514072|FG000|Overall Study|Adverse Event|2|||
157209881|NCT01787188|567514073|FG001|Overall Study|Adverse Event|4|||
157209882|NCT01787188|567514074|FG002|Overall Study|Adverse Event|6|||
157209883|NCT01787188|567514072|FG000|Overall Study|Lack of Efficacy|7|||
156779647|NCT02394756|565942637|FG000|Period 2|Unsatisfactory Visual Response|0|||
156779648|NCT02394756|565942638|FG001|Period 2|Unsatisfactory Visual Response|0|||
156779649|NCT02394756|565942639|FG002|Period 2|Unsatisfactory Visual Response|0|||
156779650|NCT02394756|565942640|FG003|Period 2|Unsatisfactory Visual Response|0|||
156866143|NCT01342211|566269178|FG003|Overall Study|Randomized, but not Treated|0|||
156866144|NCT01342211|566269179|FG004|Overall Study|Randomized, but not Treated|1|||
156866145|NCT02594124|566269182|FG000|Overall Study|Adverse Event|0|||
156866146|NCT02594124|566269183|FG001|Overall Study|Adverse Event|5|||
156866147|NCT02594124|566269184|FG002|Overall Study|Adverse Event|8|||
156866148|NCT02594124|566269185|FG003|Overall Study|Adverse Event|1|||
156866149|NCT02594124|566269186|FG004|Overall Study|Adverse Event|0|||
156866150|NCT02594124|566269187|FG005|Overall Study|Adverse Event|0|||
156866151|NCT02594124|566269188|FG006|Overall Study|Adverse Event|2|||
156866152|NCT02594124|566269189|FG007|Overall Study|Adverse Event|2|||
157209884|NCT01787188|567514073|FG001|Overall Study|Lack of Efficacy|3|||
157209885|NCT01787188|567514074|FG002|Overall Study|Lack of Efficacy|5|||
157209886|NCT01787188|567514072|FG000|Overall Study|Non-compliance with Study Drug|0|||
157009634|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009635|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009636|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009637|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009638|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009639|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
157009640|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009641|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009642|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
157009643|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009644|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009645|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009646|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009647|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009648|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009649|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009650|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009651|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
157009652|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
157009653|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
157009654|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
157009655|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
157009656|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009657|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009658|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009659|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009660|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009661|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009662|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009663|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
157009664|NCT05061693|566786735|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
157009665|NCT05061693|566786736|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
157009666|NCT05061693|566786737|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
157009667|NCT05061693|566786738|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
157009668|NCT05061693|566786739|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009669|NCT05061693|566786740|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009670|NCT05061693|566786741|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009671|NCT05061693|566786742|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009672|NCT05061693|566786743|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009673|NCT05061693|566786744|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009674|NCT05061693|566786745|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009675|NCT05061693|566786746|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
157009676|NCT05061693|566786735|FG000|24-week Extension Period|Adverse Event|0|||
157009677|NCT05061693|566786736|FG001|24-week Extension Period|Adverse Event|0|||
157009678|NCT05061693|566786737|FG002|24-week Extension Period|Adverse Event|0|||
157009679|NCT05061693|566786738|FG003|24-week Extension Period|Adverse Event|0|||
157009680|NCT05061693|566786739|FG004|24-week Extension Period|Adverse Event|0|||
157009681|NCT05061693|566786740|FG005|24-week Extension Period|Adverse Event|0|||
157009682|NCT05061693|566786741|FG006|24-week Extension Period|Adverse Event|0|||
156866153|NCT02594124|566269190|FG008|Overall Study|Adverse Event|0|||
156866154|NCT02594124|566269182|FG000|Overall Study|Withdrawal by Subject|2|||
157009683|NCT05061693|566786742|FG007|24-week Extension Period|Adverse Event|2|||
157009684|NCT05061693|566786743|FG008|24-week Extension Period|Adverse Event|2|||
157009685|NCT05061693|566786744|FG009|24-week Extension Period|Adverse Event|0|||
157009686|NCT05061693|566786745|FG010|24-week Extension Period|Adverse Event|1|||
157009687|NCT05061693|566786746|FG011|24-week Extension Period|Adverse Event|3|||
156866155|NCT02594124|566269183|FG001|Overall Study|Withdrawal by Subject|3|||
156866156|NCT02594124|566269184|FG002|Overall Study|Withdrawal by Subject|5|||
156866157|NCT02594124|566269185|FG003|Overall Study|Withdrawal by Subject|1|||
156866158|NCT02594124|566269186|FG004|Overall Study|Withdrawal by Subject|8|||
156866159|NCT02594124|566269187|FG005|Overall Study|Withdrawal by Subject|4|||
156866160|NCT02594124|566269188|FG006|Overall Study|Withdrawal by Subject|13|||
156866161|NCT02594124|566269189|FG007|Overall Study|Withdrawal by Subject|19|||
156866162|NCT02594124|566269190|FG008|Overall Study|Withdrawal by Subject|0|||
156866163|NCT02594124|566269182|FG000|Overall Study|Physician Decision|0|||
156866164|NCT02594124|566269183|FG001|Overall Study|Physician Decision|2|||
156866165|NCT02594124|566269184|FG002|Overall Study|Physician Decision|0|||
156866166|NCT02594124|566269185|FG003|Overall Study|Physician Decision|0|||
156866167|NCT02594124|566269186|FG004|Overall Study|Physician Decision|0|||
156866168|NCT02594124|566269187|FG005|Overall Study|Physician Decision|0|||
156866169|NCT02594124|566269188|FG006|Overall Study|Physician Decision|0|||
156866170|NCT02594124|566269189|FG007|Overall Study|Physician Decision|1|||
156866171|NCT02594124|566269190|FG008|Overall Study|Physician Decision|0|||
156866172|NCT02594124|566269182|FG000|Overall Study|Commercial drug|0|||
156866173|NCT02594124|566269183|FG001|Overall Study|Commercial drug|1|||
156866174|NCT02594124|566269184|FG002|Overall Study|Commercial drug|6|||
156866175|NCT02594124|566269185|FG003|Overall Study|Commercial drug|3|||
157115694|NCT00183274|567177429|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
156866176|NCT02594124|566269186|FG004|Overall Study|Commercial drug|0|||
156866177|NCT02594124|566269187|FG005|Overall Study|Commercial drug|0|||
156866178|NCT02594124|566269188|FG006|Overall Study|Commercial drug|7|||
156866179|NCT02594124|566269189|FG007|Overall Study|Commercial drug|11|||
156866180|NCT02594124|566269190|FG008|Overall Study|Commercial drug|2|||
156866181|NCT02594124|566269182|FG000|Overall Study|Reason Not Specified|1|||
156866182|NCT02594124|566269183|FG001|Overall Study|Reason Not Specified|3|||
156866183|NCT02594124|566269184|FG002|Overall Study|Reason Not Specified|4|||
156866184|NCT02594124|566269185|FG003|Overall Study|Reason Not Specified|0|||
156866185|NCT02594124|566269186|FG004|Overall Study|Reason Not Specified|0|||
156866186|NCT02594124|566269187|FG005|Overall Study|Reason Not Specified|1|||
156866187|NCT02594124|566269188|FG006|Overall Study|Reason Not Specified|1|||
156866188|NCT02594124|566269189|FG007|Overall Study|Reason Not Specified|6|||
156866189|NCT02594124|566269190|FG008|Overall Study|Reason Not Specified|1|||
156866190|NCT01824836|566269191|FG000|Overall Study|Adverse Event|48|||
156866191|NCT01824836|566269191|FG000|Overall Study|Withdrawal by Subject|63|||
156866192|NCT01824836|566269191|FG000|Overall Study|Other complicating disease|116|||
156866193|NCT01824836|566269191|FG000|Overall Study|Disease progression|5|||
156866194|NCT01824836|566269191|FG000|Overall Study|Alternative therapy|2|||
156866195|NCT01824836|566269191|FG000|Overall Study|Depression|1|||
156866196|NCT01824836|566269191|FG000|Overall Study|Non-compliance|3|||
156866197|NCT01824836|566269191|FG000|Overall Study|Patient regained ovarian function|3|||
156866198|NCT01824836|566269191|FG000|Overall Study|Lost to Follow-up|8|||
156866199|NCT01824836|566269191|FG000|Overall Study|Physician Decision|2|||
156866200|NCT01824836|566269191|FG000|Overall Study|Research office was closed|3|||
156866201|NCT01824836|566269191|FG000|Overall Study|Relocation|3|||
156866202|NCT01824836|566269191|FG000|Overall Study|Insurance-related issue|1|||
156866203|NCT01824836|566269191|FG000|Overall Study|Transportation issue|1|||
156866204|NCT01824836|566269191|FG000|Overall Study|Patient transferred care|1|||
156866205|NCT01824836|566269191|FG000|Overall Study|Unknown reasons|4|||
156866206|NCT01824836|566269191|FG000|Overall Study|Never started treatment|16|||
156866207|NCT05523089|566269192|FG000|Overall Study|Withdrawal by Subject|1|||
156866208|NCT05523089|566269193|FG001|Overall Study|Withdrawal by Subject|0|||
156866209|NCT05523089|566269194|FG002|Overall Study|Withdrawal by Subject|0|||
156866210|NCT05523089|566269192|FG000|Overall Study|Lost to Follow-up|1|||
156866211|NCT05523089|566269193|FG001|Overall Study|Lost to Follow-up|0|||
156866212|NCT05523089|566269194|FG002|Overall Study|Lost to Follow-up|0|||
156866213|NCT01148979|566271113|FG000|Overall Study|Lost to Follow-up|0|||
156866214|NCT01148979|566271114|FG001|Overall Study|Lost to Follow-up|1|||
156866215|NCT05291520|566271115|FG000|Overall Study|Lost to Follow-up|0|||
157209887|NCT01787188|567514073|FG001|Overall Study|Non-compliance with Study Drug|1|||
157209888|NCT01787188|567514074|FG002|Overall Study|Non-compliance with Study Drug|0|||
157209889|NCT01787188|567514072|FG000|Overall Study|Withdrawal by Subject|4|||
157209890|NCT01787188|567514073|FG001|Overall Study|Withdrawal by Subject|3|||
157209891|NCT01787188|567514074|FG002|Overall Study|Withdrawal by Subject|2|||
157209892|NCT01787188|567514072|FG000|Overall Study|Protocol Violation|3|||
157209893|NCT01787188|567514073|FG001|Overall Study|Protocol Violation|2|||
157209894|NCT01787188|567514074|FG002|Overall Study|Protocol Violation|3|||
157209895|NCT01787188|567514072|FG000|Overall Study|Lost to Follow-up|1|||
157209896|NCT01787188|567514073|FG001|Overall Study|Lost to Follow-up|2|||
157209897|NCT01787188|567514074|FG002|Overall Study|Lost to Follow-up|2|||
157209898|NCT01787188|567514072|FG000|Overall Study|Other, including patient moved|0|||
157209899|NCT01787188|567514073|FG001|Overall Study|Other, including patient moved|3|||
157209900|NCT01787188|567514074|FG002|Overall Study|Other, including patient moved|0|||
157209901|NCT00854607|567514075|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
157209902|NCT00965263|567514083|FG000|Overall Study|Physician Decision|2|||
157209903|NCT00965263|567514084|FG001|Overall Study|Physician Decision|0|||
156808609|NCT00237042|566052730|FG002|Treatment|Completed no treatment|21|||
156808610|NCT00237042|566052728|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
156808611|NCT00237042|566052729|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
156808612|NCT00237042|566052730|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
156808613|NCT00237042|566052728|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
156808614|NCT00237042|566052729|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
156808615|NCT00237042|566052730|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
156808616|NCT03132467|566052735|FG000|Overall Study|Adverse Event|2|||
156808617|NCT03132467|566052735|FG000|Overall Study|Withdrawal by Subject|2|||
156808618|NCT01365455|566052742|FG000|Induction Period|Adverse Event|5|||
156808619|NCT01365455|566052743|FG001|Induction Period|Adverse Event|3|||
156808620|NCT01365455|566052744|FG002|Induction Period|Adverse Event|4|||
156808621|NCT01365455|566052745|FG003|Induction Period|Adverse Event|0|||
156808622|NCT01365455|566052746|FG004|Induction Period|Adverse Event|0|||
156808623|NCT01365455|566052742|FG000|Induction Period|Lack of Efficacy|1|||
156808624|NCT01365455|566052743|FG001|Induction Period|Lack of Efficacy|1|||
156808625|NCT01365455|566052744|FG002|Induction Period|Lack of Efficacy|0|||
156808626|NCT01365455|566052745|FG003|Induction Period|Lack of Efficacy|0|||
156808627|NCT01365455|566052746|FG004|Induction Period|Lack of Efficacy|0|||
156808628|NCT01365455|566052742|FG000|Induction Period|Pregnancy|0|||
156808629|NCT01365455|566052743|FG001|Induction Period|Pregnancy|1|||
156808630|NCT01365455|566052744|FG002|Induction Period|Pregnancy|0|||
156808631|NCT01365455|566052745|FG003|Induction Period|Pregnancy|0|||
156808632|NCT01365455|566052746|FG004|Induction Period|Pregnancy|0|||
156808633|NCT01365455|566052742|FG000|Induction Period|Protocol deviation|0|||
156808634|NCT01365455|566052743|FG001|Induction Period|Protocol deviation|1|||
156808635|NCT01365455|566052744|FG002|Induction Period|Protocol deviation|1|||
156808636|NCT01365455|566052745|FG003|Induction Period|Protocol deviation|0|||
156808637|NCT01365455|566052746|FG004|Induction Period|Protocol deviation|0|||
156808638|NCT01365455|566052742|FG000|Induction Period|Subject/guardian decision|9|||
156808639|NCT01365455|566052743|FG001|Induction Period|Subject/guardian decision|1|||
156808640|NCT01365455|566052744|FG002|Induction Period|Subject/guardian decision|8|||
156808641|NCT01365455|566052745|FG003|Induction Period|Subject/guardian decision|0|||
156808642|NCT01365455|566052746|FG004|Induction Period|Subject/guardian decision|0|||
156808643|NCT01365455|566052742|FG000|Induction Period|Lost to Follow-up|0|||
156808644|NCT01365455|566052743|FG001|Induction Period|Lost to Follow-up|0|||
156808645|NCT01365455|566052744|FG002|Induction Period|Lost to Follow-up|3|||
156808646|NCT01365455|566052745|FG003|Induction Period|Lost to Follow-up|0|||
156808647|NCT01365455|566052746|FG004|Induction Period|Lost to Follow-up|0|||
156808648|NCT01365455|566052742|FG000|Maintenance Period|Adverse Event|12|||
156808649|NCT01365455|566052743|FG001|Maintenance Period|Adverse Event|5|||
156808650|NCT01365455|566052744|FG002|Maintenance Period|Adverse Event|1|||
156808651|NCT01365455|566052745|FG003|Maintenance Period|Adverse Event|2|||
156808652|NCT01365455|566052746|FG004|Maintenance Period|Adverse Event|4|||
156808653|NCT01365455|566052742|FG000|Maintenance Period|Lack of Efficacy|10|||
156808654|NCT01365455|566052743|FG001|Maintenance Period|Lack of Efficacy|2|||
156808655|NCT01365455|566052744|FG002|Maintenance Period|Lack of Efficacy|0|||
156808656|NCT01365455|566052745|FG003|Maintenance Period|Lack of Efficacy|2|||
156808657|NCT01365455|566052746|FG004|Maintenance Period|Lack of Efficacy|2|||
156808658|NCT01365455|566052742|FG000|Maintenance Period|Lost to Follow-up|2|||
156808659|NCT01365455|566052743|FG001|Maintenance Period|Lost to Follow-up|4|||
156808660|NCT01365455|566052744|FG002|Maintenance Period|Lost to Follow-up|0|||
156808661|NCT01365455|566052745|FG003|Maintenance Period|Lost to Follow-up|0|||
156808662|NCT01365455|566052746|FG004|Maintenance Period|Lost to Follow-up|3|||
156808663|NCT01365455|566052742|FG000|Maintenance Period|Non-compliance with study treatment|0|||
156808664|NCT01365455|566052743|FG001|Maintenance Period|Non-compliance with study treatment|0|||
156808665|NCT01365455|566052744|FG002|Maintenance Period|Non-compliance with study treatment|0|||
156808666|NCT01365455|566052745|FG003|Maintenance Period|Non-compliance with study treatment|1|||
156808667|NCT01365455|566052746|FG004|Maintenance Period|Non-compliance with study treatment|0|||
156808668|NCT01365455|566052742|FG000|Maintenance Period|Physician Decision|0|||
156808669|NCT01365455|566052743|FG001|Maintenance Period|Physician Decision|1|||
156808670|NCT01365455|566052744|FG002|Maintenance Period|Physician Decision|0|||
156808671|NCT01365455|566052745|FG003|Maintenance Period|Physician Decision|0|||
156808672|NCT01365455|566052746|FG004|Maintenance Period|Physician Decision|1|||
156808673|NCT01365455|566052742|FG000|Maintenance Period|Pregnancy|0|||
157209904|NCT00965263|567514083|FG000|Overall Study|Family emergency|0|||
157209905|NCT00965263|567514084|FG001|Overall Study|Family emergency|1|||
157209906|NCT00965263|567514083|FG000|Overall Study|Protocol Violation|0|||
157209907|NCT00965263|567514084|FG001|Overall Study|Protocol Violation|2|||
157209908|NCT02756078|567514085|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
157209909|NCT02756078|567514086|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
157209910|NCT02756078|567514085|FG000|Period 1|Lost to Follow-up|0|||
157209911|NCT02756078|567514086|FG001|Period 1|Lost to Follow-up|2|||
157009688|NCT05061693|566786735|FG000|24-week Extension Period|Lack of Efficacy|0|||
157009689|NCT05061693|566786736|FG001|24-week Extension Period|Lack of Efficacy|0|||
157009690|NCT05061693|566786737|FG002|24-week Extension Period|Lack of Efficacy|0|||
157009691|NCT05061693|566786738|FG003|24-week Extension Period|Lack of Efficacy|0|||
157009692|NCT05061693|566786739|FG004|24-week Extension Period|Lack of Efficacy|0|||
157209912|NCT02756078|567514085|FG000|Period 1|Protocol Violation|0|||
157009693|NCT05061693|566786740|FG005|24-week Extension Period|Lack of Efficacy|0|||
157009694|NCT05061693|566786741|FG006|24-week Extension Period|Lack of Efficacy|0|||
157209913|NCT02756078|567514086|FG001|Period 1|Protocol Violation|1|||
156808674|NCT01365455|566052743|FG001|Maintenance Period|Pregnancy|4|||
156866216|NCT05291520|566271116|FG001|Overall Study|Lost to Follow-up|0|||
157209914|NCT02756078|567514085|FG000|Period 1|Adverse Event|1|||
157209915|NCT02756078|567514086|FG001|Period 1|Adverse Event|10|||
157209916|NCT02756078|567514085|FG000|Period 1|Withdrawal by Subject|6|||
157209917|NCT02756078|567514086|FG001|Period 1|Withdrawal by Subject|6|||
157209918|NCT02756078|567514085|FG000|Period 1|Lens Discomfort|2|||
157209919|NCT02756078|567514086|FG001|Period 1|Lens Discomfort|2|||
157209920|NCT02756078|567514085|FG000|Period 2|Adverse Event|3|||
157209921|NCT02756078|567514086|FG001|Period 2|Adverse Event|5|||
157209922|NCT02756078|567514085|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
157209923|NCT02756078|567514086|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
157209924|NCT02756078|567514085|FG000|Period 2|Withdrawal by Subject|3|||
157209925|NCT02756078|567514086|FG001|Period 2|Withdrawal by Subject|1|||
157209926|NCT01591499|567514087|FG000|Baseline Visit|Withdrawal by Subject|0|||
157209927|NCT01591499|567514088|FG001|Baseline Visit|Withdrawal by Subject|2|||
157209928|NCT01591499|567514089|FG002|Baseline Visit|Withdrawal by Subject|0|||
157209929|NCT01591499|567514090|FG003|Baseline Visit|Withdrawal by Subject|2|||
157209930|NCT01591499|567514087|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
157209931|NCT01591499|567514088|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
157209932|NCT01591499|567514089|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
157209933|NCT01591499|567514090|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
157209934|NCT01591499|567514087|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
157209935|NCT01591499|567514088|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
157209936|NCT01591499|567514089|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
157209937|NCT01591499|567514090|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
157209938|NCT00646282|567514091|FG000|Overall Study|Protocol terminated|4|||
157209939|NCT00646282|567514092|FG001|Overall Study|Protocol terminated|4|||
157209940|NCT00530088|567514093|FG000|Overall Study|Disease Progression|4|||
157209941|NCT00530088|567514093|FG000|Overall Study|Physician Decision|4|||
157209942|NCT00530088|567514093|FG000|Overall Study|Other Not Specified|2|||
157209943|NCT02058368|567514097|FG000|Overall Study|Adverse Event|15|||
157209944|NCT02058368|567514098|FG001|Overall Study|Adverse Event|20|||
157209945|NCT02058368|567514097|FG000|Overall Study|Lack of Efficacy|0|||
157209946|NCT02058368|567514098|FG001|Overall Study|Lack of Efficacy|1|||
157209947|NCT02058368|567514097|FG000|Overall Study|Protocol Violation|0|||
157209948|NCT02058368|567514098|FG001|Overall Study|Protocol Violation|4|||
157209949|NCT02058368|567514097|FG000|Overall Study|Lost to Follow-up|2|||
157209950|NCT02058368|567514098|FG001|Overall Study|Lost to Follow-up|0|||
157209951|NCT02058368|567514097|FG000|Overall Study|Physician Decision|2|||
157209952|NCT02058368|567514098|FG001|Overall Study|Physician Decision|3|||
157209953|NCT02058368|567514097|FG000|Overall Study|Withdrawal by Subject|22|||
157209954|NCT02058368|567514098|FG001|Overall Study|Withdrawal by Subject|26|||
157209955|NCT02181842|567514100|FG000|Overall Study|Case Report Forms Uncollected|2|||
157209956|NCT00758706|567514101|FG000|Overall Study|Adverse Event|4|||
157209957|NCT00758706|567514102|FG001|Overall Study|Adverse Event|4|||
157209958|NCT05899218|567514116|FG000|Overall Study|Lost to Follow-up|2|||
157209959|NCT05899218|567514117|FG001|Overall Study|Lost to Follow-up|2|||
157209960|NCT05899218|567514116|FG000|Overall Study|deemed ineligible out of country|1|||
156866217|NCT05291520|566271117|FG002|Overall Study|Lost to Follow-up|1|||
156866218|NCT01347112|566271118|FG000|Overall Study|Withdrawal by Subject|1|||
156866219|NCT01347112|566271119|FG001|Overall Study|Withdrawal by Subject|7|||
156866220|NCT01347112|566271118|FG000|Overall Study|Lost to Follow-up|3|||
156866221|NCT01347112|566271119|FG001|Overall Study|Lost to Follow-up|5|||
156866222|NCT05462756|566271136|FG000|Treatment Period|Adverse Event|3|||
156866223|NCT05462756|566271137|FG001|Treatment Period|Adverse Event|0|||
157209961|NCT05899218|567514117|FG001|Overall Study|deemed ineligible out of country|0|||
157209962|NCT02587325|567514118|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
157209963|NCT02587325|567514119|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
156866224|NCT05462756|566271136|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
156866225|NCT05462756|566271137|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
156866226|NCT05462756|566271136|FG000|Treatment Period|Death|0|||
156866227|NCT05462756|566271137|FG001|Treatment Period|Death|1|||
157209964|NCT02587325|567514120|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
157209965|NCT02587325|567514121|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
157209966|NCT02587325|567514122|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
157209967|NCT02587325|567514118|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
157209968|NCT02587325|567514119|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
157209969|NCT02587325|567514120|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
157209970|NCT02587325|567514121|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
157209971|NCT02587325|567514122|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
156866228|NCT05462756|566271136|FG000|Treatment Period|Lost to Follow-up|2|||
156866229|NCT05462756|566271137|FG001|Treatment Period|Lost to Follow-up|1|||
156866230|NCT05462756|566271136|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
156866231|NCT05462756|566271137|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
156866232|NCT05462756|566271136|FG000|Treatment Period|Physician Decision|2|||
156866233|NCT05462756|566271137|FG001|Treatment Period|Physician Decision|0|||
156866234|NCT05462756|566271136|FG000|Treatment Period|Protocol Violation|0|||
156866235|NCT05462756|566271137|FG001|Treatment Period|Protocol Violation|1|||
156866236|NCT05462756|566271136|FG000|Treatment Period|Withdrawal by Subject|5|||
156866237|NCT05462756|566271137|FG001|Treatment Period|Withdrawal by Subject|12|||
156866238|NCT05462756|566271136|FG000|Follow-Up Period|Adverse Event|1|||
156866239|NCT05462756|566271137|FG001|Follow-Up Period|Adverse Event|0|||
156866240|NCT05462756|566271136|FG000|Follow-Up Period|Death|1|||
156866241|NCT05462756|566271137|FG001|Follow-Up Period|Death|0|||
156866242|NCT05462756|566271136|FG000|Follow-Up Period|Lost to Follow-up|3|||
156866243|NCT05462756|566271137|FG001|Follow-Up Period|Lost to Follow-up|1|||
156866244|NCT05462756|566271136|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156866245|NCT05462756|566271137|FG001|Follow-Up Period|Withdrawal by Subject|4|||
157209972|NCT02587325|567514118|FG000|32-Week Optional Extension Part|Adverse Event|0|||
157209973|NCT02587325|567514119|FG001|32-Week Optional Extension Part|Adverse Event|0|||
157209974|NCT02587325|567514120|FG002|32-Week Optional Extension Part|Adverse Event|1|||
157209975|NCT02587325|567514121|FG003|32-Week Optional Extension Part|Adverse Event|0|||
156866246|NCT02536976|566271143|FG000|Overall Study|Physician Decision|0|||
156866247|NCT02536976|566271144|FG001|Overall Study|Physician Decision|1|||
156866248|NCT01389596|566271147|FG000|Overall Study|Protocol Violation|3|||
157209976|NCT02587325|567514122|FG004|32-Week Optional Extension Part|Adverse Event|0|||
156866249|NCT01389596|566271148|FG001|Overall Study|Protocol Violation|4|||
156866250|NCT01389596|566271149|FG002|Overall Study|Protocol Violation|3|||
157209977|NCT02587325|567514118|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
156779651|NCT02394756|565942641|FG004|Period 2|Unsatisfactory Visual Response|1|||
156779652|NCT02394756|565942642|FG005|Period 2|Unsatisfactory Visual Response|0|||
156779653|NCT02916771|565942643|FG000|Overall Study|Withdrawal by Subject|9|||
156779654|NCT02916771|565942643|FG000|Overall Study|Physician Decision|1|||
156779655|NCT02916771|565942643|FG000|Overall Study|Began treatment for another active malignancy|1|||
156779656|NCT06455111|565942645|FG000|Overall Study|Withdrawal by Subject|11|||
156779657|NCT06455111|565942646|FG001|Overall Study|Withdrawal by Subject|4|||
156779658|NCT03611946|565942651|FG000|Overall Study|Withdrawal by Subject|0|||
156779659|NCT03611946|565942652|FG001|Overall Study|Withdrawal by Subject|0|||
156779660|NCT03611946|565942653|FG002|Overall Study|Withdrawal by Subject|1|||
157209978|NCT02587325|567514119|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
157209979|NCT02587325|567514120|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
157209980|NCT02587325|567514121|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
157009695|NCT05061693|566786742|FG007|24-week Extension Period|Lack of Efficacy|0|||
157009696|NCT05061693|566786743|FG008|24-week Extension Period|Lack of Efficacy|0|||
157009697|NCT05061693|566786744|FG009|24-week Extension Period|Lack of Efficacy|0|||
157009698|NCT05061693|566786745|FG010|24-week Extension Period|Lack of Efficacy|2|||
157009699|NCT05061693|566786746|FG011|24-week Extension Period|Lack of Efficacy|0|||
157009700|NCT05061693|566786735|FG000|24-week Extension Period|Lost to Follow-up|0|||
157009701|NCT05061693|566786736|FG001|24-week Extension Period|Lost to Follow-up|0|||
157009702|NCT05061693|566786737|FG002|24-week Extension Period|Lost to Follow-up|0|||
157009703|NCT05061693|566786738|FG003|24-week Extension Period|Lost to Follow-up|0|||
157009704|NCT05061693|566786739|FG004|24-week Extension Period|Lost to Follow-up|0|||
157009705|NCT05061693|566786740|FG005|24-week Extension Period|Lost to Follow-up|0|||
157009706|NCT05061693|566786741|FG006|24-week Extension Period|Lost to Follow-up|1|||
157009707|NCT05061693|566786742|FG007|24-week Extension Period|Lost to Follow-up|0|||
157009708|NCT05061693|566786743|FG008|24-week Extension Period|Lost to Follow-up|1|||
157009709|NCT05061693|566786744|FG009|24-week Extension Period|Lost to Follow-up|1|||
157009710|NCT05061693|566786745|FG010|24-week Extension Period|Lost to Follow-up|0|||
157009711|NCT05061693|566786746|FG011|24-week Extension Period|Lost to Follow-up|0|||
157009712|NCT05061693|566786735|FG000|24-week Extension Period|Withdrawal by Subject|0|||
157009713|NCT05061693|566786736|FG001|24-week Extension Period|Withdrawal by Subject|0|||
157009714|NCT05061693|566786737|FG002|24-week Extension Period|Withdrawal by Subject|0|||
156866251|NCT01389596|566271147|FG000|Overall Study|Withdrawal by Subject|1|||
157209981|NCT02587325|567514122|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
157209982|NCT00390572|567514123|FG000|Overall Study|Lost to Follow-up|8|||
157209983|NCT00390572|567514124|FG001|Overall Study|Lost to Follow-up|4|||
157209984|NCT00390572|567514123|FG000|Overall Study|health condition|0|||
157209985|NCT00390572|567514124|FG001|Overall Study|health condition|1|||
157209986|NCT00314262|567514156|FG000|Overall Study|Adverse Event|2|||
157209987|NCT00314262|567514156|FG000|Overall Study|Withdrawal by Subject|2|||
157209988|NCT00314262|567514156|FG000|Overall Study|Physician Decision|1|||
157209989|NCT02787746|567514157|FG000|Overall Study|Adverse Event|42|||
157209990|NCT02787746|567514157|FG000|Overall Study|Withdrawal by Subject|65|||
157209991|NCT02787746|567514157|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
157209992|NCT01142466|567516881|FG000|Overall Study|Adverse Event|2|||
157209993|NCT01142466|567516882|FG001|Overall Study|Adverse Event|1|||
157209994|NCT01142466|567516881|FG000|Overall Study|Withdrawal by Subject|1|||
157209995|NCT01142466|567516882|FG001|Overall Study|Withdrawal by Subject|1|||
157209996|NCT00700310|567516887|FG000|Overall Study|Adverse Event|6|||
156808675|NCT01365455|566052744|FG002|Maintenance Period|Pregnancy|0|||
156808676|NCT01365455|566052745|FG003|Maintenance Period|Pregnancy|0|||
156808677|NCT01365455|566052746|FG004|Maintenance Period|Pregnancy|2|||
156808678|NCT01365455|566052742|FG000|Maintenance Period|Protocol deviation|1|||
156808679|NCT01365455|566052743|FG001|Maintenance Period|Protocol deviation|1|||
156808680|NCT01365455|566052744|FG002|Maintenance Period|Protocol deviation|0|||
156808681|NCT01365455|566052745|FG003|Maintenance Period|Protocol deviation|0|||
156808682|NCT01365455|566052746|FG004|Maintenance Period|Protocol deviation|0|||
156808683|NCT01365455|566052742|FG000|Maintenance Period|Subject/guardian decision|4|||
156808684|NCT01365455|566052743|FG001|Maintenance Period|Subject/guardian decision|6|||
156808685|NCT01365455|566052744|FG002|Maintenance Period|Subject/guardian decision|2|||
156808686|NCT01365455|566052745|FG003|Maintenance Period|Subject/guardian decision|4|||
156808687|NCT01365455|566052746|FG004|Maintenance Period|Subject/guardian decision|1|||
156808688|NCT03965403|566052747|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
156808689|NCT04267926|566054428|FG000|Overall Study|abnormal labs. No longer eligible|0|||
156808690|NCT04267926|566054429|FG001|Overall Study|abnormal labs. No longer eligible|0|||
156808691|NCT04267926|566054430|FG002|Overall Study|abnormal labs. No longer eligible|1|||
156808692|NCT04267926|566054428|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
156808693|NCT04267926|566054429|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
156808694|NCT04267926|566054430|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
156808695|NCT03718325|566054431|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
156808696|NCT03718325|566054432|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
156808697|NCT03718325|566054433|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
156808698|NCT03718325|566054431|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
156808699|NCT03718325|566054432|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
156808700|NCT03718325|566054433|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
156808701|NCT00972023|566054438|FG000|Overall Study|Withdrawal by Subject|1|||
156808702|NCT03052608|566054440|FG000|Treatment Phase|Adverse Event|10|||
156808703|NCT03052608|566054441|FG001|Treatment Phase|Adverse Event|12|||
156808704|NCT03052608|566054440|FG000|Treatment Phase|Death|6|||
156808705|NCT03052608|566054441|FG001|Treatment Phase|Death|4|||
156808706|NCT03052608|566054440|FG000|Treatment Phase|Withdrawal by Subject|4|||
156808707|NCT03052608|566054441|FG001|Treatment Phase|Withdrawal by Subject|12|||
156808708|NCT03052608|566054440|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
156808709|NCT03052608|566054441|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
156808710|NCT03052608|566054440|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
156808711|NCT03052608|566054441|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
156808712|NCT03052608|566054440|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
156808713|NCT03052608|566054441|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
156808714|NCT03052608|566054440|FG000|Treatment Phase|Ongoing|103|||
156808715|NCT03052608|566054441|FG001|Treatment Phase|Ongoing|31|||
156808716|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Death|23|||
156808717|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Death|28|||
156808718|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
156866252|NCT01389596|566271148|FG001|Overall Study|Withdrawal by Subject|2|||
156866253|NCT01389596|566271149|FG002|Overall Study|Withdrawal by Subject|2|||
156866254|NCT01389596|566271147|FG000|Overall Study|Insufficient Clinical Response|3|||
156866255|NCT01389596|566271148|FG001|Overall Study|Insufficient Clinical Response|4|||
156866256|NCT01389596|566271149|FG002|Overall Study|Insufficient Clinical Response|5|||
156866257|NCT01389596|566271147|FG000|Overall Study|Adverse Event|1|||
156866258|NCT01389596|566271148|FG001|Overall Study|Adverse Event|4|||
156866259|NCT01389596|566271149|FG002|Overall Study|Adverse Event|0|||
156866260|NCT01389596|566271147|FG000|Overall Study|Death|0|||
156866261|NCT01389596|566271148|FG001|Overall Study|Death|1|||
156866262|NCT01389596|566271149|FG002|Overall Study|Death|0|||
156866263|NCT01389596|566271147|FG000|Overall Study|Other Unspecified|2|||
156866264|NCT01389596|566271148|FG001|Overall Study|Other Unspecified|1|||
156866265|NCT01389596|566271149|FG002|Overall Study|Other Unspecified|0|||
156866266|NCT01671319|566271150|FG000|Overall Study|Withdrawal by Subject|1|||
156866267|NCT01709084|566271151|FG000|Overall Study|Lost to Follow-up|4|||
156866268|NCT01709084|566271152|FG001|Overall Study|Lost to Follow-up|7|||
156866269|NCT01709084|566271151|FG000|Overall Study|Withdrawal by Subject|2|||
156866270|NCT01709084|566271152|FG001|Overall Study|Withdrawal by Subject|2|||
156866271|NCT01709084|566271151|FG000|Overall Study|Adverse Event|5|||
156866272|NCT01709084|566271152|FG001|Overall Study|Adverse Event|0|||
156866273|NCT01709084|566271151|FG000|Overall Study|Other|5|||
156866274|NCT01709084|566271152|FG001|Overall Study|Other|3|||
157115695|NCT00183274|567177430|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
157115696|NCT00183274|567177431|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
157115697|NCT00183274|567177432|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
157115698|NCT00183274|567177433|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
157115699|NCT00183274|567177434|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
157115700|NCT00183274|567177429|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
157115701|NCT00183274|567177430|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
157115702|NCT00183274|567177431|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
157115703|NCT00183274|567177432|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
157115704|NCT00183274|567177433|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
157115705|NCT00183274|567177434|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
156866275|NCT01709084|566271151|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
156866276|NCT01709084|566271152|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
156866277|NCT01709084|566271151|FG000|Overall Study|Not Treated|0|||
156866278|NCT01709084|566271152|FG001|Overall Study|Not Treated|2|||
156866279|NCT00214201|566271153|FG000|Overall Study|Withdrawal by Subject|2|||
156866280|NCT00214201|566271154|FG001|Overall Study|Withdrawal by Subject|0|||
156866281|NCT00214201|566271153|FG000|Overall Study|Death|0|||
156866282|NCT00214201|566271154|FG001|Overall Study|Death|2|||
156866283|NCT01354899|566271155|FG000|Overall Study|discharge from the hospital|2|||
156866284|NCT01354899|566271155|FG000|Overall Study|Protocol Violation|1|||
156866285|NCT00463567|566271156|FG000|Overall Study|Adverse Event|29|||
156866286|NCT00463567|566271157|FG001|Overall Study|Adverse Event|26|||
156866287|NCT00463567|566271158|FG002|Overall Study|Adverse Event|17|||
156866288|NCT00463567|566271159|FG003|Overall Study|Adverse Event|46|||
156866289|NCT00463567|566271160|FG004|Overall Study|Adverse Event|10|||
156866290|NCT00463567|566271161|FG005|Overall Study|Adverse Event|10|||
156866291|NCT00463567|566271162|FG006|Overall Study|Adverse Event|4|||
156866292|NCT00463567|566271156|FG000|Overall Study|Withdrawal by Subject|29|||
156866293|NCT00463567|566271157|FG001|Overall Study|Withdrawal by Subject|22|||
156866294|NCT00463567|566271158|FG002|Overall Study|Withdrawal by Subject|20|||
156866295|NCT00463567|566271159|FG003|Overall Study|Withdrawal by Subject|37|||
156866296|NCT00463567|566271160|FG004|Overall Study|Withdrawal by Subject|6|||
156866297|NCT00463567|566271161|FG005|Overall Study|Withdrawal by Subject|5|||
156866298|NCT00463567|566271162|FG006|Overall Study|Withdrawal by Subject|1|||
156866299|NCT00463567|566271156|FG000|Overall Study|Protocol Deviation|13|||
156866300|NCT00463567|566271157|FG001|Overall Study|Protocol Deviation|9|||
156866301|NCT00463567|566271158|FG002|Overall Study|Protocol Deviation|14|||
156866302|NCT00463567|566271159|FG003|Overall Study|Protocol Deviation|11|||
156866303|NCT00463567|566271160|FG004|Overall Study|Protocol Deviation|1|||
156866304|NCT00463567|566271161|FG005|Overall Study|Protocol Deviation|1|||
156866305|NCT00463567|566271162|FG006|Overall Study|Protocol Deviation|2|||
156866306|NCT00463567|566271156|FG000|Overall Study|Lost to Follow-up|12|||
156866307|NCT00463567|566271157|FG001|Overall Study|Lost to Follow-up|6|||
156866308|NCT00463567|566271158|FG002|Overall Study|Lost to Follow-up|13|||
156866309|NCT00463567|566271159|FG003|Overall Study|Lost to Follow-up|8|||
156866310|NCT00463567|566271160|FG004|Overall Study|Lost to Follow-up|1|||
156866311|NCT00463567|566271161|FG005|Overall Study|Lost to Follow-up|1|||
156866312|NCT00463567|566271162|FG006|Overall Study|Lost to Follow-up|1|||
156866313|NCT00463567|566271156|FG000|Overall Study|Administrative problems|5|||
156866314|NCT00463567|566271157|FG001|Overall Study|Administrative problems|3|||
156866315|NCT00463567|566271158|FG002|Overall Study|Administrative problems|6|||
156866316|NCT00463567|566271159|FG003|Overall Study|Administrative problems|9|||
156866317|NCT00463567|566271160|FG004|Overall Study|Administrative problems|3|||
156866318|NCT00463567|566271161|FG005|Overall Study|Administrative problems|2|||
157009715|NCT05061693|566786738|FG003|24-week Extension Period|Withdrawal by Subject|0|||
157009716|NCT05061693|566786739|FG004|24-week Extension Period|Withdrawal by Subject|0|||
157009717|NCT05061693|566786740|FG005|24-week Extension Period|Withdrawal by Subject|0|||
157009718|NCT05061693|566786741|FG006|24-week Extension Period|Withdrawal by Subject|0|||
157009719|NCT05061693|566786742|FG007|24-week Extension Period|Withdrawal by Subject|0|||
157009720|NCT05061693|566786743|FG008|24-week Extension Period|Withdrawal by Subject|1|||
157009721|NCT05061693|566786744|FG009|24-week Extension Period|Withdrawal by Subject|2|||
157009722|NCT05061693|566786745|FG010|24-week Extension Period|Withdrawal by Subject|2|||
157009723|NCT05061693|566786746|FG011|24-week Extension Period|Withdrawal by Subject|1|||
157009724|NCT05061693|566786735|FG000|24-week Extension Period|Sponsor Decision|0|||
157009725|NCT05061693|566786736|FG001|24-week Extension Period|Sponsor Decision|0|||
157009726|NCT05061693|566786737|FG002|24-week Extension Period|Sponsor Decision|0|||
157009727|NCT05061693|566786738|FG003|24-week Extension Period|Sponsor Decision|0|||
157009728|NCT05061693|566786739|FG004|24-week Extension Period|Sponsor Decision|0|||
157009729|NCT05061693|566786740|FG005|24-week Extension Period|Sponsor Decision|0|||
157009730|NCT05061693|566786741|FG006|24-week Extension Period|Sponsor Decision|0|||
157009731|NCT05061693|566786742|FG007|24-week Extension Period|Sponsor Decision|1|||
157009732|NCT05061693|566786743|FG008|24-week Extension Period|Sponsor Decision|0|||
157009733|NCT05061693|566786744|FG009|24-week Extension Period|Sponsor Decision|0|||
157009734|NCT05061693|566786745|FG010|24-week Extension Period|Sponsor Decision|0|||
157009735|NCT05061693|566786746|FG011|24-week Extension Period|Sponsor Decision|0|||
157009736|NCT05061693|566786735|FG000|24-week Extension Period|Site Closure|0|||
157009737|NCT05061693|566786736|FG001|24-week Extension Period|Site Closure|0|||
157009738|NCT05061693|566786737|FG002|24-week Extension Period|Site Closure|0|||
157009739|NCT05061693|566786738|FG003|24-week Extension Period|Site Closure|0|||
157009740|NCT05061693|566786739|FG004|24-week Extension Period|Site Closure|0|||
157009741|NCT05061693|566786740|FG005|24-week Extension Period|Site Closure|0|||
157009742|NCT05061693|566786741|FG006|24-week Extension Period|Site Closure|0|||
157009743|NCT05061693|566786742|FG007|24-week Extension Period|Site Closure|0|||
157009744|NCT05061693|566786743|FG008|24-week Extension Period|Site Closure|1|||
157009745|NCT05061693|566786744|FG009|24-week Extension Period|Site Closure|0|||
157009746|NCT05061693|566786745|FG010|24-week Extension Period|Site Closure|0|||
157009747|NCT05061693|566786746|FG011|24-week Extension Period|Site Closure|1|||
157009748|NCT03823911|566786747|FG000|Overall Study|Lost to Follow-up|1|||
157009749|NCT03823911|566786748|FG001|Overall Study|Lost to Follow-up|5|||
157009750|NCT03823911|566786749|FG002|Overall Study|Lost to Follow-up|2|||
157009751|NCT03823911|566786747|FG000|Overall Study|Did not meet eligibility criteria|13|||
157009752|NCT03823911|566786748|FG001|Overall Study|Did not meet eligibility criteria|7|||
157009753|NCT03823911|566786749|FG002|Overall Study|Did not meet eligibility criteria|4|||
157009754|NCT03823911|566786747|FG000|Overall Study|Death|0|||
157009755|NCT03823911|566786748|FG001|Overall Study|Death|1|||
157009756|NCT03823911|566786749|FG002|Overall Study|Death|0|||
157009757|NCT04009577|566786750|FG000|Core Study|Adverse Event|1|||
157009758|NCT04009577|566786751|FG001|Core Study|Adverse Event|0|||
157009759|NCT04009577|566786752|FG002|Core Study|Adverse Event|2|||
157009760|NCT04009577|566786753|FG003|Core Study|Adverse Event|4|||
157009761|NCT04009577|566786750|FG000|Core Study|Withdrawal by Subject|0|||
157009762|NCT04009577|566786751|FG001|Core Study|Withdrawal by Subject|0|||
157009763|NCT04009577|566786752|FG002|Core Study|Withdrawal by Subject|2|||
157009764|NCT04009577|566786753|FG003|Core Study|Withdrawal by Subject|0|||
157009765|NCT04009577|566786750|FG000|Core Study|Other|0|||
157009766|NCT04009577|566786751|FG001|Core Study|Other|0|||
157009767|NCT04009577|566786752|FG002|Core Study|Other|0|||
157009768|NCT04009577|566786753|FG003|Core Study|Other|1|||
157009769|NCT04009577|566786750|FG000|Extension Phase|Adverse Event|0|||
157009770|NCT04009577|566786751|FG001|Extension Phase|Adverse Event|0|||
157009771|NCT04009577|566786752|FG002|Extension Phase|Adverse Event|0|||
157009772|NCT04009577|566786753|FG003|Extension Phase|Adverse Event|1|||
157009773|NCT04009577|566786750|FG000|Extension Phase|Inadequate therapeutic effect|0|||
157009774|NCT04009577|566786751|FG001|Extension Phase|Inadequate therapeutic effect|0|||
157009775|NCT04009577|566786752|FG002|Extension Phase|Inadequate therapeutic effect|1|||
157009776|NCT04009577|566786753|FG003|Extension Phase|Inadequate therapeutic effect|0|||
157009777|NCT04009577|566786750|FG000|Extension Phase|Withdrawal by Subject|0|||
157009778|NCT04009577|566786751|FG001|Extension Phase|Withdrawal by Subject|0|||
157009779|NCT04009577|566786752|FG002|Extension Phase|Withdrawal by Subject|1|||
157009780|NCT04009577|566786753|FG003|Extension Phase|Withdrawal by Subject|0|||
157009781|NCT04009577|566786750|FG000|Extension Phase|Not Treated|0|||
157009782|NCT04009577|566786751|FG001|Extension Phase|Not Treated|0|||
157009783|NCT04009577|566786752|FG002|Extension Phase|Not Treated|2|||
157009784|NCT04009577|566786753|FG003|Extension Phase|Not Treated|0|||
156866319|NCT00463567|566271162|FG006|Overall Study|Administrative problems|2|||
156866320|NCT00463567|566271156|FG000|Overall Study|Lack of Efficacy|4|||
157009785|NCT01832480|566786754|FG000|Overall Study|Lost to Follow-up|33|||
157009786|NCT01832480|566786755|FG001|Overall Study|Lost to Follow-up|30|||
157009787|NCT01832480|566786754|FG000|Overall Study|Withdrawal by Subject|0|||
157009788|NCT01832480|566786755|FG001|Overall Study|Withdrawal by Subject|2|||
157009789|NCT01832480|566786754|FG000|Overall Study|post randomization ineligible|8|||
156866321|NCT00463567|566271157|FG001|Overall Study|Lack of Efficacy|9|||
156866322|NCT00463567|566271158|FG002|Overall Study|Lack of Efficacy|9|||
156866323|NCT00463567|566271159|FG003|Overall Study|Lack of Efficacy|17|||
156866324|NCT00463567|566271160|FG004|Overall Study|Lack of Efficacy|1|||
156866325|NCT00463567|566271161|FG005|Overall Study|Lack of Efficacy|0|||
156866326|NCT00463567|566271162|FG006|Overall Study|Lack of Efficacy|1|||
156866327|NCT00463567|566271156|FG000|Overall Study|Abnormal lab value(s)|1|||
156866328|NCT00463567|566271157|FG001|Overall Study|Abnormal lab value(s)|1|||
156866329|NCT00463567|566271158|FG002|Overall Study|Abnormal lab value(s)|2|||
156866330|NCT00463567|566271159|FG003|Overall Study|Abnormal lab value(s)|1|||
156866331|NCT00463567|566271160|FG004|Overall Study|Abnormal lab value(s)|1|||
156866332|NCT00463567|566271161|FG005|Overall Study|Abnormal lab value(s)|0|||
156866333|NCT00463567|566271162|FG006|Overall Study|Abnormal lab value(s)|0|||
156866334|NCT00463567|566271156|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156866335|NCT00463567|566271157|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156866336|NCT00463567|566271158|FG002|Overall Study|Abnormal test procedure result(s)|6|||
156866337|NCT00463567|566271159|FG003|Overall Study|Abnormal test procedure result(s)|2|||
156866338|NCT00463567|566271160|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156866339|NCT00463567|566271161|FG005|Overall Study|Abnormal test procedure result(s)|2|||
156866340|NCT00463567|566271162|FG006|Overall Study|Abnormal test procedure result(s)|0|||
156866341|NCT00463567|566271156|FG000|Overall Study|Death|1|||
156866342|NCT00463567|566271157|FG001|Overall Study|Death|0|||
156866343|NCT00463567|566271158|FG002|Overall Study|Death|2|||
156866344|NCT00463567|566271159|FG003|Overall Study|Death|0|||
156866345|NCT00463567|566271160|FG004|Overall Study|Death|0|||
157009790|NCT01832480|566786755|FG001|Overall Study|post randomization ineligible|10|||
157009791|NCT02261467|566786759|FG000|Overall Study|Enrolled in Error|1|||
157009792|NCT02261467|566786760|FG001|Overall Study|Enrolled in Error|0|||
157009793|NCT02261467|566786759|FG000|Overall Study|Protocol Violation|0|||
156866346|NCT00463567|566271161|FG005|Overall Study|Death|0|||
156866347|NCT00463567|566271162|FG006|Overall Study|Death|0|||
156866348|NCT00641667|566271165|FG000|Overall Study|Withdrawal by Subject|1|||
156866349|NCT00641667|566271165|FG000|Overall Study|Adverse Event|1|||
156866350|NCT00641667|566271165|FG000|Overall Study|Physician Decision|1|||
157009794|NCT02261467|566786760|FG001|Overall Study|Protocol Violation|1|||
157009795|NCT02261467|566786759|FG000|Overall Study|Personal Reasons|17|||
157009796|NCT02261467|566786760|FG001|Overall Study|Personal Reasons|22|||
157009797|NCT02261467|566786759|FG000|Overall Study|Lost to Follow-up|2|||
157009798|NCT02261467|566786760|FG001|Overall Study|Lost to Follow-up|13|||
157009799|NCT02261467|566786759|FG000|Overall Study|Adverse Event|1|||
157009800|NCT02261467|566786760|FG001|Overall Study|Adverse Event|1|||
157009801|NCT00837616|566786771|FG000|Overall Study|Withdrawal by Subject|0|||
157009802|NCT00837616|566786772|FG001|Overall Study|Withdrawal by Subject|1|||
157009803|NCT00736853|566786773|FG000|Open-Label Period|Physician Decision|2|||
157009804|NCT00736853|566786774|FG001|Open-Label Period|Physician Decision|0|||
157009805|NCT00736853|566786775|FG002|Open-Label Period|Physician Decision|0|||
157009806|NCT00736853|566786773|FG000|Open-Label Period|Adverse Event|31|||
157009807|NCT00736853|566786774|FG001|Open-Label Period|Adverse Event|0|||
157009808|NCT00736853|566786775|FG002|Open-Label Period|Adverse Event|0|||
157009809|NCT00736853|566786773|FG000|Open-Label Period|Withdrawal by Subject|16|||
157009810|NCT00736853|566786774|FG001|Open-Label Period|Withdrawal by Subject|0|||
157009811|NCT00736853|566786775|FG002|Open-Label Period|Withdrawal by Subject|0|||
157115706|NCT00183274|567177429|FG000|Phase 1: Open-Label|Other|9|||
157115707|NCT00183274|567177430|FG001|Phase 1: Open-Label|Other|0|||
157115708|NCT00183274|567177431|FG002|Phase 1: Open-Label|Other|0|||
157115709|NCT00183274|567177432|FG003|Phase 1: Open-Label|Other|0|||
157115710|NCT00183274|567177433|FG004|Phase 1: Open-Label|Other|0|||
157115711|NCT00183274|567177434|FG005|Phase 1: Open-Label|Other|0|||
157115712|NCT00183274|567177429|FG000|Phase 2: Double-Blind|Relapsed|0|||
157115713|NCT00183274|567177430|FG001|Phase 2: Double-Blind|Relapsed|8|||
157115714|NCT00183274|567177431|FG002|Phase 2: Double-Blind|Relapsed|29|||
157009812|NCT00736853|566786773|FG000|Open-Label Period|Started but not treated|42|||
157009813|NCT00736853|566786774|FG001|Open-Label Period|Started but not treated|0|||
157009814|NCT00736853|566786775|FG002|Open-Label Period|Started but not treated|0|||
157009815|NCT00736853|566786773|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
157009816|NCT00736853|566786774|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
157009817|NCT00736853|566786775|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
157009818|NCT00736853|566786773|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
157009819|NCT00736853|566786774|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
157009820|NCT00736853|566786775|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
157009821|NCT00736853|566786773|FG000|Double-Blind Period|Lack of Efficacy|0|||
157009822|NCT00736853|566786774|FG001|Double-Blind Period|Lack of Efficacy|19|||
157009823|NCT00736853|566786775|FG002|Double-Blind Period|Lack of Efficacy|42|||
157009824|NCT00736853|566786773|FG000|Double-Blind Period|Adverse Event|0|||
157009825|NCT00736853|566786774|FG001|Double-Blind Period|Adverse Event|3|||
157009826|NCT00736853|566786775|FG002|Double-Blind Period|Adverse Event|2|||
157009827|NCT00736853|566786773|FG000|Double-Blind Period|Withdrawal by Subject|0|||
157009828|NCT00736853|566786774|FG001|Double-Blind Period|Withdrawal by Subject|1|||
157009829|NCT00736853|566786775|FG002|Double-Blind Period|Withdrawal by Subject|4|||
157009830|NCT00736853|566786773|FG000|Double-Blind Period|Ineligible to participate the study|0|||
157009831|NCT00736853|566786774|FG001|Double-Blind Period|Ineligible to participate the study|1|||
157009832|NCT00736853|566786775|FG002|Double-Blind Period|Ineligible to participate the study|0|||
157009833|NCT01597258|566786776|FG000|Overall Study|No Drug Administration|1|||
157009834|NCT03473340|566786777|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
157009835|NCT03473340|566786778|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
157009836|NCT03473340|566786777|FG000|Overall Study|Withdrawal by Subject|1|||
157009837|NCT03473340|566786778|FG001|Overall Study|Withdrawal by Subject|0|||
157009838|NCT03473340|566786777|FG000|Overall Study|Lost to Follow-up|1|||
157009839|NCT03473340|566786778|FG001|Overall Study|Lost to Follow-up|2|||
157009840|NCT03394885|566786780|FG000|Overall Study|Adverse Event|4|||
157009841|NCT03394885|566786780|FG000|Overall Study|Lack of Efficacy|1|||
157009842|NCT03394885|566786780|FG000|Overall Study|Physician Decision|1|||
157009843|NCT03394885|566786780|FG000|Overall Study|Withdrawal by Subject|8|||
157009844|NCT03394885|566786780|FG000|Overall Study|Alternative Therapy|1|||
157009845|NCT00203411|566786781|FG000|Follow-up|Progressive Disease|4|||
157009846|NCT04980755|566786782|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
157009847|NCT04980755|566786782|FG000|Body Reprogramming Courses|Work commitment|2|||
157009848|NCT04980755|566786782|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
157009849|NCT04980755|566786782|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
157009850|NCT01212991|566786785|FG000|Double-blind|Lost to Follow-up|8|||
157009851|NCT01212991|566786786|FG001|Double-blind|Lost to Follow-up|4|||
157009852|NCT01212991|566786787|FG002|Double-blind|Lost to Follow-up|0|||
157009853|NCT01212991|566786785|FG000|Double-blind|Death|699|||
157009854|NCT01212991|566786786|FG001|Double-blind|Death|550|||
157009855|NCT01212991|566786787|FG002|Double-blind|Death|0|||
157009856|NCT01212991|566786785|FG000|Double-blind|Withdrawal by Subject|16|||
157009857|NCT01212991|566786786|FG001|Double-blind|Withdrawal by Subject|19|||
157009858|NCT01212991|566786787|FG002|Double-blind|Withdrawal by Subject|0|||
157009859|NCT01212991|566786785|FG000|Double-blind|Other|7|||
157009860|NCT01212991|566786786|FG001|Double-blind|Other|0|||
157009861|NCT01212991|566786787|FG002|Double-blind|Other|0|||
157009862|NCT01212991|566786785|FG000|Double-blind|Sponsor decision|142|||
157009863|NCT01212991|566786786|FG001|Double-blind|Sponsor decision|38|||
157009864|NCT01212991|566786787|FG002|Double-blind|Sponsor decision|0|||
157009865|NCT01212991|566786785|FG000|Open-label|Death|0|||
157009866|NCT01212991|566786786|FG001|Open-label|Death|0|||
157009867|NCT01212991|566786787|FG002|Open-label|Death|166|||
157009868|NCT01212991|566786785|FG000|Open-label|Lost to Follow-up|0|||
157009869|NCT01212991|566786786|FG001|Open-label|Lost to Follow-up|0|||
157009870|NCT01212991|566786787|FG002|Open-label|Lost to Follow-up|5|||
157009871|NCT01212991|566786785|FG000|Open-label|Withdrawal by Subject|0|||
157009872|NCT01212991|566786786|FG001|Open-label|Withdrawal by Subject|0|||
157009873|NCT01212991|566786787|FG002|Open-label|Withdrawal by Subject|7|||
157009874|NCT01212991|566786785|FG000|Open-label|Sponsor decision|0|||
157009875|NCT01212991|566786786|FG001|Open-label|Sponsor decision|0|||
157009876|NCT01212991|566786787|FG002|Open-label|Sponsor decision|53|||
157009877|NCT01212991|566786785|FG000|Open-label|Other|0|||
157009878|NCT01212991|566786786|FG001|Open-label|Other|0|||
157009879|NCT01212991|566786787|FG002|Open-label|Other|3|||
157009880|NCT02531113|566786790|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
157009881|NCT02531113|566786790|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
157009882|NCT02531113|566786790|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
157115715|NCT00183274|567177432|FG003|Phase 2: Double-Blind|Relapsed|0|||
157009883|NCT02531113|566786790|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
157009884|NCT02531113|566786790|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
157009885|NCT02531113|566786790|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
157009886|NCT02531113|566786790|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
157009887|NCT02531113|566786790|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
157009888|NCT00632424|566786791|FG000|Overall Study|Disease Progression|17|||
157009889|NCT00632424|566786791|FG000|Overall Study|Study Drug Toxicity|1|||
157009890|NCT04411056|566788100|FG000|Overall Study|surgery cancelled|1|||
157009891|NCT04411056|566788101|FG001|Overall Study|surgery cancelled|0|||
157009892|NCT04411056|566788100|FG000|Overall Study|Equipment problem during intubation|0|||
157009893|NCT04411056|566788101|FG001|Overall Study|Equipment problem during intubation|1|||
157009894|NCT04623008|566788102|FG000|Baseline to T2|Withdrawal by Subject|4|||
157009895|NCT04623008|566788103|FG001|Baseline to T2|Withdrawal by Subject|2|||
157209997|NCT00700310|567516888|FG001|Overall Study|Adverse Event|10|||
157209998|NCT00700310|567516889|FG002|Overall Study|Adverse Event|5|||
157209999|NCT00700310|567516890|FG003|Overall Study|Adverse Event|11|||
157210000|NCT00700310|567516887|FG000|Overall Study|Lost to Follow-up|4|||
157210001|NCT00700310|567516888|FG001|Overall Study|Lost to Follow-up|1|||
157210002|NCT00700310|567516889|FG002|Overall Study|Lost to Follow-up|0|||
157210003|NCT00700310|567516890|FG003|Overall Study|Lost to Follow-up|1|||
157210004|NCT00700310|567516887|FG000|Overall Study|Withdrawal by Subject|8|||
157210005|NCT00700310|567516888|FG001|Overall Study|Withdrawal by Subject|9|||
157210006|NCT00700310|567516889|FG002|Overall Study|Withdrawal by Subject|8|||
157210007|NCT00700310|567516890|FG003|Overall Study|Withdrawal by Subject|8|||
157210008|NCT00700310|567516887|FG000|Overall Study|Lack of Efficacy|0|||
157210009|NCT00700310|567516888|FG001|Overall Study|Lack of Efficacy|3|||
157210010|NCT00700310|567516889|FG002|Overall Study|Lack of Efficacy|0|||
157210011|NCT00700310|567516890|FG003|Overall Study|Lack of Efficacy|1|||
157210012|NCT00700310|567516887|FG000|Overall Study|Administrative/Other|1|||
157210013|NCT00700310|567516888|FG001|Overall Study|Administrative/Other|3|||
157210014|NCT00700310|567516889|FG002|Overall Study|Administrative/Other|1|||
157210015|NCT00700310|567516890|FG003|Overall Study|Administrative/Other|3|||
157210016|NCT00700310|567516887|FG000|Overall Study|Randomized, Not Treated|2|||
157210017|NCT00700310|567516888|FG001|Overall Study|Randomized, Not Treated|0|||
157210018|NCT00700310|567516889|FG002|Overall Study|Randomized, Not Treated|2|||
157210019|NCT00700310|567516890|FG003|Overall Study|Randomized, Not Treated|2|||
157210020|NCT02414854|567516891|FG000|Overall Study|Adverse Event|9|||
157210021|NCT02414854|567516892|FG001|Overall Study|Adverse Event|7|||
157210022|NCT02414854|567516893|FG002|Overall Study|Adverse Event|1|||
157210023|NCT02414854|567516894|FG003|Overall Study|Adverse Event|12|||
157210024|NCT02414854|567516891|FG000|Overall Study|Poor compliance to protocol|1|||
157210025|NCT02414854|567516892|FG001|Overall Study|Poor compliance to protocol|1|||
157210026|NCT02414854|567516893|FG002|Overall Study|Poor compliance to protocol|2|||
157210027|NCT02414854|567516894|FG003|Overall Study|Poor compliance to protocol|2|||
157009896|NCT04623008|566788102|FG000|Baseline to T3|Withdrawal by Subject|4|||
157009897|NCT04623008|566788103|FG001|Baseline to T3|Withdrawal by Subject|2|||
157009898|NCT03122886|566788109|FG000|Overall Study|Withdrawal by Subject|1|||
157210028|NCT02414854|567516891|FG000|Overall Study|Other than specified above|12|||
157210029|NCT02414854|567516892|FG001|Overall Study|Other than specified above|37|||
157210030|NCT02414854|567516893|FG002|Overall Study|Other than specified above|17|||
157210031|NCT02414854|567516894|FG003|Overall Study|Other than specified above|37|||
157210032|NCT01422720|567516895|FG000|Overall Study|Adverse Event|16|||
157210033|NCT01422720|567516895|FG000|Overall Study|Lack of Efficacy|1|||
157210034|NCT01422720|567516895|FG000|Overall Study|Withdrawal by Subject|4|||
157210035|NCT01422720|567516895|FG000|Overall Study|Ineligibility|1|||
157210036|NCT00606801|567516896|FG000|Intervention|Protocol Violation|3|||
157210037|NCT00606801|567516897|FG001|Intervention|Protocol Violation|3|||
157210038|NCT02082262|567516898|FG000|Overall Study|Withdrawal by Subject|3|||
157210039|NCT02082262|567516898|FG000|Overall Study|Adverse Event|48|||
157210040|NCT01726335|567516899|FG000|Overall Study|Lost to Follow-up|2|||
157210041|NCT01726335|567516899|FG000|Overall Study|Withdrawal by Subject|15|||
157210042|NCT01726335|567516899|FG000|Overall Study|Adverse Event|4|||
157210043|NCT01726335|567516899|FG000|Overall Study|Lost to Follow-up|2|||
157210044|NCT01726335|567516899|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
157210045|NCT01074307|567516903|FG000|Overall Study|No primary endpoint evaluation|14|||
157210046|NCT01074307|567516904|FG001|Overall Study|No primary endpoint evaluation|6|||
157210047|NCT01074307|567516903|FG000|Overall Study|Exclusion criterion|0|||
157210048|NCT01074307|567516904|FG001|Overall Study|Exclusion criterion|1|||
157210049|NCT01074307|567516903|FG000|Overall Study|Protocol Violation|8|||
157210050|NCT01074307|567516904|FG001|Overall Study|Protocol Violation|5|||
157009899|NCT03122886|566788110|FG001|Overall Study|Withdrawal by Subject|2|||
157210051|NCT02162511|567516909|FG000|Overall Study|Lack of Efficacy|0|||
157210052|NCT02162511|567516910|FG001|Overall Study|Lack of Efficacy|0|||
157210053|NCT02162511|567516911|FG002|Overall Study|Lack of Efficacy|2|||
157210054|NCT02016755|567516916|FG000|Overall Study|Major amputation of index limb|2|||
157210055|NCT02016755|567516916|FG000|Overall Study|Adverse Event|2|||
157210056|NCT02016755|567516916|FG000|Overall Study|Physician Decision|1|||
157210057|NCT02016755|567516916|FG000|Overall Study|Death|2|||
157210058|NCT00552617|567516917|FG000|Overall Study|Not Treated|0|||
156866351|NCT00641667|566271165|FG000|Overall Study|Worsening of underlying disease|3|||
156866352|NCT01124006|566271166|FG000|Overall Study|Withdrawal by Subject|2|||
156866353|NCT01124006|566271167|FG001|Overall Study|Withdrawal by Subject|2|||
156866354|NCT01124006|566271168|FG002|Overall Study|Withdrawal by Subject|0|||
156866355|NCT01124006|566271166|FG000|Overall Study|Lost to Follow-up|1|||
156866356|NCT01124006|566271167|FG001|Overall Study|Lost to Follow-up|0|||
156866357|NCT01124006|566271168|FG002|Overall Study|Lost to Follow-up|1|||
156866358|NCT01124006|566271166|FG000|Overall Study|Other|0|||
156866359|NCT01124006|566271167|FG001|Overall Study|Other|0|||
156866360|NCT01124006|566271168|FG002|Overall Study|Other|1|||
156866361|NCT01712399|566271172|FG000|Overall Study|Lost to Follow-up|1|||
156866362|NCT01712399|566271172|FG000|Overall Study|Withdrawal by Subject|39|||
156866363|NCT01712399|566271172|FG000|Overall Study|Death|1|||
156866364|NCT01712399|566271172|FG000|Overall Study|Adverse Event|11|||
156866365|NCT01712399|566271172|FG000|Overall Study|Study closure|345|||
157009900|NCT02279095|566788118|FG000|Overall Study|Non-Compliance|1|||
157009901|NCT02279095|566788118|FG000|Overall Study|Withdrawal by Subject|8|||
157009902|NCT02279095|566788118|FG000|Overall Study|Adverse Event|2|||
157009903|NCT02279095|566788118|FG000|Overall Study|Other|7|||
157009904|NCT02279095|566788118|FG000|Overall Study|Lost to Follow-up|1|||
157009905|NCT05938413|566788119|FG000|Overall Study|Lost to Follow-up|1|||
157009906|NCT05938413|566788120|FG001|Overall Study|Lost to Follow-up|7|||
157009907|NCT05938413|566788119|FG000|Overall Study|Withdrawal by Subject|1|||
157009908|NCT05938413|566788120|FG001|Overall Study|Withdrawal by Subject|1|||
157009909|NCT04252586|566788122|FG000|Overall Study|Withdrawal by parent/guardian|3|||
157009910|NCT04252586|566788122|FG000|Overall Study|Adverse Event|1|||
157009911|NCT04252586|566788122|FG000|Overall Study|Death|2|||
157009912|NCT04252586|566788122|FG000|Overall Study|Study terminated by sponsor|4|||
157009913|NCT04252586|566788122|FG000|Overall Study|Sponsor request|10|||
157009914|NCT04252586|566788122|FG000|Overall Study|Did not complete treatment period|1|||
157009915|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Death|186|||
157009916|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Death|222|||
157009917|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Death|0|||
157009918|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
157009919|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
157009920|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
157009921|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
157009922|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
157009923|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
157009924|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
157009925|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
157009926|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
157009927|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Adverse Event|83|||
157009928|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Adverse Event|100|||
157009929|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Adverse Event|0|||
157009930|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Other|70|||
157009931|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Other|75|||
157009932|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Other|0|||
157009933|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
156779661|NCT03611946|565942654|FG003|Overall Study|Withdrawal by Subject|0|||
156779662|NCT06717399|565942662|FG000|Overall Study|Death|1|||
156779663|NCT03043573|565942663|FG000|Overall Study|Lost to Follow-up|3|||
156779664|NCT03043573|565942664|FG001|Overall Study|Lost to Follow-up|3|||
156779665|NCT03043573|565942663|FG000|Overall Study|Physician Decision|0|||
156779666|NCT03043573|565942664|FG001|Overall Study|Physician Decision|5|||
156779667|NCT03043573|565942663|FG000|Overall Study|Withdrawal by Subject|0|||
156779668|NCT03043573|565942664|FG001|Overall Study|Withdrawal by Subject|4|||
156779669|NCT04333498|565943825|FG000|Overall Study|Lost to Follow-up|1|||
156779670|NCT04333498|565943826|FG001|Overall Study|Lost to Follow-up|0|||
156779671|NCT04333498|565943825|FG000|Overall Study|Lost to Follow-up|0|||
156779672|NCT04333498|565943826|FG001|Overall Study|Lost to Follow-up|1|||
156779673|NCT00484159|565943827|FG000|Overall Study|Lost to Follow-up|1|||
156779674|NCT00484159|565943828|FG001|Overall Study|Lost to Follow-up|1|||
156779675|NCT00484159|565943829|FG002|Overall Study|Lost to Follow-up|0|||
156779676|NCT04766333|565943830|FG000|Overall Study|Lost to Follow-up|40|||
156779677|NCT04766333|565943831|FG001|Overall Study|Lost to Follow-up|826|||
156779678|NCT01312129|565943832|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
156779679|NCT01312129|565943833|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
156779680|NCT01239680|565943834|FG000|Overall Study|Withdrawal by Subject|2|||
156779681|NCT01239680|565943835|FG001|Overall Study|Withdrawal by Subject|0|||
156779682|NCT02260986|565943838|FG000|Overall Study|Adverse Event|24|||
156779683|NCT02260986|565943839|FG001|Overall Study|Adverse Event|0|||
156779684|NCT02260986|565943840|FG002|Overall Study|Adverse Event|11|||
156779685|NCT02260986|565943838|FG000|Overall Study|Lack of Efficacy|27|||
156779686|NCT02260986|565943839|FG001|Overall Study|Lack of Efficacy|3|||
156779687|NCT02260986|565943840|FG002|Overall Study|Lack of Efficacy|0|||
156779688|NCT02260986|565943838|FG000|Overall Study|Protocol Violation|14|||
156779689|NCT02260986|565943839|FG001|Overall Study|Protocol Violation|5|||
157009934|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
157009935|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
157009936|NCT00232180|566788123|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
157009937|NCT00232180|566788124|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
157009938|NCT00232180|566788125|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
157009939|NCT00232180|566788123|FG000|Open Label Phase|Death|0|||
157009940|NCT00232180|566788124|FG001|Open Label Phase|Death|0|||
157009941|NCT00232180|566788125|FG002|Open Label Phase|Death|48|||
157009942|NCT00232180|566788123|FG000|Open Label Phase|Lost to Follow-up|0|||
157009943|NCT00232180|566788124|FG001|Open Label Phase|Lost to Follow-up|0|||
157009944|NCT00232180|566788125|FG002|Open Label Phase|Lost to Follow-up|5|||
157009945|NCT00232180|566788123|FG000|Open Label Phase|Protocol Violation|0|||
157009946|NCT00232180|566788124|FG001|Open Label Phase|Protocol Violation|0|||
157009947|NCT00232180|566788125|FG002|Open Label Phase|Protocol Violation|3|||
157009948|NCT00232180|566788123|FG000|Open Label Phase|Study terminated by sponsor|0|||
157009949|NCT00232180|566788124|FG001|Open Label Phase|Study terminated by sponsor|0|||
157009950|NCT00232180|566788125|FG002|Open Label Phase|Study terminated by sponsor|3|||
157009951|NCT00232180|566788123|FG000|Open Label Phase|Withdrawal by Subject|0|||
157115716|NCT00183274|567177433|FG004|Phase 2: Double-Blind|Relapsed|0|||
157115717|NCT00183274|567177434|FG005|Phase 2: Double-Blind|Relapsed|0|||
156779690|NCT02260986|565943840|FG002|Overall Study|Protocol Violation|16|||
156779691|NCT02260986|565943838|FG000|Overall Study|Car accident|0|||
156779692|NCT02260986|565943839|FG001|Overall Study|Car accident|0|||
156779693|NCT02260986|565943840|FG002|Overall Study|Car accident|1|||
156779694|NCT02260986|565943838|FG000|Overall Study|Withdrawal by Subject|17|||
156779695|NCT02260986|565943839|FG001|Overall Study|Withdrawal by Subject|4|||
157009952|NCT00232180|566788124|FG001|Open Label Phase|Withdrawal by Subject|0|||
157009953|NCT00232180|566788125|FG002|Open Label Phase|Withdrawal by Subject|37|||
157009954|NCT00232180|566788123|FG000|Open Label Phase|Other|0|||
157009955|NCT00232180|566788124|FG001|Open Label Phase|Other|0|||
157009956|NCT00232180|566788125|FG002|Open Label Phase|Other|16|||
156779696|NCT02260986|565943840|FG002|Overall Study|Withdrawal by Subject|9|||
157009957|NCT00232180|566788123|FG000|Open Label Phase|Adverse Event|0|||
157009958|NCT00232180|566788124|FG001|Open Label Phase|Adverse Event|0|||
157009959|NCT00232180|566788125|FG002|Open Label Phase|Adverse Event|25|||
157009960|NCT00232180|566788123|FG000|Open Label Phase|Laboratory abnormality|0|||
157009961|NCT00232180|566788124|FG001|Open Label Phase|Laboratory abnormality|0|||
157009962|NCT00232180|566788125|FG002|Open Label Phase|Laboratory abnormality|10|||
157009963|NCT00232180|566788123|FG000|Open Label Phase|Randomized but not treated|0|||
157009964|NCT00232180|566788124|FG001|Open Label Phase|Randomized but not treated|0|||
157009965|NCT00232180|566788125|FG002|Open Label Phase|Randomized but not treated|1|||
157009966|NCT02748317|566788126|FG000|Overall Study|Withdrawal by Subject|14|||
157009967|NCT02748317|566788126|FG000|Overall Study|Lost to Follow-up|8|||
157009968|NCT02748317|566788126|FG000|Overall Study|Death|1|||
157009969|NCT03452189|566788127|FG000|First Intervention (3 Months)|Adverse Event|1|||
157009970|NCT03452189|566788128|FG001|First Intervention (3 Months)|Adverse Event|0|||
157009971|NCT03452189|566788127|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
157009972|NCT03452189|566788128|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
157009973|NCT02724592|566788129|FG000|Overall Study|Lost to Follow-up|4|||
157009974|NCT02724592|566788130|FG001|Overall Study|Lost to Follow-up|1|||
157210059|NCT00552617|567516918|FG001|Overall Study|Not Treated|0|||
157210060|NCT00552617|567516919|FG002|Overall Study|Not Treated|1|||
157009975|NCT00434304|566788131|FG000|Overall Study|Adverse Event|14|||
157009976|NCT00434304|566788131|FG000|Overall Study|Lack of Efficacy|2|||
157009977|NCT00434304|566788131|FG000|Overall Study|Withdrawal by Subject|4|||
157009978|NCT05262738|566788132|FG000|Overall Study|Withdrawal by Subject|1|||
157210061|NCT00552617|567516920|FG003|Overall Study|Not Treated|0|||
157210062|NCT00552617|567516921|FG004|Overall Study|Not Treated|0|||
157210063|NCT00552617|567516922|FG005|Overall Study|Not Treated|0|||
157210064|NCT00552617|567516923|FG006|Overall Study|Not Treated|0|||
157210065|NCT00552617|567516924|FG007|Overall Study|Not Treated|0|||
157210066|NCT00552617|567516925|FG008|Overall Study|Not Treated|0|||
157210067|NCT00552617|567516926|FG009|Overall Study|Not Treated|1|||
157210068|NCT00552617|567516917|FG000|Overall Study|Lost to Follow-up|0|||
157210069|NCT00552617|567516918|FG001|Overall Study|Lost to Follow-up|0|||
157210070|NCT00552617|567516919|FG002|Overall Study|Lost to Follow-up|0|||
157210071|NCT00552617|567516920|FG003|Overall Study|Lost to Follow-up|1|||
157210072|NCT00552617|567516921|FG004|Overall Study|Lost to Follow-up|0|||
157210073|NCT00552617|567516922|FG005|Overall Study|Lost to Follow-up|2|||
157210074|NCT00552617|567516923|FG006|Overall Study|Lost to Follow-up|0|||
157210075|NCT00552617|567516924|FG007|Overall Study|Lost to Follow-up|0|||
157210076|NCT00552617|567516925|FG008|Overall Study|Lost to Follow-up|2|||
157210077|NCT00552617|567516926|FG009|Overall Study|Lost to Follow-up|0|||
157210078|NCT01084603|567516936|FG000|Baseline|Withdrawal by Subject|2|||
157210079|NCT01084603|567516936|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
157210080|NCT01084603|567516936|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
157210081|NCT01084603|567516936|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
157210082|NCT01084603|567516936|FG000|Washout Period 4|Adverse Event|1|||
157210083|NCT01392170|567516938|FG000|Overall Study|Withdrawal by Subject|1|||
157210084|NCT01392170|567516938|FG000|Overall Study|Ineligible|1|||
157210085|NCT02748616|567516945|FG000|Overall Study|Lost to Follow-up|1|||
157210086|NCT02748616|567516945|FG000|Overall Study|Withdrawal by Subject|2|||
157210087|NCT02748616|567516945|FG000|Overall Study|Physician Decision|2|||
157210088|NCT02748616|567516945|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
157210089|NCT04075292|567516946|FG000|Overall Study|Withdrawal by Subject|1|||
157210090|NCT04075292|567516947|FG001|Overall Study|Withdrawal by Subject|9|||
157210091|NCT04075292|567516946|FG000|Overall Study|Death|2|||
157210092|NCT04075292|567516947|FG001|Overall Study|Death|5|||
157210093|NCT04075292|567516946|FG000|Overall Study|Remained on study at time of DCO|74|||
157210094|NCT04075292|567516947|FG001|Overall Study|Remained on study at time of DCO|64|||
157210095|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
157210096|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
157210097|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
157210098|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
157210099|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
157210100|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
157210101|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
157009979|NCT05262738|566788133|FG001|Overall Study|Withdrawal by Subject|0|||
157210102|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
157210103|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
157210104|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
157009980|NCT01424397|566788136|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009981|NCT01424397|566788137|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
157210105|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
157210106|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
157210107|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
157210108|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
157009982|NCT01424397|566788138|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
157009983|NCT01424397|566788139|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009984|NCT01424397|566788140|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009985|NCT01424397|566788141|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009986|NCT01424397|566788142|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009987|NCT01424397|566788143|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009988|NCT01424397|566788144|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
157115718|NCT00183274|567177429|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
157009989|NCT01424397|566788145|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009990|NCT01424397|566788146|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
157009991|NCT01424397|566788147|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
156779697|NCT02260986|565943838|FG000|Overall Study|Incorrect randomization|0|||
156779698|NCT02260986|565943839|FG001|Overall Study|Incorrect randomization|1|||
157009992|NCT01951170|566788149|FG000|Overall Study|Investigator decision|1|||
157009993|NCT02601820|566788161|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
157009994|NCT02601820|566788161|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
157009995|NCT02601820|566788161|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
157009996|NCT02601820|566788161|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
157009997|NCT01972724|566788162|FG000|Double-Blind|Rescue Criteria Met|1|||
157009998|NCT01972724|566788163|FG001|Double-Blind|Rescue Criteria Met|0|||
157009999|NCT01972724|566788164|FG002|Double-Blind|Rescue Criteria Met|0|||
157010000|NCT01972724|566788162|FG000|Double-Blind|Adverse Event|1|||
157010001|NCT01972724|566788163|FG001|Double-Blind|Adverse Event|0|||
157010002|NCT01972724|566788164|FG002|Double-Blind|Adverse Event|0|||
157010003|NCT01972724|566788162|FG000|Double-Blind|Withdrawal of Consent|2|||
157010004|NCT01972724|566788163|FG001|Double-Blind|Withdrawal of Consent|1|||
157010005|NCT01972724|566788164|FG002|Double-Blind|Withdrawal of Consent|0|||
157010006|NCT01972724|566788162|FG000|Double-Blind|Significant Protocol Deviation|5|||
157010007|NCT01972724|566788163|FG001|Double-Blind|Significant Protocol Deviation|8|||
157010008|NCT01972724|566788164|FG002|Double-Blind|Significant Protocol Deviation|0|||
157010009|NCT01972724|566788162|FG000|Open-Label|Withdrew Consent|0|||
157010010|NCT01972724|566788163|FG001|Open-Label|Withdrew Consent|0|||
157010011|NCT01972724|566788164|FG002|Open-Label|Withdrew Consent|3|||
157010012|NCT01972724|566788162|FG000|Open-Label|Significant Protocol Deviation|0|||
157010013|NCT01972724|566788163|FG001|Open-Label|Significant Protocol Deviation|0|||
157010014|NCT01972724|566788164|FG002|Open-Label|Significant Protocol Deviation|2|||
157010015|NCT02675244|566788165|FG000|Overall Study|Death|9|||
157010016|NCT02675244|566788166|FG001|Overall Study|Death|6|||
157010017|NCT02675244|566788165|FG000|Overall Study|Withdrawal by Subject|3|||
157010018|NCT02675244|566788166|FG001|Overall Study|Withdrawal by Subject|6|||
157010019|NCT02675244|566788165|FG000|Overall Study|Lost to Follow-up|1|||
157010020|NCT02675244|566788166|FG001|Overall Study|Lost to Follow-up|1|||
157010021|NCT02675244|566788165|FG000|Overall Study|Ongoing at 2 Years|190|||
157010022|NCT02675244|566788166|FG001|Overall Study|Ongoing at 2 Years|185|||
157010023|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
157010024|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
157010025|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
157010026|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
157010027|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
157010028|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
157010029|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
157010030|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
157010031|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
157010032|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
157010033|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
157010034|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
157010035|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
157010036|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
157010037|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
157010038|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
157010039|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
157010040|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
157010041|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
157010042|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
157010043|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
157010044|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
157010045|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
157010046|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
157010047|NCT01061151|566788174|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
156866366|NCT01357850|566271173|FG000|Overall Study|Lost to Follow-up|1|||
156866367|NCT01357850|566271174|FG001|Overall Study|Lost to Follow-up|0|||
156866368|NCT01357850|566271175|FG002|Overall Study|Lost to Follow-up|0|||
156866369|NCT01357850|566271176|FG003|Overall Study|Lost to Follow-up|0|||
156866370|NCT04610281|566271177|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
156866371|NCT04610281|566271178|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
156866372|NCT01803607|566271180|FG000|Overall Study|Adverse Event|5|||
156866373|NCT01803607|566271181|FG001|Overall Study|Adverse Event|3|||
156866374|NCT01803607|566271180|FG000|Overall Study|Lack of Efficacy|0|||
156866375|NCT01803607|566271181|FG001|Overall Study|Lack of Efficacy|1|||
157010048|NCT01061151|566788175|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
157010049|NCT01061151|566788176|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
157010050|NCT01061151|566788177|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
157010051|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
157210109|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
157210110|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
157210111|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
157210112|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
157010052|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
157010053|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
157010054|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
157010055|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
157010056|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
157210113|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
157210114|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
157210115|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
157210116|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
157210117|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
157210118|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
157210119|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
157210120|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
157210121|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
157210122|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
157210123|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
157210124|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
157210125|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
157210126|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
157210127|NCT03747939|567516950|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
157210128|NCT03747939|567516951|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
157210129|NCT03747939|567516952|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
157210130|NCT03747939|567516953|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
157210131|NCT03747939|567516950|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
157210132|NCT03747939|567516951|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
157210133|NCT03747939|567516952|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
157210134|NCT03747939|567516953|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
157210135|NCT03747939|567516950|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
157210136|NCT03747939|567516951|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
157210137|NCT03747939|567516952|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
157210138|NCT03747939|567516953|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
157210139|NCT03747939|567516950|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
157210140|NCT03747939|567516951|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
157210141|NCT03747939|567516952|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
157210142|NCT03747939|567516953|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
157210143|NCT03747939|567516950|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
157210144|NCT03747939|567516951|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
157210145|NCT03747939|567516952|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
157210146|NCT03747939|567516953|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
157210147|NCT03747939|567516950|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
157210148|NCT03747939|567516951|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
157210149|NCT03747939|567516952|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
157210150|NCT03747939|567516953|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
157210151|NCT01447628|567516954|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
157210152|NCT01447628|567516955|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
157210153|NCT01447628|567516956|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
157210154|NCT01447628|567516957|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
157210155|NCT03087773|567516958|FG000|Overall Study|Withdrawal by Subject|8|||
157210156|NCT03087773|567516959|FG001|Overall Study|Withdrawal by Subject|4|||
157210157|NCT03087773|567516958|FG000|Overall Study|Lost to Follow-up|12|||
157210158|NCT03087773|567516959|FG001|Overall Study|Lost to Follow-up|8|||
157210159|NCT00627458|567516962|FG000|Overall Study|Migrated from study area|1|||
157210160|NCT00627458|567516963|FG001|Overall Study|Migrated from study area|0|||
157210161|NCT00627458|567516964|FG002|Overall Study|Migrated from study area|1|||
157210162|NCT00627458|567516962|FG000|Overall Study|Withdrawal by Subject|2|||
157210163|NCT00627458|567516963|FG001|Overall Study|Withdrawal by Subject|6|||
157210164|NCT00627458|567516964|FG002|Overall Study|Withdrawal by Subject|5|||
157210165|NCT00627458|567516962|FG000|Overall Study|Lost to Follow-up|1|||
157210166|NCT00627458|567516963|FG001|Overall Study|Lost to Follow-up|1|||
157210167|NCT00627458|567516964|FG002|Overall Study|Lost to Follow-up|0|||
157210168|NCT03959137|567516965|FG000|Overall Study|Protocol Violation|6|||
157210169|NCT00810615|567516966|FG000|Overall Study|Withdrawal by Subject|1|||
157210170|NCT00810615|567516967|FG001|Overall Study|Withdrawal by Subject|1|||
157210171|NCT01766310|567516969|FG000|Overall Study|Lost to Follow-up|1|||
157210172|NCT01766310|567516970|FG001|Overall Study|Lost to Follow-up|3|||
157210173|NCT01289990|567516973|FG000|Overall Study|Death|0|||
157210174|NCT01289990|567516974|FG001|Overall Study|Death|0|||
157210175|NCT01289990|567516975|FG002|Overall Study|Death|0|||
157210176|NCT01289990|567516976|FG003|Overall Study|Death|1|||
157210177|NCT01289990|567516977|FG004|Overall Study|Death|2|||
157210178|NCT01289990|567516978|FG005|Overall Study|Death|1|||
157210179|NCT01289990|567516979|FG006|Overall Study|Death|0|||
157210180|NCT01289990|567516980|FG007|Overall Study|Death|0|||
157210181|NCT01289990|567516981|FG008|Overall Study|Death|0|||
157210182|NCT01289990|567516982|FG009|Overall Study|Death|0|||
157010057|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
157010058|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
157010059|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
157010060|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
157010061|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
157010062|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
157010063|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
157010064|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
157010065|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
157010066|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
157010067|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
157010068|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
157210183|NCT01289990|567516983|FG010|Overall Study|Death|0|||
157010069|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
157010070|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
157010071|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
157010072|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
157010073|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
157010074|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
157210184|NCT01289990|567516984|FG011|Overall Study|Death|1|||
156866376|NCT01803607|566271180|FG000|Overall Study|Protocol Violation|3|||
157010075|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
157010076|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
157210185|NCT01289990|567516985|FG012|Overall Study|Death|0|||
156866377|NCT01803607|566271181|FG001|Overall Study|Protocol Violation|2|||
156779699|NCT02260986|565943840|FG002|Overall Study|Incorrect randomization|0|||
156779700|NCT02260986|565943838|FG000|Overall Study|Lack of investigation product supply|2|||
156779701|NCT02260986|565943839|FG001|Overall Study|Lack of investigation product supply|0|||
156779702|NCT02260986|565943840|FG002|Overall Study|Lack of investigation product supply|1|||
156779703|NCT02260986|565943838|FG000|Overall Study|Lost to Follow-up|4|||
156779704|NCT02260986|565943839|FG001|Overall Study|Lost to Follow-up|0|||
156779705|NCT02260986|565943840|FG002|Overall Study|Lost to Follow-up|3|||
156779706|NCT02260986|565943838|FG000|Overall Study|Pregnancy|2|||
156779707|NCT02260986|565943839|FG001|Overall Study|Pregnancy|0|||
156779708|NCT02260986|565943840|FG002|Overall Study|Pregnancy|0|||
156779709|NCT00313170|565943842|FG000|Overall Study|Death|2|||
156779710|NCT00313170|565943843|FG001|Overall Study|Death|4|||
156866378|NCT01803607|566271180|FG000|Overall Study|Study terminated by sponsor|54|||
156866379|NCT01803607|566271181|FG001|Overall Study|Study terminated by sponsor|56|||
156866380|NCT01803607|566271180|FG000|Overall Study|Withdrawal by Subject|6|||
156866381|NCT01803607|566271181|FG001|Overall Study|Withdrawal by Subject|5|||
156866382|NCT02266888|566271192|FG000|Overall Study|Death|2|||
156866383|NCT02266888|566271193|FG001|Overall Study|Death|2|||
156866384|NCT02266888|566271194|FG002|Overall Study|Death|4|||
156866385|NCT02266888|566271195|FG003|Overall Study|Death|2|||
156866386|NCT02266888|566271192|FG000|Overall Study|Physician Decision|0|||
156866387|NCT02266888|566271193|FG001|Overall Study|Physician Decision|1|||
156866388|NCT02266888|566271194|FG002|Overall Study|Physician Decision|2|||
156866389|NCT02266888|566271195|FG003|Overall Study|Physician Decision|2|||
156866390|NCT02266888|566271192|FG000|Overall Study|Study Terminated|5|||
156866391|NCT02266888|566271193|FG001|Overall Study|Study Terminated|1|||
156866392|NCT02266888|566271194|FG002|Overall Study|Study Terminated|0|||
156866393|NCT02266888|566271195|FG003|Overall Study|Study Terminated|0|||
156866394|NCT02266888|566271192|FG000|Overall Study|No Longer Eligible|0|||
156866395|NCT02266888|566271193|FG001|Overall Study|No Longer Eligible|0|||
156866396|NCT02266888|566271194|FG002|Overall Study|No Longer Eligible|0|||
156866397|NCT02266888|566271195|FG003|Overall Study|No Longer Eligible|2|||
156866398|NCT02266888|566271192|FG000|Overall Study|Randomization Closed|0|||
156866399|NCT02266888|566271193|FG001|Overall Study|Randomization Closed|0|||
156866400|NCT02266888|566271194|FG002|Overall Study|Randomization Closed|4|||
156866401|NCT02266888|566271195|FG003|Overall Study|Randomization Closed|0|||
156866402|NCT02266888|566271192|FG000|Overall Study|Personnel unavailable at transplant|0|||
156866403|NCT02266888|566271193|FG001|Overall Study|Personnel unavailable at transplant|0|||
156866404|NCT02266888|566271194|FG002|Overall Study|Personnel unavailable at transplant|0|||
156866405|NCT02266888|566271195|FG003|Overall Study|Personnel unavailable at transplant|1|||
156866406|NCT02266888|566271192|FG000|Overall Study|Transfer of care|0|||
156866407|NCT02266888|566271193|FG001|Overall Study|Transfer of care|0|||
156866408|NCT02266888|566271194|FG002|Overall Study|Transfer of care|1|||
156866409|NCT02266888|566271195|FG003|Overall Study|Transfer of care|0|||
156866410|NCT02351856|566271196|FG000|Overall Study|Adverse Event|2|||
156866411|NCT02351856|566271196|FG000|Overall Study|Physician Decision|5|||
156866412|NCT02351856|566271196|FG000|Overall Study|Study terminated by sponsor|1|||
156866413|NCT01458392|566271201|FG000|Overall Study|Death|2|||
156866414|NCT01458392|566271202|FG001|Overall Study|Death|11|||
156866415|NCT01458392|566271203|FG002|Overall Study|Death|22|||
156779711|NCT00313170|565943844|FG002|Overall Study|Death|2|||
156866416|NCT01458392|566271201|FG000|Overall Study|At the discretion of the sponsor|0|||
156866417|NCT01458392|566271202|FG001|Overall Study|At the discretion of the sponsor|2|||
156866418|NCT01458392|566271203|FG002|Overall Study|At the discretion of the sponsor|7|||
156866419|NCT01458392|566271201|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
156866420|NCT01458392|566271202|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
156866421|NCT01458392|566271203|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
156866422|NCT01281124|566271212|FG000|Overall Study|Death|1|||
156866423|NCT01198795|566271213|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
157210186|NCT01289990|567516973|FG000|Overall Study|Lost to Follow-up|3|||
157210187|NCT01289990|567516974|FG001|Overall Study|Lost to Follow-up|2|||
157210188|NCT01289990|567516975|FG002|Overall Study|Lost to Follow-up|5|||
157210189|NCT01289990|567516976|FG003|Overall Study|Lost to Follow-up|5|||
157210190|NCT01289990|567516977|FG004|Overall Study|Lost to Follow-up|3|||
157210191|NCT01289990|567516978|FG005|Overall Study|Lost to Follow-up|4|||
157210192|NCT01289990|567516979|FG006|Overall Study|Lost to Follow-up|2|||
157210193|NCT01289990|567516980|FG007|Overall Study|Lost to Follow-up|2|||
157210194|NCT01289990|567516981|FG008|Overall Study|Lost to Follow-up|1|||
157210195|NCT01289990|567516982|FG009|Overall Study|Lost to Follow-up|4|||
157210196|NCT01289990|567516983|FG010|Overall Study|Lost to Follow-up|2|||
157010077|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
157010078|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
157010079|NCT01061151|566788174|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
157010080|NCT01061151|566788175|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
157010081|NCT01061151|566788176|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
157010082|NCT01061151|566788177|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
157010083|NCT03292913|566788178|FG000|Overall Study|Death|9|||
157010084|NCT03292913|566788179|FG001|Overall Study|Death|3|||
157010085|NCT03292913|566788178|FG000|Overall Study|Lost to Follow-up|49|||
157010086|NCT03292913|566788179|FG001|Overall Study|Lost to Follow-up|49|||
157010087|NCT03292913|566788178|FG000|Overall Study|Withdrawal by Subject|2|||
157010088|NCT03292913|566788179|FG001|Overall Study|Withdrawal by Subject|0|||
157010089|NCT03292913|566788178|FG000|Overall Study|Clinic closed due to COVID|22|||
157010090|NCT03292913|566788179|FG001|Overall Study|Clinic closed due to COVID|36|||
157010091|NCT04056624|566788180|FG000|Overall Study|Withdrawal by Subject|0|||
157010092|NCT04056624|566788181|FG001|Overall Study|Withdrawal by Subject|0|||
157010093|NCT04056624|566788182|FG002|Overall Study|Withdrawal by Subject|1|||
157010094|NCT04056624|566788180|FG000|Overall Study|Protocol Violation|1|||
157010095|NCT04056624|566788181|FG001|Overall Study|Protocol Violation|2|||
157010096|NCT04056624|566788182|FG002|Overall Study|Protocol Violation|0|||
157010097|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
157010098|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
157010099|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
157010100|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
157010101|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
157010102|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
157010103|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
157010104|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
157010105|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
157010106|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
157010107|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
157010108|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
157010109|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
157010110|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
157010111|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
157010112|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
157010113|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
157010114|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
157010115|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
157010116|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
157010117|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
157010118|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
157010119|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
157010120|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
157010121|NCT00311363|566788191|FG000|24-Week Single-Blind Treatment Period|Death|1|||
157010122|NCT00311363|566788192|FG001|24-Week Single-Blind Treatment Period|Death|0|||
157010123|NCT00311363|566788193|FG002|24-Week Single-Blind Treatment Period|Death|0|||
157010124|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
157010125|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
157010126|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
157010127|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
157010128|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
157010129|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
157010130|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
157010131|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
157010132|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
157010133|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
157010134|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
157010135|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
157010136|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
157010137|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
157010138|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
157010139|NCT00311363|566788191|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
157010140|NCT00311363|566788192|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
156866424|NCT01198795|566271213|FG000|Overall Study|Withdrawal by Subject|17|||
156866425|NCT01198795|566271213|FG000|Overall Study|Lost to Follow-up|15|||
156866426|NCT01198795|566271213|FG000|Overall Study|Adverse Event|9|||
156866427|NCT01198795|566271213|FG000|Overall Study|Lack of Efficacy|5|||
156866428|NCT01198795|566271213|FG000|Overall Study|Protocol Violation|2|||
156866429|NCT01198795|566271213|FG000|Overall Study|Other Reason|4|||
156866430|NCT03038100|566271214|FG000|Overall Study|Death|289|||
156866431|NCT03038100|566271215|FG001|Overall Study|Death|272|||
156866432|NCT03038100|566271214|FG000|Overall Study|Lost to Follow-up|9|||
156866433|NCT03038100|566271215|FG001|Overall Study|Lost to Follow-up|10|||
156866434|NCT03038100|566271214|FG000|Overall Study|Protocol Deviation|1|||
156866435|NCT03038100|566271215|FG001|Overall Study|Protocol Deviation|4|||
157210197|NCT01289990|567516984|FG011|Overall Study|Lost to Follow-up|1|||
156866436|NCT03038100|566271214|FG000|Overall Study|Withdrawal by Subject|45|||
156866437|NCT03038100|566271215|FG001|Overall Study|Withdrawal by Subject|51|||
157210198|NCT01289990|567516985|FG012|Overall Study|Lost to Follow-up|2|||
157210199|NCT01289990|567516973|FG000|Overall Study|Withdrawal by Subject|15|||
157210200|NCT01289990|567516974|FG001|Overall Study|Withdrawal by Subject|14|||
157010141|NCT00311363|566788193|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
157010142|NCT03811574|566788196|FG000|Overall Study|Withdrawal by Subject|2|||
157010143|NCT03811574|566788197|FG001|Overall Study|Withdrawal by Subject|4|||
157010144|NCT03811574|566788198|FG002|Overall Study|Withdrawal by Subject|0|||
157210201|NCT01289990|567516975|FG002|Overall Study|Withdrawal by Subject|12|||
157210202|NCT01289990|567516976|FG003|Overall Study|Withdrawal by Subject|13|||
156866438|NCT03038100|566271214|FG000|Overall Study|Study Terminated By Sponsor|305|||
156866439|NCT03038100|566271215|FG001|Overall Study|Study Terminated By Sponsor|311|||
156866440|NCT03038100|566271214|FG000|Overall Study|Physician Decision|1|||
156866441|NCT03038100|566271215|FG001|Overall Study|Physician Decision|3|||
156866442|NCT02038933|566271216|FG000|Overall Study|Disease progression|104|||
156866443|NCT02038933|566271216|FG000|Overall Study|Study drug toxicity|6|||
156866444|NCT02038933|566271216|FG000|Overall Study|Adverse event unrelated to study drug|6|||
156866445|NCT02038933|566271216|FG000|Overall Study|Participant request to discontinue treatment|2|||
156866446|NCT02038933|566271216|FG000|Overall Study|Lost to Follow-up|1|||
156866447|NCT02038933|566271216|FG000|Overall Study|Other reasons|2|||
156866448|NCT03250273|566271249|FG000|Overall Study|Disease Progression|2|||
156866449|NCT03250273|566271250|FG001|Overall Study|Disease Progression|11|||
157210203|NCT01289990|567516977|FG004|Overall Study|Withdrawal by Subject|8|||
157210204|NCT01289990|567516978|FG005|Overall Study|Withdrawal by Subject|7|||
157210205|NCT01289990|567516979|FG006|Overall Study|Withdrawal by Subject|13|||
157210206|NCT01289990|567516980|FG007|Overall Study|Withdrawal by Subject|9|||
157210207|NCT01289990|567516981|FG008|Overall Study|Withdrawal by Subject|12|||
157210208|NCT01289990|567516982|FG009|Overall Study|Withdrawal by Subject|13|||
156866450|NCT03250273|566271249|FG000|Overall Study|Death|0|||
156866451|NCT03250273|566271250|FG001|Overall Study|Death|1|||
156866452|NCT00706238|566271251|FG000|Overall Study|Disease progression|4|||
156866453|NCT00706238|566271251|FG000|Overall Study|Other|1|||
156866454|NCT00936715|566271252|FG000|Overall Study|Investigators Discretion|1|||
156866455|NCT00936715|566271252|FG000|Overall Study|Protocol Violation|1|||
156866456|NCT00936715|566271252|FG000|Overall Study|Safety or Tolerability Reasons|4|||
156866457|NCT01337960|566271255|FG000|Overall Study|Lost to Follow-up|1|||
157210209|NCT01289990|567516983|FG010|Overall Study|Withdrawal by Subject|11|||
157210210|NCT01289990|567516984|FG011|Overall Study|Withdrawal by Subject|13|||
157210211|NCT01289990|567516985|FG012|Overall Study|Withdrawal by Subject|16|||
157210212|NCT01289990|567516973|FG000|Overall Study|discontinued in preceding trial|18|||
157210213|NCT01289990|567516974|FG001|Overall Study|discontinued in preceding trial|20|||
157210214|NCT01289990|567516975|FG002|Overall Study|discontinued in preceding trial|41|||
157210215|NCT01289990|567516976|FG003|Overall Study|discontinued in preceding trial|17|||
157210216|NCT01289990|567516977|FG004|Overall Study|discontinued in preceding trial|11|||
157210217|NCT01289990|567516978|FG005|Overall Study|discontinued in preceding trial|12|||
157210218|NCT01289990|567516979|FG006|Overall Study|discontinued in preceding trial|18|||
157210219|NCT01289990|567516980|FG007|Overall Study|discontinued in preceding trial|8|||
157210220|NCT01289990|567516981|FG008|Overall Study|discontinued in preceding trial|17|||
157210221|NCT01289990|567516982|FG009|Overall Study|discontinued in preceding trial|21|||
157210222|NCT01289990|567516983|FG010|Overall Study|discontinued in preceding trial|17|||
157210223|NCT01289990|567516984|FG011|Overall Study|discontinued in preceding trial|17|||
157210224|NCT01289990|567516985|FG012|Overall Study|discontinued in preceding trial|24|||
157210225|NCT01289990|567516973|FG000|Overall Study|did not continue in extension|41|||
157210226|NCT01289990|567516974|FG001|Overall Study|did not continue in extension|45|||
157210227|NCT01289990|567516975|FG002|Overall Study|did not continue in extension|51|||
157210228|NCT01289990|567516976|FG003|Overall Study|did not continue in extension|51|||
157210229|NCT01289990|567516977|FG004|Overall Study|did not continue in extension|48|||
157210230|NCT01289990|567516978|FG005|Overall Study|did not continue in extension|50|||
157210231|NCT01289990|567516979|FG006|Overall Study|did not continue in extension|54|||
157210232|NCT01289990|567516980|FG007|Overall Study|did not continue in extension|36|||
157210233|NCT01289990|567516981|FG008|Overall Study|did not continue in extension|44|||
157210234|NCT01289990|567516982|FG009|Overall Study|did not continue in extension|48|||
157210235|NCT01289990|567516983|FG010|Overall Study|did not continue in extension|45|||
157210236|NCT01289990|567516984|FG011|Overall Study|did not continue in extension|34|||
157210237|NCT01289990|567516985|FG012|Overall Study|did not continue in extension|56|||
157210238|NCT01289990|567516973|FG000|Overall Study|Not treated|0|||
157210239|NCT01289990|567516974|FG001|Overall Study|Not treated|0|||
157210240|NCT01289990|567516975|FG002|Overall Study|Not treated|0|||
157210241|NCT01289990|567516976|FG003|Overall Study|Not treated|0|||
157210242|NCT01289990|567516977|FG004|Overall Study|Not treated|0|||
157210243|NCT01289990|567516978|FG005|Overall Study|Not treated|0|||
157210244|NCT01289990|567516979|FG006|Overall Study|Not treated|1|||
157210245|NCT01289990|567516980|FG007|Overall Study|Not treated|0|||
157210246|NCT01289990|567516981|FG008|Overall Study|Not treated|1|||
157210247|NCT01289990|567516982|FG009|Overall Study|Not treated|0|||
157210248|NCT01289990|567516983|FG010|Overall Study|Not treated|1|||
157210249|NCT01289990|567516984|FG011|Overall Study|Not treated|2|||
157210250|NCT01289990|567516985|FG012|Overall Study|Not treated|0|||
157210251|NCT02441179|567516987|FG000|Overall Study|Withdrawal by Subject|1|||
157210252|NCT02441179|567516988|FG001|Overall Study|Withdrawal by Subject|1|||
157210253|NCT03454672|567516989|FG000|Overall Study|Adverse Event|1|||
157210254|NCT03454672|567516990|FG001|Overall Study|Adverse Event|1|||
157210255|NCT03454672|567516989|FG000|Overall Study|Lost to Follow-up|1|||
157210256|NCT03454672|567516990|FG001|Overall Study|Lost to Follow-up|3|||
157210257|NCT03454672|567516989|FG000|Overall Study|painful|1|||
157210258|NCT03454672|567516990|FG001|Overall Study|painful|2|||
157210259|NCT03454672|567516989|FG000|Overall Study|Non-compliance|2|||
157210260|NCT03454672|567516990|FG001|Overall Study|Non-compliance|4|||
157210261|NCT03454672|567516989|FG000|Overall Study|personal reasons|3|||
157210262|NCT03454672|567516990|FG001|Overall Study|personal reasons|2|||
157210263|NCT03454672|567516989|FG000|Overall Study|Withdrawal by Subject|1|||
157210264|NCT03454672|567516990|FG001|Overall Study|Withdrawal by Subject|0|||
157210265|NCT02139306|567516991|FG000|Overall Study|Withdrawal by Subject|4|||
157210266|NCT02139306|567516992|FG001|Overall Study|Withdrawal by Subject|6|||
157210267|NCT02139306|567516991|FG000|Overall Study|Adverse Event|3|||
157210268|NCT02139306|567516992|FG001|Overall Study|Adverse Event|4|||
157210269|NCT02139306|567516991|FG000|Overall Study|Physician Decision|0|||
157210270|NCT02139306|567516992|FG001|Overall Study|Physician Decision|1|||
157210271|NCT02139306|567516991|FG000|Overall Study|Other Unspecified|2|||
157210272|NCT02139306|567516992|FG001|Overall Study|Other Unspecified|3|||
157210273|NCT02139306|567516991|FG000|Overall Study|Protocol Violation|4|||
157210274|NCT02139306|567516992|FG001|Overall Study|Protocol Violation|0|||
156866458|NCT01337960|566271256|FG001|Overall Study|Lost to Follow-up|0|||
156866459|NCT01337960|566271257|FG002|Overall Study|Lost to Follow-up|0|||
157210275|NCT01220128|567516993|FG000|Overall Study|Progressive disease|0|||
157210276|NCT01220128|567516994|FG001|Overall Study|Progressive disease|0|||
156779712|NCT00313170|565943842|FG000|Overall Study|Adverse Event|1|||
157010145|NCT01764464|566788205|FG000|First Intervention|Withdrawal by Subject|1|||
157010146|NCT01764464|566788206|FG001|First Intervention|Withdrawal by Subject|0|||
157010147|NCT01764464|566788205|FG000|First Intervention|Lost to Follow-up|1|||
157010148|NCT01764464|566788206|FG001|First Intervention|Lost to Follow-up|0|||
157010149|NCT01764464|566788205|FG000|First Intervention|Adverse Event|0|||
157010150|NCT01764464|566788206|FG001|First Intervention|Adverse Event|2|||
157010151|NCT01764464|566788205|FG000|First Intervention|did not receive study drug|0|||
157010152|NCT01764464|566788206|FG001|First Intervention|did not receive study drug|1|||
157010153|NCT01764464|566788205|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
157010154|NCT01764464|566788206|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
157010155|NCT02079844|566788209|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
157010156|NCT02079844|566788210|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
157010157|NCT02079844|566788211|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
157010158|NCT02079844|566788209|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
157010159|NCT02079844|566788210|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
157010160|NCT02079844|566788211|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
157010161|NCT00801983|566788214|FG000|Period 1|Lost to Follow-up|2|||
157010162|NCT00801983|566788215|FG001|Period 1|Lost to Follow-up|0|||
157010163|NCT00801983|566788214|FG000|Period 1|Withdrawal by Subject|2|||
157010164|NCT00801983|566788215|FG001|Period 1|Withdrawal by Subject|8|||
157010165|NCT00801983|566788214|FG000|Period 2|Withdrawal by Subject|2|||
157010166|NCT00801983|566788215|FG001|Period 2|Withdrawal by Subject|1|||
157010167|NCT05985044|566790126|FG000|Overall Study|Death|6|||
157010168|NCT05985044|566790126|FG000|Overall Study|Lost to Follow-up|4|||
157010169|NCT05985044|566790126|FG000|Overall Study|Incapacitation|3|||
157010170|NCT05985044|566790126|FG000|Overall Study|Withdrawal by Subject|2|||
157010171|NCT04714320|566790137|FG000|Overall Study|Voluntary Withdrawal|4|||
157010172|NCT04714320|566790138|FG001|Overall Study|Voluntary Withdrawal|1|||
157010173|NCT04714320|566790139|FG002|Overall Study|Voluntary Withdrawal|2|||
156866460|NCT01337960|566271255|FG000|Overall Study|Withdrawal by Subject|1|||
156866461|NCT01337960|566271256|FG001|Overall Study|Withdrawal by Subject|0|||
156866462|NCT01337960|566271257|FG002|Overall Study|Withdrawal by Subject|0|||
157115719|NCT00183274|567177430|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
156866463|NCT03877510|566271258|FG000|Overall Study|Death|6|||
156866464|NCT03877510|566271258|FG000|Overall Study|Lost to Follow-up|2|||
156866465|NCT03877510|566271258|FG000|Overall Study|Non-compliance with study drug|2|||
156866466|NCT03877510|566271258|FG000|Overall Study|Lack of Efficacy|14|||
156866467|NCT03877510|566271258|FG000|Overall Study|Adverse Event|20|||
156866468|NCT03877510|566271258|FG000|Overall Study|Withdrawal by Subject|22|||
156866469|NCT03877510|566271258|FG000|Overall Study|Miscellaneous|1|||
156866470|NCT03763877|566271260|FG000|Overall Study|Withdrawal by Subject|3|||
156866471|NCT03763877|566271261|FG001|Overall Study|Withdrawal by Subject|1|||
156866472|NCT03763877|566271262|FG002|Overall Study|Withdrawal by Subject|3|||
156866473|NCT03763877|566271263|FG003|Overall Study|Withdrawal by Subject|4|||
156866474|NCT03763877|566271260|FG000|Overall Study|Adverse Event|1|||
156866475|NCT03763877|566271261|FG001|Overall Study|Adverse Event|1|||
156866476|NCT03763877|566271262|FG002|Overall Study|Adverse Event|3|||
156866477|NCT03763877|566271263|FG003|Overall Study|Adverse Event|1|||
156866478|NCT03763877|566271260|FG000|Overall Study|Protocol Violation|1|||
156866479|NCT03763877|566271261|FG001|Overall Study|Protocol Violation|1|||
156866480|NCT03763877|566271262|FG002|Overall Study|Protocol Violation|0|||
156866481|NCT03763877|566271263|FG003|Overall Study|Protocol Violation|0|||
156866482|NCT03763877|566271260|FG000|Overall Study|Lost to Follow-up|0|||
156866483|NCT03763877|566271261|FG001|Overall Study|Lost to Follow-up|1|||
156866484|NCT03763877|566271262|FG002|Overall Study|Lost to Follow-up|1|||
156866485|NCT03763877|566271263|FG003|Overall Study|Lost to Follow-up|0|||
156866486|NCT03040336|566271264|FG000|Overall Study|Death|1|||
156866487|NCT03040336|566271265|FG001|Overall Study|Death|0|||
156866488|NCT03040336|566271264|FG000|Overall Study|Withdrawal by Subject|2|||
156866489|NCT03040336|566271265|FG001|Overall Study|Withdrawal by Subject|3|||
156866490|NCT01774721|566271273|FG000|Overall Study|Death|133|||
156866491|NCT01774721|566271274|FG001|Overall Study|Death|152|||
156866492|NCT01774721|566271273|FG000|Overall Study|Withdrawal by Subject|20|||
156866493|NCT01774721|566271274|FG001|Overall Study|Withdrawal by Subject|14|||
156866494|NCT01774721|566271273|FG000|Overall Study|Lost to Follow-up|6|||
157010174|NCT04714320|566790137|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
157010175|NCT04714320|566790138|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
157210277|NCT01220128|567516995|FG002|Overall Study|Progressive disease|2|||
157210278|NCT01220128|567516996|FG003|Overall Study|Progressive disease|0|||
157210279|NCT01220128|567516997|FG004|Overall Study|Progressive disease|0|||
157210280|NCT01220128|567516998|FG005|Overall Study|Progressive disease|0|||
157210281|NCT01220128|567516999|FG006|Overall Study|Progressive disease|0|||
157210282|NCT01220128|567516993|FG000|Overall Study|Sponsor study termination|0|||
157210283|NCT01220128|567516994|FG001|Overall Study|Sponsor study termination|1|||
157210284|NCT01220128|567516995|FG002|Overall Study|Sponsor study termination|0|||
157210285|NCT01220128|567516996|FG003|Overall Study|Sponsor study termination|0|||
157210286|NCT01220128|567516997|FG004|Overall Study|Sponsor study termination|0|||
157210287|NCT01220128|567516998|FG005|Overall Study|Sponsor study termination|0|||
157210288|NCT01220128|567516999|FG006|Overall Study|Sponsor study termination|1|||
157210289|NCT01220128|567516993|FG000|Overall Study|Adverse event, serious fatal|2|||
157210290|NCT01220128|567516994|FG001|Overall Study|Adverse event, serious fatal|0|||
157210291|NCT01220128|567516995|FG002|Overall Study|Adverse event, serious fatal|0|||
157210292|NCT01220128|567516996|FG003|Overall Study|Adverse event, serious fatal|0|||
157210293|NCT01220128|567516997|FG004|Overall Study|Adverse event, serious fatal|0|||
157210294|NCT01220128|567516998|FG005|Overall Study|Adverse event, serious fatal|0|||
157210295|NCT01220128|567516999|FG006|Overall Study|Adverse event, serious fatal|1|||
157210296|NCT01220128|567516993|FG000|Overall Study|Adverse event, non-fatal|1|||
157210297|NCT01220128|567516994|FG001|Overall Study|Adverse event, non-fatal|0|||
157210298|NCT01220128|567516995|FG002|Overall Study|Adverse event, non-fatal|0|||
157210299|NCT01220128|567516996|FG003|Overall Study|Adverse event, non-fatal|0|||
157210300|NCT01220128|567516997|FG004|Overall Study|Adverse event, non-fatal|0|||
157210301|NCT01220128|567516998|FG005|Overall Study|Adverse event, non-fatal|0|||
157210302|NCT01220128|567516999|FG006|Overall Study|Adverse event, non-fatal|3|||
157210303|NCT01220128|567516993|FG000|Overall Study|Other|0|||
157210304|NCT01220128|567516994|FG001|Overall Study|Other|0|||
157210305|NCT01220128|567516995|FG002|Overall Study|Other|1|||
157210306|NCT01220128|567516996|FG003|Overall Study|Other|0|||
157210307|NCT01220128|567516997|FG004|Overall Study|Other|0|||
157210308|NCT01220128|567516998|FG005|Overall Study|Other|0|||
157210309|NCT01220128|567516999|FG006|Overall Study|Other|0|||
157210310|NCT01220128|567516993|FG000|Overall Study|Consent withdrawn by subject|1|||
157210311|NCT01220128|567516994|FG001|Overall Study|Consent withdrawn by subject|0|||
157210312|NCT01220128|567516995|FG002|Overall Study|Consent withdrawn by subject|0|||
157210313|NCT01220128|567516996|FG003|Overall Study|Consent withdrawn by subject|0|||
157210314|NCT01220128|567516997|FG004|Overall Study|Consent withdrawn by subject|0|||
157210315|NCT01220128|567516998|FG005|Overall Study|Consent withdrawn by subject|0|||
157210316|NCT01220128|567516999|FG006|Overall Study|Consent withdrawn by subject|0|||
157210317|NCT02913261|567517000|FG000|Overall Study|Technical problems|0|||
157210318|NCT02913261|567517001|FG001|Overall Study|Technical problems|1|||
157210319|NCT02913261|567517000|FG000|Overall Study|Lack of Efficacy|32|||
157210320|NCT02913261|567517001|FG001|Overall Study|Lack of Efficacy|69|||
157210321|NCT02913261|567517000|FG000|Overall Study|Adverse Event|27|||
157210322|NCT02913261|567517001|FG001|Overall Study|Adverse Event|5|||
157210323|NCT02913261|567517000|FG000|Overall Study|Death|25|||
157210324|NCT02913261|567517001|FG001|Overall Study|Death|22|||
157210325|NCT02913261|567517000|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
157210326|NCT02913261|567517001|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
157210327|NCT02913261|567517000|FG000|Overall Study|Disease relapse|8|||
157210328|NCT02913261|567517001|FG001|Overall Study|Disease relapse|13|||
157210329|NCT02913261|567517000|FG000|Overall Study|Physician Decision|8|||
157210330|NCT02913261|567517001|FG001|Overall Study|Physician Decision|9|||
157210331|NCT02913261|567517000|FG000|Overall Study|Subject/guardian decision|4|||
157210332|NCT02913261|567517001|FG001|Overall Study|Subject/guardian decision|6|||
157210333|NCT02913261|567517000|FG000|Overall Study|Graft loss|2|||
157210334|NCT02913261|567517001|FG001|Overall Study|Graft loss|0|||
157210335|NCT02304302|567517002|FG000|Overall Study|Adverse Event|2|||
157210336|NCT02304302|567517003|FG001|Overall Study|Adverse Event|3|||
157210337|NCT02304302|567517002|FG000|Overall Study|Lost to Follow-up|1|||
157210338|NCT02304302|567517003|FG001|Overall Study|Lost to Follow-up|4|||
157210339|NCT02304302|567517002|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
157210340|NCT02304302|567517003|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
157210341|NCT00391118|567517004|FG000|Overall Study|Adverse Event|3|||
157210342|NCT00391118|567517005|FG001|Overall Study|Adverse Event|10|||
157210343|NCT00391118|567517006|FG002|Overall Study|Adverse Event|7|||
157210344|NCT00391118|567517004|FG000|Overall Study|Lost to Follow-up|0|||
157210345|NCT00391118|567517005|FG001|Overall Study|Lost to Follow-up|2|||
157210346|NCT00391118|567517006|FG002|Overall Study|Lost to Follow-up|3|||
157210347|NCT00391118|567517004|FG000|Overall Study|Withdrawal by Subject|0|||
157210348|NCT00391118|567517005|FG001|Overall Study|Withdrawal by Subject|9|||
157210349|NCT00391118|567517006|FG002|Overall Study|Withdrawal by Subject|1|||
157210350|NCT00391118|567517004|FG000|Overall Study|Death|0|||
157210351|NCT00391118|567517005|FG001|Overall Study|Death|1|||
157210352|NCT00391118|567517006|FG002|Overall Study|Death|0|||
157010176|NCT04714320|566790139|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
157010177|NCT04714320|566790137|FG000|Overall Study|Reason Not Specified|1|||
157010178|NCT04714320|566790138|FG001|Overall Study|Reason Not Specified|3|||
157010179|NCT04714320|566790139|FG002|Overall Study|Reason Not Specified|3|||
157010180|NCT05672667|566790140|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
157010181|NCT04524390|566790141|FG000|Double Blind|Consent Withdrawal by subject|2|||
157210353|NCT00391118|567517004|FG000|Overall Study|Physician Decision|0|||
157210354|NCT00391118|567517005|FG001|Overall Study|Physician Decision|3|||
156866495|NCT01774721|566271274|FG001|Overall Study|Lost to Follow-up|7|||
157210355|NCT00391118|567517006|FG002|Overall Study|Physician Decision|0|||
157210356|NCT00391118|567517004|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
157210357|NCT00391118|567517005|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
157210358|NCT00391118|567517006|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
157210359|NCT00391118|567517004|FG000|Overall Study|Progressive Disease|7|||
157210360|NCT00391118|567517005|FG001|Overall Study|Progressive Disease|26|||
157210361|NCT00391118|567517006|FG002|Overall Study|Progressive Disease|43|||
156866496|NCT01774721|566271273|FG000|Overall Study|Did not meet eligibility criteria|0|||
157210362|NCT00391118|567517004|FG000|Overall Study|Sponsor Decision|0|||
157210363|NCT00391118|567517005|FG001|Overall Study|Sponsor Decision|1|||
156866497|NCT01774721|566271274|FG001|Overall Study|Did not meet eligibility criteria|3|||
156779713|NCT00313170|565943843|FG001|Overall Study|Adverse Event|2|||
156779714|NCT00313170|565943844|FG002|Overall Study|Adverse Event|0|||
156779715|NCT00313170|565943842|FG000|Overall Study|Disease progression|31|||
156779716|NCT00313170|565943843|FG001|Overall Study|Disease progression|26|||
156779717|NCT00313170|565943844|FG002|Overall Study|Disease progression|27|||
156779718|NCT00313170|565943842|FG000|Overall Study|Withdrawal by Subject|1|||
156779719|NCT00313170|565943843|FG001|Overall Study|Withdrawal by Subject|0|||
156779720|NCT00313170|565943844|FG002|Overall Study|Withdrawal by Subject|1|||
156779721|NCT00313170|565943842|FG000|Overall Study|Incorrect enrollment|0|||
156779722|NCT00313170|565943843|FG001|Overall Study|Incorrect enrollment|2|||
156779723|NCT00313170|565943844|FG002|Overall Study|Incorrect enrollment|1|||
156779724|NCT00313170|565943842|FG000|Overall Study|Lost to Follow-up|0|||
156779725|NCT00313170|565943843|FG001|Overall Study|Lost to Follow-up|0|||
156779726|NCT00313170|565943844|FG002|Overall Study|Lost to Follow-up|1|||
156779727|NCT00313170|565943842|FG000|Overall Study|Progression (investigators opinion)|1|||
156779728|NCT00313170|565943843|FG001|Overall Study|Progression (investigators opinion)|0|||
156779729|NCT00313170|565943844|FG002|Overall Study|Progression (investigators opinion)|0|||
156779730|NCT02827708|565943845|FG000|Overall Study|Lost to Follow-up|3|||
156779731|NCT02827708|565943846|FG001|Overall Study|Lost to Follow-up|1|||
156779732|NCT02827708|565943845|FG000|Overall Study|Withdrawal by Subject|1|||
156779733|NCT02827708|565943846|FG001|Overall Study|Withdrawal by Subject|2|||
156779734|NCT02827708|565943845|FG000|Overall Study|Death|1|||
156779735|NCT02827708|565943846|FG001|Overall Study|Death|2|||
156779736|NCT00407511|565943847|FG000|Overall Study|Adverse Event|9|||
156779737|NCT00407511|565943847|FG000|Overall Study|Lost to Follow-up|4|||
156779738|NCT00407511|565943847|FG000|Overall Study|Other|5|||
156779739|NCT00407511|565943847|FG000|Overall Study|Withdrawal by Subject|4|||
156779740|NCT01521364|565943848|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
156779741|NCT01521364|565943848|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
156779742|NCT02636283|565943849|FG000|Overall Study|Adverse Event|2|||
156779743|NCT02636283|565943850|FG001|Overall Study|Adverse Event|0|||
156779744|NCT02636283|565943849|FG000|Overall Study|Trial Terminated Prematurely|0|||
156779745|NCT02636283|565943850|FG001|Overall Study|Trial Terminated Prematurely|3|||
156779746|NCT03418675|565943851|FG000|Overall Study|Lost to Follow-up|13|||
156779747|NCT03418675|565943852|FG001|Overall Study|Lost to Follow-up|10|||
156779748|NCT03418675|565943851|FG000|Overall Study|Adverse Event|2|||
156779749|NCT03418675|565943852|FG001|Overall Study|Adverse Event|0|||
156779750|NCT01879852|565943853|FG000|Overall Study|Withdrawal by Subject|2|||
156779751|NCT01879852|565943854|FG001|Overall Study|Withdrawal by Subject|0|||
156779752|NCT02115386|565943855|FG000|Overall Study|Protocol Violation|1|||
156779753|NCT02115386|565943855|FG000|Overall Study|Administrative - trial was terminated|6|||
156779754|NCT04398134|565943860|FG000|Overall Study|Adverse Event|0|||
156779755|NCT04398134|565943861|FG001|Overall Study|Adverse Event|0|||
156779756|NCT04398134|565943862|FG002|Overall Study|Adverse Event|1|||
156779757|NCT04398134|565943863|FG003|Overall Study|Adverse Event|0|||
156779758|NCT04398134|565943860|FG000|Overall Study|Withdrawal by Subject|2|||
156779759|NCT04398134|565943861|FG001|Overall Study|Withdrawal by Subject|0|||
156779760|NCT04398134|565943862|FG002|Overall Study|Withdrawal by Subject|0|||
156779761|NCT04398134|565943863|FG003|Overall Study|Withdrawal by Subject|1|||
156779762|NCT04398134|565943860|FG000|Overall Study|Study Terminated by Sponsor|30|||
156779763|NCT04398134|565943861|FG001|Overall Study|Study Terminated by Sponsor|11|||
156779764|NCT04398134|565943862|FG002|Overall Study|Study Terminated by Sponsor|32|||
156779765|NCT04398134|565943863|FG003|Overall Study|Study Terminated by Sponsor|11|||
156779766|NCT05513950|565943866|FG000|Overall Study|Not treated due to technical reasons|0|||
156779767|NCT05513950|565943867|FG001|Overall Study|Not treated due to technical reasons|0|||
156779768|NCT05513950|565943868|FG002|Overall Study|Not treated due to technical reasons|1|||
156779769|NCT05513950|565943869|FG003|Overall Study|Not treated due to technical reasons|0|||
156779770|NCT00221104|565943872|FG000|Overall Study|Adverse Event|1|||
156779771|NCT00221104|565943873|FG001|Overall Study|Adverse Event|0|||
156779772|NCT00221104|565943872|FG000|Overall Study|Physician Decision|1|||
156779773|NCT00221104|565943873|FG001|Overall Study|Physician Decision|0|||
156779774|NCT00221104|565943872|FG000|Overall Study|Protocol Violation|2|||
156779775|NCT00221104|565943873|FG001|Overall Study|Protocol Violation|0|||
156779776|NCT00221104|565943872|FG000|Overall Study|Withdrawal by Subject|42|||
157010182|NCT04524390|566790142|FG001|Double Blind|Consent Withdrawal by subject|1|||
156779777|NCT00221104|565943873|FG001|Overall Study|Withdrawal by Subject|29|||
157010183|NCT04524390|566790143|FG002|Double Blind|Consent Withdrawal by subject|0|||
157010184|NCT04524390|566790141|FG000|Double Blind|Adverse Event|5|||
157010185|NCT04524390|566790142|FG001|Double Blind|Adverse Event|3|||
156866498|NCT01774721|566271273|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
156866499|NCT01774721|566271274|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
156866500|NCT01774721|566271273|FG000|Overall Study|Study terminated by sponsor|5|||
156866501|NCT01774721|566271274|FG001|Overall Study|Study terminated by sponsor|0|||
156866502|NCT01774721|566271273|FG000|Overall Study|Disease progression|5|||
156866503|NCT01774721|566271274|FG001|Overall Study|Disease progression|0|||
156866504|NCT02282605|566271275|FG000|Overall Study|negative SA result on Day -1|3|||
157115720|NCT00183274|567177431|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
157010186|NCT04524390|566790143|FG002|Double Blind|Adverse Event|0|||
157010187|NCT04524390|566790141|FG000|Double Blind|Liver Transplant|5|||
157010188|NCT04524390|566790142|FG001|Double Blind|Liver Transplant|6|||
157010189|NCT04524390|566790143|FG002|Double Blind|Liver Transplant|0|||
157010190|NCT04524390|566790141|FG000|Double Blind|Disease Progression|0|||
157010191|NCT04524390|566790142|FG001|Double Blind|Disease Progression|1|||
157010192|NCT04524390|566790143|FG002|Double Blind|Disease Progression|0|||
157010193|NCT04524390|566790141|FG000|Open-Label|Drug interruption criteria|0|||
157010194|NCT04524390|566790142|FG001|Open-Label|Drug interruption criteria|0|||
157010195|NCT04524390|566790143|FG002|Open-Label|Drug interruption criteria|1|||
157010196|NCT04524390|566790141|FG000|Open-Label|Liver Transplant|0|||
157010197|NCT04524390|566790142|FG001|Open-Label|Liver Transplant|0|||
157210364|NCT00391118|567517006|FG002|Overall Study|Sponsor Decision|3|||
157210365|NCT00391118|567517004|FG000|Overall Study|Protocol Violation|1|||
157210366|NCT00391118|567517005|FG001|Overall Study|Protocol Violation|0|||
157210367|NCT00391118|567517006|FG002|Overall Study|Protocol Violation|0|||
157210368|NCT01892020|567517008|FG000|Period 1|Adverse Event|1|||
157210369|NCT01892020|567517009|FG001|Period 1|Adverse Event|1|||
157210370|NCT01892020|567517008|FG000|Period 1|Protocol Violation|2|||
157210371|NCT01892020|567517009|FG001|Period 1|Protocol Violation|4|||
157210372|NCT01892020|567517008|FG000|Period 1|Unclassified|0|||
157210373|NCT01892020|567517009|FG001|Period 1|Unclassified|1|||
157210374|NCT01892020|567517008|FG000|Period 2|Protocol Violation|1|||
157210375|NCT01892020|567517009|FG001|Period 2|Protocol Violation|0|||
157210376|NCT01311505|567517011|FG000|First Intervention Period|Protocol Violation|0|||
157210377|NCT01311505|567517012|FG001|First Intervention Period|Protocol Violation|1|||
157210378|NCT00567996|567517019|FG000|Overall Study|Adverse Event|18|||
157210379|NCT00567996|567517020|FG001|Overall Study|Adverse Event|16|||
157210380|NCT00567996|567517021|FG002|Overall Study|Adverse Event|13|||
157210381|NCT00567996|567517019|FG000|Overall Study|Protocol Deviation|9|||
157210382|NCT00567996|567517020|FG001|Overall Study|Protocol Deviation|11|||
157210383|NCT00567996|567517021|FG002|Overall Study|Protocol Deviation|13|||
157210384|NCT00567996|567517019|FG000|Overall Study|Withdrawal by Subject|8|||
157210385|NCT00567996|567517020|FG001|Overall Study|Withdrawal by Subject|12|||
157210386|NCT00567996|567517021|FG002|Overall Study|Withdrawal by Subject|22|||
157210387|NCT00567996|567517019|FG000|Overall Study|Abnormal Lab value(s)|2|||
157210388|NCT00567996|567517020|FG001|Overall Study|Abnormal Lab value(s)|1|||
157210389|NCT00567996|567517021|FG002|Overall Study|Abnormal Lab value(s)|2|||
157210390|NCT00567996|567517019|FG000|Overall Study|Abnormal test procedure result(s)|2|||
157210391|NCT00567996|567517020|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157210392|NCT00567996|567517021|FG002|Overall Study|Abnormal test procedure result(s)|1|||
157210393|NCT00567996|567517019|FG000|Overall Study|Lost to Follow-up|2|||
157210394|NCT00567996|567517020|FG001|Overall Study|Lost to Follow-up|5|||
157210395|NCT00567996|567517021|FG002|Overall Study|Lost to Follow-up|2|||
157210396|NCT00567996|567517019|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157210397|NCT00567996|567517020|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157210398|NCT00567996|567517021|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
157210399|NCT00567996|567517019|FG000|Overall Study|Administrative problems|1|||
157210400|NCT00567996|567517020|FG001|Overall Study|Administrative problems|1|||
157210401|NCT00567996|567517021|FG002|Overall Study|Administrative problems|0|||
157210402|NCT00567996|567517019|FG000|Overall Study|Death|1|||
157210403|NCT00567996|567517020|FG001|Overall Study|Death|0|||
157210404|NCT00567996|567517021|FG002|Overall Study|Death|2|||
157210405|NCT00567996|567517019|FG000|Overall Study|Patient's inability to use the device|0|||
157210406|NCT00567996|567517020|FG001|Overall Study|Patient's inability to use the device|1|||
157210407|NCT00567996|567517021|FG002|Overall Study|Patient's inability to use the device|0|||
157210408|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210409|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210410|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210411|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
157210412|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
157210413|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210414|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210415|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210416|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210417|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
157210418|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210419|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210420|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
157210421|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
157210422|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
157210423|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
157210424|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
157210425|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
157210426|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
157210427|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210428|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210429|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210430|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210431|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210432|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
157210433|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210434|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210435|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210436|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
157210437|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210438|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
156866505|NCT02282605|566271276|FG001|Overall Study|negative SA result on Day -1|0|||
156866506|NCT02282605|566271277|FG002|Overall Study|negative SA result on Day -1|0|||
156866507|NCT00836693|566271278|FG000|Overall Study|Adverse Event|4|||
156866508|NCT00836693|566271279|FG001|Overall Study|Adverse Event|1|||
156866509|NCT00836693|566271278|FG000|Overall Study|Sponsor Decision|0|||
156866510|NCT00836693|566271279|FG001|Overall Study|Sponsor Decision|1|||
156866511|NCT00836693|566271278|FG000|Overall Study|Physician Decision|2|||
156866512|NCT00836693|566271279|FG001|Overall Study|Physician Decision|0|||
156866513|NCT00836693|566271278|FG000|Overall Study|Withdrawal by Subject|9|||
156866514|NCT00836693|566271279|FG001|Overall Study|Withdrawal by Subject|4|||
156866515|NCT00836693|566271278|FG000|Overall Study|Protocol Violation|1|||
156866516|NCT00836693|566271279|FG001|Overall Study|Protocol Violation|0|||
156866517|NCT00836693|566271278|FG000|Overall Study|Lost to Follow-up|1|||
156866518|NCT00836693|566271279|FG001|Overall Study|Lost to Follow-up|0|||
156866519|NCT03938259|566271280|FG000|Overall Study|unable to establish baseline for ventilation|1|||
156866520|NCT03938259|566271281|FG001|Overall Study|unable to establish baseline for ventilation|1|||
156866521|NCT01213472|566271282|FG000|Overall Study|Recurrence/Progressive disease|25|||
156866522|NCT01213472|566271282|FG000|Overall Study|Withdrawal by Subject|1|||
156866523|NCT01213472|566271282|FG000|Overall Study|Physician Decision|1|||
156866524|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866525|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866526|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866527|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866528|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866529|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
156866530|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
156866531|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866532|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866533|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866534|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866535|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866536|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
156866537|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
156866538|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866539|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866540|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866541|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
156866542|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866543|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866544|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
156866545|NCT00129402|566271283|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866546|NCT00129402|566271284|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866547|NCT00129402|566271285|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
156866548|NCT00129402|566271286|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866549|NCT00129402|566271287|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
156866550|NCT00129402|566271288|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866551|NCT00129402|566271289|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
156866552|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866553|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866554|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
156866555|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866556|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866557|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866558|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
156866559|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866560|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866561|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
156866562|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866563|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866564|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
156866565|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
156866566|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866567|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866568|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
156866569|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866570|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866571|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866572|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
156866573|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866574|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866575|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
156866576|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866577|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866578|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
156866579|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
156866580|NCT00129402|566271283|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866581|NCT00129402|566271284|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866582|NCT00129402|566271285|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
156866583|NCT00129402|566271286|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
156866584|NCT00129402|566271287|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
157010198|NCT04524390|566790143|FG002|Open-Label|Liver Transplant|1|||
157210439|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210440|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
157210441|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
157210442|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
157210443|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
157210444|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
157210445|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
157210446|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
157210447|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210448|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210449|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210450|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210451|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
157210452|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210453|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210454|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210455|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210456|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210457|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210458|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210459|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210460|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
157210461|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210462|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210463|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
157210464|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
157210465|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210466|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210467|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210468|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210469|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210470|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210471|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210472|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210473|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210474|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210475|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
157210476|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210477|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210478|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
157210479|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210480|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210481|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
157210482|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
157210483|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
157210484|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
157210485|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
157210486|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157210487|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
157210488|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157010199|NCT04524390|566790141|FG000|Open-Label|Disease Progression|0|||
157010200|NCT04524390|566790142|FG001|Open-Label|Disease Progression|0|||
157010201|NCT04524390|566790143|FG002|Open-Label|Disease Progression|1|||
157010202|NCT04524390|566790141|FG000|Open-Label|Adverse Event|0|||
157010203|NCT04524390|566790142|FG001|Open-Label|Adverse Event|0|||
157010204|NCT04524390|566790143|FG002|Open-Label|Adverse Event|3|||
157010205|NCT04524390|566790141|FG000|Open-Label|Study Termination by sponsor|0|||
157010206|NCT04524390|566790142|FG001|Open-Label|Study Termination by sponsor|0|||
157010207|NCT04524390|566790143|FG002|Open-Label|Study Termination by sponsor|45|||
157010208|NCT03873779|566790144|FG000|Overall Study|Withdrawal by Subject|1|||
157010209|NCT02581215|566790145|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
157010210|NCT02581215|566790146|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
157115721|NCT00183274|567177432|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
157115722|NCT00183274|567177433|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
157115723|NCT00183274|567177434|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
157115724|NCT00183274|567177429|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
157115725|NCT00183274|567177430|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
157115726|NCT00183274|567177431|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
157115727|NCT00183274|567177432|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
157115728|NCT00183274|567177433|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
157115729|NCT00183274|567177434|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
157115730|NCT00183274|567177429|FG000|Phase 3: Double-Blind|Relapsed|0|||
157115731|NCT00183274|567177430|FG001|Phase 3: Double-Blind|Relapsed|0|||
157115732|NCT00183274|567177431|FG002|Phase 3: Double-Blind|Relapsed|0|||
157115733|NCT00183274|567177432|FG003|Phase 3: Double-Blind|Relapsed|1|||
157115734|NCT00183274|567177433|FG004|Phase 3: Double-Blind|Relapsed|11|||
157115735|NCT00183274|567177434|FG005|Phase 3: Double-Blind|Relapsed|2|||
157115736|NCT00586495|567177437|FG000|Treatment Period|Adverse Event|11|||
157115737|NCT00586495|567177437|FG000|Treatment Period|Death|1|||
157115738|NCT00586495|567177437|FG000|Treatment Period|Protocol Violation|1|||
157115739|NCT00586495|567177437|FG000|Treatment Period|Withdrawal by Subject|1|||
157115740|NCT00586495|567177437|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
157115741|NCT00586495|567177437|FG000|Treatment Period|Switch to commercial drug|10|||
157115742|NCT00586495|567177437|FG000|Follow-up|Death|40|||
157115743|NCT00586495|567177437|FG000|Follow-up|Lost to Follow-up|1|||
157115744|NCT00586495|567177437|FG000|Follow-up|Withdrawal by Subject|4|||
157115745|NCT00586495|567177437|FG000|Follow-up|Protocol driven decision point|37|||
157115746|NCT00586495|567177437|FG000|Follow-up|Switch to commercial drug|10|||
157115747|NCT03882970|567177440|FG000|Overall Study|Adverse Event|5|||
157115748|NCT03882970|567177441|FG001|Overall Study|Adverse Event|7|||
157115749|NCT03882970|567177442|FG002|Overall Study|Adverse Event|3|||
157115750|NCT03882970|567177443|FG003|Overall Study|Adverse Event|1|||
157115751|NCT03882970|567177440|FG000|Overall Study|Death|1|||
157115752|NCT03882970|567177441|FG001|Overall Study|Death|2|||
157115753|NCT03882970|567177442|FG002|Overall Study|Death|1|||
157115754|NCT03882970|567177443|FG003|Overall Study|Death|1|||
157115755|NCT03882970|567177440|FG000|Overall Study|Lost to Follow-up|8|||
157115756|NCT03882970|567177441|FG001|Overall Study|Lost to Follow-up|9|||
157115757|NCT03882970|567177442|FG002|Overall Study|Lost to Follow-up|5|||
157115758|NCT03882970|567177443|FG003|Overall Study|Lost to Follow-up|5|||
157115759|NCT03882970|567177440|FG000|Overall Study|Physician Decision|0|||
157115760|NCT03882970|567177441|FG001|Overall Study|Physician Decision|2|||
157115761|NCT03882970|567177442|FG002|Overall Study|Physician Decision|2|||
157115762|NCT03882970|567177443|FG003|Overall Study|Physician Decision|2|||
157115763|NCT03882970|567177440|FG000|Overall Study|Protocol Violation|2|||
157115764|NCT03882970|567177441|FG001|Overall Study|Protocol Violation|0|||
157115765|NCT03882970|567177442|FG002|Overall Study|Protocol Violation|0|||
157115766|NCT03882970|567177443|FG003|Overall Study|Protocol Violation|0|||
157115767|NCT03882970|567177440|FG000|Overall Study|Withdrawal by Subject|8|||
157115768|NCT03882970|567177441|FG001|Overall Study|Withdrawal by Subject|17|||
157115769|NCT03882970|567177442|FG002|Overall Study|Withdrawal by Subject|7|||
157115770|NCT03882970|567177443|FG003|Overall Study|Withdrawal by Subject|22|||
157115771|NCT03882970|567177440|FG000|Overall Study|Personal Reason|2|||
156779778|NCT00221104|565943872|FG000|Overall Study|Others|37|||
157115772|NCT03882970|567177441|FG001|Overall Study|Personal Reason|3|||
157115773|NCT03882970|567177442|FG002|Overall Study|Personal Reason|1|||
157115774|NCT03882970|567177443|FG003|Overall Study|Personal Reason|3|||
157115775|NCT02863809|567177444|FG000|Overall Study|Adverse Event|8|||
157115776|NCT02863809|567177445|FG001|Overall Study|Adverse Event|8|||
157115777|NCT02863809|567177444|FG000|Overall Study|Withdrawal by Subject|0|||
157115778|NCT02863809|567177445|FG001|Overall Study|Withdrawal by Subject|1|||
157115779|NCT02863809|567177444|FG000|Overall Study|Lost to Follow-up|1|||
157115780|NCT02863809|567177445|FG001|Overall Study|Lost to Follow-up|1|||
157115781|NCT02863809|567177444|FG000|Overall Study|Death|1|||
157115782|NCT02863809|567177445|FG001|Overall Study|Death|0|||
157115783|NCT02980224|567177449|FG000|Overall Study|Adverse Event|4|||
157115784|NCT02980224|567177450|FG001|Overall Study|Adverse Event|1|||
157115785|NCT02980224|567177449|FG000|Overall Study|Withdrawal by Subject|0|||
157115786|NCT02980224|567177450|FG001|Overall Study|Withdrawal by Subject|2|||
157115787|NCT00606320|567177451|FG000|Overall Study|Adverse Event|3|||
157115788|NCT00606320|567177451|FG000|Overall Study|Lack of Efficacy|5|||
157115789|NCT00606320|567177451|FG000|Overall Study|Physician Decision|7|||
157115790|NCT00606320|567177451|FG000|Overall Study|Protocol Violation|8|||
157115791|NCT00606320|567177451|FG000|Overall Study|Withdrawal by Subject|10|||
157115792|NCT00606320|567177451|FG000|Overall Study|Progression to depressive phase|4|||
157115793|NCT00879645|567177452|FG000|Overall Study|Adverse Event|1|||
157115794|NCT00879645|567177453|FG001|Overall Study|Adverse Event|0|||
157115795|NCT00879645|567177454|FG002|Overall Study|Adverse Event|0|||
157115796|NCT00879645|567177455|FG003|Overall Study|Adverse Event|0|||
157115797|NCT00749996|567177456|FG000|Overall Study|Lost to Follow-up|7|||
157115798|NCT00749996|567177457|FG001|Overall Study|Lost to Follow-up|4|||
157210489|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157115799|NCT00749996|567177456|FG000|Overall Study|Withdrawal by Subject|5|||
157115800|NCT00749996|567177457|FG001|Overall Study|Withdrawal by Subject|4|||
157115801|NCT00749996|567177456|FG000|Overall Study|Protocol Violation|2|||
157115802|NCT00749996|567177457|FG001|Overall Study|Protocol Violation|3|||
157115803|NCT00749996|567177456|FG000|Overall Study|Physician Decision|2|||
157115804|NCT00749996|567177457|FG001|Overall Study|Physician Decision|0|||
157115805|NCT00749996|567177456|FG000|Overall Study|Pregnancy|0|||
157115806|NCT00749996|567177457|FG001|Overall Study|Pregnancy|2|||
157115807|NCT00749996|567177456|FG000|Overall Study|Adverse Event|1|||
157115808|NCT00749996|567177457|FG001|Overall Study|Adverse Event|0|||
157115809|NCT00749996|567177456|FG000|Overall Study|Death|1|||
157115810|NCT00749996|567177457|FG001|Overall Study|Death|0|||
157115811|NCT00996944|567177458|FG000|Double-blind Treatment Period|Adverse Event|2|||
157115812|NCT00996944|567177459|FG001|Double-blind Treatment Period|Adverse Event|1|||
157115813|NCT00996944|567177458|FG000|Double-blind Treatment Period|Protocol Violation|1|||
157115814|NCT00996944|567177459|FG001|Double-blind Treatment Period|Protocol Violation|0|||
157115815|NCT00996944|567177458|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
157115816|NCT00996944|567177459|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
157115817|NCT00996944|567177458|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
157115818|NCT00996944|567177459|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
157115819|NCT00996944|567177458|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
157115820|NCT00996944|567177459|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
157115821|NCT01227044|567177460|FG000|Overall Study|Lost to Follow-up|5|||
157115822|NCT01227044|567177461|FG001|Overall Study|Lost to Follow-up|7|||
157115823|NCT01227044|567177460|FG000|Overall Study|Discontinued Intervention|1|||
157210490|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
157210491|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157010211|NCT02581215|566790145|FG000|Overall Study|Eligibility Criteria Not Met|0|||
157010212|NCT02581215|566790146|FG001|Overall Study|Eligibility Criteria Not Met|1|||
157010213|NCT02300298|566790153|FG000|Disposition for Nintedanib|Progressive disease|10|||
157210492|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157010214|NCT02300298|566790154|FG001|Disposition for Nintedanib|Progressive disease|0|||
157010215|NCT02300298|566790153|FG000|Disposition for Docetaxel|Progressive disease|0|||
157010216|NCT02300298|566790154|FG001|Disposition for Docetaxel|Progressive disease|6|||
157010217|NCT02300298|566790153|FG000|Disposition for Docetaxel|other adverse event|0|||
157010218|NCT02300298|566790154|FG001|Disposition for Docetaxel|other adverse event|4|||
157010219|NCT01875848|566790155|FG000|Overall Study|Withdrawal by Subject|2|||
157010220|NCT01875848|566790156|FG001|Overall Study|Withdrawal by Subject|0|||
157210493|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157210494|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
157210495|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157210496|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
157210497|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
157210498|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
157210499|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
157210500|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
157210501|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
157210502|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
157210503|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210504|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210505|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
157210506|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210507|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210508|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210509|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210510|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210511|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210512|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210513|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210514|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210515|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210516|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210517|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210518|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
157210519|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
157210520|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
157210521|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
157210522|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210523|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210524|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210525|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210526|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
157210527|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210528|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210529|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210530|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210531|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
157210532|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210533|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210534|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210535|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210536|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210537|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210538|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210539|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157010221|NCT01622868|566790157|FG000|Overall Study|Protocol Violation|7|||
157210540|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
157210541|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
157210542|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210543|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210544|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210545|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210546|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
157210547|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157210548|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210549|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157210550|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157010222|NCT01622868|566790158|FG001|Overall Study|Protocol Violation|0|||
157010223|NCT03285763|566790160|FG000|Overall Study|Death|470|||
157010224|NCT03285763|566790160|FG000|Overall Study|Lost to Follow-up|18|||
157010225|NCT03285763|566790160|FG000|Overall Study|Physician Decision|2|||
157010226|NCT03285763|566790160|FG000|Overall Study|Study Terminated By Sponsor|79|||
157010227|NCT03285763|566790160|FG000|Overall Study|Withdrawal by Subject|33|||
157010228|NCT04425629|566790161|FG000|Overall Study|Adverse Event|0|||
157115824|NCT01227044|567177461|FG001|Overall Study|Discontinued Intervention|2|||
157115825|NCT02250274|567177462|FG000|Overall Study|Insufficient blood draw amount|7|||
157115826|NCT02250274|567177463|FG001|Overall Study|Insufficient blood draw amount|6|||
157115827|NCT00583362|567177464|FG000|Overall Study|Adverse Event|44|||
157115828|NCT00583362|567177464|FG000|Overall Study|Lack of Efficacy|22|||
157115829|NCT00583362|567177464|FG000|Overall Study|Lost to Follow-up|4|||
157115830|NCT00583362|567177464|FG000|Overall Study|Non-compliance with study drug|28|||
156866585|NCT00129402|566271288|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
157115831|NCT00583362|567177464|FG000|Overall Study|Pregnancy|7|||
157115832|NCT00583362|567177464|FG000|Overall Study|Miscommunication of visit window|5|||
157115833|NCT00583362|567177464|FG000|Overall Study|Current site closed|7|||
157115834|NCT00583362|567177464|FG000|Overall Study|Subject not dosed in LBSL99|1|||
157115835|NCT00583362|567177464|FG000|Overall Study|Subject moved out of the country/state|2|||
157115836|NCT00583362|567177464|FG000|Overall Study|Missed visits due to staff changes|1|||
157115837|NCT00583362|567177464|FG000|Overall Study|Misunderstanding of protocol|1|||
157115838|NCT00583362|567177464|FG000|Overall Study|Behavioral problems and non-compliance|1|||
157115839|NCT00583362|567177464|FG000|Overall Study|Sponsor request due to missed doses|1|||
157115840|NCT00583362|567177464|FG000|Overall Study|Physician Decision|19|||
157115841|NCT00583362|567177464|FG000|Overall Study|Protocol Violation|2|||
157115842|NCT00583362|567177464|FG000|Overall Study|Withdrawal by Subject|57|||
157115843|NCT04247061|567177465|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
157115844|NCT04247061|567177465|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
157115845|NCT04247061|567177465|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
157115846|NCT04770389|567177468|FG000|Overall Study|Adverse Event|1|||
157115847|NCT04770389|567177469|FG001|Overall Study|Adverse Event|2|||
157115848|NCT04770389|567177470|FG002|Overall Study|Adverse Event|0|||
157115849|NCT04770389|567177471|FG003|Overall Study|Adverse Event|1|||
157115850|NCT04770389|567177468|FG000|Overall Study|Withdrawal by Subject|0|||
157115851|NCT04770389|567177469|FG001|Overall Study|Withdrawal by Subject|2|||
157115852|NCT04770389|567177470|FG002|Overall Study|Withdrawal by Subject|1|||
157115853|NCT04770389|567177471|FG003|Overall Study|Withdrawal by Subject|0|||
157115854|NCT04770389|567177468|FG000|Overall Study|Failed attempt to draw blood|1|||
157115855|NCT04770389|567177469|FG001|Overall Study|Failed attempt to draw blood|0|||
157115856|NCT04770389|567177470|FG002|Overall Study|Failed attempt to draw blood|0|||
157115857|NCT04770389|567177471|FG003|Overall Study|Failed attempt to draw blood|0|||
157115858|NCT04770389|567177468|FG000|Overall Study|Left the country|0|||
157115859|NCT04770389|567177469|FG001|Overall Study|Left the country|0|||
157115860|NCT04770389|567177470|FG002|Overall Study|Left the country|1|||
157115861|NCT04770389|567177471|FG003|Overall Study|Left the country|2|||
157115862|NCT04770389|567177468|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
157115863|NCT04770389|567177469|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
157115864|NCT04770389|567177470|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
157115865|NCT04770389|567177471|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
157115866|NCT04770389|567177468|FG000|Overall Study|Lost to Follow-up|0|||
157115867|NCT04770389|567177469|FG001|Overall Study|Lost to Follow-up|0|||
157115868|NCT04770389|567177470|FG002|Overall Study|Lost to Follow-up|0|||
157115869|NCT04770389|567177471|FG003|Overall Study|Lost to Follow-up|1|||
157115870|NCT04770389|567177468|FG000|Overall Study|Moved away from study site|0|||
157115871|NCT04770389|567177469|FG001|Overall Study|Moved away from study site|1|||
157115872|NCT04770389|567177470|FG002|Overall Study|Moved away from study site|0|||
157115873|NCT04770389|567177471|FG003|Overall Study|Moved away from study site|0|||
157115874|NCT03765138|567177472|FG000|Overall Study|Lost to Follow-up|1|||
157115875|NCT02821715|567177477|FG000|Overall Study|Protocol Violation|1|||
157115876|NCT02821715|567177478|FG001|Overall Study|Protocol Violation|0|||
157115877|NCT02821715|567177479|FG002|Overall Study|Protocol Violation|0|||
157115878|NCT02821715|567177480|FG003|Overall Study|Protocol Violation|0|||
157115879|NCT02821715|567177481|FG004|Overall Study|Protocol Violation|0|||
157115880|NCT02821715|567177482|FG005|Overall Study|Protocol Violation|0|||
157115881|NCT04294719|567177483|FG000|Overall Study|Withdrawal by Subject|1|||
157115882|NCT03921424|567177491|FG000|Overall Study|Lost to Follow-up|0|||
157115883|NCT03921424|567177492|FG001|Overall Study|Lost to Follow-up|1|||
157115884|NCT03921424|567177491|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
157115885|NCT03921424|567177492|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
157115886|NCT00805480|567177496|FG000|Overall Study|Withdrawal by Subject|13|||
157115887|NCT00805480|567177497|FG001|Overall Study|Withdrawal by Subject|5|||
157115888|NCT00805480|567177498|FG002|Overall Study|Withdrawal by Subject|11|||
157115889|NCT00805480|567177499|FG003|Overall Study|Withdrawal by Subject|5|||
157115890|NCT00805480|567177496|FG000|Overall Study|Lost to Follow-up|1|||
157115891|NCT00805480|567177497|FG001|Overall Study|Lost to Follow-up|2|||
157115892|NCT00805480|567177498|FG002|Overall Study|Lost to Follow-up|0|||
157115893|NCT00805480|567177499|FG003|Overall Study|Lost to Follow-up|0|||
157115894|NCT00805480|567177496|FG000|Overall Study|Adverse Event|0|||
157115895|NCT00805480|567177497|FG001|Overall Study|Adverse Event|0|||
157115896|NCT00805480|567177498|FG002|Overall Study|Adverse Event|1|||
157115897|NCT00805480|567177499|FG003|Overall Study|Adverse Event|0|||
157115898|NCT02595450|567177502|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
157115899|NCT02595450|567177502|FG000|Overall Study|Enrolled, but not treated|8|||
157115900|NCT00733954|567177505|FG000|Overall Study|Lost to Follow-up|5|||
157115901|NCT00733954|567177506|FG001|Overall Study|Lost to Follow-up|2|||
157115902|NCT00733954|567177505|FG000|Overall Study|Protocol Violation|1|||
157115903|NCT00733954|567177506|FG001|Overall Study|Protocol Violation|0|||
157115904|NCT00733954|567177505|FG000|Overall Study|Withdrawal by Subject|2|||
157115905|NCT00733954|567177506|FG001|Overall Study|Withdrawal by Subject|0|||
157115906|NCT02663453|567177507|FG000|Overall Study|Death|4|||
157210551|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
157115907|NCT02663453|567177508|FG001|Overall Study|Death|4|||
157115908|NCT02663453|567177507|FG000|Overall Study|Withdrawal by Subject|1|||
157115909|NCT02663453|567177508|FG001|Overall Study|Withdrawal by Subject|0|||
157115910|NCT03770260|567178905|FG000|Overall Study|Disease progression|0|||
157115911|NCT03770260|567178906|FG001|Overall Study|Disease progression|1|||
157115912|NCT03770260|567178907|FG002|Overall Study|Disease progression|0|||
157115913|NCT03770260|567178908|FG003|Overall Study|Disease progression|0|||
157115914|NCT01908101|567178915|FG000|Overall Study|Physician Decision|1|||
157115915|NCT01908101|567178915|FG000|Overall Study|Withdrawal by Subject|1|||
157115916|NCT01908101|567178915|FG000|Overall Study|Incorrect Diagnosis|2|||
157115917|NCT01908101|567178915|FG000|Overall Study|Incorrect Starting Dose|1|||
157210552|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157210553|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157010229|NCT04425629|566790162|FG001|Overall Study|Adverse Event|0|||
157010230|NCT04425629|566790163|FG002|Overall Study|Adverse Event|0|||
157010231|NCT04425629|566790164|FG003|Overall Study|Adverse Event|0|||
157010232|NCT04425629|566790165|FG004|Overall Study|Adverse Event|1|||
157010233|NCT04425629|566790166|FG005|Overall Study|Adverse Event|0|||
157010234|NCT04425629|566790167|FG006|Overall Study|Adverse Event|0|||
157010235|NCT04425629|566790168|FG007|Overall Study|Adverse Event|0|||
157010236|NCT04425629|566790169|FG008|Overall Study|Adverse Event|0|||
157010237|NCT04425629|566790170|FG009|Overall Study|Adverse Event|3|||
157010238|NCT04425629|566790171|FG010|Overall Study|Adverse Event|2|||
157010239|NCT04425629|566790172|FG011|Overall Study|Adverse Event|1|||
157010240|NCT04425629|566790173|FG012|Overall Study|Adverse Event|1|||
157010241|NCT04425629|566790174|FG013|Overall Study|Adverse Event|0|||
157010242|NCT04425629|566790175|FG014|Overall Study|Adverse Event|0|||
157010243|NCT04425629|566790176|FG015|Overall Study|Adverse Event|0|||
157010244|NCT04425629|566790177|FG016|Overall Study|Adverse Event|0|||
157010245|NCT04425629|566790178|FG017|Overall Study|Adverse Event|0|||
157010246|NCT04425629|566790179|FG018|Overall Study|Adverse Event|0|||
157010247|NCT04425629|566790161|FG000|Overall Study|Lost to Follow-up|1|||
157010248|NCT04425629|566790162|FG001|Overall Study|Lost to Follow-up|3|||
157010249|NCT04425629|566790163|FG002|Overall Study|Lost to Follow-up|1|||
157010250|NCT04425629|566790164|FG003|Overall Study|Lost to Follow-up|7|||
157010251|NCT04425629|566790165|FG004|Overall Study|Lost to Follow-up|1|||
157010252|NCT04425629|566790166|FG005|Overall Study|Lost to Follow-up|2|||
157010253|NCT04425629|566790167|FG006|Overall Study|Lost to Follow-up|1|||
157010254|NCT04425629|566790168|FG007|Overall Study|Lost to Follow-up|0|||
157010255|NCT04425629|566790169|FG008|Overall Study|Lost to Follow-up|1|||
157010256|NCT04425629|566790170|FG009|Overall Study|Lost to Follow-up|64|||
157010257|NCT04425629|566790171|FG010|Overall Study|Lost to Follow-up|70|||
157010258|NCT04425629|566790172|FG011|Overall Study|Lost to Follow-up|98|||
157010259|NCT04425629|566790173|FG012|Overall Study|Lost to Follow-up|30|||
157010260|NCT04425629|566790174|FG013|Overall Study|Lost to Follow-up|0|||
157010261|NCT04425629|566790175|FG014|Overall Study|Lost to Follow-up|5|||
157010262|NCT04425629|566790176|FG015|Overall Study|Lost to Follow-up|4|||
157010263|NCT04425629|566790177|FG016|Overall Study|Lost to Follow-up|0|||
157010264|NCT04425629|566790178|FG017|Overall Study|Lost to Follow-up|3|||
157010265|NCT04425629|566790179|FG018|Overall Study|Lost to Follow-up|1|||
157010266|NCT04425629|566790161|FG000|Overall Study|Subject Decision|0|||
157115918|NCT01908101|567178915|FG000|Overall Study|Did not complete the first cycle|4|||
157115919|NCT00772954|567178917|FG000|Overall Study|Adverse Event|0|||
157115920|NCT00772954|567178918|FG001|Overall Study|Adverse Event|0|||
157115921|NCT00772954|567178919|FG002|Overall Study|Adverse Event|1|||
157115922|NCT01659320|567178924|FG000|Overall Study|Withdrawal by Subject|2|||
157115923|NCT01659320|567178924|FG000|Overall Study|Physician Decision|1|||
157115924|NCT00590590|567178925|FG000|Overall Study|Lack of Efficacy|1|||
157115925|NCT00590590|567178926|FG001|Overall Study|Lack of Efficacy|2|||
157115926|NCT00590590|567178927|FG002|Overall Study|Lack of Efficacy|0|||
157115927|NCT00590590|567178925|FG000|Overall Study|Adverse Event|1|||
157115928|NCT00590590|567178926|FG001|Overall Study|Adverse Event|0|||
157115929|NCT00590590|567178927|FG002|Overall Study|Adverse Event|0|||
157115930|NCT00590590|567178925|FG000|Overall Study|Protocol Violation|0|||
157115931|NCT00590590|567178926|FG001|Overall Study|Protocol Violation|0|||
157115932|NCT00590590|567178927|FG002|Overall Study|Protocol Violation|2|||
157115933|NCT00590590|567178925|FG000|Overall Study|Lost to Follow-up|4|||
157115934|NCT00590590|567178926|FG001|Overall Study|Lost to Follow-up|1|||
157115935|NCT00590590|567178927|FG002|Overall Study|Lost to Follow-up|2|||
157115936|NCT00590590|567178925|FG000|Overall Study|Withdrawal by Subject|0|||
157115937|NCT00590590|567178926|FG001|Overall Study|Withdrawal by Subject|1|||
157115938|NCT00590590|567178927|FG002|Overall Study|Withdrawal by Subject|1|||
157115939|NCT00590590|567178925|FG000|Overall Study|Did not complete due to study closure|1|||
157115940|NCT00590590|567178926|FG001|Overall Study|Did not complete due to study closure|1|||
157115941|NCT00590590|567178927|FG002|Overall Study|Did not complete due to study closure|1|||
157115942|NCT00590590|567178925|FG000|Overall Study|Did not complete study|0|||
157115943|NCT00590590|567178926|FG001|Overall Study|Did not complete study|1|||
157210554|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
157115944|NCT00590590|567178927|FG002|Overall Study|Did not complete study|0|||
157115945|NCT00132132|567178928|FG000|Overall Study|Lost to Follow-up|7|||
157115946|NCT00132132|567178929|FG001|Overall Study|Lost to Follow-up|2|||
157115947|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
157115948|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
157115949|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
157115950|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
157115951|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
157115952|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
157115953|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
157115954|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
157115955|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
157115956|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
157115957|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
157210555|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
157210556|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
157210557|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
157210558|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
157210559|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
157115958|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
157115959|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
157115960|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
157115961|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
157115962|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
157115963|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
157115964|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
157115965|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
157115966|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
157115967|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
157115968|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
157115969|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
157115970|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
157115971|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
157115972|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
157115973|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
157115974|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
157115975|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
157115976|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
157115977|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
157210560|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210561|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157115978|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
157210562|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210563|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210564|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210565|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210566|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210567|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210568|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210569|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210570|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
157210571|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210572|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210573|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210574|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210575|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210576|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210577|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210578|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
157210579|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
157210580|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
157210581|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157115979|NCT03605680|567178932|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
157115980|NCT03605680|567178933|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
157115981|NCT03605680|567178934|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
157115982|NCT03605680|567178935|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
157115983|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
157115984|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
157210582|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157115985|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
157115986|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
157115987|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
157115988|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
157210583|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
157210584|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
157210585|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157010267|NCT04425629|566790162|FG001|Overall Study|Subject Decision|2|||
157010268|NCT04425629|566790163|FG002|Overall Study|Subject Decision|1|||
157010269|NCT04425629|566790164|FG003|Overall Study|Subject Decision|3|||
157010270|NCT04425629|566790165|FG004|Overall Study|Subject Decision|6|||
157010271|NCT04425629|566790166|FG005|Overall Study|Subject Decision|6|||
157010272|NCT04425629|566790167|FG006|Overall Study|Subject Decision|3|||
157010273|NCT04425629|566790168|FG007|Overall Study|Subject Decision|3|||
157010274|NCT04425629|566790169|FG008|Overall Study|Subject Decision|1|||
157010275|NCT04425629|566790170|FG009|Overall Study|Subject Decision|70|||
157010276|NCT04425629|566790171|FG010|Overall Study|Subject Decision|95|||
157010277|NCT04425629|566790172|FG011|Overall Study|Subject Decision|124|||
157010278|NCT04425629|566790173|FG012|Overall Study|Subject Decision|25|||
157010279|NCT04425629|566790174|FG013|Overall Study|Subject Decision|0|||
157010280|NCT04425629|566790175|FG014|Overall Study|Subject Decision|1|||
157010281|NCT04425629|566790176|FG015|Overall Study|Subject Decision|4|||
157010282|NCT04425629|566790177|FG016|Overall Study|Subject Decision|1|||
157115989|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
157010283|NCT04425629|566790178|FG017|Overall Study|Subject Decision|0|||
157010284|NCT04425629|566790179|FG018|Overall Study|Subject Decision|2|||
157010285|NCT04425629|566790161|FG000|Overall Study|Death|0|||
157010286|NCT04425629|566790162|FG001|Overall Study|Death|0|||
157010287|NCT04425629|566790163|FG002|Overall Study|Death|0|||
157010288|NCT04425629|566790164|FG003|Overall Study|Death|0|||
157010289|NCT04425629|566790165|FG004|Overall Study|Death|0|||
157010290|NCT04425629|566790166|FG005|Overall Study|Death|0|||
157010291|NCT04425629|566790167|FG006|Overall Study|Death|0|||
157010292|NCT04425629|566790168|FG007|Overall Study|Death|0|||
157010293|NCT04425629|566790169|FG008|Overall Study|Death|0|||
157210586|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
157115990|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
157115991|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157115992|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157115993|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157115994|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
157115995|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
157115996|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
157115997|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
157115998|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
157115999|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
157116000|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
157116001|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
157116002|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
157116003|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
157116004|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
157116005|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
157116006|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
157116007|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
157116008|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
157116009|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
157116010|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
157116011|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
157116012|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
157116013|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
157116014|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
157116015|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
157116016|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
157116017|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
157116018|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
157116019|NCT03605680|567178932|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
157116020|NCT03605680|567178933|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
157116021|NCT03605680|567178934|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
157116022|NCT03605680|567178935|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
157116023|NCT00647556|567178936|FG000|Overall Study|Adverse Event|0|||
157210587|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157116024|NCT00647556|567178937|FG001|Overall Study|Adverse Event|1|||
157116025|NCT00647556|567178936|FG000|Overall Study|Lost to Follow-up|1|||
157116026|NCT00647556|567178937|FG001|Overall Study|Lost to Follow-up|0|||
157116027|NCT00647556|567178936|FG000|Overall Study|Protocol Violation|0|||
157116028|NCT00647556|567178937|FG001|Overall Study|Protocol Violation|1|||
157116029|NCT00647556|567178936|FG000|Overall Study|Withdrawal by Subject|1|||
157116030|NCT00647556|567178937|FG001|Overall Study|Withdrawal by Subject|0|||
157116031|NCT00647556|567178936|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
157116032|NCT00647556|567178937|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
157116033|NCT03865706|567178941|FG000|Overall Study|Death|0|||
157116034|NCT03865706|567178942|FG001|Overall Study|Death|3|||
157116035|NCT03865706|567178943|FG002|Overall Study|Death|1|||
157116036|NCT02646982|567178944|FG000|Overall Study|Adverse Event|1|||
157116037|NCT02646982|567178945|FG001|Overall Study|Adverse Event|1|||
157116038|NCT02646982|567178944|FG000|Overall Study|Withdrawal by Subject|2|||
157210588|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
157210589|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157210590|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157210591|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
157210592|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
157210593|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
157210594|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
157210595|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
157210596|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
157210597|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
157210598|NCT01915498|567517023|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
157210599|NCT01915498|567517024|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
157210600|NCT01915498|567517025|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
157210601|NCT01915498|567517026|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
157210602|NCT01915498|567517027|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
157210603|NCT01915498|567517028|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
157210604|NCT01915498|567517029|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
157210605|NCT01915498|567517030|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
157210606|NCT01915498|567517031|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
157210607|NCT01915498|567517032|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
157210608|NCT01915498|567517033|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
157210609|NCT01915498|567517034|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
157210610|NCT01915498|567517035|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
157210611|NCT01915498|567517036|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
157210612|NCT01915498|567517037|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
157210613|NCT01915498|567517038|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
157210614|NCT01915498|567517039|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
157210615|NCT01915498|567517040|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
157210616|NCT01915498|567517041|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
157210617|NCT01915498|567517023|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210618|NCT01915498|567517024|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210619|NCT01915498|567517025|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210620|NCT01915498|567517026|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210621|NCT01915498|567517027|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210622|NCT01915498|567517028|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157010294|NCT04425629|566790170|FG009|Overall Study|Death|11|||
157010295|NCT04425629|566790171|FG010|Overall Study|Death|2|||
157010296|NCT04425629|566790172|FG011|Overall Study|Death|4|||
157116039|NCT02646982|567178945|FG001|Overall Study|Withdrawal by Subject|1|||
157116040|NCT02095535|567178946|FG000|Recruitment|Protocol Violation|2|||
157116041|NCT00769002|567178947|FG000|Overall Study|Study was not completed, no data|9|||
157116042|NCT00769002|567178948|FG001|Overall Study|Study was not completed, no data|9|||
157116043|NCT04677712|567178949|FG000|Overall Study|Lost to Follow-up|0|||
157116044|NCT04677712|567178950|FG001|Overall Study|Lost to Follow-up|1|||
157116045|NCT04677712|567178951|FG002|Overall Study|Lost to Follow-up|0|||
157116046|NCT04677712|567178952|FG003|Overall Study|Lost to Follow-up|0|||
157116047|NCT04677712|567178953|FG004|Overall Study|Lost to Follow-up|0|||
157116048|NCT04677712|567178954|FG005|Overall Study|Lost to Follow-up|0|||
157116049|NCT00847912|567178955|FG000|Overall Study|Protocol Violation|6|||
157116050|NCT00847912|567178956|FG001|Overall Study|Protocol Violation|7|||
157116051|NCT00847912|567178955|FG000|Overall Study|Withdrawal by Subject|3|||
157116052|NCT00847912|567178956|FG001|Overall Study|Withdrawal by Subject|6|||
157116053|NCT01496885|567178957|FG000|Overall Study|Lost to Follow-up|13|||
157116054|NCT01496885|567178957|FG000|Overall Study|Withdrawal by Subject|7|||
157116055|NCT01496885|567178957|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
157116056|NCT01496885|567178957|FG000|Overall Study|Death|1|||
157116057|NCT03273166|567178958|FG000|Overall Study|Withdrawn prior to Completion|31|||
157116058|NCT01294670|567178959|FG000|Overall Study|Not treated|1|||
157116059|NCT01294670|567178960|FG001|Overall Study|Not treated|0|||
157116060|NCT01294670|567178961|FG002|Overall Study|Not treated|0|||
157116061|NCT01294670|567178962|FG003|Overall Study|Not treated|0|||
157116062|NCT01294670|567178963|FG004|Overall Study|Not treated|0|||
157116063|NCT02083380|567178965|FG000|Overall Study|Lack of Efficacy|68|||
157116064|NCT02083380|567178966|FG001|Overall Study|Lack of Efficacy|79|||
157116065|NCT02083380|567178967|FG002|Overall Study|Lack of Efficacy|64|||
157116066|NCT02083380|567178965|FG000|Overall Study|Withdrawal by Subject|9|||
157116067|NCT02083380|567178966|FG001|Overall Study|Withdrawal by Subject|3|||
157116068|NCT02083380|567178967|FG002|Overall Study|Withdrawal by Subject|7|||
157116069|NCT02083380|567178965|FG000|Overall Study|Physician Decision|1|||
157116070|NCT02083380|567178966|FG001|Overall Study|Physician Decision|6|||
157116071|NCT02083380|567178967|FG002|Overall Study|Physician Decision|3|||
157116072|NCT02083380|567178965|FG000|Overall Study|Adverse Event|0|||
157116073|NCT02083380|567178966|FG001|Overall Study|Adverse Event|0|||
157116074|NCT02083380|567178967|FG002|Overall Study|Adverse Event|1|||
157116075|NCT02083380|567178965|FG000|Overall Study|Lost to Follow-up|5|||
157116076|NCT02083380|567178966|FG001|Overall Study|Lost to Follow-up|3|||
157116077|NCT02083380|567178967|FG002|Overall Study|Lost to Follow-up|3|||
157116078|NCT02083380|567178965|FG000|Overall Study|Other|8|||
157116079|NCT02083380|567178966|FG001|Overall Study|Other|4|||
157116080|NCT02083380|567178967|FG002|Overall Study|Other|6|||
157116081|NCT01577186|567178970|FG000|Overall Study|Adverse Event|23|||
157116082|NCT01577186|567178970|FG000|Overall Study|Death|1|||
157116083|NCT01577186|567178970|FG000|Overall Study|Lost to Follow-up|28|||
156779779|NCT00221104|565943873|FG001|Overall Study|Others|47|||
157116084|NCT01577186|567178970|FG000|Overall Study|Withdrawal by Subject|35|||
157116085|NCT01577186|567178970|FG000|Overall Study|Insufficient Response|18|||
157116086|NCT01577186|567178970|FG000|Overall Study|Ineligible to Continue|15|||
157010297|NCT04425629|566790173|FG012|Overall Study|Death|0|||
157010298|NCT04425629|566790174|FG013|Overall Study|Death|0|||
157010299|NCT04425629|566790175|FG014|Overall Study|Death|0|||
157010300|NCT04425629|566790176|FG015|Overall Study|Death|0|||
157010301|NCT04425629|566790177|FG016|Overall Study|Death|0|||
157010302|NCT04425629|566790178|FG017|Overall Study|Death|0|||
157010303|NCT04425629|566790179|FG018|Overall Study|Death|0|||
157010304|NCT04425629|566790161|FG000|Overall Study|Sponsor Request|0|||
157010305|NCT04425629|566790162|FG001|Overall Study|Sponsor Request|0|||
157010306|NCT04425629|566790163|FG002|Overall Study|Sponsor Request|0|||
157010307|NCT04425629|566790164|FG003|Overall Study|Sponsor Request|2|||
157010308|NCT04425629|566790165|FG004|Overall Study|Sponsor Request|2|||
157010309|NCT04425629|566790166|FG005|Overall Study|Sponsor Request|2|||
157010310|NCT04425629|566790167|FG006|Overall Study|Sponsor Request|1|||
157010311|NCT04425629|566790168|FG007|Overall Study|Sponsor Request|0|||
157010312|NCT04425629|566790169|FG008|Overall Study|Sponsor Request|0|||
157010313|NCT04425629|566790170|FG009|Overall Study|Sponsor Request|9|||
157010314|NCT04425629|566790171|FG010|Overall Study|Sponsor Request|9|||
157010315|NCT04425629|566790172|FG011|Overall Study|Sponsor Request|10|||
157010316|NCT04425629|566790173|FG012|Overall Study|Sponsor Request|8|||
157010317|NCT04425629|566790174|FG013|Overall Study|Sponsor Request|0|||
157010318|NCT04425629|566790175|FG014|Overall Study|Sponsor Request|0|||
157010319|NCT04425629|566790176|FG015|Overall Study|Sponsor Request|1|||
157010320|NCT04425629|566790177|FG016|Overall Study|Sponsor Request|0|||
157010321|NCT04425629|566790178|FG017|Overall Study|Sponsor Request|0|||
157010322|NCT04425629|566790179|FG018|Overall Study|Sponsor Request|0|||
157010323|NCT04425629|566790161|FG000|Overall Study|Physician Decision|0|||
157010324|NCT04425629|566790162|FG001|Overall Study|Physician Decision|0|||
157010325|NCT04425629|566790163|FG002|Overall Study|Physician Decision|0|||
157010326|NCT04425629|566790164|FG003|Overall Study|Physician Decision|0|||
157010327|NCT04425629|566790165|FG004|Overall Study|Physician Decision|0|||
157010328|NCT04425629|566790166|FG005|Overall Study|Physician Decision|0|||
157010329|NCT04425629|566790167|FG006|Overall Study|Physician Decision|0|||
157010330|NCT04425629|566790168|FG007|Overall Study|Physician Decision|0|||
157010331|NCT04425629|566790169|FG008|Overall Study|Physician Decision|0|||
157010332|NCT04425629|566790170|FG009|Overall Study|Physician Decision|4|||
157010333|NCT04425629|566790171|FG010|Overall Study|Physician Decision|3|||
157010334|NCT04425629|566790172|FG011|Overall Study|Physician Decision|5|||
157010335|NCT04425629|566790173|FG012|Overall Study|Physician Decision|1|||
157010336|NCT04425629|566790174|FG013|Overall Study|Physician Decision|0|||
157010337|NCT04425629|566790175|FG014|Overall Study|Physician Decision|0|||
157010338|NCT04425629|566790176|FG015|Overall Study|Physician Decision|1|||
157010339|NCT04425629|566790177|FG016|Overall Study|Physician Decision|0|||
157010340|NCT04425629|566790178|FG017|Overall Study|Physician Decision|0|||
157010341|NCT04425629|566790179|FG018|Overall Study|Physician Decision|0|||
157010342|NCT04425629|566790161|FG000|Overall Study|Lack of Efficacy|0|||
157010343|NCT04425629|566790162|FG001|Overall Study|Lack of Efficacy|0|||
157010344|NCT04425629|566790163|FG002|Overall Study|Lack of Efficacy|0|||
157010345|NCT04425629|566790164|FG003|Overall Study|Lack of Efficacy|0|||
157010346|NCT04425629|566790165|FG004|Overall Study|Lack of Efficacy|0|||
157010347|NCT04425629|566790166|FG005|Overall Study|Lack of Efficacy|0|||
157010348|NCT04425629|566790167|FG006|Overall Study|Lack of Efficacy|0|||
157010349|NCT04425629|566790168|FG007|Overall Study|Lack of Efficacy|0|||
157010350|NCT04425629|566790169|FG008|Overall Study|Lack of Efficacy|0|||
157010351|NCT04425629|566790170|FG009|Overall Study|Lack of Efficacy|0|||
157010352|NCT04425629|566790171|FG010|Overall Study|Lack of Efficacy|1|||
157010353|NCT04425629|566790172|FG011|Overall Study|Lack of Efficacy|0|||
157010354|NCT04425629|566790173|FG012|Overall Study|Lack of Efficacy|0|||
157010355|NCT04425629|566790174|FG013|Overall Study|Lack of Efficacy|0|||
157010356|NCT04425629|566790175|FG014|Overall Study|Lack of Efficacy|0|||
157010357|NCT04425629|566790176|FG015|Overall Study|Lack of Efficacy|0|||
157010358|NCT04425629|566790177|FG016|Overall Study|Lack of Efficacy|0|||
157010359|NCT04425629|566790178|FG017|Overall Study|Lack of Efficacy|0|||
157010360|NCT04425629|566790179|FG018|Overall Study|Lack of Efficacy|0|||
157010361|NCT04259450|566790182|FG000|Overall Study|Adverse event/ Toxicity|0|||
157010362|NCT04259450|566790183|FG001|Overall Study|Adverse event/ Toxicity|3|||
157010363|NCT04259450|566790184|FG002|Overall Study|Adverse event/ Toxicity|0|||
157010364|NCT04259450|566790185|FG003|Overall Study|Adverse event/ Toxicity|1|||
157010365|NCT04259450|566790186|FG004|Overall Study|Adverse event/ Toxicity|0|||
157010366|NCT04259450|566790187|FG005|Overall Study|Adverse event/ Toxicity|0|||
157010367|NCT04259450|566790188|FG006|Overall Study|Adverse event/ Toxicity|0|||
157010368|NCT04259450|566790189|FG007|Overall Study|Adverse event/ Toxicity|1|||
157210623|NCT01915498|567517029|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210624|NCT01915498|567517030|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157116087|NCT01577186|567178970|FG000|Overall Study|Non-Compliant|8|||
157116088|NCT01577186|567178970|FG000|Overall Study|Other|2|||
157116089|NCT01032915|567178971|FG000|Overall Study|Adverse Event|2|||
157116090|NCT01032915|567178972|FG001|Overall Study|Adverse Event|2|||
157116091|NCT01032915|567178973|FG002|Overall Study|Adverse Event|1|||
157116092|NCT01032915|567178974|FG003|Overall Study|Adverse Event|1|||
157116093|NCT01032915|567178971|FG000|Overall Study|Abnormal test procedure result|0|||
157116094|NCT01032915|567178972|FG001|Overall Study|Abnormal test procedure result|0|||
157116095|NCT01032915|567178973|FG002|Overall Study|Abnormal test procedure result|1|||
157116096|NCT01032915|567178974|FG003|Overall Study|Abnormal test procedure result|0|||
157116097|NCT01032915|567178971|FG000|Overall Study|Withdrawal by Subject|0|||
157116098|NCT01032915|567178972|FG001|Overall Study|Withdrawal by Subject|3|||
157116099|NCT01032915|567178973|FG002|Overall Study|Withdrawal by Subject|1|||
157116100|NCT01032915|567178974|FG003|Overall Study|Withdrawal by Subject|1|||
157116101|NCT01032915|567178971|FG000|Overall Study|Administrative reasons|5|||
157116102|NCT01032915|567178972|FG001|Overall Study|Administrative reasons|6|||
157210625|NCT01915498|567517031|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210626|NCT01915498|567517032|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210627|NCT01915498|567517033|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210628|NCT01915498|567517034|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157010369|NCT04259450|566790190|FG008|Overall Study|Adverse event/ Toxicity|0|||
157010370|NCT04259450|566790191|FG009|Overall Study|Adverse event/ Toxicity|3|||
157010371|NCT04259450|566790182|FG000|Overall Study|Disease progression|2|||
157010372|NCT04259450|566790183|FG001|Overall Study|Disease progression|3|||
157010373|NCT04259450|566790184|FG002|Overall Study|Disease progression|4|||
157010374|NCT04259450|566790185|FG003|Overall Study|Disease progression|4|||
157010375|NCT04259450|566790186|FG004|Overall Study|Disease progression|6|||
157010376|NCT04259450|566790187|FG005|Overall Study|Disease progression|6|||
157010377|NCT04259450|566790188|FG006|Overall Study|Disease progression|6|||
157010378|NCT04259450|566790189|FG007|Overall Study|Disease progression|15|||
157010379|NCT04259450|566790190|FG008|Overall Study|Disease progression|6|||
157010380|NCT04259450|566790191|FG009|Overall Study|Disease progression|18|||
157010381|NCT04259450|566790182|FG000|Overall Study|Death|0|||
157010382|NCT04259450|566790183|FG001|Overall Study|Death|0|||
157010383|NCT04259450|566790184|FG002|Overall Study|Death|0|||
157010384|NCT04259450|566790185|FG003|Overall Study|Death|0|||
157010385|NCT04259450|566790186|FG004|Overall Study|Death|0|||
157010386|NCT04259450|566790187|FG005|Overall Study|Death|0|||
157010387|NCT04259450|566790188|FG006|Overall Study|Death|0|||
157010388|NCT04259450|566790189|FG007|Overall Study|Death|1|||
157010389|NCT04259450|566790190|FG008|Overall Study|Death|1|||
157010390|NCT04259450|566790191|FG009|Overall Study|Death|0|||
157010391|NCT04259450|566790182|FG000|Overall Study|Withdrawal by Subject|0|||
157010392|NCT04259450|566790183|FG001|Overall Study|Withdrawal by Subject|0|||
157010393|NCT04259450|566790184|FG002|Overall Study|Withdrawal by Subject|0|||
157010394|NCT04259450|566790185|FG003|Overall Study|Withdrawal by Subject|0|||
157010395|NCT04259450|566790186|FG004|Overall Study|Withdrawal by Subject|0|||
157010396|NCT04259450|566790187|FG005|Overall Study|Withdrawal by Subject|0|||
157010397|NCT04259450|566790188|FG006|Overall Study|Withdrawal by Subject|0|||
157010398|NCT04259450|566790189|FG007|Overall Study|Withdrawal by Subject|1|||
157010399|NCT04259450|566790190|FG008|Overall Study|Withdrawal by Subject|0|||
157010400|NCT04259450|566790191|FG009|Overall Study|Withdrawal by Subject|0|||
157010401|NCT04259450|566790182|FG000|Overall Study|Other than listed|0|||
157010402|NCT04259450|566790183|FG001|Overall Study|Other than listed|0|||
157010403|NCT04259450|566790184|FG002|Overall Study|Other than listed|0|||
157010404|NCT04259450|566790185|FG003|Overall Study|Other than listed|0|||
157116103|NCT01032915|567178973|FG002|Overall Study|Administrative reasons|4|||
157116104|NCT01032915|567178974|FG003|Overall Study|Administrative reasons|4|||
157116105|NCT01032915|567178971|FG000|Overall Study|Protocol Violation|1|||
157116106|NCT01032915|567178972|FG001|Overall Study|Protocol Violation|0|||
157116107|NCT01032915|567178973|FG002|Overall Study|Protocol Violation|0|||
157116108|NCT01032915|567178974|FG003|Overall Study|Protocol Violation|1|||
157116109|NCT02915523|567178976|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
157116110|NCT02915523|567178977|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
157116111|NCT02915523|567178978|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
157116112|NCT02915523|567178979|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
157210629|NCT01915498|567517035|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157010405|NCT04259450|566790186|FG004|Overall Study|Other than listed|0|||
157010406|NCT04259450|566790187|FG005|Overall Study|Other than listed|0|||
157010407|NCT04259450|566790188|FG006|Overall Study|Other than listed|0|||
157116113|NCT02915523|567178976|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
157210630|NCT01915498|567517036|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157010408|NCT04259450|566790189|FG007|Overall Study|Other than listed|1|||
157010409|NCT04259450|566790190|FG008|Overall Study|Other than listed|1|||
157010410|NCT04259450|566790191|FG009|Overall Study|Other than listed|2|||
157210631|NCT01915498|567517037|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210632|NCT01915498|567517038|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157010411|NCT00542789|566790198|FG000|Overall Study|Adverse Event|18|||
157010412|NCT00542789|566790199|FG001|Overall Study|Adverse Event|17|||
157010413|NCT00542789|566790198|FG000|Overall Study|Withdrawal by Subject|7|||
157010414|NCT00542789|566790199|FG001|Overall Study|Withdrawal by Subject|3|||
157010415|NCT00542789|566790198|FG000|Overall Study|Protocol Violation|8|||
157010416|NCT00542789|566790199|FG001|Overall Study|Protocol Violation|1|||
157010417|NCT00542789|566790198|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
157010418|NCT00542789|566790199|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
157010419|NCT02584829|566790201|FG000|Overall Study|Physician Decision|1|||
157010420|NCT02584829|566790202|FG001|Overall Study|Physician Decision|0|||
157010421|NCT02584829|566790201|FG000|Overall Study|Withdrawal by Subject|0|||
157010422|NCT02584829|566790202|FG001|Overall Study|Withdrawal by Subject|1|||
157010423|NCT02584829|566790201|FG000|Overall Study|Progressive Disease|0|||
157010424|NCT02584829|566790202|FG001|Overall Study|Progressive Disease|3|||
157010425|NCT00446459|566790204|FG000|8 Months|Protocol Violation|12|||
157010426|NCT00446459|566790204|FG000|12 Months|Protocol Violation|4|||
157010427|NCT00446459|566790204|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
157010428|NCT02597920|566790212|FG000|Overall Study|Worsening of other pre-existing disease|0|||
157010429|NCT02597920|566790213|FG001|Overall Study|Worsening of other pre-existing disease|1|||
157010430|NCT02597920|566790214|FG002|Overall Study|Worsening of other pre-existing disease|0|||
157010431|NCT02597920|566790212|FG000|Overall Study|Other adverse event|20|||
157010432|NCT02597920|566790213|FG001|Overall Study|Other adverse event|30|||
157010433|NCT02597920|566790214|FG002|Overall Study|Other adverse event|0|||
157010434|NCT02597920|566790212|FG000|Overall Study|Lost to Follow-up|7|||
157010435|NCT02597920|566790213|FG001|Overall Study|Lost to Follow-up|9|||
157010436|NCT02597920|566790214|FG002|Overall Study|Lost to Follow-up|0|||
157010437|NCT02597920|566790212|FG000|Overall Study|Refuse to continue in the study|3|||
157010438|NCT02597920|566790213|FG001|Overall Study|Refuse to continue in the study|13|||
157010439|NCT02597920|566790214|FG002|Overall Study|Refuse to continue in the study|1|||
157010440|NCT02597920|566790212|FG000|Overall Study|Other than specified|10|||
157010441|NCT02597920|566790213|FG001|Overall Study|Other than specified|31|||
157010442|NCT02597920|566790214|FG002|Overall Study|Other than specified|5|||
157010443|NCT02597920|566790212|FG000|Overall Study|Other|1|||
157010444|NCT02597920|566790213|FG001|Overall Study|Other|0|||
157010445|NCT02597920|566790214|FG002|Overall Study|Other|0|||
157010446|NCT00391898|566790218|FG000|Overall Study|Adverse Event|3|||
157010447|NCT00391898|566790219|FG001|Overall Study|Adverse Event|0|||
157010448|NCT00391898|566790218|FG000|Overall Study|Other|8|||
157010449|NCT00391898|566790219|FG001|Overall Study|Other|10|||
157010450|NCT00960141|566790221|FG000|Overall Study|Adverse Event|4|||
157010451|NCT00960141|566790222|FG001|Overall Study|Adverse Event|8|||
157010452|NCT00960141|566790223|FG002|Overall Study|Adverse Event|2|||
157010453|NCT00960141|566790221|FG000|Overall Study|Lack of Efficacy|3|||
157010454|NCT00960141|566790222|FG001|Overall Study|Lack of Efficacy|4|||
157010455|NCT00960141|566790223|FG002|Overall Study|Lack of Efficacy|2|||
157010456|NCT00960141|566790221|FG000|Overall Study|Lost to Follow-up|1|||
157010457|NCT00960141|566790222|FG001|Overall Study|Lost to Follow-up|0|||
157010458|NCT00960141|566790223|FG002|Overall Study|Lost to Follow-up|0|||
157010459|NCT00960141|566790221|FG000|Overall Study|Protocol Violation|1|||
157010460|NCT00960141|566790222|FG001|Overall Study|Protocol Violation|3|||
157010461|NCT00960141|566790223|FG002|Overall Study|Protocol Violation|2|||
157010462|NCT00960141|566790221|FG000|Overall Study|Withdrawal by Subject|1|||
157010463|NCT00960141|566790222|FG001|Overall Study|Withdrawal by Subject|2|||
157010464|NCT00960141|566790223|FG002|Overall Study|Withdrawal by Subject|1|||
157010465|NCT03036813|566790224|FG000|Overall Study|Adverse Event|6|||
157010466|NCT03036813|566790225|FG001|Overall Study|Adverse Event|11|||
157010467|NCT03036813|566790226|FG002|Overall Study|Adverse Event|6|||
157010468|NCT03036813|566790224|FG000|Overall Study|Withdrawal by Subject|12|||
157010469|NCT03036813|566790225|FG001|Overall Study|Withdrawal by Subject|6|||
157010470|NCT03036813|566790226|FG002|Overall Study|Withdrawal by Subject|10|||
157010471|NCT03036813|566790224|FG000|Overall Study|Lost to Follow-up|1|||
157010472|NCT03036813|566790225|FG001|Overall Study|Lost to Follow-up|1|||
157010473|NCT03036813|566790226|FG002|Overall Study|Lost to Follow-up|0|||
157010474|NCT03036813|566790224|FG000|Overall Study|Physician Decision|2|||
157210633|NCT01915498|567517039|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210634|NCT01915498|567517040|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
157210635|NCT01915498|567517041|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
157210636|NCT01915498|567517023|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210637|NCT01915498|567517024|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210638|NCT01915498|567517025|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210639|NCT01915498|567517026|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210640|NCT01915498|567517027|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210641|NCT01915498|567517028|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210642|NCT01915498|567517029|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210643|NCT01915498|567517030|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210644|NCT01915498|567517031|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210645|NCT01915498|567517032|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157010475|NCT03036813|566790225|FG001|Overall Study|Physician Decision|1|||
157010476|NCT03036813|566790226|FG002|Overall Study|Physician Decision|1|||
157010477|NCT03036813|566790224|FG000|Overall Study|Non-Compliance|1|||
157010478|NCT03036813|566790225|FG001|Overall Study|Non-Compliance|5|||
157010479|NCT03036813|566790226|FG002|Overall Study|Non-Compliance|3|||
157010480|NCT03036813|566790224|FG000|Overall Study|Pregnancy|0|||
157010481|NCT03036813|566790225|FG001|Overall Study|Pregnancy|0|||
157010482|NCT03036813|566790226|FG002|Overall Study|Pregnancy|1|||
157210646|NCT01915498|567517033|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210647|NCT01915498|567517034|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210648|NCT01915498|567517035|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210649|NCT01915498|567517036|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210650|NCT01915498|567517037|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210651|NCT01915498|567517038|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210652|NCT01915498|567517039|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210653|NCT01915498|567517040|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
157210654|NCT01915498|567517041|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
157210655|NCT01915498|567517023|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210656|NCT01915498|567517024|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210657|NCT01915498|567517025|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210658|NCT01915498|567517026|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210659|NCT01915498|567517027|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210660|NCT01915498|567517028|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210661|NCT01915498|567517029|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210662|NCT01915498|567517030|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210663|NCT01915498|567517031|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210664|NCT01915498|567517032|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210665|NCT01915498|567517033|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210666|NCT01915498|567517034|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210667|NCT01915498|567517035|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210668|NCT01915498|567517036|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210669|NCT01915498|567517037|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210670|NCT01915498|567517038|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210671|NCT01915498|567517039|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210672|NCT01915498|567517040|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
157210673|NCT01915498|567517041|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
157210674|NCT00883129|567517045|FG000|Overall Study|Adverse Event|7|||
157210675|NCT00883129|567517046|FG001|Overall Study|Adverse Event|15|||
157210676|NCT00883129|567517045|FG000|Overall Study|Withdrawal by Subject|8|||
157210677|NCT00883129|567517046|FG001|Overall Study|Withdrawal by Subject|9|||
157210678|NCT00883129|567517045|FG000|Overall Study|Non-compliance|3|||
157210679|NCT00883129|567517046|FG001|Overall Study|Non-compliance|6|||
157210680|NCT00883129|567517045|FG000|Overall Study|Lost to Follow-up|1|||
157210681|NCT00883129|567517046|FG001|Overall Study|Lost to Follow-up|2|||
157210682|NCT00883129|567517045|FG000|Overall Study|Death|1|||
157210683|NCT00883129|567517046|FG001|Overall Study|Death|2|||
157210684|NCT00883129|567517045|FG000|Overall Study|Defined Treatment Failure|0|||
157210685|NCT00883129|567517046|FG001|Overall Study|Defined Treatment Failure|2|||
157210686|NCT01966107|567517048|FG000|Overall Study|excluded from FAS|21|||
157210687|NCT01966107|567517049|FG001|Overall Study|excluded from FAS|20|||
157210688|NCT01966107|567517048|FG000|Overall Study|discontinued treatment|345|||
156779780|NCT01757847|565943879|FG000|Overall Study|Withdrawal by Subject|3|||
156779781|NCT01757847|565943880|FG001|Overall Study|Withdrawal by Subject|4|||
157210689|NCT01966107|567517049|FG001|Overall Study|discontinued treatment|372|||
157210690|NCT01966107|567517048|FG000|Overall Study|due to study closure|164|||
157210691|NCT01966107|567517049|FG001|Overall Study|due to study closure|186|||
157210692|NCT01966107|567517048|FG000|Overall Study|withdrew from the study|272|||
157210693|NCT01966107|567517049|FG001|Overall Study|withdrew from the study|303|||
157210694|NCT01185639|567517050|FG000|Overall Study|Progressed and didn't receive therapy|2|||
157210695|NCT02200614|567517051|FG000|Double Blind Treatment|Adverse Event|86|||
157210696|NCT02200614|567517052|FG001|Double Blind Treatment|Adverse Event|48|||
157210697|NCT02200614|567517051|FG000|Double Blind Treatment|Confirmed metastasis|120|||
157210698|NCT02200614|567517052|FG001|Double Blind Treatment|Confirmed metastasis|140|||
157210699|NCT02200614|567517051|FG000|Double Blind Treatment|Judgment of the investigator|59|||
157210700|NCT02200614|567517052|FG001|Double Blind Treatment|Judgment of the investigator|99|||
156866586|NCT00129402|566271289|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
157010483|NCT03036813|566790224|FG000|Overall Study|Other|0|||
157010484|NCT03036813|566790225|FG001|Overall Study|Other|3|||
157010485|NCT03036813|566790226|FG002|Overall Study|Other|5|||
157010486|NCT01102231|566790227|FG000|Overall Study|Protocol Violation|3|||
157010487|NCT01102231|566790227|FG000|Overall Study|Lack of Efficacy|2|||
157010488|NCT01102231|566790227|FG000|Overall Study|Death|2|||
156866587|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
157010489|NCT01102231|566790227|FG000|Overall Study|Adverse Event|3|||
157010490|NCT01102231|566790227|FG000|Overall Study|Withdrawal by Subject|1|||
157210701|NCT02200614|567517051|FG000|Double Blind Treatment|Metastasis by local reading|1|||
157210702|NCT02200614|567517052|FG001|Double Blind Treatment|Metastasis by local reading|3|||
157210703|NCT02200614|567517051|FG000|Double Blind Treatment|Other reason|6|||
157210704|NCT02200614|567517052|FG001|Double Blind Treatment|Other reason|2|||
157210705|NCT02200614|567517051|FG000|Double Blind Treatment|Personal reason|77|||
157210706|NCT02200614|567517052|FG001|Double Blind Treatment|Personal reason|85|||
157210707|NCT02200614|567517051|FG000|Double Blind Treatment|Protocol deviation|14|||
157210708|NCT02200614|567517052|FG001|Double Blind Treatment|Protocol deviation|7|||
157210709|NCT02200614|567517051|FG000|Double Blind Treatment|Not treated|1|||
157210710|NCT02200614|567517052|FG001|Double Blind Treatment|Not treated|0|||
157210711|NCT02200614|567517051|FG000|Open Label|Adverse Event|41|||
157210712|NCT02200614|567517052|FG001|Open Label|Adverse Event|11|||
157210713|NCT02200614|567517051|FG000|Open Label|Confirmed metastasis|1|||
157210714|NCT02200614|567517052|FG001|Open Label|Confirmed metastasis|0|||
157210715|NCT02200614|567517051|FG000|Open Label|Judgment of the investigator|29|||
157210716|NCT02200614|567517052|FG001|Open Label|Judgment of the investigator|2|||
157210717|NCT02200614|567517051|FG000|Open Label|Metastasis by local reading|138|||
157210718|NCT02200614|567517052|FG001|Open Label|Metastasis by local reading|27|||
157210719|NCT02200614|567517051|FG000|Open Label|Other reason|22|||
157210720|NCT02200614|567517052|FG001|Open Label|Other reason|4|||
157210721|NCT02200614|567517051|FG000|Open Label|Personal reason|60|||
157010491|NCT01102231|566790227|FG000|Overall Study|Did not received the treatment|4|||
157010492|NCT00546754|566790228|FG000|Overall Study|Serious Adverse Event|1|||
157010493|NCT00546754|566790229|FG001|Overall Study|Serious Adverse Event|1|||
157010494|NCT00546754|566790228|FG000|Overall Study|Adverse Event|11|||
157010495|NCT00546754|566790229|FG001|Overall Study|Adverse Event|16|||
157010496|NCT00546754|566790228|FG000|Overall Study|Lack of Efficacy|1|||
157010497|NCT00546754|566790229|FG001|Overall Study|Lack of Efficacy|1|||
157010498|NCT00546754|566790228|FG000|Overall Study|Lost to Follow-up|9|||
157010499|NCT00546754|566790229|FG001|Overall Study|Lost to Follow-up|15|||
157010500|NCT00546754|566790228|FG000|Overall Study|Protocol Violation|3|||
157010501|NCT00546754|566790229|FG001|Overall Study|Protocol Violation|0|||
157010502|NCT00546754|566790228|FG000|Overall Study|Withdrawal by Subject|6|||
157010503|NCT00546754|566790229|FG001|Overall Study|Withdrawal by Subject|7|||
157010504|NCT00546754|566790228|FG000|Overall Study|Dyspnea|1|||
157010505|NCT00546754|566790229|FG001|Overall Study|Dyspnea|0|||
157010506|NCT00546754|566790228|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
157010507|NCT00546754|566790229|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
157010508|NCT00546754|566790228|FG000|Overall Study|Hip Replacement|1|||
157010509|NCT00546754|566790229|FG001|Overall Study|Hip Replacement|0|||
157116114|NCT02915523|567178977|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
157116115|NCT02915523|567178978|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
157116116|NCT02915523|567178979|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
157116117|NCT02915523|567178976|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
157116118|NCT02915523|567178977|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
157116119|NCT02915523|567178978|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
157116120|NCT02915523|567178979|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
157116121|NCT02915523|567178976|FG000|Expansion Phase (Phase 2)|Death|0|||
157116122|NCT02915523|567178977|FG001|Expansion Phase (Phase 2)|Death|0|||
157116123|NCT02915523|567178978|FG002|Expansion Phase (Phase 2)|Death|26|||
157116124|NCT02915523|567178979|FG003|Expansion Phase (Phase 2)|Death|53|||
157116125|NCT02915523|567178976|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
157116126|NCT02915523|567178977|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
157116127|NCT02915523|567178978|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
157116128|NCT02915523|567178979|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
156779782|NCT01078662|565943883|FG000|Overall Study|Death|41|||
157010510|NCT00546754|566790228|FG000|Overall Study|Suicide|1|||
157010511|NCT00546754|566790229|FG001|Overall Study|Suicide|0|||
157010512|NCT00546754|566790228|FG000|Overall Study|Missing Cooperation|1|||
157010513|NCT00546754|566790229|FG001|Overall Study|Missing Cooperation|0|||
157116129|NCT02915523|567178976|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
157010514|NCT00546754|566790228|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
157116130|NCT02915523|567178977|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
157116131|NCT02915523|567178978|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
157116132|NCT02915523|567178979|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
157116133|NCT02915523|567178976|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
157116134|NCT02915523|567178977|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
157116135|NCT02915523|567178978|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
157116136|NCT02915523|567178979|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
157116137|NCT00708500|567178981|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
157116138|NCT00708500|567178982|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
157116139|NCT00708500|567178983|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
157116140|NCT00708500|567178981|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
157116141|NCT00708500|567178982|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
157116142|NCT00708500|567178983|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
157116143|NCT00708500|567178981|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
157116144|NCT00708500|567178982|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
157145130|NCT03237845|567277997|FG001|Overall Study|Withdrawal by Subject|3|||
157116145|NCT00708500|567178983|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
157116146|NCT00708500|567178981|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
157116147|NCT00708500|567178982|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
157116148|NCT00708500|567178983|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
157116149|NCT00708500|567178981|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
157116150|NCT00708500|567178982|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
157116151|NCT00708500|567178983|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
157116152|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
157116153|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
157116154|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
157010515|NCT00546754|566790229|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
157210722|NCT02200614|567517052|FG001|Open Label|Personal reason|8|||
157210723|NCT02200614|567517051|FG000|Open Label|Protocol deviation|3|||
157210724|NCT02200614|567517052|FG001|Open Label|Protocol deviation|2|||
157210725|NCT02200614|567517051|FG000|Open Label|Missing|2|||
157210726|NCT02200614|567517052|FG001|Open Label|Missing|2|||
157210727|NCT00532779|567517053|FG000|Overall Study|Adverse Event|122|||
157210728|NCT00532779|567517054|FG001|Overall Study|Adverse Event|112|||
157210729|NCT00532779|567517055|FG002|Overall Study|Adverse Event|56|||
157210730|NCT00532779|567517053|FG000|Overall Study|Lost to Follow-up|76|||
157210731|NCT00532779|567517054|FG001|Overall Study|Lost to Follow-up|65|||
157210732|NCT00532779|567517055|FG002|Overall Study|Lost to Follow-up|66|||
157210733|NCT00532779|567517053|FG000|Overall Study|Withdrawal by Subject|63|||
157210734|NCT00532779|567517054|FG001|Overall Study|Withdrawal by Subject|60|||
157210735|NCT00532779|567517055|FG002|Overall Study|Withdrawal by Subject|90|||
157210736|NCT00532779|567517053|FG000|Overall Study|Lack of Efficacy|12|||
157210737|NCT00532779|567517054|FG001|Overall Study|Lack of Efficacy|12|||
157210738|NCT00532779|567517055|FG002|Overall Study|Lack of Efficacy|40|||
157210739|NCT00532779|567517053|FG000|Overall Study|Protocol Violation|5|||
156779783|NCT01078662|565943884|FG001|Overall Study|Death|103|||
157210740|NCT00532779|567517054|FG001|Overall Study|Protocol Violation|9|||
157210741|NCT00532779|567517055|FG002|Overall Study|Protocol Violation|7|||
157210742|NCT00532779|567517053|FG000|Overall Study|Pregnancy|2|||
157210743|NCT00532779|567517054|FG001|Overall Study|Pregnancy|5|||
157210744|NCT00532779|567517055|FG002|Overall Study|Pregnancy|3|||
157210745|NCT00532779|567517053|FG000|Overall Study|Death|0|||
157010516|NCT00546754|566790228|FG000|Overall Study|Patient's Decision|0|||
157010517|NCT00546754|566790229|FG001|Overall Study|Patient's Decision|1|||
157010518|NCT00546754|566790228|FG000|Overall Study|Missing|14|||
156779784|NCT01078662|565943885|FG002|Overall Study|Death|18|||
157010519|NCT00546754|566790229|FG001|Overall Study|Missing|7|||
157116155|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
157116156|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
157116157|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
157116158|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
157116159|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
157116160|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
157116161|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
157116162|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
157116163|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
157116164|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
157116165|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
157116166|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
156866588|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
157116167|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
157116168|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
157116169|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
157116170|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
157116171|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
157116172|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
157116173|NCT00708500|567178981|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
157116174|NCT00708500|567178982|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
157116175|NCT00708500|567178983|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
157116176|NCT00708500|567178981|FG000|FOLLOWUP|Adverse Event|0|||
157116177|NCT00708500|567178982|FG001|FOLLOWUP|Adverse Event|1|||
157116178|NCT00708500|567178983|FG002|FOLLOWUP|Adverse Event|0|||
157116179|NCT00708500|567178981|FG000|FOLLOWUP|Lost to Follow-up|1|||
157116180|NCT00708500|567178982|FG001|FOLLOWUP|Lost to Follow-up|6|||
157116181|NCT00708500|567178983|FG002|FOLLOWUP|Lost to Follow-up|4|||
157116182|NCT00708500|567178981|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
157116183|NCT00708500|567178982|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
157116184|NCT00708500|567178983|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
157116185|NCT00708500|567178981|FG000|FOLLOWUP|Subject withdrew consent|31|||
157116186|NCT00708500|567178982|FG001|FOLLOWUP|Subject withdrew consent|4|||
157116187|NCT00708500|567178983|FG002|FOLLOWUP|Subject withdrew consent|5|||
157116188|NCT00708500|567178981|FG000|FOLLOWUP|Non-compliance with protocol|5|||
157116189|NCT00708500|567178982|FG001|FOLLOWUP|Non-compliance with protocol|0|||
157116190|NCT00708500|567178983|FG002|FOLLOWUP|Non-compliance with protocol|1|||
157116191|NCT01029366|567178989|FG000|Overall Study|Withdrawal by Subject|1|||
157116192|NCT01029366|567178990|FG001|Overall Study|Withdrawal by Subject|0|||
157116193|NCT01029366|567178989|FG000|Overall Study|Death|1|||
157116194|NCT01029366|567178990|FG001|Overall Study|Death|1|||
157116195|NCT01029366|567178989|FG000|Overall Study|disease progression|2|||
157116196|NCT01029366|567178990|FG001|Overall Study|disease progression|0|||
157116197|NCT01029366|567178989|FG000|Overall Study|manufacturing failure|0|||
157116198|NCT01029366|567178990|FG001|Overall Study|manufacturing failure|1|||
157116199|NCT00607386|567178991|FG000|Overall Study|Physician Decision|1|||
157116200|NCT00440947|567178992|FG000|36-Week Induction Phase|Adverse Event|16|||
157116201|NCT00440947|567178993|FG001|36-Week Induction Phase|Adverse Event|0|||
157116202|NCT00440947|567178994|FG002|36-Week Induction Phase|Adverse Event|0|||
157116203|NCT00440947|567178995|FG003|36-Week Induction Phase|Adverse Event|0|||
157116204|NCT00440947|567178996|FG004|36-Week Induction Phase|Adverse Event|0|||
157116205|NCT00440947|567178992|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
157116206|NCT00440947|567178993|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
157116207|NCT00440947|567178994|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
157116208|NCT00440947|567178995|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
157116209|NCT00440947|567178996|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
157116210|NCT00440947|567178992|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
157116211|NCT00440947|567178993|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
157116212|NCT00440947|567178994|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
157116213|NCT00440947|567178995|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
157116214|NCT00440947|567178996|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
157116215|NCT00440947|567178992|FG000|36-Week Induction Phase|Non-compliance|10|||
157116216|NCT00440947|567178993|FG001|36-Week Induction Phase|Non-compliance|0|||
157116217|NCT00440947|567178994|FG002|36-Week Induction Phase|Non-compliance|0|||
157116218|NCT00440947|567178995|FG003|36-Week Induction Phase|Non-compliance|0|||
157116219|NCT00440947|567178996|FG004|36-Week Induction Phase|Non-compliance|0|||
157116220|NCT00440947|567178992|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
157116221|NCT00440947|567178993|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
157116222|NCT00440947|567178994|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
157116223|NCT00440947|567178995|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
157116224|NCT00440947|567178996|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
157116225|NCT00440947|567178992|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
157116226|NCT00440947|567178993|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
157116227|NCT00440947|567178994|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
157116228|NCT00440947|567178995|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
157116229|NCT00440947|567178996|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
157116230|NCT00440947|567178992|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
157116231|NCT00440947|567178993|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
157116232|NCT00440947|567178994|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
157116233|NCT00440947|567178995|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
157116234|NCT00440947|567178996|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
157116235|NCT00440947|567178992|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
157116236|NCT00440947|567178993|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
157116237|NCT00440947|567178994|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
157116238|NCT00440947|567178995|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
157116239|NCT00440947|567178996|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
157116240|NCT00440947|567178992|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
157010520|NCT01792830|566790232|FG000|Overall Study|Withdrawal by Subject|22|||
157010521|NCT01792830|566790233|FG001|Overall Study|Withdrawal by Subject|0|||
157010522|NCT01792830|566790234|FG002|Overall Study|Withdrawal by Subject|0|||
157010523|NCT01792830|566790235|FG003|Overall Study|Withdrawal by Subject|2|||
157010524|NCT01792830|566790236|FG004|Overall Study|Withdrawal by Subject|1|||
157010525|NCT01792830|566790237|FG005|Overall Study|Withdrawal by Subject|1|||
157010526|NCT01792830|566790238|FG006|Overall Study|Withdrawal by Subject|1|||
157010527|NCT01792830|566790239|FG007|Overall Study|Withdrawal by Subject|1|||
157010528|NCT01792830|566790240|FG008|Overall Study|Withdrawal by Subject|7|||
157010529|NCT01792830|566790241|FG009|Overall Study|Withdrawal by Subject|0|||
157010530|NCT01792830|566790242|FG010|Overall Study|Withdrawal by Subject|2|||
157010531|NCT01792830|566790232|FG000|Overall Study|Death|3|||
157010532|NCT01792830|566790233|FG001|Overall Study|Death|0|||
157010533|NCT01792830|566790234|FG002|Overall Study|Death|0|||
157010534|NCT01792830|566790235|FG003|Overall Study|Death|1|||
157116241|NCT00440947|567178993|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
157116242|NCT00440947|567178994|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
157116243|NCT00440947|567178995|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
157116244|NCT00440947|567178996|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
157116245|NCT00440947|567178992|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
157116246|NCT00440947|567178993|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
157116247|NCT00440947|567178994|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
157116248|NCT00440947|567178995|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
157116249|NCT00440947|567178996|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
157210746|NCT00532779|567517054|FG001|Overall Study|Death|1|||
157210747|NCT00532779|567517055|FG002|Overall Study|Death|0|||
157210748|NCT00532779|567517053|FG000|Overall Study|Drug noncompliance, moved, other|14|||
157210749|NCT00532779|567517054|FG001|Overall Study|Drug noncompliance, moved, other|23|||
157210750|NCT00532779|567517055|FG002|Overall Study|Drug noncompliance, moved, other|29|||
157210751|NCT02662556|567517056|FG000|Overall Study|Adverse Event|4|||
157210752|NCT02662556|567517056|FG000|Overall Study|Lack of Efficacy|4|||
157210753|NCT00828516|567517065|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
157210754|NCT00689273|567517066|FG000|Overall Study|Adverse Event|3|||
157210755|NCT00689273|567517067|FG001|Overall Study|Adverse Event|1|||
157210756|NCT00689273|567517066|FG000|Overall Study|Lack of Efficacy|3|||
157210757|NCT00689273|567517067|FG001|Overall Study|Lack of Efficacy|0|||
157010535|NCT01792830|566790236|FG004|Overall Study|Death|0|||
157010536|NCT01792830|566790237|FG005|Overall Study|Death|0|||
157210758|NCT00689273|567517066|FG000|Overall Study|Lost to Follow-up|0|||
157210759|NCT00689273|567517067|FG001|Overall Study|Lost to Follow-up|2|||
157010537|NCT01792830|566790238|FG006|Overall Study|Death|1|||
157010538|NCT01792830|566790239|FG007|Overall Study|Death|0|||
157010539|NCT01792830|566790240|FG008|Overall Study|Death|1|||
157010540|NCT01792830|566790241|FG009|Overall Study|Death|0|||
157010541|NCT01792830|566790242|FG010|Overall Study|Death|1|||
157010542|NCT01792830|566790232|FG000|Overall Study|Adverse Event|0|||
157010543|NCT01792830|566790233|FG001|Overall Study|Adverse Event|0|||
157010544|NCT01792830|566790234|FG002|Overall Study|Adverse Event|0|||
157010545|NCT01792830|566790235|FG003|Overall Study|Adverse Event|0|||
157010546|NCT01792830|566790236|FG004|Overall Study|Adverse Event|0|||
157010547|NCT01792830|566790237|FG005|Overall Study|Adverse Event|0|||
157010548|NCT01792830|566790238|FG006|Overall Study|Adverse Event|0|||
157010549|NCT01792830|566790239|FG007|Overall Study|Adverse Event|0|||
157010550|NCT01792830|566790240|FG008|Overall Study|Adverse Event|1|||
157010551|NCT01792830|566790241|FG009|Overall Study|Adverse Event|0|||
157010552|NCT01792830|566790242|FG010|Overall Study|Adverse Event|0|||
157010553|NCT01943799|566790258|FG000|Overall Study|Lost to Follow-up|0|||
157010554|NCT01943799|566790259|FG001|Overall Study|Lost to Follow-up|1|||
157010555|NCT01943799|566790260|FG002|Overall Study|Lost to Follow-up|1|||
157010556|NCT01943799|566790261|FG003|Overall Study|Lost to Follow-up|0|||
157010557|NCT01943799|566790258|FG000|Overall Study|Protocol Violation|1|||
157010558|NCT01943799|566790259|FG001|Overall Study|Protocol Violation|0|||
157010559|NCT01943799|566790260|FG002|Overall Study|Protocol Violation|0|||
157010560|NCT01943799|566790261|FG003|Overall Study|Protocol Violation|0|||
157010561|NCT01943799|566790258|FG000|Overall Study|Withdrawal by Subject|4|||
157010562|NCT01943799|566790259|FG001|Overall Study|Withdrawal by Subject|2|||
157010563|NCT01943799|566790260|FG002|Overall Study|Withdrawal by Subject|1|||
157010564|NCT01943799|566790261|FG003|Overall Study|Withdrawal by Subject|0|||
157010565|NCT05274217|566790262|FG000|Overall Study|Study terminated.|11|||
157010566|NCT05274217|566790263|FG001|Overall Study|Study terminated.|0|||
157010567|NCT04594759|566790264|FG000|Overall Study|Lost to Follow-up|3|||
157010568|NCT00396084|566790265|FG000|Overall Study|Adverse Event|0|||
157010569|NCT00396084|566790266|FG001|Overall Study|Adverse Event|0|||
157010570|NCT00396084|566790267|FG002|Overall Study|Adverse Event|0|||
157010571|NCT00396084|566790268|FG003|Overall Study|Adverse Event|0|||
157010572|NCT00396084|566790269|FG004|Overall Study|Adverse Event|1|||
157010573|NCT00396084|566790270|FG005|Overall Study|Adverse Event|2|||
157010574|NCT00396084|566790265|FG000|Overall Study|Withdrawal by Subject|0|||
157010575|NCT00396084|566790266|FG001|Overall Study|Withdrawal by Subject|0|||
157010576|NCT00396084|566790267|FG002|Overall Study|Withdrawal by Subject|0|||
157010577|NCT00396084|566790268|FG003|Overall Study|Withdrawal by Subject|1|||
157010578|NCT00396084|566790269|FG004|Overall Study|Withdrawal by Subject|0|||
157010579|NCT00396084|566790270|FG005|Overall Study|Withdrawal by Subject|0|||
157010580|NCT01697969|566790271|FG000|Overall Study|Did not meet inc/exc criteria|3|||
157010581|NCT04556981|566790275|FG000|Overall Study|Death|0|||
157010582|NCT04556981|566790276|FG001|Overall Study|Death|1|||
157010583|NCT04556981|566790275|FG000|Overall Study|Lost to Follow-up|2|||
157010584|NCT04556981|566790276|FG001|Overall Study|Lost to Follow-up|11|||
157010585|NCT04556981|566790275|FG000|Overall Study|Moved from the study area|1|||
157010586|NCT04556981|566790276|FG001|Overall Study|Moved from the study area|4|||
157010587|NCT04556981|566790275|FG000|Overall Study|Withdrawal by Subject|2|||
157010588|NCT04556981|566790276|FG001|Overall Study|Withdrawal by Subject|2|||
157010589|NCT04556981|566790275|FG000|Overall Study|Other|2|||
157210760|NCT00689273|567517066|FG000|Overall Study|Other|6|||
157210761|NCT00689273|567517067|FG001|Overall Study|Other|2|||
157010590|NCT04556981|566790276|FG001|Overall Study|Other|1|||
157010591|NCT03764475|566790277|FG000|Overall Study|Adverse Event|11|||
157010592|NCT03764475|566790278|FG001|Overall Study|Adverse Event|2|||
157210762|NCT00689273|567517066|FG000|Overall Study|Randomized but not Treated|1|||
157010593|NCT03764475|566790277|FG000|Overall Study|Lost to Follow-up|24|||
157010594|NCT03764475|566790278|FG001|Overall Study|Lost to Follow-up|10|||
157010595|NCT03764475|566790277|FG000|Overall Study|Withdrawal by Subject|26|||
157010596|NCT03764475|566790278|FG001|Overall Study|Withdrawal by Subject|10|||
157210763|NCT00689273|567517067|FG001|Overall Study|Randomized but not Treated|0|||
157210764|NCT03703297|567517074|FG000|Overall Study|Death|115|||
157210765|NCT03703297|567517075|FG001|Overall Study|Death|0|||
157210766|NCT03703297|567517076|FG002|Overall Study|Death|144|||
157210767|NCT03703297|567517074|FG000|Overall Study|Withdrawal by Subject|9|||
157210768|NCT03703297|567517075|FG001|Overall Study|Withdrawal by Subject|0|||
157210769|NCT03703297|567517076|FG002|Overall Study|Withdrawal by Subject|11|||
157210770|NCT03703297|567517074|FG000|Overall Study|Ongoing at the time of DCO|140|||
157210771|NCT03703297|567517075|FG001|Overall Study|Ongoing at the time of DCO|200|||
157210772|NCT03703297|567517076|FG002|Overall Study|Ongoing at the time of DCO|111|||
157210773|NCT01355523|567518964|FG000|Overall Study|Withdrawal by Subject|1|||
157210774|NCT01355523|567518965|FG001|Overall Study|Withdrawal by Subject|4|||
157210775|NCT01355523|567518964|FG000|Overall Study|Lost to Follow-up|0|||
157210776|NCT01355523|567518965|FG001|Overall Study|Lost to Follow-up|2|||
157210777|NCT01355523|567518964|FG000|Overall Study|Protocol Violation|0|||
157210778|NCT01355523|567518965|FG001|Overall Study|Protocol Violation|2|||
157210779|NCT01355523|567518964|FG000|Overall Study|Adverse Event|0|||
157210780|NCT01355523|567518965|FG001|Overall Study|Adverse Event|2|||
157210781|NCT00303316|567518966|FG000|Overall Study|Protocol Violation|1|||
157210782|NCT00303316|567518967|FG001|Overall Study|Protocol Violation|0|||
157210783|NCT00303316|567518966|FG000|Overall Study|Lost to Follow-up|0|||
157210784|NCT00303316|567518967|FG001|Overall Study|Lost to Follow-up|1|||
157210785|NCT00303316|567518966|FG000|Overall Study|Withdrawal by Subject|1|||
157210786|NCT00303316|567518967|FG001|Overall Study|Withdrawal by Subject|2|||
157210787|NCT02703454|567518969|FG000|Overall Study|Not treated|1|||
157210788|NCT02703454|567518970|FG001|Overall Study|Not treated|3|||
157210789|NCT02703454|567518969|FG000|Overall Study|Withdrawal by Subject|4|||
157210790|NCT02703454|567518970|FG001|Overall Study|Withdrawal by Subject|3|||
157210791|NCT02703454|567518969|FG000|Overall Study|Lost to Follow-up|1|||
157210792|NCT02703454|567518970|FG001|Overall Study|Lost to Follow-up|2|||
157010597|NCT03764475|566790277|FG000|Overall Study|Lack of Efficacy|3|||
157010598|NCT03764475|566790278|FG001|Overall Study|Lack of Efficacy|0|||
157210793|NCT02703454|567518969|FG000|Overall Study|Study discontinuation|5|||
157210794|NCT02703454|567518970|FG001|Overall Study|Study discontinuation|8|||
157210795|NCT02284373|567518971|FG000|Overall Study|Withdrawal by Subject|0|||
157210796|NCT02284373|567518972|FG001|Overall Study|Withdrawal by Subject|1|||
157010599|NCT03764475|566790277|FG000|Overall Study|COVID-19 Disruption|2|||
157010600|NCT03764475|566790278|FG001|Overall Study|COVID-19 Disruption|0|||
157010601|NCT00580866|566790279|FG000|Overall Study|Lost to Follow-up|2|||
157010602|NCT00580866|566790280|FG001|Overall Study|Lost to Follow-up|2|||
157010603|NCT05510245|566790284|FG000|Overall Study|Withdrawal by Subject|1|||
157010604|NCT05510245|566790285|FG001|Overall Study|Withdrawal by Subject|0|||
157010605|NCT05510245|566790286|FG002|Overall Study|Withdrawal by Subject|0|||
157010606|NCT01395758|566790289|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
157010607|NCT01395758|566790290|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
157010608|NCT01395758|566790291|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
157010609|NCT01759771|566790292|FG000|Overall Study|Withdrawal by Subject|1|||
157010610|NCT01759771|566790293|FG001|Overall Study|Withdrawal by Subject|1|||
157010611|NCT01415349|566790294|FG000|Treatment Period 1|Adverse Event|0|||
157010612|NCT01415349|566790295|FG001|Treatment Period 1|Adverse Event|1|||
157010613|NCT01415349|566790294|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157116250|NCT00440947|567178992|FG000|36-Week Induction Phase|Incarceration|3|||
157116251|NCT00440947|567178993|FG001|36-Week Induction Phase|Incarceration|0|||
157116252|NCT00440947|567178994|FG002|36-Week Induction Phase|Incarceration|0|||
157010614|NCT01415349|566790295|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157210797|NCT02284373|567518973|FG002|Overall Study|Withdrawal by Subject|0|||
157210798|NCT02284373|567518971|FG000|Overall Study|Other|0|||
157210799|NCT02284373|567518972|FG001|Overall Study|Other|1|||
157210800|NCT02284373|567518973|FG002|Overall Study|Other|0|||
157210801|NCT02284373|567518971|FG000|Overall Study|Lost to Follow-up|0|||
157210802|NCT02284373|567518972|FG001|Overall Study|Lost to Follow-up|1|||
157210803|NCT02284373|567518973|FG002|Overall Study|Lost to Follow-up|0|||
157210804|NCT04651218|567518974|FG000|Overall Study|Withdrawal by Subject|0|||
157210805|NCT04651218|567518975|FG001|Overall Study|Withdrawal by Subject|2|||
157210806|NCT03174925|567518978|FG000|Overall Study|Elastographic images not retrievable|2|||
157210807|NCT03174925|567518978|FG000|Overall Study|Elastography image not interpretable|1|||
157210808|NCT04247594|567518981|FG000|Overall Study|Withdrawal by Subject|4|||
157210809|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
157010615|NCT00933400|566790296|FG000|Overall Study|Withdrawal by Subject|21|||
157010616|NCT00933400|566790297|FG001|Overall Study|Withdrawal by Subject|1|||
157210810|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
157210811|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
157210812|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
157210813|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
157210814|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
157210815|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
157010617|NCT02139943|566790298|FG000|Overall Study|Adverse Event|0|||
157010618|NCT02139943|566790299|FG001|Overall Study|Adverse Event|1|||
157010619|NCT02139943|566790300|FG002|Overall Study|Adverse Event|2|||
157010620|NCT02139943|566790298|FG000|Overall Study|Lost to Follow-up|3|||
157010621|NCT02139943|566790299|FG001|Overall Study|Lost to Follow-up|2|||
157010622|NCT02139943|566790300|FG002|Overall Study|Lost to Follow-up|2|||
157010623|NCT02139943|566790298|FG000|Overall Study|Withdrawal by Subject|4|||
157010624|NCT02139943|566790299|FG001|Overall Study|Withdrawal by Subject|3|||
157010625|NCT02139943|566790300|FG002|Overall Study|Withdrawal by Subject|0|||
157010626|NCT02139943|566790298|FG000|Overall Study|Other|0|||
157010627|NCT02139943|566790299|FG001|Overall Study|Other|0|||
157010628|NCT02139943|566790300|FG002|Overall Study|Other|1|||
157010629|NCT02139943|566790298|FG000|Overall Study|Participant wishes to discontinue|2|||
157010630|NCT02139943|566790299|FG001|Overall Study|Participant wishes to discontinue|0|||
157010631|NCT02139943|566790300|FG002|Overall Study|Participant wishes to discontinue|0|||
157010632|NCT02139943|566790298|FG000|Overall Study|Participant in Poor Compliance|1|||
157116253|NCT00440947|567178995|FG003|36-Week Induction Phase|Incarceration|0|||
157116254|NCT00440947|567178996|FG004|36-Week Induction Phase|Incarceration|0|||
157116255|NCT00440947|567178992|FG000|36-Week Induction Phase|Pregnancy|1|||
157116256|NCT00440947|567178993|FG001|36-Week Induction Phase|Pregnancy|0|||
157116257|NCT00440947|567178994|FG002|36-Week Induction Phase|Pregnancy|0|||
157116258|NCT00440947|567178995|FG003|36-Week Induction Phase|Pregnancy|0|||
157116259|NCT00440947|567178996|FG004|36-Week Induction Phase|Pregnancy|0|||
157116260|NCT00440947|567178992|FG000|48-Week Randomization Phase|Adverse Event|0|||
157116261|NCT00440947|567178993|FG001|48-Week Randomization Phase|Adverse Event|2|||
157116262|NCT00440947|567178994|FG002|48-Week Randomization Phase|Adverse Event|5|||
157116263|NCT00440947|567178995|FG003|48-Week Randomization Phase|Adverse Event|0|||
157116264|NCT00440947|567178996|FG004|48-Week Randomization Phase|Adverse Event|0|||
157116265|NCT00440947|567178992|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
157116266|NCT00440947|567178993|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
157116267|NCT00440947|567178994|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
157116268|NCT00440947|567178995|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
157116269|NCT00440947|567178996|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
157116270|NCT00440947|567178992|FG000|48-Week Randomization Phase|Non-compliance|0|||
157116271|NCT00440947|567178993|FG001|48-Week Randomization Phase|Non-compliance|3|||
157116272|NCT00440947|567178994|FG002|48-Week Randomization Phase|Non-compliance|4|||
157116273|NCT00440947|567178995|FG003|48-Week Randomization Phase|Non-compliance|0|||
157116274|NCT00440947|567178996|FG004|48-Week Randomization Phase|Non-compliance|0|||
157116275|NCT00440947|567178992|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
157116276|NCT00440947|567178993|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
157116277|NCT00440947|567178994|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
157116278|NCT00440947|567178995|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
157116279|NCT00440947|567178996|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
157116280|NCT00440947|567178992|FG000|48-Week Randomization Phase|Protocol Violation|0|||
157116281|NCT00440947|567178993|FG001|48-Week Randomization Phase|Protocol Violation|0|||
157116282|NCT00440947|567178994|FG002|48-Week Randomization Phase|Protocol Violation|1|||
157116283|NCT00440947|567178995|FG003|48-Week Randomization Phase|Protocol Violation|0|||
157116284|NCT00440947|567178996|FG004|48-Week Randomization Phase|Protocol Violation|0|||
157116285|NCT00440947|567178992|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
157116286|NCT00440947|567178993|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
157116287|NCT00440947|567178994|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
157116288|NCT00440947|567178995|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
157116289|NCT00440947|567178996|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
157116290|NCT00440947|567178992|FG000|48-Week Randomization Phase|Pregnancy|0|||
157116291|NCT00440947|567178993|FG001|48-Week Randomization Phase|Pregnancy|0|||
157116292|NCT00440947|567178994|FG002|48-Week Randomization Phase|Pregnancy|1|||
157116293|NCT00440947|567178995|FG003|48-Week Randomization Phase|Pregnancy|0|||
157116294|NCT00440947|567178996|FG004|48-Week Randomization Phase|Pregnancy|0|||
157116295|NCT00440947|567178992|FG000|48-Week Randomization Phase|Incarceration|0|||
157116296|NCT00440947|567178993|FG001|48-Week Randomization Phase|Incarceration|3|||
157116297|NCT00440947|567178994|FG002|48-Week Randomization Phase|Incarceration|0|||
157116298|NCT00440947|567178995|FG003|48-Week Randomization Phase|Incarceration|0|||
157116299|NCT00440947|567178996|FG004|48-Week Randomization Phase|Incarceration|0|||
157116300|NCT00440947|567178992|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
157116301|NCT00440947|567178993|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
157116302|NCT00440947|567178994|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
157116303|NCT00440947|567178995|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
157116304|NCT00440947|567178996|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
157116305|NCT00440947|567178992|FG000|48-Week Randomization Phase|Physician Decision|0|||
157116306|NCT00440947|567178993|FG001|48-Week Randomization Phase|Physician Decision|2|||
157116307|NCT00440947|567178994|FG002|48-Week Randomization Phase|Physician Decision|0|||
157116308|NCT00440947|567178995|FG003|48-Week Randomization Phase|Physician Decision|0|||
157116309|NCT00440947|567178996|FG004|48-Week Randomization Phase|Physician Decision|0|||
157116310|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
157116311|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
157116312|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
157116313|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
157116314|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
157116315|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
157116316|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
157116317|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
157116318|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
157116319|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
157116320|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
157116321|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
157116322|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
157116323|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
157116324|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
157116325|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
157116326|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
157116327|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
157116328|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
157116329|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
157116330|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
157116331|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
157116332|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
157116333|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
157116334|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
157116335|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
157116336|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
157116337|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
157116338|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
157116339|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
157116340|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
157116341|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
157116342|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
157116343|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
157116344|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
157116345|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
157116346|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
157116347|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
157116348|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
157116349|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
157116350|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
157116351|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
157116352|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
157116353|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
157116354|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
157116355|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
157116356|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
157116357|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
157116358|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
157116359|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
157116360|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
157210816|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
157210817|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210818|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210819|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210820|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
157210821|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
157210822|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210823|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210824|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
157210825|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
157210826|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
157210827|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
157210828|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
157210829|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
157210830|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
157210831|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
157210832|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
157210833|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
157210834|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
157210835|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
157210836|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
157210837|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
157210838|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
157210839|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
157210840|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
157210841|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
157210842|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
157210843|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
157210844|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
157210845|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
157210846|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
157210847|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
157210848|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
157210849|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
157116361|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
157116362|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
157116363|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
157116364|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
157116365|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Other|0|||
157116366|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Other|0|||
157116367|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Other|0|||
157116368|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Other|1|||
157116369|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Other|0|||
157116370|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
157116371|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
157116372|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
157116373|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
157116374|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
157116375|NCT00440947|567178992|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
157116376|NCT00440947|567178993|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
157116377|NCT00440947|567178994|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
157116378|NCT00440947|567178995|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
157116379|NCT00440947|567178996|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
157116380|NCT01827670|567178997|FG000|Overall Study|Withdrawal of Consent|3|||
157116381|NCT01827670|567178998|FG001|Overall Study|Withdrawal of Consent|2|||
157116382|NCT01827670|567178997|FG000|Overall Study|Lost to Follow-up|0|||
157116383|NCT01827670|567178998|FG001|Overall Study|Lost to Follow-up|1|||
157116384|NCT02813694|567179004|FG000|Overall Study|Physician Decision|0|||
157116385|NCT02813694|567179005|FG001|Overall Study|Physician Decision|1|||
157116386|NCT02813694|567179004|FG000|Overall Study|Withdrawal by Subject|10|||
157116387|NCT02813694|567179005|FG001|Overall Study|Withdrawal by Subject|9|||
157116388|NCT02813694|567179004|FG000|Overall Study|Lost to Follow-up|1|||
157116389|NCT02813694|567179005|FG001|Overall Study|Lost to Follow-up|1|||
157116390|NCT02813694|567179004|FG000|Overall Study|Death|3|||
157116391|NCT02813694|567179005|FG001|Overall Study|Death|3|||
157116392|NCT02813694|567179004|FG000|Overall Study|Randomized- did not receive study drug|2|||
157116393|NCT02813694|567179005|FG001|Overall Study|Randomized- did not receive study drug|0|||
157116394|NCT02813694|567179004|FG000|Overall Study|Patient hospitalized|1|||
157116395|NCT02813694|567179005|FG001|Overall Study|Patient hospitalized|0|||
157116396|NCT00513500|567179015|FG000|Overall Study|Lost to Follow-up|35|||
157116397|NCT00513500|567179016|FG001|Overall Study|Lost to Follow-up|39|||
157116398|NCT00513500|567179015|FG000|Overall Study|Death|2|||
157116399|NCT00513500|567179016|FG001|Overall Study|Death|1|||
157116400|NCT00513500|567179015|FG000|Overall Study|Hospitalized|4|||
157210850|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
157116401|NCT00513500|567179016|FG001|Overall Study|Hospitalized|14|||
157116402|NCT01136655|567179018|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
157116403|NCT01136655|567179018|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
157116404|NCT01136655|567179018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
157116405|NCT01136655|567179018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
157116406|NCT01265550|567179019|FG000|Pre Randomization|Withdrawal by Subject|0|||
157116407|NCT01265550|567179020|FG001|Pre Randomization|Withdrawal by Subject|0|||
157116408|NCT01265550|567179021|FG002|Pre Randomization|Withdrawal by Subject|0|||
157116409|NCT01265550|567179022|FG003|Pre Randomization|Withdrawal by Subject|70|||
157116410|NCT01265550|567179019|FG000|Pre Randomization|Technical Exclusions|0|||
157116411|NCT01265550|567179020|FG001|Pre Randomization|Technical Exclusions|0|||
157116412|NCT01265550|567179021|FG002|Pre Randomization|Technical Exclusions|0|||
157210851|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
157116413|NCT01265550|567179022|FG003|Pre Randomization|Technical Exclusions|54|||
157116414|NCT01265550|567179019|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
157116415|NCT01265550|567179020|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
157116416|NCT01265550|567179021|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
157116417|NCT01265550|567179022|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
157116418|NCT01265550|567179019|FG000|Pre Randomization|Non-GERD organic disorders|0|||
157210852|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
157210853|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
157210854|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
157210855|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
157210856|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
157210857|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
157210858|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
157210859|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
157210860|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
157210861|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
157210862|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
157210863|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
157210864|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
157210865|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
157210866|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
157210867|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
157210868|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
157210869|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
157210870|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
157210871|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
157210872|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
157210873|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
157210874|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
157210875|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
157210876|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
157210877|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
157210878|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
157210879|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
157210880|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
157210881|NCT04440163|567518983|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
157210882|NCT04440163|567518984|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
157210883|NCT04440163|567518985|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
157210884|NCT04440163|567518986|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
157010633|NCT02139943|566790299|FG001|Overall Study|Participant in Poor Compliance|0|||
157010634|NCT02139943|566790300|FG002|Overall Study|Participant in Poor Compliance|1|||
157010635|NCT02139943|566790298|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
157010636|NCT02139943|566790299|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
157010637|NCT02139943|566790300|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
157010638|NCT01041417|566790301|FG000|Overall Study|Adverse Event|5|||
157010639|NCT01041417|566790302|FG001|Overall Study|Adverse Event|2|||
157010640|NCT01041417|566790301|FG000|Overall Study|Lost to Follow-up|1|||
157210885|NCT04440163|567518987|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
157210886|NCT04440163|567518988|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
157210887|NCT04440163|567518989|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
157210888|NCT04440163|567518990|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
157210889|NCT04440163|567518983|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
157210890|NCT04440163|567518984|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
157210891|NCT04440163|567518985|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
157210892|NCT04440163|567518986|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
157210893|NCT04440163|567518987|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
157210894|NCT04440163|567518988|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
157210895|NCT04440163|567518989|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
157210896|NCT04440163|567518990|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
157210897|NCT04440163|567518983|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210898|NCT04440163|567518984|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210899|NCT04440163|567518985|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210900|NCT04440163|567518986|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
157210901|NCT04440163|567518987|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210902|NCT04440163|567518988|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210903|NCT04440163|567518989|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210904|NCT04440163|567518990|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
157210905|NCT00068406|567518993|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
157210906|NCT00068406|567518993|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
157210907|NCT03231709|567518997|FG000|Treatment Period 1|Reason not Specified|0|||
157210908|NCT03231709|567518998|FG001|Treatment Period 1|Reason not Specified|1|||
157210909|NCT03231709|567518997|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
157210910|NCT03231709|567518998|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
157210911|NCT02609178|567518999|FG000|First Crown|Withdrawal by Subject|0|||
157210912|NCT02609178|567519000|FG001|First Crown|Withdrawal by Subject|0|||
157210913|NCT02609178|567519001|FG002|First Crown|Withdrawal by Subject|1|||
157210914|NCT02609178|567519002|FG003|First Crown|Withdrawal by Subject|1|||
157210915|NCT02609178|567519003|FG004|First Crown|Withdrawal by Subject|0|||
157210916|NCT02609178|567519004|FG005|First Crown|Withdrawal by Subject|0|||
157010641|NCT01041417|566790302|FG001|Overall Study|Lost to Follow-up|1|||
157010642|NCT01041417|566790301|FG000|Overall Study|Death|1|||
157210917|NCT01128153|567519005|FG000|Overall Study|Adverse Event|1|||
157210918|NCT01128153|567519006|FG001|Overall Study|Adverse Event|3|||
157210919|NCT01128153|567519005|FG000|Overall Study|Condition under investigation worsened|8|||
157210920|NCT01128153|567519006|FG001|Overall Study|Condition under investigation worsened|7|||
157210921|NCT01128153|567519005|FG000|Overall Study|Withdrawal by Subject|2|||
157210922|NCT01128153|567519006|FG001|Overall Study|Withdrawal by Subject|3|||
157210923|NCT01128153|567519005|FG000|Overall Study|Incorrect enrolment to study|2|||
157210924|NCT01128153|567519006|FG001|Overall Study|Incorrect enrolment to study|1|||
157210925|NCT01128153|567519005|FG000|Overall Study|Protocol Violation|2|||
157210926|NCT01128153|567519006|FG001|Overall Study|Protocol Violation|0|||
157210927|NCT01128153|567519005|FG000|Overall Study|Developed discontinuation criteria|1|||
157210928|NCT01128153|567519006|FG001|Overall Study|Developed discontinuation criteria|1|||
157210929|NCT01954082|567519007|FG000|Overall Study|Study Suspension|42|||
157010643|NCT01041417|566790302|FG001|Overall Study|Death|0|||
157010644|NCT00716859|566790307|FG000|Overall Study|Adverse Event|4|||
157010645|NCT00716859|566790308|FG001|Overall Study|Adverse Event|1|||
157010646|NCT00716859|566790307|FG000|Overall Study|Lack of Efficacy|3|||
157010647|NCT00716859|566790308|FG001|Overall Study|Lack of Efficacy|0|||
157010648|NCT00716859|566790307|FG000|Overall Study|Withdrawal by Subject|1|||
157010649|NCT00716859|566790308|FG001|Overall Study|Withdrawal by Subject|3|||
157010650|NCT00716859|566790307|FG000|Overall Study|Not treated|1|||
157010651|NCT00716859|566790308|FG001|Overall Study|Not treated|1|||
157010652|NCT02918071|566790313|FG000|Overall Study|Withdrawal by Subject|2|||
157010653|NCT02918071|566790313|FG000|Overall Study|Lost to Follow-up|1|||
157010654|NCT01616459|566790315|FG000|Overall Study|Adverse Event|1|||
157010655|NCT01616459|566790316|FG001|Overall Study|Adverse Event|1|||
157010656|NCT01616459|566790317|FG002|Overall Study|Adverse Event|2|||
157116419|NCT01265550|567179020|FG001|Pre Randomization|Non-GERD organic disorders|0|||
157116420|NCT01265550|567179021|FG002|Pre Randomization|Non-GERD organic disorders|0|||
157116421|NCT01265550|567179022|FG003|Pre Randomization|Non-GERD organic disorders|23|||
157116422|NCT01265550|567179019|FG000|Pre Randomization|Functional heartburn|0|||
157116423|NCT01265550|567179020|FG001|Pre Randomization|Functional heartburn|0|||
157116424|NCT01265550|567179021|FG002|Pre Randomization|Functional heartburn|0|||
157116425|NCT01265550|567179022|FG003|Pre Randomization|Functional heartburn|99|||
157116426|NCT00794157|567179027|FG000|Overall Study|Adverse Event|4|||
157116427|NCT00794157|567179028|FG001|Overall Study|Adverse Event|1|||
157116428|NCT00794157|567179029|FG002|Overall Study|Adverse Event|8|||
157116429|NCT00794157|567179027|FG000|Overall Study|Subject withdrew consent|2|||
157116430|NCT00794157|567179028|FG001|Overall Study|Subject withdrew consent|0|||
157116431|NCT00794157|567179029|FG002|Overall Study|Subject withdrew consent|3|||
157116432|NCT00794157|567179027|FG000|Overall Study|Lost to Follow-up|2|||
157116433|NCT00794157|567179028|FG001|Overall Study|Lost to Follow-up|0|||
157116434|NCT00794157|567179029|FG002|Overall Study|Lost to Follow-up|1|||
157116435|NCT00794157|567179027|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157116436|NCT00794157|567179028|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157116437|NCT00794157|567179029|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
157116438|NCT00794157|567179027|FG000|Overall Study|Administrative problems|1|||
157116439|NCT00794157|567179028|FG001|Overall Study|Administrative problems|7|||
157116440|NCT00794157|567179029|FG002|Overall Study|Administrative problems|4|||
157116441|NCT00794157|567179027|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157116442|NCT00794157|567179028|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157116443|NCT00794157|567179029|FG002|Overall Study|Abnormal test procedure result(s)|0|||
157116444|NCT00794157|567179027|FG000|Overall Study|Protocol deviation|0|||
157116445|NCT00794157|567179028|FG001|Overall Study|Protocol deviation|1|||
157116446|NCT00794157|567179029|FG002|Overall Study|Protocol deviation|1|||
157116447|NCT02970292|567179030|FG000|Overall Study|Physician Decision|1|||
157116448|NCT02970292|567179031|FG001|Overall Study|Physician Decision|1|||
157116449|NCT02970292|567179030|FG000|Overall Study|Withdrawal by Subject|11|||
157116450|NCT02970292|567179031|FG001|Overall Study|Withdrawal by Subject|5|||
157116451|NCT02970292|567179030|FG000|Overall Study|Noncompliance with study drug|2|||
157116452|NCT02970292|567179031|FG001|Overall Study|Noncompliance with study drug|2|||
157116453|NCT02970292|567179030|FG000|Overall Study|Adverse Event|5|||
157116454|NCT02970292|567179031|FG001|Overall Study|Adverse Event|0|||
157116455|NCT02970292|567179030|FG000|Overall Study|Lack of Efficacy|1|||
157116456|NCT02970292|567179031|FG001|Overall Study|Lack of Efficacy|0|||
157116457|NCT02970292|567179030|FG000|Overall Study|Lost to Follow-up|1|||
157116458|NCT02970292|567179031|FG001|Overall Study|Lost to Follow-up|0|||
157116459|NCT02970292|567179030|FG000|Overall Study|Protocol Violation|2|||
157116460|NCT02970292|567179031|FG001|Overall Study|Protocol Violation|0|||
157116461|NCT02970292|567179030|FG000|Overall Study|Other|1|||
157116462|NCT02970292|567179031|FG001|Overall Study|Other|0|||
157116463|NCT04486950|567179033|FG000|Overall Study|Lost to Follow-up|0|||
157116464|NCT04486950|567179034|FG001|Overall Study|Lost to Follow-up|0|||
157116465|NCT04486950|567179035|FG002|Overall Study|Lost to Follow-up|0|||
157116466|NCT04486950|567179036|FG003|Overall Study|Lost to Follow-up|0|||
157116467|NCT04486950|567179037|FG004|Overall Study|Lost to Follow-up|0|||
157116468|NCT04486950|567179038|FG005|Overall Study|Lost to Follow-up|1|||
157116469|NCT04486950|567179039|FG006|Overall Study|Lost to Follow-up|0|||
157116470|NCT01464307|567179041|FG000|Main Period|Death|0|||
157116471|NCT01464307|567179042|FG001|Main Period|Death|1|||
157116472|NCT01464307|567179041|FG000|Main Period|Adverse Event|6|||
157116473|NCT01464307|567179042|FG001|Main Period|Adverse Event|1|||
157116474|NCT01464307|567179041|FG000|Main Period|Lack of Efficacy|2|||
157116475|NCT01464307|567179042|FG001|Main Period|Lack of Efficacy|0|||
157116476|NCT01464307|567179041|FG000|Main Period|Withdrawal by Subject|5|||
157116477|NCT01464307|567179042|FG001|Main Period|Withdrawal by Subject|2|||
157116478|NCT01464307|567179041|FG000|Main Period|Predefined discontinuation criteria|2|||
157116479|NCT01464307|567179042|FG001|Main Period|Predefined discontinuation criteria|1|||
157116480|NCT01464307|567179041|FG000|Open-Label Extension Period|Adverse Event|15|||
157116481|NCT01464307|567179042|FG001|Open-Label Extension Period|Adverse Event|0|||
157116482|NCT01464307|567179041|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
157116483|NCT01464307|567179042|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
157116484|NCT01464307|567179041|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
157116485|NCT01464307|567179042|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
157116486|NCT01464307|567179041|FG000|Open-Label Extension Period|Death|1|||
157116487|NCT01464307|567179042|FG001|Open-Label Extension Period|Death|0|||
157116488|NCT01464307|567179041|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
157116489|NCT01464307|567179042|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
157116490|NCT01464307|567179041|FG000|Open-Label Extension Period|Non-compliance|9|||
157116491|NCT01464307|567179042|FG001|Open-Label Extension Period|Non-compliance|0|||
157116492|NCT01464307|567179041|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
157116493|NCT01464307|567179042|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
157116494|NCT00761514|567179045|FG000|Overall Study|Adverse Event|1|||
157116495|NCT00761514|567179045|FG000|Overall Study|Withdrawal by Subject|2|||
157116496|NCT00761514|567179045|FG000|Overall Study|Lost to Follow-up|1|||
157116497|NCT00761514|567179045|FG000|Overall Study|Health insurance didn't cover study drug|1|||
157116498|NCT00761514|567179045|FG000|Overall Study|Problem complying with study visit|1|||
157116499|NCT00761514|567179045|FG000|Overall Study|Unable to pay for medications|1|||
157210930|NCT01954082|567519008|FG001|Overall Study|Study Suspension|36|||
157210931|NCT01954082|567519007|FG000|Overall Study|Adverse Event|10|||
157210932|NCT01954082|567519008|FG001|Overall Study|Adverse Event|4|||
157210933|NCT01954082|567519007|FG000|Overall Study|Intolerance|0|||
157210934|NCT01954082|567519008|FG001|Overall Study|Intolerance|1|||
157210935|NCT01954082|567519007|FG000|Overall Study|Non-compliance|6|||
157116500|NCT00894556|567179046|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
157116501|NCT00894556|567179047|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
157116502|NCT00894556|567179048|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
157116503|NCT00894556|567179049|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
157116504|NCT00894556|567179046|FG000|Treatment Phase|Lost to Follow-up|2|||
157116505|NCT00894556|567179047|FG001|Treatment Phase|Lost to Follow-up|3|||
157116506|NCT00894556|567179048|FG002|Treatment Phase|Lost to Follow-up|1|||
157116507|NCT00894556|567179049|FG003|Treatment Phase|Lost to Follow-up|0|||
157116508|NCT00894556|567179046|FG000|Treatment Phase|Lack of Qualifying Event|2|||
157116509|NCT00894556|567179047|FG001|Treatment Phase|Lack of Qualifying Event|1|||
157116510|NCT00894556|567179048|FG002|Treatment Phase|Lack of Qualifying Event|0|||
157210936|NCT01954082|567519008|FG001|Overall Study|Non-compliance|4|||
157210937|NCT01954082|567519007|FG000|Overall Study|Physician Decision|2|||
157116511|NCT00894556|567179049|FG003|Treatment Phase|Lack of Qualifying Event|0|||
157116512|NCT05054114|567179050|FG000|Overall Study|Protocol Violation|13|||
157116513|NCT05054114|567179051|FG001|Overall Study|Protocol Violation|1|||
157210938|NCT01954082|567519008|FG001|Overall Study|Physician Decision|0|||
157116514|NCT05054114|567179050|FG000|Overall Study|Pregnancy|0|||
157116515|NCT05054114|567179051|FG001|Overall Study|Pregnancy|1|||
157116516|NCT01806779|567179052|FG000|Overall Study|Physician Decision|2|||
157116517|NCT01806779|567179053|FG001|Overall Study|Physician Decision|0|||
157116518|NCT01806779|567179054|FG002|Overall Study|Physician Decision|1|||
157116519|NCT01806779|567179052|FG000|Overall Study|Lack of Efficacy|1|||
157116520|NCT01806779|567179053|FG001|Overall Study|Lack of Efficacy|1|||
157116521|NCT01806779|567179054|FG002|Overall Study|Lack of Efficacy|0|||
157116522|NCT01806779|567179052|FG000|Overall Study|Lost to Follow-up|19|||
157116523|NCT01806779|567179053|FG001|Overall Study|Lost to Follow-up|20|||
157116524|NCT01806779|567179054|FG002|Overall Study|Lost to Follow-up|0|||
157116525|NCT01806779|567179052|FG000|Overall Study|Withdrawal by Subject|20|||
157116526|NCT01806779|567179053|FG001|Overall Study|Withdrawal by Subject|23|||
157116527|NCT01806779|567179054|FG002|Overall Study|Withdrawal by Subject|22|||
157116528|NCT04294901|567179055|FG000|Overall Study|Death|86|||
157116529|NCT04294901|567179056|FG001|Overall Study|Death|110|||
157116530|NCT04294901|567179055|FG000|Overall Study|Provider did not have historical control patients|581|||
157116531|NCT04294901|567179056|FG001|Overall Study|Provider did not have historical control patients|0|||
157116532|NCT04294901|567179055|FG000|Overall Study|Provider did not have intervention patients|0|||
157116533|NCT04294901|567179056|FG001|Overall Study|Provider did not have intervention patients|98|||
157210939|NCT01954082|567519007|FG000|Overall Study|Parent Decision|1|||
157010657|NCT01616459|566790318|FG003|Overall Study|Adverse Event|0|||
157010658|NCT01616459|566790315|FG000|Overall Study|Lost to Follow-up|1|||
157010659|NCT01616459|566790316|FG001|Overall Study|Lost to Follow-up|11|||
157010660|NCT01616459|566790317|FG002|Overall Study|Lost to Follow-up|3|||
157010661|NCT01616459|566790318|FG003|Overall Study|Lost to Follow-up|2|||
157010662|NCT01616459|566790315|FG000|Overall Study|Protocol Violation|0|||
157010663|NCT01616459|566790316|FG001|Overall Study|Protocol Violation|0|||
157010664|NCT01616459|566790317|FG002|Overall Study|Protocol Violation|0|||
157010665|NCT01616459|566790318|FG003|Overall Study|Protocol Violation|2|||
157010666|NCT01616459|566790315|FG000|Overall Study|Withdrawal by Subject|2|||
157010667|NCT01616459|566790316|FG001|Overall Study|Withdrawal by Subject|4|||
157010668|NCT01616459|566790317|FG002|Overall Study|Withdrawal by Subject|4|||
157010669|NCT01616459|566790318|FG003|Overall Study|Withdrawal by Subject|4|||
157010670|NCT01616459|566790315|FG000|Overall Study|Other reason|0|||
157010671|NCT01616459|566790316|FG001|Overall Study|Other reason|1|||
157010672|NCT01616459|566790317|FG002|Overall Study|Other reason|1|||
157010673|NCT01616459|566790318|FG003|Overall Study|Other reason|0|||
157010674|NCT04922021|566791889|FG000|Overall Study|Withdrawal by Subject|4|||
157010675|NCT04922021|566791890|FG001|Overall Study|Withdrawal by Subject|10|||
157010676|NCT04922021|566791889|FG000|Overall Study|Adverse Event|2|||
157010677|NCT04922021|566791890|FG001|Overall Study|Adverse Event|2|||
157010678|NCT04922021|566791889|FG000|Overall Study|Lack of Efficacy|0|||
157010679|NCT04922021|566791890|FG001|Overall Study|Lack of Efficacy|1|||
157010680|NCT04922021|566791889|FG000|Overall Study|Multiple reasons|1|||
157010681|NCT04922021|566791890|FG001|Overall Study|Multiple reasons|0|||
157010682|NCT03237481|566791893|FG000|Overall Study|Lost to Follow-up|1|||
157010683|NCT03237481|566791894|FG001|Overall Study|Lost to Follow-up|0|||
157010684|NCT03237481|566791895|FG002|Overall Study|Lost to Follow-up|0|||
157010685|NCT03237481|566791893|FG000|Overall Study|Protocol Violation|1|||
157010686|NCT03237481|566791894|FG001|Overall Study|Protocol Violation|0|||
157010687|NCT03237481|566791895|FG002|Overall Study|Protocol Violation|0|||
157010688|NCT03237481|566791893|FG000|Overall Study|Withdrawal by Subject|3|||
157010689|NCT03237481|566791894|FG001|Overall Study|Withdrawal by Subject|2|||
157010690|NCT03237481|566791895|FG002|Overall Study|Withdrawal by Subject|1|||
157010691|NCT02544074|566791896|FG000|Overall Study|Withdrawal by Subject|0|||
157010692|NCT02544074|566791897|FG001|Overall Study|Withdrawal by Subject|1|||
157010693|NCT02544074|566791898|FG002|Overall Study|Withdrawal by Subject|0|||
157010694|NCT02544074|566791899|FG003|Overall Study|Withdrawal by Subject|0|||
157010695|NCT02544074|566791900|FG004|Overall Study|Withdrawal by Subject|0|||
157010696|NCT02544074|566791901|FG005|Overall Study|Withdrawal by Subject|0|||
157010697|NCT02544074|566791902|FG006|Overall Study|Withdrawal by Subject|0|||
157010698|NCT02544074|566791903|FG007|Overall Study|Withdrawal by Subject|0|||
157010699|NCT02544074|566791904|FG008|Overall Study|Withdrawal by Subject|0|||
157010700|NCT02544074|566791905|FG009|Overall Study|Withdrawal by Subject|0|||
157010701|NCT02544074|566791906|FG010|Overall Study|Withdrawal by Subject|0|||
157010702|NCT02544074|566791907|FG011|Overall Study|Withdrawal by Subject|0|||
157010703|NCT02544074|566791908|FG012|Overall Study|Withdrawal by Subject|0|||
157010704|NCT02544074|566791909|FG013|Overall Study|Withdrawal by Subject|0|||
157010705|NCT02544074|566791910|FG014|Overall Study|Withdrawal by Subject|0|||
157010706|NCT02544074|566791911|FG015|Overall Study|Withdrawal by Subject|0|||
157010707|NCT02544074|566791912|FG016|Overall Study|Withdrawal by Subject|0|||
157010708|NCT02544074|566791913|FG017|Overall Study|Withdrawal by Subject|0|||
157010709|NCT02544074|566791914|FG018|Overall Study|Withdrawal by Subject|0|||
157010710|NCT02544074|566791915|FG019|Overall Study|Withdrawal by Subject|0|||
157010711|NCT02544074|566791916|FG020|Overall Study|Withdrawal by Subject|0|||
157116534|NCT01934556|567179059|FG000|Overall Study|Withdrawal by Subject|0|||
157010712|NCT02544074|566791896|FG000|Overall Study|Tablet error|0|||
157010713|NCT02544074|566791897|FG001|Overall Study|Tablet error|0|||
157010714|NCT02544074|566791898|FG002|Overall Study|Tablet error|0|||
157010715|NCT02544074|566791899|FG003|Overall Study|Tablet error|0|||
157010716|NCT02544074|566791900|FG004|Overall Study|Tablet error|0|||
157010717|NCT02544074|566791901|FG005|Overall Study|Tablet error|1|||
157010718|NCT02544074|566791902|FG006|Overall Study|Tablet error|0|||
157010719|NCT02544074|566791903|FG007|Overall Study|Tablet error|0|||
157010720|NCT02544074|566791904|FG008|Overall Study|Tablet error|0|||
157010721|NCT02544074|566791905|FG009|Overall Study|Tablet error|1|||
157010722|NCT02544074|566791906|FG010|Overall Study|Tablet error|0|||
157010723|NCT02544074|566791907|FG011|Overall Study|Tablet error|0|||
157010724|NCT02544074|566791908|FG012|Overall Study|Tablet error|0|||
157010725|NCT02544074|566791909|FG013|Overall Study|Tablet error|0|||
157010726|NCT02544074|566791910|FG014|Overall Study|Tablet error|0|||
157010727|NCT02544074|566791911|FG015|Overall Study|Tablet error|0|||
157010728|NCT02544074|566791912|FG016|Overall Study|Tablet error|0|||
157010729|NCT02544074|566791913|FG017|Overall Study|Tablet error|0|||
157010730|NCT02544074|566791914|FG018|Overall Study|Tablet error|0|||
157010731|NCT02544074|566791915|FG019|Overall Study|Tablet error|0|||
157010732|NCT02544074|566791916|FG020|Overall Study|Tablet error|0|||
157010733|NCT04300647|566791917|FG000|Pre-Crossover|Death|19|||
157010734|NCT04300647|566791918|FG001|Pre-Crossover|Death|58|||
157010735|NCT04300647|566791919|FG002|Pre-Crossover|Death|0|||
157010736|NCT04300647|566791917|FG000|Pre-Crossover|Lost to Follow-up|0|||
157010737|NCT04300647|566791918|FG001|Pre-Crossover|Lost to Follow-up|3|||
157010738|NCT04300647|566791919|FG002|Pre-Crossover|Lost to Follow-up|0|||
157010739|NCT04300647|566791917|FG000|Pre-Crossover|Withdrawal by Subject|2|||
157010740|NCT04300647|566791918|FG001|Pre-Crossover|Withdrawal by Subject|4|||
157010741|NCT04300647|566791919|FG002|Pre-Crossover|Withdrawal by Subject|0|||
157010742|NCT04300647|566791917|FG000|Pre-Crossover|On-going in Study|24|||
157010743|NCT04300647|566791918|FG001|Pre-Crossover|On-going in Study|61|||
157010744|NCT04300647|566791919|FG002|Pre-Crossover|On-going in Study|0|||
157010745|NCT04300647|566791917|FG000|Post-Crossover|Death|0|||
157010746|NCT04300647|566791918|FG001|Post-Crossover|Death|0|||
157010747|NCT04300647|566791919|FG002|Post-Crossover|Death|3|||
157010748|NCT04300647|566791917|FG000|Post-Crossover|Lost to Follow-up|0|||
157010749|NCT04300647|566791918|FG001|Post-Crossover|Lost to Follow-up|0|||
157010750|NCT04300647|566791919|FG002|Post-Crossover|Lost to Follow-up|1|||
157010751|NCT04300647|566791917|FG000|Post-Crossover|Withdrawal by Subject|0|||
157010752|NCT04300647|566791918|FG001|Post-Crossover|Withdrawal by Subject|0|||
157010753|NCT04300647|566791919|FG002|Post-Crossover|Withdrawal by Subject|1|||
157010754|NCT04300647|566791917|FG000|Post-Crossover|On-going in Study|0|||
157010755|NCT04300647|566791918|FG001|Post-Crossover|On-going in Study|0|||
157010756|NCT04300647|566791919|FG002|Post-Crossover|On-going in Study|8|||
157010757|NCT05386238|566791920|FG000|Overall Study|Lost to Follow-up|3|||
157010758|NCT05386238|566791921|FG001|Overall Study|Lost to Follow-up|2|||
157010759|NCT05386238|566791920|FG000|Overall Study|Withdrawal by Subject|0|||
157010760|NCT05386238|566791921|FG001|Overall Study|Withdrawal by Subject|1|||
157010761|NCT04907474|566791922|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
157010762|NCT04907474|566791923|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
157010763|NCT01353313|566791924|FG000|Overall Study|Lost to Follow-up|22|||
157010764|NCT01353313|566791925|FG001|Overall Study|Lost to Follow-up|23|||
157010765|NCT01353313|566791924|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
157010766|NCT01353313|566791925|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
157010767|NCT04755660|566791926|FG000|Overall Study|Lost to Follow-up|1|||
157010768|NCT04755660|566791927|FG001|Overall Study|Lost to Follow-up|1|||
157010769|NCT04755660|566791928|FG002|Overall Study|Lost to Follow-up|0|||
157010770|NCT04755660|566791926|FG000|Overall Study|Withdrawal by Subject|0|||
157010771|NCT04755660|566791927|FG001|Overall Study|Withdrawal by Subject|1|||
157010772|NCT04755660|566791928|FG002|Overall Study|Withdrawal by Subject|1|||
157010773|NCT04755660|566791926|FG000|Overall Study|Physician Decision|0|||
157010774|NCT04755660|566791927|FG001|Overall Study|Physician Decision|0|||
157010775|NCT04755660|566791928|FG002|Overall Study|Physician Decision|1|||
157010776|NCT02824029|566791929|FG000|Overall Study|Didn't receive treatment|2|||
157010777|NCT02824029|566791929|FG000|Overall Study|Patient decision to discontinue treatment|3|||
157010778|NCT02824029|566791929|FG000|Overall Study|Non-compliant|5|||
157010779|NCT02824029|566791929|FG000|Overall Study|Progression of disease|15|||
157010780|NCT02824029|566791929|FG000|Overall Study|Inadequate response to therapy|2|||
157010781|NCT02824029|566791929|FG000|Overall Study|Possible progression per treating physician|1|||
157010782|NCT01693120|566791931|FG000|Enrollment|Lost to Follow-up|1|||
157010783|NCT01693120|566791931|FG000|Enrollment|Withdrawal by Subject|10|||
157010784|NCT01693120|566791931|FG000|Enrollment|Protocol Violation|46|||
157116535|NCT01934556|567179060|FG001|Overall Study|Withdrawal by Subject|1|||
157116536|NCT01934556|567179061|FG002|Overall Study|Withdrawal by Subject|1|||
157116537|NCT01934556|567179059|FG000|Overall Study|Lost to Follow-up|4|||
157116538|NCT01934556|567179060|FG001|Overall Study|Lost to Follow-up|10|||
157116539|NCT01934556|567179061|FG002|Overall Study|Lost to Follow-up|7|||
157116540|NCT01934556|567179059|FG000|Overall Study|Death|1|||
157116541|NCT01934556|567179060|FG001|Overall Study|Death|5|||
157116542|NCT01934556|567179061|FG002|Overall Study|Death|2|||
157116543|NCT05038020|567179063|FG000|Overall Study|Early Termination|3|||
157116544|NCT05038020|567179064|FG001|Overall Study|Early Termination|0|||
157116545|NCT03416153|567179066|FG000|Overall Study|Physician Decision|1|||
157116546|NCT03416153|567179067|FG001|Overall Study|Physician Decision|1|||
157116547|NCT03416153|567179066|FG000|Overall Study|Withdrawal by Subject|1|||
157116548|NCT03416153|567179067|FG001|Overall Study|Withdrawal by Subject|0|||
157116549|NCT03657043|567180406|FG000|Overall Study|Withdrawal by Subject|1|||
157116550|NCT03657043|567180407|FG001|Overall Study|Withdrawal by Subject|1|||
157116551|NCT03657043|567180408|FG002|Overall Study|Withdrawal by Subject|0|||
157116552|NCT03657043|567180409|FG003|Overall Study|Withdrawal by Subject|0|||
157116553|NCT03657043|567180410|FG004|Overall Study|Withdrawal by Subject|4|||
157116554|NCT03657043|567180406|FG000|Overall Study|Study closure by Sponsor|0|||
157116555|NCT03657043|567180407|FG001|Overall Study|Study closure by Sponsor|2|||
157116556|NCT03657043|567180408|FG002|Overall Study|Study closure by Sponsor|0|||
157116557|NCT03657043|567180409|FG003|Overall Study|Study closure by Sponsor|0|||
157116558|NCT03657043|567180410|FG004|Overall Study|Study closure by Sponsor|17|||
157116559|NCT03657043|567180406|FG000|Overall Study|Lost to Follow-up|0|||
157116560|NCT03657043|567180407|FG001|Overall Study|Lost to Follow-up|0|||
157116561|NCT03657043|567180408|FG002|Overall Study|Lost to Follow-up|0|||
157116562|NCT03657043|567180409|FG003|Overall Study|Lost to Follow-up|0|||
157116563|NCT03657043|567180410|FG004|Overall Study|Lost to Follow-up|4|||
157116564|NCT03657043|567180406|FG000|Overall Study|Death|6|||
157116565|NCT03657043|567180407|FG001|Overall Study|Death|5|||
157116566|NCT03657043|567180408|FG002|Overall Study|Death|0|||
157116567|NCT03657043|567180409|FG003|Overall Study|Death|0|||
157116568|NCT03657043|567180410|FG004|Overall Study|Death|53|||
157116569|NCT03657043|567180406|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
157116570|NCT03657043|567180407|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
157116571|NCT03657043|567180408|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
157116572|NCT03657043|567180409|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
157116573|NCT03657043|567180410|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
157116574|NCT03657043|567180406|FG000|Overall Study|Adverse Event|0|||
157116575|NCT03657043|567180407|FG001|Overall Study|Adverse Event|0|||
157116576|NCT03657043|567180408|FG002|Overall Study|Adverse Event|0|||
157116577|NCT03657043|567180409|FG003|Overall Study|Adverse Event|0|||
157116578|NCT03657043|567180410|FG004|Overall Study|Adverse Event|2|||
157116579|NCT03657043|567180406|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
157116580|NCT03657043|567180407|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
157116581|NCT03657043|567180408|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
157116582|NCT03657043|567180409|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
157116583|NCT03657043|567180410|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
157116584|NCT03657043|567180406|FG000|Overall Study|Withdrawal - declined follow-up|0|||
157116585|NCT03657043|567180407|FG001|Overall Study|Withdrawal - declined follow-up|0|||
157116586|NCT03657043|567180408|FG002|Overall Study|Withdrawal - declined follow-up|0|||
157116587|NCT03657043|567180409|FG003|Overall Study|Withdrawal - declined follow-up|0|||
157116588|NCT03657043|567180410|FG004|Overall Study|Withdrawal - declined follow-up|1|||
157116589|NCT02239939|567180415|FG000|Overall Study|Adverse Event|1|||
157116590|NCT02239939|567180416|FG001|Overall Study|Adverse Event|0|||
157116591|NCT02239939|567180415|FG000|Overall Study|Withdrawal by Subject|1|||
157116592|NCT02239939|567180416|FG001|Overall Study|Withdrawal by Subject|1|||
157116593|NCT02239939|567180415|FG000|Overall Study|Lost to Follow-up|0|||
157116594|NCT02239939|567180416|FG001|Overall Study|Lost to Follow-up|1|||
157116595|NCT05634577|567180417|FG000|Overall Study|Lost to Follow-up|1|||
157116596|NCT05634577|567180417|FG000|Overall Study|Withdrawal by Subject|1|||
157116597|NCT02590588|567180423|FG000|Overall Study|Adverse Event|1|||
157116598|NCT01780831|567180431|FG000|Overall Study|Withdrawal by Subject|0|||
157116599|NCT01780831|567180432|FG001|Overall Study|Withdrawal by Subject|0|||
157116600|NCT01780831|567180433|FG002|Overall Study|Withdrawal by Subject|4|||
157116601|NCT01780831|567180434|FG003|Overall Study|Withdrawal by Subject|0|||
157116602|NCT01780831|567180431|FG000|Overall Study|Lost to Follow-up|0|||
157116603|NCT01780831|567180432|FG001|Overall Study|Lost to Follow-up|0|||
157116604|NCT01780831|567180433|FG002|Overall Study|Lost to Follow-up|0|||
157116605|NCT01780831|567180434|FG003|Overall Study|Lost to Follow-up|1|||
157116606|NCT01784861|567180437|FG000|Overall Study|Adverse Event|0|||
157116607|NCT01784861|567180438|FG001|Overall Study|Adverse Event|0|||
157116608|NCT01784861|567180439|FG002|Overall Study|Adverse Event|1|||
157116609|NCT01784861|567180440|FG003|Overall Study|Adverse Event|2|||
157116610|NCT01784861|567180441|FG004|Overall Study|Adverse Event|1|||
157116611|NCT01784861|567180442|FG005|Overall Study|Adverse Event|0|||
157116612|NCT01784861|567180437|FG000|Overall Study|Withdrawal by Subject|0|||
157116613|NCT01784861|567180438|FG001|Overall Study|Withdrawal by Subject|0|||
157116614|NCT01784861|567180439|FG002|Overall Study|Withdrawal by Subject|0|||
157116615|NCT01784861|567180440|FG003|Overall Study|Withdrawal by Subject|1|||
157116616|NCT01784861|567180441|FG004|Overall Study|Withdrawal by Subject|0|||
157116617|NCT01784861|567180442|FG005|Overall Study|Withdrawal by Subject|0|||
157116618|NCT01784861|567180437|FG000|Overall Study|Physician Decision|0|||
157116619|NCT01784861|567180438|FG001|Overall Study|Physician Decision|0|||
157116620|NCT01784861|567180439|FG002|Overall Study|Physician Decision|0|||
157116621|NCT01784861|567180440|FG003|Overall Study|Physician Decision|2|||
157116622|NCT01784861|567180441|FG004|Overall Study|Physician Decision|0|||
157116623|NCT01784861|567180442|FG005|Overall Study|Physician Decision|1|||
157116624|NCT00794677|567180457|FG000|First Intervention|Withdrawal by Subject|2|||
157116625|NCT00794677|567180458|FG001|First Intervention|Withdrawal by Subject|0|||
157116626|NCT01965262|567180471|FG000|Second Intervention (7 Days)|Discontinued|0|||
157116627|NCT01965262|567180472|FG001|Second Intervention (7 Days)|Discontinued|1|||
157116628|NCT01965262|567180471|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
157116629|NCT01965262|567180472|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
157116630|NCT01965262|567180471|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
157116631|NCT01965262|567180472|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
157116632|NCT00143312|567180473|FG000|Overall Study|Death|11|||
157116633|NCT00143312|567180473|FG000|Overall Study|Adverse Event|2|||
157116634|NCT00143312|567180473|FG000|Overall Study|Lost to Follow-up|1|||
157116635|NCT00143312|567180473|FG000|Overall Study|Other|1|||
157116636|NCT00143312|567180473|FG000|Overall Study|Withdrawal by Subject|1|||
157116637|NCT01046877|567180477|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
157116638|NCT01046877|567180477|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
157116639|NCT00563186|567180481|FG000|Overall Study|LOS<48 hours|97|||
157116640|NCT00563186|567180482|FG001|Overall Study|LOS<48 hours|74|||
157116641|NCT00563186|567180481|FG000|Overall Study|Incomplete data|1|||
157116642|NCT00563186|567180482|FG001|Overall Study|Incomplete data|1|||
157116643|NCT01902290|567180488|FG000|Overall Study|Withdrawal by Subject|19|||
157116644|NCT01902290|567180489|FG001|Overall Study|Withdrawal by Subject|27|||
157116645|NCT01902290|567180488|FG000|Overall Study|Lost to Follow-up|2|||
157116646|NCT01902290|567180489|FG001|Overall Study|Lost to Follow-up|2|||
157116647|NCT01902290|567180488|FG000|Overall Study|Death|1|||
157116648|NCT01902290|567180489|FG001|Overall Study|Death|0|||
157116649|NCT01902290|567180488|FG000|Overall Study|Sponsor Decision|26|||
157116650|NCT01902290|567180489|FG001|Overall Study|Sponsor Decision|24|||
157116651|NCT00769184|567180490|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
157116652|NCT00769184|567180491|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
157116653|NCT00769184|567180490|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
157116654|NCT00769184|567180491|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
157116655|NCT00769184|567180490|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
157116656|NCT00769184|567180491|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
157116657|NCT00517829|567180492|FG000|Overall Study|Adverse Event|22|||
157116658|NCT00517829|567180493|FG001|Overall Study|Adverse Event|34|||
157116659|NCT00517829|567180492|FG000|Overall Study|Disease Progression|39|||
157116660|NCT00517829|567180493|FG001|Overall Study|Disease Progression|32|||
157116661|NCT00517829|567180492|FG000|Overall Study|Patient Request|6|||
157116662|NCT00517829|567180493|FG001|Overall Study|Patient Request|5|||
157116663|NCT00517829|567180492|FG000|Overall Study|Investigator Request|5|||
157116664|NCT00517829|567180493|FG001|Overall Study|Investigator Request|3|||
157210940|NCT01954082|567519008|FG001|Overall Study|Parent Decision|0|||
157116665|NCT00517829|567180492|FG000|Overall Study|Other|3|||
157116666|NCT00517829|567180493|FG001|Overall Study|Other|1|||
157116667|NCT00446511|567180494|FG000|Overall Study|Adverse Event|7|||
157116668|NCT00446511|567180495|FG001|Overall Study|Adverse Event|2|||
157210941|NCT01954082|567519007|FG000|Overall Study|Withdrawal by Subject|0|||
157210942|NCT01954082|567519008|FG001|Overall Study|Withdrawal by Subject|1|||
157210943|NCT01954082|567519007|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
157210944|NCT01954082|567519008|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
157210945|NCT01954082|567519007|FG000|Overall Study|Redirection of Care|0|||
157210946|NCT01954082|567519008|FG001|Overall Study|Redirection of Care|2|||
157210947|NCT01954082|567519007|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
157116669|NCT00446511|567180496|FG002|Overall Study|Adverse Event|3|||
157210948|NCT01954082|567519008|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
157210949|NCT01954082|567519007|FG000|Overall Study|Comfort Care|0|||
157116670|NCT00446511|567180497|FG003|Overall Study|Adverse Event|1|||
157116671|NCT00446511|567180494|FG000|Overall Study|Protocol Violation|0|||
157116672|NCT00446511|567180495|FG001|Overall Study|Protocol Violation|0|||
157116673|NCT00446511|567180496|FG002|Overall Study|Protocol Violation|0|||
157116674|NCT00446511|567180497|FG003|Overall Study|Protocol Violation|1|||
157210950|NCT01954082|567519008|FG001|Overall Study|Comfort Care|1|||
157116675|NCT00446511|567180494|FG000|Overall Study|Withdrawal by Subject|0|||
157116676|NCT00446511|567180495|FG001|Overall Study|Withdrawal by Subject|0|||
157116677|NCT00446511|567180496|FG002|Overall Study|Withdrawal by Subject|0|||
157116678|NCT00446511|567180497|FG003|Overall Study|Withdrawal by Subject|3|||
157116679|NCT00446511|567180494|FG000|Overall Study|Administrative Problems|3|||
157116680|NCT00446511|567180495|FG001|Overall Study|Administrative Problems|0|||
157116681|NCT00446511|567180496|FG002|Overall Study|Administrative Problems|4|||
157116682|NCT00446511|567180497|FG003|Overall Study|Administrative Problems|1|||
157116683|NCT03873714|567180506|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
157116684|NCT01970501|567180507|FG000|Overall Study|Discontinuation of study by sponsor|16|||
157116685|NCT01970501|567180508|FG001|Overall Study|Discontinuation of study by sponsor|14|||
157116686|NCT01970501|567180507|FG000|Overall Study|Withdrawal by Subject|6|||
157116687|NCT01970501|567180508|FG001|Overall Study|Withdrawal by Subject|7|||
157116688|NCT01970501|567180507|FG000|Overall Study|Adverse Event|2|||
157116689|NCT01970501|567180508|FG001|Overall Study|Adverse Event|4|||
157116690|NCT01970501|567180507|FG000|Overall Study|Death|1|||
157116691|NCT01970501|567180508|FG001|Overall Study|Death|3|||
157116692|NCT01970501|567180507|FG000|Overall Study|Physician Decision|2|||
157116693|NCT01970501|567180508|FG001|Overall Study|Physician Decision|0|||
157116694|NCT00708123|567180509|FG000|Period 1|Protocol Violation|0|||
157116695|NCT00708123|567180510|FG001|Period 1|Protocol Violation|1|||
157116696|NCT00708123|567180511|FG002|Period 1|Protocol Violation|0|||
157116697|NCT00708123|567180512|FG003|Period 1|Protocol Violation|1|||
157116698|NCT00708123|567180513|FG004|Period 1|Protocol Violation|0|||
157116699|NCT00708123|567180509|FG000|Period 1|Adverse Event|0|||
157116700|NCT00708123|567180510|FG001|Period 1|Adverse Event|0|||
157116701|NCT00708123|567180511|FG002|Period 1|Adverse Event|1|||
157116702|NCT00708123|567180512|FG003|Period 1|Adverse Event|0|||
157116703|NCT00708123|567180513|FG004|Period 1|Adverse Event|0|||
157116704|NCT00708123|567180509|FG000|Period 2|Protocol Violation|0|||
157116705|NCT00708123|567180510|FG001|Period 2|Protocol Violation|0|||
157116706|NCT00708123|567180511|FG002|Period 2|Protocol Violation|0|||
157116707|NCT00708123|567180512|FG003|Period 2|Protocol Violation|1|||
157116708|NCT00708123|567180513|FG004|Period 2|Protocol Violation|0|||
157116709|NCT00708123|567180509|FG000|Period 2|Other Reason|1|||
157116710|NCT00708123|567180510|FG001|Period 2|Other Reason|0|||
157116711|NCT00708123|567180511|FG002|Period 2|Other Reason|0|||
157116712|NCT00708123|567180512|FG003|Period 2|Other Reason|0|||
157116713|NCT00708123|567180513|FG004|Period 2|Other Reason|0|||
157116714|NCT00708123|567180509|FG000|Period 3|Lost to Follow-up|0|||
157116715|NCT00708123|567180510|FG001|Period 3|Lost to Follow-up|0|||
157116716|NCT00708123|567180511|FG002|Period 3|Lost to Follow-up|1|||
157116717|NCT00708123|567180512|FG003|Period 3|Lost to Follow-up|1|||
157116718|NCT00708123|567180513|FG004|Period 3|Lost to Follow-up|0|||
157116719|NCT00708123|567180509|FG000|Period 4|Protocol Violation|0|||
157116720|NCT00708123|567180510|FG001|Period 4|Protocol Violation|1|||
157210951|NCT01954082|567519007|FG000|Overall Study|Infant Moved|0|||
157210952|NCT01954082|567519008|FG001|Overall Study|Infant Moved|1|||
157210953|NCT01954082|567519007|FG000|Overall Study|Randomized not Treated|4|||
157210954|NCT01954082|567519008|FG001|Overall Study|Randomized not Treated|2|||
157210955|NCT01682512|567519009|FG000|Overall Study|Adverse Event|6|||
157210956|NCT01682512|567519010|FG001|Overall Study|Adverse Event|5|||
157210957|NCT01682512|567519011|FG002|Overall Study|Adverse Event|2|||
157210958|NCT01682512|567519009|FG000|Overall Study|Withdrawal by Subject|2|||
157210959|NCT01682512|567519010|FG001|Overall Study|Withdrawal by Subject|6|||
157210960|NCT01682512|567519011|FG002|Overall Study|Withdrawal by Subject|3|||
157210961|NCT01682512|567519009|FG000|Overall Study|Physician Decision|0|||
157210962|NCT01682512|567519010|FG001|Overall Study|Physician Decision|2|||
157210963|NCT01682512|567519011|FG002|Overall Study|Physician Decision|0|||
157210964|NCT01682512|567519009|FG000|Overall Study|Study terminated by sponsor|46|||
157210965|NCT01682512|567519010|FG001|Overall Study|Study terminated by sponsor|43|||
157210966|NCT01682512|567519011|FG002|Overall Study|Study terminated by sponsor|0|||
157210967|NCT01682512|567519009|FG000|Overall Study|Lost to Follow-up|3|||
157116721|NCT00708123|567180511|FG002|Period 4|Protocol Violation|0|||
157116722|NCT00708123|567180512|FG003|Period 4|Protocol Violation|0|||
157116723|NCT00708123|567180513|FG004|Period 4|Protocol Violation|0|||
157116724|NCT00845650|567180514|FG000|Overall Study|Withdrawal by Subject|0|||
157116725|NCT00845650|567180515|FG001|Overall Study|Withdrawal by Subject|0|||
157116726|NCT00845650|567180516|FG002|Overall Study|Withdrawal by Subject|0|||
157116727|NCT00845650|567180517|FG003|Overall Study|Withdrawal by Subject|0|||
157116728|NCT00845650|567180518|FG004|Overall Study|Withdrawal by Subject|2|||
157116729|NCT00845650|567180519|FG005|Overall Study|Withdrawal by Subject|0|||
157116730|NCT00845650|567180514|FG000|Overall Study|Lost to Follow-up|0|||
157116731|NCT00845650|567180515|FG001|Overall Study|Lost to Follow-up|0|||
157116732|NCT00845650|567180516|FG002|Overall Study|Lost to Follow-up|3|||
157210968|NCT01682512|567519010|FG001|Overall Study|Lost to Follow-up|0|||
157210969|NCT01682512|567519011|FG002|Overall Study|Lost to Follow-up|2|||
157116733|NCT00845650|567180517|FG003|Overall Study|Lost to Follow-up|1|||
157116734|NCT00845650|567180518|FG004|Overall Study|Lost to Follow-up|0|||
157116735|NCT00845650|567180519|FG005|Overall Study|Lost to Follow-up|1|||
157116736|NCT00845650|567180514|FG000|Overall Study|Sponsor hold on dosing|0|||
157116737|NCT00845650|567180515|FG001|Overall Study|Sponsor hold on dosing|0|||
157116738|NCT00845650|567180516|FG002|Overall Study|Sponsor hold on dosing|0|||
157116739|NCT00845650|567180517|FG003|Overall Study|Sponsor hold on dosing|0|||
157116740|NCT00845650|567180518|FG004|Overall Study|Sponsor hold on dosing|1|||
157116741|NCT00845650|567180519|FG005|Overall Study|Sponsor hold on dosing|1|||
157116742|NCT00845650|567180514|FG000|Overall Study|Unable to access IV line|1|||
157116743|NCT00845650|567180515|FG001|Overall Study|Unable to access IV line|0|||
157116744|NCT00845650|567180516|FG002|Overall Study|Unable to access IV line|0|||
157116745|NCT00845650|567180517|FG003|Overall Study|Unable to access IV line|0|||
157116746|NCT00845650|567180518|FG004|Overall Study|Unable to access IV line|0|||
157116747|NCT00845650|567180519|FG005|Overall Study|Unable to access IV line|0|||
157116748|NCT00814892|567180520|FG000|Overall Study|Disease Progression|1|||
157116749|NCT00814892|567180520|FG000|Overall Study|Study Termination|1|||
157116750|NCT00531752|567180524|FG000|First Double-blind Intervention Period|Adverse Event|2|||
157116751|NCT00531752|567180525|FG001|First Double-blind Intervention Period|Adverse Event|0|||
157116752|NCT00531752|567180526|FG002|First Double-blind Intervention Period|Adverse Event|1|||
157116753|NCT00531752|567180527|FG003|First Double-blind Intervention Period|Adverse Event|1|||
157116754|NCT00531752|567180524|FG000|First Double-blind Intervention Period|Other|1|||
157116755|NCT00531752|567180525|FG001|First Double-blind Intervention Period|Other|4|||
157116756|NCT00531752|567180526|FG002|First Double-blind Intervention Period|Other|4|||
157116757|NCT00531752|567180527|FG003|First Double-blind Intervention Period|Other|0|||
157116758|NCT00531752|567180524|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
157116759|NCT00531752|567180525|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
157116760|NCT00531752|567180526|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
157116761|NCT00531752|567180527|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
157116762|NCT00531752|567180524|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
157116763|NCT00531752|567180525|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
157116764|NCT00531752|567180526|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
157116765|NCT00531752|567180527|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
157116766|NCT00531752|567180524|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
157116767|NCT00531752|567180525|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
157116768|NCT00531752|567180526|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
157116769|NCT00531752|567180527|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
157116770|NCT00531752|567180524|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
157116771|NCT00531752|567180525|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
157116772|NCT00531752|567180526|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
157116773|NCT00531752|567180527|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
157116774|NCT00531752|567180524|FG000|Second Double-blind Intervention Period|Other|1|||
157116775|NCT00531752|567180525|FG001|Second Double-blind Intervention Period|Other|1|||
157116776|NCT00531752|567180526|FG002|Second Double-blind Intervention Period|Other|0|||
157116777|NCT00531752|567180527|FG003|Second Double-blind Intervention Period|Other|0|||
157116778|NCT00531752|567180524|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
157116779|NCT00531752|567180525|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
157116780|NCT00531752|567180526|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
157116781|NCT00531752|567180527|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
157116782|NCT00531752|567180524|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
157116783|NCT00531752|567180525|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
157116784|NCT00531752|567180526|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
157116785|NCT00531752|567180527|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
157116786|NCT01181011|567180528|FG000|Overall Study|Adverse Event|2|||
157116787|NCT01181011|567180528|FG000|Overall Study|Lost to Follow-up|1|||
157116788|NCT00401375|567180529|FG000|Overall Study|Protocol Violation|2|||
157116789|NCT00401375|567180530|FG001|Overall Study|Protocol Violation|2|||
157116790|NCT00401375|567180531|FG002|Overall Study|Protocol Violation|1|||
157116791|NCT00401375|567180529|FG000|Overall Study|Adverse Event|6|||
157116792|NCT00401375|567180530|FG001|Overall Study|Adverse Event|11|||
157116793|NCT00401375|567180531|FG002|Overall Study|Adverse Event|10|||
157210970|NCT01682512|567519009|FG000|Overall Study|Protocol Violation|2|||
157010785|NCT01693120|566791931|FG000|Enrollment|Physician Decision|3|||
157010786|NCT01693120|566791931|FG000|Enrollment|Adverse Event|1|||
157010787|NCT01693120|566791931|FG000|Enrollment|Study closed|8|||
157010788|NCT01693120|566791931|FG000|Enrollment|Other|1|||
157010789|NCT01693120|566791931|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
157010790|NCT01693120|566791931|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
157010791|NCT01693120|566791931|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
157010792|NCT01693120|566791931|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
157010793|NCT01693120|566791931|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
157010794|NCT02411084|566791939|FG000|Overall Study|Lack of Efficacy|6|||
157010795|NCT02411084|566791940|FG001|Overall Study|Lack of Efficacy|3|||
157010796|NCT02411084|566791939|FG000|Overall Study|Death|5|||
157010797|NCT02411084|566791940|FG001|Overall Study|Death|4|||
157010798|NCT02411084|566791939|FG000|Overall Study|Adverse Event|2|||
157010799|NCT02411084|566791940|FG001|Overall Study|Adverse Event|1|||
157010800|NCT02411084|566791939|FG000|Overall Study|Other reasons|0|||
157010801|NCT02411084|566791940|FG001|Overall Study|Other reasons|5|||
157010802|NCT00610649|566791941|FG000|Overall Study|Adverse Event|1|||
157010803|NCT00610649|566791942|FG001|Overall Study|Adverse Event|0|||
157010804|NCT00610649|566791943|FG002|Overall Study|Adverse Event|0|||
157010805|NCT00610649|566791944|FG003|Overall Study|Adverse Event|0|||
157010806|NCT00610649|566791945|FG004|Overall Study|Adverse Event|0|||
157010807|NCT00610649|566791946|FG005|Overall Study|Adverse Event|0|||
157010808|NCT00610649|566791947|FG006|Overall Study|Adverse Event|0|||
157010809|NCT00610649|566791948|FG007|Overall Study|Adverse Event|0|||
157010810|NCT00610649|566791949|FG008|Overall Study|Adverse Event|0|||
157010811|NCT00610649|566791950|FG009|Overall Study|Adverse Event|0|||
157010812|NCT00610649|566791951|FG010|Overall Study|Adverse Event|1|||
157010813|NCT00610649|566791941|FG000|Overall Study|Family Emergency|0|||
157010814|NCT00610649|566791942|FG001|Overall Study|Family Emergency|1|||
157010815|NCT00610649|566791943|FG002|Overall Study|Family Emergency|0|||
157010816|NCT00610649|566791944|FG003|Overall Study|Family Emergency|0|||
157010817|NCT00610649|566791945|FG004|Overall Study|Family Emergency|0|||
157010818|NCT00610649|566791946|FG005|Overall Study|Family Emergency|0|||
157010819|NCT00610649|566791947|FG006|Overall Study|Family Emergency|0|||
157010820|NCT00610649|566791948|FG007|Overall Study|Family Emergency|0|||
157010821|NCT00610649|566791949|FG008|Overall Study|Family Emergency|0|||
157010822|NCT00610649|566791950|FG009|Overall Study|Family Emergency|0|||
157010823|NCT00610649|566791951|FG010|Overall Study|Family Emergency|0|||
157010824|NCT00610649|566791941|FG000|Overall Study|Withdrawal by Subject|0|||
157010825|NCT00610649|566791942|FG001|Overall Study|Withdrawal by Subject|0|||
157010826|NCT00610649|566791943|FG002|Overall Study|Withdrawal by Subject|0|||
157010827|NCT00610649|566791944|FG003|Overall Study|Withdrawal by Subject|0|||
157010828|NCT00610649|566791945|FG004|Overall Study|Withdrawal by Subject|0|||
157010829|NCT00610649|566791946|FG005|Overall Study|Withdrawal by Subject|0|||
157010830|NCT00610649|566791947|FG006|Overall Study|Withdrawal by Subject|0|||
157010831|NCT00610649|566791948|FG007|Overall Study|Withdrawal by Subject|0|||
157010832|NCT00610649|566791949|FG008|Overall Study|Withdrawal by Subject|0|||
157010833|NCT00610649|566791950|FG009|Overall Study|Withdrawal by Subject|1|||
157010834|NCT00610649|566791951|FG010|Overall Study|Withdrawal by Subject|0|||
157010835|NCT00858117|566791961|FG000|Treatment on Study|Adverse Event|2|||
157010836|NCT00858117|566791961|FG000|Follow up for 5 Years|Death|4|||
157010837|NCT00858117|566791961|FG000|Follow up for 5 Years|No further data collected for study|9|||
157010838|NCT00371787|566791962|FG000|Overall Study|Withdrawal by Subject|3|||
157010839|NCT00371787|566791963|FG001|Overall Study|Withdrawal by Subject|1|||
157010840|NCT02765100|566791966|FG000|Overall Study|subject found ineligible after baseline|1|||
157010841|NCT02765100|566791967|FG001|Overall Study|subject found ineligible after baseline|1|||
157010842|NCT02765100|566791966|FG000|Overall Study|Lost to Follow-up|0|||
157010843|NCT02765100|566791967|FG001|Overall Study|Lost to Follow-up|1|||
157010844|NCT00642850|566791970|FG000|Overall Study|Death|7|||
157010845|NCT00642850|566791970|FG000|Overall Study|Adverse Event|2|||
157010846|NCT00642850|566791970|FG000|Overall Study|Lack of Efficacy|1|||
157010847|NCT00642850|566791970|FG000|Overall Study|Protocol Violation|2|||
157010848|NCT00642850|566791970|FG000|Overall Study|Kidney transplantation|8|||
157010849|NCT00642850|566791970|FG000|Overall Study|Blood transfusion|6|||
157010850|NCT00642850|566791970|FG000|Overall Study|Other reasons|7|||
157010851|NCT05489484|566791973|FG000|Overall Study|withdrawn|1|||
157010852|NCT02529995|566791976|FG000|Part A|Ongoing Study at Data Cut-off|14|||
157010853|NCT02529995|566791977|FG001|Part A|Ongoing Study at Data Cut-off|16|||
157010854|NCT02529995|566791976|FG000|Part A|Discontinued Study|1|||
157010855|NCT02529995|566791977|FG001|Part A|Discontinued Study|0|||
157010856|NCT02529995|566791976|FG000|Part B|Ongoing Study at Data Cut-off|0|||
157010857|NCT02529995|566791977|FG001|Part B|Ongoing Study at Data Cut-off|7|||
157010858|NCT02529995|566791976|FG000|Part B|Discontinued Study|6|||
157010859|NCT02529995|566791977|FG001|Part B|Discontinued Study|5|||
157010860|NCT00444600|566791981|FG000|Overall Study|Death|7|||
157010861|NCT00444600|566791982|FG001|Overall Study|Death|5|||
157010862|NCT00444600|566791983|FG002|Overall Study|Death|3|||
157010863|NCT00444600|566791984|FG003|Overall Study|Death|2|||
157010864|NCT00444600|566791981|FG000|Overall Study|Dropped|11|||
157010865|NCT00444600|566791982|FG001|Overall Study|Dropped|11|||
157010866|NCT00444600|566791983|FG002|Overall Study|Dropped|7|||
157010867|NCT00444600|566791984|FG003|Overall Study|Dropped|7|||
157010868|NCT00444600|566791981|FG000|Overall Study|Missed visit|1|||
157010869|NCT00444600|566791982|FG001|Overall Study|Missed visit|0|||
157010870|NCT00444600|566791983|FG002|Overall Study|Missed visit|0|||
157010871|NCT00444600|566791984|FG003|Overall Study|Missed visit|1|||
157010872|NCT05132478|566791985|FG000|Overall Study|did not complete survey after consent|1|||
157010873|NCT05132478|566791986|FG001|Overall Study|did not complete survey after consent|1|||
157010874|NCT05132478|566791985|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
157010875|NCT05132478|566791986|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
157010876|NCT00106080|566791987|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
157010877|NCT00106080|566791988|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
157010878|NCT02988817|566791989|FG000|Overall Study|Withdrawal by Subject|1|||
157116794|NCT00401375|567180529|FG000|Overall Study|Withdrawal by Subject|9|||
157116795|NCT00401375|567180530|FG001|Overall Study|Withdrawal by Subject|7|||
157116796|NCT00401375|567180531|FG002|Overall Study|Withdrawal by Subject|7|||
157116797|NCT00401375|567180529|FG000|Overall Study|Lost to Follow-up|0|||
157116798|NCT00401375|567180530|FG001|Overall Study|Lost to Follow-up|1|||
157116799|NCT00401375|567180531|FG002|Overall Study|Lost to Follow-up|1|||
157116800|NCT00401375|567180529|FG000|Overall Study|Other than specified|2|||
157116801|NCT00401375|567180530|FG001|Overall Study|Other than specified|1|||
157116802|NCT00401375|567180531|FG002|Overall Study|Other than specified|3|||
157116803|NCT00401375|567180529|FG000|Overall Study|Randomized but not treated|3|||
157116804|NCT00401375|567180530|FG001|Overall Study|Randomized but not treated|3|||
157116805|NCT00401375|567180531|FG002|Overall Study|Randomized but not treated|3|||
157116806|NCT00950664|567180532|FG000|First Intervention|Lost to Follow-up|1|||
157116807|NCT00950664|567180533|FG001|First Intervention|Lost to Follow-up|3|||
157116808|NCT00950664|567180532|FG000|First Intervention|Withdrawal by Subject|2|||
157116809|NCT00950664|567180533|FG001|First Intervention|Withdrawal by Subject|2|||
157116810|NCT00677014|567180534|FG000|Overall Study|Lost to Follow-up|20|||
157116811|NCT00677014|567180535|FG001|Overall Study|Lost to Follow-up|12|||
157116812|NCT00677014|567180536|FG002|Overall Study|Lost to Follow-up|24|||
157116813|NCT00677014|567180534|FG000|Overall Study|Death|6|||
157116814|NCT00677014|567180535|FG001|Overall Study|Death|15|||
157116815|NCT00677014|567180536|FG002|Overall Study|Death|7|||
157116816|NCT00677014|567180534|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
157116817|NCT00677014|567180535|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
157116818|NCT00677014|567180536|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
157116819|NCT01326546|567180539|FG000|Overall Study|Lost to Follow-up|8|||
157116820|NCT01326546|567180540|FG001|Overall Study|Lost to Follow-up|7|||
157116821|NCT01326546|567180539|FG000|Overall Study|Protocol Violation|3|||
157116822|NCT01326546|567180540|FG001|Overall Study|Protocol Violation|4|||
157116823|NCT01326546|567180539|FG000|Overall Study|Pregnancy|0|||
157116824|NCT01326546|567180540|FG001|Overall Study|Pregnancy|1|||
157116825|NCT01326546|567180539|FG000|Overall Study|Adverse Event|1|||
157116826|NCT01326546|567180540|FG001|Overall Study|Adverse Event|0|||
157116827|NCT01326546|567180539|FG000|Overall Study|Withdrawal by Subject|5|||
157116828|NCT01326546|567180540|FG001|Overall Study|Withdrawal by Subject|1|||
157116829|NCT03152019|567180541|FG000|Overall Study|Adverse Event|0|||
157116830|NCT03152019|567180542|FG001|Overall Study|Adverse Event|1|||
157116831|NCT00081159|567180546|FG000|Overall Study|Withdrawal by Subject|0|||
157116832|NCT00081159|567180547|FG001|Overall Study|Withdrawal by Subject|3|||
157116833|NCT00081159|567180546|FG000|Overall Study|Myelosuppression prior to treatment|0|||
157116834|NCT00081159|567180547|FG001|Overall Study|Myelosuppression prior to treatment|1|||
157116835|NCT00081159|567180546|FG000|Overall Study|Lost to Follow-up|2|||
157116836|NCT00081159|567180547|FG001|Overall Study|Lost to Follow-up|1|||
157116837|NCT00923130|567180550|FG000|Overall Study|Stopped treatment due to progression|17|||
157116838|NCT00923130|567180550|FG000|Overall Study|Death|1|||
157116839|NCT00923130|567180550|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
157116840|NCT00923130|567180550|FG000|Overall Study|Switched to alternative treatment|2|||
157116841|NCT00923130|567180550|FG000|Overall Study|Refused further treatment|2|||
157116842|NCT03693625|567180551|FG000|Overall Study|Adverse Event|2|||
157116843|NCT03693625|567180552|FG001|Overall Study|Adverse Event|0|||
157116844|NCT03693625|567180551|FG000|Overall Study|Study Terminated By Sponsor|20|||
157116845|NCT03693625|567180552|FG001|Overall Study|Study Terminated By Sponsor|7|||
157116846|NCT03693625|567180551|FG000|Overall Study|Withdrawal by Subject|1|||
157116847|NCT03693625|567180552|FG001|Overall Study|Withdrawal by Subject|1|||
157116848|NCT01883635|567180553|FG000|Overall Study|Withdrawal by Subject|4|||
157116849|NCT01883635|567180554|FG001|Overall Study|Withdrawal by Subject|0|||
157116850|NCT01187953|567180555|FG000|Overall Study|Death|11|||
157116851|NCT01187953|567180556|FG001|Overall Study|Death|13|||
157116852|NCT01187953|567180555|FG000|Overall Study|Adverse Event|1|||
157116853|NCT01187953|567180556|FG001|Overall Study|Adverse Event|2|||
157116854|NCT01187953|567180555|FG000|Overall Study|Lost to Follow-up|0|||
157116855|NCT01187953|567180556|FG001|Overall Study|Lost to Follow-up|3|||
157116856|NCT01187953|567180555|FG000|Overall Study|Withdrawal by Subject|3|||
157116857|NCT01187953|567180556|FG001|Overall Study|Withdrawal by Subject|3|||
157116858|NCT02457637|567180559|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
157116859|NCT01035905|567180561|FG000|Overall Study|Lack of Efficacy|1|||
157116860|NCT01035905|567180562|FG001|Overall Study|Lack of Efficacy|1|||
157116861|NCT01273883|567180563|FG000|First Intervention|Adverse Event|2|||
157116862|NCT01273883|567180564|FG001|First Intervention|Adverse Event|1|||
157116863|NCT01273883|567180563|FG000|Second Intervention|Lost to Follow-up|1|||
157116864|NCT01273883|567180564|FG001|Second Intervention|Lost to Follow-up|1|||
157116865|NCT01273883|567180563|FG000|Second Intervention|Lack of Efficacy|1|||
157116866|NCT01273883|567180564|FG001|Second Intervention|Lack of Efficacy|0|||
157116867|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Death|3|||
157116868|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Death|0|||
157116869|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Adverse Event|12|||
157116870|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Adverse Event|6|||
157116871|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
157116872|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
157116873|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
157116874|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
157116875|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
157116876|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
157116877|NCT00159861|567180565|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
157116878|NCT00159861|567180566|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
157116879|NCT00159861|567180565|FG000|Extension Study - up to 3 Years|Death|24|||
157116880|NCT00159861|567180566|FG001|Extension Study - up to 3 Years|Death|28|||
157116881|NCT00159861|567180565|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
157116882|NCT00159861|567180566|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
157116883|NCT00159861|567180565|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
157116884|NCT00159861|567180566|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
157116885|NCT00159861|567180565|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
157116886|NCT00159861|567180566|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
157116887|NCT00159861|567180565|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
157116888|NCT00159861|567180566|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
157116889|NCT01553136|567180568|FG000|Overall Study|Adverse Event|3|||
157116890|NCT01553136|567180569|FG001|Overall Study|Adverse Event|2|||
157116891|NCT01553136|567180568|FG000|Overall Study|Withdrawal by Subject|2|||
157116892|NCT01553136|567180569|FG001|Overall Study|Withdrawal by Subject|3|||
157116893|NCT01553136|567180568|FG000|Overall Study|Lost to Follow-up|4|||
157116894|NCT01553136|567180569|FG001|Overall Study|Lost to Follow-up|10|||
157116895|NCT01553136|567180568|FG000|Overall Study|Physician Decision|2|||
157116896|NCT01553136|567180569|FG001|Overall Study|Physician Decision|3|||
157116897|NCT01553136|567180568|FG000|Overall Study|Scheduling Difficulties|5|||
157116898|NCT01553136|567180569|FG001|Overall Study|Scheduling Difficulties|4|||
157116899|NCT03040999|567182292|FG000|Overall Study|Lost to Follow-up|2|||
157116900|NCT03040999|567182293|FG001|Overall Study|Lost to Follow-up|2|||
157116901|NCT03040999|567182292|FG000|Overall Study|Withdrawal by Subject|12|||
156779785|NCT01078662|565943886|FG003|Overall Study|Death|5|||
157116902|NCT03040999|567182293|FG001|Overall Study|Withdrawal by Subject|13|||
157116903|NCT03040999|567182292|FG000|Overall Study|Death|155|||
157116904|NCT03040999|567182293|FG001|Overall Study|Death|171|||
157116905|NCT03040999|567182292|FG000|Overall Study|Physician Decision|0|||
157116906|NCT03040999|567182293|FG001|Overall Study|Physician Decision|3|||
157116907|NCT02068547|567182295|FG000|Overall Study|Lost to Follow-up|3|||
157116908|NCT02068547|567182296|FG001|Overall Study|Lost to Follow-up|3|||
157116909|NCT02068547|567182295|FG000|Overall Study|Physician Decision|1|||
157116910|NCT02068547|567182296|FG001|Overall Study|Physician Decision|0|||
157116911|NCT01995071|567182297|FG000|Overall Study|Adverse Event|0|||
157116912|NCT01995071|567182298|FG001|Overall Study|Adverse Event|0|||
157116913|NCT01995071|567182299|FG002|Overall Study|Adverse Event|0|||
157116914|NCT01995071|567182300|FG003|Overall Study|Adverse Event|0|||
157116915|NCT01995071|567182301|FG004|Overall Study|Adverse Event|0|||
157116916|NCT01995071|567182302|FG005|Overall Study|Adverse Event|0|||
157116917|NCT01995071|567182303|FG006|Overall Study|Adverse Event|1|||
157116918|NCT01995071|567182304|FG007|Overall Study|Adverse Event|0|||
157116919|NCT01995071|567182305|FG008|Overall Study|Adverse Event|0|||
157116920|NCT01995071|567182306|FG009|Overall Study|Adverse Event|0|||
157116921|NCT01995071|567182307|FG010|Overall Study|Adverse Event|0|||
157116922|NCT01995071|567182308|FG011|Overall Study|Adverse Event|0|||
157116923|NCT01995071|567182297|FG000|Overall Study|Moved|0|||
157116924|NCT01995071|567182298|FG001|Overall Study|Moved|0|||
157116925|NCT01995071|567182299|FG002|Overall Study|Moved|1|||
157116926|NCT01995071|567182300|FG003|Overall Study|Moved|0|||
157116927|NCT01995071|567182301|FG004|Overall Study|Moved|1|||
157116928|NCT01995071|567182302|FG005|Overall Study|Moved|0|||
157116929|NCT01995071|567182303|FG006|Overall Study|Moved|0|||
157116930|NCT01995071|567182304|FG007|Overall Study|Moved|0|||
157116931|NCT01995071|567182305|FG008|Overall Study|Moved|0|||
157116932|NCT01995071|567182306|FG009|Overall Study|Moved|0|||
157116933|NCT01995071|567182307|FG010|Overall Study|Moved|1|||
157116934|NCT01995071|567182308|FG011|Overall Study|Moved|0|||
157116935|NCT01995071|567182297|FG000|Overall Study|Lost to Follow-up|1|||
157116936|NCT01995071|567182298|FG001|Overall Study|Lost to Follow-up|0|||
157116937|NCT01995071|567182299|FG002|Overall Study|Lost to Follow-up|0|||
157116938|NCT01995071|567182300|FG003|Overall Study|Lost to Follow-up|0|||
157116939|NCT01995071|567182301|FG004|Overall Study|Lost to Follow-up|0|||
157116940|NCT01995071|567182302|FG005|Overall Study|Lost to Follow-up|0|||
157116941|NCT01995071|567182303|FG006|Overall Study|Lost to Follow-up|0|||
157116942|NCT01995071|567182304|FG007|Overall Study|Lost to Follow-up|1|||
157116943|NCT01995071|567182305|FG008|Overall Study|Lost to Follow-up|1|||
157116944|NCT01995071|567182306|FG009|Overall Study|Lost to Follow-up|0|||
157116945|NCT01995071|567182307|FG010|Overall Study|Lost to Follow-up|0|||
157116946|NCT01995071|567182308|FG011|Overall Study|Lost to Follow-up|0|||
157116947|NCT01995071|567182297|FG000|Overall Study|Incarcerated|0|||
157116948|NCT01995071|567182298|FG001|Overall Study|Incarcerated|0|||
157116949|NCT01995071|567182299|FG002|Overall Study|Incarcerated|0|||
157116950|NCT01995071|567182300|FG003|Overall Study|Incarcerated|0|||
157116951|NCT01995071|567182301|FG004|Overall Study|Incarcerated|0|||
157116952|NCT01995071|567182302|FG005|Overall Study|Incarcerated|0|||
157116953|NCT01995071|567182303|FG006|Overall Study|Incarcerated|0|||
157116954|NCT01995071|567182304|FG007|Overall Study|Incarcerated|1|||
157116955|NCT01995071|567182305|FG008|Overall Study|Incarcerated|0|||
157116956|NCT01995071|567182306|FG009|Overall Study|Incarcerated|0|||
157116957|NCT01995071|567182307|FG010|Overall Study|Incarcerated|0|||
157116958|NCT01995071|567182308|FG011|Overall Study|Incarcerated|0|||
157116959|NCT00631371|567182315|FG000|Overall Study|Lost to Follow-up|24|||
157116960|NCT00631371|567182316|FG001|Overall Study|Lost to Follow-up|19|||
157116961|NCT00631371|567182315|FG000|Overall Study|Other reason|5|||
157116962|NCT00631371|567182316|FG001|Overall Study|Other reason|12|||
157116963|NCT00631371|567182315|FG000|Overall Study|subject request|38|||
157116964|NCT00631371|567182316|FG001|Overall Study|subject request|45|||
157116965|NCT00631371|567182315|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
157116966|NCT00631371|567182316|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
157116967|NCT00631371|567182315|FG000|Overall Study|Death|263|||
157116968|NCT00631371|567182316|FG001|Overall Study|Death|239|||
157116969|NCT03354663|567182317|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
157210971|NCT01682512|567519010|FG001|Overall Study|Protocol Violation|3|||
157210972|NCT01682512|567519011|FG002|Overall Study|Protocol Violation|2|||
157116970|NCT03354663|567182317|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
157116971|NCT03354663|567182317|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
157116972|NCT03354663|567182317|FG000|Completed 30-day Visit|Missed Visit|1|||
157116973|NCT01661140|567182320|FG000|Open-Label Period|Adverse Event|44|||
157210973|NCT01682512|567519009|FG000|Overall Study|Primary lack of efficacy|10|||
157210974|NCT01682512|567519010|FG001|Overall Study|Primary lack of efficacy|7|||
157210975|NCT01682512|567519011|FG002|Overall Study|Primary lack of efficacy|7|||
157116974|NCT01661140|567182321|FG001|Open-Label Period|Adverse Event|0|||
157116975|NCT01661140|567182322|FG002|Open-Label Period|Adverse Event|0|||
157116976|NCT01661140|567182320|FG000|Open-Label Period|Protocol Violation|3|||
157116977|NCT01661140|567182321|FG001|Open-Label Period|Protocol Violation|0|||
157116978|NCT01661140|567182322|FG002|Open-Label Period|Protocol Violation|0|||
157116979|NCT01661140|567182320|FG000|Open-Label Period|Withdrawal by Subject|5|||
157116980|NCT01661140|567182321|FG001|Open-Label Period|Withdrawal by Subject|0|||
157116981|NCT01661140|567182322|FG002|Open-Label Period|Withdrawal by Subject|0|||
157116982|NCT01661140|567182320|FG000|Open-Label Period|Investigator Decision|3|||
157116983|NCT01661140|567182321|FG001|Open-Label Period|Investigator Decision|0|||
157116984|NCT01661140|567182322|FG002|Open-Label Period|Investigator Decision|0|||
157116985|NCT01661140|567182320|FG000|Open-Label Period|Death|1|||
157116986|NCT01661140|567182321|FG001|Open-Label Period|Death|0|||
157116987|NCT01661140|567182322|FG002|Open-Label Period|Death|0|||
157116988|NCT01661140|567182320|FG000|Open-Label Period|Administrative/Other|1|||
157116989|NCT01661140|567182321|FG001|Open-Label Period|Administrative/Other|0|||
157116990|NCT01661140|567182322|FG002|Open-Label Period|Administrative/Other|0|||
157116991|NCT01661140|567182320|FG000|Open-Label Period|Sponsor termination|16|||
157116992|NCT01661140|567182321|FG001|Open-Label Period|Sponsor termination|0|||
157116993|NCT01661140|567182322|FG002|Open-Label Period|Sponsor termination|0|||
157116994|NCT01661140|567182320|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
157116995|NCT01661140|567182321|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
157116996|NCT01661140|567182322|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
157116997|NCT01661140|567182320|FG000|Open-Label Period|Lost to Follow-up|2|||
157116998|NCT01661140|567182321|FG001|Open-Label Period|Lost to Follow-up|0|||
157116999|NCT01661140|567182322|FG002|Open-Label Period|Lost to Follow-up|0|||
157117000|NCT01661140|567182320|FG000|Double-Blind Period|Refused Treatment|0|||
157117001|NCT01661140|567182321|FG001|Double-Blind Period|Refused Treatment|0|||
157117002|NCT01661140|567182322|FG002|Double-Blind Period|Refused Treatment|1|||
157117003|NCT01661140|567182320|FG000|Double-Blind Period|Adverse Event|0|||
157117004|NCT01661140|567182321|FG001|Double-Blind Period|Adverse Event|16|||
157117005|NCT01661140|567182322|FG002|Double-Blind Period|Adverse Event|18|||
157117006|NCT01661140|567182320|FG000|Double-Blind Period|Protocol Violation|0|||
157117007|NCT01661140|567182321|FG001|Double-Blind Period|Protocol Violation|2|||
157117008|NCT01661140|567182322|FG002|Double-Blind Period|Protocol Violation|3|||
157117009|NCT01661140|567182320|FG000|Double-Blind Period|Withdrawal by Subject|0|||
157117010|NCT01661140|567182321|FG001|Double-Blind Period|Withdrawal by Subject|1|||
157117011|NCT01661140|567182322|FG002|Double-Blind Period|Withdrawal by Subject|3|||
157117012|NCT01661140|567182320|FG000|Double-Blind Period|Investigator's Decision|0|||
157117013|NCT01661140|567182321|FG001|Double-Blind Period|Investigator's Decision|1|||
157117014|NCT01661140|567182322|FG002|Double-Blind Period|Investigator's Decision|2|||
157117015|NCT01661140|567182320|FG000|Double-Blind Period|Sponsor Termination|0|||
157117016|NCT01661140|567182321|FG001|Double-Blind Period|Sponsor Termination|14|||
157117017|NCT01661140|567182322|FG002|Double-Blind Period|Sponsor Termination|17|||
157117018|NCT01661140|567182320|FG000|Double-Blind Period|Administrative/Other|0|||
157117019|NCT01661140|567182321|FG001|Double-Blind Period|Administrative/Other|7|||
157117020|NCT01661140|567182322|FG002|Double-Blind Period|Administrative/Other|6|||
157117021|NCT00781456|567182323|FG000|Overall Study|Adverse Event|3|||
157117022|NCT00781456|567182324|FG001|Overall Study|Adverse Event|3|||
157117023|NCT00781456|567182323|FG000|Overall Study|Withdrawal by Subject|3|||
157117024|NCT00781456|567182324|FG001|Overall Study|Withdrawal by Subject|5|||
157117025|NCT00781456|567182323|FG000|Overall Study|Protocol Violation|4|||
157117026|NCT00781456|567182324|FG001|Overall Study|Protocol Violation|1|||
157117027|NCT00781456|567182323|FG000|Overall Study|Noncompliance With Protocol|1|||
157117028|NCT00781456|567182324|FG001|Overall Study|Noncompliance With Protocol|1|||
157117029|NCT00781456|567182323|FG000|Overall Study|Lost to Follow-up|10|||
157210976|NCT01682512|567519009|FG000|Overall Study|Secondary lack of efficacy|1|||
157117030|NCT00781456|567182324|FG001|Overall Study|Lost to Follow-up|5|||
157210977|NCT01682512|567519010|FG001|Overall Study|Secondary lack of efficacy|1|||
157210978|NCT01682512|567519011|FG002|Overall Study|Secondary lack of efficacy|0|||
157210979|NCT01682512|567519009|FG000|Overall Study|Other than stated above|2|||
157210980|NCT01682512|567519010|FG001|Overall Study|Other than stated above|4|||
157117031|NCT00781456|567182323|FG000|Overall Study|Other Reason, Unknown|0|||
157117032|NCT00781456|567182324|FG001|Overall Study|Other Reason, Unknown|1|||
157117033|NCT02631200|567182327|FG000|First Period|Death|1|||
157117034|NCT02631200|567182328|FG001|First Period|Death|2|||
157010879|NCT02988817|566791990|FG001|Overall Study|Withdrawal by Subject|0|||
157010880|NCT02988817|566791991|FG002|Overall Study|Withdrawal by Subject|0|||
157010881|NCT02988817|566791992|FG003|Overall Study|Withdrawal by Subject|1|||
157010882|NCT02988817|566791993|FG004|Overall Study|Withdrawal by Subject|3|||
157010883|NCT02988817|566791994|FG005|Overall Study|Withdrawal by Subject|1|||
157010884|NCT02988817|566791995|FG006|Overall Study|Withdrawal by Subject|2|||
157010885|NCT02988817|566791996|FG007|Overall Study|Withdrawal by Subject|1|||
157010886|NCT02988817|566791997|FG008|Overall Study|Withdrawal by Subject|1|||
157010887|NCT02988817|566791998|FG009|Overall Study|Withdrawal by Subject|1|||
157010888|NCT02988817|566791999|FG010|Overall Study|Withdrawal by Subject|1|||
157010889|NCT02988817|566792000|FG011|Overall Study|Withdrawal by Subject|12|||
157010890|NCT02988817|566792001|FG012|Overall Study|Withdrawal by Subject|6|||
157010891|NCT02988817|566792002|FG013|Overall Study|Withdrawal by Subject|6|||
157010892|NCT02988817|566792003|FG014|Overall Study|Withdrawal by Subject|4|||
157010893|NCT02988817|566792004|FG015|Overall Study|Withdrawal by Subject|5|||
157010894|NCT02988817|566792005|FG016|Overall Study|Withdrawal by Subject|4|||
157010895|NCT02988817|566792006|FG017|Overall Study|Withdrawal by Subject|11|||
157010896|NCT02988817|566792007|FG018|Overall Study|Withdrawal by Subject|4|||
157010897|NCT02988817|566792008|FG019|Overall Study|Withdrawal by Subject|2|||
157010898|NCT02988817|566791989|FG000|Overall Study|Death|0|||
157010899|NCT02988817|566791990|FG001|Overall Study|Death|1|||
157010900|NCT02988817|566791991|FG002|Overall Study|Death|3|||
157010901|NCT02988817|566791992|FG003|Overall Study|Death|1|||
157010902|NCT02988817|566791993|FG004|Overall Study|Death|6|||
157010903|NCT02988817|566791994|FG005|Overall Study|Death|10|||
157010904|NCT02988817|566791995|FG006|Overall Study|Death|1|||
157010905|NCT02988817|566791996|FG007|Overall Study|Death|2|||
157010906|NCT02988817|566791997|FG008|Overall Study|Death|1|||
157010907|NCT02988817|566791998|FG009|Overall Study|Death|5|||
157010908|NCT02988817|566791999|FG010|Overall Study|Death|1|||
157010909|NCT02988817|566792000|FG011|Overall Study|Death|8|||
157010910|NCT02988817|566792001|FG012|Overall Study|Death|9|||
157010911|NCT02988817|566792002|FG013|Overall Study|Death|17|||
157010912|NCT02988817|566792003|FG014|Overall Study|Death|18|||
157010913|NCT02988817|566792004|FG015|Overall Study|Death|30|||
157010914|NCT02988817|566792005|FG016|Overall Study|Death|17|||
157010915|NCT02988817|566792006|FG017|Overall Study|Death|38|||
157010916|NCT02988817|566792007|FG018|Overall Study|Death|14|||
157117035|NCT02631200|567182327|FG000|First Period|Patient ill-health|2|||
157117036|NCT02631200|567182328|FG001|First Period|Patient ill-health|4|||
157117037|NCT02631200|567182327|FG000|First Period|Withdrawal by Subject|4|||
157117038|NCT02631200|567182328|FG001|First Period|Withdrawal by Subject|1|||
156779786|NCT01078662|565943887|FG004|Overall Study|Death|8|||
157010917|NCT02988817|566792008|FG019|Overall Study|Death|16|||
157010918|NCT02988817|566791989|FG000|Overall Study|Other|0|||
157010919|NCT02988817|566791990|FG001|Overall Study|Other|0|||
157010920|NCT02988817|566791991|FG002|Overall Study|Other|0|||
157010921|NCT02988817|566791992|FG003|Overall Study|Other|1|||
157010922|NCT02988817|566791993|FG004|Overall Study|Other|1|||
157010923|NCT02988817|566791994|FG005|Overall Study|Other|0|||
157010924|NCT02988817|566791995|FG006|Overall Study|Other|0|||
157210981|NCT01682512|567519011|FG002|Overall Study|Other than stated above|2|||
157210982|NCT01377233|567519012|FG000|Open-label|Adverse Event|1|||
157210983|NCT01377233|567519013|FG001|Open-label|Adverse Event|0|||
157210984|NCT01377233|567519014|FG002|Open-label|Adverse Event|0|||
157210985|NCT01377233|567519015|FG003|Open-label|Adverse Event|0|||
157210986|NCT01377233|567519016|FG004|Open-label|Adverse Event|0|||
157210987|NCT01377233|567519012|FG000|Open-label|Withdrawal by Subject|3|||
157210988|NCT01377233|567519013|FG001|Open-label|Withdrawal by Subject|0|||
157210989|NCT01377233|567519014|FG002|Open-label|Withdrawal by Subject|0|||
157210990|NCT01377233|567519015|FG003|Open-label|Withdrawal by Subject|0|||
157210991|NCT01377233|567519016|FG004|Open-label|Withdrawal by Subject|0|||
157210992|NCT01377233|567519012|FG000|Double-blind|Adverse Event|0|||
157210993|NCT01377233|567519013|FG001|Double-blind|Adverse Event|1|||
157210994|NCT01377233|567519014|FG002|Double-blind|Adverse Event|2|||
157210995|NCT01377233|567519015|FG003|Double-blind|Adverse Event|2|||
157210996|NCT01377233|567519016|FG004|Double-blind|Adverse Event|0|||
157210997|NCT01377233|567519012|FG000|Double-blind|Protocol Violation|0|||
157210998|NCT01377233|567519013|FG001|Double-blind|Protocol Violation|0|||
157210999|NCT01377233|567519014|FG002|Double-blind|Protocol Violation|0|||
157211000|NCT01377233|567519015|FG003|Double-blind|Protocol Violation|0|||
157010925|NCT02988817|566791996|FG007|Overall Study|Other|0|||
157211001|NCT01377233|567519016|FG004|Double-blind|Protocol Violation|1|||
157211002|NCT01377233|567519012|FG000|Double-blind|Withdrawal by Subject|0|||
157211003|NCT01377233|567519013|FG001|Double-blind|Withdrawal by Subject|0|||
157211004|NCT01377233|567519014|FG002|Double-blind|Withdrawal by Subject|0|||
157211005|NCT01377233|567519015|FG003|Double-blind|Withdrawal by Subject|1|||
157211006|NCT01377233|567519016|FG004|Double-blind|Withdrawal by Subject|0|||
157010926|NCT02988817|566791997|FG008|Overall Study|Other|0|||
157010927|NCT02988817|566791998|FG009|Overall Study|Other|0|||
157010928|NCT02988817|566791999|FG010|Overall Study|Other|0|||
157010929|NCT02988817|566792000|FG011|Overall Study|Other|0|||
157010930|NCT02988817|566792001|FG012|Overall Study|Other|0|||
157010931|NCT02988817|566792002|FG013|Overall Study|Other|0|||
157010932|NCT02988817|566792003|FG014|Overall Study|Other|0|||
157010933|NCT02988817|566792004|FG015|Overall Study|Other|1|||
157010934|NCT02988817|566792005|FG016|Overall Study|Other|0|||
157010935|NCT02988817|566792006|FG017|Overall Study|Other|0|||
157010936|NCT02988817|566792007|FG018|Overall Study|Other|0|||
157010937|NCT02988817|566792008|FG019|Overall Study|Other|0|||
157010938|NCT02988817|566791989|FG000|Overall Study|Lost to Follow-up|0|||
157010939|NCT02988817|566791990|FG001|Overall Study|Lost to Follow-up|0|||
157010940|NCT02988817|566791991|FG002|Overall Study|Lost to Follow-up|0|||
157010941|NCT02988817|566791992|FG003|Overall Study|Lost to Follow-up|0|||
157010942|NCT02988817|566791993|FG004|Overall Study|Lost to Follow-up|0|||
157010943|NCT02988817|566791994|FG005|Overall Study|Lost to Follow-up|0|||
157010944|NCT02988817|566791995|FG006|Overall Study|Lost to Follow-up|0|||
157010945|NCT02988817|566791996|FG007|Overall Study|Lost to Follow-up|0|||
157010946|NCT02988817|566791997|FG008|Overall Study|Lost to Follow-up|1|||
157010947|NCT02988817|566791998|FG009|Overall Study|Lost to Follow-up|0|||
157010948|NCT02988817|566791999|FG010|Overall Study|Lost to Follow-up|1|||
157010949|NCT02988817|566792000|FG011|Overall Study|Lost to Follow-up|1|||
157010950|NCT02988817|566792001|FG012|Overall Study|Lost to Follow-up|0|||
157010951|NCT02988817|566792002|FG013|Overall Study|Lost to Follow-up|0|||
157010952|NCT02988817|566792003|FG014|Overall Study|Lost to Follow-up|1|||
157010953|NCT02988817|566792004|FG015|Overall Study|Lost to Follow-up|1|||
157010954|NCT02988817|566792005|FG016|Overall Study|Lost to Follow-up|2|||
157010955|NCT02988817|566792006|FG017|Overall Study|Lost to Follow-up|3|||
157010956|NCT02988817|566792007|FG018|Overall Study|Lost to Follow-up|0|||
157010957|NCT02988817|566792008|FG019|Overall Study|Lost to Follow-up|0|||
157010958|NCT02988817|566791989|FG000|Overall Study|Sponsor decision|0|||
157010959|NCT02988817|566791990|FG001|Overall Study|Sponsor decision|0|||
157010960|NCT02988817|566791991|FG002|Overall Study|Sponsor decision|0|||
157211007|NCT01377233|567519012|FG000|Double-blind|Administrative or other|0|||
157010961|NCT02988817|566791992|FG003|Overall Study|Sponsor decision|0|||
157010962|NCT02988817|566791993|FG004|Overall Study|Sponsor decision|0|||
157010963|NCT02988817|566791994|FG005|Overall Study|Sponsor decision|0|||
157211008|NCT01377233|567519013|FG001|Double-blind|Administrative or other|0|||
157211009|NCT01377233|567519014|FG002|Double-blind|Administrative or other|0|||
157211010|NCT01377233|567519015|FG003|Double-blind|Administrative or other|1|||
157117039|NCT02631200|567182327|FG000|Deferred Period|Death|0|||
157117040|NCT02631200|567182328|FG001|Deferred Period|Death|1|||
157117041|NCT02631200|567182327|FG000|Deferred Period|Received kidney transplant|0|||
157117042|NCT02631200|567182328|FG001|Deferred Period|Received kidney transplant|1|||
157117043|NCT02631200|567182327|FG000|Deferred Period|Withdrawal by Subject|0|||
157117044|NCT02631200|567182328|FG001|Deferred Period|Withdrawal by Subject|2|||
157117045|NCT02631200|567182327|FG000|Deferred Period|Lost to Follow-up|0|||
157117046|NCT02631200|567182328|FG001|Deferred Period|Lost to Follow-up|1|||
157117047|NCT01877187|567182330|FG000|Overall Study|Death|2|||
157117048|NCT01877187|567182330|FG000|Overall Study|Withdrawal by Subject|4|||
157117049|NCT01877187|567182330|FG000|Overall Study|Lost to Follow-up|3|||
157117050|NCT01877187|567182330|FG000|Overall Study|Declining clinical status|11|||
157117051|NCT01877187|567182330|FG000|Overall Study|Liver transplant|2|||
157117052|NCT04091087|567182334|FG000|Overall Study|Not treated|1|||
157117053|NCT04091087|567182335|FG001|Overall Study|Not treated|0|||
157117054|NCT04091087|567182334|FG000|Overall Study|Adverse Event|4|||
157117055|NCT04091087|567182335|FG001|Overall Study|Adverse Event|4|||
157117056|NCT04091087|567182334|FG000|Overall Study|Protocol Violation|0|||
157117057|NCT04091087|567182335|FG001|Overall Study|Protocol Violation|1|||
157117058|NCT04091087|567182334|FG000|Overall Study|Withdrawal by Subject|5|||
157117059|NCT04091087|567182335|FG001|Overall Study|Withdrawal by Subject|2|||
157117060|NCT04152161|567182336|FG000|Overall Study|Death|0|||
157117061|NCT04152161|567182337|FG001|Overall Study|Death|1|||
157117062|NCT04152161|567182336|FG000|Overall Study|Physician Decision|0|||
157117063|NCT04152161|567182337|FG001|Overall Study|Physician Decision|1|||
157117064|NCT04152161|567182336|FG000|Overall Study|Lost to Follow-up|9|||
157117065|NCT04152161|567182337|FG001|Overall Study|Lost to Follow-up|3|||
157117066|NCT04152161|567182336|FG000|Overall Study|Protocol Violation|1|||
157117067|NCT04152161|567182337|FG001|Overall Study|Protocol Violation|0|||
157117068|NCT04152161|567182336|FG000|Overall Study|Withdrawal by Subject|29|||
157117069|NCT04152161|567182337|FG001|Overall Study|Withdrawal by Subject|28|||
157117070|NCT04152161|567182336|FG000|Overall Study|Sponsor termination of study|750|||
157117071|NCT04152161|567182337|FG001|Overall Study|Sponsor termination of study|755|||
157117072|NCT04152161|567182336|FG000|Overall Study|Other|20|||
157117073|NCT04152161|567182337|FG001|Overall Study|Other|18|||
157117074|NCT03363321|567182338|FG000|Overall Study|Withdrawal by Subject|0|||
157117075|NCT03363321|567182339|FG001|Overall Study|Withdrawal by Subject|1|||
157117076|NCT03363321|567182340|FG002|Overall Study|Withdrawal by Subject|0|||
157117077|NCT03363321|567182341|FG003|Overall Study|Withdrawal by Subject|1|||
157117078|NCT03363321|567182342|FG004|Overall Study|Withdrawal by Subject|0|||
157117079|NCT05098041|567182344|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
157117080|NCT01297270|567182345|FG000|Overall Study|Adverse Event|19|||
157117081|NCT01297270|567182346|FG001|Overall Study|Adverse Event|32|||
157117082|NCT01297270|567182347|FG002|Overall Study|Adverse Event|5|||
157117083|NCT01297270|567182345|FG000|Overall Study|Lack of Efficacy|15|||
157117084|NCT01297270|567182346|FG001|Overall Study|Lack of Efficacy|17|||
157117085|NCT01297270|567182347|FG002|Overall Study|Lack of Efficacy|15|||
157117086|NCT01297270|567182345|FG000|Overall Study|Lost to Follow-up|1|||
157117087|NCT01297270|567182346|FG001|Overall Study|Lost to Follow-up|2|||
157117088|NCT01297270|567182347|FG002|Overall Study|Lost to Follow-up|1|||
157117089|NCT01297270|567182345|FG000|Overall Study|Protocol Violation|0|||
157117090|NCT01297270|567182346|FG001|Overall Study|Protocol Violation|2|||
157117091|NCT01297270|567182347|FG002|Overall Study|Protocol Violation|0|||
157117092|NCT01297270|567182345|FG000|Overall Study|Withdrawal by Subject|7|||
157117093|NCT01297270|567182346|FG001|Overall Study|Withdrawal by Subject|15|||
157117094|NCT01297270|567182347|FG002|Overall Study|Withdrawal by Subject|7|||
157117095|NCT01297270|567182345|FG000|Overall Study|Other reason not defined above|3|||
157117096|NCT01297270|567182346|FG001|Overall Study|Other reason not defined above|3|||
157117097|NCT01297270|567182347|FG002|Overall Study|Other reason not defined above|1|||
157117098|NCT01297270|567182345|FG000|Overall Study|Not treated|0|||
157117099|NCT01297270|567182346|FG001|Overall Study|Not treated|1|||
157117100|NCT01297270|567182347|FG002|Overall Study|Not treated|0|||
157117101|NCT00382993|567182350|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
157117102|NCT00382993|567182351|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
157211011|NCT01377233|567519016|FG004|Double-blind|Administrative or other|1|||
157117103|NCT00382993|567182350|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
157117104|NCT00382993|567182351|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
157117105|NCT00382993|567182350|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
157117106|NCT00382993|567182351|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
157117107|NCT00382993|567182350|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
157117108|NCT00382993|567182351|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
157117109|NCT00382993|567182350|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
157117110|NCT00382993|567182351|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
157117111|NCT00382993|567182350|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
157117112|NCT00382993|567182351|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
157117113|NCT00382993|567182350|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
157117114|NCT00382993|567182351|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
157117115|NCT00382993|567182350|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
157117116|NCT00382993|567182351|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
157117117|NCT00382993|567182350|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
157117118|NCT00382993|567182351|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
157117119|NCT00382993|567182350|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
157117120|NCT00382993|567182351|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
157117121|NCT00906087|567182364|FG000|Initial Washout|Withdrawal by Subject|1|||
157117122|NCT00906087|567182364|FG000|Initial Washout|Physician Decision|1|||
157117123|NCT02898259|567182365|FG000|Overall Study|Adverse Event|0|||
157117124|NCT02898259|567182366|FG001|Overall Study|Adverse Event|0|||
157117125|NCT02898259|567182367|FG002|Overall Study|Adverse Event|1|||
157117126|NCT02898259|567182368|FG003|Overall Study|Adverse Event|0|||
157117127|NCT02898259|567182369|FG004|Overall Study|Adverse Event|0|||
157117128|NCT02898259|567182365|FG000|Overall Study|Lack of Efficacy|1|||
157117129|NCT02898259|567182366|FG001|Overall Study|Lack of Efficacy|1|||
157117130|NCT02898259|567182367|FG002|Overall Study|Lack of Efficacy|3|||
157117131|NCT02898259|567182368|FG003|Overall Study|Lack of Efficacy|0|||
157117132|NCT02898259|567182369|FG004|Overall Study|Lack of Efficacy|0|||
157117133|NCT02898259|567182365|FG000|Overall Study|Lost to Follow-up|0|||
157117134|NCT02898259|567182366|FG001|Overall Study|Lost to Follow-up|0|||
157117135|NCT02898259|567182367|FG002|Overall Study|Lost to Follow-up|1|||
157117136|NCT02898259|567182368|FG003|Overall Study|Lost to Follow-up|0|||
157117137|NCT02898259|567182369|FG004|Overall Study|Lost to Follow-up|0|||
157117138|NCT02898259|567182365|FG000|Overall Study|Transformation before study began|0|||
157117139|NCT02898259|567182366|FG001|Overall Study|Transformation before study began|0|||
157117140|NCT02898259|567182367|FG002|Overall Study|Transformation before study began|0|||
157117141|NCT02898259|567182368|FG003|Overall Study|Transformation before study began|1|||
157117142|NCT02898259|567182369|FG004|Overall Study|Transformation before study began|0|||
157117143|NCT01834274|567182380|FG000|Overall Study|Study Termination|41|||
157117144|NCT01834274|567182381|FG001|Overall Study|Study Termination|38|||
157117145|NCT01834274|567182380|FG000|Overall Study|Withdrawal by Subject|1|||
157117146|NCT01834274|567182381|FG001|Overall Study|Withdrawal by Subject|1|||
157117147|NCT01834274|567182380|FG000|Overall Study|Lost to Follow-up|3|||
157117148|NCT01834274|567182381|FG001|Overall Study|Lost to Follow-up|1|||
157117149|NCT01834274|567182380|FG000|Overall Study|Other|2|||
157117150|NCT01834274|567182381|FG001|Overall Study|Other|1|||
157117151|NCT03681119|567182390|FG000|Overall Study|No specific reason|4|||
157117152|NCT03681119|567182391|FG001|Overall Study|No specific reason|0|||
157117153|NCT03681119|567182390|FG000|Overall Study|Sickness|2|||
157117154|NCT03681119|567182391|FG001|Overall Study|Sickness|0|||
157117155|NCT03016325|567182392|FG000|Treatment Period|Participant withdrew consent|0|||
157117156|NCT03016325|567182393|FG001|Treatment Period|Participant withdrew consent|1|||
157117157|NCT03016325|567182394|FG002|Treatment Period|Participant withdrew consent|0|||
157117158|NCT03016325|567182395|FG003|Treatment Period|Participant withdrew consent|0|||
157117159|NCT03016325|567182396|FG004|Treatment Period|Participant withdrew consent|0|||
157117160|NCT03016325|567182397|FG005|Treatment Period|Participant withdrew consent|0|||
157117161|NCT03016325|567182398|FG006|Treatment Period|Participant withdrew consent|0|||
157117162|NCT03016325|567182399|FG007|Treatment Period|Participant withdrew consent|0|||
157117163|NCT03016325|567182392|FG000|Treatment Period|Death|0|||
157117164|NCT03016325|567182393|FG001|Treatment Period|Death|0|||
157117165|NCT03016325|567182394|FG002|Treatment Period|Death|0|||
157117166|NCT03016325|567182395|FG003|Treatment Period|Death|0|||
157117167|NCT03016325|567182396|FG004|Treatment Period|Death|2|||
157117168|NCT03016325|567182397|FG005|Treatment Period|Death|0|||
157117169|NCT03016325|567182398|FG006|Treatment Period|Death|0|||
157117170|NCT03016325|567182399|FG007|Treatment Period|Death|0|||
157117171|NCT03016325|567182392|FG000|Treatment Period|Participant refuses assessments|0|||
157117172|NCT03016325|567182393|FG001|Treatment Period|Participant refuses assessments|0|||
157117173|NCT03016325|567182394|FG002|Treatment Period|Participant refuses assessments|1|||
157117174|NCT03016325|567182395|FG003|Treatment Period|Participant refuses assessments|0|||
157211012|NCT01785875|567519017|FG000|Overall Study|Withdrawal by Subject|41|||
157117175|NCT03016325|567182396|FG004|Treatment Period|Participant refuses assessments|0|||
157117176|NCT03016325|567182397|FG005|Treatment Period|Participant refuses assessments|0|||
157117177|NCT03016325|567182398|FG006|Treatment Period|Participant refuses assessments|0|||
157211013|NCT01785875|567519018|FG001|Overall Study|Withdrawal by Subject|34|||
157117178|NCT03016325|567182399|FG007|Treatment Period|Participant refuses assessments|0|||
157117179|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Death|2|||
157117180|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Death|0|||
157117181|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Death|5|||
157211014|NCT01785875|567519019|FG002|Overall Study|Withdrawal by Subject|36|||
157117182|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Death|6|||
157117183|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Death|3|||
157117184|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Death|0|||
157117185|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Death|0|||
157117186|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Death|0|||
157117187|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
157117188|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
157117189|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
157117190|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
157117191|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
157117192|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
157117193|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
157117194|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
157117195|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
157117196|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
157117197|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
157117198|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
157117199|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
157117200|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
157117201|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
157117202|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
157117203|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
157117204|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
157117205|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
157117206|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
157117207|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
157117208|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
157117209|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
157117210|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
157117211|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117212|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117213|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117214|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117215|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
157117216|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117217|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
157117218|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
157117219|NCT03016325|567182392|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117220|NCT03016325|567182393|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157010964|NCT02988817|566791995|FG006|Overall Study|Sponsor decision|0|||
157010965|NCT02988817|566791996|FG007|Overall Study|Sponsor decision|0|||
157010966|NCT02988817|566791997|FG008|Overall Study|Sponsor decision|0|||
157010967|NCT02988817|566791998|FG009|Overall Study|Sponsor decision|0|||
157010968|NCT02988817|566791999|FG010|Overall Study|Sponsor decision|0|||
157010969|NCT02988817|566792000|FG011|Overall Study|Sponsor decision|1|||
157010970|NCT02988817|566792001|FG012|Overall Study|Sponsor decision|1|||
157010971|NCT02988817|566792002|FG013|Overall Study|Sponsor decision|2|||
157010972|NCT02988817|566792003|FG014|Overall Study|Sponsor decision|2|||
157010973|NCT02988817|566792004|FG015|Overall Study|Sponsor decision|6|||
157010974|NCT02988817|566792005|FG016|Overall Study|Sponsor decision|2|||
157010975|NCT02988817|566792006|FG017|Overall Study|Sponsor decision|3|||
157010976|NCT02988817|566792007|FG018|Overall Study|Sponsor decision|2|||
157010977|NCT02988817|566792008|FG019|Overall Study|Sponsor decision|7|||
157010978|NCT02988817|566791989|FG000|Overall Study|Physician Decision|0|||
157010979|NCT02988817|566791990|FG001|Overall Study|Physician Decision|0|||
157010980|NCT02988817|566791991|FG002|Overall Study|Physician Decision|0|||
157010981|NCT02988817|566791992|FG003|Overall Study|Physician Decision|0|||
157010982|NCT02988817|566791993|FG004|Overall Study|Physician Decision|0|||
157010983|NCT02988817|566791994|FG005|Overall Study|Physician Decision|0|||
157010984|NCT02988817|566791995|FG006|Overall Study|Physician Decision|0|||
157010985|NCT02988817|566791996|FG007|Overall Study|Physician Decision|0|||
157010986|NCT02988817|566791997|FG008|Overall Study|Physician Decision|0|||
157010987|NCT02988817|566791998|FG009|Overall Study|Physician Decision|0|||
157010988|NCT02988817|566791999|FG010|Overall Study|Physician Decision|0|||
157010989|NCT02988817|566792000|FG011|Overall Study|Physician Decision|0|||
157010990|NCT02988817|566792001|FG012|Overall Study|Physician Decision|0|||
157010991|NCT02988817|566792002|FG013|Overall Study|Physician Decision|0|||
157010992|NCT02988817|566792003|FG014|Overall Study|Physician Decision|0|||
157010993|NCT02988817|566792004|FG015|Overall Study|Physician Decision|1|||
157010994|NCT02988817|566792005|FG016|Overall Study|Physician Decision|0|||
157117221|NCT03016325|567182394|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
157117222|NCT03016325|567182395|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117223|NCT03016325|567182396|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117224|NCT03016325|567182397|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117225|NCT03016325|567182398|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117226|NCT03016325|567182399|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
157117227|NCT03016325|567182392|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117228|NCT03016325|567182393|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
157117229|NCT03016325|567182394|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157211015|NCT01785875|567519017|FG000|Overall Study|Lost to Follow-up|19|||
157211016|NCT01785875|567519018|FG001|Overall Study|Lost to Follow-up|22|||
157010995|NCT02988817|566792006|FG017|Overall Study|Physician Decision|0|||
157117230|NCT03016325|567182395|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117231|NCT03016325|567182396|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117232|NCT03016325|567182397|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117233|NCT03016325|567182398|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117234|NCT03016325|567182399|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
157117235|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Death|3|||
157117236|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Death|3|||
157117237|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Death|11|||
157117238|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Death|12|||
157117239|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Death|9|||
157117240|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Death|0|||
157117241|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Death|0|||
157117242|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Death|1|||
157117243|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
157117244|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117245|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117246|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117247|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117248|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117249|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117250|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
157117251|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
157117252|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
157117253|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
157211017|NCT01785875|567519019|FG002|Overall Study|Lost to Follow-up|6|||
157211018|NCT01785875|567519017|FG000|Overall Study|Death|27|||
157211019|NCT01785875|567519018|FG001|Overall Study|Death|16|||
157211020|NCT01785875|567519019|FG002|Overall Study|Death|7|||
157211021|NCT01785875|567519017|FG000|Overall Study|Sponsor Decision|0|||
157211022|NCT01785875|567519018|FG001|Overall Study|Sponsor Decision|2|||
157211023|NCT01785875|567519019|FG002|Overall Study|Sponsor Decision|0|||
157211024|NCT01785875|567519017|FG000|Overall Study|Protocol Specified Criteria|207|||
157211025|NCT01785875|567519018|FG001|Overall Study|Protocol Specified Criteria|214|||
157211026|NCT01785875|567519019|FG002|Overall Study|Protocol Specified Criteria|55|||
157211027|NCT01785875|567519017|FG000|Overall Study|Missing|0|||
157211028|NCT01785875|567519018|FG001|Overall Study|Missing|1|||
157211029|NCT01785875|567519019|FG002|Overall Study|Missing|3|||
157010996|NCT02988817|566792007|FG018|Overall Study|Physician Decision|1|||
157010997|NCT02988817|566792008|FG019|Overall Study|Physician Decision|1|||
157010998|NCT01414738|566792017|FG000|Overall Study|Death|26|||
157010999|NCT01414738|566792017|FG000|Overall Study|Refused testing|5|||
157011000|NCT01414738|566792017|FG000|Overall Study|Lost to Follow-up|2|||
157011001|NCT01414738|566792017|FG000|Overall Study|Refused, disease progression|8|||
157011002|NCT01414738|566792017|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
157011003|NCT01266122|566792018|FG000|Overall Study|Lost to Follow-up|6|||
157011004|NCT01266122|566792019|FG001|Overall Study|Lost to Follow-up|6|||
157011005|NCT03756571|566792020|FG000|Overall Study|Lost to Follow-up|1|||
157011006|NCT03756571|566792021|FG001|Overall Study|Lost to Follow-up|1|||
157011007|NCT02379819|566792022|FG000|Overall Study|Withdrawal by Subject|10|||
157011008|NCT02379819|566792022|FG000|Overall Study|Death|2|||
157011009|NCT02379819|566792022|FG000|Overall Study|Lack of Efficacy|1|||
157011010|NCT02379819|566792022|FG000|Overall Study|Lost to Follow-up|1|||
157011011|NCT03752151|566792023|FG000|Overall Study|Withdrawal by Subject|1|||
157011012|NCT03752151|566792023|FG000|Overall Study|Protocol Violation|1|||
157117254|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
157117255|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
157211030|NCT00417027|567519022|FG000|Overall Study|Protocol Violation|0|||
157211031|NCT00417027|567519023|FG001|Overall Study|Protocol Violation|5|||
157011013|NCT01839331|566792024|FG000|Overall Study|Early Termination|3|||
157211032|NCT00417027|567519024|FG002|Overall Study|Protocol Violation|5|||
157211033|NCT03137082|567519025|FG000|Overall Study|Withdrawal by Subject|1|||
157117256|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
157117257|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
157117258|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
157117259|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117260|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117261|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117262|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117263|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
157117264|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117265|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117266|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
157117267|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117268|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117269|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117270|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117271|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
157117272|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117273|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117274|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
157117275|NCT03016325|567182392|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117276|NCT03016325|567182393|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117277|NCT03016325|567182394|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117278|NCT03016325|567182395|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
157117279|NCT03016325|567182396|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117280|NCT03016325|567182397|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117281|NCT03016325|567182398|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117282|NCT03016325|567182399|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
157117283|NCT03016325|567182392|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117284|NCT03016325|567182393|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
157117285|NCT03016325|567182394|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117286|NCT03016325|567182395|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117287|NCT03016325|567182396|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117288|NCT03016325|567182397|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117289|NCT03016325|567182398|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117290|NCT03016325|567182399|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
157117291|NCT03016325|567182392|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
157117292|NCT03016325|567182393|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
157117293|NCT03016325|567182394|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
157117294|NCT03016325|567182395|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
157117295|NCT03016325|567182396|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
157117296|NCT03016325|567182397|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
157117297|NCT03016325|567182398|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
157117298|NCT03016325|567182399|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
157117299|NCT02941627|567182403|FG000|Overall Study|Death|1|||
157117300|NCT02941627|567182403|FG000|Overall Study|Surgical failure|1|||
157117301|NCT02941627|567182403|FG000|Overall Study|cholesteatoma prevented implantation|1|||
157117302|NCT01152021|567182404|FG000|Overall Study|Adverse Event|4|||
157117303|NCT01152021|567182405|FG001|Overall Study|Adverse Event|4|||
157117304|NCT01152021|567182404|FG000|Overall Study|Study drug had expired|1|||
157117305|NCT01152021|567182405|FG001|Overall Study|Study drug had expired|0|||
157117306|NCT01152021|567182404|FG000|Overall Study|Physician Decision|1|||
157117307|NCT01152021|567182405|FG001|Overall Study|Physician Decision|1|||
157117308|NCT01152021|567182404|FG000|Overall Study|No access to study drug in Pharmacy|0|||
157117309|NCT01152021|567182405|FG001|Overall Study|No access to study drug in Pharmacy|1|||
157117310|NCT02595723|567182406|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
157117311|NCT02595723|567182407|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
157117312|NCT02595723|567182408|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
157117313|NCT02595723|567182406|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
157117314|NCT02595723|567182407|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
157117315|NCT02595723|567182408|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
157117316|NCT01087905|567182409|FG000|Overall Study|Lost to Follow-up|24|||
157117317|NCT01087905|567182410|FG001|Overall Study|Lost to Follow-up|28|||
157117318|NCT01087905|567182411|FG002|Overall Study|Lost to Follow-up|18|||
157117319|NCT01087905|567182412|FG003|Overall Study|Lost to Follow-up|31|||
157117320|NCT01087905|567182413|FG004|Overall Study|Lost to Follow-up|27|||
157117321|NCT01087905|567182414|FG005|Overall Study|Lost to Follow-up|25|||
157117322|NCT01087905|567182415|FG006|Overall Study|Lost to Follow-up|20|||
157117323|NCT01087905|567182416|FG007|Overall Study|Lost to Follow-up|24|||
157211034|NCT03137082|567519026|FG001|Overall Study|Withdrawal by Subject|1|||
157117324|NCT01087905|567182409|FG000|Overall Study|Withdrawal by Subject|5|||
157117325|NCT01087905|567182410|FG001|Overall Study|Withdrawal by Subject|4|||
157117326|NCT01087905|567182411|FG002|Overall Study|Withdrawal by Subject|4|||
157117327|NCT01087905|567182412|FG003|Overall Study|Withdrawal by Subject|5|||
157117328|NCT01087905|567182413|FG004|Overall Study|Withdrawal by Subject|4|||
157117329|NCT01087905|567182414|FG005|Overall Study|Withdrawal by Subject|3|||
157117330|NCT01087905|567182415|FG006|Overall Study|Withdrawal by Subject|3|||
157117331|NCT01087905|567182416|FG007|Overall Study|Withdrawal by Subject|5|||
157117332|NCT04288154|567182417|FG000|Overall Study|Withdrawal by Subject|9|||
157117333|NCT04288154|567182418|FG001|Overall Study|Withdrawal by Subject|9|||
157117334|NCT00385255|567182419|FG000|Overall Study|Serious Adverse Event|1|||
157117335|NCT00385255|567182420|FG001|Overall Study|Serious Adverse Event|2|||
157117336|NCT00385255|567182419|FG000|Overall Study|Protocol Violation|0|||
157117337|NCT00385255|567182420|FG001|Overall Study|Protocol Violation|4|||
157117338|NCT00385255|567182419|FG000|Overall Study|Withdrawal by Subject|0|||
157117339|NCT00385255|567182420|FG001|Overall Study|Withdrawal by Subject|8|||
157117340|NCT00385255|567182419|FG000|Overall Study|Migrated/moved from study area|0|||
157117341|NCT00385255|567182420|FG001|Overall Study|Migrated/moved from study area|1|||
157117342|NCT00385255|567182419|FG000|Overall Study|Lost to Follow-up|20|||
157117343|NCT00385255|567182420|FG001|Overall Study|Lost to Follow-up|58|||
157117344|NCT00835237|567182421|FG000|Overall Study|Lost to Follow-up|4|||
157117345|NCT00835237|567182422|FG001|Overall Study|Lost to Follow-up|0|||
157117346|NCT00835237|567182421|FG000|Overall Study|Withdrawal by Subject|2|||
157117347|NCT00835237|567182422|FG001|Overall Study|Withdrawal by Subject|0|||
157117348|NCT00606086|567182426|FG000|Overall Study|Adverse Event|1|||
157117349|NCT00606086|567182427|FG001|Overall Study|Adverse Event|1|||
157117350|NCT00606086|567182426|FG000|Overall Study|Lost to Follow-up|4|||
157117351|NCT00606086|567182427|FG001|Overall Study|Lost to Follow-up|8|||
157117352|NCT00606086|567182426|FG000|Overall Study|Protocol Violation|1|||
157117353|NCT00606086|567182427|FG001|Overall Study|Protocol Violation|0|||
157117354|NCT00606086|567182426|FG000|Overall Study|Withdrawal by Subject|5|||
157117355|NCT00606086|567182427|FG001|Overall Study|Withdrawal by Subject|3|||
157117356|NCT00606086|567182426|FG000|Overall Study|Non-compliance|0|||
157117357|NCT00606086|567182427|FG001|Overall Study|Non-compliance|1|||
157117358|NCT00606086|567182426|FG000|Overall Study|Randomized, not treated|1|||
157117359|NCT00606086|567182427|FG001|Overall Study|Randomized, not treated|2|||
157117360|NCT01929408|567182428|FG000|Overall Study|received HCT as initial treatment|8|||
157117361|NCT01015768|567182433|FG000|Overall Study|Some subject data unuseable|4|||
157117362|NCT01015768|567182434|FG001|Overall Study|Some subject data unuseable|4|||
157117363|NCT01225731|567182435|FG000|Part 1|Did not meet eligibility criteria|1|||
157117364|NCT01225731|567182436|FG001|Part 1|Did not meet eligibility criteria|0|||
157117365|NCT01225731|567182437|FG002|Part 1|Did not meet eligibility criteria|0|||
157117366|NCT01225731|567182438|FG003|Part 1|Did not meet eligibility criteria|0|||
157117367|NCT01225731|567182439|FG004|Part 1|Did not meet eligibility criteria|1|||
157117368|NCT01225731|567182440|FG005|Part 1|Did not meet eligibility criteria|0|||
157117369|NCT01225731|567182441|FG006|Part 1|Did not meet eligibility criteria|0|||
157117370|NCT01225731|567182442|FG007|Part 1|Did not meet eligibility criteria|0|||
157117371|NCT01225731|567182443|FG008|Part 1|Did not meet eligibility criteria|0|||
157117372|NCT01225731|567182444|FG009|Part 1|Did not meet eligibility criteria|0|||
157117373|NCT01225731|567182445|FG010|Part 1|Did not meet eligibility criteria|0|||
157117374|NCT01225731|567182446|FG011|Part 1|Did not meet eligibility criteria|0|||
157117375|NCT01225731|567182447|FG012|Part 1|Did not meet eligibility criteria|0|||
157117376|NCT01225731|567182435|FG000|Part 1|Adverse Event|1|||
157117377|NCT01225731|567182436|FG001|Part 1|Adverse Event|2|||
157117378|NCT01225731|567182437|FG002|Part 1|Adverse Event|1|||
157117379|NCT01225731|567182438|FG003|Part 1|Adverse Event|1|||
157117380|NCT01225731|567182439|FG004|Part 1|Adverse Event|1|||
157117381|NCT01225731|567182440|FG005|Part 1|Adverse Event|0|||
157117382|NCT01225731|567182441|FG006|Part 1|Adverse Event|0|||
157117383|NCT01225731|567182442|FG007|Part 1|Adverse Event|0|||
157117384|NCT01225731|567182443|FG008|Part 1|Adverse Event|0|||
157117385|NCT01225731|567182444|FG009|Part 1|Adverse Event|0|||
157211035|NCT03137082|567519025|FG000|Overall Study|Lost to Follow-up|1|||
157117386|NCT01225731|567182445|FG010|Part 1|Adverse Event|0|||
157117387|NCT01225731|567182446|FG011|Part 1|Adverse Event|0|||
157117388|NCT01225731|567182447|FG012|Part 1|Adverse Event|0|||
157117389|NCT01225731|567182435|FG000|Part 1|Withdrawal by Subject|0|||
157117390|NCT01225731|567182436|FG001|Part 1|Withdrawal by Subject|3|||
157117391|NCT01225731|567182437|FG002|Part 1|Withdrawal by Subject|0|||
157117392|NCT01225731|567182438|FG003|Part 1|Withdrawal by Subject|0|||
157117393|NCT01225731|567182439|FG004|Part 1|Withdrawal by Subject|4|||
157117394|NCT01225731|567182440|FG005|Part 1|Withdrawal by Subject|0|||
157117395|NCT01225731|567182441|FG006|Part 1|Withdrawal by Subject|0|||
157117396|NCT01225731|567182442|FG007|Part 1|Withdrawal by Subject|0|||
157117397|NCT01225731|567182443|FG008|Part 1|Withdrawal by Subject|0|||
157117398|NCT01225731|567182444|FG009|Part 1|Withdrawal by Subject|0|||
157117399|NCT01225731|567182445|FG010|Part 1|Withdrawal by Subject|0|||
157117400|NCT01225731|567182446|FG011|Part 1|Withdrawal by Subject|0|||
157117401|NCT01225731|567182447|FG012|Part 1|Withdrawal by Subject|0|||
157117402|NCT01225731|567182435|FG000|Part 1|Protocol Violation|0|||
157117403|NCT01225731|567182436|FG001|Part 1|Protocol Violation|0|||
157117404|NCT01225731|567182437|FG002|Part 1|Protocol Violation|0|||
157117405|NCT01225731|567182438|FG003|Part 1|Protocol Violation|1|||
157117406|NCT01225731|567182439|FG004|Part 1|Protocol Violation|0|||
157117407|NCT01225731|567182440|FG005|Part 1|Protocol Violation|0|||
157117408|NCT01225731|567182441|FG006|Part 1|Protocol Violation|0|||
157117409|NCT01225731|567182442|FG007|Part 1|Protocol Violation|0|||
157117410|NCT01225731|567182443|FG008|Part 1|Protocol Violation|0|||
157117411|NCT01225731|567182444|FG009|Part 1|Protocol Violation|0|||
157117412|NCT01225731|567182445|FG010|Part 1|Protocol Violation|0|||
157117413|NCT01225731|567182446|FG011|Part 1|Protocol Violation|0|||
157117414|NCT01225731|567182447|FG012|Part 1|Protocol Violation|0|||
157117415|NCT01225731|567182435|FG000|Part 2|Protocol Violation|0|||
157117416|NCT01225731|567182436|FG001|Part 2|Protocol Violation|0|||
157117417|NCT01225731|567182437|FG002|Part 2|Protocol Violation|0|||
157117418|NCT01225731|567182438|FG003|Part 2|Protocol Violation|0|||
157117419|NCT01225731|567182439|FG004|Part 2|Protocol Violation|0|||
157117420|NCT01225731|567182440|FG005|Part 2|Protocol Violation|1|||
157117421|NCT01225731|567182441|FG006|Part 2|Protocol Violation|0|||
157117422|NCT01225731|567182442|FG007|Part 2|Protocol Violation|0|||
157117423|NCT01225731|567182443|FG008|Part 2|Protocol Violation|1|||
157117424|NCT01225731|567182444|FG009|Part 2|Protocol Violation|0|||
157117425|NCT01225731|567182445|FG010|Part 2|Protocol Violation|0|||
157117426|NCT01225731|567182446|FG011|Part 2|Protocol Violation|0|||
157117427|NCT01225731|567182447|FG012|Part 2|Protocol Violation|0|||
157117428|NCT01225731|567182435|FG000|Part 2|Adverse Event|0|||
157117429|NCT01225731|567182436|FG001|Part 2|Adverse Event|0|||
157117430|NCT01225731|567182437|FG002|Part 2|Adverse Event|0|||
157117431|NCT01225731|567182438|FG003|Part 2|Adverse Event|0|||
157117432|NCT01225731|567182439|FG004|Part 2|Adverse Event|0|||
157117433|NCT01225731|567182440|FG005|Part 2|Adverse Event|0|||
157117434|NCT01225731|567182441|FG006|Part 2|Adverse Event|4|||
157117435|NCT01225731|567182442|FG007|Part 2|Adverse Event|4|||
157117436|NCT01225731|567182443|FG008|Part 2|Adverse Event|2|||
157117437|NCT01225731|567182444|FG009|Part 2|Adverse Event|0|||
157117438|NCT01225731|567182445|FG010|Part 2|Adverse Event|0|||
157117439|NCT01225731|567182446|FG011|Part 2|Adverse Event|0|||
157117440|NCT01225731|567182447|FG012|Part 2|Adverse Event|0|||
157117441|NCT01225731|567182435|FG000|Part 2|Lack of Efficacy|0|||
157117442|NCT01225731|567182436|FG001|Part 2|Lack of Efficacy|0|||
157117443|NCT01225731|567182437|FG002|Part 2|Lack of Efficacy|0|||
157117444|NCT01225731|567182438|FG003|Part 2|Lack of Efficacy|0|||
157117445|NCT01225731|567182439|FG004|Part 2|Lack of Efficacy|0|||
157117446|NCT01225731|567182440|FG005|Part 2|Lack of Efficacy|1|||
157117447|NCT01225731|567182441|FG006|Part 2|Lack of Efficacy|0|||
157117448|NCT01225731|567182442|FG007|Part 2|Lack of Efficacy|12|||
157117449|NCT01225731|567182443|FG008|Part 2|Lack of Efficacy|3|||
157117450|NCT01225731|567182444|FG009|Part 2|Lack of Efficacy|0|||
157117451|NCT01225731|567182445|FG010|Part 2|Lack of Efficacy|0|||
157117452|NCT01225731|567182446|FG011|Part 2|Lack of Efficacy|0|||
157117453|NCT01225731|567182447|FG012|Part 2|Lack of Efficacy|0|||
157117454|NCT01225731|567182435|FG000|Part 2|Pregnancy|0|||
157117455|NCT01225731|567182436|FG001|Part 2|Pregnancy|0|||
157117456|NCT01225731|567182437|FG002|Part 2|Pregnancy|0|||
157117457|NCT01225731|567182438|FG003|Part 2|Pregnancy|0|||
157117458|NCT01225731|567182439|FG004|Part 2|Pregnancy|0|||
157117459|NCT01225731|567182440|FG005|Part 2|Pregnancy|0|||
157117460|NCT01225731|567182441|FG006|Part 2|Pregnancy|1|||
157117461|NCT01225731|567182442|FG007|Part 2|Pregnancy|0|||
157117462|NCT01225731|567182443|FG008|Part 2|Pregnancy|1|||
157117463|NCT01225731|567182444|FG009|Part 2|Pregnancy|0|||
157117464|NCT01225731|567182445|FG010|Part 2|Pregnancy|0|||
157117465|NCT01225731|567182446|FG011|Part 2|Pregnancy|0|||
157117466|NCT01225731|567182447|FG012|Part 2|Pregnancy|0|||
157117467|NCT01225731|567182435|FG000|Part 2|Lost to Follow-up|0|||
157117468|NCT01225731|567182436|FG001|Part 2|Lost to Follow-up|0|||
157117469|NCT01225731|567182437|FG002|Part 2|Lost to Follow-up|0|||
157117470|NCT01225731|567182438|FG003|Part 2|Lost to Follow-up|0|||
157117471|NCT01225731|567182439|FG004|Part 2|Lost to Follow-up|0|||
157117472|NCT01225731|567182440|FG005|Part 2|Lost to Follow-up|0|||
157117473|NCT01225731|567182441|FG006|Part 2|Lost to Follow-up|0|||
157117474|NCT01225731|567182442|FG007|Part 2|Lost to Follow-up|3|||
157117475|NCT01225731|567182443|FG008|Part 2|Lost to Follow-up|1|||
157117476|NCT01225731|567182444|FG009|Part 2|Lost to Follow-up|0|||
157117477|NCT01225731|567182445|FG010|Part 2|Lost to Follow-up|0|||
157117478|NCT01225731|567182446|FG011|Part 2|Lost to Follow-up|0|||
157117479|NCT01225731|567182447|FG012|Part 2|Lost to Follow-up|0|||
157117480|NCT01225731|567182435|FG000|Part 2|Physician Decision|0|||
157117481|NCT01225731|567182436|FG001|Part 2|Physician Decision|0|||
157117482|NCT01225731|567182437|FG002|Part 2|Physician Decision|0|||
157117483|NCT01225731|567182438|FG003|Part 2|Physician Decision|0|||
157117484|NCT01225731|567182439|FG004|Part 2|Physician Decision|0|||
157117485|NCT01225731|567182440|FG005|Part 2|Physician Decision|0|||
157117486|NCT01225731|567182441|FG006|Part 2|Physician Decision|0|||
157117487|NCT01225731|567182442|FG007|Part 2|Physician Decision|2|||
157117488|NCT01225731|567182443|FG008|Part 2|Physician Decision|2|||
157117489|NCT01225731|567182444|FG009|Part 2|Physician Decision|0|||
157117490|NCT01225731|567182445|FG010|Part 2|Physician Decision|0|||
157117491|NCT01225731|567182446|FG011|Part 2|Physician Decision|0|||
157117492|NCT01225731|567182447|FG012|Part 2|Physician Decision|0|||
157117493|NCT01225731|567182435|FG000|Part 2|Withdrawal by Subject|0|||
157117494|NCT01225731|567182436|FG001|Part 2|Withdrawal by Subject|0|||
157117495|NCT01225731|567182437|FG002|Part 2|Withdrawal by Subject|0|||
157117496|NCT01225731|567182438|FG003|Part 2|Withdrawal by Subject|0|||
157117497|NCT01225731|567182439|FG004|Part 2|Withdrawal by Subject|0|||
157117498|NCT01225731|567182440|FG005|Part 2|Withdrawal by Subject|1|||
157117499|NCT01225731|567182441|FG006|Part 2|Withdrawal by Subject|3|||
157117500|NCT01225731|567182442|FG007|Part 2|Withdrawal by Subject|4|||
157117501|NCT01225731|567182443|FG008|Part 2|Withdrawal by Subject|1|||
157117502|NCT01225731|567182444|FG009|Part 2|Withdrawal by Subject|0|||
157117503|NCT01225731|567182445|FG010|Part 2|Withdrawal by Subject|0|||
157117504|NCT01225731|567182446|FG011|Part 2|Withdrawal by Subject|0|||
157117505|NCT01225731|567182447|FG012|Part 2|Withdrawal by Subject|0|||
157117506|NCT01225731|567182435|FG000|Part 3|Adverse Event|0|||
157117507|NCT01225731|567182436|FG001|Part 3|Adverse Event|0|||
157117508|NCT01225731|567182437|FG002|Part 3|Adverse Event|0|||
157117509|NCT01225731|567182438|FG003|Part 3|Adverse Event|0|||
157117510|NCT01225731|567182439|FG004|Part 3|Adverse Event|0|||
157117511|NCT01225731|567182440|FG005|Part 3|Adverse Event|0|||
157117512|NCT01225731|567182441|FG006|Part 3|Adverse Event|0|||
157117513|NCT01225731|567182442|FG007|Part 3|Adverse Event|0|||
157117514|NCT01225731|567182443|FG008|Part 3|Adverse Event|0|||
157117515|NCT01225731|567182444|FG009|Part 3|Adverse Event|0|||
157117516|NCT01225731|567182445|FG010|Part 3|Adverse Event|1|||
157117517|NCT01225731|567182446|FG011|Part 3|Adverse Event|1|||
157117518|NCT01225731|567182447|FG012|Part 3|Adverse Event|0|||
157117519|NCT01225731|567182435|FG000|Part 3|Lost to Follow-up|0|||
157117520|NCT01225731|567182436|FG001|Part 3|Lost to Follow-up|0|||
157117521|NCT01225731|567182437|FG002|Part 3|Lost to Follow-up|0|||
157117522|NCT01225731|567182438|FG003|Part 3|Lost to Follow-up|0|||
157117523|NCT01225731|567182439|FG004|Part 3|Lost to Follow-up|0|||
157211036|NCT03137082|567519026|FG001|Overall Study|Lost to Follow-up|0|||
157211037|NCT01988493|567519027|FG000|Overall Study|Randomized but not treated|0|||
157211038|NCT01988493|567519028|FG001|Overall Study|Randomized but not treated|0|||
157211039|NCT01988493|567519029|FG002|Overall Study|Randomized but not treated|0|||
157211040|NCT01988493|567519030|FG003|Overall Study|Randomized but not treated|0|||
157211041|NCT01988493|567519031|FG004|Overall Study|Randomized but not treated|1|||
157211042|NCT03496207|567519036|FG000|Base Study|Adverse Event|0|||
157117524|NCT01225731|567182440|FG005|Part 3|Lost to Follow-up|0|||
157117525|NCT01225731|567182441|FG006|Part 3|Lost to Follow-up|0|||
157117526|NCT01225731|567182442|FG007|Part 3|Lost to Follow-up|0|||
157117527|NCT01225731|567182443|FG008|Part 3|Lost to Follow-up|0|||
157117528|NCT01225731|567182444|FG009|Part 3|Lost to Follow-up|0|||
157117529|NCT01225731|567182445|FG010|Part 3|Lost to Follow-up|1|||
157117530|NCT01225731|567182446|FG011|Part 3|Lost to Follow-up|2|||
157117531|NCT01225731|567182447|FG012|Part 3|Lost to Follow-up|1|||
157117532|NCT01225731|567182435|FG000|Part 3|Physician Decision|0|||
157117533|NCT01225731|567182436|FG001|Part 3|Physician Decision|0|||
157117534|NCT01225731|567182437|FG002|Part 3|Physician Decision|0|||
157117535|NCT01225731|567182438|FG003|Part 3|Physician Decision|0|||
157117536|NCT01225731|567182439|FG004|Part 3|Physician Decision|0|||
157117537|NCT01225731|567182440|FG005|Part 3|Physician Decision|0|||
157117538|NCT01225731|567182441|FG006|Part 3|Physician Decision|0|||
157211043|NCT03496207|567519037|FG001|Base Study|Adverse Event|0|||
157117539|NCT01225731|567182442|FG007|Part 3|Physician Decision|0|||
157117540|NCT01225731|567182443|FG008|Part 3|Physician Decision|0|||
157211044|NCT03496207|567519038|FG002|Base Study|Adverse Event|1|||
157117541|NCT01225731|567182444|FG009|Part 3|Physician Decision|0|||
157117542|NCT01225731|567182445|FG010|Part 3|Physician Decision|0|||
157211045|NCT03496207|567519039|FG003|Base Study|Adverse Event|1|||
157211046|NCT03496207|567519040|FG004|Base Study|Adverse Event|4|||
157211047|NCT03496207|567519036|FG000|Base Study|Death|0|||
157211048|NCT03496207|567519037|FG001|Base Study|Death|0|||
157211049|NCT03496207|567519038|FG002|Base Study|Death|0|||
157211050|NCT03496207|567519039|FG003|Base Study|Death|0|||
157211051|NCT03496207|567519040|FG004|Base Study|Death|1|||
157211052|NCT03496207|567519036|FG000|Base Study|Withdrawal by Subject|0|||
157211053|NCT03496207|567519037|FG001|Base Study|Withdrawal by Subject|0|||
157211054|NCT03496207|567519038|FG002|Base Study|Withdrawal by Subject|1|||
157211055|NCT03496207|567519039|FG003|Base Study|Withdrawal by Subject|0|||
157211056|NCT03496207|567519040|FG004|Base Study|Withdrawal by Subject|1|||
157211057|NCT03496207|567519036|FG000|Extension Period|Adverse Event|0|||
157211058|NCT03496207|567519037|FG001|Extension Period|Adverse Event|0|||
157211059|NCT03496207|567519038|FG002|Extension Period|Adverse Event|0|||
157211060|NCT03496207|567519039|FG003|Extension Period|Adverse Event|1|||
157211061|NCT03496207|567519040|FG004|Extension Period|Adverse Event|1|||
157211062|NCT03496207|567519036|FG000|Extension Period|Death|1|||
157211063|NCT03496207|567519037|FG001|Extension Period|Death|0|||
157211064|NCT03496207|567519038|FG002|Extension Period|Death|0|||
157211065|NCT03496207|567519039|FG003|Extension Period|Death|1|||
157211066|NCT03496207|567519040|FG004|Extension Period|Death|2|||
157211067|NCT03496207|567519036|FG000|Extension Period|Withdrawal by Subject|1|||
157211068|NCT03496207|567519037|FG001|Extension Period|Withdrawal by Subject|0|||
157011014|NCT01839331|566792025|FG001|Overall Study|Early Termination|0|||
157011015|NCT01839331|566792026|FG002|Overall Study|Early Termination|1|||
157011016|NCT01839331|566792027|FG003|Overall Study|Early Termination|2|||
157011017|NCT01839331|566792024|FG000|Overall Study|Protocol Violation|1|||
157011018|NCT01839331|566792025|FG001|Overall Study|Protocol Violation|6|||
157011019|NCT01839331|566792026|FG002|Overall Study|Protocol Violation|4|||
157011020|NCT01839331|566792027|FG003|Overall Study|Protocol Violation|3|||
157011021|NCT00529516|566792028|FG000|Overall Study|Adverse Event|2|||
157011022|NCT00529516|566792029|FG001|Overall Study|Adverse Event|1|||
157011023|NCT00529516|566792030|FG002|Overall Study|Adverse Event|0|||
157011024|NCT00529516|566792028|FG000|Overall Study|Withdrawal by Subject|1|||
157011025|NCT00529516|566792029|FG001|Overall Study|Withdrawal by Subject|1|||
157011026|NCT00529516|566792030|FG002|Overall Study|Withdrawal by Subject|0|||
157011027|NCT00529516|566792028|FG000|Overall Study|Lost to Follow-up|0|||
157011028|NCT00529516|566792029|FG001|Overall Study|Lost to Follow-up|0|||
157011029|NCT00529516|566792030|FG002|Overall Study|Lost to Follow-up|1|||
157011030|NCT00703820|566792034|FG000|Overall Study|Adverse Event|12|||
157011031|NCT00703820|566792035|FG001|Overall Study|Adverse Event|17|||
157011032|NCT00703820|566792034|FG000|Overall Study|Death|5|||
157011033|NCT00703820|566792035|FG001|Overall Study|Death|0|||
157011034|NCT00703820|566792034|FG000|Overall Study|Lack of Efficacy|11|||
157011035|NCT00703820|566792035|FG001|Overall Study|Lack of Efficacy|11|||
157011036|NCT00703820|566792034|FG000|Overall Study|Received non-protocol therapy|1|||
157011037|NCT00703820|566792035|FG001|Overall Study|Received non-protocol therapy|0|||
157011038|NCT00703820|566792034|FG000|Overall Study|Physician Decision|4|||
157011039|NCT00703820|566792035|FG001|Overall Study|Physician Decision|5|||
157117543|NCT01225731|567182446|FG011|Part 3|Physician Decision|1|||
157117544|NCT01225731|567182447|FG012|Part 3|Physician Decision|2|||
157117545|NCT01225731|567182435|FG000|Part 3|Withdrawal by Subject|0|||
157117546|NCT01225731|567182436|FG001|Part 3|Withdrawal by Subject|0|||
157117547|NCT01225731|567182437|FG002|Part 3|Withdrawal by Subject|0|||
157117548|NCT01225731|567182438|FG003|Part 3|Withdrawal by Subject|0|||
157117549|NCT01225731|567182439|FG004|Part 3|Withdrawal by Subject|0|||
157117550|NCT01225731|567182440|FG005|Part 3|Withdrawal by Subject|0|||
157117551|NCT01225731|567182441|FG006|Part 3|Withdrawal by Subject|0|||
157117552|NCT01225731|567182442|FG007|Part 3|Withdrawal by Subject|0|||
157117553|NCT01225731|567182443|FG008|Part 3|Withdrawal by Subject|0|||
157117554|NCT01225731|567182444|FG009|Part 3|Withdrawal by Subject|0|||
157117555|NCT01225731|567182445|FG010|Part 3|Withdrawal by Subject|4|||
157117556|NCT01225731|567182446|FG011|Part 3|Withdrawal by Subject|6|||
157117557|NCT01225731|567182447|FG012|Part 3|Withdrawal by Subject|4|||
157117558|NCT01073267|567182448|FG000|Overall Study|Disease Progression|3|||
157211069|NCT03496207|567519038|FG002|Extension Period|Withdrawal by Subject|0|||
157211070|NCT03496207|567519039|FG003|Extension Period|Withdrawal by Subject|1|||
157211071|NCT03496207|567519040|FG004|Extension Period|Withdrawal by Subject|1|||
157211072|NCT03496207|567519036|FG000|Extension Period|Elevated hemoglobin levels|0|||
157211073|NCT03496207|567519037|FG001|Extension Period|Elevated hemoglobin levels|0|||
157211074|NCT03496207|567519038|FG002|Extension Period|Elevated hemoglobin levels|0|||
157211075|NCT03496207|567519039|FG003|Extension Period|Elevated hemoglobin levels|0|||
157211076|NCT03496207|567519040|FG004|Extension Period|Elevated hemoglobin levels|1|||
157211077|NCT00902278|567519041|FG000|Overall Study|Physician Decision|1|||
157211078|NCT00902278|567519042|FG001|Overall Study|Physician Decision|0|||
157211079|NCT00902278|567519043|FG002|Overall Study|Physician Decision|2|||
157211080|NCT00902278|567519044|FG003|Overall Study|Physician Decision|0|||
157211081|NCT00902278|567519045|FG004|Overall Study|Physician Decision|1|||
157211082|NCT00902278|567519041|FG000|Overall Study|Lost to Follow-up|3|||
157211083|NCT00902278|567519042|FG001|Overall Study|Lost to Follow-up|2|||
157211084|NCT00902278|567519043|FG002|Overall Study|Lost to Follow-up|3|||
157117559|NCT00577642|567182449|FG000|Overall Study|Clinical Disease Progression|1|||
157117560|NCT01505634|567182457|FG000|Overall Study|Withdrawal by Subject|2|||
157117561|NCT01505634|567182458|FG001|Overall Study|Withdrawal by Subject|5|||
157117562|NCT01505634|567182459|FG002|Overall Study|Withdrawal by Subject|1|||
157117563|NCT01505634|567182457|FG000|Overall Study|Physician Decision|1|||
157117564|NCT01505634|567182458|FG001|Overall Study|Physician Decision|1|||
157117565|NCT01505634|567182459|FG002|Overall Study|Physician Decision|0|||
157117566|NCT01505634|567182457|FG000|Overall Study|Adverse Event|1|||
157117567|NCT01505634|567182458|FG001|Overall Study|Adverse Event|0|||
157117568|NCT01505634|567182459|FG002|Overall Study|Adverse Event|0|||
157211085|NCT00902278|567519044|FG003|Overall Study|Lost to Follow-up|0|||
157117569|NCT01505634|567182457|FG000|Overall Study|Insufficient supply of drug at site|1|||
157117570|NCT01505634|567182458|FG001|Overall Study|Insufficient supply of drug at site|0|||
157117571|NCT01505634|567182459|FG002|Overall Study|Insufficient supply of drug at site|0|||
157117572|NCT01505634|567182457|FG000|Overall Study|Protocol Violation|2|||
157117573|NCT01505634|567182458|FG001|Overall Study|Protocol Violation|0|||
157117574|NCT01505634|567182459|FG002|Overall Study|Protocol Violation|0|||
157117575|NCT01505634|567182457|FG000|Overall Study|Lost to Follow-up|1|||
157117576|NCT01505634|567182458|FG001|Overall Study|Lost to Follow-up|4|||
157117577|NCT01505634|567182459|FG002|Overall Study|Lost to Follow-up|4|||
157117578|NCT01505634|567182457|FG000|Overall Study|Death|1|||
157117579|NCT01505634|567182458|FG001|Overall Study|Death|0|||
157117580|NCT01505634|567182459|FG002|Overall Study|Death|0|||
157117581|NCT01505634|567182457|FG000|Overall Study|In a conflict zone|0|||
157117582|NCT01505634|567182458|FG001|Overall Study|In a conflict zone|0|||
157117583|NCT01505634|567182459|FG002|Overall Study|In a conflict zone|1|||
157117584|NCT00542269|567182460|FG000|Overall Study|Adverse Event|10|||
157117585|NCT00542269|567182461|FG001|Overall Study|Adverse Event|4|||
157117586|NCT00542269|567182462|FG002|Overall Study|Adverse Event|5|||
157117587|NCT00542269|567182460|FG000|Overall Study|Protocol Violation|1|||
157117588|NCT00542269|567182461|FG001|Overall Study|Protocol Violation|1|||
157117589|NCT00542269|567182462|FG002|Overall Study|Protocol Violation|0|||
157117590|NCT00542269|567182460|FG000|Overall Study|Withdrawal by Subject|1|||
157117591|NCT00542269|567182461|FG001|Overall Study|Withdrawal by Subject|0|||
157117592|NCT00542269|567182462|FG002|Overall Study|Withdrawal by Subject|0|||
157117593|NCT00542269|567182460|FG000|Overall Study|Administrative problems|1|||
157117594|NCT00542269|567182461|FG001|Overall Study|Administrative problems|1|||
157117595|NCT00542269|567182462|FG002|Overall Study|Administrative problems|1|||
157117596|NCT00333359|567182468|FG000|Overall Study|Adverse Event|29|||
157117597|NCT00333359|567182469|FG001|Overall Study|Adverse Event|35|||
157117598|NCT00333359|567182468|FG000|Overall Study|Withdrawal by Subject|19|||
157117599|NCT00333359|567182469|FG001|Overall Study|Withdrawal by Subject|37|||
157117600|NCT00333359|567182468|FG000|Overall Study|Physician Decision|2|||
157117601|NCT00333359|567182469|FG001|Overall Study|Physician Decision|2|||
157117602|NCT00333359|567182468|FG000|Overall Study|Protocol Non-compliance|2|||
157117603|NCT00333359|567182469|FG001|Overall Study|Protocol Non-compliance|8|||
157117604|NCT00333359|567182468|FG000|Overall Study|Lost to Follow-up|15|||
157117605|NCT00333359|567182469|FG001|Overall Study|Lost to Follow-up|25|||
157117606|NCT00333359|567182468|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
157117607|NCT00333359|567182469|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
157117608|NCT00333359|567182468|FG000|Overall Study|Treatment Failure|3|||
157117609|NCT00333359|567182469|FG001|Overall Study|Treatment Failure|8|||
157117610|NCT00333359|567182468|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
157117611|NCT00333359|567182469|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
157211086|NCT00902278|567519045|FG004|Overall Study|Lost to Follow-up|1|||
157211087|NCT01488071|567519046|FG000|Overall Study|Adverse Event|15|||
157211088|NCT01488071|567519047|FG001|Overall Study|Adverse Event|23|||
157211089|NCT01488071|567519046|FG000|Overall Study|Lack of Efficacy|11|||
157211090|NCT01488071|567519047|FG001|Overall Study|Lack of Efficacy|17|||
157211091|NCT01488071|567519046|FG000|Overall Study|Non-compliance with study drug|2|||
157211092|NCT01488071|567519047|FG001|Overall Study|Non-compliance with study drug|0|||
157211093|NCT01488071|567519046|FG000|Overall Study|Protocol Violation|5|||
157211094|NCT01488071|567519047|FG001|Overall Study|Protocol Violation|7|||
157211095|NCT01488071|567519046|FG000|Overall Study|Withdrawal of Consent|14|||
157211096|NCT01488071|567519047|FG001|Overall Study|Withdrawal of Consent|12|||
157211097|NCT01488071|567519046|FG000|Overall Study|Lost to Follow-up|1|||
157211098|NCT01488071|567519047|FG001|Overall Study|Lost to Follow-up|0|||
157211099|NCT01488071|567519046|FG000|Overall Study|Administrative or Other Reason(s)|5|||
157211100|NCT01488071|567519047|FG001|Overall Study|Administrative or Other Reason(s)|4|||
157211101|NCT04449354|567519048|FG000|Overall Study|Withdrawal by Subject|1|||
157211102|NCT05473247|567519051|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
157211103|NCT01831596|567519052|FG000|Overall Study|Other|8|||
157211104|NCT02508649|567519053|FG000|Overall Study|Withdrawal by Subject|4|||
157211105|NCT02508649|567519054|FG001|Overall Study|Withdrawal by Subject|6|||
157211106|NCT02508649|567519055|FG002|Overall Study|Withdrawal by Subject|5|||
157211107|NCT02508649|567519056|FG003|Overall Study|Withdrawal by Subject|6|||
157011040|NCT00703820|566792034|FG000|Overall Study|Withdrawal by Subject|2|||
157011041|NCT00703820|566792035|FG001|Overall Study|Withdrawal by Subject|1|||
157011042|NCT00761605|566792039|FG000|Overall Study|Adverse Event|26|||
157211108|NCT02508649|567519053|FG000|Overall Study|Investigator withdrew the subject|1|||
157011043|NCT00761605|566792039|FG000|Overall Study|Death|2|||
157211109|NCT02508649|567519054|FG001|Overall Study|Investigator withdrew the subject|2|||
157211110|NCT02508649|567519055|FG002|Overall Study|Investigator withdrew the subject|1|||
157211111|NCT02508649|567519056|FG003|Overall Study|Investigator withdrew the subject|0|||
157211112|NCT02508649|567519053|FG000|Overall Study|Post randomization screening failure|12|||
157211113|NCT02508649|567519054|FG001|Overall Study|Post randomization screening failure|4|||
157211114|NCT02508649|567519055|FG002|Overall Study|Post randomization screening failure|9|||
157211115|NCT02508649|567519056|FG003|Overall Study|Post randomization screening failure|3|||
157117612|NCT01534533|567182473|FG000|Overall Study|Lost to Follow-up|3|||
157117613|NCT01534533|567182474|FG001|Overall Study|Lost to Follow-up|0|||
157117614|NCT01534533|567182475|FG002|Overall Study|Lost to Follow-up|4|||
157117615|NCT01534533|567182476|FG003|Overall Study|Lost to Follow-up|3|||
157211116|NCT02508649|567519053|FG000|Overall Study|Lost to Follow-up|1|||
157211117|NCT02508649|567519054|FG001|Overall Study|Lost to Follow-up|1|||
157117616|NCT01534533|567182473|FG000|Overall Study|Withdrawal by Subject|5|||
157117617|NCT01534533|567182474|FG001|Overall Study|Withdrawal by Subject|3|||
157117618|NCT01534533|567182475|FG002|Overall Study|Withdrawal by Subject|4|||
157117619|NCT01534533|567182476|FG003|Overall Study|Withdrawal by Subject|1|||
157211118|NCT02508649|567519055|FG002|Overall Study|Lost to Follow-up|0|||
157211119|NCT02508649|567519056|FG003|Overall Study|Lost to Follow-up|1|||
157117620|NCT04311502|567184079|FG000|Overall Study|Death|1|||
157117621|NCT04311502|567184080|FG001|Overall Study|Death|1|||
157117622|NCT04311502|567184081|FG002|Overall Study|Death|1|||
157117623|NCT04311502|567184079|FG000|Overall Study|Lost to Follow-up|2|||
157117624|NCT04311502|567184080|FG001|Overall Study|Lost to Follow-up|3|||
157117625|NCT04311502|567184081|FG002|Overall Study|Lost to Follow-up|0|||
157211120|NCT02149199|567519057|FG000|Overall Study|Study specific withdrawal criteria|4|||
157211121|NCT02149199|567519058|FG001|Overall Study|Study specific withdrawal criteria|21|||
157211122|NCT02149199|567519059|FG002|Overall Study|Study specific withdrawal criteria|6|||
157211123|NCT02149199|567519057|FG000|Overall Study|Other|20|||
157211124|NCT02149199|567519058|FG001|Overall Study|Other|25|||
157211125|NCT02149199|567519059|FG002|Overall Study|Other|20|||
157211126|NCT02149199|567519057|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
157211127|NCT02149199|567519058|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
157211128|NCT02149199|567519059|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
157211129|NCT02149199|567519057|FG000|Overall Study|Withdrawal by Subject|75|||
157211130|NCT02149199|567519058|FG001|Overall Study|Withdrawal by Subject|93|||
157211131|NCT02149199|567519059|FG002|Overall Study|Withdrawal by Subject|77|||
157211132|NCT02149199|567519057|FG000|Overall Study|Protocol Violation|16|||
157211133|NCT02149199|567519058|FG001|Overall Study|Protocol Violation|13|||
157211134|NCT02149199|567519059|FG002|Overall Study|Protocol Violation|15|||
157211135|NCT02149199|567519057|FG000|Overall Study|Lost to Follow-up|3|||
157211136|NCT02149199|567519058|FG001|Overall Study|Lost to Follow-up|12|||
157211137|NCT02149199|567519059|FG002|Overall Study|Lost to Follow-up|11|||
157211138|NCT02149199|567519057|FG000|Overall Study|Death|0|||
157211139|NCT02149199|567519058|FG001|Overall Study|Death|0|||
157211140|NCT02149199|567519059|FG002|Overall Study|Death|1|||
157211141|NCT02149199|567519057|FG000|Overall Study|Adverse Event|6|||
157211142|NCT02149199|567519058|FG001|Overall Study|Adverse Event|15|||
157211143|NCT02149199|567519059|FG002|Overall Study|Adverse Event|9|||
157211144|NCT02956005|567519060|FG000|Overall Study|Not eligible|1|||
157211145|NCT02956005|567519060|FG000|Overall Study|Withdrawal by Subject|3|||
157211146|NCT02956005|567519060|FG000|Overall Study|Physician Decision|12|||
157211147|NCT03125629|567519061|FG000|Overall Study|Withdrawal by Subject|2|||
157211148|NCT03125629|567519061|FG000|Overall Study|Equipment malfunction|1|||
157211149|NCT02524665|567519066|FG000|Overall Study|Lost to Follow-up|1|||
157211150|NCT02602080|567519069|FG000|Overall Study|Protocol Violation|6|||
157211151|NCT02602080|567519070|FG001|Overall Study|Protocol Violation|1|||
157211152|NCT02602080|567519071|FG002|Overall Study|Protocol Violation|3|||
157211153|NCT04508621|567519074|FG000|Overall Study|Adverse Event|39|||
157211154|NCT04508621|567519075|FG001|Overall Study|Adverse Event|16|||
157211155|NCT04508621|567519074|FG000|Overall Study|Lack of Efficacy|2|||
157117626|NCT04311502|567184079|FG000|Overall Study|Participant is in prison|1|||
157117627|NCT04311502|567184080|FG001|Overall Study|Participant is in prison|0|||
157117628|NCT04311502|567184081|FG002|Overall Study|Participant is in prison|0|||
157117629|NCT04311502|567184079|FG000|Overall Study|Participant moved out of country|1|||
157117630|NCT04311502|567184080|FG001|Overall Study|Participant moved out of country|0|||
157117631|NCT04311502|567184081|FG002|Overall Study|Participant moved out of country|0|||
157117632|NCT04311502|567184079|FG000|Overall Study|Withdrawal by Subject|2|||
157211156|NCT04508621|567519075|FG001|Overall Study|Lack of Efficacy|8|||
157211157|NCT04508621|567519074|FG000|Overall Study|Physician Decision|0|||
157211158|NCT04508621|567519075|FG001|Overall Study|Physician Decision|1|||
157211159|NCT04508621|567519074|FG000|Overall Study|Withdrawal by Subject|10|||
157211160|NCT04508621|567519075|FG001|Overall Study|Withdrawal by Subject|14|||
157117633|NCT04311502|567184080|FG001|Overall Study|Withdrawal by Subject|0|||
157117634|NCT04311502|567184081|FG002|Overall Study|Withdrawal by Subject|0|||
157117635|NCT04311502|567184079|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
157117636|NCT04311502|567184080|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
157211161|NCT04508621|567519074|FG000|Overall Study|Lost to Follow-up|12|||
157211162|NCT04508621|567519075|FG001|Overall Study|Lost to Follow-up|9|||
157211163|NCT04508621|567519074|FG000|Overall Study|COVID-19 related crisis|3|||
157211164|NCT04508621|567519075|FG001|Overall Study|COVID-19 related crisis|0|||
157211165|NCT04508621|567519074|FG000|Overall Study|Subject non-compliance|1|||
157211166|NCT04508621|567519075|FG001|Overall Study|Subject non-compliance|0|||
157211167|NCT01066039|567519076|FG000|Overall Study|Adverse Event|6|||
157211168|NCT01066039|567519076|FG000|Overall Study|Withdrawal by Subject|17|||
157211169|NCT01066039|567519076|FG000|Overall Study|Protocol Violation|2|||
157211170|NCT01066039|567519076|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
157211171|NCT01066039|567519076|FG000|Overall Study|Investigator's Request|1|||
157211172|NCT01066039|567519076|FG000|Overall Study|Dropout due to Insulin Administration|1|||
157211173|NCT01066039|567519076|FG000|Overall Study|Additional Antihypertensive Required|4|||
157211174|NCT01066039|567519076|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
157211175|NCT01066039|567519076|FG000|Overall Study|Failure to Control Blood Pressure|1|||
157211176|NCT01066039|567519076|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
157211177|NCT02574260|567519077|FG000|Overall Study|Disease Progression|1|||
157211178|NCT00752895|567519078|FG000|Overall Study|Withdrawal by Subject|8|||
157211179|NCT00752895|567519079|FG001|Overall Study|Withdrawal by Subject|3|||
157211180|NCT03022799|567519080|FG000|Overall Study|Adverse Event|0|||
157211181|NCT03022799|567519081|FG001|Overall Study|Adverse Event|0|||
157211182|NCT03022799|567519082|FG002|Overall Study|Adverse Event|0|||
157211183|NCT03022799|567519083|FG003|Overall Study|Adverse Event|0|||
157211184|NCT03022799|567519084|FG004|Overall Study|Adverse Event|0|||
157211185|NCT03022799|567519085|FG005|Overall Study|Adverse Event|0|||
157211186|NCT03022799|567519086|FG006|Overall Study|Adverse Event|0|||
157211187|NCT03022799|567519087|FG007|Overall Study|Adverse Event|0|||
157211188|NCT03022799|567519088|FG008|Overall Study|Adverse Event|0|||
157211189|NCT03022799|567519089|FG009|Overall Study|Adverse Event|1|||
157211190|NCT03022799|567519090|FG010|Overall Study|Adverse Event|1|||
157211191|NCT03022799|567519091|FG011|Overall Study|Adverse Event|0|||
157211192|NCT03022799|567519092|FG012|Overall Study|Adverse Event|0|||
157211193|NCT04881448|567519095|FG000|Overall Study|Study cancelled by sponsor|220|||
157211194|NCT04881448|567519095|FG000|Overall Study|Withdrawal by Subject|2|||
157211195|NCT04881448|567519095|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
157211196|NCT03273257|567519097|FG000|Overall Study|Death|0|||
157211197|NCT03273257|567519098|FG001|Overall Study|Death|1|||
157211198|NCT03273257|567519097|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
157211199|NCT03273257|567519098|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
157211200|NCT03273257|567519097|FG000|Overall Study|Study terminated|3|||
157211201|NCT03273257|567519098|FG001|Overall Study|Study terminated|2|||
157211202|NCT01898884|567519099|FG000|Multiple Dose Period|Adverse Event|0|||
157211203|NCT01898884|567519100|FG001|Multiple Dose Period|Adverse Event|0|||
157211204|NCT01898884|567519101|FG002|Multiple Dose Period|Adverse Event|0|||
157211205|NCT01898884|567519102|FG003|Multiple Dose Period|Adverse Event|0|||
157211206|NCT01898884|567519103|FG004|Multiple Dose Period|Adverse Event|0|||
157211207|NCT01898884|567519104|FG005|Multiple Dose Period|Adverse Event|0|||
157211208|NCT01898884|567519105|FG006|Multiple Dose Period|Adverse Event|1|||
157211209|NCT01898884|567519106|FG007|Multiple Dose Period|Adverse Event|0|||
157211210|NCT01898884|567519107|FG008|Multiple Dose Period|Adverse Event|0|||
157211211|NCT01898884|567519099|FG000|Multiple Dose Period|Randomized Not Treated|0|||
157211212|NCT01898884|567519100|FG001|Multiple Dose Period|Randomized Not Treated|0|||
157211213|NCT01898884|567519101|FG002|Multiple Dose Period|Randomized Not Treated|0|||
157211214|NCT01898884|567519102|FG003|Multiple Dose Period|Randomized Not Treated|0|||
157211215|NCT01898884|567519103|FG004|Multiple Dose Period|Randomized Not Treated|0|||
157211216|NCT01898884|567519104|FG005|Multiple Dose Period|Randomized Not Treated|0|||
157211217|NCT01898884|567519105|FG006|Multiple Dose Period|Randomized Not Treated|0|||
157211218|NCT01898884|567519106|FG007|Multiple Dose Period|Randomized Not Treated|0|||
157211219|NCT01898884|567519107|FG008|Multiple Dose Period|Randomized Not Treated|1|||
157211220|NCT00434148|567519108|FG000|Overall Study|Adverse Event|18|||
157211221|NCT00434148|567519109|FG001|Overall Study|Adverse Event|18|||
157211222|NCT00434148|567519108|FG000|Overall Study|Lack of Efficacy|25|||
157211223|NCT00434148|567519109|FG001|Overall Study|Lack of Efficacy|28|||
157211224|NCT00434148|567519108|FG000|Overall Study|Withdrawal by Subject|15|||
157211225|NCT00434148|567519109|FG001|Overall Study|Withdrawal by Subject|15|||
157211226|NCT00434148|567519108|FG000|Overall Study|Protocol Violation|4|||
157211227|NCT00434148|567519109|FG001|Overall Study|Protocol Violation|0|||
157211228|NCT00434148|567519108|FG000|Overall Study|Administrative problems|6|||
157211229|NCT00434148|567519109|FG001|Overall Study|Administrative problems|10|||
157211230|NCT00434148|567519108|FG000|Overall Study|Lost to Follow-up|0|||
157211231|NCT00434148|567519109|FG001|Overall Study|Lost to Follow-up|1|||
157211232|NCT00434148|567519108|FG000|Overall Study|Condition no longer requires study drug|1|||
157211233|NCT00434148|567519109|FG001|Overall Study|Condition no longer requires study drug|0|||
157211234|NCT00434148|567519108|FG000|Overall Study|Abnormal test procedure result|0|||
157211235|NCT00434148|567519109|FG001|Overall Study|Abnormal test procedure result|1|||
157211236|NCT00759759|567519110|FG000|Overall Study|didn't return for period 2|1|||
157211237|NCT00759759|567519111|FG001|Overall Study|didn't return for period 2|0|||
157211238|NCT00759759|567519110|FG000|Overall Study|Didn't receive drug in period 2|1|||
157211239|NCT00759759|567519111|FG001|Overall Study|Didn't receive drug in period 2|0|||
157211240|NCT00759759|567519110|FG000|Overall Study|Withdrawal by Subject|2|||
157211241|NCT00759759|567519111|FG001|Overall Study|Withdrawal by Subject|1|||
157211242|NCT01640964|567519118|FG000|Overall Study|Lost to Follow-up|0|||
157211243|NCT01640964|567519119|FG001|Overall Study|Lost to Follow-up|0|||
157211244|NCT01640964|567519120|FG002|Overall Study|Lost to Follow-up|1|||
157211245|NCT01640964|567519118|FG000|Overall Study|Protocol Deviation|1|||
157211246|NCT01640964|567519119|FG001|Overall Study|Protocol Deviation|1|||
157211247|NCT01640964|567519120|FG002|Overall Study|Protocol Deviation|2|||
157211248|NCT01399125|567521190|FG000|Overall Study|Adverse Event|32|||
157211249|NCT01399125|567521191|FG001|Overall Study|Adverse Event|30|||
157211250|NCT01399125|567521190|FG000|Overall Study|Abnormal Lab values|0|||
157211251|NCT01399125|567521191|FG001|Overall Study|Abnormal Lab values|1|||
157211252|NCT01399125|567521190|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
157211253|NCT01399125|567521191|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
157211254|NCT01399125|567521190|FG000|Overall Study|Withdrawal by Subject|5|||
157211255|NCT01399125|567521191|FG001|Overall Study|Withdrawal by Subject|8|||
157211256|NCT01399125|567521190|FG000|Overall Study|Lost to Follow-up|2|||
157211257|NCT01399125|567521191|FG001|Overall Study|Lost to Follow-up|3|||
157211258|NCT01399125|567521190|FG000|Overall Study|Administrative Problems|7|||
157211259|NCT01399125|567521191|FG001|Overall Study|Administrative Problems|11|||
157211260|NCT01399125|567521190|FG000|Overall Study|Death|0|||
157211261|NCT01399125|567521191|FG001|Overall Study|Death|1|||
157211262|NCT01399125|567521190|FG000|Overall Study|Protocol Deviation|5|||
157211263|NCT01399125|567521191|FG001|Overall Study|Protocol Deviation|2|||
157211264|NCT01902134|567521192|FG000|Overall Study|Adverse Event|3|||
157211265|NCT01902134|567521193|FG001|Overall Study|Adverse Event|1|||
157211266|NCT01902134|567521194|FG002|Overall Study|Adverse Event|2|||
157211267|NCT01902134|567521195|FG003|Overall Study|Adverse Event|1|||
157211268|NCT01902134|567521196|FG004|Overall Study|Adverse Event|1|||
157211269|NCT01902134|567521197|FG005|Overall Study|Adverse Event|3|||
157211270|NCT01902134|567521192|FG000|Overall Study|Lack of Efficacy|0|||
157211271|NCT01902134|567521193|FG001|Overall Study|Lack of Efficacy|0|||
157211272|NCT01902134|567521194|FG002|Overall Study|Lack of Efficacy|2|||
157211273|NCT01902134|567521195|FG003|Overall Study|Lack of Efficacy|0|||
157211274|NCT01902134|567521196|FG004|Overall Study|Lack of Efficacy|0|||
157211275|NCT01902134|567521197|FG005|Overall Study|Lack of Efficacy|1|||
157211276|NCT01902134|567521192|FG000|Overall Study|Physician Decision|0|||
157211277|NCT01902134|567521193|FG001|Overall Study|Physician Decision|1|||
157211278|NCT01902134|567521194|FG002|Overall Study|Physician Decision|0|||
157211279|NCT01902134|567521195|FG003|Overall Study|Physician Decision|0|||
157211280|NCT01902134|567521196|FG004|Overall Study|Physician Decision|0|||
157211281|NCT01902134|567521197|FG005|Overall Study|Physician Decision|0|||
157211282|NCT01902134|567521192|FG000|Overall Study|Protocol Violation|0|||
157211283|NCT01902134|567521193|FG001|Overall Study|Protocol Violation|0|||
157211284|NCT01902134|567521194|FG002|Overall Study|Protocol Violation|0|||
157211285|NCT01902134|567521195|FG003|Overall Study|Protocol Violation|0|||
157211286|NCT01902134|567521196|FG004|Overall Study|Protocol Violation|0|||
157211287|NCT01902134|567521197|FG005|Overall Study|Protocol Violation|1|||
157211288|NCT01902134|567521192|FG000|Overall Study|Withdrawal by Subject|4|||
157211289|NCT01902134|567521193|FG001|Overall Study|Withdrawal by Subject|8|||
157211290|NCT01902134|567521194|FG002|Overall Study|Withdrawal by Subject|9|||
157211291|NCT01902134|567521195|FG003|Overall Study|Withdrawal by Subject|1|||
157211292|NCT01902134|567521196|FG004|Overall Study|Withdrawal by Subject|5|||
157211293|NCT01902134|567521197|FG005|Overall Study|Withdrawal by Subject|4|||
157211294|NCT01902134|567521192|FG000|Overall Study|no compliance|1|||
157211295|NCT01902134|567521193|FG001|Overall Study|no compliance|0|||
157211296|NCT01902134|567521194|FG002|Overall Study|no compliance|0|||
157211297|NCT01902134|567521195|FG003|Overall Study|no compliance|0|||
157211298|NCT01902134|567521196|FG004|Overall Study|no compliance|0|||
157211299|NCT01902134|567521197|FG005|Overall Study|no compliance|0|||
157211300|NCT01902134|567521192|FG000|Overall Study|Other|0|||
157211301|NCT01902134|567521193|FG001|Overall Study|Other|1|||
157211302|NCT01902134|567521194|FG002|Overall Study|Other|2|||
157211303|NCT01902134|567521195|FG003|Overall Study|Other|0|||
157211304|NCT01902134|567521196|FG004|Overall Study|Other|1|||
157211305|NCT01902134|567521197|FG005|Overall Study|Other|0|||
157117637|NCT04311502|567184081|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
157211306|NCT00305110|567521198|FG000|Overall Study|Missing data|29|||
157211307|NCT00563524|567521201|FG000|Overall Study|Adverse Event|0|||
157211308|NCT00563524|567521202|FG001|Overall Study|Adverse Event|1|||
157211309|NCT00563524|567521203|FG002|Overall Study|Adverse Event|0|||
157211310|NCT00563524|567521204|FG003|Overall Study|Adverse Event|0|||
157211311|NCT00563524|567521205|FG004|Overall Study|Adverse Event|2|||
157211312|NCT00563524|567521206|FG005|Overall Study|Adverse Event|0|||
157211313|NCT00563524|567521201|FG000|Overall Study|Lost to Follow-up|1|||
157211314|NCT00563524|567521202|FG001|Overall Study|Lost to Follow-up|0|||
157211315|NCT00563524|567521203|FG002|Overall Study|Lost to Follow-up|0|||
157117638|NCT05032157|567184082|FG000|Overall Study|Adverse Event|12|||
157117639|NCT05032157|567184083|FG001|Overall Study|Adverse Event|7|||
157117640|NCT05032157|567184082|FG000|Overall Study|Pregnancy|0|||
157117641|NCT05032157|567184083|FG001|Overall Study|Pregnancy|2|||
157117642|NCT05032157|567184082|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157117643|NCT05032157|567184083|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
157117644|NCT05032157|567184082|FG000|Overall Study|Protocol Deviation|8|||
157117645|NCT05032157|567184083|FG001|Overall Study|Protocol Deviation|4|||
157117646|NCT05032157|567184082|FG000|Overall Study|Lost to Follow-up|1|||
157117647|NCT05032157|567184083|FG001|Overall Study|Lost to Follow-up|3|||
157117648|NCT05032157|567184082|FG000|Overall Study|Physician Decision|7|||
157117649|NCT05032157|567184083|FG001|Overall Study|Physician Decision|2|||
157117650|NCT05032157|567184082|FG000|Overall Study|Patient Decision|38|||
157117651|NCT05032157|567184083|FG001|Overall Study|Patient Decision|19|||
157117652|NCT03451773|567184084|FG000|Overall Study|Death on study|1|||
157117653|NCT03451773|567184085|FG001|Overall Study|Death on study|5|||
157117654|NCT03451773|567184084|FG000|Overall Study|Death during follow-up period|0|||
157117655|NCT03451773|567184085|FG001|Overall Study|Death during follow-up period|1|||
157117656|NCT03468855|567184086|FG000|Overall Study|Adverse Event|2|||
157117657|NCT03468855|567184086|FG000|Overall Study|Lost to Follow-up|5|||
157117658|NCT03468855|567184086|FG000|Overall Study|Withdrawal by Subject|3|||
157117659|NCT03468855|567184086|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
157117660|NCT02627495|567184089|FG000|Overall Study|Withdrawal by Subject|4|||
157117661|NCT00880893|567184090|FG000|Overall Study|Protocol Violation|13|||
157117662|NCT00880893|567184091|FG001|Overall Study|Protocol Violation|1|||
157117663|NCT00880893|567184090|FG000|Overall Study|Withdrawal by Subject|15|||
157211316|NCT00563524|567521204|FG003|Overall Study|Lost to Follow-up|0|||
157211317|NCT00563524|567521205|FG004|Overall Study|Lost to Follow-up|0|||
157211318|NCT00563524|567521206|FG005|Overall Study|Lost to Follow-up|0|||
157211319|NCT00563524|567521201|FG000|Overall Study|Protocol Violation|0|||
157211320|NCT00563524|567521202|FG001|Overall Study|Protocol Violation|1|||
157211321|NCT00563524|567521203|FG002|Overall Study|Protocol Violation|0|||
157211322|NCT00563524|567521204|FG003|Overall Study|Protocol Violation|0|||
157211323|NCT00563524|567521205|FG004|Overall Study|Protocol Violation|0|||
157211324|NCT00563524|567521206|FG005|Overall Study|Protocol Violation|0|||
157211325|NCT00563524|567521201|FG000|Overall Study|Withdrawal by Subject|1|||
157211326|NCT00563524|567521202|FG001|Overall Study|Withdrawal by Subject|1|||
157211327|NCT00563524|567521203|FG002|Overall Study|Withdrawal by Subject|3|||
157117664|NCT00880893|567184091|FG001|Overall Study|Withdrawal by Subject|11|||
157117665|NCT00880893|567184090|FG000|Overall Study|Lost to Follow-up|76|||
157117666|NCT00880893|567184091|FG001|Overall Study|Lost to Follow-up|33|||
157117667|NCT00880893|567184090|FG000|Overall Study|Serious adverse event|3|||
157117668|NCT00880893|567184091|FG001|Overall Study|Serious adverse event|0|||
157145131|NCT03237845|567277996|FG000|Overall Study|Other Reasons|4|||
157011044|NCT00761605|566792039|FG000|Overall Study|Lack of Efficacy|26|||
157011045|NCT00761605|566792039|FG000|Overall Study|Lost to Follow-up|29|||
157011046|NCT00761605|566792039|FG000|Overall Study|Withdrawal by Subject|37|||
157011047|NCT00761605|566792039|FG000|Overall Study|Other|21|||
157011048|NCT01007396|566792040|FG000|Overall Study|Lost to Follow-up|47|||
157011049|NCT03074331|566792041|FG000|Overall Study|Enrolled but Not Treated|1|||
157011050|NCT03074331|566792041|FG000|Overall Study|Lost to Follow-up|5|||
157011051|NCT03074331|566792041|FG000|Overall Study|Withdrew Consent|1|||
157011052|NCT03451721|566792043|FG000|Overall Study|Death|1|||
157011053|NCT03283371|566792044|FG000|Placebo-controlled|Adverse Event|1|||
157011054|NCT03283371|566792045|FG001|Placebo-controlled|Adverse Event|1|||
157011055|NCT03283371|566792046|FG002|Placebo-controlled|Adverse Event|0|||
157011056|NCT03283371|566792047|FG003|Placebo-controlled|Adverse Event|0|||
157011057|NCT03283371|566792044|FG000|Placebo-controlled|Lack of Efficacy|1|||
157011058|NCT03283371|566792045|FG001|Placebo-controlled|Lack of Efficacy|0|||
157011059|NCT03283371|566792046|FG002|Placebo-controlled|Lack of Efficacy|0|||
157011060|NCT03283371|566792047|FG003|Placebo-controlled|Lack of Efficacy|0|||
157011061|NCT03283371|566792044|FG000|Placebo-controlled|Withdrawal by Subject|1|||
157011062|NCT03283371|566792045|FG001|Placebo-controlled|Withdrawal by Subject|1|||
157011063|NCT03283371|566792046|FG002|Placebo-controlled|Withdrawal by Subject|0|||
157011064|NCT03283371|566792047|FG003|Placebo-controlled|Withdrawal by Subject|0|||
157117669|NCT01736579|567184095|FG000|Overall Study|Termination of Study by Sponsor|2|||
157211328|NCT00563524|567521204|FG003|Overall Study|Withdrawal by Subject|0|||
157211329|NCT00563524|567521205|FG004|Overall Study|Withdrawal by Subject|0|||
157211330|NCT00563524|567521206|FG005|Overall Study|Withdrawal by Subject|1|||
157211331|NCT01467570|567521208|FG000|Overall Study|Lost to Follow-up|8|||
157211332|NCT01467570|567521209|FG001|Overall Study|Lost to Follow-up|9|||
157211333|NCT01272193|567521212|FG000|Overall Study|Adverse Event|1|||
157211334|NCT01272193|567521213|FG001|Overall Study|Adverse Event|1|||
157211335|NCT01272193|567521212|FG000|Overall Study|Lack of Efficacy|0|||
157211336|NCT01272193|567521213|FG001|Overall Study|Lack of Efficacy|3|||
157211337|NCT01272193|567521212|FG000|Overall Study|Withdrawal Criteria|1|||
157211338|NCT01272193|567521213|FG001|Overall Study|Withdrawal Criteria|1|||
157211339|NCT01272193|567521212|FG000|Overall Study|Unclassified|8|||
157211340|NCT01272193|567521213|FG001|Overall Study|Unclassified|7|||
157211341|NCT02626182|567521220|FG000|Overall Study|Adverse Event|2|||
157211342|NCT02626182|567521221|FG001|Overall Study|Adverse Event|0|||
157211343|NCT02766088|567521233|FG000|Overall Study|Sponsor study termination|498|||
157211344|NCT02766088|567521233|FG000|Overall Study|Migrated/moved from the study area|1|||
157211345|NCT02766088|567521233|FG000|Overall Study|Lost to Follow-up|5|||
157211346|NCT02766088|567521233|FG000|Overall Study|Other|1|||
157211347|NCT02766088|567521233|FG000|Overall Study|Death|1|||
157211348|NCT01222715|567521234|FG000|Overall Study|Adverse Event|0|||
157211349|NCT01222715|567521235|FG001|Overall Study|Adverse Event|4|||
157211350|NCT01222715|567521234|FG000|Overall Study|Death|0|||
157211351|NCT01222715|567521235|FG001|Overall Study|Death|1|||
157211352|NCT01222715|567521234|FG000|Overall Study|Lack of Efficacy|22|||
157211353|NCT01222715|567521235|FG001|Overall Study|Lack of Efficacy|14|||
157117670|NCT01736579|567184096|FG001|Overall Study|Termination of Study by Sponsor|2|||
157117671|NCT01783678|567184103|FG000|Overall Study|Randomized but Not Treated|0|||
157117672|NCT01783678|567184104|FG001|Overall Study|Randomized but Not Treated|0|||
157117673|NCT01783678|567184105|FG002|Overall Study|Randomized but Not Treated|0|||
157117674|NCT01783678|567184106|FG003|Overall Study|Randomized but Not Treated|1|||
157117675|NCT01783678|567184107|FG004|Overall Study|Randomized but Not Treated|0|||
157117676|NCT01783678|567184108|FG005|Overall Study|Randomized but Not Treated|0|||
157117677|NCT01783678|567184103|FG000|Overall Study|Lack of Efficacy|1|||
157211354|NCT01222715|567521234|FG000|Overall Study|Physician Decision|12|||
157211355|NCT01222715|567521235|FG001|Overall Study|Physician Decision|2|||
157211356|NCT01222715|567521234|FG000|Overall Study|Refusal of further protocol therapy|0|||
157211357|NCT01222715|567521235|FG001|Overall Study|Refusal of further protocol therapy|4|||
157211358|NCT01222715|567521234|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
157211359|NCT01222715|567521235|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
157211360|NCT01222715|567521234|FG000|Overall Study|Ineligible|0|||
157211361|NCT01222715|567521235|FG001|Overall Study|Ineligible|1|||
157211362|NCT01222715|567521234|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
157211363|NCT01222715|567521235|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
157211364|NCT03836729|567521236|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
157211365|NCT00948025|567521237|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
157211366|NCT00948025|567521238|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
157211367|NCT00948025|567521237|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
157211368|NCT00948025|567521238|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
157211369|NCT00948025|567521237|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
157211370|NCT00948025|567521238|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
157211371|NCT02239601|567521241|FG000|Overall Study|Withdrawal by Subject|3|||
157211372|NCT02239601|567521242|FG001|Overall Study|Withdrawal by Subject|4|||
157211373|NCT02239601|567521241|FG000|Overall Study|Protocol Violation|4|||
157211374|NCT02239601|567521242|FG001|Overall Study|Protocol Violation|2|||
157211375|NCT01383954|567521243|FG000|Overall Study|Lack of Efficacy|2|||
157211376|NCT01383954|567521243|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
157211377|NCT01383954|567521243|FG000|Overall Study|Adverse Event|1|||
157211378|NCT01383954|567521243|FG000|Overall Study|Reason Not Specified|9|||
157211379|NCT01791127|567521247|FG000|Overall Study|Death|356|||
157211380|NCT01791127|567521247|FG000|Overall Study|Patient has withdrawn from study|293|||
157211381|NCT01791127|567521247|FG000|Overall Study|Lost to Follow-up|42|||
157211382|NCT01791127|567521247|FG000|Overall Study|All Siello leads are explanted|31|||
157211383|NCT01791127|567521247|FG000|Overall Study|Completion of 30 day safety registry|1|||
157211384|NCT01791127|567521247|FG000|Overall Study|Study terminated for EP Passion|749|||
156866589|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
157117678|NCT01783678|567184104|FG001|Overall Study|Lack of Efficacy|13|||
157117679|NCT01783678|567184105|FG002|Overall Study|Lack of Efficacy|1|||
157211385|NCT01017029|567521251|FG000|Overall Study|Lost to Follow-up|1|||
157211386|NCT01017029|567521252|FG001|Overall Study|Lost to Follow-up|0|||
157211387|NCT01017029|567521251|FG000|Overall Study|Administrative problem|0|||
157211388|NCT01017029|567521252|FG001|Overall Study|Administrative problem|1|||
157211389|NCT01017029|567521251|FG000|Overall Study|Death|3|||
157211390|NCT01017029|567521252|FG001|Overall Study|Death|1|||
157211391|NCT02216214|567521253|FG000|Overall Study|Randomized Never Received Study Drug|1|||
157211392|NCT02216214|567521254|FG001|Overall Study|Randomized Never Received Study Drug|0|||
157211393|NCT02216214|567521253|FG000|Overall Study|Adverse Event|10|||
157211394|NCT02216214|567521254|FG001|Overall Study|Adverse Event|8|||
157211395|NCT02216214|567521253|FG000|Overall Study|Lack of Efficacy|2|||
157211396|NCT02216214|567521254|FG001|Overall Study|Lack of Efficacy|2|||
157211397|NCT02216214|567521253|FG000|Overall Study|Lost to Follow-up|3|||
157211398|NCT02216214|567521254|FG001|Overall Study|Lost to Follow-up|2|||
157211399|NCT02216214|567521253|FG000|Overall Study|Protocol Violation|4|||
157211400|NCT02216214|567521254|FG001|Overall Study|Protocol Violation|2|||
157211401|NCT02216214|567521253|FG000|Overall Study|Withdrawal by Subject|22|||
157211402|NCT02216214|567521254|FG001|Overall Study|Withdrawal by Subject|20|||
157211403|NCT02216214|567521253|FG000|Overall Study|Study Terminated By Sponsor|0|||
157211404|NCT02216214|567521254|FG001|Overall Study|Study Terminated By Sponsor|1|||
157211405|NCT02216214|567521253|FG000|Overall Study|Miscellaneous|1|||
157211406|NCT02216214|567521254|FG001|Overall Study|Miscellaneous|1|||
157211407|NCT05354206|567521255|FG000|Overall Study|Withdrawal by Subject|1|||
157211408|NCT05354206|567521256|FG001|Overall Study|Withdrawal by Subject|0|||
157211409|NCT00422058|567521257|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
157211410|NCT00422058|567521258|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
157211411|NCT00422058|567521259|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
157211412|NCT00422058|567521260|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
157211413|NCT00422058|567521261|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
157211414|NCT00422058|567521262|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
157211415|NCT00422058|567521257|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
157211416|NCT00422058|567521258|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
157211417|NCT00422058|567521259|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
157211418|NCT00422058|567521260|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
157211419|NCT00422058|567521261|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
157211420|NCT00422058|567521262|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
157211421|NCT00422058|567521257|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
157211422|NCT00422058|567521258|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
157211423|NCT00422058|567521259|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
157211424|NCT00422058|567521260|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
157211425|NCT00422058|567521261|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
157211426|NCT00422058|567521262|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
157011065|NCT03283371|566792044|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
157011066|NCT03283371|566792045|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
157211427|NCT00422058|567521257|FG000|Double-Blind, Week 0-20|Other|11|||
157011067|NCT03283371|566792046|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
157011068|NCT03283371|566792047|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
157211428|NCT00422058|567521258|FG001|Double-Blind, Week 0-20|Other|3|||
157211429|NCT00422058|567521259|FG002|Double-Blind, Week 0-20|Other|8|||
157211430|NCT00422058|567521260|FG003|Double-Blind, Week 0-20|Other|8|||
157117680|NCT01783678|567184106|FG003|Overall Study|Lack of Efficacy|3|||
157117681|NCT01783678|567184107|FG004|Overall Study|Lack of Efficacy|6|||
157117682|NCT01783678|567184108|FG005|Overall Study|Lack of Efficacy|5|||
157117683|NCT01783678|567184103|FG000|Overall Study|Lost to Follow-up|0|||
157117684|NCT01783678|567184104|FG001|Overall Study|Lost to Follow-up|4|||
157117685|NCT01783678|567184105|FG002|Overall Study|Lost to Follow-up|0|||
157117686|NCT01783678|567184106|FG003|Overall Study|Lost to Follow-up|2|||
157117687|NCT01783678|567184107|FG004|Overall Study|Lost to Follow-up|1|||
157117688|NCT01783678|567184108|FG005|Overall Study|Lost to Follow-up|0|||
157117689|NCT01783678|567184103|FG000|Overall Study|Withdrew Consent|1|||
157117690|NCT01783678|567184104|FG001|Overall Study|Withdrew Consent|1|||
157117691|NCT01783678|567184105|FG002|Overall Study|Withdrew Consent|0|||
156779787|NCT01078662|565943883|FG000|Overall Study|Patients reached data cut-off|12|||
156779788|NCT01078662|565943884|FG001|Overall Study|Patients reached data cut-off|53|||
157117692|NCT01783678|567184106|FG003|Overall Study|Withdrew Consent|2|||
157117693|NCT01783678|567184107|FG004|Overall Study|Withdrew Consent|0|||
157117694|NCT01783678|567184108|FG005|Overall Study|Withdrew Consent|0|||
157117695|NCT02404103|567184109|FG000|Overall Study|Adverse Event|1|||
157117696|NCT02404103|567184110|FG001|Overall Study|Adverse Event|0|||
157117697|NCT02404103|567184109|FG000|Overall Study|Lost to Follow-up|3|||
157117698|NCT02404103|567184110|FG001|Overall Study|Lost to Follow-up|3|||
157117699|NCT02543528|567184111|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
157117700|NCT02543528|567184112|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
157117701|NCT02543528|567184113|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
157117702|NCT02543528|567184114|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
157117703|NCT02543528|567184115|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
157117704|NCT02543528|567184111|FG000|Adaptation Period|Lens Handling Difficultes|0|||
157117705|NCT02543528|567184112|FG001|Adaptation Period|Lens Handling Difficultes|0|||
157117706|NCT02543528|567184113|FG002|Adaptation Period|Lens Handling Difficultes|0|||
157211431|NCT00422058|567521261|FG004|Double-Blind, Week 0-20|Other|4|||
157211432|NCT00422058|567521262|FG005|Double-Blind, Week 0-20|Other|10|||
157211433|NCT00422058|567521257|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
157211434|NCT00422058|567521258|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
157211435|NCT00422058|567521259|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
157211436|NCT00422058|567521260|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
157211437|NCT00422058|567521261|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
157211438|NCT00422058|567521262|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
157211439|NCT00422058|567521257|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
157211440|NCT00422058|567521258|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
157211441|NCT00422058|567521259|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
157211442|NCT00422058|567521260|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
157117707|NCT02543528|567184114|FG003|Adaptation Period|Lens Handling Difficultes|0|||
157117708|NCT02543528|567184115|FG004|Adaptation Period|Lens Handling Difficultes|8|||
157117709|NCT02543528|567184111|FG000|Adaptation Period|Lost to Follow-up|0|||
157117710|NCT02543528|567184112|FG001|Adaptation Period|Lost to Follow-up|0|||
157117711|NCT02543528|567184113|FG002|Adaptation Period|Lost to Follow-up|0|||
157117712|NCT02543528|567184114|FG003|Adaptation Period|Lost to Follow-up|0|||
157117713|NCT02543528|567184115|FG004|Adaptation Period|Lost to Follow-up|14|||
157117714|NCT02543528|567184111|FG000|Adaptation Period|Adverse Event|0|||
156779789|NCT01078662|565943885|FG002|Overall Study|Patients reached data cut-off|2|||
157117715|NCT02543528|567184112|FG001|Adaptation Period|Adverse Event|0|||
157117716|NCT02543528|567184113|FG002|Adaptation Period|Adverse Event|0|||
157117717|NCT02543528|567184114|FG003|Adaptation Period|Adverse Event|0|||
157011069|NCT03283371|566792044|FG000|Open-label Phase|Adverse Event|0|||
157011070|NCT03283371|566792045|FG001|Open-label Phase|Adverse Event|0|||
157011071|NCT03283371|566792046|FG002|Open-label Phase|Adverse Event|2|||
157011072|NCT03283371|566792047|FG003|Open-label Phase|Adverse Event|0|||
157011073|NCT03283371|566792044|FG000|Open-label Phase|Withdrawal by Subject|0|||
157011074|NCT03283371|566792045|FG001|Open-label Phase|Withdrawal by Subject|0|||
157011075|NCT03283371|566792046|FG002|Open-label Phase|Withdrawal by Subject|1|||
157011076|NCT03283371|566792047|FG003|Open-label Phase|Withdrawal by Subject|0|||
157011077|NCT03283371|566792044|FG000|Open-label Phase|Other|0|||
157011078|NCT03283371|566792045|FG001|Open-label Phase|Other|0|||
157011079|NCT03283371|566792046|FG002|Open-label Phase|Other|1|||
157011080|NCT03283371|566792047|FG003|Open-label Phase|Other|1|||
157011081|NCT02574455|566792048|FG000|Overall Study|Death|197|||
157011082|NCT02574455|566792049|FG001|Overall Study|Death|210|||
157011083|NCT02574455|566792048|FG000|Overall Study|Withdrawal of Consent|11|||
157011084|NCT02574455|566792049|FG001|Overall Study|Withdrawal of Consent|28|||
157211443|NCT00422058|567521261|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
157211444|NCT00422058|567521262|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
157211445|NCT00422058|567521257|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
157211446|NCT00422058|567521258|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
157211447|NCT00422058|567521259|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
157211448|NCT00422058|567521260|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
157211449|NCT00422058|567521261|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
157211450|NCT00422058|567521262|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
157211451|NCT00422058|567521257|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
157211452|NCT00422058|567521258|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
157211453|NCT00422058|567521259|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
157211454|NCT00422058|567521260|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
157211455|NCT00422058|567521261|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
157211456|NCT00422058|567521262|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
157211457|NCT00422058|567521257|FG000|Open-Label Extension, Week 20-104|Other|13|||
157211458|NCT00422058|567521258|FG001|Open-Label Extension, Week 20-104|Other|14|||
157211459|NCT00422058|567521259|FG002|Open-Label Extension, Week 20-104|Other|6|||
157211460|NCT00422058|567521260|FG003|Open-Label Extension, Week 20-104|Other|13|||
157211461|NCT00422058|567521261|FG004|Open-Label Extension, Week 20-104|Other|16|||
157211462|NCT00422058|567521262|FG005|Open-Label Extension, Week 20-104|Other|18|||
157211463|NCT00713830|567521263|FG000|Overall Study|Adverse Event|23|||
157211464|NCT00713830|567521264|FG001|Overall Study|Adverse Event|71|||
157211465|NCT00713830|567521263|FG000|Overall Study|Lack of Efficacy|24|||
157211466|NCT00713830|567521264|FG001|Overall Study|Lack of Efficacy|16|||
157211467|NCT00713830|567521263|FG000|Overall Study|Lost to Follow-up|2|||
157211468|NCT00713830|567521264|FG001|Overall Study|Lost to Follow-up|9|||
157211469|NCT00713830|567521263|FG000|Overall Study|Withdrawal by Subject|13|||
157211470|NCT00713830|567521264|FG001|Overall Study|Withdrawal by Subject|23|||
156779790|NCT01078662|565943886|FG003|Overall Study|Patients reached data cut-off|2|||
157011085|NCT02574455|566792048|FG000|Overall Study|Lost to Follow-up|4|||
157211471|NCT00713830|567521263|FG000|Overall Study|Poor Compliance to Protocol|7|||
157211472|NCT00713830|567521264|FG001|Overall Study|Poor Compliance to Protocol|14|||
157117718|NCT02543528|567184115|FG004|Adaptation Period|Adverse Event|2|||
157117719|NCT02543528|567184111|FG000|Extended Wear Period|Adverse Event|17|||
157117720|NCT02543528|567184112|FG001|Extended Wear Period|Adverse Event|11|||
157117721|NCT02543528|567184113|FG002|Extended Wear Period|Adverse Event|16|||
157117722|NCT02543528|567184114|FG003|Extended Wear Period|Adverse Event|3|||
157117723|NCT02543528|567184115|FG004|Extended Wear Period|Adverse Event|0|||
157145132|NCT03237845|567277997|FG001|Overall Study|Other Reasons|0|||
157211473|NCT00713830|567521263|FG000|Overall Study|Familial and Personal Reasons|9|||
157211474|NCT00713830|567521264|FG001|Overall Study|Familial and Personal Reasons|34|||
157011086|NCT02574455|566792049|FG001|Overall Study|Lost to Follow-up|4|||
157011087|NCT02574455|566792048|FG000|Overall Study|Sponsor's Decision|55|||
157011088|NCT02574455|566792049|FG001|Overall Study|Sponsor's Decision|20|||
157011089|NCT03144674|566792052|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
157011090|NCT03144674|566792053|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
157011091|NCT03144674|566792054|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
157011092|NCT03144674|566792055|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
157011093|NCT03144674|566792052|FG000|Overall Study|Death|3|||
157011094|NCT03144674|566792053|FG001|Overall Study|Death|2|||
157211475|NCT00713830|567521263|FG000|Overall Study|Sponsor Decision|4|||
157011095|NCT03144674|566792054|FG002|Overall Study|Death|6|||
157011096|NCT03144674|566792055|FG003|Overall Study|Death|24|||
157011097|NCT03144674|566792052|FG000|Overall Study|Lost to Follow-up|0|||
157011098|NCT03144674|566792053|FG001|Overall Study|Lost to Follow-up|1|||
157011099|NCT03144674|566792054|FG002|Overall Study|Lost to Follow-up|0|||
157011100|NCT03144674|566792055|FG003|Overall Study|Lost to Follow-up|4|||
157211476|NCT00713830|567521264|FG001|Overall Study|Sponsor Decision|10|||
157211477|NCT01850108|567521268|FG000|Overall Study|Lost to Follow-up|4|||
157211478|NCT01850108|567521268|FG000|Overall Study|Not eligible|1|||
157211479|NCT01850108|567521268|FG000|Overall Study|Failed engraftment|2|||
157211480|NCT01850108|567521268|FG000|Overall Study|Physician Decision|1|||
157211481|NCT03273712|567521277|FG000|Overall Study|Death|5|||
157211482|NCT03273712|567521277|FG000|Overall Study|Adverse Event|1|||
157211483|NCT03273712|567521277|FG000|Overall Study|Disease Progression|1|||
157211484|NCT00666718|567521279|FG000|Overall Study|Adverse Event|0|||
157211485|NCT00666718|567521280|FG001|Overall Study|Adverse Event|1|||
157211486|NCT00666718|567521279|FG000|Overall Study|Death|1|||
157211487|NCT00666718|567521280|FG001|Overall Study|Death|0|||
157211488|NCT00666718|567521279|FG000|Overall Study|Lost to Follow-up|1|||
157211489|NCT00666718|567521280|FG001|Overall Study|Lost to Follow-up|0|||
157211490|NCT00666718|567521279|FG000|Overall Study|Entry Criteria Not Met|2|||
157211491|NCT00666718|567521280|FG001|Overall Study|Entry Criteria Not Met|0|||
157211492|NCT00666718|567521279|FG000|Overall Study|Protocol Violation|1|||
157211493|NCT00666718|567521280|FG001|Overall Study|Protocol Violation|3|||
157211494|NCT00666718|567521279|FG000|Overall Study|Withdrawal by Subject|7|||
157211495|NCT00666718|567521280|FG001|Overall Study|Withdrawal by Subject|12|||
157211496|NCT00666718|567521279|FG000|Overall Study|Physician Decision|0|||
157211497|NCT00666718|567521280|FG001|Overall Study|Physician Decision|2|||
157211498|NCT00190684|567521287|FG000|Overall Study|Adverse Event|86|||
157211499|NCT00190684|567521287|FG000|Overall Study|Satisfactory response|80|||
157211500|NCT00190684|567521287|FG000|Overall Study|Lack of efficacy|204|||
157211501|NCT00190684|567521287|FG000|Overall Study|Lost to Follow-up|232|||
157211502|NCT00190684|567521287|FG000|Overall Study|Patient moved|60|||
157211503|NCT00190684|567521287|FG000|Overall Study|Patient Decision|432|||
157211504|NCT00190684|567521287|FG000|Overall Study|Clinical relapse|67|||
157211505|NCT00190684|567521287|FG000|Overall Study|Sponsor's decision|17|||
157211506|NCT00190684|567521287|FG000|Overall Study|Physician Decision|84|||
157211507|NCT00190684|567521287|FG000|Overall Study|Protocol Violation|123|||
157211508|NCT00190684|567521287|FG000|Overall Study|Study Period III Completed|103|||
157211509|NCT00190684|567521287|FG000|Overall Study|Study Period V Completed|1|||
157211510|NCT01542736|567521293|FG000|Overall Study|Death|1|||
157211511|NCT03674827|567521294|FG000|Treatment Phase|Adverse Event|0|||
157211512|NCT03674827|567521295|FG001|Treatment Phase|Adverse Event|0|||
157211513|NCT03674827|567521296|FG002|Treatment Phase|Adverse Event|0|||
157211514|NCT03674827|567521297|FG003|Treatment Phase|Adverse Event|0|||
157211515|NCT03674827|567521298|FG004|Treatment Phase|Adverse Event|0|||
157211516|NCT03674827|567521299|FG005|Treatment Phase|Adverse Event|2|||
157211517|NCT03674827|567521294|FG000|Treatment Phase|Death|2|||
157211518|NCT03674827|567521295|FG001|Treatment Phase|Death|0|||
157211519|NCT03674827|567521296|FG002|Treatment Phase|Death|0|||
157211520|NCT03674827|567521297|FG003|Treatment Phase|Death|0|||
157211521|NCT03674827|567521298|FG004|Treatment Phase|Death|1|||
157211522|NCT03674827|567521299|FG005|Treatment Phase|Death|0|||
157211523|NCT03674827|567521294|FG000|Treatment Phase|Progressive Disease|0|||
157211524|NCT03674827|567521295|FG001|Treatment Phase|Progressive Disease|4|||
157211525|NCT03674827|567521296|FG002|Treatment Phase|Progressive Disease|3|||
157211526|NCT03674827|567521297|FG003|Treatment Phase|Progressive Disease|4|||
157211527|NCT03674827|567521298|FG004|Treatment Phase|Progressive Disease|4|||
157211528|NCT03674827|567521299|FG005|Treatment Phase|Progressive Disease|9|||
157211529|NCT03674827|567521294|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
157211530|NCT03674827|567521295|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
157211531|NCT03674827|567521296|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
157211532|NCT03674827|567521297|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
157211533|NCT03674827|567521298|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
157211534|NCT03674827|567521299|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
157211535|NCT03674827|567521294|FG000|Treatment Phase|Withdrawal by Subject|0|||
157211536|NCT03674827|567521295|FG001|Treatment Phase|Withdrawal by Subject|0|||
157211537|NCT03674827|567521296|FG002|Treatment Phase|Withdrawal by Subject|0|||
157211538|NCT03674827|567521297|FG003|Treatment Phase|Withdrawal by Subject|0|||
157211539|NCT03674827|567521298|FG004|Treatment Phase|Withdrawal by Subject|0|||
157211540|NCT03674827|567521299|FG005|Treatment Phase|Withdrawal by Subject|1|||
157211541|NCT03674827|567521294|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
157211542|NCT03674827|567521295|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
157211543|NCT03674827|567521296|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
157211544|NCT03674827|567521297|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
157211545|NCT03674827|567521298|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
157211546|NCT03674827|567521299|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
157211547|NCT03674827|567521294|FG000|Treatment Phase|Other|0|||
157211548|NCT03674827|567521295|FG001|Treatment Phase|Other|1|||
157211549|NCT03674827|567521296|FG002|Treatment Phase|Other|0|||
157211550|NCT03674827|567521297|FG003|Treatment Phase|Other|0|||
157211551|NCT03674827|567521298|FG004|Treatment Phase|Other|0|||
157211552|NCT03674827|567521299|FG005|Treatment Phase|Other|1|||
157211553|NCT03674827|567521294|FG000|Long-Term Follow-up Phase|Death|2|||
157211554|NCT03674827|567521295|FG001|Long-Term Follow-up Phase|Death|4|||
157211555|NCT03674827|567521296|FG002|Long-Term Follow-up Phase|Death|2|||
157211556|NCT03674827|567521297|FG003|Long-Term Follow-up Phase|Death|3|||
157211557|NCT03674827|567521298|FG004|Long-Term Follow-up Phase|Death|2|||
157211558|NCT03674827|567521299|FG005|Long-Term Follow-up Phase|Death|6|||
157211559|NCT03674827|567521294|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
157211560|NCT03674827|567521295|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
157211561|NCT03674827|567521296|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
157211562|NCT03674827|567521297|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
157211563|NCT03674827|567521298|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
157211564|NCT03674827|567521299|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
157211565|NCT03674827|567521294|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
157211566|NCT03674827|567521295|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
157211567|NCT03674827|567521296|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
157211568|NCT03674827|567521297|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
157211569|NCT03674827|567521298|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
157211570|NCT03674827|567521299|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
157211571|NCT04529096|567521305|FG000|Overall Study|Adverse Event|6|||
157211572|NCT04529096|567521306|FG001|Overall Study|Adverse Event|1|||
157211573|NCT04529096|567521305|FG000|Overall Study|Lack of Efficacy|1|||
157117724|NCT02543528|567184111|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
157117725|NCT02543528|567184112|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
157117726|NCT02543528|567184113|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
157117727|NCT02543528|567184114|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
157117728|NCT02543528|567184115|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
157117729|NCT02543528|567184111|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
157117730|NCT02543528|567184112|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
157117731|NCT02543528|567184113|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
157117732|NCT02543528|567184114|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
157117733|NCT02543528|567184115|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
157117734|NCT02543528|567184111|FG000|Extended Wear Period|Lost to Follow-up|0|||
157117735|NCT02543528|567184112|FG001|Extended Wear Period|Lost to Follow-up|1|||
157117736|NCT02543528|567184113|FG002|Extended Wear Period|Lost to Follow-up|2|||
157117737|NCT02543528|567184114|FG003|Extended Wear Period|Lost to Follow-up|1|||
157117738|NCT02543528|567184115|FG004|Extended Wear Period|Lost to Follow-up|0|||
157117739|NCT02543528|567184111|FG000|Extended Wear Period|Withdrawal by Subject|10|||
157117740|NCT02543528|567184112|FG001|Extended Wear Period|Withdrawal by Subject|9|||
157117741|NCT02543528|567184113|FG002|Extended Wear Period|Withdrawal by Subject|4|||
157117742|NCT02543528|567184114|FG003|Extended Wear Period|Withdrawal by Subject|5|||
157117743|NCT02543528|567184115|FG004|Extended Wear Period|Withdrawal by Subject|0|||
157117744|NCT01979523|567184119|FG000|Overall Study|Withdrawal by Subject|1|||
157117745|NCT01979523|567184120|FG001|Overall Study|Withdrawal by Subject|0|||
157117746|NCT03189446|567184122|FG000|Overall Study|Adverse Event|2|||
157117747|NCT03189446|567184122|FG000|Overall Study|Withdrawal by Subject|2|||
157117748|NCT03189446|567184122|FG000|Overall Study|Physician Decision|1|||
157117749|NCT05594173|567184123|FG000|Overall Study|Adverse Event|1|||
157117750|NCT05594173|567184123|FG000|Overall Study|COVID-19 Pandemic|2|||
157117751|NCT00883337|567184124|FG000|Core Treatment Period|Adverse Event|9|||
157117752|NCT00883337|567184125|FG001|Core Treatment Period|Adverse Event|12|||
157117753|NCT00883337|567184126|FG002|Core Treatment Period|Adverse Event|22|||
157117754|NCT00883337|567184124|FG000|Core Treatment Period|Lack of Efficacy|7|||
157117755|NCT00883337|567184125|FG001|Core Treatment Period|Lack of Efficacy|4|||
157117756|NCT00883337|567184126|FG002|Core Treatment Period|Lack of Efficacy|2|||
157117757|NCT00883337|567184124|FG000|Core Treatment Period|Lost to Follow-up|1|||
157117758|NCT00883337|567184125|FG001|Core Treatment Period|Lost to Follow-up|1|||
157211574|NCT04529096|567521306|FG001|Overall Study|Lack of Efficacy|0|||
157011101|NCT03144674|566792052|FG000|Overall Study|Withdrawal by Participant|0|||
157011102|NCT03144674|566792053|FG001|Overall Study|Withdrawal by Participant|0|||
157011103|NCT03144674|566792054|FG002|Overall Study|Withdrawal by Participant|2|||
157011104|NCT03144674|566792055|FG003|Overall Study|Withdrawal by Participant|6|||
157011105|NCT03144674|566792052|FG000|Overall Study|Discharged from the Trust|0|||
157011106|NCT03144674|566792053|FG001|Overall Study|Discharged from the Trust|0|||
157011107|NCT03144674|566792054|FG002|Overall Study|Discharged from the Trust|1|||
157011108|NCT03144674|566792055|FG003|Overall Study|Discharged from the Trust|0|||
157011109|NCT03144674|566792052|FG000|Overall Study|Exclusion Criteria Met|0|||
157011110|NCT03144674|566792053|FG001|Overall Study|Exclusion Criteria Met|0|||
157011111|NCT03144674|566792054|FG002|Overall Study|Exclusion Criteria Met|1|||
157211575|NCT04529096|567521305|FG000|Overall Study|Lost to Follow-up|1|||
157211576|NCT04529096|567521306|FG001|Overall Study|Lost to Follow-up|1|||
157211577|NCT04529096|567521305|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157211578|NCT04529096|567521306|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157211579|NCT04529096|567521305|FG000|Overall Study|Physician Decision|1|||
157211580|NCT04529096|567521306|FG001|Overall Study|Physician Decision|3|||
157211581|NCT04529096|567521305|FG000|Overall Study|Withdrawal by Subject|5|||
157211582|NCT04529096|567521306|FG001|Overall Study|Withdrawal by Subject|0|||
157211583|NCT04529499|567521307|FG000|Overall Study|Withdrawal by Subject|9|||
157211584|NCT04529499|567521308|FG001|Overall Study|Withdrawal by Subject|11|||
157211585|NCT04529499|567521307|FG000|Overall Study|Physician Decision|1|||
157211586|NCT04529499|567521308|FG001|Overall Study|Physician Decision|2|||
157211587|NCT04529499|567521307|FG000|Overall Study|Adverse Event|4|||
157211588|NCT04529499|567521308|FG001|Overall Study|Adverse Event|4|||
157211589|NCT04529499|567521307|FG000|Overall Study|Death|14|||
157211590|NCT04529499|567521308|FG001|Overall Study|Death|11|||
157211591|NCT04529499|567521307|FG000|Overall Study|Lost to Follow-up|1|||
157211592|NCT04529499|567521308|FG001|Overall Study|Lost to Follow-up|1|||
157211593|NCT04529499|567521307|FG000|Overall Study|Others|7|||
157211594|NCT04529499|567521308|FG001|Overall Study|Others|11|||
157211595|NCT00683904|567521309|FG000|Dose Level 1|Disease progression|2|||
157211596|NCT00683904|567521310|FG001|Dose Level 1|Disease progression|0|||
157211597|NCT00683904|567521309|FG000|Dose Level 1|Adverse Event|1|||
157211598|NCT00683904|567521310|FG001|Dose Level 1|Adverse Event|0|||
157211599|NCT00683904|567521309|FG000|Dose Level 2|Adverse Event|0|||
157211600|NCT00683904|567521310|FG001|Dose Level 2|Adverse Event|2|||
157211601|NCT02702271|567521311|FG000|Overall Study|Death|36|||
157211602|NCT02702271|567521312|FG001|Overall Study|Death|7|||
157211603|NCT02702271|567521311|FG000|Overall Study|Lost to Follow-up|12|||
157117759|NCT00883337|567184126|FG002|Core Treatment Period|Lost to Follow-up|0|||
157117760|NCT00883337|567184124|FG000|Core Treatment Period|Withdrawal by Subject|2|||
157117761|NCT00883337|567184125|FG001|Core Treatment Period|Withdrawal by Subject|2|||
157117762|NCT00883337|567184126|FG002|Core Treatment Period|Withdrawal by Subject|6|||
157117763|NCT00883337|567184124|FG000|Core Treatment Period|Wish to be pregnant|1|||
157117764|NCT00883337|567184125|FG001|Core Treatment Period|Wish to be pregnant|2|||
157117765|NCT00883337|567184126|FG002|Core Treatment Period|Wish to be pregnant|1|||
157117766|NCT00883337|567184124|FG000|Core Treatment Period|Poor compliance to protocol|0|||
157117767|NCT00883337|567184125|FG001|Core Treatment Period|Poor compliance to protocol|0|||
157117768|NCT00883337|567184126|FG002|Core Treatment Period|Poor compliance to protocol|1|||
157117769|NCT00883337|567184124|FG000|Core Treatment Period|Other than above|0|||
157117770|NCT00883337|567184125|FG001|Core Treatment Period|Other than above|1|||
157117771|NCT00883337|567184126|FG002|Core Treatment Period|Other than above|1|||
157117772|NCT00883337|567184124|FG000|Extension Treatment Period|Adverse Event|8|||
157117773|NCT00883337|567184125|FG001|Extension Treatment Period|Adverse Event|5|||
157117774|NCT00883337|567184126|FG002|Extension Treatment Period|Adverse Event|5|||
157117775|NCT00883337|567184124|FG000|Extension Treatment Period|Lack of Efficacy|8|||
157117776|NCT00883337|567184125|FG001|Extension Treatment Period|Lack of Efficacy|8|||
157117777|NCT00883337|567184126|FG002|Extension Treatment Period|Lack of Efficacy|8|||
157117778|NCT00883337|567184124|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
157117779|NCT00883337|567184125|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
157117780|NCT00883337|567184126|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
157117781|NCT00883337|567184124|FG000|Extension Treatment Period|Lost to Follow-up|1|||
157117782|NCT00883337|567184125|FG001|Extension Treatment Period|Lost to Follow-up|0|||
157117783|NCT00883337|567184126|FG002|Extension Treatment Period|Lost to Follow-up|0|||
157211604|NCT02702271|567521312|FG001|Overall Study|Lost to Follow-up|0|||
157117784|NCT00883337|567184124|FG000|Extension Treatment Period|Other than above|10|||
157117785|NCT00883337|567184125|FG001|Extension Treatment Period|Other than above|9|||
157117786|NCT00883337|567184126|FG002|Extension Treatment Period|Other than above|5|||
157211605|NCT02702271|567521311|FG000|Overall Study|Withdrawal by Subject|8|||
157211606|NCT02702271|567521312|FG001|Overall Study|Withdrawal by Subject|1|||
157211607|NCT02702271|567521311|FG000|Overall Study|Physician Decision|2|||
157211608|NCT02702271|567521312|FG001|Overall Study|Physician Decision|0|||
157211609|NCT02702271|567521311|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
157117787|NCT00763139|567184127|FG000|Overall Study|Adverse Event|4|||
157117788|NCT00763139|567184128|FG001|Overall Study|Adverse Event|2|||
157211610|NCT02702271|567521312|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
157117789|NCT00763139|567184127|FG000|Overall Study|Withdrawal by Subject|0|||
157211611|NCT01494649|567521313|FG000|Overall Study|Lost to Follow-up|0|||
157211612|NCT01494649|567521314|FG001|Overall Study|Lost to Follow-up|1|||
157211613|NCT03091400|567521315|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
157211614|NCT03091400|567521316|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
157211615|NCT03467971|567521317|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157211616|NCT03467971|567521318|FG001|Treatment Period 2|Withdrawal by Subject|1|||
157211617|NCT00975884|567521319|FG000|Overall Study|Adverse Event|1|||
157211618|NCT00975884|567521320|FG001|Overall Study|Adverse Event|0|||
157211619|NCT00975884|567521319|FG000|Overall Study|Lost to Follow-up|5|||
157211620|NCT00975884|567521320|FG001|Overall Study|Lost to Follow-up|3|||
157211621|NCT00975884|567521319|FG000|Overall Study|Withdrawal by Subject|9|||
157211622|NCT00975884|567521320|FG001|Overall Study|Withdrawal by Subject|9|||
157211623|NCT00975884|567521319|FG000|Overall Study|Other|1|||
157211624|NCT00975884|567521320|FG001|Overall Study|Other|3|||
157211625|NCT00363129|567521323|FG000|Overall Study|Withdrawal by Subject|11|||
157211626|NCT00363129|567521324|FG001|Overall Study|Withdrawal by Subject|18|||
157211627|NCT00363129|567521323|FG000|Overall Study|Adverse Event|8|||
157211628|NCT00363129|567521324|FG001|Overall Study|Adverse Event|3|||
157211629|NCT00363129|567521323|FG000|Overall Study|Alternate Treatment|2|||
157211630|NCT00363129|567521324|FG001|Overall Study|Alternate Treatment|4|||
157211631|NCT00363129|567521323|FG000|Overall Study|Other Medical Problems|2|||
157211632|NCT00363129|567521324|FG001|Overall Study|Other Medical Problems|4|||
157211633|NCT00363129|567521323|FG000|Overall Study|Death|0|||
157211634|NCT00363129|567521324|FG001|Overall Study|Death|1|||
157211635|NCT00363129|567521323|FG000|Overall Study|Other Reasons|6|||
157211636|NCT00363129|567521324|FG001|Overall Study|Other Reasons|3|||
157211637|NCT05166512|567521325|FG000|Randomized|Lost to Follow-up|2|||
157211638|NCT05166512|567521326|FG001|Randomized|Lost to Follow-up|0|||
157211639|NCT05166512|567521325|FG000|Randomized|Withdrawal by Subject|1|||
157211640|NCT05166512|567521326|FG001|Randomized|Withdrawal by Subject|0|||
157211641|NCT05166512|567521325|FG000|Baseline Data Collection|Lost to Follow-up|0|||
157211642|NCT05166512|567521326|FG001|Baseline Data Collection|Lost to Follow-up|3|||
157211643|NCT05166512|567521325|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
157211644|NCT05166512|567521326|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
157211645|NCT05166512|567521325|FG000|Baseline Data Collection|Protocol Violation|2|||
157211646|NCT05166512|567521326|FG001|Baseline Data Collection|Protocol Violation|0|||
157211647|NCT05166512|567521325|FG000|4 Month Data Collection|Lost to Follow-up|1|||
157211648|NCT05166512|567521326|FG001|4 Month Data Collection|Lost to Follow-up|0|||
157211649|NCT05166512|567521325|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
157211650|NCT05166512|567521326|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
157211651|NCT05166512|567521325|FG000|12 Month Data Collection|Lost to Follow-up|3|||
157211652|NCT05166512|567521326|FG001|12 Month Data Collection|Lost to Follow-up|1|||
157211653|NCT05166512|567521325|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
157211654|NCT05166512|567521326|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
157211655|NCT00420849|567521327|FG000|Overall Study|Lack of Efficacy|154|||
157211656|NCT00420849|567521327|FG000|Overall Study|Adverse Event|107|||
157011112|NCT03144674|566792055|FG003|Overall Study|Exclusion Criteria Met|0|||
157011113|NCT03144674|566792052|FG000|Overall Study|Changed Physicians|0|||
157011114|NCT03144674|566792053|FG001|Overall Study|Changed Physicians|0|||
157211657|NCT00420849|567521327|FG000|Overall Study|Withdrawal by Subject|28|||
157211658|NCT00420849|567521327|FG000|Overall Study|Death|18|||
157211659|NCT00420849|567521327|FG000|Overall Study|Other|14|||
157211660|NCT00420849|567521327|FG000|Overall Study|Transplant|8|||
157211661|NCT00420849|567521327|FG000|Overall Study|Protocol Violation|1|||
157211662|NCT00420849|567521327|FG000|Overall Study|Lost to Follow-up|1|||
157211663|NCT05789420|567521328|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
157211664|NCT05789420|567521328|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
157211665|NCT02278952|567521329|FG000|Overall Study|Insufficient Sample|6|||
157211666|NCT00659581|567521330|FG000|Overall Study|Adverse Event|1006|||
157211667|NCT00659581|567521330|FG000|Overall Study|Lack of Efficacy|1183|||
157211668|NCT00659581|567521330|FG000|Overall Study|Other|6393|||
157211669|NCT00446134|567521331|FG000|Overall Study|Adverse Event|7|||
157211670|NCT00446134|567521332|FG001|Overall Study|Adverse Event|17|||
157117790|NCT00763139|567184128|FG001|Overall Study|Withdrawal by Subject|1|||
157117791|NCT00763139|567184127|FG000|Overall Study|med change not allowed by protocol|1|||
157117792|NCT00763139|567184128|FG001|Overall Study|med change not allowed by protocol|0|||
157117793|NCT03468309|567184129|FG000|Overall Study|Lost to Follow-up|4|||
157117794|NCT03468309|567184129|FG000|Overall Study|Withdrawal by Subject|2|||
157117795|NCT00713700|567184130|FG000|Overall Study|Lost to Follow-up|3|||
157117796|NCT00713700|567184130|FG000|Overall Study|Withdrawal by Subject|1|||
157117797|NCT02669017|567184131|FG000|Overall Study|Death|1|||
157117798|NCT02669017|567184132|FG001|Overall Study|Death|2|||
157117799|NCT02669017|567184133|FG002|Overall Study|Death|2|||
157117800|NCT02669017|567184134|FG003|Overall Study|Death|3|||
157117801|NCT02669017|567184135|FG004|Overall Study|Death|8|||
157117802|NCT02669017|567184136|FG005|Overall Study|Death|18|||
157117803|NCT02669017|567184137|FG006|Overall Study|Death|10|||
157117804|NCT02669017|567184138|FG007|Overall Study|Death|47|||
157117805|NCT02669017|567184139|FG008|Overall Study|Death|20|||
157117806|NCT02669017|567184131|FG000|Overall Study|Withdrawal by Subject|0|||
157117807|NCT02669017|567184132|FG001|Overall Study|Withdrawal by Subject|0|||
157117808|NCT02669017|567184133|FG002|Overall Study|Withdrawal by Subject|0|||
157117809|NCT02669017|567184134|FG003|Overall Study|Withdrawal by Subject|1|||
157117810|NCT02669017|567184135|FG004|Overall Study|Withdrawal by Subject|2|||
157117811|NCT02669017|567184136|FG005|Overall Study|Withdrawal by Subject|0|||
157117812|NCT02669017|567184137|FG006|Overall Study|Withdrawal by Subject|0|||
157117813|NCT02669017|567184138|FG007|Overall Study|Withdrawal by Subject|2|||
157117814|NCT02669017|567184139|FG008|Overall Study|Withdrawal by Subject|2|||
157117815|NCT02669017|567184131|FG000|Overall Study|Lost to Follow-up|0|||
157117816|NCT02669017|567184132|FG001|Overall Study|Lost to Follow-up|0|||
157117817|NCT02669017|567184133|FG002|Overall Study|Lost to Follow-up|0|||
157117818|NCT02669017|567184134|FG003|Overall Study|Lost to Follow-up|0|||
157117819|NCT02669017|567184135|FG004|Overall Study|Lost to Follow-up|0|||
157211671|NCT00446134|567521333|FG002|Overall Study|Adverse Event|13|||
157211672|NCT00446134|567521334|FG003|Overall Study|Adverse Event|18|||
157211673|NCT00446134|567521331|FG000|Overall Study|Lack of Efficacy|19|||
157211674|NCT00446134|567521332|FG001|Overall Study|Lack of Efficacy|19|||
157211675|NCT00446134|567521333|FG002|Overall Study|Lack of Efficacy|24|||
157211676|NCT00446134|567521334|FG003|Overall Study|Lack of Efficacy|19|||
157211677|NCT00446134|567521331|FG000|Overall Study|Protocol Violation|0|||
157211678|NCT00446134|567521332|FG001|Overall Study|Protocol Violation|2|||
157211679|NCT00446134|567521333|FG002|Overall Study|Protocol Violation|1|||
157211680|NCT00446134|567521334|FG003|Overall Study|Protocol Violation|0|||
157211681|NCT00446134|567521331|FG000|Overall Study|Lost to Follow-up|1|||
157211682|NCT00446134|567521332|FG001|Overall Study|Lost to Follow-up|3|||
157211683|NCT00446134|567521333|FG002|Overall Study|Lost to Follow-up|1|||
157211684|NCT00446134|567521334|FG003|Overall Study|Lost to Follow-up|1|||
157211685|NCT00446134|567521331|FG000|Overall Study|Withdrawal by Subject|3|||
157211686|NCT00446134|567521332|FG001|Overall Study|Withdrawal by Subject|3|||
157211687|NCT00446134|567521333|FG002|Overall Study|Withdrawal by Subject|1|||
157211688|NCT00446134|567521334|FG003|Overall Study|Withdrawal by Subject|3|||
157211689|NCT00446134|567521331|FG000|Overall Study|Physician Decision|0|||
157211690|NCT00446134|567521332|FG001|Overall Study|Physician Decision|0|||
157211691|NCT00446134|567521333|FG002|Overall Study|Physician Decision|0|||
157211692|NCT00446134|567521334|FG003|Overall Study|Physician Decision|2|||
157211693|NCT00446134|567521331|FG000|Overall Study|Adverse Event-Diarrhea|1|||
157211694|NCT00446134|567521332|FG001|Overall Study|Adverse Event-Diarrhea|1|||
157211695|NCT00446134|567521333|FG002|Overall Study|Adverse Event-Diarrhea|2|||
157211696|NCT00446134|567521334|FG003|Overall Study|Adverse Event-Diarrhea|0|||
157211697|NCT00446134|567521331|FG000|Overall Study|Reason Not Completed|3|||
157211698|NCT00446134|567521332|FG001|Overall Study|Reason Not Completed|0|||
157211699|NCT00446134|567521333|FG002|Overall Study|Reason Not Completed|1|||
157211700|NCT00446134|567521334|FG003|Overall Study|Reason Not Completed|2|||
157211701|NCT00743119|567521335|FG000|Overall Study|unreliable|3|||
157211702|NCT00743119|567521335|FG000|Overall Study|Withdrawal by Subject|1|||
157211703|NCT02989610|567521336|FG000|Overall Study|Withdrawal by Subject|20|||
157211704|NCT02989610|567521336|FG000|Overall Study|Departure of PI from Site|8|||
157211705|NCT02989610|567521336|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
157211706|NCT02989610|567521336|FG000|Overall Study|Lost to Follow-up|3|||
157211707|NCT02989610|567521336|FG000|Overall Study|Death|3|||
157211708|NCT02989610|567521336|FG000|Overall Study|System Explant|3|||
157211709|NCT02989610|567521336|FG000|Overall Study|Subject Non-Compliance|2|||
157211710|NCT02989610|567521336|FG000|Overall Study|System Revision|2|||
157211711|NCT02989610|567521336|FG000|Overall Study|PI Left, Study Closing|1|||
157211712|NCT02989610|567521336|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
157211713|NCT02989610|567521336|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
157211714|NCT01556165|567521340|FG000|Overall Study|Adverse Event|5|||
157211715|NCT01556165|567521341|FG001|Overall Study|Adverse Event|3|||
157211716|NCT01556165|567521340|FG000|Overall Study|Protocol Violation|0|||
157211717|NCT01556165|567521341|FG001|Overall Study|Protocol Violation|3|||
157211718|NCT01556165|567521340|FG000|Overall Study|Withdrawal of Consent|7|||
157211719|NCT01556165|567521341|FG001|Overall Study|Withdrawal of Consent|1|||
157211720|NCT02531698|567521344|FG000|Overall Study|Adverse Event|2|||
157211721|NCT02531698|567521345|FG001|Overall Study|Adverse Event|1|||
157211722|NCT02531698|567521344|FG000|Overall Study|Withdrawal by Subject|6|||
157211723|NCT02531698|567521345|FG001|Overall Study|Withdrawal by Subject|1|||
157211724|NCT02531698|567521344|FG000|Overall Study|Protocol Violation|2|||
157211725|NCT02531698|567521345|FG001|Overall Study|Protocol Violation|0|||
157211726|NCT02531698|567521344|FG000|Overall Study|Lost to Follow-up|1|||
157211727|NCT02531698|567521345|FG001|Overall Study|Lost to Follow-up|0|||
157211728|NCT01861717|567521346|FG000|Overall Study|Lost to Follow-up|1|||
157211729|NCT01861717|567521346|FG000|Overall Study|Withdrawal by Subject|1|||
157211730|NCT02395536|567521347|FG000|Overall Study|Lost to Follow-up|4|||
157211731|NCT02395536|567521348|FG001|Overall Study|Lost to Follow-up|4|||
157211732|NCT02395536|567521347|FG000|Overall Study|Death|2|||
157211733|NCT02395536|567521348|FG001|Overall Study|Death|0|||
157011115|NCT03144674|566792054|FG002|Overall Study|Changed Physicians|0|||
157011116|NCT03144674|566792055|FG003|Overall Study|Changed Physicians|1|||
157211734|NCT02395536|567521347|FG000|Overall Study|Physician Decision|4|||
157211735|NCT02395536|567521348|FG001|Overall Study|Physician Decision|6|||
157211736|NCT02395536|567521347|FG000|Overall Study|Withdrawal by Subject|9|||
157211737|NCT02395536|567521348|FG001|Overall Study|Withdrawal by Subject|17|||
157211738|NCT02395536|567521347|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
157211739|NCT02395536|567521348|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
157211740|NCT02395536|567521347|FG000|Overall Study|Insurance issue|0|||
157211741|NCT02395536|567521348|FG001|Overall Study|Insurance issue|1|||
157211742|NCT00701558|567521349|FG000|Overall Study|Death|7|||
157211743|NCT00701558|567521349|FG000|Overall Study|Lost to Follow-up|8|||
157211744|NCT02499406|567523271|FG000|Overall Study|missed 3 treatment sessions|4|||
157211745|NCT03591107|567523275|FG000|Overall Study|Same patient in both arms|1|||
157211746|NCT03591107|567523276|FG001|Overall Study|Same patient in both arms|1|||
157211747|NCT03591107|567523275|FG000|Overall Study|Sought care at other clinics|0|||
157211748|NCT03591107|567523276|FG001|Overall Study|Sought care at other clinics|2|||
157211749|NCT03591107|567523275|FG000|Overall Study|Discharged from clinic|0|||
157211750|NCT03591107|567523276|FG001|Overall Study|Discharged from clinic|1|||
157211751|NCT03591107|567523275|FG000|Overall Study|Withdrawal by Subject|0|||
157211752|NCT03591107|567523276|FG001|Overall Study|Withdrawal by Subject|1|||
157211753|NCT00350519|567523279|FG000|Overall Study|Death|0|||
157211754|NCT00350519|567523280|FG001|Overall Study|Death|1|||
157211755|NCT00350519|567523279|FG000|Overall Study|Physician Decision|0|||
157211756|NCT00350519|567523280|FG001|Overall Study|Physician Decision|1|||
157211757|NCT00350519|567523279|FG000|Overall Study|Protocol Violation|1|||
157211758|NCT00350519|567523280|FG001|Overall Study|Protocol Violation|2|||
157211759|NCT00350519|567523279|FG000|Overall Study|Withdrawal by Subject|3|||
157211760|NCT00350519|567523280|FG001|Overall Study|Withdrawal by Subject|2|||
157211761|NCT00736099|567523282|FG000|Overall Study|Adverse Event|61|||
157211762|NCT00736099|567523283|FG001|Overall Study|Adverse Event|18|||
157211763|NCT00736099|567523282|FG000|Overall Study|Protocol Violation|10|||
157211764|NCT00736099|567523283|FG001|Overall Study|Protocol Violation|4|||
157211765|NCT00736099|567523282|FG000|Overall Study|Lost to Follow-up|12|||
157211766|NCT00736099|567523283|FG001|Overall Study|Lost to Follow-up|5|||
157211767|NCT00736099|567523282|FG000|Overall Study|Withdrawal by Subject|42|||
157211768|NCT00736099|567523283|FG001|Overall Study|Withdrawal by Subject|13|||
157211769|NCT00736099|567523282|FG000|Overall Study|Lack of Efficacy|15|||
157211770|NCT00736099|567523283|FG001|Overall Study|Lack of Efficacy|8|||
157211771|NCT00736099|567523282|FG000|Overall Study|Other reason|43|||
157211772|NCT00736099|567523283|FG001|Overall Study|Other reason|10|||
157211773|NCT04006847|567523286|FG000|Overall Study|Product issue|1|||
157211774|NCT03555890|567523294|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157211775|NCT03555890|567523295|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157211776|NCT03555890|567523296|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157211777|NCT03555890|567523297|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
157211778|NCT03372369|567523298|FG000|Qualification Period|Withdrawal by Subject|16|||
157211779|NCT03372369|567523299|FG001|Qualification Period|Withdrawal by Subject|13|||
157211780|NCT03372369|567523298|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
157211781|NCT03372369|567523299|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
157211782|NCT03372369|567523298|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
157211783|NCT03372369|567523299|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
157211784|NCT00763269|567523300|FG000|Overall Study|Lost to Follow-up|12|||
157211785|NCT00763269|567523301|FG001|Overall Study|Lost to Follow-up|13|||
157211786|NCT00707174|567523312|FG000|Overall Study|Adverse Event|1|||
157211787|NCT00707174|567523313|FG001|Overall Study|Adverse Event|6|||
157211788|NCT00707174|567523312|FG000|Overall Study|Withdrawal by Subject|4|||
157211789|NCT00707174|567523313|FG001|Overall Study|Withdrawal by Subject|1|||
157211790|NCT00544557|567523314|FG000|Overall Study|Adverse Event|140|||
157211791|NCT00544557|567523314|FG000|Overall Study|Lack of Efficacy|196|||
157211792|NCT00544557|567523314|FG000|Overall Study|Other|98|||
157211793|NCT01020305|567523317|FG000|Overall Study|Adverse Event|2|||
157211794|NCT00467818|567523318|FG000|Overall Study|Adverse Event|1|||
157211795|NCT00467818|567523319|FG001|Overall Study|Adverse Event|0|||
157211796|NCT00467818|567523318|FG000|Overall Study|Lost to Follow-up|2|||
157211797|NCT00467818|567523319|FG001|Overall Study|Lost to Follow-up|2|||
157211798|NCT01830920|567523324|FG000|Overall Study|Adverse Event|1|||
157211799|NCT01830920|567523325|FG001|Overall Study|Adverse Event|0|||
157211800|NCT01830920|567523326|FG002|Overall Study|Adverse Event|1|||
157211801|NCT01830920|567523327|FG003|Overall Study|Adverse Event|0|||
157211802|NCT01830920|567523328|FG004|Overall Study|Adverse Event|0|||
157211803|NCT01830920|567523324|FG000|Overall Study|Withdrawal by Subject|2|||
157211804|NCT01830920|567523325|FG001|Overall Study|Withdrawal by Subject|2|||
157211805|NCT01830920|567523326|FG002|Overall Study|Withdrawal by Subject|1|||
157211806|NCT01830920|567523327|FG003|Overall Study|Withdrawal by Subject|7|||
157211807|NCT01830920|567523328|FG004|Overall Study|Withdrawal by Subject|1|||
157211808|NCT01830920|567523324|FG000|Overall Study|Death|3|||
157211809|NCT01830920|567523325|FG001|Overall Study|Death|3|||
157211810|NCT01830920|567523326|FG002|Overall Study|Death|5|||
157211811|NCT01830920|567523327|FG003|Overall Study|Death|4|||
157211812|NCT01830920|567523328|FG004|Overall Study|Death|4|||
157211813|NCT01830920|567523324|FG000|Overall Study|Other|15|||
157211814|NCT01830920|567523325|FG001|Overall Study|Other|1|||
157211815|NCT01830920|567523326|FG002|Overall Study|Other|1|||
157211816|NCT01830920|567523327|FG003|Overall Study|Other|5|||
157211817|NCT01830920|567523328|FG004|Overall Study|Other|3|||
157211818|NCT01313728|567523329|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
157211819|NCT04936334|567523331|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
157211820|NCT04057118|567523334|FG000|Overall Study|Adverse Event|1|||
157211821|NCT04057118|567523335|FG001|Overall Study|Adverse Event|0|||
157211822|NCT04057118|567523336|FG002|Overall Study|Adverse Event|1|||
157211823|NCT04057118|567523337|FG003|Overall Study|Adverse Event|1|||
157211824|NCT04057118|567523334|FG000|Overall Study|Physician Decision|0|||
157211825|NCT04057118|567523335|FG001|Overall Study|Physician Decision|0|||
157211826|NCT04057118|567523336|FG002|Overall Study|Physician Decision|1|||
157211827|NCT04057118|567523337|FG003|Overall Study|Physician Decision|1|||
157211828|NCT04057118|567523334|FG000|Overall Study|Withdrawal by Subject|2|||
157211829|NCT04057118|567523335|FG001|Overall Study|Withdrawal by Subject|2|||
157211830|NCT04057118|567523336|FG002|Overall Study|Withdrawal by Subject|0|||
157011117|NCT03144674|566792052|FG000|Overall Study|Removed for Safety|0|||
157011118|NCT03144674|566792053|FG001|Overall Study|Removed for Safety|0|||
157011119|NCT03144674|566792054|FG002|Overall Study|Removed for Safety|0|||
157011120|NCT03144674|566792055|FG003|Overall Study|Removed for Safety|1|||
157011121|NCT03144674|566792052|FG000|Overall Study|Site Closed|0|||
157011122|NCT03144674|566792053|FG001|Overall Study|Site Closed|0|||
157011123|NCT03144674|566792054|FG002|Overall Study|Site Closed|0|||
157011124|NCT03144674|566792055|FG003|Overall Study|Site Closed|1|||
157011125|NCT03144674|566792052|FG000|Overall Study|Histological Criteria Not Met|0|||
157011126|NCT03144674|566792053|FG001|Overall Study|Histological Criteria Not Met|0|||
157011127|NCT03144674|566792054|FG002|Overall Study|Histological Criteria Not Met|0|||
157011128|NCT03144674|566792055|FG003|Overall Study|Histological Criteria Not Met|1|||
157011129|NCT03144674|566792052|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
157011130|NCT03144674|566792053|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
157011131|NCT03144674|566792054|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
157011132|NCT03144674|566792055|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
157011133|NCT03144674|566792052|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
157011134|NCT03144674|566792053|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
157011135|NCT03144674|566792054|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
157011136|NCT03144674|566792055|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
157011137|NCT03960463|566793372|FG000|Overall Study|Withdrawal by Subject|2|||
157011138|NCT03960463|566793373|FG001|Overall Study|Withdrawal by Subject|0|||
157011139|NCT03422276|566793374|FG000|Overall Study|Withdrawal by Subject|21|||
157011140|NCT03422276|566793375|FG001|Overall Study|Withdrawal by Subject|25|||
157011141|NCT03422276|566793376|FG002|Overall Study|Withdrawal by Subject|14|||
157011142|NCT03422276|566793377|FG003|Overall Study|Withdrawal by Subject|16|||
157011143|NCT03422276|566793374|FG000|Overall Study|Death|14|||
157011144|NCT03422276|566793375|FG001|Overall Study|Death|21|||
157011145|NCT03422276|566793376|FG002|Overall Study|Death|3|||
157011146|NCT03422276|566793377|FG003|Overall Study|Death|1|||
157011147|NCT03422276|566793374|FG000|Overall Study|Discontinued, ineligible|4|||
157011148|NCT03422276|566793375|FG001|Overall Study|Discontinued, ineligible|3|||
157011149|NCT03422276|566793376|FG002|Overall Study|Discontinued, ineligible|0|||
157011150|NCT03422276|566793377|FG003|Overall Study|Discontinued, ineligible|0|||
157011151|NCT03422276|566793374|FG000|Overall Study|Lost to Follow-up|15|||
157011152|NCT03422276|566793375|FG001|Overall Study|Lost to Follow-up|8|||
157011153|NCT03422276|566793376|FG002|Overall Study|Lost to Follow-up|13|||
157011154|NCT03422276|566793377|FG003|Overall Study|Lost to Follow-up|4|||
157011155|NCT03422276|566793374|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
157011156|NCT03422276|566793375|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
157011157|NCT03422276|566793376|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
157011158|NCT03422276|566793377|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
157011159|NCT03422276|566793374|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
157011160|NCT03422276|566793375|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
157011161|NCT03422276|566793376|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
157011162|NCT03422276|566793377|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
157011163|NCT03422276|566793374|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
157011164|NCT03422276|566793375|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
157011165|NCT03422276|566793376|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
157011166|NCT03422276|566793377|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
157011167|NCT03422276|566793374|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
157011168|NCT03422276|566793375|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
157011169|NCT03422276|566793376|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
157011170|NCT03422276|566793377|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
157011171|NCT03422276|566793374|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
157211831|NCT04057118|567523337|FG003|Overall Study|Withdrawal by Subject|2|||
157211832|NCT04057118|567523334|FG000|Overall Study|Not Specific|0|||
157211833|NCT04057118|567523335|FG001|Overall Study|Not Specific|0|||
157211834|NCT04057118|567523336|FG002|Overall Study|Not Specific|1|||
157117820|NCT02669017|567184136|FG005|Overall Study|Lost to Follow-up|0|||
157117821|NCT02669017|567184137|FG006|Overall Study|Lost to Follow-up|0|||
157117822|NCT02669017|567184138|FG007|Overall Study|Lost to Follow-up|0|||
157117823|NCT02669017|567184139|FG008|Overall Study|Lost to Follow-up|1|||
157117824|NCT02669017|567184131|FG000|Overall Study|Miscellaneous|0|||
157117825|NCT02669017|567184132|FG001|Overall Study|Miscellaneous|0|||
157211835|NCT04057118|567523337|FG003|Overall Study|Not Specific|1|||
157211836|NCT02787785|567523338|FG000|Overall Study|Death|3|||
157211837|NCT02787785|567523339|FG001|Overall Study|Death|4|||
157211838|NCT02787785|567523338|FG000|Overall Study|Lost to Follow-up|1|||
157211839|NCT02787785|567523339|FG001|Overall Study|Lost to Follow-up|1|||
157211840|NCT02787785|567523338|FG000|Overall Study|Withdrawal by Subject|0|||
157211841|NCT02787785|567523339|FG001|Overall Study|Withdrawal by Subject|5|||
157211842|NCT00572156|567523349|FG000|Overall Study|Adverse Event|3|||
157211843|NCT00572156|567523350|FG001|Overall Study|Adverse Event|1|||
157211844|NCT00572156|567523351|FG002|Overall Study|Adverse Event|5|||
157211845|NCT00572156|567523352|FG003|Overall Study|Adverse Event|1|||
157117826|NCT02669017|567184133|FG002|Overall Study|Miscellaneous|0|||
157117827|NCT02669017|567184134|FG003|Overall Study|Miscellaneous|0|||
157117828|NCT02669017|567184135|FG004|Overall Study|Miscellaneous|2|||
157117829|NCT02669017|567184136|FG005|Overall Study|Miscellaneous|1|||
157117830|NCT02669017|567184137|FG006|Overall Study|Miscellaneous|1|||
157211846|NCT00572156|567523349|FG000|Overall Study|Lost to Follow-up|1|||
157211847|NCT00572156|567523350|FG001|Overall Study|Lost to Follow-up|1|||
157211848|NCT00572156|567523351|FG002|Overall Study|Lost to Follow-up|1|||
157211849|NCT00572156|567523352|FG003|Overall Study|Lost to Follow-up|0|||
157211850|NCT00572156|567523349|FG000|Overall Study|Protocol Violation|1|||
157211851|NCT00572156|567523350|FG001|Overall Study|Protocol Violation|2|||
157211852|NCT00572156|567523351|FG002|Overall Study|Protocol Violation|0|||
157211853|NCT00572156|567523352|FG003|Overall Study|Protocol Violation|2|||
157211854|NCT00572156|567523349|FG000|Overall Study|Patient/Parent Decision|1|||
157211855|NCT00572156|567523350|FG001|Overall Study|Patient/Parent Decision|6|||
157211856|NCT00572156|567523351|FG002|Overall Study|Patient/Parent Decision|4|||
157211857|NCT00572156|567523352|FG003|Overall Study|Patient/Parent Decision|3|||
157211858|NCT00572156|567523349|FG000|Overall Study|Sponsor Decision|20|||
157211859|NCT00572156|567523350|FG001|Overall Study|Sponsor Decision|16|||
157211860|NCT00572156|567523351|FG002|Overall Study|Sponsor Decision|17|||
157211861|NCT00572156|567523352|FG003|Overall Study|Sponsor Decision|19|||
157211862|NCT02030834|567523353|FG000|Overall Study|Death|4|||
157211863|NCT02030834|567523354|FG001|Overall Study|Death|0|||
157211864|NCT02030834|567523355|FG002|Overall Study|Death|0|||
157211865|NCT02030834|567523353|FG000|Overall Study|Manufacturing failure|2|||
157211866|NCT02030834|567523354|FG001|Overall Study|Manufacturing failure|0|||
157211867|NCT02030834|567523355|FG002|Overall Study|Manufacturing failure|1|||
157211868|NCT02030834|567523353|FG000|Overall Study|Disease progression|2|||
157211869|NCT02030834|567523354|FG001|Overall Study|Disease progression|0|||
157211870|NCT02030834|567523355|FG002|Overall Study|Disease progression|2|||
157211871|NCT02030834|567523353|FG000|Overall Study|Lost to Follow-up|1|||
157211872|NCT02030834|567523354|FG001|Overall Study|Lost to Follow-up|0|||
157211873|NCT02030834|567523355|FG002|Overall Study|Lost to Follow-up|0|||
157211874|NCT02030834|567523353|FG000|Overall Study|Withdrawal by Subject|1|||
157211875|NCT02030834|567523354|FG001|Overall Study|Withdrawal by Subject|0|||
157211876|NCT02030834|567523355|FG002|Overall Study|Withdrawal by Subject|0|||
157211877|NCT02030834|567523353|FG000|Overall Study|Lack of funding|1|||
157211878|NCT02030834|567523354|FG001|Overall Study|Lack of funding|0|||
157211879|NCT02030834|567523355|FG002|Overall Study|Lack of funding|0|||
157211880|NCT01440595|567523356|FG000|Overall Study|Lost to Follow-up|0|||
157211881|NCT01440595|567523357|FG001|Overall Study|Lost to Follow-up|1|||
157211882|NCT01440595|567523358|FG002|Overall Study|Lost to Follow-up|0|||
157211883|NCT01440595|567523356|FG000|Overall Study|Study terminated by sponsor.|1|||
157211884|NCT01440595|567523357|FG001|Overall Study|Study terminated by sponsor.|2|||
157211885|NCT01440595|567523358|FG002|Overall Study|Study terminated by sponsor.|1|||
157211886|NCT01347879|567523359|FG000|Overall Study|Adverse Event|0|||
157211887|NCT01347879|567523360|FG001|Overall Study|Adverse Event|12|||
157211888|NCT01347879|567523359|FG000|Overall Study|Lost to Follow-up|2|||
157211889|NCT01347879|567523360|FG001|Overall Study|Lost to Follow-up|0|||
157117831|NCT02669017|567184138|FG007|Overall Study|Miscellaneous|13|||
157117832|NCT02669017|567184139|FG008|Overall Study|Miscellaneous|2|||
157117833|NCT00915681|567184144|FG000|Overall Study|Screening failures|46|||
157117834|NCT03221751|567184147|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
157117835|NCT03221751|567184148|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
157117836|NCT02559687|567184149|FG000|Overall Study|Death|112|||
157117837|NCT02559687|567184149|FG000|Overall Study|Sponsor Decision|5|||
157117838|NCT02559687|567184149|FG000|Overall Study|Withdrawal by Subject|4|||
157117839|NCT03245450|567184151|FG000|Overall Study|Radiological disease progression|3|||
157117840|NCT03245450|567184152|FG001|Overall Study|Radiological disease progression|3|||
157117841|NCT03245450|567184153|FG002|Overall Study|Radiological disease progression|2|||
157117842|NCT03245450|567184154|FG003|Overall Study|Radiological disease progression|2|||
157117843|NCT03245450|567184155|FG004|Overall Study|Radiological disease progression|7|||
157117844|NCT03245450|567184156|FG005|Overall Study|Radiological disease progression|6|||
157117845|NCT03245450|567184157|FG006|Overall Study|Radiological disease progression|6|||
157117846|NCT03245450|567184151|FG000|Overall Study|Clinical disease progression|0|||
157117847|NCT03245450|567184152|FG001|Overall Study|Clinical disease progression|0|||
157117848|NCT03245450|567184153|FG002|Overall Study|Clinical disease progression|1|||
157117849|NCT03245450|567184154|FG003|Overall Study|Clinical disease progression|0|||
157117850|NCT03245450|567184155|FG004|Overall Study|Clinical disease progression|0|||
157211890|NCT01347879|567523359|FG000|Overall Study|Withdrawal by Subject|3|||
157211891|NCT01347879|567523360|FG001|Overall Study|Withdrawal by Subject|2|||
157211892|NCT01347879|567523359|FG000|Overall Study|Other|2|||
157211893|NCT01347879|567523360|FG001|Overall Study|Other|3|||
157211894|NCT03216954|567523363|FG000|Overall Study|Adverse Event|0|||
157211895|NCT03216954|567523364|FG001|Overall Study|Adverse Event|0|||
157211896|NCT03216954|567523365|FG002|Overall Study|Adverse Event|1|||
157211897|NCT03216954|567523366|FG003|Overall Study|Adverse Event|0|||
157211898|NCT03216954|567523367|FG004|Overall Study|Adverse Event|1|||
157211899|NCT03216954|567523363|FG000|Overall Study|Withdrawal by Subject|2|||
157211900|NCT03216954|567523364|FG001|Overall Study|Withdrawal by Subject|0|||
157211901|NCT03216954|567523365|FG002|Overall Study|Withdrawal by Subject|0|||
157211902|NCT03216954|567523366|FG003|Overall Study|Withdrawal by Subject|0|||
157211903|NCT03216954|567523367|FG004|Overall Study|Withdrawal by Subject|0|||
157211904|NCT03216954|567523363|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
157211905|NCT03216954|567523364|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
157211906|NCT03216954|567523365|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
157211907|NCT03216954|567523366|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
157211908|NCT03216954|567523367|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
157211909|NCT00720304|567523370|FG000|Overall Study|Withdrawal by Subject|14|||
157211910|NCT00720304|567523371|FG001|Overall Study|Withdrawal by Subject|1|||
157211911|NCT00720304|567523370|FG000|Overall Study|Death|1|||
157211912|NCT00720304|567523371|FG001|Overall Study|Death|0|||
157211913|NCT00720304|567523370|FG000|Overall Study|Physician Decision|5|||
157211914|NCT00720304|567523371|FG001|Overall Study|Physician Decision|2|||
157211915|NCT00720304|567523370|FG000|Overall Study|Adverse Event|3|||
157117851|NCT03245450|567184156|FG005|Overall Study|Clinical disease progression|2|||
157117852|NCT03245450|567184157|FG006|Overall Study|Clinical disease progression|0|||
157117853|NCT03245450|567184151|FG000|Overall Study|Other|0|||
157117854|NCT03245450|567184152|FG001|Overall Study|Other|0|||
157117855|NCT03245450|567184153|FG002|Overall Study|Other|0|||
157117856|NCT03245450|567184154|FG003|Overall Study|Other|1|||
157211916|NCT00720304|567523371|FG001|Overall Study|Adverse Event|1|||
157211917|NCT00720304|567523370|FG000|Overall Study|Disease progression|6|||
157211918|NCT00720304|567523371|FG001|Overall Study|Disease progression|1|||
157211919|NCT04330482|567523374|FG000|Overall Study|Lost to Follow-up|2|||
157211920|NCT04330482|567523375|FG001|Overall Study|Lost to Follow-up|1|||
157211921|NCT04330482|567523374|FG000|Overall Study|Withdrawal by Subject|0|||
157211922|NCT04330482|567523375|FG001|Overall Study|Withdrawal by Subject|3|||
157117857|NCT03245450|567184155|FG004|Overall Study|Other|1|||
157117858|NCT03245450|567184156|FG005|Overall Study|Other|1|||
157117859|NCT03245450|567184157|FG006|Overall Study|Other|1|||
157211923|NCT04333199|567523376|FG000|Evaluated Patients|Lost to Follow-up|0|||
157211924|NCT04333199|567523377|FG001|Evaluated Patients|Lost to Follow-up|1|||
157211925|NCT04333199|567523378|FG002|Evaluated Patients|Lost to Follow-up|2|||
157211926|NCT02981602|567523380|FG000|Overall Study|Adverse Event|0|||
157211927|NCT02981602|567523381|FG001|Overall Study|Adverse Event|0|||
157211928|NCT02981602|567523382|FG002|Overall Study|Adverse Event|0|||
157211929|NCT02981602|567523383|FG003|Overall Study|Adverse Event|1|||
157211930|NCT02981602|567523384|FG004|Overall Study|Adverse Event|0|||
157211931|NCT00963599|567523385|FG000|Overall Study|Adverse Event|2|||
157211932|NCT00963599|567523386|FG001|Overall Study|Adverse Event|0|||
157211933|NCT00963599|567523387|FG002|Overall Study|Adverse Event|1|||
157211934|NCT00963599|567523388|FG003|Overall Study|Adverse Event|2|||
157211935|NCT00963599|567523385|FG000|Overall Study|Lack of Efficacy|0|||
157211936|NCT00963599|567523386|FG001|Overall Study|Lack of Efficacy|2|||
157211937|NCT00963599|567523387|FG002|Overall Study|Lack of Efficacy|1|||
157211938|NCT00963599|567523388|FG003|Overall Study|Lack of Efficacy|4|||
157211939|NCT00963599|567523385|FG000|Overall Study|Lost to Follow-up|0|||
157211940|NCT00963599|567523386|FG001|Overall Study|Lost to Follow-up|1|||
157211941|NCT00963599|567523387|FG002|Overall Study|Lost to Follow-up|1|||
157211942|NCT00963599|567523388|FG003|Overall Study|Lost to Follow-up|1|||
157211943|NCT00963599|567523385|FG000|Overall Study|Protocol Violation|2|||
157211944|NCT00963599|567523386|FG001|Overall Study|Protocol Violation|2|||
157211945|NCT00963599|567523387|FG002|Overall Study|Protocol Violation|3|||
157211946|NCT00963599|567523388|FG003|Overall Study|Protocol Violation|4|||
157211947|NCT00963599|567523385|FG000|Overall Study|Withdrawal by Subject|2|||
157211948|NCT00963599|567523386|FG001|Overall Study|Withdrawal by Subject|1|||
157211949|NCT00963599|567523387|FG002|Overall Study|Withdrawal by Subject|3|||
157211950|NCT00963599|567523388|FG003|Overall Study|Withdrawal by Subject|3|||
157211951|NCT02567266|567523390|FG000|Overall Study|Withdrawal by Subject|10|||
157211952|NCT02567266|567523391|FG001|Overall Study|Withdrawal by Subject|7|||
157211953|NCT02567266|567523392|FG002|Overall Study|Withdrawal by Subject|6|||
157211954|NCT02567266|567523390|FG000|Overall Study|Lost to Follow-up|13|||
157211955|NCT02567266|567523391|FG001|Overall Study|Lost to Follow-up|8|||
157211956|NCT02567266|567523392|FG002|Overall Study|Lost to Follow-up|10|||
157211957|NCT02354976|567523393|FG000|Overall Study|Other - reason not specified|1|||
157211958|NCT02354976|567523394|FG001|Overall Study|Other - reason not specified|0|||
157211959|NCT02354976|567523395|FG002|Overall Study|Other - reason not specified|1|||
157211960|NCT02354976|567523393|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
157211961|NCT02354976|567523394|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
157211962|NCT02354976|567523395|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
157211963|NCT02354976|567523393|FG000|Overall Study|Adverse Event|1|||
157211964|NCT02354976|567523394|FG001|Overall Study|Adverse Event|0|||
157211965|NCT02354976|567523395|FG002|Overall Study|Adverse Event|2|||
157211966|NCT01706770|567523396|FG000|Overall Study|Lost to Follow-up|1|||
157211967|NCT01706770|567523397|FG001|Overall Study|Lost to Follow-up|0|||
157211968|NCT01706770|567523396|FG000|Overall Study|Physician Decision|1|||
157211969|NCT01706770|567523397|FG001|Overall Study|Physician Decision|0|||
157211970|NCT00423488|567523398|FG000|Overall Study|No evidence of study drug intake|2|||
157211971|NCT00423488|567523399|FG001|Overall Study|No evidence of study drug intake|1|||
157211972|NCT00423488|567523398|FG000|Overall Study|No post baseline data|3|||
157211973|NCT00423488|567523399|FG001|Overall Study|No post baseline data|0|||
157211974|NCT03835975|567523400|FG000|Overall Study|Lost to Follow-up|1|||
157211975|NCT03835975|567523401|FG001|Overall Study|Lost to Follow-up|1|||
157211976|NCT03835975|567523402|FG002|Overall Study|Lost to Follow-up|0|||
157211977|NCT03835975|567523403|FG003|Overall Study|Lost to Follow-up|0|||
157211978|NCT03835975|567523404|FG004|Overall Study|Lost to Follow-up|0|||
157211979|NCT03835975|567523400|FG000|Overall Study|No longer met eligibility criteria|0|||
157211980|NCT03835975|567523401|FG001|Overall Study|No longer met eligibility criteria|1|||
157211981|NCT03835975|567523402|FG002|Overall Study|No longer met eligibility criteria|0|||
157211982|NCT03835975|567523403|FG003|Overall Study|No longer met eligibility criteria|0|||
157211983|NCT03835975|567523404|FG004|Overall Study|No longer met eligibility criteria|0|||
157211984|NCT03835975|567523400|FG000|Overall Study|Protocol Violation|1|||
157211985|NCT03835975|567523401|FG001|Overall Study|Protocol Violation|1|||
157211986|NCT03835975|567523402|FG002|Overall Study|Protocol Violation|2|||
157211987|NCT03835975|567523403|FG003|Overall Study|Protocol Violation|0|||
157211988|NCT03835975|567523404|FG004|Overall Study|Protocol Violation|0|||
157211989|NCT03835975|567523400|FG000|Overall Study|Withdrawal by Subject|1|||
157211990|NCT03835975|567523401|FG001|Overall Study|Withdrawal by Subject|0|||
157211991|NCT03835975|567523402|FG002|Overall Study|Withdrawal by Subject|1|||
157211992|NCT03835975|567523403|FG003|Overall Study|Withdrawal by Subject|1|||
157211993|NCT03835975|567523404|FG004|Overall Study|Withdrawal by Subject|0|||
157211994|NCT01612702|567523407|FG000|Overall Study|Protocol Violation|11|||
157211995|NCT01612702|567523408|FG001|Overall Study|Protocol Violation|11|||
157211996|NCT03070431|567523409|FG000|Overall Study|Withdrawal by Subject|2|||
157211997|NCT03070431|567523409|FG000|Overall Study|Lost to Follow-up|2|||
157211998|NCT00527397|567523412|FG000|Overall Study|Adverse Event|3|||
157211999|NCT00527397|567523412|FG000|Overall Study|Lack of Efficacy|1|||
157212000|NCT00527397|567523412|FG000|Overall Study|Protocol Violation|1|||
157212001|NCT00527397|567523412|FG000|Overall Study|Withdrawal by Subject|6|||
157212002|NCT00527397|567523412|FG000|Overall Study|Study terminated by sponsor|13|||
157212003|NCT00370396|567523418|FG000|Overall Study|Withdrawal by Subject|0|||
157212004|NCT00370396|567523419|FG001|Overall Study|Withdrawal by Subject|0|||
157212005|NCT00370396|567523420|FG002|Overall Study|Withdrawal by Subject|1|||
157011172|NCT03422276|566793375|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
157212006|NCT00370396|567523418|FG000|Overall Study|Lost to Follow-up|11|||
157212007|NCT00370396|567523419|FG001|Overall Study|Lost to Follow-up|1|||
157212008|NCT00370396|567523420|FG002|Overall Study|Lost to Follow-up|0|||
157212009|NCT02065791|567523421|FG000|Overall Study|Closed Site|1|||
157212010|NCT02065791|567523422|FG001|Overall Study|Closed Site|1|||
157212011|NCT02065791|567523421|FG000|Overall Study|Withdrawal by Subject|11|||
157212012|NCT02065791|567523422|FG001|Overall Study|Withdrawal by Subject|5|||
157212013|NCT02065791|567523421|FG000|Overall Study|Lost to Follow-up|13|||
157212014|NCT02065791|567523422|FG001|Overall Study|Lost to Follow-up|9|||
157212015|NCT03707522|567523423|FG000|Overall Study|Lost to Follow-up|24|||
157212016|NCT03707522|567523424|FG001|Overall Study|Lost to Follow-up|27|||
157212017|NCT03707522|567523425|FG002|Overall Study|Lost to Follow-up|41|||
157212018|NCT03707522|567523426|FG003|Overall Study|Lost to Follow-up|36|||
157212019|NCT00383019|567523427|FG000|Overall Study|Adverse Event|5|||
157212020|NCT00383019|567523428|FG001|Overall Study|Adverse Event|1|||
157212021|NCT00383019|567523427|FG000|Overall Study|Withdrawal by Subject|0|||
157212022|NCT00383019|567523428|FG001|Overall Study|Withdrawal by Subject|1|||
157212023|NCT01619085|567523432|FG000|Overall Study|Adverse Event|231|||
157212024|NCT01619085|567523432|FG000|Overall Study|Protocol Violation|4|||
157212025|NCT01619085|567523432|FG000|Overall Study|Lost to Follow-up|3|||
157212026|NCT01619085|567523432|FG000|Overall Study|Withdrawal by Subject|45|||
157212027|NCT01619085|567523432|FG000|Overall Study|Other than specified|96|||
157212028|NCT01619085|567523432|FG000|Overall Study|Not treated|1|||
157212029|NCT01619085|567523432|FG000|Overall Study|Death|145|||
157212030|NCT01345058|567523433|FG000|Overall Study|Withdrawal by Subject|1|||
157212031|NCT01345058|567523434|FG001|Overall Study|Withdrawal by Subject|0|||
157212032|NCT01345058|567523433|FG000|Overall Study|Participant Reported Increase in Events|1|||
157212033|NCT01345058|567523434|FG001|Overall Study|Participant Reported Increase in Events|0|||
157212034|NCT01345058|567523433|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
157212035|NCT01345058|567523434|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
157212036|NCT01345058|567523433|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
157212037|NCT01345058|567523434|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
157212038|NCT01345058|567523433|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
157212039|NCT01345058|567523434|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
157212040|NCT00000135|567523435|FG000|Overall Study|Death|27|||
157212041|NCT00000135|567523436|FG001|Overall Study|Death|14|||
157212042|NCT00833976|567524837|FG000|Overall Study|Withdrawal by Subject|5|||
157212043|NCT00833976|567524837|FG000|Overall Study|Lost to Follow-up|4|||
157212044|NCT00833976|567524837|FG000|Overall Study|Did not meet eligibility criteria|41|||
157212045|NCT00833976|567524837|FG000|Overall Study|Physician Decision|1|||
157212046|NCT02464059|567524838|FG000|Overall Study|Lost to Follow-up|6|||
157212047|NCT01637961|567524841|FG000|Overall Study|Ineligible: wrong primary|1|||
157212048|NCT01637961|567524841|FG000|Overall Study|Ineligible: inadequate pathology|1|||
157212049|NCT03101293|567524842|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
157212050|NCT03101293|567524843|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
157212051|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
157212052|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
157212053|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
157212054|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
157212055|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
157212056|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
157212057|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
157212058|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
157212059|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157212060|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157212061|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
157212062|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157212063|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157212064|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157212065|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157212066|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
157212067|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
157212068|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
157212069|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
157212070|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
157212071|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
157212072|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
157212073|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
157212074|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
157212075|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
157212076|NCT04682639|567524847|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
157212077|NCT04682639|567524848|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
157212078|NCT04682639|567524849|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
157212079|NCT04682639|567524850|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157212080|NCT04682639|567524851|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157212081|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
157212082|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
157212083|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
157212084|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
157212085|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
157212086|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Other|1|||
157212087|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Other|2|||
157212088|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Other|0|||
157011173|NCT03422276|566793376|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
157011174|NCT03422276|566793377|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
157011175|NCT05194917|566793378|FG000|Overall Study|Lost to Follow-up|7|||
157011176|NCT05194917|566793379|FG001|Overall Study|Lost to Follow-up|5|||
157212089|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Other|0|||
157212090|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Other|1|||
157212091|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
157212092|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
157212093|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
157212094|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
157212095|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
157212096|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
157212097|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
157212098|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
157212099|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
157212100|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
157212101|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
157212102|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
157212103|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
157212104|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
157212105|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
157212106|NCT04682639|567524847|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
157212107|NCT04682639|567524848|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
157212108|NCT04682639|567524849|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
157212109|NCT04682639|567524850|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
157212110|NCT04682639|567524851|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
157212111|NCT04388527|567524852|FG000|Overall Study|Death|14|||
157212112|NCT04388527|567524852|FG000|Overall Study|Withdrawal by Subject|2|||
157212113|NCT04388527|567524852|FG000|Overall Study|Lost to Follow-up|1|||
157212114|NCT03333382|567524853|FG000|Overall Study|Lost to Follow-up|1|||
157212115|NCT03333382|567524854|FG001|Overall Study|Lost to Follow-up|0|||
157011177|NCT05194917|566793380|FG002|Overall Study|Lost to Follow-up|6|||
157011178|NCT05194917|566793381|FG003|Overall Study|Lost to Follow-up|5|||
157011179|NCT04941287|566793393|FG000|Overall Study|Rapid decline before starting treatment|3|||
157011180|NCT04941287|566793394|FG001|Overall Study|Rapid decline before starting treatment|1|||
157011181|NCT01998984|566793399|FG000|Overall Study|Adverse Event|0|||
157011182|NCT01998984|566793400|FG001|Overall Study|Adverse Event|0|||
157011183|NCT01998984|566793401|FG002|Overall Study|Adverse Event|0|||
157011184|NCT01998984|566793402|FG003|Overall Study|Adverse Event|1|||
157011185|NCT01998984|566793399|FG000|Overall Study|Lost to Follow-up|0|||
157011186|NCT01998984|566793400|FG001|Overall Study|Lost to Follow-up|1|||
157011187|NCT01998984|566793401|FG002|Overall Study|Lost to Follow-up|0|||
157011188|NCT01998984|566793402|FG003|Overall Study|Lost to Follow-up|1|||
157011189|NCT01998984|566793399|FG000|Overall Study|Withdrawal by Subject|0|||
157011190|NCT01998984|566793400|FG001|Overall Study|Withdrawal by Subject|0|||
157011191|NCT01998984|566793401|FG002|Overall Study|Withdrawal by Subject|1|||
157212116|NCT03471182|567524855|FG000|Overall Study|Withdrawal by Subject|1|||
157212117|NCT03471182|567524856|FG001|Overall Study|Withdrawal by Subject|1|||
157212118|NCT03471182|567524857|FG002|Overall Study|Withdrawal by Subject|0|||
157212119|NCT03471182|567524855|FG000|Overall Study|Technical failure|2|||
157212120|NCT03471182|567524856|FG001|Overall Study|Technical failure|0|||
157212121|NCT03471182|567524857|FG002|Overall Study|Technical failure|0|||
157212122|NCT03451331|567524861|FG000|Overall Study|Withdrawal by Subject|1|||
157212123|NCT03451331|567524862|FG001|Overall Study|Withdrawal by Subject|0|||
157212124|NCT03451331|567524861|FG000|Overall Study|Unable to start treatment.|1|||
157212125|NCT03451331|567524862|FG001|Overall Study|Unable to start treatment.|1|||
157011192|NCT01998984|566793402|FG003|Overall Study|Withdrawal by Subject|0|||
157212126|NCT02773446|567524863|FG000|First Admission|Withdrawal by Subject|0|||
157212127|NCT02773446|567524864|FG001|First Admission|Withdrawal by Subject|0|||
157212128|NCT02773446|567524865|FG002|First Admission|Withdrawal by Subject|0|||
157212129|NCT02773446|567524866|FG003|First Admission|Withdrawal by Subject|1|||
157212130|NCT02773446|567524867|FG004|First Admission|Withdrawal by Subject|0|||
157212131|NCT02773446|567524868|FG005|First Admission|Withdrawal by Subject|0|||
157212132|NCT02773446|567524863|FG000|First Admission|Lost to Follow-up|1|||
157212133|NCT02773446|567524864|FG001|First Admission|Lost to Follow-up|0|||
157212134|NCT02773446|567524865|FG002|First Admission|Lost to Follow-up|0|||
157212135|NCT02773446|567524866|FG003|First Admission|Lost to Follow-up|0|||
157212136|NCT02773446|567524867|FG004|First Admission|Lost to Follow-up|0|||
157212137|NCT02773446|567524868|FG005|First Admission|Lost to Follow-up|0|||
157212138|NCT00289731|567524869|FG000|Overall Study|Adverse Event|1|||
157212139|NCT00289731|567524870|FG001|Overall Study|Adverse Event|2|||
157212140|NCT00289731|567524871|FG002|Overall Study|Adverse Event|2|||
157212141|NCT00289731|567524869|FG000|Overall Study|Other|1|||
157212142|NCT00289731|567524870|FG001|Overall Study|Other|0|||
157212143|NCT00289731|567524871|FG002|Overall Study|Other|0|||
157212144|NCT04023994|567524872|FG000|Overall Study|Lost to Follow-up|0|||
157212145|NCT04023994|567524873|FG001|Overall Study|Lost to Follow-up|1|||
157212146|NCT04023994|567524874|FG002|Overall Study|Lost to Follow-up|2|||
157212147|NCT04023994|567524875|FG003|Overall Study|Lost to Follow-up|0|||
157212148|NCT04023994|567524876|FG004|Overall Study|Lost to Follow-up|0|||
157212149|NCT04023994|567524877|FG005|Overall Study|Lost to Follow-up|0|||
157212150|NCT04023994|567524872|FG000|Overall Study|Withdrawal by Subject|0|||
157212151|NCT04023994|567524873|FG001|Overall Study|Withdrawal by Subject|0|||
157212152|NCT04023994|567524874|FG002|Overall Study|Withdrawal by Subject|0|||
157212153|NCT04023994|567524875|FG003|Overall Study|Withdrawal by Subject|1|||
157212154|NCT04023994|567524876|FG004|Overall Study|Withdrawal by Subject|0|||
157212155|NCT04023994|567524877|FG005|Overall Study|Withdrawal by Subject|0|||
157212156|NCT01613131|567524878|FG000|Overall Study|Withdrawal by Subject|3|||
157212157|NCT01613131|567524879|FG001|Overall Study|Withdrawal by Subject|5|||
157212158|NCT02454972|567524880|FG000|Overall Study|Progressive disease|17|||
157212159|NCT02454972|567524881|FG001|Overall Study|Progressive disease|16|||
157212160|NCT02454972|567524882|FG002|Overall Study|Progressive disease|59|||
157212161|NCT02454972|567524883|FG003|Overall Study|Progressive disease|23|||
157212162|NCT02454972|567524884|FG004|Overall Study|Progressive disease|16|||
157212163|NCT02454972|567524885|FG005|Overall Study|Progressive disease|12|||
157212164|NCT02454972|567524886|FG006|Overall Study|Progressive disease|19|||
157212165|NCT02454972|567524887|FG007|Overall Study|Progressive disease|27|||
157212166|NCT02454972|567524888|FG008|Overall Study|Progressive disease|0|||
157212167|NCT02454972|567524880|FG000|Overall Study|Death|0|||
157212168|NCT02454972|567524881|FG001|Overall Study|Death|0|||
157011193|NCT01998984|566793399|FG000|Overall Study|Other|0|||
157011194|NCT01998984|566793400|FG001|Overall Study|Other|0|||
157011195|NCT01998984|566793401|FG002|Overall Study|Other|0|||
157011196|NCT01998984|566793402|FG003|Overall Study|Other|1|||
157011197|NCT04279574|566793407|FG000|Overall Study|Death|1|||
157011198|NCT04279574|566793408|FG001|Overall Study|Death|0|||
157011199|NCT04279574|566793407|FG000|Overall Study|lost restoration, tooth fracture|1|||
157011200|NCT04279574|566793408|FG001|Overall Study|lost restoration, tooth fracture|0|||
157011201|NCT04279574|566793407|FG000|Overall Study|Lost to Follow-up|0|||
157011202|NCT04279574|566793408|FG001|Overall Study|Lost to Follow-up|1|||
157011203|NCT04153565|566793409|FG000|Overall Study|Death|13|||
157011204|NCT02991807|566793410|FG000|Overall Study|Withdrawal by Subject|2|||
157011205|NCT02991807|566793411|FG001|Overall Study|Withdrawal by Subject|1|||
157011206|NCT02991807|566793410|FG000|Overall Study|Physician Decision|0|||
157011207|NCT02991807|566793411|FG001|Overall Study|Physician Decision|1|||
157212169|NCT02454972|567524882|FG002|Overall Study|Death|5|||
157212170|NCT02454972|567524883|FG003|Overall Study|Death|1|||
157212171|NCT02454972|567524884|FG004|Overall Study|Death|0|||
157212172|NCT02454972|567524885|FG005|Overall Study|Death|0|||
157212173|NCT02454972|567524886|FG006|Overall Study|Death|0|||
157011208|NCT02991807|566793410|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
157212174|NCT02454972|567524887|FG007|Overall Study|Death|0|||
157212175|NCT02454972|567524888|FG008|Overall Study|Death|95|||
157212176|NCT02454972|567524880|FG000|Overall Study|Physician Decision|0|||
157212177|NCT02454972|567524881|FG001|Overall Study|Physician Decision|1|||
157212178|NCT02454972|567524882|FG002|Overall Study|Physician Decision|2|||
157212179|NCT02454972|567524883|FG003|Overall Study|Physician Decision|1|||
157212180|NCT02454972|567524884|FG004|Overall Study|Physician Decision|2|||
157212181|NCT02454972|567524885|FG005|Overall Study|Physician Decision|0|||
157212182|NCT02454972|567524886|FG006|Overall Study|Physician Decision|0|||
157212183|NCT02454972|567524887|FG007|Overall Study|Physician Decision|1|||
157212184|NCT02454972|567524888|FG008|Overall Study|Physician Decision|0|||
157212185|NCT02454972|567524880|FG000|Overall Study|Non treatment-related adverse event|2|||
157212186|NCT02454972|567524881|FG001|Overall Study|Non treatment-related adverse event|0|||
157212187|NCT02454972|567524882|FG002|Overall Study|Non treatment-related adverse event|1|||
157212188|NCT02454972|567524883|FG003|Overall Study|Non treatment-related adverse event|0|||
157212189|NCT02454972|567524884|FG004|Overall Study|Non treatment-related adverse event|0|||
157212190|NCT02454972|567524885|FG005|Overall Study|Non treatment-related adverse event|1|||
157212191|NCT02454972|567524886|FG006|Overall Study|Non treatment-related adverse event|0|||
157212192|NCT02454972|567524887|FG007|Overall Study|Non treatment-related adverse event|1|||
157212193|NCT02454972|567524888|FG008|Overall Study|Non treatment-related adverse event|0|||
157212194|NCT02454972|567524880|FG000|Overall Study|Treatment-related adverse events|0|||
157212195|NCT02454972|567524881|FG001|Overall Study|Treatment-related adverse events|1|||
157212196|NCT02454972|567524882|FG002|Overall Study|Treatment-related adverse events|1|||
157212197|NCT02454972|567524883|FG003|Overall Study|Treatment-related adverse events|0|||
157212198|NCT02454972|567524884|FG004|Overall Study|Treatment-related adverse events|2|||
157212199|NCT02454972|567524885|FG005|Overall Study|Treatment-related adverse events|0|||
157212200|NCT02454972|567524886|FG006|Overall Study|Treatment-related adverse events|0|||
157011209|NCT02991807|566793411|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
157011210|NCT02566902|566793412|FG000|Overall Study|Protocol Violation|2|||
157011211|NCT02566902|566793413|FG001|Overall Study|Protocol Violation|1|||
157011212|NCT00332241|566793416|FG000|Overall Study|Lack of Efficacy|6|||
157011213|NCT00332241|566793417|FG001|Overall Study|Lack of Efficacy|1|||
157011214|NCT00332241|566793416|FG000|Overall Study|Adverse Event|3|||
157011215|NCT00332241|566793417|FG001|Overall Study|Adverse Event|5|||
157011216|NCT00332241|566793416|FG000|Overall Study|Withdrawal by Subject|2|||
157011217|NCT00332241|566793417|FG001|Overall Study|Withdrawal by Subject|1|||
157011218|NCT00332241|566793416|FG000|Overall Study|Lost to Follow-up|4|||
157011219|NCT00332241|566793417|FG001|Overall Study|Lost to Follow-up|1|||
157011220|NCT00350792|566793418|FG000|Overall Study|Adverse Event|11|||
157011221|NCT00350792|566793418|FG000|Overall Study|Death from Study Disease|1|||
157011222|NCT00350792|566793418|FG000|Overall Study|Death from Study Drug Toxicity|1|||
157011223|NCT00350792|566793418|FG000|Overall Study|Death Not Study Drug Related|2|||
157011224|NCT00350792|566793418|FG000|Overall Study|Protocol Violation|1|||
157011225|NCT00350792|566793418|FG000|Overall Study|Withdrawal by Subject|4|||
157011226|NCT00350792|566793418|FG000|Overall Study|Physician Decision|2|||
157011227|NCT00350792|566793418|FG000|Overall Study|Lack of Efficacy|11|||
157011228|NCT01373346|566793427|FG000|Overall Study|Death|1|||
157011229|NCT01198028|566793428|FG000|Overall Study|Adverse Event|5|||
157011230|NCT01198028|566793428|FG000|Overall Study|Death|3|||
157011231|NCT01198028|566793428|FG000|Overall Study|Physician Decision|2|||
157011232|NCT00970359|566793432|FG000|Overall Study|Not Treated|4|||
157011233|NCT01565148|566793433|FG000|Overall Study|Withdrawal by Subject|1|||
157011234|NCT01565148|566793434|FG001|Overall Study|Withdrawal by Subject|1|||
157011235|NCT01565148|566793435|FG002|Overall Study|Withdrawal by Subject|1|||
157011236|NCT01565148|566793436|FG003|Overall Study|Withdrawal by Subject|2|||
157011237|NCT01565148|566793433|FG000|Overall Study|Lost to Follow-up|4|||
157011238|NCT01565148|566793434|FG001|Overall Study|Lost to Follow-up|4|||
157011239|NCT01565148|566793435|FG002|Overall Study|Lost to Follow-up|0|||
157011240|NCT01565148|566793436|FG003|Overall Study|Lost to Follow-up|3|||
157011241|NCT01565148|566793433|FG000|Overall Study|Rescue Therapy|8|||
157011242|NCT01565148|566793434|FG001|Overall Study|Rescue Therapy|5|||
157011243|NCT01565148|566793435|FG002|Overall Study|Rescue Therapy|5|||
157011244|NCT01565148|566793436|FG003|Overall Study|Rescue Therapy|8|||
157011245|NCT01565148|566793433|FG000|Overall Study|Death|0|||
157011246|NCT01565148|566793434|FG001|Overall Study|Death|0|||
157011247|NCT01565148|566793435|FG002|Overall Study|Death|1|||
157011248|NCT01565148|566793436|FG003|Overall Study|Death|0|||
157011249|NCT01565148|566793433|FG000|Overall Study|Physician Decision|2|||
157011250|NCT01565148|566793434|FG001|Overall Study|Physician Decision|5|||
157011251|NCT01565148|566793435|FG002|Overall Study|Physician Decision|0|||
157011252|NCT01565148|566793436|FG003|Overall Study|Physician Decision|0|||
157011253|NCT00529659|566793440|FG000|Overall Study|Adverse Event|8|||
157011254|NCT00529659|566793441|FG001|Overall Study|Adverse Event|7|||
157011255|NCT00529659|566793440|FG000|Overall Study|Lost to Follow-up|0|||
157011256|NCT00529659|566793441|FG001|Overall Study|Lost to Follow-up|2|||
157011257|NCT00529659|566793440|FG000|Overall Study|Physician Decision|0|||
157011258|NCT00529659|566793441|FG001|Overall Study|Physician Decision|2|||
157011259|NCT00529659|566793440|FG000|Overall Study|Protocol Violation|2|||
157011260|NCT00529659|566793441|FG001|Overall Study|Protocol Violation|6|||
157011261|NCT00529659|566793440|FG000|Overall Study|Withdrawal by Subject|1|||
157011262|NCT00529659|566793441|FG001|Overall Study|Withdrawal by Subject|6|||
157011263|NCT03565315|566793442|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
157011264|NCT03565315|566793443|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
157011265|NCT03565315|566793444|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
157212201|NCT02454972|567524887|FG007|Overall Study|Treatment-related adverse events|2|||
157212202|NCT02454972|567524888|FG008|Overall Study|Treatment-related adverse events|0|||
157212203|NCT02454972|567524880|FG000|Overall Study|Patient moves to compassionate use|0|||
157212204|NCT02454972|567524881|FG001|Overall Study|Patient moves to compassionate use|0|||
157212205|NCT02454972|567524882|FG002|Overall Study|Patient moves to compassionate use|0|||
157212206|NCT02454972|567524883|FG003|Overall Study|Patient moves to compassionate use|0|||
157212207|NCT02454972|567524884|FG004|Overall Study|Patient moves to compassionate use|0|||
157212208|NCT02454972|567524885|FG005|Overall Study|Patient moves to compassionate use|0|||
157212209|NCT02454972|567524886|FG006|Overall Study|Patient moves to compassionate use|2|||
157212210|NCT02454972|567524887|FG007|Overall Study|Patient moves to compassionate use|0|||
157212211|NCT02454972|567524888|FG008|Overall Study|Patient moves to compassionate use|0|||
157212212|NCT02454972|567524880|FG000|Overall Study|Withdrawal by Subject|0|||
157212213|NCT02454972|567524881|FG001|Overall Study|Withdrawal by Subject|1|||
157212214|NCT02454972|567524882|FG002|Overall Study|Withdrawal by Subject|5|||
157212215|NCT02454972|567524883|FG003|Overall Study|Withdrawal by Subject|2|||
157212216|NCT02454972|567524884|FG004|Overall Study|Withdrawal by Subject|3|||
157212217|NCT02454972|567524885|FG005|Overall Study|Withdrawal by Subject|2|||
157212218|NCT02454972|567524886|FG006|Overall Study|Withdrawal by Subject|0|||
157212219|NCT02454972|567524887|FG007|Overall Study|Withdrawal by Subject|1|||
157212220|NCT02454972|567524888|FG008|Overall Study|Withdrawal by Subject|2|||
157212221|NCT02454972|567524880|FG000|Overall Study|Multiple delay/holds on treatment|0|||
157212222|NCT02454972|567524881|FG001|Overall Study|Multiple delay/holds on treatment|0|||
157212223|NCT02454972|567524882|FG002|Overall Study|Multiple delay/holds on treatment|0|||
157212224|NCT02454972|567524883|FG003|Overall Study|Multiple delay/holds on treatment|1|||
157212225|NCT02454972|567524884|FG004|Overall Study|Multiple delay/holds on treatment|0|||
157212226|NCT02454972|567524885|FG005|Overall Study|Multiple delay/holds on treatment|0|||
157212227|NCT02454972|567524886|FG006|Overall Study|Multiple delay/holds on treatment|0|||
157212228|NCT02454972|567524887|FG007|Overall Study|Multiple delay/holds on treatment|0|||
157011266|NCT03565315|566793445|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
157011267|NCT03887650|566793446|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
157011268|NCT03887650|566793447|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
157011269|NCT03887650|566793446|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
157011270|NCT03887650|566793447|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
157011271|NCT03887650|566793446|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
157011272|NCT03887650|566793447|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
157011273|NCT01170962|566793448|FG000|Treatment Period|Lack of Efficacy|96|||
157011274|NCT01170962|566793449|FG001|Treatment Period|Lack of Efficacy|91|||
157011275|NCT01170962|566793450|FG002|Treatment Period|Lack of Efficacy|7|||
157011276|NCT01170962|566793448|FG000|Treatment Period|Adverse Event|11|||
157011277|NCT01170962|566793449|FG001|Treatment Period|Adverse Event|12|||
157011278|NCT01170962|566793450|FG002|Treatment Period|Adverse Event|3|||
157011279|NCT01170962|566793448|FG000|Treatment Period|Withdrawal by Subject|2|||
157011280|NCT01170962|566793449|FG001|Treatment Period|Withdrawal by Subject|1|||
157011281|NCT01170962|566793450|FG002|Treatment Period|Withdrawal by Subject|0|||
157011282|NCT01170962|566793448|FG000|Treatment Period|Lost to Follow-up|1|||
157011283|NCT01170962|566793449|FG001|Treatment Period|Lost to Follow-up|1|||
157212229|NCT02454972|567524888|FG008|Overall Study|Multiple delay/holds on treatment|0|||
157212230|NCT02454972|567524880|FG000|Overall Study|Never treated|0|||
157212231|NCT02454972|567524881|FG001|Overall Study|Never treated|0|||
157212232|NCT02454972|567524882|FG002|Overall Study|Never treated|3|||
157011284|NCT01170962|566793450|FG002|Treatment Period|Lost to Follow-up|1|||
157011285|NCT01170962|566793448|FG000|Treatment Period|Participant no longer meets criteria|0|||
157011286|NCT01170962|566793449|FG001|Treatment Period|Participant no longer meets criteria|1|||
157212233|NCT02454972|567524883|FG003|Overall Study|Never treated|1|||
157212234|NCT02454972|567524884|FG004|Overall Study|Never treated|1|||
157212235|NCT02454972|567524885|FG005|Overall Study|Never treated|0|||
157212236|NCT02454972|567524886|FG006|Overall Study|Never treated|0|||
157212237|NCT02454972|567524887|FG007|Overall Study|Never treated|0|||
157212238|NCT02454972|567524888|FG008|Overall Study|Never treated|5|||
157212239|NCT02454972|567524880|FG000|Overall Study|Lost to Follow-up|0|||
157212240|NCT02454972|567524881|FG001|Overall Study|Lost to Follow-up|0|||
157212241|NCT02454972|567524882|FG002|Overall Study|Lost to Follow-up|0|||
157212242|NCT02454972|567524883|FG003|Overall Study|Lost to Follow-up|0|||
157212243|NCT02454972|567524884|FG004|Overall Study|Lost to Follow-up|0|||
157212244|NCT02454972|567524885|FG005|Overall Study|Lost to Follow-up|0|||
157212245|NCT02454972|567524886|FG006|Overall Study|Lost to Follow-up|0|||
157212246|NCT02454972|567524887|FG007|Overall Study|Lost to Follow-up|0|||
157212247|NCT02454972|567524888|FG008|Overall Study|Lost to Follow-up|2|||
157212248|NCT02454972|567524880|FG000|Overall Study|Study termination|0|||
157212249|NCT02454972|567524881|FG001|Overall Study|Study termination|0|||
157212250|NCT02454972|567524882|FG002|Overall Study|Study termination|0|||
157212251|NCT02454972|567524883|FG003|Overall Study|Study termination|0|||
157212252|NCT02454972|567524884|FG004|Overall Study|Study termination|0|||
157212253|NCT02454972|567524885|FG005|Overall Study|Study termination|0|||
157212254|NCT02454972|567524886|FG006|Overall Study|Study termination|0|||
157212255|NCT02454972|567524887|FG007|Overall Study|Study termination|0|||
157212256|NCT02454972|567524888|FG008|Overall Study|Study termination|6|||
157212257|NCT01070966|567524895|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
157212258|NCT01070966|567524895|FG000|Participants for Safety Evaluation|Off-label use|9|||
157212259|NCT01070966|567524895|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
157212260|NCT01070966|567524895|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
157212261|NCT01070966|567524895|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
157212262|NCT01070966|567524895|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
157212263|NCT01070966|567524895|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
157212264|NCT01070966|567524895|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
157212265|NCT01725113|567524896|FG000|Overall Study|Kidney Transplant|1|||
157212266|NCT01725113|567524897|FG001|Overall Study|Kidney Transplant|1|||
157212267|NCT01725113|567524896|FG000|Overall Study|Withdrawal by Subject|0|||
157212268|NCT01725113|567524897|FG001|Overall Study|Withdrawal by Subject|1|||
157212269|NCT02753400|567524898|FG000|Overall Study|Adverse Event|3|||
157212270|NCT02753400|567524899|FG001|Overall Study|Adverse Event|0|||
157212271|NCT02753400|567524898|FG000|Overall Study|Withdrawal by Subject|2|||
157212272|NCT02753400|567524899|FG001|Overall Study|Withdrawal by Subject|1|||
157212273|NCT03989115|567524900|FG000|Overall Study|Withdrawal by Subject|2|||
157212274|NCT03989115|567524901|FG001|Overall Study|Withdrawal by Subject|1|||
157212275|NCT03989115|567524902|FG002|Overall Study|Withdrawal by Subject|3|||
157212276|NCT03989115|567524903|FG003|Overall Study|Withdrawal by Subject|0|||
157212277|NCT03989115|567524904|FG004|Overall Study|Withdrawal by Subject|17|||
157212278|NCT03989115|567524905|FG005|Overall Study|Withdrawal by Subject|1|||
157212279|NCT03989115|567524906|FG006|Overall Study|Withdrawal by Subject|0|||
157212280|NCT03989115|567524907|FG007|Overall Study|Withdrawal by Subject|0|||
157212281|NCT03989115|567524900|FG000|Overall Study|Sponsor decision to terminate the study|1|||
157212282|NCT03989115|567524901|FG001|Overall Study|Sponsor decision to terminate the study|1|||
157212283|NCT03989115|567524902|FG002|Overall Study|Sponsor decision to terminate the study|0|||
157212284|NCT03989115|567524903|FG003|Overall Study|Sponsor decision to terminate the study|1|||
157212285|NCT03989115|567524904|FG004|Overall Study|Sponsor decision to terminate the study|11|||
157212286|NCT03989115|567524905|FG005|Overall Study|Sponsor decision to terminate the study|0|||
157212287|NCT03989115|567524906|FG006|Overall Study|Sponsor decision to terminate the study|2|||
157212288|NCT03989115|567524907|FG007|Overall Study|Sponsor decision to terminate the study|1|||
157212289|NCT03989115|567524900|FG000|Overall Study|Lost to Follow-up|2|||
157212290|NCT03989115|567524901|FG001|Overall Study|Lost to Follow-up|0|||
157212291|NCT03989115|567524902|FG002|Overall Study|Lost to Follow-up|0|||
157212292|NCT03989115|567524903|FG003|Overall Study|Lost to Follow-up|0|||
157212293|NCT03989115|567524904|FG004|Overall Study|Lost to Follow-up|1|||
157212294|NCT03989115|567524905|FG005|Overall Study|Lost to Follow-up|0|||
157212295|NCT03989115|567524906|FG006|Overall Study|Lost to Follow-up|0|||
157212296|NCT03989115|567524907|FG007|Overall Study|Lost to Follow-up|0|||
157212297|NCT03989115|567524900|FG000|Overall Study|Death|2|||
157212298|NCT03989115|567524901|FG001|Overall Study|Death|2|||
157212299|NCT03989115|567524902|FG002|Overall Study|Death|9|||
157212300|NCT03989115|567524903|FG003|Overall Study|Death|6|||
157212301|NCT03989115|567524904|FG004|Overall Study|Death|31|||
157212302|NCT03989115|567524905|FG005|Overall Study|Death|6|||
157212303|NCT03989115|567524906|FG006|Overall Study|Death|2|||
157212304|NCT03989115|567524907|FG007|Overall Study|Death|3|||
157212305|NCT03989115|567524900|FG000|Overall Study|Other|1|||
157212306|NCT03989115|567524901|FG001|Overall Study|Other|2|||
157212307|NCT03989115|567524902|FG002|Overall Study|Other|0|||
157212308|NCT03989115|567524903|FG003|Overall Study|Other|0|||
157212309|NCT03989115|567524904|FG004|Overall Study|Other|5|||
157212310|NCT03989115|567524905|FG005|Overall Study|Other|0|||
157212311|NCT03989115|567524906|FG006|Overall Study|Other|0|||
157212312|NCT03989115|567524907|FG007|Overall Study|Other|0|||
157212313|NCT01415921|567524908|FG000|Overall Study|Adverse Event|0|||
157212314|NCT01415921|567524909|FG001|Overall Study|Adverse Event|1|||
157212315|NCT01415921|567524908|FG000|Overall Study|Physician Decision|1|||
157212316|NCT01415921|567524909|FG001|Overall Study|Physician Decision|1|||
157212317|NCT01415921|567524908|FG000|Overall Study|Withdrawal by Subject|0|||
157212318|NCT01415921|567524909|FG001|Overall Study|Withdrawal by Subject|1|||
157212319|NCT01415921|567524908|FG000|Overall Study|Other|2|||
157212320|NCT01415921|567524909|FG001|Overall Study|Other|0|||
157212321|NCT02143947|567524910|FG000|Overall Study|Lost to Follow-up|4|||
157212322|NCT02143947|567524911|FG001|Overall Study|Lost to Follow-up|2|||
157212323|NCT00697112|567524914|FG000|Overall Study|Adverse Event|8|||
157212324|NCT00697112|567524914|FG000|Overall Study|Lost to Follow-up|1|||
157212325|NCT00697112|567524914|FG000|Overall Study|Did not meet inclusion criteria|1|||
157212326|NCT03402126|567524919|FG000|Overall Study|Lost to Follow-up|6|||
157212327|NCT03402126|567524919|FG000|Overall Study|Protocol Violation|10|||
157212328|NCT03402126|567524919|FG000|Overall Study|Sponsor request/Study termination|29|||
157212329|NCT03402126|567524919|FG000|Overall Study|Study product no longer in use|1|||
157212330|NCT03402126|567524919|FG000|Overall Study|Technical problems|1|||
157212331|NCT03402126|567524919|FG000|Overall Study|Withdrawal by Subject|6|||
157212332|NCT03402126|567524919|FG000|Overall Study|Physician Decision|2|||
157212333|NCT03402126|567524919|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
157212334|NCT03402126|567524919|FG000|Overall Study|Death|4|||
157212335|NCT02261974|567524920|FG000|Overall Study|Withdrawal by Subject|3|||
157212336|NCT02261974|567524921|FG001|Overall Study|Withdrawal by Subject|2|||
157212337|NCT02261974|567524920|FG000|Overall Study|Pregnancy|0|||
157212338|NCT02261974|567524921|FG001|Overall Study|Pregnancy|1|||
157212339|NCT02261974|567524920|FG000|Overall Study|Missed treatment cut-off date|6|||
157212340|NCT02261974|567524921|FG001|Overall Study|Missed treatment cut-off date|3|||
157212341|NCT02261974|567524920|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
157212342|NCT02261974|567524921|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
157212343|NCT02261974|567524920|FG000|Overall Study|Lost to Follow-up|2|||
157212344|NCT02261974|567524921|FG001|Overall Study|Lost to Follow-up|0|||
157212345|NCT02261974|567524920|FG000|Overall Study|Adverse Event|1|||
157212346|NCT02261974|567524921|FG001|Overall Study|Adverse Event|0|||
157212347|NCT00996918|567524922|FG000|Overall Study|Lack of Efficacy|1|||
157212348|NCT00996918|567524923|FG001|Overall Study|Lack of Efficacy|1|||
157212349|NCT00996918|567524924|FG002|Overall Study|Lack of Efficacy|2|||
157212350|NCT00996918|567524925|FG003|Overall Study|Lack of Efficacy|2|||
157212351|NCT00996918|567524926|FG004|Overall Study|Lack of Efficacy|0|||
157212352|NCT00996918|567524922|FG000|Overall Study|Adverse Event|2|||
157212353|NCT00996918|567524923|FG001|Overall Study|Adverse Event|5|||
157212354|NCT00996918|567524924|FG002|Overall Study|Adverse Event|2|||
157212355|NCT00996918|567524925|FG003|Overall Study|Adverse Event|6|||
157212356|NCT00996918|567524926|FG004|Overall Study|Adverse Event|0|||
157212357|NCT00996918|567524922|FG000|Overall Study|Withdrawal by Subject|1|||
157212358|NCT00996918|567524923|FG001|Overall Study|Withdrawal by Subject|4|||
157212359|NCT00996918|567524924|FG002|Overall Study|Withdrawal by Subject|3|||
157212360|NCT00996918|567524925|FG003|Overall Study|Withdrawal by Subject|3|||
157212361|NCT00996918|567524926|FG004|Overall Study|Withdrawal by Subject|2|||
157212362|NCT00996918|567524922|FG000|Overall Study|Physician Decision|1|||
157212363|NCT00996918|567524923|FG001|Overall Study|Physician Decision|0|||
157212364|NCT00996918|567524924|FG002|Overall Study|Physician Decision|0|||
157212365|NCT00996918|567524925|FG003|Overall Study|Physician Decision|0|||
157212366|NCT00996918|567524926|FG004|Overall Study|Physician Decision|0|||
157212367|NCT00996918|567524922|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
157212368|NCT00996918|567524923|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
157212369|NCT00996918|567524924|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
157212370|NCT00996918|567524925|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
157212371|NCT00996918|567524926|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
157212372|NCT00996918|567524922|FG000|Overall Study|Loss of Caregiver|0|||
157212373|NCT00996918|567524923|FG001|Overall Study|Loss of Caregiver|1|||
157212374|NCT00996918|567524924|FG002|Overall Study|Loss of Caregiver|0|||
157212375|NCT00996918|567524925|FG003|Overall Study|Loss of Caregiver|0|||
157212376|NCT00996918|567524926|FG004|Overall Study|Loss of Caregiver|0|||
157212377|NCT00996918|567524922|FG000|Overall Study|Other|3|||
157212378|NCT00996918|567524923|FG001|Overall Study|Other|1|||
157212379|NCT00996918|567524924|FG002|Overall Study|Other|0|||
157212380|NCT00996918|567524925|FG003|Overall Study|Other|0|||
157212381|NCT00996918|567524926|FG004|Overall Study|Other|0|||
157212382|NCT01466673|567524929|FG000|Overall Study|Non-compliance with study treatment|2|||
157212383|NCT01466673|567524930|FG001|Overall Study|Non-compliance with study treatment|0|||
157212384|NCT01466673|567524929|FG000|Overall Study|Lost to Follow-up|3|||
157212385|NCT01466673|567524930|FG001|Overall Study|Lost to Follow-up|5|||
157212386|NCT01466673|567524929|FG000|Overall Study|Adverse Event|2|||
157212387|NCT01466673|567524930|FG001|Overall Study|Adverse Event|1|||
157212388|NCT02725671|567524931|FG000|Overall Study|Lost to Follow-up|1|||
157212389|NCT02983227|567524938|FG000|Overall Study|Adverse Event|21|||
157212390|NCT02983227|567524939|FG001|Overall Study|Adverse Event|3|||
157212391|NCT02983227|567524938|FG000|Overall Study|Death|3|||
157212392|NCT02983227|567524939|FG001|Overall Study|Death|0|||
157212393|NCT02983227|567524938|FG000|Overall Study|Lack of Efficacy|8|||
157212394|NCT02983227|567524939|FG001|Overall Study|Lack of Efficacy|1|||
157212395|NCT02983227|567524938|FG000|Overall Study|Lost to Follow-up|3|||
157212396|NCT02983227|567524939|FG001|Overall Study|Lost to Follow-up|0|||
157212397|NCT02983227|567524938|FG000|Overall Study|Multiple Reasons|2|||
157212398|NCT02983227|567524939|FG001|Overall Study|Multiple Reasons|1|||
157212399|NCT02983227|567524938|FG000|Overall Study|Physician Decision|3|||
157212400|NCT02983227|567524939|FG001|Overall Study|Physician Decision|1|||
157212401|NCT02983227|567524938|FG000|Overall Study|Withdrawal by Subject|19|||
157212402|NCT02983227|567524939|FG001|Overall Study|Withdrawal by Subject|8|||
157212403|NCT00068445|567524942|FG000|Randomization|Cancel|1|||
157212404|NCT00068445|567524943|FG001|Randomization|Cancel|3|||
157212405|NCT00068445|567524942|FG000|Randomization|Ineligible|1|||
157212406|NCT00068445|567524943|FG001|Randomization|Ineligible|1|||
157212407|NCT00068445|567524942|FG000|Treatment|Refused Further Treatment|13|||
157212408|NCT00068445|567524943|FG001|Treatment|Refused Further Treatment|10|||
157212409|NCT00068445|567524942|FG000|Treatment|Adverse Event|7|||
157212410|NCT00068445|567524943|FG001|Treatment|Adverse Event|1|||
157212411|NCT00068445|567524942|FG000|Treatment|Other (Specifics not available)|9|||
157212412|NCT00068445|567524943|FG001|Treatment|Other (Specifics not available)|5|||
157212413|NCT01155284|567524944|FG000|Overall Study|Withdrawal by Subject|4|||
157212414|NCT01155284|567524945|FG001|Overall Study|Withdrawal by Subject|3|||
157212415|NCT01155284|567524944|FG000|Overall Study|Lost to Follow-up|1|||
157212416|NCT01155284|567524945|FG001|Overall Study|Lost to Follow-up|2|||
157212417|NCT01155284|567524944|FG000|Overall Study|Physician Decision|1|||
157212418|NCT01155284|567524945|FG001|Overall Study|Physician Decision|0|||
157212419|NCT01155284|567524944|FG000|Overall Study|Adverse Event|1|||
157212420|NCT01155284|567524945|FG001|Overall Study|Adverse Event|0|||
157212421|NCT01896700|567524946|FG000|Overall Study|Adverse Event|4|||
157212422|NCT01896700|567524947|FG001|Overall Study|Adverse Event|5|||
157212423|NCT01896700|567524946|FG000|Overall Study|Withdrawal by Subject|0|||
157212424|NCT01896700|567524947|FG001|Overall Study|Withdrawal by Subject|1|||
157212425|NCT00123487|567524948|FG000|Randomized|Death prior to starting treatment|0|||
157212426|NCT00123487|567524949|FG001|Randomized|Death prior to starting treatment|1|||
157212427|NCT00123487|567524948|FG000|Randomized|SAE prior to starting treatment|1|||
157212428|NCT00123487|567524949|FG001|Randomized|SAE prior to starting treatment|0|||
157212429|NCT00123487|567524948|FG000|Treated With Study Drug|Adverse Event|23|||
157212430|NCT00123487|567524949|FG001|Treated With Study Drug|Adverse Event|22|||
157212431|NCT00123487|567524948|FG000|Treated With Study Drug|Disease Progression|141|||
157212432|NCT00123487|567524949|FG001|Treated With Study Drug|Disease Progression|122|||
157212433|NCT00123487|567524948|FG000|Treated With Study Drug|Physician Decision|8|||
157212434|NCT00123487|567524949|FG001|Treated With Study Drug|Physician Decision|9|||
157212435|NCT00123487|567524948|FG000|Treated With Study Drug|Other|59|||
157212436|NCT00123487|567524949|FG001|Treated With Study Drug|Other|58|||
157212437|NCT00123487|567524948|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
157212438|NCT00123487|567524949|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
157212439|NCT00123487|567524948|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
157212440|NCT00123487|567524949|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
157212441|NCT00123487|567524948|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
157212442|NCT00123487|567524949|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
157212443|NCT03118765|567524950|FG000|Overall Study|Withdrawal by Subject|0|||
157212444|NCT03118765|567524951|FG001|Overall Study|Withdrawal by Subject|0|||
157212445|NCT03118765|567524952|FG002|Overall Study|Withdrawal by Subject|1|||
157212446|NCT03118765|567524953|FG003|Overall Study|Withdrawal by Subject|0|||
157212447|NCT03118765|567524954|FG004|Overall Study|Withdrawal by Subject|0|||
157212448|NCT03118765|567524950|FG000|Overall Study|Adverse Event|1|||
157212449|NCT03118765|567524951|FG001|Overall Study|Adverse Event|1|||
157212450|NCT03118765|567524952|FG002|Overall Study|Adverse Event|1|||
157212451|NCT03118765|567524953|FG003|Overall Study|Adverse Event|1|||
157212452|NCT03118765|567524954|FG004|Overall Study|Adverse Event|1|||
157212453|NCT03118765|567524950|FG000|Overall Study|Non compliance with Study Procedures|0|||
157212454|NCT03118765|567524951|FG001|Overall Study|Non compliance with Study Procedures|0|||
157212455|NCT03118765|567524952|FG002|Overall Study|Non compliance with Study Procedures|0|||
157212456|NCT03118765|567524953|FG003|Overall Study|Non compliance with Study Procedures|1|||
157212457|NCT03118765|567524954|FG004|Overall Study|Non compliance with Study Procedures|0|||
157212458|NCT03118765|567524950|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
157212459|NCT03118765|567524951|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
157212460|NCT03118765|567524952|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
157212461|NCT03118765|567524953|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
157212462|NCT03118765|567524954|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
157212463|NCT03118765|567524950|FG000|Overall Study|COPD Exacerbation|1|||
157212464|NCT03118765|567524951|FG001|Overall Study|COPD Exacerbation|0|||
157212465|NCT03118765|567524952|FG002|Overall Study|COPD Exacerbation|0|||
157212466|NCT03118765|567524953|FG003|Overall Study|COPD Exacerbation|1|||
157212467|NCT03118765|567524954|FG004|Overall Study|COPD Exacerbation|0|||
157212468|NCT03118765|567524950|FG000|Overall Study|Lost to Follow-up|1|||
157212469|NCT03118765|567524951|FG001|Overall Study|Lost to Follow-up|0|||
157212470|NCT03118765|567524952|FG002|Overall Study|Lost to Follow-up|1|||
157212471|NCT03118765|567524953|FG003|Overall Study|Lost to Follow-up|0|||
157212472|NCT03118765|567524954|FG004|Overall Study|Lost to Follow-up|0|||
157212473|NCT03118765|567524950|FG000|Overall Study|Sponsor Decision|1|||
157212474|NCT03118765|567524951|FG001|Overall Study|Sponsor Decision|0|||
157212475|NCT03118765|567524952|FG002|Overall Study|Sponsor Decision|1|||
157212476|NCT03118765|567524953|FG003|Overall Study|Sponsor Decision|0|||
157212477|NCT03118765|567524954|FG004|Overall Study|Sponsor Decision|1|||
157212478|NCT01255722|567524957|FG000|Overall Study|Adverse Event|0|||
157212479|NCT01255722|567524958|FG001|Overall Study|Adverse Event|1|||
157212480|NCT01255722|567524959|FG002|Overall Study|Adverse Event|1|||
157212481|NCT01255722|567524957|FG000|Overall Study|asymptomatic patient|1|||
157212482|NCT01255722|567524958|FG001|Overall Study|asymptomatic patient|0|||
157212483|NCT01255722|567524959|FG002|Overall Study|asymptomatic patient|0|||
157212484|NCT01255722|567524957|FG000|Overall Study|beta-blocker contraindicated|2|||
157212485|NCT01255722|567524958|FG001|Overall Study|beta-blocker contraindicated|0|||
157212486|NCT01255722|567524959|FG002|Overall Study|beta-blocker contraindicated|0|||
157212487|NCT02164539|567524960|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
157212488|NCT02164539|567524961|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
157212489|NCT02164539|567524962|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
157212490|NCT02164539|567524963|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
157212491|NCT02164539|567524964|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
157212492|NCT02164539|567524965|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
157212493|NCT02164539|567524966|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
157212494|NCT02164539|567524960|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
157212495|NCT02164539|567524961|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
157212496|NCT02164539|567524962|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
157212497|NCT02164539|567524963|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
157212498|NCT02164539|567524964|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
157212499|NCT02164539|567524965|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
157212500|NCT02164539|567524966|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
157212501|NCT02164539|567524960|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
157212502|NCT02164539|567524961|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
157212503|NCT02164539|567524962|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
157212504|NCT02164539|567524963|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
157212505|NCT02164539|567524964|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
157212506|NCT02164539|567524965|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
157212507|NCT02164539|567524966|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
157212508|NCT02164539|567524960|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
157212509|NCT02164539|567524961|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212510|NCT02164539|567524962|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212511|NCT02164539|567524963|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212512|NCT02164539|567524964|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212513|NCT02164539|567524965|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212514|NCT02164539|567524966|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
157212515|NCT02164539|567524960|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
157212516|NCT02164539|567524961|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
157212517|NCT02164539|567524962|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
157212518|NCT02164539|567524963|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
157212519|NCT02164539|567524964|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
157212520|NCT02164539|567524965|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
157212521|NCT02164539|567524966|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
157212522|NCT02164539|567524960|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
157212523|NCT02164539|567524961|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
157212524|NCT02164539|567524962|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
157212525|NCT02164539|567524963|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
157212526|NCT02164539|567524964|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
157212527|NCT02164539|567524965|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
157212528|NCT02164539|567524966|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
157212529|NCT02643966|567524967|FG000|First Screening Round|ineligible|1|||
157212530|NCT02643966|567524967|FG000|First Screening Round|excluded from analysis|2|||
157212531|NCT02643966|567524967|FG000|First Screening Round|Lost to Follow-up|56|||
157212532|NCT02643966|567524967|FG000|First Screening Round|Withdrawal by Subject|28|||
157212533|NCT02643966|567524967|FG000|First Screening Round|Death|1|||
157212534|NCT02643966|567524967|FG000|Between First and Second Screening|Lost to Follow-up|65|||
157212535|NCT02643966|567524967|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
157212536|NCT02643966|567524967|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
157212537|NCT02643966|567524967|FG000|Second Screening Round|Withdrawal by Subject|20|||
157117860|NCT03245450|567184151|FG000|Overall Study|Withdrawal by Subject|0|||
157117861|NCT03245450|567184152|FG001|Overall Study|Withdrawal by Subject|1|||
157117862|NCT03245450|567184153|FG002|Overall Study|Withdrawal by Subject|0|||
157117863|NCT03245450|567184154|FG003|Overall Study|Withdrawal by Subject|0|||
157117864|NCT03245450|567184155|FG004|Overall Study|Withdrawal by Subject|0|||
157117865|NCT03245450|567184156|FG005|Overall Study|Withdrawal by Subject|0|||
157117866|NCT03245450|567184157|FG006|Overall Study|Withdrawal by Subject|0|||
157117867|NCT03245450|567184151|FG000|Overall Study|Adverse Event|0|||
157117868|NCT03245450|567184152|FG001|Overall Study|Adverse Event|0|||
157117869|NCT03245450|567184153|FG002|Overall Study|Adverse Event|0|||
157117870|NCT03245450|567184154|FG003|Overall Study|Adverse Event|0|||
157117871|NCT03245450|567184155|FG004|Overall Study|Adverse Event|1|||
157117872|NCT03245450|567184156|FG005|Overall Study|Adverse Event|0|||
157117873|NCT03245450|567184157|FG006|Overall Study|Adverse Event|2|||
157117874|NCT00705939|567184162|FG000|Overall Study|Protocol Violation|0|||
157117875|NCT00705939|567184163|FG001|Overall Study|Protocol Violation|0|||
157117876|NCT00705939|567184164|FG002|Overall Study|Protocol Violation|1|||
157117877|NCT00705939|567184162|FG000|Overall Study|Withdrawal by Subject|0|||
157117878|NCT00705939|567184163|FG001|Overall Study|Withdrawal by Subject|1|||
157117879|NCT00705939|567184164|FG002|Overall Study|Withdrawal by Subject|3|||
157117880|NCT00705939|567184162|FG000|Overall Study|Physician Decision|0|||
157117881|NCT00705939|567184163|FG001|Overall Study|Physician Decision|1|||
157117882|NCT00705939|567184164|FG002|Overall Study|Physician Decision|0|||
157117883|NCT02599961|567184165|FG000|Overall Study|Withdrawal by Subject|1|||
157117884|NCT02599961|567184165|FG000|Overall Study|Subject Non-Compliance|2|||
157117885|NCT02599961|567184165|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
157117886|NCT02599961|567184165|FG000|Overall Study|Other, Not Specified|3|||
157117887|NCT00618410|567184168|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
157117888|NCT00618410|567184169|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
157117889|NCT00464334|567184173|FG000|Overall Study|Adverse Event|0|||
157117890|NCT00464334|567184174|FG001|Overall Study|Adverse Event|0|||
157117891|NCT00464334|567184175|FG002|Overall Study|Adverse Event|0|||
157117892|NCT00464334|567184176|FG003|Overall Study|Adverse Event|1|||
157117893|NCT00464334|567184177|FG004|Overall Study|Adverse Event|1|||
157117894|NCT00464334|567184178|FG005|Overall Study|Adverse Event|1|||
157117895|NCT00464334|567184179|FG006|Overall Study|Adverse Event|0|||
157117896|NCT00464334|567184180|FG007|Overall Study|Adverse Event|0|||
157117897|NCT00464334|567184181|FG008|Overall Study|Adverse Event|2|||
157117898|NCT00464334|567184182|FG009|Overall Study|Adverse Event|1|||
157117899|NCT00464334|567184183|FG010|Overall Study|Adverse Event|2|||
157117900|NCT00464334|567184173|FG000|Overall Study|Lack of Efficacy|0|||
157117901|NCT00464334|567184174|FG001|Overall Study|Lack of Efficacy|1|||
157117902|NCT00464334|567184175|FG002|Overall Study|Lack of Efficacy|0|||
157117903|NCT00464334|567184176|FG003|Overall Study|Lack of Efficacy|0|||
157117904|NCT00464334|567184177|FG004|Overall Study|Lack of Efficacy|0|||
157117905|NCT00464334|567184178|FG005|Overall Study|Lack of Efficacy|0|||
157117906|NCT00464334|567184179|FG006|Overall Study|Lack of Efficacy|0|||
157117907|NCT00464334|567184180|FG007|Overall Study|Lack of Efficacy|0|||
157117908|NCT00464334|567184181|FG008|Overall Study|Lack of Efficacy|0|||
157117909|NCT00464334|567184182|FG009|Overall Study|Lack of Efficacy|0|||
157117910|NCT00464334|567184183|FG010|Overall Study|Lack of Efficacy|0|||
157117911|NCT00464334|567184173|FG000|Overall Study|Lost to Follow-up|0|||
157117912|NCT00464334|567184174|FG001|Overall Study|Lost to Follow-up|0|||
157117913|NCT00464334|567184175|FG002|Overall Study|Lost to Follow-up|1|||
157117914|NCT00464334|567184176|FG003|Overall Study|Lost to Follow-up|0|||
157117915|NCT00464334|567184177|FG004|Overall Study|Lost to Follow-up|1|||
157117916|NCT00464334|567184178|FG005|Overall Study|Lost to Follow-up|0|||
157117917|NCT00464334|567184179|FG006|Overall Study|Lost to Follow-up|1|||
157117918|NCT00464334|567184180|FG007|Overall Study|Lost to Follow-up|0|||
157117919|NCT00464334|567184181|FG008|Overall Study|Lost to Follow-up|0|||
157117920|NCT00464334|567184182|FG009|Overall Study|Lost to Follow-up|0|||
157117921|NCT00464334|567184183|FG010|Overall Study|Lost to Follow-up|2|||
157117922|NCT00464334|567184173|FG000|Overall Study|Progressive Disease|0|||
157117923|NCT00464334|567184174|FG001|Overall Study|Progressive Disease|0|||
157117924|NCT00464334|567184175|FG002|Overall Study|Progressive Disease|0|||
157117925|NCT00464334|567184176|FG003|Overall Study|Progressive Disease|0|||
157117926|NCT00464334|567184177|FG004|Overall Study|Progressive Disease|0|||
157117927|NCT00464334|567184178|FG005|Overall Study|Progressive Disease|1|||
157117928|NCT00464334|567184179|FG006|Overall Study|Progressive Disease|0|||
157117929|NCT00464334|567184180|FG007|Overall Study|Progressive Disease|0|||
157117930|NCT00464334|567184181|FG008|Overall Study|Progressive Disease|1|||
157117931|NCT00464334|567184182|FG009|Overall Study|Progressive Disease|0|||
157117932|NCT00464334|567184183|FG010|Overall Study|Progressive Disease|0|||
157117933|NCT00464334|567184173|FG000|Overall Study|Study Terminated by Sponsor|0|||
157117934|NCT00464334|567184174|FG001|Overall Study|Study Terminated by Sponsor|0|||
157117935|NCT00464334|567184175|FG002|Overall Study|Study Terminated by Sponsor|0|||
157117936|NCT00464334|567184176|FG003|Overall Study|Study Terminated by Sponsor|1|||
157117937|NCT00464334|567184177|FG004|Overall Study|Study Terminated by Sponsor|0|||
157117938|NCT00464334|567184178|FG005|Overall Study|Study Terminated by Sponsor|0|||
157212538|NCT02643966|567524967|FG000|Second Screening Round|Lost to Follow-up|57|||
157212539|NCT02643966|567524967|FG000|Second Screening Round|Physician Decision|2|||
157212540|NCT02643966|567524967|FG000|Second Screening Round|Death|4|||
157212541|NCT02643966|567524967|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
157212542|NCT02643966|567524967|FG000|Between Second and Third Screening|Death|1|||
157212543|NCT02643966|567524967|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
157212544|NCT02643966|567524967|FG000|Third Screening Round|PI excluded|2|||
157212545|NCT02643966|567524967|FG000|Third Screening Round|Lost to Follow-up|241|||
157212546|NCT01493531|567524968|FG000|Overall Study|Adverse Event|4|||
157212547|NCT01493531|567524969|FG001|Overall Study|Adverse Event|12|||
157212548|NCT01493531|567524970|FG002|Overall Study|Adverse Event|9|||
157212549|NCT01493531|567524968|FG000|Overall Study|Gout flare|3|||
157212550|NCT01493531|567524969|FG001|Overall Study|Gout flare|0|||
157212551|NCT01493531|567524970|FG002|Overall Study|Gout flare|2|||
157212552|NCT01493531|567524968|FG000|Overall Study|Protocol Violation|8|||
157212553|NCT01493531|567524969|FG001|Overall Study|Protocol Violation|15|||
157212554|NCT01493531|567524970|FG002|Overall Study|Protocol Violation|12|||
157212555|NCT01493531|567524968|FG000|Overall Study|Sponsor terminated study|5|||
157212556|NCT01493531|567524969|FG001|Overall Study|Sponsor terminated study|2|||
157212557|NCT01493531|567524970|FG002|Overall Study|Sponsor terminated study|3|||
157212558|NCT01493531|567524968|FG000|Overall Study|Lost to Follow-up|5|||
157212559|NCT01493531|567524969|FG001|Overall Study|Lost to Follow-up|7|||
157212560|NCT01493531|567524970|FG002|Overall Study|Lost to Follow-up|11|||
157212561|NCT01493531|567524968|FG000|Overall Study|Withdrawal by Subject|16|||
157212562|NCT01493531|567524969|FG001|Overall Study|Withdrawal by Subject|13|||
157212563|NCT01493531|567524970|FG002|Overall Study|Withdrawal by Subject|11|||
157212564|NCT01493531|567524968|FG000|Overall Study|Death|0|||
157212565|NCT01493531|567524969|FG001|Overall Study|Death|1|||
157212566|NCT01493531|567524970|FG002|Overall Study|Death|0|||
157212567|NCT03031431|567524973|FG000|Overall Study|Infant removed by maternal request|1|||
157212568|NCT00995930|567524974|FG000|Overall Study|Protocol deviation|2|||
157212569|NCT00995930|567524975|FG001|Overall Study|Protocol deviation|5|||
157212570|NCT00995930|567524974|FG000|Overall Study|Death|0|||
157212571|NCT00995930|567524975|FG001|Overall Study|Death|1|||
157212572|NCT00995930|567524974|FG000|Overall Study|Administrative problems|4|||
157212573|NCT00995930|567524975|FG001|Overall Study|Administrative problems|2|||
157212574|NCT00995930|567524974|FG000|Overall Study|Lost to Follow-up|1|||
157212575|NCT00995930|567524975|FG001|Overall Study|Lost to Follow-up|2|||
157212576|NCT00995930|567524974|FG000|Overall Study|Withdrawal by Subject|3|||
157212577|NCT00995930|567524975|FG001|Overall Study|Withdrawal by Subject|4|||
157212578|NCT00995930|567524974|FG000|Overall Study|Adverse Event|11|||
157212579|NCT00995930|567524975|FG001|Overall Study|Adverse Event|14|||
157212580|NCT01246973|567526010|FG000|Overall Study|Other|38|||
157212581|NCT01246973|567526011|FG001|Overall Study|Other|25|||
157212582|NCT01246973|567526010|FG000|Overall Study|Adverse Event|16|||
157212583|NCT01246973|567526011|FG001|Overall Study|Adverse Event|9|||
157212584|NCT01246973|567526010|FG000|Overall Study|Withdrawal by Subject|7|||
157212585|NCT01246973|567526011|FG001|Overall Study|Withdrawal by Subject|13|||
157212586|NCT02598622|567526013|FG000|Overall Study|Withdrawal by Subject|3|||
157212587|NCT02598622|567526014|FG001|Overall Study|Withdrawal by Subject|0|||
157212588|NCT02598622|567526013|FG000|Overall Study|Physician Decision|3|||
157212589|NCT02598622|567526014|FG001|Overall Study|Physician Decision|0|||
157212590|NCT00681824|567526018|FG000|Overall Study|withdrawn by investigator|0|||
157212591|NCT00681824|567526019|FG001|Overall Study|withdrawn by investigator|0|||
157212592|NCT00681824|567526020|FG002|Overall Study|withdrawn by investigator|1|||
157212593|NCT00681824|567526018|FG000|Overall Study|scheduling conflict|1|||
157212594|NCT00681824|567526019|FG001|Overall Study|scheduling conflict|0|||
157212595|NCT00681824|567526020|FG002|Overall Study|scheduling conflict|0|||
157212596|NCT00681824|567526018|FG000|Overall Study|Death|0|||
157212597|NCT00681824|567526019|FG001|Overall Study|Death|1|||
157212598|NCT00681824|567526020|FG002|Overall Study|Death|0|||
157212599|NCT04575038|567526021|FG000|Overall Study|Withdrawal by Subject|1|||
157212600|NCT04575038|567526022|FG001|Overall Study|Withdrawal by Subject|1|||
157212601|NCT01416142|567526027|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
157212602|NCT01416142|567526028|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
157212603|NCT01416142|567526029|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
157212604|NCT00678379|567526030|FG000|Overall Study|Injection performed after tonsillectomy|2|||
157212605|NCT00678379|567526031|FG001|Overall Study|Injection performed after tonsillectomy|0|||
157212606|NCT00678379|567526032|FG002|Overall Study|Injection performed after tonsillectomy|1|||
156779791|NCT01078662|565943887|FG004|Overall Study|Patients reached data cut-off|3|||
157212607|NCT00678379|567526030|FG000|Overall Study|Incomplete Data|4|||
157212608|NCT00678379|567526031|FG001|Overall Study|Incomplete Data|3|||
157212609|NCT00678379|567526032|FG002|Overall Study|Incomplete Data|3|||
157212610|NCT01835470|567526033|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
157212611|NCT01835470|567526033|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
157212612|NCT01011907|567526034|FG000|Overall Study|Withdrawal by Subject|13|||
157212613|NCT01011907|567526035|FG001|Overall Study|Withdrawal by Subject|11|||
157212614|NCT01011907|567526034|FG000|Overall Study|Adverse Event|1|||
157117939|NCT00464334|567184179|FG006|Overall Study|Study Terminated by Sponsor|0|||
157117940|NCT00464334|567184180|FG007|Overall Study|Study Terminated by Sponsor|0|||
157117941|NCT00464334|567184181|FG008|Overall Study|Study Terminated by Sponsor|0|||
157117942|NCT00464334|567184182|FG009|Overall Study|Study Terminated by Sponsor|0|||
157117943|NCT00464334|567184183|FG010|Overall Study|Study Terminated by Sponsor|0|||
157117944|NCT00464334|567184173|FG000|Overall Study|Withdrawal by Subject|1|||
157117945|NCT00464334|567184174|FG001|Overall Study|Withdrawal by Subject|7|||
157117946|NCT00464334|567184175|FG002|Overall Study|Withdrawal by Subject|4|||
157117947|NCT00464334|567184176|FG003|Overall Study|Withdrawal by Subject|2|||
157117948|NCT00464334|567184177|FG004|Overall Study|Withdrawal by Subject|2|||
157117949|NCT00464334|567184178|FG005|Overall Study|Withdrawal by Subject|2|||
157117950|NCT00464334|567184179|FG006|Overall Study|Withdrawal by Subject|2|||
157117951|NCT00464334|567184180|FG007|Overall Study|Withdrawal by Subject|1|||
157117952|NCT00464334|567184181|FG008|Overall Study|Withdrawal by Subject|3|||
157117953|NCT00464334|567184182|FG009|Overall Study|Withdrawal by Subject|0|||
157117954|NCT00464334|567184183|FG010|Overall Study|Withdrawal by Subject|0|||
157117955|NCT03948178|567184184|FG000|Overall Study|Protocol Violation|1|||
157117956|NCT03948178|567184184|FG000|Overall Study|Lost to Follow-up|2|||
157117957|NCT03948178|567184184|FG000|Overall Study|Withdrawal by Subject|2|||
157117958|NCT03948178|567184184|FG000|Overall Study|Reason not known|2|||
157117959|NCT03948178|567184184|FG000|Overall Study|Personal reason|14|||
157117960|NCT03948178|567184184|FG000|Overall Study|Disease progression|30|||
157117961|NCT03948178|567184184|FG000|Overall Study|Adverse Event|12|||
157117962|NCT03948178|567184184|FG000|Overall Study|Sponsor terminated study|164|||
157117963|NCT00401752|567184187|FG000|Overall Study|Adverse Event|2|||
157117964|NCT00401752|567184188|FG001|Overall Study|Adverse Event|5|||
157117965|NCT00401752|567184187|FG000|Overall Study|Withdrawal by Subject|2|||
157117966|NCT00401752|567184188|FG001|Overall Study|Withdrawal by Subject|6|||
157117967|NCT00401752|567184187|FG000|Overall Study|Lost to Follow-up|1|||
157117968|NCT00401752|567184188|FG001|Overall Study|Lost to Follow-up|4|||
157117969|NCT00401752|567184187|FG000|Overall Study|Development of any exclusion criteria|4|||
157117970|NCT00401752|567184188|FG001|Overall Study|Development of any exclusion criteria|2|||
157117971|NCT00401752|567184187|FG000|Overall Study|Physician Decision|1|||
157117972|NCT00401752|567184188|FG001|Overall Study|Physician Decision|1|||
157117973|NCT02432235|567184189|FG000|Overall Study|Death|1|||
157117974|NCT02432235|567184190|FG001|Overall Study|Death|1|||
157117975|NCT02432235|567184191|FG002|Overall Study|Death|2|||
157117976|NCT02432235|567184192|FG003|Overall Study|Death|2|||
157117977|NCT02432235|567184193|FG004|Overall Study|Death|1|||
157117978|NCT02432235|567184194|FG005|Overall Study|Death|3|||
157117979|NCT02432235|567184195|FG006|Overall Study|Death|11|||
157117980|NCT02432235|567184196|FG007|Overall Study|Death|15|||
157117981|NCT02432235|567184197|FG008|Overall Study|Death|15|||
157117982|NCT02432235|567184198|FG009|Overall Study|Death|3|||
157117983|NCT02432235|567184199|FG010|Overall Study|Death|1|||
157117984|NCT02432235|567184200|FG011|Overall Study|Death|0|||
157117985|NCT02432235|567184189|FG000|Overall Study|Withdrawal by Subject|0|||
157117986|NCT02432235|567184190|FG001|Overall Study|Withdrawal by Subject|1|||
157117987|NCT02432235|567184191|FG002|Overall Study|Withdrawal by Subject|0|||
157117988|NCT02432235|567184192|FG003|Overall Study|Withdrawal by Subject|0|||
157117989|NCT02432235|567184193|FG004|Overall Study|Withdrawal by Subject|0|||
157117990|NCT02432235|567184194|FG005|Overall Study|Withdrawal by Subject|2|||
157117991|NCT02432235|567184195|FG006|Overall Study|Withdrawal by Subject|5|||
157117992|NCT02432235|567184196|FG007|Overall Study|Withdrawal by Subject|3|||
157117993|NCT02432235|567184197|FG008|Overall Study|Withdrawal by Subject|1|||
157117994|NCT02432235|567184198|FG009|Overall Study|Withdrawal by Subject|0|||
157117995|NCT02432235|567184199|FG010|Overall Study|Withdrawal by Subject|0|||
157117996|NCT02432235|567184200|FG011|Overall Study|Withdrawal by Subject|0|||
157117997|NCT02432235|567184189|FG000|Overall Study|Lost to Follow-up|0|||
157117998|NCT02432235|567184190|FG001|Overall Study|Lost to Follow-up|0|||
157117999|NCT02432235|567184191|FG002|Overall Study|Lost to Follow-up|0|||
157118000|NCT02432235|567184192|FG003|Overall Study|Lost to Follow-up|0|||
157118001|NCT02432235|567184193|FG004|Overall Study|Lost to Follow-up|0|||
157118002|NCT02432235|567184194|FG005|Overall Study|Lost to Follow-up|1|||
157118003|NCT02432235|567184195|FG006|Overall Study|Lost to Follow-up|0|||
157118004|NCT02432235|567184196|FG007|Overall Study|Lost to Follow-up|0|||
157118005|NCT02432235|567184197|FG008|Overall Study|Lost to Follow-up|1|||
157118006|NCT02432235|567184198|FG009|Overall Study|Lost to Follow-up|0|||
157118007|NCT02432235|567184199|FG010|Overall Study|Lost to Follow-up|0|||
157118008|NCT02432235|567184200|FG011|Overall Study|Lost to Follow-up|0|||
157118009|NCT02432235|567184189|FG000|Overall Study|Miscellaneous|0|||
157118010|NCT02432235|567184190|FG001|Overall Study|Miscellaneous|0|||
157118011|NCT02432235|567184191|FG002|Overall Study|Miscellaneous|0|||
157118012|NCT02432235|567184192|FG003|Overall Study|Miscellaneous|0|||
157118013|NCT02432235|567184193|FG004|Overall Study|Miscellaneous|1|||
157118014|NCT02432235|567184194|FG005|Overall Study|Miscellaneous|6|||
157118015|NCT02432235|567184195|FG006|Overall Study|Miscellaneous|2|||
157118016|NCT02432235|567184196|FG007|Overall Study|Miscellaneous|2|||
157118017|NCT02432235|567184197|FG008|Overall Study|Miscellaneous|4|||
157212615|NCT01011907|567526035|FG001|Overall Study|Adverse Event|4|||
157212616|NCT00304954|567526038|FG000|Overall Study|Withdrawal by Subject|0|||
157212617|NCT00304954|567526039|FG001|Overall Study|Withdrawal by Subject|0|||
157212618|NCT00304954|567526040|FG002|Overall Study|Withdrawal by Subject|1|||
157212619|NCT00304954|567526041|FG003|Overall Study|Withdrawal by Subject|0|||
157212620|NCT00304954|567526038|FG000|Overall Study|Adverse Event|1|||
157212621|NCT00304954|567526039|FG001|Overall Study|Adverse Event|0|||
157212622|NCT00304954|567526040|FG002|Overall Study|Adverse Event|0|||
157212623|NCT00304954|567526041|FG003|Overall Study|Adverse Event|0|||
157212624|NCT02770716|567526043|FG000|Overall Study|Death|101|||
157212625|NCT02770716|567526044|FG001|Overall Study|Death|45|||
157212626|NCT02770716|567526043|FG000|Overall Study|Withdrawal by Subject|4|||
157212627|NCT02770716|567526044|FG001|Overall Study|Withdrawal by Subject|2|||
157212628|NCT02770716|567526043|FG000|Overall Study|Lost to Follow-up|1|||
157212629|NCT02770716|567526044|FG001|Overall Study|Lost to Follow-up|0|||
157212630|NCT02770716|567526043|FG000|Overall Study|Various reasons|6|||
157212631|NCT02770716|567526044|FG001|Overall Study|Various reasons|2|||
157212632|NCT01244815|567526045|FG000|Overall Study|Not Treated|0|||
157212633|NCT01244815|567526046|FG001|Overall Study|Not Treated|1|||
157212634|NCT01244815|567526047|FG002|Overall Study|Not Treated|0|||
157212635|NCT01244815|567526048|FG003|Overall Study|Not Treated|0|||
157212636|NCT01244815|567526045|FG000|Overall Study|Adverse Event|4|||
157212637|NCT01244815|567526046|FG001|Overall Study|Adverse Event|7|||
157212638|NCT01244815|567526047|FG002|Overall Study|Adverse Event|5|||
157212639|NCT01244815|567526048|FG003|Overall Study|Adverse Event|5|||
157212640|NCT01244815|567526045|FG000|Overall Study|Treatment Failure|0|||
157212641|NCT01244815|567526046|FG001|Overall Study|Treatment Failure|0|||
157212642|NCT01244815|567526047|FG002|Overall Study|Treatment Failure|0|||
157212643|NCT01244815|567526048|FG003|Overall Study|Treatment Failure|1|||
157212644|NCT01244815|567526045|FG000|Overall Study|Lost to Follow-up|3|||
157212645|NCT01244815|567526046|FG001|Overall Study|Lost to Follow-up|2|||
157212646|NCT01244815|567526047|FG002|Overall Study|Lost to Follow-up|3|||
157212647|NCT01244815|567526048|FG003|Overall Study|Lost to Follow-up|2|||
157212648|NCT01244815|567526045|FG000|Overall Study|Withdrawal by Subject|0|||
157212649|NCT01244815|567526046|FG001|Overall Study|Withdrawal by Subject|2|||
157212650|NCT01244815|567526047|FG002|Overall Study|Withdrawal by Subject|0|||
157212651|NCT01244815|567526048|FG003|Overall Study|Withdrawal by Subject|3|||
157212652|NCT01244815|567526045|FG000|Overall Study|Protocol Violation|7|||
157212653|NCT01244815|567526046|FG001|Overall Study|Protocol Violation|4|||
157212654|NCT01244815|567526047|FG002|Overall Study|Protocol Violation|3|||
157011287|NCT01170962|566793450|FG002|Treatment Period|Participant no longer meets criteria|0|||
157011288|NCT01170962|566793448|FG000|Treatment Period|Request to discontinue treatment|7|||
157011289|NCT01170962|566793449|FG001|Treatment Period|Request to discontinue treatment|3|||
157011290|NCT01170962|566793450|FG002|Treatment Period|Request to discontinue treatment|1|||
157011291|NCT01170962|566793448|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
157011292|NCT01170962|566793449|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
157011293|NCT01170962|566793450|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
157011294|NCT01170962|566793448|FG000|Follow up Period|Withdrawal by Subject|14|||
157011295|NCT01170962|566793449|FG001|Follow up Period|Withdrawal by Subject|10|||
157011296|NCT01170962|566793450|FG002|Follow up Period|Withdrawal by Subject|2|||
157011297|NCT01170962|566793448|FG000|Follow up Period|Lost to Follow-up|13|||
157011298|NCT01170962|566793449|FG001|Follow up Period|Lost to Follow-up|8|||
157011299|NCT01170962|566793450|FG002|Follow up Period|Lost to Follow-up|1|||
157011300|NCT01170962|566793448|FG000|Follow up Period|Death|2|||
157011301|NCT01170962|566793449|FG001|Follow up Period|Death|2|||
157011302|NCT01170962|566793450|FG002|Follow up Period|Death|0|||
157011303|NCT01170962|566793448|FG000|Follow up Period|Others|10|||
157011304|NCT01170962|566793449|FG001|Follow up Period|Others|7|||
157011305|NCT01170962|566793450|FG002|Follow up Period|Others|3|||
157011306|NCT03942042|566793453|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
157011307|NCT03942042|566793454|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
157212655|NCT01244815|567526048|FG003|Overall Study|Protocol Violation|1|||
157212656|NCT01244815|567526045|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
157212657|NCT01244815|567526046|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
157212658|NCT01244815|567526047|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
157212659|NCT01244815|567526048|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
157212660|NCT04736576|567526051|FG000|Overall Study|Progressive disease|3|||
157212661|NCT04736576|567526052|FG001|Overall Study|Progressive disease|1|||
157212662|NCT04736576|567526051|FG000|Overall Study|Death|1|||
157212663|NCT04736576|567526052|FG001|Overall Study|Death|0|||
157212664|NCT05180630|567526056|FG000|First Intervention|Physician Decision|0|||
157212665|NCT05180630|567526057|FG001|First Intervention|Physician Decision|0|||
157212666|NCT05180630|567526058|FG002|First Intervention|Physician Decision|3|||
157212667|NCT00709735|567526061|FG000|Overall Study|Lost to Follow-up|1|||
157011308|NCT03942042|566793453|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
157011309|NCT03942042|566793454|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
157011310|NCT01499199|566793455|FG000|Overall Study|Adverse Event|1|||
157212668|NCT00709735|567526062|FG001|Overall Study|Lost to Follow-up|1|||
157212669|NCT00709735|567526061|FG000|Overall Study|Relapse into Opioid Abuse|0|||
157212670|NCT00709735|567526062|FG001|Overall Study|Relapse into Opioid Abuse|1|||
157212671|NCT00709735|567526061|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
157212672|NCT00709735|567526062|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
157212673|NCT01333475|567526063|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
157212674|NCT01333475|567526064|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
157212675|NCT01333475|567526063|FG000|Overall Study|Toxicity|1|||
157212676|NCT01333475|567526064|FG001|Overall Study|Toxicity|3|||
157212677|NCT04440007|567526065|FG000|Overall Study|Adverse Event|0|||
157212678|NCT04440007|567526066|FG001|Overall Study|Adverse Event|1|||
157212679|NCT04440007|567526065|FG000|Overall Study|Lost to Follow-up|1|||
157212680|NCT04440007|567526066|FG001|Overall Study|Lost to Follow-up|3|||
157212681|NCT04440007|567526065|FG000|Overall Study|Death|7|||
157212682|NCT04440007|567526066|FG001|Overall Study|Death|2|||
157212683|NCT04440007|567526065|FG000|Overall Study|Physician Decision|1|||
157212684|NCT04440007|567526066|FG001|Overall Study|Physician Decision|1|||
157212685|NCT04440007|567526065|FG000|Overall Study|Withdrawal by Subject|2|||
157212686|NCT04440007|567526066|FG001|Overall Study|Withdrawal by Subject|1|||
157212687|NCT04440007|567526065|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
157212688|NCT04440007|567526066|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
157212689|NCT04440007|567526065|FG000|Overall Study|Discontinued prior to dosing|0|||
157118018|NCT02432235|567184198|FG009|Overall Study|Miscellaneous|0|||
157118019|NCT02432235|567184199|FG010|Overall Study|Miscellaneous|0|||
157212690|NCT04440007|567526066|FG001|Overall Study|Discontinued prior to dosing|2|||
157212691|NCT01946282|567526069|FG000|Year 1|Did not return FIT kit|4186|||
157212692|NCT01946282|567526070|FG001|Year 1|Did not return FIT kit|608|||
157212693|NCT01946282|567526071|FG002|Year 1|Did not return FIT kit|654|||
157212694|NCT01946282|567526069|FG000|Year 2|Did not return FIT kit|803|||
157212695|NCT01946282|567526070|FG001|Year 2|Did not return FIT kit|131|||
157212696|NCT01946282|567526071|FG002|Year 2|Did not return FIT kit|115|||
157212697|NCT01946282|567526069|FG000|Year 3|Did not return FIT kit|288|||
157212698|NCT01946282|567526070|FG001|Year 3|Did not return FIT kit|43|||
157212699|NCT01946282|567526071|FG002|Year 3|Did not return FIT kit|30|||
157212700|NCT01462695|567526072|FG000|Overall Study|Adverse Event|1|||
157212701|NCT01462695|567526073|FG001|Overall Study|Adverse Event|1|||
157212702|NCT01462695|567526072|FG000|Overall Study|Death|2|||
157212703|NCT01462695|567526073|FG001|Overall Study|Death|0|||
157212704|NCT01462695|567526072|FG000|Overall Study|Lack of Efficacy|6|||
157212705|NCT01462695|567526073|FG001|Overall Study|Lack of Efficacy|12|||
156779792|NCT01078662|565943883|FG000|Overall Study|Withdrawal by Subject|4|||
156779793|NCT01078662|565943884|FG001|Overall Study|Withdrawal by Subject|11|||
156779794|NCT01078662|565943885|FG002|Overall Study|Withdrawal by Subject|1|||
156779795|NCT01078662|565943886|FG003|Overall Study|Withdrawal by Subject|0|||
156779796|NCT01078662|565943887|FG004|Overall Study|Withdrawal by Subject|0|||
157118020|NCT02432235|567184200|FG011|Overall Study|Miscellaneous|1|||
157118021|NCT01895322|567184201|FG000|Overall Study|Adverse Event|1|||
157118022|NCT01895322|567184201|FG000|Overall Study|Withdrawal by Subject|2|||
157118023|NCT01895322|567184201|FG000|Overall Study|Protocol Violation|10|||
157118024|NCT03436862|567184204|FG000|Overall Study|Adverse Event|4|||
157118025|NCT03436862|567184204|FG000|Overall Study|Progressive Disease|2|||
157118026|NCT00391222|567184210|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
157118027|NCT00391222|567184211|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
157118028|NCT00391222|567184212|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
157118029|NCT00391222|567184213|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
157118030|NCT00391222|567184210|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
157118031|NCT00391222|567184211|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
157118032|NCT00391222|567184212|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
157118033|NCT00391222|567184213|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
157118034|NCT00391222|567184210|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
156779797|NCT01078662|565943883|FG000|Overall Study|Protocol Violation|0|||
156779798|NCT01078662|565943884|FG001|Overall Study|Protocol Violation|1|||
156779799|NCT01078662|565943885|FG002|Overall Study|Protocol Violation|0|||
156779800|NCT01078662|565943886|FG003|Overall Study|Protocol Violation|0|||
156779801|NCT01078662|565943887|FG004|Overall Study|Protocol Violation|0|||
156779802|NCT01078662|565943883|FG000|Overall Study|Lost to Follow-up|1|||
156779803|NCT01078662|565943884|FG001|Overall Study|Lost to Follow-up|0|||
157118035|NCT00391222|567184211|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
157212706|NCT01462695|567526072|FG000|Overall Study|Physician Decision|5|||
157212707|NCT01462695|567526073|FG001|Overall Study|Physician Decision|0|||
156779804|NCT01078662|565943885|FG002|Overall Study|Lost to Follow-up|0|||
156779805|NCT01078662|565943886|FG003|Overall Study|Lost to Follow-up|0|||
156779806|NCT01078662|565943887|FG004|Overall Study|Lost to Follow-up|0|||
156779807|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
157212708|NCT01462695|567526072|FG000|Overall Study|Withdrawal by Subject|2|||
157212709|NCT01462695|567526073|FG001|Overall Study|Withdrawal by Subject|0|||
157118036|NCT00391222|567184212|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
157118037|NCT00391222|567184213|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
157118038|NCT00391222|567184210|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
157118039|NCT00391222|567184211|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
157118040|NCT00391222|567184212|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
157118041|NCT00391222|567184213|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
157118042|NCT00391222|567184210|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
157118043|NCT00391222|567184211|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
157118044|NCT00391222|567184212|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
157118045|NCT00391222|567184213|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
157118046|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
157118047|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
157118048|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
157118049|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
157118050|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
157118051|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
157118052|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
157118053|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
157118054|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
157118055|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
157118056|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
157118057|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
157118058|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
157118059|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
157118060|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
157118061|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
157118062|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
157118063|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
157118064|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
157118065|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
157118066|NCT00391222|567184210|FG000|Period III (Double-Blind Treatment)|Other|6|||
157118067|NCT00391222|567184211|FG001|Period III (Double-Blind Treatment)|Other|1|||
157118068|NCT00391222|567184212|FG002|Period III (Double-Blind Treatment)|Other|6|||
157118069|NCT00391222|567184213|FG003|Period III (Double-Blind Treatment)|Other|0|||
157118070|NCT01627860|567184214|FG000|Overall Study|Adverse Event|9|||
157118071|NCT01627860|567184215|FG001|Overall Study|Adverse Event|4|||
157118072|NCT01627860|567184214|FG000|Overall Study|Withdrawal by Subject|2|||
157118073|NCT01627860|567184215|FG001|Overall Study|Withdrawal by Subject|1|||
157118074|NCT01627860|567184214|FG000|Overall Study|Seizure frequency doubled|0|||
157118075|NCT01627860|567184215|FG001|Overall Study|Seizure frequency doubled|1|||
157118076|NCT01627860|567184214|FG000|Overall Study|Protocol Violation|1|||
157118077|NCT01627860|567184215|FG001|Overall Study|Protocol Violation|0|||
157118078|NCT02054897|567184217|FG000|Overall Study|Withdrawal by Subject|2|||
157118079|NCT02054897|567184218|FG001|Overall Study|Withdrawal by Subject|0|||
157118080|NCT02054897|567184219|FG002|Overall Study|Withdrawal by Subject|2|||
157118081|NCT02054897|567184217|FG000|Overall Study|Missing follow-up information|3|||
157118082|NCT02054897|567184218|FG001|Overall Study|Missing follow-up information|5|||
157118083|NCT02054897|567184219|FG002|Overall Study|Missing follow-up information|3|||
157118084|NCT02054897|567184217|FG000|Overall Study|Lost to Follow-up|4|||
157118085|NCT02054897|567184218|FG001|Overall Study|Lost to Follow-up|2|||
157118086|NCT02054897|567184219|FG002|Overall Study|Lost to Follow-up|7|||
157118087|NCT02054897|567184217|FG000|Overall Study|Randomized but not exposed|1|||
157118088|NCT02054897|567184218|FG001|Overall Study|Randomized but not exposed|0|||
157118089|NCT02054897|567184219|FG002|Overall Study|Randomized but not exposed|0|||
157118090|NCT00960843|567184220|FG000|Overall Study|Lost to Follow-up|2|||
157118091|NCT00960843|567184221|FG001|Overall Study|Lost to Follow-up|0|||
157118092|NCT00960843|567184220|FG000|Overall Study|Protocol Violation|0|||
156779808|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
156779809|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
156779810|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
156779811|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
156779812|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
156779813|NCT00325416|565943888|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
157118093|NCT00960843|567184221|FG001|Overall Study|Protocol Violation|4|||
156779814|NCT00325416|565943889|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
157118094|NCT00960843|567184220|FG000|Overall Study|Repeated needle dislodgment|0|||
157118095|NCT00960843|567184221|FG001|Overall Study|Repeated needle dislodgment|1|||
157118096|NCT00652366|567184222|FG000|Overall Study|Adverse Event|8|||
157118097|NCT00652366|567184223|FG001|Overall Study|Adverse Event|4|||
157118098|NCT00652366|567184224|FG002|Overall Study|Adverse Event|7|||
157118099|NCT00652366|567184225|FG003|Overall Study|Adverse Event|17|||
157118100|NCT00652366|567184226|FG004|Overall Study|Adverse Event|13|||
157118101|NCT00652366|567184222|FG000|Overall Study|Death|5|||
157118102|NCT00652366|567184223|FG001|Overall Study|Death|4|||
157118103|NCT00652366|567184224|FG002|Overall Study|Death|1|||
157118104|NCT00652366|567184225|FG003|Overall Study|Death|8|||
157118105|NCT00652366|567184226|FG004|Overall Study|Death|5|||
157118106|NCT00652366|567184222|FG000|Overall Study|Lack of Efficacy|84|||
157118107|NCT00652366|567184223|FG001|Overall Study|Lack of Efficacy|58|||
157118108|NCT00652366|567184224|FG002|Overall Study|Lack of Efficacy|53|||
157118109|NCT00652366|567184225|FG003|Overall Study|Lack of Efficacy|133|||
157118110|NCT00652366|567184226|FG004|Overall Study|Lack of Efficacy|13|||
157118111|NCT00652366|567184222|FG000|Overall Study|Violation of Selection Criteria|0|||
157118112|NCT00652366|567184223|FG001|Overall Study|Violation of Selection Criteria|0|||
157118113|NCT00652366|567184224|FG002|Overall Study|Violation of Selection Criteria|1|||
157118114|NCT00652366|567184225|FG003|Overall Study|Violation of Selection Criteria|0|||
157118115|NCT00652366|567184226|FG004|Overall Study|Violation of Selection Criteria|0|||
157118116|NCT00652366|567184222|FG000|Overall Study|Protocol Violation|1|||
157118117|NCT00652366|567184223|FG001|Overall Study|Protocol Violation|0|||
157118118|NCT00652366|567184224|FG002|Overall Study|Protocol Violation|0|||
157118119|NCT00652366|567184225|FG003|Overall Study|Protocol Violation|0|||
157118120|NCT00652366|567184226|FG004|Overall Study|Protocol Violation|0|||
157118121|NCT00652366|567184222|FG000|Overall Study|Refused treatment|3|||
157118122|NCT00652366|567184223|FG001|Overall Study|Refused treatment|7|||
156779815|NCT00325416|565943888|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
156779816|NCT00325416|565943889|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
156779817|NCT00325416|565943888|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
156779818|NCT00325416|565943889|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
156779819|NCT03018938|565943892|FG000|Overall Study|Death|0|||
156779820|NCT03018938|565943893|FG001|Overall Study|Death|1|||
156779821|NCT03018938|565943892|FG000|Overall Study|Lost to Follow-up|21|||
156779822|NCT03018938|565943893|FG001|Overall Study|Lost to Follow-up|32|||
156779823|NCT03018938|565943892|FG000|Overall Study|Withdrawal by Subject|38|||
156779824|NCT03018938|565943893|FG001|Overall Study|Withdrawal by Subject|45|||
156779825|NCT03018938|565943892|FG000|Overall Study|Physician Decision|3|||
156779826|NCT03018938|565943893|FG001|Overall Study|Physician Decision|2|||
156779827|NCT03018938|565943892|FG000|Overall Study|Sponsor Decision|0|||
156779828|NCT03018938|565943893|FG001|Overall Study|Sponsor Decision|1|||
156779829|NCT03018938|565943892|FG000|Overall Study|Screen failure-After randomization|4|||
156779830|NCT03018938|565943893|FG001|Overall Study|Screen failure-After randomization|2|||
156779831|NCT03018938|565943892|FG000|Overall Study|Not recorded|0|||
156779832|NCT03018938|565943893|FG001|Overall Study|Not recorded|2|||
156779833|NCT00191100|565943896|FG000|Overall Study|Adverse Event|18|||
156779834|NCT00191100|565943897|FG001|Overall Study|Adverse Event|1|||
156779835|NCT00191100|565943896|FG000|Overall Study|Lost to Follow-up|2|||
156779836|NCT00191100|565943897|FG001|Overall Study|Lost to Follow-up|0|||
156779837|NCT00191100|565943896|FG000|Overall Study|Patient Moved|0|||
156779838|NCT00191100|565943897|FG001|Overall Study|Patient Moved|1|||
156779839|NCT00191100|565943896|FG000|Overall Study|Withdrawal by Subject|9|||
156779840|NCT00191100|565943897|FG001|Overall Study|Withdrawal by Subject|3|||
156779841|NCT00191100|565943896|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
156779842|NCT00191100|565943897|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
156779843|NCT00191100|565943896|FG000|Overall Study|Clinical Relapse|2|||
156779844|NCT00191100|565943897|FG001|Overall Study|Clinical Relapse|1|||
156779845|NCT00191100|565943896|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
156779846|NCT00191100|565943897|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
156779847|NCT00191100|565943896|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
156779848|NCT00191100|565943897|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
156779849|NCT00191100|565943896|FG000|Overall Study|Physician Decision|3|||
156779850|NCT00191100|565943897|FG001|Overall Study|Physician Decision|1|||
156779851|NCT00191100|565943896|FG000|Overall Study|Death from Study Drug Toxicity|2|||
156779852|NCT00191100|565943897|FG001|Overall Study|Death from Study Drug Toxicity|0|||
156779853|NCT00191100|565943896|FG000|Overall Study|Protocol Violation|1|||
156779854|NCT00191100|565943897|FG001|Overall Study|Protocol Violation|1|||
156779855|NCT00191100|565943896|FG000|Overall Study|Death from Other Cause|1|||
156779856|NCT00191100|565943897|FG001|Overall Study|Death from Other Cause|0|||
156779857|NCT00191100|565943896|FG000|Overall Study|Reason Not Specified|0|||
156779858|NCT00191100|565943897|FG001|Overall Study|Reason Not Specified|1|||
156779859|NCT02830087|565943898|FG000|Overall Study|No study staff to follow-up patients|4|||
157118123|NCT00652366|567184224|FG002|Overall Study|Refused treatment|6|||
157118124|NCT00652366|567184225|FG003|Overall Study|Refused treatment|17|||
157118125|NCT00652366|567184226|FG004|Overall Study|Refused treatment|5|||
157118126|NCT00652366|567184222|FG000|Overall Study|Other|5|||
157118127|NCT00652366|567184223|FG001|Overall Study|Other|2|||
157118128|NCT00652366|567184224|FG002|Overall Study|Other|3|||
157118129|NCT00652366|567184225|FG003|Overall Study|Other|4|||
156779860|NCT02830087|565943899|FG001|Overall Study|No study staff to follow-up patients|4|||
156779861|NCT02830087|565943900|FG002|Overall Study|No study staff to follow-up patients|4|||
156779862|NCT02830087|565943901|FG003|Overall Study|No study staff to follow-up patients|3|||
156779863|NCT02830087|565943902|FG004|Overall Study|No study staff to follow-up patients|3|||
156779864|NCT02830087|565943903|FG005|Overall Study|No study staff to follow-up patients|3|||
156779865|NCT02872714|565943905|FG000|Overall Study|Progressive Disease|1|||
156779866|NCT02872714|565943906|FG001|Overall Study|Progressive Disease|2|||
156779867|NCT02872714|565943907|FG002|Overall Study|Progressive Disease|0|||
156779868|NCT02872714|565943908|FG003|Overall Study|Progressive Disease|0|||
156779869|NCT02872714|565943909|FG004|Overall Study|Progressive Disease|0|||
156779870|NCT02872714|565943905|FG000|Overall Study|Death|87|||
156779871|NCT02872714|565943906|FG001|Overall Study|Death|36|||
156779872|NCT02872714|565943907|FG002|Overall Study|Death|8|||
156779873|NCT02872714|565943908|FG003|Overall Study|Death|81|||
156779874|NCT02872714|565943909|FG004|Overall Study|Death|2|||
156779875|NCT02872714|565943905|FG000|Overall Study|Lost to Follow-up|2|||
156779876|NCT02872714|565943906|FG001|Overall Study|Lost to Follow-up|1|||
156779877|NCT02872714|565943907|FG002|Overall Study|Lost to Follow-up|0|||
156779878|NCT02872714|565943908|FG003|Overall Study|Lost to Follow-up|3|||
156779879|NCT02872714|565943909|FG004|Overall Study|Lost to Follow-up|0|||
156779880|NCT02872714|565943905|FG000|Overall Study|Physician Decision|0|||
156779881|NCT02872714|565943906|FG001|Overall Study|Physician Decision|0|||
156779882|NCT02872714|565943907|FG002|Overall Study|Physician Decision|0|||
156779883|NCT02872714|565943908|FG003|Overall Study|Physician Decision|1|||
156779884|NCT02872714|565943909|FG004|Overall Study|Physician Decision|0|||
156779885|NCT02872714|565943905|FG000|Overall Study|Withdrawal by Subject|1|||
156779886|NCT02872714|565943906|FG001|Overall Study|Withdrawal by Subject|3|||
156779887|NCT02872714|565943907|FG002|Overall Study|Withdrawal by Subject|0|||
156779888|NCT02872714|565943908|FG003|Overall Study|Withdrawal by Subject|2|||
156779889|NCT02872714|565943909|FG004|Overall Study|Withdrawal by Subject|0|||
156779890|NCT02872714|565943905|FG000|Overall Study|Captured as Other|2|||
156779891|NCT02872714|565943906|FG001|Overall Study|Captured as Other|0|||
156779892|NCT02872714|565943907|FG002|Overall Study|Captured as Other|0|||
156779893|NCT02872714|565943908|FG003|Overall Study|Captured as Other|1|||
156779894|NCT02872714|565943909|FG004|Overall Study|Captured as Other|0|||
156779895|NCT00479232|565944853|FG000|Overall Study|Adverse Event|0|||
156779896|NCT00479232|565944854|FG001|Overall Study|Adverse Event|0|||
156779897|NCT00479232|565944855|FG002|Overall Study|Adverse Event|5|||
156779898|NCT00479232|565944856|FG003|Overall Study|Adverse Event|0|||
156779899|NCT00479232|565944857|FG004|Overall Study|Adverse Event|0|||
156779900|NCT00479232|565944858|FG005|Overall Study|Adverse Event|10|||
156779901|NCT00479232|565944853|FG000|Overall Study|Deviation from Protocol|0|||
156779902|NCT00479232|565944854|FG001|Overall Study|Deviation from Protocol|0|||
156779903|NCT00479232|565944855|FG002|Overall Study|Deviation from Protocol|1|||
156779904|NCT00479232|565944856|FG003|Overall Study|Deviation from Protocol|0|||
156779905|NCT00479232|565944857|FG004|Overall Study|Deviation from Protocol|0|||
156779906|NCT00479232|565944858|FG005|Overall Study|Deviation from Protocol|0|||
156779907|NCT00479232|565944853|FG000|Overall Study|Lack of Efficacy|0|||
156779908|NCT00479232|565944854|FG001|Overall Study|Lack of Efficacy|0|||
156779909|NCT00479232|565944855|FG002|Overall Study|Lack of Efficacy|2|||
156779910|NCT00479232|565944856|FG003|Overall Study|Lack of Efficacy|0|||
156779911|NCT00479232|565944857|FG004|Overall Study|Lack of Efficacy|0|||
156779912|NCT00479232|565944858|FG005|Overall Study|Lack of Efficacy|4|||
156779913|NCT00479232|565944853|FG000|Overall Study|Physician Decision|0|||
156779914|NCT00479232|565944854|FG001|Overall Study|Physician Decision|0|||
156779915|NCT00479232|565944855|FG002|Overall Study|Physician Decision|2|||
156779916|NCT00479232|565944856|FG003|Overall Study|Physician Decision|0|||
156779917|NCT00479232|565944857|FG004|Overall Study|Physician Decision|0|||
156779918|NCT00479232|565944858|FG005|Overall Study|Physician Decision|1|||
156779919|NCT00479232|565944853|FG000|Overall Study|Progressive Disease|3|||
156779920|NCT00479232|565944854|FG001|Overall Study|Progressive Disease|1|||
156779921|NCT00479232|565944855|FG002|Overall Study|Progressive Disease|12|||
156779922|NCT00479232|565944856|FG003|Overall Study|Progressive Disease|3|||
156779923|NCT00479232|565944857|FG004|Overall Study|Progressive Disease|3|||
156779924|NCT00479232|565944858|FG005|Overall Study|Progressive Disease|12|||
156779925|NCT00479232|565944853|FG000|Overall Study|Withdrew Consent|0|||
156779926|NCT00479232|565944854|FG001|Overall Study|Withdrew Consent|2|||
156779927|NCT00479232|565944855|FG002|Overall Study|Withdrew Consent|6|||
156779928|NCT00479232|565944856|FG003|Overall Study|Withdrew Consent|0|||
156779929|NCT00479232|565944857|FG004|Overall Study|Withdrew Consent|1|||
156779930|NCT00479232|565944858|FG005|Overall Study|Withdrew Consent|3|||
156779931|NCT05399771|565944859|FG000|Overall Study|Physician Decision|3|||
156779932|NCT05399771|565944859|FG000|Overall Study|Adverse Event|1|||
156779933|NCT05177094|565944867|FG000|Overall Study|Adverse Event|5|||
156779934|NCT05177094|565944868|FG001|Overall Study|Adverse Event|5|||
156779935|NCT05177094|565944867|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
156779936|NCT05177094|565944868|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
156779937|NCT05177094|565944867|FG000|Overall Study|Protocol Deviation|3|||
156779938|NCT05177094|565944868|FG001|Overall Study|Protocol Deviation|0|||
156779939|NCT05177094|565944867|FG000|Overall Study|Withdrawal by Subject|6|||
156779940|NCT05177094|565944868|FG001|Overall Study|Withdrawal by Subject|3|||
156779941|NCT05177094|565944867|FG000|Overall Study|Participant could not tolerate long study visits|1|||
156779942|NCT05177094|565944868|FG001|Overall Study|Participant could not tolerate long study visits|0|||
156779943|NCT01033942|565944869|FG000|Overall Study|Withdrawal by Subject|1|||
156779944|NCT01033942|565944870|FG001|Overall Study|Withdrawal by Subject|1|||
156779945|NCT01033942|565944871|FG002|Overall Study|Withdrawal by Subject|1|||
156779946|NCT01033942|565944869|FG000|Overall Study|Lost to Follow-up|1|||
156779947|NCT01033942|565944870|FG001|Overall Study|Lost to Follow-up|0|||
156779948|NCT01033942|565944871|FG002|Overall Study|Lost to Follow-up|0|||
156779949|NCT01033942|565944869|FG000|Overall Study|Enrolled in Extension Study|0|||
156779950|NCT01033942|565944870|FG001|Overall Study|Enrolled in Extension Study|3|||
156779951|NCT01033942|565944871|FG002|Overall Study|Enrolled in Extension Study|0|||
156779952|NCT00529035|565944873|FG000|Overall Study|Withdrawal by Subject|1|||
156779953|NCT02493855|565944874|FG000|Overall Study|Non-compliance|1|||
156779954|NCT02493855|565944875|FG001|Overall Study|Non-compliance|0|||
156779955|NCT02493855|565944876|FG002|Overall Study|Non-compliance|0|||
156779956|NCT02493855|565944874|FG000|Overall Study|Adverse Event|0|||
156779957|NCT02493855|565944875|FG001|Overall Study|Adverse Event|1|||
156779958|NCT02493855|565944876|FG002|Overall Study|Adverse Event|0|||
156779959|NCT02493855|565944874|FG000|Overall Study|Withdrawal by Subject|1|||
156779960|NCT02493855|565944875|FG001|Overall Study|Withdrawal by Subject|0|||
156779961|NCT02493855|565944876|FG002|Overall Study|Withdrawal by Subject|0|||
156779962|NCT03086343|565944879|FG000|Period 1|Adverse Event|7|||
156779963|NCT03086343|565944880|FG001|Period 1|Adverse Event|7|||
156779964|NCT03086343|565944881|FG002|Period 1|Adverse Event|0|||
156779965|NCT03086343|565944882|FG003|Period 1|Adverse Event|1|||
156779966|NCT03086343|565944879|FG000|Period 1|Withdrawal by Subject|6|||
156779967|NCT03086343|565944880|FG001|Period 1|Withdrawal by Subject|10|||
156779968|NCT03086343|565944881|FG002|Period 1|Withdrawal by Subject|0|||
156779969|NCT03086343|565944882|FG003|Period 1|Withdrawal by Subject|0|||
156779970|NCT03086343|565944879|FG000|Period 1|Lost to Follow-up|1|||
156779971|NCT03086343|565944880|FG001|Period 1|Lost to Follow-up|3|||
156779972|NCT03086343|565944881|FG002|Period 1|Lost to Follow-up|1|||
156779973|NCT03086343|565944882|FG003|Period 1|Lost to Follow-up|0|||
156779974|NCT03086343|565944879|FG000|Period 1|Other, Not Specified|10|||
156779975|NCT03086343|565944880|FG001|Period 1|Other, Not Specified|12|||
156779976|NCT03086343|565944881|FG002|Period 1|Other, Not Specified|2|||
156779977|NCT03086343|565944882|FG003|Period 1|Other, Not Specified|1|||
156779978|NCT03086343|565944879|FG000|Period 1|Missing|1|||
156779979|NCT03086343|565944880|FG001|Period 1|Missing|0|||
156779980|NCT03086343|565944881|FG002|Period 1|Missing|0|||
156779981|NCT03086343|565944882|FG003|Period 1|Missing|0|||
156779982|NCT03086343|565944879|FG000|Period 2|Adverse Event|20|||
156779983|NCT03086343|565944880|FG001|Period 2|Adverse Event|11|||
156779984|NCT03086343|565944881|FG002|Period 2|Adverse Event|1|||
156779985|NCT03086343|565944882|FG003|Period 2|Adverse Event|2|||
156779986|NCT03086343|565944879|FG000|Period 2|Withdrawal by Subject|15|||
156779987|NCT03086343|565944880|FG001|Period 2|Withdrawal by Subject|25|||
156779988|NCT03086343|565944881|FG002|Period 2|Withdrawal by Subject|2|||
156779989|NCT03086343|565944882|FG003|Period 2|Withdrawal by Subject|2|||
156779990|NCT03086343|565944879|FG000|Period 2|Lost to Follow-up|6|||
156779991|NCT03086343|565944880|FG001|Period 2|Lost to Follow-up|11|||
156779992|NCT03086343|565944881|FG002|Period 2|Lost to Follow-up|1|||
156779993|NCT03086343|565944882|FG003|Period 2|Lost to Follow-up|0|||
156779994|NCT03086343|565944879|FG000|Period 2|COVID-19 Infection|5|||
156779995|NCT03086343|565944880|FG001|Period 2|COVID-19 Infection|0|||
156779996|NCT03086343|565944881|FG002|Period 2|COVID-19 Infection|0|||
156779997|NCT03086343|565944882|FG003|Period 2|COVID-19 Infection|0|||
156779998|NCT03086343|565944879|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
156779999|NCT03086343|565944880|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
156780000|NCT03086343|565944881|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
156780001|NCT03086343|565944882|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
156780002|NCT03086343|565944879|FG000|Period 2|Other, Not Specified|23|||
156780003|NCT03086343|565944880|FG001|Period 2|Other, Not Specified|22|||
156780004|NCT03086343|565944881|FG002|Period 2|Other, Not Specified|2|||
156780005|NCT03086343|565944882|FG003|Period 2|Other, Not Specified|4|||
156780006|NCT04900272|565944883|FG000|Overall Study|Lost to Follow-up|2|||
156780007|NCT04900272|565944883|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
156780008|NCT04900272|565944883|FG000|Overall Study|Withdrawal by Subject|1|||
156780009|NCT01625182|565944885|FG000|Overall Study|Administrative problems|1|||
157011311|NCT01499199|566793455|FG000|Overall Study|Lack of Efficacy|1|||
157011312|NCT01199705|566793456|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
157011313|NCT01692730|566793457|FG000|Overall Study|Lost to Follow-up|225|||
156780010|NCT01625182|565944886|FG001|Overall Study|Administrative problems|0|||
156780011|NCT01625182|565944885|FG000|Overall Study|Protocol deviation|0|||
156780012|NCT01625182|565944886|FG001|Overall Study|Protocol deviation|2|||
156780013|NCT01625182|565944885|FG000|Overall Study|Adverse Event|2|||
156780014|NCT01625182|565944886|FG001|Overall Study|Adverse Event|0|||
156780015|NCT01625182|565944885|FG000|Overall Study|Withdrawal by Subject|5|||
156780016|NCT01625182|565944886|FG001|Overall Study|Withdrawal by Subject|1|||
156780017|NCT01625182|565944885|FG000|Overall Study|Lack of Efficacy|12|||
156780018|NCT01625182|565944886|FG001|Overall Study|Lack of Efficacy|8|||
157118130|NCT00652366|567184226|FG004|Overall Study|Other|0|||
157118131|NCT02069899|567184227|FG000|Overall Study|Adverse Event|6|||
157118132|NCT02069899|567184228|FG001|Overall Study|Adverse Event|0|||
156780019|NCT05059080|565944887|FG000|Overall Study|Withdrawal by Subject|3|||
156780020|NCT05059080|565944887|FG000|Overall Study|Study Terminated by Sponsor|64|||
156780021|NCT01047501|565944888|FG000|Overall Study|Adverse Event|7|||
156780022|NCT01047501|565944889|FG001|Overall Study|Adverse Event|8|||
156780023|NCT01047501|565944890|FG002|Overall Study|Adverse Event|5|||
156780024|NCT01047501|565944888|FG000|Overall Study|Withdrew Consent|6|||
156780025|NCT01047501|565944889|FG001|Overall Study|Withdrew Consent|2|||
156780026|NCT01047501|565944890|FG002|Overall Study|Withdrew Consent|4|||
156780027|NCT01047501|565944888|FG000|Overall Study|Lost to Follow-up|0|||
156780028|NCT01047501|565944889|FG001|Overall Study|Lost to Follow-up|1|||
156780029|NCT01047501|565944890|FG002|Overall Study|Lost to Follow-up|1|||
156780030|NCT01047501|565944888|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
156780031|NCT01047501|565944889|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
156780032|NCT01047501|565944890|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
156780033|NCT01047501|565944888|FG000|Overall Study|Death|1|||
156780034|NCT01047501|565944889|FG001|Overall Study|Death|0|||
156780035|NCT01047501|565944890|FG002|Overall Study|Death|0|||
156780036|NCT01047501|565944888|FG000|Overall Study|Other discontinuation|1|||
156780037|NCT01047501|565944889|FG001|Overall Study|Other discontinuation|0|||
156780038|NCT01047501|565944890|FG002|Overall Study|Other discontinuation|1|||
156780039|NCT01047501|565944888|FG000|Overall Study|Investigator judgement|0|||
156780040|NCT01047501|565944889|FG001|Overall Study|Investigator judgement|0|||
156780041|NCT01047501|565944890|FG002|Overall Study|Investigator judgement|1|||
156780042|NCT02447029|565944891|FG000|Overall Study|Withdrawal by Subject|3|||
156780043|NCT02447029|565944892|FG001|Overall Study|Withdrawal by Subject|2|||
156780044|NCT03600428|565944896|FG000|Overall Study|Not eligible|0|||
156780045|NCT03600428|565944897|FG001|Overall Study|Not eligible|1|||
156780046|NCT03600428|565944896|FG000|Overall Study|Lost to Follow-up|5|||
156780047|NCT03600428|565944897|FG001|Overall Study|Lost to Follow-up|4|||
156780048|NCT01666652|565944901|FG000|Overall Study|Serious Adverse Event|0|||
156780049|NCT01666652|565944902|FG001|Overall Study|Serious Adverse Event|0|||
156780050|NCT01666652|565944903|FG002|Overall Study|Serious Adverse Event|0|||
156780051|NCT01666652|565944904|FG003|Overall Study|Serious Adverse Event|1|||
156780052|NCT01666652|565944905|FG004|Overall Study|Serious Adverse Event|0|||
156780053|NCT01666652|565944901|FG000|Overall Study|Withdrawal by Subject|0|||
156780054|NCT01666652|565944902|FG001|Overall Study|Withdrawal by Subject|0|||
156780055|NCT01666652|565944903|FG002|Overall Study|Withdrawal by Subject|0|||
156780056|NCT01666652|565944904|FG003|Overall Study|Withdrawal by Subject|0|||
156780057|NCT01666652|565944905|FG004|Overall Study|Withdrawal by Subject|1|||
156780058|NCT01666652|565944901|FG000|Overall Study|Moved from study area|1|||
156780059|NCT01666652|565944902|FG001|Overall Study|Moved from study area|0|||
156780060|NCT01666652|565944903|FG002|Overall Study|Moved from study area|0|||
156780061|NCT01666652|565944904|FG003|Overall Study|Moved from study area|2|||
156780062|NCT01666652|565944905|FG004|Overall Study|Moved from study area|0|||
156780063|NCT01666652|565944901|FG000|Overall Study|Lost to Follow-up|1|||
156780064|NCT01666652|565944902|FG001|Overall Study|Lost to Follow-up|1|||
156780065|NCT01666652|565944903|FG002|Overall Study|Lost to Follow-up|1|||
156780066|NCT01666652|565944904|FG003|Overall Study|Lost to Follow-up|1|||
156780067|NCT01666652|565944905|FG004|Overall Study|Lost to Follow-up|0|||
156780068|NCT00088153|565944906|FG000|Overall Study|Physician Decision|3|||
156780069|NCT00088153|565944907|FG001|Overall Study|Physician Decision|3|||
156780070|NCT00088153|565944906|FG000|Overall Study|Withdrawal by Subject|10|||
156780071|NCT00088153|565944907|FG001|Overall Study|Withdrawal by Subject|10|||
156780072|NCT00088153|565944906|FG000|Overall Study|Lost to Follow-up|11|||
156780073|NCT00088153|565944907|FG001|Overall Study|Lost to Follow-up|12|||
156780074|NCT01695746|565944908|FG000|Overall Study|Adverse Event|1|||
156780075|NCT01695746|565944908|FG000|Overall Study|Non-compliance by the participant|3|||
156780076|NCT01695746|565944908|FG000|Overall Study|Protocol Violation|5|||
156780077|NCT01695746|565944908|FG000|Overall Study|Participant not willing to participate|3|||
156780078|NCT04598828|565944909|FG000|Overall Study|Physician Decision|1|||
156780079|NCT04598828|565944910|FG001|Overall Study|Physician Decision|0|||
156780080|NCT04598828|565944909|FG000|Overall Study|Withdrawal by Subject|0|||
156780081|NCT04598828|565944910|FG001|Overall Study|Withdrawal by Subject|1|||
156780082|NCT04598828|565944909|FG000|Overall Study|Withdrawal by Subject|0|||
156780083|NCT04598828|565944910|FG001|Overall Study|Withdrawal by Subject|1|||
156780084|NCT02324153|565944911|FG000|Overall Study|Withdrawal by Subject|4|||
156780085|NCT02324153|565944912|FG001|Overall Study|Withdrawal by Subject|1|||
156780086|NCT02324153|565944911|FG000|Overall Study|Surgery postponed after randomization|3|||
156780087|NCT02324153|565944912|FG001|Overall Study|Surgery postponed after randomization|0|||
156780088|NCT02324153|565944911|FG000|Overall Study|Developed delirium preoperatively|1|||
156780089|NCT02324153|565944912|FG001|Overall Study|Developed delirium preoperatively|0|||
156780090|NCT01937299|565944916|FG000|Overall Study|Adverse Event|13|||
156780091|NCT01937299|565944917|FG001|Overall Study|Adverse Event|0|||
156780092|NCT01937299|565944916|FG000|Overall Study|Lack of Efficacy|0|||
156780093|NCT01937299|565944917|FG001|Overall Study|Lack of Efficacy|4|||
156780094|NCT01937299|565944916|FG000|Overall Study|Withdrawal by Subject|1|||
156780095|NCT01937299|565944917|FG001|Overall Study|Withdrawal by Subject|0|||
156780096|NCT04017962|565944918|FG000|Overall Study|Death|2|||
156780097|NCT04017962|565944919|FG001|Overall Study|Death|0|||
156780098|NCT04017962|565944918|FG000|Overall Study|Lost to Follow-up|2|||
156780099|NCT04017962|565944919|FG001|Overall Study|Lost to Follow-up|0|||
156780100|NCT04017962|565944918|FG000|Overall Study|Physician Decision|1|||
156780101|NCT04017962|565944919|FG001|Overall Study|Physician Decision|0|||
156780102|NCT04017962|565944918|FG000|Overall Study|Discontinued LTV|5|||
156780103|NCT04017962|565944919|FG001|Overall Study|Discontinued LTV|0|||
156780104|NCT00700635|565944920|FG000|Overall Study|Adverse Event|1|||
156780105|NCT00700635|565944921|FG001|Overall Study|Adverse Event|0|||
156780106|NCT00700635|565944922|FG002|Overall Study|Adverse Event|0|||
156780107|NCT00700635|565944920|FG000|Overall Study|Lost to Follow-up|1|||
156780108|NCT00700635|565944921|FG001|Overall Study|Lost to Follow-up|3|||
156780109|NCT00700635|565944922|FG002|Overall Study|Lost to Follow-up|0|||
156780110|NCT00700635|565944920|FG000|Overall Study|Protocol Violation|2|||
156780111|NCT00700635|565944921|FG001|Overall Study|Protocol Violation|2|||
156780112|NCT00700635|565944922|FG002|Overall Study|Protocol Violation|0|||
156780113|NCT00700635|565944920|FG000|Overall Study|Withdrawal by Subject|7|||
156780114|NCT00700635|565944921|FG001|Overall Study|Withdrawal by Subject|3|||
156780115|NCT00700635|565944922|FG002|Overall Study|Withdrawal by Subject|1|||
156780116|NCT01260948|565944924|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
156780117|NCT01260948|565944925|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
156780118|NCT01260948|565944924|FG000|Second Intervention|Emesis|0|||
156780119|NCT01260948|565944925|FG001|Second Intervention|Emesis|1|||
156780120|NCT00768053|565944926|FG000|Overall Study|Adverse Event|10|||
156780121|NCT00768053|565944926|FG000|Overall Study|Lost to Follow-up|1|||
156780122|NCT01202591|565944927|FG000|Overall Study|Adverse Event|2|||
156780123|NCT01202591|565944928|FG001|Overall Study|Adverse Event|1|||
156780124|NCT01202591|565944929|FG002|Overall Study|Adverse Event|4|||
156780125|NCT01202591|565944930|FG003|Overall Study|Adverse Event|4|||
157118133|NCT02069899|567184229|FG002|Overall Study|Adverse Event|1|||
157118134|NCT02069899|567184227|FG000|Overall Study|Withdrawal by Participant|2|||
157118135|NCT02069899|567184228|FG001|Overall Study|Withdrawal by Participant|0|||
157118136|NCT02069899|567184229|FG002|Overall Study|Withdrawal by Participant|0|||
157118137|NCT02069899|567184227|FG000|Overall Study|Lost to Follow-up|1|||
157118138|NCT02069899|567184228|FG001|Overall Study|Lost to Follow-up|0|||
157118139|NCT02069899|567184229|FG002|Overall Study|Lost to Follow-up|1|||
157118140|NCT02069899|567184227|FG000|Overall Study|Other|4|||
157118141|NCT02069899|567184228|FG001|Overall Study|Other|0|||
157118142|NCT02069899|567184229|FG002|Overall Study|Other|0|||
157118143|NCT02069899|567184227|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
157118144|NCT02069899|567184228|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
157118145|NCT02069899|567184229|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
157118146|NCT02069899|567184227|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
157118147|NCT02069899|567184228|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
157118148|NCT02069899|567184229|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
157118149|NCT00490451|567184230|FG000|Overall Study|Adverse Event|3|||
157118150|NCT00490451|567184231|FG001|Overall Study|Adverse Event|3|||
157118151|NCT00490451|567184230|FG000|Overall Study|Death|3|||
157118152|NCT00490451|567184231|FG001|Overall Study|Death|1|||
157118153|NCT00490451|567184230|FG000|Overall Study|Withdrawal by Subject|2|||
157118154|NCT00490451|567184231|FG001|Overall Study|Withdrawal by Subject|0|||
157118155|NCT00490451|567184230|FG000|Overall Study|Investigator Decision|1|||
157118156|NCT00490451|567184231|FG001|Overall Study|Investigator Decision|0|||
156780126|NCT01202591|565944931|FG004|Overall Study|Adverse Event|0|||
156780127|NCT01202591|565944932|FG005|Overall Study|Adverse Event|0|||
156780128|NCT01202591|565944927|FG000|Overall Study|Other reason as per investigator|3|||
157118157|NCT00490451|567184230|FG000|Overall Study|Protocol Violation|1|||
157118158|NCT00490451|567184231|FG001|Overall Study|Protocol Violation|0|||
157118159|NCT00490451|567184230|FG000|Overall Study|Progressive Disease|53|||
156780129|NCT01202591|565944928|FG001|Overall Study|Other reason as per investigator|4|||
156780130|NCT01202591|565944929|FG002|Overall Study|Other reason as per investigator|7|||
156780131|NCT01202591|565944930|FG003|Overall Study|Other reason as per investigator|3|||
156780132|NCT01202591|565944931|FG004|Overall Study|Other reason as per investigator|1|||
156780133|NCT01202591|565944932|FG005|Overall Study|Other reason as per investigator|3|||
156780134|NCT01202591|565944927|FG000|Overall Study|Withdrawal by Subject|0|||
156780135|NCT01202591|565944928|FG001|Overall Study|Withdrawal by Subject|0|||
156780136|NCT01202591|565944929|FG002|Overall Study|Withdrawal by Subject|0|||
156780137|NCT01202591|565944930|FG003|Overall Study|Withdrawal by Subject|0|||
156780138|NCT01202591|565944931|FG004|Overall Study|Withdrawal by Subject|2|||
156780139|NCT01202591|565944932|FG005|Overall Study|Withdrawal by Subject|1|||
156780140|NCT01202591|565944927|FG000|Overall Study|Objective Disease Progression|0|||
156780141|NCT01202591|565944928|FG001|Overall Study|Objective Disease Progression|0|||
156780142|NCT01202591|565944929|FG002|Overall Study|Objective Disease Progression|0|||
156780143|NCT01202591|565944930|FG003|Overall Study|Objective Disease Progression|0|||
156780144|NCT01202591|565944931|FG004|Overall Study|Objective Disease Progression|2|||
156780145|NCT01202591|565944932|FG005|Overall Study|Objective Disease Progression|0|||
156780146|NCT03580928|565944935|FG000|Overall Study|Death|0|||
156780147|NCT03580928|565944936|FG001|Overall Study|Death|3|||
156780148|NCT03580928|565944935|FG000|Overall Study|Withdrawal by Subject|2|||
156780149|NCT03580928|565944936|FG001|Overall Study|Withdrawal by Subject|1|||
156780150|NCT03580928|565944935|FG000|Overall Study|Lost to Follow-up|2|||
156780151|NCT03580928|565944936|FG001|Overall Study|Lost to Follow-up|0|||
156780152|NCT03580928|565944935|FG000|Overall Study|Progressive Disease|0|||
156780153|NCT03580928|565944936|FG001|Overall Study|Progressive Disease|1|||
156780154|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
156780155|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
156780156|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
156780157|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
156780158|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
156780159|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
156780160|NCT04633447|565946168|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
156780161|NCT04633447|565946169|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
156780162|NCT04633447|565946168|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
156780163|NCT04633447|565946169|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
156780164|NCT04633447|565946168|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
156780165|NCT04633447|565946169|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
156780166|NCT03807843|565946171|FG000|Overall Study|Lost to Follow-up|1|||
156780167|NCT03807843|565946172|FG001|Overall Study|Lost to Follow-up|0|||
156780168|NCT05276804|565946181|FG000|Overall Study|screen failure|23|||
156780169|NCT05276804|565946182|FG001|Overall Study|screen failure|0|||
156780170|NCT00898807|565946183|FG000|Overall Study|Withdrawal by Subject|5|||
156780171|NCT00898807|565946184|FG001|Overall Study|Withdrawal by Subject|3|||
156780172|NCT00898807|565946183|FG000|Overall Study|Family pressure to discontinue|2|||
156780173|NCT00898807|565946184|FG001|Overall Study|Family pressure to discontinue|2|||
156780174|NCT00898807|565946183|FG000|Overall Study|Lost to Follow-up|1|||
156780175|NCT00898807|565946184|FG001|Overall Study|Lost to Follow-up|3|||
156780176|NCT00898807|565946183|FG000|Overall Study|Death|0|||
156780177|NCT00898807|565946184|FG001|Overall Study|Death|1|||
156780178|NCT01482221|565946187|FG000|Overall Study|Lack of Efficacy|1|||
156780179|NCT01482221|565946188|FG001|Overall Study|Lack of Efficacy|0|||
156780180|NCT01482221|565946189|FG002|Overall Study|Lack of Efficacy|1|||
156780181|NCT01482221|565946187|FG000|Overall Study|Lost to Follow-up|3|||
156780182|NCT01482221|565946188|FG001|Overall Study|Lost to Follow-up|2|||
156780183|NCT01482221|565946189|FG002|Overall Study|Lost to Follow-up|1|||
156780184|NCT01482221|565946187|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
156780185|NCT01482221|565946188|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
156780186|NCT01482221|565946189|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
156780187|NCT01482221|565946187|FG000|Overall Study|Condition under Investigation Worsened|3|||
156780188|NCT01482221|565946188|FG001|Overall Study|Condition under Investigation Worsened|2|||
156780189|NCT01482221|565946189|FG002|Overall Study|Condition under Investigation Worsened|4|||
157011314|NCT01692730|566793458|FG001|Overall Study|Lost to Follow-up|227|||
157011315|NCT01199575|566793459|FG000|Overall Study|Withdrawal by Subject|5|||
157011316|NCT00223795|566793460|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
157011317|NCT00223795|566793461|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
157011318|NCT00223795|566793460|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
157011319|NCT00223795|566793461|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
157011320|NCT02299375|566793466|FG000|Overall Study|Adverse Event, serious fatal|1|||
157011321|NCT02299375|566793467|FG001|Overall Study|Adverse Event, serious fatal|3|||
157011322|NCT02299375|566793466|FG000|Overall Study|Adverse Event, non-fatal|8|||
157011323|NCT02299375|566793467|FG001|Overall Study|Adverse Event, non-fatal|9|||
157011324|NCT02299375|566793466|FG000|Overall Study|Lack of Efficacy|1|||
157011325|NCT02299375|566793467|FG001|Overall Study|Lack of Efficacy|3|||
157011326|NCT02299375|566793466|FG000|Overall Study|Protocol Violation|1|||
157011327|NCT02299375|566793467|FG001|Overall Study|Protocol Violation|3|||
157011328|NCT02299375|566793466|FG000|Overall Study|Other: Met stopping criteria|1|||
157011329|NCT02299375|566793467|FG001|Overall Study|Other: Met stopping criteria|0|||
157011330|NCT02299375|566793466|FG000|Overall Study|Other: Study closed/terminated|66|||
157011331|NCT02299375|566793467|FG001|Overall Study|Other: Study closed/terminated|55|||
157011332|NCT02299375|566793466|FG000|Overall Study|Lost to Follow-up|0|||
157011333|NCT02299375|566793467|FG001|Overall Study|Lost to Follow-up|2|||
157011334|NCT02299375|566793466|FG000|Overall Study|Physician Decision|1|||
157011335|NCT02299375|566793467|FG001|Overall Study|Physician Decision|1|||
157118160|NCT00490451|567184231|FG001|Overall Study|Progressive Disease|34|||
157118161|NCT04703075|567184234|FG000|Overall Study|Adverse Event|11|||
157118162|NCT04703075|567184235|FG001|Overall Study|Adverse Event|7|||
157118163|NCT04703075|567184234|FG000|Overall Study|Lost to Follow-up|6|||
157118164|NCT04703075|567184235|FG001|Overall Study|Lost to Follow-up|12|||
157118165|NCT04703075|567184234|FG000|Overall Study|Physician Decision|3|||
157118166|NCT04703075|567184235|FG001|Overall Study|Physician Decision|0|||
157118167|NCT04703075|567184234|FG000|Overall Study|Moved|0|||
156780190|NCT01482221|565946187|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156780191|NCT01482221|565946188|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
156780192|NCT01482221|565946189|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
156780193|NCT01482221|565946187|FG000|Overall Study|Adverse Event|1|||
156780194|NCT01482221|565946188|FG001|Overall Study|Adverse Event|7|||
156780195|NCT01482221|565946189|FG002|Overall Study|Adverse Event|3|||
156780196|NCT01482221|565946187|FG000|Overall Study|Withdrawal by Subject|10|||
156780197|NCT01482221|565946188|FG001|Overall Study|Withdrawal by Subject|7|||
156780198|NCT01482221|565946189|FG002|Overall Study|Withdrawal by Subject|12|||
156780199|NCT01482221|565946187|FG000|Overall Study|Incorrect randomization|0|||
156780200|NCT01482221|565946188|FG001|Overall Study|Incorrect randomization|1|||
156780201|NCT01482221|565946189|FG002|Overall Study|Incorrect randomization|0|||
156780202|NCT01482221|565946187|FG000|Overall Study|Physician Decision|0|||
156780203|NCT01482221|565946188|FG001|Overall Study|Physician Decision|1|||
156780204|NCT01482221|565946189|FG002|Overall Study|Physician Decision|0|||
156780205|NCT00263562|565946190|FG000|Overall Study|Protocol Violation|3|||
156780206|NCT00263562|565946191|FG001|Overall Study|Protocol Violation|0|||
156780207|NCT04602000|565946192|FG000|Overall Study|Withdrawal by Subject|3|||
156780208|NCT04602000|565946193|FG001|Overall Study|Withdrawal by Subject|6|||
156780209|NCT04602000|565946194|FG002|Overall Study|Withdrawal by Subject|3|||
156780210|NCT04602000|565946195|FG003|Overall Study|Withdrawal by Subject|27|||
156780211|NCT04602000|565946196|FG004|Overall Study|Withdrawal by Subject|39|||
156780212|NCT04602000|565946192|FG000|Overall Study|Physician Decision|1|||
156780213|NCT04602000|565946193|FG001|Overall Study|Physician Decision|0|||
156780214|NCT04602000|565946194|FG002|Overall Study|Physician Decision|0|||
156780215|NCT04602000|565946195|FG003|Overall Study|Physician Decision|2|||
156780216|NCT04602000|565946196|FG004|Overall Study|Physician Decision|2|||
156780217|NCT04602000|565946192|FG000|Overall Study|Death|0|||
156780218|NCT04602000|565946193|FG001|Overall Study|Death|1|||
156780219|NCT04602000|565946194|FG002|Overall Study|Death|0|||
156780220|NCT04602000|565946195|FG003|Overall Study|Death|1|||
156780221|NCT04602000|565946196|FG004|Overall Study|Death|2|||
156780222|NCT04602000|565946192|FG000|Overall Study|Lost to Follow-up|0|||
156780223|NCT04602000|565946193|FG001|Overall Study|Lost to Follow-up|0|||
156780224|NCT04602000|565946194|FG002|Overall Study|Lost to Follow-up|0|||
156780225|NCT04602000|565946195|FG003|Overall Study|Lost to Follow-up|3|||
156780226|NCT04602000|565946196|FG004|Overall Study|Lost to Follow-up|4|||
156780227|NCT04602000|565946192|FG000|Overall Study|Other|4|||
156780228|NCT04602000|565946193|FG001|Overall Study|Other|1|||
156780229|NCT04602000|565946194|FG002|Overall Study|Other|2|||
156780230|NCT04602000|565946195|FG003|Overall Study|Other|5|||
156780231|NCT04602000|565946196|FG004|Overall Study|Other|4|||
156780232|NCT04602000|565946192|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780233|NCT04602000|565946193|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780234|NCT04602000|565946194|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
156780235|NCT04602000|565946195|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780236|NCT04602000|565946196|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
156780237|NCT05607043|565946197|FG000|Overall Study|Lost to Follow-up|2|||
156780238|NCT05427916|565946204|FG000|Overall Study|Adverse Event|3|||
156780239|NCT05427916|565946205|FG001|Overall Study|Adverse Event|0|||
156780240|NCT05427916|565946204|FG000|Overall Study|Lack of Efficacy|6|||
156780241|NCT05427916|565946205|FG001|Overall Study|Lack of Efficacy|0|||
156780242|NCT05427916|565946204|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
156780243|NCT05427916|565946205|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
156780244|NCT00429299|565946208|FG000|Overall Study|Disease Progression|1|||
156780245|NCT00429299|565946209|FG001|Overall Study|Disease Progression|1|||
156780246|NCT00429299|565946210|FG002|Overall Study|Disease Progression|0|||
156780247|NCT00429299|565946208|FG000|Overall Study|Adverse Event|2|||
157118168|NCT04703075|567184235|FG001|Overall Study|Moved|2|||
157118169|NCT04703075|567184234|FG000|Overall Study|Index INH Resistant|0|||
157118170|NCT04703075|567184235|FG001|Overall Study|Index INH Resistant|1|||
157118171|NCT04703075|567184234|FG000|Overall Study|Lack of Efficacy|6|||
157118172|NCT04703075|567184235|FG001|Overall Study|Lack of Efficacy|18|||
157118173|NCT00254501|567184238|FG000|Overall Study|Lost to Follow-up|1|||
157118174|NCT00254501|567184239|FG001|Overall Study|Lost to Follow-up|1|||
157118175|NCT01119248|567184240|FG000|Overall Study|Physician Decision|5|||
157118176|NCT00550680|567184241|FG000|Overall Study|Administrative Reasons|1|||
156780248|NCT00429299|565946209|FG001|Overall Study|Adverse Event|5|||
156780249|NCT00429299|565946210|FG002|Overall Study|Adverse Event|1|||
156780250|NCT00429299|565946208|FG000|Overall Study|Protocol Violation|1|||
156780251|NCT00429299|565946209|FG001|Overall Study|Protocol Violation|0|||
156780252|NCT00429299|565946210|FG002|Overall Study|Protocol Violation|0|||
156780253|NCT00429299|565946208|FG000|Overall Study|Withdrawal by Subject|0|||
156780254|NCT00429299|565946209|FG001|Overall Study|Withdrawal by Subject|1|||
156780255|NCT00429299|565946210|FG002|Overall Study|Withdrawal by Subject|3|||
156780256|NCT04871113|565946211|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780257|NCT04871113|565946212|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780258|NCT04871113|565946213|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780259|NCT04871113|565946214|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780260|NCT04871113|565946215|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780261|NCT04871113|565946216|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
156780262|NCT04871113|565946217|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780263|NCT04871113|565946218|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780264|NCT04871113|565946219|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780265|NCT04871113|565946220|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
156780266|NCT04871113|565946211|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780267|NCT04871113|565946212|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780268|NCT04871113|565946213|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780269|NCT04871113|565946214|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780270|NCT04871113|565946215|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780271|NCT04871113|565946216|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780272|NCT04871113|565946217|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
156780273|NCT04871113|565946218|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
156780274|NCT04871113|565946219|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780275|NCT04871113|565946220|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
156780276|NCT01257542|565946221|FG000|Overall Study|Protocol Violation|3|||
156780277|NCT01257542|565946222|FG001|Overall Study|Protocol Violation|5|||
156780278|NCT01257542|565946221|FG000|Overall Study|Withdrawal by Subject|0|||
156780279|NCT01257542|565946222|FG001|Overall Study|Withdrawal by Subject|2|||
156780280|NCT00549328|565946226|FG000|Overall Study|Adverse Event|2|||
156780281|NCT00549328|565946226|FG000|Overall Study|Disease Progression|10|||
156780282|NCT00549328|565946226|FG000|Overall Study|Death|1|||
156780283|NCT00549328|565946226|FG000|Overall Study|Use of Prohibited Medication|1|||
156780284|NCT00770484|565946227|FG000|Overall Study|Withdrawal by Subject|1|||
156780285|NCT00770484|565946228|FG001|Overall Study|Withdrawal by Subject|0|||
156780286|NCT00153920|565946229|FG000|Overall Study|Adverse Event|9|||
156780287|NCT00153920|565946229|FG000|Overall Study|Progressive Disease|9|||
156780288|NCT00153920|565946229|FG000|Overall Study|Physician Decision|3|||
156780289|NCT00153920|565946229|FG000|Overall Study|Lack of Response|3|||
156780290|NCT00153920|565946229|FG000|Overall Study|Death|2|||
156780291|NCT00153920|565946229|FG000|Overall Study|Withdrawal by Subject|1|||
156780292|NCT00153920|565946229|FG000|Overall Study|Non-Protocol Therapy|1|||
156780293|NCT00153920|565946229|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
156780294|NCT00153920|565946229|FG000|Overall Study|Progressive Disease before Trt|1|||
156780295|NCT05630755|565946230|FG000|Overall Study|Lost to Follow-up|7|||
156780296|NCT05630755|565946231|FG001|Overall Study|Lost to Follow-up|0|||
156780297|NCT05630755|565946230|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
156780298|NCT05630755|565946231|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
156780299|NCT05630755|565946230|FG000|Overall Study|Withdrawal by Subject|9|||
156780300|NCT05630755|565946231|FG001|Overall Study|Withdrawal by Subject|3|||
156780301|NCT05630755|565946230|FG000|Overall Study|Participant moved away from trial site|0|||
156780302|NCT05630755|565946231|FG001|Overall Study|Participant moved away from trial site|1|||
156780303|NCT05630755|565946230|FG000|Overall Study|Status not Recorded|316|||
156780304|NCT05630755|565946231|FG001|Overall Study|Status not Recorded|161|||
156780305|NCT04868682|565946232|FG000|Post-treatment|Lost to Follow-up|1|||
156780306|NCT04868682|565946233|FG001|Post-treatment|Lost to Follow-up|1|||
156780307|NCT04868682|565946232|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
156780308|NCT04868682|565946233|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
157118177|NCT00550680|567184241|FG000|Overall Study|Adverse Event|5|||
156780309|NCT04868682|565946232|FG000|Six-month Assessment|Lost to Follow-up|1|||
157118178|NCT00550680|567184241|FG000|Overall Study|Death|3|||
157118179|NCT00550680|567184241|FG000|Overall Study|Early Improvement|1|||
156780310|NCT04868682|565946233|FG001|Six-month Assessment|Lost to Follow-up|0|||
156780311|NCT04868682|565946232|FG000|Six-month Assessment|Death|1|||
156780312|NCT04868682|565946233|FG001|Six-month Assessment|Death|0|||
156780313|NCT04868682|565946232|FG000|Six-month Assessment|Refused|0|||
156780314|NCT04868682|565946233|FG001|Six-month Assessment|Refused|1|||
156780315|NCT04868682|565946232|FG000|12-month Assessment|Lost to Follow-up|2|||
156780316|NCT04868682|565946233|FG001|12-month Assessment|Lost to Follow-up|1|||
156780317|NCT04868682|565946232|FG000|12-month Assessment|Death|0|||
156780318|NCT04868682|565946233|FG001|12-month Assessment|Death|1|||
156780319|NCT03384966|565946234|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
156780320|NCT03384966|565946235|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
156780321|NCT03384966|565946236|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
156780322|NCT03384966|565946234|FG000|Follow-up Period|Adverse Event|1|||
156780323|NCT03384966|565946235|FG001|Follow-up Period|Adverse Event|0|||
156780324|NCT03384966|565946236|FG002|Follow-up Period|Adverse Event|0|||
156780325|NCT03880565|565946237|FG000|Overall Study|Withdrawal by Subject|1|||
156780326|NCT03880565|565946238|FG001|Overall Study|Withdrawal by Subject|0|||
156780327|NCT02202616|565946239|FG000|Overall Study|Screen failed|24|||
156780328|NCT02202616|565946239|FG000|Overall Study|Adverse Event|32|||
156780329|NCT02202616|565946239|FG000|Overall Study|Protocol deviation|18|||
156780330|NCT02202616|565946239|FG000|Overall Study|Patient withdrew consent|12|||
156780331|NCT02202616|565946239|FG000|Overall Study|Lost to Follow-up|6|||
156780332|NCT02202616|565946239|FG000|Overall Study|Administrative problems|6|||
156780333|NCT02202616|565946239|FG000|Overall Study|Abnormal test procedure result|1|||
156780334|NCT02202616|565946239|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156780335|NCT00367458|565946240|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
156780336|NCT00367458|565946241|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
156780337|NCT00776997|565946243|FG000|Overall Study|Adverse Event|2|||
156780338|NCT01716156|565946244|FG000|Overall Study|Protocol Violation|1|||
156780339|NCT01716156|565946245|FG001|Overall Study|Protocol Violation|0|||
156780340|NCT01716156|565946246|FG002|Overall Study|Protocol Violation|0|||
156780341|NCT01716156|565946244|FG000|Overall Study|Withdrawal by Subject|0|||
156780342|NCT01716156|565946245|FG001|Overall Study|Withdrawal by Subject|1|||
156780343|NCT01716156|565946246|FG002|Overall Study|Withdrawal by Subject|2|||
156780344|NCT01716156|565946244|FG000|Overall Study|Lost to Follow-up|1|||
156780345|NCT01716156|565946245|FG001|Overall Study|Lost to Follow-up|0|||
156780346|NCT01716156|565946246|FG002|Overall Study|Lost to Follow-up|0|||
156780347|NCT05221866|565946249|FG000|Overall Study|Withdrawal by Subject|5|||
156780348|NCT05221866|565946250|FG001|Overall Study|Withdrawal by Subject|7|||
156780349|NCT05221866|565946251|FG002|Overall Study|Withdrawal by Subject|6|||
156780350|NCT05221866|565946252|FG003|Overall Study|Withdrawal by Subject|4|||
156780351|NCT05221866|565946249|FG000|Overall Study|Physician Decision|3|||
156780352|NCT05221866|565946250|FG001|Overall Study|Physician Decision|2|||
156780353|NCT05221866|565946251|FG002|Overall Study|Physician Decision|1|||
156780354|NCT05221866|565946252|FG003|Overall Study|Physician Decision|4|||
156780355|NCT05221866|565946249|FG000|Overall Study|Lost to Follow-up|12|||
156780356|NCT05221866|565946250|FG001|Overall Study|Lost to Follow-up|17|||
156780357|NCT05221866|565946251|FG002|Overall Study|Lost to Follow-up|14|||
156780358|NCT05221866|565946252|FG003|Overall Study|Lost to Follow-up|14|||
156780359|NCT05221866|565946249|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
156780360|NCT05221866|565946250|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
156780361|NCT05221866|565946251|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
156780362|NCT05221866|565946252|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
156780363|NCT04470427|565946253|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
156780364|NCT04470427|565946254|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
156780365|NCT04470427|565946255|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
156780366|NCT04470427|565946256|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
156780367|NCT04470427|565946257|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
156780368|NCT04470427|565946258|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
156780369|NCT04470427|565946253|FG000|Part B :Open-label|Other than specified|0|||
156780370|NCT04470427|565946254|FG001|Part B :Open-label|Other than specified|0|||
156780371|NCT04470427|565946255|FG002|Part B :Open-label|Other than specified|788|||
156780372|NCT04470427|565946256|FG003|Part B :Open-label|Other than specified|0|||
156780373|NCT04470427|565946257|FG004|Part B :Open-label|Other than specified|523|||
156780374|NCT04470427|565946258|FG005|Part B :Open-label|Other than specified|0|||
156780375|NCT04470427|565946253|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
156780376|NCT04470427|565946254|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
156780377|NCT04470427|565946255|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
156780378|NCT04470427|565946256|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
156780379|NCT04470427|565946257|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
156780380|NCT04470427|565946258|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
157011336|NCT02299375|566793466|FG000|Overall Study|Withdrawal by Subject|1|||
156780381|NCT04470427|565946253|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
156780382|NCT04470427|565946254|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
156780383|NCT04470427|565946255|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
156780384|NCT04470427|565946256|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
156780385|NCT04470427|565946257|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
156780386|NCT04470427|565946258|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
156780387|NCT04057365|565946259|FG000|Overall Study|Withdrawal by Subject|2|||
156780388|NCT04057365|565946260|FG001|Overall Study|Withdrawal by Subject|0|||
156780389|NCT04738487|565946261|FG000|Overall Study|Participant Ongoing in Study|298|||
156780390|NCT04738487|565946262|FG001|Overall Study|Participant Ongoing in Study|297|||
156780391|NCT04738487|565946261|FG000|Overall Study|Withdrawal by Subject|7|||
156780392|NCT04738487|565946262|FG001|Overall Study|Withdrawal by Subject|9|||
156780393|NCT04738487|565946261|FG000|Overall Study|Lost to Follow-up|2|||
156780394|NCT04738487|565946262|FG001|Overall Study|Lost to Follow-up|0|||
156780395|NCT04738487|565946261|FG000|Overall Study|Death|287|||
156780396|NCT04738487|565946262|FG001|Overall Study|Death|306|||
156780397|NCT02717611|565946263|FG000|Overall Study|Death|13|||
156780398|NCT02717611|565946263|FG000|Overall Study|Withdrawal by Subject|6|||
156780399|NCT02717611|565946263|FG000|Overall Study|Active, not recruiting|40|||
156780400|NCT02717611|565946263|FG000|Overall Study|Complicating disease|1|||
156780401|NCT04818112|565946264|FG000|Overall Study|Withdrawal by Subject|54|||
156780402|NCT04818112|565946265|FG001|Overall Study|Withdrawal by Subject|12|||
156780403|NCT04818112|565946264|FG000|Overall Study|Lost to Follow-up|38|||
156780404|NCT04818112|565946265|FG001|Overall Study|Lost to Follow-up|10|||
156780405|NCT02676973|565946266|FG000|Overall Study|Withdrawal by Subject|9|||
156780406|NCT02676973|565946267|FG001|Overall Study|Withdrawal by Subject|8|||
156780407|NCT02676973|565946268|FG002|Overall Study|Withdrawal by Subject|11|||
156780408|NCT02676973|565946266|FG000|Overall Study|Lost to Follow-up|8|||
156780409|NCT02676973|565946267|FG001|Overall Study|Lost to Follow-up|12|||
156780410|NCT02676973|565946268|FG002|Overall Study|Lost to Follow-up|8|||
156780411|NCT02676973|565946266|FG000|Overall Study|Death|2|||
156780412|NCT02676973|565946267|FG001|Overall Study|Death|1|||
156780413|NCT02676973|565946268|FG002|Overall Study|Death|5|||
156780414|NCT01913353|565946270|FG000|Overall Study|Adverse Event|2|||
156780415|NCT01913353|565946271|FG001|Overall Study|Adverse Event|0|||
156780416|NCT01913353|565946270|FG000|Overall Study|Physician Decision|0|||
156780417|NCT01913353|565946271|FG001|Overall Study|Physician Decision|2|||
156780418|NCT01913353|565946270|FG000|Overall Study|Withdrawal by Subject|20|||
156780419|NCT01913353|565946271|FG001|Overall Study|Withdrawal by Subject|6|||
156780420|NCT01913353|565946270|FG000|Overall Study|multiple reasons|10|||
156780421|NCT01913353|565946271|FG001|Overall Study|multiple reasons|7|||
156780422|NCT00385840|565946272|FG000|Overall Study|Adverse Event|1|||
156780423|NCT00385840|565946273|FG001|Overall Study|Adverse Event|1|||
156780424|NCT00385840|565946272|FG000|Overall Study|Lost to Follow-up|3|||
156780425|NCT00385840|565946273|FG001|Overall Study|Lost to Follow-up|13|||
156780426|NCT05172570|565946274|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
156780427|NCT05172570|565946275|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
156780428|NCT05172570|565946276|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
156780429|NCT05172570|565946274|FG000|Overall Study|PI Decision due to equipment shortages|0|||
156780430|NCT05172570|565946275|FG001|Overall Study|PI Decision due to equipment shortages|0|||
156780431|NCT05172570|565946276|FG002|Overall Study|PI Decision due to equipment shortages|1|||
156780432|NCT06170827|565946282|FG000|Overall Study|Withdrawal by Subject|1|||
156780433|NCT06170827|565946283|FG001|Overall Study|Withdrawal by Subject|1|||
156780434|NCT00632359|565946284|FG000|Overall Study|Withdrawal by Subject|2|||
156780435|NCT04941898|565947090|FG000|Overall Study|Protocol Violation|1|||
156780436|NCT00003456|565947091|FG000|Overall Study|Not evaluable|8|||
156780437|NCT00420407|565947093|FG000|Overall Study|Lost to Follow-up|0|||
156780438|NCT00420407|565947094|FG001|Overall Study|Lost to Follow-up|3|||
156780439|NCT00420407|565947093|FG000|Overall Study|Physician Decision|2|||
156780440|NCT00420407|565947094|FG001|Overall Study|Physician Decision|1|||
156780441|NCT00420407|565947093|FG000|Overall Study|subject identified as detainee|1|||
156780442|NCT00420407|565947094|FG001|Overall Study|subject identified as detainee|0|||
156780443|NCT00420407|565947093|FG000|Overall Study|subject identified as Jehovah's witness|1|||
156780444|NCT00420407|565947094|FG001|Overall Study|subject identified as Jehovah's witness|0|||
156780445|NCT00420407|565947093|FG000|Overall Study|Withdrawal by Subject|0|||
156780446|NCT00420407|565947094|FG001|Overall Study|Withdrawal by Subject|2|||
156780447|NCT03641924|565947095|FG000|Overall Study|Withdrawal by Subject|26|||
156780448|NCT03641924|565947095|FG000|Overall Study|Lost to Follow-up|16|||
156780449|NCT03641924|565947095|FG000|Overall Study|Protocol Violation|10|||
157011337|NCT02299375|566793467|FG001|Overall Study|Withdrawal by Subject|4|||
157011338|NCT00704184|566793470|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
156780450|NCT01565694|565947096|FG000|Dose-Titration Period|Adverse Event|4|||
157011339|NCT00704184|566793471|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
156780451|NCT01565694|565947096|FG000|Dose-Titration Period|Protocol Violation|10|||
157011340|NCT00704184|566793472|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
156780452|NCT01565694|565947096|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
156780453|NCT01373229|565947097|FG000|Overall Study|Death|3|||
156780454|NCT01373229|565947097|FG000|Overall Study|Physician Decision|3|||
156780455|NCT03234881|565947098|FG000|Overall Study|Lost to Follow-up|9|||
156780456|NCT03234881|565947099|FG001|Overall Study|Lost to Follow-up|3|||
156780457|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
156780458|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
156780459|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
156780460|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
156780461|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
156780462|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
156780463|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780464|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780465|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780466|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780467|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
156780468|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
156780469|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780470|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780471|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780472|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780473|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
156780474|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
156780475|NCT00541229|565947102|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780476|NCT00541229|565947103|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
156780477|NCT00541229|565947104|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
156780478|NCT00541229|565947105|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
156780479|NCT00541229|565947106|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780480|NCT00541229|565947107|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
156780481|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
156780482|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
156780483|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
156780484|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
156780485|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
156780486|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
156780487|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
156780488|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
156780489|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
156780490|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
156780491|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
156780492|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
156780493|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780494|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780495|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780496|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780497|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
156780498|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
156780499|NCT00541229|565947102|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780500|NCT00541229|565947103|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
156780501|NCT00541229|565947104|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780502|NCT00541229|565947105|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
156780503|NCT00541229|565947106|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
156780504|NCT00541229|565947107|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
156780505|NCT00541229|565947102|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
156780506|NCT00541229|565947103|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
156780507|NCT00541229|565947104|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
156780508|NCT00541229|565947105|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
156780509|NCT00541229|565947106|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
156780510|NCT00541229|565947107|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
156780511|NCT00541229|565947102|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
156780512|NCT00541229|565947103|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780513|NCT00541229|565947104|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780514|NCT00541229|565947105|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780515|NCT00541229|565947106|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
156780516|NCT00541229|565947107|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
156780517|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
156780518|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780519|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780520|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780521|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780522|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
156780523|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780524|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780525|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780526|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780527|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
156780528|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
156780529|NCT00541229|565947102|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780530|NCT00541229|565947103|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
156780531|NCT00541229|565947104|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
156780532|NCT00541229|565947105|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
156780533|NCT00541229|565947106|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780534|NCT00541229|565947107|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
156780535|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
156780536|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
156780537|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
156780538|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
156780539|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
156780540|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
156780541|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780542|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780543|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780544|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780545|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
156780546|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
156780547|NCT00541229|565947102|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780548|NCT00541229|565947103|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780549|NCT00541229|565947104|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
156780550|NCT00541229|565947105|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780551|NCT00541229|565947106|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780552|NCT00541229|565947107|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
156780553|NCT03720847|565947108|FG000|Washout|Physician Decision|1|||
156780554|NCT03720847|565947109|FG001|Washout|Physician Decision|2|||
156780555|NCT01500096|565947110|FG000|Overall Study|Lost to Follow-up|1|||
156780556|NCT01500096|565947111|FG001|Overall Study|Lost to Follow-up|0|||
157011341|NCT00704184|566793473|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
156780557|NCT01500096|565947112|FG002|Overall Study|Lost to Follow-up|0|||
156780558|NCT01500096|565947113|FG003|Overall Study|Lost to Follow-up|2|||
157011342|NCT00704184|566793474|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
157011343|NCT00704184|566793470|FG000|Open-Label Treatment|Adverse Event|0|||
157011344|NCT00704184|566793471|FG001|Open-Label Treatment|Adverse Event|0|||
156780559|NCT03033901|565947114|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
156780560|NCT03033901|565947114|FG000|Overall Study|Refused PSG|23|||
156780561|NCT03033901|565947114|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
156780562|NCT03033901|565947114|FG000|Overall Study|Missing Oximetry Data|3|||
156780563|NCT00639379|565947115|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
156780564|NCT00639379|565947116|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
156780565|NCT00639379|565947115|FG000|Period 1 - 2 Weeks|lens issue|3|||
156780566|NCT00639379|565947116|FG001|Period 1 - 2 Weeks|lens issue|0|||
156780567|NCT00924651|565947117|FG000|Overall Study|Chemo started too soon|2|||
156780568|NCT00924651|565947118|FG001|Overall Study|Chemo started too soon|3|||
156780569|NCT00924651|565947117|FG000|Overall Study|No Reason|3|||
156780570|NCT00924651|565947118|FG001|Overall Study|No Reason|7|||
156780571|NCT00924651|565947117|FG000|Overall Study|Overwhelmed|6|||
156780572|NCT00924651|565947118|FG001|Overall Study|Overwhelmed|6|||
156780573|NCT00924651|565947117|FG000|Overall Study|Noncompliant|1|||
156780574|NCT00924651|565947118|FG001|Overall Study|Noncompliant|4|||
156780575|NCT00924651|565947117|FG000|Overall Study|Medical|1|||
156780576|NCT00924651|565947118|FG001|Overall Study|Medical|3|||
156780577|NCT00924651|565947117|FG000|Overall Study|Changed Mind|10|||
156780578|NCT00924651|565947118|FG001|Overall Study|Changed Mind|1|||
156780579|NCT00924651|565947117|FG000|Overall Study|Incomplete Form|2|||
156780580|NCT00924651|565947118|FG001|Overall Study|Incomplete Form|1|||
156780581|NCT01797185|565947119|FG000|Overall Study|Adverse Event|5|||
156780582|NCT01797185|565947120|FG001|Overall Study|Adverse Event|15|||
156780583|NCT01797185|565947121|FG002|Overall Study|Adverse Event|6|||
156780584|NCT01797185|565947119|FG000|Overall Study|Withdrawal by Subject|6|||
156780585|NCT01797185|565947120|FG001|Overall Study|Withdrawal by Subject|9|||
156780586|NCT01797185|565947121|FG002|Overall Study|Withdrawal by Subject|5|||
156780587|NCT01797185|565947119|FG000|Overall Study|Site terminated|8|||
156780588|NCT01797185|565947120|FG001|Overall Study|Site terminated|4|||
156780589|NCT01797185|565947121|FG002|Overall Study|Site terminated|0|||
156780590|NCT01797185|565947119|FG000|Overall Study|Lost to Follow-up|2|||
156780591|NCT01797185|565947120|FG001|Overall Study|Lost to Follow-up|6|||
156780592|NCT01797185|565947121|FG002|Overall Study|Lost to Follow-up|1|||
156780593|NCT01797185|565947119|FG000|Overall Study|Withdrawn per sponsor|5|||
156780594|NCT01797185|565947120|FG001|Overall Study|Withdrawn per sponsor|0|||
156780595|NCT01797185|565947121|FG002|Overall Study|Withdrawn per sponsor|0|||
156780596|NCT01797185|565947119|FG000|Overall Study|Physician Decision|1|||
156780597|NCT01797185|565947120|FG001|Overall Study|Physician Decision|3|||
156780598|NCT01797185|565947121|FG002|Overall Study|Physician Decision|0|||
156780599|NCT01797185|565947119|FG000|Overall Study|Protocol Violation|1|||
156780600|NCT01797185|565947120|FG001|Overall Study|Protocol Violation|1|||
156780601|NCT01797185|565947121|FG002|Overall Study|Protocol Violation|0|||
156780602|NCT00723944|565947122|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
156780603|NCT00723944|565947123|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
156780604|NCT00723944|565947122|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
156780605|NCT00723944|565947123|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
156780606|NCT00723944|565947122|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
156780607|NCT00723944|565947123|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
156780608|NCT01847209|565947124|FG000|Overall Study|Withdrawal by Subject|1|||
156780609|NCT01847209|565947124|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
156780610|NCT00729586|565947125|FG000|Overall Study|Ineligible|0|||
156780611|NCT00729586|565947126|FG001|Overall Study|Ineligible|1|||
156780612|NCT00729586|565947125|FG000|Overall Study|never treated|1|||
156780613|NCT00729586|565947126|FG001|Overall Study|never treated|0|||
156780614|NCT02737618|565947129|FG000|Overall Study|Withdrawal by Subject|9|||
156780615|NCT02513199|565947130|FG000|Treatment|Death|1|||
156780616|NCT02513199|565947130|FG000|Treatment|Lost to Follow-up|1|||
156780617|NCT02513199|565947130|FG000|Follow-Up|Death|11|||
156780618|NCT02397837|565947136|FG000|Overall Study|Withdrawal by Subject|6|||
156780619|NCT02397837|565947137|FG001|Overall Study|Withdrawal by Subject|5|||
156780620|NCT02397837|565947136|FG000|Overall Study|Physician Decision|1|||
156780621|NCT02397837|565947137|FG001|Overall Study|Physician Decision|1|||
156780622|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Death|1|||
156780623|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Death|0|||
156780624|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
156780625|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
156780626|NCT02506036|565947143|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
156780627|NCT02506036|565947144|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
156780628|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Adverse Event|2|||
156780629|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
156780630|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
156780631|NCT02536794|565947146|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
156780632|NCT02536794|565947146|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
156780633|NCT02536794|565947146|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
156780634|NCT01410604|565947147|FG000|Overall Study|Adverse Event|2|||
156780635|NCT01410604|565947148|FG001|Overall Study|Adverse Event|1|||
156780636|NCT01410604|565947147|FG000|Overall Study|Lost to Follow-up|1|||
156780637|NCT01410604|565947148|FG001|Overall Study|Lost to Follow-up|0|||
156780638|NCT01410604|565947147|FG000|Overall Study|Physician Decision|0|||
156780639|NCT01410604|565947148|FG001|Overall Study|Physician Decision|1|||
156780640|NCT01178411|565947153|FG000|Overall Study|Adverse Event|5|||
156780641|NCT01178411|565947153|FG000|Overall Study|Withdrawal by Subject|4|||
156780642|NCT01178411|565947153|FG000|Overall Study|Protocol Violation|1|||
156780643|NCT01178411|565947153|FG000|Overall Study|Progressive disease per RECIST|32|||
156780644|NCT01178411|565947153|FG000|Overall Study|Progressive disease per clinician|9|||
156780645|NCT01178411|565947153|FG000|Overall Study|Physician Decision|6|||
156780646|NCT01178411|565947153|FG000|Overall Study|Death|1|||
156780647|NCT01178411|565947153|FG000|Overall Study|No reason provided|1|||
156780648|NCT01178411|565947153|FG000|Overall Study|Drug manufacturing ended|1|||
156780649|NCT02453048|565947154|FG000|Overall Study|Only part of initial 6 mo. study|0|||
156780650|NCT02453048|565947155|FG001|Overall Study|Only part of initial 6 mo. study|0|||
156780651|NCT02453048|565947156|FG002|Overall Study|Only part of initial 6 mo. study|0|||
156780652|NCT02453048|565947157|FG003|Overall Study|Only part of initial 6 mo. study|0|||
156780653|NCT02453048|565947158|FG004|Overall Study|Only part of initial 6 mo. study|6|||
156780654|NCT02453048|565947154|FG000|Overall Study|Lost to Follow-up|0|||
156780655|NCT02453048|565947155|FG001|Overall Study|Lost to Follow-up|1|||
156780656|NCT02453048|565947156|FG002|Overall Study|Lost to Follow-up|2|||
156780657|NCT02453048|565947157|FG003|Overall Study|Lost to Follow-up|0|||
156780658|NCT02453048|565947158|FG004|Overall Study|Lost to Follow-up|0|||
156780659|NCT01239745|565947159|FG000|Overall Study|Study terminated by sponsor|45|||
156780660|NCT01239745|565947159|FG000|Overall Study|Adverse Event|1|||
156780661|NCT00726557|565947160|FG000|Overall Study|Screening failure|4|||
156780662|NCT00726557|565947160|FG000|Overall Study|No end of treatment documentation|37|||
156780663|NCT00726557|565947160|FG000|Overall Study|No follow-up documentation available|55|||
156780664|NCT00726557|565947160|FG000|Overall Study|Treatment less than 3 months|17|||
156780665|NCT00726557|565947160|FG000|Overall Study|Inclusion criteria not met|15|||
156780666|NCT00081458|565947163|FG000|Overall Study|Adverse Event|1|||
156780667|NCT00081458|565947164|FG001|Overall Study|Adverse Event|5|||
156780668|NCT00081458|565947165|FG002|Overall Study|Adverse Event|2|||
156780669|NCT00081458|565947163|FG000|Overall Study|Withdrawal by Subject|0|||
156780670|NCT00081458|565947164|FG001|Overall Study|Withdrawal by Subject|3|||
156780671|NCT00081458|565947165|FG002|Overall Study|Withdrawal by Subject|1|||
157011345|NCT00704184|566793472|FG002|Open-Label Treatment|Adverse Event|2|||
157011346|NCT00704184|566793473|FG003|Open-Label Treatment|Adverse Event|0|||
157011347|NCT00704184|566793474|FG004|Open-Label Treatment|Adverse Event|1|||
157011348|NCT00704184|566793470|FG000|Open-Label Treatment|Lack of Efficacy|0|||
157011349|NCT00704184|566793471|FG001|Open-Label Treatment|Lack of Efficacy|2|||
157011350|NCT00704184|566793472|FG002|Open-Label Treatment|Lack of Efficacy|2|||
157011351|NCT00704184|566793473|FG003|Open-Label Treatment|Lack of Efficacy|2|||
157011352|NCT00704184|566793474|FG004|Open-Label Treatment|Lack of Efficacy|1|||
156780672|NCT00081458|565947163|FG000|Overall Study|Randomized but not dosed|0|||
156780673|NCT00081458|565947164|FG001|Overall Study|Randomized but not dosed|0|||
156780674|NCT00081458|565947165|FG002|Overall Study|Randomized but not dosed|1|||
156780675|NCT03097315|565947170|FG000|Overall Study|Withdrawal by Subject|1|||
156780676|NCT01946802|565947171|FG000|Overall Study|Death|1|||
156780677|NCT01946802|565947171|FG000|Overall Study|Withdrawal by Subject|2|||
156780678|NCT01946802|565947171|FG000|Overall Study|Combined septic shock|1|||
156780679|NCT01946802|565947171|FG000|Overall Study|Protocol Violation|1|||
156780680|NCT00195429|565947172|FG000|Overall Study|Adverse Event|2|||
156780681|NCT00195429|565947173|FG001|Overall Study|Adverse Event|4|||
156780682|NCT00195429|565947172|FG000|Overall Study|Lack of Efficacy|2|||
156780683|NCT00195429|565947173|FG001|Overall Study|Lack of Efficacy|1|||
156780684|NCT00195429|565947172|FG000|Overall Study|Lost to Follow-up|1|||
156780685|NCT00195429|565947173|FG001|Overall Study|Lost to Follow-up|0|||
156780686|NCT01334515|565947178|FG000|Overall Study|Adverse Event|1|||
156780687|NCT01334515|565947179|FG001|Overall Study|Adverse Event|6|||
156780688|NCT01334515|565947178|FG000|Overall Study|Death|1|||
156780689|NCT01334515|565947179|FG001|Overall Study|Death|0|||
156780690|NCT01334515|565947178|FG000|Overall Study|Lack of Efficacy|8|||
156780691|NCT01334515|565947179|FG001|Overall Study|Lack of Efficacy|21|||
156780692|NCT01334515|565947178|FG000|Overall Study|Physician Decision|1|||
157011353|NCT00704184|566793470|FG000|Open-Label Treatment|Physician Decision|0|||
156780693|NCT01334515|565947179|FG001|Overall Study|Physician Decision|1|||
156780694|NCT01334515|565947178|FG000|Overall Study|Withdrawal by Subject|1|||
156780695|NCT01334515|565947179|FG001|Overall Study|Withdrawal by Subject|1|||
156780696|NCT04327271|565947180|FG000|Overall Study|Death|1|||
156780697|NCT04327271|565947181|FG001|Overall Study|Death|0|||
156780698|NCT04327271|565947180|FG000|Overall Study|Withdrawal by Subject|1|||
157212710|NCT01462695|567526072|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
157212711|NCT01462695|567526073|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
157011354|NCT00704184|566793471|FG001|Open-Label Treatment|Physician Decision|0|||
157011355|NCT00704184|566793472|FG002|Open-Label Treatment|Physician Decision|0|||
157011356|NCT00704184|566793473|FG003|Open-Label Treatment|Physician Decision|0|||
157011357|NCT00704184|566793474|FG004|Open-Label Treatment|Physician Decision|1|||
157011358|NCT00704184|566793470|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
157011359|NCT00704184|566793471|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
157011360|NCT00704184|566793472|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
157011361|NCT00704184|566793473|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
157011362|NCT00704184|566793474|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
157011363|NCT00411216|566793475|FG000|Overall Study|Ten participants were entered into the c|0|||
157011364|NCT00411216|566793476|FG001|Overall Study|Ten participants were entered into the c|2|||
157011365|NCT01251354|566793481|FG000|Overall Study|Adverse Event|1|||
157011366|NCT01251354|566793481|FG000|Overall Study|Investigator's Decision|1|||
157011367|NCT01251354|566793481|FG000|Overall Study|Disease Progression|4|||
157011368|NCT05135000|566793485|FG000|Overall Study|Adverse Event|2|||
157011369|NCT05135000|566793486|FG001|Overall Study|Adverse Event|0|||
157011370|NCT05135000|566793485|FG000|Overall Study|Lost to Follow-up|1|||
157011371|NCT05135000|566793486|FG001|Overall Study|Lost to Follow-up|0|||
157011372|NCT05135000|566793485|FG000|Overall Study|Study Terminated by Sponsor|6|||
157011373|NCT05135000|566793486|FG001|Overall Study|Study Terminated by Sponsor|3|||
157011374|NCT00802464|566795391|FG000|Month 0 - Month 8|Adverse Event|0|||
157011375|NCT00802464|566795392|FG001|Month 0 - Month 8|Adverse Event|1|||
157011376|NCT00802464|566795393|FG002|Month 0 - Month 8|Adverse Event|1|||
157011377|NCT00802464|566795394|FG003|Month 0 - Month 8|Adverse Event|2|||
157011378|NCT00802464|566795391|FG000|Month 0 - Month 8|Protocol Violation|0|||
157011379|NCT00802464|566795392|FG001|Month 0 - Month 8|Protocol Violation|0|||
157011380|NCT00802464|566795393|FG002|Month 0 - Month 8|Protocol Violation|1|||
157011381|NCT00802464|566795394|FG003|Month 0 - Month 8|Protocol Violation|0|||
157011382|NCT00802464|566795391|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
157011383|NCT00802464|566795392|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
157011384|NCT00802464|566795393|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
157011385|NCT00802464|566795394|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
157011386|NCT00802464|566795391|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
157011387|NCT00802464|566795392|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
157011388|NCT00802464|566795393|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
157011389|NCT00802464|566795394|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
157011390|NCT00802464|566795391|FG000|Month 0 - Month 8|Other|0|||
157011391|NCT00802464|566795392|FG001|Month 0 - Month 8|Other|0|||
157011392|NCT00802464|566795393|FG002|Month 0 - Month 8|Other|1|||
157011393|NCT00802464|566795394|FG003|Month 0 - Month 8|Other|0|||
157011394|NCT00802464|566795391|FG000|Month 8 - Month 14|Adverse Event|0|||
157011395|NCT00802464|566795392|FG001|Month 8 - Month 14|Adverse Event|1|||
157011396|NCT00802464|566795393|FG002|Month 8 - Month 14|Adverse Event|0|||
157011397|NCT00802464|566795394|FG003|Month 8 - Month 14|Adverse Event|0|||
157011398|NCT00802464|566795391|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
157011399|NCT00802464|566795392|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
157011400|NCT00802464|566795393|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
157011401|NCT00802464|566795394|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
157011402|NCT00802464|566795391|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
157011403|NCT00802464|566795392|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
157011404|NCT00802464|566795393|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
157011405|NCT00802464|566795394|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
157011406|NCT00402246|566795395|FG000|Overall Study|Death|62|||
157011407|NCT00402246|566795396|FG001|Overall Study|Death|58|||
157011408|NCT00402246|566795395|FG000|Overall Study|Lost to Follow-up|20|||
157011409|NCT00402246|566795396|FG001|Overall Study|Lost to Follow-up|28|||
157011410|NCT00402246|566795395|FG000|Overall Study|Withdrawal by Subject|72|||
157011411|NCT00402246|566795396|FG001|Overall Study|Withdrawal by Subject|87|||
157011412|NCT00402246|566795395|FG000|Overall Study|Physician Decision|24|||
157011413|NCT00402246|566795396|FG001|Overall Study|Physician Decision|26|||
157011414|NCT00402246|566795395|FG000|Overall Study|Protocol Violation|25|||
157011415|NCT00402246|566795396|FG001|Overall Study|Protocol Violation|24|||
157011416|NCT00402246|566795395|FG000|Overall Study|Missed Final Visit|1|||
157011417|NCT00402246|566795396|FG001|Overall Study|Missed Final Visit|2|||
157011418|NCT00402246|566795395|FG000|Overall Study|Insurance Issues|2|||
157011419|NCT00402246|566795396|FG001|Overall Study|Insurance Issues|1|||
157011420|NCT00402246|566795395|FG000|Overall Study|Heart Transplant|0|||
157011421|NCT00402246|566795396|FG001|Overall Study|Heart Transplant|1|||
157011422|NCT00402246|566795395|FG000|Overall Study|Patient's device explanted|6|||
157011423|NCT00402246|566795396|FG001|Overall Study|Patient's device explanted|2|||
157011424|NCT00402246|566795395|FG000|Overall Study|Center Closure|5|||
157011425|NCT00402246|566795396|FG001|Overall Study|Center Closure|3|||
157011426|NCT00402246|566795395|FG000|Overall Study|Deterioriating Condition|3|||
157011427|NCT00402246|566795396|FG001|Overall Study|Deterioriating Condition|2|||
157011428|NCT02622568|566795402|FG000|Overall Study|Lost to Follow-up|5|||
157011429|NCT02622568|566795403|FG001|Overall Study|Lost to Follow-up|5|||
157011430|NCT04512482|566795404|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
157011431|NCT04512482|566795405|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
157011432|NCT02647905|566795406|FG000|Overall Study|Lost to Follow-up|1|||
157011433|NCT02647905|566795406|FG000|Overall Study|Withdrawal by Subject|2|||
157118180|NCT00550680|567184241|FG000|Overall Study|Lost to Follow-up|3|||
157118181|NCT00550680|567184241|FG000|Overall Study|Lack of Efficacy|1|||
157118182|NCT00550680|567184241|FG000|Overall Study|Other|10|||
157118183|NCT00550680|567184241|FG000|Overall Study|Protocol Violation|7|||
157118184|NCT00550680|567184241|FG000|Overall Study|Refused Treatment|19|||
157118185|NCT00550680|567184241|FG000|Overall Study|Screen Failure|6|||
157118186|NCT01967550|567184242|FG000|Overall Study|Withdrawal by Subject|1|||
157118187|NCT01967550|567184243|FG001|Overall Study|Withdrawal by Subject|0|||
157118188|NCT01967550|567184242|FG000|Overall Study|Adverse Event|2|||
157118189|NCT01967550|567184243|FG001|Overall Study|Adverse Event|0|||
157118190|NCT01967550|567184242|FG000|Overall Study|Protocol Violation|2|||
157118191|NCT01967550|567184243|FG001|Overall Study|Protocol Violation|1|||
157118192|NCT01967550|567184242|FG000|Overall Study|Non Compliance|0|||
157118193|NCT01967550|567184243|FG001|Overall Study|Non Compliance|1|||
157118194|NCT00250835|567184244|FG000|Overall Study|Withdrawal by Subject|1|||
157118195|NCT01100437|567184246|FG000|Titration/Stabilization|Adverse Event|0|||
157118196|NCT01100437|567184247|FG001|Titration/Stabilization|Adverse Event|0|||
157118197|NCT01100437|567184248|FG002|Titration/Stabilization|Adverse Event|4|||
157118198|NCT01100437|567184246|FG000|Titration/Stabilization|Non-compliance|0|||
157118199|NCT01100437|567184247|FG001|Titration/Stabilization|Non-compliance|0|||
157118200|NCT01100437|567184248|FG002|Titration/Stabilization|Non-compliance|1|||
157118201|NCT01100437|567184246|FG000|Titration/Stabilization|Sponsor canceled study|0|||
157118202|NCT01100437|567184247|FG001|Titration/Stabilization|Sponsor canceled study|0|||
157118203|NCT01100437|567184248|FG002|Titration/Stabilization|Sponsor canceled study|1|||
157118204|NCT01100437|567184246|FG000|Maintenance|Withdrawal by Subject|0|||
157118205|NCT01100437|567184247|FG001|Maintenance|Withdrawal by Subject|0|||
157118206|NCT01100437|567184248|FG002|Maintenance|Withdrawal by Subject|1|||
157118207|NCT01100437|567184246|FG000|Maintenance|Sponsor termination of study|0|||
157118208|NCT01100437|567184247|FG001|Maintenance|Sponsor termination of study|0|||
157118209|NCT01100437|567184248|FG002|Maintenance|Sponsor termination of study|1|||
157118210|NCT01042600|567186365|FG000|Overall Study|Ineligible|1|||
157118211|NCT01042600|567186366|FG001|Overall Study|Ineligible|0|||
157118212|NCT00621504|567186367|FG000|Overall Study|Adverse Event|1|||
157118213|NCT00621504|567186368|FG001|Overall Study|Adverse Event|3|||
157118214|NCT00621504|567186367|FG000|Overall Study|At the request of sponsor/investigator|1|||
157118215|NCT00621504|567186368|FG001|Overall Study|At the request of sponsor/investigator|0|||
157118216|NCT00621504|567186367|FG000|Overall Study|Withdrew consent|9|||
157118217|NCT00621504|567186368|FG001|Overall Study|Withdrew consent|6|||
157118218|NCT00621504|567186367|FG000|Overall Study|Lost to Follow-up|8|||
157118219|NCT00621504|567186368|FG001|Overall Study|Lost to Follow-up|10|||
157118220|NCT00621504|567186367|FG000|Overall Study|Other|1|||
157118221|NCT00621504|567186368|FG001|Overall Study|Other|0|||
157118222|NCT00621504|567186367|FG000|Overall Study|Death|6|||
157118223|NCT00621504|567186368|FG001|Overall Study|Death|6|||
157118224|NCT03311711|567186369|FG000|Overall Study|Death|1|||
157118225|NCT03311711|567186370|FG001|Overall Study|Death|0|||
157118226|NCT03311711|567186371|FG002|Overall Study|Death|0|||
157118227|NCT03311711|567186372|FG003|Overall Study|Death|0|||
157118228|NCT03311711|567186373|FG004|Overall Study|Death|0|||
157118229|NCT03311711|567186374|FG005|Overall Study|Death|0|||
157118230|NCT03311711|567186375|FG006|Overall Study|Death|1|||
157118231|NCT03311711|567186376|FG007|Overall Study|Death|0|||
157118232|NCT03311711|567186377|FG008|Overall Study|Death|1|||
157118233|NCT03311711|567186378|FG009|Overall Study|Death|0|||
157118234|NCT03311711|567186369|FG000|Overall Study|Death of dyad partner|0|||
157118235|NCT03311711|567186370|FG001|Overall Study|Death of dyad partner|1|||
157118236|NCT03311711|567186371|FG002|Overall Study|Death of dyad partner|0|||
157118237|NCT03311711|567186372|FG003|Overall Study|Death of dyad partner|0|||
157118238|NCT03311711|567186373|FG004|Overall Study|Death of dyad partner|0|||
157118239|NCT03311711|567186374|FG005|Overall Study|Death of dyad partner|0|||
157118240|NCT03311711|567186375|FG006|Overall Study|Death of dyad partner|0|||
157118241|NCT03311711|567186376|FG007|Overall Study|Death of dyad partner|1|||
157118242|NCT03311711|567186377|FG008|Overall Study|Death of dyad partner|0|||
157118243|NCT03311711|567186378|FG009|Overall Study|Death of dyad partner|1|||
157118244|NCT03311711|567186369|FG000|Overall Study|Lost to Follow-up|2|||
157118245|NCT03311711|567186370|FG001|Overall Study|Lost to Follow-up|2|||
157118246|NCT03311711|567186371|FG002|Overall Study|Lost to Follow-up|0|||
157118247|NCT03311711|567186372|FG003|Overall Study|Lost to Follow-up|0|||
157118248|NCT03311711|567186373|FG004|Overall Study|Lost to Follow-up|0|||
157118249|NCT03311711|567186374|FG005|Overall Study|Lost to Follow-up|0|||
157118250|NCT03311711|567186375|FG006|Overall Study|Lost to Follow-up|1|||
157118251|NCT03311711|567186376|FG007|Overall Study|Lost to Follow-up|1|||
157118252|NCT03311711|567186377|FG008|Overall Study|Lost to Follow-up|0|||
157118253|NCT03311711|567186378|FG009|Overall Study|Lost to Follow-up|0|||
157118254|NCT03311711|567186369|FG000|Overall Study|Withdrawal by Subject|1|||
157118255|NCT03311711|567186370|FG001|Overall Study|Withdrawal by Subject|1|||
157118256|NCT03311711|567186371|FG002|Overall Study|Withdrawal by Subject|0|||
157118257|NCT03311711|567186372|FG003|Overall Study|Withdrawal by Subject|0|||
157118258|NCT03311711|567186373|FG004|Overall Study|Withdrawal by Subject|0|||
157118259|NCT03311711|567186374|FG005|Overall Study|Withdrawal by Subject|0|||
157118260|NCT03311711|567186375|FG006|Overall Study|Withdrawal by Subject|3|||
157118261|NCT03311711|567186376|FG007|Overall Study|Withdrawal by Subject|3|||
157118262|NCT03311711|567186377|FG008|Overall Study|Withdrawal by Subject|0|||
157118263|NCT03311711|567186378|FG009|Overall Study|Withdrawal by Subject|0|||
157118264|NCT00706134|567186379|FG000|Overall Study|Adverse Event|8|||
157118265|NCT00706134|567186380|FG001|Overall Study|Adverse Event|7|||
157118266|NCT00706134|567186381|FG002|Overall Study|Adverse Event|2|||
157118267|NCT00706134|567186382|FG003|Overall Study|Adverse Event|3|||
157118268|NCT00706134|567186379|FG000|Overall Study|Lost to Follow-up|0|||
157118269|NCT00706134|567186380|FG001|Overall Study|Lost to Follow-up|1|||
157118270|NCT00706134|567186381|FG002|Overall Study|Lost to Follow-up|0|||
157118271|NCT00706134|567186382|FG003|Overall Study|Lost to Follow-up|0|||
157118272|NCT00706134|567186379|FG000|Overall Study|Protocol Violation|0|||
157118273|NCT00706134|567186380|FG001|Overall Study|Protocol Violation|6|||
157118274|NCT00706134|567186381|FG002|Overall Study|Protocol Violation|0|||
157118275|NCT00706134|567186382|FG003|Overall Study|Protocol Violation|3|||
157118276|NCT00706134|567186379|FG000|Overall Study|Withdrawal by Subject|1|||
157118277|NCT00706134|567186380|FG001|Overall Study|Withdrawal by Subject|2|||
157118278|NCT00706134|567186381|FG002|Overall Study|Withdrawal by Subject|1|||
157118279|NCT00706134|567186382|FG003|Overall Study|Withdrawal by Subject|0|||
157118280|NCT00706134|567186379|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
157118281|NCT00706134|567186380|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
157118282|NCT00706134|567186381|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
157118283|NCT00706134|567186382|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
157118284|NCT00706134|567186379|FG000|Overall Study|Did not meet study criteria|2|||
157118285|NCT00706134|567186380|FG001|Overall Study|Did not meet study criteria|0|||
157118286|NCT00706134|567186381|FG002|Overall Study|Did not meet study criteria|0|||
157118287|NCT00706134|567186382|FG003|Overall Study|Did not meet study criteria|0|||
157118288|NCT01339559|567186389|FG000|Overall Study|Adverse Event|92|||
157118289|NCT01339559|567186389|FG000|Overall Study|Death|5|||
157118290|NCT01339559|567186389|FG000|Overall Study|Lack of Efficacy|164|||
157118291|NCT01339559|567186389|FG000|Overall Study|Lost to Follow-up|22|||
157118292|NCT01339559|567186389|FG000|Overall Study|Subject choice|89|||
157118293|NCT01339559|567186389|FG000|Overall Study|Protocol Violation|15|||
157118294|NCT01339559|567186389|FG000|Overall Study|Study closure at site|1|||
157118295|NCT01339559|567186389|FG000|Overall Study|Incarcerated|2|||
157118296|NCT01339559|567186389|FG000|Overall Study|Epilepsy surgery|1|||
157118297|NCT01339559|567186389|FG000|Overall Study|Pregnancy planned|2|||
157118298|NCT01339559|567186389|FG000|Overall Study|Left the country|1|||
157118299|NCT01339559|567186389|FG000|Overall Study|Investigator decision|2|||
157118300|NCT01339559|567186389|FG000|Overall Study|Patient didn't wish to continue|1|||
157118301|NCT01339559|567186389|FG000|Overall Study|PI decision|1|||
157118302|NCT00971945|567186390|FG000|Overall Study|Progressive Disease|3|||
157118303|NCT00971945|567186390|FG000|Overall Study|Change in treatment policy|1|||
157118304|NCT00971945|567186390|FG000|Overall Study|Other reasons|2|||
157118305|NCT03691974|567186391|FG000|Overall Study|Physician Decision|1|||
157118306|NCT03691974|567186392|FG001|Overall Study|Physician Decision|0|||
157118307|NCT03691974|567186391|FG000|Overall Study|Adverse Event|1|||
157118308|NCT03691974|567186392|FG001|Overall Study|Adverse Event|0|||
157118309|NCT03691974|567186391|FG000|Overall Study|Withdrawal by Subject|11|||
157118310|NCT03691974|567186392|FG001|Overall Study|Withdrawal by Subject|9|||
157118311|NCT03691974|567186391|FG000|Overall Study|Protocol Violation|1|||
157118312|NCT03691974|567186392|FG001|Overall Study|Protocol Violation|0|||
157118313|NCT03691974|567186391|FG000|Overall Study|Lost to Follow-up|8|||
157118314|NCT03691974|567186392|FG001|Overall Study|Lost to Follow-up|7|||
157118315|NCT00513409|567186396|FG000|Overall Study|Adverse Event|0|||
157118316|NCT00513409|567186397|FG001|Overall Study|Adverse Event|1|||
157118317|NCT00513409|567186396|FG000|Overall Study|Withdrawal by Subject|0|||
157118318|NCT00513409|567186397|FG001|Overall Study|Withdrawal by Subject|2|||
157118319|NCT00513409|567186396|FG000|Overall Study|Lost to Follow-up|0|||
157118320|NCT00513409|567186397|FG001|Overall Study|Lost to Follow-up|1|||
157118321|NCT00513409|567186396|FG000|Overall Study|Physician Decision|1|||
157118322|NCT00513409|567186397|FG001|Overall Study|Physician Decision|0|||
157118323|NCT00513409|567186396|FG000|Overall Study|Visit 3 not done|1|||
157118324|NCT00513409|567186397|FG001|Overall Study|Visit 3 not done|2|||
157118325|NCT00691483|567186398|FG000|Overall Study|Adverse Event|14|||
157011434|NCT05119855|566795409|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
157011435|NCT05119855|566795410|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
157011436|NCT05119855|566795409|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
157011437|NCT05119855|566795410|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
157011438|NCT05119855|566795409|FG000|Overall Study|Lost to Follow-up|6|||
157011439|NCT05119855|566795410|FG001|Overall Study|Lost to Follow-up|8|||
157011440|NCT02932579|566795411|FG000|Overall Study|Withdrawal by Subject|4|||
157011441|NCT02932579|566795412|FG001|Overall Study|Withdrawal by Subject|1|||
157011442|NCT02706717|566795415|FG000|Overall Study|Withdrawal by Subject|1|||
157011443|NCT02706717|566795416|FG001|Overall Study|Withdrawal by Subject|8|||
157011444|NCT02706717|566795415|FG000|Overall Study|Lost to Follow-up|0|||
157011445|NCT02706717|566795416|FG001|Overall Study|Lost to Follow-up|1|||
157011446|NCT02706717|566795415|FG000|Overall Study|Physician Decision|0|||
157011447|NCT02706717|566795416|FG001|Overall Study|Physician Decision|1|||
157011448|NCT02706717|566795415|FG000|Overall Study|Death|0|||
157011449|NCT02706717|566795416|FG001|Overall Study|Death|1|||
157011450|NCT02549170|566795419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
157011451|NCT02549170|566795420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
157011452|NCT02549170|566795421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
157011453|NCT02549170|566795422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
157011454|NCT02549170|566795423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
157011455|NCT02549170|566795419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
157011456|NCT02549170|566795420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
157011457|NCT02549170|566795421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
157011458|NCT02549170|566795422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
157011459|NCT02549170|566795423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
157011460|NCT02549170|566795419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
157011461|NCT02549170|566795420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
157011462|NCT02549170|566795421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
157011463|NCT02549170|566795422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
157011464|NCT02549170|566795423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
157011465|NCT00421889|566795425|FG000|Overall Study|Adverse Event|1|||
157011466|NCT00421889|566795426|FG001|Overall Study|Adverse Event|0|||
157011467|NCT00421889|566795427|FG002|Overall Study|Adverse Event|1|||
157011468|NCT00421889|566795428|FG003|Overall Study|Adverse Event|1|||
157011469|NCT00421889|566795429|FG004|Overall Study|Adverse Event|1|||
157011470|NCT00421889|566795430|FG005|Overall Study|Adverse Event|4|||
157011471|NCT00421889|566795431|FG006|Overall Study|Adverse Event|1|||
157011472|NCT00421889|566795432|FG007|Overall Study|Adverse Event|0|||
157011473|NCT00421889|566795433|FG008|Overall Study|Adverse Event|2|||
157011474|NCT00421889|566795425|FG000|Overall Study|Withdrawal by Subject|1|||
157011475|NCT00421889|566795426|FG001|Overall Study|Withdrawal by Subject|3|||
157011476|NCT00421889|566795427|FG002|Overall Study|Withdrawal by Subject|0|||
157011477|NCT00421889|566795428|FG003|Overall Study|Withdrawal by Subject|0|||
157011478|NCT00421889|566795429|FG004|Overall Study|Withdrawal by Subject|2|||
157011479|NCT00421889|566795430|FG005|Overall Study|Withdrawal by Subject|0|||
157011480|NCT00421889|566795431|FG006|Overall Study|Withdrawal by Subject|0|||
157011481|NCT00421889|566795432|FG007|Overall Study|Withdrawal by Subject|0|||
157011482|NCT00421889|566795433|FG008|Overall Study|Withdrawal by Subject|0|||
157011483|NCT00421889|566795425|FG000|Overall Study|Death|0|||
157011484|NCT00421889|566795426|FG001|Overall Study|Death|0|||
157011485|NCT00421889|566795427|FG002|Overall Study|Death|0|||
157011486|NCT00421889|566795428|FG003|Overall Study|Death|0|||
157118326|NCT00691483|567186399|FG001|Overall Study|Adverse Event|6|||
157118327|NCT00691483|567186398|FG000|Overall Study|Lost to Follow-up|17|||
157118328|NCT00691483|567186399|FG001|Overall Study|Lost to Follow-up|10|||
157118329|NCT00691483|567186398|FG000|Overall Study|Withdrawal by Subject|24|||
157118330|NCT00691483|567186399|FG001|Overall Study|Withdrawal by Subject|7|||
157118331|NCT00691483|567186398|FG000|Overall Study|Other known cause|6|||
157118332|NCT00691483|567186399|FG001|Overall Study|Other known cause|1|||
157118333|NCT00691483|567186398|FG000|Overall Study|Randomized by not treated|7|||
157118334|NCT00691483|567186399|FG001|Overall Study|Randomized by not treated|1|||
157118335|NCT00746252|567186400|FG000|Overall Study|weight gain >7.5 %|1|||
157118336|NCT00746252|567186401|FG001|Overall Study|weight gain >7.5 %|2|||
157118337|NCT01049035|567186402|FG000|Overall Study|Serious adverse event|0|||
157118338|NCT01049035|567186403|FG001|Overall Study|Serious adverse event|1|||
157118339|NCT01049035|567186404|FG002|Overall Study|Serious adverse event|1|||
157118340|NCT01049035|567186405|FG003|Overall Study|Serious adverse event|2|||
157118341|NCT01049035|567186406|FG004|Overall Study|Serious adverse event|0|||
157118342|NCT01049035|567186407|FG005|Overall Study|Serious adverse event|0|||
157118343|NCT01049035|567186408|FG006|Overall Study|Serious adverse event|0|||
157118344|NCT01049035|567186402|FG000|Overall Study|Other adverse event (AE)|0|||
157118345|NCT01049035|567186403|FG001|Overall Study|Other adverse event (AE)|0|||
157118346|NCT01049035|567186404|FG002|Overall Study|Other adverse event (AE)|0|||
157118347|NCT01049035|567186405|FG003|Overall Study|Other adverse event (AE)|1|||
157118348|NCT01049035|567186406|FG004|Overall Study|Other adverse event (AE)|0|||
157118349|NCT01049035|567186407|FG005|Overall Study|Other adverse event (AE)|0|||
157118350|NCT01049035|567186408|FG006|Overall Study|Other adverse event (AE)|0|||
157118351|NCT01049035|567186402|FG000|Overall Study|Non-compliance with the protocol|12|||
157118352|NCT01049035|567186403|FG001|Overall Study|Non-compliance with the protocol|6|||
157118353|NCT01049035|567186404|FG002|Overall Study|Non-compliance with the protocol|14|||
157118354|NCT01049035|567186405|FG003|Overall Study|Non-compliance with the protocol|5|||
157118355|NCT01049035|567186406|FG004|Overall Study|Non-compliance with the protocol|3|||
157118356|NCT01049035|567186407|FG005|Overall Study|Non-compliance with the protocol|4|||
157118357|NCT01049035|567186408|FG006|Overall Study|Non-compliance with the protocol|10|||
157118358|NCT01049035|567186402|FG000|Overall Study|Lost to Follow-up|5|||
157118359|NCT01049035|567186403|FG001|Overall Study|Lost to Follow-up|4|||
157118360|NCT01049035|567186404|FG002|Overall Study|Lost to Follow-up|4|||
157118361|NCT01049035|567186405|FG003|Overall Study|Lost to Follow-up|1|||
157118362|NCT01049035|567186406|FG004|Overall Study|Lost to Follow-up|0|||
157118363|NCT01049035|567186407|FG005|Overall Study|Lost to Follow-up|3|||
157118364|NCT01049035|567186408|FG006|Overall Study|Lost to Follow-up|3|||
157118365|NCT01049035|567186402|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
157118366|NCT01049035|567186403|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
157118367|NCT01049035|567186404|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
157118368|NCT01049035|567186405|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
157118369|NCT01049035|567186406|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
157118370|NCT01049035|567186407|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
157118371|NCT01049035|567186408|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
157118372|NCT01137773|567186409|FG000|Overall Study|Death|3|||
157118373|NCT01137773|567186410|FG001|Overall Study|Death|3|||
157118374|NCT01137773|567186409|FG000|Overall Study|Lost to Follow-up|6|||
157118375|NCT01137773|567186410|FG001|Overall Study|Lost to Follow-up|0|||
157118376|NCT01391000|567186412|FG000|Overall Study|Lost to Follow-up|2|||
157118377|NCT01391000|567186413|FG001|Overall Study|Lost to Follow-up|0|||
157118378|NCT03548051|567186417|FG000|Overall Study|Death|1|||
157118379|NCT03548051|567186418|FG001|Overall Study|Death|1|||
157118380|NCT03548051|567186417|FG000|Overall Study|Withdrawal by Subject|1|||
157118381|NCT03548051|567186418|FG001|Overall Study|Withdrawal by Subject|0|||
157118382|NCT00082888|567186419|FG000|Overall Study|Ineligible|1|||
157118383|NCT00082888|567186420|FG001|Overall Study|Ineligible|0|||
157118384|NCT00082888|567186421|FG002|Overall Study|Ineligible|0|||
157118385|NCT03860961|567186422|FG000|Overall Study|Withdrawal by Subject|6|||
157118386|NCT03860961|567186423|FG001|Overall Study|Withdrawal by Subject|11|||
157118387|NCT03860961|567186422|FG000|Overall Study|Death|10|||
157118388|NCT03860961|567186423|FG001|Overall Study|Death|6|||
157118389|NCT03860961|567186422|FG000|Overall Study|Incomplete two-year data|4|||
157118390|NCT03860961|567186423|FG001|Overall Study|Incomplete two-year data|0|||
157118391|NCT00817531|567186425|FG000|Overall Study|Adverse Event|1|||
157118392|NCT00817531|567186425|FG000|Overall Study|Lack of Efficacy|1|||
157118393|NCT00812214|567186426|FG000|Overall Study|Lost to Follow-up|3|||
157118394|NCT00812214|567186427|FG001|Overall Study|Lost to Follow-up|1|||
157118395|NCT03325673|567186428|FG000|Overall Study|Adverse Event|4|||
157118396|NCT03325673|567186429|FG001|Overall Study|Adverse Event|0|||
157118397|NCT02684981|567186430|FG000|Overall Study|Permanently discontinued the treatment|157|||
157118398|NCT02684981|567186431|FG001|Overall Study|Permanently discontinued the treatment|161|||
157118399|NCT02684981|567186432|FG002|Overall Study|Permanently discontinued the treatment|110|||
157118400|NCT02684981|567186430|FG000|Overall Study|Other|83|||
157118401|NCT02684981|567186431|FG001|Overall Study|Other|49|||
157118402|NCT02684981|567186432|FG002|Overall Study|Other|17|||
157118403|NCT04623242|567186433|FG000|Overall Study|Withdrawal by Subject|7|||
157118404|NCT04623242|567186434|FG001|Overall Study|Withdrawal by Subject|12|||
157118405|NCT04623242|567186435|FG002|Overall Study|Withdrawal by Subject|5|||
157118406|NCT04623242|567186436|FG003|Overall Study|Withdrawal by Subject|7|||
157118407|NCT04623242|567186437|FG004|Overall Study|Withdrawal by Subject|0|||
157118408|NCT04623242|567186433|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
157118409|NCT04623242|567186434|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
157118410|NCT04623242|567186435|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
157118411|NCT04623242|567186436|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
157118412|NCT04623242|567186437|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
157118413|NCT04623242|567186433|FG000|Overall Study|Subject unblinded to mutation status|0|||
157118414|NCT04623242|567186434|FG001|Overall Study|Subject unblinded to mutation status|0|||
157118415|NCT04623242|567186435|FG002|Overall Study|Subject unblinded to mutation status|0|||
157118416|NCT04623242|567186436|FG003|Overall Study|Subject unblinded to mutation status|13|||
157118417|NCT04623242|567186437|FG004|Overall Study|Subject unblinded to mutation status|0|||
157118418|NCT00272038|567186442|FG000|Overall Study|withdrew before they received 2 cycles|7|||
157118419|NCT00493870|567186443|FG000|Overall Study|Lost to Follow-up|12|||
157118420|NCT00493870|567186444|FG001|Overall Study|Lost to Follow-up|15|||
157118421|NCT00356278|567186447|FG000|Overall Study|Withdrawal by Subject|25|||
157118422|NCT00356278|567186448|FG001|Overall Study|Withdrawal by Subject|15|||
157118423|NCT00356278|567186449|FG002|Overall Study|Withdrawal by Subject|19|||
157118424|NCT01363986|567186450|FG000|Overall Study|Disease progression|1|||
157118425|NCT01637142|567186451|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
157118426|NCT02111564|567186452|FG000|Overall Study|Death|109|||
157118427|NCT02111564|567186453|FG001|Overall Study|Death|120|||
157118428|NCT02111564|567186452|FG000|Overall Study|Lost to Follow-up|2|||
157118429|NCT02111564|567186453|FG001|Overall Study|Lost to Follow-up|3|||
157118430|NCT02111564|567186452|FG000|Overall Study|Withdrawal by Subject|20|||
157212712|NCT00995488|567526076|FG000|Overall Study|Withdrawal by Subject|1|||
157212713|NCT01656967|567526077|FG000|Overall Study|faulty monitor|1|||
157212714|NCT01656967|567526078|FG001|Overall Study|faulty monitor|0|||
157118431|NCT02111564|567186453|FG001|Overall Study|Withdrawal by Subject|20|||
157118432|NCT03548558|567186455|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
157118433|NCT03548558|567186456|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
157118434|NCT03548558|567186457|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
157118435|NCT03548558|567186458|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
157118436|NCT03548558|567186459|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
157118437|NCT03548558|567186460|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
157118438|NCT03548558|567186461|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
157118439|NCT03548558|567186455|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
157118440|NCT03548558|567186456|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
157118441|NCT03548558|567186457|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
157118442|NCT03548558|567186458|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
157118443|NCT03548558|567186459|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
157118444|NCT03548558|567186460|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
157212715|NCT01656967|567526077|FG000|Overall Study|unsuccessful ETT insertion|3|||
157011487|NCT00421889|566795429|FG004|Overall Study|Death|1|||
157011488|NCT00421889|566795430|FG005|Overall Study|Death|1|||
157011489|NCT00421889|566795431|FG006|Overall Study|Death|0|||
157011490|NCT00421889|566795432|FG007|Overall Study|Death|0|||
157011491|NCT00421889|566795433|FG008|Overall Study|Death|0|||
157011492|NCT00421889|566795425|FG000|Overall Study|Progressive disease|3|||
157011493|NCT00421889|566795426|FG001|Overall Study|Progressive disease|2|||
157011494|NCT00421889|566795427|FG002|Overall Study|Progressive disease|2|||
157011495|NCT00421889|566795428|FG003|Overall Study|Progressive disease|3|||
157011496|NCT00421889|566795429|FG004|Overall Study|Progressive disease|2|||
157011497|NCT00421889|566795430|FG005|Overall Study|Progressive disease|21|||
157011498|NCT00421889|566795431|FG006|Overall Study|Progressive disease|3|||
157011499|NCT00421889|566795432|FG007|Overall Study|Progressive disease|1|||
157011500|NCT00421889|566795433|FG008|Overall Study|Progressive disease|5|||
157011501|NCT00421889|566795425|FG000|Overall Study|Patient/Investigator request|0|||
157011502|NCT00421889|566795426|FG001|Overall Study|Patient/Investigator request|0|||
157011503|NCT00421889|566795427|FG002|Overall Study|Patient/Investigator request|0|||
157011504|NCT00421889|566795428|FG003|Overall Study|Patient/Investigator request|0|||
157011505|NCT00421889|566795429|FG004|Overall Study|Patient/Investigator request|0|||
157011506|NCT00421889|566795430|FG005|Overall Study|Patient/Investigator request|9|||
157011507|NCT00421889|566795431|FG006|Overall Study|Patient/Investigator request|0|||
157011508|NCT00421889|566795432|FG007|Overall Study|Patient/Investigator request|1|||
157011509|NCT00421889|566795433|FG008|Overall Study|Patient/Investigator request|3|||
157011510|NCT00421889|566795425|FG000|Overall Study|Lost to Follow-up|0|||
157011511|NCT00421889|566795426|FG001|Overall Study|Lost to Follow-up|0|||
157011512|NCT00421889|566795427|FG002|Overall Study|Lost to Follow-up|0|||
157011513|NCT00421889|566795428|FG003|Overall Study|Lost to Follow-up|0|||
157011514|NCT00421889|566795429|FG004|Overall Study|Lost to Follow-up|0|||
157011515|NCT00421889|566795430|FG005|Overall Study|Lost to Follow-up|0|||
157011516|NCT00421889|566795431|FG006|Overall Study|Lost to Follow-up|0|||
157011517|NCT00421889|566795432|FG007|Overall Study|Lost to Follow-up|0|||
157011518|NCT00421889|566795433|FG008|Overall Study|Lost to Follow-up|1|||
157011519|NCT00978042|566795434|FG000|Initial Treatment Period|Treated in Error|0|||
157011520|NCT00978042|566795435|FG001|Initial Treatment Period|Treated in Error|3|||
157011521|NCT00978042|566795434|FG000|Initial Treatment Period|Ineligibility|1|||
157011522|NCT00978042|566795435|FG001|Initial Treatment Period|Ineligibility|0|||
157011523|NCT00978042|566795434|FG000|Initial Treatment Period|Lost to Follow-up|21|||
157011524|NCT00978042|566795435|FG001|Initial Treatment Period|Lost to Follow-up|3|||
157011525|NCT00978042|566795434|FG000|Initial Treatment Period|Adverse Event|2|||
157011526|NCT00978042|566795435|FG001|Initial Treatment Period|Adverse Event|0|||
157011527|NCT00978042|566795434|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
157011528|NCT00978042|566795435|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
157011529|NCT00978042|566795434|FG000|Initial Treatment Period|Consent withdrawn|22|||
157011530|NCT00978042|566795435|FG001|Initial Treatment Period|Consent withdrawn|9|||
157011531|NCT00978042|566795434|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
157011532|NCT00978042|566795435|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
157011533|NCT03051165|566795438|FG000|Overall Study|Withdrawal by Subject|1|||
157011534|NCT03051165|566795438|FG000|Overall Study|Early termination of study|12|||
157011535|NCT00818246|566795439|FG000|Overall Study|Impossible to match pictures|5|||
157011536|NCT02121002|566795440|FG000|Overall Study|Physician Decision|2|||
157011537|NCT02121002|566795441|FG001|Overall Study|Physician Decision|0|||
157011538|NCT02121002|566795442|FG002|Overall Study|Physician Decision|0|||
157011539|NCT02121002|566795440|FG000|Overall Study|Withdrawal by Subject|3|||
157011540|NCT02121002|566795441|FG001|Overall Study|Withdrawal by Subject|1|||
157011541|NCT02121002|566795442|FG002|Overall Study|Withdrawal by Subject|4|||
157011542|NCT02121002|566795440|FG000|Overall Study|Protocol Violation|1|||
157011543|NCT02121002|566795441|FG001|Overall Study|Protocol Violation|2|||
157011544|NCT02121002|566795442|FG002|Overall Study|Protocol Violation|4|||
157011545|NCT02121002|566795440|FG000|Overall Study|Concomitant therapy|0|||
157011546|NCT02121002|566795441|FG001|Overall Study|Concomitant therapy|1|||
157011547|NCT02121002|566795442|FG002|Overall Study|Concomitant therapy|1|||
157011548|NCT02121002|566795440|FG000|Overall Study|Others|1|||
157011549|NCT02121002|566795441|FG001|Overall Study|Others|0|||
157011550|NCT02121002|566795442|FG002|Overall Study|Others|1|||
157011551|NCT00409838|566795443|FG000|Short-term Period|Adverse Event|0|||
157011552|NCT00409838|566795444|FG001|Short-term Period|Adverse Event|1|||
157118445|NCT03548558|567186461|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
157118446|NCT03548558|567186455|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
157118447|NCT03548558|567186456|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
157118448|NCT03548558|567186457|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
157118449|NCT03548558|567186458|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
157118450|NCT03548558|567186459|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
157118451|NCT03548558|567186460|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
157118452|NCT03548558|567186461|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
157118453|NCT03548558|567186455|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
157118454|NCT03548558|567186456|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
157118455|NCT03548558|567186457|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
157118456|NCT03548558|567186458|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
157118457|NCT03548558|567186459|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
157118458|NCT03548558|567186460|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
157118459|NCT03548558|567186461|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
157118460|NCT03548558|567186455|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
157118461|NCT03548558|567186456|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
157118462|NCT03548558|567186457|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
157118463|NCT03548558|567186458|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
157118464|NCT03548558|567186459|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
157118465|NCT03548558|567186460|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
157118466|NCT03548558|567186461|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
157118467|NCT03548558|567186455|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
157118468|NCT03548558|567186456|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
157118469|NCT03548558|567186457|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
157118470|NCT03548558|567186458|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
157118471|NCT03548558|567186459|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
157118472|NCT03548558|567186460|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
157118473|NCT03548558|567186461|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
157118474|NCT01485627|567186462|FG000|Overall Study|Patient withdrew|6|||
157118475|NCT01485627|567186463|FG001|Overall Study|Patient withdrew|5|||
157118476|NCT01485627|567186462|FG000|Overall Study|Patient died|3|||
157118477|NCT01485627|567186463|FG001|Overall Study|Patient died|1|||
157118478|NCT01485627|567186462|FG000|Overall Study|Patient lost to followup|0|||
157118479|NCT01485627|567186463|FG001|Overall Study|Patient lost to followup|1|||
157118480|NCT01485627|567186462|FG000|Overall Study|Caregiver withdrew|3|||
157118481|NCT01485627|567186463|FG001|Overall Study|Caregiver withdrew|3|||
157118482|NCT01485627|567186462|FG000|Overall Study|Caregiver lost to follow up|11|||
157118483|NCT01485627|567186463|FG001|Overall Study|Caregiver lost to follow up|12|||
157118484|NCT01485627|567186462|FG000|Overall Study|Caregiver died|1|||
157118485|NCT01485627|567186463|FG001|Overall Study|Caregiver died|0|||
157118486|NCT01485627|567186462|FG000|Overall Study|caregiver was not bereaved|42|||
157118487|NCT01485627|567186463|FG001|Overall Study|caregiver was not bereaved|35|||
157118488|NCT00763815|567186464|FG000|Overall Study|Adverse Event|14|||
157118489|NCT00763815|567186465|FG001|Overall Study|Adverse Event|29|||
157118490|NCT00763815|567186464|FG000|Overall Study|Lack of Efficacy|10|||
157118491|NCT00763815|567186465|FG001|Overall Study|Lack of Efficacy|11|||
157118492|NCT00763815|567186464|FG000|Overall Study|Poor Compliance to Protocol|6|||
157118493|NCT00763815|567186465|FG001|Overall Study|Poor Compliance to Protocol|6|||
157118494|NCT00763815|567186464|FG000|Overall Study|Lost to Follow-up|2|||
157118495|NCT00763815|567186465|FG001|Overall Study|Lost to Follow-up|4|||
157118496|NCT00763815|567186464|FG000|Overall Study|Early Termination|1|||
157118497|NCT00763815|567186465|FG001|Overall Study|Early Termination|0|||
157118498|NCT00763815|567186464|FG000|Overall Study|Familial and Personal Reasons|9|||
157118499|NCT00763815|567186465|FG001|Overall Study|Familial and Personal Reasons|16|||
157118500|NCT00763815|567186464|FG000|Overall Study|Physician Decision|1|||
157118501|NCT00763815|567186465|FG001|Overall Study|Physician Decision|0|||
157118502|NCT00763815|567186464|FG000|Overall Study|Withdrawal by Subject|7|||
157118503|NCT00763815|567186465|FG001|Overall Study|Withdrawal by Subject|12|||
157118504|NCT00763815|567186464|FG000|Overall Study|Protocol Violation|2|||
157118505|NCT00763815|567186465|FG001|Overall Study|Protocol Violation|5|||
157118506|NCT00763815|567186464|FG000|Overall Study|Sponsor's Decision|0|||
157118507|NCT00763815|567186465|FG001|Overall Study|Sponsor's Decision|1|||
157118508|NCT04951037|567186466|FG000|Overall Study|Lost to Follow-up|16|||
157118509|NCT04951037|567186466|FG000|Overall Study|Withdrawal by Subject|5|||
157118510|NCT04951037|567186466|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
157118511|NCT05630937|567186467|FG000|Overall Study|Study terminated by sponsor|1|||
157118512|NCT05630937|567186468|FG001|Overall Study|Study terminated by sponsor|1|||
157118513|NCT05630937|567186469|FG002|Overall Study|Study terminated by sponsor|8|||
157118514|NCT05630937|567186470|FG003|Overall Study|Study terminated by sponsor|0|||
157118515|NCT05630937|567186467|FG000|Overall Study|Lost to Follow-up|0|||
157118516|NCT05630937|567186468|FG001|Overall Study|Lost to Follow-up|0|||
157118517|NCT05630937|567186469|FG002|Overall Study|Lost to Follow-up|1|||
157118518|NCT05630937|567186470|FG003|Overall Study|Lost to Follow-up|0|||
157118519|NCT05630937|567186467|FG000|Overall Study|Enrolled but not treated|0|||
157118520|NCT05630937|567186468|FG001|Overall Study|Enrolled but not treated|0|||
157118521|NCT05630937|567186469|FG002|Overall Study|Enrolled but not treated|0|||
157118522|NCT05630937|567186470|FG003|Overall Study|Enrolled but not treated|1|||
157118523|NCT00267748|567186472|FG000|Non-randomized Period|Progressive disease|10|||
157118524|NCT00267748|567186473|FG001|Non-randomized Period|Progressive disease|0|||
157118525|NCT00267748|567186474|FG002|Non-randomized Period|Progressive disease|0|||
157118526|NCT00267748|567186472|FG000|Non-randomized Period|Adverse Event|8|||
157118527|NCT00267748|567186473|FG001|Non-randomized Period|Adverse Event|0|||
157118528|NCT00267748|567186474|FG002|Non-randomized Period|Adverse Event|0|||
157118529|NCT00267748|567186472|FG000|Non-randomized Period|Death|1|||
157118530|NCT00267748|567186473|FG001|Non-randomized Period|Death|0|||
157118531|NCT00267748|567186474|FG002|Non-randomized Period|Death|0|||
157118532|NCT00267748|567186472|FG000|Non-randomized Period|Participant not willing to participate|1|||
156780699|NCT04327271|565947181|FG001|Overall Study|Withdrawal by Subject|0|||
156780700|NCT04327271|565947180|FG000|Overall Study|randomization error (data capture)|4|||
156780701|NCT04327271|565947181|FG001|Overall Study|randomization error (data capture)|3|||
156780702|NCT04339972|565947182|FG000|Overall Study|Scheduling Issues|3|||
156780703|NCT04339972|565947183|FG001|Overall Study|Scheduling Issues|3|||
156780704|NCT04339972|565947182|FG000|Overall Study|dropout|1|||
156780705|NCT04339972|565947183|FG001|Overall Study|dropout|1|||
156780706|NCT04339972|565947182|FG000|Overall Study|Technical issues|1|||
156780707|NCT04339972|565947183|FG001|Overall Study|Technical issues|0|||
156780708|NCT04339972|565947182|FG000|Overall Study|Claustraphobia|0|||
156780709|NCT04339972|565947183|FG001|Overall Study|Claustraphobia|1|||
157118533|NCT00267748|567186473|FG001|Non-randomized Period|Participant not willing to participate|0|||
157118534|NCT00267748|567186474|FG002|Non-randomized Period|Participant not willing to participate|0|||
157118535|NCT00267748|567186472|FG000|Non-randomized Period|Other|3|||
157118536|NCT00267748|567186473|FG001|Non-randomized Period|Other|0|||
157118537|NCT00267748|567186474|FG002|Non-randomized Period|Other|0|||
157118538|NCT00267748|567186472|FG000|Randomized Period|Death|0|||
157118539|NCT00267748|567186473|FG001|Randomized Period|Death|2|||
157118540|NCT00267748|567186474|FG002|Randomized Period|Death|3|||
157118541|NCT00267748|567186472|FG000|Randomized Period|Adverse Event|0|||
157118542|NCT00267748|567186473|FG001|Randomized Period|Adverse Event|23|||
157118543|NCT00267748|567186474|FG002|Randomized Period|Adverse Event|25|||
157118544|NCT00267748|567186472|FG000|Randomized Period|Global deterioration of health status|0|||
157118545|NCT00267748|567186473|FG001|Randomized Period|Global deterioration of health status|6|||
157118546|NCT00267748|567186474|FG002|Randomized Period|Global deterioration of health status|7|||
157212716|NCT01656967|567526078|FG001|Overall Study|unsuccessful ETT insertion|2|||
157212717|NCT00051636|567526079|FG000|Period 1 - Core|Adverse Event|2|||
157212718|NCT00051636|567526080|FG001|Period 1 - Core|Adverse Event|2|||
157212719|NCT00051636|567526079|FG000|Period 1 - Core|Protocol Violation|1|||
157212720|NCT00051636|567526080|FG001|Period 1 - Core|Protocol Violation|0|||
157212721|NCT00051636|567526079|FG000|Period 1 - Core|Withdrawal by Subject|1|||
157212722|NCT00051636|567526080|FG001|Period 1 - Core|Withdrawal by Subject|2|||
157212723|NCT00051636|567526079|FG000|Period 1 - Core|Lost to Follow-up|0|||
157212724|NCT00051636|567526080|FG001|Period 1 - Core|Lost to Follow-up|2|||
156780710|NCT02112552|565947185|FG000|Overall Study|Withdrawal by Subject|1|||
156780711|NCT02112552|565947185|FG000|Overall Study|Adverse Event|1|||
157118547|NCT00267748|567186472|FG000|Randomized Period|Lost to Follow-up|0|||
157118548|NCT00267748|567186473|FG001|Randomized Period|Lost to Follow-up|1|||
157212725|NCT00051636|567526079|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
157118549|NCT00267748|567186474|FG002|Randomized Period|Lost to Follow-up|0|||
157118550|NCT00267748|567186472|FG000|Randomized Period|Objective progression or relapse|0|||
157212726|NCT00051636|567526080|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
157212727|NCT00051636|567526079|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
156780712|NCT04822194|565947187|FG000|Overall Study|Withdrawal by Subject|5|||
157212728|NCT00051636|567526080|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
157212729|NCT00051636|567526079|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
157212730|NCT00051636|567526080|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
156780713|NCT04822194|565947188|FG001|Overall Study|Withdrawal by Subject|4|||
157212731|NCT00051636|567526079|FG000|Period 2- Extended Observation Period|Death|4|||
157212732|NCT00051636|567526080|FG001|Period 2- Extended Observation Period|Death|5|||
157212733|NCT00051636|567526079|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
157212734|NCT00051636|567526080|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
157212735|NCT01174368|567526081|FG000|Overall Study|Withdrawal by Subject|1|||
157212736|NCT00479765|567526082|FG000|Overall Study|study terminated|4|||
157212737|NCT01021137|567526088|FG000|Overall Study|Lost to Follow-up|9|||
157212738|NCT01021137|567526089|FG001|Overall Study|Lost to Follow-up|4|||
157212739|NCT01021137|567526090|FG002|Overall Study|Lost to Follow-up|2|||
157212740|NCT01021137|567526091|FG003|Overall Study|Lost to Follow-up|6|||
157212741|NCT01021137|567526088|FG000|Overall Study|Withdrawal by Subject|1|||
157212742|NCT01021137|567526089|FG001|Overall Study|Withdrawal by Subject|0|||
157212743|NCT01021137|567526090|FG002|Overall Study|Withdrawal by Subject|0|||
157212744|NCT01021137|567526091|FG003|Overall Study|Withdrawal by Subject|3|||
157212745|NCT00725725|567526095|FG000|Overall Study|Adverse Event|1|||
157212746|NCT00725725|567526096|FG001|Overall Study|Adverse Event|3|||
157212747|NCT00725725|567526097|FG002|Overall Study|Adverse Event|2|||
157212748|NCT00725725|567526095|FG000|Overall Study|Lost to Follow-up|2|||
157212749|NCT00725725|567526096|FG001|Overall Study|Lost to Follow-up|0|||
156780714|NCT04822194|565947187|FG000|Overall Study|Technical issues with MR scanner|1|||
156780715|NCT04822194|565947188|FG001|Overall Study|Technical issues with MR scanner|0|||
157011553|NCT00409838|566795443|FG000|Short-term Period|Lost to Follow-up|0|||
157011554|NCT00409838|566795444|FG001|Short-term Period|Lost to Follow-up|1|||
157011555|NCT00409838|566795443|FG000|Short-term Period|Withdrawal by Subject|2|||
157011556|NCT00409838|566795444|FG001|Short-term Period|Withdrawal by Subject|3|||
157011557|NCT00409838|566795443|FG000|Short-term Period|Never Treated|1|||
157011558|NCT00409838|566795444|FG001|Short-term Period|Never Treated|0|||
157011559|NCT00409838|566795443|FG000|Long-term Extension Period|Adverse Event|10|||
157011560|NCT00409838|566795444|FG001|Long-term Extension Period|Adverse Event|0|||
157011561|NCT00409838|566795443|FG000|Long-term Extension Period|Death|1|||
157011562|NCT00409838|566795444|FG001|Long-term Extension Period|Death|0|||
157011563|NCT00409838|566795443|FG000|Long-term Extension Period|Lack of Efficacy|2|||
157011564|NCT00409838|566795444|FG001|Long-term Extension Period|Lack of Efficacy|0|||
157011565|NCT00409838|566795443|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
157011566|NCT00409838|566795444|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
157011567|NCT00409838|566795443|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
157011568|NCT00409838|566795444|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
157011569|NCT00409838|566795443|FG000|Long-term Extension Period|Pregnancy|1|||
157011570|NCT00409838|566795444|FG001|Long-term Extension Period|Pregnancy|0|||
157011571|NCT04788641|566795446|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
157011572|NCT04788641|566795447|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
157011573|NCT04788641|566795448|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
157011574|NCT04788641|566795449|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
157011575|NCT04788641|566795446|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
157011576|NCT04788641|566795447|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
157011577|NCT04788641|566795448|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
157011578|NCT04788641|566795449|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
157011579|NCT04788641|566795446|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
157011580|NCT04788641|566795447|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
157011581|NCT04788641|566795448|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
157011582|NCT04788641|566795449|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
157011583|NCT01250769|566795450|FG000|Overall Study|Withdrawal by Subject|0|||
157011584|NCT01250769|566795451|FG001|Overall Study|Withdrawal by Subject|1|||
157011585|NCT01250769|566795452|FG002|Overall Study|Withdrawal by Subject|1|||
157011586|NCT01250769|566795453|FG003|Overall Study|Withdrawal by Subject|0|||
157011587|NCT01250769|566795450|FG000|Overall Study|Adverse Event|0|||
157011588|NCT01250769|566795451|FG001|Overall Study|Adverse Event|0|||
157011589|NCT01250769|566795452|FG002|Overall Study|Adverse Event|1|||
157011590|NCT01250769|566795453|FG003|Overall Study|Adverse Event|0|||
157011591|NCT01985334|566795454|FG000|Overall Study|Administrative problems|1|||
157011592|NCT01985334|566795455|FG001|Overall Study|Administrative problems|1|||
157011593|NCT01985334|566795456|FG002|Overall Study|Administrative problems|0|||
157011594|NCT01985334|566795457|FG003|Overall Study|Administrative problems|2|||
157212750|NCT00725725|567526097|FG002|Overall Study|Lost to Follow-up|2|||
157212751|NCT00725725|567526095|FG000|Overall Study|Withdrawal by Subject|1|||
156780716|NCT04822194|565947187|FG000|Overall Study|Lost to Follow-up|5|||
157011595|NCT01985334|566795458|FG004|Overall Study|Administrative problems|0|||
157212752|NCT00725725|567526096|FG001|Overall Study|Withdrawal by Subject|0|||
157118551|NCT00267748|567186473|FG001|Randomized Period|Objective progression or relapse|77|||
157118552|NCT00267748|567186474|FG002|Randomized Period|Objective progression or relapse|86|||
157118553|NCT00267748|567186472|FG000|Randomized Period|Withdrawal by Subject|0|||
157118554|NCT00267748|567186473|FG001|Randomized Period|Withdrawal by Subject|9|||
157118555|NCT00267748|567186474|FG002|Randomized Period|Withdrawal by Subject|2|||
157118556|NCT00267748|567186472|FG000|Randomized Period|Other|0|||
157118557|NCT00267748|567186473|FG001|Randomized Period|Other|9|||
157118558|NCT00267748|567186474|FG002|Randomized Period|Other|6|||
157118559|NCT00267748|567186472|FG000|Randomized Period|randomized but not treated|0|||
157118560|NCT00267748|567186473|FG001|Randomized Period|randomized but not treated|0|||
157118561|NCT00267748|567186474|FG002|Randomized Period|randomized but not treated|3|||
157118562|NCT02429414|567186475|FG000|Overall Study|Physician Decision|0|||
157118563|NCT02429414|567186476|FG001|Overall Study|Physician Decision|1|||
157118564|NCT01098071|567186489|FG000|Overall Study|Surgery (adenoidectomy)|2|||
157118565|NCT01098071|567186489|FG000|Overall Study|Lost to Follow-up|13|||
157118566|NCT01604265|567186490|FG000|Overall Study|Adverse Event|1|||
157118567|NCT01604265|567186491|FG001|Overall Study|Adverse Event|0|||
157118568|NCT01604265|567186490|FG000|Overall Study|Withdrawal by Subject|1|||
157118569|NCT01604265|567186491|FG001|Overall Study|Withdrawal by Subject|0|||
157118570|NCT01903837|567186492|FG000|Part A|Withdrawal by Subject|4|||
157118571|NCT01903837|567186493|FG001|Part A|Withdrawal by Subject|9|||
157118572|NCT01903837|567186494|FG002|Part A|Withdrawal by Subject|8|||
157118573|NCT01903837|567186495|FG003|Part A|Withdrawal by Subject|5|||
157118574|NCT01903837|567186492|FG000|Part A|Adverse Event|3|||
157118575|NCT01903837|567186493|FG001|Part A|Adverse Event|6|||
157118576|NCT01903837|567186494|FG002|Part A|Adverse Event|9|||
157118577|NCT01903837|567186495|FG003|Part A|Adverse Event|6|||
157118578|NCT01903837|567186492|FG000|Part A|Lost to Follow-up|9|||
157118579|NCT01903837|567186493|FG001|Part A|Lost to Follow-up|7|||
157118580|NCT01903837|567186494|FG002|Part A|Lost to Follow-up|7|||
157118581|NCT01903837|567186495|FG003|Part A|Lost to Follow-up|2|||
157118582|NCT01903837|567186492|FG000|Part A|Non-compliance with study drug|1|||
157118583|NCT01903837|567186493|FG001|Part A|Non-compliance with study drug|4|||
157118584|NCT01903837|567186494|FG002|Part A|Non-compliance with study drug|4|||
157118585|NCT01903837|567186495|FG003|Part A|Non-compliance with study drug|0|||
157118586|NCT01903837|567186492|FG000|Part A|Physician Decision|1|||
157118587|NCT01903837|567186493|FG001|Part A|Physician Decision|1|||
157118588|NCT01903837|567186494|FG002|Part A|Physician Decision|0|||
157118589|NCT01903837|567186495|FG003|Part A|Physician Decision|0|||
157118590|NCT01903837|567186492|FG000|Part A|Protocol Violation|1|||
157118591|NCT01903837|567186493|FG001|Part A|Protocol Violation|1|||
157118592|NCT01903837|567186494|FG002|Part A|Protocol Violation|0|||
157118593|NCT01903837|567186495|FG003|Part A|Protocol Violation|0|||
157118594|NCT01903837|567186492|FG000|Part B|Lost to Follow-up|0|||
157118595|NCT01903837|567186493|FG001|Part B|Lost to Follow-up|3|||
157118596|NCT01903837|567186494|FG002|Part B|Lost to Follow-up|3|||
156780717|NCT04822194|565947188|FG001|Overall Study|Lost to Follow-up|7|||
157118597|NCT01903837|567186495|FG003|Part B|Lost to Follow-up|4|||
157118598|NCT01903837|567186492|FG000|Part B|Withdrawal by Subject|1|||
157118599|NCT01903837|567186493|FG001|Part B|Withdrawal by Subject|2|||
157118600|NCT01903837|567186494|FG002|Part B|Withdrawal by Subject|0|||
157118601|NCT01903837|567186495|FG003|Part B|Withdrawal by Subject|3|||
157118602|NCT01903837|567186492|FG000|Part B|Adverse Event|3|||
157118603|NCT01903837|567186493|FG001|Part B|Adverse Event|0|||
157118604|NCT01903837|567186494|FG002|Part B|Adverse Event|2|||
157118605|NCT01903837|567186495|FG003|Part B|Adverse Event|0|||
157118606|NCT01903837|567186492|FG000|Part B|Non-compliance with study drug|2|||
157118607|NCT01903837|567186493|FG001|Part B|Non-compliance with study drug|0|||
157118608|NCT01903837|567186494|FG002|Part B|Non-compliance with study drug|0|||
157118609|NCT01903837|567186495|FG003|Part B|Non-compliance with study drug|1|||
157118610|NCT01903837|567186492|FG000|Part B|Incarceration|2|||
157118611|NCT01903837|567186493|FG001|Part B|Incarceration|0|||
157118612|NCT01903837|567186494|FG002|Part B|Incarceration|0|||
157118613|NCT01903837|567186495|FG003|Part B|Incarceration|1|||
157118614|NCT01903837|567186492|FG000|Part B|Physician Decision|1|||
157118615|NCT01903837|567186493|FG001|Part B|Physician Decision|0|||
157118616|NCT01903837|567186494|FG002|Part B|Physician Decision|0|||
157118617|NCT01903837|567186495|FG003|Part B|Physician Decision|2|||
157118618|NCT01903837|567186492|FG000|Part B|Lack of Efficacy|0|||
157118619|NCT01903837|567186493|FG001|Part B|Lack of Efficacy|1|||
157118620|NCT01903837|567186494|FG002|Part B|Lack of Efficacy|0|||
157118621|NCT01903837|567186495|FG003|Part B|Lack of Efficacy|0|||
157118622|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
156780718|NCT00640289|565947191|FG000|Overall Study|Death|3|||
157118623|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
157118624|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
157212753|NCT00725725|567526097|FG002|Overall Study|Withdrawal by Subject|1|||
157118625|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
157118626|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
157118627|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
157118628|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
157118629|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
157118630|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
157118631|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
157118632|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
157118633|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
157118634|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
157118635|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
157118636|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
157118637|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
157118638|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
157118639|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
157118640|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
157118641|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
157118642|NCT02706873|567186496|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
157118643|NCT02706873|567186497|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
157118644|NCT02706873|567186498|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
157118645|NCT02706873|567186499|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
157118646|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
157118647|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
157118648|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
157118649|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
157118650|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
157118651|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
157118652|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
157118653|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
157118654|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
157118655|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
157118656|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
157118657|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
157118658|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
157118659|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
157118660|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
157118661|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
157118662|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
157118663|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
157118664|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
157118665|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
157118666|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
157118667|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
157118668|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
157118669|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
157118670|NCT02706873|567186496|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
157118671|NCT02706873|567186497|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
157118672|NCT02706873|567186498|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
157118673|NCT02706873|567186499|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
157118674|NCT00797732|567186500|FG000|Overall Study|Withdrawal by Subject|3|||
157118675|NCT00797732|567186501|FG001|Overall Study|Withdrawal by Subject|3|||
157118676|NCT00797732|567186502|FG002|Overall Study|Withdrawal by Subject|0|||
157118677|NCT00797732|567186500|FG000|Overall Study|Lost to Follow-up|1|||
157118678|NCT00797732|567186501|FG001|Overall Study|Lost to Follow-up|0|||
157118679|NCT00797732|567186502|FG002|Overall Study|Lost to Follow-up|0|||
157118680|NCT00797732|567186500|FG000|Overall Study|Death|1|||
157118681|NCT00797732|567186501|FG001|Overall Study|Death|0|||
157118682|NCT00797732|567186502|FG002|Overall Study|Death|0|||
157118683|NCT00797732|567186500|FG000|Overall Study|Not meet inclusion criteria|0|||
157118684|NCT00797732|567186501|FG001|Overall Study|Not meet inclusion criteria|0|||
157118685|NCT00797732|567186502|FG002|Overall Study|Not meet inclusion criteria|7|||
157118686|NCT00797732|567186500|FG000|Overall Study|Excluded due to time constraints|0|||
157118687|NCT00797732|567186501|FG001|Overall Study|Excluded due to time constraints|0|||
157118688|NCT00797732|567186502|FG002|Overall Study|Excluded due to time constraints|24|||
157118689|NCT00797732|567186500|FG000|Overall Study|Refused to Participate|0|||
157118690|NCT00797732|567186501|FG001|Overall Study|Refused to Participate|0|||
157118691|NCT00797732|567186502|FG002|Overall Study|Refused to Participate|123|||
157118692|NCT01857869|567186503|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
157118693|NCT01857869|567186504|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
157118694|NCT01857869|567186505|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
157118695|NCT01857869|567186506|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
157118696|NCT01857869|567186507|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
157118697|NCT01857869|567186508|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
157118698|NCT01857869|567186509|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
157118699|NCT01857869|567186510|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
157118700|NCT01857869|567186511|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
157118701|NCT01857869|567186512|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
157118702|NCT01857869|567186503|FG000|Primary/Challenge Phase|Pregnancy|1|||
157118703|NCT01857869|567186504|FG001|Primary/Challenge Phase|Pregnancy|0|||
157118704|NCT01857869|567186505|FG002|Primary/Challenge Phase|Pregnancy|0|||
157118705|NCT01857869|567186506|FG003|Primary/Challenge Phase|Pregnancy|0|||
157118706|NCT01857869|567186507|FG004|Primary/Challenge Phase|Pregnancy|0|||
157118707|NCT01857869|567186508|FG005|Primary/Challenge Phase|Pregnancy|0|||
157118708|NCT01857869|567186509|FG006|Primary/Challenge Phase|Pregnancy|0|||
157118709|NCT01857869|567186510|FG007|Primary/Challenge Phase|Pregnancy|0|||
157118710|NCT01857869|567186511|FG008|Primary/Challenge Phase|Pregnancy|0|||
157118711|NCT01857869|567186512|FG009|Primary/Challenge Phase|Pregnancy|0|||
157118712|NCT01857869|567186503|FG000|Primary/Challenge Phase|Protocol Violation|1|||
157118713|NCT01857869|567186504|FG001|Primary/Challenge Phase|Protocol Violation|0|||
157118714|NCT01857869|567186505|FG002|Primary/Challenge Phase|Protocol Violation|0|||
157118715|NCT01857869|567186506|FG003|Primary/Challenge Phase|Protocol Violation|0|||
157118716|NCT01857869|567186507|FG004|Primary/Challenge Phase|Protocol Violation|0|||
157118717|NCT01857869|567186508|FG005|Primary/Challenge Phase|Protocol Violation|0|||
157118718|NCT01857869|567186509|FG006|Primary/Challenge Phase|Protocol Violation|0|||
157212754|NCT00725725|567526095|FG000|Overall Study|Protocol Violation|0|||
157212755|NCT00725725|567526096|FG001|Overall Study|Protocol Violation|1|||
157212756|NCT00725725|567526097|FG002|Overall Study|Protocol Violation|0|||
157212757|NCT02392559|567526098|FG000|Overall Study|Withdrawal by Subject|0|||
157212758|NCT02392559|567526099|FG001|Overall Study|Withdrawal by Subject|1|||
157212759|NCT02340078|567526105|FG000|Overall Study|Protocol Violation|1|||
157212760|NCT04816877|567526108|FG000|Overall Study|Withdrawal by Subject|1|||
157212761|NCT04816877|567526109|FG001|Overall Study|Withdrawal by Subject|0|||
157212762|NCT05788237|567526115|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
157212763|NCT05788237|567526116|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
157212764|NCT05788237|567526117|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
157212765|NCT05788237|567526118|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
157212766|NCT05788237|567526115|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
157212767|NCT05788237|567526116|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
157212768|NCT05788237|567526117|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
157212769|NCT05788237|567526118|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
157212770|NCT05788237|567526115|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
157212771|NCT05788237|567526116|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
157212772|NCT05788237|567526117|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
157212773|NCT05788237|567526118|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
157212774|NCT05788237|567526115|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
157118719|NCT01857869|567186510|FG007|Primary/Challenge Phase|Protocol Violation|0|||
157118720|NCT01857869|567186511|FG008|Primary/Challenge Phase|Protocol Violation|0|||
157118721|NCT01857869|567186512|FG009|Primary/Challenge Phase|Protocol Violation|0|||
157118722|NCT01857869|567186503|FG000|Primary/Challenge Phase|Other|1|||
157118723|NCT01857869|567186504|FG001|Primary/Challenge Phase|Other|1|||
157118724|NCT01857869|567186505|FG002|Primary/Challenge Phase|Other|0|||
157118725|NCT01857869|567186506|FG003|Primary/Challenge Phase|Other|0|||
157118726|NCT01857869|567186507|FG004|Primary/Challenge Phase|Other|0|||
157118727|NCT01857869|567186508|FG005|Primary/Challenge Phase|Other|0|||
157118728|NCT01857869|567186509|FG006|Primary/Challenge Phase|Other|0|||
157118729|NCT01857869|567186510|FG007|Primary/Challenge Phase|Other|0|||
157118730|NCT01857869|567186511|FG008|Primary/Challenge Phase|Other|0|||
157118731|NCT01857869|567186512|FG009|Primary/Challenge Phase|Other|0|||
157118732|NCT01857869|567186503|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118733|NCT01857869|567186504|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118734|NCT01857869|567186505|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118735|NCT01857869|567186506|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
157118736|NCT01857869|567186507|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118737|NCT01857869|567186508|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118738|NCT01857869|567186509|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118739|NCT01857869|567186510|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118740|NCT01857869|567186511|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118741|NCT01857869|567186512|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
157118742|NCT01857869|567186503|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118743|NCT01857869|567186504|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118744|NCT01857869|567186505|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118745|NCT01857869|567186506|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
157118746|NCT01857869|567186507|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118747|NCT01857869|567186508|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118748|NCT01857869|567186509|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118749|NCT01857869|567186510|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118750|NCT01857869|567186511|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118751|NCT01857869|567186512|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
157118752|NCT02728830|567186523|FG000|Overall Study|Exclusionary Surgery|9|||
157118753|NCT02728830|567186523|FG000|Overall Study|Exclusionary Pathology|6|||
157118754|NCT02728830|567186523|FG000|Overall Study|Physician Decision|3|||
157118755|NCT02728830|567186523|FG000|Overall Study|Withdrawal by Subject|2|||
157118756|NCT02728830|567186523|FG000|Overall Study|Lost to Follow-up|1|||
157118757|NCT02728830|567186523|FG000|Overall Study|Exclusionary Lab Values|1|||
157118758|NCT02728830|567186523|FG000|Overall Study|Contraindicated Illness|1|||
157118759|NCT02728830|567186523|FG000|Overall Study|Language Barrier|1|||
157118760|NCT01347554|567186524|FG000|Overall Study|Lack of Efficacy|7|||
157118761|NCT01347554|567186525|FG001|Overall Study|Lack of Efficacy|11|||
157118762|NCT03603496|567186526|FG000|Overall Study|Death|19|||
157118763|NCT03603496|567186527|FG001|Overall Study|Death|24|||
157118764|NCT03603496|567186526|FG000|Overall Study|Lost to Follow-up|141|||
157118765|NCT03603496|567186527|FG001|Overall Study|Lost to Follow-up|141|||
157118766|NCT03603496|567186526|FG000|Overall Study|Withdrawal by Subject|26|||
157118767|NCT03603496|567186527|FG001|Overall Study|Withdrawal by Subject|20|||
157118768|NCT00004259|567186530|FG000|Overall Study|Protocol Violation|1|||
157118769|NCT00004259|567186531|FG001|Overall Study|Protocol Violation|2|||
157118770|NCT00004259|567186532|FG002|Overall Study|Protocol Violation|0|||
157118771|NCT00004259|567186533|FG003|Overall Study|Protocol Violation|0|||
157118772|NCT00004259|567186530|FG000|Overall Study|Withdrawal by Subject|0|||
157118773|NCT00004259|567186531|FG001|Overall Study|Withdrawal by Subject|2|||
157118774|NCT00004259|567186532|FG002|Overall Study|Withdrawal by Subject|0|||
157118775|NCT00004259|567186533|FG003|Overall Study|Withdrawal by Subject|0|||
157118776|NCT03594227|567186534|FG000|Overall Study|Adverse Event|2|||
157118777|NCT03594227|567186535|FG001|Overall Study|Adverse Event|1|||
157118778|NCT03594227|567186536|FG002|Overall Study|Adverse Event|0|||
157118779|NCT03594227|567186537|FG003|Overall Study|Adverse Event|2|||
157118780|NCT03594227|567186534|FG000|Overall Study|Lost to Follow-up|1|||
157118781|NCT03594227|567186535|FG001|Overall Study|Lost to Follow-up|1|||
157212775|NCT05788237|567526116|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
157212776|NCT05788237|567526117|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
157212777|NCT05788237|567526118|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
157212778|NCT05788237|567526115|FG000|SSA (Approximately 2 Months)|Death|0|||
157212779|NCT05788237|567526116|FG001|SSA (Approximately 2 Months)|Death|1|||
157212780|NCT05788237|567526117|FG002|SSA (Approximately 2 Months)|Death|0|||
157212781|NCT05788237|567526118|FG003|SSA (Approximately 2 Months)|Death|0|||
157212782|NCT05788237|567526115|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
157212783|NCT05788237|567526116|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
157212784|NCT05788237|567526117|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
157212785|NCT05788237|567526118|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
157212786|NCT05788237|567526115|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
157212787|NCT05788237|567526116|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
157212788|NCT05788237|567526117|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
157212789|NCT05788237|567526118|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
157212790|NCT05788237|567526115|FG000|SSB (Approximately 1 Month)|Other|0|||
157212791|NCT05788237|567526116|FG001|SSB (Approximately 1 Month)|Other|0|||
157212792|NCT05788237|567526117|FG002|SSB (Approximately 1 Month)|Other|0|||
157212793|NCT05788237|567526118|FG003|SSB (Approximately 1 Month)|Other|1|||
157212794|NCT03724916|567527642|FG000|Overall Study|Withdrawal by Subject|0|||
157212795|NCT03724916|567527643|FG001|Overall Study|Withdrawal by Subject|1|||
157212796|NCT03724916|567527644|FG002|Overall Study|Withdrawal by Subject|1|||
157212797|NCT03724916|567527645|FG003|Overall Study|Withdrawal by Subject|2|||
157212798|NCT03724916|567527642|FG000|Overall Study|Randomized but not Treated|1|||
157212799|NCT03724916|567527643|FG001|Overall Study|Randomized but not Treated|0|||
157212800|NCT03724916|567527644|FG002|Overall Study|Randomized but not Treated|0|||
157212801|NCT03724916|567527645|FG003|Overall Study|Randomized but not Treated|0|||
157212802|NCT04335110|567527648|FG000|Overall Study|Withdrawal by Subject|1|||
157118782|NCT03594227|567186536|FG002|Overall Study|Lost to Follow-up|1|||
157118783|NCT03594227|567186537|FG003|Overall Study|Lost to Follow-up|0|||
157118784|NCT03594227|567186534|FG000|Overall Study|Withdrawal by Subject|1|||
157118785|NCT03594227|567186535|FG001|Overall Study|Withdrawal by Subject|1|||
157118786|NCT03594227|567186536|FG002|Overall Study|Withdrawal by Subject|1|||
157118787|NCT03594227|567186537|FG003|Overall Study|Withdrawal by Subject|1|||
157118788|NCT03594227|567186534|FG000|Overall Study|Pregnancy|0|||
157118789|NCT03594227|567186535|FG001|Overall Study|Pregnancy|1|||
157118790|NCT03594227|567186536|FG002|Overall Study|Pregnancy|0|||
157118791|NCT03594227|567186537|FG003|Overall Study|Pregnancy|0|||
157212803|NCT04335110|567527649|FG001|Overall Study|Withdrawal by Subject|1|||
157212804|NCT04335110|567527648|FG000|Overall Study|Death|0|||
157118792|NCT03594227|567186534|FG000|Overall Study|Sponsor Decision|0|||
157118793|NCT03594227|567186535|FG001|Overall Study|Sponsor Decision|0|||
157118794|NCT03594227|567186536|FG002|Overall Study|Sponsor Decision|0|||
157118795|NCT03594227|567186537|FG003|Overall Study|Sponsor Decision|1|||
157118796|NCT03594227|567186534|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
157118797|NCT03594227|567186535|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
157118798|NCT03594227|567186536|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
157118799|NCT03594227|567186537|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
157118800|NCT00790907|567186538|FG000|Overall Study|Adverse Event|9|||
157118801|NCT00790907|567186539|FG001|Overall Study|Adverse Event|7|||
157118802|NCT00790907|567186540|FG002|Overall Study|Adverse Event|6|||
157118803|NCT00790907|567186538|FG000|Overall Study|Physician Decision|304|||
157118804|NCT00790907|567186539|FG001|Overall Study|Physician Decision|271|||
157118805|NCT00790907|567186540|FG002|Overall Study|Physician Decision|255|||
157118806|NCT00790907|567186538|FG000|Overall Study|Withdrawal by Subject|1|||
157118807|NCT00790907|567186539|FG001|Overall Study|Withdrawal by Subject|7|||
157118808|NCT00790907|567186540|FG002|Overall Study|Withdrawal by Subject|5|||
157118809|NCT00790907|567186538|FG000|Overall Study|Bleeding Event|11|||
157212805|NCT04335110|567527649|FG001|Overall Study|Death|1|||
157212806|NCT02513459|567527650|FG000|Overall Study|Adverse Event|7|||
157118810|NCT00790907|567186539|FG001|Overall Study|Bleeding Event|16|||
157212807|NCT02513459|567527650|FG000|Overall Study|Withdrew consent|5|||
157118811|NCT00790907|567186540|FG002|Overall Study|Bleeding Event|21|||
157212808|NCT02513459|567527650|FG000|Overall Study|Loss of efficacy|2|||
157212809|NCT02513459|567527650|FG000|Overall Study|Pregnancy|2|||
157212810|NCT02513459|567527650|FG000|Overall Study|Subject decision|2|||
157118812|NCT00790907|567186538|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
157118813|NCT00790907|567186539|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
157118814|NCT00790907|567186540|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
157118815|NCT00790907|567186538|FG000|Overall Study|Qualifying Condition Not Present|29|||
157118816|NCT00790907|567186539|FG001|Overall Study|Qualifying Condition Not Present|14|||
157118817|NCT00790907|567186540|FG002|Overall Study|Qualifying Condition Not Present|16|||
157118818|NCT00790907|567186538|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
157118819|NCT00790907|567186539|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
157118820|NCT00790907|567186540|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
157118821|NCT00790907|567186538|FG000|Overall Study|Did Not Receive Study Drug|10|||
157118822|NCT00790907|567186539|FG001|Overall Study|Did Not Receive Study Drug|0|||
157118823|NCT00790907|567186540|FG002|Overall Study|Did Not Receive Study Drug|0|||
157118824|NCT00774345|567186541|FG000|Pre-treatment|Other reasons|2|||
157118825|NCT00774345|567186542|FG001|Pre-treatment|Other reasons|0|||
157118826|NCT00774345|567186541|FG000|Treatment|Adverse Event|61|||
157118827|NCT00774345|567186542|FG001|Treatment|Adverse Event|15|||
157118828|NCT00774345|567186541|FG000|Treatment|Progressive Disease without histologic transformation|51|||
157118829|NCT00774345|567186542|FG001|Treatment|Progressive Disease without histologic transformation|111|||
157118830|NCT00774345|567186541|FG000|Treatment|Progressive Disease with histologic transformation|4|||
157118831|NCT00774345|567186542|FG001|Treatment|Progressive Disease with histologic transformation|2|||
157118832|NCT00774345|567186541|FG000|Treatment|Withdrawal by Subject|5|||
157118833|NCT00774345|567186542|FG001|Treatment|Withdrawal by Subject|2|||
157118834|NCT00774345|567186541|FG000|Treatment|Lost to Follow-up|1|||
157118835|NCT00774345|567186542|FG001|Treatment|Lost to Follow-up|1|||
157118836|NCT00774345|567186541|FG000|Treatment|Death|4|||
157118837|NCT00774345|567186542|FG001|Treatment|Death|0|||
157118838|NCT00774345|567186541|FG000|Treatment|Other Reasons|32|||
157118839|NCT00774345|567186542|FG001|Treatment|Other Reasons|26|||
157118840|NCT02873936|567186550|FG000|Overall Study|Withdrew Consent|4|||
157118841|NCT02873936|567186551|FG001|Overall Study|Withdrew Consent|11|||
157118842|NCT02873936|567186552|FG002|Overall Study|Withdrew Consent|20|||
157118843|NCT02873936|567186550|FG000|Overall Study|Investigator's Discretion|3|||
157118844|NCT02873936|567186551|FG001|Overall Study|Investigator's Discretion|5|||
157118845|NCT02873936|567186552|FG002|Overall Study|Investigator's Discretion|4|||
157118846|NCT02873936|567186550|FG000|Overall Study|Adverse Event|3|||
157118847|NCT02873936|567186551|FG001|Overall Study|Adverse Event|5|||
157118848|NCT02873936|567186552|FG002|Overall Study|Adverse Event|3|||
157118849|NCT02873936|567186550|FG000|Overall Study|Protocol Violation|0|||
157118850|NCT02873936|567186551|FG001|Overall Study|Protocol Violation|1|||
157118851|NCT02873936|567186552|FG002|Overall Study|Protocol Violation|3|||
157118852|NCT02873936|567186550|FG000|Overall Study|Lost to Follow-up|1|||
157118853|NCT02873936|567186551|FG001|Overall Study|Lost to Follow-up|1|||
157118854|NCT02873936|567186552|FG002|Overall Study|Lost to Follow-up|1|||
157118855|NCT02873936|567186550|FG000|Overall Study|Non-compliance With Study Drug|1|||
157118856|NCT02873936|567186551|FG001|Overall Study|Non-compliance With Study Drug|0|||
157118857|NCT02873936|567186552|FG002|Overall Study|Non-compliance With Study Drug|1|||
157118858|NCT02873936|567186550|FG000|Overall Study|Randomized but not Dosed|1|||
157118859|NCT02873936|567186551|FG001|Overall Study|Randomized but not Dosed|0|||
157118860|NCT02873936|567186552|FG002|Overall Study|Randomized but not Dosed|0|||
157118861|NCT01967537|567186553|FG000|Overall Study|Withdrawal by Subject|52|||
157118862|NCT01967537|567186553|FG000|Overall Study|Refuse treatment|2|||
157118863|NCT01967537|567186553|FG000|Overall Study|Lost to Follow-up|6|||
157118864|NCT01836783|567186558|FG000|Overall Study|Withdrawal by Subject|0|||
157118865|NCT01836783|567186559|FG001|Overall Study|Withdrawal by Subject|2|||
157118866|NCT01014689|567186562|FG000|Overall Study|Lack of Efficacy|0|||
157118867|NCT01014689|567186563|FG001|Overall Study|Lack of Efficacy|1|||
157118868|NCT01014689|567186562|FG000|Overall Study|Adverse Event|3|||
157118869|NCT01014689|567186563|FG001|Overall Study|Adverse Event|0|||
157118870|NCT01014689|567186562|FG000|Overall Study|Withdrawal by Subject|5|||
157118871|NCT01014689|567186563|FG001|Overall Study|Withdrawal by Subject|4|||
157118872|NCT01014689|567186562|FG000|Overall Study|Protocol Violation|1|||
157118873|NCT01014689|567186563|FG001|Overall Study|Protocol Violation|1|||
157118874|NCT01014689|567186562|FG000|Overall Study|Lost to Follow-up|3|||
157118875|NCT01014689|567186563|FG001|Overall Study|Lost to Follow-up|7|||
157118876|NCT01014689|567186562|FG000|Overall Study|Pregnancy|1|||
157118877|NCT01014689|567186563|FG001|Overall Study|Pregnancy|0|||
157118878|NCT01452152|567186567|FG000|Overall Study|Study termination by sponsor|5|||
157118879|NCT01452152|567186568|FG001|Overall Study|Study termination by sponsor|0|||
157118880|NCT01452152|567186569|FG002|Overall Study|Study termination by sponsor|4|||
157118881|NCT02867995|567186571|FG000|Overall Study|Withdrawal by Subject|0|||
157118882|NCT02867995|567186572|FG001|Overall Study|Withdrawal by Subject|1|||
157118883|NCT02867995|567186571|FG000|Overall Study|Lost to Follow-up|0|||
157118884|NCT02867995|567186572|FG001|Overall Study|Lost to Follow-up|2|||
157118885|NCT03315871|567186573|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
157118886|NCT03315871|567186574|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
157118887|NCT03315871|567186575|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
157118888|NCT03315871|567186573|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
157118889|NCT03315871|567186574|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
157118890|NCT03315871|567186575|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
157118891|NCT03315871|567186573|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
157118892|NCT03315871|567186574|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
157118893|NCT03315871|567186575|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
157118894|NCT03315871|567186573|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
157118895|NCT03315871|567186574|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
157118896|NCT03315871|567186575|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
157118897|NCT03315871|567186573|FG000|PROSTVAC + CV301|Progressive disease|0|||
157118898|NCT03315871|567186574|FG001|PROSTVAC + CV301|Progressive disease|0|||
157118899|NCT03315871|567186575|FG002|PROSTVAC + CV301|Progressive disease|1|||
157118900|NCT03315871|567186573|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
157118901|NCT03315871|567186574|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
157118902|NCT03315871|567186575|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
157118903|NCT04099251|567187789|FG000|Pre-Treatment|Other reasons|1|||
157118904|NCT04099251|567187790|FG001|Pre-Treatment|Other reasons|0|||
157118905|NCT04099251|567187789|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
157118906|NCT04099251|567187790|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
156780719|NCT00640289|565947191|FG000|Overall Study|Withdrawal by Subject|1|||
156780720|NCT00640289|565947191|FG000|Overall Study|Lost to Follow-up|1|||
156780721|NCT00640289|565947191|FG000|Overall Study|Data collected under different amendment|2|||
156780722|NCT00640289|565947191|FG000|Overall Study|Transferred to another center|1|||
156780723|NCT00640289|565947191|FG000|Overall Study|Missing status|5|||
156780724|NCT03550209|565947192|FG000|Overall Study|Lost to Follow-up|1|||
156780725|NCT03550209|565947193|FG001|Overall Study|Lost to Follow-up|0|||
156780726|NCT03550209|565947194|FG002|Overall Study|Lost to Follow-up|1|||
156780727|NCT03550209|565947195|FG003|Overall Study|Lost to Follow-up|0|||
156780728|NCT03550209|565947192|FG000|Overall Study|Withdrawal by Subject|0|||
156780729|NCT03550209|565947193|FG001|Overall Study|Withdrawal by Subject|3|||
156780730|NCT03550209|565947194|FG002|Overall Study|Withdrawal by Subject|1|||
156780731|NCT03550209|565947195|FG003|Overall Study|Withdrawal by Subject|2|||
156780732|NCT03550209|565947192|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
156780733|NCT03550209|565947193|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
156780734|NCT03550209|565947194|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
156780735|NCT03550209|565947195|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
156780736|NCT01127061|565948382|FG000|Overall Study|Lost to Follow-up|7|||
156780737|NCT01127061|565948383|FG001|Overall Study|Lost to Follow-up|10|||
156780738|NCT01127061|565948382|FG000|Overall Study|Physician Decision|3|||
156780739|NCT01127061|565948383|FG001|Overall Study|Physician Decision|3|||
156780740|NCT03921541|565948384|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
156780741|NCT03921541|565948385|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
156780742|NCT00182637|565948386|FG000|Overall Study|Adverse Event|2|||
156780743|NCT00182637|565948386|FG000|Overall Study|Disease Progression|1|||
156780744|NCT02143778|565948393|FG000|Overall Study|Withdrawal by Subject|2|||
156780745|NCT02143778|565948393|FG000|Overall Study|Device malfunction|1|||
156780746|NCT03637374|565948394|FG000|Overall Study|Death|2|||
156780747|NCT03637374|565948395|FG001|Overall Study|Death|0|||
156780748|NCT00933166|565948397|FG000|Overall Study|Lost to Follow-up|4|||
156780749|NCT00933166|565948397|FG000|Overall Study|Lack of Efficacy|9|||
156780750|NCT00933166|565948397|FG000|Overall Study|Unavailable|4|||
156780751|NCT00933166|565948397|FG000|Overall Study|Withdrawal by Subject|1|||
156780752|NCT02948400|565948402|FG000|Overall Study|Withdrawal by Subject|17|||
156780753|NCT02948400|565948403|FG001|Overall Study|Withdrawal by Subject|10|||
156780754|NCT02948400|565948402|FG000|Overall Study|failed to attend appointments|47|||
156780755|NCT02948400|565948403|FG001|Overall Study|failed to attend appointments|34|||
156780756|NCT02948400|565948402|FG000|Overall Study|COVID-related closure|6|||
156780757|NCT02948400|565948403|FG001|Overall Study|COVID-related closure|2|||
157118907|NCT04099251|567187789|FG000|Blinded Treatment Phase|Other reasons|16|||
157118908|NCT04099251|567187790|FG001|Blinded Treatment Phase|Other reasons|7|||
157118909|NCT04099251|567187789|FG000|Blinded Treatment Phase|Disease recurrence|26|||
157118910|NCT04099251|567187790|FG001|Blinded Treatment Phase|Disease recurrence|41|||
157118911|NCT04099251|567187789|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
157118912|NCT04099251|567187790|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
157118913|NCT04099251|567187789|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
157118914|NCT04099251|567187790|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
157118915|NCT04099251|567187789|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
157118916|NCT04099251|567187790|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
157118917|NCT04099251|567187789|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
157118918|NCT04099251|567187790|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
157118919|NCT04099251|567187789|FG000|Blinded Treatment Phase|Death|6|||
157118920|NCT04099251|567187790|FG001|Blinded Treatment Phase|Death|2|||
157118921|NCT04099251|567187789|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
157118922|NCT04099251|567187790|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
157118923|NCT04099251|567187789|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
157118924|NCT04099251|567187790|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
157118925|NCT04099251|567187789|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
157118926|NCT04099251|567187790|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
157118927|NCT04099251|567187789|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
157118928|NCT04099251|567187790|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
157118929|NCT04099251|567187789|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
157118930|NCT04099251|567187790|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
157118931|NCT04099251|567187789|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
157118932|NCT04099251|567187790|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
157118933|NCT04099251|567187789|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
157118934|NCT04099251|567187790|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
157118935|NCT04099251|567187789|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
157118936|NCT04099251|567187790|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
157118937|NCT04099251|567187789|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
157118938|NCT04099251|567187790|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
157118939|NCT01408147|567187791|FG000|Overall Study|Withdrawal by Subject|0|||
157118940|NCT01408147|567187792|FG001|Overall Study|Withdrawal by Subject|1|||
157118941|NCT03445000|567187794|FG000|Overall Study|Disease progression|8|||
157118942|NCT03445000|567187794|FG000|Overall Study|Adverse Event|3|||
157118943|NCT03445000|567187794|FG000|Overall Study|Death|2|||
157118944|NCT03445000|567187794|FG000|Overall Study|Physician Decision|1|||
157118945|NCT01982292|567187795|FG000|Overall Study|Adverse Event|2|||
157118946|NCT01982292|567187796|FG001|Overall Study|Adverse Event|0|||
157118947|NCT01982292|567187795|FG000|Overall Study|Death|1|||
157118948|NCT01982292|567187796|FG001|Overall Study|Death|0|||
157118949|NCT01982292|567187795|FG000|Overall Study|Lost to Follow-up|2|||
157118950|NCT01982292|567187796|FG001|Overall Study|Lost to Follow-up|0|||
157118951|NCT01982292|567187795|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
157118952|NCT01982292|567187796|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
157118953|NCT01982292|567187795|FG000|Overall Study|Protocol Deviation|1|||
157118954|NCT01982292|567187796|FG001|Overall Study|Protocol Deviation|0|||
157118955|NCT01982292|567187795|FG000|Overall Study|Patient/Guardian Decision|3|||
157118956|NCT01982292|567187796|FG001|Overall Study|Patient/Guardian Decision|1|||
157118957|NCT01982292|567187795|FG000|Overall Study|Technical Problems|2|||
157118958|NCT01982292|567187796|FG001|Overall Study|Technical Problems|0|||
157118959|NCT00264004|567187798|FG000|Overall Study|Adverse Event|2|||
157118960|NCT00264004|567187799|FG001|Overall Study|Adverse Event|3|||
157118961|NCT00264004|567187800|FG002|Overall Study|Adverse Event|6|||
157118962|NCT00264004|567187801|FG003|Overall Study|Adverse Event|4|||
157118963|NCT00264004|567187798|FG000|Overall Study|Withdrawal by Subject|0|||
157118964|NCT00264004|567187799|FG001|Overall Study|Withdrawal by Subject|1|||
157118965|NCT00264004|567187800|FG002|Overall Study|Withdrawal by Subject|2|||
157118966|NCT00264004|567187801|FG003|Overall Study|Withdrawal by Subject|2|||
157118967|NCT00264004|567187798|FG000|Overall Study|Other|2|||
157118968|NCT00264004|567187799|FG001|Overall Study|Other|2|||
157118969|NCT00264004|567187800|FG002|Overall Study|Other|0|||
157118970|NCT00264004|567187801|FG003|Overall Study|Other|3|||
157118971|NCT00264004|567187798|FG000|Overall Study|Development study specific disc. crit.|1|||
157118972|NCT00264004|567187799|FG001|Overall Study|Development study specific disc. crit.|0|||
157118973|NCT00264004|567187800|FG002|Overall Study|Development study specific disc. crit.|1|||
157118974|NCT00264004|567187801|FG003|Overall Study|Development study specific disc. crit.|0|||
157118975|NCT00264004|567187798|FG000|Overall Study|Cond. under inv. worsened|9|||
157118976|NCT00264004|567187799|FG001|Overall Study|Cond. under inv. worsened|5|||
157118977|NCT00264004|567187800|FG002|Overall Study|Cond. under inv. worsened|3|||
157118978|NCT00264004|567187801|FG003|Overall Study|Cond. under inv. worsened|4|||
157118979|NCT00264004|567187798|FG000|Overall Study|Not treated|3|||
157118980|NCT00264004|567187799|FG001|Overall Study|Not treated|0|||
157118981|NCT00264004|567187800|FG002|Overall Study|Not treated|2|||
157118982|NCT00264004|567187801|FG003|Overall Study|Not treated|2|||
157118983|NCT00820898|567187808|FG000|Overall Study|Inelgible - wrong primary site|1|||
157118984|NCT00452699|567187809|FG000|Overall Study|Adverse Event|10|||
157118985|NCT00452699|567187810|FG001|Overall Study|Adverse Event|3|||
157118986|NCT00452699|567187809|FG000|Overall Study|Lack of Efficacy|6|||
157118987|NCT00452699|567187810|FG001|Overall Study|Lack of Efficacy|4|||
157118988|NCT00452699|567187809|FG000|Overall Study|Lost to Follow-up|6|||
157118989|NCT00452699|567187810|FG001|Overall Study|Lost to Follow-up|9|||
157118990|NCT00452699|567187809|FG000|Overall Study|Protocol Violation|21|||
157118991|NCT00452699|567187810|FG001|Overall Study|Protocol Violation|25|||
157118992|NCT00452699|567187809|FG000|Overall Study|Withdrawal by Subject|26|||
157118993|NCT00452699|567187810|FG001|Overall Study|Withdrawal by Subject|25|||
157118994|NCT00452699|567187809|FG000|Overall Study|Other|12|||
157118995|NCT00452699|567187810|FG001|Overall Study|Other|7|||
157118996|NCT02921971|567187811|FG000|Overall Study|Adverse Event|1|||
157118997|NCT02921971|567187812|FG001|Overall Study|Adverse Event|2|||
157118998|NCT02921971|567187811|FG000|Overall Study|Lack of Efficacy|3|||
157118999|NCT02921971|567187812|FG001|Overall Study|Lack of Efficacy|1|||
157119000|NCT02921971|567187811|FG000|Overall Study|Other than specified above|2|||
157119001|NCT02921971|567187812|FG001|Overall Study|Other than specified above|1|||
157119002|NCT02105454|567187813|FG000|Overall Study|Withdrawal by Subject|1|||
157119003|NCT00326898|567187814|FG000|Overall Study|Disease progression|52|||
157119004|NCT00326898|567187815|FG001|Overall Study|Disease progression|54|||
157119005|NCT00326898|567187816|FG002|Overall Study|Disease progression|102|||
157119006|NCT00326898|567187814|FG000|Overall Study|Adverse Event|124|||
157119007|NCT00326898|567187815|FG001|Overall Study|Adverse Event|128|||
157119008|NCT00326898|567187816|FG002|Overall Study|Adverse Event|33|||
157119009|NCT00326898|567187814|FG000|Overall Study|Death|2|||
157119010|NCT00326898|567187815|FG001|Overall Study|Death|0|||
157119011|NCT00326898|567187816|FG002|Overall Study|Death|0|||
157119012|NCT00326898|567187814|FG000|Overall Study|Withdrawal by Subject|134|||
157119013|NCT00326898|567187815|FG001|Overall Study|Withdrawal by Subject|128|||
157119014|NCT00326898|567187816|FG002|Overall Study|Withdrawal by Subject|32|||
157119015|NCT00326898|567187814|FG000|Overall Study|Alternative therapy|1|||
157119016|NCT00326898|567187815|FG001|Overall Study|Alternative therapy|0|||
157119017|NCT00326898|567187816|FG002|Overall Study|Alternative therapy|0|||
157119018|NCT00326898|567187814|FG000|Overall Study|Other complicating disease|5|||
157119019|NCT00326898|567187815|FG001|Overall Study|Other complicating disease|5|||
157119020|NCT00326898|567187816|FG002|Overall Study|Other complicating disease|4|||
157119021|NCT00326898|567187814|FG000|Overall Study|Other/Missing/Unknown|33|||
157119022|NCT00326898|567187815|FG001|Overall Study|Other/Missing/Unknown|28|||
157119023|NCT00326898|567187816|FG002|Overall Study|Other/Missing/Unknown|32|||
157119024|NCT03847987|567187817|FG000|Overall Study|Lost to Follow-up|1|||
157119025|NCT03847987|567187818|FG001|Overall Study|Lost to Follow-up|0|||
157119026|NCT03847987|567187817|FG000|Overall Study|Adverse Event|2|||
157119027|NCT03847987|567187818|FG001|Overall Study|Adverse Event|0|||
157119028|NCT02721355|567187819|FG000|Overall Study|Lost to Follow-up|6|||
157119029|NCT02721355|567187820|FG001|Overall Study|Lost to Follow-up|1|||
157119030|NCT00527605|567187825|FG000|Overall Study|Adverse Event|3|||
157119031|NCT00527605|567187826|FG001|Overall Study|Adverse Event|0|||
157119032|NCT00527605|567187825|FG000|Overall Study|Withdrawal by Subject|3|||
157119033|NCT00527605|567187826|FG001|Overall Study|Withdrawal by Subject|7|||
157119034|NCT00527605|567187825|FG000|Overall Study|Lost to Follow-up|6|||
157119035|NCT00527605|567187826|FG001|Overall Study|Lost to Follow-up|2|||
157119036|NCT00527605|567187825|FG000|Overall Study|Protocol Violation|1|||
157119037|NCT00527605|567187826|FG001|Overall Study|Protocol Violation|2|||
157119038|NCT01592760|567187832|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
157119039|NCT01592760|567187833|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
157119040|NCT01592760|567187834|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
157119041|NCT04312009|567187835|FG000|Overall Study|Withdrawal by Subject|2|||
157119042|NCT04312009|567187836|FG001|Overall Study|Withdrawal by Subject|1|||
157119043|NCT00687362|567187841|FG000|Overall Study|Protocol Violation|2|||
157119044|NCT00687362|567187841|FG000|Overall Study|Withdrawal by Subject|1|||
157119045|NCT01268293|567187843|FG000|Overall Study|Disease progression|7|||
157119046|NCT01268293|567187843|FG000|Overall Study|Adverse Event|1|||
157119047|NCT01268293|567187843|FG000|Overall Study|Subject choice|1|||
157119048|NCT00925015|567187844|FG000|Overall Study|Adverse Event|1|||
157119049|NCT00925015|567187845|FG001|Overall Study|Adverse Event|2|||
157119050|NCT00925015|567187846|FG002|Overall Study|Adverse Event|1|||
157119051|NCT00925015|567187844|FG000|Overall Study|Physician Decision|0|||
157119052|NCT00925015|567187845|FG001|Overall Study|Physician Decision|1|||
157119053|NCT00925015|567187846|FG002|Overall Study|Physician Decision|0|||
157119054|NCT00925015|567187844|FG000|Overall Study|Progressive Disease|7|||
157119055|NCT00925015|567187845|FG001|Overall Study|Progressive Disease|3|||
157119056|NCT00925015|567187846|FG002|Overall Study|Progressive Disease|4|||
157119057|NCT00925015|567187844|FG000|Overall Study|Withdrawal by Subject|0|||
157119058|NCT00925015|567187845|FG001|Overall Study|Withdrawal by Subject|0|||
157119059|NCT00925015|567187846|FG002|Overall Study|Withdrawal by Subject|1|||
157119060|NCT04986202|567187849|FG000|Overall Study|Death|10|||
157119061|NCT04986202|567187850|FG001|Overall Study|Death|3|||
157119062|NCT04986202|567187851|FG002|Overall Study|Death|10|||
157119063|NCT04986202|567187849|FG000|Overall Study|Physician Decision|3|||
156780758|NCT02948400|565948402|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
157119064|NCT04986202|567187850|FG001|Overall Study|Physician Decision|1|||
157119065|NCT04986202|567187851|FG002|Overall Study|Physician Decision|2|||
157119066|NCT04986202|567187849|FG000|Overall Study|Withdrawal by Subject|4|||
157119067|NCT04986202|567187850|FG001|Overall Study|Withdrawal by Subject|2|||
157119068|NCT04986202|567187851|FG002|Overall Study|Withdrawal by Subject|4|||
157212811|NCT02513459|567527650|FG000|Overall Study|Lack of response|1|||
157119069|NCT05882318|567187857|FG000|Overall Study|Withdrawal by Subject|1|||
157119070|NCT05882318|567187858|FG001|Overall Study|Withdrawal by Subject|0|||
157119071|NCT05882318|567187857|FG000|Overall Study|Protocol Violation|0|||
157119072|NCT05882318|567187858|FG001|Overall Study|Protocol Violation|1|||
157119073|NCT01709149|567187859|FG000|Open-label Lead-in Phase|Adverse Event|109|||
157119074|NCT01709149|567187860|FG001|Open-label Lead-in Phase|Adverse Event|0|||
157119075|NCT01709149|567187861|FG002|Open-label Lead-in Phase|Adverse Event|0|||
157119076|NCT01709149|567187859|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
157119077|NCT01709149|567187860|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
157119078|NCT01709149|567187861|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
157119079|NCT01709149|567187859|FG000|Open-label Lead-in Phase|Death|1|||
157119080|NCT01709149|567187860|FG001|Open-label Lead-in Phase|Death|0|||
157119081|NCT01709149|567187861|FG002|Open-label Lead-in Phase|Death|0|||
157119082|NCT01709149|567187859|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
157119083|NCT01709149|567187860|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
157119084|NCT01709149|567187861|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
157119085|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
157119086|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
157119087|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
157119088|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
157119089|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
157119090|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
157119091|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
157119092|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
157119093|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
157119094|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
157119095|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
157119096|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
157119097|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
157119098|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
157119099|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
157119100|NCT01709149|567187859|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
157119101|NCT01709149|567187860|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
157119102|NCT01709149|567187861|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
157119103|NCT03509350|567187862|FG000|Overall Study|Withdrawal by Subject|0|||
157119104|NCT03509350|567187863|FG001|Overall Study|Withdrawal by Subject|2|||
157119105|NCT01425203|567187864|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
157119106|NCT01425203|567187865|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
157119107|NCT01425203|567187866|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
157119108|NCT01425203|567187864|FG000|Treatment Phase|Failure at futility timepoint|8|||
157119109|NCT01425203|567187865|FG001|Treatment Phase|Failure at futility timepoint|27|||
157119110|NCT01425203|567187866|FG002|Treatment Phase|Failure at futility timepoint|0|||
157119111|NCT01425203|567187864|FG000|Treatment Phase|Other virologic failure criteria|5|||
157119112|NCT01425203|567187865|FG001|Treatment Phase|Other virologic failure criteria|3|||
157119113|NCT01425203|567187866|FG002|Treatment Phase|Other virologic failure criteria|0|||
157119114|NCT01425203|567187864|FG000|Treatment Phase|Unidentified reasons|11|||
157119115|NCT01425203|567187865|FG001|Treatment Phase|Unidentified reasons|5|||
157119116|NCT01425203|567187866|FG002|Treatment Phase|Unidentified reasons|0|||
157119117|NCT01425203|567187864|FG000|Treatment Phase|Did not receive treatment|0|||
157119118|NCT01425203|567187865|FG001|Treatment Phase|Did not receive treatment|1|||
157119119|NCT01425203|567187866|FG002|Treatment Phase|Did not receive treatment|0|||
157119120|NCT01425203|567187864|FG000|Crossover Phase|Failure at futility timepoint|0|||
157119121|NCT01425203|567187865|FG001|Crossover Phase|Failure at futility timepoint|0|||
157119122|NCT01425203|567187866|FG002|Crossover Phase|Failure at futility timepoint|3|||
157119123|NCT01425203|567187864|FG000|Crossover Phase|Other virologic failure criteria|0|||
157119124|NCT01425203|567187865|FG001|Crossover Phase|Other virologic failure criteria|0|||
157119125|NCT01425203|567187866|FG002|Crossover Phase|Other virologic failure criteria|3|||
157119126|NCT00290433|567187869|FG000|Overall Study|Disease Progression|13|||
157119127|NCT00290433|567187869|FG000|Overall Study|Adverse Event|14|||
157119128|NCT00290433|567187869|FG000|Overall Study|Withdrawal by Subject|1|||
157119129|NCT00290433|567187869|FG000|Overall Study|Non-Compliance|1|||
157119130|NCT00290433|567187869|FG000|Overall Study|Congestive Heart Failure|1|||
157119131|NCT00290433|567187869|FG000|Overall Study|Transplant in CR|5|||
157119132|NCT00290433|567187869|FG000|Overall Study|Unrelated Infection/Death|1|||
157119133|NCT01665807|567187874|FG000|Overall Study|Withdrawal by Subject|2|||
157119134|NCT01665807|567187875|FG001|Overall Study|Withdrawal by Subject|0|||
157119135|NCT01665807|567187876|FG002|Overall Study|Withdrawal by Subject|1|||
156780759|NCT02948400|565948403|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
156780760|NCT02948400|565948402|FG000|Overall Study|motion sickness in virtual reality|2|||
156780761|NCT02948400|565948403|FG001|Overall Study|motion sickness in virtual reality|0|||
156780762|NCT02403271|565948404|FG000|Period 1|Other varied reasons|1|||
156780763|NCT02403271|565948405|FG001|Period 1|Other varied reasons|0|||
156780764|NCT02403271|565948404|FG000|Period 2|Withdrawal by Subject|0|||
156780765|NCT02403271|565948405|FG001|Period 2|Withdrawal by Subject|14|||
156780766|NCT02403271|565948404|FG000|Period 2|Death|0|||
156780767|NCT02403271|565948405|FG001|Period 2|Death|84|||
156780768|NCT02403271|565948404|FG000|Period 2|Lost to Follow-up|0|||
156780769|NCT02403271|565948405|FG001|Period 2|Lost to Follow-up|2|||
156780770|NCT02403271|565948404|FG000|Period 2|Study Terminated by Sponsor|0|||
156780771|NCT02403271|565948405|FG001|Period 2|Study Terminated by Sponsor|14|||
156780772|NCT02403271|565948404|FG000|Period 2|Other varied reasons|0|||
156780773|NCT02403271|565948405|FG001|Period 2|Other varied reasons|10|||
156780774|NCT03925220|565948406|FG000|Overall Study|Withdrawal by Subject|4|||
156780775|NCT03925220|565948407|FG001|Overall Study|Withdrawal by Subject|4|||
156780776|NCT03925220|565948408|FG002|Overall Study|Withdrawal by Subject|4|||
156780777|NCT03925220|565948409|FG003|Overall Study|Withdrawal by Subject|4|||
156780778|NCT03925220|565948406|FG000|Overall Study|Lost to Follow-up|40|||
156780779|NCT03925220|565948407|FG001|Overall Study|Lost to Follow-up|46|||
156780780|NCT03925220|565948408|FG002|Overall Study|Lost to Follow-up|37|||
156780781|NCT03925220|565948409|FG003|Overall Study|Lost to Follow-up|38|||
156780782|NCT05561140|565948410|FG000|Randomized Treatment Period|Adverse Event|1|||
156780783|NCT05561140|565948411|FG001|Randomized Treatment Period|Adverse Event|0|||
156780784|NCT05561140|565948410|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156780785|NCT05561140|565948411|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156780786|NCT05561140|565948410|FG000|Open Label Treatment Period|Adverse Event|6|||
156780787|NCT05561140|565948411|FG001|Open Label Treatment Period|Adverse Event|4|||
156780788|NCT05561140|565948410|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
156780789|NCT05561140|565948411|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
156780790|NCT05561140|565948410|FG000|Open Label Treatment Period|Physician Decision|0|||
156780791|NCT05561140|565948411|FG001|Open Label Treatment Period|Physician Decision|1|||
156780792|NCT05561140|565948410|FG000|Open Label Treatment Period|Pregnancy|1|||
157119136|NCT00109707|567187877|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
157119137|NCT00109707|567187878|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
157119138|NCT00109707|567187879|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
157119139|NCT00109707|567187877|FG000|Overall Study|Abnormal laboratory values|1|||
157119140|NCT00109707|567187878|FG001|Overall Study|Abnormal laboratory values|0|||
157119141|NCT00109707|567187879|FG002|Overall Study|Abnormal laboratory values|0|||
157119142|NCT00109707|567187877|FG000|Overall Study|Administrative problems|2|||
157119143|NCT00109707|567187878|FG001|Overall Study|Administrative problems|0|||
157119144|NCT00109707|567187879|FG002|Overall Study|Administrative problems|1|||
157119145|NCT00109707|567187877|FG000|Overall Study|Adverse Event|10|||
157119146|NCT00109707|567187878|FG001|Overall Study|Adverse Event|2|||
157119147|NCT00109707|567187879|FG002|Overall Study|Adverse Event|3|||
157119148|NCT00109707|567187877|FG000|Overall Study|Death|4|||
157119149|NCT00109707|567187878|FG001|Overall Study|Death|0|||
157119150|NCT00109707|567187879|FG002|Overall Study|Death|0|||
157119151|NCT00109707|567187877|FG000|Overall Study|Disease progression|12|||
157119152|NCT00109707|567187878|FG001|Overall Study|Disease progression|4|||
157119153|NCT00109707|567187879|FG002|Overall Study|Disease progression|3|||
157119154|NCT00109707|567187877|FG000|Overall Study|Lost to Follow-up|3|||
157119155|NCT00109707|567187878|FG001|Overall Study|Lost to Follow-up|0|||
157119156|NCT00109707|567187879|FG002|Overall Study|Lost to Follow-up|0|||
157119157|NCT00109707|567187877|FG000|Overall Study|Protocol Violation|1|||
157119158|NCT00109707|567187878|FG001|Overall Study|Protocol Violation|0|||
157119159|NCT00109707|567187879|FG002|Overall Study|Protocol Violation|0|||
157119160|NCT00109707|567187877|FG000|Overall Study|Patient withdrew consent|6|||
157119161|NCT00109707|567187878|FG001|Overall Study|Patient withdrew consent|1|||
157119162|NCT00109707|567187879|FG002|Overall Study|Patient withdrew consent|0|||
157119163|NCT02443883|567187882|FG000|Overall Study|Adverse Event|0|||
157119164|NCT02443883|567187883|FG001|Overall Study|Adverse Event|1|||
157119165|NCT02443883|567187884|FG002|Overall Study|Adverse Event|0|||
157119166|NCT02443883|567187885|FG003|Overall Study|Adverse Event|0|||
157119167|NCT02443883|567187882|FG000|Overall Study|Lost to Follow-up|3|||
157119168|NCT02443883|567187883|FG001|Overall Study|Lost to Follow-up|2|||
157119169|NCT02443883|567187884|FG002|Overall Study|Lost to Follow-up|1|||
157119170|NCT02443883|567187885|FG003|Overall Study|Lost to Follow-up|0|||
157119171|NCT02443883|567187882|FG000|Overall Study|Physician Decision|1|||
157119172|NCT02443883|567187883|FG001|Overall Study|Physician Decision|1|||
157119173|NCT02443883|567187884|FG002|Overall Study|Physician Decision|0|||
157119174|NCT02443883|567187885|FG003|Overall Study|Physician Decision|3|||
157119175|NCT02443883|567187882|FG000|Overall Study|Withdrawal by Subject|1|||
157119176|NCT02443883|567187883|FG001|Overall Study|Withdrawal by Subject|0|||
157119177|NCT02443883|567187884|FG002|Overall Study|Withdrawal by Subject|0|||
157119178|NCT02443883|567187885|FG003|Overall Study|Withdrawal by Subject|2|||
157119179|NCT02443883|567187882|FG000|Overall Study|Randomized, but never treated|1|||
157119180|NCT02443883|567187883|FG001|Overall Study|Randomized, but never treated|0|||
157119181|NCT02443883|567187884|FG002|Overall Study|Randomized, but never treated|0|||
157119182|NCT02443883|567187885|FG003|Overall Study|Randomized, but never treated|0|||
157119183|NCT02199080|567187886|FG000|Overall Study|Protocol Violation|12|||
157119184|NCT01618214|567187891|FG000|Overall Study|Adverse Event|3|||
157119185|NCT01618214|567187892|FG001|Overall Study|Adverse Event|1|||
157119186|NCT01618214|567187891|FG000|Overall Study|Lack of Efficacy|1|||
157119187|NCT01618214|567187892|FG001|Overall Study|Lack of Efficacy|1|||
157119188|NCT01618214|567187891|FG000|Overall Study|Protocol Violation|1|||
157119189|NCT01618214|567187892|FG001|Overall Study|Protocol Violation|4|||
157119190|NCT01618214|567187891|FG000|Overall Study|Withdrawal Criteria|1|||
157119191|NCT01618214|567187892|FG001|Overall Study|Withdrawal Criteria|2|||
157119192|NCT01618214|567187891|FG000|Overall Study|Unclassified|4|||
157119193|NCT01618214|567187892|FG001|Overall Study|Unclassified|5|||
157119194|NCT02937818|567187893|FG000|Overall Study|Participants decision|2|||
157119195|NCT02937818|567187894|FG001|Overall Study|Participants decision|1|||
157119196|NCT02937818|567187895|FG002|Overall Study|Participants decision|1|||
157119197|NCT02937818|567187896|FG003|Overall Study|Participants decision|1|||
157119198|NCT02937818|567187893|FG000|Overall Study|Adverse Event|2|||
157119199|NCT02937818|567187894|FG001|Overall Study|Adverse Event|4|||
157119200|NCT02937818|567187895|FG002|Overall Study|Adverse Event|1|||
157119201|NCT02937818|567187896|FG003|Overall Study|Adverse Event|1|||
157119202|NCT02937818|567187893|FG000|Overall Study|Disease progression|17|||
157119203|NCT02937818|567187894|FG001|Overall Study|Disease progression|15|||
157119204|NCT02937818|567187895|FG002|Overall Study|Disease progression|7|||
157119205|NCT02937818|567187896|FG003|Overall Study|Disease progression|19|||
157119206|NCT02937818|567187893|FG000|Overall Study|Condition under investigation worsened|0|||
157119207|NCT02937818|567187894|FG001|Overall Study|Condition under investigation worsened|0|||
157119208|NCT02937818|567187895|FG002|Overall Study|Condition under investigation worsened|1|||
157119209|NCT02937818|567187896|FG003|Overall Study|Condition under investigation worsened|0|||
157119210|NCT01508702|567187900|FG000|Overall Study|Adverse Event|7|||
157119211|NCT01508702|567187901|FG001|Overall Study|Adverse Event|3|||
157119212|NCT01508702|567187900|FG000|Overall Study|Gout flare|2|||
157119213|NCT01508702|567187901|FG001|Overall Study|Gout flare|0|||
157119214|NCT01508702|567187900|FG000|Overall Study|Protocol Violation|2|||
157119215|NCT01508702|567187901|FG001|Overall Study|Protocol Violation|1|||
157119216|NCT01508702|567187900|FG000|Overall Study|Lost to Follow-up|1|||
157119217|NCT01508702|567187901|FG001|Overall Study|Lost to Follow-up|2|||
157119218|NCT01508702|567187900|FG000|Overall Study|Withdrawal by Subject|11|||
157119219|NCT01508702|567187901|FG001|Overall Study|Withdrawal by Subject|7|||
157119220|NCT03861559|567187902|FG000|Overall Study|Adverse Event|0|||
157119221|NCT03861559|567187903|FG001|Overall Study|Adverse Event|2|||
157119222|NCT03861559|567187902|FG000|Overall Study|Treatment failure|0|||
157119223|NCT03861559|567187903|FG001|Overall Study|Treatment failure|2|||
157119224|NCT03861559|567187902|FG000|Overall Study|Noncompliance|1|||
157119225|NCT03861559|567187903|FG001|Overall Study|Noncompliance|1|||
157119226|NCT03861559|567187902|FG000|Overall Study|Did not meet eligibility requirements|1|||
157119227|NCT03861559|567187903|FG001|Overall Study|Did not meet eligibility requirements|0|||
157119228|NCT00879697|567187906|FG000|Overall Study|Physician Decision|2|||
157119229|NCT00879697|567187907|FG001|Overall Study|Physician Decision|2|||
157119230|NCT02500121|567187908|FG000|Overall Study|Lost to Follow-up|0|||
157212812|NCT02513459|567527650|FG000|Overall Study|Reproductive plans|1|||
157119231|NCT02500121|567187909|FG001|Overall Study|Lost to Follow-up|1|||
157119232|NCT02500121|567187908|FG000|Overall Study|Withdrawal by Subject|1|||
157119233|NCT02500121|567187909|FG001|Overall Study|Withdrawal by Subject|1|||
157212813|NCT02513459|567527650|FG000|Overall Study|Surgery planned-- not done|1|||
157119234|NCT02500121|567187908|FG000|Overall Study|Death|26|||
157119235|NCT02500121|567187909|FG001|Overall Study|Death|24|||
157119236|NCT02124564|567187914|FG000|Treatment Period|Adverse Event|2|||
157119237|NCT02124564|567187914|FG000|Treatment Period|Lack of Efficacy|3|||
157119238|NCT02124564|567187914|FG000|Treatment Period|Withdrawal by Subject|2|||
157119239|NCT04489888|567187915|FG000|Overall Study|Death|75|||
157119240|NCT04489888|567187915|FG000|Overall Study|Sponsor Decision|26|||
157119241|NCT03368170|567190613|FG000|Overall Study|Adverse Event|2|||
157119242|NCT03368170|567190614|FG001|Overall Study|Adverse Event|1|||
157119243|NCT03047980|567190615|FG000|Overall Study|Adverse Event|1|||
157119244|NCT00328627|567190621|FG000|Overall Study|Hyperglycemic Rescue|41|||
157119245|NCT00328627|567190622|FG001|Overall Study|Hyperglycemic Rescue|18|||
157119246|NCT00328627|567190623|FG002|Overall Study|Hyperglycemic Rescue|16|||
157119247|NCT00328627|567190624|FG003|Overall Study|Hyperglycemic Rescue|13|||
157119248|NCT00328627|567190625|FG004|Overall Study|Hyperglycemic Rescue|6|||
157119249|NCT00328627|567190626|FG005|Overall Study|Hyperglycemic Rescue|5|||
157119250|NCT00328627|567190627|FG006|Overall Study|Hyperglycemic Rescue|19|||
157119251|NCT00328627|567190628|FG007|Overall Study|Hyperglycemic Rescue|6|||
157119252|NCT00328627|567190629|FG008|Overall Study|Hyperglycemic Rescue|6|||
157119253|NCT00328627|567190630|FG009|Overall Study|Hyperglycemic Rescue|11|||
157119254|NCT00328627|567190631|FG010|Overall Study|Hyperglycemic Rescue|3|||
157119255|NCT00328627|567190632|FG011|Overall Study|Hyperglycemic Rescue|2|||
157119256|NCT00328627|567190621|FG000|Overall Study|Adverse Event|3|||
157119257|NCT00328627|567190622|FG001|Overall Study|Adverse Event|1|||
157119258|NCT00328627|567190623|FG002|Overall Study|Adverse Event|2|||
157119259|NCT00328627|567190624|FG003|Overall Study|Adverse Event|3|||
157119260|NCT00328627|567190625|FG004|Overall Study|Adverse Event|1|||
157119261|NCT00328627|567190626|FG005|Overall Study|Adverse Event|2|||
157119262|NCT00328627|567190627|FG006|Overall Study|Adverse Event|1|||
157119263|NCT00328627|567190628|FG007|Overall Study|Adverse Event|2|||
157119264|NCT00328627|567190629|FG008|Overall Study|Adverse Event|0|||
157119265|NCT00328627|567190630|FG009|Overall Study|Adverse Event|7|||
157119266|NCT00328627|567190631|FG010|Overall Study|Adverse Event|5|||
157119267|NCT00328627|567190632|FG011|Overall Study|Adverse Event|4|||
157119268|NCT00328627|567190621|FG000|Overall Study|Protocol Violation|2|||
157119269|NCT00328627|567190622|FG001|Overall Study|Protocol Violation|2|||
157119270|NCT00328627|567190623|FG002|Overall Study|Protocol Violation|2|||
157119271|NCT00328627|567190624|FG003|Overall Study|Protocol Violation|8|||
157119272|NCT00328627|567190625|FG004|Overall Study|Protocol Violation|5|||
157119273|NCT00328627|567190626|FG005|Overall Study|Protocol Violation|5|||
157119274|NCT00328627|567190627|FG006|Overall Study|Protocol Violation|6|||
157212814|NCT00923195|567527651|FG000|Overall Study|Death|0|||
157212815|NCT00923195|567527652|FG001|Overall Study|Death|1|||
157212816|NCT00525031|567527653|FG000|Overall Study|Disease Progression|1|||
157212817|NCT00525031|567527654|FG001|Overall Study|Disease Progression|1|||
157212818|NCT00787566|567527659|FG000|Overall Study|AE related to chemotherapy|0|||
157212819|NCT00787566|567527660|FG001|Overall Study|AE related to chemotherapy|1|||
157212820|NCT00787566|567527661|FG002|Overall Study|AE related to chemotherapy|0|||
157212821|NCT02140164|567527662|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
157212822|NCT00775983|567527663|FG000|Overall Study|Protocol Violation|1|||
157212823|NCT00775983|567527664|FG001|Overall Study|Protocol Violation|2|||
157212824|NCT00660790|567527673|FG000|Baseline to 3 Months|Death|1|||
157212825|NCT00660790|567527673|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
157212826|NCT00660790|567527673|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
156780793|NCT05561140|565948411|FG001|Open Label Treatment Period|Pregnancy|0|||
156780794|NCT05561140|565948410|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
156780795|NCT05561140|565948411|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
157212827|NCT00686374|567527679|FG000|Overall Study|Lack of Efficacy|10|||
157212828|NCT00686374|567527679|FG000|Overall Study|Adverse Event|8|||
157212829|NCT00686374|567527679|FG000|Overall Study|Withdrew consent|5|||
157212830|NCT00686374|567527679|FG000|Overall Study|Lost to Follow-up|1|||
157212831|NCT00686374|567527679|FG000|Overall Study|Missing reason|33|||
157212832|NCT00686374|567527679|FG000|Overall Study|Other, not specified|4|||
157212833|NCT00618774|567527680|FG000|Overall Study|Adverse Event|5|||
157212834|NCT00618774|567527681|FG001|Overall Study|Adverse Event|3|||
157119275|NCT00328627|567190628|FG007|Overall Study|Protocol Violation|2|||
157119276|NCT00328627|567190629|FG008|Overall Study|Protocol Violation|1|||
157119277|NCT00328627|567190630|FG009|Overall Study|Protocol Violation|4|||
157119278|NCT00328627|567190631|FG010|Overall Study|Protocol Violation|6|||
157119279|NCT00328627|567190632|FG011|Overall Study|Protocol Violation|2|||
157119280|NCT00328627|567190621|FG000|Overall Study|Lost to Follow-up|4|||
157119281|NCT00328627|567190622|FG001|Overall Study|Lost to Follow-up|2|||
157212835|NCT00618774|567527680|FG000|Overall Study|Withdrawal by Subject|1|||
156780796|NCT05561140|565948410|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
157119282|NCT00328627|567190623|FG002|Overall Study|Lost to Follow-up|2|||
157119283|NCT00328627|567190624|FG003|Overall Study|Lost to Follow-up|4|||
157119284|NCT00328627|567190625|FG004|Overall Study|Lost to Follow-up|0|||
157119285|NCT00328627|567190626|FG005|Overall Study|Lost to Follow-up|2|||
157119286|NCT00328627|567190627|FG006|Overall Study|Lost to Follow-up|3|||
157119287|NCT00328627|567190628|FG007|Overall Study|Lost to Follow-up|0|||
157119288|NCT00328627|567190629|FG008|Overall Study|Lost to Follow-up|3|||
157119289|NCT00328627|567190630|FG009|Overall Study|Lost to Follow-up|2|||
157212836|NCT00618774|567527681|FG001|Overall Study|Withdrawal by Subject|0|||
157119290|NCT00328627|567190631|FG010|Overall Study|Lost to Follow-up|0|||
157212837|NCT02424565|567527682|FG000|Period 1 (D0)|Protocol Violation|0|||
156780797|NCT05561140|565948411|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
156780798|NCT05561140|565948410|FG000|Open Label Treatment Period|Other|1|||
156780799|NCT05561140|565948411|FG001|Open Label Treatment Period|Other|0|||
156780800|NCT05774977|565948414|FG000|Overall Study|Withdrawal by Subject|2|||
156780801|NCT03301714|565948416|FG000|Overall Study|Lost to Follow-up|10|||
156780802|NCT03301714|565948417|FG001|Overall Study|Lost to Follow-up|4|||
156780803|NCT03301714|565948418|FG002|Overall Study|Lost to Follow-up|4|||
156780804|NCT03301714|565948416|FG000|Overall Study|Did not receive allocated intervention|0|||
156780805|NCT03301714|565948417|FG001|Overall Study|Did not receive allocated intervention|2|||
156780806|NCT03301714|565948418|FG002|Overall Study|Did not receive allocated intervention|3|||
156780807|NCT03349515|565948425|FG000|Overall Study|Lack of Efficacy|2|||
156780808|NCT03349515|565948426|FG001|Overall Study|Lack of Efficacy|0|||
156780809|NCT03349515|565948425|FG000|Overall Study|Physician Decision|3|||
156780810|NCT03349515|565948426|FG001|Overall Study|Physician Decision|1|||
156780811|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
156780812|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
156780813|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
156780814|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Death|1|||
156780815|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Death|0|||
156780816|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Death|0|||
156780817|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
156780818|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
156780819|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
156780820|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
156780821|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
156780822|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
156780823|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
156780824|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
156780825|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
156780826|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
156780827|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
156780828|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
156780829|NCT05073315|565948429|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
156780830|NCT05073315|565948430|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
156780831|NCT05073315|565948431|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
156780832|NCT05073315|565948429|FG000|Period 2|Adverse Event|0|||
156780833|NCT05073315|565948430|FG001|Period 2|Adverse Event|3|||
156780834|NCT05073315|565948431|FG002|Period 2|Adverse Event|6|||
156780835|NCT05073315|565948429|FG000|Period 2|Lost to Follow-up|0|||
156780836|NCT05073315|565948430|FG001|Period 2|Lost to Follow-up|5|||
156780837|NCT05073315|565948431|FG002|Period 2|Lost to Follow-up|5|||
156780838|NCT05073315|565948429|FG000|Period 2|Withdrawal by Subject|0|||
156780839|NCT05073315|565948430|FG001|Period 2|Withdrawal by Subject|4|||
156780840|NCT05073315|565948431|FG002|Period 2|Withdrawal by Subject|9|||
156780841|NCT05073315|565948429|FG000|Period 2|Protocol Violation|0|||
156780842|NCT05073315|565948430|FG001|Period 2|Protocol Violation|0|||
156780843|NCT05073315|565948431|FG002|Period 2|Protocol Violation|1|||
156780844|NCT01529268|565948432|FG000|Overall Study|Lost to Follow-up|9|||
156780845|NCT01529268|565948433|FG001|Overall Study|Lost to Follow-up|3|||
156780846|NCT01529268|565948432|FG000|Overall Study|Moved|3|||
156780847|NCT01529268|565948433|FG001|Overall Study|Moved|0|||
156780848|NCT00303953|565948434|FG000|Overall Study|Ineligible|1|||
156780849|NCT00303953|565948434|FG000|Overall Study|Death|1|||
156780850|NCT00303953|565948434|FG000|Overall Study|Adverse Event|4|||
156780851|NCT00303953|565948434|FG000|Overall Study|Lack of Efficacy|12|||
156780852|NCT00303953|565948434|FG000|Overall Study|Physician Decision|1|||
156780853|NCT04069520|565948435|FG000|Overall Study|Lost to Follow-up|0|||
156780854|NCT04069520|565948436|FG001|Overall Study|Lost to Follow-up|2|||
156780855|NCT04069520|565948435|FG000|Overall Study|Withdrawal by Subject|0|||
156780856|NCT04069520|565948436|FG001|Overall Study|Withdrawal by Subject|1|||
156780857|NCT04069520|565948435|FG000|Overall Study|Prior Injury|1|||
156780858|NCT04069520|565948436|FG001|Overall Study|Prior Injury|0|||
157011596|NCT01985334|566795459|FG005|Overall Study|Administrative problems|1|||
157011597|NCT01985334|566795460|FG006|Overall Study|Administrative problems|1|||
157011598|NCT01985334|566795461|FG007|Overall Study|Administrative problems|3|||
157011599|NCT01985334|566795454|FG000|Overall Study|Death|1|||
157011600|NCT01985334|566795455|FG001|Overall Study|Death|0|||
157011601|NCT01985334|566795456|FG002|Overall Study|Death|0|||
157011602|NCT01985334|566795457|FG003|Overall Study|Death|3|||
157011603|NCT01985334|566795458|FG004|Overall Study|Death|0|||
157011604|NCT01985334|566795459|FG005|Overall Study|Death|0|||
157011605|NCT01985334|566795460|FG006|Overall Study|Death|1|||
157011606|NCT01985334|566795461|FG007|Overall Study|Death|2|||
157011607|NCT01985334|566795454|FG000|Overall Study|Worsening of disease|0|||
157011608|NCT01985334|566795455|FG001|Overall Study|Worsening of disease|0|||
157011609|NCT01985334|566795456|FG002|Overall Study|Worsening of disease|0|||
157011610|NCT01985334|566795457|FG003|Overall Study|Worsening of disease|1|||
157011611|NCT01985334|566795458|FG004|Overall Study|Worsening of disease|0|||
156780859|NCT04069520|565948435|FG000|Overall Study|Orthodontia|1|||
156780860|NCT04069520|565948436|FG001|Overall Study|Orthodontia|0|||
156780861|NCT04069520|565948435|FG000|Overall Study|Cut from team|0|||
156780862|NCT04069520|565948436|FG001|Overall Study|Cut from team|2|||
156780863|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
156780864|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
156780865|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
156780866|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
156780867|NCT00849472|565948437|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
156780868|NCT00849472|565948437|FG000|Weekly Paclitaxel|Disease Progression|1|||
156780869|NCT00849472|565948437|FG000|Weekly Paclitaxel|Adverse Event|11|||
156780870|NCT00849472|565948437|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
156780871|NCT00849472|565948437|FG000|Weekly Paclitaxel|Physician Decision|3|||
156780872|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
156780873|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
156780874|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
156780875|NCT00849472|565948437|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
156780876|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
156780877|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
156780878|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
156780879|NCT00849472|565948437|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
156780880|NCT00825175|565948438|FG000|Overall Study|Withdrawal by Subject|0|||
156780881|NCT00825175|565948439|FG001|Overall Study|Withdrawal by Subject|5|||
156780882|NCT03998462|565948443|FG000|Overall Study|Withdrawal by Subject|10|||
156780883|NCT03998462|565948444|FG001|Overall Study|Withdrawal by Subject|4|||
156780884|NCT03998462|565948443|FG000|Overall Study|Lost to Follow-up|1|||
156780885|NCT03998462|565948444|FG001|Overall Study|Lost to Follow-up|0|||
156780886|NCT03998462|565948443|FG000|Overall Study|Technical Difficulties|1|||
156780887|NCT03998462|565948444|FG001|Overall Study|Technical Difficulties|2|||
157119291|NCT00328627|567190632|FG011|Overall Study|Lost to Follow-up|1|||
156780888|NCT05710224|565948445|FG000|Overall Study|Death|1|||
156780889|NCT05710224|565948446|FG001|Overall Study|Death|0|||
156780890|NCT05710224|565948445|FG000|Overall Study|Lost to Follow-up|16|||
156780891|NCT05710224|565948446|FG001|Overall Study|Lost to Follow-up|7|||
156780892|NCT05710224|565948445|FG000|Overall Study|Withdrawal by Subject|4|||
156780893|NCT05710224|565948446|FG001|Overall Study|Withdrawal by Subject|6|||
156780894|NCT05710224|565948445|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156780895|NCT05710224|565948446|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156780896|NCT05710224|565948445|FG000|Overall Study|Participants Left The City|0|||
156780897|NCT05710224|565948446|FG001|Overall Study|Participants Left The City|2|||
156780898|NCT03369223|565948449|FG000|Overall Study|Lost to Follow-up|0|||
156780899|NCT03369223|565948450|FG001|Overall Study|Lost to Follow-up|0|||
156780900|NCT03369223|565948451|FG002|Overall Study|Lost to Follow-up|0|||
156780901|NCT03369223|565948452|FG003|Overall Study|Lost to Follow-up|0|||
156780902|NCT03369223|565948453|FG004|Overall Study|Lost to Follow-up|0|||
156780903|NCT03369223|565948454|FG005|Overall Study|Lost to Follow-up|0|||
156780904|NCT03369223|565948455|FG006|Overall Study|Lost to Follow-up|0|||
157119292|NCT00328627|567190621|FG000|Overall Study|Withdrawal by Subject|5|||
157119293|NCT00328627|567190622|FG001|Overall Study|Withdrawal by Subject|4|||
157119294|NCT00328627|567190623|FG002|Overall Study|Withdrawal by Subject|5|||
157119295|NCT00328627|567190624|FG003|Overall Study|Withdrawal by Subject|6|||
157119296|NCT00328627|567190625|FG004|Overall Study|Withdrawal by Subject|2|||
157119297|NCT00328627|567190626|FG005|Overall Study|Withdrawal by Subject|5|||
157119298|NCT00328627|567190627|FG006|Overall Study|Withdrawal by Subject|4|||
157119299|NCT00328627|567190628|FG007|Overall Study|Withdrawal by Subject|4|||
156780905|NCT03369223|565948456|FG007|Overall Study|Lost to Follow-up|0|||
156780906|NCT03369223|565948457|FG008|Overall Study|Lost to Follow-up|0|||
156780907|NCT03369223|565948458|FG009|Overall Study|Lost to Follow-up|0|||
156780908|NCT03369223|565948459|FG010|Overall Study|Lost to Follow-up|0|||
156780909|NCT03369223|565948460|FG011|Overall Study|Lost to Follow-up|0|||
156780910|NCT03369223|565948461|FG012|Overall Study|Lost to Follow-up|0|||
156780911|NCT03369223|565948462|FG013|Overall Study|Lost to Follow-up|0|||
156780912|NCT03369223|565948463|FG014|Overall Study|Lost to Follow-up|0|||
156780913|NCT03369223|565948464|FG015|Overall Study|Lost to Follow-up|0|||
156780914|NCT03369223|565948465|FG016|Overall Study|Lost to Follow-up|0|||
156780915|NCT03369223|565948466|FG017|Overall Study|Lost to Follow-up|0|||
156780916|NCT03369223|565948467|FG018|Overall Study|Lost to Follow-up|2|||
156780917|NCT03369223|565948468|FG019|Overall Study|Lost to Follow-up|1|||
156780918|NCT03369223|565948449|FG000|Overall Study|Participant no longer meets study criteria|0|||
156780919|NCT03369223|565948450|FG001|Overall Study|Participant no longer meets study criteria|0|||
156780920|NCT03369223|565948451|FG002|Overall Study|Participant no longer meets study criteria|0|||
156780921|NCT03369223|565948452|FG003|Overall Study|Participant no longer meets study criteria|0|||
156780922|NCT03369223|565948453|FG004|Overall Study|Participant no longer meets study criteria|0|||
156780923|NCT03369223|565948454|FG005|Overall Study|Participant no longer meets study criteria|0|||
156780924|NCT03369223|565948455|FG006|Overall Study|Participant no longer meets study criteria|0|||
156780925|NCT03369223|565948456|FG007|Overall Study|Participant no longer meets study criteria|0|||
156780926|NCT03369223|565948457|FG008|Overall Study|Participant no longer meets study criteria|0|||
156780927|NCT03369223|565948458|FG009|Overall Study|Participant no longer meets study criteria|0|||
156780928|NCT03369223|565948459|FG010|Overall Study|Participant no longer meets study criteria|0|||
156780929|NCT03369223|565948460|FG011|Overall Study|Participant no longer meets study criteria|0|||
156780930|NCT03369223|565948461|FG012|Overall Study|Participant no longer meets study criteria|0|||
156780931|NCT03369223|565948462|FG013|Overall Study|Participant no longer meets study criteria|0|||
156780932|NCT03369223|565948463|FG014|Overall Study|Participant no longer meets study criteria|2|||
156780933|NCT03369223|565948464|FG015|Overall Study|Participant no longer meets study criteria|0|||
156780934|NCT03369223|565948465|FG016|Overall Study|Participant no longer meets study criteria|2|||
156780935|NCT03369223|565948466|FG017|Overall Study|Participant no longer meets study criteria|0|||
156780936|NCT03369223|565948467|FG018|Overall Study|Participant no longer meets study criteria|0|||
156780937|NCT03369223|565948468|FG019|Overall Study|Participant no longer meets study criteria|0|||
156780938|NCT03369223|565948449|FG000|Overall Study|Other reasons|0|||
156780939|NCT03369223|565948450|FG001|Overall Study|Other reasons|0|||
156780940|NCT03369223|565948451|FG002|Overall Study|Other reasons|0|||
156780941|NCT03369223|565948452|FG003|Overall Study|Other reasons|0|||
156780942|NCT03369223|565948453|FG004|Overall Study|Other reasons|0|||
156780943|NCT03369223|565948454|FG005|Overall Study|Other reasons|0|||
156780944|NCT03369223|565948455|FG006|Overall Study|Other reasons|0|||
156780945|NCT03369223|565948456|FG007|Overall Study|Other reasons|0|||
156780946|NCT03369223|565948457|FG008|Overall Study|Other reasons|0|||
156780947|NCT03369223|565948458|FG009|Overall Study|Other reasons|0|||
156780948|NCT03369223|565948459|FG010|Overall Study|Other reasons|0|||
156780949|NCT03369223|565948460|FG011|Overall Study|Other reasons|0|||
156780950|NCT03369223|565948461|FG012|Overall Study|Other reasons|0|||
156780951|NCT03369223|565948462|FG013|Overall Study|Other reasons|1|||
156780952|NCT03369223|565948463|FG014|Overall Study|Other reasons|2|||
156780953|NCT03369223|565948464|FG015|Overall Study|Other reasons|0|||
156780954|NCT03369223|565948465|FG016|Overall Study|Other reasons|1|||
156780955|NCT03369223|565948466|FG017|Overall Study|Other reasons|0|||
156780956|NCT03369223|565948467|FG018|Overall Study|Other reasons|0|||
156780957|NCT03369223|565948468|FG019|Overall Study|Other reasons|2|||
156780958|NCT03369223|565948449|FG000|Overall Study|Death|0|||
156780959|NCT03369223|565948450|FG001|Overall Study|Death|0|||
156780960|NCT03369223|565948451|FG002|Overall Study|Death|0|||
156780961|NCT03369223|565948452|FG003|Overall Study|Death|0|||
156780962|NCT03369223|565948453|FG004|Overall Study|Death|0|||
156780963|NCT03369223|565948454|FG005|Overall Study|Death|0|||
156780964|NCT03369223|565948455|FG006|Overall Study|Death|0|||
156780965|NCT03369223|565948456|FG007|Overall Study|Death|0|||
156780966|NCT03369223|565948457|FG008|Overall Study|Death|0|||
156780967|NCT03369223|565948458|FG009|Overall Study|Death|0|||
156780968|NCT03369223|565948459|FG010|Overall Study|Death|0|||
156780969|NCT03369223|565948460|FG011|Overall Study|Death|0|||
156780970|NCT03369223|565948461|FG012|Overall Study|Death|0|||
156780971|NCT03369223|565948462|FG013|Overall Study|Death|1|||
156780972|NCT03369223|565948463|FG014|Overall Study|Death|0|||
156780973|NCT03369223|565948464|FG015|Overall Study|Death|0|||
156780974|NCT03369223|565948465|FG016|Overall Study|Death|0|||
156780975|NCT03369223|565948466|FG017|Overall Study|Death|0|||
156780976|NCT03369223|565948467|FG018|Overall Study|Death|1|||
156780977|NCT03369223|565948468|FG019|Overall Study|Death|0|||
156780978|NCT03369223|565948449|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156780979|NCT03369223|565948450|FG001|Overall Study|Adverse event unrelated to study drug|0|||
156780980|NCT03369223|565948451|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156780981|NCT03369223|565948452|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156780982|NCT03369223|565948453|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156780983|NCT03369223|565948454|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156780984|NCT03369223|565948455|FG006|Overall Study|Adverse event unrelated to study drug|1|||
156780985|NCT03369223|565948456|FG007|Overall Study|Adverse event unrelated to study drug|0|||
156780986|NCT03369223|565948457|FG008|Overall Study|Adverse event unrelated to study drug|0|||
156780987|NCT03369223|565948458|FG009|Overall Study|Adverse event unrelated to study drug|1|||
156780988|NCT03369223|565948459|FG010|Overall Study|Adverse event unrelated to study drug|0|||
156780989|NCT03369223|565948460|FG011|Overall Study|Adverse event unrelated to study drug|0|||
156780990|NCT03369223|565948461|FG012|Overall Study|Adverse event unrelated to study drug|0|||
156780991|NCT03369223|565948462|FG013|Overall Study|Adverse event unrelated to study drug|4|||
156780992|NCT03369223|565948463|FG014|Overall Study|Adverse event unrelated to study drug|2|||
156780993|NCT03369223|565948464|FG015|Overall Study|Adverse event unrelated to study drug|0|||
156780994|NCT03369223|565948465|FG016|Overall Study|Adverse event unrelated to study drug|2|||
156780995|NCT03369223|565948466|FG017|Overall Study|Adverse event unrelated to study drug|1|||
156780996|NCT03369223|565948467|FG018|Overall Study|Adverse event unrelated to study drug|3|||
156780997|NCT03369223|565948468|FG019|Overall Study|Adverse event unrelated to study drug|2|||
156780998|NCT03369223|565948449|FG000|Overall Study|Disease progression|6|||
156780999|NCT03369223|565948450|FG001|Overall Study|Disease progression|8|||
156781000|NCT03369223|565948451|FG002|Overall Study|Disease progression|5|||
156781001|NCT03369223|565948452|FG003|Overall Study|Disease progression|1|||
156781002|NCT03369223|565948453|FG004|Overall Study|Disease progression|9|||
156781003|NCT03369223|565948454|FG005|Overall Study|Disease progression|9|||
156781004|NCT03369223|565948455|FG006|Overall Study|Disease progression|4|||
156781005|NCT03369223|565948456|FG007|Overall Study|Disease progression|6|||
156781006|NCT03369223|565948457|FG008|Overall Study|Disease progression|10|||
156781007|NCT03369223|565948458|FG009|Overall Study|Disease progression|7|||
156781008|NCT03369223|565948459|FG010|Overall Study|Disease progression|4|||
156781009|NCT03369223|565948460|FG011|Overall Study|Disease progression|1|||
156781010|NCT03369223|565948461|FG012|Overall Study|Disease progression|1|||
156781011|NCT03369223|565948462|FG013|Overall Study|Disease progression|25|||
156781012|NCT03369223|565948463|FG014|Overall Study|Disease progression|22|||
156781013|NCT03369223|565948464|FG015|Overall Study|Disease progression|2|||
156781014|NCT03369223|565948465|FG016|Overall Study|Disease progression|10|||
156781015|NCT03369223|565948466|FG017|Overall Study|Disease progression|1|||
156781016|NCT03369223|565948467|FG018|Overall Study|Disease progression|18|||
156781017|NCT03369223|565948468|FG019|Overall Study|Disease progression|28|||
156781018|NCT03369223|565948449|FG000|Overall Study|Study drug toxicity|0|||
156781019|NCT03369223|565948450|FG001|Overall Study|Study drug toxicity|1|||
156781020|NCT03369223|565948451|FG002|Overall Study|Study drug toxicity|4|||
156781021|NCT03369223|565948452|FG003|Overall Study|Study drug toxicity|0|||
156781022|NCT03369223|565948453|FG004|Overall Study|Study drug toxicity|1|||
156781023|NCT03369223|565948454|FG005|Overall Study|Study drug toxicity|2|||
156781024|NCT03369223|565948455|FG006|Overall Study|Study drug toxicity|4|||
156781025|NCT03369223|565948456|FG007|Overall Study|Study drug toxicity|2|||
156781026|NCT03369223|565948457|FG008|Overall Study|Study drug toxicity|2|||
156781027|NCT03369223|565948458|FG009|Overall Study|Study drug toxicity|0|||
156781028|NCT03369223|565948459|FG010|Overall Study|Study drug toxicity|6|||
156781029|NCT03369223|565948460|FG011|Overall Study|Study drug toxicity|1|||
156781030|NCT03369223|565948461|FG012|Overall Study|Study drug toxicity|2|||
156781031|NCT03369223|565948462|FG013|Overall Study|Study drug toxicity|19|||
156781032|NCT03369223|565948463|FG014|Overall Study|Study drug toxicity|19|||
156781033|NCT03369223|565948464|FG015|Overall Study|Study drug toxicity|0|||
156781034|NCT03369223|565948465|FG016|Overall Study|Study drug toxicity|18|||
156781035|NCT03369223|565948466|FG017|Overall Study|Study drug toxicity|3|||
156781036|NCT03369223|565948467|FG018|Overall Study|Study drug toxicity|11|||
157212838|NCT02424565|567527683|FG001|Period 1 (D0)|Protocol Violation|1|||
157212839|NCT01427920|567527691|FG000|Overall Study|Adverse Event|1|||
156781037|NCT03369223|565948468|FG019|Overall Study|Study drug toxicity|7|||
156781038|NCT03369223|565948449|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156781039|NCT03369223|565948450|FG001|Overall Study|Participant request to discontinue study treatment|1|||
156781040|NCT03369223|565948451|FG002|Overall Study|Participant request to discontinue study treatment|0|||
157212840|NCT01427920|567527692|FG001|Overall Study|Adverse Event|2|||
157212841|NCT01427920|567527691|FG000|Overall Study|Lack of Efficacy|1|||
156781041|NCT03369223|565948452|FG003|Overall Study|Participant request to discontinue study treatment|0|||
157119300|NCT00328627|567190629|FG008|Overall Study|Withdrawal by Subject|4|||
157119301|NCT00328627|567190630|FG009|Overall Study|Withdrawal by Subject|5|||
157119302|NCT00328627|567190631|FG010|Overall Study|Withdrawal by Subject|2|||
157119303|NCT00328627|567190632|FG011|Overall Study|Withdrawal by Subject|7|||
156781042|NCT03369223|565948453|FG004|Overall Study|Participant request to discontinue study treatment|1|||
156781043|NCT03369223|565948454|FG005|Overall Study|Participant request to discontinue study treatment|1|||
156781044|NCT03369223|565948455|FG006|Overall Study|Participant request to discontinue study treatment|1|||
156781045|NCT03369223|565948456|FG007|Overall Study|Participant request to discontinue study treatment|0|||
156781046|NCT03369223|565948457|FG008|Overall Study|Participant request to discontinue study treatment|0|||
156781047|NCT03369223|565948458|FG009|Overall Study|Participant request to discontinue study treatment|0|||
156781048|NCT03369223|565948459|FG010|Overall Study|Participant request to discontinue study treatment|0|||
156781049|NCT03369223|565948460|FG011|Overall Study|Participant request to discontinue study treatment|0|||
156781050|NCT03369223|565948461|FG012|Overall Study|Participant request to discontinue study treatment|0|||
156781051|NCT03369223|565948462|FG013|Overall Study|Participant request to discontinue study treatment|1|||
157119304|NCT00328627|567190621|FG000|Overall Study|Pregnancy|0|||
157119305|NCT00328627|567190622|FG001|Overall Study|Pregnancy|1|||
157119306|NCT00328627|567190623|FG002|Overall Study|Pregnancy|0|||
157119307|NCT00328627|567190624|FG003|Overall Study|Pregnancy|0|||
157119308|NCT00328627|567190625|FG004|Overall Study|Pregnancy|0|||
157119309|NCT00328627|567190626|FG005|Overall Study|Pregnancy|0|||
157119310|NCT00328627|567190627|FG006|Overall Study|Pregnancy|0|||
157119311|NCT00328627|567190628|FG007|Overall Study|Pregnancy|0|||
157119312|NCT00328627|567190629|FG008|Overall Study|Pregnancy|0|||
157212842|NCT01427920|567527692|FG001|Overall Study|Lack of Efficacy|0|||
157212843|NCT01427920|567527691|FG000|Overall Study|Protocol Violation|1|||
157212844|NCT01427920|567527692|FG001|Overall Study|Protocol Violation|3|||
157212845|NCT01427920|567527691|FG000|Overall Study|Withdrawal Criteria|4|||
157212846|NCT01427920|567527692|FG001|Overall Study|Withdrawal Criteria|4|||
157212847|NCT01427920|567527691|FG000|Overall Study|Unclassified|2|||
157212848|NCT01427920|567527692|FG001|Overall Study|Unclassified|8|||
157212849|NCT04228302|567527693|FG000|Overall Study|Adverse Event|0|||
157212850|NCT04228302|567527694|FG001|Overall Study|Adverse Event|0|||
157212851|NCT04228302|567527695|FG002|Overall Study|Adverse Event|0|||
157212852|NCT04228302|567527696|FG003|Overall Study|Adverse Event|0|||
157212853|NCT04228302|567527697|FG004|Overall Study|Adverse Event|1|||
157212854|NCT04228302|567527698|FG005|Overall Study|Adverse Event|0|||
157212855|NCT03066440|567527701|FG000|Overall Study|Physician Decision|1|||
157119313|NCT00328627|567190630|FG009|Overall Study|Pregnancy|0|||
157119314|NCT00328627|567190631|FG010|Overall Study|Pregnancy|0|||
157119315|NCT00328627|567190632|FG011|Overall Study|Pregnancy|0|||
157119316|NCT00328627|567190621|FG000|Overall Study|Physician Decision|4|||
157119317|NCT00328627|567190622|FG001|Overall Study|Physician Decision|3|||
157119318|NCT00328627|567190623|FG002|Overall Study|Physician Decision|1|||
157119319|NCT00328627|567190624|FG003|Overall Study|Physician Decision|2|||
157119320|NCT00328627|567190625|FG004|Overall Study|Physician Decision|1|||
157119321|NCT00328627|567190626|FG005|Overall Study|Physician Decision|1|||
157119322|NCT00328627|567190627|FG006|Overall Study|Physician Decision|1|||
157119323|NCT00328627|567190628|FG007|Overall Study|Physician Decision|0|||
157119324|NCT00328627|567190629|FG008|Overall Study|Physician Decision|3|||
157119325|NCT00328627|567190630|FG009|Overall Study|Physician Decision|2|||
157119326|NCT00328627|567190631|FG010|Overall Study|Physician Decision|1|||
157119327|NCT00328627|567190632|FG011|Overall Study|Physician Decision|0|||
157119328|NCT00328627|567190621|FG000|Overall Study|Other|0|||
157119329|NCT00328627|567190622|FG001|Overall Study|Other|0|||
157119330|NCT00328627|567190623|FG002|Overall Study|Other|0|||
157119331|NCT00328627|567190624|FG003|Overall Study|Other|1|||
157119332|NCT00328627|567190625|FG004|Overall Study|Other|0|||
157119333|NCT00328627|567190626|FG005|Overall Study|Other|0|||
157119334|NCT00328627|567190627|FG006|Overall Study|Other|1|||
157119335|NCT00328627|567190628|FG007|Overall Study|Other|0|||
157212856|NCT03066440|567527702|FG001|Overall Study|Physician Decision|1|||
157212857|NCT03066440|567527701|FG000|Overall Study|Protocol Violation|0|||
157212858|NCT03066440|567527702|FG001|Overall Study|Protocol Violation|2|||
157212859|NCT00736333|567527703|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
156781052|NCT03369223|565948463|FG014|Overall Study|Participant request to discontinue study treatment|1|||
156781053|NCT03369223|565948464|FG015|Overall Study|Participant request to discontinue study treatment|0|||
156781054|NCT03369223|565948465|FG016|Overall Study|Participant request to discontinue study treatment|0|||
156781055|NCT03369223|565948466|FG017|Overall Study|Participant request to discontinue study treatment|0|||
156781056|NCT03369223|565948467|FG018|Overall Study|Participant request to discontinue study treatment|1|||
156781057|NCT03369223|565948468|FG019|Overall Study|Participant request to discontinue study treatment|0|||
156781058|NCT03369223|565948449|FG000|Overall Study|Participant withdrew consent|0|||
156781059|NCT03369223|565948450|FG001|Overall Study|Participant withdrew consent|1|||
156781060|NCT03369223|565948451|FG002|Overall Study|Participant withdrew consent|1|||
156781061|NCT03369223|565948452|FG003|Overall Study|Participant withdrew consent|0|||
156781062|NCT03369223|565948453|FG004|Overall Study|Participant withdrew consent|0|||
156781063|NCT03369223|565948454|FG005|Overall Study|Participant withdrew consent|0|||
156781064|NCT03369223|565948455|FG006|Overall Study|Participant withdrew consent|1|||
156781065|NCT03369223|565948456|FG007|Overall Study|Participant withdrew consent|1|||
156781066|NCT03369223|565948457|FG008|Overall Study|Participant withdrew consent|1|||
156781067|NCT03369223|565948458|FG009|Overall Study|Participant withdrew consent|0|||
156781068|NCT03369223|565948459|FG010|Overall Study|Participant withdrew consent|0|||
156781069|NCT03369223|565948460|FG011|Overall Study|Participant withdrew consent|1|||
156781070|NCT03369223|565948461|FG012|Overall Study|Participant withdrew consent|0|||
156781071|NCT03369223|565948462|FG013|Overall Study|Participant withdrew consent|0|||
156781072|NCT03369223|565948463|FG014|Overall Study|Participant withdrew consent|3|||
156781073|NCT03369223|565948464|FG015|Overall Study|Participant withdrew consent|0|||
156781074|NCT03369223|565948465|FG016|Overall Study|Participant withdrew consent|1|||
156781075|NCT03369223|565948466|FG017|Overall Study|Participant withdrew consent|0|||
156781076|NCT03369223|565948467|FG018|Overall Study|Participant withdrew consent|4|||
156781077|NCT03369223|565948468|FG019|Overall Study|Participant withdrew consent|2|||
157119336|NCT00328627|567190629|FG008|Overall Study|Other|0|||
157119337|NCT00328627|567190630|FG009|Overall Study|Other|1|||
157119338|NCT00328627|567190631|FG010|Overall Study|Other|1|||
157119339|NCT00328627|567190632|FG011|Overall Study|Other|0|||
156781078|NCT03369223|565948449|FG000|Overall Study|Randomized but not treated|0|||
156781079|NCT03369223|565948450|FG001|Overall Study|Randomized but not treated|0|||
156781080|NCT03369223|565948451|FG002|Overall Study|Randomized but not treated|0|||
156781081|NCT03369223|565948452|FG003|Overall Study|Randomized but not treated|0|||
156781082|NCT03369223|565948453|FG004|Overall Study|Randomized but not treated|0|||
156781083|NCT03369223|565948454|FG005|Overall Study|Randomized but not treated|0|||
156781084|NCT03369223|565948455|FG006|Overall Study|Randomized but not treated|0|||
156781085|NCT03369223|565948456|FG007|Overall Study|Randomized but not treated|0|||
156781086|NCT03369223|565948457|FG008|Overall Study|Randomized but not treated|0|||
156781087|NCT03369223|565948458|FG009|Overall Study|Randomized but not treated|0|||
156781088|NCT03369223|565948459|FG010|Overall Study|Randomized but not treated|0|||
156781089|NCT03369223|565948460|FG011|Overall Study|Randomized but not treated|0|||
156781090|NCT03369223|565948461|FG012|Overall Study|Randomized but not treated|0|||
156781091|NCT03369223|565948462|FG013|Overall Study|Randomized but not treated|1|||
156781092|NCT03369223|565948463|FG014|Overall Study|Randomized but not treated|1|||
156781093|NCT03369223|565948464|FG015|Overall Study|Randomized but not treated|0|||
157119340|NCT02049944|567190633|FG000|Overall Study|Protocol Violation|2|||
157119341|NCT01765673|567190634|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
157119342|NCT02600507|567190635|FG000|Overall Study|Adverse Event|3|||
157119343|NCT02600507|567190636|FG001|Overall Study|Adverse Event|15|||
157119344|NCT02600507|567190637|FG002|Overall Study|Adverse Event|5|||
157119345|NCT02600507|567190635|FG000|Overall Study|Lack of Efficacy|3|||
157119346|NCT02600507|567190636|FG001|Overall Study|Lack of Efficacy|8|||
157119347|NCT02600507|567190637|FG002|Overall Study|Lack of Efficacy|5|||
157119348|NCT02600507|567190635|FG000|Overall Study|Lost to Follow-up|3|||
157119349|NCT02600507|567190636|FG001|Overall Study|Lost to Follow-up|5|||
157119350|NCT02600507|567190637|FG002|Overall Study|Lost to Follow-up|2|||
157119351|NCT02600507|567190635|FG000|Overall Study|Protocol Violation|12|||
157119352|NCT02600507|567190636|FG001|Overall Study|Protocol Violation|4|||
157119353|NCT02600507|567190637|FG002|Overall Study|Protocol Violation|4|||
157119354|NCT02600507|567190635|FG000|Overall Study|Physician Decision|1|||
157119355|NCT02600507|567190636|FG001|Overall Study|Physician Decision|0|||
156781094|NCT03369223|565948465|FG016|Overall Study|Randomized but not treated|0|||
156781095|NCT03369223|565948466|FG017|Overall Study|Randomized but not treated|0|||
156781096|NCT03369223|565948467|FG018|Overall Study|Randomized but not treated|0|||
156781097|NCT03369223|565948468|FG019|Overall Study|Randomized but not treated|0|||
156781098|NCT04615507|565948470|FG000|Period 1|Covid-19 exposure|2|||
157119356|NCT02600507|567190637|FG002|Overall Study|Physician Decision|1|||
157119357|NCT02600507|567190635|FG000|Overall Study|Withdrawal by Subject|7|||
157119358|NCT02600507|567190636|FG001|Overall Study|Withdrawal by Subject|11|||
156781099|NCT04615507|565948471|FG001|Period 1|Covid-19 exposure|1|||
156781100|NCT04615507|565948470|FG000|Period 2|Covid-19 exposure|0|||
156781101|NCT04615507|565948471|FG001|Period 2|Covid-19 exposure|1|||
156781102|NCT04615507|565948470|FG000|Period 2|Protocol Violation|1|||
156781103|NCT04615507|565948471|FG001|Period 2|Protocol Violation|0|||
156781104|NCT04615507|565948470|FG000|Period 2|Withdrawal by Subject|1|||
156781105|NCT04615507|565948471|FG001|Period 2|Withdrawal by Subject|0|||
156781106|NCT04615507|565948470|FG000|Period 2|Adverse Event|0|||
156781107|NCT04615507|565948471|FG001|Period 2|Adverse Event|1|||
156781108|NCT04615507|565948470|FG000|Period 3|Covid-19 exposure|0|||
156781109|NCT04615507|565948471|FG001|Period 3|Covid-19 exposure|1|||
156781110|NCT03976375|565948474|FG000|Overall Study|Death|158|||
156781111|NCT03976375|565948475|FG001|Overall Study|Death|160|||
156781112|NCT03976375|565948476|FG002|Overall Study|Death|42|||
156781113|NCT03976375|565948474|FG000|Overall Study|Lost to Follow-up|2|||
156781114|NCT03976375|565948475|FG001|Overall Study|Lost to Follow-up|1|||
156781115|NCT03976375|565948476|FG002|Overall Study|Lost to Follow-up|1|||
156781116|NCT03976375|565948474|FG000|Overall Study|Withdrawal by Subject|5|||
156781117|NCT03976375|565948475|FG001|Overall Study|Withdrawal by Subject|9|||
156781118|NCT03976375|565948476|FG002|Overall Study|Withdrawal by Subject|4|||
156781119|NCT03976375|565948474|FG000|Overall Study|Sponsor decision|20|||
156781120|NCT03976375|565948475|FG001|Overall Study|Sponsor decision|19|||
156781121|NCT03976375|565948476|FG002|Overall Study|Sponsor decision|1|||
156781122|NCT03091439|565948477|FG000|Overall Study|Study Terminated by the Sponsor|1|||
156781123|NCT03091439|565948478|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156781124|NCT03122106|565948479|FG000|Overall Study|Not enough tissue|1|||
156781125|NCT03122106|565948479|FG000|Overall Study|Disease progression during screening|2|||
156781126|NCT03122106|565948479|FG000|Overall Study|Poor RNA quality for vaccine|1|||
156781127|NCT02347787|565948480|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
156781128|NCT02347787|565948481|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
156781129|NCT02347787|565948480|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
156781130|NCT02347787|565948481|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
156781131|NCT02347787|565948480|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
156781132|NCT02347787|565948481|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
156781133|NCT02347787|565948480|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
156781134|NCT02347787|565948481|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
156781135|NCT00308685|565948482|FG000|Overall Study|Lost to Follow-up|1|||
156781136|NCT00308685|565948483|FG001|Overall Study|Lost to Follow-up|0|||
156781137|NCT00308685|565948482|FG000|Overall Study|Need to administer prohibited medication|1|||
156781138|NCT00308685|565948483|FG001|Overall Study|Need to administer prohibited medication|2|||
156781139|NCT00308685|565948482|FG000|Overall Study|Other than specified|1|||
156781140|NCT00308685|565948483|FG001|Overall Study|Other than specified|3|||
156781141|NCT03244189|565948484|FG000|Overall Study|Death|0|||
156781142|NCT03244189|565948485|FG001|Overall Study|Death|2|||
156781143|NCT03244189|565948484|FG000|Overall Study|Lost to Follow-up|92|||
156781144|NCT03244189|565948485|FG001|Overall Study|Lost to Follow-up|107|||
156781145|NCT03244189|565948484|FG000|Overall Study|Physician Decision|4|||
156781146|NCT03244189|565948485|FG001|Overall Study|Physician Decision|2|||
156781147|NCT03244189|565948484|FG000|Overall Study|Pregnancy|7|||
156781148|NCT03244189|565948485|FG001|Overall Study|Pregnancy|5|||
156781149|NCT03244189|565948484|FG000|Overall Study|Protocol Violation|0|||
156781150|NCT03244189|565948485|FG001|Overall Study|Protocol Violation|2|||
156781151|NCT03244189|565948484|FG000|Overall Study|Withdrawal by Subject|45|||
156781152|NCT03244189|565948485|FG001|Overall Study|Withdrawal by Subject|23|||
156781153|NCT03244189|565948484|FG000|Overall Study|Technical Problems|2|||
156781154|NCT03244189|565948485|FG001|Overall Study|Technical Problems|0|||
156781155|NCT03599713|565948486|FG000|Overall Study|Death|38|||
156781156|NCT03599713|565948487|FG001|Overall Study|Death|3|||
156781157|NCT03599713|565948486|FG000|Overall Study|Withdrawal by Subject|17|||
156781158|NCT03599713|565948487|FG001|Overall Study|Withdrawal by Subject|0|||
156781159|NCT03599713|565948486|FG000|Overall Study|Lost to Follow-up|4|||
156781160|NCT03599713|565948487|FG001|Overall Study|Lost to Follow-up|0|||
156781161|NCT03599713|565948486|FG000|Overall Study|Discontinued Due to End of Study|42|||
156781162|NCT03599713|565948487|FG001|Overall Study|Discontinued Due to End of Study|3|||
156781163|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781164|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781165|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781166|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
156781167|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781168|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781169|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781170|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
156781171|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781172|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781173|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
156781174|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
156781175|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781176|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781177|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781178|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
156781179|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781180|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781181|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
156781182|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781183|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781184|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781185|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781186|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
156781187|NCT02850406|565948490|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
156781188|NCT02850406|565948491|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
156781189|NCT02850406|565948492|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
156781190|NCT02850406|565948493|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
156781191|NCT02850406|565948494|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
156781192|NCT02850406|565948495|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
156781193|NCT02850406|565948496|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
156781194|NCT02850406|565948497|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
156781195|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781196|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781197|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781198|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781199|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
156781200|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
156781201|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781202|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
156781203|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781204|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781205|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781206|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781207|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
156781208|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
156781209|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781210|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781211|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781212|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781213|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781214|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781215|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
157119359|NCT02600507|567190637|FG002|Overall Study|Withdrawal by Subject|7|||
157119360|NCT02600507|567190635|FG000|Overall Study|Other|0|||
156781216|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781217|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781218|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
156781219|NCT02850406|565948490|FG000|Part C (Up to 52 Weeks)|Other|0|||
156781220|NCT02850406|565948491|FG001|Part C (Up to 52 Weeks)|Other|0|||
156781221|NCT02850406|565948492|FG002|Part C (Up to 52 Weeks)|Other|0|||
156781222|NCT02850406|565948493|FG003|Part C (Up to 52 Weeks)|Other|0|||
156781223|NCT02850406|565948494|FG004|Part C (Up to 52 Weeks)|Other|1|||
156781224|NCT02850406|565948495|FG005|Part C (Up to 52 Weeks)|Other|3|||
156781225|NCT02850406|565948496|FG006|Part C (Up to 52 Weeks)|Other|0|||
157119361|NCT02600507|567190636|FG001|Overall Study|Other|1|||
157119362|NCT02600507|567190637|FG002|Overall Study|Other|1|||
157119363|NCT00605085|567190640|FG000|Overall Study|Withdrawal by Subject|8|||
157119364|NCT00605085|567190641|FG001|Overall Study|Withdrawal by Subject|5|||
157119365|NCT00605085|567190640|FG000|Overall Study|Adverse Event|9|||
157119366|NCT00605085|567190641|FG001|Overall Study|Adverse Event|5|||
157119367|NCT00605085|567190640|FG000|Overall Study|Pregnancy|2|||
157119368|NCT00605085|567190641|FG001|Overall Study|Pregnancy|0|||
157119369|NCT00605085|567190640|FG000|Overall Study|Protocol Violation|3|||
157119370|NCT00605085|567190641|FG001|Overall Study|Protocol Violation|2|||
157119371|NCT00605085|567190640|FG000|Overall Study|Lost to Follow-up|10|||
157119372|NCT00605085|567190641|FG001|Overall Study|Lost to Follow-up|5|||
157119373|NCT00605085|567190640|FG000|Overall Study|administrative reasons|18|||
157119374|NCT00605085|567190641|FG001|Overall Study|administrative reasons|8|||
157119375|NCT02229552|567190644|FG000|Baseline|Withdrawal by Subject|6|||
156781226|NCT02850406|565948497|FG007|Part C (Up to 52 Weeks)|Other|0|||
156781227|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781228|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781229|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
157119376|NCT02229552|567190644|FG000|1-year Follow up|Withdrawal by Subject|7|||
157212860|NCT00736333|567527703|FG000|Overall Study|Data Missing|2|||
157212861|NCT00736333|567527703|FG000|Overall Study|Tumor Progression|75|||
157212862|NCT00736333|567527703|FG000|Overall Study|Toxicity|6|||
157212863|NCT00736333|567527703|FG000|Overall Study|Withdrawal by Subject|10|||
157119377|NCT02229552|567190644|FG000|1-year Follow up|Lost to Follow-up|18|||
157119378|NCT02229552|567190644|FG000|2-Year Follow up|Withdrawal by Subject|9|||
157119379|NCT02229552|567190644|FG000|2-Year Follow up|Lost to Follow-up|17|||
157119380|NCT00879229|567190645|FG000|Overall Study|Study terminated by Sponsor|13|||
157119381|NCT00879229|567190646|FG001|Overall Study|Study terminated by Sponsor|12|||
156781230|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781231|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781232|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781233|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
156781234|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
156781235|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781236|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781237|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781238|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781239|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781240|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781241|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
156781242|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
156781243|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781244|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781245|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781246|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781247|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781248|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
156781249|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
156781250|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
156781251|NCT02850406|565948490|FG000|Part D (Up to 52 Weeks)|Other|0|||
156781252|NCT02850406|565948491|FG001|Part D (Up to 52 Weeks)|Other|0|||
156781253|NCT02850406|565948492|FG002|Part D (Up to 52 Weeks)|Other|0|||
156781254|NCT02850406|565948493|FG003|Part D (Up to 52 Weeks)|Other|0|||
156781255|NCT02850406|565948494|FG004|Part D (Up to 52 Weeks)|Other|0|||
156781256|NCT02850406|565948495|FG005|Part D (Up to 52 Weeks)|Other|0|||
156781257|NCT02850406|565948496|FG006|Part D (Up to 52 Weeks)|Other|0|||
156781258|NCT02850406|565948497|FG007|Part D (Up to 52 Weeks)|Other|1|||
156781259|NCT05578872|565948498|FG000|Overall Study|Withdrawal by Subject|2|||
156781260|NCT05578872|565948499|FG001|Overall Study|Withdrawal by Subject|1|||
156781261|NCT05578872|565948498|FG000|Overall Study|Adverse Event|1|||
156781262|NCT05578872|565948499|FG001|Overall Study|Adverse Event|1|||
156781263|NCT05578872|565948498|FG000|Overall Study|Physician Decision|1|||
156781264|NCT05578872|565948499|FG001|Overall Study|Physician Decision|2|||
156781265|NCT05578872|565948498|FG000|Overall Study|Progressive disease|10|||
157212864|NCT00736333|567527703|FG000|Overall Study|Death|7|||
156781266|NCT05578872|565948499|FG001|Overall Study|Progressive disease|9|||
156781267|NCT05578872|565948498|FG000|Overall Study|Sponsor decision|0|||
156781268|NCT05578872|565948499|FG001|Overall Study|Sponsor decision|1|||
156781269|NCT05578872|565948498|FG000|Overall Study|Toxicity and Patient's decision|0|||
156781270|NCT05578872|565948499|FG001|Overall Study|Toxicity and Patient's decision|1|||
156781271|NCT00587457|565949997|FG000|Overall Study|Adverse Event|1|||
156781272|NCT00587457|565949998|FG001|Overall Study|Adverse Event|2|||
156781273|NCT00587457|565949999|FG002|Overall Study|Adverse Event|1|||
156781274|NCT00587457|565949997|FG000|Overall Study|Disease progression|2|||
156781275|NCT00587457|565949998|FG001|Overall Study|Disease progression|0|||
156781276|NCT00587457|565949999|FG002|Overall Study|Disease progression|2|||
157119382|NCT00879229|567190645|FG000|Overall Study|Death|4|||
157119383|NCT00879229|567190646|FG001|Overall Study|Death|2|||
157119384|NCT00879229|567190645|FG000|Overall Study|Adverse Event|2|||
157119385|NCT00879229|567190646|FG001|Overall Study|Adverse Event|0|||
156781277|NCT00587457|565949997|FG000|Overall Study|Initiation of alternative therapy|0|||
157212865|NCT00736333|567527703|FG000|Overall Study|Other|4|||
157212866|NCT04991311|567527705|FG000|Overall Study|Adverse Event|1|||
157119386|NCT00879229|567190645|FG000|Overall Study|Withdrawal by Subject|1|||
157119387|NCT00879229|567190646|FG001|Overall Study|Withdrawal by Subject|0|||
157119388|NCT00879229|567190645|FG000|Overall Study|Clinical status did not improve|1|||
157119389|NCT00879229|567190646|FG001|Overall Study|Clinical status did not improve|0|||
157119390|NCT00879229|567190645|FG000|Overall Study|Other|1|||
157119391|NCT00879229|567190646|FG001|Overall Study|Other|0|||
157119392|NCT01652287|567190655|FG000|Overall Study|Withdrawal by Subject|2|||
157212867|NCT00054275|567527707|FG000|Overall Study|Withdrawal by Subject|4|||
156781278|NCT00587457|565949998|FG001|Overall Study|Initiation of alternative therapy|1|||
156781279|NCT00587457|565949999|FG002|Overall Study|Initiation of alternative therapy|0|||
156781280|NCT00587457|565949997|FG000|Overall Study|Undefined|0|||
156781281|NCT00587457|565949998|FG001|Overall Study|Undefined|0|||
156781282|NCT00587457|565949999|FG002|Overall Study|Undefined|1|||
156781283|NCT00587457|565949997|FG000|Overall Study|Development of neutralizing Abs|0|||
156781284|NCT00587457|565949998|FG001|Overall Study|Development of neutralizing Abs|0|||
156781285|NCT00587457|565949999|FG002|Overall Study|Development of neutralizing Abs|1|||
156781286|NCT03439839|565950000|FG000|Overall Study|Death|3|||
156781287|NCT03439839|565950001|FG001|Overall Study|Death|0|||
156781288|NCT03298061|565950012|FG000|Overall Study|Adverse Event|3|||
156781289|NCT03298061|565950012|FG000|Overall Study|Lack of Efficacy|6|||
156781290|NCT03298061|565950012|FG000|Overall Study|Protocol Violation|1|||
156781291|NCT03298061|565950012|FG000|Overall Study|Physician Decision|7|||
156781292|NCT03298061|565950012|FG000|Overall Study|Withdrawal by Subject|10|||
156781293|NCT04307394|565950015|FG000|Overall Study|Lost to Follow-up|3|||
156781294|NCT04307394|565950015|FG000|Overall Study|Withdrawal by Subject|2|||
156781295|NCT00416949|565950017|FG000|Overall Study|Patients refused to participate|5|||
156781296|NCT02383173|565950020|FG000|Overall Study|Palliative Care Team withdrew|0|||
156781297|NCT02383173|565950021|FG001|Overall Study|Palliative Care Team withdrew|2|||
156781298|NCT00800540|565950022|FG000|Period One: 6 Weeks|Noncompliance|1|||
156781299|NCT00800540|565950023|FG001|Period One: 6 Weeks|Noncompliance|0|||
156781300|NCT00800540|565950022|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
156781301|NCT00800540|565950023|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
156781302|NCT00800540|565950022|FG000|Period 2: 6 Weeks|Adverse Event|0|||
156781303|NCT00800540|565950023|FG001|Period 2: 6 Weeks|Adverse Event|1|||
156781304|NCT05950906|565950024|FG000|Overall Study|Adverse Event|0|||
156781305|NCT05950906|565950025|FG001|Overall Study|Adverse Event|0|||
156781306|NCT05950906|565950026|FG002|Overall Study|Adverse Event|0|||
156781307|NCT05950906|565950027|FG003|Overall Study|Adverse Event|0|||
156781308|NCT05950906|565950028|FG004|Overall Study|Adverse Event|0|||
156781309|NCT05950906|565950029|FG005|Overall Study|Adverse Event|0|||
156781310|NCT05950906|565950030|FG006|Overall Study|Adverse Event|0|||
156781311|NCT05950906|565950031|FG007|Overall Study|Adverse Event|0|||
156781312|NCT05950906|565950032|FG008|Overall Study|Adverse Event|0|||
156781313|NCT05950906|565950033|FG009|Overall Study|Adverse Event|0|||
156781314|NCT05950906|565950034|FG010|Overall Study|Adverse Event|0|||
156781315|NCT05950906|565950035|FG011|Overall Study|Adverse Event|0|||
156781316|NCT05950906|565950036|FG012|Overall Study|Adverse Event|1|||
156781317|NCT05950906|565950037|FG013|Overall Study|Adverse Event|0|||
156781318|NCT05950906|565950024|FG000|Overall Study|Physician Decision|0|||
156781319|NCT05950906|565950025|FG001|Overall Study|Physician Decision|0|||
156781320|NCT05950906|565950026|FG002|Overall Study|Physician Decision|0|||
156781321|NCT05950906|565950027|FG003|Overall Study|Physician Decision|0|||
156781322|NCT05950906|565950028|FG004|Overall Study|Physician Decision|0|||
156781323|NCT05950906|565950029|FG005|Overall Study|Physician Decision|0|||
156781324|NCT05950906|565950030|FG006|Overall Study|Physician Decision|0|||
156781325|NCT05950906|565950031|FG007|Overall Study|Physician Decision|0|||
156781326|NCT05950906|565950032|FG008|Overall Study|Physician Decision|0|||
156781327|NCT05950906|565950033|FG009|Overall Study|Physician Decision|0|||
156781328|NCT05950906|565950034|FG010|Overall Study|Physician Decision|0|||
156781329|NCT05950906|565950035|FG011|Overall Study|Physician Decision|0|||
156781330|NCT05950906|565950036|FG012|Overall Study|Physician Decision|1|||
156781331|NCT05950906|565950037|FG013|Overall Study|Physician Decision|0|||
156781332|NCT02969018|565950042|FG000|Overall Study|Adverse Event|2|||
156781333|NCT02969018|565950043|FG001|Overall Study|Adverse Event|4|||
156781334|NCT02969018|565950044|FG002|Overall Study|Adverse Event|1|||
156781335|NCT02969018|565950045|FG003|Overall Study|Adverse Event|2|||
156781336|NCT02969018|565950046|FG004|Overall Study|Adverse Event|0|||
156781337|NCT02969018|565950047|FG005|Overall Study|Adverse Event|1|||
156781338|NCT02969018|565950048|FG006|Overall Study|Adverse Event|2|||
156781339|NCT02969018|565950049|FG007|Overall Study|Adverse Event|0|||
156781340|NCT02969018|565950042|FG000|Overall Study|Lack of Efficacy|0|||
156781341|NCT02969018|565950043|FG001|Overall Study|Lack of Efficacy|1|||
156781342|NCT02969018|565950044|FG002|Overall Study|Lack of Efficacy|0|||
156866590|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
157119393|NCT01652287|567190656|FG001|Overall Study|Withdrawal by Subject|0|||
157119394|NCT03704194|567190661|FG000|Overall Study|Withdrawal by Subject|0|||
156781343|NCT02969018|565950045|FG003|Overall Study|Lack of Efficacy|0|||
156781344|NCT02969018|565950046|FG004|Overall Study|Lack of Efficacy|1|||
157212868|NCT00054275|567527707|FG000|Overall Study|Adverse Event|5|||
156781345|NCT02969018|565950047|FG005|Overall Study|Lack of Efficacy|1|||
156781346|NCT02969018|565950048|FG006|Overall Study|Lack of Efficacy|1|||
156781347|NCT02969018|565950049|FG007|Overall Study|Lack of Efficacy|1|||
156781348|NCT02969018|565950042|FG000|Overall Study|Lost to Follow-up|1|||
156781349|NCT02969018|565950043|FG001|Overall Study|Lost to Follow-up|2|||
156781350|NCT02969018|565950044|FG002|Overall Study|Lost to Follow-up|2|||
156781351|NCT02969018|565950045|FG003|Overall Study|Lost to Follow-up|0|||
156781352|NCT02969018|565950046|FG004|Overall Study|Lost to Follow-up|1|||
156781353|NCT02969018|565950047|FG005|Overall Study|Lost to Follow-up|1|||
156781354|NCT02969018|565950048|FG006|Overall Study|Lost to Follow-up|0|||
156781355|NCT02969018|565950049|FG007|Overall Study|Lost to Follow-up|1|||
156781356|NCT02969018|565950042|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781357|NCT02969018|565950043|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781358|NCT02969018|565950044|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781359|NCT02969018|565950045|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781360|NCT02969018|565950046|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781361|NCT02969018|565950047|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781362|NCT02969018|565950048|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
156781363|NCT02969018|565950049|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156781364|NCT02969018|565950042|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156781365|NCT02969018|565950043|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156781366|NCT02969018|565950044|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156781367|NCT02969018|565950045|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156781368|NCT02969018|565950046|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156781369|NCT02969018|565950047|FG005|Overall Study|Non-Compliance With Study Drug|0|||
156781370|NCT02969018|565950048|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156781371|NCT02969018|565950049|FG007|Overall Study|Non-Compliance With Study Drug|0|||
157212869|NCT00054275|567527707|FG000|Overall Study|Progressive disease in cycle 1|1|||
157212870|NCT00054275|567527707|FG000|Overall Study|Physician Decision|1|||
157212871|NCT03876873|567527708|FG000|Overall Study|Physician Decision|0|||
157212872|NCT03876873|567527709|FG001|Overall Study|Physician Decision|1|||
157212873|NCT01106352|567527710|FG000|Overall Study|Subjects untreated|0|||
157212874|NCT01106352|567527711|FG001|Overall Study|Subjects untreated|0|||
157212875|NCT01106352|567527712|FG002|Overall Study|Subjects untreated|0|||
157212876|NCT01106352|567527713|FG003|Overall Study|Subjects untreated|3|||
157212877|NCT01106352|567527714|FG004|Overall Study|Subjects untreated|4|||
157212878|NCT01106352|567527710|FG000|Overall Study|Sponsor Decision|1|||
157212879|NCT01106352|567527711|FG001|Overall Study|Sponsor Decision|0|||
157212880|NCT01106352|567527712|FG002|Overall Study|Sponsor Decision|0|||
157212881|NCT01106352|567527713|FG003|Overall Study|Sponsor Decision|0|||
157212882|NCT01106352|567527714|FG004|Overall Study|Sponsor Decision|0|||
157212883|NCT01106352|567527710|FG000|Overall Study|Too ill to come in for the visit|0|||
157212884|NCT01106352|567527711|FG001|Overall Study|Too ill to come in for the visit|0|||
157212885|NCT01106352|567527712|FG002|Overall Study|Too ill to come in for the visit|1|||
157212886|NCT01106352|567527713|FG003|Overall Study|Too ill to come in for the visit|0|||
157212887|NCT01106352|567527714|FG004|Overall Study|Too ill to come in for the visit|0|||
157212888|NCT01106352|567527710|FG000|Overall Study|Lost to Follow-up|0|||
157212889|NCT01106352|567527711|FG001|Overall Study|Lost to Follow-up|0|||
157212890|NCT01106352|567527712|FG002|Overall Study|Lost to Follow-up|0|||
157212891|NCT01106352|567527713|FG003|Overall Study|Lost to Follow-up|0|||
157212892|NCT01106352|567527714|FG004|Overall Study|Lost to Follow-up|1|||
157212893|NCT01106352|567527710|FG000|Overall Study|Death|0|||
157212894|NCT01106352|567527711|FG001|Overall Study|Death|0|||
157212895|NCT01106352|567527712|FG002|Overall Study|Death|1|||
157212896|NCT01106352|567527713|FG003|Overall Study|Death|3|||
157212897|NCT01106352|567527714|FG004|Overall Study|Death|1|||
157212898|NCT01106352|567527710|FG000|Overall Study|Disease progression|0|||
157212899|NCT01106352|567527711|FG001|Overall Study|Disease progression|0|||
157212900|NCT01106352|567527712|FG002|Overall Study|Disease progression|0|||
157212901|NCT01106352|567527713|FG003|Overall Study|Disease progression|1|||
157212902|NCT01106352|567527714|FG004|Overall Study|Disease progression|0|||
156781372|NCT02969018|565950042|FG000|Overall Study|Other|0|||
156781373|NCT02969018|565950043|FG001|Overall Study|Other|0|||
156781374|NCT02969018|565950044|FG002|Overall Study|Other|0|||
156781375|NCT02969018|565950045|FG003|Overall Study|Other|1|||
156781376|NCT02969018|565950046|FG004|Overall Study|Other|0|||
156781377|NCT02969018|565950047|FG005|Overall Study|Other|0|||
156781378|NCT02969018|565950048|FG006|Overall Study|Other|0|||
156781379|NCT02969018|565950049|FG007|Overall Study|Other|2|||
157212903|NCT01106352|567527710|FG000|Overall Study|Withdrawal by Subject|0|||
157212904|NCT01106352|567527711|FG001|Overall Study|Withdrawal by Subject|0|||
157212905|NCT01106352|567527712|FG002|Overall Study|Withdrawal by Subject|0|||
157212906|NCT01106352|567527713|FG003|Overall Study|Withdrawal by Subject|3|||
157212907|NCT01106352|567527714|FG004|Overall Study|Withdrawal by Subject|2|||
157212908|NCT01106352|567527710|FG000|Overall Study|Went on hospice|0|||
157212909|NCT01106352|567527711|FG001|Overall Study|Went on hospice|0|||
157212910|NCT01106352|567527712|FG002|Overall Study|Went on hospice|0|||
157212911|NCT01106352|567527713|FG003|Overall Study|Went on hospice|1|||
157119395|NCT03704194|567190662|FG001|Overall Study|Withdrawal by Subject|1|||
157119396|NCT05131204|567190663|FG000|Overall Study|Sponsor request|2|||
157119397|NCT05131204|567190664|FG001|Overall Study|Sponsor request|1|||
157119398|NCT00488982|567190665|FG000|Course 1|Physician Decision|0|||
157119399|NCT00488982|567190666|FG001|Course 1|Physician Decision|2|||
156781380|NCT02969018|565950042|FG000|Overall Study|Pregnancy|0|||
156781381|NCT02969018|565950043|FG001|Overall Study|Pregnancy|0|||
156781382|NCT02969018|565950044|FG002|Overall Study|Pregnancy|0|||
156781383|NCT02969018|565950045|FG003|Overall Study|Pregnancy|0|||
156781384|NCT02969018|565950046|FG004|Overall Study|Pregnancy|0|||
156781385|NCT02969018|565950047|FG005|Overall Study|Pregnancy|1|||
156781386|NCT02969018|565950048|FG006|Overall Study|Pregnancy|0|||
156781387|NCT02969018|565950049|FG007|Overall Study|Pregnancy|0|||
156781388|NCT02969018|565950042|FG000|Overall Study|Protocol Violation|0|||
156781389|NCT02969018|565950043|FG001|Overall Study|Protocol Violation|0|||
156781390|NCT02969018|565950044|FG002|Overall Study|Protocol Violation|1|||
156781391|NCT02969018|565950045|FG003|Overall Study|Protocol Violation|1|||
156781392|NCT02969018|565950046|FG004|Overall Study|Protocol Violation|0|||
156781393|NCT02969018|565950047|FG005|Overall Study|Protocol Violation|0|||
156781394|NCT02969018|565950048|FG006|Overall Study|Protocol Violation|0|||
156781395|NCT02969018|565950049|FG007|Overall Study|Protocol Violation|0|||
156781396|NCT02969018|565950042|FG000|Overall Study|Withdrawal by Subject|0|||
156781397|NCT02969018|565950043|FG001|Overall Study|Withdrawal by Subject|1|||
156781398|NCT02969018|565950044|FG002|Overall Study|Withdrawal by Subject|2|||
156781399|NCT02969018|565950045|FG003|Overall Study|Withdrawal by Subject|1|||
156781400|NCT02969018|565950046|FG004|Overall Study|Withdrawal by Subject|0|||
156781401|NCT02969018|565950047|FG005|Overall Study|Withdrawal by Subject|4|||
156781402|NCT02969018|565950048|FG006|Overall Study|Withdrawal by Subject|4|||
156781403|NCT02969018|565950049|FG007|Overall Study|Withdrawal by Subject|3|||
156781404|NCT04790201|565950050|FG000|Overall Study|Lost to Follow-up|0|||
156781405|NCT04790201|565950051|FG001|Overall Study|Lost to Follow-up|0|||
156781406|NCT04790201|565950052|FG002|Overall Study|Lost to Follow-up|2|||
156781407|NCT04790201|565950050|FG000|Overall Study|Death|0|||
156781408|NCT04790201|565950051|FG001|Overall Study|Death|1|||
156781409|NCT04790201|565950052|FG002|Overall Study|Death|0|||
156781410|NCT04790201|565950050|FG000|Overall Study|Protocol Violation|1|||
156781411|NCT04790201|565950051|FG001|Overall Study|Protocol Violation|0|||
156781412|NCT04790201|565950052|FG002|Overall Study|Protocol Violation|1|||
156781413|NCT04795323|565950057|FG000|Overall Study|Did not interact with TARA|1|||
156781414|NCT04795323|565950058|FG001|Overall Study|Did not interact with TARA|0|||
156781415|NCT01479530|565950059|FG000|Overall Study|Adverse Event|5|||
156781416|NCT01479530|565950060|FG001|Overall Study|Adverse Event|6|||
156781417|NCT01479530|565950059|FG000|Overall Study|Lack of Efficacy|0|||
156781418|NCT01479530|565950060|FG001|Overall Study|Lack of Efficacy|1|||
156781419|NCT01479530|565950059|FG000|Overall Study|Protocol Violation|2|||
156781420|NCT01479530|565950060|FG001|Overall Study|Protocol Violation|3|||
156781421|NCT01479530|565950059|FG000|Overall Study|Withdrawal of Consent|3|||
156781422|NCT01479530|565950060|FG001|Overall Study|Withdrawal of Consent|2|||
156781423|NCT02836769|565950061|FG000|Overall Study|Lost to Follow-up|10|||
156781424|NCT02836769|565950061|FG000|Overall Study|Medical withdrawal|2|||
156781425|NCT02836769|565950061|FG000|Overall Study|Withdrawal by Subject|3|||
156781426|NCT02503865|565950068|FG000|Overall Study|Moved out of area|1|||
156781427|NCT02503865|565950069|FG001|Overall Study|Moved out of area|8|||
156781428|NCT02503865|565950070|FG002|Overall Study|Moved out of area|0|||
156781429|NCT02503865|565950068|FG000|Overall Study|Refused treatment|4|||
156781430|NCT02503865|565950069|FG001|Overall Study|Refused treatment|39|||
156781431|NCT02503865|565950070|FG002|Overall Study|Refused treatment|2|||
156781432|NCT04465955|565950071|FG000|Overall Study|Withdrew consent|6|||
156781433|NCT04465955|565950072|FG001|Overall Study|Withdrew consent|10|||
156781434|NCT04465955|565950073|FG002|Overall Study|Withdrew consent|7|||
156781435|NCT04465955|565950071|FG000|Overall Study|Adverse Event|6|||
156781436|NCT04465955|565950072|FG001|Overall Study|Adverse Event|5|||
156781437|NCT04465955|565950073|FG002|Overall Study|Adverse Event|1|||
156781438|NCT04465955|565950071|FG000|Overall Study|Lost to Follow-up|2|||
156781439|NCT04465955|565950072|FG001|Overall Study|Lost to Follow-up|0|||
156781440|NCT04465955|565950073|FG002|Overall Study|Lost to Follow-up|3|||
156781441|NCT04465955|565950071|FG000|Overall Study|Other|1|||
156781442|NCT04465955|565950072|FG001|Overall Study|Other|1|||
156781443|NCT04465955|565950073|FG002|Overall Study|Other|3|||
156781444|NCT00021255|565950074|FG000|Overall Study|Death|1|||
157119400|NCT00488982|567190667|FG002|Course 1|Physician Decision|4|||
157119401|NCT00488982|567190665|FG000|Course 1|Withdrawal by Subject|0|||
156781445|NCT00021255|565950075|FG001|Overall Study|Death|0|||
156781446|NCT00021255|565950076|FG002|Overall Study|Death|2|||
156781447|NCT00021255|565950074|FG000|Overall Study|Breast cancer relapse|5|||
156781448|NCT00021255|565950075|FG001|Overall Study|Breast cancer relapse|18|||
156781449|NCT00021255|565950076|FG002|Overall Study|Breast cancer relapse|11|||
156781450|NCT00021255|565950074|FG000|Overall Study|Second primary malignancy|0|||
156781451|NCT00021255|565950075|FG001|Overall Study|Second primary malignancy|4|||
156781452|NCT00021255|565950076|FG002|Overall Study|Second primary malignancy|1|||
156781453|NCT00021255|565950074|FG000|Overall Study|Withdrawal by Subject|41|||
157212912|NCT01106352|567527714|FG004|Overall Study|Went on hospice|0|||
156781454|NCT00021255|565950075|FG001|Overall Study|Withdrawal by Subject|64|||
156781455|NCT00021255|565950076|FG002|Overall Study|Withdrawal by Subject|26|||
157119402|NCT00488982|567190666|FG001|Course 1|Withdrawal by Subject|8|||
157212913|NCT01106352|567527710|FG000|Overall Study|Subject entered hospice|0|||
157212914|NCT01106352|567527711|FG001|Overall Study|Subject entered hospice|0|||
157212915|NCT01106352|567527712|FG002|Overall Study|Subject entered hospice|0|||
157119403|NCT00488982|567190667|FG002|Course 1|Withdrawal by Subject|2|||
157119404|NCT00488982|567190665|FG000|Course 1|nonprotocol therapy|0|||
157119405|NCT00488982|567190666|FG001|Course 1|nonprotocol therapy|2|||
157119406|NCT00488982|567190667|FG002|Course 1|nonprotocol therapy|2|||
157119407|NCT00488982|567190665|FG000|Course 1|Adverse Event|0|||
157119408|NCT00488982|567190666|FG001|Course 1|Adverse Event|0|||
157119409|NCT00488982|567190667|FG002|Course 1|Adverse Event|6|||
157119410|NCT01368835|567190668|FG000|Overall Study|Inclusion criteria/photography quality|22|||
157119411|NCT01368835|567190668|FG000|Overall Study|Lost to Follow-up|11|||
157119412|NCT01885000|567190669|FG000|Overall Study|Adverse Event|1|||
157119413|NCT01885000|567190670|FG001|Overall Study|Adverse Event|0|||
157119414|NCT01885000|567190669|FG000|Overall Study|Withdrawal by Subject|1|||
157119415|NCT01885000|567190670|FG001|Overall Study|Withdrawal by Subject|1|||
157119416|NCT01885000|567190669|FG000|Overall Study|Protocol Violation|0|||
157119417|NCT01885000|567190670|FG001|Overall Study|Protocol Violation|1|||
157119418|NCT01777152|567190671|FG000|Overall Study|Withdrawal by Subject|22|||
157119419|NCT01777152|567190672|FG001|Overall Study|Withdrawal by Subject|16|||
157119420|NCT01777152|567190671|FG000|Overall Study|Lost to Follow-up|3|||
157119421|NCT01777152|567190672|FG001|Overall Study|Lost to Follow-up|5|||
157119422|NCT01777152|567190671|FG000|Overall Study|Death|68|||
157119423|NCT01777152|567190672|FG001|Overall Study|Death|89|||
157119424|NCT01777152|567190671|FG000|Overall Study|Not eligible, no study drug received|1|||
157119425|NCT01777152|567190672|FG001|Overall Study|Not eligible, no study drug received|0|||
157119426|NCT01777152|567190671|FG000|Overall Study|Change of diagnosis|1|||
157119427|NCT01777152|567190672|FG001|Overall Study|Change of diagnosis|0|||
157119428|NCT01289015|567190678|FG000|Overall Study|Protocol Violation|12|||
157119429|NCT01289015|567190679|FG001|Overall Study|Protocol Violation|9|||
157119430|NCT01289015|567190678|FG000|Overall Study|Adverse Event|3|||
157119431|NCT01289015|567190679|FG001|Overall Study|Adverse Event|0|||
157119432|NCT01289015|567190678|FG000|Overall Study|Lost to Follow-up|33|||
157119433|NCT01289015|567190679|FG001|Overall Study|Lost to Follow-up|17|||
157119434|NCT01289015|567190678|FG000|Overall Study|Withdrawal by Subject|17|||
157119435|NCT01289015|567190679|FG001|Overall Study|Withdrawal by Subject|8|||
157119436|NCT01289015|567190678|FG000|Overall Study|Disease progression|1|||
157119437|NCT01289015|567190679|FG001|Overall Study|Disease progression|0|||
157119438|NCT01289015|567190678|FG000|Overall Study|Negative baseline culture and others|33|||
157119439|NCT01289015|567190679|FG001|Overall Study|Negative baseline culture and others|20|||
157119440|NCT02275338|567190688|FG000|Overall Study|Adverse Event|15|||
157119441|NCT02275338|567190688|FG000|Overall Study|Lack of Efficacy|3|||
157119442|NCT02275338|567190688|FG000|Overall Study|Withdrawal by Subject|4|||
157119443|NCT02275338|567190688|FG000|Overall Study|Disease progression (death)|1|||
157119444|NCT02275338|567190688|FG000|Overall Study|Ineligible to start Phase 2|4|||
157119445|NCT02275338|567190688|FG000|Overall Study|Reason not specified|5|||
157119446|NCT02275338|567190688|FG000|Overall Study|Does not meet entry criteria|1|||
157119447|NCT02228590|567190693|FG000|Overall Study|Withdrawal by Subject|1|||
157119448|NCT02109484|567190694|FG000|Overall Study|Lost to Follow-up|0|||
157119449|NCT02109484|567190695|FG001|Overall Study|Lost to Follow-up|0|||
157119450|NCT02109484|567190696|FG002|Overall Study|Lost to Follow-up|0|||
157119451|NCT02109484|567190697|FG003|Overall Study|Lost to Follow-up|1|||
157119452|NCT02109484|567190698|FG004|Overall Study|Lost to Follow-up|1|||
157119453|NCT02109484|567190699|FG005|Overall Study|Lost to Follow-up|0|||
157119454|NCT02109484|567190700|FG006|Overall Study|Lost to Follow-up|1|||
157119455|NCT02109484|567190701|FG007|Overall Study|Lost to Follow-up|0|||
157119456|NCT02109484|567190694|FG000|Overall Study|Withdrawal by Subject|0|||
157119457|NCT02109484|567190695|FG001|Overall Study|Withdrawal by Subject|0|||
157212916|NCT01106352|567527713|FG003|Overall Study|Subject entered hospice|1|||
157119458|NCT02109484|567190696|FG002|Overall Study|Withdrawal by Subject|0|||
157119459|NCT02109484|567190697|FG003|Overall Study|Withdrawal by Subject|0|||
157119460|NCT02109484|567190698|FG004|Overall Study|Withdrawal by Subject|1|||
157212917|NCT01106352|567527714|FG004|Overall Study|Subject entered hospice|0|||
157212918|NCT01106352|567527710|FG000|Overall Study|Home hospice since July 2013|0|||
157119461|NCT02109484|567190699|FG005|Overall Study|Withdrawal by Subject|1|||
157119462|NCT02109484|567190700|FG006|Overall Study|Withdrawal by Subject|1|||
157119463|NCT02109484|567190701|FG007|Overall Study|Withdrawal by Subject|0|||
157119464|NCT02109484|567190694|FG000|Overall Study|Physician Decision|0|||
157212919|NCT01106352|567527711|FG001|Overall Study|Home hospice since July 2013|0|||
157119465|NCT02109484|567190695|FG001|Overall Study|Physician Decision|0|||
157119466|NCT02109484|567190696|FG002|Overall Study|Physician Decision|0|||
157119467|NCT02109484|567190697|FG003|Overall Study|Physician Decision|0|||
157119468|NCT02109484|567190698|FG004|Overall Study|Physician Decision|2|||
157212920|NCT01106352|567527712|FG002|Overall Study|Home hospice since July 2013|0|||
157119469|NCT02109484|567190699|FG005|Overall Study|Physician Decision|0|||
157119470|NCT02109484|567190700|FG006|Overall Study|Physician Decision|0|||
157119471|NCT02109484|567190701|FG007|Overall Study|Physician Decision|0|||
157119472|NCT02109484|567190694|FG000|Overall Study|Death|0|||
157119473|NCT02109484|567190695|FG001|Overall Study|Death|0|||
157119474|NCT02109484|567190696|FG002|Overall Study|Death|0|||
157119475|NCT02109484|567190697|FG003|Overall Study|Death|0|||
157119476|NCT02109484|567190698|FG004|Overall Study|Death|0|||
157119477|NCT02109484|567190699|FG005|Overall Study|Death|0|||
157119478|NCT02109484|567190700|FG006|Overall Study|Death|0|||
157119479|NCT02109484|567190701|FG007|Overall Study|Death|2|||
157119480|NCT02109484|567190694|FG000|Overall Study|Moved away from study area|0|||
157119481|NCT02109484|567190695|FG001|Overall Study|Moved away from study area|0|||
157119482|NCT02109484|567190696|FG002|Overall Study|Moved away from study area|0|||
157119483|NCT02109484|567190697|FG003|Overall Study|Moved away from study area|0|||
157119484|NCT02109484|567190698|FG004|Overall Study|Moved away from study area|0|||
157119485|NCT02109484|567190699|FG005|Overall Study|Moved away from study area|0|||
157212921|NCT01106352|567527713|FG003|Overall Study|Home hospice since July 2013|1|||
157212922|NCT01106352|567527714|FG004|Overall Study|Home hospice since July 2013|0|||
157212923|NCT03547531|567527715|FG000|Overall Study|not coming in data collection : sick|2|||
157212924|NCT03547531|567527716|FG001|Overall Study|not coming in data collection : sick|2|||
157212925|NCT03547531|567527715|FG000|Overall Study|having family occasion|0|||
157212926|NCT03547531|567527716|FG001|Overall Study|having family occasion|2|||
157212927|NCT03944707|567527724|FG000|Overall Study|Adverse Event|0|||
157212928|NCT03944707|567527725|FG001|Overall Study|Adverse Event|2|||
157212929|NCT03944707|567527724|FG000|Overall Study|Study terminated by sponsor|12|||
157119486|NCT02109484|567190700|FG006|Overall Study|Moved away from study area|1|||
157119487|NCT02109484|567190701|FG007|Overall Study|Moved away from study area|1|||
157119488|NCT01400451|567190714|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
157119489|NCT01400451|567190715|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
157119490|NCT01400451|567190716|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
157119491|NCT01400451|567190714|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
157119492|NCT01400451|567190715|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
157119493|NCT01400451|567190716|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
157119494|NCT01400451|567190714|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
157119495|NCT01400451|567190715|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
157119496|NCT01400451|567190716|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
157119497|NCT01400451|567190714|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
157119498|NCT01400451|567190715|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
157119499|NCT01400451|567190716|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
157119500|NCT01400451|567190714|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
157119501|NCT01400451|567190715|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
157119502|NCT01400451|567190716|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
157119503|NCT00574275|567190717|FG000|Overall Study|Randomized but not treated|2|||
157119504|NCT00574275|567190718|FG001|Overall Study|Randomized but not treated|3|||
157119505|NCT00574275|567190717|FG000|Overall Study|Adverse Event|32|||
157119506|NCT00574275|567190718|FG001|Overall Study|Adverse Event|76|||
157119507|NCT00574275|567190717|FG000|Overall Study|Disease progression|160|||
157119508|NCT00574275|567190718|FG001|Overall Study|Disease progression|146|||
157119509|NCT00574275|567190717|FG000|Overall Study|Lost to Follow-up|2|||
157119510|NCT00574275|567190718|FG001|Overall Study|Lost to Follow-up|1|||
157119511|NCT00574275|567190717|FG000|Overall Study|Study stopped based on DMC decision|62|||
157119512|NCT00574275|567190718|FG001|Overall Study|Study stopped based on DMC decision|23|||
157119513|NCT00574275|567190717|FG000|Overall Study|Withdrawal by Subject|15|||
157119514|NCT00574275|567190718|FG001|Overall Study|Withdrawal by Subject|17|||
157119515|NCT00574275|567190717|FG000|Overall Study|Error calculating tumor measurement|1|||
157119516|NCT00574275|567190718|FG001|Overall Study|Error calculating tumor measurement|0|||
157212930|NCT03944707|567527725|FG001|Overall Study|Study terminated by sponsor|7|||
157119517|NCT00574275|567190717|FG000|Overall Study|Physician Decision|1|||
157119518|NCT00574275|567190718|FG001|Overall Study|Physician Decision|1|||
157119519|NCT00574275|567190717|FG000|Overall Study|Protocol Violation|0|||
157119520|NCT00574275|567190718|FG001|Overall Study|Protocol Violation|1|||
157119521|NCT00574275|567190717|FG000|Overall Study|Patient and Investigator decision|0|||
157119522|NCT00574275|567190718|FG001|Overall Study|Patient and Investigator decision|1|||
157119523|NCT00574275|567190717|FG000|Overall Study|Insurance change|0|||
157119524|NCT00574275|567190718|FG001|Overall Study|Insurance change|1|||
157119525|NCT00574275|567190717|FG000|Overall Study|Operation for curative intent|0|||
157119526|NCT00574275|567190718|FG001|Overall Study|Operation for curative intent|1|||
157119527|NCT00889265|567190722|FG000|Overall Study|Adverse Event|1|||
157119528|NCT00889265|567190722|FG000|Overall Study|Lost to Follow-up|5|||
157119529|NCT00889265|567190722|FG000|Overall Study|Protocol Violation|1|||
157212931|NCT03944707|567527724|FG000|Overall Study|Subject decision|0|||
157212932|NCT03944707|567527725|FG001|Overall Study|Subject decision|1|||
157119530|NCT03028870|567190723|FG000|Overall Study|Adverse Event|7|||
157119531|NCT03028870|567190724|FG001|Overall Study|Adverse Event|4|||
156781456|NCT00021255|565950074|FG000|Overall Study|Lost to Follow-up|0|||
156781457|NCT00021255|565950075|FG001|Overall Study|Lost to Follow-up|2|||
156781458|NCT00021255|565950076|FG002|Overall Study|Lost to Follow-up|3|||
156781459|NCT00021255|565950074|FG000|Overall Study|Cardiac toxicity|0|||
156781460|NCT00021255|565950075|FG001|Overall Study|Cardiac toxicity|61|||
156781461|NCT00021255|565950076|FG002|Overall Study|Cardiac toxicity|32|||
156781462|NCT00021255|565950074|FG000|Overall Study|Herceptin toxicity|0|||
156781463|NCT00021255|565950075|FG001|Overall Study|Herceptin toxicity|22|||
156781464|NCT00021255|565950076|FG002|Overall Study|Herceptin toxicity|6|||
156781465|NCT00021255|565950074|FG000|Overall Study|Adverse Event|46|||
156781466|NCT00021255|565950075|FG001|Overall Study|Adverse Event|30|||
156781467|NCT00021255|565950076|FG002|Overall Study|Adverse Event|18|||
156781468|NCT00021255|565950074|FG000|Overall Study|Protocol Violation|0|||
156781469|NCT00021255|565950075|FG001|Overall Study|Protocol Violation|2|||
156781470|NCT00021255|565950076|FG002|Overall Study|Protocol Violation|0|||
156781471|NCT00021255|565950074|FG000|Overall Study|Other than specified above|0|||
156781472|NCT00021255|565950075|FG001|Overall Study|Other than specified above|38|||
156781473|NCT00021255|565950076|FG002|Overall Study|Other than specified above|19|||
156781474|NCT00021255|565950074|FG000|Overall Study|Missing|0|||
156781475|NCT00021255|565950075|FG001|Overall Study|Missing|27|||
156781476|NCT00021255|565950076|FG002|Overall Study|Missing|13|||
156781477|NCT00021255|565950074|FG000|Overall Study|Randomized but not treated|28|||
156781478|NCT00021255|565950075|FG001|Overall Study|Randomized but not treated|2|||
156781479|NCT00021255|565950076|FG002|Overall Study|Randomized but not treated|18|||
156781480|NCT01132755|565950079|FG000|Overall Study|Procedure not done due to medical reason|23|||
156781481|NCT01132755|565950079|FG000|Overall Study|Protocol Violation|15|||
156781482|NCT01132755|565950079|FG000|Overall Study|Withdrawal by Subject|4|||
156781483|NCT02232698|565950080|FG000|Overall Study|Pregnancy|1|||
156781484|NCT02232698|565950081|FG001|Overall Study|Pregnancy|1|||
156781485|NCT02232698|565950080|FG000|Overall Study|Met exclusion criteria|1|||
156781486|NCT02232698|565950081|FG001|Overall Study|Met exclusion criteria|1|||
156781487|NCT02232698|565950080|FG000|Overall Study|Had device-associated symptoms|7|||
156781488|NCT02232698|565950081|FG001|Overall Study|Had device-associated symptoms|0|||
156781489|NCT02232698|565950080|FG000|Overall Study|Non-compliance with study device|1|||
156781490|NCT02232698|565950081|FG001|Overall Study|Non-compliance with study device|4|||
156781491|NCT02232698|565950080|FG000|Overall Study|Allocated to control group|0|||
156781492|NCT02232698|565950081|FG001|Overall Study|Allocated to control group|3|||
156781493|NCT02232698|565950080|FG000|Overall Study|Withdrawal by Subject|0|||
156781494|NCT02232698|565950081|FG001|Overall Study|Withdrawal by Subject|11|||
156781495|NCT02393755|565950082|FG000|Overall Study|Withdrawal by Subject|0|||
156781496|NCT02393755|565950083|FG001|Overall Study|Withdrawal by Subject|3|||
157011612|NCT01985334|566795459|FG005|Overall Study|Worsening of disease|3|||
157011613|NCT01985334|566795460|FG006|Overall Study|Worsening of disease|0|||
157011614|NCT01985334|566795461|FG007|Overall Study|Worsening of disease|1|||
157011615|NCT01985334|566795454|FG000|Overall Study|Other|2|||
157011616|NCT01985334|566795455|FG001|Overall Study|Other|9|||
157011617|NCT01985334|566795456|FG002|Overall Study|Other|7|||
157011618|NCT01985334|566795457|FG003|Overall Study|Other|17|||
157011619|NCT01985334|566795458|FG004|Overall Study|Other|4|||
157011620|NCT01985334|566795459|FG005|Overall Study|Other|8|||
157011621|NCT01985334|566795460|FG006|Overall Study|Other|4|||
157011622|NCT01985334|566795461|FG007|Overall Study|Other|7|||
157011623|NCT01985334|566795454|FG000|Overall Study|Protocol deviation|6|||
157011624|NCT01985334|566795455|FG001|Overall Study|Protocol deviation|31|||
157011625|NCT01985334|566795456|FG002|Overall Study|Protocol deviation|25|||
157011626|NCT01985334|566795457|FG003|Overall Study|Protocol deviation|84|||
157011627|NCT01985334|566795458|FG004|Overall Study|Protocol deviation|17|||
157011628|NCT01985334|566795459|FG005|Overall Study|Protocol deviation|47|||
157011629|NCT01985334|566795460|FG006|Overall Study|Protocol deviation|15|||
157011630|NCT01985334|566795461|FG007|Overall Study|Protocol deviation|42|||
157011631|NCT01985334|566795454|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
157011632|NCT01985334|566795455|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
157011633|NCT01985334|566795456|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
157011634|NCT01985334|566795457|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
157011635|NCT01985334|566795458|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
157011636|NCT01985334|566795459|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
157011637|NCT01985334|566795460|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
157011638|NCT01985334|566795461|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
157011639|NCT01985334|566795454|FG000|Overall Study|Subject withdrawal of consent|3|||
157011640|NCT01985334|566795455|FG001|Overall Study|Subject withdrawal of consent|6|||
157011641|NCT01985334|566795456|FG002|Overall Study|Subject withdrawal of consent|2|||
157011642|NCT01985334|566795457|FG003|Overall Study|Subject withdrawal of consent|28|||
157011643|NCT01985334|566795458|FG004|Overall Study|Subject withdrawal of consent|4|||
157011644|NCT01985334|566795459|FG005|Overall Study|Subject withdrawal of consent|19|||
157011645|NCT01985334|566795460|FG006|Overall Study|Subject withdrawal of consent|0|||
157011646|NCT01985334|566795461|FG007|Overall Study|Subject withdrawal of consent|20|||
157011647|NCT01985334|566795454|FG000|Overall Study|Adverse Event|0|||
156781497|NCT02393755|565950082|FG000|Overall Study|Adverse Event|0|||
156781498|NCT02393755|565950083|FG001|Overall Study|Adverse Event|2|||
156781499|NCT02393755|565950082|FG000|Overall Study|Physician Decision|0|||
156781500|NCT02393755|565950083|FG001|Overall Study|Physician Decision|2|||
156781501|NCT01327703|565950084|FG000|Second Treatment Period|Adverse Event|1|||
156781502|NCT01327703|565950085|FG001|Second Treatment Period|Adverse Event|1|||
156781503|NCT01327703|565950084|FG000|Second Treatment Period|Protocol Violation|0|||
156781504|NCT01327703|565950085|FG001|Second Treatment Period|Protocol Violation|1|||
156781505|NCT05324371|565950087|FG000|Overall Study|Withdrawal by Subject|1|||
156781506|NCT05324371|565950087|FG000|Overall Study|Death|1|||
156781507|NCT01131585|565950088|FG000|Overall Study|Adverse Event|0|||
156781508|NCT01131585|565950089|FG001|Overall Study|Adverse Event|2|||
156781509|NCT01131585|565950088|FG000|Overall Study|Abnormal laboratory value|1|||
156781510|NCT01131585|565950089|FG001|Overall Study|Abnormal laboratory value|0|||
156781511|NCT01131585|565950088|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156781512|NCT01131585|565950089|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156781513|NCT01131585|565950088|FG000|Overall Study|Protocol Violation|2|||
156781514|NCT01131585|565950089|FG001|Overall Study|Protocol Violation|1|||
156781515|NCT01131585|565950088|FG000|Overall Study|Withdrawal by Subject|3|||
156781516|NCT01131585|565950089|FG001|Overall Study|Withdrawal by Subject|3|||
156781517|NCT01131585|565950088|FG000|Overall Study|Lost to Follow-up|0|||
156781518|NCT01131585|565950089|FG001|Overall Study|Lost to Follow-up|1|||
157119532|NCT03028870|567190725|FG002|Overall Study|Adverse Event|3|||
157119533|NCT03028870|567190726|FG003|Overall Study|Adverse Event|3|||
157119534|NCT03028870|567190723|FG000|Overall Study|Withdrawal by Subject|1|||
157119535|NCT03028870|567190724|FG001|Overall Study|Withdrawal by Subject|1|||
157119536|NCT03028870|567190725|FG002|Overall Study|Withdrawal by Subject|1|||
157119537|NCT03028870|567190726|FG003|Overall Study|Withdrawal by Subject|2|||
157119538|NCT03028870|567190723|FG000|Overall Study|Lost to Follow-up|1|||
157119539|NCT03028870|567190724|FG001|Overall Study|Lost to Follow-up|0|||
157119540|NCT03028870|567190725|FG002|Overall Study|Lost to Follow-up|0|||
157119541|NCT03028870|567190726|FG003|Overall Study|Lost to Follow-up|0|||
157119542|NCT03028870|567190723|FG000|Overall Study|Lack of Efficacy|3|||
157119543|NCT03028870|567190724|FG001|Overall Study|Lack of Efficacy|0|||
157119544|NCT03028870|567190725|FG002|Overall Study|Lack of Efficacy|0|||
157119545|NCT03028870|567190726|FG003|Overall Study|Lack of Efficacy|0|||
157119546|NCT03028870|567190723|FG000|Overall Study|Administrative|5|||
157119547|NCT03028870|567190724|FG001|Overall Study|Administrative|5|||
156781519|NCT01131585|565950088|FG000|Overall Study|Administrative problems|1|||
156781520|NCT01131585|565950089|FG001|Overall Study|Administrative problems|1|||
156781521|NCT01131585|565950088|FG000|Overall Study|Study termination|78|||
156781522|NCT01131585|565950089|FG001|Overall Study|Study termination|32|||
156781523|NCT00927082|565950090|FG000|Overall Study|Lost to Follow-up|9|||
156781524|NCT00927082|565950091|FG001|Overall Study|Lost to Follow-up|8|||
156781525|NCT00927082|565950092|FG002|Overall Study|Lost to Follow-up|12|||
156781526|NCT00927082|565950093|FG003|Overall Study|Lost to Follow-up|16|||
156781527|NCT00927082|565950090|FG000|Overall Study|Withdrawal by Subject|3|||
156781528|NCT00927082|565950091|FG001|Overall Study|Withdrawal by Subject|2|||
156781529|NCT00927082|565950092|FG002|Overall Study|Withdrawal by Subject|7|||
156781530|NCT00927082|565950093|FG003|Overall Study|Withdrawal by Subject|2|||
156781531|NCT00927082|565950090|FG000|Overall Study|Death|0|||
156781532|NCT00927082|565950091|FG001|Overall Study|Death|0|||
157212933|NCT02117479|567527727|FG000|Overall Study|Death|13|||
157212934|NCT02117479|567527728|FG001|Overall Study|Death|8|||
157212935|NCT02117479|567527727|FG000|Overall Study|Adverse Event|8|||
157212936|NCT02117479|567527728|FG001|Overall Study|Adverse Event|16|||
157212937|NCT02117479|567527727|FG000|Overall Study|Subject decision|8|||
157212938|NCT02117479|567527728|FG001|Overall Study|Subject decision|9|||
157212939|NCT02117479|567527727|FG000|Overall Study|Disease progression|104|||
157212940|NCT02117479|567527728|FG001|Overall Study|Disease progression|108|||
156781533|NCT00927082|565950092|FG002|Overall Study|Death|1|||
156781534|NCT00927082|565950093|FG003|Overall Study|Death|0|||
156781535|NCT00927082|565950090|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
156781536|NCT00927082|565950091|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
156781537|NCT00927082|565950092|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
156781538|NCT00927082|565950093|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
156781539|NCT00812097|565950094|FG000|Overall Study|Death|3|||
156781540|NCT00812097|565950095|FG001|Overall Study|Death|10|||
156781541|NCT00812097|565950096|FG002|Overall Study|Death|3|||
156781542|NCT00812097|565950097|FG003|Overall Study|Death|3|||
156781543|NCT00812097|565950094|FG000|Overall Study|Withdrawal by Subject|14|||
156781544|NCT00812097|565950095|FG001|Overall Study|Withdrawal by Subject|12|||
156781545|NCT00812097|565950096|FG002|Overall Study|Withdrawal by Subject|8|||
157119548|NCT03028870|567190725|FG002|Overall Study|Administrative|12|||
157212941|NCT02117479|567527727|FG000|Overall Study|Noncompliance with study treatment|1|||
156781546|NCT00812097|565950097|FG003|Overall Study|Withdrawal by Subject|2|||
157119549|NCT03028870|567190726|FG003|Overall Study|Administrative|4|||
157212942|NCT02117479|567527728|FG001|Overall Study|Noncompliance with study treatment|0|||
156781547|NCT00812097|565950094|FG000|Overall Study|Lost to Follow-up|90|||
156781548|NCT00812097|565950095|FG001|Overall Study|Lost to Follow-up|14|||
156781549|NCT00812097|565950096|FG002|Overall Study|Lost to Follow-up|17|||
156781550|NCT00812097|565950097|FG003|Overall Study|Lost to Follow-up|5|||
156781551|NCT00812097|565950094|FG000|Overall Study|Explantation of study device(s)|27|||
157011648|NCT01985334|566795455|FG001|Overall Study|Adverse Event|8|||
157011649|NCT01985334|566795456|FG002|Overall Study|Adverse Event|2|||
157011650|NCT01985334|566795457|FG003|Overall Study|Adverse Event|26|||
157011651|NCT01985334|566795458|FG004|Overall Study|Adverse Event|3|||
157011652|NCT01985334|566795459|FG005|Overall Study|Adverse Event|18|||
157011653|NCT01985334|566795460|FG006|Overall Study|Adverse Event|3|||
157011654|NCT01985334|566795461|FG007|Overall Study|Adverse Event|15|||
157011655|NCT01985334|566795454|FG000|Overall Study|Other|4|||
157011656|NCT01985334|566795455|FG001|Overall Study|Other|2|||
157011657|NCT01985334|566795456|FG002|Overall Study|Other|3|||
157011658|NCT01985334|566795457|FG003|Overall Study|Other|10|||
157011659|NCT01985334|566795458|FG004|Overall Study|Other|1|||
157011660|NCT01985334|566795459|FG005|Overall Study|Other|6|||
157011661|NCT01985334|566795460|FG006|Overall Study|Other|2|||
157011662|NCT01985334|566795461|FG007|Overall Study|Other|2|||
157011663|NCT01985334|566795454|FG000|Overall Study|Medication non-compliance|0|||
157011664|NCT01985334|566795455|FG001|Overall Study|Medication non-compliance|4|||
157011665|NCT01985334|566795456|FG002|Overall Study|Medication non-compliance|1|||
157011666|NCT01985334|566795457|FG003|Overall Study|Medication non-compliance|6|||
157011667|NCT01985334|566795458|FG004|Overall Study|Medication non-compliance|2|||
157011668|NCT01985334|566795459|FG005|Overall Study|Medication non-compliance|3|||
157011669|NCT01985334|566795460|FG006|Overall Study|Medication non-compliance|1|||
157011670|NCT01985334|566795461|FG007|Overall Study|Medication non-compliance|3|||
157011671|NCT01985334|566795454|FG000|Overall Study|Use of prohibited treatment|1|||
157011672|NCT01985334|566795455|FG001|Overall Study|Use of prohibited treatment|4|||
157011673|NCT01985334|566795456|FG002|Overall Study|Use of prohibited treatment|1|||
157011674|NCT01985334|566795457|FG003|Overall Study|Use of prohibited treatment|2|||
157011675|NCT01985334|566795458|FG004|Overall Study|Use of prohibited treatment|1|||
157011676|NCT01985334|566795459|FG005|Overall Study|Use of prohibited treatment|6|||
157011677|NCT01985334|566795460|FG006|Overall Study|Use of prohibited treatment|2|||
157011678|NCT01985334|566795461|FG007|Overall Study|Use of prohibited treatment|0|||
157011679|NCT01985334|566795454|FG000|Overall Study|Investigator decision|0|||
157011680|NCT01985334|566795455|FG001|Overall Study|Investigator decision|3|||
157011681|NCT01985334|566795456|FG002|Overall Study|Investigator decision|0|||
157011682|NCT01985334|566795457|FG003|Overall Study|Investigator decision|7|||
157011683|NCT01985334|566795458|FG004|Overall Study|Investigator decision|1|||
157011684|NCT01985334|566795459|FG005|Overall Study|Investigator decision|1|||
157011685|NCT01985334|566795460|FG006|Overall Study|Investigator decision|0|||
157011686|NCT01985334|566795461|FG007|Overall Study|Investigator decision|4|||
157011687|NCT01985334|566795454|FG000|Overall Study|Lost to Follow-up|0|||
157011688|NCT01985334|566795455|FG001|Overall Study|Lost to Follow-up|2|||
157011689|NCT01985334|566795456|FG002|Overall Study|Lost to Follow-up|0|||
157011690|NCT01985334|566795457|FG003|Overall Study|Lost to Follow-up|3|||
157011691|NCT01985334|566795458|FG004|Overall Study|Lost to Follow-up|1|||
157011692|NCT01985334|566795459|FG005|Overall Study|Lost to Follow-up|4|||
157011693|NCT01985334|566795460|FG006|Overall Study|Lost to Follow-up|0|||
157011694|NCT01985334|566795461|FG007|Overall Study|Lost to Follow-up|3|||
157011695|NCT01290341|566795462|FG000|Overall Study|Protocol Violation|7|||
157011696|NCT01290341|566795463|FG001|Overall Study|Protocol Violation|3|||
157011697|NCT01290341|566795462|FG000|Overall Study|Adverse Event|1|||
157011698|NCT01290341|566795463|FG001|Overall Study|Adverse Event|0|||
157011699|NCT01290341|566795462|FG000|Overall Study|Lost to Follow-up|21|||
157011700|NCT01290341|566795463|FG001|Overall Study|Lost to Follow-up|10|||
157011701|NCT01290341|566795462|FG000|Overall Study|Withdrawal by Subject|19|||
157011702|NCT01290341|566795463|FG001|Overall Study|Withdrawal by Subject|5|||
157011703|NCT01290341|566795462|FG000|Overall Study|Negative baseline culture and others|44|||
157011704|NCT01290341|566795463|FG001|Overall Study|Negative baseline culture and others|11|||
157011705|NCT03988023|566795464|FG000|Overall Study|Non-compliance|3|||
157011706|NCT03988023|566795465|FG001|Overall Study|Non-compliance|0|||
157011707|NCT03988023|566795464|FG000|Overall Study|Withdrawal by Subject|39|||
157011708|NCT03988023|566795465|FG001|Overall Study|Withdrawal by Subject|37|||
157011709|NCT03988023|566795464|FG000|Overall Study|Adverse Event|0|||
157011710|NCT03988023|566795465|FG001|Overall Study|Adverse Event|2|||
157011711|NCT03988023|566795464|FG000|Overall Study|Physician Decision|0|||
157011712|NCT03988023|566795465|FG001|Overall Study|Physician Decision|1|||
157011713|NCT03988023|566795464|FG000|Overall Study|Lost to Follow-up|5|||
157011714|NCT03988023|566795465|FG001|Overall Study|Lost to Follow-up|8|||
157011715|NCT03988023|566795464|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
157011716|NCT03988023|566795465|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
157011717|NCT03988023|566795464|FG000|Overall Study|Lack of Efficacy|3|||
157011718|NCT03988023|566795465|FG001|Overall Study|Lack of Efficacy|1|||
157011719|NCT03988023|566795464|FG000|Overall Study|COVID-19 pandemic|225|||
157011720|NCT03988023|566795465|FG001|Overall Study|COVID-19 pandemic|227|||
157011721|NCT00174382|566795466|FG000|Overall Study|Death|2|||
157011722|NCT00174382|566795466|FG000|Overall Study|Adverse Event|19|||
156781552|NCT00812097|565950095|FG001|Overall Study|Explantation of study device(s)|29|||
156781553|NCT00812097|565950096|FG002|Overall Study|Explantation of study device(s)|14|||
156781554|NCT00812097|565950097|FG003|Overall Study|Explantation of study device(s)|20|||
156781555|NCT00812097|565950094|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
156781556|NCT00812097|565950095|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
156781557|NCT00812097|565950096|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
156781558|NCT00812097|565950097|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
156781559|NCT01786109|565950099|FG000|Overall Study|fail manometry barostat tube placement|1|||
156781560|NCT01786109|565950100|FG001|Overall Study|fail manometry barostat tube placement|0|||
156781561|NCT01786109|565950101|FG002|Overall Study|fail manometry barostat tube placement|0|||
156781562|NCT01786109|565950099|FG000|Overall Study|unrelated illness|0|||
156781563|NCT01786109|565950100|FG001|Overall Study|unrelated illness|0|||
156781564|NCT01786109|565950101|FG002|Overall Study|unrelated illness|1|||
156781565|NCT01786109|565950099|FG000|Overall Study|adverse effects colon preparation|0|||
156781566|NCT01786109|565950100|FG001|Overall Study|adverse effects colon preparation|0|||
156781567|NCT01786109|565950101|FG002|Overall Study|adverse effects colon preparation|1|||
156781568|NCT00317369|565950104|FG000|Overall Study|Adverse Event|2|||
156781569|NCT00317369|565950105|FG001|Overall Study|Adverse Event|1|||
156781570|NCT00317369|565950106|FG002|Overall Study|Adverse Event|0|||
156781571|NCT00317369|565950104|FG000|Overall Study|Lack of Efficacy|0|||
157011723|NCT00174382|566795466|FG000|Overall Study|Withdrawal by Subject|6|||
157011724|NCT00174382|566795466|FG000|Overall Study|Protocol Violation|3|||
157011725|NCT00174382|566795466|FG000|Overall Study|Arrived early for last visit in error|1|||
157011726|NCT00174382|566795466|FG000|Overall Study|Subject felt pill not effective enough|1|||
157011727|NCT00174382|566795466|FG000|Overall Study|Lost to Follow-up|1|||
157011728|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
157011729|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
157011730|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
156781572|NCT00317369|565950105|FG001|Overall Study|Lack of Efficacy|1|||
156781573|NCT00317369|565950106|FG002|Overall Study|Lack of Efficacy|1|||
156781574|NCT00317369|565950104|FG000|Overall Study|Withdrawal by Subject|0|||
156781575|NCT00317369|565950105|FG001|Overall Study|Withdrawal by Subject|0|||
156781576|NCT00317369|565950106|FG002|Overall Study|Withdrawal by Subject|1|||
156781577|NCT02949934|565950111|FG000|Natural Drinking Period|Adverse Event|1|||
156781578|NCT02949934|565950112|FG001|Natural Drinking Period|Adverse Event|0|||
156781579|NCT02949934|565950113|FG002|Natural Drinking Period|Adverse Event|0|||
156781580|NCT02949934|565950114|FG003|Natural Drinking Period|Adverse Event|1|||
156781581|NCT02949934|565950115|FG004|Natural Drinking Period|Adverse Event|0|||
156781582|NCT02949934|565950116|FG005|Natural Drinking Period|Adverse Event|0|||
156781583|NCT02949934|565950111|FG000|Natural Drinking Period|Lost to Follow-up|0|||
156781584|NCT02949934|565950112|FG001|Natural Drinking Period|Lost to Follow-up|0|||
156781585|NCT02949934|565950113|FG002|Natural Drinking Period|Lost to Follow-up|0|||
156781586|NCT02949934|565950114|FG003|Natural Drinking Period|Lost to Follow-up|0|||
156781587|NCT02949934|565950115|FG004|Natural Drinking Period|Lost to Follow-up|1|||
156781588|NCT02949934|565950116|FG005|Natural Drinking Period|Lost to Follow-up|0|||
156781589|NCT02949934|565950111|FG000|Neuroimaging|Protocol Violation|2|||
156781590|NCT02949934|565950112|FG001|Neuroimaging|Protocol Violation|0|||
156781591|NCT02949934|565950113|FG002|Neuroimaging|Protocol Violation|0|||
156781592|NCT02949934|565950114|FG003|Neuroimaging|Protocol Violation|0|||
156781593|NCT02949934|565950115|FG004|Neuroimaging|Protocol Violation|1|||
156781594|NCT02949934|565950116|FG005|Neuroimaging|Protocol Violation|0|||
156781595|NCT02949934|565950111|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
156781596|NCT02949934|565950112|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
156781597|NCT02949934|565950113|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
156781598|NCT02949934|565950114|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
156781599|NCT02949934|565950115|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
156781600|NCT02949934|565950116|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
156781601|NCT02949934|565950111|FG000|Neuroimaging|Not scanned|0|||
156781602|NCT02949934|565950112|FG001|Neuroimaging|Not scanned|0|||
156781603|NCT02949934|565950113|FG002|Neuroimaging|Not scanned|1|||
156781604|NCT02949934|565950114|FG003|Neuroimaging|Not scanned|0|||
156781605|NCT02949934|565950115|FG004|Neuroimaging|Not scanned|0|||
156781606|NCT02949934|565950116|FG005|Neuroimaging|Not scanned|2|||
156781607|NCT02949934|565950111|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
157119550|NCT00317109|567190729|FG000|Overall Study|Withdrawal by Subject|2|||
157119551|NCT00317109|567190730|FG001|Overall Study|Withdrawal by Subject|0|||
157119552|NCT00317109|567190729|FG000|Overall Study|Migated/moved from study area|1|||
157119553|NCT00317109|567190730|FG001|Overall Study|Migated/moved from study area|0|||
157119554|NCT04472429|567190731|FG000|Randomized Period|Ongoing|90|||
156781608|NCT02949934|565950112|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
157119555|NCT04472429|567190732|FG001|Randomized Period|Ongoing|40|||
156781609|NCT02949934|565950113|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
156781610|NCT02949934|565950114|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
157119556|NCT04472429|567190733|FG002|Randomized Period|Ongoing|0|||
157212943|NCT02117479|567527727|FG000|Overall Study|Study terminated by the sponsor|4|||
157212944|NCT02117479|567527728|FG001|Overall Study|Study terminated by the sponsor|6|||
157212945|NCT02117479|567527727|FG000|Overall Study|Physician Decision|7|||
157212946|NCT02117479|567527728|FG001|Overall Study|Physician Decision|2|||
157212947|NCT02117479|567527727|FG000|Overall Study|Other unspecified|11|||
157212948|NCT02117479|567527728|FG001|Overall Study|Other unspecified|7|||
157212949|NCT02444182|567527729|FG000|Overall Study|non-compliance|2|||
157212950|NCT02444182|567527730|FG001|Overall Study|non-compliance|1|||
157212951|NCT02444182|567527729|FG000|Overall Study|Lost to Follow-up|0|||
157011731|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
157011732|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
157011733|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
157011734|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
157011735|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
157011736|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011737|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011738|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011739|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011740|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
157011741|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
157011742|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011743|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
157011744|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011745|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011746|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011747|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011748|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011749|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
157011750|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
157011751|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
157011752|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011753|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
157011754|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011755|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011756|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011757|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
157212952|NCT02444182|567527730|FG001|Overall Study|Lost to Follow-up|4|||
157212953|NCT01959230|567527731|FG000|Overall Study|Failure to follow study procedures|0|||
157212954|NCT01959230|567527732|FG001|Overall Study|Failure to follow study procedures|1|||
157212955|NCT01959230|567527731|FG000|Overall Study|Administrative reasons|2|||
157212956|NCT01959230|567527732|FG001|Overall Study|Administrative reasons|0|||
156781611|NCT02949934|565950115|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
156781612|NCT02949934|565950116|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
156781613|NCT02949934|565950111|FG000|Bar Laboratory|Adverse Event|1|||
156781614|NCT02949934|565950112|FG001|Bar Laboratory|Adverse Event|0|||
156781615|NCT02949934|565950113|FG002|Bar Laboratory|Adverse Event|2|||
156781616|NCT02949934|565950114|FG003|Bar Laboratory|Adverse Event|0|||
157011758|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011759|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
157011760|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
157011761|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
157212957|NCT01959230|567527731|FG000|Overall Study|Withdrawal by Subject|2|||
157212958|NCT01959230|567527732|FG001|Overall Study|Withdrawal by Subject|0|||
157011762|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
157011763|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
157011764|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
157011765|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
157011766|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
157011767|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
157011768|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011769|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011770|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011771|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
157011772|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011773|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011774|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011775|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
157011776|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
157011777|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
157011778|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
157011779|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
157011780|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
157011781|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
157011782|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
157011783|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
157011784|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
157011785|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011786|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011787|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011788|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011789|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
157011790|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011791|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
157011792|NCT03903822|566795471|FG000|Treatment Phase (6 Weeks)|Other|2|||
157011793|NCT03903822|566795472|FG001|Treatment Phase (6 Weeks)|Other|1|||
157011794|NCT03903822|566795473|FG002|Treatment Phase (6 Weeks)|Other|0|||
157011795|NCT03903822|566795474|FG003|Treatment Phase (6 Weeks)|Other|0|||
157011796|NCT03903822|566795475|FG004|Treatment Phase (6 Weeks)|Other|1|||
157011797|NCT03903822|566795476|FG005|Treatment Phase (6 Weeks)|Other|1|||
157011798|NCT03903822|566795477|FG006|Treatment Phase (6 Weeks)|Other|0|||
157011799|NCT03903822|566795478|FG007|Treatment Phase (6 Weeks)|Other|0|||
157011800|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
157011801|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
157011802|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
157011803|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
157011804|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
157011805|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
157011806|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
157011807|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
157011808|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011809|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011810|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011811|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011812|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
157011813|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011814|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011815|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
157011816|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
157011817|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
157011818|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
157011819|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
157011820|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
157011821|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
157011822|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
157011823|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
157011824|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
157011825|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
157011826|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
157011827|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
157011828|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
157011829|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
157011830|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
157011831|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
157119557|NCT04472429|567190731|FG000|Randomized Period|Death|52|||
157119558|NCT04472429|567190732|FG001|Randomized Period|Death|37|||
157119559|NCT04472429|567190733|FG002|Randomized Period|Death|0|||
157119560|NCT04472429|567190731|FG000|Randomized Period|Lost to Follow-up|4|||
157119561|NCT04472429|567190732|FG001|Randomized Period|Lost to Follow-up|0|||
157119562|NCT04472429|567190733|FG002|Randomized Period|Lost to Follow-up|0|||
157119563|NCT04472429|567190731|FG000|Randomized Period|Physician Decision|1|||
157119564|NCT04472429|567190732|FG001|Randomized Period|Physician Decision|2|||
157119565|NCT04472429|567190733|FG002|Randomized Period|Physician Decision|0|||
157119566|NCT04472429|567190731|FG000|Randomized Period|Withdrawal by Subject|6|||
157119567|NCT04472429|567190732|FG001|Randomized Period|Withdrawal by Subject|5|||
157119568|NCT04472429|567190733|FG002|Randomized Period|Withdrawal by Subject|0|||
157119569|NCT04472429|567190731|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
157119570|NCT04472429|567190732|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
157119571|NCT04472429|567190733|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
157119572|NCT04472429|567190731|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
157119573|NCT04472429|567190732|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
157119574|NCT04472429|567190733|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
157119575|NCT04472429|567190731|FG000|Open-label Monotherapy Period|Ongoing|0|||
156866591|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156866592|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
156866593|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
157119576|NCT04472429|567190732|FG001|Open-label Monotherapy Period|Ongoing|0|||
157119577|NCT04472429|567190733|FG002|Open-label Monotherapy Period|Ongoing|32|||
157119578|NCT04472429|567190731|FG000|Open-label Monotherapy Period|Death|0|||
157119579|NCT04472429|567190732|FG001|Open-label Monotherapy Period|Death|0|||
156781617|NCT02949934|565950115|FG004|Bar Laboratory|Adverse Event|1|||
156781618|NCT02949934|565950116|FG005|Bar Laboratory|Adverse Event|0|||
156781619|NCT02949934|565950111|FG000|Bar Laboratory|Protocol Violation|0|||
156781620|NCT02949934|565950112|FG001|Bar Laboratory|Protocol Violation|0|||
156781621|NCT02949934|565950113|FG002|Bar Laboratory|Protocol Violation|0|||
156781622|NCT02949934|565950114|FG003|Bar Laboratory|Protocol Violation|1|||
156781623|NCT02949934|565950115|FG004|Bar Laboratory|Protocol Violation|0|||
156781624|NCT02949934|565950116|FG005|Bar Laboratory|Protocol Violation|0|||
156781625|NCT00118287|565950120|FG000|Overall Study|Intracranial haemorrhage|1|||
156781626|NCT00118287|565950120|FG000|Overall Study|Muscle pain|1|||
156781627|NCT03010501|565950122|FG000|Study Week 1|Withdrawal by Subject|2|||
156781628|NCT03010501|565950123|FG001|Study Week 1|Withdrawal by Subject|1|||
156781629|NCT03010501|565950124|FG002|Study Week 1|Withdrawal by Subject|0|||
156781630|NCT03010501|565950125|FG003|Study Week 1|Withdrawal by Subject|2|||
156781631|NCT03010501|565950126|FG004|Study Week 1|Withdrawal by Subject|0|||
156781632|NCT03010501|565950127|FG005|Study Week 1|Withdrawal by Subject|0|||
156781633|NCT03010501|565950122|FG000|Study Week 3|Withdrawal by Subject|0|||
156781634|NCT03010501|565950123|FG001|Study Week 3|Withdrawal by Subject|0|||
156781635|NCT03010501|565950124|FG002|Study Week 3|Withdrawal by Subject|0|||
156781636|NCT03010501|565950125|FG003|Study Week 3|Withdrawal by Subject|1|||
156781637|NCT03010501|565950126|FG004|Study Week 3|Withdrawal by Subject|0|||
156781638|NCT03010501|565950127|FG005|Study Week 3|Withdrawal by Subject|0|||
156781639|NCT00544882|565950132|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
156781640|NCT00544882|565950133|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
156781641|NCT00544882|565950134|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
156781642|NCT00544882|565950132|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
156781643|NCT00544882|565950133|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
156781644|NCT00544882|565950134|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
156781645|NCT00544882|565950132|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
156866594|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866595|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866596|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866597|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866598|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866599|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
156866600|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
156866601|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866602|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866603|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866604|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866605|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866606|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
156866607|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
157212959|NCT01453374|567527733|FG000|Overall Study|Adverse Event|7|||
156781646|NCT00544882|565950133|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
156781647|NCT00544882|565950134|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
156781648|NCT00544882|565950132|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
156781649|NCT00544882|565950133|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
156781650|NCT00544882|565950134|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
157011832|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
157011833|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
157011834|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
157011835|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
157011836|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
157011837|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
157011838|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
157011839|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
157011840|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011841|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011842|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011843|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011844|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011845|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
157011846|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011847|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
157011848|NCT03903822|566795471|FG000|Follow up Phase (4 Weeks)|Other|1|||
157011849|NCT03903822|566795472|FG001|Follow up Phase (4 Weeks)|Other|1|||
157011850|NCT03903822|566795473|FG002|Follow up Phase (4 Weeks)|Other|0|||
157011851|NCT03903822|566795474|FG003|Follow up Phase (4 Weeks)|Other|0|||
157011852|NCT03903822|566795475|FG004|Follow up Phase (4 Weeks)|Other|0|||
157011853|NCT03903822|566795476|FG005|Follow up Phase (4 Weeks)|Other|0|||
157011854|NCT03903822|566795477|FG006|Follow up Phase (4 Weeks)|Other|0|||
157011855|NCT03903822|566795478|FG007|Follow up Phase (4 Weeks)|Other|0|||
157011856|NCT00785512|566795479|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
157011857|NCT00785512|566795480|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
157011858|NCT00785512|566795479|FG000|Overall Study|Adverse Event|0|||
157011859|NCT00785512|566795480|FG001|Overall Study|Adverse Event|0|||
157011860|NCT00785512|566795479|FG000|Overall Study|Lack of Efficacy|0|||
157011861|NCT00785512|566795480|FG001|Overall Study|Lack of Efficacy|2|||
157011862|NCT00785512|566795479|FG000|Overall Study|Withdrawal by Subject|0|||
157011863|NCT00785512|566795480|FG001|Overall Study|Withdrawal by Subject|1|||
157011864|NCT00785512|566795479|FG000|Overall Study|Lost to Follow-up|3|||
157011865|NCT00785512|566795480|FG001|Overall Study|Lost to Follow-up|0|||
157011866|NCT00785512|566795479|FG000|Overall Study|Precedure Refused|0|||
157011867|NCT00785512|566795480|FG001|Overall Study|Precedure Refused|0|||
157011868|NCT00785512|566795479|FG000|Overall Study|IVRS Programing Error|0|||
157011869|NCT00785512|566795480|FG001|Overall Study|IVRS Programing Error|0|||
157011870|NCT00785512|566795479|FG000|Overall Study|Physician Decision|0|||
157011871|NCT00785512|566795480|FG001|Overall Study|Physician Decision|0|||
157011872|NCT00785512|566795479|FG000|Overall Study|Lack of compliance|0|||
157011873|NCT00785512|566795480|FG001|Overall Study|Lack of compliance|1|||
157011874|NCT03403413|566795481|FG000|Overall Study|Lack of Efficacy|2|||
157011875|NCT03951805|566795483|FG000|Overall Study|Adverse Event|1|||
157011876|NCT03951805|566795484|FG001|Overall Study|Adverse Event|0|||
157011877|NCT03951805|566795485|FG002|Overall Study|Adverse Event|0|||
157011878|NCT03951805|566795486|FG003|Overall Study|Adverse Event|0|||
157011879|NCT03684044|566795491|FG000|Overall Study|Adverse Event|3|||
157011880|NCT03684044|566795492|FG001|Overall Study|Adverse Event|0|||
157011881|NCT03684044|566795491|FG000|Overall Study|Death|4|||
157011882|NCT03684044|566795492|FG001|Overall Study|Death|7|||
157011883|NCT03684044|566795491|FG000|Overall Study|Lost to Follow-up|3|||
157011884|NCT03684044|566795492|FG001|Overall Study|Lost to Follow-up|2|||
157011885|NCT03684044|566795491|FG000|Overall Study|Patient Not Available|0|||
157011886|NCT03684044|566795492|FG001|Overall Study|Patient Not Available|2|||
157011887|NCT03684044|566795491|FG000|Overall Study|Physician Decision|1|||
157011888|NCT03684044|566795492|FG001|Overall Study|Physician Decision|0|||
157011889|NCT03684044|566795491|FG000|Overall Study|Withdrawal by Subject|11|||
157011890|NCT03684044|566795492|FG001|Overall Study|Withdrawal by Subject|9|||
157011891|NCT03703336|566795493|FG000|Overall Study|Parent withdrew consent|29|||
157011892|NCT03703336|566795494|FG001|Overall Study|Parent withdrew consent|8|||
157011893|NCT03703336|566795493|FG000|Overall Study|Migration|3|||
157011894|NCT03703336|566795494|FG001|Overall Study|Migration|3|||
157011895|NCT03703336|566795493|FG000|Overall Study|Protocol Violation|3|||
157011896|NCT03703336|566795494|FG001|Overall Study|Protocol Violation|1|||
157011897|NCT03703336|566795493|FG000|Overall Study|Physician Decision|2|||
157011898|NCT03703336|566795494|FG001|Overall Study|Physician Decision|0|||
157011899|NCT03703336|566795493|FG000|Overall Study|Adverse Event|0|||
157011900|NCT03703336|566795494|FG001|Overall Study|Adverse Event|2|||
157011901|NCT03703336|566795493|FG000|Overall Study|Lost to Follow-up|1|||
157011902|NCT03703336|566795494|FG001|Overall Study|Lost to Follow-up|0|||
156781651|NCT00544882|565950132|FG000|Cycle 3: Follow-up|Noncompliance|0|||
157011903|NCT00595413|566795495|FG000|Overall Study|Adverse Event|0|||
157011904|NCT00595413|566795496|FG001|Overall Study|Adverse Event|2|||
157011905|NCT00595413|566795497|FG002|Overall Study|Adverse Event|1|||
157011906|NCT00595413|566795498|FG003|Overall Study|Adverse Event|1|||
157011907|NCT00595413|566795495|FG000|Overall Study|Lost to Follow-up|2|||
157011908|NCT00595413|566795496|FG001|Overall Study|Lost to Follow-up|2|||
157011909|NCT00595413|566795497|FG002|Overall Study|Lost to Follow-up|1|||
157011910|NCT00595413|566795498|FG003|Overall Study|Lost to Follow-up|3|||
157011911|NCT00595413|566795495|FG000|Overall Study|Death|0|||
157011912|NCT00595413|566795496|FG001|Overall Study|Death|0|||
157011913|NCT00595413|566795497|FG002|Overall Study|Death|1|||
157011914|NCT00595413|566795498|FG003|Overall Study|Death|0|||
157011915|NCT00595413|566795495|FG000|Overall Study|Other|5|||
157011916|NCT00595413|566795496|FG001|Overall Study|Other|1|||
157011917|NCT00595413|566795497|FG002|Overall Study|Other|5|||
157011918|NCT00595413|566795498|FG003|Overall Study|Other|0|||
157011919|NCT03233633|566795499|FG000|Overall Study|Adverse Event|2|||
157011920|NCT03233633|566795499|FG000|Overall Study|Less Than 3 Days of Data|6|||
157011921|NCT02088853|566795500|FG000|Overall Study|Pregnancy|1|||
157011922|NCT02088853|566795501|FG001|Overall Study|Pregnancy|0|||
157011923|NCT00603954|566795504|FG000|Overall Study|Protocol Violation|1|||
157011924|NCT00603954|566795505|FG001|Overall Study|Protocol Violation|2|||
157011925|NCT02708108|566795506|FG000|Overall Study|Death|1|||
157011926|NCT02708108|566795507|FG001|Overall Study|Death|2|||
157011927|NCT02708108|566795506|FG000|Overall Study|Regimen change|1|||
157011928|NCT02708108|566795507|FG001|Overall Study|Regimen change|0|||
157011929|NCT02708108|566795506|FG000|Overall Study|No MRD and no imaging available|0|||
157011930|NCT02708108|566795507|FG001|Overall Study|No MRD and no imaging available|1|||
157011931|NCT01388361|566795511|FG000|Overall Study|Adverse Event|0|||
157011932|NCT01388361|566795512|FG001|Overall Study|Adverse Event|5|||
157011933|NCT01388361|566795513|FG002|Overall Study|Adverse Event|1|||
157011934|NCT01388361|566795511|FG000|Overall Study|Protocol Violation|0|||
157011935|NCT01388361|566795512|FG001|Overall Study|Protocol Violation|0|||
157011936|NCT01388361|566795513|FG002|Overall Study|Protocol Violation|2|||
157011937|NCT01388361|566795511|FG000|Overall Study|Withdrawal criteria|12|||
157011938|NCT01388361|566795512|FG001|Overall Study|Withdrawal criteria|7|||
157011939|NCT01388361|566795513|FG002|Overall Study|Withdrawal criteria|10|||
157011940|NCT01388361|566795511|FG000|Overall Study|Unclassified|0|||
157011941|NCT01388361|566795512|FG001|Overall Study|Unclassified|0|||
157011942|NCT01388361|566795513|FG002|Overall Study|Unclassified|1|||
157011943|NCT02528188|566795514|FG000|Overall Study|Adverse Event|23|||
157011944|NCT02528188|566795515|FG001|Overall Study|Adverse Event|22|||
157011945|NCT02528188|566795516|FG002|Overall Study|Adverse Event|8|||
157011946|NCT02528188|566795514|FG000|Overall Study|Protocol Violation|4|||
157011947|NCT02528188|566795515|FG001|Overall Study|Protocol Violation|6|||
157011948|NCT02528188|566795516|FG002|Overall Study|Protocol Violation|4|||
157011949|NCT02528188|566795514|FG000|Overall Study|Lack of Efficacy|19|||
157011950|NCT02528188|566795515|FG001|Overall Study|Lack of Efficacy|21|||
157011951|NCT02528188|566795516|FG002|Overall Study|Lack of Efficacy|22|||
157011952|NCT02528188|566795514|FG000|Overall Study|Withdrawal by Subject|97|||
157011953|NCT02528188|566795515|FG001|Overall Study|Withdrawal by Subject|104|||
157011954|NCT02528188|566795516|FG002|Overall Study|Withdrawal by Subject|100|||
157011955|NCT02528188|566795514|FG000|Overall Study|Lost to Follow-up|25|||
157011956|NCT02528188|566795515|FG001|Overall Study|Lost to Follow-up|21|||
157011957|NCT02528188|566795516|FG002|Overall Study|Lost to Follow-up|31|||
157011958|NCT02528188|566795514|FG000|Overall Study|Death|4|||
157011959|NCT02528188|566795515|FG001|Overall Study|Death|4|||
157011960|NCT02528188|566795516|FG002|Overall Study|Death|0|||
157011961|NCT02528188|566795514|FG000|Overall Study|Other|89|||
157011962|NCT02528188|566795515|FG001|Overall Study|Other|91|||
157011963|NCT02528188|566795516|FG002|Overall Study|Other|74|||
157011964|NCT02528188|566795514|FG000|Overall Study|Randomized but not treated|6|||
157119580|NCT04472429|567190733|FG002|Open-label Monotherapy Period|Death|35|||
157011965|NCT02528188|566795515|FG001|Overall Study|Randomized but not treated|7|||
157011966|NCT02528188|566795516|FG002|Overall Study|Randomized but not treated|12|||
157011967|NCT05368831|566795517|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
157011968|NCT01083316|566795522|FG000|Overall Study|Adverse Event|2|||
157011969|NCT01083316|566795522|FG000|Overall Study|Withdrawal by Subject|1|||
156781652|NCT00544882|565950133|FG001|Cycle 3: Follow-up|Noncompliance|1|||
156781653|NCT00544882|565950134|FG002|Cycle 3: Follow-up|Noncompliance|0|||
156781654|NCT00544882|565950132|FG000|Cycle 3: Follow-up|Pregnancy|0|||
156781655|NCT00544882|565950133|FG001|Cycle 3: Follow-up|Pregnancy|1|||
156781656|NCT00544882|565950134|FG002|Cycle 3: Follow-up|Pregnancy|0|||
156781657|NCT04937387|565950135|FG000|Overall Study|Adverse Event|1|||
156781658|NCT04937387|565950136|FG001|Overall Study|Adverse Event|0|||
156781659|NCT04937387|565950137|FG002|Overall Study|Adverse Event|2|||
156781660|NCT04937387|565950138|FG003|Overall Study|Adverse Event|0|||
156781661|NCT04937387|565950135|FG000|Overall Study|Lack of Efficacy|1|||
156781662|NCT04937387|565950136|FG001|Overall Study|Lack of Efficacy|0|||
156781663|NCT04937387|565950137|FG002|Overall Study|Lack of Efficacy|0|||
156781664|NCT04937387|565950138|FG003|Overall Study|Lack of Efficacy|1|||
156781665|NCT04937387|565950135|FG000|Overall Study|Withdrawal by Subject|1|||
156781666|NCT04937387|565950136|FG001|Overall Study|Withdrawal by Subject|0|||
156781667|NCT04937387|565950137|FG002|Overall Study|Withdrawal by Subject|1|||
156781668|NCT04937387|565950138|FG003|Overall Study|Withdrawal by Subject|1|||
156781669|NCT04937387|565950135|FG000|Overall Study|Randomized in error|0|||
156781670|NCT04937387|565950136|FG001|Overall Study|Randomized in error|0|||
156781671|NCT04937387|565950137|FG002|Overall Study|Randomized in error|0|||
156781672|NCT04937387|565950138|FG003|Overall Study|Randomized in error|1|||
156781673|NCT02583269|565950139|FG000|Overall Study|Patient hospitalized prior to start|1|||
156781674|NCT02583269|565950140|FG001|Overall Study|Patient hospitalized prior to start|0|||
156781675|NCT02583269|565950141|FG002|Overall Study|Patient hospitalized prior to start|0|||
156781676|NCT02583269|565950142|FG003|Overall Study|Patient hospitalized prior to start|0|||
156781677|NCT02583269|565950143|FG004|Overall Study|Patient hospitalized prior to start|0|||
156781678|NCT02369458|565950145|FG000|Overall Study|Determined to be not eligible|1|||
156781679|NCT02369458|565950146|FG001|Overall Study|Determined to be not eligible|0|||
156781680|NCT05399485|565951468|FG000|DBT Phase|Other|6|||
156781681|NCT05399485|565951469|FG001|DBT Phase|Other|5|||
156781682|NCT05399485|565951468|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
156781683|NCT05399485|565951469|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
156781684|NCT05399485|565951468|FG000|DBT Phase|Withdrawal by Subject|3|||
156781685|NCT05399485|565951469|FG001|DBT Phase|Withdrawal by Subject|2|||
156781686|NCT05399485|565951468|FG000|DBT Phase|Protocol Violation|2|||
156781687|NCT05399485|565951469|FG001|DBT Phase|Protocol Violation|1|||
156781688|NCT05399485|565951468|FG000|DBT Phase|Physician Decision|0|||
156781689|NCT05399485|565951469|FG001|DBT Phase|Physician Decision|1|||
156781690|NCT05399485|565951468|FG000|DBT Phase|Adverse Event|2|||
156781691|NCT05399485|565951469|FG001|DBT Phase|Adverse Event|1|||
156781692|NCT05399485|565951468|FG000|OLE Phase|Protocol deviation|1|||
156781693|NCT05399485|565951469|FG001|OLE Phase|Protocol deviation|0|||
156781694|NCT05399485|565951468|FG000|OLE Phase|Other|5|||
156781695|NCT05399485|565951469|FG001|OLE Phase|Other|5|||
156781696|NCT05399485|565951468|FG000|OLE Phase|Withdrawal by Subject|12|||
156781697|NCT05399485|565951469|FG001|OLE Phase|Withdrawal by Subject|7|||
156781698|NCT05399485|565951468|FG000|OLE Phase|Pregnancy|0|||
156866608|NCT00129402|566271283|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156781699|NCT05399485|565951469|FG001|OLE Phase|Pregnancy|2|||
156781700|NCT05399485|565951468|FG000|OLE Phase|Physician Decision|3|||
157119581|NCT04472429|567190731|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
156781701|NCT05399485|565951469|FG001|OLE Phase|Physician Decision|0|||
156781702|NCT05399485|565951468|FG000|OLE Phase|Adverse Event|2|||
156781703|NCT05399485|565951469|FG001|OLE Phase|Adverse Event|2|||
156781704|NCT01363076|565951470|FG000|Overall Study|Withdrawal by Subject|0|||
156781705|NCT01363076|565951471|FG001|Overall Study|Withdrawal by Subject|1|||
156781706|NCT04706403|565951472|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
156781707|NCT04706403|565951473|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
156781708|NCT04706403|565951474|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
156781709|NCT04706403|565951475|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
156781710|NCT04706403|565951476|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
156781711|NCT02642679|565951477|FG000|Overall Study|Withdrawal by Subject|1|||
156781712|NCT02642679|565951477|FG000|Overall Study|Physician Decision|1|||
156781713|NCT02642679|565951477|FG000|Overall Study|Physician Decision|1|||
156781714|NCT01105130|565951478|FG000|Overall Study|Withdrawal by Subject|4|||
156781715|NCT01105130|565951479|FG001|Overall Study|Withdrawal by Subject|6|||
156781716|NCT01105130|565951480|FG002|Overall Study|Withdrawal by Subject|2|||
156781717|NCT01105130|565951478|FG000|Overall Study|Never Started|2|||
156781718|NCT01105130|565951479|FG001|Overall Study|Never Started|2|||
156781719|NCT01105130|565951480|FG002|Overall Study|Never Started|4|||
156781720|NCT01105130|565951478|FG000|Overall Study|Toxicity|1|||
156781721|NCT01105130|565951479|FG001|Overall Study|Toxicity|3|||
156781722|NCT01105130|565951480|FG002|Overall Study|Toxicity|2|||
157011970|NCT04200365|566795523|FG000|Overall Study|Adverse Event|2|||
157011971|NCT04200365|566795523|FG000|Overall Study|Progressive Disease|4|||
157011972|NCT04200365|566795523|FG000|Overall Study|Lack of Efficacy|1|||
157011973|NCT04200365|566795523|FG000|Overall Study|Study Closure|4|||
157011974|NCT01239316|566795526|FG000|Overall Study|Progression/Relapse|11|||
156781723|NCT01105130|565951478|FG000|Overall Study|Multiple Reasons|3|||
156781724|NCT01105130|565951479|FG001|Overall Study|Multiple Reasons|0|||
156781725|NCT01105130|565951480|FG002|Overall Study|Multiple Reasons|2|||
156781726|NCT02927145|565951481|FG000|Initial Recruitment|Withdrawal by Subject|0|||
156781727|NCT02927145|565951482|FG001|Initial Recruitment|Withdrawal by Subject|1|||
157011975|NCT01239316|566795526|FG000|Overall Study|Adverse Event|1|||
157212960|NCT01453374|567527733|FG000|Overall Study|Lack of Efficacy|1|||
157212961|NCT01453374|567527733|FG000|Overall Study|Lost to Follow-up|3|||
157212962|NCT01453374|567527733|FG000|Overall Study|Withdrawal by Subject|5|||
157011976|NCT04201834|566797303|FG000|Overall Study|Screen fail|1|||
157011977|NCT04139668|566797308|FG000|Overall Study|Withdrawal by Subject|1|||
157011978|NCT01903811|566797318|FG000|Overall Study|No measurable disease|1|||
157011979|NCT01903811|566797319|FG001|Overall Study|No measurable disease|1|||
157011980|NCT01903811|566797318|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
157011981|NCT01903811|566797319|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
157011982|NCT01903811|566797318|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
157011983|NCT01903811|566797319|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
157011984|NCT01903811|566797318|FG000|Overall Study|Withdrawal by Subject|0|||
157011985|NCT01903811|566797319|FG001|Overall Study|Withdrawal by Subject|1|||
157011986|NCT04440176|566797320|FG000|Overall Study|Withdrawal by Subject|5|||
157011987|NCT04440176|566797321|FG001|Overall Study|Withdrawal by Subject|3|||
157011988|NCT04440176|566797320|FG000|Overall Study|Withdrawal by parent/guardian|4|||
157011989|NCT04440176|566797321|FG001|Overall Study|Withdrawal by parent/guardian|5|||
157011990|NCT04440176|566797320|FG000|Overall Study|Adverse Event|2|||
157011991|NCT04440176|566797321|FG001|Overall Study|Adverse Event|6|||
157011992|NCT04440176|566797320|FG000|Overall Study|Lost to Follow-up|22|||
157011993|NCT04440176|566797321|FG001|Overall Study|Lost to Follow-up|23|||
157011994|NCT04440176|566797320|FG000|Overall Study|Medication error without associated adverse event|0|||
157011995|NCT04440176|566797321|FG001|Overall Study|Medication error without associated adverse event|1|||
157011996|NCT04440176|566797320|FG000|Overall Study|No longer met eligibility criteria|7|||
157011997|NCT04440176|566797321|FG001|Overall Study|No longer met eligibility criteria|1|||
157011998|NCT04440176|566797320|FG000|Overall Study|Other|1|||
157011999|NCT04440176|566797321|FG001|Overall Study|Other|2|||
156781728|NCT02927145|565951483|FG002|Initial Recruitment|Withdrawal by Subject|1|||
156781729|NCT02927145|565951484|FG003|Initial Recruitment|Withdrawal by Subject|4|||
156781730|NCT02927145|565951485|FG004|Initial Recruitment|Withdrawal by Subject|1|||
156781731|NCT02927145|565951486|FG005|Initial Recruitment|Withdrawal by Subject|1|||
156781732|NCT02927145|565951487|FG006|Initial Recruitment|Withdrawal by Subject|0|||
156781733|NCT02927145|565951488|FG007|Initial Recruitment|Withdrawal by Subject|0|||
156781734|NCT02927145|565951489|FG008|Initial Recruitment|Withdrawal by Subject|2|||
156781735|NCT02927145|565951481|FG000|Initial Recruitment|Adverse Event|0|||
156781736|NCT02927145|565951482|FG001|Initial Recruitment|Adverse Event|0|||
156781737|NCT02927145|565951483|FG002|Initial Recruitment|Adverse Event|0|||
157212963|NCT01453374|567527733|FG000|Overall Study|Incarcerated|2|||
157212964|NCT00447694|567527734|FG000|Overall Study|Adverse Event|2|||
156781738|NCT02927145|565951484|FG003|Initial Recruitment|Adverse Event|0|||
157212965|NCT00447694|567527734|FG000|Overall Study|Abnormal laboratory value|1|||
157212966|NCT00447694|567527734|FG000|Overall Study|Abnormal test procedure result|1|||
157119582|NCT04472429|567190732|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
157119583|NCT04472429|567190733|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
157119584|NCT01180660|567190734|FG000|Overall Study|Changed to open surgery|1|||
157119585|NCT01180660|567190735|FG001|Overall Study|Changed to open surgery|0|||
157119586|NCT03461757|567190736|FG000|Overall Study|Adverse Event|1|||
157119587|NCT03461757|567190737|FG001|Overall Study|Adverse Event|0|||
157119588|NCT03461757|567190736|FG000|Overall Study|Lost to Follow-up|13|||
157119589|NCT03461757|567190737|FG001|Overall Study|Lost to Follow-up|7|||
157119590|NCT03461757|567190736|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
157119591|NCT03461757|567190737|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
157119592|NCT03461757|567190736|FG000|Overall Study|Non-compliance with study treatment|0|||
157212967|NCT00447694|567527734|FG000|Overall Study|Withdrawal by Subject|2|||
157212968|NCT01965535|567527735|FG000|Overall Study|Lack of Efficacy|2|||
156781739|NCT02927145|565951485|FG004|Initial Recruitment|Adverse Event|2|||
157119593|NCT03461757|567190737|FG001|Overall Study|Non-compliance with study treatment|1|||
157119594|NCT03461757|567190736|FG000|Overall Study|Pregnancy|2|||
157212969|NCT01965535|567527736|FG001|Overall Study|Lack of Efficacy|1|||
157212970|NCT01169987|567527737|FG000|Overall Study|Withdrawal by Subject|3|||
157212971|NCT01169987|567527737|FG000|Overall Study|Lost to Follow-up|24|||
157212972|NCT01169987|567527737|FG000|Overall Study|Other|4|||
157119595|NCT03461757|567190737|FG001|Overall Study|Pregnancy|0|||
156781740|NCT02927145|565951486|FG005|Initial Recruitment|Adverse Event|0|||
156781741|NCT02927145|565951487|FG006|Initial Recruitment|Adverse Event|0|||
156781742|NCT02927145|565951488|FG007|Initial Recruitment|Adverse Event|0|||
157012000|NCT04440176|566797320|FG000|Overall Study|Protocol deviation|6|||
157212973|NCT00829439|567527738|FG000|Overall Study|Adverse Event|0|||
157212974|NCT00829439|567527739|FG001|Overall Study|Adverse Event|0|||
157212975|NCT00829439|567527740|FG002|Overall Study|Adverse Event|1|||
157212976|NCT00829439|567527741|FG003|Overall Study|Adverse Event|0|||
157212977|NCT00386100|567527742|FG000|Overall Study|Did not receive study medication|6|||
157212978|NCT00386100|567527743|FG001|Overall Study|Did not receive study medication|4|||
157212979|NCT00386100|567527742|FG000|Overall Study|Adverse Event|15|||
157212980|NCT00386100|567527743|FG001|Overall Study|Adverse Event|25|||
157212981|NCT00386100|567527742|FG000|Overall Study|Death|0|||
157212982|NCT00386100|567527743|FG001|Overall Study|Death|1|||
156781743|NCT02927145|565951489|FG008|Initial Recruitment|Adverse Event|0|||
157012001|NCT04440176|566797321|FG001|Overall Study|Protocol deviation|8|||
156781744|NCT02927145|565951481|FG000|Invitation for Additional Challenge|Pregnancy|0|||
156781745|NCT02927145|565951482|FG001|Invitation for Additional Challenge|Pregnancy|0|||
156781746|NCT02927145|565951483|FG002|Invitation for Additional Challenge|Pregnancy|0|||
156781747|NCT02927145|565951484|FG003|Invitation for Additional Challenge|Pregnancy|0|||
156781748|NCT02927145|565951485|FG004|Invitation for Additional Challenge|Pregnancy|0|||
156781749|NCT02927145|565951486|FG005|Invitation for Additional Challenge|Pregnancy|0|||
156781750|NCT02927145|565951487|FG006|Invitation for Additional Challenge|Pregnancy|1|||
156781751|NCT02927145|565951488|FG007|Invitation for Additional Challenge|Pregnancy|0|||
156781752|NCT02927145|565951489|FG008|Invitation for Additional Challenge|Pregnancy|0|||
156781753|NCT01471574|565951497|FG000|Treatment Period|Lack of Efficacy|12|||
156781754|NCT01471574|565951498|FG001|Treatment Period|Lack of Efficacy|4|||
156781755|NCT01471574|565951499|FG002|Treatment Period|Lack of Efficacy|14|||
156781756|NCT01471574|565951500|FG003|Treatment Period|Lack of Efficacy|1|||
156781757|NCT01471574|565951497|FG000|Treatment Period|Adverse Event|7|||
156781758|NCT01471574|565951498|FG001|Treatment Period|Adverse Event|3|||
156781759|NCT01471574|565951499|FG002|Treatment Period|Adverse Event|6|||
156781760|NCT01471574|565951500|FG003|Treatment Period|Adverse Event|1|||
156781761|NCT01471574|565951497|FG000|Treatment Period|Withdrawal by Subject|5|||
156781762|NCT01471574|565951498|FG001|Treatment Period|Withdrawal by Subject|1|||
156781763|NCT01471574|565951499|FG002|Treatment Period|Withdrawal by Subject|1|||
156781764|NCT01471574|565951500|FG003|Treatment Period|Withdrawal by Subject|0|||
156781765|NCT01471574|565951497|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
156781766|NCT01471574|565951498|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
156781767|NCT01471574|565951499|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
157012002|NCT04440176|566797320|FG000|Overall Study|Randomized but not vaccinated|6|||
156781768|NCT01471574|565951500|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
157012003|NCT04440176|566797321|FG001|Overall Study|Randomized but not vaccinated|3|||
157012004|NCT01631214|566797325|FG000|Overall Study|Withdrawal by Subject|276|||
157012005|NCT01631214|566797326|FG001|Overall Study|Withdrawal by Subject|290|||
157012006|NCT01631214|566797325|FG000|Overall Study|Death|113|||
156781769|NCT01471574|565951497|FG000|Treatment Period|Lost to Follow-up|1|||
156781770|NCT01471574|565951498|FG001|Treatment Period|Lost to Follow-up|2|||
156781771|NCT01471574|565951499|FG002|Treatment Period|Lost to Follow-up|2|||
156781772|NCT01471574|565951500|FG003|Treatment Period|Lost to Follow-up|0|||
156781773|NCT01471574|565951497|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
156781774|NCT01471574|565951498|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781775|NCT01471574|565951499|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781776|NCT01471574|565951500|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
156781777|NCT01471574|565951497|FG000|Treatment Period|Other|1|||
156781778|NCT01471574|565951498|FG001|Treatment Period|Other|0|||
156781779|NCT01471574|565951499|FG002|Treatment Period|Other|0|||
156781780|NCT01471574|565951500|FG003|Treatment Period|Other|0|||
156781781|NCT01471574|565951497|FG000|Follow-up Period|Withdrawal by Subject|3|||
156781782|NCT01471574|565951498|FG001|Follow-up Period|Withdrawal by Subject|0|||
156781783|NCT01471574|565951499|FG002|Follow-up Period|Withdrawal by Subject|3|||
156781784|NCT01471574|565951500|FG003|Follow-up Period|Withdrawal by Subject|1|||
156781785|NCT01471574|565951497|FG000|Follow-up Period|Lost to Follow-up|4|||
157012007|NCT01631214|566797326|FG001|Overall Study|Death|106|||
157012008|NCT01631214|566797325|FG000|Overall Study|Lost to Follow-up|54|||
157012009|NCT01631214|566797326|FG001|Overall Study|Lost to Follow-up|40|||
157012010|NCT01631214|566797325|FG000|Overall Study|Adverse Event|45|||
157012011|NCT01631214|566797326|FG001|Overall Study|Adverse Event|45|||
157012012|NCT01631214|566797325|FG000|Overall Study|Other|22|||
157012013|NCT01631214|566797326|FG001|Overall Study|Other|19|||
157012014|NCT01631214|566797325|FG000|Overall Study|Noncompliance|16|||
157012015|NCT01631214|566797326|FG001|Overall Study|Noncompliance|15|||
157012016|NCT01631214|566797325|FG000|Overall Study|Requirement for Alternative Therapy|8|||
157012017|NCT01631214|566797326|FG001|Overall Study|Requirement for Alternative Therapy|3|||
157012018|NCT01631214|566797325|FG000|Overall Study|Protocol Deviation|4|||
157012019|NCT01631214|566797326|FG001|Overall Study|Protocol Deviation|3|||
156781786|NCT01471574|565951498|FG001|Follow-up Period|Lost to Follow-up|1|||
156781787|NCT01471574|565951499|FG002|Follow-up Period|Lost to Follow-up|3|||
157012020|NCT01631214|566797325|FG000|Overall Study|Ineligibility determined|5|||
157012021|NCT01631214|566797326|FG001|Overall Study|Ineligibility determined|2|||
157012022|NCT01631214|566797325|FG000|Overall Study|Administrative Decision|1|||
157012023|NCT01631214|566797326|FG001|Overall Study|Administrative Decision|0|||
156781788|NCT01471574|565951500|FG003|Follow-up Period|Lost to Follow-up|2|||
156781789|NCT01471574|565951497|FG000|Follow-up Period|Death|0|||
156781790|NCT01471574|565951498|FG001|Follow-up Period|Death|0|||
156781791|NCT01471574|565951499|FG002|Follow-up Period|Death|1|||
156781792|NCT01471574|565951500|FG003|Follow-up Period|Death|0|||
156781793|NCT01471574|565951497|FG000|Follow-up Period|Follow-up no longer required|0|||
156781794|NCT01471574|565951498|FG001|Follow-up Period|Follow-up no longer required|1|||
156781795|NCT01471574|565951499|FG002|Follow-up Period|Follow-up no longer required|0|||
156781796|NCT01471574|565951500|FG003|Follow-up Period|Follow-up no longer required|0|||
156781797|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
156781798|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
156781799|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
157012024|NCT03575052|566797327|FG000|Overall Study|Adverse Event|6|||
156781800|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
156781801|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
156781802|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
156781803|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
157119596|NCT03461757|567190736|FG000|Overall Study|Protocol Violation|1|||
157119597|NCT03461757|567190737|FG001|Overall Study|Protocol Violation|1|||
156781804|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
156781805|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
156781806|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
156781807|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
156866609|NCT00129402|566271284|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156781808|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
156781809|NCT00447278|565951503|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
156781810|NCT00447278|565951504|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
156781811|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
156781812|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
156781813|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
156781814|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
156781815|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
156781816|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
156781817|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
156781818|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
156781819|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
156781820|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
156866610|NCT00129402|566271285|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
157012025|NCT03575052|566797328|FG001|Overall Study|Adverse Event|10|||
156866611|NCT00129402|566271286|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
157012026|NCT03575052|566797327|FG000|Overall Study|Not further specified|5|||
156781821|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
156781822|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
156781823|NCT00447278|565951503|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
157012027|NCT03575052|566797328|FG001|Overall Study|Not further specified|7|||
156866612|NCT00129402|566271287|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
157012028|NCT03575052|566797327|FG000|Overall Study|Withdrawal by Subject|5|||
157012029|NCT03575052|566797328|FG001|Overall Study|Withdrawal by Subject|6|||
156781824|NCT00447278|565951504|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
156781825|NCT03677401|565951505|FG000|Overall Study|Adverse Event|4|||
157012030|NCT03575052|566797327|FG000|Overall Study|Lost to Follow-up|3|||
157212983|NCT00386100|567527742|FG000|Overall Study|Insufficient therapeutic effect|30|||
157212984|NCT00386100|567527743|FG001|Overall Study|Insufficient therapeutic effect|6|||
157212985|NCT00386100|567527742|FG000|Overall Study|Lost to Follow-up|29|||
157212986|NCT00386100|567527743|FG001|Overall Study|Lost to Follow-up|29|||
156781826|NCT03677401|565951506|FG001|Overall Study|Adverse Event|14|||
156781827|NCT03677401|565951505|FG000|Overall Study|Lack of Efficacy|3|||
156781828|NCT03677401|565951506|FG001|Overall Study|Lack of Efficacy|1|||
156781829|NCT03677401|565951505|FG000|Overall Study|Withdrawal by Subject|2|||
156781830|NCT03677401|565951506|FG001|Overall Study|Withdrawal by Subject|2|||
156781831|NCT03677401|565951505|FG000|Overall Study|Sponsor decision|0|||
156781832|NCT03677401|565951506|FG001|Overall Study|Sponsor decision|1|||
156781833|NCT03677401|565951505|FG000|Overall Study|Reason Unspecified|1|||
156781834|NCT03677401|565951506|FG001|Overall Study|Reason Unspecified|0|||
156781835|NCT03927157|565951508|FG000|Overall Study|Adverse Event|1|||
156781836|NCT03927157|565951509|FG001|Overall Study|Adverse Event|3|||
156781837|NCT03927157|565951508|FG000|Overall Study|Protocol Violation|1|||
156781838|NCT03927157|565951509|FG001|Overall Study|Protocol Violation|2|||
156781839|NCT03927157|565951508|FG000|Overall Study|Withdrawal by Subject|8|||
156781840|NCT03927157|565951509|FG001|Overall Study|Withdrawal by Subject|21|||
156781841|NCT03927157|565951508|FG000|Overall Study|Due to COVID-19 pandemic|5|||
156781842|NCT03927157|565951509|FG001|Overall Study|Due to COVID-19 pandemic|2|||
156781843|NCT03927157|565951508|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
156781844|NCT03927157|565951509|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
156781845|NCT03927157|565951508|FG000|Overall Study|Other than above|0|||
157012031|NCT03575052|566797328|FG001|Overall Study|Lost to Follow-up|0|||
156781846|NCT03927157|565951509|FG001|Overall Study|Other than above|1|||
156781847|NCT02265744|565951510|FG000|Overall Study|Poor/Non-compliance|1|||
156781848|NCT02265744|565951511|FG001|Overall Study|Poor/Non-compliance|1|||
156781849|NCT02265744|565951512|FG002|Overall Study|Poor/Non-compliance|0|||
156781850|NCT02265744|565951513|FG003|Overall Study|Poor/Non-compliance|0|||
156781851|NCT02265744|565951514|FG004|Overall Study|Poor/Non-compliance|2|||
156781852|NCT02265744|565951510|FG000|Overall Study|Lost to Follow-up|0|||
156781853|NCT02265744|565951511|FG001|Overall Study|Lost to Follow-up|0|||
157212987|NCT00386100|567527742|FG000|Overall Study|Non-compliance|18|||
157212988|NCT00386100|567527743|FG001|Overall Study|Non-compliance|19|||
157212989|NCT00386100|567527742|FG000|Overall Study|Protocol Violation|5|||
157212990|NCT00386100|567527743|FG001|Overall Study|Protocol Violation|3|||
157212991|NCT00386100|567527742|FG000|Overall Study|Withdrawal by Subject|32|||
157212992|NCT00386100|567527743|FG001|Overall Study|Withdrawal by Subject|31|||
157212993|NCT00386100|567527742|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
157212994|NCT00386100|567527743|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
157212995|NCT00386100|567527742|FG000|Overall Study|BMD <2.5|1|||
157212996|NCT00386100|567527743|FG001|Overall Study|BMD <2.5|0|||
157212997|NCT00386100|567527742|FG000|Overall Study|Consecutive elevated Hba1C|1|||
157212998|NCT00386100|567527743|FG001|Overall Study|Consecutive elevated Hba1C|0|||
157212999|NCT00386100|567527742|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
157213000|NCT00386100|567527743|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
157213001|NCT00386100|567527742|FG000|Overall Study|Laboratory findings|1|||
157213002|NCT00386100|567527743|FG001|Overall Study|Laboratory findings|0|||
157213003|NCT00386100|567527742|FG000|Overall Study|Participant's concern due to CPK levels|1|||
157213004|NCT00386100|567527743|FG001|Overall Study|Participant's concern due to CPK levels|0|||
157213005|NCT00386100|567527742|FG000|Overall Study|Participant moving out of state|2|||
157213006|NCT00386100|567527743|FG001|Overall Study|Participant moving out of state|0|||
157213007|NCT00386100|567527742|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
157213008|NCT00386100|567527743|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
157213009|NCT00386100|567527742|FG000|Overall Study|Didn't meet entry criteria|1|||
156781854|NCT02265744|565951512|FG002|Overall Study|Lost to Follow-up|0|||
157213010|NCT00386100|567527743|FG001|Overall Study|Didn't meet entry criteria|1|||
157213011|NCT00386100|567527742|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
156781855|NCT02265744|565951513|FG003|Overall Study|Lost to Follow-up|1|||
156781856|NCT02265744|565951514|FG004|Overall Study|Lost to Follow-up|0|||
157213012|NCT00386100|567527743|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
157213013|NCT00386100|567527742|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
157213014|NCT00386100|567527743|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
157213015|NCT00386100|567527742|FG000|Overall Study|Bad metabolic control & patient security|1|||
157213016|NCT00386100|567527743|FG001|Overall Study|Bad metabolic control & patient security|0|||
157213017|NCT00386100|567527742|FG000|Overall Study|Bone loss by DXA bone scan|1|||
157213018|NCT00386100|567527743|FG001|Overall Study|Bone loss by DXA bone scan|0|||
157213019|NCT00386100|567527742|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
157213020|NCT00386100|567527743|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
157213021|NCT00386100|567527742|FG000|Overall Study|7.6% bone loss|1|||
157213022|NCT00386100|567527743|FG001|Overall Study|7.6% bone loss|0|||
157213023|NCT00386100|567527742|FG000|Overall Study|Osteoporosis|0|||
157213024|NCT00386100|567527743|FG001|Overall Study|Osteoporosis|1|||
156781857|NCT02265744|565951510|FG000|Overall Study|Death|0|||
157213025|NCT00386100|567527742|FG000|Overall Study|Positive pregnancy test|1|||
157213026|NCT00386100|567527743|FG001|Overall Study|Positive pregnancy test|3|||
157213027|NCT00386100|567527742|FG000|Overall Study|Out of country for 5 months|1|||
157213028|NCT00386100|567527743|FG001|Overall Study|Out of country for 5 months|0|||
157213029|NCT00386100|567527742|FG000|Overall Study|Hb1Ac >8%|0|||
157213030|NCT00386100|567527743|FG001|Overall Study|Hb1Ac >8%|1|||
157213031|NCT00386100|567527742|FG000|Overall Study|Participant randomized in error|1|||
157213032|NCT00386100|567527743|FG001|Overall Study|Participant randomized in error|0|||
157213033|NCT02525562|567527744|FG000|Overall Study|Death|9|||
157213034|NCT02525562|567527745|FG001|Overall Study|Death|0|||
157213035|NCT02525562|567527746|FG002|Overall Study|Death|0|||
157213036|NCT02525562|567527744|FG000|Overall Study|Lost to Follow-up|19|||
157213037|NCT02525562|567527745|FG001|Overall Study|Lost to Follow-up|0|||
157213038|NCT02525562|567527746|FG002|Overall Study|Lost to Follow-up|0|||
157213039|NCT02525562|567527744|FG000|Overall Study|Withdrawal by Subject|37|||
157213040|NCT02525562|567527745|FG001|Overall Study|Withdrawal by Subject|0|||
157213041|NCT02525562|567527746|FG002|Overall Study|Withdrawal by Subject|0|||
157213042|NCT02525562|567527744|FG000|Overall Study|Revision/Removal of Study Device|4|||
156781858|NCT02265744|565951511|FG001|Overall Study|Death|0|||
156781859|NCT02265744|565951512|FG002|Overall Study|Death|0|||
157213043|NCT02525562|567527745|FG001|Overall Study|Revision/Removal of Study Device|0|||
157213044|NCT02525562|567527746|FG002|Overall Study|Revision/Removal of Study Device|0|||
157213045|NCT02525562|567527744|FG000|Overall Study|Study Closed by Sponsor|154|||
157213046|NCT02525562|567527745|FG001|Overall Study|Study Closed by Sponsor|0|||
157213047|NCT02525562|567527746|FG002|Overall Study|Study Closed by Sponsor|0|||
157213048|NCT00886782|567527749|FG000|Overall Study|Disease progression|3|||
157213049|NCT00886782|567527750|FG001|Overall Study|Disease progression|3|||
157213050|NCT00886782|567527751|FG002|Overall Study|Disease progression|3|||
156781860|NCT02265744|565951513|FG003|Overall Study|Death|2|||
156781861|NCT02265744|565951514|FG004|Overall Study|Death|0|||
156781862|NCT02265744|565951510|FG000|Overall Study|Withdrawal by Subject|2|||
156781863|NCT02265744|565951511|FG001|Overall Study|Withdrawal by Subject|0|||
156781864|NCT02265744|565951512|FG002|Overall Study|Withdrawal by Subject|0|||
156781865|NCT02265744|565951513|FG003|Overall Study|Withdrawal by Subject|2|||
156781866|NCT02265744|565951514|FG004|Overall Study|Withdrawal by Subject|0|||
156781867|NCT02265744|565951510|FG000|Overall Study|Participant request to discontinue|2|||
156781868|NCT02265744|565951511|FG001|Overall Study|Participant request to discontinue|2|||
156781869|NCT02265744|565951512|FG002|Overall Study|Participant request to discontinue|2|||
156781870|NCT02265744|565951513|FG003|Overall Study|Participant request to discontinue|0|||
156781871|NCT02265744|565951514|FG004|Overall Study|Participant request to discontinue|0|||
156781872|NCT02265744|565951510|FG000|Overall Study|Adverse Event|8|||
157213051|NCT00886782|567527749|FG000|Overall Study|Study drug toxicity|0|||
157213052|NCT00886782|567527750|FG001|Overall Study|Study drug toxicity|0|||
157213053|NCT00886782|567527751|FG002|Overall Study|Study drug toxicity|1|||
156781873|NCT02265744|565951511|FG001|Overall Study|Adverse Event|4|||
156781874|NCT02265744|565951512|FG002|Overall Study|Adverse Event|9|||
156781875|NCT02265744|565951513|FG003|Overall Study|Adverse Event|8|||
156781876|NCT02265744|565951514|FG004|Overall Study|Adverse Event|2|||
156781877|NCT02265744|565951510|FG000|Overall Study|Lack of Efficacy|2|||
157213054|NCT00886782|567527749|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
157213055|NCT00886782|567527750|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
157213056|NCT00886782|567527751|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
157213057|NCT00849524|567527752|FG000|Overall Study|Lack of Efficacy|3|||
157213058|NCT00078819|567527753|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
157213059|NCT00078819|567527754|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
157213060|NCT00078819|567527755|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
157213061|NCT00078819|567527756|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
157213062|NCT00078819|567527753|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
157213063|NCT00078819|567527754|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
157213064|NCT00078819|567527755|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
157213065|NCT00078819|567527756|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
157213066|NCT00078819|567527753|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
157213067|NCT00078819|567527754|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
157213068|NCT00078819|567527755|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
157213069|NCT00078819|567527756|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
157213070|NCT00078819|567527753|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
157213071|NCT00078819|567527754|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
157213072|NCT00078819|567527755|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
157213073|NCT00078819|567527756|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
157213074|NCT00078819|567527753|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
157213075|NCT00078819|567527754|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
157213076|NCT00078819|567527755|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
157213077|NCT00078819|567527756|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
157213078|NCT00078819|567527753|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
157213079|NCT00078819|567527754|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
157213080|NCT00078819|567527755|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
157213081|NCT00078819|567527756|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
157213082|NCT00078819|567527753|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
157213083|NCT00078819|567527754|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
157213084|NCT00078819|567527755|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
157213085|NCT00078819|567527756|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
157213086|NCT00078819|567527753|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
157213087|NCT00078819|567527754|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
157213088|NCT00078819|567527755|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
157213089|NCT00078819|567527756|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
157213090|NCT02555618|567527757|FG000|Overall Study|Sponsor's Circumstances|1|||
157213091|NCT02555618|567527758|FG001|Overall Study|Sponsor's Circumstances|0|||
157213092|NCT02217345|567527759|FG000|Overall Study|Lost to Follow-up|2|||
157213093|NCT02217345|567527760|FG001|Overall Study|Lost to Follow-up|1|||
157213094|NCT02217345|567527759|FG000|Overall Study|Withdrawal by Subject|3|||
157213095|NCT02217345|567527760|FG001|Overall Study|Withdrawal by Subject|2|||
157213096|NCT02217345|567527759|FG000|Overall Study|Adverse Event|2|||
157213097|NCT02217345|567527760|FG001|Overall Study|Adverse Event|1|||
157213098|NCT02217345|567527759|FG000|Overall Study|Physician Decision|0|||
157213099|NCT02217345|567527760|FG001|Overall Study|Physician Decision|1|||
156781878|NCT02265744|565951511|FG001|Overall Study|Lack of Efficacy|4|||
156781879|NCT02265744|565951512|FG002|Overall Study|Lack of Efficacy|3|||
157012032|NCT03575052|566797327|FG000|Overall Study|Death|2|||
157012033|NCT03575052|566797328|FG001|Overall Study|Death|1|||
157012034|NCT03575052|566797327|FG000|Overall Study|Lack of Efficacy|2|||
157012035|NCT03575052|566797328|FG001|Overall Study|Lack of Efficacy|1|||
157012036|NCT03575052|566797327|FG000|Overall Study|Study drug noncompliance|1|||
157012037|NCT03575052|566797328|FG001|Overall Study|Study drug noncompliance|2|||
157012038|NCT03575052|566797327|FG000|Overall Study|Protocol Violation|0|||
157213100|NCT00971204|567527761|FG000|Overall Study|Did not meet all criteria-not treated|14|||
157213101|NCT00971204|567527761|FG000|Overall Study|Lost to Follow-up|10|||
157213102|NCT04130919|567527762|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
157213103|NCT04130919|567527763|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
157012039|NCT03575052|566797328|FG001|Overall Study|Protocol Violation|2|||
157012040|NCT03575052|566797327|FG000|Overall Study|Physician Decision|1|||
157012041|NCT03575052|566797328|FG001|Overall Study|Physician Decision|0|||
157012042|NCT04188379|566797329|FG000|Overall Study|Withdrawal by Subject|10|||
157213104|NCT04130919|567527764|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
157213105|NCT04130919|567527765|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
157213106|NCT04130919|567527766|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
157213107|NCT04130919|567527767|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
157213108|NCT04130919|567527762|FG000|Blinded Treatment Phase|Adverse Event|0|||
157213109|NCT04130919|567527763|FG001|Blinded Treatment Phase|Adverse Event|0|||
157213110|NCT04130919|567527764|FG002|Blinded Treatment Phase|Adverse Event|1|||
157213111|NCT04130919|567527765|FG003|Blinded Treatment Phase|Adverse Event|0|||
157213112|NCT04130919|567527766|FG004|Blinded Treatment Phase|Adverse Event|0|||
157213113|NCT04130919|567527767|FG005|Blinded Treatment Phase|Adverse Event|0|||
157213114|NCT04130919|567527762|FG000|Blinded Treatment Phase|Disease worsening|0|||
157213115|NCT04130919|567527763|FG001|Blinded Treatment Phase|Disease worsening|0|||
157012043|NCT04188379|566797330|FG001|Overall Study|Withdrawal by Subject|3|||
157213116|NCT04130919|567527764|FG002|Blinded Treatment Phase|Disease worsening|1|||
157213117|NCT04130919|567527765|FG003|Blinded Treatment Phase|Disease worsening|0|||
157213118|NCT04130919|567527766|FG004|Blinded Treatment Phase|Disease worsening|0|||
157213119|NCT04130919|567527767|FG005|Blinded Treatment Phase|Disease worsening|0|||
157213120|NCT04130919|567527762|FG000|Blinded Treatment Phase|Investigator's decision|0|||
156781880|NCT02265744|565951513|FG003|Overall Study|Lack of Efficacy|4|||
156781881|NCT02265744|565951514|FG004|Overall Study|Lack of Efficacy|5|||
157213121|NCT04130919|567527763|FG001|Blinded Treatment Phase|Investigator's decision|1|||
157213122|NCT04130919|567527764|FG002|Blinded Treatment Phase|Investigator's decision|0|||
157213123|NCT04130919|567527765|FG003|Blinded Treatment Phase|Investigator's decision|0|||
157213124|NCT04130919|567527766|FG004|Blinded Treatment Phase|Investigator's decision|0|||
157213125|NCT04130919|567527767|FG005|Blinded Treatment Phase|Investigator's decision|0|||
157213126|NCT04130919|567527762|FG000|Blinded Treatment Phase|Withdrew consent|1|||
157012044|NCT04188379|566797329|FG000|Overall Study|Physician Decision|0|||
157012045|NCT04188379|566797330|FG001|Overall Study|Physician Decision|1|||
157012046|NCT04188379|566797329|FG000|Overall Study|Adverse Event|3|||
157012047|NCT04188379|566797330|FG001|Overall Study|Adverse Event|1|||
157012048|NCT04188379|566797329|FG000|Overall Study|Pregnancy|1|||
157012049|NCT04188379|566797330|FG001|Overall Study|Pregnancy|0|||
157012050|NCT04188379|566797329|FG000|Overall Study|Lack of Efficacy|8|||
157012051|NCT04188379|566797330|FG001|Overall Study|Lack of Efficacy|5|||
157012052|NCT04188379|566797329|FG000|Overall Study|Other|0|||
157012053|NCT04188379|566797330|FG001|Overall Study|Other|3|||
157012054|NCT05288283|566797341|FG000|Overall Study|Study Terminated Early|1|||
157012055|NCT05288283|566797342|FG001|Overall Study|Study Terminated Early|1|||
157012056|NCT03624972|566797347|FG000|Overall Study|Lost to Follow-up|2|||
157012057|NCT03624972|566797348|FG001|Overall Study|Lost to Follow-up|0|||
157012058|NCT03624972|566797349|FG002|Overall Study|Lost to Follow-up|0|||
157012059|NCT03624972|566797347|FG000|Overall Study|Withdrawal by Subject|0|||
157012060|NCT03624972|566797348|FG001|Overall Study|Withdrawal by Subject|2|||
157012061|NCT03624972|566797349|FG002|Overall Study|Withdrawal by Subject|0|||
157012062|NCT03112174|566797350|FG000|Overall Study|Withdrawal by Subject|3|||
157012063|NCT03112174|566797351|FG001|Overall Study|Withdrawal by Subject|0|||
157012064|NCT03112174|566797352|FG002|Overall Study|Withdrawal by Subject|11|||
157012065|NCT03112174|566797353|FG003|Overall Study|Withdrawal by Subject|9|||
157012066|NCT03112174|566797354|FG004|Overall Study|Withdrawal by Subject|7|||
157012067|NCT03112174|566797350|FG000|Overall Study|Lost to Follow-up|1|||
157012068|NCT03112174|566797351|FG001|Overall Study|Lost to Follow-up|1|||
157012069|NCT03112174|566797352|FG002|Overall Study|Lost to Follow-up|2|||
157012070|NCT03112174|566797353|FG003|Overall Study|Lost to Follow-up|3|||
157012071|NCT03112174|566797354|FG004|Overall Study|Lost to Follow-up|2|||
157012072|NCT03112174|566797350|FG000|Overall Study|Death|8|||
157012073|NCT03112174|566797351|FG001|Overall Study|Death|3|||
157012074|NCT03112174|566797352|FG002|Overall Study|Death|67|||
157012075|NCT03112174|566797353|FG003|Overall Study|Death|73|||
157012076|NCT03112174|566797354|FG004|Overall Study|Death|18|||
157012077|NCT03112174|566797350|FG000|Overall Study|Other, Not Specified|1|||
157012078|NCT03112174|566797351|FG001|Overall Study|Other, Not Specified|0|||
157012079|NCT03112174|566797352|FG002|Overall Study|Other, Not Specified|1|||
157012080|NCT03112174|566797353|FG003|Overall Study|Other, Not Specified|2|||
157012081|NCT03112174|566797354|FG004|Overall Study|Other, Not Specified|0|||
157012082|NCT05773313|566797357|FG000|Overall Study|Lost to Follow-up|3|||
157012083|NCT05137236|566797358|FG000|Part A|Other than Specified|1|||
157012084|NCT05137236|566797359|FG001|Part A|Other than Specified|0|||
157012085|NCT05137236|566797360|FG002|Part A|Other than Specified|0|||
157012086|NCT05137236|566797361|FG003|Part A|Other than Specified|0|||
157012087|NCT05137236|566797362|FG004|Part A|Other than Specified|0|||
157012088|NCT05137236|566797363|FG005|Part A|Other than Specified|0|||
157012089|NCT05137236|566797364|FG006|Part A|Other than Specified|0|||
157012090|NCT05137236|566797365|FG007|Part A|Other than Specified|0|||
157012091|NCT05137236|566797358|FG000|Part A|Withdrawal by Subject|0|||
157012092|NCT05137236|566797359|FG001|Part A|Withdrawal by Subject|4|||
157012093|NCT05137236|566797360|FG002|Part A|Withdrawal by Subject|1|||
157012094|NCT05137236|566797361|FG003|Part A|Withdrawal by Subject|1|||
157012095|NCT05137236|566797362|FG004|Part A|Withdrawal by Subject|3|||
157012096|NCT05137236|566797363|FG005|Part A|Withdrawal by Subject|2|||
157012097|NCT05137236|566797364|FG006|Part A|Withdrawal by Subject|0|||
157012098|NCT05137236|566797365|FG007|Part A|Withdrawal by Subject|0|||
157012099|NCT05137236|566797358|FG000|Part A|Lost to Follow-up|5|||
157012100|NCT05137236|566797359|FG001|Part A|Lost to Follow-up|7|||
157012101|NCT05137236|566797360|FG002|Part A|Lost to Follow-up|1|||
157012102|NCT05137236|566797361|FG003|Part A|Lost to Follow-up|3|||
157012103|NCT05137236|566797362|FG004|Part A|Lost to Follow-up|3|||
157012104|NCT05137236|566797363|FG005|Part A|Lost to Follow-up|8|||
157012105|NCT05137236|566797364|FG006|Part A|Lost to Follow-up|0|||
157012106|NCT05137236|566797365|FG007|Part A|Lost to Follow-up|0|||
156781882|NCT02265744|565951510|FG000|Overall Study|Reason not provided by Investigator|1|||
157012107|NCT05137236|566797358|FG000|Part B|Withdrawal by Subject|0|||
157012108|NCT05137236|566797359|FG001|Part B|Withdrawal by Subject|0|||
157012109|NCT05137236|566797360|FG002|Part B|Withdrawal by Subject|0|||
157012110|NCT05137236|566797361|FG003|Part B|Withdrawal by Subject|0|||
157012111|NCT05137236|566797362|FG004|Part B|Withdrawal by Subject|0|||
157012112|NCT05137236|566797363|FG005|Part B|Withdrawal by Subject|0|||
156781883|NCT02265744|565951511|FG001|Overall Study|Reason not provided by Investigator|0|||
156781884|NCT02265744|565951512|FG002|Overall Study|Reason not provided by Investigator|0|||
156781885|NCT02265744|565951513|FG003|Overall Study|Reason not provided by Investigator|2|||
156781886|NCT02265744|565951514|FG004|Overall Study|Reason not provided by Investigator|0|||
156781887|NCT02265744|565951510|FG000|Overall Study|Administrative reason by sponsor|3|||
156781888|NCT02265744|565951511|FG001|Overall Study|Administrative reason by sponsor|2|||
156781889|NCT02265744|565951512|FG002|Overall Study|Administrative reason by sponsor|2|||
156781890|NCT02265744|565951513|FG003|Overall Study|Administrative reason by sponsor|3|||
156781891|NCT02265744|565951514|FG004|Overall Study|Administrative reason by sponsor|3|||
156781892|NCT02265744|565951510|FG000|Overall Study|Subject no longer meets study criteria|0|||
156781893|NCT02265744|565951511|FG001|Overall Study|Subject no longer meets study criteria|0|||
156781894|NCT02265744|565951512|FG002|Overall Study|Subject no longer meets study criteria|0|||
156781895|NCT02265744|565951513|FG003|Overall Study|Subject no longer meets study criteria|0|||
156781896|NCT02265744|565951514|FG004|Overall Study|Subject no longer meets study criteria|1|||
156781897|NCT02265744|565951510|FG000|Overall Study|Pregnancy|1|||
156781898|NCT02265744|565951511|FG001|Overall Study|Pregnancy|2|||
156781899|NCT02265744|565951512|FG002|Overall Study|Pregnancy|1|||
156781900|NCT02265744|565951513|FG003|Overall Study|Pregnancy|1|||
156781901|NCT02265744|565951514|FG004|Overall Study|Pregnancy|0|||
156781902|NCT06262607|565951515|FG000|Overall Study|Physician Decision|0|||
156781903|NCT06262607|565951516|FG001|Overall Study|Physician Decision|1|||
156781904|NCT06262607|565951515|FG000|Overall Study|Withdrawal by Subject|2|||
156781905|NCT06262607|565951516|FG001|Overall Study|Withdrawal by Subject|0|||
156781906|NCT00923702|565951517|FG000|Overall Study|Ongoing enrollment|0|||
156781907|NCT00923702|565951518|FG001|Overall Study|Ongoing enrollment|0|||
156781908|NCT00923702|565951519|FG002|Overall Study|Ongoing enrollment|0|||
156781909|NCT00923702|565951520|FG003|Overall Study|Ongoing enrollment|0|||
156781910|NCT00923702|565951521|FG004|Overall Study|Ongoing enrollment|354|||
156781911|NCT02541903|565951525|FG000|Overall Study|Death|1|||
156781912|NCT02448043|565951526|FG000|Overall Study|Withdrawal by Subject|2|||
156781913|NCT02448043|565951527|FG001|Overall Study|Withdrawal by Subject|2|||
156781914|NCT02448043|565951526|FG000|Overall Study|Protocol Violation|1|||
156781915|NCT02448043|565951527|FG001|Overall Study|Protocol Violation|2|||
156781916|NCT00827242|565951529|FG000|Overall Study|Withdrawal by Subject|2|||
156781917|NCT00827242|565951530|FG001|Overall Study|Withdrawal by Subject|4|||
156781918|NCT00827242|565951529|FG000|Overall Study|Protocol Violation|1|||
156781919|NCT00827242|565951530|FG001|Overall Study|Protocol Violation|3|||
156781920|NCT00827242|565951529|FG000|Overall Study|Lost to Follow-up|0|||
156781921|NCT00827242|565951530|FG001|Overall Study|Lost to Follow-up|3|||
156781922|NCT00827242|565951529|FG000|Overall Study|Adverse Event Excluding Death|2|||
156781923|NCT00827242|565951530|FG001|Overall Study|Adverse Event Excluding Death|1|||
156781924|NCT00827242|565951529|FG000|Overall Study|Entry Criteria Not Met|4|||
156781925|NCT00827242|565951530|FG001|Overall Study|Entry Criteria Not Met|1|||
156781926|NCT00827242|565951529|FG000|Overall Study|Physician Decision|2|||
156781927|NCT00827242|565951530|FG001|Overall Study|Physician Decision|0|||
156781928|NCT00827242|565951529|FG000|Overall Study|Death|1|||
156781929|NCT00827242|565951530|FG001|Overall Study|Death|0|||
157012113|NCT05137236|566797364|FG006|Part B|Withdrawal by Subject|0|||
157012114|NCT05137236|566797365|FG007|Part B|Withdrawal by Subject|2|||
157012115|NCT05137236|566797358|FG000|Part B|Lost to Follow-up|0|||
157012116|NCT05137236|566797359|FG001|Part B|Lost to Follow-up|0|||
157012117|NCT05137236|566797360|FG002|Part B|Lost to Follow-up|0|||
157012118|NCT05137236|566797361|FG003|Part B|Lost to Follow-up|0|||
156781930|NCT00827242|565951529|FG000|Overall Study|Lack of Efficacy|1|||
156781931|NCT00827242|565951530|FG001|Overall Study|Lack of Efficacy|0|||
156781932|NCT05762679|565951531|FG000|Overall Study|Withdrawal by Subject|1|||
156781933|NCT05762679|565951531|FG000|Overall Study|No analyzable imaging data|1|||
156781934|NCT03142750|565951536|FG000|Overall Study|Lost to Follow-up|4|||
156781935|NCT03142750|565951537|FG001|Overall Study|Lost to Follow-up|1|||
156781936|NCT00303628|565951540|FG000|Overall Study|Disease progression|0|||
157012119|NCT05137236|566797362|FG004|Part B|Lost to Follow-up|0|||
157012120|NCT05137236|566797363|FG005|Part B|Lost to Follow-up|0|||
157012121|NCT05137236|566797364|FG006|Part B|Lost to Follow-up|5|||
156781937|NCT00303628|565951541|FG001|Overall Study|Disease progression|1|||
156781938|NCT00303628|565951540|FG000|Overall Study|Adverse Event|26|||
156781939|NCT00303628|565951541|FG001|Overall Study|Adverse Event|36|||
156781940|NCT00303628|565951540|FG000|Overall Study|Death|0|||
157012122|NCT05137236|566797365|FG007|Part B|Lost to Follow-up|5|||
157012123|NCT05137236|566797358|FG000|Part B|Death|0|||
157012124|NCT05137236|566797359|FG001|Part B|Death|0|||
157012125|NCT05137236|566797360|FG002|Part B|Death|0|||
156781941|NCT00303628|565951541|FG001|Overall Study|Death|1|||
156781942|NCT00303628|565951540|FG000|Overall Study|Withdrawal by Subject|11|||
156781943|NCT00303628|565951541|FG001|Overall Study|Withdrawal by Subject|20|||
156781944|NCT00303628|565951540|FG000|Overall Study|Alternative therapy|2|||
156781945|NCT00303628|565951541|FG001|Overall Study|Alternative therapy|0|||
156781946|NCT00303628|565951540|FG000|Overall Study|Other complicating disease|0|||
156781947|NCT00303628|565951541|FG001|Overall Study|Other complicating disease|1|||
156781948|NCT00303628|565951540|FG000|Overall Study|Not start protocol therapy|3|||
156781949|NCT00303628|565951541|FG001|Overall Study|Not start protocol therapy|5|||
156781950|NCT00303628|565951540|FG000|Overall Study|Other|8|||
156781951|NCT00303628|565951541|FG001|Overall Study|Other|9|||
156781952|NCT04925934|565951542|FG000|Overall Study|Adverse Event|1|||
156781953|NCT04925934|565951543|FG001|Overall Study|Adverse Event|0|||
156781954|NCT04925934|565951544|FG002|Overall Study|Adverse Event|0|||
156781955|NCT04925934|565951542|FG000|Overall Study|Lost to Follow-up|2|||
156781956|NCT04925934|565951543|FG001|Overall Study|Lost to Follow-up|0|||
156781957|NCT04925934|565951544|FG002|Overall Study|Lost to Follow-up|1|||
156781958|NCT04925934|565951542|FG000|Overall Study|Death|0|||
156781959|NCT04925934|565951543|FG001|Overall Study|Death|1|||
156781960|NCT04925934|565951544|FG002|Overall Study|Death|0|||
157012126|NCT05137236|566797361|FG003|Part B|Death|0|||
156781961|NCT04925934|565951542|FG000|Overall Study|Withdrawal by Subject|8|||
156781962|NCT04925934|565951543|FG001|Overall Study|Withdrawal by Subject|5|||
156781963|NCT04925934|565951544|FG002|Overall Study|Withdrawal by Subject|9|||
156781964|NCT04925934|565951542|FG000|Overall Study|Other|2|||
156781965|NCT04925934|565951543|FG001|Overall Study|Other|2|||
156781966|NCT04925934|565951544|FG002|Overall Study|Other|2|||
156781967|NCT04925934|565951542|FG000|Overall Study|Eastern European Conflict|7|||
156781968|NCT04925934|565951543|FG001|Overall Study|Eastern European Conflict|3|||
156781969|NCT04925934|565951544|FG002|Overall Study|Eastern European Conflict|2|||
156781970|NCT00376506|565951545|FG000|Overall Study|Death|0|||
156781971|NCT00376506|565951546|FG001|Overall Study|Death|2|||
156781972|NCT03158688|565951547|FG000|Overall Study|Withdrawal by Subject|14|||
156781973|NCT03158688|565951548|FG001|Overall Study|Withdrawal by Subject|28|||
157119598|NCT03461757|567190736|FG000|Overall Study|Withdrawal by Subject|7|||
157119599|NCT03461757|567190737|FG001|Overall Study|Withdrawal by Subject|7|||
157119600|NCT03461757|567190736|FG000|Overall Study|Other Reasons|1|||
157119601|NCT03461757|567190737|FG001|Overall Study|Other Reasons|4|||
157213127|NCT04130919|567527763|FG001|Blinded Treatment Phase|Withdrew consent|0|||
157213128|NCT04130919|567527764|FG002|Blinded Treatment Phase|Withdrew consent|0|||
157012127|NCT05137236|566797362|FG004|Part B|Death|0|||
157012128|NCT05137236|566797363|FG005|Part B|Death|0|||
157012129|NCT05137236|566797364|FG006|Part B|Death|0|||
157012130|NCT05137236|566797365|FG007|Part B|Death|2|||
157012131|NCT01534494|566797366|FG000|Overall Study|Withdrawal by Subject|1|||
157012132|NCT01939899|566797367|FG000|Lead-in Dose Finding Phase|Death|0|||
157012133|NCT01939899|566797368|FG001|Lead-in Dose Finding Phase|Death|3|||
157012134|NCT01939899|566797369|FG002|Lead-in Dose Finding Phase|Death|1|||
157012135|NCT01939899|566797370|FG003|Lead-in Dose Finding Phase|Death|0|||
157012136|NCT01939899|566797371|FG004|Lead-in Dose Finding Phase|Death|0|||
157012137|NCT01939899|566797367|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
157012138|NCT01939899|566797368|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
157012139|NCT01939899|566797369|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
157012140|NCT01939899|566797370|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
157012141|NCT01939899|566797371|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
157012142|NCT01939899|566797367|FG000|Lead-in Dose Finding Phase|Other|0|||
157012143|NCT01939899|566797368|FG001|Lead-in Dose Finding Phase|Other|0|||
157012144|NCT01939899|566797369|FG002|Lead-in Dose Finding Phase|Other|1|||
157012145|NCT01939899|566797370|FG003|Lead-in Dose Finding Phase|Other|0|||
157012146|NCT01939899|566797371|FG004|Lead-in Dose Finding Phase|Other|0|||
157012147|NCT01939899|566797367|FG000|Phase 2|Withdrawal by Subject|0|||
157119602|NCT02425826|567190738|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
157119603|NCT02425826|567190739|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
157119604|NCT02425826|567190740|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
157119605|NCT02425826|567190738|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
157119606|NCT02425826|567190739|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
157119607|NCT02425826|567190740|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
157119608|NCT02425826|567190738|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
157119609|NCT02425826|567190739|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
157213129|NCT04130919|567527765|FG003|Blinded Treatment Phase|Withdrew consent|0|||
156781974|NCT03158688|565951547|FG000|Overall Study|Decision by sponsor|13|||
156781975|NCT03158688|565951548|FG001|Overall Study|Decision by sponsor|37|||
156781976|NCT03158688|565951547|FG000|Overall Study|Lost to Follow-up|4|||
157012148|NCT01939899|566797368|FG001|Phase 2|Withdrawal by Subject|0|||
157012149|NCT01939899|566797369|FG002|Phase 2|Withdrawal by Subject|0|||
156781977|NCT03158688|565951548|FG001|Overall Study|Lost to Follow-up|3|||
156781978|NCT03158688|565951547|FG000|Overall Study|Death|74|||
157012150|NCT01939899|566797370|FG003|Phase 2|Withdrawal by Subject|2|||
157119610|NCT02425826|567190740|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
157119611|NCT02425826|567190738|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
157119612|NCT02425826|567190739|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
157119613|NCT02425826|567190740|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
157119614|NCT02425826|567190738|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
157119615|NCT02425826|567190739|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
157119616|NCT02425826|567190740|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
157119617|NCT02425826|567190738|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
157119618|NCT02425826|567190739|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
157119619|NCT02425826|567190740|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
157119620|NCT02425826|567190738|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
157119621|NCT02425826|567190739|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
157119622|NCT02425826|567190740|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
157119623|NCT02425826|567190738|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
157119624|NCT02425826|567190739|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
157119625|NCT02425826|567190740|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
157119626|NCT02425826|567190738|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
157119627|NCT02425826|567190739|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
157119628|NCT02425826|567190740|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
157119629|NCT02425826|567190738|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
157119630|NCT02425826|567190739|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
157119631|NCT02425826|567190740|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
157119632|NCT04942925|567190743|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
157119633|NCT04942925|567190744|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
157119634|NCT04942925|567190743|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
157119635|NCT04942925|567190744|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
157119636|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
157119637|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
157119638|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
157119639|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
157119640|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
157119641|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
157119642|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
157119643|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
157119644|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
157119645|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
157119646|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
157119647|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
157119648|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
157119649|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
157119650|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
157119651|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
157119652|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
157119653|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
157119654|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
157119655|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
157119656|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
157119657|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
157119658|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
157119659|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
157119660|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
157119661|NCT03829657|567190746|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
157119662|NCT03829657|567190747|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
157213130|NCT04130919|567527766|FG004|Blinded Treatment Phase|Withdrew consent|0|||
157012151|NCT01939899|566797371|FG004|Phase 2|Withdrawal by Subject|0|||
157012152|NCT01939899|566797367|FG000|Phase 2|Disease Progression|0|||
157012153|NCT01939899|566797368|FG001|Phase 2|Disease Progression|0|||
157012154|NCT01939899|566797369|FG002|Phase 2|Disease Progression|0|||
157012155|NCT01939899|566797370|FG003|Phase 2|Disease Progression|9|||
157012156|NCT01939899|566797371|FG004|Phase 2|Disease Progression|1|||
157012157|NCT00093015|566797377|FG000|Overall Study|Withdrawal by Subject|194|||
157012158|NCT00093015|566797378|FG001|Overall Study|Withdrawal by Subject|171|||
156781979|NCT03158688|565951548|FG001|Overall Study|Death|142|||
157213131|NCT04130919|567527767|FG005|Blinded Treatment Phase|Withdrew consent|0|||
157213132|NCT04130919|567527762|FG000|Open-label Treatment Phase|Withdrew consent|0|||
157213133|NCT04130919|567527763|FG001|Open-label Treatment Phase|Withdrew consent|0|||
157213134|NCT04130919|567527764|FG002|Open-label Treatment Phase|Withdrew consent|0|||
157213135|NCT04130919|567527765|FG003|Open-label Treatment Phase|Withdrew consent|1|||
157213136|NCT04130919|567527766|FG004|Open-label Treatment Phase|Withdrew consent|1|||
157213137|NCT04130919|567527767|FG005|Open-label Treatment Phase|Withdrew consent|1|||
156781980|NCT02942407|565951549|FG000|Overall Study|Lost to Follow-up|3|||
156781981|NCT02942407|565951550|FG001|Overall Study|Lost to Follow-up|2|||
156781982|NCT02942407|565951549|FG000|Overall Study|Withdrawal by Subject|7|||
156781983|NCT02942407|565951550|FG001|Overall Study|Withdrawal by Subject|9|||
156781984|NCT02942407|565951549|FG000|Overall Study|Death|16|||
156781985|NCT02942407|565951550|FG001|Overall Study|Death|13|||
156781986|NCT01944774|565951551|FG000|Overall Study|Withdrawal by Subject|2|||
156781987|NCT01944774|565951552|FG001|Overall Study|Withdrawal by Subject|3|||
156781988|NCT01944774|565951553|FG002|Overall Study|Withdrawal by Subject|3|||
156781989|NCT01944774|565951551|FG000|Overall Study|Adverse Event|3|||
156781990|NCT01944774|565951552|FG001|Overall Study|Adverse Event|2|||
157012159|NCT00093015|566797377|FG000|Overall Study|Lost to Follow-up|96|||
157012160|NCT00093015|566797378|FG001|Overall Study|Lost to Follow-up|108|||
157119663|NCT03829657|567190748|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
157119664|NCT03829657|567190749|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
157119665|NCT03829657|567190750|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
157119666|NCT03829657|567190746|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
157119667|NCT03829657|567190747|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
157119668|NCT03829657|567190748|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
157119669|NCT03829657|567190749|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
157119670|NCT03829657|567190750|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
157119671|NCT03829657|567190746|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
157119672|NCT03829657|567190747|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
157012161|NCT00093015|566797377|FG000|Overall Study|Death|375|||
157012162|NCT00093015|566797378|FG001|Overall Study|Death|385|||
157012163|NCT03076515|566797381|FG000|Overall Study|DMC decision based on interim analysis|25|||
157012164|NCT03076515|566797382|FG001|Overall Study|DMC decision based on interim analysis|29|||
157012165|NCT00296036|566797383|FG000|Overall Study|Withdrawal by Subject|1|||
157012166|NCT00296036|566797384|FG001|Overall Study|Withdrawal by Subject|0|||
157012167|NCT00296036|566797385|FG002|Overall Study|Withdrawal by Subject|2|||
157012168|NCT00296036|566797386|FG003|Overall Study|Withdrawal by Subject|1|||
157012169|NCT00296036|566797387|FG004|Overall Study|Withdrawal by Subject|2|||
157012170|NCT00296036|566797388|FG005|Overall Study|Withdrawal by Subject|1|||
157012171|NCT00296036|566797383|FG000|Overall Study|Protocol Violation|0|||
157012172|NCT00296036|566797384|FG001|Overall Study|Protocol Violation|0|||
157012173|NCT00296036|566797385|FG002|Overall Study|Protocol Violation|0|||
157012174|NCT00296036|566797386|FG003|Overall Study|Protocol Violation|0|||
157012175|NCT00296036|566797387|FG004|Overall Study|Protocol Violation|0|||
157012176|NCT00296036|566797388|FG005|Overall Study|Protocol Violation|3|||
157012177|NCT00807937|566797391|FG000|Overall Study|Adverse Event|12|||
157012178|NCT00807937|566797392|FG001|Overall Study|Adverse Event|12|||
157012179|NCT00807937|566797393|FG002|Overall Study|Adverse Event|5|||
157012180|NCT00807937|566797394|FG003|Overall Study|Adverse Event|4|||
157012181|NCT00807937|566797391|FG000|Overall Study|Protocol Violation|4|||
157012182|NCT00807937|566797392|FG001|Overall Study|Protocol Violation|5|||
157012183|NCT00807937|566797393|FG002|Overall Study|Protocol Violation|3|||
157012184|NCT00807937|566797394|FG003|Overall Study|Protocol Violation|3|||
157012185|NCT00807937|566797391|FG000|Overall Study|Withdrawal by Subject|5|||
157119673|NCT03829657|567190748|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
157119674|NCT03829657|567190749|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
157119675|NCT03829657|567190750|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
157119676|NCT03829657|567190746|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
157119677|NCT03829657|567190747|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
157119678|NCT03829657|567190748|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
157119679|NCT03829657|567190749|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
157119680|NCT03829657|567190750|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
157119681|NCT03829657|567190746|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
157119682|NCT03829657|567190747|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
157119683|NCT03829657|567190748|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
157119684|NCT03829657|567190749|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
157119685|NCT03829657|567190750|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
157119686|NCT04418076|567190751|FG000|Overall Study|Death|1|||
157119687|NCT04418076|567190752|FG001|Overall Study|Death|0|||
157119688|NCT04418076|567190753|FG002|Overall Study|Death|0|||
157119689|NCT04418076|567190754|FG003|Overall Study|Death|0|||
157119690|NCT04418076|567190751|FG000|Overall Study|Lost to Follow-up|2|||
157119691|NCT04418076|567190752|FG001|Overall Study|Lost to Follow-up|5|||
157119692|NCT04418076|567190753|FG002|Overall Study|Lost to Follow-up|1|||
157119693|NCT04418076|567190754|FG003|Overall Study|Lost to Follow-up|2|||
157119694|NCT04418076|567190751|FG000|Overall Study|Withdrawal by Subject|1|||
157119695|NCT04418076|567190752|FG001|Overall Study|Withdrawal by Subject|0|||
157119696|NCT04418076|567190753|FG002|Overall Study|Withdrawal by Subject|1|||
157119697|NCT04418076|567190754|FG003|Overall Study|Withdrawal by Subject|1|||
157119698|NCT04418076|567190751|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
157119699|NCT04418076|567190752|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
157119700|NCT04418076|567190753|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
157119701|NCT04418076|567190754|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
157119702|NCT01344876|567190755|FG000|Overall Study|Adverse Event|0|||
157119703|NCT01344876|567190756|FG001|Overall Study|Adverse Event|0|||
157119704|NCT01344876|567190757|FG002|Overall Study|Adverse Event|0|||
157119705|NCT01344876|567190758|FG003|Overall Study|Adverse Event|0|||
157119706|NCT01344876|567190759|FG004|Overall Study|Adverse Event|1|||
157119707|NCT01344876|567190755|FG000|Overall Study|Withdrawal by Subject|0|||
157119708|NCT01344876|567190756|FG001|Overall Study|Withdrawal by Subject|0|||
157119709|NCT01344876|567190757|FG002|Overall Study|Withdrawal by Subject|1|||
157119710|NCT01344876|567190758|FG003|Overall Study|Withdrawal by Subject|0|||
157119711|NCT01344876|567190759|FG004|Overall Study|Withdrawal by Subject|0|||
157119712|NCT01344876|567190755|FG000|Overall Study|Definite progression of primary disease|1|||
157119713|NCT01344876|567190756|FG001|Overall Study|Definite progression of primary disease|0|||
157119714|NCT01344876|567190757|FG002|Overall Study|Definite progression of primary disease|0|||
157119715|NCT01344876|567190758|FG003|Overall Study|Definite progression of primary disease|3|||
157119716|NCT01344876|567190759|FG004|Overall Study|Definite progression of primary disease|0|||
157119717|NCT05107765|567190760|FG000|Overall Study|Lost to Follow-up|4|||
157119718|NCT05107765|567190761|FG001|Overall Study|Lost to Follow-up|1|||
157119719|NCT05107765|567190760|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
157119720|NCT05107765|567190761|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
157119721|NCT05107765|567190760|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
157119722|NCT05107765|567190761|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
157119723|NCT00562588|567190762|FG000|Overall Study|Adverse Event|40|||
156781991|NCT01944774|565951553|FG002|Overall Study|Adverse Event|3|||
156781992|NCT01944774|565951551|FG000|Overall Study|Lack of Efficacy|1|||
156781993|NCT01944774|565951552|FG001|Overall Study|Lack of Efficacy|2|||
156781994|NCT01944774|565951553|FG002|Overall Study|Lack of Efficacy|2|||
156781995|NCT01944774|565951551|FG000|Overall Study|Lost to Follow-up|0|||
157119724|NCT00562588|567190763|FG001|Overall Study|Adverse Event|58|||
157119725|NCT00562588|567190762|FG000|Overall Study|Protocol Violation|30|||
157119726|NCT00562588|567190763|FG001|Overall Study|Protocol Violation|26|||
157119727|NCT00562588|567190762|FG000|Overall Study|Lost to Follow-up|12|||
157119728|NCT00562588|567190763|FG001|Overall Study|Lost to Follow-up|4|||
156781996|NCT01944774|565951552|FG001|Overall Study|Lost to Follow-up|1|||
156781997|NCT01944774|565951553|FG002|Overall Study|Lost to Follow-up|0|||
156781998|NCT00374868|565951554|FG000|Overall Study|Adverse Event|12|||
156781999|NCT00374868|565951554|FG000|Overall Study|Progressive Disease|7|||
156782000|NCT00374868|565951554|FG000|Overall Study|Physician Decision|13|||
156782001|NCT00374868|565951554|FG000|Overall Study|Lost to Follow-up|1|||
156782002|NCT00374868|565951554|FG000|Overall Study|Death|2|||
156782003|NCT00374868|565951554|FG000|Overall Study|Other - Not Specified|1|||
156782004|NCT03188185|565951555|FG000|Stage 1|Adverse Event|4|||
156782005|NCT03188185|565951556|FG001|Stage 1|Adverse Event|12|||
156782006|NCT03188185|565951557|FG002|Stage 1|Adverse Event|0|||
156782007|NCT03188185|565951558|FG003|Stage 1|Adverse Event|0|||
156782008|NCT03188185|565951555|FG000|Stage 1|Lack of Efficacy|0|||
156782009|NCT03188185|565951556|FG001|Stage 1|Lack of Efficacy|2|||
156782010|NCT03188185|565951557|FG002|Stage 1|Lack of Efficacy|0|||
156782011|NCT03188185|565951558|FG003|Stage 1|Lack of Efficacy|0|||
156782012|NCT03188185|565951555|FG000|Stage 1|Lost to Follow-up|6|||
156782013|NCT03188185|565951556|FG001|Stage 1|Lost to Follow-up|1|||
156782014|NCT03188185|565951557|FG002|Stage 1|Lost to Follow-up|0|||
156782015|NCT03188185|565951558|FG003|Stage 1|Lost to Follow-up|0|||
156782016|NCT03188185|565951555|FG000|Stage 1|Withdrawal by Subject|9|||
156782017|NCT03188185|565951556|FG001|Stage 1|Withdrawal by Subject|0|||
156782018|NCT03188185|565951557|FG002|Stage 1|Withdrawal by Subject|0|||
157119729|NCT00562588|567190762|FG000|Overall Study|Withdrawal by Subject|10|||
157119730|NCT00562588|567190763|FG001|Overall Study|Withdrawal by Subject|9|||
157119731|NCT00562588|567190762|FG000|Overall Study|Other|0|||
157119732|NCT00562588|567190763|FG001|Overall Study|Other|2|||
157119733|NCT02164981|567192891|FG000|Started|Withdrawal by Subject|2|||
157119734|NCT02164981|567192892|FG001|Started|Withdrawal by Subject|1|||
157119735|NCT02164981|567192893|FG002|Started|Withdrawal by Subject|0|||
157119736|NCT02164981|567192891|FG000|Started|Protocol Violation|2|||
157119737|NCT02164981|567192892|FG001|Started|Protocol Violation|0|||
157119738|NCT02164981|567192893|FG002|Started|Protocol Violation|0|||
157119739|NCT02164981|567192891|FG000|Started|Adverse Event|1|||
157119740|NCT02164981|567192892|FG001|Started|Adverse Event|2|||
157119741|NCT02164981|567192893|FG002|Started|Adverse Event|0|||
157119742|NCT02164981|567192891|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
157119743|NCT02164981|567192892|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
157119744|NCT02164981|567192893|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
157119745|NCT02164981|567192891|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
157119746|NCT02164981|567192892|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
157119747|NCT02164981|567192893|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
157119748|NCT02164981|567192891|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
157119749|NCT02164981|567192892|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
156782019|NCT03188185|565951558|FG003|Stage 1|Withdrawal by Subject|0|||
156782020|NCT03188185|565951555|FG000|Stage 1|Identified as a professional patient|0|||
157119750|NCT02164981|567192893|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
156782021|NCT03188185|565951556|FG001|Stage 1|Identified as a professional patient|1|||
156782022|NCT03188185|565951557|FG002|Stage 1|Identified as a professional patient|0|||
156782023|NCT03188185|565951558|FG003|Stage 1|Identified as a professional patient|0|||
156782024|NCT03188185|565951555|FG000|Stage 2|Adverse Event|0|||
156782025|NCT03188185|565951556|FG001|Stage 2|Adverse Event|0|||
156782026|NCT03188185|565951557|FG002|Stage 2|Adverse Event|2|||
156782027|NCT03188185|565951558|FG003|Stage 2|Adverse Event|4|||
156782028|NCT03188185|565951555|FG000|Stage 2|Lack of Efficacy|0|||
156782029|NCT03188185|565951556|FG001|Stage 2|Lack of Efficacy|0|||
156782030|NCT03188185|565951557|FG002|Stage 2|Lack of Efficacy|3|||
156782031|NCT03188185|565951558|FG003|Stage 2|Lack of Efficacy|0|||
156782032|NCT03188185|565951555|FG000|Stage 2|Lost to Follow-up|0|||
156782033|NCT03188185|565951556|FG001|Stage 2|Lost to Follow-up|0|||
156782034|NCT03188185|565951557|FG002|Stage 2|Lost to Follow-up|1|||
156782035|NCT03188185|565951558|FG003|Stage 2|Lost to Follow-up|0|||
156782036|NCT03188185|565951555|FG000|Stage 2|Physician Decision|0|||
156782037|NCT03188185|565951556|FG001|Stage 2|Physician Decision|0|||
156782038|NCT03188185|565951557|FG002|Stage 2|Physician Decision|0|||
156782039|NCT03188185|565951558|FG003|Stage 2|Physician Decision|1|||
156782040|NCT03188185|565951555|FG000|Stage 2|Withdrawal by Subject|0|||
156782041|NCT03188185|565951556|FG001|Stage 2|Withdrawal by Subject|0|||
156782042|NCT03188185|565951557|FG002|Stage 2|Withdrawal by Subject|3|||
156782043|NCT03188185|565951558|FG003|Stage 2|Withdrawal by Subject|1|||
156782044|NCT00774748|565951559|FG000|Overall Study|Lost to Follow-up|3|||
156782045|NCT02965456|565951562|FG000|Overall Study|Lost to Follow-up|40|||
156782046|NCT02965456|565951563|FG001|Overall Study|Lost to Follow-up|18|||
156782047|NCT02965456|565951562|FG000|Overall Study|Subject Request|22|||
156782048|NCT02965456|565951563|FG001|Overall Study|Subject Request|13|||
156782049|NCT02965456|565951562|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
156782050|NCT02965456|565951563|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
156782051|NCT02965456|565951562|FG000|Overall Study|Adverse Event|3|||
156782052|NCT02965456|565951563|FG001|Overall Study|Adverse Event|0|||
156782053|NCT02965456|565951562|FG000|Overall Study|Noncompliance with Study Drug|1|||
156782054|NCT02965456|565951563|FG001|Overall Study|Noncompliance with Study Drug|1|||
156782055|NCT02965456|565951562|FG000|Overall Study|Worsening Condition|0|||
156782056|NCT02965456|565951563|FG001|Overall Study|Worsening Condition|2|||
156782057|NCT02965456|565951562|FG000|Overall Study|Lack of Efficacy|1|||
156782058|NCT02965456|565951563|FG001|Overall Study|Lack of Efficacy|0|||
156782059|NCT02965456|565951562|FG000|Overall Study|Physician Decision|0|||
156782060|NCT02965456|565951563|FG001|Overall Study|Physician Decision|1|||
156782061|NCT02965456|565951562|FG000|Overall Study|Pregnancy|1|||
156782062|NCT02965456|565951563|FG001|Overall Study|Pregnancy|0|||
156782063|NCT02965456|565951562|FG000|Overall Study|Protocol Violation|0|||
156782064|NCT02965456|565951563|FG001|Overall Study|Protocol Violation|1|||
156782065|NCT02965456|565951562|FG000|Overall Study|Participant ran out of study drug|0|||
156782066|NCT02965456|565951563|FG001|Overall Study|Participant ran out of study drug|1|||
156782067|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
156782068|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
156782069|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
156782070|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
156782071|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
156782072|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
156782073|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
156782074|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
156782075|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
156782076|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
156782077|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
156782078|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
156782079|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
156782080|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
156782081|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
156782082|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
157119751|NCT01761266|567192894|FG000|Overall Study|Death|415|||
157119752|NCT01761266|567192895|FG001|Overall Study|Death|402|||
156782083|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
156782084|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
156782085|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
156782086|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
156782087|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
156782088|NCT02337946|565951564|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
156782089|NCT02337946|565951565|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
157119753|NCT01761266|567192894|FG000|Overall Study|Lost to Follow-up|8|||
156782090|NCT02337946|565951566|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
156782091|NCT02337946|565951564|FG000|In-between Period|Without Informed Consent|1|||
156782092|NCT02337946|565951565|FG001|In-between Period|Without Informed Consent|0|||
157012186|NCT00807937|566797392|FG001|Overall Study|Withdrawal by Subject|4|||
157213138|NCT04130919|567527762|FG000|Open-label Treatment Phase|Disease worsening|0|||
157213139|NCT04130919|567527763|FG001|Open-label Treatment Phase|Disease worsening|0|||
157012187|NCT00807937|566797393|FG002|Overall Study|Withdrawal by Subject|1|||
157012188|NCT00807937|566797394|FG003|Overall Study|Withdrawal by Subject|4|||
157012189|NCT00807937|566797391|FG000|Overall Study|Lost to Follow-up|4|||
157012190|NCT00807937|566797392|FG001|Overall Study|Lost to Follow-up|0|||
157012191|NCT00807937|566797393|FG002|Overall Study|Lost to Follow-up|2|||
157012192|NCT00807937|566797394|FG003|Overall Study|Lost to Follow-up|1|||
157012193|NCT00807937|566797391|FG000|Overall Study|Lack of Efficacy|0|||
157012194|NCT00807937|566797392|FG001|Overall Study|Lack of Efficacy|0|||
157012195|NCT00807937|566797393|FG002|Overall Study|Lack of Efficacy|1|||
157012196|NCT00807937|566797394|FG003|Overall Study|Lack of Efficacy|2|||
157012197|NCT00807937|566797391|FG000|Overall Study|Intake of prohibited medicine|0|||
157012198|NCT00807937|566797392|FG001|Overall Study|Intake of prohibited medicine|0|||
157012199|NCT00807937|566797393|FG002|Overall Study|Intake of prohibited medicine|2|||
157012200|NCT00807937|566797394|FG003|Overall Study|Intake of prohibited medicine|0|||
157012201|NCT00807937|566797391|FG000|Overall Study|All other reasons (not provided)|2|||
157012202|NCT00807937|566797392|FG001|Overall Study|All other reasons (not provided)|4|||
157012203|NCT00807937|566797393|FG002|Overall Study|All other reasons (not provided)|0|||
157012204|NCT00807937|566797394|FG003|Overall Study|All other reasons (not provided)|1|||
157012205|NCT04629950|566797397|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
157012206|NCT04629950|566797398|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
157012207|NCT04629950|566797399|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
157012208|NCT04629950|566797400|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
157012209|NCT04629950|566797397|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
157012210|NCT04629950|566797398|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
157012211|NCT04629950|566797399|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
157012212|NCT04629950|566797400|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
157012213|NCT04629950|566797397|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
157012214|NCT04629950|566797398|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
157012215|NCT04629950|566797399|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
157012216|NCT04629950|566797400|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
157012217|NCT04629950|566797397|FG000|Extension Study|Withdrawal by Subject|0|||
157012218|NCT04629950|566797398|FG001|Extension Study|Withdrawal by Subject|0|||
157012219|NCT04629950|566797399|FG002|Extension Study|Withdrawal by Subject|1|||
157012220|NCT04629950|566797400|FG003|Extension Study|Withdrawal by Subject|0|||
157012221|NCT04629950|566797397|FG000|Extension Study|Adverse Event|0|||
157012222|NCT04629950|566797398|FG001|Extension Study|Adverse Event|0|||
157012223|NCT04629950|566797399|FG002|Extension Study|Adverse Event|0|||
157012224|NCT04629950|566797400|FG003|Extension Study|Adverse Event|1|||
157012225|NCT02568683|566797402|FG000|Overall Study|Death|0|||
157012226|NCT02568683|566797403|FG001|Overall Study|Death|2|||
157012227|NCT02568683|566797402|FG000|Overall Study|Withdrew Consent|1|||
157012228|NCT02568683|566797403|FG001|Overall Study|Withdrew Consent|0|||
157012229|NCT02568683|566797402|FG000|Overall Study|Study Terminated By Sponsor|5|||
157012230|NCT02568683|566797403|FG001|Overall Study|Study Terminated By Sponsor|2|||
157012231|NCT01561989|566797406|FG000|Overall Study|accural target not met.|5|||
157012232|NCT01561989|566797407|FG001|Overall Study|accural target not met.|6|||
157012233|NCT03485950|566797412|FG000|Overall Study|Adverse Event|1|||
157012234|NCT03485950|566797413|FG001|Overall Study|Adverse Event|0|||
157012235|NCT03485950|566797412|FG000|Overall Study|Death|3|||
157012236|NCT03485950|566797413|FG001|Overall Study|Death|2|||
157012237|NCT03485950|566797412|FG000|Overall Study|Withdrawal by Subject|3|||
157012238|NCT03485950|566797413|FG001|Overall Study|Withdrawal by Subject|0|||
157012239|NCT03930420|566797414|FG000|Overall Study|Withdrawal by Subject|7|||
157012240|NCT03930420|566797415|FG001|Overall Study|Withdrawal by Subject|9|||
157012241|NCT05609032|566797416|FG000|Overall Study|Lost to Follow-up|3|||
157012242|NCT05609032|566797417|FG001|Overall Study|Lost to Follow-up|1|||
157012243|NCT05609032|566797416|FG000|Overall Study|Withdrawal by Subject|1|||
157012244|NCT05609032|566797417|FG001|Overall Study|Withdrawal by Subject|0|||
157012245|NCT00609336|566797418|FG000|Overall Study|Protocol Violation|3|||
157012246|NCT00609336|566797418|FG000|Overall Study|Death|1|||
157012247|NCT00609336|566797418|FG000|Overall Study|LA or Met at Surgery|9|||
157012248|NCT02477605|566797419|FG000|Overall Study|Discontinued prior to treatment|1|||
157012249|NCT02477605|566797420|FG001|Overall Study|Discontinued prior to treatment|0|||
157012250|NCT02477605|566797419|FG000|Overall Study|Lost to Follow-up|0|||
157012251|NCT02477605|566797420|FG001|Overall Study|Lost to Follow-up|2|||
157012252|NCT02477605|566797419|FG000|Overall Study|Withdrawal by Subject|0|||
157012253|NCT02477605|566797420|FG001|Overall Study|Withdrawal by Subject|1|||
157012254|NCT02477605|566797419|FG000|Overall Study|Administered gas during surgery|0|||
157012255|NCT02477605|566797420|FG001|Overall Study|Administered gas during surgery|1|||
157012256|NCT00567489|566797421|FG000|Overall Study|Adverse Event|6|||
157012257|NCT00567489|566797422|FG001|Overall Study|Adverse Event|14|||
157012258|NCT00567489|566797421|FG000|Overall Study|Physician Decision|0|||
157012259|NCT00567489|566797422|FG001|Overall Study|Physician Decision|4|||
157012260|NCT00567489|566797421|FG000|Overall Study|Withdrawal by Subject|0|||
157012261|NCT00567489|566797422|FG001|Overall Study|Withdrawal by Subject|2|||
157012262|NCT00567489|566797421|FG000|Overall Study|Renal Transplantation|0|||
157119754|NCT01761266|567192895|FG001|Overall Study|Lost to Follow-up|12|||
157119755|NCT01761266|567192894|FG000|Overall Study|Withdrawal by Subject|14|||
157119756|NCT01761266|567192895|FG001|Overall Study|Withdrawal by Subject|10|||
157119757|NCT01761266|567192894|FG000|Overall Study|Sponsor Decision|41|||
157012263|NCT00567489|566797422|FG001|Overall Study|Renal Transplantation|3|||
157012264|NCT00567489|566797421|FG000|Overall Study|Other|1|||
157012265|NCT00567489|566797422|FG001|Overall Study|Other|0|||
157012266|NCT00068601|566797424|FG000|Overall Study|Ineligible|11|||
157012267|NCT00068601|566797425|FG001|Overall Study|Ineligible|13|||
157012268|NCT00068601|566797424|FG000|Overall Study|Not evaluable: withdrew consent|5|||
157119758|NCT01761266|567192895|FG001|Overall Study|Sponsor Decision|52|||
157119759|NCT01662440|567192896|FG000|Overall Study|Adverse Event|1|||
157119760|NCT01662440|567192897|FG001|Overall Study|Adverse Event|0|||
157119761|NCT01662440|567192898|FG002|Overall Study|Adverse Event|0|||
157119762|NCT01662440|567192899|FG003|Overall Study|Adverse Event|1|||
157119763|NCT01662440|567192896|FG000|Overall Study|Death|0|||
157119764|NCT01662440|567192897|FG001|Overall Study|Death|1|||
157119765|NCT01662440|567192898|FG002|Overall Study|Death|0|||
157119766|NCT01662440|567192899|FG003|Overall Study|Death|0|||
157119767|NCT01662440|567192896|FG000|Overall Study|Lost to Follow-up|2|||
157119768|NCT01662440|567192897|FG001|Overall Study|Lost to Follow-up|2|||
157119769|NCT01662440|567192898|FG002|Overall Study|Lost to Follow-up|4|||
157119770|NCT01662440|567192899|FG003|Overall Study|Lost to Follow-up|1|||
157119771|NCT01662440|567192896|FG000|Overall Study|Subject moved to another country.|0|||
157119772|NCT01662440|567192897|FG001|Overall Study|Subject moved to another country.|1|||
157119773|NCT01662440|567192898|FG002|Overall Study|Subject moved to another country.|0|||
157119774|NCT01662440|567192899|FG003|Overall Study|Subject moved to another country.|0|||
157119775|NCT01662440|567192896|FG000|Overall Study|Protocol Violation|1|||
157119776|NCT01662440|567192897|FG001|Overall Study|Protocol Violation|0|||
157119777|NCT01662440|567192898|FG002|Overall Study|Protocol Violation|0|||
157119778|NCT01662440|567192899|FG003|Overall Study|Protocol Violation|0|||
157119779|NCT01662440|567192896|FG000|Overall Study|Withdrawal by Subject|5|||
157119780|NCT01662440|567192897|FG001|Overall Study|Withdrawal by Subject|2|||
157119781|NCT01662440|567192898|FG002|Overall Study|Withdrawal by Subject|2|||
157119782|NCT01662440|567192899|FG003|Overall Study|Withdrawal by Subject|2|||
157119783|NCT00112905|567192900|FG000|Overall Study|Adverse Event|4|||
157119784|NCT00112905|567192900|FG000|Overall Study|Death|1|||
157119785|NCT00112905|567192900|FG000|Overall Study|Ineligibility|5|||
157119786|NCT00112905|567192900|FG000|Overall Study|Alternative treatment|1|||
157119787|NCT00112905|567192900|FG000|Overall Study|performance status was deteiorating|1|||
157119788|NCT05048719|567192903|FG000|Overall Study|Withdrawal by Subject|2|||
157119789|NCT05048719|567192904|FG001|Overall Study|Withdrawal by Subject|1|||
157119790|NCT05048719|567192905|FG002|Overall Study|Withdrawal by Subject|3|||
157119791|NCT05048719|567192906|FG003|Overall Study|Withdrawal by Subject|1|||
157119792|NCT05048719|567192907|FG004|Overall Study|Withdrawal by Subject|0|||
157119793|NCT05048719|567192908|FG005|Overall Study|Withdrawal by Subject|2|||
157119794|NCT05048719|567192909|FG006|Overall Study|Withdrawal by Subject|1|||
157119795|NCT05048719|567192910|FG007|Overall Study|Withdrawal by Subject|1|||
157119796|NCT05048719|567192911|FG008|Overall Study|Withdrawal by Subject|0|||
157119797|NCT05048719|567192903|FG000|Overall Study|Death|1|||
157119798|NCT05048719|567192904|FG001|Overall Study|Death|0|||
157119799|NCT05048719|567192905|FG002|Overall Study|Death|0|||
157119800|NCT05048719|567192906|FG003|Overall Study|Death|0|||
157119801|NCT05048719|567192907|FG004|Overall Study|Death|0|||
157119802|NCT05048719|567192908|FG005|Overall Study|Death|0|||
157119803|NCT05048719|567192909|FG006|Overall Study|Death|0|||
157119804|NCT05048719|567192910|FG007|Overall Study|Death|0|||
157119805|NCT05048719|567192911|FG008|Overall Study|Death|0|||
157119806|NCT05048719|567192903|FG000|Overall Study|Adverse Event|0|||
157119807|NCT05048719|567192904|FG001|Overall Study|Adverse Event|1|||
157119808|NCT05048719|567192905|FG002|Overall Study|Adverse Event|2|||
157119809|NCT05048719|567192906|FG003|Overall Study|Adverse Event|0|||
157119810|NCT05048719|567192907|FG004|Overall Study|Adverse Event|1|||
157119811|NCT05048719|567192908|FG005|Overall Study|Adverse Event|0|||
157119812|NCT05048719|567192909|FG006|Overall Study|Adverse Event|0|||
157119813|NCT05048719|567192910|FG007|Overall Study|Adverse Event|0|||
157119814|NCT05048719|567192911|FG008|Overall Study|Adverse Event|0|||
157119815|NCT05048719|567192903|FG000|Overall Study|Lost to Follow-up|0|||
157119816|NCT05048719|567192904|FG001|Overall Study|Lost to Follow-up|0|||
157119817|NCT05048719|567192905|FG002|Overall Study|Lost to Follow-up|1|||
157119818|NCT05048719|567192906|FG003|Overall Study|Lost to Follow-up|3|||
157119819|NCT05048719|567192907|FG004|Overall Study|Lost to Follow-up|1|||
157119820|NCT05048719|567192908|FG005|Overall Study|Lost to Follow-up|1|||
157119821|NCT05048719|567192909|FG006|Overall Study|Lost to Follow-up|1|||
157119822|NCT05048719|567192910|FG007|Overall Study|Lost to Follow-up|1|||
157119823|NCT05048719|567192911|FG008|Overall Study|Lost to Follow-up|0|||
157119824|NCT05048719|567192903|FG000|Overall Study|Physician Decision|0|||
157119825|NCT05048719|567192904|FG001|Overall Study|Physician Decision|0|||
157119826|NCT05048719|567192905|FG002|Overall Study|Physician Decision|0|||
157119827|NCT05048719|567192906|FG003|Overall Study|Physician Decision|0|||
157119828|NCT05048719|567192907|FG004|Overall Study|Physician Decision|0|||
157119829|NCT05048719|567192908|FG005|Overall Study|Physician Decision|0|||
157119830|NCT05048719|567192909|FG006|Overall Study|Physician Decision|0|||
157119831|NCT05048719|567192910|FG007|Overall Study|Physician Decision|1|||
157119832|NCT05048719|567192911|FG008|Overall Study|Physician Decision|1|||
157119833|NCT05048719|567192903|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
157119834|NCT05048719|567192904|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119835|NCT05048719|567192905|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119836|NCT05048719|567192906|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119837|NCT05048719|567192907|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119838|NCT05048719|567192908|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119839|NCT05048719|567192909|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119840|NCT05048719|567192910|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119841|NCT05048719|567192911|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
157119842|NCT05048719|567192903|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119843|NCT05048719|567192904|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
157119844|NCT05048719|567192905|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119845|NCT05048719|567192906|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119846|NCT05048719|567192907|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
156782093|NCT02337946|565951566|FG002|In-between Period|Without Informed Consent|0|||
157213140|NCT04130919|567527764|FG002|Open-label Treatment Phase|Disease worsening|0|||
157213141|NCT04130919|567527765|FG003|Open-label Treatment Phase|Disease worsening|1|||
157213142|NCT04130919|567527766|FG004|Open-label Treatment Phase|Disease worsening|0|||
157213143|NCT04130919|567527767|FG005|Open-label Treatment Phase|Disease worsening|1|||
157213144|NCT04130919|567527762|FG000|Open-label Treatment Phase|Investigator's decision|0|||
157213145|NCT04130919|567527763|FG001|Open-label Treatment Phase|Investigator's decision|0|||
157213146|NCT04130919|567527764|FG002|Open-label Treatment Phase|Investigator's decision|0|||
157213147|NCT04130919|567527765|FG003|Open-label Treatment Phase|Investigator's decision|1|||
157213148|NCT04130919|567527766|FG004|Open-label Treatment Phase|Investigator's decision|0|||
157213149|NCT04130919|567527767|FG005|Open-label Treatment Phase|Investigator's decision|0|||
157213150|NCT04130919|567527762|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
157213151|NCT04130919|567527763|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
156782094|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
156782095|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
156782096|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
156782097|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
156782098|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
156782099|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
156782100|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
156782101|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
156782102|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
156782103|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
156782104|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
156782105|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
157119847|NCT05048719|567192908|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119848|NCT05048719|567192909|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119849|NCT05048719|567192910|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119850|NCT05048719|567192911|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
157119851|NCT05048719|567192903|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119852|NCT05048719|567192904|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
157119853|NCT05048719|567192905|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119854|NCT05048719|567192906|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119855|NCT05048719|567192907|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119856|NCT05048719|567192908|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119857|NCT05048719|567192909|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119858|NCT05048719|567192910|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119859|NCT05048719|567192911|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
157119860|NCT05048719|567192903|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119861|NCT05048719|567192904|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119862|NCT05048719|567192905|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119863|NCT05048719|567192906|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
157119864|NCT05048719|567192907|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119865|NCT05048719|567192908|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119866|NCT05048719|567192909|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119867|NCT05048719|567192910|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119868|NCT05048719|567192911|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
157119869|NCT05048719|567192903|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119870|NCT05048719|567192904|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119871|NCT05048719|567192905|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119872|NCT05048719|567192906|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119873|NCT05048719|567192907|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157145133|NCT02460822|567278002|FG000|Overall Study|Withdrawal by Subject|1|||
157145134|NCT00845429|567278005|FG000|Overall Study|Protocol Violation|5|||
157145135|NCT00845429|567278006|FG001|Overall Study|Protocol Violation|4|||
157145136|NCT00845429|567278007|FG002|Overall Study|Protocol Violation|7|||
157145137|NCT00845429|567278005|FG000|Overall Study|Lost to Follow-up|7|||
157145138|NCT00845429|567278006|FG001|Overall Study|Lost to Follow-up|9|||
157145139|NCT00845429|567278007|FG002|Overall Study|Lost to Follow-up|10|||
157145140|NCT00845429|567278005|FG000|Overall Study|Withdrawal by Subject|2|||
157145141|NCT00845429|567278006|FG001|Overall Study|Withdrawal by Subject|2|||
157119874|NCT05048719|567192908|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
157119875|NCT05048719|567192909|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119876|NCT05048719|567192910|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119877|NCT05048719|567192911|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
157119878|NCT04541004|567192912|FG000|Overall Study|Adverse Event|2|||
157119879|NCT03257267|567192913|FG000|Overall Study|Adverse Event|17|||
157119880|NCT03257267|567192914|FG001|Overall Study|Adverse Event|7|||
157119881|NCT03257267|567192913|FG000|Overall Study|Death|96|||
157119882|NCT03257267|567192914|FG001|Overall Study|Death|98|||
157119883|NCT03257267|567192913|FG000|Overall Study|Lost to Follow-up|2|||
157119884|NCT03257267|567192914|FG001|Overall Study|Lost to Follow-up|2|||
157119885|NCT03257267|567192913|FG000|Overall Study|Non-compliance with Study Drug|0|||
157119886|NCT03257267|567192914|FG001|Overall Study|Non-compliance with Study Drug|2|||
157119887|NCT03257267|567192913|FG000|Overall Study|Participant Decision|35|||
157119888|NCT03257267|567192914|FG001|Overall Study|Participant Decision|43|||
157119889|NCT03257267|567192913|FG000|Overall Study|Sponsor Decision|1|||
157119890|NCT03257267|567192914|FG001|Overall Study|Sponsor Decision|0|||
157119891|NCT03257267|567192913|FG000|Overall Study|Physician Decision|1|||
157119892|NCT03257267|567192914|FG001|Overall Study|Physician Decision|3|||
157119893|NCT03257267|567192913|FG000|Overall Study|Disease Progression|109|||
157119894|NCT03257267|567192914|FG001|Overall Study|Disease Progression|121|||
157119895|NCT03257267|567192913|FG000|Overall Study|Withdrawal by Subject|8|||
157119896|NCT03257267|567192914|FG001|Overall Study|Withdrawal by Subject|26|||
157119897|NCT03257267|567192913|FG000|Overall Study|Other|0|||
157119898|NCT03257267|567192914|FG001|Overall Study|Other|2|||
157119899|NCT04872101|567192915|FG000|Overall Study|Withdrawal by Subject|10|||
157119900|NCT04872101|567192916|FG001|Overall Study|Withdrawal by Subject|16|||
157119901|NCT04872101|567192915|FG000|Overall Study|Lack of Efficacy|6|||
157119902|NCT04872101|567192916|FG001|Overall Study|Lack of Efficacy|14|||
157119903|NCT04872101|567192915|FG000|Overall Study|Adverse Event|1|||
157119904|NCT04872101|567192916|FG001|Overall Study|Adverse Event|6|||
157119905|NCT04872101|567192915|FG000|Overall Study|Lost to Follow-up|2|||
157119906|NCT04872101|567192916|FG001|Overall Study|Lost to Follow-up|1|||
157119907|NCT04872101|567192915|FG000|Overall Study|Pregnancy|2|||
157119908|NCT04872101|567192916|FG001|Overall Study|Pregnancy|0|||
157119909|NCT04872101|567192915|FG000|Overall Study|Prohibited Medication|1|||
157119910|NCT04872101|567192916|FG001|Overall Study|Prohibited Medication|0|||
157119911|NCT04872101|567192915|FG000|Overall Study|Not dosed|1|||
156782106|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
157119912|NCT04872101|567192916|FG001|Overall Study|Not dosed|0|||
157119913|NCT02475681|567192917|FG000|Overall Study|Death|16|||
157119914|NCT02475681|567192918|FG001|Overall Study|Death|6|||
157119915|NCT02475681|567192919|FG002|Overall Study|Death|9|||
157119916|NCT02475681|567192917|FG000|Overall Study|Physician Decision|0|||
157119917|NCT02475681|567192918|FG001|Overall Study|Physician Decision|3|||
157119918|NCT02475681|567192919|FG002|Overall Study|Physician Decision|1|||
157119919|NCT02475681|567192917|FG000|Overall Study|Withdrawal by Subject|12|||
157119920|NCT02475681|567192918|FG001|Overall Study|Withdrawal by Subject|6|||
157119921|NCT02475681|567192919|FG002|Overall Study|Withdrawal by Subject|9|||
157119922|NCT02475681|567192917|FG000|Overall Study|Lost to Follow-up|2|||
157119923|NCT02475681|567192918|FG001|Overall Study|Lost to Follow-up|1|||
157119924|NCT02475681|567192919|FG002|Overall Study|Lost to Follow-up|3|||
157119925|NCT02475681|567192917|FG000|Overall Study|Ongoing in Study|0|||
157119926|NCT02475681|567192918|FG001|Overall Study|Ongoing in Study|163|||
157119927|NCT02475681|567192919|FG002|Overall Study|Ongoing in Study|157|||
157119928|NCT02475681|567192917|FG000|Overall Study|Reasons other than above listed|2|||
157119929|NCT02475681|567192918|FG001|Overall Study|Reasons other than above listed|0|||
157119930|NCT02475681|567192919|FG002|Overall Study|Reasons other than above listed|0|||
157119931|NCT02605642|567192923|FG000|Overall Study|Other|11|||
157119932|NCT02605642|567192924|FG001|Overall Study|Other|1|||
157119933|NCT02605642|567192923|FG000|Overall Study|Participant non-compliance|2|||
157119934|NCT02605642|567192924|FG001|Overall Study|Participant non-compliance|4|||
157119935|NCT02605642|567192923|FG000|Overall Study|Physician Decision|10|||
157119936|NCT02605642|567192924|FG001|Overall Study|Physician Decision|0|||
157119937|NCT02605642|567192923|FG000|Overall Study|Lost to Follow-up|12|||
157119938|NCT02605642|567192924|FG001|Overall Study|Lost to Follow-up|1|||
157119939|NCT02605642|567192923|FG000|Overall Study|Adverse Event|14|||
157119940|NCT02605642|567192924|FG001|Overall Study|Adverse Event|2|||
156678173|NCT01120899|565567209|FG000|Overall Study|Withdrawal by Subject|3|||
156678174|NCT01490190|565567210|FG000|Overall Study|Withdrawal by Subject|9|||
156678175|NCT01490190|565567210|FG000|Overall Study|Adverse Event|17|||
156678176|NCT01490190|565567210|FG000|Overall Study|Protocol Violation|5|||
156678177|NCT01490190|565567210|FG000|Overall Study|Lost to Follow-up|13|||
156678178|NCT01490190|565567210|FG000|Overall Study|Relocation|1|||
156678179|NCT01490190|565567210|FG000|Overall Study|Inconvenience|1|||
156678180|NCT01490190|565567210|FG000|Overall Study|Ring expulsion|2|||
156678181|NCT02655224|565567216|FG000|Overall Study|Adverse Event|1|||
156678182|NCT02655224|565567217|FG001|Overall Study|Adverse Event|1|||
156678183|NCT01741545|565567228|FG000|Treatment Period|Lack of Efficacy|0|||
156678184|NCT01741545|565567229|FG001|Treatment Period|Lack of Efficacy|1|||
156678185|NCT01741545|565567228|FG000|Treatment Period|Adverse event, non-fatal|1|||
157012269|NCT00068601|566797425|FG001|Overall Study|Not evaluable: withdrew consent|4|||
157012270|NCT00068601|566797424|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
157012271|NCT00068601|566797425|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
157012272|NCT00068601|566797424|FG000|Overall Study|Death|11|||
157012273|NCT00068601|566797425|FG001|Overall Study|Death|3|||
157012274|NCT00068601|566797424|FG000|Overall Study|Lost to Follow-up|3|||
157012275|NCT00068601|566797425|FG001|Overall Study|Lost to Follow-up|2|||
157012276|NCT00068601|566797424|FG000|Overall Study|Missing primary outcome data|30|||
157012277|NCT00068601|566797425|FG001|Overall Study|Missing primary outcome data|34|||
157012278|NCT01061671|566797426|FG000|Overall Study|Withdrawal by Subject|16|||
157012279|NCT01061671|566797427|FG001|Overall Study|Withdrawal by Subject|20|||
157012280|NCT01061671|566797426|FG000|Overall Study|Lost to Follow-up|3|||
157012281|NCT01061671|566797427|FG001|Overall Study|Lost to Follow-up|5|||
157012282|NCT01061671|566797426|FG000|Overall Study|Death|28|||
157012283|NCT01061671|566797427|FG001|Overall Study|Death|30|||
157012284|NCT00440011|566797431|FG000|Overall Study|Adverse Event|2|||
157012285|NCT00440011|566797432|FG001|Overall Study|Adverse Event|0|||
157012286|NCT00440011|566797431|FG000|Overall Study|Lost to Follow-up|0|||
157012287|NCT00440011|566797432|FG001|Overall Study|Lost to Follow-up|2|||
157012288|NCT00440011|566797431|FG000|Overall Study|Protocol Violation|1|||
157012289|NCT00440011|566797432|FG001|Overall Study|Protocol Violation|1|||
157012290|NCT00440011|566797431|FG000|Overall Study|Withdrawal by Subject|1|||
157119941|NCT02605642|567192923|FG000|Overall Study|Withdrawal by Subject|23|||
157119942|NCT02605642|567192924|FG001|Overall Study|Withdrawal by Subject|2|||
157119943|NCT02605642|567192923|FG000|Overall Study|Lack of response|24|||
157119944|NCT02605642|567192924|FG001|Overall Study|Lack of response|11|||
157119945|NCT02354703|567192925|FG000|Overall Study|Withdrawal by Subject|1|||
157119946|NCT02354703|567192926|FG001|Overall Study|Withdrawal by Subject|1|||
157119947|NCT02354703|567192927|FG002|Overall Study|Withdrawal by Subject|1|||
157119948|NCT02354703|567192928|FG003|Overall Study|Withdrawal by Subject|1|||
157119949|NCT02354703|567192925|FG000|Overall Study|Lost to Follow-up|2|||
157119950|NCT02354703|567192926|FG001|Overall Study|Lost to Follow-up|7|||
157119951|NCT02354703|567192927|FG002|Overall Study|Lost to Follow-up|9|||
157119952|NCT02354703|567192928|FG003|Overall Study|Lost to Follow-up|2|||
157119953|NCT02354703|567192925|FG000|Overall Study|Adverse Event|0|||
157119954|NCT02354703|567192926|FG001|Overall Study|Adverse Event|0|||
157119955|NCT02354703|567192927|FG002|Overall Study|Adverse Event|1|||
157119956|NCT02354703|567192928|FG003|Overall Study|Adverse Event|0|||
157119957|NCT02597855|567192929|FG000|Overall Study|Lost to Follow-up|2|||
157119958|NCT02597855|567192930|FG001|Overall Study|Lost to Follow-up|1|||
157119959|NCT00179309|567192938|FG000|Treatment|Toxicity|2|||
157119960|NCT00179309|567192939|FG001|Treatment|Toxicity|3|||
157119961|NCT00179309|567192938|FG000|Treatment|Withdrawal by Subject|1|||
157119962|NCT00179309|567192939|FG001|Treatment|Withdrawal by Subject|2|||
157119963|NCT00179309|567192938|FG000|Treatment|Allergy|1|||
157119964|NCT00179309|567192939|FG001|Treatment|Allergy|0|||
157119965|NCT04681170|567192940|FG000|Stratified Enrolment & run-in|Death|1|||
157119966|NCT04681170|567192941|FG001|Stratified Enrolment & run-in|Death|0|||
156678186|NCT01741545|565567229|FG001|Treatment Period|Adverse event, non-fatal|3|||
156678187|NCT01741545|565567228|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
157012291|NCT00440011|566797432|FG001|Overall Study|Withdrawal by Subject|0|||
156678188|NCT01741545|565567229|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
156678189|NCT01741545|565567228|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
156678190|NCT01741545|565567229|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
157119967|NCT04681170|567192940|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
157119968|NCT04681170|567192941|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
156782107|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
156782108|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
156782109|NCT02337946|565951564|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
156782110|NCT02337946|565951565|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
156782111|NCT02337946|565951566|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
156782112|NCT02513563|565951567|FG000|Overall Study|Death|4|||
156782113|NCT02513563|565951567|FG000|Overall Study|Withdrawal by Subject|4|||
156782114|NCT02513563|565951567|FG000|Overall Study|Physician Decision|1|||
156782115|NCT01068912|565951570|FG000|Overall Study|Adverse Event|2|||
156782116|NCT01068912|565951571|FG001|Overall Study|Adverse Event|3|||
156782117|NCT01068912|565951572|FG002|Overall Study|Adverse Event|2|||
156782118|NCT01068912|565951570|FG000|Overall Study|Withdrawal by Subject|5|||
156782119|NCT01068912|565951571|FG001|Overall Study|Withdrawal by Subject|6|||
156782120|NCT01068912|565951572|FG002|Overall Study|Withdrawal by Subject|6|||
156782121|NCT01068912|565951570|FG000|Overall Study|Lost to Follow-up|3|||
156782122|NCT01068912|565951571|FG001|Overall Study|Lost to Follow-up|7|||
156782123|NCT01068912|565951572|FG002|Overall Study|Lost to Follow-up|3|||
157012292|NCT00419341|566797433|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
157012293|NCT00419341|566797433|FG000|Wash in/Wash Out Period|Adverse Event|2|||
157012294|NCT00419341|566797433|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
157012295|NCT00419341|566797433|FG000|Efficacy Period|Withdrawal by Subject|6|||
157012296|NCT00419341|566797433|FG000|Efficacy Period|Protocol Violation|1|||
157012297|NCT00419341|566797433|FG000|Efficacy Period|Lost to Follow-up|1|||
157012298|NCT00419341|566797433|FG000|Efficacy Period|Non-compliance|1|||
157012299|NCT00419341|566797433|FG000|Efficacy Period|Termination of study site|1|||
157012300|NCT01849055|566797441|FG000|Overall Study|Withdrawal by Subject|0|||
157012301|NCT01849055|566797442|FG001|Overall Study|Withdrawal by Subject|0|||
157012302|NCT01849055|566797443|FG002|Overall Study|Withdrawal by Subject|1|||
157012303|NCT01849055|566797444|FG003|Overall Study|Withdrawal by Subject|0|||
157012304|NCT01849055|566797445|FG004|Overall Study|Withdrawal by Subject|0|||
157012305|NCT01849055|566797446|FG005|Overall Study|Withdrawal by Subject|0|||
157012306|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
157012307|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
157012308|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
157012309|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
157012310|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
157012311|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
157012312|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
157012313|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
157012314|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
157012315|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
157012316|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
157012317|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
157012318|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
157012319|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
157012320|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
157012321|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
157012322|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
157012323|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
157012324|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
157012325|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
157012326|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
157012327|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
157012328|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
157012329|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
157012330|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
157012331|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
157012332|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
157012333|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
157012334|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
157012335|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
157012336|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
157012337|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
157012338|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
157012339|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
157012340|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
157012341|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
156782124|NCT01068912|565951570|FG000|Overall Study|Protocol Violation|0|||
156782125|NCT01068912|565951571|FG001|Overall Study|Protocol Violation|2|||
156678191|NCT01456962|565567230|FG000|Overall Study|Lost to Follow-up|2|||
156678192|NCT01456962|565567231|FG001|Overall Study|Lost to Follow-up|1|||
156678193|NCT03387462|565567232|FG000|Overall Study|Lost to Follow-up|1|||
156678194|NCT01460628|565567233|FG000|Overall Study|Adverse Event|3|||
156678195|NCT01460628|565567233|FG000|Overall Study|Withdrawal by Subject|2|||
156678196|NCT02854800|565567235|FG000|Overall Study|Protocol Violation|16|||
156678197|NCT02854800|565567236|FG001|Overall Study|Protocol Violation|11|||
156678198|NCT02854800|565567237|FG002|Overall Study|Protocol Violation|3|||
156678199|NCT02854800|565567235|FG000|Overall Study|Withdrawal by Subject|4|||
156678200|NCT02854800|565567236|FG001|Overall Study|Withdrawal by Subject|2|||
156678201|NCT02854800|565567237|FG002|Overall Study|Withdrawal by Subject|3|||
156678202|NCT02627963|565567238|FG000|Overall Study|Randomized but not treated|2|||
156678203|NCT02627963|565567239|FG001|Overall Study|Randomized but not treated|6|||
156678204|NCT03073798|565567240|FG000|Overall Study|Adverse Event|1|||
156678205|NCT03073798|565567240|FG000|Overall Study|Withdrawal by Subject|1|||
156678206|NCT05278858|565567241|FG000|Overall Study|Withdrawal by Subject|1|||
156678207|NCT00840658|565567242|FG000|Overall Study|Death|2|||
156678208|NCT00840658|565567243|FG001|Overall Study|Death|2|||
156678209|NCT00840658|565567244|FG002|Overall Study|Death|3|||
156678210|NCT00840658|565567245|FG003|Overall Study|Death|3|||
156678211|NCT00840658|565567242|FG000|Overall Study|Lost to Follow-up|3|||
156678212|NCT00840658|565567243|FG001|Overall Study|Lost to Follow-up|1|||
156678213|NCT00840658|565567244|FG002|Overall Study|Lost to Follow-up|2|||
156678214|NCT00840658|565567245|FG003|Overall Study|Lost to Follow-up|1|||
156678215|NCT02372006|565567257|FG000|Overall Study|Progressive disease|8|||
156678216|NCT02372006|565567258|FG001|Overall Study|Progressive disease|7|||
156678217|NCT02372006|565567259|FG002|Overall Study|Progressive disease|34|||
156678218|NCT02372006|565567257|FG000|Overall Study|Dose limiting toxicity|0|||
156678219|NCT02372006|565567258|FG001|Overall Study|Dose limiting toxicity|1|||
156678220|NCT02372006|565567259|FG002|Overall Study|Dose limiting toxicity|0|||
156678221|NCT02372006|565567257|FG000|Overall Study|Adverse Event|0|||
156678222|NCT02372006|565567258|FG001|Overall Study|Adverse Event|0|||
156678223|NCT02372006|565567259|FG002|Overall Study|Adverse Event|3|||
156678224|NCT02372006|565567257|FG000|Overall Study|Withdrawal by Subject|0|||
156678225|NCT02372006|565567258|FG001|Overall Study|Withdrawal by Subject|1|||
156678226|NCT02372006|565567259|FG002|Overall Study|Withdrawal by Subject|1|||
156678227|NCT02372006|565567257|FG000|Overall Study|Other reason for not completing|0|||
156678228|NCT02372006|565567258|FG001|Overall Study|Other reason for not completing|0|||
156678229|NCT02372006|565567259|FG002|Overall Study|Other reason for not completing|1|||
156678230|NCT01143337|565567260|FG000|Overall Study|Adverse Event|3|||
156678231|NCT01143337|565567261|FG001|Overall Study|Adverse Event|9|||
156678232|NCT01143337|565567262|FG002|Overall Study|Adverse Event|5|||
156678233|NCT01143337|565567260|FG000|Overall Study|Lack of Efficacy|6|||
156678234|NCT01143337|565567261|FG001|Overall Study|Lack of Efficacy|2|||
156678235|NCT01143337|565567262|FG002|Overall Study|Lack of Efficacy|1|||
156678236|NCT01143337|565567260|FG000|Overall Study|Protocol Violation|1|||
156678237|NCT01143337|565567261|FG001|Overall Study|Protocol Violation|0|||
156678238|NCT01143337|565567262|FG002|Overall Study|Protocol Violation|0|||
156678239|NCT01143337|565567260|FG000|Overall Study|Withdrawal by Subject|0|||
156678240|NCT01143337|565567261|FG001|Overall Study|Withdrawal by Subject|0|||
156678241|NCT01143337|565567262|FG002|Overall Study|Withdrawal by Subject|1|||
156782126|NCT01068912|565951572|FG002|Overall Study|Protocol Violation|0|||
156782127|NCT01068912|565951570|FG000|Overall Study|aggravation influenza|1|||
156782128|NCT01068912|565951571|FG001|Overall Study|aggravation influenza|1|||
156782129|NCT01068912|565951572|FG002|Overall Study|aggravation influenza|1|||
156782130|NCT01068912|565951570|FG000|Overall Study|other underlying illness|0|||
156782131|NCT01068912|565951571|FG001|Overall Study|other underlying illness|3|||
156678242|NCT01143337|565567260|FG000|Overall Study|Other reason|0|||
156678243|NCT01143337|565567261|FG001|Overall Study|Other reason|0|||
156782132|NCT01068912|565951572|FG002|Overall Study|other underlying illness|3|||
156678244|NCT01143337|565567262|FG002|Overall Study|Other reason|5|||
156678245|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Death|1|||
156678246|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Death|0|||
156678247|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Death|0|||
156782133|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
157012342|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156678248|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Death|0|||
156678249|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
156678250|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
156678251|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
156678252|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
156678253|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
156678254|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
156782134|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
156678255|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
156678256|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
156678257|NCT04133311|565567263|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678258|NCT04133311|565567264|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
156678259|NCT04133311|565567265|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678260|NCT04133311|565567266|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
156678261|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
156678262|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
156782135|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156782136|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156782137|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
156782138|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
156782139|NCT02965833|565951573|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
156782140|NCT02965833|565951574|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
156782141|NCT02965833|565951573|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
156782142|NCT02965833|565951574|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
156782143|NCT03370302|565951575|FG000|Dose Escalation Phase|Other|0|||
156782144|NCT03370302|565951576|FG001|Dose Escalation Phase|Other|1|||
156782145|NCT03370302|565951577|FG002|Dose Escalation Phase|Other|1|||
156782146|NCT03370302|565951578|FG003|Dose Escalation Phase|Other|0|||
156782147|NCT03370302|565951579|FG004|Dose Escalation Phase|Other|0|||
156782148|NCT03370302|565951580|FG005|Dose Escalation Phase|Other|0|||
156782149|NCT03370302|565951575|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156782150|NCT03370302|565951576|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
156782151|NCT03370302|565951577|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
156782152|NCT03370302|565951578|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156782153|NCT03370302|565951579|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
156782154|NCT03370302|565951580|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
156782155|NCT03370302|565951575|FG000|Dose Escalation Phase|Adverse Event|1|||
156782156|NCT03370302|565951576|FG001|Dose Escalation Phase|Adverse Event|0|||
156782157|NCT03370302|565951577|FG002|Dose Escalation Phase|Adverse Event|2|||
156782158|NCT03370302|565951578|FG003|Dose Escalation Phase|Adverse Event|0|||
156782159|NCT03370302|565951579|FG004|Dose Escalation Phase|Adverse Event|0|||
156782160|NCT03370302|565951580|FG005|Dose Escalation Phase|Adverse Event|0|||
156782161|NCT03370302|565951575|FG000|Dose Escalation Phase|Progressive Disease|2|||
156782162|NCT03370302|565951576|FG001|Dose Escalation Phase|Progressive Disease|4|||
156782163|NCT03370302|565951577|FG002|Dose Escalation Phase|Progressive Disease|2|||
156782164|NCT03370302|565951578|FG003|Dose Escalation Phase|Progressive Disease|0|||
156782165|NCT03370302|565951579|FG004|Dose Escalation Phase|Progressive Disease|3|||
156782166|NCT03370302|565951580|FG005|Dose Escalation Phase|Progressive Disease|1|||
156782167|NCT03370302|565951575|FG000|Dose Expansion Phase|Progressive Disease|0|||
156782168|NCT03370302|565951576|FG001|Dose Expansion Phase|Progressive Disease|0|||
156782169|NCT03370302|565951577|FG002|Dose Expansion Phase|Progressive Disease|0|||
156782170|NCT03370302|565951578|FG003|Dose Expansion Phase|Progressive Disease|6|||
156782171|NCT03370302|565951579|FG004|Dose Expansion Phase|Progressive Disease|0|||
156782172|NCT03370302|565951580|FG005|Dose Expansion Phase|Progressive Disease|0|||
156782173|NCT03442569|565951584|FG000|Overall Study|Subject was ineligible after enrollment|1|||
156782174|NCT03853798|565951585|FG000|Overall Study|Death|0|||
156782175|NCT03853798|565951586|FG001|Overall Study|Death|0|||
156782176|NCT03853798|565951587|FG002|Overall Study|Death|0|||
156782177|NCT03853798|565951588|FG003|Overall Study|Death|0|||
156782178|NCT03853798|565951589|FG004|Overall Study|Death|0|||
156782179|NCT03853798|565951590|FG005|Overall Study|Death|1|||
156782180|NCT03853798|565951591|FG006|Overall Study|Death|0|||
156782181|NCT03853798|565951592|FG007|Overall Study|Death|0|||
156678263|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
156678264|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
156678265|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
156678266|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
156678267|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
156782182|NCT03853798|565951593|FG008|Overall Study|Death|0|||
156782183|NCT03853798|565951585|FG000|Overall Study|Adverse Event|0|||
156782184|NCT03853798|565951586|FG001|Overall Study|Adverse Event|0|||
156782185|NCT03853798|565951587|FG002|Overall Study|Adverse Event|2|||
156678268|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
156782186|NCT03853798|565951588|FG003|Overall Study|Adverse Event|0|||
156782187|NCT03853798|565951589|FG004|Overall Study|Adverse Event|0|||
156782188|NCT03853798|565951590|FG005|Overall Study|Adverse Event|0|||
156782189|NCT03853798|565951591|FG006|Overall Study|Adverse Event|0|||
156782190|NCT03853798|565951592|FG007|Overall Study|Adverse Event|0|||
156782191|NCT03853798|565951593|FG008|Overall Study|Adverse Event|0|||
156782192|NCT03853798|565951585|FG000|Overall Study|Withdrawal by Subject|0|||
156782193|NCT03853798|565951586|FG001|Overall Study|Withdrawal by Subject|1|||
156782194|NCT03853798|565951587|FG002|Overall Study|Withdrawal by Subject|4|||
156782195|NCT03853798|565951588|FG003|Overall Study|Withdrawal by Subject|0|||
156782196|NCT03853798|565951589|FG004|Overall Study|Withdrawal by Subject|0|||
156782197|NCT03853798|565951590|FG005|Overall Study|Withdrawal by Subject|5|||
156782198|NCT03853798|565951591|FG006|Overall Study|Withdrawal by Subject|0|||
156782199|NCT03853798|565951592|FG007|Overall Study|Withdrawal by Subject|0|||
156782200|NCT03853798|565951593|FG008|Overall Study|Withdrawal by Subject|4|||
156782201|NCT03853798|565951585|FG000|Overall Study|Physician Decision|1|||
156782202|NCT03853798|565951586|FG001|Overall Study|Physician Decision|0|||
156782203|NCT03853798|565951587|FG002|Overall Study|Physician Decision|0|||
156782204|NCT03853798|565951588|FG003|Overall Study|Physician Decision|0|||
156678269|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678270|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678271|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
156678272|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
156678273|NCT04133311|565567263|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
156678274|NCT04133311|565567264|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
156678275|NCT04133311|565567265|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
156782205|NCT03853798|565951589|FG004|Overall Study|Physician Decision|0|||
156782206|NCT03853798|565951590|FG005|Overall Study|Physician Decision|0|||
156782207|NCT03853798|565951591|FG006|Overall Study|Physician Decision|0|||
156782208|NCT03853798|565951592|FG007|Overall Study|Physician Decision|0|||
156782209|NCT03853798|565951593|FG008|Overall Study|Physician Decision|1|||
156782210|NCT03853798|565951585|FG000|Overall Study|Lack of Efficacy|0|||
156782211|NCT03853798|565951586|FG001|Overall Study|Lack of Efficacy|0|||
156782212|NCT03853798|565951587|FG002|Overall Study|Lack of Efficacy|2|||
156782213|NCT03853798|565951588|FG003|Overall Study|Lack of Efficacy|0|||
156782214|NCT03853798|565951589|FG004|Overall Study|Lack of Efficacy|0|||
156782215|NCT03853798|565951590|FG005|Overall Study|Lack of Efficacy|0|||
156782216|NCT03853798|565951591|FG006|Overall Study|Lack of Efficacy|0|||
156782217|NCT03853798|565951592|FG007|Overall Study|Lack of Efficacy|0|||
156866613|NCT00129402|566271288|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
156866614|NCT00129402|566271289|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
156866615|NCT00763035|566271290|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
156866616|NCT00763035|566271291|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
156866617|NCT00763035|566271290|FG000|First Intervention|Adverse Event|0|||
156866618|NCT00763035|566271291|FG001|First Intervention|Adverse Event|1|||
156866619|NCT00763035|566271290|FG000|Second Intervention|Adverse Event|1|||
156866620|NCT00763035|566271291|FG001|Second Intervention|Adverse Event|0|||
156866621|NCT00763035|566271290|FG000|Second Intervention|Physician Decision|2|||
156866622|NCT00763035|566271291|FG001|Second Intervention|Physician Decision|0|||
156866623|NCT02131259|566271292|FG000|Overall Study|Progressive disease|751|||
156866624|NCT02131259|566271292|FG000|Overall Study|Adverse Event|341|||
156866625|NCT02131259|566271292|FG000|Overall Study|Lost to Follow-up|7|||
156866626|NCT02131259|566271292|FG000|Overall Study|Relocation|32|||
156866627|NCT02131259|566271292|FG000|Overall Study|Other|63|||
156866628|NCT02131259|566271292|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
156866629|NCT02131259|566271292|FG000|Overall Study|Progressive disease/relocation|1|||
156866630|NCT02131259|566271292|FG000|Overall Study|Progressive disease/other|2|||
156866631|NCT02131259|566271292|FG000|Overall Study|AE/lost to follow-up|1|||
156866632|NCT02131259|566271292|FG000|Overall Study|AE/other|1|||
156866633|NCT02131259|566271292|FG000|Overall Study|Progressive disease/AE/other|1|||
156866634|NCT02131259|566271292|FG000|Overall Study|Missing|3|||
156866635|NCT01472289|566271293|FG000|Overall Study|Death|2|||
156866636|NCT02435992|566271294|FG000|Overall Study|non compliance with protocol|2|||
156866637|NCT02435992|566271295|FG001|Overall Study|non compliance with protocol|0|||
156866638|NCT02435992|566271296|FG002|Overall Study|non compliance with protocol|1|||
156866639|NCT02435992|566271297|FG003|Overall Study|non compliance with protocol|0|||
156866640|NCT02435992|566271298|FG004|Overall Study|non compliance with protocol|0|||
156866641|NCT02435992|566271294|FG000|Overall Study|Adverse Event|11|||
156866642|NCT02435992|566271295|FG001|Overall Study|Adverse Event|6|||
156866643|NCT02435992|566271296|FG002|Overall Study|Adverse Event|12|||
156866644|NCT02435992|566271297|FG003|Overall Study|Adverse Event|0|||
156866645|NCT02435992|566271298|FG004|Overall Study|Adverse Event|0|||
156866646|NCT02435992|566271294|FG000|Overall Study|Lack of Efficacy|4|||
156866647|NCT02435992|566271295|FG001|Overall Study|Lack of Efficacy|10|||
156866648|NCT02435992|566271296|FG002|Overall Study|Lack of Efficacy|9|||
156866649|NCT02435992|566271297|FG003|Overall Study|Lack of Efficacy|0|||
156678276|NCT04133311|565567266|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
156678277|NCT00728754|565567275|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
156782218|NCT03853798|565951593|FG008|Overall Study|Lack of Efficacy|1|||
156782219|NCT03853798|565951585|FG000|Overall Study|Approved Drug Available for Indication|0|||
156782220|NCT03853798|565951586|FG001|Overall Study|Approved Drug Available for Indication|0|||
156782221|NCT03853798|565951587|FG002|Overall Study|Approved Drug Available for Indication|1|||
156782222|NCT03853798|565951588|FG003|Overall Study|Approved Drug Available for Indication|0|||
157119969|NCT04681170|567192940|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
156678278|NCT00728754|565567276|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
156678279|NCT00728754|565567275|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
156678280|NCT00728754|565567276|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
156678281|NCT00728754|565567275|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
156678282|NCT00728754|565567276|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
156678283|NCT01859598|565567277|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
156678284|NCT00009945|565567278|FG000|Overall Study|no follow up data|7|||
156678285|NCT00009945|565567279|FG001|Overall Study|no follow up data|5|||
156678286|NCT00672984|565567280|FG000|First Intervention|Adverse Event|5|||
156678287|NCT00672984|565567281|FG001|First Intervention|Adverse Event|0|||
156678288|NCT00672984|565567282|FG002|First Intervention|Adverse Event|0|||
156678289|NCT00672984|565567280|FG000|First Intervention|Withdrawal by Subject|1|||
156678290|NCT00672984|565567281|FG001|First Intervention|Withdrawal by Subject|2|||
156678291|NCT00672984|565567282|FG002|First Intervention|Withdrawal by Subject|2|||
156782223|NCT03853798|565951589|FG004|Overall Study|Approved Drug Available for Indication|0|||
156782224|NCT03853798|565951590|FG005|Overall Study|Approved Drug Available for Indication|1|||
156782225|NCT03853798|565951591|FG006|Overall Study|Approved Drug Available for Indication|0|||
156782226|NCT03853798|565951592|FG007|Overall Study|Approved Drug Available for Indication|0|||
156782227|NCT03853798|565951593|FG008|Overall Study|Approved Drug Available for Indication|0|||
156782228|NCT03853798|565951585|FG000|Overall Study|Other un-specified|0|||
156782229|NCT03853798|565951586|FG001|Overall Study|Other un-specified|0|||
156782230|NCT03853798|565951587|FG002|Overall Study|Other un-specified|2|||
156782231|NCT03853798|565951588|FG003|Overall Study|Other un-specified|0|||
156782232|NCT03853798|565951589|FG004|Overall Study|Other un-specified|0|||
156782233|NCT03853798|565951590|FG005|Overall Study|Other un-specified|1|||
156782234|NCT03853798|565951591|FG006|Overall Study|Other un-specified|0|||
156782235|NCT03853798|565951592|FG007|Overall Study|Other un-specified|0|||
156782236|NCT03853798|565951593|FG008|Overall Study|Other un-specified|0|||
156782237|NCT02743494|565951594|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
156782238|NCT02743494|565951595|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
156782239|NCT02743494|565951594|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
156782240|NCT02743494|565951595|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
156782241|NCT02743494|565951594|FG000|Treatment Period|Disease recurrence|152|||
156782242|NCT02743494|565951595|FG001|Treatment Period|Disease recurrence|115|||
156782243|NCT02743494|565951594|FG000|Treatment Period|Study drug toxicity|56|||
156782244|NCT02743494|565951595|FG001|Treatment Period|Study drug toxicity|8|||
156782245|NCT02743494|565951594|FG000|Treatment Period|Death|1|||
156782246|NCT02743494|565951595|FG001|Treatment Period|Death|1|||
156782247|NCT02743494|565951594|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
156782248|NCT02743494|565951595|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
156782249|NCT02743494|565951594|FG000|Treatment Period|Participant request to discontinue treatment|31|||
156782250|NCT02743494|565951595|FG001|Treatment Period|Participant request to discontinue treatment|5|||
156782251|NCT02743494|565951594|FG000|Treatment Period|Participant withdrew consent|11|||
156782252|NCT02743494|565951595|FG001|Treatment Period|Participant withdrew consent|4|||
156782253|NCT02743494|565951594|FG000|Treatment Period|Lost to Follow-up|0|||
156782254|NCT02743494|565951595|FG001|Treatment Period|Lost to Follow-up|1|||
156782255|NCT02743494|565951594|FG000|Treatment Period|Poor/Non-compliance|2|||
156782256|NCT02743494|565951595|FG001|Treatment Period|Poor/Non-compliance|0|||
156782257|NCT02743494|565951594|FG000|Treatment Period|Other reasons|4|||
156782258|NCT02743494|565951595|FG001|Treatment Period|Other reasons|1|||
156782259|NCT02207608|565951596|FG000|Overall Study|Adverse Event|1|||
156782260|NCT02207608|565951597|FG001|Overall Study|Adverse Event|0|||
156782261|NCT05800145|565951598|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
156782262|NCT05800145|565951599|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782263|NCT05800145|565951600|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782264|NCT05800145|565951601|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
156782265|NCT05800145|565951602|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782266|NCT05800145|565951603|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156782267|NCT05800145|565951598|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
156782268|NCT05800145|565951599|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782269|NCT05800145|565951600|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782270|NCT05800145|565951601|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
156782271|NCT05800145|565951602|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782272|NCT05800145|565951603|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
156782273|NCT05800145|565951598|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156866650|NCT02435992|566271298|FG004|Overall Study|Lack of Efficacy|0|||
156782274|NCT05800145|565951599|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
156782275|NCT05800145|565951600|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
156782276|NCT05800145|565951601|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
156782277|NCT05800145|565951602|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
156866651|NCT02435992|566271294|FG000|Overall Study|Withdrawal by Subject|10|||
156866652|NCT02435992|566271295|FG001|Overall Study|Withdrawal by Subject|8|||
156866653|NCT02435992|566271296|FG002|Overall Study|Withdrawal by Subject|20|||
156866654|NCT02435992|566271297|FG003|Overall Study|Withdrawal by Subject|0|||
156866655|NCT02435992|566271298|FG004|Overall Study|Withdrawal by Subject|0|||
156866656|NCT02435992|566271294|FG000|Overall Study|Other Reason|1|||
156866657|NCT02435992|566271295|FG001|Overall Study|Other Reason|0|||
156866658|NCT02435992|566271296|FG002|Overall Study|Other Reason|0|||
156866659|NCT02435992|566271297|FG003|Overall Study|Other Reason|0|||
156866660|NCT02435992|566271298|FG004|Overall Study|Other Reason|0|||
156866661|NCT02435992|566271294|FG000|Overall Study|Physician Decision|0|||
156866662|NCT02435992|566271295|FG001|Overall Study|Physician Decision|0|||
156866663|NCT02435992|566271296|FG002|Overall Study|Physician Decision|1|||
156866664|NCT02435992|566271297|FG003|Overall Study|Physician Decision|0|||
156866665|NCT02435992|566271298|FG004|Overall Study|Physician Decision|0|||
156866666|NCT04298697|566271301|FG000|Overall Study|Lost to Follow-up|5|||
156866667|NCT04298697|566271302|FG001|Overall Study|Lost to Follow-up|5|||
156866668|NCT04298697|566271303|FG002|Overall Study|Lost to Follow-up|1|||
156866669|NCT04298697|566271304|FG003|Overall Study|Lost to Follow-up|0|||
156866670|NCT04298697|566271301|FG000|Overall Study|Withdrawal by Subject|0|||
156866671|NCT04298697|566271302|FG001|Overall Study|Withdrawal by Subject|3|||
156866672|NCT04298697|566271303|FG002|Overall Study|Withdrawal by Subject|2|||
156866673|NCT04298697|566271304|FG003|Overall Study|Withdrawal by Subject|3|||
156866674|NCT03205423|566271308|FG000|Overall Study|Personal|1|||
156866675|NCT03205423|566271309|FG001|Overall Study|Personal|1|||
156866676|NCT03205423|566271308|FG000|Overall Study|Physician Decision|0|||
156866677|NCT03205423|566271309|FG001|Overall Study|Physician Decision|2|||
156866678|NCT02749422|566271310|FG000|Overall Study|Lost to Follow-up|0|||
156866679|NCT02749422|566271311|FG001|Overall Study|Lost to Follow-up|2|||
156866680|NCT02749422|566271310|FG000|Overall Study|Ineligible|0|||
156866681|NCT02749422|566271311|FG001|Overall Study|Ineligible|1|||
156866682|NCT02638220|566271317|FG000|Overall Study|Lost to Follow-up|6|||
156866683|NCT02638220|566271317|FG000|Overall Study|Withdrawal by Subject|3|||
156866684|NCT02638220|566271317|FG000|Overall Study|Physician Decision|1|||
156866685|NCT02638220|566271317|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
156866686|NCT04323124|566271318|FG000|Overall Study|Adverse Event|0|||
156866687|NCT04323124|566271319|FG001|Overall Study|Adverse Event|0|||
156866688|NCT04323124|566271320|FG002|Overall Study|Adverse Event|0|||
156866689|NCT04323124|566271321|FG003|Overall Study|Adverse Event|0|||
156866690|NCT04323124|566271322|FG004|Overall Study|Adverse Event|0|||
156866691|NCT04323124|566271323|FG005|Overall Study|Adverse Event|1|||
156866692|NCT04323124|566271324|FG006|Overall Study|Adverse Event|0|||
156866693|NCT04323124|566271325|FG007|Overall Study|Adverse Event|1|||
156866694|NCT04323124|566271326|FG008|Overall Study|Adverse Event|1|||
156866695|NCT04323124|566271327|FG009|Overall Study|Adverse Event|0|||
156866696|NCT04323124|566271328|FG010|Overall Study|Adverse Event|0|||
156866697|NCT04323124|566271329|FG011|Overall Study|Adverse Event|0|||
156866698|NCT04323124|566271330|FG012|Overall Study|Adverse Event|0|||
156866699|NCT04323124|566271331|FG013|Overall Study|Adverse Event|0|||
156866700|NCT04323124|566271332|FG014|Overall Study|Adverse Event|0|||
156866701|NCT04323124|566271318|FG000|Overall Study|Other|0|||
156866702|NCT04323124|566271319|FG001|Overall Study|Other|0|||
156866703|NCT04323124|566271320|FG002|Overall Study|Other|0|||
156866704|NCT04323124|566271321|FG003|Overall Study|Other|0|||
156866705|NCT04323124|566271322|FG004|Overall Study|Other|1|||
156866706|NCT04323124|566271323|FG005|Overall Study|Other|0|||
156866707|NCT04323124|566271324|FG006|Overall Study|Other|0|||
156866708|NCT04323124|566271325|FG007|Overall Study|Other|0|||
156866709|NCT04323124|566271326|FG008|Overall Study|Other|1|||
156866710|NCT04323124|566271327|FG009|Overall Study|Other|0|||
156866711|NCT04323124|566271328|FG010|Overall Study|Other|0|||
156866712|NCT04323124|566271329|FG011|Overall Study|Other|0|||
156866713|NCT04323124|566271330|FG012|Overall Study|Other|0|||
156866714|NCT04323124|566271331|FG013|Overall Study|Other|0|||
156866715|NCT04323124|566271332|FG014|Overall Study|Other|0|||
156866716|NCT04323124|566271318|FG000|Overall Study|Coming from a red zone (COVID)|0|||
156866717|NCT04323124|566271319|FG001|Overall Study|Coming from a red zone (COVID)|0|||
156866718|NCT04323124|566271320|FG002|Overall Study|Coming from a red zone (COVID)|0|||
156866719|NCT04323124|566271321|FG003|Overall Study|Coming from a red zone (COVID)|0|||
156866720|NCT04323124|566271322|FG004|Overall Study|Coming from a red zone (COVID)|1|||
157012343|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156866721|NCT04323124|566271323|FG005|Overall Study|Coming from a red zone (COVID)|1|||
156866722|NCT04323124|566271324|FG006|Overall Study|Coming from a red zone (COVID)|0|||
156866723|NCT04323124|566271325|FG007|Overall Study|Coming from a red zone (COVID)|0|||
156866724|NCT04323124|566271326|FG008|Overall Study|Coming from a red zone (COVID)|0|||
156866725|NCT04323124|566271327|FG009|Overall Study|Coming from a red zone (COVID)|0|||
156866726|NCT04323124|566271328|FG010|Overall Study|Coming from a red zone (COVID)|0|||
156866727|NCT04323124|566271329|FG011|Overall Study|Coming from a red zone (COVID)|0|||
156866728|NCT04323124|566271330|FG012|Overall Study|Coming from a red zone (COVID)|0|||
156678292|NCT00672984|565567280|FG000|First Intervention|Sponsor decision|3|||
156678293|NCT00672984|565567281|FG001|First Intervention|Sponsor decision|0|||
156678294|NCT00672984|565567282|FG002|First Intervention|Sponsor decision|0|||
156678295|NCT00672984|565567280|FG000|Second Intervention|Non-compliance with facility policies|0|||
156678296|NCT00672984|565567281|FG001|Second Intervention|Non-compliance with facility policies|2|||
156678297|NCT00672984|565567282|FG002|Second Intervention|Non-compliance with facility policies|0|||
156678298|NCT00672984|565567280|FG000|Second Intervention|Withdrawal by Subject|0|||
156678299|NCT00672984|565567281|FG001|Second Intervention|Withdrawal by Subject|3|||
156678300|NCT00672984|565567282|FG002|Second Intervention|Withdrawal by Subject|0|||
156678301|NCT00672984|565567280|FG000|Second Intervention|Protocol Violation|0|||
156678302|NCT00672984|565567281|FG001|Second Intervention|Protocol Violation|1|||
156678303|NCT00672984|565567282|FG002|Second Intervention|Protocol Violation|1|||
156678304|NCT00672984|565567280|FG000|Third Intervention|Adverse Event|1|||
156678305|NCT00672984|565567281|FG001|Third Intervention|Adverse Event|0|||
156678306|NCT00672984|565567282|FG002|Third Intervention|Adverse Event|1|||
156678307|NCT00573313|565567287|FG000|Overall Study|Protocol Violation|5|||
156678308|NCT00573313|565567288|FG001|Overall Study|Protocol Violation|0|||
156678309|NCT00573313|565567289|FG002|Overall Study|Protocol Violation|6|||
156866729|NCT04323124|566271331|FG013|Overall Study|Coming from a red zone (COVID)|0|||
156866730|NCT04323124|566271332|FG014|Overall Study|Coming from a red zone (COVID)|0|||
156866731|NCT04323124|566271318|FG000|Overall Study|No longer meets eligibility criteria|0|||
156866732|NCT04323124|566271319|FG001|Overall Study|No longer meets eligibility criteria|0|||
156866733|NCT04323124|566271320|FG002|Overall Study|No longer meets eligibility criteria|0|||
156678310|NCT00573313|565567290|FG003|Overall Study|Protocol Violation|0|||
156678311|NCT00295490|565567293|FG000|Overall Study|Protocol Violation|0|||
156678312|NCT00295490|565567294|FG001|Overall Study|Protocol Violation|0|||
156678313|NCT00295490|565567295|FG002|Overall Study|Protocol Violation|3|||
156678314|NCT00295490|565567296|FG003|Overall Study|Protocol Violation|3|||
156678315|NCT00295490|565567293|FG000|Overall Study|Withdrawal by Subject|0|||
156678316|NCT00295490|565567294|FG001|Overall Study|Withdrawal by Subject|2|||
156678317|NCT00295490|565567295|FG002|Overall Study|Withdrawal by Subject|0|||
156678318|NCT00295490|565567296|FG003|Overall Study|Withdrawal by Subject|1|||
156678319|NCT00295490|565567293|FG000|Overall Study|Lost to Follow-up|0|||
156678320|NCT00295490|565567294|FG001|Overall Study|Lost to Follow-up|0|||
156678321|NCT00295490|565567295|FG002|Overall Study|Lost to Follow-up|1|||
156678322|NCT00295490|565567296|FG003|Overall Study|Lost to Follow-up|0|||
156678323|NCT00295490|565567293|FG000|Overall Study|Adverse Event|1|||
156678324|NCT00295490|565567294|FG001|Overall Study|Adverse Event|0|||
156678325|NCT00295490|565567295|FG002|Overall Study|Adverse Event|0|||
156678326|NCT00295490|565567296|FG003|Overall Study|Adverse Event|0|||
156678327|NCT00295490|565567293|FG000|Overall Study|Other|0|||
156678328|NCT00295490|565567294|FG001|Overall Study|Other|2|||
156678329|NCT00295490|565567295|FG002|Overall Study|Other|0|||
156678330|NCT00295490|565567296|FG003|Overall Study|Other|1|||
156678331|NCT03255980|565567297|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
156678332|NCT03255980|565567298|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
156678333|NCT03255980|565567299|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
156678334|NCT03255980|565567300|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
156678335|NCT03255980|565567297|FG000|Overall Study|Adverse Event|1|||
156678336|NCT03255980|565567298|FG001|Overall Study|Adverse Event|1|||
156678337|NCT03255980|565567299|FG002|Overall Study|Adverse Event|0|||
156678338|NCT03255980|565567300|FG003|Overall Study|Adverse Event|1|||
156678339|NCT03255980|565567297|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
156678340|NCT03255980|565567298|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
156678341|NCT03255980|565567299|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
156678342|NCT03255980|565567300|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
156678343|NCT03255980|565567297|FG000|Overall Study|Lost to Follow-up|1|||
156678344|NCT03255980|565567298|FG001|Overall Study|Lost to Follow-up|1|||
156678345|NCT03255980|565567299|FG002|Overall Study|Lost to Follow-up|0|||
156678346|NCT03255980|565567300|FG003|Overall Study|Lost to Follow-up|3|||
156678347|NCT03255980|565567297|FG000|Overall Study|Withdrawal by Subject|0|||
156678348|NCT03255980|565567298|FG001|Overall Study|Withdrawal by Subject|1|||
156678349|NCT03255980|565567299|FG002|Overall Study|Withdrawal by Subject|0|||
156678350|NCT03255980|565567300|FG003|Overall Study|Withdrawal by Subject|3|||
156678351|NCT01597791|565567301|FG000|Overall Study|Physician Decision|2|||
156678352|NCT01597791|565567302|FG001|Overall Study|Physician Decision|1|||
156678353|NCT01597791|565567301|FG000|Overall Study|Cesarean Section|6|||
156678354|NCT01597791|565567302|FG001|Overall Study|Cesarean Section|7|||
156678355|NCT01597791|565567301|FG000|Overall Study|Subject withdrawal|0|||
156678356|NCT01597791|565567302|FG001|Overall Study|Subject withdrawal|1|||
156678357|NCT01597791|565567301|FG000|Overall Study|Protocol Violation|0|||
156866734|NCT04323124|566271321|FG003|Overall Study|No longer meets eligibility criteria|0|||
156678358|NCT01597791|565567302|FG001|Overall Study|Protocol Violation|1|||
156678359|NCT02611362|565567303|FG000|Overall Study|Withdrawal by Subject|7|||
156678360|NCT02611362|565567304|FG001|Overall Study|Withdrawal by Subject|2|||
156678361|NCT02611362|565567303|FG000|Overall Study|Lost to Follow-up|2|||
156678362|NCT02611362|565567304|FG001|Overall Study|Lost to Follow-up|4|||
156678363|NCT00354159|565567305|FG000|Randomized Study Period|Withdrawal by Subject|5|||
156678364|NCT00354159|565567306|FG001|Randomized Study Period|Withdrawal by Subject|3|||
156678365|NCT00354159|565567305|FG000|Randomized Study Period|Physician Decision|6|||
156678366|NCT00354159|565567306|FG001|Randomized Study Period|Physician Decision|10|||
156678367|NCT00354159|565567305|FG000|Randomized Study Period|Lost to Follow-up|4|||
156678368|NCT00354159|565567306|FG001|Randomized Study Period|Lost to Follow-up|0|||
156678369|NCT00354159|565567305|FG000|Randomized Study Period|Death|7|||
156678370|NCT00354159|565567306|FG001|Randomized Study Period|Death|9|||
156678371|NCT00354159|565567305|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
156678372|NCT00354159|565567306|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
156678373|NCT00354159|565567305|FG000|Long-term Follow-up|Physician Decision|127|||
156782278|NCT05800145|565951603|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156782279|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
156782280|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
156782281|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156782282|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156782283|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156782284|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156782285|NCT05643794|565952725|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782286|NCT05643794|565952726|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
156782287|NCT05643794|565952727|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782288|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
157213152|NCT04130919|567527764|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
156782289|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156782290|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
156782291|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
156782292|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
156782293|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
157213153|NCT04130919|567527765|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
157213154|NCT04130919|567527766|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
157213155|NCT04130919|567527767|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
157213156|NCT04130919|567527762|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
157213157|NCT04130919|567527763|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
157213158|NCT04130919|567527764|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
157213159|NCT04130919|567527765|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
157213160|NCT04130919|567527766|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
157213161|NCT04130919|567527767|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
157213162|NCT02624518|567527768|FG000|Overall Study|Physician Decision|1|||
157213163|NCT02729194|567527769|FG000|Overall Study|Withdrawal by Subject|3|||
157213164|NCT00845026|567527770|FG000|Study Period III|Adverse Event|23|||
157213165|NCT00845026|567527771|FG001|Study Period III|Adverse Event|19|||
157213166|NCT00845026|567527770|FG000|Study Period III|Perceived lack of efficacy|27|||
157213167|NCT00845026|567527771|FG001|Study Period III|Perceived lack of efficacy|15|||
157213168|NCT00845026|567527770|FG000|Study Period III|Withdrawal by Subject|19|||
157213169|NCT00845026|567527771|FG001|Study Period III|Withdrawal by Subject|15|||
157213170|NCT00845026|567527770|FG000|Study Period III|Entry Criteria not met|8|||
157213171|NCT00845026|567527771|FG001|Study Period III|Entry Criteria not met|11|||
157213172|NCT00845026|567527770|FG000|Study Period III|Lost to Follow-up|4|||
157213173|NCT00845026|567527771|FG001|Study Period III|Lost to Follow-up|5|||
157213174|NCT00845026|567527770|FG000|Study Period III|Protocol Violation|8|||
157213175|NCT00845026|567527771|FG001|Study Period III|Protocol Violation|1|||
157213176|NCT00845026|567527770|FG000|Study Period III|Scheduled conflict|3|||
157213177|NCT00845026|567527771|FG001|Study Period III|Scheduled conflict|1|||
157213178|NCT00845026|567527770|FG000|Study Period III|Subject is moving or has moved|2|||
157213179|NCT00845026|567527771|FG001|Study Period III|Subject is moving or has moved|4|||
157213180|NCT00845026|567527770|FG000|Study Period III|Transportation issues|1|||
157213181|NCT00845026|567527771|FG001|Study Period III|Transportation issues|1|||
157213182|NCT00845026|567527770|FG000|Study Period IV|Adverse Event|4|||
157213183|NCT00845026|567527771|FG001|Study Period IV|Adverse Event|0|||
157213184|NCT00845026|567527770|FG000|Study Period IV|Perceived lack of efficacy|2|||
157213185|NCT00845026|567527771|FG001|Study Period IV|Perceived lack of efficacy|1|||
157213186|NCT00845026|567527770|FG000|Study Period IV|Protocol Violation|3|||
157213187|NCT00845026|567527771|FG001|Study Period IV|Protocol Violation|1|||
157213188|NCT00845026|567527770|FG000|Study Period IV|Lost to Follow-up|1|||
157213189|NCT00845026|567527771|FG001|Study Period IV|Lost to Follow-up|0|||
157213190|NCT00845026|567527770|FG000|Study Period IV|Withdrawal by Subject|4|||
156678374|NCT00354159|565567306|FG001|Long-term Follow-up|Physician Decision|122|||
156678375|NCT00354159|565567305|FG000|Long-term Follow-up|Lost to Follow-up|1|||
156678376|NCT00354159|565567306|FG001|Long-term Follow-up|Lost to Follow-up|0|||
156678377|NCT00354159|565567305|FG000|Long-term Follow-up|Death|14|||
156678378|NCT00354159|565567306|FG001|Long-term Follow-up|Death|11|||
156678379|NCT00354159|565567305|FG000|Long-term Follow-up|Study Closed|29|||
156678380|NCT00354159|565567306|FG001|Long-term Follow-up|Study Closed|34|||
156678381|NCT02229084|565567308|FG000|Overall Study|Adverse Event|1|||
156678382|NCT02229084|565567309|FG001|Overall Study|Adverse Event|0|||
156678383|NCT02229084|565567310|FG002|Overall Study|Adverse Event|0|||
156678384|NCT02229084|565567311|FG003|Overall Study|Adverse Event|0|||
156678385|NCT02229084|565567312|FG004|Overall Study|Adverse Event|0|||
156678386|NCT02229084|565567313|FG005|Overall Study|Adverse Event|0|||
156678387|NCT02229084|565567314|FG006|Overall Study|Adverse Event|0|||
156678388|NCT02229084|565567308|FG000|Overall Study|Lost to Follow-up|0|||
156678389|NCT02229084|565567309|FG001|Overall Study|Lost to Follow-up|0|||
156678390|NCT02229084|565567310|FG002|Overall Study|Lost to Follow-up|1|||
156678391|NCT02229084|565567311|FG003|Overall Study|Lost to Follow-up|1|||
156678392|NCT02229084|565567312|FG004|Overall Study|Lost to Follow-up|0|||
156678393|NCT02229084|565567313|FG005|Overall Study|Lost to Follow-up|0|||
156678394|NCT02229084|565567314|FG006|Overall Study|Lost to Follow-up|1|||
156678395|NCT02229084|565567308|FG000|Overall Study|Physician Decision|0|||
156678396|NCT02229084|565567309|FG001|Overall Study|Physician Decision|0|||
156678397|NCT02229084|565567310|FG002|Overall Study|Physician Decision|0|||
156678398|NCT02229084|565567311|FG003|Overall Study|Physician Decision|1|||
156678399|NCT02229084|565567312|FG004|Overall Study|Physician Decision|3|||
156678400|NCT02229084|565567313|FG005|Overall Study|Physician Decision|0|||
156678401|NCT02229084|565567314|FG006|Overall Study|Physician Decision|1|||
156678402|NCT02229084|565567308|FG000|Overall Study|Withdrawal by Subject|0|||
156678403|NCT02229084|565567309|FG001|Overall Study|Withdrawal by Subject|0|||
156678404|NCT02229084|565567310|FG002|Overall Study|Withdrawal by Subject|1|||
156678405|NCT02229084|565567311|FG003|Overall Study|Withdrawal by Subject|0|||
156678406|NCT02229084|565567312|FG004|Overall Study|Withdrawal by Subject|1|||
156678407|NCT02229084|565567313|FG005|Overall Study|Withdrawal by Subject|1|||
156678408|NCT02229084|565567314|FG006|Overall Study|Withdrawal by Subject|1|||
156678409|NCT02229084|565567308|FG000|Overall Study|Death|0|||
156678410|NCT02229084|565567309|FG001|Overall Study|Death|0|||
156678411|NCT02229084|565567310|FG002|Overall Study|Death|0|||
156678412|NCT02229084|565567311|FG003|Overall Study|Death|0|||
156678413|NCT02229084|565567312|FG004|Overall Study|Death|0|||
156678414|NCT02229084|565567313|FG005|Overall Study|Death|0|||
156678415|NCT02229084|565567314|FG006|Overall Study|Death|1|||
156678416|NCT01728116|565567317|FG000|Overall Study|Sponsor Terminated Study|106|||
156678417|NCT01728116|565567318|FG001|Overall Study|Sponsor Terminated Study|35|||
156678418|NCT01728116|565567317|FG000|Overall Study|Withdrawal by Subject|16|||
156678419|NCT01728116|565567318|FG001|Overall Study|Withdrawal by Subject|9|||
156678420|NCT01728116|565567317|FG000|Overall Study|Adverse Event|13|||
156678421|NCT01728116|565567318|FG001|Overall Study|Adverse Event|0|||
156678422|NCT01728116|565567317|FG000|Overall Study|Procedure/device failure|7|||
156678423|NCT01728116|565567318|FG001|Overall Study|Procedure/device failure|0|||
156678424|NCT01728116|565567317|FG000|Overall Study|Lost to Follow-up|9|||
156678425|NCT01728116|565567318|FG001|Overall Study|Lost to Follow-up|2|||
156678426|NCT01728116|565567317|FG000|Overall Study|Physician Decision|2|||
156678427|NCT01728116|565567318|FG001|Overall Study|Physician Decision|0|||
156678428|NCT01728116|565567317|FG000|Overall Study|Subject Non-Compliance|2|||
156678429|NCT01728116|565567318|FG001|Overall Study|Subject Non-Compliance|0|||
156678430|NCT01728116|565567317|FG000|Overall Study|Inter-current finding at procedure|1|||
156678431|NCT01728116|565567318|FG001|Overall Study|Inter-current finding at procedure|0|||
156678432|NCT01728116|565567317|FG000|Overall Study|Incorrectly enrolled in Study|0|||
156678433|NCT01728116|565567318|FG001|Overall Study|Incorrectly enrolled in Study|1|||
156866735|NCT04323124|566271322|FG004|Overall Study|No longer meets eligibility criteria|0|||
156866736|NCT04323124|566271323|FG005|Overall Study|No longer meets eligibility criteria|0|||
156866737|NCT04323124|566271324|FG006|Overall Study|No longer meets eligibility criteria|0|||
156678434|NCT01728116|565567317|FG000|Overall Study|various not noted previously|5|||
156678435|NCT01728116|565567318|FG001|Overall Study|various not noted previously|0|||
156678436|NCT01559116|565567329|FG000|Overall Study|Adverse Event|10|||
156678437|NCT01559116|565567329|FG000|Overall Study|Lack of Efficacy|1|||
156678438|NCT01559116|565567329|FG000|Overall Study|Lost to Follow-up|1|||
156678439|NCT01559116|565567329|FG000|Overall Study|Protocol Violation|1|||
156678440|NCT01559116|565567329|FG000|Overall Study|Withdrawal by Subject|4|||
156678441|NCT01559116|565567329|FG000|Overall Study|other than stated above|9|||
156678442|NCT01532908|565567330|FG000|Overall Study|Not Transplanted|1|||
156678443|NCT01532908|565567331|FG001|Overall Study|Not Transplanted|0|||
156678444|NCT03277248|565567337|FG000|Overall Study|Adverse Event|3|||
156678445|NCT03277248|565567338|FG001|Overall Study|Adverse Event|1|||
156678446|NCT03277248|565567337|FG000|Overall Study|Subject Withdrawal of Consent|6|||
156678447|NCT03277248|565567338|FG001|Overall Study|Subject Withdrawal of Consent|23|||
156678448|NCT03277248|565567337|FG000|Overall Study|Investigator/Sponsor Decision|2|||
156678449|NCT03277248|565567338|FG001|Overall Study|Investigator/Sponsor Decision|2|||
156678450|NCT03277248|565567337|FG000|Overall Study|Pregnancy|4|||
156678451|NCT03277248|565567338|FG001|Overall Study|Pregnancy|1|||
156678452|NCT03277248|565567337|FG000|Overall Study|Lost to Follow-up|0|||
156678453|NCT03277248|565567338|FG001|Overall Study|Lost to Follow-up|2|||
156678454|NCT03277248|565567337|FG000|Overall Study|Lack of Efficacy|0|||
156678455|NCT03277248|565567338|FG001|Overall Study|Lack of Efficacy|2|||
156678456|NCT03277248|565567337|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
156678457|NCT03277248|565567338|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
156678458|NCT01993940|565567345|FG000|Overall Study|Adverse Event|16|||
156678459|NCT01993940|565567346|FG001|Overall Study|Adverse Event|11|||
156678460|NCT01993940|565567345|FG000|Overall Study|Withdrawal by Subject|15|||
156678461|NCT01993940|565567346|FG001|Overall Study|Withdrawal by Subject|19|||
156678462|NCT01993940|565567345|FG000|Overall Study|Lost to Follow-up|2|||
156678463|NCT01993940|565567346|FG001|Overall Study|Lost to Follow-up|5|||
156678464|NCT01993940|565567345|FG000|Overall Study|Protocol Violation|5|||
156678465|NCT01993940|565567346|FG001|Overall Study|Protocol Violation|8|||
156678466|NCT01993940|565567345|FG000|Overall Study|Death|1|||
156678467|NCT01993940|565567346|FG001|Overall Study|Death|0|||
156678468|NCT01993940|565567345|FG000|Overall Study|Other - Miscellaneous|1|||
156678469|NCT01993940|565567346|FG001|Overall Study|Other - Miscellaneous|1|||
156678470|NCT03922750|565567347|FG000|Overall Study|Unclassified|0|||
156678471|NCT03922750|565567348|FG001|Overall Study|Unclassified|0|||
156678472|NCT03922750|565567349|FG002|Overall Study|Unclassified|1|||
156678473|NCT03922750|565567347|FG000|Overall Study|Adverse Event|0|||
156678474|NCT03922750|565567348|FG001|Overall Study|Adverse Event|1|||
156678475|NCT03922750|565567349|FG002|Overall Study|Adverse Event|0|||
156678476|NCT01451541|565567350|FG000|Overall Study|Adverse Event|4|||
156678477|NCT01451541|565567351|FG001|Overall Study|Adverse Event|3|||
156678478|NCT01451541|565567352|FG002|Overall Study|Adverse Event|6|||
156678479|NCT01451541|565567350|FG000|Overall Study|Lack of Efficacy|2|||
156678480|NCT01451541|565567351|FG001|Overall Study|Lack of Efficacy|0|||
156678481|NCT01451541|565567352|FG002|Overall Study|Lack of Efficacy|0|||
156678482|NCT01451541|565567350|FG000|Overall Study|Lost to Follow-up|4|||
156678483|NCT01451541|565567351|FG001|Overall Study|Lost to Follow-up|4|||
156678484|NCT01451541|565567352|FG002|Overall Study|Lost to Follow-up|7|||
156678485|NCT01451541|565567350|FG000|Overall Study|Withdrawal by Subject|15|||
156678486|NCT01451541|565567351|FG001|Overall Study|Withdrawal by Subject|8|||
156678487|NCT01451541|565567352|FG002|Overall Study|Withdrawal by Subject|6|||
156678488|NCT01451541|565567350|FG000|Overall Study|randomization error, noncompliance|11|||
156678489|NCT01451541|565567351|FG001|Overall Study|randomization error, noncompliance|10|||
156678490|NCT01451541|565567352|FG002|Overall Study|randomization error, noncompliance|8|||
156678491|NCT00379353|565567357|FG000|Overall Study|Hospitalization|3|||
156678492|NCT00379353|565567358|FG001|Overall Study|Hospitalization|3|||
156678493|NCT00379353|565567357|FG000|Overall Study|Withdrawal by Subject|5|||
156678494|NCT00379353|565567358|FG001|Overall Study|Withdrawal by Subject|2|||
156678495|NCT00379353|565567357|FG000|Overall Study|Death|1|||
156678496|NCT00379353|565567358|FG001|Overall Study|Death|0|||
156678497|NCT00379353|565567357|FG000|Overall Study|Cardiac Tamponade|1|||
156678498|NCT00379353|565567358|FG001|Overall Study|Cardiac Tamponade|0|||
156678499|NCT00379353|565567357|FG000|Overall Study|Non-compliance|1|||
156678500|NCT00379353|565567358|FG001|Overall Study|Non-compliance|0|||
156678501|NCT00379353|565567357|FG000|Overall Study|Conflicting drug treatment|0|||
156678502|NCT00379353|565567358|FG001|Overall Study|Conflicting drug treatment|1|||
156678503|NCT05065619|565567359|FG000|Up to Day 42|Lost to Follow-up|1|||
156678504|NCT05065619|565567360|FG001|Up to Day 42|Lost to Follow-up|0|||
156678505|NCT05065619|565567359|FG000|Up to Day 42|Withdrawal by Subject|1|||
156678506|NCT05065619|565567360|FG001|Up to Day 42|Withdrawal by Subject|0|||
156678507|NCT05065619|565567359|FG000|After Day 43|Lost to Follow-up|1|||
156678508|NCT05065619|565567360|FG001|After Day 43|Lost to Follow-up|0|||
156678509|NCT05065619|565567359|FG000|After Day 43|Physician Decision|3|||
156678510|NCT05065619|565567360|FG001|After Day 43|Physician Decision|0|||
156678511|NCT05065619|565567359|FG000|After Day 43|Withdrawal by Subject|1|||
156678512|NCT05065619|565567360|FG001|After Day 43|Withdrawal by Subject|2|||
156678513|NCT05065619|565567359|FG000|After Day 43|Public vaccination|6|||
156678514|NCT05065619|565567360|FG001|After Day 43|Public vaccination|8|||
156678515|NCT05065619|565567359|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
156678516|NCT05065619|565567360|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
156678517|NCT05065619|565567359|FG000|After Day 43|Study Terminated by Sponsor|88|||
156678518|NCT05065619|565567360|FG001|After Day 43|Study Terminated by Sponsor|16|||
156678519|NCT00939523|565567361|FG000|Overall Study|Lack of Efficacy|1|||
156678520|NCT00939523|565567361|FG000|Overall Study|Physician Decision|2|||
156678521|NCT01050764|565567362|FG000|Overall Study|Death, before HSCT|1|||
156678522|NCT01050764|565567362|FG000|Overall Study|Donor mobilization failure, death|1|||
156678523|NCT01050764|565567362|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
156866738|NCT04323124|566271325|FG007|Overall Study|No longer meets eligibility criteria|1|||
156678524|NCT00570128|565567376|FG000|Overall Study|Adverse Event|1|||
156678525|NCT00570128|565567377|FG001|Overall Study|Adverse Event|0|||
156678526|NCT00570128|565567376|FG000|Overall Study|Lost to Follow-up|1|||
156866739|NCT04323124|566271326|FG008|Overall Study|No longer meets eligibility criteria|0|||
156866740|NCT04323124|566271327|FG009|Overall Study|No longer meets eligibility criteria|0|||
156866741|NCT04323124|566271328|FG010|Overall Study|No longer meets eligibility criteria|0|||
156866742|NCT04323124|566271329|FG011|Overall Study|No longer meets eligibility criteria|0|||
156866743|NCT04323124|566271330|FG012|Overall Study|No longer meets eligibility criteria|0|||
156866744|NCT04323124|566271331|FG013|Overall Study|No longer meets eligibility criteria|1|||
156866745|NCT04323124|566271332|FG014|Overall Study|No longer meets eligibility criteria|1|||
156866746|NCT04323124|566271318|FG000|Overall Study|Study terminated by sponsor|0|||
156866747|NCT04323124|566271319|FG001|Overall Study|Study terminated by sponsor|0|||
156866748|NCT04323124|566271320|FG002|Overall Study|Study terminated by sponsor|0|||
156866749|NCT04323124|566271321|FG003|Overall Study|Study terminated by sponsor|0|||
156866750|NCT04323124|566271322|FG004|Overall Study|Study terminated by sponsor|0|||
156866751|NCT04323124|566271323|FG005|Overall Study|Study terminated by sponsor|0|||
156866752|NCT04323124|566271324|FG006|Overall Study|Study terminated by sponsor|0|||
157012344|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
157012345|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
156678527|NCT00570128|565567377|FG001|Overall Study|Lost to Follow-up|0|||
156678528|NCT00570128|565567376|FG000|Overall Study|Withdrawal by Subject|2|||
156678529|NCT00570128|565567377|FG001|Overall Study|Withdrawal by Subject|0|||
156678530|NCT01426854|565567380|FG000|Overall Study|Adverse Event|1|||
156678531|NCT01426854|565567381|FG001|Overall Study|Adverse Event|5|||
156678532|NCT01426854|565567380|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
156678533|NCT01426854|565567381|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
156678534|NCT01426854|565567380|FG000|Overall Study|Lost to Follow-up|3|||
156678535|NCT01426854|565567381|FG001|Overall Study|Lost to Follow-up|0|||
156678536|NCT01426854|565567380|FG000|Overall Study|Noncompliance|0|||
156678537|NCT01426854|565567381|FG001|Overall Study|Noncompliance|1|||
156678538|NCT01426854|565567380|FG000|Overall Study|Treatment Failure|0|||
156678539|NCT01426854|565567381|FG001|Overall Study|Treatment Failure|16|||
156678540|NCT01426854|565567380|FG000|Overall Study|Protocol Deviation|0|||
156678541|NCT01426854|565567381|FG001|Overall Study|Protocol Deviation|1|||
156678542|NCT01426854|565567380|FG000|Overall Study|Other|3|||
156678543|NCT01426854|565567381|FG001|Overall Study|Other|2|||
156678544|NCT03555695|565567382|FG000|Overall Study|Withdrawal by Subject|1|||
156678545|NCT03555695|565567382|FG000|Overall Study|Lost to Follow-up|1|||
156678546|NCT03555695|565567382|FG000|Overall Study|appendicitis (unrelated)|1|||
156678547|NCT03555695|565567382|FG000|Overall Study|pre-existing sciatica|1|||
156678548|NCT00685334|565567390|FG000|Overall Study|Withdrawal by Subject|5|||
156678549|NCT00685334|565567391|FG001|Overall Study|Withdrawal by Subject|6|||
156678550|NCT00685334|565567390|FG000|Overall Study|Lost to Follow-up|4|||
156678551|NCT00685334|565567391|FG001|Overall Study|Lost to Follow-up|0|||
156678552|NCT00685334|565567390|FG000|Overall Study|Chose to enter hospital|1|||
156678553|NCT00685334|565567391|FG001|Overall Study|Chose to enter hospital|1|||
156678554|NCT00762411|565568960|FG000|Initial Treatment|Death|7|||
156678555|NCT00762411|565568961|FG001|Initial Treatment|Death|6|||
156678556|NCT00762411|565568960|FG000|Initial Treatment|Adverse Event|132|||
156678557|NCT00762411|565568961|FG001|Initial Treatment|Adverse Event|40|||
156678558|NCT00762411|565568960|FG000|Initial Treatment|Protocol Violation|4|||
156678559|NCT00762411|565568961|FG001|Initial Treatment|Protocol Violation|1|||
156678560|NCT00762411|565568960|FG000|Initial Treatment|Withdrawal by Subject|65|||
156678561|NCT00762411|565568961|FG001|Initial Treatment|Withdrawal by Subject|52|||
156678562|NCT00762411|565568960|FG000|Initial Treatment|Physician Decision|1|||
156678563|NCT00762411|565568961|FG001|Initial Treatment|Physician Decision|0|||
156678564|NCT00762411|565568960|FG000|Initial Treatment|Sponsor Decision|293|||
156678565|NCT00762411|565568961|FG001|Initial Treatment|Sponsor Decision|401|||
156678566|NCT00762411|565568960|FG000|Initial Treatment|Lost to Follow-up|5|||
156678567|NCT00762411|565568961|FG001|Initial Treatment|Lost to Follow-up|0|||
156678568|NCT00762411|565568960|FG000|Initial Treatment|Caregiver Decision|21|||
156678569|NCT00762411|565568961|FG001|Initial Treatment|Caregiver Decision|16|||
156678570|NCT00762411|565568960|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
156678571|NCT00762411|565568961|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
156678572|NCT00762411|565568960|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
156678573|NCT00762411|565568961|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
156678574|NCT00762411|565568960|FG000|Delayed Start|Adverse Event|0|||
156678575|NCT00762411|565568961|FG001|Delayed Start|Adverse Event|4|||
156678576|NCT00762411|565568960|FG000|Delayed Start|Protocol Violation|0|||
156866753|NCT04323124|566271325|FG007|Overall Study|Study terminated by sponsor|0|||
156866754|NCT04323124|566271326|FG008|Overall Study|Study terminated by sponsor|0|||
156866755|NCT04323124|566271327|FG009|Overall Study|Study terminated by sponsor|0|||
156678577|NCT00762411|565568961|FG001|Delayed Start|Protocol Violation|1|||
156678578|NCT00762411|565568960|FG000|Delayed Start|Sponsor Decision|16|||
156678579|NCT00762411|565568961|FG001|Delayed Start|Sponsor Decision|20|||
156678580|NCT00762411|565568960|FG000|Delayed Start|Caregiver Decision|1|||
157012346|NCT02409667|566797451|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
156678581|NCT00762411|565568961|FG001|Delayed Start|Caregiver Decision|1|||
156678582|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
156678583|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
156678584|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
156678585|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
156678586|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
156678587|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
156678588|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
156678589|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
156678590|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
156678591|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
156678592|NCT00762411|565568960|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
156678593|NCT00762411|565568961|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
156678594|NCT02710214|565568965|FG000|Overall Study|Lost to Follow-up|1|||
156678595|NCT02710214|565568966|FG001|Overall Study|Lost to Follow-up|0|||
156678596|NCT02710214|565568965|FG000|Overall Study|Lack of Efficacy|0|||
156678597|NCT02710214|565568966|FG001|Overall Study|Lack of Efficacy|1|||
156678598|NCT02710214|565568965|FG000|Overall Study|Death|0|||
156678599|NCT02710214|565568966|FG001|Overall Study|Death|1|||
156678600|NCT02832167|565568967|FG000|Treatment Period 1|Disease progression|90|||
156678601|NCT02832167|565568967|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
156678602|NCT02832167|565568967|FG000|Treatment Period 1|Death|2|||
156678603|NCT02832167|565568967|FG000|Treatment Period 1|Study Drug Toxicity|6|||
156678604|NCT02832167|565568967|FG000|Treatment Period 1|Participant request to discontinue|9|||
156678605|NCT02832167|565568967|FG000|Treatment Period 1|No longer meet study criteria|1|||
156678606|NCT02832167|565568967|FG000|Treatment Period 1|Participant withdrew consent|3|||
156678607|NCT02832167|565568967|FG000|Treatment Period 1|Other reasons|6|||
156678608|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
156678609|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
156678610|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Death|2|||
156678611|NCT02832167|565568967|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
156678612|NCT02832167|565568967|FG000|Treatment Period 2|Disease progression|69|||
156678613|NCT02832167|565568967|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
156678614|NCT02832167|565568967|FG000|Treatment Period 2|Maximum clinical benefit|1|||
156678615|NCT02832167|565568967|FG000|Treatment Period 2|Study Drug Toxicity|5|||
156678616|NCT02832167|565568967|FG000|Treatment Period 2|Participant request to discontinue|2|||
156678617|NCT02832167|565568967|FG000|Treatment Period 2|Participant withdrew consent|3|||
156866756|NCT04323124|566271328|FG010|Overall Study|Study terminated by sponsor|0|||
156866757|NCT04323124|566271329|FG011|Overall Study|Study terminated by sponsor|2|||
157119970|NCT04681170|567192941|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
157119971|NCT04681170|567192940|FG000|Open Label Efficacy Phase|Adverse Event|0|||
156678618|NCT02832167|565568967|FG000|Treatment Period 2|Other reasons|3|||
156678619|NCT01754376|565568968|FG000|Overall Study|Adverse Event|1|||
156678620|NCT01754376|565568968|FG000|Overall Study|Lack of Efficacy|2|||
156678621|NCT04590781|565568969|FG000|Overall Study|Death|0|||
156678622|NCT04590781|565568970|FG001|Overall Study|Death|2|||
156678623|NCT04590781|565568969|FG000|Overall Study|Withdrawal by Subject|2|||
156678624|NCT04590781|565568970|FG001|Overall Study|Withdrawal by Subject|0|||
156678625|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
156678626|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156678627|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
156678628|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678629|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678630|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678631|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678632|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156678633|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
156678634|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678635|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678636|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678637|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678638|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678639|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678640|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
156678641|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156678642|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678643|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
156678644|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678645|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678646|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678647|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157119972|NCT04681170|567192941|FG001|Open Label Efficacy Phase|Adverse Event|2|||
156678648|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
156678649|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
157119973|NCT04681170|567192940|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
157119974|NCT04681170|567192941|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
157119975|NCT04681170|567192940|FG000|Open Label Safety Phase|AEs and none compliance|0|||
156678650|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678651|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678652|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678653|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678654|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678655|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
156678656|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
157119976|NCT04681170|567192941|FG001|Open Label Safety Phase|AEs and none compliance|1|||
156866758|NCT04323124|566271330|FG012|Overall Study|Study terminated by sponsor|1|||
156866759|NCT04323124|566271331|FG013|Overall Study|Study terminated by sponsor|0|||
156866760|NCT04323124|566271332|FG014|Overall Study|Study terminated by sponsor|0|||
156866761|NCT02083354|566273364|FG000|Overall Study|Withdrawal by Subject|9|||
156866762|NCT02083354|566273364|FG000|Overall Study|Lost to Follow-up|1|||
156866763|NCT02083354|566273364|FG000|Overall Study|Adverse Event|3|||
156866764|NCT02083354|566273364|FG000|Overall Study|Disease progression|46|||
156866765|NCT02083354|566273364|FG000|Overall Study|Study closed/terminated|5|||
156866766|NCT03312634|566273365|FG000|Overall Study|Adverse Event|11|||
156866767|NCT03312634|566273366|FG001|Overall Study|Adverse Event|0|||
156866768|NCT03312634|566273365|FG000|Overall Study|Sponsor request|2|||
156866769|NCT03312634|566273366|FG001|Overall Study|Sponsor request|0|||
156866770|NCT03312634|566273365|FG000|Overall Study|Withdrawal by Subject|31|||
156866771|NCT03312634|566273366|FG001|Overall Study|Withdrawal by Subject|9|||
156866772|NCT03312634|566273365|FG000|Overall Study|Enrolled in an interventional study|0|||
156866773|NCT03312634|566273366|FG001|Overall Study|Enrolled in an interventional study|52|||
156866774|NCT03312634|566273365|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
156866775|NCT03312634|566273366|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
156866776|NCT03312634|566273365|FG000|Overall Study|Death|0|||
156866777|NCT03312634|566273366|FG001|Overall Study|Death|1|||
156866778|NCT03312634|566273365|FG000|Overall Study|Non-compliance|0|||
156866779|NCT03312634|566273366|FG001|Overall Study|Non-compliance|2|||
156866780|NCT03312634|566273365|FG000|Overall Study|Lost to Follow-up|0|||
156866781|NCT03312634|566273366|FG001|Overall Study|Lost to Follow-up|1|||
156866782|NCT03312634|566273365|FG000|Overall Study|Enrolled into non-interventional study|0|||
156866783|NCT03312634|566273366|FG001|Overall Study|Enrolled into non-interventional study|5|||
157119977|NCT02468648|567192946|FG000|Overall Study|Death|1|||
157119978|NCT02118792|567192947|FG000|Overall Study|Withdrawal by Subject|6|||
157119979|NCT02118792|567192948|FG001|Overall Study|Withdrawal by Subject|3|||
157119980|NCT02118792|567192947|FG000|Overall Study|Lost to Follow-up|4|||
157119981|NCT02118792|567192948|FG001|Overall Study|Lost to Follow-up|4|||
157119982|NCT02118792|567192947|FG000|Overall Study|Adverse Event|5|||
156866784|NCT03312634|566273365|FG000|Overall Study|Worsening clinical condition|0|||
156866785|NCT03312634|566273366|FG001|Overall Study|Worsening clinical condition|1|||
156866786|NCT03312634|566273365|FG000|Overall Study|Participant did not want to travel|0|||
156866787|NCT03312634|566273366|FG001|Overall Study|Participant did not want to travel|1|||
156866788|NCT03312634|566273365|FG000|Overall Study|Physician Decision|1|||
156866789|NCT03312634|566273366|FG001|Overall Study|Physician Decision|0|||
156866790|NCT03312634|566273365|FG000|Overall Study|Other|13|||
156866791|NCT03312634|566273366|FG001|Overall Study|Other|0|||
156866792|NCT00777153|566273367|FG000|Overall Study|Lost to Follow-up|1|||
156866793|NCT00777153|566273368|FG001|Overall Study|Lost to Follow-up|1|||
156866794|NCT00777153|566273369|FG002|Overall Study|Lost to Follow-up|0|||
156866795|NCT00777153|566273367|FG000|Overall Study|Death|85|||
156866796|NCT00777153|566273368|FG001|Overall Study|Death|73|||
156866797|NCT00777153|566273369|FG002|Overall Study|Death|33|||
156866798|NCT00777153|566273367|FG000|Overall Study|Withdrawal by Subject|3|||
156866799|NCT00777153|566273368|FG001|Overall Study|Withdrawal by Subject|4|||
156866800|NCT00777153|566273369|FG002|Overall Study|Withdrawal by Subject|3|||
156866801|NCT00777153|566273367|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
156678657|NCT04556734|565568971|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678658|NCT04556734|565568972|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678659|NCT04556734|565568973|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
156866802|NCT00777153|566273368|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
157119983|NCT02118792|567192948|FG001|Overall Study|Adverse Event|4|||
156866803|NCT00777153|566273369|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
157119984|NCT02118792|567192947|FG000|Overall Study|Withdrawal by parent/guardian|14|||
156866804|NCT00554216|566273373|FG000|Overall Study|Lost to Follow-up|92|||
156866805|NCT00554216|566273374|FG001|Overall Study|Lost to Follow-up|31|||
156866806|NCT00554216|566273375|FG002|Overall Study|Lost to Follow-up|63|||
156866807|NCT00554216|566273373|FG000|Overall Study|Adverse Event|16|||
157119985|NCT02118792|567192948|FG001|Overall Study|Withdrawal by parent/guardian|20|||
156866808|NCT00554216|566273374|FG001|Overall Study|Adverse Event|16|||
156866809|NCT00554216|566273375|FG002|Overall Study|Adverse Event|36|||
156866810|NCT00554216|566273373|FG000|Overall Study|Withdrawal by Subject|92|||
156678660|NCT04556734|565568974|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678661|NCT04556734|565568975|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678662|NCT04556734|565568976|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678663|NCT04556734|565568977|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678664|NCT04556734|565568978|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
156678665|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Not reported|0|||
156678666|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Not reported|0|||
156678667|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Not reported|0|||
156678668|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Not reported|0|||
156678669|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Not reported|0|||
156678670|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Not reported|1|||
156678671|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Not reported|0|||
156678672|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Not reported|0|||
156678673|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678674|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678675|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678676|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678677|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678678|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678679|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
156678680|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
156678681|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
156678682|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
156678683|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
156678684|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
156782294|NCT05643794|565952725|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
156782295|NCT05643794|565952726|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
156782296|NCT05643794|565952727|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
156782297|NCT04167670|565952728|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
156782298|NCT04167670|565952729|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
156866811|NCT00554216|566273374|FG001|Overall Study|Withdrawal by Subject|31|||
156782299|NCT04167670|565952730|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
156782300|NCT04167670|565952728|FG000|Overall Study|Significant protocol deviation|3|||
156782301|NCT04167670|565952729|FG001|Overall Study|Significant protocol deviation|1|||
156782302|NCT04167670|565952730|FG002|Overall Study|Significant protocol deviation|0|||
156782303|NCT04167670|565952728|FG000|Overall Study|Lost to Follow-up|0|||
156782304|NCT04167670|565952729|FG001|Overall Study|Lost to Follow-up|3|||
156782305|NCT04167670|565952730|FG002|Overall Study|Lost to Follow-up|3|||
156782306|NCT04167670|565952728|FG000|Overall Study|Voluntary Withdrawal|0|||
156782307|NCT04167670|565952729|FG001|Overall Study|Voluntary Withdrawal|1|||
156782308|NCT04167670|565952730|FG002|Overall Study|Voluntary Withdrawal|1|||
156782309|NCT04167670|565952728|FG000|Overall Study|Withdrawal of Consent|4|||
156782310|NCT04167670|565952729|FG001|Overall Study|Withdrawal of Consent|1|||
156782311|NCT04167670|565952730|FG002|Overall Study|Withdrawal of Consent|3|||
156782312|NCT04167670|565952728|FG000|Overall Study|Miscellaneous|7|||
156782313|NCT04167670|565952729|FG001|Overall Study|Miscellaneous|5|||
156782314|NCT04167670|565952730|FG002|Overall Study|Miscellaneous|3|||
156782315|NCT04827446|565952731|FG000|Overall Study|Lost to Follow-up|1|||
156782316|NCT04827446|565952732|FG001|Overall Study|Lost to Follow-up|1|||
156782317|NCT04827446|565952731|FG000|Overall Study|Death|2|||
156782318|NCT04827446|565952732|FG001|Overall Study|Death|0|||
156782319|NCT04827446|565952731|FG000|Overall Study|Withdrawal by Subject|2|||
156782320|NCT04827446|565952732|FG001|Overall Study|Withdrawal by Subject|2|||
156782321|NCT01653262|565952735|FG000|Overall Study|Lack of Efficacy|1|||
156782322|NCT01653262|565952735|FG000|Overall Study|SAE, non-fatal|1|||
156782323|NCT01653262|565952735|FG000|Overall Study|AE, non-serious non-fatal|1|||
156866812|NCT00554216|566273375|FG002|Overall Study|Withdrawal by Subject|43|||
156866813|NCT00554216|566273373|FG000|Overall Study|Non compliance|10|||
156678685|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
156678686|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
156678687|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
156678688|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
156678689|NCT04556734|565568971|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678690|NCT04556734|565568972|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678691|NCT04556734|565568973|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678692|NCT04556734|565568974|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
156678693|NCT04556734|565568975|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
156678694|NCT04556734|565568976|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
156782324|NCT03735498|565952736|FG000|Overall Study|Withdrawal by Subject|3|||
156782325|NCT03735498|565952736|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
156866814|NCT00554216|566273374|FG001|Overall Study|Non compliance|4|||
156678695|NCT04556734|565568977|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
156678696|NCT04556734|565568978|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
156678697|NCT00820599|565568981|FG000|Overall Study|Death|129|||
156678698|NCT00820599|565568981|FG000|Overall Study|Withdrawal by Subject|2|||
156678699|NCT03686215|565568982|FG000|Overall Study|Adverse Event|0|||
156678700|NCT03686215|565568983|FG001|Overall Study|Adverse Event|0|||
156678701|NCT03686215|565568984|FG002|Overall Study|Adverse Event|7|||
156678702|NCT03686215|565568982|FG000|Overall Study|Physician Decision|0|||
156678703|NCT03686215|565568983|FG001|Overall Study|Physician Decision|0|||
156678704|NCT03686215|565568984|FG002|Overall Study|Physician Decision|1|||
156678705|NCT03686215|565568982|FG000|Overall Study|Protocol Violation|0|||
156678706|NCT03686215|565568983|FG001|Overall Study|Protocol Violation|0|||
156678707|NCT03686215|565568984|FG002|Overall Study|Protocol Violation|4|||
156678708|NCT03686215|565568982|FG000|Overall Study|Device issue|1|||
156678709|NCT03686215|565568983|FG001|Overall Study|Device issue|0|||
156678710|NCT03686215|565568984|FG002|Overall Study|Device issue|2|||
156678711|NCT00202839|565568985|FG000|Overall Study|Adverse Event|1|||
156678712|NCT00202839|565568986|FG001|Overall Study|Adverse Event|5|||
156678713|NCT00202839|565568985|FG000|Overall Study|Physician Decision|12|||
156678714|NCT00202839|565568986|FG001|Overall Study|Physician Decision|0|||
156678715|NCT00202839|565568985|FG000|Overall Study|Withdrawal by Subject|6|||
156678716|NCT00202839|565568986|FG001|Overall Study|Withdrawal by Subject|2|||
156678717|NCT00202839|565568985|FG000|Overall Study|Protocol Violation|2|||
156678718|NCT00202839|565568986|FG001|Overall Study|Protocol Violation|1|||
156678719|NCT00202839|565568985|FG000|Overall Study|Lost to Follow-up|3|||
156678720|NCT00202839|565568986|FG001|Overall Study|Lost to Follow-up|2|||
156678721|NCT04768296|565568987|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
156678722|NCT04768296|565568988|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
156678723|NCT00452348|565568989|FG000|Overall Study|Adverse Event|6|||
156678724|NCT00452348|565568990|FG001|Overall Study|Adverse Event|9|||
156678725|NCT00452348|565568989|FG000|Overall Study|Lack of Efficacy|10|||
156678726|NCT00452348|565568990|FG001|Overall Study|Lack of Efficacy|9|||
156678727|NCT00452348|565568989|FG000|Overall Study|Lost to Follow-up|14|||
156678728|NCT00452348|565568990|FG001|Overall Study|Lost to Follow-up|8|||
156678729|NCT00452348|565568989|FG000|Overall Study|Protocol Violation|22|||
156678730|NCT00452348|565568990|FG001|Overall Study|Protocol Violation|28|||
156678731|NCT00452348|565568989|FG000|Overall Study|Withdrawal by Subject|18|||
156678732|NCT00452348|565568990|FG001|Overall Study|Withdrawal by Subject|21|||
156678733|NCT00452348|565568989|FG000|Overall Study|Other|9|||
156678734|NCT00452348|565568990|FG001|Overall Study|Other|9|||
156678735|NCT03119662|565568991|FG000|Overall Study|Withdrawal by Subject|0|||
156678736|NCT03119662|565568992|FG001|Overall Study|Withdrawal by Subject|1|||
156678737|NCT02817828|565568993|FG000|Overall Study|Lost to Follow-up|41|||
156678738|NCT02817828|565568993|FG000|Overall Study|Adverse event not related to bleeding|104|||
156678739|NCT02817828|565568993|FG000|Overall Study|Adverse event related to bleeding|53|||
156678740|NCT02817828|565568993|FG000|Overall Study|Protocol Violation|11|||
156678741|NCT02817828|565568993|FG000|Overall Study|Pregnancy|7|||
156678742|NCT02817828|565568993|FG000|Overall Study|Pregnancy wish|15|||
156678743|NCT02817828|565568993|FG000|Overall Study|Withdrawal by Subject|78|||
156678744|NCT02817828|565568993|FG000|Overall Study|Other|26|||
156678745|NCT00522041|565568995|FG000|Overall Study|Adverse Event|9|||
156678746|NCT00522041|565568996|FG001|Overall Study|Adverse Event|3|||
156678747|NCT00522041|565568995|FG000|Overall Study|Protocol Violation|2|||
156678748|NCT00522041|565568996|FG001|Overall Study|Protocol Violation|0|||
156678749|NCT00522041|565568995|FG000|Overall Study|Lost to Follow-up|1|||
156678750|NCT00522041|565568996|FG001|Overall Study|Lost to Follow-up|4|||
156678751|NCT00522041|565568995|FG000|Overall Study|Voluntary withdrawal|5|||
156678752|NCT00522041|565568996|FG001|Overall Study|Voluntary withdrawal|4|||
156678753|NCT00522041|565568995|FG000|Overall Study|Did not receive treatment|0|||
156678754|NCT00522041|565568996|FG001|Overall Study|Did not receive treatment|1|||
156678755|NCT00874549|565568997|FG000|Overall Study|Adverse Event|0|||
156782326|NCT01112267|565952738|FG000|Overall Study|Adverse Event|24|||
156782327|NCT01112267|565952739|FG001|Overall Study|Adverse Event|6|||
156782328|NCT01112267|565952738|FG000|Overall Study|Withdrawal by Subject|3|||
156782329|NCT01112267|565952739|FG001|Overall Study|Withdrawal by Subject|5|||
156782330|NCT01112267|565952738|FG000|Overall Study|Protocol Violation|5|||
156782331|NCT01112267|565952739|FG001|Overall Study|Protocol Violation|3|||
156782332|NCT01112267|565952738|FG000|Overall Study|Participants not compliant|1|||
156678756|NCT00874549|565568998|FG001|Overall Study|Adverse Event|0|||
156678757|NCT00874549|565568999|FG002|Overall Study|Adverse Event|1|||
156678758|NCT00874549|565569000|FG003|Overall Study|Adverse Event|0|||
156678759|NCT00874549|565568997|FG000|Overall Study|Protocol Violation|1|||
156678760|NCT00874549|565568998|FG001|Overall Study|Protocol Violation|0|||
156678761|NCT00874549|565568999|FG002|Overall Study|Protocol Violation|2|||
156678762|NCT00874549|565569000|FG003|Overall Study|Protocol Violation|1|||
156678763|NCT00874549|565568997|FG000|Overall Study|Lost to Follow-up|0|||
156678764|NCT00874549|565568998|FG001|Overall Study|Lost to Follow-up|0|||
156678765|NCT00874549|565568999|FG002|Overall Study|Lost to Follow-up|1|||
156782333|NCT01112267|565952739|FG001|Overall Study|Participants not compliant|2|||
156866815|NCT00554216|566273375|FG002|Overall Study|Non compliance|5|||
156866816|NCT00554216|566273373|FG000|Overall Study|Pregnancy|2|||
156866817|NCT00554216|566273374|FG001|Overall Study|Pregnancy|1|||
156866818|NCT00554216|566273375|FG002|Overall Study|Pregnancy|14|||
156866819|NCT00554216|566273373|FG000|Overall Study|Restricted med|3|||
156866820|NCT00554216|566273374|FG001|Overall Study|Restricted med|1|||
156866821|NCT00554216|566273375|FG002|Overall Study|Restricted med|1|||
156866822|NCT00554216|566273373|FG000|Overall Study|Other|12|||
156866823|NCT00554216|566273374|FG001|Overall Study|Other|7|||
156866824|NCT00554216|566273375|FG002|Overall Study|Other|10|||
156866825|NCT00554216|566273373|FG000|Overall Study|Lack of Efficacy|15|||
157119986|NCT02118792|567192947|FG000|Overall Study|Other|1|||
157119987|NCT02118792|567192948|FG001|Overall Study|Other|6|||
157119988|NCT02118792|567192947|FG000|Overall Study|Randomised but not treated|1|||
157119989|NCT02118792|567192948|FG001|Overall Study|Randomised but not treated|0|||
157119990|NCT02469090|567192952|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
157119991|NCT02469090|567192953|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
157119992|NCT02469090|567192954|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
157119993|NCT02469090|567192952|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
157119994|NCT02469090|567192953|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
157119995|NCT02469090|567192954|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
157119996|NCT02469090|567192952|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
157119997|NCT02469090|567192953|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
157119998|NCT02469090|567192954|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
157119999|NCT02469090|567192952|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
157120000|NCT02469090|567192953|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
157120001|NCT02469090|567192954|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
156866826|NCT00554216|566273374|FG001|Overall Study|Lack of Efficacy|3|||
156866827|NCT00554216|566273375|FG002|Overall Study|Lack of Efficacy|0|||
156866828|NCT04040933|566273376|FG000|Overall Study|Protocol Violation|1|||
156866829|NCT04040933|566273376|FG000|Overall Study|Withdrawal by Subject|2|||
156866830|NCT00775190|566273377|FG000|Overall Study|Lost to Follow-up|2|||
156866831|NCT00775190|566273378|FG001|Overall Study|Lost to Follow-up|3|||
157120002|NCT02469090|567192952|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
157120003|NCT02469090|567192953|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
156678766|NCT00874549|565569000|FG003|Overall Study|Lost to Follow-up|0|||
156678767|NCT00874549|565568997|FG000|Overall Study|Withdrawal by Subject|0|||
156678768|NCT00874549|565568998|FG001|Overall Study|Withdrawal by Subject|1|||
156678769|NCT00874549|565568999|FG002|Overall Study|Withdrawal by Subject|0|||
156678770|NCT00874549|565569000|FG003|Overall Study|Withdrawal by Subject|1|||
156678771|NCT03343639|565569001|FG000|Overall Study|Withdrawal by Subject|10|||
156678772|NCT03343639|565569002|FG001|Overall Study|Withdrawal by Subject|6|||
156678773|NCT03343639|565569001|FG000|Overall Study|Lost to Follow-up|4|||
156678774|NCT03343639|565569002|FG001|Overall Study|Lost to Follow-up|5|||
156678775|NCT03343639|565569001|FG000|Overall Study|Protocol Violation|0|||
156678776|NCT03343639|565569002|FG001|Overall Study|Protocol Violation|1|||
156678777|NCT00735696|565569003|FG000|Overall Study|Withdrawal by Subject|1|||
156678778|NCT00735696|565569003|FG000|Overall Study|Enrolled but never Treated|1|||
156678779|NCT02786953|565569011|FG000|Overall Study|Withdrawal by Subject|3|||
156678780|NCT02786953|565569012|FG001|Overall Study|Withdrawal by Subject|0|||
156678781|NCT02786953|565569011|FG000|Overall Study|Physician Decision|0|||
156678782|NCT02786953|565569012|FG001|Overall Study|Physician Decision|1|||
156678783|NCT01186458|565569018|FG000|Overall Study|Adverse Event|1|||
156678784|NCT04281472|565569019|FG000|Stage A|Lack of Efficacy|8|||
156678785|NCT04281472|565569020|FG001|Stage A|Lack of Efficacy|0|||
156678786|NCT04281472|565569021|FG002|Stage A|Lack of Efficacy|0|||
156678787|NCT04281472|565569019|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
156678788|NCT04281472|565569020|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
156678789|NCT04281472|565569021|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
156678790|NCT04281472|565569019|FG000|Stage A|Adverse Event|20|||
156678791|NCT04281472|565569020|FG001|Stage A|Adverse Event|0|||
156678792|NCT04281472|565569021|FG002|Stage A|Adverse Event|0|||
156678793|NCT04281472|565569019|FG000|Stage A|Death|1|||
156678794|NCT04281472|565569020|FG001|Stage A|Death|0|||
156678795|NCT04281472|565569021|FG002|Stage A|Death|0|||
156678796|NCT04281472|565569019|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
156678797|NCT04281472|565569020|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
156678798|NCT04281472|565569021|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
156678799|NCT04281472|565569019|FG000|Stage A|Lost to Follow-up|2|||
156678800|NCT04281472|565569020|FG001|Stage A|Lost to Follow-up|0|||
156678801|NCT04281472|565569021|FG002|Stage A|Lost to Follow-up|0|||
156866832|NCT00775190|566273377|FG000|Overall Study|Withdrawal by Subject|1|||
156866833|NCT00775190|566273378|FG001|Overall Study|Withdrawal by Subject|2|||
156678802|NCT04281472|565569019|FG000|Stage A|Non-compliance with study drug|1|||
156866834|NCT00775190|566273377|FG000|Overall Study|Protocol Violation|1|||
156678803|NCT04281472|565569020|FG001|Stage A|Non-compliance with study drug|0|||
156866835|NCT00775190|566273378|FG001|Overall Study|Protocol Violation|0|||
157120004|NCT02469090|567192954|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
157120005|NCT02469090|567192952|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
157120006|NCT02469090|567192953|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
157120007|NCT02469090|567192954|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
157120008|NCT02469090|567192952|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
157120009|NCT02469090|567192953|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
157120010|NCT02469090|567192954|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
157120011|NCT02469090|567192952|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
157120012|NCT02469090|567192953|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
157120013|NCT02469090|567192954|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
157120014|NCT03806127|567192956|FG000|Overall Study|Withdrawal by Subject|4|||
157120015|NCT03806127|567192957|FG001|Overall Study|Withdrawal by Subject|5|||
157120016|NCT03806127|567192956|FG000|Overall Study|Protocol Violation|3|||
157120017|NCT03806127|567192957|FG001|Overall Study|Protocol Violation|1|||
157120018|NCT03806127|567192956|FG000|Overall Study|Adverse Event|3|||
157120019|NCT03806127|567192957|FG001|Overall Study|Adverse Event|0|||
157120020|NCT03806127|567192956|FG000|Overall Study|Unable to Complete Procedures|0|||
157120021|NCT03806127|567192957|FG001|Overall Study|Unable to Complete Procedures|1|||
157120022|NCT03806127|567192956|FG000|Overall Study|Pregnancy|0|||
157120023|NCT03806127|567192957|FG001|Overall Study|Pregnancy|1|||
157120024|NCT03806127|567192956|FG000|Overall Study|Lost to Follow-up|5|||
157120025|NCT03806127|567192957|FG001|Overall Study|Lost to Follow-up|1|||
157120026|NCT03806127|567192956|FG000|Overall Study|Physician Decision|1|||
157120027|NCT03806127|567192957|FG001|Overall Study|Physician Decision|1|||
157120028|NCT03806127|567192956|FG000|Overall Study|Could Not Come Due to Covid|1|||
157120029|NCT03806127|567192957|FG001|Overall Study|Could Not Come Due to Covid|0|||
157120030|NCT03806127|567192956|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
157120031|NCT03806127|567192957|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
157120032|NCT03806127|567192956|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
157120033|NCT03806127|567192957|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
157120034|NCT03806127|567192956|FG000|Overall Study|Covid 19 Restrictions|2|||
157120035|NCT03806127|567192957|FG001|Overall Study|Covid 19 Restrictions|0|||
157120036|NCT03806127|567192956|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
157120037|NCT03806127|567192957|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
157213191|NCT00845026|567527771|FG001|Study Period IV|Withdrawal by Subject|1|||
157213192|NCT00845026|567527770|FG000|Study Period IV|Entry Criteria Not Met|1|||
157213193|NCT00845026|567527771|FG001|Study Period IV|Entry Criteria Not Met|0|||
157213194|NCT00845026|567527770|FG000|Study Period IV|Subject is moving or has moved|0|||
157213195|NCT00845026|567527771|FG001|Study Period IV|Subject is moving or has moved|1|||
157213196|NCT00845026|567527770|FG000|Study Period IV|Scheduling conflict|1|||
157213197|NCT00845026|567527771|FG001|Study Period IV|Scheduling conflict|0|||
157213198|NCT01325532|567527772|FG000|Overall Study|Withdrawal by Subject|2|||
157213199|NCT01325532|567527773|FG001|Overall Study|Withdrawal by Subject|0|||
157213200|NCT03012815|567527774|FG000|Overall Study|Lost to Follow-up|1|||
157213201|NCT03012815|567527775|FG001|Overall Study|Lost to Follow-up|0|||
157213202|NCT03012815|567527774|FG000|Overall Study|Physician Decision|3|||
156782334|NCT01112267|565952738|FG000|Overall Study|Participants not receive any study drug|1|||
156782335|NCT01112267|565952739|FG001|Overall Study|Participants not receive any study drug|2|||
156782336|NCT00160615|565952740|FG000|Overall Study|Adverse Event|5|||
156782337|NCT00160615|565952741|FG001|Overall Study|Adverse Event|12|||
156782338|NCT00160615|565952740|FG000|Overall Study|Withdrawal by Subject|0|||
156782339|NCT00160615|565952741|FG001|Overall Study|Withdrawal by Subject|2|||
157213203|NCT03012815|567527775|FG001|Overall Study|Physician Decision|2|||
157213204|NCT03012815|567527774|FG000|Overall Study|Adverse Event|1|||
157213205|NCT03012815|567527775|FG001|Overall Study|Adverse Event|0|||
156782340|NCT00160615|565952740|FG000|Overall Study|Lack of Efficacy|11|||
156782341|NCT00160615|565952741|FG001|Overall Study|Lack of Efficacy|23|||
156782342|NCT00160615|565952740|FG000|Overall Study|Patient decision|1|||
156782343|NCT00160615|565952741|FG001|Overall Study|Patient decision|2|||
156782344|NCT00160615|565952740|FG000|Overall Study|Investigator decision|1|||
156782345|NCT00160615|565952741|FG001|Overall Study|Investigator decision|1|||
156782346|NCT00160615|565952740|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
156782347|NCT00160615|565952741|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
156782348|NCT00160615|565952740|FG000|Overall Study|Switch to surgical treatment|0|||
156782349|NCT00160615|565952741|FG001|Overall Study|Switch to surgical treatment|2|||
156782350|NCT00160615|565952740|FG000|Overall Study|Non-compliance was suspected|0|||
156782351|NCT00160615|565952741|FG001|Overall Study|Non-compliance was suspected|1|||
156782352|NCT00160615|565952740|FG000|Overall Study|Poor compliance|0|||
156782353|NCT00160615|565952741|FG001|Overall Study|Poor compliance|1|||
156782354|NCT02014103|565952742|FG000|Overall Study|Protocol Violation|7|||
157213206|NCT00272961|567527776|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
156782355|NCT02014103|565952743|FG001|Overall Study|Protocol Violation|7|||
156782356|NCT02014103|565952742|FG000|Overall Study|Adverse Event|1|||
156782357|NCT02014103|565952743|FG001|Overall Study|Adverse Event|0|||
156678804|NCT04281472|565569021|FG002|Stage A|Non-compliance with study drug|0|||
156678805|NCT04281472|565569019|FG000|Stage A|Physician Decision|1|||
156678806|NCT04281472|565569020|FG001|Stage A|Physician Decision|0|||
156678807|NCT04281472|565569021|FG002|Stage A|Physician Decision|0|||
156678808|NCT04281472|565569019|FG000|Stage A|Prohibited medications|2|||
156678809|NCT04281472|565569020|FG001|Stage A|Prohibited medications|0|||
156678810|NCT04281472|565569021|FG002|Stage A|Prohibited medications|0|||
156678811|NCT04281472|565569019|FG000|Stage A|Withdrawal by Subject|11|||
156678812|NCT04281472|565569020|FG001|Stage A|Withdrawal by Subject|0|||
156678813|NCT04281472|565569021|FG002|Stage A|Withdrawal by Subject|0|||
156678814|NCT04281472|565569019|FG000|Stage A|Other|5|||
156678815|NCT04281472|565569020|FG001|Stage A|Other|0|||
156678816|NCT04281472|565569021|FG002|Stage A|Other|0|||
156678817|NCT04281472|565569019|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
157012347|NCT02409667|566797452|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
157012348|NCT02409667|566797453|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
157012349|NCT02409667|566797454|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
157012350|NCT02409667|566797455|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
157012351|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
157012352|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
157012353|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
157012354|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
157012355|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
157012356|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
157012357|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
157012358|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
157012359|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
157012360|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
157012361|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
157012362|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
157012363|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
157012364|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
157012365|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
157012366|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
157012367|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
157012368|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
157012369|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
157012370|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
157012371|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
156678818|NCT04281472|565569020|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
156678819|NCT04281472|565569021|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
156678820|NCT04281472|565569019|FG000|Stage B|Adverse Event|0|||
156678821|NCT04281472|565569020|FG001|Stage B|Adverse Event|3|||
156678822|NCT04281472|565569021|FG002|Stage B|Adverse Event|0|||
156678823|NCT04281472|565569019|FG000|Stage B|Death|0|||
156678824|NCT04281472|565569020|FG001|Stage B|Death|0|||
156678825|NCT04281472|565569021|FG002|Stage B|Death|1|||
156678826|NCT04281472|565569019|FG000|Stage B|Lack of Efficacy|0|||
156678827|NCT04281472|565569020|FG001|Stage B|Lack of Efficacy|0|||
156678828|NCT04281472|565569021|FG002|Stage B|Lack of Efficacy|1|||
156678829|NCT04281472|565569019|FG000|Stage B|Lost to Follow-up|0|||
156678830|NCT04281472|565569020|FG001|Stage B|Lost to Follow-up|0|||
156678831|NCT04281472|565569021|FG002|Stage B|Lost to Follow-up|2|||
156678832|NCT04281472|565569019|FG000|Stage B|Prohibited medications|0|||
156678833|NCT04281472|565569020|FG001|Stage B|Prohibited medications|2|||
156678834|NCT04281472|565569021|FG002|Stage B|Prohibited medications|1|||
156678835|NCT04281472|565569019|FG000|Stage B|Protocol Violation|0|||
156678836|NCT04281472|565569020|FG001|Stage B|Protocol Violation|1|||
156678837|NCT04281472|565569021|FG002|Stage B|Protocol Violation|1|||
156678838|NCT04281472|565569019|FG000|Stage B|Sponsor decision|0|||
156678839|NCT04281472|565569020|FG001|Stage B|Sponsor decision|0|||
156678840|NCT04281472|565569021|FG002|Stage B|Sponsor decision|1|||
156678841|NCT04281472|565569019|FG000|Stage B|Withdrawal by Subject|0|||
156678842|NCT04281472|565569020|FG001|Stage B|Withdrawal by Subject|3|||
156678843|NCT04281472|565569021|FG002|Stage B|Withdrawal by Subject|3|||
156678844|NCT04281472|565569019|FG000|Stage B|Other|0|||
156678845|NCT04281472|565569020|FG001|Stage B|Other|3|||
156678846|NCT04281472|565569021|FG002|Stage B|Other|0|||
156678847|NCT04697173|565569025|FG000|Overall Study|Withdrawal by Subject|34|||
156678848|NCT04697173|565569026|FG001|Overall Study|Withdrawal by Subject|38|||
156678849|NCT01055834|565569027|FG000|Treatment Period I|Adverse Event|1|||
156678850|NCT01055834|565569028|FG001|Treatment Period I|Adverse Event|0|||
156678851|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Death|0|||
156678852|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Death|1|||
156678853|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
156678854|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
156678855|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
156678856|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
156678857|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
156678858|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
156678859|NCT01717313|565569029|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
156678860|NCT01717313|565569030|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
156678861|NCT01717313|565569029|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
156678862|NCT01717313|565569030|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
156678863|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
156678864|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
156678865|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
156678866|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
156678867|NCT01717313|565569029|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
156678868|NCT01717313|565569030|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
156678869|NCT03504085|565569031|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
156678870|NCT03504085|565569032|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
156678871|NCT03504085|565569031|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
156678872|NCT03504085|565569032|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
156678873|NCT01868243|565569034|FG000|Overall Study|Death|0|||
156678874|NCT01868243|565569035|FG001|Overall Study|Death|1|||
156678875|NCT00467597|565569037|FG000|Overall Study|Withdrawal by Subject|2|||
156678876|NCT00467597|565569038|FG001|Overall Study|Withdrawal by Subject|0|||
156782358|NCT02014103|565952742|FG000|Overall Study|Lost venous access|1|||
156782359|NCT02014103|565952743|FG001|Overall Study|Lost venous access|0|||
156782360|NCT02014103|565952742|FG000|Overall Study|Withdrawal by Subject|0|||
156782361|NCT02014103|565952743|FG001|Overall Study|Withdrawal by Subject|2|||
156782362|NCT05638737|565952744|FG000|Overall Study|Withdrawal by Subject|4|||
156782363|NCT05638737|565952745|FG001|Overall Study|Withdrawal by Subject|7|||
156782364|NCT02068794|565952746|FG000|Overall Study|Withdrawal by Subject|0|||
156782365|NCT02068794|565952747|FG001|Overall Study|Withdrawal by Subject|1|||
156782366|NCT02068794|565952748|FG002|Overall Study|Withdrawal by Subject|2|||
156782367|NCT02068794|565952746|FG000|Overall Study|Early Progression|1|||
156782368|NCT02068794|565952747|FG001|Overall Study|Early Progression|0|||
156678877|NCT01745094|565569039|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
156678878|NCT01745094|565569040|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
156678879|NCT01745094|565569041|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
156678880|NCT01745094|565569042|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
156678881|NCT01745094|565569039|FG000|Overall Study|Adverse Event|0|||
156678882|NCT01745094|565569040|FG001|Overall Study|Adverse Event|0|||
156678883|NCT01745094|565569041|FG002|Overall Study|Adverse Event|3|||
156678884|NCT01745094|565569042|FG003|Overall Study|Adverse Event|0|||
156678885|NCT01745094|565569039|FG000|Overall Study|Withdrawal by Subject|2|||
156678886|NCT01745094|565569040|FG001|Overall Study|Withdrawal by Subject|0|||
156678887|NCT01745094|565569041|FG002|Overall Study|Withdrawal by Subject|1|||
156678888|NCT01745094|565569042|FG003|Overall Study|Withdrawal by Subject|2|||
156678889|NCT01745094|565569039|FG000|Overall Study|Protocol Violation|1|||
156678890|NCT01745094|565569040|FG001|Overall Study|Protocol Violation|0|||
156678891|NCT01745094|565569041|FG002|Overall Study|Protocol Violation|3|||
156678892|NCT01745094|565569042|FG003|Overall Study|Protocol Violation|1|||
156678893|NCT01745094|565569039|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678894|NCT01745094|565569040|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678895|NCT01745094|565569041|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
156678896|NCT01745094|565569042|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
156678897|NCT01745094|565569039|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
156678898|NCT01745094|565569040|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
156678899|NCT01745094|565569041|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
156678900|NCT01745094|565569042|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
156678901|NCT01745094|565569039|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
156678902|NCT01745094|565569040|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678903|NCT01745094|565569041|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678904|NCT01745094|565569042|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
156678905|NCT04610580|565569043|FG000|Two-way Crossover Period|Adverse Event|1|||
156678906|NCT04610580|565569044|FG001|Two-way Crossover Period|Adverse Event|0|||
156678907|NCT04610580|565569045|FG002|Two-way Crossover Period|Adverse Event|0|||
156678908|NCT04610580|565569046|FG003|Two-way Crossover Period|Adverse Event|0|||
156678909|NCT04610580|565569047|FG004|Two-way Crossover Period|Adverse Event|0|||
156678910|NCT04610580|565569048|FG005|Two-way Crossover Period|Adverse Event|0|||
156782369|NCT02068794|565952748|FG002|Overall Study|Early Progression|1|||
156782370|NCT02068794|565952746|FG000|Overall Study|Ineligible|0|||
156782371|NCT02068794|565952747|FG001|Overall Study|Ineligible|0|||
156782372|NCT02068794|565952748|FG002|Overall Study|Ineligible|1|||
157120038|NCT03806127|567192956|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
157120039|NCT03806127|567192957|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
157120040|NCT03446885|567192961|FG000|Overall Study|Lost to Follow-up|1|||
157120041|NCT03446885|567192962|FG001|Overall Study|Lost to Follow-up|0|||
157120042|NCT03446885|567192961|FG000|Overall Study|Did not complete entire visit|1|||
157120043|NCT03446885|567192962|FG001|Overall Study|Did not complete entire visit|0|||
157120044|NCT03823391|567192964|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
156678911|NCT04610580|565569043|FG000|Two-way Crossover Period|Physician Decision|1|||
156678912|NCT04610580|565569044|FG001|Two-way Crossover Period|Physician Decision|0|||
156678913|NCT04610580|565569045|FG002|Two-way Crossover Period|Physician Decision|0|||
156678914|NCT04610580|565569046|FG003|Two-way Crossover Period|Physician Decision|0|||
156678915|NCT04610580|565569047|FG004|Two-way Crossover Period|Physician Decision|0|||
156678916|NCT04610580|565569048|FG005|Two-way Crossover Period|Physician Decision|0|||
156678917|NCT04610580|565569043|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
156678918|NCT04610580|565569044|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
156678919|NCT04610580|565569045|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
156678920|NCT04610580|565569046|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
156678921|NCT04610580|565569047|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
156678922|NCT04610580|565569048|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
156678923|NCT04610580|565569043|FG000|Two-way Crossover Period|Other than specified|0|||
156678924|NCT04610580|565569044|FG001|Two-way Crossover Period|Other than specified|1|||
156678925|NCT04610580|565569045|FG002|Two-way Crossover Period|Other than specified|0|||
156678926|NCT04610580|565569046|FG003|Two-way Crossover Period|Other than specified|0|||
156678927|NCT04610580|565569047|FG004|Two-way Crossover Period|Other than specified|0|||
156678928|NCT04610580|565569048|FG005|Two-way Crossover Period|Other than specified|0|||
156678929|NCT04610580|565569043|FG000|Washout Before Extension Period|Other than specified|0|||
156678930|NCT04610580|565569044|FG001|Washout Before Extension Period|Other than specified|1|||
156678931|NCT04610580|565569045|FG002|Washout Before Extension Period|Other than specified|0|||
156678932|NCT04610580|565569046|FG003|Washout Before Extension Period|Other than specified|0|||
156678933|NCT04610580|565569047|FG004|Washout Before Extension Period|Other than specified|0|||
156678934|NCT04610580|565569048|FG005|Washout Before Extension Period|Other than specified|0|||
156678935|NCT04610580|565569043|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
156678936|NCT04610580|565569044|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
156678937|NCT04610580|565569045|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
156678938|NCT04610580|565569046|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
156678939|NCT04610580|565569047|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
156678940|NCT04610580|565569048|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
156678941|NCT04610580|565569043|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678942|NCT04610580|565569044|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678943|NCT04610580|565569045|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678944|NCT04610580|565569046|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678945|NCT04610580|565569047|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
156678946|NCT04610580|565569048|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
156678947|NCT04164758|565569049|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
156678948|NCT04164758|565569050|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
156678949|NCT04164758|565569051|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
156678950|NCT04164758|565569049|FG000|Overall Study|Adverse Event|0|||
156678951|NCT04164758|565569050|FG001|Overall Study|Adverse Event|1|||
156678952|NCT04164758|565569051|FG002|Overall Study|Adverse Event|0|||
156678953|NCT01670097|565569052|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
156678954|NCT01670097|565569053|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
156678955|NCT01670097|565569052|FG000|Overall Study|Study burden|1|||
156678956|NCT01670097|565569053|FG001|Overall Study|Study burden|0|||
156678957|NCT01670097|565569052|FG000|Overall Study|COPD exacerbation|0|||
156678958|NCT01670097|565569053|FG001|Overall Study|COPD exacerbation|1|||
156678959|NCT01670097|565569052|FG000|Overall Study|Neutropenia|0|||
156678960|NCT01670097|565569053|FG001|Overall Study|Neutropenia|1|||
156678961|NCT01670097|565569052|FG000|Overall Study|Clinical deterioration|0|||
156678962|NCT01670097|565569053|FG001|Overall Study|Clinical deterioration|1|||
156678963|NCT01670097|565569052|FG000|Overall Study|Disease progression|0|||
156678964|NCT01670097|565569053|FG001|Overall Study|Disease progression|1|||
156678965|NCT01949532|565569054|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
156678966|NCT01949532|565569055|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
157120045|NCT03823391|567192965|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
157120046|NCT03823391|567192964|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
156678967|NCT01824498|565569056|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
156678968|NCT01824498|565569057|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
157120047|NCT03823391|567192965|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
156678969|NCT01824498|565569058|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
156678970|NCT01824498|565569059|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
156678971|NCT01824498|565569060|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
156678972|NCT01824498|565569061|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
156678973|NCT00884390|565569063|FG000|Overall Study|Adverse Event|0|||
156678974|NCT00884390|565569064|FG001|Overall Study|Adverse Event|1|||
156678975|NCT00884390|565569063|FG000|Overall Study|Lost to Follow-up|0|||
156678976|NCT00884390|565569064|FG001|Overall Study|Lost to Follow-up|1|||
156678977|NCT00884390|565569063|FG000|Overall Study|Physician Decision|2|||
156678978|NCT00884390|565569064|FG001|Overall Study|Physician Decision|1|||
156678979|NCT00884390|565569063|FG000|Overall Study|Protocol Violation|4|||
156678980|NCT00884390|565569064|FG001|Overall Study|Protocol Violation|1|||
156678981|NCT00884390|565569063|FG000|Overall Study|Withdrawal by Subject|4|||
156678982|NCT00884390|565569064|FG001|Overall Study|Withdrawal by Subject|1|||
156678983|NCT00884390|565569063|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
156678984|NCT00884390|565569064|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
156678985|NCT00884390|565569063|FG000|Overall Study|Other|11|||
156678986|NCT00884390|565569064|FG001|Overall Study|Other|1|||
156678987|NCT01691612|565569067|FG000|Overall Study|deemed ineligible after 1st visit|6|||
156678988|NCT01691612|565569067|FG000|Overall Study|Adverse Event|1|||
156678989|NCT00533507|565569072|FG000|Overall Study|Withdrawal by Subject|1|||
156678990|NCT01528735|565569077|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
156678991|NCT01528735|565569078|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
156678992|NCT01528735|565569077|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
156678993|NCT01528735|565569078|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
156678994|NCT00757172|565569079|FG000|Overall Study|Withdrawal by Subject|4|||
156678995|NCT00757172|565569079|FG000|Overall Study|Physician Decision|3|||
156678996|NCT00757172|565569079|FG000|Overall Study|Progression|4|||
156678997|NCT01942135|565569081|FG000|Overall Study|Adverse Event|21|||
156678998|NCT01942135|565569082|FG001|Overall Study|Adverse Event|7|||
156678999|NCT01942135|565569081|FG000|Overall Study|Global Deterioration of Health Status|9|||
156679000|NCT01942135|565569082|FG001|Overall Study|Global Deterioration of Health Status|6|||
156679001|NCT01942135|565569081|FG000|Overall Study|Randomized Not Treated|2|||
156679002|NCT01942135|565569082|FG001|Overall Study|Randomized Not Treated|2|||
156679003|NCT01942135|565569081|FG000|Overall Study|Death|2|||
156679004|NCT01942135|565569082|FG001|Overall Study|Death|1|||
156679005|NCT01942135|565569081|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
156679006|NCT01942135|565569082|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
156679007|NCT01942135|565569081|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
156679008|NCT01942135|565569082|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
156679009|NCT01942135|565569081|FG000|Overall Study|Withdrawal by Subject|4|||
156679010|NCT01942135|565569082|FG001|Overall Study|Withdrawal by Subject|3|||
156679011|NCT01942135|565569081|FG000|Overall Study|Protocol Violation|1|||
156679012|NCT01942135|565569082|FG001|Overall Study|Protocol Violation|0|||
156679013|NCT01942135|565569081|FG000|Overall Study|Other|19|||
156679014|NCT01942135|565569082|FG001|Overall Study|Other|4|||
156679015|NCT01717040|565569083|FG000|Overall Study|Lost to Follow-up|2|||
156679016|NCT01717040|565569084|FG001|Overall Study|Lost to Follow-up|3|||
156679017|NCT01717040|565569083|FG000|Overall Study|Lack of Efficacy|1|||
156679018|NCT01717040|565569084|FG001|Overall Study|Lack of Efficacy|1|||
156679019|NCT01717040|565569083|FG000|Overall Study|Adverse Event|1|||
156679020|NCT01717040|565569084|FG001|Overall Study|Adverse Event|0|||
156679021|NCT01717040|565569083|FG000|Overall Study|Required Medication Change|0|||
156679022|NCT01717040|565569084|FG001|Overall Study|Required Medication Change|1|||
156679023|NCT01717040|565569083|FG000|Overall Study|New Substance Use Disorder|1|||
156679024|NCT01717040|565569084|FG001|Overall Study|New Substance Use Disorder|0|||
156679025|NCT01499043|565569085|FG000|Overall Study|Progressive disease (radiographic)|2|||
156782373|NCT04439175|565952750|FG000|Overall Study|Never started treatment|4|||
156782374|NCT04439175|565952750|FG000|Overall Study|Ineligible|5|||
156782375|NCT04439175|565952750|FG000|Overall Study|Adverse Event|6|||
156782376|NCT04439175|565952750|FG000|Overall Study|Death|4|||
156782377|NCT04439175|565952750|FG000|Overall Study|Disease progression|44|||
156782378|NCT04439175|565952750|FG000|Overall Study|Withdrawal by Subject|4|||
156679026|NCT01499043|565569085|FG000|Overall Study|Progressive disease (clinical)|1|||
156782379|NCT04439175|565952750|FG000|Overall Study|Alternative Therapy|1|||
156782380|NCT04439175|565952750|FG000|Overall Study|Other|2|||
156782381|NCT01022580|565952751|FG000|Overall Study|Death|18|||
156679027|NCT01499043|565569085|FG000|Overall Study|Withdrawal by Subject|2|||
156782382|NCT01022580|565952752|FG001|Overall Study|Death|22|||
156679028|NCT01499043|565569085|FG000|Overall Study|Adverse Event|1|||
156679029|NCT01596127|565569087|FG000|Overall Study|Patient Ineligible|1|||
156679030|NCT01566435|565569088|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
156679031|NCT00438633|565569089|FG000|Overall Study|Withdrawal by Subject|1|||
156679032|NCT00438633|565569090|FG001|Overall Study|Withdrawal by Subject|0|||
156679033|NCT00438633|565569089|FG000|Overall Study|Lost to Follow-up|15|||
156679034|NCT00438633|565569090|FG001|Overall Study|Lost to Follow-up|17|||
156782383|NCT00835978|565952753|FG000|Overall Study|Death|33|||
156782384|NCT00835978|565952754|FG001|Overall Study|Death|40|||
156782385|NCT00835978|565952755|FG002|Overall Study|Death|49|||
156679035|NCT03196284|565569091|FG000|Main Part|Withdrawal by Subject|0|||
156679036|NCT03196284|565569092|FG001|Main Part|Withdrawal by Subject|1|||
156679037|NCT03196284|565569093|FG002|Main Part|Withdrawal by Subject|0|||
156679038|NCT03196284|565569091|FG000|Extension Part|Lack of Efficacy|0|||
156679039|NCT03196284|565569092|FG001|Extension Part|Lack of Efficacy|0|||
156679040|NCT03196284|565569093|FG002|Extension Part|Lack of Efficacy|1|||
156679041|NCT03196284|565569091|FG000|Extension Part|Withdrawal by Subject|0|||
156679042|NCT03196284|565569092|FG001|Extension Part|Withdrawal by Subject|0|||
156679043|NCT03196284|565569093|FG002|Extension Part|Withdrawal by Subject|1|||
156679044|NCT03196284|565569091|FG000|Extension Part|Physician Decision|0|||
156866836|NCT01710501|566273379|FG000|Overall Study|Lost to Follow-up|2|||
156866837|NCT01710501|566273380|FG001|Overall Study|Lost to Follow-up|0|||
156866838|NCT01710501|566273381|FG002|Overall Study|Lost to Follow-up|0|||
156866839|NCT01942837|566273386|FG000|Overall Study|Death|1|||
156866840|NCT01942837|566273386|FG000|Overall Study|Symptomatic or radiographic progression|49|||
156866841|NCT01942837|566273386|FG000|Overall Study|Adverse Event|6|||
156866842|NCT01942837|566273386|FG000|Overall Study|Physician Decision|3|||
156866843|NCT01942837|566273386|FG000|Overall Study|Withdrawal by Subject|2|||
156866844|NCT01942837|566273386|FG000|Overall Study|Intercurrent Illness|1|||
156866845|NCT01942837|566273386|FG000|Overall Study|On treatment|3|||
156866846|NCT01942837|566273386|FG000|Overall Study|Never initiate the treatment|2|||
156866847|NCT01298648|566273387|FG000|Overall Study|Withdrawal by Subject|2|||
156866848|NCT01298648|566273387|FG000|Overall Study|Lost to Follow-up|21|||
156866849|NCT00918255|566273388|FG000|Overall Study|Adverse Event|1|||
156866850|NCT00918255|566273389|FG001|Overall Study|Adverse Event|0|||
156866851|NCT00918255|566273390|FG002|Overall Study|Adverse Event|0|||
156866852|NCT00918255|566273388|FG000|Overall Study|Withdrawal by Subject|1|||
156866853|NCT00918255|566273389|FG001|Overall Study|Withdrawal by Subject|0|||
156866854|NCT00918255|566273390|FG002|Overall Study|Withdrawal by Subject|2|||
156866855|NCT00918255|566273388|FG000|Overall Study|Lack of Efficacy|1|||
156866856|NCT00918255|566273389|FG001|Overall Study|Lack of Efficacy|0|||
156866857|NCT00918255|566273390|FG002|Overall Study|Lack of Efficacy|0|||
156866858|NCT00918255|566273388|FG000|Overall Study|Lost to Follow-up|1|||
156679045|NCT03196284|565569092|FG001|Extension Part|Physician Decision|0|||
156679046|NCT03196284|565569093|FG002|Extension Part|Physician Decision|1|||
156679047|NCT04729101|565570502|FG000|Overall Study|Adverse Event|1|||
156679048|NCT04729101|565570503|FG001|Overall Study|Adverse Event|0|||
156679049|NCT04729101|565570502|FG000|Overall Study|Physician Decision|1|||
156679050|NCT04729101|565570503|FG001|Overall Study|Physician Decision|0|||
156679051|NCT04729101|565570502|FG000|Overall Study|Withdrawal by Subject|1|||
156679052|NCT04729101|565570503|FG001|Overall Study|Withdrawal by Subject|0|||
156679053|NCT00274625|565570504|FG000|Overall Study|Lost to Follow-up|46|||
156679054|NCT00274625|565570505|FG001|Overall Study|Lost to Follow-up|54|||
156679055|NCT00274625|565570504|FG000|Overall Study|Excluded from analysis|14|||
156679056|NCT00274625|565570505|FG001|Overall Study|Excluded from analysis|8|||
156679057|NCT04264819|565570511|FG000|Overall Study|Physician Decision|19|||
156679058|NCT04264819|565570511|FG000|Overall Study|Adverse Event|12|||
156679059|NCT04264819|565570511|FG000|Overall Study|Withdrawal by Subject|11|||
156679060|NCT04264819|565570511|FG000|Overall Study|Lost to Follow-up|2|||
156679061|NCT04264819|565570511|FG000|Overall Study|Death|2|||
156679062|NCT01662024|565570516|FG000|Overall Study|Pregnancy|2|||
156679063|NCT01662024|565570516|FG000|Overall Study|Withdrawal by Subject|3|||
156679064|NCT00927251|565570519|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
156679065|NCT00544167|565570523|FG000|Overall Study|Adverse Event|21|||
156679066|NCT00544167|565570523|FG000|Overall Study|Physician Decision|8|||
156679067|NCT00084864|565570528|FG000|Overall Study|Adverse Event|1|||
156679068|NCT00084864|565570529|FG001|Overall Study|Adverse Event|0|||
156679069|NCT00084864|565570530|FG002|Overall Study|Adverse Event|0|||
156679070|NCT00084864|565570531|FG003|Overall Study|Adverse Event|0|||
156679071|NCT02460835|565570535|FG000|Overall Study|Disease progression prior to treatment|3|||
156679072|NCT02460835|565570535|FG000|Overall Study|Unable to complete planning scans|2|||
156679073|NCT02460835|565570535|FG000|Overall Study|Decrease in performance status|1|||
156679074|NCT02460835|565570535|FG000|Overall Study|Withdrawal by Subject|3|||
156679075|NCT02460835|565570535|FG000|Overall Study|Underwent fractionated RT|10|||
156679076|NCT02460835|565570535|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
156679077|NCT00063258|565570548|FG000|Overall Study|Physician Decision|2|||
156679078|NCT00063258|565570549|FG001|Overall Study|Physician Decision|0|||
156679079|NCT00063258|565570548|FG000|Overall Study|Lack of Efficacy|2|||
156679080|NCT00063258|565570549|FG001|Overall Study|Lack of Efficacy|0|||
156679081|NCT02483416|565570552|FG000|Overall Study|Other reason|0|||
156679082|NCT02483416|565570553|FG001|Overall Study|Other reason|1|||
156679083|NCT02483416|565570552|FG000|Overall Study|Treatment stop|3|||
156679084|NCT02483416|565570553|FG001|Overall Study|Treatment stop|0|||
156679085|NCT02587143|565570555|FG000|Overall Study|Adverse Event|1|||
156679086|NCT02587143|565570556|FG001|Overall Study|Adverse Event|0|||
156679087|NCT03314857|565570557|FG000|Overall Study|Death|4|||
156679088|NCT03314857|565570557|FG000|Overall Study|Physician Decision|1|||
156679089|NCT02754492|565570558|FG000|Overall Study|Protocol Violation|2|||
156679090|NCT02754492|565570559|FG001|Overall Study|Protocol Violation|2|||
156679091|NCT02754492|565570560|FG002|Overall Study|Protocol Violation|0|||
156679092|NCT02754492|565570561|FG003|Overall Study|Protocol Violation|1|||
156679093|NCT02754492|565570558|FG000|Overall Study|Withdrawal by Subject|2|||
156679094|NCT02754492|565570559|FG001|Overall Study|Withdrawal by Subject|0|||
156679095|NCT02754492|565570560|FG002|Overall Study|Withdrawal by Subject|0|||
156679096|NCT02754492|565570561|FG003|Overall Study|Withdrawal by Subject|0|||
156679097|NCT02754492|565570558|FG000|Overall Study|Equipment malfuntion|0|||
156679098|NCT02754492|565570559|FG001|Overall Study|Equipment malfuntion|0|||
156679099|NCT02754492|565570560|FG002|Overall Study|Equipment malfuntion|2|||
156679100|NCT02754492|565570561|FG003|Overall Study|Equipment malfuntion|5|||
156679101|NCT02754492|565570558|FG000|Overall Study|Adverse Event|0|||
156679102|NCT02754492|565570559|FG001|Overall Study|Adverse Event|0|||
156679103|NCT02754492|565570560|FG002|Overall Study|Adverse Event|0|||
156679104|NCT02754492|565570561|FG003|Overall Study|Adverse Event|13|||
156679105|NCT02754492|565570558|FG000|Overall Study|Venous access issues not resulting in AE|0|||
156679106|NCT02754492|565570559|FG001|Overall Study|Venous access issues not resulting in AE|0|||
156679107|NCT02754492|565570560|FG002|Overall Study|Venous access issues not resulting in AE|0|||
156679108|NCT02754492|565570561|FG003|Overall Study|Venous access issues not resulting in AE|4|||
156679109|NCT05387408|565570562|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
156679110|NCT01632306|565570572|FG000|Overall Study|Protocol Violation|1|||
156679111|NCT01632306|565570573|FG001|Overall Study|Protocol Violation|0|||
156679112|NCT01632306|565570574|FG002|Overall Study|Protocol Violation|0|||
156679113|NCT03480022|565570577|FG000|Overall Study|Pregnancy|2|||
156679114|NCT03480022|565570578|FG001|Overall Study|Pregnancy|0|||
156679115|NCT03480022|565570577|FG000|Overall Study|Adverse Event|6|||
156679116|NCT03480022|565570578|FG001|Overall Study|Adverse Event|0|||
156679117|NCT03480022|565570577|FG000|Overall Study|Lack of Efficacy|0|||
156679118|NCT03480022|565570578|FG001|Overall Study|Lack of Efficacy|2|||
156679119|NCT03480022|565570577|FG000|Overall Study|Physician Decision|0|||
156679120|NCT03480022|565570578|FG001|Overall Study|Physician Decision|1|||
156679121|NCT03480022|565570577|FG000|Overall Study|Withdrawal by Subject|2|||
156679122|NCT03480022|565570578|FG001|Overall Study|Withdrawal by Subject|0|||
156679123|NCT03480022|565570577|FG000|Overall Study|Medication concerns|1|||
156679124|NCT03480022|565570578|FG001|Overall Study|Medication concerns|0|||
156679125|NCT03480022|565570577|FG000|Overall Study|Family member COVID exposure|0|||
156679126|NCT03480022|565570578|FG001|Overall Study|Family member COVID exposure|1|||
156679127|NCT00881569|565570579|FG000|Overall Study|Disease progression|1|||
156679128|NCT00881569|565570580|FG001|Overall Study|Disease progression|1|||
156679129|NCT00668395|565570581|FG000|Overall Study|Withdrawal by Subject|4|||
156679130|NCT00668395|565570582|FG001|Overall Study|Withdrawal by Subject|4|||
156679131|NCT00668395|565570583|FG002|Overall Study|Withdrawal by Subject|1|||
156679132|NCT00668395|565570581|FG000|Overall Study|Adverse Event|1|||
156679133|NCT00668395|565570582|FG001|Overall Study|Adverse Event|1|||
156679134|NCT00668395|565570583|FG002|Overall Study|Adverse Event|0|||
156679135|NCT00668395|565570581|FG000|Overall Study|Physician Decision|1|||
156679136|NCT00668395|565570582|FG001|Overall Study|Physician Decision|1|||
156679137|NCT00668395|565570583|FG002|Overall Study|Physician Decision|0|||
156679138|NCT05665387|565570584|FG000|Overall Study|Withdrawal by Subject|1|||
156679139|NCT05665387|565570585|FG001|Overall Study|Withdrawal by Subject|0|||
156679140|NCT05665387|565570586|FG002|Overall Study|Withdrawal by Subject|1|||
156679141|NCT01567527|565570587|FG000|Conversion Phase.|Protocol deviation|3|||
156679142|NCT01567527|565570588|FG001|Conversion Phase.|Protocol deviation|0|||
156679143|NCT01567527|565570589|FG002|Conversion Phase.|Protocol deviation|0|||
156679144|NCT01567527|565570590|FG003|Conversion Phase.|Protocol deviation|0|||
156679145|NCT01567527|565570591|FG004|Conversion Phase.|Protocol deviation|0|||
156679146|NCT01567527|565570587|FG000|Conversion Phase.|Met withdrawal criteria|10|||
156679147|NCT01567527|565570588|FG001|Conversion Phase.|Met withdrawal criteria|0|||
156679148|NCT01567527|565570589|FG002|Conversion Phase.|Met withdrawal criteria|0|||
156679149|NCT01567527|565570590|FG003|Conversion Phase.|Met withdrawal criteria|0|||
156679150|NCT01567527|565570591|FG004|Conversion Phase.|Met withdrawal criteria|0|||
156679151|NCT01567527|565570587|FG000|Conversion Phase.|Withdrawal by Subject|32|||
156679152|NCT01567527|565570588|FG001|Conversion Phase.|Withdrawal by Subject|0|||
156679153|NCT01567527|565570589|FG002|Conversion Phase.|Withdrawal by Subject|0|||
156679154|NCT01567527|565570590|FG003|Conversion Phase.|Withdrawal by Subject|0|||
156679155|NCT01567527|565570591|FG004|Conversion Phase.|Withdrawal by Subject|0|||
156679156|NCT01567527|565570587|FG000|Conversion Phase.|Lost to Follow-up|16|||
156679157|NCT01567527|565570588|FG001|Conversion Phase.|Lost to Follow-up|0|||
156679158|NCT01567527|565570589|FG002|Conversion Phase.|Lost to Follow-up|0|||
156679159|NCT01567527|565570590|FG003|Conversion Phase.|Lost to Follow-up|0|||
156679160|NCT01567527|565570591|FG004|Conversion Phase.|Lost to Follow-up|0|||
156679161|NCT01567527|565570587|FG000|Conversion Phase.|Lack of Efficacy|2|||
156679162|NCT01567527|565570588|FG001|Conversion Phase.|Lack of Efficacy|0|||
156679163|NCT01567527|565570589|FG002|Conversion Phase.|Lack of Efficacy|0|||
156679164|NCT01567527|565570590|FG003|Conversion Phase.|Lack of Efficacy|0|||
156679165|NCT01567527|565570591|FG004|Conversion Phase.|Lack of Efficacy|0|||
156679166|NCT01567527|565570587|FG000|Conversion Phase.|Adverse Event|33|||
156679167|NCT01567527|565570588|FG001|Conversion Phase.|Adverse Event|0|||
156679168|NCT01567527|565570589|FG002|Conversion Phase.|Adverse Event|0|||
156679169|NCT01567527|565570590|FG003|Conversion Phase.|Adverse Event|0|||
156679170|NCT01567527|565570591|FG004|Conversion Phase.|Adverse Event|0|||
156679171|NCT01567527|565570587|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
156679172|NCT01567527|565570588|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
156679173|NCT01567527|565570589|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
156679174|NCT01567527|565570590|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
156679175|NCT01567527|565570591|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
156679176|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679177|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
156679178|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156782386|NCT00835978|565952756|FG003|Overall Study|Death|4|||
156782387|NCT00835978|565952753|FG000|Overall Study|Lost to Follow-up|3|||
156782388|NCT00835978|565952754|FG001|Overall Study|Lost to Follow-up|4|||
156866859|NCT00918255|566273389|FG001|Overall Study|Lost to Follow-up|0|||
156866860|NCT00918255|566273390|FG002|Overall Study|Lost to Follow-up|2|||
156866861|NCT00918255|566273388|FG000|Overall Study|Exceeded allowed number of interventions|0|||
156866862|NCT00918255|566273389|FG001|Overall Study|Exceeded allowed number of interventions|0|||
156782389|NCT00835978|565952755|FG002|Overall Study|Lost to Follow-up|2|||
156782390|NCT00835978|565952756|FG003|Overall Study|Lost to Follow-up|1|||
156782391|NCT00835978|565952753|FG000|Overall Study|Other|5|||
156782392|NCT00835978|565952754|FG001|Overall Study|Other|1|||
156782393|NCT00835978|565952755|FG002|Overall Study|Other|8|||
156782394|NCT00835978|565952756|FG003|Overall Study|Other|0|||
156782395|NCT00835978|565952753|FG000|Overall Study|Objective progression or relapse|2|||
156782396|NCT00835978|565952754|FG001|Overall Study|Objective progression or relapse|0|||
156782397|NCT00835978|565952755|FG002|Overall Study|Objective progression or relapse|1|||
156782398|NCT00835978|565952756|FG003|Overall Study|Objective progression or relapse|0|||
156782399|NCT00835978|565952753|FG000|Overall Study|Adverse Event|1|||
156782400|NCT00835978|565952754|FG001|Overall Study|Adverse Event|0|||
156782401|NCT00835978|565952755|FG002|Overall Study|Adverse Event|1|||
156782402|NCT00835978|565952756|FG003|Overall Study|Adverse Event|0|||
156782403|NCT00835978|565952753|FG000|Overall Study|Withdrawal by Subject|0|||
156782404|NCT00835978|565952754|FG001|Overall Study|Withdrawal by Subject|3|||
156782405|NCT00835978|565952755|FG002|Overall Study|Withdrawal by Subject|0|||
156782406|NCT00835978|565952756|FG003|Overall Study|Withdrawal by Subject|5|||
156782407|NCT00835978|565952753|FG000|Overall Study|Study terminated by sponsor|12|||
156782408|NCT00835978|565952754|FG001|Overall Study|Study terminated by sponsor|8|||
156782409|NCT00835978|565952755|FG002|Overall Study|Study terminated by sponsor|30|||
156782410|NCT00835978|565952756|FG003|Overall Study|Study terminated by sponsor|0|||
156782411|NCT01617967|565952757|FG000|Overall Study|Protocol Violation|0|||
156782412|NCT01617967|565952758|FG001|Overall Study|Protocol Violation|0|||
156782413|NCT01617967|565952759|FG002|Overall Study|Protocol Violation|0|||
156782414|NCT01617967|565952760|FG003|Overall Study|Protocol Violation|1|||
156782415|NCT01617967|565952761|FG004|Overall Study|Protocol Violation|0|||
156782416|NCT01617967|565952762|FG005|Overall Study|Protocol Violation|0|||
156782417|NCT01617967|565952757|FG000|Overall Study|Withdrawal by Subject|0|||
156782418|NCT01617967|565952758|FG001|Overall Study|Withdrawal by Subject|0|||
156782419|NCT01617967|565952759|FG002|Overall Study|Withdrawal by Subject|0|||
156782420|NCT01617967|565952760|FG003|Overall Study|Withdrawal by Subject|0|||
156782421|NCT01617967|565952761|FG004|Overall Study|Withdrawal by Subject|0|||
156782422|NCT01617967|565952762|FG005|Overall Study|Withdrawal by Subject|1|||
156782423|NCT01617967|565952757|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
156782424|NCT01617967|565952758|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
156782425|NCT01617967|565952759|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
156782426|NCT01617967|565952760|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
156866863|NCT00918255|566273390|FG002|Overall Study|Exceeded allowed number of interventions|1|||
156866864|NCT00918255|566273388|FG000|Overall Study|Non-compliance|1|||
156679179|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679180|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
156679181|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679182|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
156679183|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156782427|NCT01617967|565952761|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
156782428|NCT01617967|565952762|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
156782429|NCT00530075|565952763|FG000|Overall Study|Adverse Event|1|||
156782430|NCT00530075|565952763|FG000|Overall Study|Death|1|||
156782431|NCT00530075|565952763|FG000|Overall Study|Lack of Efficacy|3|||
156782432|NCT00530075|565952763|FG000|Overall Study|Protocol Violation|1|||
156782433|NCT00530075|565952763|FG000|Overall Study|Withdrawal by Subject|1|||
156782434|NCT01166945|565952766|FG000|Randomized|diagnosed with Group A strep|4|||
156782435|NCT01166945|565952767|FG001|Randomized|diagnosed with Group A strep|4|||
156679184|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679185|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
156679186|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679187|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
156679188|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679189|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679190|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
156679191|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679192|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
156679193|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679194|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679195|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
156679196|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679197|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
156679198|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679199|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679200|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
156679201|NCT01567527|565570587|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156782436|NCT01166945|565952766|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
156782437|NCT01166945|565952767|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
156782438|NCT01166945|565952766|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
156782439|NCT01166945|565952767|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
156782440|NCT01166945|565952766|FG000|Day 30|Lost to Follow-up|4|||
156782441|NCT01166945|565952767|FG001|Day 30|Lost to Follow-up|3|||
156782442|NCT01137812|565952768|FG000|Overall Study|Adverse Event|21|||
156782443|NCT01137812|565952769|FG001|Overall Study|Adverse Event|14|||
156782444|NCT01137812|565952768|FG000|Overall Study|Lost to Follow-up|6|||
156866865|NCT00918255|566273389|FG001|Overall Study|Non-compliance|0|||
156866866|NCT00918255|566273390|FG002|Overall Study|Non-compliance|0|||
156866867|NCT00918255|566273388|FG000|Overall Study|Investigator discretion|1|||
156866868|NCT00918255|566273389|FG001|Overall Study|Investigator discretion|0|||
156866869|NCT00918255|566273390|FG002|Overall Study|Investigator discretion|0|||
156866870|NCT04154904|566273391|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
156866871|NCT04154904|566273392|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
156866872|NCT04154904|566273393|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
156866873|NCT02392624|566273394|FG000|Overall Study|Withdrawal by Subject|15|||
156866874|NCT02392624|566273395|FG001|Overall Study|Withdrawal by Subject|12|||
156866875|NCT02392624|566273396|FG002|Overall Study|Withdrawal by Subject|9|||
156866876|NCT02392624|566273394|FG000|Overall Study|Adverse Event|4|||
156866877|NCT02392624|566273395|FG001|Overall Study|Adverse Event|1|||
156866878|NCT02392624|566273396|FG002|Overall Study|Adverse Event|2|||
156866879|NCT02392624|566273394|FG000|Overall Study|Pregnancy|1|||
156866880|NCT02392624|566273395|FG001|Overall Study|Pregnancy|0|||
156866881|NCT02392624|566273396|FG002|Overall Study|Pregnancy|0|||
156866882|NCT02392624|566273394|FG000|Overall Study|Protocol Violation|0|||
156866883|NCT02392624|566273395|FG001|Overall Study|Protocol Violation|0|||
156782445|NCT01137812|565952769|FG001|Overall Study|Lost to Follow-up|8|||
156782446|NCT01137812|565952768|FG000|Overall Study|Physician Decision|25|||
156782447|NCT01137812|565952769|FG001|Overall Study|Physician Decision|17|||
156782448|NCT01137812|565952768|FG000|Overall Study|Protocol Violation|5|||
156782449|NCT01137812|565952769|FG001|Overall Study|Protocol Violation|4|||
156782450|NCT01137812|565952768|FG000|Overall Study|Withdrawal by Subject|5|||
156782451|NCT01137812|565952769|FG001|Overall Study|Withdrawal by Subject|13|||
156866884|NCT02392624|566273396|FG002|Overall Study|Protocol Violation|1|||
156866885|NCT02392624|566273394|FG000|Overall Study|Sponsor/Investigator Decision|2|||
156866886|NCT02392624|566273395|FG001|Overall Study|Sponsor/Investigator Decision|1|||
156866887|NCT02392624|566273396|FG002|Overall Study|Sponsor/Investigator Decision|0|||
156866888|NCT02392624|566273394|FG000|Overall Study|Other|49|||
156866889|NCT02392624|566273395|FG001|Overall Study|Other|1|||
156866890|NCT02392624|566273396|FG002|Overall Study|Other|1|||
156679202|NCT01567527|565570588|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
156679203|NCT01567527|565570589|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679204|NCT01567527|565570590|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679205|NCT01567527|565570591|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
156679206|NCT01567527|565570587|FG000|IM Depot Stabilization.|Protocol deviation|0|||
156679207|NCT01567527|565570588|FG001|IM Depot Stabilization.|Protocol deviation|0|||
156679208|NCT01567527|565570589|FG002|IM Depot Stabilization.|Protocol deviation|5|||
156679209|NCT01567527|565570590|FG003|IM Depot Stabilization.|Protocol deviation|0|||
156679210|NCT01567527|565570591|FG004|IM Depot Stabilization.|Protocol deviation|0|||
156782452|NCT01137812|565952768|FG000|Overall Study|Death|2|||
156782453|NCT01137812|565952769|FG001|Overall Study|Death|0|||
156782454|NCT01137812|565952768|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
156866891|NCT03841604|566273397|FG000|Overall Study|Withdrawal by Subject|3|||
156679211|NCT01567527|565570587|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679212|NCT01567527|565570588|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679213|NCT01567527|565570589|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
156679214|NCT01567527|565570590|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679215|NCT01567527|565570591|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
156679216|NCT01567527|565570587|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679217|NCT01567527|565570588|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679218|NCT01567527|565570589|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
156679219|NCT01567527|565570590|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679220|NCT01567527|565570591|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
156679221|NCT01567527|565570587|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
156782455|NCT01137812|565952769|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
156866892|NCT03841604|566273398|FG001|Overall Study|Withdrawal by Subject|1|||
156866893|NCT03841604|566273397|FG000|Overall Study|Adverse Event|4|||
156866894|NCT03841604|566273398|FG001|Overall Study|Adverse Event|2|||
156782456|NCT01137812|565952768|FG000|Overall Study|Other|19|||
156782457|NCT01137812|565952769|FG001|Overall Study|Other|27|||
156782458|NCT05558410|565952776|FG000|Overall Study|Adverse Event|1|||
156782459|NCT05558410|565952777|FG001|Overall Study|Adverse Event|2|||
156782460|NCT05558410|565952778|FG002|Overall Study|Adverse Event|0|||
156782461|NCT05558410|565952776|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
156782462|NCT05558410|565952777|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156782463|NCT05558410|565952778|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
156782464|NCT05558410|565952776|FG000|Overall Study|Lost to Follow-up|10|||
156782465|NCT05558410|565952777|FG001|Overall Study|Lost to Follow-up|17|||
156782466|NCT05558410|565952778|FG002|Overall Study|Lost to Follow-up|19|||
156782467|NCT05558410|565952776|FG000|Overall Study|Death|1|||
156782468|NCT05558410|565952777|FG001|Overall Study|Death|0|||
156782469|NCT05558410|565952778|FG002|Overall Study|Death|0|||
156782470|NCT05558410|565952776|FG000|Overall Study|Other non-compliance|0|||
156782471|NCT05558410|565952777|FG001|Overall Study|Other non-compliance|1|||
156782472|NCT05558410|565952778|FG002|Overall Study|Other non-compliance|2|||
156782473|NCT05558410|565952776|FG000|Overall Study|Sponsor Decision|1|||
156782474|NCT05558410|565952777|FG001|Overall Study|Sponsor Decision|0|||
156782475|NCT05558410|565952778|FG002|Overall Study|Sponsor Decision|0|||
156782476|NCT05558410|565952776|FG000|Overall Study|Other|1|||
156782477|NCT05558410|565952777|FG001|Overall Study|Other|0|||
156782478|NCT05558410|565952778|FG002|Overall Study|Other|1|||
156782479|NCT00574951|565952781|FG000|Overall Study|Ineligible - improper prior treatment|1|||
156782480|NCT05161936|565952782|FG000|Overall Study|Study terminated by Sponsor|1|||
156782481|NCT05161936|565952783|FG001|Overall Study|Study terminated by Sponsor|0|||
156782482|NCT05161936|565952784|FG002|Overall Study|Study terminated by Sponsor|0|||
156782483|NCT05161936|565952782|FG000|Overall Study|Withdrawal by Subject|0|||
156782484|NCT05161936|565952783|FG001|Overall Study|Withdrawal by Subject|0|||
156782485|NCT05161936|565952784|FG002|Overall Study|Withdrawal by Subject|1|||
156782486|NCT04425018|565952785|FG000|Overall Study|Withdrawal by Subject|1|||
156782487|NCT04425018|565952786|FG001|Overall Study|Withdrawal by Subject|2|||
156782488|NCT03407482|565952791|FG000|Overall Study|Adverse Event|12|||
156782489|NCT03407482|565952791|FG000|Overall Study|Disease Relapse|1|||
156782490|NCT03407482|565952791|FG000|Overall Study|Lost to Follow-up|1|||
156782491|NCT03407482|565952791|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156782492|NCT03407482|565952791|FG000|Overall Study|Pregnancy|2|||
156782493|NCT03407482|565952791|FG000|Overall Study|Protocol Violation|1|||
156782494|NCT03407482|565952791|FG000|Overall Study|Study Terminated By Sponsor|106|||
156782495|NCT03407482|565952791|FG000|Overall Study|Withdrawal by Subject|6|||
156866895|NCT03841604|566273397|FG000|Overall Study|Physician Decision|1|||
157120048|NCT05030311|567192974|FG000|Overall Study|Technical problems|0|||
156679222|NCT01567527|565570588|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679223|NCT01567527|565570589|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
156679224|NCT01567527|565570590|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679225|NCT01567527|565570591|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
156679226|NCT01567527|565570587|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
156679227|NCT01567527|565570588|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
156679228|NCT01567527|565570589|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
156679229|NCT01567527|565570590|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
156782496|NCT03407482|565952791|FG000|Overall Study|Data Entry Error|1|||
156782497|NCT05179603|565952792|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156782498|NCT05179603|565952792|FG000|Overall Study|Withdrawal by Subject|1|||
156782499|NCT05179603|565952792|FG000|Overall Study|Progressive disease|4|||
156782500|NCT05179603|565952792|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
156782501|NCT05937373|565952793|FG000|Overall Study|Out of Window|2|||
156782502|NCT05937373|565952794|FG001|Overall Study|Out of Window|0|||
156782503|NCT05937373|565952793|FG000|Overall Study|Device fell off prior to date of surgery|0|||
156782504|NCT05937373|565952794|FG001|Overall Study|Device fell off prior to date of surgery|2|||
156866896|NCT03841604|566273398|FG001|Overall Study|Physician Decision|0|||
157012372|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
157012373|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
157012374|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
157012375|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
157012376|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
156679230|NCT01567527|565570591|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
156679231|NCT01567527|565570587|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
156679232|NCT01567527|565570588|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
156679233|NCT01567527|565570589|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
156679234|NCT01567527|565570590|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
156679235|NCT01567527|565570591|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
156679236|NCT01567527|565570587|FG000|IM Depot Stabilization.|Adverse Event|0|||
156679237|NCT01567527|565570588|FG001|IM Depot Stabilization.|Adverse Event|0|||
156679238|NCT01567527|565570589|FG002|IM Depot Stabilization.|Adverse Event|37|||
156679239|NCT01567527|565570590|FG003|IM Depot Stabilization.|Adverse Event|0|||
156679240|NCT01567527|565570591|FG004|IM Depot Stabilization.|Adverse Event|0|||
156679241|NCT01567527|565570587|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679242|NCT01567527|565570588|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679243|NCT01567527|565570589|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
156679244|NCT01567527|565570590|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679245|NCT01567527|565570591|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
156679246|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679247|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679248|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
156679249|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
156679250|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
156679251|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679252|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679253|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
156679254|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
156679255|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
156679256|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679257|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679258|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
156679259|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
156679260|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
156679261|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679262|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679263|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
156679264|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
156679265|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
156679266|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679267|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679268|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156679269|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
156679270|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
156679271|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
156679272|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
156679273|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
157012377|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
157012378|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
157012379|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
156679274|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
156679275|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
156679276|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679277|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679278|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
156679279|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
156679280|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
156679281|NCT01567527|565570587|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156679282|NCT01567527|565570588|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156679283|NCT01567527|565570589|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
157120049|NCT05030311|567192975|FG001|Overall Study|Technical problems|1|||
156679284|NCT01567527|565570590|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
156679285|NCT01567527|565570591|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
156679286|NCT02311894|565570592|FG000|Overall Study|Discontinued in error|1|||
156679287|NCT02311894|565570592|FG000|Overall Study|Lost to Follow-up|1|||
156679288|NCT02311894|565570592|FG000|Overall Study|Adverse Event|1|||
156679289|NCT02311894|565570592|FG000|Overall Study|Withdrawal by Subject|1|||
156679290|NCT01211262|565570594|FG000|Overall Study|Progressive Disease|18|||
156679291|NCT01211262|565570595|FG001|Overall Study|Progressive Disease|9|||
156679292|NCT01211262|565570594|FG000|Overall Study|Adverse Event|4|||
157012380|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
157012381|NCT02409667|566797451|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
157012382|NCT02409667|566797452|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
157012383|NCT02409667|566797453|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
156679293|NCT01211262|565570595|FG001|Overall Study|Adverse Event|0|||
157012384|NCT02409667|566797454|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
156679294|NCT01211262|565570594|FG000|Overall Study|Withdrawal of Consent|1|||
156679295|NCT01211262|565570595|FG001|Overall Study|Withdrawal of Consent|0|||
156679296|NCT01211262|565570594|FG000|Overall Study|Other|0|||
156679297|NCT01211262|565570595|FG001|Overall Study|Other|1|||
156679298|NCT01277510|565570596|FG000|Double-blind Phase|Non-compliance|0|||
156679299|NCT01277510|565570597|FG001|Double-blind Phase|Non-compliance|1|||
156679300|NCT01277510|565570596|FG000|Double-blind Phase|Adverse Event|1|||
157012385|NCT02409667|566797455|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
157012386|NCT01205048|566797458|FG000|Overall Study|Withdrawal by Subject|14|||
156679301|NCT01277510|565570597|FG001|Double-blind Phase|Adverse Event|0|||
156679302|NCT01277510|565570596|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156679303|NCT01277510|565570597|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156679304|NCT01277510|565570596|FG000|Double-blind Phase|Administrative decision|7|||
156679305|NCT01277510|565570597|FG001|Double-blind Phase|Administrative decision|9|||
156679306|NCT01277510|565570596|FG000|Double-blind Phase|Death|0|||
156679307|NCT01277510|565570597|FG001|Double-blind Phase|Death|1|||
156679308|NCT01277510|565570596|FG000|Double-blind Phase|Protocol-specified criteria|2|||
156679309|NCT01277510|565570597|FG001|Double-blind Phase|Protocol-specified criteria|6|||
156679310|NCT01277510|565570596|FG000|Double-blind Phase|Other|1|||
156679311|NCT01277510|565570597|FG001|Double-blind Phase|Other|1|||
156679312|NCT01277510|565570596|FG000|Open-label Phase|Administrative decision|4|||
156679313|NCT01277510|565570597|FG001|Open-label Phase|Administrative decision|3|||
156679314|NCT01277510|565570596|FG000|Open-label Phase|Protocol-specified criteria|1|||
156679315|NCT01277510|565570597|FG001|Open-label Phase|Protocol-specified criteria|0|||
156679316|NCT01277510|565570596|FG000|Open-label Phase|Never received investigational product|2|||
156679317|NCT01277510|565570597|FG001|Open-label Phase|Never received investigational product|0|||
156679318|NCT04049097|565570599|FG000|Overall Study|Adverse Event|18|||
156679319|NCT04049097|565570599|FG000|Overall Study|Death|2|||
156679320|NCT04049097|565570599|FG000|Overall Study|Lost to Follow-up|1|||
156679321|NCT04049097|565570599|FG000|Overall Study|Physician Decision|2|||
156679322|NCT04049097|565570599|FG000|Overall Study|Withdrawal by Subject|9|||
156679323|NCT04049097|565570599|FG000|Overall Study|Protocol Violation|2|||
156679324|NCT04049097|565570599|FG000|Overall Study|Other|1|||
156679325|NCT04049097|565570599|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
156679326|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
156679327|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
156679328|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
156679329|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
156679330|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Death|3|||
156679331|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Death|1|||
156679332|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
156679333|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
156679334|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
156679335|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
156679336|NCT00537095|565570600|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
156679337|NCT00537095|565570601|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
156679338|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Adverse Event|2|||
156679339|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Adverse Event|11|||
156679340|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
156679341|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
156679342|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Death|2|||
156679343|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Death|2|||
157012387|NCT01205048|566797458|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
156679344|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
156679345|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
156679346|NCT00537095|565570600|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
156679347|NCT00537095|565570601|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
156679348|NCT00021541|565570602|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
156679349|NCT00021541|565570603|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
156679350|NCT00021541|565570602|FG000|Period 1-First Treatment|Adverse Event|2|||
156679351|NCT00021541|565570603|FG001|Period 1-First Treatment|Adverse Event|1|||
156679352|NCT00021541|565570602|FG000|Period 1-First Treatment|non-adherence|3|||
156679353|NCT00021541|565570603|FG001|Period 1-First Treatment|non-adherence|0|||
156679354|NCT00021541|565570602|FG000|Period 1-First Treatment|Death|1|||
156679355|NCT00021541|565570603|FG001|Period 1-First Treatment|Death|0|||
156679356|NCT00021541|565570602|FG000|Period 1-First Treatment|Pts that did not progress|2|||
156679357|NCT00021541|565570603|FG001|Period 1-First Treatment|Pts that did not progress|2|||
156679358|NCT00021541|565570602|FG000|Period 1-First Treatment|Ineligible|0|||
156679359|NCT00021541|565570603|FG001|Period 1-First Treatment|Ineligible|2|||
156679360|NCT00021541|565570602|FG000|Period 2-crossover|refused phase B|2|||
156679361|NCT00021541|565570603|FG001|Period 2-crossover|refused phase B|2|||
156679362|NCT00021541|565570602|FG000|Period 2-crossover|Withdrawal by Subject|3|||
156679363|NCT00021541|565570603|FG001|Period 2-crossover|Withdrawal by Subject|4|||
156679364|NCT00021541|565570602|FG000|Period 2-crossover|Adverse Event|2|||
156679365|NCT00021541|565570603|FG001|Period 2-crossover|Adverse Event|2|||
156679366|NCT00021541|565570602|FG000|Period 2-crossover|non-adherence|1|||
156679367|NCT00021541|565570603|FG001|Period 2-crossover|non-adherence|0|||
156679368|NCT00021541|565570602|FG000|Period 2-crossover|Pts that did not progress|2|||
156679369|NCT00021541|565570603|FG001|Period 2-crossover|Pts that did not progress|3|||
156679370|NCT01874535|565570604|FG000|Overall Study|Lost to Follow-up|10|||
156679371|NCT01874535|565570605|FG001|Overall Study|Lost to Follow-up|9|||
156679372|NCT01874535|565570604|FG000|Overall Study|incomplete symptom resolution|45|||
156679373|NCT01874535|565570605|FG001|Overall Study|incomplete symptom resolution|35|||
156679374|NCT05263505|565570606|FG000|Overall Study|Adverse Event|0|||
156679375|NCT05263505|565570607|FG001|Overall Study|Adverse Event|1|||
156679376|NCT02616380|565570608|FG000|Overall Study|Lost to Follow-up|1|||
156679377|NCT02616380|565570608|FG000|Overall Study|Other|2|||
156679378|NCT02119936|565570609|FG000|Overall Study|Lost to Follow-up|10|||
156679379|NCT01929681|565570610|FG000|Overall Study|Withdrawal by Subject|1|||
156679380|NCT01929681|565570611|FG001|Overall Study|Withdrawal by Subject|0|||
156679381|NCT01929681|565570610|FG000|Overall Study|Physician Decision|1|||
156679382|NCT01929681|565570611|FG001|Overall Study|Physician Decision|1|||
156679383|NCT05315713|565570612|FG000|Overall Study|Death|5|||
156679384|NCT05315713|565570612|FG000|Overall Study|Progressive disease|1|||
156679385|NCT05315713|565570612|FG000|Overall Study|Withdrawal by Subject|1|||
156679386|NCT05315713|565570612|FG000|Overall Study|Study terminated by sponsor|1|||
156679387|NCT00556673|565570614|FG000|Overall Study|Protocol deviation|3|||
156679388|NCT00556673|565570615|FG001|Overall Study|Protocol deviation|2|||
156679389|NCT01971554|565570616|FG000|Overall Study|Lost to Follow-up|1|||
156782505|NCT05942040|565952795|FG000|Overall Study|No longer employed at study site.|0|||
156782506|NCT05942040|565952796|FG001|Overall Study|No longer employed at study site.|0|||
156782507|NCT05942040|565952797|FG002|Overall Study|No longer employed at study site.|3|||
156782508|NCT06061952|565952798|FG000|Overall Study|Withdrawal by Subject|1|||
156782509|NCT06061952|565952799|FG001|Overall Study|Withdrawal by Subject|2|||
156782510|NCT06061952|565952798|FG000|Overall Study|Lost to Follow-up|2|||
156782511|NCT06061952|565952799|FG001|Overall Study|Lost to Follow-up|2|||
156782512|NCT06142383|565952800|FG000|Overall Study|Mis-randomized|0|||
156782513|NCT06142383|565952801|FG001|Overall Study|Mis-randomized|0|||
156679390|NCT01971554|565570617|FG001|Overall Study|Lost to Follow-up|0|||
156679391|NCT01971554|565570618|FG002|Overall Study|Lost to Follow-up|0|||
156679392|NCT01971554|565570619|FG003|Overall Study|Lost to Follow-up|0|||
156679393|NCT04194151|565570620|FG000|Overall Study|Physician Decision|1|||
156679394|NCT04194151|565570621|FG001|Overall Study|Physician Decision|1|||
156679395|NCT04194151|565570622|FG002|Overall Study|Physician Decision|1|||
156679396|NCT04194151|565570623|FG003|Overall Study|Physician Decision|1|||
156679397|NCT04194151|565570624|FG004|Overall Study|Physician Decision|0|||
156679398|NCT04194151|565570625|FG005|Overall Study|Physician Decision|1|||
156679399|NCT04194151|565570620|FG000|Overall Study|Monitorization problem|0|||
156679400|NCT04194151|565570621|FG001|Overall Study|Monitorization problem|1|||
156679401|NCT04194151|565570622|FG002|Overall Study|Monitorization problem|0|||
156679402|NCT04194151|565570623|FG003|Overall Study|Monitorization problem|0|||
156679403|NCT04194151|565570624|FG004|Overall Study|Monitorization problem|0|||
156679404|NCT04194151|565570625|FG005|Overall Study|Monitorization problem|0|||
156679405|NCT00421304|565570626|FG000|Overall Study|Lost to Follow-up|5|||
156679406|NCT00421304|565570627|FG001|Overall Study|Lost to Follow-up|2|||
156679407|NCT00421304|565570628|FG002|Overall Study|Lost to Follow-up|5|||
156679408|NCT00421304|565570626|FG000|Overall Study|Withdrawal by Subject|2|||
156679409|NCT00421304|565570627|FG001|Overall Study|Withdrawal by Subject|2|||
156782514|NCT06142383|565952802|FG002|Overall Study|Mis-randomized|1|||
156782515|NCT06142383|565952803|FG003|Overall Study|Mis-randomized|0|||
156782516|NCT06142383|565952804|FG004|Overall Study|Mis-randomized|0|||
156679410|NCT00421304|565570628|FG002|Overall Study|Withdrawal by Subject|2|||
156679411|NCT00421304|565570626|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
156679412|NCT00421304|565570627|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
156679413|NCT00421304|565570628|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
156679414|NCT00421304|565570626|FG000|Overall Study|Did not attend Day 360 visit|0|||
156679415|NCT00421304|565570627|FG001|Overall Study|Did not attend Day 360 visit|0|||
156679416|NCT00421304|565570628|FG002|Overall Study|Did not attend Day 360 visit|1|||
156679417|NCT01912807|565570629|FG000|Overall Study|Did not meet elegibility criteria|6|||
156679418|NCT01912807|565570630|FG001|Overall Study|Did not meet elegibility criteria|4|||
156679419|NCT01912807|565570629|FG000|Overall Study|Lost to Follow-up|36|||
156679420|NCT01912807|565570630|FG001|Overall Study|Lost to Follow-up|37|||
156679421|NCT04750239|565570631|FG000|Overall Study|Withdrawal by Subject|2|||
156679422|NCT04750239|565570631|FG000|Overall Study|Trial terminated by sponsor|1|||
156679423|NCT00919711|565570632|FG000|Overall Study|Withdrawal by Subject|15|||
156679424|NCT00919711|565570633|FG001|Overall Study|Withdrawal by Subject|7|||
156679425|NCT00919711|565570632|FG000|Overall Study|Adverse Event|13|||
156679426|NCT00919711|565570633|FG001|Overall Study|Adverse Event|3|||
156679427|NCT00919711|565570632|FG000|Overall Study|Other|1|||
156679428|NCT00919711|565570633|FG001|Overall Study|Other|2|||
156679429|NCT00919711|565570632|FG000|Overall Study|Administrative Decision|0|||
156679430|NCT00919711|565570633|FG001|Overall Study|Administrative Decision|1|||
156679431|NCT00919711|565570632|FG000|Overall Study|Lost to Follow-up|2|||
156679432|NCT00919711|565570633|FG001|Overall Study|Lost to Follow-up|0|||
156679433|NCT00919711|565570632|FG000|Overall Study|Death|1|||
156679434|NCT00919711|565570633|FG001|Overall Study|Death|0|||
156679435|NCT00919711|565570632|FG000|Overall Study|Noncompliance|1|||
156679436|NCT00919711|565570633|FG001|Overall Study|Noncompliance|0|||
156679437|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Adverse Event|8|||
156679438|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Adverse Event|5|||
156679439|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Adverse Event|9|||
156679440|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Adverse Event|0|||
156679441|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Adverse Event|0|||
156679442|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Adverse Event|0|||
156679443|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
156679444|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
156782517|NCT06142383|565952800|FG000|Overall Study|Adverse Event|0|||
156782518|NCT06142383|565952801|FG001|Overall Study|Adverse Event|1|||
156782519|NCT06142383|565952802|FG002|Overall Study|Adverse Event|1|||
156782520|NCT06142383|565952803|FG003|Overall Study|Adverse Event|0|||
156782521|NCT06142383|565952804|FG004|Overall Study|Adverse Event|0|||
156782522|NCT06142383|565952800|FG000|Overall Study|Death|0|||
156782523|NCT06142383|565952801|FG001|Overall Study|Death|1|||
156782524|NCT06142383|565952802|FG002|Overall Study|Death|3|||
156782525|NCT06142383|565952803|FG003|Overall Study|Death|0|||
156782526|NCT06142383|565952804|FG004|Overall Study|Death|1|||
156782527|NCT06142383|565952800|FG000|Overall Study|Study Terminated by Sponsor|20|||
156782528|NCT06142383|565952801|FG001|Overall Study|Study Terminated by Sponsor|17|||
156782529|NCT06142383|565952802|FG002|Overall Study|Study Terminated by Sponsor|33|||
156782530|NCT06142383|565952803|FG003|Overall Study|Study Terminated by Sponsor|0|||
156782531|NCT06142383|565952804|FG004|Overall Study|Study Terminated by Sponsor|21|||
156782532|NCT06142383|565952800|FG000|Overall Study|Subject Decision|0|||
156782533|NCT06142383|565952801|FG001|Overall Study|Subject Decision|1|||
156782534|NCT06142383|565952802|FG002|Overall Study|Subject Decision|2|||
156782535|NCT06142383|565952803|FG003|Overall Study|Subject Decision|0|||
156782536|NCT06142383|565952804|FG004|Overall Study|Subject Decision|0|||
156782537|NCT01685437|565952809|FG000|Overall Study|Withdrawal by Subject|22|||
156782538|NCT01685437|565952809|FG000|Overall Study|Lost to Follow-up|3|||
156782539|NCT01685437|565952809|FG000|Overall Study|Adverse Event|1|||
156782540|NCT01685437|565952809|FG000|Overall Study|Protocol Violation|4|||
156782541|NCT01685437|565952809|FG000|Overall Study|Unable to make visits due to work|1|||
156782542|NCT03770455|565952816|FG000|Overall Study|Screen failures|3|||
156782543|NCT01121575|565952817|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
156782544|NCT01121575|565952818|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
156782545|NCT01121575|565952819|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
156782546|NCT01121575|565952820|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
156782547|NCT01121575|565952821|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
156782548|NCT01121575|565952822|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
156782549|NCT01121575|565952817|FG000|Overall Study|Unspecified Reasons|8|||
156782550|NCT01121575|565952818|FG001|Overall Study|Unspecified Reasons|6|||
156782551|NCT01121575|565952819|FG002|Overall Study|Unspecified Reasons|7|||
156782552|NCT01121575|565952820|FG003|Overall Study|Unspecified Reasons|5|||
156782553|NCT01121575|565952821|FG004|Overall Study|Unspecified Reasons|13|||
156782554|NCT01121575|565952822|FG005|Overall Study|Unspecified Reasons|10|||
156782555|NCT01121575|565952817|FG000|Overall Study|Death|6|||
156782556|NCT01121575|565952818|FG001|Overall Study|Death|0|||
156866897|NCT01193244|566273399|FG000|Overall Study|Withdrawal by Subject|79|||
156866898|NCT01193244|566273400|FG001|Overall Study|Withdrawal by Subject|97|||
156866899|NCT01193244|566273399|FG000|Overall Study|Other|303|||
156866900|NCT01193244|566273400|FG001|Overall Study|Other|278|||
156866901|NCT01193244|566273399|FG000|Overall Study|Lost to Follow-up|6|||
156866902|NCT01193244|566273400|FG001|Overall Study|Lost to Follow-up|15|||
156866903|NCT01936870|566273401|FG000|Overall Study|No Visit After Treatment|176|||
156866904|NCT01936870|566273401|FG000|Overall Study|Protocol Violation|12|||
156866905|NCT01936870|566273401|FG000|Overall Study|No Drug Administration|1|||
156866906|NCT00248040|566273406|FG000|Overall Study|transplantectomy|2|||
156866907|NCT00248040|566273407|FG001|Overall Study|transplantectomy|1|||
156866908|NCT00248040|566273408|FG002|Overall Study|transplantectomy|3|||
156866909|NCT00248040|566273406|FG000|Overall Study|transplant cancelled post treat start|1|||
156866910|NCT00248040|566273407|FG001|Overall Study|transplant cancelled post treat start|0|||
156866911|NCT00248040|566273408|FG002|Overall Study|transplant cancelled post treat start|0|||
156866912|NCT00248040|566273406|FG000|Overall Study|Death|0|||
156866913|NCT00248040|566273407|FG001|Overall Study|Death|0|||
156866914|NCT00248040|566273408|FG002|Overall Study|Death|1|||
156866915|NCT00628108|566273416|FG000|Overall Study|Adverse Event|0|||
156866916|NCT00628108|566273417|FG001|Overall Study|Adverse Event|3|||
156866917|NCT00628108|566273416|FG000|Overall Study|Withdrawal by Subject|1|||
156866918|NCT00628108|566273417|FG001|Overall Study|Withdrawal by Subject|0|||
156866919|NCT03848832|566273418|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
156866920|NCT03848832|566273419|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
156866921|NCT03848832|566273420|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
156866922|NCT03848832|566273418|FG000|Overall Study|Withdrawal by Subject|0|||
156866923|NCT03848832|566273419|FG001|Overall Study|Withdrawal by Subject|0|||
156782557|NCT01121575|565952819|FG002|Overall Study|Death|0|||
156782558|NCT01121575|565952820|FG003|Overall Study|Death|1|||
156782559|NCT01121575|565952821|FG004|Overall Study|Death|7|||
156782560|NCT01121575|565952822|FG005|Overall Study|Death|1|||
156866924|NCT03848832|566273420|FG002|Overall Study|Withdrawal by Subject|1|||
157012388|NCT01205048|566797458|FG000|Overall Study|Lost to Follow-up|4|||
157012389|NCT01205048|566797458|FG000|Overall Study|Other|2|||
157012390|NCT01255670|566797459|FG000|Overall Study|Adverse Event|10|||
156782561|NCT03860584|565952833|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
156782562|NCT03860584|565952834|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
156782563|NCT03860584|565952833|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156782564|NCT03860584|565952834|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
156782565|NCT03860584|565952833|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
156782566|NCT03860584|565952834|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
156782567|NCT03860584|565952833|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
156782568|NCT03860584|565952834|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
156782569|NCT03971422|565954726|FG000|Overall Study|Lost to Follow-up|0|||
156782570|NCT03971422|565954727|FG001|Overall Study|Lost to Follow-up|1|||
156782571|NCT03971422|565954728|FG002|Overall Study|Lost to Follow-up|0|||
156782572|NCT03971422|565954726|FG000|Overall Study|Lack of Efficacy|5|||
156782573|NCT03971422|565954727|FG001|Overall Study|Lack of Efficacy|1|||
156782574|NCT03971422|565954728|FG002|Overall Study|Lack of Efficacy|1|||
156782575|NCT03971422|565954726|FG000|Overall Study|Adverse event, not fatal|2|||
156782576|NCT03971422|565954727|FG001|Overall Study|Adverse event, not fatal|2|||
156782577|NCT03971422|565954728|FG002|Overall Study|Adverse event, not fatal|5|||
156782578|NCT03971422|565954726|FG000|Overall Study|Worsening of MG Symptoms|1|||
156782579|NCT03971422|565954727|FG001|Overall Study|Worsening of MG Symptoms|4|||
156782580|NCT03971422|565954728|FG002|Overall Study|Worsening of MG Symptoms|2|||
156782581|NCT03971422|565954726|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
156782582|NCT03971422|565954727|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
156782583|NCT03971422|565954728|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
156782584|NCT03971422|565954726|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
156782585|NCT03971422|565954727|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
156866925|NCT03848832|566273418|FG000|Overall Study|Withdrawal (Covid-19)|0|||
157012391|NCT01255670|566797460|FG001|Overall Study|Adverse Event|10|||
157012392|NCT01255670|566797459|FG000|Overall Study|Lost to Follow-up|16|||
157012393|NCT01255670|566797460|FG001|Overall Study|Lost to Follow-up|10|||
157012394|NCT00823472|566797461|FG000|Overall Study|Physician Decision|24|||
156782586|NCT03971422|565954728|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
156782587|NCT03971422|565954726|FG000|Overall Study|Due to COVID-19 pandemic|0|||
156782588|NCT03971422|565954727|FG001|Overall Study|Due to COVID-19 pandemic|1|||
156782589|NCT03971422|565954728|FG002|Overall Study|Due to COVID-19 pandemic|1|||
156782590|NCT01658878|565954729|FG000|Treatment Period|Disease Progression|1|||
156866926|NCT03848832|566273419|FG001|Overall Study|Withdrawal (Covid-19)|2|||
156866927|NCT03848832|566273420|FG002|Overall Study|Withdrawal (Covid-19)|0|||
156866928|NCT03848832|566273418|FG000|Overall Study|Physician Decision|2|||
156866929|NCT03848832|566273419|FG001|Overall Study|Physician Decision|1|||
156866930|NCT03848832|566273420|FG002|Overall Study|Physician Decision|3|||
156866931|NCT03848832|566273418|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
157213207|NCT00272961|567527777|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
157213208|NCT00272961|567527778|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
157213209|NCT00272961|567527779|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
157213210|NCT00272961|567527780|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
157213211|NCT00272961|567527776|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
157213212|NCT00272961|567527777|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
157213213|NCT00272961|567527778|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
157213214|NCT00272961|567527779|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
157213215|NCT00272961|567527780|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
157213216|NCT00272961|567527776|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
157213217|NCT00272961|567527777|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
157213218|NCT00272961|567527778|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
157213219|NCT00272961|567527779|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
157213220|NCT00272961|567527780|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
156679445|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
156679446|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679447|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679448|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
156679449|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
156679450|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
156679451|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
156679452|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679453|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679454|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
156679455|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Physician Decision|4|||
156679456|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Physician Decision|0|||
156679457|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Physician Decision|2|||
156679458|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Physician Decision|0|||
156679459|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Physician Decision|0|||
156679460|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Physician Decision|0|||
156679461|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Pregnancy|1|||
156679462|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Pregnancy|2|||
156679463|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Pregnancy|0|||
156679464|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Pregnancy|0|||
156679465|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Pregnancy|0|||
156679466|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Pregnancy|0|||
156679467|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
156679468|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
156679469|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
156679470|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
156679471|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
156679472|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
156679473|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
156679474|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679475|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679476|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679477|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679478|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
156679479|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
156679480|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
156679481|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
156679482|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
156679483|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156679484|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156679485|NCT02614196|565570634|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
156679486|NCT02614196|565570635|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
156679487|NCT02614196|565570636|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
156679488|NCT02614196|565570637|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
156679489|NCT02614196|565570638|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
156679490|NCT02614196|565570639|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
156679491|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
156679492|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
156679493|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
156679494|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
156679495|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
157012395|NCT00823472|566797462|FG001|Overall Study|Physician Decision|28|||
156679496|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
157213221|NCT00272961|567527776|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
156866932|NCT03848832|566273419|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
156866933|NCT03848832|566273420|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
156866934|NCT03848832|566273418|FG000|Overall Study|Adverse Event|1|||
156866935|NCT03848832|566273419|FG001|Overall Study|Adverse Event|0|||
156866936|NCT03848832|566273420|FG002|Overall Study|Adverse Event|0|||
156866937|NCT00711191|566273428|FG000|Overall Study|Adverse Event|1|||
156866938|NCT00711191|566273429|FG001|Overall Study|Adverse Event|1|||
156866939|NCT00711191|566273430|FG002|Overall Study|Adverse Event|2|||
156866940|NCT00711191|566273428|FG000|Overall Study|Objective progression or relapse|2|||
156866941|NCT00711191|566273429|FG001|Overall Study|Objective progression or relapse|3|||
156866942|NCT00711191|566273430|FG002|Overall Study|Objective progression or relapse|7|||
156866943|NCT00711191|566273428|FG000|Overall Study|Withdrawal by Subject|0|||
156866944|NCT00711191|566273429|FG001|Overall Study|Withdrawal by Subject|1|||
156866945|NCT00711191|566273430|FG002|Overall Study|Withdrawal by Subject|3|||
156866946|NCT00084136|566273431|FG000|PI Comparison|Death|10|||
156866947|NCT00084136|566273432|FG001|PI Comparison|Death|9|||
156866948|NCT00084136|566273433|FG002|PI Comparison|Death|0|||
156866949|NCT00084136|566273431|FG000|PI Comparison|Lost to Follow-up|11|||
156782591|NCT01658878|565954730|FG001|Treatment Period|Disease Progression|3|||
156782592|NCT01658878|565954731|FG002|Treatment Period|Disease Progression|2|||
156782593|NCT01658878|565954732|FG003|Treatment Period|Disease Progression|1|||
156782594|NCT01658878|565954733|FG004|Treatment Period|Disease Progression|13|||
156782595|NCT01658878|565954734|FG005|Treatment Period|Disease Progression|3|||
156782596|NCT01658878|565954735|FG006|Treatment Period|Disease Progression|4|||
156782597|NCT01658878|565954736|FG007|Treatment Period|Disease Progression|3|||
156782598|NCT01658878|565954737|FG008|Treatment Period|Disease Progression|5|||
156782599|NCT01658878|565954738|FG009|Treatment Period|Disease Progression|3|||
156782600|NCT01658878|565954739|FG010|Treatment Period|Disease Progression|3|||
156782601|NCT01658878|565954740|FG011|Treatment Period|Disease Progression|4|||
156782602|NCT01658878|565954741|FG012|Treatment Period|Disease Progression|43|||
156782603|NCT01658878|565954742|FG013|Treatment Period|Disease Progression|48|||
156782604|NCT01658878|565954743|FG014|Treatment Period|Disease Progression|33|||
156782605|NCT01658878|565954744|FG015|Treatment Period|Disease Progression|46|||
156782606|NCT01658878|565954745|FG016|Treatment Period|Disease Progression|41|||
156782607|NCT01658878|565954746|FG017|Treatment Period|Disease Progression|42|||
156782608|NCT01658878|565954747|FG018|Treatment Period|Disease Progression|28|||
156782609|NCT01658878|565954748|FG019|Treatment Period|Disease Progression|37|||
156782610|NCT01658878|565954749|FG020|Treatment Period|Disease Progression|37|||
156782611|NCT01658878|565954750|FG021|Treatment Period|Disease Progression|39|||
156782612|NCT01658878|565954751|FG022|Treatment Period|Disease Progression|27|||
156782613|NCT01658878|565954752|FG023|Treatment Period|Disease Progression|19|||
156782614|NCT01658878|565954729|FG000|Treatment Period|Study Drug Toxicity|0|||
156782615|NCT01658878|565954730|FG001|Treatment Period|Study Drug Toxicity|0|||
156782616|NCT01658878|565954731|FG002|Treatment Period|Study Drug Toxicity|0|||
156782617|NCT01658878|565954732|FG003|Treatment Period|Study Drug Toxicity|1|||
156782618|NCT01658878|565954733|FG004|Treatment Period|Study Drug Toxicity|0|||
156782619|NCT01658878|565954734|FG005|Treatment Period|Study Drug Toxicity|0|||
156782620|NCT01658878|565954735|FG006|Treatment Period|Study Drug Toxicity|0|||
156782621|NCT01658878|565954736|FG007|Treatment Period|Study Drug Toxicity|0|||
156782622|NCT01658878|565954737|FG008|Treatment Period|Study Drug Toxicity|0|||
156782623|NCT01658878|565954738|FG009|Treatment Period|Study Drug Toxicity|0|||
156782624|NCT01658878|565954739|FG010|Treatment Period|Study Drug Toxicity|0|||
156782625|NCT01658878|565954740|FG011|Treatment Period|Study Drug Toxicity|0|||
156782626|NCT01658878|565954741|FG012|Treatment Period|Study Drug Toxicity|7|||
156782627|NCT01658878|565954742|FG013|Treatment Period|Study Drug Toxicity|1|||
156782628|NCT01658878|565954743|FG014|Treatment Period|Study Drug Toxicity|5|||
156782629|NCT01658878|565954744|FG015|Treatment Period|Study Drug Toxicity|0|||
156782630|NCT01658878|565954745|FG016|Treatment Period|Study Drug Toxicity|5|||
156782631|NCT01658878|565954746|FG017|Treatment Period|Study Drug Toxicity|10|||
156866950|NCT00084136|566273432|FG001|PI Comparison|Lost to Follow-up|8|||
156782632|NCT01658878|565954747|FG018|Treatment Period|Study Drug Toxicity|12|||
156782633|NCT01658878|565954748|FG019|Treatment Period|Study Drug Toxicity|4|||
156782634|NCT01658878|565954749|FG020|Treatment Period|Study Drug Toxicity|2|||
156866951|NCT00084136|566273433|FG002|PI Comparison|Lost to Follow-up|0|||
157012396|NCT02769858|566797472|FG000|Overall Study|Withdrawal by Subject|2|||
156782635|NCT01658878|565954750|FG021|Treatment Period|Study Drug Toxicity|3|||
156782636|NCT01658878|565954751|FG022|Treatment Period|Study Drug Toxicity|2|||
156782637|NCT01658878|565954752|FG023|Treatment Period|Study Drug Toxicity|6|||
156782638|NCT01658878|565954729|FG000|Treatment Period|Maximum Clinical Benefit|0|||
156782639|NCT01658878|565954730|FG001|Treatment Period|Maximum Clinical Benefit|0|||
156782640|NCT01658878|565954731|FG002|Treatment Period|Maximum Clinical Benefit|1|||
156866952|NCT00084136|566273431|FG000|PI Comparison|Withdrawal by Subject|33|||
156866953|NCT00084136|566273432|FG001|PI Comparison|Withdrawal by Subject|30|||
156866954|NCT00084136|566273433|FG002|PI Comparison|Withdrawal by Subject|0|||
156866955|NCT00084136|566273431|FG000|PI Comparison|Clinic site closed|1|||
156866956|NCT00084136|566273432|FG001|PI Comparison|Clinic site closed|0|||
156679497|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
156679498|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
156679499|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
156679500|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
156679501|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
156679502|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
156679503|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679504|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
156679505|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679506|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679507|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
156679508|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
156679509|NCT02614196|565570634|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
156679510|NCT02614196|565570635|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
156679511|NCT02614196|565570636|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
156782641|NCT01658878|565954732|FG003|Treatment Period|Maximum Clinical Benefit|0|||
156782642|NCT01658878|565954733|FG004|Treatment Period|Maximum Clinical Benefit|0|||
156782643|NCT01658878|565954734|FG005|Treatment Period|Maximum Clinical Benefit|0|||
156782644|NCT01658878|565954735|FG006|Treatment Period|Maximum Clinical Benefit|0|||
156782645|NCT01658878|565954736|FG007|Treatment Period|Maximum Clinical Benefit|0|||
156782646|NCT01658878|565954737|FG008|Treatment Period|Maximum Clinical Benefit|0|||
156782647|NCT01658878|565954738|FG009|Treatment Period|Maximum Clinical Benefit|0|||
156782648|NCT01658878|565954739|FG010|Treatment Period|Maximum Clinical Benefit|0|||
156782649|NCT01658878|565954740|FG011|Treatment Period|Maximum Clinical Benefit|0|||
156782650|NCT01658878|565954741|FG012|Treatment Period|Maximum Clinical Benefit|0|||
156782651|NCT01658878|565954742|FG013|Treatment Period|Maximum Clinical Benefit|0|||
156782652|NCT01658878|565954743|FG014|Treatment Period|Maximum Clinical Benefit|0|||
156782653|NCT01658878|565954744|FG015|Treatment Period|Maximum Clinical Benefit|0|||
156782654|NCT01658878|565954745|FG016|Treatment Period|Maximum Clinical Benefit|0|||
156782655|NCT01658878|565954746|FG017|Treatment Period|Maximum Clinical Benefit|0|||
156782656|NCT01658878|565954747|FG018|Treatment Period|Maximum Clinical Benefit|1|||
156782657|NCT01658878|565954748|FG019|Treatment Period|Maximum Clinical Benefit|1|||
156782658|NCT01658878|565954749|FG020|Treatment Period|Maximum Clinical Benefit|0|||
156782659|NCT01658878|565954750|FG021|Treatment Period|Maximum Clinical Benefit|0|||
156782660|NCT01658878|565954751|FG022|Treatment Period|Maximum Clinical Benefit|0|||
156782661|NCT01658878|565954752|FG023|Treatment Period|Maximum Clinical Benefit|0|||
156782662|NCT01658878|565954729|FG000|Treatment Period|Other Reasons|0|||
156782663|NCT01658878|565954730|FG001|Treatment Period|Other Reasons|0|||
156782664|NCT01658878|565954731|FG002|Treatment Period|Other Reasons|0|||
156782665|NCT01658878|565954732|FG003|Treatment Period|Other Reasons|1|||
156782666|NCT01658878|565954733|FG004|Treatment Period|Other Reasons|0|||
156782667|NCT01658878|565954734|FG005|Treatment Period|Other Reasons|0|||
156782668|NCT01658878|565954735|FG006|Treatment Period|Other Reasons|0|||
156782669|NCT01658878|565954736|FG007|Treatment Period|Other Reasons|0|||
156782670|NCT01658878|565954737|FG008|Treatment Period|Other Reasons|0|||
156782671|NCT01658878|565954738|FG009|Treatment Period|Other Reasons|0|||
156782672|NCT01658878|565954739|FG010|Treatment Period|Other Reasons|0|||
156782673|NCT01658878|565954740|FG011|Treatment Period|Other Reasons|0|||
156782674|NCT01658878|565954741|FG012|Treatment Period|Other Reasons|2|||
156782675|NCT01658878|565954742|FG013|Treatment Period|Other Reasons|0|||
156782676|NCT01658878|565954743|FG014|Treatment Period|Other Reasons|0|||
156782677|NCT01658878|565954744|FG015|Treatment Period|Other Reasons|2|||
156782678|NCT01658878|565954745|FG016|Treatment Period|Other Reasons|1|||
156782679|NCT01658878|565954746|FG017|Treatment Period|Other Reasons|1|||
156782680|NCT01658878|565954747|FG018|Treatment Period|Other Reasons|3|||
156782681|NCT01658878|565954748|FG019|Treatment Period|Other Reasons|1|||
156782682|NCT01658878|565954749|FG020|Treatment Period|Other Reasons|4|||
156782683|NCT01658878|565954750|FG021|Treatment Period|Other Reasons|0|||
156782684|NCT01658878|565954751|FG022|Treatment Period|Other Reasons|0|||
156782685|NCT01658878|565954752|FG023|Treatment Period|Other Reasons|4|||
156782686|NCT01658878|565954729|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866957|NCT00084136|566273433|FG002|PI Comparison|Clinic site closed|0|||
156782687|NCT01658878|565954730|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866958|NCT00084136|566273431|FG000|NRTI Comparison|Death|20|||
156679512|NCT02614196|565570637|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
156782688|NCT01658878|565954731|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782689|NCT01658878|565954732|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782690|NCT01658878|565954733|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782691|NCT01658878|565954734|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782692|NCT01658878|565954735|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782693|NCT01658878|565954736|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782694|NCT01658878|565954737|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782695|NCT01658878|565954738|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866959|NCT00084136|566273432|FG001|NRTI Comparison|Death|0|||
156679513|NCT02614196|565570638|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
156679514|NCT02614196|565570639|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
156679515|NCT00903877|565570640|FG000|Overall Study|Did not meet study criteria|33|||
156679516|NCT00903877|565570640|FG000|Overall Study|Withdrawal by Subject|3|||
156679517|NCT00903877|565570640|FG000|Overall Study|Adverse Event|2|||
156679518|NCT00903877|565570640|FG000|Overall Study|Lost to Follow-up|1|||
156679519|NCT00903877|565570640|FG000|Overall Study|Participation put on hold|4|||
156679520|NCT00087529|565570642|FG000|Overall Study|Death|1|||
156679521|NCT00087529|565570643|FG001|Overall Study|Death|0|||
156679522|NCT00087529|565570642|FG000|Overall Study|Adverse Event|0|||
156679523|NCT00087529|565570643|FG001|Overall Study|Adverse Event|8|||
156679524|NCT00087529|565570642|FG000|Overall Study|Pregnancy|0|||
156679525|NCT00087529|565570643|FG001|Overall Study|Pregnancy|1|||
156679526|NCT00087529|565570642|FG000|Overall Study|Lost to Follow-up|2|||
156679527|NCT00087529|565570643|FG001|Overall Study|Lost to Follow-up|3|||
156679528|NCT00087529|565570642|FG000|Overall Study|Participant Decision|14|||
156679529|NCT00087529|565570643|FG001|Overall Study|Participant Decision|37|||
156679530|NCT00087529|565570642|FG000|Overall Study|Physician Decision|4|||
156679531|NCT00087529|565570643|FG001|Overall Study|Physician Decision|8|||
156679532|NCT00087529|565570642|FG000|Overall Study|Initiation of Excluded Therapy|0|||
156679533|NCT00087529|565570643|FG001|Overall Study|Initiation of Excluded Therapy|1|||
156679534|NCT00087529|565570642|FG000|Overall Study|Participant Noncompliance|0|||
156679535|NCT00087529|565570643|FG001|Overall Study|Participant Noncompliance|1|||
156679536|NCT00087529|565570642|FG000|Overall Study|Disease Progression|5|||
156679537|NCT00087529|565570643|FG001|Overall Study|Disease Progression|4|||
156679538|NCT00087529|565570642|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
156679539|NCT00087529|565570643|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
156679540|NCT02535923|565570644|FG000|Overall Study|Lost to Follow-up|5|||
156679541|NCT02535923|565570645|FG001|Overall Study|Lost to Follow-up|5|||
156679542|NCT02535923|565570644|FG000|Overall Study|Withdrawal by Subject|4|||
156679543|NCT02535923|565570645|FG001|Overall Study|Withdrawal by Subject|3|||
156679544|NCT01562613|565570646|FG000|Overall Study|Lost to Follow-up|2|||
156679545|NCT01562613|565570646|FG000|Overall Study|Withdrawal by Subject|2|||
156679546|NCT04388787|565570649|FG000|Blinded Period|Patient could not follow instructions|1|||
156679547|NCT04388787|565570649|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
156679548|NCT00663234|565570650|FG000|Overall Study|Not willing to adhere to requirements|1|||
156679549|NCT01253564|565570653|FG000|Overall Study|Disease Progression|22|||
156679550|NCT01253564|565570653|FG000|Overall Study|Withdrawal by Subject|1|||
156679551|NCT01253564|565570653|FG000|Overall Study|Serious Adverse Event|1|||
156679552|NCT03694197|565570656|FG000|Overall Study|Adverse Event|9|||
156679553|NCT03694197|565570656|FG000|Overall Study|Protocol became inconvenient to participate|1|||
156679554|NCT03694197|565570656|FG000|Overall Study|Physician Decision|4|||
156679555|NCT03694197|565570656|FG000|Overall Study|Study terminated by sponsor|1350|||
156679556|NCT03694197|565570656|FG000|Overall Study|Participant moved|5|||
156679557|NCT03694197|565570656|FG000|Overall Study|Participant withdrew consent|10|||
156679558|NCT03694197|565570656|FG000|Overall Study|Related to IMP administration|1|||
156679559|NCT03694197|565570656|FG000|Overall Study|Not disclosed|5|||
156679560|NCT02940522|565572286|FG000|Overall Study|Lost to Follow-up|1|||
156679561|NCT02940522|565572287|FG001|Overall Study|Lost to Follow-up|2|||
156679562|NCT02940522|565572286|FG000|Overall Study|Withdrawal by Subject|1|||
156679563|NCT02940522|565572287|FG001|Overall Study|Withdrawal by Subject|0|||
156679564|NCT05135273|565572288|FG000|Overall Study|Recruited into the army|0|||
156679565|NCT05135273|565572289|FG001|Overall Study|Recruited into the army|0|||
156679566|NCT05135273|565572290|FG002|Overall Study|Recruited into the army|0|||
156679567|NCT05135273|565572291|FG003|Overall Study|Recruited into the army|0|||
156679568|NCT05135273|565572292|FG004|Overall Study|Recruited into the army|1|||
156679569|NCT05135273|565572293|FG005|Overall Study|Recruited into the army|0|||
156679570|NCT05135273|565572294|FG006|Overall Study|Recruited into the army|0|||
156679571|NCT05135273|565572295|FG007|Overall Study|Recruited into the army|0|||
156679572|NCT05135273|565572288|FG000|Overall Study|Moved away from study site|0|||
156679573|NCT05135273|565572289|FG001|Overall Study|Moved away from study site|0|||
156782696|NCT01658878|565954739|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782697|NCT01658878|565954740|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782698|NCT01658878|565954741|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782699|NCT01658878|565954742|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782700|NCT01658878|565954743|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156782701|NCT01658878|565954744|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782702|NCT01658878|565954745|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866960|NCT00084136|566273433|FG002|NRTI Comparison|Death|18|||
156679574|NCT05135273|565572290|FG002|Overall Study|Moved away from study site|0|||
156679575|NCT05135273|565572291|FG003|Overall Study|Moved away from study site|0|||
156679576|NCT05135273|565572292|FG004|Overall Study|Moved away from study site|0|||
156679577|NCT05135273|565572293|FG005|Overall Study|Moved away from study site|1|||
156679578|NCT05135273|565572294|FG006|Overall Study|Moved away from study site|1|||
156679579|NCT05135273|565572295|FG007|Overall Study|Moved away from study site|0|||
156679580|NCT05135273|565572288|FG000|Overall Study|Travel|0|||
156679581|NCT05135273|565572289|FG001|Overall Study|Travel|0|||
156866961|NCT00084136|566273431|FG000|NRTI Comparison|Lost to Follow-up|14|||
156679582|NCT05135273|565572290|FG002|Overall Study|Travel|0|||
156679583|NCT05135273|565572291|FG003|Overall Study|Travel|0|||
156679584|NCT05135273|565572292|FG004|Overall Study|Travel|0|||
156679585|NCT05135273|565572293|FG005|Overall Study|Travel|0|||
156679586|NCT05135273|565572294|FG006|Overall Study|Travel|0|||
156679587|NCT05135273|565572295|FG007|Overall Study|Travel|1|||
156679588|NCT01680016|565572296|FG000|Overall Study|Adverse Event|0|||
156679589|NCT01680016|565572297|FG001|Overall Study|Adverse Event|0|||
156679590|NCT01680016|565572298|FG002|Overall Study|Adverse Event|1|||
156679591|NCT01680016|565572299|FG003|Overall Study|Adverse Event|4|||
156679592|NCT01680016|565572296|FG000|Overall Study|The Subject went out of The Trial|1|||
156679593|NCT01680016|565572297|FG001|Overall Study|The Subject went out of The Trial|0|||
156679594|NCT01680016|565572298|FG002|Overall Study|The Subject went out of The Trial|3|||
156679595|NCT01680016|565572299|FG003|Overall Study|The Subject went out of The Trial|0|||
156679596|NCT01680016|565572296|FG000|Overall Study|Protocol Violation|0|||
156679597|NCT01680016|565572297|FG001|Overall Study|Protocol Violation|1|||
156679598|NCT01680016|565572298|FG002|Overall Study|Protocol Violation|0|||
156679599|NCT01680016|565572299|FG003|Overall Study|Protocol Violation|0|||
156679600|NCT01680016|565572296|FG000|Overall Study|Withdrawal by Subject|5|||
156679601|NCT01680016|565572297|FG001|Overall Study|Withdrawal by Subject|7|||
156679602|NCT01680016|565572298|FG002|Overall Study|Withdrawal by Subject|1|||
156679603|NCT01680016|565572299|FG003|Overall Study|Withdrawal by Subject|1|||
156679604|NCT01958060|565572303|FG000|Overall Study|Not treated|2|||
156679605|NCT01958060|565572304|FG001|Overall Study|Not treated|0|||
156679606|NCT01958060|565572305|FG002|Overall Study|Not treated|0|||
156679607|NCT01958060|565572306|FG003|Overall Study|Not treated|0|||
156679608|NCT01958060|565572307|FG004|Overall Study|Not treated|1|||
156679609|NCT01958060|565572308|FG005|Overall Study|Not treated|0|||
156679610|NCT02846883|565572311|FG000|Overall Study|Death|0|||
156679611|NCT02846883|565572312|FG001|Overall Study|Death|1|||
156679612|NCT02846883|565572313|FG002|Overall Study|Death|1|||
156679613|NCT02846883|565572311|FG000|Overall Study|Lost to Follow-up|0|||
156679614|NCT02846883|565572312|FG001|Overall Study|Lost to Follow-up|0|||
156679615|NCT02846883|565572313|FG002|Overall Study|Lost to Follow-up|1|||
156679616|NCT02846883|565572311|FG000|Overall Study|Withdrawal by Subject|1|||
156679617|NCT02846883|565572312|FG001|Overall Study|Withdrawal by Subject|0|||
156679618|NCT02846883|565572313|FG002|Overall Study|Withdrawal by Subject|0|||
156679619|NCT02846883|565572311|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
156679620|NCT02846883|565572312|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
156679621|NCT02846883|565572313|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
156679622|NCT02846883|565572311|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
156679623|NCT02846883|565572312|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
156679624|NCT02846883|565572313|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
156679625|NCT00108628|565572318|FG000|Overall Study|Withdrawal by Subject|17|||
156679626|NCT00108628|565572319|FG001|Overall Study|Withdrawal by Subject|9|||
156679627|NCT00108628|565572318|FG000|Overall Study|Lack of Efficacy|2|||
156679628|NCT00108628|565572319|FG001|Overall Study|Lack of Efficacy|1|||
156679629|NCT00108628|565572318|FG000|Overall Study|Death|1|||
156679630|NCT00108628|565572319|FG001|Overall Study|Death|0|||
156679631|NCT01350934|565572320|FG000|Base Study|Adverse Event|6|||
156679632|NCT01350934|565572321|FG001|Base Study|Adverse Event|0|||
156679633|NCT01350934|565572320|FG000|Base Study|Lost to Follow-up|1|||
156679634|NCT01350934|565572321|FG001|Base Study|Lost to Follow-up|0|||
156679635|NCT01350934|565572320|FG000|Base Study|Protocol Violation|1|||
156679636|NCT01350934|565572321|FG001|Base Study|Protocol Violation|1|||
156679637|NCT01350934|565572320|FG000|Base Study|Withdrawal by Subject|1|||
156782703|NCT01658878|565954746|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
156782704|NCT01658878|565954747|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782705|NCT01658878|565954748|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782706|NCT01658878|565954749|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782707|NCT01658878|565954750|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782708|NCT01658878|565954751|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156782709|NCT01658878|565954752|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
156866962|NCT00084136|566273432|FG001|NRTI Comparison|Lost to Follow-up|0|||
156866963|NCT00084136|566273433|FG002|NRTI Comparison|Lost to Follow-up|12|||
156679638|NCT01350934|565572321|FG001|Base Study|Withdrawal by Subject|2|||
156679639|NCT01350934|565572320|FG000|Base Study|Non-Compliance With Study Drug|2|||
156679640|NCT01350934|565572321|FG001|Base Study|Non-Compliance With Study Drug|0|||
156679641|NCT01350934|565572320|FG000|Extension Study|Adverse Event|2|||
156679642|NCT01350934|565572321|FG001|Extension Study|Adverse Event|1|||
156679643|NCT01350934|565572320|FG000|Extension Study|Lost to Follow-up|2|||
156679644|NCT01350934|565572321|FG001|Extension Study|Lost to Follow-up|0|||
156679645|NCT01350934|565572320|FG000|Extension Study|Protocol Violation|1|||
156866964|NCT00084136|566273431|FG000|NRTI Comparison|Withdrawal by Subject|54|||
156679646|NCT01350934|565572321|FG001|Extension Study|Protocol Violation|1|||
156679647|NCT01350934|565572320|FG000|Extension Study|Lack of Efficacy|0|||
156679648|NCT01350934|565572321|FG001|Extension Study|Lack of Efficacy|1|||
156679649|NCT01350934|565572320|FG000|Extension Study|Withdrawal by Subject|0|||
156679650|NCT01350934|565572321|FG001|Extension Study|Withdrawal by Subject|1|||
156679651|NCT03547635|565572322|FG000|Overall Study|Adverse Event|5|||
156679652|NCT03547635|565572323|FG001|Overall Study|Adverse Event|2|||
156679653|NCT03547635|565572324|FG002|Overall Study|Adverse Event|3|||
156679654|NCT03547635|565572322|FG000|Overall Study|Lost to Follow-up|1|||
156679655|NCT03547635|565572323|FG001|Overall Study|Lost to Follow-up|3|||
156679656|NCT03547635|565572324|FG002|Overall Study|Lost to Follow-up|4|||
156679657|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Subject|1|||
156679658|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Subject|0|||
156679659|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Subject|0|||
156679660|NCT03547635|565572322|FG000|Overall Study|Withdrawal By PI|0|||
156679661|NCT03547635|565572323|FG001|Overall Study|Withdrawal By PI|1|||
156679662|NCT03547635|565572324|FG002|Overall Study|Withdrawal By PI|0|||
156679663|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Sponsor|0|||
156679664|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Sponsor|0|||
156679665|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Sponsor|1|||
156679666|NCT03547635|565572322|FG000|Overall Study|Errant Randomization before Treatment|0|||
156679667|NCT03547635|565572323|FG001|Overall Study|Errant Randomization before Treatment|1|||
156679668|NCT03547635|565572324|FG002|Overall Study|Errant Randomization before Treatment|0|||
156679669|NCT03547635|565572322|FG000|Overall Study|Withdrawal by Subject|1|||
156679670|NCT03547635|565572323|FG001|Overall Study|Withdrawal by Subject|0|||
156679671|NCT03547635|565572324|FG002|Overall Study|Withdrawal by Subject|0|||
156679672|NCT01813435|565572325|FG000|Overall Study|did not finish experimental regimen|1902|||
156679673|NCT01813435|565572326|FG001|Overall Study|did not finish experimental regimen|770|||
156679674|NCT01813435|565572325|FG000|Overall Study|Lost to Follow-up|268|||
156679675|NCT01813435|565572326|FG001|Overall Study|Lost to Follow-up|237|||
156679676|NCT01011335|565572329|FG000|Overall Study|Lost to Follow-up|0|||
156679677|NCT01011335|565572330|FG001|Overall Study|Lost to Follow-up|0|||
156679678|NCT01011335|565572331|FG002|Overall Study|Lost to Follow-up|1|||
156679679|NCT01011335|565572332|FG003|Overall Study|Lost to Follow-up|1|||
156679680|NCT01011335|565572333|FG004|Overall Study|Lost to Follow-up|1|||
156679681|NCT01011335|565572334|FG005|Overall Study|Lost to Follow-up|1|||
156679682|NCT01011335|565572335|FG006|Overall Study|Lost to Follow-up|2|||
156679683|NCT01011335|565572336|FG007|Overall Study|Lost to Follow-up|2|||
156679684|NCT01011335|565572337|FG008|Overall Study|Lost to Follow-up|1|||
156679685|NCT01011335|565572338|FG009|Overall Study|Lost to Follow-up|0|||
156679686|NCT01011335|565572339|FG010|Overall Study|Lost to Follow-up|0|||
156679687|NCT01011335|565572340|FG011|Overall Study|Lost to Follow-up|1|||
156679688|NCT01011335|565572341|FG012|Overall Study|Lost to Follow-up|2|||
156679689|NCT01011335|565572329|FG000|Overall Study|Protocol Violation|0|||
156679690|NCT01011335|565572330|FG001|Overall Study|Protocol Violation|1|||
156679691|NCT01011335|565572331|FG002|Overall Study|Protocol Violation|0|||
156679692|NCT01011335|565572332|FG003|Overall Study|Protocol Violation|0|||
156679693|NCT01011335|565572333|FG004|Overall Study|Protocol Violation|0|||
156679694|NCT01011335|565572334|FG005|Overall Study|Protocol Violation|0|||
156679695|NCT01011335|565572335|FG006|Overall Study|Protocol Violation|0|||
156679696|NCT01011335|565572336|FG007|Overall Study|Protocol Violation|0|||
156679697|NCT01011335|565572337|FG008|Overall Study|Protocol Violation|0|||
156679698|NCT01011335|565572338|FG009|Overall Study|Protocol Violation|0|||
156679699|NCT01011335|565572339|FG010|Overall Study|Protocol Violation|0|||
156679700|NCT01011335|565572340|FG011|Overall Study|Protocol Violation|0|||
156679701|NCT01011335|565572341|FG012|Overall Study|Protocol Violation|0|||
156679702|NCT01011335|565572329|FG000|Overall Study|Moved/deployed or no booster|1|||
156679703|NCT01011335|565572330|FG001|Overall Study|Moved/deployed or no booster|0|||
156866965|NCT00084136|566273432|FG001|NRTI Comparison|Withdrawal by Subject|0|||
156866966|NCT00084136|566273433|FG002|NRTI Comparison|Withdrawal by Subject|38|||
156679704|NCT01011335|565572331|FG002|Overall Study|Moved/deployed or no booster|0|||
156866967|NCT00084136|566273431|FG000|NRTI Comparison|Clinic site closed|12|||
157120050|NCT05030311|567192974|FG000|Overall Study|Withdrawal by Subject|31|||
156679705|NCT01011335|565572332|FG003|Overall Study|Moved/deployed or no booster|1|||
156679706|NCT01011335|565572333|FG004|Overall Study|Moved/deployed or no booster|0|||
156679707|NCT01011335|565572334|FG005|Overall Study|Moved/deployed or no booster|0|||
156679708|NCT01011335|565572335|FG006|Overall Study|Moved/deployed or no booster|1|||
156679709|NCT01011335|565572336|FG007|Overall Study|Moved/deployed or no booster|0|||
156679710|NCT01011335|565572337|FG008|Overall Study|Moved/deployed or no booster|1|||
156679711|NCT01011335|565572338|FG009|Overall Study|Moved/deployed or no booster|0|||
156679712|NCT01011335|565572339|FG010|Overall Study|Moved/deployed or no booster|2|||
156679713|NCT01011335|565572340|FG011|Overall Study|Moved/deployed or no booster|0|||
156679714|NCT01011335|565572341|FG012|Overall Study|Moved/deployed or no booster|0|||
156679715|NCT01011335|565572329|FG000|Overall Study|Adverse Event|0|||
156866968|NCT00084136|566273432|FG001|NRTI Comparison|Clinic site closed|0|||
157120051|NCT05030311|567192975|FG001|Overall Study|Withdrawal by Subject|17|||
156866969|NCT00084136|566273433|FG002|NRTI Comparison|Clinic site closed|14|||
156866970|NCT00084136|566273431|FG000|NRTI Comparison|Not reason above|1|||
156866971|NCT00084136|566273432|FG001|NRTI Comparison|Not reason above|0|||
156866972|NCT00084136|566273433|FG002|NRTI Comparison|Not reason above|0|||
156866973|NCT01524796|566273434|FG000|Overall Study|Adverse Event|13|||
156866974|NCT01524796|566273434|FG000|Overall Study|Lack of Efficacy|3|||
156866975|NCT01524796|566273434|FG000|Overall Study|Lost to Follow-up|1|||
156866976|NCT01524796|566273434|FG000|Overall Study|The price|1|||
156866977|NCT01524796|566273434|FG000|Overall Study|Withdrawal by Subject|4|||
156866978|NCT01524796|566273434|FG000|Overall Study|Move|1|||
156866979|NCT01524796|566273434|FG000|Overall Study|Deterioration of pains|1|||
156866980|NCT01524796|566273434|FG000|Overall Study|Gall stone surgery|1|||
156866981|NCT01524796|566273434|FG000|Overall Study|Nervous about confidentiality|1|||
156866982|NCT01524796|566273434|FG000|Overall Study|Switch to carbamazapine|1|||
156679716|NCT01011335|565572330|FG001|Overall Study|Adverse Event|0|||
156679717|NCT01011335|565572331|FG002|Overall Study|Adverse Event|0|||
156679718|NCT01011335|565572332|FG003|Overall Study|Adverse Event|0|||
156679719|NCT01011335|565572333|FG004|Overall Study|Adverse Event|0|||
156679720|NCT01011335|565572334|FG005|Overall Study|Adverse Event|0|||
156679721|NCT01011335|565572335|FG006|Overall Study|Adverse Event|0|||
156679722|NCT01011335|565572336|FG007|Overall Study|Adverse Event|0|||
156679723|NCT01011335|565572337|FG008|Overall Study|Adverse Event|0|||
156679724|NCT01011335|565572338|FG009|Overall Study|Adverse Event|0|||
156679725|NCT01011335|565572339|FG010|Overall Study|Adverse Event|4|||
156679726|NCT01011335|565572340|FG011|Overall Study|Adverse Event|0|||
156679727|NCT01011335|565572341|FG012|Overall Study|Adverse Event|1|||
156679728|NCT01765751|565572346|FG000|Overall Study|Lost to Follow-up|0|||
156679729|NCT01765751|565572347|FG001|Overall Study|Lost to Follow-up|2|||
156679730|NCT01765751|565572348|FG002|Overall Study|Lost to Follow-up|1|||
156679731|NCT01151280|565572351|FG000|Overall Study|Adverse Event|1|||
156679732|NCT01151280|565572351|FG000|Overall Study|Lack of Efficacy|3|||
156679733|NCT02435433|565572352|FG000|Overall Study|Withdrawal by Subject|2|||
156679734|NCT02435433|565572353|FG001|Overall Study|Withdrawal by Subject|3|||
156679735|NCT02435433|565572354|FG002|Overall Study|Withdrawal by Subject|1|||
156679736|NCT02435433|565572355|FG003|Overall Study|Withdrawal by Subject|0|||
156679737|NCT02435433|565572356|FG004|Overall Study|Withdrawal by Subject|0|||
156679738|NCT02435433|565572352|FG000|Overall Study|Lost to Follow-up|2|||
156679739|NCT02435433|565572353|FG001|Overall Study|Lost to Follow-up|2|||
156679740|NCT02435433|565572354|FG002|Overall Study|Lost to Follow-up|4|||
156679741|NCT02435433|565572355|FG003|Overall Study|Lost to Follow-up|1|||
156679742|NCT02435433|565572356|FG004|Overall Study|Lost to Follow-up|0|||
156679743|NCT01243151|565572357|FG000|Overall Study|Adverse Event|0|||
156679744|NCT01243151|565572358|FG001|Overall Study|Adverse Event|1|||
156679745|NCT01243151|565572359|FG002|Overall Study|Adverse Event|0|||
156679746|NCT01243151|565572360|FG003|Overall Study|Adverse Event|0|||
156679747|NCT01243151|565572361|FG004|Overall Study|Adverse Event|0|||
156679748|NCT01243151|565572357|FG000|Overall Study|Protocol Violation|0|||
156679749|NCT01243151|565572358|FG001|Overall Study|Protocol Violation|0|||
156679750|NCT01243151|565572359|FG002|Overall Study|Protocol Violation|1|||
156679751|NCT01243151|565572360|FG003|Overall Study|Protocol Violation|0|||
156679752|NCT01243151|565572361|FG004|Overall Study|Protocol Violation|0|||
156679753|NCT01243151|565572357|FG000|Overall Study|Other|0|||
156679754|NCT01243151|565572358|FG001|Overall Study|Other|0|||
156679755|NCT01243151|565572359|FG002|Overall Study|Other|0|||
156679756|NCT01243151|565572360|FG003|Overall Study|Other|1|||
156679757|NCT01243151|565572361|FG004|Overall Study|Other|0|||
156679758|NCT01243151|565572357|FG000|Overall Study|Randomized but not treated|0|||
156679759|NCT01243151|565572358|FG001|Overall Study|Randomized but not treated|0|||
156679760|NCT01243151|565572359|FG002|Overall Study|Randomized but not treated|0|||
156679761|NCT01243151|565572360|FG003|Overall Study|Randomized but not treated|1|||
156679762|NCT01243151|565572361|FG004|Overall Study|Randomized but not treated|0|||
156679763|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
156679764|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
156679765|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
156679766|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
156866983|NCT01524796|566273434|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
156866984|NCT02612779|566273437|FG000|Overall Study|Administrative reason by sponsor|4|||
156866985|NCT02612779|566273438|FG001|Overall Study|Administrative reason by sponsor|1|||
156866986|NCT02612779|566273437|FG000|Overall Study|No longer meet study criteria|0|||
157012397|NCT03783026|566799343|FG000|Treatment Phase|Adverse Event|15|||
157012398|NCT03783026|566799343|FG000|Treatment Phase|Lack of Efficacy|11|||
157012399|NCT03783026|566799343|FG000|Treatment Phase|Withdrawal by Subject|6|||
157012400|NCT03783026|566799343|FG000|Treatment Phase|Lost to Follow-up|2|||
157012401|NCT03783026|566799343|FG000|Treatment Phase|Protocol Deviation|8|||
157012402|NCT03783026|566799343|FG000|Treatment Phase|Did Not Receive Treatment|1|||
157012403|NCT03783026|566799343|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
157012404|NCT04814186|566799344|FG000|Treatment Phase|Adverse Event|1|||
157012405|NCT04814186|566799344|FG000|Treatment Phase|Death|6|||
156679767|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
156679768|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
156679769|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
156679770|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
156679771|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
156679772|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
156679773|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
156679774|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
156679775|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
156679776|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
156679777|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
156679778|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
156679779|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
156679780|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
156679781|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
156679782|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
156679783|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
156679784|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
156679785|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
156679786|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
156679787|NCT01710358|565572365|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
156679788|NCT01710358|565572366|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
156679789|NCT01710358|565572367|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
156679790|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
156679791|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
156679792|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
156679793|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
156679794|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
156679795|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
156679796|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
156679797|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
156679798|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
156679799|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
156679800|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
156679801|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
156679802|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
156679803|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
156679804|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
156679805|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
156679806|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
156679807|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
156679808|NCT01710358|565572365|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
156679809|NCT01710358|565572366|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
156679810|NCT01710358|565572367|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
157120052|NCT05030311|567192974|FG000|Overall Study|Adverse Event|13|||
157120053|NCT05030311|567192975|FG001|Overall Study|Adverse Event|5|||
157120054|NCT05030311|567192974|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157120055|NCT05030311|567192975|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156679811|NCT01710358|565572365|FG000|Rescue Period|Adverse Event|0|||
156866987|NCT02612779|566273438|FG001|Overall Study|No longer meet study criteria|1|||
156866988|NCT02612779|566273437|FG000|Overall Study|Disease progression|29|||
156866989|NCT02612779|566273438|FG001|Overall Study|Disease progression|2|||
156866990|NCT02612779|566273437|FG000|Overall Study|Study drug toxicity|10|||
156866991|NCT02612779|566273438|FG001|Overall Study|Study drug toxicity|1|||
156866992|NCT02612779|566273437|FG000|Overall Study|Death|1|||
157120056|NCT05030311|567192974|FG000|Overall Study|Physician Decision|5|||
156679812|NCT01710358|565572366|FG001|Rescue Period|Adverse Event|15|||
156679813|NCT01710358|565572367|FG002|Rescue Period|Adverse Event|0|||
156679814|NCT01710358|565572365|FG000|Rescue Period|Death|0|||
156679815|NCT01710358|565572366|FG001|Rescue Period|Death|1|||
156679816|NCT01710358|565572367|FG002|Rescue Period|Death|0|||
156679817|NCT01710358|565572365|FG000|Rescue Period|Lack of Efficacy|0|||
156679818|NCT01710358|565572366|FG001|Rescue Period|Lack of Efficacy|7|||
156679819|NCT01710358|565572367|FG002|Rescue Period|Lack of Efficacy|0|||
156679820|NCT01710358|565572365|FG000|Rescue Period|Withdrawal by Subject|0|||
156679821|NCT01710358|565572366|FG001|Rescue Period|Withdrawal by Subject|8|||
156679822|NCT01710358|565572367|FG002|Rescue Period|Withdrawal by Subject|0|||
156866993|NCT02612779|566273438|FG001|Overall Study|Death|0|||
157120057|NCT05030311|567192975|FG001|Overall Study|Physician Decision|2|||
156679823|NCT00799708|565572370|FG000|Overall Study|non-compliance|1|||
156679824|NCT00799708|565572371|FG001|Overall Study|non-compliance|0|||
156679825|NCT00799708|565572372|FG002|Overall Study|non-compliance|0|||
156679826|NCT00880334|565572373|FG000|Randomized Phase|Physician Decision|1|||
156679827|NCT00880334|565572374|FG001|Randomized Phase|Physician Decision|0|||
156679828|NCT00880334|565572373|FG000|Randomized Phase|Withdrawal by Subject|2|||
156679829|NCT00880334|565572374|FG001|Randomized Phase|Withdrawal by Subject|1|||
156679830|NCT00880334|565572373|FG000|Randomized Phase|Inadequate Labs|1|||
156679831|NCT00880334|565572374|FG001|Randomized Phase|Inadequate Labs|1|||
156679832|NCT00880334|565572373|FG000|Randomized Phase|Brain Metastasis|0|||
156679833|NCT00880334|565572374|FG001|Randomized Phase|Brain Metastasis|1|||
156679834|NCT00880334|565572373|FG000|Randomized Phase|Crossover Participants|0|||
156679835|NCT00880334|565572374|FG001|Randomized Phase|Crossover Participants|37|||
156679836|NCT02274558|565572379|FG000|Overall Study|Adverse Event|2|||
156679837|NCT02274558|565572380|FG001|Overall Study|Adverse Event|4|||
156679838|NCT02274558|565572381|FG002|Overall Study|Adverse Event|2|||
156679839|NCT02274558|565572379|FG000|Overall Study|Non-compliance|2|||
156679840|NCT02274558|565572380|FG001|Overall Study|Non-compliance|1|||
156679841|NCT02274558|565572381|FG002|Overall Study|Non-compliance|0|||
156679842|NCT02274558|565572379|FG000|Overall Study|Withdrawal by Subject|1|||
156679843|NCT02274558|565572380|FG001|Overall Study|Withdrawal by Subject|5|||
156679844|NCT02274558|565572381|FG002|Overall Study|Withdrawal by Subject|4|||
156679845|NCT02274558|565572379|FG000|Overall Study|Death|0|||
156679846|NCT02274558|565572380|FG001|Overall Study|Death|0|||
156679847|NCT02274558|565572381|FG002|Overall Study|Death|1|||
156679848|NCT02274558|565572379|FG000|Overall Study|Lost to Follow-up|2|||
156679849|NCT02274558|565572380|FG001|Overall Study|Lost to Follow-up|1|||
156679850|NCT02274558|565572381|FG002|Overall Study|Lost to Follow-up|1|||
156679851|NCT02274558|565572379|FG000|Overall Study|Physician Decision|0|||
156679852|NCT02274558|565572380|FG001|Overall Study|Physician Decision|2|||
156679853|NCT02274558|565572381|FG002|Overall Study|Physician Decision|1|||
156679854|NCT01119625|565572382|FG000|Overall Study|Lost to Follow-up|1|||
156679855|NCT01119625|565572383|FG001|Overall Study|Lost to Follow-up|2|||
156679856|NCT01119625|565572382|FG000|Overall Study|Withdrawal by Subject|2|||
156679857|NCT01119625|565572383|FG001|Overall Study|Withdrawal by Subject|1|||
156679858|NCT01119625|565572382|FG000|Overall Study|Other|0|||
156679859|NCT01119625|565572383|FG001|Overall Study|Other|1|||
156679860|NCT01721772|565572388|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
156679861|NCT01721772|565572389|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
156679862|NCT01721772|565572388|FG000|Pre-Treatment|Poor/non-compliance|0|||
156679863|NCT01721772|565572389|FG001|Pre-Treatment|Poor/non-compliance|1|||
156679864|NCT01721772|565572388|FG000|Pre-Treatment|Participant withdrew consent|0|||
156679865|NCT01721772|565572389|FG001|Pre-Treatment|Participant withdrew consent|1|||
156679866|NCT01721772|565572388|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
156679867|NCT01721772|565572389|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
156679868|NCT01721772|565572388|FG000|Treatment|Disease progression|119|||
156679869|NCT01721772|565572389|FG001|Treatment|Disease progression|168|||
156679870|NCT01721772|565572388|FG000|Treatment|Study drug toxicity|19|||
156679871|NCT01721772|565572389|FG001|Treatment|Study drug toxicity|10|||
156679872|NCT01721772|565572388|FG000|Treatment|Adverse event unrelated to study drug|7|||
156679873|NCT01721772|565572389|FG001|Treatment|Adverse event unrelated to study drug|7|||
156679874|NCT01721772|565572388|FG000|Treatment|Maximum clinical benefit|16|||
156679875|NCT01721772|565572389|FG001|Treatment|Maximum clinical benefit|4|||
156679876|NCT01721772|565572388|FG000|Treatment|Other|19|||
156679877|NCT01721772|565572389|FG001|Treatment|Other|2|||
156679878|NCT01721772|565572388|FG000|Treatment|Participant withdrew consent|2|||
156679879|NCT01721772|565572389|FG001|Treatment|Participant withdrew consent|5|||
156679880|NCT01721772|565572388|FG000|Treatment|Participant request to discontinue study treatment|21|||
156679881|NCT01721772|565572389|FG001|Treatment|Participant request to discontinue study treatment|8|||
156679882|NCT01721772|565572388|FG000|Treatment|Death|1|||
156679883|NCT01721772|565572389|FG001|Treatment|Death|0|||
156679884|NCT01721772|565572388|FG000|Treatment|Not reported|1|||
156679885|NCT01721772|565572389|FG001|Treatment|Not reported|0|||
156679886|NCT01721772|565572388|FG000|Treatment|Poor/non-compliance|1|||
156679887|NCT01721772|565572389|FG001|Treatment|Poor/non-compliance|0|||
156679888|NCT01721772|565572388|FG000|Treatment|Lost to Follow-up|0|||
156679889|NCT01721772|565572389|FG001|Treatment|Lost to Follow-up|1|||
156679890|NCT01408888|565572390|FG000|First Intervention|Adverse Event|0|||
156679891|NCT01408888|565572391|FG001|First Intervention|Adverse Event|1|||
156679892|NCT01408888|565572390|FG000|First Intervention|Withdrawal by Subject|0|||
156679893|NCT01408888|565572391|FG001|First Intervention|Withdrawal by Subject|2|||
156679894|NCT01408888|565572390|FG000|Second Intervention|Withdrawal by Subject|1|||
156679895|NCT01408888|565572391|FG001|Second Intervention|Withdrawal by Subject|0|||
156679896|NCT01408888|565572390|FG000|Second Intervention|Adverse Event|1|||
156679897|NCT01408888|565572391|FG001|Second Intervention|Adverse Event|0|||
156679898|NCT04542694|565572392|FG000|Overall Study|The need for prohibited therapy|2|||
156679899|NCT04542694|565572393|FG001|Overall Study|The need for prohibited therapy|0|||
156679900|NCT04542694|565572392|FG000|Overall Study|Adverse Event|1|||
156679901|NCT04542694|565572393|FG001|Overall Study|Adverse Event|0|||
156679902|NCT04542694|565572392|FG000|Overall Study|Protocol Violation|1|||
156679903|NCT04542694|565572393|FG001|Overall Study|Protocol Violation|0|||
156679904|NCT00969124|565572394|FG000|Overall Study|Protocol Violation|2|||
156679905|NCT00969124|565572394|FG000|Overall Study|Inadequate bowel preparation|15|||
156679906|NCT00969124|565572394|FG000|Overall Study|Inability to reach cecum|9|||
156679907|NCT00969124|565572394|FG000|Overall Study|Previously unrecognized disease|3|||
156679908|NCT00969124|565572394|FG000|Overall Study|Technical error|1|||
156679909|NCT00210639|565572395|FG000|Overall Study|Lost to Follow-up|37|||
156679910|NCT00210639|565572396|FG001|Overall Study|Lost to Follow-up|29|||
156679911|NCT00210639|565572395|FG000|Overall Study|Withdrawal by Subject|8|||
156679912|NCT00210639|565572396|FG001|Overall Study|Withdrawal by Subject|1|||
156782710|NCT01658878|565954729|FG000|Treatment Period|Poor/Non-compliance|0|||
156782711|NCT01658878|565954730|FG001|Treatment Period|Poor/Non-compliance|0|||
156782712|NCT01658878|565954731|FG002|Treatment Period|Poor/Non-compliance|0|||
156782713|NCT01658878|565954732|FG003|Treatment Period|Poor/Non-compliance|0|||
156782714|NCT01658878|565954733|FG004|Treatment Period|Poor/Non-compliance|0|||
156782715|NCT01658878|565954734|FG005|Treatment Period|Poor/Non-compliance|0|||
156782716|NCT01658878|565954735|FG006|Treatment Period|Poor/Non-compliance|0|||
156782717|NCT01658878|565954736|FG007|Treatment Period|Poor/Non-compliance|0|||
156782718|NCT01658878|565954737|FG008|Treatment Period|Poor/Non-compliance|0|||
156782719|NCT01658878|565954738|FG009|Treatment Period|Poor/Non-compliance|0|||
156782720|NCT01658878|565954739|FG010|Treatment Period|Poor/Non-compliance|0|||
156782721|NCT01658878|565954740|FG011|Treatment Period|Poor/Non-compliance|0|||
156782722|NCT01658878|565954741|FG012|Treatment Period|Poor/Non-compliance|0|||
156782723|NCT01658878|565954742|FG013|Treatment Period|Poor/Non-compliance|0|||
156782724|NCT01658878|565954743|FG014|Treatment Period|Poor/Non-compliance|0|||
156782725|NCT01658878|565954744|FG015|Treatment Period|Poor/Non-compliance|1|||
156782726|NCT01658878|565954745|FG016|Treatment Period|Poor/Non-compliance|0|||
156782727|NCT01658878|565954746|FG017|Treatment Period|Poor/Non-compliance|0|||
156782728|NCT01658878|565954747|FG018|Treatment Period|Poor/Non-compliance|0|||
156782729|NCT01658878|565954748|FG019|Treatment Period|Poor/Non-compliance|0|||
156782730|NCT01658878|565954749|FG020|Treatment Period|Poor/Non-compliance|0|||
156782731|NCT01658878|565954750|FG021|Treatment Period|Poor/Non-compliance|0|||
156782732|NCT01658878|565954751|FG022|Treatment Period|Poor/Non-compliance|0|||
156782733|NCT01658878|565954752|FG023|Treatment Period|Poor/Non-compliance|0|||
156782734|NCT01658878|565954729|FG000|Treatment Period|Participant Withdrew Consent|0|||
156782735|NCT01658878|565954730|FG001|Treatment Period|Participant Withdrew Consent|0|||
156782736|NCT01658878|565954731|FG002|Treatment Period|Participant Withdrew Consent|0|||
156782737|NCT01658878|565954732|FG003|Treatment Period|Participant Withdrew Consent|0|||
156782738|NCT01658878|565954733|FG004|Treatment Period|Participant Withdrew Consent|0|||
156782739|NCT01658878|565954734|FG005|Treatment Period|Participant Withdrew Consent|0|||
156782740|NCT01658878|565954735|FG006|Treatment Period|Participant Withdrew Consent|0|||
156782741|NCT01658878|565954736|FG007|Treatment Period|Participant Withdrew Consent|0|||
156782742|NCT01658878|565954737|FG008|Treatment Period|Participant Withdrew Consent|0|||
156782743|NCT01658878|565954738|FG009|Treatment Period|Participant Withdrew Consent|0|||
156782744|NCT01658878|565954739|FG010|Treatment Period|Participant Withdrew Consent|0|||
156782745|NCT01658878|565954740|FG011|Treatment Period|Participant Withdrew Consent|0|||
156782746|NCT01658878|565954741|FG012|Treatment Period|Participant Withdrew Consent|1|||
156782747|NCT01658878|565954742|FG013|Treatment Period|Participant Withdrew Consent|0|||
156782748|NCT01658878|565954743|FG014|Treatment Period|Participant Withdrew Consent|2|||
156782749|NCT01658878|565954744|FG015|Treatment Period|Participant Withdrew Consent|0|||
156782750|NCT01658878|565954745|FG016|Treatment Period|Participant Withdrew Consent|0|||
156782751|NCT01658878|565954746|FG017|Treatment Period|Participant Withdrew Consent|2|||
156782752|NCT01658878|565954747|FG018|Treatment Period|Participant Withdrew Consent|1|||
156782753|NCT01658878|565954748|FG019|Treatment Period|Participant Withdrew Consent|2|||
156782754|NCT01658878|565954749|FG020|Treatment Period|Participant Withdrew Consent|1|||
156782755|NCT01658878|565954750|FG021|Treatment Period|Participant Withdrew Consent|0|||
156782756|NCT01658878|565954751|FG022|Treatment Period|Participant Withdrew Consent|2|||
156782757|NCT01658878|565954752|FG023|Treatment Period|Participant Withdrew Consent|2|||
156782758|NCT01658878|565954729|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156679913|NCT00210639|565572395|FG000|Overall Study|Other|18|||
156679914|NCT00210639|565572396|FG001|Overall Study|Other|12|||
156679915|NCT00397254|565572397|FG000|Overall Study|Lost to Follow-up|2|||
156782759|NCT01658878|565954730|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782760|NCT01658878|565954731|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782761|NCT01658878|565954732|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782762|NCT01658878|565954733|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782763|NCT01658878|565954734|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156808719|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
156808720|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
156808721|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
156679916|NCT00397254|565572398|FG001|Overall Study|Lost to Follow-up|2|||
156679917|NCT00152451|565572405|FG000|Overall Study|Adverse Event|4|||
156679918|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
156679919|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
156679920|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
156679921|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
157012406|NCT04814186|566799344|FG000|Treatment Phase|Withdrawal by Subject|2|||
157012407|NCT04814186|566799344|FG000|Treatment Phase|Other|1|||
157012408|NCT04814186|566799344|FG000|Follow-Up Phase|Adverse Event|1|||
157012409|NCT04814186|566799344|FG000|Follow-Up Phase|Death|6|||
157012410|NCT04814186|566799344|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
157012411|NCT04814186|566799344|FG000|Follow-Up Phase|Other|1|||
157012412|NCT01853748|566799347|FG000|Allocation|Withdrawal by Subject|1|||
157012413|NCT01853748|566799348|FG001|Allocation|Withdrawal by Subject|13|||
157012414|NCT01853748|566799347|FG000|Allocation|not sufficient to receive intervention|0|||
157012415|NCT01853748|566799348|FG001|Allocation|not sufficient to receive intervention|1|||
157012416|NCT01853748|566799347|FG000|Follow-Up|Withdrawal by Subject|7|||
157012417|NCT01853748|566799348|FG001|Follow-Up|Withdrawal by Subject|6|||
157012418|NCT01853748|566799347|FG000|Follow-Up|Adverse Event|67|||
157012419|NCT01853748|566799348|FG001|Follow-Up|Adverse Event|7|||
157012420|NCT01853748|566799347|FG000|Follow-Up|not available for data collection|16|||
157012421|NCT01853748|566799348|FG001|Follow-Up|not available for data collection|4|||
157012422|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
157012423|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
157012424|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
157012425|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
157012426|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
156679922|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
157012427|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
157012428|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
157012429|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
157012430|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
157012431|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
157012432|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
157012433|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
157012434|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
157012435|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
157012436|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
157012437|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
157012438|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
157012439|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
157012440|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
157012441|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
157012442|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
157012443|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
157012444|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
157012445|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
157012446|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156679923|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
156679924|NCT00323258|565572408|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
156679925|NCT00323258|565572409|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
156679926|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
156679927|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
156679928|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
156679929|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
156679930|NCT00323258|565572408|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
156679931|NCT00323258|565572409|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
156679932|NCT01943435|565572419|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
156679933|NCT01943435|565572420|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
156679934|NCT01943435|565572421|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
156679935|NCT01943435|565572419|FG000|Intervention Period|Withdrawal by Subject|3|||
156679936|NCT01943435|565572420|FG001|Intervention Period|Withdrawal by Subject|3|||
156679937|NCT01943435|565572421|FG002|Intervention Period|Withdrawal by Subject|4|||
156679938|NCT01943435|565572419|FG000|2 Month Follow up|Lost to Follow-up|2|||
156679939|NCT01943435|565572420|FG001|2 Month Follow up|Lost to Follow-up|3|||
156679940|NCT01943435|565572421|FG002|2 Month Follow up|Lost to Follow-up|0|||
156679941|NCT01943435|565572419|FG000|6 Month Follow up|Lost to Follow-up|12|||
156866994|NCT02612779|566273437|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156866995|NCT02612779|566273438|FG001|Overall Study|Adverse event unrelated to study drug|0|||
156866996|NCT02612779|566273437|FG000|Overall Study|Participant withdrew consent|4|||
156866997|NCT02612779|566273438|FG001|Overall Study|Participant withdrew consent|0|||
156866998|NCT02612779|566273437|FG000|Overall Study|Lost to Follow-up|1|||
156866999|NCT02612779|566273438|FG001|Overall Study|Lost to Follow-up|0|||
156867000|NCT02612779|566273437|FG000|Overall Study|Maximum clinical benefit|10|||
156867001|NCT02612779|566273438|FG001|Overall Study|Maximum clinical benefit|1|||
156867002|NCT02612779|566273437|FG000|Overall Study|Other reasons|4|||
156867003|NCT02612779|566273438|FG001|Overall Study|Other reasons|0|||
156867004|NCT02633306|566273441|FG000|Overall Study|Withdrawal by Subject|3|||
156867005|NCT01744977|566273442|FG000|Overall Study|Withdrawal by Subject|1|||
156867006|NCT01744977|566273443|FG001|Overall Study|Withdrawal by Subject|2|||
156867007|NCT01744977|566273442|FG000|Overall Study|Death|2|||
156867008|NCT01744977|566273443|FG001|Overall Study|Death|3|||
156867009|NCT01744977|566273442|FG000|Overall Study|Lost to Follow-up|2|||
156867010|NCT01744977|566273443|FG001|Overall Study|Lost to Follow-up|0|||
156867011|NCT01744977|566273442|FG000|Overall Study|No longer meets inclusion|6|||
156867012|NCT01744977|566273443|FG001|Overall Study|No longer meets inclusion|0|||
156867013|NCT03774576|566273446|FG000|Period 2|Adverse Event|1|||
156867014|NCT01746901|566273447|FG000|Naloxone Challenge Phase|Adverse Event|2|||
156867015|NCT01746901|566273448|FG001|Naloxone Challenge Phase|Adverse Event|0|||
156867016|NCT01746901|566273449|FG002|Naloxone Challenge Phase|Adverse Event|0|||
156867017|NCT01746901|566273450|FG003|Naloxone Challenge Phase|Adverse Event|0|||
156867018|NCT01746901|566273451|FG004|Naloxone Challenge Phase|Adverse Event|0|||
156867019|NCT01746901|566273452|FG005|Naloxone Challenge Phase|Adverse Event|0|||
156867020|NCT01746901|566273453|FG006|Naloxone Challenge Phase|Adverse Event|0|||
156867021|NCT01746901|566273454|FG007|Naloxone Challenge Phase|Adverse Event|0|||
156867022|NCT01746901|566273455|FG008|Naloxone Challenge Phase|Adverse Event|0|||
156867023|NCT01746901|566273447|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
156867024|NCT01746901|566273448|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867025|NCT01746901|566273449|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867026|NCT01746901|566273450|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867027|NCT01746901|566273451|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867028|NCT01746901|566273452|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867029|NCT01746901|566273453|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867030|NCT01746901|566273454|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
157012447|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
157012448|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
157012449|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
157012450|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
156867031|NCT01746901|566273455|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
156867032|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156679942|NCT01943435|565572420|FG001|6 Month Follow up|Lost to Follow-up|7|||
156679943|NCT01943435|565572421|FG002|6 Month Follow up|Lost to Follow-up|15|||
156679944|NCT01617096|565572428|FG000|Overall Study|Withdrawal by Subject|96|||
156679945|NCT01617096|565572429|FG001|Overall Study|Withdrawal by Subject|81|||
156679946|NCT01617096|565572428|FG000|Overall Study|Lost to Follow-up|37|||
156679947|NCT01617096|565572429|FG001|Overall Study|Lost to Follow-up|32|||
156679948|NCT01617096|565572428|FG000|Overall Study|Physician Decision|10|||
156679949|NCT01617096|565572429|FG001|Overall Study|Physician Decision|18|||
156679950|NCT01617096|565572428|FG000|Overall Study|Death|4|||
156679951|NCT01617096|565572429|FG001|Overall Study|Death|3|||
156679952|NCT01617096|565572428|FG000|Overall Study|Other|1|||
156679953|NCT01617096|565572429|FG001|Overall Study|Other|3|||
156679954|NCT04473326|565572434|FG000|Overall Study|Death|0|||
156679955|NCT04473326|565572435|FG001|Overall Study|Death|1|||
156679956|NCT04473326|565572434|FG000|Overall Study|Withdrawal by Subject|1|||
156679957|NCT04473326|565572435|FG001|Overall Study|Withdrawal by Subject|2|||
156867033|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
157012451|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
157012452|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
157012453|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
157012454|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
157012455|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
157012456|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
157021653|NCT04072380|566830971|FG000|Overall Study|Withdrawal by Subject|3|||
156867034|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867035|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156679958|NCT02046122|565572436|FG000|Overall Study|Physician Decision|8|||
156679959|NCT02046122|565572436|FG000|Overall Study|Withdrawal by Subject|1|||
156679960|NCT04535986|565572439|FG000|Overall Study|Death|4|||
156867036|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867037|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867038|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867039|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867040|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156867041|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867042|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
156867043|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
156867044|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867045|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867046|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867047|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867048|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867049|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
156867050|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867051|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
156867052|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
156867053|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867054|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867055|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867056|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867057|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867058|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
156867059|NCT01746901|566273447|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867060|NCT01746901|566273448|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
156867061|NCT01746901|566273449|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
156867062|NCT01746901|566273450|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867063|NCT01746901|566273451|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156679961|NCT04535986|565572440|FG001|Overall Study|Death|5|||
156679962|NCT04535986|565572439|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
156679963|NCT04535986|565572440|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
156679964|NCT04535986|565572439|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
156867064|NCT01746901|566273452|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867065|NCT01746901|566273453|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867066|NCT01746901|566273454|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867067|NCT01746901|566273455|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156867068|NCT01746901|566273447|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
156867069|NCT01746901|566273448|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
156867070|NCT01746901|566273449|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
156867071|NCT01746901|566273450|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
156679965|NCT04535986|565572440|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
156679966|NCT04535986|565572439|FG000|Overall Study|Adverse Event|10|||
156679967|NCT04535986|565572440|FG001|Overall Study|Adverse Event|1|||
156679968|NCT04535986|565572439|FG000|Overall Study|Lack of Efficacy|3|||
156679969|NCT04535986|565572440|FG001|Overall Study|Lack of Efficacy|2|||
156679970|NCT04535986|565572439|FG000|Overall Study|Investigator discretion|3|||
156679971|NCT04535986|565572440|FG001|Overall Study|Investigator discretion|0|||
156679972|NCT04535986|565572439|FG000|Overall Study|Withdrawal by Subject|32|||
156679973|NCT04535986|565572440|FG001|Overall Study|Withdrawal by Subject|14|||
156679974|NCT04535986|565572439|FG000|Overall Study|Lost to Follow-up|5|||
156679975|NCT04535986|565572440|FG001|Overall Study|Lost to Follow-up|3|||
156679976|NCT04535986|565572439|FG000|Overall Study|Other|7|||
156679977|NCT04535986|565572440|FG001|Overall Study|Other|3|||
157012457|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
156679978|NCT01196390|565572441|FG000|Overall Study|Protocol Violation|4|||
157012458|NCT04043455|566799353|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
157012459|NCT04043455|566799354|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
157012460|NCT04043455|566799355|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
157012461|NCT04043455|566799356|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
157012462|NCT04043455|566799357|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
157012463|NCT04043455|566799358|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
157012464|NCT04043455|566799353|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
157012465|NCT04043455|566799354|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
157012466|NCT04043455|566799355|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
157012467|NCT04043455|566799356|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
156679979|NCT01196390|565572442|FG001|Overall Study|Protocol Violation|5|||
156679980|NCT00252564|565572443|FG000|Overall Study|Adverse Event|17|||
156679981|NCT00252564|565572444|FG001|Overall Study|Adverse Event|13|||
156679982|NCT00252564|565572443|FG000|Overall Study|Unrelated Complication|2|||
156679983|NCT00252564|565572444|FG001|Overall Study|Unrelated Complication|1|||
156679984|NCT00252564|565572443|FG000|Overall Study|Disease Progression|14|||
156679985|NCT00252564|565572444|FG001|Overall Study|Disease Progression|20|||
156679986|NCT00252564|565572443|FG000|Overall Study|Death|0|||
156679987|NCT00252564|565572444|FG001|Overall Study|Death|3|||
156679988|NCT00252564|565572443|FG000|Overall Study|Physician Decision|1|||
156679989|NCT00252564|565572444|FG001|Overall Study|Physician Decision|0|||
156679990|NCT00252564|565572443|FG000|Overall Study|Lost to Follow-up|1|||
156679991|NCT00252564|565572444|FG001|Overall Study|Lost to Follow-up|0|||
156679992|NCT00252564|565572443|FG000|Overall Study|Patient Request|4|||
156679993|NCT00252564|565572444|FG001|Overall Study|Patient Request|5|||
156679994|NCT00252564|565572443|FG000|Overall Study|Withdrawal by Subject|0|||
156679995|NCT00252564|565572444|FG001|Overall Study|Withdrawal by Subject|2|||
156679996|NCT03141151|565572447|FG000|Overall Study|Lost to Follow-up|3|||
156679997|NCT03141151|565572448|FG001|Overall Study|Lost to Follow-up|2|||
156679998|NCT03141151|565572447|FG000|Overall Study|Withdrawal by Subject|3|||
156679999|NCT03141151|565572448|FG001|Overall Study|Withdrawal by Subject|2|||
156680000|NCT04561115|565572455|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
156680001|NCT04561115|565572456|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
156680002|NCT04561115|565572455|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
156680003|NCT04561115|565572456|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
156680004|NCT04561115|565572455|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
156680005|NCT04561115|565572456|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
156680006|NCT00743145|565572457|FG000|Overall Study|Withdrawal by Subject|1|||
156680007|NCT00743145|565572457|FG000|Overall Study|Adverse Event|2|||
156680008|NCT00743145|565572457|FG000|Overall Study|Pregnancy|1|||
156680009|NCT01097694|565572458|FG000|Overall Study|Adverse Event|5|||
156680010|NCT01097694|565572459|FG001|Overall Study|Adverse Event|0|||
156680011|NCT01097694|565572458|FG000|Overall Study|Lost to Follow-up|0|||
156680012|NCT01097694|565572459|FG001|Overall Study|Lost to Follow-up|3|||
156680013|NCT01097694|565572458|FG000|Overall Study|Withdrawal by Subject|3|||
156680014|NCT01097694|565572459|FG001|Overall Study|Withdrawal by Subject|1|||
156680015|NCT02179190|565572460|FG000|Enrollment|Exit Prior to Device Attempt|11|||
156680016|NCT02179190|565572460|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
156680017|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
156680018|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
156680019|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
156680020|NCT02179190|565572460|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
156680021|NCT01188226|565574408|FG000|Overall Study|Withdrawal by Subject|4|||
156680022|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
156680023|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
156680024|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
156680025|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
156680026|NCT04980456|565574409|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
156680027|NCT04980456|565574410|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
156680028|NCT04980456|565574409|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
156680029|NCT04980456|565574410|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
156680030|NCT00442351|565574412|FG000|Overall Study|Administrative|6|||
156680031|NCT00442351|565574413|FG001|Overall Study|Administrative|5|||
156680032|NCT00442351|565574412|FG000|Overall Study|Did not meet protocol eligibility|1|||
156680033|NCT00442351|565574413|FG001|Overall Study|Did not meet protocol eligibility|0|||
156680034|NCT00442351|565574412|FG000|Overall Study|Other|0|||
156680035|NCT00442351|565574413|FG001|Overall Study|Other|1|||
156680036|NCT00500318|565574415|FG000|Overall Study|Adverse Event|3|||
156680037|NCT00500318|565574416|FG001|Overall Study|Adverse Event|8|||
156680038|NCT00500318|565574415|FG000|Overall Study|Protocol Violation|1|||
156680039|NCT00500318|565574416|FG001|Overall Study|Protocol Violation|3|||
156680040|NCT00500318|565574415|FG000|Overall Study|Withdrawal by Subject|1|||
156782764|NCT01658878|565954735|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782765|NCT01658878|565954736|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
157012468|NCT04043455|566799357|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
157012469|NCT04043455|566799358|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
157012470|NCT04043455|566799353|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
156680041|NCT00500318|565574416|FG001|Overall Study|Withdrawal by Subject|2|||
156680042|NCT00500318|565574415|FG000|Overall Study|Lack of Efficacy|0|||
156680043|NCT00500318|565574416|FG001|Overall Study|Lack of Efficacy|3|||
156680044|NCT00500318|565574415|FG000|Overall Study|Other Reason|0|||
156680045|NCT00500318|565574416|FG001|Overall Study|Other Reason|1|||
156680046|NCT01074008|565574437|FG000|Overall Study|Adverse Event|0|||
156680047|NCT01074008|565574438|FG001|Overall Study|Adverse Event|1|||
156680048|NCT01074008|565574439|FG002|Overall Study|Adverse Event|0|||
156680049|NCT01074008|565574440|FG003|Overall Study|Adverse Event|0|||
156680050|NCT01074008|565574441|FG004|Overall Study|Adverse Event|0|||
156680051|NCT01074008|565574442|FG005|Overall Study|Adverse Event|0|||
156680052|NCT01074008|565574443|FG006|Overall Study|Adverse Event|0|||
156680053|NCT01074008|565574444|FG007|Overall Study|Adverse Event|0|||
156680054|NCT01074008|565574445|FG008|Overall Study|Adverse Event|0|||
156680055|NCT01074008|565574437|FG000|Overall Study|Withdrawal by Subject|1|||
156680056|NCT01074008|565574438|FG001|Overall Study|Withdrawal by Subject|1|||
156680057|NCT01074008|565574439|FG002|Overall Study|Withdrawal by Subject|1|||
156680058|NCT01074008|565574440|FG003|Overall Study|Withdrawal by Subject|0|||
156680059|NCT01074008|565574441|FG004|Overall Study|Withdrawal by Subject|1|||
156680060|NCT01074008|565574442|FG005|Overall Study|Withdrawal by Subject|0|||
156680061|NCT01074008|565574443|FG006|Overall Study|Withdrawal by Subject|0|||
156680062|NCT01074008|565574444|FG007|Overall Study|Withdrawal by Subject|0|||
156680063|NCT01074008|565574445|FG008|Overall Study|Withdrawal by Subject|0|||
156680064|NCT01074008|565574437|FG000|Overall Study|Lost to Follow-up|0|||
156680065|NCT01074008|565574438|FG001|Overall Study|Lost to Follow-up|1|||
156680066|NCT01074008|565574439|FG002|Overall Study|Lost to Follow-up|1|||
156680067|NCT01074008|565574440|FG003|Overall Study|Lost to Follow-up|1|||
156680068|NCT01074008|565574441|FG004|Overall Study|Lost to Follow-up|1|||
156680069|NCT01074008|565574442|FG005|Overall Study|Lost to Follow-up|0|||
156680070|NCT01074008|565574443|FG006|Overall Study|Lost to Follow-up|1|||
156680071|NCT01074008|565574444|FG007|Overall Study|Lost to Follow-up|0|||
156680072|NCT01074008|565574445|FG008|Overall Study|Lost to Follow-up|4|||
156680073|NCT00224484|565574446|FG000|Overall Study|Serious Adverse Event|1|||
156680074|NCT00224484|565574447|FG001|Overall Study|Serious Adverse Event|1|||
156680075|NCT00224484|565574448|FG002|Overall Study|Serious Adverse Event|0|||
156680076|NCT00224484|565574446|FG000|Overall Study|Non-Serious Adverse Event|5|||
156680077|NCT00224484|565574447|FG001|Overall Study|Non-Serious Adverse Event|7|||
156680078|NCT00224484|565574448|FG002|Overall Study|Non-Serious Adverse Event|3|||
156680079|NCT00224484|565574446|FG000|Overall Study|Protocol Violation|2|||
156680080|NCT00224484|565574447|FG001|Overall Study|Protocol Violation|2|||
156680081|NCT00224484|565574448|FG002|Overall Study|Protocol Violation|0|||
156680082|NCT00224484|565574446|FG000|Overall Study|Withdrawal by Subject|49|||
156680083|NCT00224484|565574447|FG001|Overall Study|Withdrawal by Subject|18|||
156680084|NCT00224484|565574448|FG002|Overall Study|Withdrawal by Subject|16|||
156680085|NCT00224484|565574446|FG000|Overall Study|Migrated/moved from study area|18|||
156680086|NCT00224484|565574447|FG001|Overall Study|Migrated/moved from study area|5|||
156680087|NCT00224484|565574448|FG002|Overall Study|Migrated/moved from study area|5|||
156680088|NCT00224484|565574446|FG000|Overall Study|Lost to Follow-up|66|||
156680089|NCT00224484|565574447|FG001|Overall Study|Lost to Follow-up|28|||
156680090|NCT00224484|565574448|FG002|Overall Study|Lost to Follow-up|36|||
156680091|NCT00224484|565574446|FG000|Overall Study|Reason not specified|5|||
156680092|NCT00224484|565574447|FG001|Overall Study|Reason not specified|4|||
156680093|NCT00224484|565574448|FG002|Overall Study|Reason not specified|2|||
156680094|NCT01453153|565574456|FG000|Overall Study|Physician Decision|0|||
156680095|NCT01453153|565574457|FG001|Overall Study|Physician Decision|0|||
156680096|NCT01453153|565574458|FG002|Overall Study|Physician Decision|1|||
156680097|NCT01453153|565574456|FG000|Overall Study|Progressive Disease|3|||
156680098|NCT01453153|565574457|FG001|Overall Study|Progressive Disease|2|||
156680099|NCT01453153|565574458|FG002|Overall Study|Progressive Disease|16|||
156680100|NCT01453153|565574456|FG000|Overall Study|Withdrawal by Subject|0|||
156680101|NCT01453153|565574457|FG001|Overall Study|Withdrawal by Subject|1|||
156680102|NCT01453153|565574458|FG002|Overall Study|Withdrawal by Subject|2|||
156680103|NCT01453153|565574456|FG000|Overall Study|Adverse Event|1|||
156680104|NCT01453153|565574457|FG001|Overall Study|Adverse Event|1|||
156680105|NCT01453153|565574458|FG002|Overall Study|Adverse Event|1|||
156680106|NCT02415387|565574464|FG000|Overall Study|Withdrawal by Subject|6|||
156782766|NCT01658878|565954737|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782767|NCT01658878|565954738|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156808722|NCT03052608|566054440|FG000|Long-Term Follow-up Phase|Ongoing|122|||
156680107|NCT02415387|565574465|FG001|Overall Study|Withdrawal by Subject|1|||
156680108|NCT02415387|565574464|FG000|Overall Study|blood draw problem|0|||
156680109|NCT02415387|565574465|FG001|Overall Study|blood draw problem|1|||
156680110|NCT02415387|565574464|FG000|Overall Study|Protocol Violation|1|||
156680111|NCT02415387|565574465|FG001|Overall Study|Protocol Violation|0|||
156680112|NCT03243396|565574466|FG000|Overall Study|Lost to Follow-up|2|||
156680113|NCT03243396|565574467|FG001|Overall Study|Lost to Follow-up|3|||
156680114|NCT03243396|565574468|FG002|Overall Study|Lost to Follow-up|15|||
156680115|NCT03243396|565574469|FG003|Overall Study|Lost to Follow-up|8|||
156680116|NCT03243396|565574470|FG004|Overall Study|Lost to Follow-up|1|||
156680117|NCT03243396|565574471|FG005|Overall Study|Lost to Follow-up|4|||
156680118|NCT03243396|565574472|FG006|Overall Study|Lost to Follow-up|9|||
156680119|NCT03687242|565574473|FG000|Overall Study|Adverse Event|1|||
156680120|NCT01579006|565574475|FG000|Overall Study|Lack of Efficacy|10|||
156680121|NCT01579006|565574475|FG000|Overall Study|Adverse Event|13|||
156680122|NCT01579006|565574475|FG000|Overall Study|Withdrawal by Subject|5|||
156867072|NCT01746901|566273451|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
156867073|NCT01746901|566273452|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
156867074|NCT01746901|566273453|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
156867075|NCT01746901|566273454|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
156680123|NCT01579006|565574475|FG000|Overall Study|Non-compliance|3|||
156680124|NCT01579006|565574475|FG000|Overall Study|Due to participant's health fund|1|||
156680125|NCT01579006|565574475|FG000|Overall Study|Scheduled surgery|1|||
156680126|NCT02733627|565574477|FG000|Overall Study|Adverse Event|0|||
156680127|NCT02733627|565574478|FG001|Overall Study|Adverse Event|1|||
156680128|NCT02733627|565574479|FG002|Overall Study|Adverse Event|1|||
156680129|NCT02733627|565574480|FG003|Overall Study|Adverse Event|0|||
156680130|NCT02733627|565574477|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680131|NCT02733627|565574478|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680132|NCT02733627|565574479|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
156680133|NCT02733627|565574480|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
156680134|NCT05393271|565574481|FG000|Overall Study|Physician Decision|0|||
156680135|NCT05393271|565574482|FG001|Overall Study|Physician Decision|0|||
156867076|NCT01746901|566273455|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
156867077|NCT01746901|566273447|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867078|NCT01746901|566273448|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867079|NCT01746901|566273449|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867080|NCT01746901|566273450|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867081|NCT01746901|566273451|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867082|NCT01746901|566273452|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867083|NCT01746901|566273453|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867084|NCT01746901|566273454|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
156867085|NCT01746901|566273455|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
156867086|NCT01746901|566273447|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867087|NCT01746901|566273448|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
156680136|NCT05393271|565574483|FG002|Overall Study|Physician Decision|0|||
156680137|NCT05393271|565574484|FG003|Overall Study|Physician Decision|0|||
156680138|NCT05393271|565574485|FG004|Overall Study|Physician Decision|0|||
156680139|NCT05393271|565574486|FG005|Overall Study|Physician Decision|0|||
156680140|NCT05393271|565574487|FG006|Overall Study|Physician Decision|1|||
156680141|NCT05393271|565574488|FG007|Overall Study|Physician Decision|0|||
156680142|NCT05393271|565574489|FG008|Overall Study|Physician Decision|0|||
156680143|NCT05393271|565574490|FG009|Overall Study|Physician Decision|0|||
156680144|NCT05393271|565574491|FG010|Overall Study|Physician Decision|0|||
156867088|NCT01746901|566273449|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867089|NCT01746901|566273450|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867090|NCT01746901|566273451|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867091|NCT01746901|566273452|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
156867092|NCT01746901|566273453|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
156867093|NCT01746901|566273454|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
156867094|NCT01746901|566273455|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
157012471|NCT04043455|566799354|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
157012472|NCT04043455|566799355|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
157012473|NCT04043455|566799356|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
157012474|NCT04043455|566799357|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
157012475|NCT04043455|566799358|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
157012476|NCT04043455|566799353|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
157012477|NCT04043455|566799354|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
157012478|NCT04043455|566799355|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
157012479|NCT04043455|566799356|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
157012480|NCT04043455|566799357|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
157012481|NCT04043455|566799358|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
157012482|NCT04043455|566799353|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
157012483|NCT04043455|566799354|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
157012484|NCT04043455|566799355|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
157012485|NCT04043455|566799356|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
157012486|NCT04043455|566799357|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
157012487|NCT04043455|566799358|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
157012488|NCT05505045|566799359|FG000|Overall Study|Withdrawal by Subject|2|||
157012489|NCT05505045|566799360|FG001|Overall Study|Withdrawal by Subject|1|||
156680145|NCT03167606|565574492|FG000|Overall Study|Lost to Follow-up|73|||
156680146|NCT03167606|565574493|FG001|Overall Study|Lost to Follow-up|64|||
156680147|NCT03167606|565574492|FG000|Overall Study|Withdrawal by Subject|6|||
156680148|NCT03167606|565574493|FG001|Overall Study|Withdrawal by Subject|5|||
156680149|NCT03167606|565574492|FG000|Overall Study|Withdrawal by Investigator|0|||
156680150|NCT03167606|565574493|FG001|Overall Study|Withdrawal by Investigator|2|||
156680151|NCT01698554|565574500|FG000|Overall Study|Adverse Event|2|||
156680152|NCT01698554|565574501|FG001|Overall Study|Adverse Event|5|||
156680153|NCT01698554|565574502|FG002|Overall Study|Adverse Event|0|||
156680154|NCT01698554|565574503|FG003|Overall Study|Adverse Event|1|||
156680155|NCT01698554|565574500|FG000|Overall Study|Lost to Follow-up|1|||
156680156|NCT01698554|565574501|FG001|Overall Study|Lost to Follow-up|0|||
156680157|NCT01698554|565574502|FG002|Overall Study|Lost to Follow-up|0|||
156867095|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867096|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156680158|NCT01698554|565574503|FG003|Overall Study|Lost to Follow-up|0|||
156680159|NCT01698554|565574500|FG000|Overall Study|Personal Reasons|0|||
156680160|NCT01698554|565574501|FG001|Overall Study|Personal Reasons|5|||
156680161|NCT01698554|565574502|FG002|Overall Study|Personal Reasons|1|||
156680162|NCT01698554|565574503|FG003|Overall Study|Personal Reasons|1|||
156867097|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867098|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
156867099|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867100|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867101|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867102|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867103|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
156867104|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867105|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867106|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867107|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867108|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867109|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
156867110|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867111|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
156867112|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
156867113|NCT01746901|566273447|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867114|NCT01746901|566273448|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867115|NCT01746901|566273449|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867116|NCT01746901|566273450|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867117|NCT01746901|566273451|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867118|NCT01746901|566273452|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867119|NCT01746901|566273453|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
156867120|NCT01746901|566273454|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
156867121|NCT01746901|566273455|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
156867122|NCT03041038|566273456|FG000|Overall Study|Withdrawal by Subject|4|||
156867123|NCT03041038|566273457|FG001|Overall Study|Withdrawal by Subject|0|||
156867124|NCT03041038|566273456|FG000|Overall Study|Lost to Follow-up|1|||
156867125|NCT03041038|566273457|FG001|Overall Study|Lost to Follow-up|1|||
156867126|NCT03041038|566273456|FG000|Overall Study|Protocol Violation|1|||
156867127|NCT03041038|566273457|FG001|Overall Study|Protocol Violation|1|||
156867128|NCT00803569|566273458|FG000|Overall Study|Progressive Disease|3|||
156867129|NCT00803569|566273458|FG000|Overall Study|Noncompliance|1|||
156867130|NCT00930046|566273459|FG000|Overall Study|Wound catheter malfunctioned|1|||
156867131|NCT00930046|566273460|FG001|Overall Study|Wound catheter malfunctioned|2|||
156867132|NCT01598532|566273461|FG000|Overall Study|Lost to Follow-up|3|||
156867133|NCT01598532|566273461|FG000|Overall Study|Did not meet inclusion criteria|8|||
156867134|NCT00912808|566273462|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
156867135|NCT00912808|566273463|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156867136|NCT00912808|566273462|FG000|Washout|Withdrawal by Subject|0|||
156867137|NCT00912808|566273463|FG001|Washout|Withdrawal by Subject|1|||
156680163|NCT01698554|565574500|FG000|Overall Study|Protocol Violation|2|||
156680164|NCT01698554|565574501|FG001|Overall Study|Protocol Violation|0|||
156867138|NCT00912808|566273462|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156680165|NCT01698554|565574502|FG002|Overall Study|Protocol Violation|1|||
156867139|NCT00912808|566273463|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
156867140|NCT00912808|566273462|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
156867141|NCT00912808|566273463|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156867142|NCT00702221|566273464|FG000|Overall Study|Adverse Event|4|||
156867143|NCT00702221|566273465|FG001|Overall Study|Adverse Event|3|||
156680166|NCT01698554|565574503|FG003|Overall Study|Protocol Violation|0|||
156680167|NCT01698554|565574500|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156680168|NCT01698554|565574501|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156680169|NCT01698554|565574502|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156867144|NCT02900378|566273466|FG000|Randomization (Visit 2)|Adverse Event|14|||
156867145|NCT02900378|566273467|FG001|Randomization (Visit 2)|Adverse Event|11|||
156867146|NCT02900378|566273466|FG000|Randomization (Visit 2)|Death|1|||
156867147|NCT02900378|566273467|FG001|Randomization (Visit 2)|Death|4|||
156867148|NCT02900378|566273466|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
156867149|NCT02900378|566273467|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
156867150|NCT02900378|566273466|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
156867151|NCT02900378|566273467|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
156867152|NCT02900378|566273466|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
156867153|NCT02900378|566273467|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
156867154|NCT02900378|566273466|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
156867155|NCT02900378|566273467|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
156867156|NCT02900378|566273466|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
156867157|NCT02900378|566273467|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
156867158|NCT03345784|566273472|FG000|Overall Study|Withdrawal by Subject|2|||
156867159|NCT03345784|566273473|FG001|Overall Study|Withdrawal by Subject|1|||
156680170|NCT01698554|565574503|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156680171|NCT00697827|565574504|FG000|Overall Study|enrolled but not treated|2|||
156680172|NCT00697827|565574505|FG001|Overall Study|enrolled but not treated|1|||
156680173|NCT03259165|565574506|FG000|Overall Study|COVID 19 pandemic|1|||
156680174|NCT03259165|565574507|FG001|Overall Study|COVID 19 pandemic|1|||
156680175|NCT03732833|565574514|FG000|Overall Study|Adverse Event|0|||
156680176|NCT03732833|565574515|FG001|Overall Study|Adverse Event|3|||
156680177|NCT03732833|565574516|FG002|Overall Study|Adverse Event|1|||
156680178|NCT03732833|565574514|FG000|Overall Study|Withdrawal by Subject|11|||
156680179|NCT03732833|565574515|FG001|Overall Study|Withdrawal by Subject|13|||
156680180|NCT03732833|565574516|FG002|Overall Study|Withdrawal by Subject|8|||
156680181|NCT03732833|565574514|FG000|Overall Study|Lost to Follow-up|3|||
156680182|NCT03732833|565574515|FG001|Overall Study|Lost to Follow-up|5|||
156680183|NCT03732833|565574516|FG002|Overall Study|Lost to Follow-up|4|||
156680184|NCT03732833|565574514|FG000|Overall Study|Pregnancy|0|||
156680185|NCT03732833|565574515|FG001|Overall Study|Pregnancy|2|||
156680186|NCT03732833|565574516|FG002|Overall Study|Pregnancy|0|||
156680187|NCT03732833|565574514|FG000|Overall Study|Physician Decision|2|||
156680188|NCT03732833|565574515|FG001|Overall Study|Physician Decision|3|||
156680189|NCT03732833|565574516|FG002|Overall Study|Physician Decision|1|||
156680190|NCT03732833|565574514|FG000|Overall Study|Covid-19 related and other reasons|2|||
156680191|NCT03732833|565574515|FG001|Overall Study|Covid-19 related and other reasons|7|||
156680192|NCT03732833|565574516|FG002|Overall Study|Covid-19 related and other reasons|3|||
156680193|NCT02004691|565574517|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
156680194|NCT02004691|565574518|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
156680195|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
156680196|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
156680197|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
156680198|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
156680199|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
156680200|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
156680201|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
156680202|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
156680203|NCT02004691|565574517|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
156680204|NCT02004691|565574518|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
156680205|NCT02623218|565574519|FG000|Overall Study|Lost to Follow-up|0|||
156680206|NCT02623218|565574520|FG001|Overall Study|Lost to Follow-up|1|||
156680207|NCT02623218|565574521|FG002|Overall Study|Lost to Follow-up|0|||
156680208|NCT02623218|565574522|FG003|Overall Study|Lost to Follow-up|0|||
156680209|NCT02623218|565574523|FG004|Overall Study|Lost to Follow-up|0|||
156680210|NCT01726803|565574524|FG000|Overall Study|Lost to Follow-up|6|||
156680211|NCT01726803|565574525|FG001|Overall Study|Lost to Follow-up|1|||
156680212|NCT01726803|565574524|FG000|Overall Study|Withdrawal by Subject|1|||
156680213|NCT01726803|565574525|FG001|Overall Study|Withdrawal by Subject|0|||
157012490|NCT01643070|566799361|FG000|Overall Study|Withdrawal by Subject|3|||
157012491|NCT01643070|566799362|FG001|Overall Study|Withdrawal by Subject|1|||
157012492|NCT01643070|566799361|FG000|Overall Study|Death|1|||
156867160|NCT01249261|566273474|FG000|Overall Study|Withdrawal by Subject|1|||
157012493|NCT01643070|566799362|FG001|Overall Study|Death|0|||
157012494|NCT01643070|566799361|FG000|Overall Study|Pregressive disease|0|||
157012495|NCT01643070|566799362|FG001|Overall Study|Pregressive disease|2|||
157012496|NCT04104321|566799364|FG000|Overall Study|didn't take the study drug|3|||
156680214|NCT03980522|565574532|FG000|Treatment Period|Adverse Event|1|||
156680215|NCT03980522|565574533|FG001|Treatment Period|Adverse Event|0|||
156680216|NCT03980522|565574534|FG002|Treatment Period|Adverse Event|0|||
156680217|NCT03980522|565574535|FG003|Treatment Period|Adverse Event|0|||
156680218|NCT03980522|565574536|FG004|Treatment Period|Adverse Event|0|||
156680219|NCT01091363|565574537|FG000|Overall Study|Withdrawal by Subject|11|||
156867161|NCT01249261|566273475|FG001|Overall Study|Withdrawal by Subject|0|||
156867162|NCT01055197|566273483|FG000|Overall Study|Protocol Violation|7|||
156680220|NCT01091363|565574538|FG001|Overall Study|Withdrawal by Subject|15|||
156680221|NCT01091363|565574537|FG000|Overall Study|Lost to Follow-up|2|||
156680222|NCT01091363|565574538|FG001|Overall Study|Lost to Follow-up|2|||
156680223|NCT00045162|565574539|FG000|Overall Study|Ineligible|12|||
156680224|NCT00045162|565574540|FG001|Overall Study|Ineligible|8|||
156680225|NCT00045162|565574539|FG000|Overall Study|Not treated|7|||
156680226|NCT00045162|565574540|FG001|Overall Study|Not treated|2|||
156680227|NCT00045162|565574539|FG000|Overall Study|Adverse Event|55|||
156680228|NCT00045162|565574540|FG001|Overall Study|Adverse Event|50|||
156680229|NCT00045162|565574539|FG000|Overall Study|Lack of Efficacy|32|||
156680230|NCT00045162|565574540|FG001|Overall Study|Lack of Efficacy|29|||
156680231|NCT00045162|565574539|FG000|Overall Study|Death|10|||
156680232|NCT00045162|565574540|FG001|Overall Study|Death|10|||
156680233|NCT00045162|565574539|FG000|Overall Study|Withdrawal by Subject|5|||
156680234|NCT00045162|565574540|FG001|Overall Study|Withdrawal by Subject|3|||
156680235|NCT00045162|565574539|FG000|Overall Study|Other|21|||
156680236|NCT00045162|565574540|FG001|Overall Study|Other|16|||
156680237|NCT03407729|565574541|FG000|Overall Study|Lost to Follow-up|2|||
156680238|NCT03407729|565574542|FG001|Overall Study|Lost to Follow-up|0|||
156680239|NCT03407729|565574541|FG000|Overall Study|Unable to schedule|0|||
156680240|NCT03407729|565574542|FG001|Overall Study|Unable to schedule|3|||
156680241|NCT00830167|565574545|FG000|Overall Study|Lack of Efficacy|26|||
156680242|NCT00830167|565574546|FG001|Overall Study|Lack of Efficacy|10|||
156680243|NCT00830167|565574545|FG000|Overall Study|Adverse Event|8|||
156680244|NCT00830167|565574546|FG001|Overall Study|Adverse Event|24|||
156680245|NCT00830167|565574545|FG000|Overall Study|Not meeting entrance criteria|2|||
156680246|NCT00830167|565574546|FG001|Overall Study|Not meeting entrance criteria|5|||
156680247|NCT00830167|565574545|FG000|Overall Study|Withdrawal by Subject|2|||
156680248|NCT00830167|565574546|FG001|Overall Study|Withdrawal by Subject|0|||
156680249|NCT00830167|565574545|FG000|Overall Study|Lost to Follow-up|0|||
156680250|NCT00830167|565574546|FG001|Overall Study|Lost to Follow-up|1|||
156782768|NCT01658878|565954739|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782769|NCT01658878|565954740|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782770|NCT01658878|565954741|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782771|NCT01658878|565954742|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
156782772|NCT01658878|565954743|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
156782773|NCT01658878|565954744|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782774|NCT01658878|565954745|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782775|NCT01658878|565954746|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782776|NCT01658878|565954747|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782777|NCT01658878|565954748|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782778|NCT01658878|565954749|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782779|NCT01658878|565954750|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
156782780|NCT01658878|565954751|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
156782781|NCT01658878|565954752|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
156782782|NCT01658878|565954729|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
156782783|NCT01658878|565954730|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
156782784|NCT01658878|565954731|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
156782785|NCT01658878|565954732|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
156782786|NCT01658878|565954733|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
156782787|NCT01658878|565954734|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
156782788|NCT01658878|565954735|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
156782789|NCT01658878|565954736|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
156782790|NCT01658878|565954737|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
156782791|NCT01658878|565954738|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
156782792|NCT01658878|565954739|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
156782793|NCT01658878|565954740|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
156782794|NCT01658878|565954741|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
156782795|NCT01658878|565954742|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
156782796|NCT01658878|565954743|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
156782797|NCT01658878|565954744|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
157120058|NCT05030311|567192974|FG000|Overall Study|Lost to Follow-up|5|||
157120059|NCT05030311|567192975|FG001|Overall Study|Lost to Follow-up|1|||
156680251|NCT00830167|565574545|FG000|Overall Study|Protocol Violation|0|||
156680252|NCT00830167|565574546|FG001|Overall Study|Protocol Violation|1|||
156680253|NCT00830167|565574545|FG000|Overall Study|Other|2|||
156680254|NCT00830167|565574546|FG001|Overall Study|Other|2|||
156680255|NCT00360490|565574549|FG000|Overall Study|Adverse Event|4|||
156680256|NCT00360490|565574550|FG001|Overall Study|Adverse Event|2|||
156680257|NCT00360490|565574549|FG000|Overall Study|Lost to Follow-up|2|||
156680258|NCT00360490|565574550|FG001|Overall Study|Lost to Follow-up|1|||
157120060|NCT05030311|567192974|FG000|Overall Study|Protocol Violation|4|||
156867163|NCT01055197|566273484|FG001|Overall Study|Protocol Violation|2|||
156867164|NCT01055197|566273483|FG000|Overall Study|Withdrawal by Subject|2|||
156867165|NCT01055197|566273484|FG001|Overall Study|Withdrawal by Subject|0|||
156867166|NCT00389610|566273485|FG000|Overall Study|Disease Progression|0|||
156867167|NCT00389610|566273486|FG001|Overall Study|Disease Progression|19|||
156867168|NCT00389610|566273485|FG000|Overall Study|Death|0|||
156867169|NCT00389610|566273486|FG001|Overall Study|Death|1|||
156867170|NCT00389610|566273485|FG000|Overall Study|Physician Decision|0|||
156867171|NCT00389610|566273486|FG001|Overall Study|Physician Decision|1|||
156867172|NCT00389610|566273485|FG000|Overall Study|Withdrawal by Subject|0|||
156867173|NCT00389610|566273486|FG001|Overall Study|Withdrawal by Subject|1|||
156867174|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
156867175|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
156867176|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
156867177|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
156867178|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
156867179|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
156867180|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
156867181|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
156867182|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
156867183|NCT00538902|566273487|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867184|NCT00538902|566273488|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867185|NCT00538902|566273489|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
156867186|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
156867187|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
156867188|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
156867189|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
156867190|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
156867191|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
156867192|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
156867193|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
156867194|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
156867195|NCT00538902|566273487|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
156867196|NCT00538902|566273488|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
156867197|NCT00538902|566273489|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
156867198|NCT01967940|566273494|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867199|NCT01967940|566273495|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867200|NCT01967940|566273496|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
156867201|NCT01967940|566273497|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
156867202|NCT01967940|566273494|FG000|Part 2|Adverse Event|0|||
156867203|NCT01967940|566273495|FG001|Part 2|Adverse Event|0|||
156867204|NCT01967940|566273496|FG002|Part 2|Adverse Event|0|||
156867205|NCT01967940|566273497|FG003|Part 2|Adverse Event|1|||
156867206|NCT01967940|566273494|FG000|Part 2|Unknown Reason|0|||
156867207|NCT01967940|566273495|FG001|Part 2|Unknown Reason|0|||
156867208|NCT01967940|566273496|FG002|Part 2|Unknown Reason|0|||
156867209|NCT01967940|566273497|FG003|Part 2|Unknown Reason|1|||
156867210|NCT04109547|566273498|FG000|Overall Study|Withdrawal by Subject|3|||
156867211|NCT04109547|566273499|FG001|Overall Study|Withdrawal by Subject|2|||
156867212|NCT04109547|566273500|FG002|Overall Study|Withdrawal by Subject|6|||
156867213|NCT04109547|566273501|FG003|Overall Study|Withdrawal by Subject|6|||
156867214|NCT04109547|566273498|FG000|Overall Study|Lost to Follow-up|0|||
156680259|NCT00360490|565574549|FG000|Overall Study|Physician Decision|2|||
156680260|NCT00360490|565574550|FG001|Overall Study|Physician Decision|1|||
156680261|NCT00360490|565574549|FG000|Overall Study|Protocol Violation|0|||
156680262|NCT00360490|565574550|FG001|Overall Study|Protocol Violation|4|||
156680263|NCT00360490|565574549|FG000|Overall Study|Withdrawal by Subject|1|||
156680264|NCT00360490|565574550|FG001|Overall Study|Withdrawal by Subject|3|||
156680265|NCT02289820|565574551|FG000|Overall Study|Withdrawal by Subject|2|||
156680266|NCT02289820|565574552|FG001|Overall Study|Withdrawal by Subject|1|||
156680267|NCT02289820|565574553|FG002|Overall Study|Withdrawal by Subject|2|||
156680268|NCT02289820|565574554|FG003|Overall Study|Withdrawal by Subject|1|||
156680269|NCT02289820|565574555|FG004|Overall Study|Withdrawal by Subject|0|||
156680270|NCT02289820|565574556|FG005|Overall Study|Withdrawal by Subject|0|||
156680271|NCT02289820|565574557|FG006|Overall Study|Withdrawal by Subject|1|||
156680272|NCT02289820|565574551|FG000|Overall Study|Death|0|||
156680273|NCT02289820|565574552|FG001|Overall Study|Death|0|||
156867215|NCT04109547|566273499|FG001|Overall Study|Lost to Follow-up|0|||
156867216|NCT04109547|566273500|FG002|Overall Study|Lost to Follow-up|0|||
156867217|NCT04109547|566273501|FG003|Overall Study|Lost to Follow-up|1|||
156867218|NCT04109547|566273498|FG000|Overall Study|Physician Decision|1|||
156867219|NCT04109547|566273499|FG001|Overall Study|Physician Decision|2|||
156867220|NCT04109547|566273500|FG002|Overall Study|Physician Decision|0|||
156867221|NCT04109547|566273501|FG003|Overall Study|Physician Decision|0|||
156867222|NCT01550003|566273502|FG000|Overall Study|Adverse Event|0|||
156867223|NCT01550003|566273503|FG001|Overall Study|Adverse Event|9|||
156867224|NCT01550003|566273504|FG002|Overall Study|Adverse Event|15|||
156867225|NCT01550003|566273502|FG000|Overall Study|Lack of Efficacy|4|||
156867226|NCT01550003|566273503|FG001|Overall Study|Lack of Efficacy|11|||
156867227|NCT01550003|566273504|FG002|Overall Study|Lack of Efficacy|15|||
156867228|NCT01550003|566273502|FG000|Overall Study|Protocol Violation|0|||
156867229|NCT01550003|566273503|FG001|Overall Study|Protocol Violation|3|||
156867230|NCT01550003|566273504|FG002|Overall Study|Protocol Violation|2|||
156867231|NCT01550003|566273502|FG000|Overall Study|Lost to Follow-up|1|||
156867232|NCT01550003|566273503|FG001|Overall Study|Lost to Follow-up|4|||
156867233|NCT01550003|566273504|FG002|Overall Study|Lost to Follow-up|8|||
156867234|NCT01550003|566273502|FG000|Overall Study|Consent withdrawn|2|||
156867235|NCT01550003|566273503|FG001|Overall Study|Consent withdrawn|11|||
156867236|NCT01550003|566273504|FG002|Overall Study|Consent withdrawn|23|||
156867237|NCT01550003|566273502|FG000|Overall Study|Missing|1|||
156867238|NCT01550003|566273503|FG001|Overall Study|Missing|0|||
156867239|NCT01550003|566273504|FG002|Overall Study|Missing|2|||
156867240|NCT01550003|566273502|FG000|Overall Study|Study closure as announced by sponsor|7|||
156867241|NCT01550003|566273503|FG001|Overall Study|Study closure as announced by sponsor|6|||
156867242|NCT01550003|566273504|FG002|Overall Study|Study closure as announced by sponsor|24|||
156867243|NCT01550003|566273502|FG000|Overall Study|Protocol Noncompliance|1|||
156867244|NCT01550003|566273503|FG001|Overall Study|Protocol Noncompliance|0|||
156867245|NCT01550003|566273504|FG002|Overall Study|Protocol Noncompliance|0|||
156867246|NCT01550003|566273502|FG000|Overall Study|Study closure|0|||
156867247|NCT01550003|566273503|FG001|Overall Study|Study closure|1|||
156867248|NCT01550003|566273504|FG002|Overall Study|Study closure|1|||
156680274|NCT02289820|565574553|FG002|Overall Study|Death|1|||
156680275|NCT02289820|565574554|FG003|Overall Study|Death|0|||
156680276|NCT02289820|565574555|FG004|Overall Study|Death|0|||
156680277|NCT02289820|565574556|FG005|Overall Study|Death|0|||
156680278|NCT02289820|565574557|FG006|Overall Study|Death|0|||
156680279|NCT02289820|565574551|FG000|Overall Study|Lost to Follow-up|0|||
156782798|NCT01658878|565954745|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
156867249|NCT01550003|566273502|FG000|Overall Study|Patient reached adulthood|0|||
156867250|NCT01550003|566273503|FG001|Overall Study|Patient reached adulthood|1|||
156680280|NCT02289820|565574552|FG001|Overall Study|Lost to Follow-up|0|||
156782799|NCT01658878|565954746|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
156782800|NCT01658878|565954747|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
156782801|NCT01658878|565954748|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
156782802|NCT01658878|565954749|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
156782803|NCT01658878|565954750|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
156782804|NCT01658878|565954751|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
156782805|NCT01658878|565954752|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
156782806|NCT01658878|565954729|FG000|Treatment Period|Death|0|||
156782807|NCT01658878|565954730|FG001|Treatment Period|Death|0|||
156782808|NCT01658878|565954731|FG002|Treatment Period|Death|0|||
156782809|NCT01658878|565954732|FG003|Treatment Period|Death|0|||
156782810|NCT01658878|565954733|FG004|Treatment Period|Death|0|||
156782811|NCT01658878|565954734|FG005|Treatment Period|Death|0|||
156782812|NCT01658878|565954735|FG006|Treatment Period|Death|0|||
156782813|NCT01658878|565954736|FG007|Treatment Period|Death|0|||
156782814|NCT01658878|565954737|FG008|Treatment Period|Death|0|||
156782815|NCT01658878|565954738|FG009|Treatment Period|Death|0|||
156782816|NCT01658878|565954739|FG010|Treatment Period|Death|0|||
156782817|NCT01658878|565954740|FG011|Treatment Period|Death|0|||
156782818|NCT01658878|565954741|FG012|Treatment Period|Death|1|||
156782819|NCT01658878|565954742|FG013|Treatment Period|Death|0|||
156782820|NCT01658878|565954743|FG014|Treatment Period|Death|0|||
156782821|NCT01658878|565954744|FG015|Treatment Period|Death|0|||
156782822|NCT01658878|565954745|FG016|Treatment Period|Death|1|||
156867251|NCT01550003|566273504|FG002|Overall Study|Patient reached adulthood|0|||
156867252|NCT01550003|566273502|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
156867253|NCT01550003|566273503|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
156867254|NCT01550003|566273504|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
156867255|NCT01550003|566273502|FG000|Overall Study|Sponsor's order|0|||
156867256|NCT01550003|566273503|FG001|Overall Study|Sponsor's order|3|||
156680281|NCT02289820|565574553|FG002|Overall Study|Lost to Follow-up|3|||
156680282|NCT02289820|565574554|FG003|Overall Study|Lost to Follow-up|1|||
156680283|NCT02289820|565574555|FG004|Overall Study|Lost to Follow-up|0|||
156782823|NCT01658878|565954746|FG017|Treatment Period|Death|1|||
156782824|NCT01658878|565954747|FG018|Treatment Period|Death|0|||
156782825|NCT01658878|565954748|FG019|Treatment Period|Death|0|||
156782826|NCT01658878|565954749|FG020|Treatment Period|Death|0|||
156782827|NCT01658878|565954750|FG021|Treatment Period|Death|2|||
156782828|NCT01658878|565954751|FG022|Treatment Period|Death|0|||
156782829|NCT01658878|565954752|FG023|Treatment Period|Death|0|||
156782830|NCT01658878|565954729|FG000|Treatment Period|Adverse Event|0|||
156867257|NCT01550003|566273504|FG002|Overall Study|Sponsor's order|3|||
156867258|NCT01550003|566273502|FG000|Overall Study|Sponsor's decision|1|||
156680284|NCT02289820|565574556|FG005|Overall Study|Lost to Follow-up|1|||
156680285|NCT02289820|565574557|FG006|Overall Study|Lost to Follow-up|1|||
156680286|NCT02289820|565574551|FG000|Overall Study|withdrawal of consent|0|||
156680287|NCT02289820|565574552|FG001|Overall Study|withdrawal of consent|1|||
156680288|NCT02289820|565574553|FG002|Overall Study|withdrawal of consent|0|||
156680289|NCT02289820|565574554|FG003|Overall Study|withdrawal of consent|0|||
156680290|NCT02289820|565574555|FG004|Overall Study|withdrawal of consent|0|||
156680291|NCT02289820|565574556|FG005|Overall Study|withdrawal of consent|0|||
156680292|NCT02289820|565574557|FG006|Overall Study|withdrawal of consent|0|||
156680293|NCT02005276|565574558|FG000|Overall Study|No longer interested|5|||
156680294|NCT02005276|565574559|FG001|Overall Study|No longer interested|2|||
156680295|NCT02005276|565574560|FG002|Overall Study|No longer interested|3|||
156680296|NCT02005276|565574561|FG003|Overall Study|No longer interested|3|||
156680297|NCT02786927|565574568|FG000|Overall Study|Adverse Event|1|||
156680298|NCT02786927|565574568|FG000|Overall Study|Protocol Violation|4|||
156680299|NCT01801917|565574569|FG000|Period 1 - Randomized|Adverse Event|1|||
156680300|NCT01801917|565574570|FG001|Period 1 - Randomized|Adverse Event|0|||
156680301|NCT01801917|565574571|FG002|Period 1 - Randomized|Adverse Event|1|||
156680302|NCT01801917|565574572|FG003|Period 1 - Randomized|Adverse Event|0|||
156680303|NCT03919695|565574573|FG000|3-month Follow-up|Death|1|||
156680304|NCT03919695|565574574|FG001|3-month Follow-up|Death|1|||
156680305|NCT03919695|565574573|FG000|3-month Follow-up|unable to contact|0|||
156680306|NCT03919695|565574574|FG001|3-month Follow-up|unable to contact|3|||
156680307|NCT03919695|565574573|FG000|3-month Follow-up|in prison|0|||
156680308|NCT03919695|565574574|FG001|3-month Follow-up|in prison|1|||
156680309|NCT03919695|565574573|FG000|6-month Follow-up|Death|0|||
156680310|NCT03919695|565574574|FG001|6-month Follow-up|Death|1|||
156680311|NCT03919695|565574573|FG000|6-month Follow-up|Lost to Follow-up|1|||
156680312|NCT03919695|565574574|FG001|6-month Follow-up|Lost to Follow-up|2|||
156680313|NCT03919695|565574573|FG000|6-month Follow-up|in prison|0|||
156680314|NCT03919695|565574574|FG001|6-month Follow-up|in prison|2|||
156680315|NCT03919695|565574573|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
156680316|NCT03919695|565574574|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
156680317|NCT03919695|565574573|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
156680318|NCT03919695|565574574|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
156680319|NCT01688882|565574575|FG000|Overall Study|Adverse Event|1|||
156680320|NCT01688882|565574576|FG001|Overall Study|Adverse Event|0|||
156680321|NCT01688882|565574575|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156680322|NCT01688882|565574576|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156680323|NCT01688882|565574575|FG000|Overall Study|Administrative problems|1|||
156680324|NCT01688882|565574576|FG001|Overall Study|Administrative problems|0|||
156782831|NCT01658878|565954730|FG001|Treatment Period|Adverse Event|0|||
156782832|NCT01658878|565954731|FG002|Treatment Period|Adverse Event|0|||
156782833|NCT01658878|565954732|FG003|Treatment Period|Adverse Event|0|||
156782834|NCT01658878|565954733|FG004|Treatment Period|Adverse Event|0|||
156782835|NCT01658878|565954734|FG005|Treatment Period|Adverse Event|0|||
156782836|NCT01658878|565954735|FG006|Treatment Period|Adverse Event|0|||
156782837|NCT01658878|565954736|FG007|Treatment Period|Adverse Event|0|||
156782838|NCT01658878|565954737|FG008|Treatment Period|Adverse Event|0|||
156782839|NCT01658878|565954738|FG009|Treatment Period|Adverse Event|0|||
156782840|NCT01658878|565954739|FG010|Treatment Period|Adverse Event|0|||
156782841|NCT01658878|565954740|FG011|Treatment Period|Adverse Event|0|||
156782842|NCT01658878|565954741|FG012|Treatment Period|Adverse Event|0|||
156782843|NCT01658878|565954742|FG013|Treatment Period|Adverse Event|0|||
156782844|NCT01658878|565954743|FG014|Treatment Period|Adverse Event|0|||
156782845|NCT01658878|565954744|FG015|Treatment Period|Adverse Event|0|||
156782846|NCT01658878|565954745|FG016|Treatment Period|Adverse Event|10|||
156782847|NCT01658878|565954746|FG017|Treatment Period|Adverse Event|3|||
156680325|NCT02416934|565574578|FG000|Overall Study|given steroids|1|||
156680326|NCT02416934|565574579|FG001|Overall Study|given steroids|2|||
156680327|NCT02416934|565574578|FG000|Overall Study|Lost to Follow-up|0|||
156680328|NCT02416934|565574579|FG001|Overall Study|Lost to Follow-up|2|||
156782848|NCT01658878|565954747|FG018|Treatment Period|Adverse Event|3|||
156782849|NCT01658878|565954748|FG019|Treatment Period|Adverse Event|2|||
156782850|NCT01658878|565954749|FG020|Treatment Period|Adverse Event|3|||
156782851|NCT01658878|565954750|FG021|Treatment Period|Adverse Event|3|||
156680329|NCT02416934|565574578|FG000|Overall Study|Withdrawal by Subject|1|||
156680330|NCT02416934|565574579|FG001|Overall Study|Withdrawal by Subject|0|||
156680331|NCT02416934|565574578|FG000|Overall Study|recruited during continuing renewal proc|0|||
156680332|NCT02416934|565574579|FG001|Overall Study|recruited during continuing renewal proc|1|||
156680333|NCT02416934|565574578|FG000|Overall Study|Protocol Violation|0|||
156680334|NCT02416934|565574579|FG001|Overall Study|Protocol Violation|1|||
156782852|NCT01658878|565954751|FG022|Treatment Period|Adverse Event|4|||
156782853|NCT01658878|565954752|FG023|Treatment Period|Adverse Event|3|||
156782854|NCT01658878|565954729|FG000|Treatment Period|Lost to Follow-up|0|||
156782855|NCT01658878|565954730|FG001|Treatment Period|Lost to Follow-up|0|||
156782856|NCT01658878|565954731|FG002|Treatment Period|Lost to Follow-up|0|||
156782857|NCT01658878|565954732|FG003|Treatment Period|Lost to Follow-up|0|||
156782858|NCT01658878|565954733|FG004|Treatment Period|Lost to Follow-up|0|||
156782859|NCT01658878|565954734|FG005|Treatment Period|Lost to Follow-up|0|||
156782860|NCT01658878|565954735|FG006|Treatment Period|Lost to Follow-up|0|||
156782861|NCT01658878|565954736|FG007|Treatment Period|Lost to Follow-up|0|||
156782862|NCT01658878|565954737|FG008|Treatment Period|Lost to Follow-up|0|||
156782863|NCT01658878|565954738|FG009|Treatment Period|Lost to Follow-up|0|||
156782864|NCT01658878|565954739|FG010|Treatment Period|Lost to Follow-up|0|||
156782865|NCT01658878|565954740|FG011|Treatment Period|Lost to Follow-up|0|||
156782866|NCT01658878|565954741|FG012|Treatment Period|Lost to Follow-up|0|||
156782867|NCT01658878|565954742|FG013|Treatment Period|Lost to Follow-up|0|||
156782868|NCT01658878|565954743|FG014|Treatment Period|Lost to Follow-up|0|||
156782869|NCT01658878|565954744|FG015|Treatment Period|Lost to Follow-up|0|||
156782870|NCT01658878|565954745|FG016|Treatment Period|Lost to Follow-up|1|||
156782871|NCT01658878|565954746|FG017|Treatment Period|Lost to Follow-up|0|||
156782872|NCT01658878|565954747|FG018|Treatment Period|Lost to Follow-up|1|||
156782873|NCT01658878|565954748|FG019|Treatment Period|Lost to Follow-up|1|||
156782874|NCT01658878|565954749|FG020|Treatment Period|Lost to Follow-up|0|||
156782875|NCT01658878|565954750|FG021|Treatment Period|Lost to Follow-up|0|||
156782876|NCT01658878|565954751|FG022|Treatment Period|Lost to Follow-up|1|||
156782877|NCT01658878|565954752|FG023|Treatment Period|Lost to Follow-up|0|||
156782878|NCT05417113|565954758|FG000|Overall Study|Lost to Follow-up|2|||
156782879|NCT05417113|565954759|FG001|Overall Study|Lost to Follow-up|2|||
156782880|NCT00134719|565954760|FG000|Primary Vaccination Phase|Adverse Event|4|||
156782881|NCT00134719|565954761|FG001|Primary Vaccination Phase|Adverse Event|0|||
156782882|NCT00134719|565954762|FG002|Primary Vaccination Phase|Adverse Event|0|||
156782883|NCT00134719|565954760|FG000|Primary Vaccination Phase|Protocol Violation|1|||
156782884|NCT00134719|565954761|FG001|Primary Vaccination Phase|Protocol Violation|0|||
156782885|NCT00134719|565954762|FG002|Primary Vaccination Phase|Protocol Violation|0|||
156782886|NCT00134719|565954760|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
156782887|NCT00134719|565954761|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
156782888|NCT00134719|565954762|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
156782889|NCT00134719|565954760|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
156782890|NCT00134719|565954761|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
156782891|NCT00134719|565954762|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
156782892|NCT00134719|565954760|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
156782893|NCT00134719|565954761|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
156782894|NCT00134719|565954762|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
156782895|NCT00134719|565954760|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
156782896|NCT00134719|565954761|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
156782897|NCT00134719|565954762|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
156782898|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782899|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
156782900|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
156782901|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782902|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782903|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782904|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
156782905|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
156782906|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782907|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
156782908|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782909|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782910|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782911|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
156782912|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782913|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782914|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
156782915|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782916|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782917|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
157012497|NCT04842500|566799365|FG000|Overall Study|Withdrawal by Subject|4|||
157012498|NCT04842500|566799366|FG001|Overall Study|Withdrawal by Subject|1|||
157012499|NCT04842500|566799367|FG002|Overall Study|Withdrawal by Subject|2|||
156782918|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
156782919|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
156782920|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782921|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782922|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782923|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156808723|NCT03052608|566054441|FG001|Long-Term Follow-up Phase|Ongoing|99|||
157213222|NCT00272961|567527777|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156782924|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782925|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
156782926|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782927|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782928|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
156782929|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782930|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782931|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782932|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
156782933|NCT01807520|565954763|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
156782934|NCT01807520|565954764|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782935|NCT01807520|565954765|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782936|NCT01807520|565954766|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782937|NCT01807520|565954767|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782938|NCT01807520|565954768|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782939|NCT01807520|565954769|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
156782940|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
156782941|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
156782942|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782943|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782944|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
156782945|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782946|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
156782947|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782948|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782949|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782950|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
156782951|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782952|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782953|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
156782954|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
156782955|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782956|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782957|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782958|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782959|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782960|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
156782961|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782962|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
156782963|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782964|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782965|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782966|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782967|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
156782968|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
156782969|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782970|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156867259|NCT01550003|566273503|FG001|Overall Study|Sponsor's decision|5|||
157012500|NCT04842500|566799368|FG003|Overall Study|Withdrawal by Subject|3|||
157012501|NCT04842500|566799365|FG000|Overall Study|Protocol Violation|1|||
157012502|NCT04842500|566799366|FG001|Overall Study|Protocol Violation|0|||
157012503|NCT04842500|566799367|FG002|Overall Study|Protocol Violation|0|||
157012504|NCT04842500|566799368|FG003|Overall Study|Protocol Violation|1|||
157012505|NCT02980276|566799369|FG000|Overall Study|Withdrawal by Subject|4|||
157012506|NCT02980276|566799370|FG001|Overall Study|Withdrawal by Subject|4|||
157213223|NCT00272961|567527778|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156782971|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
156782972|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782973|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782974|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
156782975|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
156782976|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
156782977|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
157012507|NCT02980276|566799369|FG000|Overall Study|Physician Decision|0|||
157012508|NCT02980276|566799370|FG001|Overall Study|Physician Decision|1|||
157012509|NCT02980276|566799369|FG000|Overall Study|Lost to Follow-up|18|||
157012510|NCT02980276|566799370|FG001|Overall Study|Lost to Follow-up|18|||
156680335|NCT02416934|565574578|FG000|Overall Study|surgery started late|0|||
156680336|NCT02416934|565574579|FG001|Overall Study|surgery started late|1|||
156680337|NCT02416934|565574578|FG000|Overall Study|re-operation|1|||
156680338|NCT02416934|565574579|FG001|Overall Study|re-operation|0|||
156680339|NCT00494013|565574582|FG000|Overall Study|Adverse Event|0|||
156680340|NCT00494013|565574583|FG001|Overall Study|Adverse Event|1|||
156680341|NCT00494013|565574582|FG000|Overall Study|Entry Criteria Not Met|1|||
156680342|NCT00494013|565574583|FG001|Overall Study|Entry Criteria Not Met|4|||
156680343|NCT00494013|565574582|FG000|Overall Study|Lost to Follow-up|5|||
156680344|NCT00494013|565574583|FG001|Overall Study|Lost to Follow-up|6|||
156680345|NCT00494013|565574582|FG000|Overall Study|Physician Decision|3|||
156680346|NCT00494013|565574583|FG001|Overall Study|Physician Decision|5|||
156680347|NCT00494013|565574582|FG000|Overall Study|Protocol Violation|8|||
156680348|NCT00494013|565574583|FG001|Overall Study|Protocol Violation|5|||
156680349|NCT00494013|565574582|FG000|Overall Study|Withdrawal by Subject|13|||
156680350|NCT00494013|565574583|FG001|Overall Study|Withdrawal by Subject|14|||
156680351|NCT00494013|565574582|FG000|Overall Study|Sponsor Decision|0|||
156680352|NCT00494013|565574583|FG001|Overall Study|Sponsor Decision|1|||
156680353|NCT00633022|565574584|FG000|Overall Study|Adverse Event|1|||
156680354|NCT00633022|565574585|FG001|Overall Study|Adverse Event|0|||
156680355|NCT00633022|565574586|FG002|Overall Study|Adverse Event|5|||
156867260|NCT01550003|566273504|FG002|Overall Study|Sponsor's decision|4|||
156867261|NCT01550003|566273502|FG000|Overall Study|Subject mother passed away|0|||
156867262|NCT01550003|566273503|FG001|Overall Study|Subject mother passed away|1|||
156867263|NCT01550003|566273504|FG002|Overall Study|Subject mother passed away|0|||
156867264|NCT01550003|566273502|FG000|Overall Study|Discontinuation|0|||
157012511|NCT02980276|566799369|FG000|Overall Study|Death|1|||
157012512|NCT02980276|566799370|FG001|Overall Study|Death|0|||
157012513|NCT02980276|566799369|FG000|Overall Study|Miscellaneous other|10|||
157012514|NCT02980276|566799370|FG001|Overall Study|Miscellaneous other|4|||
157012515|NCT03025789|566799371|FG000|Overall Study|Lack of Efficacy|6|||
157012516|NCT03025789|566799372|FG001|Overall Study|Lack of Efficacy|1|||
157012517|NCT03025789|566799371|FG000|Overall Study|Death|1|||
157012518|NCT03025789|566799372|FG001|Overall Study|Death|0|||
157012519|NCT03025789|566799371|FG000|Overall Study|Withdrawal by Subject|0|||
157012520|NCT03025789|566799372|FG001|Overall Study|Withdrawal by Subject|2|||
157012521|NCT03554265|566799373|FG000|Overall Study|Withdrawal by Subject|2|||
157012522|NCT03554265|566799374|FG001|Overall Study|Withdrawal by Subject|2|||
157012523|NCT03554265|566799375|FG002|Overall Study|Withdrawal by Subject|3|||
157012524|NCT03554265|566799373|FG000|Overall Study|Physician Decision|0|||
157012525|NCT03554265|566799374|FG001|Overall Study|Physician Decision|0|||
157012526|NCT03554265|566799375|FG002|Overall Study|Physician Decision|1|||
157012527|NCT02652260|566799376|FG000|Base Study|Pregnancy|0|||
157012528|NCT02652260|566799377|FG001|Base Study|Pregnancy|1|||
157012529|NCT02652260|566799376|FG000|Base Study|Withdrawal by Subject|0|||
157012530|NCT02652260|566799377|FG001|Base Study|Withdrawal by Subject|1|||
157012531|NCT02652260|566799376|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
157012532|NCT02652260|566799377|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
157012533|NCT02652260|566799376|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
157012534|NCT02652260|566799377|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
157012535|NCT02652260|566799376|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
157012536|NCT02652260|566799377|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
157012537|NCT02652260|566799376|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
157012538|NCT02652260|566799377|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
157012539|NCT02652260|566799376|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
157012540|NCT02652260|566799377|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
157012541|NCT02652260|566799376|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
157012542|NCT02652260|566799377|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
157012543|NCT02652260|566799376|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
157012544|NCT02652260|566799377|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
157012545|NCT02652260|566799376|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
157012546|NCT02652260|566799377|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
157012547|NCT02652260|566799376|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
157012548|NCT02652260|566799377|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
157012549|NCT02652260|566799376|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
157012550|NCT02652260|566799377|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
157012551|NCT02652260|566799376|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
157012552|NCT02652260|566799377|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
157012553|NCT02652260|566799376|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
157012554|NCT02652260|566799377|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
157012555|NCT04999085|566799378|FG000|Overall Study|Death|1|||
157221653|NCT00094302|567558465|FG000|Overall Study|Withdrawal by Subject|103|||
156680356|NCT00633022|565574584|FG000|Overall Study|Physician Decision|0|||
156680357|NCT00633022|565574585|FG001|Overall Study|Physician Decision|1|||
156680358|NCT00633022|565574586|FG002|Overall Study|Physician Decision|0|||
157012556|NCT05056246|566799379|FG000|Overall Study|Adverse Event|0|||
156680359|NCT01751087|565574590|FG000|Overall Study|Withdrawal by Subject|1|||
156680360|NCT01751087|565574591|FG001|Overall Study|Withdrawal by Subject|0|||
156680361|NCT01751087|565574592|FG002|Overall Study|Withdrawal by Subject|0|||
156680362|NCT01751087|565574590|FG000|Overall Study|Physician Decision|0|||
156680363|NCT01751087|565574591|FG001|Overall Study|Physician Decision|0|||
156680364|NCT01751087|565574592|FG002|Overall Study|Physician Decision|1|||
156680365|NCT02293460|565575949|FG000|Overall Study|Protocol Violation|1|||
156680366|NCT02293460|565575949|FG000|Overall Study|Lack of Efficacy|2|||
156680367|NCT02293460|565575949|FG000|Overall Study|Adverse Event|2|||
156680368|NCT02293460|565575949|FG000|Overall Study|Withdrawal by Subject|1|||
156680369|NCT02805309|565575954|FG000|Overall Study|Lost to Follow-up|2|||
156680370|NCT02805309|565575955|FG001|Overall Study|Lost to Follow-up|2|||
156680371|NCT02805309|565575956|FG002|Overall Study|Lost to Follow-up|2|||
156680372|NCT02805309|565575954|FG000|Overall Study|Post-Randomization Exclusion|0|||
156680373|NCT02805309|565575955|FG001|Overall Study|Post-Randomization Exclusion|2|||
156680374|NCT02805309|565575956|FG002|Overall Study|Post-Randomization Exclusion|1|||
156680375|NCT01636934|565575957|FG000|Overall Study|Withdrawal by Subject|3|||
156680376|NCT01636934|565575958|FG001|Overall Study|Withdrawal by Subject|2|||
156680377|NCT01636934|565575957|FG000|Overall Study|Chemo cancel|1|||
156680378|NCT01636934|565575958|FG001|Overall Study|Chemo cancel|0|||
156680379|NCT01636934|565575957|FG000|Overall Study|Too ill to continue|1|||
156680380|NCT01636934|565575958|FG001|Overall Study|Too ill to continue|0|||
156680381|NCT01636934|565575957|FG000|Overall Study|Never started study medication|1|||
156680382|NCT01636934|565575958|FG001|Overall Study|Never started study medication|1|||
156680383|NCT03035890|565575963|FG000|Overall Study|Death|1|||
156680384|NCT00288704|565575967|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
156680385|NCT00288704|565575968|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
156680386|NCT00288704|565575969|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
156680387|NCT00288704|565575967|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
156680388|NCT00288704|565575968|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
156680389|NCT00288704|565575969|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
156680390|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
156680391|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
156680392|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
156680393|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
156680394|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
156680395|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
156680396|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
156680397|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
156680398|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
156680399|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
156680400|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
156680401|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
156680402|NCT00288704|565575967|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
156680403|NCT00288704|565575968|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
156680404|NCT00288704|565575969|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
156680405|NCT02473393|565575970|FG000|Overall Study|Adverse Event|0|||
156680406|NCT02473393|565575971|FG001|Overall Study|Adverse Event|0|||
156680407|NCT02473393|565575972|FG002|Overall Study|Adverse Event|1|||
156680408|NCT02473393|565575973|FG003|Overall Study|Adverse Event|0|||
156680409|NCT02473393|565575970|FG000|Overall Study|Withdrawal by Subject|0|||
156680410|NCT02473393|565575971|FG001|Overall Study|Withdrawal by Subject|0|||
156680411|NCT02473393|565575972|FG002|Overall Study|Withdrawal by Subject|1|||
156680412|NCT02473393|565575973|FG003|Overall Study|Withdrawal by Subject|1|||
156680413|NCT01257581|565575975|FG000|Overall Study|Early Termination|3|||
156680414|NCT01257581|565575976|FG001|Overall Study|Early Termination|1|||
156680415|NCT01257581|565575977|FG002|Overall Study|Early Termination|2|||
156680416|NCT01257581|565575975|FG000|Overall Study|Death|2|||
156680417|NCT01257581|565575976|FG001|Overall Study|Death|2|||
156680418|NCT01257581|565575977|FG002|Overall Study|Death|4|||
156782978|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
157012557|NCT05056246|566799380|FG001|Overall Study|Adverse Event|0|||
156680419|NCT01157234|565575978|FG000|Overall Study|Withdrawal by Subject|1|||
156680420|NCT01157234|565575979|FG001|Overall Study|Withdrawal by Subject|0|||
156680421|NCT02048813|565575992|FG000|Overall Study|Still on treatment|279|||
156680422|NCT02048813|565575993|FG001|Overall Study|Still on treatment|0|||
156680423|NCT02048813|565575992|FG000|Overall Study|Adverse Event|40|||
156680424|NCT02048813|565575993|FG001|Overall Study|Adverse Event|38|||
156680425|NCT02048813|565575992|FG000|Overall Study|Disease progression|13|||
156680426|NCT02048813|565575993|FG001|Overall Study|Disease progression|3|||
156680427|NCT02048813|565575992|FG000|Overall Study|Withdrawal by Subject|7|||
156680428|NCT02048813|565575993|FG001|Overall Study|Withdrawal by Subject|8|||
156680429|NCT02048813|565575992|FG000|Overall Study|Death|2|||
156680430|NCT02048813|565575993|FG001|Overall Study|Death|1|||
156680431|NCT02048813|565575992|FG000|Overall Study|Complication|2|||
156680432|NCT02048813|565575993|FG001|Overall Study|Complication|2|||
156680433|NCT02048813|565575992|FG000|Overall Study|Non-protocol therapy|0|||
156680434|NCT02048813|565575993|FG001|Overall Study|Non-protocol therapy|1|||
156680435|NCT02048813|565575992|FG000|Overall Study|Second primary cancer|2|||
156680436|NCT02048813|565575993|FG001|Overall Study|Second primary cancer|0|||
156680437|NCT02048813|565575992|FG000|Overall Study|Insurance|2|||
156680438|NCT02048813|565575993|FG001|Overall Study|Insurance|0|||
156680439|NCT02048813|565575992|FG000|Overall Study|Wound infection/healing|2|||
156680440|NCT02048813|565575993|FG001|Overall Study|Wound infection/healing|0|||
156680441|NCT02048813|565575992|FG000|Overall Study|Missed appointment|3|||
156680442|NCT02048813|565575993|FG001|Overall Study|Missed appointment|0|||
156680443|NCT02048813|565575992|FG000|Overall Study|Never started treatment|2|||
156680444|NCT02048813|565575993|FG001|Overall Study|Never started treatment|17|||
156680445|NCT01708954|565575994|FG000|Step 1|Disease progression|26|||
156680446|NCT01708954|565575995|FG001|Step 1|Disease progression|17|||
156680447|NCT01708954|565575996|FG002|Step 1|Disease progression|14|||
156680448|NCT01708954|565575994|FG000|Step 1|Adverse Event|3|||
156680449|NCT01708954|565575995|FG001|Step 1|Adverse Event|11|||
156680450|NCT01708954|565575996|FG002|Step 1|Adverse Event|13|||
156680451|NCT01708954|565575994|FG000|Step 1|Death|3|||
156680452|NCT01708954|565575995|FG001|Step 1|Death|2|||
156680453|NCT01708954|565575996|FG002|Step 1|Death|3|||
156680454|NCT01708954|565575994|FG000|Step 1|Withdrawal by Subject|2|||
156680455|NCT01708954|565575995|FG001|Step 1|Withdrawal by Subject|5|||
156680456|NCT01708954|565575996|FG002|Step 1|Withdrawal by Subject|3|||
156680457|NCT01708954|565575994|FG000|Step 1|Other complicating disease|0|||
156680458|NCT01708954|565575995|FG001|Step 1|Other complicating disease|2|||
156680459|NCT01708954|565575996|FG002|Step 1|Other complicating disease|0|||
156680460|NCT01708954|565575994|FG000|Step 1|Crossed over to Step 2|2|||
156680461|NCT01708954|565575995|FG001|Step 1|Crossed over to Step 2|0|||
156680462|NCT01708954|565575996|FG002|Step 1|Crossed over to Step 2|0|||
156680463|NCT01708954|565575994|FG000|Step 1|Symptomatic deterioration|1|||
156680464|NCT01708954|565575995|FG001|Step 1|Symptomatic deterioration|0|||
156680465|NCT01708954|565575996|FG002|Step 1|Symptomatic deterioration|1|||
156680466|NCT01708954|565575994|FG000|Step 1|Off-treatment reason not submitted|1|||
156680467|NCT01708954|565575995|FG001|Step 1|Off-treatment reason not submitted|1|||
156680468|NCT01708954|565575996|FG002|Step 1|Off-treatment reason not submitted|1|||
156680469|NCT01708954|565575994|FG000|Step 1|Ineligible or never received treatment|4|||
156680470|NCT01708954|565575995|FG001|Step 1|Ineligible or never received treatment|2|||
156680471|NCT01708954|565575996|FG002|Step 1|Ineligible or never received treatment|8|||
156782979|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
156782980|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156782981|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
156782982|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782983|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782984|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782985|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
156782986|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782987|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782988|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
156782989|NCT01807520|565954763|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
156782990|NCT01807520|565954764|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
156782991|NCT01807520|565954765|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782992|NCT01807520|565954766|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
156782993|NCT01807520|565954767|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
156782994|NCT01807520|565954768|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782995|NCT01807520|565954769|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
156782996|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782997|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782998|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156782999|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
157012558|NCT05056246|566799381|FG002|Overall Study|Adverse Event|0|||
157213224|NCT00272961|567527779|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
157213225|NCT00272961|567527780|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
156680472|NCT01708954|565575994|FG000|Step 2|Disease progression|9|||
156680473|NCT01708954|565575995|FG001|Step 2|Disease progression|4|||
156680474|NCT01708954|565575996|FG002|Step 2|Disease progression|0|||
156680475|NCT01708954|565575994|FG000|Step 2|Adverse Event|3|||
156680476|NCT01708954|565575995|FG001|Step 2|Adverse Event|2|||
156680477|NCT01708954|565575996|FG002|Step 2|Adverse Event|0|||
156680478|NCT01708954|565575994|FG000|Step 2|Withdrawal by Subject|1|||
156680479|NCT01708954|565575995|FG001|Step 2|Withdrawal by Subject|1|||
156680480|NCT01708954|565575996|FG002|Step 2|Withdrawal by Subject|0|||
156680481|NCT05996198|565575997|FG000|Overall Study|Withdrawal by Subject|1|||
156680482|NCT05996198|565575998|FG001|Overall Study|Withdrawal by Subject|0|||
156867265|NCT01550003|566273503|FG001|Overall Study|Discontinuation|1|||
156680483|NCT01192776|565575999|FG000|Overall Study|Death|8|||
156680484|NCT01192776|565576000|FG001|Overall Study|Death|15|||
156680485|NCT01192776|565576001|FG002|Overall Study|Death|18|||
156680486|NCT01192776|565576002|FG003|Overall Study|Death|15|||
156680487|NCT01192776|565575999|FG000|Overall Study|Lost to Follow-up|3|||
156680488|NCT01192776|565576000|FG001|Overall Study|Lost to Follow-up|6|||
156680489|NCT01192776|565576001|FG002|Overall Study|Lost to Follow-up|3|||
156680490|NCT01192776|565576002|FG003|Overall Study|Lost to Follow-up|5|||
156680491|NCT00059332|565576006|FG000|Overall Study|Withdrawal by Subject|2|||
156680492|NCT00059332|565576007|FG001|Overall Study|Withdrawal by Subject|1|||
156680493|NCT00059332|565576006|FG000|Overall Study|Lost to Follow-up|1|||
156680494|NCT00059332|565576007|FG001|Overall Study|Lost to Follow-up|1|||
156680495|NCT00981799|565576010|FG000|Overall Study|Adverse Event|1|||
156680496|NCT00981799|565576011|FG001|Overall Study|Adverse Event|1|||
156783000|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156783001|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
156783002|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
156783003|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783004|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156867266|NCT01550003|566273504|FG002|Overall Study|Discontinuation|0|||
156867267|NCT01550003|566273502|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
156867268|NCT01550003|566273503|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
156867269|NCT01550003|566273504|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
156867270|NCT01550003|566273502|FG000|Overall Study|Site closure|0|||
156867271|NCT01550003|566273503|FG001|Overall Study|Site closure|2|||
156867272|NCT01550003|566273504|FG002|Overall Study|Site closure|0|||
156867273|NCT01550003|566273502|FG000|Overall Study|Pregnancy|0|||
156867274|NCT01550003|566273503|FG001|Overall Study|Pregnancy|1|||
156783005|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783006|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783007|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783008|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
156783009|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
156783010|NCT01807520|565954763|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783011|NCT01807520|565954764|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783012|NCT01807520|565954765|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783013|NCT01807520|565954766|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783014|NCT01807520|565954767|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
156783015|NCT01807520|565954768|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
156783016|NCT01807520|565954769|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
156783017|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783018|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
156783019|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783020|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783021|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783022|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
156783023|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
156783024|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783025|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783026|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783027|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783028|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
156783029|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
156783030|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783031|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783032|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156867275|NCT01550003|566273504|FG002|Overall Study|Pregnancy|0|||
156867276|NCT01550003|566273502|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
156867277|NCT01550003|566273503|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
156867278|NCT01550003|566273504|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
156867279|NCT01550003|566273502|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
156680497|NCT00981799|565576012|FG002|Overall Study|Adverse Event|0|||
156783033|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156867280|NCT01550003|566273503|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
156867281|NCT01550003|566273504|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
156680498|NCT00981799|565576013|FG003|Overall Study|Adverse Event|0|||
156680499|NCT03422068|565576016|FG000|Overall Study|Adverse Event|0|||
156680500|NCT03422068|565576017|FG001|Overall Study|Adverse Event|1|||
156680501|NCT03422068|565576016|FG000|Overall Study|Inconvenience to frequent study visits|0|||
156680502|NCT03422068|565576017|FG001|Overall Study|Inconvenience to frequent study visits|1|||
156680503|NCT02985398|565576018|FG000|Overall Study|Adverse Event|1|||
156680504|NCT02985398|565576018|FG000|Overall Study|Lost to Follow-up|4|||
156680505|NCT02985398|565576018|FG000|Overall Study|Withdrawal by Subject|8|||
156680506|NCT02985398|565576018|FG000|Overall Study|Study Burden|9|||
156680507|NCT01970592|565576023|FG000|Overall Study|Withdrawal by Subject|4|||
156680508|NCT01970592|565576023|FG000|Overall Study|Physician Decision|1|||
157012559|NCT05056246|566799382|FG003|Overall Study|Adverse Event|0|||
157012560|NCT05056246|566799383|FG004|Overall Study|Adverse Event|1|||
157012561|NCT05056246|566799379|FG000|Overall Study|Lost to Follow-up|0|||
157012562|NCT05056246|566799380|FG001|Overall Study|Lost to Follow-up|0|||
157012563|NCT05056246|566799381|FG002|Overall Study|Lost to Follow-up|0|||
156680509|NCT01970592|565576023|FG000|Overall Study|Adverse Event|1|||
156680510|NCT01320722|565576024|FG000|Overall Study|Did not Receive Intervention|3|||
156680511|NCT01320722|565576025|FG001|Overall Study|Did not Receive Intervention|2|||
156680512|NCT01320722|565576026|FG002|Overall Study|Did not Receive Intervention|1|||
156680513|NCT01320722|565576027|FG003|Overall Study|Did not Receive Intervention|1|||
156680514|NCT01320722|565576028|FG004|Overall Study|Did not Receive Intervention|2|||
156680515|NCT01320722|565576024|FG000|Overall Study|Lost to Follow-up|0|||
156680516|NCT01320722|565576025|FG001|Overall Study|Lost to Follow-up|1|||
156680517|NCT01320722|565576026|FG002|Overall Study|Lost to Follow-up|0|||
156680518|NCT01320722|565576027|FG003|Overall Study|Lost to Follow-up|1|||
156680519|NCT01320722|565576028|FG004|Overall Study|Lost to Follow-up|3|||
156680520|NCT01320722|565576024|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
156680521|NCT01320722|565576025|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
156680522|NCT01320722|565576026|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
156680523|NCT01320722|565576027|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
156680524|NCT01320722|565576028|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
156680525|NCT01320722|565576024|FG000|Overall Study|Participant Developed a Rash|0|||
156680526|NCT01320722|565576025|FG001|Overall Study|Participant Developed a Rash|0|||
156680527|NCT01320722|565576026|FG002|Overall Study|Participant Developed a Rash|2|||
156680528|NCT01320722|565576027|FG003|Overall Study|Participant Developed a Rash|1|||
157012564|NCT05056246|566799382|FG003|Overall Study|Lost to Follow-up|2|||
157012565|NCT05056246|566799383|FG004|Overall Study|Lost to Follow-up|0|||
157012566|NCT05056246|566799379|FG000|Overall Study|Withdrawal by Subject|0|||
156680529|NCT01320722|565576028|FG004|Overall Study|Participant Developed a Rash|1|||
156680530|NCT01320722|565576024|FG000|Overall Study|Non-compliant with Medication|0|||
157012567|NCT05056246|566799380|FG001|Overall Study|Withdrawal by Subject|1|||
157012568|NCT05056246|566799381|FG002|Overall Study|Withdrawal by Subject|0|||
157012569|NCT05056246|566799382|FG003|Overall Study|Withdrawal by Subject|0|||
157012570|NCT05056246|566799383|FG004|Overall Study|Withdrawal by Subject|0|||
157012571|NCT05057897|566799384|FG000|Overall Study|Site closure|2|||
157012572|NCT05057897|566799385|FG001|Overall Study|Site closure|2|||
157012573|NCT05057897|566799384|FG000|Overall Study|Death|1|||
157012574|NCT05057897|566799385|FG001|Overall Study|Death|0|||
157012575|NCT03346538|566799390|FG000|Overall Study|Physician Decision|0|||
157012576|NCT03346538|566799391|FG001|Overall Study|Physician Decision|1|||
157012577|NCT03346538|566799392|FG002|Overall Study|Physician Decision|0|||
157012578|NCT03346538|566799390|FG000|Overall Study|Withdrawal by Subject|3|||
157012579|NCT03346538|566799391|FG001|Overall Study|Withdrawal by Subject|2|||
157012580|NCT03346538|566799392|FG002|Overall Study|Withdrawal by Subject|0|||
157012581|NCT03346538|566799390|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
157012582|NCT03346538|566799391|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
157012583|NCT03346538|566799392|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
157012584|NCT03088813|566799396|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
157012585|NCT03088813|566799397|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
157012586|NCT03088813|566799398|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
157012587|NCT03088813|566799399|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
157012588|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
157012589|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
157012590|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
157012591|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
157012592|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
157012593|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
157012594|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
157012595|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
157120061|NCT05030311|567192975|FG001|Overall Study|Protocol Violation|4|||
156680531|NCT01320722|565576025|FG001|Overall Study|Non-compliant with Medication|0|||
156680532|NCT01320722|565576026|FG002|Overall Study|Non-compliant with Medication|1|||
156680533|NCT01320722|565576027|FG003|Overall Study|Non-compliant with Medication|0|||
156680534|NCT01320722|565576028|FG004|Overall Study|Non-compliant with Medication|0|||
156783034|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
156783035|NCT03928704|565954773|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
156783036|NCT03928704|565954774|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
156783037|NCT03928704|565954775|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783038|NCT03928704|565954776|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783039|NCT03928704|565954777|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783040|NCT03928704|565954778|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
156783041|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783042|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783043|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
156783044|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783045|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783046|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
156783047|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783048|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783049|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
156783050|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783051|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783052|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
156783053|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
156783054|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
156783055|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
156783056|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
156783057|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
156783058|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
156783059|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783060|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783061|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
156783062|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783063|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783064|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
156783065|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783066|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783067|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783068|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783069|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
156783070|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
156783071|NCT03928704|565954773|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783072|NCT03928704|565954774|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783073|NCT03928704|565954775|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783074|NCT03928704|565954776|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783075|NCT03928704|565954777|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
156783076|NCT03928704|565954778|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
156783077|NCT01631188|565954779|FG000|Overall Study|Physician Decision|75|||
156783078|NCT04575324|565954782|FG000|Overall Study|Lost to Follow-up|29|||
156783079|NCT04575324|565954783|FG001|Overall Study|Lost to Follow-up|25|||
156783080|NCT04575324|565954782|FG000|Overall Study|Death|1|||
156783081|NCT04575324|565954783|FG001|Overall Study|Death|2|||
156783082|NCT04575324|565954782|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
156783083|NCT04575324|565954783|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
156783084|NCT02582632|565954785|FG000|Overall Study|Other|1|||
156783085|NCT00327171|565954786|FG000|Overall Study|Did not receive study medication|3|||
156783086|NCT00327171|565954787|FG001|Overall Study|Did not receive study medication|0|||
156783087|NCT00327171|565954786|FG000|Overall Study|Adverse Event|23|||
156783088|NCT00327171|565954787|FG001|Overall Study|Adverse Event|23|||
157012596|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
157012597|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
157012598|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
157012599|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
157012600|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
157012601|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
157012602|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
157012603|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
157012604|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
157012605|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
157120062|NCT03042468|567192976|FG000|Overall Study|Death|0|||
157120063|NCT03042468|567192977|FG001|Overall Study|Death|1|||
156680535|NCT01320722|565576024|FG000|Overall Study|Adverse Event|0|||
156680536|NCT01320722|565576025|FG001|Overall Study|Adverse Event|0|||
156680537|NCT01320722|565576026|FG002|Overall Study|Adverse Event|3|||
156680538|NCT01320722|565576027|FG003|Overall Study|Adverse Event|6|||
156680539|NCT01320722|565576028|FG004|Overall Study|Adverse Event|0|||
156680540|NCT01320722|565576024|FG000|Overall Study|Not Compliant with Study Procedures|0|||
156680541|NCT01320722|565576025|FG001|Overall Study|Not Compliant with Study Procedures|0|||
156680542|NCT01320722|565576026|FG002|Overall Study|Not Compliant with Study Procedures|0|||
156680543|NCT01320722|565576027|FG003|Overall Study|Not Compliant with Study Procedures|4|||
156680544|NCT01320722|565576028|FG004|Overall Study|Not Compliant with Study Procedures|0|||
156680545|NCT01320722|565576024|FG000|Overall Study|Pregnancy|0|||
156680546|NCT01320722|565576025|FG001|Overall Study|Pregnancy|0|||
156680547|NCT01320722|565576026|FG002|Overall Study|Pregnancy|0|||
156680548|NCT01320722|565576027|FG003|Overall Study|Pregnancy|1|||
156680549|NCT01320722|565576028|FG004|Overall Study|Pregnancy|0|||
156680550|NCT01320722|565576024|FG000|Overall Study|Started an Exclusionary Medication|0|||
156680551|NCT01320722|565576025|FG001|Overall Study|Started an Exclusionary Medication|0|||
156680552|NCT01320722|565576026|FG002|Overall Study|Started an Exclusionary Medication|0|||
156680553|NCT01320722|565576027|FG003|Overall Study|Started an Exclusionary Medication|0|||
156680554|NCT01320722|565576028|FG004|Overall Study|Started an Exclusionary Medication|1|||
156680555|NCT01320722|565576024|FG000|Overall Study|Withdrew due to Health Condition|0|||
156680556|NCT01320722|565576025|FG001|Overall Study|Withdrew due to Health Condition|0|||
156680557|NCT01320722|565576026|FG002|Overall Study|Withdrew due to Health Condition|0|||
156680558|NCT01320722|565576027|FG003|Overall Study|Withdrew due to Health Condition|0|||
156680559|NCT01320722|565576028|FG004|Overall Study|Withdrew due to Health Condition|1|||
156680560|NCT00160524|565576029|FG000|Overall Study|Adverse Event|119|||
156680561|NCT00160524|565576029|FG000|Overall Study|Adverse Event and Other|94|||
156680562|NCT00160524|565576029|FG000|Overall Study|Protocol Violation|16|||
156680563|NCT00160524|565576029|FG000|Overall Study|Protocol Violation and Other|2|||
156680564|NCT00160524|565576029|FG000|Overall Study|Withdrawal by Subject|141|||
156680565|NCT00160524|565576029|FG000|Overall Study|Withdrawal by Subject and Other|17|||
156680566|NCT00160524|565576029|FG000|Overall Study|Physician Decision|27|||
156680567|NCT00160524|565576029|FG000|Overall Study|Physician Decision and Other|6|||
156680568|NCT00160524|565576029|FG000|Overall Study|Lost to Follow-up|13|||
156680569|NCT00160524|565576029|FG000|Overall Study|Lost to Follow-up and Other|1|||
156680570|NCT00160524|565576029|FG000|Overall Study|Lack of Efficacy|21|||
156680571|NCT00160524|565576029|FG000|Overall Study|Lack of Efficacy and Other|1|||
156680572|NCT00160524|565576029|FG000|Overall Study|Other|20|||
156680573|NCT04892147|565576034|FG000|Overall Study|Withdrawal by Subject|2|||
156783089|NCT00327171|565954786|FG000|Overall Study|Disease progression/lack of efficacy|68|||
156783090|NCT00327171|565954787|FG001|Overall Study|Disease progression/lack of efficacy|69|||
156783091|NCT00327171|565954786|FG000|Overall Study|Investigator/participant request|1|||
156783092|NCT00327171|565954787|FG001|Overall Study|Investigator/participant request|8|||
156783093|NCT00327171|565954786|FG000|Overall Study|Clinical progression|12|||
156783094|NCT00327171|565954787|FG001|Overall Study|Clinical progression|8|||
156783095|NCT00327171|565954786|FG000|Overall Study|Undisclosed history of ischemia|0|||
156783096|NCT00327171|565954787|FG001|Overall Study|Undisclosed history of ischemia|1|||
156783097|NCT00327171|565954786|FG000|Overall Study|Other|1|||
156783098|NCT00327171|565954787|FG001|Overall Study|Other|0|||
156783099|NCT01771913|565954788|FG000|Overall Study|Withdrawal by Subject|1|||
156783100|NCT01771913|565954789|FG001|Overall Study|Withdrawal by Subject|0|||
156783101|NCT01363440|565954790|FG000|Overall Study|Adverse Event|5|||
156783102|NCT01363440|565954791|FG001|Overall Study|Adverse Event|4|||
156783103|NCT01363440|565954792|FG002|Overall Study|Adverse Event|4|||
156783104|NCT01363440|565954790|FG000|Overall Study|Death|3|||
156783105|NCT01363440|565954791|FG001|Overall Study|Death|7|||
156783106|NCT01363440|565954792|FG002|Overall Study|Death|5|||
156783107|NCT01363440|565954790|FG000|Overall Study|Withdrawal by Subject|9|||
156783108|NCT01363440|565954791|FG001|Overall Study|Withdrawal by Subject|11|||
156783109|NCT01363440|565954792|FG002|Overall Study|Withdrawal by Subject|11|||
156783110|NCT01363440|565954790|FG000|Overall Study|Lost to Follow-up|2|||
156680574|NCT04892147|565576035|FG001|Overall Study|Withdrawal by Subject|0|||
156783111|NCT01363440|565954791|FG001|Overall Study|Lost to Follow-up|4|||
156783112|NCT01363440|565954792|FG002|Overall Study|Lost to Follow-up|5|||
156783113|NCT01363440|565954790|FG000|Overall Study|Other|4|||
156783114|NCT01363440|565954791|FG001|Overall Study|Other|5|||
156783115|NCT01363440|565954792|FG002|Overall Study|Other|2|||
156783116|NCT00992836|565954793|FG000|Overall Study|Lost to Follow-up|1|||
156783117|NCT00992836|565954793|FG000|Overall Study|Withdrawal by Subject|2|||
156680575|NCT01215721|565576037|FG000|Overall Study|Adverse Event|2|||
156680576|NCT01044433|565576038|FG000|Overall Study|Lost to Follow-up|3|||
156680577|NCT01044433|565576038|FG000|Overall Study|Withdrawal by Subject|3|||
156680578|NCT00826241|565576039|FG000|Overall Study|Withdrawal from Follow-up|1|||
156680579|NCT00826241|565576039|FG000|Overall Study|Withdrew consent|2|||
156680580|NCT00826241|565576039|FG000|Overall Study|Death|4|||
156680581|NCT00826241|565576039|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
156680582|NCT00826241|565576039|FG000|Overall Study|Non-compliance|1|||
156867282|NCT01550003|566273502|FG000|Overall Study|Switching to adult rheumatologist|0|||
156867283|NCT01550003|566273503|FG001|Overall Study|Switching to adult rheumatologist|0|||
156867284|NCT01550003|566273504|FG002|Overall Study|Switching to adult rheumatologist|1|||
156867285|NCT01550003|566273502|FG000|Overall Study|Patient transition to adult care|0|||
156867286|NCT01550003|566273503|FG001|Overall Study|Patient transition to adult care|0|||
156867287|NCT01550003|566273504|FG002|Overall Study|Patient transition to adult care|1|||
156867288|NCT01550003|566273502|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
156867289|NCT01550003|566273503|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
156867290|NCT01550003|566273504|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
156867291|NCT01550003|566273502|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
156867292|NCT01550003|566273503|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
156867293|NCT01550003|566273504|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
156867294|NCT01550003|566273502|FG000|Overall Study|Per Sponsor request|1|||
156867295|NCT01550003|566273503|FG001|Overall Study|Per Sponsor request|0|||
156867296|NCT01550003|566273504|FG002|Overall Study|Per Sponsor request|1|||
156867297|NCT01550003|566273502|FG000|Overall Study|Patient not compliance|0|||
156867298|NCT01550003|566273503|FG001|Overall Study|Patient not compliance|0|||
156867299|NCT01550003|566273504|FG002|Overall Study|Patient not compliance|1|||
156867300|NCT01550003|566273502|FG000|Overall Study|Non-compliance|0|||
156867301|NCT01550003|566273503|FG001|Overall Study|Non-compliance|0|||
156867302|NCT01550003|566273504|FG002|Overall Study|Non-compliance|1|||
156867303|NCT01550003|566273502|FG000|Overall Study|Study closed|0|||
156867304|NCT01550003|566273503|FG001|Overall Study|Study closed|1|||
156867305|NCT01550003|566273504|FG002|Overall Study|Study closed|0|||
156867306|NCT01550003|566273502|FG000|Overall Study|Transitioned to adult rheumatology|0|||
156867307|NCT01550003|566273503|FG001|Overall Study|Transitioned to adult rheumatology|0|||
156867308|NCT01550003|566273504|FG002|Overall Study|Transitioned to adult rheumatology|1|||
156867309|NCT05567783|566273505|FG000|Overall Study|Death|2|||
156867310|NCT05567783|566273506|FG001|Overall Study|Death|3|||
156867311|NCT05567783|566273507|FG002|Overall Study|Death|0|||
156867312|NCT05567783|566273505|FG000|Overall Study|Lost to Follow-up|25|||
156867313|NCT05567783|566273506|FG001|Overall Study|Lost to Follow-up|19|||
156867314|NCT05567783|566273507|FG002|Overall Study|Lost to Follow-up|17|||
156867315|NCT05567783|566273505|FG000|Overall Study|Physician Decision|10|||
156867316|NCT05567783|566273506|FG001|Overall Study|Physician Decision|7|||
156867317|NCT05567783|566273507|FG002|Overall Study|Physician Decision|9|||
156867318|NCT05567783|566273505|FG000|Overall Study|Study Terminated by Sponsor|924|||
156867319|NCT05567783|566273506|FG001|Overall Study|Study Terminated by Sponsor|937|||
156867320|NCT05567783|566273507|FG002|Overall Study|Study Terminated by Sponsor|941|||
156867321|NCT05567783|566273505|FG000|Overall Study|Withdrawal by Subject|23|||
156867322|NCT05567783|566273506|FG001|Overall Study|Withdrawal by Subject|27|||
156867323|NCT05567783|566273507|FG002|Overall Study|Withdrawal by Subject|24|||
156867324|NCT05567783|566273505|FG000|Overall Study|Incarcerated|1|||
156867325|NCT05567783|566273506|FG001|Overall Study|Incarcerated|0|||
156867326|NCT05567783|566273507|FG002|Overall Study|Incarcerated|0|||
156867327|NCT05567783|566273505|FG000|Overall Study|Participant randomized in error|4|||
156867328|NCT05567783|566273506|FG001|Overall Study|Participant randomized in error|2|||
156867329|NCT05567783|566273507|FG002|Overall Study|Participant randomized in error|2|||
156867330|NCT03675126|566273510|FG000|Overall Study|Study Terminated by Sponsor|9|||
156867331|NCT03675126|566273510|FG000|Overall Study|Death|2|||
156867332|NCT03675126|566273510|FG000|Overall Study|Withdrawal by Subject|4|||
156867333|NCT00001959|566273511|FG000|Overall Study|newly diagnosed colon cancer|1|||
156867334|NCT00001959|566273511|FG000|Overall Study|disabling sedation|1|||
156867335|NCT00001959|566273511|FG000|Overall Study|non-compliance|1|||
156867336|NCT02066181|566275598|FG000|Overall Study|Withdrawal by Subject|1|||
156867337|NCT02066181|566275599|FG001|Overall Study|Withdrawal by Subject|1|||
156867338|NCT01421719|566275600|FG000|Overall Study|Withdrawal by Subject|4|||
156867339|NCT03819114|566275605|FG000|Overall Study|Protocol Violation|0|||
156867340|NCT03819114|566275606|FG001|Overall Study|Protocol Violation|1|||
156867341|NCT03819114|566275607|FG002|Overall Study|Protocol Violation|1|||
156867342|NCT03819114|566275608|FG003|Overall Study|Protocol Violation|0|||
156867343|NCT03819114|566275605|FG000|Overall Study|Lost to Follow-up|0|||
156867344|NCT03819114|566275606|FG001|Overall Study|Lost to Follow-up|0|||
156867345|NCT03819114|566275607|FG002|Overall Study|Lost to Follow-up|1|||
156867346|NCT03819114|566275608|FG003|Overall Study|Lost to Follow-up|0|||
156867347|NCT02492763|566275611|FG000|Overall Study|Withdrawal by Subject|0|||
156867348|NCT02492763|566275612|FG001|Overall Study|Withdrawal by Subject|2|||
156867349|NCT02492763|566275613|FG002|Overall Study|Withdrawal by Subject|1|||
156867350|NCT02492763|566275614|FG003|Overall Study|Withdrawal by Subject|0|||
156867351|NCT02492763|566275611|FG000|Overall Study|Adverse Event|3|||
156867352|NCT02492763|566275612|FG001|Overall Study|Adverse Event|1|||
156867353|NCT02492763|566275613|FG002|Overall Study|Adverse Event|1|||
156867354|NCT02492763|566275614|FG003|Overall Study|Adverse Event|2|||
156867355|NCT02492763|566275611|FG000|Overall Study|Death|0|||
156867356|NCT02492763|566275612|FG001|Overall Study|Death|0|||
156867357|NCT02492763|566275613|FG002|Overall Study|Death|1|||
156783118|NCT00992836|565954793|FG000|Overall Study|Protocol Violation|2|||
156783119|NCT03695094|565954794|FG000|Overall Study|Adverse Event|1|||
156783120|NCT03695094|565954795|FG001|Overall Study|Adverse Event|1|||
156783121|NCT03695094|565954794|FG000|Overall Study|Withdrawal by Subject|1|||
156783122|NCT03695094|565954795|FG001|Overall Study|Withdrawal by Subject|0|||
156783123|NCT00266812|565954796|FG000|Overall Study|Disease Progression|9|||
156783124|NCT00266812|565954797|FG001|Overall Study|Disease Progression|3|||
156783125|NCT00266812|565954796|FG000|Overall Study|Death|5|||
156783126|NCT00266812|565954797|FG001|Overall Study|Death|4|||
156783127|NCT00266812|565954796|FG000|Overall Study|Adverse Event|3|||
156783128|NCT00266812|565954797|FG001|Overall Study|Adverse Event|1|||
156783129|NCT00266812|565954796|FG000|Overall Study|Protocol Violation|0|||
156783130|NCT00266812|565954797|FG001|Overall Study|Protocol Violation|1|||
156783131|NCT00266812|565954796|FG000|Overall Study|Withdrawal by Subject|0|||
156783132|NCT00266812|565954797|FG001|Overall Study|Withdrawal by Subject|2|||
156783133|NCT00266812|565954796|FG000|Overall Study|Discontinued before starting study drug|4|||
156783134|NCT00266812|565954797|FG001|Overall Study|Discontinued before starting study drug|0|||
156783135|NCT02323334|565954798|FG000|Period 3|Lost to Follow-up|0|||
156783136|NCT02323334|565954799|FG001|Period 3|Lost to Follow-up|0|||
156783137|NCT02323334|565954800|FG002|Period 3|Lost to Follow-up|1|||
156783138|NCT02323334|565954801|FG003|Period 3|Lost to Follow-up|0|||
156783139|NCT02323334|565954802|FG004|Period 3|Lost to Follow-up|0|||
156783140|NCT02323334|565954803|FG005|Period 3|Lost to Follow-up|0|||
156783141|NCT02323334|565954804|FG006|Period 3|Lost to Follow-up|0|||
156783142|NCT02323334|565954805|FG007|Period 3|Lost to Follow-up|0|||
156783143|NCT02323334|565954806|FG008|Period 3|Lost to Follow-up|0|||
156783144|NCT02323334|565954807|FG009|Period 3|Lost to Follow-up|0|||
156783145|NCT02323334|565954808|FG010|Period 3|Lost to Follow-up|0|||
156783146|NCT02323334|565954809|FG011|Period 3|Lost to Follow-up|0|||
156783147|NCT02323334|565954810|FG012|Period 3|Lost to Follow-up|0|||
156783148|NCT02323334|565954811|FG013|Period 3|Lost to Follow-up|0|||
156783149|NCT02323334|565954812|FG014|Period 3|Lost to Follow-up|0|||
156783150|NCT02323334|565954813|FG015|Period 3|Lost to Follow-up|0|||
156783151|NCT02323334|565954814|FG016|Period 3|Lost to Follow-up|0|||
156783152|NCT02323334|565954798|FG000|Period 3|Withdrawal by Subject|1|||
156783153|NCT02323334|565954799|FG001|Period 3|Withdrawal by Subject|0|||
156783154|NCT02323334|565954800|FG002|Period 3|Withdrawal by Subject|0|||
156783155|NCT02323334|565954801|FG003|Period 3|Withdrawal by Subject|0|||
156783156|NCT02323334|565954802|FG004|Period 3|Withdrawal by Subject|0|||
156783157|NCT02323334|565954803|FG005|Period 3|Withdrawal by Subject|0|||
156783158|NCT02323334|565954804|FG006|Period 3|Withdrawal by Subject|0|||
156783159|NCT02323334|565954805|FG007|Period 3|Withdrawal by Subject|0|||
156783160|NCT02323334|565954806|FG008|Period 3|Withdrawal by Subject|0|||
156783161|NCT02323334|565954807|FG009|Period 3|Withdrawal by Subject|0|||
156783162|NCT02323334|565954808|FG010|Period 3|Withdrawal by Subject|0|||
156783163|NCT02323334|565954809|FG011|Period 3|Withdrawal by Subject|0|||
156783164|NCT02323334|565954810|FG012|Period 3|Withdrawal by Subject|0|||
156783165|NCT02323334|565954811|FG013|Period 3|Withdrawal by Subject|0|||
156783166|NCT02323334|565954812|FG014|Period 3|Withdrawal by Subject|0|||
156783167|NCT02323334|565954813|FG015|Period 3|Withdrawal by Subject|0|||
156783168|NCT02323334|565954814|FG016|Period 3|Withdrawal by Subject|0|||
156783169|NCT01177410|565954821|FG000|Overall Study|Adverse Event|0|||
156783170|NCT01177410|565954822|FG001|Overall Study|Adverse Event|2|||
156783171|NCT01177410|565954823|FG002|Overall Study|Adverse Event|2|||
156783172|NCT01177410|565954821|FG000|Overall Study|Withdrawal by Subject|1|||
156783173|NCT01177410|565954822|FG001|Overall Study|Withdrawal by Subject|4|||
156783174|NCT01177410|565954823|FG002|Overall Study|Withdrawal by Subject|3|||
156783175|NCT01177410|565954821|FG000|Overall Study|Lost to Follow-up|0|||
156783176|NCT01177410|565954822|FG001|Overall Study|Lost to Follow-up|1|||
156783177|NCT01177410|565954823|FG002|Overall Study|Lost to Follow-up|0|||
156783178|NCT00471354|565954824|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
156783179|NCT00471354|565954824|FG000|Overall Study|Adverse Event|13|||
156783180|NCT00471354|565954824|FG000|Overall Study|Protocol Violation|12|||
156783181|NCT00471354|565954824|FG000|Overall Study|Withdrawal by Subject|1|||
156783182|NCT00471354|565954824|FG000|Overall Study|Physician Decision|4|||
156783183|NCT00471354|565954824|FG000|Overall Study|Sponsor Decision|1|||
156783184|NCT00471354|565954824|FG000|Overall Study|Lost to Follow-up|3|||
156783185|NCT00471354|565954824|FG000|Overall Study|Lack of Efficacy|5|||
156783186|NCT00471354|565954824|FG000|Overall Study|Patient/Caregiver Decision|12|||
156783187|NCT06204887|565954825|FG000|Overall Study|Lost to Follow-up|3|||
156783188|NCT06204887|565954826|FG001|Overall Study|Lost to Follow-up|4|||
156783189|NCT06204887|565954827|FG002|Overall Study|Lost to Follow-up|1|||
156783190|NCT06204887|565954828|FG003|Overall Study|Lost to Follow-up|6|||
156783191|NCT02762604|565954829|FG000|Overall Study|Lost to Follow-up|2|||
156783192|NCT02762604|565954830|FG001|Overall Study|Lost to Follow-up|7|||
156783193|NCT02762604|565954829|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
156783194|NCT02762604|565954830|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
156783195|NCT05128942|565954831|FG000|Overall Study|Withdrawal by Subject|1|||
156783196|NCT05128942|565954832|FG001|Overall Study|Withdrawal by Subject|0|||
156867358|NCT02492763|566275614|FG003|Overall Study|Death|0|||
156867359|NCT02492763|566275611|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867360|NCT02492763|566275612|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
156867361|NCT02492763|566275613|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867362|NCT02492763|566275614|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
156867363|NCT02492763|566275611|FG000|Overall Study|Lost to Follow-up|0|||
156867364|NCT02492763|566275612|FG001|Overall Study|Lost to Follow-up|0|||
156867365|NCT02492763|566275613|FG002|Overall Study|Lost to Follow-up|1|||
156867366|NCT02492763|566275614|FG003|Overall Study|Lost to Follow-up|0|||
156867367|NCT02492763|566275611|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156867368|NCT02492763|566275612|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156867369|NCT02492763|566275613|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156867370|NCT02492763|566275614|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156867371|NCT02492763|566275611|FG000|Overall Study|Screen Failure|0|||
156867372|NCT02492763|566275612|FG001|Overall Study|Screen Failure|0|||
156867373|NCT02492763|566275613|FG002|Overall Study|Screen Failure|0|||
156867374|NCT02492763|566275614|FG003|Overall Study|Screen Failure|1|||
156867375|NCT02492763|566275611|FG000|Overall Study|Study Terminated by Sponsor|13|||
156867376|NCT02492763|566275612|FG001|Overall Study|Study Terminated by Sponsor|10|||
156867377|NCT02492763|566275613|FG002|Overall Study|Study Terminated by Sponsor|6|||
156867378|NCT02492763|566275614|FG003|Overall Study|Study Terminated by Sponsor|10|||
156867379|NCT01772316|566275615|FG000|Overall Study|Serious adverse event|1|||
156867380|NCT01772316|566275615|FG000|Overall Study|Inform consent withdrawn|1|||
156867381|NCT01772316|566275615|FG000|Overall Study|Withdrawn by sponsor decision|5|||
156867382|NCT01760733|566275616|FG000|Waiting List|Death|18|||
156867383|NCT01760733|566275616|FG000|Waiting List|Removed from waiting list|41|||
156867384|NCT01760733|566275616|FG000|Waiting List|Not received a transplant yet|13|||
156867385|NCT01760733|566275616|FG000|Transplanted|Not reached 10 years post transplant|184|||
156867386|NCT01760733|566275616|FG000|Transplanted|Death|26|||
156867387|NCT01760733|566275616|FG000|Transplanted|Graft loss|7|||
156867388|NCT00815659|566275617|FG000|Overall Study|Adverse Event|9|||
156867389|NCT00815659|566275617|FG000|Overall Study|Withdrawal by Subject|9|||
156867390|NCT00815659|566275617|FG000|Overall Study|Lost to Follow-up|4|||
156867391|NCT00815659|566275617|FG000|Overall Study|Protocol Violation|1|||
156867392|NCT00719472|566275618|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
156867393|NCT00719472|566275618|FG000|Enrolled in Study|Subject decision to withdraw|8|||
156867394|NCT00719472|566275618|FG000|Enrolled in Study|Various Reasons|17|||
156867395|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
156867396|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Death|5|||
156867397|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
156867398|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
156867399|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
156867400|NCT00719472|566275618|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
156867401|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
156867402|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Death|6|||
156867403|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Disease progression|3|||
156867404|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
156867405|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
156867406|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
156867407|NCT00719472|566275618|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
156867408|NCT03847896|566275619|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
157120064|NCT03042468|567192978|FG002|Overall Study|Death|1|||
157120065|NCT03042468|567192979|FG003|Overall Study|Death|0|||
157120066|NCT03042468|567192980|FG004|Overall Study|Death|0|||
157120067|NCT03042468|567192981|FG005|Overall Study|Death|0|||
157120068|NCT03042468|567192976|FG000|Overall Study|Withdrawal by Subject|0|||
157120069|NCT03042468|567192977|FG001|Overall Study|Withdrawal by Subject|0|||
157120070|NCT03042468|567192978|FG002|Overall Study|Withdrawal by Subject|0|||
157120071|NCT03042468|567192979|FG003|Overall Study|Withdrawal by Subject|0|||
157120072|NCT03042468|567192980|FG004|Overall Study|Withdrawal by Subject|0|||
157120073|NCT03042468|567192981|FG005|Overall Study|Withdrawal by Subject|1|||
157120074|NCT03042468|567192976|FG000|Overall Study|Lost to Follow-up|0|||
157120075|NCT03042468|567192977|FG001|Overall Study|Lost to Follow-up|0|||
157120076|NCT03042468|567192978|FG002|Overall Study|Lost to Follow-up|0|||
157120077|NCT03042468|567192979|FG003|Overall Study|Lost to Follow-up|0|||
157120078|NCT03042468|567192980|FG004|Overall Study|Lost to Follow-up|1|||
157120079|NCT03042468|567192981|FG005|Overall Study|Lost to Follow-up|1|||
156867409|NCT03847896|566275620|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867410|NCT03847896|566275621|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
156867411|NCT03847896|566275622|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867412|NCT03847896|566275623|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
156867413|NCT03847896|566275619|FG000|Overall Study|Withdrawal by Subject|2|||
157120080|NCT03557359|567192982|FG000|Dose 1: 240 mg|Adverse Event|1|||
156680583|NCT00826241|565576039|FG000|Overall Study|Progression of disease|1|||
156680584|NCT00826241|565576039|FG000|Overall Study|Patient refused follow-up|3|||
156680585|NCT00826241|565576039|FG000|Overall Study|Lost to Follow-up|9|||
156680586|NCT00826241|565576039|FG000|Overall Study|Could not obtain records|1|||
156680587|NCT00826241|565576039|FG000|Overall Study|Screen failure|2|||
156680588|NCT00826241|565576039|FG000|Overall Study|Pt unable to proceed to registration|1|||
156680589|NCT00826241|565576039|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
156680590|NCT03428945|565576042|FG000|Overall Study|Lost to Follow-up|5|||
156680591|NCT03428945|565576043|FG001|Overall Study|Lost to Follow-up|3|||
156680592|NCT03428945|565576042|FG000|Overall Study|Withdrawal by Subject|10|||
156680593|NCT03428945|565576043|FG001|Overall Study|Withdrawal by Subject|10|||
156680594|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
156680595|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
156680596|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
156680597|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
156680598|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
156680599|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
156680600|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
156680601|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
156680602|NCT00982228|565576044|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
156680603|NCT00982228|565576045|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
156680604|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
156680605|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
156680606|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
156680607|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
156680608|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
156680609|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
156680610|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
156680611|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
156680612|NCT00982228|565576044|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
156680613|NCT00982228|565576045|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
156680614|NCT01924364|565576047|FG000|Overall Study|Physician Decision|3|||
156680615|NCT00265785|565576048|FG000|Overall Study|Adverse Event|4|||
156680616|NCT00265785|565576048|FG000|Overall Study|Withdrawal by Subject|3|||
156680617|NCT00265785|565576048|FG000|Overall Study|Progression/Relapse|15|||
156680618|NCT00265785|565576048|FG000|Overall Study|Not protocol specified|2|||
156680619|NCT00265785|565576048|FG000|Overall Study|Ineligible|1|||
156680620|NCT00265785|565576048|FG000|Overall Study|Did not receive protocol treatment|2|||
156680621|NCT00124618|565576049|FG000|Overall Study|Ineligible|1|||
156680622|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
156680623|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
156680624|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
156680625|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
156680626|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
156680627|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
156680628|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
156680629|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
156680630|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
156680631|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
156680632|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
156680633|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
156680634|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
156680635|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
156680636|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
156680637|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
156680638|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
156680639|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
156680640|NCT00950300|565576050|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
156680641|NCT00950300|565576051|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
156680642|NCT00950300|565576050|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
156680643|NCT00950300|565576051|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
156680644|NCT00950300|565576050|FG000|TFFU Period|Death|4|||
156680645|NCT00950300|565576051|FG001|TFFU Period|Death|1|||
156680646|NCT00950300|565576050|FG000|TFFU Period|Refused Treatment|10|||
156680647|NCT00950300|565576051|FG001|TFFU Period|Refused Treatment|11|||
156680648|NCT00950300|565576050|FG000|TFFU Period|Failure to Return|16|||
156680649|NCT00950300|565576051|FG001|TFFU Period|Failure to Return|16|||
156680650|NCT00950300|565576050|FG000|TFFU Period|Recurrence of Disease|63|||
156680651|NCT00950300|565576051|FG001|TFFU Period|Recurrence of Disease|72|||
156680652|NCT00950300|565576050|FG000|TFFU Period|Other|4|||
157120081|NCT03557359|567192983|FG001|Dose 1: 240 mg|Adverse Event|0|||
157120082|NCT05980299|567192988|FG000|Overall Study|Death|28|||
157120083|NCT05980299|567192989|FG001|Overall Study|Death|0|||
156867414|NCT03847896|566275620|FG001|Overall Study|Withdrawal by Subject|10|||
156867415|NCT03847896|566275621|FG002|Overall Study|Withdrawal by Subject|5|||
156867416|NCT03847896|566275622|FG003|Overall Study|Withdrawal by Subject|9|||
156867417|NCT03847896|566275623|FG004|Overall Study|Withdrawal by Subject|8|||
156867418|NCT03847896|566275619|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156867419|NCT03847896|566275620|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156867420|NCT03847896|566275621|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156867421|NCT03847896|566275622|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156867422|NCT03847896|566275623|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156867423|NCT03847896|566275619|FG000|Overall Study|Adverse Event|2|||
156867424|NCT03847896|566275620|FG001|Overall Study|Adverse Event|1|||
156867425|NCT03847896|566275621|FG002|Overall Study|Adverse Event|3|||
156867426|NCT03847896|566275622|FG003|Overall Study|Adverse Event|2|||
156867427|NCT03847896|566275623|FG004|Overall Study|Adverse Event|4|||
156867428|NCT03847896|566275619|FG000|Overall Study|A severe exacerbation event|0|||
156680653|NCT00950300|565576051|FG001|TFFU Period|Other|3|||
156680654|NCT00950300|565576050|FG000|SFU Period|Death|44|||
156680655|NCT00950300|565576051|FG001|SFU Period|Death|42|||
156680656|NCT00950300|565576050|FG000|SFU Period|Lost to Follow-up|30|||
156680657|NCT00950300|565576051|FG001|SFU Period|Lost to Follow-up|28|||
156680658|NCT00950300|565576050|FG000|SFU Period|Withdrawal by Subject|4|||
156680659|NCT00950300|565576051|FG001|SFU Period|Withdrawal by Subject|8|||
156680660|NCT01539239|565576056|FG000|Overall Study|Death|5|||
156680661|NCT01539239|565576057|FG001|Overall Study|Death|5|||
156680662|NCT01539239|565576056|FG000|Overall Study|Lost to Follow-up|7|||
156680663|NCT01539239|565576057|FG001|Overall Study|Lost to Follow-up|12|||
156680664|NCT01337596|565576060|FG000|Overall Study|Withdrawal by Subject|0|||
156680665|NCT01337596|565576061|FG001|Overall Study|Withdrawal by Subject|0|||
156680666|NCT01337596|565576062|FG002|Overall Study|Withdrawal by Subject|0|||
156680667|NCT01337596|565576063|FG003|Overall Study|Withdrawal by Subject|0|||
156680668|NCT01337596|565576064|FG004|Overall Study|Withdrawal by Subject|2|||
156680669|NCT01337596|565576065|FG005|Overall Study|Withdrawal by Subject|0|||
156680670|NCT01337596|565576066|FG006|Overall Study|Withdrawal by Subject|0|||
156680671|NCT01337596|565576067|FG007|Overall Study|Withdrawal by Subject|0|||
156680672|NCT01337596|565576068|FG008|Overall Study|Withdrawal by Subject|0|||
156680673|NCT04640194|565576069|FG000|Overall Study|Adverse Event|3|||
156680674|NCT04640194|565576070|FG001|Overall Study|Adverse Event|7|||
156680675|NCT04640194|565576071|FG002|Overall Study|Adverse Event|0|||
156680676|NCT04640194|565576072|FG003|Overall Study|Adverse Event|5|||
156680677|NCT04640194|565576073|FG004|Overall Study|Adverse Event|0|||
156680678|NCT04640194|565576074|FG005|Overall Study|Adverse Event|4|||
156680679|NCT04640194|565576075|FG006|Overall Study|Adverse Event|0|||
156680680|NCT04640194|565576069|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
156680681|NCT04640194|565576070|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
156680682|NCT04640194|565576071|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
156783197|NCT05128942|565954833|FG002|Overall Study|Withdrawal by Subject|1|||
156783198|NCT05128942|565954834|FG003|Overall Study|Withdrawal by Subject|0|||
156783199|NCT05128942|565954835|FG004|Overall Study|Withdrawal by Subject|0|||
156783200|NCT05128942|565954836|FG005|Overall Study|Withdrawal by Subject|0|||
156783201|NCT05128942|565954837|FG006|Overall Study|Withdrawal by Subject|0|||
156783202|NCT05128942|565954838|FG007|Overall Study|Withdrawal by Subject|0|||
156783203|NCT05128942|565954839|FG008|Overall Study|Withdrawal by Subject|0|||
156783204|NCT05128942|565954831|FG000|Overall Study|Other|2|||
156783205|NCT05128942|565954832|FG001|Overall Study|Other|0|||
156783206|NCT05128942|565954833|FG002|Overall Study|Other|2|||
156783207|NCT05128942|565954834|FG003|Overall Study|Other|0|||
156867429|NCT03847896|566275620|FG001|Overall Study|A severe exacerbation event|0|||
156867430|NCT03847896|566275621|FG002|Overall Study|A severe exacerbation event|0|||
156867431|NCT03847896|566275622|FG003|Overall Study|A severe exacerbation event|0|||
156867432|NCT03847896|566275623|FG004|Overall Study|A severe exacerbation event|3|||
156867433|NCT03847896|566275619|FG000|Overall Study|Protocol Violation|0|||
156867434|NCT03847896|566275620|FG001|Overall Study|Protocol Violation|2|||
156867435|NCT03847896|566275621|FG002|Overall Study|Protocol Violation|1|||
157120084|NCT05980299|567192988|FG000|Overall Study|Discharged from Nursing Home|9|||
157120085|NCT05980299|567192989|FG001|Overall Study|Discharged from Nursing Home|0|||
157120086|NCT05980299|567192988|FG000|Overall Study|Lost to Follow-up|0|||
157120087|NCT05980299|567192989|FG001|Overall Study|Lost to Follow-up|10|||
157120088|NCT02264990|567192990|FG000|Overall Study|Death|255|||
156680683|NCT04640194|565576072|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
156680684|NCT04640194|565576073|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
156680685|NCT04640194|565576074|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
156680686|NCT04640194|565576075|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
157120089|NCT02264990|567192991|FG001|Overall Study|Death|250|||
157120090|NCT02264990|567192990|FG000|Overall Study|Withdrawal by Subject|4|||
157120091|NCT02264990|567192991|FG001|Overall Study|Withdrawal by Subject|5|||
156680687|NCT04640194|565576069|FG000|Overall Study|fibrinogen level too low|0|||
156680688|NCT04640194|565576070|FG001|Overall Study|fibrinogen level too low|0|||
156680689|NCT04640194|565576071|FG002|Overall Study|fibrinogen level too low|0|||
156680690|NCT04640194|565576072|FG003|Overall Study|fibrinogen level too low|1|||
156680691|NCT04640194|565576073|FG004|Overall Study|fibrinogen level too low|0|||
156680692|NCT04640194|565576074|FG005|Overall Study|fibrinogen level too low|0|||
156680693|NCT04640194|565576075|FG006|Overall Study|fibrinogen level too low|0|||
156680694|NCT04640194|565576069|FG000|Overall Study|mild bleeding|0|||
156680695|NCT04640194|565576070|FG001|Overall Study|mild bleeding|0|||
156680696|NCT04640194|565576071|FG002|Overall Study|mild bleeding|0|||
156680697|NCT04640194|565576072|FG003|Overall Study|mild bleeding|1|||
156680698|NCT04640194|565576073|FG004|Overall Study|mild bleeding|0|||
156680699|NCT04640194|565576074|FG005|Overall Study|mild bleeding|0|||
156680700|NCT04640194|565576075|FG006|Overall Study|mild bleeding|0|||
156680701|NCT04640194|565576069|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
157213226|NCT00272961|567527776|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
157213227|NCT00272961|567527777|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
156680702|NCT04640194|565576070|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
156680703|NCT04640194|565576071|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680704|NCT04640194|565576072|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680705|NCT04640194|565576073|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680706|NCT04640194|565576074|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680707|NCT04640194|565576075|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
156680708|NCT03201003|565576079|FG000|Overall Study|Adverse Event|14|||
156680709|NCT03201003|565576080|FG001|Overall Study|Adverse Event|1|||
156680710|NCT03201003|565576079|FG000|Overall Study|Other reasons|5|||
156680711|NCT03201003|565576080|FG001|Overall Study|Other reasons|1|||
156680712|NCT03201003|565576079|FG000|Overall Study|Withdrawal by Subject|4|||
156680713|NCT03201003|565576080|FG001|Overall Study|Withdrawal by Subject|1|||
156680714|NCT03201003|565576079|FG000|Overall Study|Lost to Follow-up|2|||
156680715|NCT03201003|565576080|FG001|Overall Study|Lost to Follow-up|0|||
156680716|NCT03201003|565576079|FG000|Overall Study|Protocol Violation|1|||
156680717|NCT03201003|565576080|FG001|Overall Study|Protocol Violation|0|||
156680718|NCT00834613|565576081|FG000|First Intervention|Protocol Violation|1|||
156680719|NCT00834613|565576082|FG001|First Intervention|Protocol Violation|0|||
156680720|NCT01709903|565576086|FG000|Overall Study|administrative problems|2|||
156680721|NCT01709903|565576087|FG001|Overall Study|administrative problems|6|||
156680722|NCT01709903|565576086|FG000|Overall Study|Abnormal test procedure results|1|||
156680723|NCT01709903|565576087|FG001|Overall Study|Abnormal test procedure results|0|||
156680724|NCT01709903|565576086|FG000|Overall Study|In ability to use device|1|||
156680725|NCT01709903|565576087|FG001|Overall Study|In ability to use device|1|||
156680726|NCT01709903|565576086|FG000|Overall Study|no longer needed study drug|0|||
156680727|NCT01709903|565576087|FG001|Overall Study|no longer needed study drug|1|||
156680728|NCT01709903|565576086|FG000|Overall Study|Lost to Follow-up|0|||
156680729|NCT01709903|565576087|FG001|Overall Study|Lost to Follow-up|2|||
156680730|NCT01709903|565576086|FG000|Overall Study|Death|2|||
156680731|NCT01709903|565576087|FG001|Overall Study|Death|0|||
156680732|NCT01709903|565576086|FG000|Overall Study|Protocol Violation|3|||
156680733|NCT01709903|565576087|FG001|Overall Study|Protocol Violation|2|||
156680734|NCT01709903|565576086|FG000|Overall Study|Lack of Efficacy|3|||
156680735|NCT01709903|565576087|FG001|Overall Study|Lack of Efficacy|3|||
156680736|NCT01709903|565576086|FG000|Overall Study|Withdrawal by Subject|6|||
156680737|NCT01709903|565576087|FG001|Overall Study|Withdrawal by Subject|6|||
156783208|NCT05128942|565954835|FG004|Overall Study|Other|0|||
156783209|NCT05128942|565954836|FG005|Overall Study|Other|0|||
156783210|NCT05128942|565954837|FG006|Overall Study|Other|0|||
156783211|NCT05128942|565954838|FG007|Overall Study|Other|0|||
156783212|NCT05128942|565954839|FG008|Overall Study|Other|0|||
156783213|NCT05128942|565954831|FG000|Overall Study|Termination by Sponsor|2|||
156783214|NCT05128942|565954832|FG001|Overall Study|Termination by Sponsor|6|||
156783215|NCT05128942|565954833|FG002|Overall Study|Termination by Sponsor|14|||
156783216|NCT05128942|565954834|FG003|Overall Study|Termination by Sponsor|2|||
156783217|NCT05128942|565954835|FG004|Overall Study|Termination by Sponsor|4|||
156783218|NCT05128942|565954836|FG005|Overall Study|Termination by Sponsor|8|||
156783219|NCT05128942|565954837|FG006|Overall Study|Termination by Sponsor|11|||
156783220|NCT05128942|565954838|FG007|Overall Study|Termination by Sponsor|6|||
156783221|NCT05128942|565954839|FG008|Overall Study|Termination by Sponsor|0|||
156783222|NCT05128942|565954831|FG000|Overall Study|Adverse Event|0|||
156783223|NCT05128942|565954832|FG001|Overall Study|Adverse Event|0|||
156680738|NCT01709903|565576086|FG000|Overall Study|Adverse Event|11|||
156680739|NCT01709903|565576087|FG001|Overall Study|Adverse Event|18|||
156680740|NCT04490057|565576090|FG000|Stage 1|Death|1|||
156680741|NCT04490057|565576091|FG001|Stage 1|Death|2|||
156680742|NCT04490057|565576092|FG002|Stage 1|Death|0|||
156783224|NCT05128942|565954833|FG002|Overall Study|Adverse Event|0|||
156783225|NCT05128942|565954834|FG003|Overall Study|Adverse Event|0|||
156783226|NCT05128942|565954835|FG004|Overall Study|Adverse Event|0|||
156867436|NCT03847896|566275622|FG003|Overall Study|Protocol Violation|0|||
156867437|NCT03847896|566275623|FG004|Overall Study|Protocol Violation|2|||
156680743|NCT04490057|565576093|FG003|Stage 1|Death|0|||
156680744|NCT04490057|565576094|FG004|Stage 1|Death|0|||
156680745|NCT04490057|565576095|FG005|Stage 1|Death|0|||
156680746|NCT04490057|565576096|FG006|Stage 1|Death|0|||
156680747|NCT04490057|565576097|FG007|Stage 1|Death|0|||
156680748|NCT04490057|565576090|FG000|Stage 1|Withdrawal by Subject|2|||
156680749|NCT04490057|565576091|FG001|Stage 1|Withdrawal by Subject|0|||
156680750|NCT04490057|565576092|FG002|Stage 1|Withdrawal by Subject|0|||
156680751|NCT04490057|565576093|FG003|Stage 1|Withdrawal by Subject|0|||
156680752|NCT04490057|565576094|FG004|Stage 1|Withdrawal by Subject|0|||
156783227|NCT05128942|565954836|FG005|Overall Study|Adverse Event|0|||
156783228|NCT05128942|565954837|FG006|Overall Study|Adverse Event|1|||
156783229|NCT05128942|565954838|FG007|Overall Study|Adverse Event|1|||
156783230|NCT05128942|565954839|FG008|Overall Study|Adverse Event|0|||
156783231|NCT05128942|565954831|FG000|Overall Study|Lost to Follow-up|0|||
156783232|NCT05128942|565954832|FG001|Overall Study|Lost to Follow-up|0|||
156783233|NCT05128942|565954833|FG002|Overall Study|Lost to Follow-up|0|||
156783234|NCT05128942|565954834|FG003|Overall Study|Lost to Follow-up|0|||
156783235|NCT05128942|565954835|FG004|Overall Study|Lost to Follow-up|1|||
156783236|NCT05128942|565954836|FG005|Overall Study|Lost to Follow-up|0|||
156783237|NCT05128942|565954837|FG006|Overall Study|Lost to Follow-up|0|||
156783238|NCT05128942|565954838|FG007|Overall Study|Lost to Follow-up|0|||
156783239|NCT05128942|565954839|FG008|Overall Study|Lost to Follow-up|0|||
156783240|NCT05182125|565954843|FG000|Overall Study|Withdrawal by Subject|0|||
156783241|NCT05182125|565954844|FG001|Overall Study|Withdrawal by Subject|0|||
156783242|NCT05182125|565954845|FG002|Overall Study|Withdrawal by Subject|0|||
156783243|NCT05182125|565954846|FG003|Overall Study|Withdrawal by Subject|0|||
156783244|NCT05182125|565954847|FG004|Overall Study|Withdrawal by Subject|2|||
156783245|NCT05182125|565954848|FG005|Overall Study|Withdrawal by Subject|0|||
156783246|NCT05182125|565954843|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783247|NCT05182125|565954844|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783248|NCT05182125|565954845|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783249|NCT05182125|565954846|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
156783250|NCT05182125|565954847|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783251|NCT05182125|565954848|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
156783252|NCT05182125|565954843|FG000|Overall Study|Death|0|||
156783253|NCT05182125|565954844|FG001|Overall Study|Death|0|||
156783254|NCT05182125|565954845|FG002|Overall Study|Death|0|||
156783255|NCT05182125|565954846|FG003|Overall Study|Death|0|||
156783256|NCT05182125|565954847|FG004|Overall Study|Death|1|||
156783257|NCT05182125|565954848|FG005|Overall Study|Death|0|||
156783258|NCT05887401|565954850|FG000|Overall Study|Withdrawal by Subject|0|||
156783259|NCT05887401|565954851|FG001|Overall Study|Withdrawal by Subject|0|||
156783260|NCT05887401|565954852|FG002|Overall Study|Withdrawal by Subject|0|||
156783261|NCT05887401|565954853|FG003|Overall Study|Withdrawal by Subject|0|||
156783262|NCT05887401|565954854|FG004|Overall Study|Withdrawal by Subject|0|||
156783263|NCT05887401|565954855|FG005|Overall Study|Withdrawal by Subject|0|||
156783264|NCT05887401|565954856|FG006|Overall Study|Withdrawal by Subject|0|||
156783265|NCT05887401|565954857|FG007|Overall Study|Withdrawal by Subject|0|||
156783266|NCT05887401|565954858|FG008|Overall Study|Withdrawal by Subject|0|||
156783267|NCT05887401|565954859|FG009|Overall Study|Withdrawal by Subject|1|||
156783268|NCT05887401|565954860|FG010|Overall Study|Withdrawal by Subject|0|||
156783269|NCT05887401|565954861|FG011|Overall Study|Withdrawal by Subject|0|||
156867438|NCT03847896|566275619|FG000|Overall Study|Lost to Follow-up|0|||
156867439|NCT03847896|566275620|FG001|Overall Study|Lost to Follow-up|0|||
156867440|NCT03847896|566275621|FG002|Overall Study|Lost to Follow-up|0|||
156867441|NCT03847896|566275622|FG003|Overall Study|Lost to Follow-up|1|||
156867442|NCT03847896|566275623|FG004|Overall Study|Lost to Follow-up|0|||
156867443|NCT03847896|566275619|FG000|Overall Study|Condition under investigation worsened|0|||
156867444|NCT03847896|566275620|FG001|Overall Study|Condition under investigation worsened|0|||
157120092|NCT02264990|567192990|FG000|Overall Study|Lost to Follow-up|1|||
156680753|NCT04490057|565576095|FG005|Stage 1|Withdrawal by Subject|0|||
156680754|NCT04490057|565576096|FG006|Stage 1|Withdrawal by Subject|0|||
156680755|NCT04490057|565576097|FG007|Stage 1|Withdrawal by Subject|0|||
156680756|NCT04490057|565576090|FG000|Stage 2|Death|0|||
156680757|NCT04490057|565576091|FG001|Stage 2|Death|0|||
156783270|NCT05887401|565954862|FG012|Overall Study|Withdrawal by Subject|0|||
156783271|NCT05887401|565954863|FG013|Overall Study|Withdrawal by Subject|0|||
156783272|NCT05887401|565954864|FG014|Overall Study|Withdrawal by Subject|0|||
156783273|NCT05887401|565954865|FG015|Overall Study|Withdrawal by Subject|1|||
156783274|NCT05887401|565954850|FG000|Overall Study|Lost to Follow-up|0|||
156783275|NCT05887401|565954851|FG001|Overall Study|Lost to Follow-up|1|||
156783276|NCT05887401|565954852|FG002|Overall Study|Lost to Follow-up|1|||
156783277|NCT05887401|565954853|FG003|Overall Study|Lost to Follow-up|2|||
156783278|NCT05887401|565954854|FG004|Overall Study|Lost to Follow-up|0|||
156680758|NCT04490057|565576092|FG002|Stage 2|Death|0|||
156680759|NCT04490057|565576093|FG003|Stage 2|Death|0|||
156680760|NCT04490057|565576094|FG004|Stage 2|Death|1|||
156680761|NCT04490057|565576095|FG005|Stage 2|Death|0|||
156680762|NCT04490057|565576096|FG006|Stage 2|Death|0|||
156680763|NCT04490057|565576097|FG007|Stage 2|Death|0|||
156680764|NCT04490057|565576090|FG000|Stage 2|Lost to Follow-up|0|||
156680765|NCT04490057|565576091|FG001|Stage 2|Lost to Follow-up|0|||
156680766|NCT04490057|565576092|FG002|Stage 2|Lost to Follow-up|0|||
156680767|NCT04490057|565576093|FG003|Stage 2|Lost to Follow-up|11|||
156680768|NCT04490057|565576094|FG004|Stage 2|Lost to Follow-up|17|||
156680769|NCT04490057|565576095|FG005|Stage 2|Lost to Follow-up|4|||
156680770|NCT04490057|565576096|FG006|Stage 2|Lost to Follow-up|21|||
156680771|NCT04490057|565576097|FG007|Stage 2|Lost to Follow-up|14|||
156680772|NCT04584983|565576100|FG000|Overall Study|Parental request for withdraw|2|||
156680773|NCT04584983|565576101|FG001|Overall Study|Parental request for withdraw|0|||
156680774|NCT05377489|565576102|FG000|Overall Study|Withdrawal by Subject|122|||
156680775|NCT05377489|565576102|FG000|Overall Study|Lost to Follow-up|21|||
156680776|NCT05377489|565576102|FG000|Overall Study|Lack of Efficacy|10|||
156680777|NCT05377489|565576102|FG000|Overall Study|Adverse Event|5|||
156680778|NCT05377489|565576102|FG000|Overall Study|Death|4|||
156783279|NCT05887401|565954855|FG005|Overall Study|Lost to Follow-up|0|||
156783280|NCT05887401|565954856|FG006|Overall Study|Lost to Follow-up|0|||
156783281|NCT05887401|565954857|FG007|Overall Study|Lost to Follow-up|0|||
156783282|NCT05887401|565954858|FG008|Overall Study|Lost to Follow-up|1|||
156783283|NCT05887401|565954859|FG009|Overall Study|Lost to Follow-up|1|||
156783284|NCT05887401|565954860|FG010|Overall Study|Lost to Follow-up|2|||
156783285|NCT05887401|565954861|FG011|Overall Study|Lost to Follow-up|1|||
156783286|NCT05887401|565954862|FG012|Overall Study|Lost to Follow-up|0|||
156783287|NCT05887401|565954863|FG013|Overall Study|Lost to Follow-up|0|||
156783288|NCT05887401|565954864|FG014|Overall Study|Lost to Follow-up|0|||
156783289|NCT05887401|565954865|FG015|Overall Study|Lost to Follow-up|0|||
156783290|NCT04530526|565954866|FG000|Overall Study|Withdrawal by Subject|6|||
156783291|NCT06461455|565954867|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
156783292|NCT06461455|565954868|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
156783293|NCT06461455|565954867|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
156783294|NCT06461455|565954868|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
156783295|NCT06461455|565954867|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
156783296|NCT06461455|565954868|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
156783297|NCT06991803|565954871|FG000|Overall Study|Lost to Follow-up|0|||
156783298|NCT06991803|565954872|FG001|Overall Study|Lost to Follow-up|4|||
156783299|NCT06991803|565954873|FG002|Overall Study|Lost to Follow-up|0|||
156783300|NCT06991803|565954874|FG003|Overall Study|Lost to Follow-up|3|||
156783301|NCT06991803|565954875|FG004|Overall Study|Lost to Follow-up|2|||
156783302|NCT06991803|565954876|FG005|Overall Study|Lost to Follow-up|5|||
156783303|NCT03520569|565955461|FG000|Overall Study|Withdrawal by Subject|1|||
156783304|NCT00784927|565955462|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
156783305|NCT00784927|565955462|FG000|Overall Study|Protocol Violation|1|||
156783306|NCT00784927|565955462|FG000|Overall Study|Ineligible|1|||
156783307|NCT05141357|565955463|FG000|Overall Study|Adverse Event|3|||
156783308|NCT05141357|565955463|FG000|Overall Study|Lack of Efficacy|2|||
156783309|NCT05887908|565955464|FG000|Overall Study|Adverse Event|6|||
156783310|NCT05887908|565955465|FG001|Overall Study|Adverse Event|1|||
156783311|NCT05887908|565955466|FG002|Overall Study|Adverse Event|1|||
156783312|NCT05887908|565955464|FG000|Overall Study|Physician Decision|4|||
156783313|NCT05887908|565955465|FG001|Overall Study|Physician Decision|1|||
156783314|NCT05887908|565955466|FG002|Overall Study|Physician Decision|0|||
156783315|NCT05887908|565955464|FG000|Overall Study|Withdrawal by Subject|3|||
156783316|NCT05887908|565955465|FG001|Overall Study|Withdrawal by Subject|2|||
156783317|NCT05887908|565955466|FG002|Overall Study|Withdrawal by Subject|3|||
156783318|NCT05887908|565955464|FG000|Overall Study|Ineligibility after the start of the study|4|||
156783319|NCT05887908|565955465|FG001|Overall Study|Ineligibility after the start of the study|1|||
156783320|NCT05887908|565955466|FG002|Overall Study|Ineligibility after the start of the study|0|||
156783321|NCT05887908|565955464|FG000|Overall Study|Subject non-compliance|4|||
156680779|NCT05377489|565576102|FG000|Overall Study|Physician Decision|3|||
156783322|NCT05887908|565955465|FG001|Overall Study|Subject non-compliance|0|||
156783323|NCT05887908|565955466|FG002|Overall Study|Subject non-compliance|4|||
156783324|NCT05887908|565955464|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
156783325|NCT05887908|565955465|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
156783326|NCT05887908|565955466|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
156783327|NCT05887908|565955464|FG000|Overall Study|Pregnancy|0|||
156783328|NCT05887908|565955465|FG001|Overall Study|Pregnancy|1|||
156783329|NCT05887908|565955466|FG002|Overall Study|Pregnancy|0|||
156783330|NCT05887908|565955464|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
156680780|NCT05377489|565576102|FG000|Overall Study|Protocol Violation|1|||
156680781|NCT05377489|565576102|FG000|Overall Study|Other|9|||
156680782|NCT00724958|565576103|FG000|Overall Study|Adverse Event|28|||
156783331|NCT05887908|565955465|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
156680783|NCT00724958|565576103|FG000|Overall Study|Loss of Response|40|||
157120093|NCT02264990|567192991|FG001|Overall Study|Lost to Follow-up|3|||
156783332|NCT05887908|565955466|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
156783333|NCT05887908|565955464|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
156783334|NCT05887908|565955465|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
156783335|NCT05887908|565955466|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
156783336|NCT05887908|565955464|FG000|Overall Study|Other Reason|3|||
156783337|NCT05887908|565955465|FG001|Overall Study|Other Reason|3|||
156783338|NCT05887908|565955466|FG002|Overall Study|Other Reason|3|||
156783339|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
156783340|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
156783341|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
156783342|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
156783343|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
156783344|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
156783345|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
156783346|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
156783347|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
156783348|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
156783349|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
156783350|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
156783351|NCT03928743|565955470|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
156783352|NCT03928743|565955471|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
156783353|NCT03928743|565955472|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
156783354|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
156783355|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
156783356|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
156783357|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
156783358|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
156783359|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
156783360|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
156783361|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
156783362|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
156783363|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
156783364|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
156783365|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
156783366|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
156783367|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
156783368|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
156783369|NCT03928743|565955470|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
156783370|NCT03928743|565955471|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
156783371|NCT03928743|565955472|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
156783372|NCT04740567|565955475|FG000|Overall Study|Death|31|||
156783373|NCT04740567|565955476|FG001|Overall Study|Death|43|||
156783374|NCT04740567|565955475|FG000|Overall Study|Lost to Follow-up|2|||
156783375|NCT04740567|565955476|FG001|Overall Study|Lost to Follow-up|11|||
156783376|NCT04740567|565955475|FG000|Overall Study|Patient declined to participate|13|||
156783377|NCT04740567|565955476|FG001|Overall Study|Patient declined to participate|26|||
156783378|NCT04740567|565955475|FG000|Overall Study|Patient was physically incapable|1|||
156783379|NCT04740567|565955476|FG001|Overall Study|Patient was physically incapable|3|||
156783380|NCT04740567|565955475|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
156783381|NCT04740567|565955476|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
156783382|NCT06132386|565955477|FG000|Overall Study|ineligble laboratory|1|||
156783383|NCT06132386|565955478|FG001|Overall Study|ineligble laboratory|0|||
156783384|NCT06132386|565955479|FG002|Overall Study|ineligble laboratory|0|||
156783385|NCT06132386|565955480|FG003|Overall Study|ineligble laboratory|0|||
156783386|NCT06132386|565955481|FG004|Overall Study|ineligble laboratory|1|||
156783387|NCT06132386|565955482|FG005|Overall Study|ineligble laboratory|0|||
156783388|NCT06132386|565955477|FG000|Overall Study|ineligible vital signs|0|||
156783389|NCT06132386|565955478|FG001|Overall Study|ineligible vital signs|1|||
156783390|NCT06132386|565955479|FG002|Overall Study|ineligible vital signs|0|||
156783391|NCT06132386|565955480|FG003|Overall Study|ineligible vital signs|0|||
156783392|NCT06132386|565955481|FG004|Overall Study|ineligible vital signs|0|||
156783393|NCT06132386|565955482|FG005|Overall Study|ineligible vital signs|0|||
156783394|NCT03833167|565955483|FG000|Overall Study|Withdrawal by Subject|4|||
157120094|NCT02264990|567192990|FG000|Overall Study|Other|0|||
157120095|NCT02264990|567192991|FG001|Overall Study|Other|1|||
156783395|NCT03833167|565955484|FG001|Overall Study|Withdrawal by Subject|6|||
157120096|NCT03031301|567192993|FG000|Overall Study|Protocol Violation|4|||
157120097|NCT03031301|567192994|FG001|Overall Study|Protocol Violation|8|||
156680784|NCT00724958|565576103|FG000|Overall Study|No Response|18|||
156680785|NCT00724958|565576103|FG000|Overall Study|Remission|7|||
156680786|NCT00724958|565576103|FG000|Overall Study|Other Reason|76|||
156680787|NCT00724958|565576103|FG000|Overall Study|No documentation for end of therapy|13|||
156680788|NCT00697619|565576104|FG000|Overall Study|Lack of Efficacy|2|||
157012606|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
157012607|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
157012608|NCT03088813|566799396|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
157012609|NCT03088813|566799397|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
157012610|NCT03088813|566799398|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
157012611|NCT03088813|566799399|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
157012612|NCT02152137|566799400|FG000|Overall Study|Withdrawal by Subject|1|||
157012613|NCT02152137|566799400|FG000|Overall Study|Originally assigned to Arm B|3|||
157012614|NCT04878354|566799401|FG000|Overall Study|Adverse Event|4|||
157012615|NCT04878354|566799402|FG001|Overall Study|Adverse Event|13|||
157012616|NCT04878354|566799401|FG000|Overall Study|Withdrawal by Subject|14|||
157012617|NCT04878354|566799402|FG001|Overall Study|Withdrawal by Subject|12|||
157012618|NCT04878354|566799401|FG000|Overall Study|Lost to Follow-up|4|||
157012619|NCT04878354|566799402|FG001|Overall Study|Lost to Follow-up|1|||
157012620|NCT04878354|566799401|FG000|Overall Study|Lack of Efficacy|1|||
157012621|NCT04878354|566799402|FG001|Overall Study|Lack of Efficacy|0|||
157012622|NCT04878354|566799401|FG000|Overall Study|Protocol Violation|0|||
157012623|NCT04878354|566799402|FG001|Overall Study|Protocol Violation|1|||
157012624|NCT04878354|566799401|FG000|Overall Study|"Reason stated as other in CRF"|2|||
157012625|NCT04878354|566799402|FG001|Overall Study|"Reason stated as other in CRF"|3|||
157012626|NCT05307783|566799414|FG000|Overall Study|Death|7|||
157012627|NCT05307783|566799414|FG000|Overall Study|Lost to Follow-up|4|||
157012628|NCT04883645|566799415|FG000|Overall Study|Death|1|||
157012629|NCT03460236|566799420|FG000|Overall Study|failed radiographic screening|16|||
157012630|NCT03460236|566799420|FG000|Overall Study|Withdrawal by Subject|11|||
157213228|NCT00272961|567527778|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
156680789|NCT00697619|565576105|FG001|Overall Study|Lack of Efficacy|2|||
156680790|NCT00697619|565576104|FG000|Overall Study|Adverse Event|4|||
156680791|NCT00697619|565576105|FG001|Overall Study|Adverse Event|6|||
156680792|NCT04662710|565577444|FG000|Overall Study|Death|14|||
156680793|NCT04662710|565577445|FG001|Overall Study|Death|331|||
156680794|NCT04662710|565577446|FG002|Overall Study|Death|367|||
156680795|NCT04662710|565577444|FG000|Overall Study|Ongoing|1|||
156680796|NCT04662710|565577445|FG001|Overall Study|Ongoing|109|||
156680797|NCT04662710|565577446|FG002|Overall Study|Ongoing|56|||
156680798|NCT04662710|565577444|FG000|Overall Study|Withdrawal by Subject|0|||
156680799|NCT04662710|565577445|FG001|Overall Study|Withdrawal by Subject|3|||
156680800|NCT04662710|565577446|FG002|Overall Study|Withdrawal by Subject|14|||
156680801|NCT02722616|565577447|FG000|Overall Study|Sponsor closed study after one month|2|||
156680802|NCT02722616|565577448|FG001|Overall Study|Sponsor closed study after one month|0|||
156680803|NCT02722616|565577449|FG002|Overall Study|Sponsor closed study after one month|0|||
156680804|NCT01705717|565577450|FG000|Overall Study|Adverse Event|2|||
156680805|NCT01705717|565577451|FG001|Overall Study|Adverse Event|2|||
156680806|NCT01705717|565577450|FG000|Overall Study|Lack of Efficacy|0|||
156680807|NCT01705717|565577451|FG001|Overall Study|Lack of Efficacy|1|||
156680808|NCT01705717|565577450|FG000|Overall Study|Other|0|||
156680809|NCT01705717|565577451|FG001|Overall Study|Other|2|||
156680810|NCT05480800|565577454|FG000|Overall Study|Withdrawal by Subject|0|||
156680811|NCT05480800|565577455|FG001|Overall Study|Withdrawal by Subject|0|||
156680812|NCT05480800|565577456|FG002|Overall Study|Withdrawal by Subject|2|||
156680813|NCT05480800|565577457|FG003|Overall Study|Withdrawal by Subject|1|||
156680814|NCT05480800|565577458|FG004|Overall Study|Withdrawal by Subject|0|||
156680815|NCT05480800|565577459|FG005|Overall Study|Withdrawal by Subject|0|||
156680816|NCT05480800|565577460|FG006|Overall Study|Withdrawal by Subject|1|||
156680817|NCT05480800|565577461|FG007|Overall Study|Withdrawal by Subject|0|||
156680818|NCT05480800|565577454|FG000|Overall Study|Other|0|||
156680819|NCT05480800|565577455|FG001|Overall Study|Other|0|||
156680820|NCT05480800|565577456|FG002|Overall Study|Other|0|||
156680821|NCT05480800|565577457|FG003|Overall Study|Other|0|||
156680822|NCT05480800|565577458|FG004|Overall Study|Other|0|||
156680823|NCT05480800|565577459|FG005|Overall Study|Other|0|||
156680824|NCT05480800|565577460|FG006|Overall Study|Other|1|||
156680825|NCT05480800|565577461|FG007|Overall Study|Other|0|||
156680826|NCT00676650|565577466|FG000|Overall Study|Death|45|||
156680827|NCT00676650|565577467|FG001|Overall Study|Death|14|||
156680828|NCT00676650|565577466|FG000|Overall Study|Adverse Event|159|||
156680829|NCT00676650|565577467|FG001|Overall Study|Adverse Event|21|||
156680830|NCT00676650|565577466|FG000|Overall Study|Global deterioration of health status|66|||
156680831|NCT00676650|565577467|FG001|Overall Study|Global deterioration of health status|31|||
156680832|NCT00676650|565577466|FG000|Overall Study|Lost to Follow-up|0|||
156680833|NCT00676650|565577467|FG001|Overall Study|Lost to Follow-up|1|||
156680834|NCT00676650|565577466|FG000|Overall Study|Objective progression or relapse|189|||
157120098|NCT03031301|567192993|FG000|Overall Study|Withdrawal by Subject|7|||
157120099|NCT03031301|567192994|FG001|Overall Study|Withdrawal by Subject|4|||
157120100|NCT03031301|567192993|FG000|Overall Study|Lost to Follow-up|4|||
157120101|NCT03031301|567192994|FG001|Overall Study|Lost to Follow-up|12|||
157120102|NCT03031301|567192993|FG000|Overall Study|Noncompliance|1|||
157120103|NCT03031301|567192994|FG001|Overall Study|Noncompliance|3|||
157120104|NCT03031301|567192993|FG000|Overall Study|Technical issue|1|||
157120105|NCT03031301|567192994|FG001|Overall Study|Technical issue|1|||
157120106|NCT03031301|567192993|FG000|Overall Study|Adverse Event|1|||
156783396|NCT03833167|565955483|FG000|Overall Study|Ongoing|186|||
156783397|NCT03833167|565955484|FG001|Overall Study|Ongoing|194|||
156783398|NCT03833167|565955483|FG000|Overall Study|Lost to Follow-up|1|||
156783399|NCT03833167|565955484|FG001|Overall Study|Lost to Follow-up|1|||
156783400|NCT03833167|565955483|FG000|Overall Study|Physician Decision|0|||
156783401|NCT03833167|565955484|FG001|Overall Study|Physician Decision|2|||
156783402|NCT03833167|565955483|FG000|Overall Study|Death|34|||
156783403|NCT03833167|565955484|FG001|Overall Study|Death|22|||
156783404|NCT03003962|565955485|FG000|Overall Study|Withdrawal by Subject|5|||
156783405|NCT03003962|565955486|FG001|Overall Study|Withdrawal by Subject|17|||
156783406|NCT03003962|565955485|FG000|Overall Study|Death|274|||
156783407|NCT03003962|565955486|FG001|Overall Study|Death|277|||
156783408|NCT03003962|565955485|FG000|Overall Study|Participants ongoing at DCO|55|||
156783409|NCT03003962|565955486|FG001|Overall Study|Participants ongoing at DCO|40|||
156783410|NCT01405911|565955487|FG000|Overall Study|Pre-treatment lab AE|0|||
156783411|NCT01405911|565955488|FG001|Overall Study|Pre-treatment lab AE|1|||
156783412|NCT01405911|565955489|FG002|Overall Study|Pre-treatment lab AE|0|||
156783413|NCT01405911|565955487|FG000|Overall Study|Lost to Follow-up|0|||
156783414|NCT01405911|565955488|FG001|Overall Study|Lost to Follow-up|1|||
156783415|NCT01405911|565955489|FG002|Overall Study|Lost to Follow-up|0|||
156783416|NCT01405911|565955487|FG000|Overall Study|Protocol Violation|1|||
156783417|NCT01405911|565955488|FG001|Overall Study|Protocol Violation|0|||
156783418|NCT01405911|565955489|FG002|Overall Study|Protocol Violation|0|||
156783419|NCT01405911|565955487|FG000|Overall Study|Withdrawal by Subject|3|||
156783420|NCT01405911|565955488|FG001|Overall Study|Withdrawal by Subject|1|||
156783421|NCT01405911|565955489|FG002|Overall Study|Withdrawal by Subject|1|||
156783422|NCT06375655|565955490|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
156783423|NCT06375655|565955491|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
156783424|NCT02530242|565955495|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
156783425|NCT02530242|565955496|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
156783426|NCT00283959|565955497|FG000|Extension Period|Low Compliance|1|||
156783427|NCT03514017|565955503|FG000|Overall Study|Death|1|||
156783428|NCT03514017|565955503|FG000|Overall Study|Adverse Event|1|||
156783429|NCT03600350|565956326|FG000|Overall Study|Death|1|||
156783430|NCT03600350|565956326|FG000|Overall Study|On Follow Up|18|||
156783431|NCT02400736|565956329|FG000|Overall Study|Lost to Follow-up|6|||
156783432|NCT02400736|565956330|FG001|Overall Study|Lost to Follow-up|6|||
156783433|NCT02400736|565956329|FG000|Overall Study|Withdrawal by Subject|2|||
156783434|NCT02400736|565956330|FG001|Overall Study|Withdrawal by Subject|1|||
156783435|NCT02400736|565956329|FG000|Overall Study|Moved from the area|3|||
156783436|NCT02400736|565956330|FG001|Overall Study|Moved from the area|1|||
156783437|NCT01002105|565956331|FG000|Overall Study|Lost to Follow-up|10|||
156783438|NCT01002105|565956332|FG001|Overall Study|Lost to Follow-up|16|||
156783439|NCT01002105|565956331|FG000|Overall Study|non compliance|5|||
156783440|NCT01002105|565956332|FG001|Overall Study|non compliance|3|||
156783441|NCT01002105|565956331|FG000|Overall Study|condition worsened|4|||
156783442|NCT01002105|565956332|FG001|Overall Study|condition worsened|2|||
156783443|NCT00422461|565956333|FG000|Overall Study|Adverse Event|1|||
156783444|NCT00422461|565956334|FG001|Overall Study|Adverse Event|2|||
156783445|NCT00422461|565956335|FG002|Overall Study|Adverse Event|1|||
156783446|NCT00422461|565956336|FG003|Overall Study|Adverse Event|1|||
156783447|NCT00422461|565956333|FG000|Overall Study|Other|0|||
156783448|NCT00422461|565956334|FG001|Overall Study|Other|0|||
156783449|NCT00422461|565956335|FG002|Overall Study|Other|0|||
156783450|NCT00422461|565956336|FG003|Overall Study|Other|2|||
156783451|NCT00422461|565956333|FG000|Overall Study|Participants no longer willing to participate in study|1|||
156783452|NCT00422461|565956334|FG001|Overall Study|Participants no longer willing to participate in study|0|||
156783453|NCT00422461|565956335|FG002|Overall Study|Participants no longer willing to participate in study|0|||
156783454|NCT00422461|565956336|FG003|Overall Study|Participants no longer willing to participate in study|0|||
156783455|NCT00422461|565956333|FG000|Overall Study|Randomized but not treated|1|||
156783456|NCT00422461|565956334|FG001|Overall Study|Randomized but not treated|1|||
156783457|NCT00422461|565956335|FG002|Overall Study|Randomized but not treated|0|||
156783458|NCT00422461|565956336|FG003|Overall Study|Randomized but not treated|0|||
156783459|NCT01795937|565956338|FG000|Overall Study|Withdrawal by Subject|1|||
156783460|NCT01795937|565956339|FG001|Overall Study|Withdrawal by Subject|0|||
156783461|NCT01795937|565956340|FG002|Overall Study|Withdrawal by Subject|0|||
156783462|NCT01795937|565956338|FG000|Overall Study|Physician Decision|0|||
156783463|NCT01795937|565956339|FG001|Overall Study|Physician Decision|1|||
156783464|NCT01795937|565956340|FG002|Overall Study|Physician Decision|0|||
156783465|NCT01028053|565956341|FG000|Overall Study|Screen Failure|113|||
156783466|NCT01028053|565956341|FG000|Overall Study|Patient Request|11|||
156783467|NCT01028053|565956341|FG000|Overall Study|Protocol Violation|1|||
156783468|NCT01028053|565956341|FG000|Overall Study|Physician Decision|2|||
156783469|NCT01028053|565956341|FG000|Overall Study|Technical Problem|1|||
156783470|NCT01028053|565956341|FG000|Overall Study|Terminated by Sponsor|1|||
156783471|NCT01028053|565956341|FG000|Overall Study|Various reasons|4|||
156783472|NCT00845182|565956342|FG000|Overall Study|Lost to Follow-up|3|||
156783473|NCT00845182|565956343|FG001|Overall Study|Lost to Follow-up|3|||
156867445|NCT03847896|566275621|FG002|Overall Study|Condition under investigation worsened|0|||
156867446|NCT03847896|566275622|FG003|Overall Study|Condition under investigation worsened|1|||
156867447|NCT03847896|566275623|FG004|Overall Study|Condition under investigation worsened|1|||
156783474|NCT00845182|565956344|FG002|Overall Study|Lost to Follow-up|4|||
156783475|NCT00845182|565956342|FG000|Overall Study|Adverse Event|0|||
156783476|NCT00845182|565956343|FG001|Overall Study|Adverse Event|1|||
156783477|NCT00845182|565956344|FG002|Overall Study|Adverse Event|1|||
156783478|NCT00845182|565956342|FG000|Overall Study|Physician Decision|0|||
156783479|NCT00845182|565956343|FG001|Overall Study|Physician Decision|0|||
156783480|NCT00845182|565956344|FG002|Overall Study|Physician Decision|1|||
156783481|NCT04621760|565956345|FG000|Overall Study|Lost to Follow-up|2|||
156783482|NCT04621760|565956346|FG001|Overall Study|Lost to Follow-up|4|||
156783483|NCT04621760|565956345|FG000|Overall Study|Withdrawal by Subject|1|||
156783484|NCT04621760|565956346|FG001|Overall Study|Withdrawal by Subject|0|||
156783485|NCT02965716|565956348|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156783486|NCT02965716|565956349|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
156783487|NCT02965716|565956348|FG000|Overall Study|Progression/Relapse|8|||
156783488|NCT02965716|565956349|FG001|Overall Study|Progression/Relapse|16|||
156783489|NCT02965716|565956348|FG000|Overall Study|Death|1|||
156783490|NCT02965716|565956349|FG001|Overall Study|Death|0|||
156783491|NCT02965716|565956348|FG000|Overall Study|Not Protocol Specified|1|||
156783492|NCT02965716|565956349|FG001|Overall Study|Not Protocol Specified|3|||
156783493|NCT01336972|565956353|FG000|Overall Study|Adverse Event|1|||
156783494|NCT01336972|565956354|FG001|Overall Study|Adverse Event|1|||
156783495|NCT01336972|565956355|FG002|Overall Study|Adverse Event|0|||
156783496|NCT02441114|565956356|FG000|Washout2|Withdrawal by Subject|4|||
156783497|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
156783498|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
156783499|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
156783500|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
156783501|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
156783502|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
156783503|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
156783504|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
156783505|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
156783506|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
156783507|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
156783508|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
156783509|NCT03446573|565956358|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
156783510|NCT03446573|565956359|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
156783511|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
156867448|NCT03847896|566275619|FG000|Overall Study|Lack of Efficacy|0|||
156867449|NCT03847896|566275620|FG001|Overall Study|Lack of Efficacy|0|||
156867450|NCT03847896|566275621|FG002|Overall Study|Lack of Efficacy|0|||
156867451|NCT03847896|566275622|FG003|Overall Study|Lack of Efficacy|2|||
156867452|NCT03847896|566275623|FG004|Overall Study|Lack of Efficacy|2|||
156867453|NCT03847896|566275619|FG000|Overall Study|Other reasons|3|||
156867454|NCT03847896|566275620|FG001|Overall Study|Other reasons|3|||
156867455|NCT03847896|566275621|FG002|Overall Study|Other reasons|1|||
156867456|NCT03847896|566275622|FG003|Overall Study|Other reasons|2|||
156867457|NCT03847896|566275623|FG004|Overall Study|Other reasons|1|||
156867458|NCT02395471|566275624|FG000|Overall Study|Lost to Follow-up|2|||
156783512|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
156783513|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
156783514|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
156783515|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
156783516|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
156783517|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
156867459|NCT02395471|566275625|FG001|Overall Study|Lost to Follow-up|0|||
156867460|NCT02395471|566275624|FG000|Overall Study|Withdrawal by Subject|2|||
156867461|NCT02395471|566275625|FG001|Overall Study|Withdrawal by Subject|1|||
156867462|NCT02395471|566275624|FG000|Overall Study|Physician Decision|1|||
156867463|NCT02395471|566275625|FG001|Overall Study|Physician Decision|0|||
156783518|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
156783519|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
156783520|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
156783521|NCT03446573|565956358|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
156783522|NCT03446573|565956359|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
156783523|NCT02639559|565956365|FG000|Overall Study|Mobilization failure|0|||
156783524|NCT02639559|565956366|FG001|Overall Study|Mobilization failure|3|||
156783525|NCT02639559|565956365|FG000|Overall Study|Issues with vascular acess|1|||
156783526|NCT02639559|565956366|FG001|Overall Study|Issues with vascular acess|0|||
156783527|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
156783528|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
156783529|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
156783530|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
156783531|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
156783532|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
156783533|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
156783534|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
156783535|NCT04999020|565956367|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
156783536|NCT04999020|565956368|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783537|NCT04999020|565956369|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783538|NCT04999020|565956370|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
156783539|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156783540|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156783541|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
156783542|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
156783543|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156783544|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
156783545|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
156783546|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
156783547|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783548|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783549|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
156783550|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
156783551|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783552|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783553|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
156783554|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
156783555|NCT04999020|565956367|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783556|NCT04999020|565956368|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783557|NCT04999020|565956369|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
156783558|NCT04999020|565956370|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
156783559|NCT02691663|565956377|FG000|Overall Study|Screen failure after baseline|2|||
156783560|NCT02691663|565956378|FG001|Overall Study|Screen failure after baseline|2|||
156783561|NCT02691663|565956377|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
156783562|NCT02691663|565956378|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
156783563|NCT02691663|565956377|FG000|Overall Study|Withdrawn after Follow up 2|1|||
156783564|NCT02691663|565956378|FG001|Overall Study|Withdrawn after Follow up 2|1|||
156783565|NCT02691663|565956377|FG000|Overall Study|Lost to Follow-up|3|||
156783566|NCT02691663|565956378|FG001|Overall Study|Lost to Follow-up|2|||
156783567|NCT04828486|565956381|FG000|Overall Study|Adverse Event|2|||
156783568|NCT04828486|565956381|FG000|Overall Study|Death|1|||
156783569|NCT04828486|565956381|FG000|Overall Study|Disease Progression|8|||
156783570|NCT04828486|565956381|FG000|Overall Study|Other Complicating Disease|1|||
156783571|NCT04828486|565956381|FG000|Overall Study|Withdrawal by Subject|1|||
156783572|NCT03325439|565956382|FG000|Overall Study|Ineligibility|3|||
156783573|NCT00896233|565956383|FG000|Overall Study|Claustrophobia during MRI|1|||
156783574|NCT03674411|565956388|FG000|Overall Study|Non-treatment|4|||
156783575|NCT02227199|565956389|FG000|Overall Study|Physician Decision|0|||
156783576|NCT02227199|565956390|FG001|Overall Study|Physician Decision|0|||
156783577|NCT02227199|565956391|FG002|Overall Study|Physician Decision|1|||
156783578|NCT02227199|565956389|FG000|Overall Study|Adverse Event|0|||
156783579|NCT02227199|565956390|FG001|Overall Study|Adverse Event|0|||
156783580|NCT02227199|565956391|FG002|Overall Study|Adverse Event|3|||
156783581|NCT03573882|565956392|FG000|Overall Study|Study Terminated by Sponsor|22|||
156783582|NCT03573882|565956393|FG001|Overall Study|Study Terminated by Sponsor|17|||
156783583|NCT03573882|565956394|FG002|Overall Study|Study Terminated by Sponsor|18|||
156783584|NCT03573882|565956392|FG000|Overall Study|Withdrawal by Subject|6|||
156783585|NCT03573882|565956393|FG001|Overall Study|Withdrawal by Subject|11|||
156783586|NCT03573882|565956394|FG002|Overall Study|Withdrawal by Subject|7|||
156783587|NCT03573882|565956392|FG000|Overall Study|Adverse Event|7|||
156680835|NCT00676650|565577467|FG001|Overall Study|Objective progression or relapse|140|||
156680836|NCT00676650|565577466|FG000|Overall Study|Other|14|||
156680837|NCT00676650|565577467|FG001|Overall Study|Other|10|||
156680838|NCT00676650|565577466|FG000|Overall Study|Protocol Violation|3|||
156680839|NCT00676650|565577467|FG001|Overall Study|Protocol Violation|1|||
156680840|NCT00676650|565577466|FG000|Overall Study|Study terminated by sponsor|57|||
156680841|NCT00676650|565577467|FG001|Overall Study|Study terminated by sponsor|43|||
156680842|NCT00676650|565577466|FG000|Overall Study|Withdrawal by Subject|48|||
156680843|NCT00676650|565577467|FG001|Overall Study|Withdrawal by Subject|24|||
156680844|NCT00676650|565577466|FG000|Overall Study|Randomized but not treated|3|||
156680845|NCT00676650|565577467|FG001|Overall Study|Randomized but not treated|4|||
156680846|NCT02297841|565577471|FG000|Overall Study|Withdrawal by Subject|1|||
156680847|NCT02297841|565577471|FG000|Overall Study|Protocol Violation|7|||
156680848|NCT05061992|565577472|FG000|Overall Study|Excess bowel movements|1|||
156680849|NCT05061992|565577473|FG001|Overall Study|Excess bowel movements|0|||
156680850|NCT05061992|565577472|FG000|Overall Study|Complications of Medical Care|1|||
156680851|NCT05061992|565577473|FG001|Overall Study|Complications of Medical Care|0|||
156680852|NCT05061992|565577472|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
156680853|NCT05061992|565577473|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
156680854|NCT05061992|565577472|FG000|Overall Study|Withdrawal by Subject|0|||
156680855|NCT05061992|565577473|FG001|Overall Study|Withdrawal by Subject|1|||
156680856|NCT02246764|565577478|FG000|Overall Study|Adverse Event|15|||
156680857|NCT02246764|565577479|FG001|Overall Study|Adverse Event|29|||
156680858|NCT02246764|565577480|FG002|Overall Study|Adverse Event|1|||
156680859|NCT02246764|565577478|FG000|Overall Study|Withdrawal by Subject|0|||
156680860|NCT02246764|565577479|FG001|Overall Study|Withdrawal by Subject|0|||
156680861|NCT02246764|565577480|FG002|Overall Study|Withdrawal by Subject|1|||
156680862|NCT02246764|565577478|FG000|Overall Study|Disallowed Concomitant Medication|1|||
156680863|NCT02246764|565577479|FG001|Overall Study|Disallowed Concomitant Medication|0|||
156680864|NCT02246764|565577480|FG002|Overall Study|Disallowed Concomitant Medication|0|||
156680865|NCT02246764|565577478|FG000|Overall Study|Physician Decision|0|||
156680866|NCT02246764|565577479|FG001|Overall Study|Physician Decision|2|||
156680867|NCT02246764|565577480|FG002|Overall Study|Physician Decision|1|||
156680868|NCT02246764|565577478|FG000|Overall Study|Protocol Violation|2|||
156680869|NCT02246764|565577479|FG001|Overall Study|Protocol Violation|1|||
156680870|NCT02246764|565577480|FG002|Overall Study|Protocol Violation|1|||
156680871|NCT00413049|565577481|FG000|Overall Study|Adverse Event|10|||
156680872|NCT00413049|565577482|FG001|Overall Study|Adverse Event|8|||
156680873|NCT00413049|565577481|FG000|Overall Study|Withdrawal by Subject|7|||
156680874|NCT00413049|565577482|FG001|Overall Study|Withdrawal by Subject|5|||
156680875|NCT00413049|565577481|FG000|Overall Study|Lost to Follow-up|2|||
156680876|NCT00413049|565577482|FG001|Overall Study|Lost to Follow-up|3|||
156680877|NCT00413049|565577481|FG000|Overall Study|Protocol Violation|3|||
156680878|NCT00413049|565577482|FG001|Overall Study|Protocol Violation|1|||
156680879|NCT00413049|565577481|FG000|Overall Study|Subject no longer requires study drug|0|||
156680880|NCT00413049|565577482|FG001|Overall Study|Subject no longer requires study drug|1|||
156680881|NCT00413049|565577481|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156680882|NCT00413049|565577482|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156680883|NCT00413049|565577481|FG000|Overall Study|Lack of Efficacy|1|||
156680884|NCT00413049|565577482|FG001|Overall Study|Lack of Efficacy|0|||
156680885|NCT00487695|565577487|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
156680886|NCT00487695|565577488|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
156680887|NCT00487695|565577487|FG000|First Procedure|active wheezing (did not have procedure)|1|||
156680888|NCT00487695|565577488|FG001|First Procedure|active wheezing (did not have procedure)|0|||
156680889|NCT00487695|565577487|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
156680890|NCT00487695|565577488|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
156680891|NCT00487695|565577487|FG000|Second Procedure|active wheezing|0|||
156680892|NCT00487695|565577488|FG001|Second Procedure|active wheezing|1|||
156680893|NCT00487695|565577487|FG000|Second Procedure|Withdrawal by Subject|1|||
156680894|NCT00487695|565577488|FG001|Second Procedure|Withdrawal by Subject|2|||
156680895|NCT02104817|565577489|FG000|Overall Study|Death|363|||
156680896|NCT02104817|565577490|FG001|Overall Study|Death|330|||
156680897|NCT02104817|565577489|FG000|Overall Study|Lost to Follow-up|3|||
156680898|NCT02104817|565577490|FG001|Overall Study|Lost to Follow-up|2|||
156680899|NCT02104817|565577489|FG000|Overall Study|Protocol Violation|0|||
156680900|NCT02104817|565577490|FG001|Overall Study|Protocol Violation|1|||
156680901|NCT02104817|565577489|FG000|Overall Study|Study terminated by sponsor|5854|||
156680902|NCT02104817|565577490|FG001|Overall Study|Study terminated by sponsor|5901|||
156680903|NCT02104817|565577489|FG000|Overall Study|Withdrawal by Subject|111|||
156680904|NCT02104817|565577490|FG001|Overall Study|Withdrawal by Subject|78|||
156680905|NCT02104817|565577489|FG000|Overall Study|Other reasons|128|||
156680906|NCT02104817|565577490|FG001|Overall Study|Other reasons|135|||
156680907|NCT04633642|565577491|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
156680908|NCT04633642|565577492|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
156680909|NCT00611884|565577493|FG000|Overall Study|Adverse Event|1|||
156680910|NCT00611884|565577494|FG001|Overall Study|Adverse Event|0|||
156680911|NCT00611884|565577495|FG002|Overall Study|Adverse Event|0|||
156680912|NCT00611884|565577496|FG003|Overall Study|Adverse Event|1|||
156680913|NCT00611884|565577493|FG000|Overall Study|Non-Compliance|1|||
156680914|NCT00611884|565577494|FG001|Overall Study|Non-Compliance|4|||
156680915|NCT00611884|565577495|FG002|Overall Study|Non-Compliance|2|||
156680916|NCT00611884|565577496|FG003|Overall Study|Non-Compliance|2|||
156680917|NCT00611884|565577493|FG000|Overall Study|Lack of Efficacy|0|||
156680918|NCT00611884|565577494|FG001|Overall Study|Lack of Efficacy|1|||
156680919|NCT00611884|565577495|FG002|Overall Study|Lack of Efficacy|0|||
156680920|NCT00611884|565577496|FG003|Overall Study|Lack of Efficacy|0|||
156680921|NCT00611884|565577493|FG000|Overall Study|Unclassified|7|||
156680922|NCT00611884|565577494|FG001|Overall Study|Unclassified|4|||
156680923|NCT00611884|565577495|FG002|Overall Study|Unclassified|2|||
156680924|NCT00611884|565577496|FG003|Overall Study|Unclassified|3|||
156680925|NCT02858037|565577501|FG000|Overall Study|Death|1|||
156680926|NCT02858037|565577501|FG000|Overall Study|Withdrawal by Subject|18|||
156680927|NCT02858037|565577501|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
156680928|NCT02858037|565577501|FG000|Overall Study|Lost to Follow-up|3|||
156680929|NCT02858037|565577501|FG000|Overall Study|Other|4|||
156680930|NCT00283842|565577502|FG000|Overall Study|Adverse Event|8|||
156680931|NCT00283842|565577503|FG001|Overall Study|Adverse Event|7|||
156680932|NCT00283842|565577504|FG002|Overall Study|Adverse Event|21|||
156680933|NCT00283842|565577505|FG003|Overall Study|Adverse Event|21|||
156680934|NCT00283842|565577506|FG004|Overall Study|Adverse Event|5|||
156680935|NCT00283842|565577502|FG000|Overall Study|Protocol Violation|1|||
156680936|NCT00283842|565577503|FG001|Overall Study|Protocol Violation|5|||
156680937|NCT00283842|565577504|FG002|Overall Study|Protocol Violation|4|||
156680938|NCT00283842|565577505|FG003|Overall Study|Protocol Violation|0|||
156680939|NCT00283842|565577506|FG004|Overall Study|Protocol Violation|0|||
156680940|NCT00283842|565577502|FG000|Overall Study|Protocol deviation|0|||
156680941|NCT00283842|565577503|FG001|Overall Study|Protocol deviation|0|||
156867464|NCT02395471|566275624|FG000|Overall Study|Protocol Violation|0|||
156680942|NCT00283842|565577504|FG002|Overall Study|Protocol deviation|0|||
156680943|NCT00283842|565577505|FG003|Overall Study|Protocol deviation|0|||
156680944|NCT00283842|565577506|FG004|Overall Study|Protocol deviation|2|||
156680945|NCT00283842|565577502|FG000|Overall Study|Withdrawal by Subject|2|||
156680946|NCT00283842|565577503|FG001|Overall Study|Withdrawal by Subject|1|||
156680947|NCT00283842|565577504|FG002|Overall Study|Withdrawal by Subject|1|||
156680948|NCT00283842|565577505|FG003|Overall Study|Withdrawal by Subject|5|||
156680949|NCT00283842|565577506|FG004|Overall Study|Withdrawal by Subject|4|||
156867465|NCT02395471|566275625|FG001|Overall Study|Protocol Violation|1|||
156867466|NCT02395471|566275624|FG000|Overall Study|Failure to swollow sponge twice|1|||
156867467|NCT02395471|566275625|FG001|Overall Study|Failure to swollow sponge twice|0|||
156867468|NCT02395471|566275624|FG000|Overall Study|Patient did not return for procedure|0|||
156867469|NCT02395471|566275625|FG001|Overall Study|Patient did not return for procedure|1|||
156867470|NCT02395471|566275624|FG000|Overall Study|Subject not eligible|1|||
156867471|NCT02395471|566275625|FG001|Overall Study|Subject not eligible|0|||
156680950|NCT00283842|565577502|FG000|Overall Study|Lack of Efficacy|1|||
156680951|NCT00283842|565577503|FG001|Overall Study|Lack of Efficacy|3|||
156680952|NCT00283842|565577504|FG002|Overall Study|Lack of Efficacy|1|||
156680953|NCT00283842|565577505|FG003|Overall Study|Lack of Efficacy|0|||
156680954|NCT00283842|565577506|FG004|Overall Study|Lack of Efficacy|3|||
156680955|NCT00283842|565577502|FG000|Overall Study|Lost to Follow-up|0|||
156680956|NCT00283842|565577503|FG001|Overall Study|Lost to Follow-up|2|||
156680957|NCT00283842|565577504|FG002|Overall Study|Lost to Follow-up|4|||
156680958|NCT00283842|565577505|FG003|Overall Study|Lost to Follow-up|1|||
156680959|NCT00283842|565577506|FG004|Overall Study|Lost to Follow-up|1|||
156680960|NCT04768114|565577509|FG000|Overall Study|Lost to Follow-up|5|||
156680961|NCT04768114|565577510|FG001|Overall Study|Lost to Follow-up|10|||
156680962|NCT04768114|565577509|FG000|Overall Study|Withdrawal by Subject|0|||
156680963|NCT04768114|565577510|FG001|Overall Study|Withdrawal by Subject|1|||
156680964|NCT00715676|565577511|FG000|Overall Study|Adverse Event|3|||
156680965|NCT00715676|565577512|FG001|Overall Study|Adverse Event|5|||
156680966|NCT00715676|565577513|FG002|Overall Study|Adverse Event|21|||
156680967|NCT00715676|565577511|FG000|Overall Study|Withdrawal by Subject|1|||
156680968|NCT00715676|565577512|FG001|Overall Study|Withdrawal by Subject|3|||
156680969|NCT00715676|565577513|FG002|Overall Study|Withdrawal by Subject|8|||
156680970|NCT00715676|565577511|FG000|Overall Study|Lost to Follow-up|1|||
156680971|NCT00715676|565577512|FG001|Overall Study|Lost to Follow-up|2|||
156680972|NCT00715676|565577513|FG002|Overall Study|Lost to Follow-up|1|||
156680973|NCT00715676|565577511|FG000|Overall Study|Terminated by Sponsor|1|||
156867472|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
156867473|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
156867474|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
156680974|NCT00715676|565577512|FG001|Overall Study|Terminated by Sponsor|0|||
156680975|NCT00715676|565577513|FG002|Overall Study|Terminated by Sponsor|0|||
156680976|NCT00715676|565577511|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
156867475|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
156680977|NCT00715676|565577512|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
156680978|NCT00715676|565577513|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
156680979|NCT00715676|565577511|FG000|Overall Study|Use of Exclusionary Medication|0|||
156680980|NCT00715676|565577512|FG001|Overall Study|Use of Exclusionary Medication|0|||
156680981|NCT00715676|565577513|FG002|Overall Study|Use of Exclusionary Medication|1|||
156680982|NCT00715676|565577511|FG000|Overall Study|Elevated Blood Glucose|0|||
156680983|NCT00715676|565577512|FG001|Overall Study|Elevated Blood Glucose|1|||
156680984|NCT00715676|565577513|FG002|Overall Study|Elevated Blood Glucose|0|||
156680985|NCT01963260|565577514|FG000|Overall Study|Withdrawal by Subject|2|||
156680986|NCT01963260|565577515|FG001|Overall Study|Withdrawal by Subject|0|||
156680987|NCT01963260|565577516|FG002|Overall Study|Withdrawal by Subject|0|||
156680988|NCT01963260|565577517|FG003|Overall Study|Withdrawal by Subject|1|||
156680989|NCT01963260|565577518|FG004|Overall Study|Withdrawal by Subject|2|||
156680990|NCT01963260|565577519|FG005|Overall Study|Withdrawal by Subject|0|||
156680991|NCT01963260|565577520|FG006|Overall Study|Withdrawal by Subject|0|||
156680992|NCT01963260|565577521|FG007|Overall Study|Withdrawal by Subject|0|||
156680993|NCT01963260|565577522|FG008|Overall Study|Withdrawal by Subject|0|||
156680994|NCT01963260|565577523|FG009|Overall Study|Withdrawal by Subject|0|||
156680995|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
156680996|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
156680997|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
156680998|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
156680999|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
156681000|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
156681001|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
156681002|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
156681003|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
156681004|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
156681005|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
156681006|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
156681007|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
156681008|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
156681009|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
156681010|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
156681011|NCT01067521|565577524|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
156681012|NCT01067521|565577525|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
156681013|NCT01067521|565577524|FG000|Open-Label Period|Death|3|||
156681014|NCT01067521|565577525|FG001|Open-Label Period|Death|1|||
156681015|NCT01067521|565577524|FG000|Open-Label Period|Adverse Event|30|||
156681016|NCT01067521|565577525|FG001|Open-Label Period|Adverse Event|28|||
156681017|NCT01067521|565577524|FG000|Open-Label Period|Withdrawal by Subject|160|||
156681018|NCT01067521|565577525|FG001|Open-Label Period|Withdrawal by Subject|88|||
156681019|NCT01067521|565577524|FG000|Open-Label Period|Physician Decision|13|||
156681020|NCT01067521|565577525|FG001|Open-Label Period|Physician Decision|11|||
156681021|NCT01067521|565577524|FG000|Open-Label Period|Non-compliance with study drug|5|||
156681022|NCT01067521|565577525|FG001|Open-Label Period|Non-compliance with study drug|0|||
156681023|NCT01067521|565577524|FG000|Open-Label Period|Protocol Violation|3|||
156681024|NCT01067521|565577525|FG001|Open-Label Period|Protocol Violation|0|||
156681025|NCT01067521|565577524|FG000|Open-Label Period|Pregnancy|14|||
156681026|NCT01067521|565577525|FG001|Open-Label Period|Pregnancy|8|||
156681027|NCT01067521|565577524|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
156681028|NCT01067521|565577525|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
156681029|NCT01067521|565577524|FG000|Open-Label Period|Lost to Follow-up|21|||
156681030|NCT01067521|565577525|FG001|Open-Label Period|Lost to Follow-up|20|||
156681031|NCT01547728|565577529|FG000|Overall Study|Change in procedure and equipment|1|||
156681032|NCT01547728|565577529|FG000|Overall Study|Drug not ready for subject|1|||
156681033|NCT01547728|565577529|FG000|Overall Study|Screen failure|39|||
156681034|NCT03828539|565577530|FG000|Overall Study|Adverse Event|3|||
156783588|NCT03573882|565956393|FG001|Overall Study|Adverse Event|5|||
156783589|NCT03573882|565956394|FG002|Overall Study|Adverse Event|6|||
156783590|NCT03573882|565956392|FG000|Overall Study|Lost to Follow-up|2|||
156783591|NCT03573882|565956393|FG001|Overall Study|Lost to Follow-up|5|||
156783592|NCT03573882|565956394|FG002|Overall Study|Lost to Follow-up|3|||
156783593|NCT03573882|565956392|FG000|Overall Study|Physician Decision|4|||
156783594|NCT03573882|565956393|FG001|Overall Study|Physician Decision|3|||
156783595|NCT03573882|565956394|FG002|Overall Study|Physician Decision|2|||
156783596|NCT03573882|565956392|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
156783597|NCT03573882|565956393|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
156783598|NCT03573882|565956394|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
157120107|NCT03031301|567192994|FG001|Overall Study|Adverse Event|0|||
156681035|NCT03828539|565577531|FG001|Overall Study|Adverse Event|12|||
156783599|NCT03573882|565956392|FG000|Overall Study|Pregnancy|1|||
156783600|NCT03573882|565956393|FG001|Overall Study|Pregnancy|2|||
156867476|NCT00118417|566275626|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
156867477|NCT00118417|566275627|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
156867478|NCT00118417|566275626|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
156681036|NCT03828539|565577530|FG000|Overall Study|Patient's/guardian's decision|3|||
156681037|NCT03828539|565577531|FG001|Overall Study|Patient's/guardian's decision|5|||
156681038|NCT03828539|565577530|FG000|Overall Study|Lost to Follow-up|4|||
156681039|NCT03828539|565577531|FG001|Overall Study|Lost to Follow-up|2|||
156681040|NCT03828539|565577530|FG000|Overall Study|Protocol Violation|3|||
156681041|NCT03828539|565577531|FG001|Overall Study|Protocol Violation|2|||
156681042|NCT03828539|565577530|FG000|Overall Study|Withdrawal of informed consent|2|||
156681043|NCT03828539|565577531|FG001|Overall Study|Withdrawal of informed consent|1|||
156681044|NCT03828539|565577530|FG000|Overall Study|New therapy for study indication|1|||
156681045|NCT03828539|565577531|FG001|Overall Study|New therapy for study indication|0|||
156681046|NCT01341405|565577532|FG000|Overall Study|Adverse Event|0|||
156681047|NCT01341405|565577533|FG001|Overall Study|Adverse Event|1|||
156681048|NCT01341405|565577534|FG002|Overall Study|Adverse Event|1|||
156681049|NCT01341405|565577532|FG000|Overall Study|Withdrawal by Subject|3|||
156681050|NCT01341405|565577533|FG001|Overall Study|Withdrawal by Subject|2|||
156681051|NCT01341405|565577534|FG002|Overall Study|Withdrawal by Subject|1|||
156681052|NCT02760433|565577535|FG000|Overall Study|Lost to Follow-up|1|||
156681053|NCT02760433|565577536|FG001|Overall Study|Lost to Follow-up|0|||
156681054|NCT02760433|565577537|FG002|Overall Study|Lost to Follow-up|1|||
156681055|NCT02760433|565577538|FG003|Overall Study|Lost to Follow-up|0|||
156681056|NCT02760433|565577539|FG004|Overall Study|Lost to Follow-up|0|||
156681057|NCT02760433|565577535|FG000|Overall Study|Withdrawal by Subject|23|||
156681058|NCT02760433|565577536|FG001|Overall Study|Withdrawal by Subject|9|||
156681059|NCT02760433|565577537|FG002|Overall Study|Withdrawal by Subject|0|||
156681060|NCT02760433|565577538|FG003|Overall Study|Withdrawal by Subject|2|||
156783601|NCT03573882|565956394|FG002|Overall Study|Pregnancy|0|||
156783602|NCT03573882|565956392|FG000|Overall Study|Other|4|||
156783603|NCT03573882|565956393|FG001|Overall Study|Other|2|||
156783604|NCT03573882|565956394|FG002|Overall Study|Other|2|||
156783605|NCT02691572|565956395|FG000|Overall Study|Withdrawal by Subject|1|||
156783606|NCT02691572|565956396|FG001|Overall Study|Withdrawal by Subject|0|||
156783607|NCT02691572|565956395|FG000|Overall Study|Protocol Violation|0|||
156783608|NCT02691572|565956396|FG001|Overall Study|Protocol Violation|1|||
156783609|NCT04337021|565956400|FG000|Overall Study|Lost to Follow-up|54|||
156783610|NCT04337021|565956401|FG001|Overall Study|Lost to Follow-up|66|||
156783611|NCT06394323|565956404|FG000|Overall Study|Death|0|||
156783612|NCT06394323|565956405|FG001|Overall Study|Death|1|||
156783613|NCT06394323|565956406|FG002|Overall Study|Death|0|||
156783614|NCT06394323|565956407|FG003|Overall Study|Death|0|||
156783615|NCT06394323|565956404|FG000|Overall Study|Physician Decision|0|||
156783616|NCT06394323|565956405|FG001|Overall Study|Physician Decision|2|||
156783617|NCT06394323|565956406|FG002|Overall Study|Physician Decision|0|||
156783618|NCT06394323|565956407|FG003|Overall Study|Physician Decision|0|||
156783619|NCT06394323|565956404|FG000|Overall Study|Withdrawal by Subject|4|||
156783620|NCT06394323|565956405|FG001|Overall Study|Withdrawal by Subject|4|||
156783621|NCT06394323|565956406|FG002|Overall Study|Withdrawal by Subject|0|||
156783622|NCT06394323|565956407|FG003|Overall Study|Withdrawal by Subject|0|||
156783623|NCT03554473|565957482|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
156783624|NCT03554473|565957483|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
156783625|NCT03554473|565957484|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
156783626|NCT03554473|565957482|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
156783627|NCT03554473|565957483|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
156783628|NCT03554473|565957484|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
156783629|NCT03554473|565957482|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
156783630|NCT03554473|565957483|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
156783631|NCT03554473|565957484|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
156783632|NCT05206604|565957485|FG000|Overall Study|Non-compliance with study drug|0|||
156783633|NCT05206604|565957486|FG001|Overall Study|Non-compliance with study drug|0|||
156783634|NCT05206604|565957487|FG002|Overall Study|Non-compliance with study drug|0|||
156783635|NCT05206604|565957488|FG003|Overall Study|Non-compliance with study drug|0|||
156783636|NCT05206604|565957489|FG004|Overall Study|Non-compliance with study drug|0|||
156783637|NCT05206604|565957490|FG005|Overall Study|Non-compliance with study drug|1|||
156867479|NCT00118417|566275627|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
156681061|NCT02760433|565577539|FG004|Overall Study|Withdrawal by Subject|9|||
156681062|NCT02760433|565577535|FG000|Overall Study|Lack of Response At Week 14|0|||
156681063|NCT02760433|565577536|FG001|Overall Study|Lack of Response At Week 14|0|||
156681064|NCT02760433|565577537|FG002|Overall Study|Lack of Response At Week 14|0|||
156681065|NCT02760433|565577538|FG003|Overall Study|Lack of Response At Week 14|0|||
156681066|NCT02760433|565577539|FG004|Overall Study|Lack of Response At Week 14|1|||
156681067|NCT02760433|565577535|FG000|Overall Study|Subject refused to continue the study|1|||
156681068|NCT02760433|565577536|FG001|Overall Study|Subject refused to continue the study|0|||
156681069|NCT02760433|565577537|FG002|Overall Study|Subject refused to continue the study|0|||
156681070|NCT02760433|565577538|FG003|Overall Study|Subject refused to continue the study|0|||
156681071|NCT02760433|565577539|FG004|Overall Study|Subject refused to continue the study|0|||
156681072|NCT02760433|565577535|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
156681073|NCT02760433|565577536|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681074|NCT02760433|565577537|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681075|NCT02760433|565577538|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681076|NCT02760433|565577539|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
156681077|NCT02760433|565577535|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681078|NCT02760433|565577536|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
156681079|NCT02760433|565577537|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681080|NCT02760433|565577538|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681081|NCT02760433|565577539|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
156681082|NCT00766493|565577540|FG000|30 Days Post-Procedure|Discontinued|7|||
156681083|NCT00766493|565577540|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
156681084|NCT00766493|565577540|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
156681085|NCT01849458|565577542|FG000|Overall Study|Lost to Follow-up|4|||
156681086|NCT00024258|565577545|FG000|Overall Study|Withdrawal by Subject|1|||
156681087|NCT00024258|565577545|FG000|Overall Study|Disease Progression|8|||
156681088|NCT01863433|565577546|FG000|Overall Study|Protocol Violation|1|||
156681089|NCT03950674|565577547|FG000|Overall Study|Death|16|||
156681090|NCT03950674|565577548|FG001|Overall Study|Death|15|||
156681091|NCT03950674|565577547|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
156681092|NCT03950674|565577548|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
156681093|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
156681094|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
156681095|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
156681096|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
156681097|NCT02224053|565577549|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
156681098|NCT01898598|565577550|FG000|Overall Study|Adverse Event|1|||
156681099|NCT01898598|565577551|FG001|Overall Study|Adverse Event|0|||
156681100|NCT01898598|565577550|FG000|Overall Study|Withdrawal by Subject|3|||
156681101|NCT01898598|565577551|FG001|Overall Study|Withdrawal by Subject|0|||
157120108|NCT01294800|567192995|FG000|Overall Study|Adverse Event|7|||
156681102|NCT01898598|565577550|FG000|Overall Study|Lost to Follow-up|0|||
156681103|NCT01898598|565577551|FG001|Overall Study|Lost to Follow-up|1|||
156681104|NCT01898598|565577550|FG000|Overall Study|Other|0|||
156681105|NCT01898598|565577551|FG001|Overall Study|Other|1|||
156681106|NCT03833427|565577552|FG000|Overall Study|Death|4|||
156681107|NCT03833427|565577553|FG001|Overall Study|Death|2|||
156681108|NCT03833427|565577554|FG002|Overall Study|Death|9|||
156681109|NCT03833427|565577555|FG003|Overall Study|Death|11|||
156681110|NCT03833427|565577556|FG004|Overall Study|Death|0|||
156681111|NCT03833427|565577557|FG005|Overall Study|Death|0|||
156681112|NCT03833427|565577558|FG006|Overall Study|Death|0|||
156681113|NCT03833427|565577552|FG000|Overall Study|Withdrawal by Subject|0|||
156681114|NCT03833427|565577553|FG001|Overall Study|Withdrawal by Subject|1|||
156681115|NCT03833427|565577554|FG002|Overall Study|Withdrawal by Subject|1|||
156681116|NCT03833427|565577555|FG003|Overall Study|Withdrawal by Subject|0|||
156681117|NCT03833427|565577556|FG004|Overall Study|Withdrawal by Subject|0|||
156681118|NCT03833427|565577557|FG005|Overall Study|Withdrawal by Subject|0|||
156681119|NCT03833427|565577558|FG006|Overall Study|Withdrawal by Subject|0|||
156681120|NCT03833427|565577552|FG000|Overall Study|Sponsor Decision|0|||
156681121|NCT03833427|565577553|FG001|Overall Study|Sponsor Decision|0|||
156681122|NCT03833427|565577554|FG002|Overall Study|Sponsor Decision|1|||
156681123|NCT03833427|565577555|FG003|Overall Study|Sponsor Decision|3|||
156681124|NCT03833427|565577556|FG004|Overall Study|Sponsor Decision|0|||
156681125|NCT03833427|565577557|FG005|Overall Study|Sponsor Decision|0|||
156681126|NCT03833427|565577558|FG006|Overall Study|Sponsor Decision|0|||
156681127|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
156681128|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
156783638|NCT05206604|565957491|FG006|Overall Study|Non-compliance with study drug|0|||
156681129|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
156681130|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
156681131|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
156681132|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
156681133|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
156681134|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
156681135|NCT03448692|565577564|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
156681136|NCT03448692|565577565|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
156681137|NCT05467540|565577568|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
156681138|NCT05467540|565577568|FG000|3-Month Follow-up|Lost to Follow-up|4|||
156681139|NCT05467540|565577568|FG000|3-Month Follow-up|Death|5|||
156681140|NCT05467540|565577568|FG000|12-Month Follow-up|Lost to Follow-up|6|||
156681141|NCT05467540|565577568|FG000|12-Month Follow-up|Death|8|||
156681142|NCT05467540|565577568|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
156681143|NCT03382041|565577592|FG000|Overall Study|Consent Form Lost|2|||
156681144|NCT03382041|565577593|FG001|Overall Study|Consent Form Lost|1|||
156681145|NCT03382041|565577592|FG000|Overall Study|Withdrawal by Subject|1|||
156681146|NCT03382041|565577593|FG001|Overall Study|Withdrawal by Subject|4|||
156681147|NCT03382041|565577592|FG000|Overall Study|Lost to Follow-up|1|||
156681148|NCT03382041|565577593|FG001|Overall Study|Lost to Follow-up|4|||
156681149|NCT01374451|565577596|FG000|Overall Study|Administrative problems|1|||
156681150|NCT01374451|565577597|FG001|Overall Study|Administrative problems|0|||
156681151|NCT00089973|565577598|FG000|Overall Study|Adverse Event|3|||
156681152|NCT00089973|565577598|FG000|Overall Study|Withdrawal by Subject|1|||
156681153|NCT00089973|565577598|FG000|Overall Study|Disease progression|45|||
156681154|NCT00089973|565577598|FG000|Overall Study|Death|1|||
156681155|NCT03493919|565577602|FG000|Overall Study|Other|2|||
156681156|NCT03493919|565577603|FG001|Overall Study|Other|0|||
156681157|NCT03493919|565577604|FG002|Overall Study|Other|1|||
156681158|NCT03493919|565577605|FG003|Overall Study|Other|0|||
156681159|NCT03493919|565577602|FG000|Overall Study|Withdrawal by Subject|9|||
156681160|NCT03493919|565577603|FG001|Overall Study|Withdrawal by Subject|3|||
156681161|NCT03493919|565577604|FG002|Overall Study|Withdrawal by Subject|1|||
156681162|NCT03493919|565577605|FG003|Overall Study|Withdrawal by Subject|1|||
156681163|NCT03493919|565577602|FG000|Overall Study|Lost to Follow-up|5|||
156681164|NCT03493919|565577603|FG001|Overall Study|Lost to Follow-up|0|||
156681165|NCT03493919|565577604|FG002|Overall Study|Lost to Follow-up|0|||
156681166|NCT03493919|565577605|FG003|Overall Study|Lost to Follow-up|3|||
156681167|NCT03493919|565577602|FG000|Overall Study|Adverse Event|0|||
156681168|NCT03493919|565577603|FG001|Overall Study|Adverse Event|1|||
156681169|NCT03493919|565577604|FG002|Overall Study|Adverse Event|0|||
156681170|NCT03493919|565577605|FG003|Overall Study|Adverse Event|0|||
156681171|NCT02129062|565578918|FG000|Overall Study|Death|1|||
156681172|NCT02129062|565578918|FG000|Overall Study|Disease Progression|2|||
156681173|NCT02031237|565578919|FG000|Overall Study|Death|1|||
156681174|NCT02031237|565578920|FG001|Overall Study|Death|5|||
156681175|NCT02031237|565578921|FG002|Overall Study|Death|0|||
156681176|NCT02031237|565578919|FG000|Overall Study|Physician Decision|0|||
156681177|NCT02031237|565578920|FG001|Overall Study|Physician Decision|1|||
156681178|NCT02031237|565578921|FG002|Overall Study|Physician Decision|0|||
156681179|NCT02031237|565578919|FG000|Overall Study|Withdrawal by Subject|2|||
156681180|NCT02031237|565578920|FG001|Overall Study|Withdrawal by Subject|2|||
156681181|NCT02031237|565578921|FG002|Overall Study|Withdrawal by Subject|0|||
156681182|NCT02031237|565578919|FG000|Overall Study|Protocol Violation|2|||
156681183|NCT02031237|565578920|FG001|Overall Study|Protocol Violation|6|||
156681184|NCT02031237|565578921|FG002|Overall Study|Protocol Violation|0|||
156681185|NCT02031237|565578919|FG000|Overall Study|Alternate Treatment Given|0|||
156681186|NCT02031237|565578920|FG001|Overall Study|Alternate Treatment Given|0|||
156681187|NCT02031237|565578921|FG002|Overall Study|Alternate Treatment Given|3|||
156681188|NCT00377156|565578927|FG000|Overall Study|Death|23|||
156681189|NCT00377156|565578928|FG001|Overall Study|Death|19|||
156681190|NCT00377156|565578927|FG000|Overall Study|Withdrawal by Subject|16|||
156681191|NCT00377156|565578928|FG001|Overall Study|Withdrawal by Subject|24|||
156681192|NCT00377156|565578927|FG000|Overall Study|Had follow-up <90 d|3|||
156681193|NCT00377156|565578928|FG001|Overall Study|Had follow-up <90 d|6|||
156681194|NCT00377156|565578927|FG000|Overall Study|Cancellation|1|||
156681195|NCT00377156|565578928|FG001|Overall Study|Cancellation|0|||
156681196|NCT00377156|565578927|FG000|Overall Study|Refused testing|0|||
156681197|NCT00377156|565578928|FG001|Overall Study|Refused testing|1|||
156681198|NCT00377156|565578927|FG000|Overall Study|Ineligible|0|||
156681199|NCT00377156|565578928|FG001|Overall Study|Ineligible|1|||
156681200|NCT00377156|565578927|FG000|Overall Study|Disability or language problem|0|||
156681201|NCT00377156|565578928|FG001|Overall Study|Disability or language problem|1|||
156681202|NCT00377156|565578927|FG000|Overall Study|Other|5|||
156783639|NCT05206604|565957492|FG007|Overall Study|Non-compliance with study drug|0|||
156681203|NCT00377156|565578928|FG001|Overall Study|Other|2|||
156681204|NCT01802216|565578929|FG000|4 Month Visit|Participant did not show to visit|3|||
156681205|NCT01802216|565578930|FG001|4 Month Visit|Participant did not show to visit|4|||
156681206|NCT01802216|565578929|FG000|8 Month Visit|Participant did not show to visit|3|||
156681207|NCT01802216|565578930|FG001|8 Month Visit|Participant did not show to visit|5|||
156681208|NCT01802216|565578929|FG000|12 Month Visit|Participant did not show to visit|3|||
156681209|NCT01802216|565578930|FG001|12 Month Visit|Participant did not show to visit|4|||
156681210|NCT00517192|565578935|FG000|Overall Study|Adverse Event|1|||
156681211|NCT00517192|565578936|FG001|Overall Study|Adverse Event|1|||
156681212|NCT00517192|565578935|FG000|Overall Study|Lost to Follow-up|1|||
156681213|NCT00517192|565578936|FG001|Overall Study|Lost to Follow-up|1|||
156681214|NCT00517192|565578935|FG000|Overall Study|Withdrawal by Subject|1|||
156681215|NCT00517192|565578936|FG001|Overall Study|Withdrawal by Subject|0|||
156681216|NCT00517192|565578935|FG000|Overall Study|Early termination of the trial|16|||
156681217|NCT00517192|565578936|FG001|Overall Study|Early termination of the trial|18|||
156681218|NCT05212948|565578942|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
156681219|NCT05212948|565578943|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
156681220|NCT05212948|565578942|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
156681221|NCT05212948|565578943|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
156681222|NCT05212948|565578942|FG000|Initial Vaccination Period|Pregnancy|20|||
156681223|NCT05212948|565578943|FG001|Initial Vaccination Period|Pregnancy|14|||
156681224|NCT05212948|565578942|FG000|Initial Vaccination Period|Physician Decision|686|||
156681225|NCT05212948|565578943|FG001|Initial Vaccination Period|Physician Decision|401|||
156681226|NCT05212948|565578942|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
156681227|NCT05212948|565578943|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
156681228|NCT05212948|565578942|FG000|Initial Vaccination Period|Death|23|||
156681229|NCT05212948|565578943|FG001|Initial Vaccination Period|Death|18|||
156681230|NCT05212948|565578942|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
156681231|NCT05212948|565578943|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
156681232|NCT05212948|565578942|FG000|Initial Vaccination Period|Adverse Event|36|||
156681233|NCT05212948|565578943|FG001|Initial Vaccination Period|Adverse Event|23|||
156681234|NCT05212948|565578942|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
156681235|NCT05212948|565578943|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
156681236|NCT05212948|565578942|FG000|Crossover Vaccination Period|Pregnancy|6|||
156681237|NCT05212948|565578943|FG001|Crossover Vaccination Period|Pregnancy|1|||
157120109|NCT01294800|567192996|FG001|Overall Study|Adverse Event|6|||
156681238|NCT05212948|565578942|FG000|Crossover Vaccination Period|Physician Decision|49|||
156681239|NCT05212948|565578943|FG001|Crossover Vaccination Period|Physician Decision|24|||
156681240|NCT05212948|565578942|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
156681241|NCT05212948|565578943|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
156681242|NCT05212948|565578942|FG000|Crossover Vaccination Period|Death|10|||
156681243|NCT05212948|565578943|FG001|Crossover Vaccination Period|Death|5|||
156681244|NCT05212948|565578942|FG000|Crossover Vaccination Period|Adverse Event|9|||
156783640|NCT00567580|565957493|FG000|Overall Study|Protocol Violation|28|||
156783641|NCT00567580|565957494|FG001|Overall Study|Protocol Violation|24|||
156783642|NCT00567580|565957495|FG002|Overall Study|Protocol Violation|24|||
156783643|NCT00552058|565957501|FG000|Overall Study|Adverse Event|8|||
156783644|NCT00552058|565957502|FG001|Overall Study|Adverse Event|7|||
156783645|NCT00552058|565957501|FG000|Overall Study|Lack of Efficacy|1|||
156783646|NCT00552058|565957502|FG001|Overall Study|Lack of Efficacy|5|||
156783647|NCT00552058|565957501|FG000|Overall Study|Lost to Follow-up|1|||
156783648|NCT00552058|565957502|FG001|Overall Study|Lost to Follow-up|0|||
156783649|NCT00552058|565957501|FG000|Overall Study|Withdrawal by Subject|4|||
157213229|NCT00272961|567527779|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
157213230|NCT00272961|567527780|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
157213231|NCT00272961|567527776|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
157120110|NCT01294800|567192997|FG002|Overall Study|Adverse Event|12|||
157120111|NCT01294800|567192998|FG003|Overall Study|Adverse Event|5|||
157120112|NCT01294800|567192995|FG000|Overall Study|Subject Withdrew Consent|2|||
156681245|NCT05212948|565578943|FG001|Crossover Vaccination Period|Adverse Event|4|||
156681246|NCT05347693|565578944|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
156681247|NCT05347693|565578945|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
156681248|NCT05347693|565578946|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
156681249|NCT05347693|565578944|FG000|Inpatient Period|Withdrawal of consent|10|||
156681250|NCT05347693|565578945|FG001|Inpatient Period|Withdrawal of consent|0|||
156681251|NCT05347693|565578946|FG002|Inpatient Period|Withdrawal of consent|0|||
156681252|NCT05347693|565578944|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
156681253|NCT05347693|565578945|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
157120113|NCT01294800|567192996|FG001|Overall Study|Subject Withdrew Consent|2|||
157120114|NCT01294800|567192997|FG002|Overall Study|Subject Withdrew Consent|2|||
157120115|NCT01294800|567192998|FG003|Overall Study|Subject Withdrew Consent|11|||
156681254|NCT05347693|565578946|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
157213232|NCT00272961|567527777|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
157213233|NCT00272961|567527778|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
157120116|NCT01294800|567192995|FG000|Overall Study|Lost to Follow-up|0|||
156681255|NCT05347693|565578944|FG000|Inpatient Period|Screening Failure|8|||
156681256|NCT05347693|565578945|FG001|Inpatient Period|Screening Failure|0|||
156783650|NCT00552058|565957502|FG001|Overall Study|Withdrawal by Subject|4|||
156783651|NCT00552058|565957501|FG000|Overall Study|Other: Protocol Violation|0|||
157213234|NCT00272961|567527779|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
157213235|NCT00272961|567527780|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
157213236|NCT00272961|567527776|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
156783652|NCT00552058|565957502|FG001|Overall Study|Other: Protocol Violation|1|||
156783653|NCT00552058|565957501|FG000|Overall Study|Other: Non Compliance|1|||
156783654|NCT00552058|565957502|FG001|Overall Study|Other: Non Compliance|2|||
156783655|NCT00552058|565957501|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
156783656|NCT00552058|565957502|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
156783657|NCT00552058|565957501|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
156783658|NCT00552058|565957502|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
156783659|NCT00552058|565957501|FG000|Overall Study|Other: Positive Stool Result|0|||
156783660|NCT00552058|565957502|FG001|Overall Study|Other: Positive Stool Result|1|||
156783661|NCT00552058|565957501|FG000|Overall Study|Other: Randomized in error|0|||
156783662|NCT00552058|565957502|FG001|Overall Study|Other: Randomized in error|1|||
156783663|NCT00552058|565957501|FG000|Overall Study|Other: Sponsors Decision|0|||
156783664|NCT00552058|565957502|FG001|Overall Study|Other: Sponsors Decision|1|||
156783665|NCT00552058|565957501|FG000|Overall Study|Other: Early Roll Over|1|||
156783666|NCT00552058|565957502|FG001|Overall Study|Other: Early Roll Over|0|||
156783667|NCT02609633|565957503|FG000|Overall Study|Consent Withdrawn|0|||
156783668|NCT02609633|565957504|FG001|Overall Study|Consent Withdrawn|1|||
156783669|NCT02609633|565957503|FG000|Overall Study|Protocol Deviation|1|||
156783670|NCT02609633|565957504|FG001|Overall Study|Protocol Deviation|0|||
156783671|NCT02609633|565957503|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
156783672|NCT02609633|565957504|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
156783673|NCT02609633|565957503|FG000|Overall Study|Reason not Specified|2|||
156783674|NCT02609633|565957504|FG001|Overall Study|Reason not Specified|1|||
156783675|NCT00471107|565957511|FG000|Overall Study|Technical problems/data loss|3|||
156783676|NCT00471107|565957512|FG001|Overall Study|Technical problems/data loss|1|||
156783677|NCT00471107|565957513|FG002|Overall Study|Technical problems/data loss|3|||
156783678|NCT00387127|565957515|FG000|Overall Study|Lost to Follow-up|0|||
156783679|NCT00387127|565957516|FG001|Overall Study|Lost to Follow-up|4|||
156783680|NCT00387127|565957515|FG000|Overall Study|Death|16|||
156783681|NCT00387127|565957516|FG001|Overall Study|Death|16|||
156783682|NCT00387127|565957515|FG000|Overall Study|Physician Decision|0|||
156783683|NCT00387127|565957516|FG001|Overall Study|Physician Decision|1|||
156783684|NCT00387127|565957515|FG000|Overall Study|Withdrawal by Subject|3|||
156783685|NCT00387127|565957516|FG001|Overall Study|Withdrawal by Subject|2|||
156783686|NCT00387127|565957515|FG000|Overall Study|Required by Protocol Amendment #4|12|||
156783687|NCT00387127|565957516|FG001|Overall Study|Required by Protocol Amendment #4|10|||
156783688|NCT00387127|565957515|FG000|Overall Study|Serious Adverse Event|1|||
156783689|NCT00387127|565957516|FG001|Overall Study|Serious Adverse Event|1|||
156783690|NCT00387127|565957515|FG000|Overall Study|Sponsor Unblinded|1|||
156783691|NCT00387127|565957516|FG001|Overall Study|Sponsor Unblinded|0|||
156783692|NCT02068599|565957522|FG000|Overall Study|Adverse Event|4|||
156783693|NCT02068599|565957523|FG001|Overall Study|Adverse Event|1|||
156783694|NCT02068599|565957524|FG002|Overall Study|Adverse Event|1|||
156783695|NCT02068599|565957522|FG000|Overall Study|Withdrawal by Subject|2|||
156783696|NCT02068599|565957523|FG001|Overall Study|Withdrawal by Subject|7|||
156783697|NCT02068599|565957524|FG002|Overall Study|Withdrawal by Subject|5|||
156783698|NCT02068599|565957522|FG000|Overall Study|Protocol Violation|4|||
156783699|NCT02068599|565957523|FG001|Overall Study|Protocol Violation|2|||
156783700|NCT02068599|565957524|FG002|Overall Study|Protocol Violation|3|||
156783701|NCT02068599|565957522|FG000|Overall Study|Lost to Follow-up|1|||
156783702|NCT02068599|565957523|FG001|Overall Study|Lost to Follow-up|0|||
156783703|NCT02068599|565957524|FG002|Overall Study|Lost to Follow-up|0|||
156783704|NCT02068599|565957522|FG000|Overall Study|Lack of Efficacy|0|||
156783705|NCT02068599|565957523|FG001|Overall Study|Lack of Efficacy|0|||
156783706|NCT02068599|565957524|FG002|Overall Study|Lack of Efficacy|3|||
156783707|NCT02068599|565957522|FG000|Overall Study|Noncompliance|0|||
156783708|NCT02068599|565957523|FG001|Overall Study|Noncompliance|0|||
156783709|NCT02068599|565957524|FG002|Overall Study|Noncompliance|1|||
156783710|NCT01263028|565957525|FG000|Overall Study|Withdrawal by Subject|1|||
156783711|NCT01263028|565957525|FG000|Overall Study|Adverse Event|1|||
156783712|NCT01263028|565957525|FG000|Overall Study|Study terminated due to low enrollment.|4|||
156783713|NCT06042855|565957526|FG000|Overall Study|No Receipt of Study Drug|48|||
156783714|NCT06042855|565957527|FG001|Overall Study|No Receipt of Study Drug|57|||
156783715|NCT06042855|565957526|FG000|Overall Study|Administratively Withdrawn|59|||
156783716|NCT06042855|565957527|FG001|Overall Study|Administratively Withdrawn|59|||
156783717|NCT06038643|565957529|FG000|Overall Study|Withdrawal by Subject|9|||
156783718|NCT06038643|565957530|FG001|Overall Study|Withdrawal by Subject|4|||
156783719|NCT06038643|565957529|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
156783720|NCT06038643|565957530|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
156783721|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
156783722|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
156783723|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Death|28|||
156681257|NCT05347693|565578946|FG002|Inpatient Period|Screening Failure|0|||
157012631|NCT04540913|566799421|FG000|Overall Study|Withdrawal by Subject|14|||
157012632|NCT04540913|566799422|FG001|Overall Study|Withdrawal by Subject|3|||
157012633|NCT04300231|566799423|FG000|Overall Study|Protocol Violation|4|||
157012634|NCT04300231|566799424|FG001|Overall Study|Protocol Violation|3|||
156681258|NCT05347693|565578944|FG000|Inpatient Period|Death|2|||
156681259|NCT05347693|565578945|FG001|Inpatient Period|Death|0|||
156681260|NCT05347693|565578946|FG002|Inpatient Period|Death|0|||
156681261|NCT05347693|565578944|FG000|Inpatient Period|Physician Decision|5|||
156681262|NCT05347693|565578945|FG001|Inpatient Period|Physician Decision|0|||
156681263|NCT05347693|565578946|FG002|Inpatient Period|Physician Decision|0|||
156681264|NCT05347693|565578944|FG000|Inpatient Period|Adverse Event|3|||
156681265|NCT05347693|565578945|FG001|Inpatient Period|Adverse Event|0|||
156681266|NCT05347693|565578946|FG002|Inpatient Period|Adverse Event|0|||
156681267|NCT05347693|565578944|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
156681268|NCT05347693|565578945|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
156681269|NCT05347693|565578946|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
156681270|NCT05347693|565578944|FG000|Outpatient Period|Adverse Event|0|||
156681271|NCT05347693|565578945|FG001|Outpatient Period|Adverse Event|9|||
156681272|NCT05347693|565578946|FG002|Outpatient Period|Adverse Event|0|||
156681273|NCT05347693|565578944|FG000|Outpatient Period|Death|0|||
156681274|NCT05347693|565578945|FG001|Outpatient Period|Death|6|||
156681275|NCT05347693|565578946|FG002|Outpatient Period|Death|2|||
156681276|NCT05347693|565578944|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
156681277|NCT05347693|565578945|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
156681278|NCT05347693|565578946|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
156681279|NCT05347693|565578944|FG000|Outpatient Period|Lost to Follow-up|0|||
156681280|NCT05347693|565578945|FG001|Outpatient Period|Lost to Follow-up|0|||
156681281|NCT05347693|565578946|FG002|Outpatient Period|Lost to Follow-up|1|||
156681282|NCT05347693|565578944|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
156681283|NCT05347693|565578945|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
156681284|NCT05347693|565578946|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
156681285|NCT05347693|565578944|FG000|Outpatient Period|Scheduled hemodialysis|0|||
156681286|NCT05347693|565578945|FG001|Outpatient Period|Scheduled hemodialysis|1|||
156681287|NCT05347693|565578946|FG002|Outpatient Period|Scheduled hemodialysis|0|||
156681288|NCT05347693|565578944|FG000|Outpatient Period|Severe HK|0|||
156681289|NCT05347693|565578945|FG001|Outpatient Period|Severe HK|0|||
156681290|NCT05347693|565578946|FG002|Outpatient Period|Severe HK|1|||
156681291|NCT05347693|565578944|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
156681292|NCT05347693|565578945|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
156681293|NCT05347693|565578946|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
156681294|NCT05347693|565578944|FG000|Outpatient Period|Start of dialysis|0|||
156681295|NCT05347693|565578945|FG001|Outpatient Period|Start of dialysis|0|||
156681296|NCT05347693|565578946|FG002|Outpatient Period|Start of dialysis|1|||
156681297|NCT05347693|565578944|FG000|Outpatient Period|The participant entered hemodialysis|0|||
156681298|NCT05347693|565578945|FG001|Outpatient Period|The participant entered hemodialysis|0|||
156681299|NCT05347693|565578946|FG002|Outpatient Period|The participant entered hemodialysis|1|||
156681300|NCT05347693|565578944|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
156681301|NCT05347693|565578945|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
156681302|NCT05347693|565578946|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
156783724|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Death|29|||
156783725|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
156783726|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
156783727|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Other|30|||
156783728|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Other|20|||
156783729|NCT00699751|565957531|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
156783730|NCT00699751|565957532|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
156783731|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
156783732|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
156783733|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
156783734|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
156783735|NCT00699751|565957531|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
156783736|NCT00699751|565957532|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
156783737|NCT01947933|565957533|FG000|Overall Study|Withdrawal by Subject|0|||
156783738|NCT01947933|565957534|FG001|Overall Study|Withdrawal by Subject|0|||
156783739|NCT01947933|565957535|FG002|Overall Study|Withdrawal by Subject|1|||
156783740|NCT01947933|565957536|FG003|Overall Study|Withdrawal by Subject|0|||
157012635|NCT04300231|566799425|FG002|Overall Study|Protocol Violation|0|||
156681303|NCT05347693|565578944|FG000|Outpatient Period|Withdrawal by Subject|0|||
156681304|NCT05347693|565578945|FG001|Outpatient Period|Withdrawal by Subject|8|||
156681305|NCT05347693|565578946|FG002|Outpatient Period|Withdrawal by Subject|5|||
156681306|NCT00695110|565578949|FG000|Treatment Period 1|Adverse Event|1|||
156681307|NCT00695110|565578949|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156681308|NCT00695110|565578949|FG000|Treatment Period 3|Withdrawal by Subject|1|||
156681309|NCT00695110|565578949|FG000|Treatment Period 4|Adverse Event|1|||
156681310|NCT04675775|565578953|FG000|Overall Study|Withdrawal by Subject|7|||
156681311|NCT04941768|565578957|FG000|Overall Study|Lost to Follow-up|10|||
156681312|NCT04941768|565578957|FG000|Overall Study|Death|24|||
156681313|NCT04941768|565578957|FG000|Overall Study|Progressive Disease|4|||
156681314|NCT04941768|565578957|FG000|Overall Study|Withdrawal by Subject|4|||
156681315|NCT04941768|565578957|FG000|Overall Study|Other|3|||
156681316|NCT04941768|565578957|FG000|Overall Study|Treatment ongoing|21|||
156681317|NCT04941768|565578957|FG000|Overall Study|Off treatment and in follow-up|21|||
156681318|NCT03302078|565578958|FG000|Washout Period|Adverse Event|0|||
156681319|NCT03302078|565578959|FG001|Washout Period|Adverse Event|1|||
156681320|NCT05148299|565578960|FG000|Treatment Period|Adverse Event|1|||
156681321|NCT05148299|565578960|FG000|Treatment Period|Physician Decision|1|||
156681322|NCT05148299|565578960|FG000|Treatment Period|Death|1|||
156681323|NCT05148299|565578960|FG000|Follow-up Period|Death|3|||
156681324|NCT02161549|565578961|FG000|Overall Study|Physician Decision|6|||
156681325|NCT02161549|565578962|FG001|Overall Study|Physician Decision|2|||
156681326|NCT02340780|565578963|FG000|Overall Study|Ineligible|1|||
156681327|NCT03433703|565578964|FG000|Overall Study|Study terminated by Sponsor|2|||
156681328|NCT01957150|565578965|FG000|Overall Study|Adverse Event|23|||
156681329|NCT01957150|565578966|FG001|Overall Study|Adverse Event|20|||
156681330|NCT01957150|565578965|FG000|Overall Study|Withdrawal by Subject|13|||
156681331|NCT01957150|565578966|FG001|Overall Study|Withdrawal by Subject|17|||
156681332|NCT01957150|565578965|FG000|Overall Study|Physician Decision|3|||
156681333|NCT01957150|565578966|FG001|Overall Study|Physician Decision|6|||
156681334|NCT01957150|565578965|FG000|Overall Study|Lost to Follow-up|4|||
156681335|NCT01957150|565578966|FG001|Overall Study|Lost to Follow-up|4|||
157012636|NCT04300231|566799426|FG003|Overall Study|Protocol Violation|2|||
157012637|NCT00431834|566799432|FG000|Overall Study|Withdrawal by Subject|7|||
157012638|NCT00431834|566799432|FG000|Overall Study|Death|3|||
157012639|NCT00431834|566799432|FG000|Overall Study|Missed Endpoint Visit|2|||
157012640|NCT00431834|566799432|FG000|Overall Study|Lost to Follow-up|1|||
157012641|NCT01808339|566799433|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012642|NCT01808339|566799434|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012643|NCT01808339|566799435|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012644|NCT01808339|566799436|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
157012645|NCT01808339|566799437|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
157012646|NCT01808339|566799438|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
157012647|NCT01808339|566799433|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
157012648|NCT01808339|566799434|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
157012649|NCT01808339|566799435|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
157012650|NCT01808339|566799436|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
157012651|NCT01808339|566799437|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
157012652|NCT01808339|566799438|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
157012653|NCT01808339|566799433|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012654|NCT01808339|566799434|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012655|NCT01808339|566799435|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
157012656|NCT01808339|566799436|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012657|NCT01808339|566799437|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012658|NCT01808339|566799438|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
157012659|NCT01610297|566799444|FG000|Overall Study|Lost to Follow-up|1|||
157012660|NCT02101281|566799445|FG000|Overall Study|Adverse Event|0|||
157012661|NCT02101281|566799446|FG001|Overall Study|Adverse Event|1|||
157012662|NCT00529100|566799449|FG000|Overall Study|Adverse Event|0|||
157012663|NCT00529100|566799450|FG001|Overall Study|Adverse Event|5|||
157012664|NCT00529100|566799449|FG000|Overall Study|Protocol Violation|0|||
157012665|NCT00529100|566799450|FG001|Overall Study|Protocol Violation|1|||
157012666|NCT00529100|566799449|FG000|Overall Study|Progressive Disease|0|||
157012667|NCT00529100|566799450|FG001|Overall Study|Progressive Disease|1|||
157012668|NCT00529100|566799449|FG000|Overall Study|Withdrawal by Subject|0|||
157012669|NCT00529100|566799450|FG001|Overall Study|Withdrawal by Subject|1|||
157012670|NCT00529100|566799449|FG000|Overall Study|Participant Ineligibility|0|||
157012671|NCT00529100|566799450|FG001|Overall Study|Participant Ineligibility|1|||
156681336|NCT01957150|565578965|FG000|Overall Study|Protocol Violation|1|||
156681337|NCT01957150|565578966|FG001|Overall Study|Protocol Violation|0|||
156681338|NCT01957150|565578965|FG000|Overall Study|Lack of Efficacy|11|||
156681339|NCT01957150|565578966|FG001|Overall Study|Lack of Efficacy|11|||
156681340|NCT03223909|565578967|FG000|Overall Study|Protocol Violation|48|||
156783741|NCT01947933|565957537|FG004|Overall Study|Withdrawal by Subject|0|||
156783742|NCT01947933|565957538|FG005|Overall Study|Withdrawal by Subject|0|||
156783743|NCT01947933|565957539|FG006|Overall Study|Withdrawal by Subject|0|||
156783744|NCT01947933|565957540|FG007|Overall Study|Withdrawal by Subject|0|||
156783745|NCT01947933|565957541|FG008|Overall Study|Withdrawal by Subject|0|||
156783746|NCT01947933|565957533|FG000|Overall Study|Lost to Follow-up|0|||
156783747|NCT01947933|565957534|FG001|Overall Study|Lost to Follow-up|0|||
157012672|NCT03733119|566799451|FG000|Overall Study|Physician Decision|2|||
157213237|NCT00272961|567527777|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
157213238|NCT00272961|567527778|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
157213239|NCT00272961|567527779|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
157213240|NCT00272961|567527780|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
157213241|NCT00272961|567527776|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
157213242|NCT00272961|567527777|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
157213243|NCT00272961|567527778|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
157213244|NCT00272961|567527779|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
157213245|NCT00272961|567527780|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
157213246|NCT02400905|567527782|FG000|Overall Study|Death|24|||
157213247|NCT02400905|567527782|FG000|Overall Study|Lost to Follow-up|18|||
157213248|NCT02400905|567527782|FG000|Overall Study|Withdrawal by Subject|16|||
157213249|NCT02400905|567527782|FG000|Overall Study|Physician Decision|4|||
157213250|NCT02400905|567527782|FG000|Overall Study|Other|1|||
157213251|NCT03196791|567527785|FG000|Overall Study|Protocol Violation|7|||
157213252|NCT03196791|567527786|FG001|Overall Study|Protocol Violation|3|||
157213253|NCT03196791|567527785|FG000|Overall Study|Withdrawal by Subject|3|||
157213254|NCT03196791|567527786|FG001|Overall Study|Withdrawal by Subject|2|||
157012673|NCT03733119|566799452|FG001|Overall Study|Physician Decision|1|||
157012674|NCT03733119|566799451|FG000|Overall Study|ineligible to treat per protocol|0|||
157012675|NCT03733119|566799452|FG001|Overall Study|ineligible to treat per protocol|1|||
157012676|NCT01198145|566799453|FG000|Overall Study|Withdrawal by Subject|1|||
157012677|NCT01198145|566799454|FG001|Overall Study|Withdrawal by Subject|1|||
157012678|NCT02178098|566799465|FG000|Overall Study|Withdrawal by Subject|0|||
157012679|NCT02178098|566799466|FG001|Overall Study|Withdrawal by Subject|6|||
157012680|NCT02178098|566799465|FG000|Overall Study|Adverse Event|1|||
157012681|NCT02178098|566799466|FG001|Overall Study|Adverse Event|2|||
157012682|NCT02178098|566799465|FG000|Overall Study|Protocol Violation|1|||
157012683|NCT02178098|566799466|FG001|Overall Study|Protocol Violation|1|||
157012684|NCT02178098|566799465|FG000|Overall Study|Lost to Follow-up|0|||
157012685|NCT02178098|566799466|FG001|Overall Study|Lost to Follow-up|1|||
157012686|NCT02178098|566799465|FG000|Overall Study|Sponsor Request|1|||
157012687|NCT02178098|566799466|FG001|Overall Study|Sponsor Request|0|||
157012688|NCT02178098|566799465|FG000|Overall Study|Other|2|||
157012689|NCT02178098|566799466|FG001|Overall Study|Other|2|||
157012690|NCT01109524|566799471|FG000|Overall Study|Disease Progression|29|||
157012691|NCT01109524|566799471|FG000|Overall Study|Study Drug toxicity|6|||
157012692|NCT01109524|566799471|FG000|Overall Study|Adverse Event|4|||
157012693|NCT01109524|566799471|FG000|Overall Study|Withdrawal by Subject|2|||
157012694|NCT01109524|566799471|FG000|Overall Study|Maximum clinical benefit|3|||
157012695|NCT01109524|566799471|FG000|Overall Study|Death|2|||
157012696|NCT01109524|566799471|FG000|Overall Study|No longer meets criteria|2|||
157012697|NCT01109524|566799471|FG000|Overall Study|Participant requested to end treatment|4|||
157012698|NCT01109524|566799471|FG000|Overall Study|Other|5|||
157012699|NCT01925339|566799478|FG000|Overall Study|Adverse Event|2|||
157012700|NCT01925339|566799479|FG001|Overall Study|Adverse Event|0|||
157012701|NCT03997916|566799486|FG000|Overall Study|Protocol Violation|35|||
157012702|NCT04992390|566799487|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
157012703|NCT04992390|566799488|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
157012704|NCT04992390|566799489|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
157012705|NCT04992390|566799487|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
157213255|NCT00944125|567527791|FG000|3 to 6 Months|Withdrawal by Subject|0|||
157213256|NCT00944125|567527792|FG001|3 to 6 Months|Withdrawal by Subject|2|||
157213257|NCT00944125|567527791|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
157213258|NCT00944125|567527792|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
157213259|NCT02176642|567527793|FG000|Overall Study|Withdrawal by Subject|0|||
157213260|NCT02176642|567527794|FG001|Overall Study|Withdrawal by Subject|1|||
156783748|NCT01947933|565957535|FG002|Overall Study|Lost to Follow-up|0|||
156783749|NCT01947933|565957536|FG003|Overall Study|Lost to Follow-up|0|||
156783750|NCT01947933|565957537|FG004|Overall Study|Lost to Follow-up|0|||
156783751|NCT01947933|565957538|FG005|Overall Study|Lost to Follow-up|0|||
157012706|NCT04992390|566799488|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
157012707|NCT04992390|566799489|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
157012708|NCT04992390|566799487|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
156783752|NCT01947933|565957539|FG006|Overall Study|Lost to Follow-up|0|||
156783753|NCT01947933|565957540|FG007|Overall Study|Lost to Follow-up|0|||
157012709|NCT04992390|566799488|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
157120117|NCT01294800|567192996|FG001|Overall Study|Lost to Follow-up|0|||
157120118|NCT01294800|567192997|FG002|Overall Study|Lost to Follow-up|1|||
157120119|NCT01294800|567192998|FG003|Overall Study|Lost to Follow-up|0|||
157120120|NCT01294800|567192995|FG000|Overall Study|Non-compliance With Protocol|0|||
157120121|NCT01294800|567192996|FG001|Overall Study|Non-compliance With Protocol|1|||
157120122|NCT01294800|567192997|FG002|Overall Study|Non-compliance With Protocol|1|||
157120123|NCT01294800|567192998|FG003|Overall Study|Non-compliance With Protocol|0|||
157120124|NCT01294800|567192995|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
157120125|NCT01294800|567192996|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
157120126|NCT01294800|567192997|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
157120127|NCT01294800|567192998|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
157120128|NCT01662895|567193000|FG000|Overall Study|Lost to Follow-up|0|||
157120129|NCT01662895|567193001|FG001|Overall Study|Lost to Follow-up|1|||
157120130|NCT05048342|567193002|FG000|Overall Study|Adverse Event|1|||
157120131|NCT05048342|567193002|FG000|Overall Study|Subject decision|2|||
157120132|NCT01100944|567193003|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
157120133|NCT01100944|567193004|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
157120134|NCT01100944|567193005|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
157120135|NCT01100944|567193003|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
157120136|NCT01100944|567193004|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
157120137|NCT01100944|567193005|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
157120138|NCT01100944|567193003|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
157120139|NCT01100944|567193004|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
157120140|NCT01100944|567193005|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
157120141|NCT01100944|567193003|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
157120142|NCT01100944|567193004|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
157120143|NCT01100944|567193005|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
157120144|NCT04607733|567193006|FG000|Overall Study|Lost to Follow-up|1|||
157120145|NCT04607733|567193007|FG001|Overall Study|Lost to Follow-up|0|||
157120146|NCT04607733|567193008|FG002|Overall Study|Lost to Follow-up|0|||
157120147|NCT04607733|567193009|FG003|Overall Study|Lost to Follow-up|1|||
157120148|NCT04607733|567193010|FG004|Overall Study|Lost to Follow-up|1|||
157120149|NCT04607733|567193011|FG005|Overall Study|Lost to Follow-up|0|||
157120150|NCT04607733|567193006|FG000|Overall Study|Withdrawal by Subject|0|||
157120151|NCT04607733|567193007|FG001|Overall Study|Withdrawal by Subject|0|||
157120152|NCT04607733|567193008|FG002|Overall Study|Withdrawal by Subject|0|||
157120153|NCT04607733|567193009|FG003|Overall Study|Withdrawal by Subject|0|||
157120154|NCT04607733|567193010|FG004|Overall Study|Withdrawal by Subject|1|||
157120155|NCT04607733|567193011|FG005|Overall Study|Withdrawal by Subject|0|||
157120156|NCT02296242|567193037|FG000|Overall Study|Death|1|||
157120157|NCT02296242|567193038|FG001|Overall Study|Death|1|||
157120158|NCT02296242|567193039|FG002|Overall Study|Death|1|||
157120159|NCT02296242|567193040|FG003|Overall Study|Death|1|||
157120160|NCT02296242|567193041|FG004|Overall Study|Death|1|||
156867480|NCT00118417|566275626|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
156867481|NCT00118417|566275627|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
157120161|NCT02296242|567193037|FG000|Overall Study|Withdrawal by Subject|0|||
157120162|NCT02296242|567193038|FG001|Overall Study|Withdrawal by Subject|0|||
157120163|NCT02296242|567193039|FG002|Overall Study|Withdrawal by Subject|1|||
157120164|NCT02296242|567193040|FG003|Overall Study|Withdrawal by Subject|1|||
157120165|NCT02296242|567193041|FG004|Overall Study|Withdrawal by Subject|3|||
157120166|NCT02296242|567193037|FG000|Overall Study|Disease Progression|1|||
157120167|NCT02296242|567193038|FG001|Overall Study|Disease Progression|3|||
157120168|NCT02296242|567193039|FG002|Overall Study|Disease Progression|2|||
157120169|NCT02296242|567193040|FG003|Overall Study|Disease Progression|8|||
157120170|NCT02296242|567193041|FG004|Overall Study|Disease Progression|11|||
157120171|NCT02296242|567193037|FG000|Overall Study|Unacceptable Toxicity|0|||
157120172|NCT02296242|567193038|FG001|Overall Study|Unacceptable Toxicity|0|||
157120173|NCT02296242|567193039|FG002|Overall Study|Unacceptable Toxicity|0|||
157120174|NCT02296242|567193040|FG003|Overall Study|Unacceptable Toxicity|0|||
157120175|NCT02296242|567193041|FG004|Overall Study|Unacceptable Toxicity|1|||
157120176|NCT02296242|567193037|FG000|Overall Study|Patient Condition Changed|0|||
157120177|NCT02296242|567193038|FG001|Overall Study|Patient Condition Changed|0|||
157120178|NCT02296242|567193039|FG002|Overall Study|Patient Condition Changed|2|||
157120179|NCT02296242|567193040|FG003|Overall Study|Patient Condition Changed|0|||
156867482|NCT02978781|566275628|FG000|Part A|Adverse Event|1|||
156867483|NCT02978781|566275629|FG001|Part A|Adverse Event|1|||
156867484|NCT02978781|566275630|FG002|Part A|Adverse Event|0|||
156867485|NCT02978781|566275631|FG003|Part A|Adverse Event|0|||
156867486|NCT02978781|566275632|FG004|Part A|Adverse Event|0|||
156867487|NCT02978781|566275628|FG000|Part A|Withdrawal by Subject|0|||
156867488|NCT02978781|566275629|FG001|Part A|Withdrawal by Subject|1|||
156867489|NCT02978781|566275630|FG002|Part A|Withdrawal by Subject|0|||
156867490|NCT02978781|566275631|FG003|Part A|Withdrawal by Subject|0|||
156867491|NCT02978781|566275632|FG004|Part A|Withdrawal by Subject|0|||
156867492|NCT02978781|566275628|FG000|Part B|Withdrawal by Subject|0|||
156867493|NCT02978781|566275629|FG001|Part B|Withdrawal by Subject|0|||
156867494|NCT02978781|566275630|FG002|Part B|Withdrawal by Subject|0|||
156867495|NCT02978781|566275631|FG003|Part B|Withdrawal by Subject|1|||
157213261|NCT03338673|567527796|FG000|Overall Study|Lost to Follow-up|1|||
157213262|NCT03338673|567527797|FG001|Overall Study|Lost to Follow-up|1|||
157213263|NCT04556838|567527806|FG000|Overall Study|Withdrawal by Subject|3|||
157213264|NCT04556838|567527807|FG001|Overall Study|Withdrawal by Subject|1|||
157213265|NCT04556838|567527808|FG002|Overall Study|Withdrawal by Subject|2|||
157213266|NCT04556838|567527806|FG000|Overall Study|Adverse Event|0|||
157213267|NCT04556838|567527807|FG001|Overall Study|Adverse Event|1|||
157213268|NCT04556838|567527808|FG002|Overall Study|Adverse Event|1|||
157213269|NCT04556838|567527806|FG000|Overall Study|Lost to Follow-up|0|||
157213270|NCT04556838|567527807|FG001|Overall Study|Lost to Follow-up|0|||
157213271|NCT04556838|567527808|FG002|Overall Study|Lost to Follow-up|2|||
157213272|NCT04556838|567527806|FG000|Overall Study|Subject travel|0|||
157213273|NCT04556838|567527807|FG001|Overall Study|Subject travel|1|||
157213274|NCT04556838|567527808|FG002|Overall Study|Subject travel|0|||
157213275|NCT04556838|567527806|FG000|Overall Study|Physician Decision|1|||
157213276|NCT04556838|567527807|FG001|Overall Study|Physician Decision|0|||
157213277|NCT04556838|567527808|FG002|Overall Study|Physician Decision|0|||
157213278|NCT04523831|567527809|FG000|Overall Study|Lost to Follow-up|15|||
157213279|NCT04523831|567527810|FG001|Overall Study|Lost to Follow-up|17|||
157213280|NCT04523831|567527809|FG000|Overall Study|Death|0|||
157213281|NCT04523831|567527810|FG001|Overall Study|Death|3|||
157213282|NCT04523831|567527809|FG000|Overall Study|Adverse Event|2|||
157213283|NCT04523831|567527810|FG001|Overall Study|Adverse Event|0|||
157213284|NCT03033069|567527811|FG000|Overall Study|Adverse Event|6|||
157213285|NCT03033069|567527812|FG001|Overall Study|Adverse Event|7|||
157213286|NCT03033069|567527813|FG002|Overall Study|Adverse Event|4|||
157213287|NCT03033069|567527814|FG003|Overall Study|Adverse Event|6|||
157213288|NCT03033069|567527811|FG000|Overall Study|Lack of Efficacy|0|||
157213289|NCT03033069|567527812|FG001|Overall Study|Lack of Efficacy|0|||
157213290|NCT03033069|567527813|FG002|Overall Study|Lack of Efficacy|1|||
157213291|NCT03033069|567527814|FG003|Overall Study|Lack of Efficacy|0|||
157213292|NCT03033069|567527811|FG000|Overall Study|Lost to Follow-up|6|||
157213293|NCT03033069|567527812|FG001|Overall Study|Lost to Follow-up|5|||
157213294|NCT03033069|567527813|FG002|Overall Study|Lost to Follow-up|5|||
157213295|NCT03033069|567527814|FG003|Overall Study|Lost to Follow-up|6|||
157213296|NCT03033069|567527811|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157213297|NCT03033069|567527812|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157213298|NCT03033069|567527813|FG002|Overall Study|Non-Compliance With Study Drug|1|||
157213299|NCT03033069|567527814|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156783754|NCT01947933|565957541|FG008|Overall Study|Lost to Follow-up|1|||
156783755|NCT00294398|565957542|FG000|Overall Study|Lost to Follow-up|21|||
156783756|NCT00294398|565957543|FG001|Overall Study|Lost to Follow-up|26|||
156783757|NCT01428128|565957547|FG000|Overall Study|Withdrawal by Subject|4|||
156783758|NCT01428128|565957547|FG000|Overall Study|Screen failure by p53|10|||
156783759|NCT01428128|565957547|FG000|Overall Study|Received Neulasta in one cycle|2|||
156783760|NCT01428128|565957547|FG000|Overall Study|Adverse Event|1|||
156867496|NCT02978781|566275632|FG004|Part B|Withdrawal by Subject|0|||
156867497|NCT02978781|566275628|FG000|Part C|Adverse Event|0|||
156867498|NCT02978781|566275629|FG001|Part C|Adverse Event|0|||
156867499|NCT02978781|566275630|FG002|Part C|Adverse Event|0|||
156867500|NCT02978781|566275631|FG003|Part C|Adverse Event|0|||
157213300|NCT03033069|567527811|FG000|Overall Study|Protocol Deviation|0|||
157213301|NCT03033069|567527812|FG001|Overall Study|Protocol Deviation|1|||
157213302|NCT03033069|567527813|FG002|Overall Study|Protocol Deviation|0|||
156783761|NCT00250718|565957551|FG000|Overall Study|Death|1|||
156783762|NCT00250718|565957551|FG000|Overall Study|Adverse Event|1|||
156783763|NCT00250718|565957551|FG000|Overall Study|Withdrawal by Subject|1|||
156783764|NCT06100250|565957554|FG000|Overall Study|Lost to Follow-up|5|||
156783765|NCT00424008|565957556|FG000|Overall Study|Adverse Event|8|||
156783766|NCT00424008|565957557|FG001|Overall Study|Adverse Event|6|||
156783767|NCT00424008|565957556|FG000|Overall Study|Lack of Efficacy|40|||
156783768|NCT00424008|565957557|FG001|Overall Study|Lack of Efficacy|34|||
156783769|NCT00424008|565957556|FG000|Overall Study|Lost to Follow-up|1|||
156783770|NCT00424008|565957557|FG001|Overall Study|Lost to Follow-up|2|||
156783771|NCT00424008|565957556|FG000|Overall Study|Withdrawal by Subject|5|||
156783772|NCT00424008|565957557|FG001|Overall Study|Withdrawal by Subject|8|||
156783773|NCT00424008|565957556|FG000|Overall Study|Noncompliance with protocol|13|||
156783774|NCT00424008|565957557|FG001|Overall Study|Noncompliance with protocol|7|||
157213303|NCT03033069|567527814|FG003|Overall Study|Protocol Deviation|0|||
157213304|NCT03033069|567527811|FG000|Overall Study|Withdrawal by Subject|10|||
157213305|NCT03033069|567527812|FG001|Overall Study|Withdrawal by Subject|10|||
156783775|NCT00424008|565957556|FG000|Overall Study|Did not meet protocol eligibility|16|||
156783776|NCT00424008|565957557|FG001|Overall Study|Did not meet protocol eligibility|21|||
156867501|NCT02978781|566275632|FG004|Part C|Adverse Event|2|||
156867502|NCT02978781|566275628|FG000|Part C|Withdrawal by Subject|0|||
157213306|NCT03033069|567527813|FG002|Overall Study|Withdrawal by Subject|11|||
156681341|NCT03223909|565578968|FG001|Overall Study|Protocol Violation|45|||
156681342|NCT03223909|565578969|FG002|Overall Study|Protocol Violation|16|||
156681343|NCT01856192|565578970|FG000|Overall Study|Adverse Event|12|||
156681344|NCT01856192|565578971|FG001|Overall Study|Adverse Event|4|||
156681345|NCT01856192|565578970|FG000|Overall Study|Alternative therapy|0|||
156783777|NCT00424008|565957556|FG000|Overall Study|Administrative|266|||
156783778|NCT00424008|565957557|FG001|Overall Study|Administrative|257|||
156783779|NCT02593864|565957558|FG000|Overall Study|Withdrawal by Subject|3|||
156783780|NCT02593864|565957558|FG000|Overall Study|Lost to Follow-up|3|||
156783781|NCT02114684|565957566|FG000|Overall Study|Death|6|||
156783782|NCT02114684|565957567|FG001|Overall Study|Death|4|||
156783783|NCT02114684|565957566|FG000|Overall Study|Lost to Follow-up|1|||
156783784|NCT02114684|565957567|FG001|Overall Study|Lost to Follow-up|2|||
156783785|NCT02114684|565957566|FG000|Overall Study|Withdrawal by Subject|1|||
156783786|NCT02114684|565957567|FG001|Overall Study|Withdrawal by Subject|2|||
156783787|NCT02114684|565957566|FG000|Overall Study|Relocation|3|||
156783788|NCT02114684|565957567|FG001|Overall Study|Relocation|1|||
156783789|NCT02114684|565957566|FG000|Overall Study|Rifampicin resistant on culture|0|||
156783790|NCT02114684|565957567|FG001|Overall Study|Rifampicin resistant on culture|1|||
156783791|NCT02114684|565957566|FG000|Overall Study|Patient Incarcerated|1|||
156783792|NCT02114684|565957567|FG001|Overall Study|Patient Incarcerated|0|||
156783793|NCT01397747|565957582|FG000|Overall Study|Multitarget DNA test excluded|689|||
156783794|NCT01397747|565957582|FG000|Overall Study|Colonoscopy excluded|304|||
156783795|NCT01397747|565957582|FG000|Overall Study|FIT excluded|34|||
156783796|NCT03828383|565957583|FG000|Overall Study|Lost to Follow-up|3|||
156783797|NCT03828383|565957584|FG001|Overall Study|Lost to Follow-up|2|||
156783798|NCT03828383|565957583|FG000|Overall Study|Withdrawal by Subject|4|||
156783799|NCT03828383|565957584|FG001|Overall Study|Withdrawal by Subject|5|||
156783800|NCT00504309|565957586|FG000|Overall Study|Death|0|||
156783801|NCT00504309|565957587|FG001|Overall Study|Death|0|||
156783802|NCT00504309|565957588|FG002|Overall Study|Death|0|||
156783803|NCT00504309|565957589|FG003|Overall Study|Death|0|||
156783804|NCT00504309|565957590|FG004|Overall Study|Death|1|||
156783805|NCT00504309|565957591|FG005|Overall Study|Death|0|||
156783806|NCT00504309|565957586|FG000|Overall Study|Withdrawal by Subject|0|||
156783807|NCT00504309|565957587|FG001|Overall Study|Withdrawal by Subject|0|||
156783808|NCT00504309|565957588|FG002|Overall Study|Withdrawal by Subject|1|||
156783809|NCT00504309|565957589|FG003|Overall Study|Withdrawal by Subject|0|||
156783810|NCT00504309|565957590|FG004|Overall Study|Withdrawal by Subject|0|||
156783811|NCT00504309|565957591|FG005|Overall Study|Withdrawal by Subject|0|||
156783812|NCT03345095|565957592|FG000|Overall Study|Lack of Efficacy|184|||
156783813|NCT03345095|565957593|FG001|Overall Study|Lack of Efficacy|156|||
156783814|NCT03345095|565957592|FG000|Overall Study|Adverse Event|36|||
156783815|NCT03345095|565957593|FG001|Overall Study|Adverse Event|118|||
156783816|NCT03345095|565957592|FG000|Overall Study|Withdrawal by Subject|22|||
156783817|NCT03345095|565957593|FG001|Overall Study|Withdrawal by Subject|59|||
156783818|NCT03345095|565957592|FG000|Overall Study|Physician Decision|3|||
156681346|NCT01856192|565578971|FG001|Overall Study|Alternative therapy|3|||
156681347|NCT01856192|565578970|FG000|Overall Study|Death|3|||
156681348|NCT01856192|565578971|FG001|Overall Study|Death|5|||
156681349|NCT01856192|565578970|FG000|Overall Study|Lack of Efficacy|0|||
156681350|NCT01856192|565578971|FG001|Overall Study|Lack of Efficacy|5|||
156681351|NCT01856192|565578970|FG000|Overall Study|Withdrawal by Subject|1|||
156681352|NCT01856192|565578971|FG001|Overall Study|Withdrawal by Subject|1|||
156681353|NCT01856192|565578970|FG000|Overall Study|Other diseases|1|||
156681354|NCT01856192|565578971|FG001|Overall Study|Other diseases|0|||
156681355|NCT01856192|565578970|FG000|Overall Study|Never started treatment|7|||
156681356|NCT01856192|565578971|FG001|Overall Study|Never started treatment|5|||
156681357|NCT01856192|565578970|FG000|Overall Study|Path ineligible|20|||
156681358|NCT01856192|565578971|FG001|Overall Study|Path ineligible|34|||
156783819|NCT03345095|565957593|FG001|Overall Study|Physician Decision|18|||
156783820|NCT03345095|565957592|FG000|Overall Study|Death|2|||
156783821|NCT03345095|565957593|FG001|Overall Study|Death|4|||
156783822|NCT03345095|565957592|FG000|Overall Study|Other reasons|2|||
157012710|NCT04992390|566799489|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
157012711|NCT04992390|566799487|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
157012712|NCT04992390|566799488|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
157012713|NCT04992390|566799489|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
157012714|NCT04992390|566799487|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
157012715|NCT04992390|566799488|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
157012716|NCT04992390|566799489|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
156681359|NCT01856192|565578970|FG000|Overall Study|Non-path ineligible|2|||
156783823|NCT03345095|565957593|FG001|Overall Study|Other reasons|11|||
156783824|NCT03345095|565957592|FG000|Overall Study|Protocol Violation|0|||
156783825|NCT03345095|565957593|FG001|Overall Study|Protocol Violation|1|||
156783826|NCT02665455|565957594|FG000|Overall Study|Withdrawal by Subject|6|||
156681360|NCT01856192|565578971|FG001|Overall Study|Non-path ineligible|2|||
156681361|NCT01856192|565578970|FG000|Overall Study|Physician Decision|1|||
156681362|NCT01856192|565578971|FG001|Overall Study|Physician Decision|1|||
156867503|NCT02978781|566275629|FG001|Part C|Withdrawal by Subject|0|||
156867504|NCT02978781|566275630|FG002|Part C|Withdrawal by Subject|0|||
156867505|NCT02978781|566275631|FG003|Part C|Withdrawal by Subject|0|||
156867506|NCT02978781|566275632|FG004|Part C|Withdrawal by Subject|1|||
156867507|NCT02978781|566275628|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867508|NCT02978781|566275629|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867509|NCT02978781|566275630|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867510|NCT02978781|566275631|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
156867511|NCT02978781|566275632|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
156867512|NCT01039376|566275633|FG000|Overall Study|Lost to Follow-up|5|||
156867513|NCT01039376|566275634|FG001|Overall Study|Lost to Follow-up|12|||
156867514|NCT01039376|566275633|FG000|Overall Study|Physician Decision|15|||
156867515|NCT01039376|566275634|FG001|Overall Study|Physician Decision|10|||
156867516|NCT01039376|566275633|FG000|Overall Study|Withdrawal by Subject|20|||
156867517|NCT01039376|566275634|FG001|Overall Study|Withdrawal by Subject|32|||
156867518|NCT01039376|566275633|FG000|Overall Study|Study terminated by Sponsor|90|||
156867519|NCT01039376|566275634|FG001|Overall Study|Study terminated by Sponsor|72|||
156867520|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
156867521|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
156867522|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Adverse Event|31|||
156867523|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Adverse Event|21|||
156867524|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
156867525|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
156867526|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
156867527|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
156867528|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
156867529|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
156867530|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
156867531|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
156867532|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Administrative problems|3|||
156867533|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Administrative problems|3|||
156867534|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Death|5|||
156867535|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Death|8|||
156867536|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Disease progression|139|||
156867537|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Disease progression|119|||
156867538|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
156867539|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
156867540|NCT00785785|566275635|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
156867541|NCT00785785|566275636|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
156867542|NCT00785785|566275635|FG000|Optional Extension Phase|Adverse Event|4|||
156867543|NCT00785785|566275636|FG001|Optional Extension Phase|Adverse Event|5|||
156867544|NCT00785785|566275635|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
156867545|NCT00785785|566275636|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
156867546|NCT00785785|566275635|FG000|Optional Extension Phase|Lost to Follow-up|1|||
156867547|NCT00785785|566275636|FG001|Optional Extension Phase|Lost to Follow-up|0|||
156867548|NCT00785785|566275635|FG000|Optional Extension Phase|Administrative problems|2|||
157012717|NCT04992390|566799487|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
157012718|NCT04992390|566799488|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
157012719|NCT04992390|566799489|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
157012720|NCT04992390|566799487|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
157012721|NCT04992390|566799488|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
157012722|NCT04992390|566799489|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
157012723|NCT04992390|566799487|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
157012724|NCT04992390|566799488|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
157012725|NCT04992390|566799489|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
157012726|NCT04992390|566799487|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
157012727|NCT04992390|566799488|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
157012728|NCT04992390|566799489|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
157012729|NCT04992390|566799487|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
157012730|NCT04992390|566799488|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
157012731|NCT04992390|566799489|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
157012732|NCT04992390|566799487|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
157012733|NCT04992390|566799488|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
157012734|NCT04992390|566799489|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
157012735|NCT04992390|566799487|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
157012736|NCT04992390|566799488|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
157012737|NCT04992390|566799489|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
157012738|NCT04992390|566799487|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
156867549|NCT00785785|566275636|FG001|Optional Extension Phase|Administrative problems|0|||
156867550|NCT00785785|566275635|FG000|Optional Extension Phase|Death|1|||
156867551|NCT00785785|566275636|FG001|Optional Extension Phase|Death|5|||
156867552|NCT00785785|566275635|FG000|Optional Extension Phase|Disease progression|22|||
156867553|NCT00785785|566275636|FG001|Optional Extension Phase|Disease progression|70|||
156867554|NCT00785785|566275635|FG000|Optional Extension Phase|Protocol deviation|0|||
156867555|NCT00785785|566275636|FG001|Optional Extension Phase|Protocol deviation|2|||
156867556|NCT00785785|566275635|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
156867557|NCT00785785|566275636|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
156867558|NCT02453321|566275637|FG000|Overall Study|Weakness|1|||
156867559|NCT02453321|566275638|FG001|Overall Study|Weakness|1|||
156867560|NCT02453321|566275639|FG002|Overall Study|Weakness|2|||
156867561|NCT02453321|566275637|FG000|Overall Study|Deep Venous Thrombosis|0|||
156867562|NCT02453321|566275638|FG001|Overall Study|Deep Venous Thrombosis|1|||
156867563|NCT02453321|566275639|FG002|Overall Study|Deep Venous Thrombosis|0|||
156867564|NCT03252925|566275640|FG000|Overall Study|Withdrawal by Subject|1|||
156867565|NCT03252925|566275641|FG001|Overall Study|Withdrawal by Subject|0|||
156867566|NCT03252925|566275640|FG000|Overall Study|Protocol Violation|6|||
156867567|NCT03252925|566275641|FG001|Overall Study|Protocol Violation|0|||
156867568|NCT03252925|566275640|FG000|Overall Study|Adverse Event|1|||
156867569|NCT03252925|566275641|FG001|Overall Study|Adverse Event|0|||
156867570|NCT03252925|566275640|FG000|Overall Study|Lost to Follow-up|6|||
156867571|NCT03252925|566275641|FG001|Overall Study|Lost to Follow-up|6|||
156867572|NCT01244893|566275642|FG000|Baseline|Protocol Violation|0|||
156867573|NCT01244893|566275643|FG001|Baseline|Protocol Violation|1|||
156867574|NCT01244893|566275642|FG000|1-Week Follow Up|Lost to Follow-up|1|||
156867575|NCT01244893|566275643|FG001|1-Week Follow Up|Lost to Follow-up|0|||
156867576|NCT00357552|566275644|FG000|Screening|Did not meet eligibility criteria|84|||
156867577|NCT00357552|566275644|FG000|Weeks 0 to 24|Death|1|||
156867578|NCT00357552|566275644|FG000|Weeks 24 to 104|Death|3|||
156867579|NCT00357552|566275644|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
156867580|NCT00521404|566275645|FG000|Overall Study|Adverse Event|13|||
156867581|NCT00521404|566275645|FG000|Overall Study|Disease Progression|33|||
156867582|NCT00521404|566275645|FG000|Overall Study|Investigator decision|5|||
156867583|NCT00521404|566275645|FG000|Overall Study|Withdrawal of consent|3|||
156867584|NCT00521404|566275645|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
156867585|NCT00521404|566275645|FG000|Overall Study|Other|7|||
156867586|NCT04555616|566275646|FG000|Overall Study|Death|1|||
156867587|NCT04555616|566275647|FG001|Overall Study|Death|0|||
156867588|NCT04555616|566275648|FG002|Overall Study|Death|1|||
156867589|NCT04555616|566275646|FG000|Overall Study|Withdrawal by Subject|2|||
156867590|NCT04555616|566275647|FG001|Overall Study|Withdrawal by Subject|1|||
156867591|NCT04555616|566275648|FG002|Overall Study|Withdrawal by Subject|0|||
156867592|NCT00882557|566275651|FG000|Overall Study|Withdrawal by Subject|1|||
156867593|NCT00882557|566275652|FG001|Overall Study|Withdrawal by Subject|0|||
156867594|NCT00882557|566275651|FG000|Overall Study|Trouble with Vein Access|1|||
156867595|NCT00882557|566275652|FG001|Overall Study|Trouble with Vein Access|0|||
156867596|NCT00882557|566275651|FG000|Overall Study|Randomized Not Treated|0|||
156867597|NCT00882557|566275652|FG001|Overall Study|Randomized Not Treated|1|||
156867598|NCT01383356|566275653|FG000|Period 1|Adverse Event|5|||
156867599|NCT01383356|566275654|FG001|Period 1|Adverse Event|3|||
156867600|NCT01383356|566275653|FG000|Period 1|Non-compliance|3|||
156867601|NCT01383356|566275654|FG001|Period 1|Non-compliance|0|||
156867602|NCT01383356|566275653|FG000|Period 1|Out of Range Mid-study-Test|0|||
156867603|NCT01383356|566275654|FG001|Period 1|Out of Range Mid-study-Test|1|||
156867604|NCT01383356|566275653|FG000|Period 1|Personal|0|||
156867605|NCT01383356|566275654|FG001|Period 1|Personal|2|||
156867606|NCT02035267|566275655|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
156867607|NCT02035267|566275656|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
156867608|NCT02035267|566275657|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
156867609|NCT02035267|566275658|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
156867610|NCT02035267|566275655|FG000|Overall Study|Adverse Event|0|||
156867611|NCT02035267|566275656|FG001|Overall Study|Adverse Event|0|||
156867612|NCT02035267|566275657|FG002|Overall Study|Adverse Event|1|||
156867613|NCT02035267|566275658|FG003|Overall Study|Adverse Event|0|||
156867614|NCT02035267|566275655|FG000|Overall Study|Lost to Follow-up|0|||
156867615|NCT02035267|566275656|FG001|Overall Study|Lost to Follow-up|0|||
156867616|NCT02035267|566275657|FG002|Overall Study|Lost to Follow-up|0|||
156867617|NCT02035267|566275658|FG003|Overall Study|Lost to Follow-up|1|||
156867618|NCT02035267|566275655|FG000|Overall Study|Other unspecified|0|||
156867619|NCT02035267|566275656|FG001|Overall Study|Other unspecified|1|||
156867620|NCT02035267|566275657|FG002|Overall Study|Other unspecified|0|||
156867621|NCT02035267|566275658|FG003|Overall Study|Other unspecified|0|||
156867622|NCT03038880|566275665|FG000|Overall Study|Death|1|||
156867623|NCT03038880|566275666|FG001|Overall Study|Death|2|||
156867624|NCT03038880|566275667|FG002|Overall Study|Death|0|||
156867625|NCT03038880|566275665|FG000|Overall Study|Physician Decision|2|||
156867626|NCT03038880|566275666|FG001|Overall Study|Physician Decision|1|||
156867627|NCT03038880|566275667|FG002|Overall Study|Physician Decision|0|||
156867628|NCT03926611|566275668|FG000|Overall Study|Adverse Event|0|||
156867629|NCT03926611|566275669|FG001|Overall Study|Adverse Event|0|||
156867630|NCT03926611|566275670|FG002|Overall Study|Adverse Event|0|||
156867631|NCT03926611|566275671|FG003|Overall Study|Adverse Event|3|||
156867632|NCT03926611|566275672|FG004|Overall Study|Adverse Event|1|||
156867633|NCT03926611|566275673|FG005|Overall Study|Adverse Event|3|||
156867634|NCT03926611|566275674|FG006|Overall Study|Adverse Event|0|||
156867635|NCT03926611|566275668|FG000|Overall Study|Lack of Efficacy|1|||
156867636|NCT03926611|566275669|FG001|Overall Study|Lack of Efficacy|2|||
156867637|NCT03926611|566275670|FG002|Overall Study|Lack of Efficacy|0|||
156867638|NCT03926611|566275671|FG003|Overall Study|Lack of Efficacy|0|||
156867639|NCT03926611|566275672|FG004|Overall Study|Lack of Efficacy|1|||
156867640|NCT03926611|566275673|FG005|Overall Study|Lack of Efficacy|0|||
156867641|NCT03926611|566275674|FG006|Overall Study|Lack of Efficacy|1|||
156867642|NCT03926611|566275668|FG000|Overall Study|Physician Decision|0|||
156867643|NCT03926611|566275669|FG001|Overall Study|Physician Decision|0|||
156867644|NCT03926611|566275670|FG002|Overall Study|Physician Decision|0|||
156867645|NCT03926611|566275671|FG003|Overall Study|Physician Decision|0|||
156867646|NCT03926611|566275672|FG004|Overall Study|Physician Decision|0|||
156867647|NCT03926611|566275673|FG005|Overall Study|Physician Decision|1|||
156867648|NCT03926611|566275674|FG006|Overall Study|Physician Decision|0|||
156867649|NCT03926611|566275668|FG000|Overall Study|Protocol Violation|1|||
156867650|NCT03926611|566275669|FG001|Overall Study|Protocol Violation|0|||
156867651|NCT03926611|566275670|FG002|Overall Study|Protocol Violation|0|||
156867652|NCT03926611|566275671|FG003|Overall Study|Protocol Violation|1|||
156867653|NCT03926611|566275672|FG004|Overall Study|Protocol Violation|1|||
156867654|NCT03926611|566275673|FG005|Overall Study|Protocol Violation|1|||
156867655|NCT03926611|566275674|FG006|Overall Study|Protocol Violation|1|||
156867656|NCT03926611|566275668|FG000|Overall Study|Technical problems|0|||
156867657|NCT03926611|566275669|FG001|Overall Study|Technical problems|0|||
156867658|NCT03926611|566275670|FG002|Overall Study|Technical problems|0|||
156867659|NCT03926611|566275671|FG003|Overall Study|Technical problems|0|||
156867660|NCT03926611|566275672|FG004|Overall Study|Technical problems|0|||
156867661|NCT03926611|566275673|FG005|Overall Study|Technical problems|1|||
156867662|NCT03926611|566275674|FG006|Overall Study|Technical problems|0|||
156867663|NCT03926611|566275668|FG000|Overall Study|Withdrawal by Subject|1|||
156867664|NCT03926611|566275669|FG001|Overall Study|Withdrawal by Subject|1|||
156867665|NCT03926611|566275670|FG002|Overall Study|Withdrawal by Subject|1|||
156867666|NCT03926611|566275671|FG003|Overall Study|Withdrawal by Subject|0|||
156867667|NCT03926611|566275672|FG004|Overall Study|Withdrawal by Subject|0|||
156867668|NCT03926611|566275673|FG005|Overall Study|Withdrawal by Subject|1|||
156867669|NCT03926611|566275674|FG006|Overall Study|Withdrawal by Subject|3|||
156867670|NCT03926611|566275668|FG000|Overall Study|Covid-19 pandemic|0|||
156867671|NCT03926611|566275669|FG001|Overall Study|Covid-19 pandemic|0|||
156867672|NCT03926611|566275670|FG002|Overall Study|Covid-19 pandemic|1|||
156867673|NCT03926611|566275671|FG003|Overall Study|Covid-19 pandemic|0|||
156867674|NCT03926611|566275672|FG004|Overall Study|Covid-19 pandemic|1|||
156867675|NCT03926611|566275673|FG005|Overall Study|Covid-19 pandemic|2|||
156867676|NCT03926611|566275674|FG006|Overall Study|Covid-19 pandemic|0|||
156867677|NCT00956007|566275680|FG000|Overall Study|Protocol Violation|27|||
156867678|NCT00956007|566275681|FG001|Overall Study|Protocol Violation|23|||
156867679|NCT01750229|566275682|FG000|Randomized Crossover Phase|Adverse Event|1|||
156867680|NCT01750229|566275682|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
156867681|NCT01750229|566275682|FG000|Long-term Follow-up Phase|Adverse Event|2|||
156867682|NCT01750229|566275682|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
156867683|NCT02177032|566275683|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
156867684|NCT02177032|566275684|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
156867685|NCT02177032|566275685|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
156867686|NCT02177032|566275686|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
156867687|NCT02177032|566275683|FG000|Overall Study|Lost to Follow-up|0|||
156867688|NCT02177032|566275684|FG001|Overall Study|Lost to Follow-up|2|||
156867689|NCT02177032|566275685|FG002|Overall Study|Lost to Follow-up|0|||
156867690|NCT02177032|566275686|FG003|Overall Study|Lost to Follow-up|0|||
156867691|NCT02177032|566275683|FG000|Overall Study|OTHER|2|||
156867692|NCT02177032|566275684|FG001|Overall Study|OTHER|0|||
156867693|NCT02177032|566275685|FG002|Overall Study|OTHER|1|||
156867694|NCT02177032|566275686|FG003|Overall Study|OTHER|0|||
156867695|NCT02177032|566275683|FG000|Overall Study|Withdrawal by Subject|1|||
156867696|NCT02177032|566275684|FG001|Overall Study|Withdrawal by Subject|0|||
156867697|NCT02177032|566275685|FG002|Overall Study|Withdrawal by Subject|1|||
156867698|NCT02177032|566275686|FG003|Overall Study|Withdrawal by Subject|0|||
156867699|NCT01134055|566275687|FG000|Overall Study|Adverse Event|5|||
156867700|NCT01134055|566275688|FG001|Overall Study|Adverse Event|2|||
156867701|NCT01134055|566275689|FG002|Overall Study|Adverse Event|2|||
156867702|NCT01134055|566275690|FG003|Overall Study|Adverse Event|2|||
156867703|NCT01134055|566275691|FG004|Overall Study|Adverse Event|5|||
156867704|NCT01134055|566275692|FG005|Overall Study|Adverse Event|7|||
156867705|NCT01134055|566275693|FG006|Overall Study|Adverse Event|2|||
156867706|NCT01134055|566275687|FG000|Overall Study|Lost to Follow-up|0|||
156867707|NCT01134055|566275688|FG001|Overall Study|Lost to Follow-up|1|||
156867708|NCT01134055|566275689|FG002|Overall Study|Lost to Follow-up|0|||
156867709|NCT01134055|566275690|FG003|Overall Study|Lost to Follow-up|1|||
156867710|NCT01134055|566275691|FG004|Overall Study|Lost to Follow-up|0|||
156867711|NCT01134055|566275692|FG005|Overall Study|Lost to Follow-up|0|||
156867712|NCT01134055|566275693|FG006|Overall Study|Lost to Follow-up|0|||
156867713|NCT01134055|566275687|FG000|Overall Study|Withdrawal by Subject|3|||
156867714|NCT01134055|566275688|FG001|Overall Study|Withdrawal by Subject|3|||
156867715|NCT01134055|566275689|FG002|Overall Study|Withdrawal by Subject|1|||
156867716|NCT01134055|566275690|FG003|Overall Study|Withdrawal by Subject|2|||
156867717|NCT01134055|566275691|FG004|Overall Study|Withdrawal by Subject|0|||
156867718|NCT01134055|566275692|FG005|Overall Study|Withdrawal by Subject|0|||
156867719|NCT01134055|566275693|FG006|Overall Study|Withdrawal by Subject|8|||
156867720|NCT01134055|566275687|FG000|Overall Study|Protocol Violation|0|||
156867721|NCT01134055|566275688|FG001|Overall Study|Protocol Violation|0|||
156867722|NCT01134055|566275689|FG002|Overall Study|Protocol Violation|0|||
156867723|NCT01134055|566275690|FG003|Overall Study|Protocol Violation|1|||
156867724|NCT01134055|566275691|FG004|Overall Study|Protocol Violation|1|||
156867725|NCT01134055|566275692|FG005|Overall Study|Protocol Violation|0|||
156867726|NCT01134055|566275693|FG006|Overall Study|Protocol Violation|0|||
156867727|NCT01134055|566275687|FG000|Overall Study|Physician Decision|0|||
156867728|NCT01134055|566275688|FG001|Overall Study|Physician Decision|0|||
156867729|NCT01134055|566275689|FG002|Overall Study|Physician Decision|0|||
156867730|NCT01134055|566275690|FG003|Overall Study|Physician Decision|0|||
156867731|NCT01134055|566275691|FG004|Overall Study|Physician Decision|0|||
156867732|NCT01134055|566275692|FG005|Overall Study|Physician Decision|0|||
156867733|NCT01134055|566275693|FG006|Overall Study|Physician Decision|1|||
156867734|NCT04798196|566275695|FG000|Overall Study|Lost to Follow-up|3|||
156867735|NCT04798196|566275696|FG001|Overall Study|Lost to Follow-up|1|||
156867736|NCT04798196|566275697|FG002|Overall Study|Lost to Follow-up|3|||
156867737|NCT00734539|566275710|FG000|Main Study|Death|33|||
156867738|NCT00734539|566275711|FG001|Main Study|Death|32|||
156867739|NCT00734539|566275710|FG000|Main Study|Physician Decision|2|||
156867740|NCT00734539|566275711|FG001|Main Study|Physician Decision|0|||
156867741|NCT00734539|566275710|FG000|Main Study|Withdrawal by Subject|1|||
156867742|NCT00734539|566275711|FG001|Main Study|Withdrawal by Subject|3|||
156867743|NCT00734539|566275710|FG000|Main Study|Enrolled in error; ineligible|1|||
156867744|NCT00734539|566275711|FG001|Main Study|Enrolled in error; ineligible|0|||
156867745|NCT00705016|566275714|FG000|Overall Study|Adverse Event|6|||
156867746|NCT00705016|566275715|FG001|Overall Study|Adverse Event|11|||
156867747|NCT00705016|566275716|FG002|Overall Study|Adverse Event|10|||
156867748|NCT00705016|566275714|FG000|Overall Study|Death|5|||
156867749|NCT00705016|566275715|FG001|Overall Study|Death|7|||
156867750|NCT00705016|566275716|FG002|Overall Study|Death|5|||
157012739|NCT04992390|566799488|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
157012740|NCT04992390|566799489|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
157012741|NCT04992390|566799487|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
157012742|NCT04992390|566799488|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
157012743|NCT04992390|566799489|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
157012744|NCT04992390|566799487|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
157012745|NCT04992390|566799488|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
157012746|NCT04992390|566799489|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
157012747|NCT04992390|566799487|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
157012748|NCT04992390|566799488|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
157012749|NCT04992390|566799489|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
157012750|NCT03807778|566799490|FG000|Overall Study|Adverse Event|0|||
157012751|NCT03807778|566799491|FG001|Overall Study|Adverse Event|0|||
157012752|NCT03807778|566799492|FG002|Overall Study|Adverse Event|3|||
157012753|NCT03807778|566799493|FG003|Overall Study|Adverse Event|5|||
157012754|NCT03807778|566799490|FG000|Overall Study|Progressive Disease|4|||
157012755|NCT03807778|566799491|FG001|Overall Study|Progressive Disease|2|||
157012756|NCT03807778|566799492|FG002|Overall Study|Progressive Disease|8|||
157120180|NCT02296242|567193041|FG004|Overall Study|Patient Condition Changed|1|||
156867751|NCT00705016|566275714|FG000|Overall Study|Protocol Violation|0|||
156867752|NCT00705016|566275715|FG001|Overall Study|Protocol Violation|1|||
156867753|NCT00705016|566275716|FG002|Overall Study|Protocol Violation|1|||
156867754|NCT00705016|566275714|FG000|Overall Study|Withdrawal by Subject|4|||
156867755|NCT00705016|566275715|FG001|Overall Study|Withdrawal by Subject|3|||
156867756|NCT00705016|566275716|FG002|Overall Study|Withdrawal by Subject|2|||
156867757|NCT00705016|566275714|FG000|Overall Study|Progressive Disease|33|||
156867758|NCT00705016|566275715|FG001|Overall Study|Progressive Disease|29|||
156867759|NCT00705016|566275716|FG002|Overall Study|Progressive Disease|33|||
156867760|NCT00705016|566275714|FG000|Overall Study|Symptomatic Deterioration|3|||
156867761|NCT00705016|566275715|FG001|Overall Study|Symptomatic Deterioration|1|||
157120181|NCT02296242|567193037|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
156867762|NCT00705016|566275716|FG002|Overall Study|Symptomatic Deterioration|1|||
156867763|NCT00705016|566275714|FG000|Overall Study|Other|9|||
156867764|NCT00705016|566275715|FG001|Overall Study|Other|6|||
157012757|NCT03807778|566799493|FG003|Overall Study|Progressive Disease|15|||
156783827|NCT02665455|565957594|FG000|Overall Study|Lost to Follow-up|1|||
156783828|NCT02665455|565957594|FG000|Overall Study|Adverse Event|1|||
156783829|NCT02665455|565957594|FG000|Overall Study|Protocol Violation|1|||
156783830|NCT01039675|565957596|FG000|Overall Study|Adverse Event|0|||
156783831|NCT01039675|565957597|FG001|Overall Study|Adverse Event|2|||
156783832|NCT01039675|565957596|FG000|Overall Study|Lack of Efficacy|0|||
156783833|NCT01039675|565957597|FG001|Overall Study|Lack of Efficacy|2|||
156783834|NCT01039675|565957596|FG000|Overall Study|Withdrawal by Subject|0|||
156783835|NCT01039675|565957597|FG001|Overall Study|Withdrawal by Subject|1|||
156783836|NCT01039675|565957596|FG000|Overall Study|Lost to Follow-up|0|||
156783837|NCT01039675|565957597|FG001|Overall Study|Lost to Follow-up|1|||
156783838|NCT01039675|565957596|FG000|Overall Study|Physician Decision|0|||
156783839|NCT01039675|565957597|FG001|Overall Study|Physician Decision|1|||
156783840|NCT05865886|565957598|FG000|Overall Study|Serious adverse event|0|||
156783841|NCT05865886|565957599|FG001|Overall Study|Serious adverse event|1|||
156783842|NCT01671059|565957600|FG000|Overall Study|Adverse Event|4|||
156783843|NCT01671059|565957600|FG000|Overall Study|Lack of Efficacy|1|||
156783844|NCT02564978|565957601|FG000|Overall Study|Adverse Event|8|||
156783845|NCT02564978|565957601|FG000|Overall Study|Death|1|||
156783846|NCT02564978|565957601|FG000|Overall Study|Lost to Follow-up|1|||
156783847|NCT02564978|565957601|FG000|Overall Study|Withdrawal by Subject|15|||
156783848|NCT02564978|565957601|FG000|Overall Study|Early Study Closure|2|||
156783849|NCT02564978|565957601|FG000|Overall Study|Other Reason|5|||
156783850|NCT04971837|565958867|FG000|Overall Study|Long Term Illness|1|||
156783851|NCT04971837|565958867|FG000|Overall Study|BMI too low|9|||
156783852|NCT04971837|565958867|FG000|Overall Study|geographic location|1|||
156783853|NCT04971837|565958867|FG000|Overall Study|Discontinued scheduling conflict|1|||
156783854|NCT03787212|565958871|FG000|Period 1|Study Termination|2|||
156783855|NCT03787212|565958872|FG001|Period 1|Study Termination|2|||
156783856|NCT04289298|565958875|FG000|Overall Study|Lost to Follow-up|5|||
156783857|NCT04289298|565958876|FG001|Overall Study|Lost to Follow-up|0|||
156783858|NCT04289298|565958875|FG000|Overall Study|Withdrawal by Subject|2|||
156783859|NCT04289298|565958876|FG001|Overall Study|Withdrawal by Subject|0|||
156783860|NCT01778985|565958878|FG000|Overall Study|Lost to Follow-up|1|||
156783861|NCT01778985|565958879|FG001|Overall Study|Lost to Follow-up|0|||
156783862|NCT01778985|565958878|FG000|Overall Study|Physician Decision|2|||
156783863|NCT01778985|565958879|FG001|Overall Study|Physician Decision|2|||
156783864|NCT01778985|565958878|FG000|Overall Study|Protocol Violation|4|||
156783865|NCT01778985|565958879|FG001|Overall Study|Protocol Violation|1|||
156783866|NCT00504231|565958880|FG000|Overall Study|Discrepant chart documentation re route|0|||
157012758|NCT03807778|566799490|FG000|Overall Study|Symptomatic Deterioration|0|||
157012759|NCT03807778|566799491|FG001|Overall Study|Symptomatic Deterioration|1|||
157012760|NCT03807778|566799492|FG002|Overall Study|Symptomatic Deterioration|0|||
157012761|NCT03807778|566799493|FG003|Overall Study|Symptomatic Deterioration|1|||
157012762|NCT03807778|566799490|FG000|Overall Study|Withdrawal by Subject|0|||
156681363|NCT01856192|565578970|FG000|Overall Study|Suspicion of progressive disease|1|||
156681364|NCT01856192|565578971|FG001|Overall Study|Suspicion of progressive disease|0|||
156681365|NCT01856192|565578970|FG000|Overall Study|Non-compliance|1|||
156681366|NCT01856192|565578971|FG001|Overall Study|Non-compliance|0|||
156681367|NCT00098475|565578972|FG000|Step 1|Progressive disease|33|||
156681368|NCT00098475|565578973|FG001|Step 1|Progressive disease|35|||
156681369|NCT00098475|565578974|FG002|Step 1|Progressive disease|2|||
156681370|NCT00098475|565578975|FG003|Step 1|Progressive disease|1|||
156681371|NCT00098475|565578972|FG000|Step 1|Adverse Event|56|||
156681372|NCT00098475|565578973|FG001|Step 1|Adverse Event|37|||
156681373|NCT00098475|565578974|FG002|Step 1|Adverse Event|0|||
156681374|NCT00098475|565578975|FG003|Step 1|Adverse Event|1|||
156681375|NCT00098475|565578972|FG000|Step 1|Death|8|||
157012763|NCT03807778|566799491|FG001|Overall Study|Withdrawal by Subject|1|||
157012764|NCT03807778|566799492|FG002|Overall Study|Withdrawal by Subject|0|||
157012765|NCT03807778|566799493|FG003|Overall Study|Withdrawal by Subject|1|||
157012766|NCT03807778|566799490|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
157012767|NCT03807778|566799491|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
156681376|NCT00098475|565578973|FG001|Step 1|Death|5|||
156681377|NCT00098475|565578974|FG002|Step 1|Death|0|||
156681378|NCT00098475|565578975|FG003|Step 1|Death|1|||
156783867|NCT00504231|565958881|FG001|Overall Study|Discrepant chart documentation re route|0|||
156783868|NCT00504231|565958882|FG002|Overall Study|Discrepant chart documentation re route|1|||
156783869|NCT00504231|565958883|FG003|Overall Study|Discrepant chart documentation re route|0|||
156783870|NCT01629563|565958884|FG000|Overall Study|Adverse Event|16|||
156783871|NCT01629563|565958885|FG001|Overall Study|Adverse Event|16|||
156783872|NCT01629563|565958884|FG000|Overall Study|Death|2|||
157012768|NCT03807778|566799492|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
157012769|NCT03807778|566799493|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
156681379|NCT00098475|565578972|FG000|Step 1|Withdrawal by Subject|14|||
156681380|NCT00098475|565578973|FG001|Step 1|Withdrawal by Subject|11|||
156783873|NCT01629563|565958885|FG001|Overall Study|Death|0|||
156783874|NCT01629563|565958884|FG000|Overall Study|Lack of Efficacy|2|||
156783875|NCT01629563|565958885|FG001|Overall Study|Lack of Efficacy|3|||
156783876|NCT01629563|565958884|FG000|Overall Study|Lost to Follow-up|1|||
156783877|NCT01629563|565958885|FG001|Overall Study|Lost to Follow-up|0|||
156783878|NCT01629563|565958884|FG000|Overall Study|Pregnancy|1|||
156783879|NCT01629563|565958885|FG001|Overall Study|Pregnancy|2|||
156783880|NCT01629563|565958884|FG000|Overall Study|Protocol Violation|0|||
156783881|NCT01629563|565958885|FG001|Overall Study|Protocol Violation|1|||
156783882|NCT01629563|565958884|FG000|Overall Study|Withdrawal by Subject|27|||
156783883|NCT01629563|565958885|FG001|Overall Study|Withdrawal by Subject|20|||
156783884|NCT01629563|565958884|FG000|Overall Study|surgery|0|||
156783885|NCT01629563|565958885|FG001|Overall Study|surgery|3|||
156783886|NCT01629563|565958884|FG000|Overall Study|Lack of return of menses|12|||
156783887|NCT01629563|565958885|FG001|Overall Study|Lack of return of menses|7|||
156783888|NCT01629563|565958884|FG000|Overall Study|Protocol Violation|0|||
156783889|NCT01629563|565958885|FG001|Overall Study|Protocol Violation|1|||
156783890|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
156783891|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Adverse Event|1|||
156783892|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
156783893|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Physician Decision|1|||
156783894|NCT00088881|565958886|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
156783895|NCT00088881|565958886|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
156783896|NCT00088881|565958886|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
156783897|NCT01129284|565958888|FG000|Overall Study|Adverse Event|2|||
156783898|NCT01129284|565958889|FG001|Overall Study|Adverse Event|0|||
156783899|NCT01129284|565958890|FG002|Overall Study|Adverse Event|1|||
156783900|NCT02082483|565958891|FG000|Overall Study|Lost to Follow-up|1|||
156783901|NCT02082483|565958892|FG001|Overall Study|Lost to Follow-up|1|||
156783902|NCT02082483|565958891|FG000|Overall Study|Withdrawal by Subject|2|||
156783903|NCT02082483|565958892|FG001|Overall Study|Withdrawal by Subject|1|||
156783904|NCT02082483|565958891|FG000|Overall Study|Physician Decision|1|||
156783905|NCT02082483|565958892|FG001|Overall Study|Physician Decision|1|||
156783906|NCT02082483|565958891|FG000|Overall Study|Death|2|||
156783907|NCT02082483|565958892|FG001|Overall Study|Death|3|||
156783908|NCT01028560|565958895|FG000|Overall Study|Lack of Efficacy|3|||
156783909|NCT01028560|565958896|FG001|Overall Study|Lack of Efficacy|6|||
156783910|NCT01028560|565958895|FG000|Overall Study|Withdrawal by Subject|7|||
156783911|NCT01028560|565958896|FG001|Overall Study|Withdrawal by Subject|12|||
156783912|NCT01060111|565958897|FG000|Overall Study|Adverse Event|9|||
156783913|NCT01060111|565958898|FG001|Overall Study|Adverse Event|5|||
156783914|NCT01060111|565958899|FG002|Overall Study|Adverse Event|18|||
156783915|NCT01060111|565958897|FG000|Overall Study|Lack of Efficacy|2|||
156783916|NCT01060111|565958898|FG001|Overall Study|Lack of Efficacy|1|||
156783917|NCT01060111|565958899|FG002|Overall Study|Lack of Efficacy|0|||
156783918|NCT01060111|565958897|FG000|Overall Study|Inappropriate participant|5|||
156783919|NCT01060111|565958898|FG001|Overall Study|Inappropriate participant|4|||
156783920|NCT01060111|565958899|FG002|Overall Study|Inappropriate participant|5|||
156783921|NCT01060111|565958897|FG000|Overall Study|Participants' evasion for hospital visit|0|||
156783922|NCT01060111|565958898|FG001|Overall Study|Participants' evasion for hospital visit|3|||
156783923|NCT01060111|565958899|FG002|Overall Study|Participants' evasion for hospital visit|2|||
156783924|NCT01060111|565958897|FG000|Overall Study|Participants' non-cooperation|8|||
156783925|NCT01060111|565958898|FG001|Overall Study|Participants' non-cooperation|6|||
156783926|NCT01060111|565958899|FG002|Overall Study|Participants' non-cooperation|6|||
156783927|NCT01060111|565958897|FG000|Overall Study|Adverse event and insufficient effect|0|||
156783928|NCT01060111|565958898|FG001|Overall Study|Adverse event and insufficient effect|1|||
156783929|NCT01060111|565958899|FG002|Overall Study|Adverse event and insufficient effect|0|||
156783930|NCT01060111|565958897|FG000|Overall Study|Participants' non-cooperation|1|||
156783931|NCT01060111|565958898|FG001|Overall Study|Participants' non-cooperation|0|||
156783932|NCT01060111|565958899|FG002|Overall Study|Participants' non-cooperation|0|||
156783933|NCT01060111|565958897|FG000|Overall Study|Other|2|||
156783934|NCT01060111|565958898|FG001|Overall Study|Other|3|||
156783935|NCT01060111|565958899|FG002|Overall Study|Other|4|||
156783936|NCT05278065|565958900|FG000|Overall Study|Withdrawal by Subject|1|||
156783937|NCT05278065|565958901|FG001|Overall Study|Withdrawal by Subject|0|||
156783938|NCT02070991|565958902|FG000|Overall Study|Death|2|||
156783939|NCT02070991|565958903|FG001|Overall Study|Death|0|||
156783940|NCT02070991|565958902|FG000|Overall Study|Withdrawal by Subject|1|||
156783941|NCT02070991|565958903|FG001|Overall Study|Withdrawal by Subject|0|||
156783942|NCT03670628|565958906|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
156783943|NCT03670628|565958907|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
156783944|NCT03670628|565958906|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
156783945|NCT03670628|565958907|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
156783946|NCT03123588|565958908|FG000|Overall Study|Study Terminated by Sponsor|2|||
156783947|NCT03123588|565958909|FG001|Overall Study|Study Terminated by Sponsor|5|||
157012770|NCT05028582|566799494|FG000|Overall Study|Lost to Follow-up|11|||
157012771|NCT05028582|566799495|FG001|Overall Study|Lost to Follow-up|9|||
157012772|NCT05028582|566799494|FG000|Overall Study|Withdrawal by Subject|9|||
157012773|NCT05028582|566799495|FG001|Overall Study|Withdrawal by Subject|10|||
157012774|NCT05028582|566799494|FG000|Overall Study|Adverse Event|5|||
157012775|NCT05028582|566799495|FG001|Overall Study|Adverse Event|2|||
157012776|NCT05028582|566799494|FG000|Overall Study|Miscellaneous|3|||
157012777|NCT05028582|566799495|FG001|Overall Study|Miscellaneous|2|||
157012778|NCT05028582|566799494|FG000|Overall Study|Lack of Efficacy|3|||
157012779|NCT05028582|566799495|FG001|Overall Study|Lack of Efficacy|1|||
157012780|NCT05028582|566799494|FG000|Overall Study|Physician Decision|0|||
157012781|NCT05028582|566799495|FG001|Overall Study|Physician Decision|1|||
157012782|NCT04939246|566799496|FG000|After Treatment|Death|4|||
156681381|NCT00098475|565578974|FG002|Step 1|Withdrawal by Subject|0|||
156681382|NCT00098475|565578975|FG003|Step 1|Withdrawal by Subject|0|||
156867765|NCT00705016|566275716|FG002|Overall Study|Other|6|||
156867766|NCT00942604|566275719|FG000|Overall Study|Protocol Violation|1|||
156867767|NCT00942604|566275720|FG001|Overall Study|Protocol Violation|1|||
156867768|NCT00942604|566275719|FG000|Overall Study|Adverse Event|0|||
156867769|NCT00942604|566275720|FG001|Overall Study|Adverse Event|1|||
156867770|NCT00942604|566275719|FG000|Overall Study|Withdrawal by Subject|0|||
156867771|NCT00942604|566275720|FG001|Overall Study|Withdrawal by Subject|1|||
156867772|NCT00942604|566275719|FG000|Overall Study|Patient relocation|1|||
156867773|NCT00942604|566275720|FG001|Overall Study|Patient relocation|1|||
156867774|NCT01656408|566275721|FG000|Overall Study|Adverse Event|0|||
156867775|NCT01656408|566275722|FG001|Overall Study|Adverse Event|0|||
156867776|NCT01656408|566275723|FG002|Overall Study|Adverse Event|1|||
156867777|NCT01656408|566275724|FG003|Overall Study|Adverse Event|0|||
156867778|NCT01656408|566275725|FG004|Overall Study|Adverse Event|0|||
156867779|NCT01656408|566275726|FG005|Overall Study|Adverse Event|1|||
156867780|NCT01656408|566275727|FG006|Overall Study|Adverse Event|1|||
156867781|NCT01656408|566275728|FG007|Overall Study|Adverse Event|0|||
156867782|NCT01656408|566275729|FG008|Overall Study|Adverse Event|1|||
156867783|NCT01656408|566275730|FG009|Overall Study|Adverse Event|0|||
156867784|NCT01656408|566275721|FG000|Overall Study|Physician Decision|1|||
156867785|NCT01656408|566275722|FG001|Overall Study|Physician Decision|0|||
156867786|NCT01656408|566275723|FG002|Overall Study|Physician Decision|1|||
156867787|NCT01656408|566275724|FG003|Overall Study|Physician Decision|0|||
156867788|NCT01656408|566275725|FG004|Overall Study|Physician Decision|1|||
156867789|NCT01656408|566275726|FG005|Overall Study|Physician Decision|1|||
156867790|NCT01656408|566275727|FG006|Overall Study|Physician Decision|0|||
156867791|NCT01656408|566275728|FG007|Overall Study|Physician Decision|1|||
156867792|NCT01656408|566275729|FG008|Overall Study|Physician Decision|1|||
156867793|NCT01656408|566275730|FG009|Overall Study|Physician Decision|3|||
156867794|NCT00904982|566275736|FG000|Overall Study|Withdrawal by Subject|2|||
156867795|NCT00904982|566275737|FG001|Overall Study|Withdrawal by Subject|0|||
156867796|NCT00904982|566275738|FG002|Overall Study|Withdrawal by Subject|0|||
156867797|NCT00904982|566275739|FG003|Overall Study|Withdrawal by Subject|0|||
156867798|NCT01318915|566275743|FG000|Overall Study|Lost to Follow-up|1|||
156867799|NCT04119414|566275744|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
156867800|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
156867801|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
156867802|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
156867803|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
156867804|NCT01929317|566275750|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
156867805|NCT01929317|566275751|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
156867806|NCT01929317|566275750|FG000|Long-term Phase|Adverse Event|5|||
156867807|NCT01929317|566275751|FG001|Long-term Phase|Adverse Event|1|||
156867808|NCT01929317|566275750|FG000|Long-term Phase|Physician Decision|3|||
156867809|NCT01929317|566275751|FG001|Long-term Phase|Physician Decision|0|||
156867810|NCT01929317|566275750|FG000|Long-term Phase|Withdrawal by Subject|4|||
156867811|NCT01929317|566275751|FG001|Long-term Phase|Withdrawal by Subject|0|||
156867812|NCT01929317|566275750|FG000|Long-term Phase|Protocol Violation|1|||
156867813|NCT01929317|566275751|FG001|Long-term Phase|Protocol Violation|0|||
156681383|NCT00098475|565578972|FG000|Step 1|Physician Decision|5|||
156867814|NCT01929317|566275750|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
156867815|NCT01929317|566275751|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
157012783|NCT04939246|566799496|FG000|After Treatment|Lost to Follow-up|1|||
157012784|NCT04939246|566799496|FG000|After Treatment|Discharged to hospice|2|||
157012785|NCT02723955|566801737|FG000|Escalation Phase|Death|1|||
157012786|NCT02723955|566801738|FG001|Escalation Phase|Death|1|||
156681384|NCT00098475|565578973|FG001|Step 1|Physician Decision|2|||
156681385|NCT00098475|565578974|FG002|Step 1|Physician Decision|0|||
156867816|NCT01929317|566275750|FG000|Long-term Phase|Study Closed/Terminated|5|||
156867817|NCT01929317|566275751|FG001|Long-term Phase|Study Closed/Terminated|3|||
157012787|NCT02723955|566801739|FG002|Escalation Phase|Death|2|||
157012788|NCT02723955|566801740|FG003|Escalation Phase|Death|7|||
157012789|NCT02723955|566801741|FG004|Escalation Phase|Death|18|||
156867818|NCT03815929|566275754|FG000|Overall Study|Lost to Follow-up|2|||
156867819|NCT03815929|566275755|FG001|Overall Study|Lost to Follow-up|1|||
156867820|NCT03815929|566275756|FG002|Overall Study|Lost to Follow-up|0|||
156867821|NCT03815929|566275754|FG000|Overall Study|Physician Decision|2|||
156867822|NCT03815929|566275755|FG001|Overall Study|Physician Decision|2|||
156867823|NCT03815929|566275756|FG002|Overall Study|Physician Decision|0|||
156867824|NCT03815929|566275754|FG000|Overall Study|Withdrawal by Subject|0|||
156867825|NCT03815929|566275755|FG001|Overall Study|Withdrawal by Subject|0|||
156867826|NCT03815929|566275756|FG002|Overall Study|Withdrawal by Subject|1|||
156867827|NCT02205736|566275757|FG000|Overall Study|Lost to Follow-up|106|||
156867828|NCT01198977|566275761|FG000|Overall Study|Lost to Follow-up|1|||
156867829|NCT01198977|566275762|FG001|Overall Study|Lost to Follow-up|0|||
156867830|NCT01588522|566275768|FG000|Overall Study|Withdrawal by Subject|1|||
156867831|NCT01588522|566275769|FG001|Overall Study|Withdrawal by Subject|5|||
156867832|NCT01588522|566275770|FG002|Overall Study|Withdrawal by Subject|3|||
156867833|NCT01588522|566275771|FG003|Overall Study|Withdrawal by Subject|1|||
156867834|NCT01588522|566275772|FG004|Overall Study|Withdrawal by Subject|2|||
156867835|NCT01588522|566275773|FG005|Overall Study|Withdrawal by Subject|0|||
156867836|NCT01588522|566275768|FG000|Overall Study|Lack of Efficacy|0|||
156867837|NCT01588522|566275769|FG001|Overall Study|Lack of Efficacy|0|||
156867838|NCT01588522|566275770|FG002|Overall Study|Lack of Efficacy|0|||
156867839|NCT01588522|566275771|FG003|Overall Study|Lack of Efficacy|0|||
156867840|NCT01588522|566275772|FG004|Overall Study|Lack of Efficacy|1|||
156867841|NCT01588522|566275773|FG005|Overall Study|Lack of Efficacy|0|||
156867842|NCT01588522|566275768|FG000|Overall Study|Adverse Event|0|||
156867843|NCT01588522|566275769|FG001|Overall Study|Adverse Event|0|||
156867844|NCT01588522|566275770|FG002|Overall Study|Adverse Event|0|||
156867845|NCT01588522|566275771|FG003|Overall Study|Adverse Event|1|||
156867846|NCT01588522|566275772|FG004|Overall Study|Adverse Event|0|||
156867847|NCT01588522|566275773|FG005|Overall Study|Adverse Event|0|||
156867848|NCT01588522|566275768|FG000|Overall Study|Grade 2 alopecia|1|||
156867849|NCT01588522|566275769|FG001|Overall Study|Grade 2 alopecia|0|||
156867850|NCT01588522|566275770|FG002|Overall Study|Grade 2 alopecia|0|||
156681386|NCT00098475|565578975|FG003|Step 1|Physician Decision|0|||
156867851|NCT01588522|566275771|FG003|Overall Study|Grade 2 alopecia|0|||
157120182|NCT02296242|567193038|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
157120183|NCT02296242|567193039|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
157120184|NCT02296242|567193040|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
157120185|NCT02296242|567193041|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
157120186|NCT02296242|567193037|FG000|Overall Study|Lost to Follow-up|1|||
156681387|NCT00098475|565578972|FG000|Step 1|Alternative therapy|31|||
156681388|NCT00098475|565578973|FG001|Step 1|Alternative therapy|43|||
156681389|NCT00098475|565578974|FG002|Step 1|Alternative therapy|1|||
157120187|NCT02296242|567193038|FG001|Overall Study|Lost to Follow-up|0|||
157120188|NCT02296242|567193039|FG002|Overall Study|Lost to Follow-up|0|||
157120189|NCT02296242|567193040|FG003|Overall Study|Lost to Follow-up|0|||
156681390|NCT00098475|565578975|FG003|Step 1|Alternative therapy|0|||
156681391|NCT00098475|565578972|FG000|Step 1|Other disease|2|||
156681392|NCT00098475|565578973|FG001|Step 1|Other disease|1|||
156681393|NCT00098475|565578974|FG002|Step 1|Other disease|1|||
156681394|NCT00098475|565578975|FG003|Step 1|Other disease|0|||
156681395|NCT00098475|565578972|FG000|Step 1|Never started treatment|0|||
156681396|NCT00098475|565578973|FG001|Step 1|Never started treatment|2|||
156681397|NCT00098475|565578974|FG002|Step 1|Never started treatment|0|||
156681398|NCT00098475|565578975|FG003|Step 1|Never started treatment|0|||
156681399|NCT00098475|565578972|FG000|Step 1|Still on treatment as of this analysis|14|||
156681400|NCT00098475|565578973|FG001|Step 1|Still on treatment as of this analysis|27|||
156681401|NCT00098475|565578974|FG002|Step 1|Still on treatment as of this analysis|0|||
156681402|NCT00098475|565578975|FG003|Step 1|Still on treatment as of this analysis|0|||
156681403|NCT00098475|565578972|FG000|Step 1|Knee surgery|1|||
156681404|NCT00098475|565578973|FG001|Step 1|Knee surgery|0|||
156681405|NCT00098475|565578974|FG002|Step 1|Knee surgery|0|||
157120190|NCT02296242|567193041|FG004|Overall Study|Lost to Follow-up|0|||
157120191|NCT02296242|567193037|FG000|Overall Study|Need for Hydroxyurea|2|||
156681406|NCT00098475|565578975|FG003|Step 1|Knee surgery|0|||
156681407|NCT00098475|565578972|FG000|Step 1|Complications|1|||
156681408|NCT00098475|565578973|FG001|Step 1|Complications|0|||
156681409|NCT00098475|565578974|FG002|Step 1|Complications|0|||
156681410|NCT00098475|565578975|FG003|Step 1|Complications|0|||
156681411|NCT00098475|565578972|FG000|Step 1|Cannot comply due to other tx|0|||
156681412|NCT00098475|565578973|FG001|Step 1|Cannot comply due to other tx|1|||
156681413|NCT00098475|565578974|FG002|Step 1|Cannot comply due to other tx|0|||
156681414|NCT00098475|565578975|FG003|Step 1|Cannot comply due to other tx|0|||
156681415|NCT00098475|565578972|FG000|Step 1|Both patient and physician's decision|2|||
156681416|NCT00098475|565578973|FG001|Step 1|Both patient and physician's decision|1|||
156681417|NCT00098475|565578974|FG002|Step 1|Both patient and physician's decision|0|||
156867852|NCT01588522|566275772|FG004|Overall Study|Grade 2 alopecia|0|||
156867853|NCT01588522|566275773|FG005|Overall Study|Grade 2 alopecia|0|||
156867854|NCT01588522|566275768|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
156867855|NCT01588522|566275769|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
156867856|NCT01588522|566275770|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
156867857|NCT01588522|566275771|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
156867858|NCT01588522|566275772|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
156867859|NCT01588522|566275773|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
156867860|NCT01588522|566275768|FG000|Overall Study|Taken off taxane-based regimen|0|||
156867861|NCT01588522|566275769|FG001|Overall Study|Taken off taxane-based regimen|0|||
156867862|NCT01588522|566275770|FG002|Overall Study|Taken off taxane-based regimen|0|||
156867863|NCT01588522|566275771|FG003|Overall Study|Taken off taxane-based regimen|1|||
156867864|NCT01588522|566275772|FG004|Overall Study|Taken off taxane-based regimen|0|||
156867865|NCT01588522|566275773|FG005|Overall Study|Taken off taxane-based regimen|0|||
156867866|NCT01588522|566275768|FG000|Overall Study|Did not initiate chemotherapy|0|||
157012790|NCT02723955|566801742|FG005|Escalation Phase|Death|17|||
157012791|NCT02723955|566801743|FG006|Escalation Phase|Death|11|||
157012792|NCT02723955|566801744|FG007|Escalation Phase|Death|21|||
157012793|NCT02723955|566801745|FG008|Escalation Phase|Death|3|||
157012794|NCT02723955|566801746|FG009|Escalation Phase|Death|0|||
157012795|NCT02723955|566801747|FG010|Escalation Phase|Death|0|||
157012796|NCT02723955|566801748|FG011|Escalation Phase|Death|0|||
157012797|NCT02723955|566801749|FG012|Escalation Phase|Death|2|||
157012798|NCT02723955|566801750|FG013|Escalation Phase|Death|4|||
157012799|NCT02723955|566801751|FG014|Escalation Phase|Death|5|||
157012800|NCT02723955|566801752|FG015|Escalation Phase|Death|6|||
157012801|NCT02723955|566801753|FG016|Escalation Phase|Death|6|||
157012802|NCT02723955|566801754|FG017|Escalation Phase|Death|7|||
157012803|NCT02723955|566801755|FG018|Escalation Phase|Death|1|||
157012804|NCT02723955|566801756|FG019|Escalation Phase|Death|3|||
157012805|NCT02723955|566801757|FG020|Escalation Phase|Death|13|||
157012806|NCT02723955|566801758|FG021|Escalation Phase|Death|3|||
157012807|NCT02723955|566801759|FG022|Escalation Phase|Death|2|||
157012808|NCT02723955|566801760|FG023|Escalation Phase|Death|4|||
157012809|NCT02723955|566801761|FG024|Escalation Phase|Death|31|||
157012810|NCT02723955|566801762|FG025|Escalation Phase|Death|7|||
157012811|NCT02723955|566801763|FG026|Escalation Phase|Death|13|||
157012812|NCT02723955|566801764|FG027|Escalation Phase|Death|0|||
157012813|NCT02723955|566801765|FG028|Escalation Phase|Death|1|||
157012814|NCT02723955|566801766|FG029|Escalation Phase|Death|0|||
157012815|NCT02723955|566801767|FG030|Escalation Phase|Death|0|||
157012816|NCT02723955|566801768|FG031|Escalation Phase|Death|0|||
157012817|NCT02723955|566801769|FG032|Escalation Phase|Death|0|||
157012818|NCT02723955|566801770|FG033|Escalation Phase|Death|0|||
157012819|NCT02723955|566801771|FG034|Escalation Phase|Death|0|||
157012820|NCT02723955|566801772|FG035|Escalation Phase|Death|0|||
157012821|NCT02723955|566801773|FG036|Escalation Phase|Death|0|||
157012822|NCT02723955|566801774|FG037|Escalation Phase|Death|0|||
157012823|NCT02723955|566801775|FG038|Escalation Phase|Death|0|||
157012824|NCT02723955|566801776|FG039|Escalation Phase|Death|0|||
157012825|NCT02723955|566801777|FG040|Escalation Phase|Death|0|||
157012826|NCT02723955|566801778|FG041|Escalation Phase|Death|0|||
157012827|NCT02723955|566801779|FG042|Escalation Phase|Death|0|||
157012828|NCT02723955|566801737|FG000|Escalation Phase|Lost to Follow-up|0|||
157012829|NCT02723955|566801738|FG001|Escalation Phase|Lost to Follow-up|0|||
157012830|NCT02723955|566801739|FG002|Escalation Phase|Lost to Follow-up|0|||
157012831|NCT02723955|566801740|FG003|Escalation Phase|Lost to Follow-up|0|||
157012832|NCT02723955|566801741|FG004|Escalation Phase|Lost to Follow-up|0|||
157012833|NCT02723955|566801742|FG005|Escalation Phase|Lost to Follow-up|2|||
157012834|NCT02723955|566801743|FG006|Escalation Phase|Lost to Follow-up|1|||
157012835|NCT02723955|566801744|FG007|Escalation Phase|Lost to Follow-up|1|||
157012836|NCT02723955|566801745|FG008|Escalation Phase|Lost to Follow-up|1|||
157012837|NCT02723955|566801746|FG009|Escalation Phase|Lost to Follow-up|0|||
157012838|NCT02723955|566801747|FG010|Escalation Phase|Lost to Follow-up|0|||
157012839|NCT02723955|566801748|FG011|Escalation Phase|Lost to Follow-up|0|||
157012840|NCT02723955|566801749|FG012|Escalation Phase|Lost to Follow-up|1|||
157012841|NCT02723955|566801750|FG013|Escalation Phase|Lost to Follow-up|0|||
157012842|NCT02723955|566801751|FG014|Escalation Phase|Lost to Follow-up|0|||
157012843|NCT02723955|566801752|FG015|Escalation Phase|Lost to Follow-up|0|||
157012844|NCT02723955|566801753|FG016|Escalation Phase|Lost to Follow-up|1|||
157012845|NCT02723955|566801754|FG017|Escalation Phase|Lost to Follow-up|2|||
157012846|NCT02723955|566801755|FG018|Escalation Phase|Lost to Follow-up|0|||
157012847|NCT02723955|566801756|FG019|Escalation Phase|Lost to Follow-up|1|||
157012848|NCT02723955|566801757|FG020|Escalation Phase|Lost to Follow-up|2|||
157012849|NCT02723955|566801758|FG021|Escalation Phase|Lost to Follow-up|1|||
157012850|NCT02723955|566801759|FG022|Escalation Phase|Lost to Follow-up|0|||
157012851|NCT02723955|566801760|FG023|Escalation Phase|Lost to Follow-up|0|||
157012852|NCT02723955|566801761|FG024|Escalation Phase|Lost to Follow-up|1|||
157012853|NCT02723955|566801762|FG025|Escalation Phase|Lost to Follow-up|1|||
157012854|NCT02723955|566801763|FG026|Escalation Phase|Lost to Follow-up|3|||
157012855|NCT02723955|566801764|FG027|Escalation Phase|Lost to Follow-up|0|||
157012856|NCT02723955|566801765|FG028|Escalation Phase|Lost to Follow-up|1|||
157012857|NCT02723955|566801766|FG029|Escalation Phase|Lost to Follow-up|0|||
157012858|NCT02723955|566801767|FG030|Escalation Phase|Lost to Follow-up|0|||
157012859|NCT02723955|566801768|FG031|Escalation Phase|Lost to Follow-up|0|||
157012860|NCT02723955|566801769|FG032|Escalation Phase|Lost to Follow-up|0|||
157012861|NCT02723955|566801770|FG033|Escalation Phase|Lost to Follow-up|0|||
157012862|NCT02723955|566801771|FG034|Escalation Phase|Lost to Follow-up|0|||
157012863|NCT02723955|566801772|FG035|Escalation Phase|Lost to Follow-up|0|||
157012864|NCT02723955|566801773|FG036|Escalation Phase|Lost to Follow-up|0|||
157012865|NCT02723955|566801774|FG037|Escalation Phase|Lost to Follow-up|0|||
157012866|NCT02723955|566801775|FG038|Escalation Phase|Lost to Follow-up|0|||
157012867|NCT02723955|566801776|FG039|Escalation Phase|Lost to Follow-up|0|||
157012868|NCT02723955|566801777|FG040|Escalation Phase|Lost to Follow-up|0|||
157012869|NCT02723955|566801778|FG041|Escalation Phase|Lost to Follow-up|0|||
157012870|NCT02723955|566801779|FG042|Escalation Phase|Lost to Follow-up|0|||
157012871|NCT02723955|566801737|FG000|Escalation Phase|Physician Decision|0|||
157012872|NCT02723955|566801738|FG001|Escalation Phase|Physician Decision|0|||
157012873|NCT02723955|566801739|FG002|Escalation Phase|Physician Decision|0|||
157012874|NCT02723955|566801740|FG003|Escalation Phase|Physician Decision|0|||
157012875|NCT02723955|566801741|FG004|Escalation Phase|Physician Decision|0|||
157012876|NCT02723955|566801742|FG005|Escalation Phase|Physician Decision|2|||
157012877|NCT02723955|566801743|FG006|Escalation Phase|Physician Decision|0|||
157012878|NCT02723955|566801744|FG007|Escalation Phase|Physician Decision|0|||
157012879|NCT02723955|566801745|FG008|Escalation Phase|Physician Decision|0|||
157012880|NCT02723955|566801746|FG009|Escalation Phase|Physician Decision|0|||
157012881|NCT02723955|566801747|FG010|Escalation Phase|Physician Decision|0|||
157012882|NCT02723955|566801748|FG011|Escalation Phase|Physician Decision|0|||
157012883|NCT02723955|566801749|FG012|Escalation Phase|Physician Decision|0|||
157012884|NCT02723955|566801750|FG013|Escalation Phase|Physician Decision|0|||
157012885|NCT02723955|566801751|FG014|Escalation Phase|Physician Decision|0|||
157012886|NCT02723955|566801752|FG015|Escalation Phase|Physician Decision|0|||
156783948|NCT03123588|565958908|FG000|Overall Study|Withdrawal by Subject|1|||
156783949|NCT03123588|565958909|FG001|Overall Study|Withdrawal by Subject|0|||
156783950|NCT03123588|565958908|FG000|Overall Study|Adverse Event|1|||
156783951|NCT03123588|565958909|FG001|Overall Study|Adverse Event|0|||
156783952|NCT03123588|565958908|FG000|Overall Study|Physician Decision|2|||
156783953|NCT03123588|565958909|FG001|Overall Study|Physician Decision|1|||
156783954|NCT00997126|565958911|FG000|Overall Study|Physician Decision|7|||
156783955|NCT00997126|565958912|FG001|Overall Study|Physician Decision|11|||
156783956|NCT01769443|565958914|FG000|Overall Study|Study closure|1|||
156783957|NCT01769443|565958915|FG001|Overall Study|Study closure|0|||
156783958|NCT00866320|565958918|FG000|Overall Study|Withdrawal by Subject|4|||
156783959|NCT00866320|565958918|FG000|Overall Study|Death|2|||
156783960|NCT02063724|565958919|FG000|Overall Study|Disease progression|1|||
156867867|NCT01588522|566275769|FG001|Overall Study|Did not initiate chemotherapy|0|||
156867868|NCT01588522|566275770|FG002|Overall Study|Did not initiate chemotherapy|0|||
156867869|NCT01588522|566275771|FG003|Overall Study|Did not initiate chemotherapy|0|||
156867870|NCT01588522|566275772|FG004|Overall Study|Did not initiate chemotherapy|1|||
156867871|NCT01588522|566275773|FG005|Overall Study|Did not initiate chemotherapy|0|||
156867872|NCT02855125|566275776|FG000|Overall Study|Withdrawal by Subject|2|||
156867873|NCT02855125|566275777|FG001|Overall Study|Withdrawal by Subject|2|||
156867874|NCT02855125|566275776|FG000|Overall Study|Clinical Disease Progression|5|||
156867875|NCT02855125|566275777|FG001|Overall Study|Clinical Disease Progression|4|||
156867876|NCT02855125|566275776|FG000|Overall Study|Radiologic Disease Progression|36|||
156867877|NCT02855125|566275777|FG001|Overall Study|Radiologic Disease Progression|39|||
156867878|NCT02855125|566275776|FG000|Overall Study|Adverse Event|11|||
156867879|NCT02855125|566275777|FG001|Overall Study|Adverse Event|7|||
156867880|NCT02855125|566275776|FG000|Overall Study|Physician Decision|1|||
156867881|NCT02855125|566275777|FG001|Overall Study|Physician Decision|0|||
156867882|NCT02855125|566275776|FG000|Overall Study|On Treatment|9|||
156867883|NCT02855125|566275777|FG001|Overall Study|On Treatment|11|||
156867884|NCT02855125|566275776|FG000|Overall Study|Randomized but not treated|0|||
156867885|NCT02855125|566275777|FG001|Overall Study|Randomized but not treated|1|||
156867886|NCT04467905|566275778|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
157012887|NCT02723955|566801753|FG016|Escalation Phase|Physician Decision|0|||
157012888|NCT02723955|566801754|FG017|Escalation Phase|Physician Decision|0|||
157012889|NCT02723955|566801755|FG018|Escalation Phase|Physician Decision|0|||
157012890|NCT02723955|566801756|FG019|Escalation Phase|Physician Decision|0|||
156783961|NCT02315625|565958920|FG000|First Intervention|Disease Progression|1|||
156783962|NCT02315625|565958921|FG001|First Intervention|Disease Progression|0|||
156867887|NCT04467905|566275779|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
157012891|NCT02723955|566801757|FG020|Escalation Phase|Physician Decision|0|||
157012892|NCT02723955|566801758|FG021|Escalation Phase|Physician Decision|0|||
157012893|NCT02723955|566801759|FG022|Escalation Phase|Physician Decision|0|||
157012894|NCT02723955|566801760|FG023|Escalation Phase|Physician Decision|0|||
157012895|NCT02723955|566801761|FG024|Escalation Phase|Physician Decision|0|||
157012896|NCT02723955|566801762|FG025|Escalation Phase|Physician Decision|0|||
156783963|NCT02315625|565958920|FG000|Second Intervention|Physician Decision|2|||
157213307|NCT03033069|567527814|FG003|Overall Study|Withdrawal by Subject|6|||
156681418|NCT00098475|565578975|FG003|Step 1|Both patient and physician's decision|0|||
156681419|NCT00098475|565578972|FG000|Step 1|Incorrect disease assessment|2|||
156681420|NCT00098475|565578973|FG001|Step 1|Incorrect disease assessment|0|||
156681421|NCT00098475|565578974|FG002|Step 1|Incorrect disease assessment|0|||
156681422|NCT00098475|565578975|FG003|Step 1|Incorrect disease assessment|0|||
156681423|NCT00098475|565578972|FG000|Step 1|Off treatment for > specified timeframe|1|||
156681424|NCT00098475|565578973|FG001|Step 1|Off treatment for > specified timeframe|1|||
156681425|NCT00098475|565578974|FG002|Step 1|Off treatment for > specified timeframe|0|||
156681426|NCT00098475|565578975|FG003|Step 1|Off treatment for > specified timeframe|0|||
156681427|NCT00098475|565578972|FG000|Step 1|Declining performance status|0|||
156681428|NCT00098475|565578973|FG001|Step 1|Declining performance status|1|||
156681429|NCT00098475|565578974|FG002|Step 1|Declining performance status|0|||
156681430|NCT00098475|565578975|FG003|Step 1|Declining performance status|0|||
156681431|NCT00098475|565578972|FG000|Step 1|Insurance issue|0|||
156681432|NCT00098475|565578973|FG001|Step 1|Insurance issue|1|||
156681433|NCT00098475|565578974|FG002|Step 1|Insurance issue|0|||
156681434|NCT00098475|565578975|FG003|Step 1|Insurance issue|0|||
156681435|NCT00098475|565578972|FG000|Step 1|Rising paraprotein|0|||
156681436|NCT00098475|565578973|FG001|Step 1|Rising paraprotein|1|||
156681437|NCT00098475|565578974|FG002|Step 1|Rising paraprotein|0|||
156681438|NCT00098475|565578975|FG003|Step 1|Rising paraprotein|0|||
156681439|NCT00098475|565578972|FG000|Step 1|Referred to other physicians|0|||
156681440|NCT00098475|565578973|FG001|Step 1|Referred to other physicians|1|||
156681441|NCT00098475|565578974|FG002|Step 1|Referred to other physicians|0|||
156681442|NCT00098475|565578975|FG003|Step 1|Referred to other physicians|0|||
156681443|NCT00098475|565578972|FG000|Step 1|Criteria to continue treatment not met|0|||
157213308|NCT03033069|567527811|FG000|Overall Study|Withdrawal By Caregiver|1|||
157213309|NCT03033069|567527812|FG001|Overall Study|Withdrawal By Caregiver|0|||
157213310|NCT03033069|567527813|FG002|Overall Study|Withdrawal By Caregiver|0|||
157213311|NCT03033069|567527814|FG003|Overall Study|Withdrawal By Caregiver|0|||
156681444|NCT00098475|565578973|FG001|Step 1|Criteria to continue treatment not met|1|||
156681445|NCT00098475|565578974|FG002|Step 1|Criteria to continue treatment not met|0|||
156681446|NCT00098475|565578975|FG003|Step 1|Criteria to continue treatment not met|0|||
156681447|NCT00098475|565578972|FG000|Step 1|Misinterpretation of lab data|0|||
156681448|NCT00098475|565578973|FG001|Step 1|Misinterpretation of lab data|1|||
156681449|NCT00098475|565578974|FG002|Step 1|Misinterpretation of lab data|0|||
156681450|NCT00098475|565578975|FG003|Step 1|Misinterpretation of lab data|0|||
156681451|NCT00098475|565578972|FG000|Step 1|Patient fell with fracture|1|||
156681452|NCT00098475|565578973|FG001|Step 1|Patient fell with fracture|0|||
156681453|NCT00098475|565578974|FG002|Step 1|Patient fell with fracture|0|||
156681454|NCT00098475|565578975|FG003|Step 1|Patient fell with fracture|0|||
156681455|NCT00098475|565578972|FG000|Step 1|Not documented|0|||
156681456|NCT00098475|565578973|FG001|Step 1|Not documented|1|||
156681457|NCT00098475|565578974|FG002|Step 1|Not documented|0|||
156681458|NCT00098475|565578975|FG003|Step 1|Not documented|0|||
156681459|NCT00098475|565578972|FG000|Step 2|Disease progression|1|||
156681460|NCT00098475|565578973|FG001|Step 2|Disease progression|4|||
156681461|NCT00098475|565578974|FG002|Step 2|Disease progression|0|||
156681462|NCT00098475|565578975|FG003|Step 2|Disease progression|0|||
156681463|NCT00098475|565578972|FG000|Step 2|Adverse Event|2|||
156681464|NCT00098475|565578973|FG001|Step 2|Adverse Event|0|||
156681465|NCT00098475|565578974|FG002|Step 2|Adverse Event|0|||
156681466|NCT00098475|565578975|FG003|Step 2|Adverse Event|0|||
156681467|NCT00098475|565578972|FG000|Step 2|Withdrawal by Subject|0|||
156681468|NCT00098475|565578973|FG001|Step 2|Withdrawal by Subject|2|||
156681469|NCT00098475|565578974|FG002|Step 2|Withdrawal by Subject|0|||
156681470|NCT00098475|565578975|FG003|Step 2|Withdrawal by Subject|0|||
156681471|NCT00098475|565578972|FG000|Step 2|Physician Decision|0|||
156681472|NCT00098475|565578973|FG001|Step 2|Physician Decision|1|||
156681473|NCT00098475|565578974|FG002|Step 2|Physician Decision|0|||
156681474|NCT00098475|565578975|FG003|Step 2|Physician Decision|0|||
156681475|NCT00098475|565578972|FG000|Step 2|Alternative therapy|1|||
156681476|NCT00098475|565578973|FG001|Step 2|Alternative therapy|2|||
156681477|NCT00098475|565578974|FG002|Step 2|Alternative therapy|0|||
156681478|NCT00098475|565578975|FG003|Step 2|Alternative therapy|0|||
156681479|NCT00098475|565578972|FG000|Step 2|Never started treatment|1|||
156681480|NCT00098475|565578973|FG001|Step 2|Never started treatment|1|||
156681481|NCT00098475|565578974|FG002|Step 2|Never started treatment|0|||
156681482|NCT00098475|565578975|FG003|Step 2|Never started treatment|0|||
156681483|NCT01583530|565578977|FG000|Overall Study|Adverse Event|0|||
156681484|NCT01583530|565578978|FG001|Overall Study|Adverse Event|0|||
156681485|NCT01583530|565578979|FG002|Overall Study|Adverse Event|0|||
157213312|NCT03033069|567527811|FG000|Overall Study|Reason not Specified|0|||
156681486|NCT01583530|565578980|FG003|Overall Study|Adverse Event|0|||
156681487|NCT01583530|565578981|FG004|Overall Study|Adverse Event|0|||
156681488|NCT01583530|565578982|FG005|Overall Study|Adverse Event|1|||
156681489|NCT01583530|565578977|FG000|Overall Study|Withdrawal by Subject|0|||
157213313|NCT03033069|567527812|FG001|Overall Study|Reason not Specified|1|||
156681490|NCT01583530|565578978|FG001|Overall Study|Withdrawal by Subject|3|||
156681491|NCT01583530|565578979|FG002|Overall Study|Withdrawal by Subject|0|||
156681492|NCT01583530|565578980|FG003|Overall Study|Withdrawal by Subject|1|||
156681493|NCT01583530|565578981|FG004|Overall Study|Withdrawal by Subject|1|||
156681494|NCT01583530|565578982|FG005|Overall Study|Withdrawal by Subject|2|||
156681495|NCT01583530|565578977|FG000|Overall Study|Lost to Follow-up|0|||
156681496|NCT01583530|565578978|FG001|Overall Study|Lost to Follow-up|0|||
156681497|NCT01583530|565578979|FG002|Overall Study|Lost to Follow-up|0|||
156681498|NCT01583530|565578980|FG003|Overall Study|Lost to Follow-up|0|||
156681499|NCT01583530|565578981|FG004|Overall Study|Lost to Follow-up|3|||
156681500|NCT01583530|565578982|FG005|Overall Study|Lost to Follow-up|0|||
156681501|NCT01583530|565578977|FG000|Overall Study|Lack of compliance|0|||
156681502|NCT01583530|565578978|FG001|Overall Study|Lack of compliance|0|||
156681503|NCT01583530|565578979|FG002|Overall Study|Lack of compliance|0|||
156681504|NCT01583530|565578980|FG003|Overall Study|Lack of compliance|0|||
156681505|NCT01583530|565578981|FG004|Overall Study|Lack of compliance|1|||
156783964|NCT02315625|565958921|FG001|Second Intervention|Physician Decision|1|||
156783965|NCT02315625|565958920|FG000|Second Intervention|Study closure|1|||
156783966|NCT02315625|565958921|FG001|Second Intervention|Study closure|0|||
156783967|NCT02315625|565958920|FG000|Second Intervention|Disease Progression|1|||
156783968|NCT02315625|565958921|FG001|Second Intervention|Disease Progression|0|||
156783969|NCT02697422|565958922|FG000|Overall Study|Declined exit survey|9|||
156783970|NCT02697422|565958923|FG001|Overall Study|Declined exit survey|2|||
156783971|NCT02697422|565958922|FG000|Overall Study|Lost to Follow-up|13|||
156783972|NCT02697422|565958923|FG001|Overall Study|Lost to Follow-up|8|||
156783973|NCT02697422|565958922|FG000|Overall Study|Death|2|||
156783974|NCT02697422|565958923|FG001|Overall Study|Death|1|||
156783975|NCT02697422|565958922|FG000|Overall Study|Withdrawal by Subject|0|||
156783976|NCT02697422|565958923|FG001|Overall Study|Withdrawal by Subject|1|||
156783977|NCT02697422|565958922|FG000|Overall Study|Physician Decision|1|||
156783978|NCT02697422|565958923|FG001|Overall Study|Physician Decision|1|||
156783979|NCT02697422|565958922|FG000|Overall Study|Exit survey data lost|1|||
156783980|NCT02697422|565958923|FG001|Overall Study|Exit survey data lost|0|||
156783981|NCT04149353|565958924|FG000|Overall Study|Study terminated|1|||
156783982|NCT01871727|565958925|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
156783983|NCT01871727|565958926|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
156783984|NCT01871727|565958927|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
156783985|NCT01871727|565958928|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
156783986|NCT01871727|565958929|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
156783987|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
156783988|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
156783989|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
156783990|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
156783991|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
156783992|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783993|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783994|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783995|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
156783996|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
156783997|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156783998|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156681506|NCT01583530|565578982|FG005|Overall Study|Lack of compliance|0|||
156783999|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156784000|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
156784001|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
156784002|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156784003|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156784004|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156867888|NCT04467905|566275780|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
156681507|NCT02416180|565578983|FG000|Overall Study|Withdrawal by Subject|1|||
156867889|NCT04467905|566275778|FG000|Overall Study|Conversion to SR|0|||
156867890|NCT04467905|566275779|FG001|Overall Study|Conversion to SR|0|||
156867891|NCT04467905|566275780|FG002|Overall Study|Conversion to SR|3|||
156867892|NCT04467905|566275778|FG000|Overall Study|Technical issue with Holter ECG|0|||
156681508|NCT00640926|565578984|FG000|Overall Study|Adverse Event|2|||
156681509|NCT00640926|565578985|FG001|Overall Study|Adverse Event|3|||
156681510|NCT00640926|565578986|FG002|Overall Study|Adverse Event|2|||
156681511|NCT00640926|565578984|FG000|Overall Study|Lack of Efficacy|0|||
156681512|NCT00640926|565578985|FG001|Overall Study|Lack of Efficacy|2|||
156681513|NCT00640926|565578986|FG002|Overall Study|Lack of Efficacy|1|||
156681514|NCT00640926|565578984|FG000|Overall Study|Protocol Violation|2|||
156784005|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
156681515|NCT00640926|565578985|FG001|Overall Study|Protocol Violation|0|||
156784006|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
156681516|NCT00640926|565578986|FG002|Overall Study|Protocol Violation|2|||
156681517|NCT00640926|565578984|FG000|Overall Study|Lost to Follow-up|3|||
156681518|NCT00640926|565578985|FG001|Overall Study|Lost to Follow-up|1|||
156681519|NCT00640926|565578986|FG002|Overall Study|Lost to Follow-up|2|||
156681520|NCT00640926|565578984|FG000|Overall Study|Withdrawal by Subject|1|||
156681521|NCT00640926|565578985|FG001|Overall Study|Withdrawal by Subject|0|||
156681522|NCT00640926|565578986|FG002|Overall Study|Withdrawal by Subject|1|||
156681523|NCT01841073|565578987|FG000|Overall Study|Adverse Event|1|||
156681524|NCT01841073|565578988|FG001|Overall Study|Adverse Event|1|||
156681525|NCT01841073|565578987|FG000|Overall Study|Physician Decision|1|||
156681526|NCT01841073|565578988|FG001|Overall Study|Physician Decision|0|||
156681527|NCT01841073|565578987|FG000|Overall Study|Lost to Follow-up|0|||
156681528|NCT01841073|565578988|FG001|Overall Study|Lost to Follow-up|2|||
156681529|NCT00550147|565578989|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
156681530|NCT00550147|565578989|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
156681531|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
156681532|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
156681533|NCT00550147|565578989|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
156681534|NCT04320745|565578990|FG000|Overall Study|Adverse Event|26|||
156681535|NCT04320745|565578990|FG000|Overall Study|Withdrawal by Subject|4|||
156681536|NCT04320745|565578990|FG000|Overall Study|Lost to Follow-up|12|||
156681537|NCT04320745|565578990|FG000|Overall Study|Protocol Deviation|2|||
156681538|NCT04320745|565578990|FG000|Overall Study|Non-compliance With Study Drug|2|||
156681539|NCT04320745|565578990|FG000|Overall Study|Reason Not Specified|1|||
156681540|NCT00046839|565578991|FG000|Overall Study|Ineligible / No protocol treatment|0|||
156681541|NCT00046839|565578992|FG001|Overall Study|Ineligible / No protocol treatment|2|||
156681542|NCT00046839|565578991|FG000|Overall Study|Withdrawal of consent|1|||
156681543|NCT00046839|565578992|FG001|Overall Study|Withdrawal of consent|0|||
156681544|NCT02472639|565578994|FG000|Overall Study|Physician Decision|4|||
156681545|NCT02472639|565578995|FG001|Overall Study|Physician Decision|3|||
157012897|NCT02723955|566801763|FG026|Escalation Phase|Physician Decision|2|||
156681546|NCT00751023|565578996|FG000|Overall Study|Lost to Follow-up|11|||
156681547|NCT00751023|565578997|FG001|Overall Study|Lost to Follow-up|7|||
156681548|NCT02050321|565578998|FG000|Overall Study|Withdrawal by Subject|1|||
156681549|NCT02050321|565578998|FG000|Overall Study|Adverse Event|1|||
156681550|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
156681551|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
156681552|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
156681553|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
156681554|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681555|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
156681556|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681557|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
156681558|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681559|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
156681560|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681561|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
156681562|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
156681563|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
156681564|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
156681565|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
156681566|NCT01685008|565578999|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
156681567|NCT01685008|565579000|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
156681568|NCT01685008|565579001|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
156681569|NCT01685008|565579002|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
156681570|NCT02151149|565579014|FG000|Treatment Period|Death|2|||
156681571|NCT02151149|565579015|FG001|Treatment Period|Death|3|||
156681572|NCT02151149|565579014|FG000|Treatment Period|Adverse Event|17|||
156681573|NCT02151149|565579015|FG001|Treatment Period|Adverse Event|14|||
156681574|NCT02151149|565579014|FG000|Treatment Period|Progressive Disease|25|||
156681575|NCT02151149|565579015|FG001|Treatment Period|Progressive Disease|24|||
156681576|NCT02151149|565579014|FG000|Treatment Period|Symptomatic Deterioration|2|||
156681577|NCT02151149|565579015|FG001|Treatment Period|Symptomatic Deterioration|10|||
156784007|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156784008|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
157012898|NCT02723955|566801764|FG027|Escalation Phase|Physician Decision|0|||
156681578|NCT02151149|565579014|FG000|Treatment Period|Withdrawal by Subject|13|||
156681579|NCT02151149|565579015|FG001|Treatment Period|Withdrawal by Subject|11|||
156681580|NCT02151149|565579014|FG000|Treatment Period|Miscellaneous|8|||
156681581|NCT02151149|565579015|FG001|Treatment Period|Miscellaneous|7|||
156681582|NCT02151149|565579014|FG000|Treatment Period|Participants randomized but not treated|3|||
156784009|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
157012899|NCT02723955|566801765|FG028|Escalation Phase|Physician Decision|0|||
156867893|NCT04467905|566275779|FG001|Overall Study|Technical issue with Holter ECG|0|||
156867894|NCT04467905|566275780|FG002|Overall Study|Technical issue with Holter ECG|3|||
156867895|NCT04467905|566275778|FG000|Overall Study|Hemodynamic instability|0|||
156867896|NCT04467905|566275779|FG001|Overall Study|Hemodynamic instability|0|||
156867897|NCT04467905|566275780|FG002|Overall Study|Hemodynamic instability|1|||
156867898|NCT04467905|566275778|FG000|Overall Study|Site misinterpretation of protocol|0|||
156867899|NCT04467905|566275779|FG001|Overall Study|Site misinterpretation of protocol|0|||
156867900|NCT04467905|566275780|FG002|Overall Study|Site misinterpretation of protocol|1|||
156867901|NCT02514083|566275781|FG000|Overall Study|Adverse Event|1|||
156867902|NCT01899040|566275782|FG000|Overall Study|Randomized in error|0|||
156867903|NCT01899040|566275783|FG001|Overall Study|Randomized in error|1|||
156867904|NCT01899040|566275784|FG002|Overall Study|Randomized in error|1|||
156867905|NCT01899040|566275782|FG000|Overall Study|Adverse Event|3|||
157120192|NCT02296242|567193038|FG001|Overall Study|Need for Hydroxyurea|0|||
157120193|NCT02296242|567193039|FG002|Overall Study|Need for Hydroxyurea|0|||
156867906|NCT01899040|566275783|FG001|Overall Study|Adverse Event|1|||
156867907|NCT01899040|566275784|FG002|Overall Study|Adverse Event|2|||
156867908|NCT01899040|566275782|FG000|Overall Study|Unspecified reasons|4|||
156784010|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
156784011|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
156784012|NCT01871727|565958925|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784013|NCT01871727|565958926|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
156867909|NCT01899040|566275783|FG001|Overall Study|Unspecified reasons|4|||
156867910|NCT01899040|566275784|FG002|Overall Study|Unspecified reasons|0|||
156867911|NCT01899040|566275782|FG000|Overall Study|Compliance issues|1|||
156867912|NCT01899040|566275783|FG001|Overall Study|Compliance issues|2|||
156867913|NCT01899040|566275784|FG002|Overall Study|Compliance issues|0|||
156867914|NCT04586205|566275792|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
156867915|NCT04586205|566275793|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
156867916|NCT01590888|566277244|FG000|Overall Study|Adverse Event|3|||
156784014|NCT01871727|565958927|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784015|NCT01871727|565958928|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
156784016|NCT01871727|565958929|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
156784017|NCT03019588|565958930|FG000|Overall Study|Death|44|||
156784018|NCT03019588|565958931|FG001|Overall Study|Death|46|||
156784019|NCT03019588|565958930|FG000|Overall Study|Study terminated by Sponsor|3|||
156784020|NCT03019588|565958931|FG001|Overall Study|Study terminated by Sponsor|1|||
156784021|NCT00366535|565958934|FG000|First Phase: 12 Weeks|Adverse Event|1|||
156784022|NCT00366535|565958935|FG001|First Phase: 12 Weeks|Adverse Event|3|||
156784023|NCT00366535|565958934|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
156784024|NCT00366535|565958935|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
156784025|NCT00366535|565958934|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
156784026|NCT00366535|565958935|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
156784027|NCT00366535|565958934|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
156784028|NCT00366535|565958935|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
156784029|NCT02958527|565958940|FG000|Overall Study|Not collected CRFs|12|||
156784030|NCT02939781|565958942|FG000|Overall Study|Protocol Violation|8|||
156784031|NCT02939781|565958942|FG000|Overall Study|Withdrawal by Subject|1|||
156784032|NCT05259033|565958943|FG000|Overall Study|Withdrawal by Subject|10|||
156784033|NCT05259033|565958944|FG001|Overall Study|Withdrawal by Subject|5|||
156784034|NCT05259033|565958943|FG000|Overall Study|Lost to Follow-up|1|||
156784035|NCT05259033|565958944|FG001|Overall Study|Lost to Follow-up|0|||
156784036|NCT05259033|565958943|FG000|Overall Study|Death|2|||
156784037|NCT05259033|565958944|FG001|Overall Study|Death|0|||
156784038|NCT01068249|565958948|FG000|Overall Study|Death|1|||
156784039|NCT01068249|565958948|FG000|Overall Study|Withdrawal by Subject|3|||
156867917|NCT01590888|566277245|FG001|Overall Study|Adverse Event|0|||
156867918|NCT01590888|566277246|FG002|Overall Study|Adverse Event|1|||
156867919|NCT01590888|566277244|FG000|Overall Study|Lost to Follow-up|1|||
156867920|NCT01590888|566277245|FG001|Overall Study|Lost to Follow-up|0|||
156867921|NCT01590888|566277246|FG002|Overall Study|Lost to Follow-up|0|||
156867922|NCT02141295|566277250|FG000|Overall Study|Adverse Event|1|||
156867923|NCT02141295|566277251|FG001|Overall Study|Adverse Event|18|||
156867924|NCT02141295|566277252|FG002|Overall Study|Adverse Event|11|||
156784040|NCT05537571|565958949|FG000|Overall Study|Withdrawal by Subject|1|||
156784041|NCT05537571|565958950|FG001|Overall Study|Withdrawal by Subject|1|||
156784042|NCT05537571|565958951|FG002|Overall Study|Withdrawal by Subject|0|||
156867925|NCT02141295|566277250|FG000|Overall Study|Physician Decision|2|||
157120194|NCT02296242|567193040|FG003|Overall Study|Need for Hydroxyurea|0|||
156784043|NCT05537571|565958952|FG003|Overall Study|Withdrawal by Subject|0|||
156867926|NCT02141295|566277251|FG001|Overall Study|Physician Decision|19|||
156867927|NCT02141295|566277252|FG002|Overall Study|Physician Decision|14|||
156784044|NCT05537571|565958953|FG004|Overall Study|Withdrawal by Subject|0|||
156784045|NCT05537571|565958949|FG000|Overall Study|Adverse Event|2|||
156867928|NCT02141295|566277250|FG000|Overall Study|Study terminated by sponsor|0|||
156867929|NCT02141295|566277251|FG001|Overall Study|Study terminated by sponsor|6|||
156681583|NCT02151149|565579015|FG001|Treatment Period|Participants randomized but not treated|2|||
156681584|NCT02151149|565579014|FG000|Follow-Up Period|Lost to Follow-up|2|||
156681585|NCT02151149|565579015|FG001|Follow-Up Period|Lost to Follow-up|3|||
156681586|NCT02151149|565579014|FG000|Follow-Up Period|Death|37|||
156681587|NCT02151149|565579015|FG001|Follow-Up Period|Death|34|||
156681588|NCT00057941|565579016|FG000|Overall Study|Death|1|||
156681589|NCT00057941|565579017|FG001|Overall Study|Death|2|||
156681590|NCT00057941|565579016|FG000|Overall Study|Adverse Event|7|||
156681591|NCT00057941|565579017|FG001|Overall Study|Adverse Event|9|||
156681592|NCT00057941|565579016|FG000|Overall Study|Lack of Efficacy|54|||
156681593|NCT00057941|565579017|FG001|Overall Study|Lack of Efficacy|53|||
156681594|NCT00057941|565579016|FG000|Overall Study|Withdrawal by Subject|6|||
156681595|NCT00057941|565579017|FG001|Overall Study|Withdrawal by Subject|1|||
156681596|NCT00057941|565579016|FG000|Overall Study|still on treatment|3|||
156681597|NCT00057941|565579017|FG001|Overall Study|still on treatment|1|||
157120195|NCT02296242|567193041|FG004|Overall Study|Need for Hydroxyurea|0|||
156681598|NCT00057941|565579016|FG000|Overall Study|insurance, symptomatic deterioration|1|||
156681599|NCT00057941|565579017|FG001|Overall Study|insurance, symptomatic deterioration|3|||
156681600|NCT00057941|565579016|FG000|Overall Study|Ineligible|2|||
156681601|NCT00057941|565579017|FG001|Overall Study|Ineligible|5|||
156681602|NCT03419962|565579018|FG000|Overall Study|Change to other medication|1|||
156681603|NCT03419962|565579018|FG000|Overall Study|Refusal of continuing with trial drug|1|||
156681604|NCT03419962|565579018|FG000|Overall Study|Lost to Follow-up|3|||
156681605|NCT03419962|565579018|FG000|Overall Study|Difficulty in inhaling the doses|1|||
156681606|NCT03419962|565579018|FG000|Overall Study|Missing completion data|31|||
156681607|NCT04142658|565579021|FG000|Overall Study|Death|2|||
156681608|NCT04142658|565579022|FG001|Overall Study|Death|1|||
156681609|NCT04142658|565579021|FG000|Overall Study|Lost to Follow-up|4|||
156681610|NCT04142658|565579022|FG001|Overall Study|Lost to Follow-up|13|||
156681611|NCT04142658|565579021|FG000|Overall Study|Withdrawal by Subject|9|||
156681612|NCT04142658|565579022|FG001|Overall Study|Withdrawal by Subject|16|||
156681613|NCT01781234|565579023|FG000|Overall Study|Adverse Event|2|||
156681614|NCT01781234|565579024|FG001|Overall Study|Adverse Event|0|||
156681615|NCT01781234|565579023|FG000|Overall Study|Protocol Violation|3|||
156681616|NCT01781234|565579024|FG001|Overall Study|Protocol Violation|0|||
156681617|NCT01781234|565579023|FG000|Overall Study|Withdrawal by Subject|4|||
156681618|NCT01781234|565579024|FG001|Overall Study|Withdrawal by Subject|3|||
156681619|NCT03439085|565579025|FG000|Overall Study|Death|2|||
156681620|NCT03439085|565579025|FG000|Overall Study|Screen Failure|20|||
156681621|NCT01499160|565579029|FG000|Overall Study|Adverse Event|1|||
156681622|NCT01499160|565579029|FG000|Overall Study|Withdrawal by Subject|1|||
156681623|NCT01438476|565579033|FG000|Overall Study|Protocol Violation|1|||
156681624|NCT01438476|565579034|FG001|Overall Study|Protocol Violation|0|||
156681625|NCT01438476|565579033|FG000|Overall Study|Withdrawal by Subject|1|||
156681626|NCT01438476|565579034|FG001|Overall Study|Withdrawal by Subject|0|||
156681627|NCT01438476|565579033|FG000|Overall Study|No Surgery- Disease|8|||
156681628|NCT01438476|565579034|FG001|Overall Study|No Surgery- Disease|10|||
156681629|NCT01438476|565579033|FG000|Overall Study|Communication barrier|0|||
156681630|NCT01438476|565579034|FG001|Overall Study|Communication barrier|1|||
156681631|NCT03294317|565579037|FG000|Overall Study|Physician Decision|1|||
156681632|NCT03294317|565579037|FG000|Overall Study|Withdrawal by Subject|6|||
156681633|NCT03294317|565579037|FG000|Overall Study|Lost to Follow-up|1|||
156681634|NCT03294317|565579037|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
156681635|NCT03294317|565579037|FG000|Overall Study|Failed HB lead implant|8|||
156681636|NCT03294317|565579037|FG000|Overall Study|Received CRT instead|1|||
156681637|NCT03294317|565579037|FG000|Overall Study|Exited after lead revision|2|||
156681638|NCT00860262|565579038|FG000|Overall Study|Adverse Event|9|||
156681639|NCT00860262|565579039|FG001|Overall Study|Adverse Event|6|||
156681640|NCT00860262|565579040|FG002|Overall Study|Adverse Event|7|||
156681641|NCT00860262|565579038|FG000|Overall Study|Protocol Violation|0|||
156681642|NCT00860262|565579039|FG001|Overall Study|Protocol Violation|1|||
156681643|NCT00860262|565579040|FG002|Overall Study|Protocol Violation|0|||
156681644|NCT00860262|565579038|FG000|Overall Study|Lost to Follow-up|2|||
156681645|NCT00860262|565579039|FG001|Overall Study|Lost to Follow-up|0|||
156681646|NCT00860262|565579040|FG002|Overall Study|Lost to Follow-up|1|||
156681647|NCT00860262|565579038|FG000|Overall Study|Withdrawal by Subject|4|||
156681648|NCT00860262|565579039|FG001|Overall Study|Withdrawal by Subject|8|||
156681649|NCT00860262|565579040|FG002|Overall Study|Withdrawal by Subject|6|||
156681650|NCT00860262|565579038|FG000|Overall Study|Lack of Efficacy|0|||
156681651|NCT00860262|565579039|FG001|Overall Study|Lack of Efficacy|4|||
156681652|NCT00860262|565579040|FG002|Overall Study|Lack of Efficacy|3|||
156681653|NCT00860262|565579038|FG000|Overall Study|Other|5|||
156681654|NCT00860262|565579039|FG001|Overall Study|Other|3|||
156681655|NCT00860262|565579040|FG002|Overall Study|Other|1|||
156681656|NCT00857818|565579041|FG000|Overall Study|Lack of Efficacy|1|||
156681657|NCT00857818|565579042|FG001|Overall Study|Lack of Efficacy|0|||
156681658|NCT00857818|565579041|FG000|Overall Study|Adverse Event|3|||
156681659|NCT00857818|565579042|FG001|Overall Study|Adverse Event|0|||
156681660|NCT00857818|565579041|FG000|Overall Study|Withdrawal by Subject|0|||
157012900|NCT02723955|566801766|FG029|Escalation Phase|Physician Decision|0|||
157012901|NCT02723955|566801767|FG030|Escalation Phase|Physician Decision|0|||
157012902|NCT02723955|566801768|FG031|Escalation Phase|Physician Decision|0|||
157012903|NCT02723955|566801769|FG032|Escalation Phase|Physician Decision|0|||
157012904|NCT02723955|566801770|FG033|Escalation Phase|Physician Decision|0|||
157012905|NCT02723955|566801771|FG034|Escalation Phase|Physician Decision|0|||
157012906|NCT02723955|566801772|FG035|Escalation Phase|Physician Decision|0|||
157012907|NCT02723955|566801773|FG036|Escalation Phase|Physician Decision|0|||
157012908|NCT02723955|566801774|FG037|Escalation Phase|Physician Decision|0|||
157012909|NCT02723955|566801775|FG038|Escalation Phase|Physician Decision|0|||
157012910|NCT02723955|566801776|FG039|Escalation Phase|Physician Decision|0|||
157012911|NCT02723955|566801777|FG040|Escalation Phase|Physician Decision|0|||
157012912|NCT02723955|566801778|FG041|Escalation Phase|Physician Decision|0|||
157012913|NCT02723955|566801779|FG042|Escalation Phase|Physician Decision|0|||
157012914|NCT02723955|566801737|FG000|Escalation Phase|Withdrawal by Subject|0|||
157012915|NCT02723955|566801738|FG001|Escalation Phase|Withdrawal by Subject|0|||
157012916|NCT02723955|566801739|FG002|Escalation Phase|Withdrawal by Subject|0|||
157012917|NCT02723955|566801740|FG003|Escalation Phase|Withdrawal by Subject|0|||
157012918|NCT02723955|566801741|FG004|Escalation Phase|Withdrawal by Subject|1|||
157012919|NCT02723955|566801742|FG005|Escalation Phase|Withdrawal by Subject|1|||
157012920|NCT02723955|566801743|FG006|Escalation Phase|Withdrawal by Subject|1|||
157012921|NCT02723955|566801744|FG007|Escalation Phase|Withdrawal by Subject|1|||
157012922|NCT02723955|566801745|FG008|Escalation Phase|Withdrawal by Subject|0|||
157012923|NCT02723955|566801746|FG009|Escalation Phase|Withdrawal by Subject|0|||
157012924|NCT02723955|566801747|FG010|Escalation Phase|Withdrawal by Subject|0|||
157012925|NCT02723955|566801748|FG011|Escalation Phase|Withdrawal by Subject|0|||
157012926|NCT02723955|566801749|FG012|Escalation Phase|Withdrawal by Subject|1|||
157012927|NCT02723955|566801750|FG013|Escalation Phase|Withdrawal by Subject|0|||
157012928|NCT02723955|566801751|FG014|Escalation Phase|Withdrawal by Subject|0|||
157012929|NCT02723955|566801752|FG015|Escalation Phase|Withdrawal by Subject|0|||
157012930|NCT02723955|566801753|FG016|Escalation Phase|Withdrawal by Subject|1|||
157012931|NCT02723955|566801754|FG017|Escalation Phase|Withdrawal by Subject|0|||
157012932|NCT02723955|566801755|FG018|Escalation Phase|Withdrawal by Subject|0|||
157012933|NCT02723955|566801756|FG019|Escalation Phase|Withdrawal by Subject|0|||
157012934|NCT02723955|566801757|FG020|Escalation Phase|Withdrawal by Subject|0|||
157012935|NCT02723955|566801758|FG021|Escalation Phase|Withdrawal by Subject|0|||
157012936|NCT02723955|566801759|FG022|Escalation Phase|Withdrawal by Subject|0|||
157012937|NCT02723955|566801760|FG023|Escalation Phase|Withdrawal by Subject|2|||
157012938|NCT02723955|566801761|FG024|Escalation Phase|Withdrawal by Subject|0|||
157012939|NCT02723955|566801762|FG025|Escalation Phase|Withdrawal by Subject|1|||
157012940|NCT02723955|566801763|FG026|Escalation Phase|Withdrawal by Subject|0|||
157012941|NCT02723955|566801764|FG027|Escalation Phase|Withdrawal by Subject|0|||
157012942|NCT02723955|566801765|FG028|Escalation Phase|Withdrawal by Subject|1|||
157012943|NCT02723955|566801766|FG029|Escalation Phase|Withdrawal by Subject|0|||
157012944|NCT02723955|566801767|FG030|Escalation Phase|Withdrawal by Subject|0|||
157012945|NCT02723955|566801768|FG031|Escalation Phase|Withdrawal by Subject|0|||
157012946|NCT02723955|566801769|FG032|Escalation Phase|Withdrawal by Subject|0|||
157012947|NCT02723955|566801770|FG033|Escalation Phase|Withdrawal by Subject|0|||
157012948|NCT02723955|566801771|FG034|Escalation Phase|Withdrawal by Subject|0|||
157012949|NCT02723955|566801772|FG035|Escalation Phase|Withdrawal by Subject|0|||
157012950|NCT02723955|566801773|FG036|Escalation Phase|Withdrawal by Subject|0|||
157012951|NCT02723955|566801774|FG037|Escalation Phase|Withdrawal by Subject|0|||
157012952|NCT02723955|566801775|FG038|Escalation Phase|Withdrawal by Subject|0|||
157012953|NCT02723955|566801776|FG039|Escalation Phase|Withdrawal by Subject|0|||
157012954|NCT02723955|566801777|FG040|Escalation Phase|Withdrawal by Subject|0|||
157012955|NCT02723955|566801778|FG041|Escalation Phase|Withdrawal by Subject|0|||
157012956|NCT02723955|566801779|FG042|Escalation Phase|Withdrawal by Subject|0|||
157012957|NCT02723955|566801737|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012958|NCT02723955|566801738|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012959|NCT02723955|566801739|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012960|NCT02723955|566801740|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012961|NCT02723955|566801741|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
157012962|NCT02723955|566801742|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
157012963|NCT02723955|566801743|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
157012964|NCT02723955|566801744|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
157012965|NCT02723955|566801745|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
157012966|NCT02723955|566801746|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012967|NCT02723955|566801747|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012968|NCT02723955|566801748|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156784046|NCT05537571|565958950|FG001|Overall Study|Adverse Event|0|||
156867930|NCT02141295|566277252|FG002|Overall Study|Study terminated by sponsor|6|||
156867931|NCT02141295|566277250|FG000|Overall Study|Non-compliance|0|||
156867932|NCT02141295|566277251|FG001|Overall Study|Non-compliance|1|||
156867933|NCT02141295|566277252|FG002|Overall Study|Non-compliance|0|||
156867934|NCT02141295|566277250|FG000|Overall Study|Progressive disease|3|||
156867935|NCT02141295|566277251|FG001|Overall Study|Progressive disease|32|||
156867936|NCT02141295|566277252|FG002|Overall Study|Progressive disease|50|||
156867937|NCT02141295|566277250|FG000|Overall Study|Reason not specified|0|||
156867938|NCT02141295|566277251|FG001|Overall Study|Reason not specified|9|||
156867939|NCT02141295|566277252|FG002|Overall Study|Reason not specified|10|||
156867940|NCT02141295|566277250|FG000|Overall Study|Withdrawal by Subject|0|||
156867941|NCT02141295|566277251|FG001|Overall Study|Withdrawal by Subject|9|||
156867942|NCT02141295|566277252|FG002|Overall Study|Withdrawal by Subject|4|||
156867943|NCT01432730|566277259|FG000|Period 1|Adverse Event|2|||
156867944|NCT01432730|566277260|FG001|Period 1|Adverse Event|0|||
156867945|NCT01432730|566277259|FG000|Period 2|Adverse Event|0|||
156867946|NCT01432730|566277260|FG001|Period 2|Adverse Event|4|||
156867947|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
156867948|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
156867949|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
156867950|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
156867951|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
156867952|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
156867953|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
156867954|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
156867955|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
156867956|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
156867957|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
156867958|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
156867959|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
156867960|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
156867961|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
156867962|NCT01235741|566277261|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
156867963|NCT01235741|566277262|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
156867964|NCT01235741|566277263|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
156867965|NCT01235741|566277261|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
156867966|NCT01235741|566277262|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
156867967|NCT01235741|566277263|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
156867968|NCT01235741|566277261|FG000|Randomized to Treatment|Adverse Event|0|||
156867969|NCT01235741|566277262|FG001|Randomized to Treatment|Adverse Event|1|||
156867970|NCT01235741|566277263|FG002|Randomized to Treatment|Adverse Event|1|||
156867971|NCT01235741|566277261|FG000|Randomized to Treatment|Sponsor terminated study|0|||
156867972|NCT01235741|566277262|FG001|Randomized to Treatment|Sponsor terminated study|35|||
156867973|NCT01235741|566277263|FG002|Randomized to Treatment|Sponsor terminated study|34|||
156867974|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
156867975|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
156867976|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
156867977|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
156867978|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
156867979|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
156867980|NCT01235741|566277261|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
156867981|NCT01235741|566277262|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
156867982|NCT01235741|566277263|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
156867983|NCT01705509|566277267|FG000|Inclusion CPET|Screen Failure|5|||
156867984|NCT01705509|566277267|FG000|Inclusion CPET|Withdrawal by Subject|2|||
156867985|NCT01705509|566277267|FG000|CPET w/ Ranexa|Screen Failure|2|||
156867986|NCT00904033|566277268|FG000|Overall Study|Withdrawal by Subject|1|||
156867987|NCT00904033|566277269|FG001|Overall Study|Withdrawal by Subject|1|||
156867988|NCT00904033|566277270|FG002|Overall Study|Withdrawal by Subject|0|||
156867989|NCT00904033|566277271|FG003|Overall Study|Withdrawal by Subject|0|||
157213314|NCT03033069|567527813|FG002|Overall Study|Reason not Specified|0|||
157213315|NCT03033069|567527814|FG003|Overall Study|Reason not Specified|1|||
156867990|NCT00904033|566277268|FG000|Overall Study|Physician Decision|0|||
156867991|NCT00904033|566277269|FG001|Overall Study|Physician Decision|0|||
156867992|NCT00904033|566277270|FG002|Overall Study|Physician Decision|1|||
156867993|NCT00904033|566277271|FG003|Overall Study|Physician Decision|0|||
156867994|NCT00904033|566277268|FG000|Overall Study|Unable to obtain final blood draw|0|||
156867995|NCT00904033|566277269|FG001|Overall Study|Unable to obtain final blood draw|0|||
156867996|NCT00904033|566277270|FG002|Overall Study|Unable to obtain final blood draw|0|||
156867997|NCT00904033|566277271|FG003|Overall Study|Unable to obtain final blood draw|2|||
156681661|NCT00857818|565579042|FG001|Overall Study|Withdrawal by Subject|4|||
156681662|NCT00857818|565579041|FG000|Overall Study|Sponsor terminated study|6|||
156681663|NCT00857818|565579042|FG001|Overall Study|Sponsor terminated study|4|||
156681664|NCT00857818|565579041|FG000|Overall Study|Investigator decision|1|||
156681665|NCT00857818|565579042|FG001|Overall Study|Investigator decision|0|||
156681666|NCT01049581|565579043|FG000|Overall Study|Lost to Follow-up|2|||
156681667|NCT01049581|565579044|FG001|Overall Study|Lost to Follow-up|1|||
156681668|NCT02459418|565580700|FG000|Overall Study|Exclusion Criteria|4|||
156681669|NCT02459418|565580701|FG001|Overall Study|Exclusion Criteria|0|||
156681670|NCT02459418|565580700|FG000|Overall Study|Protocol Violation|0|||
156681671|NCT02459418|565580701|FG001|Overall Study|Protocol Violation|2|||
156681672|NCT02459418|565580700|FG000|Overall Study|Physician Decision|0|||
156681673|NCT02459418|565580701|FG001|Overall Study|Physician Decision|2|||
156681674|NCT02459418|565580700|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
156681675|NCT02459418|565580701|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
156681676|NCT02459418|565580700|FG000|Overall Study|Adverse Event|0|||
156681677|NCT02459418|565580701|FG001|Overall Study|Adverse Event|1|||
156681678|NCT02459418|565580700|FG000|Overall Study|Withdrawal by Subject|1|||
156681679|NCT02459418|565580701|FG001|Overall Study|Withdrawal by Subject|1|||
156681680|NCT02459418|565580700|FG000|Overall Study|Elevated Creatine Kinase|1|||
156681681|NCT02459418|565580701|FG001|Overall Study|Elevated Creatine Kinase|0|||
156681682|NCT02459418|565580700|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
156681683|NCT02459418|565580701|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
156681684|NCT02697617|565580702|FG000|Overall Study|Withdrawal by Subject|0|||
156681685|NCT02697617|565580703|FG001|Overall Study|Withdrawal by Subject|2|||
156681686|NCT02697617|565580702|FG000|Overall Study|Pregnancy|1|||
156681687|NCT02697617|565580703|FG001|Overall Study|Pregnancy|0|||
156681688|NCT03303417|565580704|FG000|Overall Study|Withdrawal by Subject|1|||
156681689|NCT03303417|565580705|FG001|Overall Study|Withdrawal by Subject|1|||
156681690|NCT00381849|565580709|FG000|Wash Out|Withdrawal by Subject|0|||
156681691|NCT00381849|565580710|FG001|Wash Out|Withdrawal by Subject|1|||
156681692|NCT01765270|565580712|FG000|Overall Study|Physician Decision|1|||
156681693|NCT01765270|565580713|FG001|Overall Study|Physician Decision|0|||
156681694|NCT01765270|565580712|FG000|Overall Study|Withdrawal by Subject|0|||
156681695|NCT01765270|565580713|FG001|Overall Study|Withdrawal by Subject|1|||
156681696|NCT00329160|565580714|FG000|Overall Study|Adverse Event|27|||
156681697|NCT00329160|565580714|FG000|Overall Study|Withdrawal by Subject|13|||
156681698|NCT00329160|565580714|FG000|Overall Study|Protocol Violation|2|||
156681699|NCT00329160|565580714|FG000|Overall Study|Did not Receive Study Drug|1|||
156867998|NCT02736890|566277272|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
156867999|NCT02736890|566277273|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
156868000|NCT02736890|566277272|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
156868001|NCT02736890|566277273|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
156868002|NCT03077412|566277275|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
156868003|NCT03077412|566277276|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
157012969|NCT02723955|566801749|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012970|NCT02723955|566801750|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012971|NCT02723955|566801751|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012972|NCT02723955|566801752|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012973|NCT02723955|566801753|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012974|NCT02723955|566801754|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012975|NCT02723955|566801755|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012976|NCT02723955|566801756|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012977|NCT02723955|566801757|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012978|NCT02723955|566801758|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012979|NCT02723955|566801759|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156681700|NCT00329160|565580714|FG000|Overall Study|Incomplete IVUS|45|||
156681701|NCT01755975|565580720|FG000|Overall Study|Adverse Event|0|||
157012980|NCT02723955|566801760|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156681702|NCT01755975|565580721|FG001|Overall Study|Adverse Event|0|||
156681703|NCT01755975|565580722|FG002|Overall Study|Adverse Event|1|||
156681704|NCT01755975|565580723|FG003|Overall Study|Adverse Event|0|||
156681705|NCT01755975|565580724|FG004|Overall Study|Adverse Event|2|||
156681706|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
156681707|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
156681708|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
156681709|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
156681710|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
156681711|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
156681712|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156681713|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156681714|NCT03653026|565580725|FG000|Part 1: Placebo-controlled Period|Other|0|||
156681715|NCT03653026|565580726|FG001|Part 1: Placebo-controlled Period|Other|3|||
156681716|NCT03653026|565580727|FG002|Part 1: Placebo-controlled Period|Other|0|||
156681717|NCT03653026|565580728|FG003|Part 1: Placebo-controlled Period|Other|0|||
156681718|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Adverse Event|0|||
156681719|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Adverse Event|0|||
156681720|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Adverse Event|1|||
156681721|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Adverse Event|1|||
156681722|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156681723|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156681724|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
156681725|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
156681726|NCT03653026|565580725|FG000|Part 2: Open-label Extension|Other|0|||
156681727|NCT03653026|565580726|FG001|Part 2: Open-label Extension|Other|0|||
156681728|NCT03653026|565580727|FG002|Part 2: Open-label Extension|Other|1|||
156681729|NCT03653026|565580728|FG003|Part 2: Open-label Extension|Other|2|||
156681730|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
156681731|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
156681732|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
156681733|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
156681734|NCT01933919|565580731|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
156784047|NCT05537571|565958951|FG002|Overall Study|Adverse Event|0|||
156784048|NCT05537571|565958952|FG003|Overall Study|Adverse Event|0|||
156681735|NCT01933919|565580732|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
156681736|NCT01933919|565580731|FG000|Open-label Long-term Phase|Adverse Event|2|||
156681737|NCT01933919|565580732|FG001|Open-label Long-term Phase|Adverse Event|0|||
156681738|NCT01933919|565580731|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
156681739|NCT01933919|565580732|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
156784049|NCT05537571|565958953|FG004|Overall Study|Adverse Event|0|||
156784050|NCT05537571|565958949|FG000|Overall Study|Hepatitis A screening result|2|||
156784051|NCT05537571|565958950|FG001|Overall Study|Hepatitis A screening result|0|||
156784052|NCT05537571|565958951|FG002|Overall Study|Hepatitis A screening result|0|||
156784053|NCT05537571|565958952|FG003|Overall Study|Hepatitis A screening result|0|||
156784054|NCT05537571|565958953|FG004|Overall Study|Hepatitis A screening result|0|||
156784055|NCT05537571|565958949|FG000|Overall Study|Lost to Follow-up|0|||
156784056|NCT05537571|565958950|FG001|Overall Study|Lost to Follow-up|0|||
156784057|NCT05537571|565958951|FG002|Overall Study|Lost to Follow-up|1|||
156784058|NCT05537571|565958952|FG003|Overall Study|Lost to Follow-up|0|||
156784059|NCT05537571|565958953|FG004|Overall Study|Lost to Follow-up|1|||
156784060|NCT04439123|565958956|FG000|Overall Study|Adverse Event|11|||
156784061|NCT04439123|565958956|FG000|Overall Study|Death|1|||
156784062|NCT04439123|565958956|FG000|Overall Study|Disease progression|19|||
156784063|NCT04439123|565958956|FG000|Overall Study|Withdrawal by Subject|2|||
156784064|NCT04439123|565958956|FG000|Overall Study|Still on treatment|2|||
156784065|NCT03022630|565961083|FG000|Overall Study|Death|9|||
156784066|NCT03022630|565961084|FG001|Overall Study|Death|7|||
156784067|NCT03022630|565961083|FG000|Overall Study|Withdrawal by Subject|0|||
156784068|NCT03022630|565961084|FG001|Overall Study|Withdrawal by Subject|5|||
156784069|NCT00884949|565961085|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
156784070|NCT00884949|565961085|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
156784071|NCT00382070|565961086|FG000|Overall Study|No follow up data mapped to Other|17|||
156784072|NCT00382070|565961087|FG001|Overall Study|No follow up data mapped to Other|19|||
156784073|NCT00382070|565961086|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
156784074|NCT00382070|565961087|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
156784075|NCT00382070|565961086|FG000|Overall Study|No clinical assessment|9|||
156784076|NCT00382070|565961087|FG001|Overall Study|No clinical assessment|11|||
156784077|NCT01734928|565961088|FG000|Randomization|Physician Decision|0|||
156784078|NCT01734928|565961089|FG001|Randomization|Physician Decision|1|||
156868004|NCT03077412|566277277|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
156784079|NCT01734928|565961088|FG000|Randomization|clinical progression|0|||
156681740|NCT01933919|565580731|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
156681741|NCT01933919|565580732|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
156681742|NCT01933919|565580731|FG000|Open-label Long-term Phase|Other|1|||
156784080|NCT01734928|565961089|FG001|Randomization|clinical progression|1|||
156784081|NCT01734928|565961088|FG000|Randomization|progressive disease|0|||
156784082|NCT01734928|565961089|FG001|Randomization|progressive disease|2|||
156784083|NCT01734928|565961088|FG000|Randomization|Withdrew informed consent|0|||
156784084|NCT01734928|565961089|FG001|Randomization|Withdrew informed consent|4|||
156784085|NCT01734928|565961088|FG000|Randomization|Death|1|||
156784086|NCT01734928|565961089|FG001|Randomization|Death|0|||
156784087|NCT01734928|565961088|FG000|Randomization|Randomization error|1|||
156681743|NCT01933919|565580732|FG001|Open-label Long-term Phase|Other|2|||
156681744|NCT00852917|565580733|FG000|Overall Study|Adverse Event|13|||
156784088|NCT01734928|565961089|FG001|Randomization|Randomization error|0|||
156784089|NCT01734928|565961088|FG000|Randomization|Lost to Follow-up|1|||
156784090|NCT01734928|565961089|FG001|Randomization|Lost to Follow-up|0|||
156784091|NCT01734928|565961088|FG000|Treatment Period|Lost to Follow-up|0|||
156784092|NCT01734928|565961089|FG001|Treatment Period|Lost to Follow-up|2|||
156784093|NCT01734928|565961088|FG000|Treatment Period|Progressive Disease|167|||
156784094|NCT01734928|565961089|FG001|Treatment Period|Progressive Disease|165|||
156784095|NCT01734928|565961088|FG000|Treatment Period|Adverse Event|39|||
156784096|NCT01734928|565961089|FG001|Treatment Period|Adverse Event|52|||
156784097|NCT01734928|565961088|FG000|Treatment Period|Withdrawal of Consent|25|||
156784098|NCT01734928|565961089|FG001|Treatment Period|Withdrawal of Consent|22|||
156784099|NCT01734928|565961088|FG000|Treatment Period|Death|20|||
156784100|NCT01734928|565961089|FG001|Treatment Period|Death|9|||
156784101|NCT01734928|565961088|FG000|Treatment Period|Other Reasons|27|||
156784102|NCT01734928|565961089|FG001|Treatment Period|Other Reasons|19|||
156784103|NCT01734928|565961088|FG000|Treatment Period|Pregnancy|0|||
156784104|NCT01734928|565961089|FG001|Treatment Period|Pregnancy|1|||
156784105|NCT00620035|565961090|FG000|Overall Study|Adverse Event|106|||
156784106|NCT00620035|565961090|FG000|Overall Study|Withdrawal of Informed Consent|1|||
156784107|NCT00620035|565961090|FG000|Overall Study|Other Reason|38|||
156784108|NCT03684057|565961092|FG000|Overall Study|Withdrawal by Subject|4|||
156681745|NCT00852917|565580734|FG001|Overall Study|Adverse Event|20|||
156681746|NCT00852917|565580735|FG002|Overall Study|Adverse Event|35|||
156681747|NCT00852917|565580736|FG003|Overall Study|Adverse Event|17|||
156681748|NCT00852917|565580733|FG000|Overall Study|Lack of Efficacy|21|||
156681749|NCT00852917|565580734|FG001|Overall Study|Lack of Efficacy|11|||
156681750|NCT00852917|565580735|FG002|Overall Study|Lack of Efficacy|11|||
156681751|NCT00852917|565580736|FG003|Overall Study|Lack of Efficacy|47|||
156681752|NCT00852917|565580733|FG000|Overall Study|Withdrawal by Subject|4|||
156681753|NCT00852917|565580734|FG001|Overall Study|Withdrawal by Subject|8|||
156681754|NCT00852917|565580735|FG002|Overall Study|Withdrawal by Subject|10|||
156681755|NCT00852917|565580736|FG003|Overall Study|Withdrawal by Subject|9|||
156681756|NCT00852917|565580733|FG000|Overall Study|Physician Decision|6|||
156681757|NCT00852917|565580734|FG001|Overall Study|Physician Decision|7|||
156681758|NCT00852917|565580735|FG002|Overall Study|Physician Decision|2|||
156681759|NCT00852917|565580736|FG003|Overall Study|Physician Decision|19|||
156681760|NCT00852917|565580733|FG000|Overall Study|Death|0|||
156681761|NCT00852917|565580734|FG001|Overall Study|Death|0|||
156681762|NCT00852917|565580735|FG002|Overall Study|Death|0|||
156681763|NCT00852917|565580736|FG003|Overall Study|Death|1|||
156681764|NCT02575339|565580737|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
156681765|NCT02575339|565580738|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156681766|NCT02575339|565580739|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
156681767|NCT02575339|565580737|FG000|Study Treatment|Disease Progression|5|||
156681768|NCT02575339|565580738|FG001|Study Treatment|Disease Progression|2|||
156681769|NCT02575339|565580739|FG002|Study Treatment|Disease Progression|0|||
156681770|NCT02575339|565580737|FG000|Study Treatment|Adverse Event|1|||
156681771|NCT02575339|565580738|FG001|Study Treatment|Adverse Event|2|||
156681772|NCT02575339|565580739|FG002|Study Treatment|Adverse Event|0|||
156681773|NCT02575339|565580737|FG000|Follow up|Death|6|||
156681774|NCT02575339|565580738|FG001|Follow up|Death|2|||
156681775|NCT02575339|565580739|FG002|Follow up|Death|0|||
156681776|NCT02575339|565580737|FG000|Follow up|Study Terminated|0|||
156681777|NCT02575339|565580738|FG001|Follow up|Study Terminated|2|||
156681778|NCT02575339|565580739|FG002|Follow up|Study Terminated|0|||
156681779|NCT02575339|565580737|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
156681780|NCT02575339|565580738|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
156681781|NCT02575339|565580739|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
156681782|NCT01358877|565580740|FG000|Overall Study|Withdrawal by Subject|475|||
156681783|NCT01358877|565580741|FG001|Overall Study|Withdrawal by Subject|466|||
156784109|NCT03684057|565961093|FG001|Overall Study|Withdrawal by Subject|5|||
156784110|NCT00456612|565961095|FG000|Overall Study|Withdrawal by Subject|3|||
156784111|NCT02316613|565961096|FG000|Overall Study|Death|63|||
156681784|NCT01358877|565580740|FG000|Overall Study|Recurrence of disease|181|||
156681785|NCT01358877|565580741|FG001|Overall Study|Recurrence of disease|269|||
156784112|NCT02316613|565961096|FG000|Overall Study|Lost to Follow-up|9|||
156784113|NCT02316613|565961096|FG000|Overall Study|Lymphoma transformation|2|||
156784114|NCT02316613|565961096|FG000|Overall Study|Participant moved/changed medical team|11|||
156681786|NCT01358877|565580740|FG000|Overall Study|Lost to Follow-up|181|||
156681787|NCT01358877|565580741|FG001|Overall Study|Lost to Follow-up|176|||
156681788|NCT01358877|565580740|FG000|Overall Study|Death|41|||
156681789|NCT01358877|565580741|FG001|Overall Study|Death|46|||
156681790|NCT01358877|565580740|FG000|Overall Study|Adverse Event|39|||
156681791|NCT01358877|565580741|FG001|Overall Study|Adverse Event|42|||
156681792|NCT01358877|565580740|FG000|Overall Study|Physician Decision|43|||
156784115|NCT02316613|565961096|FG000|Overall Study|No data and duplicate cases|5|||
156681793|NCT01358877|565580741|FG001|Overall Study|Physician Decision|32|||
156681794|NCT01358877|565580740|FG000|Overall Study|Contralateral breast cancer|42|||
156681795|NCT01358877|565580741|FG001|Overall Study|Contralateral breast cancer|28|||
156681796|NCT01358877|565580740|FG000|Overall Study|Reason not specified|37|||
156681797|NCT01358877|565580741|FG001|Overall Study|Reason not specified|29|||
156681798|NCT02510261|565580742|FG000|Overall Study|Adverse Event|5|||
156681799|NCT02510261|565580743|FG001|Overall Study|Adverse Event|8|||
156681800|NCT02510261|565580744|FG002|Overall Study|Adverse Event|0|||
156681801|NCT02510261|565580742|FG000|Overall Study|Physician Decision|1|||
156681802|NCT02510261|565580743|FG001|Overall Study|Physician Decision|5|||
156681803|NCT02510261|565580744|FG002|Overall Study|Physician Decision|0|||
156681804|NCT02510261|565580742|FG000|Overall Study|Death|19|||
156681805|NCT02510261|565580743|FG001|Overall Study|Death|19|||
156681806|NCT02510261|565580744|FG002|Overall Study|Death|0|||
156681807|NCT02510261|565580742|FG000|Overall Study|Withdrawal by Subject|3|||
156681808|NCT02510261|565580743|FG001|Overall Study|Withdrawal by Subject|10|||
156681809|NCT02510261|565580744|FG002|Overall Study|Withdrawal by Subject|3|||
156681810|NCT01597479|565580748|FG000|Overall Study|Protocol Violation|1|||
156681811|NCT01597479|565580749|FG001|Overall Study|Protocol Violation|0|||
156681812|NCT01597479|565580748|FG000|Overall Study|Lost to Follow-up|1|||
156681813|NCT01597479|565580749|FG001|Overall Study|Lost to Follow-up|0|||
156681814|NCT02003222|565580750|FG000|Induction|Never started treatment|0|||
156681815|NCT02003222|565580751|FG001|Induction|Never started treatment|0|||
156681816|NCT02003222|565580752|FG002|Induction|Never started treatment|0|||
156681817|NCT02003222|565580753|FG003|Induction|Never started treatment|0|||
156681818|NCT02003222|565580754|FG004|Induction|Never started treatment|8|||
156681819|NCT02003222|565580750|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681820|NCT02003222|565580751|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681821|NCT02003222|565580752|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681822|NCT02003222|565580753|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
156681823|NCT02003222|565580754|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
156681824|NCT02003222|565580750|FG000|Induction|Adverse Event|0|||
156681825|NCT02003222|565580751|FG001|Induction|Adverse Event|0|||
156681826|NCT02003222|565580752|FG002|Induction|Adverse Event|0|||
156681827|NCT02003222|565580753|FG003|Induction|Adverse Event|0|||
156681828|NCT02003222|565580754|FG004|Induction|Adverse Event|13|||
156681829|NCT02003222|565580750|FG000|Induction|Alternative therapy|0|||
156681830|NCT02003222|565580751|FG001|Induction|Alternative therapy|0|||
156681831|NCT02003222|565580752|FG002|Induction|Alternative therapy|0|||
156681832|NCT02003222|565580753|FG003|Induction|Alternative therapy|0|||
156681833|NCT02003222|565580754|FG004|Induction|Alternative therapy|12|||
156681834|NCT02003222|565580750|FG000|Induction|Disease progression|0|||
156681835|NCT02003222|565580751|FG001|Induction|Disease progression|0|||
156681836|NCT02003222|565580752|FG002|Induction|Disease progression|0|||
156681837|NCT02003222|565580753|FG003|Induction|Disease progression|0|||
156681838|NCT02003222|565580754|FG004|Induction|Disease progression|22|||
156681839|NCT02003222|565580750|FG000|Induction|Death|0|||
156681840|NCT02003222|565580751|FG001|Induction|Death|0|||
156681841|NCT02003222|565580752|FG002|Induction|Death|0|||
156681842|NCT02003222|565580753|FG003|Induction|Death|0|||
156681843|NCT02003222|565580754|FG004|Induction|Death|3|||
156681844|NCT02003222|565580750|FG000|Induction|Withdrawal by Subject|0|||
156681845|NCT02003222|565580751|FG001|Induction|Withdrawal by Subject|0|||
156681846|NCT02003222|565580752|FG002|Induction|Withdrawal by Subject|0|||
156681847|NCT02003222|565580753|FG003|Induction|Withdrawal by Subject|0|||
156681848|NCT02003222|565580754|FG004|Induction|Withdrawal by Subject|8|||
156681849|NCT02003222|565580750|FG000|Induction|Other reasons|0|||
156681850|NCT02003222|565580751|FG001|Induction|Other reasons|0|||
156681851|NCT02003222|565580752|FG002|Induction|Other reasons|0|||
156681852|NCT02003222|565580753|FG003|Induction|Other reasons|0|||
156681853|NCT02003222|565580754|FG004|Induction|Other reasons|22|||
156681854|NCT02003222|565580750|FG000|Intensification|Never started treatment|0|||
156681855|NCT02003222|565580751|FG001|Intensification|Never started treatment|0|||
156681856|NCT02003222|565580752|FG002|Intensification|Never started treatment|0|||
156681857|NCT02003222|565580753|FG003|Intensification|Never started treatment|0|||
156681858|NCT02003222|565580754|FG004|Intensification|Never started treatment|2|||
156681859|NCT02003222|565580750|FG000|Intensification|Adverse Event|0|||
156681860|NCT02003222|565580751|FG001|Intensification|Adverse Event|0|||
156681861|NCT02003222|565580752|FG002|Intensification|Adverse Event|0|||
156681862|NCT02003222|565580753|FG003|Intensification|Adverse Event|0|||
156681863|NCT02003222|565580754|FG004|Intensification|Adverse Event|6|||
156681864|NCT02003222|565580750|FG000|Intensification|Alternative therapy|0|||
156681865|NCT02003222|565580751|FG001|Intensification|Alternative therapy|0|||
156681866|NCT02003222|565580752|FG002|Intensification|Alternative therapy|0|||
156681867|NCT02003222|565580753|FG003|Intensification|Alternative therapy|0|||
156681868|NCT02003222|565580754|FG004|Intensification|Alternative therapy|8|||
156681869|NCT02003222|565580750|FG000|Intensification|Disease progression|0|||
156681870|NCT02003222|565580751|FG001|Intensification|Disease progression|0|||
156681871|NCT02003222|565580752|FG002|Intensification|Disease progression|0|||
156681872|NCT02003222|565580753|FG003|Intensification|Disease progression|0|||
156681873|NCT02003222|565580754|FG004|Intensification|Disease progression|18|||
156681874|NCT02003222|565580750|FG000|Intensification|Withdrawal by Subject|0|||
156681875|NCT02003222|565580751|FG001|Intensification|Withdrawal by Subject|0|||
156681876|NCT02003222|565580752|FG002|Intensification|Withdrawal by Subject|0|||
156681877|NCT02003222|565580753|FG003|Intensification|Withdrawal by Subject|0|||
156681878|NCT02003222|565580754|FG004|Intensification|Withdrawal by Subject|5|||
156681879|NCT02003222|565580750|FG000|Intensification|Other reasons|0|||
156681880|NCT02003222|565580751|FG001|Intensification|Other reasons|0|||
156681881|NCT02003222|565580752|FG002|Intensification|Other reasons|0|||
156681882|NCT02003222|565580753|FG003|Intensification|Other reasons|0|||
156681883|NCT02003222|565580754|FG004|Intensification|Other reasons|8|||
156681884|NCT01886872|565580760|FG000|Overall Study|Ineligible|7|||
156681885|NCT01886872|565580761|FG001|Overall Study|Ineligible|4|||
156681886|NCT01886872|565580762|FG002|Overall Study|Ineligible|12|||
156681887|NCT02167594|565580763|FG000|Overall Study|Withdrawal by Subject|2|||
156681888|NCT02167594|565580764|FG001|Overall Study|Withdrawal by Subject|0|||
156681889|NCT02167594|565580765|FG002|Overall Study|Withdrawal by Subject|0|||
156681890|NCT02167594|565580763|FG000|Overall Study|Death|0|||
156681891|NCT02167594|565580764|FG001|Overall Study|Death|1|||
156681892|NCT02167594|565580765|FG002|Overall Study|Death|0|||
156681893|NCT02340962|565580770|FG000|Overall Study|Lost to Follow-up|1|||
156681894|NCT02340962|565580771|FG001|Overall Study|Lost to Follow-up|0|||
156681895|NCT04994431|565580772|FG000|Overall Study|Adverse Event|1|||
156681896|NCT04994431|565580773|FG001|Overall Study|Adverse Event|0|||
156681897|NCT02911935|565580774|FG000|Overall Study|Lost to Follow-up|5|||
156681898|NCT02911935|565580775|FG001|Overall Study|Lost to Follow-up|7|||
156681899|NCT00603512|565580776|FG000|Overall Study|Adverse Event|0|||
156681900|NCT00603512|565580777|FG001|Overall Study|Adverse Event|2|||
156681901|NCT00603512|565580778|FG002|Overall Study|Adverse Event|4|||
156681902|NCT00603512|565580779|FG003|Overall Study|Adverse Event|4|||
156681903|NCT00603512|565580780|FG004|Overall Study|Adverse Event|2|||
156681904|NCT00603512|565580776|FG000|Overall Study|Lack of Efficacy|0|||
156681905|NCT00603512|565580777|FG001|Overall Study|Lack of Efficacy|1|||
156681906|NCT00603512|565580778|FG002|Overall Study|Lack of Efficacy|0|||
156681907|NCT00603512|565580779|FG003|Overall Study|Lack of Efficacy|0|||
156681908|NCT00603512|565580780|FG004|Overall Study|Lack of Efficacy|1|||
156681909|NCT00603512|565580776|FG000|Overall Study|Other|2|||
156681910|NCT00603512|565580777|FG001|Overall Study|Other|1|||
156681911|NCT00603512|565580778|FG002|Overall Study|Other|0|||
156681912|NCT00603512|565580779|FG003|Overall Study|Other|1|||
156681913|NCT00603512|565580780|FG004|Overall Study|Other|1|||
156681914|NCT00603512|565580776|FG000|Overall Study|Withdrawal by Subject|0|||
156681915|NCT00603512|565580777|FG001|Overall Study|Withdrawal by Subject|0|||
156681916|NCT00603512|565580778|FG002|Overall Study|Withdrawal by Subject|0|||
156681917|NCT00603512|565580779|FG003|Overall Study|Withdrawal by Subject|0|||
156681918|NCT00603512|565580780|FG004|Overall Study|Withdrawal by Subject|1|||
156681919|NCT00603512|565580776|FG000|Overall Study|Randomized but not treated|0|||
156681920|NCT00603512|565580777|FG001|Overall Study|Randomized but not treated|1|||
156681921|NCT00603512|565580778|FG002|Overall Study|Randomized but not treated|1|||
156681922|NCT00603512|565580779|FG003|Overall Study|Randomized but not treated|2|||
156681923|NCT00603512|565580780|FG004|Overall Study|Randomized but not treated|0|||
156681924|NCT04979858|565580781|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
156681925|NCT04979858|565580782|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
156681926|NCT04253236|565580783|FG000|Overall Study|Adverse Event|1|||
156681927|NCT04253236|565580784|FG001|Overall Study|Adverse Event|0|||
156681928|NCT04253236|565580783|FG000|Overall Study|Safety Concerns|1|||
156681929|NCT04253236|565580784|FG001|Overall Study|Safety Concerns|0|||
156681930|NCT04253236|565580783|FG000|Overall Study|Study Terminated by Sponsor|1|||
156681931|NCT04253236|565580784|FG001|Overall Study|Study Terminated by Sponsor|0|||
156681932|NCT03259789|565580785|FG000|Overall Study|Adverse Event|3|||
156681933|NCT03259789|565580786|FG001|Overall Study|Adverse Event|2|||
156681934|NCT03259789|565580787|FG002|Overall Study|Adverse Event|1|||
156681935|NCT03259789|565580785|FG000|Overall Study|Withdrawal by Subject|9|||
156681936|NCT03259789|565580786|FG001|Overall Study|Withdrawal by Subject|5|||
156681937|NCT03259789|565580787|FG002|Overall Study|Withdrawal by Subject|1|||
156681938|NCT03259789|565580785|FG000|Overall Study|Lost to Follow-up|5|||
156681939|NCT03259789|565580786|FG001|Overall Study|Lost to Follow-up|9|||
156681940|NCT03259789|565580787|FG002|Overall Study|Lost to Follow-up|4|||
156681941|NCT03259789|565580785|FG000|Overall Study|Physician Decision|0|||
156681942|NCT03259789|565580786|FG001|Overall Study|Physician Decision|1|||
156681943|NCT03259789|565580787|FG002|Overall Study|Physician Decision|0|||
156681944|NCT02063217|565580788|FG000|Overall Study|Withdrawal by Subject|1|||
156681945|NCT02063217|565580789|FG001|Overall Study|Withdrawal by Subject|0|||
156681946|NCT02063217|565580790|FG002|Overall Study|Withdrawal by Subject|0|||
156681947|NCT00889252|565580791|FG000|Overall Study|Adverse Event|2|||
156681948|NCT00889252|565580792|FG001|Overall Study|Adverse Event|4|||
156681949|NCT00889252|565580791|FG000|Overall Study|Withdrawal by Subject|3|||
156681950|NCT00889252|565580792|FG001|Overall Study|Withdrawal by Subject|0|||
156681951|NCT00889252|565580791|FG000|Overall Study|Protocol Violation|2|||
156681952|NCT00889252|565580792|FG001|Overall Study|Protocol Violation|0|||
156681953|NCT04291508|565580793|FG000|Overall Study|Withdrawal by Subject|1|||
156681954|NCT04291508|565580794|FG001|Overall Study|Withdrawal by Subject|0|||
156681955|NCT04291508|565580795|FG002|Overall Study|Withdrawal by Subject|1|||
156681956|NCT04291508|565580796|FG003|Overall Study|Withdrawal by Subject|0|||
156681957|NCT04291508|565580793|FG000|Overall Study|lost to follow up|4|||
156681958|NCT04291508|565580794|FG001|Overall Study|lost to follow up|0|||
156681959|NCT04291508|565580795|FG002|Overall Study|lost to follow up|1|||
156681960|NCT04291508|565580796|FG003|Overall Study|lost to follow up|0|||
156681961|NCT03566238|565580797|FG000|Overall Study|Adverse Event|0|||
156681962|NCT03566238|565580798|FG001|Overall Study|Adverse Event|0|||
156681963|NCT03566238|565580799|FG002|Overall Study|Adverse Event|1|||
156681964|NCT03566238|565580797|FG000|Overall Study|Lack of Efficacy|5|||
156681965|NCT03566238|565580798|FG001|Overall Study|Lack of Efficacy|4|||
156681966|NCT03566238|565580799|FG002|Overall Study|Lack of Efficacy|2|||
156681967|NCT03566238|565580797|FG000|Overall Study|Other|0|||
156681968|NCT03566238|565580798|FG001|Overall Study|Other|1|||
156681969|NCT03566238|565580799|FG002|Overall Study|Other|0|||
156681970|NCT01833169|565580812|FG000|Overall Study|Disease Progression|99|||
156681971|NCT01833169|565580812|FG000|Overall Study|Adverse Event|33|||
156784116|NCT02316613|565961096|FG000|Overall Study|Did not met selection criteria|14|||
156784117|NCT03422718|565961106|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
156784118|NCT03422718|565961107|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
156784119|NCT03422718|565961108|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
156784120|NCT03422718|565961109|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
156784121|NCT03422718|565961110|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
156784122|NCT03422718|565961111|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
156784123|NCT03422718|565961112|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
156784124|NCT03422718|565961113|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
156784125|NCT03422718|565961106|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
156784126|NCT03422718|565961107|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
156784127|NCT03422718|565961108|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
156784128|NCT03422718|565961109|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
156784129|NCT03422718|565961110|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
156784130|NCT03422718|565961111|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
156784131|NCT03422718|565961112|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
156784132|NCT03422718|565961113|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
156784133|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
156784134|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
156784135|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
156784136|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784137|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
156784138|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784139|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
156784140|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
156784141|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784142|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
156868005|NCT03077412|566277275|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
156868006|NCT03077412|566277276|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
156868007|NCT03077412|566277277|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
156784143|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156868008|NCT03077412|566277275|FG000|Overall Study|Adverse Event|1|||
156868009|NCT03077412|566277276|FG001|Overall Study|Adverse Event|2|||
156681972|NCT01833169|565580812|FG000|Overall Study|Withdrawal by Subject|9|||
156681973|NCT01833169|565580812|FG000|Overall Study|Death|3|||
156681974|NCT01833169|565580812|FG000|Overall Study|Physician Decision|2|||
156681975|NCT02169336|565580817|FG000|Overall Study|Lack of Efficacy|1|||
156681976|NCT02169336|565580818|FG001|Overall Study|Lack of Efficacy|1|||
156681977|NCT02169336|565580819|FG002|Overall Study|Lack of Efficacy|0|||
156681978|NCT02169336|565580817|FG000|Overall Study|Adverse Event|2|||
156681979|NCT02169336|565580818|FG001|Overall Study|Adverse Event|3|||
156681980|NCT02169336|565580819|FG002|Overall Study|Adverse Event|1|||
156681981|NCT02169336|565580817|FG000|Overall Study|Withdrawal by Subject|1|||
156681982|NCT02169336|565580818|FG001|Overall Study|Withdrawal by Subject|0|||
156681983|NCT02169336|565580819|FG002|Overall Study|Withdrawal by Subject|0|||
156681984|NCT02169336|565580817|FG000|Overall Study|Physician Decision|0|||
156681985|NCT02169336|565580818|FG001|Overall Study|Physician Decision|0|||
156681986|NCT02169336|565580819|FG002|Overall Study|Physician Decision|1|||
156681987|NCT02169336|565580817|FG000|Overall Study|Subject declined to continue dosing|0|||
156681988|NCT02169336|565580818|FG001|Overall Study|Subject declined to continue dosing|0|||
156681989|NCT02169336|565580819|FG002|Overall Study|Subject declined to continue dosing|1|||
156681990|NCT04718129|565580820|FG000|Overall Study|Lost to Follow-up|6|||
156681991|NCT04718129|565580821|FG001|Overall Study|Lost to Follow-up|7|||
156681992|NCT01598896|565580822|FG000|Overall Study|Withdrawal by Subject|0|||
156681993|NCT01598896|565580823|FG001|Overall Study|Withdrawal by Subject|1|||
156681994|NCT01598896|565580822|FG000|Overall Study|Lack of Efficacy|0|||
156681995|NCT01598896|565580823|FG001|Overall Study|Lack of Efficacy|1|||
156681996|NCT00420095|565580824|FG000|Overall Study|Adverse Event|1|||
156681997|NCT00420095|565580825|FG001|Overall Study|Adverse Event|0|||
156681998|NCT00420095|565580824|FG000|Overall Study|Protocol Violation|1|||
156681999|NCT00420095|565580825|FG001|Overall Study|Protocol Violation|1|||
156682000|NCT00420095|565580824|FG000|Overall Study|Lost to Follow-up|1|||
156682001|NCT00420095|565580825|FG001|Overall Study|Lost to Follow-up|0|||
156682002|NCT00393705|565580826|FG000|Overall Study|Adverse Event|0|||
156682003|NCT00393705|565580827|FG001|Overall Study|Adverse Event|2|||
156682004|NCT00393705|565580826|FG000|Overall Study|Death|0|||
156682005|NCT00393705|565580827|FG001|Overall Study|Death|1|||
156682006|NCT00393705|565580826|FG000|Overall Study|Lost to Follow-up|2|||
156682007|NCT00393705|565580827|FG001|Overall Study|Lost to Follow-up|2|||
156682008|NCT00393705|565580826|FG000|Overall Study|Entry Criteria Not Met|10|||
156682009|NCT00393705|565580827|FG001|Overall Study|Entry Criteria Not Met|10|||
156682010|NCT00393705|565580826|FG000|Overall Study|Protocol Violation|4|||
156682011|NCT00393705|565580827|FG001|Overall Study|Protocol Violation|3|||
156682012|NCT00393705|565580826|FG000|Overall Study|Withdrawal by Subject|5|||
156682013|NCT00393705|565580827|FG001|Overall Study|Withdrawal by Subject|3|||
156682014|NCT00393705|565580826|FG000|Overall Study|Physician Decision|2|||
156682015|NCT00393705|565580827|FG001|Overall Study|Physician Decision|2|||
156682016|NCT01120691|565580830|FG000|Overall Study|Adverse Event|59|||
156682017|NCT01120691|565580831|FG001|Overall Study|Adverse Event|67|||
156682018|NCT01120691|565580832|FG002|Overall Study|Adverse Event|47|||
156682019|NCT01120691|565580830|FG000|Overall Study|Subject withdrew consent|33|||
156682020|NCT01120691|565580831|FG001|Overall Study|Subject withdrew consent|50|||
156682021|NCT01120691|565580832|FG002|Overall Study|Subject withdrew consent|44|||
156682022|NCT01120691|565580830|FG000|Overall Study|Death|21|||
156682023|NCT01120691|565580831|FG001|Overall Study|Death|22|||
156682024|NCT01120691|565580832|FG002|Overall Study|Death|24|||
156682025|NCT01120691|565580830|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156682026|NCT01120691|565580831|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
156682027|NCT01120691|565580832|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
156682028|NCT01120691|565580830|FG000|Overall Study|Administrative problems|15|||
156682029|NCT01120691|565580831|FG001|Overall Study|Administrative problems|8|||
156682030|NCT01120691|565580832|FG002|Overall Study|Administrative problems|9|||
156682031|NCT01120691|565580830|FG000|Overall Study|Protocol deviation|13|||
156682032|NCT01120691|565580831|FG001|Overall Study|Protocol deviation|12|||
156682033|NCT01120691|565580832|FG002|Overall Study|Protocol deviation|12|||
156682034|NCT01120691|565580830|FG000|Overall Study|Lost to Follow-up|5|||
156682035|NCT01120691|565580831|FG001|Overall Study|Lost to Follow-up|6|||
156682036|NCT01120691|565580832|FG002|Overall Study|Lost to Follow-up|4|||
156784144|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784145|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
157012981|NCT02723955|566801761|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156682037|NCT01120691|565580830|FG000|Overall Study|Abnormal test procedure result(s)|3|||
156784146|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
156868010|NCT03077412|566277277|FG002|Overall Study|Adverse Event|2|||
157012982|NCT02723955|566801762|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012983|NCT02723955|566801763|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012984|NCT02723955|566801764|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012985|NCT02723955|566801765|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012986|NCT02723955|566801766|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157213316|NCT00550420|567529476|FG000|Overall Study|Adverse Event|28|||
156682038|NCT01120691|565580831|FG001|Overall Study|Abnormal test procedure result(s)|2|||
156682039|NCT01120691|565580832|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156682040|NCT01120691|565580830|FG000|Overall Study|Patient's inability to use the device|3|||
156682041|NCT01120691|565580831|FG001|Overall Study|Patient's inability to use the device|1|||
156682042|NCT01120691|565580832|FG002|Overall Study|Patient's inability to use the device|0|||
156682043|NCT01120691|565580830|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156682044|NCT01120691|565580831|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156682045|NCT01120691|565580832|FG002|Overall Study|Abnormal laboratory value(s)|4|||
156682046|NCT03370510|565580836|FG000|Overall Study|COVID-19|2|||
156682047|NCT03370510|565580837|FG001|Overall Study|COVID-19|0|||
156682048|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
156682049|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
156682050|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
157012987|NCT02723955|566801767|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012988|NCT02723955|566801768|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012989|NCT02723955|566801769|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012990|NCT02723955|566801770|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012991|NCT02723955|566801771|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156682051|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
156682052|NCT00772148|565580838|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
156682053|NCT00772148|565580839|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
156682054|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Death|2|||
156682055|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Death|2|||
156682056|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
156682057|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
156682058|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
156682059|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
156682060|NCT00772148|565580838|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
156682061|NCT00772148|565580839|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
156682062|NCT00688844|565580840|FG000|Overall Study|Lost to Follow-up|10|||
156682063|NCT01223027|565580843|FG000|Overall Study|Adverse Event|20|||
156682064|NCT01223027|565580844|FG001|Overall Study|Adverse Event|10|||
156682065|NCT01223027|565580843|FG000|Overall Study|Death|42|||
156682066|NCT01223027|565580844|FG001|Overall Study|Death|42|||
156682067|NCT01223027|565580843|FG000|Overall Study|Lost to Follow-up|2|||
156682068|NCT01223027|565580844|FG001|Overall Study|Lost to Follow-up|1|||
156682069|NCT01223027|565580843|FG000|Overall Study|Physician Decision|4|||
156682070|NCT01223027|565580844|FG001|Overall Study|Physician Decision|8|||
156682071|NCT01223027|565580843|FG000|Overall Study|Progressive Disease|167|||
156682072|NCT01223027|565580844|FG001|Overall Study|Progressive Disease|183|||
156682073|NCT01223027|565580843|FG000|Overall Study|Protocol Violation|2|||
156682074|NCT01223027|565580844|FG001|Overall Study|Protocol Violation|1|||
156682075|NCT01223027|565580843|FG000|Overall Study|Subject/guardian decicion|18|||
156682076|NCT01223027|565580844|FG001|Overall Study|Subject/guardian decicion|16|||
156682077|NCT01223027|565580843|FG000|Overall Study|New therapy for study indication|17|||
157012992|NCT02723955|566801772|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156682078|NCT01223027|565580844|FG001|Overall Study|New therapy for study indication|8|||
156682079|NCT01223027|565580843|FG000|Overall Study|Study terminated by sponsor|2|||
156682080|NCT01223027|565580844|FG001|Overall Study|Study terminated by sponsor|8|||
156682081|NCT01475487|565580845|FG000|Overall Study|had to leave early for personal reasons|2|||
156682082|NCT01475487|565580846|FG001|Overall Study|had to leave early for personal reasons|1|||
156682083|NCT04428645|565580849|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
156682084|NCT01321697|565580850|FG000|Overall Study|Study Terminated|7|||
156682085|NCT02061280|565580851|FG000|Overall Study|Protocol Violation|12|||
156682086|NCT02061280|565580852|FG001|Overall Study|Protocol Violation|8|||
156682087|NCT02061280|565580851|FG000|Overall Study|moved out of state|0|||
156682088|NCT02061280|565580852|FG001|Overall Study|moved out of state|1|||
156682089|NCT02061280|565580851|FG000|Overall Study|Withdrawal by Subject|1|||
156682090|NCT02061280|565580852|FG001|Overall Study|Withdrawal by Subject|2|||
156682091|NCT02061280|565580851|FG000|Overall Study|Lost to Follow-up|5|||
156682092|NCT02061280|565580852|FG001|Overall Study|Lost to Follow-up|1|||
156682093|NCT01977456|565580853|FG000|Overall Study|Death|5|||
156682094|NCT00559637|565582520|FG000|Overall Study|Adverse Event|22|||
156682095|NCT00559637|565582520|FG000|Overall Study|Withdrawal by Subject|4|||
156682096|NCT00559637|565582520|FG000|Overall Study|Protocol Violation|6|||
156682097|NCT00559637|565582520|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
156682098|NCT00559637|565582520|FG000|Overall Study|Failure to return|6|||
156682099|NCT00559637|565582520|FG000|Overall Study|Insufficient response|3|||
156682100|NCT00559637|565582520|FG000|Overall Study|Started requiring dialysis after month 7|2|||
156682101|NCT00559637|565582520|FG000|Overall Study|Suspected lung cancer|1|||
156682102|NCT00559637|565582520|FG000|Overall Study|Participation in another study|1|||
156682103|NCT00559637|565582520|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
156682104|NCT00559637|565582520|FG000|Overall Study|Change of center|1|||
156682105|NCT00559637|565582520|FG000|Overall Study|Change of home|1|||
156682106|NCT00559637|565582520|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
156682107|NCT00653159|565582521|FG000|Overall Study|Adverse Event|4|||
156682108|NCT00653159|565582522|FG001|Overall Study|Adverse Event|1|||
156682109|NCT00653159|565582521|FG000|Overall Study|Lost to Follow-up|1|||
156682110|NCT00653159|565582522|FG001|Overall Study|Lost to Follow-up|2|||
156682111|NCT01872715|565582523|FG000|Overall Study|Adverse Event|1|||
156682112|NCT01872715|565582523|FG000|Overall Study|Protocol Violation|1|||
156682113|NCT01872715|565582523|FG000|Overall Study|Withdrawal by Subject|2|||
156682114|NCT00683592|565582524|FG000|Overall Study|Adverse Event|12|||
156682115|NCT00683592|565582525|FG001|Overall Study|Adverse Event|4|||
156682116|NCT00683592|565582524|FG000|Overall Study|Withdrawal by Subject|11|||
156682117|NCT00683592|565582525|FG001|Overall Study|Withdrawal by Subject|11|||
156784147|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784148|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
156784149|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
156784150|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
156784151|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
156784152|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
156784153|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
156784154|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
156868011|NCT03077412|566277275|FG000|Overall Study|Investigator's Discretion|0|||
156868012|NCT03077412|566277276|FG001|Overall Study|Investigator's Discretion|1|||
156868013|NCT03077412|566277277|FG002|Overall Study|Investigator's Discretion|1|||
156868014|NCT03077412|566277275|FG000|Overall Study|Withdrew Consent|0|||
156868015|NCT03077412|566277276|FG001|Overall Study|Withdrew Consent|2|||
157213317|NCT00550420|567529476|FG000|Overall Study|Lost to Follow-up|8|||
157213318|NCT00550420|567529476|FG000|Overall Study|Protocol Violation|11|||
157213319|NCT00550420|567529476|FG000|Overall Study|Withdrawal by Subject|30|||
157213320|NCT00550420|567529476|FG000|Overall Study|Still in study at termination|206|||
157213321|NCT00550420|567529476|FG000|Overall Study|Missing|2|||
157213322|NCT00550420|567529476|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
157213323|NCT00550420|567529476|FG000|Overall Study|Investigators opinion|1|||
157213324|NCT00550420|567529476|FG000|Overall Study|Lack of curative effect|1|||
157213325|NCT00550420|567529476|FG000|Overall Study|Unethical stop of enrollment|2|||
157213326|NCT00550420|567529476|FG000|Overall Study|Caregiver's decision to withdraw|1|||
157213327|NCT00550420|567529476|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
157213328|NCT00550420|567529476|FG000|Overall Study|Exclusion criteria|1|||
157213329|NCT00550420|567529476|FG000|Overall Study|Prohibited medicine|1|||
157213330|NCT00331773|567529477|FG000|Overall Study|Withdrawal by Subject|6|||
157213331|NCT00331773|567529478|FG001|Overall Study|Withdrawal by Subject|4|||
157213332|NCT00331773|567529477|FG000|Overall Study|Protocol Violation|10|||
157213333|NCT00331773|567529478|FG001|Overall Study|Protocol Violation|3|||
157213334|NCT01677910|567529479|FG000|Double-Blind Treatment Period|Adverse Event|6|||
157213335|NCT01677910|567529480|FG001|Double-Blind Treatment Period|Adverse Event|2|||
157213336|NCT01677910|567529481|FG002|Double-Blind Treatment Period|Adverse Event|3|||
157213337|NCT01677910|567529482|FG003|Double-Blind Treatment Period|Adverse Event|0|||
157213338|NCT01677910|567529479|FG000|Double-Blind Treatment Period|Physician Decision|0|||
157213339|NCT01677910|567529480|FG001|Double-Blind Treatment Period|Physician Decision|0|||
157213340|NCT01677910|567529481|FG002|Double-Blind Treatment Period|Physician Decision|1|||
157213341|NCT01677910|567529482|FG003|Double-Blind Treatment Period|Physician Decision|0|||
157213342|NCT01677910|567529479|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
156784155|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
156784156|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
156784157|NCT03422718|565961106|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
156868016|NCT03077412|566277277|FG002|Overall Study|Withdrew Consent|0|||
156868017|NCT05097963|566277278|FG000|Overall Study|Protocol Violation|13|||
156868018|NCT05097963|566277278|FG000|Overall Study|Withdrawal by Subject|21|||
156868019|NCT01417377|566277279|FG000|Overall Study|Lost to Follow-up|12|||
156868020|NCT01417377|566277279|FG000|Overall Study|Enrolled, but not treated|1|||
156868021|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
156868022|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
156868023|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
156868024|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
156868025|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
156868026|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
156868027|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
156868028|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
156868029|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
156868030|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
156868031|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
156868032|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
157120196|NCT02296242|567193037|FG000|Overall Study|Screened for Other Protocol|0|||
157120197|NCT02296242|567193038|FG001|Overall Study|Screened for Other Protocol|1|||
157120198|NCT02296242|567193039|FG002|Overall Study|Screened for Other Protocol|0|||
157120199|NCT02296242|567193040|FG003|Overall Study|Screened for Other Protocol|0|||
157120200|NCT02296242|567193041|FG004|Overall Study|Screened for Other Protocol|0|||
157120201|NCT02296242|567193037|FG000|Overall Study|Physician Decision|0|||
157120202|NCT02296242|567193038|FG001|Overall Study|Physician Decision|1|||
157120203|NCT02296242|567193039|FG002|Overall Study|Physician Decision|0|||
157120204|NCT02296242|567193040|FG003|Overall Study|Physician Decision|1|||
157120205|NCT02296242|567193041|FG004|Overall Study|Physician Decision|0|||
157213343|NCT01677910|567529480|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
157213344|NCT01677910|567529481|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
156868033|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
156868034|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
157120206|NCT02296242|567193037|FG000|Overall Study|Alternative Treatment|0|||
156682118|NCT00683592|565582524|FG000|Overall Study|Lost to Follow-up|17|||
156682119|NCT00683592|565582525|FG001|Overall Study|Lost to Follow-up|17|||
156682120|NCT00683592|565582524|FG000|Overall Study|Lack of Efficacy|3|||
156682121|NCT00683592|565582525|FG001|Overall Study|Lack of Efficacy|7|||
156868035|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
156868036|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
156868037|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
156868038|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
156868039|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
156868040|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
156868041|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
156868042|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
156868043|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
156868044|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
156868045|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
156868046|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
156868047|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
156868048|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
156868049|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868050|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868051|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868052|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868053|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868054|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868055|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
156868056|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868057|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868058|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868059|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156682122|NCT00683592|565582524|FG000|Overall Study|Physician Decision|0|||
156682123|NCT00683592|565582525|FG001|Overall Study|Physician Decision|1|||
156682124|NCT00683592|565582524|FG000|Overall Study|Non-compliance|3|||
156682125|NCT00683592|565582525|FG001|Overall Study|Non-compliance|5|||
156682126|NCT00683592|565582524|FG000|Overall Study|Other|1|||
156682127|NCT00683592|565582525|FG001|Overall Study|Other|1|||
156682128|NCT02419573|565582535|FG000|Overall Study|Lost to Follow-up|3|||
156682129|NCT02419573|565582536|FG001|Overall Study|Lost to Follow-up|0|||
156682130|NCT02419573|565582535|FG000|Overall Study|Withdrawal by Subject|1|||
156682131|NCT02419573|565582536|FG001|Overall Study|Withdrawal by Subject|0|||
156868060|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868061|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868062|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
156868063|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Transplant|0|||
156868064|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Transplant|1|||
156868065|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Transplant|0|||
156868066|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Transplant|0|||
156868067|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Transplant|0|||
156868068|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Transplant|1|||
156682132|NCT00493792|565582537|FG000|Overall Study|Death|55|||
156682133|NCT00493792|565582538|FG001|Overall Study|Death|50|||
156682134|NCT00493792|565582537|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
156682135|NCT00493792|565582538|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
156682136|NCT04501094|565582539|FG000|Overall Study|Death (unrelated to research)|1|||
156682137|NCT04501094|565582540|FG001|Overall Study|Death (unrelated to research)|0|||
156682138|NCT02426541|565582541|FG000|Overall Study|Protocol Violation|1|||
156682139|NCT02426541|565582542|FG001|Overall Study|Protocol Violation|0|||
156682140|NCT02674633|565582547|FG000|Overall Study|Lost to Follow-up|3|||
156682141|NCT02674633|565582548|FG001|Overall Study|Lost to Follow-up|2|||
156682142|NCT02674633|565582547|FG000|Overall Study|Physician Decision|1|||
156682143|NCT02674633|565582548|FG001|Overall Study|Physician Decision|0|||
156682144|NCT02674633|565582547|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156682145|NCT02674633|565582548|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156682146|NCT04167618|565582549|FG000|Overall Study|Trial terminated by sponsor|1|||
156868069|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Transplant|0|||
156868070|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Transplant|0|||
157012993|NCT02723955|566801773|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012994|NCT02723955|566801774|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012995|NCT02723955|566801775|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156682147|NCT04167618|565582550|FG001|Overall Study|Trial terminated by sponsor|1|||
156682148|NCT02994394|565582551|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682149|NCT02994394|565582552|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682150|NCT02994394|565582553|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
156682151|NCT02994394|565582554|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682152|NCT02994394|565582555|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682153|NCT02994394|565582556|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
156682154|NCT02994394|565582551|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682155|NCT02994394|565582552|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
156682156|NCT02994394|565582553|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682157|NCT02994394|565582554|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682158|NCT02994394|565582555|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
156682159|NCT02994394|565582556|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
156682160|NCT05693805|565582557|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
156682161|NCT05693805|565582558|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
156682162|NCT04982445|565582562|FG000|Overall Study|Protocol Violation|1|||
156682163|NCT04982445|565582562|FG000|Overall Study|Withdrawal by Subject|4|||
156682164|NCT04982445|565582562|FG000|Overall Study|Lost to Follow-up|1|||
156682165|NCT02152982|565582563|FG000|Overall Study|Withdrawal by Subject|17|||
156682166|NCT02152982|565582564|FG001|Overall Study|Withdrawal by Subject|16|||
156682167|NCT02152982|565582563|FG000|Overall Study|Did not start treatment|11|||
156682168|NCT02152982|565582564|FG001|Overall Study|Did not start treatment|5|||
156682169|NCT02152982|565582563|FG000|Overall Study|Disease progression|41|||
156682170|NCT02152982|565582564|FG001|Overall Study|Disease progression|52|||
156682171|NCT02152982|565582563|FG000|Overall Study|Adverse Event|7|||
156682172|NCT02152982|565582564|FG001|Overall Study|Adverse Event|12|||
156682173|NCT02152982|565582563|FG000|Overall Study|Complicating disease|1|||
156682174|NCT02152982|565582564|FG001|Overall Study|Complicating disease|1|||
156682175|NCT02152982|565582563|FG000|Overall Study|Death|0|||
156682176|NCT02152982|565582564|FG001|Overall Study|Death|3|||
156682177|NCT02152982|565582563|FG000|Overall Study|Physician Decision|3|||
156682178|NCT02152982|565582564|FG001|Overall Study|Physician Decision|0|||
156682179|NCT03230487|565582567|FG000|Overall Study|Adverse Event|0|||
156682180|NCT03230487|565582568|FG001|Overall Study|Adverse Event|0|||
156682181|NCT03230487|565582569|FG002|Overall Study|Adverse Event|0|||
156682182|NCT03230487|565582570|FG003|Overall Study|Adverse Event|1|||
156682183|NCT03230487|565582571|FG004|Overall Study|Adverse Event|0|||
156682184|NCT03230487|565582572|FG005|Overall Study|Adverse Event|0|||
156682185|NCT00835796|565582575|FG000|First Intervention|Withdrawal by Subject|0|||
156682186|NCT00835796|565582576|FG001|First Intervention|Withdrawal by Subject|1|||
156682187|NCT00348816|565582577|FG000|Overall Study|Noncompliance with radiation treatment|1|||
156682188|NCT06128525|565582578|FG000|Overall Study|Patient withdrew consent|1|||
156682189|NCT05070754|565582579|FG000|Overall Study|Withdrawal by Subject|0|||
156682190|NCT05070754|565582580|FG001|Overall Study|Withdrawal by Subject|0|||
156682191|NCT05070754|565582581|FG002|Overall Study|Withdrawal by Subject|0|||
156682192|NCT05070754|565582582|FG003|Overall Study|Withdrawal by Subject|1|||
156682193|NCT05070754|565582579|FG000|Overall Study|Protocol Violation|0|||
156682194|NCT05070754|565582580|FG001|Overall Study|Protocol Violation|0|||
156682195|NCT05070754|565582581|FG002|Overall Study|Protocol Violation|0|||
156682196|NCT05070754|565582582|FG003|Overall Study|Protocol Violation|1|||
156784158|NCT03422718|565961107|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
156784159|NCT03422718|565961108|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
156784160|NCT03422718|565961109|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
156784161|NCT03422718|565961110|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
156784162|NCT03422718|565961111|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
156784163|NCT03422718|565961112|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
156784164|NCT03422718|565961113|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
156784165|NCT03309605|565961114|FG000|Overall Study|Adverse Event|0|||
156784166|NCT03309605|565961115|FG001|Overall Study|Adverse Event|0|||
156784167|NCT03309605|565961116|FG002|Overall Study|Adverse Event|0|||
157012996|NCT02723955|566801776|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156682197|NCT01398787|565582583|FG000|Overall Study|Adverse Event|1|||
156682198|NCT03414034|565582584|FG000|Overall Study|Adverse Event|6|||
156682199|NCT03414034|565582585|FG001|Overall Study|Adverse Event|1|||
156682200|NCT03414034|565582586|FG002|Overall Study|Adverse Event|1|||
156682201|NCT03414034|565582584|FG000|Overall Study|Death|0|||
156682202|NCT03414034|565582585|FG001|Overall Study|Death|0|||
156784168|NCT03309605|565961117|FG003|Overall Study|Adverse Event|1|||
157012997|NCT02723955|566801777|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012998|NCT02723955|566801778|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
157012999|NCT02723955|566801779|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
156784169|NCT03309605|565961118|FG004|Overall Study|Adverse Event|0|||
156784170|NCT03309605|565961119|FG005|Overall Study|Adverse Event|0|||
156682203|NCT03414034|565582586|FG002|Overall Study|Death|1|||
156682204|NCT03414034|565582584|FG000|Overall Study|Non-compliance With Study Drug|0|||
156682205|NCT03414034|565582585|FG001|Overall Study|Non-compliance With Study Drug|0|||
156682206|NCT03414034|565582586|FG002|Overall Study|Non-compliance With Study Drug|1|||
156682207|NCT03414034|565582584|FG000|Overall Study|Physician Decision|1|||
156682208|NCT03414034|565582585|FG001|Overall Study|Physician Decision|3|||
156682209|NCT03414034|565582586|FG002|Overall Study|Physician Decision|2|||
156682210|NCT03414034|565582584|FG000|Overall Study|Withdrawal of Informed Consent|2|||
156682211|NCT03414034|565582585|FG001|Overall Study|Withdrawal of Informed Consent|1|||
156682212|NCT03414034|565582586|FG002|Overall Study|Withdrawal of Informed Consent|4|||
156682213|NCT03414034|565582584|FG000|Overall Study|Progressive Disease|15|||
156682214|NCT03414034|565582585|FG001|Overall Study|Progressive Disease|15|||
156682215|NCT03414034|565582586|FG002|Overall Study|Progressive Disease|17|||
156682216|NCT03414034|565582584|FG000|Overall Study|Miscellaneous|0|||
156682217|NCT03414034|565582585|FG001|Overall Study|Miscellaneous|0|||
156682218|NCT03414034|565582586|FG002|Overall Study|Miscellaneous|2|||
156682219|NCT04010227|565582587|FG000|Overall Study|Death|1|||
156682220|NCT04010227|565582588|FG001|Overall Study|Death|2|||
156682221|NCT04010227|565582587|FG000|Overall Study|Medical Reasons|4|||
156682222|NCT04010227|565582588|FG001|Overall Study|Medical Reasons|3|||
156682223|NCT04010227|565582587|FG000|Overall Study|Withdrawal by Subject|2|||
156682224|NCT04010227|565582588|FG001|Overall Study|Withdrawal by Subject|0|||
156682225|NCT04010227|565582587|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
156682226|NCT04010227|565582588|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
156682227|NCT00194792|565582589|FG000|Overall Study|Withdrawal by Subject|1|||
156682228|NCT02448563|565582590|FG000|Overall Study|Lost to Follow-up|16|||
156682229|NCT02448563|565582591|FG001|Overall Study|Lost to Follow-up|10|||
156682230|NCT02448563|565582590|FG000|Overall Study|Withdrawal by Subject|0|||
156682231|NCT02448563|565582591|FG001|Overall Study|Withdrawal by Subject|1|||
156682232|NCT00702507|565582592|FG000|Initial Treatment Phase|Adverse Event|2|||
156682233|NCT00702507|565582592|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
156682234|NCT00702507|565582592|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
156682235|NCT00702507|565582592|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
156682236|NCT00702507|565582592|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
156682237|NCT00702507|565582592|FG000|Follow-up Phase|Protocol Violation|2|||
156682238|NCT00702507|565582592|FG000|Follow-up Phase|Lost to Follow-up|23|||
156682239|NCT00702507|565582592|FG000|Follow-up Phase|Late Enrollment|1|||
156682240|NCT02308696|565582593|FG000|Overall Study|Lost to Follow-up|28|||
156682241|NCT02308696|565582594|FG001|Overall Study|Lost to Follow-up|21|||
156682242|NCT02308696|565582593|FG000|Overall Study|Death|8|||
156682243|NCT02308696|565582594|FG001|Overall Study|Death|4|||
156682244|NCT02308696|565582593|FG000|Overall Study|Moved to a Higher Level of Care|17|||
156682245|NCT02308696|565582594|FG001|Overall Study|Moved to a Higher Level of Care|6|||
156682246|NCT00113919|565582595|FG000|Overall Study|Physician Decision|8|||
156682247|NCT00113919|565582595|FG000|Overall Study|Death|6|||
156682248|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
156682249|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
156682250|NCT04194008|565582600|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
156682251|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
156682252|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Missing data|4|||
156682253|NCT04194008|565582600|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
156682254|NCT01785615|565582601|FG000|Dietary Phase|Lost to Follow-up|0|||
156682255|NCT01785615|565582602|FG001|Dietary Phase|Lost to Follow-up|0|||
156682256|NCT01785615|565582603|FG002|Dietary Phase|Lost to Follow-up|0|||
156682257|NCT01785615|565582604|FG003|Dietary Phase|Lost to Follow-up|24|||
156682258|NCT01881737|565582605|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
156682259|NCT01881737|565582605|FG000|Overall Study|Withdrawal by Subject|1|||
156682260|NCT01881737|565582605|FG000|Overall Study|Worsening of baseline behavior|1|||
156682261|NCT02522780|565582606|FG000|Overall Study|Consent withdrawn by subject|5|||
156682262|NCT02522780|565582607|FG001|Overall Study|Consent withdrawn by subject|7|||
156682263|NCT02522780|565582606|FG000|Overall Study|Protocol deviation|1|||
156682264|NCT02522780|565582607|FG001|Overall Study|Protocol deviation|3|||
156682265|NCT02522780|565582606|FG000|Overall Study|Subject refused endoscopic procedure|0|||
156682266|NCT02522780|565582607|FG001|Overall Study|Subject refused endoscopic procedure|1|||
156682267|NCT02522780|565582606|FG000|Overall Study|Adverse event, non-fatal|11|||
156682268|NCT02522780|565582607|FG001|Overall Study|Adverse event, non-fatal|16|||
156682269|NCT02260635|565582608|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
156682270|NCT02260635|565582609|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
156682271|NCT02260635|565582608|FG000|Open-Label Extension|Study Termination|25|||
156682272|NCT02260635|565582609|FG001|Open-Label Extension|Study Termination|25|||
156682273|NCT02260635|565582608|FG000|Open-Label Extension|Withdrawal by Subject|1|||
156682274|NCT02260635|565582609|FG001|Open-Label Extension|Withdrawal by Subject|0|||
156682275|NCT04106817|565582610|FG000|Overall Study|Lost to Follow-up|1|||
156682276|NCT04106817|565582611|FG001|Overall Study|Lost to Follow-up|0|||
156682277|NCT04106817|565582612|FG002|Overall Study|Lost to Follow-up|0|||
156682278|NCT00926367|565582616|FG000|Overall Study|Withdrawal by Subject|0|||
156682279|NCT00926367|565582617|FG001|Overall Study|Withdrawal by Subject|1|||
156682280|NCT00926367|565582616|FG000|Overall Study|Lost to Follow-up|1|||
156682281|NCT00926367|565582617|FG001|Overall Study|Lost to Follow-up|0|||
156682282|NCT00926367|565582616|FG000|Overall Study|Skin Irritation|1|||
156682283|NCT00926367|565582617|FG001|Overall Study|Skin Irritation|2|||
157013000|NCT02723955|566801737|FG000|Escalation Phase|Site Closed|0|||
157013001|NCT02723955|566801738|FG001|Escalation Phase|Site Closed|0|||
157120207|NCT02296242|567193038|FG001|Overall Study|Alternative Treatment|0|||
157120208|NCT02296242|567193039|FG002|Overall Study|Alternative Treatment|0|||
157120209|NCT02296242|567193040|FG003|Overall Study|Alternative Treatment|1|||
157120210|NCT02296242|567193041|FG004|Overall Study|Alternative Treatment|0|||
157120211|NCT02296242|567193037|FG000|Overall Study|Adverse Event|0|||
157120212|NCT02296242|567193038|FG001|Overall Study|Adverse Event|0|||
157120213|NCT02296242|567193039|FG002|Overall Study|Adverse Event|0|||
157120214|NCT02296242|567193040|FG003|Overall Study|Adverse Event|1|||
157120215|NCT02296242|567193041|FG004|Overall Study|Adverse Event|0|||
157120216|NCT02296242|567193037|FG000|Overall Study|Lack of Efficacy|0|||
157013002|NCT02723955|566801739|FG002|Escalation Phase|Site Closed|0|||
157120217|NCT02296242|567193038|FG001|Overall Study|Lack of Efficacy|0|||
157120218|NCT02296242|567193039|FG002|Overall Study|Lack of Efficacy|0|||
157120219|NCT02296242|567193040|FG003|Overall Study|Lack of Efficacy|0|||
156784171|NCT03309605|565961120|FG006|Overall Study|Adverse Event|2|||
156784172|NCT03309605|565961121|FG007|Overall Study|Adverse Event|1|||
156784173|NCT03309605|565961114|FG000|Overall Study|Withdrawal by Subject|0|||
156784174|NCT03309605|565961115|FG001|Overall Study|Withdrawal by Subject|0|||
156784175|NCT03309605|565961116|FG002|Overall Study|Withdrawal by Subject|0|||
156784176|NCT03309605|565961117|FG003|Overall Study|Withdrawal by Subject|0|||
156784177|NCT03309605|565961118|FG004|Overall Study|Withdrawal by Subject|1|||
156784178|NCT03309605|565961119|FG005|Overall Study|Withdrawal by Subject|0|||
156784179|NCT03309605|565961120|FG006|Overall Study|Withdrawal by Subject|1|||
156784180|NCT03309605|565961121|FG007|Overall Study|Withdrawal by Subject|1|||
156784181|NCT05788328|565961122|FG000|Treatment Period 4 (5 Days)|Other|1|||
157013003|NCT02723955|566801740|FG003|Escalation Phase|Site Closed|0|||
157013004|NCT02723955|566801741|FG004|Escalation Phase|Site Closed|0|||
157013005|NCT02723955|566801742|FG005|Escalation Phase|Site Closed|0|||
157013006|NCT02723955|566801743|FG006|Escalation Phase|Site Closed|0|||
157013007|NCT02723955|566801744|FG007|Escalation Phase|Site Closed|0|||
157013008|NCT02723955|566801745|FG008|Escalation Phase|Site Closed|0|||
157013009|NCT02723955|566801746|FG009|Escalation Phase|Site Closed|0|||
157013010|NCT02723955|566801747|FG010|Escalation Phase|Site Closed|0|||
157013011|NCT02723955|566801748|FG011|Escalation Phase|Site Closed|0|||
157013012|NCT02723955|566801749|FG012|Escalation Phase|Site Closed|0|||
157013013|NCT02723955|566801750|FG013|Escalation Phase|Site Closed|0|||
157013014|NCT02723955|566801751|FG014|Escalation Phase|Site Closed|0|||
157013015|NCT02723955|566801752|FG015|Escalation Phase|Site Closed|1|||
157013016|NCT02723955|566801753|FG016|Escalation Phase|Site Closed|0|||
157013017|NCT02723955|566801754|FG017|Escalation Phase|Site Closed|2|||
157013018|NCT02723955|566801755|FG018|Escalation Phase|Site Closed|0|||
157013019|NCT02723955|566801756|FG019|Escalation Phase|Site Closed|0|||
157013020|NCT02723955|566801757|FG020|Escalation Phase|Site Closed|1|||
157013021|NCT02723955|566801758|FG021|Escalation Phase|Site Closed|0|||
157013022|NCT02723955|566801759|FG022|Escalation Phase|Site Closed|0|||
157013023|NCT02723955|566801760|FG023|Escalation Phase|Site Closed|0|||
157013024|NCT02723955|566801761|FG024|Escalation Phase|Site Closed|3|||
157013025|NCT02723955|566801762|FG025|Escalation Phase|Site Closed|1|||
157013026|NCT02723955|566801763|FG026|Escalation Phase|Site Closed|3|||
157013027|NCT02723955|566801764|FG027|Escalation Phase|Site Closed|1|||
157013028|NCT02723955|566801765|FG028|Escalation Phase|Site Closed|1|||
157013029|NCT02723955|566801766|FG029|Escalation Phase|Site Closed|0|||
157013030|NCT02723955|566801767|FG030|Escalation Phase|Site Closed|0|||
157013031|NCT02723955|566801768|FG031|Escalation Phase|Site Closed|0|||
157013032|NCT02723955|566801769|FG032|Escalation Phase|Site Closed|0|||
157013033|NCT02723955|566801770|FG033|Escalation Phase|Site Closed|0|||
157013034|NCT02723955|566801771|FG034|Escalation Phase|Site Closed|0|||
157013035|NCT02723955|566801772|FG035|Escalation Phase|Site Closed|0|||
157013036|NCT02723955|566801773|FG036|Escalation Phase|Site Closed|0|||
157013037|NCT02723955|566801774|FG037|Escalation Phase|Site Closed|0|||
157013038|NCT02723955|566801775|FG038|Escalation Phase|Site Closed|0|||
157013039|NCT02723955|566801776|FG039|Escalation Phase|Site Closed|0|||
157013040|NCT02723955|566801777|FG040|Escalation Phase|Site Closed|0|||
157120220|NCT02296242|567193041|FG004|Overall Study|Lack of Efficacy|3|||
157120221|NCT01639833|567193042|FG000|Overall Study|Death|4|||
156784182|NCT05788328|565961122|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
157013041|NCT02723955|566801778|FG041|Escalation Phase|Site Closed|0|||
157013042|NCT02723955|566801779|FG042|Escalation Phase|Site Closed|0|||
157013043|NCT02723955|566801737|FG000|Expansion Phase|Death|0|||
157013044|NCT02723955|566801738|FG001|Expansion Phase|Death|0|||
157013045|NCT02723955|566801739|FG002|Expansion Phase|Death|0|||
157013046|NCT02723955|566801740|FG003|Expansion Phase|Death|0|||
157013047|NCT02723955|566801741|FG004|Expansion Phase|Death|0|||
157120222|NCT01639833|567193043|FG001|Overall Study|Death|2|||
157013048|NCT02723955|566801742|FG005|Expansion Phase|Death|0|||
157013049|NCT02723955|566801743|FG006|Expansion Phase|Death|0|||
157013050|NCT02723955|566801744|FG007|Expansion Phase|Death|0|||
157013051|NCT02723955|566801745|FG008|Expansion Phase|Death|0|||
157013052|NCT02723955|566801746|FG009|Expansion Phase|Death|25|||
156682284|NCT01517867|565582618|FG000|Overall Study|never started treatment|29|||
156682285|NCT01517867|565582619|FG001|Overall Study|never started treatment|32|||
156682286|NCT01517867|565582618|FG000|Overall Study|Withdrawal by Subject|34|||
156682287|NCT01517867|565582619|FG001|Overall Study|Withdrawal by Subject|30|||
156682288|NCT01517867|565582618|FG000|Overall Study|Still in treatment at study end|0|||
156682289|NCT01517867|565582619|FG001|Overall Study|Still in treatment at study end|3|||
156784183|NCT02181621|565961123|FG000|Overall Study|Adverse Event|1|||
156784184|NCT02181621|565961124|FG001|Overall Study|Adverse Event|0|||
156784185|NCT02181621|565961123|FG000|Overall Study|Previously Enrolled|0|||
156784186|NCT02181621|565961124|FG001|Overall Study|Previously Enrolled|1|||
156784187|NCT02181621|565961123|FG000|Overall Study|Enrollment Hold|1|||
156784188|NCT02181621|565961124|FG001|Overall Study|Enrollment Hold|1|||
156784189|NCT00145327|565961125|FG000|Overall Study|Withdrawal by Subject|77|||
156784190|NCT00145327|565961126|FG001|Overall Study|Withdrawal by Subject|72|||
156784191|NCT00145327|565961127|FG002|Overall Study|Withdrawal by Subject|164|||
156784192|NCT00145327|565961125|FG000|Overall Study|Death|26|||
156784193|NCT00145327|565961126|FG001|Overall Study|Death|18|||
156784194|NCT00145327|565961127|FG002|Overall Study|Death|30|||
156784195|NCT00145327|565961125|FG000|Overall Study|Adverse Event|14|||
156784196|NCT00145327|565961126|FG001|Overall Study|Adverse Event|11|||
156784197|NCT00145327|565961127|FG002|Overall Study|Adverse Event|22|||
156784198|NCT00145327|565961125|FG000|Overall Study|Lost to Follow-up|9|||
156784199|NCT00145327|565961126|FG001|Overall Study|Lost to Follow-up|14|||
156784200|NCT00145327|565961127|FG002|Overall Study|Lost to Follow-up|14|||
156784201|NCT00145327|565961125|FG000|Overall Study|Administrative problems|12|||
156784202|NCT00145327|565961126|FG001|Overall Study|Administrative problems|9|||
156784203|NCT00145327|565961127|FG002|Overall Study|Administrative problems|13|||
156784204|NCT00145327|565961125|FG000|Overall Study|Protocol Violation|2|||
156784205|NCT00145327|565961126|FG001|Overall Study|Protocol Violation|0|||
156784206|NCT00145327|565961127|FG002|Overall Study|Protocol Violation|2|||
156784207|NCT00145327|565961125|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156784208|NCT00145327|565961126|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156784209|NCT00145327|565961127|FG002|Overall Study|Abnormal laboratory value(s)|2|||
156784210|NCT00145327|565961125|FG000|Overall Study|Missing - not stated|1|||
156784211|NCT00145327|565961126|FG001|Overall Study|Missing - not stated|0|||
156784212|NCT00145327|565961127|FG002|Overall Study|Missing - not stated|1|||
156784213|NCT00864513|565961129|FG000|Overall Study|Withdrawal by Subject|3|||
156784214|NCT00762788|565961130|FG000|Overall Study|Lost to Follow-up|26|||
156784215|NCT00762788|565961131|FG001|Overall Study|Lost to Follow-up|37|||
156784216|NCT00762788|565961132|FG002|Overall Study|Lost to Follow-up|21|||
156784217|NCT00762788|565961133|FG003|Overall Study|Lost to Follow-up|26|||
156784218|NCT00762788|565961134|FG004|Overall Study|Lost to Follow-up|13|||
156784219|NCT00762788|565961135|FG005|Overall Study|Lost to Follow-up|21|||
156784220|NCT03073109|565961137|FG000|Overall Study|Adverse Event|0|||
156784221|NCT03073109|565961138|FG001|Overall Study|Adverse Event|1|||
156784222|NCT03073109|565961137|FG000|Overall Study|Other|2|||
156784223|NCT03073109|565961138|FG001|Overall Study|Other|0|||
156784224|NCT03073109|565961137|FG000|Overall Study|Lost to Follow-up|8|||
156784225|NCT03073109|565961138|FG001|Overall Study|Lost to Follow-up|1|||
156784226|NCT05938010|565961139|FG000|Overall Study|Lost to Follow-up|2|||
156784227|NCT00985192|565961140|FG000|Overall Study|Withdrawal by Subject|1|||
156784228|NCT00985192|565961140|FG000|Overall Study|Disease Progression|1|||
156784229|NCT00985192|565961140|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
156784230|NCT01875237|565961141|FG000|Overall Study|GVDH before DLI|1|||
156784231|NCT01875237|565961142|FG001|Overall Study|GVDH before DLI|0|||
156784232|NCT01875237|565961141|FG000|Overall Study|DLI cells could not be produced|1|||
156784233|NCT01875237|565961142|FG001|Overall Study|DLI cells could not be produced|0|||
156784234|NCT00983957|565961145|FG000|Overall Study|Adverse Event|1|||
156784235|NCT00983957|565961145|FG000|Overall Study|Personal Reasons|1|||
156784236|NCT03055195|565961146|FG000|Overall Study|Lack of Efficacy|1|||
156784237|NCT03055195|565961147|FG001|Overall Study|Lack of Efficacy|0|||
156784238|NCT03055195|565961146|FG000|Overall Study|Withdrawal by Subject|6|||
157013053|NCT02723955|566801747|FG010|Expansion Phase|Death|69|||
156682290|NCT03847974|565582620|FG000|Overall Study|relocated out of region|3|||
156682291|NCT03847974|565582620|FG000|Overall Study|Withdrawal by Subject|2|||
156682292|NCT03847974|565582620|FG000|Overall Study|Adverse Event|1|||
156682293|NCT01685216|565582623|FG000|Overall Study|Did not receive study drug|1|||
156682294|NCT01294449|565582624|FG000|Overall Study|Death|11|||
156784239|NCT03055195|565961147|FG001|Overall Study|Withdrawal by Subject|7|||
156784240|NCT03055195|565961146|FG000|Overall Study|Study Terminated by Sponsor|2|||
156784241|NCT03055195|565961147|FG001|Overall Study|Study Terminated by Sponsor|6|||
156784242|NCT03055195|565961146|FG000|Overall Study|Protocol Violation|2|||
156784243|NCT03055195|565961147|FG001|Overall Study|Protocol Violation|1|||
156784244|NCT03055195|565961146|FG000|Overall Study|Physician Decision|1|||
156784245|NCT03055195|565961147|FG001|Overall Study|Physician Decision|0|||
156784246|NCT00986232|565961148|FG000|Overall Study|Adverse Event|1|||
156784247|NCT00986232|565961149|FG001|Overall Study|Adverse Event|2|||
157013054|NCT02723955|566801748|FG011|Expansion Phase|Death|48|||
156784248|NCT00986232|565961150|FG002|Overall Study|Adverse Event|3|||
156784249|NCT00986232|565961151|FG003|Overall Study|Adverse Event|0|||
156784250|NCT00986232|565961148|FG000|Overall Study|Lost to Follow-up|19|||
156784251|NCT00986232|565961149|FG001|Overall Study|Lost to Follow-up|12|||
156784252|NCT00986232|565961150|FG002|Overall Study|Lost to Follow-up|12|||
156784253|NCT00986232|565961151|FG003|Overall Study|Lost to Follow-up|7|||
156784254|NCT00986232|565961148|FG000|Overall Study|Protocol Violation|2|||
156784255|NCT00986232|565961149|FG001|Overall Study|Protocol Violation|3|||
156784256|NCT00986232|565961150|FG002|Overall Study|Protocol Violation|0|||
156784257|NCT00986232|565961151|FG003|Overall Study|Protocol Violation|1|||
156784258|NCT00986232|565961148|FG000|Overall Study|Withdrawal by Subject|13|||
156784259|NCT00986232|565961149|FG001|Overall Study|Withdrawal by Subject|16|||
156784260|NCT00986232|565961150|FG002|Overall Study|Withdrawal by Subject|12|||
156784261|NCT00986232|565961151|FG003|Overall Study|Withdrawal by Subject|3|||
156784262|NCT00986232|565961148|FG000|Overall Study|Missed one or more bleeds|13|||
156784263|NCT00986232|565961149|FG001|Overall Study|Missed one or more bleeds|10|||
156784264|NCT00986232|565961150|FG002|Overall Study|Missed one or more bleeds|6|||
156784265|NCT00986232|565961151|FG003|Overall Study|Missed one or more bleeds|7|||
156784266|NCT00986232|565961148|FG000|Overall Study|Incomplete safety follow-up|3|||
156784267|NCT00986232|565961149|FG001|Overall Study|Incomplete safety follow-up|7|||
156784268|NCT00986232|565961150|FG002|Overall Study|Incomplete safety follow-up|2|||
156784269|NCT00986232|565961151|FG003|Overall Study|Incomplete safety follow-up|2|||
156784270|NCT02568423|565961152|FG000|Overall Study|Lost to Follow-up|0|||
156784271|NCT02568423|565961153|FG001|Overall Study|Lost to Follow-up|2|||
156784272|NCT02568423|565961154|FG002|Overall Study|Lost to Follow-up|0|||
156784273|NCT02568423|565961155|FG003|Overall Study|Lost to Follow-up|0|||
156784274|NCT02568423|565961156|FG004|Overall Study|Lost to Follow-up|0|||
156784275|NCT02568423|565961157|FG005|Overall Study|Lost to Follow-up|0|||
156784276|NCT02568423|565961158|FG006|Overall Study|Lost to Follow-up|0|||
156784277|NCT02568423|565961159|FG007|Overall Study|Lost to Follow-up|0|||
156784278|NCT02568423|565961152|FG000|Overall Study|Physician Decision|0|||
156784279|NCT02568423|565961153|FG001|Overall Study|Physician Decision|0|||
156784280|NCT02568423|565961154|FG002|Overall Study|Physician Decision|0|||
156784281|NCT02568423|565961155|FG003|Overall Study|Physician Decision|0|||
156784282|NCT02568423|565961156|FG004|Overall Study|Physician Decision|0|||
156784283|NCT02568423|565961157|FG005|Overall Study|Physician Decision|1|||
156784284|NCT02568423|565961158|FG006|Overall Study|Physician Decision|0|||
156784285|NCT02568423|565961159|FG007|Overall Study|Physician Decision|0|||
156784286|NCT00790933|565961160|FG000|Overall Study|Adverse Event|94|||
156784287|NCT00790933|565961161|FG001|Overall Study|Adverse Event|119|||
156784288|NCT00790933|565961162|FG002|Overall Study|Adverse Event|65|||
156784289|NCT00790933|565961163|FG003|Overall Study|Adverse Event|5|||
156784290|NCT00790933|565961164|FG004|Overall Study|Adverse Event|69|||
156784291|NCT00790933|565961160|FG000|Overall Study|Protocol Violation(s)|8|||
156784292|NCT00790933|565961161|FG001|Overall Study|Protocol Violation(s)|18|||
156784293|NCT00790933|565961162|FG002|Overall Study|Protocol Violation(s)|7|||
156784294|NCT00790933|565961163|FG003|Overall Study|Protocol Violation(s)|0|||
156784295|NCT00790933|565961164|FG004|Overall Study|Protocol Violation(s)|12|||
156784296|NCT00790933|565961160|FG000|Overall Study|Lack of Efficacy|192|||
156784297|NCT00790933|565961161|FG001|Overall Study|Lack of Efficacy|176|||
156784298|NCT00790933|565961162|FG002|Overall Study|Lack of Efficacy|130|||
156784299|NCT00790933|565961163|FG003|Overall Study|Lack of Efficacy|1|||
156784300|NCT00790933|565961164|FG004|Overall Study|Lack of Efficacy|121|||
156784301|NCT00790933|565961160|FG000|Overall Study|Study Terminated by Sponsor|0|||
156784302|NCT00790933|565961161|FG001|Overall Study|Study Terminated by Sponsor|0|||
156784303|NCT00790933|565961162|FG002|Overall Study|Study Terminated by Sponsor|1|||
156784304|NCT00790933|565961163|FG003|Overall Study|Study Terminated by Sponsor|0|||
156784305|NCT00790933|565961164|FG004|Overall Study|Study Terminated by Sponsor|0|||
157213345|NCT01677910|567529482|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
157213346|NCT01677910|567529479|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
157213347|NCT01677910|567529480|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
157213348|NCT01677910|567529481|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
157213349|NCT01677910|567529482|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
157213350|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
157213351|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
157213352|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
157213353|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
157213354|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
156784306|NCT00790933|565961160|FG000|Overall Study|Withdrawal by Subject|123|||
156784307|NCT00790933|565961161|FG001|Overall Study|Withdrawal by Subject|120|||
156784308|NCT00790933|565961162|FG002|Overall Study|Withdrawal by Subject|52|||
156784309|NCT00790933|565961163|FG003|Overall Study|Withdrawal by Subject|6|||
156784310|NCT00790933|565961164|FG004|Overall Study|Withdrawal by Subject|50|||
156784311|NCT00790933|565961160|FG000|Overall Study|Lost to Follow-up|13|||
156784312|NCT00790933|565961161|FG001|Overall Study|Lost to Follow-up|31|||
156784313|NCT00790933|565961162|FG002|Overall Study|Lost to Follow-up|10|||
156682295|NCT01294449|565582625|FG001|Overall Study|Death|12|||
156682296|NCT01294449|565582624|FG000|Overall Study|Withdrawal by Subject|1|||
156682297|NCT01294449|565582625|FG001|Overall Study|Withdrawal by Subject|3|||
156682298|NCT02654015|565582626|FG000|Overall Study|Death|12|||
156682299|NCT02654015|565582626|FG000|Overall Study|Lost to Follow-up|3|||
156682300|NCT01896505|565582629|FG000|Overall Study|Adverse Event|1|||
156682301|NCT01896505|565582630|FG001|Overall Study|Adverse Event|0|||
156682302|NCT01896505|565582631|FG002|Overall Study|Adverse Event|2|||
156682303|NCT01896505|565582632|FG003|Overall Study|Adverse Event|1|||
156682304|NCT01896505|565582633|FG004|Overall Study|Adverse Event|1|||
156682305|NCT01896505|565582634|FG005|Overall Study|Adverse Event|0|||
156682306|NCT01896505|565582629|FG000|Overall Study|Physician Decision|1|||
156682307|NCT01896505|565582630|FG001|Overall Study|Physician Decision|3|||
156682308|NCT01896505|565582631|FG002|Overall Study|Physician Decision|2|||
156682309|NCT01896505|565582632|FG003|Overall Study|Physician Decision|0|||
156682310|NCT01896505|565582633|FG004|Overall Study|Physician Decision|0|||
156682311|NCT01896505|565582634|FG005|Overall Study|Physician Decision|1|||
156682312|NCT01896505|565582629|FG000|Overall Study|Withdrawal by Subject|1|||
156682313|NCT01896505|565582630|FG001|Overall Study|Withdrawal by Subject|0|||
156682314|NCT01896505|565582631|FG002|Overall Study|Withdrawal by Subject|3|||
156682315|NCT01896505|565582632|FG003|Overall Study|Withdrawal by Subject|1|||
156682316|NCT01896505|565582633|FG004|Overall Study|Withdrawal by Subject|0|||
156682317|NCT01896505|565582634|FG005|Overall Study|Withdrawal by Subject|0|||
156682318|NCT01896505|565582629|FG000|Overall Study|Disease Progression|7|||
156682319|NCT01896505|565582630|FG001|Overall Study|Disease Progression|5|||
156682320|NCT01896505|565582631|FG002|Overall Study|Disease Progression|8|||
156682321|NCT01896505|565582632|FG003|Overall Study|Disease Progression|4|||
156682322|NCT01896505|565582633|FG004|Overall Study|Disease Progression|4|||
156682323|NCT01896505|565582634|FG005|Overall Study|Disease Progression|4|||
156682324|NCT01896505|565582629|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
156682325|NCT01896505|565582630|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
156682326|NCT01896505|565582631|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
156682327|NCT01896505|565582632|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
156682328|NCT01896505|565582633|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
156682329|NCT01896505|565582634|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
156682330|NCT01896505|565582629|FG000|Overall Study|Intercurrent illness|0|||
156682331|NCT01896505|565582630|FG001|Overall Study|Intercurrent illness|1|||
156682332|NCT01896505|565582631|FG002|Overall Study|Intercurrent illness|0|||
156682333|NCT01896505|565582632|FG003|Overall Study|Intercurrent illness|0|||
156682334|NCT01896505|565582633|FG004|Overall Study|Intercurrent illness|0|||
156682335|NCT01896505|565582634|FG005|Overall Study|Intercurrent illness|0|||
156682336|NCT01896505|565582629|FG000|Overall Study|Death|0|||
156682337|NCT01896505|565582630|FG001|Overall Study|Death|0|||
156682338|NCT01896505|565582631|FG002|Overall Study|Death|1|||
156682339|NCT01896505|565582632|FG003|Overall Study|Death|1|||
156682340|NCT01896505|565582633|FG004|Overall Study|Death|0|||
156682341|NCT01896505|565582634|FG005|Overall Study|Death|1|||
156682342|NCT02466386|565582637|FG000|Overall Study|Adverse Event|5|||
156682343|NCT02466386|565582637|FG000|Overall Study|Protocol Violation|2|||
156682344|NCT02466386|565582637|FG000|Overall Study|Withdrawal by Subject|14|||
156682345|NCT02466386|565582637|FG000|Overall Study|Lost to Follow-up|5|||
156682346|NCT02466386|565582637|FG000|Overall Study|Lack of Efficacy|8|||
156682347|NCT02466386|565582637|FG000|Overall Study|Other|10|||
156682348|NCT05317195|565582638|FG000|Randomization|Withdrawal by Subject|1|||
156784314|NCT00790933|565961163|FG003|Overall Study|Lost to Follow-up|1|||
156784315|NCT00790933|565961164|FG004|Overall Study|Lost to Follow-up|15|||
157120223|NCT01639833|567193042|FG000|Overall Study|Withdrawal by Subject|2|||
157120224|NCT01639833|567193043|FG001|Overall Study|Withdrawal by Subject|2|||
157120225|NCT03504397|567193045|FG000|Overall Study|Progressive Disease|151|||
157120226|NCT03504397|567193046|FG001|Overall Study|Progressive Disease|199|||
156784316|NCT00790933|565961160|FG000|Overall Study|Reason Not Specified|8|||
156784317|NCT00790933|565961161|FG001|Overall Study|Reason Not Specified|16|||
157120227|NCT03504397|567193045|FG000|Overall Study|Withdrawal by Subject|29|||
157120228|NCT03504397|567193046|FG001|Overall Study|Withdrawal by Subject|17|||
156682349|NCT05317195|565582638|FG000|Randomization|Discontinued|6|||
156682350|NCT05317195|565582638|FG000|Admission|Withdrawal by Subject|2|||
156682351|NCT00593827|565582639|FG000|Overall Study|On Active Treatment/Pending|0|||
156682352|NCT00593827|565582640|FG001|Overall Study|On Active Treatment/Pending|2|||
156682353|NCT01183884|565582641|FG000|Overall Study|Progressive Disease|26|||
156682354|NCT01183884|565582641|FG000|Overall Study|Adverse Event|3|||
156784318|NCT00790933|565961162|FG002|Overall Study|Reason Not Specified|4|||
157120229|NCT03504397|567193045|FG000|Overall Study|Lost to Follow-up|1|||
156682355|NCT01183884|565582641|FG000|Overall Study|Withdrawal by Subject|1|||
156682356|NCT01183884|565582641|FG000|Overall Study|Other Complicating Disease|3|||
156682357|NCT01183884|565582641|FG000|Overall Study|Not Treated|1|||
156682358|NCT01183884|565582641|FG000|Overall Study|Other|4|||
156682359|NCT02212457|565582642|FG000|Overall Study|Adverse Event|1|||
156682360|NCT02212457|565582643|FG001|Overall Study|Adverse Event|2|||
156682361|NCT02212457|565582644|FG002|Overall Study|Adverse Event|2|||
156682362|NCT02212457|565582645|FG003|Overall Study|Adverse Event|2|||
156682363|NCT02212457|565582646|FG004|Overall Study|Adverse Event|0|||
156682364|NCT02212457|565582647|FG005|Overall Study|Adverse Event|1|||
156682365|NCT02212457|565582642|FG000|Overall Study|Withdrawal by Subject|8|||
156682366|NCT02212457|565582643|FG001|Overall Study|Withdrawal by Subject|10|||
156682367|NCT02212457|565582644|FG002|Overall Study|Withdrawal by Subject|8|||
156682368|NCT02212457|565582645|FG003|Overall Study|Withdrawal by Subject|6|||
156682369|NCT02212457|565582646|FG004|Overall Study|Withdrawal by Subject|5|||
156682370|NCT02212457|565582647|FG005|Overall Study|Withdrawal by Subject|4|||
156682371|NCT02212457|565582642|FG000|Overall Study|Lost to Follow-up|6|||
156682372|NCT02212457|565582643|FG001|Overall Study|Lost to Follow-up|7|||
156682373|NCT02212457|565582644|FG002|Overall Study|Lost to Follow-up|4|||
156682374|NCT02212457|565582645|FG003|Overall Study|Lost to Follow-up|1|||
156682375|NCT02212457|565582646|FG004|Overall Study|Lost to Follow-up|8|||
156682376|NCT02212457|565582647|FG005|Overall Study|Lost to Follow-up|4|||
156682377|NCT02212457|565582642|FG000|Overall Study|Protocol Violation|2|||
156682378|NCT02212457|565582643|FG001|Overall Study|Protocol Violation|1|||
156682379|NCT02212457|565582644|FG002|Overall Study|Protocol Violation|0|||
156682380|NCT02212457|565582645|FG003|Overall Study|Protocol Violation|1|||
156682381|NCT02212457|565582646|FG004|Overall Study|Protocol Violation|2|||
156682382|NCT02212457|565582647|FG005|Overall Study|Protocol Violation|3|||
156682383|NCT02212457|565582642|FG000|Overall Study|Other|2|||
156682384|NCT02212457|565582643|FG001|Overall Study|Other|1|||
156682385|NCT02212457|565582644|FG002|Overall Study|Other|2|||
156682386|NCT02212457|565582645|FG003|Overall Study|Other|1|||
156682387|NCT02212457|565582646|FG004|Overall Study|Other|0|||
156682388|NCT02212457|565582647|FG005|Overall Study|Other|1|||
156682389|NCT04553406|565582648|FG000|Overall Study|Study Discontinuation|0|||
156682390|NCT04553406|565582649|FG001|Overall Study|Study Discontinuation|1|||
156682391|NCT01214239|565582650|FG000|Overall Study|Adverse Event|3|||
156682392|NCT01214239|565582651|FG001|Overall Study|Adverse Event|4|||
156682393|NCT01214239|565582650|FG000|Overall Study|Protocol Violation|2|||
156682394|NCT01214239|565582651|FG001|Overall Study|Protocol Violation|1|||
156682395|NCT01214239|565582650|FG000|Overall Study|Lost to Follow-up|1|||
156682396|NCT01214239|565582651|FG001|Overall Study|Lost to Follow-up|1|||
156682397|NCT01214239|565582650|FG000|Overall Study|Withdrawal by Subject|4|||
156682398|NCT01214239|565582651|FG001|Overall Study|Withdrawal by Subject|9|||
156682399|NCT01214239|565582650|FG000|Overall Study|Lack of Efficacy|1|||
156682400|NCT01214239|565582651|FG001|Overall Study|Lack of Efficacy|2|||
156682401|NCT01214239|565582650|FG000|Overall Study|patient's private reason|1|||
156682402|NCT01214239|565582651|FG001|Overall Study|patient's private reason|1|||
156682403|NCT01841060|565584767|FG000|Overall Study|Protocol Violation|10|||
156682404|NCT01848210|565584768|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
156682405|NCT01848210|565584769|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
156682406|NCT01848210|565584768|FG000|Overall Study|Lost to Follow-up|24|||
156682407|NCT01848210|565584769|FG001|Overall Study|Lost to Follow-up|12|||
156682408|NCT01848210|565584768|FG000|Overall Study|Protocol Violation|3|||
156682409|NCT01848210|565584769|FG001|Overall Study|Protocol Violation|5|||
156682410|NCT01848210|565584768|FG000|Overall Study|Use of Forbidden Drugs|9|||
156682411|NCT01848210|565584769|FG001|Overall Study|Use of Forbidden Drugs|10|||
156682412|NCT01848210|565584768|FG000|Overall Study|Impedition Condition|5|||
156682413|NCT01848210|565584769|FG001|Overall Study|Impedition Condition|9|||
156682414|NCT01848210|565584768|FG000|Overall Study|Adverse Event|7|||
156682415|NCT01848210|565584769|FG001|Overall Study|Adverse Event|9|||
156682416|NCT01848210|565584768|FG000|Overall Study|Discontinuation Criterion|5|||
156682417|NCT01848210|565584769|FG001|Overall Study|Discontinuation Criterion|7|||
156682418|NCT01848210|565584768|FG000|Overall Study|Hypesensitivity|1|||
156682419|NCT01848210|565584769|FG001|Overall Study|Hypesensitivity|0|||
156682420|NCT01848210|565584768|FG000|Overall Study|Hepatic Function Alteration|4|||
156682421|NCT01848210|565584769|FG001|Overall Study|Hepatic Function Alteration|0|||
156682422|NCT01848210|565584768|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
156682423|NCT01848210|565584769|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
156682424|NCT01848210|565584768|FG000|Overall Study|Administrative|1|||
156682425|NCT01848210|565584769|FG001|Overall Study|Administrative|0|||
156682426|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
156682427|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
156682428|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
156682429|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
156682430|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
156682431|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
156682432|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
156682433|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
156682434|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
156682435|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
156682436|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
156682437|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
156682438|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
156682439|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
156682440|NCT04592419|565584770|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
156682441|NCT04592419|565584771|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
156682442|NCT04592419|565584770|FG000|Open-Label Extension Period|Adverse Event|1|||
156682443|NCT04592419|565584771|FG001|Open-Label Extension Period|Adverse Event|2|||
156682444|NCT04592419|565584770|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
156682445|NCT04592419|565584771|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
156682446|NCT04592419|565584770|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
156682447|NCT04592419|565584771|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
156682448|NCT04592419|565584770|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
156682449|NCT04592419|565584771|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
156682450|NCT04592419|565584770|FG000|Open-Label Extension Period|Sponsor Request|73|||
156682451|NCT04592419|565584771|FG001|Open-Label Extension Period|Sponsor Request|84|||
156682452|NCT00685035|565584776|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
156682453|NCT00685035|565584777|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
156682454|NCT00784979|565584783|FG000|Overall Study|incomplete data|6|||
156682455|NCT00894933|565584787|FG000|Overall Study|Lost to Follow-up|2|||
156682456|NCT00894933|565584787|FG000|Overall Study|Cancelled Procedure|1|||
156682457|NCT00894933|565584787|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
156682458|NCT04241133|565584789|FG000|Overall Study|COVID19 Precautions|14|||
156682459|NCT04241133|565584790|FG001|Overall Study|COVID19 Precautions|34|||
156682460|NCT00631007|565584792|FG000|Overall Study|Adverse Event|0|||
156682461|NCT00631007|565584793|FG001|Overall Study|Adverse Event|2|||
156682462|NCT00631007|565584794|FG002|Overall Study|Adverse Event|0|||
156682463|NCT00631007|565584795|FG003|Overall Study|Adverse Event|2|||
156682464|NCT00631007|565584796|FG004|Overall Study|Adverse Event|3|||
156682465|NCT00631007|565584797|FG005|Overall Study|Adverse Event|2|||
156682466|NCT00631007|565584792|FG000|Overall Study|Lost to Follow-up|2|||
156682467|NCT00631007|565584793|FG001|Overall Study|Lost to Follow-up|1|||
156682468|NCT00631007|565584794|FG002|Overall Study|Lost to Follow-up|2|||
156682469|NCT00631007|565584795|FG003|Overall Study|Lost to Follow-up|4|||
156682470|NCT00631007|565584796|FG004|Overall Study|Lost to Follow-up|5|||
156682471|NCT00631007|565584797|FG005|Overall Study|Lost to Follow-up|3|||
156682472|NCT00631007|565584792|FG000|Overall Study|Physician Decision|1|||
156682473|NCT00631007|565584793|FG001|Overall Study|Physician Decision|0|||
156682474|NCT00631007|565584794|FG002|Overall Study|Physician Decision|1|||
156682475|NCT00631007|565584795|FG003|Overall Study|Physician Decision|0|||
156682476|NCT00631007|565584796|FG004|Overall Study|Physician Decision|0|||
156682477|NCT00631007|565584797|FG005|Overall Study|Physician Decision|2|||
156682478|NCT00631007|565584792|FG000|Overall Study|Persistent Hyperglycemia|2|||
156682479|NCT00631007|565584793|FG001|Overall Study|Persistent Hyperglycemia|2|||
156682480|NCT00631007|565584794|FG002|Overall Study|Persistent Hyperglycemia|5|||
156682481|NCT00631007|565584795|FG003|Overall Study|Persistent Hyperglycemia|1|||
156682482|NCT00631007|565584796|FG004|Overall Study|Persistent Hyperglycemia|2|||
156682483|NCT00631007|565584797|FG005|Overall Study|Persistent Hyperglycemia|5|||
156682484|NCT00631007|565584792|FG000|Overall Study|Withdrawal by Subject|4|||
156682485|NCT00631007|565584793|FG001|Overall Study|Withdrawal by Subject|5|||
156784319|NCT00790933|565961163|FG003|Overall Study|Reason Not Specified|1|||
156784320|NCT00790933|565961164|FG004|Overall Study|Reason Not Specified|9|||
156784321|NCT00720083|565961167|FG000|Overall Study|Ineligible|1|||
156784322|NCT00720083|565961168|FG001|Overall Study|Ineligible|2|||
156784323|NCT00245570|565961170|FG000|Washout Between Periods III and IV|Adverse Event|0|||
156784324|NCT00245570|565961171|FG001|Washout Between Periods III and IV|Adverse Event|1|||
156784325|NCT00245570|565961172|FG002|Washout Between Periods III and IV|Adverse Event|0|||
156784326|NCT00245570|565961173|FG003|Washout Between Periods III and IV|Adverse Event|0|||
157013055|NCT02723955|566801749|FG012|Expansion Phase|Death|0|||
157013056|NCT02723955|566801750|FG013|Expansion Phase|Death|0|||
157013057|NCT02723955|566801751|FG014|Expansion Phase|Death|0|||
157013058|NCT02723955|566801752|FG015|Expansion Phase|Death|0|||
157013059|NCT02723955|566801753|FG016|Expansion Phase|Death|0|||
157013060|NCT02723955|566801754|FG017|Expansion Phase|Death|0|||
157013061|NCT02723955|566801755|FG018|Expansion Phase|Death|0|||
156682486|NCT00631007|565584794|FG002|Overall Study|Withdrawal by Subject|2|||
156682487|NCT00631007|565584795|FG003|Overall Study|Withdrawal by Subject|2|||
156682488|NCT00631007|565584796|FG004|Overall Study|Withdrawal by Subject|1|||
156682489|NCT00631007|565584797|FG005|Overall Study|Withdrawal by Subject|3|||
156682490|NCT00631007|565584792|FG000|Overall Study|Other|2|||
156682491|NCT00631007|565584793|FG001|Overall Study|Other|1|||
156682492|NCT00631007|565584794|FG002|Overall Study|Other|0|||
156682493|NCT00631007|565584795|FG003|Overall Study|Other|0|||
157013062|NCT02723955|566801756|FG019|Expansion Phase|Death|0|||
157013063|NCT02723955|566801757|FG020|Expansion Phase|Death|0|||
157013064|NCT02723955|566801758|FG021|Expansion Phase|Death|0|||
157013065|NCT02723955|566801759|FG022|Expansion Phase|Death|0|||
157013066|NCT02723955|566801760|FG023|Expansion Phase|Death|0|||
156682494|NCT00631007|565584796|FG004|Overall Study|Other|1|||
156682495|NCT00631007|565584797|FG005|Overall Study|Other|0|||
156682496|NCT00683787|565584798|FG000|Overall Study|Progression|3|||
156682497|NCT00683787|565584799|FG001|Overall Study|Progression|3|||
156682498|NCT00683787|565584800|FG002|Overall Study|Progression|0|||
156682499|NCT00683787|565584798|FG000|Overall Study|Adverse Event|0|||
156682500|NCT00683787|565584799|FG001|Overall Study|Adverse Event|0|||
156682501|NCT00683787|565584800|FG002|Overall Study|Adverse Event|2|||
156682502|NCT00460109|565584801|FG000|Overall Study|Death|1|||
156682503|NCT01235715|565584802|FG000|Overall Study|Physician Decision|0|||
156682504|NCT01235715|565584803|FG001|Overall Study|Physician Decision|2|||
156682505|NCT03619876|565584804|FG000|Overall Study|Withdrawal by Subject|1|||
156682506|NCT03619876|565584805|FG001|Overall Study|Withdrawal by Subject|2|||
156682507|NCT03619876|565584804|FG000|Overall Study|Withdrawal due to incidental finding|0|||
156682508|NCT03619876|565584805|FG001|Overall Study|Withdrawal due to incidental finding|2|||
156682509|NCT02344745|565584806|FG000|Overall Study|Data collection sheets were lost|2|||
156682510|NCT02344745|565584807|FG001|Overall Study|Data collection sheets were lost|0|||
156682511|NCT02788513|565584808|FG000|Overall Study|Withdrawal by Subject|3|||
156682512|NCT02788513|565584809|FG001|Overall Study|Withdrawal by Subject|0|||
156682513|NCT02788513|565584810|FG002|Overall Study|Withdrawal by Subject|2|||
156682514|NCT02788513|565584811|FG003|Overall Study|Withdrawal by Subject|3|||
156682515|NCT02788513|565584812|FG004|Overall Study|Withdrawal by Subject|1|||
156682516|NCT02788513|565584808|FG000|Overall Study|Lost to Follow-up|1|||
156682517|NCT02788513|565584809|FG001|Overall Study|Lost to Follow-up|0|||
156682518|NCT02788513|565584810|FG002|Overall Study|Lost to Follow-up|0|||
156682519|NCT02788513|565584811|FG003|Overall Study|Lost to Follow-up|0|||
156682520|NCT02788513|565584812|FG004|Overall Study|Lost to Follow-up|1|||
156682521|NCT02788513|565584808|FG000|Overall Study|Adverse Event|5|||
156682522|NCT02788513|565584809|FG001|Overall Study|Adverse Event|8|||
156682523|NCT02788513|565584810|FG002|Overall Study|Adverse Event|4|||
156682524|NCT02788513|565584811|FG003|Overall Study|Adverse Event|2|||
156682525|NCT02788513|565584812|FG004|Overall Study|Adverse Event|2|||
156682526|NCT02788513|565584808|FG000|Overall Study|Protocol Violation|0|||
156682527|NCT02788513|565584809|FG001|Overall Study|Protocol Violation|0|||
156682528|NCT02788513|565584810|FG002|Overall Study|Protocol Violation|1|||
156784327|NCT00245570|565961174|FG004|Washout Between Periods III and IV|Adverse Event|0|||
156784328|NCT00245570|565961175|FG005|Washout Between Periods III and IV|Adverse Event|0|||
156784329|NCT01913470|565961176|FG000|Overall Study|Lost to Follow-up|0|||
156784330|NCT01913470|565961177|FG001|Overall Study|Lost to Follow-up|1|||
156784331|NCT01913470|565961176|FG000|Overall Study|Physician Decision|0|||
156784332|NCT01913470|565961177|FG001|Overall Study|Physician Decision|1|||
156784333|NCT01913470|565961176|FG000|Overall Study|Withdrawal by Subject|0|||
156784334|NCT01913470|565961177|FG001|Overall Study|Withdrawal by Subject|1|||
156784335|NCT01829165|565961189|FG000|Overall Study|Did not complete intervention|2|||
156784336|NCT01829165|565961190|FG001|Overall Study|Did not complete intervention|0|||
156784337|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784338|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784339|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
156784340|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
156784341|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
156784342|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
156784343|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
156784344|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
156784345|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
156784346|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
156784347|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
156784348|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
157120230|NCT03504397|567193046|FG001|Overall Study|Lost to Follow-up|0|||
157120231|NCT03504397|567193045|FG000|Overall Study|Death|14|||
156784349|NCT02573467|565961191|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
156784350|NCT02573467|565961192|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
157120232|NCT03504397|567193046|FG001|Overall Study|Death|16|||
157120233|NCT03504397|567193045|FG000|Overall Study|Adverse Event|40|||
156682529|NCT02788513|565584811|FG003|Overall Study|Protocol Violation|1|||
156682530|NCT02788513|565584812|FG004|Overall Study|Protocol Violation|0|||
156682531|NCT02788513|565584808|FG000|Overall Study|Subject decided to stop taking treatment|0|||
156784351|NCT02573467|565961193|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
156784352|NCT02573467|565961194|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
156784353|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Death|1|||
156784354|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Death|1|||
156784355|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Death|0|||
156784356|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Death|1|||
156682532|NCT02788513|565584809|FG001|Overall Study|Subject decided to stop taking treatment|0|||
156682533|NCT02788513|565584810|FG002|Overall Study|Subject decided to stop taking treatment|1|||
156682534|NCT02788513|565584811|FG003|Overall Study|Subject decided to stop taking treatment|0|||
156868071|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Transplant|0|||
156868072|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Transplant|0|||
156868073|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Transplant|0|||
156868074|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Transplant|0|||
156868075|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Transplant|0|||
156868076|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Transplant|0|||
156868077|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
156868078|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
156868079|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
156868080|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
156868081|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
156868082|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
156868083|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
156868084|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
156868085|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
156868086|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
156868087|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
156868088|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
156868089|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
156868090|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
156868091|NCT02113982|566277280|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
156868092|NCT02113982|566277281|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
156868093|NCT02113982|566277282|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
156868094|NCT02113982|566277283|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
156868095|NCT02113982|566277284|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
156868096|NCT02113982|566277285|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
156868097|NCT02113982|566277286|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
156868098|NCT02113982|566277287|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
156868099|NCT02113982|566277288|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
156868100|NCT02113982|566277289|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
156868101|NCT02113982|566277290|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
156868102|NCT02113982|566277291|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
156868103|NCT02113982|566277292|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
156868104|NCT02113982|566277293|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
156868105|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
156868106|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
156868107|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
156868108|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
156868109|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
156868110|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
156868111|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
156868112|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
156868113|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
156868114|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
156868115|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
156868116|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
156868117|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
156868118|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
156868119|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
156868120|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
156868121|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
156868122|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
156868123|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
156868124|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
156868125|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
156868126|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
156868127|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
156868128|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
156868129|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
156868130|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
156868131|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
156868132|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
156868133|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868134|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868135|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868136|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868137|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868138|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868139|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868140|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
156868141|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868142|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
156682535|NCT02788513|565584812|FG004|Overall Study|Subject decided to stop taking treatment|0|||
156682536|NCT02788513|565584808|FG000|Overall Study|Decision by the study team|0|||
156682537|NCT02788513|565584809|FG001|Overall Study|Decision by the study team|0|||
156682538|NCT02788513|565584810|FG002|Overall Study|Decision by the study team|0|||
156682539|NCT02788513|565584811|FG003|Overall Study|Decision by the study team|0|||
156682540|NCT02788513|565584812|FG004|Overall Study|Decision by the study team|1|||
156682541|NCT02943993|565584813|FG000|Overall Study|Withdrawal by Subject|52|||
156682542|NCT02943993|565584813|FG000|Overall Study|Transfer to another institution|6|||
156682543|NCT02943993|565584813|FG000|Overall Study|Lost to Follow-up|135|||
156682544|NCT02943993|565584813|FG000|Overall Study|Death|98|||
156682545|NCT02943993|565584813|FG000|Overall Study|Other reason for premature termination|32|||
156682546|NCT02943993|565584813|FG000|Overall Study|Missing reason for termination|7|||
156682547|NCT04968925|565584819|FG000|Phase I- Period 1|COVID-19 related|0|||
157213355|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
157213356|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
157213357|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
157213358|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157213359|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157213360|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157213361|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
157213362|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157213363|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157213364|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157213365|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
157213366|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
157213367|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
157213368|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
157213369|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
157213370|NCT01677910|567529479|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
156784357|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
156784358|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
156784359|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
156784360|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
156784361|NCT02573467|565961191|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
156784362|NCT02573467|565961192|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
156784363|NCT02573467|565961193|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
156784364|NCT02573467|565961194|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
156784365|NCT00710970|565961195|FG000|Overall Study|Never took drug|3|||
156784366|NCT01960842|565961200|FG000|Overall Study|Adverse Event|1|||
156784367|NCT01960842|565961200|FG000|Overall Study|Withdrawal by Subject|2|||
156784368|NCT01158404|565961205|FG000|Overall Study|Withdrawal by Subject|0|||
156784369|NCT01158404|565961206|FG001|Overall Study|Withdrawal by Subject|1|||
156784370|NCT01158404|565961207|FG002|Overall Study|Withdrawal by Subject|0|||
156784371|NCT01158404|565961208|FG003|Overall Study|Withdrawal by Subject|0|||
156784372|NCT01158404|565961209|FG004|Overall Study|Withdrawal by Subject|3|||
156784373|NCT01158404|565961210|FG005|Overall Study|Withdrawal by Subject|1|||
156784374|NCT01158404|565961211|FG006|Overall Study|Withdrawal by Subject|0|||
156784375|NCT01158404|565961212|FG007|Overall Study|Withdrawal by Subject|1|||
156784376|NCT01158404|565961205|FG000|Overall Study|Physician Decision|0|||
156784377|NCT01158404|565961206|FG001|Overall Study|Physician Decision|0|||
156784378|NCT01158404|565961207|FG002|Overall Study|Physician Decision|0|||
156784379|NCT01158404|565961208|FG003|Overall Study|Physician Decision|0|||
156784380|NCT01158404|565961209|FG004|Overall Study|Physician Decision|0|||
156784381|NCT01158404|565961210|FG005|Overall Study|Physician Decision|0|||
156784382|NCT01158404|565961211|FG006|Overall Study|Physician Decision|0|||
156784383|NCT01158404|565961212|FG007|Overall Study|Physician Decision|1|||
156784384|NCT01158404|565961205|FG000|Overall Study|Progressive Disease|0|||
156784385|NCT01158404|565961206|FG001|Overall Study|Progressive Disease|0|||
156784386|NCT01158404|565961207|FG002|Overall Study|Progressive Disease|0|||
156784387|NCT01158404|565961208|FG003|Overall Study|Progressive Disease|0|||
156784388|NCT01158404|565961209|FG004|Overall Study|Progressive Disease|0|||
156784389|NCT01158404|565961210|FG005|Overall Study|Progressive Disease|0|||
156784390|NCT01158404|565961211|FG006|Overall Study|Progressive Disease|1|||
156784391|NCT01158404|565961212|FG007|Overall Study|Progressive Disease|0|||
156784392|NCT02056288|565961213|FG000|In-Hospital Data|Surgery cancelled|1|||
156784393|NCT02056288|565961214|FG001|In-Hospital Data|Surgery cancelled|0|||
157013067|NCT02723955|566801761|FG024|Expansion Phase|Death|0|||
157013068|NCT02723955|566801762|FG025|Expansion Phase|Death|0|||
157213371|NCT01677910|567529480|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
156784394|NCT02056288|565961213|FG000|In-Hospital Data|Protocol Violation|3|||
156784395|NCT02056288|565961214|FG001|In-Hospital Data|Protocol Violation|0|||
157013069|NCT02723955|566801763|FG026|Expansion Phase|Death|0|||
157013070|NCT02723955|566801764|FG027|Expansion Phase|Death|0|||
156682548|NCT04968925|565584820|FG001|Phase I- Period 1|COVID-19 related|1|||
156682549|NCT04968925|565584821|FG002|Phase I- Period 1|COVID-19 related|0|||
156682550|NCT04968925|565584822|FG003|Phase I- Period 1|COVID-19 related|0|||
156682551|NCT04968925|565584819|FG000|Phase I- Period 1|Subject enrolled in error|1|||
156682552|NCT04968925|565584820|FG001|Phase I- Period 1|Subject enrolled in error|1|||
156682553|NCT04968925|565584821|FG002|Phase I- Period 1|Subject enrolled in error|0|||
156682554|NCT04968925|565584822|FG003|Phase I- Period 1|Subject enrolled in error|0|||
156682555|NCT04968925|565584819|FG000|Phase II- Period 1|COVID-19 Related|0|||
156682556|NCT04968925|565584820|FG001|Phase II- Period 1|COVID-19 Related|0|||
156682557|NCT04968925|565584821|FG002|Phase II- Period 1|COVID-19 Related|6|||
156682558|NCT04968925|565584822|FG003|Phase II- Period 1|COVID-19 Related|6|||
156682559|NCT04968925|565584819|FG000|Phase II- Period 1|Subject enrolled in error|0|||
156682560|NCT04968925|565584820|FG001|Phase II- Period 1|Subject enrolled in error|0|||
156682561|NCT04968925|565584821|FG002|Phase II- Period 1|Subject enrolled in error|1|||
156682562|NCT04968925|565584822|FG003|Phase II- Period 1|Subject enrolled in error|0|||
156682563|NCT04968925|565584819|FG000|Phase II -Period 2|COVID-19 related|0|||
156682564|NCT04968925|565584820|FG001|Phase II -Period 2|COVID-19 related|0|||
156682565|NCT04968925|565584821|FG002|Phase II -Period 2|COVID-19 related|4|||
156682566|NCT04968925|565584822|FG003|Phase II -Period 2|COVID-19 related|3|||
156682567|NCT04968925|565584819|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
156682568|NCT04968925|565584820|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
156682569|NCT04968925|565584821|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
156682570|NCT04968925|565584822|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
156682571|NCT00396630|565584824|FG000|Overall Study|Lost to Follow-up|1|||
156682572|NCT00396630|565584825|FG001|Overall Study|Lost to Follow-up|1|||
156682573|NCT00396630|565584824|FG000|Overall Study|Withdrawal by Subject|1|||
156682574|NCT00396630|565584825|FG001|Overall Study|Withdrawal by Subject|1|||
156682575|NCT00396630|565584824|FG000|Overall Study|Not vaccinated at Visit 3|3|||
156682576|NCT00396630|565584825|FG001|Overall Study|Not vaccinated at Visit 3|3|||
156682577|NCT00876265|565584826|FG000|Overall Study|Miscellaneous reasons|4|||
156682578|NCT00876265|565584826|FG000|Overall Study|Lost to Follow-up|6|||
156682579|NCT00876265|565584826|FG000|Overall Study|Withdrawal by Subject|2|||
156682580|NCT02327325|565584827|FG000|Overall Study|Withdrawal by Subject|1|||
156682581|NCT02327325|565584828|FG001|Overall Study|Withdrawal by Subject|4|||
156682582|NCT02327325|565584829|FG002|Overall Study|Withdrawal by Subject|4|||
156682583|NCT02327325|565584827|FG000|Overall Study|Excluded by Study Team|0|||
156682584|NCT02327325|565584828|FG001|Overall Study|Excluded by Study Team|0|||
156682585|NCT02327325|565584829|FG002|Overall Study|Excluded by Study Team|1|||
156682586|NCT00651183|565584832|FG000|Overall Study|Lack of Efficacy|1|||
156682587|NCT00651183|565584833|FG001|Overall Study|Lack of Efficacy|0|||
156682588|NCT00651183|565584832|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
156682589|NCT00651183|565584833|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
156682590|NCT00651183|565584832|FG000|Overall Study|Tolerability insufficient|5|||
156682591|NCT00651183|565584833|FG001|Overall Study|Tolerability insufficient|2|||
156682592|NCT00651183|565584832|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
157120234|NCT03504397|567193046|FG001|Overall Study|Adverse Event|14|||
157120235|NCT03504397|567193045|FG000|Overall Study|miscellaneous|17|||
157120236|NCT03504397|567193046|FG001|Overall Study|miscellaneous|15|||
157120237|NCT03504397|567193045|FG000|Overall Study|Protocol deviation|1|||
157120238|NCT03504397|567193046|FG001|Overall Study|Protocol deviation|0|||
157120239|NCT03504397|567193045|FG000|Overall Study|Participants who did not take the study drug|4|||
157120240|NCT03504397|567193046|FG001|Overall Study|Participants who did not take the study drug|4|||
156682593|NCT00651183|565584833|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
156682594|NCT00651183|565584832|FG000|Overall Study|Withdrawal by Subject|6|||
156682595|NCT00651183|565584833|FG001|Overall Study|Withdrawal by Subject|3|||
156682596|NCT00651183|565584832|FG000|Overall Study|Lost to Follow-up|3|||
156682597|NCT00651183|565584833|FG001|Overall Study|Lost to Follow-up|1|||
156784396|NCT02056288|565961213|FG000|In-Hospital Data|Physician Decision|1|||
156784397|NCT02056288|565961214|FG001|In-Hospital Data|Physician Decision|0|||
157120241|NCT00070941|567193047|FG000|Overall Study|Adverse Event|10|||
157120242|NCT00070941|567193048|FG001|Overall Study|Adverse Event|8|||
157120243|NCT00070941|567193049|FG002|Overall Study|Adverse Event|4|||
157120244|NCT01888640|567193051|FG000|Overall Study|Lost to Follow-up|1|||
157120245|NCT01888640|567193052|FG001|Overall Study|Lost to Follow-up|2|||
157120246|NCT01888640|567193053|FG002|Overall Study|Lost to Follow-up|0|||
157120247|NCT01888640|567193051|FG000|Overall Study|Withdrawal by Subject|15|||
157120248|NCT01888640|567193052|FG001|Overall Study|Withdrawal by Subject|11|||
157120249|NCT01888640|567193053|FG002|Overall Study|Withdrawal by Subject|4|||
157120250|NCT01888640|567193051|FG000|Overall Study|Minimum dose not met|10|||
157120251|NCT01888640|567193052|FG001|Overall Study|Minimum dose not met|16|||
157120252|NCT01888640|567193053|FG002|Overall Study|Minimum dose not met|0|||
157120253|NCT01888640|567193051|FG000|Overall Study|Given wrong unit (placebo)|1|||
157120254|NCT01888640|567193052|FG001|Overall Study|Given wrong unit (placebo)|0|||
157120255|NCT01888640|567193053|FG002|Overall Study|Given wrong unit (placebo)|0|||
157120256|NCT01888640|567193051|FG000|Overall Study|Excluded for prior TENS|0|||
156682598|NCT00651183|565584832|FG000|Overall Study|Other reasons|4|||
156682599|NCT00651183|565584833|FG001|Overall Study|Other reasons|2|||
156682600|NCT00651183|565584832|FG000|Overall Study|missing|1|||
156682601|NCT00651183|565584833|FG001|Overall Study|missing|0|||
156682602|NCT00996437|565584840|FG000|Overall Study|Death|1|||
156682603|NCT00996437|565584841|FG001|Overall Study|Death|0|||
156682604|NCT00996437|565584840|FG000|Overall Study|Dropped|2|||
156682605|NCT00996437|565584841|FG001|Overall Study|Dropped|2|||
156682606|NCT00996437|565584840|FG000|Overall Study|Missed|2|||
156682607|NCT00996437|565584841|FG001|Overall Study|Missed|5|||
156682608|NCT01091103|565584842|FG000|Overall Study|Adverse Event|1|||
156682609|NCT01091103|565584842|FG000|Overall Study|Progressive Disease|3|||
156682610|NCT01270620|565584843|FG000|Overall Study|Withdrawal by Subject|1|||
156682611|NCT01270620|565584844|FG001|Overall Study|Withdrawal by Subject|3|||
156682612|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
156682613|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
156682614|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
156682615|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
156682616|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
156682617|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
156682618|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
156682619|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
156682620|NCT01045707|565584846|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
156682621|NCT01045707|565584847|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
156682622|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
156682623|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
156682624|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
156682625|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
156682626|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
156682627|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
156682628|NCT01045707|565584846|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
156682629|NCT01045707|565584847|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
156682630|NCT00809965|565584848|FG000|Overall Study|Death|194|||
156682631|NCT00809965|565584849|FG001|Overall Study|Death|147|||
156682632|NCT00809965|565584850|FG002|Overall Study|Death|196|||
156682633|NCT00809965|565584848|FG000|Overall Study|Lost to Follow-up|17|||
156682634|NCT00809965|565584849|FG001|Overall Study|Lost to Follow-up|10|||
156682635|NCT00809965|565584850|FG002|Overall Study|Lost to Follow-up|18|||
156682636|NCT00809965|565584848|FG000|Overall Study|Withdrawal by Subject|405|||
156682637|NCT00809965|565584849|FG001|Overall Study|Withdrawal by Subject|448|||
156682638|NCT00809965|565584850|FG002|Overall Study|Withdrawal by Subject|441|||
156682639|NCT00809965|565584848|FG000|Overall Study|Other Reason|167|||
156682640|NCT00809965|565584849|FG001|Overall Study|Other Reason|170|||
156682641|NCT00809965|565584850|FG002|Overall Study|Other Reason|189|||
156682642|NCT02780167|565584851|FG000|Overall Study|Adverse Event|9|||
156682643|NCT02780167|565584852|FG001|Overall Study|Adverse Event|8|||
156682644|NCT02780167|565584853|FG002|Overall Study|Adverse Event|8|||
156682645|NCT02780167|565584854|FG003|Overall Study|Adverse Event|12|||
156682646|NCT02780167|565584855|FG004|Overall Study|Adverse Event|8|||
156682647|NCT02780167|565584851|FG000|Overall Study|Lack of Efficacy|6|||
156682648|NCT02780167|565584852|FG001|Overall Study|Lack of Efficacy|5|||
156682649|NCT02780167|565584853|FG002|Overall Study|Lack of Efficacy|6|||
156682650|NCT02780167|565584854|FG003|Overall Study|Lack of Efficacy|1|||
156682651|NCT02780167|565584855|FG004|Overall Study|Lack of Efficacy|0|||
156682652|NCT02780167|565584851|FG000|Overall Study|Lost to Follow-up|2|||
156682653|NCT02780167|565584852|FG001|Overall Study|Lost to Follow-up|0|||
156682654|NCT02780167|565584853|FG002|Overall Study|Lost to Follow-up|1|||
156784398|NCT02056288|565961213|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
156784399|NCT02056288|565961214|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
156784400|NCT02384460|565961217|FG000|Overall Study|Protocol Violation|0|||
156784401|NCT02384460|565961218|FG001|Overall Study|Protocol Violation|1|||
156784402|NCT02384460|565961217|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
156784403|NCT02384460|565961218|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
156784404|NCT02384460|565961217|FG000|Overall Study|Adverse Event|5|||
156784405|NCT02384460|565961218|FG001|Overall Study|Adverse Event|2|||
156682655|NCT02780167|565584854|FG003|Overall Study|Lost to Follow-up|0|||
156682656|NCT02780167|565584855|FG004|Overall Study|Lost to Follow-up|0|||
156682657|NCT02780167|565584851|FG000|Overall Study|Does not meet entrance criteria|0|||
156682658|NCT02780167|565584852|FG001|Overall Study|Does not meet entrance criteria|0|||
156682659|NCT02780167|565584853|FG002|Overall Study|Does not meet entrance criteria|1|||
156682660|NCT02780167|565584854|FG003|Overall Study|Does not meet entrance criteria|0|||
156682661|NCT02780167|565584855|FG004|Overall Study|Does not meet entrance criteria|0|||
156682662|NCT02780167|565584851|FG000|Overall Study|No longer meets eligibility criteria|0|||
156784406|NCT02384460|565961217|FG000|Overall Study|Withdrawal by Subject|0|||
156784407|NCT02384460|565961218|FG001|Overall Study|Withdrawal by Subject|3|||
156784408|NCT02384460|565961217|FG000|Overall Study|Elective medical treatment|1|||
157120257|NCT01888640|567193052|FG001|Overall Study|Excluded for prior TENS|1|||
157120258|NCT01888640|567193053|FG002|Overall Study|Excluded for prior TENS|0|||
157120259|NCT01888640|567193051|FG000|Overall Study|Researcher Termination of Participant|0|||
157120260|NCT01888640|567193052|FG001|Overall Study|Researcher Termination of Participant|1|||
157120261|NCT01888640|567193053|FG002|Overall Study|Researcher Termination of Participant|1|||
157120262|NCT01277549|567193054|FG000|Overall Study|Failed to meet eligibility criteria|13|||
157120263|NCT01277549|567193055|FG001|Overall Study|Failed to meet eligibility criteria|9|||
157120264|NCT01277549|567193054|FG000|Overall Study|Withdrawal by Subject|1|||
157120265|NCT01277549|567193055|FG001|Overall Study|Withdrawal by Subject|3|||
157120266|NCT01277549|567193054|FG000|Overall Study|Protocol Violation|10|||
157120267|NCT01277549|567193055|FG001|Overall Study|Protocol Violation|1|||
157120268|NCT01277549|567193054|FG000|Overall Study|Physician Decision|2|||
157120269|NCT01277549|567193055|FG001|Overall Study|Physician Decision|1|||
157120270|NCT00623428|567193058|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
157120271|NCT00623428|567193059|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
157120272|NCT00623428|567193058|FG000|Treatment Period|Death|0|||
157120273|NCT00623428|567193059|FG001|Treatment Period|Death|1|||
157120274|NCT00623428|567193058|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
157120275|NCT00623428|567193059|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
157120276|NCT00623428|567193058|FG000|Treatment Period|Insufficient therapeutic response|0|||
157120277|NCT00623428|567193059|FG001|Treatment Period|Insufficient therapeutic response|2|||
157120278|NCT00623428|567193058|FG000|Treatment Period|Other|0|||
157120279|NCT00623428|567193059|FG001|Treatment Period|Other|1|||
157120280|NCT00623428|567193058|FG000|Treatment Period|Withdrawal by Subject|0|||
157120281|NCT00623428|567193059|FG001|Treatment Period|Withdrawal by Subject|1|||
157120282|NCT00623428|567193058|FG000|Follow-up Period|Relapse post-treatment|11|||
157120283|NCT00623428|567193059|FG001|Follow-up Period|Relapse post-treatment|3|||
157120284|NCT00623428|567193058|FG000|Follow-up Period|Failure to return|10|||
157120285|NCT00623428|567193059|FG001|Follow-up Period|Failure to return|2|||
157120286|NCT00623428|567193058|FG000|Follow-up Period|Patient withdrew consent|5|||
157120287|NCT00623428|567193059|FG001|Follow-up Period|Patient withdrew consent|4|||
157120288|NCT00623428|567193058|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
157120289|NCT00623428|567193059|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
157120290|NCT00623428|567193058|FG000|Follow-up Period|Did not cooperate|0|||
157120291|NCT00623428|567193059|FG001|Follow-up Period|Did not cooperate|3|||
157120292|NCT00623428|567193058|FG000|Follow-up Period|Reason not specified|1|||
157120293|NCT00623428|567193059|FG001|Follow-up Period|Reason not specified|1|||
157120294|NCT00623428|567193058|FG000|Follow-up Period|Death|0|||
157120295|NCT00623428|567193059|FG001|Follow-up Period|Death|1|||
157120296|NCT01692301|567193060|FG000|Overall Study|Adverse Event|15|||
157120297|NCT01692301|567193061|FG001|Overall Study|Adverse Event|12|||
157120298|NCT01692301|567193060|FG000|Overall Study|Death|1|||
157120299|NCT01692301|567193061|FG001|Overall Study|Death|2|||
157120300|NCT01692301|567193060|FG000|Overall Study|Lack of Efficacy|0|||
157120301|NCT01692301|567193061|FG001|Overall Study|Lack of Efficacy|5|||
157120302|NCT01692301|567193060|FG000|Overall Study|Non-compliance with study treatment|1|||
157120303|NCT01692301|567193061|FG001|Overall Study|Non-compliance with study treatment|2|||
156784409|NCT02384460|565961218|FG001|Overall Study|Elective medical treatment|0|||
156784410|NCT02384460|565961217|FG000|Overall Study|Non-compliance|1|||
156784411|NCT02384460|565961218|FG001|Overall Study|Non-compliance|0|||
156784412|NCT02400580|565961219|FG000|Overall Study|Withdrawal by Subject|1|||
156784413|NCT02400580|565961220|FG001|Overall Study|Withdrawal by Subject|1|||
157120304|NCT01692301|567193060|FG000|Overall Study|Protocol deviation|9|||
157120305|NCT01692301|567193061|FG001|Overall Study|Protocol deviation|2|||
157120306|NCT01692301|567193060|FG000|Overall Study|Patient/guardian decision|16|||
157120307|NCT01692301|567193061|FG001|Overall Study|Patient/guardian decision|15|||
157120308|NCT01692301|567193060|FG000|Overall Study|Technical problems|0|||
157120309|NCT01692301|567193061|FG001|Overall Study|Technical problems|1|||
157120310|NCT01692301|567193060|FG000|Overall Study|Physician Decision|2|||
157120311|NCT01692301|567193061|FG001|Overall Study|Physician Decision|2|||
156784414|NCT02400580|565961219|FG000|Overall Study|Adverse Event|1|||
156784415|NCT02400580|565961220|FG001|Overall Study|Adverse Event|0|||
156784416|NCT04233580|565961223|FG000|Overall Study|Adverse Event|3|||
157120312|NCT01692301|567193060|FG000|Overall Study|Lost to Follow-up|1|||
157120313|NCT01692301|567193061|FG001|Overall Study|Lost to Follow-up|1|||
157120314|NCT01142726|567193062|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
156784417|NCT04233580|565961224|FG001|Overall Study|Adverse Event|3|||
156784418|NCT04233580|565961223|FG000|Overall Study|Withdrawal by Subject|2|||
156784419|NCT04233580|565961224|FG001|Overall Study|Withdrawal by Subject|1|||
157120315|NCT01142726|567193063|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
156784420|NCT02029443|565961225|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
156784421|NCT02029443|565961226|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
157120316|NCT01142726|567193064|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
157120317|NCT01142726|567193062|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
157120318|NCT01142726|567193063|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
156784422|NCT02029443|565961227|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
156784423|NCT02029443|565961228|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
156784424|NCT02029443|565961229|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
156784425|NCT02029443|565961225|FG000|Overall Study|Death|13|||
156784426|NCT02029443|565961226|FG001|Overall Study|Death|2|||
156784427|NCT02029443|565961227|FG002|Overall Study|Death|2|||
156784428|NCT02029443|565961228|FG003|Overall Study|Death|11|||
156784429|NCT02029443|565961229|FG004|Overall Study|Death|2|||
156784430|NCT02029443|565961225|FG000|Overall Study|Lost to Follow-up|1|||
156784431|NCT02029443|565961226|FG001|Overall Study|Lost to Follow-up|0|||
156784432|NCT02029443|565961227|FG002|Overall Study|Lost to Follow-up|1|||
156784433|NCT02029443|565961228|FG003|Overall Study|Lost to Follow-up|1|||
156784434|NCT02029443|565961229|FG004|Overall Study|Lost to Follow-up|0|||
156784435|NCT02029443|565961225|FG000|Overall Study|Started other anti-cancer therapy|17|||
156784436|NCT02029443|565961226|FG001|Overall Study|Started other anti-cancer therapy|4|||
156784437|NCT02029443|565961227|FG002|Overall Study|Started other anti-cancer therapy|7|||
156784438|NCT02029443|565961228|FG003|Overall Study|Started other anti-cancer therapy|9|||
156784439|NCT02029443|565961229|FG004|Overall Study|Started other anti-cancer therapy|3|||
156784440|NCT02029443|565961225|FG000|Overall Study|Withdrawal by Subject|3|||
156784441|NCT02029443|565961226|FG001|Overall Study|Withdrawal by Subject|1|||
156784442|NCT02029443|565961227|FG002|Overall Study|Withdrawal by Subject|1|||
156784443|NCT02029443|565961228|FG003|Overall Study|Withdrawal by Subject|1|||
156784444|NCT02029443|565961229|FG004|Overall Study|Withdrawal by Subject|0|||
156784445|NCT02029443|565961225|FG000|Overall Study|Other|6|||
156784446|NCT02029443|565961226|FG001|Overall Study|Other|6|||
157120319|NCT01142726|567193064|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
156784447|NCT02029443|565961227|FG002|Overall Study|Other|4|||
156784448|NCT02029443|565961228|FG003|Overall Study|Other|2|||
156784449|NCT02029443|565961229|FG004|Overall Study|Other|0|||
156784450|NCT00625378|565961230|FG000|Overall Study|Adverse Event|22|||
156784451|NCT00625378|565961231|FG001|Overall Study|Adverse Event|0|||
156784452|NCT00625378|565961230|FG000|Overall Study|Withdrawal by Subject|16|||
157120320|NCT01142726|567193062|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
157120321|NCT01142726|567193063|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
157120322|NCT01142726|567193064|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
157120323|NCT01142726|567193062|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
157120324|NCT01142726|567193063|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
157120325|NCT01142726|567193064|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
157120326|NCT01142726|567193062|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
157120327|NCT01142726|567193063|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
157120328|NCT01142726|567193064|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
157120329|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
157120330|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
157120331|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
157120332|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
157120333|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
157120334|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
157120335|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
157120336|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
157120337|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
157120338|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
157120339|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
157120340|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
157120341|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
157120342|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
157120343|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
157120344|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
157120345|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
157120346|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
157120347|NCT01142726|567193062|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
157120348|NCT01142726|567193063|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
157120349|NCT01142726|567193064|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
157120350|NCT01142726|567193062|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
157120351|NCT01142726|567193063|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
157120352|NCT01142726|567193064|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
157120353|NCT01142726|567193062|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
157120354|NCT01142726|567193063|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
156784453|NCT00625378|565961231|FG001|Overall Study|Withdrawal by Subject|0|||
156784454|NCT00625378|565961230|FG000|Overall Study|Death|38|||
156784455|NCT00625378|565961231|FG001|Overall Study|Death|0|||
157120355|NCT01142726|567193064|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
157120356|NCT01142726|567193062|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
157120357|NCT01142726|567193063|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
157120358|NCT01142726|567193064|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
157120359|NCT01142726|567193062|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
157120360|NCT01142726|567193063|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
157120361|NCT01142726|567193064|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
157120362|NCT01568593|567193065|FG000|Overall Study|Lack of Efficacy|4|||
157120363|NCT01568593|567193066|FG001|Overall Study|Lack of Efficacy|1|||
157120364|NCT01568593|567193065|FG000|Overall Study|Adverse Event|3|||
157120365|NCT01568593|567193066|FG001|Overall Study|Adverse Event|2|||
157120366|NCT02111993|567193067|FG000|Overall Study|Physician Decision|5|||
157120367|NCT02111993|567193068|FG001|Overall Study|Physician Decision|4|||
157120368|NCT00419380|567193069|FG000|Overall Study|Lack of Efficacy|1|||
157120369|NCT00419380|567193070|FG001|Overall Study|Lack of Efficacy|7|||
157120370|NCT00419380|567193069|FG000|Overall Study|Physician Decision|0|||
157120371|NCT00419380|567193070|FG001|Overall Study|Physician Decision|1|||
156682663|NCT02780167|565584852|FG001|Overall Study|No longer meets eligibility criteria|0|||
156682664|NCT02780167|565584853|FG002|Overall Study|No longer meets eligibility criteria|0|||
156682665|NCT02780167|565584854|FG003|Overall Study|No longer meets eligibility criteria|1|||
156682666|NCT02780167|565584855|FG004|Overall Study|No longer meets eligibility criteria|1|||
156682667|NCT02780167|565584851|FG000|Overall Study|Protocol Violation|5|||
156682668|NCT02780167|565584852|FG001|Overall Study|Protocol Violation|5|||
156682669|NCT02780167|565584853|FG002|Overall Study|Protocol Violation|1|||
156682670|NCT02780167|565584854|FG003|Overall Study|Protocol Violation|1|||
156682671|NCT02780167|565584855|FG004|Overall Study|Protocol Violation|2|||
156682672|NCT02780167|565584851|FG000|Overall Study|Withdrawal by Subject|6|||
156682673|NCT02780167|565584852|FG001|Overall Study|Withdrawal by Subject|4|||
156682674|NCT02780167|565584853|FG002|Overall Study|Withdrawal by Subject|4|||
156682675|NCT02780167|565584854|FG003|Overall Study|Withdrawal by Subject|3|||
156682676|NCT02780167|565584855|FG004|Overall Study|Withdrawal by Subject|4|||
156682677|NCT02780167|565584851|FG000|Overall Study|Other|0|||
156682678|NCT02780167|565584852|FG001|Overall Study|Other|0|||
156682679|NCT02780167|565584853|FG002|Overall Study|Other|3|||
156682680|NCT02780167|565584854|FG003|Overall Study|Other|1|||
156682681|NCT02780167|565584855|FG004|Overall Study|Other|2|||
157120372|NCT00419380|567193069|FG000|Overall Study|Lost to Follow-up|0|||
157120373|NCT00419380|567193070|FG001|Overall Study|Lost to Follow-up|1|||
157120374|NCT00419380|567193069|FG000|Overall Study|Withdrawal by Subject|0|||
157120375|NCT00419380|567193070|FG001|Overall Study|Withdrawal by Subject|1|||
156682682|NCT05552261|565584857|FG000|Overall Study|Withdrawal by Subject|1|||
156682683|NCT05552261|565584857|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
156682684|NCT02315066|565584858|FG000|Overall Study|Lost to Follow-up|0|||
156682685|NCT02315066|565584859|FG001|Overall Study|Lost to Follow-up|1|||
156682686|NCT02315066|565584860|FG002|Overall Study|Lost to Follow-up|1|||
156682687|NCT02315066|565584861|FG003|Overall Study|Lost to Follow-up|0|||
156682688|NCT02315066|565584862|FG004|Overall Study|Lost to Follow-up|1|||
156682689|NCT02315066|565584863|FG005|Overall Study|Lost to Follow-up|0|||
157120376|NCT00796315|567193071|FG000|Overall Study|Protocol Violation|0|||
156682690|NCT02315066|565584864|FG006|Overall Study|Lost to Follow-up|2|||
156682691|NCT02315066|565584865|FG007|Overall Study|Lost to Follow-up|1|||
156682692|NCT02315066|565584866|FG008|Overall Study|Lost to Follow-up|0|||
156682693|NCT02315066|565584867|FG009|Overall Study|Lost to Follow-up|0|||
156682694|NCT02315066|565584868|FG010|Overall Study|Lost to Follow-up|1|||
156682695|NCT02315066|565584869|FG011|Overall Study|Lost to Follow-up|2|||
156682696|NCT02315066|565584870|FG012|Overall Study|Lost to Follow-up|0|||
156682697|NCT02315066|565584871|FG013|Overall Study|Lost to Follow-up|4|||
156682698|NCT02315066|565584858|FG000|Overall Study|Death|2|||
156682699|NCT02315066|565584859|FG001|Overall Study|Death|7|||
156682700|NCT02315066|565584860|FG002|Overall Study|Death|6|||
156682701|NCT02315066|565584861|FG003|Overall Study|Death|11|||
156682702|NCT02315066|565584862|FG004|Overall Study|Death|10|||
156682703|NCT02315066|565584863|FG005|Overall Study|Death|3|||
156682704|NCT02315066|565584864|FG006|Overall Study|Death|9|||
157120377|NCT00796315|567193072|FG001|Overall Study|Protocol Violation|1|||
157120378|NCT00796315|567193073|FG002|Overall Study|Protocol Violation|0|||
157120379|NCT02788747|567193078|FG000|Overall Study|Adverse Event|1|||
156682705|NCT02315066|565584865|FG007|Overall Study|Death|9|||
156682706|NCT02315066|565584866|FG008|Overall Study|Death|10|||
156682707|NCT02315066|565584867|FG009|Overall Study|Death|8|||
157120380|NCT02788747|567193079|FG001|Overall Study|Adverse Event|0|||
157120381|NCT02788747|567193080|FG002|Overall Study|Adverse Event|0|||
157120382|NCT01079182|567193081|FG000|Overall Study|Lost to Follow-up|1634|||
156682708|NCT02315066|565584868|FG010|Overall Study|Death|10|||
156682709|NCT02315066|565584869|FG011|Overall Study|Death|7|||
156682710|NCT02315066|565584870|FG012|Overall Study|Death|8|||
156682711|NCT02315066|565584871|FG013|Overall Study|Death|21|||
156682712|NCT02315066|565584858|FG000|Overall Study|Other|0|||
156682713|NCT02315066|565584859|FG001|Overall Study|Other|0|||
157120383|NCT01079182|567193081|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
157120384|NCT01079182|567193081|FG000|Overall Study|Lack of Efficacy|514|||
157120385|NCT01079182|567193081|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
157120386|NCT01079182|567193081|FG000|Overall Study|Reasons not Evaluated|271|||
157120387|NCT01026831|567193082|FG000|Overall Study|Adverse Event|4|||
157213372|NCT01677910|567529481|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
157213373|NCT01677910|567529482|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
157213374|NCT01808209|567529485|FG000|Overall Study|Lost to Follow-up|0|||
157213375|NCT01808209|567529486|FG001|Overall Study|Lost to Follow-up|1|||
157213376|NCT01703741|567529487|FG000|Overall Study|Withdrawal by Subject|6|||
157213377|NCT01703741|567529487|FG000|Overall Study|Adverse Event|2|||
157213378|NCT01703741|567529487|FG000|Overall Study|Physician Decision|2|||
157213379|NCT01703741|567529487|FG000|Overall Study|Protocol Violation|1|||
157213380|NCT01703741|567529487|FG000|Overall Study|Lost to Follow-up|3|||
157213381|NCT01703741|567529487|FG000|Overall Study|Subject did not want to continue|2|||
157213382|NCT01703741|567529487|FG000|Overall Study|Subject cannot comply with study visits|1|||
157120388|NCT01026831|567193083|FG001|Overall Study|Adverse Event|3|||
157120389|NCT01026831|567193082|FG000|Overall Study|Lost to Follow-up|2|||
157120390|NCT01026831|567193083|FG001|Overall Study|Lost to Follow-up|0|||
157120391|NCT01026831|567193082|FG000|Overall Study|Physician Decision|1|||
157213383|NCT01703741|567529487|FG000|Overall Study|Subject started testosterone injections|1|||
156682714|NCT02315066|565584860|FG002|Overall Study|Other|0|||
156682715|NCT02315066|565584861|FG003|Overall Study|Other|0|||
156682716|NCT02315066|565584862|FG004|Overall Study|Other|0|||
156682717|NCT02315066|565584863|FG005|Overall Study|Other|0|||
156682718|NCT02315066|565584864|FG006|Overall Study|Other|0|||
156682719|NCT02315066|565584865|FG007|Overall Study|Other|1|||
156682720|NCT02315066|565584866|FG008|Overall Study|Other|1|||
156682721|NCT02315066|565584867|FG009|Overall Study|Other|2|||
156682722|NCT02315066|565584868|FG010|Overall Study|Other|0|||
156682723|NCT02315066|565584869|FG011|Overall Study|Other|0|||
156682724|NCT02315066|565584870|FG012|Overall Study|Other|0|||
156682725|NCT02315066|565584871|FG013|Overall Study|Other|0|||
156682726|NCT02315066|565584858|FG000|Overall Study|Subject refused further follow-up|0|||
156682727|NCT02315066|565584859|FG001|Overall Study|Subject refused further follow-up|2|||
156682728|NCT02315066|565584860|FG002|Overall Study|Subject refused further follow-up|2|||
156682729|NCT02315066|565584861|FG003|Overall Study|Subject refused further follow-up|0|||
156682730|NCT02315066|565584862|FG004|Overall Study|Subject refused further follow-up|0|||
156682731|NCT02315066|565584863|FG005|Overall Study|Subject refused further follow-up|0|||
156682732|NCT02315066|565584864|FG006|Overall Study|Subject refused further follow-up|2|||
156682733|NCT02315066|565584865|FG007|Overall Study|Subject refused further follow-up|3|||
156682734|NCT02315066|565584866|FG008|Overall Study|Subject refused further follow-up|0|||
156682735|NCT02315066|565584867|FG009|Overall Study|Subject refused further follow-up|1|||
156682736|NCT02315066|565584868|FG010|Overall Study|Subject refused further follow-up|1|||
156682737|NCT02315066|565584869|FG011|Overall Study|Subject refused further follow-up|2|||
156682738|NCT02315066|565584870|FG012|Overall Study|Subject refused further follow-up|2|||
156682739|NCT02315066|565584871|FG013|Overall Study|Subject refused further follow-up|4|||
156682740|NCT02315066|565584858|FG000|Overall Study|Study ongoing at date of cut-off|0|||
156682741|NCT02315066|565584859|FG001|Overall Study|Study ongoing at date of cut-off|0|||
156682742|NCT02315066|565584860|FG002|Overall Study|Study ongoing at date of cut-off|0|||
156682743|NCT02315066|565584861|FG003|Overall Study|Study ongoing at date of cut-off|0|||
156682744|NCT02315066|565584862|FG004|Overall Study|Study ongoing at date of cut-off|0|||
156682745|NCT02315066|565584863|FG005|Overall Study|Study ongoing at date of cut-off|0|||
156682746|NCT02315066|565584864|FG006|Overall Study|Study ongoing at date of cut-off|0|||
156682747|NCT02315066|565584865|FG007|Overall Study|Study ongoing at date of cut-off|0|||
156682748|NCT02315066|565584866|FG008|Overall Study|Study ongoing at date of cut-off|0|||
156682749|NCT02315066|565584867|FG009|Overall Study|Study ongoing at date of cut-off|0|||
156682750|NCT02315066|565584868|FG010|Overall Study|Study ongoing at date of cut-off|0|||
156682751|NCT02315066|565584869|FG011|Overall Study|Study ongoing at date of cut-off|0|||
156682752|NCT02315066|565584870|FG012|Overall Study|Study ongoing at date of cut-off|0|||
156682753|NCT02315066|565584871|FG013|Overall Study|Study ongoing at date of cut-off|1|||
156682754|NCT02916693|565584872|FG000|Overall Study|Lost to Follow-up|7|||
157213384|NCT00368537|567529488|FG000|Randomization|No study drug dosed|13|||
156682755|NCT01190930|565584873|FG000|Induction|Adverse Event|17|||
156682756|NCT01190930|565584874|FG001|Induction|Adverse Event|0|||
156682757|NCT01190930|565584875|FG002|Induction|Adverse Event|0|||
156682758|NCT01190930|565584876|FG003|Induction|Adverse Event|0|||
156682759|NCT01190930|565584877|FG004|Induction|Adverse Event|0|||
156682760|NCT01190930|565584878|FG005|Induction|Adverse Event|0|||
156682761|NCT01190930|565584879|FG006|Induction|Adverse Event|0|||
156682762|NCT01190930|565584880|FG007|Induction|Adverse Event|0|||
156682763|NCT01190930|565584881|FG008|Induction|Adverse Event|0|||
156682764|NCT01190930|565584882|FG009|Induction|Adverse Event|0|||
157213385|NCT00368537|567529489|FG001|Randomization|No study drug dosed|6|||
157213386|NCT00368537|567529488|FG000|Baseline Participants|Lost to Follow-up|16|||
157120392|NCT01026831|567193083|FG001|Overall Study|Physician Decision|1|||
157120393|NCT01026831|567193082|FG000|Overall Study|Protocol Violation|0|||
157120394|NCT01026831|567193083|FG001|Overall Study|Protocol Violation|2|||
157120395|NCT01026831|567193082|FG000|Overall Study|Withdrawal by Subject|7|||
157120396|NCT01026831|567193083|FG001|Overall Study|Withdrawal by Subject|5|||
157120397|NCT04417894|567193084|FG000|Overall Study|Lost to Follow-up|3|||
157120398|NCT04417894|567193085|FG001|Overall Study|Lost to Follow-up|0|||
156868143|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
156868144|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868145|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868146|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
156868147|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868148|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868149|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868150|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868151|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868152|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868153|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868154|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
156868155|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868156|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
156868157|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868158|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868159|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868160|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
156868161|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868162|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
157120399|NCT04417894|567193084|FG000|Overall Study|Withdrawal by Subject|7|||
157120400|NCT04417894|567193085|FG001|Overall Study|Withdrawal by Subject|6|||
157120401|NCT04417894|567193084|FG000|Overall Study|Lack of Efficacy|3|||
156868163|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868164|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868165|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868166|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868167|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868168|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
156868169|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868170|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868171|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868172|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868173|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868174|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
156868175|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Transplant|0|||
156868176|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Transplant|0|||
156868177|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Transplant|0|||
156868178|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Transplant|0|||
156868179|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Transplant|0|||
156868180|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Transplant|0|||
156868181|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Transplant|0|||
156868182|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Transplant|0|||
156868183|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Transplant|0|||
156868184|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Transplant|4|||
156868185|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Transplant|2|||
156868186|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Transplant|0|||
156868187|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Transplant|0|||
156868188|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Transplant|0|||
156868189|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
156868190|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
157120402|NCT04417894|567193085|FG001|Overall Study|Lack of Efficacy|1|||
157120403|NCT00371865|567193094|FG000|Overall Study|Lack of Efficacy|0|||
157120404|NCT00371865|567193095|FG001|Overall Study|Lack of Efficacy|2|||
157120405|NCT00371865|567193094|FG000|Overall Study|Protocol Violation|3|||
157120406|NCT00371865|567193095|FG001|Overall Study|Protocol Violation|2|||
157120407|NCT00371865|567193094|FG000|Overall Study|Withdrawal by Subject|12|||
157120408|NCT00371865|567193095|FG001|Overall Study|Withdrawal by Subject|10|||
157120409|NCT02043548|567193098|FG000|Overall Study|Lack of Efficacy|1|||
156868191|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
156682765|NCT01190930|565584873|FG000|Induction|Death|34|||
156868192|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
156868193|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
156868194|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
156868195|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
156868196|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
157120410|NCT02043548|567193099|FG001|Overall Study|Lack of Efficacy|0|||
156682766|NCT01190930|565584874|FG001|Induction|Death|0|||
156868197|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
156868198|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
156868199|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
156868200|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
156868201|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
156868202|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
156868203|NCT02113982|566277280|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
156868204|NCT02113982|566277281|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
156868205|NCT02113982|566277282|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
156868206|NCT02113982|566277283|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
156868207|NCT02113982|566277284|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
156868208|NCT02113982|566277285|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
156868209|NCT02113982|566277286|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
156868210|NCT02113982|566277287|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
156868211|NCT02113982|566277288|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
156868212|NCT02113982|566277289|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
156868213|NCT02113982|566277290|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
156868214|NCT02113982|566277291|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
156868215|NCT02113982|566277292|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
156868216|NCT02113982|566277293|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
156868217|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868218|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868219|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868220|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868221|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868222|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868223|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868224|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868225|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868226|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868227|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868228|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
156868229|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868230|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
156868231|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868232|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868233|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868234|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868235|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868236|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868237|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868238|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868239|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868240|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868241|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868242|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
156868243|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868244|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
156868245|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868246|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868247|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868248|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868249|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868250|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868251|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868252|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868253|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868254|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
157120411|NCT02043548|567193098|FG000|Overall Study|Adverse Event|0|||
157120412|NCT02043548|567193099|FG001|Overall Study|Adverse Event|1|||
157120413|NCT01425008|567193100|FG000|Dose Escalation Phase|Progressive Disease|2|||
157120414|NCT01425008|567193101|FG001|Dose Escalation Phase|Progressive Disease|3|||
157120415|NCT01425008|567193102|FG002|Dose Escalation Phase|Progressive Disease|2|||
157120416|NCT01425008|567193103|FG003|Dose Escalation Phase|Progressive Disease|3|||
156868255|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868256|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
156868257|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868258|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
156868259|NCT02113982|566277280|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
156868260|NCT02113982|566277281|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
156868261|NCT02113982|566277282|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
157120417|NCT01425008|567193104|FG004|Dose Escalation Phase|Progressive Disease|5|||
157120418|NCT01425008|567193105|FG005|Dose Escalation Phase|Progressive Disease|4|||
156682767|NCT01190930|565584875|FG002|Induction|Death|0|||
156682768|NCT01190930|565584876|FG003|Induction|Death|0|||
156682769|NCT01190930|565584877|FG004|Induction|Death|0|||
156682770|NCT01190930|565584878|FG005|Induction|Death|0|||
156682771|NCT01190930|565584879|FG006|Induction|Death|0|||
156682772|NCT01190930|565584880|FG007|Induction|Death|0|||
156682773|NCT01190930|565584881|FG008|Induction|Death|0|||
156682774|NCT01190930|565584882|FG009|Induction|Death|0|||
156682775|NCT01190930|565584873|FG000|Induction|Lost to Follow-up|1|||
156682776|NCT01190930|565584874|FG001|Induction|Lost to Follow-up|0|||
156682777|NCT01190930|565584875|FG002|Induction|Lost to Follow-up|0|||
156682778|NCT01190930|565584876|FG003|Induction|Lost to Follow-up|0|||
156682779|NCT01190930|565584877|FG004|Induction|Lost to Follow-up|0|||
156682780|NCT01190930|565584878|FG005|Induction|Lost to Follow-up|0|||
156682781|NCT01190930|565584879|FG006|Induction|Lost to Follow-up|0|||
156682782|NCT01190930|565584880|FG007|Induction|Lost to Follow-up|0|||
156682783|NCT01190930|565584881|FG008|Induction|Lost to Follow-up|0|||
156682784|NCT01190930|565584882|FG009|Induction|Lost to Follow-up|0|||
156682785|NCT01190930|565584873|FG000|Induction|Physician Decision|125|||
156682786|NCT01190930|565584874|FG001|Induction|Physician Decision|3|||
156682787|NCT01190930|565584875|FG002|Induction|Physician Decision|0|||
156682788|NCT01190930|565584876|FG003|Induction|Physician Decision|0|||
156682789|NCT01190930|565584877|FG004|Induction|Physician Decision|0|||
156682790|NCT01190930|565584878|FG005|Induction|Physician Decision|0|||
156682791|NCT01190930|565584879|FG006|Induction|Physician Decision|0|||
156682792|NCT01190930|565584880|FG007|Induction|Physician Decision|0|||
156682793|NCT01190930|565584881|FG008|Induction|Physician Decision|0|||
156682794|NCT01190930|565584882|FG009|Induction|Physician Decision|0|||
156682795|NCT01190930|565584873|FG000|Induction|Withdrawal by Subject|9|||
156682796|NCT01190930|565584874|FG001|Induction|Withdrawal by Subject|0|||
156682797|NCT01190930|565584875|FG002|Induction|Withdrawal by Subject|0|||
156682798|NCT01190930|565584876|FG003|Induction|Withdrawal by Subject|0|||
156682799|NCT01190930|565584877|FG004|Induction|Withdrawal by Subject|0|||
156682800|NCT01190930|565584878|FG005|Induction|Withdrawal by Subject|0|||
156682801|NCT01190930|565584879|FG006|Induction|Withdrawal by Subject|0|||
156682802|NCT01190930|565584880|FG007|Induction|Withdrawal by Subject|0|||
156682803|NCT01190930|565584881|FG008|Induction|Withdrawal by Subject|0|||
156682804|NCT01190930|565584882|FG009|Induction|Withdrawal by Subject|0|||
156682805|NCT01190930|565584873|FG000|Induction|Refusal|235|||
156682806|NCT01190930|565584874|FG001|Induction|Refusal|0|||
156682807|NCT01190930|565584875|FG002|Induction|Refusal|0|||
156682808|NCT01190930|565584876|FG003|Induction|Refusal|0|||
156682809|NCT01190930|565584877|FG004|Induction|Refusal|0|||
156682810|NCT01190930|565584878|FG005|Induction|Refusal|0|||
156682811|NCT01190930|565584879|FG006|Induction|Refusal|0|||
156682812|NCT01190930|565584880|FG007|Induction|Refusal|0|||
156682813|NCT01190930|565584881|FG008|Induction|Refusal|0|||
156682814|NCT01190930|565584882|FG009|Induction|Refusal|0|||
156682815|NCT01190930|565584873|FG000|Induction|Inevaluable|23|||
156682816|NCT01190930|565584874|FG001|Induction|Inevaluable|1|||
156682817|NCT01190930|565584875|FG002|Induction|Inevaluable|0|||
156682818|NCT01190930|565584876|FG003|Induction|Inevaluable|0|||
156682819|NCT01190930|565584877|FG004|Induction|Inevaluable|0|||
156682820|NCT01190930|565584878|FG005|Induction|Inevaluable|0|||
156682821|NCT01190930|565584879|FG006|Induction|Inevaluable|0|||
156682822|NCT01190930|565584880|FG007|Induction|Inevaluable|0|||
156682823|NCT01190930|565584881|FG008|Induction|Inevaluable|0|||
156682824|NCT01190930|565584882|FG009|Induction|Inevaluable|0|||
156682825|NCT01190930|565584873|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
156682826|NCT01190930|565584874|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682827|NCT01190930|565584875|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156784456|NCT00625378|565961230|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
156784457|NCT00625378|565961231|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
156784458|NCT00625378|565961230|FG000|Overall Study|Lost to Follow-up|17|||
156784459|NCT00625378|565961231|FG001|Overall Study|Lost to Follow-up|0|||
156682828|NCT01190930|565584876|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156784460|NCT00625378|565961230|FG000|Overall Study|Non-compliant with study medication|3|||
156784461|NCT00625378|565961231|FG001|Overall Study|Non-compliant with study medication|0|||
156682829|NCT01190930|565584877|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682830|NCT01190930|565584878|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682831|NCT01190930|565584879|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682832|NCT01190930|565584880|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682833|NCT01190930|565584881|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682834|NCT01190930|565584882|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
156682835|NCT01190930|565584873|FG000|Induction|High Risk Downs|80|||
156682836|NCT01190930|565584874|FG001|Induction|High Risk Downs|0|||
156682837|NCT01190930|565584875|FG002|Induction|High Risk Downs|0|||
156682838|NCT01190930|565584876|FG003|Induction|High Risk Downs|0|||
156682839|NCT01190930|565584877|FG004|Induction|High Risk Downs|0|||
156682840|NCT01190930|565584878|FG005|Induction|High Risk Downs|0|||
156682841|NCT01190930|565584879|FG006|Induction|High Risk Downs|0|||
156682842|NCT01190930|565584880|FG007|Induction|High Risk Downs|0|||
156682843|NCT01190930|565584881|FG008|Induction|High Risk Downs|0|||
156682844|NCT01190930|565584882|FG009|Induction|High Risk Downs|0|||
156682845|NCT01190930|565584873|FG000|Induction|Enrollment onto another COG Protocol|1|||
156682846|NCT01190930|565584874|FG001|Induction|Enrollment onto another COG Protocol|0|||
156682847|NCT01190930|565584875|FG002|Induction|Enrollment onto another COG Protocol|0|||
156784462|NCT00625378|565961230|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
156784463|NCT00625378|565961231|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
156784464|NCT00625378|565961230|FG000|Overall Study|Medical decision|1|||
156784465|NCT00625378|565961231|FG001|Overall Study|Medical decision|0|||
156784466|NCT00625378|565961230|FG000|Overall Study|Multiple toxicities|1|||
156784467|NCT00625378|565961231|FG001|Overall Study|Multiple toxicities|0|||
156784468|NCT00625378|565961230|FG000|Overall Study|New cancer|1|||
156784469|NCT00625378|565961231|FG001|Overall Study|New cancer|0|||
156784470|NCT00625378|565961230|FG000|Overall Study|PTA program|2|||
156784471|NCT00625378|565961231|FG001|Overall Study|PTA program|0|||
156784472|NCT00625378|565961230|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
156784473|NCT00625378|565961231|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
156784474|NCT00625378|565961230|FG000|Overall Study|Sponsor decision|1|||
156784475|NCT00625378|565961231|FG001|Overall Study|Sponsor decision|0|||
156784476|NCT00625378|565961230|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
156784477|NCT00625378|565961231|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
156784478|NCT00625378|565961230|FG000|Overall Study|Switch to commercial drug|6|||
156784479|NCT00625378|565961231|FG001|Overall Study|Switch to commercial drug|1|||
156784480|NCT00625378|565961230|FG000|Overall Study|Missing|2|||
156784481|NCT00625378|565961231|FG001|Overall Study|Missing|0|||
156868262|NCT02113982|566277283|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
156868263|NCT02113982|566277284|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
156868264|NCT02113982|566277285|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
156682848|NCT01190930|565584876|FG003|Induction|Enrollment onto another COG Protocol|0|||
156682849|NCT01190930|565584877|FG004|Induction|Enrollment onto another COG Protocol|0|||
156682850|NCT01190930|565584878|FG005|Induction|Enrollment onto another COG Protocol|0|||
156682851|NCT01190930|565584879|FG006|Induction|Enrollment onto another COG Protocol|0|||
156682852|NCT01190930|565584880|FG007|Induction|Enrollment onto another COG Protocol|0|||
156682853|NCT01190930|565584881|FG008|Induction|Enrollment onto another COG Protocol|0|||
156682854|NCT01190930|565584882|FG009|Induction|Enrollment onto another COG Protocol|0|||
156682855|NCT01190930|565584873|FG000|Induction|Average Risk|1847|||
156682856|NCT01190930|565584874|FG001|Induction|Average Risk|0|||
156682857|NCT01190930|565584875|FG002|Induction|Average Risk|0|||
156682858|NCT01190930|565584876|FG003|Induction|Average Risk|0|||
156682859|NCT01190930|565584877|FG004|Induction|Average Risk|0|||
156682860|NCT01190930|565584878|FG005|Induction|Average Risk|0|||
156682861|NCT01190930|565584879|FG006|Induction|Average Risk|0|||
156682862|NCT01190930|565584880|FG007|Induction|Average Risk|0|||
156682863|NCT01190930|565584881|FG008|Induction|Average Risk|0|||
156682864|NCT01190930|565584882|FG009|Induction|Average Risk|0|||
156682865|NCT01190930|565584873|FG000|Induction|High Risk|1227|||
156682866|NCT01190930|565584874|FG001|Induction|High Risk|0|||
156682867|NCT01190930|565584875|FG002|Induction|High Risk|0|||
156682868|NCT01190930|565584876|FG003|Induction|High Risk|0|||
156682869|NCT01190930|565584877|FG004|Induction|High Risk|0|||
156682870|NCT01190930|565584878|FG005|Induction|High Risk|0|||
156682871|NCT01190930|565584879|FG006|Induction|High Risk|0|||
156682872|NCT01190930|565584880|FG007|Induction|High Risk|0|||
156682873|NCT01190930|565584881|FG008|Induction|High Risk|0|||
156682874|NCT01190930|565584882|FG009|Induction|High Risk|0|||
156682875|NCT01190930|565584873|FG000|Induction|Low Risk|443|||
156682876|NCT01190930|565584874|FG001|Induction|Low Risk|0|||
156682877|NCT01190930|565584875|FG002|Induction|Low Risk|0|||
156682878|NCT01190930|565584876|FG003|Induction|Low Risk|0|||
156682879|NCT01190930|565584877|FG004|Induction|Low Risk|0|||
156682880|NCT01190930|565584878|FG005|Induction|Low Risk|0|||
156682881|NCT01190930|565584879|FG006|Induction|Low Risk|0|||
156682882|NCT01190930|565584880|FG007|Induction|Low Risk|0|||
156682883|NCT01190930|565584881|FG008|Induction|Low Risk|0|||
156682884|NCT01190930|565584882|FG009|Induction|Low Risk|0|||
156682885|NCT01190930|565584873|FG000|Induction|Very High Risk|1012|||
156784482|NCT00625378|565961230|FG000|Overall Study|End of treatment not available|2|||
156784483|NCT00625378|565961231|FG001|Overall Study|End of treatment not available|0|||
156784484|NCT00625378|565961230|FG000|Overall Study|Never treated|2|||
156784485|NCT00625378|565961231|FG001|Overall Study|Never treated|0|||
156784486|NCT03753542|565961233|FG000|Overall Study|Lost to Follow-up|9|||
156682886|NCT01190930|565584874|FG001|Induction|Very High Risk|0|||
156682887|NCT01190930|565584875|FG002|Induction|Very High Risk|0|||
156682888|NCT01190930|565584876|FG003|Induction|Very High Risk|0|||
156682889|NCT01190930|565584877|FG004|Induction|Very High Risk|0|||
156682890|NCT01190930|565584878|FG005|Induction|Very High Risk|0|||
156682891|NCT01190930|565584879|FG006|Induction|Very High Risk|0|||
156682892|NCT01190930|565584880|FG007|Induction|Very High Risk|0|||
156682893|NCT01190930|565584881|FG008|Induction|Very High Risk|0|||
156682894|NCT01190930|565584882|FG009|Induction|Very High Risk|0|||
156682895|NCT01190930|565584873|FG000|Induction|Philadelphia chromosome-positive|99|||
156682896|NCT01190930|565584874|FG001|Induction|Philadelphia chromosome-positive|0|||
156682897|NCT01190930|565584875|FG002|Induction|Philadelphia chromosome-positive|0|||
156682898|NCT01190930|565584876|FG003|Induction|Philadelphia chromosome-positive|0|||
157120419|NCT01425008|567193106|FG006|Dose Escalation Phase|Progressive Disease|0|||
157120420|NCT01425008|567193107|FG007|Dose Escalation Phase|Progressive Disease|2|||
157120421|NCT01425008|567193108|FG008|Dose Escalation Phase|Progressive Disease|6|||
157120422|NCT01425008|567193109|FG009|Dose Escalation Phase|Progressive Disease|2|||
157120423|NCT01425008|567193110|FG010|Dose Escalation Phase|Progressive Disease|0|||
156682899|NCT01190930|565584877|FG004|Induction|Philadelphia chromosome-positive|0|||
156682900|NCT01190930|565584878|FG005|Induction|Philadelphia chromosome-positive|0|||
156682901|NCT01190930|565584879|FG006|Induction|Philadelphia chromosome-positive|0|||
156682902|NCT01190930|565584880|FG007|Induction|Philadelphia chromosome-positive|0|||
156682903|NCT01190930|565584881|FG008|Induction|Philadelphia chromosome-positive|0|||
156682904|NCT01190930|565584882|FG009|Induction|Philadelphia chromosome-positive|0|||
156682905|NCT01190930|565584873|FG000|Induction|Incomplete Induction data|63|||
156682906|NCT01190930|565584874|FG001|Induction|Incomplete Induction data|0|||
156682907|NCT01190930|565584875|FG002|Induction|Incomplete Induction data|0|||
156682908|NCT01190930|565584876|FG003|Induction|Incomplete Induction data|0|||
156682909|NCT01190930|565584877|FG004|Induction|Incomplete Induction data|0|||
156682910|NCT01190930|565584878|FG005|Induction|Incomplete Induction data|0|||
156682911|NCT01190930|565584879|FG006|Induction|Incomplete Induction data|0|||
156682912|NCT01190930|565584880|FG007|Induction|Incomplete Induction data|0|||
156682913|NCT01190930|565584881|FG008|Induction|Incomplete Induction data|0|||
156682914|NCT01190930|565584882|FG009|Induction|Incomplete Induction data|0|||
156682915|NCT01190930|565584873|FG000|Induction|Progressive disease|0|||
156682916|NCT01190930|565584874|FG001|Induction|Progressive disease|1|||
156682917|NCT01190930|565584875|FG002|Induction|Progressive disease|0|||
156682918|NCT01190930|565584876|FG003|Induction|Progressive disease|0|||
156682919|NCT01190930|565584877|FG004|Induction|Progressive disease|0|||
156682920|NCT01190930|565584878|FG005|Induction|Progressive disease|0|||
156682921|NCT01190930|565584879|FG006|Induction|Progressive disease|0|||
156682922|NCT01190930|565584880|FG007|Induction|Progressive disease|0|||
156682923|NCT01190930|565584881|FG008|Induction|Progressive disease|0|||
156682924|NCT01190930|565584882|FG009|Induction|Progressive disease|0|||
156682925|NCT01190930|565584873|FG000|Induction|No treatment|3|||
156682926|NCT01190930|565584874|FG001|Induction|No treatment|0|||
156682927|NCT01190930|565584875|FG002|Induction|No treatment|0|||
156682928|NCT01190930|565584876|FG003|Induction|No treatment|0|||
156682929|NCT01190930|565584877|FG004|Induction|No treatment|0|||
156682930|NCT01190930|565584878|FG005|Induction|No treatment|0|||
156682931|NCT01190930|565584879|FG006|Induction|No treatment|0|||
156682932|NCT01190930|565584880|FG007|Induction|No treatment|0|||
156682933|NCT01190930|565584881|FG008|Induction|No treatment|0|||
156682934|NCT01190930|565584882|FG009|Induction|No treatment|0|||
156682935|NCT01190930|565584873|FG000|Induction|Ineligible|69|||
156682936|NCT01190930|565584874|FG001|Induction|Ineligible|4|||
156682937|NCT01190930|565584875|FG002|Induction|Ineligible|0|||
156682938|NCT01190930|565584876|FG003|Induction|Ineligible|0|||
156682939|NCT01190930|565584877|FG004|Induction|Ineligible|0|||
156682940|NCT01190930|565584878|FG005|Induction|Ineligible|0|||
156682941|NCT01190930|565584879|FG006|Induction|Ineligible|0|||
156682942|NCT01190930|565584880|FG007|Induction|Ineligible|0|||
156682943|NCT01190930|565584881|FG008|Induction|Ineligible|0|||
156682944|NCT01190930|565584882|FG009|Induction|Ineligible|0|||
156682945|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
156682946|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
156682947|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
156682948|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
156682949|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
156682950|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
156682951|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
156682952|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
156682953|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
156682954|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
156682955|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Death|0|||
156682956|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Death|0|||
156682957|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Death|8|||
156682958|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Death|4|||
156682959|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Death|0|||
156682960|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Death|0|||
156682961|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Death|0|||
156682962|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Death|0|||
156784487|NCT03753542|565961234|FG001|Overall Study|Lost to Follow-up|14|||
156682963|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Death|0|||
156682964|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Death|0|||
156682965|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
156682966|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
156682967|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
156868265|NCT02113982|566277286|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
156868266|NCT02113982|566277287|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
156868267|NCT02113982|566277288|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
156868268|NCT02113982|566277289|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
156868269|NCT02113982|566277290|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
156868270|NCT02113982|566277291|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
156868271|NCT02113982|566277292|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
156868272|NCT02113982|566277293|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
156868273|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868274|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868275|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868276|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868277|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868278|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868279|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868280|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868281|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868282|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868283|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868284|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868285|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
156868286|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
156868287|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868288|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868289|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868290|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868291|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868292|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868293|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868294|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868295|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868296|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868297|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868298|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
156868299|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
156868300|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
156868301|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868302|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868303|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868304|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868305|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868306|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868307|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868308|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868309|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868310|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868311|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868312|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
156868313|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
156868314|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
156868315|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868316|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868317|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868318|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868319|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868320|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868321|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868322|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868323|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868324|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868325|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868326|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
156868327|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
156868328|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
156868329|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868330|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
157013071|NCT02723955|566801765|FG028|Expansion Phase|Death|0|||
157213387|NCT00368537|567529489|FG001|Baseline Participants|Lost to Follow-up|17|||
156682968|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
156682969|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
156682970|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
156682971|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
156682972|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
156682973|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
156682974|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
156682975|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682976|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
156682977|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
156682978|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
156682979|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682980|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682981|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682982|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682983|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682984|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
156682985|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Refusal|0|||
156682986|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Refusal|2|||
156682987|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Refusal|694|||
156682988|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Refusal|4|||
156682989|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Refusal|0|||
156682990|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Refusal|3|||
156682991|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Refusal|0|||
156682992|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Refusal|0|||
156682993|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Refusal|0|||
156682994|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Refusal|0|||
156682995|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
156682996|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
156682997|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
156682998|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
156682999|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
156683000|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
156683001|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
156683002|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
156683003|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
156683004|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
156683005|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683006|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
156683007|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683008|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683009|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683010|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683011|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683012|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683013|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683014|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
156683015|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
156683016|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
156683017|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
156683018|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
156683019|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
156683020|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
156683021|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
156683022|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
156683023|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
156683024|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
156683025|NCT01190930|565584873|FG000|Post Induction Pre-Maintenance|Relapse|0|||
156683026|NCT01190930|565584874|FG001|Post Induction Pre-Maintenance|Relapse|0|||
156683027|NCT01190930|565584875|FG002|Post Induction Pre-Maintenance|Relapse|1|||
156683028|NCT01190930|565584876|FG003|Post Induction Pre-Maintenance|Relapse|0|||
156683029|NCT01190930|565584877|FG004|Post Induction Pre-Maintenance|Relapse|0|||
156683030|NCT01190930|565584878|FG005|Post Induction Pre-Maintenance|Relapse|0|||
156683031|NCT01190930|565584879|FG006|Post Induction Pre-Maintenance|Relapse|0|||
156683032|NCT01190930|565584880|FG007|Post Induction Pre-Maintenance|Relapse|0|||
156683033|NCT01190930|565584881|FG008|Post Induction Pre-Maintenance|Relapse|0|||
156683034|NCT01190930|565584882|FG009|Post Induction Pre-Maintenance|Relapse|0|||
156683035|NCT01190930|565584873|FG000|Maintenance|Adverse Event|0|||
156683036|NCT01190930|565584874|FG001|Maintenance|Adverse Event|0|||
156683037|NCT01190930|565584875|FG002|Maintenance|Adverse Event|0|||
156683038|NCT01190930|565584876|FG003|Maintenance|Adverse Event|0|||
156683039|NCT01190930|565584877|FG004|Maintenance|Adverse Event|0|||
156683040|NCT01190930|565584878|FG005|Maintenance|Adverse Event|1|||
156683041|NCT01190930|565584879|FG006|Maintenance|Adverse Event|1|||
156683042|NCT01190930|565584880|FG007|Maintenance|Adverse Event|3|||
156683043|NCT01190930|565584881|FG008|Maintenance|Adverse Event|3|||
156683044|NCT01190930|565584882|FG009|Maintenance|Adverse Event|0|||
156683045|NCT01190930|565584873|FG000|Maintenance|Death|0|||
156683046|NCT01190930|565584874|FG001|Maintenance|Death|0|||
156683047|NCT01190930|565584875|FG002|Maintenance|Death|0|||
156683048|NCT01190930|565584876|FG003|Maintenance|Death|1|||
156683049|NCT01190930|565584877|FG004|Maintenance|Death|0|||
156683050|NCT01190930|565584878|FG005|Maintenance|Death|0|||
156683051|NCT01190930|565584879|FG006|Maintenance|Death|2|||
156683052|NCT01190930|565584880|FG007|Maintenance|Death|2|||
156683053|NCT01190930|565584881|FG008|Maintenance|Death|2|||
156683054|NCT01190930|565584882|FG009|Maintenance|Death|2|||
156683055|NCT01190930|565584873|FG000|Maintenance|Lost to Follow-up|0|||
156683056|NCT01190930|565584874|FG001|Maintenance|Lost to Follow-up|0|||
156683057|NCT01190930|565584875|FG002|Maintenance|Lost to Follow-up|0|||
156683058|NCT01190930|565584876|FG003|Maintenance|Lost to Follow-up|0|||
156683059|NCT01190930|565584877|FG004|Maintenance|Lost to Follow-up|0|||
156683060|NCT01190930|565584878|FG005|Maintenance|Lost to Follow-up|0|||
156683061|NCT01190930|565584879|FG006|Maintenance|Lost to Follow-up|1|||
156683062|NCT01190930|565584880|FG007|Maintenance|Lost to Follow-up|1|||
156683063|NCT01190930|565584881|FG008|Maintenance|Lost to Follow-up|1|||
156683064|NCT01190930|565584882|FG009|Maintenance|Lost to Follow-up|0|||
156683065|NCT01190930|565584873|FG000|Maintenance|Physician Decision|0|||
156683066|NCT01190930|565584874|FG001|Maintenance|Physician Decision|1|||
156683067|NCT01190930|565584875|FG002|Maintenance|Physician Decision|0|||
156683068|NCT01190930|565584876|FG003|Maintenance|Physician Decision|5|||
156683069|NCT01190930|565584877|FG004|Maintenance|Physician Decision|9|||
156683070|NCT01190930|565584878|FG005|Maintenance|Physician Decision|4|||
156683071|NCT01190930|565584879|FG006|Maintenance|Physician Decision|8|||
156683072|NCT01190930|565584880|FG007|Maintenance|Physician Decision|8|||
156683073|NCT01190930|565584881|FG008|Maintenance|Physician Decision|10|||
156683074|NCT01190930|565584882|FG009|Maintenance|Physician Decision|17|||
156683075|NCT01190930|565584873|FG000|Maintenance|Withdrawal by Subject|0|||
156683076|NCT01190930|565584874|FG001|Maintenance|Withdrawal by Subject|0|||
156683077|NCT01190930|565584875|FG002|Maintenance|Withdrawal by Subject|0|||
156683078|NCT01190930|565584876|FG003|Maintenance|Withdrawal by Subject|0|||
156683079|NCT01190930|565584877|FG004|Maintenance|Withdrawal by Subject|0|||
156683080|NCT01190930|565584878|FG005|Maintenance|Withdrawal by Subject|0|||
156683081|NCT01190930|565584879|FG006|Maintenance|Withdrawal by Subject|2|||
156683082|NCT01190930|565584880|FG007|Maintenance|Withdrawal by Subject|1|||
156683083|NCT01190930|565584881|FG008|Maintenance|Withdrawal by Subject|4|||
156683084|NCT01190930|565584882|FG009|Maintenance|Withdrawal by Subject|1|||
156683085|NCT01190930|565584873|FG000|Maintenance|Refusal|0|||
156683086|NCT01190930|565584874|FG001|Maintenance|Refusal|1|||
156683087|NCT01190930|565584875|FG002|Maintenance|Refusal|0|||
156683088|NCT01190930|565584876|FG003|Maintenance|Refusal|2|||
156683089|NCT01190930|565584877|FG004|Maintenance|Refusal|0|||
156683090|NCT01190930|565584878|FG005|Maintenance|Refusal|4|||
156683091|NCT01190930|565584879|FG006|Maintenance|Refusal|5|||
156683092|NCT01190930|565584880|FG007|Maintenance|Refusal|17|||
156683093|NCT01190930|565584881|FG008|Maintenance|Refusal|13|||
156683094|NCT01190930|565584882|FG009|Maintenance|Refusal|6|||
156683095|NCT01190930|565584873|FG000|Maintenance|second malignant neoplasm|0|||
156683096|NCT01190930|565584874|FG001|Maintenance|second malignant neoplasm|0|||
156683097|NCT01190930|565584875|FG002|Maintenance|second malignant neoplasm|0|||
156683098|NCT01190930|565584876|FG003|Maintenance|second malignant neoplasm|1|||
156683099|NCT01190930|565584877|FG004|Maintenance|second malignant neoplasm|0|||
156683100|NCT01190930|565584878|FG005|Maintenance|second malignant neoplasm|1|||
156683101|NCT01190930|565584879|FG006|Maintenance|second malignant neoplasm|0|||
156683102|NCT01190930|565584880|FG007|Maintenance|second malignant neoplasm|0|||
156683103|NCT01190930|565584881|FG008|Maintenance|second malignant neoplasm|1|||
156683104|NCT01190930|565584882|FG009|Maintenance|second malignant neoplasm|0|||
156683105|NCT01190930|565584873|FG000|Maintenance|Inevaluable|0|||
156683106|NCT01190930|565584874|FG001|Maintenance|Inevaluable|0|||
156683107|NCT01190930|565584875|FG002|Maintenance|Inevaluable|0|||
156683108|NCT01190930|565584876|FG003|Maintenance|Inevaluable|0|||
156683109|NCT01190930|565584877|FG004|Maintenance|Inevaluable|0|||
156683110|NCT01190930|565584878|FG005|Maintenance|Inevaluable|1|||
156683111|NCT01190930|565584879|FG006|Maintenance|Inevaluable|1|||
156683112|NCT01190930|565584880|FG007|Maintenance|Inevaluable|1|||
156683113|NCT01190930|565584881|FG008|Maintenance|Inevaluable|0|||
156683114|NCT01190930|565584882|FG009|Maintenance|Inevaluable|0|||
156683115|NCT01190930|565584873|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
156683116|NCT01190930|565584874|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
156683117|NCT01190930|565584875|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
156683118|NCT01190930|565584876|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
156683119|NCT01190930|565584877|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
156683120|NCT01190930|565584878|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
156683121|NCT01190930|565584879|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
156683122|NCT01190930|565584880|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
156683123|NCT01190930|565584881|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
156683124|NCT01190930|565584882|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
156683125|NCT01190930|565584873|FG000|Maintenance|Relapse|0|||
156683126|NCT01190930|565584874|FG001|Maintenance|Relapse|0|||
156683127|NCT01190930|565584875|FG002|Maintenance|Relapse|0|||
156683128|NCT01190930|565584876|FG003|Maintenance|Relapse|2|||
156683129|NCT01190930|565584877|FG004|Maintenance|Relapse|0|||
156683130|NCT01190930|565584878|FG005|Maintenance|Relapse|1|||
156683131|NCT01190930|565584879|FG006|Maintenance|Relapse|6|||
156683132|NCT01190930|565584880|FG007|Maintenance|Relapse|13|||
156683133|NCT01190930|565584881|FG008|Maintenance|Relapse|11|||
156683134|NCT01190930|565584882|FG009|Maintenance|Relapse|11|||
156683135|NCT01190930|565584873|FG000|Maintenance|Still on therapy|0|||
156683136|NCT01190930|565584874|FG001|Maintenance|Still on therapy|8|||
156683137|NCT01190930|565584875|FG002|Maintenance|Still on therapy|0|||
156683138|NCT01190930|565584876|FG003|Maintenance|Still on therapy|29|||
156683139|NCT01190930|565584877|FG004|Maintenance|Still on therapy|0|||
156683140|NCT01190930|565584878|FG005|Maintenance|Still on therapy|0|||
156683141|NCT01190930|565584879|FG006|Maintenance|Still on therapy|0|||
157213388|NCT00368537|567529488|FG000|Baseline Participants|Withdrawal by Subject|6|||
156683142|NCT01190930|565584880|FG007|Maintenance|Still on therapy|0|||
156683143|NCT01190930|565584881|FG008|Maintenance|Still on therapy|0|||
156683144|NCT01190930|565584882|FG009|Maintenance|Still on therapy|0|||
156683145|NCT00979212|565584886|FG000|Overall Study|Protocol Violation|1|||
156683146|NCT00979212|565584887|FG001|Overall Study|Protocol Violation|8|||
156683147|NCT00979212|565584886|FG000|Overall Study|No protocol therapy received|1|||
156683148|NCT00979212|565584887|FG001|Overall Study|No protocol therapy received|0|||
156683149|NCT00035555|565584888|FG000|Overall Study|Adverse Event|5|||
156683150|NCT00035555|565584889|FG001|Overall Study|Adverse Event|8|||
156683151|NCT00035555|565584890|FG002|Overall Study|Adverse Event|9|||
156683152|NCT00035555|565584888|FG000|Overall Study|Allograft loss|1|||
156683153|NCT00035555|565584889|FG001|Overall Study|Allograft loss|1|||
156683154|NCT00035555|565584890|FG002|Overall Study|Allograft loss|2|||
156683155|NCT00035555|565584888|FG000|Overall Study|Death|0|||
156683156|NCT00035555|565584889|FG001|Overall Study|Death|0|||
156683157|NCT00035555|565584890|FG002|Overall Study|Death|2|||
156683158|NCT00035555|565584888|FG000|Overall Study|Lost to Follow-up|0|||
156683159|NCT00035555|565584889|FG001|Overall Study|Lost to Follow-up|0|||
156683160|NCT00035555|565584890|FG002|Overall Study|Lost to Follow-up|1|||
156683161|NCT00035555|565584888|FG000|Overall Study|Noncompliance|0|||
156683162|NCT00035555|565584889|FG001|Overall Study|Noncompliance|1|||
156683163|NCT00035555|565584890|FG002|Overall Study|Noncompliance|1|||
156683164|NCT00035555|565584888|FG000|Overall Study|Prohibited medication|1|||
156683165|NCT00035555|565584889|FG001|Overall Study|Prohibited medication|1|||
156683166|NCT00035555|565584890|FG002|Overall Study|Prohibited medication|0|||
156683167|NCT00035555|565584888|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
156683168|NCT00035555|565584889|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
156683169|NCT00035555|565584890|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
157213389|NCT00368537|567529489|FG001|Baseline Participants|Withdrawal by Subject|4|||
156683170|NCT00035555|565584888|FG000|Overall Study|Withdrawal by Subject|2|||
156683171|NCT00035555|565584889|FG001|Overall Study|Withdrawal by Subject|0|||
156683172|NCT00035555|565584890|FG002|Overall Study|Withdrawal by Subject|2|||
156683173|NCT00035555|565584888|FG000|Overall Study|Investigator deemed not a good candidate|0|||
156683174|NCT00035555|565584889|FG001|Overall Study|Investigator deemed not a good candidate|0|||
156683175|NCT00035555|565584890|FG002|Overall Study|Investigator deemed not a good candidate|1|||
156784488|NCT04210375|565961236|FG000|Overall Study|Death|0|||
156784489|NCT04210375|565961237|FG001|Overall Study|Death|1|||
156784490|NCT04210375|565961238|FG002|Overall Study|Death|0|||
156784491|NCT04210375|565961239|FG003|Overall Study|Death|0|||
156784492|NCT05752487|565961240|FG000|Overall Study|Enrolled, not treated|9|||
156683176|NCT00035555|565584888|FG000|Overall Study|Received cyclosporin in error|0|||
156683177|NCT00035555|565584889|FG001|Overall Study|Received cyclosporin in error|0|||
156683178|NCT00035555|565584890|FG002|Overall Study|Received cyclosporin in error|1|||
157213390|NCT00368537|567529488|FG000|Baseline Participants|Death|1|||
156683179|NCT00337428|565584891|FG000|Overall Study|Withdrawal by Subject|1|||
156683180|NCT00337428|565584892|FG001|Overall Study|Withdrawal by Subject|2|||
156784493|NCT05752487|565961240|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
156683181|NCT00337428|565584891|FG000|Overall Study|Lack of Time|1|||
156683182|NCT00337428|565584892|FG001|Overall Study|Lack of Time|1|||
156683183|NCT00337428|565584891|FG000|Overall Study|Unwilling to Continue|1|||
156683184|NCT00337428|565584892|FG001|Overall Study|Unwilling to Continue|0|||
156683185|NCT00337428|565584891|FG000|Overall Study|Anorexia|1|||
156683186|NCT00337428|565584892|FG001|Overall Study|Anorexia|0|||
156683187|NCT02618382|565584893|FG000|Overall Study|Physician Decision|1|||
156683188|NCT02618382|565584893|FG000|Overall Study|Withdrawal by Subject|1|||
156683189|NCT02618382|565584893|FG000|Overall Study|Protocol Violation|1|||
156683190|NCT04886063|565584900|FG000|Overall Study|Adverse Event|50|||
156683191|NCT04886063|565584900|FG000|Overall Study|Lack of Efficacy|31|||
156683192|NCT04886063|565584900|FG000|Overall Study|Withdrawal by Subject|45|||
156683193|NCT04886063|565584900|FG000|Overall Study|Physician Decision|3|||
156683194|NCT04886063|565584900|FG000|Overall Study|Protocol Violation|3|||
156683195|NCT04886063|565584900|FG000|Overall Study|Site closure|4|||
156683196|NCT04886063|565584900|FG000|Overall Study|Nursing home replacement|3|||
156683197|NCT04886063|565584900|FG000|Overall Study|Lost to Follow-up|5|||
156683198|NCT04886063|565584900|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
156683199|NCT04886063|565584900|FG000|Overall Study|>1 reason|20|||
156683200|NCT01628549|565584901|FG000|Overall Study|Adverse Event|1|||
156683201|NCT01628549|565584902|FG001|Overall Study|Adverse Event|1|||
156683202|NCT01628549|565584903|FG002|Overall Study|Adverse Event|0|||
157213391|NCT00368537|567529489|FG001|Baseline Participants|Death|2|||
156784494|NCT05752487|565961240|FG000|Overall Study|Withdrawal by Subject|2|||
156784495|NCT04124965|565961242|FG000|Overall Study|Adverse event, non-fatal|3|||
156683203|NCT01628549|565584904|FG003|Overall Study|Adverse Event|4|||
156683204|NCT01628549|565584901|FG000|Overall Study|Lost to Follow-up|3|||
156683205|NCT01628549|565584902|FG001|Overall Study|Lost to Follow-up|4|||
156683206|NCT01628549|565584903|FG002|Overall Study|Lost to Follow-up|3|||
157013072|NCT02723955|566801766|FG029|Expansion Phase|Death|12|||
156683207|NCT01628549|565584904|FG003|Overall Study|Lost to Follow-up|3|||
157013073|NCT02723955|566801767|FG030|Expansion Phase|Death|202|||
157013074|NCT02723955|566801768|FG031|Expansion Phase|Death|31|||
157013075|NCT02723955|566801769|FG032|Expansion Phase|Death|17|||
157013076|NCT02723955|566801770|FG033|Expansion Phase|Death|2|||
157013077|NCT02723955|566801771|FG034|Expansion Phase|Death|3|||
157013078|NCT02723955|566801772|FG035|Expansion Phase|Death|3|||
157013079|NCT02723955|566801773|FG036|Expansion Phase|Death|1|||
157013080|NCT02723955|566801774|FG037|Expansion Phase|Death|0|||
157013081|NCT02723955|566801775|FG038|Expansion Phase|Death|0|||
157013082|NCT02723955|566801776|FG039|Expansion Phase|Death|0|||
157013083|NCT02723955|566801777|FG040|Expansion Phase|Death|0|||
157013084|NCT02723955|566801778|FG041|Expansion Phase|Death|0|||
157013085|NCT02723955|566801779|FG042|Expansion Phase|Death|0|||
157013086|NCT02723955|566801737|FG000|Expansion Phase|Lost to Follow-up|0|||
157013087|NCT02723955|566801738|FG001|Expansion Phase|Lost to Follow-up|0|||
157013088|NCT02723955|566801739|FG002|Expansion Phase|Lost to Follow-up|0|||
157013089|NCT02723955|566801740|FG003|Expansion Phase|Lost to Follow-up|0|||
157013090|NCT02723955|566801741|FG004|Expansion Phase|Lost to Follow-up|0|||
157013091|NCT02723955|566801742|FG005|Expansion Phase|Lost to Follow-up|0|||
157013092|NCT02723955|566801743|FG006|Expansion Phase|Lost to Follow-up|0|||
157013093|NCT02723955|566801744|FG007|Expansion Phase|Lost to Follow-up|0|||
157013094|NCT02723955|566801745|FG008|Expansion Phase|Lost to Follow-up|0|||
157013095|NCT02723955|566801746|FG009|Expansion Phase|Lost to Follow-up|0|||
157013096|NCT02723955|566801747|FG010|Expansion Phase|Lost to Follow-up|4|||
157013097|NCT02723955|566801748|FG011|Expansion Phase|Lost to Follow-up|1|||
157013098|NCT02723955|566801749|FG012|Expansion Phase|Lost to Follow-up|0|||
157013099|NCT02723955|566801750|FG013|Expansion Phase|Lost to Follow-up|0|||
157013100|NCT02723955|566801751|FG014|Expansion Phase|Lost to Follow-up|0|||
157013101|NCT02723955|566801752|FG015|Expansion Phase|Lost to Follow-up|0|||
157013102|NCT02723955|566801753|FG016|Expansion Phase|Lost to Follow-up|0|||
157013103|NCT02723955|566801754|FG017|Expansion Phase|Lost to Follow-up|0|||
157013104|NCT02723955|566801755|FG018|Expansion Phase|Lost to Follow-up|0|||
157013105|NCT02723955|566801756|FG019|Expansion Phase|Lost to Follow-up|0|||
157013106|NCT02723955|566801757|FG020|Expansion Phase|Lost to Follow-up|0|||
157013107|NCT02723955|566801758|FG021|Expansion Phase|Lost to Follow-up|0|||
157013108|NCT02723955|566801759|FG022|Expansion Phase|Lost to Follow-up|0|||
157013109|NCT02723955|566801760|FG023|Expansion Phase|Lost to Follow-up|0|||
157013110|NCT02723955|566801761|FG024|Expansion Phase|Lost to Follow-up|0|||
157013111|NCT02723955|566801762|FG025|Expansion Phase|Lost to Follow-up|0|||
157013112|NCT02723955|566801763|FG026|Expansion Phase|Lost to Follow-up|0|||
157013113|NCT02723955|566801764|FG027|Expansion Phase|Lost to Follow-up|0|||
157013114|NCT02723955|566801765|FG028|Expansion Phase|Lost to Follow-up|0|||
157013115|NCT02723955|566801766|FG029|Expansion Phase|Lost to Follow-up|1|||
157013116|NCT02723955|566801767|FG030|Expansion Phase|Lost to Follow-up|19|||
157013117|NCT02723955|566801768|FG031|Expansion Phase|Lost to Follow-up|2|||
157013118|NCT02723955|566801769|FG032|Expansion Phase|Lost to Follow-up|1|||
157013119|NCT02723955|566801770|FG033|Expansion Phase|Lost to Follow-up|0|||
157013120|NCT02723955|566801771|FG034|Expansion Phase|Lost to Follow-up|0|||
157013121|NCT02723955|566801772|FG035|Expansion Phase|Lost to Follow-up|0|||
157013122|NCT02723955|566801773|FG036|Expansion Phase|Lost to Follow-up|0|||
157013123|NCT02723955|566801774|FG037|Expansion Phase|Lost to Follow-up|0|||
157013124|NCT02723955|566801775|FG038|Expansion Phase|Lost to Follow-up|0|||
157013125|NCT02723955|566801776|FG039|Expansion Phase|Lost to Follow-up|0|||
157013126|NCT02723955|566801777|FG040|Expansion Phase|Lost to Follow-up|0|||
157013127|NCT02723955|566801778|FG041|Expansion Phase|Lost to Follow-up|0|||
157013128|NCT02723955|566801779|FG042|Expansion Phase|Lost to Follow-up|0|||
157013129|NCT02723955|566801737|FG000|Expansion Phase|Physician Decision|0|||
156683208|NCT01628549|565584901|FG000|Overall Study|Withdrawal by Subject|3|||
156683209|NCT01628549|565584902|FG001|Overall Study|Withdrawal by Subject|4|||
156683210|NCT01628549|565584903|FG002|Overall Study|Withdrawal by Subject|4|||
156683211|NCT01628549|565584904|FG003|Overall Study|Withdrawal by Subject|1|||
156683212|NCT01628549|565584901|FG000|Overall Study|Protocol Violation|2|||
156683213|NCT01628549|565584902|FG001|Overall Study|Protocol Violation|1|||
156683214|NCT01628549|565584903|FG002|Overall Study|Protocol Violation|1|||
156683215|NCT01628549|565584904|FG003|Overall Study|Protocol Violation|0|||
156683216|NCT01628549|565584901|FG000|Overall Study|withdrawn for noncompliance|0|||
156784496|NCT04124965|565961243|FG001|Overall Study|Adverse event, non-fatal|1|||
156784497|NCT04124965|565961242|FG000|Overall Study|Withdrawal by Subject|1|||
156784498|NCT04124965|565961243|FG001|Overall Study|Withdrawal by Subject|1|||
156784499|NCT04124965|565961242|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
156784500|NCT04124965|565961243|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
156784501|NCT04124965|565961242|FG000|Overall Study|Pregnancy|1|||
156784502|NCT04124965|565961243|FG001|Overall Study|Pregnancy|0|||
156784503|NCT04124965|565961242|FG000|Overall Study|Sponsor and participant decision|0|||
156784504|NCT04124965|565961243|FG001|Overall Study|Sponsor and participant decision|1|||
157213392|NCT00368537|567529488|FG000|Baseline Participants|No susceptibility|1|||
157213393|NCT00368537|567529489|FG001|Baseline Participants|No susceptibility|0|||
157213394|NCT00368537|567529488|FG000|Baseline Participants|Patient uncompliant|0|||
157213395|NCT00368537|567529489|FG001|Baseline Participants|Patient uncompliant|1|||
157213396|NCT00685919|567529491|FG000|Overall Study|Withdrawal by Subject|0|||
157213397|NCT00685919|567529492|FG001|Overall Study|Withdrawal by Subject|0|||
157213398|NCT00685919|567529493|FG002|Overall Study|Withdrawal by Subject|1|||
157213399|NCT00685919|567529494|FG003|Overall Study|Withdrawal by Subject|0|||
157213400|NCT00685919|567529491|FG000|Overall Study|Physician Decision|1|||
157213401|NCT00685919|567529492|FG001|Overall Study|Physician Decision|0|||
157213402|NCT00685919|567529493|FG002|Overall Study|Physician Decision|0|||
157213403|NCT00685919|567529494|FG003|Overall Study|Physician Decision|0|||
157213404|NCT01717456|567529499|FG000|End of Treatment|Physician Decision|0|||
157213405|NCT01717456|567529500|FG001|End of Treatment|Physician Decision|1|||
157213406|NCT01717456|567529499|FG000|End of Treatment|Lost to Follow-up|0|||
157213407|NCT01717456|567529500|FG001|End of Treatment|Lost to Follow-up|1|||
157213408|NCT01717456|567529499|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
157213409|NCT01717456|567529500|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
157213410|NCT02732561|567529502|FG000|Overall Study|Lost to Follow-up|1|||
157213411|NCT02732561|567529503|FG001|Overall Study|Lost to Follow-up|1|||
157213412|NCT02732561|567529502|FG000|Overall Study|Withdrawal by Subject|1|||
157213413|NCT02732561|567529503|FG001|Overall Study|Withdrawal by Subject|0|||
157213414|NCT00755937|567529504|FG000|Recruitment|Unknown if infliximab received|164|||
157213415|NCT00755937|567529504|FG000|Observational Follow-up|Lost to Follow-up|148|||
157213416|NCT00751998|567529513|FG000|Overall Study|Lost to Follow-up|7|||
157213417|NCT00751998|567529513|FG000|Overall Study|Death|11|||
157213418|NCT00751998|567529513|FG000|Overall Study|Withdrawal by Subject|2|||
157213419|NCT01223196|567529515|FG000|Overall Study|Lost to Follow-up|2|||
157213420|NCT01223196|567529516|FG001|Overall Study|Lost to Follow-up|0|||
157213421|NCT01223196|567529515|FG000|Overall Study|Physician Decision|1|||
157213422|NCT01223196|567529516|FG001|Overall Study|Physician Decision|0|||
157213423|NCT01223196|567529515|FG000|Overall Study|Withdrawal by Subject|1|||
157213424|NCT01223196|567529516|FG001|Overall Study|Withdrawal by Subject|0|||
157213425|NCT02629133|567529517|FG000|Overall Study|Lost to Follow-up|3|||
157213426|NCT02629133|567529518|FG001|Overall Study|Lost to Follow-up|1|||
157213427|NCT02629133|567529517|FG000|Overall Study|Withdrawal by Subject|1|||
157213428|NCT02629133|567529518|FG001|Overall Study|Withdrawal by Subject|1|||
157213429|NCT01238822|567529519|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
157213430|NCT02598193|567529520|FG000|Overall Study|Adverse Event|13|||
157213431|NCT02598193|567529520|FG000|Overall Study|Withdrawal by Subject|1|||
157213432|NCT02598193|567529520|FG000|Overall Study|Listed in active lung transplant list|1|||
157213433|NCT02598193|567529520|FG000|Overall Study|Does not want to take Nintedanib|1|||
157213434|NCT02487979|567529521|FG000|Overall Study|Physician Decision|2|||
157213435|NCT02487979|567529521|FG000|Overall Study|Withdrawal by Subject|2|||
157213436|NCT02487979|567529521|FG000|Overall Study|Progressive Disease|17|||
157213437|NCT02410837|567529522|FG000|Overall Study|Death|387|||
157213438|NCT02410837|567529522|FG000|Overall Study|Lost to Follow-up|50|||
156683217|NCT01628549|565584902|FG001|Overall Study|withdrawn for noncompliance|2|||
156683218|NCT01628549|565584903|FG002|Overall Study|withdrawn for noncompliance|1|||
157213439|NCT02410837|567529522|FG000|Overall Study|Withdrawal by Subject|44|||
157213440|NCT02410837|567529522|FG000|Overall Study|Physician Decision|6|||
157213441|NCT02410837|567529522|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
157213442|NCT00837577|567529523|FG000|Double-blind Period|Clinical Adverse Event|1|||
157213443|NCT00837577|567529524|FG001|Double-blind Period|Clinical Adverse Event|0|||
157213444|NCT00837577|567529523|FG000|Double-blind Period|Withdrawal by Subject|1|||
156784505|NCT04124965|565961242|FG000|Overall Study|Personal surgery|0|||
156784506|NCT04124965|565961243|FG001|Overall Study|Personal surgery|1|||
157213445|NCT00837577|567529524|FG001|Double-blind Period|Withdrawal by Subject|0|||
156784507|NCT04124965|565961242|FG000|Overall Study|Physician Decision|0|||
157213446|NCT00837577|567529523|FG000|Open-label Period|Clinical Adverse Event|2|||
157213447|NCT00837577|567529524|FG001|Open-label Period|Clinical Adverse Event|2|||
157213448|NCT00837577|567529523|FG000|Open-label Period|Laboratory Adverse Event|0|||
157213449|NCT00837577|567529524|FG001|Open-label Period|Laboratory Adverse Event|1|||
157213450|NCT00837577|567529523|FG000|Open-label Period|Lack of Efficacy|4|||
157213451|NCT00837577|567529524|FG001|Open-label Period|Lack of Efficacy|3|||
157213452|NCT00837577|567529523|FG000|Open-label Period|Withdrawal by Subject|1|||
157213453|NCT00837577|567529524|FG001|Open-label Period|Withdrawal by Subject|2|||
157213454|NCT00837577|567529523|FG000|Open-label Period|Other Reason|1|||
157213455|NCT00837577|567529524|FG001|Open-label Period|Other Reason|1|||
157213456|NCT01825876|567529528|FG000|Period 2|Withdrawal by Subject|0|||
157213457|NCT01825876|567529529|FG001|Period 2|Withdrawal by Subject|1|||
157213458|NCT00879970|567529530|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
157213459|NCT00879970|567529531|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
157213460|NCT00879970|567529532|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
157213461|NCT00879970|567529533|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
157213462|NCT00879970|567529534|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
157213463|NCT00879970|567529530|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
157213464|NCT00879970|567529531|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
157213465|NCT00879970|567529532|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
157213466|NCT00879970|567529533|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
157213467|NCT00879970|567529534|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
157213468|NCT00879970|567529530|FG000|Period 1 TZD Randomization|Death|2|||
157213469|NCT00879970|567529531|FG001|Period 1 TZD Randomization|Death|1|||
157213470|NCT00879970|567529532|FG002|Period 1 TZD Randomization|Death|0|||
157213471|NCT00879970|567529533|FG003|Period 1 TZD Randomization|Death|0|||
157213472|NCT00879970|567529534|FG004|Period 1 TZD Randomization|Death|0|||
157213473|NCT00879970|567529530|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
157213474|NCT00879970|567529531|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
157213475|NCT00879970|567529532|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
157213476|NCT00879970|567529533|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
157213477|NCT00879970|567529534|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
157213478|NCT00879970|567529530|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
157213479|NCT00879970|567529531|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
157213480|NCT00879970|567529532|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
157213481|NCT00879970|567529533|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
157213482|NCT00879970|567529534|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
157213483|NCT00879970|567529530|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
157213484|NCT00879970|567529531|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
157213485|NCT00879970|567529532|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
157213486|NCT00879970|567529533|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
157213487|NCT00879970|567529534|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
157213488|NCT00879970|567529530|FG000|Period 2 Vitamin D Randomization|Death|0|||
157213489|NCT00879970|567529531|FG001|Period 2 Vitamin D Randomization|Death|0|||
157213490|NCT00879970|567529532|FG002|Period 2 Vitamin D Randomization|Death|0|||
157213491|NCT00879970|567529533|FG003|Period 2 Vitamin D Randomization|Death|2|||
157213492|NCT00879970|567529534|FG004|Period 2 Vitamin D Randomization|Death|0|||
157213493|NCT01749033|567529540|FG000|Overall Study|Did not receive allocated intervention|3|||
157213494|NCT01749033|567529541|FG001|Overall Study|Did not receive allocated intervention|3|||
157213495|NCT01749033|567529542|FG002|Overall Study|Did not receive allocated intervention|0|||
157213496|NCT01749033|567529540|FG000|Overall Study|Lost to Follow-up|0|||
157213497|NCT01749033|567529541|FG001|Overall Study|Lost to Follow-up|2|||
157213498|NCT01749033|567529542|FG002|Overall Study|Lost to Follow-up|1|||
157213499|NCT01256398|567529543|FG000|Overall Study|Withdrawal by Subject|1|||
157213500|NCT00061945|567529544|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
157213501|NCT00061945|567529545|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
157213502|NCT00061945|567529544|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
157213503|NCT00061945|567529545|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
157213504|NCT00061945|567529544|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
157213505|NCT00061945|567529545|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
156784508|NCT04124965|565961243|FG001|Overall Study|Physician Decision|1|||
156784509|NCT00002874|565961244|FG000|Overall Study|Withdrawal by Subject|1|||
157213506|NCT00061945|567529544|FG000|Course IV: Alemtuzumab|Early exits|6|||
157213507|NCT00061945|567529545|FG001|Course IV: Alemtuzumab|Early exits|15|||
157213508|NCT01039584|567529546|FG000|Overall Study|Withdrawal by Subject|4|||
157213509|NCT01039584|567529547|FG001|Overall Study|Withdrawal by Subject|2|||
157213510|NCT01039584|567529548|FG002|Overall Study|Withdrawal by Subject|1|||
157213511|NCT01039584|567529546|FG000|Overall Study|Protocol Violation|10|||
157213512|NCT01039584|567529547|FG001|Overall Study|Protocol Violation|4|||
156683219|NCT01628549|565584904|FG003|Overall Study|withdrawn for noncompliance|0|||
156683220|NCT01628549|565584901|FG000|Overall Study|abnormal laboratory test results|0|||
156683221|NCT01628549|565584902|FG001|Overall Study|abnormal laboratory test results|0|||
156683222|NCT01628549|565584903|FG002|Overall Study|abnormal laboratory test results|1|||
156683223|NCT01628549|565584904|FG003|Overall Study|abnormal laboratory test results|0|||
156683224|NCT01628549|565584901|FG000|Overall Study|positive pregnancy test|0|||
156683225|NCT01628549|565584902|FG001|Overall Study|positive pregnancy test|0|||
156683226|NCT01628549|565584903|FG002|Overall Study|positive pregnancy test|0|||
156683227|NCT01628549|565584904|FG003|Overall Study|positive pregnancy test|1|||
156683228|NCT00177164|565584912|FG000|Overall Study|Protocol Violation|0|||
156683229|NCT00177164|565584913|FG001|Overall Study|Protocol Violation|7|||
156683230|NCT00177164|565584912|FG000|Overall Study|Lost to Follow-up|4|||
156683231|NCT00177164|565584913|FG001|Overall Study|Lost to Follow-up|5|||
156683232|NCT00177164|565584912|FG000|Overall Study|increase in alcohol and drug use|1|||
156683233|NCT00177164|565584913|FG001|Overall Study|increase in alcohol and drug use|2|||
156683234|NCT00177164|565584912|FG000|Overall Study|Adverse Event|1|||
156683235|NCT00177164|565584913|FG001|Overall Study|Adverse Event|0|||
156683236|NCT00177164|565584912|FG000|Overall Study|discharge from hospital|1|||
156683237|NCT00177164|565584913|FG001|Overall Study|discharge from hospital|0|||
156683238|NCT00177164|565584912|FG000|Overall Study|Lack of Efficacy|2|||
156683239|NCT00177164|565584913|FG001|Overall Study|Lack of Efficacy|1|||
156683240|NCT00177164|565584912|FG000|Overall Study|Pregnancy|0|||
156683241|NCT00177164|565584913|FG001|Overall Study|Pregnancy|1|||
156683242|NCT00965757|565584916|FG000|Double-blind Phase|Progression of concomitant disease|1|||
156683243|NCT00965757|565584917|FG001|Double-blind Phase|Progression of concomitant disease|2|||
156683244|NCT00965757|565584918|FG002|Double-blind Phase|Progression of concomitant disease|0|||
156683245|NCT00965757|565584919|FG003|Double-blind Phase|Progression of concomitant disease|0|||
156683246|NCT00965757|565584916|FG000|Double-blind Phase|Adverse drug reaction|2|||
156683247|NCT00965757|565584917|FG001|Double-blind Phase|Adverse drug reaction|1|||
156683248|NCT00965757|565584918|FG002|Double-blind Phase|Adverse drug reaction|0|||
156683249|NCT00965757|565584919|FG003|Double-blind Phase|Adverse drug reaction|0|||
156683250|NCT00965757|565584916|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
156683251|NCT00965757|565584917|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
156683252|NCT00965757|565584918|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
156683253|NCT00965757|565584919|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
156683254|NCT00965757|565584916|FG000|Double-blind Phase|Lack of Efficacy|7|||
156683255|NCT00965757|565584917|FG001|Double-blind Phase|Lack of Efficacy|11|||
156683256|NCT00965757|565584918|FG002|Double-blind Phase|Lack of Efficacy|0|||
156683257|NCT00965757|565584919|FG003|Double-blind Phase|Lack of Efficacy|0|||
156683258|NCT00965757|565584916|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
156683259|NCT00965757|565584917|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683260|NCT00965757|565584918|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683261|NCT00965757|565584919|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
156683262|NCT00965757|565584916|FG000|Double-blind Phase|Lost to Follow-up|0|||
156683263|NCT00965757|565584917|FG001|Double-blind Phase|Lost to Follow-up|1|||
156683264|NCT00965757|565584918|FG002|Double-blind Phase|Lost to Follow-up|0|||
156683265|NCT00965757|565584919|FG003|Double-blind Phase|Lost to Follow-up|0|||
156683266|NCT00965757|565584916|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
156683267|NCT00965757|565584917|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
156683268|NCT00965757|565584918|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
156683269|NCT00965757|565584919|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
156683270|NCT00965757|565584916|FG000|Double-blind Phase|Other|1|||
156683271|NCT00965757|565584917|FG001|Double-blind Phase|Other|0|||
156683272|NCT00965757|565584918|FG002|Double-blind Phase|Other|0|||
156683273|NCT00965757|565584919|FG003|Double-blind Phase|Other|0|||
156683274|NCT00965757|565584916|FG000|Extension Phase|Progression of concomitant disease|0|||
156683275|NCT00965757|565584917|FG001|Extension Phase|Progression of concomitant disease|0|||
156683276|NCT00965757|565584918|FG002|Extension Phase|Progression of concomitant disease|4|||
156683277|NCT00965757|565584919|FG003|Extension Phase|Progression of concomitant disease|2|||
156683278|NCT00965757|565584916|FG000|Extension Phase|Adverse drug reaction|0|||
156683279|NCT00965757|565584917|FG001|Extension Phase|Adverse drug reaction|0|||
156683280|NCT00965757|565584918|FG002|Extension Phase|Adverse drug reaction|6|||
156683281|NCT00965757|565584919|FG003|Extension Phase|Adverse drug reaction|3|||
156683282|NCT00965757|565584916|FG000|Extension Phase|Abnormal Laboratory Value|0|||
156683283|NCT00965757|565584917|FG001|Extension Phase|Abnormal Laboratory Value|0|||
156683284|NCT00965757|565584918|FG002|Extension Phase|Abnormal Laboratory Value|6|||
156683285|NCT00965757|565584919|FG003|Extension Phase|Abnormal Laboratory Value|1|||
156683286|NCT00965757|565584916|FG000|Extension Phase|Lack of Efficacy|0|||
156683287|NCT00965757|565584917|FG001|Extension Phase|Lack of Efficacy|0|||
156683288|NCT00965757|565584918|FG002|Extension Phase|Lack of Efficacy|8|||
156784510|NCT00002874|565961245|FG001|Overall Study|Withdrawal by Subject|1|||
156784511|NCT00002874|565961244|FG000|Overall Study|Protocol Violation|44|||
156683289|NCT00965757|565584919|FG003|Extension Phase|Lack of Efficacy|12|||
156683290|NCT00965757|565584916|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683291|NCT00965757|565584917|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683292|NCT00965757|565584918|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
156683293|NCT00965757|565584919|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
156683294|NCT00965757|565584916|FG000|Extension Phase|Lost to Follow-up|0|||
156683295|NCT00965757|565584917|FG001|Extension Phase|Lost to Follow-up|0|||
156683296|NCT00965757|565584918|FG002|Extension Phase|Lost to Follow-up|0|||
156683297|NCT00965757|565584919|FG003|Extension Phase|Lost to Follow-up|1|||
156683298|NCT00965757|565584916|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
156683299|NCT00965757|565584917|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
156683300|NCT00965757|565584918|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
156683301|NCT00965757|565584919|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
156683302|NCT00965757|565584916|FG000|Extension Phase|Protocol Violation|0|||
156683303|NCT00965757|565584917|FG001|Extension Phase|Protocol Violation|0|||
156683304|NCT00965757|565584918|FG002|Extension Phase|Protocol Violation|0|||
156683305|NCT00965757|565584919|FG003|Extension Phase|Protocol Violation|1|||
156683306|NCT00965757|565584916|FG000|Extension Phase|Other|0|||
156683307|NCT00965757|565584917|FG001|Extension Phase|Other|0|||
156683308|NCT00965757|565584918|FG002|Extension Phase|Other|2|||
156683309|NCT00965757|565584919|FG003|Extension Phase|Other|1|||
156683310|NCT03807440|565584920|FG000|Overall Study|No documentation of index date 2|320|||
156683311|NCT03807440|565584920|FG000|Overall Study|No informed consent for index date 2|117|||
156683312|NCT02451358|565584921|FG000|Overall Study|Withdrawal by Subject|1|||
156683313|NCT02451358|565584922|FG001|Overall Study|Withdrawal by Subject|1|||
156683314|NCT02451358|565584923|FG002|Overall Study|Withdrawal by Subject|0|||
156683315|NCT02451358|565584924|FG003|Overall Study|Withdrawal by Subject|0|||
156683316|NCT02451358|565584921|FG000|Overall Study|Protocol Violation|0|||
156683317|NCT02451358|565584922|FG001|Overall Study|Protocol Violation|1|||
156683318|NCT02451358|565584923|FG002|Overall Study|Protocol Violation|1|||
156683319|NCT02451358|565584924|FG003|Overall Study|Protocol Violation|0|||
156683320|NCT01344018|565584932|FG000|Overall Study|Death|22|||
156683321|NCT01344018|565584933|FG001|Overall Study|Death|25|||
156683322|NCT01344018|565584932|FG000|Overall Study|Lost to Follow-up|4|||
156683323|NCT01344018|565584933|FG001|Overall Study|Lost to Follow-up|7|||
156683324|NCT01332968|565584935|FG000|Induction Period|Adverse Event|23|||
156683325|NCT01332968|565584936|FG001|Induction Period|Adverse Event|26|||
156683326|NCT01332968|565584937|FG002|Induction Period|Adverse Event|0|||
156683327|NCT01332968|565584938|FG003|Induction Period|Adverse Event|0|||
156683328|NCT01332968|565584939|FG004|Induction Period|Adverse Event|0|||
156683329|NCT01332968|565584940|FG005|Induction Period|Adverse Event|0|||
156683330|NCT01332968|565584941|FG006|Induction Period|Adverse Event|0|||
156683331|NCT01332968|565584942|FG007|Induction Period|Adverse Event|0|||
156683332|NCT01332968|565584935|FG000|Induction Period|Death|1|||
156683333|NCT01332968|565584936|FG001|Induction Period|Death|4|||
156683334|NCT01332968|565584937|FG002|Induction Period|Death|0|||
156683335|NCT01332968|565584938|FG003|Induction Period|Death|0|||
156683336|NCT01332968|565584939|FG004|Induction Period|Death|0|||
156683337|NCT01332968|565584940|FG005|Induction Period|Death|0|||
156683338|NCT01332968|565584941|FG006|Induction Period|Death|0|||
156683339|NCT01332968|565584942|FG007|Induction Period|Death|0|||
156683340|NCT01332968|565584935|FG000|Induction Period|Non-compliance|1|||
156683341|NCT01332968|565584936|FG001|Induction Period|Non-compliance|0|||
156683342|NCT01332968|565584937|FG002|Induction Period|Non-compliance|0|||
156683343|NCT01332968|565584938|FG003|Induction Period|Non-compliance|0|||
156683344|NCT01332968|565584939|FG004|Induction Period|Non-compliance|0|||
156683345|NCT01332968|565584940|FG005|Induction Period|Non-compliance|0|||
156683346|NCT01332968|565584941|FG006|Induction Period|Non-compliance|0|||
156683347|NCT01332968|565584942|FG007|Induction Period|Non-compliance|0|||
156683348|NCT01332968|565584935|FG000|Induction Period|Other|2|||
156683349|NCT01332968|565584936|FG001|Induction Period|Other|2|||
156683350|NCT01332968|565584937|FG002|Induction Period|Other|0|||
156683351|NCT01332968|565584938|FG003|Induction Period|Other|0|||
156683352|NCT01332968|565584939|FG004|Induction Period|Other|0|||
156683353|NCT01332968|565584940|FG005|Induction Period|Other|0|||
156784512|NCT00002874|565961245|FG001|Overall Study|Protocol Violation|34|||
156784513|NCT01214720|565961248|FG000|Overall Study|Alive and still on treatment|34|||
156784514|NCT01214720|565961249|FG001|Overall Study|Alive and still on treatment|18|||
156784515|NCT01214720|565961248|FG000|Overall Study|Alive and in follow-up|45|||
156683354|NCT01332968|565584941|FG006|Induction Period|Other|0|||
156683355|NCT01332968|565584942|FG007|Induction Period|Other|0|||
156683356|NCT01332968|565584935|FG000|Induction Period|Physician Decision|6|||
156683357|NCT01332968|565584936|FG001|Induction Period|Physician Decision|1|||
156683358|NCT01332968|565584937|FG002|Induction Period|Physician Decision|0|||
156683359|NCT01332968|565584938|FG003|Induction Period|Physician Decision|0|||
156683360|NCT01332968|565584939|FG004|Induction Period|Physician Decision|0|||
156683361|NCT01332968|565584940|FG005|Induction Period|Physician Decision|0|||
156683362|NCT01332968|565584941|FG006|Induction Period|Physician Decision|0|||
156683363|NCT01332968|565584942|FG007|Induction Period|Physician Decision|0|||
156683364|NCT01332968|565584935|FG000|Induction Period|Progressive Disease|15|||
156683365|NCT01332968|565584936|FG001|Induction Period|Progressive Disease|7|||
156683366|NCT01332968|565584937|FG002|Induction Period|Progressive Disease|0|||
156683367|NCT01332968|565584938|FG003|Induction Period|Progressive Disease|0|||
156683368|NCT01332968|565584939|FG004|Induction Period|Progressive Disease|0|||
156683369|NCT01332968|565584940|FG005|Induction Period|Progressive Disease|0|||
156683370|NCT01332968|565584941|FG006|Induction Period|Progressive Disease|0|||
156683371|NCT01332968|565584942|FG007|Induction Period|Progressive Disease|0|||
156683372|NCT01332968|565584935|FG000|Induction Period|Protocol Violation|3|||
156683373|NCT01332968|565584936|FG001|Induction Period|Protocol Violation|4|||
156683374|NCT01332968|565584937|FG002|Induction Period|Protocol Violation|0|||
156683375|NCT01332968|565584938|FG003|Induction Period|Protocol Violation|0|||
156683376|NCT01332968|565584939|FG004|Induction Period|Protocol Violation|0|||
156683377|NCT01332968|565584940|FG005|Induction Period|Protocol Violation|0|||
156683378|NCT01332968|565584941|FG006|Induction Period|Protocol Violation|0|||
156683379|NCT01332968|565584942|FG007|Induction Period|Protocol Violation|0|||
156683380|NCT01332968|565584935|FG000|Induction Period|Withdrawal by Subject|3|||
156683381|NCT01332968|565584936|FG001|Induction Period|Withdrawal by Subject|5|||
156683382|NCT01332968|565584937|FG002|Induction Period|Withdrawal by Subject|0|||
156683383|NCT01332968|565584938|FG003|Induction Period|Withdrawal by Subject|0|||
156683384|NCT01332968|565584939|FG004|Induction Period|Withdrawal by Subject|0|||
156683385|NCT01332968|565584940|FG005|Induction Period|Withdrawal by Subject|0|||
156683386|NCT01332968|565584941|FG006|Induction Period|Withdrawal by Subject|0|||
156683387|NCT01332968|565584942|FG007|Induction Period|Withdrawal by Subject|0|||
156683388|NCT01332968|565584935|FG000|Induction Period|Randomised but not treated|4|||
156683389|NCT01332968|565584936|FG001|Induction Period|Randomised but not treated|7|||
156683390|NCT01332968|565584937|FG002|Induction Period|Randomised but not treated|0|||
156683391|NCT01332968|565584938|FG003|Induction Period|Randomised but not treated|0|||
156683392|NCT01332968|565584939|FG004|Induction Period|Randomised but not treated|0|||
156683393|NCT01332968|565584940|FG005|Induction Period|Randomised but not treated|0|||
156683394|NCT01332968|565584941|FG006|Induction Period|Randomised but not treated|0|||
156683395|NCT01332968|565584942|FG007|Induction Period|Randomised but not treated|0|||
156683396|NCT01332968|565584935|FG000|Maintenance/Observation Period|Adverse Event|0|||
156683397|NCT01332968|565584936|FG001|Maintenance/Observation Period|Adverse Event|0|||
156683398|NCT01332968|565584937|FG002|Maintenance/Observation Period|Adverse Event|53|||
156683399|NCT01332968|565584938|FG003|Maintenance/Observation Period|Adverse Event|66|||
156683400|NCT01332968|565584939|FG004|Maintenance/Observation Period|Adverse Event|0|||
156683401|NCT01332968|565584940|FG005|Maintenance/Observation Period|Adverse Event|0|||
156683402|NCT01332968|565584941|FG006|Maintenance/Observation Period|Adverse Event|0|||
156683403|NCT01332968|565584942|FG007|Maintenance/Observation Period|Adverse Event|0|||
156683404|NCT01332968|565584935|FG000|Maintenance/Observation Period|Death|0|||
156683405|NCT01332968|565584936|FG001|Maintenance/Observation Period|Death|0|||
156683406|NCT01332968|565584937|FG002|Maintenance/Observation Period|Death|5|||
156683407|NCT01332968|565584938|FG003|Maintenance/Observation Period|Death|6|||
156683408|NCT01332968|565584939|FG004|Maintenance/Observation Period|Death|0|||
156683409|NCT01332968|565584940|FG005|Maintenance/Observation Period|Death|0|||
156683410|NCT01332968|565584941|FG006|Maintenance/Observation Period|Death|0|||
156683411|NCT01332968|565584942|FG007|Maintenance/Observation Period|Death|0|||
156683412|NCT01332968|565584935|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
156683413|NCT01332968|565584936|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
156683414|NCT01332968|565584937|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
156683415|NCT01332968|565584938|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
156683416|NCT01332968|565584939|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
156683417|NCT01332968|565584940|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
156683418|NCT01332968|565584941|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
156683419|NCT01332968|565584942|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
156683420|NCT01332968|565584935|FG000|Maintenance/Observation Period|Non-compliance|0|||
156683421|NCT01332968|565584936|FG001|Maintenance/Observation Period|Non-compliance|0|||
156683422|NCT01332968|565584937|FG002|Maintenance/Observation Period|Non-compliance|4|||
156683423|NCT01332968|565584938|FG003|Maintenance/Observation Period|Non-compliance|3|||
156683424|NCT01332968|565584939|FG004|Maintenance/Observation Period|Non-compliance|0|||
156683425|NCT01332968|565584940|FG005|Maintenance/Observation Period|Non-compliance|0|||
156683426|NCT01332968|565584941|FG006|Maintenance/Observation Period|Non-compliance|0|||
156683427|NCT01332968|565584942|FG007|Maintenance/Observation Period|Non-compliance|0|||
156683428|NCT01332968|565584935|FG000|Maintenance/Observation Period|Other|0|||
156683429|NCT01332968|565584936|FG001|Maintenance/Observation Period|Other|0|||
156683430|NCT01332968|565584937|FG002|Maintenance/Observation Period|Other|4|||
157213513|NCT01039584|567529548|FG002|Overall Study|Protocol Violation|6|||
157213514|NCT01039584|567529546|FG000|Overall Study|Lost to Follow-up|5|||
156683431|NCT01332968|565584938|FG003|Maintenance/Observation Period|Other|7|||
156683432|NCT01332968|565584939|FG004|Maintenance/Observation Period|Other|0|||
156683433|NCT01332968|565584940|FG005|Maintenance/Observation Period|Other|0|||
156683434|NCT01332968|565584941|FG006|Maintenance/Observation Period|Other|0|||
156683435|NCT01332968|565584942|FG007|Maintenance/Observation Period|Other|0|||
156683436|NCT01332968|565584935|FG000|Maintenance/Observation Period|Physician Decision|0|||
156868331|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868332|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868333|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868334|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
157013130|NCT02723955|566801738|FG001|Expansion Phase|Physician Decision|0|||
157213515|NCT01039584|567529547|FG001|Overall Study|Lost to Follow-up|3|||
157213516|NCT01039584|567529548|FG002|Overall Study|Lost to Follow-up|4|||
157213517|NCT01039584|567529546|FG000|Overall Study|Negative Baseline culture for Candida|59|||
157213518|NCT01039584|567529547|FG001|Overall Study|Negative Baseline culture for Candida|59|||
157213519|NCT01039584|567529548|FG002|Overall Study|Negative Baseline culture for Candida|24|||
157213520|NCT01039584|567529546|FG000|Overall Study|Lack of Efficacy|7|||
157213521|NCT01039584|567529547|FG001|Overall Study|Lack of Efficacy|6|||
157213522|NCT01039584|567529548|FG002|Overall Study|Lack of Efficacy|10|||
157213523|NCT01039584|567529546|FG000|Overall Study|other|1|||
157213524|NCT01039584|567529547|FG001|Overall Study|other|3|||
157213525|NCT01039584|567529548|FG002|Overall Study|other|1|||
157213526|NCT01039584|567529546|FG000|Overall Study|Pap smear with significant pathology|10|||
157213527|NCT01039584|567529547|FG001|Overall Study|Pap smear with significant pathology|10|||
157213528|NCT01039584|567529548|FG002|Overall Study|Pap smear with significant pathology|3|||
157213529|NCT01039584|567529546|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
157213530|NCT01039584|567529547|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
157213531|NCT01039584|567529548|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
157213532|NCT03672396|567529551|FG000|Overall Study|Withdrawal by Subject|4|||
157213533|NCT03672396|567529551|FG000|Overall Study|Physician Decision|1|||
157213534|NCT03672396|567529551|FG000|Overall Study|Adverse Event|1|||
157213535|NCT04380701|567529552|FG000|Overall Study|Pregnancy|0|||
157213536|NCT04380701|567529553|FG001|Overall Study|Pregnancy|0|||
157213537|NCT04380701|567529554|FG002|Overall Study|Pregnancy|0|||
157213538|NCT04380701|567529555|FG003|Overall Study|Pregnancy|0|||
157213539|NCT04380701|567529556|FG004|Overall Study|Pregnancy|0|||
157213540|NCT04380701|567529557|FG005|Overall Study|Pregnancy|0|||
157213541|NCT04380701|567529558|FG006|Overall Study|Pregnancy|0|||
157213542|NCT04380701|567529559|FG007|Overall Study|Pregnancy|0|||
157213543|NCT04380701|567529560|FG008|Overall Study|Pregnancy|0|||
157213544|NCT04380701|567529561|FG009|Overall Study|Pregnancy|0|||
157213545|NCT04380701|567529562|FG010|Overall Study|Pregnancy|0|||
157213546|NCT04380701|567529563|FG011|Overall Study|Pregnancy|0|||
157213547|NCT04380701|567529564|FG012|Overall Study|Pregnancy|0|||
157213548|NCT04380701|567529565|FG013|Overall Study|Pregnancy|0|||
157213549|NCT04380701|567529566|FG014|Overall Study|Pregnancy|0|||
157213550|NCT04380701|567529567|FG015|Overall Study|Pregnancy|0|||
157213551|NCT04380701|567529568|FG016|Overall Study|Pregnancy|0|||
157213552|NCT04380701|567529569|FG017|Overall Study|Pregnancy|0|||
157213553|NCT04380701|567529570|FG018|Overall Study|Pregnancy|0|||
157213554|NCT04380701|567529571|FG019|Overall Study|Pregnancy|0|||
157213555|NCT04380701|567529572|FG020|Overall Study|Pregnancy|0|||
157213556|NCT04380701|567529573|FG021|Overall Study|Pregnancy|0|||
157213557|NCT04380701|567529574|FG022|Overall Study|Pregnancy|0|||
157213558|NCT04380701|567529575|FG023|Overall Study|Pregnancy|0|||
157213559|NCT04380701|567529576|FG024|Overall Study|Pregnancy|0|||
157213560|NCT04380701|567529577|FG025|Overall Study|Pregnancy|0|||
157213561|NCT04380701|567529578|FG026|Overall Study|Pregnancy|0|||
157213562|NCT04380701|567529579|FG027|Overall Study|Pregnancy|0|||
157213563|NCT04380701|567529580|FG028|Overall Study|Pregnancy|0|||
157213564|NCT04380701|567529581|FG029|Overall Study|Pregnancy|0|||
157213565|NCT04380701|567529582|FG030|Overall Study|Pregnancy|0|||
157213566|NCT04380701|567529583|FG031|Overall Study|Pregnancy|0|||
157213567|NCT04380701|567529584|FG032|Overall Study|Pregnancy|1|||
157213568|NCT04380701|567529585|FG033|Overall Study|Pregnancy|0|||
157213569|NCT04380701|567529552|FG000|Overall Study|Lost to Follow-up|0|||
157213570|NCT04380701|567529553|FG001|Overall Study|Lost to Follow-up|0|||
157213571|NCT04380701|567529554|FG002|Overall Study|Lost to Follow-up|0|||
157213572|NCT04380701|567529555|FG003|Overall Study|Lost to Follow-up|0|||
157213573|NCT04380701|567529556|FG004|Overall Study|Lost to Follow-up|0|||
157213574|NCT04380701|567529557|FG005|Overall Study|Lost to Follow-up|0|||
157213575|NCT04380701|567529558|FG006|Overall Study|Lost to Follow-up|0|||
157213576|NCT04380701|567529559|FG007|Overall Study|Lost to Follow-up|0|||
157213577|NCT04380701|567529560|FG008|Overall Study|Lost to Follow-up|0|||
157213578|NCT04380701|567529561|FG009|Overall Study|Lost to Follow-up|0|||
157213579|NCT04380701|567529562|FG010|Overall Study|Lost to Follow-up|0|||
157213580|NCT04380701|567529563|FG011|Overall Study|Lost to Follow-up|0|||
157213581|NCT04380701|567529564|FG012|Overall Study|Lost to Follow-up|0|||
157213582|NCT04380701|567529565|FG013|Overall Study|Lost to Follow-up|0|||
157213583|NCT04380701|567529566|FG014|Overall Study|Lost to Follow-up|0|||
157213584|NCT04380701|567529567|FG015|Overall Study|Lost to Follow-up|0|||
157213585|NCT04380701|567529568|FG016|Overall Study|Lost to Follow-up|0|||
157013131|NCT02723955|566801739|FG002|Expansion Phase|Physician Decision|0|||
157213586|NCT04380701|567529569|FG017|Overall Study|Lost to Follow-up|0|||
157213587|NCT04380701|567529570|FG018|Overall Study|Lost to Follow-up|0|||
157213588|NCT04380701|567529571|FG019|Overall Study|Lost to Follow-up|0|||
157213589|NCT04380701|567529572|FG020|Overall Study|Lost to Follow-up|1|||
157120424|NCT01425008|567193111|FG011|Dose Escalation Phase|Progressive Disease|0|||
157120425|NCT01425008|567193112|FG012|Dose Escalation Phase|Progressive Disease|0|||
157120426|NCT01425008|567193113|FG013|Dose Escalation Phase|Progressive Disease|0|||
157120427|NCT01425008|567193114|FG014|Dose Escalation Phase|Progressive Disease|0|||
156683437|NCT01332968|565584936|FG001|Maintenance/Observation Period|Physician Decision|0|||
157120428|NCT01425008|567193115|FG015|Dose Escalation Phase|Progressive Disease|0|||
157120429|NCT01425008|567193116|FG016|Dose Escalation Phase|Progressive Disease|0|||
157120430|NCT01425008|567193117|FG017|Dose Escalation Phase|Progressive Disease|0|||
157120431|NCT01425008|567193118|FG018|Dose Escalation Phase|Progressive Disease|0|||
157120432|NCT01425008|567193100|FG000|Dose Escalation Phase|Adverse Event|2|||
157120433|NCT01425008|567193101|FG001|Dose Escalation Phase|Adverse Event|0|||
157120434|NCT01425008|567193102|FG002|Dose Escalation Phase|Adverse Event|0|||
157120435|NCT01425008|567193103|FG003|Dose Escalation Phase|Adverse Event|0|||
157120436|NCT01425008|567193104|FG004|Dose Escalation Phase|Adverse Event|0|||
157120437|NCT01425008|567193105|FG005|Dose Escalation Phase|Adverse Event|2|||
157120438|NCT01425008|567193106|FG006|Dose Escalation Phase|Adverse Event|0|||
157120439|NCT01425008|567193107|FG007|Dose Escalation Phase|Adverse Event|0|||
157120440|NCT01425008|567193108|FG008|Dose Escalation Phase|Adverse Event|2|||
157120441|NCT01425008|567193109|FG009|Dose Escalation Phase|Adverse Event|0|||
157120442|NCT01425008|567193110|FG010|Dose Escalation Phase|Adverse Event|0|||
157120443|NCT01425008|567193111|FG011|Dose Escalation Phase|Adverse Event|0|||
157120444|NCT01425008|567193112|FG012|Dose Escalation Phase|Adverse Event|0|||
157120445|NCT01425008|567193113|FG013|Dose Escalation Phase|Adverse Event|0|||
157120446|NCT01425008|567193114|FG014|Dose Escalation Phase|Adverse Event|0|||
157120447|NCT01425008|567193115|FG015|Dose Escalation Phase|Adverse Event|0|||
157120448|NCT01425008|567193116|FG016|Dose Escalation Phase|Adverse Event|0|||
157120449|NCT01425008|567193117|FG017|Dose Escalation Phase|Adverse Event|0|||
157120450|NCT01425008|567193118|FG018|Dose Escalation Phase|Adverse Event|0|||
157120451|NCT01425008|567193100|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120452|NCT01425008|567193101|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120453|NCT01425008|567193102|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120454|NCT01425008|567193103|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120455|NCT01425008|567193104|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
157120456|NCT01425008|567193105|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120457|NCT01425008|567193106|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
157120458|NCT01425008|567193107|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
157120459|NCT01425008|567193108|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
157120460|NCT01425008|567193109|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120461|NCT01425008|567193110|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120462|NCT01425008|567193111|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120463|NCT01425008|567193112|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120464|NCT01425008|567193113|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120465|NCT01425008|567193114|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120466|NCT01425008|567193115|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120467|NCT01425008|567193116|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120468|NCT01425008|567193117|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120469|NCT01425008|567193118|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157120470|NCT01425008|567193100|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
157120471|NCT01425008|567193101|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
157120472|NCT01425008|567193102|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
157120473|NCT01425008|567193103|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
157120474|NCT01425008|567193104|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
157120475|NCT01425008|567193105|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
157120476|NCT01425008|567193106|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
157120477|NCT01425008|567193107|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
157120478|NCT01425008|567193108|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
157120479|NCT01425008|567193109|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
157120480|NCT01425008|567193110|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
157120481|NCT01425008|567193111|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
157120482|NCT01425008|567193112|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
157120483|NCT01425008|567193113|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
157120484|NCT01425008|567193114|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
157120485|NCT01425008|567193115|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
157120486|NCT01425008|567193116|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
157120487|NCT01425008|567193117|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
157120488|NCT01425008|567193118|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
157120489|NCT01425008|567193100|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120490|NCT01425008|567193101|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
156784516|NCT01214720|565961249|FG001|Overall Study|Alive and in follow-up|48|||
156784517|NCT01214720|565961248|FG000|Overall Study|Lost to Follow-up|6|||
157120491|NCT01425008|567193102|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
156683438|NCT01332968|565584937|FG002|Maintenance/Observation Period|Physician Decision|14|||
156683439|NCT01332968|565584938|FG003|Maintenance/Observation Period|Physician Decision|19|||
156683440|NCT01332968|565584939|FG004|Maintenance/Observation Period|Physician Decision|0|||
156683441|NCT01332968|565584940|FG005|Maintenance/Observation Period|Physician Decision|1|||
156683442|NCT01332968|565584941|FG006|Maintenance/Observation Period|Physician Decision|0|||
156683443|NCT01332968|565584942|FG007|Maintenance/Observation Period|Physician Decision|0|||
156683444|NCT01332968|565584935|FG000|Maintenance/Observation Period|Progressive Disease|0|||
156683445|NCT01332968|565584936|FG001|Maintenance/Observation Period|Progressive Disease|0|||
156683446|NCT01332968|565584937|FG002|Maintenance/Observation Period|Progressive Disease|72|||
156683447|NCT01332968|565584938|FG003|Maintenance/Observation Period|Progressive Disease|40|||
156683448|NCT01332968|565584939|FG004|Maintenance/Observation Period|Progressive Disease|0|||
156683449|NCT01332968|565584940|FG005|Maintenance/Observation Period|Progressive Disease|0|||
156683450|NCT01332968|565584941|FG006|Maintenance/Observation Period|Progressive Disease|0|||
156683451|NCT01332968|565584942|FG007|Maintenance/Observation Period|Progressive Disease|0|||
156683452|NCT01332968|565584935|FG000|Maintenance/Observation Period|Protocol Violation|0|||
156683453|NCT01332968|565584936|FG001|Maintenance/Observation Period|Protocol Violation|0|||
156683454|NCT01332968|565584937|FG002|Maintenance/Observation Period|Protocol Violation|1|||
156683455|NCT01332968|565584938|FG003|Maintenance/Observation Period|Protocol Violation|1|||
156683456|NCT01332968|565584939|FG004|Maintenance/Observation Period|Protocol Violation|0|||
156683457|NCT01332968|565584940|FG005|Maintenance/Observation Period|Protocol Violation|0|||
156683458|NCT01332968|565584941|FG006|Maintenance/Observation Period|Protocol Violation|0|||
156683459|NCT01332968|565584942|FG007|Maintenance/Observation Period|Protocol Violation|0|||
156683460|NCT01332968|565584935|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683461|NCT01332968|565584936|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683462|NCT01332968|565584937|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
156683463|NCT01332968|565584938|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
156683464|NCT01332968|565584939|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683465|NCT01332968|565584940|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683466|NCT01332968|565584941|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683467|NCT01332968|565584942|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
156683468|NCT01332968|565584935|FG000|Follow-Up Period|Adverse Event|0|||
156683469|NCT01332968|565584936|FG001|Follow-Up Period|Adverse Event|0|||
156683470|NCT01332968|565584937|FG002|Follow-Up Period|Adverse Event|0|||
156683471|NCT01332968|565584938|FG003|Follow-Up Period|Adverse Event|0|||
156683472|NCT01332968|565584939|FG004|Follow-Up Period|Adverse Event|0|||
156683473|NCT01332968|565584940|FG005|Follow-Up Period|Adverse Event|0|||
156683474|NCT01332968|565584941|FG006|Follow-Up Period|Adverse Event|0|||
156683475|NCT01332968|565584942|FG007|Follow-Up Period|Adverse Event|4|||
156683476|NCT01332968|565584935|FG000|Follow-Up Period|Death|0|||
156683477|NCT01332968|565584936|FG001|Follow-Up Period|Death|0|||
156683478|NCT01332968|565584937|FG002|Follow-Up Period|Death|0|||
156784518|NCT01214720|565961249|FG001|Overall Study|Lost to Follow-up|2|||
156784519|NCT03166631|565963177|FG000|Overall Study|Progressive disease|2|||
156784520|NCT03166631|565963178|FG001|Overall Study|Progressive disease|1|||
156784521|NCT03166631|565963179|FG002|Overall Study|Progressive disease|3|||
156784522|NCT03166631|565963180|FG003|Overall Study|Progressive disease|4|||
156784523|NCT03166631|565963181|FG004|Overall Study|Progressive disease|2|||
156784524|NCT03166631|565963182|FG005|Overall Study|Progressive disease|2|||
156784525|NCT03166631|565963183|FG006|Overall Study|Progressive disease|5|||
156784526|NCT03166631|565963184|FG007|Overall Study|Progressive disease|6|||
156784527|NCT03166631|565963185|FG008|Overall Study|Progressive disease|11|||
156784528|NCT03166631|565963186|FG009|Overall Study|Progressive disease|5|||
156784529|NCT03166631|565963187|FG010|Overall Study|Progressive disease|7|||
156784530|NCT03166631|565963177|FG000|Overall Study|Physician Decision|0|||
156784531|NCT03166631|565963178|FG001|Overall Study|Physician Decision|0|||
156784532|NCT03166631|565963179|FG002|Overall Study|Physician Decision|0|||
156784533|NCT03166631|565963180|FG003|Overall Study|Physician Decision|0|||
156784534|NCT03166631|565963181|FG004|Overall Study|Physician Decision|0|||
156784535|NCT03166631|565963182|FG005|Overall Study|Physician Decision|0|||
156784536|NCT03166631|565963183|FG006|Overall Study|Physician Decision|1|||
156784537|NCT03166631|565963184|FG007|Overall Study|Physician Decision|0|||
156784538|NCT03166631|565963185|FG008|Overall Study|Physician Decision|1|||
156784539|NCT03166631|565963186|FG009|Overall Study|Physician Decision|0|||
156868335|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156784540|NCT03166631|565963187|FG010|Overall Study|Physician Decision|1|||
156868336|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868337|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156683479|NCT01332968|565584938|FG003|Follow-Up Period|Death|0|||
156683480|NCT01332968|565584939|FG004|Follow-Up Period|Death|0|||
156683481|NCT01332968|565584940|FG005|Follow-Up Period|Death|0|||
156683482|NCT01332968|565584941|FG006|Follow-Up Period|Death|27|||
156784541|NCT03166631|565963177|FG000|Overall Study|Death|0|||
156784542|NCT03166631|565963178|FG001|Overall Study|Death|0|||
156784543|NCT03166631|565963179|FG002|Overall Study|Death|0|||
156784544|NCT03166631|565963180|FG003|Overall Study|Death|0|||
156784545|NCT03166631|565963181|FG004|Overall Study|Death|1|||
156784546|NCT03166631|565963182|FG005|Overall Study|Death|0|||
156784547|NCT03166631|565963183|FG006|Overall Study|Death|1|||
156784548|NCT03166631|565963184|FG007|Overall Study|Death|0|||
156784549|NCT03166631|565963185|FG008|Overall Study|Death|0|||
156784550|NCT03166631|565963186|FG009|Overall Study|Death|0|||
156784551|NCT03166631|565963187|FG010|Overall Study|Death|0|||
156784552|NCT03166631|565963177|FG000|Overall Study|Adverse Event|1|||
156784553|NCT03166631|565963178|FG001|Overall Study|Adverse Event|0|||
156784554|NCT03166631|565963179|FG002|Overall Study|Adverse Event|0|||
156784555|NCT03166631|565963180|FG003|Overall Study|Adverse Event|0|||
156784556|NCT03166631|565963181|FG004|Overall Study|Adverse Event|0|||
156784557|NCT03166631|565963182|FG005|Overall Study|Adverse Event|1|||
156784558|NCT03166631|565963183|FG006|Overall Study|Adverse Event|1|||
156784559|NCT03166631|565963184|FG007|Overall Study|Adverse Event|0|||
156784560|NCT03166631|565963185|FG008|Overall Study|Adverse Event|1|||
156784561|NCT03166631|565963186|FG009|Overall Study|Adverse Event|2|||
156784562|NCT03166631|565963187|FG010|Overall Study|Adverse Event|1|||
156784563|NCT03166631|565963177|FG000|Overall Study|Withdrawal by Subject|0|||
156784564|NCT03166631|565963178|FG001|Overall Study|Withdrawal by Subject|0|||
156784565|NCT03166631|565963179|FG002|Overall Study|Withdrawal by Subject|0|||
156784566|NCT03166631|565963180|FG003|Overall Study|Withdrawal by Subject|0|||
156784567|NCT03166631|565963181|FG004|Overall Study|Withdrawal by Subject|0|||
156784568|NCT03166631|565963182|FG005|Overall Study|Withdrawal by Subject|0|||
156784569|NCT03166631|565963183|FG006|Overall Study|Withdrawal by Subject|0|||
156784570|NCT03166631|565963184|FG007|Overall Study|Withdrawal by Subject|0|||
156784571|NCT03166631|565963185|FG008|Overall Study|Withdrawal by Subject|1|||
156784572|NCT03166631|565963186|FG009|Overall Study|Withdrawal by Subject|1|||
157213590|NCT04380701|567529573|FG021|Overall Study|Lost to Follow-up|0|||
157213591|NCT04380701|567529574|FG022|Overall Study|Lost to Follow-up|0|||
157213592|NCT04380701|567529575|FG023|Overall Study|Lost to Follow-up|1|||
157213593|NCT04380701|567529576|FG024|Overall Study|Lost to Follow-up|0|||
157213594|NCT04380701|567529577|FG025|Overall Study|Lost to Follow-up|0|||
157213595|NCT04380701|567529578|FG026|Overall Study|Lost to Follow-up|0|||
156784573|NCT03166631|565963187|FG010|Overall Study|Withdrawal by Subject|0|||
156784574|NCT02370394|565963197|FG000|Overall Study|Lost to Follow-up|2|||
156784575|NCT02370394|565963198|FG001|Overall Study|Lost to Follow-up|1|||
156784576|NCT02370394|565963197|FG000|Overall Study|Withdrawal by Subject|0|||
156784577|NCT02370394|565963198|FG001|Overall Study|Withdrawal by Subject|1|||
156784578|NCT01108796|565963201|FG000|Overall Study|Adverse Event|0|||
156784579|NCT01108796|565963202|FG001|Overall Study|Adverse Event|1|||
157013132|NCT02723955|566801740|FG003|Expansion Phase|Physician Decision|0|||
157013133|NCT02723955|566801741|FG004|Expansion Phase|Physician Decision|0|||
157013134|NCT02723955|566801742|FG005|Expansion Phase|Physician Decision|0|||
157013135|NCT02723955|566801743|FG006|Expansion Phase|Physician Decision|0|||
157213596|NCT04380701|567529579|FG027|Overall Study|Lost to Follow-up|0|||
157213597|NCT04380701|567529580|FG028|Overall Study|Lost to Follow-up|0|||
157213598|NCT04380701|567529581|FG029|Overall Study|Lost to Follow-up|1|||
157213599|NCT04380701|567529582|FG030|Overall Study|Lost to Follow-up|0|||
157213600|NCT04380701|567529583|FG031|Overall Study|Lost to Follow-up|0|||
157213601|NCT04380701|567529584|FG032|Overall Study|Lost to Follow-up|0|||
157213602|NCT04380701|567529585|FG033|Overall Study|Lost to Follow-up|1|||
157213603|NCT04380701|567529552|FG000|Overall Study|Private reason(s)|0|||
157213604|NCT04380701|567529553|FG001|Overall Study|Private reason(s)|0|||
157213605|NCT04380701|567529554|FG002|Overall Study|Private reason(s)|0|||
157213606|NCT04380701|567529555|FG003|Overall Study|Private reason(s)|0|||
157213607|NCT04380701|567529556|FG004|Overall Study|Private reason(s)|0|||
157213608|NCT04380701|567529557|FG005|Overall Study|Private reason(s)|0|||
156784580|NCT01108796|565963201|FG000|Overall Study|Lost to Follow-up|7|||
156784581|NCT01108796|565963202|FG001|Overall Study|Lost to Follow-up|6|||
157013136|NCT02723955|566801744|FG007|Expansion Phase|Physician Decision|0|||
157013137|NCT02723955|566801745|FG008|Expansion Phase|Physician Decision|0|||
157213609|NCT04380701|567529558|FG006|Overall Study|Private reason(s)|1|||
157213610|NCT04380701|567529559|FG007|Overall Study|Private reason(s)|0|||
157213611|NCT04380701|567529560|FG008|Overall Study|Private reason(s)|1|||
157213612|NCT04380701|567529561|FG009|Overall Study|Private reason(s)|1|||
157213613|NCT04380701|567529562|FG010|Overall Study|Private reason(s)|0|||
156784582|NCT00758043|565963203|FG000|Overall Study|Adverse Event|1|||
156784583|NCT00758043|565963204|FG001|Overall Study|Adverse Event|20|||
156784584|NCT00758043|565963205|FG002|Overall Study|Adverse Event|12|||
156784585|NCT00758043|565963206|FG003|Overall Study|Adverse Event|62|||
156784586|NCT00758043|565963203|FG000|Overall Study|Lack of Efficacy|0|||
156784587|NCT00758043|565963204|FG001|Overall Study|Lack of Efficacy|6|||
156784588|NCT00758043|565963205|FG002|Overall Study|Lack of Efficacy|18|||
157013138|NCT02723955|566801746|FG009|Expansion Phase|Physician Decision|0|||
157013139|NCT02723955|566801747|FG010|Expansion Phase|Physician Decision|0|||
157013140|NCT02723955|566801748|FG011|Expansion Phase|Physician Decision|0|||
157013141|NCT02723955|566801749|FG012|Expansion Phase|Physician Decision|0|||
157013142|NCT02723955|566801750|FG013|Expansion Phase|Physician Decision|0|||
157213614|NCT04380701|567529563|FG011|Overall Study|Private reason(s)|0|||
157213615|NCT04380701|567529564|FG012|Overall Study|Private reason(s)|0|||
156683483|NCT01332968|565584942|FG007|Follow-Up Period|Death|30|||
156683484|NCT01332968|565584935|FG000|Follow-Up Period|Lost to Follow-up|0|||
156683485|NCT01332968|565584936|FG001|Follow-Up Period|Lost to Follow-up|0|||
156683486|NCT01332968|565584937|FG002|Follow-Up Period|Lost to Follow-up|0|||
156683487|NCT01332968|565584938|FG003|Follow-Up Period|Lost to Follow-up|0|||
156683488|NCT01332968|565584939|FG004|Follow-Up Period|Lost to Follow-up|0|||
156683489|NCT01332968|565584940|FG005|Follow-Up Period|Lost to Follow-up|0|||
156683490|NCT01332968|565584941|FG006|Follow-Up Period|Lost to Follow-up|11|||
156683491|NCT01332968|565584942|FG007|Follow-Up Period|Lost to Follow-up|15|||
156683492|NCT01332968|565584935|FG000|Follow-Up Period|Non-compliance|0|||
156683493|NCT01332968|565584936|FG001|Follow-Up Period|Non-compliance|0|||
156683494|NCT01332968|565584937|FG002|Follow-Up Period|Non-compliance|0|||
156784589|NCT00758043|565963206|FG003|Overall Study|Lack of Efficacy|12|||
156784590|NCT00758043|565963203|FG000|Overall Study|Refused Further Treatment|0|||
156784591|NCT00758043|565963204|FG001|Overall Study|Refused Further Treatment|11|||
156784592|NCT00758043|565963205|FG002|Overall Study|Refused Further Treatment|5|||
156784593|NCT00758043|565963206|FG003|Overall Study|Refused Further Treatment|8|||
156784594|NCT00758043|565963203|FG000|Overall Study|Lost to Follow-up|0|||
157120492|NCT01425008|567193103|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120493|NCT01425008|567193104|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120494|NCT01425008|567193105|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120495|NCT01425008|567193106|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120496|NCT01425008|567193107|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120497|NCT01425008|567193108|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
157120498|NCT01425008|567193109|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
157120499|NCT01425008|567193110|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120500|NCT01425008|567193111|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120501|NCT01425008|567193112|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120502|NCT01425008|567193113|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120503|NCT01425008|567193114|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120504|NCT01425008|567193115|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120505|NCT01425008|567193116|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120506|NCT01425008|567193117|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120507|NCT01425008|567193118|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
157120508|NCT01425008|567193100|FG000|Dose Escalation Phase|Other|0|||
157120509|NCT01425008|567193101|FG001|Dose Escalation Phase|Other|0|||
157120510|NCT01425008|567193102|FG002|Dose Escalation Phase|Other|0|||
157120511|NCT01425008|567193103|FG003|Dose Escalation Phase|Other|0|||
157120512|NCT01425008|567193104|FG004|Dose Escalation Phase|Other|0|||
157120513|NCT01425008|567193105|FG005|Dose Escalation Phase|Other|0|||
157120514|NCT01425008|567193106|FG006|Dose Escalation Phase|Other|0|||
157120515|NCT01425008|567193107|FG007|Dose Escalation Phase|Other|0|||
157120516|NCT01425008|567193108|FG008|Dose Escalation Phase|Other|1|||
157120517|NCT01425008|567193109|FG009|Dose Escalation Phase|Other|0|||
157120518|NCT01425008|567193110|FG010|Dose Escalation Phase|Other|0|||
157120519|NCT01425008|567193111|FG011|Dose Escalation Phase|Other|0|||
157120520|NCT01425008|567193112|FG012|Dose Escalation Phase|Other|0|||
157120521|NCT01425008|567193113|FG013|Dose Escalation Phase|Other|0|||
157120522|NCT01425008|567193114|FG014|Dose Escalation Phase|Other|0|||
157120523|NCT01425008|567193115|FG015|Dose Escalation Phase|Other|0|||
157120524|NCT01425008|567193116|FG016|Dose Escalation Phase|Other|0|||
157120525|NCT01425008|567193117|FG017|Dose Escalation Phase|Other|0|||
157120526|NCT01425008|567193118|FG018|Dose Escalation Phase|Other|0|||
157120527|NCT01425008|567193100|FG000|Dose Expansion Phase|Progressive Disease|0|||
157120528|NCT01425008|567193101|FG001|Dose Expansion Phase|Progressive Disease|0|||
157120529|NCT01425008|567193102|FG002|Dose Expansion Phase|Progressive Disease|0|||
157120530|NCT01425008|567193103|FG003|Dose Expansion Phase|Progressive Disease|0|||
157120531|NCT01425008|567193104|FG004|Dose Expansion Phase|Progressive Disease|0|||
157120532|NCT01425008|567193105|FG005|Dose Expansion Phase|Progressive Disease|0|||
157120533|NCT01425008|567193106|FG006|Dose Expansion Phase|Progressive Disease|0|||
157120534|NCT01425008|567193107|FG007|Dose Expansion Phase|Progressive Disease|0|||
157120535|NCT01425008|567193108|FG008|Dose Expansion Phase|Progressive Disease|0|||
157120536|NCT01425008|567193109|FG009|Dose Expansion Phase|Progressive Disease|0|||
157120537|NCT01425008|567193110|FG010|Dose Expansion Phase|Progressive Disease|10|||
157120538|NCT01425008|567193111|FG011|Dose Expansion Phase|Progressive Disease|4|||
156683495|NCT01332968|565584938|FG003|Follow-Up Period|Non-compliance|0|||
156683496|NCT01332968|565584939|FG004|Follow-Up Period|Non-compliance|0|||
156683497|NCT01332968|565584940|FG005|Follow-Up Period|Non-compliance|0|||
156683498|NCT01332968|565584941|FG006|Follow-Up Period|Non-compliance|4|||
156784595|NCT00758043|565963204|FG001|Overall Study|Lost to Follow-up|2|||
157120539|NCT01425008|567193112|FG012|Dose Expansion Phase|Progressive Disease|12|||
157120540|NCT01425008|567193113|FG013|Dose Expansion Phase|Progressive Disease|1|||
157120541|NCT01425008|567193114|FG014|Dose Expansion Phase|Progressive Disease|5|||
157120542|NCT01425008|567193115|FG015|Dose Expansion Phase|Progressive Disease|8|||
157120543|NCT01425008|567193116|FG016|Dose Expansion Phase|Progressive Disease|9|||
157120544|NCT01425008|567193117|FG017|Dose Expansion Phase|Progressive Disease|2|||
156683499|NCT01332968|565584942|FG007|Follow-Up Period|Non-compliance|9|||
156683500|NCT01332968|565584935|FG000|Follow-Up Period|Other|0|||
156683501|NCT01332968|565584936|FG001|Follow-Up Period|Other|0|||
156683502|NCT01332968|565584937|FG002|Follow-Up Period|Other|0|||
156683503|NCT01332968|565584938|FG003|Follow-Up Period|Other|0|||
156683504|NCT01332968|565584939|FG004|Follow-Up Period|Other|0|||
156683505|NCT01332968|565584940|FG005|Follow-Up Period|Other|0|||
156683506|NCT01332968|565584941|FG006|Follow-Up Period|Other|18|||
156683507|NCT01332968|565584942|FG007|Follow-Up Period|Other|21|||
156683508|NCT01332968|565584935|FG000|Follow-Up Period|Physician Decision|0|||
156683509|NCT01332968|565584936|FG001|Follow-Up Period|Physician Decision|0|||
156683510|NCT01332968|565584937|FG002|Follow-Up Period|Physician Decision|0|||
156683511|NCT01332968|565584938|FG003|Follow-Up Period|Physician Decision|0|||
157120545|NCT01425008|567193118|FG018|Dose Expansion Phase|Progressive Disease|10|||
156683512|NCT01332968|565584939|FG004|Follow-Up Period|Physician Decision|0|||
156683513|NCT01332968|565584940|FG005|Follow-Up Period|Physician Decision|0|||
156683514|NCT01332968|565584941|FG006|Follow-Up Period|Physician Decision|12|||
156683515|NCT01332968|565584942|FG007|Follow-Up Period|Physician Decision|15|||
156683516|NCT01332968|565584935|FG000|Follow-Up Period|Progressive Disease|0|||
156683517|NCT01332968|565584936|FG001|Follow-Up Period|Progressive Disease|0|||
156683518|NCT01332968|565584937|FG002|Follow-Up Period|Progressive Disease|0|||
156683519|NCT01332968|565584938|FG003|Follow-Up Period|Progressive Disease|0|||
156683520|NCT01332968|565584939|FG004|Follow-Up Period|Progressive Disease|0|||
156683521|NCT01332968|565584940|FG005|Follow-Up Period|Progressive Disease|0|||
156683522|NCT01332968|565584941|FG006|Follow-Up Period|Progressive Disease|126|||
156683523|NCT01332968|565584942|FG007|Follow-Up Period|Progressive Disease|106|||
156683524|NCT01332968|565584935|FG000|Follow-Up Period|Protocol Violation|0|||
156683525|NCT01332968|565584936|FG001|Follow-Up Period|Protocol Violation|0|||
156683526|NCT01332968|565584937|FG002|Follow-Up Period|Protocol Violation|0|||
156683527|NCT01332968|565584938|FG003|Follow-Up Period|Protocol Violation|0|||
156683528|NCT01332968|565584939|FG004|Follow-Up Period|Protocol Violation|0|||
156683529|NCT01332968|565584940|FG005|Follow-Up Period|Protocol Violation|0|||
156683530|NCT01332968|565584941|FG006|Follow-Up Period|Protocol Violation|1|||
156683531|NCT01332968|565584942|FG007|Follow-Up Period|Protocol Violation|0|||
156683532|NCT01332968|565584935|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156683533|NCT01332968|565584936|FG001|Follow-Up Period|Withdrawal by Subject|0|||
156683534|NCT01332968|565584937|FG002|Follow-Up Period|Withdrawal by Subject|0|||
156683535|NCT01332968|565584938|FG003|Follow-Up Period|Withdrawal by Subject|0|||
156683536|NCT01332968|565584939|FG004|Follow-Up Period|Withdrawal by Subject|0|||
156683537|NCT01332968|565584940|FG005|Follow-Up Period|Withdrawal by Subject|0|||
156683538|NCT01332968|565584941|FG006|Follow-Up Period|Withdrawal by Subject|29|||
156683539|NCT01332968|565584942|FG007|Follow-Up Period|Withdrawal by Subject|32|||
156683540|NCT01332968|565584935|FG000|Follow-Up Period|No reason provided|0|||
156683541|NCT01332968|565584936|FG001|Follow-Up Period|No reason provided|0|||
156683542|NCT01332968|565584937|FG002|Follow-Up Period|No reason provided|0|||
156683543|NCT01332968|565584938|FG003|Follow-Up Period|No reason provided|0|||
156683544|NCT01332968|565584939|FG004|Follow-Up Period|No reason provided|0|||
156683545|NCT01332968|565584940|FG005|Follow-Up Period|No reason provided|0|||
156683546|NCT01332968|565584941|FG006|Follow-Up Period|No reason provided|2|||
156683547|NCT01332968|565584942|FG007|Follow-Up Period|No reason provided|3|||
156683548|NCT02351167|565584943|FG000|Overall Study|Withdrawal by Subject|19|||
156683549|NCT02351167|565584944|FG001|Overall Study|Withdrawal by Subject|18|||
156683550|NCT02351167|565584945|FG002|Overall Study|Withdrawal by Subject|21|||
156683551|NCT02914457|565584949|FG000|Overall Study|Withdrawal by Subject|1|||
156683552|NCT02914457|565584949|FG000|Overall Study|Physician Decision|1|||
157120546|NCT01425008|567193100|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
156683553|NCT02914457|565584949|FG000|Overall Study|No veins available for lead placement|1|||
156683554|NCT02914457|565584949|FG000|Overall Study|Electrical instability of patient|1|||
156683555|NCT02914457|565584949|FG000|Overall Study|ECG acquisition error due to sweating|1|||
156683556|NCT02914457|565584949|FG000|Overall Study|Protocol Violation|1|||
156683557|NCT02014441|565586998|FG000|Overall Study|Withdrawal by Subject|12|||
156683558|NCT02576717|565586999|FG000|Overall Study|Other Reasons|16|||
156683559|NCT02576717|565587000|FG001|Overall Study|Other Reasons|18|||
156683560|NCT02576717|565587001|FG002|Overall Study|Other Reasons|15|||
156683561|NCT02576717|565586999|FG000|Overall Study|Covid-19 Pandemic|0|||
156683562|NCT02576717|565587000|FG001|Overall Study|Covid-19 Pandemic|1|||
157120547|NCT01425008|567193101|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
156683563|NCT02576717|565587001|FG002|Overall Study|Covid-19 Pandemic|1|||
156683564|NCT02576717|565586999|FG000|Overall Study|Sponsor Decision|0|||
156683565|NCT02576717|565587000|FG001|Overall Study|Sponsor Decision|0|||
156683566|NCT02576717|565587001|FG002|Overall Study|Sponsor Decision|1|||
156683567|NCT02576717|565586999|FG000|Overall Study|Physician Decision|3|||
156683568|NCT02576717|565587000|FG001|Overall Study|Physician Decision|8|||
156683569|NCT02576717|565587001|FG002|Overall Study|Physician Decision|9|||
156683570|NCT02576717|565586999|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
156683571|NCT02576717|565587000|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
156784596|NCT00758043|565963205|FG002|Overall Study|Lost to Follow-up|2|||
156683572|NCT02576717|565587001|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
156683573|NCT02576717|565586999|FG000|Overall Study|Death|3|||
156683574|NCT02576717|565587000|FG001|Overall Study|Death|5|||
156683575|NCT02576717|565587001|FG002|Overall Study|Death|3|||
156683576|NCT02576717|565586999|FG000|Overall Study|Lost to Follow-up|9|||
156683577|NCT02576717|565587000|FG001|Overall Study|Lost to Follow-up|10|||
156683578|NCT02576717|565587001|FG002|Overall Study|Lost to Follow-up|19|||
156683579|NCT02576717|565586999|FG000|Overall Study|Protocol Violation|4|||
156683580|NCT02576717|565587000|FG001|Overall Study|Protocol Violation|0|||
156683581|NCT02576717|565587001|FG002|Overall Study|Protocol Violation|5|||
156683582|NCT02576717|565586999|FG000|Overall Study|Lack of Efficacy|24|||
156683583|NCT02576717|565587000|FG001|Overall Study|Lack of Efficacy|28|||
156683584|NCT02576717|565587001|FG002|Overall Study|Lack of Efficacy|20|||
156683585|NCT02576717|565586999|FG000|Overall Study|Adverse Event|26|||
156683586|NCT02576717|565587000|FG001|Overall Study|Adverse Event|32|||
156683587|NCT02576717|565587001|FG002|Overall Study|Adverse Event|26|||
156683588|NCT01363011|565587002|FG000|Main Study|Adverse Event|2|||
156683589|NCT01363011|565587003|FG001|Main Study|Adverse Event|3|||
156683590|NCT01363011|565587002|FG000|Main Study|Investigator's Discretion|1|||
156683591|NCT01363011|565587003|FG001|Main Study|Investigator's Discretion|1|||
156683592|NCT01363011|565587002|FG000|Main Study|Withdrew Consent|1|||
156683593|NCT01363011|565587003|FG001|Main Study|Withdrew Consent|4|||
156683594|NCT01363011|565587002|FG000|Main Study|Protocol Violation|0|||
156683595|NCT01363011|565587003|FG001|Main Study|Protocol Violation|1|||
156683596|NCT01363011|565587002|FG000|Extension Phase|Adverse Event|1|||
156683597|NCT01363011|565587003|FG001|Extension Phase|Adverse Event|1|||
156683598|NCT01363011|565587002|FG000|Extension Phase|Lack of Efficacy|0|||
156683599|NCT01363011|565587003|FG001|Extension Phase|Lack of Efficacy|1|||
156683600|NCT01363011|565587002|FG000|Extension Phase|Investigator's Discretion|2|||
156683601|NCT01363011|565587003|FG001|Extension Phase|Investigator's Discretion|2|||
156683602|NCT01363011|565587002|FG000|Extension Phase|Withdrew Consent|0|||
156683603|NCT01363011|565587003|FG001|Extension Phase|Withdrew Consent|1|||
156683604|NCT01363011|565587002|FG000|Extension Phase|Lost to Follow-up|0|||
156683605|NCT01363011|565587003|FG001|Extension Phase|Lost to Follow-up|2|||
156683606|NCT01363011|565587002|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
156683607|NCT01363011|565587003|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
156683608|NCT02457819|565587007|FG000|Overall Study|reason not given|8|||
156683609|NCT02457819|565587007|FG000|Overall Study|Withdrawal by Subject|24|||
156683610|NCT02457819|565587007|FG000|Overall Study|Protocol Violation|1|||
156683611|NCT02457819|565587007|FG000|Overall Study|non compliance with study drug|4|||
156683612|NCT02457819|565587007|FG000|Overall Study|Lost to Follow-up|10|||
156683613|NCT02457819|565587007|FG000|Overall Study|Lack of Efficacy|19|||
156683614|NCT02457819|565587007|FG000|Overall Study|Adverse Event|33|||
156683615|NCT03330236|565587010|FG000|Overall Study|Death|2|||
156683616|NCT03330236|565587011|FG001|Overall Study|Death|1|||
156683617|NCT03330236|565587010|FG000|Overall Study|Withdrawal by Subject|2|||
156683618|NCT03330236|565587011|FG001|Overall Study|Withdrawal by Subject|4|||
156683619|NCT03330236|565587010|FG000|Overall Study|Lost to Follow-up|0|||
156683620|NCT03330236|565587011|FG001|Overall Study|Lost to Follow-up|2|||
156683621|NCT03330236|565587010|FG000|Overall Study|Physician Decision|2|||
156683622|NCT03330236|565587011|FG001|Overall Study|Physician Decision|0|||
156683623|NCT03330236|565587010|FG000|Overall Study|Protocol Violation|4|||
156683624|NCT03330236|565587011|FG001|Overall Study|Protocol Violation|3|||
156683625|NCT03330236|565587010|FG000|Overall Study|SedLine malfunction/blinding|19|||
156683626|NCT03330236|565587011|FG001|Overall Study|SedLine malfunction/blinding|14|||
156683627|NCT03330236|565587010|FG000|Overall Study|Volatile anesthetics used|11|||
157013143|NCT02723955|566801751|FG014|Expansion Phase|Physician Decision|0|||
156683628|NCT03330236|565587011|FG001|Overall Study|Volatile anesthetics used|8|||
156683629|NCT03330236|565587010|FG000|Overall Study|Surgery aborted/converted to open|60|||
156683630|NCT03330236|565587011|FG001|Overall Study|Surgery aborted/converted to open|52|||
156683631|NCT01961882|565587015|FG000|Overall Study|Adverse Event|3|||
157013144|NCT02723955|566801752|FG015|Expansion Phase|Physician Decision|0|||
157013145|NCT02723955|566801753|FG016|Expansion Phase|Physician Decision|0|||
157013146|NCT02723955|566801754|FG017|Expansion Phase|Physician Decision|0|||
157013147|NCT02723955|566801755|FG018|Expansion Phase|Physician Decision|0|||
157013148|NCT02723955|566801756|FG019|Expansion Phase|Physician Decision|0|||
156683632|NCT01961882|565587016|FG001|Overall Study|Adverse Event|2|||
156683633|NCT01961882|565587015|FG000|Overall Study|Physician Decision|1|||
156683634|NCT01961882|565587016|FG001|Overall Study|Physician Decision|0|||
156683635|NCT01961882|565587015|FG000|Overall Study|Withdrawal by Subject|4|||
156683636|NCT01961882|565587016|FG001|Overall Study|Withdrawal by Subject|1|||
156683637|NCT01961882|565587015|FG000|Overall Study|Relapse of AML|39|||
156683638|NCT01961882|565587016|FG001|Overall Study|Relapse of AML|37|||
156683639|NCT01961882|565587015|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
156683640|NCT01961882|565587016|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
156683641|NCT01961882|565587015|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
156784597|NCT00758043|565963206|FG003|Overall Study|Lost to Follow-up|5|||
157013149|NCT02723955|566801757|FG020|Expansion Phase|Physician Decision|0|||
156683642|NCT01961882|565587016|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
156683643|NCT01901848|565587017|FG000|Randomized and Treated|Lost to Follow-up|3|||
156683644|NCT01901848|565587018|FG001|Randomized and Treated|Lost to Follow-up|6|||
156683645|NCT01901848|565587017|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
156683646|NCT01901848|565587018|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
156683647|NCT00763555|565587019|FG000|Overall Study|Adverse Event|2|||
156683648|NCT00763555|565587020|FG001|Overall Study|Adverse Event|1|||
156683649|NCT00763555|565587019|FG000|Overall Study|Withdrawal by Subject|2|||
156683650|NCT00763555|565587020|FG001|Overall Study|Withdrawal by Subject|6|||
156683651|NCT00763555|565587019|FG000|Overall Study|Lost to Follow-up|0|||
156683652|NCT00763555|565587020|FG001|Overall Study|Lost to Follow-up|3|||
156683653|NCT01729026|565587021|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
156683654|NCT01729026|565587022|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
156683655|NCT01729026|565587021|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
156683656|NCT01729026|565587022|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
156683657|NCT00407745|565587024|FG000|Overall Study|Lack of Efficacy|1|||
156683658|NCT00407745|565587025|FG001|Overall Study|Lack of Efficacy|2|||
156683659|NCT00407745|565587024|FG000|Overall Study|Withdrawal by Subject|3|||
156683660|NCT00407745|565587025|FG001|Overall Study|Withdrawal by Subject|3|||
156683661|NCT00407745|565587024|FG000|Overall Study|Protocol Violation|5|||
156683662|NCT00407745|565587025|FG001|Overall Study|Protocol Violation|3|||
156683663|NCT00407745|565587024|FG000|Overall Study|Adverse Event|8|||
156683664|NCT00407745|565587025|FG001|Overall Study|Adverse Event|8|||
156683665|NCT00407745|565587024|FG000|Overall Study|Other|2|||
156683666|NCT00407745|565587025|FG001|Overall Study|Other|0|||
156683667|NCT00407745|565587024|FG000|Overall Study|Randomized, unknown if treated|0|||
156683668|NCT00407745|565587025|FG001|Overall Study|Randomized, unknown if treated|1|||
156683669|NCT00108082|565587028|FG000|Overall Study|Adverse Event|14|||
156683670|NCT00108082|565587029|FG001|Overall Study|Adverse Event|12|||
156683671|NCT00108082|565587030|FG002|Overall Study|Adverse Event|17|||
156683672|NCT00108082|565587028|FG000|Overall Study|Lost to Follow-up|6|||
156683673|NCT00108082|565587029|FG001|Overall Study|Lost to Follow-up|3|||
156683674|NCT00108082|565587030|FG002|Overall Study|Lost to Follow-up|7|||
156683675|NCT00108082|565587028|FG000|Overall Study|Consent Withdrawn|3|||
156683676|NCT00108082|565587029|FG001|Overall Study|Consent Withdrawn|3|||
156683677|NCT00108082|565587030|FG002|Overall Study|Consent Withdrawn|5|||
156683678|NCT00108082|565587028|FG000|Overall Study|Protocol Violation|1|||
156683679|NCT00108082|565587029|FG001|Overall Study|Protocol Violation|2|||
156683680|NCT00108082|565587030|FG002|Overall Study|Protocol Violation|0|||
156683681|NCT00108082|565587028|FG000|Overall Study|Lack of Efficacy|3|||
156683682|NCT00108082|565587029|FG001|Overall Study|Lack of Efficacy|1|||
156683683|NCT00108082|565587030|FG002|Overall Study|Lack of Efficacy|2|||
156683684|NCT00108082|565587028|FG000|Overall Study|Amendment 4: > Month 12|5|||
156683685|NCT00108082|565587029|FG001|Overall Study|Amendment 4: > Month 12|7|||
156683686|NCT00108082|565587030|FG002|Overall Study|Amendment 4: > Month 12|5|||
156683687|NCT00108082|565587028|FG000|Overall Study|Woman of Child-bearing Potential|2|||
156683688|NCT00108082|565587029|FG001|Overall Study|Woman of Child-bearing Potential|0|||
156683689|NCT00108082|565587030|FG002|Overall Study|Woman of Child-bearing Potential|2|||
156683690|NCT00108082|565587028|FG000|Overall Study|Incorrectly Randomized|0|||
156683691|NCT00108082|565587029|FG001|Overall Study|Incorrectly Randomized|0|||
156683692|NCT00108082|565587030|FG002|Overall Study|Incorrectly Randomized|2|||
156683693|NCT00108082|565587028|FG000|Overall Study|Non-compliance|1|||
156683694|NCT00108082|565587029|FG001|Overall Study|Non-compliance|0|||
156683695|NCT00108082|565587030|FG002|Overall Study|Non-compliance|2|||
156683696|NCT00108082|565587028|FG000|Overall Study|Stopped Study Medication|0|||
156683697|NCT00108082|565587029|FG001|Overall Study|Stopped Study Medication|0|||
156683698|NCT00108082|565587030|FG002|Overall Study|Stopped Study Medication|1|||
156868338|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868339|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868340|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156683699|NCT00108082|565587028|FG000|Overall Study|Site Closed Study|0|||
156683700|NCT00108082|565587029|FG001|Overall Study|Site Closed Study|2|||
156683701|NCT00108082|565587030|FG002|Overall Study|Site Closed Study|0|||
156683702|NCT00108082|565587028|FG000|Overall Study|Protocol Amendment|0|||
156683703|NCT00108082|565587029|FG001|Overall Study|Protocol Amendment|1|||
156683704|NCT00108082|565587030|FG002|Overall Study|Protocol Amendment|0|||
156683705|NCT00108082|565587028|FG000|Overall Study|Study Medication Not Tapered|0|||
156683706|NCT00108082|565587029|FG001|Overall Study|Study Medication Not Tapered|1|||
156683707|NCT00108082|565587030|FG002|Overall Study|Study Medication Not Tapered|0|||
156683708|NCT00108082|565587028|FG000|Overall Study|Subject Left Site Location|1|||
156683709|NCT00108082|565587029|FG001|Overall Study|Subject Left Site Location|0|||
156683710|NCT00108082|565587030|FG002|Overall Study|Subject Left Site Location|0|||
156868341|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
156683711|NCT00108082|565587028|FG000|Overall Study|Investigator Not at Site|1|||
156683712|NCT00108082|565587029|FG001|Overall Study|Investigator Not at Site|0|||
156683713|NCT00108082|565587030|FG002|Overall Study|Investigator Not at Site|0|||
156683714|NCT00108082|565587028|FG000|Overall Study|Blood Pressure Not Controlled|1|||
156683715|NCT00108082|565587029|FG001|Overall Study|Blood Pressure Not Controlled|0|||
156683716|NCT00108082|565587030|FG002|Overall Study|Blood Pressure Not Controlled|0|||
156683717|NCT02940730|565587034|FG000|Intervention 2|Physician Decision|7|||
156683718|NCT02940730|565587035|FG001|Intervention 2|Physician Decision|0|||
156683719|NCT00298740|565587039|FG000|Overall Study|Lack of Efficacy|6|||
156683720|NCT00298740|565587039|FG000|Overall Study|Withdrawal by Subject|3|||
156683721|NCT01064531|565587040|FG000|Overall Study|Lost to Follow-up|0|||
156683722|NCT01064531|565587041|FG001|Overall Study|Lost to Follow-up|2|||
156683723|NCT01064531|565587040|FG000|Overall Study|Physician Decision|0|||
156683724|NCT01064531|565587041|FG001|Overall Study|Physician Decision|1|||
156683725|NCT01064531|565587040|FG000|Overall Study|Withdrawal by Subject|2|||
156683726|NCT01064531|565587041|FG001|Overall Study|Withdrawal by Subject|2|||
156683727|NCT01064531|565587040|FG000|Overall Study|Revision due to femoral stem loosening|1|||
156683728|NCT01064531|565587041|FG001|Overall Study|Revision due to femoral stem loosening|0|||
156683729|NCT01064531|565587040|FG000|Overall Study|Revision due to dislocation|0|||
156683730|NCT01064531|565587041|FG001|Overall Study|Revision due to dislocation|1|||
156784598|NCT00758043|565963203|FG000|Overall Study|Withdrawal by Subject|0|||
156784599|NCT00758043|565963204|FG001|Overall Study|Withdrawal by Subject|1|||
156784600|NCT00758043|565963205|FG002|Overall Study|Withdrawal by Subject|1|||
156784601|NCT00758043|565963206|FG003|Overall Study|Withdrawal by Subject|4|||
156784602|NCT00758043|565963203|FG000|Overall Study|Required Prohibited Medication|0|||
156784603|NCT00758043|565963204|FG001|Overall Study|Required Prohibited Medication|0|||
156784604|NCT00758043|565963205|FG002|Overall Study|Required Prohibited Medication|1|||
156784605|NCT00758043|565963206|FG003|Overall Study|Required Prohibited Medication|3|||
156784606|NCT00758043|565963203|FG000|Overall Study|Non-Compliant With study Drug|0|||
156784607|NCT00758043|565963204|FG001|Overall Study|Non-Compliant With study Drug|0|||
156784608|NCT00758043|565963205|FG002|Overall Study|Non-Compliant With study Drug|0|||
156784609|NCT00758043|565963206|FG003|Overall Study|Non-Compliant With study Drug|1|||
156784610|NCT00758043|565963203|FG000|Overall Study|Other Reasons|0|||
156784611|NCT00758043|565963204|FG001|Overall Study|Other Reasons|1|||
156784612|NCT00758043|565963205|FG002|Overall Study|Other Reasons|0|||
156784613|NCT00758043|565963206|FG003|Overall Study|Other Reasons|5|||
156784614|NCT02545127|565963213|FG000|Overall Study|Lost to Follow-up|1|||
156784615|NCT02545127|565963214|FG001|Overall Study|Lost to Follow-up|0|||
156784616|NCT03197935|565963215|FG000|Overall Study|Death due to any cause|26|||
156784617|NCT03197935|565963216|FG001|Overall Study|Death due to any cause|15|||
156784618|NCT03197935|565963215|FG000|Overall Study|Lost to Follow-up|3|||
156784619|NCT03197935|565963216|FG001|Overall Study|Lost to Follow-up|5|||
156784620|NCT03197935|565963215|FG000|Overall Study|Physician Decision|2|||
156784621|NCT03197935|565963216|FG001|Overall Study|Physician Decision|1|||
156784622|NCT03197935|565963215|FG000|Overall Study|Withdrawal by Subject|16|||
156784623|NCT03197935|565963216|FG001|Overall Study|Withdrawal by Subject|8|||
156784624|NCT04027946|565963217|FG000|Overall Study|Screen failures|3|||
156784625|NCT01562444|565963224|FG000|Overall Study|Did not meet entry criteria|2|||
156784626|NCT01562444|565963225|FG001|Overall Study|Did not meet entry criteria|0|||
156784627|NCT01562444|565963226|FG002|Overall Study|Did not meet entry criteria|3|||
156784628|NCT01562444|565963224|FG000|Overall Study|Did not comply with blood draw schedule|1|||
156784629|NCT01562444|565963225|FG001|Overall Study|Did not comply with blood draw schedule|0|||
156784630|NCT01562444|565963226|FG002|Overall Study|Did not comply with blood draw schedule|1|||
156784631|NCT01562444|565963224|FG000|Overall Study|Unavailable serological results|0|||
156784632|NCT01562444|565963225|FG001|Overall Study|Unavailable serological results|2|||
156784633|NCT01562444|565963226|FG002|Overall Study|Unavailable serological results|2|||
156784634|NCT01562444|565963224|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
156784635|NCT01562444|565963225|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
156784636|NCT01562444|565963226|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
156784637|NCT01562444|565963224|FG000|Overall Study|Protocol forbidden medication|1|||
156784638|NCT01562444|565963225|FG001|Overall Study|Protocol forbidden medication|0|||
156784639|NCT01562444|565963226|FG002|Overall Study|Protocol forbidden medication|0|||
156784640|NCT03794544|565963236|FG000|Overall Study|Withdrawal by Subject|1|||
156784641|NCT03794544|565963237|FG001|Overall Study|Withdrawal by Subject|1|||
156784642|NCT03794544|565963238|FG002|Overall Study|Withdrawal by Subject|0|||
156784643|NCT03794544|565963239|FG003|Overall Study|Withdrawal by Subject|0|||
156784644|NCT03794544|565963236|FG000|Overall Study|Death|0|||
156784645|NCT03794544|565963237|FG001|Overall Study|Death|0|||
156784646|NCT03794544|565963238|FG002|Overall Study|Death|0|||
157013150|NCT02723955|566801758|FG021|Expansion Phase|Physician Decision|0|||
156683731|NCT01064531|565587040|FG000|Overall Study|Death|0|||
156683732|NCT01064531|565587041|FG001|Overall Study|Death|1|||
156683733|NCT03449199|565587045|FG000|Overall Study|Lost to Follow-up|1|||
156683734|NCT03449199|565587046|FG001|Overall Study|Lost to Follow-up|1|||
156683735|NCT03449199|565587047|FG002|Overall Study|Lost to Follow-up|0|||
156683736|NCT03449199|565587045|FG000|Overall Study|Protocol Deviation|0|||
156683737|NCT03449199|565587046|FG001|Overall Study|Protocol Deviation|0|||
156683738|NCT03449199|565587047|FG002|Overall Study|Protocol Deviation|1|||
156683739|NCT03449199|565587045|FG000|Overall Study|Withdrawal by Subject|0|||
156683740|NCT03449199|565587046|FG001|Overall Study|Withdrawal by Subject|0|||
156683741|NCT03449199|565587047|FG002|Overall Study|Withdrawal by Subject|1|||
156683742|NCT00684567|565587048|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
156683743|NCT00684567|565587048|FG000|Monotherapy Period|Adverse Event|2|||
156683744|NCT00684567|565587048|FG000|Monotherapy Period|Death|1|||
156683745|NCT00684567|565587048|FG000|Monotherapy Period|Progression of primary disease|11|||
156683746|NCT03136406|565587049|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
156683747|NCT01201759|565587050|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
156683748|NCT01201759|565587051|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
156683749|NCT01201759|565587050|FG000|Visit 3 - Washout|Adverse Event|0|||
156683750|NCT01201759|565587051|FG001|Visit 3 - Washout|Adverse Event|3|||
156683751|NCT01201759|565587050|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
156683752|NCT01201759|565587051|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
156683753|NCT01201759|565587050|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
156683754|NCT01201759|565587051|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
156683755|NCT00906373|565587052|FG000|Overall Study|Withdrawal by Subject|0|||
156683756|NCT00906373|565587053|FG001|Overall Study|Withdrawal by Subject|5|||
156683757|NCT00906373|565587052|FG000|Overall Study|Other|0|||
156683758|NCT00906373|565587053|FG001|Overall Study|Other|1|||
156683759|NCT00906373|565587052|FG000|Overall Study|Still on treatment at cutoff date|0|||
156683760|NCT00906373|565587053|FG001|Overall Study|Still on treatment at cutoff date|2|||
156683761|NCT00848042|565587054|FG000|Overall Study|Death|1|||
156683762|NCT00848042|565587055|FG001|Overall Study|Death|2|||
156683763|NCT00848042|565587056|FG002|Overall Study|Death|0|||
156683764|NCT00848042|565587054|FG000|Overall Study|Other Therapy|3|||
156683765|NCT00848042|565587055|FG001|Overall Study|Other Therapy|0|||
156683766|NCT00848042|565587056|FG002|Overall Study|Other Therapy|0|||
156683767|NCT02744755|565587057|FG000|Study Period 1|Protocol Violation|2|||
156683768|NCT02744755|565587058|FG001|Study Period 1|Protocol Violation|1|||
156683769|NCT02744755|565587057|FG000|Study Period 1|not defined|0|||
156683770|NCT02744755|565587058|FG001|Study Period 1|not defined|1|||
156683771|NCT02744755|565587057|FG000|Study Period 1|Pregnancy|1|||
156683772|NCT02744755|565587058|FG001|Study Period 1|Pregnancy|0|||
156683773|NCT02744755|565587057|FG000|Study Period 1|Adverse Event|1|||
156683774|NCT02744755|565587058|FG001|Study Period 1|Adverse Event|1|||
156683775|NCT02744755|565587057|FG000|Study Period 1|Lost to Follow-up|1|||
156683776|NCT02744755|565587058|FG001|Study Period 1|Lost to Follow-up|1|||
156683777|NCT02744755|565587057|FG000|Study Period 1|Lack of Efficacy|1|||
156683778|NCT02744755|565587058|FG001|Study Period 1|Lack of Efficacy|0|||
156683779|NCT02744755|565587057|FG000|Study Period 1|Withdrawal by Subject|8|||
156683780|NCT02744755|565587058|FG001|Study Period 1|Withdrawal by Subject|4|||
156683781|NCT02744755|565587057|FG000|Study Period 2|Adverse Event|5|||
156683782|NCT02744755|565587058|FG001|Study Period 2|Adverse Event|0|||
156683783|NCT02744755|565587057|FG000|Study Period 2|Protocol Violation|1|||
156683784|NCT02744755|565587058|FG001|Study Period 2|Protocol Violation|0|||
156868342|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
156868343|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868344|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868345|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868346|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868347|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868348|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868349|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868350|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868351|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868352|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868353|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868354|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
156868355|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
156868356|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
157013151|NCT02723955|566801759|FG022|Expansion Phase|Physician Decision|0|||
157213616|NCT04380701|567529565|FG013|Overall Study|Private reason(s)|0|||
156683785|NCT02744755|565587057|FG000|Study Period 2|not defined|3|||
156683786|NCT02744755|565587058|FG001|Study Period 2|not defined|2|||
156683787|NCT02744755|565587057|FG000|Study Period 2|Lost to Follow-up|0|||
156683788|NCT02744755|565587058|FG001|Study Period 2|Lost to Follow-up|2|||
156683789|NCT02744755|565587057|FG000|Study Period 2|Withdrawal by Subject|2|||
156683790|NCT02744755|565587058|FG001|Study Period 2|Withdrawal by Subject|2|||
156683791|NCT02744755|565587057|FG000|Study Period 2|Lack of Efficacy|3|||
156683792|NCT02744755|565587058|FG001|Study Period 2|Lack of Efficacy|2|||
157013152|NCT02723955|566801760|FG023|Expansion Phase|Physician Decision|0|||
157013153|NCT02723955|566801761|FG024|Expansion Phase|Physician Decision|0|||
157013154|NCT02723955|566801762|FG025|Expansion Phase|Physician Decision|0|||
156683795|NCT00112294|565587060|FG000|Overall Study|Still on study|5|||
156683796|NCT00112294|565587061|FG001|Overall Study|Still on study|0|||
156683797|NCT03843125|565587064|FG000|Overall Study|Adverse Event|17|||
156683798|NCT03843125|565587065|FG001|Overall Study|Adverse Event|13|||
156683799|NCT03843125|565587066|FG002|Overall Study|Adverse Event|5|||
156683800|NCT03843125|565587067|FG003|Overall Study|Adverse Event|9|||
156683801|NCT03843125|565587064|FG000|Overall Study|Death|0|||
156683802|NCT03843125|565587065|FG001|Overall Study|Death|6|||
156683803|NCT03843125|565587066|FG002|Overall Study|Death|2|||
156683804|NCT03843125|565587067|FG003|Overall Study|Death|0|||
156683805|NCT03843125|565587064|FG000|Overall Study|Lack of Efficacy|14|||
156683806|NCT03843125|565587065|FG001|Overall Study|Lack of Efficacy|11|||
156683807|NCT03843125|565587066|FG002|Overall Study|Lack of Efficacy|9|||
156683808|NCT03843125|565587067|FG003|Overall Study|Lack of Efficacy|4|||
156683809|NCT03843125|565587064|FG000|Overall Study|Lost to Follow-up|3|||
156683810|NCT03843125|565587065|FG001|Overall Study|Lost to Follow-up|4|||
156683811|NCT03843125|565587066|FG002|Overall Study|Lost to Follow-up|0|||
156683812|NCT03843125|565587067|FG003|Overall Study|Lost to Follow-up|2|||
156683813|NCT03843125|565587064|FG000|Overall Study|Other|12|||
156683814|NCT03843125|565587065|FG001|Overall Study|Other|14|||
156683815|NCT03843125|565587066|FG002|Overall Study|Other|3|||
156683816|NCT03843125|565587067|FG003|Overall Study|Other|4|||
156683817|NCT03843125|565587064|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
156683818|NCT03843125|565587065|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
156683819|NCT03843125|565587066|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
156683820|NCT03843125|565587067|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
156683821|NCT03843125|565587064|FG000|Overall Study|Study Terminated by Sponsor|318|||
156683822|NCT03843125|565587065|FG001|Overall Study|Study Terminated by Sponsor|318|||
156683823|NCT03843125|565587066|FG002|Overall Study|Study Terminated by Sponsor|163|||
156683824|NCT03843125|565587067|FG003|Overall Study|Study Terminated by Sponsor|163|||
156683825|NCT03843125|565587064|FG000|Overall Study|Withdrawal by Subject|23|||
156683826|NCT03843125|565587065|FG001|Overall Study|Withdrawal by Subject|12|||
156683827|NCT03843125|565587066|FG002|Overall Study|Withdrawal by Subject|6|||
156683828|NCT03843125|565587067|FG003|Overall Study|Withdrawal by Subject|9|||
156683829|NCT03843125|565587064|FG000|Overall Study|Missing data|0|||
156683830|NCT03843125|565587065|FG001|Overall Study|Missing data|1|||
156683831|NCT03843125|565587066|FG002|Overall Study|Missing data|1|||
156683832|NCT03843125|565587067|FG003|Overall Study|Missing data|0|||
156683833|NCT00721955|565587068|FG000|Overall Study|Adverse Event|0|||
156683834|NCT00721955|565587069|FG001|Overall Study|Adverse Event|0|||
156683835|NCT00721955|565587070|FG002|Overall Study|Adverse Event|2|||
156683836|NCT01292837|565587071|FG000|Overall Study|Adverse Event|1|||
156683837|NCT01292837|565587071|FG000|Overall Study|Further treatment determined|1|||
156683838|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
156683839|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683840|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683841|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
156683842|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683843|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683844|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
156683845|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
156683846|NCT02174276|565587072|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
156683847|NCT02174276|565587073|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
156683848|NCT02174276|565587074|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
156683849|NCT02174276|565587075|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
156683850|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683851|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683852|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
156683853|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
156683854|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683855|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683856|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
156683857|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
156683858|NCT02174276|565587072|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
156868357|NCT02113982|566277280|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
157213617|NCT04380701|567529566|FG014|Overall Study|Private reason(s)|0|||
156683859|NCT02174276|565587073|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
156683860|NCT02174276|565587074|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
156683861|NCT02174276|565587075|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
156683862|NCT01206439|565587078|FG000|Overall Study|subject did not meet inclusion criteria|1|||
156683863|NCT01055886|565587080|FG000|Overall Study|Withdrawal by Subject|4|||
156683864|NCT01055886|565587081|FG001|Overall Study|Withdrawal by Subject|9|||
156683865|NCT01055886|565587080|FG000|Overall Study|Lost to Follow-up|1|||
156683866|NCT01055886|565587081|FG001|Overall Study|Lost to Follow-up|1|||
156683867|NCT01055886|565587080|FG000|Overall Study|Withdrawal by PI|0|||
156683868|NCT01055886|565587081|FG001|Overall Study|Withdrawal by PI|1|||
156683869|NCT04254809|565587084|FG000|Overall Study|Lost to Follow-up|5|||
156683870|NCT04254809|565587085|FG001|Overall Study|Lost to Follow-up|10|||
156683871|NCT02972515|565587086|FG000|Overall Study|Lost to Follow-up|78|||
156683872|NCT01928615|565587087|FG000|Overall Study|Study Terminated by Sponsor|2|||
156683873|NCT00609154|565587088|FG000|Overall Study|Protocol Violation|1|||
156683874|NCT00609154|565587089|FG001|Overall Study|Protocol Violation|2|||
156683875|NCT00609154|565587088|FG000|Overall Study|Unable to establish IV access|0|||
156683876|NCT00609154|565587089|FG001|Overall Study|Unable to establish IV access|4|||
156683877|NCT00609154|565587088|FG000|Overall Study|Adverse Event|0|||
156683878|NCT00609154|565587089|FG001|Overall Study|Adverse Event|2|||
156683879|NCT04531527|565587090|FG000|Overall Study|Found to be Ineligible|3|||
156683880|NCT01077258|565587098|FG000|Overall Study|Lost to Follow-up|1390|||
156683881|NCT01077258|565587098|FG000|Overall Study|Adverse drug reaction|218|||
156683882|NCT01077258|565587098|FG000|Overall Study|Lack of Efficacy|663|||
156683883|NCT01077258|565587098|FG000|Overall Study|Clinical remission|37|||
156683884|NCT01077258|565587098|FG000|Overall Study|Other reasons|260|||
156683885|NCT00434837|565587099|FG000|Overall Study|Lost to Follow-up|20|||
156683886|NCT00434837|565587100|FG001|Overall Study|Lost to Follow-up|23|||
156683887|NCT00434837|565587101|FG002|Overall Study|Lost to Follow-up|30|||
156683888|NCT00726895|565587103|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156683889|NCT00726895|565587104|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156683890|NCT03310619|565587108|FG000|Pre-Treatment Period|Death|1|||
156683891|NCT03310619|565587109|FG001|Pre-Treatment Period|Death|0|||
156683892|NCT03310619|565587110|FG002|Pre-Treatment Period|Death|0|||
156683893|NCT03310619|565587111|FG003|Pre-Treatment Period|Death|0|||
156683894|NCT03310619|565587112|FG004|Pre-Treatment Period|Death|1|||
156683895|NCT03310619|565587113|FG005|Pre-Treatment Period|Death|0|||
156683896|NCT03310619|565587114|FG006|Pre-Treatment Period|Death|0|||
156683897|NCT03310619|565587115|FG007|Pre-Treatment Period|Death|0|||
156683898|NCT03310619|565587108|FG000|Pre-Treatment Period|Other reasons|2|||
156683899|NCT03310619|565587109|FG001|Pre-Treatment Period|Other reasons|1|||
156683900|NCT03310619|565587110|FG002|Pre-Treatment Period|Other reasons|2|||
156683901|NCT03310619|565587111|FG003|Pre-Treatment Period|Other reasons|0|||
156683902|NCT03310619|565587112|FG004|Pre-Treatment Period|Other reasons|0|||
156683903|NCT03310619|565587113|FG005|Pre-Treatment Period|Other reasons|0|||
156683904|NCT03310619|565587114|FG006|Pre-Treatment Period|Other reasons|2|||
156683905|NCT03310619|565587115|FG007|Pre-Treatment Period|Other reasons|0|||
156683906|NCT03310619|565587108|FG000|Treatment Period|Death|1|||
156683907|NCT03310619|565587109|FG001|Treatment Period|Death|2|||
156683908|NCT03310619|565587110|FG002|Treatment Period|Death|0|||
156683909|NCT03310619|565587111|FG003|Treatment Period|Death|0|||
156683910|NCT03310619|565587112|FG004|Treatment Period|Death|1|||
156683911|NCT03310619|565587113|FG005|Treatment Period|Death|0|||
156683912|NCT03310619|565587114|FG006|Treatment Period|Death|2|||
156683913|NCT03310619|565587115|FG007|Treatment Period|Death|0|||
156683914|NCT03310619|565587108|FG000|Treatment Period|Adverse Event|0|||
156683915|NCT03310619|565587109|FG001|Treatment Period|Adverse Event|1|||
156683916|NCT03310619|565587110|FG002|Treatment Period|Adverse Event|4|||
156683917|NCT03310619|565587111|FG003|Treatment Period|Adverse Event|1|||
156683918|NCT03310619|565587112|FG004|Treatment Period|Adverse Event|0|||
156683919|NCT03310619|565587113|FG005|Treatment Period|Adverse Event|0|||
156683920|NCT03310619|565587114|FG006|Treatment Period|Adverse Event|0|||
156683921|NCT03310619|565587115|FG007|Treatment Period|Adverse Event|0|||
156683922|NCT03310619|565587108|FG000|Treatment Period|Withdrawal by participant|0|||
157013155|NCT02723955|566801763|FG026|Expansion Phase|Physician Decision|0|||
156683923|NCT03310619|565587109|FG001|Treatment Period|Withdrawal by participant|0|||
156683924|NCT03310619|565587110|FG002|Treatment Period|Withdrawal by participant|1|||
156683925|NCT03310619|565587111|FG003|Treatment Period|Withdrawal by participant|0|||
156683926|NCT03310619|565587112|FG004|Treatment Period|Withdrawal by participant|0|||
156683927|NCT03310619|565587113|FG005|Treatment Period|Withdrawal by participant|0|||
156683928|NCT03310619|565587114|FG006|Treatment Period|Withdrawal by participant|0|||
156683929|NCT03310619|565587115|FG007|Treatment Period|Withdrawal by participant|0|||
156683930|NCT03310619|565587108|FG000|Treatment Period|Lost to Follow-up|0|||
156683931|NCT03310619|565587109|FG001|Treatment Period|Lost to Follow-up|0|||
157013156|NCT02723955|566801764|FG027|Expansion Phase|Physician Decision|0|||
157013157|NCT02723955|566801765|FG028|Expansion Phase|Physician Decision|0|||
157013158|NCT02723955|566801766|FG029|Expansion Phase|Physician Decision|0|||
157013159|NCT02723955|566801767|FG030|Expansion Phase|Physician Decision|1|||
156683932|NCT03310619|565587110|FG002|Treatment Period|Lost to Follow-up|0|||
156683933|NCT03310619|565587111|FG003|Treatment Period|Lost to Follow-up|0|||
156683934|NCT03310619|565587112|FG004|Treatment Period|Lost to Follow-up|0|||
156683935|NCT03310619|565587113|FG005|Treatment Period|Lost to Follow-up|0|||
156683936|NCT03310619|565587114|FG006|Treatment Period|Lost to Follow-up|0|||
156683937|NCT03310619|565587115|FG007|Treatment Period|Lost to Follow-up|1|||
156683938|NCT03310619|565587108|FG000|Treatment Period|Study terminated by sponsor|0|||
156683939|NCT03310619|565587109|FG001|Treatment Period|Study terminated by sponsor|0|||
156683940|NCT03310619|565587110|FG002|Treatment Period|Study terminated by sponsor|0|||
156683941|NCT03310619|565587111|FG003|Treatment Period|Study terminated by sponsor|0|||
156683942|NCT03310619|565587112|FG004|Treatment Period|Study terminated by sponsor|0|||
157013160|NCT02723955|566801768|FG031|Expansion Phase|Physician Decision|1|||
156683943|NCT03310619|565587113|FG005|Treatment Period|Study terminated by sponsor|0|||
156683944|NCT03310619|565587114|FG006|Treatment Period|Study terminated by sponsor|0|||
156683945|NCT03310619|565587115|FG007|Treatment Period|Study terminated by sponsor|1|||
156683946|NCT03310619|565587108|FG000|Treatment Period|Physician Decision|0|||
156683947|NCT03310619|565587109|FG001|Treatment Period|Physician Decision|0|||
156683948|NCT03310619|565587110|FG002|Treatment Period|Physician Decision|0|||
156683949|NCT03310619|565587111|FG003|Treatment Period|Physician Decision|0|||
156683950|NCT03310619|565587112|FG004|Treatment Period|Physician Decision|3|||
156683951|NCT03310619|565587113|FG005|Treatment Period|Physician Decision|0|||
156683952|NCT03310619|565587114|FG006|Treatment Period|Physician Decision|0|||
156683953|NCT03310619|565587115|FG007|Treatment Period|Physician Decision|0|||
156683954|NCT03310619|565587108|FG000|Treatment Period|Other reasons|1|||
156683955|NCT03310619|565587109|FG001|Treatment Period|Other reasons|0|||
156683956|NCT03310619|565587110|FG002|Treatment Period|Other reasons|2|||
156683957|NCT03310619|565587111|FG003|Treatment Period|Other reasons|0|||
156683958|NCT03310619|565587112|FG004|Treatment Period|Other reasons|0|||
156683959|NCT03310619|565587113|FG005|Treatment Period|Other reasons|0|||
156683960|NCT03310619|565587114|FG006|Treatment Period|Other reasons|0|||
156683961|NCT03310619|565587115|FG007|Treatment Period|Other reasons|0|||
156683962|NCT01266603|565587118|FG000|Overall Study|Adverse Event|1|||
156683963|NCT01266603|565587118|FG000|Overall Study|Lack of Efficacy|14|||
156683964|NCT01266603|565587118|FG000|Overall Study|Withdrawal by Subject|1|||
156683965|NCT01266603|565587118|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
156683966|NCT04307849|565587119|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683967|NCT04307849|565587120|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683968|NCT04307849|565587121|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
156683969|NCT04307849|565587122|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
156683970|NCT04307849|565587123|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
156683971|NCT04307849|565587124|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
156683972|NCT04307849|565587119|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683973|NCT04307849|565587120|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683974|NCT04307849|565587121|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
156683975|NCT04307849|565587122|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683976|NCT04307849|565587123|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683977|NCT04307849|565587124|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
156683978|NCT04307849|565587119|FG000|Overall Study|Family member did not want them to continue|0|||
156683979|NCT04307849|565587120|FG001|Overall Study|Family member did not want them to continue|0|||
156683980|NCT04307849|565587121|FG002|Overall Study|Family member did not want them to continue|1|||
156683981|NCT04307849|565587122|FG003|Overall Study|Family member did not want them to continue|0|||
156683982|NCT04307849|565587123|FG004|Overall Study|Family member did not want them to continue|0|||
156683983|NCT04307849|565587124|FG005|Overall Study|Family member did not want them to continue|0|||
156683984|NCT04307849|565587119|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
156683985|NCT04307849|565587120|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
156683986|NCT04307849|565587121|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
156683987|NCT04307849|565587122|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
156683988|NCT04307849|565587123|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
156683989|NCT04307849|565587124|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
156683990|NCT00756717|565587125|FG000|Overall Study|Withdrawal by Subject|2|||
156683991|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683992|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
157213618|NCT04380701|567529567|FG015|Overall Study|Private reason(s)|0|||
157213619|NCT04380701|567529568|FG016|Overall Study|Private reason(s)|0|||
157213620|NCT04380701|567529569|FG017|Overall Study|Private reason(s)|0|||
157213621|NCT04380701|567529570|FG018|Overall Study|Private reason(s)|0|||
157213622|NCT04380701|567529571|FG019|Overall Study|Private reason(s)|0|||
157213623|NCT04380701|567529572|FG020|Overall Study|Private reason(s)|0|||
157213624|NCT04380701|567529573|FG021|Overall Study|Private reason(s)|0|||
157213625|NCT04380701|567529574|FG022|Overall Study|Private reason(s)|0|||
157213626|NCT04380701|567529575|FG023|Overall Study|Private reason(s)|1|||
157213627|NCT04380701|567529576|FG024|Overall Study|Private reason(s)|0|||
156683993|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683994|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683995|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
156683996|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
156683997|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
156784647|NCT03794544|565963239|FG003|Overall Study|Death|1|||
157213628|NCT04380701|567529577|FG025|Overall Study|Private reason(s)|0|||
156683998|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
156683999|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
156684000|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
157213629|NCT04380701|567529578|FG026|Overall Study|Private reason(s)|0|||
156684001|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
156684002|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684003|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684004|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684005|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
156684006|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684007|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
156684008|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
156684009|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684010|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
156684011|NCT02418754|565587126|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684012|NCT02418754|565587127|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684013|NCT02418754|565587128|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
156684014|NCT02418754|565587129|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684015|NCT02418754|565587130|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
156684016|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
156684017|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
156684018|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
156684019|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
156684020|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
156684021|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
156684022|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684023|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684024|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684025|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
156684026|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
156684027|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
156684028|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
156684029|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
156684030|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
156684031|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
156684032|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
156684033|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
156684034|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
156684035|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
156684036|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
156684037|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
156684038|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
156684039|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
156684040|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
156684041|NCT02418754|565587126|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684042|NCT02418754|565587127|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
156684043|NCT02418754|565587128|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684044|NCT02418754|565587129|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
156684045|NCT02418754|565587130|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
156684046|NCT02762994|565587131|FG000|Overall Study|Withdrawal by Subject|0|||
156684047|NCT02762994|565587132|FG001|Overall Study|Withdrawal by Subject|1|||
156684048|NCT02762994|565587133|FG002|Overall Study|Withdrawal by Subject|2|||
156684049|NCT02762994|565587134|FG003|Overall Study|Withdrawal by Subject|0|||
156684050|NCT02762994|565587131|FG000|Overall Study|Protocol Violation|1|||
156684051|NCT02762994|565587132|FG001|Overall Study|Protocol Violation|0|||
157120548|NCT01425008|567193102|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
157120549|NCT01425008|567193103|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
157120550|NCT01425008|567193104|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
157120551|NCT01425008|567193105|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
157120552|NCT01425008|567193106|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
157120553|NCT01425008|567193107|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
157120554|NCT01425008|567193108|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
157120555|NCT01425008|567193109|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
157120556|NCT01425008|567193110|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
157120557|NCT01425008|567193111|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
157120558|NCT01425008|567193112|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
156684052|NCT02762994|565587133|FG002|Overall Study|Protocol Violation|0|||
156684053|NCT02762994|565587134|FG003|Overall Study|Protocol Violation|2|||
156684054|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
156684055|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
156684056|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
156684057|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
156684058|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
156684059|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
156684060|NCT03507686|565587145|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
156684061|NCT03507686|565587146|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
156684062|NCT03507686|565587145|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
156684063|NCT03507686|565587146|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
156684064|NCT03507686|565587145|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
156684065|NCT03507686|565587146|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
156684066|NCT00585312|565587147|FG000|Overall Study|Adverse Event|3|||
156684067|NCT00585312|565587148|FG001|Overall Study|Adverse Event|0|||
156684068|NCT00585312|565587147|FG000|Overall Study|Lack of Efficacy|6|||
156684069|NCT00585312|565587148|FG001|Overall Study|Lack of Efficacy|11|||
156684070|NCT00585312|565587147|FG000|Overall Study|Lost to Follow-up|1|||
156684071|NCT00585312|565587148|FG001|Overall Study|Lost to Follow-up|1|||
156684072|NCT00585312|565587147|FG000|Overall Study|Reason not specified|2|||
156684073|NCT00585312|565587148|FG001|Overall Study|Reason not specified|0|||
156684074|NCT00585312|565587147|FG000|Overall Study|Withdrawal by Subject|5|||
156684075|NCT00585312|565587148|FG001|Overall Study|Withdrawal by Subject|1|||
156684076|NCT00585312|565587147|FG000|Overall Study|Study terminated by the sponsor|34|||
156684077|NCT00585312|565587148|FG001|Overall Study|Study terminated by the sponsor|31|||
156684078|NCT02387762|565587149|FG000|Overall Study|Withdrawal by Subject|1|||
156684079|NCT02387762|565587150|FG001|Overall Study|Withdrawal by Subject|0|||
156684080|NCT04203667|565587151|FG000|Overall Study|Withdrawal by Subject|1|||
156684081|NCT04203667|565587151|FG000|Overall Study|Lost to Follow-up|1|||
156684082|NCT04203667|565587151|FG000|Overall Study|Death|1|||
156684083|NCT04203667|565587151|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
156684084|NCT01160640|565587152|FG000|Overall Study|Physician Decision|3|||
156684085|NCT01160640|565587153|FG001|Overall Study|Physician Decision|3|||
156684086|NCT01160640|565587152|FG000|Overall Study|Incarceration|1|||
156684087|NCT01160640|565587153|FG001|Overall Study|Incarceration|0|||
156684088|NCT01160640|565587152|FG000|Overall Study|Withdrawal by Subject|0|||
156684089|NCT01160640|565587153|FG001|Overall Study|Withdrawal by Subject|3|||
156684090|NCT00642811|565587155|FG000|Overall Study|Adverse Event|2|||
156684091|NCT00642811|565587156|FG001|Overall Study|Adverse Event|3|||
156684092|NCT00642811|565587157|FG002|Overall Study|Adverse Event|0|||
156684093|NCT00642811|565587158|FG003|Overall Study|Adverse Event|0|||
156684094|NCT00642811|565587159|FG004|Overall Study|Adverse Event|0|||
156684095|NCT00642811|565587160|FG005|Overall Study|Adverse Event|1|||
157013161|NCT02723955|566801769|FG032|Expansion Phase|Physician Decision|0|||
156684096|NCT00642811|565587155|FG000|Overall Study|Developement of discontinuation criteria|0|||
156684097|NCT00642811|565587156|FG001|Overall Study|Developement of discontinuation criteria|0|||
156684098|NCT00642811|565587157|FG002|Overall Study|Developement of discontinuation criteria|0|||
156684099|NCT00642811|565587158|FG003|Overall Study|Developement of discontinuation criteria|0|||
156684100|NCT00642811|565587159|FG004|Overall Study|Developement of discontinuation criteria|1|||
156684101|NCT00642811|565587160|FG005|Overall Study|Developement of discontinuation criteria|0|||
156684102|NCT00642811|565587155|FG000|Overall Study|Severe Non-compliance to protocol|1|||
156684103|NCT00642811|565587156|FG001|Overall Study|Severe Non-compliance to protocol|0|||
156684104|NCT00642811|565587157|FG002|Overall Study|Severe Non-compliance to protocol|0|||
156684105|NCT00642811|565587158|FG003|Overall Study|Severe Non-compliance to protocol|0|||
156684106|NCT00642811|565587159|FG004|Overall Study|Severe Non-compliance to protocol|0|||
157013162|NCT02723955|566801770|FG033|Expansion Phase|Physician Decision|0|||
157013163|NCT02723955|566801771|FG034|Expansion Phase|Physician Decision|0|||
157013164|NCT02723955|566801772|FG035|Expansion Phase|Physician Decision|0|||
157013165|NCT02723955|566801773|FG036|Expansion Phase|Physician Decision|0|||
157013166|NCT02723955|566801774|FG037|Expansion Phase|Physician Decision|0|||
157013167|NCT02723955|566801775|FG038|Expansion Phase|Physician Decision|0|||
157013168|NCT02723955|566801776|FG039|Expansion Phase|Physician Decision|0|||
157013169|NCT02723955|566801777|FG040|Expansion Phase|Physician Decision|0|||
157013170|NCT02723955|566801778|FG041|Expansion Phase|Physician Decision|0|||
156684107|NCT00642811|565587160|FG005|Overall Study|Severe Non-compliance to protocol|0|||
156684108|NCT00642811|565587155|FG000|Overall Study|Other|0|||
156684109|NCT00642811|565587156|FG001|Overall Study|Other|1|||
156684110|NCT00642811|565587157|FG002|Overall Study|Other|0|||
156684111|NCT00642811|565587158|FG003|Overall Study|Other|1|||
156684112|NCT00642811|565587159|FG004|Overall Study|Other|0|||
156684113|NCT00642811|565587160|FG005|Overall Study|Other|0|||
156684114|NCT02614898|565587161|FG000|Overall Study|Participated until study termination|10|||
156784648|NCT03794544|565963236|FG000|Overall Study|Lost to Follow-up|0|||
157013171|NCT02723955|566801779|FG042|Expansion Phase|Physician Decision|0|||
157013172|NCT02723955|566801737|FG000|Expansion Phase|Withdrawal by Subject|0|||
157013173|NCT02723955|566801738|FG001|Expansion Phase|Withdrawal by Subject|0|||
157013174|NCT02723955|566801739|FG002|Expansion Phase|Withdrawal by Subject|0|||
157013175|NCT02723955|566801740|FG003|Expansion Phase|Withdrawal by Subject|0|||
156684115|NCT02614898|565587162|FG001|Overall Study|Participated until study termination|26|||
156684116|NCT02614898|565587161|FG000|Overall Study|Lost to Follow-up|0|||
156684117|NCT02614898|565587162|FG001|Overall Study|Lost to Follow-up|2|||
156684118|NCT02614898|565587161|FG000|Overall Study|Physician Decision|1|||
156684119|NCT02614898|565587162|FG001|Overall Study|Physician Decision|8|||
156684120|NCT02614898|565587161|FG000|Overall Study|Study Terminated by Sponsor|3|||
156684121|NCT02614898|565587162|FG001|Overall Study|Study Terminated by Sponsor|0|||
156684122|NCT02614898|565587161|FG000|Overall Study|Withdrawal by Subject|0|||
156684123|NCT02614898|565587162|FG001|Overall Study|Withdrawal by Subject|2|||
156684124|NCT02614898|565587161|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156684125|NCT02614898|565587162|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156684126|NCT02614898|565587161|FG000|Overall Study|Other-Additional Information Unavailable|0|||
156684127|NCT02614898|565587162|FG001|Overall Study|Other-Additional Information Unavailable|11|||
156684128|NCT02614898|565587161|FG000|Overall Study|Missing|0|||
156684129|NCT02614898|565587162|FG001|Overall Study|Missing|1|||
156684130|NCT03168906|565587163|FG000|Overall Study|Lack of Efficacy|6|||
156684131|NCT03168906|565587164|FG001|Overall Study|Lack of Efficacy|6|||
156684132|NCT05258630|565589137|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
156684133|NCT05258630|565589138|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
156684134|NCT05258630|565589137|FG000|Overall Study|Lost to Follow-up|0|||
156684135|NCT05258630|565589138|FG001|Overall Study|Lost to Follow-up|2|||
156684136|NCT03431337|565589139|FG000|Overall Study|Lost to Follow-up|21|||
156684137|NCT03431337|565589140|FG001|Overall Study|Lost to Follow-up|19|||
156684138|NCT03431337|565589139|FG000|Overall Study|Withdrawal by Subject|8|||
156684139|NCT03431337|565589140|FG001|Overall Study|Withdrawal by Subject|3|||
156684140|NCT00401245|565589141|FG000|Double Blind Titration Phase|Adverse Event|3|||
156684141|NCT00401245|565589142|FG001|Double Blind Titration Phase|Adverse Event|2|||
156684142|NCT00401245|565589143|FG002|Double Blind Titration Phase|Adverse Event|5|||
156684143|NCT00401245|565589144|FG003|Double Blind Titration Phase|Adverse Event|12|||
156684144|NCT00401245|565589145|FG004|Double Blind Titration Phase|Adverse Event|0|||
156684145|NCT00401245|565589146|FG005|Double Blind Titration Phase|Adverse Event|0|||
156684146|NCT00401245|565589147|FG006|Double Blind Titration Phase|Adverse Event|0|||
156684147|NCT00401245|565589148|FG007|Double Blind Titration Phase|Adverse Event|0|||
156684148|NCT00401245|565589141|FG000|Double Blind Titration Phase|Other|0|||
156684149|NCT00401245|565589142|FG001|Double Blind Titration Phase|Other|0|||
156684150|NCT00401245|565589143|FG002|Double Blind Titration Phase|Other|1|||
156684151|NCT00401245|565589144|FG003|Double Blind Titration Phase|Other|0|||
156684152|NCT00401245|565589145|FG004|Double Blind Titration Phase|Other|0|||
156684153|NCT00401245|565589146|FG005|Double Blind Titration Phase|Other|0|||
156684154|NCT00401245|565589147|FG006|Double Blind Titration Phase|Other|0|||
156684155|NCT00401245|565589148|FG007|Double Blind Titration Phase|Other|0|||
157213630|NCT04380701|567529579|FG027|Overall Study|Private reason(s)|0|||
157213631|NCT04380701|567529580|FG028|Overall Study|Private reason(s)|0|||
157213632|NCT04380701|567529581|FG029|Overall Study|Private reason(s)|1|||
157213633|NCT04380701|567529582|FG030|Overall Study|Private reason(s)|0|||
157213634|NCT04380701|567529583|FG031|Overall Study|Private reason(s)|0|||
157213635|NCT04380701|567529584|FG032|Overall Study|Private reason(s)|0|||
156684156|NCT00401245|565589141|FG000|Double Blind Titration Phase|Protocol Violation|0|||
156684157|NCT00401245|565589142|FG001|Double Blind Titration Phase|Protocol Violation|0|||
156684158|NCT00401245|565589143|FG002|Double Blind Titration Phase|Protocol Violation|0|||
156684159|NCT00401245|565589144|FG003|Double Blind Titration Phase|Protocol Violation|1|||
156684160|NCT00401245|565589145|FG004|Double Blind Titration Phase|Protocol Violation|0|||
156684161|NCT00401245|565589146|FG005|Double Blind Titration Phase|Protocol Violation|0|||
156684162|NCT00401245|565589147|FG006|Double Blind Titration Phase|Protocol Violation|0|||
156684163|NCT00401245|565589148|FG007|Double Blind Titration Phase|Protocol Violation|0|||
156684164|NCT00401245|565589141|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
156684165|NCT00401245|565589142|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
156684166|NCT00401245|565589143|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684167|NCT00401245|565589144|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
156684168|NCT00401245|565589145|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
156784649|NCT03794544|565963237|FG001|Overall Study|Lost to Follow-up|1|||
157013176|NCT02723955|566801741|FG004|Expansion Phase|Withdrawal by Subject|0|||
157013177|NCT02723955|566801742|FG005|Expansion Phase|Withdrawal by Subject|0|||
157013178|NCT02723955|566801743|FG006|Expansion Phase|Withdrawal by Subject|0|||
157013179|NCT02723955|566801744|FG007|Expansion Phase|Withdrawal by Subject|0|||
157213636|NCT04380701|567529585|FG033|Overall Study|Private reason(s)|0|||
157213637|NCT04380701|567529552|FG000|Overall Study|Withdrawal by Subject|0|||
156684169|NCT00401245|565589146|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684170|NCT00401245|565589147|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
156684171|NCT00401245|565589148|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
157013180|NCT02723955|566801745|FG008|Expansion Phase|Withdrawal by Subject|0|||
157013181|NCT02723955|566801746|FG009|Expansion Phase|Withdrawal by Subject|2|||
157013182|NCT02723955|566801747|FG010|Expansion Phase|Withdrawal by Subject|1|||
157213638|NCT04380701|567529553|FG001|Overall Study|Withdrawal by Subject|0|||
156684172|NCT00401245|565589141|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684173|NCT00401245|565589142|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
156684174|NCT00401245|565589143|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684175|NCT00401245|565589144|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
156684176|NCT00401245|565589145|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684177|NCT00401245|565589146|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684178|NCT00401245|565589147|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684179|NCT00401245|565589148|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
156684180|NCT00401245|565589141|FG000|Open Label Phase|Adverse Event|5|||
156684181|NCT00401245|565589142|FG001|Open Label Phase|Adverse Event|14|||
156684182|NCT00401245|565589143|FG002|Open Label Phase|Adverse Event|6|||
156684183|NCT00401245|565589144|FG003|Open Label Phase|Adverse Event|7|||
156684184|NCT00401245|565589145|FG004|Open Label Phase|Adverse Event|0|||
156684185|NCT00401245|565589146|FG005|Open Label Phase|Adverse Event|0|||
156684186|NCT00401245|565589147|FG006|Open Label Phase|Adverse Event|0|||
156684187|NCT00401245|565589148|FG007|Open Label Phase|Adverse Event|0|||
156684188|NCT00401245|565589141|FG000|Open Label Phase|Lost to Follow-up|5|||
156684189|NCT00401245|565589142|FG001|Open Label Phase|Lost to Follow-up|7|||
156684190|NCT00401245|565589143|FG002|Open Label Phase|Lost to Follow-up|5|||
156684191|NCT00401245|565589144|FG003|Open Label Phase|Lost to Follow-up|4|||
156684192|NCT00401245|565589145|FG004|Open Label Phase|Lost to Follow-up|0|||
156684193|NCT00401245|565589146|FG005|Open Label Phase|Lost to Follow-up|0|||
156684194|NCT00401245|565589147|FG006|Open Label Phase|Lost to Follow-up|0|||
156684195|NCT00401245|565589148|FG007|Open Label Phase|Lost to Follow-up|0|||
156684196|NCT00401245|565589141|FG000|Open Label Phase|Other|4|||
156684197|NCT00401245|565589142|FG001|Open Label Phase|Other|8|||
156684198|NCT00401245|565589143|FG002|Open Label Phase|Other|7|||
156684199|NCT00401245|565589144|FG003|Open Label Phase|Other|8|||
156684200|NCT00401245|565589145|FG004|Open Label Phase|Other|0|||
156684201|NCT00401245|565589146|FG005|Open Label Phase|Other|0|||
156684202|NCT00401245|565589147|FG006|Open Label Phase|Other|0|||
156684203|NCT00401245|565589148|FG007|Open Label Phase|Other|0|||
156684204|NCT00401245|565589141|FG000|Open Label Phase|Protocol Violation|0|||
156684205|NCT00401245|565589142|FG001|Open Label Phase|Protocol Violation|1|||
157120559|NCT01425008|567193113|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
156684206|NCT00401245|565589143|FG002|Open Label Phase|Protocol Violation|0|||
156684207|NCT00401245|565589144|FG003|Open Label Phase|Protocol Violation|1|||
157120560|NCT01425008|567193114|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
157120561|NCT01425008|567193115|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
156684208|NCT00401245|565589145|FG004|Open Label Phase|Protocol Violation|0|||
156684209|NCT00401245|565589146|FG005|Open Label Phase|Protocol Violation|0|||
156684210|NCT00401245|565589147|FG006|Open Label Phase|Protocol Violation|0|||
156684211|NCT00401245|565589148|FG007|Open Label Phase|Protocol Violation|0|||
156684212|NCT00401245|565589141|FG000|Open Label Phase|Withdrawal by Subject|3|||
157120562|NCT01425008|567193116|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
157120563|NCT01425008|567193117|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
157120564|NCT01425008|567193118|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
157120565|NCT01425008|567193100|FG000|Dose Expansion Phase|Other|0|||
157120566|NCT01425008|567193101|FG001|Dose Expansion Phase|Other|0|||
156684213|NCT00401245|565589142|FG001|Open Label Phase|Withdrawal by Subject|3|||
156684214|NCT00401245|565589143|FG002|Open Label Phase|Withdrawal by Subject|2|||
156684215|NCT00401245|565589144|FG003|Open Label Phase|Withdrawal by Subject|1|||
156684216|NCT00401245|565589145|FG004|Open Label Phase|Withdrawal by Subject|0|||
156684217|NCT00401245|565589146|FG005|Open Label Phase|Withdrawal by Subject|0|||
156684218|NCT00401245|565589147|FG006|Open Label Phase|Withdrawal by Subject|0|||
156684219|NCT00401245|565589148|FG007|Open Label Phase|Withdrawal by Subject|0|||
156684220|NCT00401245|565589141|FG000|Open Label Phase|Lack of Efficacy|4|||
156684221|NCT00401245|565589142|FG001|Open Label Phase|Lack of Efficacy|2|||
156684222|NCT00401245|565589143|FG002|Open Label Phase|Lack of Efficacy|3|||
156684223|NCT00401245|565589144|FG003|Open Label Phase|Lack of Efficacy|0|||
156684224|NCT00401245|565589145|FG004|Open Label Phase|Lack of Efficacy|0|||
156684225|NCT00401245|565589146|FG005|Open Label Phase|Lack of Efficacy|0|||
156684226|NCT00401245|565589147|FG006|Open Label Phase|Lack of Efficacy|0|||
156684227|NCT00401245|565589148|FG007|Open Label Phase|Lack of Efficacy|0|||
156684228|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Adverse Event|0|||
157120567|NCT01425008|567193102|FG002|Dose Expansion Phase|Other|0|||
157120568|NCT01425008|567193103|FG003|Dose Expansion Phase|Other|0|||
157120569|NCT01425008|567193104|FG004|Dose Expansion Phase|Other|0|||
156684229|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Adverse Event|0|||
156684230|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Adverse Event|0|||
156684231|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Adverse Event|0|||
156684232|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Adverse Event|1|||
156684233|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Adverse Event|1|||
156684234|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Adverse Event|2|||
156684235|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Adverse Event|4|||
156684236|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Investigator request|0|||
156684237|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Investigator request|0|||
156684238|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Investigator request|0|||
156684239|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Investigator request|0|||
156684240|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Investigator request|0|||
156684241|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Investigator request|0|||
156684242|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Investigator request|0|||
156684243|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Investigator request|1|||
156684244|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Other|0|||
156684245|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Other|0|||
156684246|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Other|0|||
156684247|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Other|0|||
156684248|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Other|1|||
156684249|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Other|0|||
156684250|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Other|2|||
156684251|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Other|2|||
156684252|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684253|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156868358|NCT02113982|566277281|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156684254|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684255|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684256|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
156684257|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
156868359|NCT02113982|566277282|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868360|NCT02113982|566277283|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868361|NCT02113982|566277284|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868362|NCT02113982|566277285|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868363|NCT02113982|566277286|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868364|NCT02113982|566277287|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868365|NCT02113982|566277288|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868366|NCT02113982|566277289|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
157120570|NCT01425008|567193105|FG005|Dose Expansion Phase|Other|0|||
156684258|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
156684259|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
156684260|NCT00401245|565589141|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684261|NCT00401245|565589142|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684262|NCT00401245|565589143|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684263|NCT00401245|565589144|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684264|NCT00401245|565589145|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684265|NCT00401245|565589146|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
156684266|NCT00401245|565589147|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684267|NCT00401245|565589148|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
156684268|NCT04412057|565589149|FG000|Overall Study|Death|3|||
156684269|NCT04412057|565589150|FG001|Overall Study|Death|7|||
156684270|NCT04412057|565589149|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
156684271|NCT04412057|565589150|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
156684272|NCT05889039|565589152|FG000|Overall Study|error in completing survey|0|||
156684273|NCT05889039|565589153|FG001|Overall Study|error in completing survey|2|||
156684274|NCT05889039|565589154|FG002|Overall Study|error in completing survey|0|||
156684275|NCT05889039|565589155|FG003|Overall Study|error in completing survey|0|||
156684276|NCT05889039|565589152|FG000|Overall Study|Lost to Follow-up|4|||
156684277|NCT05889039|565589153|FG001|Overall Study|Lost to Follow-up|0|||
156684278|NCT05889039|565589154|FG002|Overall Study|Lost to Follow-up|0|||
156684279|NCT05889039|565589155|FG003|Overall Study|Lost to Follow-up|0|||
156684280|NCT03023137|565589156|FG000|Overall Study|Multiple pregnancy|2|||
156684281|NCT03023137|565589157|FG001|Overall Study|Multiple pregnancy|4|||
156868367|NCT02113982|566277290|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868368|NCT02113982|566277291|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
157120571|NCT01425008|567193106|FG006|Dose Expansion Phase|Other|0|||
157120572|NCT01425008|567193107|FG007|Dose Expansion Phase|Other|0|||
157120573|NCT01425008|567193108|FG008|Dose Expansion Phase|Other|0|||
157120574|NCT01425008|567193109|FG009|Dose Expansion Phase|Other|0|||
157120575|NCT01425008|567193110|FG010|Dose Expansion Phase|Other|0|||
157120576|NCT01425008|567193111|FG011|Dose Expansion Phase|Other|0|||
157120577|NCT01425008|567193112|FG012|Dose Expansion Phase|Other|1|||
157120578|NCT01425008|567193113|FG013|Dose Expansion Phase|Other|0|||
157120579|NCT01425008|567193114|FG014|Dose Expansion Phase|Other|0|||
156684282|NCT03023137|565589156|FG000|Overall Study|Lost to Follow-up|1|||
156684283|NCT03023137|565589157|FG001|Overall Study|Lost to Follow-up|1|||
156684284|NCT03023137|565589156|FG000|Overall Study|Protocol Violation|0|||
156684285|NCT03023137|565589157|FG001|Overall Study|Protocol Violation|4|||
156684286|NCT03023137|565589156|FG000|Overall Study|Lost the baby in a car accident|1|||
156684287|NCT03023137|565589157|FG001|Overall Study|Lost the baby in a car accident|0|||
156684288|NCT01450800|565589166|FG000|Overall Study|Protocol Violation|1|||
156684289|NCT01450800|565589167|FG001|Overall Study|Protocol Violation|3|||
156684290|NCT03496298|565589170|FG000|Overall Study|Adverse Event|49|||
156684291|NCT03496298|565589171|FG001|Overall Study|Adverse Event|68|||
156684292|NCT03496298|565589172|FG002|Overall Study|Adverse Event|79|||
156684293|NCT03496298|565589170|FG000|Overall Study|Study terminated by Sponsor|1050|||
156684294|NCT03496298|565589171|FG001|Overall Study|Study terminated by Sponsor|1063|||
156684295|NCT03496298|565589172|FG002|Overall Study|Study terminated by Sponsor|1071|||
156684296|NCT03496298|565589170|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
156684297|NCT03496298|565589171|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
156684298|NCT03496298|565589172|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
156684299|NCT03496298|565589170|FG000|Overall Study|Withdrawal by Subject|176|||
156684300|NCT03496298|565589171|FG001|Overall Study|Withdrawal by Subject|154|||
156684301|NCT03496298|565589172|FG002|Overall Study|Withdrawal by Subject|151|||
156684302|NCT03496298|565589170|FG000|Overall Study|Other|29|||
156684303|NCT03496298|565589171|FG001|Overall Study|Other|20|||
156684304|NCT03496298|565589172|FG002|Overall Study|Other|23|||
156684305|NCT03496298|565589170|FG000|Overall Study|Randomized and not treated|1|||
156684306|NCT03496298|565589171|FG001|Overall Study|Randomized and not treated|1|||
156684307|NCT03496298|565589172|FG002|Overall Study|Randomized and not treated|1|||
156684308|NCT02608476|565589178|FG000|Overall Study|Withdrawal by Subject|30|||
156684309|NCT02608476|565589179|FG001|Overall Study|Withdrawal by Subject|37|||
156684310|NCT02608476|565589178|FG000|Overall Study|Lost to Follow-up|24|||
156684311|NCT02608476|565589179|FG001|Overall Study|Lost to Follow-up|24|||
156684312|NCT02608476|565589178|FG000|Overall Study|Adverse Event|2|||
156684313|NCT02608476|565589179|FG001|Overall Study|Adverse Event|8|||
156684314|NCT02608476|565589178|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
156684315|NCT02608476|565589179|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
156684316|NCT02608476|565589178|FG000|Overall Study|Noncompliance with treatment|1|||
156684317|NCT02608476|565589179|FG001|Overall Study|Noncompliance with treatment|5|||
156684318|NCT02608476|565589178|FG000|Overall Study|Lack of Efficacy|3|||
156684319|NCT02608476|565589179|FG001|Overall Study|Lack of Efficacy|1|||
156684320|NCT02608476|565589178|FG000|Overall Study|Other|0|||
156684321|NCT02608476|565589179|FG001|Overall Study|Other|1|||
156684322|NCT02608476|565589178|FG000|Overall Study|Physician Decision|1|||
156684323|NCT02608476|565589179|FG001|Overall Study|Physician Decision|0|||
156684324|NCT02608476|565589178|FG000|Overall Study|Pregnancy|0|||
156684325|NCT02608476|565589179|FG001|Overall Study|Pregnancy|1|||
156684326|NCT02608476|565589178|FG000|Overall Study|Progressive disease|1|||
156684327|NCT02608476|565589179|FG001|Overall Study|Progressive disease|0|||
156684328|NCT00676494|565589180|FG000|Overall Study|Missed Visit|8|||
156684329|NCT00676494|565589180|FG000|Overall Study|Withdrawal by Subject|6|||
156684330|NCT02795676|565589181|FG000|Overall Study|Adverse Event|2|||
156684331|NCT02795676|565589182|FG001|Overall Study|Adverse Event|0|||
156684332|NCT02795676|565589181|FG000|Overall Study|Withdrawal by Subject|3|||
156684333|NCT02795676|565589182|FG001|Overall Study|Withdrawal by Subject|1|||
156684334|NCT02058160|565589188|FG000|Overall Study|Randomized but not treated|2|||
156684335|NCT02058160|565589189|FG001|Overall Study|Randomized but not treated|4|||
156684336|NCT02058160|565589188|FG000|Overall Study|Poor compliance to protocol|4|||
156684337|NCT02058160|565589189|FG001|Overall Study|Poor compliance to protocol|1|||
156684338|NCT02058160|565589188|FG000|Overall Study|Adverse Event|12|||
156684339|NCT02058160|565589189|FG001|Overall Study|Adverse Event|3|||
156684340|NCT02058160|565589188|FG000|Overall Study|Lost to Follow-up|1|||
156684341|NCT02058160|565589189|FG001|Overall Study|Lost to Follow-up|0|||
156684342|NCT02058160|565589188|FG000|Overall Study|Other than specified above|12|||
156684343|NCT02058160|565589189|FG001|Overall Study|Other than specified above|6|||
156684344|NCT01203917|565589190|FG000|Overall Study|Death|29|||
156684345|NCT01203917|565589190|FG000|Overall Study|Lost to Follow-up|2|||
156684346|NCT01203917|565589190|FG000|Overall Study|Withdrawal by Subject|3|||
156684347|NCT01203917|565589190|FG000|Overall Study|Due to objective disease progression|1|||
156684348|NCT01203917|565589190|FG000|Overall Study|Due to EGFR M+I patient|1|||
156784650|NCT03794544|565963238|FG002|Overall Study|Lost to Follow-up|1|||
157013183|NCT02723955|566801748|FG011|Expansion Phase|Withdrawal by Subject|0|||
157013184|NCT02723955|566801749|FG012|Expansion Phase|Withdrawal by Subject|0|||
156684349|NCT00152516|565589195|FG000|Overall Study|Adverse Event|18|||
156684350|NCT00152516|565589195|FG000|Overall Study|Lack and Loss of Efficacy|30|||
156684351|NCT00152516|565589195|FG000|Overall Study|Lost to Follow-up|5|||
156684352|NCT00152516|565589195|FG000|Overall Study|Withdrawal by Subject|8|||
156684353|NCT00152516|565589195|FG000|Overall Study|Protocol Violation|3|||
156684354|NCT00152516|565589195|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
156684355|NCT00152516|565589195|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
156684356|NCT00152516|565589195|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
156684357|NCT00152516|565589195|FG000|Overall Study|Other: Non-Compliance|2|||
156684358|NCT00152516|565589195|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
156684359|NCT00152516|565589195|FG000|Overall Study|Other: Moved Out Of State|1|||
156684360|NCT00152516|565589195|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
157013185|NCT02723955|566801750|FG013|Expansion Phase|Withdrawal by Subject|0|||
157013186|NCT02723955|566801751|FG014|Expansion Phase|Withdrawal by Subject|0|||
156684361|NCT00152516|565589195|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
156684362|NCT04660032|565589198|FG000|Overall Study|Protocol Violation|1|||
156684363|NCT04660032|565589199|FG001|Overall Study|Protocol Violation|1|||
156684364|NCT01086969|565589202|FG000|Overall Study|Withdrawal by Subject|1|||
156684365|NCT01086969|565589203|FG001|Overall Study|Withdrawal by Subject|2|||
156684366|NCT01086969|565589204|FG002|Overall Study|Withdrawal by Subject|0|||
156684367|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
156684368|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
156684369|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
156684370|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
156684371|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
156684372|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
156684373|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
156684374|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
156684375|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
156684376|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Other|1|||
156684377|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Other|4|||
156684378|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Other|5|||
156684379|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
156684380|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
156684381|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
156684382|NCT02725411|565589205|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
156684383|NCT02725411|565589206|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
156684384|NCT02725411|565589207|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
156684385|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
156684386|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
156684387|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
156684388|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
156684389|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
156684390|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
156684391|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
156684392|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
156684393|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
156684394|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Other|1|||
156684395|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Other|4|||
156684396|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Other|2|||
156684397|NCT02725411|565589205|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
156684398|NCT02725411|565589206|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
156684399|NCT02725411|565589207|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
156684400|NCT00819767|565589212|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156684401|NCT00819767|565589213|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156684402|NCT00250705|565589214|FG000|Overall Study|Lack of Efficacy|2|||
156684403|NCT00761176|565589217|FG000|Overall Study|Death|1|||
156684404|NCT00761176|565589218|FG001|Overall Study|Death|0|||
156684405|NCT00761176|565589217|FG000|Overall Study|Withdrawal by Subject|1|||
156684406|NCT00761176|565589218|FG001|Overall Study|Withdrawal by Subject|1|||
156684407|NCT05103657|565589219|FG000|Overall Study|Other reasons than listed|9|||
156684408|NCT05103657|565589220|FG001|Overall Study|Other reasons than listed|8|||
156684409|NCT05103657|565589219|FG000|Overall Study|Protocol deviation|2|||
156684410|NCT05103657|565589220|FG001|Overall Study|Protocol deviation|2|||
156684411|NCT05103657|565589219|FG000|Overall Study|No reason available|5|||
156684412|NCT05103657|565589220|FG001|Overall Study|No reason available|4|||
156684413|NCT05103657|565589219|FG000|Overall Study|Burden of study procedures|3|||
156684414|NCT05103657|565589220|FG001|Overall Study|Burden of study procedures|1|||
156684415|NCT05103657|565589219|FG000|Overall Study|Perceived lack of efficacy|1|||
156684416|NCT05103657|565589220|FG001|Overall Study|Perceived lack of efficacy|1|||
156684417|NCT05103657|565589219|FG000|Overall Study|Adverse Event|6|||
156684418|NCT05103657|565589220|FG001|Overall Study|Adverse Event|14|||
156684419|NCT05103657|565589219|FG000|Overall Study|Not Treated|1|||
157213639|NCT04380701|567529554|FG002|Overall Study|Withdrawal by Subject|0|||
157213640|NCT04380701|567529555|FG003|Overall Study|Withdrawal by Subject|0|||
157213641|NCT04380701|567529556|FG004|Overall Study|Withdrawal by Subject|0|||
157213642|NCT04380701|567529557|FG005|Overall Study|Withdrawal by Subject|0|||
157213643|NCT04380701|567529558|FG006|Overall Study|Withdrawal by Subject|1|||
157213644|NCT04380701|567529559|FG007|Overall Study|Withdrawal by Subject|1|||
156684420|NCT05103657|565589220|FG001|Overall Study|Not Treated|1|||
156684421|NCT02020967|565589221|FG000|Overall Study|Withdrawal by Subject|51|||
156684422|NCT00129116|565589222|FG000|Primary Phase|Lost to Follow-up|1|||
156684423|NCT00129116|565589223|FG001|Primary Phase|Lost to Follow-up|1|||
156684424|NCT00129116|565589224|FG002|Primary Phase|Lost to Follow-up|0|||
156684425|NCT00129116|565589225|FG003|Primary Phase|Lost to Follow-up|1|||
156684426|NCT00129116|565589226|FG004|Primary Phase|Lost to Follow-up|1|||
156684427|NCT00129116|565589222|FG000|Primary Phase|Protocol Violation|0|||
156684428|NCT00129116|565589223|FG001|Primary Phase|Protocol Violation|1|||
156684429|NCT00129116|565589224|FG002|Primary Phase|Protocol Violation|0|||
156684430|NCT00129116|565589225|FG003|Primary Phase|Protocol Violation|0|||
156684431|NCT00129116|565589226|FG004|Primary Phase|Protocol Violation|0|||
156684432|NCT00129116|565589222|FG000|Primary Phase|Adverse Event|1|||
156684433|NCT00129116|565589223|FG001|Primary Phase|Adverse Event|1|||
156684434|NCT00129116|565589224|FG002|Primary Phase|Adverse Event|0|||
156684435|NCT00129116|565589225|FG003|Primary Phase|Adverse Event|0|||
156684436|NCT00129116|565589226|FG004|Primary Phase|Adverse Event|0|||
156684437|NCT00129116|565589222|FG000|Primary Phase|Withdrawal by Subject|0|||
156684438|NCT00129116|565589223|FG001|Primary Phase|Withdrawal by Subject|1|||
156684439|NCT00129116|565589224|FG002|Primary Phase|Withdrawal by Subject|0|||
156684440|NCT00129116|565589225|FG003|Primary Phase|Withdrawal by Subject|0|||
156684441|NCT00129116|565589226|FG004|Primary Phase|Withdrawal by Subject|0|||
156684442|NCT00129116|565589222|FG000|Primary Phase|Other|0|||
156684443|NCT00129116|565589223|FG001|Primary Phase|Other|0|||
156684444|NCT00129116|565589224|FG002|Primary Phase|Other|1|||
156684445|NCT00129116|565589225|FG003|Primary Phase|Other|0|||
156684446|NCT00129116|565589226|FG004|Primary Phase|Other|0|||
156684447|NCT00129116|565589222|FG000|Booster Phase|Lost to Follow-up|2|||
156684448|NCT00129116|565589223|FG001|Booster Phase|Lost to Follow-up|0|||
156684449|NCT00129116|565589224|FG002|Booster Phase|Lost to Follow-up|0|||
156684450|NCT00129116|565589225|FG003|Booster Phase|Lost to Follow-up|0|||
156684451|NCT00129116|565589226|FG004|Booster Phase|Lost to Follow-up|1|||
156684452|NCT02539368|565589229|FG000|Overall Study|Death|4|||
156684453|NCT02539368|565589230|FG001|Overall Study|Death|2|||
156684454|NCT02539368|565589231|FG002|Overall Study|Death|1|||
156684455|NCT02539368|565589232|FG003|Overall Study|Death|0|||
156684456|NCT02539368|565589233|FG004|Overall Study|Death|0|||
156684457|NCT02539368|565589229|FG000|Overall Study|Withdrawal by Subject|44|||
156684458|NCT02539368|565589230|FG001|Overall Study|Withdrawal by Subject|35|||
156684459|NCT02539368|565589231|FG002|Overall Study|Withdrawal by Subject|9|||
156684460|NCT02539368|565589232|FG003|Overall Study|Withdrawal by Subject|1|||
157120580|NCT01425008|567193115|FG015|Dose Expansion Phase|Other|0|||
157120581|NCT01425008|567193116|FG016|Dose Expansion Phase|Other|2|||
157120582|NCT01425008|567193117|FG017|Dose Expansion Phase|Other|0|||
157120583|NCT01425008|567193118|FG018|Dose Expansion Phase|Other|4|||
157120584|NCT01425008|567193100|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120585|NCT01425008|567193101|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120586|NCT01425008|567193102|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120587|NCT01425008|567193103|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120588|NCT01425008|567193104|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
156684461|NCT02539368|565589233|FG004|Overall Study|Withdrawal by Subject|3|||
156684462|NCT02539368|565589229|FG000|Overall Study|Physician Decision|49|||
156684463|NCT02539368|565589230|FG001|Overall Study|Physician Decision|15|||
156684464|NCT02539368|565589231|FG002|Overall Study|Physician Decision|7|||
156684465|NCT02539368|565589232|FG003|Overall Study|Physician Decision|0|||
156684466|NCT02539368|565589233|FG004|Overall Study|Physician Decision|2|||
156684467|NCT02539368|565589229|FG000|Overall Study|Lost to Follow-up|96|||
156684468|NCT02539368|565589230|FG001|Overall Study|Lost to Follow-up|21|||
156684469|NCT02539368|565589231|FG002|Overall Study|Lost to Follow-up|16|||
156684470|NCT02539368|565589232|FG003|Overall Study|Lost to Follow-up|4|||
156684471|NCT02539368|565589233|FG004|Overall Study|Lost to Follow-up|3|||
156684472|NCT02539368|565589229|FG000|Overall Study|Adverse Event|44|||
156684473|NCT02539368|565589230|FG001|Overall Study|Adverse Event|5|||
156684474|NCT02539368|565589231|FG002|Overall Study|Adverse Event|9|||
156684475|NCT02539368|565589232|FG003|Overall Study|Adverse Event|0|||
156684476|NCT02539368|565589233|FG004|Overall Study|Adverse Event|3|||
156684477|NCT02539368|565589229|FG000|Overall Study|Participant Non-compliant|13|||
156684478|NCT02539368|565589230|FG001|Overall Study|Participant Non-compliant|2|||
156684479|NCT02539368|565589231|FG002|Overall Study|Participant Non-compliant|1|||
156684480|NCT02539368|565589232|FG003|Overall Study|Participant Non-compliant|1|||
156684481|NCT02539368|565589233|FG004|Overall Study|Participant Non-compliant|0|||
156684482|NCT02539368|565589229|FG000|Overall Study|Other|145|||
156684483|NCT02539368|565589230|FG001|Overall Study|Other|18|||
156684484|NCT02539368|565589231|FG002|Overall Study|Other|24|||
156684485|NCT02539368|565589232|FG003|Overall Study|Other|1|||
156684486|NCT02539368|565589233|FG004|Overall Study|Other|3|||
156684487|NCT02539368|565589229|FG000|Overall Study|Missing|10|||
156684488|NCT02539368|565589230|FG001|Overall Study|Missing|3|||
156684489|NCT02539368|565589231|FG002|Overall Study|Missing|0|||
157120589|NCT01425008|567193105|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120590|NCT01425008|567193106|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
157213645|NCT04380701|567529560|FG008|Overall Study|Withdrawal by Subject|0|||
156684490|NCT02539368|565589232|FG003|Overall Study|Missing|0|||
156684491|NCT02539368|565589233|FG004|Overall Study|Missing|0|||
156684492|NCT00398073|565589235|FG000|Overall Study|Withdrawal by Subject|1|||
156684493|NCT00398073|565589236|FG001|Overall Study|Withdrawal by Subject|0|||
156684494|NCT01263561|565589237|FG000|Overall Study|Death|1|||
157213646|NCT04380701|567529561|FG009|Overall Study|Withdrawal by Subject|0|||
156684495|NCT01263561|565589238|FG001|Overall Study|Death|2|||
156684496|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
156684497|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
156684498|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
156684499|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
156684500|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
156684501|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
156684502|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
156684503|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
156684504|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
156684505|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
156684506|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
156684507|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
156684508|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
156684509|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
156684510|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684511|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684512|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
156684513|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
156684514|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684515|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684516|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
156684517|NCT00879684|565589239|FG000|Stage 1: Dose Escalation|Death|0|||
156684518|NCT00879684|565589240|FG001|Stage 1: Dose Escalation|Death|0|||
156684519|NCT00879684|565589241|FG002|Stage 1: Dose Escalation|Death|1|||
156684520|NCT00879684|565589242|FG003|Stage 1: Dose Escalation|Death|0|||
156684521|NCT00879684|565589243|FG004|Stage 1: Dose Escalation|Death|0|||
156684522|NCT00879684|565589244|FG005|Stage 1: Dose Escalation|Death|0|||
156684523|NCT00879684|565589245|FG006|Stage 1: Dose Escalation|Death|0|||
156684524|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684525|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684526|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684527|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684528|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684529|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
156684530|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
156684531|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
157013187|NCT02723955|566801752|FG015|Expansion Phase|Withdrawal by Subject|0|||
157013188|NCT02723955|566801753|FG016|Expansion Phase|Withdrawal by Subject|0|||
157013189|NCT02723955|566801754|FG017|Expansion Phase|Withdrawal by Subject|0|||
157013190|NCT02723955|566801755|FG018|Expansion Phase|Withdrawal by Subject|0|||
157013191|NCT02723955|566801756|FG019|Expansion Phase|Withdrawal by Subject|0|||
157013192|NCT02723955|566801757|FG020|Expansion Phase|Withdrawal by Subject|0|||
157013193|NCT02723955|566801758|FG021|Expansion Phase|Withdrawal by Subject|0|||
157013194|NCT02723955|566801759|FG022|Expansion Phase|Withdrawal by Subject|0|||
157013195|NCT02723955|566801760|FG023|Expansion Phase|Withdrawal by Subject|0|||
157013196|NCT02723955|566801761|FG024|Expansion Phase|Withdrawal by Subject|0|||
157013197|NCT02723955|566801762|FG025|Expansion Phase|Withdrawal by Subject|0|||
157013198|NCT02723955|566801763|FG026|Expansion Phase|Withdrawal by Subject|0|||
157013199|NCT02723955|566801764|FG027|Expansion Phase|Withdrawal by Subject|0|||
157013200|NCT02723955|566801765|FG028|Expansion Phase|Withdrawal by Subject|0|||
157013201|NCT02723955|566801766|FG029|Expansion Phase|Withdrawal by Subject|0|||
157013202|NCT02723955|566801767|FG030|Expansion Phase|Withdrawal by Subject|8|||
157013203|NCT02723955|566801768|FG031|Expansion Phase|Withdrawal by Subject|4|||
157013204|NCT02723955|566801769|FG032|Expansion Phase|Withdrawal by Subject|0|||
157013205|NCT02723955|566801770|FG033|Expansion Phase|Withdrawal by Subject|0|||
157013206|NCT02723955|566801771|FG034|Expansion Phase|Withdrawal by Subject|0|||
157013207|NCT02723955|566801772|FG035|Expansion Phase|Withdrawal by Subject|1|||
157013208|NCT02723955|566801773|FG036|Expansion Phase|Withdrawal by Subject|0|||
157013209|NCT02723955|566801774|FG037|Expansion Phase|Withdrawal by Subject|0|||
157013210|NCT02723955|566801775|FG038|Expansion Phase|Withdrawal by Subject|0|||
157013211|NCT02723955|566801776|FG039|Expansion Phase|Withdrawal by Subject|0|||
157013212|NCT02723955|566801777|FG040|Expansion Phase|Withdrawal by Subject|0|||
157013213|NCT02723955|566801778|FG041|Expansion Phase|Withdrawal by Subject|0|||
157013214|NCT02723955|566801779|FG042|Expansion Phase|Withdrawal by Subject|0|||
157013215|NCT02723955|566801737|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013216|NCT02723955|566801738|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013217|NCT02723955|566801739|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013218|NCT02723955|566801740|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013219|NCT02723955|566801741|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013220|NCT02723955|566801742|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013221|NCT02723955|566801743|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156684532|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684533|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684534|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684535|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684536|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
156684537|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
156684538|NCT00879684|565589239|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684539|NCT00879684|565589240|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684540|NCT00879684|565589241|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684541|NCT00879684|565589242|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684542|NCT00879684|565589243|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684543|NCT00879684|565589244|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
156684544|NCT00879684|565589245|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
156684545|NCT00708682|565589246|FG000|Infant Series|Adverse Event|1|||
156684546|NCT00708682|565589246|FG000|Infant Series|Lost to Follow-up|4|||
156684547|NCT00708682|565589246|FG000|Infant Series|Protocol Violation|1|||
156684548|NCT00708682|565589246|FG000|Infant Series|Parent/legal guardian request|6|||
156684549|NCT00708682|565589246|FG000|Infant Series|Failed to return|2|||
156684550|NCT00708682|565589246|FG000|Infant Series|Other|19|||
156684551|NCT00708682|565589246|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
156684552|NCT00708682|565589246|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
156684553|NCT00708682|565589246|FG000|Toddler Dose|Lost to Follow-up|3|||
156684554|NCT00708682|565589246|FG000|Toddler Dose|Failed to Return|4|||
156684555|NCT03185741|565589252|FG000|Baseline|Withdrawal by Subject|1|||
156684556|NCT03185741|565589253|FG001|Baseline|Withdrawal by Subject|3|||
156684557|NCT03185741|565589254|FG002|Baseline|Withdrawal by Subject|2|||
156684558|NCT03185741|565589252|FG000|Baseline|Lost to Follow-up|1|||
156684559|NCT03185741|565589253|FG001|Baseline|Lost to Follow-up|2|||
156684560|NCT03185741|565589254|FG002|Baseline|Lost to Follow-up|3|||
156684561|NCT03185741|565589252|FG000|3Month|Death|1|||
156684562|NCT03185741|565589253|FG001|3Month|Death|1|||
156684563|NCT03185741|565589254|FG002|3Month|Death|2|||
156684564|NCT03185741|565589252|FG000|3Month|Withdrawal by Subject|1|||
156684565|NCT03185741|565589253|FG001|3Month|Withdrawal by Subject|5|||
156684566|NCT03185741|565589254|FG002|3Month|Withdrawal by Subject|1|||
156684567|NCT03185741|565589252|FG000|3Month|Lost to Follow-up|7|||
156684568|NCT03185741|565589253|FG001|3Month|Lost to Follow-up|9|||
156684569|NCT03185741|565589254|FG002|3Month|Lost to Follow-up|8|||
156684570|NCT03185741|565589252|FG000|3Month|Unavailable for 3Month|11|||
156684571|NCT03185741|565589253|FG001|3Month|Unavailable for 3Month|10|||
156684572|NCT03185741|565589254|FG002|3Month|Unavailable for 3Month|11|||
156684573|NCT03185741|565589252|FG000|3Month|Protocol Violation|0|||
156684574|NCT03185741|565589253|FG001|3Month|Protocol Violation|0|||
156684575|NCT03185741|565589254|FG002|3Month|Protocol Violation|3|||
156684576|NCT03185741|565589252|FG000|6Month|Death|1|||
156684577|NCT03185741|565589253|FG001|6Month|Death|1|||
156684578|NCT03185741|565589254|FG002|6Month|Death|2|||
156684579|NCT03185741|565589252|FG000|6Month|Withdrawal by Subject|2|||
156684580|NCT03185741|565589253|FG001|6Month|Withdrawal by Subject|3|||
156784651|NCT03794544|565963239|FG003|Overall Study|Lost to Follow-up|0|||
156784652|NCT03794544|565963236|FG000|Overall Study|Other|0|||
157013222|NCT02723955|566801744|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013223|NCT02723955|566801745|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013224|NCT02723955|566801746|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
157013225|NCT02723955|566801747|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
157013226|NCT02723955|566801748|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
157013227|NCT02723955|566801749|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013228|NCT02723955|566801750|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013229|NCT02723955|566801751|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013230|NCT02723955|566801752|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013231|NCT02723955|566801753|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013232|NCT02723955|566801754|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013233|NCT02723955|566801755|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013234|NCT02723955|566801756|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013235|NCT02723955|566801757|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013236|NCT02723955|566801758|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157120591|NCT01425008|567193107|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
156684581|NCT03185741|565589254|FG002|6Month|Withdrawal by Subject|1|||
156684582|NCT03185741|565589252|FG000|6Month|Lost to Follow-up|16|||
156684583|NCT03185741|565589253|FG001|6Month|Lost to Follow-up|15|||
157120592|NCT01425008|567193108|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120593|NCT01425008|567193109|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
156784653|NCT03794544|565963237|FG001|Overall Study|Other|1|||
156784654|NCT03794544|565963238|FG002|Overall Study|Other|0|||
156784655|NCT03794544|565963239|FG003|Overall Study|Other|0|||
156784656|NCT00421733|565963241|FG000|Overall Study|Adverse Event|4|||
156784657|NCT00421733|565963242|FG001|Overall Study|Adverse Event|9|||
156784658|NCT00421733|565963243|FG002|Overall Study|Adverse Event|2|||
156784659|NCT00421733|565963241|FG000|Overall Study|Lost to Follow-up|1|||
156784660|NCT00421733|565963242|FG001|Overall Study|Lost to Follow-up|2|||
156784661|NCT00421733|565963243|FG002|Overall Study|Lost to Follow-up|4|||
156784662|NCT00421733|565963241|FG000|Overall Study|Withdrawal by Subject|1|||
156784663|NCT00421733|565963242|FG001|Overall Study|Withdrawal by Subject|2|||
156784664|NCT00421733|565963243|FG002|Overall Study|Withdrawal by Subject|7|||
156784665|NCT00421733|565963241|FG000|Overall Study|Death|0|||
156784666|NCT00421733|565963242|FG001|Overall Study|Death|3|||
156784667|NCT00421733|565963243|FG002|Overall Study|Death|0|||
156784668|NCT00421733|565963241|FG000|Overall Study|Required dialysis|1|||
156784669|NCT00421733|565963242|FG001|Overall Study|Required dialysis|0|||
156784670|NCT00421733|565963243|FG002|Overall Study|Required dialysis|0|||
156784671|NCT00421733|565963241|FG000|Overall Study|Administrative|2|||
156784672|NCT00421733|565963242|FG001|Overall Study|Administrative|0|||
156784673|NCT00421733|565963243|FG002|Overall Study|Administrative|0|||
156784674|NCT00421733|565963241|FG000|Overall Study|Did not satisfy entry criteria|1|||
156784675|NCT00421733|565963242|FG001|Overall Study|Did not satisfy entry criteria|3|||
156784676|NCT00421733|565963243|FG002|Overall Study|Did not satisfy entry criteria|2|||
156784677|NCT00421733|565963241|FG000|Overall Study|Sponsor request|1|||
156784678|NCT00421733|565963242|FG001|Overall Study|Sponsor request|0|||
156784679|NCT00421733|565963243|FG002|Overall Study|Sponsor request|3|||
156784680|NCT00421733|565963241|FG000|Overall Study|Protocol deviation|4|||
156784681|NCT00421733|565963242|FG001|Overall Study|Protocol deviation|7|||
156784682|NCT00421733|565963243|FG002|Overall Study|Protocol deviation|2|||
156784683|NCT00894647|565963244|FG000|Overall Study|Adverse Event|5|||
156784684|NCT00894647|565963245|FG001|Overall Study|Adverse Event|4|||
156784685|NCT00894647|565963244|FG000|Overall Study|Withdrawal by Subject|4|||
156784686|NCT00894647|565963245|FG001|Overall Study|Withdrawal by Subject|4|||
156784687|NCT00894647|565963244|FG000|Overall Study|Lost to Follow-up|0|||
156784688|NCT00894647|565963245|FG001|Overall Study|Lost to Follow-up|2|||
156784689|NCT00894647|565963244|FG000|Overall Study|Non-compliance with study procedures|0|||
156784690|NCT00894647|565963245|FG001|Overall Study|Non-compliance with study procedures|2|||
156784691|NCT00894647|565963244|FG000|Overall Study|Other, not due to AE|1|||
156784692|NCT00894647|565963245|FG001|Overall Study|Other, not due to AE|2|||
156784693|NCT00397930|565963252|FG000|Overall Study|Personal reasons|14|||
156784694|NCT00397930|565963253|FG001|Overall Study|Personal reasons|8|||
156784695|NCT00397930|565963252|FG000|Overall Study|Other medical|9|||
156784696|NCT00397930|565963253|FG001|Overall Study|Other medical|4|||
156784697|NCT00397930|565963252|FG000|Overall Study|Unknown reasons|9|||
156784698|NCT00397930|565963253|FG001|Overall Study|Unknown reasons|14|||
156784699|NCT00397930|565963252|FG000|Overall Study|Noncompliant|3|||
156784700|NCT00397930|565963253|FG001|Overall Study|Noncompliant|2|||
156784701|NCT00397930|565963252|FG000|Overall Study|Too time-consuming|2|||
156784702|NCT00397930|565963253|FG001|Overall Study|Too time-consuming|9|||
156784703|NCT00397930|565963252|FG000|Overall Study|Started own yoga program|1|||
156784704|NCT00397930|565963253|FG001|Overall Study|Started own yoga program|1|||
156784705|NCT00397930|565963252|FG000|Overall Study|Did not want to be in control group|0|||
156784706|NCT00397930|565963253|FG001|Overall Study|Did not want to be in control group|1|||
156784707|NCT00397930|565963252|FG000|Overall Study|Withdrawal by Subject|0|||
156784708|NCT00397930|565963253|FG001|Overall Study|Withdrawal by Subject|8|||
157120594|NCT01425008|567193110|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
157120595|NCT01425008|567193111|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
157120596|NCT01425008|567193112|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120597|NCT01425008|567193113|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120598|NCT01425008|567193114|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120599|NCT01425008|567193115|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
157120600|NCT01425008|567193116|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
157120601|NCT01425008|567193117|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
157120602|NCT01425008|567193118|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
157120603|NCT01425008|567193100|FG000|Dose Expansion Phase|Adverse Event|0|||
157120604|NCT01425008|567193101|FG001|Dose Expansion Phase|Adverse Event|0|||
157120605|NCT01425008|567193102|FG002|Dose Expansion Phase|Adverse Event|0|||
157120606|NCT01425008|567193103|FG003|Dose Expansion Phase|Adverse Event|0|||
157120607|NCT01425008|567193104|FG004|Dose Expansion Phase|Adverse Event|0|||
156784709|NCT00397930|565963252|FG000|Overall Study|Missing data|0|||
156784710|NCT00397930|565963253|FG001|Overall Study|Missing data|4|||
156784711|NCT01433978|565963256|FG000|Core Study|Adverse Event, Non-Fatal|0|||
157120608|NCT01425008|567193105|FG005|Dose Expansion Phase|Adverse Event|0|||
157120609|NCT01425008|567193106|FG006|Dose Expansion Phase|Adverse Event|0|||
156784712|NCT01433978|565963257|FG001|Core Study|Adverse Event, Non-Fatal|1|||
156784713|NCT01433978|565963258|FG002|Core Study|Adverse Event, Non-Fatal|0|||
156784714|NCT01433978|565963256|FG000|Core Study|Lack of Efficacy|5|||
156784715|NCT01433978|565963257|FG001|Core Study|Lack of Efficacy|1|||
156784716|NCT01433978|565963258|FG002|Core Study|Lack of Efficacy|0|||
156784717|NCT01433978|565963256|FG000|Core Study|Study Terminated by Sponsor|6|||
156784718|NCT01433978|565963257|FG001|Core Study|Study Terminated by Sponsor|9|||
156784719|NCT01433978|565963258|FG002|Core Study|Study Terminated by Sponsor|0|||
156784720|NCT01433978|565963256|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
156784721|NCT01433978|565963257|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
156784722|NCT01433978|565963258|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
156784723|NCT01433978|565963256|FG000|Extension Phase|Lack of Efficacy|0|||
156784724|NCT01433978|565963257|FG001|Extension Phase|Lack of Efficacy|0|||
156784725|NCT01433978|565963258|FG002|Extension Phase|Lack of Efficacy|1|||
156784726|NCT01433978|565963256|FG000|Extension Phase|Study Terminated by Sponsor|0|||
156784727|NCT01433978|565963257|FG001|Extension Phase|Study Terminated by Sponsor|0|||
157213647|NCT04380701|567529562|FG010|Overall Study|Withdrawal by Subject|0|||
157213648|NCT04380701|567529563|FG011|Overall Study|Withdrawal by Subject|1|||
157213649|NCT04380701|567529564|FG012|Overall Study|Withdrawal by Subject|0|||
157213650|NCT04380701|567529565|FG013|Overall Study|Withdrawal by Subject|1|||
157213651|NCT04380701|567529566|FG014|Overall Study|Withdrawal by Subject|0|||
156684584|NCT03185741|565589254|FG002|6Month|Lost to Follow-up|16|||
156684585|NCT03573336|565589257|FG000|Overall Study|Study terminated|2|||
156684586|NCT03573336|565589258|FG001|Overall Study|Study terminated|4|||
156684587|NCT03573336|565589259|FG002|Overall Study|Study terminated|2|||
156684588|NCT01525628|565589260|FG000|Overall Study|Adverse Event|1|||
156684589|NCT01525628|565589261|FG001|Overall Study|Adverse Event|1|||
156684590|NCT01525628|565589262|FG002|Overall Study|Adverse Event|2|||
156684591|NCT01525628|565589263|FG003|Overall Study|Adverse Event|0|||
156684592|NCT01525628|565589264|FG004|Overall Study|Adverse Event|1|||
156684593|NCT01525628|565589260|FG000|Overall Study|Lack of Efficacy|0|||
156684594|NCT01525628|565589261|FG001|Overall Study|Lack of Efficacy|2|||
156684595|NCT01525628|565589262|FG002|Overall Study|Lack of Efficacy|2|||
156684596|NCT01525628|565589263|FG003|Overall Study|Lack of Efficacy|1|||
156684597|NCT01525628|565589264|FG004|Overall Study|Lack of Efficacy|2|||
156684598|NCT01525628|565589260|FG000|Overall Study|Protocol Violation|0|||
156684599|NCT01525628|565589261|FG001|Overall Study|Protocol Violation|0|||
156684600|NCT01525628|565589262|FG002|Overall Study|Protocol Violation|1|||
156684601|NCT01525628|565589263|FG003|Overall Study|Protocol Violation|0|||
156684602|NCT01525628|565589264|FG004|Overall Study|Protocol Violation|0|||
156684603|NCT01525628|565589260|FG000|Overall Study|Lost to Follow-up|1|||
156684604|NCT01525628|565589261|FG001|Overall Study|Lost to Follow-up|1|||
156684605|NCT01525628|565589262|FG002|Overall Study|Lost to Follow-up|0|||
156684606|NCT01525628|565589263|FG003|Overall Study|Lost to Follow-up|0|||
156684607|NCT01525628|565589264|FG004|Overall Study|Lost to Follow-up|0|||
156684608|NCT01525628|565589260|FG000|Overall Study|Withdrawal by Subject|0|||
156684609|NCT01525628|565589261|FG001|Overall Study|Withdrawal by Subject|1|||
156684610|NCT01525628|565589262|FG002|Overall Study|Withdrawal by Subject|0|||
156684611|NCT01525628|565589263|FG003|Overall Study|Withdrawal by Subject|0|||
156684612|NCT01525628|565589264|FG004|Overall Study|Withdrawal by Subject|0|||
156684613|NCT01525628|565589260|FG000|Overall Study|Other reason not defined above|0|||
156684614|NCT01525628|565589261|FG001|Overall Study|Other reason not defined above|0|||
156684615|NCT01525628|565589262|FG002|Overall Study|Other reason not defined above|0|||
156684616|NCT01525628|565589263|FG003|Overall Study|Other reason not defined above|3|||
156684617|NCT01525628|565589264|FG004|Overall Study|Other reason not defined above|0|||
156684618|NCT00239005|565589265|FG000|Overall Study|Adverse Event|6|||
156684619|NCT00239005|565589266|FG001|Overall Study|Adverse Event|6|||
156684620|NCT00239005|565589265|FG000|Overall Study|Withdrawal by Subject|3|||
156684621|NCT00239005|565589266|FG001|Overall Study|Withdrawal by Subject|4|||
156684622|NCT00239005|565589265|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
156684623|NCT00239005|565589266|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
156684624|NCT00239005|565589265|FG000|Overall Study|Protocol Violation|1|||
156684625|NCT00239005|565589266|FG001|Overall Study|Protocol Violation|0|||
156684626|NCT00239005|565589265|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
156684627|NCT00239005|565589266|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
156684628|NCT00239005|565589265|FG000|Overall Study|Lost to Follow-up|0|||
156684629|NCT00239005|565589266|FG001|Overall Study|Lost to Follow-up|1|||
156684630|NCT03108820|565589267|FG000|Overall Study|Lost to Follow-up|30|||
156684631|NCT03108820|565589268|FG001|Overall Study|Lost to Follow-up|28|||
156684632|NCT03108820|565589267|FG000|Overall Study|Withdrawal by Subject|32|||
156784728|NCT01433978|565963258|FG002|Extension Phase|Study Terminated by Sponsor|4|||
157213652|NCT04380701|567529567|FG015|Overall Study|Withdrawal by Subject|0|||
156684633|NCT03108820|565589268|FG001|Overall Study|Withdrawal by Subject|24|||
156684634|NCT03108820|565589267|FG000|Overall Study|Death|6|||
156684635|NCT03108820|565589268|FG001|Overall Study|Death|11|||
156684636|NCT00787605|565589269|FG000|Overall Study|Administrative Problems|3|||
156784729|NCT01773889|565963259|FG000|Overall Study|lack of funding|2|||
157213653|NCT04380701|567529568|FG016|Overall Study|Withdrawal by Subject|1|||
157213654|NCT04380701|567529569|FG017|Overall Study|Withdrawal by Subject|0|||
157213655|NCT04380701|567529570|FG018|Overall Study|Withdrawal by Subject|0|||
156784730|NCT03954938|565963260|FG000|Overall Study|Withdrawal by Subject|2|||
156784731|NCT03954938|565963260|FG000|Overall Study|Adverse Event|1|||
156784732|NCT01371565|565963261|FG000|Overall Study|Withdrawal by Subject|1|||
156784733|NCT01371565|565963261|FG000|Overall Study|Death|1|||
156784734|NCT01371565|565963261|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
156784735|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
156784736|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
156784737|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
156784738|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
156784739|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
156784740|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
156784741|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
156784742|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
156784743|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
156784744|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
156784745|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
156784746|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
156784747|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
156784748|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
156784749|NCT00976391|565963262|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
156784750|NCT00976391|565963263|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
156784751|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
156784752|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
156784753|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
157213656|NCT04380701|567529571|FG019|Overall Study|Withdrawal by Subject|0|||
156784754|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
156784755|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
157013237|NCT02723955|566801759|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157213657|NCT04380701|567529572|FG020|Overall Study|Withdrawal by Subject|0|||
157213658|NCT04380701|567529573|FG021|Overall Study|Withdrawal by Subject|0|||
157213659|NCT04380701|567529574|FG022|Overall Study|Withdrawal by Subject|2|||
157213660|NCT04380701|567529575|FG023|Overall Study|Withdrawal by Subject|2|||
157213661|NCT04380701|567529576|FG024|Overall Study|Withdrawal by Subject|1|||
157213662|NCT04380701|567529577|FG025|Overall Study|Withdrawal by Subject|1|||
157213663|NCT04380701|567529578|FG026|Overall Study|Withdrawal by Subject|0|||
157213664|NCT04380701|567529579|FG027|Overall Study|Withdrawal by Subject|0|||
157213665|NCT04380701|567529580|FG028|Overall Study|Withdrawal by Subject|0|||
157213666|NCT04380701|567529581|FG029|Overall Study|Withdrawal by Subject|0|||
157213667|NCT04380701|567529582|FG030|Overall Study|Withdrawal by Subject|0|||
157213668|NCT04380701|567529583|FG031|Overall Study|Withdrawal by Subject|0|||
157213669|NCT04380701|567529584|FG032|Overall Study|Withdrawal by Subject|0|||
157213670|NCT04380701|567529585|FG033|Overall Study|Withdrawal by Subject|0|||
157213671|NCT04380701|567529552|FG000|Overall Study|Adverse Event|0|||
157213672|NCT04380701|567529553|FG001|Overall Study|Adverse Event|0|||
157213673|NCT04380701|567529554|FG002|Overall Study|Adverse Event|0|||
157213674|NCT04380701|567529555|FG003|Overall Study|Adverse Event|0|||
157213675|NCT04380701|567529556|FG004|Overall Study|Adverse Event|0|||
157213676|NCT04380701|567529557|FG005|Overall Study|Adverse Event|1|||
157213677|NCT04380701|567529558|FG006|Overall Study|Adverse Event|0|||
157213678|NCT04380701|567529559|FG007|Overall Study|Adverse Event|0|||
157213679|NCT04380701|567529560|FG008|Overall Study|Adverse Event|0|||
157213680|NCT04380701|567529561|FG009|Overall Study|Adverse Event|0|||
157213681|NCT04380701|567529562|FG010|Overall Study|Adverse Event|0|||
157213682|NCT04380701|567529563|FG011|Overall Study|Adverse Event|0|||
157213683|NCT04380701|567529564|FG012|Overall Study|Adverse Event|0|||
157213684|NCT04380701|567529565|FG013|Overall Study|Adverse Event|0|||
157213685|NCT04380701|567529566|FG014|Overall Study|Adverse Event|0|||
157213686|NCT04380701|567529567|FG015|Overall Study|Adverse Event|1|||
157213687|NCT04380701|567529568|FG016|Overall Study|Adverse Event|0|||
157213688|NCT04380701|567529569|FG017|Overall Study|Adverse Event|0|||
157213689|NCT04380701|567529570|FG018|Overall Study|Adverse Event|0|||
157213690|NCT04380701|567529571|FG019|Overall Study|Adverse Event|1|||
157213691|NCT04380701|567529572|FG020|Overall Study|Adverse Event|0|||
157213692|NCT04380701|567529573|FG021|Overall Study|Adverse Event|0|||
157213693|NCT04380701|567529574|FG022|Overall Study|Adverse Event|0|||
157213694|NCT04380701|567529575|FG023|Overall Study|Adverse Event|0|||
156784756|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
157213695|NCT04380701|567529576|FG024|Overall Study|Adverse Event|0|||
157213696|NCT04380701|567529577|FG025|Overall Study|Adverse Event|0|||
157213697|NCT04380701|567529578|FG026|Overall Study|Adverse Event|0|||
156784757|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
156784758|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
157120610|NCT01425008|567193107|FG007|Dose Expansion Phase|Adverse Event|0|||
157120611|NCT01425008|567193108|FG008|Dose Expansion Phase|Adverse Event|0|||
157120612|NCT01425008|567193109|FG009|Dose Expansion Phase|Adverse Event|0|||
157120613|NCT01425008|567193110|FG010|Dose Expansion Phase|Adverse Event|2|||
157120614|NCT01425008|567193111|FG011|Dose Expansion Phase|Adverse Event|3|||
157120615|NCT01425008|567193112|FG012|Dose Expansion Phase|Adverse Event|3|||
157120616|NCT01425008|567193113|FG013|Dose Expansion Phase|Adverse Event|0|||
157120617|NCT01425008|567193114|FG014|Dose Expansion Phase|Adverse Event|1|||
157120618|NCT01425008|567193115|FG015|Dose Expansion Phase|Adverse Event|1|||
157120619|NCT01425008|567193116|FG016|Dose Expansion Phase|Adverse Event|5|||
157120620|NCT01425008|567193117|FG017|Dose Expansion Phase|Adverse Event|0|||
157120621|NCT01425008|567193118|FG018|Dose Expansion Phase|Adverse Event|3|||
157120622|NCT01425008|567193100|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
157120623|NCT01425008|567193101|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
157120624|NCT01425008|567193102|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
157120625|NCT01425008|567193103|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
157120626|NCT01425008|567193104|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
157120627|NCT01425008|567193105|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
157120628|NCT01425008|567193106|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
157120629|NCT01425008|567193107|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
157120630|NCT01425008|567193108|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
157120631|NCT01425008|567193109|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
157120632|NCT01425008|567193110|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
157120633|NCT01425008|567193111|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
157120634|NCT01425008|567193112|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
157120635|NCT01425008|567193113|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
157120636|NCT01425008|567193114|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
157120637|NCT01425008|567193115|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
157120638|NCT01425008|567193116|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
157120639|NCT01425008|567193117|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
157120640|NCT01425008|567193118|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
157120641|NCT01425008|567193100|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120642|NCT01425008|567193101|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120643|NCT01425008|567193102|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120644|NCT01425008|567193103|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120645|NCT01425008|567193104|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120646|NCT01425008|567193105|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120647|NCT01425008|567193106|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120648|NCT01425008|567193107|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120649|NCT01425008|567193108|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120650|NCT01425008|567193109|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120651|NCT01425008|567193110|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120652|NCT01425008|567193111|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120653|NCT01425008|567193112|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120654|NCT01425008|567193113|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120655|NCT01425008|567193114|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120656|NCT01425008|567193115|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120657|NCT01425008|567193116|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120658|NCT01425008|567193117|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157120659|NCT01425008|567193118|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
157145142|NCT00845429|567278007|FG002|Overall Study|Withdrawal by Subject|2|||
157145143|NCT00845429|567278005|FG000|Overall Study|Serious adverse event|0|||
157145144|NCT00845429|567278006|FG001|Overall Study|Serious adverse event|0|||
157145145|NCT00845429|567278007|FG002|Overall Study|Serious adverse event|1|||
157145146|NCT04222725|567278008|FG000|Overall Study|Adverse Event|0|||
157145147|NCT04222725|567278009|FG001|Overall Study|Adverse Event|1|||
157145148|NCT04222725|567278010|FG002|Overall Study|Adverse Event|0|||
157145149|NCT04222725|567278011|FG003|Overall Study|Adverse Event|0|||
157145150|NCT05755438|567278012|FG000|12-week DBVC Period|Adverse Event|4|||
157145151|NCT05755438|567278013|FG001|12-week DBVC Period|Adverse Event|1|||
157145152|NCT05755438|567278012|FG000|12-week DBVC Period|Physician Decision|1|||
157145153|NCT05755438|567278013|FG001|12-week DBVC Period|Physician Decision|1|||
157145154|NCT05755438|567278012|FG000|12-week DBVC Period|Protocol Violation|4|||
157145155|NCT05755438|567278013|FG001|12-week DBVC Period|Protocol Violation|2|||
157145156|NCT05755438|567278012|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
157145157|NCT05755438|567278013|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
157145158|NCT05755438|567278012|FG000|12-week DBVC Period|Sponsor Decision|1|||
157145159|NCT05755438|567278013|FG001|12-week DBVC Period|Sponsor Decision|0|||
157145160|NCT05755438|567278012|FG000|40-week OLE Period|Adverse Event|0|||
157145161|NCT05755438|567278013|FG001|40-week OLE Period|Adverse Event|2|||
157145162|NCT05755438|567278012|FG000|40-week OLE Period|Lack of Efficacy|1|||
157145163|NCT05755438|567278013|FG001|40-week OLE Period|Lack of Efficacy|1|||
157145164|NCT05755438|567278012|FG000|40-week OLE Period|Lost to Follow-up|1|||
157120660|NCT03409744|567194232|FG000|Overall Study|Death|2|||
157120661|NCT03409744|567194232|FG000|Overall Study|Physician Decision|5|||
157120662|NCT03409744|567194232|FG000|Overall Study|Pregnancy|1|||
157120663|NCT03409744|567194232|FG000|Overall Study|Lost to Follow-up|1|||
157120664|NCT03409744|567194232|FG000|Overall Study|Protocol Violation|1|||
157120665|NCT05804877|567194233|FG000|Overall Study|Lost to Follow-up|1|||
157120666|NCT05804877|567194234|FG001|Overall Study|Lost to Follow-up|3|||
157120667|NCT05804877|567194233|FG000|Overall Study|Withdrawal by Subject|1|||
157120668|NCT05804877|567194234|FG001|Overall Study|Withdrawal by Subject|0|||
157120669|NCT05804877|567194233|FG000|Overall Study|Withdrawal by Subject|1|||
157120670|NCT05804877|567194234|FG001|Overall Study|Withdrawal by Subject|0|||
157120671|NCT01262365|567194236|FG000|Overall Study|Lack of Efficacy|35|||
157120672|NCT01262365|567194237|FG001|Overall Study|Lack of Efficacy|30|||
157120673|NCT01262365|567194238|FG002|Overall Study|Lack of Efficacy|47|||
157120674|NCT01262365|567194236|FG000|Overall Study|Protocol Violation|3|||
156684637|NCT00787605|565589270|FG001|Overall Study|Administrative Problems|0|||
156684638|NCT00787605|565589269|FG000|Overall Study|Adverse Event|14|||
156684639|NCT00787605|565589270|FG001|Overall Study|Adverse Event|25|||
156684640|NCT00787605|565589269|FG000|Overall Study|Lost to Follow-up|3|||
156684641|NCT00787605|565589270|FG001|Overall Study|Lost to Follow-up|6|||
156684642|NCT00787605|565589269|FG000|Overall Study|Protocol Violation|7|||
156684643|NCT00787605|565589270|FG001|Overall Study|Protocol Violation|3|||
156684644|NCT00787605|565589269|FG000|Overall Study|Withdrawal by Subject|6|||
156684645|NCT00787605|565589270|FG001|Overall Study|Withdrawal by Subject|13|||
156684646|NCT00787605|565589269|FG000|Overall Study|Lack of Efficacy|13|||
156684647|NCT00787605|565589270|FG001|Overall Study|Lack of Efficacy|9|||
156684648|NCT01488448|565589276|FG000|Overall Study|Withdrawal by Subject|3|||
156684649|NCT01488448|565589277|FG001|Overall Study|Withdrawal by Subject|1|||
156684650|NCT01488448|565589276|FG000|Overall Study|Adverse Event|9|||
156684651|NCT01488448|565589277|FG001|Overall Study|Adverse Event|4|||
156684652|NCT01488448|565589276|FG000|Overall Study|Physician Decision|4|||
156684653|NCT01488448|565589277|FG001|Overall Study|Physician Decision|9|||
156684654|NCT01488448|565589276|FG000|Overall Study|Protocol Violation|4|||
156684655|NCT01488448|565589277|FG001|Overall Study|Protocol Violation|3|||
156684656|NCT00654641|565589278|FG000|Overall Study|Lost to Follow-up|2|||
156684657|NCT00654641|565589279|FG001|Overall Study|Lost to Follow-up|3|||
157120675|NCT01262365|567194237|FG001|Overall Study|Protocol Violation|1|||
157120676|NCT01262365|567194238|FG002|Overall Study|Protocol Violation|1|||
157120677|NCT01262365|567194236|FG000|Overall Study|Lost to Follow-up|3|||
157120678|NCT01262365|567194237|FG001|Overall Study|Lost to Follow-up|7|||
156684658|NCT01992094|565589280|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
156684659|NCT01992094|565589281|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
156684660|NCT01992094|565589282|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
156684661|NCT01992094|565589280|FG000|Overall Study|Adverse Event|1|||
156684662|NCT01992094|565589281|FG001|Overall Study|Adverse Event|0|||
156684663|NCT01992094|565589282|FG002|Overall Study|Adverse Event|0|||
156684664|NCT01992094|565589280|FG000|Overall Study|Death|5|||
157120679|NCT01262365|567194238|FG002|Overall Study|Lost to Follow-up|6|||
156684665|NCT01992094|565589281|FG001|Overall Study|Death|5|||
156684666|NCT01992094|565589282|FG002|Overall Study|Death|2|||
156684667|NCT01992094|565589280|FG000|Overall Study|Lost to Follow-up|26|||
156684668|NCT01992094|565589281|FG001|Overall Study|Lost to Follow-up|9|||
156684669|NCT01992094|565589282|FG002|Overall Study|Lost to Follow-up|13|||
156684670|NCT01992094|565589280|FG000|Overall Study|OTHER|4|||
156684671|NCT01992094|565589281|FG001|Overall Study|OTHER|0|||
156684672|NCT01992094|565589282|FG002|Overall Study|OTHER|0|||
156684673|NCT01992094|565589280|FG000|Overall Study|Protocol Violation|1|||
156684674|NCT01992094|565589281|FG001|Overall Study|Protocol Violation|0|||
156684675|NCT01992094|565589282|FG002|Overall Study|Protocol Violation|1|||
157120680|NCT01262365|567194236|FG000|Overall Study|Withdrawal by Subject|17|||
156684676|NCT01992094|565589280|FG000|Overall Study|Withdrawal by Subject|7|||
156684677|NCT01992094|565589281|FG001|Overall Study|Withdrawal by Subject|3|||
156684678|NCT01992094|565589282|FG002|Overall Study|Withdrawal by Subject|4|||
156684679|NCT00810602|565589285|FG000|Overall Study|Withdrawal by Subject|8|||
156684680|NCT00810602|565589286|FG001|Overall Study|Withdrawal by Subject|3|||
156684681|NCT03840382|565589287|FG000|Overall Study|Lost to Follow-up|11|||
156684682|NCT02625974|565589288|FG000|Part 1|Lost to Follow-up|9|||
157120681|NCT01262365|567194237|FG001|Overall Study|Withdrawal by Subject|22|||
157120682|NCT01262365|567194238|FG002|Overall Study|Withdrawal by Subject|22|||
157120683|NCT01262365|567194236|FG000|Overall Study|Death|1|||
157120684|NCT01262365|567194237|FG001|Overall Study|Death|2|||
157120685|NCT01262365|567194238|FG002|Overall Study|Death|1|||
156684683|NCT02625974|565589289|FG001|Part 1|Lost to Follow-up|3|||
156684684|NCT02625974|565589288|FG000|Part 2|Lost to Follow-up|4|||
156684685|NCT02625974|565589289|FG001|Part 2|Lost to Follow-up|6|||
156684686|NCT02625974|565589288|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
157120686|NCT01262365|567194236|FG000|Overall Study|Adverse Event|26|||
157120687|NCT01262365|567194237|FG001|Overall Study|Adverse Event|16|||
157120688|NCT01262365|567194238|FG002|Overall Study|Adverse Event|11|||
157120689|NCT01262365|567194236|FG000|Overall Study|sponsor decision|1|||
157120690|NCT01262365|567194237|FG001|Overall Study|sponsor decision|1|||
156684687|NCT02625974|565589289|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
156684688|NCT01142661|565589290|FG000|Overall Study|Adverse Event|2|||
156684689|NCT01142661|565589290|FG000|Overall Study|Withdrawal by Subject|1|||
156684690|NCT01142661|565589290|FG000|Overall Study|Physician Decision|1|||
156684691|NCT00434590|565589291|FG000|Overall Study|Administrative problems|5|||
156684692|NCT00434590|565589292|FG001|Overall Study|Administrative problems|5|||
156684693|NCT00965731|565589295|FG000|Overall Study|Death|0|||
156684694|NCT00965731|565589296|FG001|Overall Study|Death|4|||
156684695|NCT00965731|565589295|FG000|Overall Study|Withdrawal by Subject|0|||
156684696|NCT00965731|565589296|FG001|Overall Study|Withdrawal by Subject|1|||
156684697|NCT00965731|565589295|FG000|Overall Study|Other|7|||
156684698|NCT00965731|565589296|FG001|Overall Study|Other|15|||
156684699|NCT03429049|565590629|FG000|Overall Study|Adverse Event|2|||
156684700|NCT03429049|565590630|FG001|Overall Study|Adverse Event|3|||
156684701|NCT03429049|565590629|FG000|Overall Study|Death|0|||
156684702|NCT03429049|565590630|FG001|Overall Study|Death|1|||
156684703|NCT03429049|565590629|FG000|Overall Study|Lack of Efficacy|4|||
156684704|NCT03429049|565590630|FG001|Overall Study|Lack of Efficacy|2|||
156684705|NCT03429049|565590629|FG000|Overall Study|Lost to Follow-up|9|||
156684706|NCT03429049|565590630|FG001|Overall Study|Lost to Follow-up|8|||
156784759|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
156784760|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
156684707|NCT03429049|565590629|FG000|Overall Study|Physician Decision|1|||
156684708|NCT03429049|565590630|FG001|Overall Study|Physician Decision|0|||
156784761|NCT00976391|565963262|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
157120691|NCT01262365|567194238|FG002|Overall Study|sponsor decision|0|||
157120692|NCT01262365|567194236|FG000|Overall Study|Randomization error|1|||
157120693|NCT01262365|567194237|FG001|Overall Study|Randomization error|0|||
157120694|NCT01262365|567194238|FG002|Overall Study|Randomization error|2|||
157120695|NCT01262365|567194236|FG000|Overall Study|Non-compliance|1|||
157120696|NCT01262365|567194237|FG001|Overall Study|Non-compliance|0|||
157120697|NCT01262365|567194238|FG002|Overall Study|Non-compliance|2|||
157120698|NCT01262365|567194236|FG000|Overall Study|Suspected pregnancy|1|||
157120699|NCT01262365|567194237|FG001|Overall Study|Suspected pregnancy|0|||
157120700|NCT01262365|567194238|FG002|Overall Study|Suspected pregnancy|0|||
157120701|NCT01262365|567194236|FG000|Overall Study|Patient pregnant|1|||
157120702|NCT01262365|567194237|FG001|Overall Study|Patient pregnant|0|||
157120703|NCT01262365|567194238|FG002|Overall Study|Patient pregnant|1|||
157120704|NCT01262365|567194236|FG000|Overall Study|Toxicity related to study drug|0|||
157120705|NCT01262365|567194237|FG001|Overall Study|Toxicity related to study drug|1|||
157120706|NCT01262365|567194238|FG002|Overall Study|Toxicity related to study drug|0|||
157120707|NCT01262365|567194236|FG000|Overall Study|Cannot tolerate the protocol|0|||
157120708|NCT01262365|567194237|FG001|Overall Study|Cannot tolerate the protocol|1|||
157120709|NCT01262365|567194238|FG002|Overall Study|Cannot tolerate the protocol|0|||
157120710|NCT01262365|567194236|FG000|Overall Study|Patient unavailable|0|||
157120711|NCT01262365|567194237|FG001|Overall Study|Patient unavailable|0|||
157120712|NCT01262365|567194238|FG002|Overall Study|Patient unavailable|1|||
157120713|NCT00494091|567194239|FG000|Overall Study|Death|5|||
157120714|NCT00494091|567194240|FG001|Overall Study|Death|54|||
157120715|NCT00494091|567194239|FG000|Overall Study|Lost to Follow-up|0|||
157120716|NCT00494091|567194240|FG001|Overall Study|Lost to Follow-up|4|||
157120717|NCT00494091|567194239|FG000|Overall Study|Other|1|||
157120718|NCT00494091|567194240|FG001|Overall Study|Other|11|||
157120719|NCT00494091|567194239|FG000|Overall Study|Withdrawal by Subject|0|||
157120720|NCT00494091|567194240|FG001|Overall Study|Withdrawal by Subject|7|||
157120721|NCT00984204|567194245|FG000|Overall Study|Death|1|||
157120722|NCT00984204|567194245|FG000|Overall Study|Lost to Follow-up|4|||
157120723|NCT00984204|567194245|FG000|Overall Study|Lack of Efficacy|10|||
157120724|NCT00699348|567194247|FG000|Overall Study|Death|6|||
157120725|NCT00699348|567194247|FG000|Overall Study|Adverse Event|15|||
157120726|NCT00699348|567194247|FG000|Overall Study|Withdrawal by Subject|11|||
157120727|NCT00699348|567194247|FG000|Overall Study|Protocol Violation|10|||
157120728|NCT00699348|567194247|FG000|Overall Study|Lack of Efficacy|8|||
157120729|NCT00699348|567194247|FG000|Overall Study|Failure to return|1|||
157120730|NCT00699348|567194247|FG000|Overall Study|Blood transfusion|24|||
156684709|NCT03429049|565590629|FG000|Overall Study|Protocol Violation|3|||
156684710|NCT03429049|565590630|FG001|Overall Study|Protocol Violation|0|||
156684711|NCT03429049|565590629|FG000|Overall Study|Sponsor Decision|2|||
156684712|NCT03429049|565590630|FG001|Overall Study|Sponsor Decision|0|||
156784762|NCT00976391|565963263|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
157120731|NCT00699348|567194247|FG000|Overall Study|Renal transplantation|10|||
157120732|NCT00699348|567194247|FG000|Overall Study|Other|5|||
157120733|NCT00122135|567194248|FG000|Overall Study|Withdrawal by Subject|3|||
157120734|NCT00122135|567194249|FG001|Overall Study|Withdrawal by Subject|0|||
157120735|NCT04478708|567194252|FG000|Overall Study|Lost to Follow-up|0|||
157120736|NCT04478708|567194253|FG001|Overall Study|Lost to Follow-up|0|||
157120737|NCT04478708|567194254|FG002|Overall Study|Lost to Follow-up|0|||
157120738|NCT04478708|567194255|FG003|Overall Study|Lost to Follow-up|0|||
156684713|NCT03429049|565590629|FG000|Overall Study|Withdrawal by Subject|4|||
156684714|NCT03429049|565590630|FG001|Overall Study|Withdrawal by Subject|20|||
156684715|NCT03429049|565590629|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
156684716|NCT03429049|565590630|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
156684717|NCT04703855|565590631|FG000|Overall Study|Heart Transplant|1|||
156684718|NCT01560819|565590633|FG000|Overall Study|Physician Decision|1|||
156684719|NCT01560819|565590634|FG001|Overall Study|Physician Decision|0|||
156684720|NCT00399893|565590637|FG000|Overall Study|Withdrawal by Subject|1|||
156684721|NCT00399893|565590638|FG001|Overall Study|Withdrawal by Subject|0|||
156868369|NCT02113982|566277292|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
156868370|NCT02113982|566277293|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
156868371|NCT02085161|566277294|FG000|Overall Study|Not Treated|1|||
156868372|NCT02085161|566277295|FG001|Overall Study|Not Treated|0|||
156868373|NCT02085161|566277296|FG002|Overall Study|Not Treated|0|||
156868374|NCT02085161|566277297|FG003|Overall Study|Not Treated|0|||
156868375|NCT02085161|566277294|FG000|Overall Study|Adverse Event|8|||
156868376|NCT02085161|566277295|FG001|Overall Study|Adverse Event|5|||
156868377|NCT02085161|566277296|FG002|Overall Study|Adverse Event|4|||
156868378|NCT02085161|566277297|FG003|Overall Study|Adverse Event|5|||
156868379|NCT02085161|566277294|FG000|Overall Study|Protocol Violation|0|||
156868380|NCT02085161|566277295|FG001|Overall Study|Protocol Violation|1|||
156868381|NCT02085161|566277296|FG002|Overall Study|Protocol Violation|0|||
156868382|NCT02085161|566277297|FG003|Overall Study|Protocol Violation|1|||
156868383|NCT02085161|566277294|FG000|Overall Study|Withdrawal by Subject|2|||
156868384|NCT02085161|566277295|FG001|Overall Study|Withdrawal by Subject|4|||
156868385|NCT02085161|566277296|FG002|Overall Study|Withdrawal by Subject|0|||
156868386|NCT02085161|566277297|FG003|Overall Study|Withdrawal by Subject|3|||
156868387|NCT02085161|566277294|FG000|Overall Study|Other Reason|1|||
156868388|NCT02085161|566277295|FG001|Overall Study|Other Reason|0|||
156868389|NCT02085161|566277296|FG002|Overall Study|Other Reason|1|||
156868390|NCT02085161|566277297|FG003|Overall Study|Other Reason|1|||
156868391|NCT00068692|566277308|FG000|Step 1: Registration|Disese progression/relapse|5|||
156868392|NCT00068692|566277309|FG001|Step 1: Registration|Disese progression/relapse|0|||
156868393|NCT00068692|566277310|FG002|Step 1: Registration|Disese progression/relapse|0|||
156868394|NCT00068692|566277311|FG003|Step 1: Registration|Disese progression/relapse|0|||
156868395|NCT00068692|566277312|FG004|Step 1: Registration|Disese progression/relapse|0|||
156868396|NCT00068692|566277313|FG005|Step 1: Registration|Disese progression/relapse|0|||
157213698|NCT04380701|567529579|FG027|Overall Study|Adverse Event|0|||
157213699|NCT04380701|567529580|FG028|Overall Study|Adverse Event|0|||
157213700|NCT04380701|567529581|FG029|Overall Study|Adverse Event|0|||
157213701|NCT04380701|567529582|FG030|Overall Study|Adverse Event|0|||
157213702|NCT04380701|567529583|FG031|Overall Study|Adverse Event|0|||
157213703|NCT04380701|567529584|FG032|Overall Study|Adverse Event|0|||
157213704|NCT04380701|567529585|FG033|Overall Study|Adverse Event|0|||
156868397|NCT00068692|566277314|FG006|Step 1: Registration|Disese progression/relapse|0|||
156868398|NCT00068692|566277315|FG007|Step 1: Registration|Disese progression/relapse|0|||
156868399|NCT00068692|566277308|FG000|Step 1: Registration|Adverse Event|7|||
156868400|NCT00068692|566277309|FG001|Step 1: Registration|Adverse Event|0|||
156868401|NCT00068692|566277310|FG002|Step 1: Registration|Adverse Event|0|||
156868402|NCT00068692|566277311|FG003|Step 1: Registration|Adverse Event|0|||
156868403|NCT00068692|566277312|FG004|Step 1: Registration|Adverse Event|0|||
156868404|NCT00068692|566277313|FG005|Step 1: Registration|Adverse Event|0|||
156868405|NCT00068692|566277314|FG006|Step 1: Registration|Adverse Event|0|||
156868406|NCT00068692|566277315|FG007|Step 1: Registration|Adverse Event|0|||
156868407|NCT00068692|566277308|FG000|Step 1: Registration|Death|1|||
156868408|NCT00068692|566277309|FG001|Step 1: Registration|Death|0|||
156868409|NCT00068692|566277310|FG002|Step 1: Registration|Death|0|||
156868410|NCT00068692|566277311|FG003|Step 1: Registration|Death|0|||
157213705|NCT04380701|567529552|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
157213706|NCT04380701|567529553|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
157213707|NCT04380701|567529554|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
156684722|NCT00114231|565590639|FG000|Overall Study|No consent|2|||
156684723|NCT00114231|565590640|FG001|Overall Study|No consent|0|||
156684724|NCT00114231|565590639|FG000|Overall Study|QARC requirement not met|1|||
156684725|NCT00114231|565590640|FG001|Overall Study|QARC requirement not met|0|||
156684726|NCT00114231|565590639|FG000|Overall Study|Suspected metastatic disease|1|||
156684727|NCT00114231|565590640|FG001|Overall Study|Suspected metastatic disease|0|||
156868411|NCT00068692|566277312|FG004|Step 1: Registration|Death|0|||
156868412|NCT00068692|566277313|FG005|Step 1: Registration|Death|0|||
156868413|NCT00068692|566277314|FG006|Step 1: Registration|Death|0|||
156868414|NCT00068692|566277315|FG007|Step 1: Registration|Death|0|||
156868415|NCT00068692|566277308|FG000|Step 1: Registration|Withdrawal by Subject|11|||
156868416|NCT00068692|566277309|FG001|Step 1: Registration|Withdrawal by Subject|0|||
156868417|NCT00068692|566277310|FG002|Step 1: Registration|Withdrawal by Subject|0|||
156868418|NCT00068692|566277311|FG003|Step 1: Registration|Withdrawal by Subject|0|||
157213708|NCT04380701|567529555|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
157213709|NCT04380701|567529556|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
157213710|NCT04380701|567529557|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
157213711|NCT04380701|567529558|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
157213712|NCT04380701|567529559|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
157213713|NCT04380701|567529560|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
157213714|NCT04380701|567529561|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
157213715|NCT04380701|567529562|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
157213716|NCT04380701|567529563|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
157213717|NCT04380701|567529564|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
157213718|NCT04380701|567529565|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
157213719|NCT04380701|567529566|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
157213720|NCT04380701|567529567|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
157213721|NCT04380701|567529568|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
157213722|NCT04380701|567529569|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
157213723|NCT04380701|567529570|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
157213724|NCT04380701|567529571|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
157213725|NCT04380701|567529572|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
157213726|NCT04380701|567529573|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
157213727|NCT04380701|567529574|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
157213728|NCT04380701|567529575|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
157213729|NCT04380701|567529576|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
157213730|NCT04380701|567529577|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
156784763|NCT00617903|565963264|FG000|Overall Study|Withdrawal by Subject|2|||
156784764|NCT00617903|565963265|FG001|Overall Study|Withdrawal by Subject|3|||
156784765|NCT00617903|565963264|FG000|Overall Study|Lost to Follow-up|1|||
156784766|NCT00617903|565963265|FG001|Overall Study|Lost to Follow-up|1|||
156784767|NCT00617903|565963264|FG000|Overall Study|Lack of Efficacy|0|||
156784768|NCT00617903|565963265|FG001|Overall Study|Lack of Efficacy|1|||
156784769|NCT00617903|565963264|FG000|Overall Study|Adverse Event|0|||
156784770|NCT00617903|565963265|FG001|Overall Study|Adverse Event|1|||
156784771|NCT00617903|565963264|FG000|Overall Study|noncompliance|0|||
156784772|NCT00617903|565963265|FG001|Overall Study|noncompliance|1|||
156784773|NCT02565186|565963266|FG000|Overall Study|Adverse Event|113|||
156784774|NCT02565186|565963267|FG001|Overall Study|Adverse Event|148|||
156784775|NCT02565186|565963266|FG000|Overall Study|Lost to Follow-up|102|||
156784776|NCT02565186|565963267|FG001|Overall Study|Lost to Follow-up|93|||
156784777|NCT02565186|565963266|FG000|Overall Study|Non-Compliance|57|||
156784778|NCT02565186|565963267|FG001|Overall Study|Non-Compliance|55|||
156784779|NCT02565186|565963266|FG000|Overall Study|Withdrawal by Subject|229|||
156784780|NCT02565186|565963267|FG001|Overall Study|Withdrawal by Subject|214|||
156784781|NCT02565186|565963266|FG000|Overall Study|Physician Decision|18|||
156784782|NCT02565186|565963267|FG001|Overall Study|Physician Decision|16|||
156784783|NCT02565186|565963266|FG000|Overall Study|Sponsor Request|5|||
156784784|NCT02565186|565963267|FG001|Overall Study|Sponsor Request|9|||
156784785|NCT02565186|565963266|FG000|Overall Study|Missing|1|||
156784786|NCT02565186|565963267|FG001|Overall Study|Missing|0|||
157213731|NCT04380701|567529578|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
157213732|NCT04380701|567529579|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
157213733|NCT04380701|567529580|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
157213734|NCT04380701|567529581|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
157213735|NCT04380701|567529582|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
157120739|NCT04478708|567194256|FG004|Overall Study|Lost to Follow-up|0|||
157120740|NCT04478708|567194257|FG005|Overall Study|Lost to Follow-up|0|||
157120741|NCT04478708|567194258|FG006|Overall Study|Lost to Follow-up|0|||
157120742|NCT04478708|567194259|FG007|Overall Study|Lost to Follow-up|0|||
157120743|NCT04478708|567194260|FG008|Overall Study|Lost to Follow-up|1|||
157120744|NCT04478708|567194261|FG009|Overall Study|Lost to Follow-up|1|||
157120745|NCT04478708|567194262|FG010|Overall Study|Lost to Follow-up|1|||
157120746|NCT04478708|567194263|FG011|Overall Study|Lost to Follow-up|2|||
157120747|NCT04478708|567194264|FG012|Overall Study|Lost to Follow-up|1|||
157120748|NCT04478708|567194265|FG013|Overall Study|Lost to Follow-up|0|||
157120749|NCT04478708|567194266|FG014|Overall Study|Lost to Follow-up|0|||
157120750|NCT04478708|567194267|FG015|Overall Study|Lost to Follow-up|0|||
157120751|NCT04478708|567194268|FG016|Overall Study|Lost to Follow-up|0|||
157120752|NCT04478708|567194252|FG000|Overall Study|Withdrawal of consent from study|0|||
157120753|NCT04478708|567194253|FG001|Overall Study|Withdrawal of consent from study|1|||
156784787|NCT02565186|565963266|FG000|Overall Study|Did Not Receive Study Drug|55|||
157120754|NCT04478708|567194254|FG002|Overall Study|Withdrawal of consent from study|2|||
157120755|NCT04478708|567194255|FG003|Overall Study|Withdrawal of consent from study|0|||
157213736|NCT04380701|567529583|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
157213737|NCT04380701|567529584|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
156784788|NCT02565186|565963267|FG001|Overall Study|Did Not Receive Study Drug|86|||
156784789|NCT02217982|565963268|FG000|Overall Study|Trial discontinued|1|||
156784790|NCT02217982|565963269|FG001|Overall Study|Trial discontinued|0|||
156784791|NCT02217982|565963268|FG000|Overall Study|Adverse Event|0|||
156784792|NCT02217982|565963269|FG001|Overall Study|Adverse Event|1|||
156784793|NCT04676646|565963270|FG000|Open-label Run-in Phase|Adverse Event|3|||
156684728|NCT00114231|565590639|FG000|Overall Study|No adenocarcinoma|1|||
156684729|NCT00114231|565590640|FG001|Overall Study|No adenocarcinoma|0|||
156784794|NCT04676646|565963271|FG001|Open-label Run-in Phase|Adverse Event|0|||
156784795|NCT04676646|565963272|FG002|Open-label Run-in Phase|Adverse Event|0|||
156784796|NCT04676646|565963270|FG000|Open-label Run-in Phase|Death|3|||
156784797|NCT04676646|565963271|FG001|Open-label Run-in Phase|Death|0|||
156784798|NCT04676646|565963272|FG002|Open-label Run-in Phase|Death|0|||
156784799|NCT04676646|565963270|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
156784800|NCT04676646|565963271|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
156784801|NCT04676646|565963272|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
156784802|NCT04676646|565963270|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
156784803|NCT04676646|565963271|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
156784804|NCT04676646|565963272|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
156684730|NCT00114231|565590639|FG000|Overall Study|Low creatinine clearance|0|||
156684731|NCT00114231|565590640|FG001|Overall Study|Low creatinine clearance|1|||
156684732|NCT00114231|565590639|FG000|Overall Study|Tumor size > 4cm|1|||
156684733|NCT00114231|565590640|FG001|Overall Study|Tumor size > 4cm|0|||
156684734|NCT00114231|565590639|FG000|Overall Study|Tumor fixed on digital exam|0|||
156684735|NCT00114231|565590640|FG001|Overall Study|Tumor fixed on digital exam|1|||
156684736|NCT00114231|565590639|FG000|Overall Study|No Absolute Neutrophil Count|2|||
156684737|NCT00114231|565590640|FG001|Overall Study|No Absolute Neutrophil Count|0|||
156784805|NCT04676646|565963270|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
156784806|NCT04676646|565963271|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
156784807|NCT04676646|565963272|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
156784808|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
156784809|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
156784810|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
157120756|NCT04478708|567194256|FG004|Overall Study|Withdrawal of consent from study|1|||
156684738|NCT00114231|565590639|FG000|Overall Study|Biopsy done after registration|1|||
156684739|NCT00114231|565590640|FG001|Overall Study|Biopsy done after registration|0|||
156684740|NCT02668822|565590650|FG000|Overall Study|Protocol Violation|2|||
156684741|NCT02668822|565590651|FG001|Overall Study|Protocol Violation|0|||
156684742|NCT02668822|565590650|FG000|Overall Study|Study Terminated by Sponsor|7|||
156684743|NCT02668822|565590651|FG001|Overall Study|Study Terminated by Sponsor|9|||
156684744|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
156684745|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
156684746|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
156684747|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
156684748|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
156684749|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
156684750|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
156684751|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
156684752|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
156684753|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684754|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684755|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
156684756|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
156684757|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
156684758|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
156684759|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
156684760|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684761|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684762|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
156684763|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
156684764|NCT02960438|565590652|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
156684765|NCT02960438|565590653|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
156684766|NCT02960438|565590654|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
156684767|NCT02960438|565590655|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
156684768|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
156684769|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
156784811|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
157120757|NCT04478708|567194257|FG005|Overall Study|Withdrawal of consent from study|1|||
157120758|NCT04478708|567194258|FG006|Overall Study|Withdrawal of consent from study|1|||
157120759|NCT04478708|567194259|FG007|Overall Study|Withdrawal of consent from study|0|||
157120760|NCT04478708|567194260|FG008|Overall Study|Withdrawal of consent from study|0|||
157120761|NCT04478708|567194261|FG009|Overall Study|Withdrawal of consent from study|0|||
157120762|NCT04478708|567194262|FG010|Overall Study|Withdrawal of consent from study|4|||
157120763|NCT04478708|567194263|FG011|Overall Study|Withdrawal of consent from study|3|||
157213738|NCT04380701|567529585|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
156784812|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
156784813|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
156784814|NCT04676646|565963270|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
156784815|NCT04676646|565963271|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
156784816|NCT04676646|565963272|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
157213739|NCT04380701|567529552|FG000|Overall Study|Physician Decision|0|||
157213740|NCT04380701|567529553|FG001|Overall Study|Physician Decision|0|||
157213741|NCT04380701|567529554|FG002|Overall Study|Physician Decision|0|||
157213742|NCT04380701|567529555|FG003|Overall Study|Physician Decision|0|||
157213743|NCT04380701|567529556|FG004|Overall Study|Physician Decision|0|||
157213744|NCT04380701|567529557|FG005|Overall Study|Physician Decision|0|||
157213745|NCT04380701|567529558|FG006|Overall Study|Physician Decision|0|||
157213746|NCT04380701|567529559|FG007|Overall Study|Physician Decision|0|||
157213747|NCT04380701|567529560|FG008|Overall Study|Physician Decision|0|||
157213748|NCT04380701|567529561|FG009|Overall Study|Physician Decision|0|||
157213749|NCT04380701|567529562|FG010|Overall Study|Physician Decision|0|||
157213750|NCT04380701|567529563|FG011|Overall Study|Physician Decision|0|||
157213751|NCT04380701|567529564|FG012|Overall Study|Physician Decision|0|||
157213752|NCT04380701|567529565|FG013|Overall Study|Physician Decision|0|||
157213753|NCT04380701|567529566|FG014|Overall Study|Physician Decision|0|||
157213754|NCT04380701|567529567|FG015|Overall Study|Physician Decision|0|||
157213755|NCT04380701|567529568|FG016|Overall Study|Physician Decision|0|||
157213756|NCT04380701|567529569|FG017|Overall Study|Physician Decision|0|||
157213757|NCT04380701|567529570|FG018|Overall Study|Physician Decision|0|||
157213758|NCT04380701|567529571|FG019|Overall Study|Physician Decision|0|||
157213759|NCT04380701|567529572|FG020|Overall Study|Physician Decision|0|||
157213760|NCT04380701|567529573|FG021|Overall Study|Physician Decision|0|||
157213761|NCT04380701|567529574|FG022|Overall Study|Physician Decision|0|||
157213762|NCT04380701|567529575|FG023|Overall Study|Physician Decision|0|||
157213763|NCT04380701|567529576|FG024|Overall Study|Physician Decision|2|||
157213764|NCT04380701|567529577|FG025|Overall Study|Physician Decision|0|||
157213765|NCT04380701|567529578|FG026|Overall Study|Physician Decision|0|||
157213766|NCT04380701|567529579|FG027|Overall Study|Physician Decision|0|||
157213767|NCT04380701|567529580|FG028|Overall Study|Physician Decision|0|||
157213768|NCT04380701|567529581|FG029|Overall Study|Physician Decision|0|||
157213769|NCT04380701|567529582|FG030|Overall Study|Physician Decision|0|||
157213770|NCT04380701|567529583|FG031|Overall Study|Physician Decision|0|||
157213771|NCT04380701|567529584|FG032|Overall Study|Physician Decision|0|||
157213772|NCT04380701|567529585|FG033|Overall Study|Physician Decision|0|||
157213773|NCT04380701|567529552|FG000|Overall Study|Death|0|||
157213774|NCT04380701|567529553|FG001|Overall Study|Death|0|||
157213775|NCT04380701|567529554|FG002|Overall Study|Death|0|||
157213776|NCT04380701|567529555|FG003|Overall Study|Death|0|||
157213777|NCT04380701|567529556|FG004|Overall Study|Death|0|||
157213778|NCT04380701|567529557|FG005|Overall Study|Death|0|||
157213779|NCT04380701|567529558|FG006|Overall Study|Death|0|||
157213780|NCT04380701|567529559|FG007|Overall Study|Death|0|||
157213781|NCT04380701|567529560|FG008|Overall Study|Death|0|||
157213782|NCT04380701|567529561|FG009|Overall Study|Death|0|||
157213783|NCT04380701|567529562|FG010|Overall Study|Death|0|||
157213784|NCT04380701|567529563|FG011|Overall Study|Death|0|||
157213785|NCT04380701|567529564|FG012|Overall Study|Death|0|||
157213786|NCT04380701|567529565|FG013|Overall Study|Death|0|||
157213787|NCT04380701|567529566|FG014|Overall Study|Death|0|||
157213788|NCT04380701|567529567|FG015|Overall Study|Death|0|||
157213789|NCT04380701|567529568|FG016|Overall Study|Death|0|||
157213790|NCT04380701|567529569|FG017|Overall Study|Death|0|||
157213791|NCT04380701|567529570|FG018|Overall Study|Death|0|||
157213792|NCT04380701|567529571|FG019|Overall Study|Death|0|||
157213793|NCT04380701|567529572|FG020|Overall Study|Death|0|||
157213794|NCT04380701|567529573|FG021|Overall Study|Death|0|||
157213795|NCT04380701|567529574|FG022|Overall Study|Death|0|||
157213796|NCT04380701|567529575|FG023|Overall Study|Death|0|||
157213797|NCT04380701|567529576|FG024|Overall Study|Death|1|||
157213798|NCT04380701|567529577|FG025|Overall Study|Death|0|||
157213799|NCT04380701|567529578|FG026|Overall Study|Death|0|||
157213800|NCT04380701|567529579|FG027|Overall Study|Death|0|||
157213801|NCT04380701|567529580|FG028|Overall Study|Death|0|||
157213802|NCT04380701|567529581|FG029|Overall Study|Death|0|||
157213803|NCT04380701|567529582|FG030|Overall Study|Death|0|||
157213804|NCT04380701|567529583|FG031|Overall Study|Death|0|||
157213805|NCT04380701|567529584|FG032|Overall Study|Death|0|||
157213806|NCT04380701|567529585|FG033|Overall Study|Death|0|||
157213807|NCT04380701|567529552|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213808|NCT04380701|567529553|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213809|NCT04380701|567529554|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213810|NCT04380701|567529555|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213811|NCT04380701|567529556|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213812|NCT04380701|567529557|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213813|NCT04380701|567529558|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213814|NCT04380701|567529559|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213815|NCT04380701|567529560|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213816|NCT04380701|567529561|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213817|NCT04380701|567529562|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213818|NCT04380701|567529563|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213819|NCT04380701|567529564|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213820|NCT04380701|567529565|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213821|NCT04380701|567529566|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213822|NCT04380701|567529567|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213823|NCT04380701|567529568|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213824|NCT04380701|567529569|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213825|NCT04380701|567529570|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213826|NCT04380701|567529571|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213827|NCT04380701|567529572|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213828|NCT04380701|567529573|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
157213829|NCT04380701|567529574|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
157213830|NCT04380701|567529575|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
157213831|NCT04380701|567529576|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
157213832|NCT04380701|567529577|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213833|NCT04380701|567529578|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213834|NCT04380701|567529579|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213835|NCT04380701|567529580|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213836|NCT04380701|567529581|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213837|NCT04380701|567529582|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213838|NCT04380701|567529583|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213839|NCT04380701|567529584|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213840|NCT04380701|567529585|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
157213841|NCT03550794|567529586|FG000|Overall Study|No longer met inclusion criteria|1|||
157213842|NCT03550794|567529587|FG001|Overall Study|No longer met inclusion criteria|2|||
157213843|NCT03550794|567529586|FG000|Overall Study|Goals of care changed|1|||
157213844|NCT03550794|567529587|FG001|Overall Study|Goals of care changed|0|||
157213845|NCT03550794|567529586|FG000|Overall Study|Withdrawal by Subject|2|||
157213846|NCT03550794|567529587|FG001|Overall Study|Withdrawal by Subject|0|||
157213847|NCT03550794|567529586|FG000|Overall Study|Death|0|||
157213848|NCT03550794|567529587|FG001|Overall Study|Death|1|||
157213849|NCT01864525|567529588|FG000|Overall Study|Adverse Event|1|||
157213850|NCT01864525|567529589|FG001|Overall Study|Adverse Event|0|||
157213851|NCT01890785|567529590|FG000|Third Intervention|Withdrawal by Subject|0|||
157213852|NCT01890785|567529591|FG001|Third Intervention|Withdrawal by Subject|1|||
157213853|NCT01890785|567529592|FG002|Third Intervention|Withdrawal by Subject|0|||
157213854|NCT01890785|567529593|FG003|Third Intervention|Withdrawal by Subject|0|||
157213855|NCT01890785|567529594|FG004|Third Intervention|Withdrawal by Subject|0|||
157213856|NCT01890785|567529595|FG005|Third Intervention|Withdrawal by Subject|0|||
157213857|NCT03296553|567529596|FG000|Overall Study|Withdrawal by Subject|1|||
156684770|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
156684771|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
156684772|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684773|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684774|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
156684775|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
156684776|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684777|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684778|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
156684779|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
156684780|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
156684781|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
156684782|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
156684783|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
156684784|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
156684785|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
156684786|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
156684787|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
157213858|NCT03296553|567529597|FG001|Overall Study|Withdrawal by Subject|1|||
157213859|NCT03296553|567529596|FG000|Overall Study|Death|1|||
157213860|NCT03296553|567529597|FG001|Overall Study|Death|0|||
157120764|NCT04478708|567194264|FG012|Overall Study|Withdrawal of consent from study|0|||
157120765|NCT04478708|567194265|FG013|Overall Study|Withdrawal of consent from study|0|||
157120766|NCT04478708|567194266|FG014|Overall Study|Withdrawal of consent from study|1|||
157120767|NCT04478708|567194267|FG015|Overall Study|Withdrawal of consent from study|0|||
157120768|NCT04478708|567194268|FG016|Overall Study|Withdrawal of consent from study|4|||
157120769|NCT01869114|567194271|FG000|Overall Study|Death|19|||
157120770|NCT01869114|567194272|FG001|Overall Study|Death|18|||
157120771|NCT01869114|567194273|FG002|Overall Study|Death|8|||
157120772|NCT01869114|567194271|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
157120773|NCT01869114|567194272|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
157120774|NCT01869114|567194273|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
157120775|NCT01869114|567194271|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
157120776|NCT01869114|567194272|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
157120777|NCT01869114|567194273|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
157120778|NCT01869114|567194271|FG000|Overall Study|Withdrawal by Subject|0|||
157120779|NCT01869114|567194272|FG001|Overall Study|Withdrawal by Subject|3|||
157120780|NCT01869114|567194273|FG002|Overall Study|Withdrawal by Subject|0|||
157120781|NCT01869114|567194271|FG000|Overall Study|Disease Progression|0|||
157120782|NCT01869114|567194272|FG001|Overall Study|Disease Progression|1|||
157120783|NCT01869114|567194273|FG002|Overall Study|Disease Progression|0|||
157120784|NCT00559507|567194277|FG000|Overall Study|Not treated, patient ineligible|3|||
157120785|NCT01407926|567194278|FG000|Overall Study|Lost to Follow-up|55|||
157120786|NCT04232696|567194280|FG000|Overall Study|Implant attempted but not completed|5|||
157120787|NCT04232696|567194281|FG001|Overall Study|Implant attempted but not completed|2|||
157120788|NCT04232696|567194280|FG000|Overall Study|Not satisfied with therapy outcome|0|||
157120789|NCT04232696|567194281|FG001|Overall Study|Not satisfied with therapy outcome|8|||
157120790|NCT04232696|567194280|FG000|Overall Study|Adverse Event|0|||
157120791|NCT04232696|567194281|FG001|Overall Study|Adverse Event|3|||
157120792|NCT04232696|567194280|FG000|Overall Study|Withdrawal by Subject|0|||
157120793|NCT04232696|567194281|FG001|Overall Study|Withdrawal by Subject|3|||
157120794|NCT04232696|567194280|FG000|Overall Study|Missed Visit|0|||
157120795|NCT04232696|567194281|FG001|Overall Study|Missed Visit|2|||
157120796|NCT04232696|567194280|FG000|Overall Study|Other reason|0|||
157120797|NCT04232696|567194281|FG001|Overall Study|Other reason|1|||
157120798|NCT01678144|567194282|FG000|Stage 1: MAR Classic|Adverse Event|1|||
157120799|NCT03118297|567194283|FG000|Overall Study|Lost to Follow-up|0|||
157120800|NCT03118297|567194284|FG001|Overall Study|Lost to Follow-up|2|||
157120801|NCT02363686|567194290|FG000|Overall Study|Withdrawal by Subject|22|||
157120802|NCT02363686|567194290|FG000|Overall Study|incomplete FEES examinations|13|||
157120803|NCT00493038|567194291|FG000|Treatment|Adverse Event|8|||
157120804|NCT00493038|567194292|FG001|Treatment|Adverse Event|4|||
156784817|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
156784818|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
156784819|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
156784820|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Death|0|||
156784821|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Death|1|||
156784822|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Death|2|||
156784823|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
156784824|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
157120805|NCT00493038|567194291|FG000|Treatment|Lost to Follow-up|5|||
157120806|NCT00493038|567194292|FG001|Treatment|Lost to Follow-up|3|||
157120807|NCT00493038|567194291|FG000|Treatment|Withdrawal by Subject|11|||
157120808|NCT00493038|567194292|FG001|Treatment|Withdrawal by Subject|12|||
157120809|NCT00493038|567194291|FG000|Treatment|Other|0|||
157120810|NCT00493038|567194292|FG001|Treatment|Other|1|||
157120811|NCT00493038|567194291|FG000|Follow-up|Lost to Follow-up|1|||
157120812|NCT00493038|567194292|FG001|Follow-up|Lost to Follow-up|0|||
157120813|NCT01441063|567194293|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
157120814|NCT01441063|567194293|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
157120815|NCT03345472|567194295|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
157120816|NCT03345472|567194295|FG000|Implant to 3 Months|Physician Decision|1|||
157120817|NCT03345472|567194295|FG000|Implant to 3 Months|Adverse Event|1|||
157120818|NCT03345472|567194295|FG000|3 Months to 12 Months|Physician Decision|3|||
157120819|NCT03345472|567194295|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
157120820|NCT03345472|567194295|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
157120821|NCT03345472|567194295|FG000|3 Months to 12 Months|Adverse Event|1|||
157120822|NCT03345472|567194295|FG000|3 Months to 12 Months|Death|1|||
157120823|NCT01290692|567194300|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
157120824|NCT01097863|567194307|FG000|Overall Study|Discomfort|1|||
157120825|NCT01097863|567194308|FG001|Overall Study|Discomfort|0|||
157120826|NCT01097863|567194309|FG002|Overall Study|Discomfort|1|||
157120827|NCT01097863|567194307|FG000|Overall Study|Did not return for final visit|0|||
157120828|NCT01097863|567194308|FG001|Overall Study|Did not return for final visit|0|||
157120829|NCT01097863|567194309|FG002|Overall Study|Did not return for final visit|1|||
157120830|NCT03099707|567194310|FG000|Overall Study|Withdrawal by Subject|0|||
157013238|NCT02723955|566801760|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156784825|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
156784826|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
156784827|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
156784828|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
156784829|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
156784830|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
156784831|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
156784832|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
156784833|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
156784834|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
156784835|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
156784836|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
156784837|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
156784838|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
156784839|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
156784840|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
156784841|NCT04676646|565963270|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
156784842|NCT04676646|565963271|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
156784843|NCT04676646|565963272|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
156784844|NCT04270760|565963273|FG000|Overall Study|Withdrawal by Subject|0|||
156784845|NCT04270760|565963274|FG001|Overall Study|Withdrawal by Subject|1|||
156784846|NCT04270760|565963275|FG002|Overall Study|Withdrawal by Subject|3|||
156784847|NCT04270760|565963276|FG003|Overall Study|Withdrawal by Subject|0|||
156784848|NCT04270760|565963277|FG004|Overall Study|Withdrawal by Subject|0|||
156784849|NCT04270760|565963273|FG000|Overall Study|Lost to Follow-up|1|||
156784850|NCT04270760|565963274|FG001|Overall Study|Lost to Follow-up|2|||
156784851|NCT04270760|565963275|FG002|Overall Study|Lost to Follow-up|1|||
156784852|NCT04270760|565963276|FG003|Overall Study|Lost to Follow-up|0|||
156784853|NCT04270760|565963277|FG004|Overall Study|Lost to Follow-up|0|||
156784854|NCT04270760|565963273|FG000|Overall Study|Death|0|||
156784855|NCT04270760|565963274|FG001|Overall Study|Death|0|||
156784856|NCT04270760|565963275|FG002|Overall Study|Death|0|||
156784857|NCT04270760|565963276|FG003|Overall Study|Death|0|||
156784858|NCT04270760|565963277|FG004|Overall Study|Death|1|||
156784859|NCT05156125|565963278|FG000|Overall Study|Lack of Efficacy|1|||
156784860|NCT05156125|565963279|FG001|Overall Study|Lack of Efficacy|1|||
156784861|NCT05156125|565963280|FG002|Overall Study|Lack of Efficacy|1|||
156784862|NCT05156125|565963278|FG000|Overall Study|Physician Decision|0|||
156784863|NCT05156125|565963279|FG001|Overall Study|Physician Decision|0|||
156784864|NCT05156125|565963280|FG002|Overall Study|Physician Decision|1|||
156784865|NCT05156125|565963278|FG000|Overall Study|Non-compliance|0|||
156784866|NCT05156125|565963279|FG001|Overall Study|Non-compliance|1|||
156784867|NCT05156125|565963280|FG002|Overall Study|Non-compliance|1|||
156784868|NCT05156125|565963278|FG000|Overall Study|Withdrawal by Subject|0|||
156784869|NCT05156125|565963279|FG001|Overall Study|Withdrawal by Subject|0|||
156784870|NCT05156125|565963280|FG002|Overall Study|Withdrawal by Subject|1|||
156784871|NCT05156125|565963278|FG000|Overall Study|Adverse Event|2|||
156784872|NCT05156125|565963279|FG001|Overall Study|Adverse Event|1|||
156784873|NCT05156125|565963280|FG002|Overall Study|Adverse Event|0|||
156784874|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|No Data|249|||
156784875|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|No Data|66|||
156784876|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|No Data|2|||
156784877|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Other|33|||
156784878|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Other|20|||
156784879|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Other|0|||
156784880|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
156784881|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
156784882|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
156784883|NCT01623752|565963283|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
157013239|NCT02723955|566801761|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013240|NCT02723955|566801762|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013241|NCT02723955|566801763|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013242|NCT02723955|566801764|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
156784884|NCT01623752|565963284|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
157013243|NCT02723955|566801765|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013244|NCT02723955|566801766|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013245|NCT02723955|566801767|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
156684788|NCT02960438|565590652|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
156684789|NCT02960438|565590653|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
156684790|NCT02960438|565590654|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
156684791|NCT02960438|565590655|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
156684792|NCT01522950|565590656|FG000|Overall Study|Withdrawal by Subject|3|||
156684793|NCT01522950|565590657|FG001|Overall Study|Withdrawal by Subject|2|||
156684794|NCT01522950|565590658|FG002|Overall Study|Withdrawal by Subject|1|||
156684795|NCT01522950|565590656|FG000|Overall Study|Adverse Event|3|||
156684796|NCT01522950|565590657|FG001|Overall Study|Adverse Event|1|||
156684797|NCT01522950|565590658|FG002|Overall Study|Adverse Event|1|||
156684798|NCT01522950|565590656|FG000|Overall Study|Protocol Violation|0|||
156684799|NCT01522950|565590657|FG001|Overall Study|Protocol Violation|0|||
156684800|NCT01522950|565590658|FG002|Overall Study|Protocol Violation|2|||
156684801|NCT01522950|565590656|FG000|Overall Study|Death|0|||
156684802|NCT01522950|565590657|FG001|Overall Study|Death|1|||
156684803|NCT01522950|565590658|FG002|Overall Study|Death|1|||
156684804|NCT01522950|565590656|FG000|Overall Study|Study Medication Sensitivity|0|||
156684805|NCT01522950|565590657|FG001|Overall Study|Study Medication Sensitivity|1|||
156684806|NCT01522950|565590658|FG002|Overall Study|Study Medication Sensitivity|0|||
156684807|NCT03036839|565590661|FG000|Overall Study|Adverse Event|0|||
156684808|NCT03036839|565590662|FG001|Overall Study|Adverse Event|0|||
156684809|NCT03036839|565590663|FG002|Overall Study|Adverse Event|1|||
156684810|NCT03036839|565590661|FG000|Overall Study|Death|3|||
156684811|NCT03036839|565590662|FG001|Overall Study|Death|0|||
156684812|NCT03036839|565590663|FG002|Overall Study|Death|3|||
156684813|NCT03036839|565590661|FG000|Overall Study|Withdrew Consent|0|||
156684814|NCT03036839|565590662|FG001|Overall Study|Withdrew Consent|0|||
156684815|NCT03036839|565590663|FG002|Overall Study|Withdrew Consent|1|||
156684816|NCT00412737|565590665|FG000|Overall Study|Death|1|||
156684817|NCT00412737|565590666|FG001|Overall Study|Death|0|||
156684818|NCT00412737|565590665|FG000|Overall Study|Adverse Event|3|||
156684819|NCT00412737|565590666|FG001|Overall Study|Adverse Event|2|||
156684820|NCT00412737|565590665|FG000|Overall Study|Refused Treatment|6|||
156684821|NCT00412737|565590666|FG001|Overall Study|Refused Treatment|2|||
156684822|NCT00412737|565590665|FG000|Overall Study|Failure to Return|6|||
156684823|NCT00412737|565590666|FG001|Overall Study|Failure to Return|2|||
156684824|NCT01652729|565590672|FG000|Overall Study|Withdrawal by Subject|14|||
156684825|NCT01652729|565590673|FG001|Overall Study|Withdrawal by Subject|7|||
156684826|NCT01652729|565590674|FG002|Overall Study|Withdrawal by Subject|7|||
156684827|NCT01652729|565590672|FG000|Overall Study|Adverse Event|4|||
156684828|NCT01652729|565590673|FG001|Overall Study|Adverse Event|0|||
156684829|NCT01652729|565590674|FG002|Overall Study|Adverse Event|3|||
156684830|NCT01652729|565590672|FG000|Overall Study|Physician Decision|1|||
156684831|NCT01652729|565590673|FG001|Overall Study|Physician Decision|0|||
156684832|NCT01652729|565590674|FG002|Overall Study|Physician Decision|1|||
156684833|NCT01652729|565590672|FG000|Overall Study|Protocol Violation|1|||
156684834|NCT01652729|565590673|FG001|Overall Study|Protocol Violation|0|||
156684835|NCT01652729|565590674|FG002|Overall Study|Protocol Violation|0|||
156684836|NCT01652729|565590672|FG000|Overall Study|Lost to Follow-up|6|||
156684837|NCT01652729|565590673|FG001|Overall Study|Lost to Follow-up|6|||
156684838|NCT01652729|565590674|FG002|Overall Study|Lost to Follow-up|3|||
156684839|NCT01652729|565590672|FG000|Overall Study|Administrative|1|||
156684840|NCT01652729|565590673|FG001|Overall Study|Administrative|0|||
156684841|NCT01652729|565590674|FG002|Overall Study|Administrative|0|||
156684842|NCT00483548|565590675|FG000|Overall Study|Randomized; not treated with study drug|1|||
156684843|NCT00483548|565590676|FG001|Overall Study|Randomized; not treated with study drug|3|||
156684844|NCT00483548|565590675|FG000|Overall Study|Adverse Event|25|||
156684845|NCT00483548|565590676|FG001|Overall Study|Adverse Event|14|||
156684846|NCT00483548|565590675|FG000|Overall Study|Laboratory abnormality|1|||
156684847|NCT00483548|565590676|FG001|Overall Study|Laboratory abnormality|2|||
156684848|NCT00483548|565590675|FG000|Overall Study|Lack of Efficacy|4|||
156684849|NCT00483548|565590676|FG001|Overall Study|Lack of Efficacy|8|||
156684850|NCT00483548|565590675|FG000|Overall Study|Protocol Violation|11|||
156684851|NCT00483548|565590676|FG001|Overall Study|Protocol Violation|7|||
156684852|NCT00483548|565590675|FG000|Overall Study|Pregnancy|1|||
156684853|NCT00483548|565590676|FG001|Overall Study|Pregnancy|0|||
156684854|NCT00483548|565590675|FG000|Overall Study|Protocol required discontinuation|6|||
156684855|NCT00483548|565590676|FG001|Overall Study|Protocol required discontinuation|6|||
156684856|NCT00483548|565590675|FG000|Overall Study|Unable to comply with protocol schedule|1|||
156684857|NCT00483548|565590676|FG001|Overall Study|Unable to comply with protocol schedule|0|||
156684858|NCT00483548|565590675|FG000|Overall Study|Non-compliance with medication|2|||
156684859|NCT00483548|565590676|FG001|Overall Study|Non-compliance with medication|0|||
156684860|NCT00483548|565590675|FG000|Overall Study|Lost to Follow-up|3|||
156684861|NCT00483548|565590676|FG001|Overall Study|Lost to Follow-up|4|||
156684862|NCT00483548|565590675|FG000|Overall Study|Withdrawal by Subject|5|||
156784885|NCT01623752|565963285|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
156784886|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
156784887|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
156784888|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
156784889|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Other|5|||
156784890|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Other|1|||
156784891|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Other|0|||
156784892|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|No Data|43|||
156784893|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|No Data|11|||
156784894|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|No Data|0|||
156784895|NCT01623752|565963283|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
156784896|NCT01623752|565963284|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
156784897|NCT01623752|565963285|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
156784898|NCT01755637|565963287|FG000|Period 1|Adverse Event|0|||
156784899|NCT01755637|565963288|FG001|Period 1|Adverse Event|1|||
156784900|NCT01814332|565963289|FG000|Overall Study|Adverse Event|8|||
156784901|NCT01814332|565963290|FG001|Overall Study|Adverse Event|3|||
156784902|NCT01814332|565963289|FG000|Overall Study|Withdrawal by Subject|3|||
156784903|NCT01814332|565963290|FG001|Overall Study|Withdrawal by Subject|8|||
156784904|NCT01814332|565963289|FG000|Overall Study|Protocol Violation|0|||
156784905|NCT01814332|565963290|FG001|Overall Study|Protocol Violation|4|||
156784906|NCT01814332|565963289|FG000|Overall Study|Lost to Follow-up|5|||
156784907|NCT01814332|565963290|FG001|Overall Study|Lost to Follow-up|1|||
156784908|NCT04389671|565963291|FG000|Overall Study|Death|7|||
156784909|NCT03338023|565963292|FG000|Overall Study|Withdrawal by Subject|3|||
156784910|NCT03338023|565963293|FG001|Overall Study|Withdrawal by Subject|4|||
156784911|NCT03338023|565963292|FG000|Overall Study|Protocol Violation|3|||
156784912|NCT03338023|565963293|FG001|Overall Study|Protocol Violation|3|||
156784913|NCT03338023|565963292|FG000|Overall Study|Lost to Follow-up|2|||
156784914|NCT03338023|565963293|FG001|Overall Study|Lost to Follow-up|1|||
156784915|NCT03338023|565963292|FG000|Overall Study|Physician Decision|1|||
156784916|NCT03338023|565963293|FG001|Overall Study|Physician Decision|2|||
156784917|NCT04996264|565963294|FG000|Overall Study|Lost to Follow-up|0|||
156784918|NCT04996264|565963295|FG001|Overall Study|Lost to Follow-up|1|||
156784919|NCT04996264|565963294|FG000|Overall Study|Withdrawal by Subject|4|||
156784920|NCT04996264|565963295|FG001|Overall Study|Withdrawal by Subject|3|||
156784921|NCT04996264|565963294|FG000|Overall Study|1 left AMA|0|||
156784922|NCT04996264|565963295|FG001|Overall Study|1 left AMA|1|||
156784923|NCT04996264|565963294|FG000|Overall Study|Subject changed hospitals|0|||
156784924|NCT04996264|565963295|FG001|Overall Study|Subject changed hospitals|1|||
156784925|NCT04996264|565963294|FG000|Overall Study|unable to complete due to work|0|||
156784926|NCT04996264|565963295|FG001|Overall Study|unable to complete due to work|1|||
156784927|NCT00685698|565963296|FG000|Overall Study|Withdrawal by Subject|1|||
156784928|NCT00685698|565963296|FG000|Overall Study|Protocol Violation|6|||
156784929|NCT00685698|565963296|FG000|Overall Study|Adverse Event|3|||
156784930|NCT00685698|565963296|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
156784931|NCT00685698|565963296|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
156784932|NCT00685698|565963296|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
156784933|NCT02030418|565963297|FG000|Overall Study|Death|78|||
156784934|NCT02030418|565963297|FG000|Overall Study|Missed 12-Month Visit|9|||
156784935|NCT02030418|565963297|FG000|Overall Study|Withdrawn|57|||
156784936|NCT03412890|565963308|FG000|Overall Study|Adverse Event|5|||
156784937|NCT03412890|565963309|FG001|Overall Study|Adverse Event|5|||
156784938|NCT03412890|565963310|FG002|Overall Study|Adverse Event|9|||
156784939|NCT03412890|565963308|FG000|Overall Study|Protocol deviation|2|||
156784940|NCT03412890|565963309|FG001|Overall Study|Protocol deviation|1|||
156784941|NCT03412890|565963310|FG002|Overall Study|Protocol deviation|2|||
156784942|NCT03412890|565963308|FG000|Overall Study|Lost to Follow-up|7|||
156784943|NCT03412890|565963309|FG001|Overall Study|Lost to Follow-up|10|||
156784944|NCT03412890|565963310|FG002|Overall Study|Lost to Follow-up|10|||
156784945|NCT03412890|565963308|FG000|Overall Study|Withdrawal by Subject|9|||
156784946|NCT03412890|565963309|FG001|Overall Study|Withdrawal by Subject|12|||
156784947|NCT03412890|565963310|FG002|Overall Study|Withdrawal by Subject|11|||
156784948|NCT03412890|565963308|FG000|Overall Study|Lack of Efficacy|2|||
156784949|NCT03412890|565963309|FG001|Overall Study|Lack of Efficacy|7|||
156784950|NCT03412890|565963310|FG002|Overall Study|Lack of Efficacy|5|||
156784951|NCT03412890|565963308|FG000|Overall Study|Other|5|||
156784952|NCT03412890|565963309|FG001|Overall Study|Other|6|||
156784953|NCT03412890|565963310|FG002|Overall Study|Other|5|||
156784954|NCT03412890|565963308|FG000|Overall Study|Participants who did not receive any study drug|0|||
156784955|NCT03412890|565963309|FG001|Overall Study|Participants who did not receive any study drug|1|||
156784956|NCT03412890|565963310|FG002|Overall Study|Participants who did not receive any study drug|0|||
156784957|NCT02583477|565963312|FG000|Overall Study|Adverse Event|0|||
156784958|NCT02583477|565963313|FG001|Overall Study|Adverse Event|2|||
156784959|NCT02583477|565963312|FG000|Overall Study|Death|1|||
156784960|NCT02583477|565963313|FG001|Overall Study|Death|16|||
156784961|NCT02583477|565963312|FG000|Overall Study|Study terminated|2|||
156784962|NCT02583477|565963313|FG001|Overall Study|Study terminated|2|||
156784963|NCT05507450|565963314|FG000|Overall Study|Death|0|||
156784964|NCT05507450|565963315|FG001|Overall Study|Death|0|||
156784965|NCT05507450|565963316|FG002|Overall Study|Death|1|||
156784966|NCT05507450|565963317|FG003|Overall Study|Death|0|||
156784967|NCT05507450|565963314|FG000|Overall Study|Lost to Follow-up|22|||
156784968|NCT05507450|565963315|FG001|Overall Study|Lost to Follow-up|20|||
156784969|NCT05507450|565963316|FG002|Overall Study|Lost to Follow-up|20|||
156784970|NCT05507450|565963317|FG003|Overall Study|Lost to Follow-up|7|||
156784971|NCT05507450|565963314|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156784972|NCT05507450|565963315|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156784973|NCT05507450|565963316|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156784974|NCT05507450|565963317|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156784975|NCT05507450|565963314|FG000|Overall Study|Withdrawal by Subject|4|||
156784976|NCT05507450|565963315|FG001|Overall Study|Withdrawal by Subject|11|||
156784977|NCT05507450|565963316|FG002|Overall Study|Withdrawal by Subject|7|||
156784978|NCT05507450|565963317|FG003|Overall Study|Withdrawal by Subject|3|||
156784979|NCT05507450|565963314|FG000|Overall Study|Participant left the country|0|||
156784980|NCT05507450|565963315|FG001|Overall Study|Participant left the country|0|||
156784981|NCT05507450|565963316|FG002|Overall Study|Participant left the country|1|||
156784982|NCT05507450|565963317|FG003|Overall Study|Participant left the country|0|||
156784983|NCT05436288|565963319|FG000|Overall Study|Lost to Follow-up|1|||
156784984|NCT05436288|565963319|FG000|Overall Study|Adverse Event|1|||
156784985|NCT03767894|565963325|FG000|Overall Study|Withdrawal by Subject|1|||
156784986|NCT01436500|565963328|FG000|Overall Study|Death|1|||
156784987|NCT01436500|565963329|FG001|Overall Study|Death|0|||
156784988|NCT01436500|565963330|FG002|Overall Study|Death|0|||
156784989|NCT01436500|565963331|FG003|Overall Study|Death|0|||
156784990|NCT01436500|565963332|FG004|Overall Study|Death|0|||
156784991|NCT01436500|565963328|FG000|Overall Study|Adverse Event|0|||
156784992|NCT01436500|565963329|FG001|Overall Study|Adverse Event|2|||
156784993|NCT01436500|565963330|FG002|Overall Study|Adverse Event|2|||
156784994|NCT01436500|565963331|FG003|Overall Study|Adverse Event|0|||
156784995|NCT01436500|565963332|FG004|Overall Study|Adverse Event|1|||
156784996|NCT01436500|565963328|FG000|Overall Study|Withdrawal by Subject|0|||
156784997|NCT01436500|565963329|FG001|Overall Study|Withdrawal by Subject|0|||
156784998|NCT01436500|565963330|FG002|Overall Study|Withdrawal by Subject|2|||
156784999|NCT01436500|565963331|FG003|Overall Study|Withdrawal by Subject|0|||
156785000|NCT01436500|565963332|FG004|Overall Study|Withdrawal by Subject|2|||
156785001|NCT01436500|565963328|FG000|Overall Study|Physician Decision|0|||
156785002|NCT01436500|565963329|FG001|Overall Study|Physician Decision|0|||
156785003|NCT01436500|565963330|FG002|Overall Study|Physician Decision|1|||
156785004|NCT01436500|565963331|FG003|Overall Study|Physician Decision|0|||
156785005|NCT01436500|565963332|FG004|Overall Study|Physician Decision|0|||
156785006|NCT01436500|565963328|FG000|Overall Study|liver transplant|1|||
156785007|NCT01436500|565963329|FG001|Overall Study|liver transplant|0|||
156785008|NCT01436500|565963330|FG002|Overall Study|liver transplant|0|||
156785009|NCT01436500|565963331|FG003|Overall Study|liver transplant|0|||
156785010|NCT01436500|565963332|FG004|Overall Study|liver transplant|0|||
156785011|NCT01436500|565963328|FG000|Overall Study|initiation of dialysis|0|||
157120831|NCT03099707|567194311|FG001|Overall Study|Withdrawal by Subject|3|||
157120832|NCT03099707|567194310|FG000|Overall Study|Lost to Follow-up|0|||
157120833|NCT03099707|567194311|FG001|Overall Study|Lost to Follow-up|1|||
157120834|NCT03167073|567194312|FG000|Overall Study|Stillbirth|1|||
157120835|NCT03167073|567194313|FG001|Overall Study|Stillbirth|0|||
157120836|NCT00689871|567194321|FG000|Overall Study|Lost to Follow-up|123|||
157120837|NCT00689871|567194322|FG001|Overall Study|Lost to Follow-up|13|||
157120838|NCT00689871|567194323|FG002|Overall Study|Lost to Follow-up|37|||
157120839|NCT00689871|567194324|FG003|Overall Study|Lost to Follow-up|1|||
157120840|NCT00689871|567194321|FG000|Overall Study|Explanted of All Study Devices|36|||
157120841|NCT00689871|567194322|FG001|Overall Study|Explanted of All Study Devices|25|||
157120842|NCT00689871|567194323|FG002|Overall Study|Explanted of All Study Devices|29|||
157120843|NCT00689871|567194324|FG003|Overall Study|Explanted of All Study Devices|3|||
157120844|NCT00689871|567194321|FG000|Overall Study|Withdrawal by Subject|13|||
157120845|NCT00689871|567194322|FG001|Overall Study|Withdrawal by Subject|3|||
157120846|NCT00689871|567194323|FG002|Overall Study|Withdrawal by Subject|4|||
157120847|NCT00689871|567194324|FG003|Overall Study|Withdrawal by Subject|1|||
157120848|NCT00689871|567194321|FG000|Overall Study|Death|1|||
157120849|NCT00689871|567194322|FG001|Overall Study|Death|10|||
157120850|NCT00689871|567194323|FG002|Overall Study|Death|2|||
156785012|NCT01436500|565963329|FG001|Overall Study|initiation of dialysis|0|||
156785013|NCT01436500|565963330|FG002|Overall Study|initiation of dialysis|0|||
156785014|NCT01436500|565963331|FG003|Overall Study|initiation of dialysis|0|||
156785015|NCT01436500|565963332|FG004|Overall Study|initiation of dialysis|1|||
156785016|NCT01436500|565963328|FG000|Overall Study|discontinued study drug|1|||
157120851|NCT00689871|567194324|FG003|Overall Study|Death|2|||
156785017|NCT01436500|565963329|FG001|Overall Study|discontinued study drug|0|||
156785018|NCT01436500|565963330|FG002|Overall Study|discontinued study drug|0|||
156785019|NCT01436500|565963331|FG003|Overall Study|discontinued study drug|0|||
157120852|NCT00689871|567194321|FG000|Overall Study|Physician Decision|2|||
157120853|NCT00689871|567194322|FG001|Overall Study|Physician Decision|1|||
156868419|NCT00068692|566277312|FG004|Step 1: Registration|Withdrawal by Subject|0|||
156868420|NCT00068692|566277313|FG005|Step 1: Registration|Withdrawal by Subject|0|||
156868421|NCT00068692|566277314|FG006|Step 1: Registration|Withdrawal by Subject|0|||
156868422|NCT00068692|566277315|FG007|Step 1: Registration|Withdrawal by Subject|0|||
156868423|NCT00068692|566277308|FG000|Step 1: Registration|Alternative therapy|2|||
156868424|NCT00068692|566277309|FG001|Step 1: Registration|Alternative therapy|0|||
156868425|NCT00068692|566277310|FG002|Step 1: Registration|Alternative therapy|0|||
156868426|NCT00068692|566277311|FG003|Step 1: Registration|Alternative therapy|0|||
156868427|NCT00068692|566277312|FG004|Step 1: Registration|Alternative therapy|0|||
156868428|NCT00068692|566277313|FG005|Step 1: Registration|Alternative therapy|0|||
156868429|NCT00068692|566277314|FG006|Step 1: Registration|Alternative therapy|0|||
156868430|NCT00068692|566277315|FG007|Step 1: Registration|Alternative therapy|0|||
156868431|NCT00068692|566277308|FG000|Step 1: Registration|Complicating disease|2|||
156868432|NCT00068692|566277309|FG001|Step 1: Registration|Complicating disease|0|||
156868433|NCT00068692|566277310|FG002|Step 1: Registration|Complicating disease|0|||
156868434|NCT00068692|566277311|FG003|Step 1: Registration|Complicating disease|0|||
156868435|NCT00068692|566277312|FG004|Step 1: Registration|Complicating disease|0|||
156868436|NCT00068692|566277313|FG005|Step 1: Registration|Complicating disease|0|||
156868437|NCT00068692|566277314|FG006|Step 1: Registration|Complicating disease|0|||
156868438|NCT00068692|566277315|FG007|Step 1: Registration|Complicating disease|0|||
156868439|NCT00068692|566277308|FG000|Step 1: Registration|Protocol Violation|1|||
156868440|NCT00068692|566277309|FG001|Step 1: Registration|Protocol Violation|0|||
156868441|NCT00068692|566277310|FG002|Step 1: Registration|Protocol Violation|0|||
156868442|NCT00068692|566277311|FG003|Step 1: Registration|Protocol Violation|0|||
156868443|NCT00068692|566277312|FG004|Step 1: Registration|Protocol Violation|0|||
156868444|NCT00068692|566277313|FG005|Step 1: Registration|Protocol Violation|0|||
156868445|NCT00068692|566277314|FG006|Step 1: Registration|Protocol Violation|0|||
156868446|NCT00068692|566277315|FG007|Step 1: Registration|Protocol Violation|0|||
156868447|NCT00068692|566277308|FG000|Step 1: Registration|Not eligible|6|||
156868448|NCT00068692|566277309|FG001|Step 1: Registration|Not eligible|0|||
156868449|NCT00068692|566277310|FG002|Step 1: Registration|Not eligible|0|||
156868450|NCT00068692|566277311|FG003|Step 1: Registration|Not eligible|0|||
156868451|NCT00068692|566277312|FG004|Step 1: Registration|Not eligible|0|||
156868452|NCT00068692|566277313|FG005|Step 1: Registration|Not eligible|0|||
156868453|NCT00068692|566277314|FG006|Step 1: Registration|Not eligible|0|||
156868454|NCT00068692|566277315|FG007|Step 1: Registration|Not eligible|0|||
156868455|NCT00068692|566277308|FG000|Step 1: Registration|Other|2|||
156868456|NCT00068692|566277309|FG001|Step 1: Registration|Other|0|||
156868457|NCT00068692|566277310|FG002|Step 1: Registration|Other|0|||
156868458|NCT00068692|566277311|FG003|Step 1: Registration|Other|0|||
156868459|NCT00068692|566277312|FG004|Step 1: Registration|Other|0|||
156868460|NCT00068692|566277313|FG005|Step 1: Registration|Other|0|||
156868461|NCT00068692|566277314|FG006|Step 1: Registration|Other|0|||
156868462|NCT00068692|566277315|FG007|Step 1: Registration|Other|0|||
156868463|NCT00068692|566277308|FG000|Step 1: Registration|Not start protocol therapy|3|||
156868464|NCT00068692|566277309|FG001|Step 1: Registration|Not start protocol therapy|0|||
156868465|NCT00068692|566277310|FG002|Step 1: Registration|Not start protocol therapy|0|||
156868466|NCT00068692|566277311|FG003|Step 1: Registration|Not start protocol therapy|0|||
156868467|NCT00068692|566277312|FG004|Step 1: Registration|Not start protocol therapy|0|||
156868468|NCT00068692|566277313|FG005|Step 1: Registration|Not start protocol therapy|0|||
156868469|NCT00068692|566277314|FG006|Step 1: Registration|Not start protocol therapy|0|||
156868470|NCT00068692|566277315|FG007|Step 1: Registration|Not start protocol therapy|0|||
156868471|NCT00068692|566277308|FG000|Step 1: Registration|Registered but not randomized|0|||
156868472|NCT00068692|566277309|FG001|Step 1: Registration|Registered but not randomized|1|||
156868473|NCT00068692|566277310|FG002|Step 1: Registration|Registered but not randomized|0|||
156868474|NCT00068692|566277311|FG003|Step 1: Registration|Registered but not randomized|0|||
156868475|NCT00068692|566277312|FG004|Step 1: Registration|Registered but not randomized|0|||
156868476|NCT00068692|566277313|FG005|Step 1: Registration|Registered but not randomized|0|||
156868477|NCT00068692|566277314|FG006|Step 1: Registration|Registered but not randomized|0|||
157120854|NCT00689871|567194323|FG002|Overall Study|Physician Decision|1|||
157120855|NCT00689871|567194324|FG003|Overall Study|Physician Decision|0|||
157120856|NCT00562354|567194325|FG000|Overall Study|Physician Decision|0|||
157120857|NCT00562354|567194326|FG001|Overall Study|Physician Decision|1|||
157120858|NCT00562354|567194325|FG000|Overall Study|Lost to Follow-up|0|||
157120859|NCT00562354|567194326|FG001|Overall Study|Lost to Follow-up|1|||
156868478|NCT00068692|566277315|FG007|Step 1: Registration|Registered but not randomized|0|||
156868479|NCT00068692|566277308|FG000|Step 2: Randomization|Disesae progression/replase|0|||
156868480|NCT00068692|566277309|FG001|Step 2: Randomization|Disesae progression/replase|0|||
156868481|NCT00068692|566277310|FG002|Step 2: Randomization|Disesae progression/replase|1|||
156868482|NCT00068692|566277311|FG003|Step 2: Randomization|Disesae progression/replase|1|||
156868483|NCT00068692|566277312|FG004|Step 2: Randomization|Disesae progression/replase|0|||
156868484|NCT00068692|566277313|FG005|Step 2: Randomization|Disesae progression/replase|0|||
157120860|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
157120861|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
156684863|NCT00483548|565590676|FG001|Overall Study|Withdrawal by Subject|2|||
156684864|NCT04364737|565590680|FG000|Overall Study|Withdrawal by Subject|4|||
156684865|NCT04364737|565590681|FG001|Overall Study|Withdrawal by Subject|9|||
156684866|NCT04364737|565590680|FG000|Overall Study|Lost to Follow-up|1|||
156684867|NCT04364737|565590681|FG001|Overall Study|Lost to Follow-up|1|||
156684868|NCT00868296|565590683|FG000|Overall Study|Adverse Event|0|||
156684869|NCT00868296|565590684|FG001|Overall Study|Adverse Event|2|||
156684870|NCT00868296|565590683|FG000|Overall Study|Withdrawal by Subject|0|||
156684871|NCT00868296|565590684|FG001|Overall Study|Withdrawal by Subject|1|||
156684872|NCT04205162|565590698|FG000|Overall Study|Lost to Follow-up|1|||
156684873|NCT04205162|565590699|FG001|Overall Study|Lost to Follow-up|0|||
156684874|NCT04205162|565590698|FG000|Overall Study|Withdrawal by Subject|2|||
156684875|NCT04205162|565590699|FG001|Overall Study|Withdrawal by Subject|0|||
156684876|NCT04205162|565590698|FG000|Overall Study|University closure due to COVID-19|1|||
156684877|NCT04205162|565590699|FG001|Overall Study|University closure due to COVID-19|0|||
156684878|NCT01999894|565590700|FG000|Overall Study|Adverse Event|9|||
156684879|NCT01999894|565590700|FG000|Overall Study|Lack of Efficacy|5|||
156684880|NCT01999894|565590700|FG000|Overall Study|Protocol Violation|1|||
156684881|NCT01999894|565590700|FG000|Overall Study|Withdrawal by Subject|7|||
156684882|NCT01999894|565590700|FG000|Overall Study|Lost to Follow-up|10|||
156684883|NCT01999894|565590700|FG000|Overall Study|Other Reason|3|||
156684884|NCT01999894|565590700|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156684885|NCT00372996|565590702|FG000|Overall Study|Death|11|||
156684886|NCT00372996|565590703|FG001|Overall Study|Death|4|||
156684887|NCT00372996|565590704|FG002|Overall Study|Death|8|||
156684888|NCT00372996|565590705|FG003|Overall Study|Death|7|||
156684889|NCT00372996|565590702|FG000|Overall Study|Lost to Follow-up|0|||
156684890|NCT00372996|565590703|FG001|Overall Study|Lost to Follow-up|2|||
156684891|NCT00372996|565590704|FG002|Overall Study|Lost to Follow-up|0|||
156684892|NCT00372996|565590705|FG003|Overall Study|Lost to Follow-up|1|||
156684893|NCT00372996|565590702|FG000|Overall Study|Withdrawal by Subject|12|||
156684894|NCT00372996|565590703|FG001|Overall Study|Withdrawal by Subject|6|||
156684895|NCT00372996|565590704|FG002|Overall Study|Withdrawal by Subject|9|||
156684896|NCT00372996|565590705|FG003|Overall Study|Withdrawal by Subject|5|||
156684897|NCT00372996|565590702|FG000|Overall Study|Study Terminated by Sponsor|4|||
156684898|NCT00372996|565590703|FG001|Overall Study|Study Terminated by Sponsor|0|||
156684899|NCT00372996|565590704|FG002|Overall Study|Study Terminated by Sponsor|4|||
156684900|NCT00372996|565590705|FG003|Overall Study|Study Terminated by Sponsor|0|||
156684901|NCT00372996|565590702|FG000|Overall Study|Other|10|||
156684902|NCT00372996|565590703|FG001|Overall Study|Other|2|||
156684903|NCT00372996|565590704|FG002|Overall Study|Other|7|||
156684904|NCT00372996|565590705|FG003|Overall Study|Other|7|||
156684905|NCT01186016|565590706|FG000|Overall Study|Withdrawal by Subject|46|||
156684906|NCT01186016|565590707|FG001|Overall Study|Withdrawal by Subject|29|||
156684907|NCT03750695|565590709|FG000|Overall Study|Lost to Follow-up|0|||
156684908|NCT03750695|565590710|FG001|Overall Study|Lost to Follow-up|1|||
156684909|NCT01098539|565590711|FG000|Overall Study|Adverse Event|26|||
156684910|NCT01098539|565590712|FG001|Overall Study|Adverse Event|26|||
156684911|NCT01098539|565590711|FG000|Overall Study|Protocol Violation|1|||
156684912|NCT01098539|565590712|FG001|Overall Study|Protocol Violation|4|||
156684913|NCT01098539|565590711|FG000|Overall Study|Noncompliance|3|||
156684914|NCT01098539|565590712|FG001|Overall Study|Noncompliance|5|||
156684915|NCT01098539|565590711|FG000|Overall Study|Lost to Follow-up|4|||
156684916|NCT01098539|565590712|FG001|Overall Study|Lost to Follow-up|4|||
156684917|NCT01098539|565590711|FG000|Overall Study|Withdrawal by Subject|12|||
156684918|NCT01098539|565590712|FG001|Overall Study|Withdrawal by Subject|26|||
156684919|NCT01098539|565590711|FG000|Overall Study|Physician Decision|5|||
156684920|NCT01098539|565590712|FG001|Overall Study|Physician Decision|3|||
156684921|NCT03173560|565590713|FG000|Overall Study|Death|70|||
156684922|NCT03173560|565590714|FG001|Overall Study|Death|60|||
156684923|NCT03173560|565590713|FG000|Overall Study|Lost to Follow-up|1|||
156684924|NCT03173560|565590714|FG001|Overall Study|Lost to Follow-up|4|||
156684925|NCT03173560|565590713|FG000|Overall Study|Withdrawal by Subject|10|||
156684926|NCT03173560|565590714|FG001|Overall Study|Withdrawal by Subject|5|||
156684927|NCT03173560|565590713|FG000|Overall Study|Other|0|||
156684928|NCT03173560|565590714|FG001|Overall Study|Other|1|||
156684929|NCT02661022|565590715|FG000|Overall Study|Withdrawal by Subject|3|||
156684930|NCT02661022|565590716|FG001|Overall Study|Withdrawal by Subject|0|||
156684931|NCT02661022|565590715|FG000|Overall Study|Adverse Event|1|||
156684932|NCT02661022|565590716|FG001|Overall Study|Adverse Event|1|||
156684933|NCT02661022|565590715|FG000|Overall Study|Physician Decision|1|||
156684934|NCT02661022|565590716|FG001|Overall Study|Physician Decision|0|||
156785020|NCT01436500|565963332|FG004|Overall Study|discontinued study drug|0|||
156684935|NCT02661022|565590715|FG000|Overall Study|Progressive Disease|2|||
156684936|NCT02661022|565590716|FG001|Overall Study|Progressive Disease|1|||
156684937|NCT00732160|565590717|FG000|Overall Study|Adverse Event|1|||
156684938|NCT00732160|565590718|FG001|Overall Study|Adverse Event|0|||
156684939|NCT00732160|565590719|FG002|Overall Study|Adverse Event|1|||
156684940|NCT00732160|565590720|FG003|Overall Study|Adverse Event|1|||
156785021|NCT01436500|565963328|FG000|Overall Study|Other|0|||
157213861|NCT00558519|567529598|FG000|Overall Study|Ph+|20|||
157213862|NCT00558519|567529598|FG000|Overall Study|Ineligible|1|||
157213863|NCT00558519|567529598|FG000|Overall Study|Insufficient data|1|||
157213864|NCT00558519|567529598|FG000|Overall Study|Never received treatment|1|||
157213865|NCT03001011|567529599|FG000|Overall Study|Adverse Event|9|||
157213866|NCT03001011|567529600|FG001|Overall Study|Adverse Event|3|||
157213867|NCT03001011|567529599|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
156684941|NCT00732160|565590717|FG000|Overall Study|scheduling|4|||
156684942|NCT00732160|565590718|FG001|Overall Study|scheduling|4|||
156684943|NCT00732160|565590719|FG002|Overall Study|scheduling|2|||
156684944|NCT00732160|565590720|FG003|Overall Study|scheduling|1|||
156684945|NCT00090753|565590721|FG000|First Treatment Period|Adverse Event|20|||
156684946|NCT00090753|565590722|FG001|First Treatment Period|Adverse Event|8|||
156684947|NCT00090753|565590721|FG000|First Treatment Period|Death|88|||
156684948|NCT00090753|565590722|FG001|First Treatment Period|Death|62|||
156684949|NCT00090753|565590721|FG000|First Treatment Period|Lack of Efficacy|2|||
156684950|NCT00090753|565590722|FG001|First Treatment Period|Lack of Efficacy|1|||
156684951|NCT00090753|565590721|FG000|First Treatment Period|Refused Treatment|32|||
156684952|NCT00090753|565590722|FG001|First Treatment Period|Refused Treatment|25|||
156684953|NCT00090753|565590721|FG000|First Treatment Period|Lost to Follow-up|4|||
156684954|NCT00090753|565590722|FG001|First Treatment Period|Lost to Follow-up|4|||
156684955|NCT00090753|565590721|FG000|First Treatment Period|Renal Transplant|70|||
156684956|NCT00090753|565590722|FG001|First Treatment Period|Renal Transplant|50|||
156684957|NCT00090753|565590721|FG000|First Treatment Period|Mircera Commercialization|1|||
156684958|NCT00090753|565590722|FG001|First Treatment Period|Mircera Commercialization|0|||
156684959|NCT00090753|565590721|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
156684960|NCT00090753|565590722|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
156684961|NCT00090753|565590721|FG000|Extended Treatment Period|Adverse Event|11|||
156684962|NCT00090753|565590722|FG001|Extended Treatment Period|Adverse Event|0|||
156684963|NCT00090753|565590721|FG000|Extended Treatment Period|Death|58|||
156684964|NCT00090753|565590722|FG001|Extended Treatment Period|Death|30|||
156684965|NCT00090753|565590721|FG000|Extended Treatment Period|Lack of Efficacy|1|||
156684966|NCT00090753|565590722|FG001|Extended Treatment Period|Lack of Efficacy|0|||
156684967|NCT00090753|565590721|FG000|Extended Treatment Period|Refused Treatment|18|||
156684968|NCT00090753|565590722|FG001|Extended Treatment Period|Refused Treatment|12|||
156684969|NCT00090753|565590721|FG000|Extended Treatment Period|Lost to Follow-up|3|||
156684970|NCT00090753|565590722|FG001|Extended Treatment Period|Lost to Follow-up|1|||
156684971|NCT00090753|565590721|FG000|Extended Treatment Period|Renal Transplant|15|||
156684972|NCT00090753|565590722|FG001|Extended Treatment Period|Renal Transplant|12|||
156684973|NCT00090753|565590721|FG000|Extended Treatment Period|Mircera Commercialization|188|||
156684974|NCT00090753|565590722|FG001|Extended Treatment Period|Mircera Commercialization|93|||
156684975|NCT00090753|565590721|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
156684976|NCT00090753|565590722|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
156684977|NCT01466036|565590729|FG000|Overall Study|Death|1|||
156684978|NCT01466036|565590730|FG001|Overall Study|Death|1|||
156684979|NCT01466036|565590729|FG000|Overall Study|Physician Decision|0|||
156684980|NCT01466036|565590730|FG001|Overall Study|Physician Decision|4|||
156684981|NCT01466036|565590729|FG000|Overall Study|Adverse Event|2|||
156684982|NCT01466036|565590730|FG001|Overall Study|Adverse Event|6|||
156684983|NCT01466036|565590729|FG000|Overall Study|Withdrawal by Subject|2|||
156684984|NCT01466036|565590730|FG001|Overall Study|Withdrawal by Subject|8|||
156684985|NCT01466036|565590729|FG000|Overall Study|progression/relapse|14|||
156684986|NCT01466036|565590730|FG001|Overall Study|progression/relapse|21|||
156684987|NCT01466036|565590729|FG000|Overall Study|prolonged treatment delay|1|||
156684988|NCT01466036|565590730|FG001|Overall Study|prolonged treatment delay|1|||
156684989|NCT01609582|565590731|FG000|Overall Study|Adverse Event|20|||
156684990|NCT01609582|565590732|FG001|Overall Study|Adverse Event|18|||
156684991|NCT01609582|565590731|FG000|Overall Study|Lost to Follow-up|10|||
156684992|NCT01609582|565590732|FG001|Overall Study|Lost to Follow-up|10|||
156684993|NCT01609582|565590731|FG000|Overall Study|Withdrawal by Subject|21|||
156684994|NCT01609582|565590732|FG001|Overall Study|Withdrawal by Subject|15|||
156684995|NCT01609582|565590731|FG000|Overall Study|Study Terminated by Sponsor|1543|||
156684996|NCT01609582|565590732|FG001|Overall Study|Study Terminated by Sponsor|1548|||
157213868|NCT03001011|567529600|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
156684997|NCT01609582|565590731|FG000|Overall Study|Other|9|||
156684998|NCT01609582|565590732|FG001|Overall Study|Other|10|||
156684999|NCT01609582|565590731|FG000|Overall Study|Randomized, but not treated|0|||
156685000|NCT01609582|565590732|FG001|Overall Study|Randomized, but not treated|3|||
156685001|NCT00685750|565590733|FG000|Overall Study|Tumor sampling failure|0|||
156685002|NCT00685750|565590734|FG001|Overall Study|Tumor sampling failure|0|||
156685003|NCT00685750|565590735|FG002|Overall Study|Tumor sampling failure|1|||
156685004|NCT00685750|565590736|FG003|Overall Study|Tumor sampling failure|0|||
157213869|NCT03001011|567529599|FG000|Overall Study|Other than specified above|3|||
157213870|NCT03001011|567529600|FG001|Overall Study|Other than specified above|8|||
156685005|NCT00685750|565590737|FG004|Overall Study|Tumor sampling failure|0|||
156685006|NCT00685750|565590738|FG005|Overall Study|Tumor sampling failure|0|||
156785022|NCT01436500|565963329|FG001|Overall Study|Other|1|||
156785023|NCT01436500|565963330|FG002|Overall Study|Other|0|||
157213871|NCT00065065|567529601|FG000|Overall Study|Adverse Event|3|||
157213872|NCT00065065|567529602|FG001|Overall Study|Adverse Event|2|||
157213873|NCT00065065|567529601|FG000|Overall Study|Withdrawal by Subject|1|||
157213874|NCT00065065|567529602|FG001|Overall Study|Withdrawal by Subject|5|||
157213875|NCT00065065|567529601|FG000|Overall Study|Lack of Efficacy|4|||
157213876|NCT00065065|567529602|FG001|Overall Study|Lack of Efficacy|11|||
157213877|NCT00065065|567529601|FG000|Overall Study|Other|2|||
157213878|NCT00065065|567529602|FG001|Overall Study|Other|2|||
157213879|NCT04363736|567529603|FG000|Overall Study|Withdrawal by Subject|1|||
157213880|NCT04363736|567529604|FG001|Overall Study|Withdrawal by Subject|0|||
157213881|NCT04363736|567529603|FG000|Overall Study|Lost to Follow-up|10|||
157213882|NCT04363736|567529604|FG001|Overall Study|Lost to Follow-up|7|||
157213883|NCT04363736|567529603|FG000|Overall Study|Death|8|||
157213884|NCT04363736|567529604|FG001|Overall Study|Death|6|||
157213885|NCT01050673|567529605|FG000|Overall Study|Physician Decision|4|||
157213886|NCT01050673|567529606|FG001|Overall Study|Physician Decision|5|||
157213887|NCT01254045|567529607|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
157213888|NCT01254045|567529608|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
157213889|NCT01254045|567529609|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
157213890|NCT01254045|567529610|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
157213891|NCT01254045|567529611|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
157213892|NCT01254045|567529612|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
157213893|NCT00597207|567529613|FG000|Overall Study|Lost to Follow-up|5|||
157213894|NCT00597207|567529614|FG001|Overall Study|Lost to Follow-up|7|||
157213895|NCT00520351|567529615|FG000|First Intervention|Withdrawal by Subject|1|||
157213896|NCT00520351|567529616|FG001|First Intervention|Withdrawal by Subject|1|||
157213897|NCT03797222|567529618|FG000|Overall Study|Withdrawal by Subject|1|||
157213898|NCT03077828|567529620|FG000|Treatment Cycles|Death|1|||
157213899|NCT03077828|567529620|FG000|Treatment Cycles|Withdrawal by Subject|1|||
157213900|NCT03077828|567529620|FG000|Treatment Cycles|Screen Fail|2|||
157213901|NCT03077828|567529620|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
157213902|NCT03077828|567529620|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
157213903|NCT03077828|567529620|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
157213904|NCT03077828|567529620|FG000|Follow-up|Patients still in follow-up|15|||
157213905|NCT04288115|567529623|FG000|Overall Study|Withdrawal by Subject|0|||
157213906|NCT04288115|567529624|FG001|Overall Study|Withdrawal by Subject|1|||
157213907|NCT04288115|567529623|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
157213908|NCT04288115|567529624|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
157213909|NCT00729365|567529626|FG000|Overall Study|Physician Decision|33|||
157213910|NCT00729365|567529627|FG001|Overall Study|Physician Decision|6|||
157213911|NCT00729365|567529628|FG002|Overall Study|Physician Decision|7|||
157213912|NCT02766400|567529629|FG000|Overall Study|Death|1|||
157213913|NCT02766400|567529630|FG001|Overall Study|Death|2|||
157213914|NCT02766400|567529629|FG000|Overall Study|Withdrawal by Subject|1|||
157213915|NCT02766400|567529630|FG001|Overall Study|Withdrawal by Subject|0|||
157213916|NCT03125915|567529635|FG000|1 Month Follow up|Lost to Follow-up|3|||
157213917|NCT03125915|567529636|FG001|1 Month Follow up|Lost to Follow-up|3|||
157213918|NCT03125915|567529637|FG002|1 Month Follow up|Lost to Follow-up|2|||
157213919|NCT03125915|567529638|FG003|1 Month Follow up|Lost to Follow-up|3|||
157213920|NCT03125915|567529635|FG000|3 Month Follow-up|Lost to Follow-up|6|||
157213921|NCT03125915|567529636|FG001|3 Month Follow-up|Lost to Follow-up|4|||
156785024|NCT01436500|565963331|FG003|Overall Study|Other|1|||
156785025|NCT01436500|565963332|FG004|Overall Study|Other|0|||
156785026|NCT03983109|565963333|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
156785027|NCT03983109|565963334|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
157213922|NCT03125915|567529637|FG002|3 Month Follow-up|Lost to Follow-up|4|||
157213923|NCT03125915|567529638|FG003|3 Month Follow-up|Lost to Follow-up|2|||
157213924|NCT03125915|567529635|FG000|6 Month Follow-up|Lost to Follow-up|7|||
156785028|NCT00887588|565963335|FG000|Core Period|Death|1|||
157013246|NCT02723955|566801768|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013247|NCT02723955|566801769|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013248|NCT02723955|566801770|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157021654|NCT04072380|566830972|FG001|Overall Study|Withdrawal by Subject|1|||
157213925|NCT03125915|567529636|FG001|6 Month Follow-up|Lost to Follow-up|3|||
157213926|NCT03125915|567529637|FG002|6 Month Follow-up|Lost to Follow-up|6|||
157213927|NCT03125915|567529638|FG003|6 Month Follow-up|Lost to Follow-up|3|||
157213928|NCT01309828|567529639|FG000|Overall Study|Adverse Event|10|||
157213929|NCT01309828|567529640|FG001|Overall Study|Adverse Event|11|||
157213930|NCT01309828|567529639|FG000|Overall Study|Voluntary Withdrawal|5|||
157213931|NCT01309828|567529640|FG001|Overall Study|Voluntary Withdrawal|4|||
157213932|NCT01309828|567529639|FG000|Overall Study|Major Protocol Deviation|0|||
157213933|NCT01309828|567529640|FG001|Overall Study|Major Protocol Deviation|1|||
157213934|NCT01309828|567529639|FG000|Overall Study|Other|1|||
157213935|NCT01309828|567529640|FG001|Overall Study|Other|0|||
157213936|NCT00295620|567529641|FG000|Overall Study|Lost to Follow-up|9|||
157213937|NCT00295620|567529642|FG001|Overall Study|Lost to Follow-up|5|||
157213938|NCT00295620|567529641|FG000|Overall Study|Withdrawal by Subject|37|||
157213939|NCT00295620|567529642|FG001|Overall Study|Withdrawal by Subject|50|||
157213940|NCT00295620|567529641|FG000|Overall Study|Death|206|||
157213941|NCT00295620|567529642|FG001|Overall Study|Death|207|||
157213942|NCT00295620|567529641|FG000|Overall Study|Other reasons|10|||
157213943|NCT00295620|567529642|FG001|Overall Study|Other reasons|9|||
157213944|NCT00295620|567529641|FG000|Overall Study|Discontinuation by sponsor|580|||
157213945|NCT00295620|567529642|FG001|Overall Study|Discontinuation by sponsor|593|||
157213946|NCT00295620|567529641|FG000|Overall Study|Protocol Violation|30|||
157213947|NCT00295620|567529642|FG001|Overall Study|Protocol Violation|32|||
157213948|NCT00217971|567529643|FG000|Overall Study|Adverse Event|1|||
157213949|NCT00217971|567529644|FG001|Overall Study|Adverse Event|1|||
157213950|NCT00217971|567529643|FG000|Overall Study|Lost to Follow-up|15|||
157213951|NCT00217971|567529644|FG001|Overall Study|Lost to Follow-up|19|||
156785029|NCT00887588|565963336|FG001|Core Period|Death|1|||
156785030|NCT00887588|565963335|FG000|Core Period|Lost to Follow-up|3|||
156785031|NCT00887588|565963336|FG001|Core Period|Lost to Follow-up|1|||
156785032|NCT00887588|565963335|FG000|Core Period|Withdrawal by Subject|6|||
157213952|NCT00217971|567529643|FG000|Overall Study|Physician Decision|0|||
157213953|NCT00217971|567529644|FG001|Overall Study|Physician Decision|1|||
157213954|NCT00217971|567529643|FG000|Overall Study|Withdrawal by Subject|7|||
157213955|NCT00217971|567529644|FG001|Overall Study|Withdrawal by Subject|12|||
157213956|NCT00217971|567529643|FG000|Overall Study|non compliant|1|||
157213957|NCT00217971|567529644|FG001|Overall Study|non compliant|0|||
157213958|NCT02556632|567529645|FG000|Overall Study|Lost to Follow-up|1|||
157213959|NCT02556632|567529646|FG001|Overall Study|Lost to Follow-up|0|||
157213960|NCT02556632|567529647|FG002|Overall Study|Lost to Follow-up|0|||
157213961|NCT02556632|567529645|FG000|Overall Study|Disliked Intervention|1|||
157213962|NCT02556632|567529646|FG001|Overall Study|Disliked Intervention|1|||
157213963|NCT02556632|567529647|FG002|Overall Study|Disliked Intervention|1|||
157213964|NCT02556632|567529645|FG000|Overall Study|No Reason|1|||
156785033|NCT00887588|565963336|FG001|Core Period|Withdrawal by Subject|8|||
156785034|NCT00887588|565963335|FG000|Core Period|Adverse Event|9|||
156785035|NCT00887588|565963336|FG001|Core Period|Adverse Event|11|||
156785036|NCT00887588|565963335|FG000|Extension Period|Adverse Event|4|||
156785037|NCT00887588|565963336|FG001|Extension Period|Adverse Event|4|||
156785038|NCT00887588|565963335|FG000|Extension Period|Death|0|||
156785039|NCT00887588|565963336|FG001|Extension Period|Death|1|||
156785040|NCT00887588|565963335|FG000|Extension Period|Protocol deviation|1|||
156785041|NCT00887588|565963336|FG001|Extension Period|Protocol deviation|0|||
156785042|NCT00887588|565963335|FG000|Extension Period|Lost to Follow-up|1|||
156785043|NCT00887588|565963336|FG001|Extension Period|Lost to Follow-up|0|||
156785044|NCT02184156|565963340|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
156785045|NCT02184156|565963341|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
156785046|NCT02184156|565963340|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
156785047|NCT02184156|565963341|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
156785048|NCT03158311|565963345|FG000|Overall Study|Subject/Guardian Decision|10|||
156785049|NCT03158311|565963346|FG001|Overall Study|Subject/Guardian Decision|6|||
156785050|NCT03158311|565963347|FG002|Overall Study|Subject/Guardian Decision|11|||
156785051|NCT03158311|565963345|FG000|Overall Study|Adverse Event|5|||
156785052|NCT03158311|565963346|FG001|Overall Study|Adverse Event|3|||
156785053|NCT03158311|565963347|FG002|Overall Study|Adverse Event|3|||
157013249|NCT02723955|566801771|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013250|NCT02723955|566801772|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013251|NCT02723955|566801773|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013252|NCT02723955|566801774|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013253|NCT02723955|566801775|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013254|NCT02723955|566801776|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013255|NCT02723955|566801777|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157013256|NCT02723955|566801778|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157213965|NCT02556632|567529646|FG001|Overall Study|No Reason|0|||
157213966|NCT02556632|567529647|FG002|Overall Study|No Reason|1|||
157213967|NCT02556632|567529645|FG000|Overall Study|Personal Issues|0|||
157213968|NCT02556632|567529646|FG001|Overall Study|Personal Issues|1|||
157213969|NCT02556632|567529647|FG002|Overall Study|Personal Issues|1|||
156785054|NCT03158311|565963345|FG000|Overall Study|Techinical Problems|3|||
157213970|NCT02556632|567529645|FG000|Overall Study|Changed Mind|0|||
157213971|NCT02556632|567529646|FG001|Overall Study|Changed Mind|1|||
157213972|NCT02556632|567529647|FG002|Overall Study|Changed Mind|0|||
156785055|NCT03158311|565963346|FG001|Overall Study|Techinical Problems|1|||
156785056|NCT03158311|565963347|FG002|Overall Study|Techinical Problems|5|||
157213973|NCT02556632|567529645|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
157120862|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
157120863|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
157120864|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
157120865|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
157120866|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
157120867|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
157120868|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
157120869|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
156785057|NCT03158311|565963345|FG000|Overall Study|Physician Decision|2|||
156785058|NCT03158311|565963346|FG001|Overall Study|Physician Decision|3|||
156785059|NCT03158311|565963347|FG002|Overall Study|Physician Decision|7|||
156785060|NCT03158311|565963345|FG000|Overall Study|Lost to Follow-up|1|||
157213974|NCT02556632|567529646|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
157213975|NCT02556632|567529647|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
157213976|NCT02556632|567529645|FG000|Overall Study|Unrelated Adverse Event|1|||
157213977|NCT02556632|567529646|FG001|Overall Study|Unrelated Adverse Event|0|||
157213978|NCT02556632|567529647|FG002|Overall Study|Unrelated Adverse Event|3|||
157213979|NCT02556632|567529645|FG000|Overall Study|Related Adverse Event|0|||
157213980|NCT02556632|567529646|FG001|Overall Study|Related Adverse Event|1|||
157213981|NCT02556632|567529647|FG002|Overall Study|Related Adverse Event|0|||
156785061|NCT03158311|565963346|FG001|Overall Study|Lost to Follow-up|1|||
156785062|NCT03158311|565963347|FG002|Overall Study|Lost to Follow-up|1|||
156785063|NCT03158311|565963345|FG000|Overall Study|Sponsor decision|1|||
156785064|NCT03158311|565963346|FG001|Overall Study|Sponsor decision|0|||
156785065|NCT03158311|565963347|FG002|Overall Study|Sponsor decision|0|||
156785066|NCT03158311|565963345|FG000|Overall Study|Pregnancy|0|||
157213982|NCT02556632|567529645|FG000|Overall Study|Possibly Related Adverse Event|0|||
157213983|NCT02556632|567529646|FG001|Overall Study|Possibly Related Adverse Event|0|||
157213984|NCT02556632|567529647|FG002|Overall Study|Possibly Related Adverse Event|1|||
157213985|NCT02556632|567529645|FG000|Overall Study|Did Not Start RT|0|||
157213986|NCT02556632|567529646|FG001|Overall Study|Did Not Start RT|1|||
157213987|NCT02556632|567529647|FG002|Overall Study|Did Not Start RT|0|||
157213988|NCT02556632|567529645|FG000|Overall Study|Ineligible|0|||
157213989|NCT02556632|567529646|FG001|Overall Study|Ineligible|1|||
157213990|NCT02556632|567529647|FG002|Overall Study|Ineligible|0|||
157213991|NCT02556632|567529645|FG000|Overall Study|Disliked Study Procedures|0|||
157213992|NCT02556632|567529646|FG001|Overall Study|Disliked Study Procedures|0|||
157213993|NCT02556632|567529647|FG002|Overall Study|Disliked Study Procedures|1|||
157213994|NCT02556632|567529645|FG000|Overall Study|Treatment or Change Delay|0|||
157213995|NCT02556632|567529646|FG001|Overall Study|Treatment or Change Delay|0|||
157213996|NCT02556632|567529647|FG002|Overall Study|Treatment or Change Delay|1|||
157213997|NCT00808015|567529650|FG000|Overall Study|Death|1|||
157213998|NCT00808015|567529650|FG000|Overall Study|Lack of Efficacy|58|||
156785067|NCT03158311|565963346|FG001|Overall Study|Pregnancy|2|||
156785068|NCT03158311|565963347|FG002|Overall Study|Pregnancy|0|||
156785069|NCT03158311|565963345|FG000|Overall Study|Randomized in error|0|||
156785070|NCT03158311|565963346|FG001|Overall Study|Randomized in error|0|||
156785071|NCT03158311|565963347|FG002|Overall Study|Randomized in error|1|||
156785072|NCT01033071|565963348|FG000|Overall Study|Adverse Event|28|||
156785073|NCT01033071|565963349|FG001|Overall Study|Adverse Event|51|||
156785074|NCT01033071|565963350|FG002|Overall Study|Adverse Event|26|||
156785075|NCT01033071|565963348|FG000|Overall Study|Protocol Violation|0|||
156785076|NCT01033071|565963349|FG001|Overall Study|Protocol Violation|2|||
156785077|NCT01033071|565963350|FG002|Overall Study|Protocol Violation|1|||
156785078|NCT01033071|565963348|FG000|Overall Study|Lost to Follow-up|4|||
156785079|NCT01033071|565963349|FG001|Overall Study|Lost to Follow-up|5|||
156785080|NCT01033071|565963350|FG002|Overall Study|Lost to Follow-up|5|||
156785081|NCT01033071|565963348|FG000|Overall Study|Withdrawal by Subject|17|||
156785082|NCT01033071|565963349|FG001|Overall Study|Withdrawal by Subject|14|||
156785083|NCT01033071|565963350|FG002|Overall Study|Withdrawal by Subject|11|||
156785084|NCT01033071|565963348|FG000|Overall Study|Lack of Efficacy|0|||
156785085|NCT01033071|565963349|FG001|Overall Study|Lack of Efficacy|1|||
156785086|NCT01033071|565963350|FG002|Overall Study|Lack of Efficacy|1|||
156785087|NCT01033071|565963348|FG000|Overall Study|Other|6|||
156785088|NCT01033071|565963349|FG001|Overall Study|Other|4|||
157120870|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
157213999|NCT00808015|567529650|FG000|Overall Study|Lost to Follow-up|76|||
157214000|NCT00808015|567529650|FG000|Overall Study|Participants not willing to participate|158|||
157214001|NCT00808015|567529650|FG000|Overall Study|Adverse Event|22|||
157214002|NCT00808015|567529650|FG000|Overall Study|Other|25|||
156785089|NCT01033071|565963350|FG002|Overall Study|Other|3|||
156785090|NCT04073407|565963353|FG000|Part 1|Withdrawal by Subject|1|||
156785091|NCT04073407|565963354|FG001|Part 1|Withdrawal by Subject|0|||
157214003|NCT00808015|567529650|FG000|Overall Study|Enrolled but not treated|4|||
156808724|NCT02595879|566054443|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
156808725|NCT02595879|566054444|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
156808726|NCT01396187|566054445|FG000|Overall Study|Adverse Event|0|||
156785092|NCT04073407|565963353|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
156785093|NCT04073407|565963354|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
156785094|NCT04073407|565963353|FG000|Part 2|Withdrawal by Subject|0|||
156785095|NCT04073407|565963354|FG001|Part 2|Withdrawal by Subject|1|||
156785096|NCT00960856|565964816|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785097|NCT00960856|565964817|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
156785098|NCT00960856|565964818|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785099|NCT00960856|565964819|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
156785100|NCT00960856|565964816|FG000|Washout Period of 7 Days|Adverse Event|0|||
156785101|NCT00960856|565964817|FG001|Washout Period of 7 Days|Adverse Event|0|||
156785102|NCT00960856|565964818|FG002|Washout Period of 7 Days|Adverse Event|1|||
156785103|NCT00960856|565964819|FG003|Washout Period of 7 Days|Adverse Event|0|||
156785104|NCT03315689|565964824|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
156785105|NCT03315689|565964825|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
156785106|NCT03315689|565964824|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
156785107|NCT03315689|565964825|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
156785108|NCT03315689|565964824|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
156785109|NCT03315689|565964825|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
156785110|NCT01297244|565964826|FG000|Overall Study|Progressive disease|22|||
156785111|NCT01297244|565964827|FG001|Overall Study|Progressive disease|3|||
156785112|NCT01297244|565964826|FG000|Overall Study|Adverse Event|9|||
156785113|NCT01297244|565964827|FG001|Overall Study|Adverse Event|1|||
156785114|NCT01297244|565964826|FG000|Overall Study|Death|1|||
156785115|NCT01297244|565964827|FG001|Overall Study|Death|1|||
156785116|NCT01297244|565964826|FG000|Overall Study|Clinical progression|1|||
156785117|NCT01297244|565964827|FG001|Overall Study|Clinical progression|1|||
156785118|NCT01297244|565964826|FG000|Overall Study|Withdrawal by Subject|2|||
156785119|NCT01297244|565964827|FG001|Overall Study|Withdrawal by Subject|0|||
156785120|NCT01348698|565964828|FG000|Overall Study|Does not meet lesion size criteria|1|||
156785121|NCT01348698|565964828|FG000|Overall Study|Death|3|||
156785122|NCT01348698|565964828|FG000|Overall Study|PI decision to close study|68|||
156785123|NCT02595749|565964829|FG000|Overall Study|Withdrawal by Subject|12|||
156785124|NCT02595749|565964830|FG001|Overall Study|Withdrawal by Subject|7|||
156785125|NCT00669331|565964831|FG000|Randomisation to First Dose|Adverse Event|1|||
156785126|NCT00669331|565964832|FG001|Randomisation to First Dose|Adverse Event|0|||
156785127|NCT00669331|565964831|FG000|Randomisation to First Dose|Protocol Violation|1|||
156785128|NCT00669331|565964832|FG001|Randomisation to First Dose|Protocol Violation|0|||
156785129|NCT00669331|565964831|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
156785130|NCT00669331|565964832|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
156785131|NCT00669331|565964831|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
156785132|NCT00669331|565964832|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
156785133|NCT00669331|565964831|FG000|Randomisation to First Dose|Death|1|||
156785134|NCT00669331|565964832|FG001|Randomisation to First Dose|Death|0|||
156785135|NCT00669331|565964831|FG000|Randomisation to First Dose|Sponsor decision|0|||
156785136|NCT00669331|565964832|FG001|Randomisation to First Dose|Sponsor decision|1|||
156785137|NCT00669331|565964831|FG000|Randomisation to First Dose|Randomised in error|3|||
156785138|NCT00669331|565964832|FG001|Randomisation to First Dose|Randomised in error|10|||
156785139|NCT00669331|565964831|FG000|Blinded Treatment Period|Adverse Event|16|||
156785140|NCT00669331|565964832|FG001|Blinded Treatment Period|Adverse Event|10|||
156785141|NCT00669331|565964831|FG000|Blinded Treatment Period|Protocol Violation|1|||
156785142|NCT00669331|565964832|FG001|Blinded Treatment Period|Protocol Violation|1|||
156785143|NCT00669331|565964831|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
156785144|NCT00669331|565964832|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
156785145|NCT00669331|565964831|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
156785146|NCT00669331|565964832|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
156785147|NCT00669331|565964831|FG000|Blinded Treatment Period|Death|0|||
156785148|NCT00669331|565964832|FG001|Blinded Treatment Period|Death|2|||
156785149|NCT00669331|565964831|FG000|Blinded Treatment Period|Physician Decision|3|||
156785150|NCT00669331|565964832|FG001|Blinded Treatment Period|Physician Decision|3|||
156868485|NCT00068692|566277314|FG006|Step 2: Randomization|Disesae progression/replase|0|||
156868486|NCT00068692|566277315|FG007|Step 2: Randomization|Disesae progression/replase|0|||
156868487|NCT00068692|566277308|FG000|Step 2: Randomization|Adverse Event|0|||
157013257|NCT02723955|566801779|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
157214004|NCT00084617|567529660|FG000|Overall Study|Withdrawal by Subject|7|||
156785151|NCT00669331|565964831|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
156785152|NCT00669331|565964832|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
156785153|NCT01454063|565964833|FG000|Randomized|Adverse Event|1|||
156785154|NCT01454063|565964834|FG001|Randomized|Adverse Event|1|||
156785155|NCT01454063|565964833|FG000|Randomized|Protocol Violation|0|||
156785156|NCT01454063|565964834|FG001|Randomized|Protocol Violation|1|||
156785157|NCT03387046|565964835|FG000|Overall Study|Adverse Event|1|||
156785158|NCT03387046|565964836|FG001|Overall Study|Adverse Event|1|||
157214005|NCT00084617|567529660|FG000|Overall Study|Lack of Efficacy|1|||
157214006|NCT00084617|567529660|FG000|Overall Study|Protocol Violation|1|||
157214007|NCT01625286|567529661|FG000|Overall Study|Adverse Event|0|||
156685007|NCT00685750|565590739|FG006|Overall Study|Tumor sampling failure|0|||
156685008|NCT00685750|565590733|FG000|Overall Study|Patient didn't receive the treatment|0|||
156685009|NCT00685750|565590734|FG001|Overall Study|Patient didn't receive the treatment|0|||
156685010|NCT00685750|565590735|FG002|Overall Study|Patient didn't receive the treatment|0|||
156685011|NCT00685750|565590736|FG003|Overall Study|Patient didn't receive the treatment|0|||
156685012|NCT00685750|565590737|FG004|Overall Study|Patient didn't receive the treatment|0|||
156685013|NCT00685750|565590738|FG005|Overall Study|Patient didn't receive the treatment|0|||
156685014|NCT00685750|565590739|FG006|Overall Study|Patient didn't receive the treatment|1|||
156685015|NCT00685750|565590733|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156685016|NCT00685750|565590734|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156685017|NCT00685750|565590735|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156685018|NCT00685750|565590736|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
156685019|NCT00685750|565590737|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156685020|NCT00685750|565590738|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
156685021|NCT00685750|565590739|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
156685022|NCT04974580|565590742|FG000|Overall Study|Lost to Follow-up|33|||
156685023|NCT04974580|565590743|FG001|Overall Study|Lost to Follow-up|39|||
156685024|NCT04974580|565590744|FG002|Overall Study|Lost to Follow-up|30|||
156685025|NCT04974580|565590745|FG003|Overall Study|Lost to Follow-up|29|||
156685026|NCT00587431|565590746|FG000|Overall Study|Adverse Event|1|||
156685027|NCT00587431|565590747|FG001|Overall Study|Adverse Event|0|||
156685028|NCT00587431|565590746|FG000|Overall Study|Withdrawal by Subject|0|||
156685029|NCT00587431|565590747|FG001|Overall Study|Withdrawal by Subject|1|||
156685030|NCT05467982|565590748|FG000|Overall Study|Death|0|||
156685031|NCT05467982|565590749|FG001|Overall Study|Death|1|||
156685032|NCT05467982|565590748|FG000|Overall Study|Lost to Follow-up|3|||
156685033|NCT05467982|565590749|FG001|Overall Study|Lost to Follow-up|1|||
156685034|NCT02941523|565590753|FG000|Monotherapy|Withdrawal by Subject|0|||
156685035|NCT02941523|565590754|FG001|Monotherapy|Withdrawal by Subject|1|||
156685036|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
156685037|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
156685038|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Death|1|||
156685039|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Death|2|||
156685040|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Disease progression|2|||
156685041|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Disease progression|0|||
156685042|NCT02941523|565590753|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
156685043|NCT02941523|565590754|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
156685044|NCT04330157|565590755|FG000|Overall Study|Protocol Violation|4|||
156685045|NCT04330157|565590755|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
156685046|NCT00869440|565590757|FG000|Overall Study|Withdrawal by Subject|1|||
156685047|NCT00869440|565590758|FG001|Overall Study|Withdrawal by Subject|0|||
156685048|NCT00869440|565590759|FG002|Overall Study|Withdrawal by Subject|0|||
156785159|NCT03558672|565964837|FG000|Overall Study|Study Early Termination|10|||
156785160|NCT00509600|565964838|FG000|Overall Study|Adverse Event|1|||
156785161|NCT01027416|565964840|FG000|Overall Study|Withdrawal by Subject|0|||
156785162|NCT01027416|565964841|FG001|Overall Study|Withdrawal by Subject|1|||
156785163|NCT01027416|565964840|FG000|Overall Study|Physician Decision|1|||
156785164|NCT01027416|565964841|FG001|Overall Study|Physician Decision|4|||
156785165|NCT01428713|565964842|FG000|Overall Study|Non-compliance|2|||
156785166|NCT01428713|565964843|FG001|Overall Study|Non-compliance|2|||
156785167|NCT01428713|565964842|FG000|Overall Study|Withdrawal by Subject|1|||
156785168|NCT01428713|565964843|FG001|Overall Study|Withdrawal by Subject|1|||
156785169|NCT01428713|565964842|FG000|Overall Study|Adverse Event|0|||
156785170|NCT01428713|565964843|FG001|Overall Study|Adverse Event|2|||
157214008|NCT01625286|567529662|FG001|Overall Study|Adverse Event|0|||
156785171|NCT00875667|565964846|FG000|Overall Study|Adverse Event|29|||
156785172|NCT00875667|565964847|FG001|Overall Study|Adverse Event|10|||
156785173|NCT00875667|565964846|FG000|Overall Study|Withdrawal by Subject|17|||
156785174|NCT00875667|565964847|FG001|Overall Study|Withdrawal by Subject|5|||
156785175|NCT00875667|565964846|FG000|Overall Study|Death|7|||
156685049|NCT00869440|565590760|FG003|Overall Study|Withdrawal by Subject|0|||
156685050|NCT00869440|565590757|FG000|Overall Study|Physician Decision|1|||
156685051|NCT00869440|565590758|FG001|Overall Study|Physician Decision|1|||
156685052|NCT00869440|565590759|FG002|Overall Study|Physician Decision|0|||
156685053|NCT00869440|565590760|FG003|Overall Study|Physician Decision|0|||
156685054|NCT03558139|565590761|FG000|Overall Study|Consent Withdrawn|1|||
156685055|NCT03558139|565590762|FG001|Overall Study|Consent Withdrawn|1|||
156685056|NCT03558139|565590763|FG002|Overall Study|Consent Withdrawn|4|||
156685057|NCT03558139|565590761|FG000|Overall Study|Death|5|||
156685058|NCT03558139|565590762|FG001|Overall Study|Death|3|||
156685059|NCT03558139|565590763|FG002|Overall Study|Death|8|||
156685060|NCT03558139|565590761|FG000|Overall Study|Lost to Follow-up|0|||
156685061|NCT03558139|565590762|FG001|Overall Study|Lost to Follow-up|0|||
156685062|NCT03558139|565590763|FG002|Overall Study|Lost to Follow-up|3|||
156685063|NCT03558139|565590761|FG000|Overall Study|Study Ended Per Protocol|0|||
156685064|NCT03558139|565590762|FG001|Overall Study|Study Ended Per Protocol|3|||
156685065|NCT03558139|565590763|FG002|Overall Study|Study Ended Per Protocol|6|||
156685066|NCT00251316|565590764|FG000|Overall Study|Physician Decision|2|||
156685067|NCT00251316|565590765|FG001|Overall Study|Physician Decision|3|||
156685068|NCT00569777|565590768|FG000|Overall Study|Withdrawal by Subject|4|||
156685069|NCT00569777|565590769|FG001|Overall Study|Withdrawal by Subject|0|||
156685070|NCT00569777|565590768|FG000|Overall Study|Adverse Event|3|||
156685071|NCT00569777|565590769|FG001|Overall Study|Adverse Event|0|||
156685072|NCT00569777|565590768|FG000|Overall Study|Lost to Follow-up|1|||
156685073|NCT00569777|565590769|FG001|Overall Study|Lost to Follow-up|0|||
156685074|NCT00569777|565590768|FG000|Overall Study|scheduled eye surgery|0|||
156685075|NCT00569777|565590769|FG001|Overall Study|scheduled eye surgery|1|||
156685076|NCT00569777|565590768|FG000|Overall Study|did not meet exclusion criteria|1|||
156685077|NCT00569777|565590769|FG001|Overall Study|did not meet exclusion criteria|2|||
156685078|NCT00569777|565590768|FG000|Overall Study|pregnant|1|||
156685079|NCT00569777|565590769|FG001|Overall Study|pregnant|0|||
156685080|NCT02030535|565590771|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
156685081|NCT04773600|565590777|FG000|Overall Study|Withdrawal by Subject|15|||
156685082|NCT04773600|565590778|FG001|Overall Study|Withdrawal by Subject|9|||
156685083|NCT04773600|565590777|FG000|Overall Study|Lost to Follow-up|10|||
156685084|NCT04773600|565590778|FG001|Overall Study|Lost to Follow-up|6|||
156685085|NCT04773600|565590777|FG000|Overall Study|Adverse Event|8|||
156685086|NCT04773600|565590778|FG001|Overall Study|Adverse Event|2|||
156685087|NCT04773600|565590777|FG000|Overall Study|Lack of Efficacy|2|||
156685088|NCT04773600|565590778|FG001|Overall Study|Lack of Efficacy|3|||
156685089|NCT04773600|565590777|FG000|Overall Study|Noncompliance|2|||
156685090|NCT04773600|565590778|FG001|Overall Study|Noncompliance|0|||
156685091|NCT04773600|565590777|FG000|Overall Study|Protocol Violation|2|||
156685092|NCT04773600|565590778|FG001|Overall Study|Protocol Violation|0|||
156685093|NCT04773600|565590777|FG000|Overall Study|Physician Decision|0|||
156685094|NCT04773600|565590778|FG001|Overall Study|Physician Decision|1|||
156685095|NCT04773600|565590777|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
156685096|NCT04773600|565590778|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
156685097|NCT04773600|565590777|FG000|Overall Study|Emergency Travel Out of Country|1|||
156685098|NCT04773600|565590778|FG001|Overall Study|Emergency Travel Out of Country|0|||
156685099|NCT01923311|565592056|FG000|Overall Study|Pregnancy|1|||
157120871|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
156685100|NCT01923311|565592057|FG001|Overall Study|Pregnancy|0|||
156685101|NCT01923311|565592056|FG000|Overall Study|Investigator's Discretion|1|||
156685102|NCT01923311|565592057|FG001|Overall Study|Investigator's Discretion|0|||
156685103|NCT01923311|565592056|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156685104|NCT01923311|565592057|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156685105|NCT01923311|565592056|FG000|Overall Study|Withdrew Consent|1|||
156685106|NCT01923311|565592057|FG001|Overall Study|Withdrew Consent|0|||
156685107|NCT01923311|565592056|FG000|Overall Study|Study Terminated by Sponsor|12|||
156685108|NCT01923311|565592057|FG001|Overall Study|Study Terminated by Sponsor|0|||
156685109|NCT03180528|565592063|FG000|Overall Study|Adverse Event|1|||
156685110|NCT03180528|565592063|FG000|Overall Study|Withdrawal by Subject|1|||
156685111|NCT03180528|565592063|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
156685112|NCT02839798|565592064|FG000|Overall Study|Withdrawal by Subject|2|||
156685113|NCT04129944|565592065|FG000|Overall Study|Death|0|||
156685114|NCT04129944|565592066|FG001|Overall Study|Death|0|||
156685115|NCT04129944|565592067|FG002|Overall Study|Death|0|||
156685116|NCT04129944|565592068|FG003|Overall Study|Death|1|||
156685117|NCT04129944|565592065|FG000|Overall Study|Lost to Follow-up|1|||
156685118|NCT04129944|565592066|FG001|Overall Study|Lost to Follow-up|0|||
156685119|NCT04129944|565592067|FG002|Overall Study|Lost to Follow-up|0|||
156685120|NCT04129944|565592068|FG003|Overall Study|Lost to Follow-up|0|||
156785176|NCT00875667|565964847|FG001|Overall Study|Death|2|||
156785177|NCT00875667|565964846|FG000|Overall Study|Protocol Violation|2|||
157120872|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
156685121|NCT04129944|565592065|FG000|Overall Study|Withdrawal by Subject|1|||
156685122|NCT04129944|565592066|FG001|Overall Study|Withdrawal by Subject|0|||
156685123|NCT04129944|565592067|FG002|Overall Study|Withdrawal by Subject|1|||
156685124|NCT04129944|565592068|FG003|Overall Study|Withdrawal by Subject|2|||
156685125|NCT03710590|565592069|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
156685126|NCT03710590|565592070|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
156685127|NCT02488824|565592071|FG000|Overall Study|Adverse Event|1|||
156685128|NCT02488824|565592072|FG001|Overall Study|Adverse Event|1|||
156685129|NCT02356211|565592073|FG000|Overall Study|Withdrawal by Subject|2|||
156685130|NCT02356211|565592074|FG001|Overall Study|Withdrawal by Subject|2|||
156685131|NCT02356211|565592073|FG000|Overall Study|ineligible|1|||
156685132|NCT02356211|565592074|FG001|Overall Study|ineligible|8|||
156685133|NCT01124695|565592079|FG000|Overall Study|Disease progression|77|||
157120873|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
156685134|NCT01124695|565592079|FG000|Overall Study|Adverse Event|11|||
156685135|NCT01124695|565592079|FG000|Overall Study|Death|1|||
156685136|NCT01124695|565592079|FG000|Overall Study|Withdrawal by Subject|7|||
156685137|NCT01124695|565592079|FG000|Overall Study|Physician Decision|3|||
156685138|NCT01124695|565592079|FG000|Overall Study|Alternative therapy|9|||
156685139|NCT01124695|565592079|FG000|Overall Study|No documentation that patient went off treatment|4|||
156685140|NCT01124695|565592079|FG000|Overall Study|Ineligible|9|||
156685141|NCT01124695|565592079|FG000|Overall Study|Ineligible and never start treatment|2|||
156685142|NCT02695719|565592090|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
156685143|NCT02695719|565592091|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
156685144|NCT02695719|565592090|FG000|Overall Study|Significant Protocol Deviation|0|||
156685145|NCT02695719|565592091|FG001|Overall Study|Significant Protocol Deviation|1|||
156685146|NCT02695719|565592090|FG000|Overall Study|Voluntary Withdrawal|1|||
156685147|NCT02695719|565592091|FG001|Overall Study|Voluntary Withdrawal|0|||
156685148|NCT03180801|565592092|FG000|Overall Study|Physician Decision|3|||
156685149|NCT03180801|565592093|FG001|Overall Study|Physician Decision|3|||
156685150|NCT03180801|565592094|FG002|Overall Study|Physician Decision|1|||
157120874|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
156685151|NCT03180801|565592092|FG000|Overall Study|Non-compliance|1|||
156685152|NCT03180801|565592093|FG001|Overall Study|Non-compliance|4|||
156685153|NCT03180801|565592094|FG002|Overall Study|Non-compliance|0|||
156685154|NCT03180801|565592092|FG000|Overall Study|Inoculation Target Reached|1|||
156685155|NCT03180801|565592093|FG001|Overall Study|Inoculation Target Reached|1|||
156685156|NCT03180801|565592094|FG002|Overall Study|Inoculation Target Reached|3|||
156685157|NCT03180801|565592092|FG000|Overall Study|Adverse Event|1|||
156685158|NCT03180801|565592093|FG001|Overall Study|Adverse Event|0|||
156685159|NCT03180801|565592094|FG002|Overall Study|Adverse Event|2|||
156685160|NCT03180801|565592092|FG000|Overall Study|Withdrawal by Subject|2|||
156685161|NCT03180801|565592093|FG001|Overall Study|Withdrawal by Subject|2|||
156685162|NCT03180801|565592094|FG002|Overall Study|Withdrawal by Subject|1|||
156685163|NCT03180801|565592092|FG000|Overall Study|Lost to Follow-up|0|||
156685164|NCT03180801|565592093|FG001|Overall Study|Lost to Follow-up|2|||
156685165|NCT03180801|565592094|FG002|Overall Study|Lost to Follow-up|3|||
156685166|NCT01220609|565592095|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
156685167|NCT01220609|565592095|FG000|Overall Study|Ineligible- Wrong cell type|1|||
156685168|NCT01220609|565592095|FG000|Overall Study|Ineligible-Never treated|1|||
156685169|NCT01142908|565592097|FG000|Overall Study|Lost to Follow-up|19|||
156685170|NCT01142908|565592098|FG001|Overall Study|Lost to Follow-up|13|||
156685171|NCT01142908|565592097|FG000|Overall Study|Death|1|||
156685172|NCT01142908|565592098|FG001|Overall Study|Death|4|||
156685173|NCT01142908|565592097|FG000|Overall Study|Excluded - did not meet criteria|9|||
156685174|NCT01142908|565592098|FG001|Overall Study|Excluded - did not meet criteria|5|||
156685175|NCT01142908|565592097|FG000|Overall Study|Withdrawal by Subject|3|||
156685176|NCT01142908|565592098|FG001|Overall Study|Withdrawal by Subject|0|||
156685177|NCT00529217|565592114|FG000|Overall Study|Lack of Efficacy|2|||
156685178|NCT00529217|565592114|FG000|Overall Study|Unable to adhere to study schedule|2|||
156685179|NCT01546519|565592115|FG000|Overall Study|Adverse Event|0|||
156685180|NCT01546519|565592116|FG001|Overall Study|Adverse Event|0|||
156685181|NCT01546519|565592117|FG002|Overall Study|Adverse Event|1|||
156685182|NCT01546519|565592118|FG003|Overall Study|Adverse Event|1|||
156685183|NCT01546519|565592115|FG000|Overall Study|Death|0|||
156685184|NCT01546519|565592116|FG001|Overall Study|Death|1|||
156685185|NCT01546519|565592117|FG002|Overall Study|Death|3|||
156685186|NCT01546519|565592118|FG003|Overall Study|Death|1|||
156685187|NCT01546519|565592115|FG000|Overall Study|related to disease progression|2|||
156685188|NCT01546519|565592116|FG001|Overall Study|related to disease progression|2|||
156685189|NCT01546519|565592117|FG002|Overall Study|related to disease progression|2|||
156685190|NCT01546519|565592118|FG003|Overall Study|related to disease progression|1|||
156685191|NCT01546519|565592115|FG000|Overall Study|Physician Decision|6|||
156685192|NCT01546519|565592116|FG001|Overall Study|Physician Decision|5|||
156685193|NCT01546519|565592117|FG002|Overall Study|Physician Decision|2|||
156685194|NCT01546519|565592118|FG003|Overall Study|Physician Decision|3|||
156685195|NCT01546519|565592115|FG000|Overall Study|Withdrawal by Subject|1|||
156685196|NCT01546519|565592116|FG001|Overall Study|Withdrawal by Subject|0|||
156685197|NCT01546519|565592117|FG002|Overall Study|Withdrawal by Subject|0|||
156685198|NCT01546519|565592118|FG003|Overall Study|Withdrawal by Subject|0|||
156685199|NCT01519947|565592119|FG000|Overall Study|Death|0|||
156685200|NCT01519947|565592120|FG001|Overall Study|Death|0|||
156685201|NCT01519947|565592121|FG002|Overall Study|Death|0|||
156685202|NCT01519947|565592122|FG003|Overall Study|Death|1|||
156685203|NCT01519947|565592119|FG000|Overall Study|Protocol Violation|0|||
157214009|NCT01625286|567529663|FG002|Overall Study|Adverse Event|0|||
156685204|NCT01519947|565592120|FG001|Overall Study|Protocol Violation|0|||
156685205|NCT01519947|565592121|FG002|Overall Study|Protocol Violation|2|||
156685206|NCT01519947|565592122|FG003|Overall Study|Protocol Violation|1|||
156685207|NCT01519947|565592119|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
156685208|NCT01519947|565592120|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
156685209|NCT01519947|565592121|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
156868488|NCT00068692|566277309|FG001|Step 2: Randomization|Adverse Event|0|||
156868489|NCT00068692|566277310|FG002|Step 2: Randomization|Adverse Event|4|||
156868490|NCT00068692|566277311|FG003|Step 2: Randomization|Adverse Event|2|||
156868491|NCT00068692|566277312|FG004|Step 2: Randomization|Adverse Event|2|||
156868492|NCT00068692|566277313|FG005|Step 2: Randomization|Adverse Event|3|||
156868493|NCT00068692|566277314|FG006|Step 2: Randomization|Adverse Event|4|||
156868494|NCT00068692|566277315|FG007|Step 2: Randomization|Adverse Event|4|||
156868495|NCT00068692|566277308|FG000|Step 2: Randomization|Death|0|||
156868496|NCT00068692|566277309|FG001|Step 2: Randomization|Death|0|||
156868497|NCT00068692|566277310|FG002|Step 2: Randomization|Death|0|||
156868498|NCT00068692|566277311|FG003|Step 2: Randomization|Death|0|||
156868499|NCT00068692|566277312|FG004|Step 2: Randomization|Death|1|||
156868500|NCT00068692|566277313|FG005|Step 2: Randomization|Death|0|||
156868501|NCT00068692|566277314|FG006|Step 2: Randomization|Death|0|||
156868502|NCT00068692|566277315|FG007|Step 2: Randomization|Death|1|||
156868503|NCT00068692|566277308|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
156868504|NCT00068692|566277309|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
156868505|NCT00068692|566277310|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
156868506|NCT00068692|566277311|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
156868507|NCT00068692|566277312|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
156868508|NCT00068692|566277313|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
156868509|NCT00068692|566277314|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
156868510|NCT00068692|566277315|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
156868511|NCT00068692|566277308|FG000|Step 2: Randomization|alternative therapy|0|||
156868512|NCT00068692|566277309|FG001|Step 2: Randomization|alternative therapy|0|||
156868513|NCT00068692|566277310|FG002|Step 2: Randomization|alternative therapy|0|||
156868514|NCT00068692|566277311|FG003|Step 2: Randomization|alternative therapy|1|||
156868515|NCT00068692|566277312|FG004|Step 2: Randomization|alternative therapy|1|||
156868516|NCT00068692|566277313|FG005|Step 2: Randomization|alternative therapy|0|||
156868517|NCT00068692|566277314|FG006|Step 2: Randomization|alternative therapy|0|||
156868518|NCT00068692|566277315|FG007|Step 2: Randomization|alternative therapy|0|||
156868519|NCT00068692|566277308|FG000|Step 2: Randomization|Physician Decision|0|||
156868520|NCT00068692|566277309|FG001|Step 2: Randomization|Physician Decision|0|||
156868521|NCT00068692|566277310|FG002|Step 2: Randomization|Physician Decision|0|||
156868522|NCT00068692|566277311|FG003|Step 2: Randomization|Physician Decision|1|||
156868523|NCT00068692|566277312|FG004|Step 2: Randomization|Physician Decision|1|||
156868524|NCT00068692|566277313|FG005|Step 2: Randomization|Physician Decision|0|||
156868525|NCT00068692|566277314|FG006|Step 2: Randomization|Physician Decision|0|||
156868526|NCT00068692|566277315|FG007|Step 2: Randomization|Physician Decision|0|||
156685210|NCT01519947|565592122|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
156685211|NCT01519947|565592119|FG000|Overall Study|Development of Anemia|0|||
156685212|NCT01519947|565592120|FG001|Overall Study|Development of Anemia|1|||
156685213|NCT01519947|565592121|FG002|Overall Study|Development of Anemia|0|||
156685214|NCT01519947|565592122|FG003|Overall Study|Development of Anemia|1|||
156785178|NCT00875667|565964847|FG001|Overall Study|Protocol Violation|0|||
156785179|NCT00875667|565964846|FG000|Overall Study|Disease Progression|100|||
156785180|NCT00875667|565964847|FG001|Overall Study|Disease Progression|49|||
156868527|NCT00068692|566277308|FG000|Step 2: Randomization|Other|0|||
156868528|NCT00068692|566277309|FG001|Step 2: Randomization|Other|0|||
156868529|NCT00068692|566277310|FG002|Step 2: Randomization|Other|0|||
156685215|NCT01519947|565592119|FG000|Overall Study|Blood Transfusion|0|||
156685216|NCT01519947|565592120|FG001|Overall Study|Blood Transfusion|1|||
156685217|NCT01519947|565592121|FG002|Overall Study|Blood Transfusion|1|||
156785181|NCT00875667|565964846|FG000|Overall Study|Miscellaneous|12|||
156785182|NCT00875667|565964847|FG001|Overall Study|Miscellaneous|6|||
156785183|NCT00875667|565964846|FG000|Overall Study|Randomized but no Study Drug Given|3|||
156785184|NCT00875667|565964847|FG001|Overall Study|Randomized but no Study Drug Given|1|||
156785185|NCT00120250|565964848|FG000|Overall Study|Lost to Follow-up|1|||
156785186|NCT00120250|565964849|FG001|Overall Study|Lost to Follow-up|1|||
156785187|NCT00120250|565964848|FG000|Overall Study|Protocol Violation|0|||
156685218|NCT01519947|565592122|FG003|Overall Study|Blood Transfusion|0|||
156785188|NCT00120250|565964849|FG001|Overall Study|Protocol Violation|1|||
156785189|NCT01967277|565964853|FG000|Overall Study|Lost to Follow-up|1|||
156785190|NCT01967277|565964854|FG001|Overall Study|Lost to Follow-up|2|||
156785191|NCT01967277|565964853|FG000|Overall Study|Unrelated illness|0|||
156785192|NCT01967277|565964854|FG001|Overall Study|Unrelated illness|1|||
156685219|NCT01519947|565592119|FG000|Overall Study|Withdrawal by Subject|0|||
156868530|NCT00068692|566277311|FG003|Step 2: Randomization|Other|1|||
156868531|NCT00068692|566277312|FG004|Step 2: Randomization|Other|0|||
156868532|NCT00068692|566277313|FG005|Step 2: Randomization|Other|1|||
156868533|NCT00068692|566277314|FG006|Step 2: Randomization|Other|0|||
156868534|NCT00068692|566277315|FG007|Step 2: Randomization|Other|0|||
156868535|NCT00068692|566277308|FG000|Step 2: Randomization|never start protocol therapy|0|||
156868536|NCT00068692|566277309|FG001|Step 2: Randomization|never start protocol therapy|0|||
157013258|NCT02723955|566801737|FG000|Expansion Phase|Site Closed|0|||
156685220|NCT01519947|565592120|FG001|Overall Study|Withdrawal by Subject|1|||
156785193|NCT01524705|565964857|FG000|Overall Study|Adverse Event|2|||
156685221|NCT01519947|565592121|FG002|Overall Study|Withdrawal by Subject|0|||
156685222|NCT01519947|565592122|FG003|Overall Study|Withdrawal by Subject|1|||
156685223|NCT01519947|565592119|FG000|Overall Study|Lost to Follow-up|0|||
156685224|NCT01519947|565592120|FG001|Overall Study|Lost to Follow-up|0|||
156685225|NCT01519947|565592121|FG002|Overall Study|Lost to Follow-up|3|||
156685226|NCT01519947|565592122|FG003|Overall Study|Lost to Follow-up|2|||
156685227|NCT01519947|565592119|FG000|Overall Study|Poor Response|1|||
156685228|NCT01519947|565592120|FG001|Overall Study|Poor Response|0|||
156685229|NCT01519947|565592121|FG002|Overall Study|Poor Response|0|||
156685230|NCT01519947|565592122|FG003|Overall Study|Poor Response|1|||
156685231|NCT01519947|565592119|FG000|Overall Study|Adverse Event|1|||
156685232|NCT01519947|565592120|FG001|Overall Study|Adverse Event|0|||
156685233|NCT01519947|565592121|FG002|Overall Study|Adverse Event|1|||
156685234|NCT01519947|565592122|FG003|Overall Study|Adverse Event|1|||
156685235|NCT01386125|565592125|FG000|Overall Study|Lost to Follow-up|3|||
156685236|NCT01386125|565592126|FG001|Overall Study|Lost to Follow-up|9|||
156685237|NCT01386125|565592125|FG000|Overall Study|Physician Decision|0|||
156685238|NCT01386125|565592126|FG001|Overall Study|Physician Decision|1|||
156685239|NCT01386125|565592125|FG000|Overall Study|Protocol Violation|5|||
156685240|NCT01386125|565592126|FG001|Overall Study|Protocol Violation|7|||
156685241|NCT01386125|565592125|FG000|Overall Study|Disease Progress|1|||
156685242|NCT01386125|565592126|FG001|Overall Study|Disease Progress|2|||
156685243|NCT01386125|565592125|FG000|Overall Study|Withdrawal by Subject|13|||
156685244|NCT01386125|565592126|FG001|Overall Study|Withdrawal by Subject|12|||
156685245|NCT01386125|565592125|FG000|Overall Study|Adverse Event|2|||
156685246|NCT01386125|565592126|FG001|Overall Study|Adverse Event|5|||
156685247|NCT01386125|565592125|FG000|Overall Study|Lack of Efficacy|0|||
156685248|NCT01386125|565592126|FG001|Overall Study|Lack of Efficacy|1|||
156685249|NCT01386125|565592125|FG000|Overall Study|Participant Leaving Country|1|||
156685250|NCT01386125|565592126|FG001|Overall Study|Participant Leaving Country|0|||
156685251|NCT02359864|565592128|FG000|Overall Study|Withdrawal by Subject|1|||
156685252|NCT02359864|565592129|FG001|Overall Study|Withdrawal by Subject|0|||
156685253|NCT00725764|565592130|FG000|Overall Study|Withdrawal by Subject|2|||
156685254|NCT00725764|565592130|FG000|Overall Study|Physician Decision|1|||
156685255|NCT00725764|565592130|FG000|Overall Study|Progressive Disease|7|||
156685256|NCT00725764|565592130|FG000|Overall Study|Lost to Follow-up|1|||
156685257|NCT00725764|565592130|FG000|Overall Study|Death|1|||
156685258|NCT00725764|565592130|FG000|Overall Study|Participant non compliant with protocol|1|||
156685259|NCT00725764|565592130|FG000|Overall Study|Decline in performance status|1|||
156685260|NCT04480307|565592132|FG000|Overall Study|Withdrawal by Subject|0|||
156685261|NCT04480307|565592133|FG001|Overall Study|Withdrawal by Subject|1|||
156685262|NCT04480307|565592134|FG002|Overall Study|Withdrawal by Subject|0|||
156685263|NCT04480307|565592135|FG003|Overall Study|Withdrawal by Subject|0|||
156685264|NCT04480307|565592132|FG000|Overall Study|Adverse Event|0|||
156685265|NCT04480307|565592133|FG001|Overall Study|Adverse Event|0|||
156685266|NCT04480307|565592134|FG002|Overall Study|Adverse Event|0|||
156685267|NCT04480307|565592135|FG003|Overall Study|Adverse Event|1|||
156685268|NCT00515216|565592140|FG000|Overall Study|Withdrawal by Subject|1|||
156685269|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
156685270|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
157120875|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
157120876|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
156685271|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
156685272|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
156685273|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156685274|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156685275|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
156685276|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
156685277|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
156685278|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
156685279|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
156685280|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
156685281|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
157120877|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
156685282|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
156685283|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
156685284|NCT02250651|565592141|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
156685285|NCT02250651|565592142|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
156685286|NCT02250651|565592143|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
156685287|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
156685288|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
156685289|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
156685290|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
156785194|NCT01524705|565964858|FG001|Overall Study|Adverse Event|0|||
156785195|NCT01524705|565964857|FG000|Overall Study|Death|1|||
156785196|NCT01524705|565964858|FG001|Overall Study|Death|0|||
156785197|NCT01524705|565964857|FG000|Overall Study|Lost to Follow-up|0|||
156785198|NCT01524705|565964858|FG001|Overall Study|Lost to Follow-up|1|||
156785199|NCT01524705|565964857|FG000|Overall Study|Withdrawal by Subject|0|||
156785200|NCT01524705|565964858|FG001|Overall Study|Withdrawal by Subject|1|||
156785201|NCT01524705|565964857|FG000|Overall Study|Pancreatic Cancer|0|||
156785202|NCT01524705|565964858|FG001|Overall Study|Pancreatic Cancer|1|||
156785203|NCT00103506|565964859|FG000|Overall Study|Study closed by sponsor|34|||
156785204|NCT00103506|565964860|FG001|Overall Study|Study closed by sponsor|37|||
156785205|NCT00103506|565964859|FG000|Overall Study|Death|257|||
156785206|NCT00103506|565964860|FG001|Overall Study|Death|253|||
156785207|NCT00103506|565964859|FG000|Overall Study|Lost to Follow-up|13|||
156785208|NCT00103506|565964860|FG001|Overall Study|Lost to Follow-up|13|||
156785209|NCT00103506|565964859|FG000|Overall Study|Withdrawal by Subject|18|||
156785210|NCT00103506|565964860|FG001|Overall Study|Withdrawal by Subject|21|||
156785211|NCT00585585|565964861|FG000|Overall Study|Adverse Event|1|||
156785212|NCT02153827|565964862|FG000|Overall Study|Lost to Follow-up|3|||
156785213|NCT02153827|565964863|FG001|Overall Study|Lost to Follow-up|9|||
156785214|NCT00965094|565964870|FG000|Overall Study|Adverse Event|5|||
156785215|NCT00965094|565964871|FG001|Overall Study|Adverse Event|0|||
156785216|NCT00965094|565964870|FG000|Overall Study|Lost to Follow-up|0|||
156785217|NCT00965094|565964871|FG001|Overall Study|Lost to Follow-up|1|||
156785218|NCT01179516|565964873|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
156785219|NCT01179516|565964874|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
156785220|NCT01179516|565964875|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
156785221|NCT01179516|565964873|FG000|Overall Study|Lack of Efficacy|4|||
156785222|NCT01179516|565964874|FG001|Overall Study|Lack of Efficacy|2|||
156785223|NCT01179516|565964875|FG002|Overall Study|Lack of Efficacy|0|||
156785224|NCT01179516|565964873|FG000|Overall Study|Noncompliance with Study Drug|2|||
156785225|NCT01179516|565964874|FG001|Overall Study|Noncompliance with Study Drug|0|||
156785226|NCT01179516|565964875|FG002|Overall Study|Noncompliance with Study Drug|1|||
156785227|NCT01179516|565964873|FG000|Overall Study|Protocol Deviations|4|||
156785228|NCT01179516|565964874|FG001|Overall Study|Protocol Deviations|3|||
156785229|NCT01179516|565964875|FG002|Overall Study|Protocol Deviations|3|||
156785230|NCT01179516|565964873|FG000|Overall Study|Withdrawal of Consent|2|||
156785231|NCT01179516|565964874|FG001|Overall Study|Withdrawal of Consent|6|||
156785232|NCT01179516|565964875|FG002|Overall Study|Withdrawal of Consent|10|||
156785233|NCT01179516|565964873|FG000|Overall Study|Lost to Follow-up|7|||
156785234|NCT01179516|565964874|FG001|Overall Study|Lost to Follow-up|7|||
156785235|NCT01179516|565964875|FG002|Overall Study|Lost to Follow-up|3|||
156785236|NCT01179516|565964873|FG000|Overall Study|Other|2|||
156785237|NCT01179516|565964874|FG001|Overall Study|Other|0|||
156785238|NCT01179516|565964875|FG002|Overall Study|Other|2|||
156785239|NCT05064800|565964880|FG000|Period 3|Withdrawal by Subject|0|||
156785240|NCT05064800|565964881|FG001|Period 3|Withdrawal by Subject|0|||
156785241|NCT05064800|565964882|FG002|Period 3|Withdrawal by Subject|0|||
156785242|NCT05064800|565964883|FG003|Period 3|Withdrawal by Subject|0|||
156785243|NCT05064800|565964884|FG004|Period 3|Withdrawal by Subject|1|||
156785244|NCT05064800|565964885|FG005|Period 3|Withdrawal by Subject|0|||
156785245|NCT00183391|565964886|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
156785246|NCT00183391|565964887|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
156785247|NCT00183391|565964886|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
156785248|NCT00183391|565964887|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
157120878|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
157120879|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
157120880|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
157120881|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
157120882|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
157120883|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
157120884|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
157120885|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
157120886|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
156785249|NCT00395512|565964888|FG000|Overall Study|Adverse Event|3|||
156785250|NCT00395512|565964889|FG001|Overall Study|Adverse Event|8|||
156785251|NCT00395512|565964890|FG002|Overall Study|Adverse Event|6|||
156785252|NCT00395512|565964891|FG003|Overall Study|Adverse Event|6|||
157120887|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
156785253|NCT00395512|565964888|FG000|Overall Study|Protocol Violation|2|||
156785254|NCT00395512|565964889|FG001|Overall Study|Protocol Violation|3|||
156785255|NCT00395512|565964890|FG002|Overall Study|Protocol Violation|6|||
156785256|NCT00395512|565964891|FG003|Overall Study|Protocol Violation|7|||
156785257|NCT00395512|565964888|FG000|Overall Study|Lost to Follow-up|2|||
156785258|NCT00395512|565964889|FG001|Overall Study|Lost to Follow-up|6|||
156785259|NCT00395512|565964890|FG002|Overall Study|Lost to Follow-up|5|||
156685291|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
156685292|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
156685293|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
156685294|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
156685295|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
156685296|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
156685297|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
156685298|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
156685299|NCT02250651|565592141|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
156685300|NCT02250651|565592142|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
156685301|NCT02250651|565592143|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
156685302|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
156685303|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
156685304|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
156685305|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
156685306|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
156685307|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
156685308|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
156685309|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
156685310|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
156685311|NCT02250651|565592141|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
156685312|NCT02250651|565592142|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
156685313|NCT02250651|565592143|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
156685314|NCT01264835|565592144|FG000|Overall Study|Lost to Follow-up|1|||
156685315|NCT02427399|565592148|FG000|Overall Study|Protocol Violation|14|||
156685316|NCT02427399|565592149|FG001|Overall Study|Protocol Violation|16|||
156785260|NCT00395512|565964891|FG003|Overall Study|Lost to Follow-up|5|||
156785261|NCT00395512|565964888|FG000|Overall Study|Withdrawal by Subject|6|||
156785262|NCT00395512|565964889|FG001|Overall Study|Withdrawal by Subject|5|||
156785263|NCT00395512|565964890|FG002|Overall Study|Withdrawal by Subject|5|||
156785264|NCT00395512|565964891|FG003|Overall Study|Withdrawal by Subject|12|||
156685317|NCT02427399|565592150|FG002|Overall Study|Protocol Violation|12|||
156685318|NCT02427399|565592151|FG003|Overall Study|Protocol Violation|18|||
156685319|NCT02427399|565592152|FG004|Overall Study|Protocol Violation|15|||
156685320|NCT01115933|565592153|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
156685321|NCT00605176|565592154|FG000|Overall Study|Adverse Event|2|||
156685322|NCT00605176|565592155|FG001|Overall Study|Adverse Event|1|||
156685323|NCT00605176|565592156|FG002|Overall Study|Adverse Event|3|||
156685324|NCT00605176|565592154|FG000|Overall Study|Withdrawal by Subject|4|||
156685325|NCT00605176|565592155|FG001|Overall Study|Withdrawal by Subject|2|||
156685326|NCT00605176|565592156|FG002|Overall Study|Withdrawal by Subject|4|||
156685327|NCT00605176|565592154|FG000|Overall Study|Lost to Follow-up|2|||
156685328|NCT00605176|565592155|FG001|Overall Study|Lost to Follow-up|2|||
156685329|NCT00605176|565592156|FG002|Overall Study|Lost to Follow-up|1|||
156685330|NCT00605176|565592154|FG000|Overall Study|Non-complicance with study procedures|1|||
156685331|NCT00605176|565592155|FG001|Overall Study|Non-complicance with study procedures|0|||
156685332|NCT00605176|565592156|FG002|Overall Study|Non-complicance with study procedures|0|||
156685333|NCT00605176|565592154|FG000|Overall Study|Use of concomitant therapy|1|||
156685334|NCT00605176|565592155|FG001|Overall Study|Use of concomitant therapy|0|||
156685335|NCT00605176|565592156|FG002|Overall Study|Use of concomitant therapy|1|||
156685336|NCT00605176|565592154|FG000|Overall Study|Other (not due to AE)|1|||
156685337|NCT00605176|565592155|FG001|Overall Study|Other (not due to AE)|1|||
156685338|NCT00605176|565592156|FG002|Overall Study|Other (not due to AE)|0|||
156685339|NCT01557920|565592159|FG000|Overall Study|Withdrawal by Subject|2|||
156685340|NCT01557920|565592160|FG001|Overall Study|Withdrawal by Subject|3|||
156685341|NCT01557920|565592159|FG000|Overall Study|Lack of Efficacy|1|||
156685342|NCT01557920|565592160|FG001|Overall Study|Lack of Efficacy|0|||
156685343|NCT01808248|565592169|FG000|Overall Study|Lack of Efficacy|3|||
156685344|NCT01808248|565592169|FG000|Overall Study|Withdrawal by Subject|1|||
156685345|NCT01808248|565592169|FG000|Overall Study|Lost to Follow-up|1|||
156685346|NCT03689894|565592175|FG000|Overall Study|Adverse Event|1|||
156685347|NCT01610063|565592176|FG000|Overall Study|Lost to Follow-up|42|||
156685348|NCT01610063|565592177|FG001|Overall Study|Lost to Follow-up|20|||
156685349|NCT01378962|565592182|FG000|Overall Study|Death|14|||
156685350|NCT01378962|565592182|FG000|Overall Study|Lost to Follow-up|1|||
156785265|NCT00395512|565964888|FG000|Overall Study|Physician Decision|6|||
156785266|NCT00395512|565964889|FG001|Overall Study|Physician Decision|4|||
156785267|NCT00395512|565964890|FG002|Overall Study|Physician Decision|2|||
156785268|NCT00395512|565964891|FG003|Overall Study|Physician Decision|2|||
156868537|NCT00068692|566277310|FG002|Step 2: Randomization|never start protocol therapy|1|||
156685351|NCT01378962|565592182|FG000|Overall Study|Other|2|||
156685352|NCT02056652|565592183|FG000|Overall Study|Withdrawal by Subject|1|||
156785269|NCT00395512|565964888|FG000|Overall Study|Other|1|||
156685353|NCT02056652|565592184|FG001|Overall Study|Withdrawal by Subject|0|||
156685354|NCT02056652|565592183|FG000|Overall Study|Lost to Follow-up|0|||
156685355|NCT02056652|565592184|FG001|Overall Study|Lost to Follow-up|3|||
156685356|NCT00987831|565592185|FG000|Overall Study|Never flared in 12 months|1|||
156685357|NCT00987831|565592186|FG001|Overall Study|Never flared in 12 months|0|||
156685358|NCT00987831|565592187|FG002|Overall Study|Never flared in 12 months|0|||
156685359|NCT00987831|565592185|FG000|Overall Study|Lost to Follow-up|0|||
156685360|NCT00987831|565592186|FG001|Overall Study|Lost to Follow-up|3|||
156685361|NCT00987831|565592187|FG002|Overall Study|Lost to Follow-up|0|||
156685362|NCT03253094|565592188|FG000|Overall Study|Adverse Event|2|||
156685363|NCT03253094|565592189|FG001|Overall Study|Adverse Event|0|||
156685364|NCT03253094|565592190|FG002|Overall Study|Adverse Event|0|||
156685365|NCT03253094|565592191|FG003|Overall Study|Adverse Event|0|||
156685366|NCT03253094|565592192|FG004|Overall Study|Adverse Event|0|||
156685367|NCT03253094|565592193|FG005|Overall Study|Adverse Event|0|||
156685368|NCT03253094|565592188|FG000|Overall Study|Lack of Efficacy|0|||
156685369|NCT03253094|565592189|FG001|Overall Study|Lack of Efficacy|0|||
156685370|NCT03253094|565592190|FG002|Overall Study|Lack of Efficacy|2|||
156685371|NCT03253094|565592191|FG003|Overall Study|Lack of Efficacy|1|||
156685372|NCT03253094|565592192|FG004|Overall Study|Lack of Efficacy|2|||
156685373|NCT03253094|565592193|FG005|Overall Study|Lack of Efficacy|1|||
156685374|NCT03253094|565592188|FG000|Overall Study|Lost to Follow-up|0|||
156685375|NCT03253094|565592189|FG001|Overall Study|Lost to Follow-up|0|||
156685376|NCT03253094|565592190|FG002|Overall Study|Lost to Follow-up|1|||
156685377|NCT03253094|565592191|FG003|Overall Study|Lost to Follow-up|1|||
156685378|NCT03253094|565592192|FG004|Overall Study|Lost to Follow-up|0|||
156685379|NCT03253094|565592193|FG005|Overall Study|Lost to Follow-up|1|||
156685380|NCT03253094|565592188|FG000|Overall Study|Physician Decision|1|||
156685381|NCT03253094|565592189|FG001|Overall Study|Physician Decision|0|||
156685382|NCT03253094|565592190|FG002|Overall Study|Physician Decision|0|||
156685383|NCT03253094|565592191|FG003|Overall Study|Physician Decision|1|||
156685384|NCT03253094|565592192|FG004|Overall Study|Physician Decision|0|||
156685385|NCT03253094|565592193|FG005|Overall Study|Physician Decision|2|||
156685386|NCT03253094|565592188|FG000|Overall Study|Withdrawal by Subject|1|||
156685387|NCT03253094|565592189|FG001|Overall Study|Withdrawal by Subject|2|||
156685388|NCT03253094|565592190|FG002|Overall Study|Withdrawal by Subject|1|||
156685389|NCT03253094|565592191|FG003|Overall Study|Withdrawal by Subject|0|||
156685390|NCT03253094|565592192|FG004|Overall Study|Withdrawal by Subject|3|||
156685391|NCT03253094|565592193|FG005|Overall Study|Withdrawal by Subject|0|||
156685392|NCT03253094|565592188|FG000|Overall Study|Other|0|||
156685393|NCT03253094|565592189|FG001|Overall Study|Other|1|||
156685394|NCT03253094|565592190|FG002|Overall Study|Other|2|||
156685395|NCT03253094|565592191|FG003|Overall Study|Other|1|||
156685396|NCT03253094|565592192|FG004|Overall Study|Other|0|||
156685397|NCT03253094|565592193|FG005|Overall Study|Other|0|||
156685398|NCT02219308|565592194|FG000|Overall Study|Withdrawal by Subject|1|||
156685399|NCT02219308|565592195|FG001|Overall Study|Withdrawal by Subject|2|||
156685400|NCT04149535|565592198|FG000|Overall Study|Death|11|||
156685401|NCT04149535|565592199|FG001|Overall Study|Death|7|||
156685402|NCT04149535|565592198|FG000|Overall Study|Physician Decision|10|||
156685403|NCT04149535|565592199|FG001|Overall Study|Physician Decision|4|||
156685404|NCT04149535|565592198|FG000|Overall Study|Withdrawal by Subject|6|||
156685405|NCT04149535|565592199|FG001|Overall Study|Withdrawal by Subject|7|||
156685406|NCT04149535|565592198|FG000|Overall Study|Not described|2|||
156685407|NCT04149535|565592199|FG001|Overall Study|Not described|0|||
156685408|NCT02175368|565592200|FG000|Overall Study|Lost to Follow-up|1|||
156685409|NCT02875028|565592201|FG000|Washout Period|Withdrawal by Subject|0|||
156685410|NCT02875028|565592202|FG001|Washout Period|Withdrawal by Subject|1|||
157120888|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
157120889|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
157120890|NCT00784654|567194327|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
157120891|NCT00784654|567194328|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
157120892|NCT00784654|567194329|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
156685411|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
156685412|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
156685413|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685414|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685415|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685416|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685417|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685418|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
156685419|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685420|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685421|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
156685422|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685423|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685424|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685425|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685426|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
156685427|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
156685428|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
156685429|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
156685430|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
156685431|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
156685432|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685433|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685434|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
156685435|NCT05068284|565592203|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685436|NCT05068284|565592204|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685437|NCT05068284|565592205|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
156685438|NCT05068284|565592206|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685439|NCT05068284|565592207|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
156685440|NCT05068284|565592208|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685441|NCT05068284|565592209|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685442|NCT05068284|565592210|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
156685443|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685444|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685445|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685446|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
156685447|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685448|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685449|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685450|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
156685451|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685452|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685453|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
156685454|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
156685455|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685456|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685457|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685458|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
156685459|NCT05068284|565592203|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685460|NCT05068284|565592204|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685461|NCT05068284|565592205|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
156685462|NCT05068284|565592206|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685463|NCT05068284|565592207|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685464|NCT05068284|565592208|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685465|NCT05068284|565592209|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685466|NCT05068284|565592210|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
156685467|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
156685468|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685469|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685470|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685471|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685472|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685473|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685474|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
156685475|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
156685476|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685477|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685478|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685479|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685480|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
156685481|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
156685482|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
156685483|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
157013259|NCT02723955|566801738|FG001|Expansion Phase|Site Closed|0|||
156685484|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685485|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685486|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685487|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685488|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685489|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
156685490|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
156685491|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
156685492|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685493|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685494|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685495|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685496|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685497|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685498|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
156685499|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
156685500|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685501|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685502|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685503|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156868538|NCT00068692|566277311|FG003|Step 2: Randomization|never start protocol therapy|0|||
156868539|NCT00068692|566277312|FG004|Step 2: Randomization|never start protocol therapy|1|||
156868540|NCT00068692|566277313|FG005|Step 2: Randomization|never start protocol therapy|0|||
156868541|NCT00068692|566277314|FG006|Step 2: Randomization|never start protocol therapy|0|||
156868542|NCT00068692|566277315|FG007|Step 2: Randomization|never start protocol therapy|0|||
156868543|NCT01600716|566277317|FG000|Overall Study|Other Reasons|3|||
156868544|NCT01600716|566277318|FG001|Overall Study|Other Reasons|1|||
156868545|NCT01600716|566277317|FG000|Overall Study|Personal Reasons|0|||
157120893|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
157120894|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
157120895|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
157120896|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
157120897|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
157120898|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
157120899|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157120900|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
157120901|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
156868546|NCT01600716|566277318|FG001|Overall Study|Personal Reasons|2|||
156868547|NCT01600716|566277317|FG000|Overall Study|Lost to Follow-up|0|||
156868548|NCT01600716|566277318|FG001|Overall Study|Lost to Follow-up|2|||
156868549|NCT01600716|566277317|FG000|Overall Study|Pregnancy|1|||
156868550|NCT01600716|566277318|FG001|Overall Study|Pregnancy|0|||
156868551|NCT01600716|566277317|FG000|Overall Study|Lack of Efficacy|2|||
156868552|NCT01600716|566277318|FG001|Overall Study|Lack of Efficacy|1|||
156868553|NCT01600716|566277317|FG000|Overall Study|Adverse Event|1|||
156868554|NCT01600716|566277318|FG001|Overall Study|Adverse Event|1|||
156868555|NCT03557034|566277321|FG000|Overall Study|Withdrawal by Subject|1|||
156868556|NCT03557034|566277322|FG001|Overall Study|Withdrawal by Subject|0|||
157120902|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
157120903|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
157120904|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
157120905|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Adverse Event|0|||
157120906|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Adverse Event|1|||
156685504|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685505|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685506|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
156685507|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
156685508|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156868557|NCT03349034|566277325|FG000|Overall Study|catheters dislodged during transport|2|||
156868558|NCT03349034|566277326|FG001|Overall Study|catheters dislodged during transport|0|||
156868559|NCT03349034|566277325|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
157120907|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Adverse Event|1|||
157120908|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
157120909|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
157120910|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
157120911|NCT00784654|567194327|FG000|Randomized Withdrawal Period|Family reasons|0|||
157120912|NCT00784654|567194328|FG001|Randomized Withdrawal Period|Family reasons|0|||
157120913|NCT00784654|567194329|FG002|Randomized Withdrawal Period|Family reasons|1|||
157120914|NCT00844753|567194330|FG000|Overall Study|Lack of Efficacy|1|||
157120915|NCT00844753|567194331|FG001|Overall Study|Lack of Efficacy|0|||
157120916|NCT00844753|567194332|FG002|Overall Study|Lack of Efficacy|2|||
157120917|NCT00844753|567194333|FG003|Overall Study|Lack of Efficacy|2|||
157120918|NCT00844753|567194330|FG000|Overall Study|Adverse Event|3|||
157120919|NCT00844753|567194331|FG001|Overall Study|Adverse Event|2|||
157120920|NCT00844753|567194332|FG002|Overall Study|Adverse Event|5|||
157120921|NCT00844753|567194333|FG003|Overall Study|Adverse Event|5|||
157120922|NCT00844753|567194330|FG000|Overall Study|Lost to Follow-up|1|||
157120923|NCT00844753|567194331|FG001|Overall Study|Lost to Follow-up|1|||
157120924|NCT00844753|567194332|FG002|Overall Study|Lost to Follow-up|0|||
157120925|NCT00844753|567194333|FG003|Overall Study|Lost to Follow-up|1|||
157120926|NCT00844753|567194330|FG000|Overall Study|could not swallow medication|2|||
157120927|NCT00844753|567194331|FG001|Overall Study|could not swallow medication|0|||
157120928|NCT00844753|567194332|FG002|Overall Study|could not swallow medication|0|||
157120929|NCT00844753|567194333|FG003|Overall Study|could not swallow medication|0|||
157120930|NCT00844753|567194330|FG000|Overall Study|Withdrawal by Subject|1|||
157120931|NCT00844753|567194331|FG001|Overall Study|Withdrawal by Subject|0|||
157120932|NCT00844753|567194332|FG002|Overall Study|Withdrawal by Subject|0|||
157120933|NCT00844753|567194333|FG003|Overall Study|Withdrawal by Subject|3|||
157120934|NCT05073458|567194342|FG000|24-week Double-blind Period|Adverse Event|1|||
157120935|NCT05073458|567194343|FG001|24-week Double-blind Period|Adverse Event|0|||
157120936|NCT05073458|567194342|FG000|24-week Double-blind Period|Physician Decision|1|||
157120937|NCT05073458|567194343|FG001|24-week Double-blind Period|Physician Decision|0|||
157120938|NCT05073458|567194342|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
157214010|NCT01625286|567529664|FG003|Overall Study|Adverse Event|0|||
157214011|NCT01625286|567529665|FG004|Overall Study|Adverse Event|1|||
156785270|NCT00395512|565964889|FG001|Overall Study|Other|1|||
156785271|NCT00395512|565964890|FG002|Overall Study|Other|0|||
156785272|NCT00395512|565964891|FG003|Overall Study|Other|0|||
156785273|NCT00395512|565964888|FG000|Overall Study|Hyperglycemic Rescue|18|||
156785274|NCT00395512|565964889|FG001|Overall Study|Hyperglycemic Rescue|10|||
156785275|NCT00395512|565964890|FG002|Overall Study|Hyperglycemic Rescue|4|||
156785276|NCT00395512|565964891|FG003|Overall Study|Hyperglycemic Rescue|6|||
156785277|NCT04584554|565964896|FG000|Overall Study|Withdrawal by Subject|2|||
156785278|NCT04584554|565964897|FG001|Overall Study|Withdrawal by Subject|2|||
156785279|NCT04625972|565964901|FG000|Overall Study|Death|3|||
156785280|NCT04625972|565964902|FG001|Overall Study|Death|2|||
156785281|NCT04625972|565964901|FG000|Overall Study|Lost to Follow-up|82|||
156785282|NCT04625972|565964902|FG001|Overall Study|Lost to Follow-up|38|||
156785283|NCT04625972|565964901|FG000|Overall Study|Physician Decision|2|||
156785284|NCT04625972|565964902|FG001|Overall Study|Physician Decision|0|||
156785285|NCT04625972|565964901|FG000|Overall Study|Protocol Violation|0|||
156785286|NCT04625972|565964902|FG001|Overall Study|Protocol Violation|1|||
156785287|NCT04625972|565964901|FG000|Overall Study|Withdrawal by Subject|37|||
156785288|NCT04625972|565964902|FG001|Overall Study|Withdrawal by Subject|24|||
156785289|NCT04625972|565964901|FG000|Overall Study|Not specified elsewhere|8|||
156785290|NCT04625972|565964902|FG001|Overall Study|Not specified elsewhere|6|||
156785291|NCT05591755|565964903|FG000|Overall Study|Screen Failure|1|||
156785292|NCT05591755|565964904|FG001|Overall Study|Screen Failure|0|||
156785293|NCT05591755|565964905|FG002|Overall Study|Screen Failure|0|||
156785294|NCT05591755|565964906|FG003|Overall Study|Screen Failure|0|||
156785295|NCT05591755|565964903|FG000|Overall Study|Protocol Violation|0|||
156785296|NCT05591755|565964904|FG001|Overall Study|Protocol Violation|0|||
156785297|NCT05591755|565964905|FG002|Overall Study|Protocol Violation|2|||
156785298|NCT05591755|565964906|FG003|Overall Study|Protocol Violation|0|||
156785299|NCT05591755|565964903|FG000|Overall Study|Withdrawal by Subject|0|||
156785300|NCT05591755|565964904|FG001|Overall Study|Withdrawal by Subject|1|||
156785301|NCT05591755|565964905|FG002|Overall Study|Withdrawal by Subject|0|||
156785302|NCT05591755|565964906|FG003|Overall Study|Withdrawal by Subject|0|||
156785303|NCT00433290|565964907|FG000|Overall Study|Adverse Event|24|||
156785304|NCT00433290|565964908|FG001|Overall Study|Adverse Event|7|||
156785305|NCT00433290|565964907|FG000|Overall Study|Lack of Efficacy|1|||
156785306|NCT00433290|565964908|FG001|Overall Study|Lack of Efficacy|5|||
156785307|NCT00433290|565964907|FG000|Overall Study|Withdrawal by Subject|4|||
156785308|NCT00433290|565964908|FG001|Overall Study|Withdrawal by Subject|2|||
156785309|NCT00433290|565964907|FG000|Overall Study|Protocol Violation|3|||
156785310|NCT00433290|565964908|FG001|Overall Study|Protocol Violation|2|||
156785311|NCT00433290|565964907|FG000|Overall Study|Physician Decision|2|||
157120939|NCT05073458|567194343|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
157120940|NCT05073458|567194342|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
157120941|NCT05073458|567194343|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
157120942|NCT05073458|567194342|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
157120943|NCT05073458|567194343|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
157120944|NCT05073458|567194342|FG000|24-week Open-label Period|Adverse Event|1|||
157120945|NCT05073458|567194343|FG001|24-week Open-label Period|Adverse Event|2|||
157120946|NCT01627899|567194344|FG000|Overall Study|Study terminated early by sponsor.|5|||
157120947|NCT01430455|567194347|FG000|Overall Study|Withdrawal by Subject|1|||
157120948|NCT01430455|567194347|FG000|Overall Study|Switched to follow-up phase|1|||
157120949|NCT00264238|567194353|FG000|Overall Study|Protocol Violation|1|||
157120950|NCT04818593|567194354|FG000|Overall Study|Low Oocyte Yield|8|||
157120951|NCT04818593|567194355|FG001|Overall Study|Low Oocyte Yield|8|||
157120952|NCT04818593|567194354|FG000|Overall Study|Not ICSI Insemination|7|||
157120953|NCT04818593|567194355|FG001|Overall Study|Not ICSI Insemination|7|||
157120954|NCT04818593|567194354|FG000|Overall Study|Poor Sperm Quality|2|||
157120955|NCT04818593|567194355|FG001|Overall Study|Poor Sperm Quality|2|||
157120956|NCT04818593|567194354|FG000|Overall Study|Withdrawal by Subject|2|||
157120957|NCT04818593|567194355|FG001|Overall Study|Withdrawal by Subject|2|||
157120958|NCT04818593|567194354|FG000|Overall Study|Conversion to IUI due to low response|1|||
157120959|NCT04818593|567194355|FG001|Overall Study|Conversion to IUI due to low response|1|||
157120960|NCT03809611|567194356|FG000|Overall Study|Withdrawal by Subject|1|||
157120961|NCT03809611|567194357|FG001|Overall Study|Withdrawal by Subject|1|||
157120962|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
157120963|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
157120964|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
157120965|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
157120966|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
157120967|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
157120968|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
157120969|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
157120970|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
157120971|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
156685509|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685510|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685511|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
156685512|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
156685513|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
156685514|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
156685515|NCT05068284|565592203|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685516|NCT05068284|565592204|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685517|NCT05068284|565592205|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685518|NCT05068284|565592206|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685519|NCT05068284|565592207|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685520|NCT05068284|565592208|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
157013260|NCT02723955|566801739|FG002|Expansion Phase|Site Closed|0|||
156685521|NCT05068284|565592209|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
156685522|NCT05068284|565592210|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
156685523|NCT02447887|565593866|FG000|Overall Study|Study was terminated|3|||
156685524|NCT03941834|565593867|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
156685525|NCT03941834|565593868|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
157013261|NCT02723955|566801740|FG003|Expansion Phase|Site Closed|0|||
157013262|NCT02723955|566801741|FG004|Expansion Phase|Site Closed|0|||
157013263|NCT02723955|566801742|FG005|Expansion Phase|Site Closed|0|||
157013264|NCT02723955|566801743|FG006|Expansion Phase|Site Closed|0|||
157013265|NCT02723955|566801744|FG007|Expansion Phase|Site Closed|0|||
157013266|NCT02723955|566801745|FG008|Expansion Phase|Site Closed|0|||
157013267|NCT02723955|566801746|FG009|Expansion Phase|Site Closed|1|||
157013268|NCT02723955|566801747|FG010|Expansion Phase|Site Closed|2|||
157013269|NCT02723955|566801748|FG011|Expansion Phase|Site Closed|6|||
157013270|NCT02723955|566801749|FG012|Expansion Phase|Site Closed|0|||
157013271|NCT02723955|566801750|FG013|Expansion Phase|Site Closed|0|||
157013272|NCT02723955|566801751|FG014|Expansion Phase|Site Closed|0|||
157013273|NCT02723955|566801752|FG015|Expansion Phase|Site Closed|0|||
157013274|NCT02723955|566801753|FG016|Expansion Phase|Site Closed|0|||
157013275|NCT02723955|566801754|FG017|Expansion Phase|Site Closed|0|||
157013276|NCT02723955|566801755|FG018|Expansion Phase|Site Closed|0|||
156785312|NCT00433290|565964908|FG001|Overall Study|Physician Decision|0|||
156785313|NCT00433290|565964907|FG000|Overall Study|Entry Criteria Not Met|0|||
156785314|NCT00433290|565964908|FG001|Overall Study|Entry Criteria Not Met|1|||
156785315|NCT00433290|565964907|FG000|Overall Study|Lost to Follow-up|1|||
156785316|NCT00433290|565964908|FG001|Overall Study|Lost to Follow-up|0|||
157013277|NCT02723955|566801756|FG019|Expansion Phase|Site Closed|0|||
157120972|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
157120973|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
157120974|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
157120975|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
157120976|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
157120977|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
157120978|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
157120979|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
157120980|NCT02600494|567194358|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
157120981|NCT02600494|567194359|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
157120982|NCT02600494|567194360|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
157120983|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
157120984|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
157120985|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
157120986|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
157120987|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
157120988|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
157120989|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
157120990|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
157120991|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
157120992|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
157120993|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
157214012|NCT01625286|567529666|FG005|Overall Study|Adverse Event|2|||
157214013|NCT01625286|567529667|FG006|Overall Study|Adverse Event|1|||
157214014|NCT01625286|567529661|FG000|Overall Study|Death|0|||
157214015|NCT01625286|567529662|FG001|Overall Study|Death|0|||
157214016|NCT01625286|567529663|FG002|Overall Study|Death|1|||
157214017|NCT01625286|567529664|FG003|Overall Study|Death|1|||
157214018|NCT01625286|567529665|FG004|Overall Study|Death|0|||
157214019|NCT01625286|567529666|FG005|Overall Study|Death|11|||
157214020|NCT01625286|567529667|FG006|Overall Study|Death|16|||
157214021|NCT01625286|567529661|FG000|Overall Study|Withdrawal by Subject|0|||
157214022|NCT01625286|567529662|FG001|Overall Study|Withdrawal by Subject|1|||
157214023|NCT01625286|567529663|FG002|Overall Study|Withdrawal by Subject|0|||
157214024|NCT01625286|567529664|FG003|Overall Study|Withdrawal by Subject|1|||
157214025|NCT01625286|567529665|FG004|Overall Study|Withdrawal by Subject|0|||
157214026|NCT01625286|567529666|FG005|Overall Study|Withdrawal by Subject|0|||
157214027|NCT01625286|567529667|FG006|Overall Study|Withdrawal by Subject|1|||
157214028|NCT01625286|567529661|FG000|Overall Study|Any reason not specifically recorded|0|||
157214029|NCT01625286|567529662|FG001|Overall Study|Any reason not specifically recorded|0|||
157214030|NCT01625286|567529663|FG002|Overall Study|Any reason not specifically recorded|0|||
157214031|NCT01625286|567529664|FG003|Overall Study|Any reason not specifically recorded|0|||
157214032|NCT01625286|567529665|FG004|Overall Study|Any reason not specifically recorded|0|||
157214033|NCT01625286|567529666|FG005|Overall Study|Any reason not specifically recorded|1|||
157214034|NCT01625286|567529667|FG006|Overall Study|Any reason not specifically recorded|0|||
157214035|NCT01625286|567529661|FG000|Overall Study|Progressive disease|6|||
157214036|NCT01625286|567529662|FG001|Overall Study|Progressive disease|3|||
157214037|NCT01625286|567529663|FG002|Overall Study|Progressive disease|4|||
157214038|NCT01625286|567529664|FG003|Overall Study|Progressive disease|5|||
157214039|NCT01625286|567529665|FG004|Overall Study|Progressive disease|5|||
157214040|NCT01625286|567529666|FG005|Overall Study|Progressive disease|0|||
157214041|NCT01625286|567529667|FG006|Overall Study|Progressive disease|0|||
157214042|NCT01625286|567529661|FG000|Overall Study|Lost to Follow-up|0|||
157214043|NCT01625286|567529662|FG001|Overall Study|Lost to Follow-up|0|||
157214044|NCT01625286|567529663|FG002|Overall Study|Lost to Follow-up|0|||
157214045|NCT01625286|567529664|FG003|Overall Study|Lost to Follow-up|0|||
157214046|NCT01625286|567529665|FG004|Overall Study|Lost to Follow-up|0|||
157214047|NCT01625286|567529666|FG005|Overall Study|Lost to Follow-up|0|||
157214048|NCT01625286|567529667|FG006|Overall Study|Lost to Follow-up|1|||
157214049|NCT00928135|567529668|FG000|Overall Study|Withdrawal by Subject|1|||
156785317|NCT02547935|565964909|FG000|Overall Study|Other|0|||
156785318|NCT02547935|565964910|FG001|Overall Study|Other|1|||
156785319|NCT02547935|565964911|FG002|Overall Study|Other|0|||
156785320|NCT02547935|565964909|FG000|Overall Study|Withdrawal by Subject|2|||
156785321|NCT02547935|565964910|FG001|Overall Study|Withdrawal by Subject|3|||
156785322|NCT02547935|565964911|FG002|Overall Study|Withdrawal by Subject|4|||
156785323|NCT02547935|565964909|FG000|Overall Study|Screen Failure|2|||
156785324|NCT02547935|565964910|FG001|Overall Study|Screen Failure|0|||
156785325|NCT02547935|565964911|FG002|Overall Study|Screen Failure|0|||
156785326|NCT02547935|565964909|FG000|Overall Study|Physician Decision|0|||
156785327|NCT02547935|565964910|FG001|Overall Study|Physician Decision|1|||
156785328|NCT02547935|565964911|FG002|Overall Study|Physician Decision|0|||
156785329|NCT02547935|565964909|FG000|Overall Study|Lost to Follow-up|0|||
156785330|NCT02547935|565964910|FG001|Overall Study|Lost to Follow-up|2|||
156785331|NCT02547935|565964911|FG002|Overall Study|Lost to Follow-up|1|||
157013278|NCT02723955|566801757|FG020|Expansion Phase|Site Closed|0|||
156785332|NCT02547935|565964909|FG000|Overall Study|Death|1|||
156785333|NCT02547935|565964910|FG001|Overall Study|Death|1|||
156785334|NCT02547935|565964911|FG002|Overall Study|Death|0|||
156785335|NCT00086307|565964912|FG000|Overall Study|Lack of Efficacy|1|||
157013279|NCT02723955|566801758|FG021|Expansion Phase|Site Closed|0|||
156785336|NCT00086307|565964913|FG001|Overall Study|Lack of Efficacy|1|||
156785337|NCT00086307|565964914|FG002|Overall Study|Lack of Efficacy|2|||
156785338|NCT00086307|565964912|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
156785339|NCT00086307|565964913|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
156785340|NCT00086307|565964914|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
156785341|NCT00086307|565964912|FG000|Overall Study|Nausea and headaches|0|||
156785342|NCT00086307|565964913|FG001|Overall Study|Nausea and headaches|0|||
156785343|NCT00086307|565964914|FG002|Overall Study|Nausea and headaches|1|||
156785344|NCT00086307|565964912|FG000|Overall Study|Constipation and sleepiness|0|||
157013280|NCT02723955|566801759|FG022|Expansion Phase|Site Closed|0|||
157013281|NCT02723955|566801760|FG023|Expansion Phase|Site Closed|0|||
157013282|NCT02723955|566801761|FG024|Expansion Phase|Site Closed|0|||
157013283|NCT02723955|566801762|FG025|Expansion Phase|Site Closed|0|||
157013284|NCT02723955|566801763|FG026|Expansion Phase|Site Closed|0|||
157013285|NCT02723955|566801764|FG027|Expansion Phase|Site Closed|0|||
157013286|NCT02723955|566801765|FG028|Expansion Phase|Site Closed|0|||
157013287|NCT02723955|566801766|FG029|Expansion Phase|Site Closed|0|||
157013288|NCT02723955|566801767|FG030|Expansion Phase|Site Closed|8|||
157013289|NCT02723955|566801768|FG031|Expansion Phase|Site Closed|4|||
157013290|NCT02723955|566801769|FG032|Expansion Phase|Site Closed|2|||
157013291|NCT02723955|566801770|FG033|Expansion Phase|Site Closed|2|||
157013292|NCT02723955|566801771|FG034|Expansion Phase|Site Closed|0|||
157013293|NCT02723955|566801772|FG035|Expansion Phase|Site Closed|0|||
157013294|NCT02723955|566801773|FG036|Expansion Phase|Site Closed|0|||
157013295|NCT02723955|566801774|FG037|Expansion Phase|Site Closed|0|||
157013296|NCT02723955|566801775|FG038|Expansion Phase|Site Closed|0|||
157013297|NCT02723955|566801776|FG039|Expansion Phase|Site Closed|0|||
157013298|NCT02723955|566801777|FG040|Expansion Phase|Site Closed|0|||
157013299|NCT02723955|566801778|FG041|Expansion Phase|Site Closed|0|||
157013300|NCT02723955|566801779|FG042|Expansion Phase|Site Closed|0|||
157013301|NCT02723955|566801737|FG000|Crossover/ Re-treatment Phase|Death|0|||
157013302|NCT02723955|566801738|FG001|Crossover/ Re-treatment Phase|Death|0|||
157013303|NCT02723955|566801739|FG002|Crossover/ Re-treatment Phase|Death|0|||
157013304|NCT02723955|566801740|FG003|Crossover/ Re-treatment Phase|Death|0|||
157013305|NCT02723955|566801741|FG004|Crossover/ Re-treatment Phase|Death|0|||
157013306|NCT02723955|566801742|FG005|Crossover/ Re-treatment Phase|Death|0|||
157013307|NCT02723955|566801743|FG006|Crossover/ Re-treatment Phase|Death|0|||
157013308|NCT02723955|566801744|FG007|Crossover/ Re-treatment Phase|Death|0|||
157013309|NCT02723955|566801745|FG008|Crossover/ Re-treatment Phase|Death|0|||
157013310|NCT02723955|566801746|FG009|Crossover/ Re-treatment Phase|Death|0|||
157013311|NCT02723955|566801747|FG010|Crossover/ Re-treatment Phase|Death|0|||
157013312|NCT02723955|566801748|FG011|Crossover/ Re-treatment Phase|Death|0|||
157013313|NCT02723955|566801749|FG012|Crossover/ Re-treatment Phase|Death|0|||
157013314|NCT02723955|566801750|FG013|Crossover/ Re-treatment Phase|Death|0|||
157013315|NCT02723955|566801751|FG014|Crossover/ Re-treatment Phase|Death|0|||
157013316|NCT02723955|566801752|FG015|Crossover/ Re-treatment Phase|Death|0|||
157013317|NCT02723955|566801753|FG016|Crossover/ Re-treatment Phase|Death|0|||
157013318|NCT02723955|566801754|FG017|Crossover/ Re-treatment Phase|Death|0|||
157013319|NCT02723955|566801755|FG018|Crossover/ Re-treatment Phase|Death|0|||
157013320|NCT02723955|566801756|FG019|Crossover/ Re-treatment Phase|Death|0|||
157013321|NCT02723955|566801757|FG020|Crossover/ Re-treatment Phase|Death|0|||
157013322|NCT02723955|566801758|FG021|Crossover/ Re-treatment Phase|Death|0|||
157013323|NCT02723955|566801759|FG022|Crossover/ Re-treatment Phase|Death|0|||
157013324|NCT02723955|566801760|FG023|Crossover/ Re-treatment Phase|Death|0|||
157013325|NCT02723955|566801761|FG024|Crossover/ Re-treatment Phase|Death|0|||
157013326|NCT02723955|566801762|FG025|Crossover/ Re-treatment Phase|Death|0|||
157013327|NCT02723955|566801763|FG026|Crossover/ Re-treatment Phase|Death|0|||
157120994|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
157013328|NCT02723955|566801764|FG027|Crossover/ Re-treatment Phase|Death|0|||
157013329|NCT02723955|566801765|FG028|Crossover/ Re-treatment Phase|Death|0|||
157013330|NCT02723955|566801766|FG029|Crossover/ Re-treatment Phase|Death|0|||
157013331|NCT02723955|566801767|FG030|Crossover/ Re-treatment Phase|Death|0|||
157013332|NCT02723955|566801768|FG031|Crossover/ Re-treatment Phase|Death|0|||
157013333|NCT02723955|566801769|FG032|Crossover/ Re-treatment Phase|Death|0|||
157013334|NCT02723955|566801770|FG033|Crossover/ Re-treatment Phase|Death|0|||
156785345|NCT00086307|565964913|FG001|Overall Study|Constipation and sleepiness|0|||
157013335|NCT02723955|566801771|FG034|Crossover/ Re-treatment Phase|Death|0|||
157013336|NCT02723955|566801772|FG035|Crossover/ Re-treatment Phase|Death|0|||
157013337|NCT02723955|566801773|FG036|Crossover/ Re-treatment Phase|Death|0|||
157013338|NCT02723955|566801774|FG037|Crossover/ Re-treatment Phase|Death|1|||
157013339|NCT02723955|566801775|FG038|Crossover/ Re-treatment Phase|Death|14|||
157120995|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
157120996|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
157120997|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
157120998|NCT02600494|567194358|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
157120999|NCT02600494|567194359|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
157121000|NCT02600494|567194360|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
157121001|NCT03124563|567194361|FG000|Overall Study|Lost to Follow-up|1|||
157121002|NCT03124563|567194362|FG001|Overall Study|Lost to Follow-up|1|||
157121003|NCT03124563|567194361|FG000|Overall Study|Withdrawal by Subject|1|||
157121004|NCT03124563|567194362|FG001|Overall Study|Withdrawal by Subject|1|||
157121005|NCT05061719|567194365|FG000|Overall Study|Adverse Event|60|||
156685526|NCT03941834|565593869|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
156685527|NCT03941834|565593867|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
157214050|NCT00928135|567529669|FG001|Overall Study|Withdrawal by Subject|0|||
156785346|NCT00086307|565964914|FG002|Overall Study|Constipation and sleepiness|1|||
156785347|NCT00086307|565964912|FG000|Overall Study|Suicidal ideation|0|||
156785348|NCT00086307|565964913|FG001|Overall Study|Suicidal ideation|0|||
156785349|NCT00086307|565964914|FG002|Overall Study|Suicidal ideation|1|||
156785350|NCT00086307|565964912|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
156785351|NCT00086307|565964913|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
156785352|NCT00086307|565964914|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
156785353|NCT00086307|565964912|FG000|Overall Study|Withdrawal by Subject|0|||
156785354|NCT00086307|565964913|FG001|Overall Study|Withdrawal by Subject|0|||
156785355|NCT00086307|565964914|FG002|Overall Study|Withdrawal by Subject|2|||
156785356|NCT01018953|565964915|FG000|Overall Study|Adverse Event|2|||
156785357|NCT01018953|565964915|FG000|Overall Study|Withdrawal by Subject|1|||
156785358|NCT01018953|565964915|FG000|Overall Study|Study termination by sponsor|5|||
156785359|NCT00724503|565964916|FG000|Overall Study|Lost to Follow-up|4|||
156785360|NCT00724503|565964917|FG001|Overall Study|Lost to Follow-up|8|||
156785361|NCT00724503|565964916|FG000|Overall Study|Withdrawal by Subject|11|||
156785362|NCT00724503|565964917|FG001|Overall Study|Withdrawal by Subject|23|||
156785363|NCT00724503|565964916|FG000|Overall Study|Death|190|||
156785364|NCT00724503|565964917|FG001|Overall Study|Death|182|||
156785365|NCT00724503|565964916|FG000|Overall Study|Adverse Event|1|||
156785366|NCT00724503|565964917|FG001|Overall Study|Adverse Event|0|||
156785367|NCT00724503|565964916|FG000|Overall Study|Not otherwise specified|4|||
156785368|NCT00724503|565964917|FG001|Overall Study|Not otherwise specified|7|||
156785369|NCT01186419|565964918|FG000|Overall Study|Withdrawal by Subject|5|||
156785370|NCT01186419|565964919|FG001|Overall Study|Withdrawal by Subject|3|||
156785371|NCT01186419|565964918|FG000|Overall Study|Adverse Event|1|||
156785372|NCT01186419|565964919|FG001|Overall Study|Adverse Event|2|||
156785373|NCT01186419|565964918|FG000|Overall Study|Physician Decision|0|||
157214051|NCT04355767|567529670|FG000|Overall Study|Withdrawal by Subject|2|||
156685528|NCT03941834|565593868|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
156685529|NCT03941834|565593869|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
156685530|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
156685531|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
156685532|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
156685533|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
156685534|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
156685535|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
156685536|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
156685537|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
156685538|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
156685539|NCT03941834|565593867|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
156685540|NCT03941834|565593868|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
156685541|NCT03941834|565593869|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
156685542|NCT02012452|565593870|FG000|Overall Study|Lost to Follow-up|2|||
156685543|NCT02012452|565593871|FG001|Overall Study|Lost to Follow-up|1|||
156685544|NCT02012452|565593870|FG000|Overall Study|Withdrawal by Subject|4|||
156685545|NCT02012452|565593871|FG001|Overall Study|Withdrawal by Subject|0|||
156685546|NCT04403399|565593872|FG000|Period 2|Physician Decision|0|||
156785374|NCT01186419|565964919|FG001|Overall Study|Physician Decision|3|||
156785375|NCT01186419|565964918|FG000|Overall Study|Other|1|||
156785376|NCT01186419|565964919|FG001|Overall Study|Other|1|||
156785377|NCT01928771|565964925|FG000|Overall Study|Adverse Event|6|||
156785378|NCT01928771|565964926|FG001|Overall Study|Adverse Event|5|||
157121006|NCT05061719|567194365|FG000|Overall Study|Death|1|||
156685547|NCT04403399|565593873|FG001|Period 2|Physician Decision|1|||
156685548|NCT01606228|565593874|FG000|Overall Study|Lost to Follow-up|20|||
156685549|NCT01606228|565593874|FG000|Overall Study|Withdrawal by Subject|3|||
156685550|NCT01606228|565593874|FG000|Overall Study|Non-compliant|3|||
156785379|NCT01928771|565964927|FG002|Overall Study|Adverse Event|1|||
156785380|NCT01928771|565964925|FG000|Overall Study|Death|2|||
156785381|NCT01928771|565964926|FG001|Overall Study|Death|2|||
157121007|NCT05061719|567194365|FG000|Overall Study|Lack of Efficacy|7|||
157121008|NCT05061719|567194365|FG000|Overall Study|Lost to Follow-up|5|||
157121009|NCT05061719|567194365|FG000|Overall Study|Pregnancy|1|||
157121010|NCT05061719|567194365|FG000|Overall Study|Protocol Violation|8|||
157121011|NCT05061719|567194365|FG000|Overall Study|Withdrawal by Subject|41|||
157121012|NCT05061719|567194365|FG000|Overall Study|Site Closure|2|||
157121013|NCT04179175|567195851|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
157121014|NCT04179175|567195852|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
157121015|NCT04179175|567195853|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
157121016|NCT04179175|567195854|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
157121017|NCT04179175|567195855|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
157121018|NCT04179175|567195856|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
157121019|NCT04179175|567195851|FG000|Overall Study|Adverse Event|5|||
157121020|NCT04179175|567195852|FG001|Overall Study|Adverse Event|3|||
157121021|NCT04179175|567195853|FG002|Overall Study|Adverse Event|3|||
157121022|NCT04179175|567195854|FG003|Overall Study|Adverse Event|4|||
157121023|NCT04179175|567195855|FG004|Overall Study|Adverse Event|6|||
157121024|NCT04179175|567195856|FG005|Overall Study|Adverse Event|6|||
157121025|NCT04179175|567195851|FG000|Overall Study|Lack of Efficacy|5|||
157121026|NCT04179175|567195852|FG001|Overall Study|Lack of Efficacy|1|||
157121027|NCT04179175|567195853|FG002|Overall Study|Lack of Efficacy|3|||
157121028|NCT04179175|567195854|FG003|Overall Study|Lack of Efficacy|2|||
157121029|NCT04179175|567195855|FG004|Overall Study|Lack of Efficacy|18|||
157121030|NCT04179175|567195856|FG005|Overall Study|Lack of Efficacy|7|||
157121031|NCT04179175|567195851|FG000|Overall Study|Lost to Follow-up|5|||
157121032|NCT04179175|567195852|FG001|Overall Study|Lost to Follow-up|3|||
157121033|NCT04179175|567195853|FG002|Overall Study|Lost to Follow-up|2|||
157121034|NCT04179175|567195854|FG003|Overall Study|Lost to Follow-up|2|||
157121035|NCT04179175|567195855|FG004|Overall Study|Lost to Follow-up|4|||
157121036|NCT04179175|567195856|FG005|Overall Study|Lost to Follow-up|5|||
157121037|NCT04179175|567195851|FG000|Overall Study|Physician Decision|2|||
157121038|NCT04179175|567195852|FG001|Overall Study|Physician Decision|0|||
157121039|NCT04179175|567195853|FG002|Overall Study|Physician Decision|2|||
157121040|NCT04179175|567195854|FG003|Overall Study|Physician Decision|3|||
157121041|NCT04179175|567195855|FG004|Overall Study|Physician Decision|1|||
157121042|NCT04179175|567195856|FG005|Overall Study|Physician Decision|1|||
156785382|NCT01928771|565964927|FG002|Overall Study|Death|2|||
156785383|NCT01928771|565964925|FG000|Overall Study|Lost to Follow-up|5|||
156785384|NCT01928771|565964926|FG001|Overall Study|Lost to Follow-up|6|||
156785385|NCT01928771|565964927|FG002|Overall Study|Lost to Follow-up|3|||
156785386|NCT01928771|565964925|FG000|Overall Study|Withdrawal by Subject|20|||
156785387|NCT01928771|565964926|FG001|Overall Study|Withdrawal by Subject|15|||
156785388|NCT01928771|565964927|FG002|Overall Study|Withdrawal by Subject|17|||
156785389|NCT01928771|565964925|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
156785390|NCT01928771|565964926|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156785391|NCT01928771|565964927|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
156785392|NCT01928771|565964925|FG000|Overall Study|Other Reasons|9|||
156785393|NCT01928771|565964926|FG001|Overall Study|Other Reasons|9|||
156785394|NCT01928771|565964927|FG002|Overall Study|Other Reasons|14|||
156785395|NCT01928771|565964925|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
156785396|NCT01928771|565964926|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
156785397|NCT01928771|565964927|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
156785398|NCT01407367|565964932|FG000|Overall Study|Death|24|||
156785399|NCT01407367|565964933|FG001|Overall Study|Death|32|||
156785400|NCT01407367|565964932|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
156785401|NCT01407367|565964933|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
156785402|NCT01407367|565964932|FG000|Overall Study|Withdrawal by Subject|4|||
156785403|NCT01407367|565964933|FG001|Overall Study|Withdrawal by Subject|15|||
156785404|NCT01407367|565964932|FG000|Overall Study|Lost to Follow-up|0|||
156785405|NCT01407367|565964933|FG001|Overall Study|Lost to Follow-up|2|||
157121043|NCT04179175|567195851|FG000|Overall Study|Pregnancy|3|||
157121044|NCT04179175|567195852|FG001|Overall Study|Pregnancy|0|||
157121045|NCT04179175|567195853|FG002|Overall Study|Pregnancy|3|||
157121046|NCT04179175|567195854|FG003|Overall Study|Pregnancy|0|||
157121047|NCT04179175|567195855|FG004|Overall Study|Pregnancy|1|||
157121048|NCT04179175|567195856|FG005|Overall Study|Pregnancy|2|||
157121049|NCT04179175|567195851|FG000|Overall Study|Withdrawal by Subject|22|||
157214052|NCT04355767|567529671|FG001|Overall Study|Withdrawal by Subject|2|||
157121050|NCT04179175|567195852|FG001|Overall Study|Withdrawal by Subject|10|||
157121051|NCT04179175|567195853|FG002|Overall Study|Withdrawal by Subject|12|||
157214053|NCT04355767|567529670|FG000|Overall Study|Death|5|||
156785406|NCT01560416|565964937|FG000|Randomized Phase|Crossover Participants|7|||
156785407|NCT01560416|565964938|FG001|Randomized Phase|Crossover Participants|0|||
157121052|NCT04179175|567195854|FG003|Overall Study|Withdrawal by Subject|8|||
157121053|NCT04179175|567195855|FG004|Overall Study|Withdrawal by Subject|23|||
157121054|NCT04179175|567195856|FG005|Overall Study|Withdrawal by Subject|31|||
157121055|NCT04179175|567195851|FG000|Overall Study|Technical problems|0|||
157121056|NCT04179175|567195852|FG001|Overall Study|Technical problems|0|||
157121057|NCT04179175|567195853|FG002|Overall Study|Technical problems|1|||
157121058|NCT04179175|567195854|FG003|Overall Study|Technical problems|1|||
157121059|NCT04179175|567195855|FG004|Overall Study|Technical problems|0|||
156685551|NCT01606228|565593874|FG000|Overall Study|Lack of Efficacy|2|||
156685552|NCT01606228|565593874|FG000|Overall Study|Adverse Event|1|||
156868560|NCT03349034|566277326|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
156868561|NCT03349034|566277325|FG000|Overall Study|soft tissue flap used|1|||
156868562|NCT03349034|566277326|FG001|Overall Study|soft tissue flap used|0|||
156868563|NCT03349034|566277325|FG000|Overall Study|Other|0|||
156868564|NCT03349034|566277326|FG001|Overall Study|Other|1|||
156868565|NCT01759446|566277327|FG000|Overall Study|Protocol Violation|1|||
156868566|NCT01759446|566277328|FG001|Overall Study|Protocol Violation|0|||
156868567|NCT01759446|566277329|FG002|Overall Study|Protocol Violation|1|||
156868568|NCT01759446|566277330|FG003|Overall Study|Protocol Violation|0|||
156868569|NCT01759446|566277331|FG004|Overall Study|Protocol Violation|0|||
156868570|NCT01759446|566277327|FG000|Overall Study|Withdrawal by Subject|0|||
156685553|NCT04100096|565593875|FG000|Overall Study|Adverse Event|19|||
156685554|NCT04100096|565593876|FG001|Overall Study|Adverse Event|7|||
156685555|NCT04100096|565593875|FG000|Overall Study|Lack of Efficacy|0|||
156685556|NCT04100096|565593876|FG001|Overall Study|Lack of Efficacy|1|||
156685557|NCT04100096|565593875|FG000|Overall Study|Lost to Follow-up|13|||
156868571|NCT01759446|566277328|FG001|Overall Study|Withdrawal by Subject|1|||
156868572|NCT01759446|566277329|FG002|Overall Study|Withdrawal by Subject|0|||
156868573|NCT01759446|566277330|FG003|Overall Study|Withdrawal by Subject|1|||
157121060|NCT04179175|567195856|FG005|Overall Study|Technical problems|0|||
157121061|NCT01745146|567195861|FG000|Overall Study|Withdrawal by Subject|1|||
157121062|NCT01745146|567195862|FG001|Overall Study|Withdrawal by Subject|3|||
157121063|NCT01745146|567195861|FG000|Overall Study|Lost to Follow-up|2|||
157121064|NCT01745146|567195862|FG001|Overall Study|Lost to Follow-up|0|||
157121065|NCT00130832|567195863|FG000|Overall Study|Adverse Event|1|||
157121066|NCT00130832|567195864|FG001|Overall Study|Adverse Event|1|||
157121067|NCT00130832|567195863|FG000|Overall Study|Lost to Follow-up|1|||
157121068|NCT00130832|567195864|FG001|Overall Study|Lost to Follow-up|2|||
157121069|NCT00130832|567195863|FG000|Overall Study|Protocol Violation|6|||
157121070|NCT00130832|567195864|FG001|Overall Study|Protocol Violation|8|||
157121071|NCT00130832|567195863|FG000|Overall Study|Withdrawal by Subject|6|||
157121072|NCT00130832|567195864|FG001|Overall Study|Withdrawal by Subject|1|||
157121073|NCT00130832|567195863|FG000|Overall Study|Moved|2|||
157121074|NCT00130832|567195864|FG001|Overall Study|Moved|2|||
157121075|NCT00130832|567195863|FG000|Overall Study|Other|0|||
157121076|NCT00130832|567195864|FG001|Overall Study|Other|3|||
157121077|NCT02754726|567195871|FG000|Overall Study|Progressive Disease by RECIST|13|||
157121078|NCT02754726|567195871|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
157121079|NCT02754726|567195871|FG000|Overall Study|Clinical Disease Progression|5|||
157121080|NCT02754726|567195871|FG000|Overall Study|Adverse Event|3|||
157121081|NCT02754726|567195871|FG000|Overall Study|Withdrawal by Subject|1|||
157121082|NCT02754726|567195871|FG000|Overall Study|Tolerability|1|||
157121083|NCT02792842|567195873|FG000|Overall Study|Adverse Event|4|||
157121084|NCT02792842|567195874|FG001|Overall Study|Adverse Event|2|||
157121085|NCT02792842|567195875|FG002|Overall Study|Adverse Event|3|||
157121086|NCT02792842|567195873|FG000|Overall Study|Withdrawal by Subject|0|||
157121087|NCT02792842|567195874|FG001|Overall Study|Withdrawal by Subject|1|||
157121088|NCT02792842|567195875|FG002|Overall Study|Withdrawal by Subject|2|||
157121089|NCT02792842|567195873|FG000|Overall Study|Lost to Follow-up|0|||
157121090|NCT02792842|567195874|FG001|Overall Study|Lost to Follow-up|0|||
157121091|NCT02792842|567195875|FG002|Overall Study|Lost to Follow-up|1|||
157121092|NCT02792842|567195873|FG000|Overall Study|Schedule delay|0|||
157121093|NCT02792842|567195874|FG001|Overall Study|Schedule delay|1|||
157121094|NCT02792842|567195875|FG002|Overall Study|Schedule delay|1|||
157121095|NCT01046825|567195882|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
157121096|NCT01046825|567195883|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
157121097|NCT01046825|567195884|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
157121098|NCT01046825|567195885|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
157121099|NCT01046825|567195886|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
157121100|NCT01046825|567195882|FG000|Overall Study|Physician Decision|0|||
157121101|NCT01046825|567195883|FG001|Overall Study|Physician Decision|1|||
157121102|NCT01046825|567195884|FG002|Overall Study|Physician Decision|2|||
157121103|NCT01046825|567195885|FG003|Overall Study|Physician Decision|0|||
157121104|NCT01046825|567195886|FG004|Overall Study|Physician Decision|0|||
157121105|NCT01046825|567195882|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
157121106|NCT01046825|567195883|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
157121107|NCT01046825|567195884|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
157121108|NCT01046825|567195885|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
157121109|NCT01046825|567195886|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
157121110|NCT01046825|567195882|FG000|Overall Study|Found to be ineligible|0|||
157121111|NCT01046825|567195883|FG001|Overall Study|Found to be ineligible|1|||
157121112|NCT01046825|567195884|FG002|Overall Study|Found to be ineligible|0|||
157121113|NCT01046825|567195885|FG003|Overall Study|Found to be ineligible|0|||
157121114|NCT01046825|567195886|FG004|Overall Study|Found to be ineligible|0|||
157121115|NCT01046825|567195882|FG000|Overall Study|Death|0|||
157121116|NCT01046825|567195883|FG001|Overall Study|Death|0|||
157121117|NCT01046825|567195884|FG002|Overall Study|Death|0|||
157121118|NCT01046825|567195885|FG003|Overall Study|Death|1|||
157121119|NCT01046825|567195886|FG004|Overall Study|Death|0|||
157121120|NCT01046825|567195882|FG000|Overall Study|Did not submit biology samples|0|||
157121121|NCT01046825|567195883|FG001|Overall Study|Did not submit biology samples|0|||
157121122|NCT01046825|567195884|FG002|Overall Study|Did not submit biology samples|0|||
157121123|NCT01046825|567195885|FG003|Overall Study|Did not submit biology samples|0|||
157121124|NCT01046825|567195886|FG004|Overall Study|Did not submit biology samples|13|||
157121125|NCT02872311|567195888|FG000|Overall Study|Death|2|||
157121126|NCT02872311|567195889|FG001|Overall Study|Death|0|||
157121127|NCT02872311|567195890|FG002|Overall Study|Death|0|||
157121128|NCT02872311|567195891|FG003|Overall Study|Death|0|||
156685558|NCT04100096|565593876|FG001|Overall Study|Lost to Follow-up|11|||
156685559|NCT04100096|565593875|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156685560|NCT04100096|565593876|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156685561|NCT04100096|565593875|FG000|Overall Study|Protocol Deviation|1|||
156685562|NCT04100096|565593876|FG001|Overall Study|Protocol Deviation|1|||
156685563|NCT04100096|565593875|FG000|Overall Study|Withdrawal by Participant|13|||
156685564|NCT04100096|565593876|FG001|Overall Study|Withdrawal by Participant|15|||
156685565|NCT00991510|565593879|FG000|Period I (Days 1-14)|Adverse Event|1|||
156685566|NCT00991510|565593880|FG001|Period I (Days 1-14)|Adverse Event|0|||
156685567|NCT00991510|565593879|FG000|Period III (Days 29-112)|Adverse Event|1|||
156685568|NCT00991510|565593880|FG001|Period III (Days 29-112)|Adverse Event|1|||
156685569|NCT01976728|565593881|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
156685570|NCT01976728|565593882|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
156685571|NCT01976728|565593883|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
156685572|NCT01976728|565593884|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
156685573|NCT01563237|565593885|FG000|Overall Study|Lost to Follow-up|6|||
156685574|NCT01563237|565593886|FG001|Overall Study|Lost to Follow-up|0|||
156685575|NCT01563237|565593885|FG000|Overall Study|Withdrawal by Subject|1|||
156685576|NCT01563237|565593886|FG001|Overall Study|Withdrawal by Subject|0|||
156685577|NCT01563237|565593885|FG000|Overall Study|Adverse Event|1|||
156685578|NCT01563237|565593886|FG001|Overall Study|Adverse Event|0|||
156685579|NCT01563237|565593885|FG000|Overall Study|Medical Reasons|1|||
156685580|NCT01563237|565593886|FG001|Overall Study|Medical Reasons|0|||
156685581|NCT01563237|565593885|FG000|Overall Study|Death|1|||
156685582|NCT01563237|565593886|FG001|Overall Study|Death|0|||
156685583|NCT01049412|565593889|FG000|Period I|Withdrawal by Subject|4|||
156685584|NCT01049412|565593890|FG001|Period I|Withdrawal by Subject|6|||
156685585|NCT01049412|565593889|FG000|Period I|Lost to Follow-up|2|||
156685586|NCT01049412|565593890|FG001|Period I|Lost to Follow-up|2|||
156685587|NCT01049412|565593889|FG000|Period I|Physician Decision|0|||
156685588|NCT01049412|565593890|FG001|Period I|Physician Decision|3|||
156685589|NCT01049412|565593889|FG000|Period I|Protocol Violation|1|||
156685590|NCT01049412|565593890|FG001|Period I|Protocol Violation|2|||
156685591|NCT01049412|565593889|FG000|Period I|Adverse Event|1|||
156685592|NCT01049412|565593890|FG001|Period I|Adverse Event|0|||
156685593|NCT01049412|565593889|FG000|Period II|Withdrawal by Subject|2|||
156685594|NCT01049412|565593890|FG001|Period II|Withdrawal by Subject|3|||
156685595|NCT01049412|565593889|FG000|Period II|Adverse Event|1|||
156685596|NCT01049412|565593890|FG001|Period II|Adverse Event|0|||
156685597|NCT01049412|565593889|FG000|Period II|Lost to Follow-up|1|||
156685598|NCT01049412|565593890|FG001|Period II|Lost to Follow-up|0|||
156685599|NCT05966090|565593891|FG000|Overall Study|Lost to Follow-up|6|||
156685600|NCT05966090|565593892|FG001|Overall Study|Lost to Follow-up|6|||
157121129|NCT02872311|567195892|FG004|Overall Study|Death|0|||
157121130|NCT02872311|567195888|FG000|Overall Study|Lost to Follow-up|2|||
157121131|NCT02872311|567195889|FG001|Overall Study|Lost to Follow-up|0|||
157121132|NCT02872311|567195890|FG002|Overall Study|Lost to Follow-up|0|||
157121133|NCT02872311|567195891|FG003|Overall Study|Lost to Follow-up|0|||
157121134|NCT02872311|567195892|FG004|Overall Study|Lost to Follow-up|0|||
157121135|NCT02872311|567195888|FG000|Overall Study|Protocol Violation|0|||
156685601|NCT05966090|565593891|FG000|Overall Study|Adverse Event|1|||
156685602|NCT05966090|565593892|FG001|Overall Study|Adverse Event|1|||
156685603|NCT05966090|565593891|FG000|Overall Study|Withdrawal by Subject|1|||
156685604|NCT05966090|565593892|FG001|Overall Study|Withdrawal by Subject|1|||
156685605|NCT05966090|565593891|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156685606|NCT05966090|565593892|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156685607|NCT05966090|565593891|FG000|Overall Study|Other|1|||
156685608|NCT05966090|565593892|FG001|Overall Study|Other|1|||
157121136|NCT02872311|567195889|FG001|Overall Study|Protocol Violation|2|||
157121137|NCT02872311|567195890|FG002|Overall Study|Protocol Violation|1|||
157121138|NCT02872311|567195891|FG003|Overall Study|Protocol Violation|0|||
157121139|NCT02872311|567195892|FG004|Overall Study|Protocol Violation|0|||
156685609|NCT00804141|565593893|FG000|Overall Study|Adverse Event|157|||
156685610|NCT00804141|565593893|FG000|Overall Study|Death|4|||
156685611|NCT00804141|565593893|FG000|Overall Study|Failed to return|96|||
156685612|NCT00804141|565593893|FG000|Overall Study|Investigator request|8|||
156685613|NCT00804141|565593893|FG000|Overall Study|Protocol Violation|85|||
157121140|NCT05617911|567195893|FG000|Overall Study|Withdrawal by Subject|1|||
157121141|NCT05617911|567195894|FG001|Overall Study|Withdrawal by Subject|0|||
157121142|NCT03975647|567195895|FG000|Overall Study|Death|71|||
157121143|NCT03975647|567195896|FG001|Overall Study|Death|63|||
157121144|NCT03975647|567195895|FG000|Overall Study|Lost to Follow-up|2|||
157121145|NCT03975647|567195896|FG001|Overall Study|Lost to Follow-up|2|||
157121146|NCT03975647|567195895|FG000|Overall Study|Subject withdrawal of consent|7|||
157121147|NCT03975647|567195896|FG001|Overall Study|Subject withdrawal of consent|11|||
157121148|NCT04868903|567195897|FG000|Overall Study|Adverse Event|0|||
157121149|NCT04868903|567195898|FG001|Overall Study|Adverse Event|0|||
157121150|NCT04868903|567195899|FG002|Overall Study|Adverse Event|0|||
157121151|NCT04868903|567195900|FG003|Overall Study|Adverse Event|1|||
157121152|NCT04868903|567195897|FG000|Overall Study|Withdrawal by Subject|29|||
157121153|NCT04868903|567195898|FG001|Overall Study|Withdrawal by Subject|44|||
157121154|NCT04868903|567195899|FG002|Overall Study|Withdrawal by Subject|17|||
157121155|NCT04868903|567195900|FG003|Overall Study|Withdrawal by Subject|12|||
157121156|NCT04868903|567195897|FG000|Overall Study|Hyperparathyroidism|3|||
157121157|NCT04868903|567195898|FG001|Overall Study|Hyperparathyroidism|5|||
157121158|NCT04868903|567195899|FG002|Overall Study|Hyperparathyroidism|2|||
157121159|NCT04868903|567195900|FG003|Overall Study|Hyperparathyroidism|3|||
157121160|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
157121161|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
157121162|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
157121163|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
157121164|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
157121165|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
157121166|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
157121167|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
157121168|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
157121169|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
157121170|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
157121171|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
157121172|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
157121173|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
157121174|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
157121175|NCT03735667|567195901|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
157121176|NCT03735667|567195902|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
157121177|NCT03735667|567195903|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
157121178|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
157121179|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
157121180|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
157121181|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
157121182|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
157121183|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
157121184|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
157121185|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
157121186|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
157121187|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
157121188|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
157121189|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
157121190|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
157121191|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
157121192|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
157121193|NCT03735667|567195901|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
157121194|NCT03735667|567195902|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
157121195|NCT03735667|567195903|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
157121196|NCT03092726|567195904|FG000|Overall Study|Adverse Event|3|||
157121197|NCT03092726|567195905|FG001|Overall Study|Adverse Event|10|||
157121198|NCT03092726|567195904|FG000|Overall Study|Lack of Efficacy|0|||
157121199|NCT03092726|567195905|FG001|Overall Study|Lack of Efficacy|1|||
157121200|NCT03092726|567195904|FG000|Overall Study|Lost to Follow-up|1|||
157121201|NCT03092726|567195905|FG001|Overall Study|Lost to Follow-up|0|||
157121202|NCT03092726|567195904|FG000|Overall Study|Withdrawal by Subject|5|||
157121203|NCT03092726|567195905|FG001|Overall Study|Withdrawal by Subject|3|||
157121204|NCT01926782|567195911|FG000|Overall Study|Participant moved|2|||
156685614|NCT00804141|565593893|FG000|Overall Study|Withdrawal by Subject|131|||
156685615|NCT00804141|565593893|FG000|Overall Study|Lack of Efficacy|46|||
157121205|NCT01926782|567195912|FG001|Overall Study|Participant moved|0|||
157121206|NCT01926782|567195913|FG002|Overall Study|Participant moved|1|||
157121207|NCT01926782|567195914|FG003|Overall Study|Participant moved|1|||
157121208|NCT01926782|567195915|FG004|Overall Study|Participant moved|0|||
157121209|NCT01926782|567195916|FG005|Overall Study|Participant moved|3|||
157121210|NCT01926782|567195911|FG000|Overall Study|Physician Decision|0|||
157121211|NCT01926782|567195912|FG001|Overall Study|Physician Decision|2|||
156685616|NCT00804141|565593893|FG000|Overall Study|Other than specified|30|||
156685617|NCT00804141|565593893|FG000|Overall Study|Enrolled but not treated|6|||
156685618|NCT02418455|565593895|FG000|48-Week Treatment Period|Other- Not Specified|1|||
156685619|NCT02418455|565593895|FG000|Continuation Period|Sponsor Decision|7|||
156685620|NCT03235479|565593898|FG000|Overall Study|Lost to Follow-up|8|||
156685621|NCT03235479|565593899|FG001|Overall Study|Lost to Follow-up|11|||
156685622|NCT03235479|565593898|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
156685623|NCT03235479|565593899|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
157121212|NCT01926782|567195913|FG002|Overall Study|Physician Decision|1|||
157121213|NCT01926782|567195914|FG003|Overall Study|Physician Decision|1|||
157121214|NCT01926782|567195915|FG004|Overall Study|Physician Decision|0|||
157121215|NCT01926782|567195916|FG005|Overall Study|Physician Decision|0|||
157121216|NCT01926782|567195911|FG000|Overall Study|Other than specified|2|||
157121217|NCT01926782|567195912|FG001|Overall Study|Other than specified|3|||
157121218|NCT01926782|567195913|FG002|Overall Study|Other than specified|5|||
157121219|NCT01926782|567195914|FG003|Overall Study|Other than specified|12|||
157121220|NCT01926782|567195915|FG004|Overall Study|Other than specified|4|||
157121221|NCT01926782|567195916|FG005|Overall Study|Other than specified|11|||
157121222|NCT01926782|567195911|FG000|Overall Study|Adverse Event|13|||
157121223|NCT01926782|567195912|FG001|Overall Study|Adverse Event|4|||
157121224|NCT01926782|567195913|FG002|Overall Study|Adverse Event|17|||
157121225|NCT01926782|567195914|FG003|Overall Study|Adverse Event|4|||
157121226|NCT01926782|567195915|FG004|Overall Study|Adverse Event|3|||
157121227|NCT01926782|567195916|FG005|Overall Study|Adverse Event|14|||
156685624|NCT03235479|565593898|FG000|Overall Study|Pregnancy|1|||
156685625|NCT03235479|565593899|FG001|Overall Study|Pregnancy|0|||
156685626|NCT03235479|565593898|FG000|Overall Study|Protocol Deviation|1|||
156685627|NCT03235479|565593899|FG001|Overall Study|Protocol Deviation|3|||
156685628|NCT03235479|565593898|FG000|Overall Study|Technical Problems|3|||
156685629|NCT03235479|565593899|FG001|Overall Study|Technical Problems|2|||
156685630|NCT03235479|565593898|FG000|Overall Study|Withdrawal by Subject|2|||
156685631|NCT03235479|565593899|FG001|Overall Study|Withdrawal by Subject|2|||
156685632|NCT03235479|565593898|FG000|Overall Study|Other Reasons|3|||
156685633|NCT03235479|565593899|FG001|Overall Study|Other Reasons|5|||
156685634|NCT02001051|565593900|FG000|Overall Study|Deemed not eligible following enrollment|0|||
156685635|NCT02001051|565593901|FG001|Overall Study|Deemed not eligible following enrollment|1|||
156685636|NCT00779402|565593902|FG000|Treatment Phase 1|Disease Progression|1|||
156685637|NCT00779402|565593903|FG001|Treatment Phase 1|Disease Progression|0|||
156685638|NCT00779402|565593902|FG000|Treatment Phase 1|Adverse Event|2|||
156685639|NCT00779402|565593903|FG001|Treatment Phase 1|Adverse Event|0|||
156685640|NCT00779402|565593902|FG000|Treatment Phase 1|Protocol Violation|1|||
156685641|NCT00779402|565593903|FG001|Treatment Phase 1|Protocol Violation|0|||
156685642|NCT00779402|565593902|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
156685643|NCT00779402|565593903|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
156785408|NCT01695772|565964940|FG000|Overall Study|Withdrawal by Subject|18|||
156785409|NCT01695772|565964940|FG000|Overall Study|Progressive Disease|8|||
156785410|NCT01695772|565964940|FG000|Overall Study|Investigator Decision|5|||
157121228|NCT01926782|567195911|FG000|Overall Study|Poor compliance to protocol|5|||
157121229|NCT01926782|567195912|FG001|Overall Study|Poor compliance to protocol|3|||
156785411|NCT01695772|565964940|FG000|Overall Study|Lost to Follow-up|4|||
156785412|NCT01695772|565964940|FG000|Overall Study|Protocol Violation|2|||
156785413|NCT01695772|565964940|FG000|Overall Study|Unspecified Reason|1|||
156785414|NCT00004859|565964943|FG000|Overall Study|Lack of Efficacy|43|||
156785415|NCT00004859|565964944|FG001|Overall Study|Lack of Efficacy|113|||
156685644|NCT00779402|565593902|FG000|Treatment Phase 1|Lost to Follow-up|0|||
156785416|NCT00004859|565964943|FG000|Overall Study|Adverse Event|31|||
156785417|NCT00004859|565964944|FG001|Overall Study|Adverse Event|93|||
156785418|NCT00004859|565964943|FG000|Overall Study|Death|5|||
157121230|NCT01926782|567195913|FG002|Overall Study|Poor compliance to protocol|8|||
156785419|NCT00004859|565964944|FG001|Overall Study|Death|5|||
157121231|NCT01926782|567195914|FG003|Overall Study|Poor compliance to protocol|0|||
157121232|NCT01926782|567195915|FG004|Overall Study|Poor compliance to protocol|1|||
157121233|NCT01926782|567195916|FG005|Overall Study|Poor compliance to protocol|6|||
157121234|NCT01926782|567195911|FG000|Overall Study|Randomized and not treated|0|||
157121235|NCT01926782|567195912|FG001|Overall Study|Randomized and not treated|0|||
157121236|NCT01926782|567195913|FG002|Overall Study|Randomized and not treated|0|||
156685645|NCT00779402|565593903|FG001|Treatment Phase 1|Lost to Follow-up|1|||
156685646|NCT00779402|565593902|FG000|Treatment Phase 1|Death|0|||
156685647|NCT00779402|565593903|FG001|Treatment Phase 1|Death|1|||
156685648|NCT00779402|565593902|FG000|Treatment Phase 1|Intercurrent Illness|1|||
156785420|NCT00004859|565964943|FG000|Overall Study|Withdrawal by Subject|7|||
156685649|NCT00779402|565593903|FG001|Treatment Phase 1|Intercurrent Illness|1|||
156685650|NCT00779402|565593902|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
156685651|NCT00779402|565593903|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
157121237|NCT01926782|567195914|FG003|Overall Study|Randomized and not treated|1|||
157121238|NCT01926782|567195915|FG004|Overall Study|Randomized and not treated|0|||
157121239|NCT01926782|567195916|FG005|Overall Study|Randomized and not treated|0|||
157121240|NCT01926782|567195911|FG000|Overall Study|Withdrawal by Subject|6|||
157121241|NCT01926782|567195912|FG001|Overall Study|Withdrawal by Subject|1|||
157121242|NCT01926782|567195913|FG002|Overall Study|Withdrawal by Subject|8|||
157121243|NCT01926782|567195914|FG003|Overall Study|Withdrawal by Subject|1|||
157121244|NCT01926782|567195915|FG004|Overall Study|Withdrawal by Subject|0|||
157121245|NCT01926782|567195916|FG005|Overall Study|Withdrawal by Subject|5|||
157121246|NCT01926782|567195911|FG000|Overall Study|Related to study drug administration|0|||
156685652|NCT00779402|565593902|FG000|Treatment Phase 1|Other|4|||
157121247|NCT01926782|567195912|FG001|Overall Study|Related to study drug administration|0|||
157121248|NCT01926782|567195913|FG002|Overall Study|Related to study drug administration|0|||
156685653|NCT00779402|565593903|FG001|Treatment Phase 1|Other|2|||
156685654|NCT00779402|565593902|FG000|Treatment Phase 1|Closure of Study|3|||
156685655|NCT00779402|565593903|FG001|Treatment Phase 1|Closure of Study|2|||
156685656|NCT00779402|565593902|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
156685657|NCT00779402|565593903|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
156685658|NCT00779402|565593902|FG000|Surveillance Phase|Protocol Violation|0|||
156685659|NCT00779402|565593903|FG001|Surveillance Phase|Protocol Violation|1|||
157121249|NCT01926782|567195914|FG003|Overall Study|Related to study drug administration|0|||
157121250|NCT01926782|567195915|FG004|Overall Study|Related to study drug administration|0|||
157121251|NCT01926782|567195916|FG005|Overall Study|Related to study drug administration|2|||
157121252|NCT02217566|567195919|FG000|Overall Study|Lost to Follow-up|2|||
157121253|NCT02217566|567195919|FG000|Overall Study|Death|3|||
157121254|NCT02217566|567195919|FG000|Overall Study|Early study termination|6|||
157214054|NCT04355767|567529671|FG001|Overall Study|Death|1|||
157214055|NCT01999322|567529672|FG000|Overall Study|Adverse Event|1|||
157214056|NCT01999322|567529673|FG001|Overall Study|Adverse Event|0|||
157214057|NCT01458119|567529678|FG000|Overall Study|Physician Decision|4|||
157214058|NCT01458119|567529678|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
157214059|NCT01458119|567529678|FG000|Overall Study|Pregnancy|1|||
157214060|NCT01458119|567529678|FG000|Overall Study|Death|2|||
157214061|NCT01458119|567529678|FG000|Overall Study|Adverse Event|1|||
157214062|NCT01458119|567529678|FG000|Overall Study|Consent Withdrawn by Participant|8|||
157214063|NCT01458119|567529678|FG000|Overall Study|Non-compliance With Study Drug|3|||
157214064|NCT03053622|567531719|FG000|Overall Study|Lost to Follow-up|0|||
157214065|NCT03053622|567531720|FG001|Overall Study|Lost to Follow-up|0|||
157214066|NCT03053622|567531721|FG002|Overall Study|Lost to Follow-up|0|||
157214067|NCT03053622|567531722|FG003|Overall Study|Lost to Follow-up|1|||
157214068|NCT01246986|567531723|FG000|Overall Study|Lost to Follow-up|0|||
156685660|NCT00779402|565593902|FG000|Surveillance Phase|Patient refused to continue|22|||
156685661|NCT00779402|565593903|FG001|Surveillance Phase|Patient refused to continue|14|||
156785421|NCT00004859|565964944|FG001|Overall Study|Withdrawal by Subject|33|||
156785422|NCT00004859|565964943|FG000|Overall Study|Protocol Violation|2|||
156785423|NCT00004859|565964944|FG001|Overall Study|Protocol Violation|2|||
156785424|NCT00004859|565964943|FG000|Overall Study|other disease|0|||
156785425|NCT00004859|565964944|FG001|Overall Study|other disease|3|||
156785426|NCT00004859|565964943|FG000|Overall Study|error|3|||
156785427|NCT00004859|565964944|FG001|Overall Study|error|1|||
156785428|NCT00004859|565964943|FG000|Overall Study|missing data|14|||
156785429|NCT00004859|565964944|FG001|Overall Study|missing data|11|||
156785430|NCT00004859|565964943|FG000|Overall Study|Other|13|||
156785431|NCT00004859|565964944|FG001|Overall Study|Other|21|||
157121255|NCT02064387|567195920|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121256|NCT02064387|567195921|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121257|NCT02064387|567195922|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157214069|NCT01246986|567531724|FG001|Overall Study|Lost to Follow-up|1|||
156685662|NCT00779402|565593902|FG000|Surveillance Phase|Lost to Follow-up|2|||
156785432|NCT00585169|565966344|FG000|Overall Study|Withdrawal by Subject|1|||
157121258|NCT02064387|567195923|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121259|NCT02064387|567195924|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121260|NCT02064387|567195925|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157214070|NCT01246986|567531725|FG002|Overall Study|Lost to Follow-up|3|||
157214071|NCT01246986|567531726|FG003|Overall Study|Lost to Follow-up|0|||
157214072|NCT01246986|567531727|FG004|Overall Study|Lost to Follow-up|0|||
156785433|NCT03055221|565966345|FG000|Overall Study|Adverse Event|2|||
156785434|NCT03055221|565966345|FG000|Overall Study|Withdrawal by Subject|4|||
156785435|NCT03055221|565966345|FG000|Overall Study|Death|6|||
156785436|NCT03055221|565966345|FG000|Overall Study|Physician Decision|1|||
156785437|NCT03055221|565966345|FG000|Overall Study|Study terminated by Sponsor|3|||
156785438|NCT03055221|565966345|FG000|Overall Study|Lost to Follow-up|4|||
156685663|NCT00779402|565593903|FG001|Surveillance Phase|Lost to Follow-up|1|||
156685664|NCT00779402|565593902|FG000|Surveillance Phase|Death|0|||
156685665|NCT00779402|565593903|FG001|Surveillance Phase|Death|1|||
156685666|NCT00779402|565593902|FG000|Surveillance Phase|Intercurrent Illness|2|||
156685667|NCT00779402|565593903|FG001|Surveillance Phase|Intercurrent Illness|0|||
156685668|NCT00779402|565593902|FG000|Surveillance Phase|Other|5|||
156685669|NCT00779402|565593903|FG001|Surveillance Phase|Other|5|||
156685670|NCT00779402|565593902|FG000|Surveillance Phase|Withdrawal by Subject|4|||
156685671|NCT00779402|565593903|FG001|Surveillance Phase|Withdrawal by Subject|1|||
156685672|NCT00779402|565593902|FG000|Surveillance Phase|Closure of study|5|||
156685673|NCT00779402|565593903|FG001|Surveillance Phase|Closure of study|6|||
156685674|NCT00779402|565593902|FG000|Surveillance Phase|Completed Protocol Visits|3|||
156685675|NCT00779402|565593903|FG001|Surveillance Phase|Completed Protocol Visits|2|||
156685676|NCT00779402|565593902|FG000|Long-term Follow-up|Patient refused to continue|2|||
156785439|NCT01964560|565966346|FG000|Overall Study|Adverse Event|23|||
156785440|NCT01964560|565966346|FG000|Overall Study|Lack of Efficacy|46|||
156785441|NCT01964560|565966346|FG000|Overall Study|Protocol deviation|2|||
156785442|NCT01964560|565966346|FG000|Overall Study|Lost to Follow-up|4|||
156785443|NCT01964560|565966346|FG000|Overall Study|Withdrawal by Subject|64|||
156785444|NCT01964560|565966346|FG000|Overall Study|Surgery-hemispherotomy|1|||
156785445|NCT01964560|565966346|FG000|Overall Study|Surgery|1|||
156785446|NCT01964560|565966346|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
156785447|NCT01964560|565966346|FG000|Overall Study|Patient and Investigator choice|1|||
157121261|NCT02064387|567195926|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121262|NCT02064387|567195927|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
157121263|NCT02064387|567195928|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121264|NCT02064387|567195929|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
157121265|NCT02064387|567195930|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121266|NCT02064387|567195931|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
157121267|NCT02064387|567195920|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121268|NCT02064387|567195921|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121269|NCT02064387|567195922|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121270|NCT02064387|567195923|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121271|NCT02064387|567195924|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121272|NCT02064387|567195925|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121273|NCT02064387|567195926|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
156785448|NCT01964560|565966346|FG000|Overall Study|Patient was prescribed CBD|1|||
156785449|NCT01964560|565966346|FG000|Overall Study|Participant moved to another country|1|||
156785450|NCT02391584|565966347|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
156785451|NCT02391584|565966348|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
156785452|NCT02391584|565966347|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
156785453|NCT02391584|565966348|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
156785454|NCT02391584|565966347|FG000|3 Month|Lost to Follow-up|1|||
156785455|NCT02391584|565966348|FG001|3 Month|Lost to Follow-up|0|||
156785456|NCT02391584|565966347|FG000|6 Month|Withdrawal by Subject|1|||
156785457|NCT02391584|565966348|FG001|6 Month|Withdrawal by Subject|0|||
156785458|NCT02391584|565966347|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
156785459|NCT02391584|565966348|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
156785460|NCT01441414|565966361|FG000|Overall Study|Participant died|9|||
156785461|NCT01441414|565966361|FG000|Overall Study|Other reasons|3|||
156785462|NCT01441414|565966361|FG000|Overall Study|Study terminated by sponsor|2|||
157121274|NCT02064387|567195927|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
157121275|NCT02064387|567195928|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121276|NCT02064387|567195929|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121277|NCT02064387|567195930|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121278|NCT02064387|567195931|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
157121279|NCT02064387|567195920|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121280|NCT02064387|567195921|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121281|NCT02064387|567195922|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121282|NCT02064387|567195923|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157214073|NCT01246986|567531728|FG005|Overall Study|Lost to Follow-up|1|||
156785463|NCT01441414|565966361|FG000|Overall Study|Subject refused further follow-up|1|||
156785464|NCT01058005|565966373|FG000|Overall Study|Adverse Event|0|||
156785465|NCT01058005|565966374|FG001|Overall Study|Adverse Event|2|||
156785466|NCT01058005|565966375|FG002|Overall Study|Adverse Event|1|||
156785467|NCT01058005|565966373|FG000|Overall Study|Physician Decision|2|||
156785468|NCT01058005|565966374|FG001|Overall Study|Physician Decision|2|||
156785469|NCT01058005|565966375|FG002|Overall Study|Physician Decision|0|||
156785470|NCT01058005|565966373|FG000|Overall Study|Withdrawal by Subject|4|||
156785471|NCT01058005|565966374|FG001|Overall Study|Withdrawal by Subject|5|||
156785472|NCT01058005|565966375|FG002|Overall Study|Withdrawal by Subject|11|||
156785473|NCT01058005|565966373|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
156808727|NCT01396187|566054446|FG001|Overall Study|Adverse Event|1|||
156685677|NCT00779402|565593903|FG001|Long-term Follow-up|Patient refused to continue|0|||
157214074|NCT01246986|567531729|FG006|Overall Study|Lost to Follow-up|0|||
157214075|NCT01246986|567531723|FG000|Overall Study|Withdrawal by Subject|3|||
157214076|NCT01246986|567531724|FG001|Overall Study|Withdrawal by Subject|4|||
157214077|NCT01246986|567531725|FG002|Overall Study|Withdrawal by Subject|3|||
157214078|NCT01246986|567531726|FG003|Overall Study|Withdrawal by Subject|0|||
157214079|NCT01246986|567531727|FG004|Overall Study|Withdrawal by Subject|4|||
157214080|NCT01246986|567531728|FG005|Overall Study|Withdrawal by Subject|0|||
157214081|NCT01246986|567531729|FG006|Overall Study|Withdrawal by Subject|0|||
157214082|NCT01440647|567531734|FG000|Overall Study|Death|2|||
157214083|NCT01440647|567531735|FG001|Overall Study|Death|3|||
157214084|NCT01406873|567531749|FG000|Overall Study|Withdrawal by Subject|1|||
157214085|NCT01406873|567531750|FG001|Overall Study|Withdrawal by Subject|1|||
157214086|NCT03990389|567531751|FG000|Overall Study|Lost to Follow-up|3|||
157214087|NCT03990389|567531752|FG001|Overall Study|Lost to Follow-up|0|||
157214088|NCT00207714|567531753|FG000|Overall Study|Adverse Event|6|||
157214089|NCT00207714|567531754|FG001|Overall Study|Adverse Event|2|||
157214090|NCT00207714|567531755|FG002|Overall Study|Adverse Event|4|||
157214091|NCT00207714|567531756|FG003|Overall Study|Adverse Event|3|||
157214092|NCT00207714|567531757|FG004|Overall Study|Adverse Event|1|||
157214093|NCT00207714|567531753|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
157214094|NCT00207714|567531754|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
157214095|NCT00207714|567531755|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
157214096|NCT00207714|567531756|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
157214097|NCT00207714|567531757|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
157214098|NCT00207714|567531753|FG000|Overall Study|Other|3|||
157214099|NCT00207714|567531754|FG001|Overall Study|Other|2|||
157214100|NCT00207714|567531755|FG002|Overall Study|Other|5|||
157214101|NCT00207714|567531756|FG003|Overall Study|Other|1|||
157214102|NCT00207714|567531757|FG004|Overall Study|Other|0|||
157214103|NCT03627195|567531758|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
157214104|NCT03627195|567531759|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
157214105|NCT03627195|567531760|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
157214106|NCT03627195|567531761|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
157214107|NCT03627195|567531762|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
157214108|NCT03627195|567531763|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
157214109|NCT03770000|567531767|FG000|Overall Study|Premature discontinuation due to PD|0|||
157214110|NCT03770000|567531768|FG001|Overall Study|Premature discontinuation due to PD|0|||
157214111|NCT03770000|567531769|FG002|Overall Study|Premature discontinuation due to PD|1|||
157214112|NCT03770000|567531770|FG003|Overall Study|Premature discontinuation due to PD|3|||
157214113|NCT03770000|567531771|FG004|Overall Study|Premature discontinuation due to PD|2|||
156868574|NCT01759446|566277331|FG004|Overall Study|Withdrawal by Subject|0|||
156868575|NCT00865566|566277332|FG000|Overall Study|Death|1|||
156868576|NCT00865566|566277333|FG001|Overall Study|Death|11|||
157121283|NCT02064387|567195924|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121284|NCT02064387|567195925|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121285|NCT02064387|567195926|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121286|NCT02064387|567195927|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121287|NCT02064387|567195928|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
157121288|NCT02064387|567195929|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121289|NCT02064387|567195930|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121290|NCT02064387|567195931|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
157121291|NCT02064387|567195920|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
157121292|NCT02064387|567195921|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
157121293|NCT02064387|567195922|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
157121294|NCT02064387|567195923|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
157121295|NCT02064387|567195924|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
157121296|NCT02064387|567195925|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
157121297|NCT02064387|567195926|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
157121298|NCT02064387|567195927|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
157121299|NCT02064387|567195928|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
157121300|NCT02064387|567195929|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
157121301|NCT02064387|567195930|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
157121302|NCT02064387|567195931|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
157214114|NCT02290028|567531772|FG000|Overall Study|Death|217|||
157214115|NCT02290028|567531772|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
157214116|NCT02290028|567531772|FG000|Overall Study|No longer under care of study physician|76|||
157214117|NCT02290028|567531772|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
157214118|NCT02290028|567531772|FG000|Overall Study|Withdrawal by Subject|52|||
157214119|NCT02290028|567531772|FG000|Overall Study|Study site closure|44|||
157214120|NCT02290028|567531772|FG000|Overall Study|Lost to Follow-up|34|||
157214121|NCT02290028|567531772|FG000|Overall Study|Miscellaneous|10|||
157214122|NCT02290028|567531772|FG000|Overall Study|Transition to EP PASSION|1295|||
157214123|NCT02290028|567531772|FG000|Overall Study|Planned study completion at 12 months|257|||
157121303|NCT02064387|567195920|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121304|NCT02064387|567195921|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121305|NCT02064387|567195922|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121306|NCT02064387|567195923|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121307|NCT02064387|567195924|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121308|NCT02064387|567195925|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121309|NCT02064387|567195926|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121310|NCT02064387|567195927|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157214124|NCT00833547|567531773|FG000|Overall Study|Withdrawal by Subject|2|||
157214125|NCT00833547|567531774|FG001|Overall Study|Withdrawal by Subject|2|||
157214126|NCT00686790|567531777|FG000|Overall Study|Adverse Event|2|||
156685678|NCT00779402|565593902|FG000|Long-term Follow-up|Other|5|||
156685679|NCT00779402|565593903|FG001|Long-term Follow-up|Other|0|||
156685680|NCT00779402|565593902|FG000|Long-term Follow-up|Closure of Study|8|||
156685681|NCT00779402|565593903|FG001|Long-term Follow-up|Closure of Study|4|||
156685682|NCT00779402|565593902|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
156685683|NCT00779402|565593903|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
156685684|NCT00693225|565593908|FG000|Overall Study|Lost to Follow-up|1|||
156685685|NCT00693225|565593909|FG001|Overall Study|Lost to Follow-up|2|||
156685686|NCT00693225|565593908|FG000|Overall Study|Adverse Event|1|||
156685687|NCT00693225|565593909|FG001|Overall Study|Adverse Event|3|||
156685688|NCT01315028|565593910|FG000|Overall Study|Lost to Follow-up|1|||
156685689|NCT01315028|565593911|FG001|Overall Study|Lost to Follow-up|0|||
156685690|NCT01315028|565593910|FG000|Overall Study|Death|0|||
156685691|NCT01315028|565593911|FG001|Overall Study|Death|1|||
156685692|NCT03585959|565593916|FG000|Overall Study|Physician Decision|1|||
156685693|NCT03585959|565593916|FG000|Overall Study|Unsuccessful Procedure|2|||
156685694|NCT02531594|565593917|FG000|Overall Study|Withdrawal by Subject|7|||
156685695|NCT02531594|565593918|FG001|Overall Study|Withdrawal by Subject|8|||
156685696|NCT00220727|565593948|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
156685697|NCT00220727|565593949|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
156685698|NCT01175473|565593950|FG000|Overall Study|Adverse Event|2|||
156685699|NCT01175473|565593951|FG001|Overall Study|Adverse Event|2|||
156685700|NCT02508116|565593954|FG000|Overall Study|Lost to Follow-up|2|||
156685701|NCT02508116|565593955|FG001|Overall Study|Lost to Follow-up|3|||
156685702|NCT02508116|565593954|FG000|Overall Study|Withdrawal by Subject|3|||
156685703|NCT02508116|565593955|FG001|Overall Study|Withdrawal by Subject|2|||
156685704|NCT02508116|565593954|FG000|Overall Study|Protocol Violation|1|||
156685705|NCT02508116|565593955|FG001|Overall Study|Protocol Violation|2|||
156685706|NCT02508116|565593954|FG000|Overall Study|Physician Decision|2|||
156685707|NCT02508116|565593955|FG001|Overall Study|Physician Decision|0|||
156685708|NCT00109850|565593961|FG000|Overall Study|Adverse Event|1|||
156685709|NCT00109850|565593961|FG000|Overall Study|Death|2|||
156685710|NCT00109850|565593961|FG000|Overall Study|Ineligible|1|||
156685711|NCT04234464|565593962|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
156685712|NCT04234464|565593963|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
156685713|NCT00476593|565593964|FG000|Overall Study|Lost to Follow-up|10|||
156685714|NCT00476593|565593965|FG001|Overall Study|Lost to Follow-up|2|||
156685715|NCT00476593|565593966|FG002|Overall Study|Lost to Follow-up|8|||
156685716|NCT00476593|565593967|FG003|Overall Study|Lost to Follow-up|22|||
156685717|NCT00983528|565593968|FG000|Overall Study|Death|4|||
156685718|NCT00983528|565593968|FG000|Overall Study|Lost to Follow-up|1|||
156685719|NCT00983528|565593968|FG000|Overall Study|Study Terminated|1|||
156685720|NCT03430011|565593970|FG000|Pre-Treatment|Death|1|||
156685721|NCT03430011|565593971|FG001|Pre-Treatment|Death|0|||
156685722|NCT03430011|565593972|FG002|Pre-Treatment|Death|0|||
156685723|NCT03430011|565593973|FG003|Pre-Treatment|Death|0|||
156685724|NCT03430011|565593974|FG004|Pre-Treatment|Death|1|||
156685725|NCT03430011|565593975|FG005|Pre-Treatment|Death|0|||
156685726|NCT03430011|565593976|FG006|Pre-Treatment|Death|1|||
156685727|NCT03430011|565593977|FG007|Pre-Treatment|Death|0|||
156685728|NCT03430011|565593970|FG000|Pre-Treatment|Screen Fail|0|||
156685729|NCT03430011|565593971|FG001|Pre-Treatment|Screen Fail|0|||
156685730|NCT03430011|565593972|FG002|Pre-Treatment|Screen Fail|0|||
156685731|NCT03430011|565593973|FG003|Pre-Treatment|Screen Fail|0|||
156685732|NCT03430011|565593974|FG004|Pre-Treatment|Screen Fail|1|||
156785474|NCT01058005|565966374|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
156685733|NCT03430011|565593975|FG005|Pre-Treatment|Screen Fail|0|||
156685734|NCT03430011|565593976|FG006|Pre-Treatment|Screen Fail|0|||
156685735|NCT03430011|565593977|FG007|Pre-Treatment|Screen Fail|0|||
156685736|NCT03430011|565593970|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685737|NCT03430011|565593971|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685738|NCT03430011|565593972|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
156685739|NCT03430011|565593973|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685740|NCT03430011|565593974|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
157214127|NCT00686790|567531777|FG000|Overall Study|Withdrawal by Subject|1|||
157214128|NCT00686790|567531777|FG000|Overall Study|Death|1|||
157214129|NCT00686790|567531777|FG000|Overall Study|Lost to Follow-up|12|||
157214130|NCT00096382|567531778|FG000|Overall Study|Not treated|1|||
157214131|NCT00096382|567531779|FG001|Overall Study|Not treated|0|||
157214132|NCT00096382|567531778|FG000|Overall Study|Death during treatment|1|||
157214133|NCT00096382|567531779|FG001|Overall Study|Death during treatment|0|||
157214134|NCT03862625|567531783|FG000|Overall Study|Lost to Follow-up|0|||
157214135|NCT03862625|567531784|FG001|Overall Study|Lost to Follow-up|1|||
157214136|NCT01326702|567531785|FG000|Overall Study|Other|1|||
156685741|NCT03430011|565593975|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
157214137|NCT01326702|567531786|FG001|Overall Study|Other|0|||
157214138|NCT01326702|567531787|FG002|Overall Study|Other|0|||
157214139|NCT01326702|567531788|FG003|Overall Study|Other|0|||
157214140|NCT01326702|567531789|FG004|Overall Study|Other|0|||
156685742|NCT03430011|565593976|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685743|NCT03430011|565593977|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
156685744|NCT03430011|565593970|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
156685745|NCT03430011|565593971|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
156685746|NCT03430011|565593972|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
156685747|NCT03430011|565593973|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
156685748|NCT03430011|565593974|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
156685749|NCT03430011|565593975|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
156685750|NCT03430011|565593976|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
156685751|NCT03430011|565593977|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
156685752|NCT03430011|565593970|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
156685753|NCT03430011|565593971|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
156685754|NCT03430011|565593972|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
156685755|NCT03430011|565593973|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
156685756|NCT03430011|565593974|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
156685757|NCT03430011|565593975|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
156685758|NCT03430011|565593976|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
156685759|NCT03430011|565593977|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
156685760|NCT03430011|565593970|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
156685761|NCT03430011|565593971|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
156685762|NCT03430011|565593972|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
156685763|NCT03430011|565593973|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
156685764|NCT03430011|565593974|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
156685765|NCT03430011|565593975|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
156685766|NCT03430011|565593976|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
156685767|NCT03430011|565593977|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
156685768|NCT03430011|565593970|FG000|JCARH125 Treatment|Death|4|||
156685769|NCT03430011|565593971|FG001|JCARH125 Treatment|Death|19|||
156685770|NCT03430011|565593972|FG002|JCARH125 Treatment|Death|10|||
156685771|NCT03430011|565593973|FG003|JCARH125 Treatment|Death|8|||
156685772|NCT03430011|565593974|FG004|JCARH125 Treatment|Death|5|||
156685773|NCT03430011|565593975|FG005|JCARH125 Treatment|Death|3|||
156685774|NCT03430011|565593976|FG006|JCARH125 Treatment|Death|4|||
156685775|NCT03430011|565593977|FG007|JCARH125 Treatment|Death|2|||
156685776|NCT03430011|565593970|FG000|JCARH125 Treatment|Other reasons|1|||
156685777|NCT03430011|565593971|FG001|JCARH125 Treatment|Other reasons|0|||
156685778|NCT03430011|565593972|FG002|JCARH125 Treatment|Other reasons|4|||
156685779|NCT03430011|565593973|FG003|JCARH125 Treatment|Other reasons|2|||
156685780|NCT03430011|565593974|FG004|JCARH125 Treatment|Other reasons|2|||
156685781|NCT03430011|565593975|FG005|JCARH125 Treatment|Other reasons|1|||
156685782|NCT03430011|565593976|FG006|JCARH125 Treatment|Other reasons|3|||
156685783|NCT03430011|565593977|FG007|JCARH125 Treatment|Other reasons|2|||
156685784|NCT00559364|565593979|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
156685785|NCT00559364|565593980|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
156685786|NCT04126343|565593981|FG000|Overall Study|Adverse Event|0|||
156685787|NCT04126343|565593982|FG001|Overall Study|Adverse Event|0|||
156685788|NCT04126343|565593983|FG002|Overall Study|Adverse Event|0|||
156685789|NCT04126343|565593984|FG003|Overall Study|Adverse Event|0|||
156685790|NCT04126343|565593985|FG004|Overall Study|Adverse Event|0|||
156685791|NCT04126343|565593986|FG005|Overall Study|Adverse Event|1|||
156685792|NCT04126343|565593981|FG000|Overall Study|Withdrawal by Subject|0|||
156685793|NCT04126343|565593982|FG001|Overall Study|Withdrawal by Subject|0|||
156685794|NCT04126343|565593983|FG002|Overall Study|Withdrawal by Subject|0|||
156685795|NCT04126343|565593984|FG003|Overall Study|Withdrawal by Subject|1|||
157214141|NCT01326702|567531790|FG005|Overall Study|Other|1|||
156685796|NCT04126343|565593985|FG004|Overall Study|Withdrawal by Subject|0|||
156685797|NCT04126343|565593986|FG005|Overall Study|Withdrawal by Subject|0|||
156685798|NCT04126343|565593981|FG000|Overall Study|Related to COVID-19 pandemic|3|||
156685799|NCT04126343|565593982|FG001|Overall Study|Related to COVID-19 pandemic|4|||
156685800|NCT04126343|565593983|FG002|Overall Study|Related to COVID-19 pandemic|3|||
156685801|NCT04126343|565593984|FG003|Overall Study|Related to COVID-19 pandemic|3|||
157214142|NCT01326702|567531791|FG006|Overall Study|Other|0|||
157121311|NCT02064387|567195928|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121312|NCT02064387|567195929|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121313|NCT02064387|567195930|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
157121314|NCT02064387|567195931|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
157121315|NCT02436876|567195935|FG000|Overall Study|Lost to Follow-up|0|||
157121316|NCT02436876|567195936|FG001|Overall Study|Lost to Follow-up|1|||
157121317|NCT02436876|567195937|FG002|Overall Study|Lost to Follow-up|1|||
157121318|NCT02436876|567195938|FG003|Overall Study|Lost to Follow-up|1|||
157121319|NCT02436876|567195935|FG000|Overall Study|Withdrawal by Subject|1|||
157121320|NCT02436876|567195936|FG001|Overall Study|Withdrawal by Subject|0|||
157121321|NCT02436876|567195937|FG002|Overall Study|Withdrawal by Subject|0|||
157121322|NCT02436876|567195938|FG003|Overall Study|Withdrawal by Subject|1|||
157121323|NCT02436876|567195935|FG000|Overall Study|Physician Decision|0|||
157121324|NCT02436876|567195936|FG001|Overall Study|Physician Decision|2|||
157121325|NCT02436876|567195937|FG002|Overall Study|Physician Decision|1|||
157121326|NCT02436876|567195938|FG003|Overall Study|Physician Decision|0|||
157121327|NCT02436876|567195935|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
157121328|NCT02436876|567195936|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
157121329|NCT02436876|567195937|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
157121330|NCT02436876|567195938|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
157121331|NCT00999908|567195939|FG000|Treatment Period 1|Subject withdrew consent|2|||
157121332|NCT00999908|567195940|FG001|Treatment Period 1|Subject withdrew consent|0|||
157121333|NCT00999908|567195941|FG002|Treatment Period 1|Subject withdrew consent|0|||
157121334|NCT00999908|567195939|FG000|Treatment Period 2|Protocol Violation|1|||
157121335|NCT00999908|567195940|FG001|Treatment Period 2|Protocol Violation|0|||
157121336|NCT00999908|567195941|FG002|Treatment Period 2|Protocol Violation|0|||
157121337|NCT00075504|567195942|FG000|Overall Study|Withdrawal by Subject|9|||
157121338|NCT00075504|567195943|FG001|Overall Study|Withdrawal by Subject|7|||
157121339|NCT02780648|567195945|FG000|Overall Study|Disease Progression|1|||
157121340|NCT02780648|567195946|FG001|Overall Study|Disease Progression|0|||
157121341|NCT00293579|567195947|FG000|Overall Study|Withdrawal by Subject|1|||
157121342|NCT03215771|567195948|FG000|Overall Study|Withdrawal by Subject|2|||
157121343|NCT03215771|567195948|FG000|Overall Study|Physician Decision|1|||
157121344|NCT03127384|567195949|FG000|Overall Study|Lost to Follow-up|4|||
157121345|NCT03127384|567195949|FG000|Overall Study|Subject request|2|||
157121346|NCT00343889|567195957|FG000|Overall Study|Lost to Follow-up|2|||
157121347|NCT00343889|567195958|FG001|Overall Study|Lost to Follow-up|0|||
157121348|NCT00343889|567195957|FG000|Overall Study|Withdrawal by Subject|0|||
157121349|NCT00343889|567195958|FG001|Overall Study|Withdrawal by Subject|1|||
157121350|NCT00343889|567195957|FG000|Overall Study|Protocol Violation|1|||
157121351|NCT00343889|567195958|FG001|Overall Study|Protocol Violation|0|||
157121352|NCT01294579|567195961|FG000|Overall Study|Disease progression|12|||
157121353|NCT01294579|567195961|FG000|Overall Study|Adverse Event|11|||
157121354|NCT01294579|567195961|FG000|Overall Study|Study closed/terminated|3|||
157121355|NCT01294579|567195961|FG000|Overall Study|Lost to Follow-up|1|||
157121356|NCT01294579|567195961|FG000|Overall Study|Physician Decision|3|||
157121357|NCT01294579|567195961|FG000|Overall Study|Withdrawal by Subject|5|||
156685802|NCT04126343|565593985|FG004|Overall Study|Related to COVID-19 pandemic|3|||
157121358|NCT00137111|567195962|FG000|Total Therapy|Death|35|||
157121359|NCT00137111|567195963|FG001|Total Therapy|Death|0|||
157121360|NCT00137111|567195964|FG002|Total Therapy|Death|0|||
157121361|NCT00137111|567195965|FG003|Total Therapy|Death|0|||
157121362|NCT00137111|567195962|FG000|Total Therapy|Non Compliance|5|||
157121363|NCT00137111|567195963|FG001|Total Therapy|Non Compliance|0|||
157121364|NCT00137111|567195964|FG002|Total Therapy|Non Compliance|0|||
157121365|NCT00137111|567195965|FG003|Total Therapy|Non Compliance|0|||
157121366|NCT00262873|567195966|FG000|Overall Study|Adverse Event|3|||
157121367|NCT00262873|567195966|FG000|Overall Study|Withdrawal by Subject|5|||
157121368|NCT00903175|567195967|FG000|Period 1 - First Line|Adverse Event|36|||
157121369|NCT00903175|567195968|FG001|Period 1 - First Line|Adverse Event|50|||
157121370|NCT00903175|567195967|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
156685803|NCT04126343|565593986|FG005|Overall Study|Related to COVID-19 pandemic|3|||
156685804|NCT00330460|565593995|FG000|Overall Study|Physician Decision|1|||
156685805|NCT00330460|565593996|FG001|Overall Study|Physician Decision|0|||
156685806|NCT00330460|565593995|FG000|Overall Study|Adverse Event|10|||
157121371|NCT00903175|567195968|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
157121372|NCT00903175|567195967|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
157121373|NCT00903175|567195968|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
157121374|NCT00903175|567195967|FG000|Period 1 - First Line|Protocol Violation|3|||
157121375|NCT00903175|567195968|FG001|Period 1 - First Line|Protocol Violation|3|||
157121376|NCT00903175|567195967|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
157121377|NCT00903175|567195968|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
157121378|NCT00903175|567195967|FG000|Period 1 - First Line|Administrative problems|12|||
157121379|NCT00903175|567195968|FG001|Period 1 - First Line|Administrative problems|13|||
157121380|NCT00903175|567195967|FG000|Period 1 - First Line|Death|17|||
156685807|NCT00330460|565593996|FG001|Overall Study|Adverse Event|8|||
156685808|NCT00330460|565593995|FG000|Overall Study|Withdrawal by Subject|18|||
156685809|NCT00330460|565593996|FG001|Overall Study|Withdrawal by Subject|17|||
156685810|NCT00330460|565593995|FG000|Overall Study|Death|1|||
156685811|NCT00330460|565593996|FG001|Overall Study|Death|1|||
156685812|NCT00330460|565593995|FG000|Overall Study|Ineligibility determined|1|||
156685813|NCT00330460|565593996|FG001|Overall Study|Ineligibility determined|3|||
156685814|NCT00330460|565593995|FG000|Overall Study|Lost to Follow-up|8|||
156685815|NCT00330460|565593996|FG001|Overall Study|Lost to Follow-up|3|||
156685816|NCT00330460|565593995|FG000|Overall Study|Noncompliance|2|||
156685817|NCT00330460|565593996|FG001|Overall Study|Noncompliance|1|||
156685818|NCT00330460|565593995|FG000|Overall Study|Other|1|||
156685819|NCT00330460|565593996|FG001|Overall Study|Other|0|||
156685820|NCT03712124|565593997|FG000|Overall Study|Protocol Violation|1|||
156685821|NCT03712124|565593998|FG001|Overall Study|Protocol Violation|0|||
156685822|NCT00388037|565594000|FG000|Overall Study|Protocol Violation|1|||
156685823|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
156685824|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
156685825|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
156685826|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
156685827|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
156685828|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
156685829|NCT00602537|565594003|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
156685830|NCT00602537|565594004|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
156685831|NCT00602537|565594003|FG000|Follow Up Study Comparison|Adverse Event|1|||
156685832|NCT00602537|565594004|FG001|Follow Up Study Comparison|Adverse Event|0|||
156685833|NCT00602537|565594003|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
156685834|NCT00602537|565594004|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
156685835|NCT00602537|565594003|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
156685836|NCT00602537|565594004|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
156685837|NCT04314843|565594005|FG000|Overall Study|Death|2|||
156685838|NCT04314843|565594006|FG001|Overall Study|Death|2|||
156685839|NCT04314843|565594005|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
156685840|NCT04314843|565594006|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
156785475|NCT01058005|565966375|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
156785476|NCT01058005|565966373|FG000|Overall Study|Reason Missing|5|||
156785477|NCT01058005|565966374|FG001|Overall Study|Reason Missing|3|||
156785478|NCT01058005|565966375|FG002|Overall Study|Reason Missing|1|||
156785479|NCT01717859|565966376|FG000|Overall Study|Adverse Event|5|||
156785480|NCT01717859|565966376|FG000|Overall Study|Moved out of state|1|||
157013340|NCT02723955|566801776|FG039|Crossover/ Re-treatment Phase|Death|32|||
157013341|NCT02723955|566801777|FG040|Crossover/ Re-treatment Phase|Death|2|||
157013342|NCT02723955|566801778|FG041|Crossover/ Re-treatment Phase|Death|1|||
157013343|NCT02723955|566801779|FG042|Crossover/ Re-treatment Phase|Death|0|||
157013344|NCT02723955|566801737|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013345|NCT02723955|566801738|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013346|NCT02723955|566801739|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013347|NCT02723955|566801740|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013348|NCT02723955|566801741|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013349|NCT02723955|566801742|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013350|NCT02723955|566801743|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013351|NCT02723955|566801744|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013352|NCT02723955|566801745|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013353|NCT02723955|566801746|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013354|NCT02723955|566801747|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013355|NCT02723955|566801748|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013356|NCT02723955|566801749|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013357|NCT02723955|566801750|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013358|NCT02723955|566801751|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013359|NCT02723955|566801752|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013360|NCT02723955|566801753|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013361|NCT02723955|566801754|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013362|NCT02723955|566801755|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
156685841|NCT01899326|565594007|FG000|Overall Study|Withdrawal by Subject|1|||
156685842|NCT01899326|565594007|FG000|Overall Study|Adverse Event|2|||
156685843|NCT01899326|565594007|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
156685844|NCT00373425|565594008|FG000|Overall Study|Relapse of NSCLC|116|||
156685845|NCT00373425|565594009|FG001|Overall Study|Relapse of NSCLC|104|||
156785481|NCT01717859|565966376|FG000|Overall Study|Patient concerned about mental health|1|||
156785482|NCT01717859|565966376|FG000|Overall Study|Lost to Follow-up|1|||
157121381|NCT00903175|567195968|FG001|Period 1 - First Line|Death|10|||
156685846|NCT00373425|565594010|FG002|Overall Study|Relapse of NSCLC|19|||
156808728|NCT01396187|566054447|FG002|Overall Study|Adverse Event|0|||
156808729|NCT01396187|566054448|FG003|Overall Study|Adverse Event|0|||
156685847|NCT00373425|565594011|FG003|Overall Study|Relapse of NSCLC|2|||
156685848|NCT00373425|565594012|FG004|Overall Study|Relapse of NSCLC|26|||
156685849|NCT00373425|565594008|FG000|Overall Study|Adverse Event|191|||
156685850|NCT00373425|565594009|FG001|Overall Study|Adverse Event|22|||
156685851|NCT00373425|565594010|FG002|Overall Study|Adverse Event|59|||
156685852|NCT00373425|565594011|FG003|Overall Study|Adverse Event|0|||
156685853|NCT00373425|565594012|FG004|Overall Study|Adverse Event|34|||
156685854|NCT00373425|565594008|FG000|Overall Study|Patient request|35|||
156685855|NCT00373425|565594009|FG001|Overall Study|Patient request|18|||
156685856|NCT00373425|565594010|FG002|Overall Study|Patient request|43|||
156685857|NCT00373425|565594011|FG003|Overall Study|Patient request|6|||
156685858|NCT00373425|565594012|FG004|Overall Study|Patient request|7|||
156685859|NCT00373425|565594008|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
156685860|NCT00373425|565594009|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
156685861|NCT00373425|565594010|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
156685862|NCT00373425|565594011|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
156685863|NCT00373425|565594012|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
156685864|NCT00373425|565594008|FG000|Overall Study|Death|7|||
156685865|NCT00373425|565594009|FG001|Overall Study|Death|0|||
156685866|NCT00373425|565594010|FG002|Overall Study|Death|3|||
156685867|NCT00373425|565594011|FG003|Overall Study|Death|1|||
156685868|NCT00373425|565594012|FG004|Overall Study|Death|0|||
156685869|NCT02752802|565594013|FG000|Overall Study|Contrast Volume Not Collected|1|||
156685870|NCT02752802|565594014|FG001|Overall Study|Contrast Volume Not Collected|0|||
156685871|NCT02808819|565594015|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
156685872|NCT02808819|565594016|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
156685873|NCT02808819|565594015|FG000|Overall Study|Withdrawal by Subject|10|||
156685874|NCT02808819|565594016|FG001|Overall Study|Withdrawal by Subject|13|||
156685875|NCT02808819|565594015|FG000|Overall Study|Site terminated by sponsor|2|||
156685876|NCT02808819|565594016|FG001|Overall Study|Site terminated by sponsor|0|||
156685877|NCT02808819|565594015|FG000|Overall Study|Pregnancy|1|||
156685878|NCT02808819|565594016|FG001|Overall Study|Pregnancy|0|||
156685879|NCT02808819|565594015|FG000|Overall Study|Lost to Follow-up|1|||
156685880|NCT02808819|565594016|FG001|Overall Study|Lost to Follow-up|6|||
156685881|NCT02808819|565594015|FG000|Overall Study|Protocol Violation|0|||
156685882|NCT02808819|565594016|FG001|Overall Study|Protocol Violation|1|||
156685883|NCT02808819|565594015|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
156685884|NCT02808819|565594016|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
156685885|NCT02808819|565594015|FG000|Overall Study|Death|1|||
156685886|NCT02808819|565594016|FG001|Overall Study|Death|0|||
156685887|NCT02808819|565594015|FG000|Overall Study|Adverse Event|3|||
156685888|NCT02808819|565594016|FG001|Overall Study|Adverse Event|4|||
156685889|NCT02692482|565594017|FG000|Overall Study|Death|2|||
156685890|NCT02692482|565594018|FG001|Overall Study|Death|2|||
156685891|NCT02692482|565594017|FG000|Overall Study|Withdrawal by Subject|1|||
156685892|NCT02692482|565594018|FG001|Overall Study|Withdrawal by Subject|2|||
156685893|NCT04405739|565594023|FG000|Overall Study|Adverse Event|0|||
156685894|NCT04405739|565594024|FG001|Overall Study|Adverse Event|1|||
156685895|NCT04405739|565594025|FG002|Overall Study|Adverse Event|0|||
156685896|NCT04405739|565594026|FG003|Overall Study|Adverse Event|0|||
156685897|NCT04405739|565594023|FG000|Overall Study|Lost to Follow-up|0|||
156685898|NCT04405739|565594024|FG001|Overall Study|Lost to Follow-up|2|||
156685899|NCT04405739|565594025|FG002|Overall Study|Lost to Follow-up|1|||
156685900|NCT04405739|565594026|FG003|Overall Study|Lost to Follow-up|3|||
156685901|NCT04405739|565594023|FG000|Overall Study|Withdrawal by Subject|0|||
156685902|NCT04405739|565594024|FG001|Overall Study|Withdrawal by Subject|2|||
156685903|NCT04405739|565594025|FG002|Overall Study|Withdrawal by Subject|1|||
156685904|NCT04405739|565594026|FG003|Overall Study|Withdrawal by Subject|1|||
156685905|NCT04405739|565594023|FG000|Overall Study|Death|0|||
156685906|NCT04405739|565594024|FG001|Overall Study|Death|0|||
156685907|NCT04405739|565594025|FG002|Overall Study|Death|1|||
156685908|NCT04405739|565594026|FG003|Overall Study|Death|0|||
156685909|NCT04405739|565594023|FG000|Overall Study|Transferred to rehab|0|||
156685910|NCT04405739|565594024|FG001|Overall Study|Transferred to rehab|0|||
156685911|NCT04405739|565594025|FG002|Overall Study|Transferred to rehab|0|||
156685912|NCT04405739|565594026|FG003|Overall Study|Transferred to rehab|1|||
156685913|NCT04405739|565594023|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
156685914|NCT04405739|565594024|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
156685915|NCT04405739|565594025|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
156685916|NCT04405739|565594026|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
156685917|NCT01835548|565594029|FG000|Dose Optimization Period|Adverse Event|0|||
156685918|NCT01835548|565594030|FG001|Dose Optimization Period|Adverse Event|0|||
156685919|NCT01835548|565594031|FG002|Dose Optimization Period|Adverse Event|1|||
156685920|NCT01835548|565594029|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
156685921|NCT01835548|565594030|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
156685922|NCT01835548|565594031|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
156685923|NCT01835548|565594029|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156808730|NCT01396187|566054449|FG004|Overall Study|Adverse Event|0|||
156685924|NCT01835548|565594030|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156685925|NCT01835548|565594031|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156685926|NCT01835548|565594029|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156685927|NCT01835548|565594030|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156685928|NCT01835548|565594031|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156685929|NCT00576303|565594032|FG000|Dose Titration Period|Early withdrawal|17|||
156685930|NCT00576303|565594032|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
156685931|NCT00576303|565594032|FG000|Long Term Safety Period|Early withdrawal|16|||
156685932|NCT00824369|565594033|FG000|Overall Study|Nolonger willing to participate in study|1|||
156685933|NCT00824369|565594034|FG001|Overall Study|Nolonger willing to participate in study|0|||
156685934|NCT00824369|565594035|FG002|Overall Study|Nolonger willing to participate in study|1|||
156685935|NCT00824369|565594036|FG003|Overall Study|Nolonger willing to participate in study|2|||
156685936|NCT00824369|565594037|FG004|Overall Study|Nolonger willing to participate in study|0|||
156685937|NCT00824369|565594038|FG005|Overall Study|Nolonger willing to participate in study|1|||
156685938|NCT00824369|565594033|FG000|Overall Study|Lost to Follow-up|0|||
156685939|NCT00824369|565594034|FG001|Overall Study|Lost to Follow-up|0|||
156685940|NCT00824369|565594035|FG002|Overall Study|Lost to Follow-up|0|||
156685941|NCT00824369|565594036|FG003|Overall Study|Lost to Follow-up|0|||
156685942|NCT00824369|565594037|FG004|Overall Study|Lost to Follow-up|1|||
156685943|NCT00824369|565594038|FG005|Overall Study|Lost to Follow-up|0|||
156685944|NCT00442546|565594039|FG000|Overall Study|Adverse Event|11|||
156685945|NCT00442546|565594040|FG001|Overall Study|Adverse Event|17|||
156685946|NCT00442546|565594041|FG002|Overall Study|Adverse Event|13|||
156685947|NCT00442546|565594039|FG000|Overall Study|Lost to Follow-up|1|||
156685948|NCT00442546|565594040|FG001|Overall Study|Lost to Follow-up|2|||
156685949|NCT00442546|565594041|FG002|Overall Study|Lost to Follow-up|1|||
156685950|NCT00442546|565594039|FG000|Overall Study|Other|4|||
156685951|NCT00442546|565594040|FG001|Overall Study|Other|9|||
156685952|NCT00442546|565594041|FG002|Overall Study|Other|6|||
156685953|NCT00442546|565594039|FG000|Overall Study|Withdrawal by Subject|5|||
156785483|NCT01717859|565966376|FG000|Overall Study|Withdrawal by Subject|2|||
156785484|NCT02287025|565966378|FG000|Overall Study|Not treated|2|||
156785485|NCT02287025|565966379|FG001|Overall Study|Not treated|0|||
156785486|NCT02287025|565966378|FG000|Overall Study|Progression of disease|3|||
156785487|NCT02287025|565966379|FG001|Overall Study|Progression of disease|2|||
156785488|NCT02287025|565966378|FG000|Overall Study|Adverse Event|2|||
156785489|NCT02287025|565966379|FG001|Overall Study|Adverse Event|4|||
156785490|NCT02287025|565966378|FG000|Overall Study|Withdrawal by Subject|2|||
156785491|NCT02287025|565966379|FG001|Overall Study|Withdrawal by Subject|2|||
156785492|NCT02287025|565966378|FG000|Overall Study|Screening failed|1|||
156785493|NCT02287025|565966379|FG001|Overall Study|Screening failed|1|||
156785494|NCT00899847|565966380|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
156785495|NCT05987540|565966381|FG000|Overall Study|Withdrawal by Subject|2|||
156785496|NCT05987540|565966381|FG000|Overall Study|Death|1|||
156785497|NCT05987540|565966381|FG000|Overall Study|Study Termination|1|||
156785498|NCT05987540|565966381|FG000|Overall Study|Adverse Event|2|||
156785499|NCT04053452|565966382|FG000|Overall Study|Withdrawal by Subject|1|||
156785500|NCT04053452|565966383|FG001|Overall Study|Withdrawal by Subject|0|||
156785501|NCT04053452|565966382|FG000|Overall Study|Time restraint due to inpatient needs|1|||
156785502|NCT04053452|565966383|FG001|Overall Study|Time restraint due to inpatient needs|2|||
156785503|NCT01421134|565966384|FG000|Overall Study|Adverse Event|3|||
156785504|NCT01421134|565966385|FG001|Overall Study|Adverse Event|5|||
156785505|NCT01421134|565966384|FG000|Overall Study|Lack of Efficacy|2|||
156785506|NCT01421134|565966385|FG001|Overall Study|Lack of Efficacy|4|||
156785507|NCT01421134|565966384|FG000|Overall Study|Protocol Violation|0|||
156785508|NCT01421134|565966385|FG001|Overall Study|Protocol Violation|3|||
156785509|NCT01421134|565966384|FG000|Overall Study|Withdrawal by Subject|1|||
156785510|NCT01421134|565966385|FG001|Overall Study|Withdrawal by Subject|1|||
156785511|NCT01421134|565966384|FG000|Overall Study|Administrative|0|||
157121382|NCT00903175|567195967|FG000|Period 2 - Second Line|Missing|1|||
157121383|NCT00903175|567195968|FG001|Period 2 - Second Line|Missing|0|||
157121384|NCT00903175|567195967|FG000|Period 2 - Second Line|Adverse Event|16|||
157121385|NCT00903175|567195968|FG001|Period 2 - Second Line|Adverse Event|20|||
156685954|NCT00442546|565594040|FG001|Overall Study|Withdrawal by Subject|5|||
156685955|NCT00442546|565594041|FG002|Overall Study|Withdrawal by Subject|7|||
156685956|NCT00442546|565594039|FG000|Overall Study|Randomized But Not Treated|5|||
156685957|NCT00442546|565594040|FG001|Overall Study|Randomized But Not Treated|4|||
156685958|NCT00442546|565594041|FG002|Overall Study|Randomized But Not Treated|6|||
156685959|NCT01557582|565594046|FG000|Overall Study|Protocol Violation|4|||
156685960|NCT01557582|565594046|FG000|Overall Study|Operator error|2|||
156685961|NCT02843659|565594047|FG000|Overall Study|Subject Withdrew Consent|0|||
156785512|NCT01421134|565966385|FG001|Overall Study|Administrative|1|||
156785513|NCT01421134|565966384|FG000|Overall Study|Lost to Follow-up|1|||
156785514|NCT01421134|565966385|FG001|Overall Study|Lost to Follow-up|1|||
156785515|NCT02959892|565966386|FG000|Overall Study|PET tracer synthesis failure|1|||
156785516|NCT02959892|565966387|FG001|Overall Study|PET tracer synthesis failure|0|||
156685962|NCT02843659|565594048|FG001|Overall Study|Subject Withdrew Consent|0|||
156685963|NCT02843659|565594049|FG002|Overall Study|Subject Withdrew Consent|1|||
156685964|NCT02843659|565594047|FG000|Overall Study|Administrative Reason by Sponsor|4|||
156685965|NCT02843659|565594048|FG001|Overall Study|Administrative Reason by Sponsor|5|||
156685966|NCT02843659|565594049|FG002|Overall Study|Administrative Reason by Sponsor|4|||
156685967|NCT02843659|565594047|FG000|Overall Study|Adverse Event|0|||
156685968|NCT02843659|565594048|FG001|Overall Study|Adverse Event|1|||
156685969|NCT02843659|565594049|FG002|Overall Study|Adverse Event|0|||
156685970|NCT03203642|565594050|FG000|Overall Study|Adverse Event|3|||
156685971|NCT03203642|565594051|FG001|Overall Study|Adverse Event|1|||
156685972|NCT03203642|565594050|FG000|Overall Study|Withdrawal by Subject|6|||
157121386|NCT00903175|567195967|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
157121387|NCT00903175|567195968|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
157121388|NCT00903175|567195967|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
157121389|NCT00903175|567195968|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
157121390|NCT00903175|567195967|FG000|Period 2 - Second Line|Administrative problems|19|||
157121391|NCT00903175|567195968|FG001|Period 2 - Second Line|Administrative problems|9|||
157121392|NCT00903175|567195967|FG000|Period 2 - Second Line|Death|5|||
157121393|NCT00903175|567195968|FG001|Period 2 - Second Line|Death|2|||
157121394|NCT03074474|567195969|FG000|Overall Study|Lost to Follow-up|10|||
157121395|NCT03074474|567195969|FG000|Overall Study|Withdrawal by Subject|10|||
157121396|NCT03074474|567195969|FG000|Overall Study|Death|4|||
157121397|NCT03074474|567195969|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
157121398|NCT05103332|567195978|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121399|NCT05103332|567195979|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
157121400|NCT05103332|567195980|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
157121401|NCT05103332|567195981|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
156685973|NCT03203642|565594051|FG001|Overall Study|Withdrawal by Subject|6|||
156685974|NCT03203642|565594050|FG000|Overall Study|Lost to Follow-up|2|||
156685975|NCT03203642|565594051|FG001|Overall Study|Lost to Follow-up|1|||
156685976|NCT03203642|565594050|FG000|Overall Study|Termination of the study by sponsor|1|||
156685977|NCT03203642|565594051|FG001|Overall Study|Termination of the study by sponsor|1|||
157121402|NCT05103332|567195982|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121403|NCT05103332|567195983|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
157121404|NCT05103332|567195984|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121405|NCT05103332|567195985|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121406|NCT05103332|567195986|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121407|NCT05103332|567195987|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121408|NCT05103332|567195988|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121409|NCT05103332|567195989|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121410|NCT05103332|567195990|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121411|NCT05103332|567195991|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121412|NCT05103332|567195992|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121413|NCT05103332|567195993|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121414|NCT05103332|567195994|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121415|NCT05103332|567195995|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121416|NCT05103332|567195978|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121417|NCT05103332|567195979|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
157121418|NCT05103332|567195980|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121419|NCT05103332|567195981|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
157121420|NCT05103332|567195982|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121421|NCT05103332|567195983|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121422|NCT05103332|567195984|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121423|NCT05103332|567195985|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121424|NCT05103332|567195986|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121425|NCT05103332|567195987|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
156785517|NCT02959892|565966386|FG000|Overall Study|Study termination|0|||
156785518|NCT02959892|565966387|FG001|Overall Study|Study termination|1|||
156785519|NCT00122187|565966388|FG000|Overall Study|Withdrew because of resource limitations|2|||
157121426|NCT05103332|567195988|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
156785520|NCT00122187|565966389|FG001|Overall Study|Withdrew because of resource limitations|2|||
156785521|NCT02061592|565966393|FG000|Period 1|Withdrawal by Subject|1|||
156785522|NCT02061592|565966394|FG001|Period 1|Withdrawal by Subject|0|||
156785523|NCT02061592|565966393|FG000|Period 1|Protocol Violation|1|||
157121427|NCT05103332|567195989|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
156685978|NCT03203642|565594050|FG000|Overall Study|Participant moved|0|||
156685979|NCT03203642|565594051|FG001|Overall Study|Participant moved|1|||
156685980|NCT03203642|565594050|FG000|Overall Study|Investigator's decision|3|||
156685981|NCT03203642|565594051|FG001|Overall Study|Investigator's decision|0|||
156685982|NCT03203642|565594050|FG000|Overall Study|Other than above specified|0|||
156685983|NCT03203642|565594051|FG001|Overall Study|Other than above specified|1|||
156785524|NCT02061592|565966394|FG001|Period 1|Protocol Violation|0|||
156785525|NCT02061592|565966393|FG000|Period 2|Lost to Follow-up|0|||
157121428|NCT05103332|567195990|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121429|NCT05103332|567195991|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121430|NCT05103332|567195992|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
156685984|NCT02413294|565594052|FG000|Overall Study|Withdrawal by Subject|1|||
156685985|NCT02688387|565596316|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685986|NCT02688387|565596317|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685987|NCT02688387|565596318|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
156685988|NCT02688387|565596319|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685989|NCT02688387|565596320|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685990|NCT02688387|565596321|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685991|NCT02688387|565596322|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685992|NCT02688387|565596323|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685993|NCT02688387|565596324|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685994|NCT02688387|565596325|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685995|NCT02688387|565596326|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685996|NCT02688387|565596327|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685997|NCT02688387|565596328|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685998|NCT02688387|565596329|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156685999|NCT02688387|565596330|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686000|NCT02688387|565596331|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686001|NCT02688387|565596332|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686002|NCT02688387|565596333|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686003|NCT02688387|565596334|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686004|NCT02688387|565596335|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686005|NCT02688387|565596336|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156686006|NCT02688387|565596337|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
156785526|NCT02061592|565966394|FG001|Period 2|Lost to Follow-up|1|||
156785527|NCT04433975|565966395|FG000|1-month Follow Up|Withdrawal by Subject|1|||
156785528|NCT04433975|565966396|FG001|1-month Follow Up|Withdrawal by Subject|1|||
156785529|NCT04433975|565966395|FG000|1-month Follow Up|Lost to Follow-up|21|||
156785530|NCT04433975|565966396|FG001|1-month Follow Up|Lost to Follow-up|25|||
157013363|NCT02723955|566801756|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013364|NCT02723955|566801757|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013365|NCT02723955|566801758|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013366|NCT02723955|566801759|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013367|NCT02723955|566801760|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013368|NCT02723955|566801761|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013369|NCT02723955|566801762|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013370|NCT02723955|566801763|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013371|NCT02723955|566801764|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013372|NCT02723955|566801765|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013373|NCT02723955|566801766|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013374|NCT02723955|566801767|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013375|NCT02723955|566801768|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013376|NCT02723955|566801769|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013377|NCT02723955|566801770|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013378|NCT02723955|566801771|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013379|NCT02723955|566801772|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013380|NCT02723955|566801773|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013381|NCT02723955|566801774|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013382|NCT02723955|566801775|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013383|NCT02723955|566801776|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
157013384|NCT02723955|566801777|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013385|NCT02723955|566801778|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013386|NCT02723955|566801779|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
157013387|NCT02723955|566801737|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013388|NCT02723955|566801738|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013389|NCT02723955|566801739|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013390|NCT02723955|566801740|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013391|NCT02723955|566801741|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013392|NCT02723955|566801742|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013393|NCT02723955|566801743|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013394|NCT02723955|566801744|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013395|NCT02723955|566801745|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013396|NCT02723955|566801746|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013397|NCT02723955|566801747|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013398|NCT02723955|566801748|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013399|NCT02723955|566801749|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013400|NCT02723955|566801750|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
157214143|NCT01326702|567531785|FG000|Overall Study|progressive disease|1|||
157013401|NCT02723955|566801751|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
157121431|NCT05103332|567195993|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121432|NCT05103332|567195994|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121433|NCT05103332|567195995|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
157121434|NCT05103332|567195978|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
157121435|NCT05103332|567195979|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
157121436|NCT05103332|567195980|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
157121437|NCT05103332|567195981|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
157121438|NCT05103332|567195982|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
157121439|NCT05103332|567195983|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
157121440|NCT05103332|567195984|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121441|NCT05103332|567195985|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121442|NCT05103332|567195986|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121443|NCT05103332|567195987|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121444|NCT05103332|567195988|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121445|NCT05103332|567195989|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121446|NCT05103332|567195990|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121447|NCT05103332|567195991|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121448|NCT05103332|567195992|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121449|NCT05103332|567195993|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121450|NCT05103332|567195994|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121451|NCT05103332|567195995|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121452|NCT05103332|567195978|FG000|DB Period (6 Months=168 Days)|Other|0|||
157121453|NCT05103332|567195979|FG001|DB Period (6 Months=168 Days)|Other|0|||
157121454|NCT05103332|567195980|FG002|DB Period (6 Months=168 Days)|Other|0|||
157121455|NCT05103332|567195981|FG003|DB Period (6 Months=168 Days)|Other|1|||
157121456|NCT05103332|567195982|FG004|DB Period (6 Months=168 Days)|Other|0|||
157121457|NCT05103332|567195983|FG005|DB Period (6 Months=168 Days)|Other|0|||
157121458|NCT05103332|567195984|FG006|DB Period (6 Months=168 Days)|Other|0|||
157121459|NCT05103332|567195985|FG007|DB Period (6 Months=168 Days)|Other|0|||
157121460|NCT05103332|567195986|FG008|DB Period (6 Months=168 Days)|Other|0|||
157121461|NCT05103332|567195987|FG009|DB Period (6 Months=168 Days)|Other|0|||
157121462|NCT05103332|567195988|FG010|DB Period (6 Months=168 Days)|Other|0|||
157121463|NCT05103332|567195989|FG011|DB Period (6 Months=168 Days)|Other|0|||
157121464|NCT05103332|567195990|FG012|DB Period (6 Months=168 Days)|Other|0|||
157121465|NCT05103332|567195991|FG013|DB Period (6 Months=168 Days)|Other|0|||
157121466|NCT05103332|567195992|FG014|DB Period (6 Months=168 Days)|Other|0|||
157121467|NCT05103332|567195993|FG015|DB Period (6 Months=168 Days)|Other|0|||
157121468|NCT05103332|567195994|FG016|DB Period (6 Months=168 Days)|Other|0|||
157121469|NCT05103332|567195995|FG017|DB Period (6 Months=168 Days)|Other|0|||
157121470|NCT05103332|567195978|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156686007|NCT02688387|565596316|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686008|NCT02688387|565596317|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686009|NCT02688387|565596318|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686010|NCT02688387|565596319|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
156686011|NCT02688387|565596320|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686012|NCT02688387|565596321|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686013|NCT02688387|565596322|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686014|NCT02688387|565596323|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686015|NCT02688387|565596324|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686016|NCT02688387|565596325|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686017|NCT02688387|565596326|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686018|NCT02688387|565596327|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686019|NCT02688387|565596328|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686020|NCT02688387|565596329|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686021|NCT02688387|565596330|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686022|NCT02688387|565596331|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686023|NCT02688387|565596332|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686024|NCT02688387|565596333|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686025|NCT02688387|565596334|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686026|NCT02688387|565596335|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156868577|NCT00865566|566277332|FG000|Overall Study|Lost to Follow-up|314|||
156868578|NCT00865566|566277333|FG001|Overall Study|Lost to Follow-up|315|||
157121471|NCT05103332|567195979|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121472|NCT05103332|567195980|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121473|NCT05103332|567195981|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157214144|NCT01326702|567531786|FG001|Overall Study|progressive disease|1|||
157214145|NCT01326702|567531787|FG002|Overall Study|progressive disease|3|||
157214146|NCT01326702|567531788|FG003|Overall Study|progressive disease|1|||
157214147|NCT01326702|567531789|FG004|Overall Study|progressive disease|3|||
157214148|NCT01326702|567531790|FG005|Overall Study|progressive disease|2|||
157214149|NCT01326702|567531791|FG006|Overall Study|progressive disease|3|||
157214150|NCT01326702|567531785|FG000|Overall Study|Death|0|||
157214151|NCT01326702|567531786|FG001|Overall Study|Death|1|||
157214152|NCT01326702|567531787|FG002|Overall Study|Death|0|||
157214153|NCT01326702|567531788|FG003|Overall Study|Death|0|||
157214154|NCT01326702|567531789|FG004|Overall Study|Death|0|||
157214155|NCT01326702|567531790|FG005|Overall Study|Death|0|||
157214156|NCT01326702|567531791|FG006|Overall Study|Death|0|||
157214157|NCT01326702|567531785|FG000|Overall Study|Adverse Event|0|||
157214158|NCT01326702|567531786|FG001|Overall Study|Adverse Event|0|||
156785531|NCT04433975|565966395|FG000|3-month Follow Up|Lost to Follow-up|20|||
156785532|NCT04433975|565966396|FG001|3-month Follow Up|Lost to Follow-up|24|||
156785533|NCT04433975|565966395|FG000|3-month Follow Up|Death|1|||
156785534|NCT04433975|565966396|FG001|3-month Follow Up|Death|0|||
156785535|NCT04433975|565966395|FG000|3-month Follow Up|Withdrawal by Subject|2|||
156785536|NCT04433975|565966396|FG001|3-month Follow Up|Withdrawal by Subject|0|||
156785537|NCT04433975|565966395|FG000|6-month Follow Up|Lost to Follow-up|23|||
156785538|NCT04433975|565966396|FG001|6-month Follow Up|Lost to Follow-up|28|||
156785539|NCT04433975|565966395|FG000|6-month Follow Up|Withdrawal by Subject|1|||
156785540|NCT04433975|565966396|FG001|6-month Follow Up|Withdrawal by Subject|1|||
156785541|NCT04433975|565966395|FG000|9-month Follow Up|Lost to Follow-up|27|||
156785542|NCT04433975|565966396|FG001|9-month Follow Up|Lost to Follow-up|36|||
156785543|NCT04433975|565966395|FG000|9-month Follow Up|Death|0|||
156785544|NCT04433975|565966396|FG001|9-month Follow Up|Death|1|||
156785545|NCT04433975|565966395|FG000|12-month Follow Up|Lost to Follow-up|27|||
157013402|NCT02723955|566801752|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013403|NCT02723955|566801753|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013404|NCT02723955|566801754|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013405|NCT02723955|566801755|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013406|NCT02723955|566801756|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013407|NCT02723955|566801757|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013408|NCT02723955|566801758|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013409|NCT02723955|566801759|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013410|NCT02723955|566801760|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013411|NCT02723955|566801761|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013412|NCT02723955|566801762|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013413|NCT02723955|566801763|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013414|NCT02723955|566801764|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013415|NCT02723955|566801765|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013416|NCT02723955|566801766|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013417|NCT02723955|566801767|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013418|NCT02723955|566801768|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013419|NCT02723955|566801769|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013420|NCT02723955|566801770|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013421|NCT02723955|566801771|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013422|NCT02723955|566801772|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013423|NCT02723955|566801773|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013424|NCT02723955|566801774|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013425|NCT02723955|566801775|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
157013426|NCT02723955|566801776|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
157013427|NCT02723955|566801777|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013428|NCT02723955|566801778|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
157013429|NCT02723955|566801779|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
157013430|NCT02723955|566801737|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
157013431|NCT02723955|566801738|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
157013432|NCT02723955|566801739|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
157013433|NCT02723955|566801740|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
157013434|NCT02723955|566801741|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
157013435|NCT02723955|566801742|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
157013436|NCT02723955|566801743|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
157013437|NCT02723955|566801744|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
157013438|NCT02723955|566801745|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
157013439|NCT02723955|566801746|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
157013440|NCT02723955|566801747|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
157013441|NCT02723955|566801748|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
157214159|NCT01326702|567531787|FG002|Overall Study|Adverse Event|1|||
157214160|NCT01326702|567531788|FG003|Overall Study|Adverse Event|1|||
156785546|NCT04433975|565966396|FG001|12-month Follow Up|Lost to Follow-up|31|||
156785547|NCT04392635|565966401|FG000|Overall Study|Lost to Follow-up|0|||
156785548|NCT04392635|565966402|FG001|Overall Study|Lost to Follow-up|1|||
156785549|NCT00724893|565966407|FG000|Overall Study|Adverse Event|76|||
157121474|NCT05103332|567195982|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121475|NCT05103332|567195983|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121476|NCT05103332|567195984|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121477|NCT05103332|567195985|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121478|NCT05103332|567195986|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121479|NCT05103332|567195987|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121480|NCT05103332|567195988|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
157121481|NCT05103332|567195989|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121482|NCT05103332|567195990|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121483|NCT05103332|567195991|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121484|NCT05103332|567195992|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121485|NCT05103332|567195993|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121486|NCT05103332|567195994|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
157121487|NCT05103332|567195995|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
156686027|NCT02688387|565596336|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686028|NCT02688387|565596337|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686029|NCT02688387|565596316|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686030|NCT02688387|565596317|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
156686031|NCT02688387|565596318|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686032|NCT02688387|565596319|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686033|NCT02688387|565596320|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156868579|NCT00865566|566277332|FG000|Overall Study|Withdrawal by Subject|45|||
156868580|NCT00865566|566277333|FG001|Overall Study|Withdrawal by Subject|65|||
156868581|NCT00865566|566277332|FG000|Overall Study|Physician Decision|0|||
156868582|NCT00865566|566277333|FG001|Overall Study|Physician Decision|1|||
156868583|NCT00865566|566277332|FG000|Overall Study|Participant relocated|78|||
156868584|NCT00865566|566277333|FG001|Overall Study|Participant relocated|107|||
156868585|NCT00865566|566277332|FG000|Overall Study|Participant unable to adhere|27|||
156868586|NCT00865566|566277333|FG001|Overall Study|Participant unable to adhere|42|||
156868587|NCT00865566|566277332|FG000|Overall Study|Other; N=245 due to early study closure|154|||
156868588|NCT00865566|566277333|FG001|Overall Study|Other; N=245 due to early study closure|139|||
156868589|NCT00865566|566277332|FG000|Overall Study|HIV infection|5|||
156868590|NCT00865566|566277333|FG001|Overall Study|HIV infection|7|||
156868591|NCT02054104|566277338|FG000|Overall Study|Did not want to continue due to college classes|1|||
156868592|NCT02054104|566277339|FG001|Overall Study|Did not want to continue due to college classes|0|||
156868593|NCT02054104|566277338|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
156868594|NCT02054104|566277339|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
156868595|NCT02054104|566277338|FG000|Overall Study|No evidence of immunologic response|2|||
156868596|NCT02054104|566277339|FG001|Overall Study|No evidence of immunologic response|2|||
156868597|NCT02054104|566277338|FG000|Overall Study|Disease Progression On Study|4|||
157121488|NCT05103332|567195978|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156686034|NCT02688387|565596321|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686035|NCT02688387|565596322|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156785550|NCT00724893|565966408|FG001|Overall Study|Adverse Event|142|||
156785551|NCT00724893|565966407|FG000|Overall Study|Withdrawal by Subject|0|||
156785552|NCT00724893|565966408|FG001|Overall Study|Withdrawal by Subject|1|||
156785553|NCT00724893|565966407|FG000|Overall Study|Lack of virologic response|94|||
156785554|NCT00724893|565966408|FG001|Overall Study|Lack of virologic response|202|||
156785555|NCT00724893|565966407|FG000|Overall Study|Reason not specified|193|||
156785556|NCT00724893|565966408|FG001|Overall Study|Reason not specified|7|||
156785557|NCT00724893|565966407|FG000|Overall Study|Patient choice|0|||
156785558|NCT00724893|565966408|FG001|Overall Study|Patient choice|26|||
156785559|NCT00724893|565966407|FG000|Overall Study|Geographic reasons|0|||
156785560|NCT00724893|565966408|FG001|Overall Study|Geographic reasons|11|||
156785561|NCT00724893|565966407|FG000|Overall Study|Incarceration|0|||
156785562|NCT00724893|565966408|FG001|Overall Study|Incarceration|9|||
156785563|NCT00724893|565966407|FG000|Overall Study|Substance abuse|0|||
156785564|NCT00724893|565966408|FG001|Overall Study|Substance abuse|3|||
156785565|NCT00724893|565966407|FG000|Overall Study|Financial reasons|0|||
156785566|NCT00724893|565966408|FG001|Overall Study|Financial reasons|2|||
156785567|NCT00724893|565966407|FG000|Overall Study|Assigned shorter treatment|0|||
156785568|NCT00724893|565966408|FG001|Overall Study|Assigned shorter treatment|2|||
156785569|NCT00724893|565966407|FG000|Overall Study|Lost to Follow-up|0|||
157121489|NCT05103332|567195979|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157214161|NCT01326702|567531789|FG004|Overall Study|Adverse Event|0|||
156785570|NCT00724893|565966408|FG001|Overall Study|Lost to Follow-up|52|||
156868598|NCT02054104|566277339|FG001|Overall Study|Disease Progression On Study|5|||
157214162|NCT01326702|567531790|FG005|Overall Study|Adverse Event|3|||
156785571|NCT00724893|565966407|FG000|Overall Study|Unknown, missing data|1|||
156785572|NCT00724893|565966408|FG001|Overall Study|Unknown, missing data|1|||
156785573|NCT01290731|565966411|FG000|Overall Study|Withdrawal by Subject|1|||
156686036|NCT02688387|565596323|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686037|NCT02688387|565596324|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686038|NCT02688387|565596325|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686039|NCT02688387|565596326|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686040|NCT02688387|565596327|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686041|NCT02688387|565596328|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686042|NCT02688387|565596329|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686043|NCT02688387|565596330|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686044|NCT02688387|565596331|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686045|NCT02688387|565596332|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686046|NCT02688387|565596333|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156785574|NCT01279200|565966416|FG000|Overall Study|Withdrawal by Subject|1|||
156785575|NCT01279200|565966417|FG001|Overall Study|Withdrawal by Subject|3|||
156785576|NCT01279200|565966416|FG000|Overall Study|Patient withdrawal due to high cost|0|||
156785577|NCT01279200|565966417|FG001|Overall Study|Patient withdrawal due to high cost|1|||
156785578|NCT01279200|565966416|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
156785579|NCT01279200|565966417|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
156785580|NCT01279200|565966416|FG000|Overall Study|ultrasound screening failure|0|||
156785581|NCT01279200|565966417|FG001|Overall Study|ultrasound screening failure|1|||
156785582|NCT01279200|565966416|FG000|Overall Study|Lost to Follow-up|0|||
156785583|NCT01279200|565966417|FG001|Overall Study|Lost to Follow-up|1|||
156785584|NCT01279200|565966416|FG000|Overall Study|Adverse Event|1|||
156785585|NCT01279200|565966417|FG001|Overall Study|Adverse Event|0|||
156785586|NCT01399099|565966418|FG000|Overall Study|Lost to Follow-up|14|||
156785587|NCT01399099|565966418|FG000|Overall Study|Physician Decision|1|||
156785588|NCT01399099|565966418|FG000|Overall Study|Protocol Violation|1|||
156785589|NCT01399099|565966418|FG000|Overall Study|Skin Irritation|13|||
156785590|NCT01399099|565966418|FG000|Overall Study|Infection|1|||
156785591|NCT01399099|565966418|FG000|Overall Study|Miscellaneous|4|||
156785592|NCT02181738|565966419|FG000|Overall Study|Participant Withdrew Consent|2|||
156785593|NCT02181738|565966420|FG001|Overall Study|Participant Withdrew Consent|1|||
156785594|NCT02181738|565966421|FG002|Overall Study|Participant Withdrew Consent|1|||
156785595|NCT02181738|565966422|FG003|Overall Study|Participant Withdrew Consent|1|||
156785596|NCT02181738|565966419|FG000|Overall Study|Lost to Follow-up|1|||
156785597|NCT02181738|565966420|FG001|Overall Study|Lost to Follow-up|2|||
156785598|NCT02181738|565966421|FG002|Overall Study|Lost to Follow-up|1|||
156785599|NCT02181738|565966422|FG003|Overall Study|Lost to Follow-up|1|||
156785600|NCT02181738|565966419|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785601|NCT02181738|565966420|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785602|NCT02181738|565966421|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
156785603|NCT02181738|565966422|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
156785604|NCT02181738|565966419|FG000|Overall Study|Poor/Non-Compliance|1|||
156785605|NCT02181738|565966420|FG001|Overall Study|Poor/Non-Compliance|0|||
156785606|NCT02181738|565966421|FG002|Overall Study|Poor/Non-Compliance|2|||
156785607|NCT02181738|565966422|FG003|Overall Study|Poor/Non-Compliance|1|||
156785608|NCT02181738|565966419|FG000|Overall Study|Disease Progression|28|||
156785609|NCT02181738|565966420|FG001|Overall Study|Disease Progression|35|||
156785610|NCT02181738|565966421|FG002|Overall Study|Disease Progression|40|||
156785611|NCT02181738|565966422|FG003|Overall Study|Disease Progression|0|||
156785612|NCT02181738|565966419|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
156785613|NCT02181738|565966420|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
156785614|NCT02181738|565966421|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
156785615|NCT02181738|565966422|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
156785616|NCT02181738|565966419|FG000|Overall Study|Study Drug Toxicity|6|||
156785617|NCT02181738|565966420|FG001|Overall Study|Study Drug Toxicity|11|||
156785618|NCT02181738|565966421|FG002|Overall Study|Study Drug Toxicity|8|||
156785619|NCT02181738|565966422|FG003|Overall Study|Study Drug Toxicity|1|||
156785620|NCT02181738|565966419|FG000|Overall Study|Other Reasons|14|||
156785621|NCT02181738|565966420|FG001|Overall Study|Other Reasons|16|||
156785622|NCT02181738|565966421|FG002|Overall Study|Other Reasons|28|||
156785623|NCT02181738|565966422|FG003|Overall Study|Other Reasons|0|||
156785624|NCT02181738|565966419|FG000|Overall Study|Maximum Clinical Benefit|3|||
156785625|NCT02181738|565966420|FG001|Overall Study|Maximum Clinical Benefit|0|||
156785626|NCT02181738|565966421|FG002|Overall Study|Maximum Clinical Benefit|1|||
156785627|NCT02181738|565966422|FG003|Overall Study|Maximum Clinical Benefit|0|||
156785628|NCT02181738|565966419|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156785629|NCT02181738|565966420|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
156785630|NCT02181738|565966421|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156785631|NCT02181738|565966422|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
156785632|NCT01668537|565966423|FG000|Overall Study|Request to Discontinue Prematurely|1|||
156785633|NCT01668537|565966424|FG001|Overall Study|Request to Discontinue Prematurely|1|||
156868599|NCT02054104|566277338|FG000|Overall Study|Diagnosis of lymphoma|0|||
156868600|NCT02054104|566277339|FG001|Overall Study|Diagnosis of lymphoma|1|||
156868601|NCT02054104|566277338|FG000|Overall Study|Inconclusive response|0|||
156868602|NCT02054104|566277339|FG001|Overall Study|Inconclusive response|1|||
156868603|NCT02404025|566277340|FG000|Overall Study|Adverse Event|1|||
156686047|NCT02688387|565596334|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686048|NCT02688387|565596335|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686049|NCT02688387|565596336|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686050|NCT02688387|565596337|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
156686051|NCT02688387|565596316|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686052|NCT02688387|565596317|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686053|NCT02688387|565596318|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
156686054|NCT02688387|565596319|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686055|NCT02688387|565596320|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
156686056|NCT02688387|565596321|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686057|NCT02688387|565596322|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686058|NCT02688387|565596323|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686059|NCT02688387|565596324|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686060|NCT02688387|565596325|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686061|NCT02688387|565596326|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686062|NCT02688387|565596327|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686063|NCT02688387|565596328|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686064|NCT02688387|565596329|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686065|NCT02688387|565596330|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686066|NCT02688387|565596331|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686067|NCT02688387|565596332|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686068|NCT02688387|565596333|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686069|NCT02688387|565596334|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686070|NCT02688387|565596335|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156868604|NCT02404025|566277340|FG000|Overall Study|Lack of Efficacy|3|||
156868605|NCT00098813|566277341|FG000|Overall Study|Death|8|||
156868606|NCT00098813|566277341|FG000|Overall Study|Protocol Violation|1|||
156868607|NCT00098813|566277341|FG000|Overall Study|Withdrawal by Subject|7|||
156868608|NCT00098813|566277341|FG000|Overall Study|Progression of Disease|1|||
156868609|NCT00098813|566277341|FG000|Overall Study|Other complicating disease|1|||
156868610|NCT00098813|566277341|FG000|Overall Study|Reversal of RAI resistance|1|||
156868611|NCT02230670|566277342|FG000|Overall Study|Adverse Event|1|||
156868612|NCT02230670|566277343|FG001|Overall Study|Adverse Event|2|||
156868613|NCT02230670|566277342|FG000|Overall Study|Withdrawal by Subject|2|||
156868614|NCT02230670|566277343|FG001|Overall Study|Withdrawal by Subject|2|||
156868615|NCT02230670|566277342|FG000|Overall Study|Physician Decision|0|||
156868616|NCT02230670|566277343|FG001|Overall Study|Physician Decision|1|||
156868617|NCT02230670|566277342|FG000|Overall Study|Protocol Violation|0|||
156868618|NCT02230670|566277343|FG001|Overall Study|Protocol Violation|1|||
156868619|NCT02230670|566277342|FG000|Overall Study|Progression to Child-Pugh C|1|||
156868620|NCT02230670|566277343|FG001|Overall Study|Progression to Child-Pugh C|2|||
156868621|NCT01907854|566277348|FG000|Overall Study|Protocol Violation|1|||
156686071|NCT02688387|565596336|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686072|NCT02688387|565596337|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
156686073|NCT02688387|565596316|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
156686074|NCT02688387|565596317|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686075|NCT02688387|565596318|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686076|NCT02688387|565596319|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686077|NCT02688387|565596320|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686078|NCT02688387|565596321|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686079|NCT02688387|565596322|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686080|NCT02688387|565596323|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156868622|NCT01907854|566277349|FG001|Overall Study|Protocol Violation|1|||
156868623|NCT01907854|566277348|FG000|Overall Study|Withdrawal by Subject|9|||
157214163|NCT01326702|567531791|FG006|Overall Study|Adverse Event|1|||
156868624|NCT01907854|566277349|FG001|Overall Study|Withdrawal by Subject|7|||
156868625|NCT01907854|566277348|FG000|Overall Study|Lost to Follow-up|2|||
156868626|NCT01907854|566277349|FG001|Overall Study|Lost to Follow-up|2|||
156868627|NCT01907854|566277348|FG000|Overall Study|Unclassified|4|||
156868628|NCT01907854|566277349|FG001|Overall Study|Unclassified|3|||
156868629|NCT00892099|566277350|FG000|Overall Study|Death|1|||
156868630|NCT00892099|566277351|FG001|Overall Study|Death|0|||
156868631|NCT00892099|566277352|FG002|Overall Study|Death|1|||
156785634|NCT01668537|565966423|FG000|Overall Study|Subject unwilling/unable to comply|5|||
156785635|NCT01668537|565966424|FG001|Overall Study|Subject unwilling/unable to comply|0|||
156785636|NCT01668537|565966423|FG000|Overall Study|Reason Precludes Participation|1|||
156785637|NCT01668537|565966424|FG001|Overall Study|Reason Precludes Participation|0|||
156785638|NCT01668537|565966423|FG000|Overall Study|Lost to Follow-up|13|||
156785639|NCT01668537|565966424|FG001|Overall Study|Lost to Follow-up|6|||
156785640|NCT01668537|565966423|FG000|Overall Study|Other|2|||
156785641|NCT01668537|565966424|FG001|Overall Study|Other|3|||
156785642|NCT01149538|565966425|FG000|Overall Study|Lost to Follow-up|0|||
156785643|NCT01149538|565966426|FG001|Overall Study|Lost to Follow-up|1|||
156785644|NCT01149538|565966425|FG000|Overall Study|Withdrawal by Subject|5|||
156785645|NCT01149538|565966426|FG001|Overall Study|Withdrawal by Subject|3|||
156785646|NCT00888849|565966427|FG000|Overall Study|Death|4|||
156785647|NCT00888849|565966428|FG001|Overall Study|Death|7|||
156785648|NCT00888849|565966427|FG000|Overall Study|Lost to Follow-up|1|||
156785649|NCT00888849|565966428|FG001|Overall Study|Lost to Follow-up|2|||
156785650|NCT00629239|565966429|FG000|Overall Study|Adverse Event|7|||
156785651|NCT00629239|565966430|FG001|Overall Study|Adverse Event|4|||
156785652|NCT00629239|565966429|FG000|Overall Study|Physician Decision|1|||
156785653|NCT00629239|565966430|FG001|Overall Study|Physician Decision|0|||
156785654|NCT01851369|565966431|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785655|NCT01851369|565966432|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785656|NCT01851369|565966433|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785657|NCT01851369|565966434|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785658|NCT01851369|565966435|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785659|NCT01851369|565966436|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
156785660|NCT01851369|565966437|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785661|NCT01851369|565966438|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785662|NCT01851369|565966439|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785663|NCT01851369|565966440|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785664|NCT01851369|565966441|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785665|NCT01851369|565966442|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785666|NCT01851369|565966443|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
156785667|NCT00567112|565966451|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
156785668|NCT00567112|565966452|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
156785669|NCT00567112|565966453|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
156785670|NCT00567112|565966451|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
156785671|NCT00567112|565966452|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
156785672|NCT00567112|565966453|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
156785673|NCT00567112|565966451|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
156785674|NCT00567112|565966452|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
156785675|NCT00567112|565966453|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
156785676|NCT01740427|565966454|FG000|Overall Study|Objective Progression or Relapse|286|||
156785677|NCT01740427|565966455|FG001|Overall Study|Objective Progression or Relapse|172|||
156785678|NCT01740427|565966454|FG000|Overall Study|Adverse Event|32|||
156785679|NCT01740427|565966455|FG001|Overall Study|Adverse Event|9|||
156785680|NCT01740427|565966454|FG000|Overall Study|Global Deterioration of Health Status|28|||
156785681|NCT01740427|565966455|FG001|Overall Study|Global Deterioration of Health Status|12|||
156785682|NCT01740427|565966454|FG000|Overall Study|Participant Refused Continued Treatment|27|||
156785683|NCT01740427|565966455|FG001|Overall Study|Participant Refused Continued Treatment|15|||
156785684|NCT01740427|565966454|FG000|Overall Study|Unspecified reasons|52|||
156785685|NCT01740427|565966455|FG001|Overall Study|Unspecified reasons|8|||
156785686|NCT01740427|565966454|FG000|Overall Study|Death|10|||
156785687|NCT01740427|565966455|FG001|Overall Study|Death|3|||
156785688|NCT01740427|565966454|FG000|Overall Study|Protocol Violation|5|||
156785689|NCT01740427|565966455|FG001|Overall Study|Protocol Violation|3|||
156785690|NCT01740427|565966454|FG000|Overall Study|Lost to Follow-up|3|||
156785691|NCT01740427|565966455|FG001|Overall Study|Lost to Follow-up|0|||
156785692|NCT01740427|565966454|FG000|Overall Study|Site Terminated by Sponsor|1|||
156785693|NCT01740427|565966455|FG001|Overall Study|Site Terminated by Sponsor|0|||
156785694|NCT04796207|565966458|FG000|Overall Study|Lost to Follow-up|7|||
156785695|NCT04796207|565966459|FG001|Overall Study|Lost to Follow-up|2|||
156785696|NCT01860989|565966462|FG000|Overall Study|Unsatisfactory therapeutic|5|||
156785697|NCT04739709|565966465|FG000|Overall Study|Physician Decision|1|||
156785698|NCT04739709|565966466|FG001|Overall Study|Physician Decision|0|||
156785699|NCT03003468|565966467|FG000|Overall Study|Withdrawal by Subject|0|||
156785700|NCT03003468|565966468|FG001|Overall Study|Withdrawal by Subject|0|||
156785701|NCT03003468|565966469|FG002|Overall Study|Withdrawal by Subject|1|||
156785702|NCT03003468|565966467|FG000|Overall Study|No measurable lesions|0|||
156785703|NCT03003468|565966468|FG001|Overall Study|No measurable lesions|0|||
156785704|NCT03003468|565966469|FG002|Overall Study|No measurable lesions|1|||
156686081|NCT02688387|565596324|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686082|NCT02688387|565596325|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686083|NCT02688387|565596326|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686084|NCT02688387|565596327|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156868632|NCT00892099|566277350|FG000|Overall Study|Adverse Event|1|||
156868633|NCT00892099|566277351|FG001|Overall Study|Adverse Event|0|||
156868634|NCT00892099|566277352|FG002|Overall Study|Adverse Event|0|||
156868635|NCT00892099|566277350|FG000|Overall Study|replocated|1|||
156868636|NCT00892099|566277351|FG001|Overall Study|replocated|0|||
156868637|NCT00892099|566277352|FG002|Overall Study|replocated|2|||
156868638|NCT00892099|566277350|FG000|Overall Study|Prolonged hospitalization|1|||
156868639|NCT00892099|566277351|FG001|Overall Study|Prolonged hospitalization|0|||
156868640|NCT00892099|566277352|FG002|Overall Study|Prolonged hospitalization|1|||
156868641|NCT00892099|566277350|FG000|Overall Study|no further details|1|||
156868642|NCT00892099|566277351|FG001|Overall Study|no further details|0|||
156868643|NCT00892099|566277352|FG002|Overall Study|no further details|1|||
156868644|NCT00892099|566277350|FG000|Overall Study|kidney function recovered|0|||
156868645|NCT00892099|566277351|FG001|Overall Study|kidney function recovered|1|||
156868646|NCT00892099|566277352|FG002|Overall Study|kidney function recovered|0|||
156868647|NCT00892099|566277350|FG000|Overall Study|investigator decision|0|||
156868648|NCT00892099|566277351|FG001|Overall Study|investigator decision|0|||
156868649|NCT00892099|566277352|FG002|Overall Study|investigator decision|1|||
156868650|NCT00892099|566277350|FG000|Overall Study|Lost to Follow-up|0|||
156868651|NCT00892099|566277351|FG001|Overall Study|Lost to Follow-up|0|||
156868652|NCT00892099|566277352|FG002|Overall Study|Lost to Follow-up|1|||
156868653|NCT02346721|566277353|FG000|Overall Study|Withdrew Consent|3|||
156868654|NCT02346721|566277353|FG000|Overall Study|Lack of Efficacy|1|||
156868655|NCT04455815|566277354|FG000|Randomisation Phase|Adverse Event|1|||
156868656|NCT04455815|566277355|FG001|Randomisation Phase|Adverse Event|0|||
156868657|NCT04455815|566277354|FG000|Treatment Phase|Adverse Event|0|||
156868658|NCT04455815|566277355|FG001|Treatment Phase|Adverse Event|1|||
156868659|NCT04455815|566277354|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
156868660|NCT04455815|566277355|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
156868661|NCT04455815|566277354|FG000|Treatment Phase|Withdrawal by Subject|1|||
156868662|NCT04455815|566277355|FG001|Treatment Phase|Withdrawal by Subject|1|||
156868663|NCT03594110|566277359|FG000|Interventional Part|Participant concerned about study treatment|23|||
156868664|NCT03594110|566277360|FG001|Interventional Part|Participant concerned about study treatment|28|||
156868665|NCT03594110|566277359|FG000|Interventional Part|Doctor advice|38|||
156868666|NCT03594110|566277360|FG001|Interventional Part|Doctor advice|40|||
156868667|NCT03594110|566277359|FG000|Interventional Part|Participants' wish|89|||
156868668|NCT03594110|566277360|FG001|Interventional Part|Participants' wish|68|||
156868669|NCT03594110|566277359|FG000|Interventional Part|Adverse event-non-fatal events|119|||
156868670|NCT03594110|566277360|FG001|Interventional Part|Adverse event-non-fatal events|116|||
156868671|NCT03594110|566277359|FG000|Interventional Part|Study drug stopped, reason missing|336|||
156868672|NCT03594110|566277360|FG001|Interventional Part|Study drug stopped, reason missing|294|||
156868673|NCT03594110|566277359|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
156868674|NCT03594110|566277360|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
156868675|NCT03594110|566277359|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
156868676|NCT03594110|566277360|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
156868677|NCT03594110|566277359|FG000|Interventional Part|Contraindicated drug started|32|||
156868678|NCT03594110|566277360|FG001|Interventional Part|Contraindicated drug started|18|||
156868679|NCT03594110|566277359|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
156868680|NCT03594110|566277360|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
156868681|NCT03594110|566277359|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
156868682|NCT03594110|566277360|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
156868683|NCT03594110|566277359|FG000|Non-interventional Part|Withdrawal by Subject|3|||
156868684|NCT03594110|566277360|FG001|Non-interventional Part|Withdrawal by Subject|4|||
156868685|NCT03594110|566277359|FG000|Non-interventional Part|Lost to Follow-up|45|||
156868686|NCT03594110|566277360|FG001|Non-interventional Part|Lost to Follow-up|41|||
157013442|NCT02723955|566801749|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
157013443|NCT02723955|566801750|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
156686085|NCT02688387|565596328|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686086|NCT02688387|565596329|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686087|NCT02688387|565596330|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686088|NCT02688387|565596331|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686089|NCT02688387|565596332|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686090|NCT02688387|565596333|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686091|NCT02688387|565596334|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686092|NCT02688387|565596335|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686093|NCT02688387|565596336|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686094|NCT02688387|565596337|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
156686095|NCT02688387|565596316|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686096|NCT02688387|565596317|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686097|NCT02688387|565596318|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686098|NCT02688387|565596319|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686099|NCT02688387|565596320|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686100|NCT02688387|565596321|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686101|NCT02688387|565596322|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686102|NCT02688387|565596323|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686103|NCT02688387|565596324|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686104|NCT02688387|565596325|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686105|NCT02688387|565596326|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
156686106|NCT02688387|565596327|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686107|NCT02688387|565596328|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686108|NCT02688387|565596329|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686109|NCT02688387|565596330|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686110|NCT02688387|565596331|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686111|NCT02688387|565596332|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686112|NCT02688387|565596333|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686113|NCT02688387|565596334|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686114|NCT02688387|565596335|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686115|NCT02688387|565596336|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686116|NCT02688387|565596337|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
156686117|NCT02688387|565596316|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686118|NCT02688387|565596317|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686119|NCT02688387|565596318|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686120|NCT02688387|565596319|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686121|NCT02688387|565596320|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686122|NCT02688387|565596321|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686123|NCT02688387|565596322|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686124|NCT02688387|565596323|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686125|NCT02688387|565596324|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686126|NCT02688387|565596325|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686127|NCT02688387|565596326|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686128|NCT02688387|565596327|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686129|NCT02688387|565596328|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686130|NCT02688387|565596329|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686131|NCT02688387|565596330|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
156686132|NCT02688387|565596331|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686133|NCT02688387|565596332|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686134|NCT02688387|565596333|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686135|NCT02688387|565596334|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686136|NCT02688387|565596335|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686137|NCT02688387|565596336|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686138|NCT02688387|565596337|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
156686139|NCT02688387|565596316|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156785705|NCT00421993|565966470|FG000|Overall Study|Withdrawal by Subject|22|||
156785706|NCT00421993|565966471|FG001|Overall Study|Withdrawal by Subject|23|||
156785707|NCT00421993|565966472|FG002|Overall Study|Withdrawal by Subject|23|||
156785708|NCT00421993|565966473|FG003|Overall Study|Withdrawal by Subject|24|||
156785709|NCT00421993|565966470|FG000|Overall Study|Lost to Follow-up|18|||
156785710|NCT00421993|565966471|FG001|Overall Study|Lost to Follow-up|19|||
156785711|NCT00421993|565966472|FG002|Overall Study|Lost to Follow-up|22|||
156785712|NCT00421993|565966473|FG003|Overall Study|Lost to Follow-up|20|||
156785713|NCT00421993|565966470|FG000|Overall Study|Adverse Event|11|||
156785714|NCT00421993|565966471|FG001|Overall Study|Adverse Event|1|||
156785715|NCT00421993|565966472|FG002|Overall Study|Adverse Event|6|||
156785716|NCT00421993|565966473|FG003|Overall Study|Adverse Event|4|||
156785717|NCT00421993|565966470|FG000|Overall Study|Protocol Violation|2|||
156785718|NCT00421993|565966471|FG001|Overall Study|Protocol Violation|2|||
156785719|NCT00421993|565966472|FG002|Overall Study|Protocol Violation|0|||
156785720|NCT00421993|565966473|FG003|Overall Study|Protocol Violation|1|||
156785721|NCT00421993|565966470|FG000|Overall Study|Lack of Efficacy|0|||
156785722|NCT00421993|565966471|FG001|Overall Study|Lack of Efficacy|3|||
156785723|NCT00421993|565966472|FG002|Overall Study|Lack of Efficacy|0|||
156785724|NCT00421993|565966473|FG003|Overall Study|Lack of Efficacy|5|||
156785725|NCT00421993|565966470|FG000|Overall Study|Pregnancy|0|||
156785726|NCT00421993|565966471|FG001|Overall Study|Pregnancy|1|||
156785727|NCT00421993|565966472|FG002|Overall Study|Pregnancy|1|||
156785728|NCT00421993|565966473|FG003|Overall Study|Pregnancy|2|||
156785729|NCT00421993|565966470|FG000|Overall Study|Subject transportation issues|0|||
156785730|NCT00421993|565966471|FG001|Overall Study|Subject transportation issues|0|||
157013444|NCT02723955|566801751|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
157013445|NCT02723955|566801752|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
156686140|NCT02688387|565596317|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686141|NCT02688387|565596318|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686142|NCT02688387|565596319|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686143|NCT02688387|565596320|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686144|NCT02688387|565596321|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686145|NCT02688387|565596322|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686146|NCT02688387|565596323|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686147|NCT02688387|565596324|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156785731|NCT00421993|565966472|FG002|Overall Study|Subject transportation issues|0|||
156785732|NCT00421993|565966473|FG003|Overall Study|Subject transportation issues|1|||
156785733|NCT02405962|565966474|FG000|Overall Study|Lost to Follow-up|1|||
156785734|NCT02405962|565966475|FG001|Overall Study|Lost to Follow-up|4|||
156785735|NCT02405962|565966474|FG000|Overall Study|A participant has moved to another place|0|||
156785736|NCT02405962|565966475|FG001|Overall Study|A participant has moved to another place|1|||
156785737|NCT01980888|565966476|FG000|Overall Study|Study Terminated by Sponsor|116|||
156785738|NCT01980888|565966477|FG001|Overall Study|Study Terminated by Sponsor|122|||
156785739|NCT01980888|565966476|FG000|Overall Study|Withdrew Consent|17|||
156785740|NCT01980888|565966477|FG001|Overall Study|Withdrew Consent|6|||
156785741|NCT01980888|565966476|FG000|Overall Study|Investigator's Discretion|8|||
156785742|NCT01980888|565966477|FG001|Overall Study|Investigator's Discretion|3|||
156785743|NCT01980888|565966476|FG000|Overall Study|Non-Compliance with Study Drug|3|||
156785744|NCT01980888|565966477|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156785745|NCT00165698|565966479|FG000|Overall Study|Adverse Event|2|||
156785746|NCT00165698|565966480|FG001|Overall Study|Adverse Event|10|||
156785747|NCT00165698|565966479|FG000|Overall Study|Lost to Follow-up|2|||
156785748|NCT00165698|565966480|FG001|Overall Study|Lost to Follow-up|2|||
156785749|NCT00165698|565966479|FG000|Overall Study|Withdrawal by Subject|2|||
156785750|NCT00165698|565966480|FG001|Overall Study|Withdrawal by Subject|1|||
156785751|NCT00165698|565966479|FG000|Overall Study|Protocol Violation|1|||
156785752|NCT00165698|565966480|FG001|Overall Study|Protocol Violation|0|||
156785753|NCT00165698|565966479|FG000|Overall Study|Not Taken/Lost the medicine|1|||
156785754|NCT00165698|565966480|FG001|Overall Study|Not Taken/Lost the medicine|2|||
156785755|NCT01483651|565966481|FG000|Overall Study|Withdrawal by Subject|0|||
156785756|NCT01483651|565966482|FG001|Overall Study|Withdrawal by Subject|1|||
156785757|NCT01483651|565966483|FG002|Overall Study|Withdrawal by Subject|1|||
156785758|NCT01483651|565966484|FG003|Overall Study|Withdrawal by Subject|0|||
156785759|NCT01483651|565966485|FG004|Overall Study|Withdrawal by Subject|0|||
156785760|NCT01483651|565966486|FG005|Overall Study|Withdrawal by Subject|1|||
156785761|NCT01184118|565966494|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
156785762|NCT01184118|565966494|FG000|Overall Study|No physiologic confirmation of asthma|8|||
156785763|NCT01184118|565966494|FG000|Overall Study|FEV1 <60% predicted|2|||
156785764|NCT01184118|565966494|FG000|Overall Study|Exclusionary medical condition|2|||
156785765|NCT01184118|565966494|FG000|Overall Study|Withdrawal by Subject|5|||
156785766|NCT01937117|565966495|FG000|Overall Study|Disease Progression|7|||
156785767|NCT01937117|565966495|FG000|Overall Study|Physician Decision|4|||
156785768|NCT01937117|565966495|FG000|Overall Study|Adverse Event|2|||
156785769|NCT02186171|565966497|FG000|Overall Study|Withdrawal by Subject|1|||
156785770|NCT02186171|565966498|FG001|Overall Study|Withdrawal by Subject|9|||
156785771|NCT02186171|565966497|FG000|Overall Study|Lost to Follow-up|2|||
156785772|NCT02186171|565966498|FG001|Overall Study|Lost to Follow-up|2|||
156785773|NCT02186171|565966497|FG000|Overall Study|Death|1|||
156785774|NCT02186171|565966498|FG001|Overall Study|Death|2|||
156785775|NCT02186171|565966497|FG000|Overall Study|Protocol-specified Criteria|0|||
156785776|NCT02186171|565966498|FG001|Overall Study|Protocol-specified Criteria|2|||
156785777|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
156785778|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
156785779|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
156785780|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Physician Decision|2|||
156785781|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Physician Decision|4|||
156785782|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Physician Decision|0|||
156785783|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
156785784|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
156785785|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
156785786|NCT01245062|565966499|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
156785787|NCT01245062|565966500|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
156785788|NCT01245062|565966501|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
156785789|NCT01245062|565966499|FG000|Cross-over Phase|Lost to Follow-up|0|||
156785790|NCT01245062|565966500|FG001|Cross-over Phase|Lost to Follow-up|0|||
156785791|NCT01245062|565966501|FG002|Cross-over Phase|Lost to Follow-up|1|||
156868687|NCT00419952|566277364|FG000|Overall Study|Adverse Event|8|||
156868688|NCT00419952|566277365|FG001|Overall Study|Adverse Event|10|||
156868689|NCT00419952|566277364|FG000|Overall Study|Withdrawal by Subject|44|||
156868690|NCT00419952|566277365|FG001|Overall Study|Withdrawal by Subject|43|||
156868691|NCT00419952|566277364|FG000|Overall Study|Lost to Follow-up|43|||
156868692|NCT00419952|566277365|FG001|Overall Study|Lost to Follow-up|34|||
156868693|NCT00419952|566277364|FG000|Overall Study|Protocol Violation|32|||
156868694|NCT00419952|566277365|FG001|Overall Study|Protocol Violation|24|||
156868695|NCT00419952|566277364|FG000|Overall Study|Pregnancy|4|||
156868696|NCT00419952|566277365|FG001|Overall Study|Pregnancy|2|||
156868697|NCT00419952|566277364|FG000|Overall Study|Physician Decision|1|||
156868698|NCT00419952|566277365|FG001|Overall Study|Physician Decision|3|||
156868699|NCT00419952|566277364|FG000|Overall Study|Incorrectly enrolled|10|||
156868700|NCT00419952|566277365|FG001|Overall Study|Incorrectly enrolled|3|||
156868701|NCT00419952|566277364|FG000|Overall Study|Intake of prohibited medication|2|||
156868702|NCT00419952|566277365|FG001|Overall Study|Intake of prohibited medication|2|||
156868703|NCT00419952|566277364|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
156868704|NCT00419952|566277365|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
156868705|NCT00419952|566277364|FG000|Overall Study|Diary or medication non-compliance|2|||
156785792|NCT01245062|565966499|FG000|Cross-over Phase|Physician Decision|0|||
156785793|NCT01245062|565966500|FG001|Cross-over Phase|Physician Decision|0|||
156785794|NCT01245062|565966501|FG002|Cross-over Phase|Physician Decision|1|||
156785795|NCT01245062|565966499|FG000|Cross-over Phase|Withdrew Consent|0|||
156785796|NCT01245062|565966500|FG001|Cross-over Phase|Withdrew Consent|0|||
156785797|NCT01245062|565966501|FG002|Cross-over Phase|Withdrew Consent|4|||
156785798|NCT01245062|565966499|FG000|Cross-over Phase|Study closed/ terminated|0|||
156785799|NCT01245062|565966500|FG001|Cross-over Phase|Study closed/ terminated|0|||
156785800|NCT01245062|565966501|FG002|Cross-over Phase|Study closed/ terminated|11|||
156785801|NCT05762744|565966503|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
156785802|NCT05762744|565966504|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
156785803|NCT05762744|565966503|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
156785804|NCT05762744|565966504|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
156785805|NCT03882801|565968150|FG000|Period 1|Adverse Event|0|||
156785806|NCT03882801|565968151|FG001|Period 1|Adverse Event|1|||
156785807|NCT03882801|565968150|FG000|Period 1|Non-compliance with study drug|1|||
156785808|NCT03882801|565968151|FG001|Period 1|Non-compliance with study drug|1|||
156785809|NCT03882801|565968150|FG000|Period 1|Never treated with study drug|1|||
156785810|NCT03882801|565968151|FG001|Period 1|Never treated with study drug|0|||
156785811|NCT03882801|565968150|FG000|Washout Period|Physician Decision|0|||
156785812|NCT03882801|565968151|FG001|Washout Period|Physician Decision|1|||
156785813|NCT03882801|565968150|FG000|Period 2|Non-compliance with study drug|0|||
156785814|NCT03882801|565968151|FG001|Period 2|Non-compliance with study drug|1|||
156785815|NCT01793129|565968152|FG000|Overall Study|Lost to Follow-up|3|||
156785816|NCT01793129|565968153|FG001|Overall Study|Lost to Follow-up|7|||
156785817|NCT01793129|565968152|FG000|Overall Study|Withdrawal by Subject|0|||
156785818|NCT01793129|565968153|FG001|Overall Study|Withdrawal by Subject|2|||
156785819|NCT04193176|565968156|FG000|Overall Study|Withdrawal by Subject|6|||
156785820|NCT04193176|565968157|FG001|Overall Study|Withdrawal by Subject|10|||
156785821|NCT00944645|565968158|FG000|Period 2|Adverse Event|1|||
156785822|NCT00944645|565968159|FG001|Period 2|Adverse Event|0|||
156785823|NCT00944645|565968158|FG000|Period 2|Lost to Follow-up|0|||
156785824|NCT00944645|565968159|FG001|Period 2|Lost to Follow-up|3|||
156785825|NCT00944645|565968158|FG000|Period 2|Withdrawal by Subject|7|||
156785826|NCT00944645|565968159|FG001|Period 2|Withdrawal by Subject|6|||
156785827|NCT00454142|565968160|FG000|Overall Study|Withdrawal by Subject|1|||
156785828|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
156785829|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
156868706|NCT00419952|566277365|FG001|Overall Study|Diary or medication non-compliance|4|||
156868707|NCT00419952|566277364|FG000|Overall Study|Abnormal ECG|1|||
156868708|NCT00419952|566277365|FG001|Overall Study|Abnormal ECG|0|||
156868709|NCT02085460|566277366|FG000|Overall Study|Adverse Event|2|||
156868710|NCT02085460|566277367|FG001|Overall Study|Adverse Event|2|||
157121490|NCT05103332|567195980|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156785830|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
156785831|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
156785832|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785833|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785834|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
156785835|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
156785836|NCT01245751|565968164|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785837|NCT01245751|565968165|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
156785838|NCT01245751|565968166|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785839|NCT01245751|565968167|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
156785840|NCT01783015|565968170|FG000|Blinded Treatment|Adverse Event|0|||
156785841|NCT01783015|565968171|FG001|Blinded Treatment|Adverse Event|1|||
156785842|NCT01783015|565968172|FG002|Blinded Treatment|Adverse Event|0|||
156868711|NCT02085460|566277368|FG002|Overall Study|Adverse Event|1|||
156868712|NCT02085460|566277366|FG000|Overall Study|Physician Decision|1|||
156868713|NCT02085460|566277367|FG001|Overall Study|Physician Decision|1|||
156868714|NCT02085460|566277368|FG002|Overall Study|Physician Decision|2|||
156868715|NCT02085460|566277366|FG000|Overall Study|Withdrawal by Subject|11|||
156868716|NCT02085460|566277367|FG001|Overall Study|Withdrawal by Subject|5|||
156868717|NCT02085460|566277368|FG002|Overall Study|Withdrawal by Subject|7|||
156868718|NCT02158546|566277376|FG000|Overall Study|Physician Decision|0|||
156868719|NCT02158546|566277377|FG001|Overall Study|Physician Decision|1|||
156868720|NCT02158546|566277378|FG002|Overall Study|Physician Decision|0|||
156868721|NCT02158546|566277379|FG003|Overall Study|Physician Decision|0|||
156868722|NCT02158546|566277376|FG000|Overall Study|Non-compliance|0|||
156868723|NCT02158546|566277377|FG001|Overall Study|Non-compliance|1|||
156868724|NCT02158546|566277378|FG002|Overall Study|Non-compliance|0|||
156868725|NCT02158546|566277379|FG003|Overall Study|Non-compliance|1|||
156868726|NCT02158546|566277376|FG000|Overall Study|Failure to meet eligibility criteria|0|||
156868727|NCT02158546|566277377|FG001|Overall Study|Failure to meet eligibility criteria|1|||
156868728|NCT02158546|566277378|FG002|Overall Study|Failure to meet eligibility criteria|0|||
156868729|NCT02158546|566277379|FG003|Overall Study|Failure to meet eligibility criteria|0|||
156868730|NCT02158546|566277376|FG000|Overall Study|Lack of Efficacy|1|||
156868731|NCT02158546|566277377|FG001|Overall Study|Lack of Efficacy|1|||
156868732|NCT02158546|566277378|FG002|Overall Study|Lack of Efficacy|0|||
156868733|NCT02158546|566277379|FG003|Overall Study|Lack of Efficacy|0|||
156868734|NCT02158546|566277376|FG000|Overall Study|Adverse Event|2|||
156868735|NCT02158546|566277377|FG001|Overall Study|Adverse Event|2|||
156868736|NCT02158546|566277378|FG002|Overall Study|Adverse Event|0|||
156868737|NCT02158546|566277379|FG003|Overall Study|Adverse Event|0|||
156868738|NCT02158546|566277376|FG000|Overall Study|Withdrawal by Subject|6|||
156868739|NCT02158546|566277377|FG001|Overall Study|Withdrawal by Subject|2|||
156868740|NCT02158546|566277378|FG002|Overall Study|Withdrawal by Subject|1|||
156868741|NCT02158546|566277379|FG003|Overall Study|Withdrawal by Subject|0|||
156868742|NCT02158546|566277376|FG000|Overall Study|Lost to Follow-up|5|||
156868743|NCT02158546|566277377|FG001|Overall Study|Lost to Follow-up|4|||
156868744|NCT02158546|566277378|FG002|Overall Study|Lost to Follow-up|0|||
156868745|NCT02158546|566277379|FG003|Overall Study|Lost to Follow-up|1|||
156868746|NCT02158546|566277376|FG000|Overall Study|Site Excluded|5|||
156868747|NCT02158546|566277377|FG001|Overall Study|Site Excluded|5|||
156868748|NCT02158546|566277378|FG002|Overall Study|Site Excluded|3|||
156868749|NCT02158546|566277379|FG003|Overall Study|Site Excluded|4|||
156868750|NCT02351817|566277381|FG000|Period 1|Adverse Event|1|||
156868751|NCT02351817|566277382|FG001|Period 1|Adverse Event|2|||
156868752|NCT02351817|566277381|FG000|Period 1|Lack of Efficacy|0|||
156868753|NCT02351817|566277382|FG001|Period 1|Lack of Efficacy|1|||
156868754|NCT02351817|566277381|FG000|Period 2|Adverse Event|0|||
156868755|NCT02351817|566277382|FG001|Period 2|Adverse Event|2|||
156868756|NCT02351817|566277381|FG000|Period 2|Protocol Violation|1|||
156868757|NCT02351817|566277382|FG001|Period 2|Protocol Violation|0|||
156868758|NCT02488915|566277385|FG000|Overall Study|Death|21|||
156868759|NCT02488915|566277385|FG000|Overall Study|Lost to Follow-up|4|||
156868760|NCT02488915|566277385|FG000|Overall Study|Withdrawal by Subject|1|||
156868761|NCT00891904|566277392|FG000|Overall Study|Death|1|||
156868762|NCT00891904|566277392|FG000|Overall Study|Adverse Event|1|||
156868763|NCT01046396|566277393|FG000|Overall Study|Withdrawal by Subject|5|||
156868764|NCT01208207|566277394|FG000|Part I|Adverse Event|19|||
156868765|NCT01208207|566277395|FG001|Part I|Adverse Event|2|||
156868766|NCT01208207|566277396|FG002|Part I|Adverse Event|6|||
156868767|NCT01208207|566277397|FG003|Part I|Adverse Event|0|||
156868768|NCT01208207|566277398|FG004|Part I|Adverse Event|0|||
156868769|NCT01208207|566277399|FG005|Part I|Adverse Event|0|||
156868770|NCT01208207|566277400|FG006|Part I|Adverse Event|0|||
156868771|NCT01208207|566277394|FG000|Part I|Lack of Efficacy|21|||
157013446|NCT02723955|566801753|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
157013447|NCT02723955|566801754|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
156868772|NCT01208207|566277395|FG001|Part I|Lack of Efficacy|3|||
156868773|NCT01208207|566277396|FG002|Part I|Lack of Efficacy|2|||
156868774|NCT01208207|566277397|FG003|Part I|Lack of Efficacy|0|||
156868775|NCT01208207|566277398|FG004|Part I|Lack of Efficacy|0|||
156868776|NCT01208207|566277399|FG005|Part I|Lack of Efficacy|0|||
156868777|NCT01208207|566277400|FG006|Part I|Lack of Efficacy|0|||
156868778|NCT01208207|566277394|FG000|Part I|Lost to Follow-up|6|||
156868779|NCT01208207|566277395|FG001|Part I|Lost to Follow-up|1|||
156868780|NCT01208207|566277396|FG002|Part I|Lost to Follow-up|0|||
156868781|NCT01208207|566277397|FG003|Part I|Lost to Follow-up|0|||
156868782|NCT01208207|566277398|FG004|Part I|Lost to Follow-up|0|||
156868783|NCT01208207|566277399|FG005|Part I|Lost to Follow-up|0|||
156868784|NCT01208207|566277400|FG006|Part I|Lost to Follow-up|0|||
156868785|NCT01208207|566277394|FG000|Part I|Non-Compliance With Study Drug|1|||
156868786|NCT01208207|566277395|FG001|Part I|Non-Compliance With Study Drug|0|||
156868787|NCT01208207|566277396|FG002|Part I|Non-Compliance With Study Drug|1|||
156868788|NCT01208207|566277397|FG003|Part I|Non-Compliance With Study Drug|0|||
156868789|NCT01208207|566277398|FG004|Part I|Non-Compliance With Study Drug|0|||
156868790|NCT01208207|566277399|FG005|Part I|Non-Compliance With Study Drug|0|||
156868791|NCT01208207|566277400|FG006|Part I|Non-Compliance With Study Drug|0|||
156868792|NCT01208207|566277394|FG000|Part I|Physician Decision|0|||
156868793|NCT01208207|566277395|FG001|Part I|Physician Decision|1|||
156868794|NCT01208207|566277396|FG002|Part I|Physician Decision|0|||
156868795|NCT01208207|566277397|FG003|Part I|Physician Decision|0|||
156868796|NCT01208207|566277398|FG004|Part I|Physician Decision|0|||
156868797|NCT01208207|566277399|FG005|Part I|Physician Decision|0|||
156868798|NCT01208207|566277400|FG006|Part I|Physician Decision|0|||
156868799|NCT01208207|566277394|FG000|Part I|Progressive Disease|1|||
156868800|NCT01208207|566277395|FG001|Part I|Progressive Disease|0|||
156868801|NCT01208207|566277396|FG002|Part I|Progressive Disease|0|||
156868802|NCT01208207|566277397|FG003|Part I|Progressive Disease|0|||
156868803|NCT01208207|566277398|FG004|Part I|Progressive Disease|0|||
156868804|NCT01208207|566277399|FG005|Part I|Progressive Disease|0|||
156868805|NCT01208207|566277400|FG006|Part I|Progressive Disease|0|||
156868806|NCT01208207|566277394|FG000|Part I|Protocol Violation|8|||
156868807|NCT01208207|566277395|FG001|Part I|Protocol Violation|0|||
156868808|NCT01208207|566277396|FG002|Part I|Protocol Violation|2|||
156868809|NCT01208207|566277397|FG003|Part I|Protocol Violation|0|||
156868810|NCT01208207|566277398|FG004|Part I|Protocol Violation|0|||
156868811|NCT01208207|566277399|FG005|Part I|Protocol Violation|0|||
156868812|NCT01208207|566277400|FG006|Part I|Protocol Violation|0|||
156868813|NCT01208207|566277394|FG000|Part I|Withdrawal by Subject|14|||
156868814|NCT01208207|566277395|FG001|Part I|Withdrawal by Subject|4|||
156868815|NCT01208207|566277396|FG002|Part I|Withdrawal by Subject|4|||
156868816|NCT01208207|566277397|FG003|Part I|Withdrawal by Subject|0|||
156868817|NCT01208207|566277398|FG004|Part I|Withdrawal by Subject|0|||
156868818|NCT01208207|566277399|FG005|Part I|Withdrawal by Subject|0|||
156868819|NCT01208207|566277400|FG006|Part I|Withdrawal by Subject|0|||
156868820|NCT01208207|566277394|FG000|Part II|Withdrawal by Subject|0|||
156868821|NCT01208207|566277395|FG001|Part II|Withdrawal by Subject|0|||
156868822|NCT01208207|566277396|FG002|Part II|Withdrawal by Subject|0|||
156868823|NCT01208207|566277397|FG003|Part II|Withdrawal by Subject|10|||
156868824|NCT01208207|566277398|FG004|Part II|Withdrawal by Subject|9|||
156868825|NCT01208207|566277399|FG005|Part II|Withdrawal by Subject|3|||
156868826|NCT01208207|566277400|FG006|Part II|Withdrawal by Subject|5|||
156868827|NCT01208207|566277394|FG000|Part II|Adverse Event|0|||
156868828|NCT01208207|566277395|FG001|Part II|Adverse Event|0|||
156686148|NCT02688387|565596325|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686149|NCT02688387|565596326|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686150|NCT02688387|565596327|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686151|NCT02688387|565596328|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686152|NCT02688387|565596329|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686153|NCT02688387|565596330|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686154|NCT02688387|565596331|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686155|NCT02688387|565596332|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686156|NCT02688387|565596333|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686157|NCT02688387|565596334|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686158|NCT02688387|565596335|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686159|NCT02688387|565596336|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
156686160|NCT02688387|565596337|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
156686161|NCT02688387|565596316|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686162|NCT02688387|565596317|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686163|NCT02688387|565596318|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156785843|NCT01783015|565968170|FG000|Blinded Treatment|Protocol Violation|0|||
156785844|NCT01783015|565968171|FG001|Blinded Treatment|Protocol Violation|1|||
156785845|NCT01783015|565968172|FG002|Blinded Treatment|Protocol Violation|0|||
156785846|NCT01783015|565968170|FG000|Blinded Treatment|Withdrawal by Subject|0|||
156785847|NCT01783015|565968171|FG001|Blinded Treatment|Withdrawal by Subject|1|||
156785848|NCT01783015|565968172|FG002|Blinded Treatment|Withdrawal by Subject|0|||
156785849|NCT01783015|565968170|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
156785850|NCT01783015|565968171|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
156785851|NCT01783015|565968172|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
156785852|NCT01783015|565968170|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
156868829|NCT01208207|566277396|FG002|Part II|Adverse Event|0|||
156868830|NCT01208207|566277397|FG003|Part II|Adverse Event|5|||
156868831|NCT01208207|566277398|FG004|Part II|Adverse Event|9|||
156868832|NCT01208207|566277399|FG005|Part II|Adverse Event|4|||
156868833|NCT01208207|566277400|FG006|Part II|Adverse Event|2|||
156868834|NCT01208207|566277394|FG000|Part II|Lack of Efficacy|0|||
156868835|NCT01208207|566277395|FG001|Part II|Lack of Efficacy|0|||
156868836|NCT01208207|566277396|FG002|Part II|Lack of Efficacy|0|||
156785853|NCT01783015|565968171|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
156868837|NCT01208207|566277397|FG003|Part II|Lack of Efficacy|6|||
156868838|NCT01208207|566277398|FG004|Part II|Lack of Efficacy|4|||
156868839|NCT01208207|566277399|FG005|Part II|Lack of Efficacy|3|||
156868840|NCT01208207|566277400|FG006|Part II|Lack of Efficacy|3|||
156868841|NCT01208207|566277394|FG000|Part II|Lost to Follow-up|0|||
156868842|NCT01208207|566277395|FG001|Part II|Lost to Follow-up|0|||
156868843|NCT01208207|566277396|FG002|Part II|Lost to Follow-up|0|||
156868844|NCT01208207|566277397|FG003|Part II|Lost to Follow-up|4|||
156868845|NCT01208207|566277398|FG004|Part II|Lost to Follow-up|0|||
156868846|NCT01208207|566277399|FG005|Part II|Lost to Follow-up|2|||
156868847|NCT01208207|566277400|FG006|Part II|Lost to Follow-up|1|||
156868848|NCT01208207|566277394|FG000|Part II|Non-Compliance With Study Drug|0|||
156868849|NCT01208207|566277395|FG001|Part II|Non-Compliance With Study Drug|0|||
156868850|NCT01208207|566277396|FG002|Part II|Non-Compliance With Study Drug|0|||
156868851|NCT01208207|566277397|FG003|Part II|Non-Compliance With Study Drug|4|||
156868852|NCT01208207|566277398|FG004|Part II|Non-Compliance With Study Drug|1|||
156868853|NCT01208207|566277399|FG005|Part II|Non-Compliance With Study Drug|1|||
156868854|NCT01208207|566277400|FG006|Part II|Non-Compliance With Study Drug|0|||
156868855|NCT01208207|566277394|FG000|Part II|Physician Decision|0|||
156868856|NCT01208207|566277395|FG001|Part II|Physician Decision|0|||
156868857|NCT01208207|566277396|FG002|Part II|Physician Decision|0|||
156868858|NCT01208207|566277397|FG003|Part II|Physician Decision|1|||
156868859|NCT01208207|566277398|FG004|Part II|Physician Decision|0|||
156868860|NCT01208207|566277399|FG005|Part II|Physician Decision|2|||
156868861|NCT01208207|566277400|FG006|Part II|Physician Decision|0|||
156868862|NCT01208207|566277394|FG000|Part II|Protocol Violation|0|||
156868863|NCT01208207|566277395|FG001|Part II|Protocol Violation|0|||
156868864|NCT01208207|566277396|FG002|Part II|Protocol Violation|0|||
156868865|NCT01208207|566277397|FG003|Part II|Protocol Violation|1|||
156868866|NCT01208207|566277398|FG004|Part II|Protocol Violation|0|||
156868867|NCT01208207|566277399|FG005|Part II|Protocol Violation|0|||
156868868|NCT01208207|566277400|FG006|Part II|Protocol Violation|0|||
156868869|NCT01208207|566277394|FG000|Part II|Technical Problems|0|||
156868870|NCT01208207|566277395|FG001|Part II|Technical Problems|0|||
156868871|NCT01208207|566277396|FG002|Part II|Technical Problems|0|||
156868872|NCT01208207|566277397|FG003|Part II|Technical Problems|1|||
156868873|NCT01208207|566277398|FG004|Part II|Technical Problems|0|||
156868874|NCT01208207|566277399|FG005|Part II|Technical Problems|1|||
156868875|NCT01208207|566277400|FG006|Part II|Technical Problems|0|||
156868876|NCT01605799|566277406|FG000|Overall Study|Withdrawal by Subject|2|||
156868877|NCT01605799|566277407|FG001|Overall Study|Withdrawal by Subject|1|||
156868878|NCT00686712|566277408|FG000|Overall Study|Protocol Violation|8|||
156868879|NCT00686712|566277409|FG001|Overall Study|Protocol Violation|8|||
156868880|NCT00686712|566277410|FG002|Overall Study|Protocol Violation|10|||
156868881|NCT00686712|566277408|FG000|Overall Study|Lost to Follow-up|1|||
156868882|NCT00686712|566277409|FG001|Overall Study|Lost to Follow-up|2|||
156868883|NCT00686712|566277410|FG002|Overall Study|Lost to Follow-up|3|||
156868884|NCT00686712|566277408|FG000|Overall Study|Adverse Event|1|||
156868885|NCT00686712|566277409|FG001|Overall Study|Adverse Event|1|||
156868886|NCT00686712|566277410|FG002|Overall Study|Adverse Event|0|||
156868887|NCT00926237|566277413|FG000|Overall Study|Withdrawal by Subject|2|||
156868888|NCT00926237|566277414|FG001|Overall Study|Withdrawal by Subject|1|||
156868889|NCT03313037|566277425|FG000|Overall Study|Protocol Violation|4|||
156868890|NCT03313037|566277426|FG001|Overall Study|Protocol Violation|1|||
156868891|NCT03313037|566277425|FG000|Overall Study|Other|1|||
156868892|NCT03313037|566277426|FG001|Overall Study|Other|1|||
156868893|NCT03313037|566277425|FG000|Overall Study|Withdrawal by Subject|4|||
156868894|NCT03313037|566277426|FG001|Overall Study|Withdrawal by Subject|3|||
156868895|NCT03313037|566277425|FG000|Overall Study|No longer meets eligibility criteria|1|||
156868896|NCT03313037|566277426|FG001|Overall Study|No longer meets eligibility criteria|7|||
156868897|NCT03313037|566277425|FG000|Overall Study|Lost to Follow-up|9|||
156868898|NCT03313037|566277426|FG001|Overall Study|Lost to Follow-up|8|||
156868899|NCT03313037|566277425|FG000|Overall Study|Randomized but not treated|1|||
156868900|NCT03313037|566277426|FG001|Overall Study|Randomized but not treated|0|||
156868901|NCT02760498|566277427|FG000|Overall Study|Adverse Event|3|||
156868902|NCT02760498|566277428|FG001|Overall Study|Adverse Event|3|||
156868903|NCT02760498|566277429|FG002|Overall Study|Adverse Event|1|||
156868904|NCT02760498|566277430|FG003|Overall Study|Adverse Event|1|||
157013448|NCT02723955|566801755|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
157013449|NCT02723955|566801756|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
157013450|NCT02723955|566801757|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
157013451|NCT02723955|566801758|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
156868905|NCT02760498|566277431|FG004|Overall Study|Adverse Event|0|||
156868906|NCT02760498|566277432|FG005|Overall Study|Adverse Event|6|||
156868907|NCT02760498|566277427|FG000|Overall Study|Death|7|||
156868908|NCT02760498|566277428|FG001|Overall Study|Death|5|||
156868909|NCT02760498|566277429|FG002|Overall Study|Death|5|||
156868910|NCT02760498|566277430|FG003|Overall Study|Death|7|||
156868911|NCT02760498|566277431|FG004|Overall Study|Death|0|||
156868912|NCT02760498|566277432|FG005|Overall Study|Death|23|||
156868913|NCT02760498|566277427|FG000|Overall Study|Lost to Follow-up|0|||
156868914|NCT02760498|566277428|FG001|Overall Study|Lost to Follow-up|0|||
156868915|NCT02760498|566277429|FG002|Overall Study|Lost to Follow-up|0|||
156868916|NCT02760498|566277430|FG003|Overall Study|Lost to Follow-up|0|||
156686164|NCT02688387|565596319|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686165|NCT02688387|565596320|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686166|NCT02688387|565596321|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686167|NCT02688387|565596322|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686168|NCT02688387|565596323|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686169|NCT02688387|565596324|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686170|NCT02688387|565596325|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686171|NCT02688387|565596326|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686172|NCT02688387|565596327|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686173|NCT02688387|565596328|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686174|NCT02688387|565596329|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686175|NCT02688387|565596330|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686176|NCT02688387|565596331|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686177|NCT02688387|565596332|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686178|NCT02688387|565596333|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686179|NCT02688387|565596334|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
156686180|NCT02688387|565596335|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686181|NCT02688387|565596336|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
156785854|NCT01783015|565968172|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
156785855|NCT00504556|565968173|FG000|Overall Study|Adverse Event|11|||
156785856|NCT00504556|565968174|FG001|Overall Study|Adverse Event|11|||
156785857|NCT00504556|565968175|FG002|Overall Study|Adverse Event|14|||
156785858|NCT00504556|565968176|FG003|Overall Study|Adverse Event|13|||
156785859|NCT00504556|565968177|FG004|Overall Study|Adverse Event|5|||
156785860|NCT00504556|565968173|FG000|Overall Study|Death|3|||
156785861|NCT00504556|565968174|FG001|Overall Study|Death|3|||
156785862|NCT00504556|565968175|FG002|Overall Study|Death|1|||
156785863|NCT00504556|565968176|FG003|Overall Study|Death|0|||
156785864|NCT00504556|565968177|FG004|Overall Study|Death|2|||
156785865|NCT00504556|565968173|FG000|Overall Study|Protocol Violation|1|||
156785866|NCT00504556|565968174|FG001|Overall Study|Protocol Violation|3|||
156785867|NCT00504556|565968175|FG002|Overall Study|Protocol Violation|2|||
156785868|NCT00504556|565968176|FG003|Overall Study|Protocol Violation|1|||
156785869|NCT00504556|565968177|FG004|Overall Study|Protocol Violation|2|||
156785870|NCT00504556|565968173|FG000|Overall Study|Lost to Follow-up|0|||
156785871|NCT00504556|565968174|FG001|Overall Study|Lost to Follow-up|0|||
156785872|NCT00504556|565968175|FG002|Overall Study|Lost to Follow-up|1|||
156785873|NCT00504556|565968176|FG003|Overall Study|Lost to Follow-up|1|||
156785874|NCT00504556|565968177|FG004|Overall Study|Lost to Follow-up|1|||
156785875|NCT00504556|565968173|FG000|Overall Study|Withdrawal by Subject|16|||
156785876|NCT00504556|565968174|FG001|Overall Study|Withdrawal by Subject|16|||
156785877|NCT00504556|565968175|FG002|Overall Study|Withdrawal by Subject|7|||
156785878|NCT00504556|565968176|FG003|Overall Study|Withdrawal by Subject|8|||
156785879|NCT00504556|565968177|FG004|Overall Study|Withdrawal by Subject|12|||
156785880|NCT00504556|565968173|FG000|Overall Study|administrative reasons|0|||
156785881|NCT00504556|565968174|FG001|Overall Study|administrative reasons|2|||
156785882|NCT00504556|565968175|FG002|Overall Study|administrative reasons|2|||
156785883|NCT00504556|565968176|FG003|Overall Study|administrative reasons|1|||
156785884|NCT00504556|565968177|FG004|Overall Study|administrative reasons|2|||
156785885|NCT00504556|565968173|FG000|Overall Study|did not meet entry criteria|2|||
156785886|NCT00504556|565968174|FG001|Overall Study|did not meet entry criteria|0|||
156785887|NCT00504556|565968175|FG002|Overall Study|did not meet entry criteria|1|||
156785888|NCT00504556|565968176|FG003|Overall Study|did not meet entry criteria|1|||
156785889|NCT00504556|565968177|FG004|Overall Study|did not meet entry criteria|0|||
156785890|NCT00504556|565968173|FG000|Overall Study|data monitor committee decision|0|||
156785891|NCT00504556|565968174|FG001|Overall Study|data monitor committee decision|0|||
156785892|NCT00504556|565968175|FG002|Overall Study|data monitor committee decision|0|||
156785893|NCT00504556|565968176|FG003|Overall Study|data monitor committee decision|100|||
156785894|NCT00504556|565968177|FG004|Overall Study|data monitor committee decision|0|||
156785895|NCT00504556|565968173|FG000|Overall Study|Other|2|||
156785896|NCT00504556|565968174|FG001|Overall Study|Other|2|||
156785897|NCT00504556|565968175|FG002|Overall Study|Other|2|||
156785898|NCT00504556|565968176|FG003|Overall Study|Other|3|||
156785899|NCT00504556|565968177|FG004|Overall Study|Other|0|||
156868917|NCT02760498|566277431|FG004|Overall Study|Lost to Follow-up|0|||
156686182|NCT02688387|565596337|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
156686183|NCT02688387|565596316|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156785900|NCT00504556|565968173|FG000|Overall Study|not in safety analysis set|0|||
156785901|NCT00504556|565968174|FG001|Overall Study|not in safety analysis set|1|||
156785902|NCT00504556|565968175|FG002|Overall Study|not in safety analysis set|1|||
156785903|NCT00504556|565968176|FG003|Overall Study|not in safety analysis set|0|||
156785904|NCT00504556|565968177|FG004|Overall Study|not in safety analysis set|1|||
156785905|NCT03607695|565968178|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
156785906|NCT03607695|565968178|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
156785907|NCT02741193|565968179|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
156868918|NCT02760498|566277432|FG005|Overall Study|Lost to Follow-up|3|||
156868919|NCT02760498|566277427|FG000|Overall Study|Non-compliance with study drug|0|||
156868920|NCT02760498|566277428|FG001|Overall Study|Non-compliance with study drug|2|||
156868921|NCT02760498|566277429|FG002|Overall Study|Non-compliance with study drug|0|||
156868922|NCT02760498|566277430|FG003|Overall Study|Non-compliance with study drug|0|||
156868923|NCT02760498|566277431|FG004|Overall Study|Non-compliance with study drug|0|||
156868924|NCT02760498|566277432|FG005|Overall Study|Non-compliance with study drug|0|||
156868925|NCT02760498|566277427|FG000|Overall Study|Participant decision|1|||
156868926|NCT02760498|566277428|FG001|Overall Study|Participant decision|4|||
156868927|NCT02760498|566277429|FG002|Overall Study|Participant decision|2|||
156868928|NCT02760498|566277430|FG003|Overall Study|Participant decision|2|||
156868929|NCT02760498|566277431|FG004|Overall Study|Participant decision|1|||
156868930|NCT02760498|566277432|FG005|Overall Study|Participant decision|6|||
156868931|NCT02760498|566277427|FG000|Overall Study|Sponsor decision|0|||
156868932|NCT02760498|566277428|FG001|Overall Study|Sponsor decision|0|||
156868933|NCT02760498|566277429|FG002|Overall Study|Sponsor decision|0|||
156868934|NCT02760498|566277430|FG003|Overall Study|Sponsor decision|3|||
156868935|NCT02760498|566277431|FG004|Overall Study|Sponsor decision|0|||
156868936|NCT02760498|566277432|FG005|Overall Study|Sponsor decision|0|||
156868937|NCT02760498|566277427|FG000|Overall Study|Physician Decision|3|||
156868938|NCT02760498|566277428|FG001|Overall Study|Physician Decision|4|||
156868939|NCT02760498|566277429|FG002|Overall Study|Physician Decision|1|||
156868940|NCT02760498|566277430|FG003|Overall Study|Physician Decision|4|||
156868941|NCT02760498|566277431|FG004|Overall Study|Physician Decision|0|||
156868942|NCT02760498|566277432|FG005|Overall Study|Physician Decision|2|||
156868943|NCT02760498|566277427|FG000|Overall Study|Disease progression|21|||
156868944|NCT02760498|566277428|FG001|Overall Study|Disease progression|19|||
156868945|NCT02760498|566277429|FG002|Overall Study|Disease progression|20|||
156868946|NCT02760498|566277430|FG003|Overall Study|Disease progression|18|||
156868947|NCT02760498|566277431|FG004|Overall Study|Disease progression|4|||
156868948|NCT02760498|566277432|FG005|Overall Study|Disease progression|55|||
156868949|NCT02760498|566277427|FG000|Overall Study|Withdrawal by Subject|4|||
156868950|NCT02760498|566277428|FG001|Overall Study|Withdrawal by Subject|7|||
156868951|NCT02760498|566277429|FG002|Overall Study|Withdrawal by Subject|5|||
156868952|NCT02760498|566277430|FG003|Overall Study|Withdrawal by Subject|1|||
156868953|NCT02760498|566277431|FG004|Overall Study|Withdrawal by Subject|0|||
156868954|NCT02760498|566277432|FG005|Overall Study|Withdrawal by Subject|6|||
156868955|NCT02760498|566277427|FG000|Overall Study|Other than specified|1|||
156868956|NCT02760498|566277428|FG001|Overall Study|Other than specified|6|||
157214164|NCT01326702|567531785|FG000|Overall Study|Withdrawal by Subject|0|||
157214165|NCT01326702|567531786|FG001|Overall Study|Withdrawal by Subject|0|||
157214166|NCT01326702|567531787|FG002|Overall Study|Withdrawal by Subject|1|||
157214167|NCT01326702|567531788|FG003|Overall Study|Withdrawal by Subject|0|||
157214168|NCT01326702|567531789|FG004|Overall Study|Withdrawal by Subject|1|||
157214169|NCT01326702|567531790|FG005|Overall Study|Withdrawal by Subject|1|||
157214170|NCT01326702|567531791|FG006|Overall Study|Withdrawal by Subject|3|||
157214171|NCT01326702|567531785|FG000|Overall Study|Not Treated|0|||
157214172|NCT01326702|567531786|FG001|Overall Study|Not Treated|0|||
157214173|NCT01326702|567531787|FG002|Overall Study|Not Treated|0|||
157214174|NCT01326702|567531788|FG003|Overall Study|Not Treated|1|||
157214175|NCT01326702|567531789|FG004|Overall Study|Not Treated|0|||
157214176|NCT01326702|567531790|FG005|Overall Study|Not Treated|1|||
157214177|NCT01326702|567531791|FG006|Overall Study|Not Treated|0|||
157214178|NCT02082912|567531792|FG000|Overall Study|Physician Decision|0|||
157214179|NCT02082912|567531793|FG001|Overall Study|Physician Decision|1|||
157214180|NCT02614703|567531795|FG000|Overall Study|Withdrawal by Subject|7|||
157214181|NCT02614703|567531796|FG001|Overall Study|Withdrawal by Subject|1|||
157214182|NCT02402933|567531797|FG000|Overall Study|Withdrawal by Subject|4|||
156686184|NCT02688387|565596317|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156868957|NCT02760498|566277429|FG002|Overall Study|Other than specified|0|||
156868958|NCT02760498|566277430|FG003|Overall Study|Other than specified|3|||
156868959|NCT02760498|566277431|FG004|Overall Study|Other than specified|1|||
157214183|NCT02402933|567531797|FG000|Overall Study|Discontinued; Site Termination|10|||
157214184|NCT01835132|567531811|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
157214185|NCT00856778|567531812|FG000|Overall Study|Adverse Event|7|||
157214186|NCT00856778|567531812|FG000|Overall Study|Withdrawal by Subject|10|||
157214187|NCT00856778|567531812|FG000|Overall Study|Study deviation|2|||
157214188|NCT00856778|567531812|FG000|Overall Study|Lost to Follow-up|5|||
157214189|NCT01681771|567531813|FG000|Overall Study|Lost to Follow-up|4|||
156868960|NCT02760498|566277432|FG005|Overall Study|Other than specified|0|||
156868961|NCT02760498|566277427|FG000|Overall Study|Not treated|0|||
156868962|NCT02760498|566277428|FG001|Overall Study|Not treated|0|||
156868963|NCT02760498|566277429|FG002|Overall Study|Not treated|0|||
156868964|NCT02760498|566277430|FG003|Overall Study|Not treated|0|||
156868965|NCT02760498|566277431|FG004|Overall Study|Not treated|0|||
156868966|NCT02760498|566277432|FG005|Overall Study|Not treated|2|||
156868967|NCT02202759|566278955|FG000|Overall Study|Study Terminated by Sponsor|3|||
157214190|NCT01681771|567531814|FG001|Overall Study|Lost to Follow-up|2|||
156785908|NCT02741193|565968179|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
156785909|NCT02502383|565968182|FG000|Overall Study|Lost to Follow-up|130|||
156785910|NCT02502383|565968183|FG001|Overall Study|Lost to Follow-up|131|||
156785911|NCT02502383|565968182|FG000|Overall Study|Withdrawal by Subject|31|||
156785912|NCT02502383|565968183|FG001|Overall Study|Withdrawal by Subject|24|||
156785913|NCT00289978|565968184|FG000|Overall Study|Withdrawal by Subject|31|||
156785914|NCT00289978|565968185|FG001|Overall Study|Withdrawal by Subject|17|||
156785915|NCT00289978|565968186|FG002|Overall Study|Withdrawal by Subject|28|||
156785916|NCT00289978|565968184|FG000|Overall Study|Adverse Event|22|||
156785917|NCT00289978|565968185|FG001|Overall Study|Adverse Event|13|||
156785918|NCT00289978|565968186|FG002|Overall Study|Adverse Event|18|||
156785919|NCT00289978|565968184|FG000|Overall Study|Lack of Efficacy|13|||
156785920|NCT00289978|565968185|FG001|Overall Study|Lack of Efficacy|6|||
156785921|NCT00289978|565968186|FG002|Overall Study|Lack of Efficacy|25|||
156785922|NCT00289978|565968184|FG000|Overall Study|Abnormal laboratory value(s)|20|||
156785923|NCT00289978|565968185|FG001|Overall Study|Abnormal laboratory value(s)|9|||
156785924|NCT00289978|565968186|FG002|Overall Study|Abnormal laboratory value(s)|1|||
156785925|NCT00289978|565968184|FG000|Overall Study|Lost to Follow-up|3|||
156785926|NCT00289978|565968185|FG001|Overall Study|Lost to Follow-up|5|||
156785927|NCT00289978|565968186|FG002|Overall Study|Lost to Follow-up|7|||
156785928|NCT00289978|565968184|FG000|Overall Study|Protocol Violation|5|||
156785929|NCT00289978|565968185|FG001|Overall Study|Protocol Violation|5|||
156785930|NCT00289978|565968186|FG002|Overall Study|Protocol Violation|4|||
156785931|NCT00289978|565968184|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156785932|NCT00289978|565968185|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156785933|NCT00289978|565968186|FG002|Overall Study|Abnormal test procedure result(s)|1|||
156785934|NCT00289978|565968184|FG000|Overall Study|Death|1|||
156785935|NCT00289978|565968185|FG001|Overall Study|Death|0|||
156785936|NCT00289978|565968186|FG002|Overall Study|Death|2|||
156785937|NCT00903344|565968187|FG000|Overall Study|Pregnancy|2|||
156785938|NCT00903344|565968188|FG001|Overall Study|Pregnancy|3|||
156785939|NCT00903344|565968187|FG000|Overall Study|Lost to Follow-up|3|||
156785940|NCT00903344|565968188|FG001|Overall Study|Lost to Follow-up|0|||
156785941|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
156785942|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
156785943|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
156785944|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
156785945|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
156785946|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
156785947|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
156785948|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
156785949|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
156785950|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
156785951|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
156785952|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
156785953|NCT01243424|565968191|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
156785954|NCT01243424|565968192|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
156785955|NCT01243424|565968191|FG000|Discontinuation From Treatment|Not treated|5|||
156785956|NCT01243424|565968192|FG001|Discontinuation From Treatment|Not treated|4|||
156785957|NCT01243424|565968191|FG000|Discontinuation From Treatment|Adverse Event|457|||
156785958|NCT01243424|565968192|FG001|Discontinuation From Treatment|Adverse Event|523|||
156785959|NCT01243424|565968191|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
156785960|NCT01243424|565968192|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
156785961|NCT01243424|565968191|FG000|Discontinuation From Treatment|Protocol Violation|46|||
156785962|NCT01243424|565968192|FG001|Discontinuation From Treatment|Protocol Violation|47|||
156785963|NCT01243424|565968191|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
156785964|NCT01243424|565968192|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
156785965|NCT01243424|565968191|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
156785966|NCT01243424|565968192|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
156785967|NCT01243424|565968191|FG000|Discontinuation From Treatment|Other than listed above|230|||
156785968|NCT01243424|565968192|FG001|Discontinuation From Treatment|Other than listed above|211|||
156785969|NCT01093885|565968212|FG000|Overall Study|Adverse Event|4|||
156785970|NCT01093885|565968212|FG000|Overall Study|Lost to Follow-up|1|||
157013452|NCT02723955|566801759|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
157013453|NCT02723955|566801760|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
156785971|NCT01301001|565968213|FG000|First Intervention|Lost to Follow-up|4|||
156785972|NCT01301001|565968214|FG001|First Intervention|Lost to Follow-up|4|||
156785973|NCT01301001|565968213|FG000|First Intervention|Withdrawal by Subject|1|||
156785974|NCT01301001|565968214|FG001|First Intervention|Withdrawal by Subject|4|||
156785975|NCT01301001|565968213|FG000|First Intervention|Adverse Event|5|||
156785976|NCT01301001|565968214|FG001|First Intervention|Adverse Event|0|||
156868968|NCT02202759|566278956|FG001|Overall Study|Study Terminated by Sponsor|3|||
156868969|NCT02202759|566278957|FG002|Overall Study|Study Terminated by Sponsor|3|||
156868970|NCT02202759|566278955|FG000|Overall Study|Withdrawal by Subject|2|||
156868971|NCT02202759|566278956|FG001|Overall Study|Withdrawal by Subject|1|||
156868972|NCT02202759|566278957|FG002|Overall Study|Withdrawal by Subject|1|||
156868973|NCT02202759|566278955|FG000|Overall Study|Reason not Specified|4|||
156868974|NCT02202759|566278956|FG001|Overall Study|Reason not Specified|11|||
156868975|NCT02202759|566278957|FG002|Overall Study|Reason not Specified|10|||
156868976|NCT01987453|566278958|FG000|Overall Study|Death|0|||
156868977|NCT01987453|566278959|FG001|Overall Study|Death|0|||
156868978|NCT01987453|566278960|FG002|Overall Study|Death|1|||
156868979|NCT01987453|566278958|FG000|Overall Study|Lack of Efficacy|1|||
156868980|NCT01987453|566278959|FG001|Overall Study|Lack of Efficacy|12|||
156868981|NCT01987453|566278960|FG002|Overall Study|Lack of Efficacy|0|||
156868982|NCT04953728|566278961|FG000|Overall Study|Withdrawal by Subject|3|||
156868983|NCT04953728|566278961|FG000|Overall Study|Physician Decision|1|||
156868984|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
156868985|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
156868986|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
156868987|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
156868988|NCT02904954|566278966|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
156868989|NCT02904954|566278967|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
156868990|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Recurrence|2|||
156868991|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Recurrence|0|||
156868992|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Adverse Event|2|||
156868993|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Adverse Event|6|||
156868994|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Participant wishes|12|||
156868995|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Participant wishes|7|||
156868996|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Physician Decision|2|||
156868997|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Physician Decision|1|||
156868998|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
156686185|NCT02688387|565596318|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686186|NCT02688387|565596319|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686187|NCT02688387|565596320|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686188|NCT02688387|565596321|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686189|NCT02688387|565596322|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686190|NCT02688387|565596323|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686191|NCT02688387|565596324|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686192|NCT02688387|565596325|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686193|NCT02688387|565596326|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686194|NCT02688387|565596327|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686195|NCT02688387|565596328|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686196|NCT02688387|565596329|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686197|NCT02688387|565596330|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686198|NCT02688387|565596331|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686199|NCT02688387|565596332|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686200|NCT02688387|565596333|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686201|NCT02688387|565596334|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686202|NCT02688387|565596335|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
156686203|NCT02688387|565596336|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686204|NCT02688387|565596337|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
156686205|NCT02190279|565596338|FG000|Overall Study|Withdrawal consent|1|||
156686206|NCT02190279|565596339|FG001|Overall Study|Withdrawal consent|0|||
156686207|NCT02190279|565596340|FG002|Overall Study|Withdrawal consent|1|||
156686208|NCT02190279|565596338|FG000|Overall Study|Lost to Follow-up|2|||
156686209|NCT02190279|565596339|FG001|Overall Study|Lost to Follow-up|0|||
156686210|NCT02190279|565596340|FG002|Overall Study|Lost to Follow-up|0|||
156686211|NCT02190279|565596338|FG000|Overall Study|Refused further treatment|0|||
156686212|NCT02190279|565596339|FG001|Overall Study|Refused further treatment|0|||
156686213|NCT02190279|565596340|FG002|Overall Study|Refused further treatment|1|||
156686214|NCT02190279|565596338|FG000|Overall Study|Screening failure|0|||
156686215|NCT02190279|565596339|FG001|Overall Study|Screening failure|0|||
156686216|NCT02190279|565596340|FG002|Overall Study|Screening failure|1|||
156686217|NCT00802178|565596341|FG000|Overall Study|Lack of Efficacy|36|||
156686218|NCT00802178|565596341|FG000|Overall Study|Insufficient tolerability (IT)|17|||
156686219|NCT00802178|565596341|FG000|Overall Study|Withdrawal by Subject|18|||
156868999|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
156869000|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Death|0|||
156869001|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Death|1|||
156869002|NCT02904954|566278966|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
156869003|NCT02904954|566278967|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
156869004|NCT00753506|566278968|FG000|Overall Study|Withdrawal by Subject|4|||
157214191|NCT00265083|567531815|FG000|Overall Study|Adverse Event|5|||
156686220|NCT00802178|565596341|FG000|Overall Study|Other|32|||
156686221|NCT00802178|565596341|FG000|Overall Study|Lack of efficacy and patient wish|1|||
156686222|NCT00802178|565596341|FG000|Overall Study|IT and patient wish|8|||
156686223|NCT00802178|565596341|FG000|Overall Study|Patients wish and other reason|1|||
156686224|NCT00831233|565596342|FG000|Overall Study|Adverse Event|0|||
156686225|NCT00831233|565596343|FG001|Overall Study|Adverse Event|1|||
156686226|NCT00831233|565596342|FG000|Overall Study|Protocol Violation|1|||
156686227|NCT00831233|565596343|FG001|Overall Study|Protocol Violation|0|||
156686228|NCT00831233|565596342|FG000|Overall Study|Selection Criteria Not Met|2|||
156686229|NCT00831233|565596343|FG001|Overall Study|Selection Criteria Not Met|0|||
156785977|NCT01301001|565968213|FG000|First Intervention|Protocol Violation|0|||
156785978|NCT01301001|565968214|FG001|First Intervention|Protocol Violation|1|||
156785979|NCT01301001|565968213|FG000|Second Intervention|Adverse Event|2|||
156785980|NCT01301001|565968214|FG001|Second Intervention|Adverse Event|0|||
156785981|NCT01301001|565968213|FG000|Second Intervention|Withdrawal by Subject|2|||
156785982|NCT01301001|565968214|FG001|Second Intervention|Withdrawal by Subject|0|||
156785983|NCT04535362|565968215|FG000|Overall Study|Lost to Follow-up|3|||
156785984|NCT04535362|565968216|FG001|Overall Study|Lost to Follow-up|1|||
156785985|NCT03791060|565968217|FG000|Overall Study|Withdrawal by Subject|1|||
156785986|NCT02852434|565968218|FG000|Overall Study|Withdrawal by Subject|0|||
156785987|NCT02852434|565968219|FG001|Overall Study|Withdrawal by Subject|1|||
156785988|NCT02852434|565968218|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
156785989|NCT02852434|565968219|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
156785990|NCT02018887|565968222|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
156785991|NCT02018887|565968223|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785992|NCT02018887|565968224|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785993|NCT02018887|565968225|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785994|NCT02018887|565968226|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785995|NCT02018887|565968227|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785996|NCT02018887|565968228|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785997|NCT02018887|565968229|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785998|NCT02018887|565968230|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156785999|NCT02018887|565968231|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156786000|NCT02018887|565968232|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
156786001|NCT02018887|565968222|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786002|NCT02018887|565968223|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786003|NCT02018887|565968224|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786004|NCT02018887|565968225|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786005|NCT02018887|565968226|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
156786006|NCT02018887|565968227|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786007|NCT02018887|565968228|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
156786008|NCT02018887|565968229|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
156786009|NCT02018887|565968230|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786010|NCT02018887|565968231|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786011|NCT02018887|565968232|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
156786012|NCT02018887|565968222|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
156786013|NCT02018887|565968223|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
156786014|NCT02018887|565968224|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
156786015|NCT02018887|565968225|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
156786016|NCT02018887|565968226|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
156786017|NCT02018887|565968227|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
156786018|NCT02018887|565968228|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
156786019|NCT02018887|565968229|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
156786020|NCT02018887|565968230|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
156786021|NCT02018887|565968231|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
156786022|NCT02018887|565968232|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
156786023|NCT02018887|565968222|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
156786024|NCT02018887|565968223|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
156786025|NCT02018887|565968224|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
156786026|NCT02018887|565968225|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
156786027|NCT02018887|565968226|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
156786028|NCT02018887|565968227|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
156786029|NCT02018887|565968228|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
156786030|NCT02018887|565968229|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
156786031|NCT02018887|565968230|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
156786032|NCT02018887|565968231|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
156786033|NCT02018887|565968232|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
156786034|NCT01145222|565968233|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786035|NCT01145222|565968234|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786036|NCT01145222|565968235|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
156786037|NCT01145222|565968236|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
156786038|NCT01145222|565968233|FG000|Overall Study|Poor bowel preparation|0|||
156786039|NCT01145222|565968234|FG001|Overall Study|Poor bowel preparation|0|||
156686230|NCT00784134|565596344|FG000|Overall Study|Lost to Follow-up|3|||
156686231|NCT00784134|565596345|FG001|Overall Study|Lost to Follow-up|6|||
156686232|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
156869005|NCT00753506|566278969|FG001|Overall Study|Withdrawal by Subject|1|||
156869006|NCT00753506|566278968|FG000|Overall Study|Lost to Follow-up|2|||
156869007|NCT00753506|566278969|FG001|Overall Study|Lost to Follow-up|0|||
156869008|NCT00753506|566278968|FG000|Overall Study|Other reason|1|||
156869009|NCT00753506|566278969|FG001|Overall Study|Other reason|1|||
156869010|NCT04226742|566278970|FG000|Overall Study|Lost to Follow-up|16|||
156869011|NCT04226742|566278971|FG001|Overall Study|Lost to Follow-up|13|||
156869012|NCT04226742|566278970|FG000|Overall Study|Withdrawal by Subject|5|||
156869013|NCT04226742|566278971|FG001|Overall Study|Withdrawal by Subject|3|||
156869014|NCT00123422|566278977|FG000|Overall Study|Physician Decision|2|||
156869015|NCT00123422|566278978|FG001|Overall Study|Physician Decision|2|||
156869016|NCT00123422|566278979|FG002|Overall Study|Physician Decision|6|||
156869017|NCT00123422|566278977|FG000|Overall Study|Withdrawal by Subject|1|||
156869018|NCT00123422|566278978|FG001|Overall Study|Withdrawal by Subject|2|||
156869019|NCT00123422|566278979|FG002|Overall Study|Withdrawal by Subject|2|||
156869020|NCT00123422|566278977|FG000|Overall Study|Lost to Follow-up|1|||
156869021|NCT00123422|566278978|FG001|Overall Study|Lost to Follow-up|2|||
156869022|NCT00123422|566278979|FG002|Overall Study|Lost to Follow-up|2|||
156869023|NCT04646044|566278980|FG000|Overall Study|Lost to Follow-up|0|||
156869024|NCT04646044|566278981|FG001|Overall Study|Lost to Follow-up|0|||
156869025|NCT04646044|566278982|FG002|Overall Study|Lost to Follow-up|1|||
156869026|NCT04646044|566278983|FG003|Overall Study|Lost to Follow-up|0|||
156686233|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
156686234|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
156686235|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
156686236|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
156686237|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
156686238|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
156686239|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
156686240|NCT03785145|565596346|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
156686241|NCT03785145|565596347|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
156686242|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
156686243|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
156686244|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
156686245|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
156686246|NCT03785145|565596346|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
156686247|NCT03785145|565596347|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
156686248|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
156686249|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
156686250|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
156686251|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
156686252|NCT03785145|565596346|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
156686253|NCT03785145|565596347|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
156686254|NCT02211014|565596348|FG000|Overall Study|Adverse Event|0|||
156686255|NCT02211014|565596349|FG001|Overall Study|Adverse Event|2|||
156686256|NCT02211014|565596348|FG000|Overall Study|Physician Decision|1|||
156686257|NCT02211014|565596349|FG001|Overall Study|Physician Decision|2|||
156686258|NCT02211014|565596348|FG000|Overall Study|Started another cancer therapy|1|||
156686259|NCT02211014|565596349|FG001|Overall Study|Started another cancer therapy|0|||
156686260|NCT02211014|565596348|FG000|Overall Study|Withdrawal by Subject|0|||
156686261|NCT02211014|565596349|FG001|Overall Study|Withdrawal by Subject|1|||
156686262|NCT02211014|565596348|FG000|Overall Study|In agreement with patient, no benefit|0|||
156686263|NCT02211014|565596349|FG001|Overall Study|In agreement with patient, no benefit|1|||
156686264|NCT00097786|565596350|FG000|Overall Study|lost to follow-up for all-cause death|296|||
156686265|NCT00097786|565596351|FG001|Overall Study|lost to follow-up for all-cause death|292|||
156686266|NCT00097786|565596352|FG002|Overall Study|lost to follow-up for all-cause death|313|||
156686267|NCT00097786|565596353|FG003|Overall Study|lost to follow-up for all-cause death|310|||
156686268|NCT02443324|565596355|FG000|Overall Study|Death|4|||
156686269|NCT02443324|565596356|FG001|Overall Study|Death|1|||
156686270|NCT02443324|565596357|FG002|Overall Study|Death|0|||
156686271|NCT02443324|565596358|FG003|Overall Study|Death|3|||
156686272|NCT02443324|565596359|FG004|Overall Study|Death|1|||
156686273|NCT02443324|565596360|FG005|Overall Study|Death|3|||
156869027|NCT04646044|566278980|FG000|Overall Study|Withdrawal by Subject|0|||
156869028|NCT04646044|566278981|FG001|Overall Study|Withdrawal by Subject|1|||
156869029|NCT04646044|566278982|FG002|Overall Study|Withdrawal by Subject|0|||
156869030|NCT04646044|566278983|FG003|Overall Study|Withdrawal by Subject|0|||
156869031|NCT01908803|566278984|FG000|Overall Study|Adverse Event|1|||
156869032|NCT01908803|566278985|FG001|Overall Study|Adverse Event|0|||
156686274|NCT02443324|565596361|FG006|Overall Study|Death|2|||
156686275|NCT02443324|565596355|FG000|Overall Study|Lost to Follow-up|0|||
156686276|NCT02443324|565596356|FG001|Overall Study|Lost to Follow-up|0|||
156686277|NCT02443324|565596357|FG002|Overall Study|Lost to Follow-up|0|||
156686278|NCT02443324|565596358|FG003|Overall Study|Lost to Follow-up|1|||
156686279|NCT02443324|565596359|FG004|Overall Study|Lost to Follow-up|0|||
156686280|NCT02443324|565596360|FG005|Overall Study|Lost to Follow-up|1|||
156686281|NCT02443324|565596361|FG006|Overall Study|Lost to Follow-up|0|||
156686282|NCT02443324|565596355|FG000|Overall Study|Physician Decision|0|||
156686283|NCT02443324|565596356|FG001|Overall Study|Physician Decision|3|||
156686284|NCT02443324|565596357|FG002|Overall Study|Physician Decision|5|||
156869033|NCT01908803|566278984|FG000|Overall Study|Physician Decision|0|||
157214192|NCT00265083|567531816|FG001|Overall Study|Adverse Event|13|||
157214193|NCT00265083|567531817|FG002|Overall Study|Adverse Event|15|||
156686285|NCT02443324|565596358|FG003|Overall Study|Physician Decision|1|||
156686286|NCT02443324|565596359|FG004|Overall Study|Physician Decision|1|||
156686287|NCT02443324|565596360|FG005|Overall Study|Physician Decision|0|||
156686288|NCT02443324|565596361|FG006|Overall Study|Physician Decision|2|||
156686289|NCT02443324|565596355|FG000|Overall Study|Progressive Disease|20|||
156686290|NCT02443324|565596356|FG001|Overall Study|Progressive Disease|20|||
156686291|NCT02443324|565596357|FG002|Overall Study|Progressive Disease|13|||
156686292|NCT02443324|565596358|FG003|Overall Study|Progressive Disease|10|||
156686293|NCT02443324|565596359|FG004|Overall Study|Progressive Disease|13|||
156686294|NCT02443324|565596360|FG005|Overall Study|Progressive Disease|17|||
156686295|NCT02443324|565596361|FG006|Overall Study|Progressive Disease|10|||
156686296|NCT02443324|565596355|FG000|Overall Study|Withdrawal by Subject|0|||
156686297|NCT02443324|565596356|FG001|Overall Study|Withdrawal by Subject|0|||
156686298|NCT02443324|565596357|FG002|Overall Study|Withdrawal by Subject|3|||
156686299|NCT02443324|565596358|FG003|Overall Study|Withdrawal by Subject|1|||
156686300|NCT02443324|565596359|FG004|Overall Study|Withdrawal by Subject|1|||
156686301|NCT02443324|565596360|FG005|Overall Study|Withdrawal by Subject|0|||
156686302|NCT02443324|565596361|FG006|Overall Study|Withdrawal by Subject|1|||
156686303|NCT02443324|565596355|FG000|Overall Study|Adverse Event|0|||
156686304|NCT02443324|565596356|FG001|Overall Study|Adverse Event|1|||
156686305|NCT02443324|565596357|FG002|Overall Study|Adverse Event|3|||
156686306|NCT02443324|565596358|FG003|Overall Study|Adverse Event|0|||
156686307|NCT02443324|565596359|FG004|Overall Study|Adverse Event|4|||
156686308|NCT02443324|565596360|FG005|Overall Study|Adverse Event|3|||
156686309|NCT02443324|565596361|FG006|Overall Study|Adverse Event|3|||
156686310|NCT02443324|565596355|FG000|Overall Study|Enrolled but Never Treated|0|||
156686311|NCT02443324|565596356|FG001|Overall Study|Enrolled but Never Treated|0|||
156686312|NCT02443324|565596357|FG002|Overall Study|Enrolled but Never Treated|1|||
156686313|NCT02443324|565596358|FG003|Overall Study|Enrolled but Never Treated|0|||
156686314|NCT02443324|565596359|FG004|Overall Study|Enrolled but Never Treated|1|||
156686315|NCT02443324|565596360|FG005|Overall Study|Enrolled but Never Treated|0|||
156686316|NCT02443324|565596361|FG006|Overall Study|Enrolled but Never Treated|1|||
156686317|NCT01647711|565596362|FG000|Overall Study|Progressive disease|6|||
156686318|NCT01647711|565596363|FG001|Overall Study|Progressive disease|2|||
156686319|NCT01647711|565596364|FG002|Overall Study|Progressive disease|6|||
156686320|NCT01647711|565596365|FG003|Overall Study|Progressive disease|8|||
156686321|NCT01647711|565596366|FG004|Overall Study|Progressive disease|2|||
156686322|NCT01647711|565596362|FG000|Overall Study|Other adverse event|0|||
156686323|NCT01647711|565596363|FG001|Overall Study|Other adverse event|0|||
156686324|NCT01647711|565596364|FG002|Overall Study|Other adverse event|2|||
156686325|NCT01647711|565596365|FG003|Overall Study|Other adverse event|0|||
156686326|NCT01647711|565596366|FG004|Overall Study|Other adverse event|2|||
157214194|NCT00265083|567531815|FG000|Overall Study|Lost to Follow-up|3|||
157214195|NCT00265083|567531816|FG001|Overall Study|Lost to Follow-up|4|||
156686327|NCT01647711|565596362|FG000|Overall Study|Protocol Violation|0|||
156686328|NCT01647711|565596363|FG001|Overall Study|Protocol Violation|0|||
156686329|NCT01647711|565596364|FG002|Overall Study|Protocol Violation|0|||
156686330|NCT01647711|565596365|FG003|Overall Study|Protocol Violation|0|||
156686331|NCT01647711|565596366|FG004|Overall Study|Protocol Violation|1|||
156686332|NCT01647711|565596362|FG000|Overall Study|Refused to continue taking medication|0|||
156686333|NCT01647711|565596363|FG001|Overall Study|Refused to continue taking medication|0|||
156686334|NCT01647711|565596364|FG002|Overall Study|Refused to continue taking medication|0|||
156686335|NCT01647711|565596365|FG003|Overall Study|Refused to continue taking medication|2|||
156686336|NCT01647711|565596366|FG004|Overall Study|Refused to continue taking medication|1|||
156686337|NCT01647711|565596362|FG000|Overall Study|Other reason not defined|0|||
156686338|NCT01647711|565596363|FG001|Overall Study|Other reason not defined|1|||
156686339|NCT01647711|565596364|FG002|Overall Study|Other reason not defined|1|||
156686340|NCT01647711|565596365|FG003|Overall Study|Other reason not defined|1|||
156686341|NCT01647711|565596366|FG004|Overall Study|Other reason not defined|0|||
156686342|NCT01316419|565596367|FG000|Overall Study|Not treated|103|||
156686343|NCT01316419|565596367|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
156686344|NCT01316419|565596367|FG000|Overall Study|Lost to Follow-up|19|||
156686345|NCT01345318|565596368|FG000|Overall Study|Adverse Event|16|||
156686346|NCT01345318|565596368|FG000|Overall Study|Lack of Efficacy|17|||
156869034|NCT01908803|566278985|FG001|Overall Study|Physician Decision|1|||
156869035|NCT01908803|566278984|FG000|Overall Study|Withdrawal by Subject|1|||
156869036|NCT01908803|566278985|FG001|Overall Study|Withdrawal by Subject|0|||
156869037|NCT01908803|566278984|FG000|Overall Study|Randomization Error|1|||
156869038|NCT01908803|566278985|FG001|Overall Study|Randomization Error|0|||
156869039|NCT01908803|566278984|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
156869040|NCT01908803|566278985|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
156869041|NCT00823615|566278986|FG000|Period 2|Lost to Follow-up|2|||
156869042|NCT00823615|566278987|FG001|Period 2|Lost to Follow-up|0|||
156869043|NCT00823615|566278986|FG000|Period 2|Time/Job Conflict|1|||
156869044|NCT00823615|566278987|FG001|Period 2|Time/Job Conflict|2|||
156869045|NCT02215252|566278989|FG000|Overall Study|Adverse Event|1|||
156869046|NCT02215252|566278990|FG001|Overall Study|Adverse Event|5|||
156869047|NCT02215252|566278991|FG002|Overall Study|Adverse Event|2|||
156869048|NCT02215252|566278989|FG000|Overall Study|Lost to Follow-up|0|||
156869049|NCT02215252|566278990|FG001|Overall Study|Lost to Follow-up|0|||
156869050|NCT02215252|566278991|FG002|Overall Study|Lost to Follow-up|1|||
156869051|NCT02215252|566278989|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
156869052|NCT02215252|566278990|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
156869053|NCT02215252|566278991|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
156869054|NCT02215252|566278989|FG000|Overall Study|Protocol Violation|0|||
156869055|NCT02215252|566278990|FG001|Overall Study|Protocol Violation|1|||
156869056|NCT02215252|566278991|FG002|Overall Study|Protocol Violation|0|||
156869057|NCT02215252|566278989|FG000|Overall Study|Withdrawal by Subject|1|||
156869058|NCT02215252|566278990|FG001|Overall Study|Withdrawal by Subject|0|||
156869059|NCT02215252|566278991|FG002|Overall Study|Withdrawal by Subject|0|||
156869060|NCT02215252|566278989|FG000|Overall Study|Other|0|||
156869061|NCT02215252|566278990|FG001|Overall Study|Other|1|||
156869062|NCT02215252|566278991|FG002|Overall Study|Other|1|||
156869063|NCT02118961|566278992|FG000|Overall Study|Withdrawal by Subject|1|||
156869064|NCT02118961|566278993|FG001|Overall Study|Withdrawal by Subject|0|||
156869065|NCT01657019|566278995|FG000|Overall Study|Withdrawal by Subject|65|||
156869066|NCT01657019|566278995|FG000|Overall Study|Adverse Event|55|||
156869067|NCT01657019|566278995|FG000|Overall Study|Lost to Follow-up|48|||
156869068|NCT01657019|566278995|FG000|Overall Study|Protocol Violation|6|||
156869069|NCT01657019|566278995|FG000|Overall Study|Lack of Efficacy|3|||
156869070|NCT01657019|566278995|FG000|Overall Study|Other|58|||
156869071|NCT03910244|566278996|FG000|Overall Study|Adverse Event|14|||
156869072|NCT03910244|566278997|FG001|Overall Study|Adverse Event|0|||
156869073|NCT03910244|566278996|FG000|Overall Study|Death|1|||
156869074|NCT03910244|566278997|FG001|Overall Study|Death|0|||
156869075|NCT03910244|566278996|FG000|Overall Study|Lost to Follow-up|0|||
156869076|NCT03910244|566278997|FG001|Overall Study|Lost to Follow-up|2|||
156869077|NCT03910244|566278996|FG000|Overall Study|Joint withdrawal decision|1|||
156869078|NCT03910244|566278997|FG001|Overall Study|Joint withdrawal decision|0|||
156786040|NCT01145222|565968235|FG002|Overall Study|Poor bowel preparation|0|||
156786041|NCT01145222|565968236|FG003|Overall Study|Poor bowel preparation|1|||
156786042|NCT01011283|565968237|FG000|Overall Study|Adverse Event|4|||
156786043|NCT01011283|565968238|FG001|Overall Study|Adverse Event|2|||
156786044|NCT01011283|565968237|FG000|Overall Study|Progressive Disease|0|||
156786045|NCT01011283|565968238|FG001|Overall Study|Progressive Disease|2|||
156786046|NCT01011283|565968237|FG000|Overall Study|Terminated by Sponsor|5|||
156786047|NCT01011283|565968238|FG001|Overall Study|Terminated by Sponsor|5|||
156786048|NCT01011283|565968237|FG000|Overall Study|Other|2|||
156786049|NCT01011283|565968238|FG001|Overall Study|Other|2|||
156786050|NCT04689009|565968239|FG000|Overall Study|Adverse Event|1|||
156786051|NCT04689009|565968240|FG001|Overall Study|Adverse Event|0|||
156786052|NCT04689009|565968239|FG000|Overall Study|Lost to Follow-up|1|||
156786053|NCT04689009|565968240|FG001|Overall Study|Lost to Follow-up|2|||
156786054|NCT04689009|565968239|FG000|Overall Study|Withdrawal by Subject|4|||
156786055|NCT04689009|565968240|FG001|Overall Study|Withdrawal by Subject|3|||
156786056|NCT04689009|565968239|FG000|Overall Study|Protocol Violation|1|||
156786057|NCT04689009|565968240|FG001|Overall Study|Protocol Violation|0|||
156786058|NCT00985790|565968241|FG000|Overall Study|Withdrawal by Subject|1|||
156786059|NCT00985790|565968242|FG001|Overall Study|Withdrawal by Subject|1|||
156786060|NCT00985790|565968241|FG000|Overall Study|Lost to Follow-up|6|||
156786061|NCT00985790|565968242|FG001|Overall Study|Lost to Follow-up|7|||
156869079|NCT03910244|566278996|FG000|Overall Study|Study Terminated by Sponsor|7|||
156786062|NCT01666314|565968243|FG000|Overall Study|Adverse Event|3|||
156869080|NCT03910244|566278997|FG001|Overall Study|Study Terminated by Sponsor|4|||
156869081|NCT03910244|566278996|FG000|Overall Study|Physician Decision|1|||
156869082|NCT03910244|566278997|FG001|Overall Study|Physician Decision|0|||
156869083|NCT03910244|566278996|FG000|Overall Study|Protocol Violation|1|||
156869084|NCT03910244|566278997|FG001|Overall Study|Protocol Violation|0|||
156869085|NCT03910244|566278996|FG000|Overall Study|Withdrawal by Subject|7|||
156869086|NCT03910244|566278997|FG001|Overall Study|Withdrawal by Subject|2|||
156786063|NCT01666314|565968244|FG001|Overall Study|Adverse Event|13|||
156786064|NCT01666314|565968245|FG002|Overall Study|Adverse Event|7|||
156786065|NCT01666314|565968246|FG003|Overall Study|Adverse Event|7|||
156786066|NCT01666314|565968243|FG000|Overall Study|Progressive Disease|11|||
156786067|NCT01666314|565968244|FG001|Overall Study|Progressive Disease|9|||
156786068|NCT01666314|565968245|FG002|Overall Study|Progressive Disease|19|||
156786069|NCT01666314|565968246|FG003|Overall Study|Progressive Disease|20|||
156786070|NCT01666314|565968243|FG000|Overall Study|Symptomatic Deterioration|1|||
156786071|NCT01666314|565968244|FG001|Overall Study|Symptomatic Deterioration|0|||
156786072|NCT01666314|565968245|FG002|Overall Study|Symptomatic Deterioration|2|||
156786073|NCT01666314|565968246|FG003|Overall Study|Symptomatic Deterioration|0|||
156786074|NCT01666314|565968243|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
156786075|NCT01666314|565968244|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
156786076|NCT01666314|565968245|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
156786077|NCT01666314|565968246|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
156786078|NCT01666314|565968243|FG000|Overall Study|Withdrawal by Subject|1|||
156786079|NCT01666314|565968244|FG001|Overall Study|Withdrawal by Subject|1|||
156786080|NCT01666314|565968245|FG002|Overall Study|Withdrawal by Subject|2|||
156786081|NCT01666314|565968246|FG003|Overall Study|Withdrawal by Subject|3|||
156786082|NCT01666314|565968243|FG000|Overall Study|Reason not Specified|10|||
156786083|NCT01666314|565968244|FG001|Overall Study|Reason not Specified|7|||
156786084|NCT01666314|565968245|FG002|Overall Study|Reason not Specified|5|||
156786085|NCT01666314|565968246|FG003|Overall Study|Reason not Specified|5|||
156786086|NCT05089357|565968253|FG000|Overall Study|Withdrawal by Subject|23|||
156786087|NCT05089357|565968253|FG000|Overall Study|Lost to Follow-up|6|||
156786088|NCT05089357|565968253|FG000|Overall Study|Medical reason|1|||
156786089|NCT05089357|565968253|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
156786090|NCT05089357|565968253|FG000|Overall Study|Pregnancy|2|||
156786091|NCT02021318|565968254|FG000|Overall Study|Adverse Event|2|||
156786092|NCT02021318|565968255|FG001|Overall Study|Adverse Event|1|||
156786093|NCT02021318|565968254|FG000|Overall Study|Death|33|||
156786094|NCT02021318|565968255|FG001|Overall Study|Death|34|||
156786095|NCT02021318|565968254|FG000|Overall Study|Lost to Follow-up|3|||
156786096|NCT02021318|565968255|FG001|Overall Study|Lost to Follow-up|3|||
156786097|NCT02021318|565968254|FG000|Overall Study|Progressive Disease|0|||
156786098|NCT02021318|565968255|FG001|Overall Study|Progressive Disease|1|||
156786099|NCT02021318|565968254|FG000|Overall Study|Withdrawal by Subject|30|||
156786100|NCT02021318|565968255|FG001|Overall Study|Withdrawal by Subject|18|||
156786101|NCT02021318|565968254|FG000|Overall Study|Physician Decision|3|||
156786102|NCT02021318|565968255|FG001|Overall Study|Physician Decision|3|||
156786103|NCT02021318|565968254|FG000|Overall Study|Miscellaneous|2|||
156786104|NCT02021318|565968255|FG001|Overall Study|Miscellaneous|3|||
156786105|NCT00689052|565968256|FG000|Overall Study|Adverse Event|4|||
156786106|NCT00689052|565968257|FG001|Overall Study|Adverse Event|6|||
156786107|NCT00689052|565968256|FG000|Overall Study|Protocol Violation|1|||
156786108|NCT00689052|565968257|FG001|Overall Study|Protocol Violation|0|||
156786109|NCT00689052|565968256|FG000|Overall Study|Lost to Follow-up|2|||
156786110|NCT00689052|565968257|FG001|Overall Study|Lost to Follow-up|0|||
156786111|NCT00689052|565968256|FG000|Overall Study|Withdrawal by Subject|2|||
156786112|NCT00689052|565968257|FG001|Overall Study|Withdrawal by Subject|0|||
156786113|NCT00689052|565968256|FG000|Overall Study|Early termination of the trial|22|||
156786114|NCT00689052|565968257|FG001|Overall Study|Early termination of the trial|24|||
156786115|NCT04180696|565968258|FG000|Overall Study|Death|5|||
156786116|NCT04180696|565968259|FG001|Overall Study|Death|6|||
156786117|NCT04180696|565968258|FG000|Overall Study|Lost to Follow-up|1|||
156786118|NCT04180696|565968259|FG001|Overall Study|Lost to Follow-up|0|||
156786119|NCT04180696|565968258|FG000|Overall Study|Withdrawal by Subject|0|||
156786120|NCT04180696|565968259|FG001|Overall Study|Withdrawal by Subject|1|||
156786121|NCT01727154|565968267|FG000|Overall Study|Death|17|||
156786122|NCT01727154|565968267|FG000|Overall Study|Withdrawal by Subject|14|||
156786123|NCT01727154|565968267|FG000|Overall Study|Subject Withdrew Consent|18|||
156786124|NCT01727154|565968267|FG000|Overall Study|Study Terminated|6|||
156786125|NCT01727154|565968267|FG000|Overall Study|No Discontinuation Documentation|4|||
156786126|NCT00003474|565968268|FG000|Overall Study|Not Evaluable|14|||
156786127|NCT03020888|565968269|FG000|Overall Study|Physician Decision|4|||
156786128|NCT03020888|565968269|FG000|Overall Study|Withdrawal by Subject|6|||
156786129|NCT03020888|565968269|FG000|Overall Study|Insurance coverage|2|||
156786130|NCT03020888|565968269|FG000|Overall Study|Lost to Follow-up|1|||
156786131|NCT01198548|565968275|FG000|Overall Study|Disease Progression|9|||
156786132|NCT01198548|565968275|FG000|Overall Study|Administrative Decision|1|||
156786133|NCT02015104|565968276|FG000|Overall Study|Withdrew consent after first dose drug|1|||
156786134|NCT02015104|565968277|FG001|Overall Study|Withdrew consent after first dose drug|0|||
156786135|NCT02015104|565968276|FG000|Overall Study|Withdrew consent prior to treatment|0|||
156786136|NCT02015104|565968277|FG001|Overall Study|Withdrew consent prior to treatment|1|||
156786137|NCT06025695|565968278|FG000|Overall Study|Adverse Event|5|||
156786138|NCT06025695|565968279|FG001|Overall Study|Adverse Event|6|||
156786139|NCT06025695|565968278|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
156786140|NCT06025695|565968279|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
156786141|NCT06025695|565968278|FG000|Overall Study|Other|23|||
156786142|NCT06025695|565968279|FG001|Overall Study|Other|19|||
156786143|NCT06025695|565968278|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
156786144|NCT06025695|565968279|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
156786145|NCT01452347|565968280|FG000|Overall Study|Adverse Event|2|||
156786146|NCT01452347|565968281|FG001|Overall Study|Adverse Event|1|||
156786147|NCT01452347|565968280|FG000|Overall Study|Non compliance protocol|2|||
156786148|NCT01452347|565968281|FG001|Overall Study|Non compliance protocol|0|||
156786149|NCT01452347|565968280|FG000|Overall Study|Lost to Follow-up|2|||
156786150|NCT01452347|565968281|FG001|Overall Study|Lost to Follow-up|0|||
156786151|NCT01452347|565968280|FG000|Overall Study|Withdrawal by Subject|3|||
156786152|NCT01452347|565968281|FG001|Overall Study|Withdrawal by Subject|3|||
156786153|NCT01452347|565968280|FG000|Overall Study|Not treated|6|||
156786154|NCT01452347|565968281|FG001|Overall Study|Not treated|3|||
156786155|NCT01452347|565968280|FG000|Overall Study|Other reason not defined above|2|||
156786156|NCT01452347|565968281|FG001|Overall Study|Other reason not defined above|0|||
156786157|NCT01030900|565968282|FG000|Overall Study|Not treated due to congestive heart failure|1|||
156786158|NCT01030900|565968282|FG000|Overall Study|Not treated due to rapid disease|1|||
156786159|NCT00441896|565968283|FG000|Overall Study|Withdrawal by Subject|0|||
156786160|NCT00441896|565968284|FG001|Overall Study|Withdrawal by Subject|0|||
156786161|NCT00441896|565968285|FG002|Overall Study|Withdrawal by Subject|0|||
156786162|NCT00441896|565968286|FG003|Overall Study|Withdrawal by Subject|1|||
156786163|NCT00441896|565968287|FG004|Overall Study|Withdrawal by Subject|0|||
156786164|NCT00441896|565968288|FG005|Overall Study|Withdrawal by Subject|0|||
156786165|NCT00441896|565968289|FG006|Overall Study|Withdrawal by Subject|0|||
156786166|NCT00441896|565968290|FG007|Overall Study|Withdrawal by Subject|0|||
156786167|NCT00441896|565968291|FG008|Overall Study|Withdrawal by Subject|0|||
156786168|NCT00441896|565968292|FG009|Overall Study|Withdrawal by Subject|0|||
156786169|NCT00441896|565968283|FG000|Overall Study|Other|0|||
156786170|NCT00441896|565968284|FG001|Overall Study|Other|0|||
156786171|NCT00441896|565968285|FG002|Overall Study|Other|0|||
156786172|NCT00441896|565968286|FG003|Overall Study|Other|0|||
156786173|NCT00441896|565968287|FG004|Overall Study|Other|1|||
156786174|NCT00441896|565968288|FG005|Overall Study|Other|0|||
156786175|NCT00441896|565968289|FG006|Overall Study|Other|0|||
156786176|NCT00441896|565968290|FG007|Overall Study|Other|0|||
156786177|NCT00441896|565968291|FG008|Overall Study|Other|0|||
156786178|NCT00441896|565968292|FG009|Overall Study|Other|0|||
156786179|NCT01301092|565968293|FG000|Overall Study|Lost to Follow-up|0|||
156786180|NCT01301092|565968294|FG001|Overall Study|Lost to Follow-up|0|||
156786181|NCT01301092|565968295|FG002|Overall Study|Lost to Follow-up|1|||
156786182|NCT03334175|565968296|FG000|Overall Study|Lost to Follow-up|0|||
156786183|NCT03334175|565968297|FG001|Overall Study|Lost to Follow-up|1|||
156786184|NCT01350973|565968301|FG000|Overall Study|Adverse Event|4|||
156786185|NCT01350973|565968302|FG001|Overall Study|Adverse Event|7|||
156786186|NCT01350973|565968303|FG002|Overall Study|Adverse Event|7|||
156786187|NCT01350973|565968301|FG000|Overall Study|Voluntary Withdrawal|2|||
156786188|NCT01350973|565968302|FG001|Overall Study|Voluntary Withdrawal|1|||
156786189|NCT01350973|565968303|FG002|Overall Study|Voluntary Withdrawal|1|||
156786190|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156786191|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
156786192|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
156786193|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
156786194|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
156786195|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156786196|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
156786197|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
156786198|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
156786199|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
156786200|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
156786201|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
156786202|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
156786203|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156786204|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
156786205|NCT03738215|565968304|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156786206|NCT03738215|565968305|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
156786207|NCT03738215|565968306|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
156786208|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
156786209|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
156786210|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
156786211|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
156786212|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
157214196|NCT00265083|567531817|FG002|Overall Study|Lost to Follow-up|4|||
156786213|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
156786214|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
156869087|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
156869088|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
156869089|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
156869090|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156869091|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156869092|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
156869093|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
156869094|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
156869095|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156869096|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
156869097|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
156869098|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
156869099|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
156869100|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
156869101|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
156869102|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156869103|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156869104|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156869105|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156869106|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156869107|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156869108|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
156869109|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156869110|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156869111|NCT01106690|566278998|FG000|Core Period: Baseline to Week 26|Other|10|||
156869112|NCT01106690|566278999|FG001|Core Period: Baseline to Week 26|Other|2|||
156869113|NCT01106690|566279000|FG002|Core Period: Baseline to Week 26|Other|6|||
156869114|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156869115|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156869116|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156869117|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156869118|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156869119|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156869120|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156869121|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156869122|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156869123|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156869124|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
156869125|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
156869126|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156869127|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156869128|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156869129|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Other|8|||
156869130|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Other|3|||
156869131|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Other|4|||
156869132|NCT01106690|566278998|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
156869133|NCT01106690|566278999|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156869134|NCT01106690|566279000|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156869135|NCT02106390|566279001|FG000|Overall Study|Withdrawal by Subject|15|||
156869136|NCT02106390|566279002|FG001|Overall Study|Withdrawal by Subject|16|||
156869137|NCT02106390|566279003|FG002|Overall Study|Withdrawal by Subject|15|||
156869138|NCT02106390|566279001|FG000|Overall Study|Lost to Follow-up|25|||
156869139|NCT02106390|566279002|FG001|Overall Study|Lost to Follow-up|20|||
156869140|NCT02106390|566279003|FG002|Overall Study|Lost to Follow-up|13|||
156869141|NCT02106390|566279001|FG000|Overall Study|Other: Administrative Reason|8|||
156869142|NCT02106390|566279002|FG001|Overall Study|Other: Administrative Reason|5|||
156869143|NCT02106390|566279003|FG002|Overall Study|Other: Administrative Reason|12|||
156869144|NCT02106390|566279001|FG000|Overall Study|Other: Unspecified|1|||
156869145|NCT02106390|566279002|FG001|Overall Study|Other: Unspecified|4|||
156869146|NCT02106390|566279003|FG002|Overall Study|Other: Unspecified|2|||
156869147|NCT02106390|566279001|FG000|Overall Study|Adverse Event|0|||
156869148|NCT02106390|566279002|FG001|Overall Study|Adverse Event|2|||
156869149|NCT02106390|566279003|FG002|Overall Study|Adverse Event|1|||
156869150|NCT02106390|566279001|FG000|Overall Study|Protocol Violation|0|||
156869151|NCT02106390|566279002|FG001|Overall Study|Protocol Violation|1|||
156869152|NCT02106390|566279003|FG002|Overall Study|Protocol Violation|0|||
156869153|NCT03219528|566279004|FG000|Overall Study|Lost to Follow-up|5|||
156786215|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
156786216|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
156786217|NCT03738215|565968304|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
156786218|NCT03738215|565968305|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
156786219|NCT03738215|565968306|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
156786220|NCT00853047|565968307|FG000|Core Phase|Participant Request|0|||
156786221|NCT00853047|565968308|FG001|Core Phase|Participant Request|0|||
156786222|NCT00853047|565968309|FG002|Core Phase|Participant Request|0|||
156786223|NCT00853047|565968310|FG003|Core Phase|Participant Request|1|||
156786224|NCT00853047|565968311|FG004|Core Phase|Participant Request|0|||
156786225|NCT00853047|565968312|FG005|Core Phase|Participant Request|0|||
156786226|NCT00853047|565968307|FG000|Open-Label Extension Phase|Participant Request|0|||
156786227|NCT00853047|565968308|FG001|Open-Label Extension Phase|Participant Request|0|||
156786228|NCT00853047|565968309|FG002|Open-Label Extension Phase|Participant Request|0|||
156786229|NCT00853047|565968310|FG003|Open-Label Extension Phase|Participant Request|0|||
156786230|NCT00853047|565968311|FG004|Open-Label Extension Phase|Participant Request|0|||
156786231|NCT00853047|565968312|FG005|Open-Label Extension Phase|Participant Request|7|||
156786232|NCT00853047|565968307|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156786233|NCT00853047|565968308|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156786234|NCT00853047|565968309|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156786235|NCT00853047|565968310|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
156786236|NCT00853047|565968311|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
156786237|NCT00853047|565968312|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
156786238|NCT00853047|565968307|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786239|NCT00853047|565968308|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786240|NCT00853047|565968309|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786241|NCT00853047|565968310|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786242|NCT00853047|565968311|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
156786243|NCT00853047|565968312|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
156786244|NCT00853047|565968307|FG000|Open-Label Extension Phase|Investigator Decision|0|||
156786245|NCT00853047|565968308|FG001|Open-Label Extension Phase|Investigator Decision|0|||
156786246|NCT00853047|565968309|FG002|Open-Label Extension Phase|Investigator Decision|0|||
156786247|NCT00853047|565968310|FG003|Open-Label Extension Phase|Investigator Decision|0|||
156786248|NCT00853047|565968311|FG004|Open-Label Extension Phase|Investigator Decision|0|||
156786249|NCT00853047|565968312|FG005|Open-Label Extension Phase|Investigator Decision|1|||
156786250|NCT00853047|565968307|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
156786251|NCT00853047|565968308|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
156786252|NCT00853047|565968309|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
156786253|NCT00853047|565968310|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
156786254|NCT00853047|565968311|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
156786255|NCT00853047|565968312|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
156786256|NCT02638493|565968313|FG000|Overall Study|Inability to provide semen samples|2|||
156786257|NCT02638493|565968314|FG001|Overall Study|Inability to provide semen samples|0|||
156786258|NCT02638493|565968315|FG002|Overall Study|Inability to provide semen samples|0|||
156786259|NCT01567085|565970313|FG000|Overall Study|Death|6|||
156786260|NCT01567085|565970313|FG000|Overall Study|Adverse Event|6|||
156786261|NCT01567085|565970313|FG000|Overall Study|Lost to Follow-up|3|||
156786262|NCT01567085|565970313|FG000|Overall Study|Graft loss|2|||
156786263|NCT01567085|565970313|FG000|Overall Study|Renal transplantectomy|1|||
156786264|NCT01567085|565970313|FG000|Overall Study|Returned to chronic dialysis|1|||
156786265|NCT01567085|565970313|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
156786266|NCT03537729|565970324|FG000|Overall Study|Death|2|||
156786267|NCT03537729|565970325|FG001|Overall Study|Death|2|||
156786268|NCT03537729|565970326|FG002|Overall Study|Death|7|||
156786269|NCT03537729|565970324|FG000|Overall Study|Withdrawal by Subject|3|||
156786270|NCT03537729|565970325|FG001|Overall Study|Withdrawal by Subject|3|||
156786271|NCT03537729|565970326|FG002|Overall Study|Withdrawal by Subject|0|||
156786272|NCT03537729|565970324|FG000|Overall Study|Subject Moved|8|||
156786273|NCT03537729|565970325|FG001|Overall Study|Subject Moved|5|||
156786274|NCT03537729|565970326|FG002|Overall Study|Subject Moved|4|||
156786275|NCT03537729|565970324|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
156786276|NCT03537729|565970325|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
156786277|NCT03537729|565970326|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
156786278|NCT03537729|565970324|FG000|Overall Study|COVID-19 Site Restrictions|11|||
156786279|NCT03537729|565970325|FG001|Overall Study|COVID-19 Site Restrictions|15|||
156786280|NCT03537729|565970326|FG002|Overall Study|COVID-19 Site Restrictions|18|||
156786281|NCT03537729|565970324|FG000|Overall Study|Decline in Health|5|||
156786282|NCT03537729|565970325|FG001|Overall Study|Decline in Health|9|||
156786283|NCT03537729|565970326|FG002|Overall Study|Decline in Health|4|||
156786284|NCT03537729|565970324|FG000|Overall Study|Determined Ineligible|0|||
156786285|NCT03537729|565970325|FG001|Overall Study|Determined Ineligible|0|||
156786286|NCT03537729|565970326|FG002|Overall Study|Determined Ineligible|1|||
157214197|NCT00265083|567531815|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
156686347|NCT01345318|565596368|FG000|Overall Study|Lost to Follow-up|2|||
156686348|NCT01345318|565596368|FG000|Overall Study|Protocol Violation|1|||
156686349|NCT01345318|565596368|FG000|Overall Study|Withdrawal by Subject|41|||
156686350|NCT01345318|565596368|FG000|Overall Study|Other|3|||
156686351|NCT01685073|565596369|FG000|Overall Study|Lost to Follow-up|6|||
156686352|NCT01685073|565596370|FG001|Overall Study|Lost to Follow-up|8|||
156686353|NCT01685073|565596369|FG000|Overall Study|Withdrawal by Subject|24|||
156686354|NCT01685073|565596370|FG001|Overall Study|Withdrawal by Subject|24|||
156686355|NCT01239472|565596371|FG000|Overall Study|Withdrawal by Subject|5|||
156686356|NCT01239472|565596372|FG001|Overall Study|Withdrawal by Subject|1|||
156686357|NCT01239472|565596371|FG000|Overall Study|Adverse Event|0|||
156686358|NCT01239472|565596372|FG001|Overall Study|Adverse Event|1|||
156686359|NCT01239472|565596371|FG000|Overall Study|Lack of Efficacy|0|||
156686360|NCT01239472|565596372|FG001|Overall Study|Lack of Efficacy|1|||
156686361|NCT00418522|565596376|FG000|Overall Study|Adverse Event|7|||
156686362|NCT00418522|565596377|FG001|Overall Study|Adverse Event|1|||
156686363|NCT00418522|565596376|FG000|Overall Study|Lack of Efficacy|1|||
156686364|NCT00418522|565596377|FG001|Overall Study|Lack of Efficacy|3|||
156686365|NCT00418522|565596376|FG000|Overall Study|Lost to Follow-up|10|||
156686366|NCT00418522|565596377|FG001|Overall Study|Lost to Follow-up|4|||
156686367|NCT00418522|565596376|FG000|Overall Study|Withdrawal by Subject|31|||
156686368|NCT00418522|565596377|FG001|Overall Study|Withdrawal by Subject|7|||
156686369|NCT00418522|565596376|FG000|Overall Study|Other|27|||
156686370|NCT00418522|565596377|FG001|Overall Study|Other|23|||
156686371|NCT00418522|565596376|FG000|Overall Study|Randomized but did not receive treatment|7|||
156686372|NCT00418522|565596377|FG001|Overall Study|Randomized but did not receive treatment|4|||
156686373|NCT01005329|565596378|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
156786287|NCT00284934|565970331|FG000|Overall Study|Adverse Event|1|||
156786288|NCT00284934|565970332|FG001|Overall Study|Adverse Event|2|||
156786289|NCT00284934|565970331|FG000|Overall Study|Other reasons|3|||
156786290|NCT00284934|565970332|FG001|Overall Study|Other reasons|1|||
156786291|NCT01560988|565970333|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
156786292|NCT01560988|565970334|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
156786293|NCT01560988|565970333|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
156786294|NCT01560988|565970334|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
156786295|NCT01560988|565970333|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
156786296|NCT01560988|565970334|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
156786297|NCT01160744|565970335|FG000|Overall Study|Withdrawal by Subject|11|||
156786298|NCT01160744|565970336|FG001|Overall Study|Withdrawal by Subject|5|||
156786299|NCT01160744|565970337|FG002|Overall Study|Withdrawal by Subject|6|||
156786300|NCT01160744|565970338|FG003|Overall Study|Withdrawal by Subject|4|||
156786301|NCT01160744|565970335|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786302|NCT01160744|565970336|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786303|NCT01160744|565970337|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
156786304|NCT01160744|565970338|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
156786305|NCT02301429|565970343|FG000|Overall Study|not acceptable vascular anatomy|3|||
156786306|NCT00500110|565970344|FG000|Overall Study|Withdrawal by Subject|3|||
156786307|NCT01502072|565970345|FG000|Overall Study|Withdrawal by Subject|1|||
156786308|NCT01502072|565970346|FG001|Overall Study|Withdrawal by Subject|0|||
156786309|NCT01502072|565970347|FG002|Overall Study|Withdrawal by Subject|0|||
156786310|NCT01502072|565970345|FG000|Overall Study|Death|0|||
156786311|NCT01502072|565970346|FG001|Overall Study|Death|1|||
156786312|NCT01502072|565970347|FG002|Overall Study|Death|0|||
156786313|NCT04821245|565970348|FG000|Overall Study|Withdrawal by Subject|3|||
156786314|NCT04821245|565970348|FG000|Overall Study|Physician Decision|1|||
156786315|NCT04821245|565970348|FG000|Overall Study|Protocol Violation|5|||
156786316|NCT00605657|565970349|FG000|Overall Study|Adverse Event|1|||
156786317|NCT00605657|565970349|FG000|Overall Study|Protocol Violation|1|||
156786318|NCT00397046|565970357|FG000|Overall Study|Disease Progression|3|||
156786319|NCT00397046|565970358|FG001|Overall Study|Disease Progression|3|||
156786320|NCT00397046|565970359|FG002|Overall Study|Disease Progression|10|||
156786321|NCT00397046|565970360|FG003|Overall Study|Disease Progression|5|||
156786322|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
156786323|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
156786324|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
156786325|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
156786326|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156786327|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
156786328|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
156686374|NCT00573170|565596381|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
156686375|NCT00573170|565596382|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
156686376|NCT00573170|565596383|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
156686377|NCT00573170|565596384|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
156686378|NCT00573170|565596385|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
156869154|NCT03219528|566279005|FG001|Overall Study|Lost to Follow-up|4|||
156869155|NCT03219528|566279004|FG000|Overall Study|Withdrawal by Subject|4|||
156869156|NCT03219528|566279005|FG001|Overall Study|Withdrawal by Subject|4|||
156869157|NCT00790842|566279006|FG000|Dose Level 1|Adverse Event|1|||
156869158|NCT00790842|566279007|FG001|Dose Level 1|Adverse Event|0|||
156869159|NCT00790842|566279008|FG002|Dose Level 1|Adverse Event|0|||
156869160|NCT00790842|566279009|FG003|Dose Level 1|Adverse Event|2|||
156869161|NCT00790842|566279010|FG004|Dose Level 1|Adverse Event|0|||
156869162|NCT00790842|566279011|FG005|Dose Level 1|Adverse Event|0|||
156869163|NCT00790842|566279012|FG006|Dose Level 1|Adverse Event|0|||
156869164|NCT00790842|566279013|FG007|Dose Level 1|Adverse Event|1|||
156869165|NCT00790842|566279014|FG008|Dose Level 1|Adverse Event|0|||
156869166|NCT00790842|566279015|FG009|Dose Level 1|Adverse Event|0|||
156869167|NCT00790842|566279016|FG010|Dose Level 1|Adverse Event|0|||
156869168|NCT00790842|566279006|FG000|Dose Level 1|Physician Decision|1|||
156869169|NCT00790842|566279007|FG001|Dose Level 1|Physician Decision|0|||
156869170|NCT00790842|566279008|FG002|Dose Level 1|Physician Decision|0|||
156869171|NCT00790842|566279009|FG003|Dose Level 1|Physician Decision|0|||
156869172|NCT00790842|566279010|FG004|Dose Level 1|Physician Decision|0|||
156869173|NCT00790842|566279011|FG005|Dose Level 1|Physician Decision|0|||
156869174|NCT00790842|566279012|FG006|Dose Level 1|Physician Decision|0|||
156869175|NCT00790842|566279013|FG007|Dose Level 1|Physician Decision|1|||
156869176|NCT00790842|566279014|FG008|Dose Level 1|Physician Decision|0|||
156869177|NCT00790842|566279015|FG009|Dose Level 1|Physician Decision|0|||
156869178|NCT00790842|566279016|FG010|Dose Level 1|Physician Decision|0|||
156869179|NCT00790842|566279006|FG000|Dose Level 1|Withdrawal by Subject|1|||
156869180|NCT00790842|566279007|FG001|Dose Level 1|Withdrawal by Subject|0|||
156869181|NCT00790842|566279008|FG002|Dose Level 1|Withdrawal by Subject|0|||
156869182|NCT00790842|566279009|FG003|Dose Level 1|Withdrawal by Subject|0|||
156869183|NCT00790842|566279010|FG004|Dose Level 1|Withdrawal by Subject|0|||
156869184|NCT00790842|566279011|FG005|Dose Level 1|Withdrawal by Subject|0|||
157013454|NCT02723955|566801761|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
157013455|NCT02723955|566801762|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
157013456|NCT02723955|566801763|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
157214198|NCT00265083|567531816|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
157214199|NCT00265083|567531817|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
157214200|NCT00265083|567531815|FG000|Overall Study|Other|1|||
157214201|NCT00265083|567531816|FG001|Overall Study|Other|12|||
157214202|NCT00265083|567531817|FG002|Overall Study|Other|9|||
157214203|NCT03208933|567531818|FG000|Overall Study|Death|3|||
157214204|NCT03208933|567531818|FG000|Overall Study|Withdrawal by Subject|3|||
157214205|NCT03208933|567531818|FG000|Overall Study|Adverse Event|1|||
157214206|NCT03208933|567531818|FG000|Overall Study|Lost to Follow-up|2|||
156686379|NCT00573170|565596386|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
156686380|NCT00573170|565596381|FG000|First Washout Period|Adverse Event|1|||
156686381|NCT00573170|565596382|FG001|First Washout Period|Adverse Event|1|||
156686382|NCT00573170|565596383|FG002|First Washout Period|Adverse Event|0|||
156686383|NCT00573170|565596384|FG003|First Washout Period|Adverse Event|0|||
156686384|NCT00573170|565596385|FG004|First Washout Period|Adverse Event|0|||
156686385|NCT00573170|565596386|FG005|First Washout Period|Adverse Event|1|||
156686386|NCT00573170|565596381|FG000|First Washout Period|Lack of Efficacy|0|||
156686387|NCT00573170|565596382|FG001|First Washout Period|Lack of Efficacy|0|||
156686388|NCT00573170|565596383|FG002|First Washout Period|Lack of Efficacy|0|||
156686389|NCT00573170|565596384|FG003|First Washout Period|Lack of Efficacy|0|||
156686390|NCT00573170|565596385|FG004|First Washout Period|Lack of Efficacy|0|||
156686391|NCT00573170|565596386|FG005|First Washout Period|Lack of Efficacy|1|||
156686392|NCT00573170|565596381|FG000|First Washout Period|Lost to Follow-up|1|||
156786329|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786330|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786331|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
156786332|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
156786333|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
156786334|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Other|6|||
156786335|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Other|3|||
156786336|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Other|0|||
156786337|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
156786338|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156786339|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
156786340|NCT03636269|565970361|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
156869185|NCT00790842|566279012|FG006|Dose Level 1|Withdrawal by Subject|0|||
156869186|NCT00790842|566279013|FG007|Dose Level 1|Withdrawal by Subject|0|||
156869187|NCT00790842|566279014|FG008|Dose Level 1|Withdrawal by Subject|0|||
157214207|NCT03208933|567531818|FG000|Overall Study|Physician Decision|3|||
156686393|NCT00573170|565596382|FG001|First Washout Period|Lost to Follow-up|1|||
156686394|NCT00573170|565596383|FG002|First Washout Period|Lost to Follow-up|0|||
156686395|NCT00573170|565596384|FG003|First Washout Period|Lost to Follow-up|2|||
156869188|NCT00790842|566279015|FG009|Dose Level 1|Withdrawal by Subject|0|||
156869189|NCT00790842|566279016|FG010|Dose Level 1|Withdrawal by Subject|0|||
156869190|NCT00790842|566279006|FG000|Dose Level 2|Death|0|||
156869191|NCT00790842|566279007|FG001|Dose Level 2|Death|1|||
156869192|NCT00790842|566279008|FG002|Dose Level 2|Death|0|||
156869193|NCT00790842|566279009|FG003|Dose Level 2|Death|0|||
156869194|NCT00790842|566279010|FG004|Dose Level 2|Death|1|||
156869195|NCT00790842|566279011|FG005|Dose Level 2|Death|0|||
156869196|NCT00790842|566279012|FG006|Dose Level 2|Death|0|||
156869197|NCT00790842|566279013|FG007|Dose Level 2|Death|0|||
156869198|NCT00790842|566279014|FG008|Dose Level 2|Death|0|||
156869199|NCT00790842|566279015|FG009|Dose Level 2|Death|0|||
156869200|NCT00790842|566279016|FG010|Dose Level 2|Death|0|||
156869201|NCT00790842|566279006|FG000|Dose Level 2|Physician Decision|0|||
156869202|NCT00790842|566279007|FG001|Dose Level 2|Physician Decision|1|||
156869203|NCT00790842|566279008|FG002|Dose Level 2|Physician Decision|0|||
156869204|NCT00790842|566279009|FG003|Dose Level 2|Physician Decision|0|||
156869205|NCT00790842|566279010|FG004|Dose Level 2|Physician Decision|0|||
156869206|NCT00790842|566279011|FG005|Dose Level 2|Physician Decision|0|||
156869207|NCT00790842|566279012|FG006|Dose Level 2|Physician Decision|0|||
156869208|NCT00790842|566279013|FG007|Dose Level 2|Physician Decision|0|||
156869209|NCT00790842|566279014|FG008|Dose Level 2|Physician Decision|0|||
156869210|NCT00790842|566279015|FG009|Dose Level 2|Physician Decision|0|||
156869211|NCT00790842|566279016|FG010|Dose Level 2|Physician Decision|0|||
156869212|NCT00790842|566279006|FG000|Dose Level 2|Withdrawal by Subject|0|||
156869213|NCT00790842|566279007|FG001|Dose Level 2|Withdrawal by Subject|1|||
156869214|NCT00790842|566279008|FG002|Dose Level 2|Withdrawal by Subject|0|||
156869215|NCT00790842|566279009|FG003|Dose Level 2|Withdrawal by Subject|0|||
156869216|NCT00790842|566279010|FG004|Dose Level 2|Withdrawal by Subject|0|||
156869217|NCT00790842|566279011|FG005|Dose Level 2|Withdrawal by Subject|0|||
156869218|NCT00790842|566279012|FG006|Dose Level 2|Withdrawal by Subject|0|||
156869219|NCT00790842|566279013|FG007|Dose Level 2|Withdrawal by Subject|0|||
156869220|NCT00790842|566279014|FG008|Dose Level 2|Withdrawal by Subject|0|||
156869221|NCT00790842|566279015|FG009|Dose Level 2|Withdrawal by Subject|0|||
156686396|NCT00573170|565596385|FG004|First Washout Period|Lost to Follow-up|0|||
156686397|NCT00573170|565596386|FG005|First Washout Period|Lost to Follow-up|2|||
156686398|NCT00573170|565596381|FG000|First Washout Period|Withdrawal by Subject|2|||
156686399|NCT00573170|565596382|FG001|First Washout Period|Withdrawal by Subject|0|||
156686400|NCT00573170|565596383|FG002|First Washout Period|Withdrawal by Subject|0|||
156686401|NCT00573170|565596384|FG003|First Washout Period|Withdrawal by Subject|2|||
156686402|NCT00573170|565596385|FG004|First Washout Period|Withdrawal by Subject|3|||
156686403|NCT00573170|565596386|FG005|First Washout Period|Withdrawal by Subject|3|||
156686404|NCT00573170|565596381|FG000|First Washout Period|Other|4|||
156686405|NCT00573170|565596382|FG001|First Washout Period|Other|0|||
156686406|NCT00573170|565596383|FG002|First Washout Period|Other|1|||
156686407|NCT00573170|565596384|FG003|First Washout Period|Other|1|||
156686408|NCT00573170|565596385|FG004|First Washout Period|Other|0|||
156686409|NCT00573170|565596386|FG005|First Washout Period|Other|0|||
156686410|NCT00573170|565596381|FG000|Second Washout Period|Adverse Event|1|||
156686411|NCT00573170|565596382|FG001|Second Washout Period|Adverse Event|0|||
156686412|NCT00573170|565596383|FG002|Second Washout Period|Adverse Event|0|||
156686413|NCT00573170|565596384|FG003|Second Washout Period|Adverse Event|0|||
156686414|NCT00573170|565596385|FG004|Second Washout Period|Adverse Event|1|||
156686415|NCT00573170|565596386|FG005|Second Washout Period|Adverse Event|0|||
156686416|NCT00573170|565596381|FG000|Second Washout Period|Protocol Violation|2|||
156686417|NCT00573170|565596382|FG001|Second Washout Period|Protocol Violation|1|||
156686418|NCT00573170|565596383|FG002|Second Washout Period|Protocol Violation|1|||
156686419|NCT00573170|565596384|FG003|Second Washout Period|Protocol Violation|0|||
156686420|NCT00573170|565596385|FG004|Second Washout Period|Protocol Violation|0|||
156869222|NCT00790842|566279016|FG010|Dose Level 2|Withdrawal by Subject|0|||
156869223|NCT00790842|566279006|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869224|NCT00790842|566279007|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869225|NCT00790842|566279008|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869226|NCT00790842|566279009|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869227|NCT00790842|566279010|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869228|NCT00790842|566279011|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869229|NCT00790842|566279012|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869230|NCT00790842|566279013|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156686421|NCT00573170|565596386|FG005|Second Washout Period|Protocol Violation|0|||
156686422|NCT00573170|565596381|FG000|Second Washout Period|Withdrawal by Subject|1|||
156869231|NCT00790842|566279014|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
157121491|NCT05103332|567195981|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156686423|NCT00573170|565596382|FG001|Second Washout Period|Withdrawal by Subject|1|||
156686424|NCT00573170|565596383|FG002|Second Washout Period|Withdrawal by Subject|2|||
156686425|NCT00573170|565596384|FG003|Second Washout Period|Withdrawal by Subject|0|||
156869232|NCT00790842|566279015|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
157214208|NCT03208933|567531818|FG000|Overall Study|Protocol Violation|1|||
156786341|NCT03636269|565970362|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
156786342|NCT03636269|565970363|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
156786343|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Adverse Event|0|||
156786344|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Adverse Event|0|||
156786345|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Adverse Event|21|||
156786346|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
156786347|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
157013457|NCT02723955|566801764|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
157013458|NCT02723955|566801765|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
156786348|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
156786349|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786350|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
156786351|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
156786352|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
156786353|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
156786354|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
156786355|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Administrative|0|||
156786356|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Administrative|0|||
156786357|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Administrative|36|||
156786358|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Other|0|||
156786359|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Other|0|||
156786360|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Other|9|||
156786361|NCT03636269|565970361|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
156786362|NCT03636269|565970362|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
156786363|NCT03636269|565970363|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
156786364|NCT01975285|565970376|FG000|Overall Study|Failed Block and follow up|2|||
156786365|NCT01975285|565970377|FG001|Overall Study|Failed Block and follow up|2|||
156786366|NCT00604383|565970380|FG000|Overall Study|Withdrawal by Subject|33|||
156786367|NCT00604383|565970381|FG001|Overall Study|Withdrawal by Subject|31|||
156786368|NCT00604383|565970380|FG000|Overall Study|Lost to Follow-up|24|||
156786369|NCT00604383|565970381|FG001|Overall Study|Lost to Follow-up|19|||
156786370|NCT00604383|565970380|FG000|Overall Study|Death|14|||
156786371|NCT00604383|565970381|FG001|Overall Study|Death|22|||
156786372|NCT00604383|565970380|FG000|Overall Study|Adverse Event|16|||
156786373|NCT00604383|565970381|FG001|Overall Study|Adverse Event|9|||
156786374|NCT00604383|565970380|FG000|Overall Study|Physician Decision|0|||
156786375|NCT00604383|565970381|FG001|Overall Study|Physician Decision|3|||
156786376|NCT01698008|565970382|FG000|Overall Study|Withdrawal by Subject|1|||
156786377|NCT01698008|565970383|FG001|Overall Study|Withdrawal by Subject|2|||
156786378|NCT02619812|565970390|FG000|Overall Study|Withdrawal by Subject|0|||
156786379|NCT02619812|565970391|FG001|Overall Study|Withdrawal by Subject|0|||
156786380|NCT02619812|565970392|FG002|Overall Study|Withdrawal by Subject|1|||
156786381|NCT02619812|565970393|FG003|Overall Study|Withdrawal by Subject|2|||
156786382|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
156786383|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
156786384|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
156786385|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
156786386|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
156786387|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786388|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786389|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
156786390|NCT04098302|565970396|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
156786391|NCT04098302|565970397|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
156786392|NCT04098302|565970398|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
156786393|NCT04098302|565970399|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
156786394|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
156786395|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
156786396|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
156786397|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
156786398|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
156786399|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
156786400|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
156786401|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
156786402|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786403|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786404|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
156786405|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
156786406|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
156786407|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
157013459|NCT02723955|566801766|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
156869233|NCT00790842|566279016|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
156869234|NCT00790842|566279006|FG000|Dose Level 3|Adverse Event|0|||
156869235|NCT00790842|566279007|FG001|Dose Level 3|Adverse Event|0|||
156869236|NCT00790842|566279008|FG002|Dose Level 3|Adverse Event|1|||
156869237|NCT00790842|566279009|FG003|Dose Level 3|Adverse Event|0|||
156869238|NCT00790842|566279010|FG004|Dose Level 3|Adverse Event|0|||
156869239|NCT00790842|566279011|FG005|Dose Level 3|Adverse Event|0|||
156869240|NCT00790842|566279012|FG006|Dose Level 3|Adverse Event|0|||
156869241|NCT00790842|566279013|FG007|Dose Level 3|Adverse Event|0|||
156869242|NCT00790842|566279014|FG008|Dose Level 3|Adverse Event|0|||
156869243|NCT00790842|566279015|FG009|Dose Level 3|Adverse Event|0|||
156869244|NCT00790842|566279016|FG010|Dose Level 3|Adverse Event|0|||
156869245|NCT00790842|566279006|FG000|Dose Level 3|Withdrawal by Subject|0|||
156869246|NCT00790842|566279007|FG001|Dose Level 3|Withdrawal by Subject|0|||
156869247|NCT00790842|566279008|FG002|Dose Level 3|Withdrawal by Subject|3|||
156869248|NCT00790842|566279009|FG003|Dose Level 3|Withdrawal by Subject|0|||
156869249|NCT00790842|566279010|FG004|Dose Level 3|Withdrawal by Subject|0|||
156869250|NCT00790842|566279011|FG005|Dose Level 3|Withdrawal by Subject|0|||
156869251|NCT00790842|566279012|FG006|Dose Level 3|Withdrawal by Subject|0|||
156869252|NCT00790842|566279013|FG007|Dose Level 3|Withdrawal by Subject|0|||
156869253|NCT00790842|566279014|FG008|Dose Level 3|Withdrawal by Subject|0|||
156869254|NCT00790842|566279015|FG009|Dose Level 3|Withdrawal by Subject|2|||
156869255|NCT00790842|566279016|FG010|Dose Level 3|Withdrawal by Subject|0|||
156869256|NCT00790842|566279006|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869257|NCT00790842|566279007|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869258|NCT00790842|566279008|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869259|NCT00790842|566279009|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869260|NCT00790842|566279010|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869261|NCT00790842|566279011|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
156869262|NCT00790842|566279012|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869263|NCT00790842|566279013|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869264|NCT00790842|566279014|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869265|NCT00790842|566279015|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869266|NCT00790842|566279016|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
156869267|NCT00790842|566279006|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869268|NCT00790842|566279007|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156686426|NCT00573170|565596385|FG004|Second Washout Period|Withdrawal by Subject|1|||
156686427|NCT00573170|565596386|FG005|Second Washout Period|Withdrawal by Subject|0|||
156686428|NCT00573170|565596381|FG000|Second Washout Period|Lost to Follow-up|0|||
156686429|NCT00573170|565596382|FG001|Second Washout Period|Lost to Follow-up|0|||
156686430|NCT00573170|565596383|FG002|Second Washout Period|Lost to Follow-up|0|||
156686431|NCT00573170|565596384|FG003|Second Washout Period|Lost to Follow-up|1|||
156686432|NCT00573170|565596385|FG004|Second Washout Period|Lost to Follow-up|0|||
156686433|NCT00573170|565596386|FG005|Second Washout Period|Lost to Follow-up|0|||
156686434|NCT00573170|565596381|FG000|Second Washout Period|Other|1|||
156686435|NCT00573170|565596382|FG001|Second Washout Period|Other|2|||
156686436|NCT00573170|565596383|FG002|Second Washout Period|Other|1|||
156686437|NCT00573170|565596384|FG003|Second Washout Period|Other|4|||
156686438|NCT00573170|565596385|FG004|Second Washout Period|Other|6|||
156686439|NCT00573170|565596386|FG005|Second Washout Period|Other|2|||
156686440|NCT00573170|565596381|FG000|Third Treatment Period|Withdrawal by Subject|1|||
156686441|NCT00573170|565596382|FG001|Third Treatment Period|Withdrawal by Subject|0|||
156686442|NCT00573170|565596383|FG002|Third Treatment Period|Withdrawal by Subject|0|||
156686443|NCT00573170|565596384|FG003|Third Treatment Period|Withdrawal by Subject|0|||
156686444|NCT00573170|565596385|FG004|Third Treatment Period|Withdrawal by Subject|0|||
156686445|NCT00573170|565596386|FG005|Third Treatment Period|Withdrawal by Subject|0|||
156686446|NCT00573170|565596381|FG000|Third Treatment Period|Lost to Follow-up|0|||
156686447|NCT00573170|565596382|FG001|Third Treatment Period|Lost to Follow-up|0|||
156686448|NCT00573170|565596383|FG002|Third Treatment Period|Lost to Follow-up|0|||
156686449|NCT00573170|565596384|FG003|Third Treatment Period|Lost to Follow-up|0|||
156686450|NCT00573170|565596385|FG004|Third Treatment Period|Lost to Follow-up|0|||
156686451|NCT00573170|565596386|FG005|Third Treatment Period|Lost to Follow-up|2|||
156686452|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
156686453|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
156686454|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156686455|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156686456|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
156869269|NCT00790842|566279008|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
156869270|NCT00790842|566279009|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869271|NCT00790842|566279010|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869272|NCT00790842|566279011|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
157013460|NCT02723955|566801767|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
157013461|NCT02723955|566801768|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
156869273|NCT00790842|566279012|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869274|NCT00790842|566279013|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869275|NCT00790842|566279014|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869276|NCT00790842|566279015|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869277|NCT00790842|566279016|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
156869278|NCT00790842|566279006|FG000|Dose Level 4|Adverse Event|0|||
156869279|NCT00790842|566279007|FG001|Dose Level 4|Adverse Event|0|||
156869280|NCT00790842|566279008|FG002|Dose Level 4|Adverse Event|0|||
156869281|NCT00790842|566279009|FG003|Dose Level 4|Adverse Event|0|||
156869282|NCT00790842|566279010|FG004|Dose Level 4|Adverse Event|0|||
156869283|NCT00790842|566279011|FG005|Dose Level 4|Adverse Event|0|||
156869284|NCT00790842|566279012|FG006|Dose Level 4|Adverse Event|1|||
156869285|NCT00790842|566279013|FG007|Dose Level 4|Adverse Event|0|||
156869286|NCT00790842|566279014|FG008|Dose Level 4|Adverse Event|0|||
156869287|NCT00790842|566279015|FG009|Dose Level 4|Adverse Event|0|||
156869288|NCT00790842|566279016|FG010|Dose Level 4|Adverse Event|0|||
156869289|NCT00790842|566279006|FG000|Dose Level 4|Physician Decision|0|||
156869290|NCT00790842|566279007|FG001|Dose Level 4|Physician Decision|0|||
156869291|NCT00790842|566279008|FG002|Dose Level 4|Physician Decision|0|||
156869292|NCT00790842|566279009|FG003|Dose Level 4|Physician Decision|0|||
156869293|NCT00790842|566279010|FG004|Dose Level 4|Physician Decision|0|||
156869294|NCT00790842|566279011|FG005|Dose Level 4|Physician Decision|0|||
156869295|NCT00790842|566279012|FG006|Dose Level 4|Physician Decision|1|||
156869296|NCT00790842|566279013|FG007|Dose Level 4|Physician Decision|0|||
156869297|NCT00790842|566279014|FG008|Dose Level 4|Physician Decision|0|||
156869298|NCT00790842|566279015|FG009|Dose Level 4|Physician Decision|0|||
156869299|NCT00790842|566279016|FG010|Dose Level 4|Physician Decision|1|||
156869300|NCT00790842|566279006|FG000|Dose Level 4|Withdrawal by Subject|0|||
156869301|NCT00790842|566279007|FG001|Dose Level 4|Withdrawal by Subject|0|||
156869302|NCT00790842|566279008|FG002|Dose Level 4|Withdrawal by Subject|0|||
156869303|NCT00790842|566279009|FG003|Dose Level 4|Withdrawal by Subject|0|||
156869304|NCT00790842|566279010|FG004|Dose Level 4|Withdrawal by Subject|0|||
156869305|NCT00790842|566279011|FG005|Dose Level 4|Withdrawal by Subject|0|||
156869306|NCT00790842|566279012|FG006|Dose Level 4|Withdrawal by Subject|0|||
156869307|NCT00790842|566279013|FG007|Dose Level 4|Withdrawal by Subject|0|||
156869308|NCT00790842|566279014|FG008|Dose Level 4|Withdrawal by Subject|0|||
156869309|NCT00790842|566279015|FG009|Dose Level 4|Withdrawal by Subject|0|||
156869310|NCT00790842|566279016|FG010|Dose Level 4|Withdrawal by Subject|1|||
156869311|NCT00790842|566279006|FG000|Expansion Cohort|Adverse Event|0|||
156869312|NCT00790842|566279007|FG001|Expansion Cohort|Adverse Event|0|||
156869313|NCT00790842|566279008|FG002|Expansion Cohort|Adverse Event|0|||
156869314|NCT00790842|566279009|FG003|Expansion Cohort|Adverse Event|0|||
156869315|NCT00790842|566279010|FG004|Expansion Cohort|Adverse Event|0|||
156869316|NCT00790842|566279011|FG005|Expansion Cohort|Adverse Event|0|||
156869317|NCT00790842|566279012|FG006|Expansion Cohort|Adverse Event|1|||
156869318|NCT00790842|566279013|FG007|Expansion Cohort|Adverse Event|0|||
156869319|NCT00790842|566279014|FG008|Expansion Cohort|Adverse Event|0|||
156869320|NCT00790842|566279015|FG009|Expansion Cohort|Adverse Event|0|||
156869321|NCT00790842|566279016|FG010|Expansion Cohort|Adverse Event|0|||
156869322|NCT00790842|566279006|FG000|Expansion Cohort|Death|0|||
156869323|NCT00790842|566279007|FG001|Expansion Cohort|Death|0|||
156869324|NCT00790842|566279008|FG002|Expansion Cohort|Death|2|||
156869325|NCT00790842|566279009|FG003|Expansion Cohort|Death|0|||
156869326|NCT00790842|566279010|FG004|Expansion Cohort|Death|0|||
156869327|NCT00790842|566279011|FG005|Expansion Cohort|Death|0|||
156869328|NCT00790842|566279012|FG006|Expansion Cohort|Death|0|||
156869329|NCT00790842|566279013|FG007|Expansion Cohort|Death|0|||
156869330|NCT00790842|566279014|FG008|Expansion Cohort|Death|0|||
156869331|NCT00790842|566279015|FG009|Expansion Cohort|Death|0|||
157013462|NCT02723955|566801769|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
156869332|NCT00790842|566279016|FG010|Expansion Cohort|Death|0|||
156869333|NCT00790842|566279006|FG000|Expansion Cohort|Physician Decision|0|||
156869334|NCT00790842|566279007|FG001|Expansion Cohort|Physician Decision|0|||
156869335|NCT00790842|566279008|FG002|Expansion Cohort|Physician Decision|1|||
156869336|NCT00790842|566279009|FG003|Expansion Cohort|Physician Decision|0|||
156869337|NCT00790842|566279010|FG004|Expansion Cohort|Physician Decision|0|||
156869338|NCT00790842|566279011|FG005|Expansion Cohort|Physician Decision|0|||
156869339|NCT00790842|566279012|FG006|Expansion Cohort|Physician Decision|0|||
157013463|NCT02723955|566801770|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
156869340|NCT00790842|566279013|FG007|Expansion Cohort|Physician Decision|0|||
156869341|NCT00790842|566279014|FG008|Expansion Cohort|Physician Decision|0|||
156869342|NCT00790842|566279015|FG009|Expansion Cohort|Physician Decision|0|||
156869343|NCT00790842|566279016|FG010|Expansion Cohort|Physician Decision|0|||
156869344|NCT00790842|566279006|FG000|Expansion Cohort|Withdrawal by Subject|0|||
156869345|NCT00790842|566279007|FG001|Expansion Cohort|Withdrawal by Subject|0|||
156869346|NCT00790842|566279008|FG002|Expansion Cohort|Withdrawal by Subject|3|||
156869347|NCT00790842|566279009|FG003|Expansion Cohort|Withdrawal by Subject|0|||
156869348|NCT00790842|566279010|FG004|Expansion Cohort|Withdrawal by Subject|0|||
156869349|NCT00790842|566279011|FG005|Expansion Cohort|Withdrawal by Subject|0|||
156786408|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
156786409|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
156786410|NCT04098302|565970396|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786411|NCT04098302|565970397|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786412|NCT04098302|565970398|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
156786413|NCT04098302|565970399|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
156786414|NCT05061706|565970400|FG000|Overall Study|Adverse Event|29|||
156786415|NCT05061706|565970401|FG001|Overall Study|Adverse Event|1|||
156786416|NCT05061706|565970400|FG000|Overall Study|Lack of Efficacy|0|||
156786417|NCT05061706|565970401|FG001|Overall Study|Lack of Efficacy|1|||
156786418|NCT05061706|565970400|FG000|Overall Study|Lost to Follow-up|2|||
156786419|NCT05061706|565970401|FG001|Overall Study|Lost to Follow-up|2|||
156786420|NCT05061706|565970400|FG000|Overall Study|Protocol Violation|3|||
156786421|NCT05061706|565970401|FG001|Overall Study|Protocol Violation|1|||
156786422|NCT05061706|565970400|FG000|Overall Study|Withdrawal by Subject|3|||
156786423|NCT05061706|565970401|FG001|Overall Study|Withdrawal by Subject|9|||
156786424|NCT00601107|565970402|FG000|Overall Study|Adverse Event|0|||
156786425|NCT00601107|565970403|FG001|Overall Study|Adverse Event|1|||
156786426|NCT00601107|565970404|FG002|Overall Study|Adverse Event|3|||
156786427|NCT00601107|565970405|FG003|Overall Study|Adverse Event|0|||
156786428|NCT00601107|565970402|FG000|Overall Study|Withdrawal by Subject|5|||
156786429|NCT00601107|565970403|FG001|Overall Study|Withdrawal by Subject|4|||
156786430|NCT00601107|565970404|FG002|Overall Study|Withdrawal by Subject|7|||
156786431|NCT00601107|565970405|FG003|Overall Study|Withdrawal by Subject|4|||
156786432|NCT00601107|565970402|FG000|Overall Study|Lost to Follow-up|3|||
156786433|NCT00601107|565970403|FG001|Overall Study|Lost to Follow-up|3|||
156786434|NCT00601107|565970404|FG002|Overall Study|Lost to Follow-up|0|||
156786435|NCT00601107|565970405|FG003|Overall Study|Lost to Follow-up|3|||
156786436|NCT00601107|565970402|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786437|NCT00601107|565970403|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786438|NCT00601107|565970404|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
156786439|NCT00601107|565970405|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
156786440|NCT00601107|565970402|FG000|Overall Study|Worsening of Psoriasis|4|||
156786441|NCT00601107|565970403|FG001|Overall Study|Worsening of Psoriasis|1|||
156786442|NCT00601107|565970404|FG002|Overall Study|Worsening of Psoriasis|1|||
156786443|NCT00601107|565970405|FG003|Overall Study|Worsening of Psoriasis|4|||
156786444|NCT00601107|565970402|FG000|Overall Study|Undefined|1|||
156786445|NCT00601107|565970403|FG001|Overall Study|Undefined|0|||
156786446|NCT00601107|565970404|FG002|Overall Study|Undefined|1|||
156786447|NCT00601107|565970405|FG003|Overall Study|Undefined|0|||
156786448|NCT03892915|565970406|FG000|Overall Study|Lost to Follow-up|6|||
156786449|NCT03892915|565970407|FG001|Overall Study|Lost to Follow-up|12|||
156786450|NCT03892915|565970406|FG000|Overall Study|Death|0|||
156786451|NCT03892915|565970407|FG001|Overall Study|Death|2|||
156786452|NCT03892915|565970406|FG000|Overall Study|Withdrawal by Subject|1|||
156786453|NCT03892915|565970407|FG001|Overall Study|Withdrawal by Subject|1|||
156786454|NCT03892915|565970406|FG000|Overall Study|unsuccessful delivery|13|||
156786455|NCT03892915|565970407|FG001|Overall Study|unsuccessful delivery|18|||
156786456|NCT00191152|565970408|FG000|Initial Treatment|Adverse Event|43|||
156786457|NCT00191152|565970409|FG001|Initial Treatment|Adverse Event|67|||
156786458|NCT00191152|565970408|FG000|Initial Treatment|Physician Decision|40|||
156786459|NCT00191152|565970409|FG001|Initial Treatment|Physician Decision|31|||
156786460|NCT00191152|565970408|FG000|Initial Treatment|Withdrawal by Subject|40|||
156786461|NCT00191152|565970409|FG001|Initial Treatment|Withdrawal by Subject|28|||
156786462|NCT00191152|565970408|FG000|Initial Treatment|Lost to Follow-up|0|||
156786463|NCT00191152|565970409|FG001|Initial Treatment|Lost to Follow-up|6|||
156786464|NCT00191152|565970408|FG000|Initial Treatment|Other|18|||
156786465|NCT00191152|565970409|FG001|Initial Treatment|Other|21|||
156786466|NCT00191152|565970408|FG000|Crossover Treatment|Adverse Event|8|||
156786467|NCT00191152|565970409|FG001|Crossover Treatment|Adverse Event|8|||
156786468|NCT00191152|565970408|FG000|Crossover Treatment|Physician Decision|7|||
157013464|NCT02723955|566801771|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
156786469|NCT00191152|565970409|FG001|Crossover Treatment|Physician Decision|7|||
156786470|NCT00191152|565970408|FG000|Crossover Treatment|Withdrawal by Subject|6|||
156786471|NCT00191152|565970409|FG001|Crossover Treatment|Withdrawal by Subject|9|||
156786472|NCT00191152|565970408|FG000|Crossover Treatment|Lost to Follow-up|2|||
156786473|NCT00191152|565970409|FG001|Crossover Treatment|Lost to Follow-up|1|||
157013465|NCT02723955|566801772|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
156786474|NCT00191152|565970408|FG000|Crossover Treatment|Other|4|||
156786475|NCT00191152|565970409|FG001|Crossover Treatment|Other|3|||
156786476|NCT00114777|565970410|FG000|Randomization to Month 36|Death|10|||
156786477|NCT00114777|565970411|FG001|Randomization to Month 36|Death|4|||
157013466|NCT02723955|566801773|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
156786478|NCT00114777|565970412|FG002|Randomization to Month 36|Death|3|||
156786479|NCT00114777|565970410|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
156786480|NCT00114777|565970411|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
156786481|NCT00114777|565970412|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
156786482|NCT00114777|565970410|FG000|Randomization to Month 36|Lack of Efficacy|19|||
156786483|NCT00114777|565970411|FG001|Randomization to Month 36|Lack of Efficacy|15|||
156786484|NCT00114777|565970412|FG002|Randomization to Month 36|Lack of Efficacy|17|||
156786485|NCT00114777|565970410|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
156786486|NCT00114777|565970411|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
156786487|NCT00114777|565970412|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
156786488|NCT00114777|565970410|FG000|Randomization to Month 36|Adverse Event|34|||
156786489|NCT00114777|565970411|FG001|Randomization to Month 36|Adverse Event|35|||
156786490|NCT00114777|565970412|FG002|Randomization to Month 36|Adverse Event|44|||
156786491|NCT00114777|565970410|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
156786492|NCT00114777|565970411|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
156786493|NCT00114777|565970412|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
156786494|NCT00114777|565970410|FG000|Randomization to Month 36|Other|9|||
156786495|NCT00114777|565970411|FG001|Randomization to Month 36|Other|3|||
156786496|NCT00114777|565970412|FG002|Randomization to Month 36|Other|12|||
156786497|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Death|8|||
156786498|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Death|13|||
156786499|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Death|7|||
156786500|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
156786501|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
156786502|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
156786503|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
156786504|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
156786505|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
156786506|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
156786507|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
156786508|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
156786509|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
156786510|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
156786511|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
156786512|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
156786513|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
156786514|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
156786515|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
156786516|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
156786517|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
156786518|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
156786519|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
156786520|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
156786521|NCT00114777|565970410|FG000|Long-Term Extension to Month 84|Other|2|||
156786522|NCT00114777|565970411|FG001|Long-Term Extension to Month 84|Other|0|||
156786523|NCT00114777|565970412|FG002|Long-Term Extension to Month 84|Other|2|||
156786524|NCT01181128|565970416|FG000|Overall Study|Withdrawal by Subject|2|||
156786525|NCT01181128|565970417|FG001|Overall Study|Withdrawal by Subject|2|||
156786526|NCT01181128|565970418|FG002|Overall Study|Withdrawal by Subject|0|||
156786527|NCT01181128|565970416|FG000|Overall Study|Death|1|||
156786528|NCT01181128|565970417|FG001|Overall Study|Death|0|||
156786529|NCT01181128|565970418|FG002|Overall Study|Death|0|||
156786530|NCT01181128|565970416|FG000|Overall Study|Physician Decision|2|||
156786531|NCT01181128|565970417|FG001|Overall Study|Physician Decision|0|||
156786532|NCT01181128|565970418|FG002|Overall Study|Physician Decision|0|||
156786533|NCT01181128|565970416|FG000|Overall Study|Adverse Event|0|||
156786534|NCT01181128|565970417|FG001|Overall Study|Adverse Event|2|||
156786535|NCT01181128|565970418|FG002|Overall Study|Adverse Event|0|||
156786536|NCT01181128|565970416|FG000|Overall Study|Other|1|||
156786537|NCT01181128|565970417|FG001|Overall Study|Other|1|||
156786538|NCT01181128|565970418|FG002|Overall Study|Other|1|||
156786539|NCT04477486|565970421|FG000|Overall Study|Death|2|||
156786540|NCT04477486|565970421|FG000|Overall Study|Ongoing at Time of Analysis|11|||
156786541|NCT02336503|565970424|FG000|Overall Study|Lost to Follow-up|0|||
156786542|NCT02336503|565970425|FG001|Overall Study|Lost to Follow-up|3|||
156786543|NCT02336503|565970426|FG002|Overall Study|Lost to Follow-up|0|||
156786544|NCT02336503|565970427|FG003|Overall Study|Lost to Follow-up|2|||
156786545|NCT02336503|565970424|FG000|Overall Study|Withdrawal by Subject|2|||
156786546|NCT02336503|565970425|FG001|Overall Study|Withdrawal by Subject|0|||
156786547|NCT02336503|565970426|FG002|Overall Study|Withdrawal by Subject|0|||
156786548|NCT02336503|565970427|FG003|Overall Study|Withdrawal by Subject|4|||
156786549|NCT02336503|565970424|FG000|Overall Study|Adverse Event|0|||
156786550|NCT02336503|565970425|FG001|Overall Study|Adverse Event|0|||
156786551|NCT02336503|565970426|FG002|Overall Study|Adverse Event|1|||
156786552|NCT02336503|565970427|FG003|Overall Study|Adverse Event|0|||
156786553|NCT01543503|565970428|FG000|Overall Study|Lost to Follow-up|32|||
156786554|NCT01543503|565970429|FG001|Overall Study|Lost to Follow-up|36|||
156786555|NCT01543503|565970428|FG000|Overall Study|Adverse Event|9|||
156686457|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
156686458|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156686459|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156686460|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
156686461|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156686462|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156686463|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156686464|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
156686465|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
156686466|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156686467|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156686468|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Death|2|||
156686469|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Death|1|||
156686470|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Death|0|||
156686471|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Death|0|||
156686472|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
156686473|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
156686474|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
156686475|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
156686476|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
156686477|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156686478|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156686479|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
156686480|NCT03110380|565596390|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686481|NCT03110380|565596391|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
156686482|NCT03110380|565596392|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686483|NCT03110380|565596393|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
156686484|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156686485|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156686486|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
156686487|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
156686488|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
156686489|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
156686490|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
156686491|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
156686492|NCT03110380|565596390|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686493|NCT03110380|565596391|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686494|NCT03110380|565596392|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
156686495|NCT03110380|565596393|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
156686496|NCT02147587|565596394|FG000|Overall Study|Adverse Event|9|||
156686497|NCT02147587|565596395|FG001|Overall Study|Adverse Event|4|||
156686498|NCT02147587|565596394|FG000|Overall Study|Lack of Efficacy|2|||
156686499|NCT02147587|565596395|FG001|Overall Study|Lack of Efficacy|1|||
156686500|NCT01714739|565596396|FG000|Overall Study|Disease progression|3|||
156686501|NCT01714739|565596397|FG001|Overall Study|Disease progression|5|||
156686502|NCT01714739|565596398|FG002|Overall Study|Disease progression|5|||
156686503|NCT01714739|565596399|FG003|Overall Study|Disease progression|204|||
156686504|NCT01714739|565596400|FG004|Overall Study|Disease progression|1|||
156686505|NCT01714739|565596401|FG005|Overall Study|Disease progression|3|||
156686506|NCT01714739|565596402|FG006|Overall Study|Disease progression|5|||
156686507|NCT01714739|565596396|FG000|Overall Study|Study drug toxicity|1|||
156686508|NCT01714739|565596397|FG001|Overall Study|Study drug toxicity|1|||
156686509|NCT01714739|565596398|FG002|Overall Study|Study drug toxicity|1|||
156686510|NCT01714739|565596399|FG003|Overall Study|Study drug toxicity|15|||
156686511|NCT01714739|565596400|FG004|Overall Study|Study drug toxicity|0|||
156686512|NCT01714739|565596401|FG005|Overall Study|Study drug toxicity|0|||
156686513|NCT01714739|565596402|FG006|Overall Study|Study drug toxicity|5|||
156686514|NCT01714739|565596396|FG000|Overall Study|Death|0|||
156686515|NCT01714739|565596397|FG001|Overall Study|Death|0|||
156686516|NCT01714739|565596398|FG002|Overall Study|Death|0|||
156686517|NCT01714739|565596399|FG003|Overall Study|Death|1|||
156686518|NCT01714739|565596400|FG004|Overall Study|Death|0|||
156686519|NCT01714739|565596401|FG005|Overall Study|Death|0|||
156686520|NCT01714739|565596402|FG006|Overall Study|Death|0|||
156686521|NCT01714739|565596396|FG000|Overall Study|Adverse Event unrelated to drug|0|||
156686522|NCT01714739|565596397|FG001|Overall Study|Adverse Event unrelated to drug|0|||
156686523|NCT01714739|565596398|FG002|Overall Study|Adverse Event unrelated to drug|3|||
156686524|NCT01714739|565596399|FG003|Overall Study|Adverse Event unrelated to drug|21|||
156686525|NCT01714739|565596400|FG004|Overall Study|Adverse Event unrelated to drug|0|||
156686526|NCT01714739|565596401|FG005|Overall Study|Adverse Event unrelated to drug|0|||
156786556|NCT01543503|565970429|FG001|Overall Study|Adverse Event|13|||
156686527|NCT01714739|565596402|FG006|Overall Study|Adverse Event unrelated to drug|0|||
156786557|NCT01543503|565970428|FG000|Overall Study|Lack of Efficacy|4|||
157214209|NCT04242186|567531828|FG000|Overall Study|Death|5|||
157214210|NCT00782275|567531831|FG000|Overall Study|Adverse Event|11|||
156869350|NCT00790842|566279012|FG006|Expansion Cohort|Withdrawal by Subject|0|||
157214211|NCT00782275|567531831|FG000|Overall Study|Withdrawal by Subject|1|||
157214212|NCT00782275|567531831|FG000|Overall Study|Progressive Disease|21|||
157214213|NCT00782275|567531831|FG000|Overall Study|Physician Decision|4|||
157214214|NCT00782275|567531831|FG000|Overall Study|Not started treatment|1|||
157214215|NCT00782275|567531831|FG000|Overall Study|Other|3|||
157214216|NCT04378010|567531832|FG000|Overall Study|Adverse Event|8|||
157214217|NCT04378010|567531833|FG001|Overall Study|Adverse Event|14|||
157214218|NCT04378010|567531834|FG002|Overall Study|Adverse Event|4|||
157214219|NCT04378010|567531832|FG000|Overall Study|Withdrawal by Subject|0|||
157214220|NCT04378010|567531833|FG001|Overall Study|Withdrawal by Subject|2|||
157214221|NCT04378010|567531834|FG002|Overall Study|Withdrawal by Subject|1|||
157214222|NCT04378010|567531832|FG000|Overall Study|Protocol Violation|2|||
157214223|NCT04378010|567531833|FG001|Overall Study|Protocol Violation|1|||
157214224|NCT04378010|567531834|FG002|Overall Study|Protocol Violation|4|||
157214225|NCT04378010|567531832|FG000|Overall Study|Study terminated by Sponsor|22|||
157214226|NCT04378010|567531833|FG001|Overall Study|Study terminated by Sponsor|16|||
157214227|NCT04378010|567531834|FG002|Overall Study|Study terminated by Sponsor|22|||
157214228|NCT04378010|567531832|FG000|Overall Study|Subject inability to complete study visit|0|||
157214229|NCT04378010|567531833|FG001|Overall Study|Subject inability to complete study visit|0|||
157214230|NCT04378010|567531834|FG002|Overall Study|Subject inability to complete study visit|1|||
157214231|NCT04378010|567531832|FG000|Overall Study|Subject never dosed|0|||
157214232|NCT04378010|567531833|FG001|Overall Study|Subject never dosed|1|||
157214233|NCT04378010|567531834|FG002|Overall Study|Subject never dosed|0|||
157214234|NCT01792284|567531835|FG000|Lead-in Period|Adverse Event|15|||
157214235|NCT01792284|567531836|FG001|Lead-in Period|Adverse Event|0|||
157214236|NCT01792284|567531837|FG002|Lead-in Period|Adverse Event|0|||
157214237|NCT01792284|567531835|FG000|Lead-in Period|Lost to Follow-up|2|||
157214238|NCT01792284|567531836|FG001|Lead-in Period|Lost to Follow-up|0|||
157214239|NCT01792284|567531837|FG002|Lead-in Period|Lost to Follow-up|0|||
157214240|NCT01792284|567531835|FG000|Lead-in Period|Protocol Violation|1|||
157214241|NCT01792284|567531836|FG001|Lead-in Period|Protocol Violation|0|||
157214242|NCT01792284|567531837|FG002|Lead-in Period|Protocol Violation|0|||
157214243|NCT01792284|567531835|FG000|Lead-in Period|Withdrawal by Subject|10|||
157214244|NCT01792284|567531836|FG001|Lead-in Period|Withdrawal by Subject|0|||
157214245|NCT01792284|567531837|FG002|Lead-in Period|Withdrawal by Subject|0|||
157214246|NCT01792284|567531835|FG000|Lead-in Period|Physician Decision|1|||
157214247|NCT01792284|567531836|FG001|Lead-in Period|Physician Decision|0|||
157214248|NCT01792284|567531837|FG002|Lead-in Period|Physician Decision|0|||
157214249|NCT01792284|567531835|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
157214250|NCT01792284|567531836|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
157214251|NCT01792284|567531837|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
157214252|NCT01792284|567531835|FG000|Randomization Period 1|Withdrawal by Subject|0|||
157214253|NCT01792284|567531836|FG001|Randomization Period 1|Withdrawal by Subject|1|||
156869351|NCT00790842|566279013|FG007|Expansion Cohort|Withdrawal by Subject|0|||
156869352|NCT00790842|566279014|FG008|Expansion Cohort|Withdrawal by Subject|0|||
156869353|NCT00790842|566279015|FG009|Expansion Cohort|Withdrawal by Subject|0|||
156869354|NCT00790842|566279016|FG010|Expansion Cohort|Withdrawal by Subject|0|||
156869355|NCT00790842|566279006|FG000|Expansion Cohort|Study Closure|0|||
156869356|NCT00790842|566279007|FG001|Expansion Cohort|Study Closure|0|||
156869357|NCT00790842|566279008|FG002|Expansion Cohort|Study Closure|1|||
156869358|NCT00790842|566279009|FG003|Expansion Cohort|Study Closure|0|||
156869359|NCT00790842|566279010|FG004|Expansion Cohort|Study Closure|0|||
156869360|NCT00790842|566279011|FG005|Expansion Cohort|Study Closure|0|||
156869361|NCT00790842|566279012|FG006|Expansion Cohort|Study Closure|0|||
156869362|NCT00790842|566279013|FG007|Expansion Cohort|Study Closure|0|||
157214254|NCT01792284|567531837|FG002|Randomization Period 1|Withdrawal by Subject|1|||
157214255|NCT01792284|567531835|FG000|Randomization Period 1|Physician Decision|0|||
157214256|NCT01792284|567531836|FG001|Randomization Period 1|Physician Decision|1|||
157214257|NCT01792284|567531837|FG002|Randomization Period 1|Physician Decision|1|||
157214258|NCT01792284|567531835|FG000|Randomization Period 1|Adverse Event|0|||
157214259|NCT01792284|567531836|FG001|Randomization Period 1|Adverse Event|0|||
156869363|NCT00790842|566279014|FG008|Expansion Cohort|Study Closure|0|||
157214260|NCT01792284|567531837|FG002|Randomization Period 1|Adverse Event|2|||
157214261|NCT01792284|567531835|FG000|Randomization Period 1|Lost to Follow-up|0|||
157214262|NCT01792284|567531836|FG001|Randomization Period 1|Lost to Follow-up|0|||
157214263|NCT01792284|567531837|FG002|Randomization Period 1|Lost to Follow-up|1|||
157214264|NCT01792284|567531835|FG000|Randomization Period 2|Protocol Violation|0|||
157214265|NCT01792284|567531836|FG001|Randomization Period 2|Protocol Violation|1|||
157214266|NCT01792284|567531837|FG002|Randomization Period 2|Protocol Violation|0|||
157214267|NCT01792284|567531835|FG000|Randomization Period 2|Withdrawal by Subject|0|||
156869364|NCT00790842|566279015|FG009|Expansion Cohort|Study Closure|0|||
156869365|NCT00790842|566279016|FG010|Expansion Cohort|Study Closure|0|||
156869366|NCT02968004|566279017|FG000|Main Study Phase|Adverse Event|1|||
157214268|NCT01792284|567531836|FG001|Randomization Period 2|Withdrawal by Subject|2|||
156686528|NCT01714739|565596396|FG000|Overall Study|Participant request to stop therapy|0|||
156686529|NCT01714739|565596397|FG001|Overall Study|Participant request to stop therapy|1|||
156686530|NCT01714739|565596398|FG002|Overall Study|Participant request to stop therapy|0|||
156686531|NCT01714739|565596399|FG003|Overall Study|Participant request to stop therapy|6|||
156686532|NCT01714739|565596400|FG004|Overall Study|Participant request to stop therapy|0|||
156686533|NCT01714739|565596401|FG005|Overall Study|Participant request to stop therapy|0|||
156686534|NCT01714739|565596402|FG006|Overall Study|Participant request to stop therapy|0|||
156686535|NCT01714739|565596396|FG000|Overall Study|Participant withdrew consent|0|||
156686536|NCT01714739|565596397|FG001|Overall Study|Participant withdrew consent|1|||
156686537|NCT01714739|565596398|FG002|Overall Study|Participant withdrew consent|0|||
156686538|NCT01714739|565596399|FG003|Overall Study|Participant withdrew consent|8|||
156686539|NCT01714739|565596400|FG004|Overall Study|Participant withdrew consent|0|||
156686540|NCT01714739|565596401|FG005|Overall Study|Participant withdrew consent|0|||
156686541|NCT01714739|565596402|FG006|Overall Study|Participant withdrew consent|0|||
156686542|NCT01714739|565596396|FG000|Overall Study|Lost to Follow-up|0|||
156686543|NCT01714739|565596397|FG001|Overall Study|Lost to Follow-up|0|||
156686544|NCT01714739|565596398|FG002|Overall Study|Lost to Follow-up|0|||
156686545|NCT01714739|565596399|FG003|Overall Study|Lost to Follow-up|1|||
156686546|NCT01714739|565596400|FG004|Overall Study|Lost to Follow-up|0|||
156686547|NCT01714739|565596401|FG005|Overall Study|Lost to Follow-up|0|||
156686548|NCT01714739|565596402|FG006|Overall Study|Lost to Follow-up|0|||
156686549|NCT01714739|565596396|FG000|Overall Study|Maximum clinical benefit|0|||
156686550|NCT01714739|565596397|FG001|Overall Study|Maximum clinical benefit|1|||
156686551|NCT01714739|565596398|FG002|Overall Study|Maximum clinical benefit|1|||
156686552|NCT01714739|565596399|FG003|Overall Study|Maximum clinical benefit|3|||
156686553|NCT01714739|565596400|FG004|Overall Study|Maximum clinical benefit|0|||
156686554|NCT01714739|565596401|FG005|Overall Study|Maximum clinical benefit|0|||
156686555|NCT01714739|565596402|FG006|Overall Study|Maximum clinical benefit|0|||
156686556|NCT01714739|565596396|FG000|Overall Study|Poor/non-comliance|0|||
156686557|NCT01714739|565596397|FG001|Overall Study|Poor/non-comliance|1|||
156686558|NCT01714739|565596398|FG002|Overall Study|Poor/non-comliance|0|||
156686559|NCT01714739|565596399|FG003|Overall Study|Poor/non-comliance|1|||
156686560|NCT01714739|565596400|FG004|Overall Study|Poor/non-comliance|0|||
156686561|NCT01714739|565596401|FG005|Overall Study|Poor/non-comliance|0|||
156686562|NCT01714739|565596402|FG006|Overall Study|Poor/non-comliance|0|||
156686563|NCT01714739|565596396|FG000|Overall Study|No longer meets study criteria|0|||
156686564|NCT01714739|565596397|FG001|Overall Study|No longer meets study criteria|0|||
156686565|NCT01714739|565596398|FG002|Overall Study|No longer meets study criteria|0|||
156686566|NCT01714739|565596399|FG003|Overall Study|No longer meets study criteria|1|||
156686567|NCT01714739|565596400|FG004|Overall Study|No longer meets study criteria|0|||
156686568|NCT01714739|565596401|FG005|Overall Study|No longer meets study criteria|0|||
156686569|NCT01714739|565596402|FG006|Overall Study|No longer meets study criteria|0|||
156686570|NCT01714739|565596396|FG000|Overall Study|Other reason|0|||
156686571|NCT01714739|565596397|FG001|Overall Study|Other reason|0|||
156686572|NCT01714739|565596398|FG002|Overall Study|Other reason|0|||
156686573|NCT01714739|565596399|FG003|Overall Study|Other reason|3|||
156686574|NCT01714739|565596400|FG004|Overall Study|Other reason|1|||
156686575|NCT01714739|565596401|FG005|Overall Study|Other reason|0|||
156686576|NCT01714739|565596402|FG006|Overall Study|Other reason|0|||
156686577|NCT03170869|565596413|FG000|Overall Study|Protocol Violation|5|||
156686578|NCT03170869|565596413|FG000|Overall Study|Early study termination|3|||
156686579|NCT03635983|565596416|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
156686580|NCT03635983|565596417|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
156686581|NCT03635983|565596416|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156686582|NCT03635983|565596417|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156686583|NCT03635983|565596416|FG000|Pre-Treatment Period|Other reasons|0|||
156686584|NCT03635983|565596417|FG001|Pre-Treatment Period|Other reasons|1|||
156686585|NCT03635983|565596416|FG000|Pre-Treatment Period|Disease Progression|0|||
156686586|NCT03635983|565596417|FG001|Pre-Treatment Period|Disease Progression|1|||
156686587|NCT03635983|565596416|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
156686588|NCT03635983|565596417|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
156686589|NCT03635983|565596416|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
156686590|NCT03635983|565596417|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
156686591|NCT03635983|565596416|FG000|Treatment Period|Withdrawal by Subject|3|||
156786558|NCT01543503|565970429|FG001|Overall Study|Lack of Efficacy|16|||
156786559|NCT01543503|565970428|FG000|Overall Study|Participant withdrew informed consent|8|||
156686592|NCT03635983|565596417|FG001|Treatment Period|Withdrawal by Subject|5|||
156786560|NCT01543503|565970429|FG001|Overall Study|Participant withdrew informed consent|10|||
156786561|NCT01543503|565970428|FG000|Overall Study|Change of jobs|0|||
156786562|NCT01543503|565970429|FG001|Overall Study|Change of jobs|1|||
156786563|NCT01543503|565970428|FG000|Overall Study|Intolerance to the biologic treatment|0|||
156869367|NCT02968004|566279018|FG001|Main Study Phase|Adverse Event|0|||
156686593|NCT03635983|565596416|FG000|Treatment Period|Death|3|||
156686594|NCT03635983|565596417|FG001|Treatment Period|Death|5|||
156686595|NCT03635983|565596416|FG000|Treatment Period|Poor/Non-compliance|2|||
156686596|NCT03635983|565596417|FG001|Treatment Period|Poor/Non-compliance|1|||
156686597|NCT03635983|565596416|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
156686598|NCT03635983|565596417|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
156686599|NCT03635983|565596416|FG000|Treatment Period|Other reasons|7|||
156686600|NCT03635983|565596417|FG001|Treatment Period|Other reasons|4|||
156686601|NCT03635983|565596416|FG000|Treatment Period|Disease progression|230|||
156686602|NCT03635983|565596417|FG001|Treatment Period|Disease progression|201|||
156686603|NCT03635983|565596416|FG000|Treatment Period|Study drug toxicity|35|||
156686604|NCT03635983|565596417|FG001|Treatment Period|Study drug toxicity|36|||
156686605|NCT03635983|565596416|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
156686606|NCT03635983|565596417|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
156686607|NCT03635983|565596416|FG000|Treatment Period|Maximum clinical benefit|3|||
156686608|NCT03635983|565596417|FG001|Treatment Period|Maximum clinical benefit|5|||
156686609|NCT03635983|565596416|FG000|Treatment Period|Administrative reason by the sponsor|1|||
156686610|NCT03635983|565596417|FG001|Treatment Period|Administrative reason by the sponsor|2|||
156686611|NCT03635983|565596416|FG000|Treatment Period|Lost to Follow-up|0|||
156686612|NCT03635983|565596417|FG001|Treatment Period|Lost to Follow-up|1|||
156686613|NCT01235442|565596418|FG000|Overall Study|Lost to Follow-up|12|||
156686614|NCT01235442|565596419|FG001|Overall Study|Lost to Follow-up|10|||
156686615|NCT01235442|565596418|FG000|Overall Study|Death|0|||
156686616|NCT01235442|565596419|FG001|Overall Study|Death|2|||
156686617|NCT01235442|565596418|FG000|Overall Study|Pregnancy|1|||
156686618|NCT01235442|565596419|FG001|Overall Study|Pregnancy|1|||
156686619|NCT01235442|565596418|FG000|Overall Study|Ineligibility determined|5|||
156686620|NCT01235442|565596419|FG001|Overall Study|Ineligibility determined|4|||
156686621|NCT01235442|565596418|FG000|Overall Study|Protocol Violation|3|||
156686622|NCT01235442|565596419|FG001|Overall Study|Protocol Violation|3|||
156686623|NCT01235442|565596418|FG000|Overall Study|Adverse Event|4|||
156686624|NCT01235442|565596419|FG001|Overall Study|Adverse Event|6|||
156686625|NCT01235442|565596418|FG000|Overall Study|Withdrawal by Subject|15|||
156686626|NCT01235442|565596419|FG001|Overall Study|Withdrawal by Subject|9|||
156686627|NCT01235442|565596418|FG000|Overall Study|Lack of Efficacy|1|||
156686628|NCT01235442|565596419|FG001|Overall Study|Lack of Efficacy|3|||
156686629|NCT01235442|565596418|FG000|Overall Study|Noncompliance|1|||
156686630|NCT01235442|565596419|FG001|Overall Study|Noncompliance|2|||
156686631|NCT01235442|565596418|FG000|Overall Study|Administrative decision|1|||
156686632|NCT01235442|565596419|FG001|Overall Study|Administrative decision|2|||
156686633|NCT01235442|565596418|FG000|Overall Study|Other unspecified|1|||
156786564|NCT01543503|565970429|FG001|Overall Study|Intolerance to the biologic treatment|1|||
156786565|NCT01543503|565970428|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
156786566|NCT01543503|565970429|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
156786567|NCT01543503|565970428|FG000|Overall Study|Participant did not complete last visit|0|||
156786568|NCT01543503|565970429|FG001|Overall Study|Participant did not complete last visit|2|||
156786569|NCT01543503|565970428|FG000|Overall Study|Refused to continue treatment|7|||
156786570|NCT01543503|565970429|FG001|Overall Study|Refused to continue treatment|0|||
156786571|NCT01543503|565970428|FG000|Overall Study|Incorrect medication received|1|||
156786572|NCT01543503|565970429|FG001|Overall Study|Incorrect medication received|0|||
156786573|NCT01543503|565970428|FG000|Overall Study|Participant moved to another city|2|||
156786574|NCT01543503|565970429|FG001|Overall Study|Participant moved to another city|0|||
156786575|NCT01543503|565970428|FG000|Overall Study|Participant will not return for visits|0|||
156786576|NCT01543503|565970429|FG001|Overall Study|Participant will not return for visits|2|||
156786577|NCT01543503|565970428|FG000|Overall Study|Participant transferred to another city|1|||
156786578|NCT01543503|565970429|FG001|Overall Study|Participant transferred to another city|0|||
156786579|NCT01543503|565970428|FG000|Overall Study|Participant moved to Scotland|1|||
156786580|NCT01543503|565970429|FG001|Overall Study|Participant moved to Scotland|0|||
156786581|NCT01543503|565970428|FG000|Overall Study|Participant decision to stop treatment|1|||
156786582|NCT01543503|565970429|FG001|Overall Study|Participant decision to stop treatment|0|||
156786583|NCT01543503|565970428|FG000|Overall Study|Investigator did not wish to participate|1|||
156786584|NCT01543503|565970429|FG001|Overall Study|Investigator did not wish to participate|1|||
156786585|NCT01543503|565970428|FG000|Overall Study|Participant recruited after closing date|0|||
156786586|NCT01543503|565970429|FG001|Overall Study|Participant recruited after closing date|1|||
156869368|NCT02968004|566279017|FG000|Main Study Phase|Withdrawal by Subject|0|||
156869369|NCT02968004|566279018|FG001|Main Study Phase|Withdrawal by Subject|1|||
156869370|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
156869371|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
156686634|NCT01235442|565596419|FG001|Overall Study|Other unspecified|2|||
156686635|NCT01857973|565596420|FG000|Overall Study|Subject did not meet required BG range|3|||
156686636|NCT01857973|565596420|FG000|Overall Study|drop out after 3 failed attempts|1|||
156686637|NCT01857973|565596420|FG000|Overall Study|Physician Decision|1|||
156686638|NCT02663882|565596421|FG000|Overall Study|Lost to Follow-up|4|||
156686639|NCT02663882|565596422|FG001|Overall Study|Lost to Follow-up|2|||
156686640|NCT01701973|565596423|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156869372|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
156869373|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
156869374|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
156869375|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
156869376|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
156869377|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
156869378|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
156869379|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
156869380|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
156869381|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
156869382|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
156869383|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
156869384|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
156869385|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
156869386|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
156869387|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
156869388|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
156869389|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
156869390|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
156869391|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
156869392|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
156869393|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
156869394|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
156869395|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
156869396|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
156869397|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
156869398|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
156869399|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
156869400|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
156869401|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
156869402|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
156869403|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
156869404|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
156869405|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
156869406|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
156869407|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
156869408|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
156869409|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
156869410|NCT02968004|566279017|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
156869411|NCT02968004|566279018|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
156869412|NCT05029362|566279019|FG000|Overall Study|Lost to Follow-up|9|||
156869413|NCT00561925|566279020|FG000|14 Day Lead-In Period|Adverse Event|38|||
156869414|NCT00561925|566279021|FG001|14 Day Lead-In Period|Adverse Event|0|||
156869415|NCT00561925|566279022|FG002|14 Day Lead-In Period|Adverse Event|0|||
156869416|NCT00561925|566279023|FG003|14 Day Lead-In Period|Adverse Event|0|||
156869417|NCT00561925|566279024|FG004|14 Day Lead-In Period|Adverse Event|0|||
156869418|NCT00561925|566279020|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
156869419|NCT00561925|566279021|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869420|NCT00561925|566279022|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869421|NCT00561925|566279023|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869422|NCT00561925|566279024|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
156869423|NCT00561925|566279020|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
156869424|NCT00561925|566279021|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
156869425|NCT00561925|566279022|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
156869426|NCT00561925|566279023|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
156869427|NCT00561925|566279024|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
156869428|NCT00561925|566279020|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
156869429|NCT00561925|566279021|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869430|NCT00561925|566279022|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869431|NCT00561925|566279023|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869432|NCT00561925|566279024|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
156869433|NCT00561925|566279020|FG000|14 Day Lead-In Period|Other|5|||
156869434|NCT00561925|566279021|FG001|14 Day Lead-In Period|Other|0|||
156869435|NCT00561925|566279022|FG002|14 Day Lead-In Period|Other|0|||
156869436|NCT00561925|566279023|FG003|14 Day Lead-In Period|Other|0|||
156869437|NCT00561925|566279024|FG004|14 Day Lead-In Period|Other|0|||
156869438|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
156869439|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
156869440|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
156686641|NCT01701973|565596424|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
156686642|NCT01701973|565596425|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686643|NCT01701973|565596426|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686644|NCT01701973|565596427|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686645|NCT01701973|565596428|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686646|NCT01701973|565596429|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686647|NCT01701973|565596430|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
156686648|NCT02412722|565596437|FG000|Overall Study|Adverse Event|0|||
156686649|NCT02412722|565596438|FG001|Overall Study|Adverse Event|2|||
156686650|NCT02412722|565596439|FG002|Overall Study|Adverse Event|0|||
156686651|NCT02412722|565596440|FG003|Overall Study|Adverse Event|3|||
156686652|NCT02412722|565596441|FG004|Overall Study|Adverse Event|0|||
156686653|NCT02412722|565596442|FG005|Overall Study|Adverse Event|3|||
156686654|NCT02412722|565596437|FG000|Overall Study|Progressive Disease|6|||
156686655|NCT02412722|565596438|FG001|Overall Study|Progressive Disease|4|||
156686656|NCT02412722|565596439|FG002|Overall Study|Progressive Disease|4|||
156686657|NCT02412722|565596440|FG003|Overall Study|Progressive Disease|9|||
156686658|NCT02412722|565596441|FG004|Overall Study|Progressive Disease|3|||
156686659|NCT02412722|565596442|FG005|Overall Study|Progressive Disease|3|||
156686660|NCT02412722|565596437|FG000|Overall Study|Withdrawal by Subject|2|||
156686661|NCT02412722|565596438|FG001|Overall Study|Withdrawal by Subject|0|||
156686662|NCT02412722|565596439|FG002|Overall Study|Withdrawal by Subject|1|||
156686663|NCT02412722|565596440|FG003|Overall Study|Withdrawal by Subject|2|||
156686664|NCT02412722|565596441|FG004|Overall Study|Withdrawal by Subject|1|||
156686665|NCT02412722|565596442|FG005|Overall Study|Withdrawal by Subject|1|||
156686666|NCT02412722|565596437|FG000|Overall Study|Lost to Follow-up|0|||
156686667|NCT02412722|565596438|FG001|Overall Study|Lost to Follow-up|0|||
156686668|NCT02412722|565596439|FG002|Overall Study|Lost to Follow-up|0|||
156686669|NCT02412722|565596440|FG003|Overall Study|Lost to Follow-up|0|||
156686670|NCT02412722|565596441|FG004|Overall Study|Lost to Follow-up|1|||
156686671|NCT02412722|565596442|FG005|Overall Study|Lost to Follow-up|0|||
156686672|NCT02412722|565596437|FG000|Overall Study|Received drug in run-in and discontinued|0|||
156686673|NCT02412722|565596438|FG001|Overall Study|Received drug in run-in and discontinued|2|||
156686674|NCT02412722|565596439|FG002|Overall Study|Received drug in run-in and discontinued|0|||
156686675|NCT02412722|565596440|FG003|Overall Study|Received drug in run-in and discontinued|0|||
156686676|NCT02412722|565596441|FG004|Overall Study|Received drug in run-in and discontinued|0|||
156686677|NCT02412722|565596442|FG005|Overall Study|Received drug in run-in and discontinued|0|||
156686678|NCT02412722|565596437|FG000|Overall Study|Reason not Specified|3|||
156686679|NCT02412722|565596438|FG001|Overall Study|Reason not Specified|0|||
156686680|NCT02412722|565596439|FG002|Overall Study|Reason not Specified|2|||
156686681|NCT02412722|565596440|FG003|Overall Study|Reason not Specified|1|||
156686682|NCT02412722|565596441|FG004|Overall Study|Reason not Specified|2|||
156686683|NCT02412722|565596442|FG005|Overall Study|Reason not Specified|6|||
156686684|NCT04449341|565596445|FG000|Overall Study|Protocol Violation|1|||
156686685|NCT04449341|565596446|FG001|Overall Study|Protocol Violation|0|||
156686686|NCT01020526|565596448|FG000|Overall Study|Withdrawal by Subject|5|||
156686687|NCT01020526|565596448|FG000|Overall Study|Other reasons|3|||
156686688|NCT01020526|565596448|FG000|Overall Study|Insufficient clinical response|3|||
156686689|NCT01020526|565596448|FG000|Overall Study|Lost to Follow-up|1|||
156686690|NCT01020526|565596448|FG000|Overall Study|Adverse Event|2|||
156686691|NCT00551616|565596451|FG000|Overall Study|Lost to Follow-up|48|||
156686692|NCT00551616|565596452|FG001|Overall Study|Lost to Follow-up|40|||
156686693|NCT03546647|565596453|FG000|Overall Study|Adverse Event|1|||
156686694|NCT03546647|565596454|FG001|Overall Study|Adverse Event|0|||
156686695|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
156686696|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
156686697|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686698|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686699|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
156686700|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
156686701|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
156686702|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686703|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686704|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156686705|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
156686706|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
156686707|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156786587|NCT01543503|565970428|FG000|Overall Study|Site stopped participation|5|||
157121492|NCT05103332|567195982|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
156686708|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156686709|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
156686710|NCT03297294|565596455|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
156686711|NCT03297294|565596456|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
156686712|NCT03297294|565596457|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686713|NCT03297294|565596458|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686714|NCT03297294|565596459|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156686715|NCT03297294|565596455|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686716|NCT03297294|565596456|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686717|NCT03297294|565596457|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686718|NCT03297294|565596458|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
156686719|NCT03297294|565596459|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
156686720|NCT01435031|565596460|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
156686721|NCT01435031|565596460|FG000|ITT at 1 Month|Death|1|||
156686722|NCT01435031|565596460|FG000|ITT at 1 Month|Lost to Follow-up|4|||
156686723|NCT01435031|565596460|FG000|ITT at 6 Months|Death|2|||
156686724|NCT01435031|565596460|FG000|ITT at 6 Months|Lost to Follow-up|3|||
156686725|NCT01435031|565596460|FG000|ITT at 1 Year|Death|1|||
156686726|NCT01435031|565596460|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
156686727|NCT01435031|565596460|FG000|ITT at 1 Year|Lost to Follow-up|6|||
156686728|NCT01435031|565596460|FG000|ITT at 2 Years|Death|7|||
156686729|NCT01435031|565596460|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
156686730|NCT01435031|565596460|FG000|ITT at 2 Years|Lost to Follow-up|4|||
156686731|NCT01435031|565596460|FG000|ITT at 3 Years|Death|5|||
156686732|NCT01435031|565596460|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
156686733|NCT01435031|565596460|FG000|ITT at 3 Years|Lost to Follow-up|4|||
156686734|NCT01435031|565596460|FG000|ITT at 4 Years|Death|4|||
156686735|NCT01435031|565596460|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
156686736|NCT01435031|565596460|FG000|ITT at 4 Years|Lost to Follow-up|1|||
156686737|NCT00105157|565596461|FG000|Double-Blind (DB)|Never Treated|1|||
156686738|NCT00105157|565596462|FG001|Double-Blind (DB)|Never Treated|0|||
156686739|NCT00105157|565596463|FG002|Double-Blind (DB)|Never Treated|0|||
156686740|NCT00105157|565596464|FG003|Double-Blind (DB)|Never Treated|0|||
156686741|NCT00105157|565596461|FG000|Double-Blind (DB)|Adverse Event|2|||
156686742|NCT00105157|565596462|FG001|Double-Blind (DB)|Adverse Event|0|||
156686743|NCT00105157|565596463|FG002|Double-Blind (DB)|Adverse Event|1|||
156686744|NCT00105157|565596464|FG003|Double-Blind (DB)|Adverse Event|1|||
156686745|NCT00105157|565596461|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
156686746|NCT00105157|565596462|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
156686747|NCT00105157|565596463|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
156686748|NCT00105157|565596464|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
156686749|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Adverse Event|3|||
156686750|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Adverse Event|1|||
156686751|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Adverse Event|0|||
156686752|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Adverse Event|0|||
156686753|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
156686754|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
156686755|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
156686756|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
156686757|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686758|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686759|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
156686760|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
156686761|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
156686762|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
156686763|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
156686764|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
156686765|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
156686766|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686767|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686768|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
156686769|NCT00105157|565596461|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
156686770|NCT00105157|565596462|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
156686771|NCT00105157|565596463|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
156686772|NCT00105157|565596464|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
156686773|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686774|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686775|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
156686776|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
156686777|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
156686778|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
156686779|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
156686780|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
156686781|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
156786588|NCT01543503|565970429|FG001|Overall Study|Site stopped participation|1|||
156786589|NCT01543503|565970428|FG000|Overall Study|Participant did not attend a visit|1|||
156786590|NCT01543503|565970429|FG001|Overall Study|Participant did not attend a visit|0|||
156786591|NCT01543503|565970428|FG000|Overall Study|Moved to other rheumatologic site|0|||
157214269|NCT01792284|567531837|FG002|Randomization Period 2|Withdrawal by Subject|0|||
157214270|NCT02019979|567531838|FG000|Overall Study|study terminated|14|||
157214271|NCT00379587|567531844|FG000|Overall Study|Lost to Follow-up|2|||
157214272|NCT03237611|567531845|FG000|Overall Study|Withdrawal by Subject|1|||
156786592|NCT01543503|565970429|FG001|Overall Study|Moved to other rheumatologic site|1|||
156786593|NCT01543503|565970428|FG000|Overall Study|Participant consented to another study|0|||
157214273|NCT03237611|567531845|FG000|Overall Study|Ineligible|1|||
157214274|NCT00534092|567531849|FG000|Overall Study|Lost to Follow-up|1|||
157214275|NCT00534092|567531850|FG001|Overall Study|Lost to Follow-up|0|||
157214276|NCT00534092|567531849|FG000|Overall Study|personal reasons/family concerns|1|||
157214277|NCT00534092|567531850|FG001|Overall Study|personal reasons/family concerns|0|||
157214278|NCT01169649|567531851|FG000|Overall Study|Patient Not Treated|3|||
157214279|NCT02919475|567531852|FG000|Overall Study|Adverse Event|3|||
157214280|NCT02919475|567531853|FG001|Overall Study|Adverse Event|3|||
157214281|NCT02919475|567531854|FG002|Overall Study|Adverse Event|3|||
157214282|NCT02919475|567531855|FG003|Overall Study|Adverse Event|9|||
157214283|NCT02919475|567531856|FG004|Overall Study|Adverse Event|2|||
157214284|NCT02919475|567531852|FG000|Overall Study|Death|0|||
157214285|NCT02919475|567531853|FG001|Overall Study|Death|1|||
157214286|NCT02919475|567531854|FG002|Overall Study|Death|0|||
157214287|NCT02919475|567531855|FG003|Overall Study|Death|0|||
157214288|NCT02919475|567531856|FG004|Overall Study|Death|0|||
157214289|NCT02919475|567531852|FG000|Overall Study|Lost to Follow-up|0|||
157214290|NCT02919475|567531853|FG001|Overall Study|Lost to Follow-up|0|||
157214291|NCT02919475|567531854|FG002|Overall Study|Lost to Follow-up|0|||
157214292|NCT02919475|567531855|FG003|Overall Study|Lost to Follow-up|1|||
157214293|NCT02919475|567531856|FG004|Overall Study|Lost to Follow-up|0|||
157214294|NCT02919475|567531852|FG000|Overall Study|Withdrawal by Subject|2|||
157214295|NCT02919475|567531853|FG001|Overall Study|Withdrawal by Subject|3|||
157214296|NCT02919475|567531854|FG002|Overall Study|Withdrawal by Subject|1|||
157214297|NCT02919475|567531855|FG003|Overall Study|Withdrawal by Subject|2|||
157214298|NCT02919475|567531856|FG004|Overall Study|Withdrawal by Subject|2|||
157214299|NCT02919475|567531852|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
157214300|NCT02919475|567531853|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156786594|NCT01543503|565970429|FG001|Overall Study|Participant consented to another study|2|||
157121493|NCT05103332|567195983|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121494|NCT05103332|567195984|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121495|NCT05103332|567195985|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121496|NCT05103332|567195986|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
157121497|NCT05103332|567195987|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121498|NCT05103332|567195988|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121499|NCT05103332|567195989|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121500|NCT05103332|567195990|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121501|NCT05103332|567195991|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121502|NCT05103332|567195992|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121503|NCT05103332|567195993|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121504|NCT05103332|567195994|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121505|NCT05103332|567195995|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
157121506|NCT05103332|567195978|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121507|NCT05103332|567195979|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121508|NCT05103332|567195980|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121509|NCT05103332|567195981|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121510|NCT05103332|567195982|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121511|NCT05103332|567195983|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121512|NCT05103332|567195984|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121513|NCT05103332|567195985|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121514|NCT05103332|567195986|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121515|NCT05103332|567195987|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121516|NCT05103332|567195988|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121517|NCT05103332|567195989|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
157121518|NCT05103332|567195990|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121519|NCT05103332|567195991|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121520|NCT05103332|567195992|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121521|NCT05103332|567195993|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121522|NCT05103332|567195994|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121523|NCT05103332|567195995|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
157121524|NCT05103332|567195978|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121525|NCT05103332|567195979|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156686782|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
156686783|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
156686784|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
156686785|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686786|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686787|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
156686788|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
156686789|NCT00105157|565596461|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686790|NCT00105157|565596462|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
156686791|NCT00105157|565596463|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686792|NCT00105157|565596464|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
156686793|NCT01396421|565596465|FG000|Overall Study|Lost to Follow-up|0|||
156786595|NCT01543503|565970428|FG000|Overall Study|Participant went to United States|1|||
156786596|NCT01543503|565970429|FG001|Overall Study|Participant went to United States|0|||
156786597|NCT01543503|565970428|FG000|Overall Study|Screen failure|1|||
156786598|NCT01543503|565970429|FG001|Overall Study|Screen failure|0|||
156786599|NCT02460380|565970430|FG000|Overall Study|Withdrawal by Subject|10|||
156786600|NCT02460380|565970431|FG001|Overall Study|Withdrawal by Subject|5|||
156786601|NCT01478087|565970434|FG000|Overall Study|due to sponsor closing study|1|||
156786602|NCT03566550|565970436|FG000|Overall Study|Withdrawal by Subject|0|||
156686794|NCT01396421|565596466|FG001|Overall Study|Lost to Follow-up|0|||
156686795|NCT01396421|565596467|FG002|Overall Study|Lost to Follow-up|0|||
156686796|NCT01396421|565596468|FG003|Overall Study|Lost to Follow-up|1|||
156686797|NCT01396421|565596465|FG000|Overall Study|Adverse Event|17|||
156686798|NCT01396421|565596466|FG001|Overall Study|Adverse Event|15|||
156686799|NCT01396421|565596467|FG002|Overall Study|Adverse Event|12|||
156686800|NCT01396421|565596468|FG003|Overall Study|Adverse Event|32|||
156686801|NCT01396421|565596465|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156686802|NCT01396421|565596466|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
156686803|NCT01396421|565596467|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
156686804|NCT01396421|565596468|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
156686805|NCT01396421|565596465|FG000|Overall Study|Physician Decision|1|||
156686806|NCT01396421|565596466|FG001|Overall Study|Physician Decision|1|||
156686807|NCT01396421|565596467|FG002|Overall Study|Physician Decision|0|||
156686808|NCT01396421|565596468|FG003|Overall Study|Physician Decision|3|||
156686809|NCT01396421|565596465|FG000|Overall Study|Withdrawal by Subject|31|||
156686810|NCT01396421|565596466|FG001|Overall Study|Withdrawal by Subject|24|||
156686811|NCT01396421|565596467|FG002|Overall Study|Withdrawal by Subject|13|||
156686812|NCT01396421|565596468|FG003|Overall Study|Withdrawal by Subject|21|||
156686813|NCT01396421|565596465|FG000|Overall Study|Protocol Deviation|2|||
156869441|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
156869442|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
156686814|NCT01396421|565596466|FG001|Overall Study|Protocol Deviation|1|||
156686815|NCT01396421|565596467|FG002|Overall Study|Protocol Deviation|1|||
156686816|NCT01396421|565596468|FG003|Overall Study|Protocol Deviation|0|||
156786603|NCT03566550|565970437|FG001|Overall Study|Withdrawal by Subject|1|||
156786604|NCT04576949|565970439|FG000|Overall Study|Adverse Event|1|||
156786605|NCT04576949|565970440|FG001|Overall Study|Adverse Event|3|||
156786606|NCT04576949|565970441|FG002|Overall Study|Adverse Event|2|||
156786607|NCT04576949|565970439|FG000|Overall Study|Withdrawal by Subject|41|||
156786608|NCT04576949|565970440|FG001|Overall Study|Withdrawal by Subject|26|||
156786609|NCT04576949|565970441|FG002|Overall Study|Withdrawal by Subject|18|||
156786610|NCT04576949|565970439|FG000|Overall Study|Physician Decision|3|||
156786611|NCT04576949|565970440|FG001|Overall Study|Physician Decision|0|||
156786612|NCT04576949|565970441|FG002|Overall Study|Physician Decision|0|||
156786613|NCT04576949|565970439|FG000|Overall Study|Death|0|||
156786614|NCT04576949|565970440|FG001|Overall Study|Death|1|||
156786615|NCT04576949|565970441|FG002|Overall Study|Death|0|||
156786616|NCT04576949|565970439|FG000|Overall Study|Lost to Follow-up|29|||
156786617|NCT04576949|565970440|FG001|Overall Study|Lost to Follow-up|37|||
156786618|NCT04576949|565970441|FG002|Overall Study|Lost to Follow-up|24|||
156869443|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869444|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
156686817|NCT01396421|565596465|FG000|Overall Study|Lack of Efficacy|7|||
156786619|NCT04576949|565970439|FG000|Overall Study|Other, Not Specified|2|||
156686818|NCT01396421|565596466|FG001|Overall Study|Lack of Efficacy|17|||
156686819|NCT01396421|565596467|FG002|Overall Study|Lack of Efficacy|7|||
156686820|NCT01396421|565596468|FG003|Overall Study|Lack of Efficacy|18|||
156686821|NCT00104247|565596473|FG000|Overall Study|Withdrawal by Subject|1|||
156686822|NCT00104247|565596474|FG001|Overall Study|Withdrawal by Subject|0|||
156686823|NCT00104247|565596473|FG000|Overall Study|Noncompliant with dosing|0|||
156786620|NCT04576949|565970440|FG001|Overall Study|Other, Not Specified|3|||
156786621|NCT04576949|565970441|FG002|Overall Study|Other, Not Specified|1|||
156786622|NCT04576949|565970439|FG000|Overall Study|Other|1|||
156786623|NCT04576949|565970440|FG001|Overall Study|Other|0|||
156786624|NCT04576949|565970441|FG002|Overall Study|Other|0|||
156786625|NCT00052715|565970445|FG000|Overall Study|wrong histology|1|||
156786626|NCT01936974|565970446|FG000|Overall Study|Physician Decision|2|||
156786627|NCT01936974|565970447|FG001|Overall Study|Physician Decision|5|||
156786628|NCT00063999|565970450|FG000|Overall Study|Withdrawal by Subject|1|||
157214301|NCT02919475|567531854|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
157214302|NCT02919475|567531855|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
157214303|NCT02919475|567531856|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157214304|NCT02323295|567531861|FG000|Overall Study|Adverse Event|0|||
157214305|NCT02323295|567531862|FG001|Overall Study|Adverse Event|1|||
157214306|NCT02323295|567531861|FG000|Overall Study|Withdrawal by Subject|0|||
157214307|NCT02323295|567531862|FG001|Overall Study|Withdrawal by Subject|1|||
157214308|NCT02323295|567531861|FG000|Overall Study|Patient did not have surgery as planned.|0|||
157214309|NCT02323295|567531862|FG001|Overall Study|Patient did not have surgery as planned.|1|||
157214310|NCT00830063|567531863|FG000|Overall Study|Adverse Event|7|||
157214311|NCT00830063|567531864|FG001|Overall Study|Adverse Event|13|||
157214312|NCT00830063|567531865|FG002|Overall Study|Adverse Event|16|||
157214313|NCT00830063|567531866|FG003|Overall Study|Adverse Event|13|||
157214314|NCT00830063|567531863|FG000|Overall Study|Death|1|||
157214315|NCT00830063|567531864|FG001|Overall Study|Death|0|||
157214316|NCT00830063|567531865|FG002|Overall Study|Death|0|||
157214317|NCT00830063|567531866|FG003|Overall Study|Death|0|||
157214318|NCT00830063|567531863|FG000|Overall Study|Lost to Follow-up|0|||
157214319|NCT00830063|567531864|FG001|Overall Study|Lost to Follow-up|0|||
157214320|NCT00830063|567531865|FG002|Overall Study|Lost to Follow-up|3|||
157214321|NCT00830063|567531866|FG003|Overall Study|Lost to Follow-up|1|||
157214322|NCT00830063|567531863|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
157214323|NCT00830063|567531864|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
157214324|NCT00830063|567531865|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
157214325|NCT00830063|567531866|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
157214326|NCT00830063|567531863|FG000|Overall Study|Lack of Efficacy|51|||
157214327|NCT00830063|567531864|FG001|Overall Study|Lack of Efficacy|23|||
157214328|NCT00830063|567531865|FG002|Overall Study|Lack of Efficacy|25|||
157214329|NCT00830063|567531866|FG003|Overall Study|Lack of Efficacy|32|||
157214330|NCT00830063|567531863|FG000|Overall Study|Other|5|||
157214331|NCT00830063|567531864|FG001|Overall Study|Other|5|||
157214332|NCT00830063|567531865|FG002|Overall Study|Other|8|||
157214333|NCT00830063|567531866|FG003|Overall Study|Other|6|||
157214334|NCT00830063|567531863|FG000|Overall Study|Withdrawal by Subject|16|||
157214335|NCT00830063|567531864|FG001|Overall Study|Withdrawal by Subject|10|||
157214336|NCT00830063|567531865|FG002|Overall Study|Withdrawal by Subject|16|||
157214337|NCT00830063|567531866|FG003|Overall Study|Withdrawal by Subject|13|||
157214338|NCT00830063|567531863|FG000|Overall Study|Protocol Violation|1|||
157214339|NCT00830063|567531864|FG001|Overall Study|Protocol Violation|0|||
157214340|NCT00830063|567531865|FG002|Overall Study|Protocol Violation|3|||
157214341|NCT00830063|567531866|FG003|Overall Study|Protocol Violation|2|||
157214342|NCT00830063|567531863|FG000|Overall Study|Randomized But Not Treated|0|||
157214343|NCT00830063|567531864|FG001|Overall Study|Randomized But Not Treated|2|||
157214344|NCT00830063|567531865|FG002|Overall Study|Randomized But Not Treated|0|||
157214345|NCT00830063|567531866|FG003|Overall Study|Randomized But Not Treated|2|||
157214346|NCT02370784|567531867|FG000|Overall Study|Patient started prohibited medication|0|||
157214347|NCT02370784|567531868|FG001|Overall Study|Patient started prohibited medication|1|||
157214348|NCT01814761|567531870|FG000|Overall Study|Other Reasons|1|||
157214349|NCT01814761|567531871|FG001|Overall Study|Other Reasons|10|||
157214350|NCT01814761|567531870|FG000|Overall Study|Ocular Adverse Event|6|||
157214351|NCT01814761|567531871|FG001|Overall Study|Ocular Adverse Event|15|||
157214352|NCT01814761|567531870|FG000|Overall Study|Lost to Follow-up|1|||
157214353|NCT01814761|567531871|FG001|Overall Study|Lost to Follow-up|5|||
157214354|NCT01059071|567531872|FG000|Overall Study|Lack of Efficacy|1|||
157214355|NCT01059071|567531873|FG001|Overall Study|Lack of Efficacy|4|||
157214356|NCT01059071|567531874|FG002|Overall Study|Lack of Efficacy|2|||
157214357|NCT01059071|567531875|FG003|Overall Study|Lack of Efficacy|3|||
157214358|NCT01059071|567531872|FG000|Overall Study|Withdrawal by Subject|1|||
157214359|NCT01059071|567531873|FG001|Overall Study|Withdrawal by Subject|0|||
157214360|NCT01059071|567531874|FG002|Overall Study|Withdrawal by Subject|0|||
157214361|NCT01059071|567531875|FG003|Overall Study|Withdrawal by Subject|2|||
156786629|NCT00063999|565970451|FG001|Overall Study|Withdrawal by Subject|0|||
156786630|NCT00063999|565970450|FG000|Overall Study|Ineligible|44|||
156786631|NCT00063999|565970451|FG001|Overall Study|Ineligible|24|||
156786632|NCT01078545|565970455|FG000|Overall Study|Lost to Follow-up|13|||
157214362|NCT01059071|567531872|FG000|Overall Study|Physician Decision|0|||
157214363|NCT01059071|567531873|FG001|Overall Study|Physician Decision|0|||
157214364|NCT01059071|567531874|FG002|Overall Study|Physician Decision|0|||
157214365|NCT01059071|567531875|FG003|Overall Study|Physician Decision|1|||
157214366|NCT02962882|567531876|FG000|Overall Study|Adverse Event|2|||
157214367|NCT02962882|567531876|FG000|Overall Study|Withdrawal by Subject|2|||
157214368|NCT02962882|567531876|FG000|Overall Study|Transfer from ICU|32|||
156869445|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
156869446|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869447|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
156869448|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869449|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
156869450|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
156869451|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869452|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
156869453|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869454|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
156869455|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
156786633|NCT01078545|565970455|FG000|Overall Study|Physician Decision|6|||
156786634|NCT01078545|565970455|FG000|Overall Study|Withdrawal by Subject|3|||
156786635|NCT01078545|565970455|FG000|Overall Study|Death|3|||
156786636|NCT01078545|565970455|FG000|Overall Study|Participant moved to another physician|1|||
156786637|NCT02497755|565970456|FG000|Overall Study|Protocol Violation|1|||
156786638|NCT02497755|565970457|FG001|Overall Study|Protocol Violation|0|||
156786639|NCT01774370|565970460|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
156786640|NCT01774370|565970460|FG000|Overall Study|Administered prior to the contract date|4|||
156786641|NCT01774370|565970460|FG000|Overall Study|Subjects of contraindications|34|||
156786642|NCT01774370|565970460|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
156786643|NCT01774370|565970460|FG000|Overall Study|Follow-up failure|34|||
156786644|NCT00514917|565970463|FG000|Overall Study|Death|4|||
156786645|NCT00514917|565970464|FG001|Overall Study|Death|10|||
156786646|NCT00514917|565970463|FG000|Overall Study|Protocol Violation|1|||
156786647|NCT00514917|565970464|FG001|Overall Study|Protocol Violation|0|||
156786648|NCT00514917|565970463|FG000|Overall Study|Lost to Follow-up|4|||
156786649|NCT00514917|565970464|FG001|Overall Study|Lost to Follow-up|3|||
156786650|NCT00514917|565970463|FG000|Overall Study|Withdrawal by Subject|18|||
156786651|NCT00514917|565970464|FG001|Overall Study|Withdrawal by Subject|16|||
156786652|NCT00514917|565970463|FG000|Overall Study|Discontinued due to study closure|88|||
156786653|NCT00514917|565970464|FG001|Overall Study|Discontinued due to study closure|81|||
156786654|NCT00514917|565970463|FG000|Overall Study|Undefined|11|||
156786655|NCT00514917|565970464|FG001|Overall Study|Undefined|5|||
156786656|NCT04243837|565970468|FG000|Overall Study|Adverse Event|2|||
156786657|NCT04243837|565970469|FG001|Overall Study|Adverse Event|1|||
156786658|NCT04243837|565970468|FG000|Overall Study|Withdrawal by Subject|4|||
156786659|NCT04243837|565970469|FG001|Overall Study|Withdrawal by Subject|2|||
156786660|NCT04243837|565970468|FG000|Overall Study|Covid-19 lock down|1|||
156786661|NCT04243837|565970469|FG001|Overall Study|Covid-19 lock down|0|||
156786662|NCT04243837|565970468|FG000|Overall Study|Study Terminated by Sponsor|11|||
156786663|NCT04243837|565970469|FG001|Overall Study|Study Terminated by Sponsor|12|||
156786664|NCT02280499|565970470|FG000|Overall Study|Death|14|||
156786665|NCT02280499|565970470|FG000|Overall Study|Lost to Follow-up|42|||
156786666|NCT02280499|565970470|FG000|Overall Study|Adverse Event|5|||
156786667|NCT03511066|565970484|FG000|Overall Study|Withdrawal by Subject|1|||
156786668|NCT03511066|565970485|FG001|Overall Study|Withdrawal by Subject|2|||
156786669|NCT03511066|565970486|FG002|Overall Study|Withdrawal by Subject|3|||
156786670|NCT03511066|565970484|FG000|Overall Study|Lost to Follow-up|2|||
156786671|NCT03511066|565970485|FG001|Overall Study|Lost to Follow-up|3|||
156786672|NCT03511066|565970486|FG002|Overall Study|Lost to Follow-up|0|||
156786673|NCT04560309|565970487|FG000|Overall Study|Meet drop out criteria|1|||
156786674|NCT04560309|565970488|FG001|Overall Study|Meet drop out criteria|1|||
156786675|NCT04146909|565970489|FG000|Overall Study|Withdrawal by Subject|3|||
156786676|NCT04146909|565970489|FG000|Overall Study|Did not qualify after consented|1|||
156786677|NCT05085405|565970490|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786678|NCT05085405|565970491|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786679|NCT05085405|565970492|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
156786680|NCT05085405|565970493|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
156786681|NCT05085405|565970494|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786682|NCT05085405|565970495|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
156786683|NCT05085405|565970490|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786684|NCT05085405|565970491|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786685|NCT05085405|565970492|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786686|NCT05085405|565970493|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
156786687|NCT05085405|565970494|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786688|NCT05085405|565970495|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
156786689|NCT01860404|565970496|FG000|Overall Study|Lost to Follow-up|3|||
156786690|NCT01860404|565970497|FG001|Overall Study|Lost to Follow-up|4|||
156786691|NCT01860404|565970498|FG002|Overall Study|Lost to Follow-up|1|||
156786692|NCT01860404|565970499|FG003|Overall Study|Lost to Follow-up|6|||
157214369|NCT03763331|567531879|FG000|Overall Study|Lost to Follow-up|1|||
156686824|NCT00104247|565596474|FG001|Overall Study|Noncompliant with dosing|1|||
156686825|NCT03314662|565596476|FG000|Overall Study|Withdrawal by Subject|1|||
156686826|NCT03314662|565596477|FG001|Overall Study|Withdrawal by Subject|1|||
156686827|NCT03314662|565596478|FG002|Overall Study|Withdrawal by Subject|1|||
156686828|NCT03314662|565596476|FG000|Overall Study|Lost to Follow-up|5|||
156686829|NCT03314662|565596477|FG001|Overall Study|Lost to Follow-up|4|||
156686830|NCT03314662|565596478|FG002|Overall Study|Lost to Follow-up|4|||
156686831|NCT03314662|565596476|FG000|Overall Study|Death|2|||
156686832|NCT03314662|565596477|FG001|Overall Study|Death|0|||
156686833|NCT03314662|565596478|FG002|Overall Study|Death|0|||
156686834|NCT01634854|565596479|FG000|Overall Study|Cesarean delivery|2|||
156686835|NCT01634854|565596480|FG001|Overall Study|Cesarean delivery|7|||
156686836|NCT01169038|565596481|FG000|Overall Study|Death|1|||
156686837|NCT01169038|565596481|FG000|Overall Study|Adverse Event|5|||
156686838|NCT01169038|565596481|FG000|Overall Study|Required antibiotic administration|1|||
156686839|NCT02490800|565596482|FG000|Overall Study|Adverse Event|0|||
156686840|NCT02490800|565596483|FG001|Overall Study|Adverse Event|0|||
156686841|NCT02490800|565596484|FG002|Overall Study|Adverse Event|0|||
156686842|NCT02490800|565596485|FG003|Overall Study|Adverse Event|2|||
156686843|NCT02490800|565596486|FG004|Overall Study|Adverse Event|3|||
156686844|NCT02490800|565596487|FG005|Overall Study|Adverse Event|2|||
156686845|NCT02490800|565596488|FG006|Overall Study|Adverse Event|0|||
156686846|NCT02490800|565596489|FG007|Overall Study|Adverse Event|0|||
156686847|NCT02490800|565596490|FG008|Overall Study|Adverse Event|0|||
156686848|NCT02490800|565596491|FG009|Overall Study|Adverse Event|0|||
156686849|NCT02490800|565596492|FG010|Overall Study|Adverse Event|0|||
156686850|NCT02490800|565596493|FG011|Overall Study|Adverse Event|2|||
156686851|NCT02490800|565596494|FG012|Overall Study|Adverse Event|2|||
156686852|NCT02490800|565596482|FG000|Overall Study|Withdrawal by Subject|0|||
156686853|NCT02490800|565596483|FG001|Overall Study|Withdrawal by Subject|0|||
156686854|NCT02490800|565596484|FG002|Overall Study|Withdrawal by Subject|0|||
156686855|NCT02490800|565596485|FG003|Overall Study|Withdrawal by Subject|1|||
156686856|NCT02490800|565596486|FG004|Overall Study|Withdrawal by Subject|0|||
156686857|NCT02490800|565596487|FG005|Overall Study|Withdrawal by Subject|0|||
156686858|NCT02490800|565596488|FG006|Overall Study|Withdrawal by Subject|0|||
156686859|NCT02490800|565596489|FG007|Overall Study|Withdrawal by Subject|0|||
156686860|NCT02490800|565596490|FG008|Overall Study|Withdrawal by Subject|1|||
156686861|NCT02490800|565596491|FG009|Overall Study|Withdrawal by Subject|0|||
156786693|NCT01860404|565970500|FG004|Overall Study|Lost to Follow-up|4|||
156786694|NCT01860404|565970496|FG000|Overall Study|Withdrawal by Subject|0|||
156786695|NCT01860404|565970497|FG001|Overall Study|Withdrawal by Subject|0|||
156786696|NCT01860404|565970498|FG002|Overall Study|Withdrawal by Subject|4|||
156786697|NCT01860404|565970499|FG003|Overall Study|Withdrawal by Subject|0|||
156786698|NCT01860404|565970500|FG004|Overall Study|Withdrawal by Subject|0|||
156786699|NCT00356421|565970502|FG000|Overall Study|Lack of Efficacy|3|||
156786700|NCT00356421|565970503|FG001|Overall Study|Lack of Efficacy|0|||
156786701|NCT00356421|565970502|FG000|Overall Study|Withdrawal by Subject|9|||
156786702|NCT00356421|565970503|FG001|Overall Study|Withdrawal by Subject|2|||
156786703|NCT00356421|565970502|FG000|Overall Study|Related to study drug|15|||
156786704|NCT00356421|565970503|FG001|Overall Study|Related to study drug|12|||
156786705|NCT00356421|565970502|FG000|Overall Study|Not related to study drug|5|||
156786706|NCT00356421|565970503|FG001|Overall Study|Not related to study drug|3|||
156786707|NCT00663351|565970504|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
156786708|NCT00663351|565970505|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
156786709|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
156786710|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
156786711|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
156786712|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
156786713|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
156786714|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
156786715|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
156786716|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
156786717|NCT00663351|565970504|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
156786718|NCT00663351|565970505|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
156786719|NCT03336866|565970506|FG000|Overall Study|Lost to Follow-up|2|||
156786720|NCT03336866|565970507|FG001|Overall Study|Lost to Follow-up|0|||
156686862|NCT02490800|565596492|FG010|Overall Study|Withdrawal by Subject|0|||
156686863|NCT02490800|565596493|FG011|Overall Study|Withdrawal by Subject|0|||
156686864|NCT02490800|565596494|FG012|Overall Study|Withdrawal by Subject|0|||
156686865|NCT02490800|565596482|FG000|Overall Study|Progressive disease|3|||
156686866|NCT02490800|565596483|FG001|Overall Study|Progressive disease|3|||
156686867|NCT02490800|565596484|FG002|Overall Study|Progressive disease|3|||
156786721|NCT03336866|565970508|FG002|Overall Study|Lost to Follow-up|3|||
156686868|NCT02490800|565596485|FG003|Overall Study|Progressive disease|4|||
156686869|NCT02490800|565596486|FG004|Overall Study|Progressive disease|4|||
156686870|NCT02490800|565596487|FG005|Overall Study|Progressive disease|1|||
156686871|NCT02490800|565596488|FG006|Overall Study|Progressive disease|4|||
156686872|NCT02490800|565596489|FG007|Overall Study|Progressive disease|3|||
156686873|NCT02490800|565596490|FG008|Overall Study|Progressive disease|6|||
156686874|NCT02490800|565596491|FG009|Overall Study|Progressive disease|2|||
156686875|NCT02490800|565596492|FG010|Overall Study|Progressive disease|7|||
156686876|NCT02490800|565596493|FG011|Overall Study|Progressive disease|1|||
156686877|NCT02490800|565596494|FG012|Overall Study|Progressive disease|10|||
156686878|NCT02490800|565596482|FG000|Overall Study|Patient enrolled in post-trial access|0|||
156686879|NCT02490800|565596483|FG001|Overall Study|Patient enrolled in post-trial access|0|||
156686880|NCT02490800|565596484|FG002|Overall Study|Patient enrolled in post-trial access|0|||
156686881|NCT02490800|565596485|FG003|Overall Study|Patient enrolled in post-trial access|0|||
156686882|NCT02490800|565596486|FG004|Overall Study|Patient enrolled in post-trial access|0|||
156686883|NCT02490800|565596487|FG005|Overall Study|Patient enrolled in post-trial access|0|||
156686884|NCT02490800|565596488|FG006|Overall Study|Patient enrolled in post-trial access|0|||
156686885|NCT02490800|565596489|FG007|Overall Study|Patient enrolled in post-trial access|0|||
156686886|NCT02490800|565596490|FG008|Overall Study|Patient enrolled in post-trial access|0|||
156686887|NCT02490800|565596491|FG009|Overall Study|Patient enrolled in post-trial access|1|||
156686888|NCT02490800|565596492|FG010|Overall Study|Patient enrolled in post-trial access|1|||
156686889|NCT02490800|565596493|FG011|Overall Study|Patient enrolled in post-trial access|0|||
156686890|NCT02490800|565596494|FG012|Overall Study|Patient enrolled in post-trial access|6|||
156686891|NCT03257254|565596495|FG000|Overall Study|Withdrawal by Subject|7|||
156686892|NCT03257254|565596495|FG000|Overall Study|Lost to Follow-up|9|||
156686893|NCT03257254|565596495|FG000|Overall Study|Study discontinued by sponsor|5|||
156686894|NCT03365791|565596496|FG000|Overall Study|Adverse Event|5|||
156686895|NCT03365791|565596496|FG000|Overall Study|Death|1|||
156686896|NCT03365791|565596496|FG000|Overall Study|Lost to Follow-up|1|||
156686897|NCT03365791|565596496|FG000|Overall Study|Physician Decision|9|||
156686898|NCT03365791|565596496|FG000|Overall Study|Progressive disease|51|||
156686899|NCT03365791|565596496|FG000|Overall Study|Subject/guardian decision|5|||
156686900|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
156686901|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686902|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686903|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156786722|NCT03336866|565970506|FG000|Overall Study|Withdrawal by Subject|1|||
156786723|NCT03336866|565970507|FG001|Overall Study|Withdrawal by Subject|1|||
156786724|NCT03336866|565970508|FG002|Overall Study|Withdrawal by Subject|0|||
156786725|NCT03336866|565970506|FG000|Overall Study|Noncompliance with clinic house rules|0|||
156786726|NCT03336866|565970507|FG001|Overall Study|Noncompliance with clinic house rules|0|||
156786727|NCT03336866|565970508|FG002|Overall Study|Noncompliance with clinic house rules|1|||
156786728|NCT03462563|565970509|FG000|Overall Study|Death|1|||
156786729|NCT03462563|565970510|FG001|Overall Study|Death|1|||
156869456|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869457|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
156869458|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869459|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
156869460|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
156869461|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869462|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
156869463|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869464|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
156869465|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
156869466|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869467|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
156869468|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Death|0|||
156869469|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Death|6|||
156869470|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Death|3|||
156869471|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Death|0|||
156869472|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Death|0|||
156869473|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869474|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
156869475|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
157214370|NCT03763331|567531880|FG001|Overall Study|Lost to Follow-up|0|||
156686904|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686905|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686906|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686907|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686908|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
156686909|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
156686910|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686911|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156786730|NCT03462563|565970509|FG000|Overall Study|Termination of study|2|||
156686912|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686913|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686914|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686915|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686916|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686917|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
156686918|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
156686919|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686920|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686921|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156786731|NCT03462563|565970510|FG001|Overall Study|Termination of study|1|||
156786732|NCT03462563|565970509|FG000|Overall Study|Adverse Event|1|||
156786733|NCT03462563|565970510|FG001|Overall Study|Adverse Event|3|||
156786734|NCT03462563|565970509|FG000|Overall Study|Unspecified reason|10|||
156786735|NCT03462563|565970510|FG001|Overall Study|Unspecified reason|12|||
156786736|NCT03462563|565970509|FG000|Overall Study|Physician Decision|1|||
156786737|NCT03462563|565970510|FG001|Overall Study|Physician Decision|0|||
156786738|NCT01751685|565970513|FG000|6-mo Followup|Missed study visit|1|||
156786739|NCT01751685|565970514|FG001|6-mo Followup|Missed study visit|0|||
156786740|NCT01751685|565970513|FG000|6-mo Followup|Withdrawal by Subject|2|||
156786741|NCT01751685|565970514|FG001|6-mo Followup|Withdrawal by Subject|2|||
156786742|NCT01751685|565970513|FG000|6-mo Followup|Lost to Follow-up|0|||
156786743|NCT01751685|565970514|FG001|6-mo Followup|Lost to Follow-up|1|||
156786744|NCT01751685|565970513|FG000|12-mo Followup|Lost to Follow-up|5|||
156786745|NCT01751685|565970514|FG001|12-mo Followup|Lost to Follow-up|0|||
156786746|NCT03011372|565970515|FG000|Overall Study|Death|16|||
156786747|NCT03011372|565970515|FG000|Overall Study|Lost to Follow-up|2|||
156786748|NCT03011372|565970515|FG000|Overall Study|Sponsor Decision|17|||
156786749|NCT03011372|565970515|FG000|Overall Study|Withdrawal by Subject|7|||
156786750|NCT03011372|565970515|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
156786751|NCT03011372|565970515|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
156786752|NCT03011372|565970515|FG000|Overall Study|Sponsor's Decision|2|||
156786753|NCT01179399|565970516|FG000|Overall Study|Adverse Event|1|||
156786754|NCT01179399|565970516|FG000|Overall Study|Lack of Efficacy|30|||
156786755|NCT01179399|565970516|FG000|Overall Study|Withdrawal by Subject|1|||
156786756|NCT03572218|565970517|FG000|Overall Study|Lost to Follow-up|3|||
156786757|NCT03572218|565970518|FG001|Overall Study|Lost to Follow-up|2|||
156786758|NCT03572218|565970517|FG000|Overall Study|No longer available for study visits|2|||
156786759|NCT03572218|565970518|FG001|Overall Study|No longer available for study visits|1|||
156786760|NCT03572218|565970517|FG000|Overall Study|No longer interested|1|||
156786761|NCT03572218|565970518|FG001|Overall Study|No longer interested|2|||
156786762|NCT02724644|565972723|FG000|Overall Study|Adverse Event|7|||
156786763|NCT02724644|565972724|FG001|Overall Study|Adverse Event|1|||
156786764|NCT02724644|565972723|FG000|Overall Study|Lost to Follow-up|6|||
156786765|NCT02724644|565972724|FG001|Overall Study|Lost to Follow-up|2|||
156786766|NCT02724644|565972723|FG000|Overall Study|Withdrawal by Subject|7|||
156786767|NCT02724644|565972724|FG001|Overall Study|Withdrawal by Subject|1|||
156786768|NCT02724644|565972723|FG000|Overall Study|Administrative|1|||
156786769|NCT02724644|565972724|FG001|Overall Study|Administrative|0|||
156786770|NCT00676052|565972728|FG000|Overall Study|Adverse Event|0|||
156786771|NCT00676052|565972729|FG001|Overall Study|Adverse Event|1|||
156786772|NCT00676052|565972730|FG002|Overall Study|Adverse Event|1|||
156786773|NCT00676052|565972731|FG003|Overall Study|Adverse Event|2|||
156786774|NCT00676052|565972732|FG004|Overall Study|Adverse Event|2|||
156786775|NCT00676052|565972733|FG005|Overall Study|Adverse Event|2|||
156786776|NCT00676052|565972728|FG000|Overall Study|Lack of Efficacy|2|||
156786777|NCT00676052|565972729|FG001|Overall Study|Lack of Efficacy|2|||
156786778|NCT00676052|565972730|FG002|Overall Study|Lack of Efficacy|1|||
156786779|NCT00676052|565972731|FG003|Overall Study|Lack of Efficacy|1|||
156786780|NCT00676052|565972732|FG004|Overall Study|Lack of Efficacy|2|||
156786781|NCT00676052|565972733|FG005|Overall Study|Lack of Efficacy|1|||
156786782|NCT00676052|565972728|FG000|Overall Study|Protocol Violation|5|||
156786783|NCT00676052|565972729|FG001|Overall Study|Protocol Violation|3|||
156786784|NCT00676052|565972730|FG002|Overall Study|Protocol Violation|2|||
156786785|NCT00676052|565972731|FG003|Overall Study|Protocol Violation|2|||
156786786|NCT00676052|565972732|FG004|Overall Study|Protocol Violation|1|||
156786787|NCT00676052|565972733|FG005|Overall Study|Protocol Violation|2|||
156786788|NCT00676052|565972728|FG000|Overall Study|Lost to Follow-up|0|||
156786789|NCT00676052|565972729|FG001|Overall Study|Lost to Follow-up|0|||
156786790|NCT00676052|565972730|FG002|Overall Study|Lost to Follow-up|0|||
156786791|NCT00676052|565972731|FG003|Overall Study|Lost to Follow-up|0|||
156786792|NCT00676052|565972732|FG004|Overall Study|Lost to Follow-up|1|||
156786793|NCT00676052|565972733|FG005|Overall Study|Lost to Follow-up|0|||
156786794|NCT00676052|565972728|FG000|Overall Study|Physician Decision|1|||
156786795|NCT00676052|565972729|FG001|Overall Study|Physician Decision|1|||
156786796|NCT00676052|565972730|FG002|Overall Study|Physician Decision|1|||
156686922|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686923|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686924|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686925|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686926|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
156686927|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
156686928|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686929|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686930|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686931|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686932|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686933|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686934|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686935|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
156686936|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
156686937|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686938|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686939|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686940|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686941|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686942|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686943|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686944|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
156686945|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
156686946|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686947|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686948|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686949|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686950|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686951|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686952|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686953|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
156686954|NCT00739973|565596497|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
156686955|NCT00739973|565596498|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686956|NCT00739973|565596499|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156869476|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869477|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
156869478|NCT00561925|566279020|FG000|144-week Double-blind, Double-dummy|Other|0|||
156869479|NCT00561925|566279021|FG001|144-week Double-blind, Double-dummy|Other|8|||
156869480|NCT00561925|566279022|FG002|144-week Double-blind, Double-dummy|Other|11|||
156869481|NCT00561925|566279023|FG003|144-week Double-blind, Double-dummy|Other|0|||
156869482|NCT00561925|566279024|FG004|144-week Double-blind, Double-dummy|Other|0|||
156869483|NCT00561925|566279020|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
156869484|NCT00561925|566279021|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
156869485|NCT00561925|566279022|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
156869486|NCT00561925|566279023|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
156869487|NCT00561925|566279024|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
156869488|NCT04041414|566279027|FG000|Overall Study|Lost to Follow-up|1|||
156869489|NCT04041414|566279028|FG001|Overall Study|Lost to Follow-up|2|||
156869490|NCT00665652|566279029|FG000|Overall Study|Adverse Event|4|||
156869491|NCT00665652|566279029|FG000|Overall Study|Death|1|||
156869492|NCT00665652|566279029|FG000|Overall Study|No longer met inclusion criteria.|1|||
156869493|NCT02161016|566279030|FG000|Overall Study|withdrawn by IRB|1|||
156869494|NCT00380367|566279036|FG000|Overall Study|Lost to Follow-up|1|||
156869495|NCT00380367|566279036|FG000|Overall Study|Withdrawal by Subject|1|||
156869496|NCT02504151|566279041|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
156869497|NCT02504151|566279042|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
156869498|NCT02504151|566279041|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
156869499|NCT02504151|566279042|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
156869500|NCT02504151|566279041|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156869501|NCT02504151|566279042|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156869502|NCT02504151|566279041|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
156869503|NCT02504151|566279042|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
156869504|NCT05038982|566279043|FG000|Overall Study|Withdrawal by Subject|0|||
157013467|NCT02723955|566801774|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
157013468|NCT02723955|566801775|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
156686957|NCT00739973|565596500|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686958|NCT00739973|565596501|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686959|NCT00739973|565596502|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686960|NCT00739973|565596503|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686961|NCT00739973|565596504|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686962|NCT00739973|565596505|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
156686963|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686964|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686965|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
156686966|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
156686967|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
156686968|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
156686969|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
156686970|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
156686971|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
156686972|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686973|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686974|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686975|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686976|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
156686977|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686978|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686979|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
156686980|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
156686981|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
156686982|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
156686983|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686984|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686985|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686986|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686987|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686988|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686989|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
156686990|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
156686991|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
156686992|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
156686993|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
156686994|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686995|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686996|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
156686997|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
156686998|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
156686999|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687000|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687001|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
156687002|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687003|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687004|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687005|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687006|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156687007|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
156786797|NCT00676052|565972731|FG003|Overall Study|Physician Decision|0|||
156786798|NCT00676052|565972732|FG004|Overall Study|Physician Decision|0|||
156786799|NCT00676052|565972733|FG005|Overall Study|Physician Decision|1|||
156786800|NCT00676052|565972728|FG000|Overall Study|Withdrawal by Subject|1|||
156786801|NCT00676052|565972729|FG001|Overall Study|Withdrawal by Subject|0|||
156786802|NCT00676052|565972730|FG002|Overall Study|Withdrawal by Subject|1|||
156786803|NCT00676052|565972731|FG003|Overall Study|Withdrawal by Subject|0|||
156786804|NCT00676052|565972732|FG004|Overall Study|Withdrawal by Subject|0|||
156786805|NCT00676052|565972733|FG005|Overall Study|Withdrawal by Subject|0|||
156786806|NCT02930941|565972734|FG000|Overall Study|Lost to Follow-up|1|||
156687008|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687009|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
156687010|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687011|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
156687012|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687013|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687014|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
156687015|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
156687016|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
156687017|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
156687018|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156687019|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
157013469|NCT02723955|566801776|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
156687020|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
156687021|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156687022|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
156786807|NCT02930941|565972735|FG001|Overall Study|Lost to Follow-up|2|||
156786808|NCT00527748|565972748|FG000|Overall Study|Other|3|||
156786809|NCT00710554|565972749|FG000|Overall Study|Adverse Event|24|||
156786810|NCT00710554|565972750|FG001|Overall Study|Adverse Event|7|||
156786811|NCT00710554|565972749|FG000|Overall Study|Withdrawal by Subject|7|||
156786812|NCT00710554|565972750|FG001|Overall Study|Withdrawal by Subject|3|||
156786813|NCT00710554|565972749|FG000|Overall Study|Lost to Follow-up|7|||
156786814|NCT00710554|565972750|FG001|Overall Study|Lost to Follow-up|1|||
156786815|NCT00710554|565972749|FG000|Overall Study|Lack of Efficacy|11|||
156786816|NCT00710554|565972750|FG001|Overall Study|Lack of Efficacy|12|||
156786817|NCT00710554|565972749|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
156786818|NCT00710554|565972750|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
156786819|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
156786820|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
156786821|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
156786822|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
156786823|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
156786824|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
156786825|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
156786826|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
156786827|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
156786828|NCT00292370|565972751|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
156786829|NCT00292370|565972752|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
156786830|NCT00292370|565972753|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
156786831|NCT00292370|565972751|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
156786832|NCT00292370|565972752|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
156786833|NCT00292370|565972753|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
156786834|NCT00292370|565972751|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
156786835|NCT00292370|565972752|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
156786836|NCT00292370|565972753|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
156786837|NCT01346709|565972754|FG000|Overall Study|Protocol Violation|35|||
156786838|NCT01346709|565972754|FG000|Overall Study|Lost to Follow-up|31|||
156786839|NCT01346709|565972754|FG000|Overall Study|Missing data in candidate risk factor|285|||
156786840|NCT02365064|565972763|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
156786841|NCT02365064|565972764|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
156786842|NCT02365064|565972763|FG000|Overall Study|Withdrawal by Subject|6|||
156786843|NCT02365064|565972764|FG001|Overall Study|Withdrawal by Subject|9|||
156786844|NCT02365064|565972763|FG000|Overall Study|Treatment intolerance|2|||
156786845|NCT02365064|565972764|FG001|Overall Study|Treatment intolerance|4|||
156786846|NCT02773537|565972773|FG000|Overall Study|Lost to Follow-up|0|||
156786847|NCT02773537|565972774|FG001|Overall Study|Lost to Follow-up|1|||
156786848|NCT02773537|565972775|FG002|Overall Study|Lost to Follow-up|4|||
156786849|NCT01840163|565972776|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
156786850|NCT01840163|565972777|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
156786851|NCT01840163|565972776|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
156786852|NCT01840163|565972777|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
156786853|NCT01840163|565972776|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
156786854|NCT01840163|565972777|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
156786855|NCT00662038|565972778|FG000|Overall Study|Reason not specified|3|||
156786856|NCT00662038|565972778|FG000|Overall Study|Withdrawn consent|22|||
156786857|NCT00662038|565972778|FG000|Overall Study|Withdrawal by Subject|83|||
156786858|NCT00662038|565972778|FG000|Overall Study|Sponsor decision|1|||
156869505|NCT05038982|566279044|FG001|Overall Study|Withdrawal by Subject|2|||
156869506|NCT01454102|566279048|FG000|Overall Study|Continuing in the treatment period|0|||
156869507|NCT01454102|566279049|FG001|Overall Study|Continuing in the treatment period|0|||
156869508|NCT01454102|566279050|FG002|Overall Study|Continuing in the treatment period|0|||
156869509|NCT01454102|566279051|FG003|Overall Study|Continuing in the treatment period|0|||
156869510|NCT01454102|566279052|FG004|Overall Study|Continuing in the treatment period|3|||
156869511|NCT01454102|566279053|FG005|Overall Study|Continuing in the treatment period|3|||
156869512|NCT01454102|566279054|FG006|Overall Study|Continuing in the treatment period|2|||
156869513|NCT01454102|566279055|FG007|Overall Study|Continuing in the treatment period|0|||
156869514|NCT01454102|566279056|FG008|Overall Study|Continuing in the treatment period|1|||
156869515|NCT01454102|566279057|FG009|Overall Study|Continuing in the treatment period|0|||
156869516|NCT01454102|566279058|FG010|Overall Study|Continuing in the treatment period|0|||
156869517|NCT01454102|566279059|FG011|Overall Study|Continuing in the treatment period|4|||
156869518|NCT01454102|566279060|FG012|Overall Study|Continuing in the treatment period|7|||
156869519|NCT01454102|566279061|FG013|Overall Study|Continuing in the treatment period|4|||
156869520|NCT01454102|566279062|FG014|Overall Study|Continuing in the treatment period|3|||
156869521|NCT01454102|566279063|FG015|Overall Study|Continuing in the treatment period|1|||
156869522|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
156869523|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
156869524|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
156869525|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156869526|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
156869527|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
156869528|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
156869529|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
156869530|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
156869531|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156869532|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
156869533|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
156869534|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
156869535|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
156869536|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
156869537|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
156869538|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
156869539|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
156869540|NCT03739203|566279066|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
156869541|NCT03739203|566279067|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
156869542|NCT03739203|566279068|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
156869543|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
156869544|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
156869545|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
156869546|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
156869547|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
156869548|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
156869549|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
156869550|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
156869551|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
156869552|NCT03739203|566279066|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
156869553|NCT03739203|566279067|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
156869554|NCT03739203|566279068|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
156869555|NCT01782378|566279069|FG000|First Series|Lost to Follow-up|7|||
156869556|NCT01782378|566279070|FG001|First Series|Lost to Follow-up|8|||
156869557|NCT01782378|566279069|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
156869558|NCT01782378|566279070|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
156869559|NCT01782378|566279069|FG000|Second Series|Lost to Follow-up|8|||
156869560|NCT01782378|566279070|FG001|Second Series|Lost to Follow-up|7|||
156869561|NCT01782378|566279069|FG000|Second Series|Did not choose to complete S2 Optional|18|||
156687023|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
156687024|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
156687025|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
156687026|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687027|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687028|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687029|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156869562|NCT01782378|566279070|FG001|Second Series|Did not choose to complete S2 Optional|0|||
156869563|NCT00830440|566279071|FG000|Overall Study|Protocol Violation|1|||
156687030|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687031|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687032|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
156687033|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687034|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
156687035|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
156687036|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156687037|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
156687038|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687039|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156786859|NCT00662038|565972778|FG000|Overall Study|Physician Decision|19|||
156786860|NCT00662038|565972778|FG000|Overall Study|Lung transplantation|44|||
156786861|NCT00662038|565972778|FG000|Overall Study|Lost to Follow-up|1|||
156786862|NCT00662038|565972778|FG000|Overall Study|Death|95|||
156786863|NCT00662038|565972778|FG000|Overall Study|Adverse Event|358|||
156786864|NCT00662038|565972778|FG000|Overall Study|Continued treatment|5|||
156786865|NCT02421510|565972780|FG000|Overall Study|Other|4|||
156786866|NCT02421510|565972781|FG001|Overall Study|Other|2|||
156786867|NCT02421510|565972782|FG002|Overall Study|Other|3|||
156786868|NCT02421510|565972780|FG000|Overall Study|Protocol Violation|1|||
156786869|NCT02421510|565972781|FG001|Overall Study|Protocol Violation|2|||
156786870|NCT02421510|565972782|FG002|Overall Study|Protocol Violation|0|||
156786871|NCT02421510|565972780|FG000|Overall Study|Death|1|||
156786872|NCT02421510|565972781|FG001|Overall Study|Death|0|||
156786873|NCT02421510|565972782|FG002|Overall Study|Death|0|||
156786874|NCT02421510|565972780|FG000|Overall Study|Noncompliance with study drug|1|||
156786875|NCT02421510|565972781|FG001|Overall Study|Noncompliance with study drug|0|||
156786876|NCT02421510|565972782|FG002|Overall Study|Noncompliance with study drug|0|||
156786877|NCT02421510|565972780|FG000|Overall Study|Physician Decision|1|||
156786878|NCT02421510|565972781|FG001|Overall Study|Physician Decision|1|||
156786879|NCT02421510|565972782|FG002|Overall Study|Physician Decision|3|||
156786880|NCT02421510|565972780|FG000|Overall Study|Adverse Event|9|||
156786881|NCT02421510|565972781|FG001|Overall Study|Adverse Event|10|||
156786882|NCT02421510|565972782|FG002|Overall Study|Adverse Event|18|||
156786883|NCT02421510|565972780|FG000|Overall Study|Pregnancy|1|||
156786884|NCT02421510|565972781|FG001|Overall Study|Pregnancy|1|||
156786885|NCT02421510|565972782|FG002|Overall Study|Pregnancy|0|||
156786886|NCT02421510|565972780|FG000|Overall Study|Withdrawal by Subject|14|||
156786887|NCT02421510|565972781|FG001|Overall Study|Withdrawal by Subject|18|||
156786888|NCT02421510|565972782|FG002|Overall Study|Withdrawal by Subject|12|||
156786889|NCT02421510|565972780|FG000|Overall Study|Lost to Follow-up|1|||
156786890|NCT02421510|565972781|FG001|Overall Study|Lost to Follow-up|1|||
156786891|NCT02421510|565972782|FG002|Overall Study|Lost to Follow-up|0|||
156786892|NCT03774810|565972783|FG000|Phase 1|Lack of Efficacy|21|||
156786893|NCT03774810|565972784|FG001|Phase 1|Lack of Efficacy|0|||
156786894|NCT03774810|565972785|FG002|Phase 1|Lack of Efficacy|0|||
156786895|NCT03774810|565972786|FG003|Phase 1|Lack of Efficacy|0|||
156786896|NCT03774810|565972787|FG004|Phase 1|Lack of Efficacy|0|||
156786897|NCT03774810|565972783|FG000|Phase 1|Withdrawal by Subject|9|||
156786898|NCT03774810|565972784|FG001|Phase 1|Withdrawal by Subject|0|||
156786899|NCT03774810|565972785|FG002|Phase 1|Withdrawal by Subject|0|||
156786900|NCT03774810|565972786|FG003|Phase 1|Withdrawal by Subject|0|||
156786901|NCT03774810|565972787|FG004|Phase 1|Withdrawal by Subject|0|||
156786902|NCT03774810|565972783|FG000|Phase 1|Lost to Follow-up|2|||
156786903|NCT03774810|565972784|FG001|Phase 1|Lost to Follow-up|0|||
156786904|NCT03774810|565972785|FG002|Phase 1|Lost to Follow-up|0|||
156786905|NCT03774810|565972786|FG003|Phase 1|Lost to Follow-up|0|||
156786906|NCT03774810|565972787|FG004|Phase 1|Lost to Follow-up|0|||
156786907|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
156786908|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
156786909|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
156786910|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
156786911|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
156687040|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
156786912|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
156786913|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
157214371|NCT03763331|567531879|FG000|Overall Study|Withdrawal by Subject|1|||
156786914|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
156786915|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
156786916|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
156786917|NCT03774810|565972783|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786918|NCT03774810|565972784|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
156786919|NCT03774810|565972785|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786920|NCT03774810|565972786|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786921|NCT03774810|565972787|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
156786922|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
156869564|NCT00830440|566279072|FG001|Overall Study|Protocol Violation|0|||
157013470|NCT02723955|566801777|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
156687041|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687042|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
156687043|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
156687044|NCT00739973|565596497|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687045|NCT00739973|565596498|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
156687046|NCT00739973|565596499|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687047|NCT00739973|565596500|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687048|NCT00739973|565596501|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687049|NCT00739973|565596502|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687050|NCT00739973|565596503|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
156687051|NCT00739973|565596504|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687052|NCT00739973|565596505|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
156687053|NCT00109837|565599206|FG000|Overall Study|Adverse Event|2|||
156687054|NCT00109837|565599206|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
156687055|NCT00109837|565599206|FG000|Overall Study|Death|1|||
156687056|NCT00109837|565599206|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
156687057|NCT00109837|565599206|FG000|Overall Study|Not treated|1|||
156687058|NCT00109837|565599206|FG000|Overall Study|Ineligible|1|||
156687059|NCT01989676|565599207|FG000|Overall Study|Death|52|||
156687060|NCT01989676|565599208|FG001|Overall Study|Death|60|||
156687061|NCT01989676|565599207|FG000|Overall Study|Protocol Violation|2|||
156687062|NCT01989676|565599208|FG001|Overall Study|Protocol Violation|1|||
156687063|NCT01989676|565599207|FG000|Overall Study|Lost to Follow-up|8|||
156687064|NCT01989676|565599208|FG001|Overall Study|Lost to Follow-up|18|||
156687065|NCT01989676|565599207|FG000|Overall Study|No longer willing to participate in study|26|||
156687066|NCT01989676|565599208|FG001|Overall Study|No longer willing to participate in study|26|||
156687067|NCT01989676|565599207|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
156687068|NCT01989676|565599208|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
156687069|NCT01989676|565599207|FG000|Overall Study|Other|4|||
156786923|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
156786924|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
156786925|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
156786926|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
156786927|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
156786928|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
156786929|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
156786930|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
156786931|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
156786932|NCT03774810|565972783|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786933|NCT03774810|565972784|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786934|NCT03774810|565972785|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
156786935|NCT03774810|565972786|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
156786936|NCT03774810|565972787|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
156786937|NCT00927186|565972790|FG000|12 Months Primary Study|Adverse Event|5|||
156786938|NCT00927186|565972791|FG001|12 Months Primary Study|Adverse Event|2|||
156786939|NCT00927186|565972790|FG000|12 Months Primary Study|Lost to Follow-up|1|||
156786940|NCT00927186|565972791|FG001|12 Months Primary Study|Lost to Follow-up|0|||
156786941|NCT00927186|565972790|FG000|12 Months Primary Study|Protocol Violation|0|||
156786942|NCT00927186|565972791|FG001|12 Months Primary Study|Protocol Violation|1|||
156786943|NCT00927186|565972790|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
156786944|NCT00927186|565972791|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
156786945|NCT04641975|565972797|FG000|Overall Study|Protocol Violation|1|||
156786946|NCT04641975|565972798|FG001|Overall Study|Protocol Violation|2|||
156786947|NCT04641975|565972799|FG002|Overall Study|Protocol Violation|0|||
156786948|NCT04641975|565972800|FG003|Overall Study|Protocol Violation|0|||
156786949|NCT04641975|565972797|FG000|Overall Study|Adverse Event|0|||
156687070|NCT01989676|565599208|FG001|Overall Study|Other|3|||
156687071|NCT01619579|565599209|FG000|Overall Study|Withdrawal by Subject|0|||
156687072|NCT01619579|565599210|FG001|Overall Study|Withdrawal by Subject|3|||
156786950|NCT04641975|565972798|FG001|Overall Study|Adverse Event|0|||
156786951|NCT04641975|565972799|FG002|Overall Study|Adverse Event|1|||
157013471|NCT02723955|566801778|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
156786952|NCT04641975|565972800|FG003|Overall Study|Adverse Event|1|||
157013472|NCT02723955|566801779|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
156687073|NCT02938442|565599212|FG000|Overall Study|Death|0|||
156687074|NCT02938442|565599213|FG001|Overall Study|Death|1|||
157013473|NCT05096819|566801782|FG000|Overall Study|Withdrawal by Subject|3|||
156687075|NCT02938442|565599212|FG000|Overall Study|Lost to Follow-up|0|||
156687076|NCT02938442|565599213|FG001|Overall Study|Lost to Follow-up|1|||
156687077|NCT02938442|565599212|FG000|Overall Study|Physician Decision|0|||
156687078|NCT02938442|565599213|FG001|Overall Study|Physician Decision|1|||
156869565|NCT00830440|566279071|FG000|Overall Study|Withdrawal by Subject|1|||
156687079|NCT02938442|565599212|FG000|Overall Study|Withdrawal by Subject|2|||
156687080|NCT02938442|565599213|FG001|Overall Study|Withdrawal by Subject|0|||
156687081|NCT01115855|565599214|FG000|Overall Study|Adverse Event|16|||
156687082|NCT01115855|565599215|FG001|Overall Study|Adverse Event|18|||
156687083|NCT01115855|565599214|FG000|Overall Study|Death|6|||
156687084|NCT01115855|565599215|FG001|Overall Study|Death|5|||
156687085|NCT01115855|565599214|FG000|Overall Study|Lab Abnormality|1|||
156687086|NCT01115855|565599215|FG001|Overall Study|Lab Abnormality|1|||
156687087|NCT01115855|565599214|FG000|Overall Study|Protocol Violation|0|||
156687088|NCT01115855|565599215|FG001|Overall Study|Protocol Violation|1|||
156687089|NCT01115855|565599214|FG000|Overall Study|Withdrawal by Subject|5|||
156687090|NCT01115855|565599215|FG001|Overall Study|Withdrawal by Subject|5|||
156687091|NCT01115855|565599214|FG000|Overall Study|Other|8|||
156687092|NCT01115855|565599215|FG001|Overall Study|Other|6|||
156687093|NCT01684215|565599216|FG000|Phase 1, Part 1|Adverse Event|1|||
156687094|NCT01684215|565599217|FG001|Phase 1, Part 1|Adverse Event|0|||
156687095|NCT01684215|565599218|FG002|Phase 1, Part 1|Adverse Event|0|||
156687096|NCT01684215|565599219|FG003|Phase 1, Part 1|Adverse Event|0|||
156687097|NCT01684215|565599216|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
156687098|NCT01684215|565599217|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
156687099|NCT01684215|565599218|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
156687100|NCT01684215|565599219|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
156687101|NCT01684215|565599216|FG000|Phase 1, Part 2|Adverse Event|0|||
156687102|NCT01684215|565599217|FG001|Phase 1, Part 2|Adverse Event|0|||
156687103|NCT01684215|565599218|FG002|Phase 1, Part 2|Adverse Event|1|||
156687104|NCT01684215|565599219|FG003|Phase 1, Part 2|Adverse Event|0|||
156687105|NCT01684215|565599216|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687106|NCT01684215|565599217|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687107|NCT01684215|565599218|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
156687108|NCT01684215|565599219|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
156687109|NCT01684215|565599216|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
156687110|NCT01684215|565599217|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
156687111|NCT01684215|565599218|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
156687112|NCT01684215|565599219|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
156687113|NCT01684215|565599216|FG000|Phase 2|Death|0|||
156687114|NCT01684215|565599217|FG001|Phase 2|Death|0|||
156869566|NCT00830440|566279072|FG001|Overall Study|Withdrawal by Subject|0|||
156687115|NCT01684215|565599218|FG002|Phase 2|Death|0|||
156869567|NCT00830440|566279071|FG000|Overall Study|unsuccessful procedure|4|||
156869568|NCT00830440|566279072|FG001|Overall Study|unsuccessful procedure|0|||
156869569|NCT00830440|566279071|FG000|Overall Study|Adverse Event|2|||
156869570|NCT00830440|566279072|FG001|Overall Study|Adverse Event|0|||
156687116|NCT01684215|565599219|FG003|Phase 2|Death|8|||
156687117|NCT01684215|565599216|FG000|Phase 2|Study terminated by sponsor|0|||
156687118|NCT01684215|565599217|FG001|Phase 2|Study terminated by sponsor|0|||
156687119|NCT01684215|565599218|FG002|Phase 2|Study terminated by sponsor|0|||
156687120|NCT01684215|565599219|FG003|Phase 2|Study terminated by sponsor|30|||
156687121|NCT01684215|565599216|FG000|Phase 2|Enrolled but not treated|0|||
156687122|NCT01684215|565599217|FG001|Phase 2|Enrolled but not treated|0|||
156687123|NCT01684215|565599218|FG002|Phase 2|Enrolled but not treated|0|||
156687124|NCT01684215|565599219|FG003|Phase 2|Enrolled but not treated|1|||
156687125|NCT01684215|565599216|FG000|Phase 2|Lost to Follow-up|0|||
156687126|NCT01684215|565599217|FG001|Phase 2|Lost to Follow-up|0|||
156687127|NCT01684215|565599218|FG002|Phase 2|Lost to Follow-up|0|||
156687128|NCT01684215|565599219|FG003|Phase 2|Lost to Follow-up|4|||
156687129|NCT00480324|565599220|FG000|Overall Study|Adverse Event|1|||
156687130|NCT00480324|565599221|FG001|Overall Study|Adverse Event|1|||
156687131|NCT00480324|565599220|FG000|Overall Study|Protocol Violation|0|||
156687132|NCT00480324|565599221|FG001|Overall Study|Protocol Violation|1|||
156687133|NCT00480324|565599220|FG000|Overall Study|Withdrawal by Subject|14|||
156687134|NCT00480324|565599221|FG001|Overall Study|Withdrawal by Subject|5|||
156687135|NCT00480324|565599220|FG000|Overall Study|Lost to Follow-up|17|||
156687136|NCT00480324|565599221|FG001|Overall Study|Lost to Follow-up|8|||
156687137|NCT00480324|565599220|FG000|Overall Study|Subject's mother pregnant|0|||
156687138|NCT00480324|565599221|FG001|Overall Study|Subject's mother pregnant|1|||
156687139|NCT00966381|565599222|FG000|Overall Study|Withdrawal by Subject|2|||
156687140|NCT00966381|565599223|FG001|Overall Study|Withdrawal by Subject|2|||
156687141|NCT01915940|565599224|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
156687142|NCT01915940|565599225|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
156687143|NCT01915940|565599226|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
156687144|NCT01915940|565599224|FG000|Treatment Period|Decision of Participant|0|||
156687145|NCT01915940|565599225|FG001|Treatment Period|Decision of Participant|1|||
156687146|NCT01915940|565599226|FG002|Treatment Period|Decision of Participant|3|||
156869571|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
156687147|NCT01915940|565599224|FG000|Treatment Period|Adverse Event|0|||
156687148|NCT01915940|565599225|FG001|Treatment Period|Adverse Event|9|||
156687149|NCT01915940|565599226|FG002|Treatment Period|Adverse Event|1|||
156687150|NCT01915940|565599224|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
156687151|NCT01915940|565599225|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
156687152|NCT01915940|565599226|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
156869572|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
156869573|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
156869574|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
156869575|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
156869576|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
156869577|NCT02592798|566279073|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
156687153|NCT03686150|565599227|FG000|Overall Study|Withdrawal by Subject|1|||
156687154|NCT03686150|565599228|FG001|Overall Study|Withdrawal by Subject|1|||
156687155|NCT03686150|565599229|FG002|Overall Study|Withdrawal by Subject|1|||
156687156|NCT03686150|565599230|FG003|Overall Study|Withdrawal by Subject|0|||
156687157|NCT03686150|565599231|FG004|Overall Study|Withdrawal by Subject|1|||
156687158|NCT03686150|565599232|FG005|Overall Study|Withdrawal by Subject|2|||
156687159|NCT03686150|565599227|FG000|Overall Study|Physician Decision|1|||
156687160|NCT03686150|565599228|FG001|Overall Study|Physician Decision|0|||
156687161|NCT03686150|565599229|FG002|Overall Study|Physician Decision|0|||
156687162|NCT03686150|565599230|FG003|Overall Study|Physician Decision|0|||
156687163|NCT03686150|565599231|FG004|Overall Study|Physician Decision|0|||
156687164|NCT03686150|565599232|FG005|Overall Study|Physician Decision|1|||
156687165|NCT03686150|565599227|FG000|Overall Study|Lost to Follow-up|0|||
156687166|NCT03686150|565599228|FG001|Overall Study|Lost to Follow-up|1|||
156786953|NCT04641975|565972797|FG000|Overall Study|Withdrawal by Subject|1|||
156786954|NCT04641975|565972798|FG001|Overall Study|Withdrawal by Subject|0|||
156786955|NCT04641975|565972799|FG002|Overall Study|Withdrawal by Subject|0|||
156786956|NCT04641975|565972800|FG003|Overall Study|Withdrawal by Subject|0|||
156786957|NCT02264821|565972802|FG000|Overall Study|Protocol Violation|1|||
156786958|NCT02264821|565972803|FG001|Overall Study|Protocol Violation|3|||
156786959|NCT02264821|565972804|FG002|Overall Study|Protocol Violation|6|||
156786960|NCT03142334|565972806|FG000|Overall Study|Death|18|||
156786961|NCT03142334|565972807|FG001|Overall Study|Death|33|||
156786962|NCT03142334|565972806|FG000|Overall Study|Withdrawal by Subject|15|||
156786963|NCT03142334|565972807|FG001|Overall Study|Withdrawal by Subject|11|||
156786964|NCT03142334|565972806|FG000|Overall Study|Ongoing on trial follow up|463|||
156786965|NCT03142334|565972807|FG001|Overall Study|Ongoing on trial follow up|454|||
156786966|NCT04865978|565972808|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
156786967|NCT04865978|565972809|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
156786968|NCT05587998|565972810|FG000|Overall Study|Withdrawal by Subject|1|||
156786969|NCT05587998|565972811|FG001|Overall Study|Withdrawal by Subject|1|||
156786970|NCT05587998|565972810|FG000|Overall Study|Not treated|3|||
156786971|NCT05587998|565972811|FG001|Overall Study|Not treated|1|||
156786972|NCT05587998|565972810|FG000|Overall Study|Non-compliance with study procedures|0|||
156786973|NCT05587998|565972811|FG001|Overall Study|Non-compliance with study procedures|1|||
156786974|NCT03528577|565972814|FG000|Sequence 1|Failed Spirometry|1|||
156786975|NCT03528577|565972814|FG000|Sequence 1|Restricted medication|1|||
156786976|NCT03528577|565972814|FG000|Sequence 2|Adverse Event|1|||
156786977|NCT03528577|565972814|FG000|Sequence 2|Withdrawal by Subject|1|||
156786978|NCT03528577|565972814|FG000|Sequence 2|Failed Spirometry|1|||
156786979|NCT03528577|565972814|FG000|Sequence 3|Failed Spirometry|1|||
156786980|NCT03528577|565972814|FG000|Sequence 4|Failed Spirometry|2|||
156786981|NCT03528577|565972814|FG000|Sequence 4|Adverse Event|1|||
156786982|NCT04882215|565972815|FG000|Overall Study|Withdrawal by Subject|5|||
156786983|NCT04882215|565972816|FG001|Overall Study|Withdrawal by Subject|0|||
156786984|NCT03835117|565972817|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
156786985|NCT03835117|565972818|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
156786986|NCT04263532|565972819|FG000|Overall Study|Withdrawal by Subject|2|||
156786987|NCT04263532|565972820|FG001|Overall Study|Withdrawal by Subject|0|||
156786988|NCT06083493|565972821|FG000|Overall Study|Technical issues with the interventional device|2|||
156869578|NCT02592798|566279074|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
156687167|NCT03686150|565599229|FG002|Overall Study|Lost to Follow-up|0|||
156869579|NCT02592798|566279073|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
157214372|NCT03763331|567531880|FG001|Overall Study|Withdrawal by Subject|0|||
156687168|NCT03686150|565599230|FG003|Overall Study|Lost to Follow-up|0|||
156786989|NCT06083493|565972822|FG001|Overall Study|Technical issues with the interventional device|2|||
156687169|NCT03686150|565599231|FG004|Overall Study|Lost to Follow-up|0|||
156786990|NCT06083493|565972821|FG000|Overall Study|Performed incorrect visual task|1|||
156786991|NCT06083493|565972822|FG001|Overall Study|Performed incorrect visual task|0|||
156786992|NCT06083493|565972821|FG000|Overall Study|Insufficient baseline performance|0|||
156786993|NCT06083493|565972822|FG001|Overall Study|Insufficient baseline performance|1|||
156786994|NCT03225989|565972826|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
156687170|NCT03686150|565599232|FG005|Overall Study|Lost to Follow-up|0|||
156786995|NCT03225989|565972827|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
156786996|NCT03225989|565972828|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
156786997|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
156786998|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
156786999|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
156787000|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156787001|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
156787002|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
156787003|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
156787004|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
156787005|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
156787006|NCT03225989|565972826|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
156787007|NCT03225989|565972827|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
156787008|NCT03225989|565972828|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
156787009|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
156787010|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
156787011|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
156787012|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
156787013|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
156787014|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
156787015|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
156787016|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
156787017|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
156787018|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
156687171|NCT00983918|565599235|FG000|Overall Study|conversion to open cholecystectomy|0|||
156687172|NCT00983918|565599236|FG001|Overall Study|conversion to open cholecystectomy|2|||
156687173|NCT00983918|565599237|FG002|Overall Study|conversion to open cholecystectomy|2|||
156687174|NCT00983918|565599238|FG003|Overall Study|conversion to open cholecystectomy|2|||
156687175|NCT00988208|565599254|FG000|Overall Study|Adverse Event|71|||
156687176|NCT00988208|565599255|FG001|Overall Study|Adverse Event|122|||
156687177|NCT00988208|565599254|FG000|Overall Study|Disease Progression|103|||
156687178|NCT00988208|565599255|FG001|Overall Study|Disease Progression|89|||
156687179|NCT00988208|565599254|FG000|Overall Study|Withdrawal by Subject|50|||
156687180|NCT00988208|565599255|FG001|Overall Study|Withdrawal by Subject|57|||
156687181|NCT00988208|565599254|FG000|Overall Study|Death|9|||
156687182|NCT00988208|565599255|FG001|Overall Study|Death|15|||
156687183|NCT00988208|565599254|FG000|Overall Study|Lost to Follow-up|2|||
156687184|NCT00988208|565599255|FG001|Overall Study|Lost to Follow-up|3|||
156687185|NCT00988208|565599254|FG000|Overall Study|Protocol Violation|9|||
156687186|NCT00988208|565599255|FG001|Overall Study|Protocol Violation|2|||
156687187|NCT00988208|565599254|FG000|Overall Study|Sponsor Decision|102|||
156687188|NCT00988208|565599255|FG001|Overall Study|Sponsor Decision|78|||
156687189|NCT00988208|565599254|FG000|Overall Study|Clinical Progression|17|||
156687190|NCT00988208|565599255|FG001|Overall Study|Clinical Progression|16|||
156687191|NCT00988208|565599254|FG000|Overall Study|Biochemical Progression|21|||
156687192|NCT00988208|565599255|FG001|Overall Study|Biochemical Progression|7|||
156687193|NCT00988208|565599254|FG000|Overall Study|Clinical Deterioration|7|||
156687194|NCT00988208|565599255|FG001|Overall Study|Clinical Deterioration|14|||
156687195|NCT00988208|565599254|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
156687196|NCT00988208|565599255|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
156687197|NCT00988208|565599254|FG000|Overall Study|Other|8|||
156687198|NCT00988208|565599255|FG001|Overall Study|Other|3|||
156687199|NCT01796964|565599256|FG000|Overall Study|Adverse Event|1|||
156687200|NCT01796964|565599257|FG001|Overall Study|Adverse Event|1|||
156687201|NCT01796964|565599256|FG000|Overall Study|Death|1|||
156687202|NCT01796964|565599257|FG001|Overall Study|Death|0|||
156687203|NCT01796964|565599256|FG000|Overall Study|Protocol Violation|0|||
156687204|NCT01796964|565599257|FG001|Overall Study|Protocol Violation|1|||
156687205|NCT01796964|565599256|FG000|Overall Study|Withdrawal by Subject|1|||
156687206|NCT01796964|565599257|FG001|Overall Study|Withdrawal by Subject|1|||
156787019|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
156687207|NCT04025684|565599258|FG000|Overall Study|Withdrawal by Subject|1|||
156687208|NCT04025684|565599259|FG001|Overall Study|Withdrawal by Subject|1|||
156687209|NCT04025684|565599260|FG002|Overall Study|Withdrawal by Subject|0|||
156687210|NCT04025684|565599261|FG003|Overall Study|Withdrawal by Subject|0|||
156687211|NCT04025684|565599258|FG000|Overall Study|Multiple reasons|1|||
156687212|NCT04025684|565599259|FG001|Overall Study|Multiple reasons|3|||
156687213|NCT04025684|565599260|FG002|Overall Study|Multiple reasons|0|||
156687214|NCT04025684|565599261|FG003|Overall Study|Multiple reasons|1|||
156687215|NCT01844531|565599262|FG000|Overall Study|Withdrawal by Subject|0|||
156687216|NCT01844531|565599263|FG001|Overall Study|Withdrawal by Subject|1|||
156687217|NCT01844531|565599264|FG002|Overall Study|Withdrawal by Subject|0|||
156687218|NCT01844531|565599265|FG003|Overall Study|Withdrawal by Subject|0|||
156687219|NCT01546922|565599274|FG000|First Period of 10 Weeks|Protocol Violation|3|||
156687220|NCT01546922|565599275|FG001|First Period of 10 Weeks|Protocol Violation|1|||
156687221|NCT01546922|565599274|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
156687222|NCT01546922|565599275|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
156787020|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
156787021|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
156787022|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
156687223|NCT01546922|565599274|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
156687224|NCT01546922|565599275|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
156687225|NCT01546922|565599274|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
156687226|NCT01546922|565599275|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
156687227|NCT01546922|565599274|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
156687228|NCT01546922|565599275|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
156687229|NCT01613378|565599283|FG000|Overall Study|Lack of Efficacy|13|||
156687230|NCT01613378|565599283|FG000|Overall Study|Adverse Event|11|||
156687231|NCT01613378|565599283|FG000|Overall Study|Withdrawal by Subject|8|||
156687232|NCT01613378|565599283|FG000|Overall Study|Death|2|||
156687233|NCT01613378|565599283|FG000|Overall Study|Lost to Follow-up|1|||
156687234|NCT01613378|565599283|FG000|Overall Study|Other Reason|4|||
156687235|NCT02000531|565599284|FG000|Overall Study|Lost to Follow-up|1|||
156687236|NCT02000531|565599285|FG001|Overall Study|Lost to Follow-up|0|||
156687237|NCT02000531|565599284|FG000|Overall Study|Discontinued due to data cut-off|3|||
156687238|NCT02000531|565599285|FG001|Overall Study|Discontinued due to data cut-off|8|||
156687239|NCT00794417|565599286|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687240|NCT00794417|565599287|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687241|NCT00794417|565599288|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
156687242|NCT00794417|565599289|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
156687243|NCT00794417|565599286|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
156687244|NCT00794417|565599287|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
156687245|NCT00794417|565599288|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
156687246|NCT00794417|565599289|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
156687247|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687248|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687249|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
156687250|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
156687251|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687252|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687253|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
156687254|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
156687255|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687256|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687257|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
156687258|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
156687259|NCT00794417|565599286|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687260|NCT00794417|565599287|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687261|NCT00794417|565599288|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
156687262|NCT00794417|565599289|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
156687263|NCT00317642|565599295|FG000|Overall Study|Not Received Either Study Drug|1|||
156687264|NCT00317642|565599296|FG001|Overall Study|Not Received Either Study Drug|3|||
156687265|NCT00317642|565599295|FG000|Overall Study|Physician Decision|15|||
156687266|NCT00317642|565599296|FG001|Overall Study|Physician Decision|7|||
156687267|NCT00317642|565599295|FG000|Overall Study|Participant declined treatment|14|||
156687268|NCT00317642|565599296|FG001|Overall Study|Participant declined treatment|3|||
156687269|NCT00317642|565599295|FG000|Overall Study|Adverse Event|17|||
156687270|NCT00317642|565599296|FG001|Overall Study|Adverse Event|5|||
156687271|NCT00317642|565599295|FG000|Overall Study|Treatment Failure|56|||
156687272|NCT00317642|565599296|FG001|Overall Study|Treatment Failure|102|||
156687273|NCT00317642|565599295|FG000|Overall Study|Disease Recurrence|1|||
156687274|NCT00317642|565599296|FG001|Overall Study|Disease Recurrence|2|||
156687275|NCT00317642|565599295|FG000|Overall Study|Death|14|||
156687276|NCT00317642|565599296|FG001|Overall Study|Death|7|||
156687277|NCT00317642|565599295|FG000|Overall Study|Not Continue to Consolidation|2|||
156687278|NCT00317642|565599296|FG001|Overall Study|Not Continue to Consolidation|0|||
156687279|NCT00317642|565599295|FG000|Overall Study|Withdrawal by Subject|0|||
156687280|NCT00317642|565599296|FG001|Overall Study|Withdrawal by Subject|1|||
156687281|NCT00317642|565599295|FG000|Overall Study|Referred For Transplantation|1|||
156687282|NCT00317642|565599296|FG001|Overall Study|Referred For Transplantation|0|||
156687283|NCT00317642|565599295|FG000|Overall Study|AML Not Centrally Confirmed|1|||
156687284|NCT00317642|565599296|FG001|Overall Study|AML Not Centrally Confirmed|5|||
156687285|NCT00255151|565599297|FG000|Overall Study|Adverse Event|10|||
156787023|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
156787024|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
156787025|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
156787026|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
156787027|NCT03225989|565972826|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
156787028|NCT03225989|565972827|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
156787029|NCT03225989|565972828|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
156787030|NCT03093870|565972832|FG000|Overall Study|Withdrawal by Subject|2|||
156787031|NCT03093870|565972833|FG001|Overall Study|Withdrawal by Subject|6|||
156787032|NCT03093870|565972834|FG002|Overall Study|Withdrawal by Subject|5|||
156787033|NCT03093870|565972832|FG000|Overall Study|Death|1|||
156787034|NCT03093870|565972833|FG001|Overall Study|Death|35|||
156787035|NCT03093870|565972834|FG002|Overall Study|Death|35|||
156787036|NCT03093870|565972832|FG000|Overall Study|Radiographic disease progression|10|||
156787037|NCT03093870|565972833|FG001|Overall Study|Radiographic disease progression|0|||
156787038|NCT03093870|565972834|FG002|Overall Study|Radiographic disease progression|0|||
156787039|NCT03093870|565972832|FG000|Overall Study|Clinical disease progression|1|||
156787040|NCT03093870|565972833|FG001|Overall Study|Clinical disease progression|0|||
156787041|NCT03093870|565972834|FG002|Overall Study|Clinical disease progression|0|||
156787042|NCT03093870|565972832|FG000|Overall Study|Physician Decision|2|||
156787043|NCT03093870|565972833|FG001|Overall Study|Physician Decision|0|||
156787044|NCT03093870|565972834|FG002|Overall Study|Physician Decision|0|||
156787045|NCT03093870|565972832|FG000|Overall Study|Adverse Event|7|||
156787046|NCT03093870|565972833|FG001|Overall Study|Adverse Event|0|||
156787047|NCT03093870|565972834|FG002|Overall Study|Adverse Event|0|||
156787048|NCT03093870|565972832|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
156787049|NCT03093870|565972833|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
156787050|NCT03093870|565972834|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
156787051|NCT03093870|565972832|FG000|Overall Study|Lost to Follow-up|0|||
156787052|NCT03093870|565972833|FG001|Overall Study|Lost to Follow-up|0|||
156787053|NCT03093870|565972834|FG002|Overall Study|Lost to Follow-up|1|||
156787054|NCT01986751|565972840|FG000|Overall Study|improperly consented|10|||
156787055|NCT01986751|565972841|FG001|Overall Study|improperly consented|2|||
156787056|NCT03501277|565972845|FG000|Intervention Period 1 (4 Days)|Other|0|||
156787057|NCT03501277|565972846|FG001|Intervention Period 1 (4 Days)|Other|0|||
156787058|NCT03501277|565972847|FG002|Intervention Period 1 (4 Days)|Other|1|||
156787059|NCT03501277|565972848|FG003|Intervention Period 1 (4 Days)|Other|0|||
156787060|NCT03501277|565972845|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787061|NCT03501277|565972846|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787062|NCT03501277|565972847|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
156787063|NCT03501277|565972848|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
156787064|NCT03501277|565972845|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787065|NCT03501277|565972846|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787066|NCT03501277|565972847|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
156787067|NCT03501277|565972848|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
156787068|NCT03501277|565972845|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787069|NCT03501277|565972846|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787070|NCT03501277|565972847|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
156787071|NCT03501277|565972848|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
156787072|NCT01873833|565972850|FG000|Overall Study|Withdrawal by Subject|1|||
156787073|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Adverse Event|14|||
156787074|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Adverse Event|27|||
156787075|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Adverse Event|60|||
156787076|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Adverse Event|0|||
156787077|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Adverse Event|0|||
156787078|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Pregnancy|0|||
156787079|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Pregnancy|7|||
156787080|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Pregnancy|9|||
156787081|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Pregnancy|0|||
156787082|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Pregnancy|0|||
156787083|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
156787084|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
156787085|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
156787086|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
156787087|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
156787088|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
156787089|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
156787090|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
156787091|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
156787092|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
156787093|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Death|1|||
157013474|NCT05096819|566801783|FG001|Overall Study|Withdrawal by Subject|0|||
156869580|NCT02592798|566279074|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
156869581|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
156869582|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
156869583|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
156869584|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
156869585|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
156869586|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
156869587|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
156869588|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
156869589|NCT02592798|566279073|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
156869590|NCT02592798|566279074|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
156869591|NCT02592798|566279073|FG000|Transition From DB2 to OLE|Other reasons|1|||
156869592|NCT02592798|566279074|FG001|Transition From DB2 to OLE|Other reasons|0|||
156869593|NCT02592798|566279073|FG000|Open Label Period (OLE)|Other reasons|0|||
156869594|NCT02592798|566279074|FG001|Open Label Period (OLE)|Other reasons|2|||
156869595|NCT02592798|566279073|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
156869596|NCT02592798|566279074|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
156869597|NCT02592798|566279073|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
156869598|NCT02592798|566279074|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
156869599|NCT02592798|566279073|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
156869600|NCT02592798|566279074|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
156869601|NCT02592798|566279073|FG000|Open Label Period (OLE)|Adverse Event|0|||
156869602|NCT02592798|566279074|FG001|Open Label Period (OLE)|Adverse Event|1|||
156869603|NCT01188343|566279075|FG000|Overall Study|Not vaccinated|0|||
156869604|NCT01188343|566279076|FG001|Overall Study|Not vaccinated|2|||
156869605|NCT01188343|566279077|FG002|Overall Study|Not vaccinated|1|||
156869606|NCT01188343|566279075|FG000|Overall Study|Withdrawal by Subject|1|||
156869607|NCT01188343|566279076|FG001|Overall Study|Withdrawal by Subject|24|||
156869608|NCT01188343|566279077|FG002|Overall Study|Withdrawal by Subject|0|||
156869609|NCT01143246|566279078|FG000|Overall Study|Adverse Event|24|||
156869610|NCT01143246|566279079|FG001|Overall Study|Adverse Event|28|||
156869611|NCT01143246|566279078|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
156869612|NCT01143246|566279079|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
156869613|NCT01143246|566279078|FG000|Overall Study|Lost to Follow-up|0|||
156869614|NCT01143246|566279079|FG001|Overall Study|Lost to Follow-up|1|||
156869615|NCT01143246|566279078|FG000|Overall Study|Death|16|||
156869616|NCT01143246|566279079|FG001|Overall Study|Death|15|||
156869617|NCT01143246|566279078|FG000|Overall Study|Reason not Specified|3|||
156869618|NCT01143246|566279079|FG001|Overall Study|Reason not Specified|5|||
156869619|NCT01663103|566279080|FG000|Overall Study|Withdrawal by Subject|1|||
156869620|NCT01663103|566279081|FG001|Overall Study|Withdrawal by Subject|2|||
156869621|NCT01663103|566279080|FG000|Overall Study|Adverse Event|1|||
156869622|NCT01663103|566279081|FG001|Overall Study|Adverse Event|0|||
156869623|NCT01663103|566279080|FG000|Overall Study|dog bite|1|||
156869624|NCT01663103|566279081|FG001|Overall Study|dog bite|0|||
156869625|NCT00363480|566279082|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
156869626|NCT00363480|566279082|FG000|Overall Study|Adverse Event|4|||
156869627|NCT00363480|566279082|FG000|Overall Study|Lost to Follow-up|5|||
156869628|NCT00363480|566279082|FG000|Overall Study|Withdrawal by Subject|5|||
156869629|NCT00363480|566279082|FG000|Overall Study|Non-compliance of subject|1|||
156869630|NCT00363480|566279082|FG000|Overall Study|Participant discontinued on its own|1|||
156869631|NCT04634253|566279085|FG000|Overall Study|Adverse Event|1|||
156869632|NCT04634253|566279086|FG001|Overall Study|Adverse Event|1|||
156869633|NCT04634253|566279087|FG002|Overall Study|Adverse Event|0|||
156869634|NCT04634253|566279085|FG000|Overall Study|Physician Decision|0|||
156869635|NCT04634253|566279086|FG001|Overall Study|Physician Decision|1|||
156869636|NCT04634253|566279087|FG002|Overall Study|Physician Decision|0|||
156869637|NCT04634253|566279085|FG000|Overall Study|Withdrawal by Subject|1|||
156869638|NCT04634253|566279086|FG001|Overall Study|Withdrawal by Subject|0|||
156869639|NCT04634253|566279087|FG002|Overall Study|Withdrawal by Subject|3|||
156869640|NCT01457703|566279094|FG000|Overall Study|Screen Failure|5|||
156869641|NCT01457703|566279095|FG001|Overall Study|Screen Failure|7|||
156869642|NCT01457703|566279094|FG000|Overall Study|Withdrawal by Subject|1|||
156869643|NCT01457703|566279095|FG001|Overall Study|Withdrawal by Subject|4|||
156869644|NCT01658436|566279096|FG000|Overall Study|Adverse Event|6|||
156869645|NCT01658436|566279097|FG001|Overall Study|Adverse Event|5|||
156869646|NCT01658436|566279096|FG000|Overall Study|Physician Decision|1|||
156869647|NCT01658436|566279097|FG001|Overall Study|Physician Decision|0|||
156869648|NCT01658436|566279096|FG000|Overall Study|Progressive disease|12|||
156869649|NCT01658436|566279097|FG001|Overall Study|Progressive disease|4|||
156869650|NCT01658436|566279096|FG000|Overall Study|Study terminated by sponsor|0|||
156869651|NCT01658436|566279097|FG001|Overall Study|Study terminated by sponsor|1|||
157013475|NCT03324984|566801784|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
157214373|NCT03763331|567531879|FG000|Overall Study|Non-compliance|0|||
156869652|NCT01658436|566279096|FG000|Overall Study|Subject/guardian decision|0|||
156869653|NCT01658436|566279097|FG001|Overall Study|Subject/guardian decision|1|||
156869654|NCT01658436|566279096|FG000|Overall Study|Death|1|||
156869655|NCT01658436|566279097|FG001|Overall Study|Death|0|||
156869656|NCT03987503|566279098|FG000|Overall Study|Lost to Follow-up|20|||
156869657|NCT03987503|566279098|FG000|Overall Study|Withdrawal by Subject|2|||
156869658|NCT00888940|566279102|FG000|Overall Study|Adverse Event|12|||
156869659|NCT00888940|566279103|FG001|Overall Study|Adverse Event|3|||
156869660|NCT00888940|566279102|FG000|Overall Study|Lost to Follow-up|5|||
156869661|NCT00888940|566279103|FG001|Overall Study|Lost to Follow-up|5|||
156869662|NCT00888940|566279102|FG000|Overall Study|Randomized Not Treated|11|||
156869663|NCT00888940|566279103|FG001|Overall Study|Randomized Not Treated|13|||
156869664|NCT01646125|566280982|FG000|Overall Study|Untreated|2|||
156869665|NCT01646125|566280983|FG001|Overall Study|Untreated|5|||
156869666|NCT01646125|566280982|FG000|Overall Study|Adverse Event|2|||
156869667|NCT01646125|566280983|FG001|Overall Study|Adverse Event|1|||
156869668|NCT01646125|566280982|FG000|Overall Study|Death|1|||
156869669|NCT01646125|566280983|FG001|Overall Study|Death|1|||
156869670|NCT01646125|566280982|FG000|Overall Study|Physician Decision|1|||
156869671|NCT01646125|566280983|FG001|Overall Study|Physician Decision|3|||
156869672|NCT01646125|566280982|FG000|Overall Study|Progressive disease|22|||
156869673|NCT01646125|566280983|FG001|Overall Study|Progressive disease|16|||
156869674|NCT01646125|566280982|FG000|Overall Study|Study terminated by sponsor|2|||
156869675|NCT01646125|566280983|FG001|Overall Study|Study terminated by sponsor|1|||
156869676|NCT01646125|566280982|FG000|Overall Study|Subject/Guardian decision|1|||
156869677|NCT01646125|566280983|FG001|Overall Study|Subject/Guardian decision|1|||
156869678|NCT02105662|566280984|FG000|Overall Study|Lost to Follow-up|5|||
156869679|NCT02105662|566280984|FG000|Overall Study|Withdrawal by Subject|1|||
156869680|NCT02331277|566280985|FG000|Overall Study|Withdrawal by Subject|1|||
156869681|NCT02331277|566280986|FG001|Overall Study|Withdrawal by Subject|0|||
156869682|NCT01376804|566280988|FG000|Treatment Period|Withdrawal by Subject|1|||
156869683|NCT01376804|566280988|FG000|Treatment Period|Adverse Event|6|||
156869684|NCT01376804|566280988|FG000|Treatment Period|Patient did not receive study drug|1|||
156869685|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
156869686|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
156869687|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Patient requirement|20|||
156869688|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Death|5|||
156869689|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Change of therapy|6|||
156869690|NCT01071798|566280989|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
156869691|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
156869692|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
156869693|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
156869694|NCT01071798|566280989|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
156869695|NCT01528969|566280991|FG000|Overall Study|absent from the school at baseline|2|||
156869696|NCT01528969|566280992|FG001|Overall Study|absent from the school at baseline|0|||
156869697|NCT03584789|566280997|FG000|Overall Study|refused EHR permission|19|||
156869698|NCT03584789|566280998|FG001|Overall Study|refused EHR permission|28|||
156869699|NCT03584789|566280999|FG002|Overall Study|refused EHR permission|23|||
156869700|NCT03584789|566280997|FG000|Overall Study|patients tied to a provider who retired|0|||
156869701|NCT03584789|566280998|FG001|Overall Study|patients tied to a provider who retired|0|||
156869702|NCT03584789|566280999|FG002|Overall Study|patients tied to a provider who retired|3|||
156869703|NCT00602472|566281001|FG000|Overall Study|Adverse Event|5|||
156869704|NCT00602472|566281002|FG001|Overall Study|Adverse Event|23|||
156869705|NCT00602472|566281001|FG000|Overall Study|Protocol Violation|4|||
156869706|NCT00602472|566281002|FG001|Overall Study|Protocol Violation|19|||
156869707|NCT00602472|566281001|FG000|Overall Study|Withdrawal by Subject|8|||
156869708|NCT00602472|566281002|FG001|Overall Study|Withdrawal by Subject|14|||
156869709|NCT00602472|566281001|FG000|Overall Study|Other incl. lack of efficacy|4|||
156869710|NCT00602472|566281002|FG001|Overall Study|Other incl. lack of efficacy|2|||
156869711|NCT01938716|566281003|FG000|Overall Study|Physician Decision|2|||
156869712|NCT01938716|566281003|FG000|Overall Study|Withdrawal by Subject|2|||
156869713|NCT02803580|566281004|FG000|Overall Study|Death|13|||
156869714|NCT02803580|566281004|FG000|Overall Study|Lost to Follow-up|19|||
156869715|NCT02803580|566281004|FG000|Overall Study|Withdrawal by Subject|3|||
156869716|NCT02803580|566281004|FG000|Overall Study|Inclusion in clinical trial|1|||
156869717|NCT03126591|566281005|FG000|Overall Study|Death|6|||
156869718|NCT03126591|566281006|FG001|Overall Study|Death|3|||
156869719|NCT03126591|566281007|FG002|Overall Study|Death|17|||
156869720|NCT03126591|566281005|FG000|Overall Study|Progressive Disease|0|||
156869721|NCT03126591|566281006|FG001|Overall Study|Progressive Disease|1|||
157021655|NCT04072380|566830973|FG002|Overall Study|Withdrawal by Subject|1|||
156869722|NCT03126591|566281007|FG002|Overall Study|Progressive Disease|2|||
156869723|NCT03126591|566281005|FG000|Overall Study|Terminated by Sponsor|0|||
156869724|NCT03126591|566281006|FG001|Overall Study|Terminated by Sponsor|1|||
156869725|NCT03126591|566281007|FG002|Overall Study|Terminated by Sponsor|4|||
156869726|NCT03126591|566281005|FG000|Overall Study|Withdrawal by Subject|1|||
156869727|NCT03126591|566281006|FG001|Overall Study|Withdrawal by Subject|1|||
156869728|NCT03126591|566281007|FG002|Overall Study|Withdrawal by Subject|4|||
156869729|NCT03722238|566281010|FG000|Overall Study|Protocol Violation|1|||
156869730|NCT03722238|566281011|FG001|Overall Study|Protocol Violation|0|||
156869731|NCT03722238|566281010|FG000|Overall Study|Physician Decision|1|||
156687286|NCT00255151|565599298|FG001|Overall Study|Adverse Event|6|||
156687287|NCT00255151|565599299|FG002|Overall Study|Adverse Event|9|||
156687288|NCT00255151|565599297|FG000|Overall Study|Lost to Follow-up|4|||
156687289|NCT00255151|565599298|FG001|Overall Study|Lost to Follow-up|3|||
156687290|NCT00255151|565599299|FG002|Overall Study|Lost to Follow-up|4|||
156687291|NCT00255151|565599297|FG000|Overall Study|Withdrawal by Subject|18|||
156869732|NCT03722238|566281011|FG001|Overall Study|Physician Decision|0|||
156869733|NCT03722238|566281010|FG000|Overall Study|Death|1|||
156687292|NCT00255151|565599298|FG001|Overall Study|Withdrawal by Subject|17|||
156687293|NCT00255151|565599299|FG002|Overall Study|Withdrawal by Subject|8|||
156687294|NCT00255151|565599297|FG000|Overall Study|Noncompliance|0|||
156687295|NCT00255151|565599298|FG001|Overall Study|Noncompliance|1|||
156687296|NCT00255151|565599299|FG002|Overall Study|Noncompliance|2|||
156687297|NCT00255151|565599297|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
156687298|NCT00255151|565599298|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
156869734|NCT03722238|566281011|FG001|Overall Study|Death|0|||
156869735|NCT03722238|566281010|FG000|Overall Study|Lost to Follow-up|6|||
156869736|NCT03722238|566281011|FG001|Overall Study|Lost to Follow-up|0|||
156869737|NCT03722238|566281010|FG000|Overall Study|Partial missing data|44|||
156869738|NCT03722238|566281011|FG001|Overall Study|Partial missing data|1|||
156869739|NCT03722238|566281010|FG000|Overall Study|Withdrawal by Subject|2|||
156869740|NCT03722238|566281011|FG001|Overall Study|Withdrawal by Subject|0|||
156869741|NCT03722238|566281010|FG000|Overall Study|Other|4|||
156869742|NCT03722238|566281011|FG001|Overall Study|Other|0|||
156869743|NCT03722238|566281010|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
156869744|NCT03722238|566281011|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
156869745|NCT03722238|566281010|FG000|Overall Study|Did not meet risk classification group criteria|90|||
156869746|NCT03722238|566281011|FG001|Overall Study|Did not meet risk classification group criteria|0|||
156869747|NCT03722238|566281010|FG000|Overall Study|Did not sign consent|17|||
156869748|NCT03722238|566281011|FG001|Overall Study|Did not sign consent|0|||
156869749|NCT03722238|566281010|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
156869750|NCT03722238|566281011|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
156687299|NCT00255151|565599299|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
156687300|NCT00255151|565599297|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
156687301|NCT00255151|565599298|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
156687302|NCT00255151|565599299|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
156687303|NCT00255151|565599297|FG000|Overall Study|Possible Barrett's Esophagus|1|||
156687304|NCT00255151|565599298|FG001|Overall Study|Possible Barrett's Esophagus|3|||
156687305|NCT00255151|565599299|FG002|Overall Study|Possible Barrett's Esophagus|8|||
156869751|NCT03722238|566281010|FG000|Overall Study|Not willing to purchase study medication|142|||
156869752|NCT03722238|566281011|FG001|Overall Study|Not willing to purchase study medication|0|||
156869753|NCT03722238|566281010|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
156869754|NCT03722238|566281011|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
156869755|NCT01285323|566281012|FG000|Overall Study|Adverse Event|9|||
156869756|NCT01285323|566281013|FG001|Overall Study|Adverse Event|8|||
156869757|NCT01285323|566281012|FG000|Overall Study|Lack of Efficacy|4|||
156869758|NCT01285323|566281013|FG001|Overall Study|Lack of Efficacy|2|||
156869759|NCT01285323|566281012|FG000|Overall Study|Withdrawal by Subject|15|||
156869760|NCT01285323|566281013|FG001|Overall Study|Withdrawal by Subject|11|||
156869761|NCT01285323|566281012|FG000|Overall Study|Protocol Violation|1|||
156869762|NCT01285323|566281013|FG001|Overall Study|Protocol Violation|2|||
156869763|NCT01285323|566281012|FG000|Overall Study|Non-compliance with study procedures|2|||
156869764|NCT01285323|566281013|FG001|Overall Study|Non-compliance with study procedures|3|||
156687306|NCT00255151|565599297|FG000|Overall Study|Esophageal Stricture|0|||
156869765|NCT01285323|566281012|FG000|Overall Study|Lost to Follow-up|1|||
156869766|NCT01285323|566281013|FG001|Overall Study|Lost to Follow-up|1|||
156869767|NCT01285323|566281012|FG000|Overall Study|Other|1|||
156869768|NCT01285323|566281013|FG001|Overall Study|Other|3|||
156869769|NCT02606643|566281014|FG000|Overall Study|did not meet inclusion criteria|1|||
157013476|NCT03324984|566801785|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
157013477|NCT03358875|566801786|FG000|Overall Study|Death|409|||
156687307|NCT00255151|565599298|FG001|Overall Study|Esophageal Stricture|0|||
156869770|NCT02606643|566281015|FG001|Overall Study|did not meet inclusion criteria|3|||
156869771|NCT00885170|566281018|FG000|Overall Study|Adverse Event|12|||
156869772|NCT00885170|566281019|FG001|Overall Study|Adverse Event|4|||
156869773|NCT00885170|566281018|FG000|Overall Study|Excessive bone loss|6|||
157013478|NCT03358875|566801787|FG001|Overall Study|Death|223|||
156869774|NCT00885170|566281019|FG001|Overall Study|Excessive bone loss|3|||
156869775|NCT00885170|566281018|FG000|Overall Study|Lost to Follow-up|2|||
156869776|NCT00885170|566281019|FG001|Overall Study|Lost to Follow-up|1|||
156687308|NCT00255151|565599299|FG002|Overall Study|Esophageal Stricture|1|||
156687309|NCT00255151|565599297|FG000|Overall Study|Therapeutic Failure|11|||
156687310|NCT00255151|565599298|FG001|Overall Study|Therapeutic Failure|2|||
156687311|NCT00255151|565599299|FG002|Overall Study|Therapeutic Failure|3|||
156687312|NCT00792623|565599301|FG000|Overall Study|Adverse Event|2|||
156687313|NCT00792623|565599301|FG000|Overall Study|Withdrawal by Subject|5|||
156687314|NCT00880087|565599305|FG000|Overall Study|Lost to Follow-up|0|||
156687315|NCT00880087|565599306|FG001|Overall Study|Lost to Follow-up|2|||
156687316|NCT00743509|565599307|FG000|Overall Study|Withdrawal by Subject|2|||
156687317|NCT00931463|565599308|FG000|Overall Study|Death|8|||
156687318|NCT00931463|565599309|FG001|Overall Study|Death|4|||
156687319|NCT00931463|565599308|FG000|Overall Study|Withdrawal by Subject|5|||
156687320|NCT00931463|565599309|FG001|Overall Study|Withdrawal by Subject|0|||
156687321|NCT00931463|565599308|FG000|Overall Study|Lost to Follow-up|4|||
156687322|NCT00931463|565599309|FG001|Overall Study|Lost to Follow-up|1|||
156687323|NCT00808509|565599310|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
156687324|NCT00808509|565599311|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
156687325|NCT00808509|565599310|FG000|Randomized Phase|Reduced methotrexate dose|1|||
156687326|NCT00808509|565599311|FG001|Randomized Phase|Reduced methotrexate dose|2|||
156687327|NCT00808509|565599310|FG000|Randomized Phase|Patient refused rescue therapy|0|||
156687328|NCT00808509|565599311|FG001|Randomized Phase|Patient refused rescue therapy|3|||
156687329|NCT00575380|565599315|FG000|Overall Study|Withdrawal by Subject|1|||
156687330|NCT00575380|565599316|FG001|Overall Study|Withdrawal by Subject|0|||
156687331|NCT00575380|565599315|FG000|Overall Study|Adverse Event|0|||
156687332|NCT00575380|565599316|FG001|Overall Study|Adverse Event|1|||
156687333|NCT00575380|565599315|FG000|Overall Study|Various|0|||
156687334|NCT00575380|565599316|FG001|Overall Study|Various|2|||
156687335|NCT04019054|565599317|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
156687336|NCT04019054|565599318|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
156687337|NCT04019054|565599317|FG000|Overall Study|Withdrawal by Subject|3|||
156687338|NCT04019054|565599318|FG001|Overall Study|Withdrawal by Subject|1|||
156687339|NCT01040793|565599319|FG000|Overall Study|Adverse Event|5|||
156687340|NCT01040793|565599320|FG001|Overall Study|Adverse Event|3|||
156687341|NCT01040793|565599321|FG002|Overall Study|Adverse Event|0|||
156687342|NCT01040793|565599322|FG003|Overall Study|Adverse Event|2|||
156687343|NCT01040793|565599323|FG004|Overall Study|Adverse Event|2|||
156687344|NCT01040793|565599324|FG005|Overall Study|Adverse Event|1|||
156687345|NCT01040793|565599319|FG000|Overall Study|Protocol Violation|1|||
156687346|NCT01040793|565599320|FG001|Overall Study|Protocol Violation|1|||
156687347|NCT01040793|565599321|FG002|Overall Study|Protocol Violation|1|||
156687348|NCT01040793|565599322|FG003|Overall Study|Protocol Violation|0|||
156869777|NCT00885170|566281018|FG000|Overall Study|Physician Decision|2|||
156869778|NCT00885170|566281019|FG001|Overall Study|Physician Decision|1|||
156687349|NCT01040793|565599323|FG004|Overall Study|Protocol Violation|1|||
156687350|NCT01040793|565599324|FG005|Overall Study|Protocol Violation|0|||
156687351|NCT01040793|565599319|FG000|Overall Study|Lost to Follow-up|0|||
156687352|NCT01040793|565599320|FG001|Overall Study|Lost to Follow-up|1|||
156687353|NCT01040793|565599321|FG002|Overall Study|Lost to Follow-up|1|||
156687354|NCT01040793|565599322|FG003|Overall Study|Lost to Follow-up|0|||
156687355|NCT01040793|565599323|FG004|Overall Study|Lost to Follow-up|0|||
156687356|NCT01040793|565599324|FG005|Overall Study|Lost to Follow-up|0|||
156687357|NCT01040793|565599319|FG000|Overall Study|Withdrawal by Subject|0|||
156687358|NCT01040793|565599320|FG001|Overall Study|Withdrawal by Subject|0|||
156687359|NCT01040793|565599321|FG002|Overall Study|Withdrawal by Subject|0|||
156687360|NCT01040793|565599322|FG003|Overall Study|Withdrawal by Subject|2|||
156687361|NCT01040793|565599323|FG004|Overall Study|Withdrawal by Subject|0|||
156687362|NCT01040793|565599324|FG005|Overall Study|Withdrawal by Subject|0|||
156687363|NCT01040793|565599319|FG000|Overall Study|Other reasons not listed above|0|||
156687364|NCT01040793|565599320|FG001|Overall Study|Other reasons not listed above|0|||
156687365|NCT01040793|565599321|FG002|Overall Study|Other reasons not listed above|1|||
156687366|NCT01040793|565599322|FG003|Overall Study|Other reasons not listed above|0|||
156687367|NCT01040793|565599323|FG004|Overall Study|Other reasons not listed above|1|||
156687368|NCT01040793|565599324|FG005|Overall Study|Other reasons not listed above|0|||
156687369|NCT04499482|565599325|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
156687370|NCT00124462|565599326|FG000|Overall Study|Lost to Follow-up|3|||
156687371|NCT00124462|565599327|FG001|Overall Study|Lost to Follow-up|3|||
156687372|NCT00124462|565599326|FG000|Overall Study|Physician Decision|3|||
156687373|NCT00124462|565599327|FG001|Overall Study|Physician Decision|4|||
156687374|NCT00124462|565599326|FG000|Overall Study|Withdrawal by Subject|4|||
156687375|NCT00124462|565599327|FG001|Overall Study|Withdrawal by Subject|5|||
156687376|NCT00124462|565599326|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
156687377|NCT00124462|565599327|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
156687378|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
156869779|NCT00885170|566281018|FG000|Overall Study|Protocol Violation|3|||
157013479|NCT03358875|566801786|FG000|Overall Study|Study Closed by Sponsor|66|||
156869780|NCT00885170|566281019|FG001|Overall Study|Protocol Violation|1|||
156869781|NCT00885170|566281018|FG000|Overall Study|Withdrawal by Subject|13|||
156869782|NCT00885170|566281019|FG001|Overall Study|Withdrawal by Subject|13|||
156869783|NCT03771664|566281020|FG000|Overall Study|Adverse Event|1|||
156869784|NCT03771664|566281021|FG001|Overall Study|Adverse Event|0|||
156869785|NCT03771664|566281020|FG000|Overall Study|Lost to Follow-up|1|||
156869786|NCT03771664|566281021|FG001|Overall Study|Lost to Follow-up|0|||
156869787|NCT03771664|566281020|FG000|Overall Study|Withdrawal by Participant|1|||
156869788|NCT03771664|566281021|FG001|Overall Study|Withdrawal by Participant|4|||
156869789|NCT03771664|566281020|FG000|Overall Study|Randomized but not Treated|0|||
156869790|NCT03771664|566281021|FG001|Overall Study|Randomized but not Treated|1|||
156869791|NCT02120898|566281022|FG000|Overall Study|Withdrawal by Subject|4|||
156869792|NCT02120898|566281023|FG001|Overall Study|Withdrawal by Subject|2|||
156869793|NCT02120898|566281024|FG002|Overall Study|Withdrawal by Subject|2|||
156869794|NCT02120898|566281022|FG000|Overall Study|Non-compliance with study drug|3|||
156869795|NCT02120898|566281023|FG001|Overall Study|Non-compliance with study drug|0|||
156687379|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
156687380|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
156687381|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
156687382|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Death|15|||
156687383|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Death|20|||
156687384|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Death|0|||
156687385|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Death|0|||
156687386|NCT01684878|565599331|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687387|NCT01684878|565599332|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
156687388|NCT01684878|565599333|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687389|NCT01684878|565599334|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
156687390|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
156687391|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
156687392|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
156687393|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
156687394|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687395|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687396|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
156687397|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
156687398|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Death|0|||
156687399|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Death|0|||
156687400|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Death|62|||
156687401|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Death|68|||
156687402|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
156687403|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
156687404|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
156687405|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
156687406|NCT01684878|565599331|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
156687407|NCT01684878|565599332|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
156687408|NCT01684878|565599333|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
156687409|NCT01684878|565599334|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
156687410|NCT03942211|565599337|FG000|Overall Study|Death|1|||
156869796|NCT02120898|566281024|FG002|Overall Study|Non-compliance with study drug|0|||
156869797|NCT02120898|566281022|FG000|Overall Study|Adverse Event|1|||
156869798|NCT02120898|566281023|FG001|Overall Study|Adverse Event|2|||
156869799|NCT02120898|566281024|FG002|Overall Study|Adverse Event|1|||
156687411|NCT03942211|565599338|FG001|Overall Study|Death|0|||
156687412|NCT03942211|565599337|FG000|Overall Study|Study terminated by sponsor|5|||
156687413|NCT03942211|565599338|FG001|Overall Study|Study terminated by sponsor|3|||
156687414|NCT03942211|565599337|FG000|Overall Study|Adverse Event|0|||
156687415|NCT03942211|565599338|FG001|Overall Study|Adverse Event|1|||
156687416|NCT00127166|565599339|FG000|Period I|Protocol Violation|0|||
156687417|NCT00127166|565599340|FG001|Period I|Protocol Violation|2|||
156687418|NCT00127166|565599339|FG000|Period I|Withdrawal by Subject|2|||
156687419|NCT00127166|565599340|FG001|Period I|Withdrawal by Subject|0|||
156687420|NCT00127166|565599339|FG000|Period I|Patient did not meet inclusion criteria|1|||
156869800|NCT02120898|566281022|FG000|Overall Study|Protocol Violation|1|||
156869801|NCT02120898|566281023|FG001|Overall Study|Protocol Violation|2|||
156869802|NCT02120898|566281024|FG002|Overall Study|Protocol Violation|0|||
156687421|NCT00127166|565599340|FG001|Period I|Patient did not meet inclusion criteria|0|||
156687422|NCT00127166|565599339|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
156687423|NCT00127166|565599340|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
156687424|NCT00127166|565599339|FG000|Period II|Withdrawal by Subject|2|||
156687425|NCT00127166|565599340|FG001|Period II|Withdrawal by Subject|0|||
156869803|NCT02120898|566281022|FG000|Overall Study|Lost to Follow-up|0|||
156869804|NCT02120898|566281023|FG001|Overall Study|Lost to Follow-up|0|||
156869805|NCT02120898|566281024|FG002|Overall Study|Lost to Follow-up|1|||
156869806|NCT00684021|566281025|FG000|Overall Study|MRI Contraindicated|1|||
156687426|NCT00127166|565599339|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
156687427|NCT00127166|565599340|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
156687428|NCT01148225|565599341|FG000|Overall Study|Other|185|||
156687429|NCT00605917|565599344|FG000|Overall Study|Protocol Violation|79|||
156687430|NCT01506908|565599345|FG000|Overall Study|Adverse Event|1|||
156687431|NCT01506908|565599346|FG001|Overall Study|Adverse Event|0|||
156687432|NCT00925301|565599355|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687433|NCT00925301|565599356|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
156687434|NCT00925301|565599357|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687435|NCT00925301|565599358|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
156687436|NCT00925301|565599355|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687437|NCT00925301|565599356|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
156687438|NCT00925301|565599357|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687439|NCT00925301|565599358|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
156687440|NCT00925301|565599355|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687441|NCT00925301|565599356|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687442|NCT00925301|565599357|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
156687443|NCT00925301|565599358|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
156687444|NCT00925301|565599355|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687445|NCT00925301|565599356|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687446|NCT00925301|565599357|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
156687447|NCT00925301|565599358|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
156687448|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687449|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687450|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
156687451|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
156687452|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687453|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687454|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
156687455|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
156687456|NCT00925301|565599355|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687457|NCT00925301|565599356|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687458|NCT00925301|565599357|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
156687459|NCT00925301|565599358|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
156687460|NCT03043560|565599359|FG000|Overall Study|Discontinued Intervention|1|||
156687461|NCT03043560|565599360|FG001|Overall Study|Discontinued Intervention|2|||
156687462|NCT03043560|565599359|FG000|Overall Study|Lost to Follow-up|0|||
156687463|NCT03043560|565599360|FG001|Overall Study|Lost to Follow-up|1|||
156687464|NCT01117766|565599361|FG000|First Intervention|Adverse Event|0|||
156687465|NCT01117766|565599362|FG001|First Intervention|Adverse Event|1|||
156687466|NCT01117766|565599361|FG000|First Intervention|Protocol Violation|1|||
156687467|NCT01117766|565599362|FG001|First Intervention|Protocol Violation|0|||
156687468|NCT01117766|565599361|FG000|Washout Period|Protocol Violation|0|||
156687469|NCT01117766|565599362|FG001|Washout Period|Protocol Violation|2|||
156687470|NCT01117766|565599361|FG000|Second Intervention|Lost to Follow-up|1|||
156687471|NCT01117766|565599362|FG001|Second Intervention|Lost to Follow-up|0|||
156687472|NCT01117766|565599361|FG000|Second Intervention|Other|1|||
156687473|NCT01117766|565599362|FG001|Second Intervention|Other|2|||
156687474|NCT01117766|565599361|FG000|Second Intervention|Adverse Event|0|||
156687475|NCT01117766|565599362|FG001|Second Intervention|Adverse Event|2|||
156687476|NCT01117766|565599361|FG000|Second Intervention|Withdrawal by Subject|0|||
156687477|NCT01117766|565599362|FG001|Second Intervention|Withdrawal by Subject|1|||
156687478|NCT05766787|565599363|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
156869807|NCT00684021|566281026|FG001|Overall Study|MRI Contraindicated|1|||
156869808|NCT00684021|566281027|FG002|Overall Study|MRI Contraindicated|1|||
156869809|NCT00684021|566281028|FG003|Overall Study|MRI Contraindicated|0|||
156869810|NCT00684021|566281025|FG000|Overall Study|MRI not performed|0|||
156869811|NCT00684021|566281026|FG001|Overall Study|MRI not performed|1|||
156687479|NCT05766787|565599364|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
156687480|NCT05766787|565599363|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
156687481|NCT05766787|565599364|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
156687482|NCT05766787|565599363|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
156687483|NCT05766787|565599364|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
156687484|NCT00438659|565599365|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
156687485|NCT00438659|565599366|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
156687486|NCT00438659|565599365|FG000|Overall Study|Cancel|5|||
156687487|NCT00438659|565599366|FG001|Overall Study|Cancel|2|||
156687488|NCT03718117|565599367|FG000|Overall Study|Death|12|||
157013480|NCT03358875|566801787|FG001|Overall Study|Study Closed by Sponsor|29|||
156687489|NCT03718117|565599368|FG001|Overall Study|Death|11|||
156687490|NCT03718117|565599369|FG002|Overall Study|Death|0|||
156687491|NCT03718117|565599367|FG000|Overall Study|Other|0|||
156687492|NCT03718117|565599368|FG001|Overall Study|Other|1|||
156687493|NCT03718117|565599369|FG002|Overall Study|Other|0|||
156687494|NCT03718117|565599367|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
156687495|NCT03718117|565599368|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
156687496|NCT03718117|565599369|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
156687497|NCT03718117|565599367|FG000|Overall Study|Participant not met eligibility criteria|0|||
156687498|NCT03718117|565599368|FG001|Overall Study|Participant not met eligibility criteria|0|||
156687499|NCT03718117|565599369|FG002|Overall Study|Participant not met eligibility criteria|2|||
156687500|NCT01867606|565599370|FG000|Overall Study|Withdrawal by Subject|10|||
156687501|NCT01867606|565599371|FG001|Overall Study|Withdrawal by Subject|14|||
156687502|NCT01867606|565599370|FG000|Overall Study|Protocol Violation|0|||
156687503|NCT01867606|565599371|FG001|Overall Study|Protocol Violation|1|||
156687504|NCT00206102|565599372|FG000|Overall Study|Adverse Event|119|||
156687505|NCT00206102|565599373|FG001|Overall Study|Adverse Event|82|||
156687506|NCT00206102|565599372|FG000|Overall Study|Protocol Violation|0|||
156687507|NCT00206102|565599373|FG001|Overall Study|Protocol Violation|2|||
156687508|NCT00206102|565599372|FG000|Overall Study|Lack of therapeutic response|16|||
156687509|NCT00206102|565599373|FG001|Overall Study|Lack of therapeutic response|11|||
156687510|NCT00206102|565599372|FG000|Overall Study|Lost to Follow-up|95|||
156687511|NCT00206102|565599373|FG001|Overall Study|Lost to Follow-up|66|||
156687512|NCT00206102|565599372|FG000|Overall Study|Withdrawal by Subject|118|||
156687513|NCT00206102|565599373|FG001|Overall Study|Withdrawal by Subject|101|||
156687514|NCT00206102|565599372|FG000|Overall Study|Study-specific discontinuation criteria|18|||
156687515|NCT00206102|565599373|FG001|Overall Study|Study-specific discontinuation criteria|17|||
156687516|NCT00206102|565599372|FG000|Overall Study|None of those categories|42|||
156687517|NCT00206102|565599373|FG001|Overall Study|None of those categories|36|||
156687518|NCT01917968|565599374|FG000|Overall Study|Death|3|||
156687519|NCT01917968|565599375|FG001|Overall Study|Death|2|||
156687520|NCT01917968|565599374|FG000|Overall Study|Lost to Follow-up|21|||
156687521|NCT01917968|565599375|FG001|Overall Study|Lost to Follow-up|39|||
156687522|NCT01917968|565599374|FG000|Overall Study|Physician Decision|1|||
156687523|NCT01917968|565599375|FG001|Overall Study|Physician Decision|2|||
156869812|NCT00684021|566281027|FG002|Overall Study|MRI not performed|1|||
156869813|NCT00684021|566281028|FG003|Overall Study|MRI not performed|2|||
157021656|NCT04072380|566830971|FG000|Overall Study|Physician Decision|2|||
156687524|NCT01917968|565599374|FG000|Overall Study|Withdrawal by Subject|20|||
156687525|NCT01917968|565599375|FG001|Overall Study|Withdrawal by Subject|35|||
156687526|NCT01917968|565599374|FG000|Overall Study|Subject Relocation|5|||
156687527|NCT01917968|565599375|FG001|Overall Study|Subject Relocation|1|||
156687528|NCT01917968|565599374|FG000|Overall Study|36M Missed Visit|3|||
156687529|NCT01917968|565599375|FG001|Overall Study|36M Missed Visit|2|||
156687530|NCT01917968|565599374|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
156687531|NCT01917968|565599375|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
156687532|NCT01917968|565599374|FG000|Overall Study|Change in Family Circumstances|0|||
156687533|NCT01917968|565599375|FG001|Overall Study|Change in Family Circumstances|1|||
156687534|NCT01917968|565599374|FG000|Overall Study|No Data Available|0|||
156687535|NCT01917968|565599375|FG001|Overall Study|No Data Available|2|||
156687536|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
156687537|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
156687538|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
156687539|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
156687540|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
156687541|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
156687542|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
156687543|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
156687544|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
156687545|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
156687546|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
156687547|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
156687548|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
156687549|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
156687550|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
156687551|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
156687552|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
156687553|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
156687554|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
156687555|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
156687556|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
156687557|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
156687558|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
156687559|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
156687560|NCT01435928|565599377|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
156687561|NCT01435928|565599378|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
156687562|NCT01435928|565599379|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
156687563|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
156687564|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
156687565|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
156687566|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
156687567|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
156687568|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
156687569|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
156687570|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
156687571|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
156687572|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
156687573|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
156687574|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
156687575|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
156687576|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
156687577|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
156687578|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
156687579|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
156687580|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
156687581|NCT01435928|565599377|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
156687582|NCT01435928|565599378|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
156687583|NCT01435928|565599379|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
156687584|NCT01588548|565599381|FG000|Overall Study|Withdrawal by Subject|0|||
156687585|NCT01588548|565599382|FG001|Overall Study|Withdrawal by Subject|1|||
156687586|NCT01588548|565599383|FG002|Overall Study|Withdrawal by Subject|1|||
156687587|NCT01588548|565599384|FG003|Overall Study|Withdrawal by Subject|1|||
156687588|NCT01588548|565599385|FG004|Overall Study|Withdrawal by Subject|2|||
156687589|NCT01588548|565599386|FG005|Overall Study|Withdrawal by Subject|3|||
156687590|NCT01588548|565599381|FG000|Overall Study|Adverse Event|0|||
156687591|NCT01588548|565599382|FG001|Overall Study|Adverse Event|0|||
156687592|NCT01588548|565599383|FG002|Overall Study|Adverse Event|1|||
156687593|NCT01588548|565599384|FG003|Overall Study|Adverse Event|2|||
156687594|NCT01588548|565599385|FG004|Overall Study|Adverse Event|1|||
156687595|NCT01588548|565599386|FG005|Overall Study|Adverse Event|0|||
156687596|NCT01588548|565599381|FG000|Overall Study|Condition Under Investigation Worsened|3|||
156687597|NCT01588548|565599382|FG001|Overall Study|Condition Under Investigation Worsened|6|||
156687598|NCT01588548|565599383|FG002|Overall Study|Condition Under Investigation Worsened|4|||
156687599|NCT01588548|565599384|FG003|Overall Study|Condition Under Investigation Worsened|4|||
156687600|NCT01588548|565599385|FG004|Overall Study|Condition Under Investigation Worsened|3|||
156687601|NCT01588548|565599386|FG005|Overall Study|Condition Under Investigation Worsened|3|||
156687602|NCT00292227|565599389|FG000|Patch Period|Adverse Event|1|||
156687603|NCT00292227|565599390|FG001|Patch Period|Adverse Event|0|||
156687604|NCT00292227|565599391|FG002|Patch Period|Adverse Event|2|||
156687605|NCT00292227|565599389|FG000|Patch Period|Withdrawal by Subject|0|||
156687606|NCT00292227|565599390|FG001|Patch Period|Withdrawal by Subject|0|||
156687607|NCT00292227|565599391|FG002|Patch Period|Withdrawal by Subject|1|||
156687608|NCT00537017|565599394|FG000|Treatment Phase|Adverse Event|19|||
156687609|NCT00537017|565599394|FG000|Treatment Phase|Withdrawal by Subject|13|||
156687610|NCT00537017|565599394|FG000|Treatment Phase|Protocol Violation|2|||
156687611|NCT00537017|565599394|FG000|Follow-up Phase|Withdrawal by Subject|9|||
156687612|NCT02329431|565599396|FG000|Overall Study|Lost to Follow-up|20|||
156687613|NCT02329431|565599397|FG001|Overall Study|Lost to Follow-up|13|||
156687614|NCT03581188|565601202|FG000|Overall Study|Inclusion criteria not met|3|||
156687615|NCT03581188|565601203|FG001|Overall Study|Inclusion criteria not met|2|||
156687616|NCT03581188|565601202|FG000|Overall Study|Lost to Follow-up|5|||
156687617|NCT03581188|565601203|FG001|Overall Study|Lost to Follow-up|5|||
156687618|NCT03581188|565601202|FG000|Overall Study|Discontinued intervention|11|||
156687619|NCT03581188|565601203|FG001|Overall Study|Discontinued intervention|8|||
156687620|NCT01280617|565601209|FG000|Overall Study|Adverse Event|0|||
156687621|NCT01280617|565601210|FG001|Overall Study|Adverse Event|1|||
156687622|NCT01311557|565601211|FG000|Overall Study|Serious adverse event|0|||
156687623|NCT01311557|565601212|FG001|Overall Study|Serious adverse event|1|||
156687624|NCT01311557|565601211|FG000|Overall Study|Protocol Violation|4|||
156687625|NCT01311557|565601212|FG001|Overall Study|Protocol Violation|2|||
156687626|NCT01311557|565601211|FG000|Overall Study|Lost to Follow-up|0|||
156687627|NCT01311557|565601212|FG001|Overall Study|Lost to Follow-up|1|||
156687628|NCT01311557|565601211|FG000|Overall Study|Withdrawal by Subject|1|||
156687629|NCT01311557|565601212|FG001|Overall Study|Withdrawal by Subject|2|||
156687630|NCT00608517|565601213|FG000|Overall Study|Death|1|||
156687631|NCT00608517|565601214|FG001|Overall Study|Death|0|||
156687632|NCT00608517|565601215|FG002|Overall Study|Death|0|||
156687633|NCT00572039|565601216|FG000|Overall Study|Withdrawal by Subject|9|||
157214374|NCT03763331|567531880|FG001|Overall Study|Non-compliance|3|||
157214375|NCT00936884|567531881|FG000|Double-blind|Withdrawal by Subject|6|||
157214376|NCT00936884|567531882|FG001|Double-blind|Withdrawal by Subject|4|||
157214377|NCT00936884|567531883|FG002|Double-blind|Withdrawal by Subject|0|||
157214378|NCT00936884|567531881|FG000|Double-blind|Death|2|||
157214379|NCT00936884|567531882|FG001|Double-blind|Death|1|||
157214380|NCT00936884|567531883|FG002|Double-blind|Death|0|||
157214381|NCT00936884|567531881|FG000|Double-blind|Lack of Efficacy|1|||
157214382|NCT00936884|567531882|FG001|Double-blind|Lack of Efficacy|1|||
157214383|NCT00936884|567531883|FG002|Double-blind|Lack of Efficacy|0|||
157214384|NCT00936884|567531881|FG000|Double-blind|Adverse Event|1|||
157214385|NCT00936884|567531882|FG001|Double-blind|Adverse Event|0|||
157214386|NCT00936884|567531883|FG002|Double-blind|Adverse Event|0|||
157214387|NCT00936884|567531881|FG000|Double-blind|Physician Decision|1|||
157214388|NCT00936884|567531882|FG001|Double-blind|Physician Decision|0|||
157214389|NCT00936884|567531883|FG002|Double-blind|Physician Decision|0|||
157214390|NCT00936884|567531881|FG000|Double-blind|No post baseline diary entry|1|||
157214391|NCT00936884|567531882|FG001|Double-blind|No post baseline diary entry|0|||
157214392|NCT00936884|567531883|FG002|Double-blind|No post baseline diary entry|0|||
157214393|NCT00936884|567531881|FG000|Double-blind|Did not receive study drug|0|||
157214394|NCT00936884|567531882|FG001|Double-blind|Did not receive study drug|1|||
157214395|NCT00936884|567531883|FG002|Double-blind|Did not receive study drug|0|||
157214396|NCT04741503|567531884|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
157214397|NCT04741503|567531885|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
157214398|NCT04741503|567531886|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
157214399|NCT04741503|567531884|FG000|Initial Enrollment|Overquotas removed|0|||
157214400|NCT04741503|567531885|FG001|Initial Enrollment|Overquotas removed|0|||
157214401|NCT04741503|567531886|FG002|Initial Enrollment|Overquotas removed|186|||
157214402|NCT04741503|567531884|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
157214403|NCT04741503|567531885|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
157214404|NCT04741503|567531886|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
157214405|NCT01663714|567531887|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
157214406|NCT01663714|567531887|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
157214407|NCT01663714|567531887|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
157214408|NCT01663714|567531887|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
157214409|NCT01663714|567531887|FG000|Long-Term Follow-Up|Death|4|||
157214410|NCT01663714|567531887|FG000|Long-Term Follow-Up|Non-compliance|1|||
157214411|NCT00597584|567531888|FG000|Overall Study|Adverse Event|4|||
157214412|NCT00597584|567531889|FG001|Overall Study|Adverse Event|2|||
157214413|NCT00597584|567531888|FG000|Overall Study|Death|53|||
157214414|NCT00597584|567531889|FG001|Overall Study|Death|30|||
157214415|NCT00597584|567531888|FG000|Overall Study|Lack of Efficacy|1|||
157214416|NCT00597584|567531889|FG001|Overall Study|Lack of Efficacy|0|||
157214417|NCT00597584|567531888|FG000|Overall Study|Lost to Follow-up|2|||
157214418|NCT00597584|567531889|FG001|Overall Study|Lost to Follow-up|4|||
157214419|NCT00597584|567531888|FG000|Overall Study|Physician Decision|3|||
157214420|NCT00597584|567531889|FG001|Overall Study|Physician Decision|0|||
157214421|NCT00597584|567531888|FG000|Overall Study|Pregnancy|2|||
157214422|NCT00597584|567531889|FG001|Overall Study|Pregnancy|0|||
157214423|NCT00597584|567531888|FG000|Overall Study|Withdrawal by Subject|44|||
157214424|NCT00597584|567531889|FG001|Overall Study|Withdrawal by Subject|12|||
157214425|NCT00597584|567531888|FG000|Overall Study|Discontinued Dialysis|0|||
157214426|NCT00597584|567531889|FG001|Overall Study|Discontinued Dialysis|1|||
157214427|NCT00597584|567531888|FG000|Overall Study|Lost ability to consent|1|||
157214428|NCT00597584|567531889|FG001|Overall Study|Lost ability to consent|1|||
157214429|NCT00597584|567531888|FG000|Overall Study|Never dosed|1|||
157214430|NCT00597584|567531889|FG001|Overall Study|Never dosed|0|||
157214431|NCT00597584|567531888|FG000|Overall Study|Relocation|8|||
157214432|NCT00597584|567531889|FG001|Overall Study|Relocation|6|||
157214433|NCT00597584|567531888|FG000|Overall Study|Renal transplant|9|||
157214434|NCT00597584|567531889|FG001|Overall Study|Renal transplant|7|||
157214435|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
157214436|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
157214437|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
157214438|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
157214439|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
157214440|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
157214441|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
157214442|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
157214443|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
156687634|NCT00572039|565601217|FG001|Overall Study|Withdrawal by Subject|6|||
156687635|NCT00572039|565601216|FG000|Overall Study|Death|2|||
156687636|NCT00572039|565601217|FG001|Overall Study|Death|3|||
156687637|NCT00572039|565601216|FG000|Overall Study|Ill|5|||
157214444|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
157214445|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
156687638|NCT00572039|565601217|FG001|Overall Study|Ill|1|||
156687639|NCT01470417|565601220|FG000|Overall Study|Disease progression|0|||
156687640|NCT01470417|565601221|FG001|Overall Study|Disease progression|2|||
156687641|NCT02973321|565601224|FG000|Overall Study|Other than specified|0|||
156687642|NCT02973321|565601225|FG001|Overall Study|Other than specified|5|||
156687643|NCT02973321|565601226|FG002|Overall Study|Other than specified|3|||
156687644|NCT02973321|565601227|FG003|Overall Study|Other than specified|3|||
156687645|NCT02973321|565601228|FG004|Overall Study|Other than specified|1|||
156687646|NCT02973321|565601224|FG000|Overall Study|Lack of Efficacy|0|||
156687647|NCT02973321|565601225|FG001|Overall Study|Lack of Efficacy|0|||
156687648|NCT02973321|565601226|FG002|Overall Study|Lack of Efficacy|0|||
156687649|NCT02973321|565601227|FG003|Overall Study|Lack of Efficacy|0|||
156687650|NCT02973321|565601228|FG004|Overall Study|Lack of Efficacy|1|||
156687651|NCT02973321|565601224|FG000|Overall Study|Adverse Event|1|||
156687652|NCT02973321|565601225|FG001|Overall Study|Adverse Event|10|||
156687653|NCT02973321|565601226|FG002|Overall Study|Adverse Event|11|||
156687654|NCT02973321|565601227|FG003|Overall Study|Adverse Event|13|||
156687655|NCT02973321|565601228|FG004|Overall Study|Adverse Event|3|||
156687656|NCT01098110|565601233|FG000|Overall Study|Withdrawal by Subject|14|||
156687657|NCT01098110|565601234|FG001|Overall Study|Withdrawal by Subject|24|||
156687658|NCT01098110|565601235|FG002|Overall Study|Withdrawal by Subject|19|||
156687659|NCT01098110|565601233|FG000|Overall Study|Adverse Event|30|||
156787094|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Death|2|||
156787095|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Death|2|||
156787096|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Death|0|||
156787097|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Death|0|||
156787098|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
156787099|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
156787100|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
156787101|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
156787102|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
156787103|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
156787104|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
156787105|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
156787106|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
156787107|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
156787108|NCT00098293|565972851|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
156787109|NCT00098293|565972852|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787110|NCT00098293|565972853|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787111|NCT00098293|565972854|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787112|NCT00098293|565972855|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
156787113|NCT00098293|565972851|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787114|NCT00098293|565972852|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787115|NCT00098293|565972853|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
156787116|NCT00098293|565972854|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787117|NCT00098293|565972855|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
156787118|NCT00098293|565972851|FG000|Open-label (OL) Phase|Adverse Event|0|||
156787119|NCT00098293|565972852|FG001|Open-label (OL) Phase|Adverse Event|3|||
156787120|NCT00098293|565972853|FG002|Open-label (OL) Phase|Adverse Event|7|||
156787121|NCT00098293|565972854|FG003|Open-label (OL) Phase|Adverse Event|6|||
156787122|NCT00098293|565972855|FG004|Open-label (OL) Phase|Adverse Event|0|||
156787123|NCT00098293|565972851|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
156787124|NCT00098293|565972852|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
156787125|NCT00098293|565972853|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
156787126|NCT00098293|565972854|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
156787127|NCT00098293|565972855|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
156787128|NCT00098293|565972851|FG000|Open-label (OL) Phase|Pregnancy|0|||
156787129|NCT00098293|565972852|FG001|Open-label (OL) Phase|Pregnancy|1|||
156787130|NCT00098293|565972853|FG002|Open-label (OL) Phase|Pregnancy|0|||
156787131|NCT00098293|565972854|FG003|Open-label (OL) Phase|Pregnancy|3|||
156787132|NCT00098293|565972855|FG004|Open-label (OL) Phase|Pregnancy|0|||
156787133|NCT00098293|565972851|FG000|Open-label (OL) Phase|Protocol Violation|0|||
156787134|NCT00098293|565972852|FG001|Open-label (OL) Phase|Protocol Violation|6|||
157214446|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
156687660|NCT01098110|565601234|FG001|Overall Study|Adverse Event|32|||
156687661|NCT01098110|565601235|FG002|Overall Study|Adverse Event|43|||
156687662|NCT01098110|565601233|FG000|Overall Study|Lack of Efficacy|13|||
156787135|NCT00098293|565972853|FG002|Open-label (OL) Phase|Protocol Violation|13|||
156787136|NCT00098293|565972854|FG003|Open-label (OL) Phase|Protocol Violation|16|||
156787137|NCT00098293|565972855|FG004|Open-label (OL) Phase|Protocol Violation|0|||
156787138|NCT00098293|565972851|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
156687663|NCT01098110|565601234|FG001|Overall Study|Lack of Efficacy|9|||
156687664|NCT01098110|565601235|FG002|Overall Study|Lack of Efficacy|27|||
156687665|NCT01098110|565601233|FG000|Overall Study|Other|4|||
156687666|NCT01098110|565601234|FG001|Overall Study|Other|7|||
156687667|NCT01098110|565601235|FG002|Overall Study|Other|5|||
156687668|NCT01098110|565601233|FG000|Overall Study|Untreated|1|||
156687669|NCT01098110|565601234|FG001|Overall Study|Untreated|1|||
156687670|NCT01098110|565601235|FG002|Overall Study|Untreated|0|||
156687671|NCT00707434|565601238|FG000|Overall Study|Adverse Event|1|||
156687672|NCT01011556|565601239|FG000|Overall Study|Adverse Event|1|||
156687673|NCT01011556|565601240|FG001|Overall Study|Adverse Event|3|||
156687674|NCT01011556|565601241|FG002|Overall Study|Adverse Event|2|||
156687675|NCT01011556|565601242|FG003|Overall Study|Adverse Event|1|||
157214447|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
157214448|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
156687676|NCT01011556|565601239|FG000|Overall Study|Lost to Follow-up|1|||
156687677|NCT01011556|565601240|FG001|Overall Study|Lost to Follow-up|0|||
156687678|NCT01011556|565601241|FG002|Overall Study|Lost to Follow-up|0|||
156687679|NCT01011556|565601242|FG003|Overall Study|Lost to Follow-up|0|||
156687680|NCT01011556|565601239|FG000|Overall Study|Physician Decision|1|||
156687681|NCT01011556|565601240|FG001|Overall Study|Physician Decision|0|||
156687682|NCT01011556|565601241|FG002|Overall Study|Physician Decision|0|||
156687683|NCT01011556|565601242|FG003|Overall Study|Physician Decision|1|||
156687684|NCT01011556|565601239|FG000|Overall Study|Protocol Violation|0|||
156687685|NCT01011556|565601240|FG001|Overall Study|Protocol Violation|1|||
156687686|NCT01011556|565601241|FG002|Overall Study|Protocol Violation|0|||
156687687|NCT01011556|565601242|FG003|Overall Study|Protocol Violation|0|||
156687688|NCT01011556|565601239|FG000|Overall Study|Withdrawal by Subject|1|||
156687689|NCT01011556|565601240|FG001|Overall Study|Withdrawal by Subject|2|||
156687690|NCT01011556|565601241|FG002|Overall Study|Withdrawal by Subject|4|||
156687691|NCT01011556|565601242|FG003|Overall Study|Withdrawal by Subject|4|||
156687692|NCT01011556|565601239|FG000|Overall Study|Sponsor decision|0|||
156687693|NCT01011556|565601240|FG001|Overall Study|Sponsor decision|1|||
156687694|NCT01011556|565601241|FG002|Overall Study|Sponsor decision|1|||
156687695|NCT01011556|565601242|FG003|Overall Study|Sponsor decision|2|||
156687696|NCT01011556|565601239|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
156687697|NCT01011556|565601240|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156687698|NCT01011556|565601241|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
156687699|NCT01011556|565601242|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
156687700|NCT00614822|565601243|FG000|Overall Study|Adverse Event|3|||
156687701|NCT03649412|565601244|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
156687702|NCT03649412|565601245|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
156687703|NCT03649412|565601244|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
156787139|NCT00098293|565972852|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
156787140|NCT00098293|565972853|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
156787141|NCT00098293|565972854|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
156787142|NCT00098293|565972855|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
156787143|NCT00098293|565972851|FG000|Open-label (OL) Phase|Death|0|||
156787144|NCT00098293|565972852|FG001|Open-label (OL) Phase|Death|2|||
156787145|NCT00098293|565972853|FG002|Open-label (OL) Phase|Death|3|||
156787146|NCT00098293|565972854|FG003|Open-label (OL) Phase|Death|0|||
156787147|NCT00098293|565972855|FG004|Open-label (OL) Phase|Death|0|||
156787148|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Death|0|||
156787149|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Death|0|||
156787150|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Death|0|||
156787151|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Death|0|||
156787152|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Death|1|||
156787153|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787154|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787155|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787156|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
156787157|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
156787158|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787159|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156687704|NCT03649412|565601245|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
156687705|NCT03649412|565601244|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
156687706|NCT03649412|565601245|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
156687707|NCT03649412|565601244|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
156687708|NCT03649412|565601245|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
156787160|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787161|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
156787162|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
156787163|NCT00098293|565972851|FG000|Supplemental Phase (SP)|Other|0|||
156687709|NCT03649412|565601244|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
156687710|NCT03649412|565601245|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
156687711|NCT03649412|565601244|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
157021657|NCT04072380|566830972|FG001|Overall Study|Physician Decision|0|||
156687712|NCT03649412|565601245|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
156687713|NCT00530348|565601246|FG000|Overall Study|Adverse Event|5|||
156687714|NCT00530348|565601247|FG001|Overall Study|Adverse Event|1|||
156687715|NCT00530348|565601246|FG000|Overall Study|Death|0|||
156687716|NCT00530348|565601247|FG001|Overall Study|Death|1|||
156687717|NCT00530348|565601246|FG000|Overall Study|Lack of Efficacy|2|||
156687718|NCT00530348|565601247|FG001|Overall Study|Lack of Efficacy|0|||
156687719|NCT00530348|565601246|FG000|Overall Study|Lost to Follow-up|0|||
156687720|NCT00530348|565601247|FG001|Overall Study|Lost to Follow-up|2|||
156687721|NCT00530348|565601246|FG000|Overall Study|Physician Decision|1|||
156687722|NCT00530348|565601247|FG001|Overall Study|Physician Decision|2|||
156687723|NCT00530348|565601246|FG000|Overall Study|Pregnancy|1|||
156687724|NCT00530348|565601247|FG001|Overall Study|Pregnancy|0|||
156687725|NCT00530348|565601246|FG000|Overall Study|Withdrawal by Subject|12|||
156687726|NCT00530348|565601247|FG001|Overall Study|Withdrawal by Subject|12|||
156687727|NCT00530348|565601246|FG000|Overall Study|Randomised in error|1|||
156687728|NCT00530348|565601247|FG001|Overall Study|Randomised in error|0|||
156687729|NCT00530348|565601246|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
156687730|NCT00530348|565601247|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
156687731|NCT04364763|565601248|FG000|Overall Study|Death|1|||
156687732|NCT04364763|565601249|FG001|Overall Study|Death|2|||
156687733|NCT04364763|565601248|FG000|Overall Study|Lost to Follow-up|1|||
156687734|NCT04364763|565601249|FG001|Overall Study|Lost to Follow-up|0|||
156687735|NCT01256060|565601251|FG000|Overall Study|Lost to Follow-up|0|||
156687736|NCT01256060|565601252|FG001|Overall Study|Lost to Follow-up|1|||
156687737|NCT01256060|565601253|FG002|Overall Study|Lost to Follow-up|0|||
156687738|NCT01256060|565601254|FG003|Overall Study|Lost to Follow-up|0|||
156687739|NCT00089076|565601259|FG000|Overall Study|Alternate Therapy|1|||
156687740|NCT00089076|565601259|FG000|Overall Study|Withdrawal by Subject|2|||
156687741|NCT00089076|565601259|FG000|Overall Study|Progression|7|||
156687742|NCT01009515|565601261|FG000|Overall Study|Withdrawal by Subject|3|||
156687743|NCT01501110|565601263|FG000|Overall Study|Death|0|||
156687744|NCT01501110|565601264|FG001|Overall Study|Death|1|||
156687745|NCT00983476|565601265|FG000|Overall Study|Did not receive intervention|17|||
156687746|NCT00983476|565601266|FG001|Overall Study|Did not receive intervention|22|||
156687747|NCT00983476|565601267|FG002|Overall Study|Did not receive intervention|0|||
156787164|NCT00098293|565972852|FG001|Supplemental Phase (SP)|Other|0|||
156787165|NCT00098293|565972853|FG002|Supplemental Phase (SP)|Other|0|||
156787166|NCT00098293|565972854|FG003|Supplemental Phase (SP)|Other|0|||
156787167|NCT00098293|565972855|FG004|Supplemental Phase (SP)|Other|22|||
156787168|NCT01968785|565972856|FG000|Overall Study|Withdrawal by Subject|1|||
156787169|NCT01968785|565972857|FG001|Overall Study|Withdrawal by Subject|0|||
156787170|NCT02829957|565972859|FG000|Overall Study|Lost to Follow-up|2|||
156787171|NCT02829957|565972860|FG001|Overall Study|Lost to Follow-up|1|||
156787172|NCT04193527|565972865|FG000|Overall Study|Other|1|||
156787173|NCT04193527|565972866|FG001|Overall Study|Other|1|||
156787174|NCT04193527|565972867|FG002|Overall Study|Other|0|||
156787175|NCT03808909|565972868|FG000|Overall Study|Lost to Follow-up|3|||
156787176|NCT03808909|565972869|FG001|Overall Study|Lost to Follow-up|0|||
156787177|NCT00676689|565972872|FG000|Overall Study|Screen Failure|2|||
156787178|NCT00676689|565972872|FG000|Overall Study|Death|2|||
156787179|NCT00676689|565972872|FG000|Overall Study|Lost to Follow-up|4|||
156787180|NCT00676689|565972872|FG000|Overall Study|Physician Decision|1|||
156787181|NCT00676689|565972872|FG000|Overall Study|Withdrawal by Subject|3|||
156787182|NCT00676689|565972872|FG000|Overall Study|Continuing FU|49|||
156787183|NCT01827943|565972873|FG000|Overall Study|Protocol Violation|8|||
156787184|NCT01827943|565972873|FG000|Overall Study|Never treated because of an rapid progression|1|||
156787185|NCT01487161|565972874|FG000|Overall Study|Adverse Event|1|||
156787186|NCT01487161|565972875|FG001|Overall Study|Adverse Event|0|||
156687748|NCT01439724|565601269|FG000|Overall Study|missing consultation|9|||
156687749|NCT01439724|565601270|FG001|Overall Study|missing consultation|8|||
156687750|NCT01483625|565601277|FG000|Overall Study|Adverse Event|1|||
156687751|NCT01483625|565601278|FG001|Overall Study|Adverse Event|1|||
156687752|NCT01483625|565601277|FG000|Overall Study|Refused to continue medication|2|||
156687753|NCT01483625|565601278|FG001|Overall Study|Refused to continue medication|1|||
156687754|NCT01483625|565601277|FG000|Overall Study|Due to other reason|1|||
156687755|NCT01483625|565601278|FG001|Overall Study|Due to other reason|0|||
156787187|NCT01487161|565972876|FG002|Overall Study|Adverse Event|0|||
156787188|NCT01487161|565972877|FG003|Overall Study|Adverse Event|0|||
156787189|NCT01487161|565972874|FG000|Overall Study|Withdrawal by Subject|1|||
156787190|NCT01487161|565972875|FG001|Overall Study|Withdrawal by Subject|1|||
156787191|NCT01487161|565972876|FG002|Overall Study|Withdrawal by Subject|1|||
156787192|NCT01487161|565972877|FG003|Overall Study|Withdrawal by Subject|2|||
156687756|NCT00084799|565601279|FG000|Overall Study|Disease Progression|1|||
156687757|NCT00084799|565601280|FG001|Overall Study|Disease Progression|0|||
156687758|NCT01083680|565601292|FG000|Overall Study|Lost to Follow-up|2758|||
156687759|NCT01083680|565601292|FG000|Overall Study|Withdrawal by Subject|1086|||
156787193|NCT01487161|565972874|FG000|Overall Study|missing data|0|||
156787194|NCT01487161|565972875|FG001|Overall Study|missing data|1|||
156687760|NCT03877926|565601293|FG000|Overall Study|Adverse Event|1|||
156687761|NCT03877926|565601294|FG001|Overall Study|Adverse Event|0|||
156687762|NCT03877926|565601295|FG002|Overall Study|Adverse Event|0|||
156687763|NCT03877926|565601296|FG003|Overall Study|Adverse Event|0|||
156687764|NCT03877926|565601293|FG000|Overall Study|Death|2|||
156687765|NCT03877926|565601294|FG001|Overall Study|Death|2|||
156687766|NCT03877926|565601295|FG002|Overall Study|Death|2|||
156687767|NCT03877926|565601296|FG003|Overall Study|Death|0|||
156687768|NCT03877926|565601293|FG000|Overall Study|Lost to Follow-up|41|||
156687769|NCT03877926|565601294|FG001|Overall Study|Lost to Follow-up|52|||
156687770|NCT03877926|565601295|FG002|Overall Study|Lost to Follow-up|45|||
156687771|NCT03877926|565601296|FG003|Overall Study|Lost to Follow-up|17|||
156687772|NCT03877926|565601293|FG000|Overall Study|Physician Decision|2|||
156687773|NCT03877926|565601294|FG001|Overall Study|Physician Decision|0|||
156687774|NCT03877926|565601295|FG002|Overall Study|Physician Decision|2|||
156687775|NCT03877926|565601296|FG003|Overall Study|Physician Decision|0|||
156687776|NCT03877926|565601293|FG000|Overall Study|Withdrawal by Subject|18|||
156687777|NCT03877926|565601294|FG001|Overall Study|Withdrawal by Subject|21|||
156687778|NCT03877926|565601295|FG002|Overall Study|Withdrawal by Subject|12|||
156687779|NCT03877926|565601296|FG003|Overall Study|Withdrawal by Subject|4|||
156687780|NCT03877926|565601293|FG000|Overall Study|Other - Various|4|||
156687781|NCT03877926|565601294|FG001|Overall Study|Other - Various|1|||
156687782|NCT03877926|565601295|FG002|Overall Study|Other - Various|1|||
156687783|NCT03877926|565601296|FG003|Overall Study|Other - Various|0|||
156687784|NCT03877926|565601293|FG000|Overall Study|Not Treated|3|||
156687785|NCT03877926|565601294|FG001|Overall Study|Not Treated|1|||
156687786|NCT03877926|565601295|FG002|Overall Study|Not Treated|1|||
156687787|NCT03877926|565601296|FG003|Overall Study|Not Treated|0|||
156687788|NCT02400476|565601297|FG000|Overall Study|Adverse Event|57|||
156687789|NCT02400476|565601298|FG001|Overall Study|Adverse Event|10|||
156687790|NCT02400476|565601299|FG002|Overall Study|Adverse Event|22|||
156687791|NCT02400476|565601300|FG003|Overall Study|Adverse Event|19|||
156687792|NCT02400476|565601301|FG004|Overall Study|Adverse Event|5|||
156687793|NCT02400476|565601302|FG005|Overall Study|Adverse Event|8|||
156687794|NCT02400476|565601297|FG000|Overall Study|Withdrawal by Subject|4|||
156687795|NCT02400476|565601298|FG001|Overall Study|Withdrawal by Subject|1|||
156687796|NCT02400476|565601299|FG002|Overall Study|Withdrawal by Subject|12|||
156687797|NCT02400476|565601300|FG003|Overall Study|Withdrawal by Subject|7|||
156687798|NCT02400476|565601301|FG004|Overall Study|Withdrawal by Subject|5|||
156687799|NCT02400476|565601302|FG005|Overall Study|Withdrawal by Subject|5|||
156687800|NCT02400476|565601297|FG000|Overall Study|Lost to Follow-up|0|||
156687801|NCT02400476|565601298|FG001|Overall Study|Lost to Follow-up|0|||
156687802|NCT02400476|565601299|FG002|Overall Study|Lost to Follow-up|0|||
156687803|NCT02400476|565601300|FG003|Overall Study|Lost to Follow-up|1|||
156687804|NCT02400476|565601301|FG004|Overall Study|Lost to Follow-up|3|||
156687805|NCT02400476|565601302|FG005|Overall Study|Lost to Follow-up|1|||
156687806|NCT02400476|565601297|FG000|Overall Study|Physician Decision|0|||
156687807|NCT02400476|565601298|FG001|Overall Study|Physician Decision|0|||
156687808|NCT02400476|565601299|FG002|Overall Study|Physician Decision|1|||
156687809|NCT02400476|565601300|FG003|Overall Study|Physician Decision|1|||
156787195|NCT01487161|565972876|FG002|Overall Study|missing data|0|||
156787196|NCT01487161|565972877|FG003|Overall Study|missing data|0|||
156787197|NCT03113136|565972878|FG000|Overall Study|Lost to Follow-up|22|||
156787198|NCT03113136|565972879|FG001|Overall Study|Lost to Follow-up|47|||
156787199|NCT03113136|565972880|FG002|Overall Study|Lost to Follow-up|54|||
156787200|NCT03113136|565972878|FG000|Overall Study|Withdrawal by Subject|4|||
156787201|NCT03113136|565972879|FG001|Overall Study|Withdrawal by Subject|13|||
156787202|NCT03113136|565972880|FG002|Overall Study|Withdrawal by Subject|14|||
156787203|NCT03113136|565972878|FG000|Overall Study|Ineligible|0|||
156787204|NCT03113136|565972879|FG001|Overall Study|Ineligible|2|||
157214449|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
156687810|NCT02400476|565601301|FG004|Overall Study|Physician Decision|0|||
156687811|NCT02400476|565601302|FG005|Overall Study|Physician Decision|1|||
156687812|NCT02400476|565601297|FG000|Overall Study|Other, Disease Progression|0|||
156687813|NCT02400476|565601298|FG001|Overall Study|Other, Disease Progression|1|||
156687814|NCT02400476|565601299|FG002|Overall Study|Other, Disease Progression|2|||
156687815|NCT02400476|565601300|FG003|Overall Study|Other, Disease Progression|1|||
156687816|NCT02400476|565601301|FG004|Overall Study|Other, Disease Progression|2|||
156787205|NCT03113136|565972880|FG002|Overall Study|Ineligible|1|||
156787206|NCT03113136|565972878|FG000|Overall Study|Study Team Decision|1|||
156787207|NCT03113136|565972879|FG001|Overall Study|Study Team Decision|4|||
156687817|NCT02400476|565601302|FG005|Overall Study|Other, Disease Progression|1|||
156687818|NCT02400476|565601297|FG000|Overall Study|Other, Decreased Quality of Life|0|||
156787208|NCT03113136|565972880|FG002|Overall Study|Study Team Decision|0|||
156787209|NCT00977561|565972882|FG000|Overall Study|Death|3|||
156687819|NCT02400476|565601298|FG001|Overall Study|Other, Decreased Quality of Life|0|||
156687820|NCT02400476|565601299|FG002|Overall Study|Other, Decreased Quality of Life|2|||
156687821|NCT02400476|565601300|FG003|Overall Study|Other, Decreased Quality of Life|0|||
156687822|NCT02400476|565601301|FG004|Overall Study|Other, Decreased Quality of Life|0|||
156787210|NCT00977561|565972883|FG001|Overall Study|Death|2|||
156687823|NCT02400476|565601302|FG005|Overall Study|Other, Decreased Quality of Life|0|||
156687824|NCT02400476|565601297|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687825|NCT02400476|565601298|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687826|NCT02400476|565601299|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
156687827|NCT02400476|565601300|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
156687828|NCT02400476|565601301|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687829|NCT02400476|565601302|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
156687830|NCT02487082|565601303|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
156687831|NCT02487082|565601304|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
156687832|NCT02487082|565601303|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
156687833|NCT02487082|565601304|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
156687834|NCT00003531|565601305|FG000|Overall Study|Not evaluable|10|||
156687835|NCT00588731|565601306|FG000|Overall Study|Withdrawal by Subject|3|||
156687836|NCT00588731|565601307|FG001|Overall Study|Withdrawal by Subject|2|||
156687837|NCT00346164|565601308|FG000|Overall Study|Adverse Event|0|||
156687838|NCT00346164|565601309|FG001|Overall Study|Adverse Event|0|||
156687839|NCT00346164|565601310|FG002|Overall Study|Adverse Event|0|||
156687840|NCT00346164|565601311|FG003|Overall Study|Adverse Event|1|||
156687841|NCT00346164|565601308|FG000|Overall Study|Lack of Efficacy|0|||
156687842|NCT00346164|565601309|FG001|Overall Study|Lack of Efficacy|1|||
156687843|NCT00346164|565601310|FG002|Overall Study|Lack of Efficacy|7|||
156687844|NCT00346164|565601311|FG003|Overall Study|Lack of Efficacy|25|||
156687845|NCT00346164|565601308|FG000|Overall Study|Physician Decision|0|||
156687846|NCT00346164|565601309|FG001|Overall Study|Physician Decision|1|||
156687847|NCT00346164|565601310|FG002|Overall Study|Physician Decision|2|||
156687848|NCT00346164|565601311|FG003|Overall Study|Physician Decision|27|||
156687849|NCT00346164|565601308|FG000|Overall Study|Protocol Violation|6|||
156687850|NCT00346164|565601309|FG001|Overall Study|Protocol Violation|2|||
156687851|NCT00346164|565601310|FG002|Overall Study|Protocol Violation|10|||
156687852|NCT00346164|565601311|FG003|Overall Study|Protocol Violation|4|||
156687853|NCT00346164|565601308|FG000|Overall Study|Withdrawal by Subject|0|||
156687854|NCT00346164|565601309|FG001|Overall Study|Withdrawal by Subject|0|||
156687855|NCT00346164|565601310|FG002|Overall Study|Withdrawal by Subject|2|||
156687856|NCT00346164|565601311|FG003|Overall Study|Withdrawal by Subject|0|||
156687857|NCT00346164|565601308|FG000|Overall Study|Ineligible|11|||
156687858|NCT00346164|565601309|FG001|Overall Study|Ineligible|2|||
156687859|NCT00346164|565601310|FG002|Overall Study|Ineligible|2|||
156687860|NCT00346164|565601311|FG003|Overall Study|Ineligible|23|||
156687861|NCT00346164|565601308|FG000|Overall Study|Refusal of further protocol therapy|0|||
156687862|NCT00346164|565601309|FG001|Overall Study|Refusal of further protocol therapy|1|||
156687863|NCT00346164|565601310|FG002|Overall Study|Refusal of further protocol therapy|3|||
156687864|NCT00346164|565601311|FG003|Overall Study|Refusal of further protocol therapy|15|||
156687865|NCT00346164|565601308|FG000|Overall Study|Inability to start week 16 tx on time|0|||
156687866|NCT00346164|565601309|FG001|Overall Study|Inability to start week 16 tx on time|0|||
156687867|NCT00346164|565601310|FG002|Overall Study|Inability to start week 16 tx on time|0|||
156687868|NCT00346164|565601311|FG003|Overall Study|Inability to start week 16 tx on time|11|||
156687869|NCT03139240|565601313|FG000|Overall Study|Lost to Follow-up|0|||
156687870|NCT03139240|565601314|FG001|Overall Study|Lost to Follow-up|1|||
156687871|NCT03139240|565601315|FG002|Overall Study|Lost to Follow-up|1|||
156687872|NCT03139240|565601316|FG003|Overall Study|Lost to Follow-up|0|||
156687873|NCT04569786|565601325|FG000|Overall Study|Lost to Follow-up|1|||
156687874|NCT04569786|565601326|FG001|Overall Study|Lost to Follow-up|0|||
156687875|NCT04569786|565601327|FG002|Overall Study|Lost to Follow-up|4|||
156687876|NCT04569786|565601328|FG003|Overall Study|Lost to Follow-up|1|||
156687877|NCT04569786|565601329|FG004|Overall Study|Lost to Follow-up|0|||
156687878|NCT04569786|565601325|FG000|Overall Study|Withdrawal by Subject|0|||
156687879|NCT04569786|565601326|FG001|Overall Study|Withdrawal by Subject|0|||
156687880|NCT04569786|565601327|FG002|Overall Study|Withdrawal by Subject|0|||
156687881|NCT04569786|565601328|FG003|Overall Study|Withdrawal by Subject|5|||
156687882|NCT04569786|565601329|FG004|Overall Study|Withdrawal by Subject|1|||
156687883|NCT04569786|565601325|FG000|Overall Study|Physician Decision|0|||
156687884|NCT04569786|565601326|FG001|Overall Study|Physician Decision|0|||
156687885|NCT04569786|565601327|FG002|Overall Study|Physician Decision|0|||
156687886|NCT04569786|565601328|FG003|Overall Study|Physician Decision|1|||
156687887|NCT04569786|565601329|FG004|Overall Study|Physician Decision|0|||
156687888|NCT01955044|565601330|FG000|Overall Study|Death|1|||
156687889|NCT01955044|565601331|FG001|Overall Study|Death|1|||
156687890|NCT01955044|565601332|FG002|Overall Study|Death|0|||
156687891|NCT02260258|565601336|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
156687892|NCT02260258|565601337|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
156687893|NCT04232540|565601339|FG000|Overall Study|Lost to Follow-up|1|||
156687894|NCT04232540|565601340|FG001|Overall Study|Lost to Follow-up|0|||
156687895|NCT03234608|565601341|FG000|Overall Study|Lost to Follow-up|23|||
156687896|NCT03234608|565601342|FG001|Overall Study|Lost to Follow-up|21|||
156687897|NCT02105701|565601343|FG000|Overall Study|Lost to Follow-up|1|||
156687898|NCT02105701|565601344|FG001|Overall Study|Lost to Follow-up|0|||
156687899|NCT02105701|565601345|FG002|Overall Study|Lost to Follow-up|2|||
156687900|NCT02105701|565601346|FG003|Overall Study|Lost to Follow-up|1|||
156687901|NCT02105701|565601343|FG000|Overall Study|Protocol Violation|0|||
156687902|NCT02105701|565601344|FG001|Overall Study|Protocol Violation|0|||
156687903|NCT02105701|565601345|FG002|Overall Study|Protocol Violation|1|||
156687904|NCT02105701|565601346|FG003|Overall Study|Protocol Violation|0|||
156687905|NCT02105701|565601343|FG000|Overall Study|Withdrawal by Subject|2|||
156687906|NCT02105701|565601344|FG001|Overall Study|Withdrawal by Subject|1|||
156687907|NCT02105701|565601345|FG002|Overall Study|Withdrawal by Subject|0|||
156687908|NCT02105701|565601346|FG003|Overall Study|Withdrawal by Subject|1|||
156687909|NCT02105701|565601343|FG000|Overall Study|Death|1|||
156687910|NCT02105701|565601344|FG001|Overall Study|Death|0|||
156687911|NCT02105701|565601345|FG002|Overall Study|Death|0|||
156687912|NCT02105701|565601346|FG003|Overall Study|Death|0|||
156687913|NCT01362296|565601347|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
156687914|NCT01362296|565601348|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
156687915|NCT01362296|565601349|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
156687916|NCT01362296|565601350|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
156687917|NCT01362296|565601347|FG000|Randomized Phase (RP)|Physician Decision|1|||
156687918|NCT01362296|565601348|FG001|Randomized Phase (RP)|Physician Decision|9|||
156687919|NCT01362296|565601349|FG002|Randomized Phase (RP)|Physician Decision|0|||
156687920|NCT01362296|565601350|FG003|Randomized Phase (RP)|Physician Decision|0|||
156687921|NCT01362296|565601347|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
156687922|NCT01362296|565601348|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
156687923|NCT01362296|565601349|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
156687924|NCT01362296|565601350|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
156687925|NCT01362296|565601347|FG000|Randomized Phase (RP)|Adverse Event|20|||
156687926|NCT01362296|565601348|FG001|Randomized Phase (RP)|Adverse Event|4|||
156687927|NCT01362296|565601349|FG002|Randomized Phase (RP)|Adverse Event|0|||
156687928|NCT01362296|565601350|FG003|Randomized Phase (RP)|Adverse Event|0|||
156687929|NCT01362296|565601347|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
156687930|NCT01362296|565601348|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
156687931|NCT01362296|565601349|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
156687932|NCT01362296|565601350|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
156869814|NCT00684021|566281025|FG000|Overall Study|Death|1|||
156869815|NCT00684021|566281026|FG001|Overall Study|Death|0|||
156869816|NCT00684021|566281027|FG002|Overall Study|Death|0|||
156869817|NCT00684021|566281028|FG003|Overall Study|Death|0|||
156869818|NCT02556177|566281029|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
156869819|NCT02556177|566281030|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
156869820|NCT03818321|566281032|FG000|Overall Study|Withdrawal by Subject|1|||
156869821|NCT03818321|566281033|FG001|Overall Study|Withdrawal by Subject|2|||
156869822|NCT01721044|566281036|FG000|Treatment Period|Adverse Event|7|||
156869823|NCT01721044|566281037|FG001|Treatment Period|Adverse Event|7|||
156687933|NCT01362296|565601347|FG000|Crossover Phase|PD including Death due to PD|0|||
156687934|NCT01362296|565601348|FG001|Crossover Phase|PD including Death due to PD|0|||
156869824|NCT01721044|566281038|FG002|Treatment Period|Adverse Event|10|||
156869825|NCT01721044|566281036|FG000|Treatment Period|Death|0|||
156869826|NCT01721044|566281037|FG001|Treatment Period|Death|0|||
156869827|NCT01721044|566281038|FG002|Treatment Period|Death|1|||
156869828|NCT01721044|566281036|FG000|Treatment Period|Lack of Efficacy|16|||
156869829|NCT01721044|566281037|FG001|Treatment Period|Lack of Efficacy|4|||
156687935|NCT01362296|565601349|FG002|Crossover Phase|PD including Death due to PD|16|||
156687936|NCT01362296|565601350|FG003|Crossover Phase|PD including Death due to PD|1|||
156687937|NCT01362296|565601347|FG000|Crossover Phase|Withdrawal by Subject|0|||
156687938|NCT01362296|565601348|FG001|Crossover Phase|Withdrawal by Subject|0|||
156687939|NCT01362296|565601349|FG002|Crossover Phase|Withdrawal by Subject|2|||
156687940|NCT01362296|565601350|FG003|Crossover Phase|Withdrawal by Subject|1|||
156687941|NCT01362296|565601347|FG000|Crossover Phase|Adverse Event|0|||
156869830|NCT01721044|566281038|FG002|Treatment Period|Lack of Efficacy|4|||
156869831|NCT01721044|566281036|FG000|Treatment Period|Lost to Follow-up|0|||
157013481|NCT03358875|566801786|FG000|Overall Study|Withdrawal by Subject|13|||
157013482|NCT03358875|566801787|FG001|Overall Study|Withdrawal by Subject|16|||
157013483|NCT03358875|566801786|FG000|Overall Study|Lost to Follow-up|13|||
156687942|NCT01362296|565601348|FG001|Crossover Phase|Adverse Event|0|||
156687943|NCT01362296|565601349|FG002|Crossover Phase|Adverse Event|4|||
156687944|NCT01362296|565601350|FG003|Crossover Phase|Adverse Event|0|||
156687945|NCT01362296|565601347|FG000|Crossover Phase|Study Closed/Terminated|0|||
156687946|NCT01362296|565601348|FG001|Crossover Phase|Study Closed/Terminated|0|||
156687947|NCT01362296|565601349|FG002|Crossover Phase|Study Closed/Terminated|1|||
156687948|NCT01362296|565601350|FG003|Crossover Phase|Study Closed/Terminated|0|||
156869832|NCT01721044|566281037|FG001|Treatment Period|Lost to Follow-up|0|||
156869833|NCT01721044|566281038|FG002|Treatment Period|Lost to Follow-up|1|||
157013484|NCT03358875|566801787|FG001|Overall Study|Lost to Follow-up|2|||
156869834|NCT01721044|566281036|FG000|Treatment Period|Physician Decision|1|||
156687949|NCT03693950|565601351|FG000|Overall Study|Withdrawal by Subject|1|||
156687950|NCT03693950|565601352|FG001|Overall Study|Withdrawal by Subject|0|||
156687951|NCT04230876|565601354|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
156687952|NCT04230876|565601355|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
156687953|NCT01662362|565601356|FG000|Overall Study|Lost to Follow-up|38|||
156687954|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687955|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
156687956|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687957|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
156687958|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156869835|NCT01721044|566281037|FG001|Treatment Period|Physician Decision|0|||
156869836|NCT01721044|566281038|FG002|Treatment Period|Physician Decision|2|||
156869837|NCT01721044|566281036|FG000|Treatment Period|Protocol Violation|1|||
156869838|NCT01721044|566281037|FG001|Treatment Period|Protocol Violation|0|||
156869839|NCT01721044|566281038|FG002|Treatment Period|Protocol Violation|0|||
156869840|NCT01721044|566281036|FG000|Treatment Period|Withdrawal by Subject|7|||
156869841|NCT01721044|566281037|FG001|Treatment Period|Withdrawal by Subject|6|||
156869842|NCT01721044|566281038|FG002|Treatment Period|Withdrawal by Subject|1|||
156869843|NCT01499355|566281039|FG000|Run-In Period|Study Termination|15|||
156869844|NCT01499355|566281040|FG001|Run-In Period|Study Termination|0|||
156869845|NCT01499355|566281041|FG002|Run-In Period|Study Termination|0|||
156869846|NCT01499355|566281042|FG003|Run-In Period|Study Termination|0|||
156869847|NCT01499355|566281039|FG000|Run-In Period|Other|3|||
156869848|NCT01499355|566281040|FG001|Run-In Period|Other|0|||
156869849|NCT01499355|566281041|FG002|Run-In Period|Other|0|||
156869850|NCT01499355|566281042|FG003|Run-In Period|Other|0|||
156869851|NCT01499355|566281039|FG000|Run-In Period|Death|2|||
156869852|NCT01499355|566281040|FG001|Run-In Period|Death|0|||
156869853|NCT01499355|566281041|FG002|Run-In Period|Death|0|||
156787211|NCT00977561|565972882|FG000|Overall Study|Study terminated|0|||
156787212|NCT00977561|565972883|FG001|Overall Study|Study terminated|2|||
156787213|NCT00977561|565972882|FG000|Overall Study|Other|2|||
156787214|NCT00977561|565972883|FG001|Overall Study|Other|0|||
156787215|NCT02187055|565972884|FG000|Overall Study|Lack of Efficacy|10|||
156787216|NCT02187055|565972885|FG001|Overall Study|Lack of Efficacy|3|||
156787217|NCT02187055|565972886|FG002|Overall Study|Lack of Efficacy|7|||
156787218|NCT02187055|565972884|FG000|Overall Study|Lost to Follow-up|2|||
156787219|NCT02187055|565972885|FG001|Overall Study|Lost to Follow-up|7|||
156787220|NCT02187055|565972886|FG002|Overall Study|Lost to Follow-up|3|||
156787221|NCT02187055|565972884|FG000|Overall Study|No longer meets eligibility criteria|0|||
156787222|NCT02187055|565972885|FG001|Overall Study|No longer meets eligibility criteria|2|||
156787223|NCT02187055|565972886|FG002|Overall Study|No longer meets eligibility criteria|0|||
156787224|NCT02187055|565972884|FG000|Overall Study|No longer willing to participate|6|||
156787225|NCT02187055|565972885|FG001|Overall Study|No longer willing to participate|8|||
156787226|NCT02187055|565972886|FG002|Overall Study|No longer willing to participate|10|||
156787227|NCT02187055|565972884|FG000|Overall Study|Other|5|||
156787228|NCT02187055|565972885|FG001|Overall Study|Other|6|||
156787229|NCT02187055|565972886|FG002|Overall Study|Other|3|||
156787230|NCT02187055|565972884|FG000|Overall Study|Protocol Violation|9|||
156787231|NCT02187055|565972885|FG001|Overall Study|Protocol Violation|9|||
156787232|NCT02187055|565972886|FG002|Overall Study|Protocol Violation|4|||
156787233|NCT02187055|565972884|FG000|Overall Study|Pregnancy|3|||
156787234|NCT02187055|565972885|FG001|Overall Study|Pregnancy|1|||
156787235|NCT02187055|565972886|FG002|Overall Study|Pregnancy|0|||
156787236|NCT02187055|565972884|FG000|Overall Study|Withdrawal by Subject|11|||
156787237|NCT02187055|565972885|FG001|Overall Study|Withdrawal by Subject|11|||
156787238|NCT02187055|565972886|FG002|Overall Study|Withdrawal by Subject|11|||
156787239|NCT02187055|565972884|FG000|Overall Study|Adverse Event|21|||
156787240|NCT02187055|565972885|FG001|Overall Study|Adverse Event|26|||
156787241|NCT02187055|565972886|FG002|Overall Study|Adverse Event|36|||
156787242|NCT02187055|565972884|FG000|Overall Study|Death|2|||
156787243|NCT02187055|565972885|FG001|Overall Study|Death|0|||
156787244|NCT02187055|565972886|FG002|Overall Study|Death|0|||
156787245|NCT01107457|565972889|FG000|Part A|Adverse Event|1|||
156787246|NCT01107457|565972890|FG001|Part A|Adverse Event|2|||
156787247|NCT01107457|565972891|FG002|Part A|Adverse Event|1|||
156787248|NCT01107457|565972892|FG003|Part A|Adverse Event|0|||
156787249|NCT01107457|565972893|FG004|Part A|Adverse Event|0|||
156787250|NCT01107457|565972894|FG005|Part A|Adverse Event|0|||
156787251|NCT01107457|565972889|FG000|Part A|Withdrawal by Subject|3|||
156787252|NCT01107457|565972890|FG001|Part A|Withdrawal by Subject|3|||
156787253|NCT01107457|565972891|FG002|Part A|Withdrawal by Subject|0|||
156787254|NCT01107457|565972892|FG003|Part A|Withdrawal by Subject|3|||
156787255|NCT01107457|565972893|FG004|Part A|Withdrawal by Subject|1|||
156869854|NCT01499355|566281042|FG003|Run-In Period|Death|0|||
156869855|NCT01499355|566281039|FG000|Run-In Period|Investigator Decision|2|||
156869856|NCT01499355|566281040|FG001|Run-In Period|Investigator Decision|0|||
156869857|NCT01499355|566281041|FG002|Run-In Period|Investigator Decision|0|||
156687959|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156687960|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
156687961|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
156687962|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
156687963|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687964|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687965|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
156687966|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Death|0|||
156687967|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Death|1|||
156687968|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Death|0|||
156687969|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Death|0|||
156687970|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
156687971|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
156687972|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
156687973|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
156687974|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
156687975|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687976|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687977|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
156687978|NCT00545688|565601358|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
156687979|NCT00545688|565601359|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
156687980|NCT00545688|565601360|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
156687981|NCT00545688|565601361|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
156687982|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Disease Progression|3|||
156687983|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Disease Progression|3|||
156687984|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Disease Progression|0|||
156687985|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Disease Progression|7|||
156687986|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
156687987|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
156687988|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
156687989|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
156687990|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
156687991|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
156687992|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
156687993|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
156687994|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Adverse Event|0|||
156687995|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Adverse Event|3|||
156687996|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Adverse Event|2|||
156687997|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Adverse Event|2|||
156687998|NCT00545688|565601358|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
156687999|NCT00545688|565601359|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
156688000|NCT00545688|565601360|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
156688001|NCT00545688|565601361|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
156688002|NCT00545688|565601358|FG000|Follow-Up Period|Death|4|||
156688003|NCT00545688|565601359|FG001|Follow-Up Period|Death|2|||
156688004|NCT00545688|565601360|FG002|Follow-Up Period|Death|2|||
156688005|NCT00545688|565601361|FG003|Follow-Up Period|Death|6|||
156688006|NCT00545688|565601358|FG000|Follow-Up Period|Disease Progression|6|||
156688007|NCT00545688|565601359|FG001|Follow-Up Period|Disease Progression|5|||
156688008|NCT00545688|565601360|FG002|Follow-Up Period|Disease Progression|9|||
156688009|NCT00545688|565601361|FG003|Follow-Up Period|Disease Progression|9|||
156688010|NCT00545688|565601358|FG000|Follow-Up Period|Refused Treatment|6|||
156688011|NCT00545688|565601359|FG001|Follow-Up Period|Refused Treatment|2|||
156688012|NCT00545688|565601360|FG002|Follow-Up Period|Refused Treatment|0|||
156688013|NCT00545688|565601361|FG003|Follow-Up Period|Refused Treatment|2|||
156688014|NCT00545688|565601358|FG000|Follow-Up Period|Lost to Follow-up|3|||
156688015|NCT00545688|565601359|FG001|Follow-Up Period|Lost to Follow-up|3|||
156688016|NCT00545688|565601360|FG002|Follow-Up Period|Lost to Follow-up|3|||
156688017|NCT00545688|565601361|FG003|Follow-Up Period|Lost to Follow-up|1|||
156787256|NCT01107457|565972894|FG005|Part A|Withdrawal by Subject|0|||
156787257|NCT01107457|565972889|FG000|Part A|Lost to Follow-up|0|||
156787258|NCT01107457|565972890|FG001|Part A|Lost to Follow-up|1|||
156787259|NCT01107457|565972891|FG002|Part A|Lost to Follow-up|0|||
157013485|NCT03358875|566801786|FG000|Overall Study|Miscellaneous|33|||
156688018|NCT00545688|565601358|FG000|Follow-Up Period|Unspecified Reason|2|||
156688019|NCT00545688|565601359|FG001|Follow-Up Period|Unspecified Reason|5|||
156688020|NCT00545688|565601360|FG002|Follow-Up Period|Unspecified Reason|6|||
156688021|NCT00545688|565601361|FG003|Follow-Up Period|Unspecified Reason|8|||
156688022|NCT00545688|565601358|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
156688023|NCT00545688|565601359|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
156688024|NCT00545688|565601360|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
156688025|NCT00545688|565601361|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
156787260|NCT01107457|565972892|FG003|Part A|Lost to Follow-up|0|||
156787261|NCT01107457|565972893|FG004|Part A|Lost to Follow-up|0|||
156688026|NCT02339090|565601362|FG000|Overall Study|Adverse Event|1|||
156688027|NCT02339090|565601363|FG001|Overall Study|Adverse Event|0|||
156688028|NCT02339090|565601362|FG000|Overall Study|Lost to Follow-up|0|||
156688029|NCT02339090|565601363|FG001|Overall Study|Lost to Follow-up|1|||
156688030|NCT02339090|565601362|FG000|Overall Study|Non-compliance With Study Drug|0|||
156688031|NCT02339090|565601363|FG001|Overall Study|Non-compliance With Study Drug|1|||
156688032|NCT02339090|565601362|FG000|Overall Study|Withdrawal by Subject|2|||
156688033|NCT02339090|565601363|FG001|Overall Study|Withdrawal by Subject|1|||
156688034|NCT02339090|565601362|FG000|Overall Study|Poor Growth|3|||
156688035|NCT02339090|565601363|FG001|Overall Study|Poor Growth|0|||
156688036|NCT02339090|565601362|FG000|Overall Study|Randomized but not treated|0|||
156688037|NCT02339090|565601363|FG001|Overall Study|Randomized but not treated|2|||
156688038|NCT00248170|565601367|FG000|Overall Study|Withdrawal by Subject|71|||
156688039|NCT00248170|565601368|FG001|Overall Study|Withdrawal by Subject|79|||
156688040|NCT00248170|565601367|FG000|Overall Study|Protocol Violation|35|||
156688041|NCT00248170|565601368|FG001|Overall Study|Protocol Violation|30|||
156688042|NCT00248170|565601367|FG000|Overall Study|Lost to Follow-up|28|||
156688043|NCT00248170|565601368|FG001|Overall Study|Lost to Follow-up|35|||
156688044|NCT00248170|565601367|FG000|Overall Study|Disease progression|196|||
156688045|NCT00248170|565601368|FG001|Overall Study|Disease progression|216|||
156688046|NCT00248170|565601367|FG000|Overall Study|Death|28|||
156688047|NCT00248170|565601368|FG001|Overall Study|Death|47|||
156688048|NCT00248170|565601367|FG000|Overall Study|Adverse Event|311|||
156688049|NCT00248170|565601368|FG001|Overall Study|Adverse Event|296|||
156688050|NCT00248170|565601367|FG000|Overall Study|Administrative problems|22|||
156688051|NCT00248170|565601368|FG001|Overall Study|Administrative problems|25|||
156688052|NCT00248170|565601367|FG000|Overall Study|Abnormal test procedure(s) result|49|||
156688053|NCT00248170|565601368|FG001|Overall Study|Abnormal test procedure(s) result|61|||
156688054|NCT00248170|565601367|FG000|Overall Study|Abnormal laboratory values|4|||
156688055|NCT00248170|565601368|FG001|Overall Study|Abnormal laboratory values|0|||
156688056|NCT00248170|565601367|FG000|Overall Study|Protocol deviation|17|||
156688057|NCT00248170|565601368|FG001|Overall Study|Protocol deviation|19|||
156688058|NCT04039919|565602713|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156787262|NCT01107457|565972894|FG005|Part A|Lost to Follow-up|0|||
156787263|NCT01107457|565972889|FG000|Part A|Lack of Efficacy|1|||
156787264|NCT01107457|565972890|FG001|Part A|Lack of Efficacy|0|||
156688059|NCT04039919|565602714|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156688060|NCT04039919|565602715|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156688061|NCT04039919|565602716|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156688062|NCT04039919|565602717|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156688063|NCT04039919|565602713|FG000|Treatment Period 1|Sponsor's decision|0|||
156688064|NCT04039919|565602714|FG001|Treatment Period 1|Sponsor's decision|0|||
156688065|NCT04039919|565602715|FG002|Treatment Period 1|Sponsor's decision|0|||
156787265|NCT01107457|565972891|FG002|Part A|Lack of Efficacy|0|||
156787266|NCT01107457|565972892|FG003|Part A|Lack of Efficacy|0|||
156688066|NCT04039919|565602716|FG003|Treatment Period 1|Sponsor's decision|0|||
156688067|NCT04039919|565602717|FG004|Treatment Period 1|Sponsor's decision|16|||
156688068|NCT04039919|565602713|FG000|Treatment Period 5|Withdrawal by Subject|1|||
156688069|NCT04039919|565602714|FG001|Treatment Period 5|Withdrawal by Subject|0|||
156688070|NCT04039919|565602715|FG002|Treatment Period 5|Withdrawal by Subject|0|||
156787267|NCT01107457|565972893|FG004|Part A|Lack of Efficacy|0|||
156787268|NCT01107457|565972894|FG005|Part A|Lack of Efficacy|0|||
156787269|NCT01107457|565972889|FG000|Part A|Protocol Violation|0|||
156787270|NCT01107457|565972890|FG001|Part A|Protocol Violation|1|||
156787271|NCT01107457|565972891|FG002|Part A|Protocol Violation|0|||
156787272|NCT01107457|565972892|FG003|Part A|Protocol Violation|0|||
156787273|NCT01107457|565972893|FG004|Part A|Protocol Violation|0|||
156787274|NCT01107457|565972894|FG005|Part A|Protocol Violation|0|||
156787275|NCT01107457|565972889|FG000|Part B and C|Adverse Event|0|||
156787276|NCT01107457|565972890|FG001|Part B and C|Adverse Event|0|||
156787277|NCT01107457|565972891|FG002|Part B and C|Adverse Event|0|||
156787278|NCT01107457|565972892|FG003|Part B and C|Adverse Event|0|||
156688071|NCT04039919|565602716|FG003|Treatment Period 5|Withdrawal by Subject|0|||
156688072|NCT04039919|565602717|FG004|Treatment Period 5|Withdrawal by Subject|0|||
156688073|NCT03250299|565602722|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
156688074|NCT03250299|565602723|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
156688075|NCT03250299|565602724|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
156688076|NCT03250299|565602725|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
156688077|NCT03250299|565602726|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
156688078|NCT03250299|565602722|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
156688079|NCT03250299|565602723|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
156787279|NCT01107457|565972893|FG004|Part B and C|Adverse Event|0|||
156688080|NCT03250299|565602724|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
156688081|NCT03250299|565602725|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
156787280|NCT01107457|565972894|FG005|Part B and C|Adverse Event|12|||
156787281|NCT01107457|565972889|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787282|NCT01107457|565972890|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787283|NCT01107457|565972891|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156688082|NCT03250299|565602726|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
156688083|NCT03250299|565602722|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688084|NCT03250299|565602723|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688085|NCT03250299|565602724|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
156688086|NCT03250299|565602725|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688087|NCT03250299|565602726|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
156688088|NCT03250299|565602722|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
156688089|NCT03250299|565602723|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
156688090|NCT03250299|565602724|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
156688091|NCT03250299|565602725|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
156688092|NCT03250299|565602726|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
156688093|NCT03346070|565602727|FG000|Overall Study|Death|0|||
156688094|NCT03346070|565602728|FG001|Overall Study|Death|0|||
156688095|NCT03346070|565602729|FG002|Overall Study|Death|0|||
156688096|NCT03346070|565602730|FG003|Overall Study|Death|0|||
156688097|NCT03346070|565602731|FG004|Overall Study|Death|1|||
156688098|NCT03346070|565602727|FG000|Overall Study|Lost to Follow-up|0|||
156688099|NCT03346070|565602728|FG001|Overall Study|Lost to Follow-up|1|||
156688100|NCT03346070|565602729|FG002|Overall Study|Lost to Follow-up|2|||
156688101|NCT03346070|565602730|FG003|Overall Study|Lost to Follow-up|0|||
156688102|NCT03346070|565602731|FG004|Overall Study|Lost to Follow-up|0|||
156688103|NCT03346070|565602727|FG000|Overall Study|Physician Decision|0|||
156688104|NCT03346070|565602728|FG001|Overall Study|Physician Decision|0|||
156688105|NCT03346070|565602729|FG002|Overall Study|Physician Decision|0|||
156688106|NCT03346070|565602730|FG003|Overall Study|Physician Decision|1|||
156787284|NCT01107457|565972892|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787285|NCT01107457|565972893|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
156787286|NCT01107457|565972894|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
156787287|NCT01107457|565972889|FG000|Part B and C|Physician Decision|0|||
156787288|NCT01107457|565972890|FG001|Part B and C|Physician Decision|0|||
156787289|NCT01107457|565972891|FG002|Part B and C|Physician Decision|0|||
156787290|NCT01107457|565972892|FG003|Part B and C|Physician Decision|0|||
156787291|NCT01107457|565972893|FG004|Part B and C|Physician Decision|0|||
156787292|NCT01107457|565972894|FG005|Part B and C|Physician Decision|3|||
156787293|NCT01107457|565972889|FG000|Part B and C|Lack of Efficacy|0|||
156787294|NCT01107457|565972890|FG001|Part B and C|Lack of Efficacy|0|||
156787295|NCT01107457|565972891|FG002|Part B and C|Lack of Efficacy|0|||
156787296|NCT01107457|565972892|FG003|Part B and C|Lack of Efficacy|0|||
156787297|NCT01107457|565972893|FG004|Part B and C|Lack of Efficacy|0|||
156787298|NCT01107457|565972894|FG005|Part B and C|Lack of Efficacy|7|||
156787299|NCT01107457|565972889|FG000|Part B and C|Lost to Follow-up|0|||
156787300|NCT01107457|565972890|FG001|Part B and C|Lost to Follow-up|0|||
156787301|NCT01107457|565972891|FG002|Part B and C|Lost to Follow-up|0|||
156787302|NCT01107457|565972892|FG003|Part B and C|Lost to Follow-up|0|||
156787303|NCT01107457|565972893|FG004|Part B and C|Lost to Follow-up|0|||
156787304|NCT01107457|565972894|FG005|Part B and C|Lost to Follow-up|10|||
156787305|NCT01107457|565972889|FG000|Part B and C|Protocol Violation|0|||
156787306|NCT01107457|565972890|FG001|Part B and C|Protocol Violation|0|||
156787307|NCT01107457|565972891|FG002|Part B and C|Protocol Violation|0|||
156787308|NCT01107457|565972892|FG003|Part B and C|Protocol Violation|0|||
156787309|NCT01107457|565972893|FG004|Part B and C|Protocol Violation|0|||
156787310|NCT01107457|565972894|FG005|Part B and C|Protocol Violation|1|||
156787311|NCT01107457|565972889|FG000|Part B and C|Sponsor Decision|0|||
156787312|NCT01107457|565972890|FG001|Part B and C|Sponsor Decision|0|||
156787313|NCT01107457|565972891|FG002|Part B and C|Sponsor Decision|0|||
156787314|NCT01107457|565972892|FG003|Part B and C|Sponsor Decision|0|||
156787315|NCT01107457|565972893|FG004|Part B and C|Sponsor Decision|0|||
156787316|NCT01107457|565972894|FG005|Part B and C|Sponsor Decision|66|||
156787317|NCT01107457|565972889|FG000|Part B and C|Withdrawal by Subject|0|||
156787318|NCT01107457|565972890|FG001|Part B and C|Withdrawal by Subject|0|||
156787319|NCT01107457|565972891|FG002|Part B and C|Withdrawal by Subject|0|||
156787320|NCT01107457|565972892|FG003|Part B and C|Withdrawal by Subject|0|||
156688107|NCT03346070|565602731|FG004|Overall Study|Physician Decision|1|||
156688108|NCT03346070|565602727|FG000|Overall Study|Withdrawal by Subject|1|||
156787321|NCT01107457|565972893|FG004|Part B and C|Withdrawal by Subject|0|||
156787322|NCT01107457|565972894|FG005|Part B and C|Withdrawal by Subject|16|||
156787323|NCT01107457|565972889|FG000|Part B and C|Clinical Relapse|0|||
156688109|NCT03346070|565602728|FG001|Overall Study|Withdrawal by Subject|0|||
156688110|NCT03346070|565602729|FG002|Overall Study|Withdrawal by Subject|0|||
156688111|NCT03346070|565602730|FG003|Overall Study|Withdrawal by Subject|1|||
156688112|NCT03346070|565602731|FG004|Overall Study|Withdrawal by Subject|0|||
156787324|NCT01107457|565972890|FG001|Part B and C|Clinical Relapse|0|||
156787325|NCT01107457|565972891|FG002|Part B and C|Clinical Relapse|0|||
156787326|NCT01107457|565972892|FG003|Part B and C|Clinical Relapse|0|||
156787327|NCT01107457|565972893|FG004|Part B and C|Clinical Relapse|0|||
156787328|NCT01107457|565972894|FG005|Part B and C|Clinical Relapse|4|||
156787329|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
156787330|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
156869858|NCT01499355|566281042|FG003|Run-In Period|Investigator Decision|0|||
156869859|NCT01499355|566281039|FG000|Run-In Period|Consent Withdrawn|1|||
156869860|NCT01499355|566281040|FG001|Run-In Period|Consent Withdrawn|0|||
156869861|NCT01499355|566281041|FG002|Run-In Period|Consent Withdrawn|0|||
156869862|NCT01499355|566281042|FG003|Run-In Period|Consent Withdrawn|0|||
156869863|NCT01499355|566281039|FG000|Run-In Period|Adverse Event|8|||
156869864|NCT01499355|566281040|FG001|Run-In Period|Adverse Event|0|||
156869865|NCT01499355|566281041|FG002|Run-In Period|Adverse Event|0|||
156869866|NCT01499355|566281042|FG003|Run-In Period|Adverse Event|0|||
156869867|NCT01499355|566281039|FG000|Double-Blind Period|Adverse Event|0|||
156869868|NCT01499355|566281040|FG001|Double-Blind Period|Adverse Event|2|||
156869869|NCT01499355|566281041|FG002|Double-Blind Period|Adverse Event|3|||
156688113|NCT03346070|565602727|FG000|Overall Study|Study medication not received as planned|2|||
156688114|NCT03346070|565602728|FG001|Overall Study|Study medication not received as planned|3|||
156688115|NCT03346070|565602729|FG002|Overall Study|Study medication not received as planned|2|||
156688116|NCT03346070|565602730|FG003|Overall Study|Study medication not received as planned|3|||
156688117|NCT03346070|565602731|FG004|Overall Study|Study medication not received as planned|2|||
156688118|NCT03346070|565602727|FG000|Overall Study|Screen Failure|0|||
156688119|NCT03346070|565602728|FG001|Overall Study|Screen Failure|0|||
156688120|NCT03346070|565602729|FG002|Overall Study|Screen Failure|0|||
156688121|NCT03346070|565602730|FG003|Overall Study|Screen Failure|1|||
156688122|NCT03346070|565602731|FG004|Overall Study|Screen Failure|1|||
156688123|NCT00977548|565602732|FG000|Overall Study|Ineligible|4|||
156688124|NCT00977548|565602732|FG000|Overall Study|Adverse Event|8|||
156688125|NCT00977548|565602732|FG000|Overall Study|Withdrawal by Subject|1|||
156688126|NCT02070757|565602735|FG000|Overall Study|Adverse Event|107|||
156688127|NCT02070757|565602736|FG001|Overall Study|Adverse Event|99|||
156688128|NCT02070757|565602735|FG000|Overall Study|Lost to Follow-up|7|||
156688129|NCT02070757|565602736|FG001|Overall Study|Lost to Follow-up|4|||
156688130|NCT02070757|565602735|FG000|Overall Study|Protocol Violation|0|||
156688131|NCT02070757|565602736|FG001|Overall Study|Protocol Violation|4|||
156688132|NCT02070757|565602735|FG000|Overall Study|Withdrawal by Subject|1|||
156688133|NCT02070757|565602736|FG001|Overall Study|Withdrawal by Subject|3|||
156688134|NCT02070757|565602735|FG000|Overall Study|Investigator Decision|0|||
156688135|NCT02070757|565602736|FG001|Overall Study|Investigator Decision|2|||
156688136|NCT02070757|565602735|FG000|Overall Study|Discharged from Study Hospital|2|||
156869870|NCT01499355|566281042|FG003|Double-Blind Period|Adverse Event|2|||
156869871|NCT01499355|566281039|FG000|Double-Blind Period|Study Termination|0|||
156869872|NCT01499355|566281040|FG001|Double-Blind Period|Study Termination|18|||
156688137|NCT02070757|565602736|FG001|Overall Study|Discharged from Study Hospital|2|||
156688138|NCT04086641|565602739|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
156688139|NCT04086641|565602740|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
156688140|NCT01546142|565602741|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
156688141|NCT01546142|565602742|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
156688142|NCT01546142|565602741|FG000|Overall Study|Subject Noncompliance|1|||
156688143|NCT01546142|565602742|FG001|Overall Study|Subject Noncompliance|1|||
156688144|NCT01546142|565602741|FG000|Overall Study|Adverse Event|6|||
156688145|NCT01546142|565602742|FG001|Overall Study|Adverse Event|3|||
156688146|NCT01546142|565602741|FG000|Overall Study|Lost to Follow-up|20|||
156688147|NCT01546142|565602742|FG001|Overall Study|Lost to Follow-up|15|||
156688148|NCT01546142|565602741|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
156688149|NCT01546142|565602742|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
156688150|NCT01546142|565602741|FG000|Overall Study|Subject Randomized but Not Treated|1|||
156688151|NCT01546142|565602742|FG001|Overall Study|Subject Randomized but Not Treated|0|||
156688152|NCT01213836|565602743|FG000|Period 1, First Intervention|Adverse Event|2|||
156688153|NCT01213836|565602744|FG001|Period 1, First Intervention|Adverse Event|1|||
156688154|NCT01213836|565602743|FG000|Period 1, First Intervention|Protocol Violation|0|||
156688155|NCT01213836|565602744|FG001|Period 1, First Intervention|Protocol Violation|1|||
156688156|NCT01213836|565602743|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
156688157|NCT01213836|565602744|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
156688158|NCT00706095|565602750|FG000|Overall Study|Progressive Disease|4|||
156688159|NCT00706095|565602751|FG001|Overall Study|Progressive Disease|5|||
156688160|NCT00706095|565602752|FG002|Overall Study|Progressive Disease|3|||
156688161|NCT00706095|565602750|FG000|Overall Study|Clinical Progression|1|||
156688162|NCT00706095|565602751|FG001|Overall Study|Clinical Progression|2|||
156688163|NCT00706095|565602752|FG002|Overall Study|Clinical Progression|2|||
156688164|NCT00706095|565602750|FG000|Overall Study|Withdrawal by Subject|1|||
156688165|NCT00706095|565602751|FG001|Overall Study|Withdrawal by Subject|0|||
156688166|NCT00706095|565602752|FG002|Overall Study|Withdrawal by Subject|0|||
156688167|NCT00126126|565602762|FG000|Overall Study|Lost to Follow-up|0|||
156688168|NCT00126126|565602763|FG001|Overall Study|Lost to Follow-up|2|||
156688169|NCT00892281|565602764|FG000|Overall Study|Adverse Event|65|||
156688170|NCT00892281|565602765|FG001|Overall Study|Adverse Event|8|||
156869873|NCT01499355|566281041|FG002|Double-Blind Period|Study Termination|16|||
156869874|NCT01499355|566281042|FG003|Double-Blind Period|Study Termination|14|||
156869875|NCT01499355|566281039|FG000|Double-Blind Period|Other|0|||
156787331|NCT00694161|565972895|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
156787332|NCT03601052|565972896|FG000|Overall Study|Lost to Follow-up|2|||
156787333|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
156787334|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
156787335|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
156787336|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
156787337|NCT00694122|565972897|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
156787338|NCT00694122|565972898|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
156787339|NCT00105508|565972899|FG000|Overall Study|Prephase Dropout|1|||
156787340|NCT00105508|565972900|FG001|Overall Study|Prephase Dropout|0|||
156787341|NCT00105508|565972899|FG000|Overall Study|Adverse Event|16|||
156787342|NCT00105508|565972900|FG001|Overall Study|Adverse Event|19|||
156787343|NCT00105508|565972899|FG000|Overall Study|Insufficient Efficacy|1|||
156787344|NCT00105508|565972900|FG001|Overall Study|Insufficient Efficacy|0|||
156787345|NCT00105508|565972899|FG000|Overall Study|Withdrawal by Subject|10|||
156787346|NCT00105508|565972900|FG001|Overall Study|Withdrawal by Subject|6|||
156787347|NCT00105508|565972899|FG000|Overall Study|Lost to Follow-up|3|||
156787348|NCT00105508|565972900|FG001|Overall Study|Lost to Follow-up|0|||
156787349|NCT00105508|565972899|FG000|Overall Study|Protocol Violation|1|||
156787350|NCT00105508|565972900|FG001|Overall Study|Protocol Violation|2|||
156787351|NCT00105508|565972899|FG000|Overall Study|Other|8|||
156787352|NCT00105508|565972900|FG001|Overall Study|Other|9|||
156787353|NCT00683384|565972901|FG000|Overall Study|Death|1|||
156787354|NCT00683384|565972901|FG000|Overall Study|Adverse Event|1|||
156787355|NCT00120874|565972902|FG000|Overall Study|Death|0|||
156787356|NCT00120874|565972903|FG001|Overall Study|Death|1|||
156787357|NCT01348490|565972912|FG000|Overall Study|Death|1|||
156787358|NCT01348490|565972912|FG000|Overall Study|Adverse Event|3|||
156787359|NCT01348490|565972912|FG000|Overall Study|Consent withdrawn|7|||
156787360|NCT01348490|565972912|FG000|Overall Study|Disease progression|3|||
156787361|NCT01348490|565972912|FG000|Overall Study|Lost to Follow-up|1|||
156787362|NCT01348490|565972912|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
156787363|NCT01348490|565972912|FG000|Overall Study|Other Unspecified|8|||
156787364|NCT03632720|565972913|FG000|Overall Study|Adverse Event|2|||
156787365|NCT03632720|565972914|FG001|Overall Study|Adverse Event|0|||
156787366|NCT03632720|565972915|FG002|Overall Study|Adverse Event|0|||
156787367|NCT03632720|565972913|FG000|Overall Study|Lost to Follow-up|0|||
156787368|NCT03632720|565972914|FG001|Overall Study|Lost to Follow-up|1|||
156787369|NCT03632720|565972915|FG002|Overall Study|Lost to Follow-up|0|||
156787370|NCT03632720|565972913|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
156787371|NCT03632720|565972914|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
156787372|NCT03632720|565972915|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
156787373|NCT03632720|565972913|FG000|Overall Study|Screen failure|0|||
156787374|NCT03632720|565972914|FG001|Overall Study|Screen failure|1|||
156787375|NCT03632720|565972915|FG002|Overall Study|Screen failure|0|||
156787376|NCT01049828|565972916|FG000|Overall Study|Claustrophibia and Frustration|2|||
156787377|NCT00520572|565974712|FG000|Overall Study|Adverse Event|9|||
156787378|NCT00520572|565974713|FG001|Overall Study|Adverse Event|3|||
156787379|NCT00520572|565974714|FG002|Overall Study|Adverse Event|6|||
156787380|NCT00520572|565974715|FG003|Overall Study|Adverse Event|9|||
156787381|NCT00520572|565974716|FG004|Overall Study|Adverse Event|7|||
156787382|NCT00520572|565974717|FG005|Overall Study|Adverse Event|2|||
156787383|NCT00520572|565974712|FG000|Overall Study|Withdrawal by Subject|0|||
156787384|NCT00520572|565974713|FG001|Overall Study|Withdrawal by Subject|9|||
156787385|NCT00520572|565974714|FG002|Overall Study|Withdrawal by Subject|5|||
156787386|NCT00520572|565974715|FG003|Overall Study|Withdrawal by Subject|2|||
156787387|NCT00520572|565974716|FG004|Overall Study|Withdrawal by Subject|2|||
156787388|NCT00520572|565974717|FG005|Overall Study|Withdrawal by Subject|0|||
156869876|NCT01499355|566281040|FG001|Double-Blind Period|Other|1|||
156869877|NCT01499355|566281041|FG002|Double-Blind Period|Other|2|||
156869878|NCT01499355|566281042|FG003|Double-Blind Period|Other|2|||
156787389|NCT00520572|565974712|FG000|Overall Study|Protocol Violation|0|||
156787390|NCT00520572|565974713|FG001|Overall Study|Protocol Violation|0|||
156787391|NCT00520572|565974714|FG002|Overall Study|Protocol Violation|1|||
156787392|NCT00520572|565974715|FG003|Overall Study|Protocol Violation|0|||
156787393|NCT00520572|565974716|FG004|Overall Study|Protocol Violation|0|||
156787394|NCT00520572|565974717|FG005|Overall Study|Protocol Violation|0|||
156787395|NCT00520572|565974712|FG000|Overall Study|Lack of Efficacy|1|||
156787396|NCT00520572|565974713|FG001|Overall Study|Lack of Efficacy|1|||
156787397|NCT00520572|565974714|FG002|Overall Study|Lack of Efficacy|1|||
156787398|NCT00520572|565974715|FG003|Overall Study|Lack of Efficacy|2|||
156787399|NCT00520572|565974716|FG004|Overall Study|Lack of Efficacy|1|||
156787400|NCT00520572|565974717|FG005|Overall Study|Lack of Efficacy|0|||
156787401|NCT00520572|565974712|FG000|Overall Study|Lost to Follow-up|0|||
156787402|NCT00520572|565974713|FG001|Overall Study|Lost to Follow-up|0|||
156787403|NCT00520572|565974714|FG002|Overall Study|Lost to Follow-up|0|||
156787404|NCT00520572|565974715|FG003|Overall Study|Lost to Follow-up|0|||
156869879|NCT01499355|566281039|FG000|Double-Blind Period|Death|0|||
156688171|NCT00892281|565602764|FG000|Overall Study|Lost to Follow-up|81|||
156688172|NCT00892281|565602765|FG001|Overall Study|Lost to Follow-up|8|||
156688173|NCT00892281|565602764|FG000|Overall Study|Pregnancy|1|||
156688174|NCT00892281|565602765|FG001|Overall Study|Pregnancy|0|||
156688175|NCT00892281|565602764|FG000|Overall Study|Protocol Violation|7|||
156688176|NCT00892281|565602765|FG001|Overall Study|Protocol Violation|2|||
156688177|NCT00892281|565602764|FG000|Overall Study|Withdrawal by Subject|86|||
156688178|NCT00892281|565602765|FG001|Overall Study|Withdrawal by Subject|14|||
156688179|NCT00892281|565602764|FG000|Overall Study|Subject failed to return for final visit|2|||
156688180|NCT00892281|565602765|FG001|Overall Study|Subject failed to return for final visit|0|||
156688181|NCT00892281|565602764|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
156688182|NCT00892281|565602765|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
156688183|NCT00892281|565602764|FG000|Overall Study|Final visit completed 4 weeks late|0|||
156688184|NCT00892281|565602765|FG001|Overall Study|Final visit completed 4 weeks late|1|||
156688185|NCT00892281|565602764|FG000|Overall Study|Subject completed day after study closed|1|||
156688186|NCT00892281|565602765|FG001|Overall Study|Subject completed day after study closed|0|||
156688187|NCT00892281|565602764|FG000|Overall Study|Family emergency|1|||
156688188|NCT00892281|565602765|FG001|Overall Study|Family emergency|0|||
156688189|NCT00892281|565602764|FG000|Overall Study|Last visit not done - death in family|1|||
156688190|NCT00892281|565602765|FG001|Overall Study|Last visit not done - death in family|0|||
156688191|NCT00892281|565602764|FG000|Overall Study|Did not meet incl/excl criteria|1|||
156688192|NCT00892281|565602765|FG001|Overall Study|Did not meet incl/excl criteria|0|||
157013486|NCT03358875|566801787|FG001|Overall Study|Miscellaneous|0|||
156688193|NCT00892281|565602764|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
156688194|NCT00892281|565602765|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
156688195|NCT00892281|565602764|FG000|Overall Study|Unable to redeem the drug voucher|1|||
156688196|NCT00892281|565602765|FG001|Overall Study|Unable to redeem the drug voucher|0|||
156688197|NCT00892281|565602764|FG000|Overall Study|Subject not good candidate for study|1|||
156688198|NCT00892281|565602765|FG001|Overall Study|Subject not good candidate for study|0|||
156688199|NCT00892281|565602764|FG000|Overall Study|Subject did not return for any visits|1|||
156688200|NCT00892281|565602765|FG001|Overall Study|Subject did not return for any visits|0|||
156688201|NCT00892281|565602764|FG000|Overall Study|Subject missed several visits/lost meds|1|||
156688202|NCT00892281|565602765|FG001|Overall Study|Subject missed several visits/lost meds|0|||
156688203|NCT00892281|565602764|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
156688204|NCT00892281|565602765|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
156688205|NCT00892281|565602764|FG000|Overall Study|Scheduled for knee replacement|0|||
156688206|NCT00892281|565602765|FG001|Overall Study|Scheduled for knee replacement|1|||
156688207|NCT00892281|565602764|FG000|Overall Study|PI complained of inadequate compensation|3|||
156688208|NCT00892281|565602765|FG001|Overall Study|PI complained of inadequate compensation|0|||
156688209|NCT00892281|565602764|FG000|Overall Study|Subject lost interest in program|0|||
156688210|NCT00892281|565602765|FG001|Overall Study|Subject lost interest in program|1|||
156688211|NCT00892281|565602764|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
156688212|NCT00892281|565602765|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
156688213|NCT00892281|565602764|FG000|Overall Study|Death in family|1|||
156688214|NCT00892281|565602765|FG001|Overall Study|Death in family|0|||
156688215|NCT00892281|565602764|FG000|Overall Study|Lack of efficacy of study product|2|||
156688216|NCT00892281|565602765|FG001|Overall Study|Lack of efficacy of study product|0|||
156688217|NCT00892281|565602764|FG000|Overall Study|Subject not seen by PI at final visit|1|||
156688218|NCT00892281|565602765|FG001|Overall Study|Subject not seen by PI at final visit|0|||
156688219|NCT00892281|565602764|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
156688220|NCT00892281|565602765|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
156787405|NCT00520572|565974716|FG004|Overall Study|Lost to Follow-up|1|||
156787406|NCT00520572|565974717|FG005|Overall Study|Lost to Follow-up|0|||
156787407|NCT00520572|565974712|FG000|Overall Study|Incorrect enrollment|1|||
156787408|NCT00520572|565974713|FG001|Overall Study|Incorrect enrollment|0|||
156787409|NCT00520572|565974714|FG002|Overall Study|Incorrect enrollment|1|||
156787410|NCT00520572|565974715|FG003|Overall Study|Incorrect enrollment|0|||
156787411|NCT00520572|565974716|FG004|Overall Study|Incorrect enrollment|1|||
156787412|NCT00520572|565974717|FG005|Overall Study|Incorrect enrollment|0|||
156787413|NCT00520572|565974712|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787414|NCT00520572|565974713|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
156787415|NCT00520572|565974714|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787416|NCT00520572|565974715|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787417|NCT00520572|565974716|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787418|NCT00520572|565974717|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
156787419|NCT00520572|565974712|FG000|Overall Study|Long break in taking Medication|0|||
156787420|NCT00520572|565974713|FG001|Overall Study|Long break in taking Medication|0|||
156869880|NCT01499355|566281040|FG001|Double-Blind Period|Death|1|||
156688221|NCT00892281|565602764|FG000|Overall Study|Missed multiple visits|1|||
156688222|NCT00892281|565602765|FG001|Overall Study|Missed multiple visits|0|||
156688223|NCT00892281|565602764|FG000|Overall Study|Missed visits rescheduled out of window|1|||
156688224|NCT00892281|565602765|FG001|Overall Study|Missed visits rescheduled out of window|0|||
156688225|NCT00892281|565602764|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
156688226|NCT00892281|565602765|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
156688227|NCT00892281|565602764|FG000|Overall Study|Subject had history of drug abuse|1|||
156688228|NCT00892281|565602765|FG001|Overall Study|Subject had history of drug abuse|0|||
156688229|NCT00892281|565602764|FG000|Overall Study|Rash on hand|1|||
156688230|NCT00892281|565602765|FG001|Overall Study|Rash on hand|0|||
156688231|NCT00892281|565602764|FG000|Overall Study|Visit 4 date out of window|1|||
156688232|NCT00892281|565602765|FG001|Overall Study|Visit 4 date out of window|0|||
156688233|NCT01534078|565602766|FG000|Overall Study|Death|1|||
156688234|NCT01534078|565602766|FG000|Overall Study|Withdrawal by Subject|1|||
156688235|NCT00986570|565602767|FG000|Overall Study|Lost to Follow-up|6|||
156688236|NCT00986570|565602767|FG000|Overall Study|Potential bias for objective assessment|1|||
156688237|NCT02225665|565602768|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
156688238|NCT02225665|565602769|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
156688239|NCT02225665|565602768|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
156688240|NCT02225665|565602769|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
156688241|NCT01355302|565602770|FG000|Phase 1b|Death|4|||
156688242|NCT01355302|565602771|FG001|Phase 1b|Death|0|||
156688243|NCT01355302|565602772|FG002|Phase 1b|Death|0|||
156688244|NCT01355302|565602770|FG000|Phase 1b|Study terminated by sponsor|2|||
156688245|NCT01355302|565602771|FG001|Phase 1b|Study terminated by sponsor|0|||
156688246|NCT01355302|565602772|FG002|Phase 1b|Study terminated by sponsor|0|||
156688247|NCT00263887|565602773|FG000|Overall Study|Withdrawal by Subject|1|||
156688248|NCT00263887|565602774|FG001|Overall Study|Withdrawal by Subject|1|||
156688249|NCT00263887|565602773|FG000|Overall Study|Lung transplantation|1|||
156688250|NCT00263887|565602774|FG001|Overall Study|Lung transplantation|2|||
156688251|NCT00263887|565602773|FG000|Overall Study|Too ill to attend visit|1|||
156688252|NCT00263887|565602774|FG001|Overall Study|Too ill to attend visit|0|||
156688253|NCT00263887|565602773|FG000|Overall Study|Adverse Event|0|||
156688254|NCT00263887|565602774|FG001|Overall Study|Adverse Event|2|||
156688255|NCT00263887|565602773|FG000|Overall Study|Disease progression|0|||
156688256|NCT00263887|565602774|FG001|Overall Study|Disease progression|1|||
156688257|NCT00263887|565602773|FG000|Overall Study|Lack of Efficacy|0|||
156688258|NCT00263887|565602774|FG001|Overall Study|Lack of Efficacy|1|||
156688259|NCT02274948|565602775|FG000|Overall Study|Lost to Follow-up|28|||
156688260|NCT02274948|565602776|FG001|Overall Study|Lost to Follow-up|25|||
156688261|NCT02274948|565602775|FG000|Overall Study|Withdrawal by Subject|64|||
156688262|NCT02274948|565602776|FG001|Overall Study|Withdrawal by Subject|58|||
156688263|NCT02274948|565602775|FG000|Overall Study|Stopped on family Practitioner advice|2|||
156688264|NCT02274948|565602776|FG001|Overall Study|Stopped on family Practitioner advice|5|||
156688265|NCT02274948|565602775|FG000|Overall Study|Left the area|4|||
156688266|NCT02274948|565602776|FG001|Overall Study|Left the area|3|||
156688267|NCT02502734|565602777|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
156688268|NCT02502734|565602778|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
156688269|NCT02502734|565602777|FG000|Washout Period|Adverse Event|1|||
156688270|NCT02502734|565602778|FG001|Washout Period|Adverse Event|0|||
156688271|NCT00865514|565602787|FG000|Overall Study|Infusion cost exceeded funding|2|||
156688272|NCT03095118|565602788|FG000|Overall Study|Adverse Event|1|||
156688273|NCT03095118|565602788|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
156688274|NCT02865395|565602789|FG000|Overall Study|Physician Decision|6|||
156688275|NCT02865395|565602790|FG001|Overall Study|Physician Decision|10|||
156688276|NCT02865395|565602791|FG002|Overall Study|Physician Decision|7|||
156688277|NCT03920280|565602792|FG000|Overall Study|Adverse Event|2|||
156688278|NCT03920280|565602793|FG001|Overall Study|Adverse Event|3|||
156688279|NCT03920280|565602792|FG000|Overall Study|Lost to Follow-up|0|||
156688280|NCT03920280|565602793|FG001|Overall Study|Lost to Follow-up|1|||
156688281|NCT03920280|565602792|FG000|Overall Study|Withdrawal by Subject|1|||
156688282|NCT03920280|565602793|FG001|Overall Study|Withdrawal by Subject|1|||
156688283|NCT03920280|565602792|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
156688284|NCT03920280|565602793|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
156688285|NCT00985231|565602796|FG000|Overall Study|ineligible|1|||
156688286|NCT00985231|565602797|FG001|Overall Study|ineligible|0|||
156688287|NCT00985231|565602796|FG000|Overall Study|Protocol Violation|1|||
156688288|NCT00985231|565602797|FG001|Overall Study|Protocol Violation|0|||
156688289|NCT00985231|565602796|FG000|Overall Study|Withdrawal by Subject|1|||
156688290|NCT00985231|565602797|FG001|Overall Study|Withdrawal by Subject|0|||
156688291|NCT00985231|565602796|FG000|Overall Study|Lost to Follow-up|0|||
156688292|NCT00985231|565602797|FG001|Overall Study|Lost to Follow-up|1|||
156688293|NCT00985231|565602796|FG000|Overall Study|Study related symptoms & complaints|0|||
156688294|NCT00985231|565602797|FG001|Overall Study|Study related symptoms & complaints|2|||
156688295|NCT04220775|565602800|FG000|Overall Study|Adverse Event|1|||
156688296|NCT04220775|565602801|FG001|Overall Study|Adverse Event|0|||
156688297|NCT04220775|565602800|FG000|Overall Study|Disease Progression|1|||
156688298|NCT04220775|565602801|FG001|Overall Study|Disease Progression|0|||
156869881|NCT01499355|566281041|FG002|Double-Blind Period|Death|0|||
156688299|NCT00436917|565602802|FG000|Overall Study|Withdrawal by Subject|13|||
156688300|NCT00436917|565602802|FG000|Overall Study|Adverse Event|2|||
156688301|NCT00436917|565602802|FG000|Overall Study|Physician Decision|1|||
156688302|NCT00436917|565602802|FG000|Overall Study|Death|1|||
156688303|NCT00436917|565602802|FG000|Overall Study|Lost to Follow-up|1|||
156688304|NCT00436917|565602802|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
156688305|NCT00436917|565602802|FG000|Overall Study|Increased creatinine|1|||
156688306|NCT00436917|565602802|FG000|Overall Study|Personal conflicts of patient|1|||
156688307|NCT02169791|565602803|FG000|Overall Study|Death|6|||
156688308|NCT02169791|565602803|FG000|Overall Study|patient withdrew consent|1|||
156688309|NCT02075606|565602807|FG000|Overall Study|Adverse Event|5|||
156688310|NCT02075606|565602807|FG000|Overall Study|Withdrawal by Subject|1|||
156688311|NCT02075606|565602807|FG000|Overall Study|Death|1|||
156688312|NCT02075606|565602807|FG000|Overall Study|Investigator's decision|1|||
156688313|NCT02075606|565602807|FG000|Overall Study|Symptom management|1|||
156688314|NCT02075606|565602807|FG000|Overall Study|Increasing Symptoms|1|||
156688315|NCT01857206|565602809|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
156688316|NCT01857206|565602810|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
156688317|NCT01857206|565602809|FG000|Overall Study|Lost to Follow-up|9|||
156688318|NCT01857206|565602810|FG001|Overall Study|Lost to Follow-up|6|||
156688319|NCT01857206|565602809|FG000|Overall Study|Unclassified|3|||
156688320|NCT01857206|565602810|FG001|Overall Study|Unclassified|3|||
156688321|NCT01857206|565602809|FG000|Overall Study|Withdrawal by Subject|1|||
156688322|NCT01857206|565602810|FG001|Overall Study|Withdrawal by Subject|0|||
156688323|NCT00271024|565602811|FG000|Overall Study|Lost Interest|3|||
156688324|NCT00271024|565602812|FG001|Overall Study|Lost Interest|4|||
156688325|NCT00271024|565602813|FG002|Overall Study|Lost Interest|2|||
156688326|NCT00271024|565602814|FG003|Overall Study|Lost Interest|3|||
156688327|NCT00271024|565602811|FG000|Overall Study|Unknown/Unspecified|11|||
156688328|NCT00271024|565602812|FG001|Overall Study|Unknown/Unspecified|11|||
156688329|NCT00271024|565602813|FG002|Overall Study|Unknown/Unspecified|8|||
156688330|NCT00271024|565602814|FG003|Overall Study|Unknown/Unspecified|4|||
156688331|NCT00271024|565602811|FG000|Overall Study|Protocol Violation|1|||
156688332|NCT00271024|565602812|FG001|Overall Study|Protocol Violation|6|||
156688333|NCT00271024|565602813|FG002|Overall Study|Protocol Violation|5|||
156688334|NCT00271024|565602814|FG003|Overall Study|Protocol Violation|11|||
156688335|NCT00271024|565602811|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
156688336|NCT00271024|565602812|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
156688337|NCT00271024|565602813|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
156688338|NCT00271024|565602814|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
156688339|NCT00271024|565602811|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
156688340|NCT00271024|565602812|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
156688341|NCT00271024|565602813|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
156688342|NCT00271024|565602814|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
156688343|NCT01261624|565602815|FG000|Week 0 to Week 12|Disease Progression|1|||
156688344|NCT01261624|565602816|FG001|Week 0 to Week 12|Disease Progression|1|||
156688345|NCT01261624|565602815|FG000|Week 0 to Week 12|Insufficient Response|0|||
156688346|NCT01261624|565602816|FG001|Week 0 to Week 12|Insufficient Response|2|||
156688347|NCT01261624|565602815|FG000|Week 13 to Week 24|Insufficient Response|0|||
156688348|NCT01261624|565602816|FG001|Week 13 to Week 24|Insufficient Response|1|||
156688349|NCT02094261|565602820|FG000|Overall Study|Death|24|||
156688350|NCT02094261|565602820|FG000|Overall Study|Lost to Follow-up|1|||
156688351|NCT02094261|565602820|FG000|Overall Study|Withdrawal by Subject|4|||
156688352|NCT02094261|565602820|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
156688353|NCT00860743|565602825|FG000|Overall Study|Withdrawal by Subject|3|||
156688354|NCT00860743|565602826|FG001|Overall Study|Withdrawal by Subject|0|||
156688355|NCT02776553|565602827|FG000|Overall Study|Lost to Follow-up|1|||
156688356|NCT02776553|565602828|FG001|Overall Study|Lost to Follow-up|0|||
156688357|NCT02776553|565602827|FG000|Overall Study|got liver transplant|1|||
156688358|NCT02776553|565602828|FG001|Overall Study|got liver transplant|2|||
156688359|NCT02776553|565602827|FG000|Overall Study|had other surgery|1|||
156688360|NCT02776553|565602828|FG001|Overall Study|had other surgery|0|||
156688361|NCT02776553|565602827|FG000|Overall Study|Protocol Violation|0|||
156688362|NCT02776553|565602828|FG001|Overall Study|Protocol Violation|1|||
156688363|NCT00268892|565602830|FG000|Overall Study|Adverse Event|14|||
156688364|NCT00268892|565602831|FG001|Overall Study|Adverse Event|17|||
156688365|NCT00268892|565602832|FG002|Overall Study|Adverse Event|20|||
156688366|NCT00268892|565602830|FG000|Overall Study|Lack of Efficacy|1|||
156688367|NCT00268892|565602831|FG001|Overall Study|Lack of Efficacy|3|||
156688368|NCT00268892|565602832|FG002|Overall Study|Lack of Efficacy|0|||
156688369|NCT00268892|565602830|FG000|Overall Study|Withdrawal by Subject|14|||
156688370|NCT00268892|565602831|FG001|Overall Study|Withdrawal by Subject|15|||
156688371|NCT00268892|565602832|FG002|Overall Study|Withdrawal by Subject|13|||
156688372|NCT00268892|565602830|FG000|Overall Study|Physician Decision|0|||
156688373|NCT00268892|565602831|FG001|Overall Study|Physician Decision|1|||
156688374|NCT00268892|565602832|FG002|Overall Study|Physician Decision|0|||
156688375|NCT00268892|565602830|FG000|Overall Study|Lost to Follow-up|5|||
156688376|NCT00268892|565602831|FG001|Overall Study|Lost to Follow-up|2|||
156688377|NCT00268892|565602832|FG002|Overall Study|Lost to Follow-up|4|||
156688378|NCT00268892|565602830|FG000|Overall Study|Protocol Violation|0|||
156688379|NCT00268892|565602831|FG001|Overall Study|Protocol Violation|1|||
156688380|NCT00268892|565602832|FG002|Overall Study|Protocol Violation|0|||
156688381|NCT00268892|565602830|FG000|Overall Study|Disease Progression|1|||
156688382|NCT00268892|565602831|FG001|Overall Study|Disease Progression|1|||
156688383|NCT00268892|565602832|FG002|Overall Study|Disease Progression|0|||
156688384|NCT00268892|565602830|FG000|Overall Study|Trial Site Closed|4|||
156688385|NCT00268892|565602831|FG001|Overall Study|Trial Site Closed|2|||
156688386|NCT00268892|565602832|FG002|Overall Study|Trial Site Closed|2|||
156688387|NCT01640184|565602833|FG000|Overall Study|Death|1|||
156688388|NCT01640184|565602834|FG001|Overall Study|Death|0|||
156688389|NCT01640184|565602835|FG002|Overall Study|Death|0|||
156688390|NCT01640184|565602833|FG000|Overall Study|Lost to Follow-up|4|||
156688391|NCT01640184|565602834|FG001|Overall Study|Lost to Follow-up|1|||
156688392|NCT01640184|565602835|FG002|Overall Study|Lost to Follow-up|0|||
156688393|NCT01640184|565602833|FG000|Overall Study|Physician Decision|3|||
156688394|NCT01640184|565602834|FG001|Overall Study|Physician Decision|0|||
156688395|NCT01640184|565602835|FG002|Overall Study|Physician Decision|0|||
156688396|NCT01640184|565602833|FG000|Overall Study|Withdrawal by Subject|0|||
156688397|NCT01640184|565602834|FG001|Overall Study|Withdrawal by Subject|1|||
156688398|NCT01640184|565602835|FG002|Overall Study|Withdrawal by Subject|1|||
156688399|NCT01640184|565602833|FG000|Overall Study|Protocol Violation|0|||
156688400|NCT01640184|565602834|FG001|Overall Study|Protocol Violation|0|||
156688401|NCT01640184|565602835|FG002|Overall Study|Protocol Violation|1|||
156688402|NCT02087176|565602836|FG000|Overall Study|Withdrawal by Subject|1|||
156688403|NCT02087176|565602836|FG000|Overall Study|Death|10|||
156688404|NCT02087176|565602836|FG000|Overall Study|Censored|19|||
156688405|NCT02087176|565602836|FG000|Overall Study|Study Terminated by Sponsor|2|||
156688406|NCT02927834|565602837|FG000|Overall Study|Lost to Follow-up|1|||
156688407|NCT02927834|565602838|FG001|Overall Study|Lost to Follow-up|2|||
156688408|NCT02927834|565602839|FG002|Overall Study|Lost to Follow-up|2|||
156688409|NCT03812991|565602841|FG000|Overall Study|Lost to Follow-up|3|||
156688410|NCT03812991|565602842|FG001|Overall Study|Lost to Follow-up|1|||
156688411|NCT01644149|565602843|FG000|Overall Study|Withdrawal by Subject|1|||
156688412|NCT01644149|565602844|FG001|Overall Study|Withdrawal by Subject|0|||
156688413|NCT01644149|565602843|FG000|Overall Study|Lost to Follow-up|3|||
156688414|NCT01644149|565602844|FG001|Overall Study|Lost to Follow-up|1|||
156688415|NCT04798482|565602845|FG000|Overall Study|Physician Decision|1|||
156688416|NCT04798482|565602845|FG000|Overall Study|Lost eligibility|1|||
156688417|NCT00690482|565602846|FG000|Overall Study|Adverse Event|2|||
156688418|NCT00690482|565602847|FG001|Overall Study|Adverse Event|1|||
156688419|NCT00690482|565602846|FG000|Overall Study|Incorrect enrolment|0|||
156688420|NCT00690482|565602847|FG001|Overall Study|Incorrect enrolment|1|||
156688421|NCT00690482|565602846|FG000|Overall Study|Study-specific discontinuation criteria|1|||
156688422|NCT00690482|565602847|FG001|Overall Study|Study-specific discontinuation criteria|0|||
156688423|NCT00690482|565602846|FG000|Overall Study|Intake of prohibited medicine|1|||
156688424|NCT00690482|565602847|FG001|Overall Study|Intake of prohibited medicine|0|||
156688425|NCT00690482|565602846|FG000|Overall Study|withdrew consent at rand.day|0|||
156688426|NCT00690482|565602847|FG001|Overall Study|withdrew consent at rand.day|1|||
156688427|NCT01253317|565602858|FG000|Overall Study|Adverse Event|2|||
156688428|NCT00749411|565602863|FG000|Overall Study|Adverse Event|0|||
156688429|NCT00749411|565602864|FG001|Overall Study|Adverse Event|2|||
156688430|NCT00749411|565602863|FG000|Overall Study|Lack of Efficacy|0|||
156688431|NCT00749411|565602864|FG001|Overall Study|Lack of Efficacy|1|||
156688432|NCT00749411|565602863|FG000|Overall Study|Protocol Violation|1|||
156688433|NCT00749411|565602864|FG001|Overall Study|Protocol Violation|1|||
156688434|NCT00749411|565602863|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156688435|NCT00749411|565602864|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156688436|NCT01507090|565602867|FG000|Overall Study|incomplete dataset|18|||
156688437|NCT01301482|565604339|FG000|Overall Study|Withdrawal by Subject|1|||
156688438|NCT05212883|565604352|FG000|Overall Study|Invalid test result|125|||
156688439|NCT02363439|565604353|FG000|Overall Study|Lack of Efficacy|4|||
156688440|NCT03573817|565604358|FG000|Overall Study|Adverse Event|0|||
156688441|NCT03573817|565604359|FG001|Overall Study|Adverse Event|2|||
156869882|NCT01499355|566281042|FG003|Double-Blind Period|Death|0|||
156869883|NCT01499355|566281039|FG000|Double-Blind Period|Investigator Decision|0|||
156688442|NCT03573817|565604358|FG000|Overall Study|Protocol Violation|0|||
156688443|NCT03573817|565604359|FG001|Overall Study|Protocol Violation|1|||
156688444|NCT03573817|565604358|FG000|Overall Study|Withdrawal by Subject|1|||
156688445|NCT03573817|565604359|FG001|Overall Study|Withdrawal by Subject|1|||
156688446|NCT01719562|565604362|FG000|Overall Study|Lost to Follow-up|1|||
156688447|NCT01719562|565604363|FG001|Overall Study|Lost to Follow-up|0|||
156688448|NCT01719562|565604362|FG000|Overall Study|Death|1|||
156688449|NCT01719562|565604363|FG001|Overall Study|Death|0|||
156688450|NCT01719562|565604362|FG000|Overall Study|New cancer diagnosis|1|||
156688451|NCT01719562|565604363|FG001|Overall Study|New cancer diagnosis|0|||
156688452|NCT00508027|565604364|FG000|Dose Level 1|Lost to Follow-up|4|||
156688453|NCT00508027|565604364|FG000|Dose Level 1|Withdrawal by Subject|2|||
156688454|NCT00508027|565604364|FG000|Dose Level 1|Physician Decision|2|||
156688455|NCT00508027|565604364|FG000|Dose Level 2|Lost to Follow-up|2|||
156688456|NCT00508027|565604364|FG000|Dose Level 2|Withdrawal by Subject|2|||
156688457|NCT02013531|565604367|FG000|Overall Study|Lost to Follow-up|3|||
156688458|NCT02013531|565604367|FG000|Overall Study|Met Withdrawal Criteria|1|||
156688459|NCT02013531|565604367|FG000|Overall Study|Withdrawal by Subject|1|||
156688460|NCT03554317|565604369|FG000|Overall Study|Withdrawal by Subject|1|||
156688461|NCT03554317|565604369|FG000|Overall Study|PSA Progression|3|||
156688462|NCT03554317|565604369|FG000|Overall Study|Radiographic Progression|4|||
156688463|NCT00939627|565604374|FG000|Overall Study|Disease Progression|16|||
156688464|NCT00939627|565604375|FG001|Overall Study|Disease Progression|12|||
156688465|NCT00939627|565604376|FG002|Overall Study|Disease Progression|0|||
156688466|NCT00939627|565604374|FG000|Overall Study|Adverse Event|6|||
156688467|NCT00939627|565604375|FG001|Overall Study|Adverse Event|7|||
156688468|NCT00939627|565604376|FG002|Overall Study|Adverse Event|0|||
156688469|NCT00939627|565604374|FG000|Overall Study|Death|0|||
156688470|NCT00939627|565604375|FG001|Overall Study|Death|2|||
156688471|NCT00939627|565604376|FG002|Overall Study|Death|0|||
156688472|NCT00939627|565604374|FG000|Overall Study|Withdrawal by Subject|2|||
156688473|NCT00939627|565604375|FG001|Overall Study|Withdrawal by Subject|4|||
156688474|NCT00939627|565604376|FG002|Overall Study|Withdrawal by Subject|0|||
156688475|NCT00939627|565604374|FG000|Overall Study|Other complicating disease|1|||
156688476|NCT00939627|565604375|FG001|Overall Study|Other complicating disease|1|||
156688477|NCT00939627|565604376|FG002|Overall Study|Other complicating disease|0|||
156688478|NCT00939627|565604374|FG000|Overall Study|Not compliant|2|||
156688479|NCT00939627|565604375|FG001|Overall Study|Not compliant|0|||
156688480|NCT00939627|565604376|FG002|Overall Study|Not compliant|0|||
156688481|NCT00939627|565604374|FG000|Overall Study|No off-tx reason given|0|||
156688482|NCT00939627|565604375|FG001|Overall Study|No off-tx reason given|2|||
156688483|NCT00939627|565604376|FG002|Overall Study|No off-tx reason given|0|||
156688484|NCT00537199|565604381|FG000|Overall Study|Study Terminated|1|||
156688485|NCT00467831|565604384|FG000|Overall Study|Death|2|||
156688486|NCT00467831|565604384|FG000|Overall Study|Withdrawal by Subject|1|||
156688487|NCT01832402|565604387|FG000|Overall Study|Lost to Follow-up|2|||
156688488|NCT01832402|565604388|FG001|Overall Study|Lost to Follow-up|0|||
156688489|NCT01832402|565604387|FG000|Overall Study|Withdrawal by Subject|3|||
156688490|NCT01832402|565604388|FG001|Overall Study|Withdrawal by Subject|3|||
156688491|NCT01832402|565604387|FG000|Overall Study|Declining Performance status|2|||
156688492|NCT01832402|565604388|FG001|Overall Study|Declining Performance status|1|||
156688493|NCT00612677|565604389|FG000|Overall Study|study closed before treatment started|1|||
156688494|NCT01198873|565604390|FG000|Overall Study|Adverse Event|4|||
156688495|NCT01198873|565604391|FG001|Overall Study|Adverse Event|7|||
156688496|NCT01198873|565604390|FG000|Overall Study|Study closure|29|||
156688497|NCT01198873|565604391|FG001|Overall Study|Study closure|23|||
156869884|NCT01499355|566281040|FG001|Double-Blind Period|Investigator Decision|0|||
156869885|NCT01499355|566281041|FG002|Double-Blind Period|Investigator Decision|3|||
156869886|NCT01499355|566281042|FG003|Double-Blind Period|Investigator Decision|3|||
156869887|NCT01499355|566281039|FG000|Double-Blind Period|Consent Withdrawn|0|||
156869888|NCT01499355|566281040|FG001|Double-Blind Period|Consent Withdrawn|0|||
156869889|NCT01499355|566281041|FG002|Double-Blind Period|Consent Withdrawn|1|||
156869890|NCT01499355|566281042|FG003|Double-Blind Period|Consent Withdrawn|2|||
156869891|NCT01499355|566281039|FG000|Double-Blind Period|Lost to Follow-up|0|||
156869892|NCT01499355|566281040|FG001|Double-Blind Period|Lost to Follow-up|1|||
156869893|NCT01499355|566281041|FG002|Double-Blind Period|Lost to Follow-up|0|||
156869894|NCT01499355|566281042|FG003|Double-Blind Period|Lost to Follow-up|0|||
156869895|NCT02420821|566281044|FG000|Overall Study|Lost to Follow-up|6|||
156869896|NCT02420821|566281045|FG001|Overall Study|Lost to Follow-up|6|||
156869897|NCT02420821|566281044|FG000|Overall Study|Non-compliance|0|||
156869898|NCT02420821|566281045|FG001|Overall Study|Non-compliance|2|||
156869899|NCT02420821|566281044|FG000|Overall Study|Physician Decision|6|||
156869900|NCT02420821|566281045|FG001|Overall Study|Physician Decision|2|||
156869901|NCT02420821|566281044|FG000|Overall Study|Withdrawal by Subject|32|||
156869902|NCT02420821|566281045|FG001|Overall Study|Withdrawal by Subject|25|||
156688498|NCT01198873|565604390|FG000|Overall Study|Other than above|4|||
156869903|NCT02420821|566281044|FG000|Overall Study|Death|270|||
156688499|NCT01198873|565604391|FG001|Overall Study|Other than above|2|||
156688500|NCT03827018|565604393|FG000|Overall Study|Adverse Event|1|||
156688501|NCT03827018|565604394|FG001|Overall Study|Adverse Event|0|||
156869904|NCT02420821|566281045|FG001|Overall Study|Death|263|||
156688502|NCT03827018|565604393|FG000|Overall Study|Withdrawal by Subject|2|||
156688503|NCT03827018|565604394|FG001|Overall Study|Withdrawal by Subject|2|||
156688504|NCT03827018|565604393|FG000|Overall Study|Lack of Efficacy|0|||
156688505|NCT03827018|565604394|FG001|Overall Study|Lack of Efficacy|1|||
156688506|NCT01998243|565604395|FG000|Overall Study|Pregnancy|0|||
156688507|NCT01998243|565604396|FG001|Overall Study|Pregnancy|1|||
156688508|NCT01998243|565604395|FG000|Overall Study|Protocol Violation|5|||
156869905|NCT02420821|566281044|FG000|Overall Study|Study Terminated By Sponsor|145|||
156869906|NCT02420821|566281045|FG001|Overall Study|Study Terminated By Sponsor|149|||
157013487|NCT03358875|566801786|FG000|Overall Study|Remained on Study|1|||
156688509|NCT01998243|565604396|FG001|Overall Study|Protocol Violation|2|||
156688510|NCT01998243|565604395|FG000|Overall Study|Withdrawal by Subject|3|||
156688511|NCT01998243|565604396|FG001|Overall Study|Withdrawal by Subject|4|||
156688512|NCT02492841|565604404|FG000|Overall Study|Lost to Follow-up|34|||
156688513|NCT02492841|565604405|FG001|Overall Study|Lost to Follow-up|31|||
156688514|NCT02492841|565604406|FG002|Overall Study|Lost to Follow-up|35|||
156688515|NCT00479388|565604407|FG000|Overall Study|Adverse Event|90|||
156688516|NCT00479388|565604408|FG001|Overall Study|Adverse Event|45|||
156688517|NCT00479388|565604407|FG000|Overall Study|Lost to Follow-up|0|||
156688518|NCT00479388|565604408|FG001|Overall Study|Lost to Follow-up|2|||
156688519|NCT00479388|565604407|FG000|Overall Study|Protocol Violation|10|||
156688520|NCT00479388|565604408|FG001|Overall Study|Protocol Violation|9|||
156688521|NCT00479388|565604407|FG000|Overall Study|Withdrawal by Subject|32|||
156688522|NCT00479388|565604408|FG001|Overall Study|Withdrawal by Subject|17|||
156688523|NCT01876368|565604409|FG000|Overall Study|Adverse Event|2|||
156688524|NCT01876368|565604410|FG001|Overall Study|Adverse Event|5|||
156688525|NCT01876368|565604409|FG000|Overall Study|Lack of Efficacy|1|||
156688526|NCT01876368|565604410|FG001|Overall Study|Lack of Efficacy|0|||
156688527|NCT01876368|565604409|FG000|Overall Study|Lost to Follow-up|0|||
156688528|NCT01876368|565604410|FG001|Overall Study|Lost to Follow-up|1|||
156688529|NCT01876368|565604409|FG000|Overall Study|Non-compliance with study treatment|0|||
156688530|NCT01876368|565604410|FG001|Overall Study|Non-compliance with study treatment|1|||
156688531|NCT01876368|565604409|FG000|Overall Study|Physician Decision|0|||
156688532|NCT01876368|565604410|FG001|Overall Study|Physician Decision|2|||
156688533|NCT01876368|565604409|FG000|Overall Study|Protocol deviation|3|||
156688534|NCT01876368|565604410|FG001|Overall Study|Protocol deviation|3|||
156688535|NCT01876368|565604409|FG000|Overall Study|Subject/guardian decision|3|||
156688536|NCT01876368|565604410|FG001|Overall Study|Subject/guardian decision|1|||
156688537|NCT02563769|565604411|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
156688538|NCT02563769|565604412|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
156688539|NCT02563769|565604413|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
156688540|NCT01192399|565604417|FG000|Overall Study|Lack of Efficacy|2|||
156688541|NCT01930175|565604418|FG000|Core Study|Lost to Follow-up|0|||
156688542|NCT01930175|565604419|FG001|Core Study|Lost to Follow-up|1|||
156688543|NCT01930175|565604420|FG002|Core Study|Lost to Follow-up|0|||
156688544|NCT01930175|565604418|FG000|Core Study|Adverse Event|0|||
156688545|NCT01930175|565604419|FG001|Core Study|Adverse Event|0|||
156688546|NCT01930175|565604420|FG002|Core Study|Adverse Event|1|||
156688547|NCT02820740|565604421|FG000|Overall Study|Did not have procedure|2|||
156688548|NCT00890552|565604422|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
156688549|NCT00890552|565604422|FG000|On-treatment|Early prog disease/ death|10|||
156688550|NCT03903159|565604423|FG000|Overall Study|Discharged with Staff Approval|2|||
156688551|NCT03903159|565604423|FG000|Overall Study|Discharged at Staff Request|2|||
156688552|NCT03903159|565604423|FG000|Overall Study|Discharged Against Staff Advice|1|||
156688553|NCT02244424|565604428|FG000|Overall Study|Lost to Follow-up|20|||
156688554|NCT02244424|565604429|FG001|Overall Study|Lost to Follow-up|10|||
156688555|NCT04117945|565604430|FG000|Overall Study|Death|1|||
156688556|NCT04117945|565604431|FG001|Overall Study|Death|0|||
156688557|NCT04117945|565604430|FG000|Overall Study|Withdrawal by Subject|3|||
156688558|NCT04117945|565604431|FG001|Overall Study|Withdrawal by Subject|1|||
156787421|NCT00520572|565974714|FG002|Overall Study|Long break in taking Medication|0|||
156787422|NCT00520572|565974715|FG003|Overall Study|Long break in taking Medication|1|||
156787423|NCT00520572|565974716|FG004|Overall Study|Long break in taking Medication|0|||
156787424|NCT00520572|565974717|FG005|Overall Study|Long break in taking Medication|0|||
156787425|NCT00520572|565974712|FG000|Overall Study|Did not receive Treatment|1|||
156688559|NCT04117945|565604430|FG000|Overall Study|Disease Progression|0|||
156688560|NCT04117945|565604431|FG001|Overall Study|Disease Progression|2|||
156688561|NCT04117945|565604430|FG000|Overall Study|Ineligible|8|||
156688562|NCT04117945|565604431|FG001|Overall Study|Ineligible|7|||
156787426|NCT00520572|565974713|FG001|Overall Study|Did not receive Treatment|0|||
156787427|NCT00520572|565974714|FG002|Overall Study|Did not receive Treatment|1|||
156787428|NCT00520572|565974715|FG003|Overall Study|Did not receive Treatment|0|||
156688563|NCT00562120|565604435|FG000|First Intervention Period|Adverse Event|1|||
156688564|NCT00562120|565604436|FG001|First Intervention Period|Adverse Event|0|||
156688565|NCT00562120|565604437|FG002|First Intervention Period|Adverse Event|0|||
156688566|NCT00562120|565604438|FG003|First Intervention Period|Adverse Event|0|||
156688567|NCT00562120|565604435|FG000|First Intervention Period|Randomized but not Treated|1|||
156688568|NCT00562120|565604436|FG001|First Intervention Period|Randomized but not Treated|0|||
156688569|NCT00562120|565604437|FG002|First Intervention Period|Randomized but not Treated|0|||
156787429|NCT00520572|565974716|FG004|Overall Study|Did not receive Treatment|0|||
156787430|NCT00520572|565974717|FG005|Overall Study|Did not receive Treatment|0|||
156787431|NCT03548415|565974720|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156688570|NCT00562120|565604438|FG003|First Intervention Period|Randomized but not Treated|0|||
156688571|NCT02148445|565604439|FG000|Overall Study|Death|1|||
156688572|NCT02148445|565604440|FG001|Overall Study|Death|3|||
156688573|NCT03450629|565604441|FG000|Overall Study|Adverse Event|15|||
156688574|NCT03450629|565604442|FG001|Overall Study|Adverse Event|14|||
156688575|NCT03450629|565604441|FG000|Overall Study|Physician Decision|2|||
156688576|NCT03450629|565604442|FG001|Overall Study|Physician Decision|2|||
156869907|NCT02420821|566281044|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
156869908|NCT02420821|566281045|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
156688577|NCT03450629|565604441|FG000|Overall Study|Lack of Efficacy|2|||
156688578|NCT03450629|565604442|FG001|Overall Study|Lack of Efficacy|0|||
156688579|NCT03450629|565604441|FG000|Overall Study|Lost to Follow-up|4|||
156869909|NCT02420821|566281044|FG000|Overall Study|Adverse Event|0|||
156869910|NCT02420821|566281045|FG001|Overall Study|Adverse Event|1|||
156869911|NCT02420821|566281044|FG000|Overall Study|Protinuria|0|||
156869912|NCT02420821|566281045|FG001|Overall Study|Protinuria|1|||
156869913|NCT02420821|566281044|FG000|Overall Study|Progressive Disease|1|||
156869914|NCT02420821|566281045|FG001|Overall Study|Progressive Disease|1|||
156869915|NCT02420821|566281044|FG000|Overall Study|Disease Progression|0|||
156869916|NCT02420821|566281045|FG001|Overall Study|Disease Progression|1|||
156869917|NCT02420821|566281044|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
156869918|NCT02420821|566281045|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
156869919|NCT02745119|566281054|FG000|Overall Study|Adverse Event|1|||
156869920|NCT02745119|566281055|FG001|Overall Study|Adverse Event|0|||
156688580|NCT03450629|565604442|FG001|Overall Study|Lost to Follow-up|2|||
156688581|NCT03450629|565604441|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156688582|NCT03450629|565604442|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156688583|NCT03450629|565604441|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156688584|NCT03450629|565604442|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156688585|NCT03450629|565604441|FG000|Overall Study|Protocol Violation|11|||
156688586|NCT03450629|565604442|FG001|Overall Study|Protocol Violation|8|||
156688587|NCT03450629|565604441|FG000|Overall Study|Withdrawal by Subject|12|||
156688588|NCT03450629|565604442|FG001|Overall Study|Withdrawal by Subject|6|||
156688589|NCT03366194|565604443|FG000|Overall Study|Lost to Follow-up|2|||
156688590|NCT02093923|565604444|FG000|Overall Study|Lost to Follow-up|0|||
156688591|NCT02093923|565604445|FG001|Overall Study|Lost to Follow-up|0|||
156688592|NCT02093923|565604446|FG002|Overall Study|Lost to Follow-up|0|||
156688593|NCT02093923|565604447|FG003|Overall Study|Lost to Follow-up|1|||
156688594|NCT02093923|565604448|FG004|Overall Study|Lost to Follow-up|0|||
156869921|NCT02745119|566281056|FG002|Overall Study|Adverse Event|1|||
156869922|NCT02745119|566281057|FG003|Overall Study|Adverse Event|3|||
156869923|NCT02745119|566281054|FG000|Overall Study|Death|3|||
156869924|NCT02745119|566281055|FG001|Overall Study|Death|3|||
156869925|NCT02745119|566281056|FG002|Overall Study|Death|0|||
156869926|NCT02745119|566281057|FG003|Overall Study|Death|4|||
156869927|NCT02745119|566281054|FG000|Overall Study|Lost to Follow-up|0|||
156869928|NCT02745119|566281055|FG001|Overall Study|Lost to Follow-up|0|||
156869929|NCT02745119|566281056|FG002|Overall Study|Lost to Follow-up|0|||
156869930|NCT02745119|566281057|FG003|Overall Study|Lost to Follow-up|1|||
156688595|NCT02093923|565604444|FG000|Overall Study|Screen failure after randomization|0|||
156688596|NCT02093923|565604445|FG001|Overall Study|Screen failure after randomization|0|||
156688597|NCT02093923|565604446|FG002|Overall Study|Screen failure after randomization|0|||
156688598|NCT02093923|565604447|FG003|Overall Study|Screen failure after randomization|1|||
156688599|NCT02093923|565604448|FG004|Overall Study|Screen failure after randomization|0|||
156688600|NCT03438006|565604449|FG000|Overall Study|Adverse Event|1|||
156688601|NCT03438006|565604449|FG000|Overall Study|Lost to Follow-up|67|||
156688602|NCT03438006|565604449|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
156688603|NCT03438006|565604449|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
156688604|NCT01181531|565604450|FG000|Overall Study|Other|17|||
156688605|NCT01181531|565604451|FG001|Overall Study|Other|12|||
156688606|NCT01181531|565604450|FG000|Overall Study|Partial consent by subject withdrawn|0|||
156688607|NCT01181531|565604451|FG001|Overall Study|Partial consent by subject withdrawn|1|||
156688608|NCT01181531|565604450|FG000|Overall Study|Physician Decision|3|||
156688609|NCT01181531|565604451|FG001|Overall Study|Physician Decision|1|||
156688610|NCT01181531|565604450|FG000|Overall Study|Noncompliance|2|||
156688611|NCT01181531|565604451|FG001|Overall Study|Noncompliance|2|||
156869931|NCT02745119|566281054|FG000|Overall Study|Protocol Deviation|0|||
156869932|NCT02745119|566281055|FG001|Overall Study|Protocol Deviation|0|||
156869933|NCT02745119|566281056|FG002|Overall Study|Protocol Deviation|0|||
156869934|NCT02745119|566281057|FG003|Overall Study|Protocol Deviation|1|||
156869935|NCT02745119|566281054|FG000|Overall Study|Withdrawal by Subject|7|||
157013488|NCT03358875|566801787|FG001|Overall Study|Remained on Study|0|||
156688612|NCT01181531|565604450|FG000|Overall Study|Ineligibility determined|1|||
156688613|NCT01181531|565604451|FG001|Overall Study|Ineligibility determined|2|||
156688614|NCT01181531|565604450|FG000|Overall Study|Protocol Specified Criteria|15|||
156688615|NCT01181531|565604451|FG001|Overall Study|Protocol Specified Criteria|8|||
156688616|NCT01181531|565604450|FG000|Overall Study|Pregnancy|0|||
156688617|NCT01181531|565604451|FG001|Overall Study|Pregnancy|1|||
156869936|NCT02745119|566281055|FG001|Overall Study|Withdrawal by Subject|15|||
156869937|NCT02745119|566281056|FG002|Overall Study|Withdrawal by Subject|8|||
156869938|NCT02745119|566281057|FG003|Overall Study|Withdrawal by Subject|14|||
156869939|NCT02745119|566281054|FG000|Overall Study|Study Terminated by Sponsor|134|||
156688618|NCT01181531|565604450|FG000|Overall Study|Withdrawal by Subject|8|||
156688619|NCT01181531|565604451|FG001|Overall Study|Withdrawal by Subject|7|||
156688620|NCT01181531|565604450|FG000|Overall Study|Protocol Violation|6|||
156688621|NCT01181531|565604451|FG001|Overall Study|Protocol Violation|6|||
156688622|NCT01181531|565604450|FG000|Overall Study|Death|9|||
156688623|NCT01181531|565604451|FG001|Overall Study|Death|12|||
156688624|NCT01181531|565604450|FG000|Overall Study|Adverse Event|0|||
156688625|NCT01181531|565604451|FG001|Overall Study|Adverse Event|1|||
156688626|NCT02737592|565604452|FG000|Overall Study|Withdrawal by Subject|1|||
156688627|NCT02792218|565604453|FG000|Overall Study|Patient/guardian decision|15|||
156688628|NCT02792218|565604454|FG001|Overall Study|Patient/guardian decision|42|||
156688629|NCT02792218|565604453|FG000|Overall Study|Adverse Event|15|||
156688630|NCT02792218|565604454|FG001|Overall Study|Adverse Event|14|||
156688631|NCT02792218|565604453|FG000|Overall Study|Lost to Follow-up|10|||
156688632|NCT02792218|565604454|FG001|Overall Study|Lost to Follow-up|5|||
156688633|NCT02792218|565604453|FG000|Overall Study|Lack of Efficacy|1|||
156688634|NCT02792218|565604454|FG001|Overall Study|Lack of Efficacy|12|||
156688635|NCT02792218|565604453|FG000|Overall Study|Physician Decision|4|||
156688636|NCT02792218|565604454|FG001|Overall Study|Physician Decision|4|||
156688637|NCT02792218|565604453|FG000|Overall Study|Protocol deviation|3|||
156688638|NCT02792218|565604454|FG001|Overall Study|Protocol deviation|2|||
156688639|NCT02792218|565604453|FG000|Overall Study|New therapy for study indication|0|||
156688640|NCT02792218|565604454|FG001|Overall Study|New therapy for study indication|1|||
156688641|NCT02792218|565604453|FG000|Overall Study|Non-compliance with study treatment|0|||
156688642|NCT02792218|565604454|FG001|Overall Study|Non-compliance with study treatment|1|||
156688643|NCT02792218|565604453|FG000|Overall Study|Pregnancy|1|||
156688644|NCT02792218|565604454|FG001|Overall Study|Pregnancy|0|||
156688645|NCT03123783|565604455|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688646|NCT03123783|565604456|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
156688647|NCT03123783|565604457|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688648|NCT03123783|565604458|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688649|NCT03123783|565604459|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688650|NCT03123783|565604460|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688651|NCT03123783|565604461|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
156688652|NCT03123783|565604455|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
156688653|NCT03123783|565604456|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
156688654|NCT03123783|565604457|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
156688655|NCT03123783|565604458|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
156688656|NCT03123783|565604459|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
156688657|NCT03123783|565604460|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
156688658|NCT03123783|565604461|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
156688659|NCT03123783|565604455|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688660|NCT03123783|565604456|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688661|NCT03123783|565604457|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
156688662|NCT03123783|565604458|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
156688663|NCT03123783|565604459|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
156688664|NCT03123783|565604460|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
156688665|NCT03123783|565604461|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
156688666|NCT03123783|565604455|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688667|NCT03123783|565604456|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688668|NCT03123783|565604457|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688669|NCT03123783|565604458|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688670|NCT03123783|565604459|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
156688671|NCT03123783|565604460|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688672|NCT03123783|565604461|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
156688673|NCT00955721|565604464|FG000|Overall Study|Physician Decision|1|||
156688674|NCT00955721|565604465|FG001|Overall Study|Physician Decision|0|||
156688675|NCT00955721|565604464|FG000|Overall Study|Death|1|||
156688676|NCT00955721|565604465|FG001|Overall Study|Death|0|||
156688677|NCT00955721|565604464|FG000|Overall Study|Withdrawal by Subject|1|||
156688678|NCT00955721|565604465|FG001|Overall Study|Withdrawal by Subject|0|||
156688679|NCT03183141|565604467|FG000|Overall Study|Withdrawal by Subject|2|||
156688680|NCT03183141|565604468|FG001|Overall Study|Withdrawal by Subject|4|||
156688681|NCT03183141|565604467|FG000|Overall Study|Death|0|||
156688682|NCT03183141|565604468|FG001|Overall Study|Death|8|||
156688683|NCT02953678|565604470|FG000|Overall Study|Adverse Event|20|||
156688684|NCT02953678|565604470|FG000|Overall Study|Death|7|||
156688685|NCT02953678|565604470|FG000|Overall Study|Physician Decision|23|||
156688686|NCT02953678|565604470|FG000|Overall Study|Progressive Disease of GVHD|7|||
156688687|NCT02953678|565604470|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
156688688|NCT02953678|565604470|FG000|Overall Study|Withdrawal by participant|3|||
156688689|NCT02953678|565604470|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
156688690|NCT02953678|565604470|FG000|Overall Study|Participants were transferred to commercial product.|3|||
156688691|NCT04034355|565604473|FG000|Overall Study|Study terminated by Sponsor|10|||
156688692|NCT04034355|565604474|FG001|Overall Study|Study terminated by Sponsor|17|||
156688693|NCT04034355|565604473|FG000|Overall Study|Withdrawal by Subject|12|||
156688694|NCT04034355|565604474|FG001|Overall Study|Withdrawal by Subject|11|||
156688695|NCT04034355|565604473|FG000|Overall Study|Site terminated by Sponsor|4|||
156688696|NCT04034355|565604474|FG001|Overall Study|Site terminated by Sponsor|5|||
156688697|NCT04034355|565604473|FG000|Overall Study|Adverse Event|2|||
156688698|NCT04034355|565604474|FG001|Overall Study|Adverse Event|0|||
156688699|NCT04034355|565604473|FG000|Overall Study|Death|1|||
156688700|NCT04034355|565604474|FG001|Overall Study|Death|1|||
156688701|NCT04034355|565604473|FG000|Overall Study|Not reported|2|||
156688702|NCT04034355|565604474|FG001|Overall Study|Not reported|0|||
156688703|NCT04034355|565604473|FG000|Overall Study|Lost to Follow-up|1|||
156688704|NCT04034355|565604474|FG001|Overall Study|Lost to Follow-up|0|||
156688705|NCT04034355|565604473|FG000|Overall Study|Physician Decision|1|||
156688706|NCT04034355|565604474|FG001|Overall Study|Physician Decision|0|||
156688707|NCT04034355|565604473|FG000|Overall Study|Protocol Violation|0|||
156688708|NCT04034355|565604474|FG001|Overall Study|Protocol Violation|1|||
156688709|NCT04034355|565604473|FG000|Overall Study|Progressive disease|1|||
156787432|NCT03548415|565974721|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156787433|NCT03548415|565974722|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
156787434|NCT03548415|565974723|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
156787435|NCT03548415|565974724|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
156787436|NCT04605588|565974726|FG000|Overall Study|Withdrawal by Subject|1|||
156787437|NCT04605588|565974727|FG001|Overall Study|Withdrawal by Subject|0|||
156787438|NCT01230814|565974728|FG000|Overall Study|Lost to Follow-up|11|||
156787439|NCT01230814|565974729|FG001|Overall Study|Lost to Follow-up|3|||
156787440|NCT01230814|565974728|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
156787441|NCT01230814|565974729|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
156688710|NCT04034355|565604474|FG001|Overall Study|Progressive disease|0|||
156688711|NCT02284347|565606049|FG000|Overall Study|Lost to Follow-up|2|||
156688712|NCT02284347|565606049|FG000|Overall Study|Withdrawn prior to treatment|1|||
156688713|NCT00544817|565606052|FG000|Combined Modality|Lack of Efficacy|2|||
156688714|NCT00544817|565606052|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
156688715|NCT00544817|565606052|FG000|Combined Modality|Adverse Event|2|||
156688716|NCT00544817|565606052|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
156688717|NCT00544817|565606052|FG000|No Treatment Interval|Lack of Efficacy|8|||
156688718|NCT00544817|565606052|FG000|No Treatment Interval|Physician Decision|3|||
156688719|NCT00544817|565606052|FG000|No Treatment Interval|Adverse Event|1|||
156688720|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
156688721|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
156688722|NCT00544817|565606052|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
156688723|NCT02999984|565606053|FG000|Overall Study|Treatment Failure|1|||
156787442|NCT01803737|565974732|FG000|Overall Study|Lack of Time|1|||
156787443|NCT01803737|565974733|FG001|Overall Study|Lack of Time|0|||
156787444|NCT01803737|565974732|FG000|Overall Study|Medical Reason|0|||
156787445|NCT01803737|565974733|FG001|Overall Study|Medical Reason|1|||
156688724|NCT00754013|565606056|FG000|Overall Study|Lost to Follow-up|1|||
156688725|NCT00754013|565606057|FG001|Overall Study|Lost to Follow-up|1|||
156688726|NCT00754013|565606056|FG000|Overall Study|didn't return after study termed|3|||
156688727|NCT00754013|565606057|FG001|Overall Study|didn't return after study termed|4|||
156688728|NCT02813421|565606058|FG000|Overall Study|Withdrawal by Subject|1|||
156787446|NCT01803737|565974732|FG000|Overall Study|Lost to Follow-up|0|||
156869940|NCT02745119|566281055|FG001|Overall Study|Study Terminated by Sponsor|252|||
156869941|NCT02745119|566281056|FG002|Overall Study|Study Terminated by Sponsor|135|||
156869942|NCT02745119|566281057|FG003|Overall Study|Study Terminated by Sponsor|251|||
156869943|NCT02745119|566281054|FG000|Overall Study|Physician Decision|0|||
156688729|NCT02813421|565606059|FG001|Overall Study|Withdrawal by Subject|2|||
156688730|NCT02813421|565606058|FG000|Overall Study|Lost to Follow-up|1|||
156688731|NCT02813421|565606059|FG001|Overall Study|Lost to Follow-up|1|||
156787447|NCT01803737|565974733|FG001|Overall Study|Lost to Follow-up|2|||
156787448|NCT01748552|565974734|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
156787449|NCT01748552|565974735|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
156787450|NCT01748552|565974736|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
156869944|NCT02745119|566281055|FG001|Overall Study|Physician Decision|2|||
156688732|NCT04213209|565606066|FG000|Overall Study|Protocol Violation|1|||
156688733|NCT04213209|565606067|FG001|Overall Study|Protocol Violation|0|||
156688734|NCT04213209|565606068|FG002|Overall Study|Protocol Violation|0|||
156688735|NCT04213209|565606069|FG003|Overall Study|Protocol Violation|0|||
156688736|NCT04213209|565606070|FG004|Overall Study|Protocol Violation|0|||
156688737|NCT04213209|565606071|FG005|Overall Study|Protocol Violation|0|||
156688738|NCT02129647|565606081|FG000|Overall Study|Adverse Event|2|||
156688739|NCT02129647|565606081|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
156688740|NCT01570283|565606083|FG000|Cohort 1: Dose Level 1|Death|0|||
156688741|NCT01570283|565606084|FG001|Cohort 1: Dose Level 1|Death|1|||
156688742|NCT01570283|565606085|FG002|Cohort 1: Dose Level 1|Death|0|||
156688743|NCT01570283|565606086|FG003|Cohort 1: Dose Level 1|Death|0|||
156688744|NCT01570283|565606087|FG004|Cohort 1: Dose Level 1|Death|0|||
156688745|NCT01570283|565606088|FG005|Cohort 1: Dose Level 1|Death|0|||
156688746|NCT01570283|565606083|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688747|NCT01570283|565606084|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
156688748|NCT01570283|565606085|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688749|NCT01570283|565606086|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688750|NCT01570283|565606087|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688751|NCT01570283|565606088|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
156688752|NCT01570283|565606083|FG000|Cohort 2: Dose Level 2|Death|0|||
156688753|NCT01570283|565606084|FG001|Cohort 2: Dose Level 2|Death|0|||
156688754|NCT01570283|565606085|FG002|Cohort 2: Dose Level 2|Death|1|||
156688755|NCT01570283|565606086|FG003|Cohort 2: Dose Level 2|Death|0|||
156688756|NCT01570283|565606087|FG004|Cohort 2: Dose Level 2|Death|0|||
156688757|NCT01570283|565606088|FG005|Cohort 2: Dose Level 2|Death|0|||
156688758|NCT01570283|565606083|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688759|NCT01570283|565606084|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688760|NCT01570283|565606085|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688761|NCT01570283|565606086|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
156688762|NCT01570283|565606087|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688763|NCT01570283|565606088|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
156688764|NCT01570283|565606083|FG000|Cohort 3: Dose Level 3|Death|0|||
156688765|NCT01570283|565606084|FG001|Cohort 3: Dose Level 3|Death|0|||
156688766|NCT01570283|565606085|FG002|Cohort 3: Dose Level 3|Death|0|||
156688767|NCT01570283|565606086|FG003|Cohort 3: Dose Level 3|Death|0|||
156688768|NCT01570283|565606087|FG004|Cohort 3: Dose Level 3|Death|0|||
156688769|NCT01570283|565606088|FG005|Cohort 3: Dose Level 3|Death|1|||
156688770|NCT01570283|565606083|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688771|NCT01570283|565606084|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688772|NCT01570283|565606085|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688773|NCT01570283|565606086|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688774|NCT01570283|565606087|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
156688775|NCT01570283|565606088|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
156688776|NCT02017860|565606089|FG000|Overall Study|Adverse Event|1|||
156688777|NCT02017860|565606089|FG000|Overall Study|Withdrawal by Subject|1|||
156688778|NCT03756883|565606090|FG000|Overall Study|Adverse Event|2|||
156688779|NCT03756883|565606091|FG001|Overall Study|Adverse Event|2|||
156688780|NCT03756883|565606092|FG002|Overall Study|Adverse Event|2|||
156688781|NCT03756883|565606090|FG000|Overall Study|Lack of Efficacy|0|||
156688782|NCT03756883|565606091|FG001|Overall Study|Lack of Efficacy|1|||
156688783|NCT03756883|565606092|FG002|Overall Study|Lack of Efficacy|2|||
156688784|NCT03756883|565606090|FG000|Overall Study|Lost to Follow-up|3|||
156688785|NCT03756883|565606091|FG001|Overall Study|Lost to Follow-up|3|||
156688786|NCT03756883|565606092|FG002|Overall Study|Lost to Follow-up|0|||
156688787|NCT03756883|565606090|FG000|Overall Study|Protocol Violation|2|||
156688788|NCT03756883|565606091|FG001|Overall Study|Protocol Violation|0|||
156688789|NCT03756883|565606092|FG002|Overall Study|Protocol Violation|1|||
156688790|NCT03756883|565606090|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
156688791|NCT03756883|565606091|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
156688792|NCT03756883|565606092|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
156688793|NCT03756883|565606090|FG000|Overall Study|Withdrawal by Subject|4|||
156688794|NCT03756883|565606091|FG001|Overall Study|Withdrawal by Subject|1|||
156688795|NCT03756883|565606092|FG002|Overall Study|Withdrawal by Subject|0|||
156688796|NCT03756883|565606090|FG000|Overall Study|Other Reasons|2|||
156688797|NCT03756883|565606091|FG001|Overall Study|Other Reasons|4|||
156787451|NCT01748552|565974737|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
156787452|NCT01748552|565974738|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
156787453|NCT01748552|565974739|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
156787454|NCT01748552|565974740|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
156787455|NCT01748552|565974741|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
156688798|NCT03756883|565606092|FG002|Overall Study|Other Reasons|0|||
156688799|NCT00685802|565606095|FG000|Washout Period of 7 Days|Protocol Violation|2|||
156787456|NCT01748552|565974742|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
156787457|NCT01748552|565974743|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
156787458|NCT01748552|565974744|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
156688800|NCT00685802|565606096|FG001|Washout Period of 7 Days|Protocol Violation|0|||
156688801|NCT00685802|565606095|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156688802|NCT00685802|565606096|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156688803|NCT01333072|565606097|FG000|Overall Study|Lost to Follow-up|3|||
156688804|NCT01333072|565606098|FG001|Overall Study|Lost to Follow-up|0|||
156688805|NCT01333072|565606097|FG000|Overall Study|Adverse Event|2|||
156688806|NCT01333072|565606098|FG001|Overall Study|Adverse Event|4|||
156688807|NCT01333072|565606097|FG000|Overall Study|Physician Decision|1|||
156688808|NCT01333072|565606098|FG001|Overall Study|Physician Decision|0|||
156688809|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
156688810|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
156688811|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
156688812|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
156688813|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
156688814|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
156688815|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
156688816|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
156688817|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
156688818|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
156688819|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
156688820|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
156688821|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
156688822|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
156688823|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
156688824|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
156688825|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
156688826|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
156688827|NCT00384293|565606099|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
156688828|NCT00384293|565606100|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
156688829|NCT00384293|565606101|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
156688830|NCT00384293|565606099|FG000|Post-randomization Period|Adverse Event|0|||
156688831|NCT00384293|565606100|FG001|Post-randomization Period|Adverse Event|23|||
156688832|NCT00384293|565606101|FG002|Post-randomization Period|Adverse Event|7|||
156688833|NCT00384293|565606099|FG000|Post-randomization Period|Lost to Follow-up|0|||
156688834|NCT00384293|565606100|FG001|Post-randomization Period|Lost to Follow-up|2|||
156688835|NCT00384293|565606101|FG002|Post-randomization Period|Lost to Follow-up|1|||
156688836|NCT00384293|565606099|FG000|Post-randomization Period|Protocol Violation|0|||
156688837|NCT00384293|565606100|FG001|Post-randomization Period|Protocol Violation|1|||
156688838|NCT00384293|565606101|FG002|Post-randomization Period|Protocol Violation|0|||
156688839|NCT00384293|565606099|FG000|Post-randomization Period|Withdrawal by Subject|0|||
156688840|NCT00384293|565606100|FG001|Post-randomization Period|Withdrawal by Subject|8|||
156688841|NCT00384293|565606101|FG002|Post-randomization Period|Withdrawal by Subject|6|||
156688842|NCT00384293|565606099|FG000|Post-randomization Period|Trial Termination|0|||
156787459|NCT01748552|565974745|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
156787460|NCT01748552|565974734|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787461|NCT01748552|565974735|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787462|NCT01748552|565974736|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156869945|NCT02745119|566281056|FG002|Overall Study|Physician Decision|2|||
156869946|NCT02745119|566281057|FG003|Overall Study|Physician Decision|2|||
156869947|NCT02745119|566281054|FG000|Overall Study|Reason Not Specified|0|||
156869948|NCT02745119|566281055|FG001|Overall Study|Reason Not Specified|2|||
156869949|NCT02745119|566281056|FG002|Overall Study|Reason Not Specified|0|||
156787463|NCT01748552|565974737|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787464|NCT01748552|565974738|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787465|NCT01748552|565974739|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787466|NCT01748552|565974740|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787467|NCT01748552|565974741|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787468|NCT01748552|565974742|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
156787469|NCT01748552|565974743|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787470|NCT01748552|565974744|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787471|NCT01748552|565974745|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
156787472|NCT01386645|565974746|FG000|Overall Study|Physician Decision|0|||
156787473|NCT01386645|565974747|FG001|Overall Study|Physician Decision|0|||
156787474|NCT01386645|565974748|FG002|Overall Study|Physician Decision|1|||
156787475|NCT01386645|565974746|FG000|Overall Study|Withdrawal by Subject|0|||
156787476|NCT01386645|565974747|FG001|Overall Study|Withdrawal by Subject|1|||
156787477|NCT01386645|565974748|FG002|Overall Study|Withdrawal by Subject|1|||
156787478|NCT01530256|565974749|FG000|Overall Study|Death|2|||
156869950|NCT02745119|566281057|FG003|Overall Study|Reason Not Specified|1|||
156869951|NCT00960999|566281058|FG000|Overall Study|Withdrawal by Subject|1|||
156688843|NCT00384293|565606100|FG001|Post-randomization Period|Trial Termination|180|||
156688844|NCT00384293|565606101|FG002|Post-randomization Period|Trial Termination|204|||
156688845|NCT00384293|565606099|FG000|Post-randomization Period|Patient Randomized in Error|0|||
156688846|NCT00384293|565606100|FG001|Post-randomization Period|Patient Randomized in Error|0|||
156688847|NCT00384293|565606101|FG002|Post-randomization Period|Patient Randomized in Error|1|||
156688848|NCT00619359|565606106|FG000|Overall Study|Adverse Event|32|||
156688849|NCT00619359|565606107|FG001|Overall Study|Adverse Event|36|||
156688850|NCT00619359|565606106|FG000|Overall Study|Lost to Follow-up|12|||
156688851|NCT00619359|565606107|FG001|Overall Study|Lost to Follow-up|16|||
156688852|NCT00619359|565606106|FG000|Overall Study|Physician Decision|0|||
156688853|NCT00619359|565606107|FG001|Overall Study|Physician Decision|7|||
156688854|NCT00619359|565606106|FG000|Overall Study|Protocol Violation|1|||
156688855|NCT00619359|565606107|FG001|Overall Study|Protocol Violation|1|||
156688856|NCT00619359|565606106|FG000|Overall Study|Withdrawal by Subject|19|||
156688857|NCT00619359|565606107|FG001|Overall Study|Withdrawal by Subject|20|||
156688858|NCT00619359|565606106|FG000|Overall Study|Progressive Disease|3|||
156688859|NCT00619359|565606107|FG001|Overall Study|Progressive Disease|1|||
156688860|NCT00493454|565606112|FG000|Overall Study|Withdrawal by Subject|1|||
156688861|NCT00103038|565606114|FG000|Overall Study|Withdrawal by Subject|8|||
156688862|NCT00103038|565606114|FG000|Overall Study|Screen failure|3|||
156688863|NCT00103038|565606114|FG000|Overall Study|Death|1|||
156688864|NCT00103038|565606114|FG000|Overall Study|Physician Decision|1|||
156688865|NCT01463982|565606115|FG000|Overall Study|Withdrawal by Subject|0|||
156688866|NCT01463982|565606116|FG001|Overall Study|Withdrawal by Subject|1|||
156688867|NCT01463982|565606117|FG002|Overall Study|Withdrawal by Subject|1|||
156688868|NCT01463982|565606118|FG003|Overall Study|Withdrawal by Subject|0|||
156688869|NCT01463982|565606115|FG000|Overall Study|Treatment delay over 5 week|0|||
156688870|NCT01463982|565606116|FG001|Overall Study|Treatment delay over 5 week|0|||
156688871|NCT01463982|565606117|FG002|Overall Study|Treatment delay over 5 week|1|||
156688872|NCT01463982|565606118|FG003|Overall Study|Treatment delay over 5 week|0|||
156688873|NCT02462486|565606119|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156688874|NCT02462486|565606120|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
156688875|NCT02462486|565606121|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
156688876|NCT02462486|565606119|FG000|Overall Study|Adverse Event|53|||
156688877|NCT02462486|565606120|FG001|Overall Study|Adverse Event|48|||
156688878|NCT02462486|565606121|FG002|Overall Study|Adverse Event|21|||
156688879|NCT02462486|565606119|FG000|Overall Study|Lack of Efficacy|6|||
156688880|NCT02462486|565606120|FG001|Overall Study|Lack of Efficacy|12|||
156688881|NCT02462486|565606121|FG002|Overall Study|Lack of Efficacy|3|||
156688882|NCT02462486|565606119|FG000|Overall Study|Lost to Follow-up|3|||
156688883|NCT02462486|565606120|FG001|Overall Study|Lost to Follow-up|4|||
156688884|NCT02462486|565606121|FG002|Overall Study|Lost to Follow-up|2|||
156688885|NCT02462486|565606119|FG000|Overall Study|Withdrawal by Subject|25|||
156688886|NCT02462486|565606120|FG001|Overall Study|Withdrawal by Subject|22|||
156688887|NCT02462486|565606121|FG002|Overall Study|Withdrawal by Subject|19|||
156688888|NCT02462486|565606119|FG000|Overall Study|Protocol Violation|3|||
156688889|NCT02462486|565606120|FG001|Overall Study|Protocol Violation|1|||
156688890|NCT02462486|565606121|FG002|Overall Study|Protocol Violation|1|||
156688891|NCT02462486|565606119|FG000|Overall Study|Reason not Specified|3|||
156688892|NCT02462486|565606120|FG001|Overall Study|Reason not Specified|4|||
156688893|NCT02462486|565606121|FG002|Overall Study|Reason not Specified|3|||
156688894|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688895|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688896|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
156688897|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
156688898|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
156688899|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
156688900|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
156688901|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
156787479|NCT04621786|565974750|FG000|Overall Study|Lost to Follow-up|9|||
156787480|NCT04621786|565974750|FG000|Overall Study|Protocol Violation|3|||
156787481|NCT02533674|565974751|FG000|Dose Level I|Progressive disease|1|||
156787482|NCT02533674|565974752|FG001|Dose Level I|Progressive disease|0|||
156787483|NCT02533674|565974753|FG002|Dose Level I|Progressive disease|0|||
156787484|NCT02533674|565974754|FG003|Dose Level I|Progressive disease|0|||
157121526|NCT05103332|567195980|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156688902|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
157121527|NCT05103332|567195981|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156688903|NCT02310763|565606122|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
156688904|NCT02310763|565606123|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
156688905|NCT02310763|565606124|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
156688906|NCT02310763|565606122|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156787485|NCT02533674|565974755|FG004|Dose Level I|Progressive disease|0|||
156787486|NCT02533674|565974756|FG005|Dose Level I|Progressive disease|0|||
156787487|NCT02533674|565974757|FG006|Dose Level I|Progressive disease|0|||
156688907|NCT02310763|565606123|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156688908|NCT02310763|565606124|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
156688909|NCT01731886|565606126|FG000|Overall Study|Death|1|||
156688910|NCT01731886|565606127|FG001|Overall Study|Death|0|||
156688911|NCT01731886|565606126|FG000|Overall Study|Never started treatment|0|||
156688912|NCT01731886|565606127|FG001|Overall Study|Never started treatment|1|||
156688913|NCT01731886|565606126|FG000|Overall Study|Non-compliant|1|||
156688914|NCT01731886|565606127|FG001|Overall Study|Non-compliant|0|||
156688915|NCT02280187|565606128|FG000|Overall Study|Lost to Follow-up|218|||
156688916|NCT04668274|565606129|FG000|Part 1 Study Period 1|Adverse Event|3|||
156688917|NCT04668274|565606130|FG001|Part 1 Study Period 1|Adverse Event|0|||
156688918|NCT04668274|565606131|FG002|Part 1 Study Period 1|Adverse Event|0|||
156688919|NCT04668274|565606132|FG003|Part 1 Study Period 1|Adverse Event|0|||
156688920|NCT04668274|565606129|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
156688921|NCT04668274|565606130|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688922|NCT04668274|565606131|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688923|NCT04668274|565606132|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
156688924|NCT04668274|565606129|FG000|Part 1 Study Period 2|Other|0|||
156688925|NCT04668274|565606130|FG001|Part 1 Study Period 2|Other|1|||
156688926|NCT04668274|565606131|FG002|Part 1 Study Period 2|Other|0|||
156688927|NCT04668274|565606132|FG003|Part 1 Study Period 2|Other|0|||
156688928|NCT04668274|565606129|FG000|Part 1 Study Period 3|Adverse Event|0|||
156688929|NCT04668274|565606130|FG001|Part 1 Study Period 3|Adverse Event|0|||
156688930|NCT04668274|565606131|FG002|Part 1 Study Period 3|Adverse Event|1|||
156688931|NCT04668274|565606132|FG003|Part 1 Study Period 3|Adverse Event|0|||
156688932|NCT04668274|565606129|FG000|Part 1 Study Period 3|Other|0|||
156688933|NCT04668274|565606130|FG001|Part 1 Study Period 3|Other|0|||
156688934|NCT04668274|565606131|FG002|Part 1 Study Period 3|Other|2|||
156688935|NCT04668274|565606132|FG003|Part 1 Study Period 3|Other|0|||
156688936|NCT04668274|565606129|FG000|Part 2 Study Period 4|Other|0|||
156688937|NCT04668274|565606130|FG001|Part 2 Study Period 4|Other|0|||
156688938|NCT04668274|565606131|FG002|Part 2 Study Period 4|Other|0|||
156688939|NCT04668274|565606132|FG003|Part 2 Study Period 4|Other|1|||
156688940|NCT02010255|565606133|FG000|Overall Study|Death|0|||
156688941|NCT02010255|565606134|FG001|Overall Study|Death|1|||
156688942|NCT02010255|565606135|FG002|Overall Study|Death|4|||
156688943|NCT02010255|565606136|FG003|Overall Study|Death|4|||
156688944|NCT02010255|565606137|FG004|Overall Study|Death|2|||
156688945|NCT02010255|565606138|FG005|Overall Study|Death|0|||
156688946|NCT02010255|565606139|FG006|Overall Study|Death|1|||
156688947|NCT02010255|565606140|FG007|Overall Study|Death|1|||
156688948|NCT02010255|565606141|FG008|Overall Study|Death|1|||
156688949|NCT02010255|565606142|FG009|Overall Study|Death|0|||
156688950|NCT02010255|565606143|FG010|Overall Study|Death|1|||
156688951|NCT02010255|565606144|FG011|Overall Study|Death|1|||
156787488|NCT02533674|565974758|FG007|Dose Level I|Progressive disease|0|||
156787489|NCT02533674|565974751|FG000|Dose Level I|Withdrawal by Subject|1|||
156787490|NCT02533674|565974752|FG001|Dose Level I|Withdrawal by Subject|0|||
156787491|NCT02533674|565974753|FG002|Dose Level I|Withdrawal by Subject|0|||
156787492|NCT02533674|565974754|FG003|Dose Level I|Withdrawal by Subject|0|||
156787493|NCT02533674|565974755|FG004|Dose Level I|Withdrawal by Subject|0|||
156787494|NCT02533674|565974756|FG005|Dose Level I|Withdrawal by Subject|0|||
156787495|NCT02533674|565974757|FG006|Dose Level I|Withdrawal by Subject|0|||
156787496|NCT02533674|565974758|FG007|Dose Level I|Withdrawal by Subject|0|||
156787497|NCT02533674|565974751|FG000|Dose Level I|Physician Decision|1|||
156787498|NCT02533674|565974752|FG001|Dose Level I|Physician Decision|0|||
156787499|NCT02533674|565974753|FG002|Dose Level I|Physician Decision|0|||
156787500|NCT02533674|565974754|FG003|Dose Level I|Physician Decision|0|||
156787501|NCT02533674|565974755|FG004|Dose Level I|Physician Decision|0|||
156787502|NCT02533674|565974756|FG005|Dose Level I|Physician Decision|0|||
156787503|NCT02533674|565974757|FG006|Dose Level I|Physician Decision|0|||
156787504|NCT02533674|565974758|FG007|Dose Level I|Physician Decision|0|||
156787505|NCT02533674|565974751|FG000|Dose Level I|Death|1|||
157013489|NCT04337372|566801791|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
156787506|NCT02533674|565974752|FG001|Dose Level I|Death|0|||
157214450|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
156688952|NCT02010255|565606145|FG012|Overall Study|Death|0|||
156688953|NCT02010255|565606146|FG013|Overall Study|Death|0|||
156688954|NCT02010255|565606133|FG000|Overall Study|Lack of Efficacy|4|||
156787507|NCT02533674|565974753|FG002|Dose Level I|Death|0|||
156787508|NCT02533674|565974754|FG003|Dose Level I|Death|0|||
156688955|NCT02010255|565606134|FG001|Overall Study|Lack of Efficacy|1|||
156688956|NCT02010255|565606135|FG002|Overall Study|Lack of Efficacy|2|||
156688957|NCT02010255|565606136|FG003|Overall Study|Lack of Efficacy|1|||
156688958|NCT02010255|565606137|FG004|Overall Study|Lack of Efficacy|1|||
156688959|NCT02010255|565606138|FG005|Overall Study|Lack of Efficacy|0|||
156688960|NCT02010255|565606139|FG006|Overall Study|Lack of Efficacy|0|||
156787509|NCT02533674|565974755|FG004|Dose Level I|Death|0|||
156688961|NCT02010255|565606140|FG007|Overall Study|Lack of Efficacy|0|||
156688962|NCT02010255|565606141|FG008|Overall Study|Lack of Efficacy|0|||
156688963|NCT02010255|565606142|FG009|Overall Study|Lack of Efficacy|0|||
156688964|NCT02010255|565606143|FG010|Overall Study|Lack of Efficacy|1|||
156688965|NCT02010255|565606144|FG011|Overall Study|Lack of Efficacy|0|||
156688966|NCT02010255|565606145|FG012|Overall Study|Lack of Efficacy|0|||
156688967|NCT02010255|565606146|FG013|Overall Study|Lack of Efficacy|0|||
156688968|NCT02010255|565606133|FG000|Overall Study|Withdrew Consent|1|||
156688969|NCT02010255|565606134|FG001|Overall Study|Withdrew Consent|0|||
156688970|NCT02010255|565606135|FG002|Overall Study|Withdrew Consent|0|||
156688971|NCT02010255|565606136|FG003|Overall Study|Withdrew Consent|1|||
156688972|NCT02010255|565606137|FG004|Overall Study|Withdrew Consent|0|||
156688973|NCT02010255|565606138|FG005|Overall Study|Withdrew Consent|0|||
156688974|NCT02010255|565606139|FG006|Overall Study|Withdrew Consent|0|||
156688975|NCT02010255|565606140|FG007|Overall Study|Withdrew Consent|0|||
156688976|NCT02010255|565606141|FG008|Overall Study|Withdrew Consent|0|||
156688977|NCT02010255|565606142|FG009|Overall Study|Withdrew Consent|0|||
156688978|NCT02010255|565606143|FG010|Overall Study|Withdrew Consent|0|||
156688979|NCT02010255|565606144|FG011|Overall Study|Withdrew Consent|0|||
156688980|NCT02010255|565606145|FG012|Overall Study|Withdrew Consent|0|||
156688981|NCT02010255|565606146|FG013|Overall Study|Withdrew Consent|0|||
156688982|NCT02010255|565606133|FG000|Overall Study|Adverse Event|1|||
156688983|NCT02010255|565606134|FG001|Overall Study|Adverse Event|0|||
156688984|NCT02010255|565606135|FG002|Overall Study|Adverse Event|0|||
156688985|NCT02010255|565606136|FG003|Overall Study|Adverse Event|0|||
156688986|NCT02010255|565606137|FG004|Overall Study|Adverse Event|0|||
156688987|NCT02010255|565606138|FG005|Overall Study|Adverse Event|0|||
156688988|NCT02010255|565606139|FG006|Overall Study|Adverse Event|0|||
156688989|NCT02010255|565606140|FG007|Overall Study|Adverse Event|0|||
156688990|NCT02010255|565606141|FG008|Overall Study|Adverse Event|0|||
156688991|NCT02010255|565606142|FG009|Overall Study|Adverse Event|0|||
156688992|NCT02010255|565606143|FG010|Overall Study|Adverse Event|0|||
156688993|NCT02010255|565606144|FG011|Overall Study|Adverse Event|0|||
156688994|NCT02010255|565606145|FG012|Overall Study|Adverse Event|0|||
156688995|NCT02010255|565606146|FG013|Overall Study|Adverse Event|0|||
156688996|NCT02010255|565606133|FG000|Overall Study|Lost to Follow-up|0|||
156688997|NCT02010255|565606134|FG001|Overall Study|Lost to Follow-up|0|||
156688998|NCT02010255|565606135|FG002|Overall Study|Lost to Follow-up|1|||
156688999|NCT02010255|565606136|FG003|Overall Study|Lost to Follow-up|0|||
156689000|NCT02010255|565606137|FG004|Overall Study|Lost to Follow-up|1|||
156689001|NCT02010255|565606138|FG005|Overall Study|Lost to Follow-up|0|||
156689002|NCT02010255|565606139|FG006|Overall Study|Lost to Follow-up|0|||
156689003|NCT02010255|565606140|FG007|Overall Study|Lost to Follow-up|0|||
156689004|NCT02010255|565606141|FG008|Overall Study|Lost to Follow-up|0|||
156689005|NCT02010255|565606142|FG009|Overall Study|Lost to Follow-up|0|||
156689006|NCT02010255|565606143|FG010|Overall Study|Lost to Follow-up|0|||
156689007|NCT02010255|565606144|FG011|Overall Study|Lost to Follow-up|0|||
156689008|NCT02010255|565606145|FG012|Overall Study|Lost to Follow-up|0|||
156689009|NCT02010255|565606146|FG013|Overall Study|Lost to Follow-up|0|||
156689010|NCT02010255|565606133|FG000|Overall Study|Randomized but Not Treated|0|||
156689011|NCT02010255|565606134|FG001|Overall Study|Randomized but Not Treated|0|||
156689012|NCT02010255|565606135|FG002|Overall Study|Randomized but Not Treated|0|||
156689013|NCT02010255|565606136|FG003|Overall Study|Randomized but Not Treated|0|||
156689014|NCT02010255|565606137|FG004|Overall Study|Randomized but Not Treated|0|||
156689015|NCT02010255|565606138|FG005|Overall Study|Randomized but Not Treated|0|||
156689016|NCT02010255|565606139|FG006|Overall Study|Randomized but Not Treated|0|||
156689017|NCT02010255|565606140|FG007|Overall Study|Randomized but Not Treated|0|||
156689018|NCT02010255|565606141|FG008|Overall Study|Randomized but Not Treated|0|||
156689019|NCT02010255|565606142|FG009|Overall Study|Randomized but Not Treated|0|||
156689020|NCT02010255|565606143|FG010|Overall Study|Randomized but Not Treated|0|||
156689021|NCT02010255|565606144|FG011|Overall Study|Randomized but Not Treated|0|||
156689022|NCT02010255|565606145|FG012|Overall Study|Randomized but Not Treated|0|||
156689023|NCT02010255|565606146|FG013|Overall Study|Randomized but Not Treated|1|||
156689024|NCT02039063|565606147|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
156689025|NCT02039063|565606148|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
156689026|NCT02039063|565606149|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
156689027|NCT02039063|565606150|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
156787510|NCT02533674|565974756|FG005|Dose Level I|Death|0|||
156689028|NCT02039063|565606147|FG000|Treatment Phase|Progression of disease|0|||
156689029|NCT02039063|565606148|FG001|Treatment Phase|Progression of disease|0|||
156689030|NCT02039063|565606149|FG002|Treatment Phase|Progression of disease|1|||
156689031|NCT02039063|565606150|FG003|Treatment Phase|Progression of disease|1|||
156689032|NCT02039063|565606147|FG000|Extension Phase|Inadequate therapeutic effect|0|||
156689033|NCT02039063|565606148|FG001|Extension Phase|Inadequate therapeutic effect|1|||
156689034|NCT02039063|565606149|FG002|Extension Phase|Inadequate therapeutic effect|2|||
156689035|NCT02039063|565606150|FG003|Extension Phase|Inadequate therapeutic effect|0|||
156689036|NCT02039063|565606147|FG000|Extension Phase|Progression of disease|0|||
156689037|NCT02039063|565606148|FG001|Extension Phase|Progression of disease|0|||
156689038|NCT02039063|565606149|FG002|Extension Phase|Progression of disease|0|||
156689039|NCT02039063|565606150|FG003|Extension Phase|Progression of disease|1|||
156869952|NCT00960999|566281059|FG001|Overall Study|Withdrawal by Subject|0|||
156869953|NCT00960999|566281058|FG000|Overall Study|Protocol Violation|5|||
156869954|NCT00960999|566281059|FG001|Overall Study|Protocol Violation|2|||
156869955|NCT00960999|566281058|FG000|Overall Study|RT dose constraints not met|2|||
156869956|NCT00960999|566281059|FG001|Overall Study|RT dose constraints not met|0|||
156869957|NCT00432172|566281060|FG000|Overall Study|Physician Decision|0|||
156869958|NCT00432172|566281061|FG001|Overall Study|Physician Decision|0|||
156869959|NCT00432172|566281062|FG002|Overall Study|Physician Decision|2|||
156869960|NCT00432172|566281063|FG003|Overall Study|Physician Decision|0|||
156869961|NCT00432172|566281060|FG000|Overall Study|Adverse Event|4|||
156869962|NCT00432172|566281061|FG001|Overall Study|Adverse Event|2|||
156869963|NCT00432172|566281062|FG002|Overall Study|Adverse Event|4|||
156869964|NCT00432172|566281063|FG003|Overall Study|Adverse Event|3|||
156869965|NCT00432172|566281060|FG000|Overall Study|Disease progression|0|||
156869966|NCT00432172|566281061|FG001|Overall Study|Disease progression|2|||
156869967|NCT00432172|566281062|FG002|Overall Study|Disease progression|5|||
156869968|NCT00432172|566281063|FG003|Overall Study|Disease progression|1|||
156869969|NCT00432172|566281060|FG000|Overall Study|Withdrawal by Subject|0|||
156869970|NCT00432172|566281061|FG001|Overall Study|Withdrawal by Subject|1|||
156869971|NCT00432172|566281062|FG002|Overall Study|Withdrawal by Subject|0|||
156869972|NCT00432172|566281063|FG003|Overall Study|Withdrawal by Subject|2|||
156869973|NCT00432172|566281060|FG000|Overall Study|No treatment received|2|||
156869974|NCT00432172|566281061|FG001|Overall Study|No treatment received|2|||
156869975|NCT00432172|566281062|FG002|Overall Study|No treatment received|0|||
156869976|NCT00432172|566281063|FG003|Overall Study|No treatment received|1|||
156869977|NCT02536963|566281064|FG000|Overall Study|Withdrawal by Subject|18|||
156869978|NCT02668393|566281065|FG000|Overall Study|Progressive disease|6|||
156869979|NCT02668393|566281066|FG001|Overall Study|Progressive disease|3|||
156869980|NCT02668393|566281065|FG000|Overall Study|Adverse Event|0|||
156869981|NCT02668393|566281066|FG001|Overall Study|Adverse Event|2|||
156869982|NCT02668393|566281065|FG000|Overall Study|Withdrawal from the trial|0|||
156869983|NCT02668393|566281066|FG001|Overall Study|Withdrawal from the trial|1|||
156869984|NCT02668393|566281065|FG000|Overall Study|Lack of benefit and side effects|1|||
156869985|NCT02668393|566281066|FG001|Overall Study|Lack of benefit and side effects|0|||
156869986|NCT02141204|566281067|FG000|Overall Study|Lost to Follow-up|2|||
156869987|NCT02141204|566281068|FG001|Overall Study|Lost to Follow-up|1|||
156869988|NCT02141204|566281067|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
156869989|NCT02141204|566281068|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
156869990|NCT02141204|566281067|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156869991|NCT02141204|566281068|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
156869992|NCT02141204|566281067|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
156869993|NCT02141204|566281068|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
156869994|NCT00515619|566281071|FG000|Overall Study|Adverse Event|34|||
156869995|NCT00515619|566281071|FG000|Overall Study|Lack of Efficacy|92|||
156869996|NCT00515619|566281071|FG000|Overall Study|Withdrawal by Subject|66|||
156869997|NCT00515619|566281071|FG000|Overall Study|Protocol Violation|3|||
156869998|NCT00515619|566281071|FG000|Overall Study|Lost to Follow-up|4|||
156869999|NCT00515619|566281071|FG000|Overall Study|Unsatisfactory compliance|6|||
156870000|NCT00515619|566281071|FG000|Overall Study|Other: Site discontinuing trials|2|||
156870001|NCT00515619|566281071|FG000|Overall Study|Other: Subject cannot attend visits|2|||
156870002|NCT00515619|566281071|FG000|Overall Study|Other: Subject required surgery|1|||
156870003|NCT00515619|566281071|FG000|Overall Study|Other: Subject moved to another country|1|||
156870004|NCT00515619|566281071|FG000|Overall Study|Other: Investigator decision|1|||
156870005|NCT00515619|566281071|FG000|Overall Study|Other: Subject became pregnant|1|||
156870006|NCT00515619|566281071|FG000|Overall Study|Other: Request from sponsor|1|||
156870007|NCT00515619|566281071|FG000|Overall Study|Other: Drug available on license|1|||
156870008|NCT00515619|566281071|FG000|Overall Study|Other: Subject interested in other AED|1|||
156870009|NCT02379091|566281072|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156870010|NCT02379091|566281073|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156870011|NCT02379091|566281074|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156870012|NCT02379091|566281075|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156870013|NCT02379091|566281072|FG000|Overall Study|Principal Investigator Discretion|0|||
156870014|NCT02379091|566281073|FG001|Overall Study|Principal Investigator Discretion|1|||
156870015|NCT02379091|566281074|FG002|Overall Study|Principal Investigator Discretion|0|||
156689040|NCT02039063|565606147|FG000|Extension Phase|Adverse Event|0|||
156689041|NCT02039063|565606148|FG001|Extension Phase|Adverse Event|0|||
156870016|NCT02379091|566281075|FG003|Overall Study|Principal Investigator Discretion|0|||
156870017|NCT02379091|566281072|FG000|Overall Study|Lost to Follow-up|0|||
156870018|NCT02379091|566281073|FG001|Overall Study|Lost to Follow-up|0|||
156870019|NCT02379091|566281074|FG002|Overall Study|Lost to Follow-up|0|||
156870020|NCT02379091|566281075|FG003|Overall Study|Lost to Follow-up|1|||
156870021|NCT02379091|566281072|FG000|Overall Study|Voluntary Withdrawal|2|||
156870022|NCT02379091|566281073|FG001|Overall Study|Voluntary Withdrawal|5|||
156870023|NCT02379091|566281074|FG002|Overall Study|Voluntary Withdrawal|2|||
156870024|NCT02379091|566281075|FG003|Overall Study|Voluntary Withdrawal|4|||
156689042|NCT02039063|565606149|FG002|Extension Phase|Adverse Event|1|||
156689043|NCT02039063|565606150|FG003|Extension Phase|Adverse Event|0|||
156689044|NCT03417830|565606151|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
156689045|NCT03417830|565606152|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
156689046|NCT00823199|565606156|FG000|Overall Study|Withdrawal by Subject|2|||
156689047|NCT00941720|565606157|FG000|Overall Study|Withdrawal by Subject|1|||
156689048|NCT00941720|565606157|FG000|Overall Study|Insurance denied participation|11|||
156689049|NCT00941720|565606157|FG000|Overall Study|ineligible|2|||
156689050|NCT00171340|565606158|FG000|Overall Study|Adverse Event|46|||
156689051|NCT00171340|565606159|FG001|Overall Study|Adverse Event|42|||
156689052|NCT00171340|565606158|FG000|Overall Study|Lack of Efficacy|29|||
156689053|NCT00171340|565606159|FG001|Overall Study|Lack of Efficacy|41|||
156689054|NCT00171340|565606158|FG000|Overall Study|Protocol Violation|7|||
156689055|NCT00171340|565606159|FG001|Overall Study|Protocol Violation|8|||
156689056|NCT00171340|565606158|FG000|Overall Study|Withdrawal by Subject|22|||
156689057|NCT00171340|565606159|FG001|Overall Study|Withdrawal by Subject|19|||
156689058|NCT00171340|565606158|FG000|Overall Study|Lost to Follow-up|0|||
156689059|NCT00171340|565606159|FG001|Overall Study|Lost to Follow-up|5|||
156689060|NCT00171340|565606158|FG000|Overall Study|Abnormal Laboratory Results|2|||
156689061|NCT00171340|565606159|FG001|Overall Study|Abnormal Laboratory Results|0|||
156689062|NCT00171340|565606158|FG000|Overall Study|Abnormal Test Procedure Results|6|||
156689063|NCT00171340|565606159|FG001|Overall Study|Abnormal Test Procedure Results|11|||
156689064|NCT00171340|565606158|FG000|Overall Study|No Longer Required Study Drug|1|||
156689065|NCT00171340|565606159|FG001|Overall Study|No Longer Required Study Drug|1|||
156689066|NCT00171340|565606158|FG000|Overall Study|Administrative Problems|5|||
156689067|NCT00171340|565606159|FG001|Overall Study|Administrative Problems|2|||
156689068|NCT00171340|565606158|FG000|Overall Study|Death|6|||
156689069|NCT00171340|565606159|FG001|Overall Study|Death|6|||
156689070|NCT00680186|565606162|FG000|Overall Study|Adverse Event|47|||
156689071|NCT00680186|565606163|FG001|Overall Study|Adverse Event|44|||
156689072|NCT00680186|565606162|FG000|Overall Study|Protocol Violation|31|||
156689073|NCT00680186|565606163|FG001|Overall Study|Protocol Violation|26|||
156689074|NCT00680186|565606162|FG000|Overall Study|Lost to Follow-up|11|||
156689075|NCT00680186|565606163|FG001|Overall Study|Lost to Follow-up|6|||
156689076|NCT00680186|565606162|FG000|Overall Study|Withdrawal by Subject|32|||
156689077|NCT00680186|565606163|FG001|Overall Study|Withdrawal by Subject|39|||
156689078|NCT00680186|565606162|FG000|Overall Study|Other|4|||
156689079|NCT00680186|565606163|FG001|Overall Study|Other|1|||
156689080|NCT00613730|565606166|FG000|Overall Study|Disease progression|2|||
156689081|NCT00613730|565606166|FG000|Overall Study|Administrative decision|1|||
156689082|NCT04965389|565606172|FG000|Overall Study|Other reasons|1|||
156689083|NCT04965389|565606173|FG001|Overall Study|Other reasons|0|||
156689084|NCT04965389|565606174|FG002|Overall Study|Other reasons|0|||
156689085|NCT04965389|565606175|FG003|Overall Study|Other reasons|0|||
156689086|NCT04965389|565606172|FG000|Overall Study|Participant withdrew consent|0|||
156689087|NCT04965389|565606173|FG001|Overall Study|Participant withdrew consent|1|||
156689088|NCT04965389|565606174|FG002|Overall Study|Participant withdrew consent|0|||
156689089|NCT04965389|565606175|FG003|Overall Study|Participant withdrew consent|0|||
156689090|NCT04965389|565606172|FG000|Overall Study|Poor/Non-compliance|0|||
156689091|NCT04965389|565606173|FG001|Overall Study|Poor/Non-compliance|1|||
156689092|NCT04965389|565606174|FG002|Overall Study|Poor/Non-compliance|0|||
156689093|NCT04965389|565606175|FG003|Overall Study|Poor/Non-compliance|0|||
156787511|NCT02533674|565974757|FG006|Dose Level I|Death|0|||
156787512|NCT02533674|565974758|FG007|Dose Level I|Death|0|||
156787513|NCT02533674|565974751|FG000|Dose Level I|Never Treated|1|||
156787514|NCT02533674|565974752|FG001|Dose Level I|Never Treated|0|||
156787515|NCT02533674|565974753|FG002|Dose Level I|Never Treated|0|||
156787516|NCT02533674|565974754|FG003|Dose Level I|Never Treated|0|||
156787517|NCT02533674|565974755|FG004|Dose Level I|Never Treated|0|||
156689094|NCT00724373|565606178|FG000|Overall Study|Adverse Event|41|||
156787518|NCT02533674|565974756|FG005|Dose Level I|Never Treated|0|||
156787519|NCT02533674|565974757|FG006|Dose Level I|Never Treated|0|||
156787520|NCT02533674|565974758|FG007|Dose Level I|Never Treated|0|||
156787521|NCT02533674|565974751|FG000|Dose Level II|Progressive disease|0|||
156787522|NCT02533674|565974752|FG001|Dose Level II|Progressive disease|3|||
156787523|NCT02533674|565974753|FG002|Dose Level II|Progressive disease|0|||
156689095|NCT00724373|565606178|FG000|Overall Study|Lack of Efficacy|82|||
156689096|NCT00724373|565606178|FG000|Overall Study|Lost to Follow-up|7|||
156689097|NCT00724373|565606178|FG000|Overall Study|Non-compliance|2|||
156689098|NCT00724373|565606178|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
156689099|NCT00724373|565606178|FG000|Overall Study|Participant moved away|1|||
156689100|NCT00724373|565606178|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
156689101|NCT00724373|565606178|FG000|Overall Study|Only to have 24 week regimen|1|||
156689102|NCT00724373|565606178|FG000|Overall Study|Viral Relapse|1|||
156689103|NCT00724373|565606178|FG000|Overall Study|Acute HCV infection|1|||
156787524|NCT02533674|565974754|FG003|Dose Level II|Progressive disease|0|||
156787525|NCT02533674|565974755|FG004|Dose Level II|Progressive disease|0|||
156787526|NCT02533674|565974756|FG005|Dose Level II|Progressive disease|0|||
156689104|NCT00724373|565606178|FG000|Overall Study|Drug Relapse|1|||
156689105|NCT00724373|565606178|FG000|Overall Study|Tolerability|23|||
156689106|NCT01436643|565606179|FG000|2-week Pre-treatment|Abnormal test result|0|||
156689107|NCT01436643|565606180|FG001|2-week Pre-treatment|Abnormal test result|0|||
156689108|NCT01436643|565606181|FG002|2-week Pre-treatment|Abnormal test result|0|||
156689109|NCT01436643|565606182|FG003|2-week Pre-treatment|Abnormal test result|1|||
156689110|NCT01436643|565606179|FG000|2-week Pre-treatment|Adverse Event|0|||
156689111|NCT01436643|565606180|FG001|2-week Pre-treatment|Adverse Event|0|||
156689112|NCT01436643|565606181|FG002|2-week Pre-treatment|Adverse Event|0|||
156689113|NCT01436643|565606182|FG003|2-week Pre-treatment|Adverse Event|5|||
156689114|NCT01436643|565606179|FG000|2-week Pre-treatment|Protocol Violation|0|||
156689115|NCT01436643|565606180|FG001|2-week Pre-treatment|Protocol Violation|0|||
156689116|NCT01436643|565606181|FG002|2-week Pre-treatment|Protocol Violation|0|||
156689117|NCT01436643|565606182|FG003|2-week Pre-treatment|Protocol Violation|4|||
156689118|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
156689119|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
156689120|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
156689121|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
156689122|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689123|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689124|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
156689125|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
156689126|NCT01436643|565606179|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
156689127|NCT01436643|565606180|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
156689128|NCT01436643|565606181|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
156689129|NCT01436643|565606182|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
156689130|NCT01382251|565606183|FG000|Overall Study|Surgeries cancelled or delayed|16|||
156689131|NCT01382251|565606184|FG001|Overall Study|Surgeries cancelled or delayed|16|||
156689132|NCT01382251|565606183|FG000|Overall Study|Lost to Follow-up|4|||
156689133|NCT01382251|565606184|FG001|Overall Study|Lost to Follow-up|4|||
156689134|NCT01382251|565606183|FG000|Overall Study|Contacted after study closed|1|||
156689135|NCT01382251|565606184|FG001|Overall Study|Contacted after study closed|1|||
156689136|NCT01117987|565606185|FG000|Overall Study|Protocol deviation|0|||
156689137|NCT01117987|565606186|FG001|Overall Study|Protocol deviation|1|||
156689138|NCT01117987|565606185|FG000|Overall Study|Subject no longer requires study drug|1|||
156689139|NCT01117987|565606186|FG001|Overall Study|Subject no longer requires study drug|0|||
156689140|NCT01117987|565606185|FG000|Overall Study|Lost to Follow-up|1|||
156689141|NCT01117987|565606186|FG001|Overall Study|Lost to Follow-up|1|||
156689142|NCT01117987|565606185|FG000|Overall Study|Abnormal test procedure result|2|||
156689143|NCT01117987|565606186|FG001|Overall Study|Abnormal test procedure result|0|||
156689144|NCT01117987|565606185|FG000|Overall Study|Lack of Efficacy|3|||
156689145|NCT01117987|565606186|FG001|Overall Study|Lack of Efficacy|4|||
156689146|NCT01117987|565606185|FG000|Overall Study|Death|5|||
156689147|NCT01117987|565606186|FG001|Overall Study|Death|10|||
156689148|NCT01117987|565606185|FG000|Overall Study|Withdrawal by Subject|5|||
156689149|NCT01117987|565606186|FG001|Overall Study|Withdrawal by Subject|10|||
156689150|NCT01117987|565606185|FG000|Overall Study|Adverse Event|19|||
156689151|NCT01117987|565606186|FG001|Overall Study|Adverse Event|26|||
156689152|NCT01117987|565606185|FG000|Overall Study|Administrative problems|25|||
156689153|NCT01117987|565606186|FG001|Overall Study|Administrative problems|22|||
156689154|NCT02377063|565606187|FG000|Overall Study|Non-compliance|5|||
156870025|NCT02379091|566281072|FG000|Overall Study|Study Termination|7|||
156870026|NCT02379091|566281073|FG001|Overall Study|Study Termination|2|||
156689155|NCT01524913|565606188|FG000|Overall Study|Lost to Follow-up|4|||
156689156|NCT01524913|565606189|FG001|Overall Study|Lost to Follow-up|0|||
156689157|NCT01524913|565606190|FG002|Overall Study|Lost to Follow-up|0|||
156689158|NCT00702208|565606191|FG000|Overall Study|Lost to Follow-up|28|||
156689159|NCT00702208|565606191|FG000|Overall Study|Did not self-lavage|1|||
156689160|NCT00702208|565606191|FG000|Overall Study|Unsatisfactory colposcopy|2|||
156689161|NCT04678817|565607542|FG000|Overall Study|Lost to Follow-up|28|||
156689162|NCT04678817|565607543|FG001|Overall Study|Lost to Follow-up|0|||
156689163|NCT04678817|565607544|FG002|Overall Study|Lost to Follow-up|0|||
156689164|NCT02124902|565607552|FG000|Overall Study|Adverse Event|7|||
156689165|NCT02124902|565607553|FG001|Overall Study|Adverse Event|2|||
156689166|NCT02124902|565607552|FG000|Overall Study|Went to alternative treatment|4|||
156689167|NCT02124902|565607553|FG001|Overall Study|Went to alternative treatment|0|||
156689168|NCT02124902|565607552|FG000|Overall Study|Withdrawal by Subject|2|||
156689169|NCT02124902|565607553|FG001|Overall Study|Withdrawal by Subject|1|||
156689170|NCT02124902|565607552|FG000|Overall Study|Physician Decision|2|||
156689171|NCT02124902|565607553|FG001|Overall Study|Physician Decision|0|||
156689172|NCT02124902|565607552|FG000|Overall Study|Not eligible|1|||
156689173|NCT02124902|565607553|FG001|Overall Study|Not eligible|0|||
156689174|NCT02124902|565607552|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
156689175|NCT02124902|565607553|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
156689176|NCT01937351|565607554|FG000|Overall Study|Withdrawal by Subject|4|||
156689177|NCT01937351|565607555|FG001|Overall Study|Withdrawal by Subject|2|||
156689178|NCT01937351|565607554|FG000|Overall Study|Death|1|||
156689179|NCT01937351|565607555|FG001|Overall Study|Death|0|||
156689180|NCT01937351|565607554|FG000|Overall Study|Not treated w device, per protocol fail|4|||
156689181|NCT01937351|565607555|FG001|Overall Study|Not treated w device, per protocol fail|0|||
156689182|NCT01961687|565607556|FG000|Overall Study|Lost to Follow-up|19|||
156689183|NCT01961687|565607556|FG000|Overall Study|Re-operation|17|||
156689184|NCT01961687|565607556|FG000|Overall Study|Death|7|||
156689185|NCT01961687|565607556|FG000|Overall Study|Withdrawal by Subject|6|||
156689186|NCT01961687|565607556|FG000|Overall Study|Adverse Event|6|||
156689187|NCT01961687|565607556|FG000|Overall Study|Moved to area without study site|2|||
156689188|NCT01961687|565607556|FG000|Overall Study|Sponsor decision|2|||
156689189|NCT01961687|565607556|FG000|Overall Study|Physician Decision|1|||
156689190|NCT01961687|565607556|FG000|Overall Study|Unable to meet follow-up requirements|1|||
156689191|NCT00546910|565607559|FG000|Overall Study|Adverse Event|2|||
156689192|NCT00546910|565607560|FG001|Overall Study|Adverse Event|3|||
156689193|NCT00546910|565607559|FG000|Overall Study|Lack of Efficacy|5|||
156787527|NCT02533674|565974757|FG006|Dose Level II|Progressive disease|0|||
156787528|NCT02533674|565974758|FG007|Dose Level II|Progressive disease|0|||
156787529|NCT02533674|565974751|FG000|Dose Level II|Withdrawal by Subject|0|||
156787530|NCT02533674|565974752|FG001|Dose Level II|Withdrawal by Subject|1|||
156787531|NCT02533674|565974753|FG002|Dose Level II|Withdrawal by Subject|0|||
156787532|NCT02533674|565974754|FG003|Dose Level II|Withdrawal by Subject|0|||
156787533|NCT02533674|565974755|FG004|Dose Level II|Withdrawal by Subject|0|||
156787534|NCT02533674|565974756|FG005|Dose Level II|Withdrawal by Subject|0|||
156787535|NCT02533674|565974757|FG006|Dose Level II|Withdrawal by Subject|0|||
156787536|NCT02533674|565974758|FG007|Dose Level II|Withdrawal by Subject|0|||
156787537|NCT02533674|565974751|FG000|Dose Level II|Treatment-related AE|0|||
156787538|NCT02533674|565974752|FG001|Dose Level II|Treatment-related AE|1|||
156787539|NCT02533674|565974753|FG002|Dose Level II|Treatment-related AE|0|||
156787540|NCT02533674|565974754|FG003|Dose Level II|Treatment-related AE|0|||
156787541|NCT02533674|565974755|FG004|Dose Level II|Treatment-related AE|0|||
156787542|NCT02533674|565974756|FG005|Dose Level II|Treatment-related AE|0|||
156787543|NCT02533674|565974757|FG006|Dose Level II|Treatment-related AE|0|||
156787544|NCT02533674|565974758|FG007|Dose Level II|Treatment-related AE|0|||
156787545|NCT02533674|565974751|FG000|Dose Level II|Physician Decision|0|||
156787546|NCT02533674|565974752|FG001|Dose Level II|Physician Decision|1|||
156787547|NCT02533674|565974753|FG002|Dose Level II|Physician Decision|0|||
156787548|NCT02533674|565974754|FG003|Dose Level II|Physician Decision|0|||
156787549|NCT02533674|565974755|FG004|Dose Level II|Physician Decision|0|||
156787550|NCT02533674|565974756|FG005|Dose Level II|Physician Decision|0|||
156787551|NCT02533674|565974757|FG006|Dose Level II|Physician Decision|0|||
156787552|NCT02533674|565974758|FG007|Dose Level II|Physician Decision|0|||
156787553|NCT02533674|565974751|FG000|Dose Level II|Non-treatment-related AE|0|||
156787554|NCT02533674|565974752|FG001|Dose Level II|Non-treatment-related AE|1|||
156787555|NCT02533674|565974753|FG002|Dose Level II|Non-treatment-related AE|0|||
156787556|NCT02533674|565974754|FG003|Dose Level II|Non-treatment-related AE|0|||
156787557|NCT02533674|565974755|FG004|Dose Level II|Non-treatment-related AE|0|||
156787558|NCT02533674|565974756|FG005|Dose Level II|Non-treatment-related AE|0|||
156787559|NCT02533674|565974757|FG006|Dose Level II|Non-treatment-related AE|0|||
156787560|NCT02533674|565974758|FG007|Dose Level II|Non-treatment-related AE|0|||
156787561|NCT02533674|565974751|FG000|Dose Level III|Progressive disease|0|||
156787562|NCT02533674|565974752|FG001|Dose Level III|Progressive disease|0|||
156787563|NCT02533674|565974753|FG002|Dose Level III|Progressive disease|2|||
156787564|NCT02533674|565974754|FG003|Dose Level III|Progressive disease|0|||
156787565|NCT02533674|565974755|FG004|Dose Level III|Progressive disease|0|||
156787566|NCT02533674|565974756|FG005|Dose Level III|Progressive disease|0|||
156787567|NCT02533674|565974757|FG006|Dose Level III|Progressive disease|0|||
156787568|NCT02533674|565974758|FG007|Dose Level III|Progressive disease|0|||
156787569|NCT02533674|565974751|FG000|Dose Level III|Withdrawal by Subject|0|||
156787570|NCT02533674|565974752|FG001|Dose Level III|Withdrawal by Subject|0|||
156787571|NCT02533674|565974753|FG002|Dose Level III|Withdrawal by Subject|1|||
156787572|NCT02533674|565974754|FG003|Dose Level III|Withdrawal by Subject|0|||
156787573|NCT02533674|565974755|FG004|Dose Level III|Withdrawal by Subject|0|||
156787574|NCT02533674|565974756|FG005|Dose Level III|Withdrawal by Subject|0|||
156787575|NCT02533674|565974757|FG006|Dose Level III|Withdrawal by Subject|0|||
157013490|NCT04337372|566801792|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
157013491|NCT04337372|566801793|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
157021658|NCT04072380|566830973|FG002|Overall Study|Physician Decision|0|||
156689194|NCT00546910|565607560|FG001|Overall Study|Lack of Efficacy|7|||
156689195|NCT00546910|565607559|FG000|Overall Study|Physician Decision|0|||
156689196|NCT00546910|565607560|FG001|Overall Study|Physician Decision|1|||
156689197|NCT00546910|565607559|FG000|Overall Study|Withdrawal by Subject|2|||
156689198|NCT00546910|565607560|FG001|Overall Study|Withdrawal by Subject|0|||
156787576|NCT02533674|565974758|FG007|Dose Level III|Withdrawal by Subject|0|||
156787577|NCT02533674|565974751|FG000|Dose Level III|Treatment-related AE|0|||
156787578|NCT02533674|565974752|FG001|Dose Level III|Treatment-related AE|0|||
156787579|NCT02533674|565974753|FG002|Dose Level III|Treatment-related AE|1|||
156689199|NCT01467479|565607561|FG000|Overall Study|No Study Medication|1|||
156689200|NCT01467479|565607562|FG001|Overall Study|No Study Medication|0|||
156689201|NCT01467479|565607563|FG002|Overall Study|No Study Medication|2|||
156689202|NCT01467479|565607561|FG000|Overall Study|Adverse Event|1|||
156689203|NCT01467479|565607562|FG001|Overall Study|Adverse Event|2|||
156689204|NCT01467479|565607563|FG002|Overall Study|Adverse Event|0|||
157121528|NCT05103332|567195982|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156689205|NCT01467479|565607561|FG000|Overall Study|Death|0|||
156689206|NCT01467479|565607562|FG001|Overall Study|Death|0|||
156689207|NCT01467479|565607563|FG002|Overall Study|Death|1|||
156689208|NCT01467479|565607561|FG000|Overall Study|Lost to Follow-up|2|||
156689209|NCT01467479|565607562|FG001|Overall Study|Lost to Follow-up|5|||
156689210|NCT01467479|565607563|FG002|Overall Study|Lost to Follow-up|3|||
156689211|NCT01467479|565607561|FG000|Overall Study|Withdrawal of Consent|3|||
156689212|NCT01467479|565607562|FG001|Overall Study|Withdrawal of Consent|7|||
156689213|NCT01467479|565607563|FG002|Overall Study|Withdrawal of Consent|7|||
156689214|NCT01467479|565607561|FG000|Overall Study|Study Terminated by Sponsor|1|||
156689215|NCT01467479|565607562|FG001|Overall Study|Study Terminated by Sponsor|3|||
156689216|NCT01467479|565607563|FG002|Overall Study|Study Terminated by Sponsor|3|||
156689217|NCT01467479|565607561|FG000|Overall Study|Other|1|||
156689218|NCT01467479|565607562|FG001|Overall Study|Other|0|||
156689219|NCT01467479|565607563|FG002|Overall Study|Other|0|||
156689220|NCT01730040|565607573|FG000|Overall Study|Randomized but not treated|0|||
156689221|NCT01730040|565607574|FG001|Overall Study|Randomized but not treated|0|||
156689222|NCT01730040|565607575|FG002|Overall Study|Randomized but not treated|0|||
156689223|NCT01730040|565607576|FG003|Overall Study|Randomized but not treated|0|||
156689224|NCT01730040|565607577|FG004|Overall Study|Randomized but not treated|0|||
156689225|NCT01730040|565607578|FG005|Overall Study|Randomized but not treated|1|||
156689226|NCT01730040|565607579|FG006|Overall Study|Randomized but not treated|0|||
156689227|NCT01730040|565607573|FG000|Overall Study|Subject moved|0|||
156689228|NCT01730040|565607574|FG001|Overall Study|Subject moved|0|||
156689229|NCT01730040|565607575|FG002|Overall Study|Subject moved|1|||
156689230|NCT01730040|565607576|FG003|Overall Study|Subject moved|0|||
156689231|NCT01730040|565607577|FG004|Overall Study|Subject moved|0|||
156689232|NCT01730040|565607578|FG005|Overall Study|Subject moved|0|||
156689233|NCT01730040|565607579|FG006|Overall Study|Subject moved|1|||
156689234|NCT01730040|565607573|FG000|Overall Study|Physician Decision|0|||
156689235|NCT01730040|565607574|FG001|Overall Study|Physician Decision|0|||
156689236|NCT01730040|565607575|FG002|Overall Study|Physician Decision|0|||
156689237|NCT01730040|565607576|FG003|Overall Study|Physician Decision|0|||
156689238|NCT01730040|565607577|FG004|Overall Study|Physician Decision|0|||
156689239|NCT01730040|565607578|FG005|Overall Study|Physician Decision|1|||
156689240|NCT01730040|565607579|FG006|Overall Study|Physician Decision|1|||
156689241|NCT01730040|565607573|FG000|Overall Study|Other than specified|7|||
156689242|NCT01730040|565607574|FG001|Overall Study|Other than specified|8|||
156689243|NCT01730040|565607575|FG002|Overall Study|Other than specified|5|||
156689244|NCT01730040|565607576|FG003|Overall Study|Other than specified|5|||
156689245|NCT01730040|565607577|FG004|Overall Study|Other than specified|5|||
156689246|NCT01730040|565607578|FG005|Overall Study|Other than specified|4|||
156689247|NCT01730040|565607579|FG006|Overall Study|Other than specified|4|||
156689248|NCT01730040|565607573|FG000|Overall Study|Adverse Event|4|||
156689249|NCT01730040|565607574|FG001|Overall Study|Adverse Event|3|||
156689250|NCT01730040|565607575|FG002|Overall Study|Adverse Event|5|||
156689251|NCT01730040|565607576|FG003|Overall Study|Adverse Event|3|||
156689252|NCT01730040|565607577|FG004|Overall Study|Adverse Event|1|||
156689253|NCT01730040|565607578|FG005|Overall Study|Adverse Event|1|||
156689254|NCT01730040|565607579|FG006|Overall Study|Adverse Event|2|||
156787580|NCT02533674|565974754|FG003|Dose Level III|Treatment-related AE|0|||
156787581|NCT02533674|565974755|FG004|Dose Level III|Treatment-related AE|0|||
156787582|NCT02533674|565974756|FG005|Dose Level III|Treatment-related AE|0|||
156787583|NCT02533674|565974757|FG006|Dose Level III|Treatment-related AE|0|||
156787584|NCT02533674|565974758|FG007|Dose Level III|Treatment-related AE|0|||
156787585|NCT02533674|565974751|FG000|Dose Level IV|Progressive disease|0|||
156787586|NCT02533674|565974752|FG001|Dose Level IV|Progressive disease|0|||
156787587|NCT02533674|565974753|FG002|Dose Level IV|Progressive disease|0|||
156787588|NCT02533674|565974754|FG003|Dose Level IV|Progressive disease|3|||
156787589|NCT02533674|565974755|FG004|Dose Level IV|Progressive disease|0|||
157121529|NCT05103332|567195983|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156689255|NCT01730040|565607573|FG000|Overall Study|Poor compliance to protocol|2|||
156689256|NCT01730040|565607574|FG001|Overall Study|Poor compliance to protocol|4|||
156689257|NCT01730040|565607575|FG002|Overall Study|Poor compliance to protocol|0|||
156689258|NCT01730040|565607576|FG003|Overall Study|Poor compliance to protocol|0|||
156689259|NCT01730040|565607577|FG004|Overall Study|Poor compliance to protocol|0|||
156689260|NCT01730040|565607578|FG005|Overall Study|Poor compliance to protocol|0|||
156689261|NCT01730040|565607579|FG006|Overall Study|Poor compliance to protocol|1|||
156689262|NCT01552369|565607583|FG000|Overall Study|Did not consent to extended follow up|8|||
156689263|NCT01552369|565607584|FG001|Overall Study|Did not consent to extended follow up|9|||
156689264|NCT00614926|565607585|FG000|Overall Study|Burden of travel|1|||
156689265|NCT00614926|565607586|FG001|Overall Study|Burden of travel|0|||
156689266|NCT00614926|565607585|FG000|Overall Study|Adverse Event|3|||
156689267|NCT00614926|565607586|FG001|Overall Study|Adverse Event|0|||
156689268|NCT02310789|565607591|FG000|Overall Study|Adverse Event|1|||
156689269|NCT01197417|565607592|FG000|Overall Study|Physician Decision|3|||
156689270|NCT01197417|565607593|FG001|Overall Study|Physician Decision|2|||
156689271|NCT01197417|565607592|FG000|Overall Study|Withdrawal by Subject|2|||
156689272|NCT01197417|565607593|FG001|Overall Study|Withdrawal by Subject|4|||
156689273|NCT01197417|565607592|FG000|Overall Study|Site miscommunication|0|||
156689274|NCT01197417|565607593|FG001|Overall Study|Site miscommunication|1|||
156689275|NCT01197417|565607592|FG000|Overall Study|Subject transferred to intensive care|0|||
156689276|NCT01197417|565607593|FG001|Overall Study|Subject transferred to intensive care|1|||
156689277|NCT01197417|565607592|FG000|Overall Study|Not consented in time to receive drug|0|||
156689278|NCT01197417|565607593|FG001|Overall Study|Not consented in time to receive drug|1|||
156689279|NCT01197417|565607592|FG000|Overall Study|Hypotension|1|||
156689280|NCT01197417|565607593|FG001|Overall Study|Hypotension|2|||
156689281|NCT01197417|565607592|FG000|Overall Study|Found to be ineligible|2|||
156689282|NCT01197417|565607593|FG001|Overall Study|Found to be ineligible|5|||
156689283|NCT01197417|565607592|FG000|Overall Study|No 25-hour magnesium level|0|||
156689284|NCT01197417|565607593|FG001|Overall Study|No 25-hour magnesium level|2|||
156689285|NCT02065713|565607594|FG000|Overall Study|Adverse Event|0|||
156689286|NCT02065713|565607595|FG001|Overall Study|Adverse Event|1|||
156689287|NCT02065713|565607594|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156689288|NCT02065713|565607595|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156689289|NCT01833533|565607598|FG000|Overall Study|Adverse Event|0|||
156689290|NCT01833533|565607599|FG001|Overall Study|Adverse Event|1|||
156689291|NCT01833533|565607598|FG000|Overall Study|Lost to Follow-up|4|||
156689292|NCT01833533|565607599|FG001|Overall Study|Lost to Follow-up|9|||
156689293|NCT01833533|565607598|FG000|Overall Study|To Enter an Extension Study|0|||
156689294|NCT01833533|565607599|FG001|Overall Study|To Enter an Extension Study|4|||
156689295|NCT01833533|565607598|FG000|Overall Study|Other|2|||
156689296|NCT01833533|565607599|FG001|Overall Study|Other|7|||
156689297|NCT02772562|565607601|FG000|Overall Study|Withdrawal by Subject|1|||
156689298|NCT02772562|565607601|FG000|Overall Study|Protocol Violation|1|||
156689299|NCT01048502|565607604|FG000|Overall Study|Lost to Follow-up|2|||
156689300|NCT01048502|565607605|FG001|Overall Study|Lost to Follow-up|0|||
156689301|NCT01048502|565607606|FG002|Overall Study|Lost to Follow-up|0|||
156689302|NCT01048502|565607607|FG003|Overall Study|Lost to Follow-up|0|||
156689303|NCT01048502|565607604|FG000|Overall Study|Adverse Event|1|||
156689304|NCT01048502|565607605|FG001|Overall Study|Adverse Event|0|||
156689305|NCT01048502|565607606|FG002|Overall Study|Adverse Event|0|||
156689306|NCT01048502|565607607|FG003|Overall Study|Adverse Event|0|||
156689307|NCT01048502|565607604|FG000|Overall Study|Withdrawal by Subject|1|||
156689308|NCT01048502|565607605|FG001|Overall Study|Withdrawal by Subject|4|||
156689309|NCT01048502|565607606|FG002|Overall Study|Withdrawal by Subject|5|||
156689310|NCT01048502|565607607|FG003|Overall Study|Withdrawal by Subject|3|||
156689311|NCT01048502|565607604|FG000|Overall Study|Physician Decision|0|||
156689312|NCT01048502|565607605|FG001|Overall Study|Physician Decision|3|||
156689313|NCT01048502|565607606|FG002|Overall Study|Physician Decision|0|||
156689314|NCT01048502|565607607|FG003|Overall Study|Physician Decision|1|||
156689315|NCT03336242|565607608|FG000|Overall Study|Adverse Event|0|||
156689316|NCT03336242|565607609|FG001|Overall Study|Adverse Event|1|||
156689317|NCT02457611|565607611|FG000|Overall Study|Lost to Follow-up|3|||
156689318|NCT03005067|565607612|FG000|Overall Study|Withdrawal by Subject|3|||
156689319|NCT03005067|565607613|FG001|Overall Study|Withdrawal by Subject|2|||
156689320|NCT03005067|565607612|FG000|Overall Study|Adverse Event|4|||
156689321|NCT03005067|565607613|FG001|Overall Study|Adverse Event|3|||
156689322|NCT03005067|565607612|FG000|Overall Study|Other (reason not specified)|3|||
156689323|NCT03005067|565607613|FG001|Overall Study|Other (reason not specified)|1|||
156689324|NCT03005067|565607612|FG000|Overall Study|Protocol Violation|0|||
156689325|NCT03005067|565607613|FG001|Overall Study|Protocol Violation|1|||
156689326|NCT00296491|565607614|FG000|Overall Study|Low Pollen Counts|18|||
156689327|NCT00296491|565607615|FG001|Overall Study|Low Pollen Counts|26|||
156689328|NCT00296491|565607616|FG002|Overall Study|Low Pollen Counts|25|||
156689329|NCT00296491|565607617|FG003|Overall Study|Low Pollen Counts|16|||
156689330|NCT00296491|565607614|FG000|Overall Study|Protocol Violation|4|||
156689331|NCT00296491|565607615|FG001|Overall Study|Protocol Violation|6|||
156689332|NCT00296491|565607616|FG002|Overall Study|Protocol Violation|2|||
156689333|NCT00296491|565607617|FG003|Overall Study|Protocol Violation|3|||
156689334|NCT00296491|565607614|FG000|Overall Study|Adverse Event|1|||
156689335|NCT00296491|565607615|FG001|Overall Study|Adverse Event|3|||
156689336|NCT00296491|565607616|FG002|Overall Study|Adverse Event|1|||
156689337|NCT00296491|565607617|FG003|Overall Study|Adverse Event|4|||
156689338|NCT00296491|565607614|FG000|Overall Study|Withdrawn due to Asthma|0|||
156689339|NCT00296491|565607615|FG001|Overall Study|Withdrawn due to Asthma|0|||
156689340|NCT00296491|565607616|FG002|Overall Study|Withdrawn due to Asthma|0|||
156689341|NCT00296491|565607617|FG003|Overall Study|Withdrawn due to Asthma|4|||
156689342|NCT00296491|565607614|FG000|Overall Study|Withdrawal by Subject|7|||
156689343|NCT00296491|565607615|FG001|Overall Study|Withdrawal by Subject|3|||
156689344|NCT00296491|565607616|FG002|Overall Study|Withdrawal by Subject|3|||
156689345|NCT00296491|565607617|FG003|Overall Study|Withdrawal by Subject|2|||
156689346|NCT00296491|565607614|FG000|Overall Study|Non-Compliance|12|||
156689347|NCT00296491|565607615|FG001|Overall Study|Non-Compliance|13|||
156689348|NCT00296491|565607616|FG002|Overall Study|Non-Compliance|10|||
156689349|NCT00296491|565607617|FG003|Overall Study|Non-Compliance|14|||
156689350|NCT00296491|565607614|FG000|Overall Study|Lost to Follow-up|0|||
156689351|NCT00296491|565607615|FG001|Overall Study|Lost to Follow-up|2|||
156689352|NCT00296491|565607616|FG002|Overall Study|Lost to Follow-up|2|||
156689353|NCT00296491|565607617|FG003|Overall Study|Lost to Follow-up|0|||
156689354|NCT05575063|565607620|FG000|Overall Study|Withdrawal by Subject|1|||
156689355|NCT01740791|565607623|FG000|Overall Study|Randomized but never treated|5|||
156689356|NCT01740791|565607624|FG001|Overall Study|Randomized but never treated|3|||
156689357|NCT01740791|565607625|FG002|Overall Study|Randomized but never treated|2|||
156689358|NCT01740791|565607626|FG003|Overall Study|Randomized but never treated|2|||
156689359|NCT01740791|565607627|FG004|Overall Study|Randomized but never treated|1|||
156689360|NCT01740791|565607628|FG005|Overall Study|Randomized but never treated|3|||
156689361|NCT01740791|565607623|FG000|Overall Study|Lost to Follow-up|2|||
156689362|NCT01740791|565607624|FG001|Overall Study|Lost to Follow-up|0|||
156689363|NCT01740791|565607625|FG002|Overall Study|Lost to Follow-up|2|||
156689364|NCT01740791|565607626|FG003|Overall Study|Lost to Follow-up|3|||
156689365|NCT01740791|565607627|FG004|Overall Study|Lost to Follow-up|2|||
156689366|NCT01740791|565607628|FG005|Overall Study|Lost to Follow-up|3|||
156689367|NCT01740791|565607623|FG000|Overall Study|Withdrew Consent|4|||
156689368|NCT01740791|565607624|FG001|Overall Study|Withdrew Consent|0|||
156689369|NCT01740791|565607625|FG002|Overall Study|Withdrew Consent|1|||
156689370|NCT01740791|565607626|FG003|Overall Study|Withdrew Consent|2|||
156689371|NCT01740791|565607627|FG004|Overall Study|Withdrew Consent|0|||
156689372|NCT01740791|565607628|FG005|Overall Study|Withdrew Consent|3|||
156689373|NCT01740791|565607623|FG000|Overall Study|Investigator's discretion|1|||
156689374|NCT01740791|565607624|FG001|Overall Study|Investigator's discretion|0|||
156689375|NCT01740791|565607625|FG002|Overall Study|Investigator's discretion|1|||
156689376|NCT01740791|565607626|FG003|Overall Study|Investigator's discretion|0|||
156689377|NCT01740791|565607627|FG004|Overall Study|Investigator's discretion|0|||
156689378|NCT01740791|565607628|FG005|Overall Study|Investigator's discretion|1|||
156689379|NCT01740791|565607623|FG000|Overall Study|Adverse Event|0|||
156689380|NCT01740791|565607624|FG001|Overall Study|Adverse Event|0|||
156689381|NCT01740791|565607625|FG002|Overall Study|Adverse Event|0|||
156689382|NCT01740791|565607626|FG003|Overall Study|Adverse Event|0|||
156689383|NCT01740791|565607627|FG004|Overall Study|Adverse Event|0|||
156689384|NCT01740791|565607628|FG005|Overall Study|Adverse Event|1|||
156689385|NCT01351350|565607635|FG000|Overall Study|Disease Progression|5|||
156689386|NCT01351350|565607636|FG001|Overall Study|Disease Progression|13|||
156689387|NCT01351350|565607637|FG002|Overall Study|Disease Progression|6|||
156689388|NCT01351350|565607638|FG003|Overall Study|Disease Progression|8|||
156689389|NCT01351350|565607639|FG004|Overall Study|Disease Progression|5|||
156689390|NCT01351350|565607635|FG000|Overall Study|Adverse Event|1|||
156689391|NCT01351350|565607636|FG001|Overall Study|Adverse Event|10|||
156689392|NCT01351350|565607637|FG002|Overall Study|Adverse Event|1|||
156689393|NCT01351350|565607638|FG003|Overall Study|Adverse Event|2|||
156689394|NCT01351350|565607639|FG004|Overall Study|Adverse Event|0|||
156689395|NCT01351350|565607635|FG000|Overall Study|Participant Decision|2|||
156689396|NCT01351350|565607636|FG001|Overall Study|Participant Decision|6|||
156689397|NCT01351350|565607637|FG002|Overall Study|Participant Decision|3|||
156689398|NCT01351350|565607638|FG003|Overall Study|Participant Decision|3|||
156689399|NCT01351350|565607639|FG004|Overall Study|Participant Decision|2|||
156689400|NCT01351350|565607635|FG000|Overall Study|Enrolled but not Treated|0|||
156689401|NCT01351350|565607636|FG001|Overall Study|Enrolled but not Treated|0|||
156689402|NCT01351350|565607637|FG002|Overall Study|Enrolled but not Treated|1|||
156689403|NCT01351350|565607638|FG003|Overall Study|Enrolled but not Treated|0|||
156689404|NCT01351350|565607639|FG004|Overall Study|Enrolled but not Treated|0|||
156689405|NCT04647383|565607640|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689406|NCT04647383|565607641|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
156689407|NCT04647383|565607642|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689408|NCT04647383|565607643|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
156689409|NCT00775528|565607644|FG000|Overall Study|Protocol Violation|1|||
156689410|NCT02083926|565607649|FG000|Overall Study|Withdrawal by Subject|1|||
156689411|NCT02083926|565607650|FG001|Overall Study|Withdrawal by Subject|0|||
156689412|NCT02610816|565607651|FG000|Phase 1|Withdrawal by Subject|2|||
156689413|NCT02610816|565607652|FG001|Phase 1|Withdrawal by Subject|6|||
156689414|NCT02610816|565607653|FG002|Phase 1|Withdrawal by Subject|0|||
156689415|NCT02610816|565607654|FG003|Phase 1|Withdrawal by Subject|0|||
156689416|NCT02610816|565607651|FG000|Phase 1|Lost to Follow-up|2|||
156689417|NCT02610816|565607652|FG001|Phase 1|Lost to Follow-up|1|||
156689418|NCT02610816|565607653|FG002|Phase 1|Lost to Follow-up|0|||
156689419|NCT02610816|565607654|FG003|Phase 1|Lost to Follow-up|0|||
156689420|NCT02610816|565607651|FG000|Phase 1|Physician Decision|0|||
156689421|NCT02610816|565607652|FG001|Phase 1|Physician Decision|1|||
156689422|NCT02610816|565607653|FG002|Phase 1|Physician Decision|0|||
156689423|NCT02610816|565607654|FG003|Phase 1|Physician Decision|0|||
157214451|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
157214452|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
156689424|NCT02610816|565607651|FG000|Phase 2|Withdrawal by Subject|0|||
156689425|NCT02610816|565607652|FG001|Phase 2|Withdrawal by Subject|0|||
156689426|NCT02610816|565607653|FG002|Phase 2|Withdrawal by Subject|9|||
156689427|NCT02610816|565607654|FG003|Phase 2|Withdrawal by Subject|3|||
156689428|NCT02610816|565607651|FG000|Phase 2|Lost to Follow-up|0|||
156689429|NCT02610816|565607652|FG001|Phase 2|Lost to Follow-up|0|||
156689430|NCT02610816|565607653|FG002|Phase 2|Lost to Follow-up|2|||
156689431|NCT02610816|565607654|FG003|Phase 2|Lost to Follow-up|0|||
156689432|NCT02610816|565607651|FG000|Phase 2|Physician Decision|0|||
156689433|NCT02610816|565607652|FG001|Phase 2|Physician Decision|0|||
156689434|NCT02610816|565607653|FG002|Phase 2|Physician Decision|0|||
156689435|NCT02610816|565607654|FG003|Phase 2|Physician Decision|2|||
156689436|NCT02610816|565607651|FG000|Phase 2|Pregnancy|0|||
156689437|NCT02610816|565607652|FG001|Phase 2|Pregnancy|0|||
156689438|NCT02610816|565607653|FG002|Phase 2|Pregnancy|0|||
156689439|NCT02610816|565607654|FG003|Phase 2|Pregnancy|1|||
156689440|NCT00384176|565607657|FG000|Overall Study|Death|239|||
156689441|NCT00384176|565607658|FG001|Overall Study|Death|247|||
156689442|NCT00384176|565607659|FG002|Overall Study|Death|105|||
156689443|NCT00384176|565607657|FG000|Overall Study|Withdrawal by Subject|52|||
156689444|NCT00384176|565607658|FG001|Overall Study|Withdrawal by Subject|48|||
156689445|NCT00384176|565607659|FG002|Overall Study|Withdrawal by Subject|22|||
156689446|NCT00384176|565607657|FG000|Overall Study|Lost to Follow-up|16|||
156689447|NCT00384176|565607658|FG001|Overall Study|Lost to Follow-up|18|||
156689448|NCT00384176|565607659|FG002|Overall Study|Lost to Follow-up|4|||
156689449|NCT00384176|565607657|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
156689450|NCT00384176|565607658|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
156689451|NCT00384176|565607659|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
156689452|NCT00384176|565607657|FG000|Overall Study|Longer QTC as Visit 1|1|||
156689453|NCT00384176|565607658|FG001|Overall Study|Longer QTC as Visit 1|0|||
157121530|NCT05103332|567195984|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
157121531|NCT05103332|567195985|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
157121532|NCT05103332|567195986|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121533|NCT05103332|567195987|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
157121534|NCT05103332|567195988|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
157121535|NCT05103332|567195989|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
157121536|NCT05103332|567195990|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121537|NCT05103332|567195991|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121538|NCT05103332|567195992|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
156689454|NCT00384176|565607659|FG002|Overall Study|Longer QTC as Visit 1|0|||
156689455|NCT00384176|565607657|FG000|Overall Study|Toxicity of treatment|1|||
156689456|NCT00384176|565607658|FG001|Overall Study|Toxicity of treatment|0|||
156689457|NCT00384176|565607659|FG002|Overall Study|Toxicity of treatment|0|||
157121539|NCT05103332|567195993|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121540|NCT05103332|567195994|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121541|NCT05103332|567195995|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
157121542|NCT05103332|567195978|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121543|NCT05103332|567195979|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121544|NCT05103332|567195980|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121545|NCT05103332|567195981|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121546|NCT05103332|567195982|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121547|NCT05103332|567195983|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121548|NCT05103332|567195984|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121549|NCT05103332|567195985|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121550|NCT05103332|567195986|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121551|NCT05103332|567195987|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121552|NCT05103332|567195988|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
157121553|NCT05103332|567195989|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
156689458|NCT00384176|565607657|FG000|Overall Study|Did not receive study treatment|0|||
156689459|NCT00384176|565607658|FG001|Overall Study|Did not receive study treatment|1|||
156689460|NCT00384176|565607659|FG002|Overall Study|Did not receive study treatment|1|||
156689461|NCT00384176|565607657|FG000|Overall Study|Physician Decision|0|||
157121554|NCT05103332|567195990|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
157121555|NCT05103332|567195991|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
157121556|NCT05103332|567195992|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
156689462|NCT00384176|565607658|FG001|Overall Study|Physician Decision|2|||
156689463|NCT00384176|565607659|FG002|Overall Study|Physician Decision|0|||
156689464|NCT00384176|565607657|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
156787590|NCT02533674|565974756|FG005|Dose Level IV|Progressive disease|0|||
156689465|NCT00384176|565607658|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
156689466|NCT00384176|565607659|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
156689467|NCT00842530|565607660|FG000|Overall Study|Serious adverse event|0|||
156689468|NCT00842530|565607661|FG001|Overall Study|Serious adverse event|6|||
156689469|NCT00842530|565607660|FG000|Overall Study|Other adverse event|6|||
156689470|NCT00842530|565607661|FG001|Overall Study|Other adverse event|1|||
156689471|NCT00842530|565607660|FG000|Overall Study|Protocol Violation|32|||
156689472|NCT00842530|565607661|FG001|Overall Study|Protocol Violation|14|||
156689473|NCT00842530|565607660|FG000|Overall Study|Lost to Follow-up|6|||
156689474|NCT00842530|565607661|FG001|Overall Study|Lost to Follow-up|8|||
156689475|NCT00842530|565607660|FG000|Overall Study|Withdrawal by Subject|73|||
156689476|NCT00842530|565607661|FG001|Overall Study|Withdrawal by Subject|28|||
156689477|NCT02939950|565607662|FG000|Overall Study|Lost to Follow-up|13|||
156689478|NCT02939950|565607663|FG001|Overall Study|Lost to Follow-up|16|||
156689479|NCT02939950|565607662|FG000|Overall Study|Positive slit lamp findings|0|||
156689480|NCT02939950|565607663|FG001|Overall Study|Positive slit lamp findings|1|||
156689481|NCT02939950|565607662|FG000|Overall Study|Chalazion upper lid|0|||
156689482|NCT02939950|565607663|FG001|Overall Study|Chalazion upper lid|1|||
156689483|NCT02939950|565607662|FG000|Overall Study|Lack of motivation|0|||
156689484|NCT02939950|565607663|FG001|Overall Study|Lack of motivation|2|||
156689485|NCT02939950|565607662|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
156689486|NCT02939950|565607663|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
156689487|NCT02939950|565607662|FG000|Overall Study|Military orders|1|||
156689488|NCT02939950|565607663|FG001|Overall Study|Military orders|0|||
156689489|NCT02939950|565607662|FG000|Overall Study|Participant Relocated|5|||
156689490|NCT02939950|565607663|FG001|Overall Study|Participant Relocated|3|||
156689491|NCT02939950|565607662|FG000|Overall Study|Study related symptoms|8|||
156689492|NCT02939950|565607663|FG001|Overall Study|Study related symptoms|8|||
156689493|NCT02939950|565607662|FG000|Overall Study|Unacceptable lens movement|2|||
156689494|NCT02939950|565607663|FG001|Overall Study|Unacceptable lens movement|0|||
156689495|NCT02939950|565607662|FG000|Overall Study|Protocol Violation|6|||
156689496|NCT02939950|565607663|FG001|Overall Study|Protocol Violation|3|||
156689497|NCT02939950|565607662|FG000|Overall Study|Physician Decision|2|||
156689498|NCT02939950|565607663|FG001|Overall Study|Physician Decision|0|||
156689499|NCT02939950|565607662|FG000|Overall Study|Pregnancy|6|||
156689500|NCT02939950|565607663|FG001|Overall Study|Pregnancy|7|||
156689501|NCT02939950|565607662|FG000|Overall Study|Withdrawal by Subject|12|||
156689502|NCT02939950|565607663|FG001|Overall Study|Withdrawal by Subject|28|||
156689503|NCT02939950|565607662|FG000|Overall Study|Adverse Event|7|||
156689504|NCT02939950|565607663|FG001|Overall Study|Adverse Event|3|||
156689505|NCT02939950|565607662|FG000|Overall Study|Randomized, not dispensed|1|||
156689506|NCT02939950|565607663|FG001|Overall Study|Randomized, not dispensed|0|||
156689507|NCT02939950|565607662|FG000|Overall Study|Ineligible at Baseline|2|||
156689508|NCT02939950|565607663|FG001|Overall Study|Ineligible at Baseline|8|||
156689509|NCT00402025|565607665|FG000|Overall Study|Adverse Event|0|||
156689510|NCT00402025|565607666|FG001|Overall Study|Adverse Event|0|||
156689511|NCT00402025|565607667|FG002|Overall Study|Adverse Event|2|||
156689512|NCT00402025|565607665|FG000|Overall Study|Death|0|||
156689513|NCT00402025|565607666|FG001|Overall Study|Death|1|||
156689514|NCT00402025|565607667|FG002|Overall Study|Death|5|||
156689515|NCT00402025|565607665|FG000|Overall Study|Disease Progression|1|||
156689516|NCT00402025|565607666|FG001|Overall Study|Disease Progression|1|||
156689517|NCT00402025|565607667|FG002|Overall Study|Disease Progression|2|||
156689518|NCT00402025|565607665|FG000|Overall Study|Physician Decision|1|||
156689519|NCT00402025|565607666|FG001|Overall Study|Physician Decision|1|||
156689520|NCT00402025|565607667|FG002|Overall Study|Physician Decision|0|||
156689521|NCT00402025|565607665|FG000|Overall Study|Participant Decision|0|||
156787591|NCT02533674|565974757|FG006|Dose Level IV|Progressive disease|0|||
156787592|NCT02533674|565974758|FG007|Dose Level IV|Progressive disease|0|||
156787593|NCT02533674|565974751|FG000|Dose Level IV|Withdrawal by Subject|0|||
156787594|NCT02533674|565974752|FG001|Dose Level IV|Withdrawal by Subject|0|||
156787595|NCT02533674|565974753|FG002|Dose Level IV|Withdrawal by Subject|0|||
156787596|NCT02533674|565974754|FG003|Dose Level IV|Withdrawal by Subject|1|||
156787597|NCT02533674|565974755|FG004|Dose Level IV|Withdrawal by Subject|0|||
156787598|NCT02533674|565974756|FG005|Dose Level IV|Withdrawal by Subject|0|||
157013492|NCT04337372|566801794|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
156689522|NCT00402025|565607666|FG001|Overall Study|Participant Decision|0|||
156689523|NCT00402025|565607667|FG002|Overall Study|Participant Decision|1|||
156689524|NCT01314118|565608916|FG000|Overall Study|Adverse Event|10|||
156689525|NCT01314118|565608916|FG000|Overall Study|Progressive disease|3|||
156689526|NCT01314118|565608916|FG000|Overall Study|Death|8|||
156689527|NCT01314118|565608916|FG000|Overall Study|Physician Decision|13|||
156689528|NCT01314118|565608916|FG000|Overall Study|Sponsor Decision|1|||
156689529|NCT01314118|565608916|FG000|Overall Study|Protocol Violation|2|||
156689530|NCT01314118|565608916|FG000|Overall Study|Withdrawal by Subject|26|||
156689531|NCT01314118|565608916|FG000|Overall Study|Other|21|||
156689532|NCT00655850|565608917|FG000|Overall Study|Death|2|||
156787599|NCT02533674|565974757|FG006|Dose Level IV|Withdrawal by Subject|0|||
156689533|NCT00655850|565608917|FG000|Overall Study|Withdrawal by Subject|1|||
156689534|NCT02459665|565608918|FG000|Overall Study|Withdrawal by Subject|0|||
156689535|NCT02459665|565608919|FG001|Overall Study|Withdrawal by Subject|1|||
156689536|NCT02459665|565608920|FG002|Overall Study|Withdrawal by Subject|1|||
156689537|NCT02459665|565608921|FG003|Overall Study|Withdrawal by Subject|2|||
156689538|NCT00865098|565608923|FG000|Overall Study|Progressive disease|1|||
156689539|NCT01014624|565608924|FG000|Overall Study|Adverse Event|0|||
156689540|NCT01014624|565608925|FG001|Overall Study|Adverse Event|1|||
156689541|NCT01014624|565608924|FG000|Overall Study|Protocol Violation|1|||
156689542|NCT01014624|565608925|FG001|Overall Study|Protocol Violation|0|||
156689543|NCT01014624|565608924|FG000|Overall Study|Withdrawal by Subject|1|||
156689544|NCT01014624|565608925|FG001|Overall Study|Withdrawal by Subject|0|||
156689545|NCT01715896|565608926|FG000|Overall Study|Lost to Follow-up|0|||
156689546|NCT01715896|565608927|FG001|Overall Study|Lost to Follow-up|2|||
156689547|NCT01715896|565608926|FG000|Overall Study|Withdrawal by Subject|1|||
156689548|NCT01715896|565608927|FG001|Overall Study|Withdrawal by Subject|4|||
156689549|NCT01715896|565608926|FG000|Overall Study|Other|2|||
156689550|NCT01715896|565608927|FG001|Overall Study|Other|5|||
156689551|NCT01117337|565608929|FG000|Overall Study|Lost to Follow-up|4|||
156689552|NCT01117337|565608930|FG001|Overall Study|Lost to Follow-up|0|||
156689553|NCT01045993|565608931|FG000|Overall Study|Treated-later found eligibility not met|0|||
156689554|NCT01045993|565608932|FG001|Overall Study|Treated-later found eligibility not met|1|||
156689555|NCT01045993|565608933|FG002|Overall Study|Treated-later found eligibility not met|0|||
156689556|NCT01045993|565608934|FG003|Overall Study|Treated-later found eligibility not met|0|||
156689557|NCT00949988|565608940|FG000|Overall Study|Withdrawal by Subject|3|||
156689558|NCT01929395|565608941|FG000|Overall Study|Did not complete - non-related toxicity|1|||
156689559|NCT01929395|565608942|FG001|Overall Study|Did not complete - non-related toxicity|0|||
156689560|NCT01929395|565608943|FG002|Overall Study|Did not complete - non-related toxicity|0|||
156689561|NCT01929395|565608941|FG000|Overall Study|Withdrawal by Subject|0|||
156689562|NCT01929395|565608942|FG001|Overall Study|Withdrawal by Subject|1|||
156689563|NCT01929395|565608943|FG002|Overall Study|Withdrawal by Subject|0|||
156689564|NCT01929395|565608941|FG000|Overall Study|Screen Fail|0|||
156689565|NCT01929395|565608942|FG001|Overall Study|Screen Fail|0|||
156689566|NCT01929395|565608943|FG002|Overall Study|Screen Fail|1|||
156689567|NCT03604341|565608945|FG000|Overall Study|Withdrawal by Subject|1|||
156689568|NCT03604341|565608946|FG001|Overall Study|Withdrawal by Subject|1|||
156689569|NCT03604341|565608945|FG000|Overall Study|Adverse Event|1|||
156689570|NCT03604341|565608946|FG001|Overall Study|Adverse Event|0|||
156689571|NCT03604341|565608945|FG000|Overall Study|Protocol Violation|0|||
156689572|NCT03604341|565608946|FG001|Overall Study|Protocol Violation|1|||
156689573|NCT00484419|565608947|FG000|Overall Study|Adverse Event|3|||
156689574|NCT00484419|565608948|FG001|Overall Study|Adverse Event|0|||
156689575|NCT00484419|565608949|FG002|Overall Study|Adverse Event|0|||
156689576|NCT00484419|565608947|FG000|Overall Study|Lost to Follow-up|1|||
156689577|NCT00484419|565608948|FG001|Overall Study|Lost to Follow-up|0|||
156689578|NCT00484419|565608949|FG002|Overall Study|Lost to Follow-up|2|||
156689579|NCT00484419|565608947|FG000|Overall Study|Withdrawal by Subject|3|||
156689580|NCT00484419|565608948|FG001|Overall Study|Withdrawal by Subject|1|||
156689581|NCT00484419|565608949|FG002|Overall Study|Withdrawal by Subject|1|||
156689582|NCT00484419|565608947|FG000|Overall Study|subject met discontinuation criteria|2|||
156689583|NCT00484419|565608948|FG001|Overall Study|subject met discontinuation criteria|2|||
156689584|NCT00484419|565608949|FG002|Overall Study|subject met discontinuation criteria|4|||
156689585|NCT00484419|565608947|FG000|Overall Study|required restricted medication|1|||
156689586|NCT00484419|565608948|FG001|Overall Study|required restricted medication|0|||
156689587|NCT00484419|565608949|FG002|Overall Study|required restricted medication|1|||
156689588|NCT00484419|565608947|FG000|Overall Study|Physician Decision|1|||
156689589|NCT00484419|565608948|FG001|Overall Study|Physician Decision|1|||
156689590|NCT00484419|565608949|FG002|Overall Study|Physician Decision|1|||
156689591|NCT00484419|565608947|FG000|Overall Study|subject unable to receive medication|1|||
156689592|NCT00484419|565608948|FG001|Overall Study|subject unable to receive medication|0|||
156689593|NCT00484419|565608949|FG002|Overall Study|subject unable to receive medication|0|||
156689594|NCT00484419|565608947|FG000|Overall Study|subject relocated|0|||
156689595|NCT00484419|565608948|FG001|Overall Study|subject relocated|1|||
156689596|NCT00484419|565608949|FG002|Overall Study|subject relocated|0|||
156689597|NCT00484419|565608947|FG000|Overall Study|sponsor decision, randomized in error|0|||
156689598|NCT00484419|565608948|FG001|Overall Study|sponsor decision, randomized in error|0|||
156689599|NCT00484419|565608949|FG002|Overall Study|sponsor decision, randomized in error|2|||
156689600|NCT00355472|565608952|FG000|Overall Study|Physician Decision|1|||
156689601|NCT05445843|565608953|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
156689602|NCT05445843|565608954|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
156689603|NCT05445843|565608953|FG000|Overall Study|Progressive disease|17|||
156689604|NCT05445843|565608954|FG001|Overall Study|Progressive disease|9|||
156689605|NCT05445843|565608953|FG000|Overall Study|Physician Decision|16|||
156689606|NCT05445843|565608954|FG001|Overall Study|Physician Decision|4|||
156870027|NCT02379091|566281074|FG002|Overall Study|Study Termination|5|||
156689607|NCT05445843|565608953|FG000|Overall Study|Death|6|||
156689608|NCT05445843|565608954|FG001|Overall Study|Death|3|||
156689609|NCT05445843|565608953|FG000|Overall Study|Subject decision|6|||
156689610|NCT05445843|565608954|FG001|Overall Study|Subject decision|2|||
156689611|NCT05445843|565608953|FG000|Overall Study|Adverse Event|2|||
156689612|NCT05445843|565608954|FG001|Overall Study|Adverse Event|0|||
156689613|NCT05307679|565608959|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
156689614|NCT05307679|565608960|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
157121557|NCT05103332|567195993|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
156689615|NCT02674386|565608963|FG000|Overall Study|Lost to Follow-up|0|||
156689616|NCT02674386|565608964|FG001|Overall Study|Lost to Follow-up|1|||
156689617|NCT02674386|565608965|FG002|Overall Study|Lost to Follow-up|1|||
156689618|NCT02674386|565608963|FG000|Overall Study|Withdrawal by Subject|0|||
156689619|NCT02674386|565608964|FG001|Overall Study|Withdrawal by Subject|4|||
156689620|NCT02674386|565608965|FG002|Overall Study|Withdrawal by Subject|0|||
156689621|NCT02674386|565608963|FG000|Overall Study|Other|0|||
156689622|NCT02674386|565608964|FG001|Overall Study|Other|1|||
156689623|NCT02674386|565608965|FG002|Overall Study|Other|0|||
156689624|NCT02674386|565608963|FG000|Overall Study|Enrolled but not evaluated|0|||
156689625|NCT02674386|565608964|FG001|Overall Study|Enrolled but not evaluated|4|||
156689626|NCT02674386|565608965|FG002|Overall Study|Enrolled but not evaluated|0|||
156689627|NCT00396331|565608970|FG000|Overall Study|Failed to mobilize - no transplant|8|||
156689628|NCT00396331|565608970|FG000|Overall Study|Did not go on to transplant|5|||
156689629|NCT00396331|565608970|FG000|Overall Study|Lost to Follow-up|3|||
156689630|NCT00396331|565608970|FG000|Overall Study|Death|16|||
156689631|NCT00873119|565608981|FG000|Overall Study|Patient request|4|||
156689632|NCT00873119|565608982|FG001|Overall Study|Patient request|2|||
156689633|NCT00873119|565608981|FG000|Overall Study|Adverse Event|8|||
156689634|NCT00873119|565608982|FG001|Overall Study|Adverse Event|0|||
156689635|NCT00873119|565608981|FG000|Overall Study|Progressive disease|26|||
156689636|NCT00873119|565608982|FG001|Overall Study|Progressive disease|18|||
156689637|NCT00873119|565608981|FG000|Overall Study|Death|2|||
156689638|NCT00873119|565608982|FG001|Overall Study|Death|1|||
156689639|NCT00873119|565608981|FG000|Overall Study|Other|2|||
156689640|NCT00873119|565608982|FG001|Overall Study|Other|5|||
156689641|NCT00873119|565608981|FG000|Overall Study|Not treated|2|||
156689642|NCT00873119|565608982|FG001|Overall Study|Not treated|0|||
156689643|NCT03648879|565608983|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
156689644|NCT00285584|565608984|FG000|Month 3|Lost to Follow-up|3|||
156689645|NCT00285584|565608985|FG001|Month 3|Lost to Follow-up|3|||
156689646|NCT00285584|565608984|FG000|Month 3|Withdrawal by Subject|1|||
156689647|NCT00285584|565608985|FG001|Month 3|Withdrawal by Subject|0|||
156689648|NCT00285584|565608984|FG000|Month 6|Lost to Follow-up|0|||
156689649|NCT00285584|565608985|FG001|Month 6|Lost to Follow-up|1|||
156689650|NCT01884688|565608988|FG000|Overall Study|Screen Failure|2|||
156689651|NCT04099641|565608992|FG000|Overall Study|Death|46|||
156689652|NCT04099641|565608993|FG001|Overall Study|Death|12|||
157121558|NCT05103332|567195994|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
157121559|NCT05103332|567195995|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
157121560|NCT05103332|567195978|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121561|NCT05103332|567195979|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121562|NCT05103332|567195980|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121563|NCT05103332|567195981|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121564|NCT05103332|567195982|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121565|NCT05103332|567195983|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121566|NCT05103332|567195984|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121567|NCT05103332|567195985|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121568|NCT05103332|567195986|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121569|NCT05103332|567195987|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121570|NCT05103332|567195988|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121571|NCT05103332|567195989|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121572|NCT05103332|567195990|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121573|NCT05103332|567195991|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121574|NCT05103332|567195992|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121575|NCT05103332|567195993|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121576|NCT05103332|567195994|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
157121577|NCT05103332|567195995|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
157121578|NCT05103332|567195978|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156689653|NCT04099641|565608992|FG000|Overall Study|Lost to Follow-up|1|||
156689654|NCT04099641|565608993|FG001|Overall Study|Lost to Follow-up|0|||
156689655|NCT04099641|565608992|FG000|Overall Study|Withdrawal by Subject|2|||
156689656|NCT04099641|565608993|FG001|Overall Study|Withdrawal by Subject|0|||
156689657|NCT00895037|565608994|FG000|Overall Study|Death|0|||
156689658|NCT00895037|565608995|FG001|Overall Study|Death|2|||
156689659|NCT00895037|565608996|FG002|Overall Study|Death|1|||
156689660|NCT02470091|565609005|FG000|Overall Study|Withdrawal by Subject|1|||
156787600|NCT02533674|565974758|FG007|Dose Level IV|Withdrawal by Subject|0|||
156787601|NCT02533674|565974751|FG000|Dose Level IV|Physician Decision|0|||
156787602|NCT02533674|565974752|FG001|Dose Level IV|Physician Decision|0|||
156787603|NCT02533674|565974753|FG002|Dose Level IV|Physician Decision|0|||
156787604|NCT02533674|565974754|FG003|Dose Level IV|Physician Decision|1|||
156787605|NCT02533674|565974755|FG004|Dose Level IV|Physician Decision|0|||
156787606|NCT02533674|565974756|FG005|Dose Level IV|Physician Decision|0|||
156787607|NCT02533674|565974757|FG006|Dose Level IV|Physician Decision|0|||
156787608|NCT02533674|565974758|FG007|Dose Level IV|Physician Decision|0|||
156787609|NCT02533674|565974751|FG000|Dose Level V|Progressive disease|0|||
156787610|NCT02533674|565974752|FG001|Dose Level V|Progressive disease|0|||
156787611|NCT02533674|565974753|FG002|Dose Level V|Progressive disease|0|||
156787612|NCT02533674|565974754|FG003|Dose Level V|Progressive disease|0|||
156787613|NCT02533674|565974755|FG004|Dose Level V|Progressive disease|3|||
156787614|NCT02533674|565974756|FG005|Dose Level V|Progressive disease|0|||
156787615|NCT02533674|565974757|FG006|Dose Level V|Progressive disease|0|||
156787616|NCT02533674|565974758|FG007|Dose Level V|Progressive disease|0|||
156787617|NCT02533674|565974751|FG000|Dose Level V|Withdrawal by Subject|0|||
156787618|NCT02533674|565974752|FG001|Dose Level V|Withdrawal by Subject|0|||
156787619|NCT02533674|565974753|FG002|Dose Level V|Withdrawal by Subject|0|||
156787620|NCT02533674|565974754|FG003|Dose Level V|Withdrawal by Subject|0|||
156787621|NCT02533674|565974755|FG004|Dose Level V|Withdrawal by Subject|1|||
156787622|NCT02533674|565974756|FG005|Dose Level V|Withdrawal by Subject|0|||
156787623|NCT02533674|565974757|FG006|Dose Level V|Withdrawal by Subject|0|||
157214453|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
156689661|NCT02470091|565609006|FG001|Overall Study|Withdrawal by Subject|0|||
156689662|NCT02470091|565609005|FG000|Overall Study|Ineligible|0|||
156689663|NCT02470091|565609006|FG001|Overall Study|Ineligible|2|||
156689664|NCT00303667|565609017|FG000|Overall Study|Death|0|||
156689665|NCT00303667|565609018|FG001|Overall Study|Death|4|||
156689666|NCT01029392|565609020|FG000|Overall Study|Withdrawal by Subject|18|||
156689667|NCT01029392|565609021|FG001|Overall Study|Withdrawal by Subject|11|||
156689668|NCT01029392|565609020|FG000|Overall Study|Physician Decision|2|||
156689669|NCT01029392|565609021|FG001|Overall Study|Physician Decision|0|||
156689670|NCT01103479|565609022|FG000|Overall Study|Up to date with CRC screening|1|||
156689671|NCT01103479|565609023|FG001|Overall Study|Up to date with CRC screening|9|||
156689672|NCT01103479|565609024|FG002|Overall Study|Up to date with CRC screening|12|||
156689673|NCT01103479|565609022|FG000|Overall Study|Family history of CRC|1|||
156689674|NCT01103479|565609023|FG001|Overall Study|Family history of CRC|0|||
156689675|NCT01103479|565609024|FG002|Overall Study|Family history of CRC|2|||
156689676|NCT01103479|565609022|FG000|Overall Study|Active cancer|1|||
156689677|NCT01103479|565609023|FG001|Overall Study|Active cancer|0|||
156689678|NCT01103479|565609024|FG002|Overall Study|Active cancer|0|||
156689679|NCT01103479|565609022|FG000|Overall Study|Saw non-study physician|2|||
156689680|NCT01103479|565609023|FG001|Overall Study|Saw non-study physician|0|||
156689681|NCT01103479|565609024|FG002|Overall Study|Saw non-study physician|0|||
156689682|NCT00834899|565609025|FG000|Overall Study|Withdrawal by Subject|1|||
156689683|NCT00834899|565609026|FG001|Overall Study|Withdrawal by Subject|1|||
156689684|NCT01534637|565609027|FG000|Overall Study|Physician Decision|3|||
156689685|NCT01534637|565609027|FG000|Overall Study|Lack of Efficacy|3|||
156689686|NCT01534637|565609027|FG000|Overall Study|Withdrawal by Subject|1|||
156689687|NCT01534637|565609027|FG000|Overall Study|Adverse Event|1|||
156689688|NCT01534637|565609027|FG000|Overall Study|Liver Mets before treatment|1|||
156689689|NCT01523587|565609028|FG000|Overall Study|Other than listed|5|||
156689690|NCT01523587|565609029|FG001|Overall Study|Other than listed|5|||
156689691|NCT01523587|565609028|FG000|Overall Study|Worsening of underlying cancer disease|19|||
156787624|NCT02533674|565974758|FG007|Dose Level V|Withdrawal by Subject|0|||
156787625|NCT02533674|565974751|FG000|Dose Level V|Physician Decision|0|||
156787626|NCT02533674|565974752|FG001|Dose Level V|Physician Decision|0|||
156787627|NCT02533674|565974753|FG002|Dose Level V|Physician Decision|0|||
156787628|NCT02533674|565974754|FG003|Dose Level V|Physician Decision|0|||
156787629|NCT02533674|565974755|FG004|Dose Level V|Physician Decision|1|||
156787630|NCT02533674|565974756|FG005|Dose Level V|Physician Decision|0|||
156787631|NCT02533674|565974757|FG006|Dose Level V|Physician Decision|0|||
156787632|NCT02533674|565974758|FG007|Dose Level V|Physician Decision|0|||
156870028|NCT02379091|566281075|FG003|Overall Study|Study Termination|8|||
156689692|NCT01523587|565609029|FG001|Overall Study|Worsening of underlying cancer disease|34|||
156689693|NCT01523587|565609028|FG000|Overall Study|Adverse Event|68|||
156689694|NCT01523587|565609029|FG001|Overall Study|Adverse Event|52|||
156689695|NCT01523587|565609028|FG000|Overall Study|Protocol Violation|5|||
156689696|NCT01523587|565609029|FG001|Overall Study|Protocol Violation|3|||
156689697|NCT01523587|565609028|FG000|Overall Study|Lost to Follow-up|2|||
156787633|NCT02533674|565974751|FG000|Dose Level VI|Progressive disease|0|||
156787634|NCT02533674|565974752|FG001|Dose Level VI|Progressive disease|0|||
156787635|NCT02533674|565974753|FG002|Dose Level VI|Progressive disease|0|||
156787636|NCT02533674|565974754|FG003|Dose Level VI|Progressive disease|0|||
156787637|NCT02533674|565974755|FG004|Dose Level VI|Progressive disease|0|||
156787638|NCT02533674|565974756|FG005|Dose Level VI|Progressive disease|7|||
156689698|NCT01523587|565609029|FG001|Overall Study|Lost to Follow-up|2|||
156689699|NCT01523587|565609028|FG000|Overall Study|Withdrawal by Subject|28|||
156689700|NCT01523587|565609029|FG001|Overall Study|Withdrawal by Subject|20|||
156689701|NCT01523587|565609028|FG000|Overall Study|Withdrew due to Progressive disease|265|||
156689702|NCT01523587|565609029|FG001|Overall Study|Withdrew due to Progressive disease|279|||
156689703|NCT01523587|565609028|FG000|Overall Study|Randomised but bot treated|6|||
156689704|NCT01523587|565609029|FG001|Overall Study|Randomised but bot treated|2|||
156689705|NCT01298778|565609030|FG000|Overall Study|Lost to Follow-up|2|||
156689706|NCT01298778|565609031|FG001|Overall Study|Lost to Follow-up|3|||
156689707|NCT01298778|565609030|FG000|Overall Study|Incorrect use of VAS|1|||
156689708|NCT01298778|565609031|FG001|Overall Study|Incorrect use of VAS|0|||
156689709|NCT01298778|565609030|FG000|Overall Study|Withdrawal by Subject|0|||
156689710|NCT01298778|565609031|FG001|Overall Study|Withdrawal by Subject|1|||
156689711|NCT01298778|565609030|FG000|Overall Study|Protocol Violation|0|||
156689712|NCT01298778|565609031|FG001|Overall Study|Protocol Violation|1|||
156689713|NCT01298778|565609030|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
156689714|NCT01298778|565609031|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
156689715|NCT00536484|565609035|FG000|Overall Study|Adverse Event|21|||
156689716|NCT00536484|565609036|FG001|Overall Study|Adverse Event|34|||
156689717|NCT00536484|565609035|FG000|Overall Study|Withdrawal by Subject|11|||
156689718|NCT00536484|565609036|FG001|Overall Study|Withdrawal by Subject|11|||
156689719|NCT00536484|565609035|FG000|Overall Study|Lost to Follow-up|8|||
156689720|NCT00536484|565609036|FG001|Overall Study|Lost to Follow-up|6|||
156689721|NCT00536484|565609035|FG000|Overall Study|Lack of Efficacy|16|||
156689722|NCT00536484|565609036|FG001|Overall Study|Lack of Efficacy|5|||
156689723|NCT00536484|565609035|FG000|Overall Study|Other|4|||
157214454|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
157214455|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
157214456|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
157214457|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
157214458|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
157214459|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
157214460|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
157214461|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
157214462|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
157214463|NCT01872689|567531899|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
157214464|NCT01872689|567531900|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
157214465|NCT01872689|567531901|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
157214466|NCT01872689|567531902|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
157214467|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
157214468|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
157214469|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
157214470|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
157214471|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
157214472|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
156689724|NCT00536484|565609036|FG001|Overall Study|Other|0|||
156689725|NCT02549573|565609039|FG000|Overall Study|Withdrawal by Subject|0|||
156689726|NCT02549573|565609040|FG001|Overall Study|Withdrawal by Subject|2|||
156689727|NCT02549573|565609039|FG000|Overall Study|Protocol Violation|0|||
156689728|NCT02549573|565609040|FG001|Overall Study|Protocol Violation|1|||
156689729|NCT03064438|565610665|FG000|Overall Study|Lost to Follow-up|1|||
156689730|NCT03064438|565610666|FG001|Overall Study|Lost to Follow-up|0|||
156689731|NCT03064438|565610665|FG000|Overall Study|Withdrawal by Subject|0|||
156689732|NCT03064438|565610666|FG001|Overall Study|Withdrawal by Subject|1|||
156787639|NCT02533674|565974757|FG006|Dose Level VI|Progressive disease|0|||
156787640|NCT02533674|565974758|FG007|Dose Level VI|Progressive disease|0|||
156787641|NCT02533674|565974751|FG000|Dose Level VI|Withdrawal by Subject|0|||
156787642|NCT02533674|565974752|FG001|Dose Level VI|Withdrawal by Subject|0|||
156787643|NCT02533674|565974753|FG002|Dose Level VI|Withdrawal by Subject|0|||
156787644|NCT02533674|565974754|FG003|Dose Level VI|Withdrawal by Subject|0|||
156787645|NCT02533674|565974755|FG004|Dose Level VI|Withdrawal by Subject|0|||
156787646|NCT02533674|565974756|FG005|Dose Level VI|Withdrawal by Subject|1|||
156689733|NCT04266301|565610667|FG000|Overall Study|Progressive Disease|111|||
156689734|NCT04266301|565610668|FG001|Overall Study|Progressive Disease|92|||
156787647|NCT02533674|565974757|FG006|Dose Level VI|Withdrawal by Subject|0|||
157214473|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
157214474|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
156689735|NCT04266301|565610667|FG000|Overall Study|Adverse Event|41|||
156689736|NCT04266301|565610668|FG001|Overall Study|Adverse Event|43|||
156787648|NCT02533674|565974758|FG007|Dose Level VI|Withdrawal by Subject|0|||
156787649|NCT02533674|565974751|FG000|Dose Level VI|Treatment-related AE|0|||
156787650|NCT02533674|565974752|FG001|Dose Level VI|Treatment-related AE|0|||
156689737|NCT04266301|565610667|FG000|Overall Study|Death|26|||
157214475|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
156689738|NCT04266301|565610668|FG001|Overall Study|Death|35|||
156689739|NCT04266301|565610667|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
156689740|NCT04266301|565610668|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
156689741|NCT04266301|565610667|FG000|Overall Study|Study Terminated by Sponsor|22|||
156689742|NCT04266301|565610668|FG001|Overall Study|Study Terminated by Sponsor|27|||
156689743|NCT04266301|565610667|FG000|Overall Study|Participant Decision|22|||
156689744|NCT04266301|565610668|FG001|Overall Study|Participant Decision|28|||
156689745|NCT04266301|565610667|FG000|Overall Study|Physician Decision|14|||
156689746|NCT04266301|565610668|FG001|Overall Study|Physician Decision|9|||
156689747|NCT04266301|565610667|FG000|Overall Study|New Therapy for Study Indication|2|||
156689748|NCT04266301|565610668|FG001|Overall Study|New Therapy for Study Indication|4|||
156689749|NCT04266301|565610667|FG000|Overall Study|Protocol Deviation|2|||
156689750|NCT04266301|565610668|FG001|Overall Study|Protocol Deviation|4|||
156689751|NCT04266301|565610667|FG000|Overall Study|Guardian Decision|1|||
156689752|NCT04266301|565610668|FG001|Overall Study|Guardian Decision|0|||
156689753|NCT04266301|565610667|FG000|Overall Study|Lost to Follow-up|1|||
156689754|NCT04266301|565610668|FG001|Overall Study|Lost to Follow-up|0|||
156689755|NCT04266301|565610667|FG000|Overall Study|Participants Not Treated|1|||
156689756|NCT04266301|565610668|FG001|Overall Study|Participants Not Treated|1|||
156689757|NCT04079712|565610669|FG000|Overall Study|Disease progression before starting treatment|1|||
156689758|NCT01432574|565610671|FG000|Overall Study|Moved|2|||
156689759|NCT01432574|565610671|FG000|Overall Study|Not interested|1|||
156689760|NCT04373551|565610672|FG000|Overall Study|Lost to Follow-up|15|||
156689761|NCT04373551|565610672|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
156689762|NCT01042535|565610673|FG000|Overall Study|disease progression prior to treatment|3|||
156689763|NCT01042535|565610673|FG000|Overall Study|disease progression during treatment|3|||
156689764|NCT01042535|565610673|FG000|Overall Study|complications from other disease|2|||
156689765|NCT03438539|565610674|FG000|Overall Study|Lost to Follow-up|8|||
156689766|NCT03438539|565610675|FG001|Overall Study|Lost to Follow-up|4|||
156689767|NCT03438539|565610676|FG002|Overall Study|Lost to Follow-up|10|||
156689768|NCT03438539|565610677|FG003|Overall Study|Lost to Follow-up|9|||
156689769|NCT03438539|565610678|FG004|Overall Study|Lost to Follow-up|3|||
156689770|NCT03438539|565610679|FG005|Overall Study|Lost to Follow-up|8|||
156689771|NCT00440466|565610681|FG000|Overall Study|Death|3|||
156689772|NCT00440466|565610682|FG001|Overall Study|Death|2|||
156689773|NCT00440466|565610683|FG002|Overall Study|Death|9|||
156689774|NCT00440466|565610681|FG000|Overall Study|Adverse Event|3|||
156689775|NCT00440466|565610682|FG001|Overall Study|Adverse Event|4|||
156689776|NCT00440466|565610683|FG002|Overall Study|Adverse Event|11|||
156689777|NCT00440466|565610681|FG000|Overall Study|Lost to Follow-up|1|||
156689778|NCT00440466|565610682|FG001|Overall Study|Lost to Follow-up|0|||
156689779|NCT00440466|565610683|FG002|Overall Study|Lost to Follow-up|2|||
156689780|NCT00440466|565610681|FG000|Overall Study|Physician Decision|2|||
156689781|NCT00440466|565610682|FG001|Overall Study|Physician Decision|0|||
156689782|NCT00440466|565610683|FG002|Overall Study|Physician Decision|1|||
156689783|NCT00440466|565610681|FG000|Overall Study|Protocol Violation|2|||
156689784|NCT00440466|565610682|FG001|Overall Study|Protocol Violation|0|||
156689785|NCT00440466|565610683|FG002|Overall Study|Protocol Violation|4|||
156689786|NCT00440466|565610681|FG000|Overall Study|Withdrawal by Subject|2|||
156689787|NCT00440466|565610682|FG001|Overall Study|Withdrawal by Subject|5|||
156689788|NCT00440466|565610683|FG002|Overall Study|Withdrawal by Subject|9|||
156689789|NCT00440466|565610681|FG000|Overall Study|Began Dialysis|0|||
156689790|NCT00440466|565610682|FG001|Overall Study|Began Dialysis|0|||
156689791|NCT00440466|565610683|FG002|Overall Study|Began Dialysis|1|||
156689792|NCT00440466|565610681|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
156689793|NCT00440466|565610682|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
156689794|NCT00440466|565610683|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
156689795|NCT00140413|565610692|FG000|Overall Study|Lost to Follow-up|1|||
156689796|NCT00140413|565610693|FG001|Overall Study|Lost to Follow-up|0|||
156689797|NCT00140413|565610692|FG000|Overall Study|Withdrawal by Subject|2|||
156689798|NCT00140413|565610693|FG001|Overall Study|Withdrawal by Subject|0|||
156689799|NCT00918463|565610696|FG000|Overall Study|Death|1|||
156689800|NCT00918463|565610696|FG000|Overall Study|Lack of Efficacy|1|||
156689801|NCT01659736|565610697|FG000|Treatment Period|Adverse Event|1|||
156689802|NCT01659736|565610698|FG001|Treatment Period|Adverse Event|1|||
156689803|NCT01659736|565610697|FG000|Treatment Period|Protocol Violation|3|||
156689804|NCT01659736|565610698|FG001|Treatment Period|Protocol Violation|1|||
156689805|NCT01659736|565610697|FG000|Treatment Period|Withdrawal by Subject|1|||
156689806|NCT01659736|565610698|FG001|Treatment Period|Withdrawal by Subject|0|||
156689807|NCT01659736|565610697|FG000|3-month Follow-up|Lost to Follow-up|0|||
156787651|NCT02533674|565974753|FG002|Dose Level VI|Treatment-related AE|0|||
156787652|NCT02533674|565974754|FG003|Dose Level VI|Treatment-related AE|0|||
156689808|NCT01659736|565610698|FG001|3-month Follow-up|Lost to Follow-up|1|||
156689809|NCT05444556|565610699|FG000|Overall Study|Withdrawal by Subject|0|||
156689810|NCT05444556|565610700|FG001|Overall Study|Withdrawal by Subject|0|||
156689811|NCT05444556|565610701|FG002|Overall Study|Withdrawal by Subject|2|||
156689812|NCT05444556|565610702|FG003|Overall Study|Withdrawal by Subject|1|||
156689813|NCT02791893|565610704|FG000|Blinded Phase|Lost to Follow-up|2|||
156689814|NCT02791893|565610705|FG001|Blinded Phase|Lost to Follow-up|2|||
156689815|NCT02791893|565610704|FG000|Blinded Phase|Withdrawal by Subject|1|||
156689816|NCT02791893|565610705|FG001|Blinded Phase|Withdrawal by Subject|2|||
156689817|NCT02791893|565610704|FG000|Open Label Phase|Lost to Follow-up|3|||
156689818|NCT02791893|565610705|FG001|Open Label Phase|Lost to Follow-up|0|||
156689819|NCT02791893|565610704|FG000|Open Label Phase|Withdrawal by Subject|0|||
156689820|NCT02791893|565610705|FG001|Open Label Phase|Withdrawal by Subject|2|||
156689821|NCT04319159|565610709|FG000|Overall Study|Screening failure|13|||
156689822|NCT04319159|565610709|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
156689823|NCT04319159|565610709|FG000|Overall Study|Withdrawal by Subject|1|||
156689824|NCT04976621|565610717|FG000|Overall Study|Lost to Follow-up|2|||
156689825|NCT04976621|565610718|FG001|Overall Study|Lost to Follow-up|2|||
156689826|NCT04976621|565610717|FG000|Overall Study|Withdrawal by Subject|1|||
156689827|NCT04976621|565610718|FG001|Overall Study|Withdrawal by Subject|1|||
156689828|NCT00754442|565610719|FG000|Overall Study|Withdrawal by Subject|5|||
156689829|NCT00754442|565610720|FG001|Overall Study|Withdrawal by Subject|3|||
156689830|NCT01557842|565610721|FG000|Overall Study|Lost to Follow-up|0|||
156689831|NCT01557842|565610722|FG001|Overall Study|Lost to Follow-up|1|||
156689832|NCT01557842|565610721|FG000|Overall Study|Death|1|||
156689833|NCT01557842|565610722|FG001|Overall Study|Death|0|||
156689834|NCT01557842|565610721|FG000|Overall Study|Lack of Efficacy|0|||
156689835|NCT01557842|565610722|FG001|Overall Study|Lack of Efficacy|1|||
156689836|NCT01557842|565610721|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
156689837|NCT01557842|565610722|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
156689838|NCT01557842|565610721|FG000|Overall Study|Study Terminated by Sponsor|3|||
156689839|NCT01557842|565610722|FG001|Overall Study|Study Terminated by Sponsor|4|||
156689840|NCT01557842|565610721|FG000|Overall Study|Not Ablated|2|||
156689841|NCT01557842|565610722|FG001|Overall Study|Not Ablated|0|||
156689842|NCT05560763|565610723|FG000|Overall Study|Withdrawal by Subject|4|||
156689843|NCT01829113|565610724|FG000|Overall Study|Disease Progression|37|||
156689844|NCT01829113|565610725|FG001|Overall Study|Disease Progression|48|||
156689845|NCT01829113|565610724|FG000|Overall Study|Adverse Event|14|||
156689846|NCT01829113|565610725|FG001|Overall Study|Adverse Event|10|||
156689847|NCT01829113|565610724|FG000|Overall Study|Withdrawal by Subject|17|||
156689848|NCT01829113|565610725|FG001|Overall Study|Withdrawal by Subject|10|||
156689849|NCT01829113|565610724|FG000|Overall Study|Death|4|||
156689850|NCT01829113|565610725|FG001|Overall Study|Death|6|||
156689851|NCT01829113|565610724|FG000|Overall Study|Sponsor Decision|1|||
156689852|NCT01829113|565610725|FG001|Overall Study|Sponsor Decision|1|||
156689853|NCT01829113|565610724|FG000|Overall Study|No Study Treatment Received|3|||
156689854|NCT01829113|565610725|FG001|Overall Study|No Study Treatment Received|2|||
156689855|NCT01829113|565610724|FG000|Overall Study|Physician Decision|1|||
156689856|NCT01829113|565610725|FG001|Overall Study|Physician Decision|1|||
156689857|NCT06279871|565610726|FG000|Overall Study|Death|0|||
156689858|NCT06279871|565610727|FG001|Overall Study|Death|0|||
156870029|NCT02379091|566281072|FG000|Overall Study|Lack of Efficacy|3|||
156870030|NCT02379091|566281073|FG001|Overall Study|Lack of Efficacy|0|||
156870031|NCT02379091|566281074|FG002|Overall Study|Lack of Efficacy|0|||
156870032|NCT02379091|566281075|FG003|Overall Study|Lack of Efficacy|0|||
156689859|NCT06279871|565610728|FG002|Overall Study|Death|0|||
156689860|NCT06279871|565610729|FG003|Overall Study|Death|0|||
156689861|NCT06279871|565610730|FG004|Overall Study|Death|0|||
156689862|NCT06279871|565610731|FG005|Overall Study|Death|1|||
156689863|NCT06279871|565610732|FG006|Overall Study|Death|0|||
156689864|NCT06279871|565610726|FG000|Overall Study|Other than Specified|1|||
156689865|NCT06279871|565610727|FG001|Overall Study|Other than Specified|0|||
156689866|NCT06279871|565610728|FG002|Overall Study|Other than Specified|4|||
156689867|NCT06279871|565610729|FG003|Overall Study|Other than Specified|0|||
156689868|NCT06279871|565610730|FG004|Overall Study|Other than Specified|0|||
156689869|NCT06279871|565610731|FG005|Overall Study|Other than Specified|0|||
156689870|NCT06279871|565610732|FG006|Overall Study|Other than Specified|0|||
156870033|NCT03326713|566281077|FG000|Overall Study|Death|2|||
156870034|NCT03326713|566281078|FG001|Overall Study|Death|1|||
156870035|NCT03326713|566281079|FG002|Overall Study|Death|0|||
156689871|NCT06279871|565610726|FG000|Overall Study|Withdrawal by Subject|4|||
156870036|NCT03326713|566281077|FG000|Overall Study|Lost to Follow-up|20|||
156689872|NCT06279871|565610727|FG001|Overall Study|Withdrawal by Subject|8|||
156870037|NCT03326713|566281078|FG001|Overall Study|Lost to Follow-up|21|||
156870038|NCT03326713|566281079|FG002|Overall Study|Lost to Follow-up|33|||
156870039|NCT03326713|566281077|FG000|Overall Study|Withdrawal by Subject|1|||
156870040|NCT03326713|566281078|FG001|Overall Study|Withdrawal by Subject|2|||
156689873|NCT06279871|565610728|FG002|Overall Study|Withdrawal by Subject|4|||
156689874|NCT06279871|565610729|FG003|Overall Study|Withdrawal by Subject|2|||
156689875|NCT06279871|565610730|FG004|Overall Study|Withdrawal by Subject|0|||
156689876|NCT06279871|565610731|FG005|Overall Study|Withdrawal by Subject|0|||
156689877|NCT06279871|565610732|FG006|Overall Study|Withdrawal by Subject|0|||
156689878|NCT06279871|565610726|FG000|Overall Study|Lost to Follow-up|11|||
156689879|NCT06279871|565610727|FG001|Overall Study|Lost to Follow-up|10|||
156689880|NCT06279871|565610728|FG002|Overall Study|Lost to Follow-up|8|||
156689881|NCT06279871|565610729|FG003|Overall Study|Lost to Follow-up|0|||
156689882|NCT06279871|565610730|FG004|Overall Study|Lost to Follow-up|0|||
156689883|NCT06279871|565610731|FG005|Overall Study|Lost to Follow-up|0|||
156689884|NCT06279871|565610732|FG006|Overall Study|Lost to Follow-up|0|||
156689885|NCT06279871|565610726|FG000|Overall Study|Adverse Event|0|||
156689886|NCT06279871|565610727|FG001|Overall Study|Adverse Event|1|||
156689887|NCT06279871|565610728|FG002|Overall Study|Adverse Event|0|||
156689888|NCT06279871|565610729|FG003|Overall Study|Adverse Event|0|||
156689889|NCT06279871|565610730|FG004|Overall Study|Adverse Event|0|||
156689890|NCT06279871|565610731|FG005|Overall Study|Adverse Event|0|||
157013493|NCT04337372|566801791|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
157013494|NCT04337372|566801792|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
156689891|NCT06279871|565610732|FG006|Overall Study|Adverse Event|0|||
156689892|NCT04706507|565610733|FG000|Overall Study|Death|45|||
156689893|NCT04706507|565610734|FG001|Overall Study|Death|22|||
156689894|NCT04706507|565610733|FG000|Overall Study|Unable to adhere|0|||
156689895|NCT04706507|565610734|FG001|Overall Study|Unable to adhere|2|||
156689896|NCT04706507|565610733|FG000|Overall Study|Lost to Follow-up|13|||
156689897|NCT04706507|565610734|FG001|Overall Study|Lost to Follow-up|12|||
156689898|NCT04706507|565610733|FG000|Overall Study|Withdrawal of consent|1|||
156689899|NCT04706507|565610734|FG001|Overall Study|Withdrawal of consent|1|||
156689900|NCT04706507|565610733|FG000|Overall Study|Patient or LAR refuses further participation|0|||
156689901|NCT04706507|565610734|FG001|Overall Study|Patient or LAR refuses further participation|3|||
156689902|NCT02709486|565610735|FG000|Overall Study|Adverse Event|2|||
156689903|NCT02709486|565610736|FG001|Overall Study|Adverse Event|5|||
156689904|NCT02709486|565610737|FG002|Overall Study|Adverse Event|3|||
156689905|NCT02709486|565610735|FG000|Overall Study|Death|0|||
156689906|NCT02709486|565610736|FG001|Overall Study|Death|0|||
156689907|NCT02709486|565610737|FG002|Overall Study|Death|2|||
156689908|NCT02709486|565610735|FG000|Overall Study|Insufficient clinical response|7|||
156689909|NCT02709486|565610736|FG001|Overall Study|Insufficient clinical response|3|||
156689910|NCT02709486|565610737|FG002|Overall Study|Insufficient clinical response|3|||
156689911|NCT02709486|565610735|FG000|Overall Study|Lost to Follow-up|3|||
156689912|NCT02709486|565610736|FG001|Overall Study|Lost to Follow-up|2|||
156689913|NCT02709486|565610737|FG002|Overall Study|Lost to Follow-up|2|||
156689914|NCT02709486|565610735|FG000|Overall Study|Other|0|||
156689915|NCT02709486|565610736|FG001|Overall Study|Other|2|||
156689916|NCT02709486|565610737|FG002|Overall Study|Other|3|||
156689917|NCT02709486|565610735|FG000|Overall Study|Withdrawal by Subject|32|||
156689918|NCT02709486|565610736|FG001|Overall Study|Withdrawal by Subject|22|||
156689919|NCT02709486|565610737|FG002|Overall Study|Withdrawal by Subject|32|||
156689920|NCT00706355|565610742|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
156689921|NCT00706355|565610743|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689922|NCT00706355|565610744|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689923|NCT00706355|565610745|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
156689924|NCT00706355|565610742|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
156689925|NCT00706355|565610743|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689926|NCT00706355|565610744|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689927|NCT00706355|565610745|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
156689928|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689929|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
156689930|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689931|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
156689932|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689933|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
156689934|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689935|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
156689936|NCT00706355|565610742|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689937|NCT00706355|565610743|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
156689938|NCT00706355|565610744|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689939|NCT00706355|565610745|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
156689940|NCT00706355|565610742|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689941|NCT00706355|565610743|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689942|NCT00706355|565610744|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
156689943|NCT00706355|565610745|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
156689944|NCT00706355|565610742|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156689945|NCT00706355|565610743|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156689946|NCT00706355|565610744|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
156689947|NCT00706355|565610745|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
156689948|NCT00706355|565610742|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689949|NCT00706355|565610743|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689950|NCT00706355|565610744|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
156689951|NCT00706355|565610745|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
156689952|NCT00706355|565610742|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689953|NCT00706355|565610743|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689954|NCT00706355|565610744|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
156689955|NCT00706355|565610745|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
156689956|NCT02691741|565610748|FG000|Overall Study|Adverse Event|0|||
156689957|NCT02691741|565610749|FG001|Overall Study|Adverse Event|2|||
156689958|NCT02691741|565610748|FG000|Overall Study|Lost to Follow-up|1|||
156689959|NCT02691741|565610749|FG001|Overall Study|Lost to Follow-up|0|||
156689960|NCT02691741|565610748|FG000|Overall Study|Physician Decision|0|||
156689961|NCT02691741|565610749|FG001|Overall Study|Physician Decision|1|||
156689962|NCT02691741|565610748|FG000|Overall Study|Withdrawal by Subject|0|||
156689963|NCT02691741|565610749|FG001|Overall Study|Withdrawal by Subject|4|||
156689964|NCT02139124|565610750|FG000|Overall Study|Adverse Event|2|||
156689965|NCT02139124|565610751|FG001|Overall Study|Adverse Event|0|||
156689966|NCT02139124|565610752|FG002|Overall Study|Adverse Event|1|||
156689967|NCT02139124|565610753|FG003|Overall Study|Adverse Event|2|||
156689968|NCT02139124|565610754|FG004|Overall Study|Adverse Event|5|||
156689969|NCT02139124|565610750|FG000|Overall Study|Withdrawal by Subject|2|||
157214476|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
157214477|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
157214478|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
156689970|NCT02139124|565610751|FG001|Overall Study|Withdrawal by Subject|2|||
156689971|NCT02139124|565610752|FG002|Overall Study|Withdrawal by Subject|2|||
156689972|NCT02139124|565610753|FG003|Overall Study|Withdrawal by Subject|2|||
156689973|NCT02139124|565610754|FG004|Overall Study|Withdrawal by Subject|3|||
156689974|NCT02139124|565610750|FG000|Overall Study|Protocol Violation|0|||
156689975|NCT02139124|565610751|FG001|Overall Study|Protocol Violation|0|||
156689976|NCT02139124|565610752|FG002|Overall Study|Protocol Violation|0|||
156689977|NCT02139124|565610753|FG003|Overall Study|Protocol Violation|1|||
156689978|NCT02139124|565610754|FG004|Overall Study|Protocol Violation|1|||
156689979|NCT02139124|565610750|FG000|Overall Study|non-compliant|1|||
156689980|NCT02139124|565610751|FG001|Overall Study|non-compliant|0|||
156689981|NCT02139124|565610752|FG002|Overall Study|non-compliant|0|||
156689982|NCT02139124|565610753|FG003|Overall Study|non-compliant|2|||
156689983|NCT02139124|565610754|FG004|Overall Study|non-compliant|0|||
156689984|NCT02139124|565610750|FG000|Overall Study|incarceration|0|||
156689985|NCT02139124|565610751|FG001|Overall Study|incarceration|0|||
156689986|NCT02139124|565610752|FG002|Overall Study|incarceration|1|||
156689987|NCT02139124|565610753|FG003|Overall Study|incarceration|0|||
156689988|NCT02139124|565610754|FG004|Overall Study|incarceration|0|||
156689989|NCT02139124|565610750|FG000|Overall Study|subject moved|1|||
156689990|NCT02139124|565610751|FG001|Overall Study|subject moved|0|||
156689991|NCT02139124|565610752|FG002|Overall Study|subject moved|0|||
156689992|NCT02139124|565610753|FG003|Overall Study|subject moved|0|||
156689993|NCT02139124|565610754|FG004|Overall Study|subject moved|0|||
157013495|NCT04337372|566801793|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
156689994|NCT02139124|565610750|FG000|Overall Study|Lost to Follow-up|3|||
156689995|NCT02139124|565610751|FG001|Overall Study|Lost to Follow-up|2|||
156689996|NCT02139124|565610752|FG002|Overall Study|Lost to Follow-up|0|||
156689997|NCT02139124|565610753|FG003|Overall Study|Lost to Follow-up|5|||
156689998|NCT02139124|565610754|FG004|Overall Study|Lost to Follow-up|4|||
156689999|NCT03465436|565610755|FG000|Period 1|Protocol Violation|0|||
156690000|NCT03465436|565610756|FG001|Period 1|Protocol Violation|0|||
156690001|NCT03465436|565610757|FG002|Period 1|Protocol Violation|1|||
156690002|NCT03465436|565610758|FG003|Period 1|Protocol Violation|0|||
156690003|NCT03465436|565610755|FG000|Period 2|Protocol Violation|0|||
156690004|NCT03465436|565610756|FG001|Period 2|Protocol Violation|1|||
156690005|NCT03465436|565610757|FG002|Period 2|Protocol Violation|0|||
156690006|NCT03465436|565610758|FG003|Period 2|Protocol Violation|0|||
156690007|NCT03465436|565610755|FG000|Period 3|Protocol Violation|1|||
156690008|NCT03465436|565610756|FG001|Period 3|Protocol Violation|1|||
156690009|NCT03465436|565610757|FG002|Period 3|Protocol Violation|0|||
156690010|NCT03465436|565610758|FG003|Period 3|Protocol Violation|0|||
156690011|NCT03465436|565610755|FG000|Period 4|Protocol Violation|0|||
156690012|NCT03465436|565610756|FG001|Period 4|Protocol Violation|0|||
156690013|NCT03465436|565610757|FG002|Period 4|Protocol Violation|1|||
156690014|NCT03465436|565610758|FG003|Period 4|Protocol Violation|0|||
157013496|NCT04337372|566801794|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
156690015|NCT01425528|565610759|FG000|Overall Study|Withdrawal by Subject|1|||
156690016|NCT01425528|565610760|FG001|Overall Study|Withdrawal by Subject|1|||
156690017|NCT02697773|565610761|FG000|Overall Study|Adverse Event|2|||
156690018|NCT02697773|565610762|FG001|Overall Study|Adverse Event|1|||
156690019|NCT02697773|565610763|FG002|Overall Study|Adverse Event|2|||
156690020|NCT02697773|565610761|FG000|Overall Study|Death|0|||
156690021|NCT02697773|565610762|FG001|Overall Study|Death|0|||
156690022|NCT02697773|565610763|FG002|Overall Study|Death|2|||
156690023|NCT02697773|565610761|FG000|Overall Study|Lack of Efficacy|4|||
156690024|NCT02697773|565610762|FG001|Overall Study|Lack of Efficacy|6|||
156690025|NCT02697773|565610763|FG002|Overall Study|Lack of Efficacy|6|||
156690026|NCT02697773|565610761|FG000|Overall Study|Lost to Follow-up|5|||
156690027|NCT02697773|565610762|FG001|Overall Study|Lost to Follow-up|5|||
156690028|NCT02697773|565610763|FG002|Overall Study|Lost to Follow-up|7|||
156690029|NCT02697773|565610761|FG000|Overall Study|Other|15|||
156690030|NCT02697773|565610762|FG001|Overall Study|Other|11|||
156690031|NCT02697773|565610763|FG002|Overall Study|Other|10|||
156690032|NCT02697773|565610761|FG000|Overall Study|Protocol Violation|1|||
156690033|NCT02697773|565610762|FG001|Overall Study|Protocol Violation|1|||
156690034|NCT02697773|565610763|FG002|Overall Study|Protocol Violation|0|||
156690035|NCT02697773|565610761|FG000|Overall Study|Withdrawal by Subject|10|||
156690036|NCT02697773|565610762|FG001|Overall Study|Withdrawal by Subject|13|||
156690037|NCT02697773|565610763|FG002|Overall Study|Withdrawal by Subject|13|||
156690038|NCT02697773|565610761|FG000|Overall Study|Randomized but not treated|1|||
156690039|NCT02697773|565610762|FG001|Overall Study|Randomized but not treated|1|||
156690040|NCT02697773|565610763|FG002|Overall Study|Randomized but not treated|0|||
156690041|NCT02243293|565610764|FG000|Overall Study|Adverse Event|1|||
156690042|NCT02243293|565610765|FG001|Overall Study|Adverse Event|0|||
156690043|NCT02243293|565610766|FG002|Overall Study|Adverse Event|0|||
156690044|NCT02243293|565610767|FG003|Overall Study|Adverse Event|0|||
156690045|NCT02243293|565610768|FG004|Overall Study|Adverse Event|0|||
156690046|NCT02243293|565610769|FG005|Overall Study|Adverse Event|0|||
156690047|NCT02243293|565610770|FG006|Overall Study|Adverse Event|0|||
156690048|NCT02243293|565610771|FG007|Overall Study|Adverse Event|0|||
156690049|NCT02243293|565610772|FG008|Overall Study|Adverse Event|0|||
156690050|NCT02243293|565610773|FG009|Overall Study|Adverse Event|0|||
156690051|NCT02243293|565610774|FG010|Overall Study|Adverse Event|0|||
156690052|NCT02243293|565610775|FG011|Overall Study|Adverse Event|0|||
156690053|NCT02243293|565610776|FG012|Overall Study|Adverse Event|0|||
156690054|NCT02243293|565610777|FG013|Overall Study|Adverse Event|0|||
156690055|NCT02243293|565610778|FG014|Overall Study|Adverse Event|0|||
156690056|NCT02243293|565610779|FG015|Overall Study|Adverse Event|1|||
156690057|NCT02243293|565610780|FG016|Overall Study|Adverse Event|0|||
156690058|NCT02243293|565610781|FG017|Overall Study|Adverse Event|0|||
156690059|NCT02243293|565610782|FG018|Overall Study|Adverse Event|0|||
156690060|NCT02243293|565610783|FG019|Overall Study|Adverse Event|0|||
156690061|NCT02243293|565610784|FG020|Overall Study|Adverse Event|1|||
156690062|NCT02243293|565610785|FG021|Overall Study|Adverse Event|0|||
156690063|NCT02243293|565610764|FG000|Overall Study|Withdrawal by Subject|1|||
156690064|NCT02243293|565610765|FG001|Overall Study|Withdrawal by Subject|0|||
156690065|NCT02243293|565610766|FG002|Overall Study|Withdrawal by Subject|0|||
156690066|NCT02243293|565610767|FG003|Overall Study|Withdrawal by Subject|0|||
156690067|NCT02243293|565610768|FG004|Overall Study|Withdrawal by Subject|0|||
156690068|NCT02243293|565610769|FG005|Overall Study|Withdrawal by Subject|0|||
156690069|NCT02243293|565610770|FG006|Overall Study|Withdrawal by Subject|0|||
156690070|NCT02243293|565610771|FG007|Overall Study|Withdrawal by Subject|0|||
156690071|NCT02243293|565610772|FG008|Overall Study|Withdrawal by Subject|0|||
156690072|NCT02243293|565610773|FG009|Overall Study|Withdrawal by Subject|1|||
156690073|NCT02243293|565610774|FG010|Overall Study|Withdrawal by Subject|0|||
156787653|NCT02533674|565974755|FG004|Dose Level VI|Treatment-related AE|0|||
156787654|NCT02533674|565974756|FG005|Dose Level VI|Treatment-related AE|1|||
156787655|NCT02533674|565974757|FG006|Dose Level VI|Treatment-related AE|0|||
156787656|NCT02533674|565974758|FG007|Dose Level VI|Treatment-related AE|0|||
156787657|NCT02533674|565974751|FG000|Dose Level VII|Progressive disease|0|||
156787658|NCT02533674|565974752|FG001|Dose Level VII|Progressive disease|0|||
156787659|NCT02533674|565974753|FG002|Dose Level VII|Progressive disease|0|||
156787660|NCT02533674|565974754|FG003|Dose Level VII|Progressive disease|0|||
156870041|NCT03326713|566281079|FG002|Overall Study|Withdrawal by Subject|11|||
156870042|NCT03326713|566281077|FG000|Overall Study|Found Ineligible|11|||
156870043|NCT03326713|566281078|FG001|Overall Study|Found Ineligible|11|||
157121579|NCT05103332|567195979|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156690074|NCT02243293|565610775|FG011|Overall Study|Withdrawal by Subject|1|||
156690075|NCT02243293|565610776|FG012|Overall Study|Withdrawal by Subject|0|||
156690076|NCT02243293|565610777|FG013|Overall Study|Withdrawal by Subject|0|||
156690077|NCT02243293|565610778|FG014|Overall Study|Withdrawal by Subject|0|||
156690078|NCT02243293|565610779|FG015|Overall Study|Withdrawal by Subject|0|||
156690079|NCT02243293|565610780|FG016|Overall Study|Withdrawal by Subject|0|||
156690080|NCT02243293|565610781|FG017|Overall Study|Withdrawal by Subject|0|||
156690081|NCT02243293|565610782|FG018|Overall Study|Withdrawal by Subject|0|||
156787661|NCT02533674|565974755|FG004|Dose Level VII|Progressive disease|0|||
156870044|NCT03326713|566281079|FG002|Overall Study|Found Ineligible|8|||
156690082|NCT02243293|565610783|FG019|Overall Study|Withdrawal by Subject|0|||
156690083|NCT02243293|565610784|FG020|Overall Study|Withdrawal by Subject|0|||
156690084|NCT02243293|565610785|FG021|Overall Study|Withdrawal by Subject|1|||
156690085|NCT02243293|565610764|FG000|Overall Study|Lost to Follow-up|0|||
156690086|NCT02243293|565610765|FG001|Overall Study|Lost to Follow-up|1|||
156870045|NCT00771758|566281080|FG000|Overall Study|Adverse Event|2|||
156870046|NCT00771758|566281081|FG001|Overall Study|Adverse Event|8|||
156870047|NCT00771758|566281082|FG002|Overall Study|Adverse Event|1|||
156870048|NCT00771758|566281080|FG000|Overall Study|Lack of Efficacy|0|||
156870049|NCT00771758|566281081|FG001|Overall Study|Lack of Efficacy|2|||
156870050|NCT00771758|566281082|FG002|Overall Study|Lack of Efficacy|1|||
156870051|NCT00771758|566281080|FG000|Overall Study|Lost to Follow-up|1|||
156870052|NCT00771758|566281081|FG001|Overall Study|Lost to Follow-up|0|||
156870053|NCT00771758|566281082|FG002|Overall Study|Lost to Follow-up|0|||
156870054|NCT00771758|566281080|FG000|Overall Study|Protocol Violation|1|||
156870055|NCT00771758|566281081|FG001|Overall Study|Protocol Violation|0|||
156870056|NCT00771758|566281082|FG002|Overall Study|Protocol Violation|0|||
156870057|NCT00771758|566281080|FG000|Overall Study|Withdrawal by Subject|1|||
156870058|NCT00771758|566281081|FG001|Overall Study|Withdrawal by Subject|0|||
156870059|NCT00771758|566281082|FG002|Overall Study|Withdrawal by Subject|0|||
156870060|NCT00771758|566281080|FG000|Overall Study|Other|3|||
156870061|NCT00771758|566281081|FG001|Overall Study|Other|2|||
156870062|NCT00771758|566281082|FG002|Overall Study|Other|0|||
156870063|NCT03067077|566281083|FG000|Overall Study|Did not receive surgery|4|||
156870064|NCT03067077|566281084|FG001|Overall Study|Did not receive surgery|5|||
156870065|NCT03067077|566281083|FG000|Overall Study|Lost to Follow-up|3|||
156870066|NCT03067077|566281084|FG001|Overall Study|Lost to Follow-up|2|||
156870067|NCT00935584|566281085|FG000|Overall Study|Withdrawal by Subject|9|||
156870068|NCT00935584|566281086|FG001|Overall Study|Withdrawal by Subject|0|||
156870069|NCT00935584|566281085|FG000|Overall Study|Death|3|||
156870070|NCT00935584|566281086|FG001|Overall Study|Death|0|||
156870071|NCT00935584|566281085|FG000|Overall Study|Lost to Follow-up|8|||
156870072|NCT00935584|566281086|FG001|Overall Study|Lost to Follow-up|0|||
156870073|NCT00935584|566281085|FG000|Overall Study|No show|9|||
156870074|NCT00935584|566281086|FG001|Overall Study|No show|0|||
156870075|NCT00935584|566281085|FG000|Overall Study|Relocated|3|||
156870076|NCT00935584|566281086|FG001|Overall Study|Relocated|0|||
156870077|NCT00935584|566281085|FG000|Overall Study|Patient changed provider|3|||
156870078|NCT00935584|566281086|FG001|Overall Study|Patient changed provider|0|||
156870079|NCT00935584|566281085|FG000|Overall Study|Provider dropped out of study|14|||
156870080|NCT00935584|566281086|FG001|Overall Study|Provider dropped out of study|4|||
156870081|NCT01394016|566281087|FG000|Overall Study|Progressive Disease|2|||
156870082|NCT01394016|566281088|FG001|Overall Study|Progressive Disease|0|||
156870083|NCT01394016|566281089|FG002|Overall Study|Progressive Disease|0|||
156870084|NCT01394016|566281090|FG003|Overall Study|Progressive Disease|0|||
156870085|NCT01394016|566281091|FG004|Overall Study|Progressive Disease|0|||
156870086|NCT01394016|566281092|FG005|Overall Study|Progressive Disease|0|||
156870087|NCT01394016|566281093|FG006|Overall Study|Progressive Disease|0|||
156870088|NCT01394016|566281094|FG007|Overall Study|Progressive Disease|0|||
156870089|NCT01394016|566281095|FG008|Overall Study|Progressive Disease|0|||
156870090|NCT01394016|566281096|FG009|Overall Study|Progressive Disease|0|||
156870091|NCT01394016|566281097|FG010|Overall Study|Progressive Disease|0|||
156870092|NCT01394016|566281098|FG011|Overall Study|Progressive Disease|0|||
156870093|NCT01394016|566281099|FG012|Overall Study|Progressive Disease|0|||
156870094|NCT01394016|566281100|FG013|Overall Study|Progressive Disease|0|||
156870095|NCT01394016|566281101|FG014|Overall Study|Progressive Disease|0|||
156870096|NCT01394016|566281102|FG015|Overall Study|Progressive Disease|0|||
156870097|NCT01394016|566281103|FG016|Overall Study|Progressive Disease|0|||
156870098|NCT01394016|566281104|FG017|Overall Study|Progressive Disease|0|||
156870099|NCT01394016|566281105|FG018|Overall Study|Progressive Disease|0|||
156870100|NCT01394016|566281087|FG000|Overall Study|Withdrawal by Subject|0|||
156870101|NCT01394016|566281088|FG001|Overall Study|Withdrawal by Subject|0|||
156870102|NCT01394016|566281089|FG002|Overall Study|Withdrawal by Subject|0|||
156870103|NCT01394016|566281090|FG003|Overall Study|Withdrawal by Subject|0|||
156870104|NCT01394016|566281091|FG004|Overall Study|Withdrawal by Subject|0|||
156870105|NCT01394016|566281092|FG005|Overall Study|Withdrawal by Subject|0|||
156870106|NCT01394016|566281093|FG006|Overall Study|Withdrawal by Subject|0|||
156870107|NCT01394016|566281094|FG007|Overall Study|Withdrawal by Subject|1|||
156870108|NCT01394016|566281095|FG008|Overall Study|Withdrawal by Subject|1|||
156870109|NCT01394016|566281096|FG009|Overall Study|Withdrawal by Subject|1|||
156870110|NCT01394016|566281097|FG010|Overall Study|Withdrawal by Subject|4|||
156870111|NCT01394016|566281098|FG011|Overall Study|Withdrawal by Subject|0|||
157013497|NCT04337372|566801791|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
157013498|NCT04337372|566801792|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
156870112|NCT01394016|566281099|FG012|Overall Study|Withdrawal by Subject|0|||
156870113|NCT01394016|566281100|FG013|Overall Study|Withdrawal by Subject|3|||
156870114|NCT01394016|566281101|FG014|Overall Study|Withdrawal by Subject|1|||
156870115|NCT01394016|566281102|FG015|Overall Study|Withdrawal by Subject|3|||
156870116|NCT01394016|566281103|FG016|Overall Study|Withdrawal by Subject|1|||
157013499|NCT04337372|566801793|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
156870117|NCT01394016|566281104|FG017|Overall Study|Withdrawal by Subject|1|||
156870118|NCT01394016|566281105|FG018|Overall Study|Withdrawal by Subject|2|||
156870119|NCT01394016|566281087|FG000|Overall Study|Adverse Event|0|||
156870120|NCT01394016|566281088|FG001|Overall Study|Adverse Event|0|||
156690087|NCT02243293|565610766|FG002|Overall Study|Lost to Follow-up|1|||
156690088|NCT02243293|565610767|FG003|Overall Study|Lost to Follow-up|1|||
156690089|NCT02243293|565610768|FG004|Overall Study|Lost to Follow-up|0|||
156690090|NCT02243293|565610769|FG005|Overall Study|Lost to Follow-up|0|||
156690091|NCT02243293|565610770|FG006|Overall Study|Lost to Follow-up|3|||
156690092|NCT02243293|565610771|FG007|Overall Study|Lost to Follow-up|0|||
156787662|NCT02533674|565974756|FG005|Dose Level VII|Progressive disease|0|||
156787663|NCT02533674|565974757|FG006|Dose Level VII|Progressive disease|10|||
156787664|NCT02533674|565974758|FG007|Dose Level VII|Progressive disease|0|||
156787665|NCT02533674|565974751|FG000|Dose Level VII|Withdrawal by Subject|0|||
156787666|NCT02533674|565974752|FG001|Dose Level VII|Withdrawal by Subject|0|||
156787667|NCT02533674|565974753|FG002|Dose Level VII|Withdrawal by Subject|0|||
156787668|NCT02533674|565974754|FG003|Dose Level VII|Withdrawal by Subject|0|||
156787669|NCT02533674|565974755|FG004|Dose Level VII|Withdrawal by Subject|0|||
156787670|NCT02533674|565974756|FG005|Dose Level VII|Withdrawal by Subject|0|||
157013500|NCT04337372|566801794|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
156690093|NCT02243293|565610772|FG008|Overall Study|Lost to Follow-up|0|||
156690094|NCT02243293|565610773|FG009|Overall Study|Lost to Follow-up|0|||
156690095|NCT02243293|565610774|FG010|Overall Study|Lost to Follow-up|0|||
156690096|NCT02243293|565610775|FG011|Overall Study|Lost to Follow-up|2|||
156690097|NCT02243293|565610776|FG012|Overall Study|Lost to Follow-up|0|||
156690098|NCT02243293|565610777|FG013|Overall Study|Lost to Follow-up|0|||
156690099|NCT02243293|565610778|FG014|Overall Study|Lost to Follow-up|0|||
156690100|NCT02243293|565610779|FG015|Overall Study|Lost to Follow-up|0|||
156690101|NCT02243293|565610780|FG016|Overall Study|Lost to Follow-up|3|||
156690102|NCT02243293|565610781|FG017|Overall Study|Lost to Follow-up|1|||
156690103|NCT02243293|565610782|FG018|Overall Study|Lost to Follow-up|0|||
156690104|NCT02243293|565610783|FG019|Overall Study|Lost to Follow-up|0|||
156690105|NCT02243293|565610784|FG020|Overall Study|Lost to Follow-up|1|||
156690106|NCT02243293|565610785|FG021|Overall Study|Lost to Follow-up|2|||
156690107|NCT02243293|565610764|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
156787671|NCT02533674|565974757|FG006|Dose Level VII|Withdrawal by Subject|3|||
156787672|NCT02533674|565974758|FG007|Dose Level VII|Withdrawal by Subject|0|||
156787673|NCT02533674|565974751|FG000|Dose Level VII|Treatment-related AE|0|||
156787674|NCT02533674|565974752|FG001|Dose Level VII|Treatment-related AE|0|||
156787675|NCT02533674|565974753|FG002|Dose Level VII|Treatment-related AE|0|||
156787676|NCT02533674|565974754|FG003|Dose Level VII|Treatment-related AE|0|||
156787677|NCT02533674|565974755|FG004|Dose Level VII|Treatment-related AE|0|||
156787678|NCT02533674|565974756|FG005|Dose Level VII|Treatment-related AE|0|||
156787679|NCT02533674|565974757|FG006|Dose Level VII|Treatment-related AE|1|||
156787680|NCT02533674|565974758|FG007|Dose Level VII|Treatment-related AE|0|||
156787681|NCT02533674|565974751|FG000|Dose Level VII|Death|0|||
156787682|NCT02533674|565974752|FG001|Dose Level VII|Death|0|||
156787683|NCT02533674|565974753|FG002|Dose Level VII|Death|0|||
156787684|NCT02533674|565974754|FG003|Dose Level VII|Death|0|||
156787685|NCT02533674|565974755|FG004|Dose Level VII|Death|0|||
156787686|NCT02533674|565974756|FG005|Dose Level VII|Death|0|||
156787687|NCT02533674|565974757|FG006|Dose Level VII|Death|2|||
156787688|NCT02533674|565974758|FG007|Dose Level VII|Death|0|||
156787689|NCT02533674|565974751|FG000|Dose Level VIII|Progressive disease|0|||
156787690|NCT02533674|565974752|FG001|Dose Level VIII|Progressive disease|0|||
156787691|NCT02533674|565974753|FG002|Dose Level VIII|Progressive disease|0|||
156787692|NCT02533674|565974754|FG003|Dose Level VIII|Progressive disease|0|||
156787693|NCT02533674|565974755|FG004|Dose Level VIII|Progressive disease|0|||
156787694|NCT02533674|565974756|FG005|Dose Level VIII|Progressive disease|0|||
156787695|NCT02533674|565974757|FG006|Dose Level VIII|Progressive disease|0|||
156787696|NCT02533674|565974758|FG007|Dose Level VIII|Progressive disease|3|||
156787697|NCT02533674|565974751|FG000|Dose Level VIII|Withdrawal by Subject|0|||
156787698|NCT02533674|565974752|FG001|Dose Level VIII|Withdrawal by Subject|0|||
156787699|NCT02533674|565974753|FG002|Dose Level VIII|Withdrawal by Subject|0|||
156787700|NCT02533674|565974754|FG003|Dose Level VIII|Withdrawal by Subject|0|||
156787701|NCT02533674|565974755|FG004|Dose Level VIII|Withdrawal by Subject|0|||
156787702|NCT02533674|565974756|FG005|Dose Level VIII|Withdrawal by Subject|0|||
156787703|NCT02533674|565974757|FG006|Dose Level VIII|Withdrawal by Subject|0|||
156787704|NCT02533674|565974758|FG007|Dose Level VIII|Withdrawal by Subject|1|||
156787705|NCT02533674|565974751|FG000|Dose Level VIII|Treatment-related AE|0|||
156787706|NCT02533674|565974752|FG001|Dose Level VIII|Treatment-related AE|0|||
156787707|NCT02533674|565974753|FG002|Dose Level VIII|Treatment-related AE|0|||
156690108|NCT02243293|565610765|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
156787708|NCT02533674|565974754|FG003|Dose Level VIII|Treatment-related AE|0|||
156690109|NCT02243293|565610766|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
156690110|NCT02243293|565610767|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
156690111|NCT02243293|565610768|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
156787709|NCT02533674|565974755|FG004|Dose Level VIII|Treatment-related AE|0|||
156787710|NCT02533674|565974756|FG005|Dose Level VIII|Treatment-related AE|0|||
156690112|NCT02243293|565610769|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
156787711|NCT02533674|565974757|FG006|Dose Level VIII|Treatment-related AE|0|||
156690113|NCT02243293|565610770|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
156690114|NCT02243293|565610771|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
156690115|NCT02243293|565610772|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
156690116|NCT02243293|565610773|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
156690117|NCT02243293|565610774|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
156690118|NCT02243293|565610775|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
156690119|NCT02243293|565610776|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
156690120|NCT02243293|565610777|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
156690121|NCT02243293|565610778|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
156690122|NCT02243293|565610779|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
156690123|NCT02243293|565610780|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
156690124|NCT02243293|565610781|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
156690125|NCT02243293|565610782|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
156690126|NCT02243293|565610783|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
156690127|NCT02243293|565610784|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
156690128|NCT02243293|565610785|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
156690129|NCT02243293|565610764|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
156690130|NCT02243293|565610765|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
156690131|NCT02243293|565610766|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
156690132|NCT02243293|565610767|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
156690133|NCT02243293|565610768|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
156690134|NCT02243293|565610769|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
156690135|NCT02243293|565610770|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
156690136|NCT02243293|565610771|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
156690137|NCT02243293|565610772|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
156690138|NCT02243293|565610773|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
156690139|NCT02243293|565610774|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
156690140|NCT02243293|565610775|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
156690141|NCT02243293|565610776|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
156690142|NCT02243293|565610777|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
156690143|NCT02243293|565610778|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
156690144|NCT02243293|565610779|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
156690145|NCT02243293|565610780|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
156690146|NCT02243293|565610781|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
156690147|NCT02243293|565610782|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
156690148|NCT02243293|565610783|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
156690149|NCT02243293|565610784|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
156690150|NCT02243293|565610785|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
156690151|NCT00440115|565610786|FG000|Overall Study|Death|7|||
156690152|NCT00440115|565610787|FG001|Overall Study|Death|9|||
156690153|NCT00440115|565610788|FG002|Overall Study|Death|5|||
156690154|NCT00440115|565610786|FG000|Overall Study|Incarceration|0|||
156690155|NCT00440115|565610787|FG001|Overall Study|Incarceration|2|||
156690156|NCT00440115|565610788|FG002|Overall Study|Incarceration|1|||
156690157|NCT03069417|565610789|FG000|Overall Study|Lost to Follow-up|2|||
156690158|NCT03069417|565610790|FG001|Overall Study|Lost to Follow-up|0|||
156690159|NCT03069417|565610789|FG000|Overall Study|Reason Unknown|4|||
156690160|NCT03069417|565610790|FG001|Overall Study|Reason Unknown|7|||
156690161|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
156690162|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
156690163|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
156690164|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
156690165|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
156690166|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
156690167|NCT03078478|565610794|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
156690168|NCT03078478|565610795|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
156690169|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
156690170|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
156690171|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
156690172|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
156690173|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
156690174|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
156690175|NCT03078478|565610794|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
156787712|NCT02533674|565974758|FG007|Dose Level VIII|Treatment-related AE|1|||
156787713|NCT02533674|565974751|FG000|Dose Level VIII|Never treated|0|||
156690176|NCT03078478|565610795|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
156690177|NCT01172821|565610798|FG000|Overall Study|Adverse Event|5|||
156690178|NCT01172821|565610799|FG001|Overall Study|Adverse Event|2|||
156690179|NCT01172821|565610800|FG002|Overall Study|Adverse Event|2|||
156690180|NCT01172821|565610801|FG003|Overall Study|Adverse Event|7|||
156690181|NCT01172821|565610798|FG000|Overall Study|Protocol Violation|0|||
156690182|NCT01172821|565610799|FG001|Overall Study|Protocol Violation|2|||
156690183|NCT01172821|565610800|FG002|Overall Study|Protocol Violation|1|||
156690184|NCT01172821|565610801|FG003|Overall Study|Protocol Violation|2|||
156690185|NCT01172821|565610798|FG000|Overall Study|Lost to Follow-up|4|||
156690186|NCT01172821|565610799|FG001|Overall Study|Lost to Follow-up|1|||
156690187|NCT01172821|565610800|FG002|Overall Study|Lost to Follow-up|2|||
156690188|NCT01172821|565610801|FG003|Overall Study|Lost to Follow-up|2|||
156690189|NCT01172821|565610798|FG000|Overall Study|Withdrawal by Subject|2|||
156690190|NCT01172821|565610799|FG001|Overall Study|Withdrawal by Subject|3|||
156690191|NCT01172821|565610800|FG002|Overall Study|Withdrawal by Subject|3|||
156690192|NCT01172821|565610801|FG003|Overall Study|Withdrawal by Subject|3|||
156690193|NCT01172821|565610798|FG000|Overall Study|Other|3|||
156690194|NCT01172821|565610799|FG001|Overall Study|Other|4|||
156690195|NCT01172821|565610800|FG002|Overall Study|Other|5|||
156690196|NCT01172821|565610801|FG003|Overall Study|Other|3|||
156690197|NCT02756637|565610804|FG000|Overall Study|Not eligible for initial SWOG study|10|||
156690198|NCT02756637|565610805|FG001|Overall Study|Not eligible for initial SWOG study|10|||
156690199|NCT02756637|565610804|FG000|Overall Study|No available NLR value|44|||
156690200|NCT02756637|565610805|FG001|Overall Study|No available NLR value|44|||
156690201|NCT02756637|565610804|FG000|Overall Study|Did not complete curative therapy|33|||
156690202|NCT02756637|565610805|FG001|Overall Study|Did not complete curative therapy|0|||
156690203|NCT02985879|565610808|FG000|Overall Study|Adverse Event|7|||
156690204|NCT02985879|565610809|FG001|Overall Study|Adverse Event|9|||
156690205|NCT02985879|565610810|FG002|Overall Study|Adverse Event|7|||
156690206|NCT02985879|565610808|FG000|Overall Study|Withdrew consent|6|||
156690207|NCT02985879|565610809|FG001|Overall Study|Withdrew consent|8|||
156690208|NCT02985879|565610810|FG002|Overall Study|Withdrew consent|10|||
156690209|NCT02985879|565610808|FG000|Overall Study|Lost to Follow-up|1|||
156690210|NCT02985879|565610809|FG001|Overall Study|Lost to Follow-up|0|||
156690211|NCT02985879|565610810|FG002|Overall Study|Lost to Follow-up|2|||
156690212|NCT02985879|565610808|FG000|Overall Study|Other, not specified|62|||
156690213|NCT02985879|565610809|FG001|Overall Study|Other, not specified|58|||
156690214|NCT02985879|565610810|FG002|Overall Study|Other, not specified|58|||
156690215|NCT02723773|565612311|FG000|Overall Study|Adverse Event|934|||
156690216|NCT02723773|565612312|FG001|Overall Study|Adverse Event|3|||
156690217|NCT02723773|565612313|FG002|Overall Study|Adverse Event|1|||
156690218|NCT02723773|565612314|FG003|Overall Study|Adverse Event|9|||
156690219|NCT02723773|565612311|FG000|Overall Study|Protocol Violation|1|||
156690220|NCT02723773|565612312|FG001|Overall Study|Protocol Violation|0|||
156690221|NCT02723773|565612313|FG002|Overall Study|Protocol Violation|0|||
156690222|NCT02723773|565612314|FG003|Overall Study|Protocol Violation|0|||
156690223|NCT02723773|565612311|FG000|Overall Study|Withdrawal by Subject|360|||
156690224|NCT02723773|565612312|FG001|Overall Study|Withdrawal by Subject|5|||
156690225|NCT02723773|565612313|FG002|Overall Study|Withdrawal by Subject|6|||
156690226|NCT02723773|565612314|FG003|Overall Study|Withdrawal by Subject|10|||
156690227|NCT02723773|565612311|FG000|Overall Study|Migrated/moved from study area|37|||
156690228|NCT02723773|565612312|FG001|Overall Study|Migrated/moved from study area|0|||
156690229|NCT02723773|565612313|FG002|Overall Study|Migrated/moved from study area|0|||
156690230|NCT02723773|565612314|FG003|Overall Study|Migrated/moved from study area|1|||
156690231|NCT02723773|565612311|FG000|Overall Study|Lost to Follow-up|198|||
156690232|NCT02723773|565612312|FG001|Overall Study|Lost to Follow-up|0|||
156690233|NCT02723773|565612313|FG002|Overall Study|Lost to Follow-up|0|||
156690234|NCT02723773|565612314|FG003|Overall Study|Lost to Follow-up|0|||
156690235|NCT02723773|565612311|FG000|Overall Study|Other|189|||
156690236|NCT02723773|565612312|FG001|Overall Study|Other|1|||
156690237|NCT02723773|565612313|FG002|Overall Study|Other|2|||
156690238|NCT02723773|565612314|FG003|Overall Study|Other|2|||
156690239|NCT05168774|565612315|FG000|Overall Study|Lack of Efficacy|1|||
156690240|NCT05168774|565612316|FG001|Overall Study|Lack of Efficacy|2|||
156690241|NCT05168774|565612315|FG000|Overall Study|Withdrawal by Subject|1|||
156690242|NCT05168774|565612316|FG001|Overall Study|Withdrawal by Subject|2|||
156690243|NCT05168774|565612315|FG000|Overall Study|Adverse Event|2|||
156690244|NCT05168774|565612316|FG001|Overall Study|Adverse Event|0|||
156690245|NCT03940703|565612317|FG000|Overall Study|Still under treatment|31|||
156787714|NCT02533674|565974752|FG001|Dose Level VIII|Never treated|0|||
156690246|NCT03940703|565612318|FG001|Overall Study|Still under treatment|0|||
156690247|NCT03310957|565612319|FG000|Overall Study|Withdrawal by Subject|1|||
156690248|NCT03310957|565612320|FG001|Overall Study|Withdrawal by Subject|1|||
156690249|NCT03310957|565612321|FG002|Overall Study|Withdrawal by Subject|1|||
156690250|NCT03310957|565612322|FG003|Overall Study|Withdrawal by Subject|5|||
156690251|NCT03310957|565612323|FG004|Overall Study|Withdrawal by Subject|0|||
156690252|NCT03310957|565612324|FG005|Overall Study|Withdrawal by Subject|4|||
156690253|NCT03310957|565612325|FG006|Overall Study|Withdrawal by Subject|3|||
156690254|NCT03310957|565612319|FG000|Overall Study|Site Terminated|0|||
156690255|NCT03310957|565612320|FG001|Overall Study|Site Terminated|1|||
156690256|NCT03310957|565612321|FG002|Overall Study|Site Terminated|1|||
156690257|NCT03310957|565612322|FG003|Overall Study|Site Terminated|1|||
156690258|NCT03310957|565612323|FG004|Overall Study|Site Terminated|0|||
156787715|NCT02533674|565974753|FG002|Dose Level VIII|Never treated|0|||
156787716|NCT02533674|565974754|FG003|Dose Level VIII|Never treated|0|||
156787717|NCT02533674|565974755|FG004|Dose Level VIII|Never treated|0|||
156787718|NCT02533674|565974756|FG005|Dose Level VIII|Never treated|0|||
156787719|NCT02533674|565974757|FG006|Dose Level VIII|Never treated|0|||
156787720|NCT02533674|565974758|FG007|Dose Level VIII|Never treated|1|||
156787721|NCT03021005|565974759|FG000|Overall Study|Lost to Follow-up|39|||
156787722|NCT03021005|565974760|FG001|Overall Study|Lost to Follow-up|26|||
156787723|NCT03188705|565974761|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
156787724|NCT03188705|565974761|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
156787725|NCT01174459|565974765|FG000|Overall Study|case report form (CRF) not collected|5|||
156787726|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
156787727|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
156787728|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
156787729|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
156787730|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
156787731|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
156787732|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
156787733|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
156787734|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
156787735|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
156787736|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
156787737|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
156787738|NCT00290758|565974766|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
156787739|NCT00290758|565974767|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
156787740|NCT00290758|565974766|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
156787741|NCT00290758|565974767|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
156787742|NCT03994120|565974769|FG000|Overall Study|Lost to Follow-up|3|||
156787743|NCT03994120|565974770|FG001|Overall Study|Lost to Follow-up|1|||
156787744|NCT00474968|565974771|FG000|Overall Study|Withdrawal by Subject|8|||
156787745|NCT00474968|565974772|FG001|Overall Study|Withdrawal by Subject|7|||
156787746|NCT00474968|565974771|FG000|Overall Study|Protocol Violation|9|||
156787747|NCT00474968|565974772|FG001|Overall Study|Protocol Violation|8|||
156787748|NCT00474968|565974771|FG000|Overall Study|Sample not collected|1|||
156787749|NCT00474968|565974772|FG001|Overall Study|Sample not collected|1|||
156787750|NCT00215553|565974773|FG000|Overall Study|Adverse Event|0|||
156787751|NCT00215553|565974774|FG001|Overall Study|Adverse Event|1|||
156787752|NCT00215553|565974775|FG002|Overall Study|Adverse Event|2|||
156787753|NCT00215553|565974776|FG003|Overall Study|Adverse Event|1|||
156787754|NCT00215553|565974777|FG004|Overall Study|Adverse Event|2|||
156787755|NCT00215553|565974778|FG005|Overall Study|Adverse Event|6|||
156787756|NCT00215553|565974779|FG006|Overall Study|Adverse Event|0|||
156787757|NCT01111292|565974780|FG000|Treatment|Physician Decision|1|||
156787758|NCT01111292|565974781|FG001|Treatment|Physician Decision|1|||
156787759|NCT04914000|565974782|FG000|Overall Study|Lost to Follow-up|8|||
156787760|NCT04914000|565974782|FG000|Overall Study|Withdrawal by Subject|1|||
156787761|NCT01429623|565974783|FG000|Overall Study|Death|1|||
156787762|NCT01429623|565974784|FG001|Overall Study|Death|0|||
156787763|NCT01429623|565974783|FG000|Overall Study|Adverse Event|7|||
156787764|NCT01429623|565974784|FG001|Overall Study|Adverse Event|14|||
156787765|NCT01429623|565974783|FG000|Overall Study|Withdrawal by Subject|19|||
156787766|NCT01429623|565974784|FG001|Overall Study|Withdrawal by Subject|13|||
156787767|NCT01429623|565974783|FG000|Overall Study|Physician Decision|2|||
156787768|NCT01429623|565974784|FG001|Overall Study|Physician Decision|3|||
156787769|NCT01429623|565974783|FG000|Overall Study|Protocol Violation|3|||
156787770|NCT01429623|565974784|FG001|Overall Study|Protocol Violation|2|||
156787771|NCT01429623|565974783|FG000|Overall Study|Assorted|1|||
156787772|NCT01429623|565974784|FG001|Overall Study|Assorted|2|||
156787773|NCT01429623|565974783|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
156787774|NCT01429623|565974784|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
156787775|NCT01429623|565974783|FG000|Overall Study|No post baseline data|4|||
156787776|NCT01429623|565974784|FG001|Overall Study|No post baseline data|4|||
156787777|NCT00981175|565974785|FG000|Primary Dose Vaccination|Adverse Event|1|||
156787778|NCT00981175|565974786|FG001|Primary Dose Vaccination|Adverse Event|0|||
156787779|NCT00981175|565974785|FG000|Primary Dose Vaccination|Protocol Violation|0|||
156787780|NCT00981175|565974786|FG001|Primary Dose Vaccination|Protocol Violation|1|||
156787781|NCT00981175|565974785|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
156787782|NCT00981175|565974786|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
156787783|NCT00981175|565974785|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
156787784|NCT00981175|565974786|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
156787785|NCT01096186|565974787|FG000|Overall Study|Adverse Event|16|||
156787786|NCT01096186|565974787|FG000|Overall Study|Death|4|||
156787787|NCT01096186|565974787|FG000|Overall Study|Lack of Efficacy|4|||
156787788|NCT01096186|565974787|FG000|Overall Study|Lost to Follow-up|2|||
156787789|NCT01096186|565974787|FG000|Overall Study|Withdrawal by Subject|22|||
156690259|NCT03310957|565612324|FG005|Overall Study|Site Terminated|2|||
156690260|NCT03310957|565612325|FG006|Overall Study|Site Terminated|8|||
156690261|NCT03310957|565612319|FG000|Overall Study|Lost to Follow-up|1|||
156870121|NCT01394016|566281089|FG002|Overall Study|Adverse Event|0|||
156870122|NCT01394016|566281090|FG003|Overall Study|Adverse Event|0|||
156690262|NCT03310957|565612320|FG001|Overall Study|Lost to Follow-up|1|||
156870123|NCT01394016|566281091|FG004|Overall Study|Adverse Event|0|||
156690263|NCT03310957|565612321|FG002|Overall Study|Lost to Follow-up|1|||
156690264|NCT03310957|565612322|FG003|Overall Study|Lost to Follow-up|4|||
156690265|NCT03310957|565612323|FG004|Overall Study|Lost to Follow-up|0|||
156690266|NCT03310957|565612324|FG005|Overall Study|Lost to Follow-up|4|||
156690267|NCT03310957|565612325|FG006|Overall Study|Lost to Follow-up|2|||
156690268|NCT03310957|565612319|FG000|Overall Study|Death|5|||
156787790|NCT01096186|565974787|FG000|Overall Study|Physician Decision|1|||
156787791|NCT01096186|565974787|FG000|Overall Study|Noncompliance with study drug|1|||
156787792|NCT03156621|565974792|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
156787793|NCT03156621|565974793|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
156787794|NCT03156621|565974792|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156787795|NCT03156621|565974793|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156787796|NCT00799864|565974794|FG000|Overall Study|Participant reached a virologic endpoint|9|||
156787797|NCT00799864|565974795|FG001|Overall Study|Participant reached a virologic endpoint|2|||
156787798|NCT00799864|565974796|FG002|Overall Study|Participant reached a virologic endpoint|2|||
156787799|NCT00799864|565974797|FG003|Overall Study|Participant reached a virologic endpoint|0|||
156787800|NCT00799864|565974798|FG004|Overall Study|Participant reached a virologic endpoint|0|||
156787801|NCT00799864|565974794|FG000|Overall Study|Other|2|||
156787802|NCT00799864|565974795|FG001|Overall Study|Other|1|||
156787803|NCT00799864|565974796|FG002|Overall Study|Other|0|||
156787804|NCT00799864|565974797|FG003|Overall Study|Other|0|||
156787805|NCT00799864|565974798|FG004|Overall Study|Other|0|||
156787806|NCT00079781|565974799|FG000|Pre-implant Period|Withdrawal by Subject|2|||
156787807|NCT00079781|565974800|FG001|Pre-implant Period|Withdrawal by Subject|0|||
156787808|NCT00079781|565974801|FG002|Pre-implant Period|Withdrawal by Subject|0|||
156787809|NCT00079781|565974799|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
156787810|NCT00079781|565974800|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
156787811|NCT00079781|565974801|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
156787812|NCT00079781|565974799|FG000|Follow-up Period|Withdrawal by Subject|3|||
156787813|NCT00079781|565974800|FG001|Follow-up Period|Withdrawal by Subject|0|||
156787814|NCT00079781|565974801|FG002|Follow-up Period|Withdrawal by Subject|1|||
156787815|NCT00079781|565974799|FG000|Follow-up Period|Lost to Follow-up|1|||
156787816|NCT00079781|565974800|FG001|Follow-up Period|Lost to Follow-up|0|||
156787817|NCT00079781|565974801|FG002|Follow-up Period|Lost to Follow-up|0|||
156787818|NCT00079781|565974799|FG000|Follow-up Period|Death|0|||
156787819|NCT00079781|565974800|FG001|Follow-up Period|Death|0|||
156787820|NCT00079781|565974801|FG002|Follow-up Period|Death|1|||
156787821|NCT00576407|565974802|FG000|Overall Study|Death|7|||
156787822|NCT00576407|565974802|FG000|Overall Study|Physician Decision|1|||
156787823|NCT00225758|565974803|FG000|Overall Study|Adverse Event|4|||
156787824|NCT00621322|565974804|FG000|Overall Study|Lost to Follow-up|0|||
156787825|NCT00621322|565974805|FG001|Overall Study|Lost to Follow-up|0|||
156787826|NCT00621322|565974806|FG002|Overall Study|Lost to Follow-up|0|||
156870124|NCT01394016|566281092|FG005|Overall Study|Adverse Event|0|||
156870125|NCT01394016|566281093|FG006|Overall Study|Adverse Event|0|||
156787827|NCT00621322|565974807|FG003|Overall Study|Lost to Follow-up|0|||
156787828|NCT00621322|565974808|FG004|Overall Study|Lost to Follow-up|1|||
156787829|NCT00621322|565974809|FG005|Overall Study|Lost to Follow-up|0|||
156787830|NCT00621322|565974804|FG000|Overall Study|Physician Decision|0|||
156787831|NCT00621322|565974805|FG001|Overall Study|Physician Decision|0|||
156787832|NCT00621322|565974806|FG002|Overall Study|Physician Decision|1|||
156787833|NCT00621322|565974807|FG003|Overall Study|Physician Decision|1|||
156787834|NCT00621322|565974808|FG004|Overall Study|Physician Decision|0|||
156787835|NCT00621322|565974809|FG005|Overall Study|Physician Decision|0|||
156870126|NCT01394016|566281094|FG007|Overall Study|Adverse Event|0|||
156690269|NCT03310957|565612320|FG001|Overall Study|Death|8|||
156787836|NCT00621322|565974804|FG000|Overall Study|Withdrawal by Subject|0|||
156787837|NCT00621322|565974805|FG001|Overall Study|Withdrawal by Subject|0|||
156787838|NCT00621322|565974806|FG002|Overall Study|Withdrawal by Subject|0|||
156787839|NCT00621322|565974807|FG003|Overall Study|Withdrawal by Subject|1|||
156787840|NCT00621322|565974808|FG004|Overall Study|Withdrawal by Subject|0|||
156787841|NCT00621322|565974809|FG005|Overall Study|Withdrawal by Subject|2|||
156787842|NCT00621322|565974804|FG000|Overall Study|Migrated/moved from study area|1|||
156787843|NCT00621322|565974805|FG001|Overall Study|Migrated/moved from study area|0|||
156690270|NCT03310957|565612321|FG002|Overall Study|Death|18|||
156690271|NCT03310957|565612322|FG003|Overall Study|Death|31|||
156690272|NCT03310957|565612323|FG004|Overall Study|Death|1|||
156787844|NCT00621322|565974806|FG002|Overall Study|Migrated/moved from study area|1|||
156787845|NCT00621322|565974807|FG003|Overall Study|Migrated/moved from study area|1|||
156787846|NCT00621322|565974808|FG004|Overall Study|Migrated/moved from study area|0|||
156870127|NCT01394016|566281095|FG008|Overall Study|Adverse Event|0|||
156690273|NCT03310957|565612324|FG005|Overall Study|Death|29|||
156690274|NCT03310957|565612325|FG006|Overall Study|Death|7|||
156690275|NCT03310957|565612319|FG000|Overall Study|Discontinuation per sponsor|0|||
156690276|NCT03310957|565612320|FG001|Overall Study|Discontinuation per sponsor|1|||
156690277|NCT03310957|565612321|FG002|Overall Study|Discontinuation per sponsor|2|||
156690278|NCT03310957|565612322|FG003|Overall Study|Discontinuation per sponsor|4|||
156690279|NCT03310957|565612323|FG004|Overall Study|Discontinuation per sponsor|1|||
156690280|NCT03310957|565612324|FG005|Overall Study|Discontinuation per sponsor|9|||
156690281|NCT03310957|565612325|FG006|Overall Study|Discontinuation per sponsor|12|||
156690282|NCT03310957|565612319|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
156690283|NCT03310957|565612320|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
156690284|NCT03310957|565612321|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
156690285|NCT03310957|565612322|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
156690286|NCT03310957|565612323|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
156690287|NCT03310957|565612324|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
156690288|NCT03310957|565612325|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
156690289|NCT03310957|565612319|FG000|Overall Study|Treatment landscape|0|||
156690290|NCT03310957|565612320|FG001|Overall Study|Treatment landscape|0|||
156690291|NCT03310957|565612321|FG002|Overall Study|Treatment landscape|1|||
156690292|NCT03310957|565612322|FG003|Overall Study|Treatment landscape|1|||
156690293|NCT03310957|565612323|FG004|Overall Study|Treatment landscape|0|||
156690294|NCT03310957|565612324|FG005|Overall Study|Treatment landscape|1|||
156690295|NCT03310957|565612325|FG006|Overall Study|Treatment landscape|0|||
156690296|NCT03310957|565612319|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690297|NCT03310957|565612320|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690298|NCT03310957|565612321|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690299|NCT03310957|565612322|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690300|NCT03310957|565612323|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
156690301|NCT03310957|565612324|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690302|NCT03310957|565612325|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
156690303|NCT03310957|565612319|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690304|NCT03310957|565612320|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690305|NCT03310957|565612321|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
156690306|NCT03310957|565612322|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690307|NCT03310957|565612323|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690308|NCT03310957|565612324|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690309|NCT03310957|565612325|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
156690310|NCT03310957|565612319|FG000|Overall Study|Hospice|0|||
156690311|NCT03310957|565612320|FG001|Overall Study|Hospice|0|||
156690312|NCT03310957|565612321|FG002|Overall Study|Hospice|0|||
156690313|NCT03310957|565612322|FG003|Overall Study|Hospice|0|||
156690314|NCT03310957|565612323|FG004|Overall Study|Hospice|0|||
156690315|NCT03310957|565612324|FG005|Overall Study|Hospice|1|||
156690316|NCT03310957|565612325|FG006|Overall Study|Hospice|0|||
156690317|NCT03310957|565612319|FG000|Overall Study|Progressive|0|||
156690318|NCT03310957|565612320|FG001|Overall Study|Progressive|0|||
156690319|NCT03310957|565612321|FG002|Overall Study|Progressive|1|||
156690320|NCT03310957|565612322|FG003|Overall Study|Progressive|0|||
156690321|NCT03310957|565612323|FG004|Overall Study|Progressive|0|||
156690322|NCT03310957|565612324|FG005|Overall Study|Progressive|0|||
156690323|NCT03310957|565612325|FG006|Overall Study|Progressive|0|||
156690324|NCT02658487|565612331|FG000|Overall Study|Death|2|||
156690325|NCT02658487|565612331|FG000|Overall Study|Disease progression|10|||
156690326|NCT02658487|565612331|FG000|Overall Study|Alternative therapy|1|||
156690327|NCT02658487|565612331|FG000|Overall Study|Adverse Event|1|||
156690328|NCT02658487|565612331|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
156690329|NCT02658487|565612331|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
156690330|NCT01475253|565612345|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
156690331|NCT01475253|565612346|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
156690332|NCT01475253|565612347|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
156690333|NCT01475253|565612348|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
156690334|NCT01475253|565612345|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
156690335|NCT01475253|565612346|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
156787847|NCT00621322|565974809|FG005|Overall Study|Migrated/moved from study area|2|||
156690336|NCT01475253|565612347|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
156690337|NCT01475253|565612348|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
156690338|NCT03135899|565612349|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690339|NCT03135899|565612350|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690340|NCT03135899|565612351|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690341|NCT03135899|565612352|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690342|NCT03135899|565612353|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690343|NCT03135899|565612354|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690344|NCT03135899|565612355|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
156870128|NCT01394016|566281096|FG009|Overall Study|Adverse Event|1|||
156690345|NCT03135899|565612356|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
156690346|NCT03135899|565612349|FG000|Overall Study|Withdrawal by Subject|0|||
156690347|NCT03135899|565612350|FG001|Overall Study|Withdrawal by Subject|0|||
156690348|NCT03135899|565612351|FG002|Overall Study|Withdrawal by Subject|0|||
156690349|NCT03135899|565612352|FG003|Overall Study|Withdrawal by Subject|0|||
156690350|NCT03135899|565612353|FG004|Overall Study|Withdrawal by Subject|0|||
156690351|NCT03135899|565612354|FG005|Overall Study|Withdrawal by Subject|2|||
156690352|NCT03135899|565612355|FG006|Overall Study|Withdrawal by Subject|0|||
156690353|NCT03135899|565612356|FG007|Overall Study|Withdrawal by Subject|0|||
156870129|NCT01394016|566281097|FG010|Overall Study|Adverse Event|0|||
156870130|NCT01394016|566281098|FG011|Overall Study|Adverse Event|0|||
156690354|NCT04146363|565612357|FG000|Induction Period|Adverse Event|1|||
156690355|NCT04146363|565612358|FG001|Induction Period|Adverse Event|2|||
156690356|NCT04146363|565612359|FG002|Induction Period|Adverse Event|0|||
156690357|NCT04146363|565612360|FG003|Induction Period|Adverse Event|0|||
156690358|NCT04146363|565612361|FG004|Induction Period|Adverse Event|0|||
156690359|NCT04146363|565612362|FG005|Induction Period|Adverse Event|0|||
156690360|NCT04146363|565612363|FG006|Induction Period|Adverse Event|0|||
156690361|NCT04146363|565612364|FG007|Induction Period|Adverse Event|0|||
156690362|NCT04146363|565612365|FG008|Induction Period|Adverse Event|0|||
156690363|NCT04146363|565612366|FG009|Induction Period|Adverse Event|0|||
156690364|NCT04146363|565612367|FG010|Induction Period|Adverse Event|0|||
156690365|NCT04146363|565612357|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
156690366|NCT04146363|565612358|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
156690367|NCT04146363|565612359|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
156690368|NCT04146363|565612360|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
156690369|NCT04146363|565612361|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
156690370|NCT04146363|565612362|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
156690371|NCT04146363|565612363|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
156690372|NCT04146363|565612364|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
156690373|NCT04146363|565612365|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
156690374|NCT04146363|565612366|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
156690375|NCT04146363|565612367|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
156690376|NCT04146363|565612357|FG000|Induction Period|Lack of Efficacy|7|||
156690377|NCT04146363|565612358|FG001|Induction Period|Lack of Efficacy|2|||
156690378|NCT04146363|565612359|FG002|Induction Period|Lack of Efficacy|0|||
156690379|NCT04146363|565612360|FG003|Induction Period|Lack of Efficacy|0|||
156690380|NCT04146363|565612361|FG004|Induction Period|Lack of Efficacy|0|||
156690381|NCT04146363|565612362|FG005|Induction Period|Lack of Efficacy|0|||
156690382|NCT04146363|565612363|FG006|Induction Period|Lack of Efficacy|0|||
156690383|NCT04146363|565612364|FG007|Induction Period|Lack of Efficacy|0|||
156690384|NCT04146363|565612365|FG008|Induction Period|Lack of Efficacy|0|||
156690385|NCT04146363|565612366|FG009|Induction Period|Lack of Efficacy|0|||
156690386|NCT04146363|565612367|FG010|Induction Period|Lack of Efficacy|0|||
156690387|NCT04146363|565612357|FG000|Induction Period|Lost to Follow-up|1|||
156690388|NCT04146363|565612358|FG001|Induction Period|Lost to Follow-up|4|||
156690389|NCT04146363|565612359|FG002|Induction Period|Lost to Follow-up|0|||
156690390|NCT04146363|565612360|FG003|Induction Period|Lost to Follow-up|0|||
156690391|NCT04146363|565612361|FG004|Induction Period|Lost to Follow-up|0|||
156690392|NCT04146363|565612362|FG005|Induction Period|Lost to Follow-up|0|||
156690393|NCT04146363|565612363|FG006|Induction Period|Lost to Follow-up|0|||
156690394|NCT04146363|565612364|FG007|Induction Period|Lost to Follow-up|0|||
156690395|NCT04146363|565612365|FG008|Induction Period|Lost to Follow-up|0|||
156690396|NCT04146363|565612366|FG009|Induction Period|Lost to Follow-up|0|||
156787848|NCT01259024|565974813|FG000|Overall Study|Physician Decision|1|||
156787849|NCT01657500|565974814|FG000|Overall Study|set impropperly matched|3|||
156787850|NCT01657500|565974815|FG001|Overall Study|set impropperly matched|3|||
156787851|NCT01657500|565974814|FG000|Overall Study|Lost to Follow-up|2|||
156787852|NCT01657500|565974815|FG001|Overall Study|Lost to Follow-up|2|||
156787853|NCT00756444|565974818|FG000|Overall Study|Adverse Event|1|||
156787854|NCT00756444|565974819|FG001|Overall Study|Adverse Event|1|||
156787855|NCT00756444|565974818|FG000|Overall Study|Withdrawal by Subject|6|||
156787856|NCT00756444|565974819|FG001|Overall Study|Withdrawal by Subject|8|||
156787857|NCT00756444|565974818|FG000|Overall Study|Lost to Follow-up|0|||
156787858|NCT00756444|565974819|FG001|Overall Study|Lost to Follow-up|1|||
156787859|NCT00756444|565974818|FG000|Overall Study|Death|5|||
156787860|NCT00756444|565974819|FG001|Overall Study|Death|4|||
156690397|NCT04146363|565612367|FG010|Induction Period|Lost to Follow-up|0|||
156690398|NCT04146363|565612357|FG000|Induction Period|Positive quantiferon test|0|||
156787861|NCT00756444|565974818|FG000|Overall Study|Disease Progression|2|||
156787862|NCT00756444|565974819|FG001|Overall Study|Disease Progression|7|||
156690399|NCT04146363|565612358|FG001|Induction Period|Positive quantiferon test|1|||
156690400|NCT04146363|565612359|FG002|Induction Period|Positive quantiferon test|0|||
156690401|NCT04146363|565612360|FG003|Induction Period|Positive quantiferon test|0|||
156690402|NCT04146363|565612361|FG004|Induction Period|Positive quantiferon test|0|||
156690403|NCT04146363|565612362|FG005|Induction Period|Positive quantiferon test|0|||
156690404|NCT04146363|565612363|FG006|Induction Period|Positive quantiferon test|0|||
156690405|NCT04146363|565612364|FG007|Induction Period|Positive quantiferon test|0|||
156690406|NCT04146363|565612365|FG008|Induction Period|Positive quantiferon test|0|||
156690407|NCT04146363|565612366|FG009|Induction Period|Positive quantiferon test|0|||
156690408|NCT04146363|565612367|FG010|Induction Period|Positive quantiferon test|0|||
156690409|NCT04146363|565612357|FG000|Induction Period|Protocol Deviation|5|||
156690410|NCT04146363|565612358|FG001|Induction Period|Protocol Deviation|6|||
156690411|NCT04146363|565612359|FG002|Induction Period|Protocol Deviation|0|||
156690412|NCT04146363|565612360|FG003|Induction Period|Protocol Deviation|0|||
156690413|NCT04146363|565612361|FG004|Induction Period|Protocol Deviation|0|||
156690414|NCT04146363|565612362|FG005|Induction Period|Protocol Deviation|0|||
156690415|NCT04146363|565612363|FG006|Induction Period|Protocol Deviation|0|||
156690416|NCT04146363|565612364|FG007|Induction Period|Protocol Deviation|0|||
156690417|NCT04146363|565612365|FG008|Induction Period|Protocol Deviation|0|||
156690418|NCT04146363|565612366|FG009|Induction Period|Protocol Deviation|0|||
156690419|NCT04146363|565612367|FG010|Induction Period|Protocol Deviation|0|||
156690420|NCT04146363|565612357|FG000|Induction Period|Withdrawal by Subject|6|||
156690421|NCT04146363|565612358|FG001|Induction Period|Withdrawal by Subject|3|||
156690422|NCT04146363|565612359|FG002|Induction Period|Withdrawal by Subject|0|||
156690423|NCT04146363|565612360|FG003|Induction Period|Withdrawal by Subject|0|||
156690424|NCT04146363|565612361|FG004|Induction Period|Withdrawal by Subject|0|||
156690425|NCT04146363|565612362|FG005|Induction Period|Withdrawal by Subject|0|||
156690426|NCT04146363|565612363|FG006|Induction Period|Withdrawal by Subject|0|||
156690427|NCT04146363|565612364|FG007|Induction Period|Withdrawal by Subject|0|||
156690428|NCT04146363|565612365|FG008|Induction Period|Withdrawal by Subject|0|||
156690429|NCT04146363|565612366|FG009|Induction Period|Withdrawal by Subject|0|||
156690430|NCT04146363|565612367|FG010|Induction Period|Withdrawal by Subject|0|||
156690431|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690432|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690433|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690434|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690435|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690436|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690437|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
156690438|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
156690439|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690440|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690441|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
156690442|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690443|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690444|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690445|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690446|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690447|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690448|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690449|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
156690450|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690451|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690452|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
156690453|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690454|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690455|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690456|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690457|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690458|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690459|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
156690460|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
156690461|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690462|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690463|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
156690464|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
156787863|NCT00756444|565974818|FG000|Overall Study|Ineligibility Determined|1|||
156787864|NCT00756444|565974819|FG001|Overall Study|Ineligibility Determined|0|||
156787865|NCT00564070|565974820|FG000|Overall Study|Lost to Follow-up|9|||
156690465|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690466|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
156690467|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690468|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
156787866|NCT00564070|565974821|FG001|Overall Study|Lost to Follow-up|7|||
156690469|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
156690470|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690471|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690472|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690473|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690474|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
156690475|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690476|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690477|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690478|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690479|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
156787867|NCT00564070|565974820|FG000|Overall Study|Worsening depression, referred to care|3|||
156870131|NCT01394016|566281099|FG012|Overall Study|Adverse Event|0|||
156870132|NCT01394016|566281100|FG013|Overall Study|Adverse Event|0|||
156787868|NCT00564070|565974821|FG001|Overall Study|Worsening depression, referred to care|0|||
156787869|NCT02346370|565974822|FG000|Overall Study|Not treated|1|||
156787870|NCT02346370|565974823|FG001|Overall Study|Not treated|0|||
156787871|NCT02346370|565974824|FG002|Overall Study|Not treated|0|||
156787872|NCT02346370|565974822|FG000|Overall Study|Withdrawal of consent|1|||
156787873|NCT02346370|565974823|FG001|Overall Study|Withdrawal of consent|0|||
156787874|NCT02346370|565974824|FG002|Overall Study|Withdrawal of consent|0|||
156787875|NCT02346370|565974822|FG000|Overall Study|Death|1|||
156787876|NCT02346370|565974823|FG001|Overall Study|Death|3|||
156787877|NCT02346370|565974824|FG002|Overall Study|Death|1|||
156787878|NCT02346370|565974822|FG000|Overall Study|Sponsor discontinued study|5|||
156787879|NCT02346370|565974823|FG001|Overall Study|Sponsor discontinued study|0|||
156787880|NCT02346370|565974824|FG002|Overall Study|Sponsor discontinued study|2|||
156787881|NCT02346370|565974822|FG000|Overall Study|Radiologic progression|0|||
156787882|NCT02346370|565974823|FG001|Overall Study|Radiologic progression|0|||
156787883|NCT02346370|565974824|FG002|Overall Study|Radiologic progression|1|||
156787884|NCT02346370|565974822|FG000|Overall Study|Physician Decision|0|||
156787885|NCT02346370|565974823|FG001|Overall Study|Physician Decision|1|||
156787886|NCT02346370|565974824|FG002|Overall Study|Physician Decision|0|||
156787887|NCT01217047|565974825|FG000|Overall Study|Lost to Follow-up|0|||
156787888|NCT01217047|565974826|FG001|Overall Study|Lost to Follow-up|1|||
156787889|NCT01217047|565974827|FG002|Overall Study|Lost to Follow-up|0|||
156787890|NCT02318277|565974828|FG000|Overall Study|Physician Decision|0|||
156787891|NCT02318277|565974829|FG001|Overall Study|Physician Decision|0|||
156787892|NCT02318277|565974830|FG002|Overall Study|Physician Decision|0|||
156787893|NCT02318277|565974831|FG003|Overall Study|Physician Decision|0|||
156787894|NCT02318277|565974832|FG004|Overall Study|Physician Decision|0|||
156787895|NCT02318277|565974833|FG005|Overall Study|Physician Decision|0|||
156787896|NCT02318277|565974834|FG006|Overall Study|Physician Decision|0|||
156787897|NCT02318277|565974835|FG007|Overall Study|Physician Decision|1|||
156787898|NCT02318277|565974828|FG000|Overall Study|Other|0|||
156787899|NCT02318277|565974829|FG001|Overall Study|Other|0|||
156787900|NCT02318277|565974830|FG002|Overall Study|Other|0|||
156787901|NCT02318277|565974831|FG003|Overall Study|Other|0|||
156787902|NCT02318277|565974832|FG004|Overall Study|Other|0|||
156787903|NCT02318277|565974833|FG005|Overall Study|Other|0|||
156787904|NCT02318277|565974834|FG006|Overall Study|Other|1|||
156787905|NCT02318277|565974835|FG007|Overall Study|Other|0|||
156787906|NCT02318277|565974828|FG000|Overall Study|Withdrawal by Subject|0|||
156787907|NCT02318277|565974829|FG001|Overall Study|Withdrawal by Subject|0|||
156787908|NCT02318277|565974830|FG002|Overall Study|Withdrawal by Subject|1|||
156787909|NCT02318277|565974831|FG003|Overall Study|Withdrawal by Subject|0|||
156787910|NCT02318277|565974832|FG004|Overall Study|Withdrawal by Subject|1|||
156787911|NCT02318277|565974833|FG005|Overall Study|Withdrawal by Subject|1|||
156787912|NCT02318277|565974834|FG006|Overall Study|Withdrawal by Subject|6|||
156787913|NCT02318277|565974835|FG007|Overall Study|Withdrawal by Subject|14|||
156787914|NCT02318277|565974828|FG000|Overall Study|Participant trial terminated by sponsor|0|||
156787915|NCT02318277|565974829|FG001|Overall Study|Participant trial terminated by sponsor|0|||
156787916|NCT02318277|565974830|FG002|Overall Study|Participant trial terminated by sponsor|1|||
156787917|NCT02318277|565974831|FG003|Overall Study|Participant trial terminated by sponsor|0|||
156787918|NCT02318277|565974832|FG004|Overall Study|Participant trial terminated by sponsor|1|||
156787919|NCT02318277|565974833|FG005|Overall Study|Participant trial terminated by sponsor|2|||
156787920|NCT02318277|565974834|FG006|Overall Study|Participant trial terminated by sponsor|5|||
156787921|NCT02318277|565974835|FG007|Overall Study|Participant trial terminated by sponsor|16|||
156787922|NCT02318277|565974828|FG000|Overall Study|Lost to Follow-up|1|||
156787923|NCT02318277|565974829|FG001|Overall Study|Lost to Follow-up|0|||
156787924|NCT02318277|565974830|FG002|Overall Study|Lost to Follow-up|1|||
156787925|NCT02318277|565974831|FG003|Overall Study|Lost to Follow-up|0|||
156787926|NCT02318277|565974832|FG004|Overall Study|Lost to Follow-up|0|||
156787927|NCT02318277|565974833|FG005|Overall Study|Lost to Follow-up|0|||
156787928|NCT02318277|565974834|FG006|Overall Study|Lost to Follow-up|3|||
156870133|NCT01394016|566281101|FG014|Overall Study|Adverse Event|0|||
156690480|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
156690481|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
156690482|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
156690483|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690484|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690485|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
156690486|NCT04146363|565612357|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690487|NCT04146363|565612358|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690488|NCT04146363|565612359|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
156690489|NCT04146363|565612360|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690490|NCT04146363|565612361|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690491|NCT04146363|565612362|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
156690492|NCT04146363|565612363|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
156690493|NCT04146363|565612364|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
156690494|NCT04146363|565612365|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690495|NCT04146363|565612366|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690496|NCT04146363|565612367|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
156690497|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690498|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690499|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690500|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690501|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690502|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690503|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690504|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690505|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
156690506|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
156690507|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
156690508|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690509|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690510|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690511|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690512|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690513|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690514|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690515|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156690516|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
156690517|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
156690518|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
156690519|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690520|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690521|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690522|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690523|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690524|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690525|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690526|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690527|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
156690528|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
156690529|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156690530|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690531|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690532|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690533|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690534|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690535|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690536|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690537|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690538|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
156690539|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
156690540|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
156690541|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157214479|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
157214480|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
156690542|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690543|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156870134|NCT01394016|566281102|FG015|Overall Study|Adverse Event|0|||
156870135|NCT01394016|566281103|FG016|Overall Study|Adverse Event|1|||
156870136|NCT01394016|566281104|FG017|Overall Study|Adverse Event|1|||
156690544|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690545|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690546|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690547|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690548|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156690549|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
156690550|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
156690551|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
156690552|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690553|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690554|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690555|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690556|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690557|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690558|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690559|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690560|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690561|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
156690562|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
156690563|NCT04146363|565612357|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690564|NCT04146363|565612358|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690565|NCT04146363|565612359|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690566|NCT04146363|565612360|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690567|NCT04146363|565612361|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156787929|NCT02318277|565974835|FG007|Overall Study|Lost to Follow-up|4|||
156787930|NCT02318277|565974828|FG000|Overall Study|Death|5|||
156787931|NCT02318277|565974829|FG001|Overall Study|Death|3|||
156787932|NCT02318277|565974830|FG002|Overall Study|Death|1|||
156787933|NCT02318277|565974831|FG003|Overall Study|Death|4|||
156870137|NCT01394016|566281105|FG018|Overall Study|Adverse Event|0|||
156870138|NCT01394016|566281087|FG000|Overall Study|Sponsor Decision|0|||
156870139|NCT01394016|566281088|FG001|Overall Study|Sponsor Decision|0|||
156870140|NCT01394016|566281089|FG002|Overall Study|Sponsor Decision|0|||
156870141|NCT01394016|566281090|FG003|Overall Study|Sponsor Decision|0|||
156870142|NCT01394016|566281091|FG004|Overall Study|Sponsor Decision|0|||
156870143|NCT01394016|566281092|FG005|Overall Study|Sponsor Decision|0|||
156870144|NCT01394016|566281093|FG006|Overall Study|Sponsor Decision|0|||
156870145|NCT01394016|566281094|FG007|Overall Study|Sponsor Decision|0|||
156870146|NCT01394016|566281095|FG008|Overall Study|Sponsor Decision|0|||
156870147|NCT01394016|566281096|FG009|Overall Study|Sponsor Decision|0|||
156870148|NCT01394016|566281097|FG010|Overall Study|Sponsor Decision|0|||
156870149|NCT01394016|566281098|FG011|Overall Study|Sponsor Decision|0|||
156870150|NCT01394016|566281099|FG012|Overall Study|Sponsor Decision|1|||
156870151|NCT01394016|566281100|FG013|Overall Study|Sponsor Decision|0|||
156870152|NCT01394016|566281101|FG014|Overall Study|Sponsor Decision|0|||
156870153|NCT01394016|566281102|FG015|Overall Study|Sponsor Decision|0|||
156870154|NCT01394016|566281103|FG016|Overall Study|Sponsor Decision|0|||
156870155|NCT01394016|566281104|FG017|Overall Study|Sponsor Decision|0|||
156870156|NCT01394016|566281105|FG018|Overall Study|Sponsor Decision|0|||
156870157|NCT01394016|566281087|FG000|Overall Study|Lost to Follow-up|0|||
156870158|NCT01394016|566281088|FG001|Overall Study|Lost to Follow-up|0|||
156870159|NCT01394016|566281089|FG002|Overall Study|Lost to Follow-up|0|||
156870160|NCT01394016|566281090|FG003|Overall Study|Lost to Follow-up|0|||
156870161|NCT01394016|566281091|FG004|Overall Study|Lost to Follow-up|0|||
156787934|NCT02318277|565974832|FG004|Overall Study|Death|6|||
156787935|NCT02318277|565974833|FG005|Overall Study|Death|5|||
156787936|NCT02318277|565974834|FG006|Overall Study|Death|34|||
156787937|NCT02318277|565974835|FG007|Overall Study|Death|58|||
156690568|NCT04146363|565612362|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690569|NCT04146363|565612363|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690570|NCT04146363|565612364|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156787938|NCT02318277|565974828|FG000|Overall Study|Transitioned to Hospice|0|||
156787939|NCT02318277|565974829|FG001|Overall Study|Transitioned to Hospice|0|||
156787940|NCT02318277|565974830|FG002|Overall Study|Transitioned to Hospice|0|||
156787941|NCT02318277|565974831|FG003|Overall Study|Transitioned to Hospice|0|||
156787942|NCT02318277|565974832|FG004|Overall Study|Transitioned to Hospice|0|||
156787943|NCT02318277|565974833|FG005|Overall Study|Transitioned to Hospice|1|||
156787944|NCT02318277|565974834|FG006|Overall Study|Transitioned to Hospice|0|||
156870162|NCT01394016|566281092|FG005|Overall Study|Lost to Follow-up|0|||
156870163|NCT01394016|566281093|FG006|Overall Study|Lost to Follow-up|0|||
156870164|NCT01394016|566281094|FG007|Overall Study|Lost to Follow-up|0|||
156870165|NCT01394016|566281095|FG008|Overall Study|Lost to Follow-up|0|||
156870166|NCT01394016|566281096|FG009|Overall Study|Lost to Follow-up|0|||
157214481|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
156690571|NCT04146363|565612365|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690572|NCT04146363|565612366|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
156690573|NCT04146363|565612367|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
156690574|NCT02914236|565612372|FG000|Overall Study|Lost to Follow-up|1|||
156690575|NCT00380692|565612375|FG000|Study Period II - Double Blind|Adverse Event|1|||
156690576|NCT00380692|565612376|FG001|Study Period II - Double Blind|Adverse Event|0|||
156690577|NCT00380692|565612375|FG000|Study Period II - Double Blind|Protocol Violation|2|||
156690578|NCT00380692|565612376|FG001|Study Period II - Double Blind|Protocol Violation|2|||
156690579|NCT00380692|565612375|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
156690580|NCT00380692|565612376|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
156690581|NCT00380692|565612375|FG000|Study Period II - Double Blind|Physician Decision|0|||
156690582|NCT00380692|565612376|FG001|Study Period II - Double Blind|Physician Decision|1|||
156690583|NCT00380692|565612375|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
156690584|NCT00380692|565612376|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
156690585|NCT00380692|565612375|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
156690586|NCT00380692|565612376|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
156690587|NCT00380692|565612375|FG000|Study Period III - Open Label|Adverse Event|5|||
156690588|NCT00380692|565612376|FG001|Study Period III - Open Label|Adverse Event|3|||
156690589|NCT00380692|565612375|FG000|Study Period III - Open Label|Protocol Violation|0|||
156690590|NCT00380692|565612376|FG001|Study Period III - Open Label|Protocol Violation|0|||
156690591|NCT00380692|565612375|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
156690592|NCT00380692|565612376|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
156690593|NCT00380692|565612375|FG000|Study Period III - Open Label|Physician Decision|0|||
156690594|NCT00380692|565612376|FG001|Study Period III - Open Label|Physician Decision|3|||
156690595|NCT00380692|565612375|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
156690596|NCT00380692|565612376|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
156690597|NCT00380692|565612375|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
156690598|NCT00380692|565612376|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
156690599|NCT02676284|565612377|FG000|Overall Study|Withdrawal by Subject|1|||
156690600|NCT00107042|565612378|FG000|Overall Study|Lost to Follow-up|9|||
156690601|NCT00107042|565612379|FG001|Overall Study|Lost to Follow-up|7|||
156690602|NCT00107042|565612378|FG000|Overall Study|Withdrawal by Subject|6|||
156690603|NCT00107042|565612379|FG001|Overall Study|Withdrawal by Subject|1|||
156690604|NCT00107042|565612378|FG000|Overall Study|Moved out of area|5|||
156690605|NCT00107042|565612379|FG001|Overall Study|Moved out of area|3|||
156690606|NCT00107042|565612378|FG000|Overall Study|Pregnancy|1|||
156690607|NCT00107042|565612379|FG001|Overall Study|Pregnancy|1|||
156690608|NCT00107042|565612378|FG000|Overall Study|Inadvertent enrollment|0|||
156690609|NCT00107042|565612379|FG001|Overall Study|Inadvertent enrollment|1|||
156690610|NCT00107042|565612378|FG000|Overall Study|vaccinated outside window|1|||
156690611|NCT00107042|565612379|FG001|Overall Study|vaccinated outside window|1|||
156690612|NCT00107042|565612378|FG000|Overall Study|Disallowed medications|0|||
156690613|NCT00107042|565612379|FG001|Overall Study|Disallowed medications|2|||
156690614|NCT03919448|565612381|FG000|Overall Study|Withdrawal by Subject|1|||
156690615|NCT03919448|565612382|FG001|Overall Study|Withdrawal by Subject|0|||
156690616|NCT03919448|565612383|FG002|Overall Study|Withdrawal by Subject|0|||
156690617|NCT01221090|565612385|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
156690618|NCT01221090|565612386|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
156690619|NCT01221090|565612387|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
156690620|NCT01221090|565612388|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
156690621|NCT01221090|565612385|FG000|Overall Study|Withdrawal by Subject|0|||
156690622|NCT01221090|565612386|FG001|Overall Study|Withdrawal by Subject|22|||
156690623|NCT01221090|565612387|FG002|Overall Study|Withdrawal by Subject|27|||
156690624|NCT01221090|565612388|FG003|Overall Study|Withdrawal by Subject|2|||
156690625|NCT04507126|565612389|FG000|Overall Study|Withdrawal by Subject|3|||
156690626|NCT04507126|565612389|FG000|Overall Study|Protocol Violation|4|||
156690627|NCT00708708|565612390|FG000|Overall Study|Another therapy instead of Enbrel|141|||
156690628|NCT00708708|565612390|FG000|Overall Study|Lost to Follow-up|52|||
156690629|NCT00708708|565612390|FG000|Overall Study|Withdrawal by Subject|51|||
156690630|NCT00708708|565612390|FG000|Overall Study|Intolerance|42|||
156690631|NCT00708708|565612390|FG000|Overall Study|Another therapy along with Enbrel|15|||
156690632|NCT00708708|565612390|FG000|Overall Study|Other unspecified|11|||
156690633|NCT00708708|565612390|FG000|Overall Study|Good effectiveness|9|||
156690634|NCT00708708|565612390|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
156690635|NCT00708708|565612390|FG000|Overall Study|Administrative reasons|7|||
156690636|NCT00708708|565612390|FG000|Overall Study|Lack of effectiveness|4|||
156690637|NCT00708708|565612390|FG000|Overall Study|Lack of compliance|3|||
156690638|NCT00708708|565612390|FG000|Overall Study|Pregnancy|3|||
156690639|NCT00708708|565612390|FG000|Overall Study|Adverse Event|3|||
156690640|NCT00708708|565612390|FG000|Overall Study|Missing values|392|||
156690641|NCT01287039|565612392|FG000|Overall Study|Noncompliance with study procedures|0|||
156690642|NCT01287039|565612393|FG001|Overall Study|Noncompliance with study procedures|1|||
156690643|NCT01287039|565612392|FG000|Overall Study|Change of location/residence|0|||
156690644|NCT01287039|565612393|FG001|Overall Study|Change of location/residence|3|||
156690645|NCT01287039|565612392|FG000|Overall Study|Elective surgery|0|||
156690646|NCT01287039|565612393|FG001|Overall Study|Elective surgery|1|||
156690647|NCT01287039|565612392|FG000|Overall Study|Protocol Violation|2|||
156690648|NCT01287039|565612393|FG001|Overall Study|Protocol Violation|3|||
156690649|NCT01287039|565612392|FG000|Overall Study|Excluded medication taken|1|||
156690650|NCT01287039|565612393|FG001|Overall Study|Excluded medication taken|0|||
156787945|NCT02318277|565974835|FG007|Overall Study|Transitioned to Hospice|0|||
156787946|NCT03364686|565974836|FG000|Overall Study|Physician Decision|2|||
156787947|NCT00501085|565974837|FG000|Overall Study|Lost to Follow-up|195|||
156787948|NCT00501085|565974837|FG000|Overall Study|Withdrawal by Subject|34|||
156787949|NCT00501085|565974837|FG000|Overall Study|Subject Decision|1|||
156787950|NCT00501085|565974837|FG000|Overall Study|Revision Surgery|7|||
156787951|NCT00501085|565974837|FG000|Overall Study|Explantation Surgery|26|||
156787952|NCT00501085|565974837|FG000|Overall Study|Adverse Event|4|||
156787953|NCT00501085|565974837|FG000|Overall Study|Non-Compliance|24|||
156787954|NCT00501085|565974837|FG000|Overall Study|Study closed by sponsor|109|||
156787955|NCT00501085|565974837|FG000|Overall Study|Other loss to follow-up|32|||
156787956|NCT02362412|565974841|FG000|Treatment Period III|Lost to Follow-up|0|||
156787957|NCT02362412|565974842|FG001|Treatment Period III|Lost to Follow-up|1|||
156787958|NCT02675452|565974844|FG000|Overall Study|Sponsor decision|0|||
156787959|NCT02675452|565974845|FG001|Overall Study|Sponsor decision|0|||
156787960|NCT02675452|565974846|FG002|Overall Study|Sponsor decision|0|||
156787961|NCT02675452|565974847|FG003|Overall Study|Sponsor decision|0|||
156787962|NCT02675452|565974848|FG004|Overall Study|Sponsor decision|0|||
156787963|NCT02675452|565974849|FG005|Overall Study|Sponsor decision|0|||
156787964|NCT02675452|565974850|FG006|Overall Study|Sponsor decision|0|||
156787965|NCT02675452|565974851|FG007|Overall Study|Sponsor decision|0|||
156787966|NCT02675452|565974852|FG008|Overall Study|Sponsor decision|0|||
156787967|NCT02675452|565974853|FG009|Overall Study|Sponsor decision|1|||
156787968|NCT02675452|565974854|FG010|Overall Study|Sponsor decision|0|||
156787969|NCT02675452|565974855|FG011|Overall Study|Sponsor decision|0|||
156787970|NCT02675452|565974856|FG012|Overall Study|Sponsor decision|0|||
156787971|NCT02675452|565974857|FG013|Overall Study|Sponsor decision|2|||
156787972|NCT02675452|565974858|FG014|Overall Study|Sponsor decision|1|||
156787973|NCT02675452|565974859|FG015|Overall Study|Sponsor decision|0|||
156787974|NCT02675452|565974860|FG016|Overall Study|Sponsor decision|1|||
156787975|NCT02675452|565974861|FG017|Overall Study|Sponsor decision|0|||
156787976|NCT02675452|565974862|FG018|Overall Study|Sponsor decision|0|||
156787977|NCT02675452|565974863|FG019|Overall Study|Sponsor decision|0|||
156787978|NCT02675452|565974864|FG020|Overall Study|Sponsor decision|0|||
156787979|NCT02675452|565974865|FG021|Overall Study|Sponsor decision|0|||
156787980|NCT02675452|565974866|FG022|Overall Study|Sponsor decision|0|||
156787981|NCT02675452|565974867|FG023|Overall Study|Sponsor decision|0|||
156787982|NCT02675452|565974868|FG024|Overall Study|Sponsor decision|0|||
156787983|NCT02675452|565974869|FG025|Overall Study|Sponsor decision|0|||
156787984|NCT02675452|565974870|FG026|Overall Study|Sponsor decision|2|||
156787985|NCT02675452|565974871|FG027|Overall Study|Sponsor decision|0|||
156787986|NCT02675452|565974872|FG028|Overall Study|Sponsor decision|0|||
157121580|NCT05103332|567195980|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121581|NCT05103332|567195981|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121582|NCT05103332|567195982|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156787987|NCT02675452|565974844|FG000|Overall Study|Withdrawal by Subject|0|||
156787988|NCT02675452|565974845|FG001|Overall Study|Withdrawal by Subject|0|||
156787989|NCT02675452|565974846|FG002|Overall Study|Withdrawal by Subject|0|||
156787990|NCT02675452|565974847|FG003|Overall Study|Withdrawal by Subject|0|||
156787991|NCT02675452|565974848|FG004|Overall Study|Withdrawal by Subject|0|||
156787992|NCT02675452|565974849|FG005|Overall Study|Withdrawal by Subject|0|||
156787993|NCT02675452|565974850|FG006|Overall Study|Withdrawal by Subject|0|||
156787994|NCT02675452|565974851|FG007|Overall Study|Withdrawal by Subject|0|||
156787995|NCT02675452|565974852|FG008|Overall Study|Withdrawal by Subject|0|||
156787996|NCT02675452|565974853|FG009|Overall Study|Withdrawal by Subject|1|||
156787997|NCT02675452|565974854|FG010|Overall Study|Withdrawal by Subject|0|||
156787998|NCT02675452|565974855|FG011|Overall Study|Withdrawal by Subject|1|||
156787999|NCT02675452|565974856|FG012|Overall Study|Withdrawal by Subject|0|||
156788000|NCT02675452|565974857|FG013|Overall Study|Withdrawal by Subject|1|||
156788001|NCT02675452|565974858|FG014|Overall Study|Withdrawal by Subject|1|||
156788002|NCT02675452|565974859|FG015|Overall Study|Withdrawal by Subject|0|||
156788003|NCT02675452|565974860|FG016|Overall Study|Withdrawal by Subject|2|||
156788004|NCT02675452|565974861|FG017|Overall Study|Withdrawal by Subject|0|||
156788005|NCT02675452|565974862|FG018|Overall Study|Withdrawal by Subject|0|||
156788006|NCT02675452|565974863|FG019|Overall Study|Withdrawal by Subject|0|||
156788007|NCT02675452|565974864|FG020|Overall Study|Withdrawal by Subject|0|||
157121583|NCT05103332|567195983|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156788008|NCT02675452|565974865|FG021|Overall Study|Withdrawal by Subject|0|||
156690651|NCT01287039|565612392|FG000|Overall Study|Noncompliance with study medication|0|||
156690652|NCT01287039|565612393|FG001|Overall Study|Noncompliance with study medication|1|||
156690653|NCT01287039|565612392|FG000|Overall Study|Problem with travel|0|||
156690654|NCT01287039|565612393|FG001|Overall Study|Problem with travel|1|||
156690655|NCT01287039|565612392|FG000|Overall Study|Death|1|||
156690656|NCT01287039|565612393|FG001|Overall Study|Death|0|||
156690657|NCT01287039|565612392|FG000|Overall Study|Change of residence|1|||
156690658|NCT01287039|565612393|FG001|Overall Study|Change of residence|0|||
156690659|NCT01287039|565612392|FG000|Overall Study|Adverse Event|7|||
156690660|NCT01287039|565612393|FG001|Overall Study|Adverse Event|4|||
156690661|NCT01287039|565612392|FG000|Overall Study|Withdrawal by Subject|14|||
156690662|NCT01287039|565612393|FG001|Overall Study|Withdrawal by Subject|11|||
156690663|NCT01287039|565612392|FG000|Overall Study|Lost to Follow-up|3|||
156690664|NCT01287039|565612393|FG001|Overall Study|Lost to Follow-up|2|||
156690665|NCT01223235|565612394|FG000|Overall Study|Withdrawal by Subject|1|||
156690666|NCT06972251|565612413|FG000|Overall Study|Withdrawal by Subject|1|||
156690667|NCT06972251|565612414|FG001|Overall Study|Withdrawal by Subject|0|||
156690668|NCT06972251|565612413|FG000|Overall Study|Lost to Follow-up|10|||
156690669|NCT06972251|565612414|FG001|Overall Study|Lost to Follow-up|2|||
156690670|NCT05224544|565612418|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
156690671|NCT05224544|565612419|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
156690672|NCT00351351|565612425|FG000|Overall Study|surgical access pbs; device issues|9|||
156690673|NCT00351351|565612426|FG001|Overall Study|surgical access pbs; device issues|4|||
156690674|NCT01341587|565612427|FG000|Overall Study|Lost to Follow-up|2|||
156690675|NCT01341587|565612428|FG001|Overall Study|Lost to Follow-up|0|||
156690676|NCT01341587|565612427|FG000|Overall Study|stopped using the meters|2|||
156690677|NCT01341587|565612428|FG001|Overall Study|stopped using the meters|10|||
156690678|NCT03891329|565612430|FG000|Overall Study|Death|5|||
156690679|NCT03891329|565612430|FG000|Overall Study|Lost to Follow-up|4|||
156690680|NCT03891329|565612430|FG000|Overall Study|Physician Decision|4|||
156690681|NCT03891329|565612430|FG000|Overall Study|Device explanted|3|||
156690682|NCT03891329|565612430|FG000|Overall Study|No study device implanted|3|||
156690683|NCT03176784|565612431|FG000|Overall Study|Lost to Follow-up|77|||
156690684|NCT03176784|565612432|FG001|Overall Study|Lost to Follow-up|79|||
156690685|NCT03176784|565612433|FG002|Overall Study|Lost to Follow-up|79|||
156690686|NCT03176784|565612434|FG003|Overall Study|Lost to Follow-up|49|||
156690687|NCT03176784|565612431|FG000|Overall Study|Withdrawal by Subject|28|||
156690688|NCT03176784|565612432|FG001|Overall Study|Withdrawal by Subject|34|||
156690689|NCT03176784|565612433|FG002|Overall Study|Withdrawal by Subject|34|||
156690690|NCT03176784|565612434|FG003|Overall Study|Withdrawal by Subject|21|||
156690691|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
156690692|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
156690693|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
156690694|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
156690695|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
156690696|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
156690697|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
156690698|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
156690699|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
156690700|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
156690701|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
156690702|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
156690703|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690704|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690705|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690706|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690707|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
156690708|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
156690709|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
156690710|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
156690711|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
156690712|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
156690713|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
156690714|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
156690715|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
156690716|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
156690717|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
156690718|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
156690719|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Death|0|||
156690720|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Death|1|||
156690721|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Death|0|||
156690722|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Death|0|||
156690723|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
156690724|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
156870167|NCT01394016|566281097|FG010|Overall Study|Lost to Follow-up|0|||
156690725|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
157145165|NCT05755438|567278013|FG001|40-week OLE Period|Lost to Follow-up|0|||
156690726|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
156690727|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690728|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
156690729|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690730|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
156690731|NCT02990806|565612435|FG000|Stage 1 (22 Weeks)|Other|1|||
156690732|NCT02990806|565612436|FG001|Stage 1 (22 Weeks)|Other|3|||
156690733|NCT02990806|565612437|FG002|Stage 1 (22 Weeks)|Other|0|||
156690734|NCT02990806|565612438|FG003|Stage 1 (22 Weeks)|Other|0|||
156690735|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
156690736|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
156690737|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
156690738|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
156690739|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Death|1|||
156690740|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Death|0|||
156690741|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Death|0|||
156690742|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Death|0|||
156690743|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
156690744|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
156690745|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
156690746|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
156690747|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
156690748|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
156690749|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
156690750|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
156690751|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690752|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
156690753|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690754|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
156690755|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
156690756|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
156690757|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
156690758|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
156690759|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690760|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690761|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
156690762|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
156690763|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
156690764|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
156690765|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
156690766|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
156690767|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
156690768|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
156690769|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
156690770|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
156690771|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
156690772|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
156690773|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
156690774|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
156690775|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
156690776|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
156690777|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
156690778|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
156788009|NCT02675452|565974866|FG022|Overall Study|Withdrawal by Subject|3|||
156788010|NCT02675452|565974867|FG023|Overall Study|Withdrawal by Subject|0|||
156788011|NCT02675452|565974868|FG024|Overall Study|Withdrawal by Subject|1|||
156788012|NCT02675452|565974869|FG025|Overall Study|Withdrawal by Subject|0|||
156788013|NCT02675452|565974870|FG026|Overall Study|Withdrawal by Subject|1|||
156788014|NCT02675452|565974871|FG027|Overall Study|Withdrawal by Subject|3|||
156788015|NCT02675452|565974872|FG028|Overall Study|Withdrawal by Subject|4|||
156788016|NCT02675452|565974844|FG000|Overall Study|Death|0|||
156788017|NCT02675452|565974845|FG001|Overall Study|Death|0|||
156788018|NCT02675452|565974846|FG002|Overall Study|Death|1|||
156870168|NCT01394016|566281098|FG011|Overall Study|Lost to Follow-up|0|||
156690779|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Other|3|||
156690780|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Other|0|||
156690781|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Other|4|||
156690782|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Other|1|||
156690783|NCT02990806|565612435|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156690784|NCT02990806|565612436|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156788019|NCT02675452|565974847|FG003|Overall Study|Death|0|||
156690785|NCT02990806|565612437|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
156690786|NCT02990806|565612438|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
156690787|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
156690788|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
156690789|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
156690790|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
156690791|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690792|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
156690793|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690794|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
156690795|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690796|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
156690797|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690798|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
156690799|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
156690800|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
156690801|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
156690802|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
156690803|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
156690804|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
156690805|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
156690806|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
156690807|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690808|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690809|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
156690810|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
156690811|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690812|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690813|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
156690814|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
156690815|NCT02990806|565612435|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690816|NCT02990806|565612436|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690817|NCT02990806|565612437|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
156690818|NCT02990806|565612438|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
156690819|NCT02654587|565612439|FG000|Overall Study|patient alive at end of study|22|||
156690820|NCT02654587|565612440|FG001|Overall Study|patient alive at end of study|8|||
156690821|NCT02654587|565612439|FG000|Overall Study|Withdrawal by Subject|1|||
156690822|NCT02654587|565612440|FG001|Overall Study|Withdrawal by Subject|7|||
156690823|NCT01825837|565612441|FG000|PART I|Withdrawal by Subject|0|||
156690824|NCT01825837|565612442|FG001|PART I|Withdrawal by Subject|0|||
156690825|NCT01825837|565612443|FG002|PART I|Withdrawal by Subject|0|||
156690826|NCT01825837|565612444|FG003|PART I|Withdrawal by Subject|6|||
156690827|NCT01825837|565612441|FG000|PART I|Patient non-compliance|0|||
156690828|NCT01825837|565612442|FG001|PART I|Patient non-compliance|0|||
156690829|NCT01825837|565612443|FG002|PART I|Patient non-compliance|0|||
156690830|NCT01825837|565612444|FG003|PART I|Patient non-compliance|1|||
156690831|NCT01825837|565612441|FG000|PART I|Treatment failure|0|||
156690832|NCT01825837|565612442|FG001|PART I|Treatment failure|0|||
156788020|NCT02675452|565974848|FG004|Overall Study|Death|0|||
157214482|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
157214483|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
156788021|NCT02675452|565974849|FG005|Overall Study|Death|1|||
156788022|NCT02675452|565974850|FG006|Overall Study|Death|0|||
156788023|NCT02675452|565974851|FG007|Overall Study|Death|0|||
156788024|NCT02675452|565974852|FG008|Overall Study|Death|1|||
156788025|NCT02675452|565974853|FG009|Overall Study|Death|0|||
156788026|NCT02675452|565974854|FG010|Overall Study|Death|0|||
156788027|NCT02675452|565974855|FG011|Overall Study|Death|0|||
156788028|NCT02675452|565974856|FG012|Overall Study|Death|1|||
156788029|NCT02675452|565974857|FG013|Overall Study|Death|0|||
156788030|NCT02675452|565974858|FG014|Overall Study|Death|0|||
156788031|NCT02675452|565974859|FG015|Overall Study|Death|2|||
156788032|NCT02675452|565974860|FG016|Overall Study|Death|0|||
156788033|NCT02675452|565974861|FG017|Overall Study|Death|0|||
156788034|NCT02675452|565974862|FG018|Overall Study|Death|4|||
156788035|NCT02675452|565974863|FG019|Overall Study|Death|3|||
156788036|NCT02675452|565974864|FG020|Overall Study|Death|3|||
156788037|NCT02675452|565974865|FG021|Overall Study|Death|3|||
156788038|NCT02675452|565974866|FG022|Overall Study|Death|7|||
156788039|NCT02675452|565974867|FG023|Overall Study|Death|5|||
156788040|NCT02675452|565974868|FG024|Overall Study|Death|3|||
156690833|NCT01825837|565612443|FG002|PART I|Treatment failure|0|||
156690834|NCT01825837|565612444|FG003|PART I|Treatment failure|7|||
156690835|NCT01825837|565612441|FG000|PART I|reason unspecified|0|||
156690836|NCT01825837|565612442|FG001|PART I|reason unspecified|0|||
156690837|NCT01825837|565612443|FG002|PART I|reason unspecified|0|||
156690838|NCT01825837|565612444|FG003|PART I|reason unspecified|3|||
156690839|NCT01825837|565612441|FG000|PART II|Withdrawal by Subject|3|||
156690840|NCT01825837|565612442|FG001|PART II|Withdrawal by Subject|3|||
156690841|NCT01825837|565612443|FG002|PART II|Withdrawal by Subject|7|||
156690842|NCT01825837|565612444|FG003|PART II|Withdrawal by Subject|0|||
156690843|NCT01825837|565612441|FG000|PART II|Patient non-compliance|5|||
156690844|NCT01825837|565612442|FG001|PART II|Patient non-compliance|2|||
156690845|NCT01825837|565612443|FG002|PART II|Patient non-compliance|4|||
156690846|NCT01825837|565612444|FG003|PART II|Patient non-compliance|0|||
156690847|NCT01825837|565612441|FG000|PART II|Adverse Event|3|||
156690848|NCT01825837|565612442|FG001|PART II|Adverse Event|3|||
156690849|NCT01825837|565612443|FG002|PART II|Adverse Event|1|||
156690850|NCT01825837|565612444|FG003|PART II|Adverse Event|0|||
156690851|NCT01825837|565612441|FG000|PART II|Treatment failure|6|||
156690852|NCT01825837|565612442|FG001|PART II|Treatment failure|4|||
156690853|NCT01825837|565612443|FG002|PART II|Treatment failure|5|||
156690854|NCT01825837|565612444|FG003|PART II|Treatment failure|0|||
156690855|NCT01825837|565612441|FG000|PART II|reason unspecified|2|||
156690856|NCT01825837|565612442|FG001|PART II|reason unspecified|2|||
156690857|NCT01825837|565612443|FG002|PART II|reason unspecified|2|||
156690858|NCT01825837|565612444|FG003|PART II|reason unspecified|0|||
156690859|NCT00904748|565612447|FG000|Overall Study|Withdrawal by Subject|1|||
156690860|NCT00904748|565612448|FG001|Overall Study|Withdrawal by Subject|1|||
156690861|NCT00904748|565612449|FG002|Overall Study|Withdrawal by Subject|1|||
156690862|NCT00904748|565612450|FG003|Overall Study|Withdrawal by Subject|2|||
156690863|NCT00904748|565612451|FG004|Overall Study|Withdrawal by Subject|0|||
156690864|NCT00904748|565612452|FG005|Overall Study|Withdrawal by Subject|0|||
156690865|NCT00904748|565612447|FG000|Overall Study|Adverse Event|0|||
156690866|NCT00904748|565612448|FG001|Overall Study|Adverse Event|0|||
156690867|NCT00904748|565612449|FG002|Overall Study|Adverse Event|0|||
156690868|NCT00904748|565612450|FG003|Overall Study|Adverse Event|0|||
156690869|NCT00904748|565612451|FG004|Overall Study|Adverse Event|1|||
156690870|NCT00904748|565612452|FG005|Overall Study|Adverse Event|0|||
156690871|NCT01682148|565612453|FG000|Overall Study|Withdrawal by Subject|2|||
156690872|NCT01682148|565612454|FG001|Overall Study|Withdrawal by Subject|0|||
156690873|NCT01682148|565612453|FG000|Overall Study|Lost to Follow-up|1|||
156690874|NCT01682148|565612454|FG001|Overall Study|Lost to Follow-up|2|||
156690875|NCT01682148|565612453|FG000|Overall Study|Protocol Violation|1|||
156690876|NCT01682148|565612454|FG001|Overall Study|Protocol Violation|1|||
156690877|NCT01056640|565612455|FG000|Overall Study|Withdrawal by Subject|11|||
156690878|NCT01056640|565612456|FG001|Overall Study|Withdrawal by Subject|8|||
156690879|NCT01056640|565612455|FG000|Overall Study|Death|15|||
156690880|NCT01056640|565612456|FG001|Overall Study|Death|4|||
156690881|NCT01803269|565612457|FG000|Overall Study|Withdrawal by Subject|3|||
156690882|NCT01803269|565612458|FG001|Overall Study|Withdrawal by Subject|0|||
156690883|NCT01803269|565612459|FG002|Overall Study|Withdrawal by Subject|0|||
156690884|NCT01202877|565612460|FG000|Overall Study|Disease Progression|0|||
156690885|NCT01202877|565612461|FG001|Overall Study|Disease Progression|1|||
156690886|NCT01202877|565612462|FG002|Overall Study|Disease Progression|2|||
156690887|NCT01202877|565612460|FG000|Overall Study|Adverse Event|0|||
156690888|NCT01202877|565612461|FG001|Overall Study|Adverse Event|0|||
156690889|NCT01202877|565612462|FG002|Overall Study|Adverse Event|2|||
156690890|NCT01202877|565612460|FG000|Overall Study|Withdrawal by Subject|0|||
156690891|NCT01202877|565612461|FG001|Overall Study|Withdrawal by Subject|0|||
156690892|NCT01202877|565612462|FG002|Overall Study|Withdrawal by Subject|1|||
156690893|NCT01202877|565612460|FG000|Overall Study|Death|0|||
156690894|NCT01202877|565612461|FG001|Overall Study|Death|0|||
156788041|NCT02675452|565974869|FG025|Overall Study|Death|4|||
156788042|NCT02675452|565974870|FG026|Overall Study|Death|7|||
156788043|NCT02675452|565974871|FG027|Overall Study|Death|6|||
156788044|NCT02675452|565974872|FG028|Overall Study|Death|9|||
156788045|NCT02675452|565974844|FG000|Overall Study|Lost to Follow-up|0|||
156788046|NCT02675452|565974845|FG001|Overall Study|Lost to Follow-up|1|||
156788047|NCT02675452|565974846|FG002|Overall Study|Lost to Follow-up|0|||
156788048|NCT02675452|565974847|FG003|Overall Study|Lost to Follow-up|0|||
156788049|NCT02675452|565974848|FG004|Overall Study|Lost to Follow-up|0|||
156788050|NCT02675452|565974849|FG005|Overall Study|Lost to Follow-up|0|||
156870169|NCT01394016|566281099|FG012|Overall Study|Lost to Follow-up|0|||
156690895|NCT01202877|565612462|FG002|Overall Study|Death|1|||
156690896|NCT04403763|565612463|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
156690897|NCT04403763|565612464|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
156690898|NCT04403763|565612465|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690899|NCT04403763|565612466|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690900|NCT04403763|565612467|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
156788051|NCT02675452|565974850|FG006|Overall Study|Lost to Follow-up|0|||
156870170|NCT01394016|566281100|FG013|Overall Study|Lost to Follow-up|0|||
156690901|NCT04403763|565612468|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690902|NCT04403763|565612469|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
156690903|NCT04403763|565612463|FG000|Stage 1|Early termination due to PK tube failure|0|||
156690904|NCT04403763|565612464|FG001|Stage 1|Early termination due to PK tube failure|0|||
156690905|NCT04403763|565612465|FG002|Stage 1|Early termination due to PK tube failure|1|||
156690906|NCT04403763|565612466|FG003|Stage 1|Early termination due to PK tube failure|0|||
156690907|NCT04403763|565612467|FG004|Stage 1|Early termination due to PK tube failure|0|||
156690908|NCT04403763|565612468|FG005|Stage 1|Early termination due to PK tube failure|0|||
156690909|NCT04403763|565612469|FG006|Stage 1|Early termination due to PK tube failure|0|||
156690910|NCT04403763|565612463|FG000|Stage 2A|Adverse Event|0|||
156690911|NCT04403763|565612464|FG001|Stage 2A|Adverse Event|0|||
156690912|NCT04403763|565612465|FG002|Stage 2A|Adverse Event|0|||
156690913|NCT04403763|565612466|FG003|Stage 2A|Adverse Event|0|||
156690914|NCT04403763|565612467|FG004|Stage 2A|Adverse Event|0|||
156690915|NCT04403763|565612468|FG005|Stage 2A|Adverse Event|0|||
156690916|NCT04403763|565612469|FG006|Stage 2A|Adverse Event|1|||
156690917|NCT01885182|565614339|FG000|Overall Study|Adverse Event|11|||
156690918|NCT01885182|565614340|FG001|Overall Study|Adverse Event|13|||
156690919|NCT01885182|565614339|FG000|Overall Study|Withdrawal by Subject|13|||
156690920|NCT01885182|565614340|FG001|Overall Study|Withdrawal by Subject|6|||
156690921|NCT01885182|565614339|FG000|Overall Study|Lost to Follow-up|2|||
156690922|NCT01885182|565614340|FG001|Overall Study|Lost to Follow-up|2|||
156690923|NCT01885182|565614339|FG000|Overall Study|Lack of Efficacy|8|||
156690924|NCT01885182|565614340|FG001|Overall Study|Lack of Efficacy|1|||
156690925|NCT04776746|565614341|FG000|Overall Study|Study terminated by sponsor|61|||
156690926|NCT04776746|565614341|FG000|Overall Study|Adverse Event|5|||
156690927|NCT04776746|565614341|FG000|Overall Study|Death|4|||
156690928|NCT04776746|565614341|FG000|Overall Study|Lack of Efficacy|3|||
156690929|NCT04776746|565614341|FG000|Overall Study|Noncompliance with study drug|2|||
156690930|NCT04776746|565614341|FG000|Overall Study|Not related to COVID-19|2|||
156690931|NCT00856830|565614344|FG000|Irinotecan & Bendamustine|Death|0|||
156690932|NCT00856830|565614345|FG001|Irinotecan & Bendamustine|Death|0|||
156690933|NCT00856830|565614346|FG002|Irinotecan & Bendamustine|Death|0|||
156690934|NCT00856830|565614347|FG003|Irinotecan & Bendamustine|Death|2|||
156690935|NCT00856830|565614344|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
156690936|NCT00856830|565614345|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
156690937|NCT00856830|565614346|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
156690938|NCT00856830|565614347|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
156690939|NCT03768726|565614348|FG000|Treatment Phase|Adverse Event|2|||
156690940|NCT03768726|565614349|FG001|Treatment Phase|Adverse Event|2|||
156690941|NCT03768726|565614348|FG000|Treatment Phase|Lost to Follow-up|1|||
156690942|NCT03768726|565614349|FG001|Treatment Phase|Lost to Follow-up|0|||
156690943|NCT03768726|565614348|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
156690944|NCT03768726|565614349|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
156690945|NCT03768726|565614348|FG000|Treatment Phase|Withdrawal by Subject|3|||
156690946|NCT03768726|565614349|FG001|Treatment Phase|Withdrawal by Subject|1|||
156690947|NCT03768726|565614348|FG000|Follow-Up|Adverse Event|2|||
156690948|NCT03768726|565614349|FG001|Follow-Up|Adverse Event|2|||
156690949|NCT03768726|565614348|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
156690950|NCT03768726|565614349|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
156690951|NCT03768726|565614348|FG000|Follow-Up|Withdrawal by Subject|2|||
156690952|NCT03768726|565614349|FG001|Follow-Up|Withdrawal by Subject|0|||
156690953|NCT03768726|565614348|FG000|Follow-Up|Other|1|||
156690954|NCT03768726|565614349|FG001|Follow-Up|Other|0|||
156690955|NCT01286558|565614350|FG000|Overall Study|Adverse Event|1|||
157013501|NCT04337372|566801791|FG000|Day 2: EEG Measures|Protocol Violation|6|||
157013502|NCT04337372|566801792|FG001|Day 2: EEG Measures|Protocol Violation|6|||
156690956|NCT01286558|565614351|FG001|Overall Study|Adverse Event|1|||
156690957|NCT01286558|565614350|FG000|Overall Study|Withdrawal by Subject|0|||
156690958|NCT01286558|565614351|FG001|Overall Study|Withdrawal by Subject|1|||
156690959|NCT01787279|565614352|FG000|Overall Study|Lost to Follow-up|2|||
156690960|NCT01787279|565614352|FG000|Overall Study|Lack of Efficacy|1|||
156690961|NCT02148913|565614354|FG000|Overall Study|Death|0|||
156690962|NCT02148913|565614355|FG001|Overall Study|Death|1|||
156690963|NCT02148913|565614356|FG002|Overall Study|Death|0|||
156690964|NCT02148913|565614357|FG003|Overall Study|Death|0|||
156690965|NCT01567826|565614359|FG000|Overall Study|Lost to Follow-up|3|||
156690966|NCT01567826|565614360|FG001|Overall Study|Lost to Follow-up|2|||
156690967|NCT03265288|565614367|FG000|Overall Study|Adverse Event|0|||
156690968|NCT03265288|565614368|FG001|Overall Study|Adverse Event|1|||
156690969|NCT03265288|565614367|FG000|Overall Study|Withdrawal by Subject|13|||
157013503|NCT04337372|566801793|FG002|Day 2: EEG Measures|Protocol Violation|5|||
157013504|NCT04337372|566801794|FG003|Day 2: EEG Measures|Protocol Violation|17|||
157013505|NCT06194214|566801795|FG000|Overall Study|Adverse Event|1|||
156690970|NCT03265288|565614368|FG001|Overall Study|Withdrawal by Subject|5|||
156690971|NCT03265288|565614367|FG000|Overall Study|Drug Withdrawn|3|||
156690972|NCT03265288|565614368|FG001|Overall Study|Drug Withdrawn|3|||
156690973|NCT03265288|565614367|FG000|Overall Study|Any Other Reason|7|||
156690974|NCT03265288|565614368|FG001|Overall Study|Any Other Reason|3|||
156690975|NCT00099268|565614372|FG000|Overall Study|Withdrawal by Subject|46|||
156690976|NCT00099268|565614373|FG001|Overall Study|Withdrawal by Subject|28|||
156690977|NCT00099268|565614372|FG000|Overall Study|Adverse Event|19|||
156690978|NCT00099268|565614373|FG001|Overall Study|Adverse Event|19|||
156690979|NCT00099268|565614372|FG000|Overall Study|Protocol Violation|9|||
156690980|NCT00099268|565614373|FG001|Overall Study|Protocol Violation|8|||
156690981|NCT00099268|565614372|FG000|Overall Study|Lost to Follow-up|6|||
156690982|NCT00099268|565614373|FG001|Overall Study|Lost to Follow-up|4|||
156690983|NCT00099268|565614372|FG000|Overall Study|Lack of Efficacy|5|||
156690984|NCT00099268|565614373|FG001|Overall Study|Lack of Efficacy|18|||
156690985|NCT00099268|565614372|FG000|Overall Study|Administrative problems|4|||
156690986|NCT00099268|565614373|FG001|Overall Study|Administrative problems|4|||
156690987|NCT00099268|565614372|FG000|Overall Study|Death|3|||
156690988|NCT00099268|565614373|FG001|Overall Study|Death|1|||
156690989|NCT01360866|565614374|FG000|Overall Study|Lost to Follow-up|11|||
156690990|NCT01360866|565614375|FG001|Overall Study|Lost to Follow-up|28|||
156690991|NCT01360866|565614376|FG002|Overall Study|Lost to Follow-up|41|||
156690992|NCT01360866|565614377|FG003|Overall Study|Lost to Follow-up|0|||
156690993|NCT01360866|565614374|FG000|Overall Study|Adverse Event|56|||
156690994|NCT01360866|565614375|FG001|Overall Study|Adverse Event|61|||
156690995|NCT01360866|565614376|FG002|Overall Study|Adverse Event|134|||
156690996|NCT01360866|565614377|FG003|Overall Study|Adverse Event|6|||
156690997|NCT01360866|565614374|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
156690998|NCT01360866|565614375|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
156690999|NCT01360866|565614376|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
156691000|NCT01360866|565614377|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
156691001|NCT01360866|565614374|FG000|Overall Study|Withdrawn by Investigator|9|||
156691002|NCT01360866|565614375|FG001|Overall Study|Withdrawn by Investigator|8|||
156691003|NCT01360866|565614376|FG002|Overall Study|Withdrawn by Investigator|31|||
156691004|NCT01360866|565614377|FG003|Overall Study|Withdrawn by Investigator|2|||
156691005|NCT01360866|565614374|FG000|Overall Study|Withdrawal by participant|79|||
156691006|NCT01360866|565614375|FG001|Overall Study|Withdrawal by participant|89|||
156691007|NCT01360866|565614376|FG002|Overall Study|Withdrawal by participant|168|||
156691008|NCT01360866|565614377|FG003|Overall Study|Withdrawal by participant|8|||
156691009|NCT01360866|565614374|FG000|Overall Study|Protocol Deviation|25|||
156691010|NCT01360866|565614375|FG001|Overall Study|Protocol Deviation|33|||
156691011|NCT01360866|565614376|FG002|Overall Study|Protocol Deviation|61|||
156691012|NCT01360866|565614377|FG003|Overall Study|Protocol Deviation|2|||
156691013|NCT01360866|565614374|FG000|Overall Study|Lack of Efficacy|30|||
156691014|NCT01360866|565614375|FG001|Overall Study|Lack of Efficacy|40|||
156691015|NCT01360866|565614376|FG002|Overall Study|Lack of Efficacy|30|||
156691016|NCT01360866|565614377|FG003|Overall Study|Lack of Efficacy|4|||
156691017|NCT03702049|565614378|FG000|Overall Study|Lost to Follow-up|4|||
156691018|NCT03702049|565614378|FG000|Overall Study|Physician Decision|1|||
156691019|NCT05016622|565614379|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
156691020|NCT05016622|565614379|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
156691021|NCT03575871|565614391|FG000|Overall Study|Adverse Event|5|||
156691022|NCT03575871|565614392|FG001|Overall Study|Adverse Event|5|||
156691023|NCT03575871|565614393|FG002|Overall Study|Adverse Event|8|||
156691024|NCT03575871|565614391|FG000|Overall Study|Death|1|||
156691025|NCT03575871|565614392|FG001|Overall Study|Death|0|||
156691026|NCT03575871|565614393|FG002|Overall Study|Death|0|||
156691027|NCT03575871|565614391|FG000|Overall Study|Lack of Efficacy|5|||
156691028|NCT03575871|565614392|FG001|Overall Study|Lack of Efficacy|4|||
156691029|NCT03575871|565614393|FG002|Overall Study|Lack of Efficacy|7|||
156691030|NCT03575871|565614391|FG000|Overall Study|Lost to Follow-up|1|||
156691031|NCT03575871|565614392|FG001|Overall Study|Lost to Follow-up|1|||
156691032|NCT03575871|565614393|FG002|Overall Study|Lost to Follow-up|1|||
156691033|NCT03575871|565614391|FG000|Overall Study|Protocol Deviation|1|||
156691034|NCT03575871|565614392|FG001|Overall Study|Protocol Deviation|1|||
156691035|NCT03575871|565614393|FG002|Overall Study|Protocol Deviation|1|||
156691036|NCT03575871|565614391|FG000|Overall Study|Withdrawal by Subject|6|||
156691037|NCT03575871|565614392|FG001|Overall Study|Withdrawal by Subject|1|||
156691038|NCT03575871|565614393|FG002|Overall Study|Withdrawal by Subject|9|||
156691039|NCT03575871|565614391|FG000|Overall Study|Other than specified|2|||
156691040|NCT03575871|565614392|FG001|Overall Study|Other than specified|2|||
156691041|NCT03575871|565614393|FG002|Overall Study|Other than specified|0|||
156691042|NCT05506358|565614394|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
156691043|NCT05506358|565614395|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691044|NCT05506358|565614396|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691045|NCT05506358|565614397|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691046|NCT05506358|565614398|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
156691047|NCT05506358|565614394|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
156691048|NCT05506358|565614395|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156788052|NCT02675452|565974851|FG007|Overall Study|Lost to Follow-up|0|||
156691049|NCT05506358|565614396|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691050|NCT05506358|565614397|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691051|NCT05506358|565614398|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
156691052|NCT05506358|565614394|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691053|NCT05506358|565614395|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691054|NCT05506358|565614396|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691055|NCT05506358|565614397|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
156691056|NCT05506358|565614398|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
156691057|NCT05506358|565614394|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
156691058|NCT05506358|565614395|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
156691059|NCT05506358|565614396|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
156691060|NCT05506358|565614397|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
156691061|NCT05506358|565614398|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
156691062|NCT05506358|565614394|FG000|Overall Study|HbE trait|0|||
156691063|NCT05506358|565614395|FG001|Overall Study|HbE trait|0|||
156691064|NCT05506358|565614396|FG002|Overall Study|HbE trait|0|||
156691065|NCT05506358|565614397|FG003|Overall Study|HbE trait|1|||
156691066|NCT05506358|565614398|FG004|Overall Study|HbE trait|0|||
156691067|NCT00584844|565614406|FG000|Overall Study|Withdrawal by Subject|59|||
156691068|NCT00584844|565614406|FG000|Overall Study|Screen Failure|20|||
156691069|NCT00171301|565614407|FG000|Overall Study|Death|1|||
156691070|NCT00171301|565614408|FG001|Overall Study|Death|2|||
156691071|NCT00171301|565614407|FG000|Overall Study|Adverse Event|1|||
156691072|NCT00171301|565614408|FG001|Overall Study|Adverse Event|2|||
156691073|NCT00171301|565614407|FG000|Overall Study|Lost to Follow-up|6|||
156691074|NCT00171301|565614408|FG001|Overall Study|Lost to Follow-up|2|||
156691075|NCT00171301|565614407|FG000|Overall Study|Protocol Violation|0|||
156691076|NCT00171301|565614408|FG001|Overall Study|Protocol Violation|2|||
156691077|NCT00171301|565614407|FG000|Overall Study|Withdrawal by Subject|0|||
156691078|NCT00171301|565614408|FG001|Overall Study|Withdrawal by Subject|1|||
156691079|NCT02100319|565614411|FG000|Overall Study|Case Report Forms Uncollected|11|||
156691080|NCT02100319|565614411|FG000|Overall Study|Protocol Deviation|5|||
156691081|NCT02566993|565614412|FG000|Overall Study|Randomized but not treated|5|||
156691082|NCT02566993|565614413|FG001|Overall Study|Randomized but not treated|16|||
156691083|NCT02566993|565614412|FG000|Overall Study|Progressive disease|213|||
156691084|NCT02566993|565614413|FG001|Overall Study|Progressive disease|152|||
156691085|NCT02566993|565614412|FG000|Overall Study|Withdrawal by Subject|12|||
156691086|NCT02566993|565614413|FG001|Overall Study|Withdrawal by Subject|28|||
156691087|NCT02566993|565614412|FG000|Overall Study|Death|17|||
156691088|NCT02566993|565614413|FG001|Overall Study|Death|23|||
156691089|NCT02566993|565614412|FG000|Overall Study|Physician Decision|10|||
156691090|NCT02566993|565614413|FG001|Overall Study|Physician Decision|17|||
156691091|NCT02566993|565614412|FG000|Overall Study|Study drug-related adverse event|20|||
156691092|NCT02566993|565614413|FG001|Overall Study|Study drug-related adverse event|41|||
156691093|NCT02566993|565614412|FG000|Overall Study|Non study drug-related adverse event|9|||
156691094|NCT02566993|565614413|FG001|Overall Study|Non study drug-related adverse event|9|||
156691095|NCT02566993|565614412|FG000|Overall Study|Symptomatic deterioration|9|||
156691096|NCT02566993|565614413|FG001|Overall Study|Symptomatic deterioration|16|||
156691097|NCT02566993|565614412|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
156691098|NCT02566993|565614413|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
156691099|NCT02566993|565614412|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
156691100|NCT02566993|565614413|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
156691101|NCT02566993|565614412|FG000|Overall Study|Screening failure|2|||
156691102|NCT02566993|565614413|FG001|Overall Study|Screening failure|0|||
156691103|NCT02566993|565614412|FG000|Overall Study|Lost to Follow-up|0|||
156788053|NCT02675452|565974852|FG008|Overall Study|Lost to Follow-up|0|||
156788054|NCT02675452|565974853|FG009|Overall Study|Lost to Follow-up|0|||
156691104|NCT02566993|565614413|FG001|Overall Study|Lost to Follow-up|1|||
156691105|NCT02566993|565614412|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
156691106|NCT02566993|565614413|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
156788055|NCT02675452|565974854|FG010|Overall Study|Lost to Follow-up|0|||
156788056|NCT02675452|565974855|FG011|Overall Study|Lost to Follow-up|0|||
156788057|NCT02675452|565974856|FG012|Overall Study|Lost to Follow-up|1|||
156788058|NCT02675452|565974857|FG013|Overall Study|Lost to Follow-up|0|||
156788059|NCT02675452|565974858|FG014|Overall Study|Lost to Follow-up|0|||
156788060|NCT02675452|565974859|FG015|Overall Study|Lost to Follow-up|0|||
156788061|NCT02675452|565974860|FG016|Overall Study|Lost to Follow-up|0|||
156788062|NCT02675452|565974861|FG017|Overall Study|Lost to Follow-up|0|||
156788063|NCT02675452|565974862|FG018|Overall Study|Lost to Follow-up|0|||
156788064|NCT02675452|565974863|FG019|Overall Study|Lost to Follow-up|0|||
156788065|NCT02675452|565974864|FG020|Overall Study|Lost to Follow-up|0|||
156691107|NCT05206448|565614414|FG000|Overall Study|Lost to Follow-up|2|||
156691108|NCT05206448|565614415|FG001|Overall Study|Lost to Follow-up|2|||
156691109|NCT05206448|565614414|FG000|Overall Study|Withdrawal by Subject|2|||
156870171|NCT01394016|566281101|FG014|Overall Study|Lost to Follow-up|0|||
156870172|NCT01394016|566281102|FG015|Overall Study|Lost to Follow-up|0|||
156691110|NCT05206448|565614415|FG001|Overall Study|Withdrawal by Subject|0|||
156691111|NCT05206448|565614414|FG000|Overall Study|found ineligible after randomization|1|||
156691112|NCT05206448|565614415|FG001|Overall Study|found ineligible after randomization|1|||
156691113|NCT05206448|565614414|FG000|Overall Study|unable to complete study due to personal constraints|1|||
156691114|NCT05206448|565614415|FG001|Overall Study|unable to complete study due to personal constraints|0|||
156691115|NCT05206448|565614414|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
156691116|NCT05206448|565614415|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
156691117|NCT02589522|565614416|FG000|Overall Study|Physician Decision|1|||
156691118|NCT02589522|565614417|FG001|Overall Study|Physician Decision|2|||
156691119|NCT02589522|565614418|FG002|Overall Study|Physician Decision|0|||
156691120|NCT02589522|565614416|FG000|Overall Study|Did not start treatment|1|||
156691121|NCT02589522|565614417|FG001|Overall Study|Did not start treatment|0|||
156691122|NCT02589522|565614418|FG002|Overall Study|Did not start treatment|0|||
156691123|NCT01478828|565614419|FG000|Overall Study|Adverse Event|1|||
156691124|NCT05611996|565614420|FG000|Overall Study|Ineligible|1|||
156691125|NCT05611996|565614420|FG000|Overall Study|Withdrawal by Subject|9|||
156691126|NCT04479475|565614424|FG000|Overall Study|Withdrawal by Subject|7|||
156691127|NCT01134627|565614425|FG000|Overall Study|Adverse Event|47|||
156691128|NCT01134627|565614426|FG001|Overall Study|Adverse Event|31|||
156691129|NCT01134627|565614425|FG000|Overall Study|Lost to Follow-up|1|||
156691130|NCT01134627|565614426|FG001|Overall Study|Lost to Follow-up|2|||
156870173|NCT01394016|566281103|FG016|Overall Study|Lost to Follow-up|0|||
156870174|NCT01394016|566281104|FG017|Overall Study|Lost to Follow-up|0|||
156691131|NCT01134627|565614425|FG000|Overall Study|Protocol Violation|3|||
156691132|NCT01134627|565614426|FG001|Overall Study|Protocol Violation|5|||
156691133|NCT01134627|565614425|FG000|Overall Study|Lack of Efficacy|2|||
156691134|NCT01134627|565614426|FG001|Overall Study|Lack of Efficacy|12|||
156691135|NCT01134627|565614425|FG000|Overall Study|Withdrawal by Subject|4|||
156691136|NCT01134627|565614426|FG001|Overall Study|Withdrawal by Subject|3|||
156691137|NCT01134627|565614425|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
156691138|NCT01134627|565614426|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
156691139|NCT01134627|565614425|FG000|Overall Study|Other|11|||
156691140|NCT01134627|565614426|FG001|Overall Study|Other|14|||
156691141|NCT00466726|565614429|FG000|Overall Study|Not evaluable for response|14|||
156870175|NCT01394016|566281105|FG018|Overall Study|Lost to Follow-up|1|||
156870176|NCT03534804|566281106|FG000|Overall Study|Withdrawal by Subject|1|||
156691142|NCT00350402|565614430|FG000|Overall Study|Lost to Follow-up|1|||
156691143|NCT00350402|565614431|FG001|Overall Study|Lost to Follow-up|1|||
156691144|NCT01376310|565614432|FG000|Overall Study|Study closed/terminated|1|||
156691145|NCT01376310|565614433|FG001|Overall Study|Study closed/terminated|2|||
156691146|NCT01376310|565614432|FG000|Overall Study|Withdrawal by Subject|8|||
156691147|NCT01376310|565614433|FG001|Overall Study|Withdrawal by Subject|2|||
156691148|NCT01376310|565614432|FG000|Overall Study|Physician Decision|26|||
156691149|NCT01376310|565614433|FG001|Overall Study|Physician Decision|7|||
156691150|NCT01376310|565614432|FG000|Overall Study|Lost to Follow-up|1|||
156691151|NCT01376310|565614433|FG001|Overall Study|Lost to Follow-up|0|||
156691152|NCT02339740|565614436|FG000|Overall Study|Death|1|||
156691153|NCT02339740|565614437|FG001|Overall Study|Death|0|||
156691154|NCT02339740|565614436|FG000|Overall Study|Physician Decision|0|||
156691155|NCT02339740|565614437|FG001|Overall Study|Physician Decision|2|||
156870177|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
156870178|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
156870179|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
156870180|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
157121584|NCT05103332|567195984|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121585|NCT05103332|567195985|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156691156|NCT02339740|565614436|FG000|Overall Study|Withdrawal by Subject|5|||
156691157|NCT02339740|565614437|FG001|Overall Study|Withdrawal by Subject|1|||
156691158|NCT02339740|565614436|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
156691159|NCT02339740|565614437|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
156691160|NCT00645944|565614438|FG000|Randomized|Withdrawal by Subject|1|||
156691161|NCT00645944|565614439|FG001|Randomized|Withdrawal by Subject|2|||
156691162|NCT00645944|565614438|FG000|Received Medication|Adverse Event|2|||
156691163|NCT00645944|565614439|FG001|Received Medication|Adverse Event|1|||
156870181|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
157121586|NCT05103332|567195986|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
156691164|NCT00645944|565614438|FG000|Received Medication|Withdrawal by Subject|1|||
156691165|NCT00645944|565614439|FG001|Received Medication|Withdrawal by Subject|1|||
156691166|NCT00645944|565614438|FG000|Received Medication|Lost to Follow-up|1|||
156691167|NCT00645944|565614439|FG001|Received Medication|Lost to Follow-up|0|||
156691168|NCT00645944|565614438|FG000|Received Medication|Protocol Violation|2|||
156691169|NCT00645944|565614439|FG001|Received Medication|Protocol Violation|1|||
156691170|NCT01807117|565614441|FG000|Overall Study|Physician Decision|2|||
156691171|NCT01807117|565614441|FG000|Overall Study|Disease diagnosis not a study disease|1|||
156691172|NCT00606502|565614449|FG000|Randomization|Randomized but not treated|3|||
156691173|NCT00606502|565614450|FG001|Randomization|Randomized but not treated|0|||
156691174|NCT00606502|565614449|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
156691175|NCT00606502|565614450|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
156691176|NCT02377921|565614453|FG000|Overall Study|Subject non-compliance|1|||
156691177|NCT02377921|565614454|FG001|Overall Study|Subject non-compliance|1|||
156691178|NCT02443545|565614455|FG000|Overall Study|Adverse Event|1|||
156691179|NCT02443545|565614456|FG001|Overall Study|Adverse Event|1|||
156691180|NCT02443545|565614455|FG000|Overall Study|Lost to Follow-up|0|||
156691181|NCT02443545|565614456|FG001|Overall Study|Lost to Follow-up|2|||
157121587|NCT05103332|567195987|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121588|NCT05103332|567195988|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121589|NCT05103332|567195989|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
157121590|NCT05103332|567195990|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
157121591|NCT05103332|567195991|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
157121592|NCT05103332|567195992|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
157121593|NCT05103332|567195993|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
157121594|NCT05103332|567195994|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
157121595|NCT05103332|567195995|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
157121596|NCT05103332|567195978|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121597|NCT05103332|567195979|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
156691182|NCT02443545|565614455|FG000|Overall Study|Physician Decision|3|||
156691183|NCT02443545|565614456|FG001|Overall Study|Physician Decision|0|||
156691184|NCT02443545|565614455|FG000|Overall Study|Protocol Violation|8|||
156788066|NCT02675452|565974865|FG021|Overall Study|Lost to Follow-up|0|||
156788067|NCT02675452|565974866|FG022|Overall Study|Lost to Follow-up|0|||
156788068|NCT02675452|565974867|FG023|Overall Study|Lost to Follow-up|0|||
156788069|NCT02675452|565974868|FG024|Overall Study|Lost to Follow-up|0|||
156788070|NCT02675452|565974869|FG025|Overall Study|Lost to Follow-up|0|||
156788071|NCT02675452|565974870|FG026|Overall Study|Lost to Follow-up|1|||
156788072|NCT02675452|565974871|FG027|Overall Study|Lost to Follow-up|0|||
156788073|NCT02675452|565974872|FG028|Overall Study|Lost to Follow-up|0|||
156788074|NCT02675452|565974844|FG000|Overall Study|Other|0|||
156788075|NCT02675452|565974845|FG001|Overall Study|Other|0|||
156788076|NCT02675452|565974846|FG002|Overall Study|Other|0|||
156788077|NCT02675452|565974847|FG003|Overall Study|Other|0|||
156788078|NCT02675452|565974848|FG004|Overall Study|Other|0|||
156788079|NCT02675452|565974849|FG005|Overall Study|Other|0|||
156788080|NCT02675452|565974850|FG006|Overall Study|Other|0|||
156788081|NCT02675452|565974851|FG007|Overall Study|Other|0|||
156788082|NCT02675452|565974852|FG008|Overall Study|Other|0|||
156788083|NCT02675452|565974853|FG009|Overall Study|Other|0|||
156788084|NCT02675452|565974854|FG010|Overall Study|Other|0|||
156788085|NCT02675452|565974855|FG011|Overall Study|Other|0|||
156788086|NCT02675452|565974856|FG012|Overall Study|Other|0|||
156788087|NCT02675452|565974857|FG013|Overall Study|Other|0|||
156788088|NCT02675452|565974858|FG014|Overall Study|Other|0|||
156788089|NCT02675452|565974859|FG015|Overall Study|Other|0|||
156788090|NCT02675452|565974860|FG016|Overall Study|Other|0|||
156788091|NCT02675452|565974861|FG017|Overall Study|Other|0|||
156788092|NCT02675452|565974862|FG018|Overall Study|Other|0|||
156788093|NCT02675452|565974863|FG019|Overall Study|Other|0|||
156788094|NCT02675452|565974864|FG020|Overall Study|Other|0|||
156788095|NCT02675452|565974865|FG021|Overall Study|Other|0|||
156788096|NCT02675452|565974866|FG022|Overall Study|Other|0|||
156788097|NCT02675452|565974867|FG023|Overall Study|Other|0|||
156788098|NCT02675452|565974868|FG024|Overall Study|Other|0|||
156788099|NCT02675452|565974869|FG025|Overall Study|Other|0|||
156788100|NCT02675452|565974870|FG026|Overall Study|Other|1|||
156788101|NCT02675452|565974871|FG027|Overall Study|Other|0|||
156788102|NCT02675452|565974872|FG028|Overall Study|Other|0|||
156788103|NCT00545948|565974873|FG000|Overall Study|Not Treated|1|||
156691185|NCT02443545|565614456|FG001|Overall Study|Protocol Violation|1|||
156691186|NCT02443545|565614455|FG000|Overall Study|Pregnancy|1|||
156691187|NCT02443545|565614456|FG001|Overall Study|Pregnancy|1|||
156788104|NCT00545948|565974874|FG001|Overall Study|Not Treated|1|||
156788105|NCT00545948|565974875|FG002|Overall Study|Not Treated|7|||
156788106|NCT03467945|565974876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156788107|NCT03467945|565974877|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156788108|NCT03467945|565974878|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156788109|NCT03467945|565974879|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156788110|NCT03467945|565974876|FG000|Treatment Period 3|Withdrawal by Subject|1|||
156788111|NCT03467945|565974877|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156691188|NCT02443545|565614455|FG000|Overall Study|Withdrawal by Subject|6|||
156691189|NCT02443545|565614456|FG001|Overall Study|Withdrawal by Subject|3|||
156691190|NCT02443545|565614455|FG000|Overall Study|Termination of study|20|||
156691191|NCT02443545|565614456|FG001|Overall Study|Termination of study|11|||
156691192|NCT04179019|565614457|FG000|Overall Study|Lost to Follow-up|2|||
156691193|NCT04179019|565614457|FG000|Overall Study|Physician Decision|2|||
156691194|NCT04179019|565614457|FG000|Overall Study|Withdrawal by Subject|5|||
156691195|NCT04179019|565614457|FG000|Overall Study|Adverse Event|4|||
156691196|NCT01855048|565614461|FG000|Overall Study|Withdrawal by Subject|0|||
156691197|NCT01855048|565614462|FG001|Overall Study|Withdrawal by Subject|1|||
156691198|NCT01855048|565614463|FG002|Overall Study|Withdrawal by Subject|0|||
156691199|NCT01855048|565614464|FG003|Overall Study|Withdrawal by Subject|0|||
156691200|NCT01855048|565614465|FG004|Overall Study|Withdrawal by Subject|1|||
156691201|NCT01855048|565614466|FG005|Overall Study|Withdrawal by Subject|0|||
156691202|NCT01813071|565614467|FG000|Overall Study|Protocol Violation|0|||
156691203|NCT01813071|565614468|FG001|Overall Study|Protocol Violation|0|||
156691204|NCT01813071|565614469|FG002|Overall Study|Protocol Violation|0|||
156691205|NCT01813071|565614470|FG003|Overall Study|Protocol Violation|0|||
156691206|NCT01813071|565614471|FG004|Overall Study|Protocol Violation|1|||
156691207|NCT01813071|565614472|FG005|Overall Study|Protocol Violation|4|||
156691208|NCT01813071|565614473|FG006|Overall Study|Protocol Violation|2|||
156691209|NCT01813071|565614474|FG007|Overall Study|Protocol Violation|4|||
156691210|NCT01813071|565614475|FG008|Overall Study|Protocol Violation|2|||
156691211|NCT01813071|565614467|FG000|Overall Study|Withdrawal by Subject|0|||
156691212|NCT01813071|565614468|FG001|Overall Study|Withdrawal by Subject|0|||
156691213|NCT01813071|565614469|FG002|Overall Study|Withdrawal by Subject|0|||
156691214|NCT01813071|565614470|FG003|Overall Study|Withdrawal by Subject|0|||
156691215|NCT01813071|565614471|FG004|Overall Study|Withdrawal by Subject|0|||
156691216|NCT01813071|565614472|FG005|Overall Study|Withdrawal by Subject|1|||
156691217|NCT01813071|565614473|FG006|Overall Study|Withdrawal by Subject|0|||
156691218|NCT01813071|565614474|FG007|Overall Study|Withdrawal by Subject|0|||
156691219|NCT01813071|565614475|FG008|Overall Study|Withdrawal by Subject|0|||
156691220|NCT01813071|565614467|FG000|Overall Study|Adverse Event|0|||
156691221|NCT01813071|565614468|FG001|Overall Study|Adverse Event|0|||
156691222|NCT01813071|565614469|FG002|Overall Study|Adverse Event|0|||
156691223|NCT01813071|565614470|FG003|Overall Study|Adverse Event|0|||
156691224|NCT01813071|565614471|FG004|Overall Study|Adverse Event|0|||
156691225|NCT01813071|565614472|FG005|Overall Study|Adverse Event|1|||
156691226|NCT01813071|565614473|FG006|Overall Study|Adverse Event|0|||
156691227|NCT01813071|565614474|FG007|Overall Study|Adverse Event|0|||
156691228|NCT01813071|565614475|FG008|Overall Study|Adverse Event|0|||
156691229|NCT01813071|565614467|FG000|Overall Study|Physician Decision|0|||
156691230|NCT01813071|565614468|FG001|Overall Study|Physician Decision|0|||
156691231|NCT01813071|565614469|FG002|Overall Study|Physician Decision|0|||
156691232|NCT01813071|565614470|FG003|Overall Study|Physician Decision|0|||
156691233|NCT01813071|565614471|FG004|Overall Study|Physician Decision|0|||
156870182|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
156870183|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
156870184|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
156870185|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
156870186|NCT00174187|566281110|FG000|Period 1 (up to 3 Years)|Other|0|||
156870187|NCT00174187|566281111|FG001|Period 1 (up to 3 Years)|Other|1|||
156870188|NCT00174187|566281112|FG002|Period 1 (up to 3 Years)|Other|0|||
156870189|NCT00174187|566281110|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
156870190|NCT00174187|566281111|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
156870191|NCT00174187|566281112|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
156870192|NCT00174187|566281110|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
156870193|NCT00174187|566281111|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
156870194|NCT00174187|566281112|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
156870195|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
156870196|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
156691234|NCT01813071|565614472|FG005|Overall Study|Physician Decision|0|||
156691235|NCT01813071|565614473|FG006|Overall Study|Physician Decision|1|||
156691236|NCT01813071|565614474|FG007|Overall Study|Physician Decision|0|||
156691237|NCT01813071|565614475|FG008|Overall Study|Physician Decision|0|||
156691238|NCT01813071|565614467|FG000|Overall Study|Met inc/exc criteria|0|||
156691239|NCT01813071|565614468|FG001|Overall Study|Met inc/exc criteria|0|||
156691240|NCT01813071|565614469|FG002|Overall Study|Met inc/exc criteria|0|||
156691241|NCT01813071|565614470|FG003|Overall Study|Met inc/exc criteria|0|||
156691242|NCT01813071|565614471|FG004|Overall Study|Met inc/exc criteria|0|||
156691243|NCT01813071|565614472|FG005|Overall Study|Met inc/exc criteria|1|||
156691244|NCT01813071|565614473|FG006|Overall Study|Met inc/exc criteria|0|||
156691245|NCT01813071|565614474|FG007|Overall Study|Met inc/exc criteria|1|||
156691246|NCT01813071|565614475|FG008|Overall Study|Met inc/exc criteria|1|||
156691247|NCT05486065|565614476|FG000|Overall Study|Withdrawal by Subject|1|||
156691248|NCT05486065|565614477|FG001|Overall Study|Withdrawal by Subject|5|||
156691249|NCT05486065|565614478|FG002|Overall Study|Withdrawal by Subject|4|||
156691250|NCT05486065|565614479|FG003|Overall Study|Withdrawal by Subject|3|||
156691251|NCT05486065|565614476|FG000|Overall Study|Lost to Follow-up|4|||
156691252|NCT05486065|565614477|FG001|Overall Study|Lost to Follow-up|2|||
156691253|NCT05486065|565614478|FG002|Overall Study|Lost to Follow-up|2|||
156691254|NCT05486065|565614479|FG003|Overall Study|Lost to Follow-up|2|||
156691255|NCT05486065|565614476|FG000|Overall Study|Physician Decision|0|||
156691256|NCT05486065|565614477|FG001|Overall Study|Physician Decision|1|||
156691257|NCT05486065|565614478|FG002|Overall Study|Physician Decision|1|||
156691258|NCT05486065|565614479|FG003|Overall Study|Physician Decision|0|||
156691259|NCT05486065|565614476|FG000|Overall Study|Failure to meet randomization criteria|0|||
156691260|NCT05486065|565614477|FG001|Overall Study|Failure to meet randomization criteria|0|||
156691261|NCT05486065|565614478|FG002|Overall Study|Failure to meet randomization criteria|0|||
156691262|NCT05486065|565614479|FG003|Overall Study|Failure to meet randomization criteria|1|||
156691263|NCT00307931|565614480|FG000|Overall Study|Adverse Event|1|||
156691264|NCT00613834|565614483|FG000|Overall Study|Withdrawal by Subject|0|||
156691265|NCT00613834|565614484|FG001|Overall Study|Withdrawal by Subject|3|||
156691266|NCT00560937|565614488|FG000|Overall Study|Withdrawal by Subject|0|||
156691267|NCT00560937|565614489|FG001|Overall Study|Withdrawal by Subject|1|||
156691268|NCT00560937|565614488|FG000|Overall Study|Physician Decision|1|||
156691269|NCT00560937|565614489|FG001|Overall Study|Physician Decision|1|||
156691270|NCT03919162|565614492|FG000|Overall Study|Adverse Event|3|||
156691271|NCT03919162|565614493|FG001|Overall Study|Adverse Event|2|||
156691272|NCT03919162|565614492|FG000|Overall Study|Death|2|||
156691273|NCT03919162|565614493|FG001|Overall Study|Death|0|||
156691274|NCT03919162|565614492|FG000|Overall Study|Lost to Follow-up|1|||
156691275|NCT03919162|565614493|FG001|Overall Study|Lost to Follow-up|0|||
156691276|NCT03919162|565614492|FG000|Overall Study|Withdrawal by Subject|12|||
156691277|NCT03919162|565614493|FG001|Overall Study|Withdrawal by Subject|12|||
156691278|NCT03919162|565614492|FG000|Overall Study|Study terminated by Sponsor|20|||
156691279|NCT03919162|565614493|FG001|Overall Study|Study terminated by Sponsor|24|||
156691280|NCT03919162|565614492|FG000|Overall Study|Screen failure|1|||
156691281|NCT03919162|565614493|FG001|Overall Study|Screen failure|0|||
156691282|NCT03919162|565614492|FG000|Overall Study|Missing|1|||
156691283|NCT03919162|565614493|FG001|Overall Study|Missing|1|||
156691284|NCT04846881|565614495|FG000|Overall Study|Adverse Event|14|||
156691285|NCT04846881|565614496|FG001|Overall Study|Adverse Event|15|||
156691286|NCT04846881|565614495|FG000|Overall Study|Burden of study procedures|7|||
156691287|NCT04846881|565614496|FG001|Overall Study|Burden of study procedures|3|||
156691288|NCT04846881|565614495|FG000|Overall Study|Protocol deviation|6|||
156691289|NCT04846881|565614496|FG001|Overall Study|Protocol deviation|4|||
156691290|NCT04846881|565614495|FG000|Overall Study|Perceived lack of efficacy|5|||
156691291|NCT04846881|565614496|FG001|Overall Study|Perceived lack of efficacy|2|||
156691292|NCT04846881|565614495|FG000|Overall Study|Change of residence|2|||
156691293|NCT04846881|565614496|FG001|Overall Study|Change of residence|0|||
156691294|NCT04846881|565614495|FG000|Overall Study|Technical problems|0|||
156691295|NCT04846881|565614496|FG001|Overall Study|Technical problems|1|||
156691296|NCT04846881|565614495|FG000|Overall Study|Other than listed|3|||
156691297|NCT04846881|565614496|FG001|Overall Study|Other than listed|10|||
156691298|NCT04846881|565614495|FG000|Overall Study|No reason available|1|||
156691299|NCT04846881|565614496|FG001|Overall Study|No reason available|3|||
156691300|NCT04846881|565614495|FG000|Overall Study|Patient randomised in error|1|||
156691301|NCT04846881|565614496|FG001|Overall Study|Patient randomised in error|0|||
156691302|NCT03341000|565615636|FG000|Overall Study|Adverse Event|1|||
156691303|NCT02516410|565615639|FG000|Overall Study|Adverse Event|0|||
156691304|NCT02516410|565615640|FG001|Overall Study|Adverse Event|1|||
156691305|NCT02516410|565615639|FG000|Overall Study|Withdrawal by Subject|0|||
156691306|NCT02516410|565615640|FG001|Overall Study|Withdrawal by Subject|1|||
156691307|NCT02694549|565615643|FG000|Overall Study|screen failures|2|||
156691308|NCT03438396|565615646|FG000|Overall Study|Reason Not Specified|9|||
156691309|NCT03438396|565615646|FG000|Overall Study|Withdrawal by Subject|5|||
156691310|NCT03438396|565615646|FG000|Overall Study|Lost to Follow-up|2|||
156691311|NCT03438396|565615646|FG000|Overall Study|Death|85|||
156691312|NCT03438396|565615646|FG000|Overall Study|Not treated|1|||
156691313|NCT01173471|565615647|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156691314|NCT01173471|565615648|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156691315|NCT01173471|565615649|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156691316|NCT01173471|565615650|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156691317|NCT01173471|565615647|FG000|Overall Study|Condition under investigation worsened|2|||
156788112|NCT03467945|565974878|FG002|Treatment Period 3|Withdrawal by Subject|2|||
156788113|NCT03467945|565974879|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156788114|NCT04595370|565974884|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
156788115|NCT04595370|565974885|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788116|NCT04595370|565974886|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788117|NCT04595370|565974887|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156870197|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
156870198|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
156870199|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
156870200|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
156870201|NCT00174187|566281110|FG000|Period 2 (After 3 Years)|Other|0|||
156870202|NCT00174187|566281111|FG001|Period 2 (After 3 Years)|Other|0|||
156870203|NCT00174187|566281112|FG002|Period 2 (After 3 Years)|Other|5|||
156691318|NCT01173471|565615648|FG001|Overall Study|Condition under investigation worsened|0|||
156691319|NCT01173471|565615649|FG002|Overall Study|Condition under investigation worsened|0|||
156691320|NCT01173471|565615650|FG003|Overall Study|Condition under investigation worsened|0|||
156691321|NCT01173471|565615647|FG000|Overall Study|Lost to Follow-up|0|||
156691322|NCT01173471|565615648|FG001|Overall Study|Lost to Follow-up|0|||
156691323|NCT01173471|565615649|FG002|Overall Study|Lost to Follow-up|1|||
156691324|NCT01173471|565615650|FG003|Overall Study|Lost to Follow-up|0|||
156691325|NCT01173471|565615647|FG000|Overall Study|Reason given as Other|0|||
156691326|NCT01173471|565615648|FG001|Overall Study|Reason given as Other|0|||
156691327|NCT01173471|565615649|FG002|Overall Study|Reason given as Other|1|||
156691328|NCT01173471|565615650|FG003|Overall Study|Reason given as Other|0|||
156691329|NCT02370914|565615651|FG000|Overall Study|Protocol Violation|2|||
156691330|NCT00252174|565615653|FG000|Overall Study|Withdrawal by Subject|0|||
156691331|NCT00252174|565615654|FG001|Overall Study|Withdrawal by Subject|1|||
156691332|NCT00252174|565615655|FG002|Overall Study|Withdrawal by Subject|0|||
156691333|NCT02224573|565615656|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
156691334|NCT02224573|565615657|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
156691335|NCT02224573|565615656|FG000|Treatment Phase|Started on Other IMP|1|||
156691336|NCT02224573|565615657|FG001|Treatment Phase|Started on Other IMP|0|||
156691337|NCT02224573|565615656|FG000|Treatment Phase|Participant Discontinued IMP|0|||
156691338|NCT02224573|565615657|FG001|Treatment Phase|Participant Discontinued IMP|1|||
156691339|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficacy|15|||
156691340|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficacy|8|||
156691341|NCT02224573|565615656|FG000|Treatment Phase|Began Commercial Product|1|||
156691342|NCT02224573|565615657|FG001|Treatment Phase|Began Commercial Product|0|||
156691343|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
156691344|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
156691345|NCT02224573|565615656|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
156691346|NCT02224573|565615657|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
156691347|NCT02224573|565615656|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
156691348|NCT02224573|565615657|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
156870204|NCT04161157|566281113|FG000|Overall Study|Lost to Follow-up|4|||
156870205|NCT04161157|566281113|FG000|Overall Study|Death|3|||
156870206|NCT04161157|566281113|FG000|Overall Study|Ineligible|2|||
156870207|NCT04161157|566281113|FG000|Overall Study|Withdrawal by Subject|4|||
156870208|NCT01285557|566281118|FG000|Overall Study|Death|173|||
156870209|NCT01285557|566281119|FG001|Overall Study|Death|90|||
156870210|NCT01285557|566281118|FG000|Overall Study|Lost to Follow-up|6|||
156870211|NCT01285557|566281119|FG001|Overall Study|Lost to Follow-up|2|||
156870212|NCT01285557|566281118|FG000|Overall Study|Withdrew Consent|6|||
156870213|NCT01285557|566281119|FG001|Overall Study|Withdrew Consent|1|||
156870214|NCT01285557|566281118|FG000|Overall Study|Sponsor Study Termination|23|||
156870215|NCT01285557|566281119|FG001|Overall Study|Sponsor Study Termination|13|||
156870216|NCT01285557|566281118|FG000|Overall Study|Randomized but not treated|1|||
156870217|NCT01285557|566281119|FG001|Overall Study|Randomized but not treated|1|||
156870218|NCT01285557|566281118|FG000|Overall Study|Study follow-up ongoing|28|||
156870219|NCT01285557|566281119|FG001|Overall Study|Study follow-up ongoing|14|||
156870220|NCT01285557|566281118|FG000|Overall Study|Sponsor Decision|2|||
156870221|NCT01285557|566281119|FG001|Overall Study|Sponsor Decision|1|||
156870222|NCT02991768|566281124|FG000|Overall Study|Physician Decision|4|||
156870223|NCT05786651|566281127|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
156870224|NCT04922216|566281129|FG000|Overall Study|Withdrawal by Subject|0|||
156870225|NCT04922216|566281130|FG001|Overall Study|Withdrawal by Subject|1|||
156870226|NCT04922216|566281131|FG002|Overall Study|Withdrawal by Subject|0|||
157013506|NCT04869982|566801796|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
156691349|NCT02224573|565615656|FG000|Treatment Phase|Continued Compassionate Use|1|||
156691350|NCT02224573|565615657|FG001|Treatment Phase|Continued Compassionate Use|0|||
156691351|NCT02224573|565615656|FG000|Treatment Phase|Lack of Efficiency|2|||
156691352|NCT02224573|565615657|FG001|Treatment Phase|Lack of Efficiency|1|||
156691353|NCT02224573|565615656|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
156870227|NCT04922216|566281132|FG003|Overall Study|Withdrawal by Subject|0|||
156870228|NCT04922216|566281133|FG004|Overall Study|Withdrawal by Subject|0|||
156870229|NCT04922216|566281134|FG005|Overall Study|Withdrawal by Subject|0|||
156870230|NCT04922216|566281135|FG006|Overall Study|Withdrawal by Subject|0|||
156870231|NCT04922216|566281136|FG007|Overall Study|Withdrawal by Subject|2|||
156870232|NCT04922216|566281137|FG008|Overall Study|Withdrawal by Subject|0|||
156870233|NCT04922216|566281138|FG009|Overall Study|Withdrawal by Subject|0|||
157013507|NCT04869982|566801797|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
156691354|NCT02224573|565615657|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
156691355|NCT02224573|565615656|FG000|Treatment Phase|Participant Moved|2|||
156691356|NCT02224573|565615657|FG001|Treatment Phase|Participant Moved|0|||
156691357|NCT02224573|565615656|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
156691358|NCT02224573|565615657|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
156691359|NCT02224573|565615656|FG000|Treatment Phase|Refused Medication|1|||
156691360|NCT02224573|565615657|FG001|Treatment Phase|Refused Medication|1|||
156691361|NCT02224573|565615656|FG000|Treatment Phase|Adverse Event|26|||
156691362|NCT02224573|565615657|FG001|Treatment Phase|Adverse Event|38|||
156691363|NCT02224573|565615656|FG000|Treatment Phase|Placed in Group Home|0|||
156691364|NCT02224573|565615657|FG001|Treatment Phase|Placed in Group Home|1|||
156691365|NCT02224573|565615656|FG000|Treatment Phase|Pursued Other Trials|1|||
156691366|NCT02224573|565615657|FG001|Treatment Phase|Pursued Other Trials|0|||
156691367|NCT02224573|565615656|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
156691368|NCT02224573|565615657|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
156691369|NCT02224573|565615656|FG000|Treatment Phase|Lost to Follow-up|2|||
156691370|NCT02224573|565615657|FG001|Treatment Phase|Lost to Follow-up|1|||
156691371|NCT02224573|565615656|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
156691372|NCT02224573|565615657|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
156691373|NCT02224573|565615656|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
157013508|NCT04869982|566801796|FG000|Overall Study|Migrated / moved from the study area|1|||
157013509|NCT04869982|566801797|FG001|Overall Study|Migrated / moved from the study area|1|||
157013510|NCT04869982|566801796|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
157013511|NCT04869982|566801797|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
157013512|NCT04869982|566801796|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
157013513|NCT04869982|566801797|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
157013514|NCT04869982|566801796|FG000|Overall Study|Solicited adverse event|2|||
157013515|NCT04869982|566801797|FG001|Overall Study|Solicited adverse event|1|||
157013516|NCT02473250|566801798|FG000|Overall Study|Lost to Follow-up|10|||
157013517|NCT02473250|566801798|FG000|Overall Study|Physician Decision|5|||
157013518|NCT02473250|566801798|FG000|Overall Study|Did not tolerate medication washout|3|||
157013519|NCT02473250|566801798|FG000|Overall Study|Antidepressant effect of divalproex|2|||
157013520|NCT03103321|566801799|FG000|Overall Study|Protocol Violation|1|||
157013521|NCT03103321|566801800|FG001|Overall Study|Protocol Violation|1|||
157013522|NCT03103321|566801801|FG002|Overall Study|Protocol Violation|1|||
157013523|NCT03103321|566801802|FG003|Overall Study|Protocol Violation|0|||
157013524|NCT04847999|566801803|FG000|Overall Study|Lost to Follow-up|0|||
157013525|NCT04847999|566801804|FG001|Overall Study|Lost to Follow-up|1|||
156691374|NCT02224573|565615657|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
157121598|NCT05103332|567195980|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121599|NCT05103332|567195981|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121600|NCT05103332|567195982|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121601|NCT05103332|567195983|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121602|NCT05103332|567195984|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121603|NCT05103332|567195985|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121604|NCT05103332|567195986|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121605|NCT05103332|567195987|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121606|NCT05103332|567195988|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121607|NCT05103332|567195989|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121608|NCT05103332|567195990|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121609|NCT05103332|567195991|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121610|NCT05103332|567195992|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
157121611|NCT05103332|567195993|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
157121612|NCT05103332|567195994|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
157121613|NCT05103332|567195995|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
157121614|NCT05103332|567195978|FG000|SFU Period (6 Months=168 Days)|Death|0|||
157121615|NCT05103332|567195979|FG001|SFU Period (6 Months=168 Days)|Death|0|||
157121616|NCT05103332|567195980|FG002|SFU Period (6 Months=168 Days)|Death|0|||
156691375|NCT02224573|565615656|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
156691376|NCT02224573|565615657|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
156691377|NCT02224573|565615656|FG000|Taper Phase|Adverse Event|1|||
156691378|NCT02224573|565615657|FG001|Taper Phase|Adverse Event|1|||
156691379|NCT02546362|565615658|FG000|4-week Treatment Period|Lost to Follow-up|1|||
156691380|NCT02546362|565615658|FG000|4-week Treatment Period|Change in medication|2|||
157013526|NCT02879448|566801805|FG000|Overall Study|Death|251|||
157013527|NCT02879448|566801806|FG001|Overall Study|Death|263|||
157121617|NCT05103332|567195981|FG003|SFU Period (6 Months=168 Days)|Death|0|||
157121618|NCT05103332|567195982|FG004|SFU Period (6 Months=168 Days)|Death|0|||
157121619|NCT05103332|567195983|FG005|SFU Period (6 Months=168 Days)|Death|0|||
157121620|NCT05103332|567195984|FG006|SFU Period (6 Months=168 Days)|Death|0|||
157121621|NCT05103332|567195985|FG007|SFU Period (6 Months=168 Days)|Death|0|||
156691381|NCT02546362|565615658|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
156691382|NCT02546362|565615658|FG000|12-week Treatment Period|Lost to Follow-up|2|||
156691383|NCT02546362|565615658|FG000|12-week Treatment Period|Change in medication|1|||
156691384|NCT01138826|565615659|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691385|NCT01138826|565615660|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691386|NCT01138826|565615661|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691387|NCT01138826|565615662|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691388|NCT01138826|565615663|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
156691389|NCT01138826|565615664|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
156691390|NCT02025010|565615669|FG000|Overall Study|Symptomatic or radiographic progression|36|||
156691391|NCT02025010|565615669|FG000|Overall Study|Adverse Event|6|||
156691392|NCT02025010|565615669|FG000|Overall Study|Physician Decision|7|||
156691393|NCT02025010|565615669|FG000|Overall Study|Withdrawal by Subject|3|||
156691394|NCT02025010|565615669|FG000|Overall Study|Intercurrent illness|3|||
156691395|NCT02025010|565615669|FG000|Overall Study|Patients still on treatment|3|||
156691396|NCT02025010|565615669|FG000|Overall Study|Never initiate the treatment|2|||
156691397|NCT04440449|565615670|FG000|Overall Study|Lost to Follow-up|2|||
156691398|NCT04440449|565615671|FG001|Overall Study|Lost to Follow-up|0|||
156691399|NCT01949116|565615673|FG000|Overall Study|Death|2|||
156691400|NCT01949116|565615674|FG001|Overall Study|Death|0|||
156691401|NCT01949116|565615673|FG000|Overall Study|Lost to Follow-up|1|||
156691402|NCT01949116|565615674|FG001|Overall Study|Lost to Follow-up|3|||
156691403|NCT01949116|565615673|FG000|Overall Study|Withdrawal by Subject|5|||
156691404|NCT01949116|565615674|FG001|Overall Study|Withdrawal by Subject|3|||
156691405|NCT03832738|565615675|FG000|Overall Study|Withdrawal by Subject|6|||
156691406|NCT03832738|565615676|FG001|Overall Study|Withdrawal by Subject|7|||
156691407|NCT03832738|565615677|FG002|Overall Study|Withdrawal by Subject|16|||
156691408|NCT03832738|565615675|FG000|Overall Study|Physician Decision|0|||
156691409|NCT03832738|565615676|FG001|Overall Study|Physician Decision|1|||
156691410|NCT03832738|565615677|FG002|Overall Study|Physician Decision|2|||
156691411|NCT03832738|565615675|FG000|Overall Study|Adverse Event|2|||
156691412|NCT03832738|565615676|FG001|Overall Study|Adverse Event|3|||
156691413|NCT03832738|565615677|FG002|Overall Study|Adverse Event|1|||
156691414|NCT03832738|565615675|FG000|Overall Study|Pregnancy|0|||
156691415|NCT03832738|565615676|FG001|Overall Study|Pregnancy|1|||
156691416|NCT03832738|565615677|FG002|Overall Study|Pregnancy|0|||
156691417|NCT02442271|565615678|FG000|Overall Study|Adverse Event|1|||
156691418|NCT02442271|565615678|FG000|Overall Study|Withdrew Consent|1|||
156691419|NCT02442271|565615678|FG000|Overall Study|Lost to Follow-up|1|||
156691420|NCT02442271|565615678|FG000|Overall Study|Other|1|||
156691421|NCT00831623|565615679|FG000|Overall Study|Withdrawal by Subject|9|||
156691422|NCT00831623|565615679|FG000|Overall Study|Lost to Follow-up|1|||
156691423|NCT00831623|565615679|FG000|Overall Study|Not 2 years post-treatment|12|||
156691424|NCT02080832|565615688|FG000|Overall Study|Excluded from analysis by MRI|9|||
156691425|NCT02080832|565615689|FG001|Overall Study|Excluded from analysis by MRI|10|||
156691426|NCT02080832|565615690|FG002|Overall Study|Excluded from analysis by MRI|14|||
156691427|NCT02080832|565615688|FG000|Overall Study|Lost to Follow-up|0|||
156691428|NCT02080832|565615689|FG001|Overall Study|Lost to Follow-up|2|||
156691429|NCT02080832|565615690|FG002|Overall Study|Lost to Follow-up|2|||
156691430|NCT01560507|565615691|FG000|Overall Study|Lost to Follow-up|3|||
156691431|NCT01560507|565615692|FG001|Overall Study|Lost to Follow-up|1|||
156691432|NCT01560507|565615693|FG002|Overall Study|Lost to Follow-up|2|||
156691433|NCT01560507|565615691|FG000|Overall Study|Withdrawal by Subject|1|||
156691434|NCT01560507|565615692|FG001|Overall Study|Withdrawal by Subject|1|||
156691435|NCT01560507|565615693|FG002|Overall Study|Withdrawal by Subject|0|||
156691436|NCT01660022|565615694|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691437|NCT01660022|565615695|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
156691438|NCT01660022|565615696|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691439|NCT01660022|565615697|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
156691440|NCT01660022|565615698|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691441|NCT01660022|565615699|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
156691442|NCT01660022|565615694|FG000|First Sequence (7 Days)|Adverse Event|0|||
156691443|NCT01660022|565615695|FG001|First Sequence (7 Days)|Adverse Event|0|||
156691444|NCT01660022|565615696|FG002|First Sequence (7 Days)|Adverse Event|0|||
156691445|NCT01660022|565615697|FG003|First Sequence (7 Days)|Adverse Event|0|||
156691446|NCT01660022|565615698|FG004|First Sequence (7 Days)|Adverse Event|1|||
156691447|NCT01660022|565615699|FG005|First Sequence (7 Days)|Adverse Event|3|||
156691448|NCT01660022|565615694|FG000|First Sequence (7 Days)|Protocol Violation|0|||
156691449|NCT01660022|565615695|FG001|First Sequence (7 Days)|Protocol Violation|0|||
156691450|NCT01660022|565615696|FG002|First Sequence (7 Days)|Protocol Violation|0|||
156691451|NCT01660022|565615697|FG003|First Sequence (7 Days)|Protocol Violation|0|||
156691452|NCT01660022|565615698|FG004|First Sequence (7 Days)|Protocol Violation|0|||
156691453|NCT01660022|565615699|FG005|First Sequence (7 Days)|Protocol Violation|1|||
156691454|NCT03545191|565615701|FG000|Overall Study|Death|1|||
156691455|NCT03545191|565615702|FG001|Overall Study|Death|0|||
156691456|NCT03545191|565615703|FG002|Overall Study|Death|0|||
157214484|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
157214485|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
157214486|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
157214487|NCT01872689|567531899|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
157214488|NCT01872689|567531900|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
156691457|NCT03545191|565615701|FG000|Overall Study|Adverse Event|4|||
156691458|NCT03545191|565615702|FG001|Overall Study|Adverse Event|2|||
156691459|NCT03545191|565615703|FG002|Overall Study|Adverse Event|7|||
156691460|NCT03545191|565615701|FG000|Overall Study|Other reasons|3|||
156691461|NCT03545191|565615702|FG001|Overall Study|Other reasons|11|||
156691462|NCT03545191|565615703|FG002|Overall Study|Other reasons|8|||
156691463|NCT03545191|565615701|FG000|Overall Study|Withdrawal by Subject|13|||
156691464|NCT03545191|565615702|FG001|Overall Study|Withdrawal by Subject|10|||
156691465|NCT03545191|565615703|FG002|Overall Study|Withdrawal by Subject|12|||
156691466|NCT03545191|565615701|FG000|Overall Study|Lost to Follow-up|1|||
156691467|NCT03545191|565615702|FG001|Overall Study|Lost to Follow-up|2|||
156691468|NCT03545191|565615703|FG002|Overall Study|Lost to Follow-up|3|||
156691469|NCT01277718|565615707|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
156691470|NCT01277718|565615708|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
156691471|NCT01277718|565615707|FG000|Period 2 - Second Intervention|Physician Decision|0|||
156691472|NCT01277718|565615708|FG001|Period 2 - Second Intervention|Physician Decision|2|||
156691473|NCT02746627|565615712|FG000|Overall Study|Withdrawal by Subject|1|||
156691474|NCT02746627|565615713|FG001|Overall Study|Withdrawal by Subject|1|||
156691475|NCT02746627|565615714|FG002|Overall Study|Withdrawal by Subject|1|||
156691476|NCT02858726|565615715|FG000|Overall Study|Adverse Event|4|||
156691477|NCT02858726|565615716|FG001|Overall Study|Adverse Event|4|||
156691478|NCT02858726|565615717|FG002|Overall Study|Adverse Event|9|||
156691479|NCT02858726|565615718|FG003|Overall Study|Adverse Event|1|||
156691480|NCT02858726|565615715|FG000|Overall Study|Physician Decision|0|||
156691481|NCT02858726|565615716|FG001|Overall Study|Physician Decision|0|||
156691482|NCT02858726|565615717|FG002|Overall Study|Physician Decision|1|||
156691483|NCT02858726|565615718|FG003|Overall Study|Physician Decision|0|||
156691484|NCT02858726|565615715|FG000|Overall Study|Protocol Violation|0|||
156691485|NCT02858726|565615716|FG001|Overall Study|Protocol Violation|0|||
156691486|NCT02858726|565615717|FG002|Overall Study|Protocol Violation|0|||
156691487|NCT02858726|565615718|FG003|Overall Study|Protocol Violation|1|||
156788118|NCT04595370|565974888|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788119|NCT04595370|565974889|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
156788120|NCT04595370|565974884|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788121|NCT04595370|565974885|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788122|NCT04595370|565974886|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
156788123|NCT04595370|565974887|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788124|NCT04595370|565974888|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788125|NCT04595370|565974889|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
156788126|NCT04595370|565974884|FG000|Overall Study|Adverse Event|0|||
156788127|NCT04595370|565974885|FG001|Overall Study|Adverse Event|4|||
156788128|NCT04595370|565974886|FG002|Overall Study|Adverse Event|3|||
156788129|NCT04595370|565974887|FG003|Overall Study|Adverse Event|1|||
156788130|NCT04595370|565974888|FG004|Overall Study|Adverse Event|1|||
156788131|NCT04595370|565974889|FG005|Overall Study|Adverse Event|1|||
156788132|NCT04595370|565974884|FG000|Overall Study|Withdrawal of Consent|1|||
156788133|NCT04595370|565974885|FG001|Overall Study|Withdrawal of Consent|1|||
156788134|NCT04595370|565974886|FG002|Overall Study|Withdrawal of Consent|1|||
156788135|NCT04595370|565974887|FG003|Overall Study|Withdrawal of Consent|0|||
156788136|NCT04595370|565974888|FG004|Overall Study|Withdrawal of Consent|0|||
156788137|NCT04595370|565974889|FG005|Overall Study|Withdrawal of Consent|0|||
156788138|NCT04595370|565974884|FG000|Overall Study|Death|0|||
156788139|NCT04595370|565974885|FG001|Overall Study|Death|1|||
156788140|NCT04595370|565974886|FG002|Overall Study|Death|0|||
156788141|NCT04595370|565974887|FG003|Overall Study|Death|0|||
156788142|NCT04595370|565974888|FG004|Overall Study|Death|1|||
156788143|NCT04595370|565974889|FG005|Overall Study|Death|0|||
156788144|NCT04595370|565974884|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788145|NCT04595370|565974885|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788146|NCT04595370|565974886|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156788147|NCT04595370|565974887|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788148|NCT04595370|565974888|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
157214489|NCT01872689|567531901|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
156691488|NCT02858726|565615715|FG000|Overall Study|Study Terminated by Sponsor|0|||
156691489|NCT02858726|565615716|FG001|Overall Study|Study Terminated by Sponsor|0|||
156691490|NCT02858726|565615717|FG002|Overall Study|Study Terminated by Sponsor|0|||
156691491|NCT02858726|565615718|FG003|Overall Study|Study Terminated by Sponsor|1|||
156788149|NCT04595370|565974889|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156788150|NCT04595370|565974884|FG000|Overall Study|Withdrawal by Subject|0|||
156691492|NCT02858726|565615715|FG000|Overall Study|Withdrawal by Subject|1|||
156691493|NCT02858726|565615716|FG001|Overall Study|Withdrawal by Subject|2|||
156691494|NCT02858726|565615717|FG002|Overall Study|Withdrawal by Subject|1|||
156691495|NCT02858726|565615718|FG003|Overall Study|Withdrawal by Subject|0|||
156691496|NCT02858726|565615715|FG000|Overall Study|Noncompliance|0|||
156691497|NCT02858726|565615716|FG001|Overall Study|Noncompliance|1|||
156691498|NCT02858726|565615717|FG002|Overall Study|Noncompliance|0|||
156691499|NCT02858726|565615718|FG003|Overall Study|Noncompliance|0|||
156691500|NCT00233987|565615723|FG000|Overall Study|Withdrawal by Subject|1|||
156691501|NCT00233987|565615723|FG000|Overall Study|Lack of Efficacy|2|||
156691502|NCT00233987|565615723|FG000|Overall Study|Reason Under Review|1|||
156691503|NCT00233987|565615723|FG000|Overall Study|Other - Not Protocol Specified|5|||
156691504|NCT00233987|565615723|FG000|Overall Study|Eligible but No Treatment Received|2|||
156691505|NCT00233987|565615723|FG000|Overall Study|Ineligible|4|||
156691506|NCT01688726|565615726|FG000|Overall Study|Adverse Event|1|||
156691507|NCT01688726|565615727|FG001|Overall Study|Adverse Event|0|||
156691508|NCT01688726|565615726|FG000|Overall Study|Relocated abroad|0|||
156691509|NCT01688726|565615727|FG001|Overall Study|Relocated abroad|1|||
156788151|NCT04595370|565974885|FG001|Overall Study|Withdrawal by Subject|0|||
156788152|NCT04595370|565974886|FG002|Overall Study|Withdrawal by Subject|1|||
156788153|NCT04595370|565974887|FG003|Overall Study|Withdrawal by Subject|0|||
156691510|NCT04553913|565615728|FG000|Overall Study|patient's block resolved prior to PACU|1|||
156691511|NCT04553913|565615728|FG000|Overall Study|did not use the device properly|5|||
156691512|NCT01481324|565615729|FG000|Overall Study|Missing Data|0|||
156691513|NCT01481324|565615730|FG001|Overall Study|Missing Data|2|||
156691514|NCT01481324|565615731|FG002|Overall Study|Missing Data|2|||
156691515|NCT00710749|565615735|FG000|First Intervention|Withdrawal by Subject|1|||
156691516|NCT00710749|565615736|FG001|First Intervention|Withdrawal by Subject|0|||
156691517|NCT05478252|565615737|FG000|Overall Study|Withdrawal by Subject|2|||
156691518|NCT05478252|565615738|FG001|Overall Study|Withdrawal by Subject|3|||
156691519|NCT05478252|565615737|FG000|Overall Study|Lost to Follow-up|4|||
156691520|NCT05478252|565615738|FG001|Overall Study|Lost to Follow-up|2|||
156691521|NCT05478252|565615737|FG000|Overall Study|Physician Decision|1|||
156691522|NCT05478252|565615738|FG001|Overall Study|Physician Decision|1|||
156691523|NCT05478252|565615737|FG000|Overall Study|Death|1|||
156691524|NCT05478252|565615738|FG001|Overall Study|Death|0|||
156691525|NCT04560998|565615739|FG000|Overall Study|Withdrawal by Subject|18|||
156691526|NCT04560998|565615740|FG001|Overall Study|Withdrawal by Subject|12|||
156691527|NCT04560998|565615739|FG000|Overall Study|Lost to Follow-up|8|||
156691528|NCT04560998|565615740|FG001|Overall Study|Lost to Follow-up|5|||
156691529|NCT04560998|565615739|FG000|Overall Study|Physician Decision|4|||
156691530|NCT04560998|565615740|FG001|Overall Study|Physician Decision|0|||
156691531|NCT03821272|565617978|FG000|Overall Study|Death|1|||
156691532|NCT03821272|565617979|FG001|Overall Study|Death|0|||
156691533|NCT03821272|565617978|FG000|Overall Study|Physician Decision|1|||
156691534|NCT03821272|565617979|FG001|Overall Study|Physician Decision|0|||
156691535|NCT03821272|565617978|FG000|Overall Study|Withdrawal by Subject|1|||
156691536|NCT03821272|565617979|FG001|Overall Study|Withdrawal by Subject|0|||
156691537|NCT05904769|565617980|FG000|Overall Study|Physician Decision|0|||
156691538|NCT05904769|565617981|FG001|Overall Study|Physician Decision|6|||
156691539|NCT05626803|565617982|FG000|Overall Study|Lost to Follow-up|0|||
156691540|NCT05626803|565617983|FG001|Overall Study|Lost to Follow-up|1|||
156691541|NCT05626803|565617984|FG002|Overall Study|Lost to Follow-up|0|||
156691542|NCT05626803|565617985|FG003|Overall Study|Lost to Follow-up|0|||
156691543|NCT04974619|565617986|FG000|Overall Study|Lost to Follow-up|0|||
156691544|NCT04974619|565617987|FG001|Overall Study|Lost to Follow-up|0|||
156691545|NCT04974619|565617988|FG002|Overall Study|Lost to Follow-up|1|||
156691546|NCT04974619|565617986|FG000|Overall Study|Withdrawal by Subject|0|||
156691547|NCT04974619|565617987|FG001|Overall Study|Withdrawal by Subject|0|||
156691548|NCT04974619|565617988|FG002|Overall Study|Withdrawal by Subject|1|||
156691549|NCT04974619|565617986|FG000|Overall Study|Protocol Violation|0|||
156691550|NCT04974619|565617987|FG001|Overall Study|Protocol Violation|1|||
156691551|NCT04974619|565617988|FG002|Overall Study|Protocol Violation|0|||
156691552|NCT01688466|565617990|FG000|Overall Study|Withdrawal by Subject|2|||
156691553|NCT01688466|565617991|FG001|Overall Study|Withdrawal by Subject|1|||
156691554|NCT01688466|565617990|FG000|Overall Study|Death|0|||
156691555|NCT01688466|565617991|FG001|Overall Study|Death|1|||
156691556|NCT01688466|565617990|FG000|Overall Study|Adverse Event|0|||
156788154|NCT04595370|565974888|FG004|Overall Study|Withdrawal by Subject|2|||
156788155|NCT04595370|565974889|FG005|Overall Study|Withdrawal by Subject|0|||
156788156|NCT04595370|565974884|FG000|Overall Study|Lost to Follow-up|0|||
157121622|NCT05103332|567195986|FG008|SFU Period (6 Months=168 Days)|Death|0|||
156691557|NCT01688466|565617991|FG001|Overall Study|Adverse Event|4|||
156691558|NCT01688466|565617990|FG000|Overall Study|Not evaluable|0|||
156691559|NCT01688466|565617991|FG001|Overall Study|Not evaluable|1|||
156691560|NCT01000610|565617992|FG000|Overall Study|Adverse Event|1|||
156691561|NCT01000610|565617992|FG000|Overall Study|Lost to Follow-up|4|||
156691562|NCT01000610|565617992|FG000|Overall Study|Treatment failure|1|||
156691563|NCT04495283|565617995|FG000|Overall Study|Physician Decision|0|||
156691564|NCT04495283|565617996|FG001|Overall Study|Physician Decision|0|||
156691565|NCT04495283|565617997|FG002|Overall Study|Physician Decision|1|||
156691566|NCT04495283|565617995|FG000|Overall Study|Withdrawal by Subject|0|||
156691567|NCT04495283|565617996|FG001|Overall Study|Withdrawal by Subject|1|||
156691568|NCT04495283|565617997|FG002|Overall Study|Withdrawal by Subject|1|||
156691569|NCT04495283|565617995|FG000|Overall Study|Other|1|||
156691570|NCT04495283|565617996|FG001|Overall Study|Other|0|||
156691571|NCT04495283|565617997|FG002|Overall Study|Other|1|||
156691572|NCT01647958|565618011|FG000|Initial Study|Lost to Follow-up|2|||
156691573|NCT01647958|565618012|FG001|Initial Study|Lost to Follow-up|3|||
156788157|NCT04595370|565974885|FG001|Overall Study|Lost to Follow-up|0|||
156788158|NCT04595370|565974886|FG002|Overall Study|Lost to Follow-up|0|||
157121623|NCT05103332|567195987|FG009|SFU Period (6 Months=168 Days)|Death|0|||
157121624|NCT05103332|567195988|FG010|SFU Period (6 Months=168 Days)|Death|0|||
157121625|NCT05103332|567195989|FG011|SFU Period (6 Months=168 Days)|Death|0|||
156788159|NCT04595370|565974887|FG003|Overall Study|Lost to Follow-up|0|||
156788160|NCT04595370|565974888|FG004|Overall Study|Lost to Follow-up|1|||
156788161|NCT04595370|565974889|FG005|Overall Study|Lost to Follow-up|0|||
156788162|NCT04595370|565974884|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788163|NCT04595370|565974885|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
156788164|NCT04595370|565974886|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
156788165|NCT04595370|565974887|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788166|NCT04595370|565974888|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
156788167|NCT04595370|565974889|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
156788168|NCT00541775|565974890|FG000|Overall Study|Adverse Event|3|||
156788169|NCT00541775|565974891|FG001|Overall Study|Adverse Event|2|||
156788170|NCT00541775|565974892|FG002|Overall Study|Adverse Event|1|||
156788171|NCT00541775|565974890|FG000|Overall Study|Lack of Efficacy|0|||
156788172|NCT00541775|565974891|FG001|Overall Study|Lack of Efficacy|0|||
156788173|NCT00541775|565974892|FG002|Overall Study|Lack of Efficacy|3|||
156788174|NCT00541775|565974890|FG000|Overall Study|Lost to Follow-up|0|||
156788175|NCT00541775|565974891|FG001|Overall Study|Lost to Follow-up|0|||
156788176|NCT00541775|565974892|FG002|Overall Study|Lost to Follow-up|2|||
156788177|NCT00541775|565974890|FG000|Overall Study|Protocol Violation|1|||
156788178|NCT00541775|565974891|FG001|Overall Study|Protocol Violation|0|||
156788179|NCT00541775|565974892|FG002|Overall Study|Protocol Violation|0|||
156788180|NCT00541775|565974890|FG000|Overall Study|Withdrawal by Subject and Other|5|||
156788181|NCT00541775|565974891|FG001|Overall Study|Withdrawal by Subject and Other|0|||
156788182|NCT00541775|565974892|FG002|Overall Study|Withdrawal by Subject and Other|2|||
156788183|NCT01945242|565974893|FG000|Overall Study|Physician Decision|3|||
156788184|NCT01945242|565974894|FG001|Overall Study|Physician Decision|3|||
156788185|NCT02975700|565974895|FG000|Overall Study|Adverse Event|1|||
156788186|NCT02975700|565974895|FG000|Overall Study|Progressive disease|3|||
156788187|NCT02975700|565974895|FG000|Overall Study|Failed screening criteria|2|||
156788188|NCT01541254|565974898|FG000|Overall Study|Withdrawal by Subject|1|||
156788189|NCT01541254|565974898|FG000|Overall Study|excluded - metal allergy|1|||
156788190|NCT01541254|565974898|FG000|Overall Study|enrolled after study closed|1|||
156788191|NCT01541254|565974898|FG000|Overall Study|GI bleed prior to procedure|1|||
156788192|NCT01541254|565974898|FG000|Overall Study|stent not required|1|||
156788193|NCT01541254|565974898|FG000|Overall Study|alternate stent used|1|||
156788194|NCT05660538|565974899|FG000|Overall Study|Adverse Event|0|||
156788195|NCT05660538|565974900|FG001|Overall Study|Adverse Event|0|||
156788196|NCT05660538|565974901|FG002|Overall Study|Adverse Event|1|||
156788197|NCT05660538|565974902|FG003|Overall Study|Adverse Event|0|||
156788198|NCT05660538|565974899|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156788199|NCT05660538|565974900|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156788200|NCT05660538|565974901|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
156788201|NCT05660538|565974902|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
156788202|NCT05660538|565974899|FG000|Overall Study|Lost to Follow-up|0|||
156788203|NCT05660538|565974900|FG001|Overall Study|Lost to Follow-up|0|||
156788204|NCT05660538|565974901|FG002|Overall Study|Lost to Follow-up|1|||
156788205|NCT05660538|565974902|FG003|Overall Study|Lost to Follow-up|1|||
157121626|NCT05103332|567195990|FG012|SFU Period (6 Months=168 Days)|Death|0|||
157121627|NCT05103332|567195991|FG013|SFU Period (6 Months=168 Days)|Death|0|||
157121628|NCT05103332|567195992|FG014|SFU Period (6 Months=168 Days)|Death|1|||
156691574|NCT01647958|565618011|FG000|Continuation Phase|treatment received during Overall Study|39|||
156788206|NCT05660538|565974899|FG000|Overall Study|Death|0|||
156788207|NCT05660538|565974900|FG001|Overall Study|Death|0|||
156788208|NCT05660538|565974901|FG002|Overall Study|Death|1|||
156788209|NCT05660538|565974902|FG003|Overall Study|Death|0|||
156788210|NCT05660538|565974899|FG000|Overall Study|Physician Decision|0|||
156788211|NCT05660538|565974900|FG001|Overall Study|Physician Decision|0|||
156788212|NCT05660538|565974901|FG002|Overall Study|Physician Decision|0|||
156788213|NCT05660538|565974902|FG003|Overall Study|Physician Decision|1|||
156788214|NCT05660538|565974899|FG000|Overall Study|Sponsor Decision|1|||
156788215|NCT05660538|565974900|FG001|Overall Study|Sponsor Decision|0|||
156691575|NCT01647958|565618012|FG001|Continuation Phase|treatment received during Overall Study|0|||
156691576|NCT01647958|565618011|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
156691577|NCT01647958|565618012|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
156691578|NCT01131299|565618013|FG000|Overall Study|Withdrawal by Subject|4|||
156691579|NCT01131299|565618014|FG001|Overall Study|Withdrawal by Subject|7|||
156691580|NCT01207440|565618022|FG000|Overall Study|Adverse Event|46|||
156691581|NCT01207440|565618023|FG001|Overall Study|Adverse Event|11|||
156691582|NCT01207440|565618024|FG002|Overall Study|Adverse Event|7|||
156691583|NCT01207440|565618025|FG003|Overall Study|Adverse Event|2|||
156691584|NCT01207440|565618026|FG004|Overall Study|Adverse Event|6|||
156691585|NCT01207440|565618027|FG005|Overall Study|Adverse Event|6|||
156691586|NCT01207440|565618028|FG006|Overall Study|Adverse Event|2|||
156691587|NCT01207440|565618022|FG000|Overall Study|Death|6|||
156691588|NCT01207440|565618023|FG001|Overall Study|Death|3|||
156691589|NCT01207440|565618024|FG002|Overall Study|Death|2|||
156691590|NCT01207440|565618025|FG003|Overall Study|Death|2|||
156691591|NCT01207440|565618026|FG004|Overall Study|Death|7|||
156691592|NCT01207440|565618027|FG005|Overall Study|Death|5|||
156691593|NCT01207440|565618028|FG006|Overall Study|Death|1|||
156691594|NCT01207440|565618022|FG000|Overall Study|Lack of Efficacy|13|||
156691595|NCT01207440|565618023|FG001|Overall Study|Lack of Efficacy|2|||
156691596|NCT01207440|565618024|FG002|Overall Study|Lack of Efficacy|5|||
156691597|NCT01207440|565618025|FG003|Overall Study|Lack of Efficacy|1|||
156691598|NCT01207440|565618026|FG004|Overall Study|Lack of Efficacy|2|||
156691599|NCT01207440|565618027|FG005|Overall Study|Lack of Efficacy|3|||
156691600|NCT01207440|565618028|FG006|Overall Study|Lack of Efficacy|0|||
156691601|NCT01207440|565618022|FG000|Overall Study|Lost to Follow-up|0|||
156691602|NCT01207440|565618023|FG001|Overall Study|Lost to Follow-up|0|||
156691603|NCT01207440|565618024|FG002|Overall Study|Lost to Follow-up|2|||
156691604|NCT01207440|565618025|FG003|Overall Study|Lost to Follow-up|1|||
156691605|NCT01207440|565618026|FG004|Overall Study|Lost to Follow-up|0|||
156691606|NCT01207440|565618027|FG005|Overall Study|Lost to Follow-up|0|||
156691607|NCT01207440|565618028|FG006|Overall Study|Lost to Follow-up|0|||
156691608|NCT01207440|565618022|FG000|Overall Study|Non-compliance with Study Drug|3|||
156691609|NCT01207440|565618023|FG001|Overall Study|Non-compliance with Study Drug|0|||
156691610|NCT01207440|565618024|FG002|Overall Study|Non-compliance with Study Drug|1|||
156691611|NCT01207440|565618025|FG003|Overall Study|Non-compliance with Study Drug|0|||
156691612|NCT01207440|565618026|FG004|Overall Study|Non-compliance with Study Drug|0|||
156691613|NCT01207440|565618027|FG005|Overall Study|Non-compliance with Study Drug|0|||
156691614|NCT01207440|565618028|FG006|Overall Study|Non-compliance with Study Drug|0|||
156691615|NCT01207440|565618022|FG000|Overall Study|Physician Decision|6|||
156691616|NCT01207440|565618023|FG001|Overall Study|Physician Decision|5|||
156691617|NCT01207440|565618024|FG002|Overall Study|Physician Decision|5|||
156691618|NCT01207440|565618025|FG003|Overall Study|Physician Decision|0|||
156691619|NCT01207440|565618026|FG004|Overall Study|Physician Decision|1|||
156691620|NCT01207440|565618027|FG005|Overall Study|Physician Decision|0|||
156788216|NCT05660538|565974901|FG002|Overall Study|Sponsor Decision|0|||
156788217|NCT05660538|565974902|FG003|Overall Study|Sponsor Decision|0|||
156788218|NCT05660538|565974899|FG000|Overall Study|Other|1|||
156788219|NCT05660538|565974900|FG001|Overall Study|Other|0|||
156691621|NCT01207440|565618028|FG006|Overall Study|Physician Decision|0|||
156691622|NCT01207440|565618022|FG000|Overall Study|Progressive Disease|19|||
156691623|NCT01207440|565618023|FG001|Overall Study|Progressive Disease|10|||
156691624|NCT01207440|565618024|FG002|Overall Study|Progressive Disease|19|||
156691625|NCT01207440|565618025|FG003|Overall Study|Progressive Disease|7|||
156691626|NCT01207440|565618026|FG004|Overall Study|Progressive Disease|23|||
156691627|NCT01207440|565618027|FG005|Overall Study|Progressive Disease|27|||
156691628|NCT01207440|565618028|FG006|Overall Study|Progressive Disease|0|||
156691629|NCT01207440|565618022|FG000|Overall Study|Protocol Violation|2|||
156691630|NCT01207440|565618023|FG001|Overall Study|Protocol Violation|0|||
156691631|NCT01207440|565618024|FG002|Overall Study|Protocol Violation|0|||
156691632|NCT01207440|565618025|FG003|Overall Study|Protocol Violation|0|||
156691633|NCT01207440|565618026|FG004|Overall Study|Protocol Violation|0|||
156788220|NCT05660538|565974901|FG002|Overall Study|Other|0|||
156788221|NCT05660538|565974902|FG003|Overall Study|Other|1|||
156788222|NCT05660538|565974899|FG000|Overall Study|Randomized but did not receive study drug|1|||
156788223|NCT05660538|565974900|FG001|Overall Study|Randomized but did not receive study drug|0|||
156788224|NCT05660538|565974901|FG002|Overall Study|Randomized but did not receive study drug|0|||
156691634|NCT01207440|565618027|FG005|Overall Study|Protocol Violation|0|||
156691635|NCT01207440|565618028|FG006|Overall Study|Protocol Violation|0|||
156691636|NCT01207440|565618022|FG000|Overall Study|Site Terminated by Sponsor|69|||
156691637|NCT01207440|565618023|FG001|Overall Study|Site Terminated by Sponsor|19|||
156691638|NCT01207440|565618024|FG002|Overall Study|Site Terminated by Sponsor|12|||
156691639|NCT01207440|565618025|FG003|Overall Study|Site Terminated by Sponsor|2|||
156691640|NCT01207440|565618026|FG004|Overall Study|Site Terminated by Sponsor|3|||
156691641|NCT01207440|565618027|FG005|Overall Study|Site Terminated by Sponsor|0|||
156788225|NCT05660538|565974902|FG003|Overall Study|Randomized but did not receive study drug|1|||
156788226|NCT05660538|565974899|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
157013528|NCT02879448|566801805|FG000|Overall Study|Lost to Follow-up|23|||
157013529|NCT02879448|566801806|FG001|Overall Study|Lost to Follow-up|28|||
157013530|NCT02879448|566801805|FG000|Overall Study|Withdrawal by Subject|42|||
157013531|NCT02879448|566801806|FG001|Overall Study|Withdrawal by Subject|79|||
157013532|NCT02879448|566801805|FG000|Overall Study|Other Reasons|8|||
157013533|NCT02879448|566801806|FG001|Overall Study|Other Reasons|12|||
157013534|NCT01704079|566801808|FG000|Overall Study|Withdrawal by Subject|5|||
157013535|NCT01704079|566801809|FG001|Overall Study|Withdrawal by Subject|7|||
157013536|NCT01704079|566801808|FG000|Overall Study|Lost to Follow-up|2|||
157013537|NCT01704079|566801809|FG001|Overall Study|Lost to Follow-up|5|||
157013538|NCT01704079|566801808|FG000|Overall Study|Adverse Event|4|||
157013539|NCT01704079|566801809|FG001|Overall Study|Adverse Event|7|||
157013540|NCT01704079|566801808|FG000|Overall Study|Protocol Violation|1|||
157013541|NCT01704079|566801809|FG001|Overall Study|Protocol Violation|0|||
157013542|NCT01704079|566801808|FG000|Overall Study|Subject noncompliance|2|||
157013543|NCT01704079|566801809|FG001|Overall Study|Subject noncompliance|3|||
157013544|NCT01704079|566801808|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
157013545|NCT01704079|566801809|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
157013546|NCT03584516|566801810|FG000|Part 1|Death|2|||
157013547|NCT03584516|566801811|FG001|Part 1|Death|3|||
157013548|NCT03584516|566801812|FG002|Part 1|Death|0|||
157013549|NCT03584516|566801813|FG003|Part 1|Death|0|||
157013550|NCT03584516|566801814|FG004|Part 1|Death|0|||
157013551|NCT03584516|566801815|FG005|Part 1|Death|0|||
157013552|NCT03584516|566801810|FG000|Part 1|Withdrawal by Subject|2|||
157013553|NCT03584516|566801811|FG001|Part 1|Withdrawal by Subject|0|||
157013554|NCT03584516|566801812|FG002|Part 1|Withdrawal by Subject|0|||
157013555|NCT03584516|566801813|FG003|Part 1|Withdrawal by Subject|0|||
157013556|NCT03584516|566801814|FG004|Part 1|Withdrawal by Subject|0|||
157013557|NCT03584516|566801815|FG005|Part 1|Withdrawal by Subject|0|||
157013558|NCT03584516|566801810|FG000|Part 1|Lost to Follow-up|1|||
157013559|NCT03584516|566801811|FG001|Part 1|Lost to Follow-up|0|||
157013560|NCT03584516|566801812|FG002|Part 1|Lost to Follow-up|0|||
157013561|NCT03584516|566801813|FG003|Part 1|Lost to Follow-up|0|||
157013562|NCT03584516|566801814|FG004|Part 1|Lost to Follow-up|0|||
157013563|NCT03584516|566801815|FG005|Part 1|Lost to Follow-up|0|||
157013564|NCT03584516|566801810|FG000|Part 1|Study Terminated by Sponsor|0|||
157013565|NCT03584516|566801811|FG001|Part 1|Study Terminated by Sponsor|2|||
157013566|NCT03584516|566801812|FG002|Part 1|Study Terminated by Sponsor|0|||
157013567|NCT03584516|566801813|FG003|Part 1|Study Terminated by Sponsor|0|||
157013568|NCT03584516|566801814|FG004|Part 1|Study Terminated by Sponsor|0|||
157013569|NCT03584516|566801815|FG005|Part 1|Study Terminated by Sponsor|0|||
157013570|NCT03584516|566801810|FG000|Part 1 Expansion|Death|0|||
157013571|NCT03584516|566801811|FG001|Part 1 Expansion|Death|0|||
157013572|NCT03584516|566801812|FG002|Part 1 Expansion|Death|9|||
157013573|NCT03584516|566801813|FG003|Part 1 Expansion|Death|8|||
157013574|NCT03584516|566801814|FG004|Part 1 Expansion|Death|4|||
157013575|NCT03584516|566801815|FG005|Part 1 Expansion|Death|5|||
157013576|NCT03584516|566801810|FG000|Part 1 Expansion|Lost to Follow-up|0|||
157013577|NCT03584516|566801811|FG001|Part 1 Expansion|Lost to Follow-up|0|||
157013578|NCT03584516|566801812|FG002|Part 1 Expansion|Lost to Follow-up|0|||
157013579|NCT03584516|566801813|FG003|Part 1 Expansion|Lost to Follow-up|1|||
157013580|NCT03584516|566801814|FG004|Part 1 Expansion|Lost to Follow-up|0|||
157013581|NCT03584516|566801815|FG005|Part 1 Expansion|Lost to Follow-up|0|||
157013582|NCT03584516|566801810|FG000|Part 1 Expansion|Physician Decision|0|||
157013583|NCT03584516|566801811|FG001|Part 1 Expansion|Physician Decision|0|||
157013584|NCT03584516|566801812|FG002|Part 1 Expansion|Physician Decision|4|||
157013585|NCT03584516|566801813|FG003|Part 1 Expansion|Physician Decision|3|||
157013586|NCT03584516|566801814|FG004|Part 1 Expansion|Physician Decision|2|||
157214490|NCT01872689|567531902|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
156691642|NCT01207440|565618028|FG006|Overall Study|Site Terminated by Sponsor|2|||
156691643|NCT01207440|565618022|FG000|Overall Study|Withdrawal by Subject|29|||
157013587|NCT03584516|566801815|FG005|Part 1 Expansion|Physician Decision|3|||
157013588|NCT03584516|566801810|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
157013589|NCT03584516|566801811|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
157013590|NCT03584516|566801812|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
157013591|NCT03584516|566801813|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
157013592|NCT03584516|566801814|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
157013593|NCT03584516|566801815|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
157013594|NCT03584516|566801810|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
157013595|NCT03584516|566801811|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
157013596|NCT03584516|566801812|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
157013597|NCT03584516|566801813|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
157013598|NCT03584516|566801814|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
157013599|NCT03584516|566801815|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
157013600|NCT03584516|566801810|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
157013601|NCT03584516|566801811|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
157013602|NCT03584516|566801812|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
157013603|NCT03584516|566801813|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
157013604|NCT03584516|566801814|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
157013605|NCT03584516|566801815|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
157013606|NCT03584516|566801810|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
157013607|NCT03584516|566801811|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
157013608|NCT03584516|566801812|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
157013609|NCT03584516|566801813|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
157013610|NCT03584516|566801814|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
157013611|NCT03584516|566801815|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
157013612|NCT05846646|566801816|FG000|Overall Study|Physician Decision|1|||
157013613|NCT05846646|566801817|FG001|Overall Study|Physician Decision|0|||
157013614|NCT05846646|566801818|FG002|Overall Study|Physician Decision|0|||
157013615|NCT05846646|566801816|FG000|Overall Study|Lack of Efficacy|1|||
157013616|NCT05846646|566801817|FG001|Overall Study|Lack of Efficacy|1|||
157013617|NCT05846646|566801818|FG002|Overall Study|Lack of Efficacy|0|||
157013618|NCT05846646|566801816|FG000|Overall Study|Early Study Termination|1|||
157013619|NCT05846646|566801817|FG001|Overall Study|Early Study Termination|2|||
157013620|NCT05846646|566801818|FG002|Overall Study|Early Study Termination|0|||
157013621|NCT00670046|566801819|FG000|Overall Study|Lost to Follow-up|1|||
157013622|NCT00670046|566801820|FG001|Overall Study|Lost to Follow-up|1|||
157013623|NCT00670046|566801819|FG000|Overall Study|Withdrawal by Subject|0|||
157013624|NCT00670046|566801820|FG001|Overall Study|Withdrawal by Subject|1|||
157013625|NCT03990649|566801823|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
157013626|NCT03990649|566801824|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
157013627|NCT03990649|566801825|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
157013628|NCT03990649|566801823|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
157013629|NCT03990649|566801824|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
156691644|NCT01207440|565618023|FG001|Overall Study|Withdrawal by Subject|4|||
156691645|NCT01207440|565618024|FG002|Overall Study|Withdrawal by Subject|5|||
156691646|NCT01207440|565618025|FG003|Overall Study|Withdrawal by Subject|3|||
156691647|NCT01207440|565618026|FG004|Overall Study|Withdrawal by Subject|2|||
156691648|NCT01207440|565618027|FG005|Overall Study|Withdrawal by Subject|2|||
156691649|NCT01207440|565618028|FG006|Overall Study|Withdrawal by Subject|0|||
156691650|NCT01207440|565618022|FG000|Overall Study|Reason Not Specified|10|||
156691651|NCT01207440|565618023|FG001|Overall Study|Reason Not Specified|10|||
156691652|NCT01207440|565618024|FG002|Overall Study|Reason Not Specified|7|||
156691653|NCT01207440|565618025|FG003|Overall Study|Reason Not Specified|0|||
156691654|NCT01207440|565618026|FG004|Overall Study|Reason Not Specified|4|||
156870234|NCT04922216|566281139|FG010|Overall Study|Withdrawal by Subject|0|||
156870235|NCT04922216|566281140|FG011|Overall Study|Withdrawal by Subject|0|||
156870236|NCT04922216|566281141|FG012|Overall Study|Withdrawal by Subject|1|||
156870237|NCT04922216|566281142|FG013|Overall Study|Withdrawal by Subject|1|||
156870238|NCT04922216|566281143|FG014|Overall Study|Withdrawal by Subject|1|||
156870239|NCT04922216|566281144|FG015|Overall Study|Withdrawal by Subject|0|||
157013630|NCT03990649|566801825|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
157013631|NCT03990649|566801823|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
157013632|NCT03990649|566801824|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
157013633|NCT03990649|566801825|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
156691655|NCT01207440|565618027|FG005|Overall Study|Reason Not Specified|3|||
156691656|NCT01207440|565618028|FG006|Overall Study|Reason Not Specified|0|||
156691657|NCT01592721|565618029|FG000|Long-term Follow-up|Death|1|||
156691658|NCT04718194|565618030|FG000|Overall Study|Withdrawal by Subject|3|||
156691659|NCT04718194|565618031|FG001|Overall Study|Withdrawal by Subject|0|||
156691660|NCT04718194|565618030|FG000|Overall Study|Lost to Follow-up|3|||
156691661|NCT04718194|565618031|FG001|Overall Study|Lost to Follow-up|0|||
156691662|NCT00821873|565618032|FG000|Overall Study|Lost to Follow-up|4|||
156691663|NCT02698865|565618033|FG000|Overall Study|Other|11|||
157013634|NCT03990649|566801823|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
157013635|NCT03990649|566801824|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
157013636|NCT03990649|566801825|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
156691664|NCT02698865|565618034|FG001|Overall Study|Other|11|||
156691665|NCT02698865|565618033|FG000|Overall Study|Withdrawal by Subject|20|||
156870240|NCT04922216|566281145|FG016|Overall Study|Withdrawal by Subject|0|||
157013637|NCT03990649|566801823|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
156691666|NCT02698865|565618034|FG001|Overall Study|Withdrawal by Subject|16|||
156691667|NCT02698865|565618033|FG000|Overall Study|Physician Decision|0|||
156691668|NCT02698865|565618034|FG001|Overall Study|Physician Decision|4|||
156691669|NCT02698865|565618033|FG000|Overall Study|Lost to Follow-up|4|||
156691670|NCT02698865|565618034|FG001|Overall Study|Lost to Follow-up|2|||
156691671|NCT03861481|565618036|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
156870241|NCT04922216|566281146|FG017|Overall Study|Withdrawal by Subject|1|||
157021659|NCT04072380|566830971|FG000|Overall Study|Protocol Violation|0|||
156691672|NCT03861481|565618037|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
157013638|NCT03990649|566801824|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
157013639|NCT03990649|566801825|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
157013640|NCT03990649|566801823|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
156691673|NCT03861481|565618036|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
156691674|NCT03861481|565618037|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
156691675|NCT03861481|565618036|FG000|Overall Study|Relapse|1|||
156691676|NCT03861481|565618037|FG001|Overall Study|Relapse|0|||
156691677|NCT03861481|565618036|FG000|Overall Study|Withdrawal by Subject|0|||
156691678|NCT03861481|565618037|FG001|Overall Study|Withdrawal by Subject|1|||
156691679|NCT03861481|565618036|FG000|Overall Study|Lack of Efficacy|4|||
156691680|NCT03861481|565618037|FG001|Overall Study|Lack of Efficacy|5|||
156691681|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
156691682|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
156691683|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
156691684|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
156691685|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
156788227|NCT05660538|565974900|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
156788228|NCT05660538|565974901|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
156788229|NCT05660538|565974902|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
156788230|NCT05737745|565974903|FG000|Overall Study|Withdrawal by Subject|0|||
156788231|NCT05737745|565974904|FG001|Overall Study|Withdrawal by Subject|6|||
156788232|NCT05737745|565974905|FG002|Overall Study|Withdrawal by Subject|1|||
156788233|NCT02218268|565974906|FG000|24 Hour Washout|Physician Decision|11|||
156788234|NCT02218268|565974907|FG001|24 Hour Washout|Physician Decision|9|||
156788235|NCT02569242|565974908|FG000|Overall Study|Death|1|||
156788236|NCT02569242|565974909|FG001|Overall Study|Death|0|||
156788237|NCT02569242|565974908|FG000|Overall Study|Withdrawal by Subject|0|||
156788238|NCT02569242|565974909|FG001|Overall Study|Withdrawal by Subject|1|||
156788239|NCT03651336|565974910|FG000|Overall Study|Withdrawal by Subject|4|||
156788240|NCT01125748|565974912|FG000|Overall Study|Adverse Event|0|||
156788241|NCT01125748|565974913|FG001|Overall Study|Adverse Event|2|||
156788242|NCT01125748|565974912|FG000|Overall Study|Lost to Follow-up|0|||
156788243|NCT01125748|565974913|FG001|Overall Study|Lost to Follow-up|1|||
156788244|NCT01125748|565974912|FG000|Overall Study|Physician Decision|8|||
156788245|NCT01125748|565974913|FG001|Overall Study|Physician Decision|7|||
156788246|NCT01125748|565974912|FG000|Overall Study|Patient Decision to Withdraw|2|||
156788247|NCT01125748|565974913|FG001|Overall Study|Patient Decision to Withdraw|4|||
156788248|NCT01028391|565974914|FG000|Overall Study|Adverse Event|4|||
156788249|NCT01028391|565974915|FG001|Overall Study|Adverse Event|0|||
156788250|NCT01028391|565974914|FG000|Overall Study|Lack of Efficacy|0|||
156788251|NCT01028391|565974915|FG001|Overall Study|Lack of Efficacy|2|||
156788252|NCT01028391|565974914|FG000|Overall Study|Lost to Follow-up|3|||
156788253|NCT01028391|565974915|FG001|Overall Study|Lost to Follow-up|4|||
156788254|NCT01028391|565974914|FG000|Overall Study|Physician Decision|0|||
156788255|NCT01028391|565974915|FG001|Overall Study|Physician Decision|1|||
156788256|NCT01028391|565974914|FG000|Overall Study|Withdrawal by Subject|6|||
156788257|NCT01028391|565974915|FG001|Overall Study|Withdrawal by Subject|3|||
156788258|NCT01028391|565974914|FG000|Overall Study|Needed excluded medication|1|||
156788259|NCT01028391|565974915|FG001|Overall Study|Needed excluded medication|1|||
156788260|NCT00837330|565974916|FG000|Overall Study|Lost to Follow-up|1|||
156788261|NCT00837330|565974917|FG001|Overall Study|Lost to Follow-up|3|||
156788262|NCT01227395|565974918|FG000|Overall Study|Protocol Violation|0|||
156788263|NCT01227395|565974919|FG001|Overall Study|Protocol Violation|1|||
156788264|NCT03259308|565974924|FG000|Overall Study|Adverse Event|5|||
156788265|NCT03259308|565974925|FG001|Overall Study|Adverse Event|4|||
156788266|NCT03259308|565974926|FG002|Overall Study|Adverse Event|1|||
156788267|NCT03259308|565974924|FG000|Overall Study|Withdrawal by Subject|2|||
156788268|NCT03259308|565974925|FG001|Overall Study|Withdrawal by Subject|1|||
156788269|NCT03259308|565974926|FG002|Overall Study|Withdrawal by Subject|3|||
156788270|NCT03259308|565974924|FG000|Overall Study|Lost to Follow-up|0|||
156788271|NCT03259308|565974925|FG001|Overall Study|Lost to Follow-up|0|||
156788272|NCT03259308|565974926|FG002|Overall Study|Lost to Follow-up|1|||
156788273|NCT03259308|565974924|FG000|Overall Study|Pregnancy|0|||
156788274|NCT03259308|565974925|FG001|Overall Study|Pregnancy|0|||
157214491|NCT01456052|567531903|FG000|Overall Study|Adverse Event|1|||
156691686|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
156691687|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
156691688|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
156788275|NCT03259308|565974926|FG002|Overall Study|Pregnancy|1|||
156788276|NCT03259308|565974924|FG000|Overall Study|Protocol Deviation|0|||
156788277|NCT03259308|565974925|FG001|Overall Study|Protocol Deviation|3|||
156788278|NCT03259308|565974926|FG002|Overall Study|Protocol Deviation|0|||
156788279|NCT03259308|565974924|FG000|Overall Study|Lack of Efficacy|0|||
156788280|NCT03259308|565974925|FG001|Overall Study|Lack of Efficacy|0|||
156691689|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
156691690|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
156691691|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
156691692|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
156691693|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
156691694|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
156691695|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
156691696|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
156691697|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156691698|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156691699|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
156691700|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691701|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691702|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691703|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691704|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
156691705|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
156691706|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691707|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691708|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
157214492|NCT01456052|567531904|FG001|Overall Study|Adverse Event|1|||
156691709|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691710|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
156691711|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
156691712|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
156691713|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
156691714|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691715|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691716|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
156691717|NCT00773734|565618038|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691718|NCT00773734|565618039|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691719|NCT00773734|565618040|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691720|NCT00773734|565618041|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
156691721|NCT00773734|565618042|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
156691722|NCT00773734|565618043|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
156691723|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691724|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
156691725|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691726|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
156691727|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
156691728|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
156691729|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156691730|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
156691731|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
156691732|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
156691733|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156691734|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
156691735|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691736|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
156691737|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
156691738|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691739|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
156691740|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
156691741|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691742|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
156691743|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
156691744|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691745|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156691746|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
156788281|NCT03259308|565974926|FG002|Overall Study|Lack of Efficacy|1|||
156788282|NCT00300495|565974927|FG000|Overall Study|Protocol Violation|4|||
156788283|NCT00300495|565974928|FG001|Overall Study|Protocol Violation|1|||
156788284|NCT03004183|565977142|FG000|Overall Study|Adverse Event|7|||
156788285|NCT03004183|565977142|FG000|Overall Study|Lost to Follow-up|1|||
156788286|NCT03004183|565977142|FG000|Overall Study|Physician Decision|40|||
156788287|NCT03004183|565977142|FG000|Overall Study|Withdrawal by Subject|1|||
156691747|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
156691748|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691749|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691750|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691751|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
156691752|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
156691753|NCT00773734|565618038|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
156691754|NCT00773734|565618039|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
156691755|NCT00773734|565618040|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
156691756|NCT00773734|565618041|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
156691757|NCT00773734|565618042|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
156691758|NCT00773734|565618043|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
156691759|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691760|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691761|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691762|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
156691763|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
156691764|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
156691765|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
156691766|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
156691767|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
156691768|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
156691769|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
156691770|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
156691771|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
156691772|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
156691773|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
156691774|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
156691775|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
156691776|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
156691777|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
156691778|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
156691779|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
156691780|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
156691781|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
156691782|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
156691783|NCT00773734|565618038|FG000|Extension: Active Treatment Week 24-52|Other|0|||
156691784|NCT00773734|565618039|FG001|Extension: Active Treatment Week 24-52|Other|0|||
156691785|NCT00773734|565618040|FG002|Extension: Active Treatment Week 24-52|Other|1|||
156691786|NCT00773734|565618041|FG003|Extension: Active Treatment Week 24-52|Other|2|||
156691787|NCT00773734|565618042|FG004|Extension: Active Treatment Week 24-52|Other|0|||
156691788|NCT00773734|565618043|FG005|Extension: Active Treatment Week 24-52|Other|1|||
156691789|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691790|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691791|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691792|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
156691793|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156788288|NCT03004183|565977142|FG000|Overall Study|COVID-19|1|||
156788289|NCT03312114|565977145|FG000|Overall Study|All the five enrolled dropped out of the|5|||
156788290|NCT02469961|565977151|FG000|Overall Study|Physician Decision|4|||
156788291|NCT02469961|565977152|FG001|Overall Study|Physician Decision|1|||
156788292|NCT02123511|565977154|FG000|Overall Study|Cancelled treatment|1|||
156788293|NCT02123511|565977155|FG001|Overall Study|Cancelled treatment|0|||
156788294|NCT02123511|565977154|FG000|Overall Study|Incomplete data|1|||
156788295|NCT02123511|565977155|FG001|Overall Study|Incomplete data|3|||
156788296|NCT02123511|565977154|FG000|Overall Study|Ineligible|0|||
156788297|NCT02123511|565977155|FG001|Overall Study|Ineligible|1|||
156788298|NCT01423084|565977156|FG000|Overall Study|Adverse Event|0|||
156788299|NCT01423084|565977157|FG001|Overall Study|Adverse Event|1|||
156788300|NCT01423084|565977156|FG000|Overall Study|Withdrawal by Subject|2|||
156788301|NCT01423084|565977157|FG001|Overall Study|Withdrawal by Subject|3|||
156788302|NCT01133977|565977161|FG000|Overall Study|Adverse Event|0|||
156788303|NCT01133977|565977162|FG001|Overall Study|Adverse Event|0|||
156788304|NCT01133977|565977163|FG002|Overall Study|Adverse Event|1|||
156788305|NCT01133977|565977164|FG003|Overall Study|Adverse Event|0|||
156788306|NCT01133977|565977165|FG004|Overall Study|Adverse Event|0|||
156788307|NCT01133977|565977161|FG000|Overall Study|Death|1|||
156788308|NCT01133977|565977162|FG001|Overall Study|Death|1|||
156788309|NCT01133977|565977163|FG002|Overall Study|Death|1|||
156788310|NCT01133977|565977164|FG003|Overall Study|Death|7|||
156788311|NCT01133977|565977165|FG004|Overall Study|Death|3|||
156691794|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
156691795|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691796|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691797|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
156691798|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
156691799|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691800|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
156691801|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691802|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
157121629|NCT05103332|567195993|FG015|SFU Period (6 Months=168 Days)|Death|0|||
157121630|NCT05103332|567195994|FG016|SFU Period (6 Months=168 Days)|Death|0|||
157121631|NCT05103332|567195995|FG017|SFU Period (6 Months=168 Days)|Death|1|||
156691803|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
156691804|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
156691805|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691806|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
156691807|NCT00773734|565618038|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156691808|NCT00773734|565618039|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156788312|NCT01133977|565977161|FG000|Overall Study|Started a New Line of Therapy|2|||
156788313|NCT01133977|565977162|FG001|Overall Study|Started a New Line of Therapy|6|||
156691809|NCT00773734|565618040|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
156788314|NCT01133977|565977163|FG002|Overall Study|Started a New Line of Therapy|4|||
156788315|NCT01133977|565977164|FG003|Overall Study|Started a New Line of Therapy|25|||
156788316|NCT01133977|565977165|FG004|Overall Study|Started a New Line of Therapy|33|||
156788317|NCT01133977|565977161|FG000|Overall Study|Lost to Follow-up|0|||
156788318|NCT01133977|565977162|FG001|Overall Study|Lost to Follow-up|0|||
156788319|NCT01133977|565977163|FG002|Overall Study|Lost to Follow-up|0|||
156788320|NCT01133977|565977164|FG003|Overall Study|Lost to Follow-up|2|||
156788321|NCT01133977|565977165|FG004|Overall Study|Lost to Follow-up|1|||
156788322|NCT01133977|565977161|FG000|Overall Study|Withdrawal by Subject|0|||
156788323|NCT01133977|565977162|FG001|Overall Study|Withdrawal by Subject|0|||
156788324|NCT01133977|565977163|FG002|Overall Study|Withdrawal by Subject|0|||
156788325|NCT01133977|565977164|FG003|Overall Study|Withdrawal by Subject|5|||
156788326|NCT01133977|565977165|FG004|Overall Study|Withdrawal by Subject|1|||
156788327|NCT02462057|565977166|FG000|Overall Study|Left Vitality|32|||
156788328|NCT02462057|565977167|FG001|Overall Study|Left Vitality|27|||
156788329|NCT02462057|565977168|FG002|Overall Study|Left Vitality|23|||
156788330|NCT02462057|565977169|FG003|Overall Study|Left Vitality|35|||
156788331|NCT02462057|565977170|FG004|Overall Study|Left Vitality|33|||
156788332|NCT02462057|565977166|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
156788333|NCT02462057|565977167|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
156788334|NCT02462057|565977168|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
156788335|NCT02462057|565977169|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
156788336|NCT02462057|565977170|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
156788337|NCT01908699|565977177|FG000|Overall Study|Adverse Event|8|||
156788338|NCT01908699|565977178|FG001|Overall Study|Adverse Event|12|||
156788339|NCT01908699|565977177|FG000|Overall Study|Lack of Efficacy|2|||
156788340|NCT01908699|565977178|FG001|Overall Study|Lack of Efficacy|2|||
156788341|NCT01908699|565977177|FG000|Overall Study|Lost to Follow-up|2|||
156788342|NCT01908699|565977178|FG001|Overall Study|Lost to Follow-up|4|||
156788343|NCT01908699|565977177|FG000|Overall Study|Physician Decision|8|||
156788344|NCT01908699|565977178|FG001|Overall Study|Physician Decision|8|||
156788345|NCT01908699|565977177|FG000|Overall Study|Withdrawal by Subject|15|||
156788346|NCT01908699|565977178|FG001|Overall Study|Withdrawal by Subject|10|||
156788347|NCT01908699|565977177|FG000|Overall Study|Pregnancy|0|||
156788348|NCT01908699|565977178|FG001|Overall Study|Pregnancy|1|||
156788349|NCT01908699|565977177|FG000|Overall Study|Randomized in Error|1|||
156788350|NCT01908699|565977178|FG001|Overall Study|Randomized in Error|0|||
156788351|NCT01908699|565977177|FG000|Overall Study|Death|9|||
156691810|NCT00773734|565618041|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
156691811|NCT00773734|565618042|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156691812|NCT00773734|565618043|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
156788352|NCT01908699|565977178|FG001|Overall Study|Death|12|||
156788353|NCT01908699|565977177|FG000|Overall Study|Progressive Disease|30|||
156788354|NCT01908699|565977178|FG001|Overall Study|Progressive Disease|29|||
156788355|NCT02105012|565977179|FG000|Overall Study|Withdrawal by Subject|11|||
156788356|NCT02105012|565977179|FG000|Overall Study|Protocol Specified Criteria|9|||
156788357|NCT02105012|565977179|FG000|Overall Study|Lost to Follow-up|4|||
156788358|NCT02105012|565977179|FG000|Overall Study|Protocol Violation|4|||
157121632|NCT03215030|567197518|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
156788359|NCT02105012|565977179|FG000|Overall Study|Physician Decision|3|||
156788360|NCT02105012|565977179|FG000|Overall Study|Adverse Event|1|||
156788361|NCT02105012|565977179|FG000|Overall Study|Lack of Efficacy|1|||
156788362|NCT00493285|565977180|FG000|Overall Study|Lost to Follow-up|0|||
156788363|NCT00493285|565977181|FG001|Overall Study|Lost to Follow-up|0|||
156691813|NCT01220297|565618047|FG000|Overall Study|Death|2|||
156691814|NCT01220297|565618047|FG000|Overall Study|Lost to Follow-up|1|||
156691815|NCT02119286|565618049|FG000|Overall Study|Adverse Event|9|||
156691816|NCT02119286|565618050|FG001|Overall Study|Adverse Event|7|||
156691817|NCT02119286|565618051|FG002|Overall Study|Adverse Event|2|||
156691818|NCT02119286|565618049|FG000|Overall Study|Lack of Efficacy|11|||
156691819|NCT02119286|565618050|FG001|Overall Study|Lack of Efficacy|3|||
156691820|NCT02119286|565618051|FG002|Overall Study|Lack of Efficacy|4|||
156691821|NCT02119286|565618049|FG000|Overall Study|Lost to Follow-up|2|||
156691822|NCT02119286|565618050|FG001|Overall Study|Lost to Follow-up|0|||
156691823|NCT02119286|565618051|FG002|Overall Study|Lost to Follow-up|1|||
156691824|NCT02119286|565618049|FG000|Overall Study|Withdrawal by Subject|4|||
156691825|NCT02119286|565618050|FG001|Overall Study|Withdrawal by Subject|1|||
156691826|NCT02119286|565618051|FG002|Overall Study|Withdrawal by Subject|0|||
156691827|NCT04109313|565618052|FG000|Overall Study|Pregnancy|1|||
156691828|NCT04109313|565618052|FG000|Overall Study|Adverse Event|11|||
156691829|NCT04109313|565618052|FG000|Overall Study|Lack of Efficacy|11|||
156691830|NCT04109313|565618052|FG000|Overall Study|Lost to Follow-up|1|||
156691831|NCT04109313|565618052|FG000|Overall Study|Physician Decision|2|||
156691832|NCT04109313|565618052|FG000|Overall Study|Subject Decision|13|||
156691833|NCT04109313|565618052|FG000|Overall Study|Covid-19 situation|2|||
156691834|NCT01272921|565618053|FG000|Overall Study|Protocol Violation|2|||
156691835|NCT01272921|565618054|FG001|Overall Study|Protocol Violation|1|||
156691836|NCT01132664|565618055|FG000|Phase lb|Adverse Event|0|||
156691837|NCT01132664|565618056|FG001|Phase lb|Adverse Event|1|||
156691838|NCT01132664|565618057|FG002|Phase lb|Adverse Event|0|||
156691839|NCT01132664|565618058|FG003|Phase lb|Adverse Event|0|||
156691840|NCT01132664|565618059|FG004|Phase lb|Adverse Event|0|||
156691841|NCT01132664|565618055|FG000|Phase lb|Withdrawal by Subject|1|||
156691842|NCT01132664|565618056|FG001|Phase lb|Withdrawal by Subject|2|||
156691843|NCT01132664|565618057|FG002|Phase lb|Withdrawal by Subject|0|||
156691844|NCT01132664|565618058|FG003|Phase lb|Withdrawal by Subject|0|||
156691845|NCT01132664|565618059|FG004|Phase lb|Withdrawal by Subject|0|||
156691846|NCT01132664|565618055|FG000|Phase lb|Disease Progression|4|||
156691847|NCT01132664|565618056|FG001|Phase lb|Disease Progression|9|||
156691848|NCT01132664|565618057|FG002|Phase lb|Disease Progression|0|||
156691849|NCT01132664|565618058|FG003|Phase lb|Disease Progression|0|||
156691850|NCT01132664|565618059|FG004|Phase lb|Disease Progression|0|||
156691851|NCT01132664|565618055|FG000|Phase ll|Death|0|||
156691852|NCT01132664|565618056|FG001|Phase ll|Death|0|||
156691853|NCT01132664|565618057|FG002|Phase ll|Death|2|||
156691854|NCT01132664|565618058|FG003|Phase ll|Death|0|||
156691855|NCT01132664|565618059|FG004|Phase ll|Death|0|||
156691856|NCT01132664|565618055|FG000|Phase ll|Adverse Event|0|||
156691857|NCT01132664|565618056|FG001|Phase ll|Adverse Event|0|||
156691858|NCT01132664|565618057|FG002|Phase ll|Adverse Event|10|||
156691859|NCT01132664|565618058|FG003|Phase ll|Adverse Event|0|||
156691860|NCT01132664|565618059|FG004|Phase ll|Adverse Event|0|||
156691861|NCT01132664|565618055|FG000|Phase ll|Withdrawal by Subject|0|||
156691862|NCT01132664|565618056|FG001|Phase ll|Withdrawal by Subject|0|||
156691863|NCT01132664|565618057|FG002|Phase ll|Withdrawal by Subject|3|||
156691864|NCT01132664|565618058|FG003|Phase ll|Withdrawal by Subject|0|||
156691865|NCT01132664|565618059|FG004|Phase ll|Withdrawal by Subject|0|||
156691866|NCT01132664|565618055|FG000|Phase ll|Disease progression|0|||
156691867|NCT01132664|565618056|FG001|Phase ll|Disease progression|0|||
156691868|NCT01132664|565618057|FG002|Phase ll|Disease progression|35|||
156691869|NCT01132664|565618058|FG003|Phase ll|Disease progression|0|||
156691870|NCT01132664|565618059|FG004|Phase ll|Disease progression|0|||
156691871|NCT01132664|565618055|FG000|BM Cohort|Disease progression|0|||
156691872|NCT01132664|565618056|FG001|BM Cohort|Disease progression|0|||
156691873|NCT01132664|565618057|FG002|BM Cohort|Disease progression|0|||
156691874|NCT01132664|565618058|FG003|BM Cohort|Disease progression|3|||
156691875|NCT01132664|565618059|FG004|BM Cohort|Disease progression|4|||
156691876|NCT01132664|565618055|FG000|BM Cohort|Adverse Event|0|||
156691877|NCT01132664|565618056|FG001|BM Cohort|Adverse Event|0|||
156691878|NCT01132664|565618057|FG002|BM Cohort|Adverse Event|0|||
156691879|NCT01132664|565618058|FG003|BM Cohort|Adverse Event|0|||
156691880|NCT01132664|565618059|FG004|BM Cohort|Adverse Event|1|||
156691881|NCT01132664|565618055|FG000|BM Cohort|Withdrawal by Subject|0|||
156691882|NCT01132664|565618056|FG001|BM Cohort|Withdrawal by Subject|0|||
156691883|NCT01132664|565618057|FG002|BM Cohort|Withdrawal by Subject|0|||
156691884|NCT01132664|565618058|FG003|BM Cohort|Withdrawal by Subject|0|||
156691885|NCT01132664|565618059|FG004|BM Cohort|Withdrawal by Subject|1|||
156691886|NCT01996332|565618061|FG000|Overall Study|Adverse Event|117|||
156691887|NCT01996332|565618061|FG000|Overall Study|Lack of Efficacy|1245|||
156691888|NCT01996332|565618061|FG000|Overall Study|Death|264|||
156691889|NCT01996332|565618061|FG000|Overall Study|Protocol Violation|9|||
156691890|NCT01996332|565618061|FG000|Overall Study|Withdrawal by Subject|71|||
156691891|NCT01996332|565618061|FG000|Overall Study|Other|20|||
156691892|NCT01996332|565618061|FG000|Overall Study|Clinical Deterioration|28|||
156691893|NCT01996332|565618061|FG000|Overall Study|Physician Decision|17|||
156691894|NCT01996332|565618061|FG000|Overall Study|Lost to Follow-up|34|||
156691895|NCT02113189|565618062|FG000|Overall Study|Lost to follow up|2|||
156691896|NCT02113189|565618063|FG001|Overall Study|Lost to follow up|1|||
156691897|NCT02113189|565618064|FG002|Overall Study|Lost to follow up|3|||
156691898|NCT02954159|565618065|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
156691899|NCT02954159|565618066|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
156691900|NCT02954159|565618065|FG000|Overall Study|Withdrawal by Subject|0|||
156691901|NCT02954159|565618066|FG001|Overall Study|Withdrawal by Subject|1|||
156691902|NCT01744093|565618067|FG000|Overall Study|Withdrawal by Subject|6|||
156691903|NCT01744093|565618068|FG001|Overall Study|Withdrawal by Subject|1|||
156691904|NCT02006628|565618069|FG000|Overall Study|Adverse Event|1|||
156691905|NCT02006628|565618070|FG001|Overall Study|Adverse Event|1|||
156691906|NCT02006628|565618069|FG000|Overall Study|Withdrawal by Subject|2|||
156691907|NCT02006628|565618070|FG001|Overall Study|Withdrawal by Subject|1|||
156691908|NCT00262041|565618071|FG000|Overall Study|Withdrawal by Subject|0|||
156691909|NCT00262041|565618072|FG001|Overall Study|Withdrawal by Subject|3|||
156691910|NCT00262041|565618073|FG002|Overall Study|Withdrawal by Subject|1|||
156691911|NCT00262041|565618071|FG000|Overall Study|Lost to Follow-up|1|||
156691912|NCT00262041|565618072|FG001|Overall Study|Lost to Follow-up|1|||
156691913|NCT00262041|565618073|FG002|Overall Study|Lost to Follow-up|5|||
156691914|NCT00262041|565618071|FG000|Overall Study|Unable to classify|1|||
156691915|NCT00262041|565618072|FG001|Overall Study|Unable to classify|0|||
156691916|NCT00262041|565618073|FG002|Overall Study|Unable to classify|0|||
156691917|NCT03578237|565618076|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
156691918|NCT03578237|565618077|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
156691919|NCT04132336|565618078|FG000|Overall Study|Investigator Decision|0|||
156691920|NCT04132336|565618079|FG001|Overall Study|Investigator Decision|1|||
156691921|NCT04132336|565618080|FG002|Overall Study|Investigator Decision|0|||
156691922|NCT04132336|565618081|FG003|Overall Study|Investigator Decision|0|||
156691923|NCT04132336|565618082|FG004|Overall Study|Investigator Decision|0|||
156691924|NCT04132336|565618083|FG005|Overall Study|Investigator Decision|0|||
156691925|NCT04132336|565618084|FG006|Overall Study|Investigator Decision|0|||
156691926|NCT02488330|565618085|FG000|Overall Study|Adverse Event|1|||
156691927|NCT02488330|565618085|FG000|Overall Study|Physician Decision|2|||
156691928|NCT02488330|565618085|FG000|Overall Study|Death|2|||
156691929|NCT02488330|565618085|FG000|Overall Study|Disease Progression|3|||
156691930|NCT02488330|565618085|FG000|Overall Study|Study Termination by Sponsor|4|||
156691931|NCT02384941|565618090|FG000|Overall Study|Adverse Event|11|||
156691932|NCT02384941|565618091|FG001|Overall Study|Adverse Event|13|||
156691933|NCT02384941|565618092|FG002|Overall Study|Adverse Event|17|||
156691934|NCT02384941|565618090|FG000|Overall Study|Lost to Follow-up|3|||
156691935|NCT02384941|565618091|FG001|Overall Study|Lost to Follow-up|2|||
156691936|NCT02384941|565618092|FG002|Overall Study|Lost to Follow-up|1|||
156691937|NCT02384941|565618090|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156691938|NCT02384941|565618091|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156691939|NCT02384941|565618092|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156691940|NCT02384941|565618090|FG000|Overall Study|Physician Decision|1|||
156691941|NCT02384941|565618091|FG001|Overall Study|Physician Decision|1|||
156691942|NCT02384941|565618092|FG002|Overall Study|Physician Decision|0|||
156691943|NCT02384941|565618090|FG000|Overall Study|Protocol Violation|3|||
156691944|NCT02384941|565618091|FG001|Overall Study|Protocol Violation|0|||
156691945|NCT02384941|565618092|FG002|Overall Study|Protocol Violation|0|||
156691946|NCT02384941|565618090|FG000|Overall Study|Withdrawal by Subject|26|||
156691947|NCT02384941|565618091|FG001|Overall Study|Withdrawal by Subject|19|||
156691948|NCT02384941|565618092|FG002|Overall Study|Withdrawal by Subject|20|||
156788364|NCT00493285|565977182|FG002|Overall Study|Lost to Follow-up|0|||
156788365|NCT00493285|565977183|FG003|Overall Study|Lost to Follow-up|0|||
156788366|NCT00493285|565977184|FG004|Overall Study|Lost to Follow-up|1|||
156788367|NCT00493285|565977185|FG005|Overall Study|Lost to Follow-up|0|||
156788368|NCT05345405|565977187|FG000|Overall Study|Withdrawal by Subject|2|||
156788369|NCT05345405|565977188|FG001|Overall Study|Withdrawal by Subject|0|||
156788370|NCT05345405|565977189|FG002|Overall Study|Withdrawal by Subject|0|||
156691949|NCT02384941|565618090|FG000|Overall Study|Pregnancy|0|||
156691950|NCT02384941|565618091|FG001|Overall Study|Pregnancy|0|||
156691951|NCT02384941|565618092|FG002|Overall Study|Pregnancy|1|||
156691952|NCT02384941|565618090|FG000|Overall Study|Other than specified above|4|||
156691953|NCT02384941|565618091|FG001|Overall Study|Other than specified above|0|||
156691954|NCT02384941|565618092|FG002|Overall Study|Other than specified above|1|||
156788371|NCT05345405|565977187|FG000|Overall Study|Did not meet eligibility criteria|0|||
156788372|NCT05345405|565977188|FG001|Overall Study|Did not meet eligibility criteria|2|||
156788373|NCT05345405|565977189|FG002|Overall Study|Did not meet eligibility criteria|0|||
156691955|NCT02493777|565618093|FG000|Overall Study|Lost to Follow-up|0|||
156691956|NCT02493777|565618094|FG001|Overall Study|Lost to Follow-up|1|||
156691957|NCT00468728|565618095|FG000|Treatment|criteria for mITT population|4|||
156691958|NCT00468728|565618096|FG001|Treatment|criteria for mITT population|11|||
156691959|NCT00468728|565618095|FG000|Follow-up|mITT failure|34|||
156691960|NCT00468728|565618096|FG001|Follow-up|mITT failure|31|||
156788374|NCT05345405|565977187|FG000|Overall Study|Lost to Follow-up|0|||
156691961|NCT01642914|565618097|FG000|Overall Study|Adverse Event|11|||
156691962|NCT01642914|565618098|FG001|Overall Study|Adverse Event|7|||
156691963|NCT01642914|565618099|FG002|Overall Study|Adverse Event|15|||
156691964|NCT01642914|565618097|FG000|Overall Study|Lack of Efficacy|9|||
156691965|NCT01642914|565618098|FG001|Overall Study|Lack of Efficacy|4|||
156691966|NCT01642914|565618099|FG002|Overall Study|Lack of Efficacy|2|||
156691967|NCT01642914|565618097|FG000|Overall Study|Protocol Violation|15|||
156691968|NCT01642914|565618098|FG001|Overall Study|Protocol Violation|13|||
156691969|NCT01642914|565618099|FG002|Overall Study|Protocol Violation|6|||
156691970|NCT01642914|565618097|FG000|Overall Study|Withdrawal by Subject|5|||
156691971|NCT01642914|565618098|FG001|Overall Study|Withdrawal by Subject|5|||
156691972|NCT01642914|565618099|FG002|Overall Study|Withdrawal by Subject|10|||
156691973|NCT01642914|565618097|FG000|Overall Study|Lost to Follow-up|5|||
156691974|NCT01642914|565618098|FG001|Overall Study|Lost to Follow-up|3|||
156691975|NCT01642914|565618099|FG002|Overall Study|Lost to Follow-up|7|||
156691976|NCT01642914|565618097|FG000|Overall Study|Other Reason|1|||
156691977|NCT01642914|565618098|FG001|Overall Study|Other Reason|0|||
156691978|NCT01642914|565618099|FG002|Overall Study|Other Reason|0|||
156691979|NCT01705236|565618100|FG000|Overall Study|Lost to Follow-up|1|||
156691980|NCT01705236|565618100|FG000|Overall Study|Administrative problems|2|||
156691981|NCT01705236|565618100|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156691982|NCT01705236|565618100|FG000|Overall Study|Protocol Violation|3|||
156691983|NCT01705236|565618100|FG000|Overall Study|Abnormal test procedure result(s)|4|||
156691984|NCT01705236|565618100|FG000|Overall Study|Abnormal laboratory value(s)|4|||
156691985|NCT01705236|565618100|FG000|Overall Study|Withdrawal by Subject|5|||
156691986|NCT01705236|565618100|FG000|Overall Study|Adverse Event|5|||
156691987|NCT03028740|565618101|FG000|Overall Study|Did not Receive Study Drug|4|||
156691988|NCT03028740|565618102|FG001|Overall Study|Did not Receive Study Drug|5|||
156691989|NCT03028740|565618101|FG000|Overall Study|Adverse Event|8|||
156691990|NCT03028740|565618102|FG001|Overall Study|Adverse Event|26|||
156691991|NCT03028740|565618101|FG000|Overall Study|Lack of Efficacy|0|||
156691992|NCT03028740|565618102|FG001|Overall Study|Lack of Efficacy|1|||
156691993|NCT03028740|565618101|FG000|Overall Study|Withdrawal by Subject|48|||
156691994|NCT03028740|565618102|FG001|Overall Study|Withdrawal by Subject|101|||
156691995|NCT03028740|565618101|FG000|Overall Study|Lost to Follow-up|30|||
156691996|NCT03028740|565618102|FG001|Overall Study|Lost to Follow-up|54|||
156691997|NCT03028740|565618101|FG000|Overall Study|Physician Decision|4|||
156691998|NCT03028740|565618102|FG001|Overall Study|Physician Decision|11|||
156691999|NCT03028740|565618101|FG000|Overall Study|Protocol Violation|4|||
156692000|NCT03028740|565618102|FG001|Overall Study|Protocol Violation|8|||
156692001|NCT03028740|565618101|FG000|Overall Study|Non-compliance with Study Drug|0|||
156692002|NCT03028740|565618102|FG001|Overall Study|Non-compliance with Study Drug|2|||
156692003|NCT03028740|565618101|FG000|Overall Study|Study Terminated by Sponsor|467|||
156692004|NCT03028740|565618102|FG001|Overall Study|Study Terminated by Sponsor|917|||
156692005|NCT03028740|565618101|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
156692006|NCT03028740|565618102|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
156692007|NCT03028740|565618101|FG000|Overall Study|Reason not Specified|1|||
156692008|NCT03028740|565618102|FG001|Overall Study|Reason not Specified|5|||
156692009|NCT06005597|565618103|FG000|Overall Study|Lost to Follow-up|1|||
156692010|NCT06005597|565618104|FG001|Overall Study|Lost to Follow-up|2|||
156692011|NCT06005597|565618105|FG002|Overall Study|Lost to Follow-up|1|||
156692012|NCT06005597|565618106|FG003|Overall Study|Lost to Follow-up|2|||
156692013|NCT06005597|565618103|FG000|Overall Study|Death|1|||
156788375|NCT05345405|565977188|FG001|Overall Study|Lost to Follow-up|0|||
156788376|NCT05345405|565977189|FG002|Overall Study|Lost to Follow-up|1|||
156788377|NCT01750281|565977190|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
156788378|NCT01750281|565977191|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
156788379|NCT01750281|565977192|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
156788380|NCT01750281|565977190|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
156788381|NCT01750281|565977191|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
156788382|NCT01750281|565977192|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
156788383|NCT01750281|565977190|FG000|Overall Study|Did not receive treatment|0|||
156692014|NCT06005597|565618104|FG001|Overall Study|Death|1|||
156788384|NCT01750281|565977191|FG001|Overall Study|Did not receive treatment|1|||
156692015|NCT06005597|565618105|FG002|Overall Study|Death|1|||
156692016|NCT06005597|565618106|FG003|Overall Study|Death|0|||
156692017|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Adverse Event|1|||
156788385|NCT01750281|565977192|FG002|Overall Study|Did not receive treatment|0|||
156788386|NCT04189588|565977193|FG000|Overall Study|Death|0|||
156692018|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Adverse Event|2|||
156692019|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Adverse Event|0|||
156692020|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Adverse Event|0|||
156692021|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Subject choice|0|||
156692022|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Subject choice|2|||
156692023|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Subject choice|0|||
156692024|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Subject choice|0|||
156788387|NCT04189588|565977194|FG001|Overall Study|Death|1|||
156692025|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
156692026|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692027|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692028|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
156692029|NCT04572243|565618108|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
156692030|NCT04572243|565618109|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
156692031|NCT04572243|565618110|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
156692032|NCT04572243|565618111|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
156692033|NCT01661881|565618112|FG000|Overall Study|Disease Progression|1|||
156692034|NCT01231373|565618113|FG000|Overall Study|Withdrew consent prior to randomization|2|||
156692035|NCT01231373|565618114|FG001|Overall Study|Withdrew consent prior to randomization|1|||
156692036|NCT01231373|565618115|FG002|Overall Study|Withdrew consent prior to randomization|0|||
156692037|NCT01231373|565618116|FG003|Overall Study|Withdrew consent prior to randomization|0|||
156692038|NCT01231373|565618113|FG000|Overall Study|Lost to Follow-up|0|||
156692039|NCT01231373|565618114|FG001|Overall Study|Lost to Follow-up|0|||
156692040|NCT01231373|565618115|FG002|Overall Study|Lost to Follow-up|0|||
156692041|NCT01231373|565618116|FG003|Overall Study|Lost to Follow-up|1|||
156692042|NCT01231373|565618113|FG000|Overall Study|Withdrew Consent|1|||
156692043|NCT01231373|565618114|FG001|Overall Study|Withdrew Consent|0|||
156692044|NCT01231373|565618115|FG002|Overall Study|Withdrew Consent|0|||
156692045|NCT01231373|565618116|FG003|Overall Study|Withdrew Consent|0|||
156692046|NCT01790113|565618117|FG000|Overall Study|Adverse Event|2|||
156692047|NCT01790113|565618118|FG001|Overall Study|Adverse Event|7|||
156692048|NCT01790113|565618117|FG000|Overall Study|Study ended due to FDA clearance|1|||
156692049|NCT01790113|565618118|FG001|Overall Study|Study ended due to FDA clearance|68|||
156692050|NCT03451006|565618119|FG000|Overall Study|Withdrawal by Subject|2|||
156692051|NCT03451006|565618120|FG001|Overall Study|Withdrawal by Subject|2|||
156692052|NCT00775606|565618125|FG000|Overall Study|Study sponsor terminated funding|3|||
157214493|NCT01456052|567531905|FG002|Overall Study|Adverse Event|2|||
157214494|NCT01456052|567531903|FG000|Overall Study|Consent withdrawn|0|||
157214495|NCT01456052|567531904|FG001|Overall Study|Consent withdrawn|2|||
157214496|NCT01456052|567531905|FG002|Overall Study|Consent withdrawn|1|||
156692053|NCT00775606|565618126|FG001|Overall Study|Study sponsor terminated funding|0|||
157214497|NCT01456052|567531903|FG000|Overall Study|Protocol Violation|0|||
157214498|NCT01456052|567531904|FG001|Overall Study|Protocol Violation|1|||
156692054|NCT02278718|565618127|FG000|Overall Study|Adverse Event|1|||
156692055|NCT02278718|565618128|FG001|Overall Study|Adverse Event|0|||
156692056|NCT02278718|565618127|FG000|Overall Study|Lost to Follow-up|2|||
156692057|NCT02278718|565618128|FG001|Overall Study|Lost to Follow-up|4|||
156692058|NCT02278718|565618127|FG000|Overall Study|Withdrawal by Subject|1|||
156692059|NCT02278718|565618128|FG001|Overall Study|Withdrawal by Subject|4|||
156692060|NCT02278718|565618127|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
156692061|NCT02278718|565618128|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
156692062|NCT02278718|565618127|FG000|Overall Study|Missing|0|||
156692063|NCT02278718|565618128|FG001|Overall Study|Missing|1|||
156692064|NCT03212794|565618129|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
156692065|NCT03212794|565618130|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
156692066|NCT03212794|565618129|FG000|Overall Study|Lost to Follow-up|5|||
156692067|NCT03212794|565618130|FG001|Overall Study|Lost to Follow-up|6|||
156692068|NCT03212794|565618129|FG000|Overall Study|Incarcerated; unable to participate|2|||
156692069|NCT03212794|565618130|FG001|Overall Study|Incarcerated; unable to participate|0|||
156692070|NCT03212794|565618129|FG000|Overall Study|Withdrawal by Subject|1|||
156692071|NCT03212794|565618130|FG001|Overall Study|Withdrawal by Subject|0|||
156692072|NCT03212794|565618129|FG000|Overall Study|Death|0|||
156692073|NCT03212794|565618130|FG001|Overall Study|Death|1|||
156692074|NCT03212794|565618129|FG000|Overall Study|Found to be ineligible after allocation|0|||
156788388|NCT04189588|565977193|FG000|Overall Study|Lost to Follow-up|0|||
156788389|NCT04189588|565977194|FG001|Overall Study|Lost to Follow-up|1|||
156788390|NCT01658735|565977204|FG000|Overall Study|Lack of Efficacy|1|||
156788391|NCT01658735|565977205|FG001|Overall Study|Lack of Efficacy|0|||
156788392|NCT01658735|565977206|FG002|Overall Study|Lack of Efficacy|1|||
156788393|NCT01658735|565977204|FG000|Overall Study|Lost to Follow-up|1|||
156788394|NCT01658735|565977205|FG001|Overall Study|Lost to Follow-up|1|||
156788395|NCT01658735|565977206|FG002|Overall Study|Lost to Follow-up|0|||
156788396|NCT01658735|565977204|FG000|Overall Study|Protocol Violation|0|||
156788397|NCT01658735|565977205|FG001|Overall Study|Protocol Violation|1|||
156788398|NCT01658735|565977206|FG002|Overall Study|Protocol Violation|0|||
156788399|NCT01658735|565977204|FG000|Overall Study|Withdrawal by Subject|3|||
156788400|NCT01658735|565977205|FG001|Overall Study|Withdrawal by Subject|5|||
156788401|NCT01658735|565977206|FG002|Overall Study|Withdrawal by Subject|3|||
156788402|NCT03302936|565977207|FG000|Overall Study|Protocol Violation|3|||
156788403|NCT03302936|565977208|FG001|Overall Study|Protocol Violation|4|||
156788404|NCT01379937|565977209|FG000|Overall Study|Protocol Violation|0|||
156788405|NCT01379937|565977210|FG001|Overall Study|Protocol Violation|0|||
156788406|NCT01379937|565977211|FG002|Overall Study|Protocol Violation|0|||
156870242|NCT04922216|566281147|FG018|Overall Study|Withdrawal by Subject|1|||
156870243|NCT04922216|566281148|FG019|Overall Study|Withdrawal by Subject|1|||
156870244|NCT04922216|566281149|FG020|Overall Study|Withdrawal by Subject|1|||
156870245|NCT04922216|566281150|FG021|Overall Study|Withdrawal by Subject|0|||
156870246|NCT04922216|566281151|FG022|Overall Study|Withdrawal by Subject|0|||
156870247|NCT04922216|566281152|FG023|Overall Study|Withdrawal by Subject|2|||
156870248|NCT04922216|566281153|FG024|Overall Study|Withdrawal by Subject|0|||
156870249|NCT04922216|566281154|FG025|Overall Study|Withdrawal by Subject|0|||
156870250|NCT04922216|566281155|FG026|Overall Study|Withdrawal by Subject|1|||
156870251|NCT04922216|566281156|FG027|Overall Study|Withdrawal by Subject|0|||
156870252|NCT04922216|566281157|FG028|Overall Study|Withdrawal by Subject|0|||
157013641|NCT03990649|566801824|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
157013642|NCT03990649|566801825|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
156692075|NCT03212794|565618130|FG001|Overall Study|Found to be ineligible after allocation|1|||
156692076|NCT03212794|565618129|FG000|Overall Study|Relocated out of area|2|||
156692077|NCT03212794|565618130|FG001|Overall Study|Relocated out of area|0|||
156692078|NCT02547766|565618131|FG000|Overall Study|Withdrawal by Subject|1|||
156692079|NCT03253744|565618138|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
156692080|NCT03253744|565618139|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
156692081|NCT03253744|565618140|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
156692082|NCT03253744|565618141|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
156692083|NCT03847194|565618142|FG000|Overall Study|Lost to Follow-up|2|||
156692084|NCT03847194|565618143|FG001|Overall Study|Lost to Follow-up|5|||
156692085|NCT03847194|565618142|FG000|Overall Study|Withdrawal by Subject|1|||
156692086|NCT03847194|565618143|FG001|Overall Study|Withdrawal by Subject|2|||
156692087|NCT03847194|565618142|FG000|Overall Study|Death|0|||
156692088|NCT03847194|565618143|FG001|Overall Study|Death|1|||
156692089|NCT01010750|565618145|FG000|Second Intervention|Adverse Event|0|||
156692090|NCT01010750|565618146|FG001|Second Intervention|Adverse Event|1|||
156692091|NCT01010750|565618147|FG002|Second Intervention|Adverse Event|0|||
156692092|NCT01010750|565618148|FG003|Second Intervention|Adverse Event|0|||
156692093|NCT01010750|565618149|FG004|Second Intervention|Adverse Event|0|||
156692094|NCT01010750|565618150|FG005|Second Intervention|Adverse Event|0|||
156692095|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
156692096|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
156692097|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
156692098|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
156692099|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
156692100|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
156692101|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
156692102|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
156692103|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156692104|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156692105|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
156692106|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
156692107|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
156692108|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
156692109|NCT04740931|565618152|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
156692110|NCT04740931|565618153|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
156692111|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
156692112|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
156692113|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
156692114|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
156692115|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
156692116|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
156692117|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
156692118|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
156692119|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
156692120|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
156692121|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
156692122|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
156692123|NCT04740931|565618152|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
156692124|NCT04740931|565618153|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
157013643|NCT03990649|566801823|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
157013644|NCT03990649|566801824|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
156692125|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
156692126|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
156692127|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
156692128|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
156692129|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
156870253|NCT04922216|566281158|FG029|Overall Study|Withdrawal by Subject|0|||
156870254|NCT04922216|566281159|FG030|Overall Study|Withdrawal by Subject|1|||
157013645|NCT03990649|566801825|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
157013646|NCT03050814|566801826|FG000|Overall Study|Screen failures|0|||
157013647|NCT03050814|566801827|FG001|Overall Study|Screen failures|0|||
157013648|NCT03050814|566801828|FG002|Overall Study|Screen failures|4|||
157013649|NCT01443845|566801829|FG000|Overall Study|Protocol Violation|43|||
157013650|NCT01443845|566801830|FG001|Overall Study|Protocol Violation|45|||
156692130|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
156692131|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
156692132|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
156692133|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
156692134|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
156692135|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
156692136|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
156692137|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
156692138|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
156692139|NCT02510014|565618158|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
156692140|NCT02510014|565618159|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
156692141|NCT02510014|565618158|FG000|Treatment Period|Adverse Event|11|||
156692142|NCT02510014|565618159|FG001|Treatment Period|Adverse Event|4|||
156692143|NCT02510014|565618158|FG000|Treatment Period|Withdrawal symptoms|3|||
156692144|NCT02510014|565618159|FG001|Treatment Period|Withdrawal symptoms|0|||
156692145|NCT02510014|565618158|FG000|Treatment Period|Lost to Follow-up|80|||
156692146|NCT02510014|565618159|FG001|Treatment Period|Lost to Follow-up|19|||
156692147|NCT02510014|565618158|FG000|Treatment Period|Physician Decision|5|||
156692148|NCT02510014|565618159|FG001|Treatment Period|Physician Decision|0|||
156692149|NCT02510014|565618158|FG000|Treatment Period|Withdrawal by Subject|67|||
156692150|NCT02510014|565618159|FG001|Treatment Period|Withdrawal by Subject|24|||
156692151|NCT02510014|565618158|FG000|Treatment Period|Withdrawn by the investigator|7|||
156692152|NCT02510014|565618159|FG001|Treatment Period|Withdrawn by the investigator|1|||
156692153|NCT02510014|565618158|FG000|Treatment Period|Protocol Violation|4|||
156692154|NCT02510014|565618159|FG001|Treatment Period|Protocol Violation|4|||
156692155|NCT02510014|565618158|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
156692156|NCT02510014|565618159|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
156692157|NCT03438227|565618160|FG000|Overall Study|Withdrawal by Subject|10|||
156692158|NCT03438227|565618161|FG001|Overall Study|Withdrawal by Subject|5|||
156692159|NCT02972502|565618166|FG000|Overall Study|Lost to Follow-up|3|||
156692160|NCT02972502|565618167|FG001|Overall Study|Lost to Follow-up|1|||
156692161|NCT02972502|565618166|FG000|Overall Study|Withdrawal by Subject|1|||
156692162|NCT02972502|565618167|FG001|Overall Study|Withdrawal by Subject|1|||
156692163|NCT03852459|565618168|FG000|Overall Study|Adverse Event|2|||
156692164|NCT03852459|565618169|FG001|Overall Study|Adverse Event|2|||
156692165|NCT03852459|565618168|FG000|Overall Study|Withdrawal by Subject|1|||
156692166|NCT03852459|565618169|FG001|Overall Study|Withdrawal by Subject|1|||
156692167|NCT00049842|565618170|FG000|Treatment Phase|Adverse Event|47|||
156692168|NCT00049842|565618171|FG001|Treatment Phase|Adverse Event|12|||
156692169|NCT00049842|565618170|FG000|Treatment Phase|Withdrawal by Subject|35|||
156692170|NCT00049842|565618171|FG001|Treatment Phase|Withdrawal by Subject|46|||
156692171|NCT00049842|565618170|FG000|Treatment Phase|Non-compliance with protocol|7|||
156692172|NCT00049842|565618171|FG001|Treatment Phase|Non-compliance with protocol|8|||
156692173|NCT00049842|565618170|FG000|Treatment Phase|Lost to Follow-up|4|||
156692174|NCT00049842|565618171|FG001|Treatment Phase|Lost to Follow-up|8|||
156692175|NCT00049842|565618170|FG000|Treatment Phase|Administrative|0|||
156692176|NCT00049842|565618171|FG001|Treatment Phase|Administrative|3|||
156692177|NCT00049842|565618170|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
156692178|NCT00049842|565618171|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
157013651|NCT01443845|566801829|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
157013652|NCT01443845|566801830|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
157013653|NCT01443845|566801829|FG000|Overall Study|Deterioration in pulmonary function|1|||
157013654|NCT01443845|566801830|FG001|Overall Study|Deterioration in pulmonary function|4|||
157013655|NCT01443845|566801829|FG000|Overall Study|Lack of Efficacy|10|||
157013656|NCT01443845|566801830|FG001|Overall Study|Lack of Efficacy|5|||
157013657|NCT01443845|566801829|FG000|Overall Study|Adverse Event|64|||
157013658|NCT01443845|566801830|FG001|Overall Study|Adverse Event|138|||
156692179|NCT00049842|565618170|FG000|Follow-up Phase|Adverse Event|6|||
156692180|NCT00049842|565618171|FG001|Follow-up Phase|Adverse Event|1|||
156692181|NCT00049842|565618170|FG000|Follow-up Phase|Other|1|||
156870255|NCT04922216|566281160|FG031|Overall Study|Withdrawal by Subject|0|||
156870256|NCT04922216|566281129|FG000|Overall Study|Lost to Follow-up|1|||
156870257|NCT04922216|566281130|FG001|Overall Study|Lost to Follow-up|0|||
156692182|NCT00049842|565618171|FG001|Follow-up Phase|Other|4|||
157013659|NCT01443845|566801829|FG000|Overall Study|Withdrawal by Subject|63|||
157013660|NCT01443845|566801830|FG001|Overall Study|Withdrawal by Subject|67|||
157013661|NCT01443845|566801829|FG000|Overall Study|Military Conflict - Site Terminated|20|||
157021660|NCT04072380|566830972|FG001|Overall Study|Protocol Violation|2|||
156870258|NCT04922216|566281131|FG002|Overall Study|Lost to Follow-up|2|||
156692183|NCT01138111|565618177|FG000|Overall Study|Withdrawal by Subject|5|||
156692184|NCT01138111|565618177|FG000|Overall Study|Adverse Event|1|||
156692185|NCT01138111|565618177|FG000|Overall Study|Death|1|||
156692186|NCT01138111|565618177|FG000|Overall Study|Lost to Follow-up|2|||
156788407|NCT01379937|565977212|FG003|Overall Study|Protocol Violation|1|||
156788408|NCT01379937|565977209|FG000|Overall Study|Consent withdrawal|0|||
156692187|NCT01118117|565618178|FG000|Overall Study|Death|8|||
156788409|NCT01379937|565977210|FG001|Overall Study|Consent withdrawal|1|||
156788410|NCT01379937|565977211|FG002|Overall Study|Consent withdrawal|0|||
156788411|NCT01379937|565977212|FG003|Overall Study|Consent withdrawal|0|||
156788412|NCT01379937|565977209|FG000|Overall Study|Lost to Follow-up|1|||
156788413|NCT01379937|565977210|FG001|Overall Study|Lost to Follow-up|2|||
156788414|NCT01379937|565977211|FG002|Overall Study|Lost to Follow-up|2|||
156788415|NCT01379937|565977212|FG003|Overall Study|Lost to Follow-up|0|||
156788416|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
156788417|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
156788418|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
156788419|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
156788420|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
156788421|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
156788422|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
156788423|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
156788424|NCT01122680|565977213|FG000|Period 1 (4 Weeks)|Other|1|||
156788425|NCT01122680|565977214|FG001|Period 1 (4 Weeks)|Other|1|||
156788426|NCT01122680|565977215|FG002|Period 1 (4 Weeks)|Other|0|||
156788427|NCT01122680|565977216|FG003|Period 1 (4 Weeks)|Other|0|||
156788428|NCT01122680|565977213|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
156788429|NCT01122680|565977214|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
156788430|NCT01122680|565977215|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
156788431|NCT01122680|565977216|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
156788432|NCT01122680|565977213|FG000|Period 2 (4 Weeks)|Other|1|||
156788433|NCT01122680|565977214|FG001|Period 2 (4 Weeks)|Other|0|||
156788434|NCT01122680|565977215|FG002|Period 2 (4 Weeks)|Other|0|||
156788435|NCT01122680|565977216|FG003|Period 2 (4 Weeks)|Other|0|||
156788436|NCT01122680|565977213|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
156788437|NCT01122680|565977214|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
156788438|NCT01122680|565977215|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
156788439|NCT01122680|565977216|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
156788440|NCT01122680|565977213|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788441|NCT01122680|565977214|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
156788442|NCT01122680|565977215|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788443|NCT01122680|565977216|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
156788444|NCT04985682|565977217|FG000|Overall Study|Withdrawal by Subject|1|||
156788445|NCT03016403|565977224|FG000|Baseline|Death|5|||
156788446|NCT03016403|565977225|FG001|Baseline|Death|8|||
156788447|NCT03016403|565977226|FG002|Baseline|Death|1|||
156788448|NCT03016403|565977227|FG003|Baseline|Death|0|||
156788449|NCT03016403|565977224|FG000|Baseline|Withdrawal by Subject|2|||
156788450|NCT03016403|565977225|FG001|Baseline|Withdrawal by Subject|8|||
156788451|NCT03016403|565977226|FG002|Baseline|Withdrawal by Subject|4|||
156788452|NCT03016403|565977227|FG003|Baseline|Withdrawal by Subject|10|||
156788453|NCT03016403|565977224|FG000|Baseline|Lost to Follow-up|9|||
156788454|NCT03016403|565977225|FG001|Baseline|Lost to Follow-up|11|||
156788455|NCT03016403|565977226|FG002|Baseline|Lost to Follow-up|6|||
156788456|NCT03016403|565977227|FG003|Baseline|Lost to Follow-up|24|||
156788457|NCT03016403|565977224|FG000|6-week Follow-up|Death|1|||
156788458|NCT03016403|565977225|FG001|6-week Follow-up|Death|4|||
156788459|NCT03016403|565977226|FG002|6-week Follow-up|Death|0|||
156788460|NCT03016403|565977227|FG003|6-week Follow-up|Death|0|||
156788461|NCT03016403|565977224|FG000|6-week Follow-up|Lost to Follow-up|2|||
156788462|NCT03016403|565977225|FG001|6-week Follow-up|Lost to Follow-up|7|||
156788463|NCT03016403|565977226|FG002|6-week Follow-up|Lost to Follow-up|4|||
156788464|NCT03016403|565977227|FG003|6-week Follow-up|Lost to Follow-up|8|||
156870259|NCT04922216|566281132|FG003|Overall Study|Lost to Follow-up|0|||
156692188|NCT01118117|565618179|FG001|Overall Study|Death|0|||
156692189|NCT01118117|565618178|FG000|Overall Study|Lost to Follow-up|6|||
156692190|NCT01118117|565618179|FG001|Overall Study|Lost to Follow-up|0|||
156692191|NCT01118117|565618178|FG000|Overall Study|Missed 12 Month Visit|7|||
156692192|NCT01118117|565618179|FG001|Overall Study|Missed 12 Month Visit|0|||
156692193|NCT00706992|565618180|FG000|Overall Study|Study termination|5|||
156692194|NCT00706992|565618181|FG001|Overall Study|Study termination|5|||
156788465|NCT03016403|565977224|FG000|6-week Follow-up|Withdrawal by Subject|0|||
156788466|NCT03016403|565977225|FG001|6-week Follow-up|Withdrawal by Subject|2|||
156788467|NCT03016403|565977226|FG002|6-week Follow-up|Withdrawal by Subject|0|||
156788468|NCT03016403|565977227|FG003|6-week Follow-up|Withdrawal by Subject|1|||
156788469|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
156788470|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
156788471|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
156788472|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
156788473|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
156692195|NCT00706992|565618182|FG002|Overall Study|Study termination|6|||
156692196|NCT00706992|565618183|FG003|Overall Study|Study termination|2|||
156692197|NCT00706992|565618184|FG004|Overall Study|Study termination|3|||
156692198|NCT00706992|565618185|FG005|Overall Study|Study termination|2|||
156692199|NCT00706992|565618186|FG006|Overall Study|Study termination|3|||
156692200|NCT00706992|565618180|FG000|Overall Study|Disease progression before treatment|0|||
156692201|NCT00706992|565618181|FG001|Overall Study|Disease progression before treatment|0|||
156692202|NCT00706992|565618182|FG002|Overall Study|Disease progression before treatment|0|||
156692203|NCT00706992|565618183|FG003|Overall Study|Disease progression before treatment|0|||
156692204|NCT00706992|565618184|FG004|Overall Study|Disease progression before treatment|1|||
156692205|NCT00706992|565618185|FG005|Overall Study|Disease progression before treatment|0|||
156692206|NCT00706992|565618186|FG006|Overall Study|Disease progression before treatment|0|||
156692207|NCT03959527|565620141|FG000|Overall Study|Withdrawal by Subject|8|||
156692208|NCT03959527|565620142|FG001|Overall Study|Withdrawal by Subject|3|||
156692209|NCT03959527|565620141|FG000|Overall Study|Lost to Follow-up|31|||
156692210|NCT03959527|565620142|FG001|Overall Study|Lost to Follow-up|15|||
156692211|NCT03959527|565620141|FG000|Overall Study|Did not meet eligibility criteria|1|||
156692212|NCT03959527|565620142|FG001|Overall Study|Did not meet eligibility criteria|1|||
156692213|NCT03959527|565620141|FG000|Overall Study|Protocol Violation|10|||
156788474|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
156788475|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
156788476|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
156788477|NCT03016403|565977224|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788478|NCT03016403|565977225|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788479|NCT03016403|565977226|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
156788480|NCT03016403|565977227|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
156788481|NCT05463705|565977228|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
156788482|NCT05463705|565977229|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
156788483|NCT05463705|565977230|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
156788484|NCT05463705|565977231|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
156788485|NCT05463705|565977232|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
156788486|NCT05463705|565977233|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
156788487|NCT00552279|565977235|FG000|Overall Study|Adverse Event|0|||
156788488|NCT00552279|565977236|FG001|Overall Study|Adverse Event|1|||
156788489|NCT00552279|565977235|FG000|Overall Study|Withdrawal by Subject|12|||
156788490|NCT00552279|565977236|FG001|Overall Study|Withdrawal by Subject|1|||
156788491|NCT00552279|565977235|FG000|Overall Study|Lost to Follow-up|1|||
156788492|NCT00552279|565977236|FG001|Overall Study|Lost to Follow-up|0|||
156788493|NCT00552279|565977235|FG000|Overall Study|Other|1|||
156788494|NCT00552279|565977236|FG001|Overall Study|Other|1|||
156788495|NCT01655069|565977237|FG000|Overall Study|Physician Decision|0|||
156788496|NCT01655069|565977238|FG001|Overall Study|Physician Decision|0|||
156788497|NCT01655069|565977239|FG002|Overall Study|Physician Decision|0|||
156788498|NCT01655069|565977240|FG003|Overall Study|Physician Decision|1|||
156788499|NCT01655069|565977237|FG000|Overall Study|Adverse Event|6|||
156788500|NCT01655069|565977238|FG001|Overall Study|Adverse Event|7|||
156788501|NCT01655069|565977239|FG002|Overall Study|Adverse Event|2|||
156788502|NCT01655069|565977240|FG003|Overall Study|Adverse Event|3|||
156788503|NCT01655069|565977237|FG000|Overall Study|Lack of Efficacy|0|||
156788504|NCT01655069|565977238|FG001|Overall Study|Lack of Efficacy|1|||
156788505|NCT01655069|565977239|FG002|Overall Study|Lack of Efficacy|0|||
156788506|NCT01655069|565977240|FG003|Overall Study|Lack of Efficacy|0|||
156788507|NCT01655069|565977237|FG000|Overall Study|No Treatment Needed|0|||
156788508|NCT01655069|565977238|FG001|Overall Study|No Treatment Needed|1|||
156788509|NCT01655069|565977239|FG002|Overall Study|No Treatment Needed|0|||
156788510|NCT01655069|565977240|FG003|Overall Study|No Treatment Needed|0|||
156788511|NCT01655069|565977237|FG000|Overall Study|Withdrawal by Subject|2|||
156788512|NCT01655069|565977238|FG001|Overall Study|Withdrawal by Subject|3|||
156788513|NCT01655069|565977239|FG002|Overall Study|Withdrawal by Subject|0|||
156788514|NCT01655069|565977240|FG003|Overall Study|Withdrawal by Subject|0|||
156788515|NCT01530997|565977241|FG000|Overall Study|Physician Decision|1|||
156788516|NCT01530997|565977241|FG000|Overall Study|Withdrawal by Subject|1|||
156788517|NCT02453191|565977244|FG000|Overall Study|Withdrawal by Subject|1|||
156788518|NCT01520714|565977245|FG000|Overall Study|Protocol Violation|0|||
156788519|NCT01520714|565977246|FG001|Overall Study|Protocol Violation|3|||
156788520|NCT01520714|565977245|FG000|Overall Study|Adverse Event|0|||
156788521|NCT01520714|565977246|FG001|Overall Study|Adverse Event|2|||
156788522|NCT01520714|565977245|FG000|Overall Study|Lack of Efficacy|0|||
156788523|NCT01520714|565977246|FG001|Overall Study|Lack of Efficacy|1|||
156788524|NCT01210443|565977249|FG000|Overall Study|Study terminated by sponsor|2|||
156692214|NCT03959527|565620142|FG001|Overall Study|Protocol Violation|5|||
156692215|NCT06029959|565620143|FG000|Overall Study|Physician Decision|6|||
156788525|NCT02807181|565977252|FG000|Overall Study|Death|28|||
157214499|NCT01456052|567531905|FG002|Overall Study|Protocol Violation|0|||
156692216|NCT01010126|565620148|FG000|Overall Study|Withdrawal by Subject|1|||
156692217|NCT01010126|565620149|FG001|Overall Study|Withdrawal by Subject|0|||
156692218|NCT01010126|565620150|FG002|Overall Study|Withdrawal by Subject|1|||
156692219|NCT01010126|565620151|FG003|Overall Study|Withdrawal by Subject|0|||
156692220|NCT01010126|565620152|FG004|Overall Study|Withdrawal by Subject|3|||
156692221|NCT01010126|565620153|FG005|Overall Study|Withdrawal by Subject|0|||
156692222|NCT00493246|565620154|FG000|Overall Study|Withdrawal by Subject|0|||
156692223|NCT00493246|565620155|FG001|Overall Study|Withdrawal by Subject|0|||
156692224|NCT00493246|565620156|FG002|Overall Study|Withdrawal by Subject|0|||
156692225|NCT00493246|565620157|FG003|Overall Study|Withdrawal by Subject|0|||
156692226|NCT00493246|565620158|FG004|Overall Study|Withdrawal by Subject|1|||
156692227|NCT00493246|565620159|FG005|Overall Study|Withdrawal by Subject|0|||
156692228|NCT00493246|565620160|FG006|Overall Study|Withdrawal by Subject|0|||
156692229|NCT00493246|565620161|FG007|Overall Study|Withdrawal by Subject|0|||
156692230|NCT00493246|565620154|FG000|Overall Study|No access to draw blood|0|||
156692231|NCT00493246|565620155|FG001|Overall Study|No access to draw blood|0|||
156692232|NCT00493246|565620156|FG002|Overall Study|No access to draw blood|0|||
156692233|NCT00493246|565620157|FG003|Overall Study|No access to draw blood|0|||
156692234|NCT00493246|565620158|FG004|Overall Study|No access to draw blood|0|||
156870260|NCT04922216|566281133|FG004|Overall Study|Lost to Follow-up|0|||
156870261|NCT04922216|566281134|FG005|Overall Study|Lost to Follow-up|2|||
156870262|NCT04922216|566281135|FG006|Overall Study|Lost to Follow-up|0|||
156870263|NCT04922216|566281136|FG007|Overall Study|Lost to Follow-up|1|||
156692235|NCT00493246|565620159|FG005|Overall Study|No access to draw blood|1|||
156788526|NCT02807181|565977253|FG001|Overall Study|Death|24|||
156788527|NCT02807181|565977252|FG000|Overall Study|Withdrawal by Subject|1|||
156788528|NCT02807181|565977253|FG001|Overall Study|Withdrawal by Subject|1|||
156788529|NCT02807181|565977252|FG000|Overall Study|Lost to Follow-up|0|||
156788530|NCT02807181|565977253|FG001|Overall Study|Lost to Follow-up|2|||
156788531|NCT02807181|565977252|FG000|Overall Study|Subject decision|1|||
156788532|NCT02807181|565977253|FG001|Overall Study|Subject decision|0|||
156788533|NCT02807181|565977252|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
156788534|NCT02807181|565977253|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
156788535|NCT02807181|565977252|FG000|Overall Study|In Study|3|||
156788536|NCT02807181|565977253|FG001|Overall Study|In Study|3|||
156788537|NCT02807181|565977252|FG000|Overall Study|Post Progression|3|||
156788538|NCT02807181|565977253|FG001|Overall Study|Post Progression|2|||
156788539|NCT01489358|565977254|FG000|Overall Study|Lost to Follow-up|0|||
156788540|NCT01489358|565977255|FG001|Overall Study|Lost to Follow-up|0|||
156788541|NCT01489358|565977256|FG002|Overall Study|Lost to Follow-up|2|||
156788542|NCT03518203|565977259|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
156788543|NCT03518203|565977259|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
156788544|NCT00345592|565977261|FG000|Overall Study|Death|14|||
156788545|NCT00345592|565977262|FG001|Overall Study|Death|16|||
156788546|NCT00345592|565977261|FG000|Overall Study|Withdrawal by Subject|11|||
156788547|NCT00345592|565977262|FG001|Overall Study|Withdrawal by Subject|8|||
156788548|NCT01663987|565977263|FG000|Overall Study|Adverse Event|7|||
156788549|NCT01663987|565977264|FG001|Overall Study|Adverse Event|2|||
156788550|NCT01663987|565977263|FG000|Overall Study|Lost to Follow-up|1|||
156788551|NCT01663987|565977264|FG001|Overall Study|Lost to Follow-up|1|||
156788552|NCT01663987|565977263|FG000|Overall Study|Withdrawal by Subject|2|||
156788553|NCT01663987|565977264|FG001|Overall Study|Withdrawal by Subject|3|||
156788554|NCT01663987|565977263|FG000|Overall Study|Other reason not defined above|3|||
156788555|NCT01663987|565977264|FG001|Overall Study|Other reason not defined above|0|||
156788556|NCT01084135|565977266|FG000|20 Week|Physician Decision|0|||
156788557|NCT01084135|565977267|FG001|20 Week|Physician Decision|1|||
156788558|NCT02366130|565977268|FG000|Overall Study|Withdrawal by Subject|3|||
156788559|NCT02366130|565977268|FG000|Overall Study|Ineligible|6|||
156788560|NCT01065766|565977269|FG000|Overall Study|Assessed before the contracted date|1|||
156788561|NCT01065766|565977269|FG000|Overall Study|Contraindication to administration|6|||
156788562|NCT01065766|565977269|FG000|Overall Study|Violated dosage/administration|25|||
156788563|NCT03520387|565977273|FG000|Pre-Randomization|Withdrawal by Subject|1|||
156692236|NCT00493246|565620160|FG006|Overall Study|No access to draw blood|0|||
156692237|NCT00493246|565620161|FG007|Overall Study|No access to draw blood|0|||
156692238|NCT00493246|565620154|FG000|Overall Study|Lost to Follow-up|0|||
156788564|NCT03520387|565977274|FG001|Pre-Randomization|Withdrawal by Subject|0|||
156788565|NCT03520387|565977275|FG002|Pre-Randomization|Withdrawal by Subject|0|||
156788566|NCT03520387|565977276|FG003|Pre-Randomization|Withdrawal by Subject|0|||
156788567|NCT03520387|565977277|FG004|Pre-Randomization|Withdrawal by Subject|0|||
156692239|NCT00493246|565620155|FG001|Overall Study|Lost to Follow-up|0|||
156692240|NCT00493246|565620156|FG002|Overall Study|Lost to Follow-up|0|||
156788568|NCT03520387|565977273|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
156788569|NCT03520387|565977274|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788570|NCT03520387|565977275|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156870264|NCT04922216|566281137|FG008|Overall Study|Lost to Follow-up|1|||
156692241|NCT00493246|565620157|FG003|Overall Study|Lost to Follow-up|0|||
156692242|NCT00493246|565620158|FG004|Overall Study|Lost to Follow-up|0|||
156692243|NCT00493246|565620159|FG005|Overall Study|Lost to Follow-up|0|||
156692244|NCT00493246|565620160|FG006|Overall Study|Lost to Follow-up|1|||
156692245|NCT00493246|565620161|FG007|Overall Study|Lost to Follow-up|0|||
156692246|NCT00595335|565620162|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
156692247|NCT00595335|565620163|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
156692248|NCT00595335|565620162|FG000|Baseline to Six Months|Disease Progression|1|||
156692249|NCT00595335|565620163|FG001|Baseline to Six Months|Disease Progression|1|||
156692250|NCT00595335|565620162|FG000|Baseline to Six Months|Adverse Event|1|||
156692251|NCT00595335|565620163|FG001|Baseline to Six Months|Adverse Event|0|||
156692252|NCT00595335|565620162|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
156692253|NCT00595335|565620163|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
156692254|NCT00595335|565620162|FG000|Six Months to Twelve Months|Disease Progression|1|||
156692255|NCT00595335|565620163|FG001|Six Months to Twelve Months|Disease Progression|0|||
156692256|NCT00493779|565620166|FG000|Overall Study|Logistical issue at site|1|||
156692257|NCT01215513|565620171|FG000|Overall Study|Not completed CS42|9|||
156692258|NCT01215513|565620171|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
156692259|NCT01215513|565620171|FG000|Overall Study|Adverse event (CS42A)|2|||
156692260|NCT01215513|565620171|FG000|Overall Study|Physician decision (CS42A)|6|||
156692261|NCT01215513|565620171|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
156788571|NCT03520387|565977276|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788572|NCT03520387|565977277|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
156788573|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Death|0|||
156788574|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Death|2|||
156788575|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Death|2|||
156788576|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Death|0|||
156788577|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
156788578|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
156788579|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
156788580|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
156788581|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
156788582|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
156788583|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
156788584|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
156788585|NCT04913675|565977278|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
156788586|NCT04913675|565977279|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
156788587|NCT04913675|565977280|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
156788588|NCT04913675|565977281|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
156788589|NCT04913675|565977278|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788590|NCT04913675|565977279|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788591|NCT04913675|565977280|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
156788592|NCT04913675|565977281|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
156788593|NCT04518410|565977282|FG000|Overall Study|Lost to Follow-up|1|||
156788594|NCT04518410|565977283|FG001|Overall Study|Lost to Follow-up|1|||
156788595|NCT04518410|565977284|FG002|Overall Study|Lost to Follow-up|8|||
156788596|NCT04518410|565977285|FG003|Overall Study|Lost to Follow-up|5|||
156788597|NCT04518410|565977286|FG004|Overall Study|Lost to Follow-up|92|||
156788598|NCT04518410|565977287|FG005|Overall Study|Lost to Follow-up|25|||
156788599|NCT04518410|565977288|FG006|Overall Study|Lost to Follow-up|25|||
156788600|NCT04518410|565977289|FG007|Overall Study|Lost to Follow-up|3|||
156788601|NCT04518410|565977290|FG008|Overall Study|Lost to Follow-up|2|||
156788602|NCT04518410|565977291|FG009|Overall Study|Lost to Follow-up|13|||
156692262|NCT01215513|565620171|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
156692263|NCT01763918|565620181|FG000|Overall Study|Withdrawal by Subject|2|||
156692264|NCT01763918|565620182|FG001|Overall Study|Withdrawal by Subject|1|||
156692265|NCT01763918|565620183|FG002|Overall Study|Withdrawal by Subject|1|||
156692266|NCT01763918|565620184|FG003|Overall Study|Withdrawal by Subject|2|||
156692267|NCT01763918|565620181|FG000|Overall Study|Sponsor Decision|4|||
156692268|NCT01763918|565620182|FG001|Overall Study|Sponsor Decision|0|||
156692269|NCT01763918|565620183|FG002|Overall Study|Sponsor Decision|9|||
156692270|NCT01763918|565620184|FG003|Overall Study|Sponsor Decision|0|||
156692271|NCT00897949|565620185|FG000|Overall Study|Adverse Event|1|||
156788603|NCT04518410|565977292|FG010|Overall Study|Lost to Follow-up|9|||
156692272|NCT00897949|565620186|FG001|Overall Study|Adverse Event|1|||
156692273|NCT00897949|565620187|FG002|Overall Study|Adverse Event|0|||
156788604|NCT04518410|565977293|FG011|Overall Study|Lost to Follow-up|13|||
156788605|NCT04518410|565977294|FG012|Overall Study|Lost to Follow-up|9|||
156788606|NCT04518410|565977295|FG013|Overall Study|Lost to Follow-up|13|||
156788607|NCT04518410|565977296|FG014|Overall Study|Lost to Follow-up|8|||
156788608|NCT04518410|565977297|FG015|Overall Study|Lost to Follow-up|10|||
156788609|NCT04518410|565977298|FG016|Overall Study|Lost to Follow-up|6|||
156788610|NCT04518410|565977299|FG017|Overall Study|Lost to Follow-up|13|||
156788611|NCT04518410|565977300|FG018|Overall Study|Lost to Follow-up|21|||
156788612|NCT04518410|565977301|FG019|Overall Study|Lost to Follow-up|6|||
157013662|NCT01443845|566801830|FG001|Overall Study|Military Conflict - Site Terminated|21|||
157013663|NCT01443845|566801829|FG000|Overall Study|Lost to Follow-up|9|||
157013664|NCT01443845|566801830|FG001|Overall Study|Lost to Follow-up|13|||
157013665|NCT01471691|566801836|FG000|Overall Study|Lack of Efficacy|0|||
156692274|NCT00897949|565620185|FG000|Overall Study|Lost to Follow-up|0|||
156692275|NCT00897949|565620186|FG001|Overall Study|Lost to Follow-up|2|||
156692276|NCT00897949|565620187|FG002|Overall Study|Lost to Follow-up|1|||
156692277|NCT00897949|565620185|FG000|Overall Study|Protocol Violation|6|||
156692278|NCT00897949|565620186|FG001|Overall Study|Protocol Violation|3|||
156692279|NCT00897949|565620187|FG002|Overall Study|Protocol Violation|1|||
157013666|NCT01471691|566801837|FG001|Overall Study|Lack of Efficacy|1|||
157013667|NCT02461628|566801838|FG000|Overall Study|Refused to complete survey|4|||
157013668|NCT02461628|566801839|FG001|Overall Study|Refused to complete survey|7|||
157013669|NCT02015520|566801842|FG000|Overall Study|Lack of Efficacy|1|||
157013670|NCT02015520|566801843|FG001|Overall Study|Lack of Efficacy|0|||
157013671|NCT02015520|566801844|FG002|Overall Study|Lack of Efficacy|3|||
157013672|NCT02015520|566801845|FG003|Overall Study|Lack of Efficacy|2|||
157013673|NCT02015520|566801842|FG000|Overall Study|Adverse Event|0|||
157013674|NCT02015520|566801843|FG001|Overall Study|Adverse Event|0|||
157013675|NCT02015520|566801844|FG002|Overall Study|Adverse Event|0|||
157013676|NCT02015520|566801845|FG003|Overall Study|Adverse Event|1|||
157013677|NCT02015520|566801842|FG000|Overall Study|Withdrawal by Subject|2|||
157013678|NCT02015520|566801843|FG001|Overall Study|Withdrawal by Subject|2|||
157013679|NCT02015520|566801844|FG002|Overall Study|Withdrawal by Subject|1|||
157013680|NCT02015520|566801845|FG003|Overall Study|Withdrawal by Subject|0|||
157013681|NCT02015520|566801842|FG000|Overall Study|Death|1|||
157013682|NCT02015520|566801843|FG001|Overall Study|Death|0|||
157013683|NCT02015520|566801844|FG002|Overall Study|Death|0|||
157013684|NCT02015520|566801845|FG003|Overall Study|Death|0|||
157013685|NCT02015520|566801842|FG000|Overall Study|Lost to Follow-up|0|||
157013686|NCT02015520|566801843|FG001|Overall Study|Lost to Follow-up|0|||
157013687|NCT02015520|566801844|FG002|Overall Study|Lost to Follow-up|1|||
157013688|NCT02015520|566801845|FG003|Overall Study|Lost to Follow-up|0|||
156692280|NCT00897949|565620185|FG000|Overall Study|Withdrawal by Subject|1|||
156692281|NCT00897949|565620186|FG001|Overall Study|Withdrawal by Subject|2|||
156692282|NCT00897949|565620187|FG002|Overall Study|Withdrawal by Subject|0|||
156692283|NCT00897949|565620185|FG000|Overall Study|Patient Uncoorperative|0|||
156692284|NCT00897949|565620186|FG001|Overall Study|Patient Uncoorperative|2|||
156692285|NCT00897949|565620187|FG002|Overall Study|Patient Uncoorperative|1|||
156692286|NCT00897949|565620185|FG000|Overall Study|Lost to Follow-up|30|||
156692287|NCT00897949|565620186|FG001|Overall Study|Lost to Follow-up|23|||
156692288|NCT00897949|565620187|FG002|Overall Study|Lost to Follow-up|17|||
156788613|NCT04518410|565977302|FG020|Overall Study|Lost to Follow-up|7|||
156788614|NCT04518410|565977303|FG021|Overall Study|Lost to Follow-up|21|||
156788615|NCT04518410|565977304|FG022|Overall Study|Lost to Follow-up|1|||
156788616|NCT04518410|565977305|FG023|Overall Study|Lost to Follow-up|7|||
156788617|NCT04518410|565977306|FG024|Overall Study|Lost to Follow-up|6|||
156788618|NCT04518410|565977282|FG000|Overall Study|Withdrawal by Subject|1|||
156788619|NCT04518410|565977283|FG001|Overall Study|Withdrawal by Subject|2|||
156788620|NCT04518410|565977284|FG002|Overall Study|Withdrawal by Subject|2|||
156788621|NCT04518410|565977285|FG003|Overall Study|Withdrawal by Subject|3|||
156788622|NCT04518410|565977286|FG004|Overall Study|Withdrawal by Subject|20|||
156788623|NCT04518410|565977287|FG005|Overall Study|Withdrawal by Subject|20|||
156788624|NCT04518410|565977288|FG006|Overall Study|Withdrawal by Subject|25|||
156788625|NCT04518410|565977289|FG007|Overall Study|Withdrawal by Subject|6|||
156788626|NCT04518410|565977290|FG008|Overall Study|Withdrawal by Subject|1|||
156788627|NCT04518410|565977291|FG009|Overall Study|Withdrawal by Subject|12|||
156788628|NCT04518410|565977292|FG010|Overall Study|Withdrawal by Subject|5|||
156788629|NCT04518410|565977293|FG011|Overall Study|Withdrawal by Subject|7|||
157013689|NCT02015520|566801842|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
157013690|NCT02015520|566801843|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
157013691|NCT02015520|566801844|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
157013692|NCT02015520|566801845|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
157013693|NCT02015520|566801842|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
157021661|NCT04072380|566830973|FG002|Overall Study|Protocol Violation|3|||
156692289|NCT00897949|565620185|FG000|Overall Study|Withdrawal by Subject|24|||
156692290|NCT00897949|565620186|FG001|Overall Study|Withdrawal by Subject|31|||
156692291|NCT00897949|565620187|FG002|Overall Study|Withdrawal by Subject|17|||
156692292|NCT00897949|565620185|FG000|Overall Study|Abnormal Prestudy Labs|2|||
157021662|NCT04072380|566830971|FG000|Overall Study|Intercurrent Illness and Others|3|||
157021663|NCT04072380|566830972|FG001|Overall Study|Intercurrent Illness and Others|5|||
156788630|NCT04518410|565977294|FG012|Overall Study|Withdrawal by Subject|2|||
156788631|NCT04518410|565977295|FG013|Overall Study|Withdrawal by Subject|13|||
156788632|NCT04518410|565977296|FG014|Overall Study|Withdrawal by Subject|4|||
156788633|NCT04518410|565977297|FG015|Overall Study|Withdrawal by Subject|9|||
157021664|NCT04072380|566830973|FG002|Overall Study|Intercurrent Illness and Others|6|||
157021665|NCT03640312|566830976|FG000|Overall Study|Lost to Follow-up|3|||
156692293|NCT00897949|565620186|FG001|Overall Study|Abnormal Prestudy Labs|3|||
156692294|NCT00897949|565620187|FG002|Overall Study|Abnormal Prestudy Labs|4|||
156692295|NCT00897949|565620185|FG000|Overall Study|Abnormal Baseline ECG|2|||
156692296|NCT00897949|565620186|FG001|Overall Study|Abnormal Baseline ECG|2|||
156692297|NCT00897949|565620187|FG002|Overall Study|Abnormal Baseline ECG|4|||
156692298|NCT00897949|565620185|FG000|Overall Study|Need for Concom. Med.|0|||
156692299|NCT00897949|565620186|FG001|Overall Study|Need for Concom. Med.|1|||
156692300|NCT00897949|565620187|FG002|Overall Study|Need for Concom. Med.|1|||
156692301|NCT00897949|565620185|FG000|Overall Study|Lack of Migraine Attack|29|||
156692302|NCT00897949|565620186|FG001|Overall Study|Lack of Migraine Attack|30|||
156692303|NCT00897949|565620187|FG002|Overall Study|Lack of Migraine Attack|19|||
156692304|NCT00897949|565620185|FG000|Overall Study|Did not take study drug|9|||
156692305|NCT00897949|565620186|FG001|Overall Study|Did not take study drug|3|||
156692306|NCT00897949|565620187|FG002|Overall Study|Did not take study drug|4|||
156692307|NCT01553747|565620188|FG000|Overall Study|Protocol Violation|0|||
156692308|NCT01553747|565620189|FG001|Overall Study|Protocol Violation|2|||
156692309|NCT01553747|565620190|FG002|Overall Study|Protocol Violation|0|||
156692310|NCT01553747|565620188|FG000|Overall Study|Voluntarily withdrew|70|||
156692311|NCT01553747|565620189|FG001|Overall Study|Voluntarily withdrew|66|||
156692312|NCT01553747|565620190|FG002|Overall Study|Voluntarily withdrew|74|||
156692313|NCT01553747|565620188|FG000|Overall Study|Adverse event or SAE|32|||
156692314|NCT01553747|565620189|FG001|Overall Study|Adverse event or SAE|28|||
156692315|NCT01553747|565620190|FG002|Overall Study|Adverse event or SAE|19|||
156692316|NCT01553747|565620188|FG000|Overall Study|Physician decision: other|10|||
156692317|NCT01553747|565620189|FG001|Overall Study|Physician decision: other|8|||
156692318|NCT01553747|565620190|FG002|Overall Study|Physician decision: other|7|||
156692319|NCT01553747|565620188|FG000|Overall Study|Lost to Follow-up|11|||
156692320|NCT01553747|565620189|FG001|Overall Study|Lost to Follow-up|5|||
156692321|NCT01553747|565620190|FG002|Overall Study|Lost to Follow-up|6|||
156692322|NCT01553747|565620188|FG000|Overall Study|Sponsor decision, specify|7|||
156692323|NCT01553747|565620189|FG001|Overall Study|Sponsor decision, specify|5|||
156692324|NCT01553747|565620190|FG002|Overall Study|Sponsor decision, specify|0|||
156692325|NCT01553747|565620188|FG000|Overall Study|Physician decision: lack of efficacy|1|||
156692326|NCT01553747|565620189|FG001|Overall Study|Physician decision: lack of efficacy|5|||
156692327|NCT01553747|565620190|FG002|Overall Study|Physician decision: lack of efficacy|3|||
156692328|NCT00102687|565620191|FG000|Initial Period|Withdrawal by Subject|6|||
156692329|NCT00102687|565620192|FG001|Initial Period|Withdrawal by Subject|3|||
156692330|NCT00102687|565620193|FG002|Initial Period|Withdrawal by Subject|5|||
156692331|NCT00102687|565620194|FG003|Initial Period|Withdrawal by Subject|0|||
156692332|NCT00102687|565620195|FG004|Initial Period|Withdrawal by Subject|0|||
156692333|NCT00102687|565620191|FG000|Initial Period|Adverse Event|4|||
156692334|NCT00102687|565620192|FG001|Initial Period|Adverse Event|7|||
156692335|NCT00102687|565620193|FG002|Initial Period|Adverse Event|9|||
156692336|NCT00102687|565620194|FG003|Initial Period|Adverse Event|0|||
156692337|NCT00102687|565620195|FG004|Initial Period|Adverse Event|0|||
156692338|NCT00102687|565620191|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
156692339|NCT00102687|565620192|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
156692340|NCT00102687|565620193|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
156692341|NCT00102687|565620194|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
156692342|NCT00102687|565620195|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
156692343|NCT00102687|565620191|FG000|Initial Period|Protocol Violation|0|||
156692344|NCT00102687|565620192|FG001|Initial Period|Protocol Violation|0|||
156692345|NCT00102687|565620193|FG002|Initial Period|Protocol Violation|2|||
156692346|NCT00102687|565620194|FG003|Initial Period|Protocol Violation|0|||
156692347|NCT00102687|565620195|FG004|Initial Period|Protocol Violation|0|||
156692348|NCT00102687|565620191|FG000|Initial Period|Physician Decision|2|||
156692349|NCT00102687|565620192|FG001|Initial Period|Physician Decision|9|||
156692350|NCT00102687|565620193|FG002|Initial Period|Physician Decision|6|||
156692351|NCT00102687|565620194|FG003|Initial Period|Physician Decision|0|||
156692352|NCT00102687|565620195|FG004|Initial Period|Physician Decision|0|||
156692353|NCT00102687|565620191|FG000|Initial Period|Sponsor's decision|0|||
156692354|NCT00102687|565620192|FG001|Initial Period|Sponsor's decision|1|||
156692355|NCT00102687|565620193|FG002|Initial Period|Sponsor's decision|1|||
156692356|NCT00102687|565620194|FG003|Initial Period|Sponsor's decision|0|||
156692357|NCT00102687|565620195|FG004|Initial Period|Sponsor's decision|0|||
156692358|NCT00102687|565620191|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
156692359|NCT00102687|565620192|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
156692360|NCT00102687|565620193|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
156692361|NCT00102687|565620194|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
156692362|NCT00102687|565620195|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
156692363|NCT00102687|565620191|FG000|Initial Period|Death|1|||
156692364|NCT00102687|565620192|FG001|Initial Period|Death|1|||
156692365|NCT00102687|565620193|FG002|Initial Period|Death|1|||
156692366|NCT00102687|565620194|FG003|Initial Period|Death|0|||
156692367|NCT00102687|565620195|FG004|Initial Period|Death|0|||
156692368|NCT00102687|565620191|FG000|Maintenance Period|Withdrawal by Subject|4|||
156692369|NCT00102687|565620192|FG001|Maintenance Period|Withdrawal by Subject|0|||
156692370|NCT00102687|565620193|FG002|Maintenance Period|Withdrawal by Subject|2|||
156692371|NCT00102687|565620194|FG003|Maintenance Period|Withdrawal by Subject|3|||
156692372|NCT00102687|565620195|FG004|Maintenance Period|Withdrawal by Subject|1|||
156692373|NCT00102687|565620191|FG000|Maintenance Period|Adverse Event|1|||
156692374|NCT00102687|565620192|FG001|Maintenance Period|Adverse Event|0|||
156692375|NCT00102687|565620193|FG002|Maintenance Period|Adverse Event|0|||
156692376|NCT00102687|565620194|FG003|Maintenance Period|Adverse Event|1|||
156692377|NCT00102687|565620195|FG004|Maintenance Period|Adverse Event|3|||
156692378|NCT00102687|565620191|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692379|NCT00102687|565620192|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
156692380|NCT00102687|565620193|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692381|NCT00102687|565620194|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
156692382|NCT00102687|565620195|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
156692383|NCT00102687|565620191|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692384|NCT00102687|565620192|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692385|NCT00102687|565620193|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
156692386|NCT00102687|565620194|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
156692387|NCT00102687|565620195|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
156692388|NCT00102687|565620191|FG000|Maintenance Period|Death|0|||
156692389|NCT00102687|565620192|FG001|Maintenance Period|Death|0|||
156692390|NCT00102687|565620193|FG002|Maintenance Period|Death|0|||
156692391|NCT00102687|565620194|FG003|Maintenance Period|Death|1|||
156692392|NCT00102687|565620195|FG004|Maintenance Period|Death|1|||
156692393|NCT00102687|565620191|FG000|Maintenance Period|Physician Decision|1|||
156692394|NCT00102687|565620192|FG001|Maintenance Period|Physician Decision|2|||
156692395|NCT00102687|565620193|FG002|Maintenance Period|Physician Decision|3|||
156692396|NCT00102687|565620194|FG003|Maintenance Period|Physician Decision|0|||
156692397|NCT00102687|565620195|FG004|Maintenance Period|Physician Decision|4|||
156692398|NCT01144403|565620200|FG000|Overall Study|Lost to Follow-up|3|||
156692399|NCT01144403|565620200|FG000|Overall Study|Death|1|||
156692400|NCT01144403|565620200|FG000|Overall Study|Adverse Event|1|||
156692401|NCT00977431|565620201|FG000|Overall Study|Other than listed|1|||
156692402|NCT00977431|565620202|FG001|Overall Study|Other than listed|0|||
156692403|NCT00977431|565620203|FG002|Overall Study|Other than listed|0|||
156692404|NCT00977431|565620204|FG003|Overall Study|Other than listed|0|||
156692405|NCT00977431|565620205|FG004|Overall Study|Other than listed|2|||
156692406|NCT00977431|565620201|FG000|Overall Study|Protocol Violation|0|||
156692407|NCT00977431|565620202|FG001|Overall Study|Protocol Violation|0|||
156692408|NCT00977431|565620203|FG002|Overall Study|Protocol Violation|1|||
156692409|NCT00977431|565620204|FG003|Overall Study|Protocol Violation|0|||
156692410|NCT00977431|565620205|FG004|Overall Study|Protocol Violation|0|||
156692411|NCT00977431|565620201|FG000|Overall Study|Adverse Event|3|||
156692412|NCT00977431|565620202|FG001|Overall Study|Adverse Event|0|||
156692413|NCT00977431|565620203|FG002|Overall Study|Adverse Event|4|||
156692414|NCT00977431|565620204|FG003|Overall Study|Adverse Event|0|||
156692415|NCT00977431|565620205|FG004|Overall Study|Adverse Event|6|||
157013694|NCT02015520|566801843|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
157013695|NCT02015520|566801844|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
156692416|NCT00977431|565620201|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
156692417|NCT00977431|565620202|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692418|NCT00977431|565620203|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
156692419|NCT00977431|565620204|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692420|NCT00977431|565620205|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
156692421|NCT00977431|565620201|FG000|Overall Study|Progressive disease|2|||
156692422|NCT00977431|565620202|FG001|Overall Study|Progressive disease|6|||
156692423|NCT00977431|565620203|FG002|Overall Study|Progressive disease|1|||
156692424|NCT00977431|565620204|FG003|Overall Study|Progressive disease|3|||
156692425|NCT00977431|565620205|FG004|Overall Study|Progressive disease|5|||
156692426|NCT03739138|565620212|FG000|Overall Study|Death|0|||
156692427|NCT03739138|565620213|FG001|Overall Study|Death|7|||
156692428|NCT03739138|565620214|FG002|Overall Study|Death|4|||
156692429|NCT03739138|565620215|FG003|Overall Study|Death|13|||
156692430|NCT03739138|565620216|FG004|Overall Study|Death|0|||
156692431|NCT03739138|565620212|FG000|Overall Study|Lost to Follow-up|0|||
157013696|NCT02015520|566801845|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
157013697|NCT01854385|566801846|FG000|Pre-Treatment|Withdrawal by Subject|4|||
156692432|NCT03739138|565620213|FG001|Overall Study|Lost to Follow-up|0|||
156692433|NCT03739138|565620214|FG002|Overall Study|Lost to Follow-up|1|||
156692434|NCT03739138|565620215|FG003|Overall Study|Lost to Follow-up|0|||
156692435|NCT03739138|565620216|FG004|Overall Study|Lost to Follow-up|0|||
156692436|NCT03739138|565620212|FG000|Overall Study|Study Terminated By Sponsor|0|||
156692437|NCT03739138|565620213|FG001|Overall Study|Study Terminated By Sponsor|0|||
156692438|NCT03739138|565620214|FG002|Overall Study|Study Terminated By Sponsor|0|||
157021666|NCT03640312|566830977|FG001|Overall Study|Lost to Follow-up|6|||
156692439|NCT03739138|565620215|FG003|Overall Study|Study Terminated By Sponsor|4|||
156692440|NCT03739138|565620216|FG004|Overall Study|Study Terminated By Sponsor|0|||
156692441|NCT03739138|565620212|FG000|Overall Study|Withdrawal by Subject|0|||
156692442|NCT03739138|565620213|FG001|Overall Study|Withdrawal by Subject|0|||
156692443|NCT03739138|565620214|FG002|Overall Study|Withdrawal by Subject|0|||
156692444|NCT03739138|565620215|FG003|Overall Study|Withdrawal by Subject|1|||
156692445|NCT03739138|565620216|FG004|Overall Study|Withdrawal by Subject|0|||
156692446|NCT00597116|565620220|FG000|Overall Study|Adverse Event|2|||
156692447|NCT00597116|565620221|FG001|Overall Study|Adverse Event|1|||
156692448|NCT00597116|565620220|FG000|Overall Study|Withdrawal by Subject|0|||
156692449|NCT00597116|565620221|FG001|Overall Study|Withdrawal by Subject|2|||
156692450|NCT00597116|565620220|FG000|Overall Study|Physician Decision|0|||
156692451|NCT00597116|565620221|FG001|Overall Study|Physician Decision|1|||
156692452|NCT00597116|565620220|FG000|Overall Study|Death|0|||
156692453|NCT00597116|565620221|FG001|Overall Study|Death|1|||
156692454|NCT00597116|565620220|FG000|Overall Study|Lost to Follow-up|1|||
156692455|NCT00597116|565620221|FG001|Overall Study|Lost to Follow-up|0|||
156692456|NCT00597116|565620220|FG000|Overall Study|Progressive disease|11|||
156692457|NCT00597116|565620221|FG001|Overall Study|Progressive disease|6|||
156692458|NCT02096588|565620222|FG000|Overall Study|Lack of Efficacy|2|||
156692459|NCT02096588|565620223|FG001|Overall Study|Lack of Efficacy|0|||
156692460|NCT02096588|565620222|FG000|Overall Study|Withdrawal by Subject|0|||
156692461|NCT02096588|565620223|FG001|Overall Study|Withdrawal by Subject|1|||
156692462|NCT01258101|565620224|FG000|Overall Study|Adverse Event|5|||
156692463|NCT01258101|565620225|FG001|Overall Study|Adverse Event|6|||
156692464|NCT01258101|565620226|FG002|Overall Study|Adverse Event|0|||
156692465|NCT01258101|565620227|FG003|Overall Study|Adverse Event|0|||
156692466|NCT01258101|565620224|FG000|Overall Study|Extra exclusion criterion amended|2|||
156692467|NCT01258101|565620225|FG001|Overall Study|Extra exclusion criterion amended|1|||
156692468|NCT01258101|565620226|FG002|Overall Study|Extra exclusion criterion amended|1|||
156692469|NCT01258101|565620227|FG003|Overall Study|Extra exclusion criterion amended|1|||
156692470|NCT01258101|565620224|FG000|Overall Study|Informed consent has been withdrawn|2|||
156692471|NCT01258101|565620225|FG001|Overall Study|Informed consent has been withdrawn|2|||
156692472|NCT01258101|565620226|FG002|Overall Study|Informed consent has been withdrawn|1|||
156692473|NCT01258101|565620227|FG003|Overall Study|Informed consent has been withdrawn|1|||
156692474|NCT01258101|565620224|FG000|Overall Study|Patient is not able to attend visits|8|||
156692475|NCT01258101|565620225|FG001|Overall Study|Patient is not able to attend visits|9|||
156692476|NCT01258101|565620226|FG002|Overall Study|Patient is not able to attend visits|7|||
156692477|NCT01258101|565620227|FG003|Overall Study|Patient is not able to attend visits|6|||
156692478|NCT01258101|565620224|FG000|Overall Study|Patient´s compliance|4|||
156692479|NCT01258101|565620225|FG001|Overall Study|Patient´s compliance|3|||
156692480|NCT01258101|565620226|FG002|Overall Study|Patient´s compliance|1|||
156692481|NCT01258101|565620227|FG003|Overall Study|Patient´s compliance|2|||
156692482|NCT01258101|565620224|FG000|Overall Study|Lost to Follow-up|5|||
156692483|NCT01258101|565620225|FG001|Overall Study|Lost to Follow-up|5|||
156692484|NCT01258101|565620226|FG002|Overall Study|Lost to Follow-up|0|||
156692485|NCT01258101|565620227|FG003|Overall Study|Lost to Follow-up|6|||
156788634|NCT04518410|565977298|FG016|Overall Study|Withdrawal by Subject|0|||
156788635|NCT04518410|565977299|FG017|Overall Study|Withdrawal by Subject|15|||
156788636|NCT04518410|565977300|FG018|Overall Study|Withdrawal by Subject|12|||
156788637|NCT04518410|565977301|FG019|Overall Study|Withdrawal by Subject|9|||
156788638|NCT04518410|565977302|FG020|Overall Study|Withdrawal by Subject|14|||
156788639|NCT04518410|565977303|FG021|Overall Study|Withdrawal by Subject|3|||
156788640|NCT04518410|565977304|FG022|Overall Study|Withdrawal by Subject|2|||
156788641|NCT04518410|565977305|FG023|Overall Study|Withdrawal by Subject|9|||
156788642|NCT04518410|565977306|FG024|Overall Study|Withdrawal by Subject|8|||
156788643|NCT04518410|565977282|FG000|Overall Study|Other|1|||
156788644|NCT04518410|565977283|FG001|Overall Study|Other|0|||
156788645|NCT04518410|565977284|FG002|Overall Study|Other|0|||
156788646|NCT04518410|565977285|FG003|Overall Study|Other|1|||
156788647|NCT04518410|565977286|FG004|Overall Study|Other|6|||
156788648|NCT04518410|565977287|FG005|Overall Study|Other|6|||
156788649|NCT04518410|565977288|FG006|Overall Study|Other|5|||
156788650|NCT04518410|565977289|FG007|Overall Study|Other|2|||
156788651|NCT04518410|565977290|FG008|Overall Study|Other|0|||
156692486|NCT01258101|565620224|FG000|Overall Study|PCR positive at week 24|0|||
156692487|NCT01258101|565620225|FG001|Overall Study|PCR positive at week 24|0|||
156692488|NCT01258101|565620226|FG002|Overall Study|PCR positive at week 24|0|||
156692489|NCT01258101|565620227|FG003|Overall Study|PCR positive at week 24|1|||
156692490|NCT01258101|565620224|FG000|Overall Study|Other reason|7|||
156692491|NCT01258101|565620225|FG001|Overall Study|Other reason|8|||
156692492|NCT01258101|565620226|FG002|Overall Study|Other reason|1|||
156692493|NCT01258101|565620227|FG003|Overall Study|Other reason|8|||
156692494|NCT00063882|565620230|FG000|Overall Study|Protocol Violation|3|||
156692495|NCT00063882|565620231|FG001|Overall Study|Protocol Violation|3|||
156788652|NCT04518410|565977291|FG009|Overall Study|Other|1|||
156788653|NCT04518410|565977292|FG010|Overall Study|Other|0|||
156788654|NCT04518410|565977293|FG011|Overall Study|Other|2|||
156788655|NCT04518410|565977294|FG012|Overall Study|Other|0|||
156788656|NCT04518410|565977295|FG013|Overall Study|Other|0|||
156692496|NCT00063882|565620230|FG000|Overall Study|Withdrawal by Subject|2|||
156692497|NCT00063882|565620231|FG001|Overall Study|Withdrawal by Subject|1|||
156692498|NCT02903238|565620232|FG000|Overall Study|Lost to Follow-up|4|||
156692499|NCT02777918|565620234|FG000|Overall Study|Medical reasons|1|||
156692500|NCT02777918|565620235|FG001|Overall Study|Medical reasons|2|||
156692501|NCT02777918|565620234|FG000|Overall Study|Too busy / stressed|1|||
156692502|NCT02777918|565620235|FG001|Overall Study|Too busy / stressed|1|||
156692503|NCT02777918|565620234|FG000|Overall Study|Withdrawal by Subject|1|||
156692504|NCT02777918|565620235|FG001|Overall Study|Withdrawal by Subject|1|||
156692505|NCT00733369|565620242|FG000|Overall Study|Lost to Follow-up|2|||
156692506|NCT00733369|565620243|FG001|Overall Study|Lost to Follow-up|1|||
156692507|NCT00733369|565620242|FG000|Overall Study|Adverse Event|4|||
156692508|NCT00733369|565620243|FG001|Overall Study|Adverse Event|4|||
156692509|NCT00733369|565620242|FG000|Overall Study|Protocol Violation|4|||
156692510|NCT00733369|565620243|FG001|Overall Study|Protocol Violation|4|||
156692511|NCT01020799|565620244|FG000|Overall Study|Adverse Event|4|||
156692512|NCT01020799|565620245|FG001|Overall Study|Adverse Event|3|||
156692513|NCT01020799|565620246|FG002|Overall Study|Adverse Event|2|||
156692514|NCT01020799|565620244|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
156692515|NCT01020799|565620245|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
156692516|NCT01020799|565620246|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
156692517|NCT01020799|565620244|FG000|Overall Study|Protocol Violation|3|||
156692518|NCT01020799|565620245|FG001|Overall Study|Protocol Violation|2|||
156692519|NCT01020799|565620246|FG002|Overall Study|Protocol Violation|0|||
156692520|NCT01020799|565620244|FG000|Overall Study|Withdrawal by Subject|2|||
156692521|NCT01020799|565620245|FG001|Overall Study|Withdrawal by Subject|2|||
156692522|NCT01020799|565620246|FG002|Overall Study|Withdrawal by Subject|3|||
156692523|NCT01020799|565620244|FG000|Overall Study|Lost to Follow-up|6|||
156692524|NCT01020799|565620245|FG001|Overall Study|Lost to Follow-up|4|||
156692525|NCT01020799|565620246|FG002|Overall Study|Lost to Follow-up|2|||
156692526|NCT02556307|565620256|FG000|Overall Study|Premature treatment interruption|11|||
156692527|NCT02556307|565620256|FG000|Overall Study|Lost to Follow-up|36|||
156692528|NCT02556307|565620256|FG000|Overall Study|Change to triple therapy|4|||
156692529|NCT02556307|565620256|FG000|Overall Study|Enrolled but not treated|2|||
156692530|NCT00653991|565620258|FG000|3 Month Follow-up|Participant would not respond|150|||
156788657|NCT04518410|565977296|FG014|Overall Study|Other|0|||
156788658|NCT04518410|565977297|FG015|Overall Study|Other|3|||
156788659|NCT04518410|565977298|FG016|Overall Study|Other|1|||
156788660|NCT04518410|565977299|FG017|Overall Study|Other|1|||
156788661|NCT04518410|565977300|FG018|Overall Study|Other|1|||
156788662|NCT04518410|565977301|FG019|Overall Study|Other|0|||
156788663|NCT04518410|565977302|FG020|Overall Study|Other|1|||
156788664|NCT04518410|565977303|FG021|Overall Study|Other|0|||
156788665|NCT04518410|565977304|FG022|Overall Study|Other|1|||
156788666|NCT04518410|565977305|FG023|Overall Study|Other|2|||
156788667|NCT04518410|565977306|FG024|Overall Study|Other|2|||
156788668|NCT04518410|565977282|FG000|Overall Study|Protocol Violation|0|||
156788669|NCT04518410|565977283|FG001|Overall Study|Protocol Violation|0|||
156788670|NCT04518410|565977284|FG002|Overall Study|Protocol Violation|0|||
156692531|NCT00653991|565620259|FG001|3 Month Follow-up|Participant would not respond|157|||
156692532|NCT00653991|565620258|FG000|6 Month Follow-up|Participant would not respond|133|||
156692533|NCT00653991|565620259|FG001|6 Month Follow-up|Participant would not respond|141|||
156692534|NCT02149121|565620260|FG000|Main Study Period|Lack of Efficacy|2|||
156692535|NCT02149121|565620261|FG001|Main Study Period|Lack of Efficacy|2|||
156692536|NCT02149121|565620262|FG002|Main Study Period|Lack of Efficacy|1|||
156692537|NCT02149121|565620263|FG003|Main Study Period|Lack of Efficacy|0|||
156692538|NCT02149121|565620264|FG004|Main Study Period|Lack of Efficacy|0|||
156692539|NCT02149121|565620265|FG005|Main Study Period|Lack of Efficacy|0|||
156692540|NCT02149121|565620266|FG006|Main Study Period|Lack of Efficacy|0|||
156692541|NCT02149121|565620260|FG000|Main Study Period|Withdrawal by Subject|9|||
156692542|NCT02149121|565620261|FG001|Main Study Period|Withdrawal by Subject|5|||
156692543|NCT02149121|565620262|FG002|Main Study Period|Withdrawal by Subject|1|||
156788671|NCT04518410|565977285|FG003|Overall Study|Protocol Violation|2|||
156788672|NCT04518410|565977286|FG004|Overall Study|Protocol Violation|17|||
156788673|NCT04518410|565977287|FG005|Overall Study|Protocol Violation|1|||
156692544|NCT02149121|565620263|FG003|Main Study Period|Withdrawal by Subject|0|||
156692545|NCT02149121|565620264|FG004|Main Study Period|Withdrawal by Subject|0|||
156692546|NCT02149121|565620265|FG005|Main Study Period|Withdrawal by Subject|0|||
156788674|NCT04518410|565977288|FG006|Overall Study|Protocol Violation|2|||
156788675|NCT04518410|565977289|FG007|Overall Study|Protocol Violation|1|||
156692547|NCT02149121|565620266|FG006|Main Study Period|Withdrawal by Subject|0|||
156788676|NCT04518410|565977290|FG008|Overall Study|Protocol Violation|0|||
156788677|NCT04518410|565977291|FG009|Overall Study|Protocol Violation|0|||
156692548|NCT02149121|565620260|FG000|Main Study Period|Adverse Event|2|||
156788678|NCT04518410|565977292|FG010|Overall Study|Protocol Violation|0|||
156788679|NCT04518410|565977293|FG011|Overall Study|Protocol Violation|0|||
156788680|NCT04518410|565977294|FG012|Overall Study|Protocol Violation|0|||
156788681|NCT04518410|565977295|FG013|Overall Study|Protocol Violation|0|||
156788682|NCT04518410|565977296|FG014|Overall Study|Protocol Violation|0|||
156692549|NCT02149121|565620261|FG001|Main Study Period|Adverse Event|5|||
156692550|NCT02149121|565620262|FG002|Main Study Period|Adverse Event|1|||
156692551|NCT02149121|565620263|FG003|Main Study Period|Adverse Event|0|||
156692552|NCT02149121|565620264|FG004|Main Study Period|Adverse Event|0|||
156692553|NCT02149121|565620265|FG005|Main Study Period|Adverse Event|0|||
156692554|NCT02149121|565620266|FG006|Main Study Period|Adverse Event|0|||
156692555|NCT02149121|565620260|FG000|Main Study Period|Protocol Violation|2|||
156692556|NCT02149121|565620261|FG001|Main Study Period|Protocol Violation|0|||
156692557|NCT02149121|565620262|FG002|Main Study Period|Protocol Violation|0|||
156692558|NCT02149121|565620263|FG003|Main Study Period|Protocol Violation|0|||
156692559|NCT02149121|565620264|FG004|Main Study Period|Protocol Violation|0|||
156692560|NCT02149121|565620265|FG005|Main Study Period|Protocol Violation|0|||
156692561|NCT02149121|565620266|FG006|Main Study Period|Protocol Violation|0|||
156692562|NCT02149121|565620260|FG000|Main Study Period|Lost to Follow-up|2|||
156692563|NCT02149121|565620261|FG001|Main Study Period|Lost to Follow-up|1|||
156692564|NCT02149121|565620262|FG002|Main Study Period|Lost to Follow-up|0|||
156692565|NCT02149121|565620263|FG003|Main Study Period|Lost to Follow-up|0|||
156692566|NCT02149121|565620264|FG004|Main Study Period|Lost to Follow-up|0|||
156692567|NCT02149121|565620265|FG005|Main Study Period|Lost to Follow-up|0|||
156692568|NCT02149121|565620266|FG006|Main Study Period|Lost to Follow-up|0|||
156692569|NCT02149121|565620260|FG000|Main Study Period|Death|1|||
156692570|NCT02149121|565620261|FG001|Main Study Period|Death|0|||
156692571|NCT02149121|565620262|FG002|Main Study Period|Death|0|||
156692572|NCT02149121|565620263|FG003|Main Study Period|Death|0|||
156692573|NCT02149121|565620264|FG004|Main Study Period|Death|0|||
156692574|NCT02149121|565620265|FG005|Main Study Period|Death|0|||
156692575|NCT02149121|565620266|FG006|Main Study Period|Death|0|||
156692576|NCT02149121|565620260|FG000|Main Study Period|Physician Decision|1|||
156692577|NCT02149121|565620261|FG001|Main Study Period|Physician Decision|0|||
156692578|NCT02149121|565620262|FG002|Main Study Period|Physician Decision|0|||
156692579|NCT02149121|565620263|FG003|Main Study Period|Physician Decision|0|||
156692580|NCT02149121|565620264|FG004|Main Study Period|Physician Decision|0|||
156692581|NCT02149121|565620265|FG005|Main Study Period|Physician Decision|0|||
156692582|NCT02149121|565620266|FG006|Main Study Period|Physician Decision|0|||
156692583|NCT02149121|565620260|FG000|Main Study Period|Developed any malignancy|0|||
156692584|NCT02149121|565620261|FG001|Main Study Period|Developed any malignancy|1|||
156692585|NCT02149121|565620262|FG002|Main Study Period|Developed any malignancy|1|||
156692586|NCT02149121|565620263|FG003|Main Study Period|Developed any malignancy|0|||
156692587|NCT02149121|565620264|FG004|Main Study Period|Developed any malignancy|0|||
156692588|NCT02149121|565620265|FG005|Main Study Period|Developed any malignancy|0|||
156692589|NCT02149121|565620266|FG006|Main Study Period|Developed any malignancy|0|||
156692590|NCT02149121|565620260|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
156692591|NCT02149121|565620261|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
156692592|NCT02149121|565620262|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
156692593|NCT02149121|565620263|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
156692594|NCT02149121|565620264|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
156692595|NCT02149121|565620265|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
156692596|NCT02149121|565620266|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
156692597|NCT02149121|565620260|FG000|Main Study Period|Disease progression|0|||
156692598|NCT02149121|565620261|FG001|Main Study Period|Disease progression|1|||
156692599|NCT02149121|565620262|FG002|Main Study Period|Disease progression|0|||
156692600|NCT02149121|565620263|FG003|Main Study Period|Disease progression|0|||
156692601|NCT02149121|565620264|FG004|Main Study Period|Disease progression|0|||
156692602|NCT02149121|565620265|FG005|Main Study Period|Disease progression|0|||
156692603|NCT02149121|565620266|FG006|Main Study Period|Disease progression|0|||
156870265|NCT04922216|566281138|FG009|Overall Study|Lost to Follow-up|2|||
156870266|NCT04922216|566281139|FG010|Overall Study|Lost to Follow-up|2|||
156870267|NCT04922216|566281140|FG011|Overall Study|Lost to Follow-up|1|||
156870268|NCT04922216|566281141|FG012|Overall Study|Lost to Follow-up|1|||
157013698|NCT01854385|566801846|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
156692604|NCT02149121|565620260|FG000|Extension Study Period|Withdrawal by Subject|0|||
157013699|NCT01854385|566801846|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
156692605|NCT02149121|565620261|FG001|Extension Study Period|Withdrawal by Subject|0|||
156692606|NCT02149121|565620262|FG002|Extension Study Period|Withdrawal by Subject|0|||
156692607|NCT02149121|565620263|FG003|Extension Study Period|Withdrawal by Subject|1|||
156692608|NCT02149121|565620264|FG004|Extension Study Period|Withdrawal by Subject|0|||
156692609|NCT02149121|565620265|FG005|Extension Study Period|Withdrawal by Subject|2|||
156692610|NCT02149121|565620266|FG006|Extension Study Period|Withdrawal by Subject|0|||
156692611|NCT01244061|565620275|FG000|Overall Study|Death|1|||
156692612|NCT01244061|565620276|FG001|Overall Study|Death|0|||
156692613|NCT01244061|565620275|FG000|Overall Study|Did not meet entrance criteria|1|||
156692614|NCT01244061|565620276|FG001|Overall Study|Did not meet entrance criteria|0|||
156692615|NCT01244061|565620275|FG000|Overall Study|Lack of Efficacy|1|||
156692616|NCT01244061|565620276|FG001|Overall Study|Lack of Efficacy|3|||
156870269|NCT04922216|566281142|FG013|Overall Study|Lost to Follow-up|0|||
156788683|NCT04518410|565977297|FG015|Overall Study|Protocol Violation|0|||
156788684|NCT04518410|565977298|FG016|Overall Study|Protocol Violation|1|||
157013700|NCT01854385|566801846|FG000|Pre-Treatment|Unable to come for study visits|1|||
157013701|NCT01854385|566801846|FG000|Treatment|Lost to Follow-up|1|||
157013702|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
157013703|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
157013704|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
157013705|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
157013706|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
157013707|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
157013708|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
157013709|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
156788685|NCT04518410|565977299|FG017|Overall Study|Protocol Violation|1|||
156788686|NCT04518410|565977300|FG018|Overall Study|Protocol Violation|0|||
156788687|NCT04518410|565977301|FG019|Overall Study|Protocol Violation|0|||
156788688|NCT04518410|565977302|FG020|Overall Study|Protocol Violation|1|||
156788689|NCT04518410|565977303|FG021|Overall Study|Protocol Violation|2|||
156788690|NCT04518410|565977304|FG022|Overall Study|Protocol Violation|0|||
156788691|NCT04518410|565977305|FG023|Overall Study|Protocol Violation|3|||
156788692|NCT04518410|565977306|FG024|Overall Study|Protocol Violation|0|||
156788693|NCT04518410|565977282|FG000|Overall Study|Death|0|||
157013710|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
157013711|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
156788694|NCT04518410|565977283|FG001|Overall Study|Death|0|||
156870270|NCT04922216|566281143|FG014|Overall Study|Lost to Follow-up|1|||
156870271|NCT04922216|566281144|FG015|Overall Study|Lost to Follow-up|0|||
157013712|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
156870272|NCT04922216|566281145|FG016|Overall Study|Lost to Follow-up|0|||
156870273|NCT04922216|566281146|FG017|Overall Study|Lost to Follow-up|2|||
156870274|NCT04922216|566281147|FG018|Overall Study|Lost to Follow-up|1|||
157013713|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
157013714|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
157013715|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
157013716|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
157013717|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
157013718|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
157013719|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
157013720|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
157013721|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
156788695|NCT04518410|565977284|FG002|Overall Study|Death|0|||
156870275|NCT04922216|566281148|FG019|Overall Study|Lost to Follow-up|0|||
156870276|NCT04922216|566281149|FG020|Overall Study|Lost to Follow-up|1|||
156870277|NCT04922216|566281150|FG021|Overall Study|Lost to Follow-up|0|||
156870278|NCT04922216|566281151|FG022|Overall Study|Lost to Follow-up|2|||
156870279|NCT04922216|566281152|FG023|Overall Study|Lost to Follow-up|1|||
156870280|NCT04922216|566281153|FG024|Overall Study|Lost to Follow-up|0|||
156870281|NCT04922216|566281154|FG025|Overall Study|Lost to Follow-up|2|||
156870282|NCT04922216|566281155|FG026|Overall Study|Lost to Follow-up|0|||
156870283|NCT04922216|566281156|FG027|Overall Study|Lost to Follow-up|0|||
156870284|NCT04922216|566281157|FG028|Overall Study|Lost to Follow-up|1|||
156870285|NCT04922216|566281158|FG029|Overall Study|Lost to Follow-up|0|||
156870286|NCT04922216|566281159|FG030|Overall Study|Lost to Follow-up|2|||
156870287|NCT04922216|566281160|FG031|Overall Study|Lost to Follow-up|1|||
156870288|NCT03278249|566281161|FG000|Overall Study|Withdrawal by Subject|2|||
156870289|NCT03278249|566281161|FG000|Overall Study|Lost to Follow-up|1|||
156870290|NCT02017405|566281162|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
157013722|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
157013723|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
156788696|NCT04518410|565977285|FG003|Overall Study|Death|0|||
156788697|NCT04518410|565977286|FG004|Overall Study|Death|12|||
157013724|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
157013725|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
156788698|NCT04518410|565977287|FG005|Overall Study|Death|2|||
156788699|NCT04518410|565977288|FG006|Overall Study|Death|11|||
156788700|NCT04518410|565977289|FG007|Overall Study|Death|0|||
156788701|NCT04518410|565977290|FG008|Overall Study|Death|1|||
156788702|NCT04518410|565977291|FG009|Overall Study|Death|0|||
156788703|NCT04518410|565977292|FG010|Overall Study|Death|0|||
156870291|NCT02017405|566281163|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870292|NCT02017405|566281164|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870293|NCT02017405|566281165|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156870294|NCT02017405|566281166|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
156788704|NCT04518410|565977293|FG011|Overall Study|Death|0|||
156788705|NCT04518410|565977294|FG012|Overall Study|Death|0|||
156788706|NCT04518410|565977295|FG013|Overall Study|Death|1|||
156788707|NCT04518410|565977296|FG014|Overall Study|Death|1|||
156788708|NCT04518410|565977297|FG015|Overall Study|Death|0|||
156788709|NCT04518410|565977298|FG016|Overall Study|Death|0|||
156788710|NCT04518410|565977299|FG017|Overall Study|Death|1|||
156788711|NCT04518410|565977300|FG018|Overall Study|Death|4|||
156788712|NCT04518410|565977301|FG019|Overall Study|Death|4|||
156788713|NCT04518410|565977302|FG020|Overall Study|Death|1|||
156788714|NCT04518410|565977303|FG021|Overall Study|Death|0|||
156788715|NCT04518410|565977304|FG022|Overall Study|Death|0|||
156788716|NCT04518410|565977305|FG023|Overall Study|Death|0|||
156788717|NCT04518410|565977306|FG024|Overall Study|Death|0|||
156788718|NCT04518410|565977282|FG000|Overall Study|Requirement to start alternative therapy|0|||
156788719|NCT04518410|565977283|FG001|Overall Study|Requirement to start alternative therapy|0|||
156788720|NCT04518410|565977284|FG002|Overall Study|Requirement to start alternative therapy|1|||
156788721|NCT04518410|565977285|FG003|Overall Study|Requirement to start alternative therapy|0|||
156788722|NCT04518410|565977286|FG004|Overall Study|Requirement to start alternative therapy|0|||
156788723|NCT04518410|565977287|FG005|Overall Study|Requirement to start alternative therapy|0|||
156788724|NCT04518410|565977288|FG006|Overall Study|Requirement to start alternative therapy|0|||
156788725|NCT04518410|565977289|FG007|Overall Study|Requirement to start alternative therapy|0|||
156788726|NCT04518410|565977290|FG008|Overall Study|Requirement to start alternative therapy|0|||
157121633|NCT03215030|567197519|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
157121634|NCT03215030|567197520|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121635|NCT03215030|567197521|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
156692617|NCT01244061|565620275|FG000|Overall Study|Lost to Follow-up|34|||
156692618|NCT01244061|565620276|FG001|Overall Study|Lost to Follow-up|30|||
156692619|NCT01244061|565620275|FG000|Overall Study|Withdrawal by Subject|29|||
156692620|NCT01244061|565620276|FG001|Overall Study|Withdrawal by Subject|46|||
156692621|NCT01244061|565620275|FG000|Overall Study|Other|8|||
156692622|NCT01244061|565620276|FG001|Overall Study|Other|19|||
156692623|NCT01244061|565620275|FG000|Overall Study|Protocol Violation|1|||
156692624|NCT01244061|565620276|FG001|Overall Study|Protocol Violation|1|||
156692625|NCT01244061|565620275|FG000|Overall Study|Adverse Event|5|||
156692626|NCT01244061|565620276|FG001|Overall Study|Adverse Event|2|||
156692627|NCT01244061|565620275|FG000|Overall Study|Randomized but not treated|2|||
156692628|NCT01244061|565620276|FG001|Overall Study|Randomized but not treated|2|||
156692629|NCT03166124|565620277|FG000|Treatment Period 1|Adverse Event|0|||
156692630|NCT03166124|565620278|FG001|Treatment Period 1|Adverse Event|0|||
156692631|NCT03166124|565620279|FG002|Treatment Period 1|Adverse Event|1|||
156692632|NCT03166124|565620280|FG003|Treatment Period 1|Adverse Event|0|||
156692633|NCT03166124|565620277|FG000|Wash-out Period|Withdrawal by Subject|0|||
156692634|NCT03166124|565620278|FG001|Wash-out Period|Withdrawal by Subject|1|||
156692635|NCT03166124|565620279|FG002|Wash-out Period|Withdrawal by Subject|0|||
156692636|NCT03166124|565620280|FG003|Wash-out Period|Withdrawal by Subject|1|||
156692637|NCT03166124|565620277|FG000|Wash-out Period|Adverse Event|0|||
156692638|NCT03166124|565620278|FG001|Wash-out Period|Adverse Event|1|||
156692639|NCT03166124|565620279|FG002|Wash-out Period|Adverse Event|1|||
156692640|NCT03166124|565620280|FG003|Wash-out Period|Adverse Event|0|||
156692641|NCT00788593|565620283|FG000|Placebo Run-in Phase|Adverse Event|2|||
156692642|NCT00788593|565620284|FG001|Placebo Run-in Phase|Adverse Event|0|||
156692643|NCT00788593|565620285|FG002|Placebo Run-in Phase|Adverse Event|0|||
156692644|NCT00788593|565620283|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
156692645|NCT00788593|565620284|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
156692646|NCT00788593|565620285|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
156692647|NCT00788593|565620283|FG000|Placebo Run-in Phase|Protocol Violation|2|||
156692648|NCT00788593|565620284|FG001|Placebo Run-in Phase|Protocol Violation|0|||
156692649|NCT00788593|565620285|FG002|Placebo Run-in Phase|Protocol Violation|0|||
156692650|NCT00788593|565620283|FG000|First Intervention Period|Adverse Event|0|||
156692651|NCT00788593|565620284|FG001|First Intervention Period|Adverse Event|1|||
156692652|NCT00788593|565620285|FG002|First Intervention Period|Adverse Event|0|||
156692653|NCT00788593|565620283|FG000|Second Intervention Period|Lost to Follow-up|0|||
156692654|NCT00788593|565620284|FG001|Second Intervention Period|Lost to Follow-up|1|||
156788727|NCT04518410|565977291|FG009|Overall Study|Requirement to start alternative therapy|0|||
156788728|NCT04518410|565977292|FG010|Overall Study|Requirement to start alternative therapy|0|||
156788729|NCT04518410|565977293|FG011|Overall Study|Requirement to start alternative therapy|0|||
156788730|NCT04518410|565977294|FG012|Overall Study|Requirement to start alternative therapy|0|||
156788731|NCT04518410|565977295|FG013|Overall Study|Requirement to start alternative therapy|0|||
156788732|NCT04518410|565977296|FG014|Overall Study|Requirement to start alternative therapy|0|||
156788733|NCT04518410|565977297|FG015|Overall Study|Requirement to start alternative therapy|0|||
156692655|NCT00788593|565620285|FG002|Second Intervention Period|Lost to Follow-up|0|||
156788734|NCT04518410|565977298|FG016|Overall Study|Requirement to start alternative therapy|0|||
156788735|NCT04518410|565977299|FG017|Overall Study|Requirement to start alternative therapy|0|||
156788736|NCT04518410|565977300|FG018|Overall Study|Requirement to start alternative therapy|0|||
156692656|NCT00788593|565620283|FG000|Second Intervention Period|Other|0|||
156692657|NCT00788593|565620284|FG001|Second Intervention Period|Other|0|||
156692658|NCT00788593|565620285|FG002|Second Intervention Period|Other|1|||
156692659|NCT00515034|565620286|FG000|Overall Study|Adverse Event|2|||
156692660|NCT00515034|565620287|FG001|Overall Study|Adverse Event|0|||
156692661|NCT00515034|565620288|FG002|Overall Study|Adverse Event|1|||
156692662|NCT00515034|565620289|FG003|Overall Study|Adverse Event|0|||
156692663|NCT00515034|565620286|FG000|Overall Study|Death|4|||
156692664|NCT00515034|565620287|FG001|Overall Study|Death|2|||
156692665|NCT00515034|565620288|FG002|Overall Study|Death|1|||
156692666|NCT00515034|565620289|FG003|Overall Study|Death|3|||
156692667|NCT00515034|565620286|FG000|Overall Study|Withdrawal by Subject|1|||
156692668|NCT00515034|565620287|FG001|Overall Study|Withdrawal by Subject|0|||
156692669|NCT00515034|565620288|FG002|Overall Study|Withdrawal by Subject|3|||
156692670|NCT00515034|565620289|FG003|Overall Study|Withdrawal by Subject|0|||
156692671|NCT00515034|565620286|FG000|Overall Study|Physician Decision|0|||
156692672|NCT00515034|565620287|FG001|Overall Study|Physician Decision|0|||
156692673|NCT00515034|565620288|FG002|Overall Study|Physician Decision|1|||
156692674|NCT00515034|565620289|FG003|Overall Study|Physician Decision|1|||
156692675|NCT00515034|565620286|FG000|Overall Study|Other|1|||
156692676|NCT00515034|565620287|FG001|Overall Study|Other|0|||
156692677|NCT00515034|565620288|FG002|Overall Study|Other|2|||
156692678|NCT00515034|565620289|FG003|Overall Study|Other|1|||
156692679|NCT01392326|565620292|FG000|Overall Study|Death|2|||
156692680|NCT01392326|565620293|FG001|Overall Study|Death|0|||
156692681|NCT01392326|565620294|FG002|Overall Study|Death|0|||
156692682|NCT01392326|565620292|FG000|Overall Study|Withdrawal by Subject|12|||
156692683|NCT01392326|565620293|FG001|Overall Study|Withdrawal by Subject|11|||
156692684|NCT01392326|565620294|FG002|Overall Study|Withdrawal by Subject|15|||
156692685|NCT01392326|565620292|FG000|Overall Study|Protocol Violation|2|||
156692686|NCT01392326|565620293|FG001|Overall Study|Protocol Violation|0|||
156692687|NCT01392326|565620294|FG002|Overall Study|Protocol Violation|0|||
156692688|NCT01392326|565620292|FG000|Overall Study|Pregnancy|0|||
156692689|NCT01392326|565620293|FG001|Overall Study|Pregnancy|0|||
156692690|NCT01392326|565620294|FG002|Overall Study|Pregnancy|1|||
156692691|NCT01392326|565620292|FG000|Overall Study|Physician Decision|7|||
156692692|NCT01392326|565620293|FG001|Overall Study|Physician Decision|5|||
156692693|NCT01392326|565620294|FG002|Overall Study|Physician Decision|2|||
156692694|NCT01392326|565620292|FG000|Overall Study|Lost to Follow-up|1|||
156692695|NCT01392326|565620293|FG001|Overall Study|Lost to Follow-up|3|||
156692696|NCT01392326|565620294|FG002|Overall Study|Lost to Follow-up|4|||
156692697|NCT01392326|565620292|FG000|Overall Study|Lack of Efficacy|14|||
156692698|NCT01392326|565620293|FG001|Overall Study|Lack of Efficacy|10|||
156692699|NCT01392326|565620294|FG002|Overall Study|Lack of Efficacy|15|||
156692700|NCT01392326|565620292|FG000|Overall Study|Adverse Event|9|||
156692701|NCT01392326|565620293|FG001|Overall Study|Adverse Event|6|||
156692702|NCT01392326|565620294|FG002|Overall Study|Adverse Event|11|||
156692703|NCT00518622|565620297|FG000|Overall Study|Lost to Follow-up|0|||
156692704|NCT00518622|565620298|FG001|Overall Study|Lost to Follow-up|0|||
156692705|NCT00518622|565620299|FG002|Overall Study|Lost to Follow-up|1|||
156692706|NCT00518622|565620300|FG003|Overall Study|Lost to Follow-up|0|||
156692707|NCT00518622|565620301|FG004|Overall Study|Lost to Follow-up|0|||
156870295|NCT02017405|566281167|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
156870296|NCT02017405|566281162|FG000|Open-label Phase|Adverse Event|1|||
156870297|NCT02017405|566281163|FG001|Open-label Phase|Adverse Event|1|||
156870298|NCT02017405|566281164|FG002|Open-label Phase|Adverse Event|0|||
156870299|NCT02017405|566281165|FG003|Open-label Phase|Adverse Event|0|||
156870300|NCT02017405|566281166|FG004|Open-label Phase|Adverse Event|0|||
156870301|NCT02017405|566281167|FG005|Open-label Phase|Adverse Event|0|||
156870302|NCT03207763|566282483|FG000|Overall Study|Lost to Follow-up|1|||
156870303|NCT03207763|566282484|FG001|Overall Study|Lost to Follow-up|0|||
156870304|NCT00990704|566282485|FG000|Overall Study|Adverse Event|1|||
156870305|NCT00990704|566282486|FG001|Overall Study|Adverse Event|1|||
157013726|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
157013727|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
156692708|NCT00518622|565620302|FG005|Overall Study|Lost to Follow-up|0|||
156692709|NCT00518622|565620303|FG006|Overall Study|Lost to Follow-up|0|||
156692710|NCT00518622|565620304|FG007|Overall Study|Lost to Follow-up|0|||
156692711|NCT00518622|565620297|FG000|Overall Study|Study medication taken incorrectly|0|||
156692712|NCT00518622|565620298|FG001|Overall Study|Study medication taken incorrectly|1|||
156692713|NCT00518622|565620299|FG002|Overall Study|Study medication taken incorrectly|0|||
156692714|NCT00518622|565620300|FG003|Overall Study|Study medication taken incorrectly|0|||
156692715|NCT00518622|565620301|FG004|Overall Study|Study medication taken incorrectly|0|||
156692716|NCT00518622|565620302|FG005|Overall Study|Study medication taken incorrectly|0|||
156692717|NCT00518622|565620303|FG006|Overall Study|Study medication taken incorrectly|0|||
156692718|NCT00518622|565620304|FG007|Overall Study|Study medication taken incorrectly|0|||
156692719|NCT03487848|565620305|FG000|Overall Study|Lost to Follow-up|1|||
156692720|NCT03499119|565620306|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
156870306|NCT00990704|566282485|FG000|Overall Study|Physician Decision|0|||
156692721|NCT03499119|565620307|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
156692722|NCT03499119|565620308|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
156692723|NCT03499119|565620309|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
156692724|NCT03499119|565620306|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
156692725|NCT03499119|565620307|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
156692726|NCT03499119|565620308|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
156692727|NCT03499119|565620309|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
156692728|NCT03499119|565620306|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
156692729|NCT03499119|565620307|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
156692730|NCT03499119|565620308|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
156692731|NCT03499119|565620309|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
156692732|NCT03499119|565620306|FG000|Optional Extension Phase|Lost to Follow-up|0|||
156692733|NCT03499119|565620307|FG001|Optional Extension Phase|Lost to Follow-up|0|||
156692734|NCT03499119|565620308|FG002|Optional Extension Phase|Lost to Follow-up|0|||
156692735|NCT03499119|565620309|FG003|Optional Extension Phase|Lost to Follow-up|1|||
156692736|NCT03499119|565620306|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
156692737|NCT03499119|565620307|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
156692738|NCT03499119|565620308|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
156692739|NCT03499119|565620309|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
156692740|NCT03499119|565620306|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
156692741|NCT03499119|565620307|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
156692742|NCT03499119|565620308|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
156692743|NCT03499119|565620309|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
156692744|NCT00094094|565620310|FG000|Overall Study|Death|2|||
156692745|NCT00094094|565620310|FG000|Overall Study|Lack of Efficacy|23|||
156692746|NCT00094094|565620310|FG000|Overall Study|Adverse Event|7|||
156692747|NCT02655016|565620313|FG000|Overall Study|Disease progression|6|||
156692748|NCT02655016|565620314|FG001|Overall Study|Disease progression|4|||
156692749|NCT02655016|565620313|FG000|Overall Study|Site closed|0|||
156692750|NCT02655016|565620314|FG001|Overall Study|Site closed|1|||
156692751|NCT02655016|565620313|FG000|Overall Study|Death|30|||
156692752|NCT02655016|565620314|FG001|Overall Study|Death|48|||
156692753|NCT02655016|565620313|FG000|Overall Study|Lost to Follow-up|1|||
156692754|NCT02655016|565620314|FG001|Overall Study|Lost to Follow-up|1|||
156692755|NCT02655016|565620313|FG000|Overall Study|Withdrawal by Subject|18|||
156692756|NCT02655016|565620314|FG001|Overall Study|Withdrawal by Subject|36|||
156692757|NCT04459715|565620317|FG000|Overall Study|Adverse Event|3|||
156788737|NCT04518410|565977301|FG019|Overall Study|Requirement to start alternative therapy|0|||
156788738|NCT04518410|565977302|FG020|Overall Study|Requirement to start alternative therapy|0|||
156788739|NCT04518410|565977303|FG021|Overall Study|Requirement to start alternative therapy|0|||
156788740|NCT04518410|565977304|FG022|Overall Study|Requirement to start alternative therapy|0|||
156788741|NCT04518410|565977305|FG023|Overall Study|Requirement to start alternative therapy|0|||
156788742|NCT04518410|565977306|FG024|Overall Study|Requirement to start alternative therapy|0|||
156788743|NCT04518410|565977282|FG000|Overall Study|Randomized but not treated|0|||
156788744|NCT04518410|565977283|FG001|Overall Study|Randomized but not treated|0|||
156788745|NCT04518410|565977284|FG002|Overall Study|Randomized but not treated|0|||
156788746|NCT04518410|565977285|FG003|Overall Study|Randomized but not treated|2|||
156788747|NCT04518410|565977286|FG004|Overall Study|Randomized but not treated|6|||
156788748|NCT04518410|565977287|FG005|Overall Study|Randomized but not treated|4|||
156788749|NCT04518410|565977288|FG006|Overall Study|Randomized but not treated|3|||
156788750|NCT04518410|565977289|FG007|Overall Study|Randomized but not treated|3|||
156788751|NCT04518410|565977290|FG008|Overall Study|Randomized but not treated|0|||
156788752|NCT04518410|565977291|FG009|Overall Study|Randomized but not treated|4|||
156788753|NCT04518410|565977292|FG010|Overall Study|Randomized but not treated|0|||
156788754|NCT04518410|565977293|FG011|Overall Study|Randomized but not treated|0|||
156788755|NCT04518410|565977294|FG012|Overall Study|Randomized but not treated|1|||
156788756|NCT04518410|565977295|FG013|Overall Study|Randomized but not treated|3|||
156788757|NCT04518410|565977296|FG014|Overall Study|Randomized but not treated|3|||
156788758|NCT04518410|565977297|FG015|Overall Study|Randomized but not treated|3|||
156788759|NCT04518410|565977298|FG016|Overall Study|Randomized but not treated|4|||
156788760|NCT04518410|565977299|FG017|Overall Study|Randomized but not treated|5|||
156870307|NCT00990704|566282486|FG001|Overall Study|Physician Decision|1|||
156692758|NCT04459715|565620318|FG001|Overall Study|Adverse Event|3|||
156692759|NCT04459715|565620317|FG000|Overall Study|Death|111|||
156692760|NCT04459715|565620318|FG001|Overall Study|Death|93|||
156692761|NCT04459715|565620317|FG000|Overall Study|Lost to Follow-up|10|||
156692762|NCT04459715|565620318|FG001|Overall Study|Lost to Follow-up|9|||
156788761|NCT04518410|565977300|FG018|Overall Study|Randomized but not treated|4|||
156692763|NCT04459715|565620317|FG000|Overall Study|Other Reasons|4|||
156692764|NCT04459715|565620318|FG001|Overall Study|Other Reasons|5|||
156692765|NCT04459715|565620317|FG000|Overall Study|PROTOCOL DEVIATION|0|||
156692766|NCT04459715|565620318|FG001|Overall Study|PROTOCOL DEVIATION|1|||
156692767|NCT04459715|565620317|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
156788762|NCT04518410|565977301|FG019|Overall Study|Randomized but not treated|0|||
157121636|NCT03215030|567197522|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121637|NCT03215030|567197523|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121638|NCT03215030|567197524|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121639|NCT03215030|567197525|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121640|NCT03215030|567197526|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121641|NCT03215030|567197527|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121642|NCT03215030|567197528|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121643|NCT03215030|567197529|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
157121644|NCT03215030|567197518|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
157121645|NCT03215030|567197519|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121646|NCT03215030|567197520|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121647|NCT03215030|567197521|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
157121648|NCT03215030|567197522|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121649|NCT03215030|567197523|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121650|NCT03215030|567197524|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121651|NCT03215030|567197525|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121652|NCT03215030|567197526|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121653|NCT03215030|567197527|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121654|NCT03215030|567197528|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121655|NCT03215030|567197529|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157121656|NCT03215030|567197518|FG000|Part 1: Dose Escalation|Death|15|||
157121657|NCT03215030|567197519|FG001|Part 1: Dose Escalation|Death|6|||
157121658|NCT03215030|567197520|FG002|Part 1: Dose Escalation|Death|6|||
157121659|NCT03215030|567197521|FG003|Part 1: Dose Escalation|Death|8|||
157121660|NCT03215030|567197522|FG004|Part 1: Dose Escalation|Death|0|||
157121661|NCT03215030|567197523|FG005|Part 1: Dose Escalation|Death|0|||
157121662|NCT03215030|567197524|FG006|Part 1: Dose Escalation|Death|0|||
157121663|NCT03215030|567197525|FG007|Part 1: Dose Escalation|Death|0|||
157121664|NCT03215030|567197526|FG008|Part 1: Dose Escalation|Death|0|||
157121665|NCT03215030|567197527|FG009|Part 1: Dose Escalation|Death|0|||
157121666|NCT03215030|567197528|FG010|Part 1: Dose Escalation|Death|0|||
157121667|NCT03215030|567197529|FG011|Part 1: Dose Escalation|Death|0|||
157121668|NCT03215030|567197518|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
157121669|NCT03215030|567197519|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
157121670|NCT03215030|567197520|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
157121671|NCT03215030|567197521|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
157121672|NCT03215030|567197522|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
157121673|NCT03215030|567197523|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
157121674|NCT03215030|567197524|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
157121675|NCT03215030|567197525|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
157121676|NCT03215030|567197526|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
157121677|NCT03215030|567197527|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
157121678|NCT03215030|567197528|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
157121679|NCT03215030|567197529|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
157121680|NCT03215030|567197518|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121681|NCT03215030|567197519|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121682|NCT03215030|567197520|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121683|NCT03215030|567197521|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121684|NCT03215030|567197522|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121685|NCT03215030|567197523|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121686|NCT03215030|567197524|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121687|NCT03215030|567197525|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
157121688|NCT03215030|567197526|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157214500|NCT01456052|567531903|FG000|Overall Study|Physician Decision|1|||
157214501|NCT01456052|567531904|FG001|Overall Study|Physician Decision|0|||
157214502|NCT01456052|567531905|FG002|Overall Study|Physician Decision|1|||
157214503|NCT01456052|567531903|FG000|Overall Study|Treatment Failure|0|||
157214504|NCT01456052|567531904|FG001|Overall Study|Treatment Failure|1|||
157214505|NCT01456052|567531905|FG002|Overall Study|Treatment Failure|1|||
157214506|NCT02762565|567531908|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
157121689|NCT03215030|567197527|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121690|NCT03215030|567197528|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121691|NCT03215030|567197529|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
157121692|NCT03215030|567197518|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121693|NCT03215030|567197519|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121694|NCT03215030|567197520|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121695|NCT03215030|567197521|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121696|NCT03215030|567197522|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
157121697|NCT03215030|567197523|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
157121698|NCT03215030|567197524|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
157121699|NCT03215030|567197525|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
157121700|NCT03215030|567197526|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121701|NCT03215030|567197527|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157121702|NCT03215030|567197528|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156788763|NCT04518410|565977302|FG020|Overall Study|Randomized but not treated|0|||
156788764|NCT04518410|565977303|FG021|Overall Study|Randomized but not treated|5|||
156788765|NCT04518410|565977304|FG022|Overall Study|Randomized but not treated|0|||
156788766|NCT04518410|565977305|FG023|Overall Study|Randomized but not treated|3|||
156788767|NCT04518410|565977306|FG024|Overall Study|Randomized but not treated|1|||
156788768|NCT04518410|565977282|FG000|Overall Study|Screen Fail but Randomized|0|||
156788769|NCT04518410|565977283|FG001|Overall Study|Screen Fail but Randomized|0|||
156788770|NCT04518410|565977284|FG002|Overall Study|Screen Fail but Randomized|0|||
156788771|NCT04518410|565977285|FG003|Overall Study|Screen Fail but Randomized|0|||
156788772|NCT04518410|565977286|FG004|Overall Study|Screen Fail but Randomized|2|||
156788773|NCT04518410|565977287|FG005|Overall Study|Screen Fail but Randomized|0|||
156788774|NCT04518410|565977288|FG006|Overall Study|Screen Fail but Randomized|0|||
156788775|NCT04518410|565977289|FG007|Overall Study|Screen Fail but Randomized|0|||
156788776|NCT04518410|565977290|FG008|Overall Study|Screen Fail but Randomized|0|||
156788777|NCT04518410|565977291|FG009|Overall Study|Screen Fail but Randomized|0|||
157013728|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
157013729|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
157013730|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
157013731|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
157013732|NCT04759833|566801847|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
157013733|NCT04759833|566801848|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
157013734|NCT04759833|566801849|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
157013735|NCT04759833|566801850|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
157013736|NCT04759833|566801851|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
157013737|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
157013738|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
157013739|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
157013740|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
157013741|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
157013742|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
157013743|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
157013744|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
157013745|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
157013746|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
157013747|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
157013748|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
157013749|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
157013750|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
157013751|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
157013752|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
157013753|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
157013754|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
157013755|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
157013756|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
157013757|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
157013758|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
157013759|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
157013760|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
157013761|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
157013762|NCT04759833|566801847|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
157013763|NCT04759833|566801848|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
157013764|NCT04759833|566801849|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
157013765|NCT04759833|566801850|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
157013766|NCT04759833|566801851|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
157013767|NCT00111813|566801854|FG000|Overall Study|Adverse Event|1|||
157013768|NCT00111813|566801855|FG001|Overall Study|Adverse Event|2|||
157013769|NCT00111813|566801856|FG002|Overall Study|Adverse Event|4|||
157013770|NCT00111813|566801857|FG003|Overall Study|Adverse Event|2|||
157013771|NCT00111813|566801858|FG004|Overall Study|Adverse Event|2|||
157013772|NCT00111813|566801859|FG005|Overall Study|Adverse Event|2|||
157121703|NCT03215030|567197529|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156788778|NCT04518410|565977292|FG010|Overall Study|Screen Fail but Randomized|0|||
156788779|NCT04518410|565977293|FG011|Overall Study|Screen Fail but Randomized|0|||
156788780|NCT04518410|565977294|FG012|Overall Study|Screen Fail but Randomized|0|||
156788781|NCT04518410|565977295|FG013|Overall Study|Screen Fail but Randomized|0|||
156788782|NCT04518410|565977296|FG014|Overall Study|Screen Fail but Randomized|0|||
156788783|NCT04518410|565977297|FG015|Overall Study|Screen Fail but Randomized|0|||
156788784|NCT04518410|565977298|FG016|Overall Study|Screen Fail but Randomized|0|||
156788785|NCT04518410|565977299|FG017|Overall Study|Screen Fail but Randomized|0|||
156788786|NCT04518410|565977300|FG018|Overall Study|Screen Fail but Randomized|0|||
156788787|NCT04518410|565977301|FG019|Overall Study|Screen Fail but Randomized|0|||
156788788|NCT04518410|565977302|FG020|Overall Study|Screen Fail but Randomized|0|||
156788789|NCT04518410|565977303|FG021|Overall Study|Screen Fail but Randomized|0|||
157013773|NCT00111813|566801854|FG000|Overall Study|Progressive disease|2|||
156788790|NCT04518410|565977304|FG022|Overall Study|Screen Fail but Randomized|0|||
156788791|NCT04518410|565977305|FG023|Overall Study|Screen Fail but Randomized|0|||
156788792|NCT04518410|565977306|FG024|Overall Study|Screen Fail but Randomized|0|||
156788793|NCT04518410|565977282|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788794|NCT04518410|565977283|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788795|NCT04518410|565977284|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788796|NCT04518410|565977285|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788797|NCT04518410|565977286|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
156788798|NCT04518410|565977287|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
156788799|NCT04518410|565977288|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
156788800|NCT04518410|565977289|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788801|NCT04518410|565977290|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
157013774|NCT00111813|566801855|FG001|Overall Study|Progressive disease|1|||
157013775|NCT00111813|566801856|FG002|Overall Study|Progressive disease|5|||
157013776|NCT00111813|566801857|FG003|Overall Study|Progressive disease|3|||
157013777|NCT00111813|566801858|FG004|Overall Study|Progressive disease|4|||
157013778|NCT00111813|566801859|FG005|Overall Study|Progressive disease|3|||
157013779|NCT00111813|566801854|FG000|Overall Study|Lack of Efficacy|0|||
157013780|NCT00111813|566801855|FG001|Overall Study|Lack of Efficacy|0|||
157013781|NCT00111813|566801856|FG002|Overall Study|Lack of Efficacy|0|||
157013782|NCT00111813|566801857|FG003|Overall Study|Lack of Efficacy|0|||
157013783|NCT00111813|566801858|FG004|Overall Study|Lack of Efficacy|0|||
157013784|NCT00111813|566801859|FG005|Overall Study|Lack of Efficacy|1|||
157013785|NCT00111813|566801854|FG000|Overall Study|Other|0|||
157013786|NCT00111813|566801855|FG001|Overall Study|Other|0|||
157013787|NCT00111813|566801856|FG002|Overall Study|Other|1|||
157013788|NCT00111813|566801857|FG003|Overall Study|Other|0|||
157013789|NCT00111813|566801858|FG004|Overall Study|Other|0|||
157013790|NCT00111813|566801859|FG005|Overall Study|Other|0|||
157013791|NCT02590432|566801864|FG000|Open-label Treatment Period|Adverse Event|97|||
157013792|NCT02590432|566801865|FG001|Open-label Treatment Period|Adverse Event|79|||
157013793|NCT02590432|566801866|FG002|Open-label Treatment Period|Adverse Event|0|||
157013794|NCT02590432|566801867|FG003|Open-label Treatment Period|Adverse Event|0|||
157013795|NCT02590432|566801868|FG004|Open-label Treatment Period|Adverse Event|0|||
157013796|NCT02590432|566801869|FG005|Open-label Treatment Period|Adverse Event|0|||
157013797|NCT02590432|566801870|FG006|Open-label Treatment Period|Adverse Event|0|||
157013798|NCT02590432|566801871|FG007|Open-label Treatment Period|Adverse Event|0|||
157013799|NCT02590432|566801872|FG008|Open-label Treatment Period|Adverse Event|0|||
157013800|NCT02590432|566801864|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
157013801|NCT02590432|566801865|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
157013802|NCT02590432|566801866|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
157013803|NCT02590432|566801867|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
157013804|NCT02590432|566801868|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
157013805|NCT02590432|566801869|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
157013806|NCT02590432|566801870|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
157013807|NCT02590432|566801871|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
157013808|NCT02590432|566801872|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
157013809|NCT02590432|566801864|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
157013810|NCT02590432|566801865|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
157013811|NCT02590432|566801866|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
157013812|NCT02590432|566801867|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
157013813|NCT02590432|566801868|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
157013814|NCT02590432|566801869|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
157013815|NCT02590432|566801870|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
157013816|NCT02590432|566801871|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
157013817|NCT02590432|566801872|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
157013818|NCT02590432|566801864|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
157013819|NCT02590432|566801865|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
157013820|NCT02590432|566801866|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
157121704|NCT03215030|567197518|FG000|Part 2: Dose Expansion|Death|0|||
157121705|NCT03215030|567197519|FG001|Part 2: Dose Expansion|Death|0|||
157121706|NCT03215030|567197520|FG002|Part 2: Dose Expansion|Death|0|||
157121707|NCT03215030|567197521|FG003|Part 2: Dose Expansion|Death|0|||
157121708|NCT03215030|567197522|FG004|Part 2: Dose Expansion|Death|3|||
157121709|NCT03215030|567197523|FG005|Part 2: Dose Expansion|Death|1|||
157121710|NCT03215030|567197524|FG006|Part 2: Dose Expansion|Death|5|||
157121711|NCT03215030|567197525|FG007|Part 2: Dose Expansion|Death|4|||
157121712|NCT03215030|567197526|FG008|Part 2: Dose Expansion|Death|0|||
157121713|NCT03215030|567197527|FG009|Part 2: Dose Expansion|Death|0|||
157121714|NCT03215030|567197528|FG010|Part 2: Dose Expansion|Death|0|||
157121715|NCT03215030|567197529|FG011|Part 2: Dose Expansion|Death|0|||
157121716|NCT03215030|567197518|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
157121717|NCT03215030|567197519|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
157121718|NCT03215030|567197520|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
157121719|NCT03215030|567197521|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
157121720|NCT03215030|567197522|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
156788802|NCT04518410|565977291|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
156788803|NCT04518410|565977292|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788804|NCT04518410|565977293|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788805|NCT04518410|565977294|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788806|NCT04518410|565977295|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788807|NCT04518410|565977296|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
156788808|NCT04518410|565977297|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
156788809|NCT04518410|565977298|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
157121721|NCT03215030|567197523|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
157121722|NCT03215030|567197524|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
157121723|NCT03215030|567197525|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
157121724|NCT03215030|567197526|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
157121725|NCT03215030|567197527|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
157121726|NCT03215030|567197528|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
157121727|NCT03215030|567197529|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
157121728|NCT03215030|567197518|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
157121729|NCT03215030|567197519|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
157121730|NCT03215030|567197520|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
157121731|NCT03215030|567197521|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
157121732|NCT03215030|567197522|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
156692768|NCT04459715|565620318|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
156692769|NCT04459715|565620317|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
156692770|NCT04459715|565620318|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
156692771|NCT04459715|565620317|FG000|Overall Study|Withdrawal by Subject|22|||
156692772|NCT04459715|565620318|FG001|Overall Study|Withdrawal by Subject|22|||
156692773|NCT02631876|565621712|FG000|Overall Study|Death|96|||
156692774|NCT02631876|565621713|FG001|Overall Study|Death|50|||
156692775|NCT02631876|565621712|FG000|Overall Study|Investigator's discretion|1|||
156692776|NCT02631876|565621713|FG001|Overall Study|Investigator's discretion|0|||
156692777|NCT02631876|565621712|FG000|Overall Study|Lost to Follow-up|2|||
156692778|NCT02631876|565621713|FG001|Overall Study|Lost to Follow-up|0|||
156692779|NCT02631876|565621712|FG000|Overall Study|Withdrawal by Subject|16|||
156788810|NCT04518410|565977299|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
156808731|NCT01396187|566054445|FG000|Overall Study|Withdrawal by Subject|0|||
156808732|NCT01396187|566054446|FG001|Overall Study|Withdrawal by Subject|1|||
156808733|NCT01396187|566054447|FG002|Overall Study|Withdrawal by Subject|1|||
156808734|NCT01396187|566054448|FG003|Overall Study|Withdrawal by Subject|0|||
156808735|NCT01396187|566054449|FG004|Overall Study|Withdrawal by Subject|0|||
156808736|NCT01396187|566054445|FG000|Overall Study|Other|1|||
156692780|NCT02631876|565621713|FG001|Overall Study|Withdrawal by Subject|9|||
156692781|NCT02631876|565621712|FG000|Overall Study|Other than specified|4|||
156692782|NCT02631876|565621713|FG001|Overall Study|Other than specified|4|||
156808737|NCT01396187|566054446|FG001|Overall Study|Other|1|||
156808738|NCT01396187|566054447|FG002|Overall Study|Other|0|||
156808739|NCT01396187|566054448|FG003|Overall Study|Other|0|||
156808740|NCT01396187|566054449|FG004|Overall Study|Other|1|||
156808741|NCT01898286|566054450|FG000|Overall Study|Withdrawal by Subject|1|||
156808742|NCT01898286|566054450|FG000|Overall Study|Protocol Violation|1|||
156808743|NCT01898286|566054450|FG000|Overall Study|Lost to Follow-up|1|||
156808744|NCT05554146|566054451|FG000|Overall Study|Adverse Event|0|||
156808745|NCT05554146|566054452|FG001|Overall Study|Adverse Event|1|||
156808746|NCT05554146|566054453|FG002|Overall Study|Adverse Event|0|||
156808747|NCT05554146|566054454|FG003|Overall Study|Adverse Event|0|||
157121733|NCT03215030|567197523|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
157121734|NCT03215030|567197524|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
157121735|NCT03215030|567197525|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
157121736|NCT03215030|567197526|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
157121737|NCT03215030|567197527|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
157121738|NCT03215030|567197528|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
157121739|NCT03215030|567197529|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
157121740|NCT03215030|567197518|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121741|NCT03215030|567197519|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121742|NCT03215030|567197520|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121743|NCT03215030|567197521|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121744|NCT03215030|567197522|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121745|NCT03215030|567197523|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121746|NCT03215030|567197524|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121747|NCT03215030|567197525|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121748|NCT03215030|567197526|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
157121749|NCT03215030|567197527|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
157121750|NCT03215030|567197528|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121751|NCT03215030|567197529|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
157121752|NCT03215030|567197518|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121753|NCT03215030|567197519|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121754|NCT03215030|567197520|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121755|NCT03215030|567197521|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121756|NCT03215030|567197522|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121757|NCT03215030|567197523|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121758|NCT03215030|567197524|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121759|NCT03215030|567197525|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121760|NCT03215030|567197526|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
157121761|NCT03215030|567197527|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
157121762|NCT03215030|567197528|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121763|NCT03215030|567197529|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
157121764|NCT03215030|567197518|FG000|Part 3: Dose Extension|Death|0|||
157121765|NCT03215030|567197519|FG001|Part 3: Dose Extension|Death|0|||
157121766|NCT03215030|567197520|FG002|Part 3: Dose Extension|Death|0|||
157121767|NCT03215030|567197521|FG003|Part 3: Dose Extension|Death|0|||
157121768|NCT03215030|567197522|FG004|Part 3: Dose Extension|Death|0|||
157121769|NCT03215030|567197523|FG005|Part 3: Dose Extension|Death|0|||
157121770|NCT03215030|567197524|FG006|Part 3: Dose Extension|Death|0|||
157121771|NCT03215030|567197525|FG007|Part 3: Dose Extension|Death|0|||
157121772|NCT03215030|567197526|FG008|Part 3: Dose Extension|Death|19|||
157121773|NCT03215030|567197527|FG009|Part 3: Dose Extension|Death|20|||
157121774|NCT03215030|567197528|FG010|Part 3: Dose Extension|Death|0|||
157121775|NCT03215030|567197529|FG011|Part 3: Dose Extension|Death|0|||
157121776|NCT03215030|567197518|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
157121777|NCT03215030|567197519|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
157121778|NCT03215030|567197520|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
157121779|NCT03215030|567197521|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
157121780|NCT03215030|567197522|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
157121781|NCT03215030|567197523|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
156870308|NCT01399372|566282487|FG000|Overall Study|Protocol Violation|3|||
156870309|NCT01399372|566282488|FG001|Overall Study|Protocol Violation|1|||
156870310|NCT01177397|566282492|FG000|Overall Study|Protocol Violation|0|||
156870311|NCT01177397|566282493|FG001|Overall Study|Protocol Violation|0|||
156870312|NCT01177397|566282494|FG002|Overall Study|Protocol Violation|0|||
156870313|NCT01177397|566282495|FG003|Overall Study|Protocol Violation|0|||
156870314|NCT01177397|566282496|FG004|Overall Study|Protocol Violation|0|||
156870315|NCT01177397|566282497|FG005|Overall Study|Protocol Violation|1|||
156870316|NCT01177397|566282498|FG006|Overall Study|Protocol Violation|0|||
156870317|NCT01177397|566282499|FG007|Overall Study|Protocol Violation|0|||
156870318|NCT01177397|566282500|FG008|Overall Study|Protocol Violation|0|||
156870319|NCT01177397|566282501|FG009|Overall Study|Protocol Violation|0|||
157121782|NCT03215030|567197524|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
157121783|NCT03215030|567197525|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
157121784|NCT03215030|567197526|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
157121785|NCT03215030|567197527|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
157121786|NCT03215030|567197528|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
157121787|NCT03215030|567197529|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
157121788|NCT03215030|567197518|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121789|NCT03215030|567197519|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121790|NCT03215030|567197520|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
156870320|NCT01177397|566282502|FG010|Overall Study|Protocol Violation|0|||
156870321|NCT01177397|566282503|FG011|Overall Study|Protocol Violation|0|||
156870322|NCT01177397|566282492|FG000|Overall Study|Lost to Follow-up|0|||
157121791|NCT03215030|567197521|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121792|NCT03215030|567197522|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121793|NCT03215030|567197523|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121794|NCT03215030|567197524|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121795|NCT03215030|567197525|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121796|NCT03215030|567197526|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121797|NCT03215030|567197527|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
157121798|NCT03215030|567197528|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
157121799|NCT03215030|567197529|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
157121800|NCT05416138|567197530|FG000|Overall Study|Withdrawal by Subject|2|||
157121801|NCT05416138|567197531|FG001|Overall Study|Withdrawal by Subject|1|||
157121802|NCT04705051|567197532|FG000|Overall Study|Enrolled but not treated|1|||
157121803|NCT04705051|567197532|FG000|Overall Study|Study terminated by sponsor|23|||
157121804|NCT03686397|567197533|FG000|Overall Study|Lack of Efficacy|3|||
157121805|NCT03686397|567197534|FG001|Overall Study|Lack of Efficacy|5|||
157121806|NCT03686397|567197533|FG000|Overall Study|Adverse Event|0|||
157121807|NCT03686397|567197534|FG001|Overall Study|Adverse Event|1|||
157121808|NCT03686397|567197533|FG000|Overall Study|Protocol Violation|0|||
157121809|NCT03686397|567197534|FG001|Overall Study|Protocol Violation|1|||
157121810|NCT03686397|567197533|FG000|Overall Study|Withdrawal by Subject|0|||
157121811|NCT03686397|567197534|FG001|Overall Study|Withdrawal by Subject|1|||
157121812|NCT03686397|567197533|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
157121813|NCT03686397|567197534|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
157121814|NCT02770326|567197542|FG000|Overall Study|Death|3|||
157121815|NCT02770326|567197542|FG000|Overall Study|Lost to Follow-up|1|||
157121816|NCT02814565|567197546|FG000|Overall Study|Lack of Efficacy|0|||
157121817|NCT02814565|567197547|FG001|Overall Study|Lack of Efficacy|1|||
157121818|NCT02814565|567197546|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
157121819|NCT02814565|567197547|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
157121820|NCT03124784|567197548|FG000|Overall Study|Adverse Event|1|||
157121821|NCT03124784|567197548|FG000|Overall Study|Computer/Equip Malfunction|1|||
157121822|NCT05702515|567197549|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
157121823|NCT05289830|567197550|FG000|Overall Study|Lost to Follow-up|1|||
157121824|NCT05289830|567197551|FG001|Overall Study|Lost to Follow-up|1|||
157121825|NCT05289830|567197550|FG000|Overall Study|Physician Decision|0|||
157121826|NCT05289830|567197551|FG001|Overall Study|Physician Decision|1|||
157121827|NCT05587296|567197552|FG000|Overall Study|Adverse Event|15|||
157121828|NCT05587296|567197553|FG001|Overall Study|Adverse Event|7|||
157121829|NCT05587296|567197552|FG000|Overall Study|Lack of Efficacy|2|||
157121830|NCT05587296|567197553|FG001|Overall Study|Lack of Efficacy|0|||
157121831|NCT05587296|567197552|FG000|Overall Study|Lost to Follow-up|1|||
157121832|NCT05587296|567197553|FG001|Overall Study|Lost to Follow-up|0|||
157121833|NCT05587296|567197552|FG000|Overall Study|Withdrawal by Subject|14|||
157121834|NCT05587296|567197553|FG001|Overall Study|Withdrawal by Subject|4|||
157121835|NCT05587296|567197552|FG000|Overall Study|miscellaneous|3|||
157121836|NCT05587296|567197553|FG001|Overall Study|miscellaneous|6|||
157121837|NCT05587296|567197552|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
157121838|NCT05587296|567197553|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
157121839|NCT04735653|567197556|FG000|Overall Study|Lost to Follow-up|17|||
157121840|NCT04735653|567197557|FG001|Overall Study|Lost to Follow-up|7|||
157121841|NCT04735653|567197556|FG000|Overall Study|Withdrawal by Subject|8|||
157121842|NCT04735653|567197557|FG001|Overall Study|Withdrawal by Subject|2|||
157121843|NCT04735653|567197556|FG000|Overall Study|Death|0|||
157121844|NCT04735653|567197557|FG001|Overall Study|Death|2|||
157121845|NCT04735653|567197556|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
157121846|NCT04735653|567197557|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
157121847|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
157214507|NCT01113710|567531909|FG000|Overall Study|Adverse Event|64|||
157214508|NCT01113710|567531909|FG000|Overall Study|Lack of Efficacy|41|||
156788811|NCT04518410|565977300|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
156788812|NCT04518410|565977301|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
156788813|NCT04518410|565977302|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
157121848|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
157121849|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
157121850|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
157121851|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
157121852|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
157214509|NCT01113710|567531909|FG000|Overall Study|No Information Available|40|||
157214510|NCT01113710|567531909|FG000|Overall Study|Withdrawal by Subject|28|||
157214511|NCT01113710|567531909|FG000|Overall Study|Lost to Follow-up|20|||
156788814|NCT04518410|565977303|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
157121853|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
157121854|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
157121855|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
157121856|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
157121857|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
157121858|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
157121859|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
157121860|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
157121861|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
157121862|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
157121863|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
157121864|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
157121865|NCT04418765|567197569|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
157121866|NCT04418765|567197570|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
157121867|NCT04418765|567197571|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
157121868|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
157121869|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
157121870|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
157121871|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
157121872|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
157121873|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
157121874|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
157121875|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
157121876|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
157121877|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
157121878|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
157121879|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
157121880|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
157121881|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
157121882|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
157121883|NCT04418765|567197569|FG000|Extension Period (48 Weeks)|Other than specified|0|||
157121884|NCT04418765|567197570|FG001|Extension Period (48 Weeks)|Other than specified|5|||
157121885|NCT04418765|567197571|FG002|Extension Period (48 Weeks)|Other than specified|2|||
157121886|NCT01121393|567197572|FG000|Overall Study|Progressive disease|201|||
157121887|NCT01121393|567197573|FG001|Overall Study|Progressive disease|20|||
157121888|NCT01121393|567197572|FG000|Overall Study|Other Adverse events|24|||
157121889|NCT01121393|567197573|FG001|Overall Study|Other Adverse events|45|||
157121890|NCT01121393|567197572|FG000|Overall Study|Non-compliant with protocol|0|||
157121891|NCT01121393|567197573|FG001|Overall Study|Non-compliant with protocol|3|||
157121892|NCT01121393|567197572|FG000|Overall Study|Lost to Follow-up|1|||
157121893|NCT01121393|567197573|FG001|Overall Study|Lost to Follow-up|0|||
157121894|NCT01121393|567197572|FG000|Overall Study|Refused cont. medication|7|||
157121895|NCT01121393|567197573|FG001|Overall Study|Refused cont. medication|7|||
157121896|NCT01121393|567197572|FG000|Overall Study|Not treated|3|||
157121897|NCT01121393|567197573|FG001|Overall Study|Not treated|9|||
157121898|NCT01121393|567197572|FG000|Overall Study|Other than listed|6|||
157121899|NCT01121393|567197573|FG001|Overall Study|Other than listed|0|||
157121900|NCT00577993|567197575|FG000|Overall Study|Adverse Event|1|||
157121901|NCT00577993|567197576|FG001|Overall Study|Adverse Event|0|||
157121902|NCT00577993|567197577|FG002|Overall Study|Adverse Event|0|||
157121903|NCT00577993|567197575|FG000|Overall Study|Death|0|||
157121904|NCT00577993|567197576|FG001|Overall Study|Death|1|||
157121905|NCT00577993|567197577|FG002|Overall Study|Death|1|||
157121906|NCT00577993|567197575|FG000|Overall Study|Lack of Efficacy|0|||
157121907|NCT00577993|567197576|FG001|Overall Study|Lack of Efficacy|1|||
157121908|NCT00577993|567197577|FG002|Overall Study|Lack of Efficacy|0|||
157121909|NCT00577993|567197575|FG000|Overall Study|Protocol Violation|2|||
157121910|NCT00577993|567197576|FG001|Overall Study|Protocol Violation|3|||
157121911|NCT00577993|567197577|FG002|Overall Study|Protocol Violation|0|||
156788815|NCT04518410|565977304|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
157121912|NCT00577993|567197575|FG000|Overall Study|Withdrawal by Subject|1|||
157121913|NCT00577993|567197576|FG001|Overall Study|Withdrawal by Subject|0|||
157121914|NCT00577993|567197577|FG002|Overall Study|Withdrawal by Subject|2|||
157121915|NCT00577993|567197575|FG000|Overall Study|Conversion|2|||
157121916|NCT00577993|567197576|FG001|Overall Study|Conversion|5|||
157121917|NCT00577993|567197577|FG002|Overall Study|Conversion|0|||
157121918|NCT00577993|567197575|FG000|Overall Study|Uninsured|1|||
157121919|NCT00577993|567197576|FG001|Overall Study|Uninsured|0|||
157121920|NCT00577993|567197577|FG002|Overall Study|Uninsured|0|||
157121921|NCT00608985|567197584|FG000|Overall Study|Adverse Event|2|||
157121922|NCT00608985|567197585|FG001|Overall Study|Adverse Event|7|||
157121923|NCT00608985|567197586|FG002|Overall Study|Adverse Event|4|||
157121924|NCT00608985|567197587|FG003|Overall Study|Adverse Event|6|||
157121925|NCT00608985|567197584|FG000|Overall Study|Administrative/Other|7|||
157214512|NCT01113710|567531909|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
157214513|NCT01113710|567531909|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
157214514|NCT01113710|567531909|FG000|Overall Study|Lack of Patient's Compliance|8|||
157214515|NCT01113710|567531909|FG000|Overall Study|Other|7|||
157214516|NCT01113710|567531909|FG000|Overall Study|Adverse Event/Other|5|||
157214517|NCT01113710|567531909|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
157214518|NCT01113710|567531909|FG000|Overall Study|Lack of Efficacy/Other|4|||
157214519|NCT01113710|567531909|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
157121926|NCT00608985|567197585|FG001|Overall Study|Administrative/Other|4|||
157121927|NCT00608985|567197586|FG002|Overall Study|Administrative/Other|1|||
157121928|NCT00608985|567197587|FG003|Overall Study|Administrative/Other|2|||
157121929|NCT00608985|567197584|FG000|Overall Study|Withdrawal of Consent|5|||
157121930|NCT00608985|567197585|FG001|Overall Study|Withdrawal of Consent|1|||
157121931|NCT00608985|567197586|FG002|Overall Study|Withdrawal of Consent|1|||
157121932|NCT00608985|567197587|FG003|Overall Study|Withdrawal of Consent|1|||
157121933|NCT00608985|567197584|FG000|Overall Study|Lost to Follow-up|2|||
157121934|NCT00608985|567197585|FG001|Overall Study|Lost to Follow-up|1|||
157121935|NCT00608985|567197586|FG002|Overall Study|Lost to Follow-up|0|||
157121936|NCT00608985|567197587|FG003|Overall Study|Lost to Follow-up|0|||
157121937|NCT03033745|567197588|FG000|Overall Study|Protocol Violation|0|||
157121938|NCT03033745|567197589|FG001|Overall Study|Protocol Violation|0|||
157214520|NCT01113710|567531909|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
157214521|NCT01113710|567531909|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
157121939|NCT03033745|567197590|FG002|Overall Study|Protocol Violation|1|||
157121940|NCT03033745|567197588|FG000|Overall Study|Adverse Event|1|||
157121941|NCT03033745|567197589|FG001|Overall Study|Adverse Event|0|||
157121942|NCT03033745|567197590|FG002|Overall Study|Adverse Event|1|||
157121943|NCT03033745|567197588|FG000|Overall Study|Withdrawal by Subject|0|||
157121944|NCT03033745|567197589|FG001|Overall Study|Withdrawal by Subject|1|||
157214522|NCT01113710|567531909|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
157214523|NCT01113710|567531909|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
157214524|NCT01113710|567531909|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
157121945|NCT03033745|567197590|FG002|Overall Study|Withdrawal by Subject|0|||
157214525|NCT01113710|567531909|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
157214526|NCT01113710|567531909|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
157214527|NCT01113710|567531909|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
157214528|NCT01113710|567531909|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
157121946|NCT01276236|567197591|FG000|Overall Study|Lack of Efficacy|2|||
157121947|NCT01276236|567197591|FG000|Overall Study|Withdrawal by Subject|4|||
157121948|NCT02703311|567197592|FG000|Overall Study|Death|5|||
157121949|NCT02703311|567197592|FG000|Overall Study|Withdrawal by Subject|3|||
157121950|NCT03440814|567197595|FG000|Overall Study|Adverse Event|2|||
157121951|NCT03440814|567197596|FG001|Overall Study|Adverse Event|1|||
157121952|NCT03440814|567197595|FG000|Overall Study|Lost to Follow-up|2|||
157121953|NCT03440814|567197596|FG001|Overall Study|Lost to Follow-up|0|||
157121954|NCT03440814|567197595|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
157214529|NCT01113710|567531909|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
157214530|NCT01113710|567531909|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
157214531|NCT01113710|567531909|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
157214532|NCT01042977|567531911|FG000|Overall Study|Adverse Event|4|||
157214533|NCT01042977|567531912|FG001|Overall Study|Adverse Event|12|||
157214534|NCT01042977|567531911|FG000|Overall Study|Death|2|||
157214535|NCT01042977|567531912|FG001|Overall Study|Death|1|||
157214536|NCT01042977|567531911|FG000|Overall Study|Withdrawal by Subject|8|||
157214537|NCT01042977|567531912|FG001|Overall Study|Withdrawal by Subject|16|||
157214538|NCT01042977|567531911|FG000|Overall Study|Lost to Follow-up|0|||
157214539|NCT01042977|567531912|FG001|Overall Study|Lost to Follow-up|2|||
157214540|NCT01042977|567531911|FG000|Overall Study|Poor/non-compliance|3|||
157214541|NCT01042977|567531912|FG001|Overall Study|Poor/non-compliance|4|||
157214542|NCT01042977|567531911|FG000|Overall Study|Subject no longer meets study criteria|15|||
157214543|NCT01042977|567531912|FG001|Overall Study|Subject no longer meets study criteria|13|||
157214544|NCT01042977|567531911|FG000|Overall Study|Incorrect enrollment|6|||
157214545|NCT01042977|567531912|FG001|Overall Study|Incorrect enrollment|4|||
157214546|NCT01042977|567531911|FG000|Overall Study|Safety|0|||
157214547|NCT01042977|567531912|FG001|Overall Study|Safety|2|||
157214548|NCT01042977|567531911|FG000|Overall Study|Administrative reason by sponsor|0|||
156692783|NCT01013649|565621716|FG000|First Step|Withdrawal by Subject|36|||
156692784|NCT01013649|565621717|FG001|First Step|Withdrawal by Subject|19|||
157121955|NCT03440814|567197596|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
156692785|NCT01013649|565621718|FG002|First Step|Withdrawal by Subject|0|||
156692786|NCT01013649|565621719|FG003|First Step|Withdrawal by Subject|0|||
156692787|NCT01013649|565621716|FG000|First Step|Progression|58|||
156692788|NCT01013649|565621717|FG001|First Step|Progression|23|||
156692789|NCT01013649|565621718|FG002|First Step|Progression|0|||
156692790|NCT01013649|565621719|FG003|First Step|Progression|0|||
156692791|NCT01013649|565621716|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
156692792|NCT01013649|565621717|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
156692793|NCT01013649|565621718|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
156692794|NCT01013649|565621719|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
156692795|NCT01013649|565621716|FG000|First Step|Death|3|||
156788816|NCT04518410|565977305|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
156788817|NCT04518410|565977306|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
156788818|NCT04518410|565977282|FG000|Overall Study|Dual Enrolled Subject|0|||
156788819|NCT04518410|565977283|FG001|Overall Study|Dual Enrolled Subject|0|||
157121956|NCT00088374|567197597|FG000|Overall Study|patient did not receive any 17AAG|1|||
157121957|NCT00088374|567197597|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
157121958|NCT03205995|567197607|FG000|Overall Study|Adverse Event|1|||
157121959|NCT03205995|567197607|FG000|Overall Study|Death|1|||
157121960|NCT03205995|567197607|FG000|Overall Study|Physician Decision|2|||
157121961|NCT03205995|567197607|FG000|Overall Study|Protocol Violation|2|||
157121962|NCT05913232|567197609|FG000|Overall Study|Adverse Event|0|||
157121963|NCT05913232|567197610|FG001|Overall Study|Adverse Event|2|||
157121964|NCT05913232|567197611|FG002|Overall Study|Adverse Event|1|||
157121965|NCT05913232|567197612|FG003|Overall Study|Adverse Event|1|||
157121966|NCT04428476|567197618|FG000|Overall Study|Withdrawal by Subject|1|||
157121967|NCT04428476|567197618|FG000|Overall Study|Still on treatment|12|||
157121968|NCT01358864|567197630|FG000|Overall Study|Adverse Event|0|||
157121969|NCT01358864|567197631|FG001|Overall Study|Adverse Event|6|||
157121970|NCT01358864|567197632|FG002|Overall Study|Adverse Event|9|||
157121971|NCT01358864|567197633|FG003|Overall Study|Adverse Event|0|||
157121972|NCT01358864|567197634|FG004|Overall Study|Adverse Event|4|||
157121973|NCT01358864|567197635|FG005|Overall Study|Adverse Event|8|||
157121974|NCT01358864|567197636|FG006|Overall Study|Adverse Event|12|||
156788820|NCT04518410|565977284|FG002|Overall Study|Dual Enrolled Subject|0|||
156788821|NCT04518410|565977285|FG003|Overall Study|Dual Enrolled Subject|0|||
156788822|NCT04518410|565977286|FG004|Overall Study|Dual Enrolled Subject|0|||
156788823|NCT04518410|565977287|FG005|Overall Study|Dual Enrolled Subject|0|||
156788824|NCT04518410|565977288|FG006|Overall Study|Dual Enrolled Subject|0|||
156788825|NCT04518410|565977289|FG007|Overall Study|Dual Enrolled Subject|0|||
156788826|NCT04518410|565977290|FG008|Overall Study|Dual Enrolled Subject|0|||
156788827|NCT04518410|565977291|FG009|Overall Study|Dual Enrolled Subject|0|||
156788828|NCT04518410|565977292|FG010|Overall Study|Dual Enrolled Subject|0|||
156788829|NCT04518410|565977293|FG011|Overall Study|Dual Enrolled Subject|0|||
156788830|NCT04518410|565977294|FG012|Overall Study|Dual Enrolled Subject|0|||
156788831|NCT04518410|565977295|FG013|Overall Study|Dual Enrolled Subject|0|||
156788832|NCT04518410|565977296|FG014|Overall Study|Dual Enrolled Subject|0|||
156788833|NCT04518410|565977297|FG015|Overall Study|Dual Enrolled Subject|0|||
156788834|NCT04518410|565977298|FG016|Overall Study|Dual Enrolled Subject|0|||
156788835|NCT04518410|565977299|FG017|Overall Study|Dual Enrolled Subject|1|||
156788836|NCT04518410|565977300|FG018|Overall Study|Dual Enrolled Subject|0|||
156788837|NCT04518410|565977301|FG019|Overall Study|Dual Enrolled Subject|0|||
156788838|NCT04518410|565977302|FG020|Overall Study|Dual Enrolled Subject|0|||
156788839|NCT04518410|565977303|FG021|Overall Study|Dual Enrolled Subject|0|||
156788840|NCT04518410|565977304|FG022|Overall Study|Dual Enrolled Subject|0|||
156788841|NCT04518410|565977305|FG023|Overall Study|Dual Enrolled Subject|0|||
156788842|NCT04518410|565977306|FG024|Overall Study|Dual Enrolled Subject|0|||
156788843|NCT01341990|565977307|FG000|Overall Study|Adverse Event|0|||
156788844|NCT01341990|565977308|FG001|Overall Study|Adverse Event|1|||
156788845|NCT01341990|565977307|FG000|Overall Study|Torn Study Lens|1|||
156788846|NCT01341990|565977308|FG001|Overall Study|Torn Study Lens|0|||
157121975|NCT01358864|567197637|FG007|Overall Study|Adverse Event|7|||
157121976|NCT01358864|567197630|FG000|Overall Study|Lack of Efficacy|26|||
157121977|NCT01358864|567197631|FG001|Overall Study|Lack of Efficacy|3|||
157121978|NCT01358864|567197632|FG002|Overall Study|Lack of Efficacy|4|||
157121979|NCT01358864|567197633|FG003|Overall Study|Lack of Efficacy|19|||
157121980|NCT01358864|567197634|FG004|Overall Study|Lack of Efficacy|7|||
157121981|NCT01358864|567197635|FG005|Overall Study|Lack of Efficacy|4|||
157121982|NCT01358864|567197636|FG006|Overall Study|Lack of Efficacy|49|||
157121983|NCT01358864|567197637|FG007|Overall Study|Lack of Efficacy|44|||
156692796|NCT01013649|565621717|FG001|First Step|Death|4|||
156692797|NCT01013649|565621718|FG002|First Step|Death|0|||
156692798|NCT01013649|565621719|FG003|First Step|Death|0|||
156788847|NCT01341990|565977307|FG000|Overall Study|Withdrawal by Subject|2|||
156788848|NCT01341990|565977308|FG001|Overall Study|Withdrawal by Subject|0|||
157121984|NCT01358864|567197630|FG000|Overall Study|Lost to Follow-up|0|||
157121985|NCT01358864|567197631|FG001|Overall Study|Lost to Follow-up|0|||
157214549|NCT01042977|567531912|FG001|Overall Study|Administrative reason by sponsor|1|||
156788849|NCT00290238|565977309|FG000|Overall Study|Study terminated|27|||
157121986|NCT01358864|567197632|FG002|Overall Study|Lost to Follow-up|1|||
157121987|NCT01358864|567197633|FG003|Overall Study|Lost to Follow-up|0|||
157121988|NCT01358864|567197634|FG004|Overall Study|Lost to Follow-up|0|||
157121989|NCT01358864|567197635|FG005|Overall Study|Lost to Follow-up|0|||
157121990|NCT01358864|567197636|FG006|Overall Study|Lost to Follow-up|0|||
157121991|NCT01358864|567197637|FG007|Overall Study|Lost to Follow-up|1|||
157121992|NCT01358864|567197630|FG000|Overall Study|Withdrawal by Subject|3|||
157121993|NCT01358864|567197631|FG001|Overall Study|Withdrawal by Subject|4|||
157121994|NCT01358864|567197632|FG002|Overall Study|Withdrawal by Subject|2|||
157121995|NCT01358864|567197633|FG003|Overall Study|Withdrawal by Subject|0|||
157121996|NCT01358864|567197634|FG004|Overall Study|Withdrawal by Subject|0|||
157121997|NCT01358864|567197635|FG005|Overall Study|Withdrawal by Subject|1|||
157121998|NCT01358864|567197636|FG006|Overall Study|Withdrawal by Subject|1|||
157121999|NCT01358864|567197637|FG007|Overall Study|Withdrawal by Subject|3|||
157122000|NCT01358864|567197630|FG000|Overall Study|Other reason not defined above|2|||
157122001|NCT01358864|567197631|FG001|Overall Study|Other reason not defined above|0|||
157122002|NCT01358864|567197632|FG002|Overall Study|Other reason not defined above|0|||
157122003|NCT01358864|567197633|FG003|Overall Study|Other reason not defined above|0|||
157122004|NCT01358864|567197634|FG004|Overall Study|Other reason not defined above|0|||
157122005|NCT01358864|567197635|FG005|Overall Study|Other reason not defined above|0|||
157122006|NCT01358864|567197636|FG006|Overall Study|Other reason not defined above|2|||
157122007|NCT01358864|567197637|FG007|Overall Study|Other reason not defined above|0|||
157122008|NCT01358864|567197630|FG000|Overall Study|Not treated|0|||
157122009|NCT01358864|567197631|FG001|Overall Study|Not treated|0|||
157122010|NCT01358864|567197632|FG002|Overall Study|Not treated|0|||
157122011|NCT01358864|567197633|FG003|Overall Study|Not treated|0|||
157122012|NCT01358864|567197634|FG004|Overall Study|Not treated|0|||
157122013|NCT01358864|567197635|FG005|Overall Study|Not treated|0|||
157122014|NCT01358864|567197636|FG006|Overall Study|Not treated|1|||
157122015|NCT01358864|567197637|FG007|Overall Study|Not treated|0|||
157122016|NCT04042103|567197642|FG000|Overall Study|Lost to Follow-up|1|||
157122017|NCT04042103|567197642|FG000|Overall Study|Withdrawal by Subject|1|||
157122018|NCT00271817|567197643|FG000|Part 1|Adverse Event|68|||
157122019|NCT00271817|567197644|FG001|Part 1|Adverse Event|25|||
157122020|NCT00271817|567197645|FG002|Part 1|Adverse Event|156|||
157122021|NCT00271817|567197643|FG000|Part 1|Lost to Follow-up|6|||
157122022|NCT00271817|567197644|FG001|Part 1|Lost to Follow-up|8|||
157122023|NCT00271817|567197645|FG002|Part 1|Lost to Follow-up|24|||
157122024|NCT00271817|567197643|FG000|Part 1|Protocol Violation|5|||
157122025|NCT00271817|567197644|FG001|Part 1|Protocol Violation|4|||
157122026|NCT00271817|567197645|FG002|Part 1|Protocol Violation|7|||
157122027|NCT00271817|567197643|FG000|Part 1|Patient Moved|3|||
157122028|NCT00271817|567197644|FG001|Part 1|Patient Moved|1|||
157122029|NCT00271817|567197645|FG002|Part 1|Patient Moved|5|||
157122030|NCT00271817|567197643|FG000|Part 1|Withdrawal by Subject|23|||
157122031|NCT00271817|567197644|FG001|Part 1|Withdrawal by Subject|17|||
157122032|NCT00271817|567197645|FG002|Part 1|Withdrawal by Subject|45|||
157122033|NCT00271817|567197643|FG000|Part 1|LDL < 50 mg/dL|1|||
157122034|NCT00271817|567197644|FG001|Part 1|LDL < 50 mg/dL|4|||
157122035|NCT00271817|567197645|FG002|Part 1|LDL < 50 mg/dL|48|||
157122036|NCT00271817|567197643|FG000|Part 2|Adverse Event|0|||
157122037|NCT00271817|567197644|FG001|Part 2|Adverse Event|17|||
157122038|NCT00271817|567197645|FG002|Part 2|Adverse Event|33|||
157122039|NCT00271817|567197643|FG000|Part 2|Lack of Efficacy|0|||
157122040|NCT00271817|567197644|FG001|Part 2|Lack of Efficacy|1|||
157122041|NCT00271817|567197645|FG002|Part 2|Lack of Efficacy|6|||
157122042|NCT00271817|567197643|FG000|Part 2|Lost to Follow-up|0|||
157122043|NCT00271817|567197644|FG001|Part 2|Lost to Follow-up|6|||
157122044|NCT00271817|567197645|FG002|Part 2|Lost to Follow-up|18|||
157122045|NCT00271817|567197643|FG000|Part 2|Protocol Violation|0|||
157122046|NCT00271817|567197644|FG001|Part 2|Protocol Violation|3|||
157122047|NCT00271817|567197645|FG002|Part 2|Protocol Violation|5|||
157122048|NCT00271817|567197643|FG000|Part 2|Patient Moved|0|||
157122049|NCT00271817|567197644|FG001|Part 2|Patient Moved|0|||
157122050|NCT00271817|567197645|FG002|Part 2|Patient Moved|5|||
157122051|NCT00271817|567197643|FG000|Part 2|Withdrawal by Subject|0|||
157122052|NCT00271817|567197644|FG001|Part 2|Withdrawal by Subject|2|||
157122053|NCT00271817|567197645|FG002|Part 2|Withdrawal by Subject|13|||
157122054|NCT00271817|567197643|FG000|Part 2|LDL < 50 mg/dL|0|||
157122055|NCT00271817|567197644|FG001|Part 2|LDL < 50 mg/dL|3|||
157122056|NCT00271817|567197645|FG002|Part 2|LDL < 50 mg/dL|4|||
157122057|NCT01471782|567197647|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
157122058|NCT01471782|567197648|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
157122059|NCT01471782|567197649|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
157122060|NCT01471782|567197650|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
156692799|NCT01013649|565621716|FG000|First Step|Adverse Event|9|||
157122061|NCT01471782|567197651|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
157214550|NCT01042977|567531911|FG000|Overall Study|Various|3|||
156692800|NCT01013649|565621717|FG001|First Step|Adverse Event|5|||
157122062|NCT01471782|567197652|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
157122063|NCT01471782|567197647|FG000|Overall Study|Lack of Efficacy|1|||
157122064|NCT01471782|567197648|FG001|Overall Study|Lack of Efficacy|2|||
157122065|NCT01471782|567197649|FG002|Overall Study|Lack of Efficacy|1|||
157122066|NCT01471782|567197650|FG003|Overall Study|Lack of Efficacy|1|||
156692801|NCT01013649|565621718|FG002|First Step|Adverse Event|0|||
156692802|NCT01013649|565621719|FG003|First Step|Adverse Event|0|||
156692803|NCT01013649|565621716|FG000|First Step|Other|4|||
156692804|NCT01013649|565621717|FG001|First Step|Other|6|||
156692805|NCT01013649|565621718|FG002|First Step|Other|0|||
156692806|NCT01013649|565621719|FG003|First Step|Other|0|||
156692807|NCT04285567|565621720|FG000|Overall Study|Death|3|||
156692808|NCT04285567|565621721|FG001|Overall Study|Death|3|||
156692809|NCT04285567|565621720|FG000|Overall Study|Lost to Follow-up|1|||
156692810|NCT04285567|565621721|FG001|Overall Study|Lost to Follow-up|1|||
156692811|NCT04285567|565621720|FG000|Overall Study|Reason Not Specified|1|||
156692812|NCT04285567|565621721|FG001|Overall Study|Reason Not Specified|1|||
156788850|NCT00290238|565977310|FG001|Overall Study|Study terminated|27|||
156788851|NCT00290238|565977309|FG000|Overall Study|Lost to Follow-up|0|||
156788852|NCT00290238|565977310|FG001|Overall Study|Lost to Follow-up|1|||
156788853|NCT00290238|565977309|FG000|Overall Study|Withdrawal by Subject|15|||
156788854|NCT00290238|565977310|FG001|Overall Study|Withdrawal by Subject|13|||
156788855|NCT03834883|565977311|FG000|Second Treatment|Withdrawal by Subject|1|||
157013821|NCT02590432|566801867|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
157013822|NCT02590432|566801868|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
157013823|NCT02590432|566801869|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
157013824|NCT02590432|566801870|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
157013825|NCT02590432|566801871|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
157013826|NCT02590432|566801872|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
157013827|NCT02590432|566801864|FG000|Open-label Treatment Period|Protocol Violation|10|||
157013828|NCT02590432|566801865|FG001|Open-label Treatment Period|Protocol Violation|4|||
157013829|NCT02590432|566801866|FG002|Open-label Treatment Period|Protocol Violation|0|||
157013830|NCT02590432|566801867|FG003|Open-label Treatment Period|Protocol Violation|0|||
157013831|NCT02590432|566801868|FG004|Open-label Treatment Period|Protocol Violation|0|||
157013832|NCT02590432|566801869|FG005|Open-label Treatment Period|Protocol Violation|0|||
157013833|NCT02590432|566801870|FG006|Open-label Treatment Period|Protocol Violation|0|||
157013834|NCT02590432|566801871|FG007|Open-label Treatment Period|Protocol Violation|0|||
157013835|NCT02590432|566801872|FG008|Open-label Treatment Period|Protocol Violation|0|||
157013836|NCT02590432|566801864|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
157013837|NCT02590432|566801865|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
157013838|NCT02590432|566801866|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013839|NCT02590432|566801867|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013840|NCT02590432|566801868|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013841|NCT02590432|566801869|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013842|NCT02590432|566801870|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013843|NCT02590432|566801871|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013844|NCT02590432|566801872|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
157013845|NCT02590432|566801864|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
157013846|NCT02590432|566801865|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
157013847|NCT02590432|566801866|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013848|NCT02590432|566801867|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013849|NCT02590432|566801868|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013850|NCT02590432|566801869|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013851|NCT02590432|566801870|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013852|NCT02590432|566801871|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013853|NCT02590432|566801872|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
157013854|NCT02590432|566801864|FG000|Double-blind Treatment Period|Adverse Event|0|||
157013855|NCT02590432|566801865|FG001|Double-blind Treatment Period|Adverse Event|0|||
157013856|NCT02590432|566801866|FG002|Double-blind Treatment Period|Adverse Event|14|||
157013857|NCT02590432|566801867|FG003|Double-blind Treatment Period|Adverse Event|12|||
157013858|NCT02590432|566801868|FG004|Double-blind Treatment Period|Adverse Event|6|||
157013859|NCT02590432|566801869|FG005|Double-blind Treatment Period|Adverse Event|22|||
157013860|NCT02590432|566801870|FG006|Double-blind Treatment Period|Adverse Event|20|||
157013861|NCT02590432|566801871|FG007|Double-blind Treatment Period|Adverse Event|0|||
156692813|NCT04285567|565621720|FG000|Overall Study|Physician Decision|2|||
156788856|NCT03834883|565977312|FG001|Second Treatment|Withdrawal by Subject|0|||
156788857|NCT03834883|565977313|FG002|Second Treatment|Withdrawal by Subject|0|||
157013862|NCT02590432|566801872|FG008|Double-blind Treatment Period|Adverse Event|0|||
157013863|NCT02590432|566801864|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
157013864|NCT02590432|566801865|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
157013865|NCT02590432|566801866|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
157013866|NCT02590432|566801867|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
156692814|NCT04285567|565621721|FG001|Overall Study|Physician Decision|1|||
156692815|NCT04285567|565621720|FG000|Overall Study|Withdrawal by Subject|2|||
156692816|NCT04285567|565621721|FG001|Overall Study|Withdrawal by Subject|6|||
156788858|NCT03834883|565977314|FG003|Second Treatment|Withdrawal by Subject|0|||
157013867|NCT02590432|566801868|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
157214551|NCT01042977|567531912|FG001|Overall Study|Various|0|||
157214552|NCT02499354|567531913|FG000|Overall Study|Withdrawal by Subject|1|||
156692817|NCT04285567|565621720|FG000|Overall Study|Adverse Event|1|||
156692818|NCT04285567|565621721|FG001|Overall Study|Adverse Event|0|||
156692819|NCT04285567|565621720|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
156692820|NCT04285567|565621721|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
156692821|NCT01408563|565621722|FG000|Overall Study|Ineligible after consent/ registration|2|||
156692822|NCT02246439|565621726|FG000|Overall Study|Adverse Event|3|||
156692823|NCT02246439|565621727|FG001|Overall Study|Adverse Event|0|||
156692824|NCT02246439|565621726|FG000|Overall Study|Lost to Follow-up|7|||
156692825|NCT02246439|565621727|FG001|Overall Study|Lost to Follow-up|5|||
156692826|NCT02246439|565621726|FG000|Overall Study|Protocol Violation|0|||
156692827|NCT02246439|565621727|FG001|Overall Study|Protocol Violation|2|||
156692828|NCT02246439|565621726|FG000|Overall Study|Physician Decision|0|||
156692829|NCT02246439|565621727|FG001|Overall Study|Physician Decision|1|||
156692830|NCT02246439|565621726|FG000|Overall Study|Unkonwn|1|||
157013868|NCT02590432|566801869|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
157013869|NCT02590432|566801870|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
157013870|NCT02590432|566801871|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
157013871|NCT02590432|566801872|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
157013872|NCT02590432|566801864|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
157013873|NCT02590432|566801865|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
157013874|NCT02590432|566801866|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
157013875|NCT02590432|566801867|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
157013876|NCT02590432|566801868|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
157013877|NCT02590432|566801869|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
157013878|NCT02590432|566801870|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
157013879|NCT02590432|566801871|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
157013880|NCT02590432|566801872|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
157013881|NCT02590432|566801864|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
157013882|NCT02590432|566801865|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
157013883|NCT02590432|566801866|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
157013884|NCT02590432|566801867|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
157013885|NCT02590432|566801868|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
157013886|NCT02590432|566801869|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
157013887|NCT02590432|566801870|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
157013888|NCT02590432|566801871|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
157013889|NCT02590432|566801872|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
157013890|NCT02590432|566801864|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013891|NCT02590432|566801865|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013892|NCT02590432|566801866|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013893|NCT02590432|566801867|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013894|NCT02590432|566801868|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013895|NCT02590432|566801869|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
157013896|NCT02590432|566801870|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013897|NCT02590432|566801871|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013898|NCT02590432|566801872|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
157013899|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013900|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013901|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013902|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013903|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013904|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013905|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
157013906|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
157013907|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
157013908|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013909|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013910|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013911|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013912|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013913|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013914|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013915|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
157021667|NCT05008835|566830979|FG000|Overall Study|Adverse Event|5|||
157214553|NCT02499354|567531914|FG001|Overall Study|Withdrawal by Subject|0|||
156692831|NCT02246439|565621727|FG001|Overall Study|Unkonwn|3|||
156788859|NCT03834883|565977311|FG000|Second Treatment|COVID-19 pandemic|1|||
156692832|NCT02246439|565621726|FG000|Overall Study|Withdrawal by Subject|1|||
156870323|NCT01177397|566282493|FG001|Overall Study|Lost to Follow-up|0|||
156870324|NCT01177397|566282494|FG002|Overall Study|Lost to Follow-up|0|||
156870325|NCT01177397|566282495|FG003|Overall Study|Lost to Follow-up|0|||
156870326|NCT01177397|566282496|FG004|Overall Study|Lost to Follow-up|1|||
156870327|NCT01177397|566282497|FG005|Overall Study|Lost to Follow-up|0|||
157122067|NCT01471782|567197651|FG004|Overall Study|Lack of Efficacy|5|||
157122068|NCT01471782|567197652|FG005|Overall Study|Lack of Efficacy|18|||
157122069|NCT01471782|567197647|FG000|Overall Study|Adverse Event|1|||
157122070|NCT01471782|567197648|FG001|Overall Study|Adverse Event|1|||
157122071|NCT01471782|567197649|FG002|Overall Study|Adverse Event|2|||
157122072|NCT01471782|567197650|FG003|Overall Study|Adverse Event|2|||
157122073|NCT01471782|567197651|FG004|Overall Study|Adverse Event|3|||
157122074|NCT01471782|567197652|FG005|Overall Study|Adverse Event|1|||
157122075|NCT01471782|567197647|FG000|Overall Study|Other|0|||
157122076|NCT01471782|567197648|FG001|Overall Study|Other|0|||
157122077|NCT01471782|567197649|FG002|Overall Study|Other|1|||
157122078|NCT01471782|567197650|FG003|Overall Study|Other|1|||
157122079|NCT01471782|567197651|FG004|Overall Study|Other|6|||
157122080|NCT01471782|567197652|FG005|Overall Study|Other|5|||
157122081|NCT01471782|567197647|FG000|Overall Study|Change of Chemotherapy|1|||
157122082|NCT01471782|567197648|FG001|Overall Study|Change of Chemotherapy|1|||
157122083|NCT01471782|567197649|FG002|Overall Study|Change of Chemotherapy|0|||
157122084|NCT01471782|567197650|FG003|Overall Study|Change of Chemotherapy|0|||
157122085|NCT01471782|567197651|FG004|Overall Study|Change of Chemotherapy|1|||
157122086|NCT01471782|567197652|FG005|Overall Study|Change of Chemotherapy|4|||
157122087|NCT01471782|567197647|FG000|Overall Study|Disease Relapse|0|||
157122088|NCT01471782|567197648|FG001|Overall Study|Disease Relapse|0|||
157122089|NCT01471782|567197649|FG002|Overall Study|Disease Relapse|0|||
157122090|NCT01471782|567197650|FG003|Overall Study|Disease Relapse|1|||
156870328|NCT01177397|566282498|FG006|Overall Study|Lost to Follow-up|0|||
156870329|NCT01177397|566282499|FG007|Overall Study|Lost to Follow-up|2|||
157122091|NCT01471782|567197651|FG004|Overall Study|Disease Relapse|2|||
157122092|NCT01471782|567197652|FG005|Overall Study|Disease Relapse|1|||
157122093|NCT01471782|567197647|FG000|Overall Study|Physician Decision|0|||
157122094|NCT01471782|567197648|FG001|Overall Study|Physician Decision|0|||
157122095|NCT01471782|567197649|FG002|Overall Study|Physician Decision|0|||
156692833|NCT02246439|565621727|FG001|Overall Study|Withdrawal by Subject|0|||
156692834|NCT03439852|565621728|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
156692835|NCT03439852|565621729|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
156692836|NCT03439852|565621728|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
156692837|NCT03439852|565621729|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
156692838|NCT03439852|565621728|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
156692839|NCT03439852|565621729|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
156692840|NCT04271735|565621734|FG000|Overall Study|Physician Decision|2|||
156692841|NCT04271735|565621735|FG001|Overall Study|Physician Decision|0|||
156692842|NCT00922272|565621736|FG000|Open-label Phase|Adverse Event|5|||
156692843|NCT00922272|565621737|FG001|Open-label Phase|Adverse Event|0|||
156692844|NCT00922272|565621736|FG000|Open-label Phase|Protocol Violation|1|||
156692845|NCT00922272|565621737|FG001|Open-label Phase|Protocol Violation|0|||
156692846|NCT00922272|565621736|FG000|Open-label Phase|Withdrawal by Subject|11|||
156692847|NCT00922272|565621737|FG001|Open-label Phase|Withdrawal by Subject|0|||
156692848|NCT00922272|565621736|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
156692849|NCT00922272|565621737|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
156692850|NCT00922272|565621736|FG000|Open-label Phase|Withdrawal criteria met|5|||
156692851|NCT00922272|565621737|FG001|Open-label Phase|Withdrawal criteria met|0|||
156692852|NCT00922272|565621736|FG000|Double-blind Phase|Adverse Event|1|||
156692853|NCT00922272|565621737|FG001|Double-blind Phase|Adverse Event|1|||
156692854|NCT00922272|565621736|FG000|Double-blind Phase|Withdrawal by Subject|1|||
156692855|NCT00922272|565621737|FG001|Double-blind Phase|Withdrawal by Subject|1|||
156692856|NCT00922272|565621736|FG000|Double-blind Phase|Lost to Follow-up|2|||
156692857|NCT00922272|565621737|FG001|Double-blind Phase|Lost to Follow-up|1|||
156692858|NCT00922272|565621736|FG000|Double-blind Phase|Withdrawal criteria met|1|||
156692859|NCT00922272|565621737|FG001|Double-blind Phase|Withdrawal criteria met|1|||
156692860|NCT00922272|565621736|FG000|Double-blind Phase|Noncompliance|1|||
156692861|NCT00922272|565621737|FG001|Double-blind Phase|Noncompliance|1|||
156692862|NCT00922272|565621736|FG000|Double-blind Phase|Positive urine drug screen|1|||
156692863|NCT00922272|565621737|FG001|Double-blind Phase|Positive urine drug screen|1|||
156870330|NCT01177397|566282500|FG008|Overall Study|Lost to Follow-up|0|||
157122096|NCT01471782|567197650|FG003|Overall Study|Physician Decision|0|||
156692864|NCT03197558|565621738|FG000|Overall Study|Tubes not placed|1|||
156870331|NCT01177397|566282501|FG009|Overall Study|Lost to Follow-up|0|||
156870332|NCT01177397|566282502|FG010|Overall Study|Lost to Follow-up|0|||
157122097|NCT01471782|567197651|FG004|Overall Study|Physician Decision|3|||
157122098|NCT01471782|567197652|FG005|Overall Study|Physician Decision|8|||
157122099|NCT01471782|567197647|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157122100|NCT01471782|567197648|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157122101|NCT01471782|567197649|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157122102|NCT01471782|567197650|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
157122103|NCT01471782|567197651|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
157122104|NCT01471782|567197652|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
157122105|NCT01471782|567197647|FG000|Overall Study|Death|0|||
157122106|NCT01471782|567197648|FG001|Overall Study|Death|0|||
157122107|NCT01471782|567197649|FG002|Overall Study|Death|0|||
157122108|NCT01471782|567197650|FG003|Overall Study|Death|0|||
157122109|NCT01471782|567197651|FG004|Overall Study|Death|0|||
157122110|NCT01471782|567197652|FG005|Overall Study|Death|1|||
157122111|NCT00936208|567197653|FG000|Overall Study|Protocol Violation|37|||
157122112|NCT00936208|567197654|FG001|Overall Study|Protocol Violation|22|||
156808748|NCT05554146|566054451|FG000|Overall Study|Protocol Violation|0|||
157122113|NCT04428424|567197655|FG000|Overall Study|Does not meet entrance criteria|132|||
157122114|NCT04428424|567197655|FG000|Overall Study|Lost to Follow-up|115|||
157122115|NCT01564862|567197656|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
157122116|NCT01564862|567197657|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
157122117|NCT01564862|567197658|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
157122118|NCT01564862|567197656|FG000|Overall Study|Major Protocol Deviation|3|||
157122119|NCT01564862|567197657|FG001|Overall Study|Major Protocol Deviation|3|||
157122120|NCT01564862|567197658|FG002|Overall Study|Major Protocol Deviation|4|||
157122121|NCT01564862|567197656|FG000|Overall Study|Lost to Follow-up|10|||
157122122|NCT01564862|567197657|FG001|Overall Study|Lost to Follow-up|8|||
157122123|NCT01564862|567197658|FG002|Overall Study|Lost to Follow-up|6|||
157122124|NCT01564862|567197656|FG000|Overall Study|Voluntary Withdrawal|9|||
157122125|NCT01564862|567197657|FG001|Overall Study|Voluntary Withdrawal|6|||
157122126|NCT01564862|567197658|FG002|Overall Study|Voluntary Withdrawal|8|||
157122127|NCT01564862|567197656|FG000|Overall Study|Lack of Efficacy|1|||
157122128|NCT01564862|567197657|FG001|Overall Study|Lack of Efficacy|5|||
157122129|NCT01564862|567197658|FG002|Overall Study|Lack of Efficacy|6|||
157122130|NCT01564862|567197656|FG000|Overall Study|Other reason(s)|1|||
157122131|NCT01564862|567197657|FG001|Overall Study|Other reason(s)|0|||
157122132|NCT01564862|567197658|FG002|Overall Study|Other reason(s)|0|||
157122133|NCT02193074|567197661|FG000|Overall Study|Withdrawal by Subject|1|||
157122134|NCT02193074|567197662|FG001|Overall Study|Withdrawal by Subject|2|||
157122135|NCT02193074|567197661|FG000|Overall Study|Adverse Event|16|||
157122136|NCT02193074|567197662|FG001|Overall Study|Adverse Event|13|||
157122137|NCT05593016|567200213|FG000|Overall Study|Death|1|||
157122138|NCT05593016|567200214|FG001|Overall Study|Death|1|||
157122139|NCT05593016|567200215|FG002|Overall Study|Death|1|||
157122140|NCT05593016|567200216|FG003|Overall Study|Death|0|||
157122141|NCT05593016|567200217|FG004|Overall Study|Death|0|||
157122142|NCT05593016|567200213|FG000|Overall Study|Lost to Follow-up|1|||
157122143|NCT05593016|567200214|FG001|Overall Study|Lost to Follow-up|1|||
157122144|NCT05593016|567200215|FG002|Overall Study|Lost to Follow-up|1|||
157122145|NCT05593016|567200216|FG003|Overall Study|Lost to Follow-up|2|||
157122146|NCT05593016|567200217|FG004|Overall Study|Lost to Follow-up|0|||
157122147|NCT00482014|567200218|FG000|Overall Study|Withdrawal by Subject|1|||
157122148|NCT00482014|567200219|FG001|Overall Study|Withdrawal by Subject|2|||
157122149|NCT00482014|567200220|FG002|Overall Study|Withdrawal by Subject|3|||
157122150|NCT00482014|567200221|FG003|Overall Study|Withdrawal by Subject|4|||
157122151|NCT00482014|567200218|FG000|Overall Study|Adverse Event|3|||
157122152|NCT00482014|567200219|FG001|Overall Study|Adverse Event|0|||
157122153|NCT00482014|567200220|FG002|Overall Study|Adverse Event|2|||
157122154|NCT00482014|567200221|FG003|Overall Study|Adverse Event|8|||
157122155|NCT00482014|567200218|FG000|Overall Study|Death|1|||
157122156|NCT00482014|567200219|FG001|Overall Study|Death|2|||
157122157|NCT00482014|567200220|FG002|Overall Study|Death|1|||
157122158|NCT00482014|567200221|FG003|Overall Study|Death|4|||
157122159|NCT00482014|567200218|FG000|Overall Study|Lack of Efficacy|1|||
157122160|NCT00482014|567200219|FG001|Overall Study|Lack of Efficacy|0|||
157122161|NCT00482014|567200220|FG002|Overall Study|Lack of Efficacy|4|||
157122162|NCT00482014|567200221|FG003|Overall Study|Lack of Efficacy|6|||
157122163|NCT00482014|567200218|FG000|Overall Study|Sponsor Decision|1|||
157122164|NCT00482014|567200219|FG001|Overall Study|Sponsor Decision|2|||
157122165|NCT00482014|567200220|FG002|Overall Study|Sponsor Decision|1|||
157122166|NCT00482014|567200221|FG003|Overall Study|Sponsor Decision|1|||
157122167|NCT01284114|567200224|FG000|Overall Study|viral infection|1|||
157122168|NCT01284114|567200224|FG000|Overall Study|From the results of ALLTITUDE study|1|||
157122169|NCT01284114|567200224|FG000|Overall Study|Symptomatic hypotension|1|||
157122170|NCT01284114|567200224|FG000|Overall Study|dizziness|1|||
157122171|NCT00598975|567200225|FG000|Overall Study|Adverse Event|1|||
156692865|NCT01304693|565621747|FG000|Overall Study|Adverse Event|0|||
156692866|NCT01304693|565621748|FG001|Overall Study|Adverse Event|0|||
156692867|NCT01304693|565621749|FG002|Overall Study|Adverse Event|0|||
156692868|NCT01304693|565621750|FG003|Overall Study|Adverse Event|0|||
156692869|NCT01304693|565621751|FG004|Overall Study|Adverse Event|1|||
157122172|NCT00598975|567200226|FG001|Overall Study|Adverse Event|1|||
157122173|NCT00598975|567200225|FG000|Overall Study|Brain metastases|1|||
157122174|NCT00598975|567200226|FG001|Overall Study|Brain metastases|0|||
157122175|NCT00598975|567200225|FG000|Overall Study|Withdrawal by Subject|1|||
157214554|NCT01027884|567531930|FG000|Overall Study|Adverse Event|2|||
156808749|NCT05554146|566054452|FG001|Overall Study|Protocol Violation|1|||
156808750|NCT05554146|566054453|FG002|Overall Study|Protocol Violation|0|||
157013916|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
157013917|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013918|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013919|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013920|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013921|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013922|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013923|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
157013924|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
157013925|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
157013926|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013927|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013928|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013929|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013930|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013931|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013932|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013933|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
157013934|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
157013935|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013936|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013937|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157021668|NCT05008835|566830980|FG001|Overall Study|Adverse Event|2|||
157021669|NCT05008835|566830981|FG002|Overall Study|Adverse Event|1|||
157021670|NCT05008835|566830979|FG000|Overall Study|Lack of Efficacy|0|||
157021671|NCT05008835|566830980|FG001|Overall Study|Lack of Efficacy|0|||
157021672|NCT05008835|566830981|FG002|Overall Study|Lack of Efficacy|1|||
157021673|NCT05008835|566830979|FG000|Overall Study|Study terminated by sponsor|0|||
157021674|NCT05008835|566830980|FG001|Overall Study|Study terminated by sponsor|0|||
157021675|NCT05008835|566830981|FG002|Overall Study|Study terminated by sponsor|1|||
157021676|NCT05008835|566830979|FG000|Overall Study|Not further specified|3|||
157021677|NCT05008835|566830980|FG001|Overall Study|Not further specified|2|||
157021678|NCT05008835|566830981|FG002|Overall Study|Not further specified|1|||
156808751|NCT05554146|566054454|FG003|Overall Study|Protocol Violation|0|||
156808752|NCT05554146|566054451|FG000|Overall Study|No longer interested in participating|0|||
156808753|NCT05554146|566054452|FG001|Overall Study|No longer interested in participating|0|||
157021679|NCT00667251|566832916|FG000|Overall Study|Disease progression|232|||
157021680|NCT00667251|566832917|FG001|Overall Study|Disease progression|203|||
157021681|NCT00667251|566832916|FG000|Overall Study|Toxicity|44|||
157021682|NCT00667251|566832917|FG001|Overall Study|Toxicity|23|||
157021683|NCT00667251|566832916|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
157021684|NCT00667251|566832917|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
157021685|NCT00667251|566832916|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
156808754|NCT05554146|566054453|FG002|Overall Study|No longer interested in participating|1|||
156808755|NCT05554146|566054454|FG003|Overall Study|No longer interested in participating|0|||
156808756|NCT05554146|566054451|FG000|Overall Study|Lost to Follow-up|1|||
156808757|NCT05554146|566054452|FG001|Overall Study|Lost to Follow-up|0|||
156808758|NCT05554146|566054453|FG002|Overall Study|Lost to Follow-up|0|||
157021686|NCT00667251|566832917|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
157021687|NCT00667251|566832916|FG000|Overall Study|Symptomatic progression|8|||
157021688|NCT00667251|566832917|FG001|Overall Study|Symptomatic progression|4|||
157021689|NCT00667251|566832916|FG000|Overall Study|Death|6|||
157021690|NCT00667251|566832917|FG001|Overall Study|Death|11|||
157021691|NCT00667251|566832916|FG000|Overall Study|Intercurrent illness|5|||
157021692|NCT00667251|566832917|FG001|Overall Study|Intercurrent illness|6|||
157021693|NCT00667251|566832916|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
157021694|NCT00667251|566832917|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
157021695|NCT00667251|566832916|FG000|Overall Study|Randomized not Treated|4|||
157021696|NCT00667251|566832917|FG001|Overall Study|Randomized not Treated|1|||
157021697|NCT02671903|566832923|FG000|Period 0 (Run-In)|Death|0|||
157021698|NCT02671903|566832924|FG001|Period 0 (Run-In)|Death|0|||
157021699|NCT02671903|566832925|FG002|Period 0 (Run-In)|Death|3|||
157021700|NCT02671903|566832923|FG000|Period 0 (Run-In)|Physician Decision|0|||
157021701|NCT02671903|566832924|FG001|Period 0 (Run-In)|Physician Decision|0|||
157021702|NCT02671903|566832925|FG002|Period 0 (Run-In)|Physician Decision|4|||
157021703|NCT02671903|566832923|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
157021704|NCT02671903|566832924|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
156692870|NCT01304693|565621747|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692871|NCT01304693|565621748|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692872|NCT01304693|565621749|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
156692873|NCT01304693|565621750|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
156692874|NCT01304693|565621751|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
156692875|NCT02581163|565621752|FG000|Overall Study|Failure to return|15|||
156692876|NCT02581163|565621752|FG000|Overall Study|Insufficient virological response|3|||
156692877|NCT02581163|565621752|FG000|Overall Study|Withdrew consent|1|||
156692878|NCT02581163|565621752|FG000|Overall Study|Death|1|||
156692879|NCT02581163|565621752|FG000|Overall Study|Other, not specified|9|||
156692880|NCT00931268|565621753|FG000|Overall Study|Lost to Follow-up|6|||
156692881|NCT02072148|565621759|FG000|Overall Study|withdrew prior to surgery|23|||
156692882|NCT02072148|565621760|FG001|Overall Study|withdrew prior to surgery|0|||
156692883|NCT02072148|565621761|FG002|Overall Study|withdrew prior to surgery|0|||
156692884|NCT02072148|565621759|FG000|Overall Study|Death|0|||
156692885|NCT02072148|565621760|FG001|Overall Study|Death|0|||
156692886|NCT02072148|565621761|FG002|Overall Study|Death|1|||
156692887|NCT02072148|565621759|FG000|Overall Study|Withdrawal by Subject|0|||
156692888|NCT02072148|565621760|FG001|Overall Study|Withdrawal by Subject|13|||
156692889|NCT02072148|565621761|FG002|Overall Study|Withdrawal by Subject|12|||
156692890|NCT00430495|565621763|FG000|Overall Study|Adverse Event|2|||
156692891|NCT00430495|565621764|FG001|Overall Study|Adverse Event|3|||
156692892|NCT00430495|565621765|FG002|Overall Study|Adverse Event|2|||
156692893|NCT00430495|565621766|FG003|Overall Study|Adverse Event|0|||
156692894|NCT00430495|565621763|FG000|Overall Study|Death|0|||
156788860|NCT03834883|565977312|FG001|Second Treatment|COVID-19 pandemic|0|||
156788861|NCT03834883|565977313|FG002|Second Treatment|COVID-19 pandemic|1|||
156788862|NCT03834883|565977314|FG003|Second Treatment|COVID-19 pandemic|1|||
156788863|NCT01569763|565979056|FG000|Overall Study|Lack of Efficacy|2|||
156788864|NCT01569763|565979057|FG001|Overall Study|Lack of Efficacy|7|||
156692895|NCT00430495|565621764|FG001|Overall Study|Death|0|||
156692896|NCT00430495|565621765|FG002|Overall Study|Death|1|||
156692897|NCT00430495|565621766|FG003|Overall Study|Death|0|||
156692898|NCT00430495|565621763|FG000|Overall Study|Lost to Follow-up|0|||
156788865|NCT01569763|565979056|FG000|Overall Study|Adverse Event|1|||
156788866|NCT01569763|565979057|FG001|Overall Study|Adverse Event|0|||
156788867|NCT01926509|565979058|FG000|Overall Study|vital sign met discontinuation criteria|1|||
156788868|NCT01926509|565979059|FG001|Overall Study|vital sign met discontinuation criteria|0|||
157013938|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013939|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013940|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013941|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013942|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
157013943|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
157013944|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013945|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013946|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013947|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013948|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013949|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013950|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157021705|NCT02671903|566832925|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
157021706|NCT02671903|566832923|FG000|Period 0 (Run-In)|Protocol Violation|0|||
157021707|NCT02671903|566832924|FG001|Period 0 (Run-In)|Protocol Violation|0|||
157021708|NCT02671903|566832925|FG002|Period 0 (Run-In)|Protocol Violation|1|||
156692899|NCT00430495|565621764|FG001|Overall Study|Lost to Follow-up|1|||
156692900|NCT00430495|565621765|FG002|Overall Study|Lost to Follow-up|4|||
156692901|NCT00430495|565621766|FG003|Overall Study|Lost to Follow-up|0|||
156692902|NCT00430495|565621763|FG000|Overall Study|Protocol Violation|1|||
157021709|NCT02671903|566832923|FG000|Period 0 (Run-In)|Adverse Event|0|||
157021710|NCT02671903|566832924|FG001|Period 0 (Run-In)|Adverse Event|0|||
156808759|NCT05554146|566054454|FG003|Overall Study|Lost to Follow-up|0|||
157021711|NCT02671903|566832925|FG002|Period 0 (Run-In)|Adverse Event|1|||
157021712|NCT02671903|566832923|FG000|Period 0 (Run-In)|Implantation Failure|0|||
157021713|NCT02671903|566832924|FG001|Period 0 (Run-In)|Implantation Failure|0|||
157021714|NCT02671903|566832925|FG002|Period 0 (Run-In)|Implantation Failure|2|||
157021715|NCT02671903|566832923|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
157021716|NCT02671903|566832924|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
157021717|NCT02671903|566832925|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
157021718|NCT04390048|566832931|FG000|Overall Study|Withdrawal by Subject|1|||
157021719|NCT04390048|566832932|FG001|Overall Study|Withdrawal by Subject|3|||
157021720|NCT06283173|566832933|FG000|Overall Study|Did not show for first visit|10|||
157021721|NCT06283173|566832933|FG000|Overall Study|Lost to Follow-up|12|||
156870333|NCT01177397|566282503|FG011|Overall Study|Lost to Follow-up|0|||
156870334|NCT01177397|566282492|FG000|Overall Study|Death|0|||
156870335|NCT01177397|566282493|FG001|Overall Study|Death|0|||
156870336|NCT01177397|566282494|FG002|Overall Study|Death|1|||
156870337|NCT01177397|566282495|FG003|Overall Study|Death|1|||
156692903|NCT00430495|565621764|FG001|Overall Study|Protocol Violation|0|||
156692904|NCT00430495|565621765|FG002|Overall Study|Protocol Violation|1|||
156692905|NCT00430495|565621766|FG003|Overall Study|Protocol Violation|0|||
156692906|NCT00430495|565621763|FG000|Overall Study|Disease Progression|1|||
156692907|NCT00430495|565621764|FG001|Overall Study|Disease Progression|1|||
156692908|NCT00430495|565621765|FG002|Overall Study|Disease Progression|0|||
156870338|NCT01177397|566282496|FG004|Overall Study|Death|0|||
156692909|NCT00430495|565621766|FG003|Overall Study|Disease Progression|0|||
156692910|NCT00430495|565621763|FG000|Overall Study|Other|8|||
156692911|NCT00430495|565621764|FG001|Overall Study|Other|2|||
156692912|NCT00430495|565621765|FG002|Overall Study|Other|5|||
156692913|NCT00430495|565621766|FG003|Overall Study|Other|4|||
156692914|NCT00430495|565621763|FG000|Overall Study|Randomized but not Treated|2|||
156692915|NCT00430495|565621764|FG001|Overall Study|Randomized but not Treated|0|||
156692916|NCT00430495|565621765|FG002|Overall Study|Randomized but not Treated|0|||
156692917|NCT00430495|565621766|FG003|Overall Study|Randomized but not Treated|0|||
156788869|NCT01926509|565979060|FG002|Overall Study|vital sign met discontinuation criteria|0|||
156788870|NCT01926509|565979061|FG003|Overall Study|vital sign met discontinuation criteria|0|||
156788871|NCT02730169|565979062|FG000|Overall Study|Protocol Violation|1|||
156788872|NCT02730169|565979063|FG001|Overall Study|Protocol Violation|0|||
156788873|NCT02730169|565979064|FG002|Overall Study|Protocol Violation|0|||
156788874|NCT02730169|565979065|FG003|Overall Study|Protocol Violation|1|||
156788875|NCT02730169|565979062|FG000|Overall Study|Adverse Event|2|||
156788876|NCT02730169|565979063|FG001|Overall Study|Adverse Event|3|||
156788877|NCT02730169|565979064|FG002|Overall Study|Adverse Event|3|||
156788878|NCT02730169|565979065|FG003|Overall Study|Adverse Event|0|||
156870339|NCT01177397|566282497|FG005|Overall Study|Death|0|||
156870340|NCT01177397|566282498|FG006|Overall Study|Death|0|||
156870341|NCT01177397|566282499|FG007|Overall Study|Death|5|||
156870342|NCT01177397|566282500|FG008|Overall Study|Death|2|||
156870343|NCT01177397|566282501|FG009|Overall Study|Death|1|||
156870344|NCT01177397|566282502|FG010|Overall Study|Death|0|||
156870345|NCT01177397|566282503|FG011|Overall Study|Death|0|||
156870346|NCT01177397|566282492|FG000|Overall Study|Withdrawal by Subject|0|||
156870347|NCT01177397|566282493|FG001|Overall Study|Withdrawal by Subject|0|||
156870348|NCT01177397|566282494|FG002|Overall Study|Withdrawal by Subject|1|||
156870349|NCT01177397|566282495|FG003|Overall Study|Withdrawal by Subject|1|||
156870350|NCT01177397|566282496|FG004|Overall Study|Withdrawal by Subject|1|||
156870351|NCT01177397|566282497|FG005|Overall Study|Withdrawal by Subject|2|||
156870352|NCT01177397|566282498|FG006|Overall Study|Withdrawal by Subject|0|||
156870353|NCT01177397|566282499|FG007|Overall Study|Withdrawal by Subject|5|||
157013951|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
157013952|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
157013953|NCT02590432|566801864|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013954|NCT02590432|566801865|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013955|NCT02590432|566801866|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013956|NCT02590432|566801867|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013957|NCT02590432|566801868|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013958|NCT02590432|566801869|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013959|NCT02590432|566801870|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013960|NCT02590432|566801871|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
157013961|NCT02590432|566801872|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
157013962|NCT02006758|566801873|FG000|Overall Study|Protocol Violation|1|||
157013963|NCT02006758|566801873|FG000|Overall Study|Death|1|||
157013964|NCT02006758|566801873|FG000|Overall Study|Lost to Follow-up|4|||
157013965|NCT02006758|566801873|FG000|Overall Study|Withdrawal by Subject|4|||
156692918|NCT00158756|565621767|FG000|Overall Study|Withdrawal by Subject|5|||
156692919|NCT00158756|565621768|FG001|Overall Study|Withdrawal by Subject|0|||
156692920|NCT00158756|565621769|FG002|Overall Study|Withdrawal by Subject|6|||
156692921|NCT00158756|565621770|FG003|Overall Study|Withdrawal by Subject|1|||
156870354|NCT01177397|566282500|FG008|Overall Study|Withdrawal by Subject|9|||
156870355|NCT01177397|566282501|FG009|Overall Study|Withdrawal by Subject|1|||
156870356|NCT01177397|566282502|FG010|Overall Study|Withdrawal by Subject|1|||
156870357|NCT01177397|566282503|FG011|Overall Study|Withdrawal by Subject|0|||
156692922|NCT00158756|565621771|FG004|Overall Study|Withdrawal by Subject|3|||
156788879|NCT02730169|565979062|FG000|Overall Study|Adverse Event of Special Interest|0|||
156788880|NCT02730169|565979063|FG001|Overall Study|Adverse Event of Special Interest|1|||
156788881|NCT02730169|565979064|FG002|Overall Study|Adverse Event of Special Interest|2|||
156788882|NCT02730169|565979065|FG003|Overall Study|Adverse Event of Special Interest|0|||
156788883|NCT02730169|565979062|FG000|Overall Study|Withdrawal by Subject|6|||
156870358|NCT01177397|566282492|FG000|Overall Study|Adverse Event|0|||
156870359|NCT01177397|566282493|FG001|Overall Study|Adverse Event|0|||
156870360|NCT01177397|566282494|FG002|Overall Study|Adverse Event|1|||
156870361|NCT01177397|566282495|FG003|Overall Study|Adverse Event|2|||
156870362|NCT01177397|566282496|FG004|Overall Study|Adverse Event|0|||
156870363|NCT01177397|566282497|FG005|Overall Study|Adverse Event|12|||
157122176|NCT00598975|567200226|FG001|Overall Study|Withdrawal by Subject|1|||
157122177|NCT00598975|567200225|FG000|Overall Study|Withdrawal of consent|0|||
157122178|NCT00598975|567200226|FG001|Overall Study|Withdrawal of consent|1|||
157122179|NCT00598975|567200225|FG000|Overall Study|Disease progression|8|||
157122180|NCT00598975|567200226|FG001|Overall Study|Disease progression|3|||
157122181|NCT00598975|567200225|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
157122182|NCT00598975|567200226|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
157122183|NCT04161131|567200233|FG000|Overall Study|Ineligible|2|||
157122184|NCT04161131|567200233|FG000|Overall Study|Lost to Follow-up|4|||
157122185|NCT03733392|567200234|FG000|Overall Study|Withdrawal by Subject|11|||
157122186|NCT03733392|567200235|FG001|Overall Study|Withdrawal by Subject|1|||
157122187|NCT03733392|567200234|FG000|Overall Study|Death|1|||
157122188|NCT03733392|567200235|FG001|Overall Study|Death|0|||
157122189|NCT03733392|567200234|FG000|Overall Study|Lost to Follow-up|5|||
157122190|NCT03733392|567200235|FG001|Overall Study|Lost to Follow-up|0|||
157122191|NCT03733392|567200234|FG000|Overall Study|Protocol Violation|0|||
157122192|NCT03733392|567200235|FG001|Overall Study|Protocol Violation|1|||
157122193|NCT03733392|567200234|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
157122194|NCT03733392|567200235|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
157122195|NCT03733392|567200234|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
157122196|NCT03733392|567200235|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
157122197|NCT03733392|567200234|FG000|Overall Study|Patient Non-Compliance|2|||
157122198|NCT03733392|567200235|FG001|Overall Study|Patient Non-Compliance|1|||
157122199|NCT03733392|567200234|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
157122200|NCT03733392|567200235|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
157122201|NCT03733392|567200234|FG000|Overall Study|Withdrawal prior to procedure|5|||
157122202|NCT03733392|567200235|FG001|Overall Study|Withdrawal prior to procedure|2|||
157122203|NCT02740478|567200236|FG000|Overall Study|Withdrawal by Subject|1|||
157122204|NCT04316585|567200237|FG000|Overall Study|Adverse Event|2|||
157122205|NCT04316585|567200238|FG001|Overall Study|Adverse Event|1|||
157122206|NCT04316585|567200237|FG000|Overall Study|Lost to Follow-up|1|||
157122207|NCT04316585|567200238|FG001|Overall Study|Lost to Follow-up|0|||
157122208|NCT04316585|567200237|FG000|Overall Study|Withdrawal by Subject|2|||
157122209|NCT04316585|567200238|FG001|Overall Study|Withdrawal by Subject|3|||
157122210|NCT04316585|567200237|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
157122211|NCT04316585|567200238|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
157122212|NCT04316585|567200237|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
157122213|NCT04316585|567200238|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
157122214|NCT03269344|567200239|FG000|Overall Study|Protocol Violation|4|||
157122215|NCT03269344|567200240|FG001|Overall Study|Protocol Violation|3|||
157122216|NCT02847624|567200241|FG000|Overall Study|Lost to Follow-up|28|||
157122217|NCT02847624|567200241|FG000|Overall Study|Protocol Violation|98|||
157122218|NCT02847624|567200241|FG000|Overall Study|Case report failures|4|||
157122219|NCT04372927|567200244|FG000|Overall Study|Death|1|||
157122220|NCT01999582|567200245|FG000|Overall Study|Withdrawal by Subject|0|||
157122221|NCT01999582|567200246|FG001|Overall Study|Withdrawal by Subject|0|||
157122222|NCT01999582|567200247|FG002|Overall Study|Withdrawal by Subject|0|||
157122223|NCT01999582|567200248|FG003|Overall Study|Withdrawal by Subject|1|||
157122224|NCT01999582|567200249|FG004|Overall Study|Withdrawal by Subject|0|||
157122225|NCT01999582|567200250|FG005|Overall Study|Withdrawal by Subject|0|||
157122226|NCT01999582|567200245|FG000|Overall Study|Adverse Event|0|||
157122227|NCT01999582|567200246|FG001|Overall Study|Adverse Event|0|||
157122228|NCT01999582|567200247|FG002|Overall Study|Adverse Event|3|||
157122229|NCT01999582|567200248|FG003|Overall Study|Adverse Event|0|||
157122230|NCT01999582|567200249|FG004|Overall Study|Adverse Event|1|||
157122231|NCT01999582|567200250|FG005|Overall Study|Adverse Event|0|||
157122232|NCT01999582|567200245|FG000|Overall Study|Other Reasons|1|||
157122233|NCT01999582|567200246|FG001|Overall Study|Other Reasons|0|||
157122234|NCT01999582|567200247|FG002|Overall Study|Other Reasons|3|||
157122235|NCT01999582|567200248|FG003|Overall Study|Other Reasons|1|||
157122236|NCT01999582|567200249|FG004|Overall Study|Other Reasons|1|||
157122237|NCT01999582|567200250|FG005|Overall Study|Other Reasons|2|||
157122238|NCT01999582|567200245|FG000|Overall Study|Protocol Violation|1|||
157122239|NCT01999582|567200246|FG001|Overall Study|Protocol Violation|0|||
157122240|NCT01999582|567200247|FG002|Overall Study|Protocol Violation|0|||
157122241|NCT01999582|567200248|FG003|Overall Study|Protocol Violation|0|||
157122242|NCT01999582|567200249|FG004|Overall Study|Protocol Violation|0|||
157214555|NCT01027884|567531931|FG001|Overall Study|Adverse Event|1|||
157122243|NCT01999582|567200250|FG005|Overall Study|Protocol Violation|1|||
156870364|NCT01177397|566282498|FG006|Overall Study|Adverse Event|1|||
156692923|NCT00158756|565621767|FG000|Overall Study|Adverse Event|0|||
156692924|NCT00158756|565621768|FG001|Overall Study|Adverse Event|0|||
156692925|NCT00158756|565621769|FG002|Overall Study|Adverse Event|1|||
156692926|NCT00158756|565621770|FG003|Overall Study|Adverse Event|0|||
156692927|NCT00158756|565621771|FG004|Overall Study|Adverse Event|0|||
156692928|NCT00158756|565621767|FG000|Overall Study|Serious adverse event|0|||
156692929|NCT00158756|565621768|FG001|Overall Study|Serious adverse event|0|||
156692930|NCT00158756|565621769|FG002|Overall Study|Serious adverse event|1|||
156692931|NCT00158756|565621770|FG003|Overall Study|Serious adverse event|0|||
156692932|NCT00158756|565621771|FG004|Overall Study|Serious adverse event|0|||
156692933|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
156692934|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
156692935|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
156692936|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
156692937|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
156692938|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
156692939|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
156692940|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
156692941|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
156692942|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
156692943|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
156692944|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
156692945|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
156692946|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
156692947|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
156692948|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
156692949|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
156692950|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
156692951|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
156692952|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
156692953|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
156692954|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
156692955|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
156692956|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
156692957|NCT01421342|565621772|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
156692958|NCT01421342|565621773|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
156692959|NCT01421342|565621774|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
156692960|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
156692961|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
156692962|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
156692963|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
156692964|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
156692965|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
156692966|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
156692967|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
156692968|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
156692969|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
156692970|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
156692971|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
156692972|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
156692973|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
156692974|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
156692975|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
156692976|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
156692977|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
156692978|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
156692979|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
156692980|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
156692981|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
156692982|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
156692983|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
156692984|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
156692985|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
156788884|NCT02730169|565979063|FG001|Overall Study|Withdrawal by Subject|11|||
156788885|NCT02730169|565979064|FG002|Overall Study|Withdrawal by Subject|6|||
156788886|NCT02730169|565979065|FG003|Overall Study|Withdrawal by Subject|8|||
156692986|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
156692987|NCT01421342|565621772|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
156692988|NCT01421342|565621773|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
156692989|NCT01421342|565621774|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
156692990|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
156692991|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
156692992|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
156692993|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
156692994|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
156692995|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
156692996|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
156692997|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
156692998|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
156692999|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
156693000|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
156693001|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
156693002|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
156693003|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
156693004|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
156693005|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
156693006|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
156693007|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
156693008|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
156693009|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
156693010|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
156693011|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693012|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693013|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
156693014|NCT01421342|565621772|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
156693015|NCT01421342|565621773|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
156693016|NCT01421342|565621774|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
156693017|NCT03656874|565621777|FG000|Overall Study|Lost to Follow-up|3|||
156693018|NCT03656874|565621778|FG001|Overall Study|Lost to Follow-up|17|||
156693019|NCT01206816|565621779|FG000|Overall Study|Protocol Violation|0|||
156693020|NCT01206816|565621780|FG001|Overall Study|Protocol Violation|0|||
156693021|NCT01206816|565621781|FG002|Overall Study|Protocol Violation|1|||
156693022|NCT01206816|565621782|FG003|Overall Study|Protocol Violation|0|||
156693023|NCT01206816|565621783|FG004|Overall Study|Protocol Violation|0|||
156693024|NCT01206816|565621784|FG005|Overall Study|Protocol Violation|0|||
156693025|NCT01206816|565621785|FG006|Overall Study|Protocol Violation|0|||
156693026|NCT01206816|565621779|FG000|Overall Study|Withdrawal by Subject|0|||
156693027|NCT01206816|565621780|FG001|Overall Study|Withdrawal by Subject|0|||
156693028|NCT01206816|565621781|FG002|Overall Study|Withdrawal by Subject|1|||
156693029|NCT01206816|565621782|FG003|Overall Study|Withdrawal by Subject|0|||
156788887|NCT02730169|565979062|FG000|Overall Study|Lost to Follow-up|5|||
156788888|NCT02730169|565979063|FG001|Overall Study|Lost to Follow-up|6|||
156788889|NCT02730169|565979064|FG002|Overall Study|Lost to Follow-up|5|||
156788890|NCT02730169|565979065|FG003|Overall Study|Lost to Follow-up|6|||
156788891|NCT02730169|565979062|FG000|Overall Study|Other|0|||
156788892|NCT02730169|565979063|FG001|Overall Study|Other|0|||
156788893|NCT02730169|565979064|FG002|Overall Study|Other|1|||
156788894|NCT02730169|565979065|FG003|Overall Study|Other|1|||
156788895|NCT03681093|565979066|FG000|Overall Study|Subject decision|0|||
156788896|NCT03681093|565979067|FG001|Overall Study|Subject decision|2|||
156788897|NCT03681093|565979068|FG002|Overall Study|Subject decision|1|||
156788898|NCT01213251|565979070|FG000|Overall Study|Death|2|||
156788899|NCT01213251|565979071|FG001|Overall Study|Death|1|||
156788900|NCT01213251|565979072|FG002|Overall Study|Death|2|||
156870365|NCT01177397|566282499|FG007|Overall Study|Adverse Event|14|||
157122244|NCT01999582|567200245|FG000|Overall Study|Lack of Efficacy|1|||
157122245|NCT01999582|567200246|FG001|Overall Study|Lack of Efficacy|3|||
157122246|NCT01999582|567200247|FG002|Overall Study|Lack of Efficacy|0|||
157122247|NCT01999582|567200248|FG003|Overall Study|Lack of Efficacy|1|||
157122248|NCT01999582|567200249|FG004|Overall Study|Lack of Efficacy|0|||
157122249|NCT01999582|567200250|FG005|Overall Study|Lack of Efficacy|0|||
157122250|NCT00661271|567200251|FG000|Overall Study|Lost to Follow-up|28|||
157122251|NCT00661271|567200252|FG001|Overall Study|Lost to Follow-up|25|||
156693030|NCT01206816|565621783|FG004|Overall Study|Withdrawal by Subject|0|||
156693031|NCT01206816|565621784|FG005|Overall Study|Withdrawal by Subject|0|||
156788901|NCT01213251|565979070|FG000|Overall Study|Exit|3|||
156788902|NCT01213251|565979071|FG001|Overall Study|Exit|2|||
156788903|NCT01213251|565979072|FG002|Overall Study|Exit|8|||
156788904|NCT01213251|565979070|FG000|Overall Study|Protocol Violation|1|||
156870366|NCT01177397|566282500|FG008|Overall Study|Adverse Event|8|||
156693032|NCT01206816|565621785|FG006|Overall Study|Withdrawal by Subject|0|||
156693033|NCT01206816|565621779|FG000|Overall Study|Progressive disease|3|||
156693034|NCT01206816|565621780|FG001|Overall Study|Progressive disease|3|||
156693035|NCT01206816|565621781|FG002|Overall Study|Progressive disease|13|||
156693036|NCT01206816|565621782|FG003|Overall Study|Progressive disease|3|||
156693037|NCT01206816|565621783|FG004|Overall Study|Progressive disease|3|||
156693038|NCT01206816|565621784|FG005|Overall Study|Progressive disease|16|||
156693039|NCT01206816|565621785|FG006|Overall Study|Progressive disease|3|||
156693040|NCT01206816|565621779|FG000|Overall Study|Other AE|0|||
156693041|NCT01206816|565621780|FG001|Overall Study|Other AE|0|||
156693042|NCT01206816|565621781|FG002|Overall Study|Other AE|4|||
156693043|NCT01206816|565621782|FG003|Overall Study|Other AE|0|||
156693044|NCT01206816|565621783|FG004|Overall Study|Other AE|0|||
156693045|NCT01206816|565621784|FG005|Overall Study|Other AE|3|||
156693046|NCT01206816|565621785|FG006|Overall Study|Other AE|2|||
156693047|NCT01206816|565621779|FG000|Overall Study|other than stated above|0|||
156693048|NCT01206816|565621780|FG001|Overall Study|other than stated above|0|||
156693049|NCT01206816|565621781|FG002|Overall Study|other than stated above|1|||
156693050|NCT01206816|565621782|FG003|Overall Study|other than stated above|0|||
156693051|NCT01206816|565621783|FG004|Overall Study|other than stated above|0|||
156693052|NCT01206816|565621784|FG005|Overall Study|other than stated above|0|||
156693053|NCT01206816|565621785|FG006|Overall Study|other than stated above|1|||
156693054|NCT01939496|565621787|FG000|Overall Study|Adverse Event|2|||
156693055|NCT01939496|565621788|FG001|Overall Study|Adverse Event|0|||
156693056|NCT01939496|565621789|FG002|Overall Study|Adverse Event|0|||
156693057|NCT01939496|565621787|FG000|Overall Study|Lost to Follow-up|1|||
156693058|NCT01939496|565621788|FG001|Overall Study|Lost to Follow-up|1|||
156693059|NCT01939496|565621789|FG002|Overall Study|Lost to Follow-up|0|||
156693060|NCT01939496|565621787|FG000|Overall Study|Physician Decision|1|||
156693061|NCT01939496|565621788|FG001|Overall Study|Physician Decision|0|||
156693062|NCT01939496|565621789|FG002|Overall Study|Physician Decision|0|||
156693063|NCT01939496|565621787|FG000|Overall Study|Protocol Violation|3|||
156693064|NCT01939496|565621788|FG001|Overall Study|Protocol Violation|0|||
156693065|NCT01939496|565621789|FG002|Overall Study|Protocol Violation|0|||
156693066|NCT01939496|565621787|FG000|Overall Study|Withdrawal by Subject|0|||
156693067|NCT01939496|565621788|FG001|Overall Study|Withdrawal by Subject|1|||
156693068|NCT01939496|565621789|FG002|Overall Study|Withdrawal by Subject|1|||
156693069|NCT01939496|565621787|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
156693070|NCT01939496|565621788|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
156693071|NCT01939496|565621789|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
156693072|NCT01939496|565621787|FG000|Overall Study|Other|2|||
156693073|NCT01939496|565621788|FG001|Overall Study|Other|0|||
156693074|NCT01939496|565621789|FG002|Overall Study|Other|1|||
156693075|NCT03463993|565621793|FG000|Overall Study|Lost to Follow-up|7|||
156693076|NCT03463993|565621794|FG001|Overall Study|Lost to Follow-up|8|||
156693077|NCT03463993|565621793|FG000|Overall Study|Withdrawal by Subject|2|||
156693078|NCT03463993|565621794|FG001|Overall Study|Withdrawal by Subject|0|||
156693079|NCT03463993|565621793|FG000|Overall Study|Protocol Violation|4|||
156693080|NCT03463993|565621794|FG001|Overall Study|Protocol Violation|1|||
156693081|NCT03463993|565621793|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
156693082|NCT03463993|565621794|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
156693083|NCT03463993|565621793|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
157013966|NCT02006758|566801873|FG000|Overall Study|Procedurally excluded|1|||
157013967|NCT02006758|566801873|FG000|Overall Study|Other|2|||
157013968|NCT00243503|566801875|FG000|Overall Study|Adverse Event|11|||
157013969|NCT00243503|566801875|FG000|Overall Study|Withdrawal by Subject|1|||
157013970|NCT00243503|566801875|FG000|Overall Study|Lack of Efficacy|44|||
157013971|NCT00243503|566801875|FG000|Overall Study|Death|1|||
157013972|NCT00243503|566801875|FG000|Overall Study|Other|1|||
157013973|NCT00914589|566801876|FG000|Overall Study|Adverse Event|1|||
157013974|NCT00914589|566801877|FG001|Overall Study|Adverse Event|0|||
157013975|NCT00914589|566801878|FG002|Overall Study|Adverse Event|1|||
157013976|NCT00914589|566801876|FG000|Overall Study|Protocol Violation|8|||
157013977|NCT00914589|566801877|FG001|Overall Study|Protocol Violation|6|||
157013978|NCT00914589|566801878|FG002|Overall Study|Protocol Violation|3|||
157013979|NCT00914589|566801876|FG000|Overall Study|unclassified|16|||
157013980|NCT00914589|566801877|FG001|Overall Study|unclassified|9|||
157013981|NCT00914589|566801878|FG002|Overall Study|unclassified|7|||
157013982|NCT00914589|566801876|FG000|Overall Study|Death|0|||
157013983|NCT00914589|566801877|FG001|Overall Study|Death|1|||
157013984|NCT00914589|566801878|FG002|Overall Study|Death|1|||
157214556|NCT01027884|567531930|FG000|Overall Study|Protocol Violation|1|||
156693084|NCT03463993|565621794|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
157013985|NCT05052996|566801879|FG000|Overall Study|Still on study|0|||
157013986|NCT05052996|566801880|FG001|Overall Study|Still on study|0|||
157013987|NCT05052996|566801881|FG002|Overall Study|Still on study|47|||
157013988|NCT05052996|566801882|FG003|Overall Study|Still on study|44|||
157013989|NCT05052996|566801879|FG000|Overall Study|Cohort terminated by sponsor|21|||
157013990|NCT05052996|566801880|FG001|Overall Study|Cohort terminated by sponsor|12|||
156693085|NCT01300052|565621795|FG000|Overall Study|Adverse Event|3|||
156693086|NCT01300052|565621796|FG001|Overall Study|Adverse Event|0|||
156693087|NCT01300052|565621795|FG000|Overall Study|Withdrawal by Subject|2|||
156693088|NCT01300052|565621796|FG001|Overall Study|Withdrawal by Subject|2|||
156693089|NCT01300052|565621795|FG000|Overall Study|Protocol Violation|1|||
156693090|NCT01300052|565621796|FG001|Overall Study|Protocol Violation|1|||
156693091|NCT05444543|565621797|FG000|Overall Study|Withdrawal by Subject|1|||
156693092|NCT05444543|565621798|FG001|Overall Study|Withdrawal by Subject|0|||
156693093|NCT05444543|565621797|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
156693094|NCT05444543|565621798|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
156693095|NCT05444543|565621797|FG000|Overall Study|Adverse Event|0|||
156693096|NCT05444543|565621798|FG001|Overall Study|Adverse Event|1|||
156693097|NCT05444543|565621797|FG000|Overall Study|Family relocating at a distance from study site|0|||
156693098|NCT05444543|565621798|FG001|Overall Study|Family relocating at a distance from study site|1|||
156693099|NCT02408120|565621799|FG000|Overall Study|Withdrawal by Subject|0|||
156693100|NCT02408120|565621800|FG001|Overall Study|Withdrawal by Subject|1|||
156693101|NCT02408120|565621799|FG000|Overall Study|Treatment Refusal|1|||
156693102|NCT02408120|565621800|FG001|Overall Study|Treatment Refusal|0|||
156693103|NCT02408120|565621799|FG000|Overall Study|Received Steroids|1|||
156693104|NCT02408120|565621800|FG001|Overall Study|Received Steroids|1|||
156693105|NCT02408120|565621799|FG000|Overall Study|Discharged same day|1|||
156693106|NCT02408120|565621800|FG001|Overall Study|Discharged same day|1|||
156693107|NCT02408120|565621799|FG000|Overall Study|Did not receive insulin|1|||
156693108|NCT02408120|565621800|FG001|Overall Study|Did not receive insulin|2|||
156693109|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
156693110|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
156693111|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
156693112|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
156693113|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
156693114|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
156693115|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
156693116|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
156693117|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
156693118|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
156693119|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Subject decision|1|||
156693120|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Subject decision|1|||
156693121|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
156693122|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
156693123|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
156693124|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
156693125|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
156693126|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
157013991|NCT05052996|566801881|FG002|Overall Study|Cohort terminated by sponsor|0|||
157013992|NCT05052996|566801882|FG003|Overall Study|Cohort terminated by sponsor|0|||
157013993|NCT05052996|566801879|FG000|Overall Study|Withdrew consent|1|||
157013994|NCT05052996|566801880|FG001|Overall Study|Withdrew consent|0|||
157013995|NCT05052996|566801881|FG002|Overall Study|Withdrew consent|1|||
157013996|NCT05052996|566801882|FG003|Overall Study|Withdrew consent|2|||
157013997|NCT05052996|566801879|FG000|Overall Study|Lost to Follow-up|1|||
157013998|NCT05052996|566801880|FG001|Overall Study|Lost to Follow-up|0|||
157013999|NCT05052996|566801881|FG002|Overall Study|Lost to Follow-up|0|||
157014000|NCT05052996|566801882|FG003|Overall Study|Lost to Follow-up|2|||
157014001|NCT05052996|566801879|FG000|Overall Study|Adverse Event|0|||
157014002|NCT05052996|566801880|FG001|Overall Study|Adverse Event|0|||
157014003|NCT05052996|566801881|FG002|Overall Study|Adverse Event|2|||
157014004|NCT05052996|566801882|FG003|Overall Study|Adverse Event|0|||
157014005|NCT05052996|566801879|FG000|Overall Study|Randomized but never treated|0|||
157014006|NCT05052996|566801880|FG001|Overall Study|Randomized but never treated|0|||
157014007|NCT05052996|566801881|FG002|Overall Study|Randomized but never treated|1|||
157014008|NCT05052996|566801882|FG003|Overall Study|Randomized but never treated|1|||
157014009|NCT05052996|566801879|FG000|Overall Study|Protocol Violation|1|||
157014010|NCT05052996|566801880|FG001|Overall Study|Protocol Violation|0|||
157014011|NCT05052996|566801881|FG002|Overall Study|Protocol Violation|0|||
157014012|NCT05052996|566801882|FG003|Overall Study|Protocol Violation|0|||
157014013|NCT00510887|566801883|FG000|Overall Study|Lost to Follow-up|1|||
157014014|NCT02238483|566801884|FG000|Overall Study|Withdrawal by Subject|2|||
157014015|NCT02238483|566801885|FG001|Overall Study|Withdrawal by Subject|7|||
157014016|NCT02238483|566801884|FG000|Overall Study|Lost to Follow-up|1|||
156693127|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
156693128|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
157014017|NCT02238483|566801885|FG001|Overall Study|Lost to Follow-up|1|||
157014018|NCT02238483|566801884|FG000|Overall Study|Protocol Violation|1|||
157014019|NCT02238483|566801885|FG001|Overall Study|Protocol Violation|2|||
157014020|NCT02238483|566801884|FG000|Overall Study|Death|1|||
157014021|NCT02238483|566801885|FG001|Overall Study|Death|0|||
157014022|NCT02238483|566801884|FG000|Overall Study|Adverse Event|7|||
156693129|NCT00518882|565621801|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
156693130|NCT00518882|565621802|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
156693131|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
156693132|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
156693133|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
156693134|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
156693135|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
156693136|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
156693137|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
156693138|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
156693139|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
156693140|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
156693141|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
156693142|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
156693143|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
157122252|NCT03728309|567200257|FG000|Overall Study|Randomized but not Treated|0|||
157122253|NCT03728309|567200258|FG001|Overall Study|Randomized but not Treated|1|||
157122254|NCT03728309|567200257|FG000|Overall Study|Adverse Event|0|||
157122255|NCT03728309|567200258|FG001|Overall Study|Adverse Event|1|||
157122256|NCT03728309|567200257|FG000|Overall Study|Withdrawal by Subject|2|||
157122257|NCT03728309|567200258|FG001|Overall Study|Withdrawal by Subject|8|||
157122258|NCT03728309|567200257|FG000|Overall Study|Lost to Follow-up|9|||
157122259|NCT03728309|567200258|FG001|Overall Study|Lost to Follow-up|10|||
157122260|NCT03728309|567200257|FG000|Overall Study|Protocol Deviation|0|||
157122261|NCT03728309|567200258|FG001|Overall Study|Protocol Deviation|1|||
157122262|NCT03728309|567200257|FG000|Overall Study|Due to COVID|1|||
157122263|NCT03728309|567200258|FG001|Overall Study|Due to COVID|3|||
157122264|NCT00953758|567200259|FG000|Overall Study|Death|2|||
157122265|NCT00953758|567200260|FG001|Overall Study|Death|0|||
157122266|NCT00953758|567200261|FG002|Overall Study|Death|1|||
157122267|NCT00953758|567200262|FG003|Overall Study|Death|1|||
157122268|NCT00953758|567200263|FG004|Overall Study|Death|1|||
157122269|NCT00953758|567200264|FG005|Overall Study|Death|1|||
157122270|NCT00953758|567200265|FG006|Overall Study|Death|1|||
157122271|NCT00953758|567200266|FG007|Overall Study|Death|3|||
157122272|NCT00953758|567200267|FG008|Overall Study|Death|1|||
157122273|NCT00953758|567200268|FG009|Overall Study|Death|0|||
157122274|NCT00953758|567200259|FG000|Overall Study|Participant refused further follow-up|0|||
157122275|NCT00953758|567200260|FG001|Overall Study|Participant refused further follow-up|0|||
157122276|NCT00953758|567200261|FG002|Overall Study|Participant refused further follow-up|1|||
157122277|NCT00953758|567200262|FG003|Overall Study|Participant refused further follow-up|0|||
157122278|NCT00953758|567200263|FG004|Overall Study|Participant refused further follow-up|3|||
157122279|NCT00953758|567200264|FG005|Overall Study|Participant refused further follow-up|0|||
157122280|NCT00953758|567200265|FG006|Overall Study|Participant refused further follow-up|0|||
157122281|NCT00953758|567200266|FG007|Overall Study|Participant refused further follow-up|0|||
157122282|NCT00953758|567200267|FG008|Overall Study|Participant refused further follow-up|1|||
157122283|NCT00953758|567200268|FG009|Overall Study|Participant refused further follow-up|0|||
157122284|NCT00953758|567200259|FG000|Overall Study|Lost to Follow-up|0|||
157122285|NCT00953758|567200260|FG001|Overall Study|Lost to Follow-up|0|||
157122286|NCT00953758|567200261|FG002|Overall Study|Lost to Follow-up|0|||
157122287|NCT00953758|567200262|FG003|Overall Study|Lost to Follow-up|1|||
157122288|NCT00953758|567200263|FG004|Overall Study|Lost to Follow-up|0|||
157122289|NCT00953758|567200264|FG005|Overall Study|Lost to Follow-up|0|||
157122290|NCT00953758|567200265|FG006|Overall Study|Lost to Follow-up|0|||
157122291|NCT00953758|567200266|FG007|Overall Study|Lost to Follow-up|1|||
157122292|NCT00953758|567200267|FG008|Overall Study|Lost to Follow-up|0|||
157122293|NCT00953758|567200268|FG009|Overall Study|Lost to Follow-up|1|||
157122294|NCT00953758|567200259|FG000|Overall Study|Physician Decision|0|||
157122295|NCT00953758|567200260|FG001|Overall Study|Physician Decision|0|||
157122296|NCT00953758|567200261|FG002|Overall Study|Physician Decision|0|||
157122297|NCT00953758|567200262|FG003|Overall Study|Physician Decision|0|||
157122298|NCT00953758|567200263|FG004|Overall Study|Physician Decision|1|||
156693144|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
156693145|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
156693146|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
156693147|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
156693148|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
156693149|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
157122299|NCT00953758|567200264|FG005|Overall Study|Physician Decision|0|||
157122300|NCT00953758|567200265|FG006|Overall Study|Physician Decision|0|||
157122301|NCT00953758|567200266|FG007|Overall Study|Physician Decision|0|||
157122302|NCT00953758|567200267|FG008|Overall Study|Physician Decision|0|||
157122303|NCT00953758|567200268|FG009|Overall Study|Physician Decision|0|||
157122304|NCT00953758|567200259|FG000|Overall Study|Disease progression|0|||
157122305|NCT00953758|567200260|FG001|Overall Study|Disease progression|0|||
157122306|NCT00953758|567200261|FG002|Overall Study|Disease progression|0|||
157122307|NCT00953758|567200262|FG003|Overall Study|Disease progression|0|||
157122308|NCT00953758|567200263|FG004|Overall Study|Disease progression|1|||
157122309|NCT00953758|567200264|FG005|Overall Study|Disease progression|0|||
157122310|NCT00953758|567200265|FG006|Overall Study|Disease progression|0|||
157122311|NCT00953758|567200266|FG007|Overall Study|Disease progression|0|||
157122312|NCT00953758|567200267|FG008|Overall Study|Disease progression|0|||
157122313|NCT00953758|567200268|FG009|Overall Study|Disease progression|0|||
157122314|NCT00953758|567200259|FG000|Overall Study|Participant went for transplant|0|||
157122315|NCT00953758|567200260|FG001|Overall Study|Participant went for transplant|0|||
157122316|NCT00953758|567200261|FG002|Overall Study|Participant went for transplant|0|||
157122317|NCT00953758|567200262|FG003|Overall Study|Participant went for transplant|0|||
157122318|NCT00953758|567200263|FG004|Overall Study|Participant went for transplant|0|||
157122319|NCT00953758|567200264|FG005|Overall Study|Participant went for transplant|0|||
157122320|NCT00953758|567200265|FG006|Overall Study|Participant went for transplant|0|||
157122321|NCT00953758|567200266|FG007|Overall Study|Participant went for transplant|0|||
157122322|NCT00953758|567200267|FG008|Overall Study|Participant went for transplant|1|||
157122323|NCT00953758|567200268|FG009|Overall Study|Participant went for transplant|0|||
157122324|NCT00927095|567200271|FG000|Overall Study|Adverse Event|3|||
157122325|NCT00927095|567200272|FG001|Overall Study|Adverse Event|1|||
157122326|NCT00927095|567200273|FG002|Overall Study|Adverse Event|0|||
157122327|NCT00927095|567200271|FG000|Overall Study|Withdrawal by Subject|2|||
157122328|NCT00927095|567200272|FG001|Overall Study|Withdrawal by Subject|1|||
157122329|NCT00927095|567200273|FG002|Overall Study|Withdrawal by Subject|1|||
156693150|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
156693151|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
156693152|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
156693153|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
156693154|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
156693155|NCT00518882|565621801|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
156693156|NCT00518882|565621802|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
156693157|NCT02696031|565621803|FG000|Up to Week 24|Adverse Event|2|||
156693158|NCT02696031|565621804|FG001|Up to Week 24|Adverse Event|4|||
156693159|NCT02696031|565621805|FG002|Up to Week 24|Adverse Event|2|||
156693160|NCT02696031|565621806|FG003|Up to Week 24|Adverse Event|0|||
156693161|NCT02696031|565621807|FG004|Up to Week 24|Adverse Event|0|||
156693162|NCT02696031|565621808|FG005|Up to Week 24|Adverse Event|0|||
156693163|NCT02696031|565621803|FG000|Up to Week 24|Lack of Efficacy|2|||
156693164|NCT02696031|565621804|FG001|Up to Week 24|Lack of Efficacy|1|||
156693165|NCT02696031|565621805|FG002|Up to Week 24|Lack of Efficacy|2|||
156693166|NCT02696031|565621806|FG003|Up to Week 24|Lack of Efficacy|0|||
156693167|NCT02696031|565621807|FG004|Up to Week 24|Lack of Efficacy|0|||
156693168|NCT02696031|565621808|FG005|Up to Week 24|Lack of Efficacy|0|||
156693169|NCT02696031|565621803|FG000|Up to Week 24|Lost to Follow-up|0|||
156693170|NCT02696031|565621804|FG001|Up to Week 24|Lost to Follow-up|1|||
156693171|NCT02696031|565621805|FG002|Up to Week 24|Lost to Follow-up|1|||
156693172|NCT02696031|565621806|FG003|Up to Week 24|Lost to Follow-up|0|||
156693173|NCT02696031|565621807|FG004|Up to Week 24|Lost to Follow-up|0|||
156693174|NCT02696031|565621808|FG005|Up to Week 24|Lost to Follow-up|0|||
156693175|NCT02696031|565621803|FG000|Up to Week 24|Physician Decision|1|||
156693176|NCT02696031|565621804|FG001|Up to Week 24|Physician Decision|0|||
156693177|NCT02696031|565621805|FG002|Up to Week 24|Physician Decision|1|||
156693178|NCT02696031|565621806|FG003|Up to Week 24|Physician Decision|0|||
156693179|NCT02696031|565621807|FG004|Up to Week 24|Physician Decision|0|||
156693180|NCT02696031|565621808|FG005|Up to Week 24|Physician Decision|0|||
156693181|NCT02696031|565621803|FG000|Up to Week 24|Protocol Violation|1|||
156693182|NCT02696031|565621804|FG001|Up to Week 24|Protocol Violation|0|||
156693183|NCT02696031|565621805|FG002|Up to Week 24|Protocol Violation|0|||
157122330|NCT00927095|567200271|FG000|Overall Study|Physician Decision|1|||
156693184|NCT02696031|565621806|FG003|Up to Week 24|Protocol Violation|0|||
156693185|NCT02696031|565621807|FG004|Up to Week 24|Protocol Violation|0|||
156693186|NCT02696031|565621808|FG005|Up to Week 24|Protocol Violation|0|||
157122331|NCT00927095|567200272|FG001|Overall Study|Physician Decision|2|||
157122332|NCT00927095|567200273|FG002|Overall Study|Physician Decision|1|||
157122333|NCT00044512|567200280|FG000|Follow Up|Lost to Follow-up|2|||
157122334|NCT02678390|567200283|FG000|AE (1 Day)|Withdrawal by Subject|0|||
157214557|NCT01027884|567531931|FG001|Overall Study|Protocol Violation|0|||
156788905|NCT01213251|565979071|FG001|Overall Study|Protocol Violation|1|||
156788906|NCT01213251|565979072|FG002|Overall Study|Protocol Violation|0|||
156788907|NCT01213251|565979070|FG000|Overall Study|Missed 18-Month Follow-up|0|||
157122335|NCT02678390|567200284|FG001|AE (1 Day)|Withdrawal by Subject|1|||
157122336|NCT00852995|567200285|FG000|Overall Study|Adverse Event|1|||
157122337|NCT00852995|567200286|FG001|Overall Study|Adverse Event|0|||
157122338|NCT00852995|567200287|FG002|Overall Study|Adverse Event|4|||
156693187|NCT02696031|565621803|FG000|Up to Week 24|Withdrawal by Subject|4|||
156693188|NCT02696031|565621804|FG001|Up to Week 24|Withdrawal by Subject|1|||
156788908|NCT01213251|565979071|FG001|Overall Study|Missed 18-Month Follow-up|0|||
156693189|NCT02696031|565621805|FG002|Up to Week 24|Withdrawal by Subject|5|||
156693190|NCT02696031|565621806|FG003|Up to Week 24|Withdrawal by Subject|0|||
156693191|NCT02696031|565621807|FG004|Up to Week 24|Withdrawal by Subject|0|||
156693192|NCT02696031|565621808|FG005|Up to Week 24|Withdrawal by Subject|0|||
156693193|NCT02696031|565621803|FG000|Up to Week 52|Adverse Event|4|||
156693194|NCT02696031|565621804|FG001|Up to Week 52|Adverse Event|5|||
156693195|NCT02696031|565621805|FG002|Up to Week 52|Adverse Event|3|||
156693196|NCT02696031|565621806|FG003|Up to Week 52|Adverse Event|0|||
156693197|NCT02696031|565621807|FG004|Up to Week 52|Adverse Event|0|||
156693198|NCT02696031|565621808|FG005|Up to Week 52|Adverse Event|0|||
156693199|NCT02696031|565621803|FG000|Up to Week 52|Lack of Efficacy|10|||
156693200|NCT02696031|565621804|FG001|Up to Week 52|Lack of Efficacy|7|||
156693201|NCT02696031|565621805|FG002|Up to Week 52|Lack of Efficacy|11|||
156693202|NCT02696031|565621806|FG003|Up to Week 52|Lack of Efficacy|0|||
156693203|NCT02696031|565621807|FG004|Up to Week 52|Lack of Efficacy|0|||
156693204|NCT02696031|565621808|FG005|Up to Week 52|Lack of Efficacy|0|||
156693205|NCT02696031|565621803|FG000|Up to Week 52|Lost to Follow-up|1|||
156693206|NCT02696031|565621804|FG001|Up to Week 52|Lost to Follow-up|1|||
156693207|NCT02696031|565621805|FG002|Up to Week 52|Lost to Follow-up|1|||
156693208|NCT02696031|565621806|FG003|Up to Week 52|Lost to Follow-up|0|||
156693209|NCT02696031|565621807|FG004|Up to Week 52|Lost to Follow-up|0|||
156693210|NCT02696031|565621808|FG005|Up to Week 52|Lost to Follow-up|0|||
156693211|NCT02696031|565621803|FG000|Up to Week 52|Physician Decision|1|||
156693212|NCT02696031|565621804|FG001|Up to Week 52|Physician Decision|1|||
156693213|NCT02696031|565621805|FG002|Up to Week 52|Physician Decision|2|||
156693214|NCT02696031|565621806|FG003|Up to Week 52|Physician Decision|0|||
156693215|NCT02696031|565621807|FG004|Up to Week 52|Physician Decision|0|||
156693216|NCT02696031|565621808|FG005|Up to Week 52|Physician Decision|0|||
156693217|NCT02696031|565621803|FG000|Up to Week 52|Pregnancy|0|||
156693218|NCT02696031|565621804|FG001|Up to Week 52|Pregnancy|2|||
156693219|NCT02696031|565621805|FG002|Up to Week 52|Pregnancy|0|||
156693220|NCT02696031|565621806|FG003|Up to Week 52|Pregnancy|0|||
156693221|NCT02696031|565621807|FG004|Up to Week 52|Pregnancy|0|||
156693222|NCT02696031|565621808|FG005|Up to Week 52|Pregnancy|0|||
156693223|NCT02696031|565621803|FG000|Up to Week 52|Protocol Violation|1|||
156693224|NCT02696031|565621804|FG001|Up to Week 52|Protocol Violation|0|||
156693225|NCT02696031|565621805|FG002|Up to Week 52|Protocol Violation|0|||
156693226|NCT02696031|565621806|FG003|Up to Week 52|Protocol Violation|0|||
156693227|NCT02696031|565621807|FG004|Up to Week 52|Protocol Violation|0|||
156693228|NCT02696031|565621808|FG005|Up to Week 52|Protocol Violation|0|||
156693229|NCT02696031|565621803|FG000|Up to Week 52|Withdrawal by Subject|12|||
156693230|NCT02696031|565621804|FG001|Up to Week 52|Withdrawal by Subject|3|||
156693231|NCT02696031|565621805|FG002|Up to Week 52|Withdrawal by Subject|9|||
156693232|NCT02696031|565621806|FG003|Up to Week 52|Withdrawal by Subject|0|||
156693233|NCT02696031|565621807|FG004|Up to Week 52|Withdrawal by Subject|0|||
156693234|NCT02696031|565621808|FG005|Up to Week 52|Withdrawal by Subject|0|||
156693235|NCT02696031|565621803|FG000|Up to Week 104|Pregnancy|0|||
156693236|NCT02696031|565621804|FG001|Up to Week 104|Pregnancy|2|||
156693237|NCT02696031|565621805|FG002|Up to Week 104|Pregnancy|1|||
156788909|NCT01213251|565979072|FG002|Overall Study|Missed 18-Month Follow-up|1|||
156788910|NCT02698787|565979073|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
156788911|NCT02698787|565979074|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
156788912|NCT01882829|565979076|FG000|Overall Study|Adverse Event|4|||
156788913|NCT01882829|565979076|FG000|Overall Study|Protocol Violation|1|||
156788914|NCT01882829|565979076|FG000|Overall Study|Withdrawal by Subject|1|||
156788915|NCT00326495|565979084|FG000|Overall Study|Switched to alternative treatment|1|||
156788916|NCT00326495|565979084|FG000|Overall Study|Disease progression before treatment|1|||
156788917|NCT00326495|565979084|FG000|Overall Study|Refused further treatment|2|||
156788918|NCT00326495|565979084|FG000|Overall Study|Subject off study before assessment|1|||
156788919|NCT02802865|565979085|FG000|Overall Study|Pregnancy|1|||
156788920|NCT02802865|565979086|FG001|Overall Study|Pregnancy|1|||
156693238|NCT02696031|565621806|FG003|Up to Week 104|Pregnancy|0|||
156693239|NCT02696031|565621807|FG004|Up to Week 104|Pregnancy|0|||
156693240|NCT02696031|565621808|FG005|Up to Week 104|Pregnancy|0|||
156693241|NCT02696031|565621803|FG000|Up to Week 104|Withdrawal by Subject|15|||
156693242|NCT02696031|565621804|FG001|Up to Week 104|Withdrawal by Subject|10|||
156693243|NCT02696031|565621805|FG002|Up to Week 104|Withdrawal by Subject|16|||
156693244|NCT02696031|565621806|FG003|Up to Week 104|Withdrawal by Subject|0|||
156788921|NCT02802865|565979085|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
157214558|NCT01027884|567531930|FG000|Overall Study|Non-compliance|1|||
156693245|NCT02696031|565621807|FG004|Up to Week 104|Withdrawal by Subject|0|||
156693246|NCT02696031|565621808|FG005|Up to Week 104|Withdrawal by Subject|0|||
156693247|NCT02696031|565621803|FG000|Up to Week 104|Protocol Violation|1|||
156693248|NCT02696031|565621804|FG001|Up to Week 104|Protocol Violation|0|||
156693249|NCT02696031|565621805|FG002|Up to Week 104|Protocol Violation|0|||
156693250|NCT02696031|565621806|FG003|Up to Week 104|Protocol Violation|0|||
156693251|NCT02696031|565621807|FG004|Up to Week 104|Protocol Violation|0|||
156788922|NCT02802865|565979086|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
156788923|NCT01862029|565979087|FG000|Overall Study|Physician Decision|1|||
156693252|NCT02696031|565621808|FG005|Up to Week 104|Protocol Violation|0|||
156693253|NCT02696031|565621803|FG000|Up to Week 104|Physician Decision|1|||
156693254|NCT02696031|565621804|FG001|Up to Week 104|Physician Decision|2|||
156693255|NCT02696031|565621805|FG002|Up to Week 104|Physician Decision|3|||
156693256|NCT02696031|565621806|FG003|Up to Week 104|Physician Decision|0|||
156693257|NCT02696031|565621807|FG004|Up to Week 104|Physician Decision|0|||
156693258|NCT02696031|565621808|FG005|Up to Week 104|Physician Decision|0|||
157122339|NCT00852995|567200288|FG003|Overall Study|Adverse Event|0|||
157122340|NCT00852995|567200289|FG004|Overall Study|Adverse Event|0|||
157122341|NCT00852995|567200285|FG000|Overall Study|Lost to Follow-up|0|||
157122342|NCT00852995|567200286|FG001|Overall Study|Lost to Follow-up|1|||
157122343|NCT00852995|567200287|FG002|Overall Study|Lost to Follow-up|1|||
157122344|NCT00852995|567200288|FG003|Overall Study|Lost to Follow-up|0|||
157122345|NCT00852995|567200289|FG004|Overall Study|Lost to Follow-up|0|||
157122346|NCT00852995|567200285|FG000|Overall Study|Withdrawal by Subject|4|||
157122347|NCT00852995|567200286|FG001|Overall Study|Withdrawal by Subject|0|||
157122348|NCT00852995|567200287|FG002|Overall Study|Withdrawal by Subject|0|||
157122349|NCT00852995|567200288|FG003|Overall Study|Withdrawal by Subject|1|||
157122350|NCT00852995|567200289|FG004|Overall Study|Withdrawal by Subject|2|||
157122351|NCT00852995|567200285|FG000|Overall Study|Non-Compliance|0|||
157122352|NCT00852995|567200286|FG001|Overall Study|Non-Compliance|0|||
157122353|NCT00852995|567200287|FG002|Overall Study|Non-Compliance|0|||
157122354|NCT00852995|567200288|FG003|Overall Study|Non-Compliance|2|||
157122355|NCT00852995|567200289|FG004|Overall Study|Non-Compliance|0|||
157122356|NCT00852995|567200285|FG000|Overall Study|Progressive Disease|1|||
157122357|NCT00852995|567200286|FG001|Overall Study|Progressive Disease|0|||
157122358|NCT00852995|567200287|FG002|Overall Study|Progressive Disease|0|||
157122359|NCT00852995|567200288|FG003|Overall Study|Progressive Disease|2|||
157122360|NCT00852995|567200289|FG004|Overall Study|Progressive Disease|1|||
157122361|NCT00852995|567200285|FG000|Overall Study|Physician Decision|1|||
157122362|NCT00852995|567200286|FG001|Overall Study|Physician Decision|0|||
157122363|NCT00852995|567200287|FG002|Overall Study|Physician Decision|0|||
157122364|NCT00852995|567200288|FG003|Overall Study|Physician Decision|0|||
157122365|NCT00852995|567200289|FG004|Overall Study|Physician Decision|0|||
157122366|NCT00852995|567200285|FG000|Overall Study|Protocol Violation|0|||
157122367|NCT00852995|567200286|FG001|Overall Study|Protocol Violation|0|||
157122368|NCT00852995|567200287|FG002|Overall Study|Protocol Violation|0|||
157122369|NCT00852995|567200288|FG003|Overall Study|Protocol Violation|0|||
157122370|NCT00852995|567200289|FG004|Overall Study|Protocol Violation|1|||
156693259|NCT02696031|565621803|FG000|Up to Week 104|Lost to Follow-up|2|||
157122371|NCT00852995|567200285|FG000|Overall Study|Moved Out of Area|1|||
156788924|NCT03931785|565979088|FG000|Overall Study|Lost to Follow-up|4|||
156788925|NCT03931785|565979089|FG001|Overall Study|Lost to Follow-up|1|||
156788926|NCT03931785|565979090|FG002|Overall Study|Lost to Follow-up|4|||
156788927|NCT03931785|565979091|FG003|Overall Study|Lost to Follow-up|3|||
156788928|NCT03931785|565979088|FG000|Overall Study|Adverse Event|1|||
156788929|NCT03931785|565979089|FG001|Overall Study|Adverse Event|0|||
156788930|NCT03931785|565979090|FG002|Overall Study|Adverse Event|3|||
156788931|NCT03931785|565979091|FG003|Overall Study|Adverse Event|4|||
156788932|NCT03931785|565979088|FG000|Overall Study|Protocol Violation|0|||
156788933|NCT03931785|565979089|FG001|Overall Study|Protocol Violation|1|||
156788934|NCT03931785|565979090|FG002|Overall Study|Protocol Violation|0|||
156788935|NCT03931785|565979091|FG003|Overall Study|Protocol Violation|0|||
156788936|NCT03931785|565979088|FG000|Overall Study|Noncompliance With Study drug|0|||
156788937|NCT03931785|565979089|FG001|Overall Study|Noncompliance With Study drug|1|||
156788938|NCT03931785|565979090|FG002|Overall Study|Noncompliance With Study drug|0|||
156788939|NCT03931785|565979091|FG003|Overall Study|Noncompliance With Study drug|0|||
156788940|NCT03931785|565979088|FG000|Overall Study|Other Not specified|0|||
156788941|NCT03931785|565979089|FG001|Overall Study|Other Not specified|2|||
156788942|NCT03931785|565979090|FG002|Overall Study|Other Not specified|2|||
156788943|NCT03931785|565979091|FG003|Overall Study|Other Not specified|2|||
156788944|NCT03931785|565979088|FG000|Overall Study|Withdrawal by Subject|0|||
156788945|NCT03931785|565979089|FG001|Overall Study|Withdrawal by Subject|2|||
156788946|NCT03931785|565979090|FG002|Overall Study|Withdrawal by Subject|4|||
156788947|NCT03931785|565979091|FG003|Overall Study|Withdrawal by Subject|1|||
156788948|NCT03931785|565979088|FG000|Overall Study|Pregnancy|0|||
157122372|NCT00852995|567200286|FG001|Overall Study|Moved Out of Area|0|||
157122373|NCT00852995|567200287|FG002|Overall Study|Moved Out of Area|0|||
157122374|NCT00852995|567200288|FG003|Overall Study|Moved Out of Area|0|||
156693260|NCT02696031|565621804|FG001|Up to Week 104|Lost to Follow-up|3|||
157122375|NCT00852995|567200289|FG004|Overall Study|Moved Out of Area|0|||
157122376|NCT03499028|567200290|FG000|Overall Study|Lost to Follow-up|12|||
157122377|NCT03499028|567200291|FG001|Overall Study|Lost to Follow-up|9|||
157122378|NCT03499028|567200290|FG000|Overall Study|Withdrawal by Subject|5|||
157122379|NCT03499028|567200291|FG001|Overall Study|Withdrawal by Subject|8|||
156788949|NCT03931785|565979089|FG001|Overall Study|Pregnancy|0|||
156788950|NCT03931785|565979090|FG002|Overall Study|Pregnancy|0|||
156788951|NCT03931785|565979091|FG003|Overall Study|Pregnancy|1|||
156788952|NCT03211858|565979092|FG000|Overall Study|Adverse Event|8|||
157122380|NCT03499028|567200290|FG000|Overall Study|Unplanned SNF discharge|5|||
157122381|NCT03499028|567200291|FG001|Overall Study|Unplanned SNF discharge|8|||
157122382|NCT01110200|567200292|FG000|Overall Study|Adverse Event|28|||
157122383|NCT01110200|567200293|FG001|Overall Study|Adverse Event|28|||
157122384|NCT01110200|567200292|FG000|Overall Study|Withdrawal by Subject|25|||
157122385|NCT01110200|567200293|FG001|Overall Study|Withdrawal by Subject|32|||
157122386|NCT01110200|567200292|FG000|Overall Study|Lack of Efficacy|16|||
157122387|NCT01110200|567200293|FG001|Overall Study|Lack of Efficacy|25|||
157122388|NCT01110200|567200292|FG000|Overall Study|Protocol Violation|14|||
157122389|NCT01110200|567200293|FG001|Overall Study|Protocol Violation|12|||
157122390|NCT01110200|567200292|FG000|Overall Study|Physician Decision|13|||
157122391|NCT01110200|567200293|FG001|Overall Study|Physician Decision|17|||
157122392|NCT01110200|567200292|FG000|Overall Study|Lost to Follow-up|10|||
157122393|NCT01110200|567200293|FG001|Overall Study|Lost to Follow-up|7|||
157122394|NCT01437397|567200294|FG000|Overall Study|Lost to Follow-up|9|||
157122395|NCT01437397|567200295|FG001|Overall Study|Lost to Follow-up|4|||
157122396|NCT01437397|567200296|FG002|Overall Study|Lost to Follow-up|2|||
157122397|NCT01437397|567200297|FG003|Overall Study|Lost to Follow-up|4|||
157122398|NCT01437397|567200298|FG004|Overall Study|Lost to Follow-up|5|||
157122399|NCT01437397|567200294|FG000|Overall Study|Withdrawal by Subject|11|||
157122400|NCT01437397|567200295|FG001|Overall Study|Withdrawal by Subject|12|||
157122401|NCT01437397|567200296|FG002|Overall Study|Withdrawal by Subject|24|||
157122402|NCT01437397|567200297|FG003|Overall Study|Withdrawal by Subject|11|||
157122403|NCT01437397|567200298|FG004|Overall Study|Withdrawal by Subject|22|||
157122404|NCT01437397|567200294|FG000|Overall Study|Protocol Violation|10|||
157122405|NCT01437397|567200295|FG001|Overall Study|Protocol Violation|12|||
157122406|NCT01437397|567200296|FG002|Overall Study|Protocol Violation|13|||
157122407|NCT01437397|567200297|FG003|Overall Study|Protocol Violation|21|||
157122408|NCT01437397|567200298|FG004|Overall Study|Protocol Violation|19|||
157122409|NCT01437397|567200294|FG000|Overall Study|Lack of Efficacy|5|||
157122410|NCT01437397|567200295|FG001|Overall Study|Lack of Efficacy|4|||
157122411|NCT01437397|567200296|FG002|Overall Study|Lack of Efficacy|8|||
157122412|NCT01437397|567200297|FG003|Overall Study|Lack of Efficacy|10|||
157122413|NCT01437397|567200298|FG004|Overall Study|Lack of Efficacy|20|||
157122414|NCT01437397|567200294|FG000|Overall Study|Adverse Event|21|||
157122415|NCT01437397|567200295|FG001|Overall Study|Adverse Event|22|||
157122416|NCT01437397|567200296|FG002|Overall Study|Adverse Event|16|||
157122417|NCT01437397|567200297|FG003|Overall Study|Adverse Event|14|||
157122418|NCT01437397|567200298|FG004|Overall Study|Adverse Event|21|||
157122419|NCT01437397|567200294|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
157122420|NCT01437397|567200295|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
157122421|NCT01437397|567200296|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
157122422|NCT01437397|567200297|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
156870367|NCT01177397|566282501|FG009|Overall Study|Adverse Event|6|||
156870368|NCT01177397|566282502|FG010|Overall Study|Adverse Event|3|||
156870369|NCT01177397|566282503|FG011|Overall Study|Adverse Event|7|||
156870370|NCT01177397|566282492|FG000|Overall Study|Disease progression|1|||
156870371|NCT01177397|566282493|FG001|Overall Study|Disease progression|2|||
156870372|NCT01177397|566282494|FG002|Overall Study|Disease progression|5|||
156870373|NCT01177397|566282495|FG003|Overall Study|Disease progression|5|||
156870374|NCT01177397|566282496|FG004|Overall Study|Disease progression|4|||
156870375|NCT01177397|566282497|FG005|Overall Study|Disease progression|10|||
156870376|NCT01177397|566282498|FG006|Overall Study|Disease progression|10|||
156870377|NCT01177397|566282499|FG007|Overall Study|Disease progression|21|||
156788953|NCT03211858|565979093|FG001|Overall Study|Adverse Event|6|||
156788954|NCT03211858|565979092|FG000|Overall Study|Lack of Efficacy|0|||
156788955|NCT03211858|565979093|FG001|Overall Study|Lack of Efficacy|4|||
156788956|NCT03211858|565979092|FG000|Overall Study|Poor compliance to protocol|6|||
156788957|NCT03211858|565979093|FG001|Overall Study|Poor compliance to protocol|2|||
156788958|NCT03211858|565979092|FG000|Overall Study|Non-serious Hypoglycemia|1|||
156788959|NCT03211858|565979093|FG001|Overall Study|Non-serious Hypoglycemia|0|||
156788960|NCT03211858|565979092|FG000|Overall Study|Other than specified above|22|||
156788961|NCT03211858|565979093|FG001|Overall Study|Other than specified above|21|||
156788962|NCT01529112|565979096|FG000|Overall Study|Adverse Event|2|||
156788963|NCT01529112|565979097|FG001|Overall Study|Adverse Event|0|||
156788964|NCT01529112|565979096|FG000|Overall Study|Death|59|||
156788965|NCT01529112|565979097|FG001|Overall Study|Death|38|||
156788966|NCT01529112|565979096|FG000|Overall Study|Protocol Violation|1|||
156788967|NCT01529112|565979097|FG001|Overall Study|Protocol Violation|0|||
156788968|NCT01529112|565979096|FG000|Overall Study|Withdrawal by Subject|7|||
156788969|NCT01529112|565979097|FG001|Overall Study|Withdrawal by Subject|3|||
156788970|NCT04034056|565979102|FG000|Overall Study|Withdrawal by Subject|2|||
156788971|NCT04034056|565979102|FG000|Overall Study|Reason Not Specified|13|||
156870378|NCT01177397|566282500|FG008|Overall Study|Disease progression|18|||
156870379|NCT01177397|566282501|FG009|Overall Study|Disease progression|12|||
157122423|NCT01437397|567200298|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
156788972|NCT04034056|565979102|FG000|Overall Study|Adverse Event|56|||
156788973|NCT04135352|565979104|FG000|Overall Study|Not treated-randomization error|0|||
156870380|NCT01177397|566282502|FG010|Overall Study|Disease progression|10|||
157122424|NCT00866307|567200300|FG000|Induction|Adverse Event|5|||
156870381|NCT01177397|566282503|FG011|Overall Study|Disease progression|8|||
156870382|NCT01177397|566282492|FG000|Overall Study|Other reasons|0|||
156870383|NCT01177397|566282493|FG001|Overall Study|Other reasons|0|||
156870384|NCT01177397|566282494|FG002|Overall Study|Other reasons|1|||
156870385|NCT01177397|566282495|FG003|Overall Study|Other reasons|0|||
157014023|NCT02238483|566801885|FG001|Overall Study|Adverse Event|3|||
157014024|NCT02238483|566801884|FG000|Overall Study|Withdrawn due to physician decision|1|||
157014025|NCT02238483|566801885|FG001|Overall Study|Withdrawn due to physician decision|0|||
157014026|NCT02238483|566801884|FG000|Overall Study|Completion status not recorded|1|||
157014027|NCT02238483|566801885|FG001|Overall Study|Completion status not recorded|1|||
157014028|NCT02238483|566801884|FG000|Overall Study|Illness in family member|1|||
157014029|NCT02238483|566801885|FG001|Overall Study|Illness in family member|0|||
157014030|NCT00331136|566801891|FG000|Overall Study|Adverse Event|3|||
157014031|NCT00331136|566801892|FG001|Overall Study|Adverse Event|5|||
157014032|NCT00331136|566801893|FG002|Overall Study|Adverse Event|0|||
157014033|NCT00331136|566801894|FG003|Overall Study|Adverse Event|1|||
157014034|NCT00331136|566801891|FG000|Overall Study|Withdrawal by Subject|0|||
157014035|NCT00331136|566801892|FG001|Overall Study|Withdrawal by Subject|1|||
157014036|NCT00331136|566801893|FG002|Overall Study|Withdrawal by Subject|0|||
157014037|NCT00331136|566801894|FG003|Overall Study|Withdrawal by Subject|0|||
157014038|NCT00331136|566801891|FG000|Overall Study|Lost to Follow-up|0|||
157014039|NCT00331136|566801892|FG001|Overall Study|Lost to Follow-up|1|||
157014040|NCT00331136|566801893|FG002|Overall Study|Lost to Follow-up|0|||
157014041|NCT00331136|566801894|FG003|Overall Study|Lost to Follow-up|0|||
157014042|NCT00331136|566801891|FG000|Overall Study|Protocol Violation|1|||
157014043|NCT00331136|566801892|FG001|Overall Study|Protocol Violation|0|||
157014044|NCT00331136|566801893|FG002|Overall Study|Protocol Violation|0|||
157014045|NCT00331136|566801894|FG003|Overall Study|Protocol Violation|0|||
157014046|NCT00331136|566801891|FG000|Overall Study|Not treated|1|||
157014047|NCT00331136|566801892|FG001|Overall Study|Not treated|0|||
157014048|NCT00331136|566801893|FG002|Overall Study|Not treated|0|||
157014049|NCT00331136|566801894|FG003|Overall Study|Not treated|0|||
157014050|NCT02321514|566801895|FG000|Overall Study|Death|15|||
157014051|NCT02321514|566801895|FG000|Overall Study|Missed Visit|7|||
157014052|NCT02321514|566801895|FG000|Overall Study|Study Exit|3|||
157014053|NCT00393484|566801900|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
157014054|NCT00393484|566801901|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
157014055|NCT00393484|566801900|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
157014056|NCT00393484|566801901|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
157014057|NCT00393484|566801900|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
157014058|NCT00393484|566801901|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
157014059|NCT00393484|566801900|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
157014060|NCT00393484|566801901|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
157014061|NCT00393484|566801900|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
157014062|NCT00393484|566801901|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
157014063|NCT00393484|566801900|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
157014064|NCT00393484|566801901|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
157014065|NCT00393484|566801900|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
157014066|NCT00393484|566801901|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
157014067|NCT00393484|566801900|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
157014068|NCT00393484|566801901|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
157014069|NCT00393484|566801900|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
157014070|NCT00393484|566801901|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
157014071|NCT00393484|566801900|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
157014072|NCT00393484|566801901|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
157014073|NCT03201562|566801902|FG000|Overall Study|Physician Decision|0|||
157014074|NCT03201562|566801903|FG001|Overall Study|Physician Decision|0|||
157014075|NCT03201562|566801904|FG002|Overall Study|Physician Decision|1|||
157014076|NCT03201562|566801902|FG000|Overall Study|Adverse Event|0|||
157014077|NCT03201562|566801903|FG001|Overall Study|Adverse Event|0|||
157014078|NCT03201562|566801904|FG002|Overall Study|Adverse Event|1|||
157014079|NCT03201562|566801902|FG000|Overall Study|Lost to Follow-up|0|||
157014080|NCT03201562|566801903|FG001|Overall Study|Lost to Follow-up|1|||
157014081|NCT03201562|566801904|FG002|Overall Study|Lost to Follow-up|2|||
157014082|NCT01551355|566801910|FG000|Overall Study|Lost to Follow-up|51|||
157014083|NCT01551355|566801911|FG001|Overall Study|Lost to Follow-up|49|||
157014084|NCT01551355|566801912|FG002|Overall Study|Lost to Follow-up|34|||
157014085|NCT01551355|566801913|FG003|Overall Study|Lost to Follow-up|24|||
156870386|NCT01177397|566282496|FG004|Overall Study|Other reasons|1|||
157014086|NCT01551355|566801914|FG004|Overall Study|Lost to Follow-up|9|||
157014087|NCT01551355|566801915|FG005|Overall Study|Lost to Follow-up|6|||
157014088|NCT02318134|566801916|FG000|Overall Study|Withdrawal by Subject|2|||
157014089|NCT02318134|566801917|FG001|Overall Study|Withdrawal by Subject|1|||
157014090|NCT01094184|566801918|FG000|Overall Study|Death|35|||
157014091|NCT01094184|566801919|FG001|Overall Study|Death|11|||
157014092|NCT00031694|566801920|FG000|Overall Study|Adverse Event|12|||
156693261|NCT02696031|565621805|FG002|Up to Week 104|Lost to Follow-up|1|||
156693262|NCT02696031|565621806|FG003|Up to Week 104|Lost to Follow-up|0|||
156693263|NCT02696031|565621807|FG004|Up to Week 104|Lost to Follow-up|0|||
156693264|NCT02696031|565621808|FG005|Up to Week 104|Lost to Follow-up|0|||
156693265|NCT02696031|565621803|FG000|Up to Week 104|Lack of Efficacy|13|||
156693266|NCT02696031|565621804|FG001|Up to Week 104|Lack of Efficacy|12|||
156693267|NCT02696031|565621805|FG002|Up to Week 104|Lack of Efficacy|11|||
156693268|NCT02696031|565621806|FG003|Up to Week 104|Lack of Efficacy|0|||
156693269|NCT02696031|565621807|FG004|Up to Week 104|Lack of Efficacy|0|||
156693270|NCT02696031|565621808|FG005|Up to Week 104|Lack of Efficacy|0|||
156693271|NCT02696031|565621803|FG000|Up to Week 104|Adverse Event|7|||
156693272|NCT02696031|565621804|FG001|Up to Week 104|Adverse Event|11|||
156693273|NCT02696031|565621805|FG002|Up to Week 104|Adverse Event|5|||
156788974|NCT04135352|565979105|FG001|Overall Study|Not treated-randomization error|0|||
156788975|NCT04135352|565979106|FG002|Overall Study|Not treated-randomization error|1|||
156693274|NCT02696031|565621806|FG003|Up to Week 104|Adverse Event|0|||
156693275|NCT02696031|565621807|FG004|Up to Week 104|Adverse Event|0|||
156693276|NCT02696031|565621808|FG005|Up to Week 104|Adverse Event|0|||
156788976|NCT04135352|565979107|FG003|Overall Study|Not treated-randomization error|0|||
156788977|NCT04135352|565979108|FG004|Overall Study|Not treated-randomization error|0|||
156788978|NCT04135352|565979109|FG005|Overall Study|Not treated-randomization error|0|||
156788979|NCT04135352|565979110|FG006|Overall Study|Not treated-randomization error|0|||
156788980|NCT04135352|565979111|FG007|Overall Study|Not treated-randomization error|0|||
156788981|NCT04135352|565979104|FG000|Overall Study|Withdrawal by Subject|0|||
156788982|NCT04135352|565979105|FG001|Overall Study|Withdrawal by Subject|0|||
156788983|NCT04135352|565979106|FG002|Overall Study|Withdrawal by Subject|2|||
156788984|NCT04135352|565979107|FG003|Overall Study|Withdrawal by Subject|0|||
156788985|NCT04135352|565979108|FG004|Overall Study|Withdrawal by Subject|0|||
156788986|NCT04135352|565979109|FG005|Overall Study|Withdrawal by Subject|0|||
156788987|NCT04135352|565979110|FG006|Overall Study|Withdrawal by Subject|0|||
156788988|NCT04135352|565979111|FG007|Overall Study|Withdrawal by Subject|0|||
156788989|NCT04135352|565979104|FG000|Overall Study|Sponsor Decision|0|||
156788990|NCT04135352|565979105|FG001|Overall Study|Sponsor Decision|0|||
156788991|NCT04135352|565979106|FG002|Overall Study|Sponsor Decision|2|||
156788992|NCT04135352|565979107|FG003|Overall Study|Sponsor Decision|5|||
156788993|NCT04135352|565979108|FG004|Overall Study|Sponsor Decision|1|||
156788994|NCT04135352|565979109|FG005|Overall Study|Sponsor Decision|4|||
156788995|NCT04135352|565979110|FG006|Overall Study|Sponsor Decision|0|||
156788996|NCT04135352|565979111|FG007|Overall Study|Sponsor Decision|0|||
156788997|NCT04135352|565979104|FG000|Overall Study|Physician Decision|0|||
156788998|NCT04135352|565979105|FG001|Overall Study|Physician Decision|0|||
156788999|NCT04135352|565979106|FG002|Overall Study|Physician Decision|1|||
156789000|NCT04135352|565979107|FG003|Overall Study|Physician Decision|0|||
156789001|NCT04135352|565979108|FG004|Overall Study|Physician Decision|1|||
156789002|NCT04135352|565979109|FG005|Overall Study|Physician Decision|0|||
156789003|NCT04135352|565979110|FG006|Overall Study|Physician Decision|0|||
156789004|NCT04135352|565979111|FG007|Overall Study|Physician Decision|0|||
156789005|NCT04135352|565979104|FG000|Overall Study|Death|3|||
156789006|NCT04135352|565979105|FG001|Overall Study|Death|4|||
156789007|NCT04135352|565979106|FG002|Overall Study|Death|7|||
156789008|NCT04135352|565979107|FG003|Overall Study|Death|0|||
156789009|NCT04135352|565979108|FG004|Overall Study|Death|3|||
156789010|NCT04135352|565979109|FG005|Overall Study|Death|1|||
156789011|NCT04135352|565979110|FG006|Overall Study|Death|0|||
156789012|NCT04135352|565979111|FG007|Overall Study|Death|0|||
156789013|NCT00609973|565979112|FG000|Overall Study|Adverse Event|2|||
156789014|NCT00609973|565979113|FG001|Overall Study|Adverse Event|1|||
156789015|NCT00609973|565979112|FG000|Overall Study|Protocol Violation|4|||
156789016|NCT00609973|565979113|FG001|Overall Study|Protocol Violation|3|||
156789017|NCT00609973|565979112|FG000|Overall Study|Lost to Follow-up|2|||
156789018|NCT00609973|565979113|FG001|Overall Study|Lost to Follow-up|1|||
156789019|NCT00609973|565979112|FG000|Overall Study|Withdrawal by Subject|0|||
156789020|NCT00609973|565979113|FG001|Overall Study|Withdrawal by Subject|1|||
156789021|NCT01362270|565979114|FG000|Overall Study|Withdrawal by Subject|1|||
156789022|NCT01362270|565979115|FG001|Overall Study|Withdrawal by Subject|0|||
156789023|NCT01362270|565979114|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
156789024|NCT01362270|565979115|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
156789025|NCT01362270|565979114|FG000|Overall Study|Met excl. criteria before 1st session|1|||
156789026|NCT01362270|565979115|FG001|Overall Study|Met excl. criteria before 1st session|1|||
156789027|NCT01691482|565979118|FG000|Treatment Period 2|Adverse Event|0|||
156789028|NCT01691482|565979119|FG001|Treatment Period 2|Adverse Event|1|||
156789029|NCT01691482|565979118|FG000|Treatment Period 2|Protocol Violation|1|||
156789030|NCT01691482|565979119|FG001|Treatment Period 2|Protocol Violation|1|||
156789031|NCT01392495|565979120|FG000|Overall Study|Death|3|||
156789032|NCT01392495|565979120|FG000|Overall Study|Administrative problems|8|||
156789033|NCT01392495|565979120|FG000|Overall Study|Withdrawal by Subject|2|||
156870387|NCT01177397|566282497|FG005|Overall Study|Other reasons|1|||
156870388|NCT01177397|566282498|FG006|Overall Study|Other reasons|2|||
156870389|NCT01177397|566282499|FG007|Overall Study|Other reasons|6|||
156870390|NCT01177397|566282500|FG008|Overall Study|Other reasons|10|||
156870391|NCT01177397|566282501|FG009|Overall Study|Other reasons|8|||
156870392|NCT01177397|566282502|FG010|Overall Study|Other reasons|0|||
156870393|NCT01177397|566282503|FG011|Overall Study|Other reasons|2|||
156870394|NCT01358721|566282506|FG000|Overall Study|Withdrawal by Subject|0|||
156870395|NCT01358721|566282507|FG001|Overall Study|Withdrawal by Subject|0|||
156870396|NCT01358721|566282508|FG002|Overall Study|Withdrawal by Subject|0|||
156870397|NCT01358721|566282509|FG003|Overall Study|Withdrawal by Subject|1|||
157122425|NCT00866307|567200301|FG001|Induction|Adverse Event|0|||
157122426|NCT00866307|567200302|FG002|Induction|Adverse Event|0|||
157122427|NCT00866307|567200300|FG000|Induction|Death|2|||
157122428|NCT00866307|567200301|FG001|Induction|Death|0|||
157122429|NCT00866307|567200302|FG002|Induction|Death|0|||
157122430|NCT00866307|567200300|FG000|Induction|Physician Decision|5|||
157122431|NCT00866307|567200301|FG001|Induction|Physician Decision|0|||
157122432|NCT00866307|567200302|FG002|Induction|Physician Decision|0|||
157122433|NCT00866307|567200300|FG000|Induction|Progressive Disease|1|||
157122434|NCT00866307|567200301|FG001|Induction|Progressive Disease|0|||
157122435|NCT00866307|567200302|FG002|Induction|Progressive Disease|0|||
157122436|NCT00866307|567200300|FG000|Induction|Identification of Patients with Day 29 M|3|||
157122437|NCT00866307|567200301|FG001|Induction|Identification of Patients with Day 29 M|0|||
157122438|NCT00866307|567200302|FG002|Induction|Identification of Patients with Day 29 M|0|||
157122439|NCT00866307|567200300|FG000|Induction|Inadequate cytognetic samples th|1|||
157122440|NCT00866307|567200301|FG001|Induction|Inadequate cytognetic samples th|0|||
157122441|NCT00866307|567200302|FG002|Induction|Inadequate cytognetic samples th|0|||
157122442|NCT00866307|567200300|FG000|Induction|Improper post-induction consent|2|||
157122443|NCT00866307|567200301|FG001|Induction|Improper post-induction consent|0|||
157122444|NCT00866307|567200302|FG002|Induction|Improper post-induction consent|0|||
157122445|NCT00866307|567200300|FG000|Induction|Study was closed at the time|1|||
157122446|NCT00866307|567200301|FG001|Induction|Study was closed at the time|0|||
157122447|NCT00866307|567200302|FG002|Induction|Study was closed at the time|0|||
157122448|NCT00866307|567200300|FG000|Consolidation/Maintenance|Adverse Event|0|||
157122449|NCT00866307|567200301|FG001|Consolidation/Maintenance|Adverse Event|0|||
157122450|NCT00866307|567200302|FG002|Consolidation/Maintenance|Adverse Event|8|||
157122451|NCT00866307|567200300|FG000|Consolidation/Maintenance|Death|0|||
157122452|NCT00866307|567200301|FG001|Consolidation/Maintenance|Death|0|||
157122453|NCT00866307|567200302|FG002|Consolidation/Maintenance|Death|1|||
157122454|NCT00866307|567200300|FG000|Consolidation/Maintenance|Physician Decision|0|||
157122455|NCT00866307|567200301|FG001|Consolidation/Maintenance|Physician Decision|3|||
157122456|NCT00866307|567200302|FG002|Consolidation/Maintenance|Physician Decision|2|||
157122457|NCT00866307|567200300|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
157122458|NCT00866307|567200301|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
157122459|NCT00866307|567200302|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
157122460|NCT00866307|567200300|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
157122461|NCT00866307|567200301|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
157122462|NCT00866307|567200302|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
157122463|NCT00866307|567200300|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
157122464|NCT00866307|567200301|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
157122465|NCT00866307|567200302|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
157122466|NCT00866307|567200300|FG000|Consolidation/Maintenance|Therapy error|0|||
157122467|NCT00866307|567200301|FG001|Consolidation/Maintenance|Therapy error|1|||
157122468|NCT00866307|567200302|FG002|Consolidation/Maintenance|Therapy error|0|||
157122469|NCT00866307|567200300|FG000|Consolidation/Maintenance|Non-compliance|0|||
157122470|NCT00866307|567200301|FG001|Consolidation/Maintenance|Non-compliance|0|||
157122471|NCT00866307|567200302|FG002|Consolidation/Maintenance|Non-compliance|1|||
157122472|NCT00866307|567200300|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
157122473|NCT00866307|567200301|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
157122474|NCT00866307|567200302|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
157122475|NCT02573155|567200303|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
157122476|NCT02573155|567200304|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
157122477|NCT02573155|567200303|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
157122478|NCT02573155|567200304|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
157122479|NCT02573155|567200303|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
157122480|NCT02573155|567200304|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
157122481|NCT02573155|567200303|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
156870398|NCT01358721|566282506|FG000|Overall Study|Death|0|||
156870399|NCT01358721|566282507|FG001|Overall Study|Death|2|||
156870400|NCT01358721|566282508|FG002|Overall Study|Death|0|||
156870401|NCT01358721|566282509|FG003|Overall Study|Death|0|||
156870402|NCT01358721|566282506|FG000|Overall Study|Study Drug Toxicity|1|||
156870403|NCT01358721|566282507|FG001|Overall Study|Study Drug Toxicity|3|||
156870404|NCT01358721|566282508|FG002|Overall Study|Study Drug Toxicity|4|||
156870405|NCT01358721|566282509|FG003|Overall Study|Study Drug Toxicity|5|||
156870406|NCT01358721|566282506|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
156870407|NCT01358721|566282507|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
156870408|NCT01358721|566282508|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
156870409|NCT01358721|566282509|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
156870410|NCT01358721|566282506|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156870411|NCT01358721|566282507|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
156870412|NCT01358721|566282508|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
156870413|NCT01358721|566282509|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
156870414|NCT01358721|566282506|FG000|Overall Study|Adverse Event related to study drug|1|||
156870415|NCT01358721|566282507|FG001|Overall Study|Adverse Event related to study drug|0|||
156870416|NCT01358721|566282508|FG002|Overall Study|Adverse Event related to study drug|0|||
156870417|NCT01358721|566282509|FG003|Overall Study|Adverse Event related to study drug|1|||
156870418|NCT01358721|566282506|FG000|Overall Study|Disease Progression|19|||
156870419|NCT01358721|566282507|FG001|Overall Study|Disease Progression|15|||
156870420|NCT01358721|566282508|FG002|Overall Study|Disease Progression|17|||
156870421|NCT01358721|566282509|FG003|Overall Study|Disease Progression|15|||
156870422|NCT01358721|566282506|FG000|Overall Study|Out of State/Unmet Criteria|0|||
156870423|NCT01358721|566282507|FG001|Overall Study|Out of State/Unmet Criteria|0|||
156870424|NCT01358721|566282508|FG002|Overall Study|Out of State/Unmet Criteria|1|||
156870425|NCT01358721|566282509|FG003|Overall Study|Out of State/Unmet Criteria|0|||
156870426|NCT01002339|566282510|FG000|Overall Study|Withdrawal by Subject|0|||
156870427|NCT01002339|566282511|FG001|Overall Study|Withdrawal by Subject|1|||
156870428|NCT01002339|566282512|FG002|Overall Study|Withdrawal by Subject|0|||
156870429|NCT01002339|566282510|FG000|Overall Study|Incorrect treatment assignment|0|||
156870430|NCT01002339|566282511|FG001|Overall Study|Incorrect treatment assignment|0|||
156870431|NCT01002339|566282512|FG002|Overall Study|Incorrect treatment assignment|1|||
156870432|NCT01002339|566282510|FG000|Overall Study|Protocol Violation|0|||
156870433|NCT01002339|566282511|FG001|Overall Study|Protocol Violation|0|||
156870434|NCT01002339|566282512|FG002|Overall Study|Protocol Violation|2|||
156870435|NCT01002339|566282510|FG000|Overall Study|Lung cancer detected before transplant|0|||
156870436|NCT01002339|566282511|FG001|Overall Study|Lung cancer detected before transplant|0|||
156870437|NCT01002339|566282512|FG002|Overall Study|Lung cancer detected before transplant|1|||
156870438|NCT01002339|566282510|FG000|Overall Study|Randomized. Not transplanted|0|||
156870439|NCT01002339|566282511|FG001|Overall Study|Randomized. Not transplanted|0|||
156870440|NCT01002339|566282512|FG002|Overall Study|Randomized. Not transplanted|1|||
156870441|NCT00433004|566282513|FG000|Overall Study|Lost to Follow-up|5|||
156870442|NCT00433004|566282514|FG001|Overall Study|Lost to Follow-up|7|||
156870443|NCT00742235|566282515|FG000|Overall Study|Lost to Follow-up|0|||
156870444|NCT00742235|566282516|FG001|Overall Study|Lost to Follow-up|31|||
156870445|NCT05661409|566282518|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
156870446|NCT05661409|566282519|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
156870447|NCT05661409|566282520|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
156870448|NCT05661409|566282521|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
156870449|NCT05661409|566282522|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
156870450|NCT05661409|566282523|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
156870451|NCT05661409|566282518|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
156870452|NCT05661409|566282519|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
156870453|NCT05661409|566282520|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
156870454|NCT05661409|566282521|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
156870455|NCT05661409|566282522|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
156870456|NCT05661409|566282523|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
156870457|NCT05661409|566282518|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156693277|NCT02696031|565621803|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693278|NCT02696031|565621804|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
156693279|NCT02696031|565621805|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693280|NCT02696031|565621806|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693281|NCT02696031|565621807|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693282|NCT02696031|565621808|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
156693283|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693284|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693285|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
156693286|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
156693287|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
156870458|NCT05661409|566282519|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156870459|NCT05661409|566282520|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
156870460|NCT05661409|566282521|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
156870461|NCT05661409|566282522|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
156870462|NCT05661409|566282523|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
156870463|NCT05661409|566282518|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870464|NCT05661409|566282519|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870465|NCT05661409|566282520|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870466|NCT05661409|566282521|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870467|NCT05661409|566282522|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
156870468|NCT05661409|566282523|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
156870469|NCT05661409|566282518|FG000|Overall Study|Miscommu-nication about administration|0|||
156870470|NCT05661409|566282519|FG001|Overall Study|Miscommu-nication about administration|0|||
156870471|NCT05661409|566282520|FG002|Overall Study|Miscommu-nication about administration|0|||
156870472|NCT05661409|566282521|FG003|Overall Study|Miscommu-nication about administration|0|||
156870473|NCT05661409|566282522|FG004|Overall Study|Miscommu-nication about administration|0|||
156870474|NCT05661409|566282523|FG005|Overall Study|Miscommu-nication about administration|1|||
156870475|NCT00831181|566282530|FG000|Overall Study|Adverse Event|12|||
156870476|NCT04313244|566282531|FG000|Overall Study|Withdrawal of Consent|3|||
156870477|NCT04313244|566282532|FG001|Overall Study|Withdrawal of Consent|3|||
156870478|NCT04313244|566282531|FG000|Overall Study|Met Exclusion Criteria|1|||
156870479|NCT04313244|566282532|FG001|Overall Study|Met Exclusion Criteria|0|||
156870480|NCT04313244|566282531|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
156870481|NCT04313244|566282532|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
156870482|NCT00927953|566282533|FG000|Overall Study|Death|2|||
156870483|NCT00927953|566282534|FG001|Overall Study|Death|1|||
156870484|NCT02976038|566282535|FG000|Overall Study|Physician Decision|22|||
156870485|NCT02976038|566282535|FG000|Overall Study|Withdrawal by Subject|3|||
156870486|NCT02976038|566282535|FG000|Overall Study|Lost to Follow-up|2|||
156870487|NCT02976038|566282535|FG000|Overall Study|Adverse Event|1|||
156870488|NCT00724698|566282536|FG000|Overall Study|Adverse Event|9|||
156870489|NCT00724698|566282536|FG000|Overall Study|Failure of Therapy|4|||
156870490|NCT00724698|566282536|FG000|Overall Study|Poor Compliance|16|||
156870491|NCT00724698|566282536|FG000|Overall Study|Lost to Follow-up|36|||
156870492|NCT00724698|566282536|FG000|Overall Study|No Info|25|||
156870493|NCT05021978|566282539|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
156870494|NCT05021978|566282540|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870495|NCT05021978|566282541|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870496|NCT05021978|566282542|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
156870497|NCT05021978|566282539|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870498|NCT05021978|566282540|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
156870499|NCT05021978|566282541|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870500|NCT05021978|566282542|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
156870501|NCT00196313|566282543|FG000|Overall Study|Protocol Violation|2|||
156870502|NCT00196313|566282544|FG001|Overall Study|Protocol Violation|3|||
156870503|NCT00196313|566282543|FG000|Overall Study|Withdrawal by Subject|3|||
156870504|NCT00196313|566282544|FG001|Overall Study|Withdrawal by Subject|1|||
156870505|NCT00196313|566282543|FG000|Overall Study|Adverse Event|3|||
156870506|NCT00196313|566282544|FG001|Overall Study|Adverse Event|1|||
156870507|NCT00196313|566282543|FG000|Overall Study|Subject Pregnant|1|||
156870508|NCT00196313|566282544|FG001|Overall Study|Subject Pregnant|1|||
156870509|NCT00196313|566282543|FG000|Overall Study|Lost to Follow-up|2|||
156870510|NCT00196313|566282544|FG001|Overall Study|Lost to Follow-up|2|||
156870511|NCT00043979|566282545|FG000|Period 1|recipient with progressive disease|7|||
156870512|NCT00043979|566282546|FG001|Period 1|recipient with progressive disease|4|||
156870513|NCT00043979|566282547|FG002|Period 1|recipient with progressive disease|3|||
156870514|NCT03096288|566282549|FG000|Overall Study|Withdrawal by Subject|0|||
156870515|NCT03096288|566282550|FG001|Overall Study|Withdrawal by Subject|1|||
156870516|NCT03096288|566282551|FG002|Overall Study|Withdrawal by Subject|0|||
156870517|NCT03096288|566282552|FG003|Overall Study|Withdrawal by Subject|1|||
156870518|NCT01411891|566282558|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
156870519|NCT01411891|566282559|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
156870520|NCT01995838|566282560|FG000|Overall Study|Lost to Follow-up|0|||
156870521|NCT01995838|566282561|FG001|Overall Study|Lost to Follow-up|1|||
156870522|NCT01995838|566282562|FG002|Overall Study|Lost to Follow-up|0|||
156870523|NCT01995838|566282563|FG003|Overall Study|Lost to Follow-up|0|||
156870524|NCT01995838|566282564|FG004|Overall Study|Lost to Follow-up|0|||
156870525|NCT01995838|566282565|FG005|Overall Study|Lost to Follow-up|0|||
156870526|NCT01995838|566282566|FG006|Overall Study|Lost to Follow-up|1|||
156870527|NCT01995838|566282560|FG000|Overall Study|Participant choice|2|||
156870528|NCT01995838|566282561|FG001|Overall Study|Participant choice|0|||
156870529|NCT01995838|566282562|FG002|Overall Study|Participant choice|0|||
156870530|NCT01995838|566282563|FG003|Overall Study|Participant choice|0|||
156870531|NCT01995838|566282564|FG004|Overall Study|Participant choice|0|||
156870532|NCT01995838|566282565|FG005|Overall Study|Participant choice|1|||
156870533|NCT01995838|566282566|FG006|Overall Study|Participant choice|1|||
156870534|NCT01995838|566282560|FG000|Overall Study|Adverse Event|0|||
156693288|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
156693289|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693290|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693291|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693292|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
156693293|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
156693294|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
156693295|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693296|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693297|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693298|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
156693299|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693300|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
156693301|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693302|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693303|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693304|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693305|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
156789034|NCT01392495|565979120|FG000|Overall Study|Adverse Event|3|||
156789035|NCT02571244|565979121|FG000|Overall Study|Lost to Follow-up|0|||
156789036|NCT02571244|565979122|FG001|Overall Study|Lost to Follow-up|1|||
156789037|NCT02571244|565979121|FG000|Overall Study|Unable to reach out post discharge|3|||
156789038|NCT02571244|565979122|FG001|Overall Study|Unable to reach out post discharge|0|||
156789039|NCT01696214|565979123|FG000|Overall Study|Lost to Follow-up|1|||
156789040|NCT01696214|565979124|FG001|Overall Study|Lost to Follow-up|0|||
156789041|NCT01696214|565979125|FG002|Overall Study|Lost to Follow-up|0|||
156789042|NCT01696214|565979126|FG003|Overall Study|Lost to Follow-up|0|||
156789043|NCT02134028|565979127|FG000|Overall Study|Lack of Efficacy|1|||
156789044|NCT02134028|565979128|FG001|Overall Study|Lack of Efficacy|0|||
156789045|NCT02134028|565979129|FG002|Overall Study|Lack of Efficacy|3|||
156789046|NCT02134028|565979130|FG003|Overall Study|Lack of Efficacy|2|||
156789047|NCT02134028|565979131|FG004|Overall Study|Lack of Efficacy|1|||
156789048|NCT02134028|565979132|FG005|Overall Study|Lack of Efficacy|2|||
156789049|NCT02134028|565979133|FG006|Overall Study|Lack of Efficacy|1|||
156789050|NCT02134028|565979134|FG007|Overall Study|Lack of Efficacy|0|||
156789051|NCT02134028|565979127|FG000|Overall Study|Poor compliance to protocol|1|||
156789052|NCT02134028|565979128|FG001|Overall Study|Poor compliance to protocol|1|||
156789053|NCT02134028|565979129|FG002|Overall Study|Poor compliance to protocol|3|||
156789054|NCT02134028|565979130|FG003|Overall Study|Poor compliance to protocol|7|||
156789055|NCT02134028|565979131|FG004|Overall Study|Poor compliance to protocol|1|||
156789056|NCT02134028|565979132|FG005|Overall Study|Poor compliance to protocol|1|||
156789057|NCT02134028|565979133|FG006|Overall Study|Poor compliance to protocol|0|||
156789058|NCT02134028|565979134|FG007|Overall Study|Poor compliance to protocol|0|||
156789059|NCT02134028|565979127|FG000|Overall Study|Other unspecified|4|||
156789060|NCT02134028|565979128|FG001|Overall Study|Other unspecified|22|||
156789061|NCT02134028|565979129|FG002|Overall Study|Other unspecified|33|||
156789062|NCT02134028|565979130|FG003|Overall Study|Other unspecified|64|||
156789063|NCT02134028|565979131|FG004|Overall Study|Other unspecified|8|||
156789064|NCT02134028|565979132|FG005|Overall Study|Other unspecified|6|||
156789065|NCT02134028|565979133|FG006|Overall Study|Other unspecified|2|||
156789066|NCT02134028|565979134|FG007|Overall Study|Other unspecified|1|||
156789067|NCT02134028|565979127|FG000|Overall Study|Adverse Event|3|||
156789068|NCT02134028|565979128|FG001|Overall Study|Adverse Event|19|||
156789069|NCT02134028|565979129|FG002|Overall Study|Adverse Event|13|||
156789070|NCT02134028|565979130|FG003|Overall Study|Adverse Event|32|||
156789071|NCT02134028|565979131|FG004|Overall Study|Adverse Event|4|||
156789072|NCT02134028|565979132|FG005|Overall Study|Adverse Event|5|||
156789073|NCT02134028|565979133|FG006|Overall Study|Adverse Event|1|||
156789074|NCT02134028|565979134|FG007|Overall Study|Adverse Event|2|||
156789075|NCT01309100|565979137|FG000|Overall Study|Protocol Violation|1|||
156789076|NCT01309100|565979137|FG000|Overall Study|Positive Slit lamp finding|1|||
156789077|NCT01452789|565979140|FG000|Overall Study|Withdrawal by Subject|3|||
156789078|NCT01452789|565979141|FG001|Overall Study|Withdrawal by Subject|2|||
156789079|NCT00066170|565979142|FG000|Overall Study|Adverse Event|2|||
156789080|NCT00066170|565979143|FG001|Overall Study|Adverse Event|4|||
156789081|NCT00066170|565979144|FG002|Overall Study|Adverse Event|1|||
156789082|NCT00066170|565979145|FG003|Overall Study|Adverse Event|7|||
156789083|NCT00066170|565979142|FG000|Overall Study|Serious Adverse Event|0|||
156789084|NCT00066170|565979143|FG001|Overall Study|Serious Adverse Event|0|||
156789085|NCT00066170|565979144|FG002|Overall Study|Serious Adverse Event|1|||
156789086|NCT00066170|565979145|FG003|Overall Study|Serious Adverse Event|1|||
156789087|NCT00066170|565979142|FG000|Overall Study|Lost to Follow-up|0|||
156693306|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
156693307|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693308|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693309|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
156693310|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
156693311|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
156693312|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
156693313|NCT02696031|565621803|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693314|NCT02696031|565621804|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693315|NCT02696031|565621805|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
156693316|NCT02696031|565621806|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
156693317|NCT02696031|565621807|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
156693318|NCT02696031|565621808|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
156693319|NCT00058214|565621809|FG000|Overall Study|Adverse Event|1|||
156870535|NCT01995838|566282561|FG001|Overall Study|Adverse Event|0|||
156870536|NCT01995838|566282562|FG002|Overall Study|Adverse Event|0|||
156870537|NCT01995838|566282563|FG003|Overall Study|Adverse Event|0|||
156870538|NCT01995838|566282564|FG004|Overall Study|Adverse Event|0|||
156870539|NCT01995838|566282565|FG005|Overall Study|Adverse Event|0|||
156870540|NCT01995838|566282566|FG006|Overall Study|Adverse Event|1|||
156870541|NCT01995838|566282560|FG000|Overall Study|Withdrawal by Subject|0|||
156870542|NCT01995838|566282561|FG001|Overall Study|Withdrawal by Subject|0|||
156870543|NCT01995838|566282562|FG002|Overall Study|Withdrawal by Subject|0|||
156870544|NCT01995838|566282563|FG003|Overall Study|Withdrawal by Subject|0|||
156870545|NCT01995838|566282564|FG004|Overall Study|Withdrawal by Subject|1|||
156870546|NCT01995838|566282565|FG005|Overall Study|Withdrawal by Subject|0|||
156870547|NCT01995838|566282566|FG006|Overall Study|Withdrawal by Subject|0|||
156870548|NCT01995838|566282560|FG000|Overall Study|Other|3|||
156870549|NCT01995838|566282561|FG001|Overall Study|Other|1|||
156870550|NCT01995838|566282562|FG002|Overall Study|Other|0|||
156870551|NCT01995838|566282563|FG003|Overall Study|Other|2|||
156693320|NCT00958126|565621816|FG000|Overall Study|Serious Adverse Event|0|||
156693321|NCT00958126|565621817|FG001|Overall Study|Serious Adverse Event|2|||
156693322|NCT00958126|565621818|FG002|Overall Study|Serious Adverse Event|0|||
156789088|NCT00066170|565979143|FG001|Overall Study|Lost to Follow-up|1|||
156693323|NCT00958126|565621819|FG003|Overall Study|Serious Adverse Event|0|||
156789089|NCT00066170|565979144|FG002|Overall Study|Lost to Follow-up|0|||
156789090|NCT00066170|565979145|FG003|Overall Study|Lost to Follow-up|0|||
156789091|NCT00066170|565979142|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
156789092|NCT00066170|565979143|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
156789093|NCT00066170|565979144|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
156789094|NCT00066170|565979145|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
156789095|NCT00066170|565979142|FG000|Overall Study|Protocol Violation|3|||
156789096|NCT00066170|565979143|FG001|Overall Study|Protocol Violation|0|||
156789097|NCT00066170|565979144|FG002|Overall Study|Protocol Violation|0|||
156789098|NCT00066170|565979145|FG003|Overall Study|Protocol Violation|0|||
156789099|NCT00066170|565979142|FG000|Overall Study|Other|1|||
156789100|NCT00066170|565979143|FG001|Overall Study|Other|5|||
156789101|NCT00066170|565979144|FG002|Overall Study|Other|2|||
156870552|NCT01995838|566282564|FG004|Overall Study|Other|1|||
156870553|NCT01995838|566282565|FG005|Overall Study|Other|1|||
156870554|NCT01995838|566282566|FG006|Overall Study|Other|2|||
156870555|NCT03196349|566282567|FG000|Overall Study|Did not receive study drug|0|||
157214559|NCT01027884|567531931|FG001|Overall Study|Non-compliance|1|||
156693324|NCT00958126|565621820|FG004|Overall Study|Serious Adverse Event|0|||
156789102|NCT00066170|565979145|FG003|Overall Study|Other|0|||
156789103|NCT03722030|565979146|FG000|Overall Study|Withdrawal by Subject|1|||
156789104|NCT03722030|565979147|FG001|Overall Study|Withdrawal by Subject|0|||
156789105|NCT00754559|565979150|FG000|Overall Study|Adverse Event|15|||
156789106|NCT00754559|565979150|FG000|Overall Study|Protocol Violation|11|||
156789107|NCT00754559|565979150|FG000|Overall Study|Lack of Efficacy|10|||
156789108|NCT00754559|565979150|FG000|Overall Study|Lost to Follow-up|2|||
156789109|NCT00754559|565979150|FG000|Overall Study|Administrative reason|1|||
156789110|NCT00754559|565979150|FG000|Overall Study|Other|5|||
156789111|NCT00754559|565979150|FG000|Overall Study|Withdrawal by Subject|3|||
156789112|NCT04000724|565979154|FG000|Overall Study|Withdrawal by Subject|5|||
156789113|NCT04000724|565979155|FG001|Overall Study|Withdrawal by Subject|3|||
156789114|NCT04000724|565979156|FG002|Overall Study|Withdrawal by Subject|4|||
156789115|NCT04000724|565979154|FG000|Overall Study|Lost to Follow-up|11|||
156789116|NCT04000724|565979155|FG001|Overall Study|Lost to Follow-up|7|||
156789117|NCT04000724|565979156|FG002|Overall Study|Lost to Follow-up|13|||
156789118|NCT00455455|565979157|FG000|Washout|Withdrawal by Subject|0|||
156789119|NCT00455455|565979158|FG001|Washout|Withdrawal by Subject|1|||
156789120|NCT00455455|565979157|FG000|Washout|Withdrawal by Subject|1|||
156789121|NCT00455455|565979158|FG001|Washout|Withdrawal by Subject|0|||
156789122|NCT01370538|565979159|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
156789123|NCT01370538|565979160|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
156789124|NCT01370538|565979159|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156789125|NCT01370538|565979160|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156789126|NCT01370538|565979159|FG000|Overall Study|Adverse Event|1|||
156789127|NCT01370538|565979160|FG001|Overall Study|Adverse Event|0|||
156789128|NCT01370538|565979159|FG000|Overall Study|Protocol Violation|8|||
156789129|NCT01370538|565979160|FG001|Overall Study|Protocol Violation|5|||
156789130|NCT01370538|565979159|FG000|Overall Study|Development of study specific withdrawal|1|||
156789131|NCT01370538|565979160|FG001|Overall Study|Development of study specific withdrawal|1|||
156789132|NCT01370538|565979159|FG000|Overall Study|Lost to follow up|6|||
156789133|NCT01370538|565979160|FG001|Overall Study|Lost to follow up|10|||
156789134|NCT02945046|565979162|FG000|Overall Study|Adverse Event|1|||
156789135|NCT02945046|565979163|FG001|Overall Study|Adverse Event|0|||
156789136|NCT02945046|565979164|FG002|Overall Study|Adverse Event|2|||
156789137|NCT02945046|565979162|FG000|Overall Study|Withdrawal by Subject|3|||
156789138|NCT02945046|565979163|FG001|Overall Study|Withdrawal by Subject|3|||
156789139|NCT02945046|565979164|FG002|Overall Study|Withdrawal by Subject|3|||
156789140|NCT02945046|565979162|FG000|Overall Study|Protocol Violation|2|||
157014093|NCT00031694|566801920|FG000|Overall Study|Death|2|||
157014094|NCT00031694|566801920|FG000|Overall Study|Withdrawal by Subject|5|||
157014095|NCT03892564|566801921|FG000|Overall Study|Withdrawal by Subject|2|||
157014096|NCT04019444|566801922|FG000|Overall Study|Withdrawal by Subject|0|||
157014097|NCT04019444|566801923|FG001|Overall Study|Withdrawal by Subject|1|||
157014098|NCT04019444|566801924|FG002|Overall Study|Withdrawal by Subject|0|||
157014099|NCT04019444|566801925|FG003|Overall Study|Withdrawal by Subject|1|||
157014100|NCT04019444|566801922|FG000|Overall Study|Solicited Event|0|||
157014101|NCT04019444|566801923|FG001|Overall Study|Solicited Event|0|||
157014102|NCT04019444|566801924|FG002|Overall Study|Solicited Event|2|||
157014103|NCT04019444|566801925|FG003|Overall Study|Solicited Event|0|||
157014104|NCT01207492|566801928|FG000|Overall Study|Still on study|1|||
157014105|NCT01207492|566801928|FG000|Overall Study|Withdrawal by Subject|9|||
157014106|NCT01207492|566801928|FG000|Overall Study|Physician Decision|1|||
157014107|NCT01207492|566801928|FG000|Overall Study|Progressive disease|3|||
157014108|NCT01207492|566801928|FG000|Overall Study|Toxicity|1|||
157014109|NCT04310735|566803426|FG000|Overall Study|Withdrawal by Subject|1|||
157014110|NCT04310735|566803427|FG001|Overall Study|Withdrawal by Subject|3|||
157014111|NCT04310735|566803428|FG002|Overall Study|Withdrawal by Subject|8|||
157014112|NCT04310735|566803426|FG000|Overall Study|Equipment malfunction|0|||
157014113|NCT04310735|566803427|FG001|Overall Study|Equipment malfunction|1|||
157014114|NCT04310735|566803428|FG002|Overall Study|Equipment malfunction|0|||
157014115|NCT03012841|566803429|FG000|Overall Study|Protocol Violation|0|||
157014116|NCT03012841|566803430|FG001|Overall Study|Protocol Violation|10|||
157014117|NCT03012841|566803429|FG000|Overall Study|Lost to Follow-up|6|||
157014118|NCT03012841|566803430|FG001|Overall Study|Lost to Follow-up|1|||
157014119|NCT03012841|566803429|FG000|Overall Study|Withdrawal by Subject|6|||
157014120|NCT03012841|566803430|FG001|Overall Study|Withdrawal by Subject|0|||
157014121|NCT03012841|566803429|FG000|Overall Study|Unable to complete 12 month visit|6|||
157014122|NCT03012841|566803430|FG001|Overall Study|Unable to complete 12 month visit|0|||
157014123|NCT03012841|566803429|FG000|Overall Study|Subject relocation|1|||
157014124|NCT03012841|566803430|FG001|Overall Study|Subject relocation|0|||
157014125|NCT03012841|566803429|FG000|Overall Study|Seasonal winter travel|1|||
157014126|NCT03012841|566803430|FG001|Overall Study|Seasonal winter travel|0|||
157014127|NCT03012841|566803429|FG000|Overall Study|Physician Decision|0|||
157014128|NCT03012841|566803430|FG001|Overall Study|Physician Decision|2|||
157014129|NCT03012841|566803429|FG000|Overall Study|No ablation performed|0|||
157014130|NCT03012841|566803430|FG001|Overall Study|No ablation performed|2|||
157014131|NCT03012841|566803429|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
157014132|NCT03012841|566803430|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
157014133|NCT03012841|566803429|FG000|Overall Study|Insurance change|0|||
157014134|NCT03012841|566803430|FG001|Overall Study|Insurance change|1|||
157014135|NCT05696080|566803431|FG000|Overall Study|Lost to Follow-up|2|||
157014136|NCT05696080|566803432|FG001|Overall Study|Lost to Follow-up|1|||
157014137|NCT05696080|566803431|FG000|Overall Study|Physician Decision|1|||
157014138|NCT05696080|566803432|FG001|Overall Study|Physician Decision|0|||
157014139|NCT05696080|566803431|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
157014140|NCT05696080|566803432|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
157014141|NCT05696080|566803431|FG000|Overall Study|Withdrawal by Subject|12|||
157014142|NCT05696080|566803432|FG001|Overall Study|Withdrawal by Subject|0|||
157014143|NCT03954184|566803433|FG000|Overall Study|Lost to Follow-up|500|||
157014144|NCT03954184|566803434|FG001|Overall Study|Lost to Follow-up|0|||
157014145|NCT03398200|566803435|FG000|Overall Study|Withdrawal by Subject|0|||
157014146|NCT03398200|566803436|FG001|Overall Study|Withdrawal by Subject|1|||
157014147|NCT04065048|566803437|FG000|Overall Study|Withdrawal by Subject|1|||
157014148|NCT04065048|566803438|FG001|Overall Study|Withdrawal by Subject|2|||
157014149|NCT04065048|566803439|FG002|Overall Study|Withdrawal by Subject|1|||
157014150|NCT04065048|566803440|FG003|Overall Study|Withdrawal by Subject|1|||
156870556|NCT03196349|566282568|FG001|Overall Study|Did not receive study drug|1|||
156870557|NCT03196349|566282569|FG002|Overall Study|Did not receive study drug|2|||
156870558|NCT03196349|566282567|FG000|Overall Study|No data entered|2|||
156870559|NCT03196349|566282568|FG001|Overall Study|No data entered|4|||
156870560|NCT03196349|566282569|FG002|Overall Study|No data entered|0|||
156870561|NCT03196349|566282567|FG000|Overall Study|Study Terminated early|15|||
156870562|NCT03196349|566282568|FG001|Overall Study|Study Terminated early|9|||
156870563|NCT03196349|566282569|FG002|Overall Study|Study Terminated early|11|||
156870564|NCT02819804|566282570|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
156870565|NCT03967444|566282571|FG000|Overall Study|Lost to Follow-up|1|||
156870566|NCT03967444|566282572|FG001|Overall Study|Lost to Follow-up|2|||
156870567|NCT01821118|566282579|FG000|Overall Study|Death|0|||
156870568|NCT01821118|566282580|FG001|Overall Study|Death|1|||
156870569|NCT01519921|566282589|FG000|Overall Study|Adverse Event|10|||
156870570|NCT01519921|566282590|FG001|Overall Study|Adverse Event|9|||
156870571|NCT01519921|566282589|FG000|Overall Study|Lack of Efficacy|4|||
156870572|NCT01519921|566282590|FG001|Overall Study|Lack of Efficacy|3|||
156870573|NCT01519921|566282589|FG000|Overall Study|Withdrawal by Subject|3|||
156870574|NCT01519921|566282590|FG001|Overall Study|Withdrawal by Subject|0|||
156870575|NCT01519921|566282589|FG000|Overall Study|Lost to Follow-up|2|||
156870576|NCT01519921|566282590|FG001|Overall Study|Lost to Follow-up|1|||
156870577|NCT01519921|566282589|FG000|Overall Study|Treatment refusal|2|||
156870578|NCT01519921|566282590|FG001|Overall Study|Treatment refusal|1|||
156870579|NCT01519921|566282589|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
156870580|NCT01519921|566282590|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
156870581|NCT03133793|566282593|FG000|Overall Study|Withdrawal by Subject|0|||
156870582|NCT03133793|566282594|FG001|Overall Study|Withdrawal by Subject|4|||
156870583|NCT03133793|566282595|FG002|Overall Study|Withdrawal by Subject|2|||
156870584|NCT03133793|566282596|FG003|Overall Study|Withdrawal by Subject|4|||
156870585|NCT03133793|566282593|FG000|Overall Study|Lost to Follow-up|1|||
156870586|NCT03133793|566282594|FG001|Overall Study|Lost to Follow-up|0|||
156870587|NCT03133793|566282595|FG002|Overall Study|Lost to Follow-up|2|||
156870588|NCT03133793|566282596|FG003|Overall Study|Lost to Follow-up|0|||
156870589|NCT03133793|566282593|FG000|Overall Study|Death|0|||
156870590|NCT03133793|566282594|FG001|Overall Study|Death|0|||
156870591|NCT03133793|566282595|FG002|Overall Study|Death|0|||
156870592|NCT03133793|566282596|FG003|Overall Study|Death|1|||
156870593|NCT03486834|566282597|FG000|Overall Study|Withdrawal by Subject|46|||
156870594|NCT03486834|566282598|FG001|Overall Study|Withdrawal by Subject|46|||
156870595|NCT03486834|566282599|FG002|Overall Study|Withdrawal by Subject|52|||
156870596|NCT03486834|566282597|FG000|Overall Study|Adverse Event|8|||
156870597|NCT03486834|566282598|FG001|Overall Study|Adverse Event|7|||
156870598|NCT03486834|566282599|FG002|Overall Study|Adverse Event|0|||
156870599|NCT03486834|566282597|FG000|Overall Study|Lost to Follow-up|41|||
156870600|NCT03486834|566282598|FG001|Overall Study|Lost to Follow-up|24|||
156693325|NCT00958126|565621821|FG005|Overall Study|Serious Adverse Event|0|||
156693326|NCT00958126|565621822|FG006|Overall Study|Serious Adverse Event|1|||
156693327|NCT00958126|565621823|FG007|Overall Study|Serious Adverse Event|0|||
156693328|NCT00958126|565621816|FG000|Overall Study|Withdrawal by Subject|0|||
156693329|NCT00958126|565621817|FG001|Overall Study|Withdrawal by Subject|2|||
156693330|NCT00958126|565621818|FG002|Overall Study|Withdrawal by Subject|0|||
156693331|NCT00958126|565621819|FG003|Overall Study|Withdrawal by Subject|0|||
156693332|NCT00958126|565621820|FG004|Overall Study|Withdrawal by Subject|0|||
156693333|NCT00958126|565621821|FG005|Overall Study|Withdrawal by Subject|0|||
156693334|NCT00958126|565621822|FG006|Overall Study|Withdrawal by Subject|0|||
156693335|NCT00958126|565621823|FG007|Overall Study|Withdrawal by Subject|0|||
156693336|NCT00958126|565621816|FG000|Overall Study|Moved away from study area|0|||
156693337|NCT00958126|565621817|FG001|Overall Study|Moved away from study area|0|||
156693338|NCT00958126|565621818|FG002|Overall Study|Moved away from study area|1|||
156693339|NCT00958126|565621819|FG003|Overall Study|Moved away from study area|1|||
156693340|NCT00958126|565621820|FG004|Overall Study|Moved away from study area|0|||
156693341|NCT00958126|565621821|FG005|Overall Study|Moved away from study area|0|||
156693342|NCT00958126|565621822|FG006|Overall Study|Moved away from study area|0|||
156693343|NCT00958126|565621823|FG007|Overall Study|Moved away from study area|0|||
156693344|NCT00958126|565621816|FG000|Overall Study|Lost to Follow-up|1|||
156870601|NCT03486834|566282599|FG002|Overall Study|Lost to Follow-up|39|||
156870602|NCT03486834|566282597|FG000|Overall Study|Non-compliance with Study Drug|2|||
156870603|NCT03486834|566282598|FG001|Overall Study|Non-compliance with Study Drug|2|||
156870604|NCT03486834|566282599|FG002|Overall Study|Non-compliance with Study Drug|0|||
156870605|NCT03486834|566282597|FG000|Overall Study|Physician Decision|5|||
156870606|NCT03486834|566282598|FG001|Overall Study|Physician Decision|2|||
156870607|NCT03486834|566282599|FG002|Overall Study|Physician Decision|3|||
156870608|NCT03486834|566282597|FG000|Overall Study|Pregnancy|10|||
156870609|NCT03486834|566282598|FG001|Overall Study|Pregnancy|12|||
156870610|NCT03486834|566282599|FG002|Overall Study|Pregnancy|12|||
156870611|NCT03486834|566282597|FG000|Overall Study|Protocol Deviation|2|||
156870612|NCT03486834|566282598|FG001|Overall Study|Protocol Deviation|3|||
156870613|NCT03486834|566282599|FG002|Overall Study|Protocol Deviation|3|||
156693345|NCT00958126|565621817|FG001|Overall Study|Lost to Follow-up|5|||
156693346|NCT00958126|565621818|FG002|Overall Study|Lost to Follow-up|9|||
156693347|NCT00958126|565621819|FG003|Overall Study|Lost to Follow-up|8|||
156693348|NCT00958126|565621820|FG004|Overall Study|Lost to Follow-up|0|||
156693349|NCT00958126|565621821|FG005|Overall Study|Lost to Follow-up|0|||
156693350|NCT00958126|565621822|FG006|Overall Study|Lost to Follow-up|0|||
156693351|NCT00958126|565621823|FG007|Overall Study|Lost to Follow-up|0|||
156693352|NCT00958126|565621816|FG000|Overall Study|Sponsor/Investigator decision|0|||
156693353|NCT00958126|565621817|FG001|Overall Study|Sponsor/Investigator decision|0|||
156693354|NCT00958126|565621818|FG002|Overall Study|Sponsor/Investigator decision|0|||
156693355|NCT00958126|565621819|FG003|Overall Study|Sponsor/Investigator decision|1|||
156693356|NCT00958126|565621820|FG004|Overall Study|Sponsor/Investigator decision|0|||
156870614|NCT03486834|566282597|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156870615|NCT03486834|566282598|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156870616|NCT03486834|566282599|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156870617|NCT03486834|566282597|FG000|Overall Study|Randomized but not treated|4|||
156870618|NCT03486834|566282598|FG001|Overall Study|Randomized but not treated|4|||
156870619|NCT03486834|566282599|FG002|Overall Study|Randomized but not treated|1|||
156870620|NCT00687193|566282601|FG000|Overall Study|Adverse Event|0|||
156870621|NCT00687193|566282602|FG001|Overall Study|Adverse Event|1|||
156870622|NCT00687193|566282603|FG002|Overall Study|Adverse Event|2|||
156870623|NCT00687193|566282604|FG003|Overall Study|Adverse Event|3|||
156870624|NCT00687193|566282605|FG004|Overall Study|Adverse Event|0|||
156870625|NCT00687193|566282606|FG005|Overall Study|Adverse Event|2|||
156870626|NCT00687193|566282601|FG000|Overall Study|Lack of Efficacy|1|||
156870627|NCT00687193|566282602|FG001|Overall Study|Lack of Efficacy|1|||
156870628|NCT00687193|566282603|FG002|Overall Study|Lack of Efficacy|0|||
156870629|NCT00687193|566282604|FG003|Overall Study|Lack of Efficacy|0|||
156870630|NCT00687193|566282605|FG004|Overall Study|Lack of Efficacy|0|||
156870631|NCT00687193|566282606|FG005|Overall Study|Lack of Efficacy|2|||
156870632|NCT00687193|566282601|FG000|Overall Study|Protocol Violation|1|||
156870633|NCT00687193|566282602|FG001|Overall Study|Protocol Violation|2|||
156870634|NCT00687193|566282603|FG002|Overall Study|Protocol Violation|0|||
156870635|NCT00687193|566282604|FG003|Overall Study|Protocol Violation|1|||
156870636|NCT00687193|566282605|FG004|Overall Study|Protocol Violation|2|||
156870637|NCT00687193|566282606|FG005|Overall Study|Protocol Violation|0|||
156870638|NCT02129699|566282607|FG000|Overall Study|Did not start treatment|3|||
156870639|NCT02129699|566282608|FG001|Overall Study|Did not start treatment|2|||
156870640|NCT02446899|566284228|FG000|Overall Study|Adverse Event|4|||
156870641|NCT02446899|566284229|FG001|Overall Study|Adverse Event|7|||
156870642|NCT02446899|566284228|FG000|Overall Study|Condition Under Investigation Worsened|1|||
156870643|NCT02446899|566284229|FG001|Overall Study|Condition Under Investigation Worsened|4|||
156870644|NCT02446899|566284228|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
156870645|NCT02446899|566284229|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
156693357|NCT00958126|565621821|FG005|Overall Study|Sponsor/Investigator decision|0|||
156693358|NCT00958126|565621822|FG006|Overall Study|Sponsor/Investigator decision|0|||
156693359|NCT00958126|565621823|FG007|Overall Study|Sponsor/Investigator decision|0|||
156693360|NCT00958126|565621816|FG000|Overall Study|Other Reason|0|||
156693361|NCT00958126|565621817|FG001|Overall Study|Other Reason|0|||
156870646|NCT02446899|566284228|FG000|Overall Study|Lack of Efficacy|2|||
156870647|NCT02446899|566284229|FG001|Overall Study|Lack of Efficacy|8|||
156870648|NCT02446899|566284228|FG000|Overall Study|Lost to Follow-up|1|||
156870649|NCT02446899|566284229|FG001|Overall Study|Lost to Follow-up|3|||
156870650|NCT02446899|566284228|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
156870651|NCT02446899|566284229|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
156870652|NCT02446899|566284228|FG000|Overall Study|Withdrawal by Subject|11|||
156870653|NCT02446899|566284229|FG001|Overall Study|Withdrawal by Subject|19|||
156870654|NCT02446899|566284228|FG000|Overall Study|Miscellaneous|5|||
156870655|NCT02446899|566284229|FG001|Overall Study|Miscellaneous|4|||
156870656|NCT02446899|566284228|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156870657|NCT02446899|566284229|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
156870658|NCT01554241|566284230|FG000|Overall Study|Death|3|||
156870659|NCT01554241|566284231|FG001|Overall Study|Death|1|||
156870660|NCT01554241|566284232|FG002|Overall Study|Death|1|||
156870661|NCT01554241|566284233|FG003|Overall Study|Death|0|||
157214560|NCT01027884|567531930|FG000|Overall Study|Withdrawal by Subject|0|||
156693362|NCT00958126|565621818|FG002|Overall Study|Other Reason|0|||
156693363|NCT00958126|565621819|FG003|Overall Study|Other Reason|1|||
156693364|NCT00958126|565621820|FG004|Overall Study|Other Reason|0|||
156693365|NCT00958126|565621821|FG005|Overall Study|Other Reason|1|||
156870662|NCT01554241|566284230|FG000|Overall Study|protocol specified renal stone|0|||
156870663|NCT01554241|566284231|FG001|Overall Study|protocol specified renal stone|0|||
156870664|NCT01554241|566284232|FG002|Overall Study|protocol specified renal stone|0|||
156870665|NCT01554241|566284233|FG003|Overall Study|protocol specified renal stone|1|||
156870666|NCT01554241|566284230|FG000|Overall Study|protocol specified change in eGFR|0|||
157214561|NCT01027884|567531931|FG001|Overall Study|Withdrawal by Subject|1|||
156693366|NCT00958126|565621822|FG006|Overall Study|Other Reason|0|||
157214562|NCT01027884|567531930|FG000|Overall Study|Lost to Follow-up|0|||
156693367|NCT00958126|565621823|FG007|Overall Study|Other Reason|0|||
156693368|NCT03078582|565621824|FG000|Overall Study|Adverse Event|0|||
156693369|NCT03078582|565621825|FG001|Overall Study|Adverse Event|8|||
156693370|NCT00430950|565621826|FG000|Overall Study|Adverse Event|7|||
156693371|NCT00430950|565621827|FG001|Overall Study|Adverse Event|6|||
156693372|NCT00430950|565621826|FG000|Overall Study|Withdrawal by Subject|1|||
156693373|NCT00430950|565621827|FG001|Overall Study|Withdrawal by Subject|0|||
156693374|NCT00430950|565621826|FG000|Overall Study|concomitant medication,etc.|5|||
156693375|NCT00430950|565621827|FG001|Overall Study|concomitant medication,etc.|7|||
156693376|NCT00293202|565621830|FG000|Overall Study|Withdrawal by Subject|1|||
156693377|NCT00293202|565621831|FG001|Overall Study|Withdrawal by Subject|2|||
156693378|NCT00293202|565621830|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
156693379|NCT00293202|565621831|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
156693380|NCT00293202|565621830|FG000|Overall Study|on-hold due to fistula maturation time|1|||
156693381|NCT00293202|565621831|FG001|Overall Study|on-hold due to fistula maturation time|0|||
156693382|NCT00123955|565621833|FG000|Overall Study|Adverse Event|1|||
156693383|NCT00123955|565621834|FG001|Overall Study|Adverse Event|0|||
156693384|NCT00123955|565621833|FG000|Overall Study|Withdrawal by Subject|4|||
156693385|NCT00123955|565621834|FG001|Overall Study|Withdrawal by Subject|3|||
156693386|NCT00123955|565621833|FG000|Overall Study|Death|0|||
156693387|NCT00123955|565621834|FG001|Overall Study|Death|1|||
156693388|NCT01558297|565621835|FG000|Overall Study|Withdrawal by Subject|2|||
156693389|NCT01558297|565621836|FG001|Overall Study|Withdrawal by Subject|2|||
156693390|NCT01558297|565621837|FG002|Overall Study|Withdrawal by Subject|1|||
156693391|NCT02427984|565621838|FG000|Overall Study|Lost to Follow-up|13|||
156693392|NCT02427984|565621839|FG001|Overall Study|Lost to Follow-up|5|||
156693393|NCT02427984|565621840|FG002|Overall Study|Lost to Follow-up|18|||
156693394|NCT02054130|565624002|FG000|Overall Study|Withdrawal by Subject|4|||
156693395|NCT02054130|565624003|FG001|Overall Study|Withdrawal by Subject|4|||
157014151|NCT04065048|566803437|FG000|Overall Study|Adverse Event|1|||
157014152|NCT04065048|566803438|FG001|Overall Study|Adverse Event|0|||
157014153|NCT04065048|566803439|FG002|Overall Study|Adverse Event|1|||
157014154|NCT04065048|566803440|FG003|Overall Study|Adverse Event|0|||
157014155|NCT03397108|566803441|FG000|Overall Study|Lost to Follow-up|15|||
157014156|NCT03397108|566803442|FG001|Overall Study|Lost to Follow-up|0|||
157014157|NCT03397108|566803441|FG000|Overall Study|Insufficient milk production|3|||
157014158|NCT03397108|566803442|FG001|Overall Study|Insufficient milk production|2|||
157014159|NCT03397108|566803441|FG000|Overall Study|Withdrawal by Subject|2|||
157014160|NCT03397108|566803442|FG001|Overall Study|Withdrawal by Subject|0|||
157014161|NCT05687903|566803443|FG000|Overall Study|Protocol Deviation|1|||
157014162|NCT05687903|566803444|FG001|Overall Study|Protocol Deviation|1|||
157014163|NCT05687903|566803445|FG002|Overall Study|Protocol Deviation|0|||
157014164|NCT05687903|566803446|FG003|Overall Study|Protocol Deviation|1|||
157014165|NCT05687903|566803447|FG004|Overall Study|Protocol Deviation|0|||
157014166|NCT05613205|566803448|FG000|Overall Study|Lost to Follow-up|0|||
157014167|NCT05613205|566803449|FG001|Overall Study|Lost to Follow-up|0|||
157014168|NCT05613205|566803450|FG002|Overall Study|Lost to Follow-up|1|||
157014169|NCT05613205|566803451|FG003|Overall Study|Lost to Follow-up|1|||
157014170|NCT05613205|566803452|FG004|Overall Study|Lost to Follow-up|0|||
157014171|NCT05613205|566803448|FG000|Overall Study|Withdrawal by Subject|0|||
157014172|NCT05613205|566803449|FG001|Overall Study|Withdrawal by Subject|0|||
157014173|NCT05613205|566803450|FG002|Overall Study|Withdrawal by Subject|1|||
157014174|NCT05613205|566803451|FG003|Overall Study|Withdrawal by Subject|1|||
157014175|NCT05613205|566803452|FG004|Overall Study|Withdrawal by Subject|0|||
157014176|NCT04608045|566803459|FG000|Overall Study|Physician Decision|1|||
157014177|NCT03602014|566803461|FG000|Overall Study|Lost to Follow-up|2|||
157014178|NCT03602014|566803462|FG001|Overall Study|Lost to Follow-up|0|||
157014179|NCT03602014|566803463|FG002|Overall Study|Lost to Follow-up|0|||
157014180|NCT02728557|566803464|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
157014181|NCT02728557|566803465|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
157014182|NCT02728557|566803464|FG000|Overall Study|Dissatisfaction with research tasks|0|||
157014183|NCT02728557|566803465|FG001|Overall Study|Dissatisfaction with research tasks|1|||
157014184|NCT02728557|566803464|FG000|Overall Study|Scheduling or change in availability|1|||
157014185|NCT02728557|566803465|FG001|Overall Study|Scheduling or change in availability|1|||
157014186|NCT01718743|566803466|FG000|Overall Study|Physician Decision|7|||
157014187|NCT01718743|566803466|FG000|Overall Study|Withdrawal by Subject|14|||
157014188|NCT01718743|566803466|FG000|Overall Study|Progressive Disease|22|||
157014189|NCT01718743|566803466|FG000|Overall Study|Toxicity|1|||
157014190|NCT01718743|566803466|FG000|Overall Study|Malignancy|1|||
157014191|NCT03416010|566803467|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
157014192|NCT03416010|566803468|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
157014193|NCT03416010|566803467|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
157014194|NCT03416010|566803468|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
157014195|NCT03416010|566803467|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
156693396|NCT02054130|565624004|FG002|Overall Study|Withdrawal by Subject|7|||
156693397|NCT02054130|565624005|FG003|Overall Study|Withdrawal by Subject|10|||
156693398|NCT02054130|565624002|FG000|Overall Study|Death|0|||
156693399|NCT02054130|565624003|FG001|Overall Study|Death|1|||
156693400|NCT02054130|565624004|FG002|Overall Study|Death|0|||
156693401|NCT02054130|565624005|FG003|Overall Study|Death|0|||
156693402|NCT02054130|565624002|FG000|Overall Study|Lost to Follow-up|0|||
156693403|NCT02054130|565624003|FG001|Overall Study|Lost to Follow-up|0|||
156693404|NCT02054130|565624004|FG002|Overall Study|Lost to Follow-up|1|||
156693405|NCT02054130|565624005|FG003|Overall Study|Lost to Follow-up|2|||
156693406|NCT02054130|565624002|FG000|Overall Study|Missed dose|4|||
156693407|NCT02054130|565624003|FG001|Overall Study|Missed dose|6|||
156693408|NCT02054130|565624004|FG002|Overall Study|Missed dose|7|||
156693409|NCT02054130|565624005|FG003|Overall Study|Missed dose|10|||
156693410|NCT01386684|565624006|FG000|Overall Study|Lost to Follow-up|51|||
156693411|NCT01386684|565624006|FG000|Overall Study|Other|51|||
156693412|NCT01386684|565624006|FG000|Overall Study|Death|47|||
156693413|NCT01386684|565624006|FG000|Overall Study|Withdrawal of Consent|44|||
156693414|NCT01386684|565624006|FG000|Overall Study|Alternative Therapy Required|37|||
156693415|NCT01386684|565624006|FG000|Overall Study|Disease Progression|28|||
156693416|NCT01386684|565624006|FG000|Overall Study|Adverse Event|20|||
156693417|NCT01386684|565624006|FG000|Overall Study|Noncompliance|8|||
156693418|NCT01386684|565624006|FG000|Overall Study|Protocol Violation|4|||
156693419|NCT01386684|565624006|FG000|Overall Study|Missing|3|||
156693420|NCT04268316|565624008|FG000|Overall Study|Withdrawal by Subject|2|||
156870667|NCT01554241|566284231|FG001|Overall Study|protocol specified change in eGFR|0|||
156870668|NCT01554241|566284232|FG002|Overall Study|protocol specified change in eGFR|1|||
156870669|NCT01554241|566284233|FG003|Overall Study|protocol specified change in eGFR|0|||
156870670|NCT01554241|566284230|FG000|Overall Study|Withdrawal by Subject|0|||
156870671|NCT01554241|566284231|FG001|Overall Study|Withdrawal by Subject|0|||
156870672|NCT01554241|566284232|FG002|Overall Study|Withdrawal by Subject|2|||
156870673|NCT01554241|566284233|FG003|Overall Study|Withdrawal by Subject|0|||
156870674|NCT04730271|566284234|FG000|Overall Study|Adverse Event|0|||
156870675|NCT04730271|566284235|FG001|Overall Study|Adverse Event|2|||
156870676|NCT04730271|566284234|FG000|Overall Study|Withdrawal by Subject|1|||
156870677|NCT04730271|566284235|FG001|Overall Study|Withdrawal by Subject|1|||
156870678|NCT04730271|566284234|FG000|Overall Study|Protocol Violation|7|||
156870679|NCT04730271|566284235|FG001|Overall Study|Protocol Violation|13|||
156870680|NCT04730271|566284234|FG000|Overall Study|Lost to Follow-up|3|||
156870681|NCT04730271|566284235|FG001|Overall Study|Lost to Follow-up|3|||
156870682|NCT04730271|566284234|FG000|Overall Study|Death|1|||
156870683|NCT04730271|566284235|FG001|Overall Study|Death|0|||
156870684|NCT00998296|566284236|FG000|Overall Study|Progressive disease|0|||
156870685|NCT00998296|566284237|FG001|Overall Study|Progressive disease|1|||
156870686|NCT00998296|566284238|FG002|Overall Study|Progressive disease|0|||
156870687|NCT00998296|566284239|FG003|Overall Study|Progressive disease|0|||
156870688|NCT00998296|566284240|FG004|Overall Study|Progressive disease|0|||
156870689|NCT00998296|566284241|FG005|Overall Study|Progressive disease|0|||
156870690|NCT00998296|566284242|FG006|Overall Study|Progressive disease|1|||
156870691|NCT00998296|566284243|FG007|Overall Study|Progressive disease|0|||
156870692|NCT00998296|566284244|FG008|Overall Study|Progressive disease|0|||
156870693|NCT00998296|566284245|FG009|Overall Study|Progressive disease|14|||
156870694|NCT00998296|566284246|FG010|Overall Study|Progressive disease|5|||
156870695|NCT00998296|566284236|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870696|NCT00998296|566284237|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870697|NCT00998296|566284238|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870698|NCT00998296|566284239|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870699|NCT00998296|566284240|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
156870700|NCT00998296|566284241|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870701|NCT00998296|566284242|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870702|NCT00998296|566284243|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
156870703|NCT00998296|566284244|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
156870704|NCT00998296|566284245|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
156870705|NCT00998296|566284246|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
157214563|NCT01027884|567531931|FG001|Overall Study|Lost to Follow-up|1|||
156693421|NCT04268316|565624009|FG001|Overall Study|Withdrawal by Subject|1|||
156870706|NCT00998296|566284236|FG000|Overall Study|Other adverse event|0|||
157014196|NCT03416010|566803468|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
156693422|NCT04268316|565624010|FG002|Overall Study|Withdrawal by Subject|0|||
157014197|NCT03416010|566803467|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
157014198|NCT03416010|566803468|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
156693423|NCT02040779|565624012|FG000|Overall Study|Adverse Event|1|||
156693424|NCT02040779|565624013|FG001|Overall Study|Adverse Event|0|||
156693425|NCT02040779|565624014|FG002|Overall Study|Adverse Event|0|||
157014199|NCT03416010|566803467|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
156870707|NCT00998296|566284237|FG001|Overall Study|Other adverse event|0|||
156870708|NCT00998296|566284238|FG002|Overall Study|Other adverse event|0|||
156693426|NCT02040779|565624012|FG000|Overall Study|Withdrawal by Subject|4|||
156693427|NCT02040779|565624013|FG001|Overall Study|Withdrawal by Subject|1|||
156693428|NCT02040779|565624014|FG002|Overall Study|Withdrawal by Subject|3|||
156693429|NCT02040779|565624012|FG000|Overall Study|Non-compliance|0|||
156693430|NCT02040779|565624013|FG001|Overall Study|Non-compliance|1|||
156693431|NCT02040779|565624014|FG002|Overall Study|Non-compliance|0|||
156693432|NCT02040779|565624012|FG000|Overall Study|Protocol Violation|2|||
156693433|NCT02040779|565624013|FG001|Overall Study|Protocol Violation|1|||
156693434|NCT02040779|565624014|FG002|Overall Study|Protocol Violation|0|||
156693435|NCT02040779|565624012|FG000|Overall Study|Lost to Follow-up|1|||
156693436|NCT02040779|565624013|FG001|Overall Study|Lost to Follow-up|2|||
156693437|NCT02040779|565624014|FG002|Overall Study|Lost to Follow-up|1|||
156693438|NCT02040779|565624012|FG000|Overall Study|Lack of Efficacy|4|||
156693439|NCT02040779|565624013|FG001|Overall Study|Lack of Efficacy|2|||
156693440|NCT02040779|565624014|FG002|Overall Study|Lack of Efficacy|0|||
156693441|NCT02132637|565624015|FG000|Study Period 1|Withdrawal by Subject|0|||
156693442|NCT02132637|565624016|FG001|Study Period 1|Withdrawal by Subject|4|||
156693443|NCT02132637|565624015|FG000|Study Period 1|Physician Decision|1|||
156693444|NCT02132637|565624016|FG001|Study Period 1|Physician Decision|0|||
156693445|NCT02132637|565624015|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
156693446|NCT02132637|565624016|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
156693447|NCT02132637|565624015|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
156693448|NCT02132637|565624016|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
156693449|NCT00866658|565624025|FG000|Overall Study|Adverse Event|5|||
156693450|NCT00866658|565624026|FG001|Overall Study|Adverse Event|14|||
156693451|NCT00866658|565624025|FG000|Overall Study|Lack of Efficacy|2|||
156693452|NCT00866658|565624026|FG001|Overall Study|Lack of Efficacy|1|||
156693453|NCT00866658|565624025|FG000|Overall Study|Withdrawal by Subject|1|||
156693454|NCT00866658|565624026|FG001|Overall Study|Withdrawal by Subject|0|||
156693455|NCT00866658|565624025|FG000|Overall Study|Protocol Violation|1|||
156693456|NCT00866658|565624026|FG001|Overall Study|Protocol Violation|1|||
156693457|NCT00866658|565624025|FG000|Overall Study|Familial and Personal Reasons|4|||
156693458|NCT00866658|565624026|FG001|Overall Study|Familial and Personal Reasons|5|||
156693459|NCT02528123|565624027|FG000|Overall Study|Lost to Follow-up|1|||
156693460|NCT04505293|565624030|FG000|Overall Study|Lost to Follow-up|2|||
156693461|NCT04505293|565624030|FG000|Overall Study|Withdrawal by Subject|6|||
156693462|NCT04505293|565624030|FG000|Overall Study|CT scan unreadable|277|||
156693463|NCT00506129|565624031|FG000|Overall Study|Disease Progression/Relapse|15|||
156693464|NCT00506129|565624031|FG000|Overall Study|Death|7|||
156693465|NCT04295135|565624032|FG000|Overall Study|Withdrawal by Subject|2|||
156693466|NCT04295135|565624033|FG001|Overall Study|Withdrawal by Subject|1|||
156693467|NCT04295135|565624032|FG000|Overall Study|Subject left organization|8|||
156693468|NCT04295135|565624033|FG001|Overall Study|Subject left organization|4|||
156693469|NCT02923674|565624034|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
156693470|NCT02923674|565624035|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
156693471|NCT02923674|565624036|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
156693472|NCT02923674|565624034|FG000|Overall Study|Lost to Follow-up|7|||
156693473|NCT02923674|565624035|FG001|Overall Study|Lost to Follow-up|12|||
156693474|NCT02923674|565624036|FG002|Overall Study|Lost to Follow-up|7|||
156693475|NCT02923674|565624034|FG000|Overall Study|Problem with intervention|2|||
156693476|NCT02923674|565624035|FG001|Overall Study|Problem with intervention|2|||
156693477|NCT02923674|565624036|FG002|Overall Study|Problem with intervention|1|||
156693478|NCT02923674|565624034|FG000|Overall Study|Adverse Event|3|||
156693479|NCT02923674|565624035|FG001|Overall Study|Adverse Event|1|||
156693480|NCT02923674|565624036|FG002|Overall Study|Adverse Event|1|||
156693481|NCT02923674|565624034|FG000|Overall Study|Withdrawal by Subject|2|||
156693482|NCT02923674|565624035|FG001|Overall Study|Withdrawal by Subject|2|||
156693483|NCT02923674|565624036|FG002|Overall Study|Withdrawal by Subject|2|||
156789141|NCT02945046|565979163|FG001|Overall Study|Protocol Violation|3|||
156789142|NCT02945046|565979164|FG002|Overall Study|Protocol Violation|2|||
156789143|NCT02945046|565979162|FG000|Overall Study|Lost to Follow-up|1|||
156789144|NCT02945046|565979163|FG001|Overall Study|Lost to Follow-up|1|||
156789145|NCT02945046|565979164|FG002|Overall Study|Lost to Follow-up|0|||
156693484|NCT02712333|565624037|FG000|First Period|Withdrawal by Subject|3|||
156789146|NCT02945046|565979162|FG000|Overall Study|Lack of Efficacy|1|||
156789147|NCT02945046|565979163|FG001|Overall Study|Lack of Efficacy|2|||
156693485|NCT02712333|565624038|FG001|First Period|Withdrawal by Subject|2|||
156693486|NCT01546649|565624043|FG000|Overall Study|Adverse Event|4|||
156693487|NCT01546649|565624044|FG001|Overall Study|Adverse Event|5|||
156693488|NCT01546649|565624043|FG000|Overall Study|Protocol Violation|1|||
156693489|NCT01546649|565624044|FG001|Overall Study|Protocol Violation|0|||
156693490|NCT01546649|565624043|FG000|Overall Study|Lack of Efficacy|1|||
156693491|NCT01546649|565624044|FG001|Overall Study|Lack of Efficacy|0|||
156693492|NCT01546649|565624043|FG000|Overall Study|Recurrence|1|||
156693493|NCT01546649|565624044|FG001|Overall Study|Recurrence|1|||
156693494|NCT01546649|565624043|FG000|Overall Study|Discovery of secondary cancer|0|||
156789148|NCT02945046|565979164|FG002|Overall Study|Lack of Efficacy|1|||
156789149|NCT02945046|565979162|FG000|Overall Study|Other than specified|5|||
156693495|NCT01546649|565624044|FG001|Overall Study|Discovery of secondary cancer|1|||
156693496|NCT01546649|565624043|FG000|Overall Study|Withdrawal by Subject|1|||
156693497|NCT01546649|565624044|FG001|Overall Study|Withdrawal by Subject|2|||
156693498|NCT01621191|565624046|FG000|Overall Study|Adverse Event|9|||
156693499|NCT01621191|565624046|FG000|Overall Study|Withdrawal by Subject|8|||
156693500|NCT01621191|565624046|FG000|Overall Study|Lack of Efficacy|6|||
156693501|NCT01621191|565624046|FG000|Overall Study|Lost to Follow-up|1|||
156693502|NCT01621191|565624046|FG000|Overall Study|Site Removed From Study|1|||
156693503|NCT00706381|565624050|FG000|Overall Study|Lost to Follow-up|0|||
156693504|NCT00706381|565624051|FG001|Overall Study|Lost to Follow-up|1|||
156693505|NCT00706381|565624052|FG002|Overall Study|Lost to Follow-up|1|||
156693506|NCT00706381|565624053|FG003|Overall Study|Lost to Follow-up|0|||
156693507|NCT04355663|565624054|FG000|Overall Study|Physician Decision|2|||
156693508|NCT04355663|565624055|FG001|Overall Study|Physician Decision|7|||
156693509|NCT04355663|565624056|FG002|Overall Study|Physician Decision|0|||
156693510|NCT04355663|565624054|FG000|Overall Study|Adverse Event|0|||
156693511|NCT04355663|565624055|FG001|Overall Study|Adverse Event|0|||
156693512|NCT04355663|565624056|FG002|Overall Study|Adverse Event|1|||
156693513|NCT04355663|565624054|FG000|Overall Study|Withdrawal by Subject|0|||
156693514|NCT04355663|565624055|FG001|Overall Study|Withdrawal by Subject|8|||
156693515|NCT04355663|565624056|FG002|Overall Study|Withdrawal by Subject|3|||
156693516|NCT05420012|565624062|FG000|Overall Study|Lost to Follow-up|0|||
156693517|NCT05420012|565624063|FG001|Overall Study|Lost to Follow-up|1|||
156693518|NCT01782482|565624066|FG000|Overall Study|Adverse Event|2|||
156693519|NCT01782482|565624067|FG001|Overall Study|Adverse Event|1|||
156693520|NCT01782482|565624066|FG000|Overall Study|Lost to Follow-up|2|||
156693521|NCT01782482|565624067|FG001|Overall Study|Lost to Follow-up|3|||
156870709|NCT00998296|566284239|FG003|Overall Study|Other adverse event|0|||
156870710|NCT00998296|566284240|FG004|Overall Study|Other adverse event|1|||
156870711|NCT00998296|566284241|FG005|Overall Study|Other adverse event|0|||
156693522|NCT01782482|565624066|FG000|Overall Study|Physician Decision|1|||
156693523|NCT01782482|565624067|FG001|Overall Study|Physician Decision|0|||
156693524|NCT01782482|565624066|FG000|Overall Study|Protocol Violation|1|||
156693525|NCT01782482|565624067|FG001|Overall Study|Protocol Violation|0|||
156693526|NCT01782482|565624066|FG000|Overall Study|Withdrawal by Subject|2|||
156693527|NCT01782482|565624067|FG001|Overall Study|Withdrawal by Subject|3|||
156693528|NCT01782482|565624066|FG000|Overall Study|Randomized in Error|2|||
156693529|NCT01782482|565624067|FG001|Overall Study|Randomized in Error|2|||
156693530|NCT01782482|565624066|FG000|Overall Study|Habitually wearing toric lens OS|0|||
156693531|NCT01782482|565624067|FG001|Overall Study|Habitually wearing toric lens OS|1|||
156693532|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
156693533|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
156693534|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
156693535|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
156693536|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
156693537|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
156693538|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693539|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
156693540|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693541|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
156693542|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
156693543|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
156693544|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
156789150|NCT02945046|565979163|FG001|Overall Study|Other than specified|4|||
156789151|NCT02945046|565979164|FG002|Overall Study|Other than specified|7|||
156789152|NCT01608308|565979166|FG000|Overall Study|pretreatment medical and billing reasons|0|||
156789153|NCT01608308|565979167|FG001|Overall Study|pretreatment medical and billing reasons|2|||
156789154|NCT00032487|565979179|FG000|Overall Study|Withdrawal by Subject|67|||
156789155|NCT00032487|565979180|FG001|Overall Study|Withdrawal by Subject|43|||
156789156|NCT00032487|565979179|FG000|Overall Study|Adverse Event|3|||
156789157|NCT00032487|565979180|FG001|Overall Study|Adverse Event|7|||
156789158|NCT00032487|565979179|FG000|Overall Study|Lost to Follow-up|57|||
156789159|NCT00032487|565979180|FG001|Overall Study|Lost to Follow-up|58|||
156789160|NCT00032487|565979179|FG000|Overall Study|Had other reason|12|||
156789161|NCT00032487|565979180|FG001|Overall Study|Had other reason|12|||
156789162|NCT04648241|565979182|FG000|Overall Study|Lost to Follow-up|1|||
156693545|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
156693546|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
156693547|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
156693548|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
156693549|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
156693550|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
156693551|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
156693552|NCT00700817|565624074|FG000|Week 0-26 (Main Period)|Unclassified|14|||
156789163|NCT04648241|565979183|FG001|Overall Study|Lost to Follow-up|0|||
156789164|NCT02057666|565979184|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
156870712|NCT00998296|566284242|FG006|Overall Study|Other adverse event|0|||
156870713|NCT00998296|566284243|FG007|Overall Study|Other adverse event|0|||
156870714|NCT00998296|566284244|FG008|Overall Study|Other adverse event|0|||
156870715|NCT00998296|566284245|FG009|Overall Study|Other adverse event|1|||
156870716|NCT00998296|566284246|FG010|Overall Study|Other adverse event|2|||
156870717|NCT00998296|566284236|FG000|Overall Study|Refused to continue taking trial med.|0|||
156870718|NCT00998296|566284237|FG001|Overall Study|Refused to continue taking trial med.|0|||
156870719|NCT00998296|566284238|FG002|Overall Study|Refused to continue taking trial med.|0|||
156870720|NCT00998296|566284239|FG003|Overall Study|Refused to continue taking trial med.|0|||
156870721|NCT00998296|566284240|FG004|Overall Study|Refused to continue taking trial med.|0|||
156870722|NCT00998296|566284241|FG005|Overall Study|Refused to continue taking trial med.|0|||
156870723|NCT00998296|566284242|FG006|Overall Study|Refused to continue taking trial med.|0|||
156870724|NCT00998296|566284243|FG007|Overall Study|Refused to continue taking trial med.|0|||
156870725|NCT00998296|566284244|FG008|Overall Study|Refused to continue taking trial med.|0|||
156870726|NCT00998296|566284245|FG009|Overall Study|Refused to continue taking trial med.|2|||
156870727|NCT00998296|566284246|FG010|Overall Study|Refused to continue taking trial med.|0|||
156870728|NCT00998296|566284236|FG000|Overall Study|Reason other than those specified above|0|||
156870729|NCT00998296|566284237|FG001|Overall Study|Reason other than those specified above|0|||
156870730|NCT00998296|566284238|FG002|Overall Study|Reason other than those specified above|0|||
156870731|NCT00998296|566284239|FG003|Overall Study|Reason other than those specified above|0|||
156870732|NCT00998296|566284240|FG004|Overall Study|Reason other than those specified above|0|||
157214564|NCT01027884|567531930|FG000|Overall Study|Spinal fixation surgery|0|||
157214565|NCT01027884|567531931|FG001|Overall Study|Spinal fixation surgery|3|||
157214566|NCT03636542|567531933|FG000|Overall Study|Lost to Follow-up|1|||
157214567|NCT03636542|567531934|FG001|Overall Study|Lost to Follow-up|1|||
157214568|NCT03636542|567531933|FG000|Overall Study|Physician Decision|0|||
157214569|NCT03636542|567531934|FG001|Overall Study|Physician Decision|1|||
156870733|NCT00998296|566284241|FG005|Overall Study|Reason other than those specified above|0|||
156870734|NCT00998296|566284242|FG006|Overall Study|Reason other than those specified above|0|||
156870735|NCT00998296|566284243|FG007|Overall Study|Reason other than those specified above|0|||
156870736|NCT00998296|566284244|FG008|Overall Study|Reason other than those specified above|0|||
156870737|NCT00998296|566284245|FG009|Overall Study|Reason other than those specified above|1|||
156870738|NCT00998296|566284246|FG010|Overall Study|Reason other than those specified above|0|||
156870739|NCT04396639|566284247|FG000|Overall Study|Withdrawal by Subject|1|||
156870740|NCT04396639|566284247|FG000|Overall Study|Other|1|||
156870741|NCT01544335|566284248|FG000|Overall Study|Lost to Follow-up|27|||
156870742|NCT01544335|566284248|FG000|Overall Study|Death|4|||
156870743|NCT01544335|566284248|FG000|Overall Study|Disease progression|3|||
156870744|NCT01544335|566284248|FG000|Overall Study|Baseline Measurements not Available|19|||
156870745|NCT02223858|566284251|FG000|Overall Study|Death|1|||
156870746|NCT02223858|566284252|FG001|Overall Study|Death|1|||
156870747|NCT02223858|566284251|FG000|Overall Study|Lost to Follow-up|6|||
156870748|NCT02223858|566284252|FG001|Overall Study|Lost to Follow-up|11|||
156870749|NCT02223858|566284251|FG000|Overall Study|Withdrawal by Subject|8|||
156870750|NCT02223858|566284252|FG001|Overall Study|Withdrawal by Subject|5|||
156870751|NCT02223858|566284251|FG000|Overall Study|Refused|9|||
156870752|NCT02223858|566284252|FG001|Overall Study|Refused|9|||
156870753|NCT03198507|566284253|FG000|Overall Study|Withdrawal by Subject|1|||
156870754|NCT03198507|566284254|FG001|Overall Study|Withdrawal by Subject|0|||
156870755|NCT00241839|566284261|FG000|Overall Study|Withdrawal by Subject|18|||
156870756|NCT00241839|566284262|FG001|Overall Study|Withdrawal by Subject|17|||
157122482|NCT02573155|567200304|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
157122483|NCT02573155|567200303|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
157122484|NCT02573155|567200304|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
157122485|NCT02573155|567200303|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
157122486|NCT02573155|567200304|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
157122487|NCT02573155|567200303|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
157122488|NCT02573155|567200304|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
157122489|NCT02573155|567200303|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
157122490|NCT02573155|567200304|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
157122491|NCT02508194|567200310|FG000|Overall Study|Death|5|||
157122492|NCT02508194|567200311|FG001|Overall Study|Death|3|||
157122493|NCT02508194|567200310|FG000|Overall Study|Lost to Follow-up|25|||
157122494|NCT02508194|567200311|FG001|Overall Study|Lost to Follow-up|18|||
157122495|NCT02508194|567200310|FG000|Overall Study|Withdrawal by Subject|20|||
157122496|NCT02508194|567200311|FG001|Overall Study|Withdrawal by Subject|18|||
157122497|NCT02508194|567200310|FG000|Overall Study|Error in Randomization|1|||
157122498|NCT02508194|567200311|FG001|Overall Study|Error in Randomization|3|||
157214570|NCT03636542|567531933|FG000|Overall Study|Withdrawal by Subject|1|||
156870757|NCT00241839|566284261|FG000|Overall Study|Adverse Event|1|||
156870758|NCT00241839|566284262|FG001|Overall Study|Adverse Event|1|||
156870759|NCT03809104|566284263|FG000|Overall Study|Withdrawal by Subject|3|||
157122499|NCT02508194|567200310|FG000|Overall Study|Principal Investigator Decision|1|||
157122500|NCT02508194|567200311|FG001|Overall Study|Principal Investigator Decision|2|||
157122501|NCT00511355|567200312|FG000|Overall Study|Adverse Event|4|||
157122502|NCT00511355|567200313|FG001|Overall Study|Adverse Event|4|||
156870760|NCT01532986|566284268|FG000|Overall Study|Death|9|||
156870761|NCT01532986|566284269|FG001|Overall Study|Death|9|||
156870762|NCT01532986|566284268|FG000|Overall Study|Withdrawal by Subject|7|||
156870763|NCT01532986|566284269|FG001|Overall Study|Withdrawal by Subject|10|||
156870764|NCT01532986|566284268|FG000|Overall Study|Physician Decision|7|||
156870765|NCT01532986|566284269|FG001|Overall Study|Physician Decision|5|||
156870766|NCT04614974|566284270|FG000|Overall Study|Lost to Follow-up|14|||
157122503|NCT00511355|567200312|FG000|Overall Study|Pregnancy Wish|1|||
157122504|NCT00511355|567200313|FG001|Overall Study|Pregnancy Wish|0|||
157122505|NCT00511355|567200312|FG000|Overall Study|Lost to Follow-up|2|||
157122506|NCT00511355|567200313|FG001|Overall Study|Lost to Follow-up|1|||
157122507|NCT00511355|567200312|FG000|Overall Study|Other Reason|0|||
157122508|NCT00511355|567200313|FG001|Overall Study|Other Reason|1|||
157122509|NCT00511355|567200312|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
157122510|NCT00511355|567200313|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
157122511|NCT00511355|567200312|FG000|Overall Study|Withdrawal of informed consent|0|||
157122512|NCT00511355|567200313|FG001|Overall Study|Withdrawal of informed consent|1|||
157122513|NCT00511355|567200312|FG000|Overall Study|Other reason pre-treatment|0|||
157122514|NCT00511355|567200313|FG001|Overall Study|Other reason pre-treatment|1|||
157122515|NCT00454805|567200315|FG000|Overall Study|Withdrawal by Subject|9|||
157122516|NCT00454805|567200316|FG001|Overall Study|Withdrawal by Subject|2|||
157122517|NCT00454805|567200315|FG000|Overall Study|Death|0|||
157122518|NCT00454805|567200316|FG001|Overall Study|Death|2|||
157122519|NCT00454805|567200315|FG000|Overall Study|Disease progression|16|||
157122520|NCT00454805|567200316|FG001|Overall Study|Disease progression|19|||
157122521|NCT00454805|567200315|FG000|Overall Study|In order to begin radiotherapy|1|||
157122522|NCT00454805|567200316|FG001|Overall Study|In order to begin radiotherapy|0|||
157122523|NCT00217087|567200317|FG000|Overall Study|decided to have esophagectomy|1|||
157122524|NCT00217087|567200318|FG001|Overall Study|decided to have esophagectomy|2|||
157122525|NCT00217087|567200317|FG000|Overall Study|completed less than 12 months return|10|||
157122526|NCT00217087|567200318|FG001|Overall Study|completed less than 12 months return|18|||
157122527|NCT04947800|567200325|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
157122528|NCT04947800|567200326|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
157122529|NCT04947800|567200327|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
157122530|NCT03892746|567200328|FG000|Overall Study|Withdrawal by Subject|2|||
157122531|NCT03892746|567200329|FG001|Overall Study|Withdrawal by Subject|1|||
157122532|NCT03892746|567200328|FG000|Overall Study|Lost to Follow-up|2|||
157122533|NCT03892746|567200329|FG001|Overall Study|Lost to Follow-up|0|||
157122534|NCT02158091|567200330|FG000|Overall Study|DLT|2|||
157122535|NCT02158091|567200331|FG001|Overall Study|DLT|1|||
157122536|NCT02158091|567200332|FG002|Overall Study|DLT|0|||
157122537|NCT03977467|567200333|FG000|Overall Study|Disease Progression|1|||
157122538|NCT03977467|567200334|FG001|Overall Study|Disease Progression|1|||
157122539|NCT03977467|567200335|FG002|Overall Study|Disease Progression|30|||
157122540|NCT03977467|567200336|FG003|Overall Study|Disease Progression|0|||
157122541|NCT03977467|567200333|FG000|Overall Study|Adverse Event|0|||
157122542|NCT03977467|567200334|FG001|Overall Study|Adverse Event|1|||
157122543|NCT03977467|567200335|FG002|Overall Study|Adverse Event|0|||
157122544|NCT03977467|567200336|FG003|Overall Study|Adverse Event|0|||
157122545|NCT03977467|567200333|FG000|Overall Study|Death|0|||
157122546|NCT03977467|567200334|FG001|Overall Study|Death|0|||
157122547|NCT03977467|567200335|FG002|Overall Study|Death|3|||
157122548|NCT03977467|567200336|FG003|Overall Study|Death|0|||
157122549|NCT03977467|567200333|FG000|Overall Study|Lack of Efficacy|0|||
157122550|NCT03977467|567200334|FG001|Overall Study|Lack of Efficacy|0|||
157122551|NCT03977467|567200335|FG002|Overall Study|Lack of Efficacy|1|||
157122552|NCT03977467|567200336|FG003|Overall Study|Lack of Efficacy|0|||
157122553|NCT03977467|567200333|FG000|Overall Study|Withdrawal by Subject|2|||
157122554|NCT03977467|567200334|FG001|Overall Study|Withdrawal by Subject|1|||
157122555|NCT03977467|567200335|FG002|Overall Study|Withdrawal by Subject|4|||
157122556|NCT03977467|567200336|FG003|Overall Study|Withdrawal by Subject|0|||
157122557|NCT03977467|567200333|FG000|Overall Study|Study Terminated|1|||
157122558|NCT03977467|567200334|FG001|Overall Study|Study Terminated|0|||
157122559|NCT03977467|567200335|FG002|Overall Study|Study Terminated|0|||
157122560|NCT03977467|567200336|FG003|Overall Study|Study Terminated|1|||
157122561|NCT01318109|567200337|FG000|Overall Study|Adverse Event|0|||
157122562|NCT01318109|567200338|FG001|Overall Study|Adverse Event|2|||
157122563|NCT01318109|567200339|FG002|Overall Study|Adverse Event|0|||
157122564|NCT01318109|567200337|FG000|Overall Study|Withdrawal by Subject|1|||
157122565|NCT01318109|567200338|FG001|Overall Study|Withdrawal by Subject|0|||
157122566|NCT01318109|567200339|FG002|Overall Study|Withdrawal by Subject|0|||
157122567|NCT01318109|567200337|FG000|Overall Study|Schedule Conflict|0|||
157122568|NCT01318109|567200338|FG001|Overall Study|Schedule Conflict|1|||
156693553|NCT00700817|565624075|FG001|Week 0-26 (Main Period)|Unclassified|4|||
156693554|NCT00700817|565624076|FG002|Week 0-26 (Main Period)|Unclassified|8|||
156693555|NCT00700817|565624077|FG003|Week 0-26 (Main Period)|Unclassified|0|||
156693556|NCT00700817|565624078|FG004|Week 0-26 (Main Period)|Unclassified|0|||
156693557|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
156693558|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
156693559|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
156693560|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
156693561|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
156693562|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
156693563|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
156693564|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
156693565|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
156693566|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
156693567|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
156693568|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
156693569|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
156693570|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
156693571|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
156693572|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
156693573|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
156693574|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
156693575|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
156693576|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
156693577|NCT00700817|565624074|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
156693578|NCT00700817|565624075|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
156693579|NCT00700817|565624076|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
156693580|NCT00700817|565624077|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
156693581|NCT00700817|565624078|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
156693582|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693583|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
156693584|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693585|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
156693586|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
156693587|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693588|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
156693589|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
156693590|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693591|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
156693592|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
156693593|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
156693594|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693595|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693596|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
156693597|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
156693598|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
156693599|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
156693600|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
156693601|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
156693602|NCT00700817|565624074|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
156693603|NCT00700817|565624075|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
156693604|NCT00700817|565624076|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
156693605|NCT00700817|565624077|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
156693606|NCT00700817|565624078|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
156693607|NCT00767520|565624079|FG000|Overall Study|Participants still on treatment|11|||
156693608|NCT00767520|565624080|FG001|Overall Study|Participants still on treatment|15|||
156693609|NCT00767520|565624079|FG000|Overall Study|Randomized in error and Never treated|0|||
156693610|NCT00767520|565624080|FG001|Overall Study|Randomized in error and Never treated|2|||
156693611|NCT00720226|565624081|FG000|Overall Study|Withdrawal by Subject|7|||
156693612|NCT00720226|565624082|FG001|Overall Study|Withdrawal by Subject|4|||
156693613|NCT03401073|565624083|FG000|Overall Study|Lost to Follow-up|1|||
156693614|NCT03401073|565624084|FG001|Overall Study|Lost to Follow-up|2|||
156693615|NCT01470612|565624085|FG000|Overall Study|Adverse Event|20|||
156693616|NCT01470612|565624086|FG001|Overall Study|Adverse Event|80|||
156693617|NCT01470612|565624085|FG000|Overall Study|Death|0|||
156693618|NCT01470612|565624086|FG001|Overall Study|Death|1|||
156693619|NCT01470612|565624085|FG000|Overall Study|Lack of Efficacy|20|||
156693620|NCT01470612|565624086|FG001|Overall Study|Lack of Efficacy|326|||
156693621|NCT01470612|565624085|FG000|Overall Study|Lost to Follow-up|2|||
156693622|NCT01470612|565624086|FG001|Overall Study|Lost to Follow-up|5|||
156693623|NCT01470612|565624085|FG000|Overall Study|Did not meet entrance criteria|0|||
156693624|NCT01470612|565624086|FG001|Overall Study|Did not meet entrance criteria|1|||
156693625|NCT01470612|565624085|FG000|Overall Study|Pregnancy|2|||
156693626|NCT01470612|565624086|FG001|Overall Study|Pregnancy|10|||
156693627|NCT01470612|565624085|FG000|Overall Study|Protocol Violation|2|||
156693628|NCT01470612|565624086|FG001|Overall Study|Protocol Violation|7|||
156693629|NCT01470612|565624085|FG000|Overall Study|Withdrawal by Subject|24|||
156693630|NCT01470612|565624086|FG001|Overall Study|Withdrawal by Subject|79|||
156693631|NCT01470612|565624085|FG000|Overall Study|Other|14|||
156693632|NCT01470612|565624086|FG001|Overall Study|Other|156|||
156693633|NCT02039414|565624088|FG000|Overall Study|Delivered|1|||
156693634|NCT02039414|565624089|FG001|Overall Study|Delivered|1|||
156693635|NCT02039414|565624088|FG000|Overall Study|Lost to Follow-up|2|||
156693636|NCT02039414|565624089|FG001|Overall Study|Lost to Follow-up|0|||
156693637|NCT02039414|565624088|FG000|Overall Study|Protocol Violation|3|||
156693638|NCT02039414|565624089|FG001|Overall Study|Protocol Violation|1|||
156693639|NCT01347866|565624090|FG000|Overall Study|Death|0|||
156693640|NCT01347866|565624091|FG001|Overall Study|Death|0|||
156693641|NCT01347866|565624092|FG002|Overall Study|Death|0|||
156693642|NCT01347866|565624093|FG003|Overall Study|Death|1|||
156693643|NCT01347866|565624094|FG004|Overall Study|Death|2|||
156693644|NCT01347866|565624095|FG005|Overall Study|Death|2|||
156693645|NCT01347866|565624096|FG006|Overall Study|Death|1|||
156693646|NCT01347866|565624097|FG007|Overall Study|Death|0|||
156693647|NCT01347866|565624098|FG008|Overall Study|Death|4|||
156693648|NCT01347866|565624099|FG009|Overall Study|Death|1|||
156693649|NCT01347866|565624100|FG010|Overall Study|Death|3|||
156693650|NCT01347866|565624101|FG011|Overall Study|Death|1|||
156693651|NCT01347866|565624102|FG012|Overall Study|Death|2|||
156693652|NCT01347866|565624103|FG013|Overall Study|Death|0|||
156693653|NCT01347866|565624104|FG014|Overall Study|Death|0|||
156693654|NCT01347866|565624105|FG015|Overall Study|Death|1|||
156693655|NCT01347866|565624106|FG016|Overall Study|Death|0|||
156693656|NCT01347866|565624090|FG000|Overall Study|Lost to Follow-up|0|||
156693657|NCT01347866|565624091|FG001|Overall Study|Lost to Follow-up|0|||
156693658|NCT01347866|565624092|FG002|Overall Study|Lost to Follow-up|0|||
156870767|NCT04614974|566284271|FG001|Overall Study|Lost to Follow-up|11|||
156870768|NCT01635153|566284272|FG000|Overall Study|Lost to Follow-up|40|||
156693659|NCT01347866|565624093|FG003|Overall Study|Lost to Follow-up|0|||
156693660|NCT01347866|565624094|FG004|Overall Study|Lost to Follow-up|0|||
156693661|NCT01347866|565624095|FG005|Overall Study|Lost to Follow-up|0|||
156693662|NCT01347866|565624096|FG006|Overall Study|Lost to Follow-up|0|||
156693663|NCT01347866|565624097|FG007|Overall Study|Lost to Follow-up|1|||
156693664|NCT01347866|565624098|FG008|Overall Study|Lost to Follow-up|1|||
156693665|NCT01347866|565624099|FG009|Overall Study|Lost to Follow-up|0|||
156693666|NCT01347866|565624100|FG010|Overall Study|Lost to Follow-up|0|||
156693667|NCT01347866|565624101|FG011|Overall Study|Lost to Follow-up|0|||
156693668|NCT01347866|565624102|FG012|Overall Study|Lost to Follow-up|0|||
156693669|NCT01347866|565624103|FG013|Overall Study|Lost to Follow-up|0|||
156693670|NCT01347866|565624104|FG014|Overall Study|Lost to Follow-up|0|||
156693671|NCT01347866|565624105|FG015|Overall Study|Lost to Follow-up|0|||
156693672|NCT01347866|565624106|FG016|Overall Study|Lost to Follow-up|0|||
156693673|NCT01347866|565624090|FG000|Overall Study|Other|3|||
156693674|NCT01347866|565624091|FG001|Overall Study|Other|1|||
156693675|NCT01347866|565624092|FG002|Overall Study|Other|1|||
156693676|NCT01347866|565624093|FG003|Overall Study|Other|4|||
156693677|NCT01347866|565624094|FG004|Overall Study|Other|5|||
156693678|NCT01347866|565624095|FG005|Overall Study|Other|0|||
156693679|NCT01347866|565624096|FG006|Overall Study|Other|5|||
156693680|NCT01347866|565624097|FG007|Overall Study|Other|3|||
156693681|NCT01347866|565624098|FG008|Overall Study|Other|22|||
156693682|NCT01347866|565624099|FG009|Overall Study|Other|5|||
156693683|NCT01347866|565624100|FG010|Overall Study|Other|0|||
156693684|NCT01347866|565624101|FG011|Overall Study|Other|3|||
156693685|NCT01347866|565624102|FG012|Overall Study|Other|4|||
156693686|NCT01347866|565624103|FG013|Overall Study|Other|4|||
156870769|NCT01635153|566284273|FG001|Overall Study|Lost to Follow-up|43|||
156870770|NCT00658359|566284275|FG000|Overall Study|Death|3|||
156693687|NCT01347866|565624104|FG014|Overall Study|Other|2|||
156693688|NCT01347866|565624105|FG015|Overall Study|Other|3|||
156693689|NCT01347866|565624106|FG016|Overall Study|Other|0|||
156693690|NCT01347866|565624090|FG000|Overall Study|Subject refused further follow-up|2|||
156693691|NCT01347866|565624091|FG001|Overall Study|Subject refused further follow-up|0|||
156693692|NCT01347866|565624092|FG002|Overall Study|Subject refused further follow-up|0|||
156693693|NCT01347866|565624093|FG003|Overall Study|Subject refused further follow-up|2|||
156693694|NCT01347866|565624094|FG004|Overall Study|Subject refused further follow-up|0|||
156693695|NCT01347866|565624095|FG005|Overall Study|Subject refused further follow-up|1|||
156693696|NCT01347866|565624096|FG006|Overall Study|Subject refused further follow-up|0|||
156693697|NCT01347866|565624097|FG007|Overall Study|Subject refused further follow-up|0|||
156693698|NCT01347866|565624098|FG008|Overall Study|Subject refused further follow-up|4|||
156693699|NCT01347866|565624099|FG009|Overall Study|Subject refused further follow-up|1|||
156693700|NCT01347866|565624100|FG010|Overall Study|Subject refused further follow-up|0|||
156870771|NCT00658359|566284276|FG001|Overall Study|Death|1|||
156870772|NCT00658359|566284277|FG002|Overall Study|Death|2|||
156693701|NCT01347866|565624101|FG011|Overall Study|Subject refused further follow-up|0|||
156693702|NCT01347866|565624102|FG012|Overall Study|Subject refused further follow-up|1|||
156693703|NCT01347866|565624103|FG013|Overall Study|Subject refused further follow-up|3|||
156693704|NCT01347866|565624104|FG014|Overall Study|Subject refused further follow-up|1|||
156693705|NCT01347866|565624105|FG015|Overall Study|Subject refused further follow-up|0|||
156693706|NCT01347866|565624106|FG016|Overall Study|Subject refused further follow-up|2|||
156693707|NCT02429934|565624107|FG000|Overall Study|Withdrawal by Subject|0|||
156693708|NCT02429934|565624108|FG001|Overall Study|Withdrawal by Subject|2|||
156693709|NCT02429934|565624107|FG000|Overall Study|Adverse Event|2|||
156693710|NCT02429934|565624108|FG001|Overall Study|Adverse Event|0|||
156693711|NCT02429934|565624107|FG000|Overall Study|Lost to Follow-up|1|||
156693712|NCT02429934|565624108|FG001|Overall Study|Lost to Follow-up|1|||
156693713|NCT02429934|565624107|FG000|Overall Study|Physician Decision|1|||
156693714|NCT02429934|565624108|FG001|Overall Study|Physician Decision|0|||
156693715|NCT00869024|565624109|FG000|Overall Study|Death|2|||
156693716|NCT00869024|565624110|FG001|Overall Study|Death|3|||
156693717|NCT00869024|565624109|FG000|Overall Study|Lost to Follow-up|0|||
156693718|NCT00869024|565624110|FG001|Overall Study|Lost to Follow-up|1|||
156693719|NCT00869024|565624109|FG000|Overall Study|Protocol Violation|0|||
156693720|NCT00869024|565624110|FG001|Overall Study|Protocol Violation|1|||
156693721|NCT01564459|565624111|FG000|Run-In|Adverse Event|7|||
156693722|NCT01564459|565624112|FG001|Run-In|Adverse Event|0|||
156693723|NCT01564459|565624113|FG002|Run-In|Adverse Event|0|||
156693724|NCT01564459|565624111|FG000|Run-In|Lost to Follow-up|1|||
156693725|NCT01564459|565624112|FG001|Run-In|Lost to Follow-up|0|||
156693726|NCT01564459|565624113|FG002|Run-In|Lost to Follow-up|0|||
156693727|NCT01564459|565624111|FG000|Run-In|Non-compliance with study drug|2|||
156693728|NCT01564459|565624112|FG001|Run-In|Non-compliance with study drug|0|||
156693729|NCT01564459|565624113|FG002|Run-In|Non-compliance with study drug|0|||
156693730|NCT01564459|565624111|FG000|Run-In|Protocol Violation|1|||
156693731|NCT01564459|565624112|FG001|Run-In|Protocol Violation|0|||
156693732|NCT01564459|565624113|FG002|Run-In|Protocol Violation|0|||
156693733|NCT01564459|565624111|FG000|Run-In|Withdrawal by Subject|1|||
156693734|NCT01564459|565624112|FG001|Run-In|Withdrawal by Subject|0|||
156693735|NCT01564459|565624113|FG002|Run-In|Withdrawal by Subject|0|||
156693736|NCT01564459|565624111|FG000|Double-blind Treatment|Adverse Event|0|||
156693737|NCT01564459|565624112|FG001|Double-blind Treatment|Adverse Event|0|||
156693738|NCT01564459|565624113|FG002|Double-blind Treatment|Adverse Event|1|||
156693739|NCT02025751|565624123|FG000|Overall Study|Lost to Follow-up|1|||
156693740|NCT02025751|565624124|FG001|Overall Study|Lost to Follow-up|0|||
156693741|NCT02025751|565624123|FG000|Overall Study|Adverse Event|0|||
156693742|NCT02025751|565624124|FG001|Overall Study|Adverse Event|1|||
156693743|NCT02025751|565624123|FG000|Overall Study|Physician Decision|0|||
156693744|NCT02025751|565624124|FG001|Overall Study|Physician Decision|1|||
156693745|NCT02025751|565624123|FG000|Overall Study|Withdrawal by Subject|0|||
156693746|NCT02025751|565624124|FG001|Overall Study|Withdrawal by Subject|1|||
156693747|NCT02687360|565624127|FG000|Overall Study|Withdrawal by Subject|3|||
156693748|NCT02687360|565624128|FG001|Overall Study|Withdrawal by Subject|0|||
156693749|NCT02181296|565624130|FG000|Overall Study|Lost to Follow-up|7|||
156693750|NCT02181296|565624131|FG001|Overall Study|Lost to Follow-up|6|||
156693751|NCT02939014|565624132|FG000|Overall Study|Lost to Follow-up|1|||
156693752|NCT02939014|565624133|FG001|Overall Study|Lost to Follow-up|0|||
156693753|NCT02939014|565624132|FG000|Overall Study|Death|4|||
156693754|NCT02939014|565624133|FG001|Overall Study|Death|3|||
157014200|NCT03416010|566803468|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
157014201|NCT03416010|566803467|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
156870773|NCT00658359|566284275|FG000|Overall Study|Adverse Event|13|||
156693755|NCT01568866|565624134|FG000|Overall Study|Disease Progression|208|||
156693756|NCT01568866|565624135|FG001|Overall Study|Disease Progression|183|||
156693757|NCT01568866|565624134|FG000|Overall Study|Adverse Event|94|||
156693758|NCT01568866|565624135|FG001|Overall Study|Adverse Event|96|||
156693759|NCT01568866|565624134|FG000|Overall Study|Patient Request|55|||
156693760|NCT01568866|565624135|FG001|Overall Study|Patient Request|71|||
156693761|NCT01568866|565624134|FG000|Overall Study|Physician Decision|40|||
156693762|NCT01568866|565624135|FG001|Overall Study|Physician Decision|32|||
156693763|NCT01568866|565624134|FG000|Overall Study|Withdrawal by Subject|19|||
156693764|NCT01568866|565624135|FG001|Overall Study|Withdrawal by Subject|11|||
156870774|NCT00658359|566284276|FG001|Overall Study|Adverse Event|6|||
156870775|NCT00658359|566284277|FG002|Overall Study|Adverse Event|9|||
157021722|NCT06283173|566832933|FG000|Overall Study|Physician Decision|7|||
156693765|NCT01568866|565624134|FG000|Overall Study|Death|10|||
156693766|NCT01568866|565624135|FG001|Overall Study|Death|18|||
156693767|NCT01568866|565624134|FG000|Overall Study|Protocol Non-compliance|2|||
156693768|NCT01568866|565624135|FG001|Overall Study|Protocol Non-compliance|4|||
156693769|NCT01568866|565624134|FG000|Overall Study|Lost to Follow-up|1|||
156693770|NCT01568866|565624135|FG001|Overall Study|Lost to Follow-up|0|||
156693771|NCT01568866|565624134|FG000|Overall Study|Randomized but Not Dosed|9|||
156693772|NCT01568866|565624135|FG001|Overall Study|Randomized but Not Dosed|1|||
156693773|NCT03864042|565624136|FG000|DDI Phase|Adverse Event|2|||
156693774|NCT03864042|565624137|FG001|DDI Phase|Adverse Event|0|||
156693775|NCT03864042|565624138|FG002|DDI Phase|Adverse Event|0|||
156693776|NCT03864042|565624136|FG000|DDI Phase|Physician Decision|1|||
156693777|NCT03864042|565624137|FG001|DDI Phase|Physician Decision|0|||
156693778|NCT03864042|565624138|FG002|DDI Phase|Physician Decision|0|||
156693779|NCT03864042|565624136|FG000|DDI Phase|Progressive Disease|1|||
156693780|NCT03864042|565624137|FG001|DDI Phase|Progressive Disease|0|||
156693781|NCT03864042|565624138|FG002|DDI Phase|Progressive Disease|0|||
156693782|NCT03864042|565624136|FG000|Post-DDI Phase|Adverse Event|5|||
156693783|NCT03864042|565624137|FG001|Post-DDI Phase|Adverse Event|3|||
156693784|NCT03864042|565624138|FG002|Post-DDI Phase|Adverse Event|2|||
156693785|NCT03864042|565624136|FG000|Post-DDI Phase|Progressive Disease|11|||
156693786|NCT03864042|565624137|FG001|Post-DDI Phase|Progressive Disease|6|||
156693787|NCT03864042|565624138|FG002|Post-DDI Phase|Progressive Disease|13|||
156693788|NCT03864042|565624136|FG000|Post-DDI Phase|Discretion of investigator|1|||
156693789|NCT03864042|565624137|FG001|Post-DDI Phase|Discretion of investigator|1|||
156693790|NCT03864042|565624138|FG002|Post-DDI Phase|Discretion of investigator|0|||
156693791|NCT03864042|565624136|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
156693792|NCT03864042|565624137|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
156693793|NCT03864042|565624138|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
156693794|NCT03864042|565624136|FG000|Post-DDI Phase|Withdrawal of consent|1|||
156693795|NCT03864042|565624137|FG001|Post-DDI Phase|Withdrawal of consent|2|||
156693796|NCT03864042|565624138|FG002|Post-DDI Phase|Withdrawal of consent|0|||
156693797|NCT01698775|565624139|FG000|Phase A|Adverse Event|2|||
156693798|NCT01698775|565624140|FG001|Phase A|Adverse Event|1|||
156693799|NCT01698775|565624139|FG000|Phase A|Death|1|||
156693800|NCT01698775|565624140|FG001|Phase A|Death|1|||
156693801|NCT01698775|565624139|FG000|Phase A|Lack of Efficacy|1|||
156693802|NCT01698775|565624140|FG001|Phase A|Lack of Efficacy|0|||
156693803|NCT01698775|565624139|FG000|Phase A|Lost to Follow-up|1|||
156693804|NCT01698775|565624140|FG001|Phase A|Lost to Follow-up|2|||
156693805|NCT01698775|565624139|FG000|Phase A|Protocol Violation|1|||
156693806|NCT01698775|565624140|FG001|Phase A|Protocol Violation|0|||
156693807|NCT01698775|565624139|FG000|Phase A|Withdrawal by Subject|3|||
156693808|NCT01698775|565624140|FG001|Phase A|Withdrawal by Subject|4|||
156693809|NCT01698775|565624139|FG000|Phase A|Kidney [transplant]|0|||
156693810|NCT01698775|565624140|FG001|Phase A|Kidney [transplant]|1|||
156693811|NCT01698775|565624139|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
156693812|NCT01698775|565624140|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
156693813|NCT01698775|565624139|FG000|Phase B|Adverse Event|6|||
156693814|NCT01698775|565624140|FG001|Phase B|Adverse Event|3|||
156789165|NCT02057666|565979185|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
156789166|NCT02057666|565979184|FG000|Double Blind Treatment Period|Poor tolerability|7|||
156693815|NCT01698775|565624139|FG000|Phase B|Death|0|||
156789167|NCT02057666|565979185|FG001|Double Blind Treatment Period|Poor tolerability|2|||
156789168|NCT02057666|565979184|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
156789169|NCT02057666|565979185|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
156789170|NCT02057666|565979184|FG000|Double Blind Treatment Period|Physician Decision|1|||
156789171|NCT02057666|565979185|FG001|Double Blind Treatment Period|Physician Decision|0|||
156789172|NCT02057666|565979184|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
156789173|NCT02057666|565979185|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
156789174|NCT02057666|565979184|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
156789175|NCT02057666|565979185|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
156789176|NCT02057666|565979184|FG000|Double Blind Treatment Period|Sponsor's request|70|||
156789177|NCT02057666|565979185|FG001|Double Blind Treatment Period|Sponsor's request|34|||
156789178|NCT02057666|565979184|FG000|Open-Label Treatment Period|Poor tolerability|0|||
156789179|NCT02057666|565979185|FG001|Open-Label Treatment Period|Poor tolerability|1|||
157014202|NCT03416010|566803468|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
157014203|NCT03416010|566803467|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
157014204|NCT03416010|566803468|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
157014205|NCT03948763|566803469|FG000|Overall Study|Sponsor's decision|0|||
157014206|NCT03948763|566803470|FG001|Overall Study|Sponsor's decision|2|||
157014207|NCT03948763|566803471|FG002|Overall Study|Sponsor's decision|6|||
157214571|NCT03636542|567531934|FG001|Overall Study|Withdrawal by Subject|0|||
156693816|NCT01698775|565624140|FG001|Phase B|Death|1|||
156693817|NCT01698775|565624139|FG000|Phase B|Lack of Efficacy|0|||
156693818|NCT01698775|565624140|FG001|Phase B|Lack of Efficacy|1|||
157014208|NCT03948763|566803472|FG003|Overall Study|Sponsor's decision|4|||
157014209|NCT03948763|566803473|FG004|Overall Study|Sponsor's decision|0|||
156693819|NCT01698775|565624139|FG000|Phase B|Lost to Follow-up|0|||
156693820|NCT01698775|565624140|FG001|Phase B|Lost to Follow-up|1|||
156693821|NCT01698775|565624139|FG000|Phase B|Physician Decision|1|||
156693822|NCT01698775|565624140|FG001|Phase B|Physician Decision|1|||
156693823|NCT01698775|565624139|FG000|Phase B|Protocol Violation|1|||
156693824|NCT01698775|565624140|FG001|Phase B|Protocol Violation|1|||
156693825|NCT01698775|565624139|FG000|Phase B|Withdrawal by Subject|6|||
156693826|NCT01698775|565624140|FG001|Phase B|Withdrawal by Subject|2|||
156693827|NCT02143583|565624147|FG000|Overall Study|Withdrawal by Subject|1|||
156693828|NCT02143583|565624148|FG001|Overall Study|Withdrawal by Subject|0|||
156693829|NCT02143583|565624149|FG002|Overall Study|Withdrawal by Subject|1|||
156693830|NCT02143583|565624147|FG000|Overall Study|husband illness|0|||
156693831|NCT02143583|565624148|FG001|Overall Study|husband illness|0|||
156693832|NCT02143583|565624149|FG002|Overall Study|husband illness|1|||
156693833|NCT00766831|565624150|FG000|Overall Study|Withdrawal by Subject|4|||
156693834|NCT00766831|565624150|FG000|Overall Study|Lost to Follow-up|3|||
156693835|NCT00766831|565624150|FG000|Overall Study|Adverse Event|20|||
156693836|NCT00766831|565624150|FG000|Overall Study|Protocol Violation|15|||
156693837|NCT00766831|565624150|FG000|Overall Study|Physician Decision|5|||
156693838|NCT00766831|565624150|FG000|Overall Study|Withdrawal of consent|26|||
156693839|NCT00766831|565624150|FG000|Overall Study|Non cooperation by participants|14|||
156693840|NCT00766831|565624150|FG000|Overall Study|Other|28|||
156693841|NCT02333487|565624153|FG000|Overall Study|Adverse Event|0|||
156693842|NCT02333487|565624154|FG001|Overall Study|Adverse Event|2|||
156693843|NCT02333487|565624155|FG002|Overall Study|Adverse Event|0|||
156789180|NCT02057666|565979184|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
156789181|NCT02057666|565979185|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
156789182|NCT02057666|565979184|FG000|Open-Label Treatment Period|Sponsor's request|0|||
156789183|NCT02057666|565979185|FG001|Open-Label Treatment Period|Sponsor's request|4|||
156789184|NCT05661734|565979186|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
156789185|NCT05661734|565979186|FG000|Overall Study|Lost to Follow-up|13|||
156789186|NCT05661734|565979186|FG000|Overall Study|Enrolled but not dosed|2|||
156789187|NCT02489045|565979189|FG000|Overall Study|unable to collect usable data|53|||
156789188|NCT02489045|565979189|FG000|Follow-up|Lost to Follow-up|10|||
156789189|NCT01108055|565979196|FG000|Overall Study|Ineligible|11|||
156789190|NCT01108055|565979196|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
156789191|NCT03339453|565979198|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
156789192|NCT03339453|565979199|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
156789193|NCT01117350|565979211|FG000|Comparative Period|Not Treated|5|||
156789194|NCT01117350|565979212|FG001|Comparative Period|Not Treated|8|||
156789195|NCT01117350|565979211|FG000|Comparative Period|Adverse Event|6|||
156789196|NCT01117350|565979212|FG001|Comparative Period|Adverse Event|33|||
156789197|NCT01117350|565979211|FG000|Comparative Period|Lost to Follow-up|11|||
156789198|NCT01117350|565979212|FG001|Comparative Period|Lost to Follow-up|7|||
156789199|NCT01117350|565979211|FG000|Comparative Period|Withdrawal by Subject|9|||
156789200|NCT01117350|565979212|FG001|Comparative Period|Withdrawal by Subject|13|||
156789201|NCT01117350|565979211|FG000|Comparative Period|Protocol Violation|8|||
156789202|NCT01117350|565979212|FG001|Comparative Period|Protocol Violation|12|||
156789203|NCT01117350|565979211|FG000|Comparative Period|Lack of Efficacy|1|||
156789204|NCT01117350|565979212|FG001|Comparative Period|Lack of Efficacy|0|||
156789205|NCT01117350|565979211|FG000|Comparative Period|Physician Decision|0|||
156789206|NCT01117350|565979212|FG001|Comparative Period|Physician Decision|1|||
156789207|NCT01117350|565979211|FG000|Comparative Period|Move to another city/country|2|||
156789208|NCT01117350|565979212|FG001|Comparative Period|Move to another city/country|1|||
156789209|NCT01117350|565979211|FG000|Extension Period|Not included in extension, not treated|0|||
156789210|NCT01117350|565979212|FG001|Extension Period|Not included in extension, not treated|50|||
156789211|NCT01117350|565979211|FG000|Extension Period|Adverse Event|0|||
156789212|NCT01117350|565979212|FG001|Extension Period|Adverse Event|2|||
156789213|NCT01117350|565979211|FG000|Extension Period|Protocol Violation|0|||
156789214|NCT01117350|565979212|FG001|Extension Period|Protocol Violation|2|||
156789215|NCT01117350|565979211|FG000|Extension Period|Lost to Follow-up|0|||
156789216|NCT01117350|565979212|FG001|Extension Period|Lost to Follow-up|2|||
156870776|NCT00658359|566284275|FG000|Overall Study|Protocol Violation|1|||
156870777|NCT00658359|566284276|FG001|Overall Study|Protocol Violation|0|||
156870778|NCT00658359|566284277|FG002|Overall Study|Protocol Violation|0|||
156870779|NCT00658359|566284275|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
156789217|NCT01117350|565979211|FG000|Extension Period|Withdrawal by Subject|0|||
156789218|NCT01117350|565979212|FG001|Extension Period|Withdrawal by Subject|3|||
156789219|NCT01117350|565979211|FG000|Extension Period|Lack of Efficacy|0|||
156789220|NCT01117350|565979212|FG001|Extension Period|Lack of Efficacy|2|||
156789221|NCT01117350|565979211|FG000|Extension Period|Inclusion criteria not respected|0|||
156789222|NCT01117350|565979212|FG001|Extension Period|Inclusion criteria not respected|1|||
156789223|NCT01117350|565979211|FG000|Extension Period|Prohibited medication|0|||
156789224|NCT01117350|565979212|FG001|Extension Period|Prohibited medication|1|||
156789225|NCT02487199|565979218|FG000|Overall Study|Withdrew Consent|0|||
156789226|NCT02487199|565979219|FG001|Overall Study|Withdrew Consent|1|||
156789227|NCT00286455|565979220|FG000|Overall Study|Hyperglycemia rescue|19|||
156789228|NCT00286455|565979221|FG001|Overall Study|Hyperglycemia rescue|13|||
157014210|NCT03948763|566803469|FG000|Overall Study|Physician Decision|0|||
156789229|NCT00286455|565979222|FG002|Overall Study|Hyperglycemia rescue|10|||
156789230|NCT00286455|565979220|FG000|Overall Study|Adverse Event|1|||
156789231|NCT00286455|565979221|FG001|Overall Study|Adverse Event|3|||
156789232|NCT00286455|565979222|FG002|Overall Study|Adverse Event|2|||
156693844|NCT04189445|565625615|FG000|Overall Study|Withdrawal of consent|8|||
156693845|NCT04189445|565625616|FG001|Overall Study|Withdrawal of consent|1|||
156693846|NCT04189445|565625617|FG002|Overall Study|Withdrawal of consent|0|||
156693847|NCT04189445|565625615|FG000|Overall Study|Study Terminated by Sponsor|25|||
156693848|NCT04189445|565625616|FG001|Overall Study|Study Terminated by Sponsor|3|||
156693849|NCT04189445|565625617|FG002|Overall Study|Study Terminated by Sponsor|0|||
156693850|NCT04189445|565625615|FG000|Overall Study|Death|54|||
156693851|NCT04189445|565625616|FG001|Overall Study|Death|24|||
156693852|NCT04189445|565625617|FG002|Overall Study|Death|0|||
156693853|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
156693854|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693855|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693856|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
156693857|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
156693858|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
156693859|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
156693860|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
156693861|NCT02960893|565625619|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693862|NCT02960893|565625620|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
156693863|NCT02960893|565625621|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693864|NCT02960893|565625622|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
156693865|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
156693866|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
156693867|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
156693868|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
156693869|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
156693870|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
156693871|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
156693872|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
156693873|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
156693874|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
156693875|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
156693876|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
156693877|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
156693878|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
156693879|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
156693880|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
156693881|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
156693882|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
156693883|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
156693884|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
156693885|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
156693886|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
156693887|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
156693888|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
156693889|NCT02960893|565625619|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
156693890|NCT02960893|565625620|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
156693891|NCT02960893|565625621|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
156693892|NCT02960893|565625622|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
156693893|NCT02091141|565625623|FG000|Overall Study|Death|280|||
156693894|NCT02091141|565625624|FG001|Overall Study|Death|118|||
156693895|NCT02091141|565625625|FG002|Overall Study|Death|46|||
156693896|NCT02091141|565625626|FG003|Overall Study|Death|13|||
156693897|NCT02091141|565625627|FG004|Overall Study|Death|31|||
156693898|NCT02091141|565625628|FG005|Overall Study|Death|16|||
156693899|NCT02091141|565625629|FG006|Overall Study|Death|12|||
156693900|NCT02091141|565625623|FG000|Overall Study|Withdrawal by Subject|21|||
156693901|NCT02091141|565625624|FG001|Overall Study|Withdrawal by Subject|13|||
156693902|NCT02091141|565625625|FG002|Overall Study|Withdrawal by Subject|3|||
156693903|NCT02091141|565625626|FG003|Overall Study|Withdrawal by Subject|2|||
156789233|NCT00286455|565979220|FG000|Overall Study|Lost to Follow-up|0|||
156789234|NCT00286455|565979221|FG001|Overall Study|Lost to Follow-up|3|||
156789235|NCT00286455|565979222|FG002|Overall Study|Lost to Follow-up|3|||
156789236|NCT00286455|565979220|FG000|Overall Study|Physician Decision|3|||
156789237|NCT00286455|565979221|FG001|Overall Study|Physician Decision|0|||
156789238|NCT00286455|565979222|FG002|Overall Study|Physician Decision|2|||
156789239|NCT00286455|565979220|FG000|Overall Study|Protocol Violation|1|||
156693904|NCT02091141|565625627|FG004|Overall Study|Withdrawal by Subject|2|||
156693905|NCT02091141|565625628|FG005|Overall Study|Withdrawal by Subject|3|||
156789240|NCT00286455|565979221|FG001|Overall Study|Protocol Violation|1|||
156789241|NCT00286455|565979222|FG002|Overall Study|Protocol Violation|0|||
156789242|NCT00286455|565979220|FG000|Overall Study|Participant Non-compliance|1|||
156870780|NCT00658359|566284276|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
156870781|NCT00658359|566284277|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
157214572|NCT03670537|567531937|FG000|Overall Study|Protocol Violation|1|||
157214573|NCT02059187|567531938|FG000|Overall Study|Adverse Event|0|||
156870782|NCT00658359|566284275|FG000|Overall Study|Withdrawal by Subject|7|||
157014211|NCT03948763|566803470|FG001|Overall Study|Physician Decision|0|||
156693906|NCT02091141|565625629|FG006|Overall Study|Withdrawal by Subject|0|||
156693907|NCT02091141|565625623|FG000|Overall Study|Lost to Follow-up|21|||
156693908|NCT02091141|565625624|FG001|Overall Study|Lost to Follow-up|5|||
156693909|NCT02091141|565625625|FG002|Overall Study|Lost to Follow-up|1|||
156693910|NCT02091141|565625626|FG003|Overall Study|Lost to Follow-up|0|||
156693911|NCT02091141|565625627|FG004|Overall Study|Lost to Follow-up|1|||
156693912|NCT02091141|565625628|FG005|Overall Study|Lost to Follow-up|2|||
156693913|NCT02091141|565625629|FG006|Overall Study|Lost to Follow-up|0|||
156693914|NCT02091141|565625623|FG000|Overall Study|Reason Not Specified|6|||
156693915|NCT02091141|565625624|FG001|Overall Study|Reason Not Specified|5|||
156693916|NCT02091141|565625625|FG002|Overall Study|Reason Not Specified|2|||
156693917|NCT02091141|565625626|FG003|Overall Study|Reason Not Specified|0|||
156693918|NCT02091141|565625627|FG004|Overall Study|Reason Not Specified|0|||
156693919|NCT02091141|565625628|FG005|Overall Study|Reason Not Specified|0|||
156693920|NCT02091141|565625629|FG006|Overall Study|Reason Not Specified|1|||
156693921|NCT02091141|565625623|FG000|Overall Study|Study Ended by Sponsor|1|||
156693922|NCT02091141|565625624|FG001|Overall Study|Study Ended by Sponsor|9|||
156693923|NCT02091141|565625625|FG002|Overall Study|Study Ended by Sponsor|0|||
156693924|NCT02091141|565625626|FG003|Overall Study|Study Ended by Sponsor|0|||
156693925|NCT02091141|565625627|FG004|Overall Study|Study Ended by Sponsor|0|||
156693926|NCT02091141|565625628|FG005|Overall Study|Study Ended by Sponsor|0|||
156693927|NCT02091141|565625629|FG006|Overall Study|Study Ended by Sponsor|0|||
156693928|NCT02091141|565625623|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693929|NCT02091141|565625624|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
156693930|NCT02091141|565625625|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693931|NCT02091141|565625626|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693932|NCT02091141|565625627|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693933|NCT02091141|565625628|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693934|NCT02091141|565625629|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
156693935|NCT04551911|565625630|FG000|Overall Study|Lost to Follow-up|2|||
156693936|NCT04551911|565625631|FG001|Overall Study|Lost to Follow-up|1|||
156693937|NCT04551911|565625630|FG000|Overall Study|Withdrawal by Subject|10|||
156693938|NCT04551911|565625631|FG001|Overall Study|Withdrawal by Subject|10|||
156693939|NCT04551911|565625630|FG000|Overall Study|Did not receive the study drug|3|||
156693940|NCT04551911|565625631|FG001|Overall Study|Did not receive the study drug|4|||
156693941|NCT02177136|565625633|FG000|DB Phase|Withdrawal by Subject|2|||
156693942|NCT02177136|565625634|FG001|DB Phase|Withdrawal by Subject|0|||
156693943|NCT02177136|565625635|FG002|DB Phase|Withdrawal by Subject|0|||
156693944|NCT02177136|565625636|FG003|DB Phase|Withdrawal by Subject|0|||
156693945|NCT02177136|565625633|FG000|DB Phase|Discontinued Due to Pruritus|1|||
156693946|NCT02177136|565625634|FG001|DB Phase|Discontinued Due to Pruritus|3|||
156693947|NCT02177136|565625635|FG002|DB Phase|Discontinued Due to Pruritus|0|||
156693948|NCT02177136|565625636|FG003|DB Phase|Discontinued Due to Pruritus|0|||
156693949|NCT02177136|565625633|FG000|DB Phase|Adverse Event|3|||
156693950|NCT02177136|565625634|FG001|DB Phase|Adverse Event|2|||
156693951|NCT02177136|565625635|FG002|DB Phase|Adverse Event|3|||
156693952|NCT02177136|565625636|FG003|DB Phase|Adverse Event|0|||
156693953|NCT02177136|565625633|FG000|DB Phase|Protocol Violation|0|||
156693954|NCT02177136|565625634|FG001|DB Phase|Protocol Violation|0|||
156693955|NCT02177136|565625635|FG002|DB Phase|Protocol Violation|1|||
156693956|NCT02177136|565625636|FG003|DB Phase|Protocol Violation|0|||
156693957|NCT02177136|565625633|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
157014212|NCT03948763|566803471|FG002|Overall Study|Physician Decision|1|||
157014213|NCT03948763|566803472|FG003|Overall Study|Physician Decision|0|||
157014214|NCT03948763|566803473|FG004|Overall Study|Physician Decision|0|||
157014215|NCT03948763|566803469|FG000|Overall Study|Lost to Follow-up|0|||
157014216|NCT03948763|566803470|FG001|Overall Study|Lost to Follow-up|0|||
157014217|NCT03948763|566803471|FG002|Overall Study|Lost to Follow-up|0|||
157014218|NCT03948763|566803472|FG003|Overall Study|Lost to Follow-up|0|||
157014219|NCT03948763|566803473|FG004|Overall Study|Lost to Follow-up|1|||
157014220|NCT03948763|566803469|FG000|Overall Study|Death|2|||
157014221|NCT03948763|566803470|FG001|Overall Study|Death|12|||
157014222|NCT03948763|566803471|FG002|Overall Study|Death|13|||
157014223|NCT03948763|566803472|FG003|Overall Study|Death|10|||
157014224|NCT03948763|566803473|FG004|Overall Study|Death|11|||
157014225|NCT03948763|566803469|FG000|Overall Study|Withdrawal by Subject|1|||
157014226|NCT03948763|566803470|FG001|Overall Study|Withdrawal by Subject|1|||
157014227|NCT03948763|566803471|FG002|Overall Study|Withdrawal by Subject|0|||
157014228|NCT03948763|566803472|FG003|Overall Study|Withdrawal by Subject|2|||
156693958|NCT02177136|565625634|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693959|NCT02177136|565625635|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693960|NCT02177136|565625636|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
156693961|NCT02177136|565625633|FG000|LTSE Phase|Withdrawal by Subject|0|||
156693962|NCT02177136|565625634|FG001|LTSE Phase|Withdrawal by Subject|0|||
156693963|NCT02177136|565625635|FG002|LTSE Phase|Withdrawal by Subject|0|||
156693964|NCT02177136|565625636|FG003|LTSE Phase|Withdrawal by Subject|6|||
156693965|NCT02177136|565625633|FG000|LTSE Phase|Adverse Event|0|||
156693966|NCT02177136|565625634|FG001|LTSE Phase|Adverse Event|0|||
156693967|NCT02177136|565625635|FG002|LTSE Phase|Adverse Event|0|||
156693968|NCT02177136|565625636|FG003|LTSE Phase|Adverse Event|10|||
156693969|NCT02177136|565625633|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
156693970|NCT02177136|565625634|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
156693971|NCT02177136|565625635|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
156693972|NCT02177136|565625636|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
156693973|NCT02177136|565625633|FG000|LTSE Phase|Physician Decision|0|||
156693974|NCT02177136|565625634|FG001|LTSE Phase|Physician Decision|0|||
156693975|NCT02177136|565625635|FG002|LTSE Phase|Physician Decision|0|||
156693976|NCT02177136|565625636|FG003|LTSE Phase|Physician Decision|2|||
156693977|NCT02177136|565625633|FG000|LTSE Phase|Lost to Follow-up|0|||
156693978|NCT02177136|565625634|FG001|LTSE Phase|Lost to Follow-up|0|||
156693979|NCT02177136|565625635|FG002|LTSE Phase|Lost to Follow-up|0|||
156693980|NCT02177136|565625636|FG003|LTSE Phase|Lost to Follow-up|1|||
156693981|NCT02177136|565625633|FG000|LTSE Phase|Participant Moved|0|||
156693982|NCT02177136|565625634|FG001|LTSE Phase|Participant Moved|0|||
156693983|NCT02177136|565625635|FG002|LTSE Phase|Participant Moved|0|||
156693984|NCT02177136|565625636|FG003|LTSE Phase|Participant Moved|1|||
156693985|NCT00094458|565625639|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
156693986|NCT00094458|565625640|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
156693987|NCT00094458|565625641|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
156693988|NCT00094458|565625642|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693989|NCT00094458|565625643|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693990|NCT00094458|565625644|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
156693991|NCT00094458|565625639|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
156693992|NCT00094458|565625640|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
156693993|NCT00094458|565625641|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
156693994|NCT00094458|565625642|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
156693995|NCT00094458|565625643|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
156693996|NCT00094458|565625644|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
156693997|NCT00094458|565625639|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
156693998|NCT00094458|565625640|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
156693999|NCT00094458|565625641|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
156694000|NCT00094458|565625642|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694001|NCT00094458|565625643|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694002|NCT00094458|565625644|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
156694003|NCT00094458|565625639|FG000|Main Study: Through Week 30|Adverse Event|38|||
156694004|NCT00094458|565625640|FG001|Main Study: Through Week 30|Adverse Event|20|||
156694005|NCT00094458|565625641|FG002|Main Study: Through Week 30|Adverse Event|28|||
156694006|NCT00094458|565625642|FG003|Main Study: Through Week 30|Adverse Event|0|||
156694007|NCT00094458|565625643|FG004|Main Study: Through Week 30|Adverse Event|0|||
156694008|NCT00094458|565625644|FG005|Main Study: Through Week 30|Adverse Event|0|||
156694009|NCT00094458|565625639|FG000|Main Study: Through Week 30|Death|1|||
156694010|NCT00094458|565625640|FG001|Main Study: Through Week 30|Death|0|||
156694011|NCT00094458|565625641|FG002|Main Study: Through Week 30|Death|0|||
156694012|NCT00094458|565625642|FG003|Main Study: Through Week 30|Death|0|||
156694013|NCT00094458|565625643|FG004|Main Study: Through Week 30|Death|0|||
156694014|NCT00094458|565625644|FG005|Main Study: Through Week 30|Death|0|||
156694015|NCT00094458|565625639|FG000|Main Study: Through Week 30|Other|19|||
156694016|NCT00094458|565625640|FG001|Main Study: Through Week 30|Other|16|||
156694017|NCT00094458|565625641|FG002|Main Study: Through Week 30|Other|9|||
156694018|NCT00094458|565625642|FG003|Main Study: Through Week 30|Other|0|||
156694019|NCT00094458|565625643|FG004|Main Study: Through Week 30|Other|0|||
156694020|NCT00094458|565625644|FG005|Main Study: Through Week 30|Other|0|||
156694021|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
156694022|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
156694023|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
156694024|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694025|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694026|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
156694027|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
156870783|NCT00658359|566284276|FG001|Overall Study|Withdrawal by Subject|4|||
156694028|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694029|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
156694030|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
157014229|NCT03948763|566803473|FG004|Overall Study|Withdrawal by Subject|4|||
157014230|NCT06629454|566803477|FG000|Overall Study|Withdraw by Clinician Decision|1|||
157014231|NCT06023082|566803478|FG000|Overall Study|Withdrawal by Subject|2|||
157014232|NCT06023082|566803478|FG000|Overall Study|Lost to Follow-up|15|||
157014233|NCT06023082|566803478|FG000|Overall Study|Side effects|5|||
157014234|NCT05986565|566803484|FG000|Overall Study|Lost to Follow-up|8|||
157014235|NCT05986565|566803485|FG001|Overall Study|Lost to Follow-up|3|||
157014236|NCT05986565|566803484|FG000|Overall Study|Withdrawal by Subject|0|||
157014237|NCT05986565|566803485|FG001|Overall Study|Withdrawal by Subject|1|||
157014238|NCT03446157|566803488|FG000|Overall Study|Death|11|||
157014239|NCT03446157|566803489|FG001|Overall Study|Death|9|||
157014240|NCT03446157|566803488|FG000|Overall Study|Lost to Follow-up|0|||
157014241|NCT03446157|566803489|FG001|Overall Study|Lost to Follow-up|1|||
157014242|NCT03446157|566803488|FG000|Overall Study|Withdrawal by Subject|2|||
157014243|NCT03446157|566803489|FG001|Overall Study|Withdrawal by Subject|1|||
157014244|NCT02386553|566803490|FG000|Overall Study|Reason Not Specified|1|||
157014245|NCT02386553|566803491|FG001|Overall Study|Reason Not Specified|1|||
157014246|NCT02386553|566803490|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
157014247|NCT02386553|566803491|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
157014248|NCT00520546|566803499|FG000|Overall Study|Withdrawal by Subject|1|||
157014249|NCT00520546|566803499|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
157014250|NCT02554786|566803504|FG000|Overall Study|Subject/guardian decision|29|||
157014251|NCT02554786|566803505|FG001|Overall Study|Subject/guardian decision|17|||
157014252|NCT02554786|566803506|FG002|Overall Study|Subject/guardian decision|18|||
157014253|NCT02554786|566803507|FG003|Overall Study|Subject/guardian decision|30|||
157014254|NCT02554786|566803508|FG004|Overall Study|Subject/guardian decision|20|||
157014255|NCT02554786|566803504|FG000|Overall Study|Lost to Follow-up|4|||
157014256|NCT02554786|566803505|FG001|Overall Study|Lost to Follow-up|3|||
157014257|NCT02554786|566803506|FG002|Overall Study|Lost to Follow-up|4|||
157014258|NCT02554786|566803507|FG003|Overall Study|Lost to Follow-up|2|||
157014259|NCT02554786|566803508|FG004|Overall Study|Lost to Follow-up|2|||
157014260|NCT02554786|566803504|FG000|Overall Study|Protocol deviation|1|||
157014261|NCT02554786|566803505|FG001|Overall Study|Protocol deviation|3|||
157014262|NCT02554786|566803506|FG002|Overall Study|Protocol deviation|3|||
157014263|NCT02554786|566803507|FG003|Overall Study|Protocol deviation|4|||
157014264|NCT02554786|566803508|FG004|Overall Study|Protocol deviation|2|||
157014265|NCT02554786|566803504|FG000|Overall Study|Technical problems|1|||
157014266|NCT02554786|566803505|FG001|Overall Study|Technical problems|1|||
157014267|NCT02554786|566803506|FG002|Overall Study|Technical problems|0|||
157014268|NCT02554786|566803507|FG003|Overall Study|Technical problems|2|||
157014269|NCT02554786|566803508|FG004|Overall Study|Technical problems|1|||
157014270|NCT02554786|566803504|FG000|Overall Study|Adverse Event|0|||
157014271|NCT02554786|566803505|FG001|Overall Study|Adverse Event|0|||
157014272|NCT02554786|566803506|FG002|Overall Study|Adverse Event|0|||
157014273|NCT02554786|566803507|FG003|Overall Study|Adverse Event|0|||
157014274|NCT02554786|566803508|FG004|Overall Study|Adverse Event|2|||
157014275|NCT02554786|566803504|FG000|Overall Study|Death|0|||
157014276|NCT02554786|566803505|FG001|Overall Study|Death|0|||
157014277|NCT02554786|566803506|FG002|Overall Study|Death|0|||
156694031|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694032|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
156694033|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
156694034|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
156870784|NCT00658359|566284277|FG002|Overall Study|Withdrawal by Subject|2|||
156870785|NCT00658359|566284275|FG000|Overall Study|Lost to Follow-up|2|||
156870786|NCT00658359|566284276|FG001|Overall Study|Lost to Follow-up|2|||
156870787|NCT00658359|566284277|FG002|Overall Study|Lost to Follow-up|4|||
156870788|NCT00658359|566284275|FG000|Overall Study|Lack of Efficacy|0|||
156870789|NCT00658359|566284276|FG001|Overall Study|Lack of Efficacy|1|||
156870790|NCT00658359|566284277|FG002|Overall Study|Lack of Efficacy|0|||
156870791|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Adverse Event|9|||
156870792|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Adverse Event|3|||
156870793|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Death|7|||
156870794|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Death|7|||
157014278|NCT02554786|566803507|FG003|Overall Study|Death|1|||
157014279|NCT02554786|566803508|FG004|Overall Study|Death|0|||
157014280|NCT02554786|566803504|FG000|Overall Study|Non-compliance with study treatment|0|||
157014281|NCT02554786|566803505|FG001|Overall Study|Non-compliance with study treatment|1|||
156870795|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
156870796|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
156870797|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Physician Decision|1|||
157014282|NCT02554786|566803506|FG002|Overall Study|Non-compliance with study treatment|1|||
157122569|NCT01318109|567200339|FG002|Overall Study|Schedule Conflict|0|||
157122570|NCT01328951|567200340|FG000|Overall Study|Disease Progression|17|||
157014283|NCT02554786|566803507|FG003|Overall Study|Non-compliance with study treatment|0|||
157014284|NCT02554786|566803508|FG004|Overall Study|Non-compliance with study treatment|1|||
157014285|NCT02554786|566803504|FG000|Overall Study|Physician Decision|0|||
157214574|NCT02059187|567531939|FG001|Overall Study|Adverse Event|3|||
157214575|NCT02059187|567531938|FG000|Overall Study|Death|1|||
157014286|NCT02554786|566803505|FG001|Overall Study|Physician Decision|1|||
157014287|NCT02554786|566803506|FG002|Overall Study|Physician Decision|4|||
157014288|NCT02554786|566803507|FG003|Overall Study|Physician Decision|1|||
157014289|NCT02554786|566803508|FG004|Overall Study|Physician Decision|1|||
157014290|NCT02554786|566803504|FG000|Overall Study|Pregnancy|0|||
157014291|NCT02554786|566803505|FG001|Overall Study|Pregnancy|0|||
157014292|NCT02554786|566803506|FG002|Overall Study|Pregnancy|0|||
157014293|NCT02554786|566803507|FG003|Overall Study|Pregnancy|1|||
157014294|NCT02554786|566803508|FG004|Overall Study|Pregnancy|1|||
157014295|NCT01695954|566803509|FG000|Overall Study|Withdrawal by Subject|4|||
157014296|NCT01695954|566803510|FG001|Overall Study|Withdrawal by Subject|0|||
157014297|NCT01695954|566803509|FG000|Overall Study|Adverse Event|0|||
157014298|NCT01695954|566803510|FG001|Overall Study|Adverse Event|2|||
157014299|NCT04704284|566803527|FG000|Overall Study|Withdrawal by Subject|1|||
157014300|NCT01736215|566803532|FG000|Overall Study|Early termination of erythropoietin use|1|||
157014301|NCT01736215|566803532|FG000|Overall Study|Adverse Event|4|||
157014302|NCT01736215|566803532|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
157014303|NCT01736215|566803532|FG000|Overall Study|Insufficient data to perform analysis|8|||
157014304|NCT01248936|566803533|FG000|Overall Study|Sponsor Decision|259|||
157014305|NCT01248936|566803533|FG000|Overall Study|Progression of Disease|50|||
157014306|NCT01248936|566803533|FG000|Overall Study|Death|26|||
157014307|NCT01248936|566803533|FG000|Overall Study|Withdrawal of Consent|20|||
157014308|NCT01248936|566803533|FG000|Overall Study|Adverse Event|8|||
157014309|NCT01248936|566803533|FG000|Overall Study|Lost to Follow-up|7|||
157014310|NCT01248936|566803533|FG000|Overall Study|Refused Treatment|1|||
157014311|NCT01248936|566803533|FG000|Overall Study|Other reason|3|||
157014312|NCT02692417|566803536|FG000|Overall Study|Withdrawal by Subject|5|||
157014313|NCT02692417|566803537|FG001|Overall Study|Withdrawal by Subject|1|||
157014314|NCT02692417|566803536|FG000|Overall Study|Adverse Event|1|||
157014315|NCT02692417|566803537|FG001|Overall Study|Adverse Event|0|||
157014316|NCT02372253|566803543|FG000|Overall Study|Non Compliance|2|||
157014317|NCT02372253|566803544|FG001|Overall Study|Non Compliance|0|||
157014318|NCT01803555|566803545|FG000|Overall Study|Adverse Event|3|||
157014319|NCT01803555|566803546|FG001|Overall Study|Adverse Event|2|||
157014320|NCT01803555|566803545|FG000|Overall Study|Withdrawal by Subject|3|||
157014321|NCT01803555|566803546|FG001|Overall Study|Withdrawal by Subject|3|||
157014322|NCT01803555|566803545|FG000|Overall Study|Non-compliance|1|||
157014323|NCT01803555|566803546|FG001|Overall Study|Non-compliance|1|||
157014324|NCT01803555|566803545|FG000|Overall Study|Protocol Violation|3|||
157014325|NCT01803555|566803546|FG001|Overall Study|Protocol Violation|5|||
157014326|NCT01803555|566803545|FG000|Overall Study|Lost to Follow-up|0|||
157014327|NCT01803555|566803546|FG001|Overall Study|Lost to Follow-up|2|||
157014328|NCT01803555|566803545|FG000|Overall Study|Other than specified|3|||
157014329|NCT01803555|566803546|FG001|Overall Study|Other than specified|5|||
157214576|NCT02059187|567531939|FG001|Overall Study|Death|1|||
157214577|NCT02059187|567531938|FG000|Overall Study|Lost to Follow-up|9|||
157214578|NCT02059187|567531939|FG001|Overall Study|Lost to Follow-up|8|||
157214579|NCT02059187|567531938|FG000|Overall Study|Non-compliance with study drug|1|||
157214580|NCT02059187|567531939|FG001|Overall Study|Non-compliance with study drug|0|||
157214581|NCT02059187|567531938|FG000|Overall Study|Physician Decision|1|||
157014330|NCT03664960|566803548|FG000|Overall Study|Adverse Event|0|||
157014331|NCT03664960|566803549|FG001|Overall Study|Adverse Event|3|||
157014332|NCT03664960|566803548|FG000|Overall Study|Lost to Follow-up|3|||
157014333|NCT03664960|566803549|FG001|Overall Study|Lost to Follow-up|2|||
157014334|NCT03664960|566803548|FG000|Overall Study|Physician Decision|1|||
157014335|NCT03664960|566803549|FG001|Overall Study|Physician Decision|0|||
157014336|NCT03664960|566803548|FG000|Overall Study|Withdrawal by Subject|3|||
157014337|NCT03664960|566803549|FG001|Overall Study|Withdrawal by Subject|14|||
157014338|NCT03664960|566803548|FG000|Overall Study|Sponsor Decision|1|||
157014339|NCT03664960|566803549|FG001|Overall Study|Sponsor Decision|1|||
157014340|NCT03664960|566803548|FG000|Overall Study|Other|1|||
157014341|NCT03664960|566803549|FG001|Overall Study|Other|2|||
157014342|NCT03398148|566804996|FG000|Substudy 1 Period 1|Adverse Event|5|||
157014343|NCT03398148|566804997|FG001|Substudy 1 Period 1|Adverse Event|2|||
157014344|NCT03398148|566804998|FG002|Substudy 1 Period 1|Adverse Event|2|||
157014345|NCT03398148|566804999|FG003|Substudy 1 Period 1|Adverse Event|0|||
157014346|NCT03398148|566805000|FG004|Substudy 1 Period 1|Adverse Event|8|||
157014347|NCT03398148|566805001|FG005|Substudy 1 Period 1|Adverse Event|0|||
157014348|NCT03398148|566805002|FG006|Substudy 1 Period 1|Adverse Event|0|||
157014349|NCT03398148|566805003|FG007|Substudy 1 Period 1|Adverse Event|0|||
157014350|NCT03398148|566805004|FG008|Substudy 1 Period 1|Adverse Event|0|||
157014351|NCT03398148|566805005|FG009|Substudy 1 Period 1|Adverse Event|0|||
157014352|NCT03398148|566805006|FG010|Substudy 1 Period 1|Adverse Event|0|||
157014353|NCT03398148|566805007|FG011|Substudy 1 Period 1|Adverse Event|0|||
157014354|NCT03398148|566805008|FG012|Substudy 1 Period 1|Adverse Event|0|||
157014355|NCT03398148|566805009|FG013|Substudy 1 Period 1|Adverse Event|0|||
157214582|NCT02059187|567531939|FG001|Overall Study|Physician Decision|2|||
157214583|NCT02059187|567531938|FG000|Overall Study|Protocol Violation|1|||
156694035|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
156694036|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694037|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694038|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
156694039|NCT00094458|565625639|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
156694040|NCT00094458|565625640|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
156694041|NCT00094458|565625641|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
156694042|NCT00094458|565625642|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
156694043|NCT00094458|565625643|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
156694044|NCT00094458|565625644|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
156694045|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Adverse Event|0|||
156694046|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Adverse Event|0|||
156694047|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Adverse Event|0|||
156694048|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Adverse Event|0|||
156694049|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Adverse Event|3|||
156694050|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Adverse Event|4|||
156694051|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694052|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694053|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694054|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
156694055|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
156694056|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
156694057|NCT00094458|565625639|FG000|OLE: Open-Label Extension|Patient decision|0|||
156694058|NCT00094458|565625640|FG001|OLE: Open-Label Extension|Patient decision|0|||
157122571|NCT01328951|567200341|FG001|Overall Study|Disease Progression|14|||
157122572|NCT01328951|567200340|FG000|Overall Study|Adverse Event|2|||
157122573|NCT01328951|567200341|FG001|Overall Study|Adverse Event|0|||
157122574|NCT01328951|567200340|FG000|Overall Study|Death|243|||
157122575|NCT01328951|567200341|FG001|Overall Study|Death|258|||
157122576|NCT01328951|567200340|FG000|Overall Study|Lost to Follow-up|6|||
157122577|NCT01328951|567200341|FG001|Overall Study|Lost to Follow-up|7|||
156694059|NCT00094458|565625641|FG002|OLE: Open-Label Extension|Patient decision|0|||
156694060|NCT00094458|565625642|FG003|OLE: Open-Label Extension|Patient decision|0|||
156694061|NCT00094458|565625643|FG004|OLE: Open-Label Extension|Patient decision|1|||
156694062|NCT00094458|565625644|FG005|OLE: Open-Label Extension|Patient decision|0|||
156694063|NCT00619112|565625651|FG000|Overall Study|Adverse Event|1|||
156694064|NCT00619112|565625652|FG001|Overall Study|Adverse Event|2|||
156694065|NCT00729248|565625653|FG000|Overall Study|Physician Decision|2|||
156694066|NCT03573505|565625656|FG000|Overall Study|Adverse Event|1|||
156694067|NCT03573505|565625657|FG001|Overall Study|Adverse Event|1|||
156694068|NCT03573505|565625656|FG000|Overall Study|Consent withdrawn|0|||
156694069|NCT03573505|565625657|FG001|Overall Study|Consent withdrawn|1|||
156694070|NCT03573505|565625656|FG000|Overall Study|Disease progression|0|||
156694071|NCT03573505|565625657|FG001|Overall Study|Disease progression|1|||
156694072|NCT03573505|565625656|FG000|Overall Study|Site Terminated by Sponsor|1|||
156694073|NCT03573505|565625657|FG001|Overall Study|Site Terminated by Sponsor|1|||
156694074|NCT03573505|565625656|FG000|Overall Study|Study terminated by sponsor|50|||
156694075|NCT03573505|565625657|FG001|Overall Study|Study terminated by sponsor|45|||
156694076|NCT03573505|565625656|FG000|Overall Study|Reason not specified|0|||
156694077|NCT03573505|565625657|FG001|Overall Study|Reason not specified|1|||
156694078|NCT03573505|565625656|FG000|Overall Study|Death|0|||
156694079|NCT03573505|565625657|FG001|Overall Study|Death|4|||
156694080|NCT00652028|565625660|FG000|Overall Study|Adverse Event|1|||
156694081|NCT00652028|565625661|FG001|Overall Study|Adverse Event|0|||
156694082|NCT00652028|565625662|FG002|Overall Study|Adverse Event|0|||
156694083|NCT00652028|565625663|FG003|Overall Study|Adverse Event|0|||
156694084|NCT00652028|565625660|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
156694085|NCT00652028|565625661|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
156694086|NCT00652028|565625662|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
156694087|NCT00652028|565625663|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
156694088|NCT00652028|565625660|FG000|Overall Study|Physician Decision|0|||
156694089|NCT00652028|565625661|FG001|Overall Study|Physician Decision|0|||
156694090|NCT00652028|565625662|FG002|Overall Study|Physician Decision|1|||
156694091|NCT00652028|565625663|FG003|Overall Study|Physician Decision|0|||
156694092|NCT03835325|565625665|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
156694093|NCT03835325|565625665|FG000|Overall Study|Selection failure|1|||
156789243|NCT00286455|565979221|FG001|Overall Study|Participant Non-compliance|0|||
156789244|NCT00286455|565979222|FG002|Overall Study|Participant Non-compliance|0|||
156789245|NCT00286455|565979220|FG000|Overall Study|Withdrawal by Subject|0|||
157122578|NCT01328951|567200340|FG000|Overall Study|Withdrawal by Subject|6|||
156789246|NCT00286455|565979221|FG001|Overall Study|Withdrawal by Subject|8|||
156694094|NCT02787408|565625666|FG000|Overall Study|Death|16|||
156694095|NCT02787408|565625666|FG000|Overall Study|Withdrawal by Subject|1|||
156789247|NCT00286455|565979222|FG002|Overall Study|Withdrawal by Subject|7|||
157122579|NCT01328951|567200341|FG001|Overall Study|Withdrawal by Subject|6|||
156694096|NCT02787408|565625666|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
156694097|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
156694098|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
156694099|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
156694100|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
156694101|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
156694102|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
156694103|NCT03395639|565625669|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
156694104|NCT03395639|565625670|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
156694105|NCT03395639|565625671|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
156694106|NCT03395639|565625669|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
156694107|NCT03395639|565625670|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
156694108|NCT03395639|565625671|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
156694109|NCT03395639|565625669|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
156694110|NCT03395639|565625670|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
156694111|NCT03395639|565625671|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
156694112|NCT00942331|565625672|FG000|Overall Study|Did not start treatment|15|||
156694113|NCT00942331|565625673|FG001|Overall Study|Did not start treatment|22|||
156694114|NCT00567476|565625675|FG000|Overall Study|Adverse Event|2|||
156694115|NCT00567476|565625676|FG001|Overall Study|Adverse Event|0|||
156694116|NCT00567476|565625675|FG000|Overall Study|Pregnancy|1|||
156694117|NCT00567476|565625676|FG001|Overall Study|Pregnancy|0|||
156694118|NCT00567476|565625675|FG000|Overall Study|Protocol Violation|4|||
156694119|NCT00567476|565625676|FG001|Overall Study|Protocol Violation|1|||
156694120|NCT00567476|565625675|FG000|Overall Study|Lost to Follow-up|0|||
156694121|NCT00567476|565625676|FG001|Overall Study|Lost to Follow-up|1|||
156694122|NCT00567476|565625675|FG000|Overall Study|Administrative issues|1|||
156694123|NCT00567476|565625676|FG001|Overall Study|Administrative issues|0|||
156694124|NCT00567476|565625675|FG000|Overall Study|Medical Decision|0|||
156694125|NCT00567476|565625676|FG001|Overall Study|Medical Decision|1|||
156694126|NCT00567476|565625675|FG000|Overall Study|Non-adherence to protocol|0|||
156694127|NCT00567476|565625676|FG001|Overall Study|Non-adherence to protocol|1|||
156694128|NCT00995085|565625677|FG000|Overall Study|Withdrawal by Subject|5|||
156694129|NCT01194973|565625681|FG000|Screening Period|Screen Failure|3|||
156694130|NCT01194973|565625681|FG000|26 Week Treatment Period|Adverse Event|1|||
156694131|NCT01194973|565625681|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
156694132|NCT01194973|565625681|FG000|26 Week Treatment Period|Pregnancy|1|||
156694133|NCT00757848|565625684|FG000|Overall Study|Voluntary discontinuation|1|||
156694134|NCT00757848|565625685|FG001|Overall Study|Voluntary discontinuation|0|||
156694135|NCT00757848|565625684|FG000|Overall Study|Adverse Event|1|||
156694136|NCT00757848|565625685|FG001|Overall Study|Adverse Event|2|||
156694137|NCT00757848|565625684|FG000|Overall Study|Incorrect enrolment|1|||
156694138|NCT00757848|565625685|FG001|Overall Study|Incorrect enrolment|0|||
156694139|NCT01338987|565625686|FG000|Overall Study|enrolled on new protocol|0|||
156694140|NCT01338987|565625687|FG001|Overall Study|enrolled on new protocol|0|||
156694141|NCT01338987|565625688|FG002|Overall Study|enrolled on new protocol|1|||
156694142|NCT01338987|565625689|FG003|Overall Study|enrolled on new protocol|0|||
156694143|NCT01338987|565625690|FG004|Overall Study|enrolled on new protocol|0|||
156694144|NCT01338987|565625686|FG000|Overall Study|Disease progression on study|2|||
156694145|NCT01338987|565625687|FG001|Overall Study|Disease progression on study|1|||
156694146|NCT01338987|565625688|FG002|Overall Study|Disease progression on study|1|||
156694147|NCT01338987|565625689|FG003|Overall Study|Disease progression on study|0|||
156694148|NCT01338987|565625690|FG004|Overall Study|Disease progression on study|0|||
156694149|NCT03856593|565625698|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
156694150|NCT03856593|565625699|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
156694151|NCT01901874|565625703|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
156694152|NCT01901874|565625703|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
156694153|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
156694154|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
156694155|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
156694156|NCT01901874|565625703|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
156694157|NCT02595008|565625704|FG000|Overall Study|Enrolled In Error|1|||
156694158|NCT02595008|565625705|FG001|Overall Study|Enrolled In Error|0|||
156694159|NCT03407118|565625706|FG000|Period 2|Withdrawal by Subject|1|||
156694160|NCT03407118|565625707|FG001|Period 2|Withdrawal by Subject|0|||
156694161|NCT03977701|565625720|FG000|Overall Study|COVID-19 pandemic|0|||
156870798|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Physician Decision|0|||
156870799|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
156694162|NCT03977701|565625721|FG001|Overall Study|COVID-19 pandemic|0|||
156694163|NCT03977701|565625722|FG002|Overall Study|COVID-19 pandemic|0|||
157014356|NCT03398148|566805010|FG014|Substudy 1 Period 1|Adverse Event|0|||
157014357|NCT03398148|566804996|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
157014358|NCT03398148|566804997|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
157014359|NCT03398148|566804998|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014360|NCT03398148|566804999|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
157014361|NCT03398148|566805000|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
157014362|NCT03398148|566805001|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014363|NCT03398148|566805002|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014364|NCT03398148|566805003|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014365|NCT03398148|566805004|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014366|NCT03398148|566805005|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014367|NCT03398148|566805006|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014368|NCT03398148|566805007|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014369|NCT03398148|566805008|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014370|NCT03398148|566805009|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014371|NCT03398148|566805010|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
157014372|NCT03398148|566804996|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
157014373|NCT03398148|566804997|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
156694164|NCT03977701|565625723|FG003|Overall Study|COVID-19 pandemic|0|||
156694165|NCT03977701|565625724|FG004|Overall Study|COVID-19 pandemic|0|||
156694166|NCT03977701|565625725|FG005|Overall Study|COVID-19 pandemic|1|||
156694167|NCT03977701|565625726|FG006|Overall Study|COVID-19 pandemic|0|||
156694168|NCT03977701|565625727|FG007|Overall Study|COVID-19 pandemic|1|||
156694169|NCT03977701|565625728|FG008|Overall Study|COVID-19 pandemic|0|||
156694170|NCT03977701|565625729|FG009|Overall Study|COVID-19 pandemic|0|||
156694171|NCT02340221|565625734|FG000|Overall Study|Death|100|||
156694172|NCT02340221|565625735|FG001|Overall Study|Death|197|||
156694173|NCT02340221|565625734|FG000|Overall Study|Withdrawal by Participant|24|||
156694174|NCT02340221|565625735|FG001|Overall Study|Withdrawal by Participant|37|||
156694175|NCT02340221|565625734|FG000|Overall Study|Lost to Follow-up|4|||
156694176|NCT02340221|565625735|FG001|Overall Study|Lost to Follow-up|15|||
156694177|NCT02340221|565625734|FG000|Overall Study|Reason Not Specified|85|||
156694178|NCT02340221|565625735|FG001|Overall Study|Reason Not Specified|165|||
156694179|NCT02340221|565625734|FG000|Overall Study|Study Terminated by Sponsor|1|||
156694180|NCT02340221|565625735|FG001|Overall Study|Study Terminated by Sponsor|3|||
156694181|NCT01583218|565625736|FG000|Overall Study|Withdrawal by Subject|43|||
156694182|NCT01583218|565625737|FG001|Overall Study|Withdrawal by Subject|29|||
156694183|NCT01583218|565625736|FG000|Overall Study|Death|206|||
156694184|NCT01583218|565625737|FG001|Overall Study|Death|211|||
156694185|NCT01583218|565625736|FG000|Overall Study|Lost to Follow-up|11|||
156694186|NCT01583218|565625737|FG001|Overall Study|Lost to Follow-up|17|||
156694187|NCT01583218|565625736|FG000|Overall Study|Adverse event or serious adverse event|3|||
156694188|NCT01583218|565625737|FG001|Overall Study|Adverse event or serious adverse event|3|||
156694189|NCT01583218|565625736|FG000|Overall Study|Patient /Family decision|3|||
156694190|NCT01583218|565625737|FG001|Overall Study|Patient /Family decision|0|||
156694191|NCT01583218|565625736|FG000|Overall Study|Cannot contact patient directly|1|||
156694192|NCT01583218|565625737|FG001|Overall Study|Cannot contact patient directly|2|||
156694193|NCT01583218|565625736|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
156694194|NCT01583218|565625737|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
156694195|NCT01583218|565625736|FG000|Overall Study|Patient did not wish to attend visits|0|||
156694196|NCT01583218|565625737|FG001|Overall Study|Patient did not wish to attend visits|1|||
156694197|NCT01583218|565625736|FG000|Overall Study|Patient randomized but not dosed|17|||
156694198|NCT01583218|565625737|FG001|Overall Study|Patient randomized but not dosed|16|||
156694199|NCT01583218|565625736|FG000|Overall Study|Patient was assessed via phone in person|1|||
156694200|NCT01583218|565625737|FG001|Overall Study|Patient was assessed via phone in person|0|||
156694201|NCT01583218|565625736|FG000|Overall Study|Patient deemed ineligible after random|2|||
156694202|NCT01583218|565625737|FG001|Overall Study|Patient deemed ineligible after random|0|||
156694203|NCT01583218|565625736|FG000|Overall Study|Patient was early terminated from study|0|||
156694204|NCT01583218|565625737|FG001|Overall Study|Patient was early terminated from study|1|||
156694205|NCT01583218|565625736|FG000|Overall Study|Patient was randomized due to mistake|1|||
156694206|NCT01583218|565625737|FG001|Overall Study|Patient was randomized due to mistake|0|||
156694207|NCT01583218|565625736|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
156694208|NCT01583218|565625737|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
156870800|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
157014374|NCT03398148|566804998|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
157014375|NCT03398148|566804999|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
157014376|NCT03398148|566805000|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
157014377|NCT03398148|566805001|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
157014378|NCT03398148|566805002|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
157014379|NCT03398148|566805003|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
157014380|NCT03398148|566805004|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
156694209|NCT01583218|565625736|FG000|Overall Study|Withdraw of consent on day of random|1|||
156694210|NCT01583218|565625737|FG001|Overall Study|Withdraw of consent on day of random|0|||
156694211|NCT00952276|565625740|FG000|Overall Study|Withdrawal by Subject|1|||
156694212|NCT00952276|565625741|FG001|Overall Study|Withdrawal by Subject|0|||
156694213|NCT00952276|565625742|FG002|Overall Study|Withdrawal by Subject|0|||
156694214|NCT00952276|565625743|FG003|Overall Study|Withdrawal by Subject|1|||
156694215|NCT00952276|565625744|FG004|Overall Study|Withdrawal by Subject|0|||
156694216|NCT00003138|565627684|FG000|Step 1|Reasons off treatment not documented|60|||
156694217|NCT00003138|565627685|FG001|Step 1|Reasons off treatment not documented|57|||
156694218|NCT00003138|565627684|FG000|Step 1|Never started treatment|1|||
157122580|NCT01328951|567200340|FG000|Overall Study|Study Closed by the Sponsor|36|||
157122581|NCT01328951|567200341|FG001|Overall Study|Study Closed by the Sponsor|31|||
156694219|NCT00003138|565627685|FG001|Step 1|Never started treatment|0|||
156694220|NCT00003138|565627684|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
156694221|NCT00003138|565627685|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
156694222|NCT00003138|565627684|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
156694223|NCT00003138|565627685|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
156694224|NCT00003138|565627684|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
156694225|NCT00003138|565627685|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
156694226|NCT00003138|565627684|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
156694227|NCT00003138|565627685|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
156694228|NCT03340064|565627686|FG000|First Period|Adverse Event, non-fatal|2|||
156694229|NCT03340064|565627687|FG001|First Period|Adverse Event, non-fatal|0|||
156694230|NCT03340064|565627686|FG000|First Period|Lack of Efficacy|3|||
156694231|NCT03340064|565627687|FG001|First Period|Lack of Efficacy|0|||
156694232|NCT03340064|565627686|FG000|Second Period|Adverse Event, non-fatal|1|||
156694233|NCT03340064|565627687|FG001|Second Period|Adverse Event, non-fatal|1|||
156694234|NCT03340064|565627686|FG000|Second Period|Lack of Efficacy|11|||
156694235|NCT03340064|565627687|FG001|Second Period|Lack of Efficacy|0|||
157122582|NCT01328951|567200340|FG000|Overall Study|Other|11|||
157122583|NCT01328951|567200341|FG001|Overall Study|Other|6|||
157122584|NCT04209855|567200345|FG000|Overall Study|Death|161|||
157122585|NCT04209855|567200346|FG001|Overall Study|Death|177|||
157122586|NCT04209855|567200345|FG000|Overall Study|PI Discretion|1|||
157122587|NCT04209855|567200346|FG001|Overall Study|PI Discretion|1|||
157122588|NCT04209855|567200345|FG000|Overall Study|Lost to Follow-up|5|||
157122589|NCT04209855|567200346|FG001|Overall Study|Lost to Follow-up|2|||
157122590|NCT04209855|567200345|FG000|Overall Study|Withdrew consent|10|||
157122591|NCT04209855|567200346|FG001|Overall Study|Withdrew consent|24|||
157122592|NCT04209855|567200345|FG000|Overall Study|Sponsor decision|44|||
157122593|NCT04209855|567200346|FG001|Overall Study|Sponsor decision|18|||
157122594|NCT04209855|567200345|FG000|Overall Study|Other than specified|6|||
157122595|NCT04209855|567200346|FG001|Overall Study|Other than specified|4|||
157122596|NCT02289950|567200347|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
156694236|NCT03340064|565627686|FG000|Second Period|Physician Decision|3|||
156694237|NCT03340064|565627687|FG001|Second Period|Physician Decision|0|||
156694238|NCT03340064|565627686|FG000|Second Period|Withdrawal by Subject|2|||
156694239|NCT03340064|565627687|FG001|Second Period|Withdrawal by Subject|1|||
156789248|NCT00394472|565981202|FG000|Overall Study|Protocol Violation|1|||
156789249|NCT00394472|565981203|FG001|Overall Study|Protocol Violation|3|||
156789250|NCT00394472|565981202|FG000|Overall Study|incorrect enrolment|4|||
156789251|NCT00394472|565981203|FG001|Overall Study|incorrect enrolment|2|||
156789252|NCT00394472|565981202|FG000|Overall Study|Adverse Event|4|||
156789253|NCT00394472|565981203|FG001|Overall Study|Adverse Event|2|||
156789254|NCT00394472|565981202|FG000|Overall Study|Withdrawal by Subject|0|||
156789255|NCT00394472|565981203|FG001|Overall Study|Withdrawal by Subject|2|||
156789256|NCT00394472|565981202|FG000|Overall Study|Physician Decision|0|||
156789257|NCT00394472|565981203|FG001|Overall Study|Physician Decision|1|||
156789258|NCT00394472|565981202|FG000|Overall Study|Lost to Follow-up|0|||
156789259|NCT00394472|565981203|FG001|Overall Study|Lost to Follow-up|1|||
156789260|NCT01654250|565981204|FG000|Overall Study|Lost to Follow-up|1|||
156789261|NCT01654250|565981205|FG001|Overall Study|Lost to Follow-up|0|||
156789262|NCT01013870|565981206|FG000|Overall Study|Lost to Follow-up|1|||
156789263|NCT01013870|565981207|FG001|Overall Study|Lost to Follow-up|3|||
156789264|NCT00862277|565981210|FG000|Overall Study|Protocol Violation|1|||
156789265|NCT00862277|565981211|FG001|Overall Study|Protocol Violation|2|||
156789266|NCT00862277|565981212|FG002|Overall Study|Protocol Violation|5|||
156789267|NCT02168439|565981213|FG000|Overall Study|Protocol Violation|0|||
156789268|NCT02168439|565981214|FG001|Overall Study|Protocol Violation|2|||
156789269|NCT02004275|565981215|FG000|Phase 1|Ineligible|0|||
156789270|NCT02004275|565981216|FG001|Phase 1|Ineligible|0|||
156789271|NCT02004275|565981217|FG002|Phase 1|Ineligible|0|||
156789272|NCT02004275|565981218|FG003|Phase 1|Ineligible|1|||
156789273|NCT02004275|565981219|FG004|Phase 1|Ineligible|1|||
156789274|NCT02004275|565981220|FG005|Phase 1|Ineligible|0|||
156789275|NCT02004275|565981215|FG000|Phase 1|Protocol Violation|0|||
156789276|NCT02004275|565981216|FG001|Phase 1|Protocol Violation|0|||
156789277|NCT02004275|565981217|FG002|Phase 1|Protocol Violation|0|||
156789278|NCT02004275|565981218|FG003|Phase 1|Protocol Violation|1|||
156694240|NCT03340064|565627686|FG000|Second Period|Approved Drug Available For Indication|1|||
156694241|NCT03340064|565627687|FG001|Second Period|Approved Drug Available For Indication|0|||
156694242|NCT03340064|565627686|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
156694243|NCT03340064|565627687|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
156694244|NCT01045421|565627688|FG000|Phase 1|Progressive Disease|0|||
156694245|NCT01045421|565627689|FG001|Phase 1|Progressive Disease|0|||
156694246|NCT01045421|565627690|FG002|Phase 1|Progressive Disease|0|||
156694247|NCT01045421|565627691|FG003|Phase 1|Progressive Disease|0|||
156694248|NCT01045421|565627692|FG004|Phase 1|Progressive Disease|1|||
156694249|NCT01045421|565627693|FG005|Phase 1|Progressive Disease|0|||
156694250|NCT01045421|565627694|FG006|Phase 1|Progressive Disease|0|||
156694251|NCT01045421|565627695|FG007|Phase 1|Progressive Disease|0|||
156694252|NCT01045421|565627696|FG008|Phase 1|Progressive Disease|0|||
156694253|NCT01045421|565627697|FG009|Phase 1|Progressive Disease|0|||
156694254|NCT01045421|565627698|FG010|Phase 1|Progressive Disease|0|||
156694255|NCT01045421|565627688|FG000|Phase 1|Withdrawal by Subject|0|||
156694256|NCT01045421|565627689|FG001|Phase 1|Withdrawal by Subject|0|||
156694257|NCT01045421|565627690|FG002|Phase 1|Withdrawal by Subject|0|||
156694258|NCT01045421|565627691|FG003|Phase 1|Withdrawal by Subject|1|||
156694259|NCT01045421|565627692|FG004|Phase 1|Withdrawal by Subject|0|||
156694260|NCT01045421|565627693|FG005|Phase 1|Withdrawal by Subject|0|||
156694261|NCT01045421|565627694|FG006|Phase 1|Withdrawal by Subject|0|||
156694262|NCT01045421|565627695|FG007|Phase 1|Withdrawal by Subject|0|||
156694263|NCT01045421|565627696|FG008|Phase 1|Withdrawal by Subject|0|||
156694264|NCT01045421|565627697|FG009|Phase 1|Withdrawal by Subject|0|||
156694265|NCT01045421|565627698|FG010|Phase 1|Withdrawal by Subject|0|||
156694266|NCT01045421|565627688|FG000|Phase 2|Progressive Disease|0|||
156694267|NCT01045421|565627689|FG001|Phase 2|Progressive Disease|0|||
156694268|NCT01045421|565627690|FG002|Phase 2|Progressive Disease|0|||
156694269|NCT01045421|565627691|FG003|Phase 2|Progressive Disease|0|||
156694270|NCT01045421|565627692|FG004|Phase 2|Progressive Disease|0|||
156694271|NCT01045421|565627693|FG005|Phase 2|Progressive Disease|0|||
156694272|NCT01045421|565627694|FG006|Phase 2|Progressive Disease|0|||
156694273|NCT01045421|565627695|FG007|Phase 2|Progressive Disease|1|||
156694274|NCT01045421|565627696|FG008|Phase 2|Progressive Disease|1|||
156694275|NCT01045421|565627697|FG009|Phase 2|Progressive Disease|1|||
156694276|NCT01045421|565627698|FG010|Phase 2|Progressive Disease|1|||
156694277|NCT01045421|565627688|FG000|Phase 2|Death|0|||
156694278|NCT01045421|565627689|FG001|Phase 2|Death|0|||
156694279|NCT01045421|565627690|FG002|Phase 2|Death|0|||
156694280|NCT01045421|565627691|FG003|Phase 2|Death|0|||
156694281|NCT01045421|565627692|FG004|Phase 2|Death|0|||
156694282|NCT01045421|565627693|FG005|Phase 2|Death|0|||
156694283|NCT01045421|565627694|FG006|Phase 2|Death|0|||
156694284|NCT01045421|565627695|FG007|Phase 2|Death|1|||
156694285|NCT01045421|565627696|FG008|Phase 2|Death|1|||
156694286|NCT01045421|565627697|FG009|Phase 2|Death|2|||
156694287|NCT01045421|565627698|FG010|Phase 2|Death|0|||
156694288|NCT01045421|565627688|FG000|Phase 2|Other|0|||
156694289|NCT01045421|565627689|FG001|Phase 2|Other|0|||
156694290|NCT01045421|565627690|FG002|Phase 2|Other|0|||
156694291|NCT01045421|565627691|FG003|Phase 2|Other|0|||
156694292|NCT01045421|565627692|FG004|Phase 2|Other|0|||
156694293|NCT01045421|565627693|FG005|Phase 2|Other|0|||
156694294|NCT01045421|565627694|FG006|Phase 2|Other|0|||
156694295|NCT01045421|565627695|FG007|Phase 2|Other|3|||
156694296|NCT01045421|565627696|FG008|Phase 2|Other|0|||
156694297|NCT01045421|565627697|FG009|Phase 2|Other|0|||
156694298|NCT01045421|565627698|FG010|Phase 2|Other|1|||
156694299|NCT02522403|565627699|FG000|Overall Study|Lost to Follow-up|2|||
156694300|NCT02522403|565627700|FG001|Overall Study|Lost to Follow-up|2|||
156789279|NCT02004275|565981219|FG004|Phase 1|Protocol Violation|0|||
156789280|NCT02004275|565981220|FG005|Phase 1|Protocol Violation|5|||
156694301|NCT02522403|565627699|FG000|Overall Study|Withdrawal by Subject|2|||
156789281|NCT02004275|565981215|FG000|Phase 2 Part 1|Ineligible|6|||
156694302|NCT02522403|565627700|FG001|Overall Study|Withdrawal by Subject|4|||
156694303|NCT05142566|565627701|FG000|Overall Study|Protocol Violation|1|||
156694304|NCT01553279|565627702|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
156694305|NCT01553279|565627703|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
156694306|NCT01553279|565627702|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
156694307|NCT01553279|565627703|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
156694308|NCT01553279|565627702|FG000|Interim Period|Withdrawal by Subject|2|||
156694309|NCT01553279|565627703|FG001|Interim Period|Withdrawal by Subject|2|||
156694310|NCT01553279|565627702|FG000|Interim Period|Lost to Follow-up|1|||
156694311|NCT01553279|565627703|FG001|Interim Period|Lost to Follow-up|0|||
156694312|NCT01553279|565627702|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
156694313|NCT01553279|565627703|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
156694314|NCT01553279|565627702|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
156694315|NCT01553279|565627703|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
156694316|NCT00605865|565627704|FG000|Overall Study|Protocol Violation|115|||
156694317|NCT01884311|565627709|FG000|Overall Study|Withdrawal by Subject|3|||
156789282|NCT02004275|565981216|FG001|Phase 2 Part 1|Ineligible|9|||
156694318|NCT01884311|565627709|FG000|Overall Study|withdrew consent due to AEs|1|||
156694319|NCT01884311|565627709|FG000|Overall Study|Precautionary measure|1|||
156694320|NCT01995266|565627710|FG000|Overall Study|Death|1|||
156694321|NCT01995266|565627710|FG000|Overall Study|Lack of Efficacy|6|||
156694322|NCT01995266|565627710|FG000|Overall Study|Adverse Event|2|||
156694323|NCT03247517|565627711|FG000|Overall Study|Adverse Event|0|||
156694324|NCT03247517|565627712|FG001|Overall Study|Adverse Event|4|||
156694325|NCT03247517|565627713|FG002|Overall Study|Adverse Event|2|||
156694326|NCT03247517|565627711|FG000|Overall Study|Lost to Follow-up|2|||
156694327|NCT03247517|565627712|FG001|Overall Study|Lost to Follow-up|6|||
156694328|NCT03247517|565627713|FG002|Overall Study|Lost to Follow-up|4|||
156694329|NCT03247517|565627711|FG000|Overall Study|Consent withdrawn by caregiver|1|||
156694330|NCT03247517|565627712|FG001|Overall Study|Consent withdrawn by caregiver|4|||
156694331|NCT03247517|565627713|FG002|Overall Study|Consent withdrawn by caregiver|7|||
156694332|NCT03247517|565627711|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
156694333|NCT03247517|565627712|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
156694334|NCT03247517|565627713|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
156694335|NCT03247517|565627711|FG000|Overall Study|Protocol Violation|0|||
156694336|NCT03247517|565627712|FG001|Overall Study|Protocol Violation|2|||
156694337|NCT03247517|565627713|FG002|Overall Study|Protocol Violation|0|||
156694338|NCT03247517|565627711|FG000|Overall Study|Multiple reasons|3|||
156694339|NCT03247517|565627712|FG001|Overall Study|Multiple reasons|1|||
156694340|NCT03247517|565627713|FG002|Overall Study|Multiple reasons|0|||
156694341|NCT03310411|565627714|FG000|Period 1|Adverse Event|0|||
156694342|NCT03310411|565627715|FG001|Period 1|Adverse Event|0|||
156694343|NCT03310411|565627716|FG002|Period 1|Adverse Event|0|||
156694344|NCT03310411|565627717|FG003|Period 1|Adverse Event|1|||
156694345|NCT02751359|565627718|FG000|Overall Study|Lost to Follow-up|1|||
156694346|NCT02400671|565627719|FG000|Overall Study|Death|5|||
156694347|NCT02400671|565627720|FG001|Overall Study|Death|3|||
156694348|NCT02400671|565627721|FG002|Overall Study|Death|4|||
156694349|NCT02400671|565627719|FG000|Overall Study|Lost to Follow-up|20|||
156694350|NCT02400671|565627720|FG001|Overall Study|Lost to Follow-up|27|||
156694351|NCT02400671|565627721|FG002|Overall Study|Lost to Follow-up|24|||
156694352|NCT02400671|565627719|FG000|Overall Study|Withdrawal by Subject|2|||
156694353|NCT02400671|565627720|FG001|Overall Study|Withdrawal by Subject|2|||
156694354|NCT02400671|565627721|FG002|Overall Study|Withdrawal by Subject|0|||
156694355|NCT02145026|565627725|FG000|Overall Study|Adverse Event|2|||
156694356|NCT02145026|565627725|FG000|Overall Study|Death|4|||
156694357|NCT02145026|565627725|FG000|Overall Study|Withdrawal by Subject|2|||
156694358|NCT02145026|565627725|FG000|Overall Study|Physician Decision|4|||
156694359|NCT00127036|565627726|FG000|Overall Study|Insufficient Data for Analysis|6|||
156694360|NCT00127036|565627727|FG001|Overall Study|Insufficient Data for Analysis|11|||
156694361|NCT00127036|565627726|FG000|Overall Study|Screen Failure|2|||
156694362|NCT00127036|565627727|FG001|Overall Study|Screen Failure|0|||
156694363|NCT01797835|565627734|FG000|Overall Study|Lost to Follow-up|31|||
156694364|NCT01797835|565627735|FG001|Overall Study|Lost to Follow-up|27|||
156694365|NCT01403064|565627736|FG000|Overall Study|Death|0|||
156694366|NCT01403064|565627737|FG001|Overall Study|Death|0|||
156694367|NCT01403064|565627738|FG002|Overall Study|Death|1|||
156694368|NCT01403064|565627739|FG003|Overall Study|Death|1|||
156694369|NCT01403064|565627736|FG000|Overall Study|Withdrawal by Subject|0|||
156694370|NCT01403064|565627737|FG001|Overall Study|Withdrawal by Subject|0|||
156694371|NCT01403064|565627738|FG002|Overall Study|Withdrawal by Subject|1|||
156694372|NCT01403064|565627739|FG003|Overall Study|Withdrawal by Subject|1|||
156694373|NCT01403064|565627736|FG000|Overall Study|Other|1|||
156694374|NCT01403064|565627737|FG001|Overall Study|Other|0|||
156694375|NCT01403064|565627738|FG002|Overall Study|Other|2|||
156694376|NCT01403064|565627739|FG003|Overall Study|Other|1|||
156694377|NCT03052322|565627740|FG000|Overall Study|Other un-specified|1|||
156694378|NCT03052322|565627741|FG001|Overall Study|Other un-specified|2|||
156694379|NCT03052322|565627740|FG000|Overall Study|Withdrawal by Subject|10|||
156694380|NCT03052322|565627741|FG001|Overall Study|Withdrawal by Subject|9|||
156694381|NCT03052322|565627740|FG000|Overall Study|Death|0|||
156694382|NCT03052322|565627741|FG001|Overall Study|Death|2|||
156694383|NCT03052322|565627740|FG000|Overall Study|Lack of Efficacy|1|||
156694384|NCT03052322|565627741|FG001|Overall Study|Lack of Efficacy|2|||
156694385|NCT03052322|565627740|FG000|Overall Study|Protocol Violation|1|||
156694386|NCT03052322|565627741|FG001|Overall Study|Protocol Violation|0|||
156694387|NCT03052322|565627740|FG000|Overall Study|Lost to Follow-up|2|||
156694388|NCT03052322|565627741|FG001|Overall Study|Lost to Follow-up|4|||
156694389|NCT03052322|565627740|FG000|Overall Study|Adverse Event|6|||
156694390|NCT03052322|565627741|FG001|Overall Study|Adverse Event|13|||
156694391|NCT00973765|565627742|FG000|Overall Study|Lost to Follow-up|8|||
156694392|NCT00973765|565627743|FG001|Overall Study|Lost to Follow-up|14|||
156694393|NCT04920916|565627744|FG000|Phase IIa 60 Day Study|Death|2|||
156694394|NCT04920916|565627745|FG001|Phase IIa 60 Day Study|Death|5|||
156694395|NCT04920916|565627744|FG000|1 Year Follow up (Phone Call)|Death|1|||
156694396|NCT04920916|565627745|FG001|1 Year Follow up (Phone Call)|Death|3|||
156694397|NCT04920916|565627744|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
156870801|NCT02558296|566284278|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
156870802|NCT02558296|566284279|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
156870803|NCT02558296|566284278|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
156870804|NCT02558296|566284279|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
156870805|NCT02558296|566284278|FG000|Completed the Study|Adverse Event|14|||
156870806|NCT02558296|566284279|FG001|Completed the Study|Adverse Event|5|||
156870807|NCT02558296|566284278|FG000|Completed the Study|Death|39|||
156870808|NCT02558296|566284279|FG001|Completed the Study|Death|25|||
157122597|NCT02289950|567200348|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
157122598|NCT02289950|567200347|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
156870809|NCT02558296|566284278|FG000|Completed the Study|Lost to Follow-up|31|||
156870810|NCT02558296|566284279|FG001|Completed the Study|Lost to Follow-up|23|||
156870811|NCT02558296|566284278|FG000|Completed the Study|Physician Decision|6|||
156870812|NCT02558296|566284279|FG001|Completed the Study|Physician Decision|0|||
156870813|NCT02558296|566284278|FG000|Completed the Study|Protocol Violation|2|||
156870814|NCT02558296|566284279|FG001|Completed the Study|Protocol Violation|1|||
156870815|NCT02558296|566284278|FG000|Completed the Study|Withdrawal by Subject|53|||
156870816|NCT02558296|566284279|FG001|Completed the Study|Withdrawal by Subject|31|||
156870817|NCT02558296|566284278|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
156870818|NCT02558296|566284279|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
156870819|NCT02754440|566284280|FG000|Overall Study|Protocol Violation|3|||
156870820|NCT02754440|566284281|FG001|Overall Study|Protocol Violation|2|||
156870821|NCT02754440|566284282|FG002|Overall Study|Protocol Violation|2|||
156870822|NCT02754440|566284283|FG003|Overall Study|Protocol Violation|6|||
156870823|NCT02754440|566284280|FG000|Overall Study|Adverse Event|3|||
157122599|NCT02289950|567200348|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
156694398|NCT04920916|565627745|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
156694399|NCT02011113|565627746|FG000|Overall Study|Adverse Event|4|||
156694400|NCT02011113|565627746|FG000|Overall Study|Disease Progression (DP)|16|||
156694401|NCT02011113|565627746|FG000|Overall Study|Death|1|||
156694402|NCT02011113|565627746|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
156694403|NCT02011113|565627746|FG000|Overall Study|Investigator's judgement- DP|3|||
156694404|NCT02011113|565627746|FG000|Overall Study|Study terminated by sponsor|11|||
156694405|NCT02669940|565627749|FG000|Overall Study|Failure to return|0|||
156694406|NCT02669940|565627750|FG001|Overall Study|Failure to return|3|||
156694407|NCT02669940|565627749|FG000|Overall Study|Insufficient follow-up data|1|||
156694408|NCT02669940|565627750|FG001|Overall Study|Insufficient follow-up data|0|||
156694409|NCT01892657|565627751|FG000|Overall Study|Withdrawal by Subject|6|||
156694410|NCT01892657|565627751|FG000|Overall Study|Protocol Violation|12|||
156694411|NCT05065983|565627760|FG000|Overall Study|Lost to Follow-up|2|||
156694412|NCT00986180|565627761|FG000|Overall Study|Adverse Event|21|||
156694413|NCT00986180|565627762|FG001|Overall Study|Adverse Event|23|||
156694414|NCT00986180|565627761|FG000|Overall Study|Lack of Efficacy|4|||
156694415|NCT00986180|565627762|FG001|Overall Study|Lack of Efficacy|3|||
157122600|NCT02289950|567200347|FG000|Overall Study|Lost to Follow-up|1|||
157122601|NCT02289950|567200348|FG001|Overall Study|Lost to Follow-up|0|||
157122602|NCT02289950|567200347|FG000|Overall Study|Physician Decision|9|||
157122603|NCT02289950|567200348|FG001|Overall Study|Physician Decision|3|||
157122604|NCT02289950|567200347|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
157122605|NCT02289950|567200348|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
156694416|NCT00986180|565627761|FG000|Overall Study|Lost to Follow-up|5|||
156694417|NCT00986180|565627762|FG001|Overall Study|Lost to Follow-up|7|||
156694418|NCT00986180|565627761|FG000|Overall Study|Physician Decision|1|||
156694419|NCT00986180|565627762|FG001|Overall Study|Physician Decision|3|||
156694420|NCT00986180|565627761|FG000|Overall Study|Protocol Violation|2|||
156694421|NCT00986180|565627762|FG001|Overall Study|Protocol Violation|0|||
156694422|NCT00986180|565627761|FG000|Overall Study|Withdrawal by Subject|1|||
156694423|NCT00986180|565627762|FG001|Overall Study|Withdrawal by Subject|9|||
156694424|NCT00986180|565627761|FG000|Overall Study|Miscellanies|10|||
156694425|NCT00986180|565627762|FG001|Overall Study|Miscellanies|11|||
156694426|NCT03251963|565627765|FG000|Overall Study|inappropriate Xa level timing|6|||
156694427|NCT03251963|565627766|FG001|Overall Study|inappropriate Xa level timing|3|||
156694428|NCT03251963|565627765|FG000|Overall Study|no peak Xa level drawn|2|||
156694429|NCT03251963|565627766|FG001|Overall Study|no peak Xa level drawn|0|||
156694430|NCT03251963|565627765|FG000|Overall Study|bled prior to Xa level|1|||
156694431|NCT03251963|565627766|FG001|Overall Study|bled prior to Xa level|2|||
156694432|NCT00003875|565627767|FG000|Overall Study|Screen Failed|1|||
156694433|NCT03127644|565627768|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156694434|NCT03127644|565627769|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156694435|NCT03127644|565627770|FG002|Overall Study|Study-specific withdrawal criteria|2|||
156694436|NCT05070546|565627771|FG000|Overall Study|Death|0|||
156694437|NCT05070546|565627772|FG001|Overall Study|Death|0|||
156694438|NCT05070546|565627773|FG002|Overall Study|Death|0|||
156694439|NCT05070546|565627774|FG003|Overall Study|Death|0|||
156694440|NCT05070546|565627775|FG004|Overall Study|Death|0|||
156694441|NCT05070546|565627776|FG005|Overall Study|Death|1|||
156694442|NCT05070546|565627771|FG000|Overall Study|Lost to Follow-up|8|||
156694443|NCT05070546|565627772|FG001|Overall Study|Lost to Follow-up|2|||
156694444|NCT05070546|565627773|FG002|Overall Study|Lost to Follow-up|7|||
156694445|NCT05070546|565627774|FG003|Overall Study|Lost to Follow-up|1|||
156694446|NCT05070546|565627775|FG004|Overall Study|Lost to Follow-up|2|||
156694447|NCT05070546|565627776|FG005|Overall Study|Lost to Follow-up|0|||
156694448|NCT05070546|565627771|FG000|Overall Study|Withdrawal by Subject|1|||
156694449|NCT05070546|565627772|FG001|Overall Study|Withdrawal by Subject|1|||
156694450|NCT05070546|565627773|FG002|Overall Study|Withdrawal by Subject|3|||
156694451|NCT05070546|565627774|FG003|Overall Study|Withdrawal by Subject|0|||
156694452|NCT05070546|565627775|FG004|Overall Study|Withdrawal by Subject|0|||
156694453|NCT05070546|565627776|FG005|Overall Study|Withdrawal by Subject|0|||
156694454|NCT05070546|565627771|FG000|Overall Study|Other|0|||
156694455|NCT05070546|565627772|FG001|Overall Study|Other|0|||
156694456|NCT05070546|565627773|FG002|Overall Study|Other|0|||
156694457|NCT05070546|565627774|FG003|Overall Study|Other|0|||
156694458|NCT05070546|565627775|FG004|Overall Study|Other|3|||
156694459|NCT05070546|565627776|FG005|Overall Study|Other|0|||
156694460|NCT05070546|565627771|FG000|Overall Study|Randomized but not vaccinated|1|||
156694461|NCT05070546|565627772|FG001|Overall Study|Randomized but not vaccinated|0|||
156694462|NCT05070546|565627773|FG002|Overall Study|Randomized but not vaccinated|1|||
156694463|NCT05070546|565627774|FG003|Overall Study|Randomized but not vaccinated|1|||
156694464|NCT05070546|565627775|FG004|Overall Study|Randomized but not vaccinated|3|||
156694465|NCT05070546|565627776|FG005|Overall Study|Randomized but not vaccinated|0|||
156694466|NCT01370213|565627779|FG000|Overall Study|Early Death|1|||
156694467|NCT01370213|565627780|FG001|Overall Study|Early Death|0|||
156694468|NCT01370213|565627781|FG002|Overall Study|Early Death|0|||
156694469|NCT01370213|565627779|FG000|Overall Study|Not evaluable|0|||
156694470|NCT01370213|565627780|FG001|Overall Study|Not evaluable|2|||
156694471|NCT01370213|565627781|FG002|Overall Study|Not evaluable|0|||
156694472|NCT01550744|565627787|FG000|Open-Label|Lost to Follow-up|7|||
156694473|NCT01550744|565627788|FG001|Open-Label|Lost to Follow-up|0|||
156694474|NCT01550744|565627789|FG002|Open-Label|Lost to Follow-up|0|||
156694475|NCT01550744|565627787|FG000|Open-Label|Withdrawal by Subject|13|||
156694476|NCT01550744|565627788|FG001|Open-Label|Withdrawal by Subject|0|||
156694477|NCT01550744|565627789|FG002|Open-Label|Withdrawal by Subject|0|||
156694478|NCT01550744|565627787|FG000|Open-Label|Adverse Event|11|||
156694479|NCT01550744|565627788|FG001|Open-Label|Adverse Event|0|||
156694480|NCT01550744|565627789|FG002|Open-Label|Adverse Event|0|||
156694481|NCT01550744|565627787|FG000|Open-Label|Lack of Efficacy|4|||
156694482|NCT01550744|565627788|FG001|Open-Label|Lack of Efficacy|0|||
156694483|NCT01550744|565627789|FG002|Open-Label|Lack of Efficacy|0|||
156694484|NCT01550744|565627787|FG000|Open-Label|Protocol Violation|4|||
156694485|NCT01550744|565627788|FG001|Open-Label|Protocol Violation|0|||
156694486|NCT01550744|565627789|FG002|Open-Label|Protocol Violation|0|||
156694487|NCT01550744|565627787|FG000|Open-Label|Not all 3 study drug injections received|2|||
156694488|NCT01550744|565627788|FG001|Open-Label|Not all 3 study drug injections received|0|||
156694489|NCT01550744|565627789|FG002|Open-Label|Not all 3 study drug injections received|0|||
156694490|NCT01550744|565627787|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
156694491|NCT01550744|565627788|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
156694492|NCT01550744|565627789|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
156694493|NCT01550744|565627787|FG000|Open-Label|Other|1|||
156694494|NCT01550744|565627788|FG001|Open-Label|Other|0|||
156694495|NCT01550744|565627789|FG002|Open-Label|Other|0|||
156694496|NCT01550744|565627787|FG000|Double-Blind|Lost to Follow-up|0|||
156694497|NCT01550744|565627788|FG001|Double-Blind|Lost to Follow-up|6|||
156694498|NCT01550744|565627789|FG002|Double-Blind|Lost to Follow-up|12|||
156694499|NCT01550744|565627787|FG000|Double-Blind|Withdrawal by Subject|0|||
156694500|NCT01550744|565627788|FG001|Double-Blind|Withdrawal by Subject|2|||
156694501|NCT01550744|565627789|FG002|Double-Blind|Withdrawal by Subject|15|||
156694502|NCT01550744|565627787|FG000|Double-Blind|Adverse Event|0|||
156694503|NCT01550744|565627788|FG001|Double-Blind|Adverse Event|4|||
156694504|NCT01550744|565627789|FG002|Double-Blind|Adverse Event|15|||
156694505|NCT01550744|565627787|FG000|Double-Blind|Death|0|||
156694506|NCT01550744|565627788|FG001|Double-Blind|Death|1|||
156694507|NCT01550744|565627789|FG002|Double-Blind|Death|0|||
156694508|NCT01550744|565627787|FG000|Double-Blind|Lack of Efficacy|0|||
156694509|NCT01550744|565627788|FG001|Double-Blind|Lack of Efficacy|2|||
156694510|NCT01550744|565627789|FG002|Double-Blind|Lack of Efficacy|8|||
156694511|NCT01550744|565627787|FG000|Double-Blind|Protocol Violation|0|||
156694512|NCT01550744|565627788|FG001|Double-Blind|Protocol Violation|0|||
156694513|NCT01550744|565627789|FG002|Double-Blind|Protocol Violation|4|||
156694514|NCT01550744|565627787|FG000|Double-Blind|Pregnancy|0|||
156694515|NCT01550744|565627788|FG001|Double-Blind|Pregnancy|0|||
156694516|NCT01550744|565627789|FG002|Double-Blind|Pregnancy|3|||
156694517|NCT01550744|565627787|FG000|Double-Blind|Other|0|||
156694518|NCT01550744|565627788|FG001|Double-Blind|Other|2|||
156694519|NCT01550744|565627789|FG002|Double-Blind|Other|10|||
156694520|NCT00038649|565627791|FG000|Overall Study|Adverse Event|9|||
156694521|NCT03096847|565627792|FG000|Overall Study|Other|2|||
156694522|NCT03096847|565627793|FG001|Overall Study|Other|1|||
156694523|NCT03096847|565627794|FG002|Overall Study|Other|2|||
156694524|NCT03096847|565627792|FG000|Overall Study|Lost to Follow-up|1|||
156694525|NCT03096847|565627793|FG001|Overall Study|Lost to Follow-up|0|||
156694526|NCT03096847|565627794|FG002|Overall Study|Lost to Follow-up|1|||
156694527|NCT03096847|565627792|FG000|Overall Study|Death|6|||
156694528|NCT03096847|565627793|FG001|Overall Study|Death|0|||
156694529|NCT03096847|565627794|FG002|Overall Study|Death|2|||
156694530|NCT03096847|565627792|FG000|Overall Study|Protocol Violation|3|||
156694531|NCT03096847|565627793|FG001|Overall Study|Protocol Violation|0|||
156694532|NCT03096847|565627794|FG002|Overall Study|Protocol Violation|6|||
156694533|NCT03096847|565627792|FG000|Overall Study|Physician Decision|12|||
156694534|NCT03096847|565627793|FG001|Overall Study|Physician Decision|2|||
156694535|NCT03096847|565627794|FG002|Overall Study|Physician Decision|8|||
156694536|NCT03096847|565627792|FG000|Overall Study|Withdrawal by Subject|24|||
156694537|NCT03096847|565627793|FG001|Overall Study|Withdrawal by Subject|1|||
156694538|NCT03096847|565627794|FG002|Overall Study|Withdrawal by Subject|12|||
156694539|NCT03096847|565627792|FG000|Overall Study|Adverse Event|72|||
156694540|NCT03096847|565627793|FG001|Overall Study|Adverse Event|6|||
156694541|NCT03096847|565627794|FG002|Overall Study|Adverse Event|28|||
156694542|NCT03096847|565627792|FG000|Overall Study|Progressive disease|97|||
156694543|NCT03096847|565627793|FG001|Overall Study|Progressive disease|10|||
156694544|NCT03096847|565627794|FG002|Overall Study|Progressive disease|78|||
156694545|NCT03096847|565627792|FG000|Overall Study|Non-compliance with study medication|1|||
156694546|NCT03096847|565627793|FG001|Overall Study|Non-compliance with study medication|0|||
156694547|NCT03096847|565627794|FG002|Overall Study|Non-compliance with study medication|0|||
156694548|NCT03096847|565627792|FG000|Overall Study|New therapy for study indication|1|||
156694549|NCT03096847|565627793|FG001|Overall Study|New therapy for study indication|0|||
156694550|NCT03096847|565627794|FG002|Overall Study|New therapy for study indication|1|||
156694551|NCT00359632|565627795|FG000|Overall Study|Death|2|||
156694552|NCT00359632|565627796|FG001|Overall Study|Death|0|||
156694553|NCT00359632|565627795|FG000|Overall Study|Adverse Event|1|||
156694554|NCT00359632|565627796|FG001|Overall Study|Adverse Event|0|||
156694555|NCT00359632|565627795|FG000|Overall Study|Non-compliance with visit schedule|1|||
156694556|NCT00359632|565627796|FG001|Overall Study|Non-compliance with visit schedule|0|||
156694557|NCT03978091|565627797|FG000|Overall Study|Lost to Follow-up|0|||
156694558|NCT03978091|565627798|FG001|Overall Study|Lost to Follow-up|0|||
156694559|NCT03978091|565627799|FG002|Overall Study|Lost to Follow-up|1|||
156694560|NCT03978091|565627800|FG003|Overall Study|Lost to Follow-up|0|||
156694561|NCT03978091|565627801|FG004|Overall Study|Lost to Follow-up|0|||
156694562|NCT03978091|565627802|FG005|Overall Study|Lost to Follow-up|0|||
156694563|NCT03978091|565627797|FG000|Overall Study|Withdrawal by Subject|0|||
156694564|NCT03978091|565627798|FG001|Overall Study|Withdrawal by Subject|0|||
156694565|NCT03978091|565627799|FG002|Overall Study|Withdrawal by Subject|0|||
156694566|NCT03978091|565627800|FG003|Overall Study|Withdrawal by Subject|1|||
156694567|NCT03978091|565627801|FG004|Overall Study|Withdrawal by Subject|1|||
156694568|NCT03978091|565627802|FG005|Overall Study|Withdrawal by Subject|0|||
156694569|NCT01491035|565627820|FG000|Overall Study|Lost to Follow-up|0|||
156694570|NCT01491035|565627821|FG001|Overall Study|Lost to Follow-up|0|||
156694571|NCT01491035|565627822|FG002|Overall Study|Lost to Follow-up|0|||
156694572|NCT01491035|565627823|FG003|Overall Study|Lost to Follow-up|0|||
156694573|NCT01491035|565627824|FG004|Overall Study|Lost to Follow-up|1|||
156694574|NCT01491035|565627825|FG005|Overall Study|Lost to Follow-up|0|||
156694575|NCT01491035|565627826|FG006|Overall Study|Lost to Follow-up|0|||
156694576|NCT01491035|565627827|FG007|Overall Study|Lost to Follow-up|0|||
156694577|NCT02999477|565627828|FG000|Overall Study|found ineligible after first dose|0|||
156694578|NCT02999477|565627829|FG001|Overall Study|found ineligible after first dose|1|||
156694579|NCT02999477|565627828|FG000|Overall Study|Withdrawal by Subject|1|||
156694580|NCT02999477|565627829|FG001|Overall Study|Withdrawal by Subject|1|||
156694581|NCT01846273|565627830|FG000|Overall Study|Adverse Event|9|||
156694582|NCT01846273|565627831|FG001|Overall Study|Adverse Event|7|||
156694583|NCT01846273|565627832|FG002|Overall Study|Adverse Event|0|||
156694584|NCT01846273|565627830|FG000|Overall Study|Subject withdrew consent|5|||
156694585|NCT01846273|565627831|FG001|Overall Study|Subject withdrew consent|8|||
156694586|NCT01846273|565627832|FG002|Overall Study|Subject withdrew consent|0|||
156694587|NCT01846273|565627830|FG000|Overall Study|Lost to Follow-up|2|||
156694588|NCT01846273|565627831|FG001|Overall Study|Lost to Follow-up|1|||
156694589|NCT01846273|565627832|FG002|Overall Study|Lost to Follow-up|0|||
156694590|NCT01846273|565627830|FG000|Overall Study|Administrative problems|1|||
156694591|NCT01846273|565627831|FG001|Overall Study|Administrative problems|0|||
156694592|NCT01846273|565627832|FG002|Overall Study|Administrative problems|0|||
156694593|NCT01846273|565627830|FG000|Overall Study|Death|2|||
156694594|NCT01846273|565627831|FG001|Overall Study|Death|1|||
156694595|NCT01846273|565627832|FG002|Overall Study|Death|0|||
156694596|NCT01846273|565627830|FG000|Overall Study|Disease Progression|0|||
156694597|NCT01846273|565627831|FG001|Overall Study|Disease Progression|4|||
156694598|NCT01846273|565627832|FG002|Overall Study|Disease Progression|0|||
156694599|NCT01846273|565627830|FG000|Overall Study|Protocol Deviation|2|||
156694600|NCT01846273|565627831|FG001|Overall Study|Protocol Deviation|3|||
156694601|NCT01846273|565627832|FG002|Overall Study|Protocol Deviation|0|||
156694602|NCT01846273|565627830|FG000|Overall Study|Physician Decision|1|||
156694603|NCT01846273|565627831|FG001|Overall Study|Physician Decision|2|||
156694604|NCT01846273|565627832|FG002|Overall Study|Physician Decision|0|||
156694605|NCT00891839|565627833|FG000|Overall Study|Adverse Event|2|||
156694606|NCT00891839|565627833|FG000|Overall Study|Withdrawal by Subject|2|||
156694607|NCT00891839|565627833|FG000|Overall Study|Disease progression|3|||
156694608|NCT01641133|565627834|FG000|Overall Study|Protocol Violation|0|||
156694609|NCT01641133|565627835|FG001|Overall Study|Protocol Violation|1|||
156694610|NCT01641133|565627836|FG002|Overall Study|Protocol Violation|1|||
156694611|NCT01641133|565627834|FG000|Overall Study|Migrated/moved from study area|5|||
156694612|NCT01641133|565627835|FG001|Overall Study|Migrated/moved from study area|3|||
156789283|NCT02004275|565981217|FG002|Phase 2 Part 1|Ineligible|0|||
156789284|NCT02004275|565981218|FG003|Phase 2 Part 1|Ineligible|0|||
156789285|NCT02004275|565981219|FG004|Phase 2 Part 1|Ineligible|0|||
156789286|NCT02004275|565981220|FG005|Phase 2 Part 1|Ineligible|0|||
156789287|NCT02004275|565981215|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
156789288|NCT02004275|565981216|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
156789289|NCT02004275|565981217|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
156789290|NCT02004275|565981218|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
156789291|NCT02004275|565981219|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
156789292|NCT02004275|565981220|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
156789293|NCT04432298|565981221|FG000|Overall Study|Other than specified|1|||
156789294|NCT04432298|565981222|FG001|Overall Study|Other than specified|0|||
156789295|NCT04432298|565981221|FG000|Overall Study|Lost to Follow-up|0|||
156789296|NCT04432298|565981222|FG001|Overall Study|Lost to Follow-up|1|||
156789297|NCT04432298|565981221|FG000|Overall Study|Death|3|||
156789298|NCT04432298|565981222|FG001|Overall Study|Death|2|||
156789299|NCT04432298|565981221|FG000|Overall Study|Withdrawal by Subject|2|||
156789300|NCT04432298|565981222|FG001|Overall Study|Withdrawal by Subject|0|||
156789301|NCT00348374|565981223|FG000|Overall Study|Adverse Event|1|||
156789302|NCT00348374|565981224|FG001|Overall Study|Adverse Event|4|||
156789303|NCT00348374|565981223|FG000|Overall Study|Lost to Follow-up|1|||
156789304|NCT00348374|565981224|FG001|Overall Study|Lost to Follow-up|3|||
156789305|NCT00348374|565981223|FG000|Overall Study|Withdrawal by Subject|5|||
156789306|NCT00348374|565981224|FG001|Overall Study|Withdrawal by Subject|5|||
156789307|NCT00348374|565981223|FG000|Overall Study|Other|11|||
156789308|NCT00348374|565981224|FG001|Overall Study|Other|12|||
156789309|NCT00348374|565981223|FG000|Overall Study|ongoing at date of cutoff|1|||
156789310|NCT00348374|565981224|FG001|Overall Study|ongoing at date of cutoff|1|||
156789311|NCT00348374|565981223|FG000|Overall Study|randomized but did not receive treatment|0|||
156789312|NCT00348374|565981224|FG001|Overall Study|randomized but did not receive treatment|7|||
156789313|NCT00458705|565981228|FG000|Overall Study|Adverse Event|4|||
156789314|NCT00458705|565981228|FG000|Overall Study|Not Treated|1|||
156789315|NCT02180672|565981229|FG000|Overall Study|Lost to Follow-up|5|||
156789316|NCT02180672|565981230|FG001|Overall Study|Lost to Follow-up|7|||
156789317|NCT00378560|565981234|FG000|Overall Study|Adverse Event|1|||
156789318|NCT00378560|565981235|FG001|Overall Study|Adverse Event|0|||
156789319|NCT00378560|565981234|FG000|Overall Study|Lost to Follow-up|24|||
156789320|NCT00378560|565981235|FG001|Overall Study|Lost to Follow-up|29|||
156789321|NCT00378560|565981234|FG000|Overall Study|Protocol Violation|2|||
156789322|NCT00378560|565981235|FG001|Overall Study|Protocol Violation|0|||
156789323|NCT00378560|565981234|FG000|Overall Study|Withdrawal by Subject|17|||
156789324|NCT00378560|565981235|FG001|Overall Study|Withdrawal by Subject|21|||
156789325|NCT00378560|565981234|FG000|Overall Study|Moved|4|||
156789326|NCT00378560|565981235|FG001|Overall Study|Moved|3|||
156789327|NCT00378560|565981234|FG000|Overall Study|Pregnancy|7|||
156789328|NCT00378560|565981235|FG001|Overall Study|Pregnancy|5|||
156789329|NCT00378560|565981234|FG000|Overall Study|Laboratory test values abnormal|1|||
156789330|NCT00378560|565981235|FG001|Overall Study|Laboratory test values abnormal|0|||
156789331|NCT02070380|565981236|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
156789332|NCT02070380|565981237|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
156694613|NCT01641133|565627836|FG002|Overall Study|Migrated/moved from study area|1|||
156789333|NCT02070380|565981238|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
156789334|NCT02070380|565981239|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
156789335|NCT02070380|565981236|FG000|Second Injection|Image sets missing or technically inadeq|0|||
156789336|NCT02070380|565981237|FG001|Second Injection|Image sets missing or technically inadeq|1|||
156789337|NCT02070380|565981238|FG002|Second Injection|Image sets missing or technically inadeq|0|||
156789338|NCT02070380|565981239|FG003|Second Injection|Image sets missing or technically inadeq|0|||
156789339|NCT02070380|565981236|FG000|Second Injection|Protocol Violation|0|||
156694614|NCT01641133|565627834|FG000|Overall Study|Adverse Event|0|||
156694615|NCT01641133|565627835|FG001|Overall Study|Adverse Event|0|||
156789340|NCT02070380|565981237|FG001|Second Injection|Protocol Violation|1|||
156789341|NCT02070380|565981238|FG002|Second Injection|Protocol Violation|1|||
156789342|NCT02070380|565981239|FG003|Second Injection|Protocol Violation|5|||
156789343|NCT01682603|565981250|FG000|Overall Study|Lost to Follow-up|3|||
156789344|NCT01791205|565981251|FG000|Phase II|Lack of Efficacy|6|||
156789345|NCT01791205|565981252|FG001|Phase II|Lack of Efficacy|0|||
156789346|NCT01791205|565981251|FG000|Phase II|Adverse Event|2|||
156789347|NCT01791205|565981252|FG001|Phase II|Adverse Event|0|||
156789348|NCT01791205|565981251|FG000|Phase II|Safety|1|||
156789349|NCT01791205|565981252|FG001|Phase II|Safety|0|||
156789350|NCT01791205|565981251|FG000|Phase II|Lost to Follow-up|1|||
156789351|NCT01791205|565981252|FG001|Phase II|Lost to Follow-up|0|||
156789352|NCT01791205|565981251|FG000|Phase II|Remission of disease|1|||
156789353|NCT01791205|565981252|FG001|Phase II|Remission of disease|0|||
156789354|NCT01791205|565981251|FG000|Phase II|Physician's decision|1|||
156789355|NCT01791205|565981252|FG001|Phase II|Physician's decision|0|||
156789356|NCT01697501|565981254|FG000|Overall Study|Protocol Violation|2|||
156789357|NCT02242903|565981255|FG000|Overall Study|Withdrawal by Subject|1|||
156789358|NCT02242903|565981256|FG001|Overall Study|Withdrawal by Subject|0|||
156789359|NCT02242903|565981257|FG002|Overall Study|Withdrawal by Subject|0|||
156789360|NCT02242903|565981258|FG003|Overall Study|Withdrawal by Subject|0|||
156789361|NCT02242903|565981259|FG004|Overall Study|Withdrawal by Subject|0|||
156789362|NCT02242903|565981260|FG005|Overall Study|Withdrawal by Subject|0|||
156789363|NCT02242903|565981261|FG006|Overall Study|Withdrawal by Subject|0|||
156789364|NCT00779909|565981270|FG000|Overall Study|Lost to Follow-up|1|||
156789365|NCT00779909|565981271|FG001|Overall Study|Lost to Follow-up|0|||
156789366|NCT00779909|565981272|FG002|Overall Study|Lost to Follow-up|0|||
156789367|NCT00779909|565981273|FG003|Overall Study|Lost to Follow-up|1|||
156789368|NCT00779909|565981270|FG000|Overall Study|Withdrawal by Subject|0|||
156789369|NCT00779909|565981271|FG001|Overall Study|Withdrawal by Subject|1|||
156789370|NCT00779909|565981272|FG002|Overall Study|Withdrawal by Subject|0|||
156789371|NCT00779909|565981273|FG003|Overall Study|Withdrawal by Subject|0|||
156789372|NCT00337194|565981274|FG000|Overall Study|Adverse Event|5|||
156789373|NCT00337194|565981275|FG001|Overall Study|Adverse Event|1|||
156789374|NCT00337194|565981274|FG000|Overall Study|Death|2|||
156789375|NCT00337194|565981275|FG001|Overall Study|Death|0|||
156789376|NCT00337194|565981274|FG000|Overall Study|Withdrawal by Subject|1|||
156789377|NCT00337194|565981275|FG001|Overall Study|Withdrawal by Subject|0|||
156789378|NCT00337194|565981274|FG000|Overall Study|Disease progression|1|||
156789379|NCT00337194|565981275|FG001|Overall Study|Disease progression|2|||
156789380|NCT00337194|565981274|FG000|Overall Study|Subsequent non-protocol therapy|3|||
156789381|NCT00337194|565981275|FG001|Overall Study|Subsequent non-protocol therapy|1|||
156789382|NCT01896986|565981284|FG000|Overall Study|samples lost|14|||
156789383|NCT01896986|565981285|FG001|Overall Study|samples lost|23|||
156789384|NCT03757715|565981288|FG000|Overall Study|Lost to Follow-up|4|||
156789385|NCT03757715|565981289|FG001|Overall Study|Lost to Follow-up|9|||
156789386|NCT03757715|565981288|FG000|Overall Study|Withdrawal by Subject|1|||
156789387|NCT03757715|565981289|FG001|Overall Study|Withdrawal by Subject|1|||
156789388|NCT00281580|565981290|FG000|Overall Study|Adverse Event|2|||
156789389|NCT00281580|565981291|FG001|Overall Study|Adverse Event|0|||
156789390|NCT00281580|565981292|FG002|Overall Study|Adverse Event|2|||
156789391|NCT00281580|565981293|FG003|Overall Study|Adverse Event|4|||
156789392|NCT00281580|565981294|FG004|Overall Study|Adverse Event|1|||
156789393|NCT00281580|565981295|FG005|Overall Study|Adverse Event|0|||
156789394|NCT00281580|565981296|FG006|Overall Study|Adverse Event|1|||
156789395|NCT00281580|565981297|FG007|Overall Study|Adverse Event|0|||
156789396|NCT00281580|565981298|FG008|Overall Study|Adverse Event|1|||
156789397|NCT00281580|565981299|FG009|Overall Study|Adverse Event|6|||
156789398|NCT00281580|565981300|FG010|Overall Study|Adverse Event|0|||
156789399|NCT00281580|565981301|FG011|Overall Study|Adverse Event|5|||
156789400|NCT00281580|565981302|FG012|Overall Study|Adverse Event|8|||
156789401|NCT00281580|565981303|FG013|Overall Study|Adverse Event|2|||
156789402|NCT00281580|565981304|FG014|Overall Study|Adverse Event|3|||
156789403|NCT00281580|565981305|FG015|Overall Study|Adverse Event|3|||
157014381|NCT03398148|566805005|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
156789404|NCT00281580|565981290|FG000|Overall Study|Protocol Violation|0|||
156789405|NCT00281580|565981291|FG001|Overall Study|Protocol Violation|0|||
156789406|NCT00281580|565981292|FG002|Overall Study|Protocol Violation|1|||
156870824|NCT02754440|566284281|FG001|Overall Study|Adverse Event|1|||
157014382|NCT03398148|566805006|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
157014383|NCT03398148|566805007|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
157014384|NCT03398148|566805008|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
156789407|NCT00281580|565981293|FG003|Overall Study|Protocol Violation|1|||
156789408|NCT00281580|565981294|FG004|Overall Study|Protocol Violation|0|||
156789409|NCT00281580|565981295|FG005|Overall Study|Protocol Violation|0|||
156789410|NCT00281580|565981296|FG006|Overall Study|Protocol Violation|1|||
156789411|NCT00281580|565981297|FG007|Overall Study|Protocol Violation|0|||
156789412|NCT00281580|565981298|FG008|Overall Study|Protocol Violation|2|||
156789413|NCT00281580|565981299|FG009|Overall Study|Protocol Violation|0|||
156789414|NCT00281580|565981300|FG010|Overall Study|Protocol Violation|1|||
156789415|NCT00281580|565981301|FG011|Overall Study|Protocol Violation|2|||
156789416|NCT00281580|565981302|FG012|Overall Study|Protocol Violation|0|||
156789417|NCT00281580|565981303|FG013|Overall Study|Protocol Violation|1|||
156870825|NCT02754440|566284282|FG002|Overall Study|Adverse Event|0|||
156870826|NCT02754440|566284283|FG003|Overall Study|Adverse Event|9|||
156870827|NCT02754440|566284280|FG000|Overall Study|Withdrawal by Subject|0|||
156870828|NCT02754440|566284281|FG001|Overall Study|Withdrawal by Subject|0|||
156870829|NCT02754440|566284282|FG002|Overall Study|Withdrawal by Subject|0|||
156870830|NCT02754440|566284283|FG003|Overall Study|Withdrawal by Subject|1|||
156870831|NCT02754440|566284280|FG000|Overall Study|Equipment failure|0|||
156870832|NCT02754440|566284281|FG001|Overall Study|Equipment failure|5|||
156870833|NCT02754440|566284282|FG002|Overall Study|Equipment failure|5|||
156870834|NCT02754440|566284283|FG003|Overall Study|Equipment failure|7|||
156870835|NCT02754440|566284280|FG000|Overall Study|Subject issues not resulting in AE|0|||
156870836|NCT02754440|566284281|FG001|Overall Study|Subject issues not resulting in AE|0|||
156870837|NCT02754440|566284282|FG002|Overall Study|Subject issues not resulting in AE|0|||
156870838|NCT02754440|566284283|FG003|Overall Study|Subject issues not resulting in AE|12|||
156870839|NCT02919995|566284286|FG000|Overall Study|Adverse Event|0|||
156870840|NCT02919995|566284287|FG001|Overall Study|Adverse Event|0|||
156870841|NCT02919995|566284288|FG002|Overall Study|Adverse Event|0|||
156870842|NCT02919995|566284289|FG003|Overall Study|Adverse Event|0|||
156870843|NCT02919995|566284290|FG004|Overall Study|Adverse Event|0|||
156870844|NCT02919995|566284291|FG005|Overall Study|Adverse Event|1|||
156870845|NCT00275509|566284292|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
156870846|NCT00275509|566284293|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
156870847|NCT03388164|566284298|FG000|Overall Study|Withdrawal by Subject|3|||
156870848|NCT03388164|566284299|FG001|Overall Study|Withdrawal by Subject|1|||
156870849|NCT00345358|566284300|FG000|Primary Vaccination Phase|Other|0|||
156870850|NCT00345358|566284301|FG001|Primary Vaccination Phase|Other|1|||
156870851|NCT00345358|566284302|FG002|Primary Vaccination Phase|Other|1|||
156870852|NCT00345358|566284303|FG003|Primary Vaccination Phase|Other|0|||
156870853|NCT00345358|566284300|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
156870854|NCT00345358|566284301|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
156870855|NCT00345358|566284302|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
156870856|NCT00345358|566284303|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
156870857|NCT00345358|566284300|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
156870858|NCT00345358|566284301|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
156870859|NCT00345358|566284302|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
156870860|NCT00345358|566284303|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
156870861|NCT00345358|566284300|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
156870862|NCT00345358|566284301|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
156870863|NCT00345358|566284302|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
156870864|NCT00345358|566284303|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
156870865|NCT00345358|566284300|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
156870866|NCT00345358|566284301|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870867|NCT00345358|566284302|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870868|NCT00345358|566284303|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
156870869|NCT00345358|566284300|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
156870870|NCT00345358|566284301|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
156870871|NCT00345358|566284302|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
156870872|NCT00345358|566284303|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
156870873|NCT00346697|566284305|FG000|Overall Study|Lost to Follow-up|0|||
156870874|NCT00346697|566284306|FG001|Overall Study|Lost to Follow-up|1|||
156870875|NCT00499083|566284307|FG000|Overall Study|Not evaluable|3|||
156870876|NCT00686686|566284308|FG000|Overall Study|Non-compliance|1|||
156870877|NCT00686686|566284308|FG000|Overall Study|Adverse Event|2|||
156870878|NCT00686686|566284308|FG000|Overall Study|Lost to Follow-up|3|||
156870879|NCT01012440|566284309|FG000|Overall Study|Withdrawal by Subject|2|||
156870880|NCT00477386|566284310|FG000|Overall Study|Adverse Event|4|||
156870881|NCT00477386|566284311|FG001|Overall Study|Adverse Event|8|||
156870882|NCT00477386|566284310|FG000|Overall Study|Disease progression, relapse|3|||
156870883|NCT00477386|566284311|FG001|Overall Study|Disease progression, relapse|4|||
156870884|NCT00477386|566284310|FG000|Overall Study|Disease progression, refractory|1|||
156870885|NCT00477386|566284311|FG001|Overall Study|Disease progression, refractory|3|||
156870886|NCT00477386|566284310|FG000|Overall Study|Other|1|||
156870887|NCT00477386|566284311|FG001|Overall Study|Other|2|||
156870888|NCT00477386|566284310|FG000|Overall Study|Physician Decision|1|||
156870889|NCT00477386|566284311|FG001|Overall Study|Physician Decision|0|||
156870890|NCT00477386|566284310|FG000|Overall Study|Withdrawal by Subject|1|||
156870891|NCT00477386|566284311|FG001|Overall Study|Withdrawal by Subject|0|||
156870892|NCT01254422|566284312|FG000|Overall Study|Protocol Violation|1|||
156870893|NCT01254422|566284313|FG001|Overall Study|Protocol Violation|0|||
156870894|NCT01254422|566284312|FG000|Overall Study|Adverse Event|1|||
156870895|NCT01254422|566284313|FG001|Overall Study|Adverse Event|0|||
156870896|NCT01254422|566284312|FG000|Overall Study|Serious adverse event|0|||
156870897|NCT01254422|566284313|FG001|Overall Study|Serious adverse event|1|||
156870898|NCT01254422|566284312|FG000|Overall Study|Lost to Follow-up|1|||
157014385|NCT03398148|566805009|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
156789418|NCT00281580|565981304|FG014|Overall Study|Protocol Violation|1|||
156789419|NCT00281580|565981305|FG015|Overall Study|Protocol Violation|3|||
156789420|NCT00281580|565981290|FG000|Overall Study|Withdrawal by Subject|3|||
156789421|NCT00281580|565981291|FG001|Overall Study|Withdrawal by Subject|0|||
156789422|NCT00281580|565981292|FG002|Overall Study|Withdrawal by Subject|1|||
156789423|NCT00281580|565981293|FG003|Overall Study|Withdrawal by Subject|1|||
156789424|NCT00281580|565981294|FG004|Overall Study|Withdrawal by Subject|1|||
156789425|NCT00281580|565981295|FG005|Overall Study|Withdrawal by Subject|2|||
156789426|NCT00281580|565981296|FG006|Overall Study|Withdrawal by Subject|2|||
156789427|NCT00281580|565981297|FG007|Overall Study|Withdrawal by Subject|0|||
156789428|NCT00281580|565981298|FG008|Overall Study|Withdrawal by Subject|1|||
156789429|NCT00281580|565981299|FG009|Overall Study|Withdrawal by Subject|4|||
156789430|NCT00281580|565981300|FG010|Overall Study|Withdrawal by Subject|1|||
156789431|NCT00281580|565981301|FG011|Overall Study|Withdrawal by Subject|1|||
156789432|NCT00281580|565981302|FG012|Overall Study|Withdrawal by Subject|2|||
156789433|NCT00281580|565981303|FG013|Overall Study|Withdrawal by Subject|2|||
156789434|NCT00281580|565981304|FG014|Overall Study|Withdrawal by Subject|1|||
156789435|NCT00281580|565981305|FG015|Overall Study|Withdrawal by Subject|5|||
156789436|NCT00281580|565981290|FG000|Overall Study|Lack of Efficacy|2|||
156789437|NCT00281580|565981291|FG001|Overall Study|Lack of Efficacy|1|||
156789438|NCT00281580|565981292|FG002|Overall Study|Lack of Efficacy|1|||
156789439|NCT00281580|565981293|FG003|Overall Study|Lack of Efficacy|6|||
156789440|NCT00281580|565981294|FG004|Overall Study|Lack of Efficacy|2|||
156789441|NCT00281580|565981295|FG005|Overall Study|Lack of Efficacy|0|||
156789442|NCT00281580|565981296|FG006|Overall Study|Lack of Efficacy|0|||
156789443|NCT00281580|565981297|FG007|Overall Study|Lack of Efficacy|0|||
156789444|NCT00281580|565981298|FG008|Overall Study|Lack of Efficacy|0|||
156789445|NCT00281580|565981299|FG009|Overall Study|Lack of Efficacy|0|||
156789446|NCT00281580|565981300|FG010|Overall Study|Lack of Efficacy|0|||
156789447|NCT00281580|565981301|FG011|Overall Study|Lack of Efficacy|1|||
156789448|NCT00281580|565981302|FG012|Overall Study|Lack of Efficacy|0|||
156789449|NCT00281580|565981303|FG013|Overall Study|Lack of Efficacy|2|||
156789450|NCT00281580|565981304|FG014|Overall Study|Lack of Efficacy|1|||
156789451|NCT00281580|565981305|FG015|Overall Study|Lack of Efficacy|0|||
156789452|NCT00281580|565981290|FG000|Overall Study|Lost to Follow-up|0|||
156789453|NCT00281580|565981291|FG001|Overall Study|Lost to Follow-up|0|||
156789454|NCT00281580|565981292|FG002|Overall Study|Lost to Follow-up|0|||
156789455|NCT00281580|565981293|FG003|Overall Study|Lost to Follow-up|3|||
156789456|NCT00281580|565981294|FG004|Overall Study|Lost to Follow-up|0|||
156789457|NCT00281580|565981295|FG005|Overall Study|Lost to Follow-up|1|||
156789458|NCT00281580|565981296|FG006|Overall Study|Lost to Follow-up|0|||
156789459|NCT00281580|565981297|FG007|Overall Study|Lost to Follow-up|1|||
156789460|NCT00281580|565981298|FG008|Overall Study|Lost to Follow-up|2|||
156789461|NCT00281580|565981299|FG009|Overall Study|Lost to Follow-up|1|||
156789462|NCT00281580|565981300|FG010|Overall Study|Lost to Follow-up|1|||
156789463|NCT00281580|565981301|FG011|Overall Study|Lost to Follow-up|0|||
156789464|NCT00281580|565981302|FG012|Overall Study|Lost to Follow-up|1|||
156789465|NCT00281580|565981303|FG013|Overall Study|Lost to Follow-up|0|||
156789466|NCT00281580|565981304|FG014|Overall Study|Lost to Follow-up|0|||
156789467|NCT00281580|565981305|FG015|Overall Study|Lost to Follow-up|0|||
156789468|NCT00281580|565981290|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
156789469|NCT00281580|565981291|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
156789470|NCT00281580|565981292|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
156789471|NCT00281580|565981293|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
156789472|NCT00281580|565981294|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
156789473|NCT00281580|565981295|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
156789474|NCT00281580|565981296|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
156789475|NCT00281580|565981297|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
156870899|NCT01254422|566284313|FG001|Overall Study|Lost to Follow-up|0|||
156870900|NCT00643162|566284314|FG000|Overall Study|Withdrawal by Subject|1|||
156870901|NCT00643162|566284315|FG001|Overall Study|Withdrawal by Subject|1|||
156870902|NCT00318643|566284316|FG000|Overall Study|Adverse Event|0|||
156870903|NCT00318643|566284317|FG001|Overall Study|Adverse Event|0|||
156870904|NCT00318643|566284318|FG002|Overall Study|Adverse Event|0|||
156870905|NCT00318643|566284319|FG003|Overall Study|Adverse Event|0|||
156870906|NCT00318643|566284320|FG004|Overall Study|Adverse Event|1|||
156789476|NCT00281580|565981298|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
156789477|NCT00281580|565981299|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
156789478|NCT00281580|565981300|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
156789479|NCT00281580|565981301|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
156789480|NCT00281580|565981302|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
156789481|NCT00281580|565981303|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
156789482|NCT00281580|565981304|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
156870907|NCT00318643|566284316|FG000|Overall Study|Participant's Decision|0|||
156870908|NCT00318643|566284317|FG001|Overall Study|Participant's Decision|0|||
156870909|NCT00318643|566284318|FG002|Overall Study|Participant's Decision|0|||
157122606|NCT02289950|567200347|FG000|Overall Study|Withdrawal by Subject|1|||
157122607|NCT02289950|567200348|FG001|Overall Study|Withdrawal by Subject|3|||
157122608|NCT02289950|567200347|FG000|Overall Study|Test article held for greater than 28 days|0|||
157122609|NCT02289950|567200348|FG001|Overall Study|Test article held for greater than 28 days|1|||
157122610|NCT02289950|567200347|FG000|Overall Study|Adverse Event|11|||
157122611|NCT02289950|567200348|FG001|Overall Study|Adverse Event|3|||
157122612|NCT02289950|567200347|FG000|Overall Study|Death|1|||
157122613|NCT02289950|567200348|FG001|Overall Study|Death|1|||
157122614|NCT02289950|567200347|FG000|Overall Study|Other|5|||
157122615|NCT02289950|567200348|FG001|Overall Study|Other|2|||
156789483|NCT00281580|565981305|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
156789484|NCT00276380|565981309|FG000|Overall Study|Adverse Event|5|||
156789485|NCT00276380|565981310|FG001|Overall Study|Adverse Event|3|||
156789486|NCT00276380|565981309|FG000|Overall Study|Lost to Follow-up|1|||
156789487|NCT00276380|565981310|FG001|Overall Study|Lost to Follow-up|1|||
156789488|NCT00276380|565981309|FG000|Overall Study|Withdrawal by Subject|3|||
156789489|NCT00276380|565981310|FG001|Overall Study|Withdrawal by Subject|6|||
156789490|NCT00276380|565981309|FG000|Overall Study|Death|5|||
156789491|NCT00276380|565981310|FG001|Overall Study|Death|3|||
156789492|NCT00276380|565981309|FG000|Overall Study|Abnormal aPPT Levels|0|||
156789493|NCT00276380|565981310|FG001|Overall Study|Abnormal aPPT Levels|1|||
156789494|NCT03071965|565981311|FG000|Overall Study|Adverse Event|0|||
156789495|NCT03071965|565981312|FG001|Overall Study|Adverse Event|0|||
156789496|NCT03071965|565981313|FG002|Overall Study|Adverse Event|1|||
156789497|NCT03071965|565981314|FG003|Overall Study|Adverse Event|0|||
156789498|NCT03071965|565981311|FG000|Overall Study|Death|0|||
156789499|NCT03071965|565981312|FG001|Overall Study|Death|0|||
156789500|NCT03071965|565981313|FG002|Overall Study|Death|1|||
156789501|NCT03071965|565981314|FG003|Overall Study|Death|1|||
156789502|NCT03071965|565981311|FG000|Overall Study|COVID-19|0|||
156789503|NCT03071965|565981312|FG001|Overall Study|COVID-19|1|||
156789504|NCT03071965|565981313|FG002|Overall Study|COVID-19|0|||
156789505|NCT03071965|565981314|FG003|Overall Study|COVID-19|1|||
156789506|NCT03071965|565981311|FG000|Overall Study|Other Health Reason|0|||
156789507|NCT03071965|565981312|FG001|Overall Study|Other Health Reason|0|||
156789508|NCT03071965|565981313|FG002|Overall Study|Other Health Reason|0|||
156789509|NCT03071965|565981314|FG003|Overall Study|Other Health Reason|1|||
156789510|NCT04829214|565981315|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
156789511|NCT04829214|565981316|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
156789512|NCT04829214|565981315|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
156789513|NCT04829214|565981316|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
156694616|NCT01641133|565627836|FG002|Overall Study|Adverse Event|1|||
156694617|NCT01641133|565627834|FG000|Overall Study|Withdrawal by Subject|5|||
156694618|NCT01641133|565627835|FG001|Overall Study|Withdrawal by Subject|3|||
156694619|NCT01641133|565627836|FG002|Overall Study|Withdrawal by Subject|3|||
156694620|NCT01641133|565627834|FG000|Overall Study|Lost to Follow-up|0|||
156694621|NCT01641133|565627835|FG001|Overall Study|Lost to Follow-up|2|||
156694622|NCT01641133|565627836|FG002|Overall Study|Lost to Follow-up|2|||
156694623|NCT02220725|565627837|FG000|Overall Study|Lost to Follow-up|0|||
156694624|NCT02220725|565627838|FG001|Overall Study|Lost to Follow-up|0|||
156694625|NCT02220725|565627839|FG002|Overall Study|Lost to Follow-up|0|||
156694626|NCT02220725|565627840|FG003|Overall Study|Lost to Follow-up|1|||
156694627|NCT02220725|565627837|FG000|Overall Study|Withdrawal by Subject|0|||
156694628|NCT02220725|565627838|FG001|Overall Study|Withdrawal by Subject|0|||
156694629|NCT02220725|565627839|FG002|Overall Study|Withdrawal by Subject|0|||
156694630|NCT02220725|565627840|FG003|Overall Study|Withdrawal by Subject|1|||
156694631|NCT00712985|565627841|FG000|Overall Study|1 withdrew prior to start of drug|1|||
156694632|NCT00712985|565627841|FG000|Overall Study|1 patient moved out of state|1|||
156694633|NCT00712985|565627841|FG000|Overall Study|Lack of Efficacy|3|||
156694634|NCT02674061|565627842|FG000|Overall Study|Death|229|||
156694635|NCT02674061|565627843|FG001|Overall Study|Death|77|||
156694636|NCT02674061|565627842|FG000|Overall Study|Lost to Follow-up|3|||
156694637|NCT02674061|565627843|FG001|Overall Study|Lost to Follow-up|3|||
156694638|NCT02674061|565627842|FG000|Overall Study|Withdrawal by Subject|9|||
156694639|NCT02674061|565627843|FG001|Overall Study|Withdrawal by Subject|1|||
156694640|NCT02674061|565627842|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
156694641|NCT02674061|565627843|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
156694642|NCT03334721|565627846|FG000|Overall Study|Withdrawal by Subject|1|||
156694643|NCT03334721|565627847|FG001|Overall Study|Withdrawal by Subject|0|||
156694644|NCT03334721|565627846|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
156694645|NCT03334721|565627847|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
156694646|NCT01663727|565627848|FG000|Overall Study|Death|161|||
156694647|NCT01663727|565627849|FG001|Overall Study|Death|155|||
156694648|NCT01663727|565627848|FG000|Overall Study|Lost to Follow-up|10|||
156694649|NCT01663727|565627849|FG001|Overall Study|Lost to Follow-up|8|||
156694650|NCT01663727|565627848|FG000|Overall Study|Withdrawal by Subject|18|||
156694651|NCT01663727|565627849|FG001|Overall Study|Withdrawal by Subject|25|||
156870910|NCT00318643|566284319|FG003|Overall Study|Participant's Decision|0|||
156870911|NCT00318643|566284320|FG004|Overall Study|Participant's Decision|1|||
157014386|NCT03398148|566805010|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
157014387|NCT03398148|566804996|FG000|Substudy 1 Period 1|Other|0|||
157214584|NCT02059187|567531939|FG001|Overall Study|Protocol Violation|0|||
157214585|NCT02059187|567531938|FG000|Overall Study|Withdrawal by Subject|12|||
157214586|NCT02059187|567531939|FG001|Overall Study|Withdrawal by Subject|8|||
157214587|NCT03751020|567531940|FG000|Overall Study|Withdrawal by Subject|2|||
157214588|NCT03751020|567531941|FG001|Overall Study|Withdrawal by Subject|0|||
157214589|NCT03751020|567531942|FG002|Overall Study|Withdrawal by Subject|0|||
157214590|NCT03751020|567531940|FG000|Overall Study|Lost to Follow-up|7|||
157214591|NCT03751020|567531941|FG001|Overall Study|Lost to Follow-up|4|||
157214592|NCT03751020|567531942|FG002|Overall Study|Lost to Follow-up|10|||
156694652|NCT01663727|565627848|FG000|Overall Study|Study Terminated|51|||
156694653|NCT01663727|565627849|FG001|Overall Study|Study Terminated|50|||
156694654|NCT01663727|565627848|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
156694655|NCT01663727|565627849|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
156694656|NCT01663727|565627848|FG000|Overall Study|Withdrawal prior to dosing.|1|||
156694657|NCT01663727|565627849|FG001|Overall Study|Withdrawal prior to dosing.|0|||
156694658|NCT01902628|565627850|FG000|Overall Study|Withdrawal of participant's consent|7|||
156694659|NCT01902628|565627850|FG000|Overall Study|Adverse Event|41|||
156694660|NCT01902628|565627850|FG000|Overall Study|Lost to Follow-up|35|||
156694661|NCT01232491|565627851|FG000|Overall Study|Adverse Event|13|||
156694662|NCT01232491|565627852|FG001|Overall Study|Adverse Event|8|||
156694663|NCT01232491|565627851|FG000|Overall Study|Lack of Efficacy|1|||
156694664|NCT01232491|565627852|FG001|Overall Study|Lack of Efficacy|5|||
156694665|NCT01232491|565627851|FG000|Overall Study|Protocol Violation|13|||
156694666|NCT01232491|565627852|FG001|Overall Study|Protocol Violation|11|||
156694667|NCT01232491|565627851|FG000|Overall Study|Withdrawal Criteria|12|||
156694668|NCT01232491|565627852|FG001|Overall Study|Withdrawal Criteria|21|||
156694669|NCT01232491|565627851|FG000|Overall Study|Other|21|||
156694670|NCT01232491|565627852|FG001|Overall Study|Other|18|||
156694671|NCT02932228|565627855|FG000|Overall Study|Death|8|||
156694672|NCT02932228|565627856|FG001|Overall Study|Death|23|||
156694673|NCT02932228|565627855|FG000|Overall Study|not eligible upon chart review|2|||
156694674|NCT02932228|565627856|FG001|Overall Study|not eligible upon chart review|5|||
156694675|NCT03303625|565629520|FG000|Overall Study|Withdrawal by Subject|2|||
156694676|NCT03303625|565629521|FG001|Overall Study|Withdrawal by Subject|0|||
156694677|NCT03303625|565629522|FG002|Overall Study|Withdrawal by Subject|0|||
156694678|NCT03303625|565629523|FG003|Overall Study|Withdrawal by Subject|0|||
156694679|NCT02221037|565629525|FG000|Overall Study|Physician Decision|0|||
156694680|NCT02221037|565629526|FG001|Overall Study|Physician Decision|0|||
156694681|NCT02221037|565629527|FG002|Overall Study|Physician Decision|1|||
156694682|NCT02221037|565629528|FG003|Overall Study|Physician Decision|0|||
156694683|NCT00856973|565629529|FG000|Overall Study|Adverse Event|5|||
156694684|NCT00856973|565629530|FG001|Overall Study|Adverse Event|5|||
156694685|NCT00856973|565629531|FG002|Overall Study|Adverse Event|3|||
156694686|NCT00856973|565629529|FG000|Overall Study|Lost to Follow-up|6|||
156694687|NCT00856973|565629530|FG001|Overall Study|Lost to Follow-up|3|||
156694688|NCT00856973|565629531|FG002|Overall Study|Lost to Follow-up|5|||
156694689|NCT00856973|565629529|FG000|Overall Study|Physician Decision|0|||
156694690|NCT00856973|565629530|FG001|Overall Study|Physician Decision|3|||
156694691|NCT00856973|565629531|FG002|Overall Study|Physician Decision|1|||
156694692|NCT00856973|565629529|FG000|Overall Study|Protocol Violation|1|||
156694693|NCT00856973|565629530|FG001|Overall Study|Protocol Violation|2|||
156694694|NCT00856973|565629531|FG002|Overall Study|Protocol Violation|1|||
156694695|NCT00856973|565629529|FG000|Overall Study|Withdrawal by Subject|13|||
156694696|NCT00856973|565629530|FG001|Overall Study|Withdrawal by Subject|16|||
156694697|NCT00856973|565629531|FG002|Overall Study|Withdrawal by Subject|15|||
156694698|NCT00856973|565629529|FG000|Overall Study|Other|11|||
156694699|NCT00856973|565629530|FG001|Overall Study|Other|12|||
156694700|NCT00856973|565629531|FG002|Overall Study|Other|13|||
156694701|NCT04556552|565629534|FG000|Overall Study|Lost to Follow-up|1|||
156694702|NCT04556552|565629535|FG001|Overall Study|Lost to Follow-up|0|||
156694703|NCT04556552|565629534|FG000|Overall Study|Claustrophobia|0|||
156694704|NCT04556552|565629535|FG001|Overall Study|Claustrophobia|1|||
156694705|NCT04556552|565629534|FG000|Overall Study|Inability to continue|0|||
156694706|NCT04556552|565629535|FG001|Overall Study|Inability to continue|1|||
156694707|NCT03955471|565629536|FG000|Overall Study|Death|22|||
156694708|NCT03955471|565629536|FG000|Overall Study|Lost to Follow-up|1|||
156694709|NCT03955471|565629536|FG000|Overall Study|Withdrawal by Subject|6|||
156694710|NCT03955471|565629536|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
156694711|NCT01030341|565629537|FG000|Overall Study|Withdrawal by Subject|1|||
156694712|NCT01030341|565629537|FG000|Overall Study|Lost to Follow-up|2|||
156694713|NCT02307266|565629540|FG000|Overall Study|Adverse Event|3|||
156694714|NCT02307266|565629541|FG001|Overall Study|Adverse Event|1|||
156694715|NCT02307266|565629542|FG002|Overall Study|Adverse Event|5|||
156789514|NCT06399471|565981317|FG000|Overall Study|Withdrawal by Subject|1|||
156789515|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
156789516|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
156789517|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
156789518|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
156789519|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
156789520|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
156789521|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789522|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789523|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
156789524|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789525|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789526|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
156789527|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156789528|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156789529|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
156789530|NCT00407030|565981320|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
156789531|NCT00407030|565981321|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
156789532|NCT00407030|565981322|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
156789533|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
156789534|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
156789535|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
156789536|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
156789537|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
156789538|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
156789539|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
156789540|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
156789541|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
156789542|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
156789543|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
156789544|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
156789545|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
156789546|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
156789547|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
156789548|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
156789549|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
156789550|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
156789551|NCT00407030|565981320|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
156789552|NCT00407030|565981321|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
156789553|NCT00407030|565981322|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
156789554|NCT01370642|565981323|FG000|Overall Study|Adverse Event|2|||
156789555|NCT01370642|565981324|FG001|Overall Study|Adverse Event|1|||
156789556|NCT01370642|565981325|FG002|Overall Study|Adverse Event|1|||
156789557|NCT01370642|565981323|FG000|Overall Study|Detectable HCV RNA|0|||
156789558|NCT01370642|565981324|FG001|Overall Study|Detectable HCV RNA|0|||
156789559|NCT01370642|565981325|FG002|Overall Study|Detectable HCV RNA|22|||
156789560|NCT01370642|565981323|FG000|Overall Study|Lost to Follow-up|0|||
156789561|NCT01370642|565981324|FG001|Overall Study|Lost to Follow-up|0|||
156789562|NCT01370642|565981325|FG002|Overall Study|Lost to Follow-up|1|||
156789563|NCT01370642|565981323|FG000|Overall Study|Physician Decision|4|||
156789564|NCT01370642|565981324|FG001|Overall Study|Physician Decision|1|||
156789565|NCT01370642|565981325|FG002|Overall Study|Physician Decision|2|||
156789566|NCT01370642|565981323|FG000|Overall Study|Withdrawal by Subject|2|||
156789567|NCT01370642|565981324|FG001|Overall Study|Withdrawal by Subject|4|||
156789568|NCT01370642|565981325|FG002|Overall Study|Withdrawal by Subject|3|||
156789569|NCT00147537|565981332|FG000|Phase 1b|Death|0|||
156789570|NCT00147537|565981333|FG001|Phase 1b|Death|1|||
156789571|NCT00147537|565981334|FG002|Phase 1b|Death|2|||
156789572|NCT00147537|565981335|FG003|Phase 1b|Death|1|||
156789573|NCT00147537|565981336|FG004|Phase 1b|Death|2|||
156789574|NCT00147537|565981337|FG005|Phase 1b|Death|2|||
156789575|NCT00147537|565981338|FG006|Phase 1b|Death|1|||
156789576|NCT00147537|565981339|FG007|Phase 1b|Death|3|||
156789577|NCT00147537|565981340|FG008|Phase 1b|Death|9|||
156789578|NCT00147537|565981341|FG009|Phase 1b|Death|0|||
156789579|NCT00147537|565981342|FG010|Phase 1b|Death|0|||
156789580|NCT00147537|565981332|FG000|Phase 1b|Lost to Follow-up|2|||
156789581|NCT00147537|565981333|FG001|Phase 1b|Lost to Follow-up|1|||
156789582|NCT00147537|565981334|FG002|Phase 1b|Lost to Follow-up|0|||
156789583|NCT00147537|565981335|FG003|Phase 1b|Lost to Follow-up|0|||
156789584|NCT00147537|565981336|FG004|Phase 1b|Lost to Follow-up|0|||
156789585|NCT00147537|565981337|FG005|Phase 1b|Lost to Follow-up|0|||
156789586|NCT00147537|565981338|FG006|Phase 1b|Lost to Follow-up|2|||
156789587|NCT00147537|565981339|FG007|Phase 1b|Lost to Follow-up|0|||
156789588|NCT00147537|565981340|FG008|Phase 1b|Lost to Follow-up|1|||
156789589|NCT00147537|565981341|FG009|Phase 1b|Lost to Follow-up|0|||
156789590|NCT00147537|565981342|FG010|Phase 1b|Lost to Follow-up|0|||
156789591|NCT00147537|565981332|FG000|Phase 1b|Other|0|||
156789592|NCT00147537|565981333|FG001|Phase 1b|Other|0|||
156789593|NCT00147537|565981334|FG002|Phase 1b|Other|2|||
156789594|NCT00147537|565981335|FG003|Phase 1b|Other|1|||
156789595|NCT00147537|565981336|FG004|Phase 1b|Other|1|||
156789596|NCT00147537|565981337|FG005|Phase 1b|Other|1|||
156789597|NCT00147537|565981338|FG006|Phase 1b|Other|14|||
156789598|NCT00147537|565981339|FG007|Phase 1b|Other|4|||
156789599|NCT00147537|565981340|FG008|Phase 1b|Other|4|||
156789600|NCT00147537|565981341|FG009|Phase 1b|Other|0|||
156789601|NCT00147537|565981342|FG010|Phase 1b|Other|0|||
156789602|NCT00147537|565981332|FG000|Phase 1b|Withdrawal by Subject|0|||
156789603|NCT00147537|565981333|FG001|Phase 1b|Withdrawal by Subject|0|||
156789604|NCT00147537|565981334|FG002|Phase 1b|Withdrawal by Subject|0|||
156789605|NCT00147537|565981335|FG003|Phase 1b|Withdrawal by Subject|0|||
156789606|NCT00147537|565981336|FG004|Phase 1b|Withdrawal by Subject|0|||
156789607|NCT00147537|565981337|FG005|Phase 1b|Withdrawal by Subject|0|||
156789608|NCT00147537|565981338|FG006|Phase 1b|Withdrawal by Subject|0|||
156789609|NCT00147537|565981339|FG007|Phase 1b|Withdrawal by Subject|0|||
156789610|NCT00147537|565981340|FG008|Phase 1b|Withdrawal by Subject|2|||
156789611|NCT00147537|565981341|FG009|Phase 1b|Withdrawal by Subject|0|||
156789612|NCT00147537|565981342|FG010|Phase 1b|Withdrawal by Subject|0|||
156789613|NCT00147537|565981332|FG000|Phase 1b|Randomized but not treated|0|||
156789614|NCT00147537|565981333|FG001|Phase 1b|Randomized but not treated|0|||
156789615|NCT00147537|565981334|FG002|Phase 1b|Randomized but not treated|0|||
156789616|NCT00147537|565981335|FG003|Phase 1b|Randomized but not treated|0|||
156789617|NCT00147537|565981336|FG004|Phase 1b|Randomized but not treated|0|||
156789618|NCT00147537|565981337|FG005|Phase 1b|Randomized but not treated|0|||
156789619|NCT00147537|565981338|FG006|Phase 1b|Randomized but not treated|1|||
156789620|NCT00147537|565981339|FG007|Phase 1b|Randomized but not treated|0|||
156789621|NCT00147537|565981340|FG008|Phase 1b|Randomized but not treated|1|||
156789622|NCT00147537|565981341|FG009|Phase 1b|Randomized but not treated|0|||
156789623|NCT00147537|565981342|FG010|Phase 1b|Randomized but not treated|0|||
156789624|NCT00147537|565981332|FG000|Phase 2|Death|0|||
156789625|NCT00147537|565981333|FG001|Phase 2|Death|0|||
156789626|NCT00147537|565981334|FG002|Phase 2|Death|0|||
156789627|NCT00147537|565981335|FG003|Phase 2|Death|0|||
156789628|NCT00147537|565981336|FG004|Phase 2|Death|0|||
156789629|NCT00147537|565981337|FG005|Phase 2|Death|0|||
156789630|NCT00147537|565981338|FG006|Phase 2|Death|0|||
156789631|NCT00147537|565981339|FG007|Phase 2|Death|0|||
156789632|NCT00147537|565981340|FG008|Phase 2|Death|0|||
156789633|NCT00147537|565981341|FG009|Phase 2|Death|85|||
156789634|NCT00147537|565981342|FG010|Phase 2|Death|31|||
156789635|NCT00147537|565981332|FG000|Phase 2|Lost to Follow-up|0|||
156789636|NCT00147537|565981333|FG001|Phase 2|Lost to Follow-up|0|||
156789637|NCT00147537|565981334|FG002|Phase 2|Lost to Follow-up|0|||
156789638|NCT00147537|565981335|FG003|Phase 2|Lost to Follow-up|0|||
156789639|NCT00147537|565981336|FG004|Phase 2|Lost to Follow-up|0|||
156789640|NCT00147537|565981337|FG005|Phase 2|Lost to Follow-up|0|||
156789641|NCT00147537|565981338|FG006|Phase 2|Lost to Follow-up|0|||
156789642|NCT00147537|565981339|FG007|Phase 2|Lost to Follow-up|0|||
156789643|NCT00147537|565981340|FG008|Phase 2|Lost to Follow-up|0|||
156789644|NCT00147537|565981341|FG009|Phase 2|Lost to Follow-up|12|||
156789645|NCT00147537|565981342|FG010|Phase 2|Lost to Follow-up|4|||
156789646|NCT00147537|565981332|FG000|Phase 2|Other|0|||
156789647|NCT00147537|565981333|FG001|Phase 2|Other|0|||
156789648|NCT00147537|565981334|FG002|Phase 2|Other|0|||
156789649|NCT00147537|565981335|FG003|Phase 2|Other|0|||
156789650|NCT00147537|565981336|FG004|Phase 2|Other|0|||
156789651|NCT00147537|565981337|FG005|Phase 2|Other|0|||
156789652|NCT00147537|565981338|FG006|Phase 2|Other|0|||
156789653|NCT00147537|565981339|FG007|Phase 2|Other|0|||
156789654|NCT00147537|565981340|FG008|Phase 2|Other|0|||
156789655|NCT00147537|565981341|FG009|Phase 2|Other|47|||
156789656|NCT00147537|565981342|FG010|Phase 2|Other|12|||
156789657|NCT00147537|565981332|FG000|Phase 2|Withdrawal by Subject|0|||
156789658|NCT00147537|565981333|FG001|Phase 2|Withdrawal by Subject|0|||
156789659|NCT00147537|565981334|FG002|Phase 2|Withdrawal by Subject|0|||
156789660|NCT00147537|565981335|FG003|Phase 2|Withdrawal by Subject|0|||
156789661|NCT00147537|565981336|FG004|Phase 2|Withdrawal by Subject|0|||
156789662|NCT00147537|565981337|FG005|Phase 2|Withdrawal by Subject|0|||
156789663|NCT00147537|565981338|FG006|Phase 2|Withdrawal by Subject|0|||
156789664|NCT00147537|565981339|FG007|Phase 2|Withdrawal by Subject|0|||
156789665|NCT00147537|565981340|FG008|Phase 2|Withdrawal by Subject|0|||
156789666|NCT00147537|565981341|FG009|Phase 2|Withdrawal by Subject|16|||
156789667|NCT00147537|565981342|FG010|Phase 2|Withdrawal by Subject|4|||
156789668|NCT00147537|565981332|FG000|Phase 2|Randomized but not treated|0|||
156789669|NCT00147537|565981333|FG001|Phase 2|Randomized but not treated|0|||
156789670|NCT00147537|565981334|FG002|Phase 2|Randomized but not treated|0|||
156789671|NCT00147537|565981335|FG003|Phase 2|Randomized but not treated|0|||
156789672|NCT00147537|565981336|FG004|Phase 2|Randomized but not treated|0|||
156789673|NCT00147537|565981337|FG005|Phase 2|Randomized but not treated|0|||
156789674|NCT00147537|565981338|FG006|Phase 2|Randomized but not treated|0|||
156789675|NCT00147537|565981339|FG007|Phase 2|Randomized but not treated|0|||
156789676|NCT00147537|565981340|FG008|Phase 2|Randomized but not treated|0|||
156789677|NCT00147537|565981341|FG009|Phase 2|Randomized but not treated|1|||
156789678|NCT00147537|565981342|FG010|Phase 2|Randomized but not treated|1|||
156789679|NCT00987935|565981343|FG000|Overall Study|Progressive disease|3|||
156789680|NCT00987935|565981344|FG001|Overall Study|Progressive disease|2|||
156789681|NCT00987935|565981345|FG002|Overall Study|Progressive disease|3|||
156789682|NCT00987935|565981346|FG003|Overall Study|Progressive disease|2|||
156789683|NCT00987935|565981347|FG004|Overall Study|Progressive disease|5|||
156789684|NCT00987935|565981348|FG005|Overall Study|Progressive disease|3|||
156789685|NCT00987935|565981349|FG006|Overall Study|Progressive disease|9|||
156789686|NCT00987935|565981350|FG007|Overall Study|Progressive disease|48|||
156789687|NCT00987935|565981351|FG008|Overall Study|Progressive disease|23|||
156789688|NCT00987935|565981343|FG000|Overall Study|Adverse Event|0|||
156789689|NCT00987935|565981344|FG001|Overall Study|Adverse Event|1|||
156789690|NCT00987935|565981345|FG002|Overall Study|Adverse Event|0|||
156789691|NCT00987935|565981346|FG003|Overall Study|Adverse Event|1|||
156789692|NCT00987935|565981347|FG004|Overall Study|Adverse Event|1|||
156789693|NCT00987935|565981348|FG005|Overall Study|Adverse Event|0|||
156789694|NCT00987935|565981349|FG006|Overall Study|Adverse Event|2|||
156789695|NCT00987935|565981350|FG007|Overall Study|Adverse Event|10|||
156789696|NCT00987935|565981351|FG008|Overall Study|Adverse Event|6|||
156789697|NCT00987935|565981343|FG000|Overall Study|Refused to continue taking trial med.|1|||
156789698|NCT00987935|565981344|FG001|Overall Study|Refused to continue taking trial med.|0|||
156789699|NCT00987935|565981345|FG002|Overall Study|Refused to continue taking trial med.|0|||
156789700|NCT00987935|565981346|FG003|Overall Study|Refused to continue taking trial med.|0|||
156789701|NCT00987935|565981347|FG004|Overall Study|Refused to continue taking trial med.|1|||
156789702|NCT00987935|565981348|FG005|Overall Study|Refused to continue taking trial med.|0|||
156789703|NCT00987935|565981349|FG006|Overall Study|Refused to continue taking trial med.|4|||
156789704|NCT00987935|565981350|FG007|Overall Study|Refused to continue taking trial med.|4|||
156789705|NCT00987935|565981351|FG008|Overall Study|Refused to continue taking trial med.|2|||
156789706|NCT00987935|565981343|FG000|Overall Study|Reason other than those specified above|0|||
156789707|NCT00987935|565981344|FG001|Overall Study|Reason other than those specified above|0|||
156789708|NCT00987935|565981345|FG002|Overall Study|Reason other than those specified above|0|||
156789709|NCT00987935|565981346|FG003|Overall Study|Reason other than those specified above|0|||
156789710|NCT00987935|565981347|FG004|Overall Study|Reason other than those specified above|0|||
156789711|NCT00987935|565981348|FG005|Overall Study|Reason other than those specified above|0|||
156789712|NCT00987935|565981349|FG006|Overall Study|Reason other than those specified above|0|||
156789713|NCT00987935|565981350|FG007|Overall Study|Reason other than those specified above|0|||
156789714|NCT00987935|565981351|FG008|Overall Study|Reason other than those specified above|1|||
156789715|NCT01089543|565981352|FG000|Overall Study|Withdrawal by Subject|2|||
156789716|NCT01089543|565981353|FG001|Overall Study|Withdrawal by Subject|3|||
156789717|NCT01089543|565981354|FG002|Overall Study|Withdrawal by Subject|3|||
156789718|NCT01089543|565981355|FG003|Overall Study|Withdrawal by Subject|1|||
156789719|NCT01089543|565981352|FG000|Overall Study|Physician Decision|1|||
156789720|NCT01089543|565981353|FG001|Overall Study|Physician Decision|0|||
156789721|NCT01089543|565981354|FG002|Overall Study|Physician Decision|0|||
156789722|NCT01089543|565981355|FG003|Overall Study|Physician Decision|1|||
156789723|NCT01089543|565981352|FG000|Overall Study|Adverse Event|0|||
156789724|NCT01089543|565981353|FG001|Overall Study|Adverse Event|1|||
156789725|NCT01089543|565981354|FG002|Overall Study|Adverse Event|0|||
156789726|NCT01089543|565981355|FG003|Overall Study|Adverse Event|0|||
156789727|NCT00468546|565981356|FG000|Week 24 Analysis|Lack of Efficacy|83|||
156789728|NCT00468546|565981357|FG001|Week 24 Analysis|Lack of Efficacy|37|||
156789729|NCT00468546|565981356|FG000|Week 24 Analysis|Refused treatment|5|||
156789730|NCT00468546|565981357|FG001|Week 24 Analysis|Refused treatment|5|||
156789731|NCT00468546|565981356|FG000|Week 24 Analysis|Adverse Event|1|||
156789732|NCT00468546|565981357|FG001|Week 24 Analysis|Adverse Event|8|||
156789733|NCT00468546|565981356|FG000|Week 24 Analysis|Failure to return|3|||
156789734|NCT00468546|565981357|FG001|Week 24 Analysis|Failure to return|4|||
156789735|NCT00468546|565981356|FG000|Week 24 Analysis|Rescue therapy|2|||
156789736|NCT00468546|565981357|FG001|Week 24 Analysis|Rescue therapy|0|||
156789737|NCT00468546|565981356|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
156789738|NCT00468546|565981357|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
156870912|NCT00318643|566284316|FG000|Overall Study|Investigator's Decision|0|||
157014388|NCT03398148|566804997|FG001|Substudy 1 Period 1|Other|1|||
156789739|NCT00468546|565981356|FG000|Week 24 Analysis|Due to clinical hold|1|||
156789740|NCT00468546|565981357|FG001|Week 24 Analysis|Due to clinical hold|0|||
156789741|NCT00468546|565981356|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
156789742|NCT00468546|565981357|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
156789743|NCT00468546|565981356|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
156789744|NCT00468546|565981357|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
156789745|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
156789746|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
157014389|NCT03398148|566804998|FG002|Substudy 1 Period 1|Other|0|||
157014390|NCT03398148|566804999|FG003|Substudy 1 Period 1|Other|0|||
157014391|NCT03398148|566805000|FG004|Substudy 1 Period 1|Other|3|||
157014392|NCT03398148|566805001|FG005|Substudy 1 Period 1|Other|0|||
157014393|NCT03398148|566805002|FG006|Substudy 1 Period 1|Other|0|||
157014394|NCT03398148|566805003|FG007|Substudy 1 Period 1|Other|0|||
156789747|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Death|1|||
156789748|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Death|0|||
157014395|NCT03398148|566805004|FG008|Substudy 1 Period 1|Other|0|||
156789749|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
156789750|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
156789751|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
156789752|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
156789753|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
156789754|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
156789755|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
156789756|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
156789757|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
156789758|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
156789759|NCT00468546|565981356|FG000|Week 24 to Week 104 Analysis|Other|17|||
156789760|NCT00468546|565981357|FG001|Week 24 to Week 104 Analysis|Other|14|||
156789761|NCT00309244|565981358|FG000|Overall Study|Adverse Event|29|||
156789762|NCT00309244|565981359|FG001|Overall Study|Adverse Event|12|||
156789763|NCT00309244|565981358|FG000|Overall Study|Lost to Follow-up|6|||
156789764|NCT00309244|565981359|FG001|Overall Study|Lost to Follow-up|22|||
156789765|NCT00309244|565981358|FG000|Overall Study|Physician Decision|5|||
156789766|NCT00309244|565981359|FG001|Overall Study|Physician Decision|8|||
156789767|NCT00309244|565981358|FG000|Overall Study|Protocol Violation|6|||
156789768|NCT00309244|565981359|FG001|Overall Study|Protocol Violation|3|||
156789769|NCT00309244|565981358|FG000|Overall Study|Withdrawal by Subject|50|||
156789770|NCT00309244|565981359|FG001|Overall Study|Withdrawal by Subject|32|||
156789771|NCT00309244|565981358|FG000|Overall Study|Various|7|||
156789772|NCT00309244|565981359|FG001|Overall Study|Various|7|||
156789773|NCT00309244|565981358|FG000|Overall Study|Randomized but not dosed|11|||
156789774|NCT00309244|565981359|FG001|Overall Study|Randomized but not dosed|12|||
156789775|NCT00309244|565981358|FG000|Overall Study|Death|4|||
156789776|NCT00309244|565981359|FG001|Overall Study|Death|1|||
156789777|NCT03438656|565981360|FG000|Overall Study|Lost to Follow-up|2|||
156789778|NCT03335566|565981361|FG000|Overall Study|Adverse Event|0|||
156789779|NCT03335566|565981362|FG001|Overall Study|Adverse Event|1|||
156789780|NCT03335566|565981361|FG000|Overall Study|Lost to Follow-up|1|||
156789781|NCT03335566|565981362|FG001|Overall Study|Lost to Follow-up|0|||
156789782|NCT03335566|565981361|FG000|Overall Study|Technical Problems|1|||
156789783|NCT03335566|565981362|FG001|Overall Study|Technical Problems|0|||
156789784|NCT03335566|565981361|FG000|Overall Study|Protocol Violation|1|||
156789785|NCT03335566|565981362|FG001|Overall Study|Protocol Violation|0|||
156789786|NCT03335566|565981361|FG000|Overall Study|Other than specified above|1|||
156789787|NCT03335566|565981362|FG001|Overall Study|Other than specified above|2|||
156789788|NCT04223687|565981363|FG000|Overall Study|Missing primary outcome|1|||
156789789|NCT04223687|565981364|FG001|Overall Study|Missing primary outcome|0|||
156789790|NCT04128228|565981368|FG000|Overall Study|Withdrawal by Subject|3|||
156789791|NCT04128228|565981369|FG001|Overall Study|Withdrawal by Subject|3|||
156789792|NCT04128228|565981370|FG002|Overall Study|Withdrawal by Subject|0|||
156789793|NCT04128228|565981371|FG003|Overall Study|Withdrawal by Subject|0|||
156789794|NCT04128228|565981368|FG000|Overall Study|noncompliance|2|||
156789795|NCT04128228|565981369|FG001|Overall Study|noncompliance|2|||
156789796|NCT04128228|565981370|FG002|Overall Study|noncompliance|0|||
156789797|NCT04128228|565981371|FG003|Overall Study|noncompliance|0|||
156789798|NCT03163264|565981372|FG000|Overall Study|Withdrawal by Subject|13|||
156789799|NCT03163264|565981373|FG001|Overall Study|Withdrawal by Subject|3|||
156789800|NCT03163264|565981374|FG002|Overall Study|Withdrawal by Subject|4|||
156789801|NCT03163264|565981375|FG003|Overall Study|Withdrawal by Subject|2|||
156789802|NCT03163264|565981372|FG000|Overall Study|Lost to Follow-up|17|||
156789803|NCT03163264|565981373|FG001|Overall Study|Lost to Follow-up|20|||
156789804|NCT03163264|565981374|FG002|Overall Study|Lost to Follow-up|0|||
156789805|NCT03163264|565981375|FG003|Overall Study|Lost to Follow-up|0|||
156789806|NCT03163264|565981372|FG000|Overall Study|Death|0|||
156789807|NCT03163264|565981373|FG001|Overall Study|Death|2|||
156789808|NCT03163264|565981374|FG002|Overall Study|Death|0|||
156789809|NCT03163264|565981375|FG003|Overall Study|Death|0|||
157014396|NCT03398148|566805005|FG009|Substudy 1 Period 1|Other|0|||
157014397|NCT03398148|566805006|FG010|Substudy 1 Period 1|Other|0|||
156789810|NCT02774278|565981376|FG000|Overall Study|Lack of Efficacy|199|||
156789811|NCT02774278|565981376|FG000|Overall Study|Death|29|||
156789812|NCT02774278|565981376|FG000|Overall Study|Adverse event/intercurrent illness|16|||
156789813|NCT02774278|565981376|FG000|Overall Study|Refused treatment/did not cooperate|9|||
156789814|NCT02774278|565981376|FG000|Overall Study|Administrative reasons|6|||
157014398|NCT03398148|566805007|FG011|Substudy 1 Period 1|Other|0|||
157014399|NCT03398148|566805008|FG012|Substudy 1 Period 1|Other|0|||
156789815|NCT02774278|565981376|FG000|Overall Study|Withdrawal by Subject|3|||
156789816|NCT02774278|565981376|FG000|Overall Study|Protocol Violation|2|||
156789817|NCT00236197|565981379|FG000|Overall Study|Withdrawal by Subject|3|||
156789818|NCT00236197|565981380|FG001|Overall Study|Withdrawal by Subject|2|||
156789819|NCT00236197|565981379|FG000|Overall Study|Lost to Follow-up|1|||
156789820|NCT00236197|565981380|FG001|Overall Study|Lost to Follow-up|5|||
156789821|NCT00236197|565981379|FG000|Overall Study|Protocol Violation|0|||
156789822|NCT00236197|565981380|FG001|Overall Study|Protocol Violation|3|||
156789823|NCT00236197|565981379|FG000|Overall Study|Medication non-compliance|1|||
156789824|NCT00236197|565981380|FG001|Overall Study|Medication non-compliance|2|||
156789825|NCT00236197|565981379|FG000|Overall Study|Other|0|||
156789826|NCT00236197|565981380|FG001|Overall Study|Other|2|||
156789827|NCT03760666|565981383|FG000|Overall Study|Adverse Event|2|||
156789828|NCT03760666|565981384|FG001|Overall Study|Adverse Event|4|||
156789829|NCT03760666|565981385|FG002|Overall Study|Adverse Event|1|||
156789830|NCT03760666|565981383|FG000|Overall Study|AML Disease Progression|3|||
156789831|NCT03760666|565981384|FG001|Overall Study|AML Disease Progression|3|||
156789832|NCT03760666|565981385|FG002|Overall Study|AML Disease Progression|0|||
156789833|NCT03760666|565981383|FG000|Overall Study|Physician Decision|0|||
156789834|NCT03760666|565981384|FG001|Overall Study|Physician Decision|3|||
156789835|NCT03760666|565981385|FG002|Overall Study|Physician Decision|0|||
156789836|NCT03760666|565981383|FG000|Overall Study|Withdrawal by Subject|0|||
156789837|NCT03760666|565981384|FG001|Overall Study|Withdrawal by Subject|1|||
156789838|NCT03760666|565981385|FG002|Overall Study|Withdrawal by Subject|0|||
156694716|NCT02307266|565629540|FG000|Overall Study|Withdrawal by Subject|2|||
156694717|NCT02307266|565629541|FG001|Overall Study|Withdrawal by Subject|0|||
156694718|NCT02307266|565629542|FG002|Overall Study|Withdrawal by Subject|1|||
156694719|NCT02307266|565629540|FG000|Overall Study|Lost to Follow-up|3|||
156694720|NCT02307266|565629541|FG001|Overall Study|Lost to Follow-up|0|||
156694721|NCT02307266|565629542|FG002|Overall Study|Lost to Follow-up|0|||
156694722|NCT02856880|565629544|FG000|Overall Study|Withdrawal of consent|1|||
156694723|NCT00793780|565629545|FG000|Overall Study|Withdrawal by Subject|2|||
156694724|NCT00793780|565629546|FG001|Overall Study|Withdrawal by Subject|1|||
156694725|NCT02858492|565629547|FG000|Overall Study|Withdrawal by Subject|0|||
156694726|NCT02858492|565629548|FG001|Overall Study|Withdrawal by Subject|1|||
156694727|NCT02858492|565629549|FG002|Overall Study|Withdrawal by Subject|0|||
156789839|NCT01800058|565981390|FG000|Overall Study|Lost to Follow-up|1|||
156789840|NCT06868667|565981391|FG000|Overall Study|Death|0|||
156789841|NCT06868667|565981392|FG001|Overall Study|Death|4|||
156789842|NCT06868667|565981391|FG000|Overall Study|Lost to Follow-up|0|||
156789843|NCT06868667|565981392|FG001|Overall Study|Lost to Follow-up|1|||
156789844|NCT06868667|565981391|FG000|Overall Study|Withdrawal by Subject|1|||
156789845|NCT06868667|565981392|FG001|Overall Study|Withdrawal by Subject|0|||
156789846|NCT06868667|565981391|FG000|Overall Study|Ongoing|9|||
156789847|NCT06868667|565981392|FG001|Overall Study|Ongoing|9|||
156694728|NCT02858492|565629550|FG003|Overall Study|Withdrawal by Subject|1|||
156694729|NCT02858492|565629547|FG000|Overall Study|Adverse Event|0|||
156694730|NCT02858492|565629548|FG001|Overall Study|Adverse Event|0|||
156789848|NCT05330429|565981393|FG000|Overall Study|Study Terminated by Sponsor|4|||
156789849|NCT05330429|565981394|FG001|Overall Study|Study Terminated by Sponsor|33|||
156789850|NCT05330429|565981395|FG002|Overall Study|Study Terminated by Sponsor|12|||
156789851|NCT05330429|565981393|FG000|Overall Study|Death|5|||
156789852|NCT05330429|565981394|FG001|Overall Study|Death|2|||
156789853|NCT05330429|565981395|FG002|Overall Study|Death|4|||
156789854|NCT05330429|565981393|FG000|Overall Study|Withdrew Consent|0|||
156789855|NCT05330429|565981394|FG001|Overall Study|Withdrew Consent|5|||
156789856|NCT05330429|565981395|FG002|Overall Study|Withdrew Consent|4|||
156789857|NCT05330429|565981393|FG000|Overall Study|Investigator's Discretion|0|||
156789858|NCT05330429|565981394|FG001|Overall Study|Investigator's Discretion|1|||
156789859|NCT05330429|565981395|FG002|Overall Study|Investigator's Discretion|3|||
156789860|NCT05330429|565981393|FG000|Overall Study|Subject Decision|1|||
156789861|NCT05330429|565981394|FG001|Overall Study|Subject Decision|2|||
156789862|NCT05330429|565981395|FG002|Overall Study|Subject Decision|0|||
156789863|NCT05330429|565981393|FG000|Overall Study|Lost to Follow-up|0|||
156789864|NCT05330429|565981394|FG001|Overall Study|Lost to Follow-up|1|||
156789865|NCT05330429|565981395|FG002|Overall Study|Lost to Follow-up|0|||
156789866|NCT06097273|565981399|FG000|Overall Study|Death|2|||
156789867|NCT06097273|565981400|FG001|Overall Study|Death|1|||
156789868|NCT06097273|565981401|FG002|Overall Study|Death|2|||
156789869|NCT06097273|565981402|FG003|Overall Study|Death|2|||
156694731|NCT02858492|565629549|FG002|Overall Study|Adverse Event|0|||
156694732|NCT02858492|565629550|FG003|Overall Study|Adverse Event|3|||
156694733|NCT02858492|565629547|FG000|Overall Study|Lack of Efficacy|0|||
156789870|NCT06097273|565981399|FG000|Overall Study|Lost to Follow-up|27|||
157014400|NCT03398148|566805009|FG013|Substudy 1 Period 1|Other|0|||
156789871|NCT06097273|565981400|FG001|Overall Study|Lost to Follow-up|18|||
156789872|NCT06097273|565981401|FG002|Overall Study|Lost to Follow-up|36|||
156789873|NCT06097273|565981402|FG003|Overall Study|Lost to Follow-up|31|||
156789874|NCT06097273|565981399|FG000|Overall Study|Physician Decision|0|||
156789875|NCT06097273|565981400|FG001|Overall Study|Physician Decision|1|||
156694734|NCT02858492|565629548|FG001|Overall Study|Lack of Efficacy|0|||
156694735|NCT02858492|565629549|FG002|Overall Study|Lack of Efficacy|0|||
156694736|NCT02858492|565629550|FG003|Overall Study|Lack of Efficacy|1|||
156694737|NCT02858492|565629547|FG000|Overall Study|Protocol defined stopping criteria|0|||
156694738|NCT02858492|565629548|FG001|Overall Study|Protocol defined stopping criteria|0|||
156694739|NCT02858492|565629549|FG002|Overall Study|Protocol defined stopping criteria|0|||
156694740|NCT02858492|565629550|FG003|Overall Study|Protocol defined stopping criteria|1|||
156694741|NCT02944383|565629551|FG000|Overall Study|Lost to Follow-up|0|||
156694742|NCT02944383|565629552|FG001|Overall Study|Lost to Follow-up|0|||
156694743|NCT02944383|565629553|FG002|Overall Study|Lost to Follow-up|1|||
156694744|NCT02944383|565629551|FG000|Overall Study|Withdrawal by Subject|1|||
156694745|NCT02944383|565629552|FG001|Overall Study|Withdrawal by Subject|0|||
156694746|NCT02944383|565629553|FG002|Overall Study|Withdrawal by Subject|0|||
156694747|NCT03623386|565629556|FG000|Overall Study|Protocol Violation|3|||
157014401|NCT03398148|566805010|FG014|Substudy 1 Period 1|Other|0|||
156694748|NCT03623386|565629557|FG001|Overall Study|Protocol Violation|2|||
156694749|NCT03623386|565629558|FG002|Overall Study|Protocol Violation|0|||
156694750|NCT03623386|565629556|FG000|Overall Study|Physician Decision|1|||
157014402|NCT03398148|566804996|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014403|NCT03398148|566804997|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014404|NCT03398148|566804998|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
156694751|NCT03623386|565629557|FG001|Overall Study|Physician Decision|1|||
156694752|NCT03623386|565629558|FG002|Overall Study|Physician Decision|0|||
156694753|NCT03623386|565629556|FG000|Overall Study|Lost to Follow-up|0|||
156694754|NCT03623386|565629557|FG001|Overall Study|Lost to Follow-up|2|||
156694755|NCT03623386|565629558|FG002|Overall Study|Lost to Follow-up|0|||
156694756|NCT03623386|565629556|FG000|Overall Study|COVID-19|0|||
156694757|NCT03623386|565629557|FG001|Overall Study|COVID-19|1|||
156694758|NCT03623386|565629558|FG002|Overall Study|COVID-19|0|||
156694759|NCT00515541|565629559|FG000|Overall Study|Physician Decision|0|||
156694760|NCT00515541|565629560|FG001|Overall Study|Physician Decision|2|||
156694761|NCT00515541|565629561|FG002|Overall Study|Physician Decision|0|||
156694762|NCT00515541|565629562|FG003|Overall Study|Physician Decision|1|||
156694763|NCT00515541|565629559|FG000|Overall Study|No show for appointments|0|||
156694764|NCT00515541|565629560|FG001|Overall Study|No show for appointments|1|||
156694765|NCT00515541|565629561|FG002|Overall Study|No show for appointments|0|||
156694766|NCT00515541|565629562|FG003|Overall Study|No show for appointments|2|||
156694767|NCT00515541|565629559|FG000|Overall Study|Withdrawal by Subject|0|||
156694768|NCT00515541|565629560|FG001|Overall Study|Withdrawal by Subject|2|||
156694769|NCT00515541|565629561|FG002|Overall Study|Withdrawal by Subject|0|||
156694770|NCT00515541|565629562|FG003|Overall Study|Withdrawal by Subject|2|||
156694771|NCT02588950|565629563|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
156694772|NCT02588950|565629564|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
156694773|NCT02588950|565629565|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
156694774|NCT02588950|565629566|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
156694775|NCT02588950|565629563|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
156694776|NCT02588950|565629564|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
156694777|NCT02588950|565629565|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
156694778|NCT02588950|565629566|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
156694779|NCT02072824|565629567|FG000|Overall Study|Insufficient clinical response|1|||
156694780|NCT02072824|565629568|FG001|Overall Study|Insufficient clinical response|0|||
156694781|NCT02072824|565629569|FG002|Overall Study|Insufficient clinical response|1|||
156694782|NCT02072824|565629567|FG000|Overall Study|No longer willing to participate|1|||
156694783|NCT02072824|565629568|FG001|Overall Study|No longer willing to participate|0|||
156789876|NCT06097273|565981401|FG002|Overall Study|Physician Decision|0|||
156789877|NCT06097273|565981402|FG003|Overall Study|Physician Decision|3|||
156789878|NCT06097273|565981399|FG000|Overall Study|Protocol Violation|1|||
156789879|NCT06097273|565981400|FG001|Overall Study|Protocol Violation|1|||
157014405|NCT03398148|566804999|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014406|NCT03398148|566805000|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
157014407|NCT03398148|566805001|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014408|NCT03398148|566805002|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014409|NCT03398148|566805003|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
156694784|NCT02072824|565629569|FG002|Overall Study|No longer willing to participate|1|||
156694785|NCT02072824|565629567|FG000|Overall Study|Medication error|0|||
156694786|NCT02072824|565629568|FG001|Overall Study|Medication error|1|||
156694787|NCT02072824|565629569|FG002|Overall Study|Medication error|0|||
156694788|NCT02072824|565629567|FG000|Overall Study|Adverse Event|0|||
156694789|NCT02072824|565629568|FG001|Overall Study|Adverse Event|0|||
156789880|NCT06097273|565981401|FG002|Overall Study|Protocol Violation|2|||
156789881|NCT06097273|565981402|FG003|Overall Study|Protocol Violation|1|||
157014410|NCT03398148|566805004|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014411|NCT03398148|566805005|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014412|NCT03398148|566805006|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
156694790|NCT02072824|565629569|FG002|Overall Study|Adverse Event|1|||
156694791|NCT00841906|565629572|FG000|Overall Study|Withdrawal by Subject|2|||
157021723|NCT04179500|566832934|FG000|Treatment|Withdrawal by Subject|1|||
156694792|NCT00841906|565629573|FG001|Overall Study|Withdrawal by Subject|0|||
156694793|NCT03921151|565629574|FG000|Overall Study|Withdrawal by Subject|11|||
156694794|NCT03921151|565629575|FG001|Overall Study|Withdrawal by Subject|16|||
156694795|NCT00857792|565629577|FG000|Overall Study|inadequate image quality for analysis|12|||
156694796|NCT03001219|565629581|FG000|Proof of Concept|Study Termination by Sponsor|0|||
156694797|NCT03001219|565629582|FG001|Proof of Concept|Study Termination by Sponsor|1|||
156694798|NCT03001219|565629581|FG000|Proof of Concept|Withdrawal by Subject|0|||
156694799|NCT03001219|565629582|FG001|Proof of Concept|Withdrawal by Subject|4|||
156694800|NCT03001219|565629581|FG000|Proof of Concept|Protocol Deviation|0|||
156694801|NCT03001219|565629582|FG001|Proof of Concept|Protocol Deviation|1|||
156694802|NCT03001219|565629581|FG000|Proof of Concept|Adverse Event|1|||
156694803|NCT03001219|565629582|FG001|Proof of Concept|Adverse Event|1|||
156694804|NCT03001219|565629581|FG000|Proof of Concept|Physician Decision|1|||
156694805|NCT03001219|565629582|FG001|Proof of Concept|Physician Decision|0|||
156694806|NCT03001219|565629581|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
156694807|NCT03001219|565629582|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
156694808|NCT03001219|565629581|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
156694809|NCT03001219|565629582|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
156694810|NCT03001219|565629581|FG000|Extension Period Analysis|Physician Decision|0|||
156694811|NCT03001219|565629582|FG001|Extension Period Analysis|Physician Decision|1|||
156694812|NCT03001219|565629581|FG000|Extension Period Analysis|Adverse Event|1|||
156694813|NCT03001219|565629582|FG001|Extension Period Analysis|Adverse Event|1|||
156694814|NCT03001219|565629581|FG000|Extension Period Analysis|Protocol Deviation|0|||
156694815|NCT03001219|565629582|FG001|Extension Period Analysis|Protocol Deviation|1|||
156694816|NCT03001219|565629581|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
156694817|NCT03001219|565629582|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
156694818|NCT03760250|565629584|FG000|Overall Study|Withdrawal by Subject|1|||
156694819|NCT03760250|565629584|FG000|Overall Study|Physician Decision|1|||
156694820|NCT03733210|565629585|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
156694821|NCT03733210|565629586|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
156694822|NCT04421586|565629587|FG000|Overall Study|Death|0|||
156694823|NCT04421586|565629588|FG001|Overall Study|Death|1|||
156694824|NCT04421586|565629587|FG000|Overall Study|Lost to Follow-up|2|||
156694825|NCT04421586|565629588|FG001|Overall Study|Lost to Follow-up|2|||
156694826|NCT04421586|565629587|FG000|Overall Study|Withdrawn by PI|1|||
156694827|NCT04421586|565629588|FG001|Overall Study|Withdrawn by PI|0|||
156694828|NCT04421586|565629587|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
156694829|NCT04421586|565629588|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
156694830|NCT02963441|565629589|FG000|Overall Study|Protocol violation or withdrawn|8|||
156694831|NCT02963441|565629589|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
156694832|NCT02963441|565629589|FG000|Overall Study|IDx-DR insufficient quality|33|||
156694833|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Adverse Event|9|||
156694834|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Adverse Event|4|||
156694835|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Adverse Event|5|||
156694836|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Adverse Event|9|||
156694837|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Adverse Event|8|||
156694838|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Adverse Event|0|||
156694839|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Adverse Event|0|||
156694840|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
156694841|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694842|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694843|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
156694844|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
156694845|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694846|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
156694847|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Death|1|||
156694848|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Death|1|||
156694849|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Death|1|||
156694850|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Death|1|||
156694851|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Death|0|||
156694852|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Death|0|||
156694853|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Death|0|||
156694854|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
156789882|NCT06097273|565981399|FG000|Overall Study|Withdrawal by Subject|14|||
156694855|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694856|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694857|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
156694858|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
156694859|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
157122616|NCT02289950|567200347|FG000|Overall Study|Not Treated|2|||
156694860|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
156789883|NCT06097273|565981400|FG001|Overall Study|Withdrawal by Subject|11|||
157122617|NCT02289950|567200348|FG001|Overall Study|Not Treated|1|||
156694861|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694862|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694863|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
156694864|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694865|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694866|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694867|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
156694868|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
156694869|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
156694870|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
156694871|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
156694872|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
156694873|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
156694874|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
156694875|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Other|2|||
156694876|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Other|9|||
156694877|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Other|9|||
156694878|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Other|3|||
156694879|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Other|2|||
156694880|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Other|0|||
156694881|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Other|0|||
156694882|NCT00361335|565629590|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
156694883|NCT00361335|565629591|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
156694884|NCT00361335|565629592|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
156694885|NCT00361335|565629593|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
156694886|NCT00361335|565629594|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
156694887|NCT00361335|565629595|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
156694888|NCT00361335|565629596|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
156694889|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694890|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694891|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
156694892|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694893|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694894|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
156694895|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
156694896|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694897|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694898|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694899|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694900|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694901|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
156694902|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
156694903|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Death|0|||
156694904|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Death|0|||
156694905|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Death|0|||
156694906|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Death|0|||
156694907|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Death|0|||
156694908|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Death|0|||
156694909|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Death|1|||
156694910|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694911|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694912|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694913|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
156694914|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694915|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694916|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
156694917|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Other|1|||
156694918|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Other|0|||
156694919|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Other|0|||
156694920|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Other|1|||
156694921|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Other|0|||
156789884|NCT06097273|565981401|FG002|Overall Study|Withdrawal by Subject|14|||
156789885|NCT06097273|565981402|FG003|Overall Study|Withdrawal by Subject|15|||
156694922|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Other|1|||
156694923|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Other|2|||
156694924|NCT00361335|565629590|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694925|NCT00361335|565629591|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694926|NCT00361335|565629592|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
156694927|NCT00361335|565629593|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694928|NCT00361335|565629594|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156694929|NCT00361335|565629595|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
156789886|NCT06097273|565981399|FG000|Overall Study|Other Than Specified|7|||
156694930|NCT00361335|565629596|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
156694931|NCT01765582|565629599|FG000|Overall Study|Other|3|||
156694932|NCT01765582|565629600|FG001|Overall Study|Other|6|||
156694933|NCT01765582|565629601|FG002|Overall Study|Other|9|||
156694934|NCT01765582|565629599|FG000|Overall Study|Lost to Follow-up|2|||
157122618|NCT04518462|567200349|FG000|Overall Study|Withdrawal by Subject|0|||
157122619|NCT04518462|567200350|FG001|Overall Study|Withdrawal by Subject|0|||
157122620|NCT04518462|567200351|FG002|Overall Study|Withdrawal by Subject|1|||
157122621|NCT04518462|567200349|FG000|Overall Study|Physician Decision|1|||
157122622|NCT04518462|567200350|FG001|Overall Study|Physician Decision|1|||
157122623|NCT04518462|567200351|FG002|Overall Study|Physician Decision|0|||
157122624|NCT01003210|567200352|FG000|Overall Study|Lost to Follow-up|1|||
157122625|NCT01003210|567200353|FG001|Overall Study|Lost to Follow-up|3|||
157122626|NCT00861744|567200356|FG000|Overall Study|Adverse Event|0|||
157122627|NCT00861744|567200357|FG001|Overall Study|Adverse Event|0|||
157122628|NCT00861744|567200358|FG002|Overall Study|Adverse Event|0|||
157122629|NCT00861744|567200359|FG003|Overall Study|Adverse Event|1|||
157122630|NCT00861744|567200356|FG000|Overall Study|Lost to Follow-up|7|||
157122631|NCT00861744|567200357|FG001|Overall Study|Lost to Follow-up|19|||
157122632|NCT00861744|567200358|FG002|Overall Study|Lost to Follow-up|17|||
157122633|NCT00861744|567200359|FG003|Overall Study|Lost to Follow-up|12|||
157122634|NCT00861744|567200356|FG000|Overall Study|Withdrawal by Subject|10|||
157122635|NCT00861744|567200357|FG001|Overall Study|Withdrawal by Subject|6|||
157122636|NCT00861744|567200358|FG002|Overall Study|Withdrawal by Subject|6|||
157122637|NCT00861744|567200359|FG003|Overall Study|Withdrawal by Subject|19|||
157122638|NCT00861744|567200356|FG000|Overall Study|Protocol Violation|0|||
157122639|NCT00861744|567200357|FG001|Overall Study|Protocol Violation|1|||
157122640|NCT00861744|567200358|FG002|Overall Study|Protocol Violation|0|||
157122641|NCT00861744|567200359|FG003|Overall Study|Protocol Violation|0|||
157122642|NCT00861744|567200356|FG000|Overall Study|Migration from study area|0|||
157122643|NCT00861744|567200357|FG001|Overall Study|Migration from study area|3|||
157122644|NCT00861744|567200358|FG002|Overall Study|Migration from study area|1|||
157122645|NCT00861744|567200359|FG003|Overall Study|Migration from study area|0|||
157122646|NCT00861744|567200356|FG000|Overall Study|Blood draws|0|||
157122647|NCT00861744|567200357|FG001|Overall Study|Blood draws|0|||
157122648|NCT00861744|567200358|FG002|Overall Study|Blood draws|0|||
157122649|NCT00861744|567200359|FG003|Overall Study|Blood draws|1|||
157122650|NCT03359759|567200360|FG000|Overall Study|Death|3|||
157122651|NCT03359759|567200360|FG000|Overall Study|Lost to Follow-up|2|||
157122652|NCT01411085|567200361|FG000|Overall Study|Physician Decision|1|||
157122653|NCT01411085|567200361|FG000|Overall Study|Protocol Violation|1|||
157122654|NCT01411085|567200361|FG000|Overall Study|Adverse Event|1|||
157122655|NCT05568888|567200362|FG000|Overall Study|Physician Decision|1|||
157122656|NCT05568888|567200363|FG001|Overall Study|Physician Decision|0|||
157122657|NCT05568888|567200362|FG000|Overall Study|Protocol Deviation|2|||
157122658|NCT05568888|567200363|FG001|Overall Study|Protocol Deviation|1|||
157122659|NCT05568888|567200362|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
157122660|NCT05568888|567200363|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
157122661|NCT05568888|567200362|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
157122662|NCT05568888|567200363|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
157122663|NCT05568888|567200362|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
157122664|NCT05568888|567200363|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
157122665|NCT05036083|567200371|FG000|Overall Study|Physician Decision|1|||
157122666|NCT05036083|567200371|FG000|Overall Study|Withdrawal by Subject|1|||
157122667|NCT05036083|567200371|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
157122668|NCT05036083|567200371|FG000|Overall Study|IV not sustainable|1|||
157122669|NCT04745689|567200372|FG000|Overall Study|Death|9|||
157122670|NCT04745689|567200373|FG001|Overall Study|Death|6|||
157122671|NCT04745689|567200372|FG000|Overall Study|Lost to Follow-up|1|||
157122672|NCT04745689|567200373|FG001|Overall Study|Lost to Follow-up|0|||
157122673|NCT04745689|567200372|FG000|Overall Study|Withdrawal by Subject|2|||
157122674|NCT04745689|567200373|FG001|Overall Study|Withdrawal by Subject|0|||
157122675|NCT04745689|567200372|FG000|Overall Study|Study terminated by sponsor|10|||
157122676|NCT04745689|567200373|FG001|Overall Study|Study terminated by sponsor|3|||
157122677|NCT02028455|567200376|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122678|NCT02028455|567200377|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122679|NCT02028455|567200378|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122680|NCT02028455|567200379|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122681|NCT02028455|567200380|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122682|NCT02028455|567200381|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
157122683|NCT02028455|567200382|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
157122684|NCT02028455|567200383|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
157122685|NCT02028455|567200376|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
156694935|NCT01765582|565629600|FG001|Overall Study|Lost to Follow-up|2|||
156694936|NCT01765582|565629601|FG002|Overall Study|Lost to Follow-up|1|||
156694937|NCT01765582|565629599|FG000|Overall Study|Death|31|||
156694938|NCT01765582|565629600|FG001|Overall Study|Death|36|||
156694939|NCT01765582|565629601|FG002|Overall Study|Death|33|||
156694940|NCT01765582|565629599|FG000|Overall Study|Sponsor Decision|46|||
156694941|NCT01765582|565629600|FG001|Overall Study|Sponsor Decision|42|||
156694942|NCT01765582|565629601|FG002|Overall Study|Sponsor Decision|42|||
156694943|NCT01765582|565629599|FG000|Overall Study|Withdrawal of Consent|11|||
156694944|NCT01765582|565629600|FG001|Overall Study|Withdrawal of Consent|6|||
156694945|NCT01765582|565629601|FG002|Overall Study|Withdrawal of Consent|10|||
156694946|NCT00714493|565629604|FG000|Overall Study|Adverse Event|11|||
156694947|NCT00714493|565629604|FG000|Overall Study|Death|3|||
156694948|NCT00714493|565629604|FG000|Overall Study|Lack of Efficacy|10|||
156694949|NCT00714493|565629604|FG000|Overall Study|Lost to Follow-up|3|||
156694950|NCT00714493|565629604|FG000|Overall Study|Protocol Violation|12|||
156694951|NCT00714493|565629604|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
156694952|NCT00714493|565629604|FG000|Overall Study|OTHER|2|||
156694953|NCT01070771|565629605|FG000|Overall Study|Adverse Event|2|||
156694954|NCT01070771|565629605|FG000|Overall Study|Protocol Violation|1|||
156694955|NCT00136318|565629606|FG000|Overall Study|Adverse Event|5|||
156694956|NCT00136318|565629607|FG001|Overall Study|Adverse Event|5|||
156694957|NCT00136318|565629606|FG000|Overall Study|Withdrawal by Subject|2|||
156694958|NCT00136318|565629607|FG001|Overall Study|Withdrawal by Subject|2|||
156694959|NCT00725621|565629614|FG000|Overall Study|Adverse Event|25|||
156694960|NCT00725621|565629614|FG000|Overall Study|Lack of Efficacy|46|||
156694961|NCT00725621|565629614|FG000|Overall Study|Withdrawal by Subject|57|||
156694962|NCT00725621|565629614|FG000|Overall Study|Physician Decision|19|||
156789887|NCT06097273|565981400|FG001|Overall Study|Other Than Specified|3|||
156789888|NCT06097273|565981401|FG002|Overall Study|Other Than Specified|11|||
156870913|NCT00318643|566284317|FG001|Overall Study|Investigator's Decision|0|||
156870914|NCT00318643|566284318|FG002|Overall Study|Investigator's Decision|0|||
156870915|NCT00318643|566284319|FG003|Overall Study|Investigator's Decision|0|||
156870916|NCT00318643|566284320|FG004|Overall Study|Investigator's Decision|1|||
156870917|NCT02691507|566284323|FG000|Overall Study|Missed Visit 3|0|||
156870918|NCT02691507|566284324|FG001|Overall Study|Missed Visit 3|1|||
156870919|NCT01812252|566284325|FG000|Overall Study|Persistent Disease|1|||
156870920|NCT01812252|566284326|FG001|Overall Study|Persistent Disease|0|||
156870921|NCT01812252|566284325|FG000|Overall Study|Not transplanted|11|||
156870922|NCT01812252|566284326|FG001|Overall Study|Not transplanted|11|||
156789889|NCT06097273|565981402|FG003|Overall Study|Other Than Specified|6|||
156789890|NCT01027754|565983650|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
156789891|NCT01027754|565983651|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
156789892|NCT01027754|565983650|FG000|Overall Study|Withdrawal by Subject|0|||
156789893|NCT01027754|565983651|FG001|Overall Study|Withdrawal by Subject|5|||
156789894|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
156789895|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789896|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789897|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789898|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789899|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
156789900|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
156789901|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
156789902|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789903|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
156789904|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789905|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789906|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789907|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
156789908|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
156789909|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789910|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156870923|NCT01812252|566284325|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
157014413|NCT03398148|566805007|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014414|NCT03398148|566805008|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
156694963|NCT00725621|565629614|FG000|Overall Study|Lost to Follow-up|52|||
156694964|NCT00725621|565629614|FG000|Overall Study|Non-compliance|8|||
156694965|NCT00725621|565629614|FG000|Overall Study|Continued treatment by other physician|6|||
156789911|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156870924|NCT01812252|566284326|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
156870925|NCT01812252|566284325|FG000|Overall Study|Withdrawal by Subject|1|||
157014415|NCT03398148|566805009|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
157014416|NCT03398148|566805010|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
157214593|NCT01889862|567531943|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
156870926|NCT01812252|566284326|FG001|Overall Study|Withdrawal by Subject|1|||
156870927|NCT01812252|566284325|FG000|Overall Study|Screen Failure|1|||
156870928|NCT01812252|566284326|FG001|Overall Study|Screen Failure|0|||
156870929|NCT02557139|566284327|FG000|Overall Study|Significant liver elevation|1|||
156870930|NCT02557139|566284328|FG001|Overall Study|Significant liver elevation|0|||
156870931|NCT02557139|566284329|FG002|Overall Study|Significant liver elevation|1|||
156870932|NCT02557139|566284327|FG000|Overall Study|Withdrawal by Subject|1|||
156870933|NCT02557139|566284328|FG001|Overall Study|Withdrawal by Subject|0|||
156870934|NCT02557139|566284329|FG002|Overall Study|Withdrawal by Subject|0|||
156870935|NCT02557139|566284327|FG000|Overall Study|Illness of prohibited medication|0|||
156870936|NCT02557139|566284328|FG001|Overall Study|Illness of prohibited medication|0|||
156870937|NCT02557139|566284329|FG002|Overall Study|Illness of prohibited medication|1|||
156870938|NCT03023397|566284331|FG000|Run-In|Failed screening allergen challenge|1|||
156870939|NCT03023397|566284332|FG001|Run-In|Failed screening allergen challenge|0|||
156870940|NCT03023397|566284333|FG002|Run-In|Failed screening allergen challenge|0|||
156870941|NCT03023397|566284331|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
156870942|NCT03023397|566284332|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
156870943|NCT03023397|566284333|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
156870944|NCT01216189|566284337|FG000|Overall Study|Lost to Follow-up|21|||
156870945|NCT01216189|566284338|FG001|Overall Study|Lost to Follow-up|3|||
156870946|NCT01216189|566284337|FG000|Overall Study|Death|4|||
156870947|NCT01216189|566284338|FG001|Overall Study|Death|2|||
156870948|NCT01146795|566284339|FG000|Overall Study|Withdrawal by Subject|4|||
156870949|NCT01146795|566284339|FG000|Overall Study|Adverse Event|6|||
156870950|NCT01146795|566284339|FG000|Overall Study|Still in treatment at study closure|10|||
156870951|NCT05375760|566284340|FG000|Overall Study|Adverse Event|1|||
156870952|NCT05375760|566284341|FG001|Overall Study|Adverse Event|0|||
156870953|NCT05375760|566284340|FG000|Overall Study|Death|0|||
156870954|NCT05375760|566284341|FG001|Overall Study|Death|1|||
156870955|NCT05375760|566284340|FG000|Overall Study|Lost to Follow-up|6|||
156870956|NCT05375760|566284341|FG001|Overall Study|Lost to Follow-up|6|||
156870957|NCT05375760|566284340|FG000|Overall Study|Withdrawal by Subject|17|||
156870958|NCT05375760|566284341|FG001|Overall Study|Withdrawal by Subject|19|||
156870959|NCT05375760|566284340|FG000|Overall Study|Dosing halted by FDA|96|||
156870960|NCT05375760|566284341|FG001|Overall Study|Dosing halted by FDA|100|||
156870961|NCT05375760|566284340|FG000|Overall Study|Not compliant with study visit|2|||
156870962|NCT05375760|566284341|FG001|Overall Study|Not compliant with study visit|0|||
156870963|NCT05375760|566284340|FG000|Overall Study|Physician Decision|1|||
156870964|NCT05375760|566284341|FG001|Overall Study|Physician Decision|0|||
156870965|NCT05375760|566284340|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
156870966|NCT05375760|566284341|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
157214594|NCT01889862|567531944|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156789912|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789913|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789914|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
156789915|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
156789916|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789917|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789918|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789919|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789920|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
156789921|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
156789922|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789923|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
156789924|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789925|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789926|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789927|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789928|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
156789929|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156870967|NCT05375760|566284340|FG000|Overall Study|Participant moved|1|||
156870968|NCT05375760|566284341|FG001|Overall Study|Participant moved|0|||
156870969|NCT03853109|566284342|FG000|Overall Study|Withdrawal by Subject|0|||
156870970|NCT03853109|566284343|FG001|Overall Study|Withdrawal by Subject|0|||
156870971|NCT03853109|566284344|FG002|Overall Study|Withdrawal by Subject|1|||
156870972|NCT03853109|566284345|FG003|Overall Study|Withdrawal by Subject|2|||
156870973|NCT03853109|566284346|FG004|Overall Study|Withdrawal by Subject|1|||
157214595|NCT01889862|567531945|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
156694966|NCT00725621|565629614|FG000|Overall Study|Switched to other study|1|||
156694967|NCT00725621|565629614|FG000|Overall Study|Switched to other drug|1|||
156694968|NCT00725621|565629614|FG000|Overall Study|Prepared for elective surgery|1|||
156694969|NCT00725621|565629614|FG000|Overall Study|Reason not specified|55|||
156694970|NCT01189500|565629615|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
156694971|NCT01189500|565629615|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
156694972|NCT00851643|565629620|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
156694973|NCT00851643|565629621|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694974|NCT00851643|565629622|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694975|NCT00851643|565629623|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694976|NCT00851643|565629624|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694977|NCT00851643|565629625|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
156694978|NCT00851643|565629620|FG000|Base Study (Up to 12 Months)|Other|0|||
156694979|NCT00851643|565629621|FG001|Base Study (Up to 12 Months)|Other|0|||
156694980|NCT00851643|565629622|FG002|Base Study (Up to 12 Months)|Other|0|||
156694981|NCT00851643|565629623|FG003|Base Study (Up to 12 Months)|Other|0|||
156694982|NCT00851643|565629624|FG004|Base Study (Up to 12 Months)|Other|0|||
156694983|NCT00851643|565629625|FG005|Base Study (Up to 12 Months)|Other|1|||
156694984|NCT00851643|565629620|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
156694985|NCT00851643|565629621|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
156694986|NCT00851643|565629622|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
156694987|NCT00851643|565629623|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
156694988|NCT00851643|565629624|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
156694989|NCT00851643|565629625|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
156694990|NCT00851643|565629620|FG000|Extension Study (Up to 36 Months)|Moved|0|||
156694991|NCT00851643|565629621|FG001|Extension Study (Up to 36 Months)|Moved|2|||
156694992|NCT00851643|565629622|FG002|Extension Study (Up to 36 Months)|Moved|1|||
156694993|NCT00851643|565629623|FG003|Extension Study (Up to 36 Months)|Moved|1|||
156694994|NCT00851643|565629624|FG004|Extension Study (Up to 36 Months)|Moved|0|||
156694995|NCT00851643|565629625|FG005|Extension Study (Up to 36 Months)|Moved|1|||
156694996|NCT00359788|565629626|FG000|Overall Study|Adverse Event|11|||
156694997|NCT00359788|565629627|FG001|Overall Study|Adverse Event|10|||
156694998|NCT00359788|565629626|FG000|Overall Study|Lack of Efficacy|1|||
156694999|NCT00359788|565629627|FG001|Overall Study|Lack of Efficacy|2|||
156695000|NCT00359788|565629626|FG000|Overall Study|Lost to Follow-up|3|||
156695001|NCT00359788|565629627|FG001|Overall Study|Lost to Follow-up|2|||
156695002|NCT00359788|565629626|FG000|Overall Study|Withdrawal by Subject|4|||
156695003|NCT00359788|565629627|FG001|Overall Study|Withdrawal by Subject|1|||
156695004|NCT00359788|565629626|FG000|Overall Study|Protocol Violation|4|||
156695005|NCT00359788|565629627|FG001|Overall Study|Protocol Violation|2|||
156695006|NCT03351231|565629630|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
156695007|NCT03351231|565629630|FG000|Combination Therapy Period|Disease progression|2|||
156695008|NCT03351231|565629630|FG000|Combination Therapy Period|Study drug toxicity|1|||
156695009|NCT03351231|565629630|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
156695010|NCT03351231|565629630|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
156695011|NCT03351231|565629630|FG000|Safety Follow-Up Period|Other reason|2|||
156695012|NCT01673698|565629631|FG000|Overall Study|Lost to Follow-up|51|||
156695013|NCT01673698|565629632|FG001|Overall Study|Lost to Follow-up|13|||
156695014|NCT01297322|565629633|FG000|Overall Study|Lost to Follow-up|1|||
156695015|NCT01297322|565629634|FG001|Overall Study|Lost to Follow-up|0|||
156695016|NCT01297322|565629633|FG000|Overall Study|Withdrawal by Subject|0|||
156695017|NCT01297322|565629634|FG001|Overall Study|Withdrawal by Subject|1|||
156695018|NCT01297322|565629633|FG000|Overall Study|Protocol Violation|0|||
156695019|NCT01297322|565629634|FG001|Overall Study|Protocol Violation|3|||
156695020|NCT01111019|565629635|FG000|Overall Study|Withdrew Prematurely|2|||
156695021|NCT01111019|565629635|FG000|Overall Study|Other|1|||
156695022|NCT02013375|565629636|FG000|Overall Study|Did not engraft|1|||
157014417|NCT03398148|566804996|FG000|Substudy 1 Period 2|Adverse Event|0|||
157014418|NCT03398148|566804997|FG001|Substudy 1 Period 2|Adverse Event|0|||
157014419|NCT03398148|566804998|FG002|Substudy 1 Period 2|Adverse Event|0|||
157014420|NCT03398148|566804999|FG003|Substudy 1 Period 2|Adverse Event|0|||
157014421|NCT03398148|566805000|FG004|Substudy 1 Period 2|Adverse Event|0|||
157014422|NCT03398148|566805001|FG005|Substudy 1 Period 2|Adverse Event|2|||
156695023|NCT02013375|565629636|FG000|Overall Study|Did not engraft|1|||
156695024|NCT04062448|565631085|FG000|Overall Study|Lost to Follow-up|1|||
156695025|NCT04062448|565631085|FG000|Overall Study|Withdrawal by Subject|2|||
156695026|NCT04319718|565631089|FG000|Overall Study|Adverse Event|0|||
156695027|NCT04319718|565631090|FG001|Overall Study|Adverse Event|2|||
156695028|NCT04319718|565631089|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
156695029|NCT04319718|565631090|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
156695030|NCT00321828|565631091|FG000|Overall Study|Ineligible|3|||
156695031|NCT00321828|565631091|FG000|Overall Study|No follow up data|1|||
156695032|NCT00858143|565631094|FG000|Overall Study|Adverse Event|16|||
156695033|NCT00858143|565631094|FG000|Overall Study|Lack of Efficacy|4|||
156695034|NCT00858143|565631094|FG000|Overall Study|Death|7|||
156695035|NCT00858143|565631094|FG000|Overall Study|Other|23|||
156695036|NCT03853148|565631099|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
156695037|NCT03853148|565631100|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
156695038|NCT03853148|565631101|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
156695039|NCT03853148|565631102|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
156695040|NCT00090610|565631103|FG000|Overall Study|Withdrawal by Subject|1|||
156695041|NCT00090610|565631104|FG001|Overall Study|Withdrawal by Subject|1|||
156695042|NCT00599521|565631107|FG000|Overall Study|Lack of Efficacy|4|||
156695043|NCT00599521|565631108|FG001|Overall Study|Lack of Efficacy|8|||
156695044|NCT00599521|565631107|FG000|Overall Study|Adverse Event|4|||
156695045|NCT00599521|565631108|FG001|Overall Study|Adverse Event|1|||
156695046|NCT00599521|565631107|FG000|Overall Study|Withdrawal by Subject|28|||
156695047|NCT00599521|565631108|FG001|Overall Study|Withdrawal by Subject|34|||
156695048|NCT00599521|565631107|FG000|Overall Study|Protocol Violation|1|||
156695049|NCT00599521|565631108|FG001|Overall Study|Protocol Violation|1|||
156695050|NCT00599521|565631107|FG000|Overall Study|Lost to Follow-up|23|||
156695051|NCT00599521|565631108|FG001|Overall Study|Lost to Follow-up|23|||
156695052|NCT00599521|565631107|FG000|Overall Study|Pregnancy|0|||
156695053|NCT00599521|565631108|FG001|Overall Study|Pregnancy|2|||
156695054|NCT05855616|565631111|FG000|Overall Study|Lost to Follow-up|1|||
156695055|NCT05855616|565631112|FG001|Overall Study|Lost to Follow-up|2|||
156695056|NCT01248013|565631115|FG000|Overall Study|Withdrawal by Subject|14|||
156695057|NCT01859130|565631116|FG000|Overall Study|Death|4|||
156695058|NCT01859130|565631116|FG000|Overall Study|Lost to Follow-up|16|||
156695059|NCT01859130|565631116|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
156695060|NCT01859130|565631116|FG000|Overall Study|Physician Decision|6|||
156695061|NCT01859130|565631116|FG000|Overall Study|Withdrawal by Subject|17|||
156695062|NCT01859130|565631116|FG000|Overall Study|Adverse Event|11|||
156695063|NCT01388166|565631117|FG000|Overall Study|Adverse Event|16|||
156695064|NCT01388166|565631117|FG000|Overall Study|Lost to Follow-up|30|||
156695065|NCT01388166|565631117|FG000|Overall Study|Others than specified above|13|||
156695066|NCT04325204|565631118|FG000|Overall Study|Death|0|||
156695067|NCT04325204|565631119|FG001|Overall Study|Death|1|||
156695068|NCT04325204|565631118|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
156695069|NCT04325204|565631119|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
156695070|NCT04325204|565631118|FG000|Overall Study|Lost to Follow-up|8|||
156695071|NCT04325204|565631119|FG001|Overall Study|Lost to Follow-up|8|||
156695072|NCT04325204|565631118|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
156695073|NCT04325204|565631119|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
156695074|NCT01196078|565631125|FG000|Overall Study|Withdrawal by Subject|3|||
156695075|NCT01196078|565631126|FG001|Overall Study|Withdrawal by Subject|5|||
156695076|NCT01196078|565631125|FG000|Overall Study|Adverse Event|4|||
156695077|NCT01196078|565631126|FG001|Overall Study|Adverse Event|4|||
156695078|NCT01196078|565631125|FG000|Overall Study|Protocol Violation|2|||
156695079|NCT01196078|565631126|FG001|Overall Study|Protocol Violation|1|||
156695080|NCT01196078|565631125|FG000|Overall Study|Lack of Efficacy|17|||
156695081|NCT01196078|565631126|FG001|Overall Study|Lack of Efficacy|23|||
156695082|NCT01196078|565631125|FG000|Overall Study|Lost to Follow-up|1|||
156695083|NCT01196078|565631126|FG001|Overall Study|Lost to Follow-up|0|||
156695084|NCT01196078|565631125|FG000|Overall Study|Death|6|||
156695085|NCT01196078|565631126|FG001|Overall Study|Death|4|||
156695086|NCT02667288|565631127|FG000|Overall Study|Protocol Violation|5|||
156695087|NCT02667288|565631127|FG000|Overall Study|Lost to Follow-up|3|||
156695088|NCT02667288|565631127|FG000|Overall Study|Withdrawal by Subject|5|||
156695089|NCT01429051|565631128|FG000|Titration Phase|Death|1|||
156695090|NCT01429051|565631128|FG000|Titration Phase|Withdrawal by Subject|7|||
156695091|NCT01429051|565631128|FG000|Titration Phase|Physician Decision|1|||
156695092|NCT01429051|565631128|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
156695093|NCT01429051|565631128|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
156695094|NCT01429051|565631128|FG000|Efficacy Phase|Adverse Event|1|||
156695095|NCT01429051|565631128|FG000|Efficacy Phase|Death|1|||
156695096|NCT01429051|565631128|FG000|Tolerability Phase|Death|5|||
156695097|NCT01429051|565631128|FG000|Tolerability Phase|Adverse Event|2|||
156695098|NCT01429051|565631128|FG000|Tolerability Phase|Withdrawal by Subject|5|||
156695099|NCT01429051|565631128|FG000|Tolerability Phase|Physician Decision|1|||
156695100|NCT01429051|565631128|FG000|Tolerability Phase|Other|2|||
156695101|NCT04688931|565631137|FG000|Overall Study|Adverse Event|4|||
156695102|NCT04688931|565631138|FG001|Overall Study|Adverse Event|1|||
156695103|NCT04688931|565631137|FG000|Overall Study|Withdrawal by Subject|5|||
156695104|NCT04688931|565631138|FG001|Overall Study|Withdrawal by Subject|16|||
156695105|NCT04688931|565631137|FG000|Overall Study|Physician Decision|3|||
156695106|NCT04688931|565631138|FG001|Overall Study|Physician Decision|5|||
157122686|NCT02028455|567200377|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
156695107|NCT04688931|565631137|FG000|Overall Study|Noncompliance|0|||
156695108|NCT04688931|565631138|FG001|Overall Study|Noncompliance|1|||
156695109|NCT04688931|565631137|FG000|Overall Study|Lost to Follow-up|1|||
156695110|NCT04688931|565631138|FG001|Overall Study|Lost to Follow-up|3|||
156695111|NCT04688931|565631137|FG000|Overall Study|Randomization Error|3|||
156695112|NCT04688931|565631138|FG001|Overall Study|Randomization Error|0|||
156695113|NCT04688931|565631137|FG000|Overall Study|Not Eligible|1|||
156695114|NCT04688931|565631138|FG001|Overall Study|Not Eligible|3|||
156695115|NCT04688931|565631137|FG000|Overall Study|Disease Progression|0|||
156695116|NCT04688931|565631138|FG001|Overall Study|Disease Progression|2|||
156695117|NCT04688931|565631137|FG000|Overall Study|Sponsor Requirement|1|||
156695118|NCT04688931|565631138|FG001|Overall Study|Sponsor Requirement|1|||
156695119|NCT04688931|565631137|FG000|Overall Study|Other Reason|1|||
156695120|NCT04688931|565631138|FG001|Overall Study|Other Reason|2|||
156695121|NCT00616941|565631139|FG000|Overall Study|Progressive Disease|1|||
156695122|NCT00616941|565631140|FG001|Overall Study|Progressive Disease|2|||
156695123|NCT00616941|565631141|FG002|Overall Study|Progressive Disease|1|||
156695124|NCT00616941|565631139|FG000|Overall Study|Adverse Event|0|||
156695125|NCT00616941|565631140|FG001|Overall Study|Adverse Event|1|||
156695126|NCT00616941|565631141|FG002|Overall Study|Adverse Event|1|||
156695127|NCT00616941|565631139|FG000|Overall Study|Subject Non-compliance|0|||
156695128|NCT00616941|565631140|FG001|Overall Study|Subject Non-compliance|0|||
156695129|NCT00616941|565631141|FG002|Overall Study|Subject Non-compliance|1|||
156695130|NCT00616941|565631139|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
156695131|NCT00616941|565631140|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
156695132|NCT00616941|565631141|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
156695133|NCT00616941|565631139|FG000|Overall Study|Vaccination Suspended|0|||
156695134|NCT00616941|565631140|FG001|Overall Study|Vaccination Suspended|0|||
156695135|NCT00616941|565631141|FG002|Overall Study|Vaccination Suspended|3|||
156695136|NCT00076804|565631149|FG000|Overall Study|Death|9|||
156695137|NCT00076804|565631150|FG001|Overall Study|Death|20|||
156695138|NCT00076804|565631149|FG000|Overall Study|Lost to Follow-up|9|||
156695139|NCT00076804|565631150|FG001|Overall Study|Lost to Follow-up|9|||
156695140|NCT00076804|565631149|FG000|Overall Study|Withdrawal by Subject|10|||
156695141|NCT00076804|565631150|FG001|Overall Study|Withdrawal by Subject|8|||
156695142|NCT00076804|565631149|FG000|Overall Study|Early study Closure|32|||
156695143|NCT00076804|565631150|FG001|Overall Study|Early study Closure|32|||
156695144|NCT00354341|565631153|FG000|Overall Study|Adverse Event|1|||
156695145|NCT00354341|565631154|FG001|Overall Study|Adverse Event|0|||
156695146|NCT00354341|565631153|FG000|Overall Study|Death|0|||
156695147|NCT00354341|565631154|FG001|Overall Study|Death|2|||
156695148|NCT00354341|565631153|FG000|Overall Study|Refused treatment|1|||
156695149|NCT00354341|565631154|FG001|Overall Study|Refused treatment|2|||
156695150|NCT00354341|565631153|FG000|Overall Study|Failure to return|0|||
156695151|NCT00354341|565631154|FG001|Overall Study|Failure to return|1|||
156695152|NCT00354341|565631153|FG000|Overall Study|Other|1|||
156695153|NCT00354341|565631154|FG001|Overall Study|Other|2|||
156695154|NCT00251719|565631155|FG000|Overall Study|Adverse Event|14|||
156695155|NCT00251719|565631156|FG001|Overall Study|Adverse Event|8|||
156695156|NCT00251719|565631157|FG002|Overall Study|Adverse Event|7|||
156695157|NCT00251719|565631155|FG000|Overall Study|Protocol Violation|1|||
156695158|NCT00251719|565631156|FG001|Overall Study|Protocol Violation|1|||
156695159|NCT00251719|565631157|FG002|Overall Study|Protocol Violation|1|||
156695160|NCT00251719|565631155|FG000|Overall Study|Lost to Follow-up|5|||
156695161|NCT00251719|565631156|FG001|Overall Study|Lost to Follow-up|11|||
156695162|NCT00251719|565631157|FG002|Overall Study|Lost to Follow-up|8|||
156695163|NCT00251719|565631155|FG000|Overall Study|Withdrawal by Subject|14|||
156695164|NCT00251719|565631156|FG001|Overall Study|Withdrawal by Subject|12|||
157122687|NCT02028455|567200378|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
157122688|NCT02028455|567200379|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
157122689|NCT02028455|567200380|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
157122690|NCT02028455|567200381|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
157122691|NCT02028455|567200382|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
156695165|NCT00251719|565631157|FG002|Overall Study|Withdrawal by Subject|11|||
156695166|NCT00251719|565631155|FG000|Overall Study|Lack of Efficacy|2|||
157122692|NCT02028455|567200383|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
157122693|NCT02028455|567200376|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156695167|NCT00251719|565631156|FG001|Overall Study|Lack of Efficacy|1|||
156695168|NCT00251719|565631157|FG002|Overall Study|Lack of Efficacy|0|||
156695169|NCT00251719|565631155|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
156695170|NCT00251719|565631156|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
156695171|NCT00251719|565631157|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
156695172|NCT00251719|565631155|FG000|Overall Study|Investigator decision|1|||
156695173|NCT00251719|565631156|FG001|Overall Study|Investigator decision|1|||
156695174|NCT00251719|565631157|FG002|Overall Study|Investigator decision|0|||
156695175|NCT00251719|565631155|FG000|Overall Study|Noncompliance|2|||
157014423|NCT03398148|566805002|FG006|Substudy 1 Period 2|Adverse Event|4|||
157014424|NCT03398148|566805003|FG007|Substudy 1 Period 2|Adverse Event|0|||
156695176|NCT00251719|565631156|FG001|Overall Study|Noncompliance|3|||
156695177|NCT00251719|565631157|FG002|Overall Study|Noncompliance|1|||
156695178|NCT00251719|565631155|FG000|Overall Study|Barrett's esophagus|2|||
156695179|NCT00251719|565631156|FG001|Overall Study|Barrett's esophagus|2|||
156695180|NCT00251719|565631157|FG002|Overall Study|Barrett's esophagus|0|||
156695181|NCT01449279|565631158|FG000|Overall Study|Lack of Efficacy|5|||
156695182|NCT01449279|565631158|FG000|Overall Study|Toxicity|2|||
156695183|NCT01732874|565631160|FG000|Overall Study|Withdrawal by Subject|5|||
156695184|NCT01732874|565631161|FG001|Overall Study|Withdrawal by Subject|1|||
156695185|NCT01732874|565631160|FG000|Overall Study|Death of Infant|3|||
156695186|NCT01732874|565631161|FG001|Overall Study|Death of Infant|2|||
156695187|NCT00688376|565631164|FG000|Double-Blind Phase|Adverse Event|4|||
156695188|NCT00688376|565631165|FG001|Double-Blind Phase|Adverse Event|4|||
156695189|NCT00688376|565631164|FG000|Double-Blind Phase|Protocol Violation|1|||
156695190|NCT00688376|565631165|FG001|Double-Blind Phase|Protocol Violation|2|||
156695191|NCT00688376|565631164|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
156695192|NCT00688376|565631165|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
156695193|NCT00688376|565631164|FG000|Double-Blind Phase|Not treated|0|||
156695194|NCT00688376|565631165|FG001|Double-Blind Phase|Not treated|1|||
156695195|NCT00688376|565631164|FG000|Blinded Extension Phase|Adverse Event|3|||
156695196|NCT00688376|565631165|FG001|Blinded Extension Phase|Adverse Event|4|||
156695197|NCT00688376|565631164|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
156695198|NCT00688376|565631165|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
156695199|NCT00688376|565631164|FG000|Blinded Extension Phase|Physician Decision|1|||
156695200|NCT00688376|565631165|FG001|Blinded Extension Phase|Physician Decision|0|||
156695201|NCT00688376|565631164|FG000|Blinded Extension Phase|Other|1|||
156695202|NCT00688376|565631165|FG001|Blinded Extension Phase|Other|0|||
156695203|NCT00557076|565631166|FG000|Overall Study|Unblinding|0|||
156695204|NCT00557076|565631167|FG001|Overall Study|Unblinding|1|||
156695205|NCT02792959|565631169|FG000|Overall Study|Protocol Violation|1|||
156695206|NCT03201250|565631170|FG000|Overall Study|screen failures|3|||
156695207|NCT03201250|565631171|FG001|Overall Study|screen failures|0|||
156695208|NCT03201250|565631172|FG002|Overall Study|screen failures|0|||
156695209|NCT03484117|565631173|FG000|Overall Study|Lost to Follow-up|1|||
156695210|NCT03484117|565631174|FG001|Overall Study|Lost to Follow-up|3|||
156695211|NCT03484117|565631173|FG000|Overall Study|Declined participation in exit assess|1|||
156695212|NCT03484117|565631174|FG001|Overall Study|Declined participation in exit assess|1|||
156695213|NCT03551496|565631178|FG000|Overall Study|Death|11|||
156695214|NCT03551496|565631179|FG001|Overall Study|Death|7|||
156695215|NCT03551496|565631178|FG000|Overall Study|Withdrawal by Subject|4|||
156695216|NCT03551496|565631179|FG001|Overall Study|Withdrawal by Subject|3|||
156695217|NCT03551496|565631178|FG000|Overall Study|Other Reasons|1|||
156695218|NCT03551496|565631179|FG001|Overall Study|Other Reasons|0|||
156695219|NCT01780987|565631182|FG000|Overall Study|Adverse Event|0|||
156695220|NCT01780987|565631183|FG001|Overall Study|Adverse Event|4|||
156695221|NCT01780987|565631182|FG000|Overall Study|Withdrawal by Subject|2|||
156695222|NCT01780987|565631183|FG001|Overall Study|Withdrawal by Subject|0|||
156695223|NCT01780987|565631182|FG000|Overall Study|Request of Changing Hospital|0|||
156695224|NCT01780987|565631183|FG001|Overall Study|Request of Changing Hospital|1|||
156695225|NCT01780987|565631182|FG000|Overall Study|Changing Residence|1|||
156695226|NCT01780987|565631183|FG001|Overall Study|Changing Residence|0|||
156695227|NCT01780987|565631182|FG000|Overall Study|Not Receiving any Study Medication|0|||
156695228|NCT01780987|565631183|FG001|Overall Study|Not Receiving any Study Medication|1|||
156695229|NCT02303041|565631184|FG000|Overall Study|Adverse Event|1|||
156695230|NCT02303041|565631185|FG001|Overall Study|Adverse Event|2|||
156695231|NCT00886288|565631186|FG000|Overall Study|no respect of the 12 weeks period|657|||
156695232|NCT00886288|565631187|FG001|Overall Study|no respect of the 12 weeks period|227|||
156695233|NCT00886288|565631186|FG000|Overall Study|Lost to Follow-up|86|||
156695234|NCT00886288|565631187|FG001|Overall Study|Lost to Follow-up|0|||
156695235|NCT02335983|565631188|FG000|Overall Study|Sponsor Decision|0|||
157014425|NCT03398148|566805004|FG008|Substudy 1 Period 2|Adverse Event|0|||
157014426|NCT03398148|566805005|FG009|Substudy 1 Period 2|Adverse Event|0|||
157014427|NCT03398148|566805006|FG010|Substudy 1 Period 2|Adverse Event|0|||
157014428|NCT03398148|566805007|FG011|Substudy 1 Period 2|Adverse Event|0|||
157014429|NCT03398148|566805008|FG012|Substudy 1 Period 2|Adverse Event|0|||
156695236|NCT02335983|565631189|FG001|Overall Study|Sponsor Decision|0|||
156695237|NCT02335983|565631190|FG002|Overall Study|Sponsor Decision|1|||
156695238|NCT02335983|565631191|FG003|Overall Study|Sponsor Decision|1|||
156695239|NCT02335983|565631192|FG004|Overall Study|Sponsor Decision|0|||
156695240|NCT02335983|565631193|FG005|Overall Study|Sponsor Decision|1|||
156695241|NCT02335983|565631188|FG000|Overall Study|Withdrawal by Subject|3|||
156695242|NCT02335983|565631189|FG001|Overall Study|Withdrawal by Subject|2|||
156695243|NCT02335983|565631190|FG002|Overall Study|Withdrawal by Subject|2|||
156695244|NCT02335983|565631191|FG003|Overall Study|Withdrawal by Subject|1|||
157014430|NCT03398148|566805009|FG013|Substudy 1 Period 2|Adverse Event|0|||
157014431|NCT03398148|566805010|FG014|Substudy 1 Period 2|Adverse Event|0|||
156695245|NCT02335983|565631192|FG004|Overall Study|Withdrawal by Subject|3|||
156695246|NCT02335983|565631193|FG005|Overall Study|Withdrawal by Subject|9|||
156695247|NCT02335983|565631188|FG000|Overall Study|Death|0|||
156695248|NCT02335983|565631189|FG001|Overall Study|Death|0|||
156695249|NCT02335983|565631190|FG002|Overall Study|Death|2|||
156695250|NCT02335983|565631191|FG003|Overall Study|Death|0|||
156695251|NCT02335983|565631192|FG004|Overall Study|Death|0|||
156695252|NCT02335983|565631193|FG005|Overall Study|Death|0|||
156695253|NCT02335983|565631188|FG000|Overall Study|Lost to Follow-up|0|||
156695254|NCT02335983|565631189|FG001|Overall Study|Lost to Follow-up|0|||
156695255|NCT02335983|565631190|FG002|Overall Study|Lost to Follow-up|0|||
156695256|NCT02335983|565631191|FG003|Overall Study|Lost to Follow-up|0|||
156695257|NCT02335983|565631192|FG004|Overall Study|Lost to Follow-up|0|||
156695258|NCT02335983|565631193|FG005|Overall Study|Lost to Follow-up|1|||
156695259|NCT02335983|565631188|FG000|Overall Study|Protocol Specified Criteria|5|||
156695260|NCT02335983|565631189|FG001|Overall Study|Protocol Specified Criteria|7|||
156695261|NCT02335983|565631190|FG002|Overall Study|Protocol Specified Criteria|27|||
156695262|NCT02335983|565631191|FG003|Overall Study|Protocol Specified Criteria|7|||
156695263|NCT02335983|565631192|FG004|Overall Study|Protocol Specified Criteria|5|||
156695264|NCT02335983|565631193|FG005|Overall Study|Protocol Specified Criteria|21|||
156695265|NCT00289874|565631194|FG000|Overall Study|Adverse Event|1|||
156695266|NCT00289874|565631195|FG001|Overall Study|Adverse Event|5|||
156695267|NCT00289874|565631194|FG000|Overall Study|Lost to Follow-up|1|||
156695268|NCT00289874|565631195|FG001|Overall Study|Lost to Follow-up|1|||
156695269|NCT00289874|565631194|FG000|Overall Study|Protocol Violation|3|||
156695270|NCT00289874|565631195|FG001|Overall Study|Protocol Violation|2|||
156695271|NCT00289874|565631194|FG000|Overall Study|Did not meet eligibility|1|||
156695272|NCT00289874|565631195|FG001|Overall Study|Did not meet eligibility|0|||
156695273|NCT04700280|565631201|FG000|Overall Study|Adverse Event|4|||
156695274|NCT04700280|565631202|FG001|Overall Study|Adverse Event|0|||
156695275|NCT04700280|565631201|FG000|Overall Study|Lack of Efficacy|1|||
156695276|NCT04700280|565631202|FG001|Overall Study|Lack of Efficacy|0|||
156695277|NCT04700280|565631201|FG000|Overall Study|Study terminated by sponsor|5|||
156695278|NCT04700280|565631202|FG001|Overall Study|Study terminated by sponsor|3|||
156695279|NCT04700280|565631201|FG000|Overall Study|Other than specified|1|||
156695280|NCT04700280|565631202|FG001|Overall Study|Other than specified|0|||
156695281|NCT01843348|565631203|FG000|Overall Study|Withdrawal by Subject|4|||
157014432|NCT03398148|566804996|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014433|NCT03398148|566804997|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014434|NCT03398148|566804998|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014435|NCT03398148|566804999|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014436|NCT03398148|566805000|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014437|NCT03398148|566805001|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157122694|NCT02028455|567200377|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
157122695|NCT02028455|567200378|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
157122696|NCT02028455|567200379|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
156695282|NCT01843348|565631204|FG001|Overall Study|Withdrawal by Subject|16|||
156695283|NCT01843348|565631205|FG002|Overall Study|Withdrawal by Subject|18|||
156695284|NCT01843348|565631203|FG000|Overall Study|Lost to Follow-up|5|||
156695285|NCT01843348|565631204|FG001|Overall Study|Lost to Follow-up|4|||
156695286|NCT01843348|565631205|FG002|Overall Study|Lost to Follow-up|2|||
156695287|NCT01843348|565631203|FG000|Overall Study|Death|5|||
156695288|NCT01843348|565631204|FG001|Overall Study|Death|3|||
156695289|NCT01843348|565631205|FG002|Overall Study|Death|4|||
156695290|NCT01843348|565631203|FG000|Overall Study|Graft loss/retransplantation|5|||
156695291|NCT01843348|565631204|FG001|Overall Study|Graft loss/retransplantation|8|||
156695292|NCT01843348|565631205|FG002|Overall Study|Graft loss/retransplantation|11|||
156695293|NCT01843348|565631203|FG000|Overall Study|Various reasons|4|||
156695294|NCT01843348|565631204|FG001|Overall Study|Various reasons|9|||
157014438|NCT03398148|566805002|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
157122697|NCT02028455|567200380|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
157122698|NCT02028455|567200381|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
156695295|NCT01843348|565631205|FG002|Overall Study|Various reasons|6|||
156695296|NCT00251641|565631206|FG000|Overall Study|Adverse Event|80|||
156695297|NCT00251641|565631207|FG001|Overall Study|Adverse Event|8|||
156695298|NCT00251641|565631206|FG000|Overall Study|Lack of Efficacy|2|||
156695299|NCT00251641|565631207|FG001|Overall Study|Lack of Efficacy|1|||
156695300|NCT00251641|565631206|FG000|Overall Study|Progression of Disease|0|||
156695301|NCT00251641|565631207|FG001|Overall Study|Progression of Disease|2|||
156695302|NCT00251641|565631206|FG000|Overall Study|Lost to Follow-up|3|||
156695303|NCT00251641|565631207|FG001|Overall Study|Lost to Follow-up|3|||
156695304|NCT00251641|565631206|FG000|Overall Study|Withdrawal by Subject|6|||
156695305|NCT00251641|565631207|FG001|Overall Study|Withdrawal by Subject|8|||
156695306|NCT00251641|565631206|FG000|Overall Study|Protocol Violation|10|||
156695307|NCT00251641|565631207|FG001|Overall Study|Protocol Violation|2|||
157014439|NCT03398148|566805003|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
157014440|NCT03398148|566805004|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156695308|NCT00251641|565631206|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
156695309|NCT00251641|565631207|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
156695310|NCT00251641|565631206|FG000|Overall Study|Switched Treatment|9|||
156695311|NCT00251641|565631207|FG001|Overall Study|Switched Treatment|63|||
156695312|NCT02093221|565631208|FG000|Overall Study|Adverse Event|1|||
156695313|NCT02093221|565631209|FG001|Overall Study|Adverse Event|0|||
156695314|NCT02093221|565631210|FG002|Overall Study|Adverse Event|0|||
156695315|NCT02093221|565631211|FG003|Overall Study|Adverse Event|0|||
156695316|NCT02093221|565631212|FG004|Overall Study|Adverse Event|0|||
156695317|NCT02093221|565631208|FG000|Overall Study|Withdrawal by Subject|1|||
156695318|NCT02093221|565631209|FG001|Overall Study|Withdrawal by Subject|1|||
156695319|NCT02093221|565631210|FG002|Overall Study|Withdrawal by Subject|4|||
156695320|NCT02093221|565631211|FG003|Overall Study|Withdrawal by Subject|1|||
156695321|NCT02093221|565631212|FG004|Overall Study|Withdrawal by Subject|1|||
156695322|NCT02093221|565631208|FG000|Overall Study|Lost to Follow-up|2|||
156695323|NCT02093221|565631209|FG001|Overall Study|Lost to Follow-up|0|||
156695324|NCT02093221|565631210|FG002|Overall Study|Lost to Follow-up|1|||
156695325|NCT02093221|565631211|FG003|Overall Study|Lost to Follow-up|1|||
156695326|NCT02093221|565631212|FG004|Overall Study|Lost to Follow-up|0|||
156695327|NCT02093221|565631208|FG000|Overall Study|Death|0|||
156695328|NCT02093221|565631209|FG001|Overall Study|Death|1|||
156695329|NCT02093221|565631210|FG002|Overall Study|Death|0|||
156695330|NCT02093221|565631211|FG003|Overall Study|Death|0|||
156695331|NCT02093221|565631212|FG004|Overall Study|Death|0|||
156695332|NCT02093221|565631208|FG000|Overall Study|Protocol Violation|0|||
156695333|NCT02093221|565631209|FG001|Overall Study|Protocol Violation|1|||
156695334|NCT02093221|565631210|FG002|Overall Study|Protocol Violation|0|||
156695335|NCT02093221|565631211|FG003|Overall Study|Protocol Violation|0|||
156695336|NCT02093221|565631212|FG004|Overall Study|Protocol Violation|0|||
156695337|NCT02093221|565631208|FG000|Overall Study|Study termination|6|||
156695338|NCT02093221|565631209|FG001|Overall Study|Study termination|5|||
156695339|NCT02093221|565631210|FG002|Overall Study|Study termination|4|||
156695340|NCT02093221|565631211|FG003|Overall Study|Study termination|6|||
156695341|NCT02093221|565631212|FG004|Overall Study|Study termination|7|||
156695342|NCT05069155|565631213|FG000|Overall Study|Withdrawal by Subject|1|||
156695343|NCT05069155|565631214|FG001|Overall Study|Withdrawal by Subject|3|||
156695344|NCT01929031|565631215|FG000|Overall Study|Adverse Event|3|||
156695345|NCT01929031|565631216|FG001|Overall Study|Adverse Event|1|||
156695346|NCT01929031|565631217|FG002|Overall Study|Adverse Event|1|||
156695347|NCT01929031|565631218|FG003|Overall Study|Adverse Event|0|||
156695348|NCT01929031|565631219|FG004|Overall Study|Adverse Event|0|||
156695349|NCT01929031|565631220|FG005|Overall Study|Adverse Event|0|||
156695350|NCT01929031|565631215|FG000|Overall Study|Protocol Violation|1|||
156695351|NCT01929031|565631216|FG001|Overall Study|Protocol Violation|0|||
156695352|NCT01929031|565631217|FG002|Overall Study|Protocol Violation|0|||
156695353|NCT01929031|565631218|FG003|Overall Study|Protocol Violation|0|||
156695354|NCT01929031|565631219|FG004|Overall Study|Protocol Violation|0|||
156695355|NCT01929031|565631220|FG005|Overall Study|Protocol Violation|1|||
156695356|NCT01929031|565631215|FG000|Overall Study|Reason other than specified above|0|||
156695357|NCT01929031|565631216|FG001|Overall Study|Reason other than specified above|1|||
157122699|NCT02028455|567200382|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
157122700|NCT02028455|567200383|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
157122701|NCT02028455|567200376|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
157122702|NCT02028455|567200377|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
157122703|NCT02028455|567200378|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
157122704|NCT02028455|567200379|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
156695358|NCT01929031|565631217|FG002|Overall Study|Reason other than specified above|0|||
156695359|NCT01929031|565631218|FG003|Overall Study|Reason other than specified above|0|||
156695360|NCT01929031|565631219|FG004|Overall Study|Reason other than specified above|1|||
156695361|NCT01929031|565631220|FG005|Overall Study|Reason other than specified above|0|||
156695362|NCT01366443|565631221|FG000|Overall Study|Lost to Follow-up|2|||
156870974|NCT03853109|566284347|FG005|Overall Study|Withdrawal by Subject|4|||
156695363|NCT01366443|565631221|FG000|Overall Study|Under 18 yo|1|||
156695364|NCT05816200|565631222|FG000|Overall Study|Lost to Follow-up|2|||
156695365|NCT05816200|565631223|FG001|Overall Study|Lost to Follow-up|1|||
156695366|NCT02394730|565631224|FG000|Overall Study|Lost to Follow-up|1|||
156695367|NCT02394730|565631225|FG001|Overall Study|Lost to Follow-up|0|||
156695368|NCT02394730|565631224|FG000|Overall Study|Withdrawal by Subject|0|||
156695369|NCT02394730|565631225|FG001|Overall Study|Withdrawal by Subject|1|||
156695370|NCT00731549|565631226|FG000|Overall Study|Lost to Follow-up|19|||
156695371|NCT00731549|565631226|FG000|Overall Study|Met withdrawal criteria|24|||
156695372|NCT00731549|565631226|FG000|Overall Study|Physician Decision|16|||
156695373|NCT00731549|565631226|FG000|Overall Study|Withdrawal by Subject|89|||
156695374|NCT00731549|565631226|FG000|Overall Study|Protocol deviation|1|||
156695375|NCT00731549|565631226|FG000|Overall Study|Adverse Event|31|||
156695376|NCT00731549|565631226|FG000|Overall Study|Lack of efficacy with AE|37|||
156695377|NCT00731549|565631226|FG000|Overall Study|Lack of efficacy without AE|6|||
157214596|NCT01889862|567531946|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
157214597|NCT01889862|567531947|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
157214598|NCT01889862|567531943|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
157214599|NCT01889862|567531944|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
157214600|NCT01889862|567531945|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
157214601|NCT01889862|567531946|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
157214602|NCT01889862|567531947|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
157214603|NCT01889862|567531943|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
157214604|NCT01889862|567531944|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
157214605|NCT01889862|567531945|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
157214606|NCT01889862|567531946|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
157214607|NCT01889862|567531947|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
157214608|NCT01889862|567531943|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
157214609|NCT01889862|567531944|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
157214610|NCT01889862|567531945|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
157214611|NCT01889862|567531946|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
157214612|NCT01889862|567531947|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
157214613|NCT01889862|567531943|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
157214614|NCT01889862|567531944|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
157214615|NCT01889862|567531945|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
157214616|NCT01889862|567531946|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
157214617|NCT01889862|567531947|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
157214618|NCT01889862|567531943|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
157214619|NCT01889862|567531944|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
157214620|NCT01889862|567531945|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
157214621|NCT01889862|567531946|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
157214622|NCT01889862|567531947|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
157214623|NCT01889862|567531943|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
157214624|NCT01889862|567531944|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
157214625|NCT01889862|567531945|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
157214626|NCT01889862|567531946|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
157214627|NCT01889862|567531947|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
157214628|NCT01889862|567531943|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
157214629|NCT01889862|567531944|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
157214630|NCT01889862|567531945|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
157214631|NCT01889862|567531946|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
157214632|NCT01889862|567531947|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
157214633|NCT01889862|567531943|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
157214634|NCT01889862|567531944|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
157214635|NCT01889862|567531945|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
157214636|NCT01889862|567531946|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
157214637|NCT01889862|567531947|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
157214638|NCT01889862|567531943|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
157214639|NCT01889862|567531944|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
157214640|NCT01889862|567531945|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
157214641|NCT01889862|567531946|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
157214642|NCT01889862|567531947|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
157214643|NCT00033631|567531948|FG000|Overall Study|Protocol Violation|14|||
157214644|NCT00033631|567531949|FG001|Overall Study|Protocol Violation|11|||
157214645|NCT00033631|567531948|FG000|Overall Study|Withdrawal by Subject|4|||
157214646|NCT00033631|567531949|FG001|Overall Study|Withdrawal by Subject|4|||
157214647|NCT02595528|567533446|FG000|Overall Study|Withdrawal by Subject|1|||
157214648|NCT02595528|567533447|FG001|Overall Study|Withdrawal by Subject|2|||
157214649|NCT02595528|567533448|FG002|Overall Study|Withdrawal by Subject|1|||
157214650|NCT02595528|567533449|FG003|Overall Study|Withdrawal by Subject|3|||
157214651|NCT02595528|567533446|FG000|Overall Study|Lost to Follow-up|1|||
157214652|NCT02595528|567533447|FG001|Overall Study|Lost to Follow-up|1|||
157214653|NCT02595528|567533448|FG002|Overall Study|Lost to Follow-up|0|||
157214654|NCT02595528|567533449|FG003|Overall Study|Lost to Follow-up|1|||
157214655|NCT03202511|567533450|FG000|Overall Study|Withdrawal by Subject|1|||
157214656|NCT03202511|567533451|FG001|Overall Study|Withdrawal by Subject|0|||
157214657|NCT00382291|567533455|FG000|Overall Study|Adverse Event|1|||
157214658|NCT00382291|567533456|FG001|Overall Study|Adverse Event|2|||
157214659|NCT00382291|567533457|FG002|Overall Study|Adverse Event|2|||
157214660|NCT00382291|567533455|FG000|Overall Study|Protocol Violation|1|||
157214661|NCT00382291|567533456|FG001|Overall Study|Protocol Violation|0|||
157214662|NCT00382291|567533457|FG002|Overall Study|Protocol Violation|0|||
157214663|NCT00382291|567533455|FG000|Overall Study|Temporary study suspension|2|||
157214664|NCT00382291|567533456|FG001|Overall Study|Temporary study suspension|2|||
157214665|NCT00382291|567533457|FG002|Overall Study|Temporary study suspension|5|||
157214666|NCT00382291|567533455|FG000|Overall Study|Withdrawal by Subject|0|||
156789930|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156789931|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156695378|NCT00588640|565631227|FG000|Overall Study|Physician Decision|1|||
156695379|NCT00588640|565631227|FG000|Overall Study|Ineligible Patient|1|||
156695380|NCT01393730|565631228|FG000|Overall Study|Withdrawal by Subject|3|||
156695381|NCT01393730|565631228|FG000|Overall Study|Other|2|||
156695382|NCT01393730|565631228|FG000|Overall Study|Adverse Event|1|||
156695383|NCT00103402|565631229|FG000|Overall Study|Adverse Event|3|||
156695384|NCT00103402|565631230|FG001|Overall Study|Adverse Event|4|||
156695385|NCT00103402|565631229|FG000|Overall Study|Lost to Follow-up|8|||
156695386|NCT00103402|565631230|FG001|Overall Study|Lost to Follow-up|7|||
156695387|NCT00103402|565631229|FG000|Overall Study|Dissatisfied/No longer interested|6|||
156695388|NCT00103402|565631230|FG001|Overall Study|Dissatisfied/No longer interested|6|||
156695389|NCT00103402|565631229|FG000|Overall Study|Personal constraints/Other|5|||
156695390|NCT00103402|565631230|FG001|Overall Study|Personal constraints/Other|0|||
156695391|NCT02384850|565631231|FG000|Overall Study|Withdrawal by Subject|2|||
156695392|NCT02384850|565631232|FG001|Overall Study|Withdrawal by Subject|2|||
156695393|NCT00507546|565631233|FG000|Overall Study|Withdrawal by Subject|1|||
156695394|NCT00507546|565631234|FG001|Overall Study|Withdrawal by Subject|0|||
156695395|NCT00507546|565631233|FG000|Overall Study|Protocol Violation|1|||
156695396|NCT00507546|565631234|FG001|Overall Study|Protocol Violation|0|||
156695397|NCT00507546|565631233|FG000|Overall Study|Physician Decision|0|||
156695398|NCT00507546|565631234|FG001|Overall Study|Physician Decision|1|||
156695399|NCT03510182|565631239|FG000|Overall Study|Withdrawal by Subject|2|||
156695400|NCT04385277|565632928|FG000|Overall Study|Physician Decision|2|||
156695401|NCT04385277|565632928|FG000|Overall Study|Ineligible|1|||
156695402|NCT04385277|565632928|FG000|Overall Study|Patient/Parent Refusal|2|||
156695403|NCT04905290|565632929|FG000|Overall Study|Adverse Event|4|||
156695404|NCT04905290|565632929|FG000|Overall Study|Death|2|||
156695405|NCT04905290|565632929|FG000|Overall Study|Withdrawal by Subject|4|||
156695406|NCT04905290|565632929|FG000|Overall Study|Physician Decision|2|||
156695407|NCT04905290|565632929|FG000|Overall Study|Lost to Follow-up|2|||
156695408|NCT04905290|565632929|FG000|Overall Study|Screen Failure|2|||
156695409|NCT04905290|565632929|FG000|Overall Study|Unsuccessful Procedure|2|||
156695410|NCT03295318|565632930|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
156695411|NCT03295318|565632931|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
156695412|NCT03295318|565632932|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
156695413|NCT03295318|565632930|FG000|Overall Study|Death|1|||
156695414|NCT03295318|565632931|FG001|Overall Study|Death|1|||
156695415|NCT03295318|565632932|FG002|Overall Study|Death|1|||
156695416|NCT03295318|565632930|FG000|Overall Study|Protocol Violation|4|||
156695417|NCT03295318|565632931|FG001|Overall Study|Protocol Violation|3|||
156695418|NCT03295318|565632932|FG002|Overall Study|Protocol Violation|3|||
156695419|NCT03295318|565632930|FG000|Overall Study|Withdrawal by Subject|0|||
156695420|NCT03295318|565632931|FG001|Overall Study|Withdrawal by Subject|0|||
156695421|NCT03295318|565632932|FG002|Overall Study|Withdrawal by Subject|1|||
156695422|NCT03295318|565632930|FG000|Overall Study|Subject discontinued due to travel|0|||
156695423|NCT03295318|565632931|FG001|Overall Study|Subject discontinued due to travel|1|||
156695424|NCT03295318|565632932|FG002|Overall Study|Subject discontinued due to travel|0|||
156695425|NCT03747601|565632933|FG000|Overall Study|COVID halt to visits|4|||
156695426|NCT00573157|565632934|FG000|Overall Study|Adverse Event|3|||
156695427|NCT00573157|565632935|FG001|Overall Study|Adverse Event|1|||
156695428|NCT00573157|565632934|FG000|Overall Study|Other|1|||
156695429|NCT00573157|565632935|FG001|Overall Study|Other|1|||
156695430|NCT01032018|565632936|FG000|Overall Study|Lost to Follow-up|6|||
156695431|NCT01032018|565632937|FG001|Overall Study|Lost to Follow-up|5|||
156695432|NCT01032018|565632936|FG000|Overall Study|Death|0|||
156695433|NCT01032018|565632937|FG001|Overall Study|Death|1|||
156695434|NCT01293539|565632942|FG000|Overall Study|Physician Decision|1|||
156695435|NCT00609518|565632943|FG000|Overall Study|Death from Study Disease|32|||
156695436|NCT00609518|565632944|FG001|Overall Study|Death from Study Disease|32|||
156695437|NCT00609518|565632943|FG000|Overall Study|Withdrawal by Subject|5|||
157122705|NCT02028455|567200380|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
157122706|NCT02028455|567200381|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
157145166|NCT05755438|567278012|FG000|40-week OLE Period|Physician Decision|1|||
156695438|NCT00609518|565632944|FG001|Overall Study|Withdrawal by Subject|3|||
156695439|NCT00609518|565632943|FG000|Overall Study|Lost to Follow-up|3|||
156695440|NCT00609518|565632944|FG001|Overall Study|Lost to Follow-up|0|||
156695441|NCT00609518|565632943|FG000|Overall Study|Physician Decision|1|||
156695442|NCT00609518|565632944|FG001|Overall Study|Physician Decision|3|||
156695443|NCT00609518|565632943|FG000|Overall Study|Death from Adverse Event|2|||
156695444|NCT00609518|565632944|FG001|Overall Study|Death from Adverse Event|2|||
156695445|NCT04032158|565632945|FG000|Overall Study|Study Termination|2|||
156695446|NCT04032158|565632946|FG001|Overall Study|Study Termination|1|||
156695447|NCT00059787|565632947|FG000|Overall Study|Adverse Event|13|||
156695448|NCT00059787|565632947|FG000|Overall Study|disease progression|2|||
156695449|NCT00059787|565632947|FG000|Overall Study|ineligible|1|||
156695450|NCT00059787|565632947|FG000|Overall Study|Other|4|||
156695451|NCT04710979|565632950|FG000|Overall Study|Lost to Follow-up|2|||
156695452|NCT04710979|565632951|FG001|Overall Study|Lost to Follow-up|4|||
157122707|NCT02028455|567200382|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
157122708|NCT02028455|567200383|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
157122709|NCT07099521|567200384|FG000|Overall Study|Incompeleted stimulus program|1|||
157122710|NCT07099521|567200385|FG001|Overall Study|Incompeleted stimulus program|0|||
157122711|NCT07099521|567200384|FG000|Overall Study|Non-social anxiety symtpoms|0|||
157122712|NCT07099521|567200385|FG001|Overall Study|Non-social anxiety symtpoms|1|||
157122713|NCT07099521|567200384|FG000|Overall Study|Extreme values|2|||
157122714|NCT07099521|567200385|FG001|Overall Study|Extreme values|4|||
157122715|NCT02396589|567200386|FG000|Intervention|Lost to Follow-up|1|||
157122716|NCT02396589|567200387|FG001|Intervention|Lost to Follow-up|0|||
157122717|NCT02396589|567200386|FG000|6 Month Follow-up|change in health status|0|||
157122718|NCT02396589|567200387|FG001|6 Month Follow-up|change in health status|1|||
157122719|NCT02396589|567200386|FG000|9 Month Follow-up|Death|0|||
157122720|NCT02396589|567200387|FG001|9 Month Follow-up|Death|1|||
157122721|NCT02396589|567200386|FG000|12 Month Follow up|Lost to Follow-up|0|||
157122722|NCT02396589|567200387|FG001|12 Month Follow up|Lost to Follow-up|2|||
157122723|NCT04381650|567200388|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122724|NCT04381650|567200389|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122725|NCT04381650|567200390|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122726|NCT04381650|567200391|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
157122727|NCT04381650|567200392|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122728|NCT04381650|567200393|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122729|NCT04381650|567200394|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122730|NCT04381650|567200395|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122731|NCT04381650|567200396|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122732|NCT04381650|567200397|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122733|NCT04381650|567200398|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
157122734|NCT04381650|567200388|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122735|NCT04381650|567200389|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122736|NCT04381650|567200390|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122737|NCT04381650|567200391|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
156870975|NCT03853109|566284348|FG006|Overall Study|Withdrawal by Subject|5|||
156870976|NCT03853109|566284349|FG007|Overall Study|Withdrawal by Subject|3|||
156870977|NCT03853109|566284342|FG000|Overall Study|Decision by Sponsor|0|||
156870978|NCT03853109|566284343|FG001|Overall Study|Decision by Sponsor|0|||
156695453|NCT04710979|565632950|FG000|Overall Study|Withdrawal by Subject|1|||
156695454|NCT04710979|565632951|FG001|Overall Study|Withdrawal by Subject|0|||
156695455|NCT04397445|565632954|FG000|Overall Study|Withdrawal by Subject|1|||
156695456|NCT04397445|565632955|FG001|Overall Study|Withdrawal by Subject|0|||
156695457|NCT04397445|565632956|FG002|Overall Study|Withdrawal by Subject|0|||
156695458|NCT04397445|565632957|FG003|Overall Study|Withdrawal by Subject|0|||
156695459|NCT00891371|565632958|FG000|Pre-assignment|Inclusion/exclusion|5|||
156695460|NCT00891371|565632958|FG000|Pre-assignment|Consent withdrawal|1|||
156695461|NCT00891371|565632958|FG000|Treatment|Lack of Efficacy|5|||
156789932|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156789933|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
156695462|NCT00891371|565632958|FG000|Treatment|Adverse Event|2|||
156695463|NCT00891371|565632958|FG000|Treatment|Death|1|||
156789934|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
156789935|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
156789936|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789937|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789938|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789939|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789940|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789941|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
156789942|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
156789943|NCT01557244|565983655|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
156789944|NCT01557244|565983656|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789945|NCT01557244|565983657|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
156789946|NCT01557244|565983658|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789947|NCT01557244|565983659|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789948|NCT01557244|565983660|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789949|NCT01557244|565983661|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
156789950|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789951|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789952|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789953|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156695464|NCT00891371|565632958|FG000|Treatment|Lost to Follow-up|1|||
156695465|NCT00307034|565632959|FG000|Overall Study|Adverse Event|1|||
156695466|NCT00307034|565632960|FG001|Overall Study|Adverse Event|2|||
156695467|NCT00307034|565632959|FG000|Overall Study|Withdrawal by Subject|1|||
156695468|NCT00307034|565632960|FG001|Overall Study|Withdrawal by Subject|2|||
156695469|NCT00307034|565632959|FG000|Overall Study|Lost to Follow-up|0|||
156695470|NCT00307034|565632960|FG001|Overall Study|Lost to Follow-up|3|||
156695471|NCT02034058|565632961|FG000|Overall Study|Death|3|||
156695472|NCT03709823|565632972|FG000|Overall Study|Adverse Event|0|||
156695473|NCT03709823|565632973|FG001|Overall Study|Adverse Event|0|||
156695474|NCT03709823|565632974|FG002|Overall Study|Adverse Event|1|||
156695475|NCT03709823|565632975|FG003|Overall Study|Adverse Event|0|||
156695476|NCT03709823|565632976|FG004|Overall Study|Adverse Event|0|||
156695477|NCT03709823|565632977|FG005|Overall Study|Adverse Event|0|||
156695478|NCT03709823|565632972|FG000|Overall Study|Lost to Follow-up|2|||
156695479|NCT03709823|565632973|FG001|Overall Study|Lost to Follow-up|2|||
156695480|NCT03709823|565632974|FG002|Overall Study|Lost to Follow-up|2|||
156695481|NCT03709823|565632975|FG003|Overall Study|Lost to Follow-up|1|||
156695482|NCT03709823|565632976|FG004|Overall Study|Lost to Follow-up|1|||
156695483|NCT03709823|565632977|FG005|Overall Study|Lost to Follow-up|0|||
156695484|NCT03709823|565632972|FG000|Overall Study|Withdrawal by Subject|1|||
156695485|NCT03709823|565632973|FG001|Overall Study|Withdrawal by Subject|3|||
156695486|NCT03709823|565632974|FG002|Overall Study|Withdrawal by Subject|0|||
156695487|NCT03709823|565632975|FG003|Overall Study|Withdrawal by Subject|0|||
156695488|NCT03709823|565632976|FG004|Overall Study|Withdrawal by Subject|0|||
156695489|NCT03709823|565632977|FG005|Overall Study|Withdrawal by Subject|0|||
156695490|NCT03709823|565632972|FG000|Overall Study|Other, Not Specified|0|||
156695491|NCT03709823|565632973|FG001|Overall Study|Other, Not Specified|0|||
156695492|NCT03709823|565632974|FG002|Overall Study|Other, Not Specified|0|||
156695493|NCT03709823|565632975|FG003|Overall Study|Other, Not Specified|1|||
156695494|NCT03709823|565632976|FG004|Overall Study|Other, Not Specified|0|||
156695495|NCT03709823|565632977|FG005|Overall Study|Other, Not Specified|0|||
156695496|NCT00846521|565632978|FG000|Overall Study|Withdrawal by Subject|5|||
156695497|NCT00846521|565632978|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
156695498|NCT00846521|565632978|FG000|Overall Study|Protocol Violation|1|||
156695499|NCT04392583|565632979|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
156695500|NCT02575911|565632982|FG000|Overall Study|Lost to Follow-up|1|||
156695501|NCT01249365|565632983|FG000|Overall Study|Lost to Follow-up|1|||
156695502|NCT03579966|565632984|FG000|Overall Study|Adverse Event|6|||
156695503|NCT03579966|565632984|FG000|Overall Study|Lost to Follow-up|4|||
156695504|NCT03579966|565632984|FG000|Overall Study|Physician Decision|10|||
156695505|NCT03579966|565632984|FG000|Overall Study|Pregnancy|1|||
156695506|NCT03579966|565632984|FG000|Overall Study|Withdrawal by Subject|16|||
156695507|NCT03579966|565632984|FG000|Overall Study|Study terminated by Sponsor|22|||
156695508|NCT03579966|565632984|FG000|Overall Study|Protocol Violation|1|||
156695509|NCT02408068|565632987|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695510|NCT02408068|565632988|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695511|NCT02408068|565632989|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
156695512|NCT02408068|565632990|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695513|NCT02408068|565632991|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695514|NCT02408068|565632992|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
156695515|NCT01340768|565632993|FG000|Overall Study|Lost to Follow-up|10|||
156695516|NCT01340768|565632994|FG001|Overall Study|Lost to Follow-up|4|||
156695517|NCT01340768|565632993|FG000|Overall Study|Withdrawal by Subject|5|||
156695518|NCT01340768|565632994|FG001|Overall Study|Withdrawal by Subject|1|||
156695519|NCT01340768|565632993|FG000|Overall Study|Other|2|||
156695520|NCT01340768|565632994|FG001|Overall Study|Other|0|||
156695521|NCT03052959|565632997|FG000|Overall Study|Lost to Follow-up|4|||
156695522|NCT03052959|565632998|FG001|Overall Study|Lost to Follow-up|5|||
156695523|NCT02397408|565632999|FG000|Overall Study|Physician Decision|4|||
156695524|NCT02397408|565632999|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
157122738|NCT04381650|567200392|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156695525|NCT01524679|565633000|FG000|Overall Study|Lost to Follow-up|1|||
156695526|NCT01524679|565633001|FG001|Overall Study|Lost to Follow-up|4|||
156695527|NCT01524679|565633000|FG000|Overall Study|Withdrawal by Subject|4|||
156695528|NCT01524679|565633001|FG001|Overall Study|Withdrawal by Subject|4|||
156695529|NCT01524679|565633000|FG000|Overall Study|Adverse Event|9|||
156695530|NCT01524679|565633001|FG001|Overall Study|Adverse Event|0|||
156695531|NCT01524679|565633000|FG000|Overall Study|Protocol Violation|1|||
156695532|NCT01524679|565633001|FG001|Overall Study|Protocol Violation|0|||
156695533|NCT01524679|565633000|FG000|Overall Study|Lack of Efficacy|2|||
156695534|NCT01524679|565633001|FG001|Overall Study|Lack of Efficacy|0|||
156695535|NCT01524679|565633000|FG000|Overall Study|e.g.wish for children, relocation|6|||
156695536|NCT01524679|565633001|FG001|Overall Study|e.g.wish for children, relocation|1|||
156695537|NCT03321630|565633006|FG000|Overall Study|Adverse Event|1|||
156695538|NCT03321630|565633006|FG000|Overall Study|Investigator Discretion|2|||
156695539|NCT03321630|565633006|FG000|Overall Study|Withdrawal by Subject|1|||
156695540|NCT00140426|565633007|FG000|Overall Study|Withdrawal by Subject|0|||
157214667|NCT00382291|567533456|FG001|Overall Study|Withdrawal by Subject|2|||
157214668|NCT00382291|567533457|FG002|Overall Study|Withdrawal by Subject|0|||
157214669|NCT00382291|567533455|FG000|Overall Study|Physician Decision|0|||
157214670|NCT00382291|567533456|FG001|Overall Study|Physician Decision|1|||
157214671|NCT00382291|567533457|FG002|Overall Study|Physician Decision|0|||
157214672|NCT00382291|567533455|FG000|Overall Study|Lack of Efficacy|0|||
157214673|NCT00382291|567533456|FG001|Overall Study|Lack of Efficacy|0|||
157214674|NCT00382291|567533457|FG002|Overall Study|Lack of Efficacy|1|||
157214675|NCT01375010|567533458|FG000|Overall Study|Lost to Follow-up|8|||
157214676|NCT01375010|567533459|FG001|Overall Study|Lost to Follow-up|2|||
157214677|NCT01375010|567533458|FG000|Overall Study|Withdrawal by Subject|4|||
157214678|NCT01375010|567533459|FG001|Overall Study|Withdrawal by Subject|2|||
157214679|NCT02266706|567533460|FG000|Overall Study|Withdrawal by Subject|0|||
157214680|NCT02266706|567533461|FG001|Overall Study|Withdrawal by Subject|1|||
157214681|NCT02266706|567533462|FG002|Overall Study|Withdrawal by Subject|1|||
157214682|NCT02266706|567533463|FG003|Overall Study|Withdrawal by Subject|0|||
157214683|NCT02266706|567533464|FG004|Overall Study|Withdrawal by Subject|0|||
157214684|NCT02266706|567533465|FG005|Overall Study|Withdrawal by Subject|1|||
157214685|NCT02266706|567533466|FG006|Overall Study|Withdrawal by Subject|0|||
157214686|NCT02266706|567533467|FG007|Overall Study|Withdrawal by Subject|0|||
157214687|NCT02266706|567533468|FG008|Overall Study|Withdrawal by Subject|0|||
157214688|NCT02266706|567533460|FG000|Overall Study|Screen failure|0|||
157214689|NCT02266706|567533461|FG001|Overall Study|Screen failure|0|||
157214690|NCT02266706|567533462|FG002|Overall Study|Screen failure|0|||
157214691|NCT02266706|567533463|FG003|Overall Study|Screen failure|0|||
157214692|NCT02266706|567533464|FG004|Overall Study|Screen failure|0|||
157214693|NCT02266706|567533465|FG005|Overall Study|Screen failure|1|||
156695541|NCT00140426|565633008|FG001|Overall Study|Withdrawal by Subject|3|||
156695542|NCT02149108|565633009|FG000|Overall Study|Not treated|1|||
156695543|NCT02149108|565633010|FG001|Overall Study|Not treated|2|||
156695544|NCT02149108|565633009|FG000|Overall Study|Progressive Disease (PD)|324|||
156695545|NCT02149108|565633010|FG001|Overall Study|Progressive Disease (PD)|318|||
156695546|NCT02149108|565633009|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
156695547|NCT02149108|565633010|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
156695548|NCT02149108|565633009|FG000|Overall Study|Other Adverse Event (AE)|8|||
156695549|NCT02149108|565633010|FG001|Overall Study|Other Adverse Event (AE)|18|||
156695550|NCT02149108|565633009|FG000|Overall Study|Other not defined above|0|||
156695551|NCT02149108|565633010|FG001|Overall Study|Other not defined above|2|||
156695552|NCT02149108|565633009|FG000|Overall Study|Refusal to continue trial medication|15|||
156695553|NCT02149108|565633010|FG001|Overall Study|Refusal to continue trial medication|11|||
156695554|NCT02149108|565633009|FG000|Overall Study|Lost to Follow-up|1|||
156695555|NCT02149108|565633010|FG001|Overall Study|Lost to Follow-up|0|||
156695556|NCT00950963|565633011|FG000|Overall Study|Lost to Follow-up|29|||
156695557|NCT00950963|565633012|FG001|Overall Study|Lost to Follow-up|24|||
156695558|NCT04168190|565633013|FG000|Overall Study|Lost to Follow-up|0|||
156695559|NCT04168190|565633014|FG001|Overall Study|Lost to Follow-up|1|||
156695560|NCT04168190|565633015|FG002|Overall Study|Lost to Follow-up|0|||
156695561|NCT04168190|565633016|FG003|Overall Study|Lost to Follow-up|7|||
156695562|NCT04168190|565633017|FG004|Overall Study|Lost to Follow-up|5|||
156695563|NCT04168190|565633013|FG000|Overall Study|Withdrawal by Subject|1|||
156695564|NCT04168190|565633014|FG001|Overall Study|Withdrawal by Subject|0|||
156695565|NCT04168190|565633015|FG002|Overall Study|Withdrawal by Subject|0|||
156695566|NCT04168190|565633016|FG003|Overall Study|Withdrawal by Subject|2|||
156695567|NCT04168190|565633017|FG004|Overall Study|Withdrawal by Subject|4|||
156695568|NCT04168190|565633013|FG000|Overall Study|Death|0|||
156695569|NCT04168190|565633014|FG001|Overall Study|Death|0|||
156695570|NCT04168190|565633015|FG002|Overall Study|Death|0|||
156789954|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789955|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
156789956|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
156789957|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
157214694|NCT02266706|567533466|FG006|Overall Study|Screen failure|1|||
157214695|NCT02266706|567533467|FG007|Overall Study|Screen failure|0|||
157214696|NCT02266706|567533468|FG008|Overall Study|Screen failure|0|||
157214697|NCT02266706|567533460|FG000|Overall Study|Enrollment in another study|0|||
157214698|NCT02266706|567533461|FG001|Overall Study|Enrollment in another study|0|||
157214699|NCT02266706|567533462|FG002|Overall Study|Enrollment in another study|0|||
157214700|NCT02266706|567533463|FG003|Overall Study|Enrollment in another study|1|||
157214701|NCT02266706|567533464|FG004|Overall Study|Enrollment in another study|0|||
156695571|NCT04168190|565633016|FG003|Overall Study|Death|1|||
156695572|NCT04168190|565633017|FG004|Overall Study|Death|0|||
156695573|NCT02325518|565633018|FG000|Overall Study|Adverse Event|4|||
156695574|NCT02325518|565633019|FG001|Overall Study|Adverse Event|1|||
156695575|NCT02325518|565633018|FG000|Overall Study|Physician Decision|0|||
156695576|NCT02325518|565633019|FG001|Overall Study|Physician Decision|1|||
156695577|NCT02325518|565633018|FG000|Overall Study|Withdrawal by Subject|0|||
156695578|NCT02325518|565633019|FG001|Overall Study|Withdrawal by Subject|1|||
156870979|NCT03853109|566284344|FG002|Overall Study|Decision by Sponsor|1|||
156870980|NCT03853109|566284345|FG003|Overall Study|Decision by Sponsor|0|||
156870981|NCT03853109|566284346|FG004|Overall Study|Decision by Sponsor|1|||
156870982|NCT03853109|566284347|FG005|Overall Study|Decision by Sponsor|1|||
156870983|NCT03853109|566284348|FG006|Overall Study|Decision by Sponsor|10|||
156870984|NCT03853109|566284349|FG007|Overall Study|Decision by Sponsor|2|||
156870985|NCT03853109|566284342|FG000|Overall Study|Lost to Follow-up|0|||
156870986|NCT03853109|566284343|FG001|Overall Study|Lost to Follow-up|0|||
156870987|NCT03853109|566284344|FG002|Overall Study|Lost to Follow-up|0|||
156870988|NCT03853109|566284345|FG003|Overall Study|Lost to Follow-up|0|||
156870989|NCT03853109|566284346|FG004|Overall Study|Lost to Follow-up|1|||
156870990|NCT03853109|566284347|FG005|Overall Study|Lost to Follow-up|3|||
156870991|NCT03853109|566284348|FG006|Overall Study|Lost to Follow-up|0|||
156870992|NCT03853109|566284349|FG007|Overall Study|Lost to Follow-up|0|||
156870993|NCT03853109|566284342|FG000|Overall Study|Death|2|||
156870994|NCT03853109|566284343|FG001|Overall Study|Death|5|||
156870995|NCT03853109|566284344|FG002|Overall Study|Death|8|||
156870996|NCT03853109|566284345|FG003|Overall Study|Death|10|||
156870997|NCT03853109|566284346|FG004|Overall Study|Death|3|||
156870998|NCT03853109|566284347|FG005|Overall Study|Death|20|||
156870999|NCT03853109|566284348|FG006|Overall Study|Death|10|||
156871000|NCT03853109|566284349|FG007|Overall Study|Death|5|||
156871001|NCT04032093|566284350|FG000|Overall Study|Lost to Follow-up|7|||
156871002|NCT04032093|566284351|FG001|Overall Study|Lost to Follow-up|7|||
156871003|NCT04032093|566284352|FG002|Overall Study|Lost to Follow-up|6|||
156871004|NCT04032093|566284353|FG003|Overall Study|Lost to Follow-up|10|||
156871005|NCT04032093|566284354|FG004|Overall Study|Lost to Follow-up|13|||
156871006|NCT04032093|566284355|FG005|Overall Study|Lost to Follow-up|7|||
156871007|NCT04032093|566284356|FG006|Overall Study|Lost to Follow-up|7|||
156871008|NCT04032093|566284357|FG007|Overall Study|Lost to Follow-up|5|||
156871009|NCT04032093|566284358|FG008|Overall Study|Lost to Follow-up|9|||
156871010|NCT04032093|566284359|FG009|Overall Study|Lost to Follow-up|12|||
156871011|NCT04032093|566284350|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871012|NCT04032093|566284351|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871013|NCT04032093|566284352|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871014|NCT04032093|566284353|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
156871015|NCT04032093|566284354|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871016|NCT04032093|566284355|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871017|NCT04032093|566284356|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871018|NCT04032093|566284357|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156871019|NCT04032093|566284358|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871020|NCT04032093|566284359|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
156871021|NCT04032093|566284350|FG000|Overall Study|Other|1|||
156871022|NCT04032093|566284351|FG001|Overall Study|Other|0|||
156695579|NCT01675661|565633020|FG000|Overall Study|Lost to Follow-up|22|||
156695580|NCT01675661|565633021|FG001|Overall Study|Lost to Follow-up|23|||
156695581|NCT01675661|565633020|FG000|Overall Study|Practical problems|9|||
156695582|NCT01675661|565633021|FG001|Overall Study|Practical problems|5|||
156871023|NCT04032093|566284352|FG002|Overall Study|Other|0|||
156871024|NCT04032093|566284353|FG003|Overall Study|Other|1|||
156871025|NCT04032093|566284354|FG004|Overall Study|Other|1|||
156871026|NCT04032093|566284355|FG005|Overall Study|Other|0|||
156871027|NCT04032093|566284356|FG006|Overall Study|Other|0|||
156871028|NCT04032093|566284357|FG007|Overall Study|Other|0|||
156871029|NCT04032093|566284358|FG008|Overall Study|Other|0|||
156871030|NCT04032093|566284359|FG009|Overall Study|Other|1|||
157014441|NCT03398148|566805005|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014442|NCT03398148|566805006|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157214702|NCT02266706|567533465|FG005|Overall Study|Enrollment in another study|0|||
156695583|NCT01675661|565633020|FG000|Overall Study|Moved away|5|||
156871031|NCT04032093|566284350|FG000|Overall Study|Withdrawal by Subject|1|||
156871032|NCT04032093|566284351|FG001|Overall Study|Withdrawal by Subject|3|||
156871033|NCT04032093|566284352|FG002|Overall Study|Withdrawal by Subject|2|||
156871034|NCT04032093|566284353|FG003|Overall Study|Withdrawal by Subject|2|||
156871035|NCT04032093|566284354|FG004|Overall Study|Withdrawal by Subject|3|||
156871036|NCT04032093|566284355|FG005|Overall Study|Withdrawal by Subject|0|||
157214703|NCT02266706|567533466|FG006|Overall Study|Enrollment in another study|0|||
156695584|NCT01675661|565633021|FG001|Overall Study|Moved away|6|||
156871037|NCT04032093|566284356|FG006|Overall Study|Withdrawal by Subject|0|||
156871038|NCT04032093|566284357|FG007|Overall Study|Withdrawal by Subject|0|||
156871039|NCT04032093|566284358|FG008|Overall Study|Withdrawal by Subject|0|||
156871040|NCT04032093|566284359|FG009|Overall Study|Withdrawal by Subject|0|||
156871041|NCT04032093|566284350|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156871042|NCT04032093|566284351|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156871043|NCT04032093|566284352|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156871044|NCT04032093|566284353|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156871045|NCT04032093|566284354|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156871046|NCT04032093|566284355|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156695585|NCT01675661|565633020|FG000|Overall Study|Withdrawal by Subject|3|||
156695586|NCT01675661|565633021|FG001|Overall Study|Withdrawal by Subject|7|||
156695587|NCT01675661|565633020|FG000|Overall Study|Physician Decision|0|||
156695588|NCT01675661|565633021|FG001|Overall Study|Physician Decision|2|||
156695589|NCT01675661|565633020|FG000|Overall Study|Death|0|||
156695590|NCT01675661|565633021|FG001|Overall Study|Death|1|||
156695591|NCT01675661|565633020|FG000|Overall Study|Other reason|1|||
156695592|NCT01675661|565633021|FG001|Overall Study|Other reason|2|||
156695593|NCT04765384|565633022|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
156695594|NCT04765384|565633023|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
156695595|NCT04765384|565633024|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
156695596|NCT04765384|565633025|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
156695597|NCT04765384|565633026|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
156695598|NCT04765384|565633027|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
156695599|NCT04765384|565633022|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
156695600|NCT04765384|565633023|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
156695601|NCT04765384|565633024|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
156695602|NCT04765384|565633025|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
156695603|NCT04765384|565633026|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
156695604|NCT04765384|565633027|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
156695605|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695606|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695607|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695608|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695609|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
156695610|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
156695611|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Death|0|||
156695612|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Death|0|||
156695613|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Death|0|||
156695614|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Death|1|||
156695615|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Death|0|||
156695616|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Death|0|||
156695617|NCT04765384|565633022|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695618|NCT04765384|565633023|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695619|NCT04765384|565633024|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695620|NCT04765384|565633025|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695621|NCT04765384|565633026|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
156695622|NCT04765384|565633027|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
156695623|NCT00987389|565633028|FG000|Overall Study|Ineligible|0|||
156695624|NCT00987389|565633029|FG001|Overall Study|Ineligible|3|||
156695625|NCT00987389|565633030|FG002|Overall Study|Ineligible|0|||
156695626|NCT00987389|565633031|FG003|Overall Study|Ineligible|0|||
156695627|NCT00987389|565633028|FG000|Overall Study|Lost to Follow-up|4|||
156695628|NCT00987389|565633029|FG001|Overall Study|Lost to Follow-up|1|||
156695629|NCT00987389|565633030|FG002|Overall Study|Lost to Follow-up|3|||
156695630|NCT00987389|565633031|FG003|Overall Study|Lost to Follow-up|1|||
156695631|NCT00987389|565633028|FG000|Overall Study|Withdrawal by Subject|4|||
156695632|NCT00987389|565633029|FG001|Overall Study|Withdrawal by Subject|3|||
156695633|NCT00987389|565633030|FG002|Overall Study|Withdrawal by Subject|2|||
156695634|NCT00987389|565633031|FG003|Overall Study|Withdrawal by Subject|1|||
156695635|NCT00987389|565633028|FG000|Overall Study|Withdrawn from Treatment|0|||
156695636|NCT00987389|565633029|FG001|Overall Study|Withdrawn from Treatment|1|||
156695637|NCT00987389|565633030|FG002|Overall Study|Withdrawn from Treatment|0|||
156695638|NCT00987389|565633031|FG003|Overall Study|Withdrawn from Treatment|0|||
156695639|NCT00987389|565633028|FG000|Overall Study|Multiple different reasons|1|||
156695640|NCT00987389|565633029|FG001|Overall Study|Multiple different reasons|0|||
156695641|NCT00987389|565633030|FG002|Overall Study|Multiple different reasons|3|||
156695642|NCT00987389|565633031|FG003|Overall Study|Multiple different reasons|1|||
156695643|NCT02992418|565633034|FG000|Overall Study|Withdrawal by Subject|11|||
156695644|NCT02992418|565633035|FG001|Overall Study|Withdrawal by Subject|12|||
156695645|NCT02992418|565633034|FG000|Overall Study|Non-compliance with the protocol|308|||
156695646|NCT02992418|565633035|FG001|Overall Study|Non-compliance with the protocol|308|||
156695647|NCT02992418|565633034|FG000|Overall Study|Lost to Follow-up|27|||
156695648|NCT02992418|565633035|FG001|Overall Study|Lost to Follow-up|22|||
156695649|NCT00289536|565633036|FG000|Period 3|Lost to Follow-up|0|||
156695650|NCT00289536|565633037|FG001|Period 3|Lost to Follow-up|0|||
156695651|NCT00289536|565633038|FG002|Period 3|Lost to Follow-up|1|||
156695652|NCT03246126|565633043|FG000|Overall Study|Withdrawal by Subject|0|||
156695653|NCT03246126|565633044|FG001|Overall Study|Withdrawal by Subject|1|||
156695654|NCT00629265|565633047|FG000|Overall Study|Lost to Follow-up|4|||
156695655|NCT00629265|565633048|FG001|Overall Study|Lost to Follow-up|5|||
156695656|NCT00629265|565633047|FG000|Overall Study|Withdrawal by Subject|11|||
156695657|NCT00629265|565633048|FG001|Overall Study|Withdrawal by Subject|8|||
156695658|NCT00629265|565633047|FG000|Overall Study|Death|1|||
156695659|NCT00629265|565633048|FG001|Overall Study|Death|0|||
156695660|NCT00629265|565633047|FG000|Overall Study|Adverse Event|2|||
156695661|NCT00629265|565633048|FG001|Overall Study|Adverse Event|0|||
156695662|NCT00629265|565633047|FG000|Overall Study|HNC Recurrence|4|||
156695663|NCT00629265|565633048|FG001|Overall Study|HNC Recurrence|0|||
156695664|NCT00629265|565633047|FG000|Overall Study|Other CA Requiring Treatment|1|||
156695665|NCT00629265|565633048|FG001|Overall Study|Other CA Requiring Treatment|3|||
156695666|NCT00629265|565633047|FG000|Overall Study|Needed Esophageal Dilation|4|||
156695667|NCT00629265|565633048|FG001|Overall Study|Needed Esophageal Dilation|1|||
156695668|NCT00629265|565633047|FG000|Overall Study|Unrelated Medical Complications|3|||
156695669|NCT00629265|565633048|FG001|Overall Study|Unrelated Medical Complications|1|||
156695670|NCT00629265|565633047|FG000|Overall Study|Unknown Reason|2|||
156695671|NCT00629265|565633048|FG001|Overall Study|Unknown Reason|2|||
156695672|NCT04465630|565633049|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
156695673|NCT04465630|565633049|FG000|Overall Study|Screen failure|8|||
156695674|NCT04465630|565633049|FG000|Overall Study|Baseline failure|16|||
156695675|NCT01006135|565633050|FG000|Overall Study|Adverse Event|22|||
156695676|NCT01006135|565633050|FG000|Overall Study|Protocol Violation|14|||
156695677|NCT01006135|565633050|FG000|Overall Study|Lost to Follow-up|32|||
156695678|NCT01006135|565633050|FG000|Overall Study|Other|72|||
156695679|NCT01732484|565633054|FG000|Overall Study|Death|7|||
156695680|NCT01732484|565633054|FG000|Overall Study|Lost to Follow-up|14|||
156695681|NCT01732484|565633054|FG000|Overall Study|chronical illness|5|||
156695682|NCT05297578|565633055|FG000|Overall Study|Lost to Follow-up|1|||
156695683|NCT05297578|565633056|FG001|Overall Study|Lost to Follow-up|1|||
156695684|NCT05297578|565633057|FG002|Overall Study|Lost to Follow-up|2|||
156695685|NCT05297578|565633058|FG003|Overall Study|Lost to Follow-up|1|||
156871047|NCT04032093|566284356|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
156871048|NCT04032093|566284357|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
156871049|NCT04032093|566284358|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
156871050|NCT04032093|566284359|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
156871051|NCT04032093|566284350|FG000|Overall Study|Adverse Event|0|||
156871052|NCT04032093|566284351|FG001|Overall Study|Adverse Event|0|||
156871053|NCT04032093|566284352|FG002|Overall Study|Adverse Event|0|||
156871054|NCT04032093|566284353|FG003|Overall Study|Adverse Event|0|||
156871055|NCT04032093|566284354|FG004|Overall Study|Adverse Event|0|||
156871056|NCT04032093|566284355|FG005|Overall Study|Adverse Event|0|||
156871057|NCT04032093|566284356|FG006|Overall Study|Adverse Event|0|||
156871058|NCT04032093|566284357|FG007|Overall Study|Adverse Event|0|||
156871059|NCT04032093|566284358|FG008|Overall Study|Adverse Event|0|||
156871060|NCT04032093|566284359|FG009|Overall Study|Adverse Event|1|||
156871061|NCT04032093|566284350|FG000|Overall Study|Physician Decision|0|||
156871062|NCT04032093|566284351|FG001|Overall Study|Physician Decision|0|||
156871063|NCT04032093|566284352|FG002|Overall Study|Physician Decision|0|||
156871064|NCT04032093|566284353|FG003|Overall Study|Physician Decision|0|||
156871065|NCT04032093|566284354|FG004|Overall Study|Physician Decision|0|||
156871066|NCT04032093|566284355|FG005|Overall Study|Physician Decision|1|||
156871067|NCT04032093|566284356|FG006|Overall Study|Physician Decision|0|||
156871068|NCT04032093|566284357|FG007|Overall Study|Physician Decision|0|||
156871069|NCT04032093|566284358|FG008|Overall Study|Physician Decision|0|||
156871070|NCT04032093|566284359|FG009|Overall Study|Physician Decision|0|||
156871071|NCT02377817|566284360|FG000|Overall Study|Transportation/childcare barriers.|2|||
156871072|NCT02377817|566284361|FG001|Overall Study|Transportation/childcare barriers.|0|||
156695686|NCT05297578|565633055|FG000|Overall Study|Death|0|||
156695687|NCT05297578|565633056|FG001|Overall Study|Death|1|||
156695688|NCT05297578|565633057|FG002|Overall Study|Death|0|||
156871073|NCT02377817|566284360|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
156871074|NCT02377817|566284361|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
156871075|NCT01696188|566284379|FG000|Overall Study|Protocol Violation|1|||
156871076|NCT01696188|566284380|FG001|Overall Study|Protocol Violation|1|||
156871077|NCT01185080|566284381|FG000|Overall Study|Adverse Event|1|||
156871078|NCT01185080|566284382|FG001|Overall Study|Adverse Event|1|||
157122739|NCT04381650|567200393|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122740|NCT04381650|567200394|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122741|NCT04381650|567200395|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156695689|NCT05297578|565633058|FG003|Overall Study|Death|0|||
157122742|NCT04381650|567200396|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
157122743|NCT04381650|567200397|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156695690|NCT05297578|565633055|FG000|Overall Study|Withdrawal by Subject|0|||
156695691|NCT05297578|565633056|FG001|Overall Study|Withdrawal by Subject|0|||
156695692|NCT05297578|565633057|FG002|Overall Study|Withdrawal by Subject|1|||
156695693|NCT05297578|565633058|FG003|Overall Study|Withdrawal by Subject|0|||
156871079|NCT01185080|566284383|FG002|Overall Study|Adverse Event|0|||
156871080|NCT01185080|566284381|FG000|Overall Study|Personal reasons|0|||
156871081|NCT01185080|566284382|FG001|Overall Study|Personal reasons|0|||
156871082|NCT01185080|566284383|FG002|Overall Study|Personal reasons|1|||
156871083|NCT02876601|566284384|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
157122744|NCT04381650|567200398|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
156695694|NCT01087489|565633059|FG000|Overall Study|enrolled in another VA study|0|||
156695695|NCT01087489|565633060|FG001|Overall Study|enrolled in another VA study|1|||
156695696|NCT01087489|565633059|FG000|Overall Study|Death|0|||
156695697|NCT01087489|565633060|FG001|Overall Study|Death|1|||
156695698|NCT01087489|565633059|FG000|Overall Study|unable to survey by telephone|0|||
156695699|NCT01087489|565633060|FG001|Overall Study|unable to survey by telephone|1|||
156695700|NCT02032706|565633068|FG000|Overall Study|Did not qualify|5|||
156695701|NCT02032706|565633068|FG000|Overall Study|Protocol Violation|1|||
156695702|NCT00893737|565633069|FG000|Overall Study|Adverse Event|4|||
156695703|NCT00893737|565633069|FG000|Overall Study|Withdrawal by Subject|2|||
156695704|NCT00893737|565633069|FG000|Overall Study|Lost to Follow-up|6|||
156695705|NCT00928707|565633070|FG000|Overall Study|Protocol Violation|1|||
156695706|NCT00928707|565633071|FG001|Overall Study|Protocol Violation|0|||
156695707|NCT00132028|565633072|FG000|Overall Study|Adverse Event|7|||
156695708|NCT00132028|565633072|FG000|Overall Study|Death|2|||
156695709|NCT00132028|565633072|FG000|Overall Study|Lack of Efficacy|11|||
156695710|NCT00132028|565633072|FG000|Overall Study|Withdrawal by Subject|2|||
156695711|NCT00132028|565633072|FG000|Overall Study|not eligible|2|||
156695712|NCT00132028|565633072|FG000|Overall Study|Physician Decision|3|||
156695713|NCT02140411|565633073|FG000|Overall Study|Adverse Event|1|||
156695714|NCT03981419|565633076|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
156695715|NCT03981419|565633077|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
156695716|NCT01330459|565633082|FG000|Overall Study|Physician Decision|0|||
156695717|NCT01330459|565633083|FG001|Overall Study|Physician Decision|2|||
156695718|NCT01437943|565633085|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
156695719|NCT01437943|565633086|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
156695720|NCT01437943|565633085|FG000|Overall Study|Subject expressed pregnancy plans|1|||
156695721|NCT01437943|565633086|FG001|Overall Study|Subject expressed pregnancy plans|0|||
156695722|NCT01437943|565633085|FG000|Overall Study|Adverse Event|2|||
156695723|NCT01437943|565633086|FG001|Overall Study|Adverse Event|0|||
156695724|NCT02005887|565633088|FG000|Overall Study|Protocol Violation|0|||
156695725|NCT02005887|565633089|FG001|Overall Study|Protocol Violation|2|||
156695726|NCT01615263|565633098|FG000|Overall Study|Post-randomization exclusion|0|||
156695727|NCT01615263|565633099|FG001|Overall Study|Post-randomization exclusion|2|||
156695728|NCT00160641|565633100|FG000|Overall Study|Adverse Event|102|||
156695729|NCT00160641|565633100|FG000|Overall Study|Withdrawal by Subject|87|||
156695730|NCT00160641|565633100|FG000|Overall Study|Lost to Follow-up|8|||
156695731|NCT00160641|565633100|FG000|Overall Study|Lack of Efficacy|12|||
156695732|NCT00160641|565633100|FG000|Overall Study|Protocol Violation|3|||
156695733|NCT00160641|565633100|FG000|Overall Study|Other|9|||
156695734|NCT03097588|565633102|FG000|Overall Study|Adverse Event|1|||
156695735|NCT01144364|565633103|FG000|Induction Phase|Disease progression|14|||
156695736|NCT01144364|565633104|FG001|Induction Phase|Disease progression|0|||
156871084|NCT02876601|566284385|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
157122745|NCT04381650|567200388|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
157122746|NCT04381650|567200389|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
157122747|NCT04381650|567200390|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
157122748|NCT04381650|567200391|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
157122749|NCT04381650|567200392|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122750|NCT04381650|567200393|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122751|NCT04381650|567200394|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122752|NCT04381650|567200395|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122753|NCT04381650|567200396|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122754|NCT04381650|567200397|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122755|NCT04381650|567200398|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
157122756|NCT04381650|567200388|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122757|NCT04381650|567200389|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122758|NCT04381650|567200390|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
157122759|NCT04381650|567200391|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
157122760|NCT04381650|567200392|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122761|NCT04381650|567200393|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122762|NCT04381650|567200394|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122763|NCT04381650|567200395|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122764|NCT04381650|567200396|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122765|NCT04381650|567200397|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122766|NCT04381650|567200398|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
157122767|NCT04381650|567200388|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122768|NCT04381650|567200389|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
157122769|NCT04381650|567200390|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
157122770|NCT04381650|567200391|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
156695737|NCT01144364|565633105|FG002|Induction Phase|Disease progression|0|||
156695738|NCT01144364|565633103|FG000|Induction Phase|Adverse Event|9|||
156695739|NCT01144364|565633104|FG001|Induction Phase|Adverse Event|0|||
156695740|NCT01144364|565633105|FG002|Induction Phase|Adverse Event|0|||
156695741|NCT01144364|565633103|FG000|Induction Phase|Death|1|||
156695742|NCT01144364|565633104|FG001|Induction Phase|Death|0|||
156695743|NCT01144364|565633105|FG002|Induction Phase|Death|0|||
156695744|NCT01144364|565633103|FG000|Induction Phase|Withdrawal by Subject|1|||
156695745|NCT01144364|565633104|FG001|Induction Phase|Withdrawal by Subject|0|||
156695746|NCT01144364|565633105|FG002|Induction Phase|Withdrawal by Subject|0|||
156695747|NCT01144364|565633103|FG000|Induction Phase|Lost to Follow-up|2|||
156695748|NCT01144364|565633104|FG001|Induction Phase|Lost to Follow-up|0|||
156695749|NCT01144364|565633105|FG002|Induction Phase|Lost to Follow-up|0|||
156695750|NCT01144364|565633103|FG000|Induction Phase|Physician Decision|1|||
156695751|NCT01144364|565633104|FG001|Induction Phase|Physician Decision|0|||
156695752|NCT01144364|565633105|FG002|Induction Phase|Physician Decision|0|||
156695753|NCT01144364|565633103|FG000|Induction Phase|Stable disease|2|||
156695754|NCT01144364|565633104|FG001|Induction Phase|Stable disease|0|||
156695755|NCT01144364|565633105|FG002|Induction Phase|Stable disease|0|||
156695756|NCT01144364|565633103|FG000|Induction Phase|Secondary neoplasia|1|||
156695757|NCT01144364|565633104|FG001|Induction Phase|Secondary neoplasia|0|||
156695758|NCT01144364|565633105|FG002|Induction Phase|Secondary neoplasia|0|||
156695759|NCT01144364|565633103|FG000|Induction Phase|Protocol Violation|1|||
156695760|NCT01144364|565633104|FG001|Induction Phase|Protocol Violation|0|||
156695761|NCT01144364|565633105|FG002|Induction Phase|Protocol Violation|0|||
156695762|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
156695763|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
156695764|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
156695765|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
156695766|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
156695767|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
156695768|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Death|0|||
156695769|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Death|2|||
156695770|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Death|0|||
156695771|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
156695772|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
156695773|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
156695774|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
156695775|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
156695776|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
156695777|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
156695778|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
156695779|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
156695780|NCT01144364|565633103|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
156695781|NCT01144364|565633104|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
156695782|NCT01144364|565633105|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
156695783|NCT00673933|565633106|FG000|Overall Study|Withdrawal by Subject|2|||
156695784|NCT00673933|565633106|FG000|Overall Study|Lost to Follow-up|1|||
157122771|NCT04381650|567200392|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122772|NCT04381650|567200393|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122773|NCT04381650|567200394|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122774|NCT04381650|567200395|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122775|NCT04381650|567200396|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122776|NCT04381650|567200397|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122777|NCT04381650|567200398|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
157122778|NCT04381650|567200388|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122779|NCT04381650|567200389|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122780|NCT04381650|567200390|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122781|NCT04381650|567200391|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122782|NCT04381650|567200392|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
157122783|NCT04381650|567200393|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
157122784|NCT04381650|567200394|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122785|NCT04381650|567200395|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156695785|NCT04932941|565633107|FG000|Overall Study|Lost to Follow-up|3|||
156695786|NCT04932941|565633108|FG001|Overall Study|Lost to Follow-up|1|||
156695787|NCT04932941|565633107|FG000|Overall Study|Withdrawal by Subject|7|||
156695788|NCT04932941|565633108|FG001|Overall Study|Withdrawal by Subject|4|||
156695789|NCT04932941|565633107|FG000|Overall Study|Other|4|||
157122786|NCT04381650|567200396|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
157122787|NCT04381650|567200397|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
157122788|NCT04381650|567200398|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
156695790|NCT04932941|565633108|FG001|Overall Study|Other|2|||
156695791|NCT02206620|565633109|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156695792|NCT02206620|565633110|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156695793|NCT02206620|565633109|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
156695794|NCT02206620|565633110|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
156695795|NCT00375492|565633112|FG000|Overall Study|Adverse Event|4|||
156695796|NCT00375492|565633113|FG001|Overall Study|Adverse Event|5|||
156695797|NCT00375492|565633112|FG000|Overall Study|Entry Criteria Not Met|0|||
156695798|NCT00375492|565633113|FG001|Overall Study|Entry Criteria Not Met|1|||
156695799|NCT00375492|565633112|FG000|Overall Study|Loss of Glucose Control|0|||
156695800|NCT00375492|565633113|FG001|Overall Study|Loss of Glucose Control|1|||
156695801|NCT00375492|565633112|FG000|Overall Study|Lost to Follow-up|10|||
156695802|NCT00375492|565633113|FG001|Overall Study|Lost to Follow-up|5|||
156695803|NCT00375492|565633112|FG000|Overall Study|Physician Decision|0|||
156695804|NCT00375492|565633113|FG001|Overall Study|Physician Decision|4|||
156695805|NCT00375492|565633112|FG000|Overall Study|Protocol Violation|6|||
156695806|NCT00375492|565633113|FG001|Overall Study|Protocol Violation|3|||
156695807|NCT00375492|565633112|FG000|Overall Study|Sponsor Decision|0|||
156695808|NCT00375492|565633113|FG001|Overall Study|Sponsor Decision|1|||
156695809|NCT00375492|565633112|FG000|Overall Study|Withdrawal by Subject|6|||
156695810|NCT00375492|565633113|FG001|Overall Study|Withdrawal by Subject|6|||
156695811|NCT00912093|565634263|FG000|The Controlled Phase|Death|0|||
156695812|NCT00912093|565634264|FG001|The Controlled Phase|Death|1|||
156695813|NCT00912093|565634265|FG002|The Controlled Phase|Death|0|||
156695814|NCT00912093|565634266|FG003|The Controlled Phase|Death|0|||
156695815|NCT00912093|565634267|FG004|The Controlled Phase|Death|0|||
156695816|NCT00912093|565634263|FG000|The Controlled Phase|Medical Condition|0|||
156695817|NCT00912093|565634264|FG001|The Controlled Phase|Medical Condition|1|||
156695818|NCT00912093|565634265|FG002|The Controlled Phase|Medical Condition|0|||
156695819|NCT00912093|565634266|FG003|The Controlled Phase|Medical Condition|0|||
156695820|NCT00912093|565634267|FG004|The Controlled Phase|Medical Condition|0|||
156695821|NCT00912093|565634263|FG000|The Controlled Phase|Lost to Follow-up|0|||
156695822|NCT00912093|565634264|FG001|The Controlled Phase|Lost to Follow-up|0|||
156695823|NCT00912093|565634265|FG002|The Controlled Phase|Lost to Follow-up|0|||
156695824|NCT00912093|565634266|FG003|The Controlled Phase|Lost to Follow-up|0|||
156695825|NCT00912093|565634267|FG004|The Controlled Phase|Lost to Follow-up|1|||
156695826|NCT00103311|565634268|FG000|Overall Study|Lost to Follow-up|1|||
156695827|NCT00103311|565634269|FG001|Overall Study|Lost to Follow-up|0|||
156695828|NCT00103311|565634268|FG000|Overall Study|Withdrawal by Subject|2|||
156695829|NCT00103311|565634269|FG001|Overall Study|Withdrawal by Subject|1|||
156695830|NCT00103311|565634268|FG000|Overall Study|Adverse Event|1|||
156695831|NCT00103311|565634269|FG001|Overall Study|Adverse Event|0|||
156695832|NCT02621034|565634270|FG000|Overall Study|Lost to Follow-up|3|||
156695833|NCT02621034|565634271|FG001|Overall Study|Lost to Follow-up|2|||
156695834|NCT02621034|565634272|FG002|Overall Study|Lost to Follow-up|5|||
156695835|NCT02372071|565634273|FG000|Overall Study|Protocol Violation|18|||
156695836|NCT01968694|565634274|FG000|Washout (1 Month)|Lost to Follow-up|0|||
156695837|NCT01968694|565634275|FG001|Washout (1 Month)|Lost to Follow-up|1|||
156695838|NCT02836496|565634276|FG000|Overall Study|Adverse Event|2|||
157122789|NCT04381650|567200388|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156695839|NCT02836496|565634277|FG001|Overall Study|Adverse Event|1|||
156695840|NCT02836496|565634276|FG000|Overall Study|Withdrawal by Subject|0|||
156695841|NCT02836496|565634277|FG001|Overall Study|Withdrawal by Subject|1|||
156695842|NCT01400919|565634278|FG000|Overall Study|Withdrawal by Subject|4|||
156695843|NCT01400919|565634278|FG000|Overall Study|Lost to Follow-up|2|||
156695844|NCT01400919|565634278|FG000|Overall Study|Missed visit|2|||
156695845|NCT01246011|565634279|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
156695846|NCT01246011|565634280|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
156695847|NCT01246011|565634281|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
156695848|NCT01246011|565634279|FG000|Overall Study|Withdrawal by Subject|0|||
156695849|NCT01246011|565634280|FG001|Overall Study|Withdrawal by Subject|0|||
156695850|NCT01246011|565634281|FG002|Overall Study|Withdrawal by Subject|1|||
156695851|NCT00415194|565634291|FG000|Overall Study|Adverse Event|37|||
156695852|NCT00415194|565634292|FG001|Overall Study|Adverse Event|32|||
156695853|NCT00415194|565634291|FG000|Overall Study|Entry Criteria Not Met|4|||
156695854|NCT00415194|565634292|FG001|Overall Study|Entry Criteria Not Met|8|||
156789958|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
156789959|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789960|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789961|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789962|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789963|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
156789964|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789965|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156695855|NCT00415194|565634291|FG000|Overall Study|Lost to Follow-up|1|||
156695856|NCT00415194|565634292|FG001|Overall Study|Lost to Follow-up|0|||
156695857|NCT00415194|565634291|FG000|Overall Study|Physician Decision|10|||
156695858|NCT00415194|565634292|FG001|Overall Study|Physician Decision|16|||
156695859|NCT00415194|565634291|FG000|Overall Study|Progressive Disease|180|||
156695860|NCT00415194|565634292|FG001|Overall Study|Progressive Disease|217|||
156695861|NCT00415194|565634291|FG000|Overall Study|Protocol Violation|4|||
156695862|NCT00415194|565634292|FG001|Overall Study|Protocol Violation|2|||
156695863|NCT00415194|565634291|FG000|Overall Study|Withdrawal by Subject|28|||
156695864|NCT00415194|565634292|FG001|Overall Study|Withdrawal by Subject|21|||
156695865|NCT00415194|565634291|FG000|Overall Study|Death Due to Study Disease|26|||
156695866|NCT00415194|565634292|FG001|Overall Study|Death Due to Study Disease|29|||
156695867|NCT00415194|565634291|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
156695868|NCT00415194|565634292|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
156695869|NCT00415194|565634291|FG000|Overall Study|Death Due to Procedural Related AE|0|||
156695870|NCT00415194|565634292|FG001|Overall Study|Death Due to Procedural Related AE|1|||
156695871|NCT00415194|565634291|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
156695872|NCT00415194|565634292|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
156695873|NCT01297465|565634293|FG000|Overall Study|Lack of Ovarian Response|1|||
156695874|NCT01297465|565634294|FG001|Overall Study|Lack of Ovarian Response|1|||
156695875|NCT01297465|565634293|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156695876|NCT01297465|565634294|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156695877|NCT01297465|565634293|FG000|Overall Study|No Oocytes Retrieved|1|||
156695878|NCT01297465|565634294|FG001|Overall Study|No Oocytes Retrieved|1|||
156695879|NCT01297465|565634293|FG000|Overall Study|Poor oocyte quality|0|||
156695880|NCT01297465|565634294|FG001|Overall Study|Poor oocyte quality|1|||
156695881|NCT01297465|565634293|FG000|Overall Study|No Fertilization|6|||
156695882|NCT01297465|565634294|FG001|Overall Study|No Fertilization|4|||
156695883|NCT01297465|565634293|FG000|Overall Study|All Embryos Discarded|0|||
156695884|NCT01297465|565634294|FG001|Overall Study|All Embryos Discarded|1|||
156695885|NCT01297465|565634293|FG000|Overall Study|Intention to Freeze all Embryos|0|||
156695886|NCT01297465|565634294|FG001|Overall Study|Intention to Freeze all Embryos|1|||
156695887|NCT00969540|565634295|FG000|Overall Study|Lost to Follow-up|1|||
157014443|NCT03398148|566805007|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156871085|NCT02876601|566284386|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
156871086|NCT02876601|566284387|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
156871087|NCT06083506|566284389|FG000|Overall Study|Physician Decision|2|||
156871088|NCT06083506|566284389|FG000|Overall Study|Lack of Efficacy|1|||
156871089|NCT01648751|566284401|FG000|Overall Study|Withdrawal by Subject|2|||
157014444|NCT03398148|566805008|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014445|NCT03398148|566805009|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
156695888|NCT00969540|565634296|FG001|Overall Study|Lost to Follow-up|1|||
156695889|NCT01683838|565634297|FG000|Overall Study|Adverse Event|12|||
156695890|NCT01683838|565634298|FG001|Overall Study|Adverse Event|2|||
156789966|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789967|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
156789968|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789969|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789970|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
156789971|NCT01557244|565983655|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
156789972|NCT01557244|565983656|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
156789973|NCT01557244|565983657|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789974|NCT01557244|565983658|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789975|NCT01557244|565983659|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789976|NCT01557244|565983660|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789977|NCT01557244|565983661|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
156789978|NCT01313676|565983662|FG000|Overall Study|Adverse Event|395|||
156789979|NCT01313676|565983663|FG001|Overall Study|Adverse Event|365|||
156789980|NCT01313676|565983664|FG002|Overall Study|Adverse Event|372|||
156789981|NCT01313676|565983665|FG003|Overall Study|Adverse Event|333|||
156789982|NCT01313676|565983662|FG000|Overall Study|Lack of Efficacy|98|||
156789983|NCT01313676|565983663|FG001|Overall Study|Lack of Efficacy|90|||
156789984|NCT01313676|565983664|FG002|Overall Study|Lack of Efficacy|65|||
156789985|NCT01313676|565983665|FG003|Overall Study|Lack of Efficacy|46|||
156789986|NCT01313676|565983662|FG000|Overall Study|Protocol Violation|37|||
157014446|NCT03398148|566805010|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
157014447|NCT03398148|566804996|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
157014448|NCT03398148|566804997|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
157014449|NCT03398148|566804998|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
157014450|NCT03398148|566804999|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
157014451|NCT03398148|566805000|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
157014452|NCT03398148|566805001|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
157014453|NCT03398148|566805002|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
156695891|NCT01683838|565634297|FG000|Overall Study|Protocol Violation|3|||
156695892|NCT01683838|565634298|FG001|Overall Study|Protocol Violation|1|||
156789987|NCT01313676|565983663|FG001|Overall Study|Protocol Violation|44|||
156789988|NCT01313676|565983664|FG002|Overall Study|Protocol Violation|46|||
156871090|NCT01648751|566284402|FG001|Overall Study|Withdrawal by Subject|3|||
157014454|NCT03398148|566805003|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
157014455|NCT03398148|566805004|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
156695893|NCT01683838|565634297|FG000|Overall Study|Withdrawal by Subject|6|||
156695894|NCT01683838|565634298|FG001|Overall Study|Withdrawal by Subject|5|||
156695895|NCT01683838|565634297|FG000|Overall Study|Lost to Follow-up|1|||
156695896|NCT01683838|565634298|FG001|Overall Study|Lost to Follow-up|1|||
156695897|NCT01683838|565634297|FG000|Overall Study|Other|4|||
156695898|NCT01683838|565634298|FG001|Overall Study|Other|3|||
156695899|NCT01646138|565634299|FG000|Overall Study|Lost to Follow-up|0|||
156695900|NCT01646138|565634300|FG001|Overall Study|Lost to Follow-up|0|||
156695901|NCT01646138|565634301|FG002|Overall Study|Lost to Follow-up|0|||
156695902|NCT01646138|565634302|FG003|Overall Study|Lost to Follow-up|0|||
156695903|NCT01646138|565634303|FG004|Overall Study|Lost to Follow-up|2|||
156695904|NCT04049617|565634304|FG000|Overall Study|Adverse Event|0|||
156695905|NCT04049617|565634305|FG001|Overall Study|Adverse Event|0|||
156695906|NCT04049617|565634306|FG002|Overall Study|Adverse Event|0|||
156695907|NCT04049617|565634307|FG003|Overall Study|Adverse Event|1|||
156695908|NCT04049617|565634308|FG004|Overall Study|Adverse Event|0|||
156695909|NCT04049617|565634309|FG005|Overall Study|Adverse Event|0|||
156695910|NCT04049617|565634304|FG000|Overall Study|Death|0|||
156695911|NCT04049617|565634305|FG001|Overall Study|Death|0|||
156695912|NCT04049617|565634306|FG002|Overall Study|Death|0|||
156695913|NCT04049617|565634307|FG003|Overall Study|Death|0|||
156695914|NCT04049617|565634308|FG004|Overall Study|Death|0|||
156695915|NCT04049617|565634309|FG005|Overall Study|Death|1|||
157122790|NCT04381650|567200389|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156695916|NCT04049617|565634304|FG000|Overall Study|Lost to Follow-up|0|||
156695917|NCT04049617|565634305|FG001|Overall Study|Lost to Follow-up|0|||
156695918|NCT04049617|565634306|FG002|Overall Study|Lost to Follow-up|0|||
156695919|NCT04049617|565634307|FG003|Overall Study|Lost to Follow-up|1|||
156695920|NCT04049617|565634308|FG004|Overall Study|Lost to Follow-up|0|||
156695921|NCT04049617|565634309|FG005|Overall Study|Lost to Follow-up|0|||
156695922|NCT04049617|565634304|FG000|Overall Study|Withdrew consent|0|||
156695923|NCT04049617|565634305|FG001|Overall Study|Withdrew consent|0|||
156695924|NCT04049617|565634306|FG002|Overall Study|Withdrew consent|1|||
156695925|NCT04049617|565634307|FG003|Overall Study|Withdrew consent|0|||
156695926|NCT04049617|565634308|FG004|Overall Study|Withdrew consent|0|||
157122791|NCT04381650|567200390|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157122792|NCT04381650|567200391|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156871091|NCT03467750|566284404|FG000|Overall Study|Surgery canceled|1|||
156871092|NCT03467750|566284405|FG001|Overall Study|Surgery canceled|0|||
157122793|NCT04381650|567200392|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
156695927|NCT04049617|565634309|FG005|Overall Study|Withdrew consent|0|||
156695928|NCT00801099|565634310|FG000|Overall Study|Lost to Follow-up|101|||
156695929|NCT04078126|565634311|FG000|Washout|Study put on hold due to COVID-19|0|||
156695930|NCT04078126|565634312|FG001|Washout|Study put on hold due to COVID-19|2|||
156695931|NCT04078126|565634311|FG000|Period 2|Study put on hold due to COVID-19|1|||
156871093|NCT03467750|566284404|FG000|Overall Study|Protocol Violation|1|||
156871094|NCT03467750|566284405|FG001|Overall Study|Protocol Violation|1|||
156871095|NCT03467750|566284404|FG000|Overall Study|Withdrawal by Subject|0|||
157122794|NCT04381650|567200393|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157122795|NCT04381650|567200394|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157122796|NCT04381650|567200395|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
157122797|NCT04381650|567200396|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
156871096|NCT03467750|566284405|FG001|Overall Study|Withdrawal by Subject|1|||
157014456|NCT03398148|566805005|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
157014457|NCT03398148|566805006|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
157014458|NCT03398148|566805007|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
157014459|NCT03398148|566805008|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
157014460|NCT03398148|566805009|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
157014461|NCT03398148|566805010|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
157014462|NCT03398148|566804996|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014463|NCT03398148|566804997|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014464|NCT03398148|566804998|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014465|NCT03398148|566804999|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014466|NCT03398148|566805000|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014467|NCT03398148|566805001|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014468|NCT03398148|566805002|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
157014469|NCT03398148|566805003|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156695932|NCT04078126|565634312|FG001|Period 2|Study put on hold due to COVID-19|1|||
156695933|NCT01169532|565634313|FG000|Overall Study|Withdrawal by Subject|1|||
156695934|NCT01156142|565634317|FG000|Overall Study|Withdrawal by Subject|8|||
156695935|NCT01156142|565634318|FG001|Overall Study|Withdrawal by Subject|6|||
156695936|NCT01156142|565634317|FG000|Overall Study|Ineligible|0|||
156695937|NCT01156142|565634318|FG001|Overall Study|Ineligible|1|||
156871097|NCT05673876|566284406|FG000|Overall Study|Death|3|||
156871098|NCT05673876|566284407|FG001|Overall Study|Death|1|||
156695938|NCT02643355|565634319|FG000|Overall Study|Withdrawal by Subject|1|||
156871099|NCT05673876|566284406|FG000|Overall Study|Study Terminated by Sponsor|0|||
156871100|NCT05673876|566284407|FG001|Overall Study|Study Terminated by Sponsor|1|||
156871101|NCT05673876|566284406|FG000|Overall Study|Physician Decision|0|||
156871102|NCT05673876|566284407|FG001|Overall Study|Physician Decision|1|||
156871103|NCT03529422|566284408|FG000|Overall Study|Withdrawal by Subject|1|||
156871104|NCT03529422|566284408|FG000|Overall Study|Protocol Violation|1|||
156871105|NCT03529422|566284408|FG000|Overall Study|Disease progression|2|||
156871106|NCT05006573|566284411|FG000|Double-blind Treatment Period|Physician Decision|2|||
156871107|NCT05006573|566284412|FG001|Double-blind Treatment Period|Physician Decision|0|||
157214704|NCT02266706|567533467|FG007|Overall Study|Enrollment in another study|0|||
157214705|NCT02266706|567533468|FG008|Overall Study|Enrollment in another study|0|||
157214706|NCT01977352|567533469|FG000|Overall Study|Lost to Follow-up|1|||
157214707|NCT01977352|567533470|FG001|Overall Study|Lost to Follow-up|2|||
157214708|NCT00409188|567533471|FG000|Overall Study|Ongoing at data cut-off|383|||
157214709|NCT00409188|567533472|FG001|Overall Study|Ongoing at data cut-off|175|||
157214710|NCT02270983|567533473|FG000|Overall Study|Adverse Event|3|||
157214711|NCT02270983|567533474|FG001|Overall Study|Adverse Event|2|||
157214712|NCT02270983|567533475|FG002|Overall Study|Adverse Event|6|||
157214713|NCT02270983|567533473|FG000|Overall Study|Lack of Efficacy|2|||
157214714|NCT02270983|567533474|FG001|Overall Study|Lack of Efficacy|1|||
157214715|NCT02270983|567533475|FG002|Overall Study|Lack of Efficacy|1|||
157214716|NCT02270983|567533473|FG000|Overall Study|Withdrawal by Subject|1|||
157214717|NCT02270983|567533474|FG001|Overall Study|Withdrawal by Subject|0|||
157214718|NCT02270983|567533475|FG002|Overall Study|Withdrawal by Subject|2|||
157214719|NCT02270983|567533473|FG000|Overall Study|Lost to Follow-up|1|||
157214720|NCT02270983|567533474|FG001|Overall Study|Lost to Follow-up|1|||
157214721|NCT02270983|567533475|FG002|Overall Study|Lost to Follow-up|2|||
157214722|NCT02270983|567533473|FG000|Overall Study|Protocol Violation|1|||
157214723|NCT02270983|567533474|FG001|Overall Study|Protocol Violation|1|||
157214724|NCT02270983|567533475|FG002|Overall Study|Protocol Violation|1|||
157214725|NCT02270983|567533473|FG000|Overall Study|family emergency|0|||
157214726|NCT02270983|567533474|FG001|Overall Study|family emergency|1|||
157214727|NCT02270983|567533475|FG002|Overall Study|family emergency|0|||
157214728|NCT02270983|567533473|FG000|Overall Study|study procedure non-compliance|1|||
157214729|NCT02270983|567533474|FG001|Overall Study|study procedure non-compliance|0|||
157214730|NCT02270983|567533475|FG002|Overall Study|study procedure non-compliance|0|||
157214731|NCT02270983|567533473|FG000|Overall Study|moved away from study site|0|||
157214732|NCT02270983|567533474|FG001|Overall Study|moved away from study site|1|||
157214733|NCT02270983|567533475|FG002|Overall Study|moved away from study site|0|||
157214734|NCT00854620|567533479|FG000|Overall Study|Adverse Event|1|||
157214735|NCT00275028|567533484|FG000|Overall Study|Withdrew consent before treatment began|1|||
157214736|NCT00275028|567533484|FG000|Overall Study|Withdrawal by Subject|5|||
157214737|NCT00275028|567533484|FG000|Overall Study|Adverse Event|9|||
157214738|NCT00275028|567533484|FG000|Overall Study|Progressive Disease|30|||
157214739|NCT00275028|567533484|FG000|Overall Study|Physician Decision|2|||
157214740|NCT01847313|567533488|FG000|Overall Study|Death|0|||
157214741|NCT01847313|567533489|FG001|Overall Study|Death|1|||
157214742|NCT01847313|567533488|FG000|Overall Study|Withdrawal by Subject|0|||
157214743|NCT01847313|567533489|FG001|Overall Study|Withdrawal by Subject|1|||
157214744|NCT00598559|567533490|FG000|Overall Study|Adverse Event|11|||
157214745|NCT00598559|567533491|FG001|Overall Study|Adverse Event|7|||
157214746|NCT00598559|567533492|FG002|Overall Study|Adverse Event|0|||
157214747|NCT00598559|567533490|FG000|Overall Study|Withdrawal by Subject|2|||
157214748|NCT00598559|567533491|FG001|Overall Study|Withdrawal by Subject|2|||
157214749|NCT00598559|567533492|FG002|Overall Study|Withdrawal by Subject|0|||
157214750|NCT00598559|567533490|FG000|Overall Study|Protocol Non-compliance|1|||
157214751|NCT00598559|567533491|FG001|Overall Study|Protocol Non-compliance|0|||
157214752|NCT00598559|567533492|FG002|Overall Study|Protocol Non-compliance|0|||
157214753|NCT00598559|567533490|FG000|Overall Study|Early discharge from hospital|9|||
157214754|NCT00598559|567533491|FG001|Overall Study|Early discharge from hospital|12|||
157214755|NCT00598559|567533492|FG002|Overall Study|Early discharge from hospital|3|||
157214756|NCT00598559|567533490|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
157214757|NCT00598559|567533491|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
157214758|NCT00598559|567533492|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
157214759|NCT01155063|567533495|FG000|Overall Study|Adverse Event|1|||
157214760|NCT01155063|567533495|FG000|Overall Study|Withdrawal by Subject|1|||
157214761|NCT01155063|567533495|FG000|Overall Study|Study terminated by sponsor|87|||
157214762|NCT02280421|567533498|FG000|Washout (2 Weeks)|Adverse Event|0|||
157214763|NCT02280421|567533499|FG001|Washout (2 Weeks)|Adverse Event|1|||
156871108|NCT05006573|566284411|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
157214764|NCT02280421|567533498|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
157214765|NCT02280421|567533499|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
157214766|NCT00515073|567533505|FG000|Overall Study|Withdrawal by Subject|1|||
157214767|NCT00515073|567533505|FG000|Overall Study|Physician Decision|1|||
157214768|NCT02764489|567533506|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
157214769|NCT02764489|567533507|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
157214770|NCT02764489|567533506|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
156695939|NCT02643355|565634320|FG001|Overall Study|Withdrawal by Subject|3|||
156695940|NCT02643355|565634319|FG000|Overall Study|Protocol Violation|0|||
156695941|NCT02643355|565634320|FG001|Overall Study|Protocol Violation|2|||
156695942|NCT00857259|565634324|FG000|Overall Study|Protocol Violation|1|||
156695943|NCT00857259|565634325|FG001|Overall Study|Protocol Violation|0|||
156695944|NCT00857259|565634326|FG002|Overall Study|Protocol Violation|1|||
156695945|NCT02701413|565634327|FG000|Overall Study|Withdrawal by Subject|7|||
156695946|NCT02701413|565634328|FG001|Overall Study|Withdrawal by Subject|11|||
156695947|NCT02138136|565634329|FG000|Overall Study|Protocol Violation|4|||
156695948|NCT02138136|565634329|FG000|Overall Study|Physician Decision|7|||
156695949|NCT02138136|565634329|FG000|Overall Study|Lack of Efficacy|35|||
156695950|NCT02138136|565634329|FG000|Overall Study|Pregnancy|2|||
156695951|NCT02138136|565634329|FG000|Overall Study|Adverse Event|18|||
156695952|NCT02138136|565634329|FG000|Overall Study|Withdrawal by Subject|36|||
156695953|NCT02138136|565634329|FG000|Overall Study|Lost to Follow-up|32|||
156695954|NCT02138136|565634329|FG000|Overall Study|Withdrawn by Sponsor|5|||
156695955|NCT01660334|565634334|FG000|Overall Study|Lost to Follow-up|1|||
156695956|NCT00988065|565634335|FG000|Overall Study|Adverse Event|4|||
156695957|NCT00988065|565634336|FG001|Overall Study|Adverse Event|10|||
156695958|NCT00988065|565634337|FG002|Overall Study|Adverse Event|2|||
156695959|NCT00988065|565634335|FG000|Overall Study|Lost to Follow-up|1|||
156695960|NCT00988065|565634336|FG001|Overall Study|Lost to Follow-up|2|||
156695961|NCT00988065|565634337|FG002|Overall Study|Lost to Follow-up|2|||
156695962|NCT00988065|565634335|FG000|Overall Study|Subject withdrew consent|3|||
156695963|NCT00988065|565634336|FG001|Overall Study|Subject withdrew consent|5|||
156695964|NCT00988065|565634337|FG002|Overall Study|Subject withdrew consent|2|||
156695965|NCT00988065|565634335|FG000|Overall Study|Noncompliance with protocol|5|||
156695966|NCT00988065|565634336|FG001|Overall Study|Noncompliance with protocol|6|||
156695967|NCT00988065|565634337|FG002|Overall Study|Noncompliance with protocol|9|||
156695968|NCT00985712|565634340|FG000|Overall Study|Adverse Event|0|||
156695969|NCT00985712|565634341|FG001|Overall Study|Adverse Event|1|||
156695970|NCT00985712|565634340|FG000|Overall Study|Lost to Follow-up|2|||
156695971|NCT00985712|565634341|FG001|Overall Study|Lost to Follow-up|2|||
156695972|NCT00985712|565634340|FG000|Overall Study|Protocol Violation|0|||
156695973|NCT00985712|565634341|FG001|Overall Study|Protocol Violation|1|||
156695974|NCT00985712|565634340|FG000|Overall Study|Withdrawal by Subject|4|||
156695975|NCT00985712|565634341|FG001|Overall Study|Withdrawal by Subject|1|||
156695976|NCT00985712|565634340|FG000|Overall Study|Sponsor decision|0|||
156695977|NCT00985712|565634341|FG001|Overall Study|Sponsor decision|2|||
156695978|NCT01875471|565634342|FG000|Overall Study|Adverse Event|0|||
156695979|NCT01875471|565634343|FG001|Overall Study|Adverse Event|1|||
156695980|NCT01875471|565634342|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
156695981|NCT01875471|565634343|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
156695982|NCT01321008|565634344|FG000|Overall Study|Early Study Termination|1|||
156695983|NCT00257920|565634347|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
156695984|NCT00257920|565634348|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
156695985|NCT00257920|565634347|FG000|Period: Second Intervention|Other|2|||
156695986|NCT00257920|565634348|FG001|Period: Second Intervention|Other|1|||
156695987|NCT00770692|565634349|FG000|Overall Study|Withdrawal by Subject|7|||
156695988|NCT00770692|565634350|FG001|Overall Study|Withdrawal by Subject|9|||
156695989|NCT00770692|565634351|FG002|Overall Study|Withdrawal by Subject|9|||
156695990|NCT00770692|565634352|FG003|Overall Study|Withdrawal by Subject|6|||
156695991|NCT00770692|565634349|FG000|Overall Study|Adverse Event|3|||
156695992|NCT00770692|565634350|FG001|Overall Study|Adverse Event|0|||
156695993|NCT00770692|565634351|FG002|Overall Study|Adverse Event|4|||
156695994|NCT00770692|565634352|FG003|Overall Study|Adverse Event|4|||
156695995|NCT00770692|565634349|FG000|Overall Study|Investigator judgment|2|||
156695996|NCT00770692|565634350|FG001|Overall Study|Investigator judgment|0|||
156695997|NCT00770692|565634351|FG002|Overall Study|Investigator judgment|1|||
156695998|NCT00770692|565634352|FG003|Overall Study|Investigator judgment|1|||
156695999|NCT01230892|565634353|FG000|Overall Study|Withdrawal by Subject|1|||
157014470|NCT03398148|566805004|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014471|NCT03398148|566805005|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014472|NCT03398148|566805006|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014473|NCT03398148|566805007|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157021724|NCT04179500|566832934|FG000|Treatment|Adverse Event|2|||
156696000|NCT01230892|565634354|FG001|Overall Study|Withdrawal by Subject|1|||
156696001|NCT01230892|565634353|FG000|Overall Study|Lost to Follow-up|2|||
156696002|NCT01230892|565634354|FG001|Overall Study|Lost to Follow-up|0|||
156696003|NCT00679913|565634355|FG000|Overall Study|Protocol Violation|18|||
156696004|NCT00679913|565634356|FG001|Overall Study|Protocol Violation|13|||
156696005|NCT01000493|565634359|FG000|Overall Study|Adverse Event|3|||
156696006|NCT01000493|565634360|FG001|Overall Study|Adverse Event|6|||
156696007|NCT01000493|565634359|FG000|Overall Study|Lack of Efficacy|1|||
156696008|NCT01000493|565634360|FG001|Overall Study|Lack of Efficacy|1|||
156696009|NCT01000493|565634359|FG000|Overall Study|Protocol Violation|1|||
156696010|NCT01000493|565634360|FG001|Overall Study|Protocol Violation|8|||
156696011|NCT01000493|565634359|FG000|Overall Study|Study closed/terminated|25|||
156696012|NCT01000493|565634360|FG001|Overall Study|Study closed/terminated|23|||
156696013|NCT01000493|565634359|FG000|Overall Study|Lost to Follow-up|5|||
156696014|NCT01000493|565634360|FG001|Overall Study|Lost to Follow-up|9|||
156696015|NCT01000493|565634359|FG000|Overall Study|Physician Decision|1|||
156696016|NCT01000493|565634360|FG001|Overall Study|Physician Decision|1|||
156696017|NCT01000493|565634359|FG000|Overall Study|Withdrawal by Subject|3|||
156696018|NCT01000493|565634360|FG001|Overall Study|Withdrawal by Subject|7|||
156696019|NCT00062751|565634361|FG000|Overall Study|Disease progression|24|||
156696020|NCT00062751|565634362|FG001|Overall Study|Disease progression|17|||
156696021|NCT00062751|565634363|FG002|Overall Study|Disease progression|24|||
156696022|NCT00062751|565634364|FG003|Overall Study|Disease progression|2|||
156696023|NCT00062751|565634365|FG004|Overall Study|Disease progression|2|||
156696024|NCT00062751|565634361|FG000|Overall Study|Adverse Event|4|||
156696025|NCT00062751|565634362|FG001|Overall Study|Adverse Event|7|||
156871109|NCT05006573|566284412|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
156871110|NCT05006573|566284411|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156871111|NCT05006573|566284412|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156871112|NCT05006573|566284411|FG000|Double-blind Treatment Period|Protocol Violation|2|||
156871113|NCT05006573|566284412|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156871114|NCT05006573|566284411|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
156871115|NCT05006573|566284412|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
156696026|NCT00062751|565634363|FG002|Overall Study|Adverse Event|2|||
156696027|NCT00062751|565634364|FG003|Overall Study|Adverse Event|2|||
156696028|NCT00062751|565634365|FG004|Overall Study|Adverse Event|2|||
156696029|NCT00062751|565634361|FG000|Overall Study|Other|2|||
156696030|NCT00062751|565634362|FG001|Overall Study|Other|3|||
156696031|NCT00062751|565634363|FG002|Overall Study|Other|1|||
156696032|NCT00062751|565634364|FG003|Overall Study|Other|0|||
156696033|NCT00062751|565634365|FG004|Overall Study|Other|1|||
156696034|NCT00062751|565634361|FG000|Overall Study|Withdrawal by Subject|1|||
156696035|NCT00062751|565634362|FG001|Overall Study|Withdrawal by Subject|2|||
156696036|NCT00062751|565634363|FG002|Overall Study|Withdrawal by Subject|2|||
156696037|NCT00062751|565634364|FG003|Overall Study|Withdrawal by Subject|1|||
156696038|NCT00062751|565634365|FG004|Overall Study|Withdrawal by Subject|0|||
156696039|NCT00062751|565634361|FG000|Overall Study|Symptomatic deterioration|1|||
156696040|NCT00062751|565634362|FG001|Overall Study|Symptomatic deterioration|1|||
156696041|NCT00062751|565634363|FG002|Overall Study|Symptomatic deterioration|0|||
156696042|NCT00062751|565634364|FG003|Overall Study|Symptomatic deterioration|0|||
156696043|NCT00062751|565634365|FG004|Overall Study|Symptomatic deterioration|1|||
156696044|NCT00062751|565634361|FG000|Overall Study|Death|1|||
156696045|NCT00062751|565634362|FG001|Overall Study|Death|0|||
156696046|NCT00062751|565634363|FG002|Overall Study|Death|1|||
156696047|NCT00062751|565634364|FG003|Overall Study|Death|0|||
156696048|NCT00062751|565634365|FG004|Overall Study|Death|0|||
156696049|NCT03629028|565634366|FG000|Overall Study|Lost to Follow-up|26|||
156696050|NCT03629028|565634367|FG001|Overall Study|Lost to Follow-up|23|||
156696051|NCT03629028|565634366|FG000|Overall Study|Pregnancy|4|||
156696052|NCT03629028|565634367|FG001|Overall Study|Pregnancy|2|||
156696053|NCT03629028|565634366|FG000|Overall Study|intolerance to examination|2|||
156696054|NCT03629028|565634367|FG001|Overall Study|intolerance to examination|0|||
156696055|NCT03828448|565634376|FG000|Overall Study|Sponsor's Discretion|34|||
156696056|NCT02037165|565634377|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696057|NCT02037165|565634378|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156789989|NCT01313676|565983665|FG003|Overall Study|Protocol Violation|44|||
156789990|NCT01313676|565983662|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
156789991|NCT01313676|565983663|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
156789992|NCT01313676|565983664|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
156789993|NCT01313676|565983665|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
156789994|NCT01313676|565983662|FG000|Overall Study|Study Closed/terminated|7|||
156789995|NCT01313676|565983663|FG001|Overall Study|Study Closed/terminated|6|||
156789996|NCT01313676|565983664|FG002|Overall Study|Study Closed/terminated|9|||
156789997|NCT01313676|565983665|FG003|Overall Study|Study Closed/terminated|9|||
156789998|NCT01313676|565983662|FG000|Overall Study|Lost to Follow-up|0|||
156789999|NCT01313676|565983663|FG001|Overall Study|Lost to Follow-up|0|||
156790000|NCT01313676|565983664|FG002|Overall Study|Lost to Follow-up|1|||
156790001|NCT01313676|565983665|FG003|Overall Study|Lost to Follow-up|0|||
156790002|NCT01313676|565983662|FG000|Overall Study|Physician Decision|53|||
156790003|NCT01313676|565983663|FG001|Overall Study|Physician Decision|64|||
156790004|NCT01313676|565983664|FG002|Overall Study|Physician Decision|62|||
156696058|NCT02037165|565634379|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696059|NCT02037165|565634380|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
156696060|NCT02037165|565634381|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
156871116|NCT05006573|566284411|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
156696061|NCT02192164|565634385|FG000|Overall Study|Other|8|||
156696062|NCT02192164|565634385|FG000|Overall Study|Withdrawal by Subject|1|||
156790005|NCT01313676|565983665|FG003|Overall Study|Physician Decision|48|||
157014474|NCT03398148|566805008|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014475|NCT03398148|566805009|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014476|NCT03398148|566805010|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014477|NCT03398148|566804996|FG000|Substudy 1 Period 2|Other|0|||
156696063|NCT02192164|565634385|FG000|Overall Study|Physician Decision|4|||
157014478|NCT03398148|566804997|FG001|Substudy 1 Period 2|Other|0|||
156696064|NCT02192164|565634385|FG000|Overall Study|Did not meet the exclusion criteria|1|||
156696065|NCT01346774|565634386|FG000|Overall Study|Did not take a single dose|6|||
156696066|NCT01346774|565634387|FG001|Overall Study|Did not take a single dose|4|||
156696067|NCT01346774|565634386|FG000|Overall Study|Lost to Follow-up|3|||
156696068|NCT01346774|565634387|FG001|Overall Study|Lost to Follow-up|4|||
156696069|NCT01346774|565634386|FG000|Overall Study|Withdrawal by Subject|1|||
156696070|NCT01346774|565634387|FG001|Overall Study|Withdrawal by Subject|4|||
156696071|NCT01346774|565634386|FG000|Overall Study|Protocol Violation|2|||
156696072|NCT01346774|565634387|FG001|Overall Study|Protocol Violation|3|||
156696073|NCT01346774|565634386|FG000|Overall Study|Adverse Event|1|||
157014479|NCT03398148|566804998|FG002|Substudy 1 Period 2|Other|0|||
157014480|NCT03398148|566804999|FG003|Substudy 1 Period 2|Other|0|||
157014481|NCT03398148|566805000|FG004|Substudy 1 Period 2|Other|0|||
157014482|NCT03398148|566805001|FG005|Substudy 1 Period 2|Other|0|||
157014483|NCT03398148|566805002|FG006|Substudy 1 Period 2|Other|1|||
157014484|NCT03398148|566805003|FG007|Substudy 1 Period 2|Other|0|||
157014485|NCT03398148|566805004|FG008|Substudy 1 Period 2|Other|0|||
157014486|NCT03398148|566805005|FG009|Substudy 1 Period 2|Other|0|||
157014487|NCT03398148|566805006|FG010|Substudy 1 Period 2|Other|0|||
157014488|NCT03398148|566805007|FG011|Substudy 1 Period 2|Other|0|||
157014489|NCT03398148|566805008|FG012|Substudy 1 Period 2|Other|0|||
157014490|NCT03398148|566805009|FG013|Substudy 1 Period 2|Other|0|||
157014491|NCT03398148|566805010|FG014|Substudy 1 Period 2|Other|0|||
157014492|NCT03398148|566804996|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014493|NCT03398148|566804997|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014494|NCT03398148|566804998|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014495|NCT03398148|566804999|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014496|NCT03398148|566805000|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
157122798|NCT04381650|567200397|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
157122799|NCT04381650|567200398|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157122800|NCT04381650|567200388|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
157122801|NCT04381650|567200389|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
157122802|NCT04381650|567200390|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156696074|NCT01346774|565634387|FG001|Overall Study|Adverse Event|2|||
156696075|NCT00609466|565634397|FG000|Overall Study|Withdrawal by Subject|0|||
156696076|NCT00609466|565634398|FG001|Overall Study|Withdrawal by Subject|1|||
156696077|NCT00609466|565634399|FG002|Overall Study|Withdrawal by Subject|1|||
156696078|NCT00609466|565634397|FG000|Overall Study|Adverse Event|2|||
156696079|NCT00609466|565634398|FG001|Overall Study|Adverse Event|3|||
156696080|NCT00609466|565634399|FG002|Overall Study|Adverse Event|1|||
156696081|NCT00609466|565634397|FG000|Overall Study|Lack of Efficacy|0|||
156696082|NCT00609466|565634398|FG001|Overall Study|Lack of Efficacy|2|||
157014497|NCT03398148|566805001|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014498|NCT03398148|566805002|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
157014499|NCT03398148|566805003|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014500|NCT03398148|566805004|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
156696083|NCT00609466|565634399|FG002|Overall Study|Lack of Efficacy|2|||
156696084|NCT03512262|565634400|FG000|Overall Study|Adverse Event|8|||
157014501|NCT03398148|566805005|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014502|NCT03398148|566805006|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014503|NCT03398148|566805007|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014504|NCT03398148|566805008|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014505|NCT03398148|566805009|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014506|NCT03398148|566805010|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
157014507|NCT03398148|566804996|FG000|Substudy 2 Period 1|Adverse Event|0|||
157014508|NCT03398148|566804997|FG001|Substudy 2 Period 1|Adverse Event|0|||
157014509|NCT03398148|566804998|FG002|Substudy 2 Period 1|Adverse Event|0|||
156696085|NCT03512262|565634401|FG001|Overall Study|Adverse Event|3|||
157014510|NCT03398148|566804999|FG003|Substudy 2 Period 1|Adverse Event|0|||
157122803|NCT04381650|567200391|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
156696086|NCT03512262|565634400|FG000|Overall Study|Death (non-treatment emergent)|1|||
156696087|NCT03512262|565634401|FG001|Overall Study|Death (non-treatment emergent)|0|||
156696088|NCT03512262|565634400|FG000|Overall Study|Withdrawal by Subject|17|||
156696089|NCT03512262|565634401|FG001|Overall Study|Withdrawal by Subject|9|||
156696090|NCT03512262|565634400|FG000|Overall Study|Lost to Follow-up|7|||
157014511|NCT03398148|566805000|FG004|Substudy 2 Period 1|Adverse Event|0|||
157014512|NCT03398148|566805001|FG005|Substudy 2 Period 1|Adverse Event|0|||
157014513|NCT03398148|566805002|FG006|Substudy 2 Period 1|Adverse Event|0|||
157014514|NCT03398148|566805003|FG007|Substudy 2 Period 1|Adverse Event|0|||
157014515|NCT03398148|566805004|FG008|Substudy 2 Period 1|Adverse Event|0|||
157014516|NCT03398148|566805005|FG009|Substudy 2 Period 1|Adverse Event|12|||
156696091|NCT03512262|565634401|FG001|Overall Study|Lost to Follow-up|1|||
156696092|NCT03512262|565634400|FG000|Overall Study|Other than Specified|2|||
156696093|NCT03512262|565634401|FG001|Overall Study|Other than Specified|2|||
156696094|NCT01299805|565634402|FG000|Overall Study|Adverse Event|2|||
156696095|NCT01299805|565634403|FG001|Overall Study|Adverse Event|0|||
156696096|NCT04221789|565635984|FG000|Overall Study|deviation from protoco|22|||
156696097|NCT04221789|565635985|FG001|Overall Study|deviation from protoco|8|||
156696098|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
156696099|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696100|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696101|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696102|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
156696103|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
156696104|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
156696105|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
156696106|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
156696107|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
156696108|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696109|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
156696110|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696111|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696112|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
156696113|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
156696114|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
156696115|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696116|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696117|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
156696118|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
156696119|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
156696120|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
156696121|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
156696122|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
156696123|NCT02935686|565635986|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696124|NCT02935686|565635987|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
156696125|NCT02935686|565635988|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696126|NCT02935686|565635989|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696127|NCT02935686|565635990|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
156696128|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
156696129|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
156696130|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696131|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696132|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
156696133|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696134|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
156696135|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696136|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696137|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
156696138|NCT02935686|565635986|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696139|NCT02935686|565635987|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
156696140|NCT02935686|565635988|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696141|NCT02935686|565635989|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696142|NCT02935686|565635990|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
156696143|NCT02935686|565635986|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696144|NCT02935686|565635987|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696145|NCT02935686|565635988|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696146|NCT02935686|565635989|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
156696147|NCT02935686|565635990|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
156696148|NCT02935686|565635986|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696149|NCT02935686|565635987|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696150|NCT02935686|565635988|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
156696151|NCT02935686|565635989|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
156696152|NCT02935686|565635990|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
156696153|NCT01183221|565635991|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
156696154|NCT01183221|565635992|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
156696155|NCT00678041|565636002|FG000|Overall Study|Physician Decision|5|||
156696156|NCT00678041|565636003|FG001|Overall Study|Physician Decision|5|||
156696157|NCT02358343|565636004|FG000|Screening Intervention|Death|0|||
156696158|NCT02358343|565636005|FG001|Screening Intervention|Death|2|||
156696159|NCT02358343|565636006|FG002|Screening Intervention|Death|0|||
156696160|NCT02358343|565636007|FG003|Screening Intervention|Death|0|||
156696161|NCT02358343|565636008|FG004|Screening Intervention|Death|0|||
156696162|NCT02358343|565636004|FG000|Screening Intervention|Withdrawal by Subject|1|||
156696163|NCT02358343|565636005|FG001|Screening Intervention|Withdrawal by Subject|0|||
156696164|NCT02358343|565636006|FG002|Screening Intervention|Withdrawal by Subject|0|||
156696165|NCT02358343|565636007|FG003|Screening Intervention|Withdrawal by Subject|0|||
156696166|NCT02358343|565636008|FG004|Screening Intervention|Withdrawal by Subject|0|||
156696167|NCT02358343|565636004|FG000|Screening Intervention|Determined Ineligible|5|||
156696168|NCT02358343|565636005|FG001|Screening Intervention|Determined Ineligible|6|||
156696169|NCT02358343|565636006|FG002|Screening Intervention|Determined Ineligible|0|||
156696170|NCT02358343|565636007|FG003|Screening Intervention|Determined Ineligible|0|||
156696171|NCT02358343|565636008|FG004|Screening Intervention|Determined Ineligible|0|||
156696172|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Death|0|||
156696173|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Death|0|||
156696174|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Death|2|||
156696175|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Death|0|||
156696176|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Death|0|||
156696177|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
156696178|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
156696179|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696180|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696181|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
156696182|NCT02358343|565636004|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696183|NCT02358343|565636005|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696184|NCT02358343|565636006|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
156696185|NCT02358343|565636007|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696186|NCT02358343|565636008|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
156696187|NCT02518919|565636012|FG000|Overall Study|Protocol Violation|1|||
156696188|NCT02518919|565636013|FG001|Overall Study|Protocol Violation|1|||
156696189|NCT02518919|565636014|FG002|Overall Study|Protocol Violation|2|||
156696190|NCT04498403|565636015|FG000|Overall Study|Adverse Event|1|||
156696191|NCT04498403|565636016|FG001|Overall Study|Adverse Event|0|||
156696192|NCT04498403|565636015|FG000|Overall Study|Study Terminated By Sponsor|29|||
157214771|NCT02764489|567533507|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
157214772|NCT02764489|567533506|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
157214773|NCT02764489|567533507|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
157214774|NCT02764489|567533506|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
157214775|NCT02764489|567533507|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
157214776|NCT00881959|567533508|FG000|Overall Study|Lost to Follow-up|2|||
157214777|NCT00881959|567533509|FG001|Overall Study|Lost to Follow-up|4|||
157214778|NCT02791659|567533510|FG000|Overall Study|Protocol Violation|0|||
157214779|NCT02791659|567533511|FG001|Overall Study|Protocol Violation|1|||
156696193|NCT04498403|565636016|FG001|Overall Study|Study Terminated By Sponsor|10|||
156696194|NCT01951885|565636017|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
156696195|NCT01951885|565636018|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
156696196|NCT01951885|565636017|FG000|Overall Study|Adverse Event|1|||
156696197|NCT01951885|565636018|FG001|Overall Study|Adverse Event|0|||
156696198|NCT01951885|565636017|FG000|Overall Study|Withdrawal by Subject|0|||
156696199|NCT01951885|565636018|FG001|Overall Study|Withdrawal by Subject|1|||
156696200|NCT01951885|565636017|FG000|Overall Study|ineligible due to a change in donor|0|||
156696201|NCT01951885|565636018|FG001|Overall Study|ineligible due to a change in donor|1|||
156696202|NCT01951885|565636017|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
156696203|NCT01951885|565636018|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
156696204|NCT00577395|565636019|FG000|Overall Study|Study was terminated early by Sponsor|7|||
156696205|NCT00577395|565636020|FG001|Overall Study|Study was terminated early by Sponsor|6|||
156696206|NCT01700049|565636027|FG000|Overall Study|Withdrawal by Subject|1|||
156696207|NCT03084367|565636031|FG000|Overall Study|Lost to Follow-up|32|||
156696208|NCT03084367|565636031|FG000|Overall Study|Withdrawal by Subject|4|||
156696209|NCT03084367|565636031|FG000|Overall Study|Other|1|||
156696210|NCT01206101|565636032|FG000|Overall Study|Adverse Event|1|||
156696211|NCT01206101|565636033|FG001|Overall Study|Adverse Event|0|||
156696212|NCT01206101|565636032|FG000|Overall Study|Physician Decision|0|||
156696213|NCT01206101|565636033|FG001|Overall Study|Physician Decision|1|||
156696214|NCT01206101|565636032|FG000|Overall Study|Unclassified|1|||
156696215|NCT01206101|565636033|FG001|Overall Study|Unclassified|0|||
156696216|NCT00368979|565636039|FG000|Overall Study|Adverse Event|9|||
156696217|NCT00368979|565636040|FG001|Overall Study|Adverse Event|16|||
156696218|NCT00368979|565636039|FG000|Overall Study|Lack of Efficacy|5|||
156696219|NCT00368979|565636040|FG001|Overall Study|Lack of Efficacy|3|||
156696220|NCT00368979|565636039|FG000|Overall Study|Other|3|||
157214780|NCT03840811|567533512|FG000|Overall Study|Lost to Follow-up|0|||
157214781|NCT03840811|567533513|FG001|Overall Study|Lost to Follow-up|0|||
156696221|NCT00368979|565636040|FG001|Overall Study|Other|1|||
156696222|NCT00368979|565636039|FG000|Overall Study|Lost to Follow-up|1|||
156696223|NCT00368979|565636040|FG001|Overall Study|Lost to Follow-up|0|||
156696224|NCT00368979|565636039|FG000|Overall Study|Protocol Violation|2|||
156696225|NCT00368979|565636040|FG001|Overall Study|Protocol Violation|1|||
156696226|NCT00368979|565636039|FG000|Overall Study|Withdrawal by Subject|5|||
156696227|NCT00368979|565636040|FG001|Overall Study|Withdrawal by Subject|9|||
156696228|NCT00394524|565636041|FG000|Overall Study|Protocol Violation|2|||
156696229|NCT00394524|565636042|FG001|Overall Study|Protocol Violation|3|||
156696230|NCT00394524|565636041|FG000|Overall Study|Death|1|||
156696231|NCT00394524|565636042|FG001|Overall Study|Death|0|||
156696232|NCT00394524|565636041|FG000|Overall Study|Withdrawal by Subject|0|||
156696233|NCT00394524|565636042|FG001|Overall Study|Withdrawal by Subject|1|||
156696234|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Other|2|||
156696235|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Other|0|||
156696236|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Other|0|||
156696237|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
156696238|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
156696239|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
156696240|NCT01462318|565636045|FG000|Main Study / TP-DI Study|Adverse Event|4|||
156696241|NCT01462318|565636046|FG001|Main Study / TP-DI Study|Adverse Event|0|||
156696242|NCT01462318|565636047|FG002|Main Study / TP-DI Study|Adverse Event|0|||
156696243|NCT01462318|565636045|FG000|Extension Phase|Lost to Follow-up|0|||
156696244|NCT01462318|565636046|FG001|Extension Phase|Lost to Follow-up|0|||
156696245|NCT01462318|565636047|FG002|Extension Phase|Lost to Follow-up|1|||
156696246|NCT01462318|565636045|FG000|Extension Phase|Other|0|||
156696247|NCT01462318|565636046|FG001|Extension Phase|Other|0|||
156696248|NCT01462318|565636047|FG002|Extension Phase|Other|1|||
156696249|NCT01462318|565636045|FG000|Extension Phase|Disease Progression|0|||
156696250|NCT01462318|565636046|FG001|Extension Phase|Disease Progression|0|||
156696251|NCT01462318|565636047|FG002|Extension Phase|Disease Progression|1|||
156696252|NCT01462318|565636045|FG000|Extension Phase|Withdrawal by Subject|0|||
156696253|NCT01462318|565636046|FG001|Extension Phase|Withdrawal by Subject|0|||
156696254|NCT01462318|565636047|FG002|Extension Phase|Withdrawal by Subject|15|||
156696255|NCT01462318|565636045|FG000|Extension Phase|Investigator Decision|0|||
156696256|NCT01462318|565636046|FG001|Extension Phase|Investigator Decision|0|||
156696257|NCT01462318|565636047|FG002|Extension Phase|Investigator Decision|5|||
156696258|NCT01462318|565636045|FG000|Extension Phase|Adverse Event|0|||
156696259|NCT01462318|565636046|FG001|Extension Phase|Adverse Event|0|||
156790006|NCT01313676|565983662|FG000|Overall Study|Decision by Participant or Proxy|643|||
156790007|NCT01313676|565983663|FG001|Overall Study|Decision by Participant or Proxy|527|||
156790008|NCT01313676|565983664|FG002|Overall Study|Decision by Participant or Proxy|515|||
156696260|NCT01462318|565636047|FG002|Extension Phase|Adverse Event|22|||
156696261|NCT03827564|565636048|FG000|Overall Study|Discontinued due to Study Termination|1|||
156696262|NCT03827564|565636049|FG001|Overall Study|Discontinued due to Study Termination|0|||
156696263|NCT02238626|565636052|FG000|Overall Study|Adverse Event|3|||
156696264|NCT02238626|565636053|FG001|Overall Study|Adverse Event|5|||
156696265|NCT02238626|565636054|FG002|Overall Study|Adverse Event|0|||
156790009|NCT01313676|565983665|FG003|Overall Study|Decision by Participant or Proxy|492|||
156790010|NCT01313676|565983662|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
156790011|NCT01313676|565983663|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
157014517|NCT03398148|566805006|FG010|Substudy 2 Period 1|Adverse Event|2|||
157014518|NCT03398148|566805007|FG011|Substudy 2 Period 1|Adverse Event|0|||
157014519|NCT03398148|566805008|FG012|Substudy 2 Period 1|Adverse Event|0|||
157014520|NCT03398148|566805009|FG013|Substudy 2 Period 1|Adverse Event|0|||
157014521|NCT03398148|566805010|FG014|Substudy 2 Period 1|Adverse Event|0|||
157014522|NCT03398148|566804996|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014523|NCT03398148|566804997|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014524|NCT03398148|566804998|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014525|NCT03398148|566804999|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014526|NCT03398148|566805000|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014527|NCT03398148|566805001|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014528|NCT03398148|566805002|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014529|NCT03398148|566805003|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014530|NCT03398148|566805004|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156696266|NCT02238626|565636055|FG003|Overall Study|Adverse Event|3|||
156696267|NCT02238626|565636052|FG000|Overall Study|Lost to Follow-up|2|||
156696268|NCT02238626|565636053|FG001|Overall Study|Lost to Follow-up|4|||
156696269|NCT02238626|565636054|FG002|Overall Study|Lost to Follow-up|2|||
157014531|NCT03398148|566805005|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
157014532|NCT03398148|566805006|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
157014533|NCT03398148|566805007|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156696270|NCT02238626|565636055|FG003|Overall Study|Lost to Follow-up|2|||
156696271|NCT02238626|565636052|FG000|Overall Study|Withdrawal by Subject|0|||
156696272|NCT02238626|565636053|FG001|Overall Study|Withdrawal by Subject|3|||
156696273|NCT02238626|565636054|FG002|Overall Study|Withdrawal by Subject|0|||
156696274|NCT02238626|565636055|FG003|Overall Study|Withdrawal by Subject|1|||
156696275|NCT02238626|565636052|FG000|Overall Study|Death|0|||
156696276|NCT02238626|565636053|FG001|Overall Study|Death|0|||
156696277|NCT02238626|565636054|FG002|Overall Study|Death|1|||
156696278|NCT02238626|565636055|FG003|Overall Study|Death|1|||
156696279|NCT02238626|565636052|FG000|Overall Study|Other|0|||
156696280|NCT02238626|565636053|FG001|Overall Study|Other|2|||
156696281|NCT02238626|565636054|FG002|Overall Study|Other|0|||
156696282|NCT02238626|565636055|FG003|Overall Study|Other|0|||
156696283|NCT00270257|565636056|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
156696284|NCT00270257|565636057|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
156696285|NCT01195103|565636061|FG000|Overall Study|Withdrawal by Subject|1|||
156696286|NCT01195103|565636062|FG001|Overall Study|Withdrawal by Subject|0|||
156696287|NCT01195103|565636063|FG002|Overall Study|Withdrawal by Subject|0|||
156696288|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
156696289|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
156696290|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
156696291|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
156696292|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
156696293|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
156696294|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
156696295|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
156696296|NCT00974974|565636078|FG000|IR CD-LD Dose Adjustment|Various|0|||
156696297|NCT00974974|565636079|FG001|IR CD-LD Dose Adjustment|Various|9|||
156696298|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Adverse Event|23|||
156696299|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Adverse Event|0|||
156696300|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Death|2|||
156696301|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Death|0|||
156696302|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
156696303|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
156696304|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
156696305|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
156696306|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Various|3|||
157214782|NCT03840811|567533514|FG002|Overall Study|Lost to Follow-up|1|||
157214783|NCT01904383|567533515|FG000|Overall Study|CRF not collected|117|||
157214784|NCT01904383|567533515|FG000|Overall Study|Reason not listed|147|||
157214785|NCT01904383|567533515|FG000|Overall Study|Lost to Follow-up|674|||
157214786|NCT01904383|567533515|FG000|Overall Study|Lack of Efficacy|370|||
157214787|NCT01904383|567533515|FG000|Overall Study|Improvement|141|||
157214788|NCT01904383|567533515|FG000|Overall Study|Adverse Event|271|||
157214789|NCT01904383|567533515|FG000|Overall Study|No patient visit after entry|54|||
157214790|NCT01625845|567533516|FG000|Overall Study|Adverse Event|1|||
157214791|NCT01625845|567533517|FG001|Overall Study|Adverse Event|2|||
157214792|NCT01625845|567533516|FG000|Overall Study|Lost to Follow-up|2|||
157214793|NCT01625845|567533517|FG001|Overall Study|Lost to Follow-up|1|||
157214794|NCT01625845|567533516|FG000|Overall Study|Withdrawal by Subject|2|||
157214795|NCT01625845|567533517|FG001|Overall Study|Withdrawal by Subject|0|||
157214796|NCT01294592|567533518|FG000|Overall Study|Adverse Event|28|||
157214797|NCT01294592|567533519|FG001|Overall Study|Adverse Event|13|||
157214798|NCT01294592|567533518|FG000|Overall Study|Lack of Efficacy|7|||
157214799|NCT01294592|567533519|FG001|Overall Study|Lack of Efficacy|5|||
157214800|NCT01294592|567533518|FG000|Overall Study|Protocol Violation|1|||
157214801|NCT01294592|567533519|FG001|Overall Study|Protocol Violation|7|||
157214802|NCT01294592|567533518|FG000|Overall Study|Lost to Follow-up|7|||
157214803|NCT01294592|567533519|FG001|Overall Study|Lost to Follow-up|9|||
157214804|NCT01294592|567533518|FG000|Overall Study|Physician Decision|6|||
156696307|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Various|0|||
156696308|NCT00974974|565636078|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
156696309|NCT00974974|565636079|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
156696310|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
156696311|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
156696312|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
157014534|NCT03398148|566805008|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156696313|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
156696314|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
156696315|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
156696316|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
156696317|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
156696318|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
156696319|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
157214805|NCT01294592|567533519|FG001|Overall Study|Physician Decision|11|||
157214806|NCT01294592|567533518|FG000|Overall Study|Withdrawal by Subject|28|||
157214807|NCT01294592|567533519|FG001|Overall Study|Withdrawal by Subject|28|||
157214808|NCT02853929|567533520|FG000|Overall Study|Lost to Follow-up|3|||
157214809|NCT02853929|567533521|FG001|Overall Study|Lost to Follow-up|0|||
157214810|NCT02853929|567533520|FG000|Overall Study|Withdrawal by Subject|1|||
157214811|NCT02853929|567533521|FG001|Overall Study|Withdrawal by Subject|0|||
156696320|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
156696321|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
156696322|NCT00974974|565636078|FG000|Maintenance - Double Blind Treatment|Various|4|||
156696323|NCT00974974|565636079|FG001|Maintenance - Double Blind Treatment|Various|0|||
156696324|NCT01959035|565636080|FG000|Overall Study|Adverse Event|5|||
156696325|NCT01959035|565636080|FG000|Overall Study|Withdrawal by Subject|4|||
156696326|NCT01959035|565636080|FG000|Overall Study|Lost to Follow-up|1|||
156696327|NCT01959035|565636080|FG000|Overall Study|Other (no primary reason given)|1|||
156696328|NCT03254602|565636081|FG000|Overall Study|Lost to Follow-up|4|||
156696329|NCT01691820|565636082|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
156696330|NCT01691820|565636083|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
156696331|NCT01691820|565636082|FG000|Overall Study|Migrated/moved from study area|7|||
156696332|NCT01691820|565636083|FG001|Overall Study|Migrated/moved from study area|4|||
156696333|NCT01691820|565636082|FG000|Overall Study|Lost to Follow-up|6|||
156790012|NCT01313676|565983664|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
156790013|NCT01313676|565983665|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
156790014|NCT01313676|565983662|FG000|Overall Study|Investigator Site Closed|12|||
156790015|NCT01313676|565983663|FG001|Overall Study|Investigator Site Closed|11|||
156790016|NCT01313676|565983664|FG002|Overall Study|Investigator Site Closed|15|||
156790017|NCT01313676|565983665|FG003|Overall Study|Investigator Site Closed|10|||
156790018|NCT01313676|565983662|FG000|Overall Study|Missing|1|||
156790019|NCT01313676|565983663|FG001|Overall Study|Missing|1|||
156790020|NCT01313676|565983664|FG002|Overall Study|Missing|1|||
156790021|NCT01313676|565983665|FG003|Overall Study|Missing|0|||
156790022|NCT02562040|565983666|FG000|Overall Study|Lost to Follow-up|20|||
156790023|NCT02562040|565983667|FG001|Overall Study|Lost to Follow-up|28|||
156790024|NCT02562040|565983666|FG000|Overall Study|Withdrawal by Subject|8|||
156790025|NCT02562040|565983667|FG001|Overall Study|Withdrawal by Subject|7|||
156790026|NCT02562040|565983666|FG000|Overall Study|Adverse Event|1|||
156790027|NCT02562040|565983667|FG001|Overall Study|Adverse Event|0|||
156790028|NCT00368849|565983671|FG000|Overall Study|Withdrawal by Subject|0|||
156790029|NCT00368849|565983672|FG001|Overall Study|Withdrawal by Subject|1|||
156790030|NCT00368849|565983671|FG000|Overall Study|Physician Decision|0|||
156790031|NCT00368849|565983672|FG001|Overall Study|Physician Decision|1|||
156790032|NCT01902303|565983674|FG000|Overall Study|Adverse Event|0|||
156790033|NCT01902303|565983675|FG001|Overall Study|Adverse Event|1|||
156790034|NCT01902303|565983674|FG000|Overall Study|Lost to Follow-up|0|||
156790035|NCT01902303|565983675|FG001|Overall Study|Lost to Follow-up|1|||
156790036|NCT01902303|565983674|FG000|Overall Study|Protocol Violation|2|||
156790037|NCT01902303|565983675|FG001|Overall Study|Protocol Violation|2|||
156790038|NCT01902303|565983674|FG000|Overall Study|subject lost investigational product|0|||
156790039|NCT01902303|565983675|FG001|Overall Study|subject lost investigational product|1|||
156790040|NCT01902303|565983674|FG000|Overall Study|Did not develop a cold sore|21|||
156790041|NCT01902303|565983675|FG001|Overall Study|Did not develop a cold sore|19|||
156790042|NCT01699685|565983676|FG000|Period 1|Adverse Event|1|||
156790043|NCT01699685|565983677|FG001|Period 1|Adverse Event|1|||
156790044|NCT01699685|565983676|FG000|Period 1|Medical or ethical, noncompliance|2|||
156790045|NCT01699685|565983677|FG001|Period 1|Medical or ethical, noncompliance|0|||
156790046|NCT01699685|565983676|FG000|Period 1|Other|0|||
156790047|NCT01699685|565983677|FG001|Period 1|Other|1|||
156790048|NCT01699685|565983676|FG000|Period 1|Patient request|0|||
156790049|NCT01699685|565983677|FG001|Period 1|Patient request|1|||
156790050|NCT01699685|565983676|FG000|Period 2|Lost to Follow-up|1|||
156790051|NCT01699685|565983677|FG001|Period 2|Lost to Follow-up|0|||
156790052|NCT03635996|565983678|FG000|Overall Study|Study terminated by Sponsor|94|||
156790053|NCT03635996|565983678|FG000|Overall Study|Withdrawal by Subject|20|||
156790054|NCT03635996|565983678|FG000|Overall Study|Ablation|26|||
156790055|NCT03635996|565983678|FG000|Overall Study|Adverse Event|7|||
156790056|NCT03635996|565983678|FG000|Overall Study|Physician Decision|3|||
156790057|NCT03635996|565983678|FG000|Overall Study|Prohibited medication|5|||
156790058|NCT03635996|565983678|FG000|Overall Study|Did not meet eligibility criteria|5|||
156790059|NCT03635996|565983678|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
156790060|NCT03635996|565983678|FG000|Overall Study|Protocol Violation|1|||
156790061|NCT03635996|565983678|FG000|Overall Study|Lost to Follow-up|1|||
156790062|NCT05058456|565983679|FG000|Overall Study|Death|1|||
156790063|NCT05058456|565983679|FG000|Overall Study|End of Study data not yet due for release|34|||
156790064|NCT02933151|565983680|FG000|Overall Study|Lost to Follow-up|19|||
156790065|NCT02933151|565983681|FG001|Overall Study|Lost to Follow-up|18|||
156790066|NCT02933151|565983680|FG000|Overall Study|Death|1732|||
156790067|NCT02933151|565983681|FG001|Overall Study|Death|1827|||
156790068|NCT02933151|565983680|FG000|Overall Study|Transplant|210|||
156790069|NCT02933151|565983681|FG001|Overall Study|Transplant|278|||
156790070|NCT02933151|565983680|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
156790071|NCT02933151|565983681|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
156790072|NCT02933151|565983680|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
156790073|NCT02933151|565983681|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
156696334|NCT01691820|565636083|FG001|Overall Study|Lost to Follow-up|17|||
156696335|NCT01691820|565636082|FG000|Overall Study|Other (unspecified)|4|||
156696336|NCT01691820|565636083|FG001|Overall Study|Other (unspecified)|1|||
156696337|NCT03347422|565636084|FG000|Part A (26 Weeks)|Adverse Event|3|||
156696338|NCT03347422|565636085|FG001|Part A (26 Weeks)|Adverse Event|0|||
156696339|NCT03347422|565636084|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
156696340|NCT03347422|565636085|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
156696341|NCT03347422|565636084|FG000|Part B (149 Weeks)|Adverse Event|0|||
156696342|NCT03347422|565636085|FG001|Part B (149 Weeks)|Adverse Event|1|||
156696343|NCT03347422|565636084|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
156696344|NCT03347422|565636085|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
156696345|NCT03347422|565636084|FG000|Part B (149 Weeks)|Other|1|||
156696346|NCT03347422|565636085|FG001|Part B (149 Weeks)|Other|0|||
156696347|NCT03914950|565636092|FG000|Overall Study|Physician Decision|54|||
156696348|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
156696349|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
156696350|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
156696351|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
156696352|NCT01155024|565636093|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
156696353|NCT01155024|565636094|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
156696354|NCT02272634|565636102|FG000|Overall Study|Adverse Event|1|||
156696355|NCT02272634|565636103|FG001|Overall Study|Adverse Event|0|||
156696356|NCT02272634|565636104|FG002|Overall Study|Adverse Event|0|||
156696357|NCT02272634|565636102|FG000|Overall Study|Protocol Violation|0|||
156696358|NCT02272634|565636103|FG001|Overall Study|Protocol Violation|0|||
156696359|NCT02272634|565636104|FG002|Overall Study|Protocol Violation|1|||
156696360|NCT02272634|565636102|FG000|Overall Study|Withdrawal by Subject|0|||
156696361|NCT02272634|565636103|FG001|Overall Study|Withdrawal by Subject|1|||
156696362|NCT02272634|565636104|FG002|Overall Study|Withdrawal by Subject|0|||
156696363|NCT04647721|565636105|FG000|Overall Study|Withdrawal by Subject|0|||
156696364|NCT04647721|565636106|FG001|Overall Study|Withdrawal by Subject|2|||
156696365|NCT04647721|565636105|FG000|Overall Study|Lost to Follow-up|2|||
156696366|NCT04647721|565636106|FG001|Overall Study|Lost to Follow-up|0|||
157214812|NCT02853929|567533520|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
157214813|NCT02853929|567533521|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
157214814|NCT04313283|567533522|FG000|Overall Study|did not complete intervention|4|||
157214815|NCT04356573|567533523|FG000|Overall Study|Didn't Qualify|1|||
157214816|NCT04356573|567533524|FG001|Overall Study|Didn't Qualify|0|||
157214817|NCT03650400|567533525|FG000|Overall Study|Study terminated by sponsor|0|||
157214818|NCT03650400|567533526|FG001|Overall Study|Study terminated by sponsor|5|||
157214819|NCT01170364|567533528|FG000|Overall Study|Protocol Violation|4|||
157214820|NCT01170364|567533529|FG001|Overall Study|Protocol Violation|1|||
157214821|NCT04132232|567533530|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
157214822|NCT04132232|567533531|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
157214823|NCT04132232|567533530|FG000|Overall Study|Lost to Follow-up|6|||
157214824|NCT04132232|567533531|FG001|Overall Study|Lost to Follow-up|7|||
157214825|NCT01368276|567533533|FG000|Overall Study|Death|1|||
157214826|NCT01368276|567533534|FG001|Overall Study|Death|10|||
157214827|NCT02041494|567533537|FG000|Overall Study|Death|1|||
157214828|NCT02041494|567533538|FG001|Overall Study|Death|3|||
157214829|NCT02041494|567533537|FG000|Overall Study|Lost to Follow-up|2|||
157214830|NCT02041494|567533538|FG001|Overall Study|Lost to Follow-up|6|||
157214831|NCT02041494|567533537|FG000|Overall Study|study terminated|16|||
157214832|NCT02041494|567533538|FG001|Overall Study|study terminated|11|||
156696367|NCT01974440|565636109|FG000|Overall Study|Lost to Follow-up|7|||
156696368|NCT01974440|565636110|FG001|Overall Study|Lost to Follow-up|7|||
156696369|NCT01974440|565636109|FG000|Overall Study|Withdrawal by Subject|24|||
156696370|NCT01974440|565636110|FG001|Overall Study|Withdrawal by Subject|20|||
156696371|NCT01974440|565636109|FG000|Overall Study|Sponsor decision|109|||
156696372|NCT01974440|565636110|FG001|Overall Study|Sponsor decision|110|||
156696373|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
156696374|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
156696375|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
156696376|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
156696377|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
156696378|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
156790074|NCT02933151|565983680|FG000|Overall Study|Recovered Kidney Function|47|||
157214833|NCT03341273|567533539|FG000|Overall Study|Lost to Follow-up|7|||
157214834|NCT03341273|567533540|FG001|Overall Study|Lost to Follow-up|7|||
157214835|NCT03341273|567533539|FG000|Overall Study|Withdrawal by Subject|4|||
157214836|NCT03341273|567533540|FG001|Overall Study|Withdrawal by Subject|2|||
157214837|NCT03341273|567533539|FG000|Overall Study|Physician Decision|1|||
156696379|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
156696380|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
156696381|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
156696382|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
156696383|NCT04771403|565636111|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
156696384|NCT04771403|565636112|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
156696385|NCT04771403|565636111|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
156696386|NCT04771403|565636112|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
156696387|NCT04771403|565636111|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
156696388|NCT04771403|565636112|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
156696389|NCT01640873|565636113|FG000|Overall Study|Protocol Violation|2|||
156696390|NCT01640873|565636114|FG001|Overall Study|Protocol Violation|1|||
156696391|NCT02749292|565636115|FG000|Overall Study|Physician Decision|1|||
156696392|NCT02749292|565636116|FG001|Overall Study|Physician Decision|0|||
156696393|NCT02749292|565636115|FG000|Overall Study|Withdrawal by Subject|5|||
156696394|NCT02749292|565636116|FG001|Overall Study|Withdrawal by Subject|7|||
156696395|NCT02749292|565636115|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
156696396|NCT02749292|565636116|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
156696397|NCT02749292|565636115|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
156696398|NCT02749292|565636116|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
156696399|NCT02749292|565636115|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
156696400|NCT02749292|565636116|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
156696401|NCT02749292|565636115|FG000|Overall Study|Adverse Event|4|||
156696402|NCT02749292|565636116|FG001|Overall Study|Adverse Event|1|||
156696403|NCT02749292|565636115|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
156696404|NCT02749292|565636116|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
156696405|NCT02749292|565636115|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
156696406|NCT02749292|565636116|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
156696407|NCT02749292|565636115|FG000|Overall Study|Requiring glucocorticoids|0|||
156696408|NCT02749292|565636116|FG001|Overall Study|Requiring glucocorticoids|3|||
156696409|NCT02749292|565636115|FG000|Overall Study|Cancer|1|||
156696410|NCT02749292|565636116|FG001|Overall Study|Cancer|0|||
156696411|NCT02458092|565636117|FG000|Overall Study|Withdrawal by Subject|1|||
156696412|NCT02458092|565636118|FG001|Overall Study|Withdrawal by Subject|0|||
156696413|NCT00876018|565636119|FG000|Overall Study|Lost to Follow-up|0|||
156696414|NCT00876018|565636120|FG001|Overall Study|Lost to Follow-up|1|||
156696415|NCT00876018|565636121|FG002|Overall Study|Lost to Follow-up|1|||
156696416|NCT00876018|565636119|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
156696417|NCT00876018|565636120|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
156696418|NCT00876018|565636121|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
156696419|NCT01301508|565636122|FG000|Overall Study|Withdrawal by Subject|1|||
156696420|NCT01301508|565636123|FG001|Overall Study|Withdrawal by Subject|2|||
156696421|NCT01301508|565636122|FG000|Overall Study|Lost to Follow-up|0|||
156696422|NCT01301508|565636123|FG001|Overall Study|Lost to Follow-up|1|||
156696423|NCT01300923|565636124|FG000|Overall Study|Physician Decision|0|||
156696424|NCT01300923|565636125|FG001|Overall Study|Physician Decision|2|||
156696425|NCT02707861|565636128|FG000|Overall Study|Went onto commercial drug|30|||
156696426|NCT02707861|565636129|FG001|Overall Study|Went onto commercial drug|23|||
156696427|NCT02707861|565636128|FG000|Overall Study|Adverse Event|2|||
156696428|NCT02707861|565636129|FG001|Overall Study|Adverse Event|3|||
156696429|NCT02707861|565636128|FG000|Overall Study|Death|5|||
156696430|NCT02707861|565636129|FG001|Overall Study|Death|2|||
156696431|NCT02707861|565636128|FG000|Overall Study|Lack of Efficacy|0|||
156696432|NCT02707861|565636129|FG001|Overall Study|Lack of Efficacy|2|||
156696433|NCT02707861|565636128|FG000|Overall Study|Physician Decision|1|||
156696434|NCT02707861|565636129|FG001|Overall Study|Physician Decision|4|||
156696435|NCT02707861|565636128|FG000|Overall Study|Withdrawal by Subject|2|||
156696436|NCT02707861|565636129|FG001|Overall Study|Withdrawal by Subject|1|||
156790075|NCT02933151|565983681|FG001|Overall Study|Recovered Kidney Function|29|||
156790076|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
156790077|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
156790078|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
156696437|NCT02707861|565636128|FG000|Overall Study|Lost to Follow-up|1|||
156696438|NCT02707861|565636129|FG001|Overall Study|Lost to Follow-up|3|||
156696439|NCT00369382|565636132|FG000|Overall Study|Death|0|||
156696440|NCT00369382|565636133|FG001|Overall Study|Death|2|||
156696441|NCT00369382|565636132|FG000|Overall Study|Physician Decision|2|||
156696442|NCT00369382|565636133|FG001|Overall Study|Physician Decision|1|||
156696443|NCT00369382|565636132|FG000|Overall Study|Withdrawal by Subject|5|||
156696444|NCT00369382|565636133|FG001|Overall Study|Withdrawal by Subject|0|||
156696445|NCT00369382|565636132|FG000|Overall Study|Randomized, not treated|2|||
156696446|NCT00369382|565636133|FG001|Overall Study|Randomized, not treated|0|||
156696447|NCT00369382|565636132|FG000|Overall Study|Other|1|||
156696448|NCT00369382|565636133|FG001|Overall Study|Other|0|||
156696449|NCT00448136|565636139|FG000|Overall Study|Death|3|||
156696450|NCT00448136|565636140|FG001|Overall Study|Death|8|||
156696451|NCT00448136|565636139|FG000|Overall Study|Investigator's decision (progression)|1|||
156696452|NCT00448136|565636140|FG001|Overall Study|Investigator's decision (progression)|0|||
156696453|NCT03407430|565636143|FG000|Washout|Protocol Violation|1|||
156696454|NCT03407430|565636144|FG001|Washout|Protocol Violation|0|||
156696455|NCT00922987|565636145|FG000|Overall Study|Insufficient clinical response|1|||
156696456|NCT00922987|565636145|FG000|Overall Study|Protocol Violation|2|||
156696457|NCT00922987|565636145|FG000|Overall Study|Adverse Event|1|||
156696458|NCT01334710|565636152|FG000|Overall Study|Trial was terminated|3|||
156696459|NCT05011123|565638061|FG000|Overall Study|Withdrawal by Subject|4|||
156696460|NCT05011123|565638062|FG001|Overall Study|Withdrawal by Subject|2|||
156696461|NCT05011123|565638061|FG000|Overall Study|Lost to Follow-up|7|||
156696462|NCT05011123|565638062|FG001|Overall Study|Lost to Follow-up|6|||
156696463|NCT05011123|565638061|FG000|Overall Study|Ongoing at the time of DBL date|36|||
156696464|NCT05011123|565638062|FG001|Overall Study|Ongoing at the time of DBL date|10|||
156696465|NCT05011123|565638061|FG000|Overall Study|Randomized but did not receive vaccination|1|||
156696466|NCT05011123|565638062|FG001|Overall Study|Randomized but did not receive vaccination|0|||
156696467|NCT01687478|565638065|FG000|Overall Study|Adverse Event|3|||
156696468|NCT01687478|565638066|FG001|Overall Study|Adverse Event|10|||
156696469|NCT01687478|565638065|FG000|Overall Study|Lost to Follow-up|1|||
156696470|NCT01687478|565638066|FG001|Overall Study|Lost to Follow-up|3|||
156696471|NCT01687478|565638065|FG000|Overall Study|Protocol Violation|0|||
156696472|NCT01687478|565638066|FG001|Overall Study|Protocol Violation|2|||
156696473|NCT01687478|565638065|FG000|Overall Study|Withdrawal by Subject|21|||
156696474|NCT01687478|565638066|FG001|Overall Study|Withdrawal by Subject|19|||
156696475|NCT01687478|565638065|FG000|Overall Study|Physician Decision|1|||
156696476|NCT01687478|565638066|FG001|Overall Study|Physician Decision|3|||
156696477|NCT01687478|565638065|FG000|Overall Study|Entry Criteria Not Met|6|||
156696478|NCT01687478|565638066|FG001|Overall Study|Entry Criteria Not Met|2|||
156696479|NCT03188718|565638067|FG000|Overall Study|Participant noncompliance|4|||
156696480|NCT03188718|565638067|FG000|Overall Study|Withdrawal by Subject|1|||
156696481|NCT03188718|565638067|FG000|Overall Study|Device failure|3|||
156696482|NCT04322149|565638068|FG000|Overall Study|Adverse Event|1|||
156696483|NCT04322149|565638069|FG001|Overall Study|Adverse Event|1|||
156696484|NCT04322149|565638070|FG002|Overall Study|Adverse Event|0|||
156696485|NCT04322149|565638071|FG003|Overall Study|Adverse Event|0|||
156696486|NCT04322149|565638068|FG000|Overall Study|Withdrawal by Subject|0|||
156696487|NCT04322149|565638069|FG001|Overall Study|Withdrawal by Subject|0|||
156696488|NCT04322149|565638070|FG002|Overall Study|Withdrawal by Subject|0|||
156696489|NCT04322149|565638071|FG003|Overall Study|Withdrawal by Subject|2|||
156696490|NCT04322149|565638068|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696491|NCT04322149|565638069|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
156696492|NCT04322149|565638070|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696493|NCT04322149|565638071|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
156696494|NCT00450619|565638072|FG000|Overall Study|refused treatment after randomization|2|||
156696495|NCT00450619|565638073|FG001|Overall Study|refused treatment after randomization|0|||
156696496|NCT00450619|565638072|FG000|Overall Study|did not progress; refused further trmt|1|||
156696497|NCT00450619|565638073|FG001|Overall Study|did not progress; refused further trmt|1|||
156696498|NCT00450619|565638072|FG000|Overall Study|Adverse Event|1|||
156696499|NCT00450619|565638073|FG001|Overall Study|Adverse Event|0|||
156696500|NCT02963311|565638076|FG000|Overall Study|Withdrawal by Subject|1|||
156696501|NCT02963311|565638076|FG000|Overall Study|Screen Failure|4|||
156696502|NCT04442490|565638079|FG000|Overall Study|Withdrawal by Subject|18|||
156696503|NCT04442490|565638080|FG001|Overall Study|Withdrawal by Subject|10|||
156696504|NCT04442490|565638079|FG000|Overall Study|Lost to Follow-up|7|||
156696505|NCT04442490|565638080|FG001|Overall Study|Lost to Follow-up|7|||
156696506|NCT04442490|565638079|FG000|Overall Study|Adverse Event|2|||
156696507|NCT04442490|565638080|FG001|Overall Study|Adverse Event|6|||
156696508|NCT04442490|565638079|FG000|Overall Study|Noncompliance|3|||
156696509|NCT04442490|565638080|FG001|Overall Study|Noncompliance|1|||
156696510|NCT04442490|565638079|FG000|Overall Study|Physician Decision|2|||
156696511|NCT04442490|565638080|FG001|Overall Study|Physician Decision|1|||
156696512|NCT04442490|565638079|FG000|Overall Study|Reason not Specified|2|||
156696513|NCT04442490|565638080|FG001|Overall Study|Reason not Specified|1|||
156696514|NCT04442490|565638079|FG000|Overall Study|Randomized but not Treated|3|||
156696515|NCT04442490|565638080|FG001|Overall Study|Randomized but not Treated|3|||
156696516|NCT02227147|565638082|FG000|Controlled Treatment Period|Adverse Event|4|||
156696517|NCT02227147|565638083|FG001|Controlled Treatment Period|Adverse Event|3|||
156696518|NCT02227147|565638082|FG000|Controlled Treatment Period|Other|2|||
156696519|NCT02227147|565638083|FG001|Controlled Treatment Period|Other|0|||
156696520|NCT02227147|565638082|FG000|Follow-up Period|Other|3|||
156696521|NCT02227147|565638083|FG001|Follow-up Period|Other|5|||
156696522|NCT00158600|565638089|FG000|Overall Study|unable to commit time to study|0|||
156696523|NCT00158600|565638090|FG001|Overall Study|unable to commit time to study|1|||
156696524|NCT00158600|565638089|FG000|Overall Study|Adverse Event|2|||
156696525|NCT00158600|565638090|FG001|Overall Study|Adverse Event|1|||
156696526|NCT00158600|565638089|FG000|Overall Study|Death|1|||
156696527|NCT00158600|565638090|FG001|Overall Study|Death|0|||
156696528|NCT00158600|565638089|FG000|Overall Study|Withdrawal by Subject|2|||
156696529|NCT00158600|565638090|FG001|Overall Study|Withdrawal by Subject|2|||
156696530|NCT02038907|565638091|FG000|Overall Study|Protocol Violation|0|||
156696531|NCT02038907|565638092|FG001|Overall Study|Protocol Violation|0|||
156696532|NCT02038907|565638093|FG002|Overall Study|Protocol Violation|0|||
156696533|NCT02038907|565638094|FG003|Overall Study|Protocol Violation|0|||
156696534|NCT02038907|565638095|FG004|Overall Study|Protocol Violation|0|||
156696535|NCT02038907|565638096|FG005|Overall Study|Protocol Violation|0|||
156696536|NCT02038907|565638097|FG006|Overall Study|Protocol Violation|0|||
156696537|NCT02038907|565638098|FG007|Overall Study|Protocol Violation|0|||
156696538|NCT02038907|565638099|FG008|Overall Study|Protocol Violation|0|||
156696539|NCT02038907|565638100|FG009|Overall Study|Protocol Violation|0|||
156696540|NCT02038907|565638101|FG010|Overall Study|Protocol Violation|1|||
156696541|NCT02038907|565638102|FG011|Overall Study|Protocol Violation|0|||
156696542|NCT02038907|565638103|FG012|Overall Study|Protocol Violation|0|||
156696543|NCT02038907|565638104|FG013|Overall Study|Protocol Violation|0|||
156696544|NCT02038907|565638091|FG000|Overall Study|Withdrawal by Subject|0|||
156696545|NCT02038907|565638092|FG001|Overall Study|Withdrawal by Subject|0|||
156696546|NCT02038907|565638093|FG002|Overall Study|Withdrawal by Subject|0|||
156696547|NCT02038907|565638094|FG003|Overall Study|Withdrawal by Subject|0|||
156696548|NCT02038907|565638095|FG004|Overall Study|Withdrawal by Subject|0|||
156696549|NCT02038907|565638096|FG005|Overall Study|Withdrawal by Subject|0|||
156696550|NCT02038907|565638097|FG006|Overall Study|Withdrawal by Subject|0|||
156696551|NCT02038907|565638098|FG007|Overall Study|Withdrawal by Subject|0|||
156696552|NCT02038907|565638099|FG008|Overall Study|Withdrawal by Subject|0|||
156696553|NCT02038907|565638100|FG009|Overall Study|Withdrawal by Subject|0|||
156696554|NCT02038907|565638101|FG010|Overall Study|Withdrawal by Subject|1|||
156696555|NCT02038907|565638102|FG011|Overall Study|Withdrawal by Subject|0|||
156696556|NCT02038907|565638103|FG012|Overall Study|Withdrawal by Subject|0|||
156696557|NCT02038907|565638104|FG013|Overall Study|Withdrawal by Subject|0|||
156696558|NCT00622466|565638109|FG000|Overall Study|Death|1|||
156696559|NCT00622466|565638109|FG000|Overall Study|Adverse Event|1|||
156696560|NCT00622466|565638109|FG000|Overall Study|Withdrawal by Subject|2|||
156696561|NCT02618408|565638110|FG000|Overall Study|Withdrawal by Subject|1|||
156696562|NCT02618408|565638111|FG001|Overall Study|Withdrawal by Subject|0|||
156696563|NCT02618408|565638112|FG002|Overall Study|Withdrawal by Subject|4|||
156696564|NCT02618408|565638110|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
156696565|NCT02618408|565638111|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
156696566|NCT02618408|565638112|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
156696567|NCT02618408|565638110|FG000|Overall Study|Lost to Follow-up|4|||
156696568|NCT02618408|565638111|FG001|Overall Study|Lost to Follow-up|2|||
156696569|NCT02618408|565638112|FG002|Overall Study|Lost to Follow-up|6|||
156696570|NCT02618408|565638110|FG000|Overall Study|Adverse Event|4|||
156696571|NCT02618408|565638111|FG001|Overall Study|Adverse Event|0|||
156871117|NCT05006573|566284412|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
156871118|NCT02605122|566285963|FG000|Overall Study|Withdrawal by Subject|4|||
156871119|NCT02605122|566285964|FG001|Overall Study|Withdrawal by Subject|1|||
156871120|NCT02605122|566285963|FG000|Overall Study|Lost to Follow-up|1|||
156871121|NCT02605122|566285964|FG001|Overall Study|Lost to Follow-up|1|||
156871122|NCT02873702|566285968|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
156871123|NCT02873702|566285969|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
156871124|NCT02873702|566285970|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
156871125|NCT02873702|566285971|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
157014535|NCT03398148|566805009|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
156696572|NCT02618408|565638112|FG002|Overall Study|Adverse Event|10|||
156696573|NCT02618408|565638110|FG000|Overall Study|Physician Decision|1|||
156696574|NCT02618408|565638111|FG001|Overall Study|Physician Decision|1|||
156696575|NCT02618408|565638112|FG002|Overall Study|Physician Decision|2|||
156696576|NCT02618408|565638110|FG000|Overall Study|Protocol Violation|1|||
156696577|NCT02618408|565638111|FG001|Overall Study|Protocol Violation|1|||
156696578|NCT02618408|565638112|FG002|Overall Study|Protocol Violation|2|||
156696579|NCT02618408|565638110|FG000|Overall Study|Other, Multiple Categories|0|||
156696580|NCT02618408|565638111|FG001|Overall Study|Other, Multiple Categories|0|||
156871126|NCT02873702|566285968|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156696581|NCT02618408|565638112|FG002|Overall Study|Other, Multiple Categories|4|||
156696582|NCT05183217|565638113|FG000|Overall Study|Withdrawal by Subject|1|||
156696583|NCT05183217|565638114|FG001|Overall Study|Withdrawal by Subject|1|||
156696584|NCT01593696|565638115|FG000|Dose Escalation|Progressive Disease|2|||
156696585|NCT01593696|565638116|FG001|Dose Escalation|Progressive Disease|0|||
156696586|NCT01593696|565638117|FG002|Dose Escalation|Progressive Disease|0|||
156696587|NCT01593696|565638118|FG003|Dose Escalation|Progressive Disease|0|||
156696588|NCT01593696|565638115|FG000|Dose Expansion|Fungal infection|0|||
156696589|NCT01593696|565638116|FG001|Dose Expansion|Fungal infection|0|||
156696590|NCT01593696|565638117|FG002|Dose Expansion|Fungal infection|1|||
156696591|NCT01593696|565638118|FG003|Dose Expansion|Fungal infection|0|||
156696592|NCT01936623|565638119|FG000|Overall Study|Lost to Follow-up|0|||
156696593|NCT01936623|565638120|FG001|Overall Study|Lost to Follow-up|5|||
156696594|NCT00369655|565638124|FG000|Overall Study|Refusal of further treatment|2|||
156696595|NCT02455050|565638125|FG000|Treatment Period 1|Lost to Follow-up|1|||
156696596|NCT02455050|565638126|FG001|Treatment Period 1|Lost to Follow-up|1|||
156696597|NCT02455050|565638127|FG002|Treatment Period 1|Lost to Follow-up|1|||
156696598|NCT02455050|565638128|FG003|Treatment Period 1|Lost to Follow-up|2|||
156696599|NCT02455050|565638125|FG000|Treatment Period 2|Lost to Follow-up|1|||
156696600|NCT02455050|565638126|FG001|Treatment Period 2|Lost to Follow-up|0|||
156696601|NCT02455050|565638127|FG002|Treatment Period 2|Lost to Follow-up|2|||
156696602|NCT02455050|565638128|FG003|Treatment Period 2|Lost to Follow-up|1|||
156696603|NCT03402750|565638129|FG000|Overall Study|Lost to Follow-up|2|||
156696604|NCT03402750|565638130|FG001|Overall Study|Lost to Follow-up|1|||
156696605|NCT02981303|565638131|FG000|Overall Study|Progressive Disease|17|||
156696606|NCT02981303|565638132|FG001|Overall Study|Progressive Disease|37|||
156696607|NCT02981303|565638131|FG000|Overall Study|Adverse Event|1|||
156696608|NCT02981303|565638132|FG001|Overall Study|Adverse Event|4|||
156696609|NCT02981303|565638131|FG000|Overall Study|Withdrawal by Subject|0|||
156696610|NCT02981303|565638132|FG001|Overall Study|Withdrawal by Subject|1|||
156696611|NCT01831765|565638133|FG000|Overall Study|Lack of Efficacy|1|||
156696612|NCT01831765|565638134|FG001|Overall Study|Lack of Efficacy|0|||
156696613|NCT01831765|565638135|FG002|Overall Study|Lack of Efficacy|0|||
156696614|NCT01831765|565638133|FG000|Overall Study|Other, sponsor withdrew subject|0|||
156696615|NCT01831765|565638134|FG001|Overall Study|Other, sponsor withdrew subject|1|||
156696616|NCT01831765|565638135|FG002|Overall Study|Other, sponsor withdrew subject|0|||
156696617|NCT01831765|565638133|FG000|Overall Study|Pregnancy|1|||
156696618|NCT01831765|565638134|FG001|Overall Study|Pregnancy|1|||
156696619|NCT01831765|565638135|FG002|Overall Study|Pregnancy|2|||
156696620|NCT01831765|565638133|FG000|Overall Study|Death|0|||
156696621|NCT01831765|565638134|FG001|Overall Study|Death|1|||
156696622|NCT01831765|565638135|FG002|Overall Study|Death|1|||
156696623|NCT01831765|565638133|FG000|Overall Study|Other, site closed|1|||
156696624|NCT01831765|565638134|FG001|Overall Study|Other, site closed|1|||
156696625|NCT01831765|565638135|FG002|Overall Study|Other, site closed|0|||
156696626|NCT01831765|565638133|FG000|Overall Study|Adverse Event|5|||
156696627|NCT01831765|565638134|FG001|Overall Study|Adverse Event|3|||
156696628|NCT01831765|565638135|FG002|Overall Study|Adverse Event|3|||
156696629|NCT01831765|565638133|FG000|Overall Study|Withdrawal by Subject|22|||
156696630|NCT01831765|565638134|FG001|Overall Study|Withdrawal by Subject|7|||
156696631|NCT01831765|565638135|FG002|Overall Study|Withdrawal by Subject|17|||
156696632|NCT01831765|565638133|FG000|Overall Study|Withdrawal criteria|12|||
156696633|NCT01831765|565638134|FG001|Overall Study|Withdrawal criteria|10|||
156696634|NCT01831765|565638135|FG002|Overall Study|Withdrawal criteria|16|||
156696635|NCT01831765|565638133|FG000|Overall Study|Lost to Follow-up|2|||
156696636|NCT01831765|565638134|FG001|Overall Study|Lost to Follow-up|3|||
156696637|NCT01831765|565638135|FG002|Overall Study|Lost to Follow-up|3|||
156696638|NCT00706511|565638142|FG000|Overall Study|Withdrawal by Subject|1|||
156696639|NCT00706511|565638143|FG001|Overall Study|Withdrawal by Subject|0|||
156696640|NCT00706511|565638144|FG002|Overall Study|Withdrawal by Subject|0|||
156696641|NCT00706511|565638145|FG003|Overall Study|Withdrawal by Subject|0|||
156696642|NCT02116608|565638151|FG000|Overall Study|Lost to Follow-up|0|||
156696643|NCT02116608|565638152|FG001|Overall Study|Lost to Follow-up|0|||
156696644|NCT02116608|565638153|FG002|Overall Study|Lost to Follow-up|1|||
156696645|NCT02116608|565638151|FG000|Overall Study|Physician Decision|0|||
156696646|NCT02116608|565638152|FG001|Overall Study|Physician Decision|1|||
156696647|NCT02116608|565638153|FG002|Overall Study|Physician Decision|0|||
156696648|NCT02116608|565638151|FG000|Overall Study|Death|0|||
156696649|NCT02116608|565638152|FG001|Overall Study|Death|1|||
156696650|NCT02116608|565638153|FG002|Overall Study|Death|0|||
156696651|NCT00988442|565638154|FG000|Overall Study|Death|1|||
156696652|NCT00988442|565638155|FG001|Overall Study|Death|2|||
156696653|NCT00988442|565638154|FG000|Overall Study|Lost to Follow-up|0|||
156696654|NCT00988442|565638155|FG001|Overall Study|Lost to Follow-up|1|||
156696655|NCT00988442|565638154|FG000|Overall Study|Early Study Closure|29|||
156696656|NCT00988442|565638155|FG001|Overall Study|Early Study Closure|25|||
156696657|NCT00117325|565638156|FG000|Overall Study|Adverse Event|3|||
156696658|NCT00117325|565638157|FG001|Overall Study|Adverse Event|3|||
156696659|NCT00117325|565638156|FG000|Overall Study|Lost to Follow-up|1|||
156696660|NCT00117325|565638157|FG001|Overall Study|Lost to Follow-up|1|||
156696661|NCT00117325|565638156|FG000|Overall Study|Protocol Violation|2|||
156696662|NCT00117325|565638157|FG001|Overall Study|Protocol Violation|3|||
156696663|NCT00117325|565638156|FG000|Overall Study|Withdrawal by Subject|3|||
156696664|NCT00117325|565638157|FG001|Overall Study|Withdrawal by Subject|2|||
156696665|NCT00117325|565638156|FG000|Overall Study|Lack of Efficacy|1|||
156696666|NCT00117325|565638157|FG001|Overall Study|Lack of Efficacy|0|||
156696667|NCT00117325|565638156|FG000|Overall Study|Use of prohibited medicine|1|||
156696668|NCT00117325|565638157|FG001|Overall Study|Use of prohibited medicine|2|||
156696669|NCT00117325|565638156|FG000|Overall Study|Early termination|1|||
156696670|NCT00117325|565638157|FG001|Overall Study|Early termination|1|||
156696671|NCT00117325|565638156|FG000|Overall Study|Admisnitrative|1|||
156696672|NCT00117325|565638157|FG001|Overall Study|Admisnitrative|0|||
156696673|NCT01468818|565638161|FG000|Overall Study|Death during treatment|2|||
156696674|NCT02266134|565638162|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
156696675|NCT02266134|565638163|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
157014536|NCT03398148|566805010|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
157014537|NCT03398148|566804996|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
157014538|NCT03398148|566804997|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
157014539|NCT03398148|566804998|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
156696676|NCT02266134|565638164|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
156696677|NCT02266134|565638165|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
156696678|NCT02266134|565638162|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
156696679|NCT02266134|565638163|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
157014540|NCT03398148|566804999|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
157014541|NCT03398148|566805000|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
157014542|NCT03398148|566805001|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
157014543|NCT03398148|566805002|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
157014544|NCT03398148|566805003|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
157014545|NCT03398148|566805004|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
157014546|NCT03398148|566805005|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
157014547|NCT03398148|566805006|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
157014548|NCT03398148|566805007|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
157014549|NCT03398148|566805008|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
157014550|NCT03398148|566805009|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
157014551|NCT03398148|566805010|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
157014552|NCT03398148|566804996|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014553|NCT03398148|566804997|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014554|NCT03398148|566804998|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014555|NCT03398148|566804999|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014556|NCT03398148|566805000|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014557|NCT03398148|566805001|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014558|NCT03398148|566805002|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014559|NCT03398148|566805003|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014560|NCT03398148|566805004|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014561|NCT03398148|566805005|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014562|NCT03398148|566805006|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
157014563|NCT03398148|566805007|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014564|NCT03398148|566805008|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014565|NCT03398148|566805009|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014566|NCT03398148|566805010|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
157014567|NCT03398148|566804996|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014568|NCT03398148|566804997|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014569|NCT03398148|566804998|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014570|NCT03398148|566804999|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014571|NCT03398148|566805000|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014572|NCT03398148|566805001|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014573|NCT03398148|566805002|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014574|NCT03398148|566805003|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014575|NCT03398148|566805004|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014576|NCT03398148|566805005|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
156696680|NCT02266134|565638164|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
156696681|NCT02266134|565638165|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
156696682|NCT02266134|565638162|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
156696683|NCT02266134|565638163|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
156696684|NCT02266134|565638164|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
157014577|NCT03398148|566805006|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
157014578|NCT03398148|566805007|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157021725|NCT04179500|566832934|FG000|Treatment|pyrazinamide resistance|1|||
157021726|NCT03673111|566832945|FG000|Overall Study|Protocol Violation|0|||
157021727|NCT03673111|566832946|FG001|Overall Study|Protocol Violation|0|||
157021728|NCT03673111|566832947|FG002|Overall Study|Protocol Violation|0|||
157021729|NCT03673111|566832948|FG003|Overall Study|Protocol Violation|0|||
157021730|NCT03673111|566832949|FG004|Overall Study|Protocol Violation|0|||
157021731|NCT03673111|566832950|FG005|Overall Study|Protocol Violation|0|||
156696685|NCT02266134|565638165|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
156696686|NCT02266134|565638162|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
156696687|NCT02266134|565638163|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696688|NCT02266134|565638164|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696689|NCT02266134|565638165|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
156696690|NCT02266134|565638162|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
156696691|NCT02266134|565638163|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
156696692|NCT02266134|565638164|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
156696693|NCT02266134|565638165|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
156696694|NCT02266134|565638162|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
156696695|NCT02266134|565638163|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696696|NCT02266134|565638164|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696697|NCT02266134|565638165|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
156696698|NCT04620135|565638166|FG000|Study Completion|Adverse Event|2|||
156696699|NCT04620135|565638167|FG001|Study Completion|Adverse Event|3|||
156696700|NCT04620135|565638166|FG000|Study Completion|Withdrawal by Subject|2|||
156696701|NCT04620135|565638167|FG001|Study Completion|Withdrawal by Subject|0|||
156696702|NCT01442688|565638169|FG000|First Intervention|Withdrawal by Subject|1|||
156696703|NCT01442688|565638170|FG001|First Intervention|Withdrawal by Subject|0|||
157122804|NCT04381650|567200392|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
157122805|NCT04381650|567200393|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
157122806|NCT04381650|567200394|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
157122807|NCT04381650|567200395|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
157122808|NCT04381650|567200396|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
156696704|NCT01442688|565638169|FG000|First Intervention|subject incarcerated|1|||
156696705|NCT01442688|565638170|FG001|First Intervention|subject incarcerated|0|||
156696706|NCT01442688|565638169|FG000|Second Intervention|Adverse Event|1|||
157122809|NCT04381650|567200397|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
156696707|NCT01442688|565638170|FG001|Second Intervention|Adverse Event|0|||
156696708|NCT00762437|565638171|FG000|Overall Study|Lost to Follow-up|7|||
156696709|NCT00762437|565638171|FG000|Overall Study|Missed final study visit|11|||
156696710|NCT00762437|565638171|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
156696711|NCT00302081|565638172|FG000|Overall Study|Adverse Event|6|||
156696712|NCT00302081|565638173|FG001|Overall Study|Adverse Event|5|||
156696713|NCT00302081|565638174|FG002|Overall Study|Adverse Event|4|||
156696714|NCT00302081|565638172|FG000|Overall Study|Lost to Follow-up|21|||
156696715|NCT00302081|565638173|FG001|Overall Study|Lost to Follow-up|18|||
156696716|NCT00302081|565638174|FG002|Overall Study|Lost to Follow-up|28|||
156696717|NCT00302081|565638172|FG000|Overall Study|Withdrawal by Subject|8|||
156696718|NCT00302081|565638173|FG001|Overall Study|Withdrawal by Subject|12|||
156696719|NCT00302081|565638174|FG002|Overall Study|Withdrawal by Subject|8|||
156696720|NCT00302081|565638172|FG000|Overall Study|Protocol Violation|5|||
156696721|NCT00302081|565638173|FG001|Overall Study|Protocol Violation|1|||
156696722|NCT00302081|565638174|FG002|Overall Study|Protocol Violation|2|||
156696723|NCT00302081|565638172|FG000|Overall Study|Lack of Efficacy|1|||
156696724|NCT00302081|565638173|FG001|Overall Study|Lack of Efficacy|0|||
156696725|NCT00302081|565638174|FG002|Overall Study|Lack of Efficacy|5|||
156696726|NCT00302081|565638172|FG000|Overall Study|Death|2|||
156696727|NCT00302081|565638173|FG001|Overall Study|Death|1|||
156696728|NCT00302081|565638174|FG002|Overall Study|Death|0|||
156696729|NCT00302081|565638172|FG000|Overall Study|Other|13|||
156696730|NCT00302081|565638173|FG001|Overall Study|Other|6|||
156696731|NCT00302081|565638174|FG002|Overall Study|Other|5|||
156696732|NCT01359644|565638175|FG000|Treatment Period|Lack of Efficacy|0|||
156696733|NCT01359644|565638176|FG001|Treatment Period|Lack of Efficacy|1|||
156696734|NCT01359644|565638177|FG002|Treatment Period|Lack of Efficacy|0|||
156696735|NCT01359644|565638178|FG003|Treatment Period|Lack of Efficacy|0|||
156696736|NCT01359644|565638179|FG004|Treatment Period|Lack of Efficacy|0|||
156696737|NCT01359644|565638180|FG005|Treatment Period|Lack of Efficacy|0|||
156696738|NCT01359644|565638181|FG006|Treatment Period|Lack of Efficacy|0|||
156696739|NCT01359644|565638182|FG007|Treatment Period|Lack of Efficacy|0|||
156696740|NCT01359644|565638183|FG008|Treatment Period|Lack of Efficacy|0|||
156696741|NCT01359644|565638184|FG009|Treatment Period|Lack of Efficacy|0|||
156696742|NCT01359644|565638175|FG000|Treatment Period|Adverse Event|0|||
156696743|NCT01359644|565638176|FG001|Treatment Period|Adverse Event|0|||
156696744|NCT01359644|565638177|FG002|Treatment Period|Adverse Event|1|||
156696745|NCT01359644|565638178|FG003|Treatment Period|Adverse Event|0|||
156696746|NCT01359644|565638179|FG004|Treatment Period|Adverse Event|0|||
156696747|NCT01359644|565638180|FG005|Treatment Period|Adverse Event|1|||
156696748|NCT01359644|565638181|FG006|Treatment Period|Adverse Event|0|||
156696749|NCT01359644|565638182|FG007|Treatment Period|Adverse Event|0|||
156696750|NCT01359644|565638183|FG008|Treatment Period|Adverse Event|0|||
156696751|NCT01359644|565638184|FG009|Treatment Period|Adverse Event|0|||
156696752|NCT01359644|565638175|FG000|Treatment Period|Lost to Follow-up|0|||
156696753|NCT01359644|565638176|FG001|Treatment Period|Lost to Follow-up|0|||
156696754|NCT01359644|565638177|FG002|Treatment Period|Lost to Follow-up|0|||
157014579|NCT03398148|566805008|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014580|NCT03398148|566805009|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014581|NCT03398148|566805010|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
157014582|NCT03398148|566804996|FG000|Substudy 2 Period 1|Other|0|||
157014583|NCT03398148|566804997|FG001|Substudy 2 Period 1|Other|0|||
157014584|NCT03398148|566804998|FG002|Substudy 2 Period 1|Other|0|||
157014585|NCT03398148|566804999|FG003|Substudy 2 Period 1|Other|0|||
157014586|NCT03398148|566805000|FG004|Substudy 2 Period 1|Other|0|||
157014587|NCT03398148|566805001|FG005|Substudy 2 Period 1|Other|0|||
157014588|NCT03398148|566805002|FG006|Substudy 2 Period 1|Other|0|||
157122810|NCT04381650|567200398|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
157122811|NCT04381650|567200388|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156696755|NCT01359644|565638178|FG003|Treatment Period|Lost to Follow-up|0|||
156696756|NCT01359644|565638179|FG004|Treatment Period|Lost to Follow-up|0|||
156696757|NCT01359644|565638180|FG005|Treatment Period|Lost to Follow-up|1|||
156696758|NCT01359644|565638181|FG006|Treatment Period|Lost to Follow-up|0|||
156696759|NCT01359644|565638182|FG007|Treatment Period|Lost to Follow-up|0|||
156696760|NCT01359644|565638183|FG008|Treatment Period|Lost to Follow-up|0|||
156696761|NCT01359644|565638184|FG009|Treatment Period|Lost to Follow-up|0|||
156696762|NCT01359644|565638175|FG000|Follow-up Period|Withdrawal by Subject|0|||
156696763|NCT01359644|565638176|FG001|Follow-up Period|Withdrawal by Subject|0|||
156696764|NCT01359644|565638177|FG002|Follow-up Period|Withdrawal by Subject|0|||
156696765|NCT01359644|565638178|FG003|Follow-up Period|Withdrawal by Subject|0|||
156696766|NCT01359644|565638179|FG004|Follow-up Period|Withdrawal by Subject|0|||
156696767|NCT01359644|565638180|FG005|Follow-up Period|Withdrawal by Subject|1|||
156696768|NCT01359644|565638181|FG006|Follow-up Period|Withdrawal by Subject|0|||
156696769|NCT01359644|565638182|FG007|Follow-up Period|Withdrawal by Subject|0|||
156696770|NCT01359644|565638183|FG008|Follow-up Period|Withdrawal by Subject|0|||
156696771|NCT01359644|565638184|FG009|Follow-up Period|Withdrawal by Subject|0|||
156696772|NCT01359644|565638175|FG000|Follow-up Period|Lost to Follow-up|0|||
156696773|NCT01359644|565638176|FG001|Follow-up Period|Lost to Follow-up|0|||
156696774|NCT01359644|565638177|FG002|Follow-up Period|Lost to Follow-up|0|||
156696775|NCT01359644|565638178|FG003|Follow-up Period|Lost to Follow-up|0|||
156696776|NCT01359644|565638179|FG004|Follow-up Period|Lost to Follow-up|0|||
156696777|NCT01359644|565638180|FG005|Follow-up Period|Lost to Follow-up|0|||
156696778|NCT01359644|565638181|FG006|Follow-up Period|Lost to Follow-up|1|||
156696779|NCT01359644|565638182|FG007|Follow-up Period|Lost to Follow-up|2|||
156696780|NCT01359644|565638183|FG008|Follow-up Period|Lost to Follow-up|0|||
156696781|NCT01359644|565638184|FG009|Follow-up Period|Lost to Follow-up|0|||
156696782|NCT00311311|565638186|FG000|Overall Study|Adverse Event|3|||
156696783|NCT00311311|565638187|FG001|Overall Study|Adverse Event|2|||
156696784|NCT00311311|565638186|FG000|Overall Study|Withdrawal by Subject|1|||
156696785|NCT00311311|565638187|FG001|Overall Study|Withdrawal by Subject|1|||
156696786|NCT00311311|565638186|FG000|Overall Study|Noncompliance|0|||
156696787|NCT00311311|565638187|FG001|Overall Study|Noncompliance|1|||
156696788|NCT00311311|565638186|FG000|Overall Study|Study Termination by Sponsor|3|||
156696789|NCT00311311|565638187|FG001|Overall Study|Study Termination by Sponsor|4|||
156696790|NCT00311311|565638186|FG000|Overall Study|Death|1|||
156696791|NCT00311311|565638187|FG001|Overall Study|Death|0|||
156696792|NCT00311311|565638186|FG000|Overall Study|Lack of ancillary assistance|0|||
156696793|NCT00311311|565638187|FG001|Overall Study|Lack of ancillary assistance|1|||
156696794|NCT03979820|565638188|FG000|Overall Study|Protocol Violation|1|||
156696795|NCT03979820|565638189|FG001|Overall Study|Protocol Violation|0|||
156696796|NCT03979820|565638190|FG002|Overall Study|Protocol Violation|0|||
156696797|NCT03979820|565638191|FG003|Overall Study|Protocol Violation|0|||
156696798|NCT03979820|565638188|FG000|Overall Study|Withdrawal by Subject|0|||
156696799|NCT03979820|565638189|FG001|Overall Study|Withdrawal by Subject|0|||
156696800|NCT03979820|565638190|FG002|Overall Study|Withdrawal by Subject|1|||
156696801|NCT03979820|565638191|FG003|Overall Study|Withdrawal by Subject|0|||
156696802|NCT03979820|565638188|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
156696803|NCT03979820|565638189|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
157014589|NCT03398148|566805003|FG007|Substudy 2 Period 1|Other|0|||
157122812|NCT04381650|567200389|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
157122813|NCT04381650|567200390|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
157122814|NCT04381650|567200391|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
156696804|NCT03979820|565638190|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
157122815|NCT04381650|567200392|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
156696805|NCT03979820|565638191|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
156696806|NCT01229735|565638192|FG000|Overall Study|Lack of Efficacy|8|||
156696807|NCT01229735|565638193|FG001|Overall Study|Lack of Efficacy|8|||
156696808|NCT01229735|565638192|FG000|Overall Study|Protocol Violation|13|||
157014590|NCT03398148|566805004|FG008|Substudy 2 Period 1|Other|0|||
157014591|NCT03398148|566805005|FG009|Substudy 2 Period 1|Other|4|||
157014592|NCT03398148|566805006|FG010|Substudy 2 Period 1|Other|4|||
157122816|NCT04381650|567200393|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
156696809|NCT01229735|565638193|FG001|Overall Study|Protocol Violation|8|||
156696810|NCT01229735|565638192|FG000|Overall Study|Lost to Follow-up|0|||
156696811|NCT01229735|565638193|FG001|Overall Study|Lost to Follow-up|2|||
156696812|NCT01229735|565638192|FG000|Overall Study|Withdrawal by Subject|18|||
156696813|NCT01229735|565638193|FG001|Overall Study|Withdrawal by Subject|17|||
156696814|NCT01229735|565638192|FG000|Overall Study|Other Reason|13|||
156696815|NCT01229735|565638193|FG001|Overall Study|Other Reason|10|||
156696816|NCT01229735|565638192|FG000|Overall Study|SAE, non-fatal|0|||
156696817|NCT01229735|565638193|FG001|Overall Study|SAE, non-fatal|4|||
156696818|NCT01229735|565638192|FG000|Overall Study|AE, non-serious non-fatal|13|||
156696819|NCT01229735|565638193|FG001|Overall Study|AE, non-serious non-fatal|17|||
156696820|NCT01229735|565638192|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156696821|NCT01229735|565638193|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156696822|NCT02130882|565638194|FG000|Overall Study|Withdrawal by Subject|0|||
156696823|NCT02130882|565638195|FG001|Overall Study|Withdrawal by Subject|1|||
156696824|NCT00536263|565638198|FG000|Overall Study|Adverse Event|5|||
156696825|NCT00536263|565638199|FG001|Overall Study|Adverse Event|5|||
156696826|NCT00536263|565638200|FG002|Overall Study|Adverse Event|7|||
156696827|NCT00536263|565638198|FG000|Overall Study|Lost to Follow-up|3|||
156696828|NCT00536263|565638199|FG001|Overall Study|Lost to Follow-up|4|||
156696829|NCT00536263|565638200|FG002|Overall Study|Lost to Follow-up|4|||
156696830|NCT00536263|565638198|FG000|Overall Study|Subject withdrew - not treatment related|2|||
156696831|NCT00536263|565638199|FG001|Overall Study|Subject withdrew - not treatment related|0|||
156696832|NCT00536263|565638200|FG002|Overall Study|Subject withdrew - not treatment related|5|||
156696833|NCT00536263|565638198|FG000|Overall Study|Subject withdrew - treatment related|0|||
156696834|NCT00536263|565638199|FG001|Overall Study|Subject withdrew - treatment related|3|||
156696835|NCT00536263|565638200|FG002|Overall Study|Subject withdrew - treatment related|2|||
156696836|NCT00536263|565638198|FG000|Overall Study|Noncompliance with protocol|0|||
156696837|NCT00536263|565638199|FG001|Overall Study|Noncompliance with protocol|0|||
156696838|NCT00536263|565638200|FG002|Overall Study|Noncompliance with protocol|1|||
156696839|NCT00536263|565638198|FG000|Overall Study|Did not meet protocol eligibility|1|||
156696840|NCT00536263|565638199|FG001|Overall Study|Did not meet protocol eligibility|2|||
156696841|NCT00536263|565638200|FG002|Overall Study|Did not meet protocol eligibility|2|||
156696842|NCT00826449|565638205|FG000|Overall Study|Disease Progression|4|||
156696843|NCT00826449|565638205|FG000|Overall Study|Withdrawal by Subject|1|||
156696844|NCT02331368|565638206|FG000|Overall Study|Withdrawal by Subject|3|||
156696845|NCT02302859|565638219|FG000|Overall Study|Lost Phone|1|||
156696846|NCT02302859|565638220|FG001|Overall Study|Lost Phone|1|||
156696847|NCT02302859|565638219|FG000|Overall Study|Withdrawal by Subject|0|||
156696848|NCT02302859|565638220|FG001|Overall Study|Withdrawal by Subject|1|||
156696849|NCT04453202|565638227|FG000|Overall Study|Adverse Event|0|||
156696850|NCT04453202|565638228|FG001|Overall Study|Adverse Event|0|||
156696851|NCT04453202|565638229|FG002|Overall Study|Adverse Event|0|||
156696852|NCT04453202|565638230|FG003|Overall Study|Adverse Event|0|||
156696853|NCT04453202|565638231|FG004|Overall Study|Adverse Event|0|||
156696854|NCT04453202|565638232|FG005|Overall Study|Adverse Event|0|||
156696855|NCT04453202|565638233|FG006|Overall Study|Adverse Event|1|||
156696856|NCT04453202|565638234|FG007|Overall Study|Adverse Event|0|||
156696857|NCT04453202|565638235|FG008|Overall Study|Adverse Event|0|||
156696858|NCT04453202|565638236|FG009|Overall Study|Adverse Event|0|||
156696859|NCT04453202|565638237|FG010|Overall Study|Adverse Event|0|||
156696860|NCT04453202|565638227|FG000|Overall Study|Death|0|||
156696861|NCT04453202|565638228|FG001|Overall Study|Death|0|||
156696862|NCT04453202|565638229|FG002|Overall Study|Death|0|||
156696863|NCT04453202|565638230|FG003|Overall Study|Death|0|||
156696864|NCT04453202|565638231|FG004|Overall Study|Death|0|||
156696865|NCT04453202|565638232|FG005|Overall Study|Death|0|||
157014593|NCT03398148|566805007|FG011|Substudy 2 Period 1|Other|0|||
157014594|NCT03398148|566805008|FG012|Substudy 2 Period 1|Other|0|||
156696866|NCT04453202|565638233|FG006|Overall Study|Death|0|||
156696867|NCT04453202|565638234|FG007|Overall Study|Death|0|||
156696868|NCT04453202|565638235|FG008|Overall Study|Death|0|||
156696869|NCT04453202|565638236|FG009|Overall Study|Death|1|||
156696870|NCT04453202|565638237|FG010|Overall Study|Death|0|||
156696871|NCT04453202|565638227|FG000|Overall Study|Lost to Follow-up|0|||
157014595|NCT03398148|566805009|FG013|Substudy 2 Period 1|Other|0|||
157014596|NCT03398148|566805010|FG014|Substudy 2 Period 1|Other|0|||
157014597|NCT03398148|566804996|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014598|NCT03398148|566804997|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014599|NCT03398148|566804998|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014600|NCT03398148|566804999|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014601|NCT03398148|566805000|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014602|NCT03398148|566805001|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014603|NCT03398148|566805002|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014604|NCT03398148|566805003|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014605|NCT03398148|566805004|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
157021732|NCT03673111|566832951|FG006|Overall Study|Protocol Violation|0|||
156696872|NCT04453202|565638228|FG001|Overall Study|Lost to Follow-up|1|||
156696873|NCT04453202|565638229|FG002|Overall Study|Lost to Follow-up|0|||
156696874|NCT04453202|565638230|FG003|Overall Study|Lost to Follow-up|1|||
156696875|NCT04453202|565638231|FG004|Overall Study|Lost to Follow-up|0|||
156696876|NCT04453202|565638232|FG005|Overall Study|Lost to Follow-up|0|||
156696877|NCT04453202|565638233|FG006|Overall Study|Lost to Follow-up|0|||
156696878|NCT04453202|565638234|FG007|Overall Study|Lost to Follow-up|0|||
156696879|NCT04453202|565638235|FG008|Overall Study|Lost to Follow-up|0|||
156696880|NCT04453202|565638236|FG009|Overall Study|Lost to Follow-up|1|||
156696881|NCT04453202|565638237|FG010|Overall Study|Lost to Follow-up|1|||
156696882|NCT04453202|565638227|FG000|Overall Study|Withdrawal by Subject|1|||
156696883|NCT04453202|565638228|FG001|Overall Study|Withdrawal by Subject|2|||
156696884|NCT04453202|565638229|FG002|Overall Study|Withdrawal by Subject|1|||
156696885|NCT04453202|565638230|FG003|Overall Study|Withdrawal by Subject|2|||
156696886|NCT04453202|565638231|FG004|Overall Study|Withdrawal by Subject|1|||
156696887|NCT04453202|565638232|FG005|Overall Study|Withdrawal by Subject|1|||
156696888|NCT04453202|565638233|FG006|Overall Study|Withdrawal by Subject|0|||
156696889|NCT04453202|565638234|FG007|Overall Study|Withdrawal by Subject|0|||
156696890|NCT04453202|565638235|FG008|Overall Study|Withdrawal by Subject|0|||
156696891|NCT04453202|565638236|FG009|Overall Study|Withdrawal by Subject|1|||
156696892|NCT04453202|565638237|FG010|Overall Study|Withdrawal by Subject|0|||
156696893|NCT04453202|565638227|FG000|Overall Study|Adverse Event|0|||
156696894|NCT04453202|565638228|FG001|Overall Study|Adverse Event|0|||
156871127|NCT02873702|566285969|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
157122817|NCT04381650|567200394|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
157122818|NCT04381650|567200395|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
157122819|NCT04381650|567200396|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
157122820|NCT04381650|567200397|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
157122821|NCT04381650|567200398|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
157122822|NCT04381650|567200388|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122823|NCT04381650|567200389|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122824|NCT04381650|567200390|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122825|NCT04381650|567200391|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122826|NCT04381650|567200392|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122827|NCT04381650|567200393|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122828|NCT04381650|567200394|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122829|NCT04381650|567200395|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
156871128|NCT02873702|566285970|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156871129|NCT02873702|566285971|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
156871130|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871131|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871132|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
156871133|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
156871134|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
156871135|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
156871136|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
156871137|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
156871138|NCT02873702|566285968|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
156871139|NCT02873702|566285969|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
156871140|NCT02873702|566285970|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
156871141|NCT02873702|566285971|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
156871142|NCT01229267|566285976|FG000|Overall Study|Adverse Event|4|||
156871143|NCT01229267|566285977|FG001|Overall Study|Adverse Event|6|||
156871144|NCT01229267|566285978|FG002|Overall Study|Adverse Event|3|||
156871145|NCT01229267|566285979|FG003|Overall Study|Adverse Event|2|||
156871146|NCT01229267|566285980|FG004|Overall Study|Adverse Event|10|||
156871147|NCT01229267|566285976|FG000|Overall Study|Death|40|||
156871148|NCT01229267|566285977|FG001|Overall Study|Death|37|||
156871149|NCT01229267|566285978|FG002|Overall Study|Death|35|||
156871150|NCT01229267|566285979|FG003|Overall Study|Death|13|||
156871151|NCT01229267|566285980|FG004|Overall Study|Death|103|||
156871152|NCT01229267|566285976|FG000|Overall Study|Withdrawal by Subject|23|||
156871153|NCT01229267|566285977|FG001|Overall Study|Withdrawal by Subject|22|||
156871154|NCT01229267|566285978|FG002|Overall Study|Withdrawal by Subject|32|||
157122830|NCT04381650|567200396|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156696895|NCT04453202|565638229|FG002|Overall Study|Adverse Event|0|||
156696896|NCT04453202|565638230|FG003|Overall Study|Adverse Event|0|||
156696897|NCT04453202|565638231|FG004|Overall Study|Adverse Event|0|||
157122831|NCT04381650|567200397|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
156696898|NCT04453202|565638232|FG005|Overall Study|Adverse Event|1|||
156696899|NCT04453202|565638233|FG006|Overall Study|Adverse Event|0|||
156696900|NCT04453202|565638234|FG007|Overall Study|Adverse Event|0|||
156696901|NCT04453202|565638235|FG008|Overall Study|Adverse Event|0|||
156871155|NCT01229267|566285979|FG003|Overall Study|Withdrawal by Subject|14|||
156871156|NCT01229267|566285980|FG004|Overall Study|Withdrawal by Subject|59|||
156696902|NCT04453202|565638236|FG009|Overall Study|Adverse Event|0|||
156790079|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
156790080|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
156790081|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
156790082|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
156790083|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
156790084|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790085|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790086|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
156790087|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
156790088|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
156790089|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
156790090|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
156790091|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
156790092|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
156790093|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
156790094|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
157122832|NCT04381650|567200398|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
157122833|NCT00618748|567201461|FG000|Overall Study|Adverse Event|4|||
157122834|NCT00618748|567201462|FG001|Overall Study|Adverse Event|3|||
157122835|NCT00618748|567201463|FG002|Overall Study|Adverse Event|8|||
157122836|NCT00618748|567201461|FG000|Overall Study|Physician Decision|3|||
157122837|NCT00618748|567201462|FG001|Overall Study|Physician Decision|1|||
157122838|NCT00618748|567201463|FG002|Overall Study|Physician Decision|1|||
157122839|NCT00618748|567201461|FG000|Overall Study|Withdrawal by Subject|4|||
157122840|NCT00618748|567201462|FG001|Overall Study|Withdrawal by Subject|1|||
157122841|NCT00618748|567201463|FG002|Overall Study|Withdrawal by Subject|5|||
157122842|NCT02479802|567201468|FG000|Overall Study|Lost to Follow-up|1|||
157122843|NCT02479802|567201468|FG000|Overall Study|Adverse Event|1|||
157122844|NCT02162732|567201473|FG000|Overall Study|Biopsy not performed.|18|||
157122845|NCT01784965|567201474|FG000|Overall Study|Withdrawal by Subject|6|||
157122846|NCT01784965|567201475|FG001|Overall Study|Withdrawal by Subject|3|||
157122847|NCT01784965|567201474|FG000|Overall Study|Adverse Event|0|||
157122848|NCT01784965|567201475|FG001|Overall Study|Adverse Event|8|||
157122849|NCT03757988|567201478|FG000|Overall Study|Withdrawal by Subject|1|||
157122850|NCT02268058|567201479|FG000|Overall Study|Protocol Violation|1|||
157122851|NCT02268058|567201480|FG001|Overall Study|Protocol Violation|0|||
157122852|NCT02268058|567201481|FG002|Overall Study|Protocol Violation|0|||
157122853|NCT02268058|567201482|FG003|Overall Study|Protocol Violation|0|||
157122854|NCT04142983|567201484|FG000|Overall Study|Lost to Follow-up|73|||
157122855|NCT04142983|567201484|FG000|Overall Study|Withdrawal by Subject|10|||
157214838|NCT03341273|567533540|FG001|Overall Study|Physician Decision|0|||
156790095|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
156871157|NCT01229267|566285976|FG000|Overall Study|Protocol Violation|0|||
156871158|NCT01229267|566285977|FG001|Overall Study|Protocol Violation|1|||
156871159|NCT01229267|566285978|FG002|Overall Study|Protocol Violation|0|||
156871160|NCT01229267|566285979|FG003|Overall Study|Protocol Violation|0|||
156871161|NCT01229267|566285980|FG004|Overall Study|Protocol Violation|0|||
156871162|NCT01229267|566285976|FG000|Overall Study|Progressive disease|0|||
156871163|NCT01229267|566285977|FG001|Overall Study|Progressive disease|0|||
156871164|NCT01229267|566285978|FG002|Overall Study|Progressive disease|0|||
156871165|NCT01229267|566285979|FG003|Overall Study|Progressive disease|0|||
156790096|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
156790097|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
156790098|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
156790099|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
156790100|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
156790101|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156790102|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156871166|NCT01229267|566285980|FG004|Overall Study|Progressive disease|1|||
156871167|NCT01229267|566285976|FG000|Overall Study|Physician Decision|8|||
156871168|NCT01229267|566285977|FG001|Overall Study|Physician Decision|11|||
156871169|NCT01229267|566285978|FG002|Overall Study|Physician Decision|8|||
156871170|NCT01229267|566285979|FG003|Overall Study|Physician Decision|3|||
156871171|NCT01229267|566285980|FG004|Overall Study|Physician Decision|25|||
156871172|NCT01229267|566285976|FG000|Overall Study|Lost to Follow-up|6|||
156871173|NCT01229267|566285977|FG001|Overall Study|Lost to Follow-up|5|||
156871174|NCT01229267|566285978|FG002|Overall Study|Lost to Follow-up|8|||
157122856|NCT04142983|567201484|FG000|Overall Study|Physician Decision|1|||
157122857|NCT04142983|567201484|FG000|Overall Study|Adverse Event|1|||
157122858|NCT04142983|567201484|FG000|Overall Study|No longer eligible|4|||
157122859|NCT04142983|567201484|FG000|Overall Study|Screen Failure|10|||
156790103|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
156871175|NCT01229267|566285979|FG003|Overall Study|Lost to Follow-up|3|||
156871176|NCT01229267|566285980|FG004|Overall Study|Lost to Follow-up|22|||
156696903|NCT04453202|565638237|FG010|Overall Study|Adverse Event|0|||
156696904|NCT02615171|565638238|FG000|Overall Study|Lost to Follow-up|2|||
156696905|NCT02615171|565638239|FG001|Overall Study|Lost to Follow-up|1|||
156696906|NCT00456495|565638243|FG000|Overall Study|Physician Decision|2|||
156696907|NCT01940497|565638244|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
156696908|NCT01940497|565638245|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
156696909|NCT01940497|565638244|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
156696910|NCT01940497|565638245|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
156696911|NCT01940497|565638244|FG000|Overall Study|Violation of Entry Criteria|1|||
156696912|NCT01940497|565638245|FG001|Overall Study|Violation of Entry Criteria|1|||
157014606|NCT03398148|566805005|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014607|NCT03398148|566805006|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
157014608|NCT03398148|566805007|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014609|NCT03398148|566805008|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014610|NCT03398148|566805009|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014611|NCT03398148|566805010|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
157014612|NCT03398148|566804996|FG000|Substudy 2 Period 2|Adverse Event|0|||
157014613|NCT03398148|566804997|FG001|Substudy 2 Period 2|Adverse Event|0|||
157014614|NCT03398148|566804998|FG002|Substudy 2 Period 2|Adverse Event|0|||
157014615|NCT03398148|566804999|FG003|Substudy 2 Period 2|Adverse Event|0|||
157014616|NCT03398148|566805000|FG004|Substudy 2 Period 2|Adverse Event|0|||
157014617|NCT03398148|566805001|FG005|Substudy 2 Period 2|Adverse Event|0|||
157014618|NCT03398148|566805002|FG006|Substudy 2 Period 2|Adverse Event|0|||
157014619|NCT03398148|566805003|FG007|Substudy 2 Period 2|Adverse Event|0|||
157014620|NCT03398148|566805004|FG008|Substudy 2 Period 2|Adverse Event|0|||
157014621|NCT03398148|566805005|FG009|Substudy 2 Period 2|Adverse Event|0|||
157014622|NCT03398148|566805006|FG010|Substudy 2 Period 2|Adverse Event|0|||
157014623|NCT03398148|566805007|FG011|Substudy 2 Period 2|Adverse Event|0|||
157014624|NCT03398148|566805008|FG012|Substudy 2 Period 2|Adverse Event|0|||
157122860|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
156696913|NCT01940497|565638244|FG000|Overall Study|Refused Treatment|1|||
156696914|NCT01940497|565638245|FG001|Overall Study|Refused Treatment|3|||
156696915|NCT01940497|565638244|FG000|Overall Study|Withdrew Consent|6|||
156696916|NCT01940497|565638245|FG001|Overall Study|Withdrew Consent|2|||
156790104|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
156790105|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
156790106|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
156790107|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
156790108|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790109|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790110|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
156790111|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
156790112|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790113|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790114|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
156790115|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
156790116|NCT02596893|565983682|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
156790117|NCT02596893|565983683|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
156790118|NCT02596893|565983684|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
156790119|NCT02596893|565983685|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
156790120|NCT03280615|565983686|FG000|Overall Study|Lost to Follow-up|1|||
156790121|NCT03280615|565983687|FG001|Overall Study|Lost to Follow-up|2|||
156790122|NCT03280615|565983686|FG000|Overall Study|Adverse Event|1|||
156790123|NCT03280615|565983687|FG001|Overall Study|Adverse Event|1|||
156790124|NCT03280615|565983686|FG000|Overall Study|Withdrawal by Subject|2|||
156790125|NCT03280615|565983687|FG001|Overall Study|Withdrawal by Subject|2|||
156790126|NCT00004228|565983692|FG000|Overall Study|Adverse Event|0|||
156790127|NCT00004228|565983693|FG001|Overall Study|Adverse Event|1|||
156790128|NCT00004228|565983694|FG002|Overall Study|Adverse Event|0|||
156790129|NCT00004228|565983695|FG003|Overall Study|Adverse Event|0|||
156790130|NCT00004228|565983696|FG004|Overall Study|Adverse Event|1|||
156790131|NCT00004228|565983697|FG005|Overall Study|Adverse Event|0|||
156790132|NCT00004228|565983698|FG006|Overall Study|Adverse Event|0|||
156790133|NCT00004228|565983692|FG000|Overall Study|Death|0|||
156790134|NCT00004228|565983693|FG001|Overall Study|Death|1|||
156790135|NCT00004228|565983694|FG002|Overall Study|Death|2|||
156790136|NCT00004228|565983695|FG003|Overall Study|Death|0|||
156790137|NCT00004228|565983696|FG004|Overall Study|Death|1|||
156790138|NCT00004228|565983697|FG005|Overall Study|Death|0|||
156790139|NCT00004228|565983698|FG006|Overall Study|Death|0|||
156790140|NCT00004228|565983692|FG000|Overall Study|Lack of Efficacy|1|||
156790141|NCT00004228|565983693|FG001|Overall Study|Lack of Efficacy|6|||
157014625|NCT03398148|566805009|FG013|Substudy 2 Period 2|Adverse Event|1|||
157014626|NCT03398148|566805010|FG014|Substudy 2 Period 2|Adverse Event|3|||
157014627|NCT03398148|566804996|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
157122861|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
157122862|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
157122863|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
157122864|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157122865|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157122866|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
157122867|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157122868|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
157122869|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157122870|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157122871|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157122872|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
157122873|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
157122874|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
157122875|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
157122876|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
157122877|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
157122878|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
157122879|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
157122880|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
157122881|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
157122882|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
157122883|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
157122884|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
157122885|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
157122886|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
157122887|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
157122888|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
157122889|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
157122890|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
157122891|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
157122892|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
157122893|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
157122894|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
157122895|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
157122896|NCT03403205|567201485|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
157122897|NCT03403205|567201486|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
157122898|NCT03403205|567201487|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
157122899|NCT03403205|567201488|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
157122900|NCT03403205|567201489|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
157122901|NCT03403205|567201490|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
157122902|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
157122903|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
157122904|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
157122905|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
157122906|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
157122907|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
157122908|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
157122909|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
157122910|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
157122911|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
157122912|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
157122913|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
157122914|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Death|1|||
157122915|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Death|0|||
157122916|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Death|0|||
157122917|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Death|0|||
157122918|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Death|0|||
157122919|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Death|0|||
157122920|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
157122921|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
157122922|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
157122923|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
157122924|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
157122925|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
157122926|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
157122927|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
156696917|NCT01940497|565638244|FG000|Overall Study|Administrative/Other|1|||
156696918|NCT01940497|565638245|FG001|Overall Study|Administrative/Other|1|||
156696919|NCT03123861|565638246|FG000|Overall Study|Protocol Violation|1|||
156696920|NCT03123861|565638247|FG001|Overall Study|Protocol Violation|1|||
156696921|NCT03123861|565638246|FG000|Overall Study|Withdrawal by Subject|2|||
156696922|NCT03123861|565638247|FG001|Overall Study|Withdrawal by Subject|2|||
157122928|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
156696923|NCT06218823|565640797|FG000|Overall Study|Death|3|||
156696924|NCT06218823|565640798|FG001|Overall Study|Death|0|||
156696925|NCT06218823|565640797|FG000|Overall Study|Lost to Follow-up|0|||
156696926|NCT06218823|565640798|FG001|Overall Study|Lost to Follow-up|2|||
156696927|NCT06077487|565640799|FG000|Overall Study|Withdrawal by Subject|0|||
156696928|NCT06077487|565640800|FG001|Overall Study|Withdrawal by Subject|1|||
156696929|NCT05101486|565640801|FG000|Overall Study|Death|1|||
156696930|NCT05101486|565640802|FG001|Overall Study|Death|0|||
156696931|NCT05101486|565640803|FG002|Overall Study|Death|1|||
156696932|NCT05101486|565640801|FG000|Overall Study|Lost to Follow-up|12|||
156696933|NCT05101486|565640802|FG001|Overall Study|Lost to Follow-up|8|||
156696934|NCT05101486|565640803|FG002|Overall Study|Lost to Follow-up|17|||
156696935|NCT05101486|565640801|FG000|Overall Study|Physician Decision|1|||
156696936|NCT05101486|565640802|FG001|Overall Study|Physician Decision|0|||
156696937|NCT05101486|565640803|FG002|Overall Study|Physician Decision|0|||
156696938|NCT05101486|565640801|FG000|Overall Study|Protocol Violation|0|||
156696939|NCT05101486|565640802|FG001|Overall Study|Protocol Violation|0|||
156696940|NCT05101486|565640803|FG002|Overall Study|Protocol Violation|1|||
156696941|NCT05101486|565640801|FG000|Overall Study|Withdrawal by Subject|5|||
156696942|NCT05101486|565640802|FG001|Overall Study|Withdrawal by Subject|2|||
156696943|NCT05101486|565640803|FG002|Overall Study|Withdrawal by Subject|4|||
156696944|NCT05101486|565640801|FG000|Overall Study|Randomized but not vaccinated|1|||
156696945|NCT05101486|565640802|FG001|Overall Study|Randomized but not vaccinated|1|||
156696946|NCT05101486|565640803|FG002|Overall Study|Randomized but not vaccinated|1|||
156696947|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
156696948|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
156696949|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
156696950|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
156696951|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
156696952|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
156696953|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
156696954|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
156696955|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
156696956|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
156696957|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
156696958|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
156696959|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
156696960|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
156696961|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
156696962|NCT02788045|565640804|FG000|Main Study (Up to Week 72)|Other|3|||
156696963|NCT02788045|565640805|FG001|Main Study (Up to Week 72)|Other|0|||
156696964|NCT02788045|565640806|FG002|Main Study (Up to Week 72)|Other|0|||
156696965|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
156696966|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
156696967|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
156696968|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
156696969|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
156696970|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
156696971|NCT02788045|565640804|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
156696972|NCT02788045|565640805|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
156696973|NCT02788045|565640806|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
156696974|NCT04394351|565640807|FG000|Part A (16 Weeks)|Adverse Event|1|||
156696975|NCT04394351|565640808|FG001|Part A (16 Weeks)|Adverse Event|0|||
156696976|NCT04394351|565640809|FG002|Part A (16 Weeks)|Adverse Event|0|||
156696977|NCT04394351|565640810|FG003|Part A (16 Weeks)|Adverse Event|0|||
156696978|NCT04394351|565640811|FG004|Part A (16 Weeks)|Adverse Event|0|||
156696979|NCT04394351|565640812|FG005|Part A (16 Weeks)|Adverse Event|0|||
156696980|NCT04394351|565640813|FG006|Part A (16 Weeks)|Adverse Event|0|||
156696981|NCT04394351|565640814|FG007|Part A (16 Weeks)|Adverse Event|0|||
156696982|NCT04394351|565640807|FG000|Part A (16 Weeks)|Physician Decision|0|||
156696983|NCT04394351|565640808|FG001|Part A (16 Weeks)|Physician Decision|1|||
156696984|NCT04394351|565640809|FG002|Part A (16 Weeks)|Physician Decision|0|||
156696985|NCT04394351|565640810|FG003|Part A (16 Weeks)|Physician Decision|0|||
156696986|NCT04394351|565640811|FG004|Part A (16 Weeks)|Physician Decision|0|||
156696987|NCT04394351|565640812|FG005|Part A (16 Weeks)|Physician Decision|0|||
156696988|NCT04394351|565640813|FG006|Part A (16 Weeks)|Physician Decision|0|||
156696989|NCT04394351|565640814|FG007|Part A (16 Weeks)|Physician Decision|0|||
156696990|NCT04394351|565640807|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696991|NCT04394351|565640808|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
156696992|NCT04394351|565640809|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696993|NCT04394351|565640810|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696994|NCT04394351|565640811|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696995|NCT04394351|565640812|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696996|NCT04394351|565640813|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
156790142|NCT00004228|565983694|FG002|Overall Study|Lack of Efficacy|5|||
156790143|NCT00004228|565983695|FG003|Overall Study|Lack of Efficacy|3|||
156790144|NCT00004228|565983696|FG004|Overall Study|Lack of Efficacy|9|||
157122929|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
157122930|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
157122931|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
157122932|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
157122933|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
157122934|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
157122935|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
157122936|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
157122937|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
157122938|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
157122939|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
157122940|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
157122941|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
157122942|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
157122943|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
157122944|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
157122945|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
157122946|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
157122947|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
157122948|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
157122949|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
157122950|NCT03403205|567201485|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
157122951|NCT03403205|567201486|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
157122952|NCT03403205|567201487|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
157122953|NCT03403205|567201488|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
157122954|NCT03403205|567201489|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
157122955|NCT03403205|567201490|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
157122956|NCT00706030|567201491|FG000|Overall Study|Disease Progression|4|||
157122957|NCT00706030|567201492|FG001|Overall Study|Disease Progression|6|||
157122958|NCT00706030|567201493|FG002|Overall Study|Disease Progression|46|||
157122959|NCT00706030|567201494|FG003|Overall Study|Disease Progression|12|||
157122960|NCT00706030|567201491|FG000|Overall Study|Adverse Event|1|||
157122961|NCT00706030|567201492|FG001|Overall Study|Adverse Event|0|||
157122962|NCT00706030|567201493|FG002|Overall Study|Adverse Event|4|||
157122963|NCT00706030|567201494|FG003|Overall Study|Adverse Event|2|||
157122964|NCT00706030|567201491|FG000|Overall Study|Withdrawal by Subject|1|||
157122965|NCT00706030|567201492|FG001|Overall Study|Withdrawal by Subject|0|||
157122966|NCT00706030|567201493|FG002|Overall Study|Withdrawal by Subject|2|||
157122967|NCT00706030|567201494|FG003|Overall Study|Withdrawal by Subject|0|||
157122968|NCT00706030|567201491|FG000|Overall Study|Physician Decision|0|||
157122969|NCT00706030|567201492|FG001|Overall Study|Physician Decision|0|||
157122970|NCT00706030|567201493|FG002|Overall Study|Physician Decision|2|||
157122971|NCT00706030|567201494|FG003|Overall Study|Physician Decision|0|||
157122972|NCT00706030|567201491|FG000|Overall Study|Not recorded|0|||
157122973|NCT00706030|567201492|FG001|Overall Study|Not recorded|0|||
157122974|NCT00706030|567201493|FG002|Overall Study|Not recorded|2|||
157122975|NCT00706030|567201494|FG003|Overall Study|Not recorded|0|||
157122976|NCT00706030|567201491|FG000|Overall Study|Protocol Violation|0|||
157122977|NCT00706030|567201492|FG001|Overall Study|Protocol Violation|0|||
157122978|NCT00706030|567201493|FG002|Overall Study|Protocol Violation|1|||
157122979|NCT00706030|567201494|FG003|Overall Study|Protocol Violation|1|||
157122980|NCT00706030|567201491|FG000|Overall Study|Failed to return|0|||
157122981|NCT00706030|567201492|FG001|Overall Study|Failed to return|0|||
157122982|NCT00706030|567201493|FG002|Overall Study|Failed to return|1|||
157122983|NCT00706030|567201494|FG003|Overall Study|Failed to return|0|||
157122984|NCT00706030|567201491|FG000|Overall Study|Symptomatic Deterioration|0|||
156696997|NCT04394351|565640814|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
156696998|NCT04394351|565640807|FG000|Part B (36 Weeks)|Adverse Event|0|||
157122985|NCT00706030|567201492|FG001|Overall Study|Symptomatic Deterioration|0|||
157122986|NCT00706030|567201493|FG002|Overall Study|Symptomatic Deterioration|1|||
157122987|NCT00706030|567201494|FG003|Overall Study|Symptomatic Deterioration|0|||
157122988|NCT00706030|567201491|FG000|Overall Study|No treatment received|0|||
156696999|NCT04394351|565640808|FG001|Part B (36 Weeks)|Adverse Event|0|||
156697000|NCT04394351|565640809|FG002|Part B (36 Weeks)|Adverse Event|0|||
156697001|NCT04394351|565640810|FG003|Part B (36 Weeks)|Adverse Event|0|||
156697002|NCT04394351|565640811|FG004|Part B (36 Weeks)|Adverse Event|0|||
156697003|NCT04394351|565640812|FG005|Part B (36 Weeks)|Adverse Event|0|||
156697004|NCT04394351|565640813|FG006|Part B (36 Weeks)|Adverse Event|1|||
156697005|NCT04394351|565640814|FG007|Part B (36 Weeks)|Adverse Event|0|||
156697006|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697007|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697008|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697009|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697010|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697011|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697012|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
156697013|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
156697014|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697015|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697016|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697017|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697018|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697019|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697020|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
156697021|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
156697022|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697023|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697024|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697025|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697026|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697027|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697028|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
156697029|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
156697030|NCT04394351|565640807|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697031|NCT04394351|565640808|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697032|NCT04394351|565640809|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697033|NCT04394351|565640810|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697034|NCT04394351|565640811|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697035|NCT04394351|565640812|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697036|NCT04394351|565640813|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
156697037|NCT04394351|565640814|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
156697038|NCT03653507|565640815|FG000|Overall Study|Miscellaneous|28|||
156697039|NCT03653507|565640816|FG001|Overall Study|Miscellaneous|19|||
156697040|NCT03653507|565640815|FG000|Overall Study|Withdrawal by Subject|37|||
156697041|NCT03653507|565640816|FG001|Overall Study|Withdrawal by Subject|22|||
156697042|NCT03653507|565640815|FG000|Overall Study|Protocol Deviation|2|||
156697043|NCT03653507|565640816|FG001|Overall Study|Protocol Deviation|1|||
156697044|NCT03653507|565640815|FG000|Overall Study|Progressive disease|117|||
156697045|NCT03653507|565640816|FG001|Overall Study|Progressive disease|168|||
156697046|NCT03653507|565640815|FG000|Overall Study|Lost to Follow-up|1|||
156697047|NCT03653507|565640816|FG001|Overall Study|Lost to Follow-up|1|||
156697048|NCT03653507|565640815|FG000|Overall Study|Death|25|||
156697049|NCT03653507|565640816|FG001|Overall Study|Death|22|||
156697050|NCT03653507|565640815|FG000|Overall Study|Adverse Event|35|||
156697051|NCT03653507|565640816|FG001|Overall Study|Adverse Event|14|||
156697052|NCT01288053|565640817|FG000|Overall Study|Death|1|||
156697053|NCT03188666|565640818|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697054|NCT03188666|565640819|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
156697055|NCT03188666|565640820|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697056|NCT03188666|565640821|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
156697057|NCT03188666|565640818|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
156697058|NCT03188666|565640819|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
156697059|NCT03188666|565640820|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
156697060|NCT03188666|565640821|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
157021733|NCT03673111|566832952|FG007|Overall Study|Protocol Violation|0|||
156697061|NCT03188666|565640818|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
156697062|NCT03188666|565640819|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
157021734|NCT03673111|566832953|FG008|Overall Study|Protocol Violation|0|||
157021735|NCT03673111|566832954|FG009|Overall Study|Protocol Violation|0|||
157021736|NCT03673111|566832955|FG010|Overall Study|Protocol Violation|1|||
157021737|NCT03673111|566832956|FG011|Overall Study|Protocol Violation|0|||
157021738|NCT03673111|566832957|FG012|Overall Study|Protocol Violation|0|||
157021739|NCT03673111|566832958|FG013|Overall Study|Protocol Violation|0|||
157021740|NCT03673111|566832945|FG000|Overall Study|Adverse Event|1|||
156697063|NCT03188666|565640820|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
156697064|NCT03188666|565640821|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
156697065|NCT03188666|565640818|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
156697066|NCT03188666|565640819|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
156697067|NCT03188666|565640820|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
156697068|NCT03188666|565640821|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
156697069|NCT00144781|565640822|FG000|Overall Study|Adverse Event|0|||
157122989|NCT00706030|567201492|FG001|Overall Study|No treatment received|0|||
157122990|NCT00706030|567201493|FG002|Overall Study|No treatment received|0|||
157122991|NCT00706030|567201494|FG003|Overall Study|No treatment received|1|||
157122992|NCT00706030|567201491|FG000|Overall Study|Death|0|||
157122993|NCT00706030|567201492|FG001|Overall Study|Death|0|||
157122994|NCT00706030|567201493|FG002|Overall Study|Death|1|||
157122995|NCT00706030|567201494|FG003|Overall Study|Death|0|||
157122996|NCT03870555|567201495|FG000|Period 3 (2 Days)|Adverse Event|1|||
157122997|NCT03870555|567201496|FG001|Period 3 (2 Days)|Adverse Event|0|||
157122998|NCT03870555|567201497|FG002|Period 3 (2 Days)|Adverse Event|0|||
157122999|NCT03847610|567201498|FG000|Overall Study|Withdrawal by Subject|1|||
157123000|NCT02004873|567201499|FG000|Overall Study|Implant unsuccessful|6|||
157123001|NCT02004873|567201499|FG000|Overall Study|Awaiting 6-month visit|390|||
157123002|NCT02004873|567201499|FG000|Overall Study|Missed 6-month visit|4|||
157123003|NCT02004873|567201499|FG000|Overall Study|Death|23|||
157214839|NCT03341273|567533539|FG000|Overall Study|Protocol Violation|0|||
157214840|NCT03341273|567533540|FG001|Overall Study|Protocol Violation|1|||
157214841|NCT03341273|567533539|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
157214842|NCT03341273|567533540|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
157214843|NCT03341273|567533539|FG000|Overall Study|Became ineligible after enrollment|1|||
157214844|NCT03341273|567533540|FG001|Overall Study|Became ineligible after enrollment|0|||
157214845|NCT03341273|567533539|FG000|Overall Study|Not Eligible at Enrollment|0|||
157123004|NCT02004873|567201499|FG000|Overall Study|Withdrawal by Subject|1|||
157123005|NCT01445769|567201501|FG000|Overall Study|Consent Withdrawn|2|||
157123006|NCT01445769|567201501|FG000|Overall Study|Disease Progression|1|||
157123007|NCT01445769|567201501|FG000|Overall Study|Lost to Follow-up|5|||
157123008|NCT02799069|567201504|FG000|Overall Study|Adverse Event|0|||
157123009|NCT02799069|567201505|FG001|Overall Study|Adverse Event|2|||
157123010|NCT02799069|567201506|FG002|Overall Study|Adverse Event|2|||
157123011|NCT02799069|567201504|FG000|Overall Study|Lack of Efficacy|2|||
156697070|NCT00144781|565640823|FG001|Overall Study|Adverse Event|1|||
156697071|NCT00144781|565640824|FG002|Overall Study|Adverse Event|0|||
156697072|NCT00144781|565640825|FG003|Overall Study|Adverse Event|0|||
156697073|NCT00144781|565640822|FG000|Overall Study|Non-compliant|0|||
156790145|NCT00004228|565983697|FG005|Overall Study|Lack of Efficacy|8|||
156790146|NCT00004228|565983698|FG006|Overall Study|Lack of Efficacy|4|||
156790147|NCT00004228|565983692|FG000|Overall Study|Lost to Follow-up|0|||
156790148|NCT00004228|565983693|FG001|Overall Study|Lost to Follow-up|0|||
156790149|NCT00004228|565983694|FG002|Overall Study|Lost to Follow-up|1|||
156790150|NCT00004228|565983695|FG003|Overall Study|Lost to Follow-up|0|||
156790151|NCT00004228|565983696|FG004|Overall Study|Lost to Follow-up|0|||
156790152|NCT00004228|565983697|FG005|Overall Study|Lost to Follow-up|0|||
156790153|NCT00004228|565983698|FG006|Overall Study|Lost to Follow-up|0|||
156790154|NCT00004228|565983692|FG000|Overall Study|Physician Decision|1|||
156790155|NCT00004228|565983693|FG001|Overall Study|Physician Decision|0|||
156790156|NCT00004228|565983694|FG002|Overall Study|Physician Decision|3|||
156790157|NCT00004228|565983695|FG003|Overall Study|Physician Decision|2|||
156790158|NCT00004228|565983696|FG004|Overall Study|Physician Decision|1|||
156790159|NCT00004228|565983697|FG005|Overall Study|Physician Decision|1|||
156790160|NCT00004228|565983698|FG006|Overall Study|Physician Decision|1|||
156790161|NCT00004228|565983692|FG000|Overall Study|Protocol Violation|0|||
156790162|NCT00004228|565983693|FG001|Overall Study|Protocol Violation|5|||
156790163|NCT00004228|565983694|FG002|Overall Study|Protocol Violation|2|||
156790164|NCT00004228|565983695|FG003|Overall Study|Protocol Violation|1|||
156790165|NCT00004228|565983696|FG004|Overall Study|Protocol Violation|1|||
156790166|NCT00004228|565983697|FG005|Overall Study|Protocol Violation|2|||
156790167|NCT00004228|565983698|FG006|Overall Study|Protocol Violation|0|||
156790168|NCT00004228|565983692|FG000|Overall Study|Withdrawal by Subject|3|||
156790169|NCT00004228|565983693|FG001|Overall Study|Withdrawal by Subject|0|||
156790170|NCT00004228|565983694|FG002|Overall Study|Withdrawal by Subject|1|||
156790171|NCT00004228|565983695|FG003|Overall Study|Withdrawal by Subject|0|||
156790172|NCT00004228|565983696|FG004|Overall Study|Withdrawal by Subject|2|||
156790173|NCT00004228|565983697|FG005|Overall Study|Withdrawal by Subject|1|||
156790174|NCT00004228|565983698|FG006|Overall Study|Withdrawal by Subject|2|||
156790175|NCT00004228|565983692|FG000|Overall Study|Other|0|||
156790176|NCT00004228|565983693|FG001|Overall Study|Other|0|||
156790177|NCT00004228|565983694|FG002|Overall Study|Other|1|||
156790178|NCT00004228|565983695|FG003|Overall Study|Other|0|||
156790179|NCT00004228|565983696|FG004|Overall Study|Other|0|||
156790180|NCT00004228|565983697|FG005|Overall Study|Other|0|||
157123012|NCT02799069|567201505|FG001|Overall Study|Lack of Efficacy|0|||
157123013|NCT02799069|567201506|FG002|Overall Study|Lack of Efficacy|0|||
156871177|NCT03085797|566285983|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
156790181|NCT00004228|565983698|FG006|Overall Study|Other|0|||
156790182|NCT00004228|565983692|FG000|Overall Study|ineligible|4|||
156790183|NCT00004228|565983693|FG001|Overall Study|ineligible|2|||
156790184|NCT00004228|565983694|FG002|Overall Study|ineligible|4|||
156790185|NCT00004228|565983695|FG003|Overall Study|ineligible|1|||
156790186|NCT00004228|565983696|FG004|Overall Study|ineligible|1|||
156790187|NCT00004228|565983697|FG005|Overall Study|ineligible|2|||
156790188|NCT00004228|565983698|FG006|Overall Study|ineligible|5|||
156790189|NCT02457546|565983703|FG000|Overall Study|Other reasons|4|||
156790190|NCT02457546|565983704|FG001|Overall Study|Other reasons|1|||
156790191|NCT02457546|565983703|FG000|Overall Study|Refused to complete study/procedures|1|||
156790192|NCT02457546|565983704|FG001|Overall Study|Refused to complete study/procedures|1|||
156790193|NCT02457546|565983703|FG000|Overall Study|Lost to Follow-up|4|||
156790194|NCT02457546|565983704|FG001|Overall Study|Lost to Follow-up|1|||
156790195|NCT02457546|565983703|FG000|Overall Study|Adverse Event|0|||
156790196|NCT02457546|565983704|FG001|Overall Study|Adverse Event|1|||
156790197|NCT01897896|565983705|FG000|Overall Study|Death|1|||
156790198|NCT01897896|565983706|FG001|Overall Study|Death|0|||
156790199|NCT01897896|565983705|FG000|Overall Study|Adverse Event|11|||
156790200|NCT01897896|565983706|FG001|Overall Study|Adverse Event|1|||
156790201|NCT01897896|565983705|FG000|Overall Study|Lost to Follow-up|1|||
156790202|NCT01897896|565983706|FG001|Overall Study|Lost to Follow-up|0|||
156790203|NCT01897896|565983705|FG000|Overall Study|Non-compliance with study drug dosing|1|||
156790204|NCT01897896|565983706|FG001|Overall Study|Non-compliance with study drug dosing|1|||
156790205|NCT01897896|565983705|FG000|Overall Study|Withdrawal by Subject|7|||
156790206|NCT01897896|565983706|FG001|Overall Study|Withdrawal by Subject|1|||
156790207|NCT01897896|565983705|FG000|Overall Study|Require drug that interfere with study|1|||
156790208|NCT01897896|565983706|FG001|Overall Study|Require drug that interfere with study|4|||
156790209|NCT01897896|565983705|FG000|Overall Study|Protocol Violation|1|||
156790210|NCT01897896|565983706|FG001|Overall Study|Protocol Violation|1|||
156790211|NCT01897896|565983705|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
156790212|NCT01897896|565983706|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
156790213|NCT01897896|565983705|FG000|Overall Study|Caregiver can no longer participate|0|||
156790214|NCT01897896|565983706|FG001|Overall Study|Caregiver can no longer participate|2|||
156790215|NCT01897896|565983705|FG000|Overall Study|Other than specified|2|||
156790216|NCT01897896|565983706|FG001|Overall Study|Other than specified|1|||
156790217|NCT00090402|565983716|FG000|Overall Study|Death|1|||
156790218|NCT00090402|565983717|FG001|Overall Study|Death|1|||
156790219|NCT00090402|565983718|FG002|Overall Study|Death|0|||
156790220|NCT00090402|565983716|FG000|Overall Study|subject moved|0|||
156790221|NCT00090402|565983717|FG001|Overall Study|subject moved|1|||
156790222|NCT00090402|565983718|FG002|Overall Study|subject moved|0|||
156790223|NCT00090402|565983716|FG000|Overall Study|stopped taking study medication|1|||
156790224|NCT00090402|565983717|FG001|Overall Study|stopped taking study medication|0|||
156790225|NCT00090402|565983718|FG002|Overall Study|stopped taking study medication|1|||
156790226|NCT01052428|565983721|FG000|Overall Study|Death|1|||
156790227|NCT01052428|565983722|FG001|Overall Study|Death|0|||
156790228|NCT01052428|565983721|FG000|Overall Study|Withdrawal by Subject|0|||
156790229|NCT01052428|565983722|FG001|Overall Study|Withdrawal by Subject|1|||
156790230|NCT01292473|565983723|FG000|Overall Study|Adverse Event|1|||
156790231|NCT01292473|565983724|FG001|Overall Study|Adverse Event|0|||
156790232|NCT01292473|565983725|FG002|Overall Study|Adverse Event|1|||
156790233|NCT01292473|565983726|FG003|Overall Study|Adverse Event|1|||
156790234|NCT01292473|565983723|FG000|Overall Study|Lost to Follow-up|1|||
156790235|NCT01292473|565983724|FG001|Overall Study|Lost to Follow-up|1|||
156790236|NCT01292473|565983725|FG002|Overall Study|Lost to Follow-up|2|||
156790237|NCT01292473|565983726|FG003|Overall Study|Lost to Follow-up|2|||
156790238|NCT01292473|565983723|FG000|Overall Study|Withdrawal by Subject|3|||
156790239|NCT01292473|565983724|FG001|Overall Study|Withdrawal by Subject|4|||
156790240|NCT01292473|565983725|FG002|Overall Study|Withdrawal by Subject|3|||
156790241|NCT01292473|565983726|FG003|Overall Study|Withdrawal by Subject|3|||
156790242|NCT01292473|565983723|FG000|Overall Study|Physician Decision|0|||
156790243|NCT01292473|565983724|FG001|Overall Study|Physician Decision|1|||
156790244|NCT01292473|565983725|FG002|Overall Study|Physician Decision|0|||
156790245|NCT01292473|565983726|FG003|Overall Study|Physician Decision|0|||
156790246|NCT01292473|565983723|FG000|Overall Study|Disease Progression|0|||
156790247|NCT01292473|565983724|FG001|Overall Study|Disease Progression|1|||
156790248|NCT01292473|565983725|FG002|Overall Study|Disease Progression|3|||
156790249|NCT01292473|565983726|FG003|Overall Study|Disease Progression|6|||
156790250|NCT02451007|565983727|FG000|Overall Study|Withdrawal by Subject|4|||
156790251|NCT02451007|565983727|FG000|Overall Study|Adverse Event|1|||
156790252|NCT02451007|565983727|FG000|Overall Study|Disease Progression|2|||
156790253|NCT01716559|565983728|FG000|Overall Study|Adverse Event|11|||
156790254|NCT01716559|565983728|FG000|Overall Study|Death|21|||
156790255|NCT01716559|565983728|FG000|Overall Study|Withdrawal by Subject|4|||
156790256|NCT01716559|565983728|FG000|Overall Study|Other withdrawal reason|75|||
156790257|NCT01651208|565983744|FG000|Overall Study|Lost to Follow-up|14|||
156697074|NCT00144781|565640823|FG001|Overall Study|Non-compliant|1|||
156697075|NCT00144781|565640824|FG002|Overall Study|Non-compliant|0|||
156697076|NCT00144781|565640825|FG003|Overall Study|Non-compliant|0|||
156697077|NCT03696953|565640826|FG000|Overall Study|Withdrawal by Subject|6|||
156697078|NCT03696953|565640827|FG001|Overall Study|Withdrawal by Subject|1|||
156697079|NCT03696953|565640826|FG000|Overall Study|missed GBS swabs|2|||
156697080|NCT03696953|565640827|FG001|Overall Study|missed GBS swabs|2|||
156697081|NCT03696953|565640826|FG000|Overall Study|lost study bottle containing capsules|2|||
156697082|NCT03696953|565640827|FG001|Overall Study|lost study bottle containing capsules|0|||
156697083|NCT03696953|565640826|FG000|Overall Study|Premature birth|1|||
156697084|NCT03696953|565640827|FG001|Overall Study|Premature birth|4|||
156697085|NCT03696953|565640826|FG000|Overall Study|Gestational hypertension|1|||
156697086|NCT03696953|565640827|FG001|Overall Study|Gestational hypertension|1|||
156697087|NCT03696953|565640826|FG000|Overall Study|Gestational diabetes|2|||
156697088|NCT03696953|565640827|FG001|Overall Study|Gestational diabetes|1|||
156697089|NCT03696953|565640826|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
156697090|NCT03696953|565640827|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
156697091|NCT03696953|565640826|FG000|Overall Study|Changed prenatal provider|1|||
156697092|NCT03696953|565640827|FG001|Overall Study|Changed prenatal provider|1|||
156697093|NCT02068092|565640828|FG000|Overall Study|Physician Decision|2|||
156697094|NCT02068092|565640828|FG000|Overall Study|Adverse Event|2|||
156697095|NCT02068092|565640828|FG000|Overall Study|Lost to Follow-up|4|||
156697096|NCT02068092|565640828|FG000|Overall Study|Withdrawal by Subject|2|||
156697097|NCT03502707|565640829|FG000|Overall Study|Adverse Event|0|||
156697098|NCT03502707|565640830|FG001|Overall Study|Adverse Event|0|||
156697099|NCT03502707|565640831|FG002|Overall Study|Adverse Event|0|||
156697100|NCT03502707|565640832|FG003|Overall Study|Adverse Event|0|||
156697101|NCT03502707|565640833|FG004|Overall Study|Adverse Event|0|||
156697102|NCT03502707|565640834|FG005|Overall Study|Adverse Event|0|||
156697103|NCT03502707|565640835|FG006|Overall Study|Adverse Event|0|||
156697104|NCT03502707|565640836|FG007|Overall Study|Adverse Event|0|||
156697105|NCT03502707|565640837|FG008|Overall Study|Adverse Event|0|||
156697106|NCT03502707|565640838|FG009|Overall Study|Adverse Event|0|||
156697107|NCT03502707|565640839|FG010|Overall Study|Adverse Event|0|||
156697108|NCT03502707|565640840|FG011|Overall Study|Adverse Event|0|||
156697109|NCT03502707|565640841|FG012|Overall Study|Adverse Event|0|||
156697110|NCT03502707|565640842|FG013|Overall Study|Adverse Event|0|||
156697111|NCT03502707|565640843|FG014|Overall Study|Adverse Event|0|||
156697112|NCT03502707|565640844|FG015|Overall Study|Adverse Event|1|||
156697113|NCT03502707|565640845|FG016|Overall Study|Adverse Event|5|||
156697114|NCT03502707|565640846|FG017|Overall Study|Adverse Event|0|||
156697115|NCT03502707|565640829|FG000|Overall Study|Death|0|||
156697116|NCT03502707|565640830|FG001|Overall Study|Death|0|||
156697117|NCT03502707|565640831|FG002|Overall Study|Death|0|||
156697118|NCT03502707|565640832|FG003|Overall Study|Death|1|||
156697119|NCT03502707|565640833|FG004|Overall Study|Death|0|||
156697120|NCT03502707|565640834|FG005|Overall Study|Death|0|||
156697121|NCT03502707|565640835|FG006|Overall Study|Death|0|||
156697122|NCT03502707|565640836|FG007|Overall Study|Death|0|||
156697123|NCT03502707|565640837|FG008|Overall Study|Death|1|||
156697124|NCT03502707|565640838|FG009|Overall Study|Death|1|||
156697125|NCT03502707|565640839|FG010|Overall Study|Death|0|||
156697126|NCT03502707|565640840|FG011|Overall Study|Death|0|||
156697127|NCT03502707|565640841|FG012|Overall Study|Death|1|||
156697128|NCT03502707|565640842|FG013|Overall Study|Death|0|||
156697129|NCT03502707|565640843|FG014|Overall Study|Death|0|||
156697130|NCT03502707|565640844|FG015|Overall Study|Death|1|||
156697131|NCT03502707|565640845|FG016|Overall Study|Death|0|||
157214846|NCT03341273|567533540|FG001|Overall Study|Not Eligible at Enrollment|1|||
156697132|NCT03502707|565640846|FG017|Overall Study|Death|0|||
156697133|NCT03502707|565640829|FG000|Overall Study|Lost to Follow-up|0|||
156697134|NCT03502707|565640830|FG001|Overall Study|Lost to Follow-up|0|||
156697135|NCT03502707|565640831|FG002|Overall Study|Lost to Follow-up|0|||
156697136|NCT03502707|565640832|FG003|Overall Study|Lost to Follow-up|0|||
156697137|NCT03502707|565640833|FG004|Overall Study|Lost to Follow-up|0|||
156697138|NCT03502707|565640834|FG005|Overall Study|Lost to Follow-up|0|||
156697139|NCT03502707|565640835|FG006|Overall Study|Lost to Follow-up|0|||
156697140|NCT03502707|565640836|FG007|Overall Study|Lost to Follow-up|5|||
156697141|NCT03502707|565640837|FG008|Overall Study|Lost to Follow-up|0|||
156697142|NCT03502707|565640838|FG009|Overall Study|Lost to Follow-up|2|||
156697143|NCT03502707|565640839|FG010|Overall Study|Lost to Follow-up|1|||
156697144|NCT03502707|565640840|FG011|Overall Study|Lost to Follow-up|2|||
156697145|NCT03502707|565640841|FG012|Overall Study|Lost to Follow-up|1|||
156697146|NCT03502707|565640842|FG013|Overall Study|Lost to Follow-up|1|||
156697147|NCT03502707|565640843|FG014|Overall Study|Lost to Follow-up|0|||
156697148|NCT03502707|565640844|FG015|Overall Study|Lost to Follow-up|4|||
156697149|NCT03502707|565640845|FG016|Overall Study|Lost to Follow-up|9|||
156697150|NCT03502707|565640846|FG017|Overall Study|Lost to Follow-up|2|||
156697151|NCT03502707|565640829|FG000|Overall Study|Physician Decision|0|||
156697152|NCT03502707|565640830|FG001|Overall Study|Physician Decision|0|||
156697153|NCT03502707|565640831|FG002|Overall Study|Physician Decision|0|||
156871178|NCT03085797|566285984|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
156871179|NCT03085797|566285983|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
156871180|NCT03085797|566285984|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
156871181|NCT03085797|566285983|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
156871182|NCT03085797|566285984|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
156871183|NCT04050202|566285985|FG000|Overall Study|Lost to Follow-up|2|||
156871184|NCT00001213|566285986|FG000|Overall Study|Death|18|||
156871185|NCT02636595|566285987|FG000|Overall Study|Lost to Follow-up|1|||
156871186|NCT02636595|566285987|FG000|Overall Study|Other|1|||
156871187|NCT05782179|566285991|FG000|Overall Study|Adverse Event|0|||
156871188|NCT05782179|566285992|FG001|Overall Study|Adverse Event|0|||
156871189|NCT05782179|566285993|FG002|Overall Study|Adverse Event|2|||
156871190|NCT05782179|566285994|FG003|Overall Study|Adverse Event|0|||
156697154|NCT03502707|565640832|FG003|Overall Study|Physician Decision|0|||
156697155|NCT03502707|565640833|FG004|Overall Study|Physician Decision|0|||
156697156|NCT03502707|565640834|FG005|Overall Study|Physician Decision|0|||
156697157|NCT03502707|565640835|FG006|Overall Study|Physician Decision|0|||
156697158|NCT03502707|565640836|FG007|Overall Study|Physician Decision|0|||
156697159|NCT03502707|565640837|FG008|Overall Study|Physician Decision|2|||
156697160|NCT03502707|565640838|FG009|Overall Study|Physician Decision|1|||
156697161|NCT03502707|565640839|FG010|Overall Study|Physician Decision|0|||
156697162|NCT03502707|565640840|FG011|Overall Study|Physician Decision|0|||
156697163|NCT03502707|565640841|FG012|Overall Study|Physician Decision|0|||
156697164|NCT03502707|565640842|FG013|Overall Study|Physician Decision|0|||
156697165|NCT03502707|565640843|FG014|Overall Study|Physician Decision|1|||
156697166|NCT03502707|565640844|FG015|Overall Study|Physician Decision|3|||
156697167|NCT03502707|565640845|FG016|Overall Study|Physician Decision|0|||
156697168|NCT03502707|565640846|FG017|Overall Study|Physician Decision|0|||
156697169|NCT03502707|565640829|FG000|Overall Study|Protocol Violation|0|||
156697170|NCT03502707|565640830|FG001|Overall Study|Protocol Violation|0|||
156697171|NCT03502707|565640831|FG002|Overall Study|Protocol Violation|0|||
156697172|NCT03502707|565640832|FG003|Overall Study|Protocol Violation|0|||
156697173|NCT03502707|565640833|FG004|Overall Study|Protocol Violation|0|||
156697174|NCT03502707|565640834|FG005|Overall Study|Protocol Violation|0|||
156697175|NCT03502707|565640835|FG006|Overall Study|Protocol Violation|0|||
156697176|NCT03502707|565640836|FG007|Overall Study|Protocol Violation|0|||
156697177|NCT03502707|565640837|FG008|Overall Study|Protocol Violation|0|||
156697178|NCT03502707|565640838|FG009|Overall Study|Protocol Violation|0|||
156697179|NCT03502707|565640839|FG010|Overall Study|Protocol Violation|0|||
156697180|NCT03502707|565640840|FG011|Overall Study|Protocol Violation|0|||
156697181|NCT03502707|565640841|FG012|Overall Study|Protocol Violation|0|||
156697182|NCT03502707|565640842|FG013|Overall Study|Protocol Violation|0|||
156697183|NCT03502707|565640843|FG014|Overall Study|Protocol Violation|0|||
156697184|NCT03502707|565640844|FG015|Overall Study|Protocol Violation|1|||
156697185|NCT03502707|565640845|FG016|Overall Study|Protocol Violation|0|||
156790258|NCT01651208|565983745|FG001|Overall Study|Lost to Follow-up|16|||
156790259|NCT02067156|565983746|FG000|Overall Study|Lost to Follow-up|4|||
156790260|NCT03596983|565983747|FG000|Overall Study|Withdrawal by Subject|3|||
156790261|NCT05287685|565983748|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
156790262|NCT05287685|565983749|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
156790263|NCT05287685|565983748|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
156790264|NCT05287685|565983749|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
156790265|NCT05529173|565983750|FG000|Overall Study|Physician Decision|3|||
156790266|NCT05529173|565983751|FG001|Overall Study|Physician Decision|6|||
156790267|NCT05529173|565983750|FG000|Overall Study|Sample shipment delay more than one day|4|||
156790268|NCT05529173|565983751|FG001|Overall Study|Sample shipment delay more than one day|0|||
156790269|NCT00835549|565983754|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
156790270|NCT00835549|565983755|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156871191|NCT05782179|566285995|FG004|Overall Study|Adverse Event|0|||
156871192|NCT05782179|566285996|FG005|Overall Study|Adverse Event|0|||
156871193|NCT06170242|566285997|FG000|Overall Study|Lost to Follow-up|0|||
156871194|NCT06170242|566285998|FG001|Overall Study|Lost to Follow-up|0|||
156871195|NCT06170242|566285999|FG002|Overall Study|Lost to Follow-up|1|||
156871196|NCT06170242|566286000|FG003|Overall Study|Lost to Follow-up|1|||
156871197|NCT02004093|566286001|FG000|Overall Study|Death|2|||
156871198|NCT02004093|566286002|FG001|Overall Study|Death|1|||
156697186|NCT03502707|565640846|FG017|Overall Study|Protocol Violation|0|||
156697187|NCT03502707|565640829|FG000|Overall Study|Withdrawal by Subject|1|||
156697188|NCT03502707|565640830|FG001|Overall Study|Withdrawal by Subject|1|||
156871199|NCT02004093|566286001|FG000|Overall Study|Lack of Efficacy|66|||
156697189|NCT03502707|565640831|FG002|Overall Study|Withdrawal by Subject|0|||
156697190|NCT03502707|565640832|FG003|Overall Study|Withdrawal by Subject|0|||
156697191|NCT03502707|565640833|FG004|Overall Study|Withdrawal by Subject|0|||
156697192|NCT03502707|565640834|FG005|Overall Study|Withdrawal by Subject|2|||
156790271|NCT03760081|565983769|FG000|Overall Study|Miscellaneous|0|||
156790272|NCT03760081|565983770|FG001|Overall Study|Miscellaneous|1|||
156871200|NCT02004093|566286002|FG001|Overall Study|Lack of Efficacy|62|||
156697193|NCT03502707|565640835|FG006|Overall Study|Withdrawal by Subject|0|||
157014628|NCT03398148|566804997|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
157014629|NCT03398148|566804998|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
157014630|NCT03398148|566804999|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
157014631|NCT03398148|566805000|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
157014632|NCT03398148|566805001|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
157014633|NCT03398148|566805002|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
157014634|NCT03398148|566805003|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
157014635|NCT03398148|566805004|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
157014636|NCT03398148|566805005|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
157014637|NCT03398148|566805006|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
157014638|NCT03398148|566805007|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
157014639|NCT03398148|566805008|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
157014640|NCT03398148|566805009|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
157014641|NCT03398148|566805010|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
157214847|NCT03341273|567533539|FG000|Overall Study|Participant incarcerated|1|||
157214848|NCT03341273|567533540|FG001|Overall Study|Participant incarcerated|0|||
156697194|NCT03502707|565640836|FG007|Overall Study|Withdrawal by Subject|3|||
156697195|NCT03502707|565640837|FG008|Overall Study|Withdrawal by Subject|1|||
156697196|NCT03502707|565640838|FG009|Overall Study|Withdrawal by Subject|2|||
156697197|NCT03502707|565640839|FG010|Overall Study|Withdrawal by Subject|12|||
156697198|NCT03502707|565640840|FG011|Overall Study|Withdrawal by Subject|23|||
156697199|NCT03502707|565640841|FG012|Overall Study|Withdrawal by Subject|5|||
156697200|NCT03502707|565640842|FG013|Overall Study|Withdrawal by Subject|3|||
156697201|NCT03502707|565640843|FG014|Overall Study|Withdrawal by Subject|3|||
156697202|NCT03502707|565640844|FG015|Overall Study|Withdrawal by Subject|43|||
156697203|NCT03502707|565640845|FG016|Overall Study|Withdrawal by Subject|44|||
156697204|NCT03502707|565640846|FG017|Overall Study|Withdrawal by Subject|18|||
156697205|NCT03502707|565640829|FG000|Overall Study|Sponsor's Decision|1|||
156697206|NCT03502707|565640830|FG001|Overall Study|Sponsor's Decision|0|||
156697207|NCT03502707|565640831|FG002|Overall Study|Sponsor's Decision|0|||
156697208|NCT03502707|565640832|FG003|Overall Study|Sponsor's Decision|0|||
156697209|NCT03502707|565640833|FG004|Overall Study|Sponsor's Decision|0|||
156697210|NCT03502707|565640834|FG005|Overall Study|Sponsor's Decision|0|||
156697211|NCT03502707|565640835|FG006|Overall Study|Sponsor's Decision|0|||
156697212|NCT03502707|565640836|FG007|Overall Study|Sponsor's Decision|0|||
156697213|NCT03502707|565640837|FG008|Overall Study|Sponsor's Decision|0|||
156697214|NCT03502707|565640838|FG009|Overall Study|Sponsor's Decision|1|||
156697215|NCT03502707|565640839|FG010|Overall Study|Sponsor's Decision|0|||
156697216|NCT03502707|565640840|FG011|Overall Study|Sponsor's Decision|0|||
156697217|NCT03502707|565640841|FG012|Overall Study|Sponsor's Decision|0|||
156697218|NCT03502707|565640842|FG013|Overall Study|Sponsor's Decision|0|||
156697219|NCT03502707|565640843|FG014|Overall Study|Sponsor's Decision|0|||
156697220|NCT03502707|565640844|FG015|Overall Study|Sponsor's Decision|2|||
156697221|NCT03502707|565640845|FG016|Overall Study|Sponsor's Decision|1|||
156697222|NCT03502707|565640846|FG017|Overall Study|Sponsor's Decision|0|||
156697223|NCT03502707|565640829|FG000|Overall Study|Initiated Prohibited Medication|0|||
156697224|NCT03502707|565640830|FG001|Overall Study|Initiated Prohibited Medication|0|||
156697225|NCT03502707|565640831|FG002|Overall Study|Initiated Prohibited Medication|0|||
156697226|NCT03502707|565640832|FG003|Overall Study|Initiated Prohibited Medication|0|||
156697227|NCT03502707|565640833|FG004|Overall Study|Initiated Prohibited Medication|0|||
156697228|NCT03502707|565640834|FG005|Overall Study|Initiated Prohibited Medication|0|||
156697229|NCT03502707|565640835|FG006|Overall Study|Initiated Prohibited Medication|0|||
156697230|NCT03502707|565640836|FG007|Overall Study|Initiated Prohibited Medication|0|||
156697231|NCT03502707|565640837|FG008|Overall Study|Initiated Prohibited Medication|0|||
156697232|NCT03502707|565640838|FG009|Overall Study|Initiated Prohibited Medication|0|||
156697233|NCT03502707|565640839|FG010|Overall Study|Initiated Prohibited Medication|0|||
156697234|NCT03502707|565640840|FG011|Overall Study|Initiated Prohibited Medication|0|||
156697235|NCT03502707|565640841|FG012|Overall Study|Initiated Prohibited Medication|0|||
156697236|NCT03502707|565640842|FG013|Overall Study|Initiated Prohibited Medication|0|||
156697237|NCT03502707|565640843|FG014|Overall Study|Initiated Prohibited Medication|0|||
156697238|NCT03502707|565640844|FG015|Overall Study|Initiated Prohibited Medication|0|||
156697239|NCT03502707|565640845|FG016|Overall Study|Initiated Prohibited Medication|1|||
156697240|NCT03502707|565640846|FG017|Overall Study|Initiated Prohibited Medication|0|||
156697241|NCT03502707|565640829|FG000|Overall Study|Other|0|||
156697242|NCT03502707|565640830|FG001|Overall Study|Other|0|||
156697243|NCT03502707|565640831|FG002|Overall Study|Other|0|||
156697244|NCT03502707|565640832|FG003|Overall Study|Other|0|||
156697245|NCT03502707|565640833|FG004|Overall Study|Other|0|||
156697246|NCT03502707|565640834|FG005|Overall Study|Other|0|||
156697247|NCT03502707|565640835|FG006|Overall Study|Other|0|||
156697248|NCT03502707|565640836|FG007|Overall Study|Other|0|||
156697249|NCT03502707|565640837|FG008|Overall Study|Other|1|||
156697250|NCT03502707|565640838|FG009|Overall Study|Other|1|||
156697251|NCT03502707|565640839|FG010|Overall Study|Other|2|||
157014642|NCT03398148|566804996|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014643|NCT03398148|566804997|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014644|NCT03398148|566804998|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156871201|NCT02004093|566286001|FG000|Overall Study|Protocol Violation|0|||
156871202|NCT02004093|566286002|FG001|Overall Study|Protocol Violation|1|||
156871203|NCT02004093|566286001|FG000|Overall Study|Lost to Follow-up|0|||
156871204|NCT02004093|566286002|FG001|Overall Study|Lost to Follow-up|1|||
156871205|NCT02004093|566286001|FG000|Overall Study|Withdrawal by Subject|3|||
156871206|NCT02004093|566286002|FG001|Overall Study|Withdrawal by Subject|7|||
156871207|NCT02004093|566286001|FG000|Overall Study|Other|3|||
156871208|NCT02004093|566286002|FG001|Overall Study|Other|1|||
156871209|NCT04085289|566286003|FG000|Overall Study|Withdrawal by Subject|0|||
156697252|NCT03502707|565640840|FG011|Overall Study|Other|0|||
156871210|NCT04085289|566286004|FG001|Overall Study|Withdrawal by Subject|0|||
156871211|NCT04085289|566286005|FG002|Overall Study|Withdrawal by Subject|1|||
156871212|NCT00414596|566286006|FG000|Overall Study|Protocol Violation|2|||
156871213|NCT04639258|566286007|FG000|Overall Study|Screen failure|5|||
156871214|NCT04639258|566286007|FG000|Overall Study|Physician Decision|2|||
156871215|NCT04639258|566286007|FG000|Overall Study|Early study termination|3|||
156871216|NCT04639258|566286007|FG000|Overall Study|Withdrawal by Subject|1|||
156871217|NCT02560558|566286010|FG000|Overall Study|Adverse Event|1|||
156871218|NCT02560558|566286011|FG001|Overall Study|Adverse Event|0|||
156871219|NCT02560558|566286010|FG000|Overall Study|Death|0|||
156871220|NCT02560558|566286011|FG001|Overall Study|Death|2|||
156871221|NCT02560558|566286010|FG000|Overall Study|Lost to Follow-up|0|||
156871222|NCT02560558|566286011|FG001|Overall Study|Lost to Follow-up|4|||
156871223|NCT02560558|566286010|FG000|Overall Study|Protocol Violation|3|||
156871224|NCT02560558|566286011|FG001|Overall Study|Protocol Violation|0|||
156871225|NCT02560558|566286010|FG000|Overall Study|Withdrawal by Subject|3|||
156871226|NCT02560558|566286011|FG001|Overall Study|Withdrawal by Subject|0|||
156871227|NCT01263197|566286027|FG000|First Intervention (Period 1)|Adverse Event|0|||
156871228|NCT01263197|566286028|FG001|First Intervention (Period 1)|Adverse Event|0|||
156871229|NCT01263197|566286029|FG002|First Intervention (Period 1)|Adverse Event|0|||
156871230|NCT01263197|566286030|FG003|First Intervention (Period 1)|Adverse Event|0|||
156871231|NCT01263197|566286031|FG004|First Intervention (Period 1)|Adverse Event|0|||
156871232|NCT01263197|566286032|FG005|First Intervention (Period 1)|Adverse Event|1|||
156871233|NCT01263197|566286027|FG000|Washout Period 1|Protocol Violation|0|||
156871234|NCT01263197|566286028|FG001|Washout Period 1|Protocol Violation|0|||
156871235|NCT01263197|566286029|FG002|Washout Period 1|Protocol Violation|0|||
156871236|NCT01263197|566286030|FG003|Washout Period 1|Protocol Violation|0|||
156871237|NCT01263197|566286031|FG004|Washout Period 1|Protocol Violation|1|||
156871238|NCT01263197|566286032|FG005|Washout Period 1|Protocol Violation|0|||
156871239|NCT01263197|566286027|FG000|Washout Period 2|Physician Decision|0|||
156871240|NCT01263197|566286028|FG001|Washout Period 2|Physician Decision|0|||
156871241|NCT01263197|566286029|FG002|Washout Period 2|Physician Decision|0|||
156871242|NCT01263197|566286030|FG003|Washout Period 2|Physician Decision|0|||
156871243|NCT01263197|566286031|FG004|Washout Period 2|Physician Decision|0|||
156871244|NCT01263197|566286032|FG005|Washout Period 2|Physician Decision|1|||
156871245|NCT01263197|566286027|FG000|Washout Period 2|Protocol Violation|0|||
156697253|NCT03502707|565640841|FG012|Overall Study|Other|0|||
156697254|NCT03502707|565640842|FG013|Overall Study|Other|0|||
156697255|NCT03502707|565640843|FG014|Overall Study|Other|0|||
156697256|NCT03502707|565640844|FG015|Overall Study|Other|4|||
156697257|NCT03502707|565640845|FG016|Overall Study|Other|1|||
156697258|NCT03502707|565640846|FG017|Overall Study|Other|0|||
156697259|NCT03502707|565640829|FG000|Overall Study|Randomized but not vaccinated|0|||
156697260|NCT03502707|565640830|FG001|Overall Study|Randomized but not vaccinated|0|||
156697261|NCT03502707|565640831|FG002|Overall Study|Randomized but not vaccinated|0|||
156697262|NCT03502707|565640832|FG003|Overall Study|Randomized but not vaccinated|0|||
156871246|NCT01263197|566286028|FG001|Washout Period 2|Protocol Violation|0|||
156697263|NCT03502707|565640833|FG004|Overall Study|Randomized but not vaccinated|0|||
156697264|NCT03502707|565640834|FG005|Overall Study|Randomized but not vaccinated|0|||
156871247|NCT01263197|566286029|FG002|Washout Period 2|Protocol Violation|0|||
156871248|NCT01263197|566286030|FG003|Washout Period 2|Protocol Violation|1|||
156871249|NCT01263197|566286031|FG004|Washout Period 2|Protocol Violation|0|||
156871250|NCT01263197|566286032|FG005|Washout Period 2|Protocol Violation|0|||
156871251|NCT01263197|566286027|FG000|Third Intervention (Period 3)|Adverse Event|0|||
156871252|NCT01263197|566286028|FG001|Third Intervention (Period 3)|Adverse Event|1|||
156871253|NCT01263197|566286029|FG002|Third Intervention (Period 3)|Adverse Event|0|||
156871254|NCT01263197|566286030|FG003|Third Intervention (Period 3)|Adverse Event|0|||
156871255|NCT01263197|566286031|FG004|Third Intervention (Period 3)|Adverse Event|0|||
156871256|NCT01263197|566286032|FG005|Third Intervention (Period 3)|Adverse Event|0|||
156871257|NCT01967576|566286037|FG000|Overall Study|Withdrawal by Subject|3|||
156697265|NCT03502707|565640835|FG006|Overall Study|Randomized but not vaccinated|0|||
156697266|NCT03502707|565640836|FG007|Overall Study|Randomized but not vaccinated|0|||
156871258|NCT01967576|566286037|FG000|Overall Study|Progressed/Removed from treatment|1|||
156871259|NCT01967576|566286037|FG000|Overall Study|Study closing at site|1|||
156871260|NCT01967576|566286037|FG000|Overall Study|Adverse Event|1|||
156871261|NCT01967576|566286037|FG000|Overall Study|Refused further treatment|1|||
156871262|NCT02892448|566286040|FG000|Overall Study|Screening failure|2|||
156871263|NCT02892448|566286041|FG001|Overall Study|Screening failure|2|||
156871264|NCT02892448|566286042|FG002|Overall Study|Screening failure|1|||
156871265|NCT00131248|566286043|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
156871266|NCT00131248|566286044|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
156871267|NCT04269889|566286045|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
156871268|NCT01654302|566286050|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
156871269|NCT01654302|566286051|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
156871270|NCT02447003|566286056|FG000|Overall Study|Other|0|||
156871271|NCT02447003|566286057|FG001|Overall Study|Other|4|||
156871272|NCT02447003|566286056|FG000|Overall Study|Site discontinued|0|||
156871273|NCT02447003|566286057|FG001|Overall Study|Site discontinued|2|||
156871274|NCT02447003|566286056|FG000|Overall Study|Physician Decision|0|||
156871275|NCT02447003|566286057|FG001|Overall Study|Physician Decision|1|||
156871276|NCT02447003|566286056|FG000|Overall Study|Withdrawal by Subject|4|||
156871277|NCT02447003|566286057|FG001|Overall Study|Withdrawal by Subject|3|||
156871278|NCT02447003|566286056|FG000|Overall Study|Sponsor Decision|6|||
156871279|NCT02447003|566286057|FG001|Overall Study|Sponsor Decision|11|||
156871280|NCT02447003|566286056|FG000|Overall Study|Progressive Disease|1|||
156871281|NCT02447003|566286057|FG001|Overall Study|Progressive Disease|0|||
156871282|NCT02447003|566286056|FG000|Overall Study|Lost to Follow-up|5|||
156871283|NCT02447003|566286057|FG001|Overall Study|Lost to Follow-up|0|||
156871284|NCT02447003|566286056|FG000|Overall Study|Death|154|||
156871285|NCT02447003|566286057|FG001|Overall Study|Death|63|||
156871286|NCT03848728|566286058|FG000|Overall Study|Death|16|||
156871287|NCT03848728|566286059|FG001|Overall Study|Death|13|||
156871288|NCT03848728|566286058|FG000|Overall Study|Outmigrated to non-study community|98|||
156871289|NCT03848728|566286059|FG001|Overall Study|Outmigrated to non-study community|106|||
156871290|NCT03848728|566286058|FG000|Overall Study|Transfered to non-study clinic|32|||
156697267|NCT03502707|565640837|FG008|Overall Study|Randomized but not vaccinated|0|||
156697268|NCT03502707|565640838|FG009|Overall Study|Randomized but not vaccinated|0|||
156697269|NCT03502707|565640839|FG010|Overall Study|Randomized but not vaccinated|0|||
156697270|NCT03502707|565640840|FG011|Overall Study|Randomized but not vaccinated|1|||
156697271|NCT03502707|565640841|FG012|Overall Study|Randomized but not vaccinated|0|||
156697272|NCT03502707|565640842|FG013|Overall Study|Randomized but not vaccinated|0|||
156697273|NCT03502707|565640843|FG014|Overall Study|Randomized but not vaccinated|0|||
156697274|NCT03502707|565640844|FG015|Overall Study|Randomized but not vaccinated|0|||
156697275|NCT03502707|565640845|FG016|Overall Study|Randomized but not vaccinated|0|||
156697276|NCT03502707|565640846|FG017|Overall Study|Randomized but not vaccinated|1|||
156697277|NCT00461253|565640847|FG000|Overall Study|Death|985|||
156697278|NCT00461253|565640848|FG001|Overall Study|Death|0|||
156697279|NCT00461253|565640847|FG000|Overall Study|Protocol Violation|613|||
156697280|NCT00461253|565640848|FG001|Overall Study|Protocol Violation|236|||
156697281|NCT00461253|565640847|FG000|Overall Study|no response|2609|||
156697282|NCT00461253|565640848|FG001|Overall Study|no response|11789|||
156697283|NCT00461253|565640847|FG000|Overall Study|administrative|773|||
156871291|NCT03848728|566286059|FG001|Overall Study|Transfered to non-study clinic|48|||
156871292|NCT03848728|566286058|FG000|Overall Study|Withdrawal by Subject|1|||
156871293|NCT03848728|566286059|FG001|Overall Study|Withdrawal by Subject|0|||
156871294|NCT00536744|566286062|FG000|Overall Study|Adverse Event|13|||
156871295|NCT00536744|566286063|FG001|Overall Study|Adverse Event|10|||
156871296|NCT00536744|566286062|FG000|Overall Study|Death|2|||
156871297|NCT00536744|566286063|FG001|Overall Study|Death|1|||
156871298|NCT00536744|566286062|FG000|Overall Study|Physician Decision|3|||
156871299|NCT00536744|566286063|FG001|Overall Study|Physician Decision|1|||
156871300|NCT00536744|566286062|FG000|Overall Study|Lost to Follow-up|3|||
156871301|NCT00536744|566286063|FG001|Overall Study|Lost to Follow-up|5|||
157014645|NCT03398148|566804999|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
156697284|NCT00461253|565640848|FG001|Overall Study|administrative|7773|||
156697285|NCT01933113|565640849|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
156697286|NCT02297438|565640850|FG000|Overall Study|Death|79|||
156697287|NCT02297438|565640851|FG001|Overall Study|Death|86|||
156697288|NCT02297438|565640850|FG000|Overall Study|Lost to Follow-up|9|||
156697289|NCT02297438|565640851|FG001|Overall Study|Lost to Follow-up|7|||
156697290|NCT02297438|565640850|FG000|Overall Study|Withdrawal by Subject|7|||
156697291|NCT02297438|565640851|FG001|Overall Study|Withdrawal by Subject|0|||
156871302|NCT00536744|566286062|FG000|Overall Study|Withdrawal by Subject|7|||
156871303|NCT00536744|566286063|FG001|Overall Study|Withdrawal by Subject|8|||
156871304|NCT00536744|566286062|FG000|Overall Study|PI tried alternative treatment|1|||
156871305|NCT00536744|566286063|FG001|Overall Study|PI tried alternative treatment|3|||
156871306|NCT02581410|566286064|FG000|Vaccination Phase|Adverse Event|2|||
156871307|NCT02581410|566286065|FG001|Vaccination Phase|Adverse Event|1|||
156871308|NCT02581410|566286064|FG000|Vaccination Phase|Withdrawal by Subject|0|||
156871309|NCT02581410|566286065|FG001|Vaccination Phase|Withdrawal by Subject|1|||
156871310|NCT02581410|566286064|FG000|Vaccination Phase|Migrated/moved from study area|0|||
156871311|NCT02581410|566286065|FG001|Vaccination Phase|Migrated/moved from study area|1|||
156871312|NCT02581410|566286064|FG000|End of Study Phase|Adverse Event|4|||
156697292|NCT02297438|565640850|FG000|Overall Study|Other|9|||
156697293|NCT02297438|565640851|FG001|Overall Study|Other|5|||
156697294|NCT02297438|565640850|FG000|Overall Study|Ongoing|65|||
156697295|NCT02297438|565640851|FG001|Overall Study|Ongoing|73|||
156697296|NCT04092894|565640852|FG000|Overall Study|Withdrawal by Subject|2|||
156697297|NCT04092894|565640853|FG001|Overall Study|Withdrawal by Subject|4|||
156697298|NCT04092894|565640852|FG000|Overall Study|Discontinued EEG after randomization|10|||
156697299|NCT04092894|565640853|FG001|Overall Study|Discontinued EEG after randomization|6|||
156697300|NCT01106014|565640854|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
156697301|NCT01106014|565640855|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
156697302|NCT01106014|565640854|FG000|Overall Study|Adverse Event|78|||
156697303|NCT01106014|565640855|FG001|Overall Study|Adverse Event|42|||
156697304|NCT01106014|565640854|FG000|Overall Study|Withdrawal by Subject|43|||
156697305|NCT01106014|565640855|FG001|Overall Study|Withdrawal by Subject|37|||
156697306|NCT01106014|565640854|FG000|Overall Study|Administrative reason|7|||
156697307|NCT01106014|565640855|FG001|Overall Study|Administrative reason|6|||
156697308|NCT01106014|565640854|FG000|Overall Study|Lost to Follow-up|2|||
156697309|NCT01106014|565640855|FG001|Overall Study|Lost to Follow-up|3|||
156697310|NCT05071313|565640856|FG000|Overall Study|Lost to Follow-up|17|||
156697311|NCT05071313|565640857|FG001|Overall Study|Lost to Follow-up|10|||
156697312|NCT05071313|565640856|FG000|Overall Study|Physician Decision|1|||
156697313|NCT05071313|565640857|FG001|Overall Study|Physician Decision|6|||
156697314|NCT05071313|565640856|FG000|Overall Study|Death|1|||
156697315|NCT05071313|565640857|FG001|Overall Study|Death|0|||
156697316|NCT05071313|565640856|FG000|Overall Study|Withdrawal by Subject|10|||
156697317|NCT05071313|565640857|FG001|Overall Study|Withdrawal by Subject|15|||
156697318|NCT05071313|565640856|FG000|Overall Study|Other|1|||
156697319|NCT05071313|565640857|FG001|Overall Study|Other|0|||
156697320|NCT05071313|565640856|FG000|Overall Study|Randomized but not vaccinated|4|||
156697321|NCT05071313|565640857|FG001|Overall Study|Randomized but not vaccinated|2|||
156697322|NCT03107026|565640858|FG000|Overall Study|Adverse Event|2|||
156697323|NCT03107026|565640859|FG001|Overall Study|Adverse Event|14|||
156697324|NCT03107026|565640860|FG002|Overall Study|Adverse Event|23|||
156697325|NCT03107026|565640858|FG000|Overall Study|Lost to Follow-up|12|||
156697326|NCT03107026|565640859|FG001|Overall Study|Lost to Follow-up|12|||
156697327|NCT03107026|565640860|FG002|Overall Study|Lost to Follow-up|13|||
156697328|NCT03107026|565640858|FG000|Overall Study|Protocol Violation|1|||
156697329|NCT03107026|565640859|FG001|Overall Study|Protocol Violation|2|||
156697330|NCT03107026|565640860|FG002|Overall Study|Protocol Violation|0|||
156697331|NCT03107026|565640858|FG000|Overall Study|Pregnancy|1|||
156697332|NCT03107026|565640859|FG001|Overall Study|Pregnancy|0|||
156697333|NCT03107026|565640860|FG002|Overall Study|Pregnancy|0|||
156697334|NCT03107026|565640858|FG000|Overall Study|Withdrawal by Subject|13|||
156697335|NCT03107026|565640859|FG001|Overall Study|Withdrawal by Subject|5|||
156697336|NCT03107026|565640860|FG002|Overall Study|Withdrawal by Subject|17|||
156697337|NCT03107026|565640858|FG000|Overall Study|non compliance with study visits|1|||
156697338|NCT03107026|565640859|FG001|Overall Study|non compliance with study visits|2|||
156697339|NCT03107026|565640860|FG002|Overall Study|non compliance with study visits|0|||
156697340|NCT03107026|565640858|FG000|Overall Study|non-compliance with study drug|2|||
156697341|NCT03107026|565640859|FG001|Overall Study|non-compliance with study drug|2|||
156697342|NCT03107026|565640860|FG002|Overall Study|non-compliance with study drug|3|||
156697343|NCT03107026|565640858|FG000|Overall Study|Physician Decision|0|||
156697344|NCT03107026|565640859|FG001|Overall Study|Physician Decision|1|||
156697345|NCT03107026|565640860|FG002|Overall Study|Physician Decision|0|||
156697346|NCT00062010|565640861|FG000|Overall Study|Ineligible|3|||
156697347|NCT00852969|565640862|FG000|Overall Study|Adverse Event|0|||
156697348|NCT00852969|565640863|FG001|Overall Study|Adverse Event|1|||
156697349|NCT00852969|565640862|FG000|Overall Study|Lost to Follow-up|0|||
156790273|NCT03760081|565983769|FG000|Overall Study|Progressive Disease|5|||
156790274|NCT03760081|565983770|FG001|Overall Study|Progressive Disease|10|||
156790275|NCT03760081|565983769|FG000|Overall Study|Death|1|||
156790276|NCT03760081|565983770|FG001|Overall Study|Death|1|||
156790277|NCT00986102|565983771|FG000|Overall Study|Lost to Follow-up|0|||
156790278|NCT00986102|565983772|FG001|Overall Study|Lost to Follow-up|1|||
156790279|NCT00986102|565983773|FG002|Overall Study|Lost to Follow-up|0|||
156790280|NCT00986102|565983774|FG003|Overall Study|Lost to Follow-up|1|||
156790281|NCT00986102|565983771|FG000|Overall Study|Withdrawal by Subject|1|||
156697350|NCT00852969|565640863|FG001|Overall Study|Lost to Follow-up|1|||
156697351|NCT03596151|565640864|FG000|Overall Study|Withdrawal by Subject|1|||
156697352|NCT00807248|565640866|FG000|Overall Study|Adverse Event|1|||
156697353|NCT00807248|565640867|FG001|Overall Study|Adverse Event|2|||
156697354|NCT00807248|565640868|FG002|Overall Study|Adverse Event|2|||
156697355|NCT00807248|565640869|FG003|Overall Study|Adverse Event|6|||
156697356|NCT00807248|565640866|FG000|Overall Study|Lack of Efficacy|14|||
156697357|NCT00807248|565640867|FG001|Overall Study|Lack of Efficacy|4|||
156697358|NCT00807248|565640868|FG002|Overall Study|Lack of Efficacy|8|||
156697359|NCT00807248|565640869|FG003|Overall Study|Lack of Efficacy|3|||
156697360|NCT00807248|565640866|FG000|Overall Study|Protocol Violation|0|||
156697361|NCT00807248|565640867|FG001|Overall Study|Protocol Violation|1|||
156697362|NCT00807248|565640868|FG002|Overall Study|Protocol Violation|1|||
156697363|NCT00807248|565640869|FG003|Overall Study|Protocol Violation|0|||
156697364|NCT00807248|565640866|FG000|Overall Study|Withdrawal of Consent|5|||
156697365|NCT00807248|565640867|FG001|Overall Study|Withdrawal of Consent|5|||
156871313|NCT02581410|566286065|FG001|End of Study Phase|Adverse Event|3|||
156871314|NCT02581410|566286064|FG000|End of Study Phase|Withdrawal by Subject|1|||
156871315|NCT02581410|566286065|FG001|End of Study Phase|Withdrawal by Subject|2|||
156871316|NCT02581410|566286064|FG000|End of Study Phase|Migrated/moved from study area|0|||
156871317|NCT02581410|566286065|FG001|End of Study Phase|Migrated/moved from study area|3|||
156871318|NCT02581410|566286064|FG000|End of Study Phase|Lost to Follow-up|0|||
156871319|NCT02581410|566286065|FG001|End of Study Phase|Lost to Follow-up|2|||
156871320|NCT02581410|566286064|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
156697366|NCT00807248|565640868|FG002|Overall Study|Withdrawal of Consent|5|||
156697367|NCT00807248|565640869|FG003|Overall Study|Withdrawal of Consent|5|||
156697368|NCT00807248|565640866|FG000|Overall Study|Lost to Follow-up|1|||
156697369|NCT00807248|565640867|FG001|Overall Study|Lost to Follow-up|0|||
156697370|NCT00807248|565640868|FG002|Overall Study|Lost to Follow-up|0|||
156697371|NCT00807248|565640869|FG003|Overall Study|Lost to Follow-up|0|||
156697372|NCT00807248|565640866|FG000|Overall Study|Other Reason|0|||
156697373|NCT00807248|565640867|FG001|Overall Study|Other Reason|0|||
156697374|NCT00807248|565640868|FG002|Overall Study|Other Reason|2|||
156697375|NCT00807248|565640869|FG003|Overall Study|Other Reason|0|||
156697376|NCT02444793|565640870|FG000|Overall Study|Lost to Follow-up|2|||
156697377|NCT02444793|565640871|FG001|Overall Study|Lost to Follow-up|2|||
156697378|NCT02444793|565640872|FG002|Overall Study|Lost to Follow-up|0|||
156697379|NCT02444793|565640873|FG003|Overall Study|Lost to Follow-up|0|||
156697380|NCT02444793|565640870|FG000|Overall Study|Death|0|||
156697381|NCT02444793|565640871|FG001|Overall Study|Death|3|||
156697382|NCT02444793|565640872|FG002|Overall Study|Death|0|||
156697383|NCT02444793|565640873|FG003|Overall Study|Death|0|||
156697384|NCT02444793|565640870|FG000|Overall Study|Other|0|||
156697385|NCT02444793|565640871|FG001|Overall Study|Other|0|||
156697386|NCT02444793|565640872|FG002|Overall Study|Other|2|||
156697387|NCT02444793|565640873|FG003|Overall Study|Other|0|||
156697388|NCT02444793|565640870|FG000|Overall Study|Objective progression or relapse|9|||
156697389|NCT02444793|565640871|FG001|Overall Study|Objective progression or relapse|1|||
156697390|NCT02444793|565640872|FG002|Overall Study|Objective progression or relapse|2|||
156697391|NCT02444793|565640873|FG003|Overall Study|Objective progression or relapse|3|||
156697392|NCT02504671|565640878|FG000|Overall Study|Withdrawal by Subject|1|||
156697393|NCT02504671|565640879|FG001|Overall Study|Withdrawal by Subject|5|||
156697394|NCT02504671|565640880|FG002|Overall Study|Withdrawal by Subject|4|||
156697395|NCT02504671|565640881|FG003|Overall Study|Withdrawal by Subject|4|||
156697396|NCT02504671|565640882|FG004|Overall Study|Withdrawal by Subject|5|||
156697397|NCT02504671|565640883|FG005|Overall Study|Withdrawal by Subject|3|||
156697398|NCT02504671|565640878|FG000|Overall Study|Lack of Efficacy|1|||
156697399|NCT02504671|565640879|FG001|Overall Study|Lack of Efficacy|3|||
156790282|NCT00986102|565983772|FG001|Overall Study|Withdrawal by Subject|1|||
156790283|NCT00986102|565983773|FG002|Overall Study|Withdrawal by Subject|0|||
156790284|NCT00986102|565983774|FG003|Overall Study|Withdrawal by Subject|0|||
156790285|NCT01570192|565983775|FG000|Overall Study|no qualifying organism|6|||
156790286|NCT01570192|565983776|FG001|Overall Study|no qualifying organism|12|||
156790287|NCT01570192|565983775|FG000|Overall Study|changed to palliative care|1|||
156790288|NCT01570192|565983776|FG001|Overall Study|changed to palliative care|0|||
156790289|NCT01570192|565983775|FG000|Overall Study|Physician Decision|0|||
156790290|NCT01570192|565983776|FG001|Overall Study|Physician Decision|1|||
156871321|NCT02581410|566286065|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
156871322|NCT02908672|566286067|FG000|Run-in Period|Death|12|||
156871323|NCT02908672|566286068|FG001|Run-in Period|Death|10|||
156871324|NCT02908672|566286069|FG002|Run-in Period|Death|0|||
156871325|NCT02908672|566286070|FG003|Run-in Period|Death|0|||
156871326|NCT02908672|566286067|FG000|Run-in Period|Lost to Follow-up|1|||
156697400|NCT02504671|565640880|FG002|Overall Study|Lack of Efficacy|1|||
156697401|NCT02504671|565640881|FG003|Overall Study|Lack of Efficacy|0|||
156697402|NCT02504671|565640882|FG004|Overall Study|Lack of Efficacy|4|||
156697403|NCT02504671|565640883|FG005|Overall Study|Lack of Efficacy|4|||
156697404|NCT02504671|565640878|FG000|Overall Study|Adverse Event|1|||
156697405|NCT02504671|565640879|FG001|Overall Study|Adverse Event|1|||
156697406|NCT02504671|565640880|FG002|Overall Study|Adverse Event|0|||
156697407|NCT02504671|565640881|FG003|Overall Study|Adverse Event|1|||
156697408|NCT02504671|565640882|FG004|Overall Study|Adverse Event|0|||
156697409|NCT02504671|565640883|FG005|Overall Study|Adverse Event|2|||
156697410|NCT02504671|565640878|FG000|Overall Study|Protocol Violation|2|||
156697411|NCT02504671|565640879|FG001|Overall Study|Protocol Violation|1|||
156790291|NCT02965976|565983777|FG000|Overall Study|Withdrawal by Subject|2|||
156790292|NCT02965976|565983778|FG001|Overall Study|Withdrawal by Subject|0|||
156871327|NCT02908672|566286068|FG001|Run-in Period|Lost to Follow-up|1|||
156697412|NCT02504671|565640880|FG002|Overall Study|Protocol Violation|0|||
156871328|NCT02908672|566286069|FG002|Run-in Period|Lost to Follow-up|0|||
156871329|NCT02908672|566286070|FG003|Run-in Period|Lost to Follow-up|0|||
156871330|NCT02908672|566286067|FG000|Run-in Period|Reason Not Specified|2|||
156871331|NCT02908672|566286068|FG001|Run-in Period|Reason Not Specified|0|||
156871332|NCT02908672|566286069|FG002|Run-in Period|Reason Not Specified|0|||
157014646|NCT03398148|566805000|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014647|NCT03398148|566805001|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014648|NCT03398148|566805002|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014649|NCT03398148|566805003|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014650|NCT03398148|566805004|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014651|NCT03398148|566805005|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014652|NCT03398148|566805006|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014653|NCT03398148|566805007|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
157014654|NCT03398148|566805008|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
157014655|NCT03398148|566805009|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
157014656|NCT03398148|566805010|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
157014657|NCT03398148|566804996|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
157014658|NCT03398148|566804997|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
157014659|NCT03398148|566804998|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
157014660|NCT03398148|566804999|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
157014661|NCT03398148|566805000|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
157014662|NCT03398148|566805001|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
157014663|NCT03398148|566805002|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
157014664|NCT03398148|566805003|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
157014665|NCT03398148|566805004|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
157014666|NCT03398148|566805005|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
157014667|NCT03398148|566805006|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
156871333|NCT02908672|566286070|FG003|Run-in Period|Reason Not Specified|0|||
156871334|NCT02908672|566286067|FG000|Run-in Period|Protocol Violation|1|||
156871335|NCT02908672|566286068|FG001|Run-in Period|Protocol Violation|1|||
156871336|NCT02908672|566286069|FG002|Run-in Period|Protocol Violation|0|||
156871337|NCT02908672|566286070|FG003|Run-in Period|Protocol Violation|0|||
156871338|NCT02908672|566286067|FG000|Run-in Period|Study Ended by Sponsor|5|||
156871339|NCT02908672|566286068|FG001|Run-in Period|Study Ended by Sponsor|1|||
156871340|NCT02908672|566286069|FG002|Run-in Period|Study Ended by Sponsor|0|||
156871341|NCT02908672|566286070|FG003|Run-in Period|Study Ended by Sponsor|0|||
156871342|NCT02908672|566286067|FG000|Run-in Period|Withdrawal by Subject|3|||
156871343|NCT02908672|566286068|FG001|Run-in Period|Withdrawal by Subject|9|||
156871344|NCT02908672|566286069|FG002|Run-in Period|Withdrawal by Subject|0|||
156871345|NCT02908672|566286070|FG003|Run-in Period|Withdrawal by Subject|0|||
156871346|NCT02908672|566286067|FG000|Triple Combination Period|Death|0|||
156871347|NCT02908672|566286068|FG001|Triple Combination Period|Death|0|||
156871348|NCT02908672|566286069|FG002|Triple Combination Period|Death|150|||
156871349|NCT02908672|566286070|FG003|Triple Combination Period|Death|127|||
156871350|NCT02908672|566286067|FG000|Triple Combination Period|Lost to Follow-up|0|||
156871351|NCT02908672|566286068|FG001|Triple Combination Period|Lost to Follow-up|0|||
156871352|NCT02908672|566286069|FG002|Triple Combination Period|Lost to Follow-up|6|||
156871353|NCT02908672|566286070|FG003|Triple Combination Period|Lost to Follow-up|8|||
156871354|NCT02908672|566286067|FG000|Triple Combination Period|Reason Not Specified|0|||
156871355|NCT02908672|566286068|FG001|Triple Combination Period|Reason Not Specified|0|||
156871356|NCT02908672|566286069|FG002|Triple Combination Period|Reason Not Specified|0|||
156871357|NCT02908672|566286070|FG003|Triple Combination Period|Reason Not Specified|1|||
156871358|NCT02908672|566286067|FG000|Triple Combination Period|Physician Decision|0|||
156871359|NCT02908672|566286068|FG001|Triple Combination Period|Physician Decision|0|||
156871360|NCT02908672|566286069|FG002|Triple Combination Period|Physician Decision|1|||
156871361|NCT02908672|566286070|FG003|Triple Combination Period|Physician Decision|1|||
156871362|NCT02908672|566286067|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
156871363|NCT02908672|566286068|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
156871364|NCT02908672|566286069|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
156871365|NCT02908672|566286070|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
156871366|NCT02908672|566286067|FG000|Triple Combination Period|Withdrawal by Subject|0|||
157014668|NCT03398148|566805007|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
157014669|NCT03398148|566805008|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
156697413|NCT02504671|565640881|FG003|Overall Study|Protocol Violation|0|||
156697414|NCT02504671|565640882|FG004|Overall Study|Protocol Violation|0|||
156871367|NCT02908672|566286068|FG001|Triple Combination Period|Withdrawal by Subject|0|||
156871368|NCT02908672|566286069|FG002|Triple Combination Period|Withdrawal by Subject|13|||
156871369|NCT02908672|566286070|FG003|Triple Combination Period|Withdrawal by Subject|16|||
156871370|NCT00670748|566286071|FG000|Overall Study|Death during treatment|1|||
156871371|NCT00670748|566286072|FG001|Overall Study|Death during treatment|1|||
156871372|NCT00670748|566286073|FG002|Overall Study|Death during treatment|1|||
156871373|NCT00670748|566286074|FG003|Overall Study|Death during treatment|0|||
156871374|NCT00670748|566286071|FG000|Overall Study|Not off study|2|||
156871375|NCT00670748|566286072|FG001|Overall Study|Not off study|1|||
157014670|NCT03398148|566805009|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
157014671|NCT03398148|566805010|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
157014672|NCT03398148|566804996|FG000|Substudy 2 Period 2|Other|0|||
156871376|NCT00670748|566286073|FG002|Overall Study|Not off study|1|||
156697415|NCT02504671|565640883|FG005|Overall Study|Protocol Violation|1|||
156697416|NCT02504671|565640878|FG000|Overall Study|Lost to Follow-up|0|||
156697417|NCT02504671|565640879|FG001|Overall Study|Lost to Follow-up|0|||
156697418|NCT02504671|565640880|FG002|Overall Study|Lost to Follow-up|2|||
156697419|NCT02504671|565640881|FG003|Overall Study|Lost to Follow-up|0|||
156697420|NCT02504671|565640882|FG004|Overall Study|Lost to Follow-up|0|||
156697421|NCT02504671|565640883|FG005|Overall Study|Lost to Follow-up|1|||
156697422|NCT02504671|565640878|FG000|Overall Study|Protocol defined stopping criteria|7|||
156697423|NCT02504671|565640879|FG001|Overall Study|Protocol defined stopping criteria|4|||
156697424|NCT02504671|565640880|FG002|Overall Study|Protocol defined stopping criteria|3|||
156697425|NCT02504671|565640881|FG003|Overall Study|Protocol defined stopping criteria|5|||
156697426|NCT02504671|565640882|FG004|Overall Study|Protocol defined stopping criteria|3|||
156697427|NCT02504671|565640883|FG005|Overall Study|Protocol defined stopping criteria|3|||
156697428|NCT00210249|565640884|FG000|Overall Study|Lost to Follow-up|5|||
156697429|NCT00210249|565640884|FG000|Overall Study|Protocol Violation|11|||
156697430|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
156697431|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
156697432|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
156697433|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
156697434|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
156697435|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
156697436|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
156697437|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
156697438|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
156697439|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
156697440|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
156697441|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
156697442|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
156697443|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
156697444|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
156697445|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
156697446|NCT03182244|565640886|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
156697447|NCT03182244|565640887|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
156697448|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
156697449|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
156697450|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
156697451|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
156790293|NCT00806026|565983779|FG000|Overall Study|Death|0|||
156790294|NCT00806026|565983780|FG001|Overall Study|Death|0|||
156790295|NCT00806026|565983781|FG002|Overall Study|Death|0|||
156790296|NCT00806026|565983782|FG003|Overall Study|Death|1|||
156790297|NCT00806026|565983783|FG004|Overall Study|Death|0|||
156790298|NCT00806026|565983784|FG005|Overall Study|Death|0|||
156790299|NCT00806026|565983779|FG000|Overall Study|Did not meet entrance criteria|4|||
156790300|NCT00806026|565983780|FG001|Overall Study|Did not meet entrance criteria|1|||
156790301|NCT00806026|565983781|FG002|Overall Study|Did not meet entrance criteria|2|||
156790302|NCT00806026|565983782|FG003|Overall Study|Did not meet entrance criteria|1|||
156790303|NCT00806026|565983783|FG004|Overall Study|Did not meet entrance criteria|0|||
156790304|NCT00806026|565983784|FG005|Overall Study|Did not meet entrance criteria|0|||
156790305|NCT00806026|565983779|FG000|Overall Study|Lack of Efficacy|5|||
156790306|NCT00806026|565983780|FG001|Overall Study|Lack of Efficacy|18|||
156790307|NCT00806026|565983781|FG002|Overall Study|Lack of Efficacy|13|||
156790308|NCT00806026|565983782|FG003|Overall Study|Lack of Efficacy|4|||
156790309|NCT00806026|565983783|FG004|Overall Study|Lack of Efficacy|8|||
156790310|NCT00806026|565983784|FG005|Overall Study|Lack of Efficacy|7|||
156790311|NCT00806026|565983779|FG000|Overall Study|Lost to Follow-up|8|||
156790312|NCT00806026|565983780|FG001|Overall Study|Lost to Follow-up|15|||
156790313|NCT00806026|565983781|FG002|Overall Study|Lost to Follow-up|8|||
156790314|NCT00806026|565983782|FG003|Overall Study|Lost to Follow-up|2|||
156790315|NCT00806026|565983783|FG004|Overall Study|Lost to Follow-up|6|||
156790316|NCT00806026|565983784|FG005|Overall Study|Lost to Follow-up|6|||
156790317|NCT00806026|565983779|FG000|Overall Study|Withdrawal by Subject|14|||
156790318|NCT00806026|565983780|FG001|Overall Study|Withdrawal by Subject|17|||
156790319|NCT00806026|565983781|FG002|Overall Study|Withdrawal by Subject|9|||
156871377|NCT00670748|566286074|FG003|Overall Study|Not off study|1|||
156697452|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
156790320|NCT00806026|565983782|FG003|Overall Study|Withdrawal by Subject|2|||
156790321|NCT00806026|565983783|FG004|Overall Study|Withdrawal by Subject|5|||
156790322|NCT00806026|565983784|FG005|Overall Study|Withdrawal by Subject|3|||
156790323|NCT00806026|565983779|FG000|Overall Study|Other|3|||
156790324|NCT00806026|565983780|FG001|Overall Study|Other|6|||
156790325|NCT00806026|565983781|FG002|Overall Study|Other|8|||
156871378|NCT03863080|566286078|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156697453|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
156697454|NCT03182244|565640886|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
156697455|NCT03182244|565640887|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
156697456|NCT02049450|565640888|FG000|Overall Study|Adverse Event|2|||
156697457|NCT02049450|565640888|FG000|Overall Study|Withdrawal by Subject|1|||
156697458|NCT02049450|565640888|FG000|Overall Study|Patients/guardian decision|1|||
157014673|NCT03398148|566804997|FG001|Substudy 2 Period 2|Other|0|||
157014674|NCT03398148|566804998|FG002|Substudy 2 Period 2|Other|0|||
157014675|NCT03398148|566804999|FG003|Substudy 2 Period 2|Other|0|||
157014676|NCT03398148|566805000|FG004|Substudy 2 Period 2|Other|0|||
157014677|NCT03398148|566805001|FG005|Substudy 2 Period 2|Other|0|||
157123014|NCT02799069|567201504|FG000|Overall Study|Lost to Follow-up|1|||
157123015|NCT02799069|567201505|FG001|Overall Study|Lost to Follow-up|1|||
157123016|NCT02799069|567201506|FG002|Overall Study|Lost to Follow-up|0|||
157123017|NCT02799069|567201504|FG000|Overall Study|Withdrawal by Subject|4|||
157123018|NCT02799069|567201505|FG001|Overall Study|Withdrawal by Subject|4|||
157123019|NCT02799069|567201506|FG002|Overall Study|Withdrawal by Subject|3|||
156697459|NCT02492880|565640889|FG000|Overall Study|Lost to Follow-up|1|||
156697460|NCT02492880|565640889|FG000|Overall Study|Protocol Violation|1|||
156697461|NCT00292188|565640890|FG000|Single-Blind|Adverse Event|14|||
156697462|NCT00292188|565640891|FG001|Single-Blind|Adverse Event|0|||
156697463|NCT00292188|565640892|FG002|Single-Blind|Adverse Event|0|||
156697464|NCT00292188|565640890|FG000|Single-Blind|Lack of Efficacy|2|||
156697465|NCT00292188|565640891|FG001|Single-Blind|Lack of Efficacy|0|||
156697466|NCT00292188|565640892|FG002|Single-Blind|Lack of Efficacy|0|||
156697467|NCT00292188|565640890|FG000|Single-Blind|Laboratory Abnormality|5|||
156697468|NCT00292188|565640891|FG001|Single-Blind|Laboratory Abnormality|0|||
156697469|NCT00292188|565640892|FG002|Single-Blind|Laboratory Abnormality|0|||
156697470|NCT00292188|565640890|FG000|Single-Blind|Lost to Follow-up|3|||
156697471|NCT00292188|565640891|FG001|Single-Blind|Lost to Follow-up|0|||
156697472|NCT00292188|565640892|FG002|Single-Blind|Lost to Follow-up|0|||
156697473|NCT00292188|565640890|FG000|Single-Blind|Other|77|||
156697474|NCT00292188|565640891|FG001|Single-Blind|Other|0|||
156697475|NCT00292188|565640892|FG002|Single-Blind|Other|0|||
156697476|NCT00292188|565640890|FG000|Single-Blind|Withdrawal by Subject|12|||
156697477|NCT00292188|565640891|FG001|Single-Blind|Withdrawal by Subject|0|||
156697478|NCT00292188|565640892|FG002|Single-Blind|Withdrawal by Subject|0|||
156697479|NCT00292188|565640890|FG000|Single-Blind|Did not receive treatment|1|||
157014678|NCT03398148|566805002|FG006|Substudy 2 Period 2|Other|0|||
157014679|NCT03398148|566805003|FG007|Substudy 2 Period 2|Other|0|||
157014680|NCT03398148|566805004|FG008|Substudy 2 Period 2|Other|0|||
157014681|NCT03398148|566805005|FG009|Substudy 2 Period 2|Other|0|||
157014682|NCT03398148|566805006|FG010|Substudy 2 Period 2|Other|0|||
157014683|NCT03398148|566805007|FG011|Substudy 2 Period 2|Other|0|||
157014684|NCT03398148|566805008|FG012|Substudy 2 Period 2|Other|0|||
157014685|NCT03398148|566805009|FG013|Substudy 2 Period 2|Other|1|||
157014686|NCT03398148|566805010|FG014|Substudy 2 Period 2|Other|1|||
157014687|NCT03398148|566804996|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014688|NCT03398148|566804997|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014689|NCT03398148|566804998|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014690|NCT03398148|566804999|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014691|NCT03398148|566805000|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014692|NCT03398148|566805001|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014693|NCT03398148|566805002|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014694|NCT03398148|566805003|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014695|NCT03398148|566805004|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014696|NCT03398148|566805005|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014697|NCT03398148|566805006|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014698|NCT03398148|566805007|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014699|NCT03398148|566805008|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
156697480|NCT00292188|565640891|FG001|Single-Blind|Did not receive treatment|0|||
156697481|NCT00292188|565640892|FG002|Single-Blind|Did not receive treatment|0|||
156697482|NCT00292188|565640890|FG000|Double-Blind|Adverse Event|0|||
156697483|NCT00292188|565640891|FG001|Double-Blind|Adverse Event|25|||
156697484|NCT00292188|565640892|FG002|Double-Blind|Adverse Event|9|||
156697485|NCT00292188|565640890|FG000|Double-Blind|Lack of Efficacy|0|||
156697486|NCT00292188|565640891|FG001|Double-Blind|Lack of Efficacy|2|||
157014700|NCT03398148|566805009|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
157014701|NCT03398148|566805010|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
157014702|NCT04278586|566805011|FG000|Overall Study|Withdrawal by Subject|13|||
157014703|NCT04278586|566805012|FG001|Overall Study|Withdrawal by Subject|6|||
156697487|NCT00292188|565640892|FG002|Double-Blind|Lack of Efficacy|12|||
156697488|NCT00292188|565640890|FG000|Double-Blind|Lost to Follow-up|0|||
156697489|NCT00292188|565640891|FG001|Double-Blind|Lost to Follow-up|1|||
156697490|NCT00292188|565640892|FG002|Double-Blind|Lost to Follow-up|0|||
156697491|NCT00292188|565640890|FG000|Double-Blind|Other|0|||
156697492|NCT00292188|565640891|FG001|Double-Blind|Other|3|||
156871379|NCT03863080|566286079|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156871380|NCT03863080|566286080|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
156871381|NCT03863080|566286081|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
156871382|NCT03863080|566286078|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871383|NCT03863080|566286079|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871384|NCT03863080|566286080|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
156871385|NCT03863080|566286081|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
156871386|NCT03863080|566286078|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871387|NCT03863080|566286079|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871388|NCT03863080|566286080|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
156871389|NCT03863080|566286081|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
156871390|NCT02000115|566286082|FG000|Overall Study|Death|56|||
156871391|NCT02000115|566286083|FG001|Overall Study|Death|45|||
156871392|NCT02000115|566286084|FG002|Overall Study|Death|0|||
156871393|NCT02000115|566286085|FG003|Overall Study|Death|0|||
156871394|NCT02000115|566286082|FG000|Overall Study|Missed Visit|6|||
156871395|NCT02000115|566286083|FG001|Overall Study|Missed Visit|8|||
156871396|NCT02000115|566286084|FG002|Overall Study|Missed Visit|1|||
156871397|NCT02000115|566286085|FG003|Overall Study|Missed Visit|0|||
156871398|NCT02000115|566286082|FG000|Overall Study|Protocol Violation|2|||
156871399|NCT02000115|566286083|FG001|Overall Study|Protocol Violation|1|||
156871400|NCT02000115|566286084|FG002|Overall Study|Protocol Violation|0|||
157123020|NCT02799069|567201504|FG000|Overall Study|Protocol Violation|1|||
157123021|NCT02799069|567201505|FG001|Overall Study|Protocol Violation|0|||
157123022|NCT02799069|567201506|FG002|Overall Study|Protocol Violation|2|||
157123023|NCT05130463|567201515|FG000|Overall Study|Unspecified reasons|2|||
157123024|NCT05130463|567201515|FG000|Overall Study|off-label indication dose|435|||
157123025|NCT03652662|567201519|FG000|Overall Study|Withdrawal by Subject|2|||
157123026|NCT03652662|567201520|FG001|Overall Study|Withdrawal by Subject|1|||
157123027|NCT03652662|567201519|FG000|Overall Study|Lost to Follow-up|1|||
156697493|NCT00292188|565640892|FG002|Double-Blind|Other|4|||
156697494|NCT00292188|565640890|FG000|Double-Blind|Withdrawal by Subject|0|||
156697495|NCT00292188|565640891|FG001|Double-Blind|Withdrawal by Subject|0|||
156697496|NCT00292188|565640892|FG002|Double-Blind|Withdrawal by Subject|3|||
156697497|NCT00292188|565640890|FG000|Double-Blind|Laboratory Abnormality|0|||
156697498|NCT00292188|565640891|FG001|Double-Blind|Laboratory Abnormality|0|||
156697499|NCT00292188|565640892|FG002|Double-Blind|Laboratory Abnormality|1|||
156697500|NCT01200992|565640893|FG000|Overall Study|Study terminated early|35|||
156697501|NCT01200992|565640894|FG001|Overall Study|Study terminated early|41|||
156697502|NCT01200992|565640893|FG000|Overall Study|Randomized but not treated|2|||
156697503|NCT01200992|565640894|FG001|Overall Study|Randomized but not treated|0|||
156697504|NCT00792935|565640895|FG000|Overall Study|Adverse Event|2|||
156697505|NCT00792935|565640896|FG001|Overall Study|Adverse Event|1|||
156697506|NCT00792935|565640895|FG000|Overall Study|Lost to Follow-up|0|||
156697507|NCT00792935|565640896|FG001|Overall Study|Lost to Follow-up|1|||
156697508|NCT00792935|565640895|FG000|Overall Study|Protocol Violation|2|||
157123028|NCT03652662|567201520|FG001|Overall Study|Lost to Follow-up|0|||
156697509|NCT00792935|565640896|FG001|Overall Study|Protocol Violation|0|||
156697510|NCT00792935|565640895|FG000|Overall Study|Withdrawal by Subject|0|||
156697511|NCT00792935|565640896|FG001|Overall Study|Withdrawal by Subject|1|||
156697512|NCT03186781|565640897|FG000|Overall Study|Lost to Follow-up|0|||
156697513|NCT03186781|565640898|FG001|Overall Study|Lost to Follow-up|0|||
156697514|NCT03186781|565640899|FG002|Overall Study|Lost to Follow-up|1|||
156871401|NCT02000115|566286085|FG003|Overall Study|Protocol Violation|0|||
156871402|NCT02000115|566286082|FG000|Overall Study|Physician Decision|2|||
156871403|NCT02000115|566286083|FG001|Overall Study|Physician Decision|0|||
156871404|NCT02000115|566286084|FG002|Overall Study|Physician Decision|0|||
156871405|NCT02000115|566286085|FG003|Overall Study|Physician Decision|0|||
156871406|NCT02000115|566286082|FG000|Overall Study|Withdrawal by Subject|11|||
156871407|NCT02000115|566286083|FG001|Overall Study|Withdrawal by Subject|11|||
156871408|NCT02000115|566286084|FG002|Overall Study|Withdrawal by Subject|0|||
156871409|NCT02000115|566286085|FG003|Overall Study|Withdrawal by Subject|0|||
156871410|NCT02000115|566286082|FG000|Overall Study|Lost to Follow-up|0|||
156871411|NCT02000115|566286083|FG001|Overall Study|Lost to Follow-up|1|||
156871412|NCT02000115|566286084|FG002|Overall Study|Lost to Follow-up|0|||
156871413|NCT02000115|566286085|FG003|Overall Study|Lost to Follow-up|0|||
156871414|NCT02000115|566286082|FG000|Overall Study|Non-compliance|2|||
156871415|NCT02000115|566286083|FG001|Overall Study|Non-compliance|1|||
157123029|NCT00487539|567201521|FG000|Overall Study|Adverse Event|3|||
157123030|NCT00487539|567201522|FG001|Overall Study|Adverse Event|2|||
156697515|NCT03186781|565640900|FG003|Overall Study|Lost to Follow-up|0|||
156697516|NCT03186781|565640901|FG004|Overall Study|Lost to Follow-up|1|||
156697517|NCT03186781|565640902|FG005|Overall Study|Lost to Follow-up|0|||
156697518|NCT03186781|565640897|FG000|Overall Study|Moved from Area|0|||
156697519|NCT03186781|565640898|FG001|Overall Study|Moved from Area|0|||
156697520|NCT03186781|565640899|FG002|Overall Study|Moved from Area|0|||
157123031|NCT00487539|567201523|FG002|Overall Study|Adverse Event|1|||
156697521|NCT03186781|565640900|FG003|Overall Study|Moved from Area|0|||
156697522|NCT03186781|565640901|FG004|Overall Study|Moved from Area|1|||
156697523|NCT03186781|565640902|FG005|Overall Study|Moved from Area|0|||
156697524|NCT03186781|565640897|FG000|Overall Study|Withdrawal by Subject|0|||
156697525|NCT03186781|565640898|FG001|Overall Study|Withdrawal by Subject|0|||
156697526|NCT03186781|565640899|FG002|Overall Study|Withdrawal by Subject|0|||
156790326|NCT00806026|565983782|FG003|Overall Study|Other|2|||
156790327|NCT00806026|565983783|FG004|Overall Study|Other|0|||
156790328|NCT00806026|565983784|FG005|Overall Study|Other|4|||
156790329|NCT00806026|565983779|FG000|Overall Study|Protocol Violation|6|||
156697527|NCT03186781|565640900|FG003|Overall Study|Withdrawal by Subject|0|||
156790330|NCT00806026|565983780|FG001|Overall Study|Protocol Violation|9|||
156790331|NCT00806026|565983781|FG002|Overall Study|Protocol Violation|9|||
156790332|NCT00806026|565983782|FG003|Overall Study|Protocol Violation|0|||
156697528|NCT03186781|565640901|FG004|Overall Study|Withdrawal by Subject|1|||
156697529|NCT03186781|565640902|FG005|Overall Study|Withdrawal by Subject|0|||
156697530|NCT04709835|565640903|FG000|Overall Study|Withdrawal by Subject|0|||
156697531|NCT04709835|565640904|FG001|Overall Study|Withdrawal by Subject|1|||
156697532|NCT04709835|565640905|FG002|Overall Study|Withdrawal by Subject|0|||
156697533|NCT00667810|565640906|FG000|Overall Study|Adverse Event|13|||
156697534|NCT00667810|565640907|FG001|Overall Study|Adverse Event|14|||
156697535|NCT00667810|565640908|FG002|Overall Study|Adverse Event|19|||
156697536|NCT00667810|565640909|FG003|Overall Study|Adverse Event|1|||
156697537|NCT00667810|565640906|FG000|Overall Study|Death|1|||
156697538|NCT00667810|565640907|FG001|Overall Study|Death|1|||
156697539|NCT00667810|565640908|FG002|Overall Study|Death|3|||
156697540|NCT00667810|565640909|FG003|Overall Study|Death|0|||
156697541|NCT00667810|565640906|FG000|Overall Study|Lack of Efficacy|1|||
156697542|NCT00667810|565640907|FG001|Overall Study|Lack of Efficacy|0|||
156697543|NCT00667810|565640908|FG002|Overall Study|Lack of Efficacy|2|||
156697544|NCT00667810|565640909|FG003|Overall Study|Lack of Efficacy|0|||
156871416|NCT02000115|566286084|FG002|Overall Study|Non-compliance|0|||
156871417|NCT02000115|566286085|FG003|Overall Study|Non-compliance|0|||
156871418|NCT02000115|566286082|FG000|Overall Study|Withdrawn on day of randomization|0|||
156871419|NCT02000115|566286083|FG001|Overall Study|Withdrawn on day of randomization|1|||
156871420|NCT02000115|566286084|FG002|Overall Study|Withdrawn on day of randomization|0|||
156871421|NCT02000115|566286085|FG003|Overall Study|Withdrawn on day of randomization|0|||
156871422|NCT02000115|566286082|FG000|Overall Study|Still on Study|0|||
156871423|NCT02000115|566286083|FG001|Overall Study|Still on Study|0|||
156871424|NCT02000115|566286084|FG002|Overall Study|Still on Study|0|||
156871425|NCT02000115|566286085|FG003|Overall Study|Still on Study|53|||
156871426|NCT01967238|566286088|FG000|Overall Study|Adverse Event|1|||
156871427|NCT01967238|566286089|FG001|Overall Study|Adverse Event|1|||
156871428|NCT01967238|566286090|FG002|Overall Study|Adverse Event|0|||
156871429|NCT01967238|566286088|FG000|Overall Study|Lost to Follow-up|1|||
156871430|NCT01967238|566286089|FG001|Overall Study|Lost to Follow-up|0|||
156871431|NCT01967238|566286090|FG002|Overall Study|Lost to Follow-up|1|||
156871432|NCT01967238|566286088|FG000|Overall Study|Withdrawal by Subject|0|||
156871433|NCT01967238|566286089|FG001|Overall Study|Withdrawal by Subject|0|||
156871434|NCT01967238|566286090|FG002|Overall Study|Withdrawal by Subject|1|||
156871435|NCT02484391|566286091|FG000|Overall Study|Lack of Efficacy|15|||
156871436|NCT02484391|566286092|FG001|Overall Study|Lack of Efficacy|14|||
156871437|NCT02484391|566286093|FG002|Overall Study|Lack of Efficacy|3|||
156871438|NCT02484391|566286091|FG000|Overall Study|Lost to Follow-up|0|||
156871439|NCT02484391|566286092|FG001|Overall Study|Lost to Follow-up|0|||
156871440|NCT02484391|566286093|FG002|Overall Study|Lost to Follow-up|2|||
156871441|NCT02484391|566286091|FG000|Overall Study|Physician Decision|1|||
156871442|NCT02484391|566286092|FG001|Overall Study|Physician Decision|3|||
156871443|NCT02484391|566286093|FG002|Overall Study|Physician Decision|0|||
156871444|NCT02484391|566286091|FG000|Overall Study|Went to Transplant|5|||
156871445|NCT02484391|566286092|FG001|Overall Study|Went to Transplant|3|||
156871446|NCT02484391|566286093|FG002|Overall Study|Went to Transplant|2|||
156871447|NCT04949490|566286097|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871448|NCT04949490|566286098|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156697545|NCT00667810|565640906|FG000|Overall Study|Lost to Follow-up|1|||
156697546|NCT00667810|565640907|FG001|Overall Study|Lost to Follow-up|4|||
156697547|NCT00667810|565640908|FG002|Overall Study|Lost to Follow-up|2|||
156697548|NCT00667810|565640909|FG003|Overall Study|Lost to Follow-up|0|||
156697549|NCT00667810|565640906|FG000|Overall Study|Physician Decision|1|||
156697550|NCT00667810|565640907|FG001|Overall Study|Physician Decision|1|||
156790333|NCT00806026|565983783|FG004|Overall Study|Protocol Violation|2|||
156790334|NCT00806026|565983784|FG005|Overall Study|Protocol Violation|3|||
156790335|NCT00806026|565983779|FG000|Overall Study|Adverse Event|52|||
156871449|NCT04949490|566286099|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871450|NCT04949490|566286100|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
156871451|NCT04949490|566286101|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871452|NCT04949490|566286102|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
156871453|NCT04949490|566286097|FG000|Group A and Group B|Withdrawal by Subject|0|||
156871454|NCT04949490|566286098|FG001|Group A and Group B|Withdrawal by Subject|0|||
156697551|NCT00667810|565640908|FG002|Overall Study|Physician Decision|2|||
156697552|NCT00667810|565640909|FG003|Overall Study|Physician Decision|0|||
156697553|NCT00667810|565640906|FG000|Overall Study|Protocol Violation|0|||
156697554|NCT00667810|565640907|FG001|Overall Study|Protocol Violation|2|||
156697555|NCT00667810|565640908|FG002|Overall Study|Protocol Violation|0|||
156697556|NCT00667810|565640909|FG003|Overall Study|Protocol Violation|0|||
156697557|NCT00667810|565640906|FG000|Overall Study|Withdrawal by Subject|14|||
156697558|NCT00667810|565640907|FG001|Overall Study|Withdrawal by Subject|20|||
156697559|NCT00667810|565640908|FG002|Overall Study|Withdrawal by Subject|29|||
156697560|NCT00667810|565640909|FG003|Overall Study|Withdrawal by Subject|1|||
156697561|NCT00667810|565640906|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
156697562|NCT00667810|565640907|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
156697563|NCT00667810|565640908|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
156697564|NCT00667810|565640909|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156697565|NCT00667810|565640906|FG000|Overall Study|Failed to Return|0|||
156697566|NCT00667810|565640907|FG001|Overall Study|Failed to Return|0|||
156697567|NCT00667810|565640908|FG002|Overall Study|Failed to Return|2|||
156697568|NCT00667810|565640909|FG003|Overall Study|Failed to Return|0|||
156697569|NCT00667810|565640906|FG000|Overall Study|Loss of Caregiver|0|||
156697570|NCT00667810|565640907|FG001|Overall Study|Loss of Caregiver|1|||
156697571|NCT00667810|565640908|FG002|Overall Study|Loss of Caregiver|3|||
156697572|NCT00667810|565640909|FG003|Overall Study|Loss of Caregiver|0|||
156697573|NCT00667810|565640906|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
156697574|NCT00667810|565640907|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
156697575|NCT00667810|565640908|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
156697576|NCT00667810|565640909|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
156697577|NCT00667810|565640906|FG000|Overall Study|Other|6|||
156697578|NCT00667810|565640907|FG001|Overall Study|Other|6|||
156697579|NCT00667810|565640908|FG002|Overall Study|Other|5|||
156697580|NCT00667810|565640909|FG003|Overall Study|Other|0|||
156697581|NCT01383135|565640918|FG000|Overall Study|Not Scanned / Imaged|1|||
156697582|NCT01383135|565640919|FG001|Overall Study|Not Scanned / Imaged|0|||
156697583|NCT01383135|565640920|FG002|Overall Study|Not Scanned / Imaged|1|||
156697584|NCT01383135|565640921|FG003|Overall Study|Not Scanned / Imaged|0|||
156697585|NCT03397771|565640922|FG000|Overall Study|2 erroneously randomized, never treated|3|||
156697586|NCT03397771|565640923|FG001|Overall Study|2 erroneously randomized, never treated|1|||
156697587|NCT03397771|565640922|FG000|Overall Study|Withdrawal by Subject|1|||
156697588|NCT03397771|565640923|FG001|Overall Study|Withdrawal by Subject|3|||
156697589|NCT03397771|565640922|FG000|Overall Study|Protocol Violation|2|||
156697590|NCT03397771|565640923|FG001|Overall Study|Protocol Violation|2|||
156697591|NCT03397771|565640922|FG000|Overall Study|Adverse Event|2|||
156697592|NCT03397771|565640923|FG001|Overall Study|Adverse Event|1|||
156697593|NCT02669758|565640926|FG000|Overall Study|Withdrawal by Subject|43|||
156697594|NCT02669758|565640926|FG000|Overall Study|Lost to Follow-up|19|||
156697595|NCT02669758|565640926|FG000|Overall Study|Adverse Event|16|||
156697596|NCT02669758|565640926|FG000|Overall Study|Non-Compliance with Study Drug|8|||
156697597|NCT02669758|565640926|FG000|Overall Study|Lack of Efficacy|5|||
156697598|NCT02669758|565640926|FG000|Overall Study|Pregnancy|1|||
156697599|NCT02669758|565640926|FG000|Overall Study|Study noncompliance|1|||
156697600|NCT02669758|565640926|FG000|Overall Study|Protocol Violation|1|||
156697601|NCT03393806|565640929|FG000|Overall Study|Physician Decision|1|||
156697602|NCT03393806|565640930|FG001|Overall Study|Physician Decision|0|||
156697603|NCT02534844|565640931|FG000|Part B|Withdrawal by Subject|0|||
156697604|NCT02534844|565640932|FG001|Part B|Withdrawal by Subject|0|||
156697605|NCT02534844|565640933|FG002|Part B|Withdrawal by Subject|0|||
156697606|NCT02534844|565640934|FG003|Part B|Withdrawal by Subject|0|||
156697607|NCT02534844|565640935|FG004|Part B|Withdrawal by Subject|2|||
156697608|NCT02534844|565640936|FG005|Part B|Withdrawal by Subject|1|||
156697609|NCT01971970|565640937|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
156697610|NCT01971970|565640938|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
156697611|NCT01971970|565640937|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
156697612|NCT01971970|565640938|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
156697613|NCT01971970|565640937|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
156697614|NCT01971970|565640938|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
156697615|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
156697616|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
156697617|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
156697618|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
156697619|NCT01971970|565640937|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
156697620|NCT01971970|565640938|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
156697621|NCT01971970|565640937|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
156697622|NCT01971970|565640938|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
156697623|NCT00848107|565640939|FG000|Overall Study|Lost to Follow-up|2|||
156697624|NCT00848107|565640939|FG000|Overall Study|Withdrawal by Subject|8|||
156697625|NCT00848107|565640939|FG000|Overall Study|Adverse Event|9|||
156697626|NCT00848107|565640939|FG000|Overall Study|Death|1|||
156697627|NCT00848107|565640939|FG000|Overall Study|Pregnancy|1|||
156697628|NCT00859586|565640940|FG000|Overall Study|Donors|4|||
156697629|NCT00507130|565640941|FG000|Overall Study|Lost to Follow-up|0|||
156697630|NCT00507130|565640942|FG001|Overall Study|Lost to Follow-up|0|||
156697631|NCT00507130|565640943|FG002|Overall Study|Lost to Follow-up|1|||
156697632|NCT00507130|565640944|FG003|Overall Study|Lost to Follow-up|1|||
156697633|NCT00507130|565640941|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
157014704|NCT04278586|566805011|FG000|Overall Study|Lost to Follow-up|37|||
157014705|NCT04278586|566805012|FG001|Overall Study|Lost to Follow-up|24|||
156697634|NCT00507130|565640942|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697635|NCT00507130|565640943|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697636|NCT00507130|565640944|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
156697637|NCT02524730|565640945|FG000|Overall Study|Lost to Follow-up|5|||
156697638|NCT02524730|565640945|FG000|Overall Study|Withdrawal by Subject|18|||
156697639|NCT02524730|565640945|FG000|Overall Study|Death|10|||
156697640|NCT02524730|565640945|FG000|Overall Study|Adverse Event|8|||
156697641|NCT02524730|565640945|FG000|Overall Study|Protocol Violation|1|||
156697642|NCT02524730|565640945|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
156697643|NCT00080938|565640948|FG000|Overall Study|Adverse Event|3|||
156697644|NCT00080938|565640948|FG000|Overall Study|Withdrawal by Subject|6|||
156697645|NCT00080938|565640948|FG000|Overall Study|Death|2|||
156697646|NCT00080938|565640948|FG000|Overall Study|Lack of Efficacy|7|||
156697647|NCT00080938|565640948|FG000|Overall Study|other disease|1|||
156697648|NCT00080938|565640948|FG000|Overall Study|Not started protocol therapy|1|||
156697649|NCT00080938|565640948|FG000|Overall Study|Ineligible|4|||
156697650|NCT02605993|565640949|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697651|NCT02605993|565640950|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697652|NCT02605993|565640951|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
156697653|NCT02605993|565640952|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
156697654|NCT03493386|565640954|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697655|NCT03493386|565640955|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
156697656|NCT03493386|565640956|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697657|NCT03493386|565640957|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
156697658|NCT00546572|565640962|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
156697659|NCT00546572|565640963|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
156697660|NCT00546572|565640962|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
156697661|NCT00546572|565640963|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
156697662|NCT00546572|565640962|FG000|Vax 1 / Year 0|Protocol Violation|3|||
156697663|NCT00546572|565640963|FG001|Vax 1 / Year 0|Protocol Violation|4|||
156697664|NCT00546572|565640962|FG000|Vax 1 / Year 0|Death|2|||
156697665|NCT00546572|565640963|FG001|Vax 1 / Year 0|Death|2|||
156697666|NCT00546572|565640962|FG000|Vax 1 / Year 0|Adverse Event|0|||
156697667|NCT00546572|565640963|FG001|Vax 1 / Year 0|Adverse Event|1|||
156697668|NCT00546572|565640962|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
156697669|NCT00546572|565640963|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
156697670|NCT00546572|565640962|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
156697671|NCT00546572|565640963|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
156697672|NCT00546572|565640962|FG000|Vax 2 / Year 1|Other|1|||
156697673|NCT00546572|565640963|FG001|Vax 2 / Year 1|Other|1|||
156697674|NCT00546572|565640962|FG000|Vax 2 / Year 1|Adverse Event|1|||
156697675|NCT00546572|565640963|FG001|Vax 2 / Year 1|Adverse Event|0|||
156697676|NCT00546572|565640962|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
156697677|NCT00546572|565640963|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
156697678|NCT02685202|565640964|FG000|Overall Study|Lost to Follow-up|9|||
156697679|NCT02989168|565640974|FG000|Overall Study|Withdrawal by Subject|2|||
156697680|NCT02989168|565640975|FG001|Overall Study|Withdrawal by Subject|0|||
156697681|NCT02989168|565640974|FG000|Overall Study|Physician Decision|0|||
156697682|NCT02989168|565640975|FG001|Overall Study|Physician Decision|1|||
156697683|NCT02989168|565640974|FG000|Overall Study|Adverse Event|1|||
156697684|NCT02989168|565640975|FG001|Overall Study|Adverse Event|2|||
156697685|NCT02989168|565640974|FG000|Overall Study|Sponsor stopped study.|1|||
156697686|NCT02989168|565640975|FG001|Overall Study|Sponsor stopped study.|0|||
156697687|NCT03456960|565640976|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697688|NCT03456960|565640977|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697689|NCT03456960|565640978|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
156697690|NCT03456960|565640979|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
156697691|NCT03456960|565640980|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697692|NCT03456960|565640981|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156697693|NCT03456960|565640976|FG000|Period 2 (1 Day)|Adverse Event|1|||
156697694|NCT03456960|565640977|FG001|Period 2 (1 Day)|Adverse Event|0|||
156697695|NCT03456960|565640978|FG002|Period 2 (1 Day)|Adverse Event|0|||
156697696|NCT03456960|565640979|FG003|Period 2 (1 Day)|Adverse Event|1|||
156697697|NCT03456960|565640980|FG004|Period 2 (1 Day)|Adverse Event|0|||
156697698|NCT03456960|565640981|FG005|Period 2 (1 Day)|Adverse Event|0|||
156697699|NCT00532935|565640982|FG000|Overall Study|Adverse Event|11|||
156697700|NCT00532935|565640983|FG001|Overall Study|Adverse Event|12|||
156697701|NCT00532935|565640982|FG000|Overall Study|Lack of Efficacy|0|||
156697702|NCT00532935|565640983|FG001|Overall Study|Lack of Efficacy|3|||
156697703|NCT00532935|565640982|FG000|Overall Study|Lost to Follow-up|10|||
156697704|NCT00532935|565640983|FG001|Overall Study|Lost to Follow-up|6|||
156697705|NCT00532935|565640982|FG000|Overall Study|Physician Decision|4|||
156697706|NCT00532935|565640983|FG001|Overall Study|Physician Decision|5|||
156790336|NCT00806026|565983780|FG001|Overall Study|Adverse Event|35|||
156790337|NCT00806026|565983781|FG002|Overall Study|Adverse Event|44|||
156790338|NCT00806026|565983782|FG003|Overall Study|Adverse Event|17|||
156790339|NCT00806026|565983783|FG004|Overall Study|Adverse Event|9|||
156790340|NCT00806026|565983784|FG005|Overall Study|Adverse Event|9|||
156790341|NCT00819832|565983785|FG000|Overall Study|Sponsor Termination of Study|3|||
156790342|NCT00819832|565983786|FG001|Overall Study|Sponsor Termination of Study|0|||
156790343|NCT00819832|565983787|FG002|Overall Study|Sponsor Termination of Study|0|||
156790344|NCT00819832|565983788|FG003|Overall Study|Sponsor Termination of Study|0|||
156790345|NCT00819832|565983789|FG004|Overall Study|Sponsor Termination of Study|0|||
156790346|NCT00819832|565983790|FG005|Overall Study|Sponsor Termination of Study|0|||
156790347|NCT01063881|565983793|FG000|Overall Study|Adverse Event|12|||
156790348|NCT01063881|565983794|FG001|Overall Study|Adverse Event|2|||
156790349|NCT01063881|565983795|FG002|Overall Study|Adverse Event|0|||
156790350|NCT01063881|565983793|FG000|Overall Study|Lost to Follow-up|13|||
156790351|NCT01063881|565983794|FG001|Overall Study|Lost to Follow-up|7|||
156790352|NCT01063881|565983795|FG002|Overall Study|Lost to Follow-up|1|||
156790353|NCT01063881|565983793|FG000|Overall Study|Withdrawal by Subject|25|||
156790354|NCT01063881|565983794|FG001|Overall Study|Withdrawal by Subject|1|||
156790355|NCT01063881|565983795|FG002|Overall Study|Withdrawal by Subject|0|||
156790356|NCT01063881|565983793|FG000|Overall Study|Reason for not completed not specified|5|||
156790357|NCT01063881|565983794|FG001|Overall Study|Reason for not completed not specified|1|||
156790358|NCT01063881|565983795|FG002|Overall Study|Reason for not completed not specified|0|||
156790359|NCT01340170|565983796|FG000|Overall Study|Lost to Follow-up|2|||
156790360|NCT01340170|565983797|FG001|Overall Study|Lost to Follow-up|4|||
156790361|NCT01340170|565983798|FG002|Overall Study|Lost to Follow-up|0|||
156790362|NCT01340170|565983796|FG000|Overall Study|Implant failure|1|||
156790363|NCT01340170|565983797|FG001|Overall Study|Implant failure|3|||
156790364|NCT01340170|565983798|FG002|Overall Study|Implant failure|0|||
156790365|NCT00736476|565983799|FG000|Overall Study|Adverse Event|1|||
156790366|NCT00736476|565983800|FG001|Overall Study|Adverse Event|0|||
156790367|NCT01796470|565983802|FG000|Overall Study|Adverse Event|4|||
156790368|NCT01796470|565983803|FG001|Overall Study|Adverse Event|2|||
156790369|NCT01796470|565983804|FG002|Overall Study|Adverse Event|2|||
156790370|NCT01796470|565983805|FG003|Overall Study|Adverse Event|1|||
156790371|NCT01796470|565983806|FG004|Overall Study|Adverse Event|3|||
156790372|NCT01796470|565983802|FG000|Overall Study|Death|2|||
156790373|NCT01796470|565983803|FG001|Overall Study|Death|0|||
156871455|NCT04949490|566286099|FG002|Group A and Group B|Withdrawal by Subject|1|||
156871456|NCT04949490|566286100|FG003|Group A and Group B|Withdrawal by Subject|0|||
156871457|NCT04949490|566286101|FG004|Group A and Group B|Withdrawal by Subject|0|||
156871458|NCT04949490|566286102|FG005|Group A and Group B|Withdrawal by Subject|0|||
156871459|NCT04949490|566286097|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871460|NCT04949490|566286098|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871461|NCT04949490|566286099|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871462|NCT04949490|566286100|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871463|NCT04949490|566286101|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
156871464|NCT04949490|566286102|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
156871465|NCT04949490|566286097|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871466|NCT04949490|566286098|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156697707|NCT00532935|565640982|FG000|Overall Study|Pregnancy|1|||
156790374|NCT01796470|565983804|FG002|Overall Study|Death|0|||
156871467|NCT04949490|566286099|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871468|NCT04949490|566286100|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156790375|NCT01796470|565983805|FG003|Overall Study|Death|0|||
156790376|NCT01796470|565983806|FG004|Overall Study|Death|1|||
157014706|NCT00212355|566805013|FG000|Overall Study|Adverse Event|1|||
157014707|NCT00212355|566805013|FG000|Overall Study|Withdrawal by Subject|1|||
156697708|NCT00532935|565640983|FG001|Overall Study|Pregnancy|0|||
156790377|NCT01796470|565983802|FG000|Overall Study|Initiated New Therapy|9|||
156790378|NCT01796470|565983803|FG001|Overall Study|Initiated New Therapy|0|||
156790379|NCT01796470|565983804|FG002|Overall Study|Initiated New Therapy|0|||
156790380|NCT01796470|565983805|FG003|Overall Study|Initiated New Therapy|0|||
156790381|NCT01796470|565983806|FG004|Overall Study|Initiated New Therapy|2|||
156790382|NCT01796470|565983802|FG000|Overall Study|Lost to Follow-up|0|||
156697709|NCT00532935|565640982|FG000|Overall Study|Protocol Violation|4|||
156697710|NCT00532935|565640983|FG001|Overall Study|Protocol Violation|2|||
156697711|NCT00532935|565640982|FG000|Overall Study|Withdrawal by Subject|10|||
156697712|NCT00532935|565640983|FG001|Overall Study|Withdrawal by Subject|9|||
156697713|NCT00532935|565640982|FG000|Overall Study|Protocol Specific Criteria|11|||
156697714|NCT00532935|565640983|FG001|Overall Study|Protocol Specific Criteria|15|||
156697715|NCT00502801|565640984|FG000|Treatment Period|Withdrawal by Subject|3|||
156697716|NCT00502801|565640984|FG000|Treatment Period|Adverse Event|7|||
156697717|NCT00502801|565640984|FG000|Treatment Period|Death|14|||
156697718|NCT00502801|565640984|FG000|Treatment Period|OTHER|30|||
156697719|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
156697720|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
156697721|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|Death|3|||
156697722|NCT00502801|565640984|FG000|End of Therapy to Test of Cure|OTHER|2|||
156697723|NCT01769339|565640987|FG000|Overall Study|Lost to Follow-up|42|||
156697724|NCT01769339|565640987|FG000|Overall Study|Adverse Event|1|||
156697725|NCT01195272|565640990|FG000|Overall Study|Adverse Event|1|||
156697726|NCT01195272|565640990|FG000|Overall Study|Lack of Efficacy|3|||
156697727|NCT04969861|565640991|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
156697728|NCT04969861|565640992|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
156697729|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697730|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697731|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697732|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697733|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
156697734|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
156697735|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|headache|0|||
156697736|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|headache|0|||
156697737|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|headache|0|||
156697738|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|headache|0|||
156697739|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|headache|1|||
156697740|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|headache|0|||
156697741|NCT00290251|565640993|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697742|NCT00290251|565640994|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697743|NCT00290251|565640995|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697744|NCT00290251|565640996|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
156697745|NCT00290251|565640997|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697746|NCT00290251|565640998|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
156697747|NCT04280705|565642557|FG000|Overall Study|Enrolled but not treated|4|||
156697748|NCT04280705|565642558|FG001|Overall Study|Enrolled but not treated|10|||
156697749|NCT04280705|565642557|FG000|Overall Study|Physician Decision|1|||
156697750|NCT04280705|565642558|FG001|Overall Study|Physician Decision|0|||
156697751|NCT04280705|565642557|FG000|Overall Study|Withdrawal by Subject|7|||
156697752|NCT04280705|565642558|FG001|Overall Study|Withdrawal by Subject|9|||
156697753|NCT04280705|565642557|FG000|Overall Study|Adverse Event|0|||
156697754|NCT04280705|565642558|FG001|Overall Study|Adverse Event|4|||
156871469|NCT04949490|566286101|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
156871470|NCT04949490|566286102|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
156871471|NCT04721977|566286103|FG000|Overall Study|Death|15|||
156871472|NCT04721977|566286103|FG000|Overall Study|Ongoing|51|||
156871473|NCT02864394|566286104|FG000|Overall Study|Death|184|||
156871474|NCT02864394|566286105|FG001|Overall Study|Death|189|||
156871475|NCT02864394|566286104|FG000|Overall Study|Lost to Follow-up|0|||
156871476|NCT02864394|566286105|FG001|Overall Study|Lost to Follow-up|2|||
156871477|NCT02864394|566286104|FG000|Overall Study|Sponsor Decision|26|||
156871478|NCT02864394|566286105|FG001|Overall Study|Sponsor Decision|11|||
156871479|NCT02864394|566286104|FG000|Overall Study|Withdrawal by Subject|3|||
156871480|NCT02864394|566286105|FG001|Overall Study|Withdrawal by Subject|10|||
156871481|NCT00905164|566286106|FG000|Period 1|Protocol Violation|0|||
156871482|NCT00905164|566286107|FG001|Period 1|Protocol Violation|1|||
156871483|NCT04730804|566286108|FG000|Overall Study|Physician Decision|0|||
156871484|NCT04730804|566286109|FG001|Overall Study|Physician Decision|0|||
156871485|NCT04730804|566286110|FG002|Overall Study|Physician Decision|0|||
156871486|NCT04730804|566286111|FG003|Overall Study|Physician Decision|0|||
156871487|NCT04730804|566286112|FG004|Overall Study|Physician Decision|0|||
156871488|NCT04730804|566286113|FG005|Overall Study|Physician Decision|1|||
156871489|NCT04730804|566286108|FG000|Overall Study|Withdrawal by Subject|0|||
156871490|NCT04730804|566286109|FG001|Overall Study|Withdrawal by Subject|0|||
156871491|NCT04730804|566286110|FG002|Overall Study|Withdrawal by Subject|0|||
156697755|NCT04280705|565642557|FG000|Overall Study|Transferred to another hospital|1|||
156697756|NCT04280705|565642558|FG001|Overall Study|Transferred to another hospital|1|||
156697757|NCT03986138|565642559|FG000|First MRI Examination|Physician Decision|0|||
156697758|NCT03986138|565642560|FG001|First MRI Examination|Physician Decision|1|||
156697759|NCT03986138|565642559|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
156697760|NCT03986138|565642560|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
156697761|NCT03986138|565642559|FG000|Washout|Withdrawal by Subject|4|||
156697762|NCT03986138|565642560|FG001|Washout|Withdrawal by Subject|5|||
156697763|NCT03986138|565642559|FG000|Washout|Lost to Follow-up|0|||
156697764|NCT03986138|565642560|FG001|Washout|Lost to Follow-up|2|||
156697765|NCT03986138|565642559|FG000|Washout|Adverse Event|1|||
156697766|NCT03986138|565642560|FG001|Washout|Adverse Event|1|||
156697767|NCT03986138|565642559|FG000|Washout|Other reason|5|||
156697768|NCT03986138|565642560|FG001|Washout|Other reason|5|||
156697769|NCT03986138|565642559|FG000|Second MRI Examination|Withdrawal by Subject|0|||
156697770|NCT03986138|565642560|FG001|Second MRI Examination|Withdrawal by Subject|2|||
156697771|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Death|89|||
156697772|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Death|193|||
156697773|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Death|198|||
156697774|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
156697775|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
156697776|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
156697777|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
156697778|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
156697779|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
156697780|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
156697781|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
156697782|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
156697783|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
156697784|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
156697785|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
156697786|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
156697787|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
156697788|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
156697789|NCT02031458|565642561|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
156697790|NCT02031458|565642562|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
156697791|NCT02031458|565642563|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
156697792|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Death|36|||
156697793|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Death|87|||
156697794|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Death|100|||
156697795|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
156697796|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
156697797|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
156697798|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Physician Decision|0|||
156697799|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Physician Decision|1|||
156697800|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Physician Decision|0|||
156697801|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
156697802|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
156697803|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
156697804|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
156871492|NCT04730804|566286111|FG003|Overall Study|Withdrawal by Subject|0|||
156871493|NCT04730804|566286112|FG004|Overall Study|Withdrawal by Subject|1|||
156871494|NCT04730804|566286113|FG005|Overall Study|Withdrawal by Subject|2|||
156871495|NCT01442103|566287687|FG000|Overall Study|Lost to Follow-up|2|||
156871496|NCT02102204|566287692|FG000|Overall Study|Withdrawal by Subject|137|||
156871497|NCT02102204|566287692|FG000|Overall Study|Death|92|||
156871498|NCT02102204|566287692|FG000|Overall Study|Lost to Follow-up|65|||
156871499|NCT02102204|566287692|FG000|Overall Study|Sponsor Decision|5|||
156871500|NCT02102204|566287692|FG000|Overall Study|Ongoing|5|||
156871501|NCT03751657|566287693|FG000|Overall Study|Physician Decision|0|||
156871502|NCT03751657|566287694|FG001|Overall Study|Physician Decision|1|||
156871503|NCT03751657|566287693|FG000|Overall Study|Withdrawal by Subject|1|||
156871504|NCT03751657|566287694|FG001|Overall Study|Withdrawal by Subject|1|||
156871505|NCT03751657|566287693|FG000|Overall Study|Lost to Follow-up|2|||
156871506|NCT03751657|566287694|FG001|Overall Study|Lost to Follow-up|1|||
156871507|NCT03894813|566287701|FG000|Overall Study|Adverse Event|1|||
156871508|NCT03894813|566287702|FG001|Overall Study|Adverse Event|1|||
156871509|NCT03894813|566287701|FG000|Overall Study|Lack of Efficacy|3|||
156871510|NCT03894813|566287702|FG001|Overall Study|Lack of Efficacy|3|||
156871511|NCT03894813|566287701|FG000|Overall Study|Lost to Follow-up|1|||
156871512|NCT03894813|566287702|FG001|Overall Study|Lost to Follow-up|0|||
156871513|NCT03894813|566287701|FG000|Overall Study|Pregnancy|2|||
156871514|NCT03894813|566287702|FG001|Overall Study|Pregnancy|1|||
156697805|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
156697806|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
156697807|NCT02031458|565642561|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
156871515|NCT03894813|566287701|FG000|Overall Study|Protocol Violation|3|||
156871516|NCT03894813|566287702|FG001|Overall Study|Protocol Violation|7|||
156697808|NCT02031458|565642562|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
156871517|NCT03894813|566287701|FG000|Overall Study|Withdrawal by Subject|1|||
156697809|NCT02031458|565642563|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
156697810|NCT02031458|565642561|FG000|Baseline to May 8, 2015|On Treatment|43|||
156697811|NCT02031458|565642562|FG001|Baseline to May 8, 2015|On Treatment|81|||
156697812|NCT02031458|565642563|FG002|Baseline to May 8, 2015|On Treatment|73|||
156697813|NCT02031458|565642561|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
156697814|NCT02031458|565642562|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
156697815|NCT02031458|565642563|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
156697816|NCT04305587|565642564|FG000|Overall Study|Withdrawal by Subject|0|||
156697817|NCT04305587|565642565|FG001|Overall Study|Withdrawal by Subject|0|||
156697818|NCT04305587|565642566|FG002|Overall Study|Withdrawal by Subject|0|||
156697819|NCT04305587|565642567|FG003|Overall Study|Withdrawal by Subject|1|||
156697820|NCT04305587|565642568|FG004|Overall Study|Withdrawal by Subject|0|||
156697821|NCT04305587|565642569|FG005|Overall Study|Withdrawal by Subject|0|||
156697822|NCT04305587|565642570|FG006|Overall Study|Withdrawal by Subject|0|||
156697823|NCT04305587|565642571|FG007|Overall Study|Withdrawal by Subject|0|||
156697824|NCT04305587|565642572|FG008|Overall Study|Withdrawal by Subject|0|||
156697825|NCT02752906|565642573|FG000|Overall Study|Protocol Violation|2|||
156697826|NCT02752906|565642574|FG001|Overall Study|Protocol Violation|1|||
156697827|NCT02752906|565642573|FG000|Overall Study|Withdrawal by Subject|2|||
156697828|NCT02752906|565642574|FG001|Overall Study|Withdrawal by Subject|2|||
156697829|NCT02752906|565642573|FG000|Overall Study|Lost to Follow-up|3|||
156697830|NCT02752906|565642574|FG001|Overall Study|Lost to Follow-up|2|||
156697831|NCT00824616|565642578|FG000|Overall Study|Adverse Event|2|||
156697832|NCT00824616|565642579|FG001|Overall Study|Adverse Event|1|||
156697833|NCT00824616|565642578|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
156697834|NCT00824616|565642579|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
156697835|NCT00824616|565642578|FG000|Overall Study|Hyperglycemia|1|||
156697836|NCT00824616|565642579|FG001|Overall Study|Hyperglycemia|1|||
156697837|NCT00824616|565642578|FG000|Overall Study|Lack of Efficacy|2|||
156697838|NCT00824616|565642579|FG001|Overall Study|Lack of Efficacy|1|||
156697839|NCT00824616|565642578|FG000|Overall Study|Lost to Follow-up|0|||
156790383|NCT01796470|565983803|FG001|Overall Study|Lost to Follow-up|1|||
156790384|NCT01796470|565983804|FG002|Overall Study|Lost to Follow-up|0|||
156790385|NCT01796470|565983805|FG003|Overall Study|Lost to Follow-up|0|||
156790386|NCT01796470|565983806|FG004|Overall Study|Lost to Follow-up|0|||
156790387|NCT01796470|565983802|FG000|Overall Study|Physician Decision|5|||
156790388|NCT01796470|565983803|FG001|Overall Study|Physician Decision|4|||
156790389|NCT01796470|565983804|FG002|Overall Study|Physician Decision|1|||
156790390|NCT01796470|565983805|FG003|Overall Study|Physician Decision|0|||
156790391|NCT01796470|565983806|FG004|Overall Study|Physician Decision|1|||
156790392|NCT01796470|565983802|FG000|Overall Study|Progressive Disease|7|||
156790393|NCT01796470|565983803|FG001|Overall Study|Progressive Disease|7|||
156790394|NCT01796470|565983804|FG002|Overall Study|Progressive Disease|3|||
156790395|NCT01796470|565983805|FG003|Overall Study|Progressive Disease|2|||
156790396|NCT01796470|565983806|FG004|Overall Study|Progressive Disease|0|||
156790397|NCT01796470|565983802|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
156790398|NCT01796470|565983803|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
156790399|NCT01796470|565983804|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
156790400|NCT01796470|565983805|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
156790401|NCT01796470|565983806|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
156790402|NCT01796470|565983802|FG000|Overall Study|Withdrawal by Subject|7|||
156790403|NCT01796470|565983803|FG001|Overall Study|Withdrawal by Subject|0|||
156790404|NCT01796470|565983804|FG002|Overall Study|Withdrawal by Subject|0|||
156790405|NCT01796470|565983805|FG003|Overall Study|Withdrawal by Subject|0|||
156790406|NCT01796470|565983806|FG004|Overall Study|Withdrawal by Subject|1|||
156790407|NCT01927861|565983807|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
156790408|NCT01927861|565983808|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
156790409|NCT01927861|565983807|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
156790410|NCT01927861|565983808|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
156790411|NCT00452530|565983809|FG000|Overall Study|Death|1|||
156790412|NCT00452530|565983810|FG001|Overall Study|Death|0|||
156790413|NCT00452530|565983809|FG000|Overall Study|Adverse Event|40|||
156790414|NCT00452530|565983810|FG001|Overall Study|Adverse Event|44|||
156790415|NCT00452530|565983809|FG000|Overall Study|Withdrawal by Subject|68|||
156790416|NCT00452530|565983810|FG001|Overall Study|Withdrawal by Subject|57|||
156790417|NCT00452530|565983809|FG000|Overall Study|Lost to Follow-up|1|||
156697840|NCT00824616|565642579|FG001|Overall Study|Lost to Follow-up|1|||
156697841|NCT00824616|565642578|FG000|Overall Study|Withdrawal by Subject|1|||
156697842|NCT00824616|565642579|FG001|Overall Study|Withdrawal by Subject|1|||
156697843|NCT00721630|565642580|FG000|Overall Study|Participant found to be ineligible|1|||
156697844|NCT03412396|565642595|FG000|Overall Study|Withdrawal by Subject|2|||
156790418|NCT00452530|565983810|FG001|Overall Study|Lost to Follow-up|0|||
156790419|NCT00452530|565983809|FG000|Overall Study|Poor compliance/noncompliance|1|||
156790420|NCT00452530|565983810|FG001|Overall Study|Poor compliance/noncompliance|2|||
156790421|NCT00452530|565983809|FG000|Overall Study|No longer met study criteria|18|||
156790422|NCT00452530|565983810|FG001|Overall Study|No longer met study criteria|22|||
156790423|NCT00452530|565983809|FG000|Overall Study|Other|7|||
156697845|NCT03412396|565642595|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
156697846|NCT03412396|565642595|FG000|Overall Study|Did not undergo RP|2|||
156697847|NCT03167723|565642598|FG000|Overall Study|Protocol Violation|4|||
156697848|NCT03167723|565642599|FG001|Overall Study|Protocol Violation|6|||
156697849|NCT01259115|565642600|FG000|Period 1|Adverse Event|1|||
156697850|NCT01259115|565642601|FG001|Period 1|Adverse Event|0|||
156697851|NCT01259115|565642600|FG000|Period 1|Protocol Violation|2|||
156697852|NCT01259115|565642601|FG001|Period 1|Protocol Violation|0|||
156697853|NCT01259115|565642600|FG000|Period 1|Lost to Follow-up|0|||
156790424|NCT00452530|565983810|FG001|Overall Study|Other|11|||
156697854|NCT01259115|565642601|FG001|Period 1|Lost to Follow-up|1|||
156790425|NCT02006654|565983813|FG000|Overall Study|Withdrawal before treatment|4|||
156790426|NCT02006654|565983814|FG001|Overall Study|Withdrawal before treatment|2|||
156790427|NCT02006654|565983813|FG000|Overall Study|Adverse Event|16|||
156790428|NCT02006654|565983814|FG001|Overall Study|Adverse Event|17|||
156790429|NCT02006654|565983813|FG000|Overall Study|Death|1|||
156790430|NCT02006654|565983814|FG001|Overall Study|Death|0|||
156790431|NCT02006654|565983813|FG000|Overall Study|Withdrawal by Subject|14|||
156790432|NCT02006654|565983814|FG001|Overall Study|Withdrawal by Subject|12|||
156790433|NCT02006654|565983813|FG000|Overall Study|Protocol Violation|5|||
156790434|NCT02006654|565983814|FG001|Overall Study|Protocol Violation|8|||
156790435|NCT02006654|565983813|FG000|Overall Study|Lost to Follow-up|1|||
156790436|NCT02006654|565983814|FG001|Overall Study|Lost to Follow-up|0|||
156790437|NCT02006654|565983813|FG000|Overall Study|patient's will|2|||
156790438|NCT02006654|565983814|FG001|Overall Study|patient's will|1|||
156790439|NCT02006654|565983813|FG000|Overall Study|insufficient compliance|1|||
156790440|NCT02006654|565983814|FG001|Overall Study|insufficient compliance|0|||
156790441|NCT02006654|565983813|FG000|Overall Study|worsening cognitive condition|0|||
156790442|NCT02006654|565983814|FG001|Overall Study|worsening cognitive condition|1|||
156790443|NCT02006654|565983813|FG000|Overall Study|faecal incontinence|0|||
156790444|NCT02006654|565983814|FG001|Overall Study|faecal incontinence|1|||
156790445|NCT02006654|565983813|FG000|Overall Study|mood disorder|0|||
156790446|NCT02006654|565983814|FG001|Overall Study|mood disorder|1|||
156790447|NCT02006654|565983813|FG000|Overall Study|disallowed medication|1|||
156790448|NCT02006654|565983814|FG001|Overall Study|disallowed medication|0|||
156790449|NCT02006654|565983813|FG000|Overall Study|moving out of state|0|||
156790450|NCT02006654|565983814|FG001|Overall Study|moving out of state|1|||
156790451|NCT01905267|565983817|FG000|Overall Study|Physician Decision|2|||
156790452|NCT01905267|565983818|FG001|Overall Study|Physician Decision|2|||
156790453|NCT02294019|565983819|FG000|Overall Study|Adverse Event|2|||
156790454|NCT02294019|565983819|FG000|Overall Study|Protocol Violation|68|||
156790455|NCT02294019|565983819|FG000|Overall Study|Lost to Follow-up|31|||
156790456|NCT02294019|565983819|FG000|Overall Study|Other|1|||
156790457|NCT02294019|565983819|FG000|Overall Study|Withdrawal by Subject|1|||
156790458|NCT01189227|565983821|FG000|Overall Study|Study terminated due to low accrual|6|||
156790459|NCT01189227|565983822|FG001|Overall Study|Study terminated due to low accrual|3|||
156790460|NCT02991859|565983825|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790461|NCT02991859|565983826|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
156790462|NCT02991859|565983827|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790463|NCT02991859|565983828|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790464|NCT02991859|565983829|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
156790465|NCT02991859|565983830|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790466|NCT02991859|565983831|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790467|NCT02991859|565983832|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790468|NCT02991859|565983833|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790469|NCT02991859|565983834|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790470|NCT02991859|565983835|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790471|NCT02991859|565983836|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790472|NCT02991859|565983837|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790473|NCT02991859|565983838|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790474|NCT02991859|565983839|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156697855|NCT01259115|565642600|FG000|Period 2|Adverse Event|1|||
156790475|NCT02991859|565983840|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790476|NCT02991859|565983841|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
156790477|NCT02991859|565983825|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790478|NCT02991859|565983826|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790479|NCT02991859|565983827|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790480|NCT02991859|565983828|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790481|NCT02991859|565983829|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156697856|NCT01259115|565642601|FG001|Period 2|Adverse Event|0|||
156697857|NCT01447420|565642615|FG000|Overall Study|Adverse Event|2|||
156697858|NCT01447420|565642616|FG001|Overall Study|Adverse Event|4|||
156697859|NCT01447420|565642617|FG002|Overall Study|Adverse Event|2|||
156697860|NCT01447420|565642615|FG000|Overall Study|Protocol Violation|3|||
156697861|NCT01447420|565642616|FG001|Overall Study|Protocol Violation|3|||
156697862|NCT01447420|565642617|FG002|Overall Study|Protocol Violation|0|||
156697863|NCT01447420|565642615|FG000|Overall Study|Withdrawal by Subject|4|||
156697864|NCT01447420|565642616|FG001|Overall Study|Withdrawal by Subject|1|||
156697865|NCT01447420|565642617|FG002|Overall Study|Withdrawal by Subject|0|||
156697866|NCT01447420|565642615|FG000|Overall Study|Lack of Efficacy|1|||
156697867|NCT01447420|565642616|FG001|Overall Study|Lack of Efficacy|19|||
156697868|NCT01447420|565642617|FG002|Overall Study|Lack of Efficacy|8|||
156697869|NCT02731326|565642618|FG000|Overall Study|Withdrawal by Subject|4|||
156697870|NCT02731326|565642619|FG001|Overall Study|Withdrawal by Subject|1|||
156697871|NCT02731326|565642618|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
156697872|NCT02731326|565642619|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
156697873|NCT02731326|565642618|FG000|Overall Study|Discharged without AliveCor|10|||
156697874|NCT02731326|565642619|FG001|Overall Study|Discharged without AliveCor|0|||
156697875|NCT02731326|565642618|FG000|Overall Study|Duplicate Participant|1|||
156697876|NCT02731326|565642619|FG001|Overall Study|Duplicate Participant|1|||
156697877|NCT04480710|565642624|FG000|Overall Study|Adverse Event|0|||
156697878|NCT04480710|565642625|FG001|Overall Study|Adverse Event|2|||
156697879|NCT04480710|565642626|FG002|Overall Study|Adverse Event|0|||
156697880|NCT04480710|565642627|FG003|Overall Study|Adverse Event|0|||
156697881|NCT04480710|565642624|FG000|Overall Study|Withdrawal by Subject|0|||
156697882|NCT04480710|565642625|FG001|Overall Study|Withdrawal by Subject|1|||
156697883|NCT04480710|565642626|FG002|Overall Study|Withdrawal by Subject|0|||
156790482|NCT02991859|565983830|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790483|NCT02991859|565983831|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
157014708|NCT00212355|566805013|FG000|Overall Study|A change of address|1|||
157014709|NCT00186992|566805019|FG000|Overall Study|Withdrawal by Subject|5|||
157014710|NCT00186992|566805019|FG000|Overall Study|Physician's discretion|13|||
157014711|NCT00186992|566805019|FG000|Overall Study|PI Discretion|4|||
157014712|NCT00186992|566805019|FG000|Overall Study|Ineligible|2|||
157014713|NCT00186992|566805019|FG000|Overall Study|Lost to Follow-up|2|||
157014714|NCT00186992|566805019|FG000|Overall Study|Still on Study|9|||
157014715|NCT04607044|566805028|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
157014716|NCT04607044|566805028|FG000|Overall Study|Adverse Event|1|||
157014717|NCT04607044|566805028|FG000|Overall Study|Did not receive study device|3|||
157014718|NCT04607044|566805028|FG000|Overall Study|Death|1|||
157014719|NCT05403801|566805029|FG000|Overall Study|Withdrawal by Subject|2|||
157014720|NCT05384730|566805035|FG000|Overall Study|Adverse Event|1|||
157014721|NCT05384730|566805036|FG001|Overall Study|Adverse Event|0|||
157014722|NCT05384730|566805035|FG000|Overall Study|Lack of social support|2|||
157014723|NCT05384730|566805036|FG001|Overall Study|Lack of social support|0|||
157014724|NCT05384730|566805035|FG000|Overall Study|Hospital readmission|2|||
157014725|NCT05384730|566805036|FG001|Overall Study|Hospital readmission|0|||
157014726|NCT05384730|566805035|FG000|Overall Study|Disease progression|5|||
156697884|NCT04480710|565642627|FG003|Overall Study|Withdrawal by Subject|0|||
156790484|NCT02991859|565983832|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156697885|NCT04480710|565642624|FG000|Overall Study|Physician Decision|0|||
156697886|NCT04480710|565642625|FG001|Overall Study|Physician Decision|0|||
156697887|NCT04480710|565642626|FG002|Overall Study|Physician Decision|1|||
156790485|NCT02991859|565983833|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790486|NCT02991859|565983834|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790487|NCT02991859|565983835|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
157014727|NCT05384730|566805036|FG001|Overall Study|Disease progression|0|||
157014728|NCT05384730|566805035|FG000|Overall Study|Overwhelmed with College commitments|0|||
157014729|NCT05384730|566805036|FG001|Overall Study|Overwhelmed with College commitments|2|||
157014730|NCT01121991|566805037|FG000|Overall Study|Lack of Ovarian Response|2|||
157014731|NCT01121991|566805037|FG000|Overall Study|No Oocytes Retrieved|3|||
157014732|NCT01121991|566805037|FG000|Overall Study|No Fertilization|1|||
157014733|NCT01619410|566805038|FG000|Overall Study|Lost to Follow-up|7|||
157014734|NCT01619410|566805039|FG001|Overall Study|Lost to Follow-up|4|||
157014735|NCT02740231|566805040|FG000|Overall Study|Withdrawal by Subject|1|||
157014736|NCT02740231|566805041|FG001|Overall Study|Withdrawal by Subject|1|||
157014737|NCT02740231|566805042|FG002|Overall Study|Withdrawal by Subject|1|||
157014738|NCT02740231|566805043|FG003|Overall Study|Withdrawal by Subject|0|||
157014739|NCT02740231|566805040|FG000|Overall Study|Lack of Efficacy|0|||
157014740|NCT02740231|566805041|FG001|Overall Study|Lack of Efficacy|1|||
157014741|NCT02740231|566805042|FG002|Overall Study|Lack of Efficacy|0|||
157014742|NCT02740231|566805043|FG003|Overall Study|Lack of Efficacy|4|||
157014743|NCT02740231|566805040|FG000|Overall Study|Lost to Follow-up|1|||
157014744|NCT02740231|566805041|FG001|Overall Study|Lost to Follow-up|3|||
157014745|NCT02740231|566805042|FG002|Overall Study|Lost to Follow-up|0|||
157014746|NCT02740231|566805043|FG003|Overall Study|Lost to Follow-up|3|||
157014747|NCT02740231|566805040|FG000|Overall Study|Adverse Event|0|||
156697888|NCT04480710|565642627|FG003|Overall Study|Physician Decision|0|||
157014748|NCT02740231|566805041|FG001|Overall Study|Adverse Event|1|||
156697889|NCT04480021|565642628|FG000|Overall Study|Lost to Follow-up|3|||
156697890|NCT04480021|565642629|FG001|Overall Study|Lost to Follow-up|4|||
156697891|NCT01103466|565642630|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
156697892|NCT01103466|565642631|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
156697893|NCT01103466|565642632|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
156697894|NCT01103466|565642630|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
156697895|NCT01103466|565642631|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
156697896|NCT01103466|565642632|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
156697897|NCT01103466|565642630|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697898|NCT01103466|565642631|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697899|NCT01103466|565642632|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697900|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
156697901|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
156697902|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
156697903|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
156697904|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697905|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
156697906|NCT01103466|565642630|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
156697907|NCT01103466|565642631|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
156697908|NCT01103466|565642632|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
156697909|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
156697910|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
156697911|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
156697912|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
156697913|NCT02994940|565642635|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
156697914|NCT02994940|565642636|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
156697915|NCT02987959|565642641|FG000|Overall Study|Grantor stopped supply of drugs|6|||
156697916|NCT02853370|565642642|FG000|Overall Study|Physician Decision|1|||
156697917|NCT02853370|565642642|FG000|Overall Study|Lack of Efficacy|2|||
156697918|NCT02853370|565642642|FG000|Overall Study|Death|1|||
156697919|NCT02853370|565642642|FG000|Overall Study|Adverse Event|4|||
156697920|NCT02853370|565642642|FG000|Overall Study|Withdrawal by Subject|3|||
156697921|NCT00643565|565642644|FG000|Overall Study|Death|12|||
156697922|NCT00643565|565642645|FG001|Overall Study|Death|11|||
156697923|NCT00643565|565642644|FG000|Overall Study|Withdrawal by Subject|4|||
156697924|NCT00643565|565642645|FG001|Overall Study|Withdrawal by Subject|1|||
156697925|NCT00643565|565642644|FG000|Overall Study|Lost to Follow-up|0|||
156697926|NCT00643565|565642645|FG001|Overall Study|Lost to Follow-up|6|||
156697927|NCT00643565|565642644|FG000|Overall Study|Other|7|||
156697928|NCT00643565|565642645|FG001|Overall Study|Other|8|||
156697929|NCT00643565|565642644|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
156871518|NCT03894813|566287702|FG001|Overall Study|Withdrawal by Subject|3|||
156871519|NCT03894813|566287701|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
156871520|NCT03894813|566287702|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
156871521|NCT00807001|566287705|FG000|Overall Study|Non-compliance|0|||
156871522|NCT00807001|566287706|FG001|Overall Study|Non-compliance|1|||
156871523|NCT00807001|566287707|FG002|Overall Study|Non-compliance|0|||
156871524|NCT00807001|566287708|FG003|Overall Study|Non-compliance|0|||
156871525|NCT00807001|566287709|FG004|Overall Study|Non-compliance|0|||
156697930|NCT00643565|565642645|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
156697931|NCT00643565|565642644|FG000|Overall Study|Recurrence of Disease|2|||
156697932|NCT00643565|565642645|FG001|Overall Study|Recurrence of Disease|1|||
156697933|NCT00643565|565642644|FG000|Overall Study|Progression of Disease|18|||
156697934|NCT00643565|565642645|FG001|Overall Study|Progression of Disease|14|||
156697935|NCT00643565|565642644|FG000|Overall Study|Protocol Violation|3|||
156697936|NCT00643565|565642645|FG001|Overall Study|Protocol Violation|0|||
156697937|NCT00643565|565642644|FG000|Overall Study|Did Not Cooperate|0|||
156697938|NCT00643565|565642645|FG001|Overall Study|Did Not Cooperate|1|||
156697939|NCT00643565|565642644|FG000|Overall Study|Administrative|22|||
156697940|NCT00643565|565642645|FG001|Overall Study|Administrative|16|||
156697941|NCT00643565|565642644|FG000|Overall Study|Adverse Event|5|||
156697942|NCT00643565|565642645|FG001|Overall Study|Adverse Event|8|||
156697943|NCT02317614|565642646|FG000|Overall Study|Lost to Follow-up|1|||
156697944|NCT02317614|565642647|FG001|Overall Study|Lost to Follow-up|1|||
156871526|NCT02269267|566287711|FG000|Overall Study|Death|5|||
156697945|NCT02317614|565642646|FG000|Overall Study|Withdrawal by Subject|1|||
156697946|NCT02317614|565642647|FG001|Overall Study|Withdrawal by Subject|0|||
156697947|NCT02317614|565642646|FG000|Overall Study|Death|1|||
156697948|NCT02317614|565642647|FG001|Overall Study|Death|1|||
156697949|NCT03283761|565642650|FG000|Study Treatment|Patient Non-Compliance|1|||
156871527|NCT03773796|566287712|FG000|Overall Study|Adverse Event|1|||
156871528|NCT03773796|566287712|FG000|Overall Study|Withdrawal by Subject|1|||
156871529|NCT03773796|566287712|FG000|Overall Study|Lack of Efficacy|1|||
157214849|NCT04126733|567533541|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
157014749|NCT02740231|566805042|FG002|Overall Study|Adverse Event|0|||
157014750|NCT02740231|566805043|FG003|Overall Study|Adverse Event|1|||
157014751|NCT02462759|566805044|FG000|Part 1: Double Blind|Death|1|||
157014752|NCT02462759|566805045|FG001|Part 1: Double Blind|Death|0|||
157014753|NCT02462759|566805046|FG002|Part 1: Double Blind|Death|0|||
156697950|NCT03283761|565642650|FG000|Study Treatment|Alternative Cancer Therapy|7|||
156697951|NCT03283761|565642650|FG000|Study Treatment|Disease progression|21|||
156697952|NCT03283761|565642650|FG000|Study Treatment|Adverse Event|3|||
156697953|NCT03283761|565642650|FG000|Study Treatment|Withdrawal by Subject|4|||
156697954|NCT03283761|565642650|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
156697955|NCT03283761|565642650|FG000|Study Treatment|Symptomatic Deterioration|1|||
156697956|NCT03283761|565642650|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
156697957|NCT03283761|565642650|FG000|Follow up|Lost to Follow-up|1|||
156697958|NCT03283761|565642650|FG000|Follow up|Symptomatic Deterioration|1|||
156697959|NCT03283761|565642650|FG000|Follow up|Death|29|||
156697960|NCT03283761|565642650|FG000|Follow up|study terminated|4|||
157014754|NCT04110054|566805047|FG000|Overall Study|COVID-19 reason other than AE|0|||
157014755|NCT04110054|566805048|FG001|Overall Study|COVID-19 reason other than AE|0|||
157214850|NCT04126733|567533541|FG000|Treatment Period|Adverse Event|8|||
156697961|NCT03283761|565642650|FG000|Follow up|Primary Investigator Withdrawal|1|||
156697962|NCT03283761|565642650|FG000|Follow up|Switched to alternative therapy|1|||
156697963|NCT03283761|565642650|FG000|Follow up|Subject is now in Hospice|1|||
156697964|NCT01355159|565642657|FG000|Overall Study|Withdrew consent|39|||
156697965|NCT01355159|565642658|FG001|Overall Study|Withdrew consent|47|||
156697966|NCT01355159|565642657|FG000|Overall Study|No primary outcome data|17|||
156697967|NCT01355159|565642658|FG001|Overall Study|No primary outcome data|11|||
156697968|NCT01355159|565642657|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
156697969|NCT01355159|565642658|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
156697970|NCT01355159|565642657|FG000|Overall Study|Early intrauterine fetal death|6|||
156697971|NCT01355159|565642658|FG001|Overall Study|Early intrauterine fetal death|6|||
156697972|NCT03276221|565642659|FG000|Overall Study|Lost to Follow-up|6|||
156697973|NCT03276221|565642660|FG001|Overall Study|Lost to Follow-up|2|||
156697974|NCT03276221|565642661|FG002|Overall Study|Lost to Follow-up|0|||
156697975|NCT03276221|565642659|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
156697976|NCT03276221|565642660|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
156697977|NCT03276221|565642661|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
156697978|NCT00424775|565642662|FG000|Overall Study|Adverse Event|2|||
156697979|NCT00424775|565642663|FG001|Overall Study|Adverse Event|0|||
156697980|NCT00424775|565642662|FG000|Overall Study|Lack of Efficacy|1|||
156697981|NCT00424775|565642663|FG001|Overall Study|Lack of Efficacy|0|||
156697982|NCT00975286|565642666|FG000|Overall Study|Adverse Event|9|||
156697983|NCT00975286|565642667|FG001|Overall Study|Adverse Event|19|||
156697984|NCT00975286|565642666|FG000|Overall Study|Protocol Violation|1|||
156697985|NCT00975286|565642667|FG001|Overall Study|Protocol Violation|2|||
156697986|NCT00975286|565642666|FG000|Overall Study|Withdrawal by Subject|0|||
156697987|NCT00975286|565642667|FG001|Overall Study|Withdrawal by Subject|2|||
156697988|NCT00975286|565642666|FG000|Overall Study|Familial and Personal Reasons|2|||
156697989|NCT00975286|565642667|FG001|Overall Study|Familial and Personal Reasons|2|||
156697990|NCT00975286|565642666|FG000|Overall Study|Poor Compliance to Protocol|0|||
156790488|NCT02991859|565983836|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790489|NCT02991859|565983837|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
156790490|NCT02991859|565983838|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
156790491|NCT02991859|565983839|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790492|NCT02991859|565983840|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790493|NCT02991859|565983841|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
156790494|NCT02991859|565983825|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790495|NCT02991859|565983826|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790496|NCT02991859|565983827|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
157014756|NCT04110054|566805049|FG002|Overall Study|COVID-19 reason other than AE|2|||
156697991|NCT00975286|565642667|FG001|Overall Study|Poor Compliance to Protocol|2|||
156697992|NCT00975286|565642666|FG000|Overall Study|Sponsor Decision|0|||
156697993|NCT00975286|565642667|FG001|Overall Study|Sponsor Decision|2|||
156790497|NCT02991859|565983828|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790498|NCT02991859|565983829|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790499|NCT02991859|565983830|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
156790500|NCT02991859|565983831|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790501|NCT02991859|565983832|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790502|NCT02991859|565983833|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790503|NCT02991859|565983834|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156697994|NCT00741936|565642669|FG000|Overall Study|Lost to Follow-up|1|||
156697995|NCT00741936|565642670|FG001|Overall Study|Lost to Follow-up|1|||
157014757|NCT04110054|566805050|FG003|Overall Study|COVID-19 reason other than AE|0|||
156697996|NCT00741936|565642669|FG000|Overall Study|Adverse Event|3|||
156697997|NCT00741936|565642670|FG001|Overall Study|Adverse Event|4|||
156697998|NCT00741936|565642669|FG000|Overall Study|Pregnancy|0|||
156697999|NCT00741936|565642670|FG001|Overall Study|Pregnancy|1|||
156698000|NCT00741936|565642669|FG000|Overall Study|Protocol Violation|2|||
156698001|NCT00741936|565642670|FG001|Overall Study|Protocol Violation|0|||
156698002|NCT00741936|565642669|FG000|Overall Study|Lack of Efficacy|0|||
156698003|NCT00741936|565642670|FG001|Overall Study|Lack of Efficacy|2|||
156698004|NCT00741936|565642669|FG000|Overall Study|Low compliance|3|||
156698005|NCT00741936|565642670|FG001|Overall Study|Low compliance|0|||
156698006|NCT01941940|565642671|FG000|Overall Study|Adverse Event|11|||
156698007|NCT01941940|565642671|FG000|Overall Study|Lost to Follow-up|2|||
156698008|NCT01941940|565642671|FG000|Overall Study|Physician Decision|2|||
156698009|NCT01941940|565642671|FG000|Overall Study|Withdrawal by Subject|15|||
156698010|NCT01941940|565642671|FG000|Overall Study|Death|1|||
156698011|NCT01941940|565642671|FG000|Overall Study|Other|1|||
156698012|NCT01941940|565642671|FG000|Overall Study|Other|1|||
156698013|NCT03212521|565642674|FG000|Overall Study|Adverse Event|1|||
156698014|NCT03212521|565642674|FG000|Overall Study|Lost to Follow-up|4|||
156698015|NCT03212521|565642674|FG000|Overall Study|Withdrawal by Subject|1|||
156698016|NCT03212521|565642674|FG000|Overall Study|Other|1|||
156698017|NCT00914459|565642677|FG000|Overall Study|Protocol Violation|0|||
156698018|NCT00914459|565642678|FG001|Overall Study|Protocol Violation|1|||
156698019|NCT00914459|565642677|FG000|Overall Study|Parent/Legal guardian request|1|||
156698020|NCT00914459|565642678|FG001|Overall Study|Parent/Legal guardian request|0|||
156698021|NCT03176459|565642679|FG000|Overall Study|Lost to Follow-up|5|||
156698022|NCT03176459|565642680|FG001|Overall Study|Lost to Follow-up|7|||
156698023|NCT01661179|565642681|FG000|Overall Study|Death|1|||
156698024|NCT01661179|565642681|FG000|Overall Study|Withdrawal by Subject|1|||
156698025|NCT01661179|565642681|FG000|Overall Study|Other Eligibility criteria|4|||
156698026|NCT01083810|565642682|FG000|Overall Study|Lost to Follow-up|23|||
156698027|NCT01083810|565642683|FG001|Overall Study|Lost to Follow-up|11|||
156698028|NCT01083810|565642684|FG002|Overall Study|Lost to Follow-up|4|||
156698029|NCT01083810|565642682|FG000|Overall Study|Adverse Event|15|||
156698030|NCT01083810|565642683|FG001|Overall Study|Adverse Event|11|||
156698031|NCT01083810|565642684|FG002|Overall Study|Adverse Event|4|||
156698032|NCT01083810|565642682|FG000|Overall Study|Withdrawal by Subject|7|||
156698033|NCT01083810|565642683|FG001|Overall Study|Withdrawal by Subject|2|||
156698034|NCT01083810|565642684|FG002|Overall Study|Withdrawal by Subject|4|||
157014758|NCT04110054|566805047|FG000|Overall Study|Withdrawal by Subject|0|||
157014759|NCT04110054|566805048|FG001|Overall Study|Withdrawal by Subject|3|||
157014760|NCT04110054|566805049|FG002|Overall Study|Withdrawal by Subject|2|||
157014761|NCT04110054|566805050|FG003|Overall Study|Withdrawal by Subject|0|||
157014762|NCT04110054|566805047|FG000|Overall Study|Adverse Event|1|||
156698035|NCT01083810|565642682|FG000|Overall Study|Reason not reported|6|||
156698036|NCT01083810|565642683|FG001|Overall Study|Reason not reported|1|||
156698037|NCT01083810|565642684|FG002|Overall Study|Reason not reported|1|||
156698038|NCT01083810|565642682|FG000|Overall Study|Non-compliance|4|||
156698039|NCT01083810|565642683|FG001|Overall Study|Non-compliance|7|||
156698040|NCT01083810|565642684|FG002|Overall Study|Non-compliance|2|||
156698041|NCT01083810|565642682|FG000|Overall Study|Simplification|4|||
156698042|NCT01083810|565642683|FG001|Overall Study|Simplification|1|||
156698043|NCT01083810|565642684|FG002|Overall Study|Simplification|0|||
156698044|NCT01083810|565642682|FG000|Overall Study|Death|2|||
156698045|NCT01083810|565642683|FG001|Overall Study|Death|2|||
156698046|NCT01083810|565642684|FG002|Overall Study|Death|3|||
156698047|NCT01083810|565642682|FG000|Overall Study|Co-morbidities|1|||
157014763|NCT04110054|566805048|FG001|Overall Study|Adverse Event|1|||
157014764|NCT04110054|566805049|FG002|Overall Study|Adverse Event|4|||
157014765|NCT04110054|566805050|FG003|Overall Study|Adverse Event|3|||
156698048|NCT01083810|565642683|FG001|Overall Study|Co-morbidities|0|||
156698049|NCT01083810|565642684|FG002|Overall Study|Co-morbidities|0|||
156698050|NCT01083810|565642682|FG000|Overall Study|Participation in study|1|||
157014766|NCT01000480|566805051|FG000|Induction Phase|Adverse Event|2|||
157014767|NCT01000480|566805051|FG000|Induction Phase|Lost to Follow-up|1|||
157214851|NCT04126733|567533541|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
156698051|NCT01083810|565642683|FG001|Overall Study|Participation in study|0|||
156698052|NCT01083810|565642684|FG002|Overall Study|Participation in study|0|||
156698053|NCT01083810|565642682|FG000|Overall Study|Therapy break|1|||
157214852|NCT04126733|567533541|FG000|Treatment Period|Physician Decision|5|||
156698054|NCT01083810|565642683|FG001|Overall Study|Therapy break|2|||
156698055|NCT01083810|565642684|FG002|Overall Study|Therapy break|2|||
156698056|NCT01083810|565642682|FG000|Overall Study|Virologic failure|1|||
156698057|NCT01083810|565642683|FG001|Overall Study|Virologic failure|8|||
156698058|NCT01083810|565642684|FG002|Overall Study|Virologic failure|0|||
156698059|NCT01602965|565642685|FG000|Overall Study|Lost to Follow-up|4|||
156698060|NCT01602965|565642686|FG001|Overall Study|Lost to Follow-up|2|||
156698061|NCT00446199|565642687|FG000|Overall Study|Adverse Event|7|||
156698062|NCT00446199|565642688|FG001|Overall Study|Adverse Event|4|||
157014768|NCT01000480|566805051|FG000|Induction Phase|Physician Decision|1|||
156698063|NCT00446199|565642689|FG002|Overall Study|Adverse Event|6|||
156698064|NCT00446199|565642690|FG003|Overall Study|Adverse Event|4|||
156698065|NCT00446199|565642687|FG000|Overall Study|Lost to Follow-up|4|||
156698066|NCT00446199|565642688|FG001|Overall Study|Lost to Follow-up|5|||
156698067|NCT00446199|565642689|FG002|Overall Study|Lost to Follow-up|2|||
156698068|NCT00446199|565642690|FG003|Overall Study|Lost to Follow-up|6|||
156698069|NCT00446199|565642687|FG000|Overall Study|Protocol Violation|1|||
156698070|NCT00446199|565642688|FG001|Overall Study|Protocol Violation|2|||
156698071|NCT00446199|565642689|FG002|Overall Study|Protocol Violation|1|||
156698072|NCT00446199|565642690|FG003|Overall Study|Protocol Violation|3|||
156698073|NCT00446199|565642687|FG000|Overall Study|Withdrawal by Subject|2|||
156698074|NCT00446199|565642688|FG001|Overall Study|Withdrawal by Subject|5|||
156698075|NCT00446199|565642689|FG002|Overall Study|Withdrawal by Subject|9|||
156698076|NCT00446199|565642690|FG003|Overall Study|Withdrawal by Subject|10|||
156698077|NCT00446199|565642687|FG000|Overall Study|Site termination|2|||
156698078|NCT00446199|565642688|FG001|Overall Study|Site termination|0|||
156698079|NCT00446199|565642689|FG002|Overall Study|Site termination|0|||
156698080|NCT00446199|565642690|FG003|Overall Study|Site termination|1|||
156698081|NCT00446199|565642687|FG000|Overall Study|Randomization in Error|2|||
156698082|NCT00446199|565642688|FG001|Overall Study|Randomization in Error|0|||
156698083|NCT00446199|565642689|FG002|Overall Study|Randomization in Error|1|||
156698084|NCT00446199|565642690|FG003|Overall Study|Randomization in Error|1|||
156698085|NCT00446199|565642687|FG000|Overall Study|Lack of Efficacy|1|||
156698086|NCT00446199|565642688|FG001|Overall Study|Lack of Efficacy|0|||
156698087|NCT00446199|565642689|FG002|Overall Study|Lack of Efficacy|0|||
156698088|NCT00446199|565642690|FG003|Overall Study|Lack of Efficacy|1|||
156698089|NCT00446199|565642687|FG000|Overall Study|Non-compliant with study drug|1|||
156698090|NCT00446199|565642688|FG001|Overall Study|Non-compliant with study drug|0|||
156698091|NCT00446199|565642689|FG002|Overall Study|Non-compliant with study drug|5|||
156698092|NCT00446199|565642690|FG003|Overall Study|Non-compliant with study drug|0|||
156698093|NCT00446199|565642687|FG000|Overall Study|Non-compliant with visit schedule|1|||
156698094|NCT00446199|565642688|FG001|Overall Study|Non-compliant with visit schedule|1|||
156698095|NCT00446199|565642689|FG002|Overall Study|Non-compliant with visit schedule|1|||
156698096|NCT00446199|565642690|FG003|Overall Study|Non-compliant with visit schedule|2|||
156698097|NCT00446199|565642687|FG000|Overall Study|Hormone fear|0|||
156698098|NCT00446199|565642688|FG001|Overall Study|Hormone fear|0|||
156698099|NCT00446199|565642689|FG002|Overall Study|Hormone fear|0|||
156698100|NCT00446199|565642690|FG003|Overall Study|Hormone fear|1|||
156698101|NCT00446199|565642687|FG000|Overall Study|Lost interest in study participation|0|||
156698102|NCT00446199|565642688|FG001|Overall Study|Lost interest in study participation|1|||
156698103|NCT00446199|565642689|FG002|Overall Study|Lost interest in study participation|0|||
156698104|NCT00446199|565642690|FG003|Overall Study|Lost interest in study participation|0|||
156698105|NCT00446199|565642687|FG000|Overall Study|In-/Exclusion criterion violated|2|||
156871530|NCT03805659|566287714|FG000|Overall Study|Withdrawal by Subject|0|||
156871531|NCT03805659|566287715|FG001|Overall Study|Withdrawal by Subject|1|||
156871532|NCT02273596|566287717|FG000|24-Week Treatment Period|Adverse Event|3|||
156871533|NCT02273596|566287717|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
156871534|NCT02273596|566287717|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
157123032|NCT00487539|567201524|FG003|Overall Study|Adverse Event|1|||
157123033|NCT00487539|567201521|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157123034|NCT00487539|567201522|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157123035|NCT00487539|567201523|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156698106|NCT00446199|565642688|FG001|Overall Study|In-/Exclusion criterion violated|1|||
156698107|NCT00446199|565642689|FG002|Overall Study|In-/Exclusion criterion violated|2|||
156698108|NCT00446199|565642690|FG003|Overall Study|In-/Exclusion criterion violated|1|||
156698109|NCT00446199|565642687|FG000|Overall Study|Move|0|||
156698110|NCT00446199|565642688|FG001|Overall Study|Move|1|||
156698111|NCT00446199|565642689|FG002|Overall Study|Move|0|||
156698112|NCT00446199|565642690|FG003|Overall Study|Move|0|||
156698113|NCT03071094|565642694|FG000|Overall Study|Death|1|||
156698114|NCT03071094|565642695|FG001|Overall Study|Death|1|||
156698115|NCT03071094|565642694|FG000|Overall Study|Adverse Event|1|||
156698116|NCT03071094|565642695|FG001|Overall Study|Adverse Event|0|||
156698117|NCT02312063|565642696|FG000|Overall Study|Withdrawal by Subject|0|||
157123036|NCT00487539|567201524|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
156698118|NCT02312063|565642697|FG001|Overall Study|Withdrawal by Subject|1|||
156698119|NCT01079832|565642701|FG000|Overall Study|Withdrawal by Subject|1|||
156698120|NCT03548064|565645578|FG000|Overall Study|Withdrawal by Subject|0|||
156698121|NCT03548064|565645579|FG001|Overall Study|Withdrawal by Subject|0|||
156698122|NCT03548064|565645580|FG002|Overall Study|Withdrawal by Subject|0|||
156698123|NCT03548064|565645581|FG003|Overall Study|Withdrawal by Subject|1|||
156871535|NCT02273596|566287717|FG000|24-Week Treatment Period|Physician Decision|1|||
157123037|NCT00487539|567201521|FG000|Overall Study|Other|3|||
157123038|NCT00487539|567201522|FG001|Overall Study|Other|1|||
156698124|NCT03548064|565645582|FG004|Overall Study|Withdrawal by Subject|0|||
156698125|NCT03548064|565645583|FG005|Overall Study|Withdrawal by Subject|0|||
157014769|NCT01000480|566805051|FG000|Induction Phase|Entry Criteria Not Met|3|||
157014770|NCT01000480|566805051|FG000|Concurrent Therapy Phase|Adverse Event|4|||
157014771|NCT01000480|566805051|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
157014772|NCT01000480|566805051|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
156698126|NCT03548064|565645584|FG006|Overall Study|Withdrawal by Subject|0|||
156698127|NCT03548064|565645585|FG007|Overall Study|Withdrawal by Subject|0|||
156698128|NCT03548064|565645578|FG000|Overall Study|Lost to Follow-up|0|||
157014773|NCT01000480|566805051|FG000|Concurrent Therapy Phase|Physician Decision|1|||
157014774|NCT03655262|566805058|FG000|Overall Study|Withdrawal by Subject|0|||
157014775|NCT03655262|566805059|FG001|Overall Study|Withdrawal by Subject|0|||
157014776|NCT03655262|566805060|FG002|Overall Study|Withdrawal by Subject|1|||
157014777|NCT04328727|566805064|FG000|Overall Study|Guardian Decision|1|||
157014778|NCT04328727|566805064|FG000|Overall Study|Participant decision|4|||
157014779|NCT04328727|566805064|FG000|Overall Study|Death|3|||
157014780|NCT04149002|566805068|FG000|Overall Study|Lost to Follow-up|1|||
157014781|NCT04149002|566805069|FG001|Overall Study|Lost to Follow-up|0|||
157014782|NCT04149002|566805068|FG000|Overall Study|Withdrawal by Subject|1|||
157014783|NCT04149002|566805069|FG001|Overall Study|Withdrawal by Subject|0|||
157014784|NCT04583423|566805070|FG000|Overall Study|Lost to Follow-up|0|||
157014785|NCT04583423|566805071|FG001|Overall Study|Lost to Follow-up|1|||
157014786|NCT04583423|566805072|FG002|Overall Study|Lost to Follow-up|0|||
157014787|NCT04583423|566805073|FG003|Overall Study|Lost to Follow-up|2|||
156698129|NCT03548064|565645579|FG001|Overall Study|Lost to Follow-up|0|||
156698130|NCT03548064|565645580|FG002|Overall Study|Lost to Follow-up|0|||
156698131|NCT03548064|565645581|FG003|Overall Study|Lost to Follow-up|0|||
156698132|NCT03548064|565645582|FG004|Overall Study|Lost to Follow-up|2|||
157014788|NCT04583423|566805070|FG000|Overall Study|Study Terminated by Sponsor|32|||
157014789|NCT04583423|566805071|FG001|Overall Study|Study Terminated by Sponsor|35|||
157014790|NCT04583423|566805072|FG002|Overall Study|Study Terminated by Sponsor|36|||
157014791|NCT04583423|566805073|FG003|Overall Study|Study Terminated by Sponsor|33|||
157014792|NCT04583423|566805070|FG000|Overall Study|Withdrawal by Subject|3|||
157014793|NCT04583423|566805071|FG001|Overall Study|Withdrawal by Subject|1|||
157014794|NCT04583423|566805072|FG002|Overall Study|Withdrawal by Subject|2|||
157014795|NCT04583423|566805073|FG003|Overall Study|Withdrawal by Subject|1|||
157014796|NCT03330795|566805074|FG000|Overall Study|Death|3|||
157014797|NCT03330795|566805074|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
157014798|NCT03830866|566805075|FG000|Overall Study|Death|90|||
157014799|NCT03830866|566805076|FG001|Overall Study|Death|111|||
157014800|NCT03830866|566805075|FG000|Overall Study|Lost to Follow-up|7|||
157014801|NCT03830866|566805076|FG001|Overall Study|Lost to Follow-up|7|||
157014802|NCT03830866|566805075|FG000|Overall Study|Withdrawal by Subject|19|||
157014803|NCT03830866|566805076|FG001|Overall Study|Withdrawal by Subject|16|||
157014804|NCT03830866|566805075|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
157014805|NCT03830866|566805076|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
157014806|NCT03830866|566805075|FG000|Overall Study|Other|1|||
157014807|NCT03830866|566805076|FG001|Overall Study|Other|1|||
157014808|NCT03447249|566805086|FG000|Overall Study|Adverse Event|1|||
157014809|NCT03447249|566805087|FG001|Overall Study|Adverse Event|0|||
157014810|NCT03447249|566805086|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
157014811|NCT03447249|566805087|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
157014812|NCT03447249|566805086|FG000|Overall Study|Other|3|||
157014813|NCT03447249|566805087|FG001|Overall Study|Other|0|||
157014814|NCT01426412|566805088|FG000|Overall Study|Withdrawal by Subject|1|||
157014815|NCT01426412|566805089|FG001|Overall Study|Withdrawal by Subject|0|||
157014816|NCT01426412|566805090|FG002|Overall Study|Withdrawal by Subject|0|||
157014817|NCT01426412|566805091|FG003|Overall Study|Withdrawal by Subject|0|||
157014818|NCT01426412|566805092|FG004|Overall Study|Withdrawal by Subject|1|||
157014819|NCT01426412|566805093|FG005|Overall Study|Withdrawal by Subject|0|||
157014820|NCT01426412|566805094|FG006|Overall Study|Withdrawal by Subject|0|||
157014821|NCT01426412|566805095|FG007|Overall Study|Withdrawal by Subject|3|||
157014822|NCT01426412|566805096|FG008|Overall Study|Withdrawal by Subject|1|||
157014823|NCT02376790|566805098|FG000|Overall Study|Withdrawal by Subject|43|||
157014824|NCT02376790|566805099|FG001|Overall Study|Withdrawal by Subject|36|||
157014825|NCT02376790|566805100|FG002|Overall Study|Withdrawal by Subject|37|||
157014826|NCT02376790|566805098|FG000|Overall Study|Decision by Sponsor|2|||
157014827|NCT02376790|566805099|FG001|Overall Study|Decision by Sponsor|1|||
157014828|NCT02376790|566805100|FG002|Overall Study|Decision by Sponsor|4|||
157014829|NCT02376790|566805098|FG000|Overall Study|Lost to Follow-up|15|||
157014830|NCT02376790|566805099|FG001|Overall Study|Lost to Follow-up|10|||
157014831|NCT02376790|566805100|FG002|Overall Study|Lost to Follow-up|12|||
157014832|NCT00988858|566805101|FG000|Overall Study|Adverse Event|7|||
157014833|NCT00988858|566805101|FG000|Overall Study|Death|1|||
157014834|NCT00988858|566805101|FG000|Overall Study|Physician Decision|1|||
157014835|NCT00988858|566805101|FG000|Overall Study|Sponsor Decision|1|||
157014836|NCT03014453|566805102|FG000|Overall Study|Lost to Follow-up|12|||
157014837|NCT03014453|566805102|FG000|Overall Study|Discontinued GER|3|||
156698133|NCT03548064|565645583|FG005|Overall Study|Lost to Follow-up|0|||
156698134|NCT03548064|565645584|FG006|Overall Study|Lost to Follow-up|0|||
156698135|NCT03548064|565645585|FG007|Overall Study|Lost to Follow-up|0|||
156698136|NCT03548064|565645578|FG000|Overall Study|Covid-19 Pandemic|0|||
156698137|NCT03548064|565645579|FG001|Overall Study|Covid-19 Pandemic|0|||
156698138|NCT03548064|565645580|FG002|Overall Study|Covid-19 Pandemic|0|||
156871536|NCT02273596|566287717|FG000|24-Week Treatment Period|Protocol Deviation|1|||
156871537|NCT02273596|566287717|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
157123039|NCT00487539|567201523|FG002|Overall Study|Other|2|||
157123040|NCT00487539|567201524|FG003|Overall Study|Other|2|||
157123041|NCT02695628|567201525|FG000|Overall Study|Withdrawal by Subject|1|||
157123042|NCT02751502|567201526|FG000|Overall Study|Lack of funding|4|||
157123043|NCT01681433|567201527|FG000|Overall Study|Lack of Efficacy|23|||
157123044|NCT01681433|567201528|FG001|Overall Study|Lack of Efficacy|23|||
157123045|NCT01681433|567201527|FG000|Overall Study|Withdrawal by Subject|5|||
157123046|NCT01681433|567201528|FG001|Overall Study|Withdrawal by Subject|5|||
157123047|NCT01681433|567201527|FG000|Overall Study|Protocol Violation|2|||
157123048|NCT01681433|567201528|FG001|Overall Study|Protocol Violation|0|||
157123049|NCT01681433|567201527|FG000|Overall Study|Adverse Event|2|||
157123050|NCT01681433|567201528|FG001|Overall Study|Adverse Event|4|||
156871538|NCT02273596|566287717|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
156871539|NCT02273596|566287717|FG000|Extension Period|Lost to Follow-up|1|||
156871540|NCT02273596|566287717|FG000|Extension Period|Protocol Deviation|1|||
156871541|NCT02604160|566287719|FG000|Overall Study|Protocol Violation|0|||
156871542|NCT02604160|566287720|FG001|Overall Study|Protocol Violation|1|||
156871543|NCT02604160|566287719|FG000|Overall Study|Physician Decision|0|||
156871544|NCT02604160|566287720|FG001|Overall Study|Physician Decision|1|||
156871545|NCT02139592|566287721|FG000|Overall Study|Case Report Forms Uncollected|8|||
156871546|NCT01069900|566287725|FG000|Overall Study|Technical problems|0|||
156871547|NCT01069900|566287726|FG001|Overall Study|Technical problems|1|||
156871548|NCT01069900|566287725|FG000|Overall Study|Lost to Follow-up|7|||
156871549|NCT01069900|566287726|FG001|Overall Study|Lost to Follow-up|1|||
156871550|NCT01069900|566287725|FG000|Overall Study|Withdrawal by Subject|6|||
156871551|NCT01069900|566287726|FG001|Overall Study|Withdrawal by Subject|1|||
156871552|NCT01069900|566287725|FG000|Overall Study|Protocol Violation|4|||
156871553|NCT01069900|566287726|FG001|Overall Study|Protocol Violation|1|||
156871554|NCT01069900|566287725|FG000|Overall Study|Insufficient Therapeutic effect|1|||
156871555|NCT01069900|566287726|FG001|Overall Study|Insufficient Therapeutic effect|0|||
157123051|NCT01681433|567201527|FG000|Overall Study|Lost to Follow-up|0|||
157123052|NCT01681433|567201528|FG001|Overall Study|Lost to Follow-up|1|||
156871556|NCT00145158|566287727|FG000|Overall Study|premature withdrawal|2|||
156871557|NCT00145158|566287728|FG001|Overall Study|premature withdrawal|3|||
157123053|NCT00903929|567201529|FG000|Overall Study|Withdrawal by Subject|0|||
157123054|NCT00903929|567201530|FG001|Overall Study|Withdrawal by Subject|0|||
157123055|NCT00903929|567201531|FG002|Overall Study|Withdrawal by Subject|1|||
157123056|NCT00903929|567201532|FG003|Overall Study|Withdrawal by Subject|2|||
157123057|NCT00903929|567201529|FG000|Overall Study|Adverse Event|0|||
157123058|NCT00903929|567201530|FG001|Overall Study|Adverse Event|0|||
157123059|NCT00903929|567201531|FG002|Overall Study|Adverse Event|0|||
157123060|NCT00903929|567201532|FG003|Overall Study|Adverse Event|1|||
157123061|NCT02665286|567201533|FG000|Overall Study|Lost to Follow-up|3|||
157123062|NCT02665286|567201534|FG001|Overall Study|Lost to Follow-up|2|||
157123063|NCT02665286|567201535|FG002|Overall Study|Lost to Follow-up|1|||
157123064|NCT01844895|567201536|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
157123065|NCT01844895|567201536|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
156871558|NCT02741518|566287729|FG000|Overall Study|Withdrawal by Subject|1|||
156871559|NCT02741518|566287730|FG001|Overall Study|Withdrawal by Subject|1|||
156871560|NCT00476008|566287733|FG000|Overall Study|Adverse Event|4|||
156871561|NCT00476008|566287734|FG001|Overall Study|Adverse Event|4|||
156871562|NCT00476008|566287733|FG000|Overall Study|Placebo concerns|2|||
156871563|NCT00476008|566287734|FG001|Overall Study|Placebo concerns|2|||
156871564|NCT00476008|566287733|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
156871565|NCT00476008|566287734|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
156871566|NCT00476008|566287733|FG000|Overall Study|Withdrawal by Subject|0|||
156871567|NCT00476008|566287734|FG001|Overall Study|Withdrawal by Subject|1|||
157123066|NCT01844895|567201536|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
157123067|NCT01844895|567201536|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
157123068|NCT01844895|567201536|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
156698139|NCT03548064|565645581|FG003|Overall Study|Covid-19 Pandemic|0|||
156698140|NCT03548064|565645582|FG004|Overall Study|Covid-19 Pandemic|10|||
157123069|NCT01844895|567201536|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
156698141|NCT03548064|565645583|FG005|Overall Study|Covid-19 Pandemic|3|||
156698142|NCT03548064|565645584|FG006|Overall Study|Covid-19 Pandemic|0|||
156871568|NCT00476008|566287733|FG000|Overall Study|Death|1|||
156871569|NCT00476008|566287734|FG001|Overall Study|Death|0|||
156871570|NCT01227018|566287735|FG000|Overall Study|Disease progression|9|||
156871571|NCT01227018|566287735|FG000|Overall Study|Toxicity|2|||
156871572|NCT01227018|566287735|FG000|Overall Study|Withdrew after beginning treatment|4|||
156698143|NCT03548064|565645585|FG007|Overall Study|Covid-19 Pandemic|0|||
156698144|NCT03845296|565645588|FG000|Overall Study|On Treatment|2|||
156698145|NCT03845296|565645589|FG001|Overall Study|On Treatment|1|||
156698146|NCT03845296|565645588|FG000|Overall Study|Adverse Event|4|||
156698147|NCT03845296|565645589|FG001|Overall Study|Adverse Event|11|||
156698148|NCT03845296|565645588|FG000|Overall Study|Refusal unrelated to adverse event|0|||
156698149|NCT03845296|565645589|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156698150|NCT03845296|565645588|FG000|Overall Study|Progression/relapse|14|||
156698151|NCT03845296|565645589|FG001|Overall Study|Progression/relapse|18|||
157014838|NCT03014453|566805102|FG000|Overall Study|Excluded|19|||
157014839|NCT03014453|566805102|FG000|Overall Study|Refused to take part in|37|||
157014840|NCT02538341|566805110|FG000|Overall Study|Lost to Follow-up|51|||
157014841|NCT02538341|566805111|FG001|Overall Study|Lost to Follow-up|46|||
156698152|NCT03845296|565645588|FG000|Overall Study|Death|4|||
156698153|NCT03845296|565645589|FG001|Overall Study|Death|0|||
156698154|NCT03845296|565645588|FG000|Overall Study|Other - not protocol specified|1|||
156698155|NCT03845296|565645589|FG001|Overall Study|Other - not protocol specified|3|||
156698156|NCT02799095|565645593|FG000|Part A|Adverse Event|1|||
156698157|NCT02799095|565645594|FG001|Part A|Adverse Event|0|||
156698158|NCT02799095|565645595|FG002|Part A|Adverse Event|1|||
156698159|NCT02799095|565645596|FG003|Part A|Adverse Event|4|||
157014842|NCT02538341|566805110|FG000|Overall Study|Withdrawal by Subject|3|||
157014843|NCT02538341|566805111|FG001|Overall Study|Withdrawal by Subject|1|||
157014844|NCT02538341|566805110|FG000|Overall Study|Death|2|||
157014845|NCT02538341|566805111|FG001|Overall Study|Death|0|||
156698160|NCT02799095|565645597|FG004|Part A|Adverse Event|1|||
156698161|NCT02799095|565645598|FG005|Part A|Adverse Event|0|||
156698162|NCT02799095|565645599|FG006|Part A|Adverse Event|0|||
156790504|NCT02991859|565983835|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790505|NCT02991859|565983836|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790506|NCT02991859|565983837|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790507|NCT02991859|565983838|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790508|NCT02991859|565983839|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790509|NCT02991859|565983840|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790510|NCT02991859|565983841|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
156790511|NCT02991859|565983825|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790512|NCT02991859|565983826|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790513|NCT02991859|565983827|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790514|NCT02991859|565983828|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790515|NCT02991859|565983829|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
157014846|NCT04732338|566805115|FG000|Overall Study|Lost to Follow-up|3|||
157123070|NCT01844895|567201536|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
157123071|NCT00626093|567201537|FG000|Overall Study|Lost to Follow-up|5|||
157123072|NCT00626093|567201537|FG000|Overall Study|Death|1|||
157123073|NCT00626093|567201537|FG000|Overall Study|Physician Decision|4|||
156790516|NCT02991859|565983830|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790517|NCT02991859|565983831|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790518|NCT02991859|565983832|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790519|NCT02991859|565983833|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790520|NCT02991859|565983834|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
156790521|NCT02991859|565983835|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790522|NCT02991859|565983836|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790523|NCT02991859|565983837|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790524|NCT02991859|565983838|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790525|NCT02991859|565983839|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
157123074|NCT00626093|567201537|FG000|Overall Study|Withdrawal by Subject|6|||
157123075|NCT00626093|567201537|FG000|Overall Study|Protocol Violation|1|||
157123076|NCT00626093|567201537|FG000|Overall Study|One of the required devices not implante|6|||
157123077|NCT01632566|567201538|FG000|Overall Study|Withdrawal by Subject|0|||
157123078|NCT01632566|567201539|FG001|Overall Study|Withdrawal by Subject|1|||
156790526|NCT02991859|565983840|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790527|NCT02991859|565983841|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
156790528|NCT02991859|565983825|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790529|NCT02991859|565983826|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790530|NCT02991859|565983827|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790531|NCT02991859|565983828|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
157014847|NCT04732338|566805116|FG001|Overall Study|Lost to Follow-up|3|||
157014848|NCT00001277|566805117|FG000|Overall Study|Adverse Event|0|||
157123079|NCT01632566|567201540|FG002|Overall Study|Withdrawal by Subject|0|||
157214853|NCT04126733|567533541|FG000|Treatment Period|Death|1|||
156698163|NCT02799095|565645600|FG007|Part A|Adverse Event|0|||
156698164|NCT02799095|565645601|FG008|Part A|Adverse Event|0|||
156698165|NCT02799095|565645602|FG009|Part A|Adverse Event|0|||
156698166|NCT02799095|565645603|FG010|Part A|Adverse Event|0|||
156790532|NCT02991859|565983829|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790533|NCT02991859|565983830|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
157014849|NCT00001277|566805118|FG001|Overall Study|Adverse Event|0|||
156698167|NCT02799095|565645604|FG011|Part A|Adverse Event|0|||
156698168|NCT02799095|565645605|FG012|Part A|Adverse Event|0|||
156698169|NCT02799095|565645606|FG013|Part A|Adverse Event|0|||
156698170|NCT02799095|565645607|FG014|Part A|Adverse Event|0|||
157123080|NCT01632566|567201541|FG003|Overall Study|Withdrawal by Subject|0|||
157123081|NCT01632566|567201542|FG004|Overall Study|Withdrawal by Subject|0|||
157123082|NCT01632566|567201538|FG000|Overall Study|Sponsor Decision|0|||
157123083|NCT01632566|567201539|FG001|Overall Study|Sponsor Decision|2|||
157123084|NCT01632566|567201540|FG002|Overall Study|Sponsor Decision|9|||
157123085|NCT01632566|567201541|FG003|Overall Study|Sponsor Decision|2|||
157123086|NCT01632566|567201542|FG004|Overall Study|Sponsor Decision|2|||
157123087|NCT03208231|567201543|FG000|Overall Study|Death|1|||
157123088|NCT03208231|567201544|FG001|Overall Study|Death|2|||
157123089|NCT03208231|567201543|FG000|Overall Study|Moved and unable to get to clinic|1|||
157123090|NCT03208231|567201544|FG001|Overall Study|Moved and unable to get to clinic|0|||
157123091|NCT03208231|567201543|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
157123092|NCT03208231|567201544|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
157123093|NCT04982250|567201547|FG000|Overall Study|Lost to Follow-up|0|||
157123094|NCT04982250|567201548|FG001|Overall Study|Lost to Follow-up|26|||
157123095|NCT04982250|567201549|FG002|Overall Study|Lost to Follow-up|0|||
157123096|NCT04982250|567201550|FG003|Overall Study|Lost to Follow-up|0|||
157123097|NCT04982250|567201551|FG004|Overall Study|Lost to Follow-up|72|||
157123098|NCT04982250|567201552|FG005|Overall Study|Lost to Follow-up|69|||
157123099|NCT04982250|567201547|FG000|Overall Study|Not Eligible to Enroll|0|||
157123100|NCT04982250|567201548|FG001|Overall Study|Not Eligible to Enroll|0|||
157123101|NCT04982250|567201549|FG002|Overall Study|Not Eligible to Enroll|0|||
157123102|NCT04982250|567201550|FG003|Overall Study|Not Eligible to Enroll|0|||
157123103|NCT04982250|567201551|FG004|Overall Study|Not Eligible to Enroll|10|||
157123104|NCT04982250|567201552|FG005|Overall Study|Not Eligible to Enroll|7|||
157123105|NCT04153188|567201560|FG000|Overall Study|Lost to Follow-up|1|||
156698171|NCT02799095|565645608|FG015|Part A|Adverse Event|0|||
156698172|NCT02799095|565645609|FG016|Part A|Adverse Event|0|||
156698173|NCT02799095|565645593|FG000|Part A|Death|0|||
156871573|NCT01499277|566287738|FG000|Overall Study|Adverse Event|3|||
156871574|NCT01499277|566287739|FG001|Overall Study|Adverse Event|6|||
156871575|NCT01499277|566287738|FG000|Overall Study|Death|3|||
156871576|NCT01499277|566287739|FG001|Overall Study|Death|2|||
156871577|NCT01499277|566287738|FG000|Overall Study|Lost to Follow-up|15|||
156871578|NCT01499277|566287739|FG001|Overall Study|Lost to Follow-up|8|||
156871579|NCT01499277|566287738|FG000|Overall Study|Protocol Violation|2|||
156871580|NCT01499277|566287739|FG001|Overall Study|Protocol Violation|3|||
156871581|NCT01499277|566287738|FG000|Overall Study|Withdrawal by Subject|16|||
156871582|NCT01499277|566287739|FG001|Overall Study|Withdrawal by Subject|6|||
156871583|NCT01499277|566287738|FG000|Overall Study|Lack of therapeutic response and other|8|||
156871584|NCT01499277|566287739|FG001|Overall Study|Lack of therapeutic response and other|7|||
156871585|NCT00790088|566287742|FG000|Overall Study|Protocol Violation|11|||
156871586|NCT00790088|566287742|FG000|Overall Study|Withdrawal by Subject|17|||
156871587|NCT00790088|566287742|FG000|Overall Study|Lost to Follow-up|7|||
156871588|NCT00790088|566287742|FG000|Overall Study|Physician Decision|4|||
156871589|NCT02863419|566287747|FG000|Overall Study|Lost to Follow-up|0|||
156871590|NCT02863419|566287748|FG001|Overall Study|Lost to Follow-up|1|||
156871591|NCT02863419|566287749|FG002|Overall Study|Lost to Follow-up|4|||
156871592|NCT02863419|566287747|FG000|Overall Study|Withdrawal by Subject|5|||
156871593|NCT02863419|566287748|FG001|Overall Study|Withdrawal by Subject|5|||
156871594|NCT02863419|566287749|FG002|Overall Study|Withdrawal by Subject|3|||
156871595|NCT02863419|566287747|FG000|Overall Study|Died|3|||
156871596|NCT02863419|566287748|FG001|Overall Study|Died|4|||
156871597|NCT02863419|566287749|FG002|Overall Study|Died|1|||
156871598|NCT03682770|566287750|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871599|NCT03682770|566287751|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
156698174|NCT02799095|565645594|FG001|Part A|Death|0|||
156871600|NCT03682770|566287752|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871601|NCT03682770|566287753|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
157123106|NCT04153188|567201561|FG001|Overall Study|Lost to Follow-up|1|||
157123107|NCT04153188|567201560|FG000|Overall Study|Withdrawal by Subject|2|||
157123108|NCT04153188|567201561|FG001|Overall Study|Withdrawal by Subject|0|||
157123109|NCT04153188|567201560|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
157123110|NCT04153188|567201561|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
156698175|NCT02799095|565645595|FG002|Part A|Death|0|||
156698176|NCT02799095|565645596|FG003|Part A|Death|0|||
156698177|NCT02799095|565645597|FG004|Part A|Death|0|||
156871602|NCT03682770|566287754|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871603|NCT03682770|566287755|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871604|NCT03682770|566287756|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
156871605|NCT03682770|566287750|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
156871606|NCT03682770|566287751|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
156871607|NCT03682770|566287752|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156698178|NCT02799095|565645598|FG005|Part A|Death|0|||
156698179|NCT02799095|565645599|FG006|Part A|Death|3|||
156698180|NCT02799095|565645600|FG007|Part A|Death|0|||
156698181|NCT02799095|565645601|FG008|Part A|Death|0|||
156698182|NCT02799095|565645602|FG009|Part A|Death|0|||
156698183|NCT02799095|565645603|FG010|Part A|Death|0|||
156698184|NCT02799095|565645604|FG011|Part A|Death|0|||
156698185|NCT02799095|565645605|FG012|Part A|Death|0|||
156698186|NCT02799095|565645606|FG013|Part A|Death|0|||
156698187|NCT02799095|565645607|FG014|Part A|Death|0|||
156698188|NCT02799095|565645608|FG015|Part A|Death|0|||
156698189|NCT02799095|565645609|FG016|Part A|Death|0|||
156790534|NCT02991859|565983831|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790535|NCT02991859|565983832|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790536|NCT02991859|565983833|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
156790537|NCT02991859|565983834|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790538|NCT02991859|565983835|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790539|NCT02991859|565983836|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790540|NCT02991859|565983837|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790541|NCT02991859|565983838|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790542|NCT02991859|565983839|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790543|NCT02991859|565983840|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790544|NCT02991859|565983841|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
156790545|NCT01016015|565983842|FG000|Overall Study|Not Treated|3|||
156790546|NCT01016015|565983842|FG000|Overall Study|Withdrawal by Subject|1|||
156790547|NCT01016015|565983842|FG000|Overall Study|Adverse Event|15|||
156790548|NCT00930176|565983844|FG000|Overall Study|Death|1|||
156790549|NCT00362609|565983845|FG000|Overall Study|Withdrawal by Subject|0|||
156790550|NCT00362609|565983846|FG001|Overall Study|Withdrawal by Subject|1|||
156790551|NCT00362609|565983845|FG000|Overall Study|Protocol Violation|0|||
156790552|NCT00362609|565983846|FG001|Overall Study|Protocol Violation|1|||
157123111|NCT01489527|567201562|FG000|Overall Study|Pregnancy|9|||
157123112|NCT01489527|567201563|FG001|Overall Study|Pregnancy|14|||
156790553|NCT01251965|565985411|FG000|Overall Study|Participant/physician decision|1|||
156790554|NCT01251965|565985412|FG001|Overall Study|Participant/physician decision|2|||
156790555|NCT01251965|565985413|FG002|Overall Study|Participant/physician decision|0|||
156790556|NCT01251965|565985411|FG000|Overall Study|Death|0|||
156790557|NCT01251965|565985412|FG001|Overall Study|Death|0|||
156790558|NCT01251965|565985413|FG002|Overall Study|Death|11|||
157123113|NCT01489527|567201562|FG000|Overall Study|Participant moved|6|||
157123114|NCT01489527|567201563|FG001|Overall Study|Participant moved|7|||
157123115|NCT01489527|567201562|FG000|Overall Study|Withdrawal by Subject|0|||
157123116|NCT01489527|567201563|FG001|Overall Study|Withdrawal by Subject|4|||
157123117|NCT01489527|567201562|FG000|Overall Study|Lost to Follow-up|5|||
156790559|NCT02529488|565985414|FG000|Overall Study|Adverse Event|1|||
156790560|NCT02529488|565985414|FG000|Overall Study|Death|3|||
156871608|NCT03682770|566287753|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871609|NCT03682770|566287754|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871610|NCT03682770|566287755|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871611|NCT03682770|566287756|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
156871612|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871613|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871614|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
156871615|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
156871616|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871617|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871618|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
156871619|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871620|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871621|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871622|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
156790561|NCT02821000|565985415|FG000|Overall Study|Death|89|||
156790562|NCT02821000|565985415|FG000|Overall Study|Sponsor Decision|12|||
156871623|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
157123118|NCT01489527|567201563|FG001|Overall Study|Lost to Follow-up|1|||
157123119|NCT01489527|567201562|FG000|Overall Study|Procedures|1|||
156698190|NCT02799095|565645593|FG000|Part A|Lost to Follow-up|0|||
156698191|NCT02799095|565645594|FG001|Part A|Lost to Follow-up|1|||
156698192|NCT02799095|565645595|FG002|Part A|Lost to Follow-up|0|||
156698193|NCT02799095|565645596|FG003|Part A|Lost to Follow-up|0|||
156698194|NCT02799095|565645597|FG004|Part A|Lost to Follow-up|0|||
156698195|NCT02799095|565645598|FG005|Part A|Lost to Follow-up|0|||
156790563|NCT02821000|565985415|FG000|Overall Study|Withdrawal by Subject|2|||
156790564|NCT04359680|565985416|FG000|Overall Study|Withdrawal by Subject|29|||
156871624|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
157123120|NCT01489527|567201563|FG001|Overall Study|Procedures|0|||
156871625|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
156871626|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871627|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871628|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
156871629|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
156871630|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871631|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871632|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
156871633|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871634|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871635|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
156871636|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871637|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871638|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871639|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
156871640|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871641|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871642|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
156871643|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871644|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871645|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871646|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
156871647|NCT03682770|566287750|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871648|NCT03682770|566287751|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156698196|NCT02799095|565645599|FG006|Part A|Lost to Follow-up|1|||
156698197|NCT02799095|565645600|FG007|Part A|Lost to Follow-up|0|||
156698198|NCT02799095|565645601|FG008|Part A|Lost to Follow-up|0|||
156698199|NCT02799095|565645602|FG009|Part A|Lost to Follow-up|0|||
156698200|NCT02799095|565645603|FG010|Part A|Lost to Follow-up|0|||
156698201|NCT02799095|565645604|FG011|Part A|Lost to Follow-up|0|||
156698202|NCT02799095|565645605|FG012|Part A|Lost to Follow-up|0|||
156698203|NCT02799095|565645606|FG013|Part A|Lost to Follow-up|0|||
156698204|NCT02799095|565645607|FG014|Part A|Lost to Follow-up|0|||
156698205|NCT02799095|565645608|FG015|Part A|Lost to Follow-up|0|||
156698206|NCT02799095|565645609|FG016|Part A|Lost to Follow-up|0|||
156698207|NCT02799095|565645593|FG000|Part A|Progressive Disease|3|||
156698208|NCT02799095|565645594|FG001|Part A|Progressive Disease|3|||
156698209|NCT02799095|565645595|FG002|Part A|Progressive Disease|3|||
156698210|NCT02799095|565645596|FG003|Part A|Progressive Disease|2|||
156698211|NCT02799095|565645597|FG004|Part A|Progressive Disease|2|||
156698212|NCT02799095|565645598|FG005|Part A|Progressive Disease|0|||
156698213|NCT02799095|565645599|FG006|Part A|Progressive Disease|0|||
156698214|NCT02799095|565645600|FG007|Part A|Progressive Disease|0|||
156698215|NCT02799095|565645601|FG008|Part A|Progressive Disease|0|||
156698216|NCT02799095|565645602|FG009|Part A|Progressive Disease|0|||
156698217|NCT02799095|565645603|FG010|Part A|Progressive Disease|0|||
156790565|NCT04359680|565985417|FG001|Overall Study|Withdrawal by Subject|24|||
156790566|NCT04359680|565985416|FG000|Overall Study|Adverse Event|6|||
156790567|NCT04359680|565985417|FG001|Overall Study|Adverse Event|2|||
156790568|NCT04359680|565985416|FG000|Overall Study|Lost to Follow-up|56|||
156790569|NCT04359680|565985417|FG001|Overall Study|Lost to Follow-up|59|||
156790570|NCT04359680|565985416|FG000|Overall Study|Protocol Violation|3|||
156871649|NCT03682770|566287752|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871650|NCT03682770|566287753|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
156871651|NCT03682770|566287754|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
157123121|NCT01489527|567201562|FG000|Overall Study|Not compliant|1|||
156790571|NCT04359680|565985417|FG001|Overall Study|Protocol Violation|5|||
156790572|NCT04359680|565985416|FG000|Overall Study|Physician Decision|1|||
156790573|NCT04359680|565985417|FG001|Overall Study|Physician Decision|1|||
156790574|NCT04359680|565985416|FG000|Overall Study|Sponsor Decision|0|||
156790575|NCT04359680|565985417|FG001|Overall Study|Sponsor Decision|1|||
156698218|NCT02799095|565645604|FG011|Part A|Progressive Disease|0|||
156698219|NCT02799095|565645605|FG012|Part A|Progressive Disease|0|||
156698220|NCT02799095|565645606|FG013|Part A|Progressive Disease|0|||
156698221|NCT02799095|565645607|FG014|Part A|Progressive Disease|0|||
156698222|NCT02799095|565645608|FG015|Part A|Progressive Disease|0|||
156790576|NCT01832038|565985418|FG000|Overall Study|Death|5|||
157123122|NCT01489527|567201563|FG001|Overall Study|Not compliant|0|||
157123123|NCT02926950|567201564|FG000|Overall Study|Adverse Event|4|||
156698223|NCT02799095|565645609|FG016|Part A|Progressive Disease|0|||
156698224|NCT02799095|565645593|FG000|Part A|Clinical Progression|1|||
156698225|NCT02799095|565645594|FG001|Part A|Clinical Progression|0|||
156698226|NCT02799095|565645595|FG002|Part A|Clinical Progression|2|||
156790577|NCT01832038|565985418|FG000|Overall Study|Adverse Event|50|||
156871652|NCT03682770|566287755|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871653|NCT03682770|566287756|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
156871654|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871655|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871656|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871657|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
156871658|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
156871659|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
156871660|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
156871661|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871662|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871663|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871664|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871665|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
156871666|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871667|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
156871668|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871669|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871670|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871671|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871672|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871673|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
156871674|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
156871675|NCT03682770|566287750|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871676|NCT03682770|566287751|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871677|NCT03682770|566287752|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871678|NCT03682770|566287753|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871679|NCT03682770|566287754|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
156871680|NCT03682770|566287755|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
156871681|NCT03682770|566287756|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
156871682|NCT02362282|566287757|FG000|Overall Study|Withdrawal by Subject|1|||
156871683|NCT02362282|566287758|FG001|Overall Study|Withdrawal by Subject|0|||
156871684|NCT01189032|566287759|FG000|Overall Study|Adverse Event|1|||
156871685|NCT01189032|566287760|FG001|Overall Study|Adverse Event|3|||
156871686|NCT01189032|566287761|FG002|Overall Study|Adverse Event|4|||
156871687|NCT01189032|566287759|FG000|Overall Study|Lack of Efficacy|2|||
156871688|NCT01189032|566287760|FG001|Overall Study|Lack of Efficacy|3|||
156871689|NCT01189032|566287761|FG002|Overall Study|Lack of Efficacy|0|||
156871690|NCT01189032|566287759|FG000|Overall Study|Withdrawal by Subject|1|||
156871691|NCT01189032|566287760|FG001|Overall Study|Withdrawal by Subject|0|||
156871692|NCT01189032|566287761|FG002|Overall Study|Withdrawal by Subject|1|||
156871693|NCT01189032|566287759|FG000|Overall Study|Protocol Violation|1|||
156871694|NCT01189032|566287760|FG001|Overall Study|Protocol Violation|1|||
156871695|NCT01189032|566287761|FG002|Overall Study|Protocol Violation|1|||
156871696|NCT02284243|566287762|FG000|Overall Study|Lack of Efficacy|3|||
156871697|NCT02284243|566287763|FG001|Overall Study|Lack of Efficacy|3|||
156871698|NCT02284243|566287762|FG000|Overall Study|Adverse Event|1|||
156871699|NCT02284243|566287763|FG001|Overall Study|Adverse Event|0|||
156871700|NCT01733680|566287765|FG000|Overall Study|Withdrawal by Subject|0|||
156871701|NCT01733680|566287766|FG001|Overall Study|Withdrawal by Subject|1|||
156871702|NCT01932437|566287767|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871703|NCT01932437|566287768|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871704|NCT01932437|566287769|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156871705|NCT01932437|566287770|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
157214854|NCT04126733|567533541|FG000|Treatment Period|Other Reasons|2|||
157214855|NCT04126733|567533541|FG000|Active Follow-up Period|Death|13|||
156790578|NCT01832038|565985418|FG000|Overall Study|Lack of Efficacy|81|||
156790579|NCT01832038|565985418|FG000|Overall Study|Protocol Violation|7|||
156790580|NCT01832038|565985418|FG000|Overall Study|Lost to Follow-up|10|||
156790581|NCT01832038|565985418|FG000|Overall Study|Withdrawal by Subject|49|||
156790582|NCT01832038|565985418|FG000|Overall Study|Visit non-compliance|2|||
156790583|NCT01832038|565985418|FG000|Overall Study|Subject refused to return visit|2|||
156790584|NCT01832038|565985418|FG000|Overall Study|Not convenient to come back to site|2|||
156790585|NCT01832038|565985418|FG000|Overall Study|Participant was asked to quit|5|||
156790586|NCT01832038|565985418|FG000|Overall Study|Back home|1|||
156790587|NCT01832038|565985418|FG000|Overall Study|Pregnancy|1|||
156790588|NCT01832038|565985418|FG000|Overall Study|Low compliance|3|||
156790589|NCT01832038|565985418|FG000|Overall Study|Prohibit procedure|2|||
156790590|NCT01832038|565985418|FG000|Overall Study|Not possible to visit the hospital|1|||
156871706|NCT01932437|566287771|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
156698227|NCT02799095|565645596|FG003|Part A|Clinical Progression|1|||
156698228|NCT02799095|565645597|FG004|Part A|Clinical Progression|5|||
156698229|NCT02799095|565645598|FG005|Part A|Clinical Progression|0|||
156698230|NCT02799095|565645599|FG006|Part A|Clinical Progression|0|||
156698231|NCT02799095|565645600|FG007|Part A|Clinical Progression|0|||
156698232|NCT02799095|565645601|FG008|Part A|Clinical Progression|0|||
156871707|NCT01932437|566287772|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
156871708|NCT02699749|566287773|FG000|Overall Study|Other|0|||
156871709|NCT02699749|566287774|FG001|Overall Study|Other|0|||
156871710|NCT02699749|566287775|FG002|Overall Study|Other|2|||
156871711|NCT02699749|566287776|FG003|Overall Study|Other|0|||
156871712|NCT02699749|566287777|FG004|Overall Study|Other|0|||
156871713|NCT02699749|566287778|FG005|Overall Study|Other|1|||
156871714|NCT02699749|566287779|FG006|Overall Study|Other|1|||
156871715|NCT02699749|566287780|FG007|Overall Study|Other|0|||
156871716|NCT02699749|566287781|FG008|Overall Study|Other|0|||
156871717|NCT02699749|566287782|FG009|Overall Study|Other|0|||
156871718|NCT02699749|566287783|FG010|Overall Study|Other|1|||
156871719|NCT02699749|566287784|FG011|Overall Study|Other|0|||
156871720|NCT02699749|566287785|FG012|Overall Study|Other|0|||
156871721|NCT02699749|566287786|FG013|Overall Study|Other|0|||
156871722|NCT02699749|566287773|FG000|Overall Study|Progressive Disease|3|||
156871723|NCT02699749|566287774|FG001|Overall Study|Progressive Disease|3|||
156871724|NCT02699749|566287775|FG002|Overall Study|Progressive Disease|14|||
156871725|NCT02699749|566287776|FG003|Overall Study|Progressive Disease|3|||
156871726|NCT02699749|566287777|FG004|Overall Study|Progressive Disease|3|||
156871727|NCT02699749|566287778|FG005|Overall Study|Progressive Disease|7|||
156871728|NCT02699749|566287779|FG006|Overall Study|Progressive Disease|5|||
156871729|NCT02699749|566287780|FG007|Overall Study|Progressive Disease|5|||
156871730|NCT02699749|566287781|FG008|Overall Study|Progressive Disease|6|||
156871731|NCT02699749|566287782|FG009|Overall Study|Progressive Disease|6|||
156871732|NCT02699749|566287783|FG010|Overall Study|Progressive Disease|5|||
156871733|NCT02699749|566287784|FG011|Overall Study|Progressive Disease|4|||
156871734|NCT02699749|566287785|FG012|Overall Study|Progressive Disease|3|||
156871735|NCT02699749|566287786|FG013|Overall Study|Progressive Disease|5|||
156871736|NCT02699749|566287773|FG000|Overall Study|Death|0|||
156871737|NCT02699749|566287774|FG001|Overall Study|Death|0|||
156871738|NCT02699749|566287775|FG002|Overall Study|Death|0|||
156871739|NCT02699749|566287776|FG003|Overall Study|Death|0|||
156871740|NCT02699749|566287777|FG004|Overall Study|Death|0|||
156871741|NCT02699749|566287778|FG005|Overall Study|Death|0|||
156871742|NCT02699749|566287779|FG006|Overall Study|Death|0|||
156871743|NCT02699749|566287780|FG007|Overall Study|Death|0|||
156871744|NCT02699749|566287781|FG008|Overall Study|Death|0|||
156871745|NCT02699749|566287782|FG009|Overall Study|Death|0|||
156871746|NCT02699749|566287783|FG010|Overall Study|Death|0|||
156871747|NCT02699749|566287784|FG011|Overall Study|Death|0|||
156871748|NCT02699749|566287785|FG012|Overall Study|Death|0|||
156871749|NCT02699749|566287786|FG013|Overall Study|Death|1|||
156871750|NCT02699749|566287773|FG000|Overall Study|Lost to Follow-up|0|||
156871751|NCT02699749|566287774|FG001|Overall Study|Lost to Follow-up|0|||
156871752|NCT02699749|566287775|FG002|Overall Study|Lost to Follow-up|0|||
156698233|NCT02799095|565645602|FG009|Part A|Clinical Progression|0|||
156698234|NCT02799095|565645603|FG010|Part A|Clinical Progression|0|||
156698235|NCT02799095|565645604|FG011|Part A|Clinical Progression|0|||
156698236|NCT02799095|565645605|FG012|Part A|Clinical Progression|0|||
156871753|NCT02699749|566287776|FG003|Overall Study|Lost to Follow-up|0|||
156871754|NCT02699749|566287777|FG004|Overall Study|Lost to Follow-up|0|||
156871755|NCT02699749|566287778|FG005|Overall Study|Lost to Follow-up|1|||
156871756|NCT02699749|566287779|FG006|Overall Study|Lost to Follow-up|0|||
156871757|NCT02699749|566287780|FG007|Overall Study|Lost to Follow-up|1|||
156871758|NCT02699749|566287781|FG008|Overall Study|Lost to Follow-up|0|||
156698237|NCT02799095|565645606|FG013|Part A|Clinical Progression|0|||
156698238|NCT02799095|565645607|FG014|Part A|Clinical Progression|0|||
156698239|NCT02799095|565645608|FG015|Part A|Clinical Progression|0|||
156698240|NCT02799095|565645609|FG016|Part A|Clinical Progression|0|||
156698241|NCT02799095|565645593|FG000|Part A|Protocol Deviation|0|||
156698242|NCT02799095|565645594|FG001|Part A|Protocol Deviation|0|||
156698243|NCT02799095|565645595|FG002|Part A|Protocol Deviation|1|||
156871759|NCT02699749|566287782|FG009|Overall Study|Lost to Follow-up|0|||
156871760|NCT02699749|566287783|FG010|Overall Study|Lost to Follow-up|0|||
156871761|NCT02699749|566287784|FG011|Overall Study|Lost to Follow-up|0|||
156871762|NCT02699749|566287785|FG012|Overall Study|Lost to Follow-up|0|||
156871763|NCT02699749|566287786|FG013|Overall Study|Lost to Follow-up|0|||
156871764|NCT04139018|566287788|FG000|Overall Study|Screen fail|1|||
156871765|NCT04139018|566287789|FG001|Overall Study|Screen fail|0|||
156871766|NCT04139018|566287788|FG000|Overall Study|Withdrawal by Subject|2|||
156871767|NCT04139018|566287789|FG001|Overall Study|Withdrawal by Subject|0|||
156871768|NCT04139018|566287788|FG000|Overall Study|Lost to Follow-up|0|||
156871769|NCT04139018|566287789|FG001|Overall Study|Lost to Follow-up|1|||
156871770|NCT02565108|566287790|FG000|Overall Study|Adverse Event|1|||
156871771|NCT02565108|566287791|FG001|Overall Study|Adverse Event|0|||
156871772|NCT02565108|566287790|FG000|Overall Study|Withdrew Consent|1|||
156698244|NCT02799095|565645596|FG003|Part A|Protocol Deviation|0|||
156698245|NCT02799095|565645597|FG004|Part A|Protocol Deviation|0|||
156698246|NCT02799095|565645598|FG005|Part A|Protocol Deviation|0|||
156698247|NCT02799095|565645599|FG006|Part A|Protocol Deviation|0|||
156698248|NCT02799095|565645600|FG007|Part A|Protocol Deviation|0|||
156698249|NCT02799095|565645601|FG008|Part A|Protocol Deviation|0|||
156698250|NCT02799095|565645602|FG009|Part A|Protocol Deviation|0|||
156698251|NCT02799095|565645603|FG010|Part A|Protocol Deviation|0|||
156698252|NCT02799095|565645604|FG011|Part A|Protocol Deviation|0|||
156698253|NCT02799095|565645605|FG012|Part A|Protocol Deviation|0|||
156698254|NCT02799095|565645606|FG013|Part A|Protocol Deviation|0|||
156871773|NCT02565108|566287791|FG001|Overall Study|Withdrew Consent|0|||
156871774|NCT01310075|566287792|FG000|Overall Study|Lost to Follow-up|1|||
156871775|NCT01310075|566287793|FG001|Overall Study|Lost to Follow-up|0|||
156871776|NCT01310075|566287792|FG000|Overall Study|Physician Decision|10|||
156871777|NCT01310075|566287793|FG001|Overall Study|Physician Decision|7|||
156871778|NCT01310075|566287792|FG000|Overall Study|Protocol Violation|2|||
156871779|NCT01310075|566287793|FG001|Overall Study|Protocol Violation|2|||
156871780|NCT01310075|566287792|FG000|Overall Study|Withdrawal by Subject|1|||
156871781|NCT01310075|566287793|FG001|Overall Study|Withdrawal by Subject|1|||
156871782|NCT01209325|566287794|FG000|Overall Study|Lost to Follow-up|24|||
156871783|NCT01209325|566287794|FG000|Overall Study|Adverse Event|1|||
156871784|NCT01209325|566287794|FG000|Overall Study|Relocated|3|||
156871785|NCT01209325|566287794|FG000|Overall Study|Refusal after starting therapy|8|||
156871786|NCT01209325|566287794|FG000|Overall Study|Protocol Violation|4|||
156871787|NCT01209325|566287794|FG000|Overall Study|Refusal prior to therapy|1|||
156871788|NCT01209325|566287794|FG000|Overall Study|Incarceration|2|||
157214856|NCT04126733|567533541|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
156698255|NCT02799095|565645607|FG014|Part A|Protocol Deviation|0|||
156698256|NCT02799095|565645608|FG015|Part A|Protocol Deviation|0|||
156698257|NCT02799095|565645609|FG016|Part A|Protocol Deviation|0|||
156698258|NCT02799095|565645593|FG000|Part A|Withdrawal by Subject|0|||
156698259|NCT02799095|565645594|FG001|Part A|Withdrawal by Subject|0|||
156698260|NCT02799095|565645595|FG002|Part A|Withdrawal by Subject|0|||
156698261|NCT02799095|565645596|FG003|Part A|Withdrawal by Subject|1|||
156698262|NCT02799095|565645597|FG004|Part A|Withdrawal by Subject|3|||
156698263|NCT02799095|565645598|FG005|Part A|Withdrawal by Subject|1|||
156698264|NCT02799095|565645599|FG006|Part A|Withdrawal by Subject|1|||
156698265|NCT02799095|565645600|FG007|Part A|Withdrawal by Subject|0|||
156698266|NCT02799095|565645601|FG008|Part A|Withdrawal by Subject|0|||
156698267|NCT02799095|565645602|FG009|Part A|Withdrawal by Subject|0|||
156698268|NCT02799095|565645603|FG010|Part A|Withdrawal by Subject|0|||
156698269|NCT02799095|565645604|FG011|Part A|Withdrawal by Subject|0|||
156698270|NCT02799095|565645605|FG012|Part A|Withdrawal by Subject|0|||
156698271|NCT02799095|565645606|FG013|Part A|Withdrawal by Subject|0|||
156698272|NCT02799095|565645607|FG014|Part A|Withdrawal by Subject|0|||
156698273|NCT02799095|565645608|FG015|Part A|Withdrawal by Subject|0|||
156698274|NCT02799095|565645609|FG016|Part A|Withdrawal by Subject|0|||
156698275|NCT02799095|565645593|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
156698276|NCT02799095|565645594|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
156698277|NCT02799095|565645595|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
156698278|NCT02799095|565645596|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
156698279|NCT02799095|565645597|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
156698280|NCT02799095|565645598|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
156698281|NCT02799095|565645599|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
156698282|NCT02799095|565645600|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
156698283|NCT02799095|565645601|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
156698284|NCT02799095|565645602|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
156698285|NCT02799095|565645603|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
156698286|NCT02799095|565645604|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
157214857|NCT04126733|567533541|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
156698287|NCT02799095|565645605|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
156698288|NCT02799095|565645606|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
156698289|NCT02799095|565645607|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
156698290|NCT02799095|565645608|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
156698291|NCT02799095|565645609|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
156698292|NCT02799095|565645593|FG000|Part B|Death|0|||
156698293|NCT02799095|565645594|FG001|Part B|Death|0|||
156698294|NCT02799095|565645595|FG002|Part B|Death|0|||
156698295|NCT02799095|565645596|FG003|Part B|Death|0|||
156698296|NCT02799095|565645597|FG004|Part B|Death|0|||
156698297|NCT02799095|565645598|FG005|Part B|Death|0|||
156698298|NCT02799095|565645599|FG006|Part B|Death|0|||
156698299|NCT02799095|565645600|FG007|Part B|Death|7|||
156698300|NCT02799095|565645601|FG008|Part B|Death|7|||
156871789|NCT01160822|566287795|FG000|Overall Study|Adverse Event|0|||
156871790|NCT01160822|566287796|FG001|Overall Study|Adverse Event|0|||
156871791|NCT01160822|566287797|FG002|Overall Study|Adverse Event|0|||
156871792|NCT01160822|566287798|FG003|Overall Study|Adverse Event|0|||
156871793|NCT01160822|566287799|FG004|Overall Study|Adverse Event|1|||
156871794|NCT01160822|566287800|FG005|Overall Study|Adverse Event|2|||
156698301|NCT02799095|565645602|FG009|Part B|Death|0|||
156698302|NCT02799095|565645603|FG010|Part B|Death|0|||
156698303|NCT02799095|565645604|FG011|Part B|Death|0|||
156698304|NCT02799095|565645605|FG012|Part B|Death|0|||
156698305|NCT02799095|565645606|FG013|Part B|Death|0|||
156698306|NCT02799095|565645607|FG014|Part B|Death|0|||
156698307|NCT02799095|565645608|FG015|Part B|Death|0|||
156698308|NCT02799095|565645609|FG016|Part B|Death|0|||
156698309|NCT02799095|565645593|FG000|Part B|Progressive Disease|0|||
156698310|NCT02799095|565645594|FG001|Part B|Progressive Disease|0|||
156698311|NCT02799095|565645595|FG002|Part B|Progressive Disease|0|||
156698312|NCT02799095|565645596|FG003|Part B|Progressive Disease|0|||
156698313|NCT02799095|565645597|FG004|Part B|Progressive Disease|0|||
156698314|NCT02799095|565645598|FG005|Part B|Progressive Disease|0|||
156698315|NCT02799095|565645599|FG006|Part B|Progressive Disease|0|||
156698316|NCT02799095|565645600|FG007|Part B|Progressive Disease|1|||
156698317|NCT02799095|565645601|FG008|Part B|Progressive Disease|0|||
156698318|NCT02799095|565645602|FG009|Part B|Progressive Disease|0|||
156698319|NCT02799095|565645603|FG010|Part B|Progressive Disease|0|||
156698320|NCT02799095|565645604|FG011|Part B|Progressive Disease|0|||
156698321|NCT02799095|565645605|FG012|Part B|Progressive Disease|0|||
156698322|NCT02799095|565645606|FG013|Part B|Progressive Disease|0|||
156698323|NCT02799095|565645607|FG014|Part B|Progressive Disease|0|||
156698324|NCT02799095|565645608|FG015|Part B|Progressive Disease|0|||
156698325|NCT02799095|565645609|FG016|Part B|Progressive Disease|0|||
156698326|NCT02799095|565645593|FG000|Part B|Withdrawal by Subject|0|||
156698327|NCT02799095|565645594|FG001|Part B|Withdrawal by Subject|0|||
156698328|NCT02799095|565645595|FG002|Part B|Withdrawal by Subject|0|||
156698329|NCT02799095|565645596|FG003|Part B|Withdrawal by Subject|0|||
156698330|NCT02799095|565645597|FG004|Part B|Withdrawal by Subject|0|||
156698331|NCT02799095|565645598|FG005|Part B|Withdrawal by Subject|0|||
156698332|NCT02799095|565645599|FG006|Part B|Withdrawal by Subject|0|||
156698333|NCT02799095|565645600|FG007|Part B|Withdrawal by Subject|10|||
156698334|NCT02799095|565645601|FG008|Part B|Withdrawal by Subject|7|||
156698335|NCT02799095|565645602|FG009|Part B|Withdrawal by Subject|0|||
156698336|NCT02799095|565645603|FG010|Part B|Withdrawal by Subject|0|||
156698337|NCT02799095|565645604|FG011|Part B|Withdrawal by Subject|0|||
156698338|NCT02799095|565645605|FG012|Part B|Withdrawal by Subject|0|||
156698339|NCT02799095|565645606|FG013|Part B|Withdrawal by Subject|0|||
156698340|NCT02799095|565645607|FG014|Part B|Withdrawal by Subject|0|||
156698341|NCT02799095|565645608|FG015|Part B|Withdrawal by Subject|0|||
156698342|NCT02799095|565645609|FG016|Part B|Withdrawal by Subject|0|||
156698343|NCT02799095|565645593|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
156698344|NCT02799095|565645594|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
156698345|NCT02799095|565645595|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
156698346|NCT02799095|565645596|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
156698347|NCT02799095|565645597|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
156698348|NCT02799095|565645598|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
156698349|NCT02799095|565645599|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
156698350|NCT02799095|565645600|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
156698351|NCT02799095|565645601|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
156698352|NCT02799095|565645602|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
156698353|NCT02799095|565645603|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
156698354|NCT02799095|565645604|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
156698355|NCT02799095|565645605|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
156698356|NCT02799095|565645606|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
156698357|NCT02799095|565645607|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
156698358|NCT02799095|565645608|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
156698359|NCT02799095|565645609|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
156698360|NCT02799095|565645593|FG000|Part C|Adverse Event|0|||
156698361|NCT02799095|565645594|FG001|Part C|Adverse Event|0|||
156698362|NCT02799095|565645595|FG002|Part C|Adverse Event|0|||
156698363|NCT02799095|565645596|FG003|Part C|Adverse Event|0|||
156698364|NCT02799095|565645597|FG004|Part C|Adverse Event|0|||
156790591|NCT01832038|565985418|FG000|Overall Study|Changes of implementation system|3|||
157014850|NCT00001277|566805119|FG002|Overall Study|Adverse Event|1|||
156698365|NCT02799095|565645598|FG005|Part C|Adverse Event|0|||
156698366|NCT02799095|565645599|FG006|Part C|Adverse Event|0|||
156698367|NCT02799095|565645600|FG007|Part C|Adverse Event|0|||
156698368|NCT02799095|565645601|FG008|Part C|Adverse Event|0|||
156698369|NCT02799095|565645602|FG009|Part C|Adverse Event|0|||
156698370|NCT02799095|565645603|FG010|Part C|Adverse Event|3|||
156698371|NCT02799095|565645604|FG011|Part C|Adverse Event|1|||
156698372|NCT02799095|565645605|FG012|Part C|Adverse Event|0|||
156698373|NCT02799095|565645606|FG013|Part C|Adverse Event|1|||
156698374|NCT02799095|565645607|FG014|Part C|Adverse Event|0|||
156698375|NCT02799095|565645608|FG015|Part C|Adverse Event|0|||
156698376|NCT02799095|565645609|FG016|Part C|Adverse Event|0|||
156698377|NCT02799095|565645593|FG000|Part C|Death|0|||
156698378|NCT02799095|565645594|FG001|Part C|Death|0|||
156698379|NCT02799095|565645595|FG002|Part C|Death|0|||
156698380|NCT02799095|565645596|FG003|Part C|Death|0|||
156698381|NCT02799095|565645597|FG004|Part C|Death|0|||
156871795|NCT01160822|566287801|FG006|Overall Study|Adverse Event|5|||
156871796|NCT01160822|566287795|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156871797|NCT01160822|566287796|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156871798|NCT01160822|566287797|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156871799|NCT01160822|566287798|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156871800|NCT01160822|566287799|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
156871801|NCT01160822|566287800|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
156871802|NCT01160822|566287801|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
156871803|NCT01160822|566287795|FG000|Overall Study|Withdrawal by Subject|0|||
156871804|NCT01160822|566287796|FG001|Overall Study|Withdrawal by Subject|0|||
156871805|NCT01160822|566287797|FG002|Overall Study|Withdrawal by Subject|0|||
157021741|NCT03673111|566832946|FG001|Overall Study|Adverse Event|0|||
157214858|NCT04126733|567533541|FG000|Active Follow-up Period|Other Reasons|1|||
157214859|NCT04126733|567533541|FG000|Long-term Follow-up Period|Death|22|||
157214860|NCT04126733|567533541|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
157214861|NCT04126733|567533541|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
157214862|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
156698382|NCT02799095|565645598|FG005|Part C|Death|0|||
156698383|NCT02799095|565645599|FG006|Part C|Death|0|||
156698384|NCT02799095|565645600|FG007|Part C|Death|0|||
156698385|NCT02799095|565645601|FG008|Part C|Death|0|||
156698386|NCT02799095|565645602|FG009|Part C|Death|0|||
156698387|NCT02799095|565645603|FG010|Part C|Death|7|||
156698388|NCT02799095|565645604|FG011|Part C|Death|5|||
156698389|NCT02799095|565645605|FG012|Part C|Death|6|||
156698390|NCT02799095|565645606|FG013|Part C|Death|8|||
156698391|NCT02799095|565645607|FG014|Part C|Death|1|||
156698392|NCT02799095|565645608|FG015|Part C|Death|8|||
156698393|NCT02799095|565645609|FG016|Part C|Death|1|||
156698394|NCT02799095|565645593|FG000|Part C|Lost to Follow-up|0|||
156698395|NCT02799095|565645594|FG001|Part C|Lost to Follow-up|0|||
156698396|NCT02799095|565645595|FG002|Part C|Lost to Follow-up|0|||
156698397|NCT02799095|565645596|FG003|Part C|Lost to Follow-up|0|||
156698398|NCT02799095|565645597|FG004|Part C|Lost to Follow-up|0|||
156698399|NCT02799095|565645598|FG005|Part C|Lost to Follow-up|0|||
156698400|NCT02799095|565645599|FG006|Part C|Lost to Follow-up|0|||
156698401|NCT02799095|565645600|FG007|Part C|Lost to Follow-up|0|||
156698402|NCT02799095|565645601|FG008|Part C|Lost to Follow-up|0|||
156698403|NCT02799095|565645602|FG009|Part C|Lost to Follow-up|0|||
156698404|NCT02799095|565645603|FG010|Part C|Lost to Follow-up|1|||
156790592|NCT01832038|565985418|FG000|Overall Study|Plan to pregnancy|7|||
156790593|NCT01832038|565985418|FG000|Overall Study|Bad mood and has suicidal thought|1|||
156790594|NCT01832038|565985418|FG000|Overall Study|Prohibited concomitant medication|1|||
156790595|NCT01832038|565985418|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
156790596|NCT01832038|565985418|FG000|Overall Study|Subject considered the efficacy was poor|1|||
156790597|NCT03810365|565985419|FG000|Overall Study|Lost to Follow-up|2|||
156790598|NCT03810365|565985420|FG001|Overall Study|Lost to Follow-up|2|||
156790599|NCT03810365|565985419|FG000|Overall Study|Withdrawal by Subject|4|||
156790600|NCT03810365|565985420|FG001|Overall Study|Withdrawal by Subject|5|||
156790601|NCT02255279|565985421|FG000|Overall Study|Lost to Follow-up|2|||
156790602|NCT02255279|565985422|FG001|Overall Study|Lost to Follow-up|2|||
156790603|NCT02255279|565985421|FG000|Overall Study|Protocol Violation|0|||
156790604|NCT02255279|565985422|FG001|Overall Study|Protocol Violation|1|||
156790605|NCT02255279|565985421|FG000|Overall Study|Withdrawal by Subject|3|||
156790606|NCT02255279|565985422|FG001|Overall Study|Withdrawal by Subject|6|||
156790607|NCT00107614|565985423|FG000|Overall Study|Physician Decision|10|||
156790608|NCT00107614|565985423|FG000|Overall Study|Death|2|||
156790609|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
156790610|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
156790611|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
156790612|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
156790613|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
156790614|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
156790615|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
156790616|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
156790617|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
156790618|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
156698405|NCT02799095|565645604|FG011|Part C|Lost to Follow-up|1|||
156698406|NCT02799095|565645605|FG012|Part C|Lost to Follow-up|1|||
156698407|NCT02799095|565645606|FG013|Part C|Lost to Follow-up|3|||
156698408|NCT02799095|565645607|FG014|Part C|Lost to Follow-up|0|||
156698409|NCT02799095|565645608|FG015|Part C|Lost to Follow-up|0|||
156698410|NCT02799095|565645609|FG016|Part C|Lost to Follow-up|0|||
156698411|NCT02799095|565645593|FG000|Part C|Progressive Disease|0|||
156698412|NCT02799095|565645594|FG001|Part C|Progressive Disease|0|||
156698413|NCT02799095|565645595|FG002|Part C|Progressive Disease|0|||
156698414|NCT02799095|565645596|FG003|Part C|Progressive Disease|0|||
156790619|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
156871806|NCT01160822|566287798|FG003|Overall Study|Withdrawal by Subject|0|||
156871807|NCT01160822|566287799|FG004|Overall Study|Withdrawal by Subject|0|||
156871808|NCT01160822|566287800|FG005|Overall Study|Withdrawal by Subject|0|||
156871809|NCT01160822|566287801|FG006|Overall Study|Withdrawal by Subject|1|||
156871810|NCT01160822|566287795|FG000|Overall Study|Lost to Follow-up|0|||
156698415|NCT02799095|565645597|FG004|Part C|Progressive Disease|0|||
156698416|NCT02799095|565645598|FG005|Part C|Progressive Disease|0|||
156698417|NCT02799095|565645599|FG006|Part C|Progressive Disease|0|||
156698418|NCT02799095|565645600|FG007|Part C|Progressive Disease|0|||
156698419|NCT02799095|565645601|FG008|Part C|Progressive Disease|0|||
156698420|NCT02799095|565645602|FG009|Part C|Progressive Disease|2|||
156698421|NCT02799095|565645603|FG010|Part C|Progressive Disease|13|||
156698422|NCT02799095|565645604|FG011|Part C|Progressive Disease|2|||
156698423|NCT02799095|565645605|FG012|Part C|Progressive Disease|0|||
156698424|NCT02799095|565645606|FG013|Part C|Progressive Disease|1|||
156698425|NCT02799095|565645607|FG014|Part C|Progressive Disease|0|||
156698426|NCT02799095|565645608|FG015|Part C|Progressive Disease|0|||
156698427|NCT02799095|565645609|FG016|Part C|Progressive Disease|0|||
156698428|NCT02799095|565645593|FG000|Part C|Clinical Progression|0|||
156698429|NCT02799095|565645594|FG001|Part C|Clinical Progression|0|||
156871811|NCT01160822|566287796|FG001|Overall Study|Lost to Follow-up|0|||
156698430|NCT02799095|565645595|FG002|Part C|Clinical Progression|0|||
156698431|NCT02799095|565645596|FG003|Part C|Clinical Progression|0|||
156698432|NCT02799095|565645597|FG004|Part C|Clinical Progression|0|||
156698433|NCT02799095|565645598|FG005|Part C|Clinical Progression|0|||
156698434|NCT02799095|565645599|FG006|Part C|Clinical Progression|0|||
156698435|NCT02799095|565645600|FG007|Part C|Clinical Progression|0|||
156698436|NCT02799095|565645601|FG008|Part C|Clinical Progression|0|||
156698437|NCT02799095|565645602|FG009|Part C|Clinical Progression|1|||
156698438|NCT02799095|565645603|FG010|Part C|Clinical Progression|3|||
156698439|NCT02799095|565645604|FG011|Part C|Clinical Progression|0|||
156698440|NCT02799095|565645605|FG012|Part C|Clinical Progression|0|||
156698441|NCT02799095|565645606|FG013|Part C|Clinical Progression|1|||
156698442|NCT02799095|565645607|FG014|Part C|Clinical Progression|0|||
156698443|NCT02799095|565645608|FG015|Part C|Clinical Progression|0|||
156698444|NCT02799095|565645609|FG016|Part C|Clinical Progression|0|||
156698445|NCT02799095|565645593|FG000|Part C|Withdrawal by Subject|0|||
156698446|NCT02799095|565645594|FG001|Part C|Withdrawal by Subject|0|||
156698447|NCT02799095|565645595|FG002|Part C|Withdrawal by Subject|0|||
156698448|NCT02799095|565645596|FG003|Part C|Withdrawal by Subject|0|||
156698449|NCT02799095|565645597|FG004|Part C|Withdrawal by Subject|0|||
156698450|NCT02799095|565645598|FG005|Part C|Withdrawal by Subject|0|||
156698451|NCT02799095|565645599|FG006|Part C|Withdrawal by Subject|0|||
156698452|NCT02799095|565645600|FG007|Part C|Withdrawal by Subject|0|||
156871812|NCT01160822|566287797|FG002|Overall Study|Lost to Follow-up|0|||
156871813|NCT01160822|566287798|FG003|Overall Study|Lost to Follow-up|0|||
156871814|NCT01160822|566287799|FG004|Overall Study|Lost to Follow-up|1|||
156871815|NCT01160822|566287800|FG005|Overall Study|Lost to Follow-up|0|||
156871816|NCT01160822|566287801|FG006|Overall Study|Lost to Follow-up|0|||
156871817|NCT01160822|566287795|FG000|Overall Study|Administrative problems|0|||
156871818|NCT01160822|566287796|FG001|Overall Study|Administrative problems|0|||
156871819|NCT01160822|566287797|FG002|Overall Study|Administrative problems|0|||
156871820|NCT01160822|566287798|FG003|Overall Study|Administrative problems|0|||
156871821|NCT01160822|566287799|FG004|Overall Study|Administrative problems|1|||
156871822|NCT01160822|566287800|FG005|Overall Study|Administrative problems|0|||
156871823|NCT01160822|566287801|FG006|Overall Study|Administrative problems|0|||
156871824|NCT01160822|566287795|FG000|Overall Study|Protocol deviation|0|||
156871825|NCT01160822|566287796|FG001|Overall Study|Protocol deviation|0|||
156871826|NCT01160822|566287797|FG002|Overall Study|Protocol deviation|0|||
156698453|NCT02799095|565645601|FG008|Part C|Withdrawal by Subject|0|||
156871827|NCT01160822|566287798|FG003|Overall Study|Protocol deviation|0|||
156871828|NCT01160822|566287799|FG004|Overall Study|Protocol deviation|2|||
156871829|NCT01160822|566287800|FG005|Overall Study|Protocol deviation|0|||
156871830|NCT01160822|566287801|FG006|Overall Study|Protocol deviation|0|||
156871831|NCT00750438|566287807|FG000|Overall Study|Protocol Violation|4|||
156698454|NCT02799095|565645602|FG009|Part C|Withdrawal by Subject|0|||
156698455|NCT02799095|565645603|FG010|Part C|Withdrawal by Subject|13|||
156698456|NCT02799095|565645604|FG011|Part C|Withdrawal by Subject|15|||
156871832|NCT00750438|566287808|FG001|Overall Study|Protocol Violation|1|||
156871833|NCT00750438|566287807|FG000|Overall Study|Physician Decision|2|||
156698457|NCT02799095|565645605|FG012|Part C|Withdrawal by Subject|13|||
156698458|NCT02799095|565645606|FG013|Part C|Withdrawal by Subject|21|||
156698459|NCT02799095|565645607|FG014|Part C|Withdrawal by Subject|0|||
156698460|NCT02799095|565645608|FG015|Part C|Withdrawal by Subject|12|||
156698461|NCT02799095|565645609|FG016|Part C|Withdrawal by Subject|1|||
156698462|NCT02799095|565645593|FG000|Part C|Physician Decision|0|||
156698463|NCT02799095|565645594|FG001|Part C|Physician Decision|0|||
156698464|NCT02799095|565645595|FG002|Part C|Physician Decision|0|||
156698465|NCT02799095|565645596|FG003|Part C|Physician Decision|0|||
156698466|NCT02799095|565645597|FG004|Part C|Physician Decision|0|||
156871834|NCT00750438|566287808|FG001|Overall Study|Physician Decision|2|||
156871835|NCT00750438|566287807|FG000|Overall Study|Withdrawal by Subject|1|||
156871836|NCT00750438|566287808|FG001|Overall Study|Withdrawal by Subject|1|||
156871837|NCT00787644|566287809|FG000|Overall Study|Lost to Follow-up|1|||
156871838|NCT00787644|566287810|FG001|Overall Study|Lost to Follow-up|1|||
156871839|NCT00787644|566287809|FG000|Overall Study|Withdrawal by Subject|1|||
156871840|NCT00787644|566287810|FG001|Overall Study|Withdrawal by Subject|1|||
156871841|NCT01108185|566287814|FG000|Overall Study|Non-compliance|15|||
156871842|NCT01108185|566287814|FG000|Overall Study|Lost to Follow-up|12|||
156871843|NCT05615922|566287821|FG000|Overall Study|Lost to Follow-up|1|||
156871844|NCT04500158|566287822|FG000|Overall Study|Physician Decision|17|||
156871845|NCT04500158|566287823|FG001|Overall Study|Physician Decision|11|||
156871846|NCT04774094|566287828|FG000|Overall Study|Other|2|||
156698467|NCT02799095|565645598|FG005|Part C|Physician Decision|0|||
156698468|NCT02799095|565645599|FG006|Part C|Physician Decision|0|||
156698469|NCT02799095|565645600|FG007|Part C|Physician Decision|0|||
156698470|NCT02799095|565645601|FG008|Part C|Physician Decision|0|||
156698471|NCT02799095|565645602|FG009|Part C|Physician Decision|0|||
156698472|NCT02799095|565645603|FG010|Part C|Physician Decision|1|||
156698473|NCT02799095|565645604|FG011|Part C|Physician Decision|0|||
156698474|NCT02799095|565645605|FG012|Part C|Physician Decision|0|||
156698475|NCT02799095|565645606|FG013|Part C|Physician Decision|0|||
156698476|NCT02799095|565645607|FG014|Part C|Physician Decision|0|||
156698477|NCT02799095|565645608|FG015|Part C|Physician Decision|0|||
156698478|NCT02799095|565645609|FG016|Part C|Physician Decision|0|||
156698479|NCT02799095|565645593|FG000|Part C|Other|0|||
156698480|NCT02799095|565645594|FG001|Part C|Other|0|||
156698481|NCT02799095|565645595|FG002|Part C|Other|0|||
156698482|NCT02799095|565645596|FG003|Part C|Other|0|||
156698483|NCT02799095|565645597|FG004|Part C|Other|0|||
156698484|NCT02799095|565645598|FG005|Part C|Other|0|||
156698485|NCT02799095|565645599|FG006|Part C|Other|0|||
156698486|NCT02799095|565645600|FG007|Part C|Other|0|||
156698487|NCT02799095|565645601|FG008|Part C|Other|0|||
156698488|NCT02799095|565645602|FG009|Part C|Other|0|||
156698489|NCT02799095|565645603|FG010|Part C|Other|0|||
156698490|NCT02799095|565645604|FG011|Part C|Other|2|||
156698491|NCT02799095|565645605|FG012|Part C|Other|2|||
156698492|NCT02799095|565645606|FG013|Part C|Other|0|||
156698493|NCT02799095|565645607|FG014|Part C|Other|0|||
156698494|NCT02799095|565645608|FG015|Part C|Other|0|||
156698495|NCT02799095|565645609|FG016|Part C|Other|0|||
156698496|NCT02128217|565645614|FG000|Overall Study|Lost to Follow-up|0|||
156698497|NCT02128217|565645615|FG001|Overall Study|Lost to Follow-up|1|||
156698498|NCT00541970|565645616|FG000|Month 7|Protocol Violation|9|||
156698499|NCT00541970|565645617|FG001|Month 7|Protocol Violation|13|||
156698500|NCT00541970|565645618|FG002|Month 7|Protocol Violation|11|||
156698501|NCT00541970|565645619|FG003|Month 7|Protocol Violation|5|||
156871847|NCT04774094|566287828|FG000|Overall Study|Withdrawal by Subject|9|||
157214863|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156698502|NCT00541970|565645616|FG000|Month 12|Adverse Event|0|||
156698503|NCT00541970|565645617|FG001|Month 12|Adverse Event|1|||
156698504|NCT00541970|565645618|FG002|Month 12|Adverse Event|1|||
156698505|NCT00541970|565645619|FG003|Month 12|Adverse Event|1|||
156698506|NCT00541970|565645616|FG000|Month 12|Protocol Violation|12|||
156698507|NCT00541970|565645617|FG001|Month 12|Protocol Violation|21|||
156698508|NCT00541970|565645618|FG002|Month 12|Protocol Violation|20|||
156698509|NCT00541970|565645619|FG003|Month 12|Protocol Violation|15|||
156698510|NCT00541970|565645616|FG000|Month 18|Adverse Event|0|||
156698511|NCT00541970|565645617|FG001|Month 18|Adverse Event|1|||
156698512|NCT00541970|565645618|FG002|Month 18|Adverse Event|1|||
156698513|NCT00541970|565645619|FG003|Month 18|Adverse Event|1|||
156698514|NCT00541970|565645616|FG000|Month 18|Protocol Violation|14|||
156698515|NCT00541970|565645617|FG001|Month 18|Protocol Violation|23|||
156698516|NCT00541970|565645618|FG002|Month 18|Protocol Violation|24|||
156698517|NCT00541970|565645619|FG003|Month 18|Protocol Violation|16|||
156698518|NCT00541970|565645616|FG000|Month 24|Adverse Event|0|||
156698519|NCT00541970|565645617|FG001|Month 24|Adverse Event|1|||
156698520|NCT00541970|565645618|FG002|Month 24|Adverse Event|1|||
156698521|NCT00541970|565645619|FG003|Month 24|Adverse Event|1|||
156871848|NCT04774094|566287828|FG000|Overall Study|Lost to Follow-up|7|||
157021742|NCT03673111|566832947|FG002|Overall Study|Adverse Event|0|||
156698522|NCT00541970|565645616|FG000|Month 24|Protocol Violation|29|||
156698523|NCT00541970|565645617|FG001|Month 24|Protocol Violation|31|||
156698524|NCT00541970|565645618|FG002|Month 24|Protocol Violation|31|||
156698525|NCT00541970|565645619|FG003|Month 24|Protocol Violation|21|||
156698526|NCT00541970|565645616|FG000|Month 36|Protocol Violation|61|||
156698527|NCT00541970|565645617|FG001|Month 36|Protocol Violation|66|||
156871849|NCT04774094|566287828|FG000|Overall Study|Lack of Efficacy|5|||
156871850|NCT04774094|566287828|FG000|Overall Study|Death|17|||
156871851|NCT04774094|566287828|FG000|Overall Study|Adverse Event|4|||
156698528|NCT00541970|565645618|FG002|Month 36|Protocol Violation|66|||
156698529|NCT00541970|565645619|FG003|Month 36|Protocol Violation|60|||
156698530|NCT00541970|565645616|FG000|Month 48|Withdrawal by Subject|2|||
156698531|NCT00541970|565645617|FG001|Month 48|Withdrawal by Subject|4|||
156698532|NCT00541970|565645618|FG002|Month 48|Withdrawal by Subject|4|||
156698533|NCT00541970|565645619|FG003|Month 48|Withdrawal by Subject|2|||
156871852|NCT02374450|566287829|FG000|Overall Study|Protocol Violation|0|||
156698534|NCT00541970|565645616|FG000|Month 48|Other|3|||
156698535|NCT00541970|565645617|FG001|Month 48|Other|1|||
156698536|NCT00541970|565645618|FG002|Month 48|Other|1|||
156698537|NCT00541970|565645619|FG003|Month 48|Other|0|||
156698538|NCT00541970|565645616|FG000|Month 48|Lost to Follow-up|66|||
156698539|NCT00541970|565645617|FG001|Month 48|Lost to Follow-up|68|||
156698540|NCT00541970|565645618|FG002|Month 48|Lost to Follow-up|68|||
156698541|NCT00541970|565645619|FG003|Month 48|Lost to Follow-up|73|||
156698542|NCT00541970|565645616|FG000|Month 60|Protocol Violation|78|||
156698543|NCT00541970|565645617|FG001|Month 60|Protocol Violation|77|||
156698544|NCT00541970|565645618|FG002|Month 60|Protocol Violation|82|||
156698545|NCT00541970|565645619|FG003|Month 60|Protocol Violation|72|||
156698546|NCT03222583|565645622|FG000|Overall Study|Withdrawal by Subject|3|||
156698547|NCT03222583|565645623|FG001|Overall Study|Withdrawal by Subject|3|||
156698548|NCT03222583|565645622|FG000|Overall Study|Lost to Follow-up|1|||
156698549|NCT03222583|565645623|FG001|Overall Study|Lost to Follow-up|0|||
156698550|NCT03222583|565645622|FG000|Overall Study|Other|1|||
156698551|NCT03222583|565645623|FG001|Overall Study|Other|3|||
156698552|NCT02622113|565645624|FG000|Overall Study|Adverse Event|4|||
156698553|NCT02622113|565645625|FG001|Overall Study|Adverse Event|4|||
156698554|NCT02622113|565645624|FG000|Overall Study|Physician Decision|0|||
156698555|NCT02622113|565645625|FG001|Overall Study|Physician Decision|1|||
156698556|NCT02622113|565645624|FG000|Overall Study|Withdrawal by Subject|0|||
156698557|NCT02622113|565645625|FG001|Overall Study|Withdrawal by Subject|2|||
156698558|NCT02622113|565645624|FG000|Overall Study|Stopping Criteria|1|||
156698559|NCT02622113|565645625|FG001|Overall Study|Stopping Criteria|3|||
156698560|NCT01570686|565645626|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156698561|NCT01570686|565645627|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156698562|NCT01570686|565645626|FG000|Overall Study|Administrative problems|0|||
156698563|NCT01570686|565645627|FG001|Overall Study|Administrative problems|1|||
156698564|NCT01570686|565645626|FG000|Overall Study|Adverse Event|8|||
156698565|NCT01570686|565645627|FG001|Overall Study|Adverse Event|6|||
156698566|NCT01570686|565645626|FG000|Overall Study|Lost to Follow-up|4|||
156698567|NCT01570686|565645627|FG001|Overall Study|Lost to Follow-up|3|||
156698568|NCT01570686|565645626|FG000|Overall Study|Protocol Deviation|3|||
156698569|NCT01570686|565645627|FG001|Overall Study|Protocol Deviation|0|||
156698570|NCT01570686|565645626|FG000|Overall Study|Withdrawal by Subject|4|||
156698571|NCT01570686|565645627|FG001|Overall Study|Withdrawal by Subject|4|||
156698572|NCT01570686|565645626|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156698573|NCT01570686|565645627|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156698574|NCT00754650|565645628|FG000|Overall Study|Disease Progression|2|||
156698575|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
156698576|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
156698577|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
156698578|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
156698579|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
156698580|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
156698581|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
156698582|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
156698583|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
156698584|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
156698585|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
156698586|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
156698587|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
156698588|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
156698589|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
156698590|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
156698591|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
156698592|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
156698593|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
156698594|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
156698595|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
156698596|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698597|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698598|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
156698599|NCT03514641|565645633|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698600|NCT03514641|565645634|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
156698601|NCT03514641|565645635|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698602|NCT03514641|565645636|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
156698603|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698604|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698605|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
156698606|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
156698607|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
156871853|NCT02374450|566287830|FG001|Overall Study|Protocol Violation|1|||
156698608|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
156698609|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
156871854|NCT02374450|566287831|FG002|Overall Study|Protocol Violation|0|||
156871855|NCT02374450|566287829|FG000|Overall Study|Withdrawal by Subject|91|||
156871856|NCT02374450|566287830|FG001|Overall Study|Withdrawal by Subject|110|||
156871857|NCT02374450|566287831|FG002|Overall Study|Withdrawal by Subject|4|||
156871858|NCT02374450|566287829|FG000|Overall Study|Lost to Follow-up|168|||
156871859|NCT02374450|566287830|FG001|Overall Study|Lost to Follow-up|194|||
156871860|NCT02374450|566287831|FG002|Overall Study|Lost to Follow-up|138|||
156871861|NCT02374450|566287829|FG000|Overall Study|Death|173|||
156871862|NCT02374450|566287830|FG001|Overall Study|Death|185|||
156871863|NCT02374450|566287831|FG002|Overall Study|Death|81|||
156871864|NCT02374450|566287829|FG000|Overall Study|Migrated from the study area|538|||
156871865|NCT02374450|566287830|FG001|Overall Study|Migrated from the study area|648|||
156871866|NCT02374450|566287831|FG002|Overall Study|Migrated from the study area|181|||
156871867|NCT02374450|566287829|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
156871868|NCT02374450|566287830|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
156871869|NCT02374450|566287831|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
156698610|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
156698611|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
156698612|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
156698613|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
156698614|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
156698615|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
156698616|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
156698617|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
156698618|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
156698619|NCT03514641|565645633|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
156698620|NCT03514641|565645634|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
156698621|NCT03514641|565645635|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
156698622|NCT03514641|565645636|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
156698623|NCT01345175|565645637|FG000|Overall Study|Physician Decision|0|||
156698624|NCT01345175|565645638|FG001|Overall Study|Physician Decision|1|||
156698625|NCT01345175|565645637|FG000|Overall Study|Withdrawal by Subject|1|||
156698626|NCT01345175|565645638|FG001|Overall Study|Withdrawal by Subject|1|||
156698627|NCT01345175|565645637|FG000|Overall Study|Failed to complete BFI|3|||
156698628|NCT01345175|565645638|FG001|Overall Study|Failed to complete BFI|2|||
156698629|NCT01345175|565645637|FG000|Overall Study|Stopped taking medication|2|||
156698630|NCT01345175|565645638|FG001|Overall Study|Stopped taking medication|2|||
156698631|NCT00505375|565645639|FG000|Overall Study|Death|1|||
156698632|NCT00505375|565645640|FG001|Overall Study|Death|0|||
156698633|NCT00505375|565645639|FG000|Overall Study|Withdrawal by Subject|2|||
156698634|NCT00505375|565645640|FG001|Overall Study|Withdrawal by Subject|2|||
156698635|NCT00505375|565645639|FG000|Overall Study|Lost to Follow-up|0|||
156698636|NCT00505375|565645640|FG001|Overall Study|Lost to Follow-up|2|||
156698637|NCT00505375|565645639|FG000|Overall Study|Pregnancy|1|||
156698638|NCT00505375|565645640|FG001|Overall Study|Pregnancy|0|||
156698639|NCT00505375|565645639|FG000|Overall Study|Travel issues|0|||
156698640|NCT00505375|565645640|FG001|Overall Study|Travel issues|1|||
156698641|NCT04112173|565645644|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
156871870|NCT02374450|566287829|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
156871871|NCT02374450|566287830|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
156871872|NCT02374450|566287831|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
156871873|NCT02374450|566287829|FG000|Overall Study|Other|0|||
156698642|NCT01561430|565645645|FG000|Overall Study|Adverse Event|0|||
156698643|NCT01561430|565645646|FG001|Overall Study|Adverse Event|0|||
156698644|NCT01561430|565645647|FG002|Overall Study|Adverse Event|3|||
156698645|NCT01561430|565645648|FG003|Overall Study|Adverse Event|1|||
156698646|NCT01561430|565645645|FG000|Overall Study|Withdrawal by Subject|0|||
156871874|NCT02374450|566287830|FG001|Overall Study|Other|21|||
156871875|NCT02374450|566287831|FG002|Overall Study|Other|79|||
156871876|NCT05232682|566287834|FG000|Overall Study|Lost to Follow-up|2|||
156698647|NCT01561430|565645646|FG001|Overall Study|Withdrawal by Subject|0|||
156698648|NCT01561430|565645647|FG002|Overall Study|Withdrawal by Subject|1|||
156698649|NCT01561430|565645648|FG003|Overall Study|Withdrawal by Subject|0|||
156698650|NCT01561430|565645645|FG000|Overall Study|Physician Decision|0|||
156698651|NCT01561430|565645646|FG001|Overall Study|Physician Decision|1|||
156871877|NCT01788358|566289443|FG000|Overall Study|Other|11|||
156871878|NCT01788358|566289443|FG000|Overall Study|Logistical difficulties|1|||
156871879|NCT01788358|566289443|FG000|Overall Study|Lost to Follow-up|5|||
156871880|NCT01788358|566289443|FG000|Overall Study|Protocol Violation|3|||
157014851|NCT00001277|566805117|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
157014852|NCT00001277|566805118|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
157021743|NCT03673111|566832948|FG003|Overall Study|Adverse Event|0|||
156698652|NCT01561430|565645647|FG002|Overall Study|Physician Decision|0|||
156698653|NCT01561430|565645648|FG003|Overall Study|Physician Decision|0|||
156698654|NCT01561430|565645645|FG000|Overall Study|Sponsor Decision|1|||
156698655|NCT01561430|565645646|FG001|Overall Study|Sponsor Decision|14|||
156698656|NCT01561430|565645647|FG002|Overall Study|Sponsor Decision|13|||
156698657|NCT01561430|565645648|FG003|Overall Study|Sponsor Decision|12|||
156698658|NCT02906930|565645649|FG000|Overall Study|Withdrawal by Subject|0|||
156698659|NCT02906930|565645650|FG001|Overall Study|Withdrawal by Subject|5|||
156698660|NCT02906930|565645651|FG002|Overall Study|Withdrawal by Subject|5|||
156698661|NCT02906930|565645652|FG003|Overall Study|Withdrawal by Subject|4|||
156698662|NCT02906930|565645649|FG000|Overall Study|Lost to Follow-up|5|||
156698663|NCT02906930|565645650|FG001|Overall Study|Lost to Follow-up|7|||
156698664|NCT02906930|565645651|FG002|Overall Study|Lost to Follow-up|5|||
156698665|NCT02906930|565645652|FG003|Overall Study|Lost to Follow-up|2|||
156698666|NCT02906930|565645649|FG000|Overall Study|Death|0|||
156698667|NCT02906930|565645650|FG001|Overall Study|Death|0|||
156698668|NCT02906930|565645651|FG002|Overall Study|Death|1|||
156698669|NCT02906930|565645652|FG003|Overall Study|Death|0|||
156698670|NCT02906930|565645649|FG000|Overall Study|Other|1|||
156698671|NCT02906930|565645650|FG001|Overall Study|Other|2|||
156698672|NCT02906930|565645651|FG002|Overall Study|Other|1|||
156698673|NCT02906930|565645652|FG003|Overall Study|Other|2|||
156698674|NCT04234984|565645662|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
156698675|NCT04234984|565645662|FG000|Follow-up at the Second Time Point|Death|1|||
156698676|NCT04234984|565645662|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
156698677|NCT01055132|565645663|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
156698678|NCT01055132|565645664|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
156698679|NCT01055132|565645663|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
156698680|NCT01055132|565645664|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
156698681|NCT02570113|565645665|FG000|Overall Study|Withdrawal by Subject|3|||
156698682|NCT02746471|565645666|FG000|Overall Study|Death|43|||
156698683|NCT02746471|565645666|FG000|Overall Study|Exited before 36 months|1119|||
156698684|NCT02564211|565645667|FG000|Overall Study|Adverse Event|4|||
156698685|NCT00910091|565645669|FG000|Pre-assignment|Withdrawal by Subject|0|||
156698686|NCT00910091|565645670|FG001|Pre-assignment|Withdrawal by Subject|2|||
156698687|NCT00910091|565645669|FG000|Treatment and Survival|Withdrawal by Subject|3|||
156698688|NCT00910091|565645670|FG001|Treatment and Survival|Withdrawal by Subject|4|||
156698689|NCT00910091|565645669|FG000|Treatment and Survival|Adverse Event|1|||
156698690|NCT00910091|565645670|FG001|Treatment and Survival|Adverse Event|0|||
157014853|NCT00001277|566805119|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
157014854|NCT00065260|566805120|FG000|Overall Study|Death|0|||
156871881|NCT01788358|566289443|FG000|Overall Study|Withdrawal by Subject|26|||
156871882|NCT01788358|566289443|FG000|Overall Study|Lack of Efficacy|1|||
156698691|NCT01908816|565645671|FG000|Overall Study|Subject's no longer requires study drug|0|||
156698692|NCT01908816|565645672|FG001|Overall Study|Subject's no longer requires study drug|0|||
156698693|NCT01908816|565645673|FG002|Overall Study|Subject's no longer requires study drug|0|||
156698694|NCT01908816|565645674|FG003|Overall Study|Subject's no longer requires study drug|1|||
156698695|NCT01908816|565645671|FG000|Overall Study|Protocol deviation|1|||
156698696|NCT01908816|565645672|FG001|Overall Study|Protocol deviation|2|||
156698697|NCT01908816|565645673|FG002|Overall Study|Protocol deviation|1|||
156698698|NCT01908816|565645674|FG003|Overall Study|Protocol deviation|1|||
156698699|NCT01908816|565645671|FG000|Overall Study|Withdrawal by Subject|0|||
156698700|NCT01908816|565645672|FG001|Overall Study|Withdrawal by Subject|4|||
156698701|NCT01908816|565645673|FG002|Overall Study|Withdrawal by Subject|2|||
156698702|NCT01908816|565645674|FG003|Overall Study|Withdrawal by Subject|2|||
156698703|NCT01908816|565645671|FG000|Overall Study|Lost to Follow-up|3|||
156698704|NCT01908816|565645672|FG001|Overall Study|Lost to Follow-up|5|||
156698705|NCT01908816|565645673|FG002|Overall Study|Lost to Follow-up|4|||
156698706|NCT01908816|565645674|FG003|Overall Study|Lost to Follow-up|2|||
156698707|NCT01908816|565645671|FG000|Overall Study|Death|1|||
156698708|NCT01908816|565645672|FG001|Overall Study|Death|0|||
156698709|NCT01908816|565645673|FG002|Overall Study|Death|7|||
156698710|NCT01908816|565645674|FG003|Overall Study|Death|1|||
156698711|NCT01908816|565645671|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156698712|NCT01908816|565645672|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
156698713|NCT01908816|565645673|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
156698714|NCT01908816|565645674|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156698715|NCT01908816|565645671|FG000|Overall Study|Early termination|87|||
156698716|NCT01908816|565645672|FG001|Overall Study|Early termination|60|||
156698717|NCT01908816|565645673|FG002|Overall Study|Early termination|43|||
156871883|NCT01788358|566289443|FG000|Overall Study|Adverse Event|51|||
156698718|NCT01908816|565645674|FG003|Overall Study|Early termination|28|||
156698719|NCT01007942|565645676|FG000|Overall Study|Adverse Event|29|||
156698720|NCT01007942|565645677|FG001|Overall Study|Adverse Event|14|||
156698721|NCT01007942|565645676|FG000|Overall Study|Abnormal test procedure|0|||
157014855|NCT00065260|566805121|FG001|Overall Study|Death|1|||
156871884|NCT01168219|566289444|FG000|Overall Study|off study before starting treatment|2|||
156698722|NCT01007942|565645677|FG001|Overall Study|Abnormal test procedure|1|||
156698723|NCT01007942|565645676|FG000|Overall Study|Disease progression|217|||
156698724|NCT01007942|565645677|FG001|Overall Study|Disease progression|242|||
156698725|NCT01007942|565645676|FG000|Overall Study|New cancer therapy|5|||
156698726|NCT01007942|565645677|FG001|Overall Study|New cancer therapy|1|||
156698727|NCT01007942|565645676|FG000|Overall Study|Protocol Violation|1|||
156698728|NCT01007942|565645677|FG001|Overall Study|Protocol Violation|1|||
156698729|NCT01007942|565645676|FG000|Overall Study|Withdrawal by Subject|19|||
156698730|NCT01007942|565645677|FG001|Overall Study|Withdrawal by Subject|14|||
156698731|NCT01007942|565645676|FG000|Overall Study|Lost to Follow-up|1|||
156698732|NCT01007942|565645677|FG001|Overall Study|Lost to Follow-up|0|||
156698733|NCT01007942|565645676|FG000|Overall Study|Administrative problems|2|||
156698734|NCT01007942|565645677|FG001|Overall Study|Administrative problems|0|||
156698735|NCT01007942|565645676|FG000|Overall Study|Death|3|||
156698736|NCT01007942|565645677|FG001|Overall Study|Death|2|||
156698737|NCT01007942|565645676|FG000|Overall Study|Patients untreated|4|||
156698738|NCT01007942|565645677|FG001|Overall Study|Patients untreated|3|||
156698739|NCT04492020|565645678|FG000|Overall Study|Adverse Event|1|||
156698740|NCT04492020|565645679|FG001|Overall Study|Adverse Event|3|||
156698741|NCT04492020|565645678|FG000|Overall Study|Withdrawal by Subject|4|||
156698742|NCT04492020|565645679|FG001|Overall Study|Withdrawal by Subject|3|||
156698743|NCT04492020|565645678|FG000|Overall Study|Lost to Follow-up|4|||
156698744|NCT04492020|565645679|FG001|Overall Study|Lost to Follow-up|3|||
156698745|NCT04492020|565645678|FG000|Overall Study|Protocol Violation|5|||
156698746|NCT04492020|565645679|FG001|Overall Study|Protocol Violation|2|||
156698747|NCT04492020|565645678|FG000|Overall Study|Lack of Qualifying Event|25|||
156698748|NCT04492020|565645679|FG001|Overall Study|Lack of Qualifying Event|27|||
156698749|NCT04492020|565645678|FG000|Overall Study|Non-compliance with Study Drug|2|||
156698750|NCT04492020|565645679|FG001|Overall Study|Non-compliance with Study Drug|1|||
156698751|NCT04594707|565645680|FG000|Overall Study|Adverse Event|0|||
156698752|NCT04594707|565645681|FG001|Overall Study|Adverse Event|0|||
156698753|NCT04594707|565645682|FG002|Overall Study|Adverse Event|1|||
156698754|NCT04594707|565645680|FG000|Overall Study|Death|0|||
156698755|NCT04594707|565645681|FG001|Overall Study|Death|2|||
156698756|NCT04594707|565645682|FG002|Overall Study|Death|2|||
156698757|NCT04594707|565645680|FG000|Overall Study|Lung Transplant|0|||
156698758|NCT04594707|565645681|FG001|Overall Study|Lung Transplant|0|||
156698759|NCT04594707|565645682|FG002|Overall Study|Lung Transplant|1|||
156698760|NCT04594707|565645680|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
156698761|NCT04594707|565645681|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
156698762|NCT04594707|565645682|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
156698763|NCT04594707|565645680|FG000|Overall Study|Study Terminated By Sponsor|19|||
156698764|NCT04594707|565645681|FG001|Overall Study|Study Terminated By Sponsor|47|||
156698765|NCT04594707|565645682|FG002|Overall Study|Study Terminated By Sponsor|41|||
156698766|NCT04594707|565645680|FG000|Overall Study|Withdrawal by Subject|1|||
156698767|NCT04594707|565645681|FG001|Overall Study|Withdrawal by Subject|0|||
156698768|NCT04594707|565645682|FG002|Overall Study|Withdrawal by Subject|2|||
156698769|NCT04585789|565645683|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
156698770|NCT04585789|565645684|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
156698771|NCT04585789|565645685|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
156698772|NCT04585789|565645683|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
156698773|NCT04585789|565645684|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
156698774|NCT04585789|565645685|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
156698775|NCT01175811|565645686|FG000|Overall Study|Adverse Event|1|||
156698776|NCT01175811|565645687|FG001|Overall Study|Adverse Event|1|||
156698777|NCT01175811|565645686|FG000|Overall Study|Entry criteria not met|3|||
156698778|NCT01175811|565645687|FG001|Overall Study|Entry criteria not met|1|||
156698779|NCT01175811|565645686|FG000|Overall Study|Lack of Efficacy|1|||
156698780|NCT01175811|565645687|FG001|Overall Study|Lack of Efficacy|0|||
156698781|NCT01175811|565645686|FG000|Overall Study|Lost to Follow-up|3|||
156698782|NCT01175811|565645687|FG001|Overall Study|Lost to Follow-up|2|||
156698783|NCT01175811|565645686|FG000|Overall Study|Physician Decision|1|||
156698784|NCT01175811|565645687|FG001|Overall Study|Physician Decision|1|||
156698785|NCT01175811|565645686|FG000|Overall Study|Protocol Violation|1|||
156698786|NCT01175811|565645687|FG001|Overall Study|Protocol Violation|2|||
156698787|NCT01175811|565645686|FG000|Overall Study|Withdrawal by Subject|6|||
156698788|NCT01175811|565645687|FG001|Overall Study|Withdrawal by Subject|7|||
156698789|NCT02628743|565645690|FG000|Overall Study|Other|3|||
156698790|NCT02628743|565645690|FG000|Overall Study|Withdrawal by Subject|50|||
156698791|NCT02628743|565645690|FG000|Overall Study|Study Terminated by Sponsor|76|||
156698792|NCT02628743|565645690|FG000|Overall Study|Physician Decision|2|||
156698793|NCT00655876|565645691|FG000|Overall Study|Protocol Violation|9|||
156698794|NCT00655876|565645692|FG001|Overall Study|Protocol Violation|7|||
156698795|NCT00326963|565645693|FG000|Overall Study|Adverse Event|2|||
156698796|NCT00326963|565645693|FG000|Overall Study|Injection site reaction|1|||
156698797|NCT00326963|565645693|FG000|Overall Study|Death|1|||
156698798|NCT00326963|565645693|FG000|Overall Study|Failure to return|10|||
156698799|NCT00326963|565645693|FG000|Overall Study|Withdrawal by Subject|10|||
156698800|NCT00326963|565645693|FG000|Overall Study|Refused treatment / did not cooperate|5|||
156698801|NCT00326963|565645693|FG000|Overall Study|Violation of selection criteria at entry|2|||
156698802|NCT00326963|565645693|FG000|Overall Study|Other protocol violation|1|||
156698803|NCT00326963|565645693|FG000|Overall Study|Administrative / other|1|||
156698804|NCT04645966|565645696|FG000|Vaccination Phase|Adverse Event|1|||
156698805|NCT04645966|565645697|FG001|Vaccination Phase|Adverse Event|0|||
156698806|NCT04645966|565645698|FG002|Vaccination Phase|Adverse Event|0|||
156698807|NCT04645966|565645699|FG003|Vaccination Phase|Adverse Event|0|||
156698808|NCT04645966|565645700|FG004|Vaccination Phase|Adverse Event|0|||
156698809|NCT04645966|565645701|FG005|Vaccination Phase|Adverse Event|0|||
156698810|NCT04645966|565645702|FG006|Vaccination Phase|Adverse Event|1|||
156698811|NCT04645966|565645703|FG007|Vaccination Phase|Adverse Event|0|||
156698812|NCT04645966|565645704|FG008|Vaccination Phase|Adverse Event|0|||
156698813|NCT04645966|565645696|FG000|Vaccination Phase|Death|0|||
156698814|NCT04645966|565645697|FG001|Vaccination Phase|Death|0|||
156698815|NCT04645966|565645698|FG002|Vaccination Phase|Death|0|||
156698816|NCT04645966|565645699|FG003|Vaccination Phase|Death|0|||
156698817|NCT04645966|565645700|FG004|Vaccination Phase|Death|0|||
156698818|NCT04645966|565645701|FG005|Vaccination Phase|Death|1|||
156698819|NCT04645966|565645702|FG006|Vaccination Phase|Death|0|||
156698820|NCT04645966|565645703|FG007|Vaccination Phase|Death|0|||
156698821|NCT04645966|565645704|FG008|Vaccination Phase|Death|0|||
156698822|NCT04645966|565645696|FG000|Vaccination Phase|Protocol Violation|0|||
156698823|NCT04645966|565645697|FG001|Vaccination Phase|Protocol Violation|0|||
156698824|NCT04645966|565645698|FG002|Vaccination Phase|Protocol Violation|0|||
156698825|NCT04645966|565645699|FG003|Vaccination Phase|Protocol Violation|0|||
156698826|NCT04645966|565645700|FG004|Vaccination Phase|Protocol Violation|1|||
156698827|NCT04645966|565645701|FG005|Vaccination Phase|Protocol Violation|0|||
156698828|NCT04645966|565645702|FG006|Vaccination Phase|Protocol Violation|0|||
156698829|NCT04645966|565645703|FG007|Vaccination Phase|Protocol Violation|0|||
156698830|NCT04645966|565645704|FG008|Vaccination Phase|Protocol Violation|0|||
156698831|NCT04645966|565645696|FG000|Vaccination Phase|Study terminated by sponsor|0|||
156698832|NCT04645966|565645697|FG001|Vaccination Phase|Study terminated by sponsor|0|||
156698833|NCT04645966|565645698|FG002|Vaccination Phase|Study terminated by sponsor|14|||
156698834|NCT04645966|565645699|FG003|Vaccination Phase|Study terminated by sponsor|15|||
156698835|NCT04645966|565645700|FG004|Vaccination Phase|Study terminated by sponsor|47|||
156698836|NCT04645966|565645701|FG005|Vaccination Phase|Study terminated by sponsor|43|||
156698837|NCT04645966|565645702|FG006|Vaccination Phase|Study terminated by sponsor|29|||
156698838|NCT04645966|565645703|FG007|Vaccination Phase|Study terminated by sponsor|29|||
156698839|NCT04645966|565645704|FG008|Vaccination Phase|Study terminated by sponsor|12|||
156698840|NCT04645966|565645696|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698841|NCT04645966|565645697|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698842|NCT04645966|565645698|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
156698843|NCT04645966|565645699|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
156698844|NCT04645966|565645700|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
156698845|NCT04645966|565645701|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
156698846|NCT04645966|565645702|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698847|NCT04645966|565645703|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
156698848|NCT04645966|565645704|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
156698849|NCT04645966|565645696|FG000|Vaccination Phase|Other|0|||
156698850|NCT04645966|565645697|FG001|Vaccination Phase|Other|0|||
156698851|NCT04645966|565645698|FG002|Vaccination Phase|Other|0|||
156698852|NCT04645966|565645699|FG003|Vaccination Phase|Other|0|||
156698853|NCT04645966|565645700|FG004|Vaccination Phase|Other|0|||
156698854|NCT04645966|565645701|FG005|Vaccination Phase|Other|2|||
156698855|NCT04645966|565645702|FG006|Vaccination Phase|Other|0|||
156698856|NCT04645966|565645703|FG007|Vaccination Phase|Other|0|||
156871885|NCT01168219|566289444|FG000|Overall Study|withdrew before transplant|1|||
156871886|NCT01168219|566289444|FG000|Overall Study|ineligible due to CML|2|||
156871887|NCT01027273|566289445|FG000|Overall Study|Lost to Follow-up|57|||
156871888|NCT01027273|566289446|FG001|Overall Study|Lost to Follow-up|31|||
156871889|NCT01027273|566289445|FG000|Overall Study|Death|2|||
156698857|NCT04645966|565645704|FG008|Vaccination Phase|Other|0|||
156698858|NCT04645966|565645696|FG000|Vaccination Phase|Lost to Follow-up|0|||
156698859|NCT04645966|565645697|FG001|Vaccination Phase|Lost to Follow-up|0|||
156871890|NCT01027273|566289446|FG001|Overall Study|Death|2|||
156698860|NCT04645966|565645698|FG002|Vaccination Phase|Lost to Follow-up|0|||
156698861|NCT04645966|565645699|FG003|Vaccination Phase|Lost to Follow-up|0|||
156698862|NCT04645966|565645700|FG004|Vaccination Phase|Lost to Follow-up|0|||
156698863|NCT04645966|565645701|FG005|Vaccination Phase|Lost to Follow-up|0|||
156698864|NCT04645966|565645702|FG006|Vaccination Phase|Lost to Follow-up|0|||
156871891|NCT02948634|566289450|FG000|Overall Study|Lack of efficacy and study suspended|10|||
156698865|NCT04645966|565645703|FG007|Vaccination Phase|Lost to Follow-up|1|||
156698866|NCT04645966|565645704|FG008|Vaccination Phase|Lost to Follow-up|0|||
156698867|NCT04645966|565645696|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
156698868|NCT04645966|565645697|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
156871892|NCT02948634|566289451|FG001|Overall Study|Lack of efficacy and study suspended|2|||
157123124|NCT02926950|567201565|FG001|Overall Study|Adverse Event|6|||
157123125|NCT02926950|567201564|FG000|Overall Study|At the participant's own request|21|||
157123126|NCT02926950|567201565|FG001|Overall Study|At the participant's own request|25|||
157123127|NCT02926950|567201564|FG000|Overall Study|Reason not Specified|17|||
157123128|NCT02926950|567201565|FG001|Overall Study|Reason not Specified|9|||
157123129|NCT02926950|567201564|FG000|Overall Study|Lost to Follow-up|7|||
157123130|NCT02926950|567201565|FG001|Overall Study|Lost to Follow-up|8|||
157123131|NCT02553460|567201566|FG000|Overall Study|Death|3|||
157123132|NCT02553460|567201566|FG000|Overall Study|Withdrawal by Subject|1|||
157123133|NCT02553460|567201566|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
157123134|NCT02553460|567201566|FG000|Overall Study|Relapse or Transplant|14|||
157123135|NCT02553460|567201566|FG000|Overall Study|No response to treatment|2|||
157123136|NCT02553460|567201566|FG000|Overall Study|CAR T cells|2|||
157123137|NCT03505021|567201567|FG000|Overall Study|Protocol Violation|1|||
157123138|NCT03505021|567201568|FG001|Overall Study|Protocol Violation|0|||
157214864|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
156698869|NCT04645966|565645698|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
156698870|NCT04645966|565645699|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
156698871|NCT04645966|565645700|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
156698872|NCT04645966|565645701|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
156698873|NCT04645966|565645702|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
156698874|NCT04645966|565645703|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
156698875|NCT04645966|565645704|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
156698876|NCT04645966|565645696|FG000|Follow-up Phase|Lost to Follow-up|0|||
156698877|NCT04645966|565645697|FG001|Follow-up Phase|Lost to Follow-up|0|||
156698878|NCT04645966|565645698|FG002|Follow-up Phase|Lost to Follow-up|0|||
156698879|NCT04645966|565645699|FG003|Follow-up Phase|Lost to Follow-up|0|||
156698880|NCT04645966|565645700|FG004|Follow-up Phase|Lost to Follow-up|0|||
156698881|NCT04645966|565645701|FG005|Follow-up Phase|Lost to Follow-up|0|||
156698882|NCT04645966|565645702|FG006|Follow-up Phase|Lost to Follow-up|0|||
156698883|NCT04645966|565645703|FG007|Follow-up Phase|Lost to Follow-up|1|||
156698884|NCT04645966|565645704|FG008|Follow-up Phase|Lost to Follow-up|0|||
156698885|NCT00552578|565645708|FG000|Overall Study|Lost to Follow-up|1|||
156698886|NCT00552578|565645709|FG001|Overall Study|Lost to Follow-up|1|||
156698887|NCT00470067|565645710|FG000|Overall Study|Death|1|||
156698888|NCT00470067|565645710|FG000|Overall Study|Disease Progression|6|||
156698889|NCT01460901|565645711|FG000|Overall Study|Withdrawal by Subject|2|||
156698890|NCT04091659|565645716|FG000|Overall Study|Protocol Violation|3|||
156698891|NCT04091659|565645717|FG001|Overall Study|Protocol Violation|0|||
156698892|NCT04091659|565645716|FG000|Overall Study|Lost to Follow-up|0|||
156698893|NCT04091659|565645717|FG001|Overall Study|Lost to Follow-up|1|||
156698894|NCT00895947|565645718|FG000|Overall Study|Adverse Event|3|||
156698895|NCT00895947|565645719|FG001|Overall Study|Adverse Event|4|||
156698896|NCT00895947|565645718|FG000|Overall Study|Lost to Follow-up|3|||
156698897|NCT00895947|565645719|FG001|Overall Study|Lost to Follow-up|4|||
156790620|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
156790621|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
156790622|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
156790623|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
156790624|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
156790625|NCT01755156|565985425|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
156790626|NCT01755156|565985426|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
156790627|NCT01755156|565985425|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
156790628|NCT01755156|565985426|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
156790629|NCT01755156|565985425|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
156790630|NCT01755156|565985426|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
156790631|NCT00871000|565985427|FG000|Overall Study|Withdrawal by Subject|1|||
156790632|NCT00871000|565985428|FG001|Overall Study|Withdrawal by Subject|0|||
156790633|NCT00449787|565985431|FG000|Overall Study|Lost to Follow-up|10|||
156790634|NCT00449787|565985432|FG001|Overall Study|Lost to Follow-up|8|||
156790635|NCT00449787|565985431|FG000|Overall Study|Did not require medication|95|||
156790636|NCT00449787|565985432|FG001|Overall Study|Did not require medication|92|||
156790637|NCT03574389|565985435|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
156790638|NCT03574389|565985436|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
156790639|NCT03574389|565985437|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
156790640|NCT03574389|565985438|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
156790641|NCT03574389|565985439|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
156790642|NCT03574389|565985440|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
156871893|NCT01413204|566289452|FG000|Overall Study|Adverse Event|1|||
157123139|NCT03505021|567201567|FG000|Overall Study|Death|9|||
157123140|NCT03505021|567201568|FG001|Overall Study|Death|8|||
156698898|NCT00895947|565645718|FG000|Overall Study|Protocol Violation|4|||
156698899|NCT00895947|565645719|FG001|Overall Study|Protocol Violation|2|||
156698900|NCT00895947|565645718|FG000|Overall Study|Withdrawal by Subject|2|||
157014856|NCT03750968|566805122|FG000|Overall Study|Adverse Event|2|||
157014857|NCT03750968|566805123|FG001|Overall Study|Adverse Event|0|||
157014858|NCT03750968|566805122|FG000|Overall Study|Lost to Follow-up|1|||
157014859|NCT03750968|566805123|FG001|Overall Study|Lost to Follow-up|3|||
157014860|NCT00088413|566805130|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
157014861|NCT00088413|566805131|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
157014862|NCT00088413|566805132|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
157014863|NCT00088413|566805133|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
157014864|NCT00088413|566805130|FG000|Overall Study|Adverse Events/Side Effects|0|||
157014865|NCT00088413|566805131|FG001|Overall Study|Adverse Events/Side Effects|1|||
157014866|NCT00088413|566805132|FG002|Overall Study|Adverse Events/Side Effects|1|||
157014867|NCT00088413|566805133|FG003|Overall Study|Adverse Events/Side Effects|0|||
157014868|NCT00088413|566805130|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
157014869|NCT00088413|566805131|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
157014870|NCT00088413|566805132|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
157014871|NCT00088413|566805133|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
157014872|NCT00088413|566805130|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
157014873|NCT00088413|566805131|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
157014874|NCT00088413|566805132|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
157014875|NCT00088413|566805133|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
157014876|NCT00088413|566805130|FG000|Overall Study|Death|0|||
157014877|NCT00088413|566805131|FG001|Overall Study|Death|1|||
157014878|NCT00088413|566805132|FG002|Overall Study|Death|0|||
157014879|NCT00088413|566805133|FG003|Overall Study|Death|0|||
157014880|NCT00088413|566805130|FG000|Overall Study|Progressive disease|9|||
157014881|NCT00088413|566805131|FG001|Overall Study|Progressive disease|11|||
157014882|NCT00088413|566805132|FG002|Overall Study|Progressive disease|8|||
157014883|NCT00088413|566805133|FG003|Overall Study|Progressive disease|14|||
157014884|NCT00088413|566805130|FG000|Overall Study|Other|0|||
157014885|NCT00088413|566805131|FG001|Overall Study|Other|1|||
157014886|NCT00088413|566805132|FG002|Overall Study|Other|0|||
157014887|NCT00088413|566805133|FG003|Overall Study|Other|0|||
157014888|NCT00088413|566805130|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
157014889|NCT00088413|566805131|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
157014890|NCT00088413|566805132|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
157014891|NCT00088413|566805133|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
157014892|NCT02539225|566805136|FG000|Part A|Adverse Event|13|||
157014893|NCT02539225|566805137|FG001|Part A|Adverse Event|4|||
157014894|NCT02539225|566805136|FG000|Part A|Withdrawal by Subject|2|||
157014895|NCT02539225|566805137|FG001|Part A|Withdrawal by Subject|4|||
157014896|NCT02539225|566805136|FG000|Part A|Physician Decision|4|||
157014897|NCT02539225|566805137|FG001|Part A|Physician Decision|7|||
157014898|NCT02539225|566805136|FG000|Part A|Did Not Receive study Drug|1|||
157014899|NCT02539225|566805137|FG001|Part A|Did Not Receive study Drug|1|||
157014900|NCT02539225|566805136|FG000|Pre Treatment for Part B|Progressive disease|1|||
157014901|NCT02539225|566805137|FG001|Pre Treatment for Part B|Progressive disease|1|||
157014902|NCT02539225|566805136|FG000|Pre Treatment for Part B|Adverse Event|1|||
157014903|NCT02539225|566805137|FG001|Pre Treatment for Part B|Adverse Event|1|||
157014904|NCT02539225|566805136|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
157014905|NCT02539225|566805137|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
157014906|NCT02539225|566805136|FG000|Pre Treatment for Part B|Physician Decision|2|||
157014907|NCT02539225|566805137|FG001|Pre Treatment for Part B|Physician Decision|0|||
157014908|NCT02539225|566805136|FG000|Part B|Adverse Event|4|||
157014909|NCT02539225|566805137|FG001|Part B|Adverse Event|4|||
157014910|NCT02539225|566805136|FG000|Part B|Withdrawal by Subject|0|||
157014911|NCT02539225|566805137|FG001|Part B|Withdrawal by Subject|3|||
156790643|NCT03574389|565985441|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
156790644|NCT03574389|565985435|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
156790645|NCT03574389|565985436|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
156790646|NCT03574389|565985437|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
156790647|NCT03574389|565985438|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
156790648|NCT03574389|565985439|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
156790649|NCT03574389|565985440|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
156790650|NCT03574389|565985441|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
157014912|NCT02539225|566805136|FG000|Part B|Physician Decision|0|||
156790651|NCT03574389|565985435|FG000|Vaccination Period|Other|6|||
156790652|NCT03574389|565985436|FG001|Vaccination Period|Other|0|||
156790653|NCT03574389|565985437|FG002|Vaccination Period|Other|0|||
157014913|NCT02539225|566805137|FG001|Part B|Physician Decision|9|||
157014914|NCT03101371|566805141|FG000|Overall Study|Physician Decision|0|||
157014915|NCT03101371|566805142|FG001|Overall Study|Physician Decision|1|||
157014916|NCT03101371|566805141|FG000|Overall Study|Lost to Follow-up|1|||
157014917|NCT03101371|566805142|FG001|Overall Study|Lost to Follow-up|4|||
157014918|NCT03101371|566805141|FG000|Overall Study|Did not meet eligibility criteria|2|||
157014919|NCT03101371|566805142|FG001|Overall Study|Did not meet eligibility criteria|1|||
157014920|NCT03988842|566805143|FG000|Overall Study|Death|1|||
156698901|NCT00895947|565645719|FG001|Overall Study|Withdrawal by Subject|0|||
156698902|NCT03678285|565645728|FG000|Overall Study|Adverse Event|2|||
156698903|NCT03678285|565645728|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
156698904|NCT03678285|565645728|FG000|Overall Study|Dehydrated prior to start of workout|1|||
156698905|NCT00123474|565645729|FG000|Randomized to Treatment|Randomized, never treated|1|||
156698906|NCT00123474|565645730|FG001|Randomized to Treatment|Randomized, never treated|4|||
156698907|NCT00123474|565645731|FG002|Randomized to Treatment|Randomized, never treated|2|||
156698908|NCT00123474|565645732|FG003|Randomized to Treatment|Randomized, never treated|1|||
156698909|NCT00123474|565645729|FG000|As Treated at Study Closure|not reported when site closed|1|||
156698910|NCT00123474|565645730|FG001|As Treated at Study Closure|not reported when site closed|0|||
156698911|NCT00123474|565645731|FG002|As Treated at Study Closure|not reported when site closed|1|||
156790654|NCT03574389|565985438|FG003|Vaccination Period|Other|0|||
156790655|NCT03574389|565985439|FG004|Vaccination Period|Other|0|||
156790656|NCT03574389|565985440|FG005|Vaccination Period|Other|0|||
156790657|NCT03574389|565985441|FG006|Vaccination Period|Other|0|||
156790658|NCT03574389|565985435|FG000|Vaccination Period|Adverse Event|0|||
156790659|NCT03574389|565985436|FG001|Vaccination Period|Adverse Event|1|||
156790660|NCT03574389|565985437|FG002|Vaccination Period|Adverse Event|0|||
156790661|NCT03574389|565985438|FG003|Vaccination Period|Adverse Event|0|||
156790662|NCT03574389|565985439|FG004|Vaccination Period|Adverse Event|0|||
156790663|NCT03574389|565985440|FG005|Vaccination Period|Adverse Event|0|||
156790664|NCT03574389|565985441|FG006|Vaccination Period|Adverse Event|0|||
156790665|NCT03574389|565985435|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
156790666|NCT03574389|565985436|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
156790667|NCT03574389|565985437|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
156790668|NCT03574389|565985438|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
156790669|NCT03574389|565985439|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
156790670|NCT03574389|565985440|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
156790671|NCT03574389|565985441|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
156790672|NCT03436420|565985445|FG000|Overall Study|Lack of Efficacy|3|||
156790673|NCT01061710|565985446|FG000|Overall Study|Protocol Violation|14|||
156790674|NCT00159874|565985447|FG000|Overall Study|Adverse Event|2|||
156790675|NCT00159874|565985448|FG001|Overall Study|Adverse Event|2|||
156790676|NCT00159874|565985449|FG002|Overall Study|Adverse Event|5|||
156790677|NCT00159874|565985450|FG003|Overall Study|Adverse Event|1|||
156790678|NCT00159874|565985451|FG004|Overall Study|Adverse Event|1|||
156790679|NCT00159874|565985452|FG005|Overall Study|Adverse Event|2|||
156790680|NCT00159874|565985453|FG006|Overall Study|Adverse Event|0|||
156790681|NCT00159874|565985447|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
156790682|NCT00159874|565985448|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
156790683|NCT00159874|565985449|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
156790684|NCT00159874|565985450|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
156790685|NCT00159874|565985451|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
156790686|NCT00159874|565985452|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
156790687|NCT00159874|565985453|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
156790688|NCT00159874|565985447|FG000|Overall Study|Lack of Efficacy|2|||
156790689|NCT00159874|565985448|FG001|Overall Study|Lack of Efficacy|0|||
156790690|NCT00159874|565985449|FG002|Overall Study|Lack of Efficacy|1|||
156790691|NCT00159874|565985450|FG003|Overall Study|Lack of Efficacy|1|||
156790692|NCT00159874|565985451|FG004|Overall Study|Lack of Efficacy|0|||
156790693|NCT00159874|565985452|FG005|Overall Study|Lack of Efficacy|3|||
156790694|NCT00159874|565985453|FG006|Overall Study|Lack of Efficacy|0|||
156790695|NCT00159874|565985447|FG000|Overall Study|Lost to Follow-up|1|||
156790696|NCT00159874|565985448|FG001|Overall Study|Lost to Follow-up|0|||
156790697|NCT00159874|565985449|FG002|Overall Study|Lost to Follow-up|3|||
156790698|NCT00159874|565985450|FG003|Overall Study|Lost to Follow-up|0|||
156871894|NCT01413204|566289453|FG001|Overall Study|Adverse Event|2|||
156871895|NCT01413204|566289454|FG002|Overall Study|Adverse Event|2|||
156871896|NCT01413204|566289452|FG000|Overall Study|Physician Decision|3|||
156871897|NCT01413204|566289453|FG001|Overall Study|Physician Decision|0|||
156871898|NCT01413204|566289454|FG002|Overall Study|Physician Decision|2|||
156871899|NCT01413204|566289452|FG000|Overall Study|Withdrawal by Subject|1|||
156871900|NCT01413204|566289453|FG001|Overall Study|Withdrawal by Subject|4|||
156790699|NCT00159874|565985451|FG004|Overall Study|Lost to Follow-up|1|||
156790700|NCT00159874|565985452|FG005|Overall Study|Lost to Follow-up|2|||
156790701|NCT00159874|565985453|FG006|Overall Study|Lost to Follow-up|1|||
156790702|NCT00159874|565985447|FG000|Overall Study|Other|8|||
157123141|NCT03505021|567201567|FG000|Overall Study|Consent withdrawn by subject|6|||
157123142|NCT03505021|567201568|FG001|Overall Study|Consent withdrawn by subject|1|||
156790703|NCT00159874|565985448|FG001|Overall Study|Other|8|||
156790704|NCT00159874|565985449|FG002|Overall Study|Other|8|||
156790705|NCT00159874|565985450|FG003|Overall Study|Other|0|||
156790706|NCT00159874|565985451|FG004|Overall Study|Other|2|||
156871901|NCT01413204|566289454|FG002|Overall Study|Withdrawal by Subject|4|||
156871902|NCT01413204|566289452|FG000|Overall Study|Clearly not eligible for the study|0|||
157123143|NCT03505021|567201567|FG000|Overall Study|Lost to Follow-up|5|||
156790707|NCT00159874|565985452|FG005|Overall Study|Other|1|||
156871903|NCT01413204|566289453|FG001|Overall Study|Clearly not eligible for the study|0|||
157123144|NCT03505021|567201568|FG001|Overall Study|Lost to Follow-up|3|||
157123145|NCT03505021|567201567|FG000|Overall Study|Adverse Event|26|||
157123146|NCT03505021|567201568|FG001|Overall Study|Adverse Event|9|||
157123147|NCT03505021|567201567|FG000|Overall Study|Disease progression|33|||
157123148|NCT03505021|567201568|FG001|Overall Study|Disease progression|17|||
157123149|NCT03505021|567201567|FG000|Overall Study|Other|11|||
157123150|NCT03505021|567201568|FG001|Overall Study|Other|5|||
156698912|NCT00123474|565645732|FG003|As Treated at Study Closure|not reported when site closed|0|||
156871904|NCT01413204|566289454|FG002|Overall Study|Clearly not eligible for the study|1|||
156698913|NCT00123474|565645729|FG000|As Treated at Study Closure|Adverse Event|10|||
156698914|NCT00123474|565645730|FG001|As Treated at Study Closure|Adverse Event|4|||
156871905|NCT01413204|566289452|FG000|Overall Study|Fasting plasma glucose level increased|1|||
156871906|NCT01413204|566289453|FG001|Overall Study|Fasting plasma glucose level increased|0|||
156871907|NCT01413204|566289454|FG002|Overall Study|Fasting plasma glucose level increased|10|||
156698915|NCT00123474|565645731|FG002|As Treated at Study Closure|Adverse Event|10|||
156698916|NCT00123474|565645732|FG003|As Treated at Study Closure|Adverse Event|8|||
156698917|NCT00123474|565645729|FG000|As Treated at Study Closure|Disease Progression|35|||
156698918|NCT00123474|565645730|FG001|As Treated at Study Closure|Disease Progression|42|||
156698919|NCT00123474|565645731|FG002|As Treated at Study Closure|Disease Progression|29|||
156698920|NCT00123474|565645732|FG003|As Treated at Study Closure|Disease Progression|27|||
156698921|NCT00123474|565645729|FG000|As Treated at Study Closure|Investigator Request|12|||
156698922|NCT00123474|565645730|FG001|As Treated at Study Closure|Investigator Request|6|||
156698923|NCT00123474|565645731|FG002|As Treated at Study Closure|Investigator Request|7|||
157014921|NCT04766034|566805144|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
157014922|NCT04766034|566805145|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
157014923|NCT04766034|566805146|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
157014924|NCT04766034|566805147|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
157014925|NCT04766034|566805148|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
157014926|NCT04766034|566805144|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
157014927|NCT04766034|566805145|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
157014928|NCT04766034|566805146|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
157014929|NCT04766034|566805147|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
157014930|NCT04766034|566805148|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
157014931|NCT04766034|566805144|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
157014932|NCT04766034|566805145|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
157014933|NCT04766034|566805146|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
157014934|NCT04766034|566805147|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
157014935|NCT04766034|566805148|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
157014936|NCT04766034|566805144|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
157014937|NCT04766034|566805145|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
157014938|NCT04766034|566805146|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
157014939|NCT04766034|566805147|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
157014940|NCT04766034|566805148|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
157014941|NCT01976312|566805149|FG000|Overall Study|Pregnancy|0|||
157014942|NCT01976312|566805150|FG001|Overall Study|Pregnancy|1|||
157014943|NCT01976312|566805149|FG000|Overall Study|Lost to Follow-up|2|||
157014944|NCT01976312|566805150|FG001|Overall Study|Lost to Follow-up|0|||
157014945|NCT01976312|566805149|FG000|Overall Study|Withdrawal by Subject|7|||
157123151|NCT03505021|567201567|FG000|Overall Study|Personal reason|21|||
157123152|NCT03505021|567201568|FG001|Overall Study|Personal reason|12|||
157123153|NCT01844986|567201569|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
157214865|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156871908|NCT00499616|566289455|FG000|Overall Study|Death|1|||
156871909|NCT00499616|566289456|FG001|Overall Study|Death|5|||
156698924|NCT00123474|565645732|FG003|As Treated at Study Closure|Investigator Request|5|||
156698925|NCT00123474|565645729|FG000|As Treated at Study Closure|non-specified|54|||
156698926|NCT00123474|565645730|FG001|As Treated at Study Closure|non-specified|47|||
156698927|NCT00123474|565645731|FG002|As Treated at Study Closure|non-specified|57|||
156871910|NCT00499616|566289457|FG002|Overall Study|Death|3|||
156871911|NCT00499616|566289458|FG003|Overall Study|Death|1|||
156698928|NCT00123474|565645732|FG003|As Treated at Study Closure|non-specified|60|||
156871912|NCT00499616|566289455|FG000|Overall Study|Lack of Efficacy|5|||
156871913|NCT00499616|566289456|FG001|Overall Study|Lack of Efficacy|0|||
156871914|NCT00499616|566289457|FG002|Overall Study|Lack of Efficacy|19|||
156698929|NCT00123474|565645729|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
156698930|NCT00123474|565645730|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
156698931|NCT00123474|565645731|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
156698932|NCT00123474|565645732|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
156698933|NCT00123474|565645729|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
156698934|NCT00123474|565645730|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
156698935|NCT00123474|565645731|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
156698936|NCT00123474|565645732|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
156698937|NCT00616629|565645733|FG000|Overall Study|Protocol Violation|1|||
156698938|NCT00616629|565645734|FG001|Overall Study|Protocol Violation|2|||
156698939|NCT00616629|565645735|FG002|Overall Study|Protocol Violation|1|||
156698940|NCT00616629|565645736|FG003|Overall Study|Protocol Violation|0|||
156698941|NCT00616629|565645737|FG004|Overall Study|Protocol Violation|0|||
156698942|NCT00616629|565645733|FG000|Overall Study|AV-block|1|||
156698943|NCT00616629|565645734|FG001|Overall Study|AV-block|0|||
156698944|NCT00616629|565645735|FG002|Overall Study|AV-block|0|||
156698945|NCT00616629|565645736|FG003|Overall Study|AV-block|0|||
156698946|NCT00616629|565645737|FG004|Overall Study|AV-block|0|||
156698947|NCT01059344|565645738|FG000|Overall Study|Adverse Event|12|||
156698948|NCT01059344|565645739|FG001|Overall Study|Adverse Event|30|||
156871915|NCT00499616|566289458|FG003|Overall Study|Lack of Efficacy|0|||
156871916|NCT00499616|566289455|FG000|Overall Study|Lost to Follow-up|0|||
156871917|NCT00499616|566289456|FG001|Overall Study|Lost to Follow-up|0|||
156871918|NCT00499616|566289457|FG002|Overall Study|Lost to Follow-up|1|||
156871919|NCT00499616|566289458|FG003|Overall Study|Lost to Follow-up|0|||
156871920|NCT00499616|566289455|FG000|Overall Study|Physician Decision|6|||
156871921|NCT00499616|566289456|FG001|Overall Study|Physician Decision|16|||
156871922|NCT00499616|566289457|FG002|Overall Study|Physician Decision|9|||
156871923|NCT00499616|566289458|FG003|Overall Study|Physician Decision|0|||
156871924|NCT00499616|566289455|FG000|Overall Study|Withdrawal by Subject|1|||
156871925|NCT00499616|566289456|FG001|Overall Study|Withdrawal by Subject|0|||
156871926|NCT00499616|566289457|FG002|Overall Study|Withdrawal by Subject|1|||
156871927|NCT00499616|566289458|FG003|Overall Study|Withdrawal by Subject|0|||
156871928|NCT00499616|566289455|FG000|Overall Study|Ineligible|1|||
156871929|NCT00499616|566289456|FG001|Overall Study|Ineligible|2|||
156871930|NCT00499616|566289457|FG002|Overall Study|Ineligible|0|||
156871931|NCT00499616|566289458|FG003|Overall Study|Ineligible|15|||
156871932|NCT00499616|566289455|FG000|Overall Study|Not evaluable|0|||
156871933|NCT00499616|566289456|FG001|Overall Study|Not evaluable|0|||
156871934|NCT00499616|566289457|FG002|Overall Study|Not evaluable|0|||
156871935|NCT00499616|566289458|FG003|Overall Study|Not evaluable|41|||
156871936|NCT00499616|566289455|FG000|Overall Study|Patient/Parent Refusal|1|||
156871937|NCT00499616|566289456|FG001|Overall Study|Patient/Parent Refusal|5|||
156698949|NCT01059344|565645738|FG000|Overall Study|Withdrawal by Subject|6|||
156698950|NCT01059344|565645739|FG001|Overall Study|Withdrawal by Subject|9|||
156698951|NCT01059344|565645738|FG000|Overall Study|Lost to Follow-up|1|||
156698952|NCT01059344|565645739|FG001|Overall Study|Lost to Follow-up|1|||
156698953|NCT01059344|565645738|FG000|Overall Study|Other|3|||
156698954|NCT01059344|565645739|FG001|Overall Study|Other|6|||
156698955|NCT01739348|565645740|FG000|Part I (Base Study)|Adverse Event|41|||
156698956|NCT01739348|565645741|FG001|Part I (Base Study)|Adverse Event|52|||
156698957|NCT01739348|565645742|FG002|Part I (Base Study)|Adverse Event|8|||
156698958|NCT01739348|565645743|FG003|Part I (Base Study)|Adverse Event|33|||
156698959|NCT01739348|565645740|FG000|Part I (Base Study)|Death|10|||
156698960|NCT01739348|565645741|FG001|Part I (Base Study)|Death|7|||
156698961|NCT01739348|565645742|FG002|Part I (Base Study)|Death|2|||
156698962|NCT01739348|565645743|FG003|Part I (Base Study)|Death|8|||
156698963|NCT01739348|565645740|FG000|Part I (Base Study)|Lack of Efficacy|3|||
156698964|NCT01739348|565645741|FG001|Part I (Base Study)|Lack of Efficacy|8|||
156698965|NCT01739348|565645742|FG002|Part I (Base Study)|Lack of Efficacy|0|||
156698966|NCT01739348|565645743|FG003|Part I (Base Study)|Lack of Efficacy|7|||
156698967|NCT01739348|565645740|FG000|Part I (Base Study)|Lost to Follow-up|4|||
156698968|NCT01739348|565645741|FG001|Part I (Base Study)|Lost to Follow-up|2|||
156698969|NCT01739348|565645742|FG002|Part I (Base Study)|Lost to Follow-up|4|||
156871938|NCT00499616|566289457|FG002|Overall Study|Patient/Parent Refusal|3|||
156871939|NCT00499616|566289458|FG003|Overall Study|Patient/Parent Refusal|0|||
156871940|NCT04816669|566289459|FG000|Part 1|Adverse Event|1|||
156871941|NCT04816669|566289460|FG001|Part 1|Adverse Event|1|||
156871942|NCT04816669|566289461|FG002|Part 1|Adverse Event|0|||
156871943|NCT04816669|566289462|FG003|Part 1|Adverse Event|0|||
156871944|NCT04816669|566289459|FG000|Part 1|Lost to Follow-up|2|||
156698970|NCT01739348|565645743|FG003|Part I (Base Study)|Lost to Follow-up|4|||
156698971|NCT01739348|565645740|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
156698972|NCT01739348|565645741|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
156698973|NCT01739348|565645742|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
156698974|NCT01739348|565645743|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
156698975|NCT01739348|565645740|FG000|Part I (Base Study)|Physician Decision|10|||
156698976|NCT01739348|565645741|FG001|Part I (Base Study)|Physician Decision|7|||
156871945|NCT04816669|566289460|FG001|Part 1|Lost to Follow-up|2|||
156698977|NCT01739348|565645742|FG002|Part I (Base Study)|Physician Decision|1|||
156698978|NCT01739348|565645743|FG003|Part I (Base Study)|Physician Decision|4|||
156698979|NCT01739348|565645740|FG000|Part I (Base Study)|Protocol Violation|2|||
156698980|NCT01739348|565645741|FG001|Part I (Base Study)|Protocol Violation|0|||
156698981|NCT01739348|565645742|FG002|Part I (Base Study)|Protocol Violation|1|||
156698982|NCT01739348|565645743|FG003|Part I (Base Study)|Protocol Violation|2|||
156698983|NCT01739348|565645740|FG000|Part I (Base Study)|Screen Failure|2|||
156698984|NCT01739348|565645741|FG001|Part I (Base Study)|Screen Failure|0|||
156698985|NCT01739348|565645742|FG002|Part I (Base Study)|Screen Failure|0|||
156698986|NCT01739348|565645743|FG003|Part I (Base Study)|Screen Failure|0|||
156698987|NCT01739348|565645740|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
156698988|NCT01739348|565645741|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
156698989|NCT01739348|565645742|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
156698990|NCT01739348|565645743|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
156698991|NCT01739348|565645740|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
156698992|NCT01739348|565645741|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
156698993|NCT01739348|565645742|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
156698994|NCT01739348|565645743|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
156698995|NCT01739348|565645740|FG000|Part I (Base Study)|Participant Moved|4|||
156698996|NCT01739348|565645741|FG001|Part I (Base Study)|Participant Moved|3|||
156698997|NCT01739348|565645742|FG002|Part I (Base Study)|Participant Moved|1|||
156698998|NCT01739348|565645743|FG003|Part I (Base Study)|Participant Moved|7|||
156698999|NCT01739348|565645740|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
156699000|NCT01739348|565645741|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
156699001|NCT01739348|565645742|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
156699002|NCT01739348|565645743|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
156699003|NCT01739348|565645740|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
156699004|NCT01739348|565645741|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
156699005|NCT01739348|565645742|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
156699006|NCT01739348|565645743|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
156699007|NCT01739348|565645740|FG000|Part II (Extension Study)|Adverse Event|10|||
156699008|NCT01739348|565645741|FG001|Part II (Extension Study)|Adverse Event|11|||
156699009|NCT01739348|565645742|FG002|Part II (Extension Study)|Adverse Event|7|||
156699010|NCT01739348|565645743|FG003|Part II (Extension Study)|Adverse Event|26|||
156699011|NCT01739348|565645740|FG000|Part II (Extension Study)|Death|3|||
156699012|NCT01739348|565645741|FG001|Part II (Extension Study)|Death|3|||
156699013|NCT01739348|565645742|FG002|Part II (Extension Study)|Death|2|||
156699014|NCT01739348|565645743|FG003|Part II (Extension Study)|Death|6|||
156699015|NCT01739348|565645740|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
156699016|NCT01739348|565645741|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
156699017|NCT01739348|565645742|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
156699018|NCT01739348|565645743|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
156699019|NCT01739348|565645740|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
156699020|NCT01739348|565645741|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
156699021|NCT01739348|565645742|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
156699022|NCT01739348|565645743|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
156699023|NCT01739348|565645740|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699024|NCT01739348|565645741|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699025|NCT01739348|565645742|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
156699026|NCT01739348|565645743|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
156699027|NCT01739348|565645740|FG000|Part II (Extension Study)|Physician Decision|7|||
156699028|NCT01739348|565645741|FG001|Part II (Extension Study)|Physician Decision|11|||
156699029|NCT01739348|565645742|FG002|Part II (Extension Study)|Physician Decision|6|||
156699030|NCT01739348|565645743|FG003|Part II (Extension Study)|Physician Decision|12|||
156699031|NCT01739348|565645740|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
156699032|NCT01739348|565645741|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
156699033|NCT01739348|565645742|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
156699034|NCT01739348|565645743|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
156699035|NCT01739348|565645740|FG000|Part II (Extension Study)|Participant Moved|3|||
156699036|NCT01739348|565645741|FG001|Part II (Extension Study)|Participant Moved|3|||
156699037|NCT01739348|565645742|FG002|Part II (Extension Study)|Participant Moved|0|||
156699038|NCT01739348|565645743|FG003|Part II (Extension Study)|Participant Moved|3|||
156699039|NCT01739348|565645740|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
156699040|NCT01739348|565645741|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
156699041|NCT01739348|565645742|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
156699042|NCT01739348|565645743|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
156699043|NCT01739348|565645740|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
156790708|NCT00159874|565985453|FG006|Overall Study|Other|3|||
156699044|NCT01739348|565645741|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
156699045|NCT01739348|565645742|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
156699046|NCT01739348|565645743|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
156699047|NCT02695537|565645744|FG000|Overall Study|Adverse Event|3|||
156699048|NCT02695537|565645744|FG000|Overall Study|Lack of Efficacy|28|||
156699049|NCT02695537|565645744|FG000|Overall Study|Withdrawal by Subject|4|||
156699050|NCT02695537|565645744|FG000|Overall Study|Protocol Violation|3|||
156699051|NCT02792699|565645745|FG000|Overall Study|Adverse Event|1|||
156699052|NCT02792699|565645746|FG001|Overall Study|Adverse Event|2|||
156699053|NCT02792699|565645747|FG002|Overall Study|Adverse Event|4|||
156699054|NCT02792699|565645745|FG000|Overall Study|Withdrawal by Subject|4|||
156699055|NCT02792699|565645746|FG001|Overall Study|Withdrawal by Subject|4|||
156699056|NCT02792699|565645747|FG002|Overall Study|Withdrawal by Subject|3|||
156699057|NCT02792699|565645745|FG000|Overall Study|Lost to Follow-up|0|||
156699058|NCT02792699|565645746|FG001|Overall Study|Lost to Follow-up|1|||
156699059|NCT02792699|565645747|FG002|Overall Study|Lost to Follow-up|2|||
156699060|NCT02792699|565645745|FG000|Overall Study|Physician Decision|2|||
156699061|NCT02792699|565645746|FG001|Overall Study|Physician Decision|0|||
156699062|NCT02792699|565645747|FG002|Overall Study|Physician Decision|0|||
156699063|NCT02792699|565645745|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
156699064|NCT02792699|565645746|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
156699065|NCT02792699|565645747|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
156699066|NCT02792699|565645745|FG000|Overall Study|Other|1|||
156699067|NCT02792699|565645746|FG001|Overall Study|Other|0|||
156699068|NCT02792699|565645747|FG002|Overall Study|Other|0|||
156699069|NCT05084963|565645750|FG000|Overall Study|Withdrawal by Subject|0|||
156699070|NCT05084963|565645751|FG001|Overall Study|Withdrawal by Subject|0|||
156699071|NCT05084963|565645752|FG002|Overall Study|Withdrawal by Subject|1|||
156699072|NCT03569228|565645753|FG000|Overall Study|Withdrawal by PI|0|||
156699073|NCT03569228|565645754|FG001|Overall Study|Withdrawal by PI|0|||
156699074|NCT03569228|565645755|FG002|Overall Study|Withdrawal by PI|2|||
156699075|NCT03569228|565645756|FG003|Overall Study|Withdrawal by PI|2|||
156699076|NCT03569228|565645757|FG004|Overall Study|Withdrawal by PI|1|||
156699077|NCT03569228|565645758|FG005|Overall Study|Withdrawal by PI|0|||
156699078|NCT03569228|565645759|FG006|Overall Study|Withdrawal by PI|0|||
156699079|NCT03569228|565645760|FG007|Overall Study|Withdrawal by PI|0|||
156699080|NCT03569228|565645761|FG008|Overall Study|Withdrawal by PI|0|||
156699081|NCT03569228|565645753|FG000|Overall Study|Lost to Follow-up|0|||
156699082|NCT03569228|565645754|FG001|Overall Study|Lost to Follow-up|0|||
156699083|NCT03569228|565645755|FG002|Overall Study|Lost to Follow-up|0|||
156699084|NCT03569228|565645756|FG003|Overall Study|Lost to Follow-up|0|||
156699085|NCT03569228|565645757|FG004|Overall Study|Lost to Follow-up|0|||
156699086|NCT03569228|565645758|FG005|Overall Study|Lost to Follow-up|0|||
156699087|NCT03569228|565645759|FG006|Overall Study|Lost to Follow-up|0|||
156699088|NCT03569228|565645760|FG007|Overall Study|Lost to Follow-up|0|||
156699089|NCT03569228|565645761|FG008|Overall Study|Lost to Follow-up|1|||
156699090|NCT03569228|565645753|FG000|Overall Study|Screen Fail|2|||
156699091|NCT03569228|565645754|FG001|Overall Study|Screen Fail|2|||
156699092|NCT03569228|565645755|FG002|Overall Study|Screen Fail|1|||
156699093|NCT03569228|565645756|FG003|Overall Study|Screen Fail|1|||
156699094|NCT03569228|565645757|FG004|Overall Study|Screen Fail|1|||
156699095|NCT03569228|565645758|FG005|Overall Study|Screen Fail|3|||
156699096|NCT03569228|565645759|FG006|Overall Study|Screen Fail|1|||
156699097|NCT03569228|565645760|FG007|Overall Study|Screen Fail|5|||
156699098|NCT03569228|565645761|FG008|Overall Study|Screen Fail|2|||
156699099|NCT03819049|565645762|FG000|Overall Study|Lost to Follow-up|1|||
156790709|NCT00159874|565985447|FG000|Overall Study|Protocol Violation|0|||
156790710|NCT00159874|565985448|FG001|Overall Study|Protocol Violation|5|||
156790711|NCT00159874|565985449|FG002|Overall Study|Protocol Violation|2|||
156790712|NCT00159874|565985450|FG003|Overall Study|Protocol Violation|0|||
156790713|NCT00159874|565985451|FG004|Overall Study|Protocol Violation|0|||
156790714|NCT00159874|565985452|FG005|Overall Study|Protocol Violation|0|||
156790715|NCT00159874|565985453|FG006|Overall Study|Protocol Violation|0|||
156790716|NCT00159874|565985447|FG000|Overall Study|Death|3|||
156790717|NCT00159874|565985448|FG001|Overall Study|Death|8|||
156790718|NCT00159874|565985449|FG002|Overall Study|Death|15|||
156790719|NCT00159874|565985450|FG003|Overall Study|Death|0|||
156790720|NCT00159874|565985451|FG004|Overall Study|Death|1|||
156790721|NCT00159874|565985452|FG005|Overall Study|Death|2|||
156790722|NCT00159874|565985453|FG006|Overall Study|Death|0|||
156790723|NCT00159874|565985447|FG000|Overall Study|Withdrawal by Subject|2|||
156790724|NCT00159874|565985448|FG001|Overall Study|Withdrawal by Subject|6|||
156790725|NCT00159874|565985449|FG002|Overall Study|Withdrawal by Subject|8|||
156790726|NCT00159874|565985450|FG003|Overall Study|Withdrawal by Subject|4|||
156790727|NCT00159874|565985451|FG004|Overall Study|Withdrawal by Subject|3|||
156699100|NCT03819049|565645763|FG001|Overall Study|Lost to Follow-up|2|||
156699101|NCT03819049|565645764|FG002|Overall Study|Lost to Follow-up|9|||
156699102|NCT03819049|565645765|FG003|Overall Study|Lost to Follow-up|0|||
156699103|NCT03819049|565645766|FG004|Overall Study|Lost to Follow-up|3|||
156699104|NCT03819049|565645767|FG005|Overall Study|Lost to Follow-up|1|||
156699105|NCT03819049|565645768|FG006|Overall Study|Lost to Follow-up|0|||
156699106|NCT03819049|565645762|FG000|Overall Study|Withdrawal by Subject|0|||
156699107|NCT03819049|565645763|FG001|Overall Study|Withdrawal by Subject|0|||
156699108|NCT03819049|565645764|FG002|Overall Study|Withdrawal by Subject|18|||
156699109|NCT03819049|565645765|FG003|Overall Study|Withdrawal by Subject|0|||
157123154|NCT01844986|567201570|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
157123155|NCT01844986|567201569|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
157123156|NCT01844986|567201570|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
157123157|NCT01844986|567201569|FG000|Overall Study (Global Cohort)|Death|55|||
157123158|NCT01844986|567201570|FG001|Overall Study (Global Cohort)|Death|26|||
156699110|NCT03819049|565645766|FG004|Overall Study|Withdrawal by Subject|10|||
156699111|NCT03819049|565645767|FG005|Overall Study|Withdrawal by Subject|9|||
156699112|NCT03819049|565645768|FG006|Overall Study|Withdrawal by Subject|1|||
156699113|NCT03819049|565645762|FG000|Overall Study|Ongoing|0|||
156699114|NCT03819049|565645763|FG001|Overall Study|Ongoing|0|||
156699115|NCT03819049|565645764|FG002|Overall Study|Ongoing|75|||
156699116|NCT03819049|565645765|FG003|Overall Study|Ongoing|0|||
156699117|NCT03819049|565645766|FG004|Overall Study|Ongoing|41|||
156699118|NCT03819049|565645767|FG005|Overall Study|Ongoing|0|||
156699119|NCT03819049|565645768|FG006|Overall Study|Ongoing|0|||
156699120|NCT03819049|565645762|FG000|Overall Study|Other|0|||
156699121|NCT03819049|565645763|FG001|Overall Study|Other|0|||
156699122|NCT03819049|565645764|FG002|Overall Study|Other|2|||
156699123|NCT03819049|565645765|FG003|Overall Study|Other|0|||
156699124|NCT03819049|565645766|FG004|Overall Study|Other|0|||
156699125|NCT03819049|565645767|FG005|Overall Study|Other|0|||
156699126|NCT03819049|565645768|FG006|Overall Study|Other|0|||
156699127|NCT03819049|565645762|FG000|Overall Study|Randomized but not vaccinated|0|||
156699128|NCT03819049|565645763|FG001|Overall Study|Randomized but not vaccinated|0|||
156699129|NCT03819049|565645764|FG002|Overall Study|Randomized but not vaccinated|0|||
156699130|NCT03819049|565645765|FG003|Overall Study|Randomized but not vaccinated|1|||
156699131|NCT03819049|565645766|FG004|Overall Study|Randomized but not vaccinated|0|||
156699132|NCT03819049|565645767|FG005|Overall Study|Randomized but not vaccinated|2|||
156699133|NCT03819049|565645768|FG006|Overall Study|Randomized but not vaccinated|1|||
156699134|NCT03819049|565645762|FG000|Overall Study|Physician Decision|0|||
156699135|NCT03819049|565645763|FG001|Overall Study|Physician Decision|0|||
156699136|NCT03819049|565645764|FG002|Overall Study|Physician Decision|0|||
156699137|NCT03819049|565645765|FG003|Overall Study|Physician Decision|0|||
156699138|NCT03819049|565645766|FG004|Overall Study|Physician Decision|0|||
156699139|NCT03819049|565645767|FG005|Overall Study|Physician Decision|0|||
156699140|NCT03819049|565645768|FG006|Overall Study|Physician Decision|1|||
156699141|NCT01986010|565645769|FG000|Overall Study|Adverse Event|0|||
156699142|NCT01986010|565645770|FG001|Overall Study|Adverse Event|1|||
156699143|NCT01986010|565645771|FG002|Overall Study|Adverse Event|0|||
156699144|NCT01986010|565645772|FG003|Overall Study|Adverse Event|0|||
156699145|NCT01986010|565645773|FG004|Overall Study|Adverse Event|0|||
156699146|NCT01986010|565645774|FG005|Overall Study|Adverse Event|0|||
156699147|NCT01986010|565645775|FG006|Overall Study|Adverse Event|0|||
156699148|NCT01986010|565645776|FG007|Overall Study|Adverse Event|0|||
156699149|NCT01986010|565645777|FG008|Overall Study|Adverse Event|0|||
156699150|NCT01986010|565645778|FG009|Overall Study|Adverse Event|0|||
156699151|NCT01986010|565645779|FG010|Overall Study|Adverse Event|0|||
156699152|NCT01986010|565645780|FG011|Overall Study|Adverse Event|0|||
156699153|NCT01986010|565645781|FG012|Overall Study|Adverse Event|0|||
156699154|NCT01986010|565645782|FG013|Overall Study|Adverse Event|0|||
156699155|NCT01986010|565645783|FG014|Overall Study|Adverse Event|0|||
156699156|NCT01986010|565645784|FG015|Overall Study|Adverse Event|1|||
156699157|NCT01986010|565645785|FG016|Overall Study|Adverse Event|0|||
156699158|NCT01986010|565645769|FG000|Overall Study|Lost to Follow-up|2|||
156699159|NCT01986010|565645770|FG001|Overall Study|Lost to Follow-up|1|||
156699160|NCT01986010|565645771|FG002|Overall Study|Lost to Follow-up|2|||
156790728|NCT00159874|565985452|FG005|Overall Study|Withdrawal by Subject|2|||
156790729|NCT00159874|565985453|FG006|Overall Study|Withdrawal by Subject|1|||
156790730|NCT00159874|565985447|FG000|Overall Study|Pregnancy|1|||
156790731|NCT00159874|565985448|FG001|Overall Study|Pregnancy|1|||
156790732|NCT00159874|565985449|FG002|Overall Study|Pregnancy|0|||
156790733|NCT00159874|565985450|FG003|Overall Study|Pregnancy|0|||
156790734|NCT00159874|565985451|FG004|Overall Study|Pregnancy|0|||
156790735|NCT00159874|565985452|FG005|Overall Study|Pregnancy|0|||
156790736|NCT00159874|565985453|FG006|Overall Study|Pregnancy|0|||
157123159|NCT01844986|567201569|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
156699161|NCT01986010|565645772|FG003|Overall Study|Lost to Follow-up|2|||
156699162|NCT01986010|565645773|FG004|Overall Study|Lost to Follow-up|2|||
156699163|NCT01986010|565645774|FG005|Overall Study|Lost to Follow-up|2|||
156790737|NCT02771145|565985456|FG000|Overall Study|Adverse Event|3|||
157123160|NCT01844986|567201570|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
156699164|NCT01986010|565645775|FG006|Overall Study|Lost to Follow-up|0|||
156699165|NCT01986010|565645776|FG007|Overall Study|Lost to Follow-up|0|||
156699166|NCT01986010|565645777|FG008|Overall Study|Lost to Follow-up|4|||
156790738|NCT02771145|565985456|FG000|Overall Study|Lost to Follow-up|1|||
156699167|NCT01986010|565645778|FG009|Overall Study|Lost to Follow-up|2|||
156699168|NCT01986010|565645779|FG010|Overall Study|Lost to Follow-up|0|||
156699169|NCT01986010|565645780|FG011|Overall Study|Lost to Follow-up|1|||
156699170|NCT01986010|565645781|FG012|Overall Study|Lost to Follow-up|1|||
156699171|NCT01986010|565645782|FG013|Overall Study|Lost to Follow-up|1|||
156699172|NCT01986010|565645783|FG014|Overall Study|Lost to Follow-up|2|||
156699173|NCT01986010|565645784|FG015|Overall Study|Lost to Follow-up|0|||
156699174|NCT01986010|565645785|FG016|Overall Study|Lost to Follow-up|0|||
156699175|NCT01986010|565645769|FG000|Overall Study|Physician Decision|0|||
156699176|NCT01986010|565645770|FG001|Overall Study|Physician Decision|0|||
156871946|NCT04816669|566289461|FG002|Part 1|Lost to Follow-up|0|||
157123161|NCT01844986|567201569|FG000|Overall Study (China Cohort)|Death|10|||
157123162|NCT01844986|567201570|FG001|Overall Study (China Cohort)|Death|6|||
157123163|NCT02392429|567203665|FG000|Screening|Screen failure|15|||
157123164|NCT02392429|567203665|FG000|Enrolled Participants|Ineligible due to disease|3|||
157123165|NCT02392429|567203665|FG000|Enrolled Participants|Withdrawal by Subject|4|||
157123166|NCT02392429|567203665|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
157123167|NCT02392429|567203665|FG000|Evaluable|Death|5|||
157123168|NCT02392429|567203665|FG000|Evaluable|Withdrawal by Subject|1|||
157123169|NCT02392429|567203665|FG000|Evaluable|Adverse Event|1|||
157123170|NCT02392429|567203665|FG000|Evaluable|remission bone marrow biopsy|3|||
156871947|NCT04816669|566289462|FG003|Part 1|Lost to Follow-up|0|||
156871948|NCT04816669|566289459|FG000|Part 1|Protocol Violation|0|||
156871949|NCT04816669|566289460|FG001|Part 1|Protocol Violation|1|||
156871950|NCT04816669|566289461|FG002|Part 1|Protocol Violation|0|||
156871951|NCT04816669|566289462|FG003|Part 1|Protocol Violation|0|||
156871952|NCT04816669|566289459|FG000|Part 1|Withdrawal by Subject|1|||
156871953|NCT04816669|566289460|FG001|Part 1|Withdrawal by Subject|2|||
156871954|NCT04816669|566289461|FG002|Part 1|Withdrawal by Subject|0|||
156871955|NCT04816669|566289462|FG003|Part 1|Withdrawal by Subject|0|||
156871956|NCT04816669|566289459|FG000|Part 2|Other|0|||
156871957|NCT04816669|566289460|FG001|Part 2|Other|0|||
156871958|NCT04816669|566289461|FG002|Part 2|Other|1|||
156871959|NCT04816669|566289462|FG003|Part 2|Other|0|||
156871960|NCT04816669|566289459|FG000|Part 2|Withdrawal by Subject|0|||
156871961|NCT04816669|566289460|FG001|Part 2|Withdrawal by Subject|0|||
156699177|NCT01986010|565645771|FG002|Overall Study|Physician Decision|0|||
156699178|NCT01986010|565645772|FG003|Overall Study|Physician Decision|0|||
156699179|NCT01986010|565645773|FG004|Overall Study|Physician Decision|0|||
156699180|NCT01986010|565645774|FG005|Overall Study|Physician Decision|0|||
156699181|NCT01986010|565645775|FG006|Overall Study|Physician Decision|0|||
156699182|NCT01986010|565645776|FG007|Overall Study|Physician Decision|0|||
156699183|NCT01986010|565645777|FG008|Overall Study|Physician Decision|0|||
156699184|NCT01986010|565645778|FG009|Overall Study|Physician Decision|0|||
156699185|NCT01986010|565645779|FG010|Overall Study|Physician Decision|0|||
156699186|NCT01986010|565645780|FG011|Overall Study|Physician Decision|0|||
156699187|NCT01986010|565645781|FG012|Overall Study|Physician Decision|0|||
156699188|NCT01986010|565645782|FG013|Overall Study|Physician Decision|0|||
156699189|NCT01986010|565645783|FG014|Overall Study|Physician Decision|1|||
156699190|NCT01986010|565645784|FG015|Overall Study|Physician Decision|0|||
156699191|NCT01986010|565645785|FG016|Overall Study|Physician Decision|0|||
156699192|NCT01986010|565645769|FG000|Overall Study|Withdrawal by Subject|2|||
156699193|NCT01986010|565645770|FG001|Overall Study|Withdrawal by Subject|2|||
156699194|NCT01986010|565645771|FG002|Overall Study|Withdrawal by Subject|3|||
156699195|NCT01986010|565645772|FG003|Overall Study|Withdrawal by Subject|0|||
156699196|NCT01986010|565645773|FG004|Overall Study|Withdrawal by Subject|2|||
156699197|NCT01986010|565645774|FG005|Overall Study|Withdrawal by Subject|4|||
156699198|NCT01986010|565645775|FG006|Overall Study|Withdrawal by Subject|0|||
156871962|NCT04816669|566289461|FG002|Part 2|Withdrawal by Subject|0|||
156871963|NCT04816669|566289462|FG003|Part 2|Withdrawal by Subject|1|||
156871964|NCT04816669|566289459|FG000|Part 2|Lost to Follow-up|0|||
157123171|NCT01178138|567203666|FG000|Overall Study|Lost to Follow-up|8|||
157123172|NCT01178138|567203666|FG000|Overall Study|Withdrawal by Subject|7|||
156699199|NCT01986010|565645776|FG007|Overall Study|Withdrawal by Subject|0|||
156699200|NCT01986010|565645777|FG008|Overall Study|Withdrawal by Subject|0|||
156699201|NCT01986010|565645778|FG009|Overall Study|Withdrawal by Subject|0|||
156699202|NCT01986010|565645779|FG010|Overall Study|Withdrawal by Subject|0|||
156871965|NCT04816669|566289460|FG001|Part 2|Lost to Follow-up|0|||
157123173|NCT01178138|567203666|FG000|Overall Study|Physician Decision|8|||
157123174|NCT00403260|567203667|FG000|Overall Study|Adverse Event|5|||
156699203|NCT01986010|565645780|FG011|Overall Study|Withdrawal by Subject|2|||
156699204|NCT01986010|565645781|FG012|Overall Study|Withdrawal by Subject|0|||
156871966|NCT04816669|566289461|FG002|Part 2|Lost to Follow-up|1|||
156871967|NCT04816669|566289462|FG003|Part 2|Lost to Follow-up|0|||
156699205|NCT01986010|565645782|FG013|Overall Study|Withdrawal by Subject|1|||
156699206|NCT01986010|565645783|FG014|Overall Study|Withdrawal by Subject|2|||
156871968|NCT00867815|566289468|FG000|Overall Study|Lost to Follow-up|1|||
156871969|NCT02015637|566289469|FG000|Overall Study|Lost to Follow-up|3|||
156871970|NCT02015637|566289470|FG001|Overall Study|Lost to Follow-up|5|||
156871971|NCT02015637|566289469|FG000|Overall Study|Adverse Event|3|||
156871972|NCT02015637|566289470|FG001|Overall Study|Adverse Event|0|||
156871973|NCT02015637|566289469|FG000|Overall Study|Did not take study drug|2|||
157123175|NCT00403260|567203668|FG001|Overall Study|Adverse Event|4|||
157123176|NCT00403260|567203667|FG000|Overall Study|Withdrawal by Subject|5|||
156699207|NCT01986010|565645784|FG015|Overall Study|Withdrawal by Subject|0|||
156699208|NCT01986010|565645785|FG016|Overall Study|Withdrawal by Subject|0|||
157014946|NCT01976312|566805150|FG001|Overall Study|Withdrawal by Subject|2|||
157014947|NCT01976312|566805149|FG000|Overall Study|Adverse Event|6|||
157014948|NCT01976312|566805150|FG001|Overall Study|Adverse Event|6|||
156699209|NCT01986010|565645769|FG000|Overall Study|Status Not Recorded|2|||
156699210|NCT01986010|565645770|FG001|Overall Study|Status Not Recorded|4|||
156699211|NCT01986010|565645771|FG002|Overall Study|Status Not Recorded|2|||
156699212|NCT01986010|565645772|FG003|Overall Study|Status Not Recorded|0|||
156699213|NCT01986010|565645773|FG004|Overall Study|Status Not Recorded|1|||
156699214|NCT01986010|565645774|FG005|Overall Study|Status Not Recorded|2|||
156699215|NCT01986010|565645775|FG006|Overall Study|Status Not Recorded|0|||
156699216|NCT01986010|565645776|FG007|Overall Study|Status Not Recorded|0|||
156699217|NCT01986010|565645777|FG008|Overall Study|Status Not Recorded|2|||
156699218|NCT01986010|565645778|FG009|Overall Study|Status Not Recorded|1|||
156699219|NCT01986010|565645779|FG010|Overall Study|Status Not Recorded|7|||
156699220|NCT01986010|565645780|FG011|Overall Study|Status Not Recorded|7|||
156699221|NCT01986010|565645781|FG012|Overall Study|Status Not Recorded|9|||
156699222|NCT01986010|565645782|FG013|Overall Study|Status Not Recorded|9|||
156699223|NCT01986010|565645783|FG014|Overall Study|Status Not Recorded|5|||
156699224|NCT01986010|565645784|FG015|Overall Study|Status Not Recorded|10|||
156699225|NCT01986010|565645785|FG016|Overall Study|Status Not Recorded|4|||
157014949|NCT01976312|566805149|FG000|Overall Study|Protocol Violation|2|||
157014950|NCT01976312|566805150|FG001|Overall Study|Protocol Violation|0|||
157014951|NCT01538719|566805155|FG000|Overall Study|Lost to Follow-up|2|||
156699226|NCT01335997|565645788|FG000|Period I and II|Adverse Event|63|||
156699227|NCT01335997|565645789|FG001|Period I and II|Adverse Event|43|||
156699228|NCT01335997|565645788|FG000|Period I and II|Noncompliance with Study Drug|1|||
156699229|NCT01335997|565645789|FG001|Period I and II|Noncompliance with Study Drug|1|||
156699230|NCT01335997|565645788|FG000|Period I and II|Lost to Follow-up|3|||
156699231|NCT01335997|565645789|FG001|Period I and II|Lost to Follow-up|5|||
156699232|NCT01335997|565645788|FG000|Period I and II|Withdrawal by Subject|9|||
156699233|NCT01335997|565645789|FG001|Period I and II|Withdrawal by Subject|4|||
156699234|NCT01335997|565645788|FG000|Period I and II|Study Terminated by Sponsor|406|||
156699235|NCT01335997|565645789|FG001|Period I and II|Study Terminated by Sponsor|415|||
156699236|NCT01335997|565645788|FG000|Period I and II|Protocol Violation|9|||
156699237|NCT01335997|565645789|FG001|Period I and II|Protocol Violation|10|||
156699238|NCT01335997|565645788|FG000|Period I and II|Physician Decision|2|||
156699239|NCT01335997|565645789|FG001|Period I and II|Physician Decision|1|||
156699240|NCT01335997|565645788|FG000|Period III|Adverse Event|0|||
156699241|NCT01335997|565645789|FG001|Period III|Adverse Event|2|||
156699242|NCT01335997|565645788|FG000|Period III|Study Terminated by Sponsor|77|||
156699243|NCT01335997|565645789|FG001|Period III|Study Terminated by Sponsor|76|||
156699244|NCT01335997|565645788|FG000|Period III|Protocol Violation|0|||
156699245|NCT01335997|565645789|FG001|Period III|Protocol Violation|1|||
156699246|NCT01335997|565645788|FG000|Period III|Lost to Follow-up|1|||
156699247|NCT01335997|565645789|FG001|Period III|Lost to Follow-up|0|||
156699248|NCT02440568|565645790|FG000|Overall Study|Death|1|||
156699249|NCT02440568|565645791|FG001|Overall Study|Death|3|||
156699250|NCT02440568|565645792|FG002|Overall Study|Death|4|||
156699251|NCT02440568|565645793|FG003|Overall Study|Death|2|||
156699252|NCT02440568|565645790|FG000|Overall Study|Lack of Efficacy|2|||
156699253|NCT02440568|565645791|FG001|Overall Study|Lack of Efficacy|0|||
156699254|NCT02440568|565645792|FG002|Overall Study|Lack of Efficacy|1|||
156699255|NCT02440568|565645793|FG003|Overall Study|Lack of Efficacy|0|||
156699256|NCT02440568|565645790|FG000|Overall Study|Lost to Follow-up|1|||
156699257|NCT02440568|565645791|FG001|Overall Study|Lost to Follow-up|0|||
156699258|NCT02440568|565645792|FG002|Overall Study|Lost to Follow-up|0|||
156699259|NCT02440568|565645793|FG003|Overall Study|Lost to Follow-up|0|||
156790739|NCT02150863|565985457|FG000|Overall Study|Lost to Follow-up|0|||
156790740|NCT02150863|565985458|FG001|Overall Study|Lost to Follow-up|1|||
157014952|NCT01538719|566805156|FG001|Overall Study|Lost to Follow-up|0|||
156699260|NCT03285308|565645795|FG000|Overall Study|Adverse Event|3|||
156699261|NCT03285308|565645796|FG001|Overall Study|Adverse Event|7|||
156790741|NCT02150863|565985459|FG002|Overall Study|Lost to Follow-up|0|||
156790742|NCT01853280|565985463|FG000|Overall Study|Lack of Efficacy|2|||
156790743|NCT01853280|565985464|FG001|Overall Study|Lack of Efficacy|2|||
156790744|NCT01853280|565985463|FG000|Overall Study|Lost to Follow-up|0|||
156790745|NCT01853280|565985464|FG001|Overall Study|Lost to Follow-up|1|||
156790746|NCT01853280|565985463|FG000|Overall Study|Physician Decision|0|||
156699262|NCT03285308|565645795|FG000|Overall Study|Withdrawal by Subject|8|||
156699263|NCT03285308|565645796|FG001|Overall Study|Withdrawal by Subject|9|||
156699264|NCT03285308|565645795|FG000|Overall Study|Lost to Follow-up|3|||
156699265|NCT03285308|565645796|FG001|Overall Study|Lost to Follow-up|1|||
156699266|NCT03285308|565645795|FG000|Overall Study|Protocol Deviation|6|||
156699267|NCT03285308|565645796|FG001|Overall Study|Protocol Deviation|5|||
156790747|NCT01853280|565985464|FG001|Overall Study|Physician Decision|1|||
157014953|NCT02556138|566805157|FG000|Overall Study|Withdrawal by Subject|1|||
157014954|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
157021744|NCT03673111|566832949|FG004|Overall Study|Adverse Event|0|||
157014955|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
156699268|NCT03285308|565645795|FG000|Overall Study|Reason not Specified|0|||
156699269|NCT03285308|565645796|FG001|Overall Study|Reason not Specified|1|||
156699270|NCT00681590|565645799|FG000|Overall Study|Withdrawal by Subject|2|||
156699271|NCT00681590|565645800|FG001|Overall Study|Withdrawal by Subject|12|||
156699272|NCT02912650|565645801|FG000|Overall Study|Withdrawal by Subject|1|||
156699273|NCT02912650|565645802|FG001|Overall Study|Withdrawal by Subject|0|||
156699274|NCT02912650|565645803|FG002|Overall Study|Withdrawal by Subject|1|||
156699275|NCT02912650|565645804|FG003|Overall Study|Withdrawal by Subject|5|||
156699276|NCT02912650|565645801|FG000|Overall Study|Adverse Event|0|||
156699277|NCT02912650|565645802|FG001|Overall Study|Adverse Event|0|||
156699278|NCT02912650|565645803|FG002|Overall Study|Adverse Event|1|||
156699279|NCT02912650|565645804|FG003|Overall Study|Adverse Event|0|||
156699280|NCT02562482|565645805|FG000|Overall Study|Enrolled, but did not receive product|4|||
156699281|NCT02562482|565645806|FG001|Overall Study|Enrolled, but did not receive product|0|||
156699282|NCT02562482|565645805|FG000|Overall Study|Lost to Follow-up|9|||
156699283|NCT02562482|565645806|FG001|Overall Study|Lost to Follow-up|6|||
156699284|NCT02562482|565645805|FG000|Overall Study|Moved from area|2|||
156699285|NCT02562482|565645806|FG001|Overall Study|Moved from area|3|||
156699286|NCT02562482|565645805|FG000|Overall Study|Withdrawal by Subject|5|||
156699287|NCT02562482|565645806|FG001|Overall Study|Withdrawal by Subject|3|||
156699288|NCT02562482|565645805|FG000|Overall Study|Physician Decision|1|||
156699289|NCT02562482|565645806|FG001|Overall Study|Physician Decision|3|||
156699290|NCT02562482|565645805|FG000|Overall Study|Illness/Injury unrelated to product|0|||
156699291|NCT02562482|565645806|FG001|Overall Study|Illness/Injury unrelated to product|1|||
156699292|NCT01674647|565645807|FG000|Treatment Period|Death|4|||
156699293|NCT01674647|565645808|FG001|Treatment Period|Death|1|||
156699294|NCT01674647|565645807|FG000|Treatment Period|Efficacy outcome reached|0|||
156699295|NCT01674647|565645808|FG001|Treatment Period|Efficacy outcome reached|1|||
156699296|NCT01674647|565645807|FG000|Treatment Period|Physician Decision|3|||
156699297|NCT01674647|565645808|FG001|Treatment Period|Physician Decision|1|||
156699298|NCT01674647|565645807|FG000|Treatment Period|Adverse Event|60|||
156699299|NCT01674647|565645808|FG001|Treatment Period|Adverse Event|22|||
156699300|NCT01674647|565645807|FG000|Treatment Period|Non-compliance with study drug|3|||
156699301|NCT01674647|565645808|FG001|Treatment Period|Non-compliance with study drug|0|||
156699302|NCT01674647|565645807|FG000|Treatment Period|Lost to Follow-up|1|||
156699303|NCT01674647|565645808|FG001|Treatment Period|Lost to Follow-up|1|||
156699304|NCT01674647|565645807|FG000|Treatment Period|Withdrawal by Subject|19|||
156699305|NCT01674647|565645808|FG001|Treatment Period|Withdrawal by Subject|16|||
156699306|NCT01674647|565645807|FG000|Treatment Period|Switching to other therapy|5|||
156699307|NCT01674647|565645808|FG001|Treatment Period|Switching to other therapy|2|||
156699308|NCT01674647|565645807|FG000|Treatment Period|Logistical difficulties|5|||
156699309|NCT01674647|565645808|FG001|Treatment Period|Logistical difficulties|8|||
156699310|NCT01674647|565645807|FG000|Treatment Period|Treatment failure|0|||
157014956|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
156699311|NCT01674647|565645808|FG001|Treatment Period|Treatment failure|14|||
156699312|NCT01674647|565645807|FG000|Treatment Period|Protocol Violation|56|||
156699313|NCT01674647|565645808|FG001|Treatment Period|Protocol Violation|36|||
156699314|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Death|3|||
156699315|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Death|2|||
156699316|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
156699317|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
156699318|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
156699319|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
156699320|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
156699321|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
156699322|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
156699323|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
156699324|NCT01674647|565645807|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
156699325|NCT01674647|565645808|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
156699326|NCT04135196|565645810|FG000|Overall Study|Lost to Follow-up|8|||
156699327|NCT04135196|565645811|FG001|Overall Study|Lost to Follow-up|7|||
156699328|NCT04135196|565645812|FG002|Overall Study|Lost to Follow-up|8|||
156699329|NCT04135196|565645813|FG003|Overall Study|Lost to Follow-up|9|||
156699330|NCT04135196|565645814|FG004|Overall Study|Lost to Follow-up|1|||
156699331|NCT04135196|565645810|FG000|Overall Study|Pregnancy|0|||
156699332|NCT04135196|565645811|FG001|Overall Study|Pregnancy|0|||
156699333|NCT04135196|565645812|FG002|Overall Study|Pregnancy|1|||
156699334|NCT04135196|565645813|FG003|Overall Study|Pregnancy|0|||
156699335|NCT04135196|565645814|FG004|Overall Study|Pregnancy|0|||
156699336|NCT04135196|565645810|FG000|Overall Study|Withdrawal by Subject|0|||
156699337|NCT04135196|565645811|FG001|Overall Study|Withdrawal by Subject|0|||
156699338|NCT04135196|565645812|FG002|Overall Study|Withdrawal by Subject|0|||
156699339|NCT04135196|565645813|FG003|Overall Study|Withdrawal by Subject|0|||
156699340|NCT04135196|565645814|FG004|Overall Study|Withdrawal by Subject|1|||
156699341|NCT00444457|565645816|FG000|Infant Series|Other|0|||
156699342|NCT00444457|565645817|FG001|Infant Series|Other|1|||
156699343|NCT00444457|565645818|FG002|Infant Series|Other|0|||
156699344|NCT00444457|565645819|FG003|Infant Series|Other|0|||
156699345|NCT00444457|565645816|FG000|Infant Series|Parent or legal guardian request|18|||
156699346|NCT00444457|565645817|FG001|Infant Series|Parent or legal guardian request|29|||
156699347|NCT00444457|565645818|FG002|Infant Series|Parent or legal guardian request|34|||
156699348|NCT00444457|565645819|FG003|Infant Series|Parent or legal guardian request|14|||
156699349|NCT00444457|565645816|FG000|Infant Series|Lost to Follow-up|10|||
156699350|NCT00444457|565645817|FG001|Infant Series|Lost to Follow-up|11|||
156699351|NCT00444457|565645818|FG002|Infant Series|Lost to Follow-up|7|||
156699352|NCT00444457|565645819|FG003|Infant Series|Lost to Follow-up|6|||
156699353|NCT00444457|565645816|FG000|Infant Series|Protocol Violation|16|||
156699354|NCT00444457|565645817|FG001|Infant Series|Protocol Violation|8|||
156699355|NCT00444457|565645818|FG002|Infant Series|Protocol Violation|6|||
156699356|NCT00444457|565645819|FG003|Infant Series|Protocol Violation|3|||
156699357|NCT00444457|565645816|FG000|Infant Series|Failed to return|5|||
156699358|NCT00444457|565645817|FG001|Infant Series|Failed to return|4|||
156699359|NCT00444457|565645818|FG002|Infant Series|Failed to return|4|||
156699360|NCT00444457|565645819|FG003|Infant Series|Failed to return|2|||
156699361|NCT00444457|565645816|FG000|Infant Series|Investigator request|4|||
156699362|NCT00444457|565645817|FG001|Infant Series|Investigator request|3|||
156699363|NCT00444457|565645818|FG002|Infant Series|Investigator request|3|||
156699364|NCT00444457|565645819|FG003|Infant Series|Investigator request|2|||
156699365|NCT00444457|565645816|FG000|Infant Series|Other|0|||
156699366|NCT00444457|565645817|FG001|Infant Series|Other|2|||
156699367|NCT00444457|565645818|FG002|Infant Series|Other|4|||
156699368|NCT00444457|565645819|FG003|Infant Series|Other|0|||
156699369|NCT00444457|565645816|FG000|Infant Series|Adverse Event|1|||
156699370|NCT00444457|565645817|FG001|Infant Series|Adverse Event|2|||
156699371|NCT00444457|565645818|FG002|Infant Series|Adverse Event|2|||
156699372|NCT00444457|565645819|FG003|Infant Series|Adverse Event|0|||
156699373|NCT00444457|565645816|FG000|Infant Series|Death|0|||
156699374|NCT00444457|565645817|FG001|Infant Series|Death|1|||
156699375|NCT00444457|565645818|FG002|Infant Series|Death|1|||
156699376|NCT00444457|565645819|FG003|Infant Series|Death|1|||
156699377|NCT00444457|565645816|FG000|After Infant Series|Other|0|||
156699378|NCT00444457|565645817|FG001|After Infant Series|Other|1|||
156699379|NCT00444457|565645818|FG002|After Infant Series|Other|1|||
156699380|NCT00444457|565645819|FG003|After Infant Series|Other|1|||
156699381|NCT00444457|565645816|FG000|After Infant Series|Parent or legal guardian request|4|||
156699382|NCT00444457|565645817|FG001|After Infant Series|Parent or legal guardian request|11|||
156699383|NCT00444457|565645818|FG002|After Infant Series|Parent or legal guardian request|6|||
156699384|NCT00444457|565645819|FG003|After Infant Series|Parent or legal guardian request|3|||
156699385|NCT00444457|565645816|FG000|After Infant Series|Failed to return|7|||
156699386|NCT00444457|565645817|FG001|After Infant Series|Failed to return|6|||
156699387|NCT00444457|565645818|FG002|After Infant Series|Failed to return|5|||
156699388|NCT00444457|565645819|FG003|After Infant Series|Failed to return|1|||
156699389|NCT00444457|565645816|FG000|After Infant Series|Lost to Follow-up|5|||
156699390|NCT00444457|565645817|FG001|After Infant Series|Lost to Follow-up|5|||
156699391|NCT00444457|565645818|FG002|After Infant Series|Lost to Follow-up|5|||
156699392|NCT00444457|565645819|FG003|After Infant Series|Lost to Follow-up|2|||
156699393|NCT00444457|565645816|FG000|After Infant Series|Protocol Violation|2|||
156699394|NCT00444457|565645817|FG001|After Infant Series|Protocol Violation|4|||
156699395|NCT00444457|565645818|FG002|After Infant Series|Protocol Violation|2|||
156699396|NCT00444457|565645819|FG003|After Infant Series|Protocol Violation|2|||
156699397|NCT00444457|565645816|FG000|After Infant Series|Adverse Event|2|||
156699398|NCT00444457|565645817|FG001|After Infant Series|Adverse Event|2|||
156699399|NCT00444457|565645818|FG002|After Infant Series|Adverse Event|0|||
156699400|NCT00444457|565645819|FG003|After Infant Series|Adverse Event|0|||
156699401|NCT00444457|565645816|FG000|After Infant Series|Investigator request|0|||
156699402|NCT00444457|565645817|FG001|After Infant Series|Investigator request|0|||
156699403|NCT00444457|565645818|FG002|After Infant Series|Investigator request|0|||
156699404|NCT00444457|565645819|FG003|After Infant Series|Investigator request|1|||
156699405|NCT00444457|565645816|FG000|After Infant Series|Other|0|||
156871974|NCT02015637|566289470|FG001|Overall Study|Did not take study drug|0|||
156699406|NCT00444457|565645817|FG001|After Infant Series|Other|1|||
156699407|NCT00444457|565645818|FG002|After Infant Series|Other|0|||
156699408|NCT00444457|565645819|FG003|After Infant Series|Other|0|||
156699409|NCT00444457|565645816|FG000|Toddler Dose|Lost to Follow-up|4|||
156699410|NCT00444457|565645817|FG001|Toddler Dose|Lost to Follow-up|1|||
156871975|NCT01491607|566289473|FG000|Overall Study|Lost to Follow-up|7|||
156699411|NCT00444457|565645818|FG002|Toddler Dose|Lost to Follow-up|1|||
156699412|NCT00444457|565645819|FG003|Toddler Dose|Lost to Follow-up|3|||
156699413|NCT00444457|565645816|FG000|Toddler Dose|Failed to return|2|||
156699414|NCT00444457|565645817|FG001|Toddler Dose|Failed to return|2|||
156871976|NCT01491607|566289473|FG000|Overall Study|Withdrawal by Subject|3|||
156699415|NCT00444457|565645818|FG002|Toddler Dose|Failed to return|1|||
156699416|NCT00444457|565645819|FG003|Toddler Dose|Failed to return|3|||
156699417|NCT00444457|565645816|FG000|Toddler Dose|Parent or legal guardian request|0|||
156699418|NCT00444457|565645817|FG001|Toddler Dose|Parent or legal guardian request|3|||
156699419|NCT00444457|565645818|FG002|Toddler Dose|Parent or legal guardian request|2|||
156699420|NCT00444457|565645819|FG003|Toddler Dose|Parent or legal guardian request|1|||
156699421|NCT00444457|565645816|FG000|Toddler Dose|Protocol Violation|1|||
156699422|NCT00444457|565645817|FG001|Toddler Dose|Protocol Violation|0|||
156699423|NCT00444457|565645818|FG002|Toddler Dose|Protocol Violation|0|||
156699424|NCT00444457|565645819|FG003|Toddler Dose|Protocol Violation|1|||
156871977|NCT01317277|566289474|FG000|Overall Study|Lost to Follow-up|3|||
156871978|NCT01317277|566289475|FG001|Overall Study|Lost to Follow-up|1|||
156871979|NCT01317277|566289474|FG000|Overall Study|Lost MEMS|1|||
156871980|NCT01317277|566289475|FG001|Overall Study|Lost MEMS|1|||
156871981|NCT01317277|566289474|FG000|Overall Study|Unable to comply with intervention|1|||
156871982|NCT01317277|566289475|FG001|Overall Study|Unable to comply with intervention|0|||
156871983|NCT01317277|566289474|FG000|Overall Study|Withdrawal by Subject|1|||
156871984|NCT01317277|566289475|FG001|Overall Study|Withdrawal by Subject|0|||
156871985|NCT01317277|566289474|FG000|Overall Study|Adverse Event|1|||
156871986|NCT01317277|566289475|FG001|Overall Study|Adverse Event|0|||
156871987|NCT00774566|566289476|FG000|Overall Study|Protocol Violation|18|||
156871988|NCT00774566|566289477|FG001|Overall Study|Protocol Violation|15|||
156871989|NCT04896073|566289484|FG000|Overall Study|Screen failure|0|||
156871990|NCT04896073|566289485|FG001|Overall Study|Screen failure|2|||
156871991|NCT04896073|566289484|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
156871992|NCT04896073|566289485|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
156871993|NCT00297258|566289486|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
156871994|NCT00297258|566289486|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
156871995|NCT00297258|566289486|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
156871996|NCT00297258|566289486|FG000|Overall Study|Intercurrent Illness|3|||
156871997|NCT00297258|566289486|FG000|Overall Study|Intercurrent Death|2|||
156871998|NCT00297258|566289486|FG000|Overall Study|Deteriorization of General Condition|1|||
156871999|NCT00297258|566289486|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
156872000|NCT00297258|566289486|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
156872001|NCT00297258|566289486|FG000|Overall Study|Switch to Commercial Treatment|1|||
156872002|NCT00297258|566289486|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
156872003|NCT02454517|566289488|FG000|Overall Study|Withdrawal by Subject|3|||
156872004|NCT02454517|566289489|FG001|Overall Study|Withdrawal by Subject|0|||
156872005|NCT02454517|566289488|FG000|Overall Study|Lost to Follow-up|4|||
156872006|NCT02454517|566289489|FG001|Overall Study|Lost to Follow-up|7|||
157123177|NCT00403260|567203668|FG001|Overall Study|Withdrawal by Subject|6|||
157123178|NCT00403260|567203667|FG000|Overall Study|Lost to Follow-up|49|||
157123179|NCT00403260|567203668|FG001|Overall Study|Lost to Follow-up|25|||
157123180|NCT00403260|567203667|FG000|Overall Study|Re-appearance of P. falciparum|34|||
157123181|NCT00403260|567203668|FG001|Overall Study|Re-appearance of P. falciparum|25|||
157123182|NCT00403260|567203667|FG000|Overall Study|P. vivax infection|26|||
157123183|NCT00403260|567203668|FG001|Overall Study|P. vivax infection|4|||
157123184|NCT00403260|567203667|FG000|Overall Study|Mixed infection with P. vivax|2|||
157123185|NCT00403260|567203668|FG001|Overall Study|Mixed infection with P. vivax|0|||
157123186|NCT00403260|567203667|FG000|Overall Study|Mixed infection with P. falciparum|1|||
157123187|NCT00403260|567203668|FG001|Overall Study|Mixed infection with P. falciparum|0|||
157123188|NCT00403260|567203667|FG000|Overall Study|P. vivax infection at screening|1|||
157123189|NCT00403260|567203668|FG001|Overall Study|P. vivax infection at screening|0|||
157123190|NCT00403260|567203667|FG000|Overall Study|P. ovale infection|1|||
157123191|NCT00403260|567203668|FG001|Overall Study|P. ovale infection|0|||
157123192|NCT00403260|567203667|FG000|Overall Study|Gametocyte re-appearance|1|||
157123193|NCT00403260|567203668|FG001|Overall Study|Gametocyte re-appearance|1|||
157123194|NCT00403260|567203667|FG000|Overall Study|Withdrawn from study accidentally|0|||
157123195|NCT00403260|567203668|FG001|Overall Study|Withdrawn from study accidentally|1|||
157123196|NCT01241708|567203669|FG000|Overall Study|Withdrawal by Subject|6|||
157123197|NCT01241708|567203669|FG000|Overall Study|Screen Failure|6|||
157123198|NCT01241708|567203669|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
157123199|NCT01241708|567203669|FG000|Overall Study|Lost to Follow-up|5|||
157123200|NCT04137887|567203670|FG000|Overall Study|Death|102|||
156699425|NCT04941729|565649121|FG000|Overall Study|Death|0|||
156699426|NCT04941729|565649122|FG001|Overall Study|Death|1|||
156699427|NCT04941729|565649121|FG000|Overall Study|Study terminated by sponsor|11|||
156699428|NCT04941729|565649122|FG001|Overall Study|Study terminated by sponsor|10|||
156699429|NCT05091307|565649123|FG000|Overall Study|Death|0|||
157123201|NCT04137887|567203671|FG001|Overall Study|Death|92|||
157123202|NCT04137887|567203670|FG000|Overall Study|Withdrawal by Subject|2|||
157123203|NCT04137887|567203671|FG001|Overall Study|Withdrawal by Subject|3|||
156699430|NCT05091307|565649124|FG001|Overall Study|Death|0|||
156699431|NCT05091307|565649125|FG002|Overall Study|Death|1|||
156872007|NCT02454517|566289488|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
156872008|NCT02454517|566289489|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
156872009|NCT00473382|566289490|FG000|Core Study|Adverse Event|3|||
157123204|NCT04137887|567203670|FG000|Overall Study|Randomized but not treated|0|||
157123205|NCT04137887|567203671|FG001|Overall Study|Randomized but not treated|1|||
157123206|NCT01790503|567203674|FG000|Overall Study|Adverse Event|1|||
157123207|NCT01790503|567203675|FG001|Overall Study|Adverse Event|0|||
157123208|NCT01790503|567203676|FG002|Overall Study|Adverse Event|0|||
156699432|NCT05091307|565649126|FG003|Overall Study|Death|0|||
156699433|NCT05091307|565649123|FG000|Overall Study|Lost to Follow-up|33|||
156699434|NCT05091307|565649124|FG001|Overall Study|Lost to Follow-up|33|||
156699435|NCT05091307|565649125|FG002|Overall Study|Lost to Follow-up|2|||
156699436|NCT05091307|565649126|FG003|Overall Study|Lost to Follow-up|0|||
156699437|NCT05091307|565649123|FG000|Overall Study|Physician Decision|1|||
156699438|NCT05091307|565649124|FG001|Overall Study|Physician Decision|0|||
156699439|NCT05091307|565649125|FG002|Overall Study|Physician Decision|0|||
156699440|NCT05091307|565649126|FG003|Overall Study|Physician Decision|0|||
156699441|NCT05091307|565649123|FG000|Overall Study|Protocol Violation|1|||
156699442|NCT05091307|565649124|FG001|Overall Study|Protocol Violation|0|||
156699443|NCT05091307|565649125|FG002|Overall Study|Protocol Violation|0|||
157214866|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
156699444|NCT05091307|565649126|FG003|Overall Study|Protocol Violation|0|||
156699445|NCT05091307|565649123|FG000|Overall Study|Withdrawal by Subject|16|||
156699446|NCT05091307|565649124|FG001|Overall Study|Withdrawal by Subject|16|||
156699447|NCT05091307|565649125|FG002|Overall Study|Withdrawal by Subject|0|||
156699448|NCT05091307|565649126|FG003|Overall Study|Withdrawal by Subject|1|||
156699449|NCT05091307|565649123|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
156699450|NCT05091307|565649124|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
156699451|NCT05091307|565649125|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
156699452|NCT05091307|565649126|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
156699453|NCT05091307|565649123|FG000|Overall Study|Initiated Prohibited Medication|1|||
156699454|NCT05091307|565649124|FG001|Overall Study|Initiated Prohibited Medication|0|||
156699455|NCT05091307|565649125|FG002|Overall Study|Initiated Prohibited Medication|0|||
156699456|NCT05091307|565649126|FG003|Overall Study|Initiated Prohibited Medication|0|||
156699457|NCT05091307|565649123|FG000|Overall Study|Other|4|||
156699458|NCT05091307|565649124|FG001|Overall Study|Other|4|||
156699459|NCT05091307|565649125|FG002|Overall Study|Other|0|||
156699460|NCT05091307|565649126|FG003|Overall Study|Other|0|||
156699461|NCT05091307|565649123|FG000|Overall Study|Randomized but not vaccinated|0|||
156699462|NCT05091307|565649124|FG001|Overall Study|Randomized but not vaccinated|2|||
156699463|NCT05091307|565649125|FG002|Overall Study|Randomized but not vaccinated|0|||
156699464|NCT05091307|565649126|FG003|Overall Study|Randomized but not vaccinated|0|||
156699465|NCT04732221|565649129|FG000|Base Period|Death|2|||
156699466|NCT04732221|565649130|FG001|Base Period|Death|0|||
156699467|NCT04732221|565649131|FG002|Base Period|Death|0|||
156699468|NCT04732221|565649132|FG003|Base Period|Death|0|||
156699469|NCT04732221|565649133|FG004|Base Period|Death|0|||
156699470|NCT04732221|565649134|FG005|Base Period|Death|0|||
156699471|NCT04732221|565649135|FG006|Base Period|Death|0|||
156699472|NCT04732221|565649129|FG000|Base Period|Withdrawal by Subject|0|||
157123209|NCT01790503|567203677|FG003|Overall Study|Adverse Event|0|||
157123210|NCT01790503|567203678|FG004|Overall Study|Adverse Event|0|||
157123211|NCT01790503|567203679|FG005|Overall Study|Adverse Event|2|||
157123212|NCT01790503|567203680|FG006|Overall Study|Adverse Event|0|||
157123213|NCT01790503|567203681|FG007|Overall Study|Adverse Event|0|||
157123214|NCT01790503|567203682|FG008|Overall Study|Adverse Event|2|||
157214867|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
157214868|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
156699473|NCT04732221|565649130|FG001|Base Period|Withdrawal by Subject|1|||
156699474|NCT04732221|565649131|FG002|Base Period|Withdrawal by Subject|1|||
156699475|NCT04732221|565649132|FG003|Base Period|Withdrawal by Subject|0|||
156699476|NCT04732221|565649133|FG004|Base Period|Withdrawal by Subject|0|||
156699477|NCT04732221|565649134|FG005|Base Period|Withdrawal by Subject|0|||
156699478|NCT04732221|565649135|FG006|Base Period|Withdrawal by Subject|0|||
156699479|NCT04732221|565649129|FG000|Extension Period|Adverse Event|0|||
156699480|NCT04732221|565649130|FG001|Extension Period|Adverse Event|0|||
156699481|NCT04732221|565649131|FG002|Extension Period|Adverse Event|0|||
156699482|NCT04732221|565649132|FG003|Extension Period|Adverse Event|0|||
156790748|NCT01853280|565985463|FG000|Overall Study|Withdrawal by Subject|0|||
156790749|NCT01853280|565985464|FG001|Overall Study|Withdrawal by Subject|1|||
156790750|NCT01853280|565985463|FG000|Overall Study|Ineligible|0|||
156790751|NCT01853280|565985464|FG001|Overall Study|Ineligible|1|||
156790752|NCT00104884|565985465|FG000|Overall Study|Disease progression|4|||
156790753|NCT03654326|565985466|FG000|Overall Study|Withdrawal by Subject|5|||
156790754|NCT03654326|565985467|FG001|Overall Study|Withdrawal by Subject|3|||
157123215|NCT01790503|567203683|FG009|Overall Study|Adverse Event|4|||
156699483|NCT04732221|565649133|FG004|Extension Period|Adverse Event|0|||
156699484|NCT04732221|565649134|FG005|Extension Period|Adverse Event|1|||
156790755|NCT03654326|565985466|FG000|Overall Study|Physician Decision|0|||
156699485|NCT04732221|565649135|FG006|Extension Period|Adverse Event|0|||
156699486|NCT04732221|565649129|FG000|Extension Period|Death|0|||
157123216|NCT01790503|567203684|FG010|Overall Study|Adverse Event|7|||
157123217|NCT01790503|567203674|FG000|Overall Study|Withdrawal by Subject|0|||
157123218|NCT01790503|567203675|FG001|Overall Study|Withdrawal by Subject|0|||
157123219|NCT01790503|567203676|FG002|Overall Study|Withdrawal by Subject|1|||
157123220|NCT01790503|567203677|FG003|Overall Study|Withdrawal by Subject|1|||
157123221|NCT01790503|567203678|FG004|Overall Study|Withdrawal by Subject|1|||
157123222|NCT01790503|567203679|FG005|Overall Study|Withdrawal by Subject|2|||
157123223|NCT01790503|567203680|FG006|Overall Study|Withdrawal by Subject|1|||
157123224|NCT01790503|567203681|FG007|Overall Study|Withdrawal by Subject|0|||
157123225|NCT01790503|567203682|FG008|Overall Study|Withdrawal by Subject|0|||
157123226|NCT01790503|567203683|FG009|Overall Study|Withdrawal by Subject|0|||
157123227|NCT01790503|567203684|FG010|Overall Study|Withdrawal by Subject|1|||
157123228|NCT01790503|567203674|FG000|Overall Study|Disease progression|2|||
157123229|NCT01790503|567203675|FG001|Overall Study|Disease progression|1|||
157123230|NCT01790503|567203676|FG002|Overall Study|Disease progression|0|||
157123231|NCT01790503|567203677|FG003|Overall Study|Disease progression|1|||
156699487|NCT04732221|565649130|FG001|Extension Period|Death|0|||
156699488|NCT04732221|565649131|FG002|Extension Period|Death|0|||
156699489|NCT04732221|565649132|FG003|Extension Period|Death|0|||
156699490|NCT04732221|565649133|FG004|Extension Period|Death|1|||
156699491|NCT04732221|565649134|FG005|Extension Period|Death|0|||
156699492|NCT04732221|565649135|FG006|Extension Period|Death|2|||
156699493|NCT04732221|565649129|FG000|Extension Period|Pregnancy|0|||
156699494|NCT04732221|565649130|FG001|Extension Period|Pregnancy|0|||
156699495|NCT04732221|565649131|FG002|Extension Period|Pregnancy|0|||
156699496|NCT04732221|565649132|FG003|Extension Period|Pregnancy|0|||
156699497|NCT04732221|565649133|FG004|Extension Period|Pregnancy|1|||
156699498|NCT04732221|565649134|FG005|Extension Period|Pregnancy|0|||
156699499|NCT04732221|565649135|FG006|Extension Period|Pregnancy|0|||
156699500|NCT04732221|565649129|FG000|Extension Period|Sponsors Decision|0|||
156699501|NCT04732221|565649130|FG001|Extension Period|Sponsors Decision|0|||
156699502|NCT04732221|565649131|FG002|Extension Period|Sponsors Decision|0|||
157123232|NCT01790503|567203678|FG004|Overall Study|Disease progression|2|||
157123233|NCT01790503|567203679|FG005|Overall Study|Disease progression|1|||
156699503|NCT04732221|565649132|FG003|Extension Period|Sponsors Decision|0|||
156699504|NCT04732221|565649133|FG004|Extension Period|Sponsors Decision|41|||
156699505|NCT04732221|565649134|FG005|Extension Period|Sponsors Decision|40|||
156699506|NCT04732221|565649135|FG006|Extension Period|Sponsors Decision|40|||
156699507|NCT04732221|565649129|FG000|Extension Period|Withdrawal by Subject|0|||
156699508|NCT04732221|565649130|FG001|Extension Period|Withdrawal by Subject|0|||
156699509|NCT04732221|565649131|FG002|Extension Period|Withdrawal by Subject|0|||
156699510|NCT04732221|565649132|FG003|Extension Period|Withdrawal by Subject|0|||
156699511|NCT04732221|565649133|FG004|Extension Period|Withdrawal by Subject|1|||
156699512|NCT04732221|565649134|FG005|Extension Period|Withdrawal by Subject|5|||
156699513|NCT04732221|565649135|FG006|Extension Period|Withdrawal by Subject|2|||
156699514|NCT00379340|565649137|FG000|Overall Study|Death|0|||
156699515|NCT00379340|565649138|FG001|Overall Study|Death|0|||
156699516|NCT00379340|565649139|FG002|Overall Study|Death|0|||
156699517|NCT00379340|565649140|FG003|Overall Study|Death|2|||
156699518|NCT00379340|565649141|FG004|Overall Study|Death|0|||
156699519|NCT00379340|565649137|FG000|Overall Study|Lack of Efficacy|6|||
156699520|NCT00379340|565649138|FG001|Overall Study|Lack of Efficacy|1|||
156699521|NCT00379340|565649139|FG002|Overall Study|Lack of Efficacy|0|||
156699522|NCT00379340|565649140|FG003|Overall Study|Lack of Efficacy|4|||
156699523|NCT00379340|565649141|FG004|Overall Study|Lack of Efficacy|3|||
156699524|NCT00379340|565649137|FG000|Overall Study|Physician Decision|6|||
156699525|NCT00379340|565649138|FG001|Overall Study|Physician Decision|2|||
157123234|NCT01790503|567203680|FG006|Overall Study|Disease progression|0|||
157123235|NCT01790503|567203681|FG007|Overall Study|Disease progression|1|||
157123236|NCT01790503|567203682|FG008|Overall Study|Disease progression|0|||
157123237|NCT01790503|567203683|FG009|Overall Study|Disease progression|17|||
157123238|NCT01790503|567203684|FG010|Overall Study|Disease progression|7|||
157123239|NCT01790503|567203674|FG000|Overall Study|Protocol Violation|0|||
157123240|NCT01790503|567203675|FG001|Overall Study|Protocol Violation|0|||
156699526|NCT00379340|565649139|FG002|Overall Study|Physician Decision|1|||
156699527|NCT00379340|565649140|FG003|Overall Study|Physician Decision|2|||
156699528|NCT00379340|565649141|FG004|Overall Study|Physician Decision|3|||
156699529|NCT00379340|565649137|FG000|Overall Study|Withdrawal by Subject|0|||
156699530|NCT00379340|565649138|FG001|Overall Study|Withdrawal by Subject|0|||
156699531|NCT00379340|565649139|FG002|Overall Study|Withdrawal by Subject|0|||
156699532|NCT00379340|565649140|FG003|Overall Study|Withdrawal by Subject|1|||
156699533|NCT00379340|565649141|FG004|Overall Study|Withdrawal by Subject|0|||
156699534|NCT00379340|565649137|FG000|Overall Study|Refusal of further protocol therapy|1|||
156699535|NCT00379340|565649138|FG001|Overall Study|Refusal of further protocol therapy|0|||
156699536|NCT00379340|565649139|FG002|Overall Study|Refusal of further protocol therapy|1|||
157123241|NCT01790503|567203676|FG002|Overall Study|Protocol Violation|0|||
157123242|NCT01790503|567203677|FG003|Overall Study|Protocol Violation|0|||
157123243|NCT01790503|567203678|FG004|Overall Study|Protocol Violation|0|||
157123244|NCT01790503|567203679|FG005|Overall Study|Protocol Violation|0|||
157123245|NCT01790503|567203680|FG006|Overall Study|Protocol Violation|0|||
156699537|NCT00379340|565649140|FG003|Overall Study|Refusal of further protocol therapy|1|||
156699538|NCT00379340|565649141|FG004|Overall Study|Refusal of further protocol therapy|7|||
156699539|NCT00379340|565649137|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
156699540|NCT00379340|565649138|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
156699541|NCT00379340|565649139|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
156699542|NCT00379340|565649140|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
156699543|NCT00379340|565649141|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
156699544|NCT00379340|565649137|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699545|NCT00379340|565649138|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699546|NCT00379340|565649139|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
156699547|NCT00379340|565649140|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
156699548|NCT00379340|565649141|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
156699549|NCT05327816|565649146|FG000|Overall Study|Lost to Follow-up|1|||
156699550|NCT05327816|565649147|FG001|Overall Study|Lost to Follow-up|0|||
156699551|NCT05327816|565649148|FG002|Overall Study|Lost to Follow-up|0|||
156699552|NCT05327816|565649149|FG003|Overall Study|Lost to Follow-up|0|||
156699553|NCT05327816|565649150|FG004|Overall Study|Lost to Follow-up|0|||
156699554|NCT05327816|565649151|FG005|Overall Study|Lost to Follow-up|0|||
156699555|NCT05327816|565649152|FG006|Overall Study|Lost to Follow-up|0|||
156699556|NCT05327816|565649153|FG007|Overall Study|Lost to Follow-up|0|||
156699557|NCT05327816|565649154|FG008|Overall Study|Lost to Follow-up|0|||
156699558|NCT05327816|565649155|FG009|Overall Study|Lost to Follow-up|1|||
156699559|NCT05327816|565649156|FG010|Overall Study|Lost to Follow-up|0|||
156699560|NCT05327816|565649146|FG000|Overall Study|Withdrawal by Subject|0|||
156699561|NCT05327816|565649147|FG001|Overall Study|Withdrawal by Subject|0|||
156699562|NCT05327816|565649148|FG002|Overall Study|Withdrawal by Subject|0|||
156699563|NCT05327816|565649149|FG003|Overall Study|Withdrawal by Subject|0|||
156699564|NCT05327816|565649150|FG004|Overall Study|Withdrawal by Subject|1|||
156699565|NCT05327816|565649151|FG005|Overall Study|Withdrawal by Subject|1|||
156699566|NCT05327816|565649152|FG006|Overall Study|Withdrawal by Subject|0|||
156699567|NCT05327816|565649153|FG007|Overall Study|Withdrawal by Subject|0|||
156699568|NCT05327816|565649154|FG008|Overall Study|Withdrawal by Subject|0|||
156699569|NCT05327816|565649155|FG009|Overall Study|Withdrawal by Subject|0|||
156699570|NCT05327816|565649156|FG010|Overall Study|Withdrawal by Subject|0|||
156699571|NCT05327816|565649146|FG000|Overall Study|Study Terminated by Sponsor|11|||
156699572|NCT05327816|565649147|FG001|Overall Study|Study Terminated by Sponsor|12|||
156699573|NCT05327816|565649148|FG002|Overall Study|Study Terminated by Sponsor|12|||
156699574|NCT05327816|565649149|FG003|Overall Study|Study Terminated by Sponsor|12|||
156699575|NCT05327816|565649150|FG004|Overall Study|Study Terminated by Sponsor|11|||
156699576|NCT05327816|565649151|FG005|Overall Study|Study Terminated by Sponsor|11|||
156699577|NCT05327816|565649152|FG006|Overall Study|Study Terminated by Sponsor|11|||
156699578|NCT05327816|565649153|FG007|Overall Study|Study Terminated by Sponsor|11|||
156699579|NCT05327816|565649154|FG008|Overall Study|Study Terminated by Sponsor|11|||
156699580|NCT05327816|565649155|FG009|Overall Study|Study Terminated by Sponsor|11|||
156699581|NCT05327816|565649156|FG010|Overall Study|Study Terminated by Sponsor|12|||
156699582|NCT05327816|565649146|FG000|Overall Study|Randomized but not treated|0|||
156699583|NCT05327816|565649147|FG001|Overall Study|Randomized but not treated|0|||
156699584|NCT05327816|565649148|FG002|Overall Study|Randomized but not treated|0|||
156699585|NCT05327816|565649149|FG003|Overall Study|Randomized but not treated|0|||
156699586|NCT05327816|565649150|FG004|Overall Study|Randomized but not treated|0|||
156699587|NCT05327816|565649151|FG005|Overall Study|Randomized but not treated|0|||
156699588|NCT05327816|565649152|FG006|Overall Study|Randomized but not treated|1|||
156699589|NCT05327816|565649153|FG007|Overall Study|Randomized but not treated|1|||
157014957|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
157014958|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
157014959|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
157014960|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
157014961|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
157014962|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
157014963|NCT03939312|566805158|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
157014964|NCT03939312|566805158|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
157014965|NCT03939312|566805158|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
157014966|NCT02576509|566806723|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
157021745|NCT03673111|566832950|FG005|Overall Study|Adverse Event|0|||
156699590|NCT05327816|565649154|FG008|Overall Study|Randomized but not treated|1|||
156699591|NCT05327816|565649155|FG009|Overall Study|Randomized but not treated|0|||
156699592|NCT05327816|565649156|FG010|Overall Study|Randomized but not treated|0|||
156699593|NCT00759902|565649157|FG000|Overall Study|Adverse Event|0|||
156699594|NCT00759902|565649158|FG001|Overall Study|Adverse Event|1|||
156699595|NCT00658658|565649163|FG000|Overall Study|Withdrawal by Subject|0|||
156699596|NCT00658658|565649164|FG001|Overall Study|Withdrawal by Subject|1|||
156699597|NCT00658658|565649165|FG002|Overall Study|Withdrawal by Subject|0|||
156699598|NCT00658658|565649166|FG003|Overall Study|Withdrawal by Subject|0|||
156699599|NCT00658658|565649167|FG004|Overall Study|Withdrawal by Subject|0|||
156699600|NCT00658658|565649163|FG000|Overall Study|Death|4|||
156699601|NCT00658658|565649164|FG001|Overall Study|Death|0|||
156699602|NCT00658658|565649165|FG002|Overall Study|Death|0|||
156699603|NCT00658658|565649166|FG003|Overall Study|Death|1|||
156699604|NCT00658658|565649167|FG004|Overall Study|Death|1|||
156699605|NCT00658658|565649163|FG000|Overall Study|Disease Progression|0|||
156699606|NCT00658658|565649164|FG001|Overall Study|Disease Progression|1|||
156699607|NCT00658658|565649165|FG002|Overall Study|Disease Progression|0|||
156699608|NCT00658658|565649166|FG003|Overall Study|Disease Progression|1|||
156699609|NCT00658658|565649167|FG004|Overall Study|Disease Progression|3|||
157123246|NCT01790503|567203681|FG007|Overall Study|Protocol Violation|0|||
156699610|NCT00658658|565649163|FG000|Overall Study|Protocol-specified Criteria|1|||
156699611|NCT00658658|565649164|FG001|Overall Study|Protocol-specified Criteria|0|||
156699612|NCT00658658|565649165|FG002|Overall Study|Protocol-specified Criteria|0|||
156699613|NCT00658658|565649166|FG003|Overall Study|Protocol-specified Criteria|0|||
156699614|NCT00658658|565649167|FG004|Overall Study|Protocol-specified Criteria|0|||
156699615|NCT00658658|565649163|FG000|Overall Study|Other|0|||
156699616|NCT00658658|565649164|FG001|Overall Study|Other|0|||
156699617|NCT00658658|565649165|FG002|Overall Study|Other|0|||
156699618|NCT00658658|565649166|FG003|Overall Study|Other|0|||
156699619|NCT00658658|565649167|FG004|Overall Study|Other|1|||
156699620|NCT01523457|565649168|FG000|Overall Study|Withdrawal by Subject|7|||
156872010|NCT00473382|566289491|FG001|Core Study|Adverse Event|1|||
157014967|NCT02576509|566806724|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
157123247|NCT01790503|567203682|FG008|Overall Study|Protocol Violation|0|||
157123248|NCT01790503|567203683|FG009|Overall Study|Protocol Violation|1|||
157214869|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
157214870|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
157214871|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
157214872|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
157214873|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
157214874|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
157214875|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
157214876|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
157214877|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
157214878|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
157214879|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
157214880|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
157214881|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
157214882|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
157123249|NCT01790503|567203684|FG010|Overall Study|Protocol Violation|0|||
157123250|NCT01790503|567203674|FG000|Overall Study|Physician Decision|0|||
157123251|NCT01790503|567203675|FG001|Overall Study|Physician Decision|0|||
157123252|NCT01790503|567203676|FG002|Overall Study|Physician Decision|0|||
157123253|NCT01790503|567203677|FG003|Overall Study|Physician Decision|0|||
157123254|NCT01790503|567203678|FG004|Overall Study|Physician Decision|0|||
157123255|NCT01790503|567203679|FG005|Overall Study|Physician Decision|0|||
157123256|NCT01790503|567203680|FG006|Overall Study|Physician Decision|0|||
157123257|NCT01790503|567203681|FG007|Overall Study|Physician Decision|0|||
157123258|NCT01790503|567203682|FG008|Overall Study|Physician Decision|0|||
157123259|NCT01790503|567203683|FG009|Overall Study|Physician Decision|1|||
157123260|NCT01790503|567203684|FG010|Overall Study|Physician Decision|1|||
157123261|NCT01790503|567203674|FG000|Overall Study|Death|0|||
157123262|NCT01790503|567203675|FG001|Overall Study|Death|0|||
157123263|NCT01790503|567203676|FG002|Overall Study|Death|0|||
157123264|NCT01790503|567203677|FG003|Overall Study|Death|0|||
157123265|NCT01790503|567203678|FG004|Overall Study|Death|0|||
157214883|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
157214884|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
156699621|NCT01523457|565649169|FG001|Overall Study|Withdrawal by Subject|2|||
157014968|NCT02576509|566806723|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
157014969|NCT02576509|566806724|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
157014970|NCT02576509|566806723|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
157014971|NCT02576509|566806724|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
157014972|NCT02576509|566806723|FG000|Treatment Period|Disease progression|263|||
157014973|NCT02576509|566806724|FG001|Treatment Period|Disease progression|244|||
157014974|NCT02576509|566806723|FG000|Treatment Period|Study drug toxicity|37|||
157014975|NCT02576509|566806724|FG001|Treatment Period|Study drug toxicity|41|||
156699622|NCT01367665|565649170|FG000|Overall Study|Death|102|||
156699623|NCT01367665|565649171|FG001|Overall Study|Death|19|||
157123266|NCT01790503|567203679|FG005|Overall Study|Death|0|||
157123267|NCT01790503|567203680|FG006|Overall Study|Death|0|||
157123268|NCT01790503|567203681|FG007|Overall Study|Death|0|||
156699624|NCT01367665|565649170|FG000|Overall Study|Lost to Follow-up|222|||
157123269|NCT01790503|567203682|FG008|Overall Study|Death|0|||
157123270|NCT01790503|567203683|FG009|Overall Study|Death|1|||
157214885|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
157214886|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
157214887|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
157214888|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
157214889|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
157214890|NCT00528879|567533546|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
157214891|NCT00528879|567533547|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
157214892|NCT00528879|567533548|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
157214893|NCT00528879|567533549|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
157214894|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
157214895|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
157214896|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
157214897|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
157214898|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
157214899|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
157214900|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
157214901|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
157214902|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
157214903|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
157214904|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
157214905|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
157214906|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
157214907|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
157214908|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
157214909|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
157214910|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
157214911|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
157214912|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
157214913|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
157214914|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
157214915|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
157214916|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
157214917|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
157214918|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
157214919|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
157214920|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
157214921|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
157214922|NCT00528879|567533546|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
157214923|NCT00528879|567533547|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
157214924|NCT00528879|567533548|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
157214925|NCT00528879|567533549|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
157214926|NCT01159769|567533552|FG000|Overall Study|Adverse Event|1|||
157214927|NCT01361607|567533553|FG000|Overall Study|Adverse Event|38|||
157214928|NCT01361607|567533554|FG001|Overall Study|Adverse Event|29|||
157214929|NCT01361607|567533553|FG000|Overall Study|Withdrawal by Subject|19|||
157214930|NCT01361607|567533554|FG001|Overall Study|Withdrawal by Subject|8|||
157214931|NCT01361607|567533553|FG000|Overall Study|Withdrawal by Investigator|5|||
157214932|NCT01361607|567533554|FG001|Overall Study|Withdrawal by Investigator|3|||
157214933|NCT01361607|567533553|FG000|Overall Study|Lost to Follow-up|1|||
157214934|NCT01361607|567533554|FG001|Overall Study|Lost to Follow-up|0|||
157214935|NCT01361607|567533553|FG000|Overall Study|Met Withdrawal Criteria|1|||
157214936|NCT01361607|567533554|FG001|Overall Study|Met Withdrawal Criteria|1|||
157214937|NCT01507831|567533555|FG000|Overall Study|Randomized but not treated|0|||
157214938|NCT01507831|567533556|FG001|Overall Study|Randomized but not treated|3|||
157214939|NCT01507831|567533555|FG000|Overall Study|Adverse Event|48|||
157214940|NCT01507831|567533556|FG001|Overall Study|Adverse Event|113|||
157214941|NCT01507831|567533555|FG000|Overall Study|Death|6|||
157214942|NCT01507831|567533556|FG001|Overall Study|Death|2|||
157214943|NCT01507831|567533555|FG000|Overall Study|Poor compliance to protocol|38|||
157214944|NCT01507831|567533556|FG001|Overall Study|Poor compliance to protocol|60|||
157214945|NCT01507831|567533555|FG000|Overall Study|Physician Decision|0|||
157214946|NCT01507831|567533556|FG001|Overall Study|Physician Decision|4|||
157214947|NCT01507831|567533555|FG000|Overall Study|Participant moved|5|||
157214948|NCT01507831|567533556|FG001|Overall Study|Participant moved|19|||
157214949|NCT01507831|567533555|FG000|Overall Study|Consent withdrawn by participant|34|||
157214950|NCT01507831|567533556|FG001|Overall Study|Consent withdrawn by participant|72|||
157214951|NCT01507831|567533555|FG000|Overall Study|Related to study drug administration|5|||
156699625|NCT01367665|565649171|FG001|Overall Study|Lost to Follow-up|22|||
157214952|NCT01507831|567533556|FG001|Overall Study|Related to study drug administration|14|||
157214953|NCT01507831|567533555|FG000|Overall Study|Last visit outside protocol visit window|51|||
156790756|NCT03654326|565985467|FG001|Overall Study|Physician Decision|1|||
157123271|NCT01790503|567203684|FG010|Overall Study|Death|0|||
157123272|NCT01790503|567203674|FG000|Overall Study|Non Compliance|0|||
157123273|NCT01790503|567203675|FG001|Overall Study|Non Compliance|0|||
157123274|NCT01790503|567203676|FG002|Overall Study|Non Compliance|0|||
157123275|NCT01790503|567203677|FG003|Overall Study|Non Compliance|0|||
157123276|NCT01790503|567203678|FG004|Overall Study|Non Compliance|1|||
157123277|NCT01790503|567203679|FG005|Overall Study|Non Compliance|0|||
157123278|NCT01790503|567203680|FG006|Overall Study|Non Compliance|0|||
157123279|NCT01790503|567203681|FG007|Overall Study|Non Compliance|0|||
157123280|NCT01790503|567203682|FG008|Overall Study|Non Compliance|0|||
157123281|NCT01790503|567203683|FG009|Overall Study|Non Compliance|0|||
157123282|NCT01790503|567203684|FG010|Overall Study|Non Compliance|0|||
157123283|NCT01790503|567203674|FG000|Overall Study|Other|0|||
157123284|NCT01790503|567203675|FG001|Overall Study|Other|0|||
157123285|NCT01790503|567203676|FG002|Overall Study|Other|0|||
157123286|NCT01790503|567203677|FG003|Overall Study|Other|0|||
157123287|NCT01790503|567203678|FG004|Overall Study|Other|1|||
157123288|NCT01790503|567203679|FG005|Overall Study|Other|0|||
157123289|NCT01790503|567203680|FG006|Overall Study|Other|0|||
157123290|NCT01790503|567203681|FG007|Overall Study|Other|0|||
157123291|NCT01790503|567203682|FG008|Overall Study|Other|1|||
157123292|NCT01790503|567203683|FG009|Overall Study|Other|2|||
157123293|NCT01790503|567203684|FG010|Overall Study|Other|0|||
157123294|NCT04183335|567203685|FG000|Overall Study|Adverse Event|1|||
157123295|NCT04183335|567203686|FG001|Overall Study|Adverse Event|0|||
157123296|NCT04183335|567203685|FG000|Overall Study|Withdrawal by Subject|12|||
157123297|NCT04183335|567203686|FG001|Overall Study|Withdrawal by Subject|3|||
157123298|NCT00049673|567203687|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
157123299|NCT00049673|567203688|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
157123300|NCT02322710|567203692|FG000|Overall Study|No efficacy assessment post-baseline|0|||
157123301|NCT02322710|567203693|FG001|Overall Study|No efficacy assessment post-baseline|1|||
157123302|NCT02322710|567203692|FG000|Overall Study|Protocol Violation|20|||
157123303|NCT02322710|567203693|FG001|Overall Study|Protocol Violation|25|||
157123304|NCT05064059|567203694|FG000|Overall Study|Death|199|||
157123305|NCT05064059|567203695|FG001|Overall Study|Death|196|||
157123306|NCT05064059|567203694|FG000|Overall Study|Physician Decision|4|||
157123307|NCT05064059|567203695|FG001|Overall Study|Physician Decision|2|||
157123308|NCT05064059|567203694|FG000|Overall Study|Sponsor Decision|14|||
157123309|NCT05064059|567203695|FG001|Overall Study|Sponsor Decision|11|||
157123310|NCT05064059|567203694|FG000|Overall Study|Withdrawal by Subject|4|||
157123311|NCT05064059|567203695|FG001|Overall Study|Withdrawal by Subject|11|||
157123312|NCT02615990|567203696|FG000|Overall Study|study terminated|1|||
157123313|NCT02615990|567203697|FG001|Overall Study|study terminated|1|||
157123314|NCT01934140|567203704|FG000|Persistence Phase (Year 6-10)|Other|24|||
157123315|NCT01934140|567203705|FG001|Persistence Phase (Year 6-10)|Other|6|||
157123316|NCT01934140|567203704|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
157123317|NCT01934140|567203705|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
157123318|NCT01934140|567203704|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
157123319|NCT01934140|567203705|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
157123320|NCT01934140|567203704|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
157123321|NCT01934140|567203705|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
157123322|NCT01934140|567203704|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
157123323|NCT01934140|567203705|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
157123324|NCT01934140|567203704|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
157123325|NCT01934140|567203705|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
157123326|NCT01934140|567203704|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
157123327|NCT01934140|567203705|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
157123328|NCT01934140|567203704|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
157123329|NCT01934140|567203705|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
157123330|NCT00808444|567203711|FG000|Overall Study|Withdrawal by Subject|1|||
157123331|NCT00808444|567203712|FG001|Overall Study|Withdrawal by Subject|0|||
157123332|NCT00808444|567203711|FG000|Overall Study|Lost to Follow-up|0|||
157123333|NCT00808444|567203712|FG001|Overall Study|Lost to Follow-up|1|||
157123334|NCT01461044|567203713|FG000|Overall Study|Death|58|||
157123335|NCT01461044|567203714|FG001|Overall Study|Death|35|||
157123336|NCT01461044|567203713|FG000|Overall Study|Lost to Follow-up|12|||
157123337|NCT01461044|567203714|FG001|Overall Study|Lost to Follow-up|5|||
157123338|NCT02889796|567203720|FG000|Overall Study|Withdrew Consent|18|||
157123339|NCT02889796|567203721|FG001|Overall Study|Withdrew Consent|29|||
157123340|NCT02889796|567203722|FG002|Overall Study|Withdrew Consent|20|||
157123341|NCT02889796|567203723|FG003|Overall Study|Withdrew Consent|1|||
157123342|NCT02889796|567203724|FG004|Overall Study|Withdrew Consent|2|||
157123343|NCT02889796|567203725|FG005|Overall Study|Withdrew Consent|35|||
157123344|NCT02889796|567203720|FG000|Overall Study|Investigator's Discretion|10|||
157123345|NCT02889796|567203721|FG001|Overall Study|Investigator's Discretion|9|||
157123346|NCT02889796|567203722|FG002|Overall Study|Investigator's Discretion|10|||
157123347|NCT02889796|567203723|FG003|Overall Study|Investigator's Discretion|3|||
157123348|NCT02889796|567203724|FG004|Overall Study|Investigator's Discretion|0|||
157123349|NCT02889796|567203725|FG005|Overall Study|Investigator's Discretion|15|||
157123350|NCT02889796|567203720|FG000|Overall Study|Adverse Event|17|||
157123351|NCT02889796|567203721|FG001|Overall Study|Adverse Event|8|||
157123352|NCT02889796|567203722|FG002|Overall Study|Adverse Event|8|||
157123353|NCT02889796|567203723|FG003|Overall Study|Adverse Event|4|||
157123354|NCT02889796|567203724|FG004|Overall Study|Adverse Event|1|||
157123355|NCT02889796|567203725|FG005|Overall Study|Adverse Event|7|||
157123356|NCT02889796|567203720|FG000|Overall Study|Lost to Follow-up|5|||
157123357|NCT02889796|567203721|FG001|Overall Study|Lost to Follow-up|7|||
157123358|NCT02889796|567203722|FG002|Overall Study|Lost to Follow-up|2|||
157123359|NCT02889796|567203723|FG003|Overall Study|Lost to Follow-up|0|||
157123360|NCT02889796|567203724|FG004|Overall Study|Lost to Follow-up|2|||
157123361|NCT02889796|567203725|FG005|Overall Study|Lost to Follow-up|6|||
157123362|NCT02889796|567203720|FG000|Overall Study|Protocol Violation|0|||
157123363|NCT02889796|567203721|FG001|Overall Study|Protocol Violation|1|||
157123364|NCT02889796|567203722|FG002|Overall Study|Protocol Violation|3|||
157123365|NCT02889796|567203723|FG003|Overall Study|Protocol Violation|0|||
157123366|NCT02889796|567203724|FG004|Overall Study|Protocol Violation|0|||
157123367|NCT02889796|567203725|FG005|Overall Study|Protocol Violation|4|||
157123368|NCT02889796|567203720|FG000|Overall Study|Non-compliance With Study Drug|0|||
157123369|NCT02889796|567203721|FG001|Overall Study|Non-compliance With Study Drug|2|||
157123370|NCT02889796|567203722|FG002|Overall Study|Non-compliance With Study Drug|0|||
157123371|NCT02889796|567203723|FG003|Overall Study|Non-compliance With Study Drug|0|||
157123372|NCT02889796|567203724|FG004|Overall Study|Non-compliance With Study Drug|1|||
157123373|NCT02889796|567203725|FG005|Overall Study|Non-compliance With Study Drug|2|||
157123374|NCT02889796|567203720|FG000|Overall Study|Death|1|||
157123375|NCT02889796|567203721|FG001|Overall Study|Death|1|||
157123376|NCT02889796|567203722|FG002|Overall Study|Death|0|||
157123377|NCT02889796|567203723|FG003|Overall Study|Death|1|||
157123378|NCT02889796|567203724|FG004|Overall Study|Death|0|||
157123379|NCT02889796|567203725|FG005|Overall Study|Death|1|||
157123380|NCT02889796|567203720|FG000|Overall Study|Pregnancy|0|||
157123381|NCT02889796|567203721|FG001|Overall Study|Pregnancy|1|||
157123382|NCT02889796|567203722|FG002|Overall Study|Pregnancy|1|||
157123383|NCT02889796|567203723|FG003|Overall Study|Pregnancy|0|||
157123384|NCT02889796|567203724|FG004|Overall Study|Pregnancy|0|||
157123385|NCT02889796|567203725|FG005|Overall Study|Pregnancy|0|||
157123386|NCT02889796|567203720|FG000|Overall Study|Randomized but not Dosed|2|||
157123387|NCT02889796|567203721|FG001|Overall Study|Randomized but not Dosed|0|||
157123388|NCT02889796|567203722|FG002|Overall Study|Randomized but not Dosed|0|||
157123389|NCT02889796|567203723|FG003|Overall Study|Randomized but not Dosed|0|||
157123390|NCT02889796|567203724|FG004|Overall Study|Randomized but not Dosed|0|||
157123391|NCT02889796|567203725|FG005|Overall Study|Randomized but not Dosed|2|||
157123392|NCT04294459|567203726|FG000|Overall Study|Adverse Event|0|||
157123393|NCT04294459|567203727|FG001|Overall Study|Adverse Event|1|||
157123394|NCT02787863|567203728|FG000|Overall Study|Death|1|||
157123395|NCT02787863|567203729|FG001|Overall Study|Death|0|||
157123396|NCT02787863|567203730|FG002|Overall Study|Death|1|||
157123397|NCT02787863|567203731|FG003|Overall Study|Death|0|||
157123398|NCT02787863|567203732|FG004|Overall Study|Death|0|||
157123399|NCT02787863|567203733|FG005|Overall Study|Death|0|||
157123400|NCT02787863|567203734|FG006|Overall Study|Death|0|||
157123401|NCT02787863|567203735|FG007|Overall Study|Death|0|||
157123402|NCT02787863|567203728|FG000|Overall Study|Withdrawal by Subject|0|||
157123403|NCT02787863|567203729|FG001|Overall Study|Withdrawal by Subject|1|||
157123404|NCT02787863|567203730|FG002|Overall Study|Withdrawal by Subject|1|||
157123405|NCT02787863|567203731|FG003|Overall Study|Withdrawal by Subject|0|||
157123406|NCT02787863|567203732|FG004|Overall Study|Withdrawal by Subject|0|||
157123407|NCT02787863|567203733|FG005|Overall Study|Withdrawal by Subject|0|||
156699626|NCT01367665|565649170|FG000|Overall Study|Not Done|118|||
156699627|NCT01367665|565649171|FG001|Overall Study|Not Done|14|||
157123408|NCT02787863|567203734|FG006|Overall Study|Withdrawal by Subject|0|||
157123409|NCT02787863|567203735|FG007|Overall Study|Withdrawal by Subject|0|||
157123410|NCT01414257|567203736|FG000|Overall Study|No Visit After First Day of Treatment|12|||
157123411|NCT01414257|567203736|FG000|Overall Study|Protocol Violation|10|||
157123412|NCT02421887|567203737|FG000|Overall Study|Lost to Follow-up|5|||
157123413|NCT02421887|567203738|FG001|Overall Study|Lost to Follow-up|0|||
157123414|NCT02421887|567203737|FG000|Overall Study|Withdrawal by Subject|8|||
157123415|NCT02421887|567203738|FG001|Overall Study|Withdrawal by Subject|5|||
157123416|NCT02421887|567203737|FG000|Overall Study|Physician Decision|2|||
157123417|NCT02421887|567203738|FG001|Overall Study|Physician Decision|4|||
157123418|NCT02421887|567203737|FG000|Overall Study|Adverse Event|2|||
157123419|NCT02421887|567203738|FG001|Overall Study|Adverse Event|0|||
157123420|NCT01882907|567203739|FG000|Overall Study|Adverse Event|3|||
156699628|NCT03283319|565649172|FG000|Overall Study|Lost to Follow-up|5|||
157123421|NCT01882907|567203740|FG001|Overall Study|Adverse Event|1|||
157123422|NCT01882907|567203739|FG000|Overall Study|Lack of Efficacy|0|||
157123423|NCT01882907|567203740|FG001|Overall Study|Lack of Efficacy|3|||
157123424|NCT01882907|567203739|FG000|Overall Study|Lost to Follow-up|1|||
156699629|NCT03283319|565649173|FG001|Overall Study|Lost to Follow-up|4|||
156699630|NCT03283319|565649174|FG002|Overall Study|Lost to Follow-up|5|||
156699631|NCT03283319|565649175|FG003|Overall Study|Lost to Follow-up|5|||
156699632|NCT03283319|565649176|FG004|Overall Study|Lost to Follow-up|4|||
156699633|NCT03283319|565649177|FG005|Overall Study|Lost to Follow-up|3|||
156699634|NCT03283319|565649172|FG000|Overall Study|Withdrawal by Subject|2|||
156699635|NCT03283319|565649173|FG001|Overall Study|Withdrawal by Subject|2|||
156699636|NCT03283319|565649174|FG002|Overall Study|Withdrawal by Subject|2|||
156699637|NCT03283319|565649175|FG003|Overall Study|Withdrawal by Subject|1|||
156699638|NCT03283319|565649176|FG004|Overall Study|Withdrawal by Subject|0|||
156699639|NCT03283319|565649177|FG005|Overall Study|Withdrawal by Subject|1|||
156699640|NCT03283319|565649172|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699641|NCT03283319|565649173|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699642|NCT03283319|565649174|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699643|NCT03283319|565649175|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
156699644|NCT03283319|565649176|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699645|NCT03283319|565649177|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
156699646|NCT03954834|565649179|FG000|Overall Study|Adverse Event|1|||
156699647|NCT03954834|565649180|FG001|Overall Study|Adverse Event|3|||
156699648|NCT03954834|565649181|FG002|Overall Study|Adverse Event|1|||
156699649|NCT03954834|565649182|FG003|Overall Study|Adverse Event|1|||
156699650|NCT03954834|565649179|FG000|Overall Study|Death|0|||
156699651|NCT03954834|565649180|FG001|Overall Study|Death|0|||
156699652|NCT03954834|565649181|FG002|Overall Study|Death|0|||
156699653|NCT03954834|565649182|FG003|Overall Study|Death|1|||
156699654|NCT03954834|565649179|FG000|Overall Study|Physician Decision|0|||
156699655|NCT03954834|565649180|FG001|Overall Study|Physician Decision|1|||
156699656|NCT03954834|565649181|FG002|Overall Study|Physician Decision|0|||
156699657|NCT03954834|565649182|FG003|Overall Study|Physician Decision|2|||
156699658|NCT03954834|565649179|FG000|Overall Study|Protocol Violation|1|||
156699659|NCT03954834|565649180|FG001|Overall Study|Protocol Violation|0|||
156699660|NCT03954834|565649181|FG002|Overall Study|Protocol Violation|0|||
156699661|NCT03954834|565649182|FG003|Overall Study|Protocol Violation|1|||
156699662|NCT03954834|565649179|FG000|Overall Study|Withdrawal by Subject|2|||
156699663|NCT03954834|565649180|FG001|Overall Study|Withdrawal by Subject|3|||
156699664|NCT03954834|565649181|FG002|Overall Study|Withdrawal by Subject|13|||
156699665|NCT03954834|565649182|FG003|Overall Study|Withdrawal by Subject|6|||
156699666|NCT03954834|565649179|FG000|Overall Study|Participant left the country|0|||
156699667|NCT03954834|565649180|FG001|Overall Study|Participant left the country|0|||
157123425|NCT01882907|567203740|FG001|Overall Study|Lost to Follow-up|4|||
157123426|NCT01882907|567203739|FG000|Overall Study|Protocol Violation|10|||
157123427|NCT01882907|567203740|FG001|Overall Study|Protocol Violation|14|||
157123428|NCT01882907|567203739|FG000|Overall Study|Withdrawal by Subject|0|||
157123429|NCT01882907|567203740|FG001|Overall Study|Withdrawal by Subject|6|||
157123430|NCT01978093|567203741|FG000|Overall Study|Death|1|||
157123431|NCT01978093|567203742|FG001|Overall Study|Death|0|||
157123432|NCT01978093|567203741|FG000|Overall Study|Adverse Event|0|||
157123433|NCT01978093|567203742|FG001|Overall Study|Adverse Event|5|||
157123434|NCT01978093|567203741|FG000|Overall Study|Protocol Violation|8|||
157123435|NCT01978093|567203742|FG001|Overall Study|Protocol Violation|2|||
157123436|NCT01978093|567203741|FG000|Overall Study|Withdrawal by Subject|29|||
157123437|NCT01978093|567203742|FG001|Overall Study|Withdrawal by Subject|25|||
157123438|NCT01978093|567203741|FG000|Overall Study|Lost to Follow-up|11|||
157123439|NCT01978093|567203742|FG001|Overall Study|Lost to Follow-up|15|||
157123440|NCT01978093|567203741|FG000|Overall Study|Migrated/moved from study area|11|||
156699668|NCT03954834|565649181|FG002|Overall Study|Participant left the country|1|||
157123441|NCT01978093|567203742|FG001|Overall Study|Migrated/moved from study area|13|||
157123442|NCT01978093|567203741|FG000|Overall Study|Loss of kaiser coverage|4|||
157123443|NCT01978093|567203742|FG001|Overall Study|Loss of kaiser coverage|10|||
157123444|NCT01978093|567203741|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
157123445|NCT01978093|567203742|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
157123446|NCT01978093|567203741|FG000|Overall Study|Mother lost custody of child|0|||
157123447|NCT01978093|567203742|FG001|Overall Study|Mother lost custody of child|1|||
157214954|NCT01507831|567533556|FG001|Overall Study|Last visit outside protocol visit window|143|||
156699669|NCT03954834|565649182|FG003|Overall Study|Participant left the country|0|||
156699670|NCT03954834|565649179|FG000|Overall Study|Lost to Follow-up|3|||
157123448|NCT01978093|567203741|FG000|Overall Study|Child was in care of grandmother|0|||
156699671|NCT03954834|565649180|FG001|Overall Study|Lost to Follow-up|2|||
156699672|NCT03954834|565649181|FG002|Overall Study|Lost to Follow-up|3|||
156699673|NCT03954834|565649182|FG003|Overall Study|Lost to Follow-up|5|||
156699674|NCT04711902|565649186|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699675|NCT04711902|565649187|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699676|NCT04711902|565649188|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
157123449|NCT01978093|567203742|FG001|Overall Study|Child was in care of grandmother|1|||
156699677|NCT04711902|565649189|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
157123450|NCT01978093|567203741|FG000|Overall Study|N/A for vaccine administration|0|||
157123451|NCT01978093|567203742|FG001|Overall Study|N/A for vaccine administration|1|||
157123452|NCT01396005|567203743|FG000|Overall Study|Withdrawal by Subject|0|||
157123453|NCT01396005|567203744|FG001|Overall Study|Withdrawal by Subject|1|||
157123454|NCT01396005|567203743|FG000|Overall Study|Non-compliance with protocol|0|||
157123455|NCT01396005|567203744|FG001|Overall Study|Non-compliance with protocol|1|||
157123456|NCT01467492|567203747|FG000|Overall Study|Withdrawal by Subject|6|||
157123457|NCT01467492|567203748|FG001|Overall Study|Withdrawal by Subject|4|||
157123458|NCT01467492|567203747|FG000|Overall Study|Study Terminated by Sponsor|6|||
157123459|NCT01467492|567203748|FG001|Overall Study|Study Terminated by Sponsor|4|||
157123460|NCT01467492|567203747|FG000|Overall Study|Adverse Event|4|||
157123461|NCT01467492|567203748|FG001|Overall Study|Adverse Event|3|||
157123462|NCT01467492|567203747|FG000|Overall Study|Lost to Follow-up|3|||
157123463|NCT01467492|567203748|FG001|Overall Study|Lost to Follow-up|2|||
157123464|NCT01467492|567203747|FG000|Overall Study|Undefined|2|||
157123465|NCT01467492|567203748|FG001|Overall Study|Undefined|0|||
157123466|NCT01467492|567203747|FG000|Overall Study|Enrolled But Not Treated|1|||
157123467|NCT01467492|567203748|FG001|Overall Study|Enrolled But Not Treated|0|||
157123468|NCT02450487|567203749|FG000|Overall Study|Lost to Follow-up|3|||
157123469|NCT04269395|567203750|FG000|Overall Study|Lost to Follow-up|1|||
157123470|NCT04269395|567203751|FG001|Overall Study|Lost to Follow-up|0|||
157123471|NCT04269395|567203750|FG000|Overall Study|Study terminated by Sponsor|13|||
157123472|NCT04269395|567203751|FG001|Overall Study|Study terminated by Sponsor|10|||
157123473|NCT01491178|567203752|FG000|Overall Study|Adverse Event|1016|||
157123474|NCT01491178|567203752|FG000|Overall Study|Improvement of NVAF|210|||
157123475|NCT01491178|567203752|FG000|Overall Study|To conduct invasive treatment|59|||
157123476|NCT01491178|567203752|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
157123477|NCT01491178|567203752|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
157123478|NCT01491178|567203752|FG000|Overall Study|To take a contraindication|20|||
157123479|NCT01491178|567203752|FG000|Overall Study|Other than specified above|657|||
157214955|NCT01507831|567533555|FG000|Overall Study|Selection criteria finally not met|0|||
156699678|NCT04711902|565649190|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699679|NCT04711902|565649191|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
156699680|NCT03786718|565649192|FG000|Overall Study|Lost to Follow-up|3|||
156699681|NCT03786718|565649192|FG000|Overall Study|Withdrawal by Subject|1|||
156699682|NCT03786718|565649192|FG000|Overall Study|Did not use the intervention|2|||
156699683|NCT03786718|565649192|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
156699684|NCT00372411|565649199|FG000|Overall Study|Withdrawal by Subject|3|||
156699685|NCT00372411|565649200|FG001|Overall Study|Withdrawal by Subject|4|||
156699686|NCT00372411|565649201|FG002|Overall Study|Withdrawal by Subject|1|||
156699687|NCT00372411|565649199|FG000|Overall Study|Death|0|||
156699688|NCT00372411|565649200|FG001|Overall Study|Death|2|||
156699689|NCT00372411|565649201|FG002|Overall Study|Death|1|||
156699690|NCT00372411|565649199|FG000|Overall Study|Lost to Follow-up|1|||
156699691|NCT00372411|565649200|FG001|Overall Study|Lost to Follow-up|1|||
156699692|NCT00372411|565649201|FG002|Overall Study|Lost to Follow-up|1|||
156699693|NCT00372411|565649199|FG000|Overall Study|Adverse Event|1|||
156699694|NCT00372411|565649200|FG001|Overall Study|Adverse Event|1|||
156872011|NCT00473382|566289492|FG002|Core Study|Adverse Event|1|||
157123480|NCT05689047|567203755|FG000|Overall Study|Lost to Follow-up|0|||
157123481|NCT05689047|567203756|FG001|Overall Study|Lost to Follow-up|1|||
157123482|NCT05689047|567203755|FG000|Overall Study|Protocol Deviation|1|||
157123483|NCT05689047|567203756|FG001|Overall Study|Protocol Deviation|0|||
157123484|NCT01604512|567203757|FG000|Overall Study|Withdrawal by Subject|3|||
157123485|NCT01604512|567203757|FG000|Overall Study|Not treated|4|||
157123486|NCT03132636|567203758|FG000|Overall Study|Adverse Event|1|||
157123487|NCT03132636|567203759|FG001|Overall Study|Adverse Event|2|||
157123488|NCT03132636|567203758|FG000|Overall Study|Death|4|||
157123489|NCT03132636|567203759|FG001|Overall Study|Death|7|||
157123490|NCT03132636|567203758|FG000|Overall Study|Lost to Follow-up|3|||
157123491|NCT03132636|567203759|FG001|Overall Study|Lost to Follow-up|2|||
157123492|NCT03132636|567203758|FG000|Overall Study|Non compliance with protocol by participant|1|||
157123493|NCT03132636|567203759|FG001|Overall Study|Non compliance with protocol by participant|1|||
157123494|NCT03132636|567203758|FG000|Overall Study|Subject decision|1|||
157123495|NCT03132636|567203759|FG001|Overall Study|Subject decision|9|||
157123496|NCT03132636|567203758|FG000|Overall Study|Sponsor decision|0|||
157123497|NCT03132636|567203759|FG001|Overall Study|Sponsor decision|1|||
157123498|NCT03132636|567203758|FG000|Overall Study|Physician Decision|1|||
156699695|NCT00372411|565649201|FG002|Overall Study|Adverse Event|0|||
156699696|NCT01398514|565649202|FG000|Overall Study|Adverse Event|1|||
157123499|NCT03132636|567203759|FG001|Overall Study|Physician Decision|0|||
157123500|NCT03132636|567203758|FG000|Overall Study|Progressive disease|33|||
156699697|NCT01398514|565649203|FG001|Overall Study|Adverse Event|0|||
157123501|NCT03132636|567203759|FG001|Overall Study|Progressive disease|36|||
157123502|NCT03132636|567203758|FG000|Overall Study|Withdrawal of consent|2|||
157123503|NCT03132636|567203759|FG001|Overall Study|Withdrawal of consent|5|||
157123504|NCT03132636|567203758|FG000|Overall Study|Did not re-consent|1|||
156699698|NCT01398514|565649202|FG000|Overall Study|Non-compliance with study procedures|2|||
156699699|NCT01398514|565649203|FG001|Overall Study|Non-compliance with study procedures|0|||
156699700|NCT01398514|565649202|FG000|Overall Study|Physiologic non-responsiveness|1|||
156699701|NCT01398514|565649203|FG001|Overall Study|Physiologic non-responsiveness|3|||
156699702|NCT01398514|565649202|FG000|Overall Study|Failure to show a conditioned response|4|||
156699703|NCT01398514|565649203|FG001|Overall Study|Failure to show a conditioned response|3|||
156699704|NCT05961215|565649205|FG000|Overall Study|Withdrawal by Subject|1|||
156699705|NCT06187909|565649209|FG000|Overall Study|Withdrawal by Subject|2|||
156699706|NCT06187909|565649210|FG001|Overall Study|Withdrawal by Subject|2|||
156699707|NCT04126213|565649220|FG000|Overall Study|Lost to Follow-up|9|||
156699708|NCT04126213|565649221|FG001|Overall Study|Lost to Follow-up|1|||
156699709|NCT04126213|565649222|FG002|Overall Study|Lost to Follow-up|5|||
156699710|NCT04126213|565649223|FG003|Overall Study|Lost to Follow-up|10|||
156699711|NCT04126213|565649224|FG004|Overall Study|Lost to Follow-up|4|||
156699712|NCT04126213|565649225|FG005|Overall Study|Lost to Follow-up|7|||
156699713|NCT04126213|565649220|FG000|Overall Study|Withdrawal by Subject|3|||
156699714|NCT04126213|565649221|FG001|Overall Study|Withdrawal by Subject|2|||
156699715|NCT04126213|565649222|FG002|Overall Study|Withdrawal by Subject|1|||
156699716|NCT04126213|565649223|FG003|Overall Study|Withdrawal by Subject|1|||
156699717|NCT04126213|565649224|FG004|Overall Study|Withdrawal by Subject|1|||
156699718|NCT04126213|565649225|FG005|Overall Study|Withdrawal by Subject|1|||
156699719|NCT04126213|565649220|FG000|Overall Study|Other|0|||
156699720|NCT04126213|565649221|FG001|Overall Study|Other|0|||
156699721|NCT04126213|565649222|FG002|Overall Study|Other|2|||
156699722|NCT04126213|565649223|FG003|Overall Study|Other|2|||
156699723|NCT04126213|565649224|FG004|Overall Study|Other|0|||
156699724|NCT04126213|565649225|FG005|Overall Study|Other|1|||
156699725|NCT04126213|565649220|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156699726|NCT04126213|565649221|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156699727|NCT04126213|565649222|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156699728|NCT04126213|565649223|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156699729|NCT04126213|565649224|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156699730|NCT04126213|565649225|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156699731|NCT02283983|565649228|FG000|Overall Study|Inclusion criteria not met|0|||
156699732|NCT02283983|565649229|FG001|Overall Study|Inclusion criteria not met|1|||
156699733|NCT02283983|565649228|FG000|Overall Study|Withdrawal by Subject|4|||
156699734|NCT02283983|565649229|FG001|Overall Study|Withdrawal by Subject|2|||
156699735|NCT02283983|565649228|FG000|Overall Study|Protocol Violation|0|||
157014976|NCT02576509|566806723|FG000|Treatment Period|Death|1|||
157014977|NCT02576509|566806724|FG001|Treatment Period|Death|1|||
156699736|NCT02283983|565649229|FG001|Overall Study|Protocol Violation|4|||
156699737|NCT02283983|565649228|FG000|Overall Study|Physician Decision|2|||
156699738|NCT02283983|565649229|FG001|Overall Study|Physician Decision|4|||
156699739|NCT02283983|565649228|FG000|Overall Study|Death|1|||
156699740|NCT02283983|565649229|FG001|Overall Study|Death|0|||
156699741|NCT02283983|565649228|FG000|Overall Study|Adverse Event|1|||
156699742|NCT02283983|565649229|FG001|Overall Study|Adverse Event|0|||
156699743|NCT02283983|565649228|FG000|Overall Study|Lost to Follow-up|9|||
156699744|NCT02283983|565649229|FG001|Overall Study|Lost to Follow-up|8|||
156699745|NCT02283983|565649228|FG000|Overall Study|Relapse|1|||
156699746|NCT02283983|565649229|FG001|Overall Study|Relapse|0|||
156699747|NCT00620555|565649231|FG000|Overall Study|Adverse Event|4|||
156699748|NCT00620555|565649231|FG000|Overall Study|Protocol Violation|2|||
156699749|NCT00620555|565649231|FG000|Overall Study|Lack of Efficacy|12|||
156699750|NCT00620555|565649231|FG000|Overall Study|Withdrawal by Subject|1|||
156699751|NCT00620555|565649231|FG000|Overall Study|Choice of other treatment|1|||
156699752|NCT00620555|565649231|FG000|Overall Study|Visit failure against planned|1|||
156699753|NCT00669071|565649233|FG000|Overall Study|Lost to Follow-up|3|||
156699754|NCT00669071|565649233|FG000|Overall Study|Final visit 40 days out of window|1|||
156699755|NCT03734666|565649235|FG000|Overall Study|Other|7|||
156699756|NCT03734666|565649236|FG001|Overall Study|Other|4|||
156699757|NCT03734666|565649235|FG000|Overall Study|Lost to Follow-up|12|||
156699758|NCT03734666|565649236|FG001|Overall Study|Lost to Follow-up|12|||
157014978|NCT02576509|566806723|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
157014979|NCT02576509|566806724|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
156699759|NCT01910389|565649237|FG000|Overall Study|Withdrawal by Subject|2|||
156699760|NCT01910389|565649238|FG001|Overall Study|Withdrawal by Subject|0|||
156699761|NCT01910389|565649237|FG000|Overall Study|Study Closed|13|||
156699762|NCT01910389|565649238|FG001|Overall Study|Study Closed|8|||
157021746|NCT03673111|566832951|FG006|Overall Study|Adverse Event|0|||
156699763|NCT05896202|565649246|FG000|Overall Study|Lost to Follow-up|2|||
156699764|NCT05896202|565649247|FG001|Overall Study|Lost to Follow-up|2|||
156699765|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
156699766|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
156699767|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
156699768|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
156699769|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
156699770|NCT01490866|565649248|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
156699771|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
156699772|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
156699773|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
156699774|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
156699775|NCT01490866|565649248|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
156699776|NCT02435836|565649249|FG000|Overall Study|Lost to Follow-up|21|||
156699777|NCT02435836|565649249|FG000|Overall Study|Lack of Efficacy|1|||
156699778|NCT02435836|565649249|FG000|Overall Study|Withdrawal by Subject|236|||
156699779|NCT02435836|565649249|FG000|Overall Study|Insufficient Clinical Response|26|||
156699780|NCT02435836|565649249|FG000|Overall Study|Adverse Event|44|||
156699781|NCT02435836|565649249|FG000|Overall Study|Sponsor discontinued trial|167|||
156699782|NCT02435836|565649249|FG000|Overall Study|Noncompliance|27|||
156699783|NCT02435836|565649249|FG000|Overall Study|Protocol Violation|6|||
156699784|NCT02435836|565649249|FG000|Overall Study|Met Withdrawal Criteria|7|||
156699785|NCT02435836|565649249|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
156699786|NCT03201211|565649252|FG000|Overall Study|Adverse Event|1|||
156699787|NCT03201211|565649253|FG001|Overall Study|Adverse Event|0|||
156699788|NCT03201211|565649254|FG002|Overall Study|Adverse Event|0|||
156699789|NCT03201211|565649252|FG000|Overall Study|Protocol Violation|1|||
156699790|NCT03201211|565649253|FG001|Overall Study|Protocol Violation|0|||
156699791|NCT03201211|565649254|FG002|Overall Study|Protocol Violation|0|||
156699792|NCT03201211|565649252|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156699793|NCT03201211|565649253|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
156699794|NCT03201211|565649254|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
156699795|NCT03201211|565649252|FG000|Overall Study|OTHER unknown reasons|0|||
156699796|NCT03201211|565649253|FG001|Overall Study|OTHER unknown reasons|1|||
156699797|NCT03201211|565649254|FG002|Overall Study|OTHER unknown reasons|0|||
156699798|NCT01970865|565649255|FG000|Overall Study|Death|3|||
156699799|NCT01970865|565649256|FG001|Overall Study|Death|2|||
156699800|NCT01970865|565649257|FG002|Overall Study|Death|3|||
156699801|NCT01970865|565649258|FG003|Overall Study|Death|6|||
156699802|NCT01970865|565649259|FG004|Overall Study|Death|9|||
156699803|NCT01970865|565649260|FG005|Overall Study|Death|3|||
156699804|NCT01970865|565649261|FG006|Overall Study|Death|2|||
156699805|NCT01970865|565649262|FG007|Overall Study|Death|3|||
156790757|NCT03654326|565985466|FG000|Overall Study|Unable to adhere to study schedule|0|||
156790758|NCT03654326|565985467|FG001|Overall Study|Unable to adhere to study schedule|1|||
156790759|NCT03654326|565985466|FG000|Overall Study|Lost to Follow-up|1|||
156790760|NCT03654326|565985467|FG001|Overall Study|Lost to Follow-up|1|||
156790761|NCT03473301|565985468|FG000|Overall Study|Protocol Violation|4|||
156790762|NCT03473301|565985469|FG001|Overall Study|Protocol Violation|0|||
156790763|NCT03473301|565985470|FG002|Overall Study|Protocol Violation|0|||
156790764|NCT03473301|565985468|FG000|Overall Study|Withdrawal by Subject|0|||
156790765|NCT03473301|565985469|FG001|Overall Study|Withdrawal by Subject|1|||
156790766|NCT03473301|565985470|FG002|Overall Study|Withdrawal by Subject|0|||
156790767|NCT03473301|565985468|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
156790768|NCT03473301|565985469|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
156790769|NCT03473301|565985470|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
156790770|NCT00835042|565985471|FG000|First Intervention|Withdrawal by Subject|3|||
156790771|NCT00835042|565985472|FG001|First Intervention|Withdrawal by Subject|0|||
156790772|NCT00835042|565985471|FG000|First Intervention|Adverse Event|1|||
156790773|NCT00835042|565985472|FG001|First Intervention|Adverse Event|2|||
156790774|NCT00835042|565985471|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
156790775|NCT00835042|565985472|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
156790776|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
156790777|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
156790778|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
157123505|NCT03132636|567203759|FG001|Overall Study|Did not re-consent|0|||
157123506|NCT03132636|567203758|FG000|Overall Study|Lost insurance coverage|1|||
156699806|NCT01970865|565649263|FG008|Overall Study|Death|2|||
156699807|NCT01970865|565649264|FG009|Overall Study|Death|2|||
156699808|NCT01970865|565649265|FG010|Overall Study|Death|8|||
156699809|NCT01970865|565649266|FG011|Overall Study|Death|13|||
156790779|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
157123507|NCT03132636|567203759|FG001|Overall Study|Lost insurance coverage|0|||
157123508|NCT03132636|567203758|FG000|Overall Study|Related to radiological outcomes|0|||
156790780|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
156790781|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
156790782|NCT02662582|565985473|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156699810|NCT01970865|565649267|FG012|Overall Study|Death|25|||
156699811|NCT01970865|565649268|FG013|Overall Study|Death|46|||
156699812|NCT01970865|565649269|FG014|Overall Study|Death|37|||
156699813|NCT01970865|565649270|FG015|Overall Study|Death|22|||
156699814|NCT01970865|565649271|FG016|Overall Study|Death|1|||
156699815|NCT01970865|565649272|FG017|Overall Study|Death|17|||
156872012|NCT00473382|566289490|FG000|Core Study|Death|3|||
156872013|NCT00473382|566289491|FG001|Core Study|Death|5|||
156872014|NCT00473382|566289492|FG002|Core Study|Death|10|||
157014980|NCT02576509|566806723|FG000|Treatment Period|Participant request to stop treatment|8|||
157014981|NCT02576509|566806724|FG001|Treatment Period|Participant request to stop treatment|18|||
157014982|NCT02576509|566806723|FG000|Treatment Period|Participant withdrew consent|3|||
157014983|NCT02576509|566806724|FG001|Treatment Period|Participant withdrew consent|7|||
157014984|NCT02576509|566806723|FG000|Treatment Period|Lost to Follow-up|0|||
157014985|NCT02576509|566806724|FG001|Treatment Period|Lost to Follow-up|1|||
157014986|NCT02576509|566806723|FG000|Treatment Period|Maximum clinical benefit|1|||
157014987|NCT02576509|566806724|FG001|Treatment Period|Maximum clinical benefit|0|||
157014988|NCT02576509|566806723|FG000|Treatment Period|Poor/non-compliance|1|||
157014989|NCT02576509|566806724|FG001|Treatment Period|Poor/non-compliance|1|||
157014990|NCT02576509|566806723|FG000|Treatment Period|Participant no longer meets criteria|1|||
157014991|NCT02576509|566806724|FG001|Treatment Period|Participant no longer meets criteria|0|||
157014992|NCT02576509|566806723|FG000|Treatment Period|Other reason|12|||
157014993|NCT02576509|566806724|FG001|Treatment Period|Other reason|8|||
157014994|NCT02576509|566806723|FG000|Treatment Period|NOT REPORTED|1|||
157014995|NCT02576509|566806724|FG001|Treatment Period|NOT REPORTED|0|||
157014996|NCT02576509|566806723|FG000|Treatment Period|Administrative reason by sponsor|0|||
157014997|NCT02576509|566806724|FG001|Treatment Period|Administrative reason by sponsor|1|||
157014998|NCT01216176|566806727|FG000|Overall Study|Adverse Event|0|||
157014999|NCT01216176|566806728|FG001|Overall Study|Adverse Event|8|||
157015000|NCT01216176|566806729|FG002|Overall Study|Adverse Event|0|||
157015001|NCT01216176|566806727|FG000|Overall Study|Physician Decision|0|||
157015002|NCT01216176|566806728|FG001|Overall Study|Physician Decision|0|||
157015003|NCT01216176|566806729|FG002|Overall Study|Physician Decision|1|||
157015004|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
157015005|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
157015006|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
157015007|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
157015008|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
157015009|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
157015010|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
157015011|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
157015012|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
157015013|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
157015014|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
157015015|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
157015016|NCT01600014|566806730|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
157015017|NCT01600014|566806731|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
157015018|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
157015019|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
157015020|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
157015021|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
157015022|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
157015023|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
157015024|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
157015025|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
157015026|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
157015027|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
157015028|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
157015029|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
157015030|NCT01600014|566806730|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
157015031|NCT01600014|566806731|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
157015032|NCT01600014|566806730|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
157015033|NCT01600014|566806731|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
157015034|NCT01600014|566806730|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
157015035|NCT01600014|566806731|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
157015036|NCT01600014|566806730|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
157015037|NCT01600014|566806731|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
157015038|NCT03481660|566806732|FG000|Overall Study|Adverse Event|5|||
157015039|NCT03481660|566806733|FG001|Overall Study|Adverse Event|4|||
157015040|NCT03481660|566806732|FG000|Overall Study|Death|13|||
157015041|NCT03481660|566806733|FG001|Overall Study|Death|9|||
157015042|NCT03481660|566806732|FG000|Overall Study|Lost to Follow-up|2|||
157015043|NCT03481660|566806733|FG001|Overall Study|Lost to Follow-up|2|||
157015044|NCT03481660|566806732|FG000|Overall Study|Physician Decision|2|||
157015045|NCT03481660|566806733|FG001|Overall Study|Physician Decision|3|||
157015046|NCT03481660|566806732|FG000|Overall Study|Withdrawal by Subject|14|||
157214956|NCT01507831|567533556|FG001|Overall Study|Selection criteria finally not met|1|||
157214957|NCT01507831|567533555|FG000|Overall Study|Site closure|0|||
157214958|NCT01507831|567533556|FG001|Overall Study|Site closure|3|||
156699816|NCT01970865|565649255|FG000|Overall Study|Lost to Follow-up|0|||
156699817|NCT01970865|565649256|FG001|Overall Study|Lost to Follow-up|0|||
156699818|NCT01970865|565649257|FG002|Overall Study|Lost to Follow-up|0|||
156699819|NCT01970865|565649258|FG003|Overall Study|Lost to Follow-up|1|||
156699820|NCT01970865|565649259|FG004|Overall Study|Lost to Follow-up|1|||
156699821|NCT01970865|565649260|FG005|Overall Study|Lost to Follow-up|0|||
156699822|NCT01970865|565649261|FG006|Overall Study|Lost to Follow-up|0|||
156699823|NCT01970865|565649262|FG007|Overall Study|Lost to Follow-up|0|||
156699824|NCT01970865|565649263|FG008|Overall Study|Lost to Follow-up|0|||
156699825|NCT01970865|565649264|FG009|Overall Study|Lost to Follow-up|0|||
156699826|NCT01970865|565649265|FG010|Overall Study|Lost to Follow-up|1|||
156699827|NCT01970865|565649266|FG011|Overall Study|Lost to Follow-up|0|||
156699828|NCT01970865|565649267|FG012|Overall Study|Lost to Follow-up|2|||
156699829|NCT01970865|565649268|FG013|Overall Study|Lost to Follow-up|0|||
156699830|NCT01970865|565649269|FG014|Overall Study|Lost to Follow-up|1|||
156699831|NCT01970865|565649270|FG015|Overall Study|Lost to Follow-up|4|||
156699832|NCT01970865|565649271|FG016|Overall Study|Lost to Follow-up|0|||
156699833|NCT01970865|565649272|FG017|Overall Study|Lost to Follow-up|1|||
156699834|NCT01970865|565649255|FG000|Overall Study|Other|0|||
156699835|NCT01970865|565649256|FG001|Overall Study|Other|1|||
156699836|NCT01970865|565649257|FG002|Overall Study|Other|0|||
156699837|NCT01970865|565649258|FG003|Overall Study|Other|1|||
156699838|NCT01970865|565649259|FG004|Overall Study|Other|1|||
156699839|NCT01970865|565649260|FG005|Overall Study|Other|0|||
156699840|NCT01970865|565649261|FG006|Overall Study|Other|1|||
156699841|NCT01970865|565649262|FG007|Overall Study|Other|0|||
156699842|NCT01970865|565649263|FG008|Overall Study|Other|0|||
156699843|NCT01970865|565649264|FG009|Overall Study|Other|0|||
156699844|NCT01970865|565649265|FG010|Overall Study|Other|2|||
156699845|NCT01970865|565649266|FG011|Overall Study|Other|3|||
156699846|NCT01970865|565649267|FG012|Overall Study|Other|8|||
156699847|NCT01970865|565649268|FG013|Overall Study|Other|3|||
156699848|NCT01970865|565649269|FG014|Overall Study|Other|2|||
156699849|NCT01970865|565649270|FG015|Overall Study|Other|3|||
156699850|NCT01970865|565649271|FG016|Overall Study|Other|0|||
156699851|NCT01970865|565649272|FG017|Overall Study|Other|2|||
156699852|NCT01970865|565649255|FG000|Overall Study|Participant refused further follow-up|0|||
156699853|NCT01970865|565649256|FG001|Overall Study|Participant refused further follow-up|0|||
156699854|NCT01970865|565649257|FG002|Overall Study|Participant refused further follow-up|0|||
157015047|NCT03481660|566806733|FG001|Overall Study|Withdrawal by Subject|7|||
157015048|NCT02791230|566806734|FG000|Overall Study|Adverse Event|10|||
157214959|NCT01507831|567533555|FG000|Overall Study|Potential lost to follow-up|3|||
157214960|NCT01507831|567533556|FG001|Overall Study|Potential lost to follow-up|0|||
157214961|NCT01507831|567533555|FG000|Overall Study|Other|3|||
156699855|NCT01970865|565649258|FG003|Overall Study|Participant refused further follow-up|2|||
156699856|NCT01970865|565649259|FG004|Overall Study|Participant refused further follow-up|3|||
156699857|NCT01970865|565649260|FG005|Overall Study|Participant refused further follow-up|0|||
156699858|NCT01970865|565649261|FG006|Overall Study|Participant refused further follow-up|0|||
156699859|NCT01970865|565649262|FG007|Overall Study|Participant refused further follow-up|0|||
156699860|NCT01970865|565649263|FG008|Overall Study|Participant refused further follow-up|0|||
156699861|NCT01970865|565649264|FG009|Overall Study|Participant refused further follow-up|0|||
156699862|NCT01970865|565649265|FG010|Overall Study|Participant refused further follow-up|1|||
156699863|NCT01970865|565649266|FG011|Overall Study|Participant refused further follow-up|4|||
156699864|NCT01970865|565649267|FG012|Overall Study|Participant refused further follow-up|7|||
156699865|NCT01970865|565649268|FG013|Overall Study|Participant refused further follow-up|8|||
156699866|NCT01970865|565649269|FG014|Overall Study|Participant refused further follow-up|3|||
156699867|NCT01970865|565649270|FG015|Overall Study|Participant refused further follow-up|11|||
156699868|NCT01970865|565649271|FG016|Overall Study|Participant refused further follow-up|0|||
157015049|NCT02791230|566806735|FG001|Overall Study|Adverse Event|9|||
157015050|NCT02791230|566806736|FG002|Overall Study|Adverse Event|66|||
157015051|NCT02791230|566806734|FG000|Overall Study|Death|38|||
157015052|NCT02791230|566806735|FG001|Overall Study|Death|25|||
157015053|NCT02791230|566806736|FG002|Overall Study|Death|184|||
157015054|NCT02791230|566806734|FG000|Overall Study|Lack of Efficacy|1|||
157015055|NCT02791230|566806735|FG001|Overall Study|Lack of Efficacy|0|||
157015056|NCT02791230|566806736|FG002|Overall Study|Lack of Efficacy|3|||
157015057|NCT02791230|566806734|FG000|Overall Study|Lost to Follow-up|0|||
157015058|NCT02791230|566806735|FG001|Overall Study|Lost to Follow-up|0|||
157015059|NCT02791230|566806736|FG002|Overall Study|Lost to Follow-up|10|||
156699869|NCT01970865|565649272|FG017|Overall Study|Participant refused further follow-up|6|||
156699870|NCT01946191|565649273|FG000|Allocation|Did not complete orientation|1|||
156699871|NCT01946191|565649274|FG001|Allocation|Did not complete orientation|1|||
157015060|NCT02791230|566806734|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
157021747|NCT03673111|566832952|FG007|Overall Study|Adverse Event|0|||
157214962|NCT01507831|567533556|FG001|Overall Study|Other|6|||
156699872|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
156699873|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
156699874|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
156699875|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
156699876|NCT01946191|565649273|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
156699877|NCT01946191|565649274|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
156699878|NCT02041091|565649275|FG000|Treatment|Adverse Event|3|||
156699879|NCT02041091|565649276|FG001|Treatment|Adverse Event|3|||
156699880|NCT02041091|565649275|FG000|Treatment|Withdrawal by Subject|2|||
156699881|NCT02041091|565649276|FG001|Treatment|Withdrawal by Subject|4|||
156699882|NCT02041091|565649275|FG000|Treatment|Physician Decision|1|||
156699883|NCT02041091|565649276|FG001|Treatment|Physician Decision|0|||
156699884|NCT02041091|565649275|FG000|Treatment|Sponsor Decision|15|||
156699885|NCT02041091|565649276|FG001|Treatment|Sponsor Decision|16|||
156699886|NCT02041091|565649275|FG000|Treatment|Lost to Follow-up|1|||
156699887|NCT02041091|565649276|FG001|Treatment|Lost to Follow-up|0|||
156699888|NCT02041091|565649275|FG000|Optional Safety Extension Period|Adverse Event|4|||
156699889|NCT02041091|565649276|FG001|Optional Safety Extension Period|Adverse Event|2|||
156699890|NCT02041091|565649275|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
156699891|NCT02041091|565649276|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
156699892|NCT02041091|565649275|FG000|Optional Safety Extension Period|Protocol Violation|2|||
156699893|NCT02041091|565649276|FG001|Optional Safety Extension Period|Protocol Violation|0|||
156699894|NCT02041091|565649275|FG000|Optional Safety Extension Period|Physician Decision|2|||
156699895|NCT02041091|565649276|FG001|Optional Safety Extension Period|Physician Decision|1|||
156699896|NCT02041091|565649275|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
156699897|NCT02041091|565649276|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
156699898|NCT02041091|565649275|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
156699899|NCT02041091|565649276|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
156699900|NCT01855074|565649278|FG000|Overall Study|Adverse Event|1|||
156699901|NCT01855074|565649278|FG000|Overall Study|Lost to Follow-up|4|||
156699902|NCT01855074|565649278|FG000|Overall Study|Withdrawal by Subject|8|||
156699903|NCT01855074|565649278|FG000|Overall Study|Started but not treated|1|||
156699904|NCT03118570|565649279|FG000|Overall Study|Adverse Event|2|||
156699905|NCT03118570|565649280|FG001|Overall Study|Adverse Event|0|||
156699906|NCT03118570|565649281|FG002|Overall Study|Adverse Event|0|||
156699907|NCT03118570|565649282|FG003|Overall Study|Adverse Event|0|||
156699908|NCT03118570|565649283|FG004|Overall Study|Adverse Event|3|||
156699909|NCT03118570|565649279|FG000|Overall Study|Withdrawal by Subject|0|||
156699910|NCT03118570|565649280|FG001|Overall Study|Withdrawal by Subject|1|||
156699911|NCT03118570|565649281|FG002|Overall Study|Withdrawal by Subject|4|||
156699912|NCT03118570|565649282|FG003|Overall Study|Withdrawal by Subject|0|||
156699913|NCT03118570|565649283|FG004|Overall Study|Withdrawal by Subject|1|||
156699914|NCT03118570|565649279|FG000|Overall Study|Lost to Follow-up|2|||
156699915|NCT03118570|565649280|FG001|Overall Study|Lost to Follow-up|3|||
156699916|NCT03118570|565649281|FG002|Overall Study|Lost to Follow-up|1|||
156699917|NCT03118570|565649282|FG003|Overall Study|Lost to Follow-up|0|||
156699918|NCT03118570|565649283|FG004|Overall Study|Lost to Follow-up|1|||
156699919|NCT03118570|565649279|FG000|Overall Study|Other, Not Specified|1|||
156699920|NCT03118570|565649280|FG001|Overall Study|Other, Not Specified|3|||
157123509|NCT03132636|567203759|FG001|Overall Study|Related to radiological outcomes|1|||
156699921|NCT03118570|565649281|FG002|Overall Study|Other, Not Specified|0|||
156699922|NCT03118570|565649282|FG003|Overall Study|Other, Not Specified|0|||
156699923|NCT03118570|565649283|FG004|Overall Study|Other, Not Specified|0|||
156699924|NCT03970837|565649284|FG000|Overall Study|Adverse Event|23|||
156699925|NCT03970837|565649285|FG001|Overall Study|Adverse Event|20|||
156699926|NCT03970837|565649286|FG002|Overall Study|Adverse Event|16|||
156699927|NCT03970837|565649287|FG003|Overall Study|Adverse Event|6|||
156699928|NCT03970837|565649288|FG004|Overall Study|Adverse Event|4|||
156699929|NCT03970837|565649289|FG005|Overall Study|Adverse Event|5|||
156699930|NCT03970837|565649290|FG006|Overall Study|Adverse Event|1|||
156699931|NCT03970837|565649291|FG007|Overall Study|Adverse Event|5|||
156699932|NCT03970837|565649292|FG008|Overall Study|Adverse Event|0|||
156699933|NCT03970837|565649293|FG009|Overall Study|Adverse Event|0|||
156699934|NCT03970837|565649294|FG010|Overall Study|Adverse Event|1|||
156699935|NCT03970837|565649295|FG011|Overall Study|Adverse Event|1|||
156699936|NCT03970837|565649284|FG000|Overall Study|Lack of Efficacy|14|||
156699937|NCT03970837|565649285|FG001|Overall Study|Lack of Efficacy|12|||
156699938|NCT03970837|565649286|FG002|Overall Study|Lack of Efficacy|1|||
156699939|NCT03970837|565649287|FG003|Overall Study|Lack of Efficacy|2|||
156699940|NCT03970837|565649288|FG004|Overall Study|Lack of Efficacy|3|||
156699941|NCT03970837|565649289|FG005|Overall Study|Lack of Efficacy|4|||
156699942|NCT03970837|565649290|FG006|Overall Study|Lack of Efficacy|6|||
156699943|NCT03970837|565649291|FG007|Overall Study|Lack of Efficacy|1|||
157123510|NCT03132636|567203758|FG000|Overall Study|Unable to come to site for continued visits|0|||
156699944|NCT03970837|565649292|FG008|Overall Study|Lack of Efficacy|1|||
156699945|NCT03970837|565649293|FG009|Overall Study|Lack of Efficacy|0|||
156699946|NCT03970837|565649294|FG010|Overall Study|Lack of Efficacy|0|||
156699947|NCT03970837|565649295|FG011|Overall Study|Lack of Efficacy|0|||
156699948|NCT03970837|565649284|FG000|Overall Study|Lost to Follow-up|6|||
156699949|NCT03970837|565649285|FG001|Overall Study|Lost to Follow-up|5|||
156699950|NCT03970837|565649286|FG002|Overall Study|Lost to Follow-up|5|||
156699951|NCT03970837|565649287|FG003|Overall Study|Lost to Follow-up|1|||
156699952|NCT03970837|565649288|FG004|Overall Study|Lost to Follow-up|0|||
156699953|NCT03970837|565649289|FG005|Overall Study|Lost to Follow-up|2|||
156699954|NCT03970837|565649290|FG006|Overall Study|Lost to Follow-up|0|||
156699955|NCT03970837|565649291|FG007|Overall Study|Lost to Follow-up|0|||
156699956|NCT03970837|565649292|FG008|Overall Study|Lost to Follow-up|0|||
156699957|NCT03970837|565649293|FG009|Overall Study|Lost to Follow-up|0|||
156699958|NCT03970837|565649294|FG010|Overall Study|Lost to Follow-up|0|||
156699959|NCT03970837|565649295|FG011|Overall Study|Lost to Follow-up|0|||
156699960|NCT03970837|565649284|FG000|Overall Study|Protocol Violation|1|||
156699961|NCT03970837|565649285|FG001|Overall Study|Protocol Violation|0|||
157123511|NCT03132636|567203759|FG001|Overall Study|Unable to come to site for continued visits|1|||
157123512|NCT02926209|567203760|FG000|Study Cohort|Poor Bowel Preparation|1|||
157123513|NCT02926209|567203761|FG001|Study Cohort|Poor Bowel Preparation|0|||
157123514|NCT01789970|567203762|FG000|Open-label Titration Period|Adverse Event|68|||
157123515|NCT01789970|567203763|FG001|Open-label Titration Period|Adverse Event|0|||
156699962|NCT03970837|565649286|FG002|Overall Study|Protocol Violation|0|||
156699963|NCT03970837|565649287|FG003|Overall Study|Protocol Violation|0|||
156699964|NCT03970837|565649288|FG004|Overall Study|Protocol Violation|0|||
156699965|NCT03970837|565649289|FG005|Overall Study|Protocol Violation|0|||
156699966|NCT03970837|565649290|FG006|Overall Study|Protocol Violation|0|||
156699967|NCT03970837|565649291|FG007|Overall Study|Protocol Violation|0|||
156699968|NCT03970837|565649292|FG008|Overall Study|Protocol Violation|0|||
156699969|NCT03970837|565649293|FG009|Overall Study|Protocol Violation|0|||
156699970|NCT03970837|565649294|FG010|Overall Study|Protocol Violation|0|||
156699971|NCT03970837|565649295|FG011|Overall Study|Protocol Violation|0|||
156699972|NCT03970837|565649284|FG000|Overall Study|Physician Decision|5|||
156699973|NCT03970837|565649285|FG001|Overall Study|Physician Decision|8|||
156699974|NCT03970837|565649286|FG002|Overall Study|Physician Decision|4|||
156699975|NCT03970837|565649287|FG003|Overall Study|Physician Decision|1|||
156699976|NCT03970837|565649288|FG004|Overall Study|Physician Decision|5|||
156699977|NCT03970837|565649289|FG005|Overall Study|Physician Decision|2|||
156699978|NCT03970837|565649290|FG006|Overall Study|Physician Decision|4|||
156699979|NCT03970837|565649291|FG007|Overall Study|Physician Decision|5|||
156699980|NCT03970837|565649292|FG008|Overall Study|Physician Decision|0|||
156699981|NCT03970837|565649293|FG009|Overall Study|Physician Decision|1|||
156699982|NCT03970837|565649294|FG010|Overall Study|Physician Decision|0|||
156699983|NCT03970837|565649295|FG011|Overall Study|Physician Decision|0|||
156699984|NCT03970837|565649284|FG000|Overall Study|Withdrawal by Subject|32|||
156699985|NCT03970837|565649285|FG001|Overall Study|Withdrawal by Subject|35|||
156699986|NCT03970837|565649286|FG002|Overall Study|Withdrawal by Subject|12|||
156699987|NCT03970837|565649287|FG003|Overall Study|Withdrawal by Subject|8|||
156699988|NCT03970837|565649288|FG004|Overall Study|Withdrawal by Subject|6|||
156699989|NCT03970837|565649289|FG005|Overall Study|Withdrawal by Subject|8|||
156699990|NCT03970837|565649290|FG006|Overall Study|Withdrawal by Subject|2|||
156699991|NCT03970837|565649291|FG007|Overall Study|Withdrawal by Subject|3|||
156699992|NCT03970837|565649292|FG008|Overall Study|Withdrawal by Subject|0|||
156699993|NCT03970837|565649293|FG009|Overall Study|Withdrawal by Subject|0|||
156790783|NCT02662582|565985474|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156790784|NCT04008069|565985475|FG000|Open-Label Period|Adverse Event|1|||
156790785|NCT04008069|565985476|FG001|Open-Label Period|Adverse Event|0|||
156790786|NCT04008069|565985477|FG002|Open-Label Period|Adverse Event|0|||
156790787|NCT04008069|565985475|FG000|Open-Label Period|Lack of Efficacy|4|||
156790788|NCT04008069|565985476|FG001|Open-Label Period|Lack of Efficacy|0|||
156790789|NCT04008069|565985477|FG002|Open-Label Period|Lack of Efficacy|0|||
156790790|NCT04008069|565985475|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
157123516|NCT01789970|567203764|FG002|Open-label Titration Period|Adverse Event|0|||
157123517|NCT01789970|567203762|FG000|Open-label Titration Period|Lack of Efficacy|31|||
156699994|NCT03970837|565649294|FG010|Overall Study|Withdrawal by Subject|0|||
156699995|NCT03970837|565649295|FG011|Overall Study|Withdrawal by Subject|1|||
156699996|NCT03970837|565649284|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
156699997|NCT03970837|565649285|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
156699998|NCT03970837|565649286|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
156699999|NCT03970837|565649287|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700000|NCT03970837|565649288|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
156700001|NCT03970837|565649289|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700002|NCT03970837|565649290|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700003|NCT03970837|565649291|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156790791|NCT04008069|565985476|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
156790792|NCT04008069|565985477|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
156790793|NCT04008069|565985475|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
156700004|NCT03970837|565649292|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
156700005|NCT03970837|565649293|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700006|NCT03970837|565649294|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700007|NCT03970837|565649295|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
156700008|NCT03970837|565649284|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700009|NCT03970837|565649285|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700010|NCT03970837|565649286|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700011|NCT03970837|565649287|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700012|NCT03970837|565649288|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700013|NCT03970837|565649289|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156700014|NCT03970837|565649290|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
156700015|NCT03970837|565649291|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
156700016|NCT03970837|565649292|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
156700017|NCT03970837|565649293|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
156700018|NCT03970837|565649294|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
156700019|NCT03970837|565649295|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
157214963|NCT01280981|567533559|FG000|Overall Study|Withdrawal by Subject|11|||
157214964|NCT01280981|567533559|FG000|Overall Study|Protocol Violation|2|||
157214965|NCT01280981|567533559|FG000|Overall Study|Lack of Efficacy|13|||
156700020|NCT02582866|565649303|FG000|Overall Study|Death|1|||
156700021|NCT02582866|565649303|FG000|Overall Study|Lack of Efficacy|2|||
156700022|NCT02582866|565649303|FG000|Overall Study|Lost to Follow-up|2|||
156700023|NCT02582866|565649303|FG000|Overall Study|Withdrawal by Subject|7|||
156700024|NCT02582866|565649303|FG000|Overall Study|Investigator decision|5|||
156700025|NCT02582866|565649303|FG000|Overall Study|Participant wants to get pregnant|1|||
156700026|NCT02582866|565649303|FG000|Overall Study|Pregnancy|2|||
156700027|NCT02582866|565649303|FG000|Overall Study|Sponsor decision|1|||
156700028|NCT02582866|565649303|FG000|Overall Study|Withdrawal due to personal reasons|1|||
156700029|NCT01193127|565649312|FG000|Randomized|Surgery Cancelled|0|||
156700030|NCT01193127|565649313|FG001|Randomized|Surgery Cancelled|0|||
156700031|NCT01193127|565649314|FG002|Randomized|Surgery Cancelled|0|||
156700032|NCT01193127|565649315|FG003|Randomized|Surgery Cancelled|1|||
156700033|NCT01193127|565649312|FG000|Treated|Withdrawal by Subject|0|||
156700034|NCT01193127|565649313|FG001|Treated|Withdrawal by Subject|0|||
156700035|NCT01193127|565649314|FG002|Treated|Withdrawal by Subject|0|||
156700036|NCT01193127|565649315|FG003|Treated|Withdrawal by Subject|1|||
156700037|NCT00321737|565649325|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
156700038|NCT00321737|565649326|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
156700039|NCT00321737|565649327|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
156700040|NCT00321737|565649325|FG000|Overall Study|Adverse Event|11|||
156700041|NCT00321737|565649326|FG001|Overall Study|Adverse Event|3|||
156700042|NCT00321737|565649327|FG002|Overall Study|Adverse Event|6|||
156700043|NCT00321737|565649325|FG000|Overall Study|Lost to Follow-up|5|||
156700044|NCT00321737|565649326|FG001|Overall Study|Lost to Follow-up|5|||
156700045|NCT00321737|565649327|FG002|Overall Study|Lost to Follow-up|6|||
156700046|NCT00321737|565649325|FG000|Overall Study|Withdrawal by Subject|19|||
156790794|NCT04008069|565985476|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
156790795|NCT04008069|565985477|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
156790796|NCT00511199|565985478|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
156790797|NCT00511199|565985479|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
156790798|NCT00511199|565985478|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
156790799|NCT00511199|565985479|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
156790800|NCT00511199|565985478|FG000|Overall Study|Withdrawal of Informed Consent|19|||
156790801|NCT00511199|565985479|FG001|Overall Study|Withdrawal of Informed Consent|4|||
156790802|NCT00511199|565985478|FG000|Overall Study|Pregnancy|6|||
156790803|NCT00511199|565985479|FG001|Overall Study|Pregnancy|3|||
156790804|NCT00511199|565985478|FG000|Overall Study|Pregnancy Wish|16|||
156790805|NCT00511199|565985479|FG001|Overall Study|Pregnancy Wish|8|||
156790806|NCT00511199|565985478|FG000|Overall Study|Lost to Follow-up|40|||
156790807|NCT00511199|565985479|FG001|Overall Study|Lost to Follow-up|17|||
156790808|NCT00511199|565985478|FG000|Overall Study|Other Reason|78|||
156790809|NCT00511199|565985479|FG001|Overall Study|Other Reason|37|||
156790810|NCT02314247|565985487|FG000|Overall Study|Adverse Event|2|||
156790811|NCT02314247|565985488|FG001|Overall Study|Adverse Event|1|||
156790812|NCT02314247|565985489|FG002|Overall Study|Adverse Event|0|||
156790813|NCT02314247|565985487|FG000|Overall Study|Withdrawal by Subject|1|||
156790814|NCT02314247|565985488|FG001|Overall Study|Withdrawal by Subject|3|||
156790815|NCT02314247|565985489|FG002|Overall Study|Withdrawal by Subject|1|||
156790816|NCT02314247|565985487|FG000|Overall Study|Progression of Disease|6|||
156700047|NCT00321737|565649326|FG001|Overall Study|Withdrawal by Subject|12|||
156790817|NCT02314247|565985488|FG001|Overall Study|Progression of Disease|2|||
156790818|NCT02314247|565985489|FG002|Overall Study|Progression of Disease|0|||
156790819|NCT01953354|565985490|FG000|Overall Study|Withdrawal by Subject|0|||
156700048|NCT00321737|565649327|FG002|Overall Study|Withdrawal by Subject|17|||
156700049|NCT00321737|565649325|FG000|Overall Study|Protocol Violation|0|||
156700050|NCT00321737|565649326|FG001|Overall Study|Protocol Violation|0|||
157123518|NCT01789970|567203763|FG001|Open-label Titration Period|Lack of Efficacy|0|||
157123519|NCT01789970|567203764|FG002|Open-label Titration Period|Lack of Efficacy|0|||
157123520|NCT01789970|567203762|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
157123521|NCT01789970|567203763|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156872015|NCT00473382|566289490|FG000|Core Study|Lost to Follow-up|3|||
156872016|NCT00473382|566289491|FG001|Core Study|Lost to Follow-up|3|||
156872017|NCT00473382|566289492|FG002|Core Study|Lost to Follow-up|3|||
156872018|NCT00473382|566289490|FG000|Core Study|Physician Decision|1|||
156872019|NCT00473382|566289491|FG001|Core Study|Physician Decision|2|||
156872020|NCT00473382|566289492|FG002|Core Study|Physician Decision|2|||
156872021|NCT00473382|566289490|FG000|Core Study|Subject non-compliance|5|||
156872022|NCT00473382|566289491|FG001|Core Study|Subject non-compliance|2|||
156872023|NCT00473382|566289492|FG002|Core Study|Subject non-compliance|1|||
157123522|NCT01789970|567203764|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
157123523|NCT01789970|567203762|FG000|Open-label Titration Period|Protocol Violation|18|||
156872024|NCT00473382|566289490|FG000|Core Study|Subject needed other treatment|1|||
156872025|NCT00473382|566289491|FG001|Core Study|Subject needed other treatment|3|||
156872026|NCT00473382|566289492|FG002|Core Study|Subject needed other treatment|2|||
156872027|NCT00473382|566289490|FG000|Core Study|Subject's decision|12|||
156872028|NCT00473382|566289491|FG001|Core Study|Subject's decision|11|||
156872029|NCT00473382|566289492|FG002|Core Study|Subject's decision|10|||
156872030|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
156872031|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
156872032|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
156872033|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Death|1|||
156872034|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Death|3|||
157123524|NCT01789970|567203763|FG001|Open-label Titration Period|Protocol Violation|0|||
157123525|NCT01789970|567203764|FG002|Open-label Titration Period|Protocol Violation|0|||
157123526|NCT01789970|567203762|FG000|Open-label Titration Period|Lost to Follow-up|5|||
157123527|NCT01789970|567203763|FG001|Open-label Titration Period|Lost to Follow-up|0|||
156790820|NCT01953354|565985491|FG001|Overall Study|Withdrawal by Subject|1|||
156790821|NCT01953354|565985490|FG000|Overall Study|Decision of Sponsor|0|||
156790822|NCT01953354|565985491|FG001|Overall Study|Decision of Sponsor|1|||
156790823|NCT01953354|565985490|FG000|Overall Study|Disease Exacerbation|1|||
156790824|NCT01953354|565985491|FG001|Overall Study|Disease Exacerbation|0|||
156790825|NCT00489359|565985492|FG000|Overall Study|Death|0|||
156790826|NCT00489359|565985493|FG001|Overall Study|Death|2|||
156790827|NCT00489359|565985492|FG000|Overall Study|Progressive Disease|5|||
156790828|NCT00489359|565985493|FG001|Overall Study|Progressive Disease|6|||
156790829|NCT00489359|565985492|FG000|Overall Study|Lost to Follow-up|1|||
156790830|NCT00489359|565985493|FG001|Overall Study|Lost to Follow-up|0|||
156790831|NCT00489359|565985492|FG000|Overall Study|Withdrawal by Subject|1|||
156790832|NCT00489359|565985493|FG001|Overall Study|Withdrawal by Subject|5|||
156790833|NCT00489359|565985492|FG000|Overall Study|Adverse Event|0|||
156790834|NCT00489359|565985493|FG001|Overall Study|Adverse Event|16|||
156790835|NCT03180138|565985494|FG000|Overall Study|Mobile-phone could not be verified|2|||
156790836|NCT03180138|565985495|FG001|Overall Study|Mobile-phone could not be verified|13|||
156790837|NCT03180138|565985496|FG002|Overall Study|Mobile-phone could not be verified|15|||
156790838|NCT03180138|565985494|FG000|Overall Study|No prior immunization records|17|||
156790839|NCT03180138|565985495|FG001|Overall Study|No prior immunization records|0|||
156790840|NCT03180138|565985496|FG002|Overall Study|No prior immunization records|6|||
156790841|NCT03180138|565985494|FG000|Overall Study|Found to be >24 mon after randomization|3|||
156790842|NCT03180138|565985495|FG001|Overall Study|Found to be >24 mon after randomization|0|||
156790843|NCT03180138|565985496|FG002|Overall Study|Found to be >24 mon after randomization|3|||
156790844|NCT01260311|565985499|FG000|Overall Study|Adverse Event|11|||
156790845|NCT01260311|565985499|FG000|Overall Study|Lack of Efficacy|4|||
156790846|NCT01260311|565985499|FG000|Overall Study|Lost to Follow-up|25|||
156790847|NCT01260311|565985499|FG000|Overall Study|Withdrawal by Subject|6|||
156790848|NCT01260311|565985499|FG000|Overall Study|Financial Constraints|77|||
156790849|NCT01260311|565985499|FG000|Overall Study|Gone to Province|2|||
156790850|NCT01260311|565985499|FG000|Overall Study|Medication Stopped|1|||
156790851|NCT01260311|565985499|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
156790852|NCT01903733|565985500|FG000|Overall Study|Death|23|||
156790853|NCT01903733|565985501|FG001|Overall Study|Death|54|||
157123528|NCT01789970|567203764|FG002|Open-label Titration Period|Lost to Follow-up|0|||
157123529|NCT01789970|567203762|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
156790854|NCT01903733|565985502|FG002|Overall Study|Death|30|||
156790855|NCT01903733|565985503|FG003|Overall Study|Death|98|||
156790856|NCT01903733|565985500|FG000|Overall Study|Participant refused further follow-up|35|||
156790857|NCT01903733|565985501|FG001|Overall Study|Participant refused further follow-up|38|||
156790858|NCT01903733|565985502|FG002|Overall Study|Participant refused further follow-up|13|||
156790859|NCT01903733|565985503|FG003|Overall Study|Participant refused further follow-up|9|||
156872035|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Death|3|||
156872036|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
156872037|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
156872038|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
156872039|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
156872040|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
156872041|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
156872042|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
156872043|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
156872044|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
156872045|NCT00473382|566289490|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
156872046|NCT00473382|566289491|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
156872047|NCT00473382|566289492|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
156872048|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
156872049|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
156872050|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
156872051|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Death|1|||
156872052|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Death|7|||
156872053|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Death|4|||
156872054|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
156872055|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
156872056|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
156872057|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
156872058|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
156872059|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
156872060|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
156872061|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
156872062|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
156872063|NCT00473382|566289490|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
156872064|NCT00473382|566289491|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
156872065|NCT00473382|566289492|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
156872066|NCT03565497|566289493|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
156872067|NCT03565497|566289494|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
156872068|NCT03565497|566289495|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
156872069|NCT03565497|566289493|FG000|Overall Study|Lost to Follow-up|1|||
156872070|NCT03565497|566289494|FG001|Overall Study|Lost to Follow-up|1|||
156872071|NCT03565497|566289495|FG002|Overall Study|Lost to Follow-up|2|||
156872072|NCT03565497|566289493|FG000|Overall Study|Withdrawal by Subject|1|||
156872073|NCT03565497|566289494|FG001|Overall Study|Withdrawal by Subject|1|||
156872074|NCT03565497|566289495|FG002|Overall Study|Withdrawal by Subject|1|||
156872075|NCT02999672|566289496|FG000|Overall Study|Death|0|||
156872076|NCT02999672|566289497|FG001|Overall Study|Death|1|||
156872077|NCT02999672|566289496|FG000|Overall Study|Study Terminated by Sponsor|0|||
156872078|NCT02999672|566289497|FG001|Overall Study|Study Terminated by Sponsor|1|||
156872079|NCT02999672|566289496|FG000|Overall Study|Progressive Disease|9|||
156872080|NCT02999672|566289497|FG001|Overall Study|Progressive Disease|5|||
156872081|NCT02999672|566289496|FG000|Overall Study|Adverse Event|4|||
156872082|NCT02999672|566289497|FG001|Overall Study|Adverse Event|0|||
156872083|NCT01470326|566289498|FG000|Overall Study|Protocol Violation|32|||
156872084|NCT01470326|566289498|FG000|Overall Study|No Drug Administration Information|2|||
156872085|NCT01470326|566289498|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
156872086|NCT01166282|566289499|FG000|Open-label Period|Adverse Event|0|||
156872087|NCT01166282|566289500|FG001|Open-label Period|Adverse Event|0|||
156872088|NCT01166282|566289501|FG002|Open-label Period|Adverse Event|6|||
156872089|NCT01166282|566289499|FG000|Open-label Period|Withdrawal by Subject|0|||
156872090|NCT01166282|566289500|FG001|Open-label Period|Withdrawal by Subject|0|||
156872091|NCT01166282|566289501|FG002|Open-label Period|Withdrawal by Subject|4|||
156872092|NCT01166282|566289499|FG000|Open-label Period|Lack of Efficacy|0|||
156872093|NCT01166282|566289500|FG001|Open-label Period|Lack of Efficacy|0|||
156872094|NCT01166282|566289501|FG002|Open-label Period|Lack of Efficacy|2|||
156872095|NCT01166282|566289499|FG000|Open-label Period|Remission|0|||
156872096|NCT01166282|566289500|FG001|Open-label Period|Remission|0|||
157015061|NCT02791230|566806735|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
157015062|NCT02791230|566806736|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
157015063|NCT02791230|566806734|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
157015064|NCT02791230|566806735|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
157015065|NCT02791230|566806736|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
157015066|NCT02791230|566806734|FG000|Overall Study|Study sites terminated by sponsor|1|||
157015067|NCT02791230|566806735|FG001|Overall Study|Study sites terminated by sponsor|0|||
157015068|NCT02791230|566806736|FG002|Overall Study|Study sites terminated by sponsor|5|||
156700051|NCT00321737|565649327|FG002|Overall Study|Protocol Violation|1|||
156700052|NCT00321737|565649325|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
156700053|NCT00321737|565649326|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156700054|NCT00321737|565649327|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156700055|NCT00321737|565649325|FG000|Overall Study|Possible Barrett's Esophagus|2|||
156700056|NCT00321737|565649326|FG001|Overall Study|Possible Barrett's Esophagus|1|||
157015069|NCT02791230|566806734|FG000|Overall Study|Other|9|||
157015070|NCT02791230|566806735|FG001|Overall Study|Other|1|||
156700057|NCT00321737|565649327|FG002|Overall Study|Possible Barrett's Esophagus|1|||
156700058|NCT00321737|565649325|FG000|Overall Study|Therapeutic Failure|6|||
156700059|NCT00321737|565649326|FG001|Overall Study|Therapeutic Failure|0|||
156700060|NCT00321737|565649327|FG002|Overall Study|Therapeutic Failure|2|||
156700061|NCT00321737|565649325|FG000|Overall Study|Pregnancy|0|||
156700062|NCT00321737|565649326|FG001|Overall Study|Pregnancy|2|||
156700063|NCT00321737|565649327|FG002|Overall Study|Pregnancy|0|||
156700064|NCT00321737|565649325|FG000|Overall Study|Noncompliance|2|||
156700065|NCT00321737|565649326|FG001|Overall Study|Noncompliance|0|||
156700066|NCT00321737|565649327|FG002|Overall Study|Noncompliance|0|||
156700067|NCT00321737|565649325|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
156700068|NCT00321737|565649326|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
156700069|NCT00321737|565649327|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
156700070|NCT02283294|565649328|FG000|Overall Study|Lost to Follow-up|1|||
156700071|NCT02283294|565649329|FG001|Overall Study|Lost to Follow-up|1|||
156700072|NCT02283294|565649328|FG000|Overall Study|Withdrawal by Subject|1|||
156700073|NCT02283294|565649329|FG001|Overall Study|Withdrawal by Subject|6|||
156700074|NCT02283294|565649328|FG000|Overall Study|Protocol Violation|1|||
156700075|NCT02283294|565649329|FG001|Overall Study|Protocol Violation|0|||
156700076|NCT02283294|565649328|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
156700077|NCT02283294|565649329|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
156700078|NCT00594646|565649330|FG000|Overall Study|Withdrawal by Subject|1|||
156700079|NCT00594646|565649330|FG000|Overall Study|Lost to Follow-up|15|||
156700080|NCT00006721|565651338|FG000|Overall Study|Adverse Event|0|||
156700081|NCT00006721|565651339|FG001|Overall Study|Adverse Event|4|||
156700082|NCT00006721|565651340|FG002|Overall Study|Adverse Event|4|||
156700083|NCT00006721|565651338|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
156700084|NCT00006721|565651339|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
156700085|NCT00006721|565651340|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
156700086|NCT00006721|565651338|FG000|Overall Study|Progression/Relapse|0|||
156700087|NCT00006721|565651339|FG001|Overall Study|Progression/Relapse|1|||
156700088|NCT00006721|565651340|FG002|Overall Study|Progression/Relapse|2|||
156700089|NCT00006721|565651338|FG000|Overall Study|Death|0|||
156700090|NCT00006721|565651339|FG001|Overall Study|Death|1|||
156700091|NCT00006721|565651340|FG002|Overall Study|Death|2|||
156700092|NCT00006721|565651338|FG000|Overall Study|Other - Not Protocol Specified|0|||
156700093|NCT00006721|565651339|FG001|Overall Study|Other - Not Protocol Specified|7|||
156700094|NCT00006721|565651340|FG002|Overall Study|Other - Not Protocol Specified|7|||
156700095|NCT00006721|565651338|FG000|Overall Study|Ineligible|2|||
156700096|NCT00006721|565651339|FG001|Overall Study|Ineligible|12|||
156700097|NCT00006721|565651340|FG002|Overall Study|Ineligible|10|||
156700098|NCT00006721|565651338|FG000|Overall Study|Eligible but no Treatment Received|1|||
156700099|NCT00006721|565651339|FG001|Overall Study|Eligible but no Treatment Received|0|||
156700100|NCT00006721|565651340|FG002|Overall Study|Eligible but no Treatment Received|0|||
156700101|NCT05424042|565651341|FG000|Overall Study|Withdrawal by Subject|2|||
156700102|NCT05424042|565651342|FG001|Overall Study|Withdrawal by Subject|0|||
156700103|NCT05424042|565651343|FG002|Overall Study|Withdrawal by Subject|4|||
156700104|NCT05424042|565651341|FG000|Overall Study|Lost to Follow-up|0|||
156700105|NCT05424042|565651342|FG001|Overall Study|Lost to Follow-up|0|||
156700106|NCT05424042|565651343|FG002|Overall Study|Lost to Follow-up|1|||
156700107|NCT03611543|565651344|FG000|Overall Study|Withdrawal by Subject|4|||
156700108|NCT03611543|565651345|FG001|Overall Study|Withdrawal by Subject|4|||
156700109|NCT03611543|565651344|FG000|Overall Study|Physician Decision|1|||
156700110|NCT03611543|565651345|FG001|Overall Study|Physician Decision|1|||
156700111|NCT03611543|565651344|FG000|Overall Study|Protocol Violation|2|||
156700112|NCT03611543|565651345|FG001|Overall Study|Protocol Violation|2|||
156700113|NCT03611543|565651344|FG000|Overall Study|Device failure|2|||
156700114|NCT03611543|565651345|FG001|Overall Study|Device failure|2|||
156700115|NCT03611543|565651344|FG000|Overall Study|Missing information|5|||
156700116|NCT03611543|565651345|FG001|Overall Study|Missing information|5|||
156700117|NCT03047473|565651346|FG000|Overall Study|Lost to Follow-up|2|||
156700118|NCT01167257|565651347|FG000|Overall Study|Lost to Follow-up|2|||
156700119|NCT01167257|565651348|FG001|Overall Study|Lost to Follow-up|2|||
156700120|NCT01167257|565651347|FG000|Overall Study|Withdrew consent|1|||
156700121|NCT01167257|565651348|FG001|Overall Study|Withdrew consent|1|||
156700122|NCT02213510|565651350|FG000|Overall Study|Death|0|||
156700123|NCT02213510|565651351|FG001|Overall Study|Death|1|||
156700124|NCT02213510|565651350|FG000|Overall Study|Lost to Follow-up|1|||
156700125|NCT02213510|565651351|FG001|Overall Study|Lost to Follow-up|0|||
156700126|NCT00000378|565651354|FG000|Overall Study|Lack of Efficacy|16|||
156700127|NCT00000378|565651355|FG001|Overall Study|Lack of Efficacy|14|||
156700128|NCT01284361|565651358|FG000|Overall Study|Withdrawal by Subject|1|||
156700129|NCT01284361|565651358|FG000|Overall Study|Protocol Violation|5|||
156700130|NCT01284361|565651358|FG000|Overall Study|Adverse Event|1|||
156700131|NCT01284361|565651358|FG000|Overall Study|Lost to Follow-up|2|||
156700132|NCT00805675|565651359|FG000|Overall Study|Adverse Event|0|||
156700133|NCT00805675|565651360|FG001|Overall Study|Adverse Event|0|||
156700134|NCT00805675|565651361|FG002|Overall Study|Adverse Event|1|||
156700135|NCT01957397|565651364|FG000|Test Period 1|sudden leakage/small bag|1|||
156700136|NCT01957397|565651365|FG001|Test Period 1|sudden leakage/small bag|1|||
156700137|NCT01957397|565651364|FG000|Test Period 1|Withdrawal by Subject|1|||
156700138|NCT01957397|565651365|FG001|Test Period 1|Withdrawal by Subject|0|||
156700139|NCT01957397|565651364|FG000|Test Period 2|Adverse Event|0|||
156700140|NCT01957397|565651365|FG001|Test Period 2|Adverse Event|1|||
156700141|NCT01957397|565651364|FG000|Test Period 3|Adverse Event|1|||
156700142|NCT01957397|565651365|FG001|Test Period 3|Adverse Event|2|||
156700143|NCT01957397|565651364|FG000|Test Period 3|the adhesive did not work|1|||
156700144|NCT01957397|565651365|FG001|Test Period 3|the adhesive did not work|0|||
156700145|NCT00540293|565651366|FG000|Overall Study|Adverse event related to study drug|10|||
156700146|NCT00540293|565651366|FG000|Overall Study|Adverse event not related to study drug|7|||
156700147|NCT00540293|565651366|FG000|Overall Study|Withdrawal by Subject|6|||
156700148|NCT00540293|565651366|FG000|Overall Study|Protocol violation, & subject schedule|12|||
156700149|NCT00325195|565651369|FG000|Randomized|Not dosed|5|||
156700150|NCT00325195|565651370|FG001|Randomized|Not dosed|5|||
156700151|NCT00325195|565651371|FG002|Randomized|Not dosed|3|||
156700152|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Adverse Event|15|||
156700153|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Adverse Event|17|||
156700154|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Adverse Event|1|||
156700155|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Death|3|||
156700156|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Death|1|||
156700157|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Death|0|||
156700158|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
156700159|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
156700160|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
156700161|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
156700162|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
156700163|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
156700164|NCT00325195|565651369|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
156700165|NCT00325195|565651370|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
156700166|NCT00325195|565651371|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
157123530|NCT01789970|567203763|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
156700167|NCT04715932|565651372|FG000|Overall Study|Lost to Follow-up|1|||
156700168|NCT04715932|565651373|FG001|Overall Study|Lost to Follow-up|0|||
156700169|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
156700170|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
156700171|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
156700172|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
156700173|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
156700174|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
156700175|NCT03560986|565651374|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
156700176|NCT03560986|565651375|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
156700177|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
156700178|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
156700179|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
157123531|NCT01789970|567203764|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
157123532|NCT01789970|567203762|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
157123533|NCT01789970|567203763|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
157123534|NCT01789970|567203764|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
157123535|NCT01789970|567203762|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
156700180|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
156700181|NCT03560986|565651374|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
156700182|NCT03560986|565651375|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
156700183|NCT01059539|565651376|FG000|Overall Study|Adverse Event|66|||
156700184|NCT01059539|565651376|FG000|Overall Study|Insufficient Therapeutic Response|26|||
156700185|NCT01059539|565651376|FG000|Overall Study|Protocol Violation|55|||
156700186|NCT01059539|565651376|FG000|Overall Study|Withdrawal of Consent|80|||
156700187|NCT01059539|565651376|FG000|Overall Study|Lost to Follow-up|42|||
156700188|NCT01059539|565651376|FG000|Overall Study|Reason Not Specified|2|||
156700189|NCT01085201|565651380|FG000|Overall Study|Scheduling conflict|1|||
156700190|NCT01085201|565651381|FG001|Overall Study|Scheduling conflict|0|||
156700191|NCT01085201|565651382|FG002|Overall Study|Scheduling conflict|1|||
156700192|NCT01085201|565651383|FG003|Overall Study|Scheduling conflict|0|||
156700193|NCT01085201|565651384|FG004|Overall Study|Scheduling conflict|0|||
156700194|NCT01085201|565651380|FG000|Overall Study|Unknown- no study drug|2|||
156700195|NCT01085201|565651381|FG001|Overall Study|Unknown- no study drug|0|||
156700196|NCT01085201|565651382|FG002|Overall Study|Unknown- no study drug|0|||
156700197|NCT01085201|565651383|FG003|Overall Study|Unknown- no study drug|0|||
156700198|NCT01085201|565651384|FG004|Overall Study|Unknown- no study drug|0|||
156700199|NCT01085201|565651380|FG000|Overall Study|Fond ineligible after consent|0|||
156700200|NCT01085201|565651381|FG001|Overall Study|Fond ineligible after consent|1|||
156700201|NCT01085201|565651382|FG002|Overall Study|Fond ineligible after consent|1|||
156700202|NCT01085201|565651383|FG003|Overall Study|Fond ineligible after consent|0|||
156700203|NCT01085201|565651384|FG004|Overall Study|Fond ineligible after consent|0|||
156700204|NCT00528411|565651385|FG000|Overall Study|Adverse Event|4|||
156700205|NCT00528411|565651386|FG001|Overall Study|Adverse Event|0|||
156700206|NCT00528411|565651387|FG002|Overall Study|Adverse Event|1|||
156700207|NCT00528411|565651385|FG000|Overall Study|Incorrect Enrolment|1|||
156700208|NCT00528411|565651386|FG001|Overall Study|Incorrect Enrolment|1|||
156700209|NCT00528411|565651387|FG002|Overall Study|Incorrect Enrolment|0|||
156700210|NCT00528411|565651385|FG000|Overall Study|Severe non-compliance to protocol|0|||
156700211|NCT00528411|565651386|FG001|Overall Study|Severe non-compliance to protocol|1|||
156700212|NCT00528411|565651387|FG002|Overall Study|Severe non-compliance to protocol|0|||
156700213|NCT00528411|565651385|FG000|Overall Study|Prior commitment medication|0|||
156700214|NCT00528411|565651386|FG001|Overall Study|Prior commitment medication|1|||
156700215|NCT00528411|565651387|FG002|Overall Study|Prior commitment medication|0|||
156700216|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
156700217|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
156700218|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700219|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700220|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
156700221|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700222|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700223|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700224|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
156700225|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700226|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
156700227|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700228|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700229|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700230|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700231|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700232|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700233|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
156700234|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700235|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
156700236|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700237|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
156700238|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700239|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700240|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700241|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700242|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700243|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700244|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
156700245|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700246|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
156700247|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700248|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700249|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
157123536|NCT01789970|567203763|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
157123537|NCT01789970|567203764|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
157123538|NCT01789970|567203762|FG000|Open-label Titration Period|Pregnancy|2|||
157123539|NCT01789970|567203763|FG001|Open-label Titration Period|Pregnancy|0|||
156700250|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
157123540|NCT01789970|567203764|FG002|Open-label Titration Period|Pregnancy|0|||
156790860|NCT01903733|565985500|FG000|Overall Study|Lost to Follow-up|18|||
156700251|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
156700252|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
156700253|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
156700254|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
156700255|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700256|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
156700257|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700258|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700259|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700260|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700261|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700262|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
156700263|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700264|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700265|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700266|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700267|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700268|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700269|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
156700270|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700271|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700272|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700273|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
156700274|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700275|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700276|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700277|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700278|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700279|NCT03893565|565651388|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700280|NCT03893565|565651389|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
156700281|NCT03893565|565651390|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
156700282|NCT03893565|565651391|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
156700283|NCT03893565|565651392|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700284|NCT03893565|565651393|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700285|NCT03893565|565651394|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700286|NCT03893565|565651395|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700287|NCT03893565|565651396|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
156700288|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
156700289|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
156700290|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
156700291|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
156700292|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
156700293|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
156700294|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
156700295|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
156700296|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
156700297|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700298|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700299|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700300|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700301|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700302|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700303|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
156700304|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700305|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
156700306|NCT03893565|565651388|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700307|NCT03893565|565651389|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700308|NCT03893565|565651390|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700309|NCT03893565|565651391|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700310|NCT03893565|565651392|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156790861|NCT01903733|565985501|FG001|Overall Study|Lost to Follow-up|19|||
156790862|NCT01903733|565985502|FG002|Overall Study|Lost to Follow-up|6|||
156700311|NCT03893565|565651393|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
156700312|NCT03893565|565651394|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
156700313|NCT03893565|565651395|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700314|NCT03893565|565651396|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
156700315|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
156700316|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
156700317|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
156700318|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
156700319|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
156700320|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
156700321|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
156700322|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
156700323|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
156700324|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700325|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700326|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700327|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700328|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700329|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700330|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700331|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
156700332|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
156700333|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700334|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700335|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700336|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700337|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700338|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700339|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700340|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
156700341|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
156700342|NCT03893565|565651388|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700343|NCT03893565|565651389|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700344|NCT03893565|565651390|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700345|NCT03893565|565651391|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700346|NCT03893565|565651392|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700347|NCT03893565|565651393|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700348|NCT03893565|565651394|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700349|NCT03893565|565651395|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
156700350|NCT03893565|565651396|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
156700351|NCT03893565|565651388|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700352|NCT03893565|565651389|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700353|NCT03893565|565651390|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700354|NCT03893565|565651391|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700355|NCT03893565|565651392|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700356|NCT03893565|565651393|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700357|NCT03893565|565651394|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700358|NCT03893565|565651395|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
156700359|NCT03893565|565651396|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
156700360|NCT05005312|565651397|FG000|Overall Study|Enrolled, but not treated|0|||
156700361|NCT05005312|565651398|FG001|Overall Study|Enrolled, but not treated|1|||
156700362|NCT01283035|565651399|FG000|Overall Study|Subject later found ineligible|1|||
156700363|NCT00851318|565651400|FG000|Overall Study|Withdrawal by Subject|7|||
156700364|NCT00851318|565651401|FG001|Overall Study|Withdrawal by Subject|1|||
156700365|NCT00851318|565651402|FG002|Overall Study|Withdrawal by Subject|5|||
156700366|NCT00851318|565651403|FG003|Overall Study|Withdrawal by Subject|3|||
156700367|NCT00851318|565651400|FG000|Overall Study|Adverse Event|13|||
156700368|NCT00851318|565651401|FG001|Overall Study|Adverse Event|2|||
156790863|NCT01903733|565985503|FG003|Overall Study|Lost to Follow-up|9|||
156790864|NCT01903733|565985500|FG000|Overall Study|Other|10|||
156790865|NCT01903733|565985501|FG001|Overall Study|Other|15|||
156700369|NCT00851318|565651402|FG002|Overall Study|Adverse Event|9|||
156700370|NCT00851318|565651403|FG003|Overall Study|Adverse Event|12|||
156700371|NCT00851318|565651400|FG000|Overall Study|Pregnancy|0|||
156700372|NCT00851318|565651401|FG001|Overall Study|Pregnancy|0|||
156790866|NCT01903733|565985502|FG002|Overall Study|Other|12|||
156700373|NCT00851318|565651402|FG002|Overall Study|Pregnancy|1|||
156700374|NCT00851318|565651403|FG003|Overall Study|Pregnancy|1|||
156700375|NCT00851318|565651400|FG000|Overall Study|Lack of Efficacy|8|||
156700376|NCT00851318|565651401|FG001|Overall Study|Lack of Efficacy|2|||
156700377|NCT00851318|565651402|FG002|Overall Study|Lack of Efficacy|4|||
156700378|NCT00851318|565651403|FG003|Overall Study|Lack of Efficacy|2|||
156700379|NCT00851318|565651400|FG000|Overall Study|Non-compliance with Study Procedures|2|||
156700380|NCT00851318|565651401|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156700381|NCT00851318|565651402|FG002|Overall Study|Non-compliance with Study Procedures|1|||
156700382|NCT00851318|565651403|FG003|Overall Study|Non-compliance with Study Procedures|0|||
156700383|NCT00851318|565651400|FG000|Overall Study|Physician Decision|0|||
156700384|NCT00851318|565651401|FG001|Overall Study|Physician Decision|0|||
156700385|NCT00851318|565651402|FG002|Overall Study|Physician Decision|1|||
156700386|NCT00851318|565651403|FG003|Overall Study|Physician Decision|1|||
156700387|NCT01715571|565651413|FG000|Overall Study|Lost to Follow-up|8|||
156700388|NCT03870477|565651418|FG000|Overall Study|Early Study Termination|1|||
156700389|NCT02256436|565651427|FG000|Overall Study|Adverse Event|9|||
156700390|NCT02256436|565651428|FG001|Overall Study|Adverse Event|14|||
156700391|NCT02256436|565651427|FG000|Overall Study|Death|216|||
156700392|NCT02256436|565651428|FG001|Overall Study|Death|208|||
156700393|NCT02256436|565651427|FG000|Overall Study|Lost to Follow-up|1|||
156700394|NCT02256436|565651428|FG001|Overall Study|Lost to Follow-up|2|||
156700395|NCT02256436|565651427|FG000|Overall Study|Physician Decision|1|||
156700396|NCT02256436|565651428|FG001|Overall Study|Physician Decision|0|||
156700397|NCT02256436|565651427|FG000|Overall Study|Protocol Violation|0|||
156700398|NCT02256436|565651428|FG001|Overall Study|Protocol Violation|1|||
156700399|NCT02256436|565651427|FG000|Overall Study|Withdrawal by Subject|26|||
156700400|NCT02256436|565651428|FG001|Overall Study|Withdrawal by Subject|10|||
156700401|NCT02256436|565651427|FG000|Overall Study|Transferred to Extension Study|11|||
156700402|NCT02256436|565651428|FG001|Overall Study|Transferred to Extension Study|23|||
156700403|NCT02256436|565651427|FG000|Overall Study|Did Not Continue on Extension Study|8|||
156700404|NCT02256436|565651428|FG001|Overall Study|Did Not Continue on Extension Study|12|||
156700405|NCT00077857|565651431|FG000|Overall Study|Adverse Event|30|||
156700406|NCT00077857|565651432|FG001|Overall Study|Adverse Event|32|||
156700407|NCT00077857|565651431|FG000|Overall Study|Death|7|||
156700408|NCT00077857|565651432|FG001|Overall Study|Death|3|||
156700409|NCT00077857|565651431|FG000|Overall Study|Insufficient therapeutic response|112|||
156700410|NCT00077857|565651432|FG001|Overall Study|Insufficient therapeutic response|128|||
156700411|NCT00077857|565651431|FG000|Overall Study|Violation of selection criteria at entry|3|||
156700412|NCT00077857|565651432|FG001|Overall Study|Violation of selection criteria at entry|1|||
156700413|NCT00077857|565651431|FG000|Overall Study|Other protocol violation|0|||
156700414|NCT00077857|565651432|FG001|Overall Study|Other protocol violation|1|||
156700415|NCT00077857|565651431|FG000|Overall Study|Refused treatment|29|||
156700416|NCT00077857|565651432|FG001|Overall Study|Refused treatment|21|||
156700417|NCT00077857|565651431|FG000|Overall Study|Failure to return|5|||
156700418|NCT00077857|565651432|FG001|Overall Study|Failure to return|5|||
156700419|NCT00077857|565651431|FG000|Overall Study|Other|15|||
156700420|NCT00077857|565651432|FG001|Overall Study|Other|13|||
156700421|NCT06354998|565651433|FG000|Overall Study|Withdrawal by Subject|3|||
156700422|NCT06354998|565651434|FG001|Overall Study|Withdrawal by Subject|0|||
156700423|NCT05442866|565651435|FG000|Overall Study|Death|1|||
156700424|NCT05442866|565651435|FG000|Overall Study|Lost to Follow-up|9|||
156700425|NCT05442866|565651435|FG000|Overall Study|Protocol Violation|1|||
156700426|NCT01394952|565651436|FG000|Overall Study|Lost to Follow-up|0|||
156700427|NCT01394952|565651437|FG001|Overall Study|Lost to Follow-up|5|||
156700428|NCT01394952|565651436|FG000|Overall Study|Withdrawal by Subject|10|||
156700429|NCT01394952|565651437|FG001|Overall Study|Withdrawal by Subject|5|||
156700430|NCT01394952|565651436|FG000|Overall Study|Physician Decision|2|||
156700431|NCT01394952|565651437|FG001|Overall Study|Physician Decision|0|||
156700432|NCT01394952|565651436|FG000|Overall Study|Sponsor Decision|5|||
156700433|NCT01394952|565651437|FG001|Overall Study|Sponsor Decision|7|||
156700434|NCT04740814|565651438|FG000|Overall Study|Adverse Event|3|||
156700435|NCT04740814|565651438|FG000|Overall Study|Protocol Violation|2|||
156700436|NCT04740814|565651438|FG000|Overall Study|Lost to Follow-up|2|||
156700437|NCT04740814|565651438|FG000|Overall Study|Withdrawal by Subject|3|||
156700438|NCT00085423|565651439|FG000|Overall Study|Withdrawal by Subject|1|||
156700439|NCT00085423|565651439|FG000|Overall Study|screen failure|1|||
156700440|NCT01763684|565651441|FG000|Overall Study|Study terminated early due to low enrollment|126|||
156700441|NCT01763684|565651442|FG001|Overall Study|Study terminated early due to low enrollment|127|||
156700442|NCT01763684|565651441|FG000|Overall Study|Study surgery not performed|7|||
156700443|NCT01763684|565651442|FG001|Overall Study|Study surgery not performed|6|||
156700444|NCT02196701|565651443|FG000|Overall Study|Adverse Event|1|||
156700445|NCT02196701|565651443|FG000|Overall Study|Lost to Follow-up|1|||
156700446|NCT02196701|565651443|FG000|Overall Study|Non-adherence to Protocol|1|||
156700447|NCT03275064|565651444|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700448|NCT03275064|565651445|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156790867|NCT01903733|565985503|FG003|Overall Study|Other|3|||
156700449|NCT03275064|565651446|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700450|NCT03275064|565651447|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
156700451|NCT03275064|565651448|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
156700452|NCT03275064|565651444|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
156700453|NCT03275064|565651445|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700454|NCT03275064|565651446|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700455|NCT03275064|565651447|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700456|NCT03275064|565651448|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
156700457|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
156700458|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
156700459|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
156700460|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
156700461|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
156700462|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700463|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700464|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700465|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
156700466|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
156700467|NCT03275064|565651444|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
156700468|NCT03275064|565651445|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700469|NCT03275064|565651446|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
156700470|NCT03275064|565651447|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700471|NCT03275064|565651448|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
156700472|NCT03796039|565651450|FG000|Overall Study|Death|2|||
156700473|NCT03796039|565651451|FG001|Overall Study|Death|1|||
156700474|NCT03796039|565651450|FG000|Overall Study|Withdrawal by Subject|7|||
156700475|NCT03796039|565651451|FG001|Overall Study|Withdrawal by Subject|4|||
156700476|NCT01140503|565651452|FG000|Overall Study|Withdrawal by Subject|1|||
156700477|NCT04305496|565651453|FG000|Global Cohort|Withdrawal by Subject|13|||
156700478|NCT04305496|565651454|FG001|Global Cohort|Withdrawal by Subject|6|||
156700479|NCT04305496|565651453|FG000|Global Cohort|Physician Decision|1|||
156700480|NCT04305496|565651454|FG001|Global Cohort|Physician Decision|1|||
156700481|NCT04305496|565651453|FG000|Global Cohort|Subjective disease progression|16|||
156700482|NCT04305496|565651454|FG001|Global Cohort|Subjective disease progression|17|||
156700483|NCT04305496|565651453|FG000|Global Cohort|Condition under investigation worsened|209|||
156700484|NCT04305496|565651454|FG001|Global Cohort|Condition under investigation worsened|273|||
156700485|NCT04305496|565651453|FG000|Global Cohort|Protocol Violation|2|||
157123541|NCT01789970|567203762|FG000|Open-label Titration Period|Other|76|||
156700486|NCT04305496|565651454|FG001|Global Cohort|Protocol Violation|0|||
156700487|NCT04305496|565651453|FG000|Global Cohort|Adverse Event|44|||
156700488|NCT04305496|565651454|FG001|Global Cohort|Adverse Event|6|||
156700489|NCT04305496|565651453|FG000|Global Cohort|Death|3|||
156700490|NCT04305496|565651454|FG001|Global Cohort|Death|2|||
156700491|NCT04305496|565651453|FG000|Global Cohort|Any reason not specifically recorded|4|||
156700492|NCT04305496|565651454|FG001|Global Cohort|Any reason not specifically recorded|5|||
156700493|NCT04305496|565651453|FG000|China Cohort|Any reason not specifically recorded|1|||
156700494|NCT04305496|565651454|FG001|China Cohort|Any reason not specifically recorded|1|||
156700495|NCT04305496|565651453|FG000|China Cohort|Adverse Event|8|||
156700496|NCT04305496|565651454|FG001|China Cohort|Adverse Event|2|||
156700497|NCT04305496|565651453|FG000|China Cohort|Condition under investigation worsened|40|||
156700498|NCT04305496|565651454|FG001|China Cohort|Condition under investigation worsened|47|||
156700499|NCT04305496|565651453|FG000|China Cohort|Subjective disease progression|2|||
156700500|NCT04305496|565651454|FG001|China Cohort|Subjective disease progression|2|||
156700501|NCT04305496|565651453|FG000|China Cohort|Withdrawal by Subject|2|||
156700502|NCT04305496|565651454|FG001|China Cohort|Withdrawal by Subject|1|||
156700503|NCT01157897|565651455|FG000|Overall Study|Lost to Follow-up|2|||
156700504|NCT01157897|565651456|FG001|Overall Study|Lost to Follow-up|0|||
156790868|NCT01903733|565985500|FG000|Overall Study|Missing|2|||
156790869|NCT01903733|565985501|FG001|Overall Study|Missing|0|||
157123542|NCT01789970|567203763|FG001|Open-label Titration Period|Other|0|||
157123543|NCT01789970|567203764|FG002|Open-label Titration Period|Other|0|||
157123544|NCT01789970|567203762|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
157123545|NCT01789970|567203763|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
156700505|NCT01157897|565651457|FG002|Overall Study|Lost to Follow-up|0|||
156700506|NCT01157897|565651458|FG003|Overall Study|Lost to Follow-up|1|||
156700507|NCT01157897|565651455|FG000|Overall Study|Relocated|0|||
156700508|NCT01157897|565651456|FG001|Overall Study|Relocated|2|||
156700509|NCT01157897|565651457|FG002|Overall Study|Relocated|0|||
157123546|NCT01789970|567203764|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
156700510|NCT01157897|565651458|FG003|Overall Study|Relocated|0|||
156700511|NCT01898650|565651460|FG000|Overall Study|the subject would not lie still for imaging|1|||
156700512|NCT01791153|565651462|FG000|Part 1: Blinded Period|Adverse Event|7|||
156700513|NCT01791153|565651463|FG001|Part 1: Blinded Period|Adverse Event|3|||
156700514|NCT01791153|565651464|FG002|Part 1: Blinded Period|Adverse Event|2|||
156700515|NCT01791153|565651465|FG003|Part 1: Blinded Period|Adverse Event|0|||
156700516|NCT01791153|565651466|FG004|Part 1: Blinded Period|Adverse Event|0|||
156700517|NCT01791153|565651467|FG005|Part 1: Blinded Period|Adverse Event|0|||
156700518|NCT01791153|565651468|FG006|Part 1: Blinded Period|Adverse Event|0|||
156700519|NCT01791153|565651469|FG007|Part 1: Blinded Period|Adverse Event|0|||
156700520|NCT01791153|565651462|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
156700521|NCT01791153|565651463|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
156700522|NCT01791153|565651464|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
156700523|NCT01791153|565651465|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
156700524|NCT01791153|565651466|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
156700525|NCT01791153|565651467|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
156700526|NCT01791153|565651468|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
156700527|NCT01791153|565651469|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
156700528|NCT01791153|565651462|FG000|Part 1: Blinded Period|Non-Compliance|1|||
156700529|NCT01791153|565651463|FG001|Part 1: Blinded Period|Non-Compliance|0|||
156700530|NCT01791153|565651464|FG002|Part 1: Blinded Period|Non-Compliance|0|||
156700531|NCT01791153|565651465|FG003|Part 1: Blinded Period|Non-Compliance|0|||
156700532|NCT01791153|565651466|FG004|Part 1: Blinded Period|Non-Compliance|0|||
156700533|NCT01791153|565651467|FG005|Part 1: Blinded Period|Non-Compliance|0|||
156700534|NCT01791153|565651468|FG006|Part 1: Blinded Period|Non-Compliance|0|||
156700535|NCT01791153|565651469|FG007|Part 1: Blinded Period|Non-Compliance|0|||
156700536|NCT01791153|565651462|FG000|Part 1: Blinded Period|Physician Decision|0|||
156700537|NCT01791153|565651463|FG001|Part 1: Blinded Period|Physician Decision|0|||
156700538|NCT01791153|565651464|FG002|Part 1: Blinded Period|Physician Decision|0|||
156700539|NCT01791153|565651465|FG003|Part 1: Blinded Period|Physician Decision|1|||
156700540|NCT01791153|565651466|FG004|Part 1: Blinded Period|Physician Decision|0|||
156700541|NCT01791153|565651467|FG005|Part 1: Blinded Period|Physician Decision|0|||
156700542|NCT01791153|565651468|FG006|Part 1: Blinded Period|Physician Decision|0|||
156700543|NCT01791153|565651469|FG007|Part 1: Blinded Period|Physician Decision|0|||
156700544|NCT01791153|565651462|FG000|Part 1: Blinded Period|Protocol Violation|0|||
156700545|NCT01791153|565651463|FG001|Part 1: Blinded Period|Protocol Violation|0|||
156700546|NCT01791153|565651464|FG002|Part 1: Blinded Period|Protocol Violation|0|||
156700547|NCT01791153|565651465|FG003|Part 1: Blinded Period|Protocol Violation|1|||
156700548|NCT01791153|565651466|FG004|Part 1: Blinded Period|Protocol Violation|0|||
156700549|NCT01791153|565651467|FG005|Part 1: Blinded Period|Protocol Violation|0|||
156700550|NCT01791153|565651468|FG006|Part 1: Blinded Period|Protocol Violation|0|||
156700551|NCT01791153|565651469|FG007|Part 1: Blinded Period|Protocol Violation|0|||
156700552|NCT01791153|565651462|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
156700553|NCT01791153|565651463|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
156700554|NCT01791153|565651464|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
156700555|NCT01791153|565651465|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
156700556|NCT01791153|565651466|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700557|NCT01791153|565651467|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700558|NCT01791153|565651468|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
156700559|NCT01791153|565651469|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
156872097|NCT01166282|566289501|FG002|Open-label Period|Remission|4|||
156872098|NCT01166282|566289499|FG000|Open-label Period|Irregular Compliance|0|||
156872099|NCT01166282|566289500|FG001|Open-label Period|Irregular Compliance|0|||
157123547|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
157123548|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
157123549|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
156872100|NCT01166282|566289501|FG002|Open-label Period|Irregular Compliance|1|||
156872101|NCT02577718|566289502|FG000|Overall Study|Death|6|||
156872102|NCT02577718|566289502|FG000|Overall Study|Withdrawal by Subject|2|||
156872103|NCT01075685|566289503|FG000|Overall Study|Protocol Violation|9|||
157123550|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
157123551|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
157123552|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
157123553|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
157123554|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156700560|NCT01791153|565651462|FG000|Part 2: Open-label Period|Adverse Event|0|||
156700561|NCT01791153|565651463|FG001|Part 2: Open-label Period|Adverse Event|0|||
156872104|NCT01075685|566289504|FG001|Overall Study|Protocol Violation|1|||
156700562|NCT01791153|565651464|FG002|Part 2: Open-label Period|Adverse Event|0|||
156700563|NCT01791153|565651465|FG003|Part 2: Open-label Period|Adverse Event|0|||
156700564|NCT01791153|565651466|FG004|Part 2: Open-label Period|Adverse Event|0|||
156700565|NCT01791153|565651467|FG005|Part 2: Open-label Period|Adverse Event|1|||
156700566|NCT01791153|565651468|FG006|Part 2: Open-label Period|Adverse Event|1|||
156700567|NCT01791153|565651469|FG007|Part 2: Open-label Period|Adverse Event|2|||
157214966|NCT01280981|567533559|FG000|Overall Study|Lost to Follow-up|3|||
157214967|NCT01280981|567533559|FG000|Overall Study|Adverse Event|6|||
157214968|NCT01280981|567533559|FG000|Overall Study|Irregular or discontinued menses|3|||
157214969|NCT01280981|567533559|FG000|Overall Study|Failed to return|45|||
157214970|NCT01280981|567533559|FG000|Overall Study|Non-compliance with protocol|3|||
157214971|NCT01280981|567533559|FG000|Overall Study|Withdrawal of consent|3|||
157214972|NCT01280981|567533559|FG000|Overall Study|Elective surgery|2|||
157214973|NCT01280981|567533559|FG000|Overall Study|Study site closure|1|||
157214974|NCT03056001|567533560|FG000|Overall Study|Death|24|||
157214975|NCT01374906|567533564|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157214976|NCT01374906|567533565|FG001|Overall Study|Abnormal laboratory value(s)|3|||
157214977|NCT01374906|567533564|FG000|Overall Study|Administrative problems|2|||
157214978|NCT01374906|567533565|FG001|Overall Study|Administrative problems|2|||
157214979|NCT01374906|567533564|FG000|Overall Study|Adverse Event|10|||
157214980|NCT01374906|567533565|FG001|Overall Study|Adverse Event|11|||
157214981|NCT01374906|567533564|FG000|Overall Study|Death|0|||
157214982|NCT01374906|567533565|FG001|Overall Study|Death|2|||
156790870|NCT01903733|565985502|FG002|Overall Study|Missing|0|||
156790871|NCT01903733|565985503|FG003|Overall Study|Missing|0|||
157015071|NCT02791230|566806736|FG002|Overall Study|Other|28|||
157015072|NCT02791230|566806734|FG000|Overall Study|Protocol Violation|0|||
157015073|NCT02791230|566806735|FG001|Overall Study|Protocol Violation|0|||
157015074|NCT02791230|566806736|FG002|Overall Study|Protocol Violation|4|||
157015075|NCT02791230|566806734|FG000|Overall Study|Withdrawal by Subject|24|||
157015076|NCT02791230|566806735|FG001|Overall Study|Withdrawal by Subject|13|||
157015077|NCT02791230|566806736|FG002|Overall Study|Withdrawal by Subject|172|||
157015078|NCT02791230|566806734|FG000|Overall Study|Enrolled but not treated|0|||
157015079|NCT02791230|566806735|FG001|Overall Study|Enrolled but not treated|0|||
157015080|NCT02791230|566806736|FG002|Overall Study|Enrolled but not treated|5|||
157015081|NCT05104697|566806739|FG000|Overall Study|Withdrawal by Subject|0|||
157015082|NCT05104697|566806740|FG001|Overall Study|Withdrawal by Subject|1|||
157015083|NCT03899961|566806741|FG000|Overall Study|-delivery prior to|2|||
157015084|NCT03899961|566806742|FG001|Overall Study|-delivery prior to|7|||
157015085|NCT03899961|566806741|FG000|Overall Study|req general anesth|1|||
157015086|NCT03899961|566806742|FG001|Overall Study|req general anesth|2|||
157015087|NCT03899961|566806741|FG000|Overall Study|capacity|5|||
157015088|NCT03899961|566806742|FG001|Overall Study|capacity|6|||
157015089|NCT03899961|566806741|FG000|Overall Study|Withdrawal by Subject|1|||
157015090|NCT03899961|566806742|FG001|Overall Study|Withdrawal by Subject|1|||
157015091|NCT05307978|566806743|FG000|Overall Study|Lost to Follow-up|0|||
157015092|NCT05307978|566806744|FG001|Overall Study|Lost to Follow-up|1|||
157015093|NCT05307978|566806745|FG002|Overall Study|Lost to Follow-up|0|||
157015094|NCT05307978|566806746|FG003|Overall Study|Lost to Follow-up|4|||
157015095|NCT05307978|566806747|FG004|Overall Study|Lost to Follow-up|0|||
157015096|NCT05307978|566806748|FG005|Overall Study|Lost to Follow-up|0|||
157015097|NCT05307978|566806749|FG006|Overall Study|Lost to Follow-up|1|||
157015098|NCT05075408|566806750|FG000|Overall Study|Withdrawal by Subject|5|||
157015099|NCT05075408|566806751|FG001|Overall Study|Withdrawal by Subject|3|||
157015100|NCT05075408|566806752|FG002|Overall Study|Withdrawal by Subject|4|||
157015101|NCT05075408|566806750|FG000|Overall Study|Adverse Event|5|||
157015102|NCT05075408|566806751|FG001|Overall Study|Adverse Event|7|||
157015103|NCT05075408|566806752|FG002|Overall Study|Adverse Event|8|||
157015104|NCT05075408|566806750|FG000|Overall Study|Protocol Violation|0|||
157015105|NCT05075408|566806751|FG001|Overall Study|Protocol Violation|1|||
157015106|NCT05075408|566806752|FG002|Overall Study|Protocol Violation|0|||
157015107|NCT05075408|566806750|FG000|Overall Study|Lost to Follow-up|2|||
157015108|NCT05075408|566806751|FG001|Overall Study|Lost to Follow-up|1|||
157015109|NCT05075408|566806752|FG002|Overall Study|Lost to Follow-up|1|||
157015110|NCT05075408|566806750|FG000|Overall Study|Physician Decision|1|||
157015111|NCT05075408|566806751|FG001|Overall Study|Physician Decision|0|||
157015112|NCT05075408|566806752|FG002|Overall Study|Physician Decision|0|||
157015113|NCT05075408|566806750|FG000|Overall Study|Other-unspecified|3|||
157015114|NCT05075408|566806751|FG001|Overall Study|Other-unspecified|2|||
157015115|NCT05075408|566806752|FG002|Overall Study|Other-unspecified|0|||
157015116|NCT03416023|566806753|FG000|Overall Study|Exclusion criteria failure|1|||
157015117|NCT03416023|566806753|FG000|Overall Study|Withdrawal by Subject|6|||
157015118|NCT03416023|566806753|FG000|Overall Study|Explanted|7|||
157015119|NCT03416023|566806753|FG000|Overall Study|Physician Decision|1|||
157015120|NCT03416023|566806753|FG000|Overall Study|Lost to Follow-up|1|||
157015121|NCT03416023|566806753|FG000|Overall Study|Death|1|||
157015122|NCT03651895|566806754|FG000|First Drug Assignment|Adverse Event|4|||
157015123|NCT03651895|566806755|FG001|First Drug Assignment|Adverse Event|5|||
157015124|NCT03651895|566806754|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
157015125|NCT03651895|566806755|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
157015126|NCT05510232|566806756|FG000|Overall Study|Withdrawal by Subject|2|||
157015127|NCT05510232|566806757|FG001|Overall Study|Withdrawal by Subject|7|||
157015128|NCT05510232|566806758|FG002|Overall Study|Withdrawal by Subject|6|||
156700568|NCT01791153|565651462|FG000|Part 2: Open-label Period|Death|0|||
156700569|NCT01791153|565651463|FG001|Part 2: Open-label Period|Death|0|||
157123555|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
156700570|NCT01791153|565651464|FG002|Part 2: Open-label Period|Death|0|||
156700571|NCT01791153|565651465|FG003|Part 2: Open-label Period|Death|0|||
156700572|NCT01791153|565651466|FG004|Part 2: Open-label Period|Death|0|||
156700573|NCT01791153|565651467|FG005|Part 2: Open-label Period|Death|1|||
156700574|NCT01791153|565651468|FG006|Part 2: Open-label Period|Death|1|||
156700575|NCT01791153|565651469|FG007|Part 2: Open-label Period|Death|1|||
156700576|NCT01791153|565651462|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
156700577|NCT01791153|565651463|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
156700578|NCT01791153|565651464|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
156700579|NCT01791153|565651465|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
156700580|NCT01791153|565651466|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
156700581|NCT01791153|565651467|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
156700582|NCT01791153|565651468|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
156700583|NCT01791153|565651469|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
156700584|NCT01791153|565651462|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
156700585|NCT01791153|565651463|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
156700586|NCT01791153|565651464|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
156700587|NCT01791153|565651465|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
156700588|NCT01791153|565651466|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
156700589|NCT01791153|565651467|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
156700590|NCT01791153|565651468|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
156700591|NCT01791153|565651469|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
157123556|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
157123557|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
157123558|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
156700592|NCT01791153|565651462|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700593|NCT01791153|565651463|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700594|NCT01791153|565651464|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700595|NCT01791153|565651465|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
156700596|NCT01791153|565651466|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
156700597|NCT01791153|565651467|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
156700598|NCT01791153|565651468|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
156700599|NCT01791153|565651469|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
156700600|NCT01791153|565651462|FG000|Part 2: Open-label Period|Physician Decision|0|||
156700601|NCT01791153|565651463|FG001|Part 2: Open-label Period|Physician Decision|0|||
156700602|NCT01791153|565651464|FG002|Part 2: Open-label Period|Physician Decision|0|||
156700603|NCT01791153|565651465|FG003|Part 2: Open-label Period|Physician Decision|0|||
156700604|NCT01791153|565651466|FG004|Part 2: Open-label Period|Physician Decision|1|||
156700605|NCT01791153|565651467|FG005|Part 2: Open-label Period|Physician Decision|1|||
156700606|NCT01791153|565651468|FG006|Part 2: Open-label Period|Physician Decision|0|||
156700607|NCT01791153|565651469|FG007|Part 2: Open-label Period|Physician Decision|0|||
156700608|NCT02357342|565651470|FG000|First 6 Months|Death|2|||
157123559|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
157123560|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
157123561|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
157123562|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
157123563|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
157123564|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
157123565|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
157123566|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
157123567|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
157123568|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
157123569|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
157123570|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
157123571|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
157214983|NCT01374906|567533564|FG000|Overall Study|Protocol Violation|2|||
157214984|NCT01374906|567533565|FG001|Overall Study|Protocol Violation|2|||
157214985|NCT01374906|567533564|FG000|Overall Study|Withdrawal by Subject|15|||
157214986|NCT01374906|567533565|FG001|Overall Study|Withdrawal by Subject|9|||
157214987|NCT01374906|567533564|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
156700609|NCT02357342|565651471|FG001|First 6 Months|Death|0|||
156700610|NCT03923530|565651472|FG000|Overall Study|Withdrawal by Subject|1|||
156700611|NCT03923530|565651472|FG000|Overall Study|screen failure|3|||
156700612|NCT01408628|565651475|FG000|Consented|Withdrawal by Subject|12|||
156700613|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
156700614|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
157123572|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
157123573|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
157123574|NCT01789970|567203762|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
157123575|NCT01789970|567203763|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
157123576|NCT01789970|567203764|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
157123577|NCT01847885|567203768|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
157123578|NCT01847885|567203769|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
157123579|NCT01847885|567203770|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
157123580|NCT01847885|567203768|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
157123581|NCT01847885|567203769|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
157123582|NCT01847885|567203770|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
157123583|NCT01847885|567203768|FG000|Initial Enrollment (Consented)|Screen failure|39|||
157123584|NCT01847885|567203769|FG001|Initial Enrollment (Consented)|Screen failure|0|||
157123585|NCT01847885|567203770|FG002|Initial Enrollment (Consented)|Screen failure|0|||
157123586|NCT01847885|567203768|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
157123587|NCT01847885|567203769|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
157123588|NCT01847885|567203770|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
157123589|NCT01847885|567203768|FG000|Randomization|Protocol Violation|0|||
157123590|NCT01847885|567203769|FG001|Randomization|Protocol Violation|1|||
157123591|NCT01847885|567203770|FG002|Randomization|Protocol Violation|0|||
156700615|NCT01408628|565651475|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
156700616|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
156700617|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
156700618|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
156700619|NCT01181271|565651476|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
156700620|NCT01753336|565651477|FG000|Overall Study|Patient decision|12|||
156700621|NCT01753336|565651477|FG000|Overall Study|Lost to Follow-up|3|||
156700622|NCT01753336|565651477|FG000|Overall Study|Physician Decision|2|||
156700623|NCT01753336|565651477|FG000|Overall Study|Sponsor's decision|2|||
156700624|NCT01753336|565651477|FG000|Overall Study|Withdrawal by Subject|1|||
156700625|NCT02991430|565651480|FG000|Treatment Period 1|Adverse Event|1|||
156700626|NCT02991430|565651481|FG001|Treatment Period 1|Adverse Event|0|||
156700627|NCT02991430|565651482|FG002|Treatment Period 1|Adverse Event|2|||
156700628|NCT02991430|565651480|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156700629|NCT02991430|565651481|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156700630|NCT02991430|565651482|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156700631|NCT02991430|565651480|FG000|Treatment Period 2|Study Termination|6|||
156700632|NCT02991430|565651481|FG001|Treatment Period 2|Study Termination|3|||
156700633|NCT02991430|565651482|FG002|Treatment Period 2|Study Termination|3|||
156700634|NCT02991430|565651480|FG000|Treatment Period 2|Lost to Follow-up|0|||
156700635|NCT02991430|565651481|FG001|Treatment Period 2|Lost to Follow-up|0|||
156700636|NCT02991430|565651482|FG002|Treatment Period 2|Lost to Follow-up|1|||
156700637|NCT02991430|565651480|FG000|Post-treatment Observation Period|Study Termination|3|||
156700638|NCT02991430|565651481|FG001|Post-treatment Observation Period|Study Termination|6|||
156700639|NCT02991430|565651482|FG002|Post-treatment Observation Period|Study Termination|5|||
156700640|NCT01150890|565651483|FG000|Overall Study|Other|0|||
156700641|NCT01150890|565651484|FG001|Overall Study|Other|1|||
156700642|NCT01150890|565651485|FG002|Overall Study|Other|0|||
156700643|NCT01150890|565651486|FG003|Overall Study|Other|2|||
156700644|NCT01150890|565651483|FG000|Overall Study|Pregnancy|0|||
156700645|NCT01150890|565651484|FG001|Overall Study|Pregnancy|0|||
157123592|NCT01847885|567203768|FG000|Randomization|Withdrawal by Subject|0|||
157123593|NCT01847885|567203769|FG001|Randomization|Withdrawal by Subject|0|||
157123594|NCT01847885|567203770|FG002|Randomization|Withdrawal by Subject|2|||
157123595|NCT01847885|567203768|FG000|Randomization|Screen Failure|0|||
156700646|NCT01150890|565651485|FG002|Overall Study|Pregnancy|0|||
156700647|NCT01150890|565651486|FG003|Overall Study|Pregnancy|1|||
156700648|NCT01150890|565651483|FG000|Overall Study|Administrative Decision|4|||
156700649|NCT01150890|565651484|FG001|Overall Study|Administrative Decision|4|||
156700650|NCT01150890|565651485|FG002|Overall Study|Administrative Decision|5|||
156700651|NCT01150890|565651486|FG003|Overall Study|Administrative Decision|6|||
157015129|NCT04468776|566806761|FG000|Overall Study|Lost to Follow-up|4|||
157015130|NCT04468776|566806762|FG001|Overall Study|Lost to Follow-up|3|||
157015131|NCT04468776|566806763|FG002|Overall Study|Lost to Follow-up|4|||
157015132|NCT04468776|566806761|FG000|Overall Study|Withdrawal by Subject|1|||
157015133|NCT04468776|566806762|FG001|Overall Study|Withdrawal by Subject|10|||
157015134|NCT04468776|566806763|FG002|Overall Study|Withdrawal by Subject|4|||
157015135|NCT04468776|566806761|FG000|Overall Study|Physician Decision|0|||
157015136|NCT04468776|566806762|FG001|Overall Study|Physician Decision|1|||
157015137|NCT04468776|566806763|FG002|Overall Study|Physician Decision|1|||
157015138|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
157015139|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
157015140|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
157214988|NCT01374906|567533565|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
156700652|NCT01150890|565651483|FG000|Overall Study|Ineligibility determined|0|||
156700653|NCT01150890|565651484|FG001|Overall Study|Ineligibility determined|1|||
156700654|NCT01150890|565651485|FG002|Overall Study|Ineligibility determined|0|||
156700655|NCT01150890|565651486|FG003|Overall Study|Ineligibility determined|0|||
156700656|NCT01150890|565651483|FG000|Overall Study|Adverse Event|0|||
156700657|NCT01150890|565651484|FG001|Overall Study|Adverse Event|0|||
156700658|NCT01150890|565651485|FG002|Overall Study|Adverse Event|2|||
156700659|NCT01150890|565651486|FG003|Overall Study|Adverse Event|0|||
156700660|NCT01150890|565651483|FG000|Overall Study|Withdrawal by Subject|0|||
156700661|NCT01150890|565651484|FG001|Overall Study|Withdrawal by Subject|0|||
156700662|NCT01150890|565651485|FG002|Overall Study|Withdrawal by Subject|2|||
156700663|NCT01150890|565651486|FG003|Overall Study|Withdrawal by Subject|1|||
156700664|NCT01150890|565651483|FG000|Overall Study|Disease progression|0|||
156700665|NCT01150890|565651484|FG001|Overall Study|Disease progression|7|||
156700666|NCT01150890|565651485|FG002|Overall Study|Disease progression|3|||
156790872|NCT01903733|565985500|FG000|Overall Study|Investigator request|18|||
156790873|NCT01903733|565985501|FG001|Overall Study|Investigator request|0|||
156790874|NCT01903733|565985502|FG002|Overall Study|Investigator request|0|||
156790875|NCT01903733|565985503|FG003|Overall Study|Investigator request|0|||
156790876|NCT01714063|565985504|FG000|Overall Study|Equipment malfunction|2|||
156790877|NCT01248468|565985505|FG000|Overall Study|Administrative problem|1|||
156790878|NCT01248468|565985506|FG001|Overall Study|Administrative problem|0|||
156790879|NCT01248468|565985507|FG002|Overall Study|Administrative problem|0|||
156790880|NCT01248468|565985505|FG000|Overall Study|Lost to Follow-up|9|||
156790881|NCT01248468|565985506|FG001|Overall Study|Lost to Follow-up|12|||
156790882|NCT01248468|565985507|FG002|Overall Study|Lost to Follow-up|4|||
156790883|NCT01248468|565985505|FG000|Overall Study|Pregnancy|1|||
156790884|NCT01248468|565985506|FG001|Overall Study|Pregnancy|0|||
156790885|NCT01248468|565985507|FG002|Overall Study|Pregnancy|0|||
156790886|NCT01248468|565985505|FG000|Overall Study|Withdrawal by Subject|4|||
156790887|NCT01248468|565985506|FG001|Overall Study|Withdrawal by Subject|2|||
156790888|NCT01248468|565985507|FG002|Overall Study|Withdrawal by Subject|0|||
156790889|NCT02191397|565985508|FG000|Overall Study|Adverse Event|28|||
156790890|NCT02191397|565985509|FG001|Overall Study|Adverse Event|17|||
156790891|NCT02191397|565985508|FG000|Overall Study|Lack of Efficacy|10|||
156790892|NCT02191397|565985509|FG001|Overall Study|Lack of Efficacy|5|||
156790893|NCT02191397|565985508|FG000|Overall Study|Protocol Violation|0|||
156790894|NCT02191397|565985509|FG001|Overall Study|Protocol Violation|3|||
157015141|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
157015142|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
157015143|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
157015144|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
157015145|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
157015146|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
157015147|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
157015148|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
157015149|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
157015150|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
157015151|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
157015152|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
157015153|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
157015154|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
157015155|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
157015156|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
157015157|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
157015158|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
157015159|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
157015160|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
157015161|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
157015162|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
157015163|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
157015164|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
157015165|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
157015166|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
157015167|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
157015168|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
157015169|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
157015170|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
156700667|NCT01150890|565651486|FG003|Overall Study|Disease progression|7|||
156700668|NCT01672970|565651487|FG000|Overall Study|Lack of Efficacy|12|||
156790895|NCT02191397|565985508|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
156790896|NCT02191397|565985509|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
156700669|NCT01672970|565651487|FG000|Overall Study|Adverse Event|18|||
156700670|NCT01672970|565651487|FG000|Overall Study|Withdrawal by Subject|2|||
156700671|NCT01672970|565651487|FG000|Overall Study|Lost to Follow-up|5|||
156700672|NCT01672970|565651487|FG000|Overall Study|Other|9|||
156700673|NCT01672970|565651487|FG000|Overall Study|Enrolled but not treated|1|||
156700674|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
156700675|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
156700676|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
156700677|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
156700678|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
156700679|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
157214989|NCT00435825|567533568|FG000|Overall Study|Abnormality of Laboratory Test|0|||
157015171|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
157015172|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
157015173|NCT01898494|566806771|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
157015174|NCT01898494|566806772|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
157015175|NCT01898494|566806773|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
157015176|NCT01898494|566806774|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
157015177|NCT01898494|566806775|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
157015178|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
157015179|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
157015180|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
157015181|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
156700680|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
156700681|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
156700682|NCT04430855|565651490|FG000|Period 1 (Weeks 1-12)|Other|0|||
156700683|NCT04430855|565651491|FG001|Period 1 (Weeks 1-12)|Other|1|||
156700684|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
156700685|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
156700686|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
156700687|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
156700688|NCT04430855|565651490|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
156700689|NCT04430855|565651491|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
156700690|NCT01770392|565651492|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
156700691|NCT03401450|565651493|FG000|Overall Study|Lost to Follow-up|4|||
156700692|NCT03401450|565651494|FG001|Overall Study|Lost to Follow-up|6|||
156700693|NCT03401450|565651493|FG000|Overall Study|Anesthesia plan changed|2|||
156700694|NCT03401450|565651494|FG001|Overall Study|Anesthesia plan changed|2|||
156700695|NCT03401450|565651493|FG000|Overall Study|Did not complete medication diary|4|||
156700696|NCT03401450|565651494|FG001|Overall Study|Did not complete medication diary|2|||
156700697|NCT03401450|565651493|FG000|Overall Study|post surgery medication change|2|||
156700698|NCT03401450|565651494|FG001|Overall Study|post surgery medication change|1|||
156700699|NCT03401450|565651493|FG000|Overall Study|Cancelled surgery|0|||
156700700|NCT03401450|565651494|FG001|Overall Study|Cancelled surgery|2|||
156700701|NCT03567382|565651495|FG000|Overall Study|Lost to Follow-up|1|||
156700702|NCT03567382|565651496|FG001|Overall Study|Lost to Follow-up|21|||
156700703|NCT03567382|565651497|FG002|Overall Study|Lost to Follow-up|1|||
156700704|NCT03567382|565651498|FG003|Overall Study|Lost to Follow-up|21|||
156700705|NCT03567382|565651495|FG000|Overall Study|Withdrawal by Subject|2|||
156700706|NCT03567382|565651496|FG001|Overall Study|Withdrawal by Subject|14|||
156700707|NCT03567382|565651497|FG002|Overall Study|Withdrawal by Subject|1|||
156700708|NCT03567382|565651498|FG003|Overall Study|Withdrawal by Subject|12|||
156700709|NCT02011386|565651499|FG000|Overall Study|Non-compliance|2|||
156700710|NCT02011386|565651499|FG000|Overall Study|Lack of Efficacy|3|||
156700711|NCT02352779|565651500|FG000|Overall Study|Personal Issues|1|||
156700712|NCT02352779|565651501|FG001|Overall Study|Personal Issues|1|||
156700713|NCT02352779|565651502|FG002|Overall Study|Personal Issues|0|||
156700714|NCT02352779|565651500|FG000|Overall Study|Too Many Forms|2|||
156700715|NCT02352779|565651501|FG001|Overall Study|Too Many Forms|0|||
156700716|NCT02352779|565651502|FG002|Overall Study|Too Many Forms|0|||
156700717|NCT02352779|565651500|FG000|Overall Study|Feeling Overwhelmed|1|||
156700718|NCT02352779|565651501|FG001|Overall Study|Feeling Overwhelmed|0|||
156700719|NCT02352779|565651502|FG002|Overall Study|Feeling Overwhelmed|0|||
156700720|NCT02352779|565651500|FG000|Overall Study|Disliked Intervention|1|||
156700721|NCT02352779|565651501|FG001|Overall Study|Disliked Intervention|0|||
156700722|NCT02352779|565651502|FG002|Overall Study|Disliked Intervention|0|||
156700723|NCT02352779|565651500|FG000|Overall Study|Changed Mind|1|||
156700724|NCT02352779|565651501|FG001|Overall Study|Changed Mind|0|||
156700725|NCT02352779|565651502|FG002|Overall Study|Changed Mind|0|||
156700726|NCT02352779|565651500|FG000|Overall Study|Study Related Symptoms|1|||
156700727|NCT02352779|565651501|FG001|Overall Study|Study Related Symptoms|0|||
156700728|NCT02352779|565651502|FG002|Overall Study|Study Related Symptoms|0|||
156700729|NCT02352779|565651500|FG000|Overall Study|Absence of Symptoms|1|||
156700730|NCT02352779|565651501|FG001|Overall Study|Absence of Symptoms|0|||
156700731|NCT02352779|565651502|FG002|Overall Study|Absence of Symptoms|0|||
156700732|NCT02352779|565651500|FG000|Overall Study|Other Medical Reason|0|||
156700733|NCT02352779|565651501|FG001|Overall Study|Other Medical Reason|0|||
156700734|NCT02352779|565651502|FG002|Overall Study|Other Medical Reason|1|||
156700735|NCT02352779|565651500|FG000|Overall Study|No Reason|0|||
156700736|NCT02352779|565651501|FG001|Overall Study|No Reason|0|||
156700737|NCT02352779|565651502|FG002|Overall Study|No Reason|1|||
156700738|NCT00761865|565651503|FG000|Overall Study|Lost to Follow-up|8|||
156700739|NCT00761865|565651504|FG001|Overall Study|Lost to Follow-up|7|||
156700740|NCT04555720|565651505|FG000|Overall Study|Lost to Follow-up|2|||
156700741|NCT04555720|565651506|FG001|Overall Study|Lost to Follow-up|0|||
156700742|NCT04555720|565651507|FG002|Overall Study|Lost to Follow-up|0|||
156700743|NCT04555720|565651508|FG003|Overall Study|Lost to Follow-up|0|||
156700744|NCT04555720|565651505|FG000|Overall Study|Withdrawal by Subject|4|||
156700745|NCT04555720|565651506|FG001|Overall Study|Withdrawal by Subject|6|||
156700746|NCT04555720|565651507|FG002|Overall Study|Withdrawal by Subject|0|||
156700747|NCT04555720|565651508|FG003|Overall Study|Withdrawal by Subject|0|||
156700748|NCT00719849|565651509|FG000|Overall Study|Death|0|||
156700749|NCT00719849|565651510|FG001|Overall Study|Death|1|||
156700750|NCT02022748|565654772|FG000|Overall Study|Adverse Event|1|||
156700751|NCT02022748|565654773|FG001|Overall Study|Adverse Event|1|||
156700752|NCT02022748|565654774|FG002|Overall Study|Adverse Event|0|||
156700753|NCT02022748|565654772|FG000|Overall Study|Withdrawal by Subject|0|||
156700754|NCT02022748|565654773|FG001|Overall Study|Withdrawal by Subject|1|||
156700755|NCT02022748|565654774|FG002|Overall Study|Withdrawal by Subject|0|||
156700756|NCT04347122|565654775|FG000|Overall Study|Physician Decision|0|||
156700757|NCT04347122|565654776|FG001|Overall Study|Physician Decision|3|||
156700758|NCT04347122|565654777|FG002|Overall Study|Physician Decision|3|||
156700759|NCT04347122|565654778|FG003|Overall Study|Physician Decision|6|||
156700760|NCT03510598|565654779|FG000|Overall Study|Withdrawal by Subject|1|||
156700761|NCT04994483|565654780|FG000|Overall Study|Adverse Event|26|||
156700762|NCT04994483|565654781|FG001|Overall Study|Adverse Event|17|||
156700763|NCT04994483|565654780|FG000|Overall Study|Lost to Follow-up|6|||
156700764|NCT04994483|565654781|FG001|Overall Study|Lost to Follow-up|10|||
156700765|NCT04994483|565654780|FG000|Overall Study|Noncompliance with study drug|8|||
156700766|NCT04994483|565654781|FG001|Overall Study|Noncompliance with study drug|5|||
156700767|NCT04994483|565654780|FG000|Overall Study|Physician Decision|5|||
156700768|NCT04994483|565654781|FG001|Overall Study|Physician Decision|0|||
156700769|NCT04994483|565654780|FG000|Overall Study|Withdrawal by Subject|41|||
156700770|NCT04994483|565654781|FG001|Overall Study|Withdrawal by Subject|38|||
156700771|NCT04994483|565654780|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
156700772|NCT04994483|565654781|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
156700773|NCT04994483|565654780|FG000|Overall Study|Met stopping criteria|1|||
156700774|NCT04994483|565654781|FG001|Overall Study|Met stopping criteria|0|||
156700775|NCT04994483|565654780|FG000|Overall Study|Randomized in error, not treated|4|||
156700776|NCT04994483|565654781|FG001|Overall Study|Randomized in error, not treated|3|||
156700777|NCT04994483|565654780|FG000|Overall Study|Lack of a reliable study partner|0|||
156700778|NCT04994483|565654781|FG001|Overall Study|Lack of a reliable study partner|1|||
156872105|NCT01075685|566289503|FG000|Overall Study|Withdrawal by Subject|20|||
156872106|NCT01075685|566289504|FG001|Overall Study|Withdrawal by Subject|5|||
156872107|NCT01075685|566289503|FG000|Overall Study|Lost to Follow-up|563|||
156872108|NCT01075685|566289504|FG001|Overall Study|Lost to Follow-up|220|||
156872109|NCT02858362|566289507|FG000|Overall Study|Protocol Violation|0|||
156700779|NCT04994483|565654780|FG000|Overall Study|Met MRI exclusion criteria|0|||
156700780|NCT04994483|565654781|FG001|Overall Study|Met MRI exclusion criteria|1|||
156700781|NCT01502410|565654782|FG000|Overall Study|Adverse Event|1|||
156700782|NCT01502410|565654783|FG001|Overall Study|Adverse Event|2|||
156700783|NCT01502410|565654784|FG002|Overall Study|Adverse Event|0|||
156700784|NCT01502410|565654785|FG003|Overall Study|Adverse Event|0|||
156700785|NCT01502410|565654782|FG000|Overall Study|Lack of Efficacy|7|||
156700786|NCT01502410|565654783|FG001|Overall Study|Lack of Efficacy|7|||
156700787|NCT01502410|565654784|FG002|Overall Study|Lack of Efficacy|0|||
156700788|NCT01502410|565654785|FG003|Overall Study|Lack of Efficacy|0|||
156700789|NCT01502410|565654782|FG000|Overall Study|Physician Decision|0|||
156700790|NCT01502410|565654783|FG001|Overall Study|Physician Decision|1|||
156700791|NCT01502410|565654784|FG002|Overall Study|Physician Decision|0|||
156700792|NCT01502410|565654785|FG003|Overall Study|Physician Decision|0|||
156700793|NCT01502410|565654782|FG000|Overall Study|Withdrawal by Subject|2|||
156700794|NCT01502410|565654783|FG001|Overall Study|Withdrawal by Subject|0|||
156700795|NCT01502410|565654784|FG002|Overall Study|Withdrawal by Subject|0|||
156700796|NCT01502410|565654785|FG003|Overall Study|Withdrawal by Subject|0|||
156700797|NCT03700385|565654788|FG000|Overall Study|Lost to Follow-up|1|||
156700798|NCT04590040|565654794|FG000|Treatment Period|Lost to Follow-up|2|||
156700799|NCT04590040|565654795|FG001|Treatment Period|Lost to Follow-up|5|||
156700800|NCT04590040|565654796|FG002|Treatment Period|Lost to Follow-up|0|||
156700801|NCT04590040|565654794|FG000|Treatment Period|Physician Decision|0|||
156700802|NCT04590040|565654795|FG001|Treatment Period|Physician Decision|0|||
156700803|NCT04590040|565654796|FG002|Treatment Period|Physician Decision|2|||
156700804|NCT03537599|565654805|FG000|Overall Study|Disease Progression|2|||
156700805|NCT03537599|565654806|FG001|Overall Study|Disease Progression|1|||
156700806|NCT03537599|565654805|FG000|Overall Study|Death|0|||
156700807|NCT03537599|565654806|FG001|Overall Study|Death|1|||
156700808|NCT05083585|565654807|FG000|Overall Study|Death|1|||
156700809|NCT05083585|565654808|FG001|Overall Study|Death|1|||
156700810|NCT05083585|565654807|FG000|Overall Study|Lost to Follow-up|1|||
156700811|NCT05083585|565654808|FG001|Overall Study|Lost to Follow-up|1|||
156700812|NCT05083585|565654807|FG000|Overall Study|Withdrawal by Subject|2|||
156700813|NCT05083585|565654808|FG001|Overall Study|Withdrawal by Subject|0|||
156700814|NCT05083585|565654807|FG000|Overall Study|Randomized but not vaccinated|2|||
156700815|NCT05083585|565654808|FG001|Overall Study|Randomized but not vaccinated|0|||
156700816|NCT00114166|565654809|FG000|Overall Study|Wrong primary|0|||
156700817|NCT00114166|565654810|FG001|Overall Study|Wrong primary|1|||
156700818|NCT03469336|565654811|FG000|Overall Study|Adverse Event|1|||
156700819|NCT02740699|565654813|FG000|Overall Study|Lost to Follow-up|5|||
156700820|NCT02740699|565654813|FG000|Overall Study|Withdrawal by Subject|14|||
156700821|NCT02740699|565654813|FG000|Overall Study|Physician Decision|5|||
156700822|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700823|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700824|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700825|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700826|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700827|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700828|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
156700829|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700830|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700831|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700832|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700833|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700834|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700835|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700836|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700837|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700838|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700839|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700840|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700841|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700842|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700843|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700844|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700845|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700846|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
156700847|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700848|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
156700849|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700850|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700851|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700852|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700853|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700854|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700855|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700856|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700857|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700858|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700859|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700860|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700861|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700862|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700863|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700864|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700865|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700866|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700867|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700868|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700869|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700870|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700871|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
156700872|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
157123596|NCT01847885|567203769|FG001|Randomization|Screen Failure|3|||
156700873|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
156700874|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
156700875|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
156700876|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
156700877|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
156700878|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
156700879|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
156700880|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
156700881|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
156700882|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
156700883|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
156700884|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
156700885|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
156700886|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
156700887|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
156700888|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
156700889|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
156700890|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
156700891|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
156700892|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
156700893|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
156700894|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
156700895|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
156700896|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
156700897|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
156700898|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700899|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700900|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700901|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700902|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700903|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700904|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700905|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700906|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700907|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700908|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700909|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700910|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700911|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700912|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700913|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700914|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700915|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700916|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700917|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700918|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700919|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700920|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700921|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
156700922|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700923|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700924|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700925|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700926|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700927|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
156700928|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
156700929|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700930|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700931|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
156700932|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700933|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700934|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700935|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700936|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156790897|NCT02191397|565985508|FG000|Overall Study|Lost to Follow-up|10|||
156790898|NCT02191397|565985509|FG001|Overall Study|Lost to Follow-up|11|||
157015182|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
157015183|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
157123597|NCT01847885|567203770|FG002|Randomization|Screen Failure|0|||
157123598|NCT02574637|567203771|FG000|Double-blind Period|Adverse Event|1|||
157123599|NCT02574637|567203772|FG001|Double-blind Period|Adverse Event|0|||
157123600|NCT02574637|567203773|FG002|Double-blind Period|Adverse Event|0|||
157123601|NCT02574637|567203774|FG003|Double-blind Period|Adverse Event|0|||
157123602|NCT02574637|567203775|FG004|Double-blind Period|Adverse Event|0|||
157123603|NCT02574637|567203776|FG005|Double-blind Period|Adverse Event|0|||
157123604|NCT02574637|567203777|FG006|Double-blind Period|Adverse Event|0|||
157123605|NCT02574637|567203778|FG007|Double-blind Period|Adverse Event|0|||
157123606|NCT02574637|567203779|FG008|Double-blind Period|Adverse Event|0|||
157123607|NCT02574637|567203780|FG009|Double-blind Period|Adverse Event|0|||
157123608|NCT02574637|567203771|FG000|Double-blind Period|Lack of Efficacy|0|||
157123609|NCT02574637|567203772|FG001|Double-blind Period|Lack of Efficacy|0|||
157123610|NCT02574637|567203773|FG002|Double-blind Period|Lack of Efficacy|2|||
157123611|NCT02574637|567203774|FG003|Double-blind Period|Lack of Efficacy|0|||
157123612|NCT02574637|567203775|FG004|Double-blind Period|Lack of Efficacy|0|||
157123613|NCT02574637|567203776|FG005|Double-blind Period|Lack of Efficacy|0|||
157123614|NCT02574637|567203777|FG006|Double-blind Period|Lack of Efficacy|0|||
157123615|NCT02574637|567203778|FG007|Double-blind Period|Lack of Efficacy|0|||
157123616|NCT02574637|567203779|FG008|Double-blind Period|Lack of Efficacy|0|||
157123617|NCT02574637|567203780|FG009|Double-blind Period|Lack of Efficacy|0|||
157123618|NCT02574637|567203771|FG000|Double-blind Period|Protocol Deviation|1|||
157123619|NCT02574637|567203772|FG001|Double-blind Period|Protocol Deviation|0|||
157123620|NCT02574637|567203773|FG002|Double-blind Period|Protocol Deviation|0|||
157123621|NCT02574637|567203774|FG003|Double-blind Period|Protocol Deviation|0|||
157123622|NCT02574637|567203775|FG004|Double-blind Period|Protocol Deviation|0|||
157123623|NCT02574637|567203776|FG005|Double-blind Period|Protocol Deviation|0|||
157123624|NCT02574637|567203777|FG006|Double-blind Period|Protocol Deviation|0|||
157123625|NCT02574637|567203778|FG007|Double-blind Period|Protocol Deviation|0|||
157123626|NCT02574637|567203779|FG008|Double-blind Period|Protocol Deviation|0|||
157123627|NCT02574637|567203780|FG009|Double-blind Period|Protocol Deviation|0|||
157123628|NCT02574637|567203771|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
157123629|NCT02574637|567203772|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
157123630|NCT02574637|567203773|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
157123631|NCT02574637|567203774|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
157123632|NCT02574637|567203775|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
157123633|NCT02574637|567203776|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
157123634|NCT02574637|567203777|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
157123635|NCT02574637|567203778|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
157123636|NCT02574637|567203779|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
157123637|NCT02574637|567203780|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
157123638|NCT02574637|567203771|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
157123639|NCT02574637|567203772|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
157123640|NCT02574637|567203773|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
157123641|NCT02574637|567203774|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
157123642|NCT02574637|567203775|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
157123643|NCT02574637|567203776|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
157123644|NCT02574637|567203777|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
157123645|NCT02574637|567203778|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
157123646|NCT02574637|567203779|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
157123647|NCT02574637|567203780|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
157123648|NCT02574637|567203771|FG000|Double-blind Period|Reason Not Specified|0|||
157123649|NCT02574637|567203772|FG001|Double-blind Period|Reason Not Specified|0|||
157123650|NCT02574637|567203773|FG002|Double-blind Period|Reason Not Specified|0|||
157123651|NCT02574637|567203774|FG003|Double-blind Period|Reason Not Specified|1|||
157123652|NCT02574637|567203775|FG004|Double-blind Period|Reason Not Specified|0|||
157123653|NCT02574637|567203776|FG005|Double-blind Period|Reason Not Specified|0|||
157123654|NCT02574637|567203777|FG006|Double-blind Period|Reason Not Specified|0|||
157123655|NCT02574637|567203778|FG007|Double-blind Period|Reason Not Specified|0|||
157123656|NCT02574637|567203779|FG008|Double-blind Period|Reason Not Specified|0|||
157123657|NCT02574637|567203780|FG009|Double-blind Period|Reason Not Specified|0|||
157123658|NCT02574637|567203771|FG000|Open-label (OL) Period|Adverse Event|0|||
157123659|NCT02574637|567203772|FG001|Open-label (OL) Period|Adverse Event|0|||
157123660|NCT02574637|567203773|FG002|Open-label (OL) Period|Adverse Event|0|||
157123661|NCT02574637|567203774|FG003|Open-label (OL) Period|Adverse Event|0|||
157123662|NCT02574637|567203775|FG004|Open-label (OL) Period|Adverse Event|0|||
157123663|NCT02574637|567203776|FG005|Open-label (OL) Period|Adverse Event|0|||
157123664|NCT02574637|567203777|FG006|Open-label (OL) Period|Adverse Event|0|||
157123665|NCT02574637|567203778|FG007|Open-label (OL) Period|Adverse Event|0|||
157123666|NCT02574637|567203779|FG008|Open-label (OL) Period|Adverse Event|1|||
157123667|NCT02574637|567203780|FG009|Open-label (OL) Period|Adverse Event|0|||
157123668|NCT02574637|567203771|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
157123669|NCT02574637|567203772|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
157123670|NCT02574637|567203773|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
156700937|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700938|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700939|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700940|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700941|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700942|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700943|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700944|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700945|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700946|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
156700947|NCT02393248|565654815|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
157015184|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
157015185|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
157015186|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
157015187|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
156700948|NCT02393248|565654816|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700949|NCT02393248|565654817|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700950|NCT02393248|565654818|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700951|NCT02393248|565654819|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700952|NCT02393248|565654820|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700953|NCT02393248|565654821|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
156700954|NCT02393248|565654822|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156872110|NCT02858362|566289508|FG001|Overall Study|Protocol Violation|1|||
157015188|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
157015189|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
157015190|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
157015191|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
157015192|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
157021748|NCT03673111|566832953|FG008|Overall Study|Adverse Event|0|||
157021749|NCT03673111|566832954|FG009|Overall Study|Adverse Event|0|||
157021750|NCT03673111|566832955|FG010|Overall Study|Adverse Event|0|||
157021751|NCT03673111|566832956|FG011|Overall Study|Adverse Event|0|||
157021752|NCT03673111|566832957|FG012|Overall Study|Adverse Event|0|||
157021753|NCT03673111|566832958|FG013|Overall Study|Adverse Event|0|||
157021754|NCT03792555|566832961|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
157021755|NCT03792555|566832962|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
157021756|NCT03792555|566832963|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
157021757|NCT03792555|566832961|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
157021758|NCT03792555|566832962|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
157021759|NCT03792555|566832963|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
157021760|NCT03792555|566832961|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
157021761|NCT03792555|566832962|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
157021762|NCT03792555|566832963|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
157021763|NCT04485039|566832964|FG000|TPOXX Only|Adverse Event|2|||
157021764|NCT04485039|566832964|FG000|TPOXX Only|Physician Decision|1|||
157021765|NCT04485039|566832964|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
157021766|NCT04485039|566832964|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
157021767|NCT04005716|566832968|FG000|Overall Study|Death|175|||
157021768|NCT04005716|566832969|FG001|Overall Study|Death|196|||
157021769|NCT04005716|566832968|FG000|Overall Study|Withdrawal by Subject|1|||
157021770|NCT04005716|566832969|FG001|Overall Study|Withdrawal by Subject|6|||
157021771|NCT04005716|566832968|FG000|Overall Study|Lost to Follow-up|2|||
157021772|NCT04005716|566832969|FG001|Overall Study|Lost to Follow-up|2|||
157021773|NCT00378105|566832970|FG000|Overall Study|Adverse Event|3|||
157021774|NCT00378105|566832971|FG001|Overall Study|Adverse Event|1|||
157021775|NCT00378105|566832970|FG000|Overall Study|Withdrawal by Subject|3|||
157021776|NCT00378105|566832971|FG001|Overall Study|Withdrawal by Subject|3|||
157021777|NCT00378105|566832970|FG000|Overall Study|Death|1|||
157021778|NCT00378105|566832971|FG001|Overall Study|Death|0|||
157021779|NCT00378105|566832970|FG000|Overall Study|Going to transplant|7|||
157021780|NCT00378105|566832971|FG001|Overall Study|Going to transplant|8|||
157021781|NCT00378105|566832970|FG000|Overall Study|Progressive disease|3|||
157021782|NCT00378105|566832971|FG001|Overall Study|Progressive disease|3|||
157021783|NCT00378105|566832970|FG000|Overall Study|remain on study|3|||
157021784|NCT00378105|566832971|FG001|Overall Study|remain on study|11|||
157021785|NCT00378105|566832970|FG000|Overall Study|Physician Decision|0|||
157021786|NCT00378105|566832971|FG001|Overall Study|Physician Decision|2|||
157021787|NCT00378105|566832970|FG000|Overall Study|Going non-protocol therapy|0|||
156700955|NCT02393248|565654823|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700956|NCT02393248|565654824|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700957|NCT02393248|565654825|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700958|NCT02393248|565654826|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700959|NCT02393248|565654827|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700960|NCT02393248|565654828|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700961|NCT02393248|565654829|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700962|NCT02393248|565654830|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700963|NCT02393248|565654831|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700964|NCT02393248|565654832|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700965|NCT02393248|565654833|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700966|NCT02393248|565654834|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700967|NCT02393248|565654835|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700968|NCT02393248|565654836|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700969|NCT02393248|565654837|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700970|NCT02393248|565654838|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700971|NCT02393248|565654839|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
156700972|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700973|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700974|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700975|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700976|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700977|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700978|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700979|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700980|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700981|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700982|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700983|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
156700984|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
156700985|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
156700986|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
156700987|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700988|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700989|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700990|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700991|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700992|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700993|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700994|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700995|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700996|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
156700997|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156700998|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156700999|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701000|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701001|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701002|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701003|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701004|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701005|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701006|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701007|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
156701008|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
156701009|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701010|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701011|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701012|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701013|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701014|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701015|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
157123671|NCT02574637|567203774|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
156701016|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701017|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701018|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701019|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701020|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701021|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
156701022|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
156701023|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
156701024|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
156701025|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
156701026|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
156701027|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
156701028|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
156701029|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
156701030|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
156701031|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
156701032|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
156701033|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
156701034|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
156701035|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
156701036|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
156701037|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
156701038|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
156701039|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
156701040|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
156701041|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
156701042|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
156701043|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
156701044|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
156701045|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
156701046|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
156701047|NCT02393248|565654815|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701048|NCT02393248|565654816|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701049|NCT02393248|565654817|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701050|NCT02393248|565654818|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701051|NCT02393248|565654819|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701052|NCT02393248|565654820|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701053|NCT02393248|565654821|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701054|NCT02393248|565654822|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701055|NCT02393248|565654823|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701056|NCT02393248|565654824|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701057|NCT02393248|565654825|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701058|NCT02393248|565654826|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
156701059|NCT02393248|565654827|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701060|NCT02393248|565654828|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
156701061|NCT02393248|565654829|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701062|NCT02393248|565654830|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701063|NCT02393248|565654831|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701064|NCT02393248|565654832|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701065|NCT02393248|565654833|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701066|NCT02393248|565654834|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701067|NCT02393248|565654835|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701068|NCT02393248|565654836|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701069|NCT02393248|565654837|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701070|NCT02393248|565654838|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156790899|NCT02191397|565985508|FG000|Overall Study|Physician Decision|8|||
157015193|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
157015194|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
157015195|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
157015196|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
157123672|NCT02574637|567203775|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
157015197|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
157015198|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
157015199|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
157015200|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
157015201|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
157123673|NCT02574637|567203776|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
157123674|NCT02574637|567203777|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
156701071|NCT02393248|565654839|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
156701072|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701073|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701074|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701075|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701076|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701077|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701078|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701079|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701080|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701081|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701082|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701083|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701084|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701085|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701086|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701087|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701088|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701089|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701090|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701091|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701092|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
156701093|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701094|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701095|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
156701096|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
156701097|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Death|0|||
156701098|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Death|0|||
156701099|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Death|0|||
156701100|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Death|0|||
156701101|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Death|0|||
156701102|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Death|0|||
156701103|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Death|0|||
156701104|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Death|0|||
156701105|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Death|0|||
156701106|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Death|0|||
156701107|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Death|0|||
156701108|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Death|0|||
156701109|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Death|0|||
156701110|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Death|0|||
156701111|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Death|0|||
156701112|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Death|1|||
156701113|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Death|7|||
156701114|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Death|5|||
156701115|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Death|5|||
156701116|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Death|3|||
156701117|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Death|7|||
156701118|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Death|5|||
156701119|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Death|6|||
156701120|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Death|3|||
156701121|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Death|0|||
156701122|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701123|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701124|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701125|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701126|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701127|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701128|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701129|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701130|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701131|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701132|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701133|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156872111|NCT02858362|566289509|FG002|Overall Study|Protocol Violation|0|||
157015202|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
156701134|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701135|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701136|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701137|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701138|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701139|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701140|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701141|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
156701142|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701143|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701144|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701145|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
156701146|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
156701147|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Disease Progression|0|||
156701148|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Disease Progression|0|||
156701149|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Disease Progression|0|||
156701150|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Disease Progression|0|||
156701151|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Disease Progression|0|||
156701152|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Disease Progression|0|||
156701153|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Disease Progression|0|||
156701154|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Disease Progression|0|||
156701155|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Disease Progression|0|||
156701156|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Disease Progression|0|||
156701157|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Disease Progression|0|||
156701158|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Disease Progression|0|||
156701159|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Disease Progression|0|||
156701160|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Disease Progression|0|||
156701161|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Disease Progression|0|||
156701162|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Disease Progression|0|||
156701163|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Disease Progression|0|||
156701164|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Disease Progression|0|||
156701165|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Disease Progression|0|||
156701166|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Disease Progression|0|||
156701167|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Disease Progression|2|||
156701168|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Disease Progression|1|||
156701169|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Disease Progression|0|||
156701170|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Disease Progression|0|||
156701171|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Disease Progression|0|||
156701172|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701173|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701174|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
157123675|NCT02574637|567203778|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
157123676|NCT02574637|567203779|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
157123677|NCT02574637|567203780|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
157123678|NCT02574637|567203771|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123679|NCT02574637|567203772|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123680|NCT02574637|567203773|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123681|NCT02574637|567203774|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123682|NCT02574637|567203775|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123683|NCT02574637|567203776|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
157123684|NCT02574637|567203777|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
157123685|NCT02574637|567203778|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
157123686|NCT02574637|567203779|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
157123687|NCT02574637|567203780|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
157123688|NCT02706730|567203782|FG000|Overall Study|Adverse Event|3|||
157123689|NCT02706730|567203782|FG000|Overall Study|Lack of Efficacy|5|||
157123690|NCT02706730|567203782|FG000|Overall Study|Withdrawal by Subject|11|||
157123691|NCT02706730|567203782|FG000|Overall Study|Study Terminated by Sponsor|11|||
157123692|NCT02706730|567203782|FG000|Overall Study|Subject chose not to receive injection|3|||
157123693|NCT02499029|567203783|FG000|Overall Study|Lost to Follow-up|2|||
157123694|NCT02499029|567203784|FG001|Overall Study|Lost to Follow-up|2|||
157123695|NCT02499029|567203783|FG000|Overall Study|Physician Decision|2|||
157123696|NCT02499029|567203784|FG001|Overall Study|Physician Decision|1|||
157123697|NCT02499029|567203783|FG000|Overall Study|Death|1|||
157123698|NCT02499029|567203784|FG001|Overall Study|Death|0|||
157123699|NCT00756938|567203785|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
157123700|NCT00756938|567203786|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
157123701|NCT00756938|567203787|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
157123702|NCT00756938|567203788|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
157123703|NCT00756938|567203785|FG000|12-week Base Study|Protocol Violation|0|||
157123704|NCT00756938|567203786|FG001|12-week Base Study|Protocol Violation|0|||
157123705|NCT00756938|567203787|FG002|12-week Base Study|Protocol Violation|1|||
157123706|NCT00756938|567203788|FG003|12-week Base Study|Protocol Violation|0|||
157123707|NCT00756938|567203785|FG000|12-week Base Study|Lost to Follow-up|1|||
157123708|NCT00756938|567203786|FG001|12-week Base Study|Lost to Follow-up|0|||
157123709|NCT00756938|567203787|FG002|12-week Base Study|Lost to Follow-up|0|||
156701175|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
156790900|NCT02191397|565985509|FG001|Overall Study|Physician Decision|3|||
156701176|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701177|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701178|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701179|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701180|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701181|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701182|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701183|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701184|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701185|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701186|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701187|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701188|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701189|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701190|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701191|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701192|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
156701193|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
156701194|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701195|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701196|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
156701197|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701198|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701199|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701200|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701201|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701202|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701203|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701204|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701205|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701206|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701207|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701208|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701209|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701210|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701211|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701212|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701213|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701214|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701215|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701216|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156872112|NCT02858362|566289507|FG000|Overall Study|Withdrawal by Subject|1|||
157015203|NCT01898494|566806771|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
157123710|NCT00756938|567203788|FG003|12-week Base Study|Lost to Follow-up|0|||
157123711|NCT00756938|567203785|FG000|Optional Extension|Lack of Efficacy|0|||
157123712|NCT00756938|567203786|FG001|Optional Extension|Lack of Efficacy|0|||
157123713|NCT00756938|567203787|FG002|Optional Extension|Lack of Efficacy|0|||
157123714|NCT00756938|567203788|FG003|Optional Extension|Lack of Efficacy|1|||
157123715|NCT00756938|567203785|FG000|Optional Extension|End of Study|0|||
157015204|NCT01898494|566806772|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
157015205|NCT01898494|566806773|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
157015206|NCT01898494|566806774|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
157015207|NCT01898494|566806775|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
157015208|NCT03289039|566806776|FG000|Overall Study|Withdrawal by Subject|0|||
157015209|NCT03289039|566806777|FG001|Overall Study|Withdrawal by Subject|1|||
157015210|NCT03289039|566806776|FG000|Overall Study|Became ineligible prior to treatment start|0|||
157015211|NCT03289039|566806777|FG001|Overall Study|Became ineligible prior to treatment start|1|||
157015212|NCT03289039|566806776|FG000|Overall Study|progressed before treatment start|1|||
157015213|NCT03289039|566806777|FG001|Overall Study|progressed before treatment start|0|||
157015214|NCT02819843|566806778|FG000|Overall Study|Disease progression before RT|0|||
157015215|NCT02819843|566806779|FG001|Overall Study|Disease progression before RT|1|||
157015216|NCT04732494|566806780|FG000|Overall Study|Death|39|||
156701217|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
156701218|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701219|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701220|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701221|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
156701222|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Adverse Event|0|||
156701223|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Adverse Event|0|||
156701224|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Adverse Event|0|||
156701225|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Adverse Event|0|||
156701226|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Adverse Event|0|||
156701227|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Adverse Event|0|||
156701228|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Adverse Event|0|||
156701229|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Adverse Event|0|||
156701230|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Adverse Event|0|||
156701231|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Adverse Event|0|||
156701232|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Adverse Event|0|||
156701233|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Adverse Event|0|||
156701234|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Adverse Event|0|||
156701235|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Adverse Event|0|||
156701236|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Adverse Event|0|||
156701237|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Adverse Event|0|||
156701238|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Adverse Event|0|||
156701239|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Adverse Event|0|||
156701240|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Adverse Event|0|||
156701241|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Adverse Event|0|||
156701242|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Adverse Event|0|||
156701243|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Adverse Event|0|||
156701244|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Adverse Event|0|||
156701245|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Adverse Event|1|||
156701246|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Adverse Event|0|||
156701247|NCT02393248|565654815|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701248|NCT02393248|565654816|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701249|NCT02393248|565654817|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701250|NCT02393248|565654818|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701251|NCT02393248|565654819|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701252|NCT02393248|565654820|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701253|NCT02393248|565654821|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701254|NCT02393248|565654822|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701255|NCT02393248|565654823|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701256|NCT02393248|565654824|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
157015217|NCT04732494|566806781|FG001|Overall Study|Death|36|||
157015218|NCT04732494|566806780|FG000|Overall Study|Study Closed by Sponsor|20|||
157015219|NCT04732494|566806781|FG001|Overall Study|Study Closed by Sponsor|15|||
157015220|NCT04732494|566806780|FG000|Overall Study|Withdrawal by Subject|2|||
157015221|NCT04732494|566806781|FG001|Overall Study|Withdrawal by Subject|7|||
157015222|NCT04732494|566806780|FG000|Overall Study|Lost to Follow-up|1|||
157015223|NCT04732494|566806781|FG001|Overall Study|Lost to Follow-up|5|||
157015224|NCT04586920|566806782|FG000|Overall Study|Lost to Follow-up|0|||
157015225|NCT04586920|566806783|FG001|Overall Study|Lost to Follow-up|0|||
157015226|NCT04586920|566806784|FG002|Overall Study|Lost to Follow-up|0|||
157015227|NCT04586920|566806785|FG003|Overall Study|Lost to Follow-up|0|||
157015228|NCT04586920|566806786|FG004|Overall Study|Lost to Follow-up|0|||
157015229|NCT04586920|566806787|FG005|Overall Study|Lost to Follow-up|0|||
157015230|NCT04586920|566806788|FG006|Overall Study|Lost to Follow-up|1|||
157015231|NCT04586920|566806789|FG007|Overall Study|Lost to Follow-up|1|||
157015232|NCT04586920|566806790|FG008|Overall Study|Lost to Follow-up|0|||
157015233|NCT04586920|566806791|FG009|Overall Study|Lost to Follow-up|1|||
157015234|NCT04586920|566806792|FG010|Overall Study|Lost to Follow-up|0|||
157015235|NCT04586920|566806793|FG011|Overall Study|Lost to Follow-up|0|||
157015236|NCT04586920|566806794|FG012|Overall Study|Lost to Follow-up|0|||
157015237|NCT04586920|566806795|FG013|Overall Study|Lost to Follow-up|1|||
157015238|NCT04586920|566806796|FG014|Overall Study|Lost to Follow-up|0|||
157015239|NCT04586920|566806797|FG015|Overall Study|Lost to Follow-up|0|||
157015240|NCT04586920|566806798|FG016|Overall Study|Lost to Follow-up|0|||
157015241|NCT04586920|566806799|FG017|Overall Study|Lost to Follow-up|0|||
157015242|NCT04586920|566806782|FG000|Overall Study|Withdrawal by Subject|0|||
157015243|NCT04586920|566806783|FG001|Overall Study|Withdrawal by Subject|0|||
157015244|NCT04586920|566806784|FG002|Overall Study|Withdrawal by Subject|0|||
157015245|NCT04586920|566806785|FG003|Overall Study|Withdrawal by Subject|0|||
157015246|NCT04586920|566806786|FG004|Overall Study|Withdrawal by Subject|0|||
157015247|NCT04586920|566806787|FG005|Overall Study|Withdrawal by Subject|0|||
156701257|NCT02393248|565654825|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701258|NCT02393248|565654826|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701259|NCT02393248|565654827|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701260|NCT02393248|565654828|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701261|NCT02393248|565654829|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701262|NCT02393248|565654830|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701263|NCT02393248|565654831|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701264|NCT02393248|565654832|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701265|NCT02393248|565654833|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701266|NCT02393248|565654834|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701267|NCT02393248|565654835|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701268|NCT02393248|565654836|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701269|NCT02393248|565654837|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701270|NCT02393248|565654838|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
156701271|NCT02393248|565654839|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
156701272|NCT02585934|565654840|FG000|Overall Study|Lost to Follow-up|2|||
156701273|NCT02585934|565654841|FG001|Overall Study|Lost to Follow-up|2|||
156701274|NCT02585934|565654840|FG000|Overall Study|Protocol Violation|14|||
156701275|NCT02585934|565654841|FG001|Overall Study|Protocol Violation|11|||
156701276|NCT02585934|565654840|FG000|Overall Study|Adverse Event|21|||
156701277|NCT02585934|565654841|FG001|Overall Study|Adverse Event|22|||
156701278|NCT02585934|565654840|FG000|Overall Study|Physician Decision|3|||
156701279|NCT02585934|565654841|FG001|Overall Study|Physician Decision|2|||
156701280|NCT02585934|565654840|FG000|Overall Study|Withdrawal by Subject|7|||
156701281|NCT02585934|565654841|FG001|Overall Study|Withdrawal by Subject|21|||
157015248|NCT04586920|566806788|FG006|Overall Study|Withdrawal by Subject|0|||
157015249|NCT04586920|566806789|FG007|Overall Study|Withdrawal by Subject|1|||
157015250|NCT04586920|566806790|FG008|Overall Study|Withdrawal by Subject|0|||
157015251|NCT04586920|566806791|FG009|Overall Study|Withdrawal by Subject|1|||
157015252|NCT04586920|566806792|FG010|Overall Study|Withdrawal by Subject|0|||
157015253|NCT04586920|566806793|FG011|Overall Study|Withdrawal by Subject|1|||
157015254|NCT04586920|566806794|FG012|Overall Study|Withdrawal by Subject|0|||
157015255|NCT04586920|566806795|FG013|Overall Study|Withdrawal by Subject|0|||
157015256|NCT04586920|566806796|FG014|Overall Study|Withdrawal by Subject|0|||
157015257|NCT04586920|566806797|FG015|Overall Study|Withdrawal by Subject|0|||
157015258|NCT04586920|566806798|FG016|Overall Study|Withdrawal by Subject|0|||
157015259|NCT04586920|566806799|FG017|Overall Study|Withdrawal by Subject|0|||
157015260|NCT05136404|566806804|FG000|Period 1|Adverse Event|0|||
157015261|NCT05136404|566806805|FG001|Period 1|Adverse Event|1|||
157015262|NCT05136404|566806806|FG002|Period 1|Adverse Event|1|||
157015263|NCT05136404|566806804|FG000|Period 2|Inappropriate Behavior|0|||
157015264|NCT05136404|566806805|FG001|Period 2|Inappropriate Behavior|0|||
157015265|NCT05136404|566806806|FG002|Period 2|Inappropriate Behavior|1|||
157015266|NCT05136404|566806804|FG000|Period 3|Adverse Event|0|||
157015267|NCT05136404|566806805|FG001|Period 3|Adverse Event|0|||
157015268|NCT05136404|566806806|FG002|Period 3|Adverse Event|1|||
157015269|NCT02553642|566806807|FG000|Overall Study|Withdrawal by Subject|0|||
157015270|NCT02553642|566806808|FG001|Overall Study|Withdrawal by Subject|3|||
157015271|NCT02553642|566806807|FG000|Overall Study|Physician Decision|0|||
157015272|NCT02553642|566806808|FG001|Overall Study|Physician Decision|1|||
157015273|NCT02553642|566806807|FG000|Overall Study|Additional cancer dx|0|||
157015274|NCT02553642|566806808|FG001|Overall Study|Additional cancer dx|1|||
157015275|NCT02553642|566806807|FG000|Overall Study|Never started treatment|0|||
157015276|NCT02553642|566806808|FG001|Overall Study|Never started treatment|1|||
157015277|NCT01820260|566806814|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015278|NCT01820260|566806815|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015279|NCT01820260|566806816|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015280|NCT01820260|566806817|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015281|NCT01820260|566806818|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015282|NCT01820260|566806819|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015283|NCT01820260|566806820|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
157015284|NCT01820260|566806821|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015285|NCT01820260|566806822|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015286|NCT01820260|566806823|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015287|NCT01820260|566806824|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015288|NCT01820260|566806825|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015289|NCT01820260|566806826|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157021788|NCT00378105|566832971|FG001|Overall Study|Going non-protocol therapy|1|||
156701282|NCT02585934|565654840|FG000|Overall Study|Lack of Efficacy|2|||
156701283|NCT02585934|565654841|FG001|Overall Study|Lack of Efficacy|1|||
156701284|NCT02585934|565654840|FG000|Overall Study|Death|2|||
156701285|NCT02585934|565654841|FG001|Overall Study|Death|0|||
156701286|NCT02585934|565654840|FG000|Overall Study|Caregiver Withdrew Consent|7|||
156701287|NCT02585934|565654841|FG001|Overall Study|Caregiver Withdrew Consent|7|||
156701288|NCT02585934|565654840|FG000|Overall Study|Sponsor Termination|1|||
156701289|NCT02585934|565654841|FG001|Overall Study|Sponsor Termination|2|||
156701290|NCT02585934|565654840|FG000|Overall Study|Another Reason|10|||
156701291|NCT02585934|565654841|FG001|Overall Study|Another Reason|5|||
156701292|NCT04713553|565654842|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
156701293|NCT04713553|565654843|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
156701294|NCT04713553|565654844|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701295|NCT04713553|565654845|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701296|NCT04713553|565654846|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
156701297|NCT04713553|565654847|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701298|NCT04713553|565654848|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
156701299|NCT04713553|565654842|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701300|NCT04713553|565654843|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
157123716|NCT00756938|567203786|FG001|Optional Extension|End of Study|0|||
157123717|NCT00756938|567203787|FG002|Optional Extension|End of Study|0|||
157123718|NCT00756938|567203788|FG003|Optional Extension|End of Study|11|||
157123719|NCT00756938|567203785|FG000|Optional Extension|Protocol-specific criteria met|0|||
157123720|NCT00756938|567203786|FG001|Optional Extension|Protocol-specific criteria met|0|||
157123721|NCT00756938|567203787|FG002|Optional Extension|Protocol-specific criteria met|0|||
157123722|NCT00756938|567203788|FG003|Optional Extension|Protocol-specific criteria met|9|||
157123723|NCT00756938|567203785|FG000|Optional Extension|Physician Decision|0|||
157123724|NCT00756938|567203786|FG001|Optional Extension|Physician Decision|0|||
157123725|NCT00756938|567203787|FG002|Optional Extension|Physician Decision|0|||
157123726|NCT00756938|567203788|FG003|Optional Extension|Physician Decision|3|||
157123727|NCT00756938|567203785|FG000|Optional Extension|Lost to Follow-up|0|||
157123728|NCT00756938|567203786|FG001|Optional Extension|Lost to Follow-up|0|||
157123729|NCT00756938|567203787|FG002|Optional Extension|Lost to Follow-up|0|||
157123730|NCT00756938|567203788|FG003|Optional Extension|Lost to Follow-up|1|||
157123731|NCT00756938|567203785|FG000|Optional Extension|Protocol Violation|0|||
157123732|NCT00756938|567203786|FG001|Optional Extension|Protocol Violation|0|||
157123733|NCT00756938|567203787|FG002|Optional Extension|Protocol Violation|0|||
157123734|NCT00756938|567203788|FG003|Optional Extension|Protocol Violation|1|||
157123735|NCT00756938|567203785|FG000|Optional Extension|Withdrawal by Subject|0|||
157123736|NCT00756938|567203786|FG001|Optional Extension|Withdrawal by Subject|0|||
157123737|NCT00756938|567203787|FG002|Optional Extension|Withdrawal by Subject|0|||
157123738|NCT00756938|567203788|FG003|Optional Extension|Withdrawal by Subject|10|||
157123739|NCT00756938|567203785|FG000|Optional Extension|Adverse Event|0|||
157123740|NCT00756938|567203786|FG001|Optional Extension|Adverse Event|0|||
157123741|NCT00756938|567203787|FG002|Optional Extension|Adverse Event|0|||
157123742|NCT00756938|567203788|FG003|Optional Extension|Adverse Event|1|||
157123743|NCT00094055|567203789|FG000|Overall Study|Adverse Event|11|||
157123744|NCT00094055|567203789|FG000|Overall Study|Death|4|||
157123745|NCT00094055|567203789|FG000|Overall Study|Lack of Efficacy|17|||
157123746|NCT00094055|567203789|FG000|Overall Study|Lost to Follow-up|2|||
157123747|NCT00094055|567203789|FG000|Overall Study|progressive disease|2|||
157123748|NCT00094055|567203789|FG000|Overall Study|clinical progression|1|||
157123749|NCT00094055|567203789|FG000|Overall Study|roll-over to another study|14|||
157123750|NCT00094055|567203789|FG000|Overall Study|Withdrawal by Subject|9|||
157123751|NCT04823949|567203790|FG000|Overall Study|Withdrawal by Subject|0|||
157123752|NCT04823949|567203791|FG001|Overall Study|Withdrawal by Subject|4|||
157123753|NCT04823949|567203790|FG000|Overall Study|Physician Decision|0|||
157123754|NCT04823949|567203791|FG001|Overall Study|Physician Decision|1|||
157123755|NCT00441545|567203792|FG000|First Intervention|Adverse Event|6|||
157123756|NCT00441545|567203793|FG001|First Intervention|Adverse Event|5|||
157123757|NCT00441545|567203792|FG000|First Intervention|Protocol Violation|2|||
157123758|NCT00441545|567203793|FG001|First Intervention|Protocol Violation|2|||
157123759|NCT00441545|567203792|FG000|First Intervention|Withdrawal by Subject|3|||
157123760|NCT00441545|567203793|FG001|First Intervention|Withdrawal by Subject|3|||
157123761|NCT00441545|567203792|FG000|First Intervention|Kidney transplant|1|||
157123762|NCT00441545|567203793|FG001|First Intervention|Kidney transplant|1|||
157123763|NCT00441545|567203792|FG000|First Intervention|Lack of Efficacy|2|||
156701301|NCT04713553|565654844|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701302|NCT04713553|565654845|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
156701303|NCT04713553|565654846|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
157123764|NCT00441545|567203793|FG001|First Intervention|Lack of Efficacy|0|||
157123765|NCT00441545|567203792|FG000|First Intervention|Subject exceeded safety criteria|0|||
157123766|NCT00441545|567203793|FG001|First Intervention|Subject exceeded safety criteria|1|||
156701304|NCT04713553|565654847|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
156701305|NCT04713553|565654848|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
157214990|NCT00435825|567533569|FG001|Overall Study|Abnormality of Laboratory Test|1|||
157214991|NCT00435825|567533570|FG002|Overall Study|Abnormality of Laboratory Test|0|||
157214992|NCT00435825|567533571|FG003|Overall Study|Abnormality of Laboratory Test|0|||
157214993|NCT00435825|567533568|FG000|Overall Study|Insufficient Therapeutic Response|3|||
157214994|NCT00435825|567533569|FG001|Overall Study|Insufficient Therapeutic Response|1|||
157214995|NCT00435825|567533570|FG002|Overall Study|Insufficient Therapeutic Response|0|||
157214996|NCT00435825|567533571|FG003|Overall Study|Insufficient Therapeutic Response|3|||
157214997|NCT00435825|567533568|FG000|Overall Study|Other Protocol Violation|1|||
157214998|NCT00435825|567533569|FG001|Overall Study|Other Protocol Violation|0|||
157214999|NCT00435825|567533570|FG002|Overall Study|Other Protocol Violation|0|||
157215000|NCT00435825|567533571|FG003|Overall Study|Other Protocol Violation|0|||
157215001|NCT00435825|567533568|FG000|Overall Study|Refused treatment|2|||
157215002|NCT00435825|567533569|FG001|Overall Study|Refused treatment|0|||
157215003|NCT00435825|567533570|FG002|Overall Study|Refused treatment|0|||
157215004|NCT00435825|567533571|FG003|Overall Study|Refused treatment|5|||
157215005|NCT00435825|567533568|FG000|Overall Study|Failure to return|5|||
157215006|NCT00435825|567533569|FG001|Overall Study|Failure to return|0|||
157215007|NCT00435825|567533570|FG002|Overall Study|Failure to return|4|||
157215008|NCT00435825|567533571|FG003|Overall Study|Failure to return|0|||
157215009|NCT00435825|567533568|FG000|Overall Study|Did not receive study drug|1|||
157215010|NCT00435825|567533569|FG001|Overall Study|Did not receive study drug|0|||
157215011|NCT00435825|567533570|FG002|Overall Study|Did not receive study drug|2|||
157215012|NCT00435825|567533571|FG003|Overall Study|Did not receive study drug|0|||
157215013|NCT00435825|567533568|FG000|Overall Study|Did not enter follow-up|0|||
157215014|NCT00435825|567533569|FG001|Overall Study|Did not enter follow-up|4|||
157215015|NCT00435825|567533570|FG002|Overall Study|Did not enter follow-up|1|||
157215016|NCT00435825|567533571|FG003|Overall Study|Did not enter follow-up|3|||
157215017|NCT00435825|567533568|FG000|Overall Study|Did not complete full follow-up period|6|||
157215018|NCT00435825|567533569|FG001|Overall Study|Did not complete full follow-up period|6|||
157215019|NCT00435825|567533570|FG002|Overall Study|Did not complete full follow-up period|4|||
157215020|NCT00435825|567533571|FG003|Overall Study|Did not complete full follow-up period|5|||
157215021|NCT02367781|567533574|FG000|Overall Study|Withdrawal by Subject|20|||
157215022|NCT02367781|567533575|FG001|Overall Study|Withdrawal by Subject|13|||
157215023|NCT02367781|567533574|FG000|Overall Study|Protocol Violation|0|||
157215024|NCT02367781|567533575|FG001|Overall Study|Protocol Violation|1|||
157215025|NCT02367781|567533574|FG000|Overall Study|Physician Decision|7|||
157215026|NCT02367781|567533575|FG001|Overall Study|Physician Decision|0|||
157215027|NCT02367781|567533574|FG000|Overall Study|Randomized in Error|5|||
157215028|NCT02367781|567533575|FG001|Overall Study|Randomized in Error|4|||
157215029|NCT02367781|567533574|FG000|Overall Study|Non-Compliance|1|||
157215030|NCT02367781|567533575|FG001|Overall Study|Non-Compliance|0|||
157215031|NCT02367781|567533574|FG000|Overall Study|Lost to Follow-up|1|||
156701306|NCT04713553|565654842|FG000|Primary Study (2 Months)|Other|1|||
156701307|NCT04713553|565654843|FG001|Primary Study (2 Months)|Other|2|||
156701308|NCT04713553|565654844|FG002|Primary Study (2 Months)|Other|0|||
156701309|NCT04713553|565654845|FG003|Primary Study (2 Months)|Other|0|||
156701310|NCT04713553|565654846|FG004|Primary Study (2 Months)|Other|1|||
156701311|NCT04713553|565654847|FG005|Primary Study (2 Months)|Other|0|||
156701312|NCT04713553|565654848|FG006|Primary Study (2 Months)|Other|0|||
156701313|NCT04713553|565654842|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
156701314|NCT04713553|565654843|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
156701315|NCT04713553|565654844|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
156701316|NCT04713553|565654845|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
156701317|NCT04713553|565654846|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
156701318|NCT04713553|565654847|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
156701319|NCT04713553|565654848|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
156701320|NCT04713553|565654842|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701321|NCT04713553|565654843|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701322|NCT04713553|565654844|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
156701323|NCT04713553|565654845|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701324|NCT04713553|565654846|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
156790901|NCT02191397|565985508|FG000|Overall Study|Withdrawal by Subject|22|||
157215032|NCT02367781|567533575|FG001|Overall Study|Lost to Follow-up|2|||
157215033|NCT02367781|567533574|FG000|Overall Study|Death|330|||
157215034|NCT02367781|567533575|FG001|Overall Study|Death|176|||
157215035|NCT02367781|567533574|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
157215036|NCT02367781|567533575|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
157215037|NCT02367781|567533574|FG000|Overall Study|Prolonged Hospitalization|1|||
156701325|NCT04713553|565654847|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701326|NCT04713553|565654848|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
156701327|NCT02603393|565654862|FG000|Overall Study|Patient/guardian decision|32|||
157215038|NCT02367781|567533575|FG001|Overall Study|Prolonged Hospitalization|0|||
157215039|NCT02367781|567533574|FG000|Overall Study|Death Prior First Dose|1|||
157215040|NCT02367781|567533575|FG001|Overall Study|Death Prior First Dose|0|||
157123767|NCT00441545|567203792|FG000|First Intervention|Subject met an exclusionary criteria|1|||
157123768|NCT00441545|567203793|FG001|First Intervention|Subject met an exclusionary criteria|0|||
157123769|NCT00441545|567203792|FG000|First Intervention|Extended hospitalization|1|||
157123770|NCT00441545|567203793|FG001|First Intervention|Extended hospitalization|0|||
157123771|NCT00441545|567203792|FG000|First Intervention|Site error|1|||
157123772|NCT00441545|567203793|FG001|First Intervention|Site error|0|||
157123773|NCT00441545|567203792|FG000|First Intervention|Sponsor's request|1|||
157123774|NCT00441545|567203793|FG001|First Intervention|Sponsor's request|0|||
157123775|NCT00441545|567203792|FG000|Second Intervention|Adverse Event|5|||
157123776|NCT00441545|567203793|FG001|Second Intervention|Adverse Event|2|||
157123777|NCT00441545|567203792|FG000|Second Intervention|Protocol Violation|4|||
157123778|NCT00441545|567203793|FG001|Second Intervention|Protocol Violation|1|||
157123779|NCT00441545|567203792|FG000|Second Intervention|Withdrawal by Subject|1|||
157123780|NCT00441545|567203793|FG001|Second Intervention|Withdrawal by Subject|1|||
157123781|NCT00441545|567203792|FG000|Second Intervention|Kidney Transplant|1|||
157123782|NCT00441545|567203793|FG001|Second Intervention|Kidney Transplant|1|||
157123783|NCT00441545|567203792|FG000|Second Intervention|Lack of Efficacy|0|||
157123784|NCT00441545|567203793|FG001|Second Intervention|Lack of Efficacy|1|||
157123785|NCT00441545|567203792|FG000|Second Intervention|Subject exceeded safety criteria|1|||
157123786|NCT00441545|567203793|FG001|Second Intervention|Subject exceeded safety criteria|0|||
157123787|NCT00441545|567203792|FG000|Second Intervention|Subject moved|0|||
157123788|NCT00441545|567203793|FG001|Second Intervention|Subject moved|1|||
157123789|NCT00411554|567203796|FG000|Overall Study|Adverse Event|2|||
157123790|NCT00411554|567203797|FG001|Overall Study|Adverse Event|4|||
157123791|NCT00411554|567203796|FG000|Overall Study|Lack of Efficacy|2|||
157123792|NCT00411554|567203797|FG001|Overall Study|Lack of Efficacy|5|||
157123793|NCT00411554|567203796|FG000|Overall Study|Withdrawal by Subject|3|||
157123794|NCT00411554|567203797|FG001|Overall Study|Withdrawal by Subject|0|||
157123795|NCT00411554|567203796|FG000|Overall Study|Patient Moved|1|||
157123796|NCT00411554|567203797|FG001|Overall Study|Patient Moved|0|||
157123797|NCT01707693|567203802|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
157123798|NCT01707693|567203803|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
157123799|NCT01707693|567203802|FG000|Overall Study Allocation|Protocol Violation|4|||
156701328|NCT02603393|565654863|FG001|Overall Study|Patient/guardian decision|18|||
156701329|NCT02603393|565654862|FG000|Overall Study|Adverse Event|17|||
156701330|NCT02603393|565654863|FG001|Overall Study|Adverse Event|15|||
156701331|NCT02603393|565654862|FG000|Overall Study|Technical problems|4|||
156701332|NCT02603393|565654863|FG001|Overall Study|Technical problems|7|||
156701333|NCT02603393|565654862|FG000|Overall Study|Lack of Efficacy|7|||
156701334|NCT02603393|565654863|FG001|Overall Study|Lack of Efficacy|2|||
156701335|NCT02603393|565654862|FG000|Overall Study|Death|3|||
156701336|NCT02603393|565654863|FG001|Overall Study|Death|4|||
156701337|NCT02603393|565654862|FG000|Overall Study|Physician Decision|3|||
156701338|NCT02603393|565654863|FG001|Overall Study|Physician Decision|3|||
156701339|NCT02603393|565654862|FG000|Overall Study|Protocol deviation|2|||
156701340|NCT02603393|565654863|FG001|Overall Study|Protocol deviation|3|||
156701341|NCT02603393|565654862|FG000|Overall Study|Lost to Follow-up|1|||
156701342|NCT02603393|565654863|FG001|Overall Study|Lost to Follow-up|2|||
156701343|NCT02603393|565654862|FG000|Overall Study|Non-compliance with study treatment|1|||
156701344|NCT02603393|565654863|FG001|Overall Study|Non-compliance with study treatment|0|||
156701345|NCT02603393|565654862|FG000|Overall Study|Sponsor decision|1|||
156701346|NCT02603393|565654863|FG001|Overall Study|Sponsor decision|0|||
156701347|NCT00699374|565654864|FG000|Overall Study|Death|93|||
157123800|NCT01707693|567203803|FG001|Overall Study Allocation|Protocol Violation|3|||
157123801|NCT01707693|567203802|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
157123802|NCT01707693|567203803|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
157123803|NCT01707693|567203802|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
157123804|NCT01707693|567203803|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
157123805|NCT05779072|567203809|FG000|Overall Study|Lost to Follow-up|0|||
157123806|NCT05779072|567203810|FG001|Overall Study|Lost to Follow-up|1|||
157123807|NCT05779072|567203809|FG000|Overall Study|Withdrawal by Subject|1|||
157123808|NCT05779072|567203810|FG001|Overall Study|Withdrawal by Subject|5|||
157123809|NCT00143455|567203811|FG000|Cohort 1|Adverse Event|8|||
157123810|NCT00143455|567203812|FG001|Cohort 1|Adverse Event|4|||
156701348|NCT00699374|565654865|FG001|Overall Study|Death|83|||
156701349|NCT00699374|565654864|FG000|Overall Study|Adverse Event|70|||
156790902|NCT02191397|565985509|FG001|Overall Study|Withdrawal by Subject|27|||
156790903|NCT00472641|565985514|FG000|Overall Study|Lack of Efficacy|3|||
156701350|NCT00699374|565654865|FG001|Overall Study|Adverse Event|67|||
156701351|NCT00699374|565654864|FG000|Overall Study|Global deterioration of health status|7|||
156701352|NCT00699374|565654865|FG001|Overall Study|Global deterioration of health status|8|||
156701353|NCT00699374|565654864|FG000|Overall Study|Lost to Follow-up|3|||
156701354|NCT00699374|565654865|FG001|Overall Study|Lost to Follow-up|5|||
157123811|NCT00143455|567203813|FG002|Cohort 1|Adverse Event|0|||
157123812|NCT00143455|567203814|FG003|Cohort 1|Adverse Event|0|||
157123813|NCT00143455|567203811|FG000|Cohort 1|Death|5|||
157123814|NCT00143455|567203812|FG001|Cohort 1|Death|2|||
157123815|NCT00143455|567203813|FG002|Cohort 1|Death|0|||
156701355|NCT00699374|565654864|FG000|Overall Study|Withdrawal by Subject|34|||
156701356|NCT00699374|565654865|FG001|Overall Study|Withdrawal by Subject|44|||
156701357|NCT00699374|565654864|FG000|Overall Study|Objective progression or relapse|281|||
156701358|NCT00699374|565654865|FG001|Overall Study|Objective progression or relapse|277|||
156701359|NCT00699374|565654864|FG000|Overall Study|Other|18|||
156701360|NCT00699374|565654865|FG001|Overall Study|Other|15|||
156701361|NCT00699374|565654864|FG000|Overall Study|Protocol Violation|2|||
156701362|NCT00699374|565654865|FG001|Overall Study|Protocol Violation|6|||
157123816|NCT00143455|567203814|FG003|Cohort 1|Death|0|||
157123817|NCT00143455|567203811|FG000|Cohort 1|Progressive Disease|0|||
157123818|NCT00143455|567203812|FG001|Cohort 1|Progressive Disease|6|||
157123819|NCT00143455|567203813|FG002|Cohort 1|Progressive Disease|0|||
157123820|NCT00143455|567203814|FG003|Cohort 1|Progressive Disease|0|||
157123821|NCT00143455|567203811|FG000|Cohort 1|Withdrawal by Subject|1|||
157123822|NCT00143455|567203812|FG001|Cohort 1|Withdrawal by Subject|4|||
157123823|NCT00143455|567203813|FG002|Cohort 1|Withdrawal by Subject|0|||
157123824|NCT00143455|567203814|FG003|Cohort 1|Withdrawal by Subject|0|||
157123825|NCT00143455|567203811|FG000|Cohort 1|Randomized But Not Treated|0|||
157123826|NCT00143455|567203812|FG001|Cohort 1|Randomized But Not Treated|1|||
157123827|NCT00143455|567203813|FG002|Cohort 1|Randomized But Not Treated|0|||
157123828|NCT00143455|567203814|FG003|Cohort 1|Randomized But Not Treated|0|||
157123829|NCT00143455|567203811|FG000|Cohort 2|Adverse Event|0|||
157123830|NCT00143455|567203812|FG001|Cohort 2|Adverse Event|0|||
157123831|NCT00143455|567203813|FG002|Cohort 2|Adverse Event|42|||
157123832|NCT00143455|567203814|FG003|Cohort 2|Adverse Event|30|||
157123833|NCT00143455|567203811|FG000|Cohort 2|No Longer Required Study Treatment|0|||
157123834|NCT00143455|567203812|FG001|Cohort 2|No Longer Required Study Treatment|0|||
157123835|NCT00143455|567203813|FG002|Cohort 2|No Longer Required Study Treatment|1|||
157123836|NCT00143455|567203814|FG003|Cohort 2|No Longer Required Study Treatment|0|||
157123837|NCT00143455|567203811|FG000|Cohort 2|Protocol Violation|0|||
157123838|NCT00143455|567203812|FG001|Cohort 2|Protocol Violation|0|||
157123839|NCT00143455|567203813|FG002|Cohort 2|Protocol Violation|1|||
156701363|NCT00699374|565654864|FG000|Overall Study|Study terminated by sponsor|13|||
156701364|NCT00699374|565654865|FG001|Overall Study|Study terminated by sponsor|28|||
156701365|NCT00699374|565654864|FG000|Overall Study|Randomized but not treated|4|||
156701366|NCT00699374|565654865|FG001|Overall Study|Randomized but not treated|2|||
156701367|NCT00699374|565654864|FG000|Overall Study|Died 28 days after last dose|5|||
156701368|NCT00699374|565654865|FG001|Overall Study|Died 28 days after last dose|9|||
156701369|NCT01359969|565654869|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
156701370|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
156701371|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
156701372|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
156701373|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
156701374|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701375|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701376|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
156701377|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
156701378|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701379|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701380|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
156701381|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
156701382|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
156701383|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
156701384|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
156701385|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
156701386|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
156701387|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
157123840|NCT00143455|567203814|FG003|Cohort 2|Protocol Violation|1|||
157123841|NCT00143455|567203811|FG000|Cohort 2|Lost to Follow-up|0|||
157123842|NCT00143455|567203812|FG001|Cohort 2|Lost to Follow-up|0|||
156701388|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
156701389|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
156701390|NCT00593736|565654873|FG000|Screening Period and Placebo Run-in|Various|0|||
156701391|NCT00593736|565654874|FG001|Screening Period and Placebo Run-in|Various|0|||
156701392|NCT00593736|565654875|FG002|Screening Period and Placebo Run-in|Various|0|||
156701393|NCT00593736|565654876|FG003|Screening Period and Placebo Run-in|Various|25|||
157123843|NCT00143455|567203813|FG002|Cohort 2|Lost to Follow-up|1|||
157123844|NCT00143455|567203814|FG003|Cohort 2|Lost to Follow-up|4|||
157123845|NCT00143455|567203811|FG000|Cohort 2|Death|0|||
157123846|NCT00143455|567203812|FG001|Cohort 2|Death|0|||
157123847|NCT00143455|567203813|FG002|Cohort 2|Death|20|||
157123848|NCT00143455|567203814|FG003|Cohort 2|Death|12|||
157123849|NCT00143455|567203811|FG000|Cohort 2|Progressive Disease|0|||
157123850|NCT00143455|567203812|FG001|Cohort 2|Progressive Disease|0|||
157123851|NCT00143455|567203813|FG002|Cohort 2|Progressive Disease|20|||
156701394|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
156701395|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
156701396|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
156701397|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
156701398|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
156701399|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
156701400|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
156701401|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
156701402|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
156701403|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
156701404|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
156701405|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
156701406|NCT00593736|565654873|FG000|Treatment Period and Placebo Run-out|Various|1|||
156701407|NCT00593736|565654874|FG001|Treatment Period and Placebo Run-out|Various|1|||
156701408|NCT00593736|565654875|FG002|Treatment Period and Placebo Run-out|Various|1|||
156701409|NCT00593736|565654876|FG003|Treatment Period and Placebo Run-out|Various|0|||
156701410|NCT01868893|565654877|FG000|Overall Study|Adverse Event|2|||
156701411|NCT01868893|565654877|FG000|Overall Study|Commercial availability of study drug|17|||
156701412|NCT01868893|565654877|FG000|Overall Study|Neutropenia|1|||
156701413|NCT01857271|565654878|FG000|Overall Study|Lost to Follow-up|1|||
156701414|NCT01783548|565654879|FG000|Overall Study|Adverse Event|8|||
156701415|NCT01783548|565654880|FG001|Overall Study|Adverse Event|4|||
156701416|NCT01783548|565654879|FG000|Overall Study|Withdrawal by Subject|11|||
156701417|NCT01783548|565654880|FG001|Overall Study|Withdrawal by Subject|8|||
156701418|NCT01783548|565654879|FG000|Overall Study|Non-compliance|4|||
156701419|NCT01783548|565654880|FG001|Overall Study|Non-compliance|0|||
156701420|NCT01783548|565654879|FG000|Overall Study|Protocol Violation|2|||
156701421|NCT01783548|565654880|FG001|Overall Study|Protocol Violation|2|||
156701422|NCT01783548|565654879|FG000|Overall Study|Lost to Follow-up|8|||
156701423|NCT01783548|565654880|FG001|Overall Study|Lost to Follow-up|3|||
156701424|NCT01783548|565654879|FG000|Overall Study|Lack of Efficacy|1|||
156701425|NCT01783548|565654880|FG001|Overall Study|Lack of Efficacy|1|||
156701426|NCT03825341|565654883|FG000|Overall Study|Withdrawal by Subject|0|||
156701427|NCT03825341|565654884|FG001|Overall Study|Withdrawal by Subject|1|||
156701428|NCT04283500|565654887|FG000|Overall Study|Lost to Follow-up|8|||
156701429|NCT04283500|565654887|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
156701430|NCT04053465|565654896|FG000|Overall Study|Withdrawal by Subject|4|||
156701431|NCT04053465|565654897|FG001|Overall Study|Withdrawal by Subject|4|||
156701432|NCT04729309|565654898|FG000|Period 1|Subject unable to return for Period 2|3|||
156701433|NCT04729309|565654899|FG001|Period 1|Subject unable to return for Period 2|0|||
156701434|NCT04729309|565654898|FG000|Period 1|Lost to Follow-up|1|||
156701435|NCT04729309|565654899|FG001|Period 1|Lost to Follow-up|0|||
156701436|NCT02085135|565654900|FG000|Overall Study|Adverse Event|4|||
156701437|NCT02085135|565654901|FG001|Overall Study|Adverse Event|7|||
156701438|NCT02085135|565654900|FG000|Overall Study|Lost to Follow-up|2|||
156701439|NCT02085135|565654901|FG001|Overall Study|Lost to Follow-up|2|||
156701440|NCT02085135|565654900|FG000|Overall Study|Withdrawal by Subject|3|||
156701441|NCT02085135|565654901|FG001|Overall Study|Withdrawal by Subject|0|||
156701442|NCT02085135|565654900|FG000|Overall Study|Lack of Efficacy|2|||
156701443|NCT02085135|565654901|FG001|Overall Study|Lack of Efficacy|0|||
156701444|NCT01212588|565654904|FG000|Overall Study|Physician Decision|0|||
156701445|NCT01212588|565654905|FG001|Overall Study|Physician Decision|1|||
156701446|NCT01212588|565654904|FG000|Overall Study|Protocol Violation|1|||
156701447|NCT01212588|565654905|FG001|Overall Study|Protocol Violation|1|||
157015290|NCT01820260|566806827|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
157015291|NCT01820260|566806814|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015292|NCT01820260|566806815|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015293|NCT01820260|566806816|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015294|NCT01820260|566806817|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015295|NCT01820260|566806818|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156701448|NCT02885181|565654906|FG000|Overall Study|Investigator's Discretion|0|||
156701449|NCT02885181|565654907|FG001|Overall Study|Investigator's Discretion|1|||
156701450|NCT02885181|565654908|FG002|Overall Study|Investigator's Discretion|0|||
156701451|NCT02885181|565654909|FG003|Overall Study|Investigator's Discretion|1|||
156701452|NCT02885181|565654906|FG000|Overall Study|Adverse Event|0|||
156701453|NCT02885181|565654907|FG001|Overall Study|Adverse Event|0|||
156701454|NCT02885181|565654908|FG002|Overall Study|Adverse Event|0|||
156701455|NCT02885181|565654909|FG003|Overall Study|Adverse Event|1|||
156701456|NCT02885181|565654906|FG000|Overall Study|Withdrawal by Subject|0|||
156701457|NCT02885181|565654907|FG001|Overall Study|Withdrawal by Subject|0|||
156790904|NCT00472641|565985514|FG000|Overall Study|Adverse Event|3|||
156790905|NCT00472641|565985514|FG000|Overall Study|Lost to Follow-up|1|||
157015296|NCT01820260|566806819|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015297|NCT01820260|566806820|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157215041|NCT02367781|567533574|FG000|Overall Study|Administrative-Change Facility|1|||
156701458|NCT02885181|565654908|FG002|Overall Study|Withdrawal by Subject|0|||
156701459|NCT02885181|565654909|FG003|Overall Study|Withdrawal by Subject|1|||
156701460|NCT00626392|565654912|FG000|Run-in Period|Adverse Event|0|||
156701461|NCT00626392|565654913|FG001|Run-in Period|Adverse Event|0|||
156701462|NCT00626392|565654914|FG002|Run-in Period|Adverse Event|1|||
156701463|NCT00626392|565654915|FG003|Run-in Period|Adverse Event|0|||
156701464|NCT00626392|565654916|FG004|Run-in Period|Adverse Event|1|||
156701465|NCT00626392|565654917|FG005|Run-in Period|Adverse Event|0|||
156701466|NCT00626392|565654912|FG000|Run-in Period|Withdrawal by Subject|0|||
156701467|NCT00626392|565654913|FG001|Run-in Period|Withdrawal by Subject|1|||
156701468|NCT00626392|565654914|FG002|Run-in Period|Withdrawal by Subject|1|||
156701469|NCT00626392|565654915|FG003|Run-in Period|Withdrawal by Subject|1|||
156701470|NCT00626392|565654916|FG004|Run-in Period|Withdrawal by Subject|3|||
156701471|NCT00626392|565654917|FG005|Run-in Period|Withdrawal by Subject|1|||
156701472|NCT00626392|565654912|FG000|Run-in Period|Noncompliance|1|||
156701473|NCT00626392|565654913|FG001|Run-in Period|Noncompliance|0|||
156701474|NCT00626392|565654914|FG002|Run-in Period|Noncompliance|1|||
156701475|NCT00626392|565654915|FG003|Run-in Period|Noncompliance|0|||
156701476|NCT00626392|565654916|FG004|Run-in Period|Noncompliance|0|||
156701477|NCT00626392|565654917|FG005|Run-in Period|Noncompliance|0|||
156701478|NCT00626392|565654912|FG000|Coadministration Period|Adverse Event|3|||
156701479|NCT00626392|565654913|FG001|Coadministration Period|Adverse Event|1|||
156701480|NCT00626392|565654914|FG002|Coadministration Period|Adverse Event|7|||
156701481|NCT00626392|565654915|FG003|Coadministration Period|Adverse Event|4|||
156701482|NCT00626392|565654916|FG004|Coadministration Period|Adverse Event|3|||
156701483|NCT00626392|565654917|FG005|Coadministration Period|Adverse Event|4|||
156701484|NCT00626392|565654912|FG000|Coadministration Period|Withdrawal by Subject|1|||
156701485|NCT00626392|565654913|FG001|Coadministration Period|Withdrawal by Subject|1|||
156701486|NCT00626392|565654914|FG002|Coadministration Period|Withdrawal by Subject|0|||
156701487|NCT00626392|565654915|FG003|Coadministration Period|Withdrawal by Subject|1|||
156701488|NCT00626392|565654916|FG004|Coadministration Period|Withdrawal by Subject|0|||
156701489|NCT00626392|565654917|FG005|Coadministration Period|Withdrawal by Subject|1|||
156701490|NCT00626392|565654912|FG000|Coadministration Period|Protocol Violation|0|||
156701491|NCT00626392|565654913|FG001|Coadministration Period|Protocol Violation|1|||
156701492|NCT00626392|565654914|FG002|Coadministration Period|Protocol Violation|0|||
156701493|NCT00626392|565654915|FG003|Coadministration Period|Protocol Violation|1|||
156701494|NCT00626392|565654916|FG004|Coadministration Period|Protocol Violation|1|||
156701495|NCT00626392|565654917|FG005|Coadministration Period|Protocol Violation|0|||
156701496|NCT00626392|565654912|FG000|Coadministration Period|Other|0|||
156701497|NCT00626392|565654913|FG001|Coadministration Period|Other|2|||
156701498|NCT00626392|565654914|FG002|Coadministration Period|Other|3|||
156701499|NCT00626392|565654915|FG003|Coadministration Period|Other|1|||
156701500|NCT00626392|565654916|FG004|Coadministration Period|Other|1|||
156701501|NCT00626392|565654917|FG005|Coadministration Period|Other|1|||
156701502|NCT00338455|565654918|FG000|Overall Study|Death|2|||
156701503|NCT00338455|565654919|FG001|Overall Study|Death|1|||
156701504|NCT00338455|565654918|FG000|Overall Study|Physician Decision|1|||
157015298|NCT01820260|566806821|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015299|NCT01820260|566806822|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
156701505|NCT00338455|565654919|FG001|Overall Study|Physician Decision|0|||
157015300|NCT01820260|566806823|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
157015301|NCT01820260|566806824|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015302|NCT01820260|566806825|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015303|NCT01820260|566806826|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015304|NCT01820260|566806827|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
157015305|NCT05444192|566806828|FG000|Overall Study|Lost to Follow-up|1|||
157015306|NCT05444192|566806829|FG001|Overall Study|Lost to Follow-up|0|||
157015307|NCT04424927|566806834|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
157015308|NCT04424927|566806835|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
157015309|NCT04424927|566806836|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
157015310|NCT04424927|566806837|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
157015311|NCT04424927|566806838|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
157015312|NCT04424927|566806834|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
157015313|NCT04424927|566806835|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
157015314|NCT04424927|566806836|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
157015315|NCT04424927|566806837|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
157015316|NCT04424927|566806838|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
157015317|NCT04424927|566806834|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
157015318|NCT04424927|566806835|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
157015319|NCT04424927|566806836|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
157015320|NCT04424927|566806837|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
157015321|NCT04424927|566806838|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
157215042|NCT02367781|567533575|FG001|Overall Study|Administrative-Change Facility|0|||
156701506|NCT01517373|565654920|FG000|Run-in Period|Death|1|||
156701507|NCT01517373|565654921|FG001|Run-in Period|Death|0|||
156701508|NCT01517373|565654922|FG002|Run-in Period|Death|0|||
156701509|NCT01517373|565654923|FG003|Run-in Period|Death|0|||
156701510|NCT01517373|565654924|FG004|Run-in Period|Death|0|||
156701511|NCT01517373|565654925|FG005|Run-in Period|Death|0|||
156701512|NCT01517373|565654920|FG000|Run-in Period|Adverse Event|5|||
157215043|NCT02367781|567533574|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
157215044|NCT02367781|567533575|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
157215045|NCT02367781|567533574|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
157215046|NCT02367781|567533575|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
157215047|NCT02367781|567533574|FG000|Overall Study|Study Terminated by Sponsor|3|||
157215048|NCT02367781|567533575|FG001|Overall Study|Study Terminated by Sponsor|1|||
157215049|NCT02367781|567533574|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
157215050|NCT02367781|567533575|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
157215051|NCT02367781|567533574|FG000|Overall Study|Sponsor Decision|2|||
157215052|NCT02367781|567533575|FG001|Overall Study|Sponsor Decision|0|||
157215053|NCT02367781|567533574|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
157215054|NCT02367781|567533575|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
157215055|NCT00789828|567533576|FG000|Core Period (48 Weeks)|Administrative problems|0|||
157215056|NCT00789828|567533577|FG001|Core Period (48 Weeks)|Administrative problems|1|||
157215057|NCT00789828|567533576|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
157215058|NCT00789828|567533577|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
157215059|NCT00789828|567533576|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
157215060|NCT00789828|567533577|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
157215061|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
157215062|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
157215063|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
157215064|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
157215065|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
156701513|NCT01517373|565654921|FG001|Run-in Period|Adverse Event|0|||
156701514|NCT01517373|565654922|FG002|Run-in Period|Adverse Event|0|||
156701515|NCT01517373|565654923|FG003|Run-in Period|Adverse Event|0|||
156701516|NCT01517373|565654924|FG004|Run-in Period|Adverse Event|0|||
156701517|NCT01517373|565654925|FG005|Run-in Period|Adverse Event|0|||
156701518|NCT01517373|565654920|FG000|Run-in Period|Did not meet eligibility criteria|34|||
157123852|NCT00143455|567203814|FG003|Cohort 2|Progressive Disease|27|||
157123853|NCT00143455|567203811|FG000|Cohort 2|Withdrawal by Subject|0|||
157123854|NCT00143455|567203812|FG001|Cohort 2|Withdrawal by Subject|0|||
157123855|NCT00143455|567203813|FG002|Cohort 2|Withdrawal by Subject|13|||
157123856|NCT00143455|567203814|FG003|Cohort 2|Withdrawal by Subject|12|||
157123857|NCT00143455|567203811|FG000|Cohort 2|Other|0|||
157123858|NCT00143455|567203812|FG001|Cohort 2|Other|0|||
157123859|NCT00143455|567203813|FG002|Cohort 2|Other|7|||
157123860|NCT00143455|567203814|FG003|Cohort 2|Other|6|||
157123861|NCT00143455|567203811|FG000|Cohort 2|Randomized But Not Treated|0|||
157123862|NCT00143455|567203812|FG001|Cohort 2|Randomized But Not Treated|0|||
157123863|NCT00143455|567203813|FG002|Cohort 2|Randomized But Not Treated|1|||
157123864|NCT00143455|567203814|FG003|Cohort 2|Randomized But Not Treated|1|||
157123865|NCT01325428|567203815|FG000|Part A|Progressive disease according to RECIST|9|||
157123866|NCT01325428|567203815|FG000|Part A|Clinical signs, symptoms of progression|2|||
157123867|NCT01325428|567203815|FG000|Part A|Other adverse event|1|||
157123868|NCT01325428|567203815|FG000|Part A|Refused continue taking trial medication|2|||
157123869|NCT01325428|567203815|FG000|Part A|Other reason not defined above|2|||
157123870|NCT01325428|567203815|FG000|Part B|Refused continue taking trial medication|2|||
157123871|NCT01325428|567203815|FG000|Part B|Other reason not defined above|1|||
157123872|NCT02682901|567203816|FG000|Overall Study|Adverse Event|10|||
157123873|NCT02682901|567203817|FG001|Overall Study|Adverse Event|3|||
157123874|NCT02682901|567203816|FG000|Overall Study|Lack of Efficacy|0|||
157123875|NCT02682901|567203817|FG001|Overall Study|Lack of Efficacy|1|||
157123876|NCT03713944|567203818|FG000|Study Treatment|Patient non-compliance|1|||
157123877|NCT03713944|567203818|FG000|Study Treatment|Alternative Cancer Therapy|3|||
157123878|NCT03713944|567203818|FG000|Study Treatment|Disease Progression|18|||
157123879|NCT03713944|567203818|FG000|Study Treatment|AE/Side Effects/Complications|2|||
157123880|NCT03713944|567203818|FG000|Study Treatment|Death|2|||
157123881|NCT03713944|567203818|FG000|Study Treatment|Withdrawal by Subject|1|||
157123882|NCT03713944|567203818|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
157123883|NCT03713944|567203818|FG000|Study Treatment|Symptomatic Deterioration|2|||
157123884|NCT03713944|567203818|FG000|Follow up|Withdrawal by Subject|2|||
157123885|NCT03713944|567203818|FG000|Follow up|Death|11|||
157123886|NCT03713944|567203818|FG000|Follow up|Study Terminated|3|||
157123887|NCT01422239|567203821|FG000|Overall Study|Lost to Follow-up|4|||
156701519|NCT01517373|565654921|FG001|Run-in Period|Did not meet eligibility criteria|0|||
157123888|NCT01422239|567203822|FG001|Overall Study|Lost to Follow-up|3|||
156701520|NCT01517373|565654922|FG002|Run-in Period|Did not meet eligibility criteria|0|||
156701521|NCT01517373|565654923|FG003|Run-in Period|Did not meet eligibility criteria|0|||
156701522|NCT01517373|565654924|FG004|Run-in Period|Did not meet eligibility criteria|0|||
156701523|NCT01517373|565654925|FG005|Run-in Period|Did not meet eligibility criteria|0|||
156701524|NCT01517373|565654920|FG000|Run-in Period|Lost to Follow-up|1|||
156701525|NCT01517373|565654921|FG001|Run-in Period|Lost to Follow-up|0|||
156701526|NCT01517373|565654922|FG002|Run-in Period|Lost to Follow-up|0|||
157123889|NCT00720109|567203837|FG000|Induction Period|Did not meet eligibility criteria|3|||
157123890|NCT00720109|567203838|FG001|Induction Period|Did not meet eligibility criteria|0|||
157123891|NCT00720109|567203839|FG002|Induction Period|Did not meet eligibility criteria|0|||
157123892|NCT00720109|567203837|FG000|Induction Period|Bone Marrow Transplant|2|||
157123893|NCT00720109|567203838|FG001|Induction Period|Bone Marrow Transplant|0|||
157123894|NCT00720109|567203839|FG002|Induction Period|Bone Marrow Transplant|0|||
157123895|NCT00720109|567203837|FG000|Induction Period|Physician Decision|1|||
157123896|NCT00720109|567203838|FG001|Induction Period|Physician Decision|0|||
157123897|NCT00720109|567203839|FG002|Induction Period|Physician Decision|0|||
157123898|NCT00720109|567203837|FG000|Risk Stratification Period|Adverse Event|0|||
157123899|NCT00720109|567203838|FG001|Risk Stratification Period|Adverse Event|1|||
157123900|NCT00720109|567203839|FG002|Risk Stratification Period|Adverse Event|0|||
157123901|NCT00720109|567203837|FG000|Risk Stratification Period|Physician Decision|0|||
157123902|NCT00720109|567203838|FG001|Risk Stratification Period|Physician Decision|2|||
157123903|NCT00720109|567203839|FG002|Risk Stratification Period|Physician Decision|1|||
157123904|NCT00720109|567203837|FG000|Risk Stratification Period|Bone marrow transplant|0|||
157123905|NCT00720109|567203838|FG001|Risk Stratification Period|Bone marrow transplant|9|||
157123906|NCT00720109|567203839|FG002|Risk Stratification Period|Bone marrow transplant|7|||
157123907|NCT00720109|567203837|FG000|Risk Stratification Period|Disease progression or relapse|0|||
157123908|NCT00720109|567203838|FG001|Risk Stratification Period|Disease progression or relapse|2|||
157123909|NCT00720109|567203839|FG002|Risk Stratification Period|Disease progression or relapse|0|||
157123910|NCT00720109|567203837|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
156701527|NCT01517373|565654923|FG003|Run-in Period|Lost to Follow-up|0|||
156701528|NCT01517373|565654924|FG004|Run-in Period|Lost to Follow-up|0|||
157123911|NCT00720109|567203838|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
157123912|NCT00720109|567203839|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
157123913|NCT03595553|567203840|FG000|Overall Study|Withdrawal by Subject|20|||
157123914|NCT03595553|567203841|FG001|Overall Study|Withdrawal by Subject|8|||
157123915|NCT03595553|567203840|FG000|Overall Study|Physician Decision|3|||
157123916|NCT03595553|567203841|FG001|Overall Study|Physician Decision|2|||
157123917|NCT03595553|567203840|FG000|Overall Study|Adverse Event|2|||
157123918|NCT03595553|567203841|FG001|Overall Study|Adverse Event|5|||
157123919|NCT03595553|567203840|FG000|Overall Study|Death|24|||
157123920|NCT03595553|567203841|FG001|Overall Study|Death|22|||
156701529|NCT01517373|565654925|FG005|Run-in Period|Lost to Follow-up|0|||
156701530|NCT01517373|565654920|FG000|Run-in Period|Withdrawal by Subject|12|||
156701531|NCT01517373|565654921|FG001|Run-in Period|Withdrawal by Subject|0|||
156701532|NCT01517373|565654922|FG002|Run-in Period|Withdrawal by Subject|0|||
156701533|NCT01517373|565654923|FG003|Run-in Period|Withdrawal by Subject|0|||
156701534|NCT01517373|565654924|FG004|Run-in Period|Withdrawal by Subject|0|||
156701535|NCT01517373|565654925|FG005|Run-in Period|Withdrawal by Subject|0|||
156701536|NCT01517373|565654920|FG000|Run-in Period|Sponsor Decision|3|||
156701537|NCT01517373|565654921|FG001|Run-in Period|Sponsor Decision|0|||
156701538|NCT01517373|565654922|FG002|Run-in Period|Sponsor Decision|0|||
156701539|NCT01517373|565654923|FG003|Run-in Period|Sponsor Decision|0|||
156701540|NCT01517373|565654924|FG004|Run-in Period|Sponsor Decision|0|||
156701541|NCT01517373|565654925|FG005|Run-in Period|Sponsor Decision|0|||
156701542|NCT01517373|565654920|FG000|Run-in Period|Other|1|||
156701543|NCT01517373|565654921|FG001|Run-in Period|Other|0|||
156701544|NCT01517373|565654922|FG002|Run-in Period|Other|0|||
156701545|NCT01517373|565654923|FG003|Run-in Period|Other|0|||
156701546|NCT01517373|565654924|FG004|Run-in Period|Other|0|||
156701547|NCT01517373|565654925|FG005|Run-in Period|Other|0|||
156701548|NCT01517373|565654920|FG000|Treatment Period|Adverse Event|0|||
156701549|NCT01517373|565654921|FG001|Treatment Period|Adverse Event|0|||
156701550|NCT01517373|565654922|FG002|Treatment Period|Adverse Event|0|||
156701551|NCT01517373|565654923|FG003|Treatment Period|Adverse Event|0|||
156701552|NCT01517373|565654924|FG004|Treatment Period|Adverse Event|0|||
157123921|NCT03595553|567203840|FG000|Overall Study|Lost to Follow-up|6|||
156701553|NCT01517373|565654925|FG005|Treatment Period|Adverse Event|2|||
156701554|NCT01517373|565654920|FG000|Treatment Period|Lost to Follow-up|0|||
156701555|NCT01517373|565654921|FG001|Treatment Period|Lost to Follow-up|0|||
156701556|NCT01517373|565654922|FG002|Treatment Period|Lost to Follow-up|1|||
156701557|NCT01517373|565654923|FG003|Treatment Period|Lost to Follow-up|1|||
156701558|NCT01517373|565654924|FG004|Treatment Period|Lost to Follow-up|0|||
157123922|NCT03595553|567203841|FG001|Overall Study|Lost to Follow-up|7|||
157123923|NCT03595553|567203840|FG000|Overall Study|Other as indicated in CSR|3|||
156701559|NCT01517373|565654925|FG005|Treatment Period|Lost to Follow-up|0|||
156701560|NCT01517373|565654920|FG000|Treatment Period|Withdrawal by Subject|0|||
157123924|NCT03595553|567203841|FG001|Overall Study|Other as indicated in CSR|3|||
157123925|NCT03595553|567203840|FG000|Overall Study|Sponsor Decision|0|||
157123926|NCT03595553|567203841|FG001|Overall Study|Sponsor Decision|1|||
157123927|NCT02925156|567203842|FG000|Overall Study|Lost to Follow-up|27|||
157123928|NCT02925156|567203843|FG001|Overall Study|Lost to Follow-up|53|||
157123929|NCT02925156|567203844|FG002|Overall Study|Lost to Follow-up|51|||
157123930|NCT02925156|567203845|FG003|Overall Study|Lost to Follow-up|59|||
157123931|NCT02925156|567203846|FG004|Overall Study|Lost to Follow-up|89|||
157123932|NCT02925156|567203847|FG005|Overall Study|Lost to Follow-up|107|||
157123933|NCT02925156|567203848|FG006|Overall Study|Lost to Follow-up|34|||
157123934|NCT02925156|567203849|FG007|Overall Study|Lost to Follow-up|36|||
157123935|NCT02925156|567203850|FG008|Overall Study|Lost to Follow-up|73|||
156701561|NCT01517373|565654921|FG001|Treatment Period|Withdrawal by Subject|3|||
156701562|NCT01517373|565654922|FG002|Treatment Period|Withdrawal by Subject|2|||
156701563|NCT01517373|565654923|FG003|Treatment Period|Withdrawal by Subject|2|||
156701564|NCT01517373|565654924|FG004|Treatment Period|Withdrawal by Subject|2|||
156701565|NCT01517373|565654925|FG005|Treatment Period|Withdrawal by Subject|3|||
156701566|NCT01517373|565654920|FG000|Treatment Period|Other|0|||
156701567|NCT01517373|565654921|FG001|Treatment Period|Other|0|||
156701568|NCT01517373|565654922|FG002|Treatment Period|Other|0|||
156701569|NCT01517373|565654923|FG003|Treatment Period|Other|0|||
156701570|NCT01517373|565654924|FG004|Treatment Period|Other|1|||
156701571|NCT01517373|565654925|FG005|Treatment Period|Other|0|||
156701572|NCT01517373|565654920|FG000|Treatment Period|Protocol Violation|0|||
156701573|NCT01517373|565654921|FG001|Treatment Period|Protocol Violation|0|||
156701574|NCT01517373|565654922|FG002|Treatment Period|Protocol Violation|0|||
156701575|NCT01517373|565654923|FG003|Treatment Period|Protocol Violation|0|||
156701576|NCT01517373|565654924|FG004|Treatment Period|Protocol Violation|1|||
156701577|NCT01517373|565654925|FG005|Treatment Period|Protocol Violation|0|||
156701578|NCT01517373|565654920|FG000|Treatment Period|Lack of Efficacy|0|||
156701579|NCT01517373|565654921|FG001|Treatment Period|Lack of Efficacy|1|||
156701580|NCT01517373|565654922|FG002|Treatment Period|Lack of Efficacy|1|||
156701581|NCT01517373|565654923|FG003|Treatment Period|Lack of Efficacy|3|||
156701582|NCT01517373|565654924|FG004|Treatment Period|Lack of Efficacy|2|||
156701583|NCT01517373|565654925|FG005|Treatment Period|Lack of Efficacy|0|||
156701584|NCT01517373|565654920|FG000|Treatment Period|Medication error without AEs|0|||
156701585|NCT01517373|565654921|FG001|Treatment Period|Medication error without AEs|0|||
156701586|NCT01517373|565654922|FG002|Treatment Period|Medication error without AEs|2|||
156701587|NCT01517373|565654923|FG003|Treatment Period|Medication error without AEs|1|||
156701588|NCT01517373|565654924|FG004|Treatment Period|Medication error without AEs|0|||
157123936|NCT02925156|567203851|FG009|Overall Study|Lost to Follow-up|34|||
157123937|NCT00730639|567203854|FG000|Overall Study|Adverse Event|3|||
157123938|NCT00730639|567203855|FG001|Overall Study|Adverse Event|0|||
157123939|NCT00730639|567203856|FG002|Overall Study|Adverse Event|9|||
157123940|NCT00730639|567203857|FG003|Overall Study|Adverse Event|8|||
157123941|NCT00730639|567203858|FG004|Overall Study|Adverse Event|23|||
157123942|NCT00730639|567203854|FG000|Overall Study|Complete Response|0|||
157123943|NCT00730639|567203855|FG001|Overall Study|Complete Response|0|||
157123944|NCT00730639|567203856|FG002|Overall Study|Complete Response|2|||
157123945|NCT00730639|567203857|FG003|Overall Study|Complete Response|2|||
157123946|NCT00730639|567203858|FG004|Overall Study|Complete Response|1|||
157123947|NCT00730639|567203854|FG000|Overall Study|Completed Maximum Cycles|0|||
157123948|NCT00730639|567203855|FG001|Overall Study|Completed Maximum Cycles|0|||
157123949|NCT00730639|567203856|FG002|Overall Study|Completed Maximum Cycles|11|||
157215066|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
157215067|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
157215068|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
157215069|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Death|1|||
157215070|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Death|0|||
157215071|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
157215072|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
157215073|NCT00789828|567533576|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
157215074|NCT00789828|567533577|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
157215075|NCT02623426|567533578|FG000|Overall Study|Lost to Follow-up|0|||
157215076|NCT02623426|567533579|FG001|Overall Study|Lost to Follow-up|0|||
157215077|NCT02623426|567533580|FG002|Overall Study|Lost to Follow-up|1|||
157215078|NCT02623426|567533578|FG000|Overall Study|Withdrawal by Subject|1|||
157215079|NCT02623426|567533579|FG001|Overall Study|Withdrawal by Subject|2|||
156701589|NCT01517373|565654925|FG005|Treatment Period|Medication error without AEs|2|||
156701590|NCT01085734|565654926|FG000|Overall Study|Adverse Event|0|||
157123950|NCT00730639|567203857|FG003|Overall Study|Completed Maximum Cycles|3|||
157123951|NCT00730639|567203858|FG004|Overall Study|Completed Maximum Cycles|6|||
157123952|NCT00730639|567203854|FG000|Overall Study|Death|0|||
157123953|NCT00730639|567203855|FG001|Overall Study|Death|0|||
157123954|NCT00730639|567203856|FG002|Overall Study|Death|0|||
157123955|NCT00730639|567203857|FG003|Overall Study|Death|0|||
157123956|NCT00730639|567203858|FG004|Overall Study|Death|2|||
156701591|NCT01085734|565654927|FG001|Overall Study|Adverse Event|2|||
156701592|NCT01085734|565654926|FG000|Overall Study|Death|1|||
156701593|NCT01085734|565654927|FG001|Overall Study|Death|0|||
156701594|NCT01085734|565654926|FG000|Overall Study|Lost to Follow-up|0|||
156701595|NCT01085734|565654927|FG001|Overall Study|Lost to Follow-up|1|||
156701596|NCT01085734|565654926|FG000|Overall Study|Withdrawal by Subject|0|||
156701597|NCT01085734|565654927|FG001|Overall Study|Withdrawal by Subject|1|||
157123957|NCT00730639|567203854|FG000|Overall Study|Disease Progression|12|||
156701598|NCT04005352|565654941|FG000|Overall Study|Adverse Event|4|||
156701599|NCT04005352|565654942|FG001|Overall Study|Adverse Event|5|||
156701600|NCT04005352|565654941|FG000|Overall Study|Death|4|||
156701601|NCT04005352|565654942|FG001|Overall Study|Death|2|||
156701602|NCT04005352|565654941|FG000|Overall Study|Lost to Follow-up|6|||
156701603|NCT04005352|565654942|FG001|Overall Study|Lost to Follow-up|2|||
156701604|NCT04005352|565654941|FG000|Overall Study|Physician Decision|7|||
156701605|NCT04005352|565654942|FG001|Overall Study|Physician Decision|13|||
156701606|NCT04005352|565654941|FG000|Overall Study|Protocol Violation|0|||
156701607|NCT04005352|565654942|FG001|Overall Study|Protocol Violation|1|||
156701608|NCT04005352|565654941|FG000|Overall Study|Withdrawal by Subject|28|||
156701609|NCT04005352|565654942|FG001|Overall Study|Withdrawal by Subject|38|||
156790906|NCT03888482|565985515|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
157123958|NCT00730639|567203855|FG001|Overall Study|Disease Progression|13|||
157123959|NCT00730639|567203856|FG002|Overall Study|Disease Progression|48|||
157123960|NCT00730639|567203857|FG003|Overall Study|Disease Progression|32|||
157123961|NCT00730639|567203858|FG004|Overall Study|Disease Progression|88|||
157123962|NCT00730639|567203854|FG000|Overall Study|non-specified|0|||
157123963|NCT00730639|567203855|FG001|Overall Study|non-specified|0|||
157123964|NCT00730639|567203856|FG002|Overall Study|non-specified|4|||
156701610|NCT00849186|565654943|FG000|Overall Study|Adverse Event|2|||
156701611|NCT00849186|565654943|FG000|Overall Study|Withdrawal by Subject|1|||
156701612|NCT00849186|565654943|FG000|Overall Study|not treated|6|||
156701613|NCT00849186|565654943|FG000|Overall Study|Other|1|||
156790907|NCT03888482|565985516|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
156790908|NCT03888482|565985515|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
156790909|NCT03888482|565985516|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
156790910|NCT05652140|565985519|FG000|Overall Study|Lost to Follow-up|7|||
156790911|NCT05652140|565985520|FG001|Overall Study|Lost to Follow-up|16|||
156790912|NCT05652140|565985521|FG002|Overall Study|Lost to Follow-up|22|||
156790913|NCT05652140|565985522|FG003|Overall Study|Lost to Follow-up|31|||
156790914|NCT00968968|565985525|FG000|Overall Study|Study closed/terminated|10|||
156790915|NCT00968968|565985526|FG001|Overall Study|Study closed/terminated|10|||
156790916|NCT00968968|565985525|FG000|Overall Study|Protocol defined stopping criteria|3|||
157015322|NCT04424927|566806834|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
157015323|NCT04424927|566806835|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
157015324|NCT04424927|566806836|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
157015325|NCT04424927|566806837|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
157015326|NCT04424927|566806838|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
157015327|NCT04424927|566806834|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
157015328|NCT04424927|566806835|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
157015329|NCT04424927|566806836|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
157015330|NCT04424927|566806837|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
157015331|NCT04424927|566806838|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
157015332|NCT04424927|566806834|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
157015333|NCT04424927|566806835|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
157015334|NCT04424927|566806836|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
157015335|NCT04424927|566806837|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
157015336|NCT04424927|566806838|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
157015337|NCT04424927|566806834|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
157015338|NCT04424927|566806835|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
157015339|NCT04424927|566806836|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
157015340|NCT04424927|566806837|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
157015341|NCT04424927|566806838|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
157015342|NCT04424927|566806834|FG000|Double-blind Period (24 Weeks)|Other|0|||
157015343|NCT04424927|566806835|FG001|Double-blind Period (24 Weeks)|Other|1|||
157015344|NCT04424927|566806836|FG002|Double-blind Period (24 Weeks)|Other|3|||
157015345|NCT04424927|566806837|FG003|Double-blind Period (24 Weeks)|Other|1|||
157015346|NCT04424927|566806838|FG004|Double-blind Period (24 Weeks)|Other|0|||
157015347|NCT00505934|566806843|FG000|Overall Study|Adverse Event|1|||
157015348|NCT00505934|566806843|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
157015349|NCT00505934|566806843|FG000|Overall Study|Other: IV dose needed to be changed|1|||
157015350|NCT00894543|566806846|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
157015351|NCT00894543|566806847|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
157015352|NCT00894543|566806846|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
157123965|NCT00730639|567203857|FG003|Overall Study|non-specified|2|||
156701614|NCT00417170|565654948|FG000|Overall Study|Adverse Event|1|||
156701615|NCT00417170|565654949|FG001|Overall Study|Adverse Event|1|||
156701616|NCT00417170|565654948|FG000|Overall Study|Withdrawal by Subject|1|||
156701617|NCT00417170|565654949|FG001|Overall Study|Withdrawal by Subject|1|||
156701618|NCT00417170|565654948|FG000|Overall Study|Lost to Follow-up|0|||
156701619|NCT00417170|565654949|FG001|Overall Study|Lost to Follow-up|1|||
156701620|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
156701621|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
156701622|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
156701623|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
156701624|NCT01756079|565654950|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
156701625|NCT04015908|565654951|FG000|Overall Study|Lost to Follow-up|0|||
156701626|NCT04015908|565654952|FG001|Overall Study|Lost to Follow-up|1|||
156701627|NCT00901576|565654953|FG000|Second Intervention|Withdrawal by Subject|0|||
156701628|NCT00901576|565654954|FG001|Second Intervention|Withdrawal by Subject|0|||
156701629|NCT00901576|565654955|FG002|Second Intervention|Withdrawal by Subject|0|||
156701630|NCT00901576|565654956|FG003|Second Intervention|Withdrawal by Subject|1|||
156701631|NCT00901576|565654957|FG004|Second Intervention|Withdrawal by Subject|0|||
156701632|NCT00901576|565654958|FG005|Second Intervention|Withdrawal by Subject|1|||
156701633|NCT00901576|565654953|FG000|Second Intervention|Physician Decision|1|||
156701634|NCT00901576|565654954|FG001|Second Intervention|Physician Decision|0|||
156701635|NCT00901576|565654955|FG002|Second Intervention|Physician Decision|0|||
156701636|NCT00901576|565654956|FG003|Second Intervention|Physician Decision|0|||
156701637|NCT00901576|565654957|FG004|Second Intervention|Physician Decision|0|||
156701638|NCT00901576|565654958|FG005|Second Intervention|Physician Decision|0|||
156701639|NCT01696279|565654959|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
156701640|NCT01696279|565654960|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701641|NCT01696279|565654961|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701642|NCT01696279|565654962|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
156701643|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
157123966|NCT00730639|567203858|FG004|Overall Study|non-specified|3|||
157123967|NCT00730639|567203854|FG000|Overall Study|Protocol Violation|0|||
157123968|NCT00730639|567203855|FG001|Overall Study|Protocol Violation|0|||
157123969|NCT00730639|567203856|FG002|Overall Study|Protocol Violation|1|||
157123970|NCT00730639|567203857|FG003|Overall Study|Protocol Violation|0|||
157123971|NCT00730639|567203858|FG004|Overall Study|Protocol Violation|0|||
157123972|NCT00730639|567203854|FG000|Overall Study|Withdrawal by Subject|0|||
157123973|NCT00730639|567203855|FG001|Overall Study|Withdrawal by Subject|0|||
157123974|NCT00730639|567203856|FG002|Overall Study|Withdrawal by Subject|6|||
157123975|NCT00730639|567203857|FG003|Overall Study|Withdrawal by Subject|3|||
157123976|NCT00730639|567203858|FG004|Overall Study|Withdrawal by Subject|4|||
157123977|NCT00730639|567203854|FG000|Overall Study|Treatment on-going|2|||
157123978|NCT00730639|567203855|FG001|Overall Study|Treatment on-going|5|||
157123979|NCT00730639|567203856|FG002|Overall Study|Treatment on-going|5|||
157123980|NCT00730639|567203857|FG003|Overall Study|Treatment on-going|4|||
157123981|NCT00730639|567203858|FG004|Overall Study|Treatment on-going|4|||
157123982|NCT04622046|567203869|FG000|Intervention Period|Adverse Event|1|||
157123983|NCT04622046|567203869|FG000|Intervention Period|Withdrawal by Subject|2|||
157123984|NCT04622046|567203869|FG000|Extension Period|Ongoing in the Extension Period|21|||
157123985|NCT04401267|567206152|FG000|Overall Study|Death|0|||
157123986|NCT04401267|567206153|FG001|Overall Study|Death|1|||
157123987|NCT04401267|567206152|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
156701644|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
156701645|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
156701646|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
156701647|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701648|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
157123988|NCT04401267|567206153|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
157123989|NCT04401267|567206152|FG000|Overall Study|Found to be Ineligible|1|||
157123990|NCT04401267|567206153|FG001|Overall Study|Found to be Ineligible|0|||
157123991|NCT00200850|567206154|FG000|Overall Study|relocation|1|||
157123992|NCT00200850|567206155|FG001|Overall Study|relocation|0|||
157123993|NCT00200850|567206156|FG002|Overall Study|relocation|1|||
157123994|NCT00200850|567206154|FG000|Overall Study|too busy|1|||
157123995|NCT00200850|567206155|FG001|Overall Study|too busy|0|||
157123996|NCT00200850|567206156|FG002|Overall Study|too busy|0|||
157123997|NCT00200850|567206154|FG000|Overall Study|Pregnancy|0|||
156701649|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701650|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
156701651|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
157123998|NCT00200850|567206155|FG001|Overall Study|Pregnancy|0|||
157123999|NCT00200850|567206156|FG002|Overall Study|Pregnancy|1|||
157124000|NCT00200850|567206154|FG000|Overall Study|Poor adherence|0|||
157124001|NCT00200850|567206155|FG001|Overall Study|Poor adherence|0|||
157124002|NCT00200850|567206156|FG002|Overall Study|Poor adherence|1|||
156701652|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
156701653|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
156701654|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
156701655|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701656|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
156701657|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701658|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
156701659|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701660|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
156701661|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701662|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
156701663|NCT01696279|565654959|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701664|NCT01696279|565654960|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
156701665|NCT01696279|565654961|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701666|NCT01696279|565654962|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
156701667|NCT01696279|565654959|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701668|NCT01696279|565654960|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701669|NCT01696279|565654961|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
156701670|NCT01696279|565654962|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
156701671|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701672|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701673|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
156701674|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
156701675|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701676|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701677|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
156701678|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
156701679|NCT01696279|565654959|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701680|NCT01696279|565654960|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701681|NCT01696279|565654961|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
156701682|NCT01696279|565654962|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
156701683|NCT06077149|565654963|FG000|Overall Study|Death|1|||
156701684|NCT06077149|565654964|FG001|Overall Study|Death|0|||
156701685|NCT06077149|565654963|FG000|Overall Study|Withdrawal by Subject|2|||
156701686|NCT06077149|565654964|FG001|Overall Study|Withdrawal by Subject|0|||
156701687|NCT06077149|565654963|FG000|Overall Study|RSV infection before vaccination|3|||
156701688|NCT06077149|565654964|FG001|Overall Study|RSV infection before vaccination|0|||
156701689|NCT05788289|565654965|FG000|Overall Study|Death|3|||
156701690|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
156701691|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
156701692|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
156701693|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
156701694|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
156701695|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
156701696|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
156701697|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
156701698|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Death|41|||
156701699|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Death|33|||
156701700|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Death|0|||
156872113|NCT02858362|566289508|FG001|Overall Study|Withdrawal by Subject|0|||
156701701|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Death|0|||
156701702|NCT02970318|565654968|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701703|NCT02970318|565654969|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
156701704|NCT02970318|565654970|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701705|NCT02970318|565654971|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
156701706|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701707|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701708|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
156701709|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
156701710|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
156701711|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
156701712|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
156701713|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
156701714|NCT02970318|565654968|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
156701715|NCT02970318|565654969|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
156701716|NCT02970318|565654970|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
156701717|NCT02970318|565654971|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
156701718|NCT01096368|565654972|FG000|Overall Study|Death|0|||
156701719|NCT01096368|565654973|FG001|Overall Study|Death|1|||
156701720|NCT01096368|565654974|FG002|Overall Study|Death|0|||
156701721|NCT01096368|565654975|FG003|Overall Study|Death|0|||
156701722|NCT01096368|565654976|FG004|Overall Study|Death|0|||
156701723|NCT01096368|565654972|FG000|Overall Study|Physician Decision|0|||
156701724|NCT01096368|565654973|FG001|Overall Study|Physician Decision|13|||
156701725|NCT01096368|565654974|FG002|Overall Study|Physician Decision|2|||
156701726|NCT01096368|565654975|FG003|Overall Study|Physician Decision|4|||
156701727|NCT01096368|565654976|FG004|Overall Study|Physician Decision|6|||
156701728|NCT01096368|565654972|FG000|Overall Study|Withdrawal by Subject|0|||
156701729|NCT01096368|565654973|FG001|Overall Study|Withdrawal by Subject|52|||
157124003|NCT00200850|567206154|FG000|Overall Study|optic neuritis|0|||
157124004|NCT00200850|567206155|FG001|Overall Study|optic neuritis|0|||
157124005|NCT00200850|567206156|FG002|Overall Study|optic neuritis|1|||
157124006|NCT00200850|567206154|FG000|Overall Study|Adverse Event|1|||
157124007|NCT00200850|567206155|FG001|Overall Study|Adverse Event|1|||
157124008|NCT00200850|567206156|FG002|Overall Study|Adverse Event|2|||
157124009|NCT01449708|567206157|FG000|Overall Study|Protocol Violation|0|||
157124010|NCT01449708|567206158|FG001|Overall Study|Protocol Violation|1|||
157124011|NCT01449708|567206157|FG000|Overall Study|surgical complication|1|||
157124012|NCT01449708|567206158|FG001|Overall Study|surgical complication|2|||
157124013|NCT01449708|567206157|FG000|Overall Study|respiratory failure|1|||
157124014|NCT01449708|567206158|FG001|Overall Study|respiratory failure|0|||
157124015|NCT01415752|567206161|FG000|Induction (Step 1)|Ineligible|4|||
157124016|NCT01415752|567206162|FG001|Induction (Step 1)|Ineligible|3|||
157124017|NCT01415752|567206163|FG002|Induction (Step 1)|Ineligible|4|||
157124018|NCT01415752|567206164|FG003|Induction (Step 1)|Ineligible|4|||
157124019|NCT01415752|567206161|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
157124020|NCT01415752|567206162|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
157124021|NCT01415752|567206163|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
157124022|NCT01415752|567206164|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
157124023|NCT01415752|567206161|FG000|Maintenance (Step 2)|Adverse Event|3|||
157124024|NCT01415752|567206162|FG001|Maintenance (Step 2)|Adverse Event|4|||
157124025|NCT01415752|567206163|FG002|Maintenance (Step 2)|Adverse Event|9|||
157124026|NCT01415752|567206164|FG003|Maintenance (Step 2)|Adverse Event|6|||
156701730|NCT01096368|565654974|FG002|Overall Study|Withdrawal by Subject|0|||
156701731|NCT01096368|565654975|FG003|Overall Study|Withdrawal by Subject|10|||
156701732|NCT01096368|565654976|FG004|Overall Study|Withdrawal by Subject|14|||
156701733|NCT01096368|565654972|FG000|Overall Study|Ineligible|0|||
156701734|NCT01096368|565654973|FG001|Overall Study|Ineligible|3|||
156701735|NCT01096368|565654974|FG002|Overall Study|Ineligible|2|||
156701736|NCT01096368|565654975|FG003|Overall Study|Ineligible|0|||
156701737|NCT01096368|565654976|FG004|Overall Study|Ineligible|25|||
156701738|NCT01096368|565654972|FG000|Overall Study|Did not start treatment|0|||
156701739|NCT01096368|565654973|FG001|Overall Study|Did not start treatment|4|||
156701740|NCT01096368|565654974|FG002|Overall Study|Did not start treatment|4|||
156701741|NCT01096368|565654975|FG003|Overall Study|Did not start treatment|0|||
156701742|NCT01096368|565654976|FG004|Overall Study|Did not start treatment|0|||
156701743|NCT01096368|565654972|FG000|Overall Study|Progressive disease|0|||
156701744|NCT01096368|565654973|FG001|Overall Study|Progressive disease|6|||
156701745|NCT01096368|565654974|FG002|Overall Study|Progressive disease|0|||
156701746|NCT01096368|565654975|FG003|Overall Study|Progressive disease|10|||
156701747|NCT01096368|565654976|FG004|Overall Study|Progressive disease|3|||
156701748|NCT01096368|565654972|FG000|Overall Study|Other|0|||
156701749|NCT01096368|565654973|FG001|Overall Study|Other|0|||
156701750|NCT01096368|565654974|FG002|Overall Study|Other|1|||
156701751|NCT01096368|565654975|FG003|Overall Study|Other|0|||
156701752|NCT01096368|565654976|FG004|Overall Study|Other|0|||
157124027|NCT01415752|567206161|FG000|Maintenance (Step 2)|Death|1|||
157124028|NCT01415752|567206162|FG001|Maintenance (Step 2)|Death|1|||
157124029|NCT01415752|567206163|FG002|Maintenance (Step 2)|Death|2|||
157215080|NCT02623426|567533580|FG002|Overall Study|Withdrawal by Subject|2|||
156701753|NCT01096368|565654972|FG000|Overall Study|Treated with institutional review|0|||
156701754|NCT01096368|565654973|FG001|Overall Study|Treated with institutional review|0|||
157215081|NCT02236754|567535746|FG000|Overall Study|Withdrawal by Subject|1|||
156701755|NCT01096368|565654974|FG002|Overall Study|Treated with institutional review|0|||
156701756|NCT01096368|565654975|FG003|Overall Study|Treated with institutional review|0|||
156701757|NCT01096368|565654976|FG004|Overall Study|Treated with institutional review|1|||
156701758|NCT03384654|565654978|FG000|Overall Study|Withdrawal by Subject|0|||
157124030|NCT01415752|567206164|FG003|Maintenance (Step 2)|Death|0|||
156701759|NCT03384654|565654979|FG001|Overall Study|Withdrawal by Subject|0|||
157124031|NCT01415752|567206161|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
157124032|NCT01415752|567206162|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
157124033|NCT01415752|567206163|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
156701760|NCT03384654|565654980|FG002|Overall Study|Withdrawal by Subject|1|||
157215082|NCT02236754|567535747|FG001|Overall Study|Withdrawal by Subject|0|||
156701761|NCT03384654|565654981|FG003|Overall Study|Withdrawal by Subject|0|||
156701762|NCT01616953|565654982|FG000|Overall Study|Lost to Follow-up|1|||
156701763|NCT01616953|565654983|FG001|Overall Study|Lost to Follow-up|0|||
156701764|NCT01616953|565654982|FG000|Overall Study|lack of bone and soft tissue|1|||
157015353|NCT00894543|566806847|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
156701765|NCT01616953|565654983|FG001|Overall Study|lack of bone and soft tissue|0|||
156701766|NCT01568320|565654984|FG000|Overall Study|Death|20|||
156701767|NCT01568320|565654984|FG000|Overall Study|Lost to Follow-up|9|||
156701768|NCT01568320|565654984|FG000|Overall Study|Withdrawal by Subject|10|||
156701769|NCT01568320|565654984|FG000|Overall Study|Conversion to open repair|1|||
156701770|NCT01568320|565654984|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
156701771|NCT00816361|565654986|FG000|Overall Study|Withdrawal by Subject|0|||
156701772|NCT00816361|565654987|FG001|Overall Study|Withdrawal by Subject|0|||
156701773|NCT00816361|565654988|FG002|Overall Study|Withdrawal by Subject|0|||
156701774|NCT00816361|565654989|FG003|Overall Study|Withdrawal by Subject|0|||
156701775|NCT00816361|565654990|FG004|Overall Study|Withdrawal by Subject|1|||
156790917|NCT00968968|565985526|FG001|Overall Study|Protocol defined stopping criteria|1|||
156790918|NCT00968968|565985525|FG000|Overall Study|Withdrawal by Subject|2|||
156790919|NCT00968968|565985526|FG001|Overall Study|Withdrawal by Subject|0|||
156790920|NCT00968968|565985525|FG000|Overall Study|Physician Decision|1|||
156790921|NCT00968968|565985526|FG001|Overall Study|Physician Decision|2|||
156790922|NCT00968968|565985525|FG000|Overall Study|Lost to Follow-up|0|||
156790923|NCT00968968|565985526|FG001|Overall Study|Lost to Follow-up|1|||
156790924|NCT04401293|565985527|FG000|Overall Study|Withdrawal by Subject|1|||
156790925|NCT04401293|565985528|FG001|Overall Study|Withdrawal by Subject|3|||
156790926|NCT01026038|565985529|FG000|Overall Study|Lost to Follow-up|1|||
156790927|NCT01026038|565985530|FG001|Overall Study|Lost to Follow-up|1|||
156790928|NCT01026038|565985531|FG002|Overall Study|Lost to Follow-up|0|||
156790929|NCT03679884|565985532|FG000|Overall Study|Other|12|||
156790930|NCT03679884|565985533|FG001|Overall Study|Other|12|||
156790931|NCT03679884|565985534|FG002|Overall Study|Other|12|||
156790932|NCT03679884|565985535|FG003|Overall Study|Other|7|||
156790933|NCT03679884|565985536|FG004|Overall Study|Other|8|||
157015354|NCT05782231|566806848|FG000|Overall Study|Withdrawal by Subject|1|||
157015355|NCT02252172|566806849|FG000|Overall Study|Lost to Follow-up|9|||
157015356|NCT02252172|566806850|FG001|Overall Study|Lost to Follow-up|6|||
157015357|NCT02252172|566806849|FG000|Overall Study|Death|218|||
157015358|NCT02252172|566806850|FG001|Overall Study|Death|175|||
157015359|NCT02252172|566806849|FG000|Overall Study|Withdrawal by Subject|20|||
157015360|NCT02252172|566806850|FG001|Overall Study|Withdrawal by Subject|15|||
157015361|NCT02252172|566806849|FG000|Overall Study|Physician Decision|0|||
157015362|NCT02252172|566806850|FG001|Overall Study|Physician Decision|1|||
157015363|NCT02252172|566806849|FG000|Overall Study|End of data collection|122|||
157015364|NCT02252172|566806850|FG001|Overall Study|End of data collection|170|||
157015365|NCT02252172|566806849|FG000|Overall Study|Site closure|0|||
157015366|NCT02252172|566806850|FG001|Overall Study|Site closure|1|||
157015367|NCT05575076|566806851|FG000|Overall Study|Adverse Event|24|||
157015368|NCT05575076|566806851|FG000|Overall Study|Death|7|||
157015369|NCT05575076|566806851|FG000|Overall Study|Lost to Follow-up|16|||
157015370|NCT05575076|566806851|FG000|Overall Study|Non-Compliance|3|||
157015371|NCT05575076|566806851|FG000|Overall Study|Physician Decision|6|||
157015372|NCT05575076|566806851|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
157015373|NCT05575076|566806851|FG000|Overall Study|Withdrawal by Subject|71|||
157015374|NCT05575076|566806851|FG000|Overall Study|Study Terminated by Sponsor|630|||
157015375|NCT05575076|566806851|FG000|Overall Study|Other|17|||
157015376|NCT03380390|566806852|FG000|Overall Study|Adverse Event|3|||
157015377|NCT03101930|566806858|FG000|Overall Study|Withdrawal by Subject|2|||
157015378|NCT03101930|566806859|FG001|Overall Study|Withdrawal by Subject|1|||
157015379|NCT03101930|566806860|FG002|Overall Study|Withdrawal by Subject|2|||
157015380|NCT03481816|566806864|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
157015381|NCT03481816|566806865|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
157015382|NCT03481816|566806864|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
157015383|NCT03481816|566806865|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
157015384|NCT03481816|566806864|FG000|Dose Expansion|Withdrawal by Subject|0|||
157015385|NCT03481816|566806865|FG001|Dose Expansion|Withdrawal by Subject|2|||
157015386|NCT03481816|566806864|FG000|Dose Expansion|Physician Decision|0|||
157124034|NCT01415752|567206164|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
156701776|NCT00816361|565654991|FG005|Overall Study|Withdrawal by Subject|2|||
156701777|NCT00816361|565654992|FG006|Overall Study|Withdrawal by Subject|0|||
156790934|NCT03679884|565985532|FG000|Overall Study|Lack of Efficacy|15|||
157015387|NCT03481816|566806865|FG001|Dose Expansion|Physician Decision|5|||
157015388|NCT01609218|566806867|FG000|Period 1|Adverse Event|3|||
157015389|NCT01609218|566806868|FG001|Period 1|Adverse Event|5|||
156790935|NCT03679884|565985533|FG001|Overall Study|Lack of Efficacy|29|||
156790936|NCT03679884|565985534|FG002|Overall Study|Lack of Efficacy|13|||
156790937|NCT03679884|565985535|FG003|Overall Study|Lack of Efficacy|29|||
156790938|NCT03679884|565985536|FG004|Overall Study|Lack of Efficacy|10|||
156701778|NCT00816361|565654993|FG007|Overall Study|Withdrawal by Subject|2|||
156701779|NCT00816361|565654994|FG008|Overall Study|Withdrawal by Subject|1|||
156701780|NCT00816361|565654986|FG000|Overall Study|Death|4|||
156701781|NCT00816361|565654987|FG001|Overall Study|Death|3|||
156701782|NCT00816361|565654988|FG002|Overall Study|Death|3|||
156701783|NCT00816361|565654989|FG003|Overall Study|Death|3|||
157124035|NCT01415752|567206161|FG000|Maintenance (Step 2)|Alternative therapy|0|||
157124036|NCT01415752|567206162|FG001|Maintenance (Step 2)|Alternative therapy|1|||
156701784|NCT00816361|565654990|FG004|Overall Study|Death|1|||
156701785|NCT00816361|565654991|FG005|Overall Study|Death|1|||
156701786|NCT00816361|565654992|FG006|Overall Study|Death|3|||
156701787|NCT00816361|565654993|FG007|Overall Study|Death|7|||
156701788|NCT00816361|565654994|FG008|Overall Study|Death|8|||
156701789|NCT00816361|565654986|FG000|Overall Study|Other|0|||
156701790|NCT00816361|565654987|FG001|Overall Study|Other|0|||
156701791|NCT00816361|565654988|FG002|Overall Study|Other|0|||
156701792|NCT00816361|565654989|FG003|Overall Study|Other|0|||
156701793|NCT00816361|565654990|FG004|Overall Study|Other|0|||
156701794|NCT00816361|565654991|FG005|Overall Study|Other|0|||
156701795|NCT00816361|565654992|FG006|Overall Study|Other|0|||
156701796|NCT00816361|565654993|FG007|Overall Study|Other|0|||
156701797|NCT00816361|565654994|FG008|Overall Study|Other|1|||
156701798|NCT02500641|565654997|FG000|Overall Study|Adverse Event|0|||
157015390|NCT01609218|566806867|FG000|Period 1|Sponsor Decision|0|||
157015391|NCT01609218|566806868|FG001|Period 1|Sponsor Decision|1|||
157015392|NCT01609218|566806867|FG000|Period 2|Adverse Event|1|||
157015393|NCT01609218|566806868|FG001|Period 2|Adverse Event|0|||
157015394|NCT02807779|566806869|FG000|Overall Study|Lost to Follow-up|1|||
157015395|NCT02807779|566806870|FG001|Overall Study|Lost to Follow-up|0|||
157015396|NCT02807779|566806871|FG002|Overall Study|Lost to Follow-up|0|||
157015397|NCT02807779|566806869|FG000|Overall Study|Physician Decision|2|||
157015398|NCT02807779|566806870|FG001|Overall Study|Physician Decision|0|||
157015399|NCT02807779|566806871|FG002|Overall Study|Physician Decision|1|||
157015400|NCT02807779|566806869|FG000|Overall Study|Death|1|||
157015401|NCT02807779|566806870|FG001|Overall Study|Death|1|||
157015402|NCT02807779|566806871|FG002|Overall Study|Death|0|||
157015403|NCT03582722|566806872|FG000|Overall Study|Lost to Follow-up|1|||
157015404|NCT03582722|566806873|FG001|Overall Study|Lost to Follow-up|4|||
157015405|NCT03582722|566806872|FG000|Overall Study|Withdrawal by Subject|3|||
157015406|NCT03582722|566806873|FG001|Overall Study|Withdrawal by Subject|3|||
157015407|NCT05094141|566806877|FG000|Overall Study|Death|0|||
157015408|NCT05094141|566806878|FG001|Overall Study|Death|0|||
157015409|NCT05094141|566806879|FG002|Overall Study|Death|1|||
157124037|NCT01415752|567206163|FG002|Maintenance (Step 2)|Alternative therapy|0|||
157124038|NCT01415752|567206164|FG003|Maintenance (Step 2)|Alternative therapy|0|||
157124039|NCT01415752|567206161|FG000|Maintenance (Step 2)|Other reasons|3|||
157124040|NCT01415752|567206162|FG001|Maintenance (Step 2)|Other reasons|6|||
156701799|NCT02500641|565654998|FG001|Overall Study|Adverse Event|2|||
156701800|NCT02500641|565654997|FG000|Overall Study|Withdrawal by Subject|4|||
156701801|NCT02500641|565654998|FG001|Overall Study|Withdrawal by Subject|5|||
156701802|NCT02500641|565654997|FG000|Overall Study|Unable to follow study procedures|3|||
156701803|NCT02500641|565654998|FG001|Overall Study|Unable to follow study procedures|2|||
156701804|NCT02500641|565654997|FG000|Overall Study|Protocol Violation|1|||
156701805|NCT02500641|565654998|FG001|Overall Study|Protocol Violation|2|||
156701806|NCT02500641|565654997|FG000|Overall Study|Lost to Follow-up|1|||
156701807|NCT02500641|565654998|FG001|Overall Study|Lost to Follow-up|0|||
156701808|NCT02500641|565654997|FG000|Overall Study|Sponsor decision|1|||
156701809|NCT02500641|565654998|FG001|Overall Study|Sponsor decision|0|||
156701810|NCT02500641|565654997|FG000|Overall Study|Non compliance to study drug|0|||
156701811|NCT02500641|565654998|FG001|Overall Study|Non compliance to study drug|1|||
156701812|NCT03233230|565654999|FG000|Overall Study|Adverse Event|6|||
157124041|NCT01415752|567206163|FG002|Maintenance (Step 2)|Other reasons|4|||
156701813|NCT03233230|565655000|FG001|Overall Study|Adverse Event|3|||
156701814|NCT03233230|565655001|FG002|Overall Study|Adverse Event|6|||
156701815|NCT03233230|565655002|FG003|Overall Study|Adverse Event|3|||
156701816|NCT03233230|565654999|FG000|Overall Study|Protocol Violation|1|||
157124042|NCT01415752|567206164|FG003|Maintenance (Step 2)|Other reasons|6|||
156701817|NCT03233230|565655000|FG001|Overall Study|Protocol Violation|2|||
157124043|NCT01415752|567206161|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
156701818|NCT03233230|565655001|FG002|Overall Study|Protocol Violation|1|||
156872114|NCT02858362|566289509|FG002|Overall Study|Withdrawal by Subject|0|||
157015410|NCT05094141|566806877|FG000|Overall Study|Withdrawal by Subject|0|||
157015411|NCT05094141|566806878|FG001|Overall Study|Withdrawal by Subject|0|||
157015412|NCT05094141|566806879|FG002|Overall Study|Withdrawal by Subject|1|||
157015413|NCT05094141|566806877|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
157015414|NCT05094141|566806878|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
156701819|NCT03233230|565655002|FG003|Overall Study|Protocol Violation|1|||
156701820|NCT03233230|565654999|FG000|Overall Study|Lack of Efficacy|1|||
156701821|NCT03233230|565655000|FG001|Overall Study|Lack of Efficacy|0|||
156701822|NCT03233230|565655001|FG002|Overall Study|Lack of Efficacy|0|||
156701823|NCT03233230|565655002|FG003|Overall Study|Lack of Efficacy|0|||
156701824|NCT03233230|565654999|FG000|Overall Study|Other|5|||
156701825|NCT03233230|565655000|FG001|Overall Study|Other|5|||
156701826|NCT03233230|565655001|FG002|Overall Study|Other|5|||
156701827|NCT03233230|565655002|FG003|Overall Study|Other|3|||
156701828|NCT03233230|565654999|FG000|Overall Study|Withdrawal by Subject|2|||
156701829|NCT03233230|565655000|FG001|Overall Study|Withdrawal by Subject|2|||
156701830|NCT03233230|565655001|FG002|Overall Study|Withdrawal by Subject|0|||
156701831|NCT03233230|565655002|FG003|Overall Study|Withdrawal by Subject|1|||
156701832|NCT03233230|565654999|FG000|Overall Study|Lost to Follow-up|0|||
156701833|NCT03233230|565655000|FG001|Overall Study|Lost to Follow-up|3|||
156701834|NCT03233230|565655001|FG002|Overall Study|Lost to Follow-up|0|||
156701835|NCT03233230|565655002|FG003|Overall Study|Lost to Follow-up|0|||
156701836|NCT01584843|565655005|FG000|First Treatment Period|Adverse Event|0|||
156701837|NCT01584843|565655006|FG001|First Treatment Period|Adverse Event|0|||
156701838|NCT01584843|565655007|FG002|First Treatment Period|Adverse Event|1|||
156701839|NCT01584843|565655008|FG003|First Treatment Period|Adverse Event|0|||
156701840|NCT01584843|565655009|FG004|First Treatment Period|Adverse Event|0|||
156701841|NCT01584843|565655010|FG005|First Treatment Period|Adverse Event|0|||
156701842|NCT01584843|565655005|FG000|First Treatment Period|Protocol Violation|0|||
156701843|NCT01584843|565655006|FG001|First Treatment Period|Protocol Violation|0|||
156701844|NCT01584843|565655007|FG002|First Treatment Period|Protocol Violation|0|||
156701845|NCT01584843|565655008|FG003|First Treatment Period|Protocol Violation|0|||
156701846|NCT01584843|565655009|FG004|First Treatment Period|Protocol Violation|0|||
156701847|NCT01584843|565655010|FG005|First Treatment Period|Protocol Violation|1|||
156701848|NCT01584843|565655005|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701849|NCT01584843|565655006|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701850|NCT01584843|565655007|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701851|NCT01584843|565655008|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701852|NCT01584843|565655009|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
156701853|NCT01584843|565655010|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
156701854|NCT01584843|565655005|FG000|Second Treatment Period|Withdrawal by Subject|0|||
156701855|NCT01584843|565655006|FG001|Second Treatment Period|Withdrawal by Subject|0|||
156701856|NCT01584843|565655007|FG002|Second Treatment Period|Withdrawal by Subject|0|||
156701857|NCT01584843|565655008|FG003|Second Treatment Period|Withdrawal by Subject|0|||
156701858|NCT01584843|565655009|FG004|Second Treatment Period|Withdrawal by Subject|0|||
156701859|NCT01584843|565655010|FG005|Second Treatment Period|Withdrawal by Subject|1|||
156701860|NCT04156620|565655011|FG000|Overall Study|Adverse event - TP 1|5|||
156701861|NCT04156620|565655012|FG001|Overall Study|Adverse event - TP 1|2|||
156701862|NCT04156620|565655011|FG000|Overall Study|Lost to follow-up TP 1|1|||
156701863|NCT04156620|565655012|FG001|Overall Study|Lost to follow-up TP 1|1|||
156701864|NCT04156620|565655011|FG000|Overall Study|Progressive disease - TP 1|0|||
156701865|NCT04156620|565655012|FG001|Overall Study|Progressive disease - TP 1|1|||
156701866|NCT04156620|565655011|FG000|Overall Study|Subject decision - TP 1|3|||
156701867|NCT04156620|565655012|FG001|Overall Study|Subject decision - TP 1|5|||
156701868|NCT04156620|565655011|FG000|Overall Study|Adverse event - TP 2|5|||
156701869|NCT04156620|565655012|FG001|Overall Study|Adverse event - TP 2|6|||
156701870|NCT04156620|565655011|FG000|Overall Study|Death - TP 2|1|||
156701871|NCT04156620|565655012|FG001|Overall Study|Death - TP 2|0|||
156701872|NCT04156620|565655011|FG000|Overall Study|Lost to follow-up - TP 2|5|||
156701873|NCT04156620|565655012|FG001|Overall Study|Lost to follow-up - TP 2|2|||
156701874|NCT04156620|565655011|FG000|Overall Study|Physician decision - TP 2|4|||
156701875|NCT04156620|565655012|FG001|Overall Study|Physician decision - TP 2|2|||
156701876|NCT04156620|565655011|FG000|Overall Study|Pregnancy - TP 2|1|||
156701877|NCT04156620|565655012|FG001|Overall Study|Pregnancy - TP 2|1|||
156701878|NCT04156620|565655011|FG000|Overall Study|Subject decision - TP 2|11|||
156790939|NCT03679884|565985532|FG000|Overall Study|Death|1|||
156790940|NCT03679884|565985533|FG001|Overall Study|Death|0|||
156790941|NCT03679884|565985534|FG002|Overall Study|Death|0|||
157124044|NCT01415752|567206162|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
157124045|NCT01415752|567206163|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
157124046|NCT01415752|567206164|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
157124047|NCT01415752|567206161|FG000|Maintenance (Step 2)|ineligible|1|||
157124048|NCT01415752|567206162|FG001|Maintenance (Step 2)|ineligible|1|||
157124049|NCT01415752|567206163|FG002|Maintenance (Step 2)|ineligible|1|||
157124050|NCT01415752|567206164|FG003|Maintenance (Step 2)|ineligible|0|||
156701879|NCT04156620|565655012|FG001|Overall Study|Subject decision - TP 2|9|||
156701880|NCT04156620|565655011|FG000|Overall Study|New therapy for study indication - TP 2|1|||
156701881|NCT04156620|565655012|FG001|Overall Study|New therapy for study indication - TP 2|0|||
156701882|NCT01121666|565655013|FG000|Overall Study|Protocol Violation|29|||
156701883|NCT01121666|565655014|FG001|Overall Study|Protocol Violation|10|||
156701884|NCT01629966|565655015|FG000|Overall Study|Pregnancy|0|||
156701885|NCT01629966|565655016|FG001|Overall Study|Pregnancy|1|||
156701886|NCT01629966|565655017|FG002|Overall Study|Pregnancy|0|||
157124051|NCT01415752|567206161|FG000|Maintenance (Step 2)|Missing|4|||
156790942|NCT03679884|565985535|FG003|Overall Study|Death|0|||
157124052|NCT01415752|567206162|FG001|Maintenance (Step 2)|Missing|1|||
157124053|NCT01415752|567206163|FG002|Maintenance (Step 2)|Missing|4|||
157124054|NCT01415752|567206164|FG003|Maintenance (Step 2)|Missing|3|||
157124055|NCT03083886|567206165|FG000|Overall Study|Withdrawal by Subject|51|||
157124056|NCT03083886|567206166|FG001|Overall Study|Withdrawal by Subject|73|||
157124057|NCT03083886|567206167|FG002|Overall Study|Withdrawal by Subject|104|||
157124058|NCT03083886|567206165|FG000|Overall Study|Missing Baseline data|43|||
157124059|NCT03083886|567206166|FG001|Overall Study|Missing Baseline data|42|||
157124060|NCT03083886|567206167|FG002|Overall Study|Missing Baseline data|31|||
157124061|NCT03083886|567206165|FG000|Overall Study|Investigator terminated|1|||
157124062|NCT03083886|567206166|FG001|Overall Study|Investigator terminated|6|||
157124063|NCT03083886|567206167|FG002|Overall Study|Investigator terminated|3|||
157124064|NCT03286842|567206168|FG000|Overall Study|Patients rolled over to another study|80|||
157124065|NCT01391507|567206169|FG000|Overall Study|Death|0|||
157124066|NCT01391507|567206170|FG001|Overall Study|Death|0|||
157124067|NCT01391507|567206171|FG002|Overall Study|Death|0|||
157124068|NCT01391507|567206172|FG003|Overall Study|Death|1|||
157124069|NCT01391507|567206169|FG000|Overall Study|Adverse Event|1|||
157124070|NCT01391507|567206170|FG001|Overall Study|Adverse Event|1|||
157124071|NCT01391507|567206171|FG002|Overall Study|Adverse Event|2|||
157124072|NCT01391507|567206172|FG003|Overall Study|Adverse Event|2|||
157124073|NCT01391507|567206169|FG000|Overall Study|Withdrawal by Subject|1|||
157124074|NCT01391507|567206170|FG001|Overall Study|Withdrawal by Subject|2|||
157124075|NCT01391507|567206171|FG002|Overall Study|Withdrawal by Subject|1|||
157124076|NCT01391507|567206172|FG003|Overall Study|Withdrawal by Subject|1|||
157124077|NCT01391507|567206169|FG000|Overall Study|Lack of Efficacy|0|||
157124078|NCT01391507|567206170|FG001|Overall Study|Lack of Efficacy|0|||
157124079|NCT01391507|567206171|FG002|Overall Study|Lack of Efficacy|0|||
157124080|NCT01391507|567206172|FG003|Overall Study|Lack of Efficacy|1|||
157124081|NCT01391507|567206169|FG000|Overall Study|Protocol Violation|2|||
157124082|NCT01391507|567206170|FG001|Overall Study|Protocol Violation|1|||
157124083|NCT01391507|567206171|FG002|Overall Study|Protocol Violation|1|||
157124084|NCT01391507|567206172|FG003|Overall Study|Protocol Violation|2|||
157124085|NCT01453855|567206173|FG000|Overall Study|Adverse Event|3|||
157124086|NCT01453855|567206174|FG001|Overall Study|Adverse Event|4|||
156701887|NCT01629966|565655015|FG000|Overall Study|Lost to Follow-up|10|||
156701888|NCT01629966|565655016|FG001|Overall Study|Lost to Follow-up|13|||
156701889|NCT01629966|565655017|FG002|Overall Study|Lost to Follow-up|9|||
156701890|NCT01629966|565655015|FG000|Overall Study|Withdrawal by Subject|8|||
156701891|NCT01629966|565655016|FG001|Overall Study|Withdrawal by Subject|9|||
156701892|NCT01629966|565655017|FG002|Overall Study|Withdrawal by Subject|16|||
156701893|NCT01629966|565655015|FG000|Overall Study|Protocol Violation|7|||
156701894|NCT01629966|565655016|FG001|Overall Study|Protocol Violation|9|||
156701895|NCT01629966|565655017|FG002|Overall Study|Protocol Violation|7|||
156701896|NCT01629966|565655015|FG000|Overall Study|Lack of Efficacy|5|||
156701897|NCT01629966|565655016|FG001|Overall Study|Lack of Efficacy|2|||
156701898|NCT01629966|565655017|FG002|Overall Study|Lack of Efficacy|4|||
156701899|NCT01629966|565655015|FG000|Overall Study|Adverse Event|11|||
156701900|NCT01629966|565655016|FG001|Overall Study|Adverse Event|18|||
156701901|NCT01629966|565655017|FG002|Overall Study|Adverse Event|30|||
156701902|NCT02132754|565655018|FG000|Overall Study|Adverse Event|0|||
156701903|NCT02132754|565655019|FG001|Overall Study|Adverse Event|0|||
156701904|NCT02132754|565655020|FG002|Overall Study|Adverse Event|0|||
156701905|NCT02132754|565655021|FG003|Overall Study|Adverse Event|0|||
156701906|NCT02132754|565655022|FG004|Overall Study|Adverse Event|0|||
156701907|NCT02132754|565655023|FG005|Overall Study|Adverse Event|0|||
156701908|NCT02132754|565655024|FG006|Overall Study|Adverse Event|0|||
156701909|NCT02132754|565655025|FG007|Overall Study|Adverse Event|0|||
156701910|NCT02132754|565655026|FG008|Overall Study|Adverse Event|0|||
156701911|NCT02132754|565655027|FG009|Overall Study|Adverse Event|0|||
156701912|NCT02132754|565655028|FG010|Overall Study|Adverse Event|0|||
156701913|NCT02132754|565655029|FG011|Overall Study|Adverse Event|0|||
156701914|NCT02132754|565655030|FG012|Overall Study|Adverse Event|0|||
156872115|NCT02858362|566289507|FG000|Overall Study|Early Study Termination|0|||
156872116|NCT02858362|566289508|FG001|Overall Study|Early Study Termination|0|||
156701915|NCT02132754|565655031|FG013|Overall Study|Adverse Event|0|||
156701916|NCT02132754|565655032|FG014|Overall Study|Adverse Event|0|||
156701917|NCT02132754|565655033|FG015|Overall Study|Adverse Event|0|||
157124087|NCT01453855|567206173|FG000|Overall Study|Lost to Follow-up|2|||
157124088|NCT01453855|567206174|FG001|Overall Study|Lost to Follow-up|1|||
157124089|NCT01453855|567206173|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
157124090|NCT01453855|567206174|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
157124091|NCT01453855|567206173|FG000|Overall Study|Noncompliance|1|||
157124092|NCT01453855|567206174|FG001|Overall Study|Noncompliance|0|||
157124093|NCT01453855|567206173|FG000|Overall Study|Inadequate Control of IOP|1|||
157124094|NCT01453855|567206174|FG001|Overall Study|Inadequate Control of IOP|5|||
156701918|NCT02132754|565655034|FG016|Overall Study|Adverse Event|0|||
156701919|NCT02132754|565655035|FG017|Overall Study|Adverse Event|1|||
156701920|NCT02132754|565655036|FG018|Overall Study|Adverse Event|0|||
156701921|NCT02132754|565655037|FG019|Overall Study|Adverse Event|0|||
156701922|NCT02132754|565655038|FG020|Overall Study|Adverse Event|0|||
156701923|NCT02132754|565655039|FG021|Overall Study|Adverse Event|0|||
156701924|NCT02132754|565655040|FG022|Overall Study|Adverse Event|0|||
156701925|NCT02132754|565655041|FG023|Overall Study|Adverse Event|0|||
156701926|NCT02132754|565655042|FG024|Overall Study|Adverse Event|0|||
156701927|NCT02132754|565655043|FG025|Overall Study|Adverse Event|1|||
156701928|NCT02132754|565655044|FG026|Overall Study|Adverse Event|1|||
156701929|NCT02132754|565655045|FG027|Overall Study|Adverse Event|0|||
156701930|NCT02132754|565655046|FG028|Overall Study|Adverse Event|0|||
156701931|NCT02132754|565655047|FG029|Overall Study|Adverse Event|0|||
156701932|NCT02132754|565655048|FG030|Overall Study|Adverse Event|1|||
156701933|NCT02132754|565655049|FG031|Overall Study|Adverse Event|0|||
156701934|NCT02132754|565655050|FG032|Overall Study|Adverse Event|1|||
156701935|NCT02132754|565655051|FG033|Overall Study|Adverse Event|1|||
156701936|NCT02132754|565655018|FG000|Overall Study|Clinical Progression|0|||
156701937|NCT02132754|565655019|FG001|Overall Study|Clinical Progression|0|||
156701938|NCT02132754|565655020|FG002|Overall Study|Clinical Progression|0|||
156701939|NCT02132754|565655021|FG003|Overall Study|Clinical Progression|0|||
156701940|NCT02132754|565655022|FG004|Overall Study|Clinical Progression|0|||
156701941|NCT02132754|565655023|FG005|Overall Study|Clinical Progression|0|||
156701942|NCT02132754|565655024|FG006|Overall Study|Clinical Progression|0|||
156701943|NCT02132754|565655025|FG007|Overall Study|Clinical Progression|0|||
156701944|NCT02132754|565655026|FG008|Overall Study|Clinical Progression|0|||
156701945|NCT02132754|565655027|FG009|Overall Study|Clinical Progression|1|||
156701946|NCT02132754|565655028|FG010|Overall Study|Clinical Progression|0|||
156701947|NCT02132754|565655029|FG011|Overall Study|Clinical Progression|0|||
156701948|NCT02132754|565655030|FG012|Overall Study|Clinical Progression|0|||
156701949|NCT02132754|565655031|FG013|Overall Study|Clinical Progression|0|||
156701950|NCT02132754|565655032|FG014|Overall Study|Clinical Progression|0|||
156701951|NCT02132754|565655033|FG015|Overall Study|Clinical Progression|0|||
156701952|NCT02132754|565655034|FG016|Overall Study|Clinical Progression|1|||
156701953|NCT02132754|565655035|FG017|Overall Study|Clinical Progression|1|||
156701954|NCT02132754|565655036|FG018|Overall Study|Clinical Progression|0|||
156701955|NCT02132754|565655037|FG019|Overall Study|Clinical Progression|1|||
156701956|NCT02132754|565655038|FG020|Overall Study|Clinical Progression|0|||
156701957|NCT02132754|565655039|FG021|Overall Study|Clinical Progression|0|||
156701958|NCT02132754|565655040|FG022|Overall Study|Clinical Progression|1|||
156701959|NCT02132754|565655041|FG023|Overall Study|Clinical Progression|0|||
156701960|NCT02132754|565655042|FG024|Overall Study|Clinical Progression|1|||
156701961|NCT02132754|565655043|FG025|Overall Study|Clinical Progression|1|||
156701962|NCT02132754|565655044|FG026|Overall Study|Clinical Progression|0|||
156701963|NCT02132754|565655045|FG027|Overall Study|Clinical Progression|1|||
156701964|NCT02132754|565655046|FG028|Overall Study|Clinical Progression|1|||
156701965|NCT02132754|565655047|FG029|Overall Study|Clinical Progression|0|||
156701966|NCT02132754|565655048|FG030|Overall Study|Clinical Progression|1|||
156701967|NCT02132754|565655049|FG031|Overall Study|Clinical Progression|0|||
156701968|NCT02132754|565655050|FG032|Overall Study|Clinical Progression|0|||
156701969|NCT02132754|565655051|FG033|Overall Study|Clinical Progression|2|||
156701970|NCT02132754|565655018|FG000|Overall Study|Death|0|||
156701971|NCT02132754|565655019|FG001|Overall Study|Death|0|||
156790943|NCT03679884|565985536|FG004|Overall Study|Death|0|||
156790944|NCT03679884|565985532|FG000|Overall Study|Adverse Event|2|||
156790945|NCT03679884|565985533|FG001|Overall Study|Adverse Event|10|||
156790946|NCT03679884|565985534|FG002|Overall Study|Adverse Event|9|||
156790947|NCT03679884|565985535|FG003|Overall Study|Adverse Event|6|||
156790948|NCT03679884|565985536|FG004|Overall Study|Adverse Event|6|||
156790949|NCT03679884|565985532|FG000|Overall Study|Withdrawal by Subject|12|||
156790950|NCT03679884|565985533|FG001|Overall Study|Withdrawal by Subject|23|||
156790951|NCT03679884|565985534|FG002|Overall Study|Withdrawal by Subject|8|||
156790952|NCT03679884|565985535|FG003|Overall Study|Withdrawal by Subject|8|||
156790953|NCT03679884|565985536|FG004|Overall Study|Withdrawal by Subject|9|||
156790954|NCT03679884|565985532|FG000|Overall Study|Lost to Follow-up|1|||
156790955|NCT03679884|565985533|FG001|Overall Study|Lost to Follow-up|4|||
156701972|NCT02132754|565655020|FG002|Overall Study|Death|0|||
156701973|NCT02132754|565655021|FG003|Overall Study|Death|0|||
156701974|NCT02132754|565655022|FG004|Overall Study|Death|0|||
156790956|NCT03679884|565985534|FG002|Overall Study|Lost to Follow-up|2|||
156790957|NCT03679884|565985535|FG003|Overall Study|Lost to Follow-up|0|||
156790958|NCT03679884|565985536|FG004|Overall Study|Lost to Follow-up|3|||
156701975|NCT02132754|565655023|FG005|Overall Study|Death|0|||
156701976|NCT02132754|565655024|FG006|Overall Study|Death|0|||
156701977|NCT02132754|565655025|FG007|Overall Study|Death|0|||
156701978|NCT02132754|565655026|FG008|Overall Study|Death|0|||
156701979|NCT02132754|565655027|FG009|Overall Study|Death|0|||
156701980|NCT02132754|565655028|FG010|Overall Study|Death|0|||
156701981|NCT02132754|565655029|FG011|Overall Study|Death|0|||
156701982|NCT02132754|565655030|FG012|Overall Study|Death|0|||
156701983|NCT02132754|565655031|FG013|Overall Study|Death|0|||
156701984|NCT02132754|565655032|FG014|Overall Study|Death|0|||
156701985|NCT02132754|565655033|FG015|Overall Study|Death|1|||
156701986|NCT02132754|565655034|FG016|Overall Study|Death|0|||
156701987|NCT02132754|565655035|FG017|Overall Study|Death|0|||
156701988|NCT02132754|565655036|FG018|Overall Study|Death|0|||
156701989|NCT02132754|565655037|FG019|Overall Study|Death|1|||
156701990|NCT02132754|565655038|FG020|Overall Study|Death|0|||
156701991|NCT02132754|565655039|FG021|Overall Study|Death|1|||
156701992|NCT02132754|565655040|FG022|Overall Study|Death|0|||
156701993|NCT02132754|565655041|FG023|Overall Study|Death|0|||
156701994|NCT02132754|565655042|FG024|Overall Study|Death|0|||
156701995|NCT02132754|565655043|FG025|Overall Study|Death|0|||
156701996|NCT02132754|565655044|FG026|Overall Study|Death|1|||
156701997|NCT02132754|565655045|FG027|Overall Study|Death|0|||
156701998|NCT02132754|565655046|FG028|Overall Study|Death|0|||
156701999|NCT02132754|565655047|FG029|Overall Study|Death|0|||
156702000|NCT02132754|565655048|FG030|Overall Study|Death|0|||
156702001|NCT02132754|565655049|FG031|Overall Study|Death|0|||
157015415|NCT05094141|566806879|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
157015416|NCT05094141|566806877|FG000|Overall Study|Did not participate in randomization|0|||
156702002|NCT02132754|565655050|FG032|Overall Study|Death|0|||
156702003|NCT02132754|565655051|FG033|Overall Study|Death|2|||
156702004|NCT02132754|565655018|FG000|Overall Study|Excluded Medication|0|||
156702005|NCT02132754|565655019|FG001|Overall Study|Excluded Medication|0|||
156702006|NCT02132754|565655020|FG002|Overall Study|Excluded Medication|0|||
156702007|NCT02132754|565655021|FG003|Overall Study|Excluded Medication|0|||
156702008|NCT02132754|565655022|FG004|Overall Study|Excluded Medication|0|||
156702009|NCT02132754|565655023|FG005|Overall Study|Excluded Medication|0|||
156702010|NCT02132754|565655024|FG006|Overall Study|Excluded Medication|0|||
156702011|NCT02132754|565655025|FG007|Overall Study|Excluded Medication|0|||
156702012|NCT02132754|565655026|FG008|Overall Study|Excluded Medication|0|||
156702013|NCT02132754|565655027|FG009|Overall Study|Excluded Medication|0|||
156702014|NCT02132754|565655028|FG010|Overall Study|Excluded Medication|0|||
156702015|NCT02132754|565655029|FG011|Overall Study|Excluded Medication|0|||
156702016|NCT02132754|565655030|FG012|Overall Study|Excluded Medication|0|||
156702017|NCT02132754|565655031|FG013|Overall Study|Excluded Medication|0|||
156702018|NCT02132754|565655032|FG014|Overall Study|Excluded Medication|0|||
156702019|NCT02132754|565655033|FG015|Overall Study|Excluded Medication|0|||
156702020|NCT02132754|565655034|FG016|Overall Study|Excluded Medication|0|||
156702021|NCT02132754|565655035|FG017|Overall Study|Excluded Medication|0|||
156702022|NCT02132754|565655036|FG018|Overall Study|Excluded Medication|0|||
156702023|NCT02132754|565655037|FG019|Overall Study|Excluded Medication|0|||
156790959|NCT00480025|565985540|FG000|Overall Study|Protocol Violation|12|||
156790960|NCT00480025|565985541|FG001|Overall Study|Protocol Violation|7|||
156790961|NCT00480025|565985540|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
156790962|NCT00480025|565985541|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
156790963|NCT00480025|565985540|FG000|Overall Study|Disease Progression / Recurrence|449|||
156702024|NCT02132754|565655038|FG020|Overall Study|Excluded Medication|1|||
156702025|NCT02132754|565655039|FG021|Overall Study|Excluded Medication|0|||
156702026|NCT02132754|565655040|FG022|Overall Study|Excluded Medication|0|||
156790964|NCT00480025|565985541|FG001|Overall Study|Disease Progression / Recurrence|224|||
156790965|NCT00480025|565985540|FG000|Overall Study|Adverse Event|44|||
156790966|NCT00480025|565985541|FG001|Overall Study|Adverse Event|12|||
156790967|NCT00480025|565985540|FG000|Overall Study|Other|70|||
156790968|NCT00480025|565985541|FG001|Overall Study|Other|29|||
156790969|NCT00480025|565985540|FG000|Overall Study|SAE including intercurrent illness|76|||
156790970|NCT00480025|565985541|FG001|Overall Study|SAE including intercurrent illness|42|||
156790971|NCT00682435|565985542|FG000|Overall Study|Insufficient data|5|||
156790972|NCT00682435|565985542|FG000|Overall Study|Erroneously enrolled twice|2|||
156790973|NCT01064622|565985544|FG000|Randomized Phase II|Withdrawal by Subject|2|||
156790974|NCT01064622|565985545|FG001|Randomized Phase II|Withdrawal by Subject|2|||
156790975|NCT01064622|565985544|FG000|Randomized Phase II|Protocol Violation|0|||
156790976|NCT01064622|565985545|FG001|Randomized Phase II|Protocol Violation|1|||
156790977|NCT00432991|565987106|FG000|Overall Study|Protocol Violation|7|||
156790978|NCT00432991|565987107|FG001|Overall Study|Protocol Violation|12|||
156790979|NCT00363467|565987108|FG000|Overall Study|Physician Decision|1|||
156790980|NCT05069415|565987111|FG000|Overall Study|Withdrawal by Subject|2|||
157015417|NCT05094141|566806878|FG001|Overall Study|Did not participate in randomization|0|||
157015418|NCT05094141|566806879|FG002|Overall Study|Did not participate in randomization|33|||
157015419|NCT05756075|566808788|FG000|Overall Study|Withdrawal by Subject|16|||
157215083|NCT00623623|567535748|FG000|Overall Study|Previous enrolment into this study|1|||
156702027|NCT02132754|565655041|FG023|Overall Study|Excluded Medication|0|||
156702028|NCT02132754|565655042|FG024|Overall Study|Excluded Medication|0|||
156702029|NCT02132754|565655043|FG025|Overall Study|Excluded Medication|0|||
156702030|NCT02132754|565655044|FG026|Overall Study|Excluded Medication|0|||
156702031|NCT02132754|565655045|FG027|Overall Study|Excluded Medication|0|||
156702032|NCT02132754|565655046|FG028|Overall Study|Excluded Medication|0|||
156702033|NCT02132754|565655047|FG029|Overall Study|Excluded Medication|0|||
156702034|NCT02132754|565655048|FG030|Overall Study|Excluded Medication|0|||
156702035|NCT02132754|565655049|FG031|Overall Study|Excluded Medication|0|||
156702036|NCT02132754|565655050|FG032|Overall Study|Excluded Medication|0|||
156702037|NCT02132754|565655051|FG033|Overall Study|Excluded Medication|1|||
156702038|NCT02132754|565655018|FG000|Overall Study|Physician Decision|0|||
156702039|NCT02132754|565655019|FG001|Overall Study|Physician Decision|0|||
156702040|NCT02132754|565655020|FG002|Overall Study|Physician Decision|0|||
156702041|NCT02132754|565655021|FG003|Overall Study|Physician Decision|0|||
156702042|NCT02132754|565655022|FG004|Overall Study|Physician Decision|0|||
156702043|NCT02132754|565655023|FG005|Overall Study|Physician Decision|0|||
156702044|NCT02132754|565655024|FG006|Overall Study|Physician Decision|0|||
156702045|NCT02132754|565655025|FG007|Overall Study|Physician Decision|0|||
156702046|NCT02132754|565655026|FG008|Overall Study|Physician Decision|0|||
156702047|NCT02132754|565655027|FG009|Overall Study|Physician Decision|1|||
156702048|NCT02132754|565655028|FG010|Overall Study|Physician Decision|0|||
157124095|NCT01453855|567206173|FG000|Overall Study|Other|0|||
157124096|NCT01453855|567206174|FG001|Overall Study|Other|1|||
157124097|NCT04161495|567206177|FG000|Overall Study|Withdrawal by Subject|3|||
157124098|NCT04161495|567206178|FG001|Overall Study|Withdrawal by Subject|0|||
156702049|NCT02132754|565655029|FG011|Overall Study|Physician Decision|1|||
156702050|NCT02132754|565655030|FG012|Overall Study|Physician Decision|1|||
156702051|NCT02132754|565655031|FG013|Overall Study|Physician Decision|0|||
156702052|NCT02132754|565655032|FG014|Overall Study|Physician Decision|0|||
156702053|NCT02132754|565655033|FG015|Overall Study|Physician Decision|1|||
156702054|NCT02132754|565655034|FG016|Overall Study|Physician Decision|0|||
156702055|NCT02132754|565655035|FG017|Overall Study|Physician Decision|0|||
156702056|NCT02132754|565655036|FG018|Overall Study|Physician Decision|0|||
156702057|NCT02132754|565655037|FG019|Overall Study|Physician Decision|0|||
156702058|NCT02132754|565655038|FG020|Overall Study|Physician Decision|0|||
157124099|NCT04161495|567206177|FG000|Overall Study|Protocol Violation|1|||
157124100|NCT04161495|567206178|FG001|Overall Study|Protocol Violation|0|||
157124101|NCT04161495|567206177|FG000|Overall Study|Prohibited concomitant medication|3|||
157124102|NCT04161495|567206178|FG001|Overall Study|Prohibited concomitant medication|0|||
157124103|NCT04161495|567206177|FG000|Overall Study|Adverse Event|1|||
157124104|NCT04161495|567206178|FG001|Overall Study|Adverse Event|0|||
156702059|NCT02132754|565655039|FG021|Overall Study|Physician Decision|0|||
156702060|NCT02132754|565655040|FG022|Overall Study|Physician Decision|0|||
157124105|NCT04161495|567206177|FG000|Overall Study|Other - Unspecified|1|||
157124106|NCT04161495|567206178|FG001|Overall Study|Other - Unspecified|0|||
157124107|NCT04161495|567206177|FG000|Overall Study|Death|0|||
157124108|NCT04161495|567206178|FG001|Overall Study|Death|1|||
157124109|NCT01285908|567206181|FG000|Baseline Measurement|unable to insert catheter|1|||
157124110|NCT01285908|567206182|FG001|Baseline Measurement|unable to insert catheter|0|||
157124111|NCT01285908|567206183|FG002|Baseline Measurement|unable to insert catheter|0|||
157124112|NCT01285908|567206181|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
157124113|NCT01285908|567206182|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
157124114|NCT01285908|567206183|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
157124115|NCT01285908|567206181|FG000|Baseline Measurement|unable to tolerate procedure|1|||
157124116|NCT01285908|567206182|FG001|Baseline Measurement|unable to tolerate procedure|0|||
157124117|NCT01285908|567206183|FG002|Baseline Measurement|unable to tolerate procedure|0|||
157124118|NCT01562548|567206184|FG000|Overall Study|Lost to Follow-up|0|||
157124119|NCT01562548|567206185|FG001|Overall Study|Lost to Follow-up|0|||
157124120|NCT01562548|567206186|FG002|Overall Study|Lost to Follow-up|1|||
157124121|NCT01562548|567206187|FG003|Overall Study|Lost to Follow-up|0|||
157124122|NCT00252057|567206188|FG000|Overall Study|Withdrawal by Subject|2|||
157124123|NCT00252057|567206189|FG001|Overall Study|Withdrawal by Subject|5|||
157124124|NCT00252057|567206188|FG000|Overall Study|Death|1|||
157124125|NCT00252057|567206189|FG001|Overall Study|Death|2|||
156702061|NCT02132754|565655041|FG023|Overall Study|Physician Decision|0|||
156702062|NCT02132754|565655042|FG024|Overall Study|Physician Decision|1|||
156702063|NCT02132754|565655043|FG025|Overall Study|Physician Decision|0|||
156702064|NCT02132754|565655044|FG026|Overall Study|Physician Decision|0|||
156702065|NCT02132754|565655045|FG027|Overall Study|Physician Decision|0|||
156702066|NCT02132754|565655046|FG028|Overall Study|Physician Decision|0|||
156872117|NCT02858362|566289509|FG002|Overall Study|Early Study Termination|3|||
157124126|NCT00252057|567206188|FG000|Overall Study|Participant previously enrolled|0|||
156702067|NCT02132754|565655047|FG029|Overall Study|Physician Decision|0|||
157124127|NCT00252057|567206189|FG001|Overall Study|Participant previously enrolled|1|||
156702068|NCT02132754|565655048|FG030|Overall Study|Physician Decision|0|||
156702069|NCT02132754|565655049|FG031|Overall Study|Physician Decision|1|||
156702070|NCT02132754|565655050|FG032|Overall Study|Physician Decision|0|||
156702071|NCT02132754|565655051|FG033|Overall Study|Physician Decision|3|||
157124128|NCT03529773|567206190|FG000|Overall Study|Adverse Event|0|||
157124129|NCT03529773|567206191|FG001|Overall Study|Adverse Event|0|||
157124130|NCT03529773|567206192|FG002|Overall Study|Adverse Event|0|||
157124131|NCT03529773|567206193|FG003|Overall Study|Adverse Event|0|||
156702072|NCT02132754|565655018|FG000|Overall Study|Progressive Disease|1|||
156702073|NCT02132754|565655019|FG001|Overall Study|Progressive Disease|1|||
156702074|NCT02132754|565655020|FG002|Overall Study|Progressive Disease|1|||
157124132|NCT03529773|567206194|FG004|Overall Study|Adverse Event|0|||
157124133|NCT03529773|567206195|FG005|Overall Study|Adverse Event|0|||
156702075|NCT02132754|565655021|FG003|Overall Study|Progressive Disease|1|||
156702076|NCT02132754|565655022|FG004|Overall Study|Progressive Disease|1|||
156702077|NCT02132754|565655023|FG005|Overall Study|Progressive Disease|1|||
156702078|NCT02132754|565655024|FG006|Overall Study|Progressive Disease|1|||
156702079|NCT02132754|565655025|FG007|Overall Study|Progressive Disease|1|||
156702080|NCT02132754|565655026|FG008|Overall Study|Progressive Disease|1|||
156702081|NCT02132754|565655027|FG009|Overall Study|Progressive Disease|3|||
156702082|NCT02132754|565655028|FG010|Overall Study|Progressive Disease|3|||
156702083|NCT02132754|565655029|FG011|Overall Study|Progressive Disease|2|||
156702084|NCT02132754|565655030|FG012|Overall Study|Progressive Disease|2|||
156702085|NCT02132754|565655031|FG013|Overall Study|Progressive Disease|3|||
156702086|NCT02132754|565655032|FG014|Overall Study|Progressive Disease|2|||
156702087|NCT02132754|565655033|FG015|Overall Study|Progressive Disease|1|||
156702088|NCT02132754|565655034|FG016|Overall Study|Progressive Disease|2|||
156702089|NCT02132754|565655035|FG017|Overall Study|Progressive Disease|1|||
156702090|NCT02132754|565655036|FG018|Overall Study|Progressive Disease|3|||
156702091|NCT02132754|565655037|FG019|Overall Study|Progressive Disease|1|||
156702092|NCT02132754|565655038|FG020|Overall Study|Progressive Disease|1|||
156702093|NCT02132754|565655039|FG021|Overall Study|Progressive Disease|3|||
156702094|NCT02132754|565655040|FG022|Overall Study|Progressive Disease|2|||
156702095|NCT02132754|565655041|FG023|Overall Study|Progressive Disease|3|||
156702096|NCT02132754|565655042|FG024|Overall Study|Progressive Disease|0|||
156702097|NCT02132754|565655043|FG025|Overall Study|Progressive Disease|1|||
156702098|NCT02132754|565655044|FG026|Overall Study|Progressive Disease|2|||
156702099|NCT02132754|565655045|FG027|Overall Study|Progressive Disease|1|||
156702100|NCT02132754|565655046|FG028|Overall Study|Progressive Disease|2|||
156702101|NCT02132754|565655047|FG029|Overall Study|Progressive Disease|3|||
156702102|NCT02132754|565655048|FG030|Overall Study|Progressive Disease|1|||
156702103|NCT02132754|565655049|FG031|Overall Study|Progressive Disease|1|||
156702104|NCT02132754|565655050|FG032|Overall Study|Progressive Disease|3|||
156702105|NCT02132754|565655051|FG033|Overall Study|Progressive Disease|6|||
156702106|NCT02132754|565655018|FG000|Overall Study|Screen Failure|0|||
156702107|NCT02132754|565655019|FG001|Overall Study|Screen Failure|0|||
156702108|NCT02132754|565655020|FG002|Overall Study|Screen Failure|0|||
156702109|NCT02132754|565655021|FG003|Overall Study|Screen Failure|0|||
156702110|NCT02132754|565655022|FG004|Overall Study|Screen Failure|0|||
156702111|NCT02132754|565655023|FG005|Overall Study|Screen Failure|0|||
156702112|NCT02132754|565655024|FG006|Overall Study|Screen Failure|0|||
156702113|NCT02132754|565655025|FG007|Overall Study|Screen Failure|0|||
156702114|NCT02132754|565655026|FG008|Overall Study|Screen Failure|0|||
156702115|NCT02132754|565655027|FG009|Overall Study|Screen Failure|0|||
156702116|NCT02132754|565655028|FG010|Overall Study|Screen Failure|0|||
156702117|NCT02132754|565655029|FG011|Overall Study|Screen Failure|0|||
156702118|NCT02132754|565655030|FG012|Overall Study|Screen Failure|0|||
156702119|NCT02132754|565655031|FG013|Overall Study|Screen Failure|0|||
156702120|NCT02132754|565655032|FG014|Overall Study|Screen Failure|0|||
156702121|NCT02132754|565655033|FG015|Overall Study|Screen Failure|0|||
156702122|NCT02132754|565655034|FG016|Overall Study|Screen Failure|0|||
156702123|NCT02132754|565655035|FG017|Overall Study|Screen Failure|0|||
156702124|NCT02132754|565655036|FG018|Overall Study|Screen Failure|0|||
156702125|NCT02132754|565655037|FG019|Overall Study|Screen Failure|1|||
156702126|NCT02132754|565655038|FG020|Overall Study|Screen Failure|0|||
156702127|NCT02132754|565655039|FG021|Overall Study|Screen Failure|1|||
156702128|NCT02132754|565655040|FG022|Overall Study|Screen Failure|0|||
156702129|NCT02132754|565655041|FG023|Overall Study|Screen Failure|0|||
156702130|NCT02132754|565655042|FG024|Overall Study|Screen Failure|0|||
156702131|NCT02132754|565655043|FG025|Overall Study|Screen Failure|0|||
156702132|NCT02132754|565655044|FG026|Overall Study|Screen Failure|0|||
156702133|NCT02132754|565655045|FG027|Overall Study|Screen Failure|0|||
156702134|NCT02132754|565655046|FG028|Overall Study|Screen Failure|0|||
156702135|NCT02132754|565655047|FG029|Overall Study|Screen Failure|0|||
156702136|NCT02132754|565655048|FG030|Overall Study|Screen Failure|0|||
156702137|NCT02132754|565655049|FG031|Overall Study|Screen Failure|0|||
156702138|NCT02132754|565655050|FG032|Overall Study|Screen Failure|0|||
156702139|NCT02132754|565655051|FG033|Overall Study|Screen Failure|0|||
156702140|NCT02132754|565655018|FG000|Overall Study|Transferred to Extension Study|0|||
156702141|NCT02132754|565655019|FG001|Overall Study|Transferred to Extension Study|0|||
156702142|NCT02132754|565655020|FG002|Overall Study|Transferred to Extension Study|0|||
156790981|NCT05069415|565987112|FG001|Overall Study|Withdrawal by Subject|0|||
156702143|NCT02132754|565655021|FG003|Overall Study|Transferred to Extension Study|0|||
156702144|NCT02132754|565655022|FG004|Overall Study|Transferred to Extension Study|0|||
156702145|NCT02132754|565655023|FG005|Overall Study|Transferred to Extension Study|0|||
156702146|NCT02132754|565655024|FG006|Overall Study|Transferred to Extension Study|0|||
156702147|NCT02132754|565655025|FG007|Overall Study|Transferred to Extension Study|0|||
156702148|NCT02132754|565655026|FG008|Overall Study|Transferred to Extension Study|0|||
156702149|NCT02132754|565655027|FG009|Overall Study|Transferred to Extension Study|0|||
156702150|NCT02132754|565655028|FG010|Overall Study|Transferred to Extension Study|0|||
156702151|NCT02132754|565655029|FG011|Overall Study|Transferred to Extension Study|0|||
156702152|NCT02132754|565655030|FG012|Overall Study|Transferred to Extension Study|0|||
156702153|NCT02132754|565655031|FG013|Overall Study|Transferred to Extension Study|0|||
156702154|NCT02132754|565655032|FG014|Overall Study|Transferred to Extension Study|0|||
156702155|NCT02132754|565655033|FG015|Overall Study|Transferred to Extension Study|0|||
156702156|NCT02132754|565655034|FG016|Overall Study|Transferred to Extension Study|0|||
156702157|NCT02132754|565655035|FG017|Overall Study|Transferred to Extension Study|0|||
156702158|NCT02132754|565655036|FG018|Overall Study|Transferred to Extension Study|0|||
156702159|NCT02132754|565655037|FG019|Overall Study|Transferred to Extension Study|0|||
156702160|NCT02132754|565655038|FG020|Overall Study|Transferred to Extension Study|0|||
156702161|NCT02132754|565655039|FG021|Overall Study|Transferred to Extension Study|0|||
156702162|NCT02132754|565655040|FG022|Overall Study|Transferred to Extension Study|0|||
156702163|NCT02132754|565655041|FG023|Overall Study|Transferred to Extension Study|0|||
156702164|NCT02132754|565655042|FG024|Overall Study|Transferred to Extension Study|0|||
156702165|NCT02132754|565655043|FG025|Overall Study|Transferred to Extension Study|0|||
156702166|NCT02132754|565655044|FG026|Overall Study|Transferred to Extension Study|0|||
156702167|NCT02132754|565655045|FG027|Overall Study|Transferred to Extension Study|0|||
156702168|NCT02132754|565655046|FG028|Overall Study|Transferred to Extension Study|0|||
156702169|NCT02132754|565655047|FG029|Overall Study|Transferred to Extension Study|0|||
156702170|NCT02132754|565655048|FG030|Overall Study|Transferred to Extension Study|0|||
156702171|NCT02132754|565655049|FG031|Overall Study|Transferred to Extension Study|0|||
156702172|NCT02132754|565655050|FG032|Overall Study|Transferred to Extension Study|0|||
156702173|NCT02132754|565655051|FG033|Overall Study|Transferred to Extension Study|6|||
156702174|NCT02132754|565655018|FG000|Overall Study|Withdrawal by Subject|0|||
156702175|NCT02132754|565655019|FG001|Overall Study|Withdrawal by Subject|0|||
156702176|NCT02132754|565655020|FG002|Overall Study|Withdrawal by Subject|0|||
156702177|NCT02132754|565655021|FG003|Overall Study|Withdrawal by Subject|0|||
156702178|NCT02132754|565655022|FG004|Overall Study|Withdrawal by Subject|0|||
156702179|NCT02132754|565655023|FG005|Overall Study|Withdrawal by Subject|0|||
156702180|NCT02132754|565655024|FG006|Overall Study|Withdrawal by Subject|0|||
156702181|NCT02132754|565655025|FG007|Overall Study|Withdrawal by Subject|0|||
156702182|NCT02132754|565655026|FG008|Overall Study|Withdrawal by Subject|0|||
156702183|NCT02132754|565655027|FG009|Overall Study|Withdrawal by Subject|1|||
156702184|NCT02132754|565655028|FG010|Overall Study|Withdrawal by Subject|0|||
156702185|NCT02132754|565655029|FG011|Overall Study|Withdrawal by Subject|0|||
156702186|NCT02132754|565655030|FG012|Overall Study|Withdrawal by Subject|1|||
156702187|NCT02132754|565655031|FG013|Overall Study|Withdrawal by Subject|0|||
156702188|NCT02132754|565655032|FG014|Overall Study|Withdrawal by Subject|1|||
156702189|NCT02132754|565655033|FG015|Overall Study|Withdrawal by Subject|2|||
156702190|NCT02132754|565655034|FG016|Overall Study|Withdrawal by Subject|1|||
156702191|NCT02132754|565655035|FG017|Overall Study|Withdrawal by Subject|0|||
156702192|NCT02132754|565655036|FG018|Overall Study|Withdrawal by Subject|0|||
156702193|NCT02132754|565655037|FG019|Overall Study|Withdrawal by Subject|0|||
156702194|NCT02132754|565655038|FG020|Overall Study|Withdrawal by Subject|1|||
156702195|NCT02132754|565655039|FG021|Overall Study|Withdrawal by Subject|0|||
156702196|NCT02132754|565655040|FG022|Overall Study|Withdrawal by Subject|0|||
156702197|NCT02132754|565655041|FG023|Overall Study|Withdrawal by Subject|0|||
156702198|NCT02132754|565655042|FG024|Overall Study|Withdrawal by Subject|1|||
156702199|NCT02132754|565655043|FG025|Overall Study|Withdrawal by Subject|0|||
156702200|NCT02132754|565655044|FG026|Overall Study|Withdrawal by Subject|0|||
156702201|NCT02132754|565655045|FG027|Overall Study|Withdrawal by Subject|1|||
156702202|NCT02132754|565655046|FG028|Overall Study|Withdrawal by Subject|0|||
156702203|NCT02132754|565655047|FG029|Overall Study|Withdrawal by Subject|0|||
156702204|NCT02132754|565655048|FG030|Overall Study|Withdrawal by Subject|0|||
156702205|NCT02132754|565655049|FG031|Overall Study|Withdrawal by Subject|1|||
156702206|NCT02132754|565655050|FG032|Overall Study|Withdrawal by Subject|0|||
156702207|NCT02132754|565655051|FG033|Overall Study|Withdrawal by Subject|2|||
156702208|NCT00390221|565655052|FG000|Overall Study|Lost to Follow-up|0|||
156702209|NCT00390221|565655053|FG001|Overall Study|Lost to Follow-up|3|||
156702210|NCT00390221|565655054|FG002|Overall Study|Lost to Follow-up|0|||
156702211|NCT00390221|565655052|FG000|Overall Study|Adverse Event|1|||
156702212|NCT00390221|565655053|FG001|Overall Study|Adverse Event|4|||
156702213|NCT00390221|565655054|FG002|Overall Study|Adverse Event|3|||
156702214|NCT00390221|565655052|FG000|Overall Study|Investigator Decision|0|||
156702215|NCT00390221|565655053|FG001|Overall Study|Investigator Decision|0|||
156702216|NCT00390221|565655054|FG002|Overall Study|Investigator Decision|1|||
156702217|NCT00390221|565655052|FG000|Overall Study|Withdrawal by Subject|13|||
156702218|NCT00390221|565655053|FG001|Overall Study|Withdrawal by Subject|9|||
156702219|NCT00390221|565655054|FG002|Overall Study|Withdrawal by Subject|7|||
156702220|NCT00390221|565655052|FG000|Overall Study|Subject Non-compliance|1|||
156702221|NCT00390221|565655053|FG001|Overall Study|Subject Non-compliance|0|||
156702222|NCT00390221|565655054|FG002|Overall Study|Subject Non-compliance|2|||
156702223|NCT00390221|565655052|FG000|Overall Study|Other|3|||
156702224|NCT00390221|565655053|FG001|Overall Study|Other|4|||
156702225|NCT00390221|565655054|FG002|Overall Study|Other|2|||
156702226|NCT00389831|565655061|FG000|Overall Study|Lack of Efficacy|0|||
156702227|NCT00389831|565655062|FG001|Overall Study|Lack of Efficacy|2|||
156702228|NCT00389831|565655061|FG000|Overall Study|Did not receive treatment.|0|||
156702229|NCT00389831|565655062|FG001|Overall Study|Did not receive treatment.|2|||
156702230|NCT00389831|565655061|FG000|Overall Study|Other reasons|0|||
156702231|NCT00389831|565655062|FG001|Overall Study|Other reasons|2|||
156702232|NCT00389831|565655061|FG000|Overall Study|Lost to Follow-up|0|||
156702233|NCT00389831|565655062|FG001|Overall Study|Lost to Follow-up|1|||
156702234|NCT02201290|565655063|FG000|Overall Study|Withdrawal by Subject|2|||
156702235|NCT02201290|565655063|FG000|Overall Study|Lack of Efficacy|2|||
156702236|NCT02201290|565655063|FG000|Overall Study|Adverse Event|1|||
156702237|NCT02370329|565656890|FG000|Overall Study|Alternate treatment|1|||
156702238|NCT02370329|565656890|FG000|Overall Study|Adverse Event|1|||
156702239|NCT02370329|565656890|FG000|Overall Study|Disease progression|3|||
156702240|NCT02370329|565656890|FG000|Overall Study|Physician Decision|2|||
156702241|NCT02370329|565656890|FG000|Overall Study|Study closure|4|||
156702242|NCT00112866|565656892|FG000|Overall Study|Protocol Violation|1|||
156702243|NCT00112866|565656893|FG001|Overall Study|Protocol Violation|0|||
156702244|NCT00112866|565656892|FG000|Overall Study|did not start treatment post-op|1|||
156702245|NCT00112866|565656893|FG001|Overall Study|did not start treatment post-op|2|||
156702246|NCT04663295|565656894|FG000|Run-in Period|Withdrawal by Subject|3|||
156702247|NCT04663295|565656894|FG000|Overall Study Period|Pregnancy|1|||
156702248|NCT04663295|565656894|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
156702249|NCT00699283|565656896|FG000|Overall Study|Lack of Efficacy|15|||
156702250|NCT00699283|565656897|FG001|Overall Study|Lack of Efficacy|5|||
156702251|NCT00699283|565656896|FG000|Overall Study|Lost to Follow-up|2|||
156702252|NCT00699283|565656897|FG001|Overall Study|Lost to Follow-up|0|||
156702253|NCT00699283|565656896|FG000|Overall Study|Withdrawal by Subject|1|||
156702254|NCT00699283|565656897|FG001|Overall Study|Withdrawal by Subject|0|||
156702255|NCT00699283|565656896|FG000|Overall Study|Other Reason|5|||
156702256|NCT00699283|565656897|FG001|Overall Study|Other Reason|1|||
156702257|NCT00699283|565656896|FG000|Overall Study|SAE, non-fatal|1|||
156702258|NCT00699283|565656897|FG001|Overall Study|SAE, non-fatal|1|||
156702259|NCT00699283|565656896|FG000|Overall Study|AE, non-serious non-fatal|8|||
156702260|NCT00699283|565656897|FG001|Overall Study|AE, non-serious non-fatal|1|||
156702261|NCT00699283|565656896|FG000|Overall Study|AE of unknown type|1|||
156702262|NCT00699283|565656897|FG001|Overall Study|AE of unknown type|0|||
156702263|NCT02771795|565656898|FG000|Overall Study|Withdrawal by Subject|47|||
156702264|NCT02771795|565656899|FG001|Overall Study|Withdrawal by Subject|37|||
156702265|NCT02771795|565656898|FG000|Overall Study|Termination by premature discontinuation of study|168|||
156702266|NCT02771795|565656899|FG001|Overall Study|Termination by premature discontinuation of study|185|||
156702267|NCT03317834|565656900|FG000|Overall Study|Death|2|||
156702268|NCT03317834|565656900|FG000|Overall Study|Device Revision|5|||
156702269|NCT03317834|565656900|FG000|Overall Study|Withdrawal by Subject|13|||
156702270|NCT03317834|565656900|FG000|Overall Study|Lost to Follow-up|13|||
156702271|NCT04228783|565656901|FG000|Overall Study|Adverse Event|1|||
156702272|NCT04228783|565656902|FG001|Overall Study|Adverse Event|0|||
156702273|NCT04228783|565656903|FG002|Overall Study|Adverse Event|2|||
156702274|NCT04228783|565656904|FG003|Overall Study|Adverse Event|0|||
156702275|NCT04228783|565656905|FG004|Overall Study|Adverse Event|0|||
156702276|NCT04228783|565656906|FG005|Overall Study|Adverse Event|1|||
156702277|NCT04228783|565656901|FG000|Overall Study|Death|0|||
156702278|NCT04228783|565656902|FG001|Overall Study|Death|0|||
156702279|NCT04228783|565656903|FG002|Overall Study|Death|0|||
156702280|NCT04228783|565656904|FG003|Overall Study|Death|0|||
156702281|NCT04228783|565656905|FG004|Overall Study|Death|1|||
156702282|NCT04228783|565656906|FG005|Overall Study|Death|0|||
156702283|NCT04228783|565656901|FG000|Overall Study|Lost to Follow-up|36|||
156702284|NCT04228783|565656902|FG001|Overall Study|Lost to Follow-up|36|||
156702285|NCT04228783|565656903|FG002|Overall Study|Lost to Follow-up|28|||
156702286|NCT04228783|565656904|FG003|Overall Study|Lost to Follow-up|6|||
156702287|NCT04228783|565656905|FG004|Overall Study|Lost to Follow-up|14|||
156702288|NCT04228783|565656906|FG005|Overall Study|Lost to Follow-up|3|||
156702289|NCT04228783|565656901|FG000|Overall Study|Physician Decision|1|||
156702290|NCT04228783|565656902|FG001|Overall Study|Physician Decision|2|||
156702291|NCT04228783|565656903|FG002|Overall Study|Physician Decision|0|||
156702292|NCT04228783|565656904|FG003|Overall Study|Physician Decision|0|||
156702293|NCT04228783|565656905|FG004|Overall Study|Physician Decision|0|||
156702294|NCT04228783|565656906|FG005|Overall Study|Physician Decision|0|||
156702295|NCT04228783|565656901|FG000|Overall Study|Protocol Violation|0|||
156702296|NCT04228783|565656902|FG001|Overall Study|Protocol Violation|0|||
156702297|NCT04228783|565656903|FG002|Overall Study|Protocol Violation|0|||
156702298|NCT04228783|565656904|FG003|Overall Study|Protocol Violation|1|||
156702299|NCT04228783|565656905|FG004|Overall Study|Protocol Violation|0|||
156702300|NCT04228783|565656906|FG005|Overall Study|Protocol Violation|0|||
156872118|NCT02858362|566289507|FG000|Overall Study|Lost to Follow-up|1|||
156702301|NCT04228783|565656901|FG000|Overall Study|Withdrawal by Subject|6|||
156702302|NCT04228783|565656902|FG001|Overall Study|Withdrawal by Subject|10|||
156702303|NCT04228783|565656903|FG002|Overall Study|Withdrawal by Subject|19|||
156702304|NCT04228783|565656904|FG003|Overall Study|Withdrawal by Subject|1|||
156702305|NCT04228783|565656905|FG004|Overall Study|Withdrawal by Subject|2|||
156702306|NCT04228783|565656906|FG005|Overall Study|Withdrawal by Subject|0|||
156702307|NCT04228783|565656901|FG000|Overall Study|Other|4|||
156702308|NCT04228783|565656902|FG001|Overall Study|Other|3|||
156702309|NCT04228783|565656903|FG002|Overall Study|Other|2|||
156702310|NCT04228783|565656904|FG003|Overall Study|Other|1|||
156702311|NCT04228783|565656905|FG004|Overall Study|Other|0|||
156702312|NCT04228783|565656906|FG005|Overall Study|Other|0|||
156702313|NCT03151811|565656912|FG000|Overall Study|Randomized But Not Treated|18|||
156702314|NCT03151811|565656913|FG001|Overall Study|Randomized But Not Treated|3|||
156702315|NCT03151811|565656912|FG000|Overall Study|Progressive Disease|130|||
156702316|NCT03151811|565656913|FG001|Overall Study|Progressive Disease|170|||
156702317|NCT03151811|565656912|FG000|Overall Study|Adverse Event|49|||
156702318|NCT03151811|565656913|FG001|Overall Study|Adverse Event|40|||
156702319|NCT03151811|565656912|FG000|Overall Study|Lack of Efficacy|6|||
156702320|NCT03151811|565656913|FG001|Overall Study|Lack of Efficacy|8|||
156702321|NCT03151811|565656912|FG000|Overall Study|Physician Decision|21|||
156702322|NCT03151811|565656913|FG001|Overall Study|Physician Decision|9|||
156702323|NCT03151811|565656912|FG000|Overall Study|Withdrawal by Subject|17|||
156702324|NCT03151811|565656913|FG001|Overall Study|Withdrawal by Subject|7|||
156702325|NCT03151811|565656912|FG000|Overall Study|Lost to Follow-up|0|||
156702326|NCT03151811|565656913|FG001|Overall Study|Lost to Follow-up|1|||
156702327|NCT03151811|565656912|FG000|Overall Study|Study Terminated by Sponsor|5|||
156702328|NCT03151811|565656913|FG001|Overall Study|Study Terminated by Sponsor|11|||
156702329|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
156702330|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
156702331|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
156702332|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
156702333|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
156702334|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
156702335|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
156702336|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
156702337|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
156702338|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
156702339|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Death|1|||
156702340|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Death|0|||
156702341|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Death|0|||
156702342|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Death|0|||
156702343|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Death|0|||
156702344|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
157124134|NCT03529773|567206196|FG006|Overall Study|Adverse Event|0|||
157124135|NCT03529773|567206197|FG007|Overall Study|Adverse Event|0|||
157124136|NCT03529773|567206198|FG008|Overall Study|Adverse Event|0|||
157124137|NCT03529773|567206199|FG009|Overall Study|Adverse Event|0|||
157124138|NCT03529773|567206200|FG010|Overall Study|Adverse Event|0|||
157124139|NCT03529773|567206201|FG011|Overall Study|Adverse Event|0|||
157124140|NCT03529773|567206202|FG012|Overall Study|Adverse Event|0|||
157124141|NCT03529773|567206203|FG013|Overall Study|Adverse Event|0|||
157124142|NCT03529773|567206204|FG014|Overall Study|Adverse Event|0|||
157124143|NCT03529773|567206205|FG015|Overall Study|Adverse Event|0|||
157124144|NCT03529773|567206206|FG016|Overall Study|Adverse Event|0|||
157124145|NCT03529773|567206207|FG017|Overall Study|Adverse Event|0|||
157124146|NCT03529773|567206208|FG018|Overall Study|Adverse Event|0|||
157124147|NCT03529773|567206209|FG019|Overall Study|Adverse Event|0|||
157124148|NCT03529773|567206210|FG020|Overall Study|Adverse Event|0|||
157124149|NCT03529773|567206211|FG021|Overall Study|Adverse Event|0|||
157124150|NCT03529773|567206212|FG022|Overall Study|Adverse Event|0|||
157124151|NCT03529773|567206213|FG023|Overall Study|Adverse Event|0|||
157124152|NCT03529773|567206214|FG024|Overall Study|Adverse Event|0|||
156702345|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
156702346|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
156702347|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
156702348|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
156702349|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702350|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
157124153|NCT03529773|567206215|FG025|Overall Study|Adverse Event|0|||
157124154|NCT03529773|567206216|FG026|Overall Study|Adverse Event|0|||
157124155|NCT03529773|567206217|FG027|Overall Study|Adverse Event|0|||
156702351|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702352|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
156702353|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
156702354|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
157124156|NCT03529773|567206218|FG028|Overall Study|Adverse Event|0|||
157124157|NCT03529773|567206219|FG029|Overall Study|Adverse Event|0|||
157124158|NCT03529773|567206220|FG030|Overall Study|Adverse Event|1|||
156702355|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156702356|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
156702357|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156702358|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
156702359|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
156702360|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
156702361|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
156702362|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
156702363|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156790982|NCT05069415|565987111|FG000|Overall Study|Adverse Event|2|||
157015420|NCT05756075|566808789|FG001|Overall Study|Withdrawal by Subject|9|||
157015421|NCT03913195|566808790|FG000|Overall Study|Adverse Event|0|||
157015422|NCT03913195|566808791|FG001|Overall Study|Adverse Event|0|||
157015423|NCT03913195|566808792|FG002|Overall Study|Adverse Event|1|||
157015424|NCT03913195|566808793|FG003|Overall Study|Adverse Event|1|||
157015425|NCT03913195|566808794|FG004|Overall Study|Adverse Event|0|||
157015426|NCT03913195|566808790|FG000|Overall Study|Withdrawal by Subject|0|||
157015427|NCT03913195|566808791|FG001|Overall Study|Withdrawal by Subject|0|||
157015428|NCT03913195|566808792|FG002|Overall Study|Withdrawal by Subject|1|||
157015429|NCT03913195|566808793|FG003|Overall Study|Withdrawal by Subject|0|||
157015430|NCT03913195|566808794|FG004|Overall Study|Withdrawal by Subject|1|||
157015431|NCT03913195|566808790|FG000|Overall Study|non adherence to study|0|||
157015432|NCT03913195|566808791|FG001|Overall Study|non adherence to study|0|||
157015433|NCT03913195|566808792|FG002|Overall Study|non adherence to study|1|||
157015434|NCT03913195|566808793|FG003|Overall Study|non adherence to study|0|||
157015435|NCT03913195|566808794|FG004|Overall Study|non adherence to study|0|||
157015436|NCT02837510|566808795|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
157124159|NCT03529773|567206221|FG031|Overall Study|Adverse Event|0|||
157124160|NCT03529773|567206222|FG032|Overall Study|Adverse Event|0|||
157124161|NCT03529773|567206223|FG033|Overall Study|Adverse Event|0|||
157124162|NCT03529773|567206224|FG034|Overall Study|Adverse Event|0|||
157124163|NCT03529773|567206225|FG035|Overall Study|Adverse Event|1|||
157124164|NCT03529773|567206226|FG036|Overall Study|Adverse Event|0|||
157124165|NCT03529773|567206227|FG037|Overall Study|Adverse Event|0|||
157124166|NCT03529773|567206228|FG038|Overall Study|Adverse Event|1|||
157124167|NCT03529773|567206229|FG039|Overall Study|Adverse Event|1|||
157124168|NCT03529773|567206190|FG000|Overall Study|Death|0|||
157124169|NCT03529773|567206191|FG001|Overall Study|Death|0|||
157124170|NCT03529773|567206192|FG002|Overall Study|Death|0|||
157124171|NCT03529773|567206193|FG003|Overall Study|Death|0|||
157124172|NCT03529773|567206194|FG004|Overall Study|Death|0|||
157124173|NCT03529773|567206195|FG005|Overall Study|Death|0|||
157124174|NCT03529773|567206196|FG006|Overall Study|Death|0|||
157124175|NCT03529773|567206197|FG007|Overall Study|Death|0|||
157124176|NCT03529773|567206198|FG008|Overall Study|Death|0|||
157124177|NCT03529773|567206199|FG009|Overall Study|Death|0|||
157124178|NCT03529773|567206200|FG010|Overall Study|Death|0|||
157124179|NCT03529773|567206201|FG011|Overall Study|Death|0|||
157124180|NCT03529773|567206202|FG012|Overall Study|Death|1|||
157124181|NCT03529773|567206203|FG013|Overall Study|Death|0|||
157124182|NCT03529773|567206204|FG014|Overall Study|Death|0|||
157124183|NCT03529773|567206205|FG015|Overall Study|Death|0|||
157124184|NCT03529773|567206206|FG016|Overall Study|Death|0|||
157124185|NCT03529773|567206207|FG017|Overall Study|Death|0|||
157124186|NCT03529773|567206208|FG018|Overall Study|Death|0|||
157124187|NCT03529773|567206209|FG019|Overall Study|Death|1|||
157124188|NCT03529773|567206210|FG020|Overall Study|Death|0|||
157124189|NCT03529773|567206211|FG021|Overall Study|Death|0|||
157124190|NCT03529773|567206212|FG022|Overall Study|Death|1|||
157124191|NCT03529773|567206213|FG023|Overall Study|Death|0|||
157124192|NCT03529773|567206214|FG024|Overall Study|Death|0|||
157124193|NCT03529773|567206215|FG025|Overall Study|Death|0|||
157124194|NCT03529773|567206216|FG026|Overall Study|Death|0|||
157124195|NCT03529773|567206217|FG027|Overall Study|Death|0|||
157124196|NCT03529773|567206218|FG028|Overall Study|Death|0|||
157124197|NCT03529773|567206219|FG029|Overall Study|Death|0|||
157124198|NCT03529773|567206220|FG030|Overall Study|Death|0|||
157124199|NCT03529773|567206221|FG031|Overall Study|Death|0|||
157124200|NCT03529773|567206222|FG032|Overall Study|Death|0|||
157124201|NCT03529773|567206223|FG033|Overall Study|Death|1|||
157124202|NCT03529773|567206224|FG034|Overall Study|Death|1|||
157124203|NCT03529773|567206225|FG035|Overall Study|Death|0|||
157124204|NCT03529773|567206226|FG036|Overall Study|Death|1|||
157124205|NCT03529773|567206227|FG037|Overall Study|Death|0|||
157124206|NCT03529773|567206228|FG038|Overall Study|Death|0|||
157124207|NCT03529773|567206229|FG039|Overall Study|Death|0|||
157124208|NCT03529773|567206190|FG000|Overall Study|Lost to Follow-up|0|||
157124209|NCT03529773|567206191|FG001|Overall Study|Lost to Follow-up|0|||
157124210|NCT03529773|567206192|FG002|Overall Study|Lost to Follow-up|1|||
157124211|NCT03529773|567206193|FG003|Overall Study|Lost to Follow-up|0|||
157124212|NCT03529773|567206194|FG004|Overall Study|Lost to Follow-up|1|||
157124213|NCT03529773|567206195|FG005|Overall Study|Lost to Follow-up|1|||
157124214|NCT03529773|567206196|FG006|Overall Study|Lost to Follow-up|0|||
157124215|NCT03529773|567206197|FG007|Overall Study|Lost to Follow-up|0|||
157124216|NCT03529773|567206198|FG008|Overall Study|Lost to Follow-up|0|||
157124217|NCT03529773|567206199|FG009|Overall Study|Lost to Follow-up|0|||
157124218|NCT03529773|567206200|FG010|Overall Study|Lost to Follow-up|0|||
157124219|NCT03529773|567206201|FG011|Overall Study|Lost to Follow-up|0|||
157124220|NCT03529773|567206202|FG012|Overall Study|Lost to Follow-up|0|||
157124221|NCT03529773|567206203|FG013|Overall Study|Lost to Follow-up|1|||
157124222|NCT03529773|567206204|FG014|Overall Study|Lost to Follow-up|4|||
157124223|NCT03529773|567206205|FG015|Overall Study|Lost to Follow-up|1|||
157124224|NCT03529773|567206206|FG016|Overall Study|Lost to Follow-up|1|||
157124225|NCT03529773|567206207|FG017|Overall Study|Lost to Follow-up|0|||
157124226|NCT03529773|567206208|FG018|Overall Study|Lost to Follow-up|1|||
157124227|NCT03529773|567206209|FG019|Overall Study|Lost to Follow-up|1|||
157124228|NCT03529773|567206210|FG020|Overall Study|Lost to Follow-up|2|||
157124229|NCT03529773|567206211|FG021|Overall Study|Lost to Follow-up|4|||
157215084|NCT00623623|567535749|FG001|Overall Study|Previous enrolment into this study|1|||
156702364|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156702365|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702366|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702367|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156872119|NCT02858362|566289508|FG001|Overall Study|Lost to Follow-up|0|||
157015437|NCT02837510|566808796|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
157015438|NCT02837510|566808795|FG000|Washout (2 Weeks)|Adverse Event|0|||
157015439|NCT02837510|566808796|FG001|Washout (2 Weeks)|Adverse Event|1|||
157015440|NCT02837510|566808795|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
157015441|NCT02837510|566808796|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
157015442|NCT02837510|566808795|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
157015443|NCT02837510|566808796|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
157015444|NCT02837510|566808795|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
157015445|NCT02837510|566808796|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
157015446|NCT02837510|566808795|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
157015447|NCT02837510|566808796|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
157015448|NCT05107401|566808799|FG000|Overall Study|Lost to Follow-up|13|||
157015449|NCT05107401|566808800|FG001|Overall Study|Lost to Follow-up|12|||
157015450|NCT03857620|566808812|FG000|Overall Study|Death|4|||
157015451|NCT03857620|566808813|FG001|Overall Study|Death|5|||
157015452|NCT03857620|566808814|FG002|Overall Study|Death|7|||
157015453|NCT03857620|566808812|FG000|Overall Study|Lost to Follow-up|2|||
157015454|NCT03857620|566808813|FG001|Overall Study|Lost to Follow-up|5|||
157015455|NCT03857620|566808814|FG002|Overall Study|Lost to Follow-up|3|||
157015456|NCT03857620|566808812|FG000|Overall Study|Disease progression or relapse after study registration|1|||
157015457|NCT03857620|566808813|FG001|Overall Study|Disease progression or relapse after study registration|5|||
157015458|NCT03857620|566808814|FG002|Overall Study|Disease progression or relapse after study registration|1|||
157015459|NCT03857620|566808812|FG000|Overall Study|Ineligible|5|||
157015460|NCT03857620|566808813|FG001|Overall Study|Ineligible|0|||
157015461|NCT03857620|566808814|FG002|Overall Study|Ineligible|2|||
157015462|NCT03857620|566808812|FG000|Overall Study|No malignancy|1|||
157015463|NCT03857620|566808813|FG001|Overall Study|No malignancy|0|||
157015464|NCT03857620|566808814|FG002|Overall Study|No malignancy|1|||
157015465|NCT03857620|566808812|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
157015466|NCT03857620|566808813|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
157015467|NCT03857620|566808814|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
157015468|NCT03857620|566808812|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
157015469|NCT03857620|566808813|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
157015470|NCT03857620|566808814|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
157015471|NCT03857620|566808812|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
157015472|NCT03857620|566808813|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
157015473|NCT03857620|566808814|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
157015474|NCT03857620|566808812|FG000|Overall Study|Surgery not performed, patient decision|0|||
157015475|NCT03857620|566808813|FG001|Overall Study|Surgery not performed, patient decision|3|||
157015476|NCT03857620|566808814|FG002|Overall Study|Surgery not performed, patient decision|1|||
157015477|NCT03857620|566808812|FG000|Overall Study|Surgery not performed, other reason|3|||
157015478|NCT03857620|566808813|FG001|Overall Study|Surgery not performed, other reason|1|||
157015479|NCT03857620|566808814|FG002|Overall Study|Surgery not performed, other reason|4|||
157015480|NCT03857620|566808812|FG000|Overall Study|Worsening performance status after surgery performed|0|||
157015481|NCT03857620|566808813|FG001|Overall Study|Worsening performance status after surgery performed|1|||
157015482|NCT03857620|566808814|FG002|Overall Study|Worsening performance status after surgery performed|1|||
157124230|NCT03529773|567206212|FG022|Overall Study|Lost to Follow-up|3|||
157124231|NCT03529773|567206213|FG023|Overall Study|Lost to Follow-up|4|||
157124232|NCT03529773|567206214|FG024|Overall Study|Lost to Follow-up|3|||
156702368|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
156702369|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Other|4|||
156702370|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Other|4|||
156702371|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Other|3|||
156702372|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Other|1|||
156702373|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Other|0|||
156702374|NCT01081834|565656920|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
156702375|NCT01081834|565656921|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
156702376|NCT01081834|565656922|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156702377|NCT01081834|565656923|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
156702378|NCT01081834|565656924|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
157124233|NCT03529773|567206215|FG025|Overall Study|Lost to Follow-up|5|||
157124234|NCT03529773|567206216|FG026|Overall Study|Lost to Follow-up|5|||
157124235|NCT03529773|567206217|FG027|Overall Study|Lost to Follow-up|0|||
157124236|NCT03529773|567206218|FG028|Overall Study|Lost to Follow-up|0|||
156702379|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156702380|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702381|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702382|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702383|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
156702384|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Death|1|||
156702385|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Death|0|||
156702386|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156702387|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Death|0|||
156790983|NCT05069415|565987112|FG001|Overall Study|Adverse Event|0|||
156790984|NCT00101400|565987113|FG000|Survival Follow-Up|Alive|7|||
156790985|NCT03160573|565987114|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
156790986|NCT03160573|565987115|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
157124237|NCT03529773|567206219|FG029|Overall Study|Lost to Follow-up|0|||
157124238|NCT03529773|567206220|FG030|Overall Study|Lost to Follow-up|1|||
157124239|NCT03529773|567206221|FG031|Overall Study|Lost to Follow-up|0|||
157215085|NCT00693784|567535751|FG000|Overall Study|Lost to Follow-up|2|||
157215086|NCT00693784|567535751|FG000|Overall Study|Withdrawal by Subject|2|||
157215087|NCT02265952|567535752|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
157215088|NCT02265952|567535753|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
157215089|NCT02265952|567535752|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
157215090|NCT02265952|567535753|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
157215091|NCT00326885|567535757|FG000|Overall Study|Adverse Event|1|||
157215092|NCT00326885|567535757|FG000|Overall Study|Withdrawal by Subject|3|||
157215093|NCT00326885|567535757|FG000|Overall Study|Physician Decision|1|||
157215094|NCT00326885|567535757|FG000|Overall Study|Hospice withdrew consent|2|||
157215095|NCT03870997|567535770|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
157215096|NCT03870997|567535771|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
157215097|NCT03870997|567535772|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
157215098|NCT03870997|567535773|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
157215099|NCT03870997|567535774|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
157215100|NCT03870997|567535775|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
157215101|NCT03726437|567535776|FG000|Overall Study|Lost to Follow-up|85|||
157215102|NCT03726437|567535777|FG001|Overall Study|Lost to Follow-up|76|||
157215103|NCT00267007|567535778|FG000|Overall Study|Withdrawal by Subject|6|||
157215104|NCT00267007|567535779|FG001|Overall Study|Withdrawal by Subject|0|||
157215105|NCT00267007|567535778|FG000|Overall Study|Lost to Follow-up|1|||
157215106|NCT00267007|567535779|FG001|Overall Study|Lost to Follow-up|0|||
157215107|NCT00267007|567535778|FG000|Overall Study|Non-compliance|0|||
157215108|NCT00267007|567535779|FG001|Overall Study|Non-compliance|1|||
157215109|NCT00267007|567535778|FG000|Overall Study|Adverse Event|1|||
157215110|NCT00267007|567535779|FG001|Overall Study|Adverse Event|0|||
157215111|NCT04133519|567535785|FG000|Overall Study|Withdrawal by Subject|5|||
157215112|NCT04133519|567535786|FG001|Overall Study|Withdrawal by Subject|4|||
157215113|NCT04133519|567535785|FG000|Overall Study|Protocol Violation|0|||
157215114|NCT04133519|567535786|FG001|Overall Study|Protocol Violation|1|||
157215115|NCT04133519|567535785|FG000|Overall Study|Never started treatment|1|||
157215116|NCT04133519|567535786|FG001|Overall Study|Never started treatment|1|||
157215117|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215118|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215119|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215120|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
157215121|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215122|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215123|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157124240|NCT03529773|567206222|FG032|Overall Study|Lost to Follow-up|0|||
156702388|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Death|0|||
156702389|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
156702390|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
156702391|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702392|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702393|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156702394|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702395|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156702396|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702397|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702398|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156702399|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
157215124|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215125|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215126|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
157215127|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157215128|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Adverse Event|1|||
157215129|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Adverse Event|1|||
157215130|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Adverse Event|1|||
157215131|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Adverse Event|1|||
157215132|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Adverse Event|1|||
157215133|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Adverse Event|0|||
157215134|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Adverse Event|0|||
157215135|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Adverse Event|0|||
157215136|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Adverse Event|0|||
157215137|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
157215138|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
157215139|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
157215140|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
157215141|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
157215142|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
157215143|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
156702400|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
156702401|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702402|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702403|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
156702404|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156702405|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702406|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156702407|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702408|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156702409|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
156702410|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
156702411|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702412|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702413|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
156702414|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Other|4|||
156702415|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Other|5|||
156702416|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Other|4|||
156702417|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Other|0|||
156702418|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Other|0|||
156702419|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
156702420|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
156702421|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702422|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702423|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
156702424|NCT01081834|565656920|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702425|NCT01081834|565656921|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
156702426|NCT01081834|565656922|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702427|NCT01081834|565656923|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702428|NCT01081834|565656924|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
156702429|NCT00742924|565656927|FG000|Overall Study|Adverse Event|0|||
157215144|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
157215145|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
157124241|NCT03529773|567206223|FG033|Overall Study|Lost to Follow-up|1|||
157124242|NCT03529773|567206224|FG034|Overall Study|Lost to Follow-up|1|||
157124243|NCT03529773|567206225|FG035|Overall Study|Lost to Follow-up|0|||
157124244|NCT03529773|567206226|FG036|Overall Study|Lost to Follow-up|0|||
157124245|NCT03529773|567206227|FG037|Overall Study|Lost to Follow-up|3|||
157124246|NCT03529773|567206228|FG038|Overall Study|Lost to Follow-up|1|||
157124247|NCT03529773|567206229|FG039|Overall Study|Lost to Follow-up|1|||
157124248|NCT03529773|567206190|FG000|Overall Study|No longer meets eligibility criteria|0|||
157124249|NCT03529773|567206191|FG001|Overall Study|No longer meets eligibility criteria|0|||
157124250|NCT03529773|567206192|FG002|Overall Study|No longer meets eligibility criteria|0|||
157124251|NCT03529773|567206193|FG003|Overall Study|No longer meets eligibility criteria|0|||
157124252|NCT03529773|567206194|FG004|Overall Study|No longer meets eligibility criteria|0|||
157124253|NCT03529773|567206195|FG005|Overall Study|No longer meets eligibility criteria|0|||
157124254|NCT03529773|567206196|FG006|Overall Study|No longer meets eligibility criteria|0|||
157124255|NCT03529773|567206197|FG007|Overall Study|No longer meets eligibility criteria|0|||
157124256|NCT03529773|567206198|FG008|Overall Study|No longer meets eligibility criteria|0|||
157124257|NCT03529773|567206199|FG009|Overall Study|No longer meets eligibility criteria|0|||
157124258|NCT03529773|567206200|FG010|Overall Study|No longer meets eligibility criteria|0|||
157124259|NCT03529773|567206201|FG011|Overall Study|No longer meets eligibility criteria|0|||
157124260|NCT03529773|567206202|FG012|Overall Study|No longer meets eligibility criteria|0|||
157124261|NCT03529773|567206203|FG013|Overall Study|No longer meets eligibility criteria|0|||
157124262|NCT03529773|567206204|FG014|Overall Study|No longer meets eligibility criteria|0|||
157124263|NCT03529773|567206205|FG015|Overall Study|No longer meets eligibility criteria|0|||
157124264|NCT03529773|567206206|FG016|Overall Study|No longer meets eligibility criteria|0|||
157124265|NCT03529773|567206207|FG017|Overall Study|No longer meets eligibility criteria|0|||
156702430|NCT00742924|565656928|FG001|Overall Study|Adverse Event|0|||
156702431|NCT00742924|565656929|FG002|Overall Study|Adverse Event|1|||
156702432|NCT00742924|565656930|FG003|Overall Study|Adverse Event|1|||
156702433|NCT00742924|565656927|FG000|Overall Study|Lack of Efficacy|5|||
156702434|NCT00742924|565656928|FG001|Overall Study|Lack of Efficacy|1|||
156702435|NCT00742924|565656929|FG002|Overall Study|Lack of Efficacy|2|||
156702436|NCT00742924|565656930|FG003|Overall Study|Lack of Efficacy|4|||
156702437|NCT00742924|565656927|FG000|Overall Study|Physician Decision|0|||
156702438|NCT00742924|565656928|FG001|Overall Study|Physician Decision|0|||
156702439|NCT00742924|565656929|FG002|Overall Study|Physician Decision|0|||
157124266|NCT03529773|567206208|FG018|Overall Study|No longer meets eligibility criteria|0|||
156702440|NCT00742924|565656930|FG003|Overall Study|Physician Decision|1|||
156702441|NCT00742924|565656927|FG000|Overall Study|Withdrawal by Subject|0|||
156702442|NCT00742924|565656928|FG001|Overall Study|Withdrawal by Subject|1|||
156702443|NCT00742924|565656929|FG002|Overall Study|Withdrawal by Subject|1|||
156702444|NCT00742924|565656930|FG003|Overall Study|Withdrawal by Subject|0|||
156702445|NCT00660400|565656931|FG000|Overall Study|Lack of insurance approval|1|||
156702446|NCT00660400|565656931|FG000|Overall Study|Suboptimal organ function|1|||
156702447|NCT00660400|565656931|FG000|Overall Study|Intracranial hemorrhage|1|||
156702448|NCT00660400|565656931|FG000|Overall Study|Withdrawal by Subject|1|||
156702449|NCT01161407|565656932|FG000|Overall Study|Protocol Violation|3|||
156702450|NCT01161407|565656933|FG001|Overall Study|Protocol Violation|1|||
156702451|NCT01777620|565656934|FG000|Overall Study|Subject Withdrawal|1|||
156702452|NCT01777620|565656935|FG001|Overall Study|Subject Withdrawal|0|||
156702453|NCT04562155|565656936|FG000|Overall Study|COVID-19 pandemic|0|||
156702454|NCT04562155|565656937|FG001|Overall Study|COVID-19 pandemic|0|||
157124267|NCT03529773|567206209|FG019|Overall Study|No longer meets eligibility criteria|0|||
157124268|NCT03529773|567206210|FG020|Overall Study|No longer meets eligibility criteria|0|||
157124269|NCT03529773|567206211|FG021|Overall Study|No longer meets eligibility criteria|0|||
157124270|NCT03529773|567206212|FG022|Overall Study|No longer meets eligibility criteria|1|||
157124271|NCT03529773|567206213|FG023|Overall Study|No longer meets eligibility criteria|0|||
157124272|NCT03529773|567206214|FG024|Overall Study|No longer meets eligibility criteria|0|||
157124273|NCT03529773|567206215|FG025|Overall Study|No longer meets eligibility criteria|0|||
157124274|NCT03529773|567206216|FG026|Overall Study|No longer meets eligibility criteria|0|||
157124275|NCT03529773|567206217|FG027|Overall Study|No longer meets eligibility criteria|0|||
157124276|NCT03529773|567206218|FG028|Overall Study|No longer meets eligibility criteria|0|||
157124277|NCT03529773|567206219|FG029|Overall Study|No longer meets eligibility criteria|0|||
157124278|NCT03529773|567206220|FG030|Overall Study|No longer meets eligibility criteria|0|||
156702455|NCT04562155|565656938|FG002|Overall Study|COVID-19 pandemic|0|||
156702456|NCT04562155|565656939|FG003|Overall Study|COVID-19 pandemic|1|||
156702457|NCT04562155|565656936|FG000|Overall Study|Adverse Event|7|||
157124279|NCT03529773|567206221|FG031|Overall Study|No longer meets eligibility criteria|0|||
157124280|NCT03529773|567206222|FG032|Overall Study|No longer meets eligibility criteria|0|||
156702458|NCT04562155|565656937|FG001|Overall Study|Adverse Event|3|||
156702459|NCT04562155|565656938|FG002|Overall Study|Adverse Event|8|||
156702460|NCT04562155|565656939|FG003|Overall Study|Adverse Event|1|||
156702461|NCT04562155|565656936|FG000|Overall Study|Withdrawal by Subject|3|||
156702462|NCT04562155|565656937|FG001|Overall Study|Withdrawal by Subject|6|||
156702463|NCT04562155|565656938|FG002|Overall Study|Withdrawal by Subject|3|||
156702464|NCT04562155|565656939|FG003|Overall Study|Withdrawal by Subject|3|||
157215146|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
157215147|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
157215148|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156702465|NCT04562155|565656936|FG000|Overall Study|Participant personal reason|1|||
156702466|NCT04562155|565656937|FG001|Overall Study|Participant personal reason|0|||
156702467|NCT04562155|565656938|FG002|Overall Study|Participant personal reason|2|||
156702468|NCT04562155|565656939|FG003|Overall Study|Participant personal reason|1|||
156702469|NCT00936897|565656948|FG000|Overall Study|Withdrawal by Subject|9|||
156702470|NCT00936897|565656949|FG001|Overall Study|Withdrawal by Subject|19|||
156702471|NCT00936897|565656948|FG000|Overall Study|Adverse Event|4|||
156702472|NCT00936897|565656949|FG001|Overall Study|Adverse Event|13|||
156702473|NCT00936897|565656948|FG000|Overall Study|Other|3|||
156702474|NCT00936897|565656949|FG001|Overall Study|Other|9|||
156702475|NCT00936897|565656948|FG000|Overall Study|Lost to Follow-up|1|||
156702476|NCT00936897|565656949|FG001|Overall Study|Lost to Follow-up|10|||
156702477|NCT00936897|565656948|FG000|Overall Study|Administrative Decision|1|||
156702478|NCT00936897|565656949|FG001|Overall Study|Administrative Decision|2|||
156702479|NCT00936897|565656948|FG000|Overall Study|Protocol Violation|1|||
156702480|NCT00936897|565656949|FG001|Overall Study|Protocol Violation|1|||
156702481|NCT00936897|565656948|FG000|Overall Study|Ineligibility Determined|0|||
156702482|NCT00936897|565656949|FG001|Overall Study|Ineligibility Determined|3|||
156702483|NCT00936897|565656948|FG000|Overall Study|Noncompliance|0|||
156702484|NCT00936897|565656949|FG001|Overall Study|Noncompliance|2|||
156702485|NCT00936897|565656948|FG000|Overall Study|Death|0|||
156702486|NCT00936897|565656949|FG001|Overall Study|Death|1|||
156702487|NCT01844856|565656953|FG000|Overall Study|Lost to Follow-up|15|||
156702488|NCT01844856|565656954|FG001|Overall Study|Lost to Follow-up|3|||
156702489|NCT01844856|565656953|FG000|Overall Study|Adverse Event|3|||
156702490|NCT01844856|565656954|FG001|Overall Study|Adverse Event|6|||
156872120|NCT02858362|566289509|FG002|Overall Study|Lost to Follow-up|0|||
156872121|NCT02194985|566289511|FG000|Overall Study|Adverse Event|1|||
156702491|NCT01844856|565656953|FG000|Overall Study|Withdrawal by Subject|3|||
156702492|NCT01844856|565656954|FG001|Overall Study|Withdrawal by Subject|2|||
156702493|NCT01844856|565656953|FG000|Overall Study|Noncompliance|2|||
156702494|NCT01844856|565656954|FG001|Overall Study|Noncompliance|3|||
156702495|NCT01844856|565656953|FG000|Overall Study|Enterococcus Resistant|0|||
156702496|NCT01844856|565656954|FG001|Overall Study|Enterococcus Resistant|1|||
156702497|NCT01844856|565656953|FG000|Overall Study|Inadvertently Not Scheduled|1|||
156702498|NCT01844856|565656954|FG001|Overall Study|Inadvertently Not Scheduled|0|||
156702499|NCT01844856|565656953|FG000|Overall Study|Randomized but was a Screen Failure|0|||
156702500|NCT01844856|565656954|FG001|Overall Study|Randomized but was a Screen Failure|1|||
156702501|NCT01001988|565656955|FG000|Overall Study|Protocol Violation|84|||
156702502|NCT01001988|565656955|FG000|Overall Study|Withdrawal by Subject|18|||
156702503|NCT01001988|565656955|FG000|Overall Study|Lost to Follow-up|15|||
156702504|NCT01221363|565656956|FG000|Overall Study|Pregnancy|1|||
156702505|NCT01221363|565656957|FG001|Overall Study|Pregnancy|0|||
156702506|NCT01221363|565656956|FG000|Overall Study|Withdrawal by Subject|11|||
156702507|NCT01221363|565656957|FG001|Overall Study|Withdrawal by Subject|5|||
156702508|NCT04628793|565656958|FG000|Overall Study|Study terminated by sponsor|0|||
156702509|NCT04628793|565656959|FG001|Overall Study|Study terminated by sponsor|0|||
156702510|NCT04628793|565656960|FG002|Overall Study|Study terminated by sponsor|8|||
156702511|NCT04628793|565656958|FG000|Overall Study|Withdrawal by Subject|2|||
157015483|NCT04118452|566808815|FG000|Overall Study|Lost to Follow-up|5|||
157015484|NCT04118452|566808816|FG001|Overall Study|Lost to Follow-up|5|||
157015485|NCT04118452|566808815|FG000|Overall Study|Withdrawal by Subject|17|||
157015486|NCT04118452|566808816|FG001|Overall Study|Withdrawal by Subject|17|||
157015487|NCT05215847|566808817|FG000|Overall Study|Lost to Follow-up|1|||
157015488|NCT03433339|566808818|FG000|Overall Study|Lost to Follow-up|2|||
157015489|NCT03433339|566808819|FG001|Overall Study|Lost to Follow-up|0|||
157015490|NCT03433339|566808818|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
157015491|NCT03433339|566808819|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
157015492|NCT03433339|566808818|FG000|Overall Study|Withdrawal by Subject|0|||
157015493|NCT03433339|566808819|FG001|Overall Study|Withdrawal by Subject|2|||
157015494|NCT05952076|566808821|FG000|Overall Study|Death|1|||
157015495|NCT05952076|566808822|FG001|Overall Study|Death|1|||
157015496|NCT05952076|566808821|FG000|Overall Study|Lost to Follow-up|0|||
157015497|NCT05952076|566808822|FG001|Overall Study|Lost to Follow-up|1|||
157015498|NCT04143061|566808823|FG000|Overall Study|Protocol Deviation|0|||
157015499|NCT04143061|566808824|FG001|Overall Study|Protocol Deviation|0|||
157015500|NCT04143061|566808825|FG002|Overall Study|Protocol Deviation|0|||
157015501|NCT04143061|566808826|FG003|Overall Study|Protocol Deviation|0|||
157015502|NCT04143061|566808827|FG004|Overall Study|Protocol Deviation|0|||
157015503|NCT04143061|566808828|FG005|Overall Study|Protocol Deviation|0|||
157015504|NCT04143061|566808829|FG006|Overall Study|Protocol Deviation|5|||
157215149|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
156790987|NCT03160573|565987116|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
157124281|NCT03529773|567206223|FG033|Overall Study|No longer meets eligibility criteria|0|||
157124282|NCT03529773|567206224|FG034|Overall Study|No longer meets eligibility criteria|0|||
157124283|NCT03529773|567206225|FG035|Overall Study|No longer meets eligibility criteria|0|||
157124284|NCT03529773|567206226|FG036|Overall Study|No longer meets eligibility criteria|0|||
157124285|NCT03529773|567206227|FG037|Overall Study|No longer meets eligibility criteria|0|||
157124286|NCT03529773|567206228|FG038|Overall Study|No longer meets eligibility criteria|1|||
157124287|NCT03529773|567206229|FG039|Overall Study|No longer meets eligibility criteria|0|||
157124288|NCT03529773|567206190|FG000|Overall Study|Other|0|||
157124289|NCT03529773|567206191|FG001|Overall Study|Other|0|||
157124290|NCT03529773|567206192|FG002|Overall Study|Other|0|||
157124291|NCT03529773|567206193|FG003|Overall Study|Other|0|||
157124292|NCT03529773|567206194|FG004|Overall Study|Other|0|||
157124293|NCT03529773|567206195|FG005|Overall Study|Other|0|||
157124294|NCT03529773|567206196|FG006|Overall Study|Other|0|||
157124295|NCT03529773|567206197|FG007|Overall Study|Other|0|||
157124296|NCT03529773|567206198|FG008|Overall Study|Other|0|||
157124297|NCT03529773|567206199|FG009|Overall Study|Other|0|||
157124298|NCT03529773|567206200|FG010|Overall Study|Other|0|||
157124299|NCT03529773|567206201|FG011|Overall Study|Other|0|||
157124300|NCT03529773|567206202|FG012|Overall Study|Other|1|||
157124301|NCT03529773|567206203|FG013|Overall Study|Other|0|||
157124302|NCT03529773|567206204|FG014|Overall Study|Other|2|||
157124303|NCT03529773|567206205|FG015|Overall Study|Other|0|||
157124304|NCT03529773|567206206|FG016|Overall Study|Other|0|||
157124305|NCT03529773|567206207|FG017|Overall Study|Other|3|||
157124306|NCT03529773|567206208|FG018|Overall Study|Other|0|||
157124307|NCT03529773|567206209|FG019|Overall Study|Other|0|||
157124308|NCT03529773|567206210|FG020|Overall Study|Other|1|||
157124309|NCT03529773|567206211|FG021|Overall Study|Other|0|||
157124310|NCT03529773|567206212|FG022|Overall Study|Other|1|||
157124311|NCT03529773|567206213|FG023|Overall Study|Other|0|||
157124312|NCT03529773|567206214|FG024|Overall Study|Other|3|||
157124313|NCT03529773|567206215|FG025|Overall Study|Other|2|||
157124314|NCT03529773|567206216|FG026|Overall Study|Other|2|||
157124315|NCT03529773|567206217|FG027|Overall Study|Other|0|||
157124316|NCT03529773|567206218|FG028|Overall Study|Other|0|||
157124317|NCT03529773|567206219|FG029|Overall Study|Other|0|||
157124318|NCT03529773|567206220|FG030|Overall Study|Other|0|||
157124319|NCT03529773|567206221|FG031|Overall Study|Other|0|||
157124320|NCT03529773|567206222|FG032|Overall Study|Other|0|||
157124321|NCT03529773|567206223|FG033|Overall Study|Other|0|||
157124322|NCT03529773|567206224|FG034|Overall Study|Other|1|||
157124323|NCT03529773|567206225|FG035|Overall Study|Other|1|||
157124324|NCT03529773|567206226|FG036|Overall Study|Other|0|||
157124325|NCT03529773|567206227|FG037|Overall Study|Other|0|||
157215150|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
157215151|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
157215152|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
157215153|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
157215154|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
156702512|NCT04628793|565656959|FG001|Overall Study|Withdrawal by Subject|3|||
156702513|NCT04628793|565656960|FG002|Overall Study|Withdrawal by Subject|0|||
156702514|NCT04628793|565656958|FG000|Overall Study|Lost to Follow-up|0|||
156702515|NCT04628793|565656959|FG001|Overall Study|Lost to Follow-up|1|||
156702516|NCT04628793|565656960|FG002|Overall Study|Lost to Follow-up|0|||
156702517|NCT01329549|565656969|FG000|Overall Study|Withdrawal by Subject|1|||
156702518|NCT01329549|565656969|FG000|Overall Study|Adverse Event|1|||
156702519|NCT03597529|565656972|FG000|Overall Study|Lost to Follow-up|10|||
156702520|NCT03597529|565656973|FG001|Overall Study|Lost to Follow-up|12|||
156702521|NCT03597529|565656972|FG000|Overall Study|Physician Decision|3|||
156702522|NCT03597529|565656973|FG001|Overall Study|Physician Decision|1|||
156790988|NCT03160573|565987117|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
156790989|NCT00382863|565987122|FG000|Overall Study|Death|9|||
156790990|NCT00382863|565987123|FG001|Overall Study|Death|9|||
157124326|NCT03529773|567206228|FG038|Overall Study|Other|0|||
157124327|NCT03529773|567206229|FG039|Overall Study|Other|0|||
157124328|NCT03529773|567206190|FG000|Overall Study|Physician Decision|0|||
157124329|NCT03529773|567206191|FG001|Overall Study|Physician Decision|0|||
157124330|NCT03529773|567206192|FG002|Overall Study|Physician Decision|0|||
157124331|NCT03529773|567206193|FG003|Overall Study|Physician Decision|0|||
157124332|NCT03529773|567206194|FG004|Overall Study|Physician Decision|0|||
157124333|NCT03529773|567206195|FG005|Overall Study|Physician Decision|0|||
157124334|NCT03529773|567206196|FG006|Overall Study|Physician Decision|0|||
157215155|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
156702523|NCT03597529|565656972|FG000|Overall Study|Withdrawal by Subject|6|||
157124335|NCT03529773|567206197|FG007|Overall Study|Physician Decision|0|||
157124336|NCT03529773|567206198|FG008|Overall Study|Physician Decision|0|||
157124337|NCT03529773|567206199|FG009|Overall Study|Physician Decision|0|||
157124338|NCT03529773|567206200|FG010|Overall Study|Physician Decision|0|||
157124339|NCT03529773|567206201|FG011|Overall Study|Physician Decision|0|||
157124340|NCT03529773|567206202|FG012|Overall Study|Physician Decision|0|||
157124341|NCT03529773|567206203|FG013|Overall Study|Physician Decision|0|||
157124342|NCT03529773|567206204|FG014|Overall Study|Physician Decision|0|||
157124343|NCT03529773|567206205|FG015|Overall Study|Physician Decision|0|||
157124344|NCT03529773|567206206|FG016|Overall Study|Physician Decision|0|||
157124345|NCT03529773|567206207|FG017|Overall Study|Physician Decision|0|||
157124346|NCT03529773|567206208|FG018|Overall Study|Physician Decision|0|||
157124347|NCT03529773|567206209|FG019|Overall Study|Physician Decision|1|||
157124348|NCT03529773|567206210|FG020|Overall Study|Physician Decision|1|||
157124349|NCT03529773|567206211|FG021|Overall Study|Physician Decision|0|||
157124350|NCT03529773|567206212|FG022|Overall Study|Physician Decision|0|||
157124351|NCT03529773|567206213|FG023|Overall Study|Physician Decision|0|||
157124352|NCT03529773|567206214|FG024|Overall Study|Physician Decision|0|||
157124353|NCT03529773|567206215|FG025|Overall Study|Physician Decision|0|||
157124354|NCT03529773|567206216|FG026|Overall Study|Physician Decision|0|||
157124355|NCT03529773|567206217|FG027|Overall Study|Physician Decision|0|||
157124356|NCT03529773|567206218|FG028|Overall Study|Physician Decision|0|||
157124357|NCT03529773|567206219|FG029|Overall Study|Physician Decision|0|||
157124358|NCT03529773|567206220|FG030|Overall Study|Physician Decision|0|||
157124359|NCT03529773|567206221|FG031|Overall Study|Physician Decision|0|||
156702524|NCT03597529|565656973|FG001|Overall Study|Withdrawal by Subject|3|||
156702525|NCT03597529|565656972|FG000|Overall Study|Non-compliant with study activities|1|||
156702526|NCT03597529|565656973|FG001|Overall Study|Non-compliant with study activities|2|||
156702527|NCT01755767|565656976|FG000|Overall Study|Progressive Disease|8|||
156702528|NCT01755767|565656977|FG001|Overall Study|Progressive Disease|7|||
156702529|NCT01755767|565656978|FG002|Overall Study|Progressive Disease|91|||
156702530|NCT01755767|565656979|FG003|Overall Study|Progressive Disease|43|||
156702531|NCT01755767|565656976|FG000|Overall Study|Clinical Disease Progression|4|||
156702532|NCT01755767|565656977|FG001|Overall Study|Clinical Disease Progression|2|||
156702533|NCT01755767|565656978|FG002|Overall Study|Clinical Disease Progression|29|||
156702534|NCT01755767|565656979|FG003|Overall Study|Clinical Disease Progression|20|||
156702535|NCT01755767|565656976|FG000|Overall Study|Radiographic Disease Progression|9|||
156702536|NCT01755767|565656977|FG001|Overall Study|Radiographic Disease Progression|4|||
156702537|NCT01755767|565656978|FG002|Overall Study|Radiographic Disease Progression|44|||
156702538|NCT01755767|565656979|FG003|Overall Study|Radiographic Disease Progression|27|||
156702539|NCT01755767|565656976|FG000|Overall Study|Adverse Event|6|||
156702540|NCT01755767|565656977|FG001|Overall Study|Adverse Event|0|||
156702541|NCT01755767|565656978|FG002|Overall Study|Adverse Event|28|||
156702542|NCT01755767|565656979|FG003|Overall Study|Adverse Event|11|||
156702543|NCT01755767|565656976|FG000|Overall Study|Death|1|||
156702544|NCT01755767|565656977|FG001|Overall Study|Death|2|||
156702545|NCT01755767|565656978|FG002|Overall Study|Death|15|||
156702546|NCT01755767|565656979|FG003|Overall Study|Death|4|||
156702547|NCT01755767|565656976|FG000|Overall Study|Subject Decision|0|||
156702548|NCT01755767|565656977|FG001|Overall Study|Subject Decision|0|||
156702549|NCT01755767|565656978|FG002|Overall Study|Subject Decision|10|||
156702550|NCT01755767|565656979|FG003|Overall Study|Subject Decision|3|||
156702551|NCT01755767|565656976|FG000|Overall Study|Withdrawal by Subject|0|||
156702552|NCT01755767|565656977|FG001|Overall Study|Withdrawal by Subject|0|||
156702553|NCT01755767|565656978|FG002|Overall Study|Withdrawal by Subject|2|||
156702554|NCT01755767|565656979|FG003|Overall Study|Withdrawal by Subject|1|||
156702555|NCT01755767|565656976|FG000|Overall Study|Other|0|||
156702556|NCT01755767|565656977|FG001|Overall Study|Other|0|||
156702557|NCT01755767|565656978|FG002|Overall Study|Other|2|||
156702558|NCT01755767|565656979|FG003|Overall Study|Other|3|||
156702559|NCT01755767|565656976|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
156702560|NCT01755767|565656977|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
156702561|NCT01755767|565656978|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
156702562|NCT01755767|565656979|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
157124360|NCT03529773|567206222|FG032|Overall Study|Physician Decision|0|||
157124361|NCT03529773|567206223|FG033|Overall Study|Physician Decision|0|||
157124362|NCT03529773|567206224|FG034|Overall Study|Physician Decision|0|||
156702563|NCT04623086|565656980|FG000|Overall Study|Withdrawal by Subject|0|||
156702564|NCT04623086|565656981|FG001|Overall Study|Withdrawal by Subject|0|||
157124363|NCT03529773|567206225|FG035|Overall Study|Physician Decision|0|||
157124364|NCT03529773|567206226|FG036|Overall Study|Physician Decision|0|||
157124365|NCT03529773|567206227|FG037|Overall Study|Physician Decision|0|||
157124366|NCT03529773|567206228|FG038|Overall Study|Physician Decision|0|||
156702565|NCT04623086|565656982|FG002|Overall Study|Withdrawal by Subject|10|||
156702566|NCT03464630|565656983|FG000|Overall Study|Lost to Follow-up|62|||
156702567|NCT03464630|565656984|FG001|Overall Study|Lost to Follow-up|52|||
156702568|NCT03464630|565656983|FG000|Overall Study|Withdrawal by Subject|16|||
156702569|NCT03464630|565656984|FG001|Overall Study|Withdrawal by Subject|10|||
156702570|NCT03464630|565656983|FG000|Overall Study|Passive Disengagement|8|||
156702571|NCT03464630|565656984|FG001|Overall Study|Passive Disengagement|4|||
156702572|NCT00191165|565656985|FG000|Overall Study|Adverse Event|2|||
156702573|NCT00191165|565656986|FG001|Overall Study|Adverse Event|0|||
157124367|NCT03529773|567206229|FG039|Overall Study|Physician Decision|0|||
156702574|NCT00191165|565656985|FG000|Overall Study|Protocol Violation|0|||
156702575|NCT00191165|565656986|FG001|Overall Study|Protocol Violation|1|||
156702576|NCT00191165|565656985|FG000|Overall Study|Participant Moved Away|0|||
156702577|NCT00191165|565656986|FG001|Overall Study|Participant Moved Away|1|||
156702578|NCT00715624|565656987|FG000|Overall Study|Adverse Event|12|||
156702579|NCT00715624|565656988|FG001|Overall Study|Adverse Event|37|||
156702580|NCT00715624|565656987|FG000|Overall Study|Lack of Efficacy|11|||
156702581|NCT00715624|565656988|FG001|Overall Study|Lack of Efficacy|11|||
156702582|NCT00715624|565656987|FG000|Overall Study|Lost to Follow-up|1|||
156702583|NCT00715624|565656988|FG001|Overall Study|Lost to Follow-up|2|||
156702584|NCT00715624|565656987|FG000|Overall Study|Protocol Violation|1|||
156702585|NCT00715624|565656988|FG001|Overall Study|Protocol Violation|0|||
156702586|NCT00715624|565656987|FG000|Overall Study|Withdrawal by Subject|11|||
156702587|NCT00715624|565656988|FG001|Overall Study|Withdrawal by Subject|25|||
156702588|NCT00715624|565656987|FG000|Overall Study|Familial and personal reasons|10|||
156702589|NCT00715624|565656988|FG001|Overall Study|Familial and personal reasons|22|||
156702590|NCT00715624|565656987|FG000|Overall Study|Poor compliance|6|||
156702591|NCT00715624|565656988|FG001|Overall Study|Poor compliance|13|||
156702592|NCT00715624|565656987|FG000|Overall Study|Sponsor decision|0|||
156702593|NCT00715624|565656988|FG001|Overall Study|Sponsor decision|4|||
156702594|NCT00715624|565656987|FG000|Overall Study|Incorrect randomization (not treated)|0|||
156702595|NCT00715624|565656988|FG001|Overall Study|Incorrect randomization (not treated)|1|||
156702596|NCT00715624|565656987|FG000|Overall Study|Other|0|||
156702597|NCT00715624|565656988|FG001|Overall Study|Other|1|||
156702598|NCT03200912|565656989|FG000|Overall Study|Adverse Event|3|||
156702599|NCT03200912|565656990|FG001|Overall Study|Adverse Event|0|||
156702600|NCT03200912|565656991|FG002|Overall Study|Adverse Event|0|||
156702601|NCT03200912|565656989|FG000|Overall Study|Withdrawal by Subject|1|||
156702602|NCT03200912|565656990|FG001|Overall Study|Withdrawal by Subject|2|||
156702603|NCT03200912|565656991|FG002|Overall Study|Withdrawal by Subject|4|||
156702604|NCT03200912|565656989|FG000|Overall Study|Non-compliance with study drug|0|||
156702605|NCT03200912|565656990|FG001|Overall Study|Non-compliance with study drug|1|||
156702606|NCT03200912|565656991|FG002|Overall Study|Non-compliance with study drug|0|||
156702607|NCT03196635|565656994|FG000|Overall Study|Withdrawal by Subject|1|||
156702608|NCT00229723|565656995|FG000|Concomitant Phase|Adverse Event|4|||
156702609|NCT00229723|565656996|FG001|Concomitant Phase|Adverse Event|2|||
156702610|NCT00229723|565656997|FG002|Concomitant Phase|Adverse Event|5|||
156702611|NCT00229723|565656998|FG003|Concomitant Phase|Adverse Event|2|||
156702612|NCT00229723|565656999|FG004|Concomitant Phase|Adverse Event|0|||
156702613|NCT00229723|565657000|FG005|Concomitant Phase|Adverse Event|1|||
156702614|NCT00229723|565657001|FG006|Concomitant Phase|Adverse Event|2|||
156702615|NCT00229723|565656995|FG000|Concomitant Phase|Objective disease progression|0|||
156702616|NCT00229723|565656996|FG001|Concomitant Phase|Objective disease progression|0|||
156702617|NCT00229723|565656997|FG002|Concomitant Phase|Objective disease progression|0|||
156702618|NCT00229723|565656998|FG003|Concomitant Phase|Objective disease progression|0|||
156702619|NCT00229723|565656999|FG004|Concomitant Phase|Objective disease progression|0|||
156702620|NCT00229723|565657000|FG005|Concomitant Phase|Objective disease progression|0|||
156702621|NCT00229723|565657001|FG006|Concomitant Phase|Objective disease progression|0|||
156702622|NCT00229723|565656995|FG000|Concomitant Phase|Clinical progression|0|||
156702623|NCT00229723|565656996|FG001|Concomitant Phase|Clinical progression|0|||
156872122|NCT02194985|566289511|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
156702624|NCT00229723|565656997|FG002|Concomitant Phase|Clinical progression|0|||
156702625|NCT00229723|565656998|FG003|Concomitant Phase|Clinical progression|0|||
156702626|NCT00229723|565656999|FG004|Concomitant Phase|Clinical progression|0|||
156702627|NCT00229723|565657000|FG005|Concomitant Phase|Clinical progression|0|||
156702628|NCT00229723|565657001|FG006|Concomitant Phase|Clinical progression|1|||
156702629|NCT00229723|565656995|FG000|Concomitant Phase|Lost to Follow-up|0|||
156702630|NCT00229723|565656996|FG001|Concomitant Phase|Lost to Follow-up|0|||
156702631|NCT00229723|565656997|FG002|Concomitant Phase|Lost to Follow-up|0|||
156702632|NCT00229723|565656998|FG003|Concomitant Phase|Lost to Follow-up|0|||
156702633|NCT00229723|565656999|FG004|Concomitant Phase|Lost to Follow-up|1|||
156702634|NCT00229723|565657000|FG005|Concomitant Phase|Lost to Follow-up|0|||
156702635|NCT00229723|565657001|FG006|Concomitant Phase|Lost to Follow-up|0|||
156872123|NCT02194985|566289511|FG000|Overall Study|Physician Decision|4|||
156872124|NCT02194985|566289511|FG000|Overall Study|Lost to Follow-up|1|||
157124368|NCT03529773|567206190|FG000|Overall Study|Protocol Violation|0|||
157124369|NCT03529773|567206191|FG001|Overall Study|Protocol Violation|0|||
157124370|NCT03529773|567206192|FG002|Overall Study|Protocol Violation|0|||
157124371|NCT03529773|567206193|FG003|Overall Study|Protocol Violation|0|||
157124372|NCT03529773|567206194|FG004|Overall Study|Protocol Violation|0|||
157124373|NCT03529773|567206195|FG005|Overall Study|Protocol Violation|0|||
157124374|NCT03529773|567206196|FG006|Overall Study|Protocol Violation|0|||
157124375|NCT03529773|567206197|FG007|Overall Study|Protocol Violation|0|||
157124376|NCT03529773|567206198|FG008|Overall Study|Protocol Violation|0|||
157124377|NCT03529773|567206199|FG009|Overall Study|Protocol Violation|0|||
157124378|NCT03529773|567206200|FG010|Overall Study|Protocol Violation|0|||
157124379|NCT03529773|567206201|FG011|Overall Study|Protocol Violation|0|||
156702636|NCT00229723|565656995|FG000|Concomitant Phase|Informed consent withdrawn|3|||
156702637|NCT00229723|565656996|FG001|Concomitant Phase|Informed consent withdrawn|2|||
156702638|NCT00229723|565656997|FG002|Concomitant Phase|Informed consent withdrawn|0|||
156702639|NCT00229723|565656998|FG003|Concomitant Phase|Informed consent withdrawn|2|||
156702640|NCT00229723|565656999|FG004|Concomitant Phase|Informed consent withdrawn|0|||
156702641|NCT00229723|565657000|FG005|Concomitant Phase|Informed consent withdrawn|0|||
156702642|NCT00229723|565657001|FG006|Concomitant Phase|Informed consent withdrawn|0|||
156702643|NCT00229723|565656995|FG000|Concomitant Phase|Severe non-compliance|0|||
156702644|NCT00229723|565656996|FG001|Concomitant Phase|Severe non-compliance|1|||
156702645|NCT00229723|565656997|FG002|Concomitant Phase|Severe non-compliance|0|||
156702646|NCT00229723|565656998|FG003|Concomitant Phase|Severe non-compliance|0|||
156702647|NCT00229723|565656999|FG004|Concomitant Phase|Severe non-compliance|1|||
156702648|NCT00229723|565657000|FG005|Concomitant Phase|Severe non-compliance|0|||
156702649|NCT00229723|565657001|FG006|Concomitant Phase|Severe non-compliance|0|||
156702650|NCT00229723|565656995|FG000|Concomitant Phase|Other|3|||
156702651|NCT00229723|565656996|FG001|Concomitant Phase|Other|0|||
156702652|NCT00229723|565656997|FG002|Concomitant Phase|Other|1|||
156702653|NCT00229723|565656998|FG003|Concomitant Phase|Other|1|||
156702654|NCT00229723|565656999|FG004|Concomitant Phase|Other|0|||
156702655|NCT00229723|565657000|FG005|Concomitant Phase|Other|2|||
156702656|NCT00229723|565657001|FG006|Concomitant Phase|Other|0|||
156702657|NCT00229723|565656995|FG000|Maintenance Phase|Adverse Event|7|||
156702658|NCT00229723|565656996|FG001|Maintenance Phase|Adverse Event|2|||
156702659|NCT00229723|565656997|FG002|Maintenance Phase|Adverse Event|1|||
156702660|NCT00229723|565656998|FG003|Maintenance Phase|Adverse Event|4|||
156702661|NCT00229723|565656999|FG004|Maintenance Phase|Adverse Event|7|||
156702662|NCT00229723|565657000|FG005|Maintenance Phase|Adverse Event|5|||
156702663|NCT00229723|565657001|FG006|Maintenance Phase|Adverse Event|2|||
156702664|NCT00229723|565656995|FG000|Maintenance Phase|Objective disease progression|5|||
156702665|NCT00229723|565656996|FG001|Maintenance Phase|Objective disease progression|5|||
156702666|NCT00229723|565656997|FG002|Maintenance Phase|Objective disease progression|3|||
156702667|NCT00229723|565656998|FG003|Maintenance Phase|Objective disease progression|6|||
156702668|NCT00229723|565656999|FG004|Maintenance Phase|Objective disease progression|2|||
156702669|NCT00229723|565657000|FG005|Maintenance Phase|Objective disease progression|9|||
156702670|NCT00229723|565657001|FG006|Maintenance Phase|Objective disease progression|5|||
156702671|NCT00229723|565656995|FG000|Maintenance Phase|Clinical progression|4|||
156702672|NCT00229723|565656996|FG001|Maintenance Phase|Clinical progression|1|||
156702673|NCT00229723|565656997|FG002|Maintenance Phase|Clinical progression|2|||
156702674|NCT00229723|565656998|FG003|Maintenance Phase|Clinical progression|2|||
156702675|NCT00229723|565656999|FG004|Maintenance Phase|Clinical progression|1|||
156702676|NCT00229723|565657000|FG005|Maintenance Phase|Clinical progression|1|||
156702677|NCT00229723|565657001|FG006|Maintenance Phase|Clinical progression|1|||
156702678|NCT00229723|565656995|FG000|Maintenance Phase|Lost to Follow-up|0|||
156702679|NCT00229723|565656996|FG001|Maintenance Phase|Lost to Follow-up|1|||
156702680|NCT00229723|565656997|FG002|Maintenance Phase|Lost to Follow-up|2|||
156702681|NCT00229723|565656998|FG003|Maintenance Phase|Lost to Follow-up|2|||
156702682|NCT00229723|565656999|FG004|Maintenance Phase|Lost to Follow-up|0|||
156702683|NCT00229723|565657000|FG005|Maintenance Phase|Lost to Follow-up|0|||
156702684|NCT00229723|565657001|FG006|Maintenance Phase|Lost to Follow-up|1|||
156702685|NCT00229723|565656995|FG000|Maintenance Phase|Informed consent withdrawn|1|||
156702686|NCT00229723|565656996|FG001|Maintenance Phase|Informed consent withdrawn|0|||
156702687|NCT00229723|565656997|FG002|Maintenance Phase|Informed consent withdrawn|0|||
156702688|NCT00229723|565656998|FG003|Maintenance Phase|Informed consent withdrawn|1|||
156702689|NCT00229723|565656999|FG004|Maintenance Phase|Informed consent withdrawn|1|||
156702690|NCT00229723|565657000|FG005|Maintenance Phase|Informed consent withdrawn|1|||
156702691|NCT00229723|565657001|FG006|Maintenance Phase|Informed consent withdrawn|0|||
156702692|NCT00229723|565656995|FG000|Maintenance Phase|Severe non-compliance|3|||
156702693|NCT00229723|565656996|FG001|Maintenance Phase|Severe non-compliance|1|||
156702694|NCT00229723|565656997|FG002|Maintenance Phase|Severe non-compliance|0|||
156702695|NCT00229723|565656998|FG003|Maintenance Phase|Severe non-compliance|0|||
156702696|NCT00229723|565656999|FG004|Maintenance Phase|Severe non-compliance|1|||
156702697|NCT00229723|565657000|FG005|Maintenance Phase|Severe non-compliance|0|||
156702698|NCT00229723|565657001|FG006|Maintenance Phase|Severe non-compliance|0|||
157015505|NCT04143061|566808830|FG007|Overall Study|Protocol Deviation|5|||
156702699|NCT00229723|565656995|FG000|Maintenance Phase|Other|5|||
156702700|NCT00229723|565656996|FG001|Maintenance Phase|Other|4|||
156702701|NCT00229723|565656997|FG002|Maintenance Phase|Other|1|||
156702702|NCT00229723|565656998|FG003|Maintenance Phase|Other|2|||
156702703|NCT00229723|565656999|FG004|Maintenance Phase|Other|3|||
156702704|NCT00229723|565657000|FG005|Maintenance Phase|Other|3|||
156702705|NCT00229723|565657001|FG006|Maintenance Phase|Other|1|||
157015506|NCT04143061|566808823|FG000|Overall Study|Withdrawal by Subject|2|||
156702706|NCT00998309|565657002|FG000|Overall Study|Protocol Violation|4|||
156702707|NCT00735397|565657006|FG000|Overall Study|Adverse Event|194|||
156702708|NCT00735397|565657006|FG000|Overall Study|Lost to Follow-up|33|||
157015507|NCT04143061|566808824|FG001|Overall Study|Withdrawal by Subject|0|||
156790991|NCT00382863|565987122|FG000|Overall Study|Lost to Follow-up|1|||
156790992|NCT00382863|565987123|FG001|Overall Study|Lost to Follow-up|2|||
156790993|NCT00382863|565987122|FG000|Overall Study|Withdrawal by Subject|5|||
156790994|NCT00382863|565987123|FG001|Overall Study|Withdrawal by Subject|25|||
156790995|NCT03400787|565987124|FG000|Overall Study|Lost to Follow-up|1|||
156790996|NCT03400787|565987125|FG001|Overall Study|Lost to Follow-up|0|||
156790997|NCT03400787|565987124|FG000|Overall Study|Death|1|||
156790998|NCT03400787|565987125|FG001|Overall Study|Death|0|||
156790999|NCT03400787|565987124|FG000|Overall Study|Protocol Violation|0|||
156791000|NCT03400787|565987125|FG001|Overall Study|Protocol Violation|2|||
156791001|NCT03400787|565987124|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
156791002|NCT03400787|565987125|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
156791003|NCT02595437|565987128|FG000|Triferic Via IV|Withdrawal by Subject|1|||
156791004|NCT02094885|565987129|FG000|Overall Study|Death|1|||
156791005|NCT02094885|565987130|FG001|Overall Study|Death|5|||
156791006|NCT02094885|565987129|FG000|Overall Study|Withdrawn due to age|1|||
156791007|NCT02094885|565987130|FG001|Overall Study|Withdrawn due to age|0|||
156791008|NCT02003898|565987131|FG000|Overall Study|Death|3|||
156791009|NCT02003898|565987131|FG000|Overall Study|Lost to Follow-up|12|||
156791010|NCT02003898|565987131|FG000|Overall Study|Withdrawal by Subject|52|||
156791011|NCT05166902|565987132|FG000|First Intervention|Lost to Follow-up|0|||
156791012|NCT05166902|565987133|FG001|First Intervention|Lost to Follow-up|1|||
156791013|NCT01903720|565987134|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
156791014|NCT01903720|565987134|FG000|Overall Study|Adverse Event|1|||
156791015|NCT01903720|565987134|FG000|Overall Study|Rescinding of informed consent|2|||
156872125|NCT02194985|566289511|FG000|Overall Study|Withdrawal by Subject|2|||
156872126|NCT02561832|566289514|FG000|Overall Study|Withdrawal by Subject|1|||
156872127|NCT02561832|566289515|FG001|Overall Study|Withdrawal by Subject|1|||
156872128|NCT02561832|566289514|FG000|Overall Study|Adverse Event|3|||
156872129|NCT02561832|566289515|FG001|Overall Study|Adverse Event|0|||
157015508|NCT04143061|566808825|FG002|Overall Study|Withdrawal by Subject|0|||
157015509|NCT04143061|566808826|FG003|Overall Study|Withdrawal by Subject|0|||
156791016|NCT01903720|565987134|FG000|Overall Study|Lost to Follow-up|2|||
156791017|NCT01903720|565987134|FG000|Overall Study|Treatment with alternative drug|1|||
156872130|NCT02561832|566289514|FG000|Overall Study|Disease progression|3|||
156872131|NCT02561832|566289515|FG001|Overall Study|Disease progression|3|||
157015510|NCT04143061|566808827|FG004|Overall Study|Withdrawal by Subject|0|||
157015511|NCT04143061|566808828|FG005|Overall Study|Withdrawal by Subject|1|||
157015512|NCT04143061|566808829|FG006|Overall Study|Withdrawal by Subject|0|||
157015513|NCT04143061|566808830|FG007|Overall Study|Withdrawal by Subject|0|||
157015514|NCT04143061|566808823|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157015515|NCT04143061|566808824|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157015516|NCT04143061|566808825|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157015517|NCT04143061|566808826|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
157015518|NCT04143061|566808827|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
157015519|NCT04143061|566808828|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
157015520|NCT04143061|566808829|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
157015521|NCT04143061|566808830|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
157015522|NCT03055858|566808834|FG000|Overall Study|Death|9|||
157015523|NCT03055858|566808834|FG000|Overall Study|Withdrawal by Subject|11|||
157015524|NCT03055858|566808834|FG000|Overall Study|Lost to Follow-up|6|||
157015525|NCT03055858|566808834|FG000|Overall Study|Missed Follow-Up Visits|18|||
157015526|NCT04048681|566808850|FG000|Overall Study|family emergency|0|||
157015527|NCT04048681|566808851|FG001|Overall Study|family emergency|0|||
157015528|NCT04048681|566808852|FG002|Overall Study|family emergency|0|||
157015529|NCT04048681|566808853|FG003|Overall Study|family emergency|1|||
157015530|NCT04048681|566808854|FG004|Overall Study|family emergency|0|||
157015531|NCT04452318|566808869|FG000|Overall Study|Physician Decision|1|||
157015532|NCT04452318|566808870|FG001|Overall Study|Physician Decision|2|||
157015533|NCT04452318|566808871|FG002|Overall Study|Physician Decision|0|||
157015534|NCT04452318|566808872|FG003|Overall Study|Physician Decision|2|||
157015535|NCT04452318|566808873|FG004|Overall Study|Physician Decision|0|||
157015536|NCT04452318|566808874|FG005|Overall Study|Physician Decision|2|||
157015537|NCT04452318|566808875|FG006|Overall Study|Physician Decision|5|||
157015538|NCT04452318|566808869|FG000|Overall Study|Death|2|||
157015539|NCT04452318|566808870|FG001|Overall Study|Death|3|||
157015540|NCT04452318|566808871|FG002|Overall Study|Death|0|||
157015541|NCT04452318|566808872|FG003|Overall Study|Death|0|||
157015542|NCT04452318|566808873|FG004|Overall Study|Death|0|||
157015543|NCT04452318|566808874|FG005|Overall Study|Death|0|||
157015544|NCT04452318|566808875|FG006|Overall Study|Death|0|||
157015545|NCT04452318|566808869|FG000|Overall Study|Lost to Follow-up|38|||
157015546|NCT04452318|566808870|FG001|Overall Study|Lost to Follow-up|28|||
157015547|NCT04452318|566808871|FG002|Overall Study|Lost to Follow-up|0|||
157015548|NCT04452318|566808872|FG003|Overall Study|Lost to Follow-up|3|||
157015549|NCT04452318|566808873|FG004|Overall Study|Lost to Follow-up|3|||
157015550|NCT04452318|566808874|FG005|Overall Study|Lost to Follow-up|2|||
157015551|NCT04452318|566808875|FG006|Overall Study|Lost to Follow-up|1|||
157124380|NCT03529773|567206202|FG012|Overall Study|Protocol Violation|0|||
157124381|NCT03529773|567206203|FG013|Overall Study|Protocol Violation|0|||
157124382|NCT03529773|567206204|FG014|Overall Study|Protocol Violation|0|||
157124383|NCT03529773|567206205|FG015|Overall Study|Protocol Violation|0|||
157124384|NCT03529773|567206206|FG016|Overall Study|Protocol Violation|0|||
157124385|NCT03529773|567206207|FG017|Overall Study|Protocol Violation|0|||
157215156|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
157215157|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
157215158|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
157215159|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215160|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215161|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215162|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215163|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215164|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
157215165|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215166|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
157215167|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215168|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215169|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215170|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215171|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
157215172|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
157215173|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215174|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215175|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157215176|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
157124386|NCT03529773|567206208|FG018|Overall Study|Protocol Violation|0|||
157124387|NCT03529773|567206209|FG019|Overall Study|Protocol Violation|0|||
157124388|NCT03529773|567206210|FG020|Overall Study|Protocol Violation|0|||
157124389|NCT03529773|567206211|FG021|Overall Study|Protocol Violation|0|||
157124390|NCT03529773|567206212|FG022|Overall Study|Protocol Violation|0|||
157124391|NCT03529773|567206213|FG023|Overall Study|Protocol Violation|0|||
157124392|NCT03529773|567206214|FG024|Overall Study|Protocol Violation|0|||
157124393|NCT03529773|567206215|FG025|Overall Study|Protocol Violation|0|||
157124394|NCT03529773|567206216|FG026|Overall Study|Protocol Violation|0|||
157124395|NCT03529773|567206217|FG027|Overall Study|Protocol Violation|0|||
157124396|NCT03529773|567206218|FG028|Overall Study|Protocol Violation|0|||
157124397|NCT03529773|567206219|FG029|Overall Study|Protocol Violation|0|||
157124398|NCT03529773|567206220|FG030|Overall Study|Protocol Violation|1|||
157124399|NCT03529773|567206221|FG031|Overall Study|Protocol Violation|0|||
157124400|NCT03529773|567206222|FG032|Overall Study|Protocol Violation|0|||
157124401|NCT03529773|567206223|FG033|Overall Study|Protocol Violation|0|||
157124402|NCT03529773|567206224|FG034|Overall Study|Protocol Violation|0|||
157124403|NCT03529773|567206225|FG035|Overall Study|Protocol Violation|0|||
157124404|NCT03529773|567206226|FG036|Overall Study|Protocol Violation|0|||
157124405|NCT03529773|567206227|FG037|Overall Study|Protocol Violation|0|||
157124406|NCT03529773|567206228|FG038|Overall Study|Protocol Violation|0|||
157124407|NCT03529773|567206229|FG039|Overall Study|Protocol Violation|0|||
157124408|NCT03529773|567206190|FG000|Overall Study|Withdrawal by Subject|0|||
157215177|NCT00950599|567535787|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
157215178|NCT00950599|567535788|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
157215179|NCT00950599|567535789|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
156702709|NCT00735397|565657006|FG000|Overall Study|Participant choice|252|||
156702710|NCT00735397|565657006|FG000|Overall Study|Inadequate therapeutic effect|202|||
156702711|NCT00735397|565657006|FG000|Overall Study|Administrative/Other|502|||
156702712|NCT02677714|565657007|FG000|Overall Study|Withdrawal by Subject|2|||
157124409|NCT03529773|567206191|FG001|Overall Study|Withdrawal by Subject|0|||
157124410|NCT03529773|567206192|FG002|Overall Study|Withdrawal by Subject|0|||
157124411|NCT03529773|567206193|FG003|Overall Study|Withdrawal by Subject|0|||
157124412|NCT03529773|567206194|FG004|Overall Study|Withdrawal by Subject|0|||
157124413|NCT03529773|567206195|FG005|Overall Study|Withdrawal by Subject|0|||
157124414|NCT03529773|567206196|FG006|Overall Study|Withdrawal by Subject|0|||
157124415|NCT03529773|567206197|FG007|Overall Study|Withdrawal by Subject|1|||
157124416|NCT03529773|567206198|FG008|Overall Study|Withdrawal by Subject|0|||
157124417|NCT03529773|567206199|FG009|Overall Study|Withdrawal by Subject|1|||
157124418|NCT03529773|567206200|FG010|Overall Study|Withdrawal by Subject|1|||
157124419|NCT03529773|567206201|FG011|Overall Study|Withdrawal by Subject|0|||
156702713|NCT02677714|565657008|FG001|Overall Study|Withdrawal by Subject|0|||
157124420|NCT03529773|567206202|FG012|Overall Study|Withdrawal by Subject|0|||
157124421|NCT03529773|567206203|FG013|Overall Study|Withdrawal by Subject|0|||
157124422|NCT03529773|567206204|FG014|Overall Study|Withdrawal by Subject|0|||
157124423|NCT03529773|567206205|FG015|Overall Study|Withdrawal by Subject|3|||
157215180|NCT00950599|567535790|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
157215181|NCT00950599|567535791|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
157215182|NCT00950599|567535792|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
157215183|NCT00950599|567535793|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
157215184|NCT00950599|567535794|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
157215185|NCT00950599|567535795|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
157215186|NCT00950599|567535796|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
157215187|NCT00950599|567535787|FG000|Follow-Up Period|Adverse Event|0|||
157215188|NCT00950599|567535788|FG001|Follow-Up Period|Adverse Event|0|||
157215189|NCT00950599|567535789|FG002|Follow-Up Period|Adverse Event|0|||
157215190|NCT00950599|567535790|FG003|Follow-Up Period|Adverse Event|0|||
157215191|NCT00950599|567535791|FG004|Follow-Up Period|Adverse Event|0|||
157215192|NCT00950599|567535792|FG005|Follow-Up Period|Adverse Event|0|||
157215193|NCT00950599|567535793|FG006|Follow-Up Period|Adverse Event|0|||
157215194|NCT00950599|567535794|FG007|Follow-Up Period|Adverse Event|0|||
157215195|NCT00950599|567535795|FG008|Follow-Up Period|Adverse Event|1|||
157215196|NCT00950599|567535796|FG009|Follow-Up Period|Adverse Event|0|||
157215197|NCT00950599|567535787|FG000|Follow-Up Period|Lack of Efficacy|0|||
157215198|NCT00950599|567535788|FG001|Follow-Up Period|Lack of Efficacy|0|||
157215199|NCT00950599|567535789|FG002|Follow-Up Period|Lack of Efficacy|0|||
157215200|NCT00950599|567535790|FG003|Follow-Up Period|Lack of Efficacy|0|||
157215201|NCT00950599|567535791|FG004|Follow-Up Period|Lack of Efficacy|0|||
157215202|NCT00950599|567535792|FG005|Follow-Up Period|Lack of Efficacy|0|||
157215203|NCT00950599|567535793|FG006|Follow-Up Period|Lack of Efficacy|0|||
157215204|NCT00950599|567535794|FG007|Follow-Up Period|Lack of Efficacy|0|||
157215205|NCT00950599|567535795|FG008|Follow-Up Period|Lack of Efficacy|3|||
157215206|NCT00950599|567535796|FG009|Follow-Up Period|Lack of Efficacy|0|||
157215207|NCT00950599|567535787|FG000|Follow-Up Period|Lost to Follow-up|0|||
157215208|NCT00950599|567535788|FG001|Follow-Up Period|Lost to Follow-up|0|||
157215209|NCT00950599|567535789|FG002|Follow-Up Period|Lost to Follow-up|0|||
157215210|NCT00950599|567535790|FG003|Follow-Up Period|Lost to Follow-up|0|||
156702714|NCT02865460|565657009|FG000|Overall Study|Adverse Event|1|||
156702715|NCT02865460|565657010|FG001|Overall Study|Adverse Event|0|||
156702716|NCT02865460|565657009|FG000|Overall Study|Withdrawal by Subject|1|||
156702717|NCT02865460|565657010|FG001|Overall Study|Withdrawal by Subject|1|||
156702718|NCT02865460|565657009|FG000|Overall Study|Lost to Follow-up|7|||
156702719|NCT02865460|565657010|FG001|Overall Study|Lost to Follow-up|4|||
156702720|NCT02865460|565657009|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
156702721|NCT02865460|565657010|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
156702722|NCT00171951|565657017|FG000|Overall Study|Adverse Event|1|||
156702723|NCT00171951|565657017|FG000|Overall Study|Abnormal Laboratory Values|2|||
156702724|NCT00171951|565657017|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156702725|NCT00171951|565657017|FG000|Overall Study|Participants Withdrew Consent|3|||
156702726|NCT00171951|565657017|FG000|Overall Study|New Cancer Therapy|5|||
156702727|NCT00171951|565657017|FG000|Overall Study|Reason not Specified|2|||
156702728|NCT04658095|565657018|FG000|Overall Study|Study terminated|5|||
156702729|NCT04658095|565657019|FG001|Overall Study|Study terminated|1|||
156702730|NCT04658095|565657020|FG002|Overall Study|Study terminated|4|||
156702731|NCT04154631|565657022|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
156702732|NCT04154631|565657023|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
156702733|NCT01441947|565657024|FG000|Overall Study|Withdrawal by Subject|3|||
156702734|NCT01441947|565657025|FG001|Overall Study|Withdrawal by Subject|0|||
156702735|NCT04874636|565657026|FG000|Overall Study|Adverse Event|17|||
156702736|NCT04874636|565657027|FG001|Overall Study|Adverse Event|7|||
156702737|NCT04874636|565657026|FG000|Overall Study|Lost to Follow-up|1|||
156702738|NCT04874636|565657027|FG001|Overall Study|Lost to Follow-up|0|||
156702739|NCT04874636|565657026|FG000|Overall Study|Non-Compliance with Study Drug|2|||
156702740|NCT04874636|565657027|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156702741|NCT04874636|565657026|FG000|Overall Study|Physician Decision|1|||
156702742|NCT04874636|565657027|FG001|Overall Study|Physician Decision|0|||
157215211|NCT00950599|567535791|FG004|Follow-Up Period|Lost to Follow-up|0|||
157215212|NCT00950599|567535792|FG005|Follow-Up Period|Lost to Follow-up|0|||
156702743|NCT04874636|565657026|FG000|Overall Study|Withdrawal by Subject|6|||
156702744|NCT04874636|565657027|FG001|Overall Study|Withdrawal by Subject|5|||
157215213|NCT00950599|567535793|FG006|Follow-Up Period|Lost to Follow-up|0|||
157215214|NCT00950599|567535794|FG007|Follow-Up Period|Lost to Follow-up|0|||
157215215|NCT00950599|567535795|FG008|Follow-Up Period|Lost to Follow-up|5|||
157215216|NCT00950599|567535796|FG009|Follow-Up Period|Lost to Follow-up|1|||
157215217|NCT00950599|567535787|FG000|Follow-Up Period|Physician Decision|0|||
157215218|NCT00950599|567535788|FG001|Follow-Up Period|Physician Decision|0|||
157215219|NCT00950599|567535789|FG002|Follow-Up Period|Physician Decision|0|||
156702745|NCT00620659|565657036|FG000|Treatment Period 1|Adverse Event|1|||
156702746|NCT00620659|565657037|FG001|Treatment Period 1|Adverse Event|0|||
156702747|NCT00620659|565657038|FG002|Treatment Period 1|Adverse Event|0|||
156702748|NCT00620659|565657039|FG003|Treatment Period 1|Adverse Event|3|||
156702749|NCT00620659|565657040|FG004|Treatment Period 1|Adverse Event|0|||
156702750|NCT00620659|565657041|FG005|Treatment Period 1|Adverse Event|0|||
156702751|NCT00620659|565657036|FG000|Treatment Period 1|Protocol Violation|1|||
156702752|NCT00620659|565657037|FG001|Treatment Period 1|Protocol Violation|0|||
156702753|NCT00620659|565657038|FG002|Treatment Period 1|Protocol Violation|0|||
156702754|NCT00620659|565657039|FG003|Treatment Period 1|Protocol Violation|0|||
156702755|NCT00620659|565657040|FG004|Treatment Period 1|Protocol Violation|0|||
156702756|NCT00620659|565657041|FG005|Treatment Period 1|Protocol Violation|0|||
156702757|NCT00620659|565657036|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156702758|NCT00620659|565657037|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156702759|NCT00620659|565657038|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156702760|NCT00620659|565657039|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156702761|NCT00620659|565657040|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156702762|NCT00620659|565657041|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156702763|NCT00620659|565657036|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702764|NCT00620659|565657037|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702765|NCT00620659|565657038|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702766|NCT00620659|565657039|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
156702767|NCT00620659|565657040|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702768|NCT00620659|565657041|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
156702769|NCT00620659|565657036|FG000|Treatment Period 2|Adverse Event|0|||
156702770|NCT00620659|565657037|FG001|Treatment Period 2|Adverse Event|3|||
156702771|NCT00620659|565657038|FG002|Treatment Period 2|Adverse Event|0|||
156702772|NCT00620659|565657039|FG003|Treatment Period 2|Adverse Event|0|||
156702773|NCT00620659|565657040|FG004|Treatment Period 2|Adverse Event|2|||
156702774|NCT00620659|565657041|FG005|Treatment Period 2|Adverse Event|0|||
156702775|NCT00620659|565657036|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156702776|NCT00620659|565657037|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156702777|NCT00620659|565657038|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156702778|NCT00620659|565657039|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156702779|NCT00620659|565657040|FG004|Treatment Period 2|Withdrawal by Subject|3|||
156702780|NCT00620659|565657041|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156702781|NCT00620659|565657036|FG000|Placebo Washout Period 2|Adverse Event|2|||
156702782|NCT00620659|565657037|FG001|Placebo Washout Period 2|Adverse Event|0|||
156702783|NCT00620659|565657038|FG002|Placebo Washout Period 2|Adverse Event|0|||
156702784|NCT00620659|565657039|FG003|Placebo Washout Period 2|Adverse Event|0|||
156702785|NCT00620659|565657040|FG004|Placebo Washout Period 2|Adverse Event|0|||
156702786|NCT00620659|565657041|FG005|Placebo Washout Period 2|Adverse Event|0|||
156702787|NCT00620659|565657036|FG000|Treatment Period 3|Adverse Event|0|||
156702788|NCT00620659|565657037|FG001|Treatment Period 3|Adverse Event|2|||
156702789|NCT00620659|565657038|FG002|Treatment Period 3|Adverse Event|0|||
156702790|NCT00620659|565657039|FG003|Treatment Period 3|Adverse Event|0|||
156702791|NCT00620659|565657040|FG004|Treatment Period 3|Adverse Event|0|||
156702792|NCT00620659|565657041|FG005|Treatment Period 3|Adverse Event|0|||
156702793|NCT00620659|565657036|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156702794|NCT00620659|565657037|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156702795|NCT00620659|565657038|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156702796|NCT00620659|565657039|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156702797|NCT00620659|565657040|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156702798|NCT00620659|565657041|FG005|Treatment Period 3|Withdrawal by Subject|0|||
156702799|NCT03246646|565657044|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
157124424|NCT03529773|567206206|FG016|Overall Study|Withdrawal by Subject|0|||
157124425|NCT03529773|567206207|FG017|Overall Study|Withdrawal by Subject|2|||
157124426|NCT03529773|567206208|FG018|Overall Study|Withdrawal by Subject|3|||
157124427|NCT03529773|567206209|FG019|Overall Study|Withdrawal by Subject|1|||
157124428|NCT03529773|567206210|FG020|Overall Study|Withdrawal by Subject|3|||
157124429|NCT03529773|567206211|FG021|Overall Study|Withdrawal by Subject|1|||
157124430|NCT03529773|567206212|FG022|Overall Study|Withdrawal by Subject|1|||
157124431|NCT03529773|567206213|FG023|Overall Study|Withdrawal by Subject|2|||
157124432|NCT03529773|567206214|FG024|Overall Study|Withdrawal by Subject|2|||
157124433|NCT03529773|567206215|FG025|Overall Study|Withdrawal by Subject|4|||
157124434|NCT03529773|567206216|FG026|Overall Study|Withdrawal by Subject|2|||
157124435|NCT03529773|567206217|FG027|Overall Study|Withdrawal by Subject|1|||
157124436|NCT03529773|567206218|FG028|Overall Study|Withdrawal by Subject|1|||
157124437|NCT03529773|567206219|FG029|Overall Study|Withdrawal by Subject|0|||
157124438|NCT03529773|567206220|FG030|Overall Study|Withdrawal by Subject|0|||
157124439|NCT03529773|567206221|FG031|Overall Study|Withdrawal by Subject|0|||
157124440|NCT03529773|567206222|FG032|Overall Study|Withdrawal by Subject|0|||
157124441|NCT03529773|567206223|FG033|Overall Study|Withdrawal by Subject|0|||
157124442|NCT03529773|567206224|FG034|Overall Study|Withdrawal by Subject|1|||
157124443|NCT03529773|567206225|FG035|Overall Study|Withdrawal by Subject|2|||
156702800|NCT03246646|565657045|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
156702801|NCT03246646|565657044|FG000|Overall Study|Withdrawal by Subject|3|||
157124444|NCT03529773|567206226|FG036|Overall Study|Withdrawal by Subject|0|||
157124445|NCT03529773|567206227|FG037|Overall Study|Withdrawal by Subject|2|||
157124446|NCT03529773|567206228|FG038|Overall Study|Withdrawal by Subject|1|||
157124447|NCT03529773|567206229|FG039|Overall Study|Withdrawal by Subject|1|||
157124448|NCT03529773|567206190|FG000|Overall Study|Screen Failure|0|||
157124449|NCT03529773|567206191|FG001|Overall Study|Screen Failure|0|||
157124450|NCT03529773|567206192|FG002|Overall Study|Screen Failure|0|||
157124451|NCT03529773|567206193|FG003|Overall Study|Screen Failure|0|||
157124452|NCT03529773|567206194|FG004|Overall Study|Screen Failure|0|||
157124453|NCT03529773|567206195|FG005|Overall Study|Screen Failure|0|||
157124454|NCT03529773|567206196|FG006|Overall Study|Screen Failure|0|||
157124455|NCT03529773|567206197|FG007|Overall Study|Screen Failure|0|||
157124456|NCT03529773|567206198|FG008|Overall Study|Screen Failure|0|||
157124457|NCT03529773|567206199|FG009|Overall Study|Screen Failure|0|||
156702802|NCT03246646|565657045|FG001|Overall Study|Withdrawal by Subject|0|||
156702803|NCT03246646|565657044|FG000|Overall Study|Lost to Follow-up|7|||
156702804|NCT03246646|565657045|FG001|Overall Study|Lost to Follow-up|0|||
156702805|NCT00968799|565657048|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
156702806|NCT01372774|565657053|FG000|Overall Study|Withdrawal prior to treatment|4|||
156702807|NCT01372774|565657054|FG001|Overall Study|Withdrawal prior to treatment|5|||
156702808|NCT03907462|565657059|FG000|Overall Study|Physician Decision|1|||
156702809|NCT03907462|565657060|FG001|Overall Study|Physician Decision|3|||
156702810|NCT03907462|565657061|FG002|Overall Study|Physician Decision|1|||
156702811|NCT03907462|565657059|FG000|Overall Study|Withdrawal by Subject|6|||
156702812|NCT03907462|565657060|FG001|Overall Study|Withdrawal by Subject|3|||
156702813|NCT03907462|565657061|FG002|Overall Study|Withdrawal by Subject|3|||
156702814|NCT03907462|565657059|FG000|Overall Study|Pregnancy|4|||
157124458|NCT03529773|567206200|FG010|Overall Study|Screen Failure|0|||
156702815|NCT03907462|565657060|FG001|Overall Study|Pregnancy|2|||
156702816|NCT03907462|565657061|FG002|Overall Study|Pregnancy|6|||
156702817|NCT03907462|565657059|FG000|Overall Study|Lost to Follow-up|16|||
156702818|NCT03907462|565657060|FG001|Overall Study|Lost to Follow-up|18|||
156702819|NCT03907462|565657061|FG002|Overall Study|Lost to Follow-up|22|||
156702820|NCT04639713|565657062|FG000|Overall Study|Protocol Noncompliance|2|||
156702821|NCT04639713|565657062|FG000|Overall Study|Withdrawal by Subject|1|||
156702822|NCT03190330|565659082|FG000|Overall Study|Adverse Event|2|||
156702823|NCT03190330|565659082|FG000|Overall Study|Death|10|||
156702824|NCT03190330|565659082|FG000|Overall Study|Lost to Follow-up|1|||
156702825|NCT03190330|565659082|FG000|Overall Study|Withdrawal by Subject|6|||
156702826|NCT03190330|565659082|FG000|Overall Study|Progressive Disease|1|||
156702827|NCT02081209|565659083|FG000|Overall Study|Withdrawal by Subject|1|||
156702828|NCT00633243|565659084|FG000|Overall Study|Withdrawal by Subject|0|||
156702829|NCT00633243|565659085|FG001|Overall Study|Withdrawal by Subject|1|||
156702830|NCT00633243|565659084|FG000|Overall Study|incarceration|0|||
156702831|NCT00633243|565659085|FG001|Overall Study|incarceration|2|||
156702832|NCT00633243|565659084|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
156702833|NCT00633243|565659085|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
156702834|NCT00633243|565659084|FG000|Overall Study|Not comfortable with self-injecting|0|||
156702835|NCT00633243|565659085|FG001|Overall Study|Not comfortable with self-injecting|1|||
156702836|NCT00633243|565659084|FG000|Overall Study|Mental Health--Depression|0|||
156702837|NCT00633243|565659085|FG001|Overall Study|Mental Health--Depression|1|||
156702838|NCT00633243|565659084|FG000|Overall Study|Couldn't tolerate side-effects|1|||
156702839|NCT00633243|565659085|FG001|Overall Study|Couldn't tolerate side-effects|1|||
156702840|NCT03589768|565659086|FG000|Overall Study|Death|1|||
156702841|NCT03589768|565659087|FG001|Overall Study|Death|0|||
156702842|NCT03589768|565659088|FG002|Overall Study|Death|8|||
156702843|NCT03589768|565659089|FG003|Overall Study|Death|3|||
156702844|NCT03589768|565659086|FG000|Overall Study|Withdrawal by Subject|2|||
156702845|NCT03589768|565659087|FG001|Overall Study|Withdrawal by Subject|0|||
156702846|NCT03589768|565659088|FG002|Overall Study|Withdrawal by Subject|0|||
156702847|NCT03589768|565659089|FG003|Overall Study|Withdrawal by Subject|0|||
156702848|NCT03589768|565659086|FG000|Overall Study|Protocol Violation|1|||
156702849|NCT03589768|565659087|FG001|Overall Study|Protocol Violation|0|||
156702850|NCT03589768|565659088|FG002|Overall Study|Protocol Violation|0|||
156702851|NCT03589768|565659089|FG003|Overall Study|Protocol Violation|0|||
156702852|NCT00554190|565659092|FG000|Overall Study|Termination forms not completed|10|||
156702853|NCT00191113|565659093|FG000|Core Study|Withdrawal by Subject|25|||
156702854|NCT00191113|565659094|FG001|Core Study|Withdrawal by Subject|9|||
156702855|NCT00191113|565659093|FG000|Core Study|Protocol Violation|6|||
156702856|NCT00191113|565659094|FG001|Core Study|Protocol Violation|2|||
156791018|NCT03627468|565987135|FG000|Overall Study|Adverse Event|5|||
157124459|NCT03529773|567206201|FG011|Overall Study|Screen Failure|0|||
157124460|NCT03529773|567206202|FG012|Overall Study|Screen Failure|0|||
157124461|NCT03529773|567206203|FG013|Overall Study|Screen Failure|0|||
156702857|NCT00191113|565659093|FG000|Core Study|Lost to Follow-up|3|||
156702858|NCT00191113|565659094|FG001|Core Study|Lost to Follow-up|0|||
156702859|NCT00191113|565659093|FG000|Core Study|Adverse Event|0|||
156702860|NCT00191113|565659094|FG001|Core Study|Adverse Event|2|||
156702861|NCT00191113|565659093|FG000|Core Study|Lack of Efficacy|0|||
157124462|NCT03529773|567206204|FG014|Overall Study|Screen Failure|0|||
157124463|NCT03529773|567206205|FG015|Overall Study|Screen Failure|0|||
157124464|NCT03529773|567206206|FG016|Overall Study|Screen Failure|0|||
156702862|NCT00191113|565659094|FG001|Core Study|Lack of Efficacy|2|||
156702863|NCT00191113|565659093|FG000|Core Study|Death|1|||
156702864|NCT00191113|565659094|FG001|Core Study|Death|0|||
156702865|NCT02903030|565659095|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156702866|NCT02903030|565659096|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156702867|NCT01119508|565659097|FG000|Overall Study|Adverse Event|56|||
156702868|NCT01119508|565659097|FG000|Overall Study|Withdrawal by Subject|2|||
156702869|NCT01119508|565659097|FG000|Overall Study|Died before tumor response evaluation|1|||
156702870|NCT00265395|565659098|FG000|Overall Study|Adverse Event|3|||
156702871|NCT00265395|565659099|FG001|Overall Study|Adverse Event|6|||
156702872|NCT00265395|565659098|FG000|Overall Study|Lost to Follow-up|2|||
156702873|NCT00265395|565659099|FG001|Overall Study|Lost to Follow-up|1|||
156702874|NCT00265395|565659098|FG000|Overall Study|Withdrawal by Subject|1|||
156702875|NCT00265395|565659099|FG001|Overall Study|Withdrawal by Subject|6|||
156702876|NCT00265395|565659098|FG000|Overall Study|Protocol Violation|2|||
156702877|NCT00265395|565659099|FG001|Overall Study|Protocol Violation|2|||
156702878|NCT00265395|565659098|FG000|Overall Study|Lack of Efficacy|0|||
156702879|NCT00265395|565659099|FG001|Overall Study|Lack of Efficacy|1|||
156702880|NCT00265395|565659098|FG000|Overall Study|Administrative|0|||
156702881|NCT00265395|565659099|FG001|Overall Study|Administrative|1|||
156702882|NCT00837473|565659102|FG000|Overall Study|Lost to Follow-up|1|||
156702883|NCT00837473|565659102|FG000|Overall Study|Withdrawal by Subject|2|||
156702884|NCT03400943|565659103|FG000|Treatment Period 1|Adverse Event|0|||
156702885|NCT03400943|565659104|FG001|Treatment Period 1|Adverse Event|0|||
156702886|NCT03400943|565659105|FG002|Treatment Period 1|Adverse Event|0|||
156702887|NCT03400943|565659106|FG003|Treatment Period 1|Adverse Event|1|||
156702888|NCT03400943|565659103|FG000|Treatment Period 1|Lost to Follow-up|1|||
156702889|NCT03400943|565659104|FG001|Treatment Period 1|Lost to Follow-up|0|||
156702890|NCT03400943|565659105|FG002|Treatment Period 1|Lost to Follow-up|0|||
156702891|NCT03400943|565659106|FG003|Treatment Period 1|Lost to Follow-up|0|||
156702892|NCT03400943|565659103|FG000|Treatment Period 1|Protocol Violation|0|||
156702893|NCT03400943|565659104|FG001|Treatment Period 1|Protocol Violation|1|||
156702894|NCT03400943|565659105|FG002|Treatment Period 1|Protocol Violation|1|||
156702895|NCT03400943|565659106|FG003|Treatment Period 1|Protocol Violation|0|||
156702896|NCT03400943|565659103|FG000|Treatment Period 1|Study terminated by sponsor|2|||
156702897|NCT03400943|565659104|FG001|Treatment Period 1|Study terminated by sponsor|0|||
156702898|NCT03400943|565659105|FG002|Treatment Period 1|Study terminated by sponsor|0|||
156702899|NCT03400943|565659106|FG003|Treatment Period 1|Study terminated by sponsor|1|||
156702900|NCT03400943|565659103|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156702901|NCT03400943|565659104|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156702902|NCT03400943|565659105|FG002|Treatment Period 1|Withdrawal by Subject|3|||
156702903|NCT03400943|565659106|FG003|Treatment Period 1|Withdrawal by Subject|1|||
156702904|NCT03400943|565659103|FG000|Treatment Period 1|Other|2|||
156702905|NCT03400943|565659104|FG001|Treatment Period 1|Other|1|||
156702906|NCT03400943|565659105|FG002|Treatment Period 1|Other|2|||
156791019|NCT03627468|565987136|FG001|Overall Study|Adverse Event|33|||
156791020|NCT03627468|565987135|FG000|Overall Study|Withdrawal by Subject|13|||
157124465|NCT03529773|567206207|FG017|Overall Study|Screen Failure|0|||
157124466|NCT03529773|567206208|FG018|Overall Study|Screen Failure|0|||
157124467|NCT03529773|567206209|FG019|Overall Study|Screen Failure|0|||
157124468|NCT03529773|567206210|FG020|Overall Study|Screen Failure|0|||
157124469|NCT03529773|567206211|FG021|Overall Study|Screen Failure|0|||
157124470|NCT03529773|567206212|FG022|Overall Study|Screen Failure|0|||
157124471|NCT03529773|567206213|FG023|Overall Study|Screen Failure|0|||
157124472|NCT03529773|567206214|FG024|Overall Study|Screen Failure|0|||
157124473|NCT03529773|567206215|FG025|Overall Study|Screen Failure|0|||
157124474|NCT03529773|567206216|FG026|Overall Study|Screen Failure|0|||
157124475|NCT03529773|567206217|FG027|Overall Study|Screen Failure|0|||
156702907|NCT03400943|565659106|FG003|Treatment Period 1|Other|2|||
156702908|NCT03400943|565659103|FG000|Post-treatment Period 1|Adverse Event|2|||
156702909|NCT03400943|565659104|FG001|Post-treatment Period 1|Adverse Event|0|||
156702910|NCT03400943|565659105|FG002|Post-treatment Period 1|Adverse Event|0|||
156702911|NCT03400943|565659106|FG003|Post-treatment Period 1|Adverse Event|0|||
156702912|NCT03400943|565659103|FG000|Post-treatment Period 1|Protocol Violation|1|||
156702913|NCT03400943|565659104|FG001|Post-treatment Period 1|Protocol Violation|0|||
156702914|NCT03400943|565659105|FG002|Post-treatment Period 1|Protocol Violation|0|||
156702915|NCT03400943|565659106|FG003|Post-treatment Period 1|Protocol Violation|0|||
156702916|NCT03400943|565659103|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
157124476|NCT03529773|567206218|FG028|Overall Study|Screen Failure|0|||
157124477|NCT03529773|567206219|FG029|Overall Study|Screen Failure|0|||
156702917|NCT03400943|565659104|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
156702918|NCT03400943|565659105|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
156702919|NCT03400943|565659106|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
156791021|NCT03627468|565987136|FG001|Overall Study|Withdrawal by Subject|23|||
157124478|NCT03529773|567206220|FG030|Overall Study|Screen Failure|0|||
156702920|NCT03400943|565659103|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
156702921|NCT03400943|565659104|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
157124479|NCT03529773|567206221|FG031|Overall Study|Screen Failure|0|||
157124480|NCT03529773|567206222|FG032|Overall Study|Screen Failure|0|||
157124481|NCT03529773|567206223|FG033|Overall Study|Screen Failure|0|||
157124482|NCT03529773|567206224|FG034|Overall Study|Screen Failure|0|||
157124483|NCT03529773|567206225|FG035|Overall Study|Screen Failure|0|||
157124484|NCT03529773|567206226|FG036|Overall Study|Screen Failure|1|||
157124485|NCT03529773|567206227|FG037|Overall Study|Screen Failure|1|||
157124486|NCT03529773|567206228|FG038|Overall Study|Screen Failure|0|||
156791022|NCT03627468|565987135|FG000|Overall Study|Physician Decision|1|||
156791023|NCT03627468|565987136|FG001|Overall Study|Physician Decision|0|||
156791024|NCT03627468|565987135|FG000|Overall Study|Protocol Violation|0|||
156791025|NCT03627468|565987136|FG001|Overall Study|Protocol Violation|2|||
157124487|NCT03529773|567206229|FG039|Overall Study|Screen Failure|1|||
157124488|NCT03529773|567206190|FG000|Overall Study|Randomized but not vaccinated|0|||
157124489|NCT03529773|567206191|FG001|Overall Study|Randomized but not vaccinated|0|||
157124490|NCT03529773|567206192|FG002|Overall Study|Randomized but not vaccinated|0|||
157124491|NCT03529773|567206193|FG003|Overall Study|Randomized but not vaccinated|0|||
157124492|NCT03529773|567206194|FG004|Overall Study|Randomized but not vaccinated|0|||
157124493|NCT03529773|567206195|FG005|Overall Study|Randomized but not vaccinated|0|||
157124494|NCT03529773|567206196|FG006|Overall Study|Randomized but not vaccinated|0|||
157124495|NCT03529773|567206197|FG007|Overall Study|Randomized but not vaccinated|0|||
157124496|NCT03529773|567206198|FG008|Overall Study|Randomized but not vaccinated|0|||
157124497|NCT03529773|567206199|FG009|Overall Study|Randomized but not vaccinated|0|||
157124498|NCT03529773|567206200|FG010|Overall Study|Randomized but not vaccinated|0|||
157124499|NCT03529773|567206201|FG011|Overall Study|Randomized but not vaccinated|0|||
157124500|NCT03529773|567206202|FG012|Overall Study|Randomized but not vaccinated|0|||
157124501|NCT03529773|567206203|FG013|Overall Study|Randomized but not vaccinated|0|||
157124502|NCT03529773|567206204|FG014|Overall Study|Randomized but not vaccinated|0|||
157124503|NCT03529773|567206205|FG015|Overall Study|Randomized but not vaccinated|0|||
157124504|NCT03529773|567206206|FG016|Overall Study|Randomized but not vaccinated|0|||
157124505|NCT03529773|567206207|FG017|Overall Study|Randomized but not vaccinated|1|||
157124506|NCT03529773|567206208|FG018|Overall Study|Randomized but not vaccinated|0|||
157124507|NCT03529773|567206209|FG019|Overall Study|Randomized but not vaccinated|0|||
157124508|NCT03529773|567206210|FG020|Overall Study|Randomized but not vaccinated|0|||
157124509|NCT03529773|567206211|FG021|Overall Study|Randomized but not vaccinated|0|||
157124510|NCT03529773|567206212|FG022|Overall Study|Randomized but not vaccinated|0|||
157124511|NCT03529773|567206213|FG023|Overall Study|Randomized but not vaccinated|0|||
157124512|NCT03529773|567206214|FG024|Overall Study|Randomized but not vaccinated|0|||
157215220|NCT00950599|567535790|FG003|Follow-Up Period|Physician Decision|0|||
157124513|NCT03529773|567206215|FG025|Overall Study|Randomized but not vaccinated|0|||
157124514|NCT03529773|567206216|FG026|Overall Study|Randomized but not vaccinated|0|||
157124515|NCT03529773|567206217|FG027|Overall Study|Randomized but not vaccinated|1|||
157124516|NCT03529773|567206218|FG028|Overall Study|Randomized but not vaccinated|0|||
157124517|NCT03529773|567206219|FG029|Overall Study|Randomized but not vaccinated|0|||
157124518|NCT03529773|567206220|FG030|Overall Study|Randomized but not vaccinated|0|||
157124519|NCT03529773|567206221|FG031|Overall Study|Randomized but not vaccinated|0|||
157124520|NCT03529773|567206222|FG032|Overall Study|Randomized but not vaccinated|0|||
157215221|NCT00950599|567535791|FG004|Follow-Up Period|Physician Decision|0|||
157215222|NCT00950599|567535792|FG005|Follow-Up Period|Physician Decision|0|||
157215223|NCT00950599|567535793|FG006|Follow-Up Period|Physician Decision|0|||
157215224|NCT00950599|567535794|FG007|Follow-Up Period|Physician Decision|0|||
157215225|NCT00950599|567535795|FG008|Follow-Up Period|Physician Decision|1|||
157215226|NCT00950599|567535796|FG009|Follow-Up Period|Physician Decision|0|||
157215227|NCT00950599|567535787|FG000|Follow-Up Period|Poor/Noncompliance|0|||
157215228|NCT00950599|567535788|FG001|Follow-Up Period|Poor/Noncompliance|0|||
157215229|NCT00950599|567535789|FG002|Follow-Up Period|Poor/Noncompliance|0|||
157215230|NCT00950599|567535790|FG003|Follow-Up Period|Poor/Noncompliance|0|||
157215231|NCT00950599|567535791|FG004|Follow-Up Period|Poor/Noncompliance|0|||
157215232|NCT00950599|567535792|FG005|Follow-Up Period|Poor/Noncompliance|0|||
157215233|NCT00950599|567535793|FG006|Follow-Up Period|Poor/Noncompliance|0|||
157215234|NCT00950599|567535794|FG007|Follow-Up Period|Poor/Noncompliance|0|||
157215235|NCT00950599|567535795|FG008|Follow-Up Period|Poor/Noncompliance|1|||
157215236|NCT00950599|567535796|FG009|Follow-Up Period|Poor/Noncompliance|0|||
157215237|NCT00950599|567535787|FG000|Follow-Up Period|Subject withdrew Consent|0|||
157215238|NCT00950599|567535788|FG001|Follow-Up Period|Subject withdrew Consent|0|||
157215239|NCT00950599|567535789|FG002|Follow-Up Period|Subject withdrew Consent|0|||
157215240|NCT00950599|567535790|FG003|Follow-Up Period|Subject withdrew Consent|0|||
157215241|NCT00950599|567535791|FG004|Follow-Up Period|Subject withdrew Consent|0|||
157215242|NCT00950599|567535792|FG005|Follow-Up Period|Subject withdrew Consent|0|||
157215243|NCT00950599|567535793|FG006|Follow-Up Period|Subject withdrew Consent|0|||
157215244|NCT00950599|567535794|FG007|Follow-Up Period|Subject withdrew Consent|0|||
157215245|NCT00950599|567535795|FG008|Follow-Up Period|Subject withdrew Consent|2|||
156791026|NCT03627468|565987135|FG000|Overall Study|Lost to Follow-up|10|||
156791027|NCT03627468|565987136|FG001|Overall Study|Lost to Follow-up|16|||
156702922|NCT03400943|565659105|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
156702923|NCT03400943|565659106|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
156702924|NCT03400943|565659103|FG000|Post-treatment Period 1|Other|2|||
156702925|NCT03400943|565659104|FG001|Post-treatment Period 1|Other|0|||
156702926|NCT03400943|565659105|FG002|Post-treatment Period 1|Other|4|||
156702927|NCT03400943|565659106|FG003|Post-treatment Period 1|Other|5|||
156702928|NCT03400943|565659103|FG000|Treatment Period 2|Study terminated by sponsor|0|||
156702929|NCT03400943|565659104|FG001|Treatment Period 2|Study terminated by sponsor|1|||
156702930|NCT03400943|565659105|FG002|Treatment Period 2|Study terminated by sponsor|0|||
156702931|NCT03400943|565659106|FG003|Treatment Period 2|Study terminated by sponsor|0|||
156702932|NCT03400943|565659103|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156702933|NCT03400943|565659104|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156702934|NCT03400943|565659105|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156702935|NCT03400943|565659106|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156702936|NCT03400943|565659103|FG000|Treatment Period 2|Other|1|||
156702937|NCT03400943|565659104|FG001|Treatment Period 2|Other|6|||
156702938|NCT03400943|565659105|FG002|Treatment Period 2|Other|0|||
156702939|NCT03400943|565659106|FG003|Treatment Period 2|Other|0|||
156702940|NCT03400943|565659103|FG000|Follow-up Period|Withdrawal by Subject|1|||
156702941|NCT03400943|565659104|FG001|Follow-up Period|Withdrawal by Subject|0|||
156702942|NCT03400943|565659105|FG002|Follow-up Period|Withdrawal by Subject|0|||
156702943|NCT03400943|565659106|FG003|Follow-up Period|Withdrawal by Subject|0|||
156702944|NCT02563106|565659107|FG000|Overall Study|Withdrawal by Subject|7|||
156702945|NCT02563106|565659108|FG001|Overall Study|Withdrawal by Subject|8|||
156702946|NCT02563106|565659107|FG000|Overall Study|Adverse Event|17|||
156702947|NCT02563106|565659108|FG001|Overall Study|Adverse Event|15|||
156702948|NCT02563106|565659107|FG000|Overall Study|Protocol Violation|1|||
156702949|NCT02563106|565659108|FG001|Overall Study|Protocol Violation|0|||
156702950|NCT02563106|565659107|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
156702951|NCT02563106|565659108|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
156702952|NCT02563106|565659107|FG000|Overall Study|Lost to Follow-up|3|||
156702953|NCT02563106|565659108|FG001|Overall Study|Lost to Follow-up|2|||
156702954|NCT02563106|565659107|FG000|Overall Study|Physician Decision|3|||
156702955|NCT02563106|565659108|FG001|Overall Study|Physician Decision|1|||
156702956|NCT02563106|565659107|FG000|Overall Study|Other reason - not specified|2|||
156702957|NCT02563106|565659108|FG001|Overall Study|Other reason - not specified|1|||
156702958|NCT00537303|565659109|FG000|Overall Study|Adverse Event|1|||
156702959|NCT00537303|565659110|FG001|Overall Study|Adverse Event|4|||
156702960|NCT00537303|565659109|FG000|Overall Study|Lack of Efficacy|6|||
156702961|NCT00537303|565659110|FG001|Overall Study|Lack of Efficacy|7|||
156702962|NCT00537303|565659109|FG000|Overall Study|Protocol Violation|8|||
156702963|NCT00537303|565659110|FG001|Overall Study|Protocol Violation|4|||
156702964|NCT00537303|565659109|FG000|Overall Study|Withdrawal criteria|3|||
156702965|NCT00537303|565659110|FG001|Overall Study|Withdrawal criteria|3|||
156702966|NCT00537303|565659109|FG000|Overall Study|Unclassified|8|||
156702967|NCT00537303|565659110|FG001|Overall Study|Unclassified|7|||
156702968|NCT02338193|565659111|FG000|Overall Study|Withdrawal by Subject|0|||
156702969|NCT02338193|565659112|FG001|Overall Study|Withdrawal by Subject|0|||
156702970|NCT02338193|565659113|FG002|Overall Study|Withdrawal by Subject|2|||
156702971|NCT02338193|565659111|FG000|Overall Study|Pregnancy|0|||
156702972|NCT02338193|565659112|FG001|Overall Study|Pregnancy|1|||
156702973|NCT02338193|565659113|FG002|Overall Study|Pregnancy|1|||
156702974|NCT02338193|565659111|FG000|Overall Study|Noncompliant with visits|2|||
156702975|NCT02338193|565659112|FG001|Overall Study|Noncompliant with visits|2|||
156702976|NCT02338193|565659113|FG002|Overall Study|Noncompliant with visits|7|||
156702977|NCT02338193|565659111|FG000|Overall Study|moved out of state|0|||
156702978|NCT02338193|565659112|FG001|Overall Study|moved out of state|1|||
156702979|NCT02338193|565659113|FG002|Overall Study|moved out of state|0|||
156791028|NCT03627468|565987135|FG000|Overall Study|Death|1|||
156791029|NCT03627468|565987136|FG001|Overall Study|Death|0|||
156791030|NCT03627468|565987135|FG000|Overall Study|Pregnancy|1|||
156791031|NCT03627468|565987136|FG001|Overall Study|Pregnancy|1|||
156791032|NCT03627468|565987135|FG000|Overall Study|Lack of Efficacy|0|||
156791033|NCT03627468|565987136|FG001|Overall Study|Lack of Efficacy|2|||
156791034|NCT03627468|565987135|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
156702980|NCT02338193|565659111|FG000|Overall Study|intolerant of side effects|1|||
156791035|NCT03627468|565987136|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
156791036|NCT01104870|565987137|FG000|Overall Study|Adverse Event|1|||
156791037|NCT01104870|565987138|FG001|Overall Study|Adverse Event|1|||
156791038|NCT01104870|565987139|FG002|Overall Study|Adverse Event|0|||
156791039|NCT01104870|565987137|FG000|Overall Study|Death|0|||
156702981|NCT02338193|565659112|FG001|Overall Study|intolerant of side effects|0|||
156702982|NCT02338193|565659113|FG002|Overall Study|intolerant of side effects|0|||
156702983|NCT01136967|565659114|FG000|Overall Study|Adverse Event|9|||
156702984|NCT01136967|565659115|FG001|Overall Study|Adverse Event|12|||
156702985|NCT01136967|565659114|FG000|Overall Study|Participant Choice|8|||
156702986|NCT01136967|565659115|FG001|Overall Study|Participant Choice|3|||
156791040|NCT01104870|565987138|FG001|Overall Study|Death|0|||
156702987|NCT01136967|565659114|FG000|Overall Study|Lost to Follow-up|0|||
156702988|NCT01136967|565659115|FG001|Overall Study|Lost to Follow-up|1|||
156702989|NCT01136967|565659114|FG000|Overall Study|Withdrawal by Subject|1|||
156702990|NCT01136967|565659115|FG001|Overall Study|Withdrawal by Subject|2|||
156702991|NCT01136967|565659114|FG000|Overall Study|Clinical Progression|3|||
156702992|NCT01136967|565659115|FG001|Overall Study|Clinical Progression|5|||
156702993|NCT01136967|565659114|FG000|Overall Study|Radiation|1|||
156702994|NCT01136967|565659115|FG001|Overall Study|Radiation|0|||
156702995|NCT01136967|565659114|FG000|Overall Study|Non-compliance|1|||
156702996|NCT01136967|565659115|FG001|Overall Study|Non-compliance|0|||
156702997|NCT01136967|565659114|FG000|Overall Study|Investigator's Choice|1|||
156702998|NCT01136967|565659115|FG001|Overall Study|Investigator's Choice|1|||
156702999|NCT01136967|565659114|FG000|Overall Study|Increase in Lesion Size|0|||
156703000|NCT01136967|565659115|FG001|Overall Study|Increase in Lesion Size|2|||
156703001|NCT01136967|565659114|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
156703002|NCT01136967|565659115|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
156703003|NCT01735955|565659120|FG000|Overall Study|Administrative problems|1|||
156703004|NCT01735955|565659120|FG000|Overall Study|Patient/guardian decision|1|||
156703005|NCT01735955|565659120|FG000|Overall Study|Patient withdrew consent|2|||
156703006|NCT01735955|565659120|FG000|Overall Study|Physician Decision|4|||
156703007|NCT01735955|565659120|FG000|Overall Study|Disease progression|24|||
156703008|NCT01735955|565659120|FG000|Overall Study|Adverse Event|5|||
156703009|NCT03839823|565659124|FG000|Overall Study|Adverse Event|8|||
156703010|NCT03839823|565659125|FG001|Overall Study|Adverse Event|4|||
156703011|NCT03839823|565659124|FG000|Overall Study|Death|1|||
156703012|NCT03839823|565659125|FG001|Overall Study|Death|0|||
156703013|NCT03839823|565659124|FG000|Overall Study|Physician Decision|1|||
156703014|NCT03839823|565659125|FG001|Overall Study|Physician Decision|5|||
156703015|NCT03839823|565659124|FG000|Overall Study|Progressive Disease (PD)|65|||
156703016|NCT03839823|565659125|FG001|Overall Study|Progressive Disease (PD)|65|||
156703017|NCT03839823|565659124|FG000|Overall Study|Subject Decision|2|||
156703018|NCT03839823|565659125|FG001|Overall Study|Subject Decision|9|||
156703019|NCT03839823|565659124|FG000|Overall Study|Not Treated|0|||
156703020|NCT03839823|565659125|FG001|Overall Study|Not Treated|10|||
156703021|NCT01716715|565659126|FG000|Overall Study|Never Treated|2|||
156703022|NCT01716715|565659127|FG001|Overall Study|Never Treated|4|||
156703023|NCT03327792|565659128|FG000|Overall Study|Adverse Event|4|||
156703024|NCT03327792|565659129|FG001|Overall Study|Adverse Event|0|||
156703025|NCT03327792|565659128|FG000|Overall Study|Family/Personal issues|3|||
156703026|NCT03327792|565659129|FG001|Overall Study|Family/Personal issues|2|||
156703027|NCT03327792|565659128|FG000|Overall Study|Lost to Follow-up|0|||
156703028|NCT03327792|565659129|FG001|Overall Study|Lost to Follow-up|1|||
156703029|NCT03511326|565659136|FG000|Overall Study|Withdrawal by Subject|1|||
156703030|NCT04058067|565659139|FG000|Overall Study|Adverse Event|2|||
156703031|NCT04058067|565659140|FG001|Overall Study|Adverse Event|0|||
156703032|NCT04058067|565659139|FG000|Overall Study|Death|0|||
156703033|NCT04058067|565659140|FG001|Overall Study|Death|1|||
156703034|NCT04058067|565659139|FG000|Overall Study|Physician Decision|3|||
156703035|NCT04058067|565659140|FG001|Overall Study|Physician Decision|1|||
156703036|NCT04058067|565659139|FG000|Overall Study|Protocol Violation|0|||
156703037|NCT04058067|565659140|FG001|Overall Study|Protocol Violation|1|||
156703038|NCT04058067|565659139|FG000|Overall Study|Withdrawal by Subject|7|||
156703039|NCT04058067|565659140|FG001|Overall Study|Withdrawal by Subject|8|||
156703040|NCT00867503|565659142|FG000|Overall Study|Withdrawal by Subject|1|||
156703041|NCT03421730|565659151|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703042|NCT03421730|565659152|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
156703043|NCT03421730|565659153|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703044|NCT03421730|565659154|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703045|NCT03421730|565659155|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703046|NCT03421730|565659156|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703047|NCT03421730|565659157|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703048|NCT03421730|565659158|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703049|NCT03421730|565659159|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703050|NCT03421730|565659160|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703051|NCT03421730|565659161|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156791041|NCT01104870|565987139|FG002|Overall Study|Death|1|||
156791042|NCT01104870|565987137|FG000|Overall Study|Withdrawal by Subject|0|||
156791043|NCT01104870|565987138|FG001|Overall Study|Withdrawal by Subject|0|||
157215246|NCT00950599|567535796|FG009|Follow-Up Period|Subject withdrew Consent|1|||
156703052|NCT03421730|565659162|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
156703053|NCT03421730|565659151|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703054|NCT03421730|565659152|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156791044|NCT01104870|565987139|FG002|Overall Study|Withdrawal by Subject|1|||
156703055|NCT03421730|565659153|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703056|NCT03421730|565659154|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703057|NCT03421730|565659155|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
156703058|NCT03421730|565659156|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703059|NCT03421730|565659157|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703060|NCT03421730|565659158|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703061|NCT03421730|565659159|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703062|NCT03421730|565659160|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703063|NCT03421730|565659161|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703064|NCT03421730|565659162|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
156703065|NCT02238795|565659163|FG000|Overall Study|Patient without purpura fulminans|1|||
156703066|NCT05187013|565659165|FG000|Overall Study|Withdrawal by Subject|1|||
156703067|NCT05187013|565659166|FG001|Overall Study|Withdrawal by Subject|1|||
156703068|NCT05187013|565659167|FG002|Overall Study|Withdrawal by Subject|0|||
156703069|NCT05187013|565659165|FG000|Overall Study|Death|0|||
156703070|NCT05187013|565659166|FG001|Overall Study|Death|1|||
156703071|NCT05187013|565659167|FG002|Overall Study|Death|0|||
156703072|NCT05187013|565659165|FG000|Overall Study|Lost to Follow-up|20|||
156703073|NCT05187013|565659166|FG001|Overall Study|Lost to Follow-up|17|||
156703074|NCT05187013|565659167|FG002|Overall Study|Lost to Follow-up|0|||
156703075|NCT05187013|565659165|FG000|Overall Study|Ongoing Participants|3|||
156703076|NCT05187013|565659166|FG001|Overall Study|Ongoing Participants|5|||
156703077|NCT05187013|565659167|FG002|Overall Study|Ongoing Participants|0|||
156703078|NCT02387983|565659168|FG000|Overall Study|Adverse Event|4|||
156703079|NCT02387983|565659168|FG000|Overall Study|Protocol Violation|1|||
156703080|NCT02387983|565659168|FG000|Overall Study|Withdrawal by Subject|2|||
156703081|NCT04159935|565659169|FG000|Overall Study|Study terminated due to COVID-19|1|||
156703082|NCT04159935|565659170|FG001|Overall Study|Study terminated due to COVID-19|3|||
156703083|NCT01341782|565659171|FG000|Overall Study|Adverse Event|1|||
156703084|NCT01341782|565659172|FG001|Overall Study|Adverse Event|1|||
156703085|NCT01341782|565659171|FG000|Overall Study|Withdrawal by Subject|6|||
156703086|NCT01341782|565659172|FG001|Overall Study|Withdrawal by Subject|5|||
156703087|NCT01341782|565659171|FG000|Overall Study|Missed 3 consecutive doses|0|||
156703088|NCT01341782|565659172|FG001|Overall Study|Missed 3 consecutive doses|4|||
156703089|NCT01341782|565659171|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
156703090|NCT01341782|565659172|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
156703091|NCT01341782|565659171|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
156703092|NCT01341782|565659172|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
156703093|NCT01341782|565659171|FG000|Overall Study|Other|5|||
156703094|NCT01341782|565659172|FG001|Overall Study|Other|0|||
156703095|NCT02036775|565659173|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703096|NCT02036775|565659174|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703097|NCT02036775|565659175|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703098|NCT02036775|565659176|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703099|NCT02036775|565659177|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
156703100|NCT02036775|565659178|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
156703101|NCT02927366|565659180|FG000|Overall Study|Adverse Event|1|||
156703102|NCT02927366|565659181|FG001|Overall Study|Adverse Event|0|||
156703103|NCT02927366|565659180|FG000|Overall Study|Patient schedule|1|||
156703104|NCT02927366|565659181|FG001|Overall Study|Patient schedule|0|||
156703105|NCT00724048|565659186|FG000|Overall Study|Adverse Event|1|||
156703106|NCT00724048|565659187|FG001|Overall Study|Adverse Event|1|||
156703107|NCT00724048|565659188|FG002|Overall Study|Adverse Event|1|||
156703108|NCT00724048|565659189|FG003|Overall Study|Adverse Event|0|||
156703109|NCT00724048|565659186|FG000|Overall Study|Lost to Follow-up|0|||
157124521|NCT03529773|567206223|FG033|Overall Study|Randomized but not vaccinated|0|||
157124522|NCT03529773|567206224|FG034|Overall Study|Randomized but not vaccinated|0|||
157124523|NCT03529773|567206225|FG035|Overall Study|Randomized but not vaccinated|0|||
157124524|NCT03529773|567206226|FG036|Overall Study|Randomized but not vaccinated|0|||
156703110|NCT00724048|565659187|FG001|Overall Study|Lost to Follow-up|1|||
156703111|NCT00724048|565659188|FG002|Overall Study|Lost to Follow-up|0|||
156703112|NCT00724048|565659189|FG003|Overall Study|Lost to Follow-up|0|||
156703113|NCT00724048|565659186|FG000|Overall Study|Withdrawal by Subject|1|||
156703114|NCT00724048|565659187|FG001|Overall Study|Withdrawal by Subject|2|||
156703115|NCT00724048|565659188|FG002|Overall Study|Withdrawal by Subject|1|||
156703116|NCT00724048|565659189|FG003|Overall Study|Withdrawal by Subject|2|||
156703117|NCT00724048|565659186|FG000|Overall Study|Investigator decision|0|||
156703118|NCT00724048|565659187|FG001|Overall Study|Investigator decision|0|||
157124525|NCT03529773|567206227|FG037|Overall Study|Randomized but not vaccinated|0|||
157124526|NCT03529773|567206228|FG038|Overall Study|Randomized but not vaccinated|0|||
156703119|NCT00724048|565659188|FG002|Overall Study|Investigator decision|1|||
156703120|NCT00724048|565659189|FG003|Overall Study|Investigator decision|0|||
156703121|NCT00724048|565659186|FG000|Overall Study|Did not tolerate study drug|0|||
156703122|NCT00724048|565659187|FG001|Overall Study|Did not tolerate study drug|0|||
156703123|NCT00724048|565659188|FG002|Overall Study|Did not tolerate study drug|0|||
156703124|NCT00724048|565659189|FG003|Overall Study|Did not tolerate study drug|1|||
156703125|NCT00724048|565659186|FG000|Overall Study|Other than specified|1|||
156703126|NCT00724048|565659187|FG001|Overall Study|Other than specified|1|||
156703127|NCT00724048|565659188|FG002|Overall Study|Other than specified|0|||
156703128|NCT00724048|565659189|FG003|Overall Study|Other than specified|0|||
156703129|NCT00587990|565659192|FG000|Overall Study|Death|0|||
156703130|NCT00587990|565659193|FG001|Overall Study|Death|0|||
156703131|NCT00587990|565659194|FG002|Overall Study|Death|1|||
156703132|NCT00206323|565659197|FG000|Overall Study|Lack of Efficacy|4|||
156703133|NCT00206323|565659198|FG001|Overall Study|Lack of Efficacy|1|||
156703134|NCT00206323|565659197|FG000|Overall Study|Adverse Event|1|||
156703135|NCT00206323|565659198|FG001|Overall Study|Adverse Event|1|||
156703136|NCT00206323|565659197|FG000|Overall Study|Lost to Follow-up|1|||
156703137|NCT00206323|565659198|FG001|Overall Study|Lost to Follow-up|1|||
156703138|NCT02910063|565659199|FG000|Phase 2|Withdrawal by Subject|3|||
156703139|NCT02910063|565659200|FG001|Phase 2|Withdrawal by Subject|0|||
156703140|NCT02910063|565659201|FG002|Phase 2|Withdrawal by Subject|0|||
156703141|NCT02910063|565659199|FG000|Phase 2|Lost to Follow-up|1|||
156703142|NCT02910063|565659200|FG001|Phase 2|Lost to Follow-up|0|||
156703143|NCT02910063|565659201|FG002|Phase 2|Lost to Follow-up|0|||
156703144|NCT02910063|565659199|FG000|Phase 2|Death|24|||
156703145|NCT02910063|565659200|FG001|Phase 2|Death|0|||
156703146|NCT02910063|565659201|FG002|Phase 2|Death|0|||
156703147|NCT03496610|565659202|FG000|Overall Study|Lost to Follow-up|3|||
156703148|NCT03496610|565659203|FG001|Overall Study|Lost to Follow-up|2|||
156703149|NCT03496610|565659202|FG000|Overall Study|Physician Decision|1|||
156703150|NCT03496610|565659203|FG001|Overall Study|Physician Decision|0|||
156703151|NCT03496610|565659202|FG000|Overall Study|Withdrawal by Subject|1|||
156703152|NCT03496610|565659203|FG001|Overall Study|Withdrawal by Subject|0|||
156703153|NCT03334617|565659206|FG000|Overall Study|Adverse Event|0|||
156703154|NCT03334617|565659207|FG001|Overall Study|Adverse Event|0|||
156703155|NCT03334617|565659208|FG002|Overall Study|Adverse Event|0|||
156703156|NCT03334617|565659209|FG003|Overall Study|Adverse Event|0|||
156703157|NCT03334617|565659210|FG004|Overall Study|Adverse Event|0|||
156703158|NCT03334617|565659211|FG005|Overall Study|Adverse Event|0|||
156703159|NCT03334617|565659212|FG006|Overall Study|Adverse Event|0|||
156703160|NCT03334617|565659213|FG007|Overall Study|Adverse Event|0|||
156703161|NCT03334617|565659214|FG008|Overall Study|Adverse Event|1|||
156703162|NCT03334617|565659215|FG009|Overall Study|Adverse Event|0|||
156703163|NCT03334617|565659216|FG010|Overall Study|Adverse Event|0|||
156703164|NCT03334617|565659217|FG011|Overall Study|Adverse Event|0|||
156703165|NCT03334617|565659218|FG012|Overall Study|Adverse Event|1|||
156703166|NCT03334617|565659219|FG013|Overall Study|Adverse Event|0|||
156703167|NCT03334617|565659220|FG014|Overall Study|Adverse Event|0|||
156703168|NCT03334617|565659221|FG015|Overall Study|Adverse Event|0|||
156703169|NCT03334617|565659222|FG016|Overall Study|Adverse Event|0|||
156703170|NCT03334617|565659223|FG017|Overall Study|Adverse Event|0|||
156703171|NCT03334617|565659224|FG018|Overall Study|Adverse Event|0|||
156703172|NCT03334617|565659225|FG019|Overall Study|Adverse Event|0|||
156703173|NCT03334617|565659226|FG020|Overall Study|Adverse Event|0|||
156703174|NCT03334617|565659227|FG021|Overall Study|Adverse Event|0|||
156703175|NCT03334617|565659206|FG000|Overall Study|Death|18|||
156703176|NCT03334617|565659207|FG001|Overall Study|Death|18|||
156791045|NCT02633527|565987140|FG000|Overall Study|Failed to meet eligibility|0|||
156791046|NCT02633527|565987141|FG001|Overall Study|Failed to meet eligibility|1|||
156791047|NCT02633527|565987142|FG002|Overall Study|Failed to meet eligibility|1|||
156791048|NCT02633527|565987143|FG003|Overall Study|Failed to meet eligibility|0|||
156791049|NCT02633527|565987144|FG004|Overall Study|Failed to meet eligibility|1|||
156791050|NCT02633527|565987140|FG000|Overall Study|Adverse Event|0|||
157015552|NCT04452318|566808869|FG000|Overall Study|Withdrawal by Subject|46|||
157015553|NCT04452318|566808870|FG001|Overall Study|Withdrawal by Subject|40|||
157015554|NCT04452318|566808871|FG002|Overall Study|Withdrawal by Subject|0|||
157215247|NCT02570165|567535800|FG000|Overall Study|Adverse Event|1|||
157215248|NCT02570165|567535801|FG001|Overall Study|Adverse Event|0|||
156703177|NCT03334617|565659208|FG002|Overall Study|Death|20|||
156703178|NCT03334617|565659209|FG003|Overall Study|Death|21|||
156703179|NCT03334617|565659210|FG004|Overall Study|Death|20|||
156703180|NCT03334617|565659211|FG005|Overall Study|Death|16|||
156703181|NCT03334617|565659212|FG006|Overall Study|Death|28|||
156703182|NCT03334617|565659213|FG007|Overall Study|Death|35|||
156791051|NCT02633527|565987141|FG001|Overall Study|Adverse Event|4|||
157015555|NCT04452318|566808872|FG003|Overall Study|Withdrawal by Subject|18|||
156703183|NCT03334617|565659214|FG008|Overall Study|Death|47|||
156703184|NCT03334617|565659215|FG009|Overall Study|Death|0|||
156703185|NCT03334617|565659216|FG010|Overall Study|Death|19|||
156703186|NCT03334617|565659217|FG011|Overall Study|Death|6|||
156703187|NCT03334617|565659218|FG012|Overall Study|Death|20|||
156703188|NCT03334617|565659219|FG013|Overall Study|Death|22|||
156703189|NCT03334617|565659220|FG014|Overall Study|Death|17|||
156703190|NCT03334617|565659221|FG015|Overall Study|Death|18|||
157015556|NCT04452318|566808873|FG004|Overall Study|Withdrawal by Subject|6|||
157015557|NCT04452318|566808874|FG005|Overall Study|Withdrawal by Subject|8|||
157015558|NCT04452318|566808875|FG006|Overall Study|Withdrawal by Subject|6|||
157015559|NCT02638337|566808876|FG000|Overall Study|Adverse Event|6|||
157215249|NCT02570165|567535802|FG002|Overall Study|Adverse Event|2|||
157215250|NCT02570165|567535803|FG003|Overall Study|Adverse Event|0|||
157215251|NCT02570165|567535804|FG004|Overall Study|Adverse Event|0|||
157215252|NCT02570165|567535805|FG005|Overall Study|Adverse Event|0|||
157215253|NCT02570165|567535806|FG006|Overall Study|Adverse Event|0|||
157215254|NCT02570165|567535800|FG000|Overall Study|Lack of Efficacy|0|||
157215255|NCT02570165|567535801|FG001|Overall Study|Lack of Efficacy|1|||
157215256|NCT02570165|567535802|FG002|Overall Study|Lack of Efficacy|0|||
157215257|NCT02570165|567535803|FG003|Overall Study|Lack of Efficacy|0|||
157215258|NCT02570165|567535804|FG004|Overall Study|Lack of Efficacy|4|||
157215259|NCT02570165|567535805|FG005|Overall Study|Lack of Efficacy|0|||
157215260|NCT02570165|567535806|FG006|Overall Study|Lack of Efficacy|0|||
157215261|NCT02570165|567535800|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
157215262|NCT02570165|567535801|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
157215263|NCT02570165|567535802|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
157215264|NCT02570165|567535803|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
157215265|NCT02570165|567535804|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
157215266|NCT02570165|567535805|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
157215267|NCT02570165|567535806|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
157215268|NCT02570165|567535800|FG000|Overall Study|Lost to Follow-up|0|||
157215269|NCT02570165|567535801|FG001|Overall Study|Lost to Follow-up|0|||
157215270|NCT02570165|567535802|FG002|Overall Study|Lost to Follow-up|1|||
157215271|NCT02570165|567535803|FG003|Overall Study|Lost to Follow-up|1|||
157215272|NCT02570165|567535804|FG004|Overall Study|Lost to Follow-up|0|||
157215273|NCT02570165|567535805|FG005|Overall Study|Lost to Follow-up|0|||
157215274|NCT02570165|567535806|FG006|Overall Study|Lost to Follow-up|0|||
157215275|NCT02570165|567535800|FG000|Overall Study|Physician Decision|0|||
157215276|NCT02570165|567535801|FG001|Overall Study|Physician Decision|1|||
157215277|NCT02570165|567535802|FG002|Overall Study|Physician Decision|0|||
157215278|NCT02570165|567535803|FG003|Overall Study|Physician Decision|0|||
157215279|NCT02570165|567535804|FG004|Overall Study|Physician Decision|0|||
157215280|NCT02570165|567535805|FG005|Overall Study|Physician Decision|0|||
157215281|NCT02570165|567535806|FG006|Overall Study|Physician Decision|0|||
157215282|NCT02570165|567535800|FG000|Overall Study|Withdrawal by Subject|0|||
157215283|NCT02570165|567535801|FG001|Overall Study|Withdrawal by Subject|0|||
157215284|NCT02570165|567535802|FG002|Overall Study|Withdrawal by Subject|0|||
157215285|NCT02570165|567535803|FG003|Overall Study|Withdrawal by Subject|2|||
157215286|NCT02570165|567535804|FG004|Overall Study|Withdrawal by Subject|1|||
157215287|NCT02570165|567535805|FG005|Overall Study|Withdrawal by Subject|0|||
157215288|NCT02570165|567535806|FG006|Overall Study|Withdrawal by Subject|0|||
157215289|NCT02570165|567535800|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215290|NCT02570165|567535801|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215291|NCT02570165|567535802|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215292|NCT02570165|567535803|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215293|NCT02570165|567535804|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215294|NCT02570165|567535805|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
157215295|NCT02570165|567535806|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
157215296|NCT02570165|567535800|FG000|Overall Study|Withdrawal Request by GSK|0|||
157215297|NCT02570165|567535801|FG001|Overall Study|Withdrawal Request by GSK|0|||
156703191|NCT03334617|565659222|FG016|Overall Study|Death|12|||
156703192|NCT03334617|565659223|FG017|Overall Study|Death|15|||
157015560|NCT02638337|566808877|FG001|Overall Study|Adverse Event|10|||
157015561|NCT02638337|566808876|FG000|Overall Study|Protocol Violation|3|||
157015562|NCT02638337|566808877|FG001|Overall Study|Protocol Violation|0|||
157015563|NCT02638337|566808876|FG000|Overall Study|Withdrawal by Subject|13|||
157015564|NCT02638337|566808877|FG001|Overall Study|Withdrawal by Subject|16|||
157015565|NCT02638337|566808876|FG000|Overall Study|Lost to Follow-up|7|||
157015566|NCT02638337|566808877|FG001|Overall Study|Lost to Follow-up|7|||
157015567|NCT02638337|566808876|FG000|Overall Study|Other - Miscellaneous|4|||
157015568|NCT02638337|566808877|FG001|Overall Study|Other - Miscellaneous|3|||
157015569|NCT00604669|566808878|FG000|Overall Study|lack of information in chart|7|||
157015570|NCT06061081|566808884|FG000|Overall Study|Withdrawal by Subject|1|||
157015571|NCT06061081|566808885|FG001|Overall Study|Withdrawal by Subject|0|||
157015572|NCT06061081|566808886|FG002|Overall Study|Withdrawal by Subject|0|||
157015573|NCT06061081|566808887|FG003|Overall Study|Withdrawal by Subject|0|||
157215298|NCT02570165|567535802|FG002|Overall Study|Withdrawal Request by GSK|2|||
157215299|NCT02570165|567535803|FG003|Overall Study|Withdrawal Request by GSK|0|||
157215300|NCT02570165|567535804|FG004|Overall Study|Withdrawal Request by GSK|0|||
157215301|NCT02570165|567535805|FG005|Overall Study|Withdrawal Request by GSK|0|||
157215302|NCT02570165|567535806|FG006|Overall Study|Withdrawal Request by GSK|0|||
157015574|NCT06061081|566808888|FG004|Overall Study|Withdrawal by Subject|0|||
157215303|NCT01252238|567535811|FG000|Overall Study|Sponsor terminated study|4|||
156703193|NCT03334617|565659224|FG018|Overall Study|Death|16|||
156703194|NCT03334617|565659225|FG019|Overall Study|Death|27|||
156703195|NCT03334617|565659226|FG020|Overall Study|Death|14|||
156703196|NCT03334617|565659227|FG021|Overall Study|Death|27|||
156703197|NCT03334617|565659206|FG000|Overall Study|Lost to Follow-up|0|||
156703198|NCT03334617|565659207|FG001|Overall Study|Lost to Follow-up|0|||
156703199|NCT03334617|565659208|FG002|Overall Study|Lost to Follow-up|0|||
156703200|NCT03334617|565659209|FG003|Overall Study|Lost to Follow-up|1|||
156703201|NCT03334617|565659210|FG004|Overall Study|Lost to Follow-up|0|||
156703202|NCT03334617|565659211|FG005|Overall Study|Lost to Follow-up|1|||
156703203|NCT03334617|565659212|FG006|Overall Study|Lost to Follow-up|0|||
156703204|NCT03334617|565659213|FG007|Overall Study|Lost to Follow-up|0|||
156703205|NCT03334617|565659214|FG008|Overall Study|Lost to Follow-up|1|||
156703206|NCT03334617|565659215|FG009|Overall Study|Lost to Follow-up|0|||
156703207|NCT03334617|565659216|FG010|Overall Study|Lost to Follow-up|0|||
156703208|NCT03334617|565659217|FG011|Overall Study|Lost to Follow-up|0|||
156703209|NCT03334617|565659218|FG012|Overall Study|Lost to Follow-up|0|||
156703210|NCT03334617|565659219|FG013|Overall Study|Lost to Follow-up|0|||
156703211|NCT03334617|565659220|FG014|Overall Study|Lost to Follow-up|0|||
156703212|NCT03334617|565659221|FG015|Overall Study|Lost to Follow-up|0|||
156703213|NCT03334617|565659222|FG016|Overall Study|Lost to Follow-up|0|||
156703214|NCT03334617|565659223|FG017|Overall Study|Lost to Follow-up|0|||
156703215|NCT03334617|565659224|FG018|Overall Study|Lost to Follow-up|0|||
156703216|NCT03334617|565659225|FG019|Overall Study|Lost to Follow-up|0|||
156703217|NCT03334617|565659226|FG020|Overall Study|Lost to Follow-up|0|||
156703218|NCT03334617|565659227|FG021|Overall Study|Lost to Follow-up|0|||
156703219|NCT03334617|565659206|FG000|Overall Study|Withdrawal by Subject|0|||
156703220|NCT03334617|565659207|FG001|Overall Study|Withdrawal by Subject|1|||
156703221|NCT03334617|565659208|FG002|Overall Study|Withdrawal by Subject|0|||
156703222|NCT03334617|565659209|FG003|Overall Study|Withdrawal by Subject|0|||
156703223|NCT03334617|565659210|FG004|Overall Study|Withdrawal by Subject|1|||
156703224|NCT03334617|565659211|FG005|Overall Study|Withdrawal by Subject|1|||
156703225|NCT03334617|565659212|FG006|Overall Study|Withdrawal by Subject|1|||
156703226|NCT03334617|565659213|FG007|Overall Study|Withdrawal by Subject|2|||
156703227|NCT03334617|565659214|FG008|Overall Study|Withdrawal by Subject|0|||
156703228|NCT03334617|565659215|FG009|Overall Study|Withdrawal by Subject|0|||
156703229|NCT03334617|565659216|FG010|Overall Study|Withdrawal by Subject|0|||
156703230|NCT03334617|565659217|FG011|Overall Study|Withdrawal by Subject|1|||
156703231|NCT03334617|565659218|FG012|Overall Study|Withdrawal by Subject|1|||
156703232|NCT03334617|565659219|FG013|Overall Study|Withdrawal by Subject|0|||
156703233|NCT03334617|565659220|FG014|Overall Study|Withdrawal by Subject|2|||
156703234|NCT03334617|565659221|FG015|Overall Study|Withdrawal by Subject|1|||
156703235|NCT03334617|565659222|FG016|Overall Study|Withdrawal by Subject|0|||
156703236|NCT03334617|565659223|FG017|Overall Study|Withdrawal by Subject|1|||
156703237|NCT03334617|565659224|FG018|Overall Study|Withdrawal by Subject|1|||
156703238|NCT03334617|565659225|FG019|Overall Study|Withdrawal by Subject|1|||
156703239|NCT03334617|565659226|FG020|Overall Study|Withdrawal by Subject|0|||
156703240|NCT03334617|565659227|FG021|Overall Study|Withdrawal by Subject|1|||
156703241|NCT03334617|565659206|FG000|Overall Study|Other|1|||
156703242|NCT03334617|565659207|FG001|Overall Study|Other|2|||
156703243|NCT03334617|565659208|FG002|Overall Study|Other|0|||
156703244|NCT03334617|565659209|FG003|Overall Study|Other|1|||
156703245|NCT03334617|565659210|FG004|Overall Study|Other|1|||
156703246|NCT03334617|565659211|FG005|Overall Study|Other|0|||
156703247|NCT03334617|565659212|FG006|Overall Study|Other|2|||
157124527|NCT03529773|567206229|FG039|Overall Study|Randomized but not vaccinated|0|||
157124528|NCT01496066|567206231|FG000|Overall Study|Lost to Follow-up|8|||
157124529|NCT01496066|567206232|FG001|Overall Study|Lost to Follow-up|5|||
157124530|NCT01496066|567206231|FG000|Overall Study|Explant|3|||
157124531|NCT01496066|567206232|FG001|Overall Study|Explant|0|||
156703248|NCT03334617|565659213|FG007|Overall Study|Other|1|||
156703249|NCT03334617|565659214|FG008|Overall Study|Other|8|||
156703250|NCT03334617|565659215|FG009|Overall Study|Other|0|||
156791052|NCT02633527|565987142|FG002|Overall Study|Adverse Event|3|||
156791053|NCT02633527|565987143|FG003|Overall Study|Adverse Event|1|||
156703251|NCT03334617|565659216|FG010|Overall Study|Other|3|||
156703252|NCT03334617|565659217|FG011|Overall Study|Other|1|||
156703253|NCT03334617|565659218|FG012|Overall Study|Other|3|||
156703254|NCT03334617|565659219|FG013|Overall Study|Other|1|||
156703255|NCT03334617|565659220|FG014|Overall Study|Other|1|||
156703256|NCT03334617|565659221|FG015|Overall Study|Other|3|||
156791054|NCT02633527|565987144|FG004|Overall Study|Adverse Event|5|||
157124532|NCT01496066|567206231|FG000|Overall Study|Death|1|||
157124533|NCT01496066|567206232|FG001|Overall Study|Death|4|||
156703257|NCT03334617|565659222|FG016|Overall Study|Other|3|||
156703258|NCT03334617|565659223|FG017|Overall Study|Other|3|||
156703259|NCT03334617|565659224|FG018|Overall Study|Other|7|||
156703260|NCT03334617|565659225|FG019|Overall Study|Other|4|||
156703261|NCT03334617|565659226|FG020|Overall Study|Other|1|||
156703262|NCT03334617|565659227|FG021|Overall Study|Other|4|||
156703263|NCT03334617|565659206|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
156703264|NCT03334617|565659207|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
156703265|NCT03334617|565659208|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
156703266|NCT03334617|565659209|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
156703267|NCT03334617|565659210|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
156703268|NCT03334617|565659211|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
156703269|NCT03334617|565659212|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
156703270|NCT03334617|565659213|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
156703271|NCT03334617|565659214|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
156703272|NCT03334617|565659215|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
156703273|NCT03334617|565659216|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
156703274|NCT03334617|565659217|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
156703275|NCT03334617|565659218|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
156703276|NCT03334617|565659219|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
156703277|NCT03334617|565659220|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
156703278|NCT03334617|565659221|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
156703279|NCT03334617|565659222|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
156703280|NCT03334617|565659223|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
156703281|NCT03334617|565659224|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
156703282|NCT03334617|565659225|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
156703283|NCT03334617|565659226|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
156703284|NCT03334617|565659227|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
156703285|NCT02329847|565659229|FG000|Overall Study|Death|4|||
156703286|NCT02329847|565659230|FG001|Overall Study|Death|4|||
156703287|NCT02329847|565659231|FG002|Overall Study|Death|22|||
156703288|NCT02329847|565659232|FG003|Overall Study|Death|12|||
156703289|NCT02329847|565659233|FG004|Overall Study|Death|20|||
156703290|NCT02329847|565659234|FG005|Overall Study|Death|13|||
156703291|NCT02329847|565659229|FG000|Overall Study|Lost to Follow-up|0|||
156703292|NCT02329847|565659230|FG001|Overall Study|Lost to Follow-up|0|||
156703293|NCT02329847|565659231|FG002|Overall Study|Lost to Follow-up|2|||
156703294|NCT02329847|565659232|FG003|Overall Study|Lost to Follow-up|3|||
156703295|NCT02329847|565659233|FG004|Overall Study|Lost to Follow-up|0|||
156703296|NCT02329847|565659234|FG005|Overall Study|Lost to Follow-up|1|||
156703297|NCT02329847|565659229|FG000|Overall Study|Physician Decision|0|||
156703298|NCT02329847|565659230|FG001|Overall Study|Physician Decision|0|||
156703299|NCT02329847|565659231|FG002|Overall Study|Physician Decision|0|||
156703300|NCT02329847|565659232|FG003|Overall Study|Physician Decision|0|||
156703301|NCT02329847|565659233|FG004|Overall Study|Physician Decision|1|||
156703302|NCT02329847|565659234|FG005|Overall Study|Physician Decision|0|||
156703303|NCT02329847|565659229|FG000|Overall Study|Withdrawal by Subject|2|||
156703304|NCT02329847|565659230|FG001|Overall Study|Withdrawal by Subject|1|||
156703305|NCT02329847|565659231|FG002|Overall Study|Withdrawal by Subject|5|||
156703306|NCT02329847|565659232|FG003|Overall Study|Withdrawal by Subject|7|||
156703307|NCT02329847|565659233|FG004|Overall Study|Withdrawal by Subject|8|||
156872132|NCT01526733|566289523|FG000|Phase 1|Protocol Violation|1|||
156872133|NCT01526733|566289524|FG001|Phase 1|Protocol Violation|0|||
156872134|NCT01526733|566289523|FG000|Phase 1|Withdrawal by Subject|1|||
156872135|NCT01526733|566289524|FG001|Phase 1|Withdrawal by Subject|1|||
156872136|NCT02839200|566289525|FG000|Overall Study|Withdrawal by Subject|2|||
157124534|NCT01340209|567206233|FG000|Overall Study|Adverse Event|1|||
156703308|NCT02329847|565659234|FG005|Overall Study|Withdrawal by Subject|3|||
156703309|NCT02329847|565659229|FG000|Overall Study|Other|1|||
156703310|NCT02329847|565659230|FG001|Overall Study|Other|2|||
156703311|NCT02329847|565659231|FG002|Overall Study|Other|6|||
156703312|NCT02329847|565659232|FG003|Overall Study|Other|13|||
156703313|NCT02329847|565659233|FG004|Overall Study|Other|10|||
156703314|NCT02329847|565659234|FG005|Overall Study|Other|3|||
156703315|NCT03657342|565659235|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
156703316|NCT03657342|565659236|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
156703317|NCT03657342|565659235|FG000|Overall Study|Withdrawal by Subject|4|||
156703318|NCT03657342|565659236|FG001|Overall Study|Withdrawal by Subject|4|||
157124535|NCT01340209|567206234|FG001|Overall Study|Adverse Event|1|||
157124536|NCT01340209|567206235|FG002|Overall Study|Adverse Event|2|||
157124537|NCT01340209|567206233|FG000|Overall Study|Protocol Violation|1|||
157124538|NCT01340209|567206234|FG001|Overall Study|Protocol Violation|2|||
156703319|NCT03657342|565659235|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
156703320|NCT03657342|565659236|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
156703321|NCT03657342|565659235|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
156703322|NCT03657342|565659236|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
156703323|NCT00827632|565659237|FG000|Overall Study|Lost to Follow-up|8|||
156703324|NCT00827632|565659238|FG001|Overall Study|Lost to Follow-up|12|||
156872137|NCT02839200|566289526|FG001|Overall Study|Withdrawal by Subject|0|||
156703325|NCT00827632|565659237|FG000|Overall Study|Early withdrawal|14|||
156703326|NCT00827632|565659238|FG001|Overall Study|Early withdrawal|11|||
156703327|NCT00407758|565659239|FG000|Overall Study|ineligible -improper prior treatment|1|||
156703328|NCT00750308|565659240|FG000|First Treatment|Adverse Event|0|||
156703329|NCT00750308|565659241|FG001|First Treatment|Adverse Event|1|||
156703330|NCT00750308|565659242|FG002|First Treatment|Adverse Event|0|||
156703331|NCT00750308|565659243|FG003|First Treatment|Adverse Event|0|||
156703332|NCT00750308|565659244|FG004|First Treatment|Adverse Event|0|||
156703333|NCT00750308|565659245|FG005|First Treatment|Adverse Event|0|||
156703334|NCT00750308|565659246|FG006|First Treatment|Adverse Event|0|||
156703335|NCT00750308|565659247|FG007|First Treatment|Adverse Event|0|||
156703336|NCT00750308|565659248|FG008|First Treatment|Adverse Event|0|||
156703337|NCT00750308|565659249|FG009|First Treatment|Adverse Event|0|||
156703338|NCT00750308|565659250|FG010|First Treatment|Adverse Event|1|||
156703339|NCT00750308|565659251|FG011|First Treatment|Adverse Event|1|||
156703340|NCT00750308|565659240|FG000|First Treatment|Withdrawal by Subject|0|||
156703341|NCT00750308|565659241|FG001|First Treatment|Withdrawal by Subject|0|||
156703342|NCT00750308|565659242|FG002|First Treatment|Withdrawal by Subject|0|||
156703343|NCT00750308|565659243|FG003|First Treatment|Withdrawal by Subject|1|||
156703344|NCT00750308|565659244|FG004|First Treatment|Withdrawal by Subject|0|||
156703345|NCT00750308|565659245|FG005|First Treatment|Withdrawal by Subject|0|||
156703346|NCT00750308|565659246|FG006|First Treatment|Withdrawal by Subject|0|||
156703347|NCT00750308|565659247|FG007|First Treatment|Withdrawal by Subject|1|||
156703348|NCT00750308|565659248|FG008|First Treatment|Withdrawal by Subject|0|||
156703349|NCT00750308|565659249|FG009|First Treatment|Withdrawal by Subject|0|||
156703350|NCT00750308|565659250|FG010|First Treatment|Withdrawal by Subject|0|||
156703351|NCT00750308|565659251|FG011|First Treatment|Withdrawal by Subject|0|||
156703352|NCT00750308|565659240|FG000|Second Treatment|Adverse Event|0|||
156703353|NCT00750308|565659241|FG001|Second Treatment|Adverse Event|0|||
156703354|NCT00750308|565659242|FG002|Second Treatment|Adverse Event|0|||
156703355|NCT00750308|565659243|FG003|Second Treatment|Adverse Event|0|||
156703356|NCT00750308|565659244|FG004|Second Treatment|Adverse Event|0|||
156703357|NCT00750308|565659245|FG005|Second Treatment|Adverse Event|1|||
156703358|NCT00750308|565659246|FG006|Second Treatment|Adverse Event|0|||
156703359|NCT00750308|565659247|FG007|Second Treatment|Adverse Event|0|||
156703360|NCT00750308|565659248|FG008|Second Treatment|Adverse Event|1|||
156703361|NCT00750308|565659249|FG009|Second Treatment|Adverse Event|0|||
156703362|NCT00750308|565659250|FG010|Second Treatment|Adverse Event|0|||
156703363|NCT00750308|565659251|FG011|Second Treatment|Adverse Event|0|||
156703364|NCT00750308|565659240|FG000|Second Treatment|Withdrawal by Subject|0|||
156703365|NCT00750308|565659241|FG001|Second Treatment|Withdrawal by Subject|0|||
156703366|NCT00750308|565659242|FG002|Second Treatment|Withdrawal by Subject|0|||
156703367|NCT00750308|565659243|FG003|Second Treatment|Withdrawal by Subject|0|||
156703368|NCT00750308|565659244|FG004|Second Treatment|Withdrawal by Subject|1|||
156703369|NCT00750308|565659245|FG005|Second Treatment|Withdrawal by Subject|0|||
156703370|NCT00750308|565659246|FG006|Second Treatment|Withdrawal by Subject|0|||
156703371|NCT00750308|565659247|FG007|Second Treatment|Withdrawal by Subject|0|||
156703372|NCT00750308|565659248|FG008|Second Treatment|Withdrawal by Subject|0|||
156703373|NCT00750308|565659249|FG009|Second Treatment|Withdrawal by Subject|0|||
156703374|NCT00750308|565659250|FG010|Second Treatment|Withdrawal by Subject|0|||
156703375|NCT00750308|565659251|FG011|Second Treatment|Withdrawal by Subject|0|||
156703376|NCT00750308|565659240|FG000|Third Treatment|Withdrawal by Subject|0|||
156703377|NCT00750308|565659241|FG001|Third Treatment|Withdrawal by Subject|1|||
156703378|NCT00750308|565659242|FG002|Third Treatment|Withdrawal by Subject|0|||
156703379|NCT00750308|565659243|FG003|Third Treatment|Withdrawal by Subject|0|||
156703380|NCT00750308|565659244|FG004|Third Treatment|Withdrawal by Subject|0|||
156703381|NCT00750308|565659245|FG005|Third Treatment|Withdrawal by Subject|0|||
156703382|NCT00750308|565659246|FG006|Third Treatment|Withdrawal by Subject|0|||
156703383|NCT00750308|565659247|FG007|Third Treatment|Withdrawal by Subject|0|||
156703384|NCT00750308|565659248|FG008|Third Treatment|Withdrawal by Subject|0|||
156703385|NCT00750308|565659249|FG009|Third Treatment|Withdrawal by Subject|0|||
156791055|NCT02633527|565987140|FG000|Overall Study|Lost to Follow-up|1|||
157015575|NCT02886286|566808889|FG000|Overall Study|pump motor stall|0|||
156791056|NCT02633527|565987141|FG001|Overall Study|Lost to Follow-up|2|||
156791057|NCT02633527|565987142|FG002|Overall Study|Lost to Follow-up|5|||
156703386|NCT00750308|565659250|FG010|Third Treatment|Withdrawal by Subject|0|||
156703387|NCT00750308|565659251|FG011|Third Treatment|Withdrawal by Subject|0|||
156703388|NCT01822275|565659252|FG000|Overall Study|Withdrawal by Subject|3|||
156703389|NCT01822275|565659252|FG000|Overall Study|Adverse Event|3|||
156703390|NCT01822275|565659252|FG000|Overall Study|Progression|14|||
156703391|NCT01822275|565659252|FG000|Overall Study|Physician Decision|2|||
156703392|NCT00513682|565659253|FG000|Washout Phase|Adverse Event|2|||
156703393|NCT02980874|565659254|FG000|Overall Study|Adverse Event|2|||
156791058|NCT02633527|565987143|FG003|Overall Study|Lost to Follow-up|5|||
156703394|NCT02980874|565659255|FG001|Overall Study|Adverse Event|7|||
156703395|NCT02980874|565659254|FG000|Overall Study|Withdrawal by Subject|7|||
156703396|NCT02980874|565659255|FG001|Overall Study|Withdrawal by Subject|2|||
157015576|NCT02886286|566808890|FG001|Overall Study|pump motor stall|1|||
156703397|NCT02980874|565659254|FG000|Overall Study|Lost to Follow-up|5|||
156703398|NCT02980874|565659255|FG001|Overall Study|Lost to Follow-up|5|||
156703399|NCT02980874|565659254|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
156703400|NCT02980874|565659255|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
156703401|NCT02980874|565659254|FG000|Overall Study|Unknown study completion status|1|||
156703402|NCT02980874|565659255|FG001|Overall Study|Unknown study completion status|0|||
156703403|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Adverse Event|0|||
156703404|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Adverse Event|0|||
157124539|NCT01340209|567206235|FG002|Overall Study|Protocol Violation|1|||
156703405|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Adverse Event|2|||
156703406|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Adverse Event|0|||
156703407|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Adverse Event|0|||
156703408|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
156703409|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
157124540|NCT01340209|567206233|FG000|Overall Study|Withdrawal by Subject|0|||
157124541|NCT01340209|567206234|FG001|Overall Study|Withdrawal by Subject|0|||
157124542|NCT01340209|567206235|FG002|Overall Study|Withdrawal by Subject|1|||
157124543|NCT01340209|567206233|FG000|Overall Study|Other reason not defined above|3|||
157124544|NCT01340209|567206234|FG001|Overall Study|Other reason not defined above|5|||
157124545|NCT01340209|567206235|FG002|Overall Study|Other reason not defined above|4|||
157124546|NCT00253630|567206236|FG000|Overall Study|ineligible|2|||
157124547|NCT00209339|567206237|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
157124548|NCT00209339|567206237|FG000|At 12 Months Follow-up|Death|1|||
157124549|NCT00209339|567206237|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
157124550|NCT00209339|567206237|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
157124551|NCT00209339|567206237|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
157124552|NCT00209339|567206237|FG000|At 24 Months Follow-up|Death|1|||
157124553|NCT00209339|567206237|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
157124554|NCT00209339|567206237|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
157124555|NCT00209339|567206237|FG000|At 4 Years Follow-up|Death|1|||
157124556|NCT00209339|567206237|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
157124557|NCT00209339|567206237|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
157124558|NCT00209339|567206237|FG000|At 5 Years Follow-up|Death|1|||
157124559|NCT00429858|567206238|FG000|Overall Study|Withdrawal by Subject|1|||
157124560|NCT00429858|567206238|FG000|Overall Study|Study Termination|1|||
157124561|NCT01587079|567206239|FG000|Overall Study|Protocol-specified criteria|9|||
156703410|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
156703411|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
156703412|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
156703413|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
156703414|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703415|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703416|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703417|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
156703418|NCT02450526|565659256|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
156703419|NCT02450526|565659257|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
156703420|NCT02450526|565659258|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
156703421|NCT02450526|565659259|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
156703422|NCT02450526|565659260|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
156703423|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
156703424|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
156703425|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
156703426|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
156703427|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
156703428|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703429|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703430|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
156703431|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
157124562|NCT01587079|567206239|FG000|Overall Study|Protocol Violation|5|||
157124563|NCT01587079|567206239|FG000|Overall Study|Lost to Follow-up|2|||
157124564|NCT01587079|567206239|FG000|Overall Study|Physician Decision|2|||
157124565|NCT01587079|567206239|FG000|Overall Study|Withdrawal by Subject|7|||
157215304|NCT01252238|567535812|FG001|Overall Study|Sponsor terminated study|4|||
156703432|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
156703433|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703434|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703435|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703436|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
156703437|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
157124566|NCT01587079|567206239|FG000|Overall Study|Adverse Event|14|||
156703438|NCT02450526|565659256|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
157124567|NCT01239160|567206240|FG000|Overall Study|Lost to Follow-up|3|||
157124568|NCT01239160|567206241|FG001|Overall Study|Lost to Follow-up|5|||
157124569|NCT01239160|567206242|FG002|Overall Study|Lost to Follow-up|0|||
157215305|NCT01252238|567535813|FG002|Overall Study|Sponsor terminated study|4|||
157215306|NCT01610167|567535814|FG000|Overall Study|Scheduling conflict.|0|||
157215307|NCT01610167|567535815|FG001|Overall Study|Scheduling conflict.|0|||
157215308|NCT01610167|567535816|FG002|Overall Study|Scheduling conflict.|2|||
157215309|NCT03276962|567535822|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
157215310|NCT03276962|567535823|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
157215311|NCT03276962|567535824|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
157215312|NCT03276962|567535825|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
157215313|NCT03276962|567535826|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
157215314|NCT03276962|567535822|FG000|Overall Study|Protocol Deviation|2|||
157215315|NCT03276962|567535823|FG001|Overall Study|Protocol Deviation|0|||
157215316|NCT03276962|567535824|FG002|Overall Study|Protocol Deviation|1|||
157215317|NCT03276962|567535825|FG003|Overall Study|Protocol Deviation|2|||
157215318|NCT03276962|567535826|FG004|Overall Study|Protocol Deviation|1|||
157215319|NCT03276962|567535822|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
157215320|NCT03276962|567535823|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
157215321|NCT03276962|567535824|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
157215322|NCT03276962|567535825|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
157215323|NCT03276962|567535826|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
157215324|NCT03276962|567535822|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
157215325|NCT03276962|567535823|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
157124570|NCT01239160|567206240|FG000|Overall Study|Withdrawal by Subject|17|||
157124571|NCT01239160|567206241|FG001|Overall Study|Withdrawal by Subject|6|||
157124572|NCT01239160|567206242|FG002|Overall Study|Withdrawal by Subject|2|||
157124573|NCT01239160|567206240|FG000|Overall Study|Physician Decision|5|||
157124574|NCT01239160|567206241|FG001|Overall Study|Physician Decision|7|||
157124575|NCT01239160|567206242|FG002|Overall Study|Physician Decision|2|||
157124576|NCT01239160|567206240|FG000|Overall Study|Early Termination Due to Study Closure|0|||
157124577|NCT01239160|567206241|FG001|Overall Study|Early Termination Due to Study Closure|1|||
157124578|NCT01239160|567206242|FG002|Overall Study|Early Termination Due to Study Closure|6|||
157124579|NCT01764633|567206243|FG000|Overall Study|Withdrawal by Subject|105|||
157124580|NCT01764633|567206244|FG001|Overall Study|Withdrawal by Subject|88|||
157124581|NCT01764633|567206243|FG000|Overall Study|Lost to Follow-up|13|||
157124582|NCT01764633|567206244|FG001|Overall Study|Lost to Follow-up|5|||
157124583|NCT04781816|567206250|FG000|Overall Study|Adverse Event|0|||
157124584|NCT04781816|567206251|FG001|Overall Study|Adverse Event|1|||
157124585|NCT04781816|567206250|FG000|Overall Study|Withdrawal by Subject|1|||
157124586|NCT04781816|567206251|FG001|Overall Study|Withdrawal by Subject|1|||
157124587|NCT04781816|567206250|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
157124588|NCT04781816|567206251|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
157124589|NCT02062658|567206252|FG000|Overall Study|Withdrawal by Subject|1|||
157124590|NCT02062658|567206252|FG000|Overall Study|Lack of Efficacy|1|||
157124591|NCT00643994|567206253|FG000|Overall Study|Death|24|||
157124592|NCT00643994|567206253|FG000|Overall Study|Lost to Follow-up|72|||
157124593|NCT04016311|567206264|FG000|Overall Study|Withdrawal by Subject|1|||
157124594|NCT04016311|567206265|FG001|Overall Study|Withdrawal by Subject|0|||
157124595|NCT01081795|567206268|FG000|Overall Study|Adverse Event|18|||
157124596|NCT01081795|567206269|FG001|Overall Study|Adverse Event|23|||
157124597|NCT01081795|567206270|FG002|Overall Study|Adverse Event|6|||
157124598|NCT01081795|567206268|FG000|Overall Study|Lack of Efficacy|7|||
157124599|NCT01081795|567206269|FG001|Overall Study|Lack of Efficacy|5|||
157124600|NCT01081795|567206270|FG002|Overall Study|Lack of Efficacy|19|||
157124601|NCT01081795|567206268|FG000|Overall Study|Subject's schedule|1|||
157124602|NCT01081795|567206269|FG001|Overall Study|Subject's schedule|1|||
157124603|NCT01081795|567206270|FG002|Overall Study|Subject's schedule|2|||
157124604|NCT01081795|567206268|FG000|Overall Study|Revocation of informed consent|2|||
157124605|NCT01081795|567206269|FG001|Overall Study|Revocation of informed consent|0|||
156703439|NCT02450526|565659257|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
156703440|NCT02450526|565659258|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
157124606|NCT01081795|567206270|FG002|Overall Study|Revocation of informed consent|0|||
157124607|NCT01081795|567206268|FG000|Overall Study|Ineligible for participation|1|||
157124608|NCT01081795|567206269|FG001|Overall Study|Ineligible for participation|0|||
157124609|NCT01081795|567206270|FG002|Overall Study|Ineligible for participation|0|||
156703441|NCT02450526|565659259|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
156703442|NCT02450526|565659260|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
157124610|NCT01081795|567206268|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
156703443|NCT02722148|565659261|FG000|Overall Study|Lost to Follow-up|2|||
157124611|NCT01081795|567206269|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
157124612|NCT01081795|567206270|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
157124613|NCT01081795|567206268|FG000|Overall Study|Using drug with restricted days of use|2|||
157124614|NCT01081795|567206269|FG001|Overall Study|Using drug with restricted days of use|3|||
157215326|NCT03276962|567535824|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
156703444|NCT02722148|565659261|FG000|Overall Study|Non compliant with treatment regimen|3|||
156703445|NCT00911807|565659262|FG000|Overall Study|Adverse Event|2|||
156703446|NCT00911807|565659263|FG001|Overall Study|Adverse Event|1|||
156703447|NCT00911807|565659264|FG002|Overall Study|Adverse Event|5|||
156703448|NCT00911807|565659262|FG000|Overall Study|Death|0|||
156703449|NCT00911807|565659263|FG001|Overall Study|Death|0|||
156703450|NCT00911807|565659264|FG002|Overall Study|Death|1|||
156703451|NCT00911807|565659262|FG000|Overall Study|Protocol Violation|6|||
156703452|NCT00911807|565659263|FG001|Overall Study|Protocol Violation|4|||
156703453|NCT00911807|565659264|FG002|Overall Study|Protocol Violation|9|||
156703454|NCT00911807|565659262|FG000|Overall Study|Withdrawal by Subject|8|||
156703455|NCT00911807|565659263|FG001|Overall Study|Withdrawal by Subject|10|||
156703456|NCT00911807|565659264|FG002|Overall Study|Withdrawal by Subject|7|||
156703457|NCT00911807|565659262|FG000|Overall Study|Organizational reasons|1|||
156703458|NCT00911807|565659263|FG001|Overall Study|Organizational reasons|3|||
156703459|NCT00911807|565659264|FG002|Overall Study|Organizational reasons|1|||
156703460|NCT00855803|565659266|FG000|Overall Study|Death|2|||
156703461|NCT00855803|565659266|FG000|Overall Study|Lost to Follow-up|2|||
156703462|NCT00855803|565659266|FG000|Overall Study|Technical inability to undergo procedure|2|||
156703463|NCT00855803|565659266|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
157124615|NCT01081795|567206270|FG002|Overall Study|Using drug with restricted days of use|2|||
157124616|NCT01081795|567206268|FG000|Overall Study|Other|1|||
157124617|NCT01081795|567206269|FG001|Overall Study|Other|2|||
157124618|NCT01081795|567206270|FG002|Overall Study|Other|0|||
157124619|NCT02462473|567206271|FG000|Overall Study|Death|1|||
157124620|NCT02462473|567206271|FG000|Overall Study|Other|3|||
157124621|NCT01536860|567206272|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
157124622|NCT01536860|567206273|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
157124623|NCT01536860|567206274|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
157124624|NCT01164722|567206275|FG000|Overall Study|Adverse Event|0|||
157124625|NCT01164722|567206276|FG001|Overall Study|Adverse Event|1|||
157124626|NCT01164722|567206275|FG000|Overall Study|Withdrawal by Subject|3|||
157124627|NCT01164722|567206276|FG001|Overall Study|Withdrawal by Subject|4|||
157124628|NCT01164722|567206275|FG000|Overall Study|Lost to Follow-up|3|||
157124629|NCT01164722|567206276|FG001|Overall Study|Lost to Follow-up|6|||
157124630|NCT01164722|567206275|FG000|Overall Study|met protocol criteria for non-treatment|11|||
157124631|NCT01164722|567206276|FG001|Overall Study|met protocol criteria for non-treatment|1|||
157124632|NCT01164722|567206275|FG000|Overall Study|enrolled on other study, concomitant med|1|||
157124633|NCT01164722|567206276|FG001|Overall Study|enrolled on other study, concomitant med|3|||
157124634|NCT03889639|567206278|FG000|Overall Study|Withdrawal by Subject|0|||
157124635|NCT03889639|567206279|FG001|Overall Study|Withdrawal by Subject|0|||
157124636|NCT03889639|567206280|FG002|Overall Study|Withdrawal by Subject|0|||
157124637|NCT03889639|567206281|FG003|Overall Study|Withdrawal by Subject|0|||
157124638|NCT03889639|567206282|FG004|Overall Study|Withdrawal by Subject|0|||
157124639|NCT03889639|567206283|FG005|Overall Study|Withdrawal by Subject|0|||
157124640|NCT03889639|567206284|FG006|Overall Study|Withdrawal by Subject|0|||
157124641|NCT03889639|567206285|FG007|Overall Study|Withdrawal by Subject|1|||
157124642|NCT01703858|567206286|FG000|Overall Study|Withdrawal by Subject|0|||
157124643|NCT01703858|567206287|FG001|Overall Study|Withdrawal by Subject|1|||
157124644|NCT01703858|567206288|FG002|Overall Study|Withdrawal by Subject|0|||
157124645|NCT02556255|567206289|FG000|Overall Study|Lost to Follow-up|4|||
157124646|NCT00993031|567206290|FG000|Overall Study|Death|0|||
157124647|NCT00993031|567206291|FG001|Overall Study|Death|1|||
157124648|NCT00993031|567206290|FG000|Overall Study|Physician Decision|0|||
157124649|NCT00993031|567206291|FG001|Overall Study|Physician Decision|2|||
157124650|NCT00993031|567206290|FG000|Overall Study|Withdrawal by Subject|3|||
157124651|NCT00993031|567206291|FG001|Overall Study|Withdrawal by Subject|3|||
157124652|NCT00993031|567206290|FG000|Overall Study|Lost to Follow-up|19|||
157124653|NCT00993031|567206291|FG001|Overall Study|Lost to Follow-up|13|||
157124654|NCT03115151|567206292|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
157124655|NCT03115151|567206293|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
157124656|NCT03115151|567206292|FG000|Overall Study|Epidural catheter removal|1|||
156703464|NCT00855803|565659266|FG000|Overall Study|Withdrawal by Subject|3|||
156703465|NCT00855803|565659266|FG000|Overall Study|Physician Decision|3|||
156703466|NCT00809159|565659267|FG000|Part 1|Adverse Event|1|||
156703467|NCT00809159|565659268|FG001|Part 1|Adverse Event|1|||
156703468|NCT00809159|565659269|FG002|Part 1|Adverse Event|0|||
157124657|NCT03115151|567206293|FG001|Overall Study|Epidural catheter removal|0|||
157124658|NCT03115151|567206292|FG000|Overall Study|Withdrawal by Subject|0|||
157124659|NCT03115151|567206293|FG001|Overall Study|Withdrawal by Subject|1|||
157124660|NCT03115151|567206292|FG000|Overall Study|Intervention not received according to the protocol.|1|||
157124661|NCT03115151|567206293|FG001|Overall Study|Intervention not received according to the protocol.|1|||
156703469|NCT00809159|565659270|FG003|Part 1|Adverse Event|0|||
156703470|NCT00809159|565659271|FG004|Part 1|Adverse Event|0|||
156703471|NCT00809159|565659272|FG005|Part 1|Adverse Event|0|||
156703472|NCT00809159|565659267|FG000|Part 1|Lost to Follow-up|1|||
156703473|NCT00809159|565659268|FG001|Part 1|Lost to Follow-up|0|||
157124662|NCT03115151|567206292|FG000|Overall Study|Physician Decision|1|||
157124663|NCT03115151|567206293|FG001|Overall Study|Physician Decision|0|||
157124664|NCT03115151|567206292|FG000|Overall Study|Randomization not applied|1|||
157124665|NCT03115151|567206293|FG001|Overall Study|Randomization not applied|1|||
157124666|NCT01834729|567206296|FG000|Overall Study|Did not return bowel diaries|0|||
157124667|NCT01834729|567206297|FG001|Overall Study|Did not return bowel diaries|0|||
157124668|NCT01834729|567206298|FG002|Overall Study|Did not return bowel diaries|3|||
157215327|NCT03276962|567535825|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
157215328|NCT03276962|567535826|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
157215329|NCT03276962|567535822|FG000|Overall Study|Lost to Follow-up|10|||
157215330|NCT03276962|567535823|FG001|Overall Study|Lost to Follow-up|10|||
157215331|NCT03276962|567535824|FG002|Overall Study|Lost to Follow-up|4|||
157215332|NCT03276962|567535825|FG003|Overall Study|Lost to Follow-up|6|||
157215333|NCT03276962|567535826|FG004|Overall Study|Lost to Follow-up|10|||
157215334|NCT03276962|567535822|FG000|Overall Study|Other|0|||
157215335|NCT03276962|567535823|FG001|Overall Study|Other|2|||
157215336|NCT03276962|567535824|FG002|Overall Study|Other|0|||
157215337|NCT03276962|567535825|FG003|Overall Study|Other|2|||
157215338|NCT03276962|567535826|FG004|Overall Study|Other|1|||
157215339|NCT00411762|567535827|FG000|Overall Study|Withdrawal by Subject|5|||
157215340|NCT04428502|567535828|FG000|Overall Study|Did not meet entrance criteria|14|||
157215341|NCT01358708|567535829|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
157215342|NCT01358708|567535830|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157215343|NCT01358708|567535829|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
157215344|NCT01358708|567535830|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
157215345|NCT01364298|567535834|FG000|Overall Study|Adverse Event|3|||
157215346|NCT01364298|567535835|FG001|Overall Study|Adverse Event|4|||
157215347|NCT01364298|567535834|FG000|Overall Study|Lack of adherence to treatment|1|||
157215348|NCT01364298|567535835|FG001|Overall Study|Lack of adherence to treatment|3|||
157215349|NCT01364298|567535834|FG000|Overall Study|Lack of Efficacy|1|||
157215350|NCT01364298|567535835|FG001|Overall Study|Lack of Efficacy|0|||
157215351|NCT01364298|567535834|FG000|Overall Study|Lost to Follow-up|5|||
157215352|NCT01364298|567535835|FG001|Overall Study|Lost to Follow-up|10|||
157215353|NCT01364298|567535834|FG000|Overall Study|Withdrawal by Subject|3|||
157215354|NCT01364298|567535835|FG001|Overall Study|Withdrawal by Subject|3|||
157215355|NCT01364298|567535834|FG000|Overall Study|Other|1|||
157215356|NCT01364298|567535835|FG001|Overall Study|Other|3|||
157215357|NCT00869089|567535845|FG000|Overall Study|Lost to Follow-up|1|||
157215358|NCT00869089|567535845|FG000|Overall Study|Withdrawal by Subject|1|||
157215359|NCT00869089|567535845|FG000|Overall Study|Screen Fail|1|||
157215360|NCT05037409|567535848|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
157215361|NCT05037409|567535849|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
157215362|NCT05037409|567535850|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
157215363|NCT03499249|567535851|FG000|Overall Study|Physician Decision|1|||
157215364|NCT02475980|567535854|FG000|Overall Study|Lost to Follow-up|4|||
157215365|NCT02475980|567535854|FG000|Overall Study|Withdrawal by Subject|1|||
157215366|NCT05003167|567535862|FG000|Overall Study|Withdrawal by Subject|1|||
157215367|NCT00430638|567535863|FG000|Overall Study|Adverse Event|15|||
157215368|NCT00430638|567535864|FG001|Overall Study|Adverse Event|15|||
157215369|NCT00430638|567535863|FG000|Overall Study|Uncontrolled blood pressure|48|||
157215370|NCT00430638|567535864|FG001|Overall Study|Uncontrolled blood pressure|13|||
157215371|NCT00430638|567535863|FG000|Overall Study|Lost to Follow-up|1|||
157215372|NCT00430638|567535864|FG001|Overall Study|Lost to Follow-up|7|||
157215373|NCT00430638|567535863|FG000|Overall Study|Protocol Violation|6|||
157215374|NCT00430638|567535864|FG001|Overall Study|Protocol Violation|4|||
157215375|NCT00430638|567535863|FG000|Overall Study|Withdrawal by Subject|4|||
157215376|NCT00430638|567535864|FG001|Overall Study|Withdrawal by Subject|6|||
157215377|NCT00430638|567535863|FG000|Overall Study|Non-compliant|2|||
157215378|NCT00430638|567535864|FG001|Overall Study|Non-compliant|1|||
157215379|NCT00430638|567535863|FG000|Overall Study|Other|2|||
157215380|NCT00430638|567535864|FG001|Overall Study|Other|2|||
157215381|NCT01529749|567535865|FG000|Overall Study|Lost to Follow-up|0|||
157215382|NCT01529749|567535866|FG001|Overall Study|Lost to Follow-up|1|||
156703474|NCT00809159|565659269|FG002|Part 1|Lost to Follow-up|0|||
157124669|NCT01834729|567206299|FG003|Overall Study|Did not return bowel diaries|0|||
157215383|NCT01529749|567535867|FG002|Overall Study|Lost to Follow-up|1|||
157215384|NCT01529749|567535868|FG003|Overall Study|Lost to Follow-up|0|||
157215385|NCT01529749|567535865|FG000|Overall Study|Physician Decision|0|||
157215386|NCT01529749|567535866|FG001|Overall Study|Physician Decision|0|||
157215387|NCT01529749|567535867|FG002|Overall Study|Physician Decision|0|||
156703475|NCT00809159|565659270|FG003|Part 1|Lost to Follow-up|0|||
157215388|NCT01529749|567535868|FG003|Overall Study|Physician Decision|1|||
157215389|NCT01529749|567535865|FG000|Overall Study|Withdrawal by Subject|0|||
157215390|NCT01529749|567535866|FG001|Overall Study|Withdrawal by Subject|1|||
157215391|NCT01529749|567535867|FG002|Overall Study|Withdrawal by Subject|1|||
157215392|NCT01529749|567535868|FG003|Overall Study|Withdrawal by Subject|0|||
157215393|NCT01529749|567535865|FG000|Overall Study|Protocol Violation|0|||
157215394|NCT01529749|567535866|FG001|Overall Study|Protocol Violation|0|||
156703476|NCT00809159|565659271|FG004|Part 1|Lost to Follow-up|0|||
156703477|NCT00809159|565659272|FG005|Part 1|Lost to Follow-up|0|||
156703478|NCT00809159|565659267|FG000|Part 1|Withdrawal by Subject|3|||
156703479|NCT00809159|565659268|FG001|Part 1|Withdrawal by Subject|1|||
156703480|NCT00809159|565659269|FG002|Part 1|Withdrawal by Subject|0|||
156703481|NCT00809159|565659270|FG003|Part 1|Withdrawal by Subject|0|||
156703482|NCT00809159|565659271|FG004|Part 1|Withdrawal by Subject|0|||
156703483|NCT00809159|565659272|FG005|Part 1|Withdrawal by Subject|0|||
156703484|NCT00809159|565659267|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
156703485|NCT00809159|565659268|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
156703486|NCT00809159|565659269|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
156703487|NCT00809159|565659270|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
156703488|NCT00809159|565659271|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
156703489|NCT00809159|565659272|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
156703490|NCT00809159|565659267|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
156703491|NCT00809159|565659268|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
156703492|NCT00809159|565659269|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
156703493|NCT00809159|565659270|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
156703494|NCT00809159|565659271|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
156703495|NCT00809159|565659272|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
156703496|NCT00809159|565659267|FG000|Part 1 and 2|Administrative problems|0|||
156703497|NCT00809159|565659268|FG001|Part 1 and 2|Administrative problems|0|||
156703498|NCT00809159|565659269|FG002|Part 1 and 2|Administrative problems|0|||
156703499|NCT00809159|565659270|FG003|Part 1 and 2|Administrative problems|1|||
156703500|NCT00809159|565659271|FG004|Part 1 and 2|Administrative problems|0|||
156703501|NCT00809159|565659272|FG005|Part 1 and 2|Administrative problems|0|||
156703502|NCT00809159|565659267|FG000|Part 1 and 2|Adverse Event|0|||
156703503|NCT00809159|565659268|FG001|Part 1 and 2|Adverse Event|0|||
156703504|NCT00809159|565659269|FG002|Part 1 and 2|Adverse Event|1|||
156703505|NCT00809159|565659270|FG003|Part 1 and 2|Adverse Event|0|||
156703506|NCT00809159|565659271|FG004|Part 1 and 2|Adverse Event|1|||
156703507|NCT00809159|565659272|FG005|Part 1 and 2|Adverse Event|1|||
156703508|NCT00809159|565659267|FG000|Part 1 and 2|Lost to Follow-up|0|||
156703509|NCT00809159|565659268|FG001|Part 1 and 2|Lost to Follow-up|0|||
156703510|NCT00809159|565659269|FG002|Part 1 and 2|Lost to Follow-up|1|||
156703511|NCT00809159|565659270|FG003|Part 1 and 2|Lost to Follow-up|1|||
156703512|NCT00809159|565659271|FG004|Part 1 and 2|Lost to Follow-up|0|||
156703513|NCT00809159|565659272|FG005|Part 1 and 2|Lost to Follow-up|0|||
156703514|NCT00809159|565659267|FG000|Part 1 and 2|Withdrawal by Subject|0|||
156703515|NCT00809159|565659268|FG001|Part 1 and 2|Withdrawal by Subject|0|||
156703516|NCT00809159|565659269|FG002|Part 1 and 2|Withdrawal by Subject|4|||
156703517|NCT00809159|565659270|FG003|Part 1 and 2|Withdrawal by Subject|0|||
156703518|NCT00809159|565659271|FG004|Part 1 and 2|Withdrawal by Subject|0|||
156703519|NCT00809159|565659272|FG005|Part 1 and 2|Withdrawal by Subject|1|||
156703520|NCT04568031|565659275|FG000|Overall Study|Lost to Follow-up|1|||
156703521|NCT04568031|565659276|FG001|Overall Study|Lost to Follow-up|0|||
157124670|NCT01834729|567206296|FG000|Overall Study|Withdrawal by Subject|1|||
157124671|NCT01834729|567206297|FG001|Overall Study|Withdrawal by Subject|1|||
157124672|NCT01834729|567206298|FG002|Overall Study|Withdrawal by Subject|0|||
157124673|NCT01834729|567206299|FG003|Overall Study|Withdrawal by Subject|0|||
157124674|NCT01834729|567206296|FG000|Overall Study|Adverse Event|0|||
157124675|NCT01834729|567206297|FG001|Overall Study|Adverse Event|0|||
157124676|NCT01834729|567206298|FG002|Overall Study|Adverse Event|0|||
157124677|NCT01834729|567206299|FG003|Overall Study|Adverse Event|2|||
157124678|NCT01543087|567206300|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
157124679|NCT01543087|567206301|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
157124680|NCT01543087|567206302|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
157124681|NCT01543087|567206303|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
157124682|NCT01543087|567206304|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
157124683|NCT01543087|567206305|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
157124684|NCT01543087|567206300|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
156703522|NCT04568031|565659277|FG002|Overall Study|Lost to Follow-up|0|||
156703523|NCT04568031|565659278|FG003|Overall Study|Lost to Follow-up|0|||
156703524|NCT04568031|565659275|FG000|Overall Study|Physician Decision|1|||
157124685|NCT01543087|567206301|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
156703525|NCT04568031|565659276|FG001|Overall Study|Physician Decision|0|||
156703526|NCT04568031|565659277|FG002|Overall Study|Physician Decision|1|||
156703527|NCT04568031|565659278|FG003|Overall Study|Physician Decision|0|||
156703528|NCT04568031|565659275|FG000|Overall Study|Withdrawal by Subject|1|||
156703529|NCT04568031|565659276|FG001|Overall Study|Withdrawal by Subject|0|||
156703530|NCT04568031|565659277|FG002|Overall Study|Withdrawal by Subject|4|||
156703531|NCT04568031|565659278|FG003|Overall Study|Withdrawal by Subject|1|||
157124686|NCT01543087|567206302|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
156703532|NCT02304458|565659279|FG000|Overall Study|Adverse Event|0|||
156703533|NCT02304458|565659280|FG001|Overall Study|Adverse Event|0|||
156703534|NCT02304458|565659281|FG002|Overall Study|Adverse Event|7|||
156703535|NCT02304458|565659282|FG003|Overall Study|Adverse Event|0|||
156703536|NCT02304458|565659283|FG004|Overall Study|Adverse Event|0|||
156703537|NCT02304458|565659284|FG005|Overall Study|Adverse Event|0|||
156703538|NCT02304458|565659285|FG006|Overall Study|Adverse Event|3|||
156703539|NCT02304458|565659286|FG007|Overall Study|Adverse Event|4|||
156703540|NCT02304458|565659279|FG000|Overall Study|Death|0|||
156703541|NCT02304458|565659280|FG001|Overall Study|Death|0|||
156703542|NCT02304458|565659281|FG002|Overall Study|Death|2|||
156703543|NCT02304458|565659282|FG003|Overall Study|Death|0|||
156703544|NCT02304458|565659283|FG004|Overall Study|Death|0|||
156703545|NCT02304458|565659284|FG005|Overall Study|Death|0|||
156703546|NCT02304458|565659285|FG006|Overall Study|Death|1|||
156703547|NCT02304458|565659286|FG007|Overall Study|Death|0|||
156703548|NCT02304458|565659279|FG000|Overall Study|Lack of Efficacy|4|||
156703549|NCT02304458|565659280|FG001|Overall Study|Lack of Efficacy|6|||
156703550|NCT02304458|565659281|FG002|Overall Study|Lack of Efficacy|38|||
156703551|NCT02304458|565659282|FG003|Overall Study|Lack of Efficacy|5|||
156703552|NCT02304458|565659283|FG004|Overall Study|Lack of Efficacy|6|||
156703553|NCT02304458|565659284|FG005|Overall Study|Lack of Efficacy|6|||
156703554|NCT02304458|565659285|FG006|Overall Study|Lack of Efficacy|21|||
156703555|NCT02304458|565659286|FG007|Overall Study|Lack of Efficacy|4|||
156703556|NCT02304458|565659279|FG000|Overall Study|Physician Decision|2|||
156703557|NCT02304458|565659280|FG001|Overall Study|Physician Decision|0|||
156703558|NCT02304458|565659281|FG002|Overall Study|Physician Decision|16|||
156703559|NCT02304458|565659282|FG003|Overall Study|Physician Decision|1|||
156703560|NCT02304458|565659283|FG004|Overall Study|Physician Decision|0|||
156703561|NCT02304458|565659284|FG005|Overall Study|Physician Decision|0|||
156703562|NCT02304458|565659285|FG006|Overall Study|Physician Decision|3|||
156703563|NCT02304458|565659286|FG007|Overall Study|Physician Decision|0|||
156703564|NCT02304458|565659279|FG000|Overall Study|Protocol Violation|0|||
156703565|NCT02304458|565659280|FG001|Overall Study|Protocol Violation|0|||
156703566|NCT02304458|565659281|FG002|Overall Study|Protocol Violation|1|||
156703567|NCT02304458|565659282|FG003|Overall Study|Protocol Violation|0|||
156703568|NCT02304458|565659283|FG004|Overall Study|Protocol Violation|0|||
156703569|NCT02304458|565659284|FG005|Overall Study|Protocol Violation|0|||
156703570|NCT02304458|565659285|FG006|Overall Study|Protocol Violation|0|||
156703571|NCT02304458|565659286|FG007|Overall Study|Protocol Violation|0|||
156703572|NCT02304458|565659279|FG000|Overall Study|Withdrawal by Subject|1|||
156703573|NCT02304458|565659280|FG001|Overall Study|Withdrawal by Subject|0|||
156703574|NCT02304458|565659281|FG002|Overall Study|Withdrawal by Subject|7|||
156703575|NCT02304458|565659282|FG003|Overall Study|Withdrawal by Subject|0|||
156703576|NCT02304458|565659283|FG004|Overall Study|Withdrawal by Subject|0|||
156703577|NCT02304458|565659284|FG005|Overall Study|Withdrawal by Subject|0|||
156703578|NCT02304458|565659285|FG006|Overall Study|Withdrawal by Subject|1|||
156703579|NCT02304458|565659286|FG007|Overall Study|Withdrawal by Subject|0|||
156703580|NCT00186043|565659287|FG000|Overall Study|Lack of Efficacy|1|||
156703581|NCT00186043|565659288|FG001|Overall Study|Lack of Efficacy|3|||
156703582|NCT00186043|565659287|FG000|Overall Study|Lost to Follow-up|4|||
156703583|NCT00186043|565659288|FG001|Overall Study|Lost to Follow-up|6|||
156703584|NCT00186043|565659287|FG000|Overall Study|Withdrawal by Subject|1|||
156703585|NCT00186043|565659288|FG001|Overall Study|Withdrawal by Subject|0|||
156703586|NCT00186043|565659287|FG000|Overall Study|Adverse Event|7|||
156703587|NCT00186043|565659288|FG001|Overall Study|Adverse Event|3|||
156703588|NCT00186043|565659287|FG000|Overall Study|Protocol Violation|2|||
156703589|NCT00186043|565659288|FG001|Overall Study|Protocol Violation|1|||
156703590|NCT04188301|565659291|FG000|Month 3|Lost to Follow-up|0|||
156703591|NCT04188301|565659292|FG001|Month 3|Lost to Follow-up|0|||
156703592|NCT04188301|565659293|FG002|Month 3|Lost to Follow-up|1|||
156703593|NCT04188301|565659291|FG000|Month 12|Lost to Follow-up|0|||
156703594|NCT04188301|565659292|FG001|Month 12|Lost to Follow-up|0|||
156703595|NCT04188301|565659293|FG002|Month 12|Lost to Follow-up|2|||
156703596|NCT04188301|565659291|FG000|Month 12|Death|1|||
156703597|NCT04188301|565659292|FG001|Month 12|Death|1|||
156703598|NCT04188301|565659293|FG002|Month 12|Death|0|||
156703599|NCT04188301|565659291|FG000|Month 18|Lost to Follow-up|6|||
156703600|NCT04188301|565659292|FG001|Month 18|Lost to Follow-up|0|||
156703601|NCT04188301|565659293|FG002|Month 18|Lost to Follow-up|0|||
156703602|NCT00228423|565659294|FG000|Overall Study|Adverse Event|2|||
156703603|NCT00228423|565659295|FG001|Overall Study|Adverse Event|5|||
156703604|NCT00228423|565659294|FG000|Overall Study|Withdrawal by Subject|7|||
156703605|NCT00228423|565659295|FG001|Overall Study|Withdrawal by Subject|3|||
156703606|NCT00228423|565659294|FG000|Overall Study|Protocol Violation|1|||
156703607|NCT00228423|565659295|FG001|Overall Study|Protocol Violation|3|||
156703608|NCT00228423|565659294|FG000|Overall Study|Physician Decision|0|||
156703609|NCT00228423|565659295|FG001|Overall Study|Physician Decision|1|||
156703610|NCT03258853|565659302|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
156703611|NCT03258853|565659303|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
156703612|NCT01709838|565659304|FG000|Overall Study|Withdrawal by Subject|21|||
156703613|NCT01709838|565659304|FG000|Overall Study|Lost to Follow-up|16|||
156703614|NCT01709838|565659304|FG000|Overall Study|Pregnancy|10|||
156703615|NCT01709838|565659304|FG000|Overall Study|Subject/guardian decision|8|||
156703616|NCT01709838|565659304|FG000|Overall Study|Adverse Event|4|||
156703617|NCT01709838|565659304|FG000|Overall Study|Physician Decision|4|||
156703618|NCT01709838|565659304|FG000|Overall Study|Death|3|||
156703619|NCT01709838|565659304|FG000|Overall Study|Protocol Violation|1|||
156703620|NCT04241315|565661191|FG000|Overall Study|Withdrawal by Subject|0|||
156703621|NCT04241315|565661192|FG001|Overall Study|Withdrawal by Subject|1|||
156703622|NCT01555671|565661193|FG000|Overall Study|Physician Decision|20|||
156703623|NCT01555671|565661194|FG001|Overall Study|Physician Decision|25|||
156703624|NCT03047330|565661195|FG000|Sleep Block 1|Withdrawal by Subject|3|||
156703625|NCT00663026|565661202|FG000|Overall Study|Lost to Follow-up|1|||
156703626|NCT00663026|565661203|FG001|Overall Study|Lost to Follow-up|0|||
156703627|NCT00663026|565661204|FG002|Overall Study|Lost to Follow-up|0|||
156703628|NCT00663026|565661202|FG000|Overall Study|Other|1|||
156703629|NCT00663026|565661203|FG001|Overall Study|Other|2|||
156703630|NCT00663026|565661204|FG002|Overall Study|Other|0|||
156703631|NCT00663026|565661202|FG000|Overall Study|Adverse Event|0|||
156703632|NCT00663026|565661203|FG001|Overall Study|Adverse Event|2|||
156703633|NCT00663026|565661204|FG002|Overall Study|Adverse Event|3|||
156703634|NCT00663026|565661202|FG000|Overall Study|Caregiver Request|0|||
156703635|NCT00663026|565661203|FG001|Overall Study|Caregiver Request|2|||
156703636|NCT00663026|565661204|FG002|Overall Study|Caregiver Request|0|||
156703637|NCT00663026|565661202|FG000|Overall Study|Withdrawal by Subject|0|||
156703638|NCT00663026|565661203|FG001|Overall Study|Withdrawal by Subject|0|||
156703639|NCT00663026|565661204|FG002|Overall Study|Withdrawal by Subject|1|||
156703640|NCT04003896|565661205|FG000|Overall Study|Withdrawal by Subject|3|||
156703641|NCT04003896|565661205|FG000|Overall Study|Physician Decision|1|||
156703642|NCT03929757|565661206|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
156703643|NCT03929757|565661207|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
156703644|NCT03929757|565661208|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
156703645|NCT03929757|565661206|FG000|Main Study: Up to Day 365|Other|1|||
156703646|NCT03929757|565661207|FG001|Main Study: Up to Day 365|Other|0|||
156703647|NCT03929757|565661208|FG002|Main Study: Up to Day 365|Other|0|||
156703648|NCT03929757|565661206|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
156703649|NCT03929757|565661207|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
156703650|NCT03929757|565661208|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
156703651|NCT01154816|565661209|FG000|Overall Study|Withdrawal by Subject|1|||
156703652|NCT01154816|565661210|FG001|Overall Study|Withdrawal by Subject|0|||
156703653|NCT01154816|565661211|FG002|Overall Study|Withdrawal by Subject|0|||
156703654|NCT01154816|565661212|FG003|Overall Study|Withdrawal by Subject|1|||
156703655|NCT01154816|565661213|FG004|Overall Study|Withdrawal by Subject|0|||
156703656|NCT01154816|565661214|FG005|Overall Study|Withdrawal by Subject|0|||
156703657|NCT01154816|565661215|FG006|Overall Study|Withdrawal by Subject|0|||
156703658|NCT01154816|565661216|FG007|Overall Study|Withdrawal by Subject|0|||
156703659|NCT01154816|565661217|FG008|Overall Study|Withdrawal by Subject|1|||
156703660|NCT01154816|565661218|FG009|Overall Study|Withdrawal by Subject|3|||
156703661|NCT01154816|565661219|FG010|Overall Study|Withdrawal by Subject|0|||
156703662|NCT01154816|565661220|FG011|Overall Study|Withdrawal by Subject|0|||
156703663|NCT01154816|565661209|FG000|Overall Study|Progressive Disease|13|||
156703664|NCT01154816|565661210|FG001|Overall Study|Progressive Disease|8|||
156703665|NCT01154816|565661211|FG002|Overall Study|Progressive Disease|9|||
156703666|NCT01154816|565661212|FG003|Overall Study|Progressive Disease|9|||
156703667|NCT01154816|565661213|FG004|Overall Study|Progressive Disease|8|||
156703668|NCT01154816|565661214|FG005|Overall Study|Progressive Disease|8|||
156703669|NCT01154816|565661215|FG006|Overall Study|Progressive Disease|5|||
156703670|NCT01154816|565661216|FG007|Overall Study|Progressive Disease|6|||
156703671|NCT01154816|565661217|FG008|Overall Study|Progressive Disease|8|||
156703672|NCT01154816|565661218|FG009|Overall Study|Progressive Disease|6|||
156703673|NCT01154816|565661219|FG010|Overall Study|Progressive Disease|10|||
156703674|NCT01154816|565661220|FG011|Overall Study|Progressive Disease|3|||
156703675|NCT01154816|565661209|FG000|Overall Study|Physician Decision|1|||
156703676|NCT01154816|565661210|FG001|Overall Study|Physician Decision|0|||
156703677|NCT01154816|565661211|FG002|Overall Study|Physician Decision|1|||
157015577|NCT00390299|566808891|FG000|Overall Study|Cancellation|1|||
157015578|NCT00390299|566808892|FG001|Overall Study|Cancellation|0|||
156703678|NCT01154816|565661212|FG003|Overall Study|Physician Decision|0|||
156703679|NCT01154816|565661213|FG004|Overall Study|Physician Decision|2|||
156703680|NCT01154816|565661214|FG005|Overall Study|Physician Decision|0|||
156703681|NCT01154816|565661215|FG006|Overall Study|Physician Decision|0|||
156703682|NCT01154816|565661216|FG007|Overall Study|Physician Decision|0|||
156703683|NCT01154816|565661217|FG008|Overall Study|Physician Decision|0|||
156703684|NCT01154816|565661218|FG009|Overall Study|Physician Decision|1|||
156703685|NCT01154816|565661219|FG010|Overall Study|Physician Decision|1|||
156703686|NCT01154816|565661220|FG011|Overall Study|Physician Decision|1|||
156703687|NCT01154816|565661209|FG000|Overall Study|Adverse Event|5|||
156703688|NCT01154816|565661210|FG001|Overall Study|Adverse Event|2|||
156703689|NCT01154816|565661211|FG002|Overall Study|Adverse Event|0|||
156703690|NCT01154816|565661212|FG003|Overall Study|Adverse Event|0|||
156703691|NCT01154816|565661213|FG004|Overall Study|Adverse Event|0|||
156703692|NCT01154816|565661214|FG005|Overall Study|Adverse Event|0|||
156703693|NCT01154816|565661215|FG006|Overall Study|Adverse Event|1|||
156703694|NCT01154816|565661216|FG007|Overall Study|Adverse Event|1|||
156703695|NCT01154816|565661217|FG008|Overall Study|Adverse Event|0|||
156703696|NCT01154816|565661218|FG009|Overall Study|Adverse Event|0|||
156703697|NCT01154816|565661219|FG010|Overall Study|Adverse Event|0|||
156703698|NCT01154816|565661220|FG011|Overall Study|Adverse Event|0|||
156703699|NCT00806286|565661221|FG000|Overall Study|Adverse Event|5|||
156703700|NCT00806286|565661222|FG001|Overall Study|Adverse Event|2|||
156703701|NCT00806286|565661223|FG002|Overall Study|Adverse Event|0|||
156703702|NCT00806286|565661221|FG000|Overall Study|Disease progression|31|||
156703703|NCT00806286|565661222|FG001|Overall Study|Disease progression|38|||
156703704|NCT00806286|565661223|FG002|Overall Study|Disease progression|1|||
156703705|NCT00806286|565661221|FG000|Overall Study|Death|1|||
156703706|NCT00806286|565661222|FG001|Overall Study|Death|6|||
156703707|NCT00806286|565661223|FG002|Overall Study|Death|0|||
156703708|NCT00806286|565661221|FG000|Overall Study|Lost to Follow-up|0|||
156703709|NCT00806286|565661222|FG001|Overall Study|Lost to Follow-up|1|||
156703710|NCT00806286|565661223|FG002|Overall Study|Lost to Follow-up|0|||
156703711|NCT00806286|565661221|FG000|Overall Study|Withdrawal by Subject|8|||
156703712|NCT00806286|565661222|FG001|Overall Study|Withdrawal by Subject|3|||
156703713|NCT00806286|565661223|FG002|Overall Study|Withdrawal by Subject|1|||
156703714|NCT00806286|565661221|FG000|Overall Study|Physician Decision|2|||
156703715|NCT00806286|565661222|FG001|Overall Study|Physician Decision|2|||
156703716|NCT00806286|565661223|FG002|Overall Study|Physician Decision|0|||
156703717|NCT00806286|565661221|FG000|Overall Study|Due to a variety of reasons|7|||
156703718|NCT00806286|565661222|FG001|Overall Study|Due to a variety of reasons|2|||
156703719|NCT00806286|565661223|FG002|Overall Study|Due to a variety of reasons|1|||
156703720|NCT00686075|565661224|FG000|Overall Study|Withdrawal by Subject|4|||
156703721|NCT00686075|565661225|FG001|Overall Study|Withdrawal by Subject|3|||
156703722|NCT00686075|565661226|FG002|Overall Study|Withdrawal by Subject|3|||
156791059|NCT02633527|565987144|FG004|Overall Study|Lost to Follow-up|4|||
156791060|NCT02633527|565987140|FG000|Overall Study|Withdrawal by Subject|0|||
156791061|NCT02633527|565987141|FG001|Overall Study|Withdrawal by Subject|3|||
157215395|NCT01529749|567535867|FG002|Overall Study|Protocol Violation|0|||
156791062|NCT02633527|565987142|FG002|Overall Study|Withdrawal by Subject|5|||
156791063|NCT02633527|565987143|FG003|Overall Study|Withdrawal by Subject|4|||
156791064|NCT02633527|565987144|FG004|Overall Study|Withdrawal by Subject|4|||
156791065|NCT02633527|565987140|FG000|Overall Study|Protocol Violation|0|||
156791066|NCT02633527|565987141|FG001|Overall Study|Protocol Violation|1|||
156791067|NCT02633527|565987142|FG002|Overall Study|Protocol Violation|1|||
156791068|NCT02633527|565987143|FG003|Overall Study|Protocol Violation|1|||
156791069|NCT02633527|565987144|FG004|Overall Study|Protocol Violation|1|||
156791070|NCT02633527|565987140|FG000|Overall Study|Physician Decision|0|||
156791071|NCT02633527|565987141|FG001|Overall Study|Physician Decision|0|||
156791072|NCT02633527|565987142|FG002|Overall Study|Physician Decision|0|||
156791073|NCT02633527|565987143|FG003|Overall Study|Physician Decision|0|||
156791074|NCT02633527|565987144|FG004|Overall Study|Physician Decision|1|||
156703723|NCT00686075|565661227|FG003|Overall Study|Withdrawal by Subject|7|||
156703724|NCT00686075|565661228|FG004|Overall Study|Withdrawal by Subject|1|||
156703725|NCT00686075|565661229|FG005|Overall Study|Withdrawal by Subject|0|||
156703726|NCT00686075|565661230|FG006|Overall Study|Withdrawal by Subject|0|||
156703727|NCT00686075|565661231|FG007|Overall Study|Withdrawal by Subject|2|||
156703728|NCT00686075|565661232|FG008|Overall Study|Withdrawal by Subject|4|||
156703729|NCT00686075|565661233|FG009|Overall Study|Withdrawal by Subject|6|||
156703730|NCT00686075|565661224|FG000|Overall Study|Lost to Follow-up|3|||
156703731|NCT00686075|565661225|FG001|Overall Study|Lost to Follow-up|6|||
156703732|NCT00686075|565661226|FG002|Overall Study|Lost to Follow-up|3|||
156791075|NCT02633527|565987140|FG000|Overall Study|Administrative reason|1|||
156791076|NCT02633527|565987141|FG001|Overall Study|Administrative reason|0|||
156791077|NCT02633527|565987142|FG002|Overall Study|Administrative reason|0|||
157015579|NCT00390299|566808893|FG002|Overall Study|Cancellation|0|||
157015580|NCT00390299|566808894|FG003|Overall Study|Cancellation|0|||
157015581|NCT00390299|566808895|FG004|Overall Study|Cancellation|0|||
157015582|NCT01070069|566808897|FG000|Overall Study|Death|1|||
157015583|NCT01070069|566808898|FG001|Overall Study|Death|0|||
157015584|NCT01070069|566808899|FG002|Overall Study|Death|2|||
157015585|NCT01070069|566808900|FG003|Overall Study|Death|0|||
157015586|NCT01070069|566808901|FG004|Overall Study|Death|1|||
157015587|NCT01070069|566808897|FG000|Overall Study|Withdrawal by Subject|1|||
157015588|NCT01070069|566808898|FG001|Overall Study|Withdrawal by Subject|1|||
157015589|NCT01070069|566808899|FG002|Overall Study|Withdrawal by Subject|4|||
157015590|NCT01070069|566808900|FG003|Overall Study|Withdrawal by Subject|0|||
157015591|NCT01070069|566808901|FG004|Overall Study|Withdrawal by Subject|0|||
157015592|NCT01070069|566808897|FG000|Overall Study|Lost to Follow-up|4|||
157015593|NCT01070069|566808898|FG001|Overall Study|Lost to Follow-up|1|||
157015594|NCT01070069|566808899|FG002|Overall Study|Lost to Follow-up|0|||
157015595|NCT01070069|566808900|FG003|Overall Study|Lost to Follow-up|0|||
157015596|NCT01070069|566808901|FG004|Overall Study|Lost to Follow-up|3|||
157015597|NCT00262301|566808902|FG000|Double-blind Phase|Lost to Follow-up|1|||
157015598|NCT00262301|566808903|FG001|Double-blind Phase|Lost to Follow-up|0|||
156872138|NCT02839200|566289527|FG002|Overall Study|Withdrawal by Subject|1|||
156872139|NCT02839200|566289528|FG003|Overall Study|Withdrawal by Subject|0|||
156872140|NCT02839200|566289529|FG004|Overall Study|Withdrawal by Subject|0|||
156872141|NCT02839200|566289530|FG005|Overall Study|Withdrawal by Subject|1|||
156872142|NCT02839200|566289525|FG000|Overall Study|Lost to Follow-up|2|||
156872143|NCT02839200|566289526|FG001|Overall Study|Lost to Follow-up|0|||
156872144|NCT02839200|566289527|FG002|Overall Study|Lost to Follow-up|0|||
156872145|NCT02839200|566289528|FG003|Overall Study|Lost to Follow-up|0|||
156872146|NCT02839200|566289529|FG004|Overall Study|Lost to Follow-up|1|||
156872147|NCT02839200|566289530|FG005|Overall Study|Lost to Follow-up|0|||
156872148|NCT02839200|566289525|FG000|Overall Study|Adverse Event|0|||
156703733|NCT00686075|565661227|FG003|Overall Study|Lost to Follow-up|2|||
156703734|NCT00686075|565661228|FG004|Overall Study|Lost to Follow-up|3|||
156703735|NCT00686075|565661229|FG005|Overall Study|Lost to Follow-up|3|||
156703736|NCT00686075|565661230|FG006|Overall Study|Lost to Follow-up|0|||
156703737|NCT00686075|565661231|FG007|Overall Study|Lost to Follow-up|0|||
156703738|NCT00686075|565661232|FG008|Overall Study|Lost to Follow-up|2|||
156703739|NCT00686075|565661233|FG009|Overall Study|Lost to Follow-up|3|||
156703740|NCT00686075|565661224|FG000|Overall Study|Other|1|||
156703741|NCT00686075|565661225|FG001|Overall Study|Other|1|||
156703742|NCT00686075|565661226|FG002|Overall Study|Other|0|||
156703743|NCT00686075|565661227|FG003|Overall Study|Other|0|||
156703744|NCT00686075|565661228|FG004|Overall Study|Other|0|||
156703745|NCT00686075|565661229|FG005|Overall Study|Other|0|||
156703746|NCT00686075|565661230|FG006|Overall Study|Other|0|||
156703747|NCT00686075|565661231|FG007|Overall Study|Other|0|||
156703748|NCT00686075|565661232|FG008|Overall Study|Other|0|||
156703749|NCT00686075|565661233|FG009|Overall Study|Other|1|||
156703750|NCT03783039|565661234|FG000|Overall Study|Death|2|||
156703751|NCT03783039|565661235|FG001|Overall Study|Death|1|||
156703752|NCT01682863|565661236|FG000|Overall Study|Subject/guardian decision|19|||
156703753|NCT01682863|565661237|FG001|Overall Study|Subject/guardian decision|12|||
156703754|NCT01682863|565661238|FG002|Overall Study|Subject/guardian decision|10|||
156703755|NCT01682863|565661236|FG000|Overall Study|Lost to Follow-up|5|||
156703756|NCT01682863|565661237|FG001|Overall Study|Lost to Follow-up|1|||
156703757|NCT01682863|565661238|FG002|Overall Study|Lost to Follow-up|6|||
156703758|NCT01682863|565661236|FG000|Overall Study|Death|1|||
156703759|NCT01682863|565661237|FG001|Overall Study|Death|3|||
156703760|NCT01682863|565661238|FG002|Overall Study|Death|4|||
156703761|NCT01682863|565661236|FG000|Overall Study|Protocol deviation|1|||
156703762|NCT01682863|565661237|FG001|Overall Study|Protocol deviation|0|||
156703763|NCT01682863|565661238|FG002|Overall Study|Protocol deviation|1|||
156703764|NCT01682863|565661236|FG000|Overall Study|Technical problems|1|||
156703765|NCT01682863|565661237|FG001|Overall Study|Technical problems|0|||
156703766|NCT01682863|565661238|FG002|Overall Study|Technical problems|0|||
156703767|NCT01682863|565661236|FG000|Overall Study|Adverse Event|0|||
156703768|NCT01682863|565661237|FG001|Overall Study|Adverse Event|1|||
156703769|NCT01682863|565661238|FG002|Overall Study|Adverse Event|2|||
156703770|NCT01682863|565661236|FG000|Overall Study|Physician Decision|0|||
156703771|NCT01682863|565661237|FG001|Overall Study|Physician Decision|0|||
156703772|NCT01682863|565661238|FG002|Overall Study|Physician Decision|1|||
156703773|NCT00977379|565661239|FG000|Overall Study|Withdrawal by Subject|1|||
156703774|NCT00977379|565661240|FG001|Overall Study|Withdrawal by Subject|1|||
156703775|NCT00977379|565661239|FG000|Overall Study|Death|7|||
156703776|NCT00977379|565661240|FG001|Overall Study|Death|9|||
156703777|NCT00977379|565661239|FG000|Overall Study|Premature Study Termination|4|||
156703778|NCT00977379|565661240|FG001|Overall Study|Premature Study Termination|0|||
156703779|NCT00977379|565661239|FG000|Overall Study|Participant Moving House|0|||
156872149|NCT02839200|566289526|FG001|Overall Study|Adverse Event|0|||
156703780|NCT00977379|565661240|FG001|Overall Study|Participant Moving House|1|||
156703781|NCT00977379|565661239|FG000|Overall Study|Randomization Error|0|||
156703782|NCT00977379|565661240|FG001|Overall Study|Randomization Error|1|||
156703783|NCT00918138|565661241|FG000|Overall Study|Subject withdrew consent|1|||
156703784|NCT00918138|565661242|FG001|Overall Study|Subject withdrew consent|1|||
156703785|NCT00918138|565661241|FG000|Overall Study|Death|1|||
156703786|NCT00918138|565661242|FG001|Overall Study|Death|0|||
156703787|NCT03972163|565661243|FG000|Overall Study|Death|0|||
156703788|NCT03972163|565661244|FG001|Overall Study|Death|1|||
156872150|NCT02839200|566289527|FG002|Overall Study|Adverse Event|0|||
156872151|NCT02839200|566289528|FG003|Overall Study|Adverse Event|0|||
156872152|NCT02839200|566289529|FG004|Overall Study|Adverse Event|1|||
156703789|NCT01199471|565661245|FG000|Overall Study|Protocol Violation|4|||
156703790|NCT01199471|565661245|FG000|Overall Study|Withdrawal by Subject|1|||
156703791|NCT01199471|565661245|FG000|Overall Study|Physician Decision|1|||
156703792|NCT02006693|565661246|FG000|Overall Study|No Reason Specified|6|||
156703793|NCT02006693|565661247|FG001|Overall Study|No Reason Specified|8|||
156703794|NCT02006693|565661246|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
156703795|NCT02006693|565661247|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
156703796|NCT02006693|565661246|FG000|Overall Study|XEN Implant Explantation|0|||
156703797|NCT02006693|565661247|FG001|Overall Study|XEN Implant Explantation|1|||
156872153|NCT02839200|566289530|FG005|Overall Study|Adverse Event|0|||
156703798|NCT02006693|565661246|FG000|Overall Study|Death|2|||
156703799|NCT02006693|565661247|FG001|Overall Study|Death|2|||
156703800|NCT02006693|565661246|FG000|Overall Study|Lost to Follow-up|4|||
156703801|NCT02006693|565661247|FG001|Overall Study|Lost to Follow-up|1|||
156703802|NCT02006693|565661246|FG000|Overall Study|Patient Decision|4|||
156703803|NCT02006693|565661247|FG001|Overall Study|Patient Decision|0|||
156703804|NCT03151408|565661248|FG000|Overall Study|Adverse Event|24|||
156703805|NCT03151408|565661249|FG001|Overall Study|Adverse Event|23|||
156703806|NCT03151408|565661248|FG000|Overall Study|Death|46|||
156703807|NCT03151408|565661249|FG001|Overall Study|Death|26|||
156703808|NCT03151408|565661248|FG000|Overall Study|Physician Decision|13|||
156703809|NCT03151408|565661249|FG001|Overall Study|Physician Decision|19|||
156703810|NCT03151408|565661248|FG000|Overall Study|Withdrawal by Subject|16|||
156703811|NCT03151408|565661249|FG001|Overall Study|Withdrawal by Subject|20|||
156703812|NCT03151408|565661248|FG000|Overall Study|Progressive disease|45|||
156703813|NCT03151408|565661249|FG001|Overall Study|Progressive disease|61|||
156703814|NCT03151408|565661248|FG000|Overall Study|non-compliance by patient|1|||
156703815|NCT03151408|565661249|FG001|Overall Study|non-compliance by patient|0|||
156703816|NCT03151408|565661248|FG000|Overall Study|other reasons|56|||
156703817|NCT03151408|565661249|FG001|Overall Study|other reasons|52|||
156703818|NCT03151408|565661248|FG000|Overall Study|randomized and not treated|2|||
156703819|NCT03151408|565661249|FG001|Overall Study|randomized and not treated|2|||
156703820|NCT01475097|565661250|FG000|Overall Study|Protocol Violation|1|||
156703821|NCT01475097|565661251|FG001|Overall Study|Protocol Violation|1|||
156703822|NCT00927394|565661252|FG000|Overall Study|Adverse Event|14|||
156703823|NCT00927394|565661253|FG001|Overall Study|Adverse Event|9|||
156703824|NCT00927394|565661252|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
156703825|NCT00927394|565661253|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
156703826|NCT00927394|565661252|FG000|Overall Study|Withdrawal by Subject|20|||
156703827|NCT00927394|565661253|FG001|Overall Study|Withdrawal by Subject|24|||
156703828|NCT00927394|565661252|FG000|Overall Study|Lost to Follow-up|8|||
156703829|NCT00927394|565661253|FG001|Overall Study|Lost to Follow-up|14|||
156703830|NCT00927394|565661252|FG000|Overall Study|Administrative Problem|1|||
156703831|NCT00927394|565661253|FG001|Overall Study|Administrative Problem|0|||
156703832|NCT00927394|565661252|FG000|Overall Study|Death|1|||
156703833|NCT00927394|565661253|FG001|Overall Study|Death|1|||
156703834|NCT00927394|565661252|FG000|Overall Study|Protocol deviation|16|||
156703835|NCT00927394|565661253|FG001|Overall Study|Protocol deviation|13|||
156703836|NCT00927394|565661252|FG000|Overall Study|Randomized in error|0|||
156703837|NCT00927394|565661253|FG001|Overall Study|Randomized in error|1|||
156703838|NCT04524364|565661255|FG000|Overall Study|Physician Decision|3|||
156703839|NCT04524364|565661256|FG001|Overall Study|Physician Decision|6|||
156703840|NCT04524364|565661255|FG000|Overall Study|Adverse Event|0|||
156703841|NCT04524364|565661256|FG001|Overall Study|Adverse Event|1|||
156703842|NCT04524364|565661255|FG000|Overall Study|Investigational device deficiency|0|||
156703843|NCT04524364|565661256|FG001|Overall Study|Investigational device deficiency|1|||
156703844|NCT04524364|565661255|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
156703845|NCT04524364|565661256|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
156703846|NCT04524364|565661255|FG000|Overall Study|Device unavailability|0|||
156703847|NCT04524364|565661256|FG001|Overall Study|Device unavailability|2|||
156703848|NCT04524364|565661255|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
156872154|NCT02839200|566289525|FG000|Overall Study|Randomized in error|0|||
156872155|NCT02839200|566289526|FG001|Overall Study|Randomized in error|1|||
157015599|NCT00262301|566808904|FG002|Double-blind Phase|Lost to Follow-up|0|||
157015600|NCT00262301|566808902|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
157015601|NCT00262301|566808903|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
157015602|NCT00262301|566808904|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
157015603|NCT02814838|566808905|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
156703849|NCT04524364|565661256|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
156703850|NCT04524364|565661255|FG000|Overall Study|Low International normalized ratio (INR)|1|||
156703851|NCT04524364|565661256|FG001|Overall Study|Low International normalized ratio (INR)|0|||
156703852|NCT02309138|565661257|FG000|Overall Study|Withdrawal by Subject|44|||
156703853|NCT02309138|565661258|FG001|Overall Study|Withdrawal by Subject|15|||
156703854|NCT02309138|565661257|FG000|Overall Study|Protocol Violation|4|||
156703855|NCT02309138|565661258|FG001|Overall Study|Protocol Violation|2|||
156703856|NCT02309138|565661257|FG000|Overall Study|delivered before visit 2|0|||
156703857|NCT02309138|565661258|FG001|Overall Study|delivered before visit 2|1|||
156703858|NCT01338870|565661261|FG000|Overall Study|Lost to Follow-up|0|||
156703859|NCT01338870|565661262|FG001|Overall Study|Lost to Follow-up|0|||
156703860|NCT01338870|565661263|FG002|Overall Study|Lost to Follow-up|1|||
156703861|NCT01338870|565661264|FG003|Overall Study|Lost to Follow-up|0|||
156872156|NCT02839200|566289527|FG002|Overall Study|Randomized in error|0|||
157215396|NCT01529749|567535868|FG003|Overall Study|Protocol Violation|1|||
156703862|NCT01338870|565661265|FG004|Overall Study|Lost to Follow-up|1|||
156703863|NCT01338870|565661266|FG005|Overall Study|Lost to Follow-up|0|||
156703864|NCT01338870|565661261|FG000|Overall Study|Withdrawal by Subject|2|||
156872157|NCT02839200|566289528|FG003|Overall Study|Randomized in error|0|||
156703865|NCT01338870|565661262|FG001|Overall Study|Withdrawal by Subject|3|||
156703866|NCT01338870|565661263|FG002|Overall Study|Withdrawal by Subject|4|||
156703867|NCT01338870|565661264|FG003|Overall Study|Withdrawal by Subject|0|||
156703868|NCT01338870|565661265|FG004|Overall Study|Withdrawal by Subject|0|||
156703869|NCT01338870|565661266|FG005|Overall Study|Withdrawal by Subject|2|||
156703870|NCT01338870|565661261|FG000|Overall Study|Other|3|||
156703871|NCT01338870|565661262|FG001|Overall Study|Other|3|||
156703872|NCT01338870|565661263|FG002|Overall Study|Other|3|||
156703873|NCT01338870|565661264|FG003|Overall Study|Other|2|||
156703874|NCT01338870|565661265|FG004|Overall Study|Other|0|||
156703875|NCT01338870|565661266|FG005|Overall Study|Other|2|||
156703876|NCT01338870|565661261|FG000|Overall Study|Protocol Violation|0|||
156703877|NCT01338870|565661262|FG001|Overall Study|Protocol Violation|2|||
156703878|NCT01338870|565661263|FG002|Overall Study|Protocol Violation|2|||
156703879|NCT01338870|565661264|FG003|Overall Study|Protocol Violation|2|||
156703880|NCT01338870|565661265|FG004|Overall Study|Protocol Violation|1|||
156703881|NCT01338870|565661266|FG005|Overall Study|Protocol Violation|1|||
156703882|NCT01338870|565661261|FG000|Overall Study|Adverse Event|4|||
156703883|NCT01338870|565661262|FG001|Overall Study|Adverse Event|4|||
156703884|NCT01338870|565661263|FG002|Overall Study|Adverse Event|1|||
156703885|NCT01338870|565661264|FG003|Overall Study|Adverse Event|5|||
156703886|NCT01338870|565661265|FG004|Overall Study|Adverse Event|4|||
157124687|NCT01543087|567206303|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
157124688|NCT01543087|567206304|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
157124689|NCT01543087|567206305|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
157124690|NCT01543087|567206300|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
157124691|NCT01543087|567206301|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
157124692|NCT01543087|567206302|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
157124693|NCT01543087|567206303|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
157124694|NCT01543087|567206304|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
157124695|NCT01543087|567206305|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
157124696|NCT01543087|567206300|FG000|Stage 1 (48 Months)|Other than specified|5|||
157124697|NCT01543087|567206301|FG001|Stage 1 (48 Months)|Other than specified|0|||
157124698|NCT01543087|567206302|FG002|Stage 1 (48 Months)|Other than specified|9|||
157124699|NCT01543087|567206303|FG003|Stage 1 (48 Months)|Other than specified|0|||
157124700|NCT01543087|567206304|FG004|Stage 1 (48 Months)|Other than specified|0|||
157124701|NCT01543087|567206305|FG005|Stage 1 (48 Months)|Other than specified|0|||
157124702|NCT01543087|567206300|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
157124703|NCT01543087|567206301|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
157124704|NCT01543087|567206302|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
157124705|NCT01543087|567206303|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
157124706|NCT01543087|567206304|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
157124707|NCT01543087|567206305|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
157124708|NCT01543087|567206300|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
157124709|NCT01543087|567206301|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
157124710|NCT01543087|567206302|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
157124711|NCT01543087|567206303|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
157124712|NCT01543087|567206304|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
157124713|NCT01543087|567206305|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
157124714|NCT01543087|567206300|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
157124715|NCT01543087|567206301|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
157124716|NCT01543087|567206302|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
157124717|NCT01543087|567206303|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
157124718|NCT01543087|567206304|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
157124719|NCT01543087|567206305|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
157124720|NCT03403192|567206306|FG000|Overall Study|Lost to Follow-up|1|||
157124721|NCT03403192|567206307|FG001|Overall Study|Lost to Follow-up|2|||
157124722|NCT03403192|567206308|FG002|Overall Study|Lost to Follow-up|0|||
156703887|NCT01338870|565661266|FG005|Overall Study|Adverse Event|1|||
156703888|NCT04546724|565661279|FG000|Overall Study|Withdrawal by Subject|145|||
156703889|NCT04546724|565661280|FG001|Overall Study|Withdrawal by Subject|41|||
156703890|NCT04546724|565661279|FG000|Overall Study|Adverse Event|1|||
156703891|NCT04546724|565661280|FG001|Overall Study|Adverse Event|1|||
156703892|NCT04546724|565661279|FG000|Overall Study|Lost to Follow-up|186|||
156703893|NCT04546724|565661280|FG001|Overall Study|Lost to Follow-up|63|||
156703894|NCT04546724|565661279|FG000|Overall Study|Physician Decision|8|||
156703895|NCT04546724|565661280|FG001|Overall Study|Physician Decision|2|||
156703896|NCT04546724|565661279|FG000|Overall Study|Death|2|||
156703897|NCT04546724|565661280|FG001|Overall Study|Death|1|||
156703898|NCT04546724|565661279|FG000|Overall Study|subject has been out of town|1|||
156703899|NCT04546724|565661280|FG001|Overall Study|subject has been out of town|0|||
156703900|NCT04546724|565661279|FG000|Overall Study|subject is incarcerated|2|||
156703901|NCT04546724|565661280|FG001|Overall Study|subject is incarcerated|0|||
156703902|NCT04546724|565661279|FG000|Overall Study|subject is relocating|12|||
157124723|NCT03403192|567206309|FG003|Overall Study|Lost to Follow-up|0|||
157124724|NCT03403192|567206306|FG000|Overall Study|Unable to respond|0|||
157124725|NCT03403192|567206307|FG001|Overall Study|Unable to respond|1|||
157124726|NCT03403192|567206308|FG002|Overall Study|Unable to respond|0|||
157124727|NCT03403192|567206309|FG003|Overall Study|Unable to respond|0|||
157124728|NCT03403192|567206306|FG000|Overall Study|Incomplete|3|||
157124729|NCT03403192|567206307|FG001|Overall Study|Incomplete|1|||
157124730|NCT03403192|567206308|FG002|Overall Study|Incomplete|3|||
157124731|NCT03403192|567206309|FG003|Overall Study|Incomplete|6|||
157124732|NCT04673786|567206310|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
157124733|NCT04673786|567206311|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
157124734|NCT04673786|567206312|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
157124735|NCT04673786|567206310|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
157215397|NCT02094937|567535869|FG000|8 Weeks in Period 1|Adverse Event|9|||
157215398|NCT02094937|567535870|FG001|8 Weeks in Period 1|Adverse Event|0|||
157215399|NCT02094937|567535871|FG002|8 Weeks in Period 1|Adverse Event|0|||
157215400|NCT02094937|567535872|FG003|8 Weeks in Period 1|Adverse Event|0|||
157215401|NCT02094937|567535869|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
157215402|NCT02094937|567535870|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
157215403|NCT02094937|567535871|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
157215404|NCT02094937|567535872|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
157215405|NCT02094937|567535869|FG000|8 Weeks in Period 1|Protocol Violation|2|||
157215406|NCT02094937|567535870|FG001|8 Weeks in Period 1|Protocol Violation|0|||
157215407|NCT02094937|567535871|FG002|8 Weeks in Period 1|Protocol Violation|0|||
157215408|NCT02094937|567535872|FG003|8 Weeks in Period 1|Protocol Violation|0|||
157215409|NCT02094937|567535869|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
157215410|NCT02094937|567535870|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
157215411|NCT02094937|567535871|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
157215412|NCT02094937|567535872|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
157215413|NCT02094937|567535869|FG000|8 Weeks in Period 1|Physician Decision|1|||
157215414|NCT02094937|567535870|FG001|8 Weeks in Period 1|Physician Decision|0|||
157215415|NCT02094937|567535871|FG002|8 Weeks in Period 1|Physician Decision|0|||
157215416|NCT02094937|567535872|FG003|8 Weeks in Period 1|Physician Decision|0|||
157215417|NCT02094937|567535869|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
157215418|NCT02094937|567535870|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
157215419|NCT02094937|567535871|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
157215420|NCT02094937|567535872|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
157215421|NCT02094937|567535869|FG000|12 Weeks in Period 2|Adverse Event|0|||
157215422|NCT02094937|567535870|FG001|12 Weeks in Period 2|Adverse Event|2|||
157215423|NCT02094937|567535871|FG002|12 Weeks in Period 2|Adverse Event|4|||
157215424|NCT02094937|567535872|FG003|12 Weeks in Period 2|Adverse Event|1|||
157215425|NCT02094937|567535869|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
157215426|NCT02094937|567535870|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
157215427|NCT02094937|567535871|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
157215428|NCT02094937|567535872|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
157215429|NCT02094937|567535869|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
157215430|NCT02094937|567535870|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
157215431|NCT02094937|567535871|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
156703903|NCT04546724|565661280|FG001|Overall Study|subject is relocating|4|||
156703904|NCT04546724|565661279|FG000|Overall Study|Subject in another study|1|||
156703905|NCT04546724|565661280|FG001|Overall Study|Subject in another study|1|||
156703906|NCT03583086|565661281|FG000|Overall Study|Death|2|||
156703907|NCT03583086|565661282|FG001|Overall Study|Death|6|||
156703908|NCT03583086|565661283|FG002|Overall Study|Death|12|||
156703909|NCT03583086|565661284|FG003|Overall Study|Death|10|||
156703910|NCT03583086|565661285|FG004|Overall Study|Death|14|||
156703911|NCT03583086|565661286|FG005|Overall Study|Death|14|||
156703912|NCT03583086|565661287|FG006|Overall Study|Death|4|||
156703913|NCT03583086|565661281|FG000|Overall Study|Withdrawal by Subject|0|||
156703914|NCT03583086|565661282|FG001|Overall Study|Withdrawal by Subject|0|||
156703915|NCT03583086|565661283|FG002|Overall Study|Withdrawal by Subject|1|||
156703916|NCT03583086|565661284|FG003|Overall Study|Withdrawal by Subject|0|||
156703917|NCT03583086|565661285|FG004|Overall Study|Withdrawal by Subject|0|||
156703918|NCT03583086|565661286|FG005|Overall Study|Withdrawal by Subject|0|||
156703919|NCT03583086|565661287|FG006|Overall Study|Withdrawal by Subject|1|||
156703920|NCT03583086|565661281|FG000|Overall Study|Refused follow-up|0|||
156703921|NCT03583086|565661282|FG001|Overall Study|Refused follow-up|0|||
156703922|NCT03583086|565661283|FG002|Overall Study|Refused follow-up|1|||
156703923|NCT03583086|565661284|FG003|Overall Study|Refused follow-up|0|||
156703924|NCT03583086|565661285|FG004|Overall Study|Refused follow-up|1|||
156703925|NCT03583086|565661286|FG005|Overall Study|Refused follow-up|0|||
156703926|NCT03583086|565661287|FG006|Overall Study|Refused follow-up|0|||
156703927|NCT03583086|565661281|FG000|Overall Study|Declining Performance Status|0|||
156703928|NCT03583086|565661282|FG001|Overall Study|Declining Performance Status|0|||
156703929|NCT03583086|565661283|FG002|Overall Study|Declining Performance Status|1|||
157124736|NCT04673786|567206311|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
156703930|NCT03583086|565661284|FG003|Overall Study|Declining Performance Status|0|||
156703931|NCT03583086|565661285|FG004|Overall Study|Declining Performance Status|0|||
156703932|NCT03583086|565661286|FG005|Overall Study|Declining Performance Status|0|||
156703933|NCT03583086|565661287|FG006|Overall Study|Declining Performance Status|0|||
156703934|NCT03583086|565661281|FG000|Overall Study|Still on study|0|||
156703935|NCT03583086|565661282|FG001|Overall Study|Still on study|0|||
156703936|NCT03583086|565661283|FG002|Overall Study|Still on study|0|||
156703937|NCT03583086|565661284|FG003|Overall Study|Still on study|1|||
156703938|NCT03583086|565661285|FG004|Overall Study|Still on study|0|||
156703939|NCT03583086|565661286|FG005|Overall Study|Still on study|0|||
156703940|NCT03583086|565661287|FG006|Overall Study|Still on study|1|||
156703941|NCT03583086|565661281|FG000|Overall Study|Disease progression|0|||
156703942|NCT03583086|565661282|FG001|Overall Study|Disease progression|0|||
156703943|NCT03583086|565661283|FG002|Overall Study|Disease progression|0|||
156703944|NCT03583086|565661284|FG003|Overall Study|Disease progression|0|||
156703945|NCT03583086|565661285|FG004|Overall Study|Disease progression|0|||
156703946|NCT03583086|565661286|FG005|Overall Study|Disease progression|0|||
156703947|NCT03583086|565661287|FG006|Overall Study|Disease progression|1|||
156703948|NCT03583086|565661281|FG000|Overall Study|Undergoing radiation therapy|0|||
156703949|NCT03583086|565661282|FG001|Overall Study|Undergoing radiation therapy|0|||
156703950|NCT03583086|565661283|FG002|Overall Study|Undergoing radiation therapy|0|||
156703951|NCT03583086|565661284|FG003|Overall Study|Undergoing radiation therapy|0|||
156703952|NCT03583086|565661285|FG004|Overall Study|Undergoing radiation therapy|0|||
156703953|NCT03583086|565661286|FG005|Overall Study|Undergoing radiation therapy|0|||
156703954|NCT03583086|565661287|FG006|Overall Study|Undergoing radiation therapy|1|||
156703955|NCT03583086|565661281|FG000|Overall Study|Lost to Follow-up|0|||
156703956|NCT03583086|565661282|FG001|Overall Study|Lost to Follow-up|0|||
156703957|NCT03583086|565661283|FG002|Overall Study|Lost to Follow-up|0|||
156703958|NCT03583086|565661284|FG003|Overall Study|Lost to Follow-up|0|||
156703959|NCT03583086|565661285|FG004|Overall Study|Lost to Follow-up|0|||
156703960|NCT03583086|565661286|FG005|Overall Study|Lost to Follow-up|1|||
156703961|NCT03583086|565661287|FG006|Overall Study|Lost to Follow-up|0|||
156703962|NCT03583086|565661281|FG000|Overall Study|Adverse Event|0|||
156703963|NCT03583086|565661282|FG001|Overall Study|Adverse Event|0|||
156703964|NCT03583086|565661283|FG002|Overall Study|Adverse Event|0|||
156703965|NCT03583086|565661284|FG003|Overall Study|Adverse Event|0|||
156703966|NCT03583086|565661285|FG004|Overall Study|Adverse Event|0|||
156703967|NCT03583086|565661286|FG005|Overall Study|Adverse Event|1|||
156703968|NCT03583086|565661287|FG006|Overall Study|Adverse Event|0|||
156703969|NCT00396812|565661289|FG000|Overall Study|Physician Decision|1|||
156703970|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
156703971|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
156703972|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
156703973|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
156703974|NCT03201445|565661293|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
156703975|NCT03201445|565661294|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
156703976|NCT03201445|565661293|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
156703977|NCT03201445|565661294|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
156703978|NCT03201445|565661293|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
156703979|NCT03201445|565661294|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
156703980|NCT03201445|565661293|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
156703981|NCT03201445|565661294|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
156703982|NCT03201445|565661293|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
156703983|NCT03201445|565661294|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
156703984|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
156703985|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
156703986|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
156703987|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
156703988|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
156703989|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
156703990|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
156703991|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
156703992|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
156703993|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
156703994|NCT03201445|565661293|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
156703995|NCT03201445|565661294|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
156703996|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
156703997|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
157124737|NCT04673786|567206312|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
156703998|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
156703999|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
157124738|NCT04673786|567206310|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
157124739|NCT04673786|567206311|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
157124740|NCT04673786|567206312|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
157124741|NCT04673786|567206310|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
157124742|NCT04673786|567206311|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
157124743|NCT04673786|567206312|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
157124744|NCT04673786|567206310|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
157124745|NCT04673786|567206311|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
157124746|NCT04673786|567206312|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
157124747|NCT04673786|567206310|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
157124748|NCT04673786|567206311|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
157124749|NCT04673786|567206312|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
157124750|NCT01298492|567206313|FG000|Overall Study|Death|2|||
157124751|NCT01298492|567206313|FG000|Overall Study|Insufficient Clinical Response|22|||
157124752|NCT01298492|567206313|FG000|Overall Study|Lost to Follow-up|12|||
157124753|NCT01298492|567206313|FG000|Overall Study|Withdrawal by Subject|47|||
157124754|NCT01298492|567206313|FG000|Overall Study|Other (Unspecified)|7|||
157124755|NCT01298492|567206313|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
157124756|NCT01298492|567206313|FG000|Overall Study|Protocol Violation|2|||
157124757|NCT01298492|567206313|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
157124758|NCT01298492|567206313|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
157124759|NCT02902120|567206315|FG000|Overall Study|Lack of Efficacy|1|||
157124760|NCT03298022|567206316|FG000|Overall Study|Lack of Efficacy|4|||
157124761|NCT03298022|567206316|FG000|Overall Study|Withdrawal by Subject|7|||
157124762|NCT03298022|567206316|FG000|Overall Study|Adverse Event|1|||
157124763|NCT03298022|567206316|FG000|Overall Study|disease relapse|1|||
157124764|NCT03694925|567206317|FG000|Overall Study|Inadequate laboratory testing|0|||
157124765|NCT03694925|567206318|FG001|Overall Study|Inadequate laboratory testing|3|||
157124766|NCT03694925|567206319|FG002|Overall Study|Inadequate laboratory testing|0|||
157124767|NCT03467958|567206320|FG000|Overall Study|Adverse Event|20|||
157124768|NCT03467958|567206321|FG001|Overall Study|Adverse Event|32|||
157124769|NCT03467958|567206322|FG002|Overall Study|Adverse Event|5|||
157215432|NCT02094937|567535872|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
157215433|NCT02094937|567535869|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
157215434|NCT02094937|567535870|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
157215435|NCT02094937|567535871|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
157215436|NCT02094937|567535872|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
157215437|NCT02094937|567535869|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
157215438|NCT02094937|567535870|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
157215439|NCT02094937|567535871|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
157215440|NCT02094937|567535872|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
157215441|NCT01133392|567535873|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
157215442|NCT01133392|567535874|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
157215443|NCT01133392|567535873|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
157215444|NCT01133392|567535874|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
157215445|NCT00378482|567535875|FG000|Overall Study|Lost to Follow-up|1|||
157215446|NCT00378482|567535875|FG000|Overall Study|Lack of Efficacy|8|||
157215447|NCT00378482|567535875|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
157215448|NCT00378482|567535875|FG000|Overall Study|Withdrawal by Subject|4|||
157215449|NCT00378482|567535875|FG000|Overall Study|Adverse Event|9|||
157215450|NCT03751124|567535881|FG000|Overall Study|Adverse Event|4|||
157215451|NCT03751124|567535882|FG001|Overall Study|Adverse Event|3|||
157215452|NCT03751124|567535881|FG000|Overall Study|Protocol Deviation|0|||
157215453|NCT03751124|567535882|FG001|Overall Study|Protocol Deviation|1|||
157215454|NCT03751124|567535881|FG000|Overall Study|Lost to Follow-up|6|||
157215455|NCT03751124|567535882|FG001|Overall Study|Lost to Follow-up|4|||
157215456|NCT03751124|567535881|FG000|Overall Study|Withdrawal by Subject|6|||
157215457|NCT03751124|567535882|FG001|Overall Study|Withdrawal by Subject|8|||
157215458|NCT03751124|567535881|FG000|Overall Study|Lack of Efficacy|1|||
157215459|NCT03751124|567535882|FG001|Overall Study|Lack of Efficacy|1|||
157215460|NCT03751124|567535881|FG000|Overall Study|Pregnancy|0|||
157215461|NCT03751124|567535882|FG001|Overall Study|Pregnancy|1|||
157215462|NCT03751124|567535881|FG000|Overall Study|Other|9|||
157215463|NCT03751124|567535882|FG001|Overall Study|Other|9|||
157215464|NCT03751124|567535881|FG000|Overall Study|Participants who did not receive any study drug|0|||
157215465|NCT03751124|567535882|FG001|Overall Study|Participants who did not receive any study drug|1|||
157215466|NCT00555399|567535885|FG000|Overall Study|Withdrawal by Subject|0|||
157215467|NCT00555399|567535886|FG001|Overall Study|Withdrawal by Subject|0|||
157215468|NCT00555399|567535887|FG002|Overall Study|Withdrawal by Subject|1|||
156704000|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
157124770|NCT03467958|567206323|FG003|Overall Study|Adverse Event|3|||
157124771|NCT03467958|567206324|FG004|Overall Study|Adverse Event|3|||
157124772|NCT03467958|567206325|FG005|Overall Study|Adverse Event|3|||
157124773|NCT03467958|567206326|FG006|Overall Study|Adverse Event|6|||
156704001|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
156704002|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
156704003|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
156704004|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
156704005|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
156704006|NCT03201445|565661293|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
156704007|NCT03201445|565661294|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
156704008|NCT03201445|565661293|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
156704009|NCT03201445|565661294|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
156704010|NCT03201445|565661293|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
156704011|NCT03201445|565661294|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
156704012|NCT01228019|565661295|FG000|Overall Study|Dose Violation|70|||
156704013|NCT01228019|565661295|FG000|Overall Study|Duplicate enrollment|1|||
156704014|NCT01228019|565661295|FG000|Overall Study|Missing pre-treatment data|72|||
156704015|NCT01228019|565661295|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
156704016|NCT01228019|565661295|FG000|Overall Study|Violation of Entry Criterion|9|||
156704017|NCT01346293|565661298|FG000|Overall Study|Protocol Violation|30|||
156704018|NCT01346293|565661299|FG001|Overall Study|Protocol Violation|9|||
156704019|NCT01346293|565661298|FG000|Overall Study|Lost to Follow-up|21|||
156704020|NCT01346293|565661299|FG001|Overall Study|Lost to Follow-up|8|||
156704021|NCT01346293|565661298|FG000|Overall Study|Withdrawal by Subject|15|||
156704022|NCT01346293|565661299|FG001|Overall Study|Withdrawal by Subject|4|||
156704023|NCT01346293|565661298|FG000|Overall Study|Other|1|||
156704024|NCT01346293|565661299|FG001|Overall Study|Other|0|||
156704025|NCT01844505|565661302|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
156704026|NCT01844505|565661303|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
156704027|NCT01844505|565661304|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
156704028|NCT01844505|565661302|FG000|Treatment Period|Other Reasons|120|||
156704029|NCT01844505|565661303|FG001|Treatment Period|Other Reasons|136|||
156704030|NCT01844505|565661304|FG002|Treatment Period|Other Reasons|58|||
156704031|NCT01844505|565661302|FG000|Treatment Period|Lost to Follow-up|9|||
156704032|NCT01844505|565661303|FG001|Treatment Period|Lost to Follow-up|11|||
156704033|NCT01844505|565661304|FG002|Treatment Period|Lost to Follow-up|6|||
156704034|NCT01844505|565661302|FG000|Treatment Period|Death|175|||
156704035|NCT01844505|565661303|FG001|Treatment Period|Death|154|||
156704036|NCT01844505|565661304|FG002|Treatment Period|Death|228|||
156704037|NCT02730351|565661305|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
156704038|NCT02730351|565661306|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
156704039|NCT02730351|565661305|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
156704040|NCT02730351|565661306|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
156704041|NCT02730351|565661305|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
156704042|NCT02730351|565661306|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
156704043|NCT02730351|565661305|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
156704044|NCT02730351|565661306|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
156704045|NCT02730351|565661305|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
156704046|NCT02730351|565661306|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
156704047|NCT00128830|565661307|FG000|Overall Study|Adverse Event|10|||
156704048|NCT00128830|565661307|FG000|Overall Study|Withdrawal by Subject|14|||
156704049|NCT00128830|565661307|FG000|Overall Study|Lost to Follow-up|4|||
156704050|NCT00128830|565661307|FG000|Overall Study|Reached a virologic endpoint|29|||
156704051|NCT00128830|565661307|FG000|Overall Study|Non-compliant|4|||
156704052|NCT00128830|565661307|FG000|Overall Study|Discontinued or ineligible for study|2|||
156704053|NCT00128830|565661307|FG000|Overall Study|Other|9|||
156704054|NCT00311402|565661308|FG000|Overall Study|Adverse Event|118|||
156704055|NCT00311402|565661309|FG001|Overall Study|Adverse Event|105|||
156704056|NCT00311402|565661308|FG000|Overall Study|Lost to Follow-up|0|||
156704057|NCT00311402|565661309|FG001|Overall Study|Lost to Follow-up|3|||
156704058|NCT00311402|565661308|FG000|Overall Study|Withdrawal by Subject|17|||
156704059|NCT00311402|565661309|FG001|Overall Study|Withdrawal by Subject|18|||
156704060|NCT00311402|565661308|FG000|Overall Study|Lack of Efficacy|58|||
156704061|NCT00311402|565661309|FG001|Overall Study|Lack of Efficacy|42|||
156704062|NCT00311402|565661308|FG000|Overall Study|Protocol Violation|7|||
156704063|NCT00311402|565661309|FG001|Overall Study|Protocol Violation|6|||
156704064|NCT00311402|565661308|FG000|Overall Study|IRB's rejection etc.|10|||
156704065|NCT00311402|565661309|FG001|Overall Study|IRB's rejection etc.|3|||
156704066|NCT02640053|565661310|FG000|Overall Study|Withdrawal by Subject|2|||
156704067|NCT02640053|565661311|FG001|Overall Study|Withdrawal by Subject|1|||
156704068|NCT02640053|565661310|FG000|Overall Study|Adverse Event|1|||
156704069|NCT02640053|565661311|FG001|Overall Study|Adverse Event|1|||
156704070|NCT02640053|565661310|FG000|Overall Study|Alternative Therapy|1|||
156704071|NCT02640053|565661311|FG001|Overall Study|Alternative Therapy|1|||
156704072|NCT02640053|565661310|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
156704073|NCT02640053|565661311|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
156704074|NCT01268501|565661312|FG000|Overall Study|Lost to Follow-up|1|||
156704075|NCT01268501|565661312|FG000|Overall Study|Withdrawal by Subject|3|||
156704076|NCT01268501|565661312|FG000|Overall Study|Unacceptable Subjective Vision|3|||
156704077|NCT01268501|565661312|FG000|Overall Study|Handling Difficulties|2|||
156704078|NCT02774642|565661313|FG000|Overall Study|Lost to Follow-up|9|||
156704079|NCT02774642|565661314|FG001|Overall Study|Lost to Follow-up|7|||
156704080|NCT00426361|565661316|FG000|Overall Study|Lost to Follow-up|3|||
156704081|NCT00426361|565661317|FG001|Overall Study|Lost to Follow-up|2|||
156704082|NCT00426361|565661318|FG002|Overall Study|Lost to Follow-up|5|||
156704083|NCT00426361|565661316|FG000|Overall Study|Withdrawal by Subject|1|||
156704084|NCT00426361|565661317|FG001|Overall Study|Withdrawal by Subject|3|||
156704085|NCT00426361|565661318|FG002|Overall Study|Withdrawal by Subject|0|||
156704086|NCT02828241|565661321|FG000|Overall Study|Adverse Event|7|||
156704087|NCT02828241|565661322|FG001|Overall Study|Adverse Event|2|||
156704088|NCT02828241|565661321|FG000|Overall Study|Protocol Violation|1|||
156704089|NCT02828241|565661322|FG001|Overall Study|Protocol Violation|0|||
156704090|NCT06281171|565661337|FG000|Timepoint 2|Lost to Follow-up|6|||
156704091|NCT06281171|565661338|FG001|Timepoint 2|Lost to Follow-up|4|||
156704092|NCT06281171|565661337|FG000|Timepoint 3|Lost to Follow-up|0|||
156704093|NCT06281171|565661338|FG001|Timepoint 3|Lost to Follow-up|5|||
156704094|NCT04669691|565661351|FG000|Overall Study|Death|0|||
156704095|NCT04669691|565661352|FG001|Overall Study|Death|1|||
156704096|NCT04669691|565661353|FG002|Overall Study|Death|0|||
156704097|NCT04669691|565661354|FG003|Overall Study|Death|0|||
156704098|NCT04669691|565661355|FG004|Overall Study|Death|0|||
156704099|NCT04669691|565661356|FG005|Overall Study|Death|0|||
156704100|NCT00073021|565661359|FG000|Overall Study|Protocol Violation|2|||
156704101|NCT00073021|565661360|FG001|Overall Study|Protocol Violation|1|||
156704102|NCT00073021|565661359|FG000|Overall Study|Adverse Event|4|||
156704103|NCT00073021|565661360|FG001|Overall Study|Adverse Event|4|||
156704104|NCT00073021|565661359|FG000|Overall Study|Withdrawal by Subject|6|||
156704105|NCT00073021|565661360|FG001|Overall Study|Withdrawal by Subject|5|||
156704106|NCT00073021|565661359|FG000|Overall Study|Physician Decision|3|||
156704107|NCT00073021|565661360|FG001|Overall Study|Physician Decision|1|||
156704108|NCT00073021|565661359|FG000|Overall Study|Lack of Efficacy|11|||
156704109|NCT00073021|565661360|FG001|Overall Study|Lack of Efficacy|5|||
156704110|NCT03918109|565661366|FG000|Overall Study|Withdrawal by Subject|0|||
156704111|NCT03918109|565661367|FG001|Overall Study|Withdrawal by Subject|0|||
156704112|NCT03918109|565661368|FG002|Overall Study|Withdrawal by Subject|2|||
156704113|NCT03918109|565661369|FG003|Overall Study|Withdrawal by Subject|1|||
156704114|NCT03918109|565661366|FG000|Overall Study|Lost to Follow-up|0|||
156704115|NCT03918109|565661367|FG001|Overall Study|Lost to Follow-up|0|||
156704116|NCT03918109|565661368|FG002|Overall Study|Lost to Follow-up|0|||
156704117|NCT03918109|565661369|FG003|Overall Study|Lost to Follow-up|1|||
156704118|NCT00477295|565661374|FG000|Overall Study|Adverse Event|31|||
156704119|NCT00477295|565661375|FG001|Overall Study|Adverse Event|35|||
156704120|NCT00477295|565661374|FG000|Overall Study|Withdrawal by Subject|35|||
156704121|NCT00477295|565661375|FG001|Overall Study|Withdrawal by Subject|24|||
156704122|NCT00477295|565661374|FG000|Overall Study|Lack of Efficacy|23|||
156704123|NCT00477295|565661375|FG001|Overall Study|Lack of Efficacy|23|||
156704124|NCT00477295|565661374|FG000|Overall Study|Protocol Violation|3|||
156704125|NCT00477295|565661375|FG001|Overall Study|Protocol Violation|8|||
156704126|NCT00477295|565661374|FG000|Overall Study|Physician Decision|4|||
156704127|NCT00477295|565661375|FG001|Overall Study|Physician Decision|5|||
156704128|NCT00477295|565661374|FG000|Overall Study|Lost to Follow-up|21|||
156704129|NCT00477295|565661375|FG001|Overall Study|Lost to Follow-up|11|||
156704130|NCT00477295|565661374|FG000|Overall Study|Other|4|||
156704131|NCT00477295|565661375|FG001|Overall Study|Other|3|||
156704132|NCT03050060|565661378|FG000|Overall Study|Adverse Event|7|||
157124774|NCT03467958|567206327|FG007|Overall Study|Adverse Event|5|||
157124775|NCT03467958|567206328|FG008|Overall Study|Adverse Event|0|||
157124776|NCT03467958|567206320|FG000|Overall Study|Lack of Efficacy|59|||
157124777|NCT03467958|567206321|FG001|Overall Study|Lack of Efficacy|120|||
156704133|NCT03050060|565661378|FG000|Overall Study|Withdrawal by Subject|1|||
156704134|NCT03050060|565661378|FG000|Overall Study|Progression|7|||
156704135|NCT03276780|565661379|FG000|Overall Study|Withdrawal by Subject|5|||
156704136|NCT03276780|565661380|FG001|Overall Study|Withdrawal by Subject|3|||
156704137|NCT03276780|565661379|FG000|Overall Study|Lost to Follow-up|3|||
156704138|NCT03276780|565661380|FG001|Overall Study|Lost to Follow-up|5|||
156704139|NCT03276780|565661379|FG000|Overall Study|Moved out of state|1|||
156704140|NCT03276780|565661380|FG001|Overall Study|Moved out of state|1|||
156704141|NCT03276780|565661379|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
156704142|NCT03276780|565661380|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
156704143|NCT03276780|565661379|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
156704144|NCT03276780|565661380|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
156704145|NCT00510289|565661381|FG000|Overall Study|Withdrawal by Subject|7|||
157124778|NCT03467958|567206322|FG002|Overall Study|Lack of Efficacy|6|||
156704146|NCT00510289|565661381|FG000|Overall Study|Refused bone marrow biopsy|2|||
156704147|NCT00510289|565661381|FG000|Overall Study|Lost to Follow-up|1|||
156872158|NCT02839200|566289529|FG004|Overall Study|Randomized in error|0|||
156704148|NCT00510289|565661381|FG000|Overall Study|Progressed prior to starting drug|2|||
156704149|NCT00319982|565661385|FG000|Overall Study|Withdrawal by Subject|1|||
156704150|NCT00319982|565661386|FG001|Overall Study|Withdrawal by Subject|0|||
156704151|NCT00758680|565661387|FG000|Overall Study|Adverse Event|0|||
156704152|NCT00758680|565661388|FG001|Overall Study|Adverse Event|0|||
156704153|NCT00758680|565661389|FG002|Overall Study|Adverse Event|0|||
156704154|NCT00758680|565661390|FG003|Overall Study|Adverse Event|0|||
156704155|NCT00758680|565661391|FG004|Overall Study|Adverse Event|0|||
156704156|NCT00758680|565661392|FG005|Overall Study|Adverse Event|0|||
156704157|NCT00758680|565661393|FG006|Overall Study|Adverse Event|0|||
156704158|NCT00758680|565661394|FG007|Overall Study|Adverse Event|1|||
156704159|NCT00758680|565661395|FG008|Overall Study|Adverse Event|0|||
156704160|NCT00758680|565661396|FG009|Overall Study|Adverse Event|1|||
156704161|NCT00758680|565661387|FG000|Overall Study|Laboratory Adverse Event|0|||
156704162|NCT00758680|565661388|FG001|Overall Study|Laboratory Adverse Event|0|||
156704163|NCT00758680|565661389|FG002|Overall Study|Laboratory Adverse Event|0|||
156704164|NCT00758680|565661390|FG003|Overall Study|Laboratory Adverse Event|0|||
156704165|NCT00758680|565661391|FG004|Overall Study|Laboratory Adverse Event|0|||
156704166|NCT00758680|565661392|FG005|Overall Study|Laboratory Adverse Event|0|||
156704167|NCT00758680|565661393|FG006|Overall Study|Laboratory Adverse Event|0|||
156704168|NCT00758680|565661394|FG007|Overall Study|Laboratory Adverse Event|0|||
156704169|NCT00758680|565661395|FG008|Overall Study|Laboratory Adverse Event|1|||
156704170|NCT00758680|565661396|FG009|Overall Study|Laboratory Adverse Event|0|||
156704171|NCT00758680|565661387|FG000|Overall Study|Withdrawal by Subject|0|||
156704172|NCT00758680|565661388|FG001|Overall Study|Withdrawal by Subject|0|||
156704173|NCT00758680|565661389|FG002|Overall Study|Withdrawal by Subject|0|||
156704174|NCT00758680|565661390|FG003|Overall Study|Withdrawal by Subject|0|||
156704175|NCT00758680|565661391|FG004|Overall Study|Withdrawal by Subject|0|||
156704176|NCT00758680|565661392|FG005|Overall Study|Withdrawal by Subject|0|||
156704177|NCT00758680|565661393|FG006|Overall Study|Withdrawal by Subject|1|||
156704178|NCT00758680|565661394|FG007|Overall Study|Withdrawal by Subject|0|||
156704179|NCT00758680|565661395|FG008|Overall Study|Withdrawal by Subject|1|||
156704180|NCT00758680|565661396|FG009|Overall Study|Withdrawal by Subject|0|||
156704181|NCT03480386|565661397|FG000|Overall Study|Did not complete measures at 3-months|17|||
156704182|NCT03480386|565661398|FG001|Overall Study|Did not complete measures at 3-months|14|||
156704183|NCT03480386|565661397|FG000|Overall Study|No baseline measures|11|||
156704184|NCT03480386|565661398|FG001|Overall Study|No baseline measures|14|||
156704185|NCT03480386|565661397|FG000|Overall Study|Death|0|||
156704186|NCT03480386|565661398|FG001|Overall Study|Death|5|||
156704187|NCT03480386|565661397|FG000|Overall Study|Withdrawal by Subject|12|||
156704188|NCT03480386|565661398|FG001|Overall Study|Withdrawal by Subject|8|||
156704189|NCT03480386|565661397|FG000|Overall Study|Lost to Follow-up|2|||
156704190|NCT03480386|565661398|FG001|Overall Study|Lost to Follow-up|1|||
156704191|NCT03480386|565661397|FG000|Overall Study|Complicating disease|0|||
156704192|NCT03480386|565661398|FG001|Overall Study|Complicating disease|1|||
156704193|NCT03480386|565661397|FG000|Overall Study|Disease progression|3|||
156704194|NCT03480386|565661398|FG001|Overall Study|Disease progression|0|||
156704195|NCT03480386|565661397|FG000|Overall Study|Became ineligible|0|||
156704196|NCT03480386|565661398|FG001|Overall Study|Became ineligible|2|||
156704197|NCT00574912|565661399|FG000|Overall Study|Could not place IV lines.|3|||
156704198|NCT00574912|565661399|FG000|Overall Study|scheduling conflicts|3|||
156704199|NCT00574912|565661399|FG000|Overall Study|Physician Decision|2|||
156872159|NCT02839200|566289530|FG005|Overall Study|Randomized in error|0|||
156872160|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
156872161|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
156872162|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
156872163|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
156872164|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
156872165|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
156872166|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
156704200|NCT04240392|565663138|FG000|Overall Study|Withdrawal by Subject|13|||
156704201|NCT04240392|565663139|FG001|Overall Study|Withdrawal by Subject|4|||
156704202|NCT04240392|565663138|FG000|Overall Study|Lost to Follow-up|11|||
156704203|NCT04240392|565663139|FG001|Overall Study|Lost to Follow-up|12|||
156872167|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
156704204|NCT03665441|565663147|FG000|Overall Study|survival follow up ongoing|23|||
156704205|NCT03665441|565663148|FG001|Overall Study|survival follow up ongoing|0|||
156704206|NCT03665441|565663147|FG000|Overall Study|Patients ongoing on treatment|9|||
156704207|NCT03665441|565663148|FG001|Overall Study|Patients ongoing on treatment|6|||
156704208|NCT03665441|565663147|FG000|Overall Study|Randomized but not treated|7|||
156704209|NCT03665441|565663148|FG001|Overall Study|Randomized but not treated|11|||
156704210|NCT05307510|565663149|FG000|Overall Study|Lost to Follow-up|3|||
156704211|NCT05307510|565663150|FG001|Overall Study|Lost to Follow-up|6|||
156704212|NCT05307510|565663149|FG000|Overall Study|Withdrawal by Subject|0|||
156704213|NCT05307510|565663150|FG001|Overall Study|Withdrawal by Subject|1|||
156704214|NCT04345601|565663151|FG000|Overall Study|Death|0|||
156704215|NCT04345601|565663152|FG001|Overall Study|Death|3|||
156704216|NCT04345601|565663153|FG002|Overall Study|Death|2|||
156704217|NCT04345601|565663151|FG000|Overall Study|Lost to Follow-up|0|||
156704218|NCT04345601|565663152|FG001|Overall Study|Lost to Follow-up|0|||
156704219|NCT04345601|565663153|FG002|Overall Study|Lost to Follow-up|2|||
156704220|NCT03610516|565663154|FG000|Treatment Epoch|Adverse Event|3|||
156704221|NCT03610516|565663155|FG001|Treatment Epoch|Adverse Event|1|||
156704222|NCT03610516|565663154|FG000|Treatment Epoch|Death|1|||
156704223|NCT03610516|565663155|FG001|Treatment Epoch|Death|0|||
156704224|NCT03610516|565663154|FG000|Treatment Epoch|Lack of Efficacy|0|||
156704225|NCT03610516|565663155|FG001|Treatment Epoch|Lack of Efficacy|1|||
156704226|NCT03610516|565663154|FG000|Treatment Epoch|No longer requires treatment|1|||
156704227|NCT03610516|565663155|FG001|Treatment Epoch|No longer requires treatment|0|||
156704228|NCT03610516|565663154|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
156704229|NCT03610516|565663155|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
156704230|NCT03610516|565663154|FG000|Treatment Epoch|Physician Decision|8|||
156704231|NCT03610516|565663155|FG001|Treatment Epoch|Physician Decision|5|||
156704232|NCT03610516|565663154|FG000|Treatment Epoch|Protocol Deviation|1|||
156704233|NCT03610516|565663155|FG001|Treatment Epoch|Protocol Deviation|0|||
156704234|NCT03610516|565663154|FG000|Treatment Epoch|Withdrawal by Subject|3|||
156704235|NCT03610516|565663155|FG001|Treatment Epoch|Withdrawal by Subject|1|||
156704236|NCT03610516|565663154|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
156704237|NCT03610516|565663155|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
156704238|NCT03610516|565663154|FG000|Post-Treatment Follow-up|Death|1|||
156704239|NCT03610516|565663155|FG001|Post-Treatment Follow-up|Death|0|||
156704240|NCT00631657|565663156|FG000|6-Month Treatment Period|Adverse Event|47|||
156704241|NCT00631657|565663157|FG001|6-Month Treatment Period|Adverse Event|0|||
156704242|NCT00631657|565663158|FG002|6-Month Treatment Period|Adverse Event|7|||
156704243|NCT00631657|565663156|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
156704244|NCT00631657|565663157|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
156704245|NCT00631657|565663158|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
156704246|NCT00631657|565663156|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
156704247|NCT00631657|565663157|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
156704248|NCT00631657|565663158|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
156704249|NCT00631657|565663156|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
156704250|NCT00631657|565663157|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
156704251|NCT00631657|565663158|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
156704252|NCT00631657|565663156|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
156704253|NCT00631657|565663157|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
156704254|NCT00631657|565663158|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
156704255|NCT00631657|565663156|FG000|6-Month Treatment Period|Other|16|||
156704256|NCT00631657|565663157|FG001|6-Month Treatment Period|Other|0|||
156704257|NCT00631657|565663158|FG002|6-Month Treatment Period|Other|4|||
156704258|NCT00631657|565663156|FG000|6-Month Treatment Period|Not Treated|2|||
156704259|NCT00631657|565663157|FG001|6-Month Treatment Period|Not Treated|0|||
156704260|NCT00631657|565663158|FG002|6-Month Treatment Period|Not Treated|1|||
156704261|NCT00631657|565663156|FG000|7-Day Discontinuation Period|Not Treated|1|||
156704262|NCT00631657|565663157|FG001|7-Day Discontinuation Period|Not Treated|1|||
156704263|NCT00631657|565663158|FG002|7-Day Discontinuation Period|Not Treated|1|||
156704264|NCT00631657|565663156|FG000|7-Day Discontinuation Period|Other|1|||
156704265|NCT00631657|565663157|FG001|7-Day Discontinuation Period|Other|0|||
156704266|NCT00631657|565663158|FG002|7-Day Discontinuation Period|Other|0|||
156704267|NCT05776862|565663181|FG000|Overall Study|Adverse Event|0|||
156704268|NCT05776862|565663182|FG001|Overall Study|Adverse Event|1|||
156704269|NCT05776862|565663181|FG000|Overall Study|non-compliance|1|||
156704270|NCT05776862|565663182|FG001|Overall Study|non-compliance|0|||
156704271|NCT02448706|565663183|FG000|Overall Study|Withdrawal by Subject|4|||
156704272|NCT02448706|565663184|FG001|Overall Study|Withdrawal by Subject|3|||
156704273|NCT02448706|565663183|FG000|Overall Study|Protocol Violation|1|||
156704274|NCT02448706|565663184|FG001|Overall Study|Protocol Violation|1|||
156704275|NCT02315196|565663185|FG000|Overall Study|Withdrew consent|9|||
156704276|NCT04576923|565663186|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
156704277|NCT00049530|565663187|FG000|Overall Study|Lack of Efficacy|25|||
156791078|NCT02633527|565987143|FG003|Overall Study|Administrative reason|1|||
157015604|NCT02814838|566808906|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
156704278|NCT00049530|565663187|FG000|Overall Study|Adverse Event|2|||
156704279|NCT00049530|565663187|FG000|Overall Study|Death|1|||
156704280|NCT00049530|565663187|FG000|Overall Study|symptomatic deterioration|1|||
156704281|NCT00049530|565663187|FG000|Overall Study|ineligible|3|||
156704282|NCT02383810|565663188|FG000|Overall Study|Physician Decision|1|||
156704283|NCT02383810|565663189|FG001|Overall Study|Physician Decision|1|||
156704284|NCT02383810|565663190|FG002|Overall Study|Physician Decision|0|||
156704285|NCT02383810|565663191|FG003|Overall Study|Physician Decision|0|||
156791079|NCT02633527|565987144|FG004|Overall Study|Administrative reason|0|||
156704286|NCT02383810|565663192|FG004|Overall Study|Physician Decision|0|||
156704287|NCT02383810|565663193|FG005|Overall Study|Physician Decision|0|||
156704288|NCT02383810|565663194|FG006|Overall Study|Physician Decision|0|||
156704289|NCT02383810|565663195|FG007|Overall Study|Physician Decision|0|||
157124779|NCT03467958|567206323|FG003|Overall Study|Lack of Efficacy|9|||
157124780|NCT03467958|567206324|FG004|Overall Study|Lack of Efficacy|8|||
157124781|NCT03467958|567206325|FG005|Overall Study|Lack of Efficacy|9|||
156704290|NCT02383810|565663188|FG000|Overall Study|Withdrawal by Subject|2|||
156704291|NCT02383810|565663189|FG001|Overall Study|Withdrawal by Subject|3|||
156704292|NCT02383810|565663190|FG002|Overall Study|Withdrawal by Subject|3|||
156704293|NCT02383810|565663191|FG003|Overall Study|Withdrawal by Subject|3|||
156704294|NCT02383810|565663192|FG004|Overall Study|Withdrawal by Subject|0|||
156704295|NCT02383810|565663193|FG005|Overall Study|Withdrawal by Subject|0|||
156704296|NCT02383810|565663194|FG006|Overall Study|Withdrawal by Subject|0|||
156704297|NCT02383810|565663195|FG007|Overall Study|Withdrawal by Subject|0|||
156704298|NCT02383810|565663188|FG000|Overall Study|Adverse Event|0|||
156704299|NCT02383810|565663189|FG001|Overall Study|Adverse Event|2|||
156704300|NCT02383810|565663190|FG002|Overall Study|Adverse Event|4|||
156704301|NCT02383810|565663191|FG003|Overall Study|Adverse Event|5|||
156704302|NCT02383810|565663192|FG004|Overall Study|Adverse Event|0|||
156704303|NCT02383810|565663193|FG005|Overall Study|Adverse Event|1|||
156704304|NCT02383810|565663194|FG006|Overall Study|Adverse Event|1|||
156704305|NCT02383810|565663195|FG007|Overall Study|Adverse Event|0|||
156704306|NCT02383810|565663188|FG000|Overall Study|Lost to Follow-up|0|||
156704307|NCT02383810|565663189|FG001|Overall Study|Lost to Follow-up|1|||
156704308|NCT02383810|565663190|FG002|Overall Study|Lost to Follow-up|0|||
156704309|NCT02383810|565663191|FG003|Overall Study|Lost to Follow-up|1|||
156704310|NCT02383810|565663192|FG004|Overall Study|Lost to Follow-up|0|||
156704311|NCT02383810|565663193|FG005|Overall Study|Lost to Follow-up|0|||
156704312|NCT02383810|565663194|FG006|Overall Study|Lost to Follow-up|0|||
156704313|NCT02383810|565663195|FG007|Overall Study|Lost to Follow-up|0|||
156704314|NCT02383810|565663188|FG000|Overall Study|other|0|||
156704315|NCT02383810|565663189|FG001|Overall Study|other|0|||
156704316|NCT02383810|565663190|FG002|Overall Study|other|0|||
156704317|NCT02383810|565663191|FG003|Overall Study|other|2|||
156704318|NCT02383810|565663192|FG004|Overall Study|other|0|||
156704319|NCT02383810|565663193|FG005|Overall Study|other|0|||
156704320|NCT02383810|565663194|FG006|Overall Study|other|0|||
156704321|NCT02383810|565663195|FG007|Overall Study|other|0|||
156704322|NCT02383810|565663188|FG000|Overall Study|subject did not receive study treatment|0|||
156704323|NCT02383810|565663189|FG001|Overall Study|subject did not receive study treatment|1|||
156704324|NCT02383810|565663190|FG002|Overall Study|subject did not receive study treatment|0|||
156704325|NCT02383810|565663191|FG003|Overall Study|subject did not receive study treatment|0|||
156704326|NCT02383810|565663192|FG004|Overall Study|subject did not receive study treatment|0|||
156704327|NCT02383810|565663193|FG005|Overall Study|subject did not receive study treatment|0|||
156704328|NCT02383810|565663194|FG006|Overall Study|subject did not receive study treatment|0|||
156704329|NCT02383810|565663195|FG007|Overall Study|subject did not receive study treatment|0|||
156704330|NCT01305044|565663198|FG000|Overall Study|Withdrawal by Subject|3|||
156704331|NCT01305044|565663199|FG001|Overall Study|Withdrawal by Subject|6|||
156704332|NCT00492024|565663200|FG000|Treatment|Adverse Event|3|||
156704333|NCT00492024|565663201|FG001|Treatment|Adverse Event|1|||
156704334|NCT00492024|565663200|FG000|Treatment|Lack of Efficacy|21|||
156704335|NCT00492024|565663201|FG001|Treatment|Lack of Efficacy|20|||
156704336|NCT00492024|565663200|FG000|Treatment|Lost to Follow-up|3|||
156791080|NCT02633527|565987140|FG000|Overall Study|Multiple reasons|1|||
156791081|NCT02633527|565987141|FG001|Overall Study|Multiple reasons|0|||
156791082|NCT02633527|565987142|FG002|Overall Study|Multiple reasons|2|||
156791083|NCT02633527|565987143|FG003|Overall Study|Multiple reasons|2|||
156704337|NCT00492024|565663201|FG001|Treatment|Lost to Follow-up|1|||
156704338|NCT00492024|565663200|FG000|Treatment|Withdrawal by Subject|2|||
156704339|NCT00492024|565663201|FG001|Treatment|Withdrawal by Subject|0|||
156704340|NCT00492024|565663200|FG000|Follow up|Lack of Efficacy|0|||
156704341|NCT00492024|565663201|FG001|Follow up|Lack of Efficacy|1|||
156704342|NCT00492024|565663200|FG000|Follow up|Lost to Follow-up|1|||
156791084|NCT02633527|565987144|FG004|Overall Study|Multiple reasons|1|||
157124782|NCT03467958|567206326|FG006|Overall Study|Lack of Efficacy|11|||
156704343|NCT00492024|565663201|FG001|Follow up|Lost to Follow-up|1|||
156704344|NCT02861014|565663202|FG000|Primary Analysis|Adverse Event|7|||
156704345|NCT02861014|565663202|FG000|Primary Analysis|Death|1|||
157124783|NCT03467958|567206327|FG007|Overall Study|Lack of Efficacy|9|||
156704346|NCT02861014|565663202|FG000|Primary Analysis|Lack of Efficacy|3|||
156704347|NCT02861014|565663202|FG000|Primary Analysis|Physician Decision|2|||
156704348|NCT02861014|565663202|FG000|Primary Analysis|Pregnancy|4|||
156704349|NCT02861014|565663202|FG000|Primary Analysis|Protocol Violation|2|||
156704350|NCT02861014|565663202|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
156704351|NCT02861014|565663202|FG000|Primary Analysis|Withdrawal by Subject|14|||
156704352|NCT02861014|565663202|FG000|Primary Analysis|Commercial ocrelizumab|3|||
156791085|NCT01898091|565987147|FG000|Overall Study|Lost to Follow-up|1|||
156791086|NCT01898091|565987148|FG001|Overall Study|Lost to Follow-up|1|||
156704353|NCT02861014|565663202|FG000|Safety Follow-up|Adverse Event|1|||
156704354|NCT02861014|565663202|FG000|Safety Follow-up|Pregnancy|1|||
156704355|NCT02861014|565663202|FG000|Safety Follow-up|Withdrawal by Subject|9|||
156704356|NCT02861014|565663202|FG000|Safety Follow-up|Study terminated by sponsor|1|||
156704357|NCT02861014|565663202|FG000|Safety Follow-up|Physician Decision|1|||
156704358|NCT02861014|565663202|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
156704359|NCT02861014|565663202|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
156704360|NCT00926783|565663203|FG000|Overall Study|Incomplete CFAE Procedures|3|||
156704361|NCT00926783|565663204|FG001|Overall Study|Incomplete CFAE Procedures|3|||
156704362|NCT00696787|565663207|FG000|Overall Study|Adverse Event|1|||
156704363|NCT00696787|565663208|FG001|Overall Study|Adverse Event|0|||
156704364|NCT00696787|565663209|FG002|Overall Study|Adverse Event|6|||
156704365|NCT00696787|565663207|FG000|Overall Study|Discontinuation by Sponsor|9|||
156704366|NCT00696787|565663208|FG001|Overall Study|Discontinuation by Sponsor|13|||
156704367|NCT00696787|565663209|FG002|Overall Study|Discontinuation by Sponsor|14|||
156704368|NCT00696787|565663207|FG000|Overall Study|Lack of Efficacy|0|||
156704369|NCT00696787|565663208|FG001|Overall Study|Lack of Efficacy|1|||
156704370|NCT00696787|565663209|FG002|Overall Study|Lack of Efficacy|0|||
156704371|NCT00696787|565663207|FG000|Overall Study|Lost to Follow-up|4|||
156704372|NCT00696787|565663208|FG001|Overall Study|Lost to Follow-up|0|||
156704373|NCT00696787|565663209|FG002|Overall Study|Lost to Follow-up|3|||
156704374|NCT00696787|565663207|FG000|Overall Study|Withdrawal by Subject|0|||
156704375|NCT00696787|565663208|FG001|Overall Study|Withdrawal by Subject|3|||
156704376|NCT00696787|565663209|FG002|Overall Study|Withdrawal by Subject|2|||
156704377|NCT00696787|565663207|FG000|Overall Study|Failed to return|1|||
156704378|NCT00696787|565663208|FG001|Overall Study|Failed to return|3|||
157124784|NCT03467958|567206328|FG008|Overall Study|Lack of Efficacy|3|||
156704379|NCT00696787|565663209|FG002|Overall Study|Failed to return|1|||
156704380|NCT02704403|565663210|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
156704381|NCT02704403|565663211|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
156704382|NCT02704403|565663210|FG000|Overall Study|Administrative reasons by sponsor|1251|||
156704383|NCT02704403|565663211|FG001|Overall Study|Administrative reasons by sponsor|616|||
156704384|NCT02704403|565663210|FG000|Overall Study|Death|4|||
156704385|NCT02704403|565663211|FG001|Overall Study|Death|3|||
156704386|NCT02704403|565663210|FG000|Overall Study|Endpoint event|52|||
156704387|NCT02704403|565663211|FG001|Overall Study|Endpoint event|24|||
157124785|NCT03467958|567206320|FG000|Overall Study|Lost to Follow-up|1|||
157124786|NCT03467958|567206321|FG001|Overall Study|Lost to Follow-up|2|||
157124787|NCT03467958|567206322|FG002|Overall Study|Lost to Follow-up|1|||
157124788|NCT03467958|567206323|FG003|Overall Study|Lost to Follow-up|0|||
157124789|NCT03467958|567206324|FG004|Overall Study|Lost to Follow-up|4|||
157124790|NCT03467958|567206325|FG005|Overall Study|Lost to Follow-up|0|||
157124791|NCT03467958|567206326|FG006|Overall Study|Lost to Follow-up|0|||
157124792|NCT03467958|567206327|FG007|Overall Study|Lost to Follow-up|0|||
157124793|NCT03467958|567206328|FG008|Overall Study|Lost to Follow-up|0|||
157124794|NCT03467958|567206320|FG000|Overall Study|Other reasons|8|||
157124795|NCT03467958|567206321|FG001|Overall Study|Other reasons|14|||
157124796|NCT03467958|567206322|FG002|Overall Study|Other reasons|2|||
157124797|NCT03467958|567206323|FG003|Overall Study|Other reasons|1|||
157124798|NCT03467958|567206324|FG004|Overall Study|Other reasons|4|||
156704388|NCT02704403|565663210|FG000|Overall Study|Lost to Follow-up|22|||
156704389|NCT02704403|565663211|FG001|Overall Study|Lost to Follow-up|11|||
156704390|NCT02704403|565663210|FG000|Overall Study|Protocol Violation|15|||
156704391|NCT02704403|565663211|FG001|Overall Study|Protocol Violation|15|||
156704392|NCT02704403|565663210|FG000|Overall Study|Adverse Event|2|||
157124799|NCT03467958|567206325|FG005|Overall Study|Other reasons|0|||
157124800|NCT03467958|567206326|FG006|Overall Study|Other reasons|1|||
157124801|NCT03467958|567206327|FG007|Overall Study|Other reasons|0|||
156704393|NCT02704403|565663211|FG001|Overall Study|Adverse Event|0|||
156704394|NCT02704403|565663210|FG000|Overall Study|Withdrawal by Subject|85|||
156704395|NCT02704403|565663211|FG001|Overall Study|Withdrawal by Subject|45|||
156704396|NCT02704403|565663210|FG000|Overall Study|Investigator decision|1|||
156704397|NCT02704403|565663211|FG001|Overall Study|Investigator decision|1|||
156704398|NCT02704403|565663210|FG000|Overall Study|Follow-up not possible|1|||
156704399|NCT02704403|565663211|FG001|Overall Study|Follow-up not possible|2|||
157124802|NCT03467958|567206328|FG008|Overall Study|Other reasons|1|||
157124803|NCT03467958|567206320|FG000|Overall Study|Pregnancy|1|||
157124804|NCT03467958|567206321|FG001|Overall Study|Pregnancy|0|||
157124805|NCT03467958|567206322|FG002|Overall Study|Pregnancy|0|||
157124806|NCT03467958|567206323|FG003|Overall Study|Pregnancy|0|||
157124807|NCT03467958|567206324|FG004|Overall Study|Pregnancy|0|||
156704400|NCT00380744|565663214|FG000|Overall Study|Death|0|||
156704401|NCT00380744|565663215|FG001|Overall Study|Death|0|||
156704402|NCT00380744|565663216|FG002|Overall Study|Death|0|||
156704403|NCT00380744|565663217|FG003|Overall Study|Death|0|||
156704404|NCT00380744|565663218|FG004|Overall Study|Death|0|||
156704405|NCT00380744|565663219|FG005|Overall Study|Death|0|||
156704406|NCT00380744|565663220|FG006|Overall Study|Death|1|||
157124808|NCT03467958|567206325|FG005|Overall Study|Pregnancy|1|||
157124809|NCT03467958|567206326|FG006|Overall Study|Pregnancy|0|||
157124810|NCT03467958|567206327|FG007|Overall Study|Pregnancy|0|||
157124811|NCT03467958|567206328|FG008|Overall Study|Pregnancy|0|||
157124812|NCT03467958|567206320|FG000|Overall Study|Study terminated by sponsor|65|||
157124813|NCT03467958|567206321|FG001|Overall Study|Study terminated by sponsor|117|||
156704407|NCT00380744|565663214|FG000|Overall Study|Withdrawal by Subject|1|||
156704408|NCT00380744|565663215|FG001|Overall Study|Withdrawal by Subject|0|||
157124814|NCT03467958|567206322|FG002|Overall Study|Study terminated by sponsor|45|||
157124815|NCT03467958|567206323|FG003|Overall Study|Study terminated by sponsor|64|||
157124816|NCT03467958|567206324|FG004|Overall Study|Study terminated by sponsor|66|||
157124817|NCT03467958|567206325|FG005|Overall Study|Study terminated by sponsor|17|||
157124818|NCT03467958|567206326|FG006|Overall Study|Study terminated by sponsor|11|||
157124819|NCT03467958|567206327|FG007|Overall Study|Study terminated by sponsor|5|||
157124820|NCT03467958|567206328|FG008|Overall Study|Study terminated by sponsor|5|||
157124821|NCT03467958|567206320|FG000|Overall Study|Withdrawal by Subject|25|||
157215469|NCT00555399|567535888|FG003|Overall Study|Withdrawal by Subject|0|||
157215470|NCT00555399|567535889|FG004|Overall Study|Withdrawal by Subject|0|||
156704409|NCT00380744|565663216|FG002|Overall Study|Withdrawal by Subject|0|||
156704410|NCT00380744|565663217|FG003|Overall Study|Withdrawal by Subject|0|||
156704411|NCT00380744|565663218|FG004|Overall Study|Withdrawal by Subject|0|||
156704412|NCT00380744|565663219|FG005|Overall Study|Withdrawal by Subject|0|||
156704413|NCT00380744|565663220|FG006|Overall Study|Withdrawal by Subject|0|||
156704414|NCT01955083|565663228|FG000|Overall Study|Lost to Follow-up|1|||
156704415|NCT01955083|565663229|FG001|Overall Study|Lost to Follow-up|1|||
156704416|NCT01559389|565663230|FG000|Overall Study|Withdrawal by Subject|20|||
156704417|NCT01559389|565663231|FG001|Overall Study|Withdrawal by Subject|20|||
156704418|NCT02871492|565663232|FG000|Overall Study|Lost to Follow-up|6|||
156704419|NCT02871492|565663233|FG001|Overall Study|Lost to Follow-up|3|||
156704420|NCT02871492|565663234|FG002|Overall Study|Lost to Follow-up|5|||
156704421|NCT02871492|565663232|FG000|Overall Study|Withdrawal by Subject|0|||
156704422|NCT02871492|565663233|FG001|Overall Study|Withdrawal by Subject|0|||
156704423|NCT02871492|565663234|FG002|Overall Study|Withdrawal by Subject|1|||
156704424|NCT01661062|565663235|FG000|Overall Study|Completed Treatment Off Study|3|||
156704425|NCT01661062|565663235|FG000|Overall Study|Withdrawal by Subject|2|||
156704426|NCT02754856|565663238|FG000|Overall Study|Withdrawal by Subject|1|||
156704427|NCT04874155|565663241|FG000|Overall Study|Lost to Follow-up|1|||
156704428|NCT04874155|565663242|FG001|Overall Study|Lost to Follow-up|1|||
156704429|NCT04874155|565663241|FG000|Overall Study|Withdrawal by Subject|2|||
156704430|NCT04874155|565663242|FG001|Overall Study|Withdrawal by Subject|2|||
156704431|NCT00530218|565663243|FG000|Overall Study|CMV Not Detected|13|||
156704432|NCT00530218|565663243|FG000|Overall Study|Death|12|||
156704433|NCT03477903|565663246|FG000|Overall Study|Study Terminated by Sponsor|1|||
157215471|NCT00555399|567535890|FG005|Overall Study|Withdrawal by Subject|0|||
157215472|NCT00555399|567535891|FG006|Overall Study|Withdrawal by Subject|0|||
157215473|NCT00555399|567535892|FG007|Overall Study|Withdrawal by Subject|0|||
156704434|NCT04435184|565663247|FG000|Overall Study|follow-up blood draws missing|3|||
156704435|NCT04435184|565663248|FG001|Overall Study|follow-up blood draws missing|5|||
156704436|NCT00474266|565663249|FG000|Overall Study|Withdrawal by Subject|7|||
157215474|NCT00555399|567535893|FG008|Overall Study|Withdrawal by Subject|0|||
157215475|NCT00555399|567535894|FG009|Overall Study|Withdrawal by Subject|0|||
156704437|NCT00474266|565663250|FG001|Overall Study|Withdrawal by Subject|20|||
156704438|NCT00474266|565663251|FG002|Overall Study|Withdrawal by Subject|4|||
156704439|NCT00474266|565663252|FG003|Overall Study|Withdrawal by Subject|7|||
156704440|NCT05330468|565663253|FG000|Overall Study|Death|6|||
156704441|NCT05330468|565663253|FG000|Overall Study|Withdrawal by Subject|4|||
156704442|NCT05330468|565663253|FG000|Overall Study|Lost to Follow-up|4|||
156704443|NCT02365558|565663254|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
156704444|NCT02365558|565663255|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
156704445|NCT02365558|565663254|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
157124822|NCT03467958|567206321|FG001|Overall Study|Withdrawal by Subject|44|||
156704446|NCT02365558|565663255|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
157124823|NCT03467958|567206322|FG002|Overall Study|Withdrawal by Subject|7|||
157124824|NCT03467958|567206323|FG003|Overall Study|Withdrawal by Subject|8|||
157124825|NCT03467958|567206324|FG004|Overall Study|Withdrawal by Subject|6|||
157124826|NCT03467958|567206325|FG005|Overall Study|Withdrawal by Subject|8|||
156704447|NCT01425723|565663257|FG000|Overall Study|Lack of Efficacy|0|||
156704448|NCT01425723|565663258|FG001|Overall Study|Lack of Efficacy|1|||
156704449|NCT01425723|565663257|FG000|Overall Study|Withdrawal by Subject|1|||
156704450|NCT01425723|565663258|FG001|Overall Study|Withdrawal by Subject|4|||
156704451|NCT01425723|565663257|FG000|Overall Study|Lost to Follow-up|0|||
156704452|NCT01425723|565663258|FG001|Overall Study|Lost to Follow-up|3|||
156704453|NCT01425723|565663257|FG000|Overall Study|Physician Decision|2|||
157124827|NCT03467958|567206326|FG006|Overall Study|Withdrawal by Subject|4|||
157215476|NCT00555399|567535895|FG010|Overall Study|Withdrawal by Subject|0|||
156704454|NCT01425723|565663258|FG001|Overall Study|Physician Decision|0|||
156704455|NCT01425723|565663257|FG000|Overall Study|Other|1|||
156704456|NCT01425723|565663258|FG001|Overall Study|Other|10|||
157124828|NCT03467958|567206327|FG007|Overall Study|Withdrawal by Subject|1|||
156704457|NCT03835221|565663259|FG000|Methafilcon A|Withdrawal by Subject|1|||
156704458|NCT00861198|565663260|FG000|Overall Study|SpyGlass Failed|5|||
156704459|NCT02288182|565663261|FG000|Overall Study|Adverse Event|0|||
156704460|NCT02288182|565663262|FG001|Overall Study|Adverse Event|1|||
156704461|NCT02288182|565663261|FG000|Overall Study|Lost to Follow-up|0|||
156704462|NCT02288182|565663262|FG001|Overall Study|Lost to Follow-up|1|||
156704463|NCT04619992|565663264|FG000|Overall Study|Withdrawal by Subject|1|||
156704464|NCT04619992|565663265|FG001|Overall Study|Withdrawal by Subject|0|||
156704465|NCT01197755|565663266|FG000|Overall Study|Adverse Event|8|||
156704466|NCT01197755|565663267|FG001|Overall Study|Adverse Event|10|||
156704467|NCT01197755|565663268|FG002|Overall Study|Adverse Event|10|||
156704468|NCT01197755|565663266|FG000|Overall Study|Study-specific discontinuation criteria|2|||
156704469|NCT01197755|565663267|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156704470|NCT01197755|565663268|FG002|Overall Study|Study-specific discontinuation criteria|0|||
156704471|NCT01197755|565663266|FG000|Overall Study|Entered the long-term extension study|18|||
156704472|NCT01197755|565663267|FG001|Overall Study|Entered the long-term extension study|21|||
156704473|NCT01197755|565663268|FG002|Overall Study|Entered the long-term extension study|35|||
156704474|NCT01197755|565663266|FG000|Overall Study|Lack of therapeutic response|0|||
156704475|NCT01197755|565663267|FG001|Overall Study|Lack of therapeutic response|7|||
156704476|NCT01197755|565663268|FG002|Overall Study|Lack of therapeutic response|4|||
156704477|NCT01197755|565663266|FG000|Overall Study|Severe non-compliance to the protocol|2|||
156704478|NCT01197755|565663267|FG001|Overall Study|Severe non-compliance to the protocol|1|||
156704479|NCT01197755|565663268|FG002|Overall Study|Severe non-compliance to the protocol|2|||
156704480|NCT01197755|565663266|FG000|Overall Study|Withdrawal by Subject|1|||
157124829|NCT03467958|567206328|FG008|Overall Study|Withdrawal by Subject|4|||
157124830|NCT01687712|567206329|FG000|Cycle 1|Not Biochemically Pregnant|386|||
157124831|NCT01687712|567206330|FG001|Cycle 1|Not Biochemically Pregnant|348|||
156704481|NCT01197755|565663267|FG001|Overall Study|Withdrawal by Subject|0|||
156704482|NCT01197755|565663268|FG002|Overall Study|Withdrawal by Subject|0|||
156704483|NCT01197755|565663266|FG000|Overall Study|Lost to Follow-up|0|||
156704484|NCT01197755|565663267|FG001|Overall Study|Lost to Follow-up|0|||
156704485|NCT01197755|565663268|FG002|Overall Study|Lost to Follow-up|1|||
156704486|NCT01197755|565663266|FG000|Overall Study|eg, change in circumstances|7|||
156704487|NCT01197755|565663267|FG001|Overall Study|eg, change in circumstances|3|||
156704488|NCT01197755|565663268|FG002|Overall Study|eg, change in circumstances|2|||
156704489|NCT03365011|565663269|FG000|Overall Study|Withdrawal by Subject|1|||
156704490|NCT03365011|565663270|FG001|Overall Study|Withdrawal by Subject|2|||
156704491|NCT00499174|565663271|FG000|Overall Study|Physician Decision|78|||
156704492|NCT00499174|565663272|FG001|Overall Study|Physician Decision|9|||
156704493|NCT03582826|565663273|FG000|Overall Study|Lost to Follow-up|39|||
156704494|NCT03582826|565663274|FG001|Overall Study|Lost to Follow-up|0|||
156704495|NCT03582826|565663273|FG000|Overall Study|Withdrawal by Subject|2|||
156704496|NCT03582826|565663274|FG001|Overall Study|Withdrawal by Subject|0|||
156704497|NCT01214915|565663275|FG000|Overall Study|Adverse Event|8|||
156704498|NCT01214915|565663275|FG000|Overall Study|Lack of Efficacy|3|||
156704499|NCT01104779|565663277|FG000|Overall Study|Protocol Violation|1|||
156704500|NCT01104779|565663278|FG001|Overall Study|Protocol Violation|2|||
156704501|NCT01104779|565663279|FG002|Overall Study|Protocol Violation|2|||
156704502|NCT01104779|565663277|FG000|Overall Study|Lack of Efficacy|26|||
156704503|NCT01104779|565663278|FG001|Overall Study|Lack of Efficacy|12|||
156704504|NCT01104779|565663279|FG002|Overall Study|Lack of Efficacy|13|||
156704505|NCT01104779|565663277|FG000|Overall Study|Adverse Event|13|||
156704506|NCT01104779|565663278|FG001|Overall Study|Adverse Event|14|||
156704507|NCT01104779|565663279|FG002|Overall Study|Adverse Event|13|||
157124832|NCT01687712|567206329|FG000|Cycle 1|Early Pregnancy Loss|43|||
156704508|NCT01104779|565663277|FG000|Overall Study|Did not meet inc/exc criteria|1|||
156704509|NCT01104779|565663278|FG001|Overall Study|Did not meet inc/exc criteria|1|||
156704510|NCT01104779|565663279|FG002|Overall Study|Did not meet inc/exc criteria|1|||
156704511|NCT01104779|565663277|FG000|Overall Study|Other reasons|0|||
156704512|NCT01104779|565663278|FG001|Overall Study|Other reasons|1|||
156704513|NCT01104779|565663279|FG002|Overall Study|Other reasons|0|||
156704514|NCT01104779|565663277|FG000|Overall Study|Lost to Follow-up|2|||
156704515|NCT01104779|565663278|FG001|Overall Study|Lost to Follow-up|0|||
157124833|NCT01687712|567206330|FG001|Cycle 1|Early Pregnancy Loss|60|||
157124834|NCT01687712|567206329|FG000|Cycle 1|Ectopic Pregnancy|5|||
157124835|NCT01687712|567206330|FG001|Cycle 1|Ectopic Pregnancy|5|||
156704516|NCT01104779|565663279|FG002|Overall Study|Lost to Follow-up|1|||
157124836|NCT01687712|567206329|FG000|Cycle 1|Heterotropic Pregnancy|1|||
156704517|NCT01104779|565663277|FG000|Overall Study|Withdrawal by Subject|16|||
156704518|NCT01104779|565663278|FG001|Overall Study|Withdrawal by Subject|25|||
156704519|NCT01104779|565663279|FG002|Overall Study|Withdrawal by Subject|32|||
157124837|NCT01687712|567206330|FG001|Cycle 1|Heterotropic Pregnancy|0|||
156704520|NCT03753763|565663280|FG000|Overall Study|Adverse Event|2|||
156704521|NCT03753763|565663281|FG001|Overall Study|Adverse Event|0|||
156704522|NCT03753763|565663280|FG000|Overall Study|Withdrawal by Subject|3|||
156704523|NCT03753763|565663281|FG001|Overall Study|Withdrawal by Subject|1|||
156704524|NCT03753763|565663280|FG000|Overall Study|clinical deterioration|1|||
156704525|NCT03753763|565663281|FG001|Overall Study|clinical deterioration|0|||
156704526|NCT00871741|565663283|FG000|Overall Study|Premature study termination|9|||
156704527|NCT00871741|565663284|FG001|Overall Study|Premature study termination|7|||
156704528|NCT05323123|565663285|FG000|Overall Study|Withdrawal by Subject|2|||
156704529|NCT05323123|565663286|FG001|Overall Study|Withdrawal by Subject|1|||
156704530|NCT05323123|565663285|FG000|Overall Study|Lost to Follow-up|4|||
156704531|NCT05323123|565663286|FG001|Overall Study|Lost to Follow-up|2|||
156704532|NCT05323123|565663285|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
156704533|NCT05323123|565663286|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
156704534|NCT05529472|565663287|FG000|Overall Study|Withdrawal by Subject|1|||
156704535|NCT05529472|565663288|FG001|Overall Study|Withdrawal by Subject|1|||
156704536|NCT04975191|565665095|FG000|Overall Study|Protocol Violation|1|||
156704537|NCT04975191|565665096|FG001|Overall Study|Protocol Violation|2|||
156704538|NCT04975191|565665097|FG002|Overall Study|Protocol Violation|2|||
156704539|NCT04975191|565665098|FG003|Overall Study|Protocol Violation|2|||
156704540|NCT04975191|565665095|FG000|Overall Study|Lost to Follow-up|13|||
156704541|NCT04975191|565665096|FG001|Overall Study|Lost to Follow-up|3|||
156704542|NCT04975191|565665097|FG002|Overall Study|Lost to Follow-up|8|||
156704543|NCT04975191|565665098|FG003|Overall Study|Lost to Follow-up|8|||
156704544|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
156704545|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
156704546|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
156704547|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
156704548|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
156704549|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
156704550|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
156704551|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
156704552|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
156704553|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704554|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704555|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
156704556|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
156704557|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704558|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704559|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704560|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704561|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
156704562|NCT00761657|565665099|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704563|NCT00761657|565665100|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704564|NCT00761657|565665101|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
156704565|NCT00761657|565665102|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
156704566|NCT00761657|565665103|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704567|NCT00761657|565665104|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
156704568|NCT00761657|565665105|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704569|NCT00761657|565665106|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704570|NCT00761657|565665107|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
156704571|NCT00761657|565665099|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
156704572|NCT00761657|565665100|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
156704573|NCT00761657|565665101|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
156704574|NCT00761657|565665102|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
156704575|NCT00761657|565665103|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
156704576|NCT00761657|565665104|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
156704577|NCT00761657|565665105|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
156704578|NCT00761657|565665106|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
156704579|NCT00761657|565665107|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
157124838|NCT01687712|567206329|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
157124839|NCT01687712|567206330|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
157124840|NCT01687712|567206329|FG000|Cycle 1|Abortion|3|||
157124841|NCT01687712|567206330|FG001|Cycle 1|Abortion|0|||
156704580|NCT00359801|565665113|FG000|Overall Study|Lost to Follow-up|72|||
156704581|NCT00359801|565665114|FG001|Overall Study|Lost to Follow-up|58|||
156704582|NCT00359801|565665113|FG000|Overall Study|Withdrawal by Subject|143|||
156704583|NCT00359801|565665114|FG001|Overall Study|Withdrawal by Subject|96|||
156704584|NCT00359801|565665113|FG000|Overall Study|Other|66|||
156704585|NCT00359801|565665114|FG001|Overall Study|Other|46|||
157124842|NCT01687712|567206329|FG000|Cycle 1|Intrauterine Fetal Death|0|||
157124843|NCT01687712|567206330|FG001|Cycle 1|Intrauterine Fetal Death|1|||
156704586|NCT00359801|565665113|FG000|Overall Study|Final Status Unknown: missing data|7|||
157124844|NCT01687712|567206329|FG000|Cycle 1|Lost to Follow-up|1|||
156704587|NCT00359801|565665114|FG001|Overall Study|Final Status Unknown: missing data|4|||
156704588|NCT00359801|565665113|FG000|Overall Study|Sponsor Decision|17|||
156704589|NCT00359801|565665114|FG001|Overall Study|Sponsor Decision|16|||
156704590|NCT01392963|565665115|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
156704591|NCT01392963|565665116|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
156704592|NCT01392963|565665115|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
156704593|NCT01392963|565665116|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
156704594|NCT01392963|565665115|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
156704595|NCT01392963|565665116|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
156704596|NCT00450801|565665119|FG000|Overall Study|Death|1|||
156704597|NCT00324649|565665120|FG000|Overall Study|Adverse Event|1|||
156704598|NCT00324649|565665121|FG001|Overall Study|Adverse Event|4|||
156704599|NCT00324649|565665120|FG000|Overall Study|Withdrawal by Subject|0|||
156704600|NCT00324649|565665121|FG001|Overall Study|Withdrawal by Subject|1|||
156704601|NCT00324649|565665120|FG000|Overall Study|Noncompliance|1|||
156704602|NCT00324649|565665121|FG001|Overall Study|Noncompliance|0|||
156704603|NCT01396512|565665124|FG000|Overall Study|Withdrawal by Subject|0|||
156704604|NCT01396512|565665125|FG001|Overall Study|Withdrawal by Subject|1|||
156704605|NCT02618759|565665128|FG000|Overall Study|Lost to Follow-up|0|||
156704606|NCT02618759|565665129|FG001|Overall Study|Lost to Follow-up|1|||
156704607|NCT02618759|565665128|FG000|Overall Study|Withdrawal by Subject|1|||
156704608|NCT02618759|565665129|FG001|Overall Study|Withdrawal by Subject|0|||
156704609|NCT02618759|565665128|FG000|Overall Study|Other Reasons|1|||
156704610|NCT02618759|565665129|FG001|Overall Study|Other Reasons|4|||
156704611|NCT02152605|565665130|FG000|Overall Study|Adverse Event|6|||
156704612|NCT02152605|565665131|FG001|Overall Study|Adverse Event|8|||
156704613|NCT02152605|565665130|FG000|Overall Study|Lack of Efficacy|7|||
156704614|NCT02152605|565665131|FG001|Overall Study|Lack of Efficacy|4|||
156704615|NCT02152605|565665130|FG000|Overall Study|Protocol deviation|1|||
156704616|NCT02152605|565665131|FG001|Overall Study|Protocol deviation|4|||
156704617|NCT02152605|565665130|FG000|Overall Study|Lost to Follow-up|1|||
156704618|NCT02152605|565665131|FG001|Overall Study|Lost to Follow-up|0|||
156704619|NCT02152605|565665130|FG000|Overall Study|Withdrew consent|4|||
156704620|NCT02152605|565665131|FG001|Overall Study|Withdrew consent|2|||
156704621|NCT02500043|565665138|FG000|Overall Study|Randomized, but not Treated|2|||
156704622|NCT02500043|565665139|FG001|Overall Study|Randomized, but not Treated|2|||
156704623|NCT02500043|565665138|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
156704624|NCT02500043|565665139|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
156704625|NCT02500043|565665138|FG000|Overall Study|Adverse Event|33|||
156704626|NCT02500043|565665139|FG001|Overall Study|Adverse Event|11|||
156704627|NCT02500043|565665138|FG000|Overall Study|Clinical Progression|54|||
157015605|NCT02814838|566808905|FG000|Overall Study|Consent withdrawal|1|||
157015606|NCT02814838|566808906|FG001|Overall Study|Consent withdrawal|1|||
156704628|NCT02500043|565665139|FG001|Overall Study|Clinical Progression|35|||
156704629|NCT02500043|565665138|FG000|Overall Study|Radiological Progression|192|||
156704630|NCT02500043|565665139|FG001|Overall Study|Radiological Progression|110|||
156704631|NCT02500043|565665138|FG000|Overall Study|Physician's Decision|11|||
156704632|NCT02500043|565665139|FG001|Overall Study|Physician's Decision|3|||
157015607|NCT01771731|566808907|FG000|Overall Study|Physician Decision|1|||
157015608|NCT01771731|566808908|FG001|Overall Study|Physician Decision|0|||
157015609|NCT01771731|566808907|FG000|Overall Study|Protocol Violation|0|||
157015610|NCT01771731|566808908|FG001|Overall Study|Protocol Violation|1|||
157015611|NCT01771731|566808907|FG000|Overall Study|Adverse event: Pain Crisis|1|||
157015612|NCT01771731|566808908|FG001|Overall Study|Adverse event: Pain Crisis|1|||
157015613|NCT00073749|566808909|FG000|Overall Study|Disease Progression|2|||
157015614|NCT00073749|566808910|FG001|Overall Study|Disease Progression|0|||
157015615|NCT00073749|566808911|FG002|Overall Study|Disease Progression|3|||
157015616|NCT00073749|566808912|FG003|Overall Study|Disease Progression|2|||
157015617|NCT00073749|566808913|FG004|Overall Study|Disease Progression|3|||
157015618|NCT00073749|566808914|FG005|Overall Study|Disease Progression|1|||
157015619|NCT00073749|566808915|FG006|Overall Study|Disease Progression|3|||
157015620|NCT00073749|566808909|FG000|Overall Study|Death|0|||
157015621|NCT00073749|566808910|FG001|Overall Study|Death|1|||
157015622|NCT00073749|566808911|FG002|Overall Study|Death|1|||
157015623|NCT00073749|566808912|FG003|Overall Study|Death|0|||
157015624|NCT00073749|566808913|FG004|Overall Study|Death|0|||
157015625|NCT00073749|566808914|FG005|Overall Study|Death|0|||
157015626|NCT00073749|566808915|FG006|Overall Study|Death|29|||
157015627|NCT00073749|566808909|FG000|Overall Study|Adverse Event|0|||
156704633|NCT02500043|565665138|FG000|Overall Study|Withdrawal by Subject|14|||
156704634|NCT02500043|565665139|FG001|Overall Study|Withdrawal by Subject|4|||
157015628|NCT00073749|566808910|FG001|Overall Study|Adverse Event|3|||
157015629|NCT00073749|566808911|FG002|Overall Study|Adverse Event|6|||
157015630|NCT00073749|566808912|FG003|Overall Study|Adverse Event|4|||
157015631|NCT00073749|566808913|FG004|Overall Study|Adverse Event|2|||
157015632|NCT00073749|566808914|FG005|Overall Study|Adverse Event|1|||
157015633|NCT00073749|566808915|FG006|Overall Study|Adverse Event|0|||
157015634|NCT00073749|566808909|FG000|Overall Study|Physician Decision|0|||
157015635|NCT00073749|566808910|FG001|Overall Study|Physician Decision|0|||
156704635|NCT02500043|565665138|FG000|Overall Study|Death|11|||
156704636|NCT02500043|565665139|FG001|Overall Study|Death|2|||
156704637|NCT02500043|565665138|FG000|Overall Study|Protocol Deviation|1|||
157015636|NCT00073749|566808911|FG002|Overall Study|Physician Decision|1|||
157015637|NCT00073749|566808912|FG003|Overall Study|Physician Decision|0|||
156704638|NCT02500043|565665139|FG001|Overall Study|Protocol Deviation|0|||
156704639|NCT00580788|565665140|FG000|Overall Study|Adverse Event|0|||
156704640|NCT00580788|565665141|FG001|Overall Study|Adverse Event|0|||
156704641|NCT00580788|565665142|FG002|Overall Study|Adverse Event|0|||
156704642|NCT00580788|565665143|FG003|Overall Study|Adverse Event|1|||
156704643|NCT01564537|565665144|FG000|Overall Study|Site Terminated by Sponsor|1|||
156704644|NCT01564537|565665145|FG001|Overall Study|Site Terminated by Sponsor|0|||
156704645|NCT01564537|565665144|FG000|Overall Study|Withdrawal by Subject|12|||
156704646|NCT01564537|565665145|FG001|Overall Study|Withdrawal by Subject|14|||
156704647|NCT01564537|565665144|FG000|Overall Study|Lost to Follow-up|7|||
156704648|NCT01564537|565665145|FG001|Overall Study|Lost to Follow-up|3|||
156704649|NCT01564537|565665144|FG000|Overall Study|Reason not specified|81|||
156704650|NCT01564537|565665145|FG001|Overall Study|Reason not specified|82|||
156704651|NCT02932306|565665150|FG000|Overall Study|Withdrawal by Subject|16|||
156704652|NCT02932306|565665151|FG001|Overall Study|Withdrawal by Subject|25|||
156704653|NCT02932306|565665150|FG000|Overall Study|Adverse Event|3|||
156704654|NCT02932306|565665151|FG001|Overall Study|Adverse Event|0|||
156704655|NCT02932306|565665150|FG000|Overall Study|Pregnancy|2|||
156704656|NCT02932306|565665151|FG001|Overall Study|Pregnancy|0|||
156704657|NCT02932306|565665150|FG000|Overall Study|Protocol Violation|1|||
156704658|NCT02932306|565665151|FG001|Overall Study|Protocol Violation|1|||
156704659|NCT02932306|565665150|FG000|Overall Study|Noncompliance with Study Drug|1|||
156704660|NCT02932306|565665151|FG001|Overall Study|Noncompliance with Study Drug|1|||
156704661|NCT02932306|565665150|FG000|Overall Study|Lost to Follow-up|36|||
156704662|NCT02932306|565665151|FG001|Overall Study|Lost to Follow-up|40|||
156704663|NCT02932306|565665150|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
156704664|NCT02932306|565665151|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
156704665|NCT02932306|565665150|FG000|Overall Study|Lack of Efficacy|0|||
156704666|NCT02932306|565665151|FG001|Overall Study|Lack of Efficacy|2|||
156704667|NCT02932306|565665150|FG000|Overall Study|Worsening condition|2|||
156704668|NCT02932306|565665151|FG001|Overall Study|Worsening condition|0|||
156704669|NCT02932306|565665150|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
156704670|NCT02932306|565665151|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
156704671|NCT02065700|565665152|FG000|Overall Study|Adverse Event|165|||
156704672|NCT02065700|565665153|FG001|Overall Study|Adverse Event|101|||
156704673|NCT02065700|565665152|FG000|Overall Study|Withdrawal by Subject|90|||
156704674|NCT02065700|565665153|FG001|Overall Study|Withdrawal by Subject|29|||
156704675|NCT02065700|565665152|FG000|Overall Study|Lost to Follow-up|12|||
156704676|NCT02065700|565665153|FG001|Overall Study|Lost to Follow-up|9|||
156704677|NCT02065700|565665152|FG000|Overall Study|Physician Decision|2|||
156704678|NCT02065700|565665153|FG001|Overall Study|Physician Decision|0|||
156704679|NCT02065700|565665152|FG000|Overall Study|Sponsor Request|38|||
156704680|NCT02065700|565665153|FG001|Overall Study|Sponsor Request|15|||
156704681|NCT02065700|565665152|FG000|Overall Study|Treatment Failure|3|||
156704682|NCT02065700|565665153|FG001|Overall Study|Treatment Failure|2|||
156704683|NCT02065700|565665152|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
156704684|NCT02065700|565665153|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
156704685|NCT02065700|565665152|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
157124845|NCT01687712|567206330|FG001|Cycle 1|Lost to Follow-up|1|||
156704686|NCT02065700|565665153|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
156704687|NCT02065700|565665152|FG000|Overall Study|Non-compliance with Study Procedures|2|||
156704688|NCT02065700|565665153|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156704689|NCT02065700|565665152|FG000|Overall Study|Not Defined|21|||
156704690|NCT02065700|565665153|FG001|Overall Study|Not Defined|3|||
156704691|NCT01635218|565665156|FG000|Overall Study|Lost to Follow-up|3|||
156704692|NCT01635218|565665157|FG001|Overall Study|Lost to Follow-up|7|||
156704693|NCT01635218|565665158|FG002|Overall Study|Lost to Follow-up|6|||
156704694|NCT03559400|565665159|FG000|Overall Study|Lost to Follow-up|9|||
156704695|NCT03559400|565665160|FG001|Overall Study|Lost to Follow-up|7|||
157124846|NCT01687712|567206329|FG000|Cycle 2|Not Biochemically Pregnant|74|||
157124847|NCT01687712|567206330|FG001|Cycle 2|Not Biochemically Pregnant|77|||
157124848|NCT01687712|567206329|FG000|Cycle 2|Early Pregnancy Loss|18|||
157124849|NCT01687712|567206330|FG001|Cycle 2|Early Pregnancy Loss|16|||
157124850|NCT01687712|567206329|FG000|Cycle 2|Ectopic Pregnancy|0|||
157124851|NCT01687712|567206330|FG001|Cycle 2|Ectopic Pregnancy|1|||
156704696|NCT03559400|565665159|FG000|Overall Study|Death|0|||
156704697|NCT03559400|565665160|FG001|Overall Study|Death|2|||
156704698|NCT03262038|565665165|FG000|Overall Study|Withdrawal by Subject|0|||
156704699|NCT03262038|565665166|FG001|Overall Study|Withdrawal by Subject|1|||
156704700|NCT04933968|565665167|FG000|Overall Study|Adverse Event|0|||
156704701|NCT04933968|565665168|FG001|Overall Study|Adverse Event|0|||
156704702|NCT04933968|565665169|FG002|Overall Study|Adverse Event|1|||
156704703|NCT04933968|565665170|FG003|Overall Study|Adverse Event|1|||
156704704|NCT04933968|565665171|FG004|Overall Study|Adverse Event|0|||
156704705|NCT04933968|565665172|FG005|Overall Study|Adverse Event|0|||
156704706|NCT04933968|565665167|FG000|Overall Study|Lost to Follow-up|1|||
156704707|NCT04933968|565665168|FG001|Overall Study|Lost to Follow-up|0|||
157124852|NCT01687712|567206329|FG000|Cycle 2|Still Birth|1|||
157124853|NCT01687712|567206330|FG001|Cycle 2|Still Birth|0|||
156704708|NCT04933968|565665169|FG002|Overall Study|Lost to Follow-up|1|||
156704709|NCT04933968|565665170|FG003|Overall Study|Lost to Follow-up|0|||
156704710|NCT04933968|565665171|FG004|Overall Study|Lost to Follow-up|0|||
156704711|NCT04933968|565665172|FG005|Overall Study|Lost to Follow-up|0|||
156704712|NCT04933968|565665167|FG000|Overall Study|Randomized not treated|1|||
156704713|NCT04933968|565665168|FG001|Overall Study|Randomized not treated|0|||
156704714|NCT04933968|565665169|FG002|Overall Study|Randomized not treated|0|||
156704715|NCT04933968|565665170|FG003|Overall Study|Randomized not treated|0|||
156704716|NCT04933968|565665171|FG004|Overall Study|Randomized not treated|0|||
156704717|NCT04933968|565665172|FG005|Overall Study|Randomized not treated|0|||
156704718|NCT04933968|565665167|FG000|Overall Study|Sponsor terminated study|0|||
156704719|NCT04933968|565665168|FG001|Overall Study|Sponsor terminated study|0|||
156704720|NCT04933968|565665169|FG002|Overall Study|Sponsor terminated study|0|||
156704721|NCT04933968|565665170|FG003|Overall Study|Sponsor terminated study|1|||
156704722|NCT04933968|565665171|FG004|Overall Study|Sponsor terminated study|2|||
156704723|NCT04933968|565665172|FG005|Overall Study|Sponsor terminated study|0|||
156704724|NCT04933968|565665167|FG000|Overall Study|Other|0|||
156704725|NCT04933968|565665168|FG001|Overall Study|Other|0|||
156704726|NCT04933968|565665169|FG002|Overall Study|Other|0|||
156704727|NCT04933968|565665170|FG003|Overall Study|Other|1|||
156704728|NCT04933968|565665171|FG004|Overall Study|Other|0|||
156704729|NCT04933968|565665172|FG005|Overall Study|Other|0|||
156704730|NCT04933968|565665167|FG000|Overall Study|Missing|1|||
156704731|NCT04933968|565665168|FG001|Overall Study|Missing|3|||
156704732|NCT04933968|565665169|FG002|Overall Study|Missing|2|||
156704733|NCT04933968|565665170|FG003|Overall Study|Missing|1|||
156704734|NCT04933968|565665171|FG004|Overall Study|Missing|1|||
156704735|NCT04933968|565665172|FG005|Overall Study|Missing|0|||
156704736|NCT01724489|565665173|FG000|Overall Study|Adverse Event|8|||
156704737|NCT01724489|565665174|FG001|Overall Study|Adverse Event|3|||
156704738|NCT01724489|565665173|FG000|Overall Study|Surgery, medication|1|||
156704739|NCT01724489|565665174|FG001|Overall Study|Surgery, medication|1|||
156704740|NCT01724489|565665173|FG000|Overall Study|Lost to Follow-up|1|||
156704741|NCT01724489|565665174|FG001|Overall Study|Lost to Follow-up|2|||
156704742|NCT01724489|565665173|FG000|Overall Study|Withdrawal by Subject|6|||
156704743|NCT01724489|565665174|FG001|Overall Study|Withdrawal by Subject|6|||
156704744|NCT01664130|565665177|FG000|Overall Study|competing secondary disease|2|||
156704745|NCT03323437|565665180|FG000|Overall Study|Withdrawal by Subject|0|||
156704746|NCT03323437|565665181|FG001|Overall Study|Withdrawal by Subject|4|||
156704747|NCT01473524|565665184|FG000|DB Phase|Adverse Event|4|||
156704748|NCT01473524|565665185|FG001|DB Phase|Adverse Event|8|||
156704749|NCT01473524|565665186|FG002|DB Phase|Adverse Event|2|||
156704750|NCT01473524|565665187|FG003|DB Phase|Adverse Event|0|||
156704751|NCT01473524|565665188|FG004|DB Phase|Adverse Event|0|||
156704752|NCT01473524|565665189|FG005|DB Phase|Adverse Event|0|||
156704753|NCT01473524|565665184|FG000|DB Phase|Death|1|||
156704754|NCT01473524|565665185|FG001|DB Phase|Death|0|||
156704755|NCT01473524|565665186|FG002|DB Phase|Death|0|||
156704756|NCT01473524|565665187|FG003|DB Phase|Death|0|||
156704757|NCT01473524|565665188|FG004|DB Phase|Death|0|||
156704758|NCT01473524|565665189|FG005|DB Phase|Death|0|||
157015638|NCT00073749|566808913|FG004|Overall Study|Physician Decision|0|||
157015639|NCT00073749|566808914|FG005|Overall Study|Physician Decision|2|||
157015640|NCT00073749|566808915|FG006|Overall Study|Physician Decision|0|||
157015641|NCT00073749|566808909|FG000|Overall Study|Withdrawal by Subject|0|||
157015642|NCT00073749|566808910|FG001|Overall Study|Withdrawal by Subject|1|||
157015643|NCT00073749|566808911|FG002|Overall Study|Withdrawal by Subject|0|||
157015644|NCT00073749|566808912|FG003|Overall Study|Withdrawal by Subject|0|||
157015645|NCT00073749|566808913|FG004|Overall Study|Withdrawal by Subject|1|||
157015646|NCT00073749|566808914|FG005|Overall Study|Withdrawal by Subject|0|||
157015647|NCT00073749|566808915|FG006|Overall Study|Withdrawal by Subject|2|||
157015648|NCT00073749|566808909|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
157015649|NCT00073749|566808910|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
157015650|NCT00073749|566808911|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
157015651|NCT00073749|566808912|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
157015652|NCT00073749|566808913|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
157015653|NCT00073749|566808914|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
157015654|NCT00073749|566808915|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
157015655|NCT00073749|566808909|FG000|Overall Study|Lost to Follow-up|0|||
157015656|NCT00073749|566808910|FG001|Overall Study|Lost to Follow-up|0|||
157015657|NCT00073749|566808911|FG002|Overall Study|Lost to Follow-up|0|||
157015658|NCT00073749|566808912|FG003|Overall Study|Lost to Follow-up|0|||
157015659|NCT00073749|566808913|FG004|Overall Study|Lost to Follow-up|0|||
157015660|NCT00073749|566808914|FG005|Overall Study|Lost to Follow-up|0|||
157015661|NCT00073749|566808915|FG006|Overall Study|Lost to Follow-up|2|||
157015662|NCT00073749|566808909|FG000|Overall Study|Other|0|||
157015663|NCT00073749|566808910|FG001|Overall Study|Other|0|||
157015664|NCT00073749|566808911|FG002|Overall Study|Other|0|||
157015665|NCT00073749|566808912|FG003|Overall Study|Other|0|||
157015666|NCT00073749|566808913|FG004|Overall Study|Other|0|||
157015667|NCT00073749|566808914|FG005|Overall Study|Other|2|||
156704759|NCT01473524|565665184|FG000|DB Phase|Withdrawal by Subject|2|||
156704760|NCT01473524|565665185|FG001|DB Phase|Withdrawal by Subject|1|||
156704761|NCT01473524|565665186|FG002|DB Phase|Withdrawal by Subject|1|||
156704762|NCT01473524|565665187|FG003|DB Phase|Withdrawal by Subject|0|||
156704763|NCT01473524|565665188|FG004|DB Phase|Withdrawal by Subject|0|||
156704764|NCT01473524|565665189|FG005|DB Phase|Withdrawal by Subject|0|||
156704765|NCT01473524|565665184|FG000|LTSE Phase|Withdrawal by Subject|0|||
156704766|NCT01473524|565665185|FG001|LTSE Phase|Withdrawal by Subject|0|||
156704767|NCT01473524|565665186|FG002|LTSE Phase|Withdrawal by Subject|0|||
156704768|NCT01473524|565665187|FG003|LTSE Phase|Withdrawal by Subject|3|||
156704769|NCT01473524|565665188|FG004|LTSE Phase|Withdrawal by Subject|3|||
156704770|NCT01473524|565665189|FG005|LTSE Phase|Withdrawal by Subject|6|||
156704771|NCT01473524|565665184|FG000|LTSE Phase|Death|0|||
156704772|NCT01473524|565665185|FG001|LTSE Phase|Death|0|||
156704773|NCT01473524|565665186|FG002|LTSE Phase|Death|0|||
156704774|NCT01473524|565665187|FG003|LTSE Phase|Death|0|||
156704775|NCT01473524|565665188|FG004|LTSE Phase|Death|1|||
156704776|NCT01473524|565665189|FG005|LTSE Phase|Death|0|||
156704777|NCT01473524|565665184|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
156704778|NCT01473524|565665185|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
156704779|NCT01473524|565665186|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
156704780|NCT01473524|565665187|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
156704781|NCT01473524|565665188|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
156704782|NCT01473524|565665189|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
156704783|NCT01473524|565665184|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704784|NCT01473524|565665185|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704785|NCT01473524|565665186|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
156704786|NCT01473524|565665187|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
156704787|NCT01473524|565665188|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
156704788|NCT01473524|565665189|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
156704789|NCT01473524|565665184|FG000|LTSE Phase|Lost to Follow-up|0|||
156704790|NCT01473524|565665185|FG001|LTSE Phase|Lost to Follow-up|0|||
156704791|NCT01473524|565665186|FG002|LTSE Phase|Lost to Follow-up|0|||
156704792|NCT01473524|565665187|FG003|LTSE Phase|Lost to Follow-up|1|||
156704793|NCT01473524|565665188|FG004|LTSE Phase|Lost to Follow-up|3|||
156704794|NCT01473524|565665189|FG005|LTSE Phase|Lost to Follow-up|2|||
156704795|NCT01473524|565665184|FG000|LTSE Phase|Principal Investigator Decision|0|||
156704796|NCT01473524|565665185|FG001|LTSE Phase|Principal Investigator Decision|0|||
156704797|NCT01473524|565665186|FG002|LTSE Phase|Principal Investigator Decision|0|||
156704798|NCT01473524|565665187|FG003|LTSE Phase|Principal Investigator Decision|1|||
156704799|NCT01473524|565665188|FG004|LTSE Phase|Principal Investigator Decision|1|||
156704800|NCT01473524|565665189|FG005|LTSE Phase|Principal Investigator Decision|3|||
156704801|NCT01473524|565665184|FG000|LTSE Phase|Liver Transplantation|0|||
156704802|NCT01473524|565665185|FG001|LTSE Phase|Liver Transplantation|0|||
156704803|NCT01473524|565665186|FG002|LTSE Phase|Liver Transplantation|0|||
156704804|NCT01473524|565665187|FG003|LTSE Phase|Liver Transplantation|0|||
156704805|NCT01473524|565665188|FG004|LTSE Phase|Liver Transplantation|0|||
156704806|NCT01473524|565665189|FG005|LTSE Phase|Liver Transplantation|1|||
156704807|NCT01473524|565665184|FG000|LTSE Phase|Pregnancy|0|||
156704808|NCT01473524|565665185|FG001|LTSE Phase|Pregnancy|0|||
156704809|NCT01473524|565665186|FG002|LTSE Phase|Pregnancy|0|||
156704810|NCT01473524|565665187|FG003|LTSE Phase|Pregnancy|1|||
156704811|NCT01473524|565665188|FG004|LTSE Phase|Pregnancy|0|||
156704812|NCT01473524|565665189|FG005|LTSE Phase|Pregnancy|0|||
156704813|NCT01473524|565665184|FG000|LTSE Phase|Protocol Violation|0|||
156872168|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
156872169|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
156704814|NCT01473524|565665185|FG001|LTSE Phase|Protocol Violation|0|||
156704815|NCT01473524|565665186|FG002|LTSE Phase|Protocol Violation|0|||
156704816|NCT01473524|565665187|FG003|LTSE Phase|Protocol Violation|0|||
156704817|NCT01473524|565665188|FG004|LTSE Phase|Protocol Violation|0|||
156872170|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
156704818|NCT01473524|565665189|FG005|LTSE Phase|Protocol Violation|1|||
157015668|NCT00073749|566808915|FG006|Overall Study|Other|0|||
156704819|NCT01544179|565665190|FG000|Overall Study|Death|50|||
156704820|NCT01544179|565665191|FG001|Overall Study|Death|37|||
156704821|NCT01544179|565665190|FG000|Overall Study|Lost to Follow-up|0|||
156704822|NCT01544179|565665191|FG001|Overall Study|Lost to Follow-up|1|||
156704823|NCT01544179|565665190|FG000|Overall Study|Adverse Event|0|||
156704824|NCT01544179|565665191|FG001|Overall Study|Adverse Event|1|||
156704825|NCT01544179|565665190|FG000|Overall Study|Withdrawal by Subject|12|||
156704826|NCT01544179|565665191|FG001|Overall Study|Withdrawal by Subject|7|||
156704827|NCT01544179|565665190|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
156704828|NCT01544179|565665191|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156704829|NCT02045147|565665192|FG000|Overall Study|Withdrawal by Subject|2|||
157015669|NCT00976495|566808916|FG000|Overall Study|Withdrawal by Subject|0|||
157015670|NCT00976495|566808917|FG001|Overall Study|Withdrawal by Subject|1|||
157015671|NCT00976495|566808918|FG002|Overall Study|Withdrawal by Subject|0|||
156704830|NCT02045147|565665193|FG001|Overall Study|Withdrawal by Subject|0|||
156704831|NCT02045147|565665194|FG002|Overall Study|Withdrawal by Subject|0|||
156704832|NCT02045147|565665195|FG003|Overall Study|Withdrawal by Subject|0|||
156704833|NCT02045147|565665196|FG004|Overall Study|Withdrawal by Subject|0|||
156704834|NCT02045147|565665197|FG005|Overall Study|Withdrawal by Subject|0|||
156704835|NCT02045147|565665198|FG006|Overall Study|Withdrawal by Subject|0|||
156704836|NCT02045147|565665199|FG007|Overall Study|Withdrawal by Subject|1|||
156704837|NCT02045147|565665192|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
156704838|NCT02045147|565665193|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
156704839|NCT02045147|565665194|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
156704840|NCT02045147|565665195|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
156704841|NCT02045147|565665196|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
156704842|NCT02045147|565665197|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
156704843|NCT02045147|565665198|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
156704844|NCT02045147|565665199|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
156704845|NCT04839692|565665200|FG000|Overall Study|Withdrawal by Subject|0|||
156704846|NCT04839692|565665201|FG001|Overall Study|Withdrawal by Subject|3|||
156704847|NCT04839692|565665200|FG000|Overall Study|Physician Decision|1|||
156704848|NCT04839692|565665201|FG001|Overall Study|Physician Decision|0|||
156704849|NCT03146962|565665204|FG000|Overall Study|Lost to Follow-up|1|||
156704850|NCT03146962|565665205|FG001|Overall Study|Lost to Follow-up|1|||
156704851|NCT03146962|565665206|FG002|Overall Study|Lost to Follow-up|0|||
156704852|NCT03146962|565665207|FG003|Overall Study|Lost to Follow-up|0|||
156704853|NCT03146962|565665208|FG004|Overall Study|Lost to Follow-up|0|||
156704854|NCT03146962|565665209|FG005|Overall Study|Lost to Follow-up|0|||
156704855|NCT03146962|565665210|FG006|Overall Study|Lost to Follow-up|0|||
156704856|NCT03146962|565665211|FG007|Overall Study|Lost to Follow-up|0|||
156704857|NCT03146962|565665212|FG008|Overall Study|Lost to Follow-up|0|||
156704858|NCT03146962|565665213|FG009|Overall Study|Lost to Follow-up|0|||
156704859|NCT03146962|565665204|FG000|Overall Study|Adverse Event|0|||
156704860|NCT03146962|565665205|FG001|Overall Study|Adverse Event|3|||
156704861|NCT03146962|565665206|FG002|Overall Study|Adverse Event|0|||
156704862|NCT03146962|565665207|FG003|Overall Study|Adverse Event|0|||
156704863|NCT03146962|565665208|FG004|Overall Study|Adverse Event|0|||
156704864|NCT03146962|565665209|FG005|Overall Study|Adverse Event|0|||
156704865|NCT03146962|565665210|FG006|Overall Study|Adverse Event|0|||
156704866|NCT03146962|565665211|FG007|Overall Study|Adverse Event|1|||
156704867|NCT03146962|565665212|FG008|Overall Study|Adverse Event|0|||
156704868|NCT03146962|565665213|FG009|Overall Study|Adverse Event|0|||
156704869|NCT03146962|565665204|FG000|Overall Study|Withdrawal by Subject|0|||
156704870|NCT03146962|565665205|FG001|Overall Study|Withdrawal by Subject|0|||
156704871|NCT03146962|565665206|FG002|Overall Study|Withdrawal by Subject|0|||
156704872|NCT03146962|565665207|FG003|Overall Study|Withdrawal by Subject|0|||
156704873|NCT03146962|565665208|FG004|Overall Study|Withdrawal by Subject|1|||
156704874|NCT03146962|565665209|FG005|Overall Study|Withdrawal by Subject|0|||
156704875|NCT03146962|565665210|FG006|Overall Study|Withdrawal by Subject|0|||
156704876|NCT03146962|565665211|FG007|Overall Study|Withdrawal by Subject|0|||
156704877|NCT03146962|565665212|FG008|Overall Study|Withdrawal by Subject|0|||
156704878|NCT03146962|565665213|FG009|Overall Study|Withdrawal by Subject|0|||
156704879|NCT03146962|565665204|FG000|Overall Study|Death|0|||
156704880|NCT03146962|565665205|FG001|Overall Study|Death|1|||
156704881|NCT03146962|565665206|FG002|Overall Study|Death|0|||
157124854|NCT01687712|567206329|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
157124855|NCT01687712|567206330|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
157124856|NCT01687712|567206329|FG000|Cycle 3|Not Biochemically Pregnant|21|||
157124857|NCT01687712|567206330|FG001|Cycle 3|Not Biochemically Pregnant|22|||
157124858|NCT01687712|567206329|FG000|Cycle 3|Early Pregnancy Loss|1|||
157124859|NCT01687712|567206330|FG001|Cycle 3|Early Pregnancy Loss|2|||
157124860|NCT01687712|567206329|FG000|Cycle 3|Ectopic Pregnancy|1|||
157124861|NCT01687712|567206330|FG001|Cycle 3|Ectopic Pregnancy|0|||
157124862|NCT01687712|567206329|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
157124863|NCT01687712|567206330|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
157124864|NCT00516737|567206335|FG000|Overall Study|Lost to Follow-up|2|||
156704882|NCT03146962|565665207|FG003|Overall Study|Death|0|||
156704883|NCT03146962|565665208|FG004|Overall Study|Death|0|||
156704884|NCT03146962|565665209|FG005|Overall Study|Death|0|||
156704885|NCT03146962|565665210|FG006|Overall Study|Death|0|||
156704886|NCT03146962|565665211|FG007|Overall Study|Death|0|||
156704887|NCT03146962|565665212|FG008|Overall Study|Death|0|||
156704888|NCT03146962|565665213|FG009|Overall Study|Death|0|||
156704889|NCT03146962|565665204|FG000|Overall Study|COVID Precautions|1|||
156704890|NCT03146962|565665205|FG001|Overall Study|COVID Precautions|0|||
156704891|NCT03146962|565665206|FG002|Overall Study|COVID Precautions|0|||
157124865|NCT00516737|567206336|FG001|Overall Study|Lost to Follow-up|0|||
156704892|NCT03146962|565665207|FG003|Overall Study|COVID Precautions|0|||
156704893|NCT03146962|565665208|FG004|Overall Study|COVID Precautions|0|||
157124866|NCT00516737|567206335|FG000|Overall Study|Physician Decision|0|||
156704894|NCT03146962|565665209|FG005|Overall Study|COVID Precautions|0|||
156704895|NCT03146962|565665210|FG006|Overall Study|COVID Precautions|0|||
156704896|NCT03146962|565665211|FG007|Overall Study|COVID Precautions|0|||
157124867|NCT00516737|567206336|FG001|Overall Study|Physician Decision|1|||
156704897|NCT03146962|565665212|FG008|Overall Study|COVID Precautions|0|||
156704898|NCT03146962|565665213|FG009|Overall Study|COVID Precautions|0|||
156704899|NCT03146962|565665204|FG000|Overall Study|Physician Decision|0|||
156704900|NCT03146962|565665205|FG001|Overall Study|Physician Decision|0|||
156704901|NCT03146962|565665206|FG002|Overall Study|Physician Decision|0|||
156704902|NCT03146962|565665207|FG003|Overall Study|Physician Decision|0|||
156704903|NCT03146962|565665208|FG004|Overall Study|Physician Decision|0|||
156704904|NCT03146962|565665209|FG005|Overall Study|Physician Decision|0|||
156704905|NCT03146962|565665210|FG006|Overall Study|Physician Decision|0|||
156704906|NCT03146962|565665211|FG007|Overall Study|Physician Decision|0|||
156704907|NCT03146962|565665212|FG008|Overall Study|Physician Decision|0|||
156704908|NCT03146962|565665213|FG009|Overall Study|Physician Decision|1|||
156704909|NCT03146962|565665204|FG000|Overall Study|Started New Treatment|0|||
156704910|NCT03146962|565665205|FG001|Overall Study|Started New Treatment|1|||
156704911|NCT03146962|565665206|FG002|Overall Study|Started New Treatment|0|||
156704912|NCT03146962|565665207|FG003|Overall Study|Started New Treatment|0|||
156704913|NCT03146962|565665208|FG004|Overall Study|Started New Treatment|0|||
156704914|NCT03146962|565665209|FG005|Overall Study|Started New Treatment|0|||
156704915|NCT03146962|565665210|FG006|Overall Study|Started New Treatment|0|||
156704916|NCT03146962|565665211|FG007|Overall Study|Started New Treatment|0|||
156704917|NCT03146962|565665212|FG008|Overall Study|Started New Treatment|0|||
156704918|NCT03146962|565665213|FG009|Overall Study|Started New Treatment|0|||
156704919|NCT01635283|565665214|FG000|Overall Study|Tumor Progression|3|||
156704920|NCT01635283|565665214|FG000|Overall Study|Lost to Follow-up|1|||
156704921|NCT04516759|565665215|FG000|Overall Study|Withdrawal by Subject|1|||
156704922|NCT04516759|565665216|FG001|Overall Study|Withdrawal by Subject|1|||
156704923|NCT04516759|565665215|FG000|Overall Study|Other|0|||
156704924|NCT04516759|565665216|FG001|Overall Study|Other|1|||
156704925|NCT03247816|565665225|FG000|Overall Study|Adverse Event|12|||
156704926|NCT03247816|565665225|FG000|Overall Study|Physician Decision|3|||
156704927|NCT03247816|565665225|FG000|Overall Study|Lack of Efficacy|1|||
156704928|NCT03247816|565665225|FG000|Overall Study|Lost to Follow-up|10|||
156704929|NCT03247816|565665225|FG000|Overall Study|Missing Feraccru stop date|3|||
156704930|NCT01439009|565665228|FG000|Overall Study|Physician Decision|5|||
156704931|NCT01439009|565665229|FG001|Overall Study|Physician Decision|3|||
156704932|NCT01439009|565665228|FG000|Overall Study|Protocol Violation|2|||
156704933|NCT01439009|565665229|FG001|Overall Study|Protocol Violation|0|||
156704934|NCT01439009|565665228|FG000|Overall Study|Deviation of exclusion criteria|1|||
156704935|NCT01439009|565665229|FG001|Overall Study|Deviation of exclusion criteria|0|||
156704936|NCT02278055|565665232|FG000|Overall Study|Adverse Event|1|||
156704937|NCT02278055|565665232|FG000|Overall Study|Lost to Follow-up|1|||
156704938|NCT02278055|565665232|FG000|Overall Study|Withdrawal by Subject|2|||
156704939|NCT02278055|565665232|FG000|Overall Study|Progressive Disease|4|||
156704940|NCT01934335|565665233|FG000|Overall Study|Withdrawal by Subject|1|||
156704941|NCT01934335|565665234|FG001|Overall Study|Withdrawal by Subject|1|||
157124868|NCT00516737|567206335|FG000|Overall Study|Withdrawal by Subject|0|||
157124869|NCT00516737|567206336|FG001|Overall Study|Withdrawal by Subject|1|||
157124870|NCT00516737|567206335|FG000|Overall Study|Lack of Qualifying Event|9|||
157124871|NCT00516737|567206336|FG001|Overall Study|Lack of Qualifying Event|6|||
157124872|NCT00848354|567206337|FG000|Phase 1|Adverse Event|5|||
157124873|NCT00848354|567206338|FG001|Phase 1|Adverse Event|4|||
157124874|NCT00848354|567206337|FG000|Phase 1|Discontinuation of study by sponsor|2|||
157124875|NCT00848354|567206338|FG001|Phase 1|Discontinuation of study by sponsor|1|||
157124876|NCT00848354|567206337|FG000|Phase 1|Failed to return|0|||
157124877|NCT00848354|567206338|FG001|Phase 1|Failed to return|1|||
157124878|NCT00848354|567206337|FG000|Phase 1|Lost to Follow-up|1|||
157124879|NCT00848354|567206338|FG001|Phase 1|Lost to Follow-up|1|||
156704942|NCT01111825|565665235|FG000|Overall Study|Withdrawal by Subject|0|||
157124880|NCT00848354|567206337|FG000|Phase 1|Unspecified Reason|1|||
157124881|NCT00848354|567206338|FG001|Phase 1|Unspecified Reason|1|||
156704943|NCT01111825|565665236|FG001|Overall Study|Withdrawal by Subject|0|||
156704944|NCT01111825|565665237|FG002|Overall Study|Withdrawal by Subject|1|||
156704945|NCT01111825|565665238|FG003|Overall Study|Withdrawal by Subject|0|||
156704946|NCT01111825|565665235|FG000|Overall Study|Lost to Follow-up|0|||
156704947|NCT01111825|565665236|FG001|Overall Study|Lost to Follow-up|0|||
156704948|NCT01111825|565665237|FG002|Overall Study|Lost to Follow-up|3|||
156704949|NCT01111825|565665238|FG003|Overall Study|Lost to Follow-up|1|||
156704950|NCT01111825|565665235|FG000|Overall Study|Adverse Event|2|||
156704951|NCT01111825|565665236|FG001|Overall Study|Adverse Event|1|||
156704952|NCT01111825|565665237|FG002|Overall Study|Adverse Event|4|||
156704953|NCT01111825|565665238|FG003|Overall Study|Adverse Event|0|||
156704954|NCT01111825|565665235|FG000|Overall Study|Disease Progression|1|||
156704955|NCT01111825|565665236|FG001|Overall Study|Disease Progression|0|||
156704956|NCT01111825|565665237|FG002|Overall Study|Disease Progression|0|||
156704957|NCT01111825|565665238|FG003|Overall Study|Disease Progression|0|||
156704958|NCT01111825|565665235|FG000|Overall Study|Discontinuation by Sponsor|0|||
156704959|NCT01111825|565665236|FG001|Overall Study|Discontinuation by Sponsor|0|||
156704960|NCT01111825|565665237|FG002|Overall Study|Discontinuation by Sponsor|0|||
156704961|NCT01111825|565665238|FG003|Overall Study|Discontinuation by Sponsor|20|||
156704962|NCT01377987|565665239|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
156704963|NCT01377987|565665240|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156704964|NCT00469144|565665241|FG000|Overall Study|Death|0|||
156704965|NCT00469144|565665242|FG001|Overall Study|Death|1|||
157015672|NCT04154384|566808919|FG000|Overall Study|Lost to Follow-up|24|||
156704966|NCT00469144|565665241|FG000|Overall Study|No Response|5|||
156704967|NCT00469144|565665242|FG001|Overall Study|No Response|5|||
156704968|NCT00469144|565665241|FG000|Overall Study|Progressive Disease|1|||
156704969|NCT00469144|565665242|FG001|Overall Study|Progressive Disease|0|||
156704970|NCT01994291|565665243|FG000|Overall Study|Adverse Event|4|||
156704971|NCT01994291|565665244|FG001|Overall Study|Adverse Event|1|||
156704972|NCT01994291|565665245|FG002|Overall Study|Adverse Event|3|||
156704973|NCT01994291|565665243|FG000|Overall Study|Lost to Follow-up|1|||
156704974|NCT01994291|565665244|FG001|Overall Study|Lost to Follow-up|1|||
156704975|NCT01994291|565665245|FG002|Overall Study|Lost to Follow-up|0|||
156704976|NCT01994291|565665243|FG000|Overall Study|Does not meet entrance criteria|1|||
156704977|NCT01994291|565665244|FG001|Overall Study|Does not meet entrance criteria|0|||
156704978|NCT01994291|565665245|FG002|Overall Study|Does not meet entrance criteria|0|||
156704979|NCT01994291|565665243|FG000|Overall Study|Medication error without associated AE|1|||
156704980|NCT01994291|565665244|FG001|Overall Study|Medication error without associated AE|0|||
156704981|NCT01994291|565665245|FG002|Overall Study|Medication error without associated AE|1|||
156704982|NCT01994291|565665243|FG000|Overall Study|Protocol Violation|1|||
156704983|NCT01994291|565665244|FG001|Overall Study|Protocol Violation|0|||
156704984|NCT01994291|565665245|FG002|Overall Study|Protocol Violation|0|||
156704985|NCT01994291|565665243|FG000|Overall Study|Withdrawal by Subject|6|||
156704986|NCT01994291|565665244|FG001|Overall Study|Withdrawal by Subject|3|||
156704987|NCT01994291|565665245|FG002|Overall Study|Withdrawal by Subject|5|||
156704988|NCT01994291|565665243|FG000|Overall Study|Other|1|||
156704989|NCT01994291|565665244|FG001|Overall Study|Other|2|||
156704990|NCT01994291|565665245|FG002|Overall Study|Other|0|||
156704991|NCT00838435|565665250|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
156704992|NCT00838435|565665250|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
156704993|NCT00838435|565665250|FG000|Part 2 (7 Years)|Adverse Event|2|||
156704994|NCT00838435|565665250|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
156704995|NCT00838435|565665250|FG000|Part 2 (7 Years)|Physician Decision|1|||
156704996|NCT00838435|565665250|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
156704997|NCT00838435|565665250|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
156704998|NCT00678886|565665251|FG000|Overall Study|Withdrawal by Subject|0|||
156704999|NCT00678886|565665252|FG001|Overall Study|Withdrawal by Subject|0|||
156705000|NCT00678886|565665253|FG002|Overall Study|Withdrawal by Subject|4|||
156705001|NCT00678886|565665254|FG003|Overall Study|Withdrawal by Subject|6|||
156705002|NCT00678886|565665251|FG000|Overall Study|Physician Decision|0|||
156705003|NCT00678886|565665252|FG001|Overall Study|Physician Decision|0|||
156705004|NCT00678886|565665253|FG002|Overall Study|Physician Decision|1|||
156705005|NCT00678886|565665254|FG003|Overall Study|Physician Decision|1|||
156705006|NCT00678886|565665251|FG000|Overall Study|Lost to Follow-up|0|||
156705007|NCT00678886|565665252|FG001|Overall Study|Lost to Follow-up|0|||
156705008|NCT00678886|565665253|FG002|Overall Study|Lost to Follow-up|3|||
156705009|NCT00678886|565665254|FG003|Overall Study|Lost to Follow-up|2|||
156705010|NCT00678886|565665251|FG000|Overall Study|Other|0|||
156705011|NCT00678886|565665252|FG001|Overall Study|Other|0|||
156705012|NCT00678886|565665253|FG002|Overall Study|Other|1|||
156705013|NCT00678886|565665254|FG003|Overall Study|Other|0|||
156705014|NCT01147107|565665255|FG000|Overall Study|Lack of Efficacy|5|||
156791087|NCT01898091|565987147|FG000|Overall Study|Withdrawal by Subject|1|||
156791088|NCT01898091|565987148|FG001|Overall Study|Withdrawal by Subject|5|||
157015673|NCT04154384|566808920|FG001|Overall Study|Lost to Follow-up|33|||
157015674|NCT04154384|566808921|FG002|Overall Study|Lost to Follow-up|0|||
156705015|NCT01147107|565665256|FG001|Overall Study|Lack of Efficacy|0|||
156705016|NCT01147107|565665255|FG000|Overall Study|Withdrawal by Subject|1|||
156705017|NCT01147107|565665256|FG001|Overall Study|Withdrawal by Subject|1|||
156705018|NCT04693416|565665257|FG000|Overall Study|Lost to Follow-up|13|||
156705019|NCT04693416|565665258|FG001|Overall Study|Lost to Follow-up|0|||
156705020|NCT00369317|565665261|FG000|Overall Study|Adverse Event|3|||
156705021|NCT00369317|565665261|FG000|Overall Study|Death|1|||
157015675|NCT04154384|566808919|FG000|Overall Study|Withdrawal by Subject|7|||
156705022|NCT00369317|565665261|FG000|Overall Study|Lack of Efficacy|5|||
156705023|NCT00369317|565665261|FG000|Overall Study|Physician Decision|2|||
156705024|NCT00369317|565665261|FG000|Overall Study|Withdrawal by Subject|8|||
156705025|NCT00369317|565665261|FG000|Overall Study|Ineligible|1|||
156705026|NCT04572893|565665265|FG000|Part A|Adverse Event|1|||
156705027|NCT04572893|565665266|FG001|Part A|Adverse Event|0|||
156705028|NCT04572893|565665267|FG002|Part A|Adverse Event|0|||
156705029|NCT04572893|565665268|FG003|Part A|Adverse Event|0|||
156791089|NCT03721107|565987149|FG000|Overall Study|Adverse Event|1|||
156705030|NCT04572893|565665269|FG004|Part A|Adverse Event|0|||
156705031|NCT04572893|565665270|FG005|Part A|Adverse Event|0|||
156705032|NCT04572893|565665271|FG006|Part A|Adverse Event|0|||
156705033|NCT04572893|565665265|FG000|Part B|Withdrawal by Subject|0|||
156705034|NCT04572893|565665266|FG001|Part B|Withdrawal by Subject|0|||
156705035|NCT04572893|565665267|FG002|Part B|Withdrawal by Subject|0|||
156705036|NCT04572893|565665268|FG003|Part B|Withdrawal by Subject|0|||
156705037|NCT04572893|565665269|FG004|Part B|Withdrawal by Subject|0|||
156705038|NCT04572893|565665270|FG005|Part B|Withdrawal by Subject|1|||
156705039|NCT04572893|565665271|FG006|Part B|Withdrawal by Subject|0|||
156705040|NCT04572893|565665265|FG000|Part B|Study terminated by sponsor|0|||
156705041|NCT04572893|565665266|FG001|Part B|Study terminated by sponsor|0|||
156705042|NCT04572893|565665267|FG002|Part B|Study terminated by sponsor|0|||
156705043|NCT04572893|565665268|FG003|Part B|Study terminated by sponsor|0|||
156705044|NCT04572893|565665269|FG004|Part B|Study terminated by sponsor|7|||
156705045|NCT04572893|565665270|FG005|Part B|Study terminated by sponsor|5|||
156705046|NCT04572893|565665271|FG006|Part B|Study terminated by sponsor|3|||
156705047|NCT04572893|565665265|FG000|Part B|Lost to Follow-up|0|||
156705048|NCT04572893|565665266|FG001|Part B|Lost to Follow-up|0|||
156705049|NCT04572893|565665267|FG002|Part B|Lost to Follow-up|0|||
156705050|NCT04572893|565665268|FG003|Part B|Lost to Follow-up|0|||
156705051|NCT04572893|565665269|FG004|Part B|Lost to Follow-up|0|||
156705052|NCT04572893|565665270|FG005|Part B|Lost to Follow-up|0|||
156705053|NCT04572893|565665271|FG006|Part B|Lost to Follow-up|1|||
156705054|NCT04572893|565665265|FG000|Part B|Adverse Event|0|||
156705055|NCT04572893|565665266|FG001|Part B|Adverse Event|0|||
156705056|NCT04572893|565665267|FG002|Part B|Adverse Event|0|||
156705057|NCT04572893|565665268|FG003|Part B|Adverse Event|0|||
156705058|NCT04572893|565665269|FG004|Part B|Adverse Event|1|||
156705059|NCT04572893|565665270|FG005|Part B|Adverse Event|1|||
156705060|NCT04572893|565665271|FG006|Part B|Adverse Event|0|||
156705061|NCT02679235|565667016|FG000|Overall Study|Withdrawal by Subject|3|||
156705062|NCT02679235|565667016|FG000|Overall Study|Adverse Event|1|||
156705063|NCT00923273|565667017|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705064|NCT00923273|565667018|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705065|NCT00923273|565667019|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705066|NCT00923273|565667020|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
156705067|NCT00923273|565667021|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
156705068|NCT00923273|565667017|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705069|NCT00923273|565667018|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705070|NCT00923273|565667019|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705071|NCT00923273|565667020|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
156705072|NCT00923273|565667021|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
156705073|NCT01438996|565667024|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
156705074|NCT01438996|565667025|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
156705075|NCT01438996|565667026|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
156705076|NCT02246114|565667027|FG000|Overall Study|miscarriage|1|||
156705077|NCT02246114|565667028|FG001|Overall Study|miscarriage|0|||
156705078|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705079|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
156705080|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705081|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705082|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705083|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705084|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
156705085|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705086|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
156705087|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705088|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705089|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705090|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705091|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
156705092|NCT01775189|565667029|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705093|NCT01775189|565667030|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
156705094|NCT01775189|565667031|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
156705095|NCT01775189|565667032|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705096|NCT01775189|565667033|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705097|NCT01775189|565667034|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705098|NCT01775189|565667035|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
156705099|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705100|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705101|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705102|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705103|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705104|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
156705105|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
156705106|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705107|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705108|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705109|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
156705110|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705111|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705112|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
156705113|NCT01775189|565667029|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705114|NCT01775189|565667030|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705115|NCT01775189|565667031|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705116|NCT01775189|565667032|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
156705117|NCT01775189|565667033|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705118|NCT01775189|565667034|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
156705119|NCT01775189|565667035|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
156705120|NCT02227446|565667039|FG000|Overall Study|not eligible post randomization|18|||
156705121|NCT02227446|565667040|FG001|Overall Study|not eligible post randomization|29|||
156705122|NCT02227446|565667039|FG000|Overall Study|Withdrawal by Subject|4|||
156705123|NCT02227446|565667040|FG001|Overall Study|Withdrawal by Subject|5|||
156705124|NCT02121392|565667041|FG000|Prior to Intervention|Protocol Violation|40|||
156705125|NCT02121392|565667042|FG001|Prior to Intervention|Protocol Violation|35|||
156705126|NCT02121392|565667041|FG000|Prior to Intervention|Withdrawal by Subject|8|||
156705127|NCT02121392|565667042|FG001|Prior to Intervention|Withdrawal by Subject|6|||
156705128|NCT02121392|565667041|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
156705129|NCT02121392|565667042|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
156705130|NCT02121392|565667041|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
156705131|NCT02121392|565667042|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
156705132|NCT01352416|565667043|FG000|Overall Study|Physician Decision|1|||
156705133|NCT01352416|565667044|FG001|Overall Study|Physician Decision|2|||
156705134|NCT01352416|565667045|FG002|Overall Study|Physician Decision|2|||
156705135|NCT01352416|565667046|FG003|Overall Study|Physician Decision|1|||
156705136|NCT03016975|565667056|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
156705137|NCT03016975|565667057|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
156705138|NCT03016975|565667058|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
156705139|NCT03016975|565667056|FG000|At 6 Months Follow-up|Death|2|||
156705140|NCT03016975|565667057|FG001|At 6 Months Follow-up|Death|0|||
156705141|NCT03016975|565667058|FG002|At 6 Months Follow-up|Death|0|||
156705142|NCT03016975|565667056|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
156705143|NCT03016975|565667057|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
156705144|NCT03016975|565667058|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
156705145|NCT03016975|565667056|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
156705146|NCT03016975|565667057|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
156705147|NCT03016975|565667058|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
156705148|NCT03016975|565667056|FG000|At 6 Months Follow-up|Aborted implant|1|||
156705149|NCT03016975|565667057|FG001|At 6 Months Follow-up|Aborted implant|0|||
156705150|NCT03016975|565667058|FG002|At 6 Months Follow-up|Aborted implant|0|||
156705151|NCT03016975|565667056|FG000|At 2 Year Follow-up|Death|1|||
156705152|NCT03016975|565667057|FG001|At 2 Year Follow-up|Death|0|||
156705153|NCT03016975|565667058|FG002|At 2 Year Follow-up|Death|0|||
156705154|NCT03016975|565667056|FG000|At 3 Year Follow-up|Death|1|||
156705155|NCT03016975|565667057|FG001|At 3 Year Follow-up|Death|0|||
156705156|NCT03016975|565667058|FG002|At 3 Year Follow-up|Death|0|||
156705157|NCT03016975|565667056|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
156705158|NCT03016975|565667057|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
156705159|NCT03016975|565667058|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
156705160|NCT03016975|565667056|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
156705161|NCT03016975|565667057|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
156705162|NCT03016975|565667058|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
156705163|NCT02901548|565667059|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
156705164|NCT02348723|565667063|FG000|Overall Study|No ablation|21|||
156705165|NCT02348723|565667064|FG001|Overall Study|No ablation|20|||
156705166|NCT02348723|565667063|FG000|Overall Study|Non-compliant with Protocol|1|||
156705167|NCT02348723|565667064|FG001|Overall Study|Non-compliant with Protocol|0|||
156705168|NCT02348723|565667063|FG000|Overall Study|Lost to Follow-up|1|||
156705169|NCT02348723|565667064|FG001|Overall Study|Lost to Follow-up|1|||
156705170|NCT02348723|565667063|FG000|Overall Study|Consent withdrawn|1|||
156705171|NCT02348723|565667064|FG001|Overall Study|Consent withdrawn|3|||
156705172|NCT02348723|565667063|FG000|Overall Study|Reason other than specified|1|||
156705173|NCT02348723|565667064|FG001|Overall Study|Reason other than specified|1|||
156705174|NCT02348723|565667063|FG000|Overall Study|Adverse Event|3|||
156705175|NCT02348723|565667064|FG001|Overall Study|Adverse Event|1|||
156705176|NCT02087189|565667065|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
156705177|NCT01671332|565667069|FG000|Overall Study|Withdrawal by Subject|1|||
156705178|NCT01671332|565667070|FG001|Overall Study|Withdrawal by Subject|1|||
156705179|NCT01458106|565667076|FG000|Overall Study|Withdrawal by Subject|2|||
156705180|NCT01458106|565667077|FG001|Overall Study|Withdrawal by Subject|0|||
156705181|NCT01458106|565667076|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
156705182|NCT01458106|565667077|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
156705183|NCT01458106|565667076|FG000|Overall Study|Withdrawn Per Protocol|0|||
156705184|NCT01458106|565667077|FG001|Overall Study|Withdrawn Per Protocol|1|||
156705185|NCT04428333|565667080|FG000|Overall Study|Physician Decision|5|||
156705186|NCT04428333|565667081|FG001|Overall Study|Physician Decision|6|||
156705187|NCT04428333|565667080|FG000|Overall Study|Withdrawal by Subject|1|||
156705188|NCT04428333|565667081|FG001|Overall Study|Withdrawal by Subject|3|||
156705189|NCT04428333|565667080|FG000|Overall Study|Study Terminated By Sponsor|14|||
156705190|NCT04428333|565667081|FG001|Overall Study|Study Terminated By Sponsor|16|||
156705191|NCT02269163|565667082|FG000|Overall Study|Lost to Follow-up|1|||
156705192|NCT02269163|565667083|FG001|Overall Study|Lost to Follow-up|0|||
156705193|NCT02269163|565667082|FG000|Overall Study|Major protocol violation|0|||
156705194|NCT02269163|565667083|FG001|Overall Study|Major protocol violation|1|||
156705195|NCT02269163|565667082|FG000|Overall Study|Other|2|||
156705196|NCT02269163|565667083|FG001|Overall Study|Other|2|||
156705197|NCT02269163|565667082|FG000|Overall Study|Withdrawal by Subject|0|||
156705198|NCT02269163|565667083|FG001|Overall Study|Withdrawal by Subject|3|||
156705199|NCT02269163|565667082|FG000|Overall Study|Physician Decision|0|||
156705200|NCT02269163|565667083|FG001|Overall Study|Physician Decision|1|||
156705201|NCT02351960|565667084|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
156705202|NCT02351960|565667085|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
156705203|NCT02351960|565667084|FG000|Overall Study|Voluntary Withdrawal|5|||
156705204|NCT02351960|565667085|FG001|Overall Study|Voluntary Withdrawal|4|||
156705205|NCT02351960|565667084|FG000|Overall Study|Significant Protocol Deviation|0|||
156705206|NCT02351960|565667085|FG001|Overall Study|Significant Protocol Deviation|5|||
156705207|NCT03866902|565667088|FG000|Overall Study|Lost to Follow-up|98|||
156705208|NCT03866902|565667089|FG001|Overall Study|Lost to Follow-up|82|||
156705209|NCT03866902|565667088|FG000|Overall Study|Pregnancy|18|||
156705210|NCT03866902|565667089|FG001|Overall Study|Pregnancy|24|||
156705211|NCT04730349|565667094|FG000|Overall Study|Participant withdrew consent|1|||
156705212|NCT04730349|565667095|FG001|Overall Study|Participant withdrew consent|0|||
156705213|NCT04730349|565667094|FG000|Overall Study|Disease progression|6|||
156705214|NCT04730349|565667095|FG001|Overall Study|Disease progression|4|||
156705215|NCT04730349|565667094|FG000|Overall Study|Study drug toxicity|0|||
156705216|NCT04730349|565667095|FG001|Overall Study|Study drug toxicity|1|||
156705217|NCT00638027|565667098|FG000|Overall Study|Adverse Event|0|||
156705218|NCT00638027|565667099|FG001|Overall Study|Adverse Event|2|||
156705219|NCT02092467|565667101|FG000|Overall Study|Death|49|||
156705220|NCT02092467|565667102|FG001|Overall Study|Death|66|||
156705221|NCT02092467|565667103|FG002|Overall Study|Death|38|||
156705222|NCT02092467|565667101|FG000|Overall Study|Lost to Follow-up|38|||
156705223|NCT02092467|565667102|FG001|Overall Study|Lost to Follow-up|35|||
156705224|NCT02092467|565667103|FG002|Overall Study|Lost to Follow-up|40|||
156705225|NCT02092467|565667101|FG000|Overall Study|Global Deterioration of Health Status|1|||
156705226|NCT02092467|565667102|FG001|Overall Study|Global Deterioration of Health Status|0|||
156705227|NCT02092467|565667103|FG002|Overall Study|Global Deterioration of Health Status|0|||
156705228|NCT02092467|565667101|FG000|Overall Study|Other|32|||
156705229|NCT02092467|565667102|FG001|Overall Study|Other|30|||
156705230|NCT02092467|565667103|FG002|Overall Study|Other|24|||
156705231|NCT02092467|565667101|FG000|Overall Study|Withdrawal by Subject|282|||
156705232|NCT02092467|565667102|FG001|Overall Study|Withdrawal by Subject|327|||
156705233|NCT02092467|565667103|FG002|Overall Study|Withdrawal by Subject|289|||
156705234|NCT02092467|565667101|FG000|Overall Study|Randomized but not treated|2|||
156705235|NCT02092467|565667102|FG001|Overall Study|Randomized but not treated|1|||
156705236|NCT02092467|565667103|FG002|Overall Study|Randomized but not treated|7|||
156705237|NCT00371397|565667104|FG000|Session 1|Withdrawal by Subject|1|||
156705238|NCT00371397|565667105|FG001|Session 1|Withdrawal by Subject|0|||
156705239|NCT00371397|565667106|FG002|Session 1|Withdrawal by Subject|0|||
156705240|NCT00371397|565667107|FG003|Session 1|Withdrawal by Subject|0|||
156705241|NCT00371397|565667108|FG004|Session 1|Withdrawal by Subject|0|||
156705242|NCT00371397|565667109|FG005|Session 1|Withdrawal by Subject|0|||
156872171|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
156705243|NCT00371397|565667110|FG006|Session 1|Withdrawal by Subject|0|||
156872172|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
156705244|NCT00371397|565667111|FG007|Session 1|Withdrawal by Subject|1|||
156705245|NCT00371397|565667112|FG008|Session 1|Withdrawal by Subject|0|||
156705246|NCT00371397|565667113|FG009|Session 1|Withdrawal by Subject|0|||
156705247|NCT00371397|565667114|FG010|Session 1|Withdrawal by Subject|0|||
156705248|NCT00371397|565667115|FG011|Session 1|Withdrawal by Subject|0|||
156705249|NCT01284621|565667116|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
157015676|NCT04154384|566808920|FG001|Overall Study|Withdrawal by Subject|18|||
156705250|NCT01284621|565667117|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705251|NCT01284621|565667118|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705252|NCT01284621|565667119|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705253|NCT01284621|565667120|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
157015677|NCT04154384|566808921|FG002|Overall Study|Withdrawal by Subject|0|||
157015678|NCT04154384|566808919|FG000|Overall Study|Missing outcome data|1|||
156705254|NCT01284621|565667121|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
156705255|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Physician Decision|1|||
156705256|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Physician Decision|0|||
156705257|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Physician Decision|0|||
156705258|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Physician Decision|0|||
156705259|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Physician Decision|0|||
156705260|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
156705261|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705262|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705263|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705264|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
156705265|NCT02377427|565667124|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
156705266|NCT02377427|565667125|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705267|NCT02377427|565667126|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705268|NCT02377427|565667127|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705269|NCT02377427|565667128|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
156705270|NCT02377427|565667124|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705271|NCT02377427|565667125|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705272|NCT02377427|565667126|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
156705273|NCT02377427|565667127|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705274|NCT02377427|565667128|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
156705275|NCT02342639|565667135|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
156705276|NCT02342639|565667136|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
156705277|NCT02342639|565667135|FG000|Overall Study|Protocol Violation|0|||
156705278|NCT02342639|565667136|FG001|Overall Study|Protocol Violation|2|||
156705279|NCT02293863|565667137|FG000|Overall Study|Death|4|||
156705280|NCT02293863|565667138|FG001|Overall Study|Death|6|||
156705281|NCT02293863|565667139|FG002|Overall Study|Death|4|||
156705282|NCT02293863|565667137|FG000|Overall Study|Lost to Follow-up|2|||
156705283|NCT02293863|565667138|FG001|Overall Study|Lost to Follow-up|2|||
156705284|NCT02293863|565667139|FG002|Overall Study|Lost to Follow-up|2|||
156705285|NCT02293863|565667137|FG000|Overall Study|Withdrawal by Subject|3|||
156705286|NCT02293863|565667138|FG001|Overall Study|Withdrawal by Subject|3|||
156705287|NCT02293863|565667139|FG002|Overall Study|Withdrawal by Subject|1|||
156705288|NCT02293863|565667137|FG000|Overall Study|Reason Not Specified|0|||
156705289|NCT02293863|565667138|FG001|Overall Study|Reason Not Specified|2|||
157015679|NCT04154384|566808920|FG001|Overall Study|Missing outcome data|0|||
156705290|NCT02293863|565667139|FG002|Overall Study|Reason Not Specified|2|||
156705291|NCT00416884|565667142|FG000|Overall Study|Study terminated due to low accrual|1|||
156705292|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
156705293|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
156705294|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705295|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705296|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705297|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705298|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705299|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705300|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705301|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705302|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705303|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
157015680|NCT04154384|566808921|FG002|Overall Study|Missing outcome data|0|||
156705304|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705305|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
156705306|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
156705307|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
156705308|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705309|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156791090|NCT03721107|565987150|FG001|Overall Study|Adverse Event|1|||
157015681|NCT01136876|566808922|FG000|Overall Study|Lost to Follow-up|0|||
157015682|NCT01136876|566808923|FG001|Overall Study|Lost to Follow-up|1|||
157015683|NCT01136876|566808922|FG000|Overall Study|Physician Decision|3|||
156705310|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705311|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705312|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705313|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705314|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705315|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705316|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705317|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705318|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705319|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
156705320|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
156705321|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
156705322|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
157215477|NCT00555399|567535896|FG011|Overall Study|Withdrawal by Subject|1|||
157215478|NCT00555399|567535885|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
156705323|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705324|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705325|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705326|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705327|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705328|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705329|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705330|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705331|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705332|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705333|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
156705334|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
156705335|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
156705336|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705337|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705338|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705339|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705340|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705341|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705342|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705343|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705344|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705345|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705346|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705347|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
156705348|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
156705349|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
156705350|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705351|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705352|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705353|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705354|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705355|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705356|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705357|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705358|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705359|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705360|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705361|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
156705362|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
156705363|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
156705364|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705365|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705366|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705367|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705368|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705369|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705370|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705371|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705372|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705373|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705374|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
157215479|NCT00555399|567535886|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
157215480|NCT00555399|567535887|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
157215481|NCT00555399|567535888|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
157215482|NCT00555399|567535889|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
157215483|NCT00555399|567535890|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
157215484|NCT00555399|567535891|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
157215485|NCT00555399|567535892|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
157215486|NCT00555399|567535893|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
157215487|NCT00555399|567535894|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
157215488|NCT00555399|567535895|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
157215489|NCT00555399|567535896|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
157215490|NCT05458895|567535897|FG000|Overall Study|Withdrawal by Subject|8|||
157215491|NCT05458895|567535897|FG000|Overall Study|Lost to Follow-up|17|||
157215492|NCT05458895|567535897|FG000|Overall Study|Pregnancy|2|||
157215493|NCT05458895|567535897|FG000|Overall Study|Withdrawal by Study Team|1|||
157215494|NCT04639310|567535898|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
157215495|NCT04639310|567535899|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
157215496|NCT05166421|567535902|FG000|Overall Study|Other|3|||
157215497|NCT05166421|567535903|FG001|Overall Study|Other|1|||
157215498|NCT05166421|567535904|FG002|Overall Study|Other|1|||
157215499|NCT05166421|567535902|FG000|Overall Study|Withdrawal by Subject|5|||
157215500|NCT05166421|567535903|FG001|Overall Study|Withdrawal by Subject|3|||
157215501|NCT05166421|567535904|FG002|Overall Study|Withdrawal by Subject|6|||
157215502|NCT05166421|567535902|FG000|Overall Study|Lost to Follow-up|4|||
157215503|NCT05166421|567535903|FG001|Overall Study|Lost to Follow-up|1|||
157215504|NCT05166421|567535904|FG002|Overall Study|Lost to Follow-up|7|||
157215505|NCT01963676|567537316|FG000|Overall Study|Withdrawal by Subject|1|||
157215506|NCT01963676|567537317|FG001|Overall Study|Withdrawal by Subject|0|||
157215507|NCT00766506|567537318|FG000|Overall Study|Use rescue medication after 3 hours|3|||
157215508|NCT00766506|567537319|FG001|Overall Study|Use rescue medication after 3 hours|0|||
157215509|NCT00766506|567537318|FG000|Overall Study|Other|2|||
157215510|NCT00766506|567537319|FG001|Overall Study|Other|2|||
157215511|NCT03262233|567537320|FG000|Overall Study|Withdrawal by Subject|12|||
157215512|NCT03262233|567537321|FG001|Overall Study|Withdrawal by Subject|8|||
157215513|NCT03262233|567537322|FG002|Overall Study|Withdrawal by Subject|21|||
157215514|NCT03262233|567537323|FG003|Overall Study|Withdrawal by Subject|13|||
157215515|NCT03262233|567537320|FG000|Overall Study|Declined due to shock|1|||
157215516|NCT03262233|567537321|FG001|Overall Study|Declined due to shock|2|||
157215517|NCT03262233|567537322|FG002|Overall Study|Declined due to shock|2|||
157215518|NCT03262233|567537323|FG003|Overall Study|Declined due to shock|3|||
157215519|NCT03262233|567537320|FG000|Overall Study|Protocol Violation|5|||
157215520|NCT03262233|567537321|FG001|Overall Study|Protocol Violation|10|||
156705375|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
156705376|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
156705377|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
156705378|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705379|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705380|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705381|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705382|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705383|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705384|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705385|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705386|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705387|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705388|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156791091|NCT03721107|565987151|FG002|Overall Study|Adverse Event|6|||
156791092|NCT03721107|565987152|FG003|Overall Study|Adverse Event|5|||
156791093|NCT03721107|565987149|FG000|Overall Study|Lost to Follow-up|2|||
156791094|NCT03721107|565987150|FG001|Overall Study|Lost to Follow-up|0|||
156791095|NCT03721107|565987151|FG002|Overall Study|Lost to Follow-up|3|||
156791096|NCT03721107|565987152|FG003|Overall Study|Lost to Follow-up|0|||
157015684|NCT01136876|566808923|FG001|Overall Study|Physician Decision|5|||
157015685|NCT01136876|566808922|FG000|Overall Study|Missing NGAL measurement|2|||
157215521|NCT03262233|567537322|FG002|Overall Study|Protocol Violation|2|||
157215522|NCT03262233|567537323|FG003|Overall Study|Protocol Violation|13|||
157215523|NCT03262233|567537320|FG000|Overall Study|data collection artifact|0|||
157215524|NCT03262233|567537321|FG001|Overall Study|data collection artifact|1|||
157215525|NCT03262233|567537322|FG002|Overall Study|data collection artifact|0|||
157215526|NCT03262233|567537323|FG003|Overall Study|data collection artifact|0|||
157215527|NCT01165242|567537324|FG000|Overall Study|Unreachable Subjects|1|||
157215528|NCT01165242|567537325|FG001|Overall Study|Unreachable Subjects|0|||
156705389|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
156705390|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
156705391|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
156705392|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705393|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705394|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705395|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705396|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705397|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705398|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156872173|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
156872174|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
156872175|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
156872176|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
156872177|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
156872178|NCT02952820|566289531|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872179|NCT02952820|566289532|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872180|NCT02952820|566289533|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
156872181|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
157015686|NCT01136876|566808923|FG001|Overall Study|Missing NGAL measurement|5|||
157015687|NCT05321069|566808924|FG000|Overall Study|Adverse Event|52|||
157015688|NCT05321069|566808925|FG001|Overall Study|Adverse Event|52|||
156705399|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705400|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705401|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705402|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705403|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
156705404|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
156705405|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
156705406|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705407|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705408|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705409|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705410|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705411|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705412|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705413|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705414|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705415|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705416|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705417|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
156705418|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
156705419|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
156705420|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705421|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705422|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705423|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705424|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705425|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705426|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705427|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705428|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705429|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705430|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705431|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
156705432|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
156705433|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
156705434|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705435|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705436|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705437|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705438|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705439|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705440|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705441|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
157015689|NCT05321069|566808926|FG002|Overall Study|Adverse Event|64|||
156705442|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705443|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705444|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705445|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
156705446|NCT03982199|565667146|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
156705447|NCT03982199|565667147|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
156705448|NCT03982199|565667148|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705449|NCT03982199|565667149|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705450|NCT03982199|565667150|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705451|NCT03982199|565667151|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705452|NCT03982199|565667152|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705453|NCT03982199|565667153|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705454|NCT03982199|565667154|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705455|NCT03982199|565667155|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705456|NCT03982199|565667156|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705457|NCT03982199|565667157|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705458|NCT03982199|565667158|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705459|NCT03982199|565667159|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
156705460|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705461|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705462|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705463|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
156705464|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705465|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705466|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705467|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705468|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705469|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705470|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705471|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705472|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705473|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
156705474|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705475|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705476|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
156705477|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705478|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705479|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705480|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705481|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705482|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705483|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705484|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705485|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705486|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705487|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
156705488|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705489|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705490|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
156791097|NCT03721107|565987149|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791098|NCT03721107|565987150|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791099|NCT03721107|565987151|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
156791100|NCT03721107|565987152|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
156791101|NCT03721107|565987149|FG000|Overall Study|Physician Decision|0|||
156791102|NCT03721107|565987150|FG001|Overall Study|Physician Decision|1|||
156791103|NCT03721107|565987151|FG002|Overall Study|Physician Decision|0|||
156791104|NCT03721107|565987152|FG003|Overall Study|Physician Decision|0|||
156791105|NCT03721107|565987149|FG000|Overall Study|Pregnancy|0|||
156791106|NCT03721107|565987150|FG001|Overall Study|Pregnancy|0|||
156791107|NCT03721107|565987151|FG002|Overall Study|Pregnancy|1|||
156791108|NCT03721107|565987152|FG003|Overall Study|Pregnancy|0|||
156791109|NCT03721107|565987149|FG000|Overall Study|Withdrawal by Subject|1|||
156791110|NCT03721107|565987150|FG001|Overall Study|Withdrawal by Subject|1|||
157015690|NCT05321069|566808924|FG000|Overall Study|Protocol Violation|1|||
157015691|NCT05321069|566808925|FG001|Overall Study|Protocol Violation|1|||
157015692|NCT05321069|566808926|FG002|Overall Study|Protocol Violation|0|||
157015693|NCT05321069|566808924|FG000|Overall Study|Withdrawal by Subject|23|||
157015694|NCT05321069|566808925|FG001|Overall Study|Withdrawal by Subject|18|||
157015695|NCT05321069|566808926|FG002|Overall Study|Withdrawal by Subject|12|||
157015696|NCT05321069|566808924|FG000|Overall Study|Lost to Follow-up|1|||
157015697|NCT05321069|566808925|FG001|Overall Study|Lost to Follow-up|0|||
157015698|NCT05321069|566808926|FG002|Overall Study|Lost to Follow-up|1|||
157015699|NCT05321069|566808924|FG000|Overall Study|No reason stated by the participants|23|||
157015700|NCT05321069|566808925|FG001|Overall Study|No reason stated by the participants|22|||
157015701|NCT05321069|566808926|FG002|Overall Study|No reason stated by the participants|16|||
157015702|NCT05321069|566808924|FG000|Overall Study|Lack of Efficacy|1|||
157015703|NCT05321069|566808925|FG001|Overall Study|Lack of Efficacy|1|||
157015704|NCT05321069|566808926|FG002|Overall Study|Lack of Efficacy|0|||
157015705|NCT04128319|566808929|FG000|Overall Study|Death|3|||
157015706|NCT04484935|566808932|FG000|Overall Study|Other|0|||
157015707|NCT04484935|566808933|FG001|Overall Study|Other|1|||
157015708|NCT04484935|566808932|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157015709|NCT04484935|566808933|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157015710|NCT04484935|566808932|FG000|Overall Study|Lost to Follow-up|1|||
157015711|NCT04484935|566808933|FG001|Overall Study|Lost to Follow-up|0|||
157015712|NCT04484935|566808932|FG000|Overall Study|Death|2|||
157015713|NCT04484935|566808933|FG001|Overall Study|Death|1|||
157015714|NCT01044303|566808934|FG000|Overall Study|Lost to Follow-up|2|||
157015715|NCT04820686|566808935|FG000|Overall Study|Withdrawal by Subject|5|||
157015716|NCT04820686|566808936|FG001|Overall Study|Withdrawal by Subject|2|||
157015717|NCT04820686|566808937|FG002|Overall Study|Withdrawal by Subject|3|||
157015718|NCT04820686|566808935|FG000|Overall Study|Study Termination|25|||
157015719|NCT04820686|566808936|FG001|Overall Study|Study Termination|13|||
157015720|NCT04820686|566808937|FG002|Overall Study|Study Termination|14|||
157015721|NCT04820686|566808935|FG000|Overall Study|Adverse Event|0|||
157015722|NCT04820686|566808936|FG001|Overall Study|Adverse Event|1|||
157015723|NCT04820686|566808937|FG002|Overall Study|Adverse Event|0|||
157015724|NCT01424670|566808938|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
157015725|NCT01424670|566808939|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
157015726|NCT01424670|566808938|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
157015727|NCT01424670|566808939|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
157015728|NCT01424670|566808938|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
157015729|NCT01424670|566808939|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
157015730|NCT01424670|566808938|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
157015731|NCT01424670|566808939|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
157015732|NCT01424670|566808938|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
157015733|NCT01424670|566808939|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
157015734|NCT01424670|566808938|FG000|Continuation Period|Adverse Event|13|||
157015735|NCT01424670|566808939|FG001|Continuation Period|Adverse Event|5|||
157015736|NCT01424670|566808938|FG000|Continuation Period|Lost to Follow-up|2|||
157015737|NCT01424670|566808939|FG001|Continuation Period|Lost to Follow-up|0|||
157015738|NCT01424670|566808938|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
157015739|NCT01424670|566808939|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
157015740|NCT01424670|566808938|FG000|Continuation Period|Physician Decision|5|||
157015741|NCT01424670|566808939|FG001|Continuation Period|Physician Decision|4|||
157015742|NCT01424670|566808938|FG000|Continuation Period|Withdrawal by Subject|13|||
157015743|NCT01424670|566808939|FG001|Continuation Period|Withdrawal by Subject|4|||
157015744|NCT02759016|566808940|FG000|Overall Study|Not treated with BI 836826|1|||
157015745|NCT02759016|566808941|FG001|Overall Study|Not treated with BI 836826|0|||
157015746|NCT02759016|566808940|FG000|Overall Study|Progressive disease|1|||
157015747|NCT02759016|566808941|FG001|Overall Study|Progressive disease|0|||
157015748|NCT02759016|566808940|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
157015749|NCT02759016|566808941|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
157015750|NCT02759016|566808940|FG000|Overall Study|Other not defined above|2|||
157015751|NCT02759016|566808941|FG001|Overall Study|Other not defined above|1|||
157015752|NCT02891915|566808946|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
157015753|NCT02891915|566808947|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
157015754|NCT02891915|566808946|FG000|Overall Study|Withdrawal by Subject|3|||
156705491|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705492|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705493|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705494|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705495|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
157015755|NCT02891915|566808947|FG001|Overall Study|Withdrawal by Subject|3|||
157015756|NCT02891915|566808946|FG000|Overall Study|Became Ineligible After Enrollment|2|||
157015757|NCT02891915|566808947|FG001|Overall Study|Became Ineligible After Enrollment|1|||
157015758|NCT02891915|566808946|FG000|Overall Study|Lost to Follow-up|1|||
157015759|NCT02891915|566808947|FG001|Overall Study|Lost to Follow-up|4|||
157015760|NCT02891915|566808946|FG000|Overall Study|Physician Decision|1|||
157015761|NCT02891915|566808947|FG001|Overall Study|Physician Decision|0|||
156705496|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705497|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705498|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705499|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705500|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705501|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
156705502|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705503|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705504|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
156705505|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
156705506|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705507|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705508|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705509|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705510|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705511|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705512|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705513|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705514|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705515|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
156705516|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705517|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705518|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705519|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
156705520|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705521|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705522|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705523|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705524|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705525|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705526|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705527|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705528|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705529|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
156705530|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705531|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705532|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
156705533|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
156705534|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705535|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705536|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705537|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705538|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705539|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705540|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705541|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705542|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705543|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
156705544|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705545|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705546|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705547|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705548|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705549|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705550|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705551|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705552|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
156705553|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705554|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705555|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705556|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705557|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
156705558|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705559|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156791111|NCT03721107|565987151|FG002|Overall Study|Withdrawal by Subject|5|||
156705560|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705561|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705562|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705563|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705564|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705565|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705566|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
156705567|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705568|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705569|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705570|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705571|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
156705572|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705573|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705574|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705575|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705576|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705577|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705578|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705579|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705580|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
156705581|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705582|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705583|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705584|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705585|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
156705586|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705587|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705588|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705589|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705590|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705591|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705592|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705593|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705594|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
156705595|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705596|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705597|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705598|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705599|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
156705600|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705601|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705602|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705603|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705604|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705605|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
157124882|NCT00848354|567206337|FG000|Phase 1|Protocol Violation|1|||
156705606|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705607|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705608|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
156705609|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705610|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705611|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705612|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705613|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
156705614|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705615|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
157124883|NCT00848354|567206338|FG001|Phase 1|Protocol Violation|1|||
157124884|NCT00848354|567206337|FG000|Phase 1|Withdrawal by Subject|2|||
157124885|NCT00848354|567206338|FG001|Phase 1|Withdrawal by Subject|4|||
157124886|NCT00848354|567206337|FG000|Phase 1|Lack of Efficacy|0|||
157124887|NCT00848354|567206338|FG001|Phase 1|Lack of Efficacy|1|||
157124888|NCT00848354|567206337|FG000|Phase 2 Year 1|Adverse Event|7|||
157124889|NCT00848354|567206338|FG001|Phase 2 Year 1|Adverse Event|2|||
157124890|NCT00848354|567206337|FG000|Phase 2 Year 1|Death|1|||
156705616|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705617|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705618|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705619|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
156705620|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705621|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
156705622|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
156705623|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705624|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705625|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705626|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705627|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
156705628|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705629|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705630|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705631|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705632|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705633|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705634|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705635|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705636|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
156705637|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705638|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705639|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705640|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705641|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
156705642|NCT03982199|565667146|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705643|NCT03982199|565667147|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705644|NCT03982199|565667148|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705645|NCT03982199|565667149|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705646|NCT03982199|565667150|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705647|NCT03982199|565667151|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
156705648|NCT03982199|565667152|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705649|NCT03982199|565667153|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
156705650|NCT03982199|565667154|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
156705651|NCT03982199|565667155|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705652|NCT03982199|565667156|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705653|NCT03982199|565667157|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705654|NCT03982199|565667158|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705655|NCT03982199|565667159|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
156705656|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705657|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705658|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705659|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705660|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705661|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705662|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705663|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705664|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
156705665|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
156705666|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
156705667|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
156705668|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
156705669|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
156705670|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705671|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705672|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705673|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156791112|NCT03721107|565987152|FG003|Overall Study|Withdrawal by Subject|5|||
156791113|NCT03721107|565987149|FG000|Overall Study|Other|1|||
157015762|NCT04048382|566808948|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
156705674|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705675|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705676|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705677|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705678|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705679|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
156705680|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705681|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705682|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705683|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
156705684|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705685|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705686|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705687|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705688|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705689|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705690|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705691|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705692|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705693|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
157015763|NCT04048382|566808949|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
157015764|NCT04048382|566808948|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
156705694|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705695|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705696|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
156705697|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
156705698|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705699|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705700|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705701|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705702|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705703|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705704|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705705|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705706|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705707|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705708|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
156705709|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
156705710|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
156705711|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
156705712|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705713|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705714|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705715|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705716|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705717|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705718|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705719|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705720|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705721|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705722|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705723|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705724|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
156705725|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
156705726|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705727|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705728|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705729|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705730|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705731|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705732|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705733|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
157015765|NCT04048382|566808949|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
156705734|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705735|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705736|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705737|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
156705738|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
156705739|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
156705740|NCT03982199|565667146|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705741|NCT03982199|565667147|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705742|NCT03982199|565667148|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705743|NCT03982199|565667149|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705744|NCT03982199|565667150|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705745|NCT03982199|565667151|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705746|NCT03982199|565667152|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705747|NCT03982199|565667153|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705748|NCT03982199|565667154|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705749|NCT03982199|565667155|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705750|NCT03982199|565667156|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705751|NCT03982199|565667157|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705752|NCT03982199|565667158|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
156705753|NCT03982199|565667159|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
156705754|NCT03433755|565667160|FG000|Overall Study|Lost to Follow-up|1|||
156705755|NCT03433755|565667161|FG001|Overall Study|Lost to Follow-up|0|||
156705756|NCT03433755|565667162|FG002|Overall Study|Lost to Follow-up|0|||
156705757|NCT03433755|565667163|FG003|Overall Study|Lost to Follow-up|0|||
156705758|NCT03433755|565667160|FG000|Overall Study|Decision by Sponsor|1|||
156705759|NCT03433755|565667161|FG001|Overall Study|Decision by Sponsor|0|||
156705760|NCT03433755|565667162|FG002|Overall Study|Decision by Sponsor|0|||
156705761|NCT03433755|565667163|FG003|Overall Study|Decision by Sponsor|0|||
156705762|NCT01565850|565667164|FG000|Overall Study|Adverse Event|0|||
156705763|NCT01565850|565667165|FG001|Overall Study|Adverse Event|1|||
156705764|NCT01565850|565667164|FG000|Overall Study|Lost to Follow-up|12|||
156705765|NCT01565850|565667165|FG001|Overall Study|Lost to Follow-up|4|||
156705766|NCT01565850|565667164|FG000|Overall Study|Investigator's Discretion|2|||
156705767|NCT01565850|565667165|FG001|Overall Study|Investigator's Discretion|1|||
156705768|NCT01565850|565667164|FG000|Overall Study|Participant noncompliance|2|||
156705769|NCT01565850|565667165|FG001|Overall Study|Participant noncompliance|0|||
156705770|NCT01565850|565667164|FG000|Overall Study|Withdrew Consent|4|||
156705771|NCT01565850|565667165|FG001|Overall Study|Withdrew Consent|2|||
156705772|NCT05065567|565667169|FG000|Overall Study|Lost to Follow-up|10|||
156705773|NCT05065567|565667170|FG001|Overall Study|Lost to Follow-up|9|||
156705774|NCT05065567|565667171|FG002|Overall Study|Lost to Follow-up|6|||
156705775|NCT03395405|565668312|FG000|Overall Study|Death|0|||
156705776|NCT03395405|565668313|FG001|Overall Study|Death|2|||
156705777|NCT03395405|565668312|FG000|Overall Study|Lost to Follow-up|0|||
156705778|NCT03395405|565668313|FG001|Overall Study|Lost to Follow-up|1|||
156705779|NCT03395405|565668312|FG000|Overall Study|Protocol Violation|0|||
156705780|NCT03395405|565668313|FG001|Overall Study|Protocol Violation|1|||
156705781|NCT03395405|565668312|FG000|Overall Study|Withdrawal by Subject|3|||
156705782|NCT03395405|565668313|FG001|Overall Study|Withdrawal by Subject|1|||
156705783|NCT03395405|565668312|FG000|Overall Study|COVID-19 Pandemic|1|||
156705784|NCT03395405|565668313|FG001|Overall Study|COVID-19 Pandemic|0|||
156705785|NCT04324073|565668314|FG000|Overall Study|withdrew consent|0|||
156705786|NCT04324073|565668315|FG001|Overall Study|withdrew consent|4|||
156705787|NCT04324073|565668316|FG002|Overall Study|withdrew consent|2|||
156705788|NCT04324073|565668317|FG003|Overall Study|withdrew consent|8|||
156705789|NCT01200069|565668323|FG000|Overall Study|Withdrawal by Subject|0|||
156705790|NCT01200069|565668324|FG001|Overall Study|Withdrawal by Subject|1|||
156705791|NCT04998851|565668325|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
156705792|NCT04998851|565668326|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
156705793|NCT04998851|565668325|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
156705794|NCT04998851|565668326|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
156705795|NCT00070499|565668327|FG000|Overall Study|Adverse Event|6|||
156705796|NCT00070499|565668328|FG001|Overall Study|Adverse Event|6|||
156791114|NCT03721107|565987150|FG001|Overall Study|Other|0|||
156791115|NCT03721107|565987151|FG002|Overall Study|Other|0|||
156791116|NCT03721107|565987152|FG003|Overall Study|Other|1|||
156705797|NCT00070499|565668329|FG002|Overall Study|Adverse Event|19|||
156791117|NCT00563316|565987153|FG000|Overall Study|Adverse Event|2|||
157124891|NCT00848354|567206338|FG001|Phase 2 Year 1|Death|0|||
157124892|NCT00848354|567206337|FG000|Phase 2 Year 1|Failed to Return|1|||
157124893|NCT00848354|567206338|FG001|Phase 2 Year 1|Failed to Return|1|||
156705798|NCT00070499|565668330|FG003|Overall Study|Adverse Event|15|||
156705799|NCT00070499|565668327|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
156791118|NCT00563316|565987153|FG000|Overall Study|Physician Decision|1|||
156791119|NCT00563316|565987153|FG000|Overall Study|Lost to Follow-up|2|||
156791120|NCT00563316|565987153|FG000|Overall Study|Death|1|||
156705800|NCT00070499|565668328|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
156705801|NCT00070499|565668329|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
156705802|NCT00070499|565668330|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
156705803|NCT00070499|565668327|FG000|Overall Study|Progression/relapse|4|||
156705804|NCT00070499|565668328|FG001|Overall Study|Progression/relapse|2|||
156705805|NCT00070499|565668329|FG002|Overall Study|Progression/relapse|1|||
156705806|NCT00070499|565668330|FG003|Overall Study|Progression/relapse|4|||
156705807|NCT00070499|565668327|FG000|Overall Study|Death|1|||
156705808|NCT00070499|565668328|FG001|Overall Study|Death|1|||
156705809|NCT00070499|565668329|FG002|Overall Study|Death|1|||
156705810|NCT00070499|565668330|FG003|Overall Study|Death|2|||
156705811|NCT00070499|565668327|FG000|Overall Study|Other - not protocol specified|7|||
156705812|NCT00070499|565668328|FG001|Overall Study|Other - not protocol specified|3|||
156705813|NCT00070499|565668329|FG002|Overall Study|Other - not protocol specified|12|||
156705814|NCT00070499|565668330|FG003|Overall Study|Other - not protocol specified|20|||
156705815|NCT00070499|565668327|FG000|Overall Study|Still on protocol treatment|10|||
156705816|NCT00070499|565668328|FG001|Overall Study|Still on protocol treatment|4|||
156705817|NCT00070499|565668329|FG002|Overall Study|Still on protocol treatment|79|||
156705818|NCT00070499|565668330|FG003|Overall Study|Still on protocol treatment|57|||
156705819|NCT00070499|565668327|FG000|Overall Study|Did not start treatment|1|||
156705820|NCT00070499|565668328|FG001|Overall Study|Did not start treatment|0|||
156705821|NCT00070499|565668329|FG002|Overall Study|Did not start treatment|0|||
156705822|NCT00070499|565668330|FG003|Overall Study|Did not start treatment|2|||
156705823|NCT00070499|565668327|FG000|Overall Study|Not eligible|2|||
156705824|NCT00070499|565668328|FG001|Overall Study|Not eligible|5|||
156705825|NCT00070499|565668329|FG002|Overall Study|Not eligible|3|||
156791121|NCT00563316|565987153|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
156791122|NCT00563316|565987153|FG000|Overall Study|Other|1|||
156791123|NCT04818086|565987161|FG000|Overall Study|Physician Decision|1|||
156791124|NCT04818086|565987162|FG001|Overall Study|Physician Decision|0|||
156791125|NCT04818086|565987161|FG000|Overall Study|Withdrawal by Subject|0|||
156791126|NCT04818086|565987162|FG001|Overall Study|Withdrawal by Subject|1|||
156791127|NCT06048705|565987167|FG000|Overall Study|Physician Decision|1|||
156791128|NCT06048705|565987168|FG001|Overall Study|Physician Decision|0|||
156791129|NCT06048705|565987169|FG002|Overall Study|Physician Decision|0|||
156705826|NCT00070499|565668330|FG003|Overall Study|Not eligible|2|||
156705827|NCT00805467|565668331|FG000|Overall Study|Lack of Efficacy|0|||
156791130|NCT06048705|565987167|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
156791131|NCT06048705|565987168|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
156791132|NCT06048705|565987169|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
156791133|NCT06048705|565987167|FG000|Overall Study|Death prior to lymphodepletion|0|||
156791134|NCT06048705|565987168|FG001|Overall Study|Death prior to lymphodepletion|0|||
156791135|NCT06048705|565987169|FG002|Overall Study|Death prior to lymphodepletion|1|||
156791136|NCT02614066|565987170|FG000|Overall Study|Death|6|||
157015766|NCT04048382|566808948|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
157015767|NCT04048382|566808949|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
157015768|NCT02119650|566808951|FG000|Overall Study|Adverse Event|3|||
157015769|NCT02119650|566808952|FG001|Overall Study|Adverse Event|4|||
157015770|NCT02119650|566808951|FG000|Overall Study|Subject decision|2|||
157015771|NCT02119650|566808952|FG001|Overall Study|Subject decision|3|||
157015772|NCT02119650|566808951|FG000|Overall Study|Disease progression|11|||
157015773|NCT02119650|566808952|FG001|Overall Study|Disease progression|14|||
157015774|NCT02119650|566808951|FG000|Overall Study|Death|5|||
157015775|NCT02119650|566808952|FG001|Overall Study|Death|1|||
157015776|NCT02119650|566808951|FG000|Overall Study|Noncompliance with study treatment|1|||
157015777|NCT02119650|566808952|FG001|Overall Study|Noncompliance with study treatment|1|||
157015778|NCT02119650|566808951|FG000|Overall Study|Study terminated by the sponsor|1|||
157015779|NCT02119650|566808952|FG001|Overall Study|Study terminated by the sponsor|0|||
157015780|NCT02119650|566808951|FG000|Overall Study|Physician Decision|0|||
157015781|NCT02119650|566808952|FG001|Overall Study|Physician Decision|2|||
157015782|NCT02119650|566808951|FG000|Overall Study|Multiple reasons for termination|2|||
157015783|NCT02119650|566808952|FG001|Overall Study|Multiple reasons for termination|1|||
157015784|NCT00774852|566808955|FG000|Overall Study|Adverse Event|9|||
157015785|NCT00774852|566808956|FG001|Overall Study|Adverse Event|6|||
157015786|NCT00774852|566808955|FG000|Overall Study|Death|2|||
157015787|NCT00774852|566808956|FG001|Overall Study|Death|1|||
157015788|NCT00774852|566808955|FG000|Overall Study|Lack of Efficacy|3|||
157015789|NCT00774852|566808956|FG001|Overall Study|Lack of Efficacy|7|||
156705828|NCT00805467|565668332|FG001|Overall Study|Lack of Efficacy|8|||
156705829|NCT00805467|565668333|FG002|Overall Study|Lack of Efficacy|13|||
156705830|NCT00805467|565668334|FG003|Overall Study|Lack of Efficacy|86|||
156791137|NCT02614066|565987171|FG001|Overall Study|Death|14|||
156791138|NCT02614066|565987172|FG002|Overall Study|Death|11|||
156791139|NCT02614066|565987173|FG003|Overall Study|Death|29|||
156791140|NCT02614066|565987170|FG000|Overall Study|Full consent withdrawn|0|||
156791141|NCT02614066|565987171|FG001|Overall Study|Full consent withdrawn|1|||
157015790|NCT00774852|566808955|FG000|Overall Study|Lost to Follow-up|9|||
156705831|NCT00805467|565668331|FG000|Overall Study|Lost to Follow-up|0|||
156705832|NCT00805467|565668332|FG001|Overall Study|Lost to Follow-up|1|||
156705833|NCT00805467|565668333|FG002|Overall Study|Lost to Follow-up|7|||
156705834|NCT00805467|565668334|FG003|Overall Study|Lost to Follow-up|21|||
156705835|NCT00805467|565668331|FG000|Overall Study|Withdrawal by Subject|0|||
156705836|NCT00805467|565668332|FG001|Overall Study|Withdrawal by Subject|6|||
156705837|NCT00805467|565668333|FG002|Overall Study|Withdrawal by Subject|45|||
156705838|NCT00805467|565668334|FG003|Overall Study|Withdrawal by Subject|50|||
156705839|NCT00805467|565668331|FG000|Overall Study|Protocol Violation|0|||
156705840|NCT00805467|565668332|FG001|Overall Study|Protocol Violation|3|||
156705841|NCT00805467|565668333|FG002|Overall Study|Protocol Violation|0|||
156705842|NCT00805467|565668334|FG003|Overall Study|Protocol Violation|5|||
156705843|NCT00805467|565668331|FG000|Overall Study|Adverse Event|0|||
156705844|NCT00805467|565668332|FG001|Overall Study|Adverse Event|13|||
156705845|NCT00805467|565668333|FG002|Overall Study|Adverse Event|26|||
156705846|NCT00805467|565668334|FG003|Overall Study|Adverse Event|57|||
156705847|NCT00805467|565668331|FG000|Overall Study|Death|0|||
156705848|NCT00805467|565668332|FG001|Overall Study|Death|2|||
156705849|NCT00805467|565668333|FG002|Overall Study|Death|7|||
156705850|NCT00805467|565668334|FG003|Overall Study|Death|5|||
156705851|NCT00805467|565668331|FG000|Overall Study|Physician Decision|0|||
156705852|NCT00805467|565668332|FG001|Overall Study|Physician Decision|1|||
156705853|NCT00805467|565668333|FG002|Overall Study|Physician Decision|2|||
156705854|NCT00805467|565668334|FG003|Overall Study|Physician Decision|6|||
156705855|NCT00805467|565668331|FG000|Overall Study|Not reported|0|||
156705856|NCT00805467|565668332|FG001|Overall Study|Not reported|0|||
156705857|NCT00805467|565668333|FG002|Overall Study|Not reported|3|||
156705858|NCT00805467|565668334|FG003|Overall Study|Not reported|7|||
156705859|NCT00213135|565668343|FG000|Overall Study|Adverse Event|9|||
156705860|NCT00213135|565668344|FG001|Overall Study|Adverse Event|5|||
156705861|NCT00213135|565668345|FG002|Overall Study|Adverse Event|5|||
156705862|NCT00213135|565668343|FG000|Overall Study|Lost to Follow-up|11|||
156705863|NCT00213135|565668344|FG001|Overall Study|Lost to Follow-up|8|||
156705864|NCT00213135|565668345|FG002|Overall Study|Lost to Follow-up|4|||
156705865|NCT00213135|565668343|FG000|Overall Study|Protocol Violation|4|||
156705866|NCT00213135|565668344|FG001|Overall Study|Protocol Violation|4|||
156705867|NCT00213135|565668345|FG002|Overall Study|Protocol Violation|10|||
156705868|NCT00213135|565668343|FG000|Overall Study|Death|1|||
156705869|NCT00213135|565668344|FG001|Overall Study|Death|1|||
156705870|NCT00213135|565668345|FG002|Overall Study|Death|2|||
156705871|NCT00213135|565668343|FG000|Overall Study|Disease progression|4|||
156705872|NCT00213135|565668344|FG001|Overall Study|Disease progression|5|||
156705873|NCT00213135|565668345|FG002|Overall Study|Disease progression|21|||
156705874|NCT00213135|565668343|FG000|Overall Study|Other|21|||
156705875|NCT00213135|565668344|FG001|Overall Study|Other|12|||
156705876|NCT00213135|565668345|FG002|Overall Study|Other|15|||
156705877|NCT01908907|565668349|FG000|Overall Study|Physician Decision|1|||
156705878|NCT01908907|565668350|FG001|Overall Study|Physician Decision|0|||
156705879|NCT01908907|565668349|FG000|Overall Study|Protocol Violation|1|||
156705880|NCT01908907|565668350|FG001|Overall Study|Protocol Violation|0|||
156705881|NCT00660907|565668351|FG000|Overall Study|Incorrect Enrollment|1|||
156705882|NCT00660907|565668352|FG001|Overall Study|Incorrect Enrollment|1|||
156705883|NCT00660907|565668351|FG000|Overall Study|Adverse Event|33|||
156705884|NCT00660907|565668352|FG001|Overall Study|Adverse Event|19|||
156705885|NCT00660907|565668351|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
156705886|NCT00660907|565668352|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
156705887|NCT00660907|565668351|FG000|Overall Study|Withdrawal by Subject|23|||
156705888|NCT00660907|565668352|FG001|Overall Study|Withdrawal by Subject|32|||
156705889|NCT00660907|565668351|FG000|Overall Study|Lost to Follow-up|3|||
156705890|NCT00660907|565668352|FG001|Overall Study|Lost to Follow-up|3|||
156705891|NCT00660907|565668351|FG000|Overall Study|Poor/Non-Compliance|5|||
156705892|NCT00660907|565668352|FG001|Overall Study|Poor/Non-Compliance|1|||
156705893|NCT00660907|565668351|FG000|Overall Study|Safety|1|||
156705894|NCT00660907|565668352|FG001|Overall Study|Safety|0|||
156705895|NCT00660907|565668351|FG000|Overall Study|Death|1|||
156705896|NCT00660907|565668352|FG001|Overall Study|Death|3|||
156705897|NCT00660907|565668351|FG000|Overall Study|Various|11|||
156705898|NCT00660907|565668352|FG001|Overall Study|Various|8|||
156705899|NCT00478244|565668357|FG000|Overall Study|Did not receive transplant|1|||
156705900|NCT02886624|565668358|FG000|12-week Post Treatment Follow-up|Death|1|||
156872182|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
157015791|NCT00774852|566808956|FG001|Overall Study|Lost to Follow-up|5|||
156705901|NCT02886624|565668358|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
156705902|NCT02929056|565668364|FG000|Overall Study|Lost to Follow-up|0|||
156705903|NCT02929056|565668365|FG001|Overall Study|Lost to Follow-up|1|||
156705904|NCT02245412|565668369|FG000|Treatment Period|Death|1|||
156705905|NCT02245412|565668370|FG001|Treatment Period|Death|1|||
156705906|NCT02245412|565668371|FG002|Treatment Period|Death|0|||
156705907|NCT02245412|565668369|FG000|Treatment Period|Physician Decision|1|||
156705908|NCT02245412|565668370|FG001|Treatment Period|Physician Decision|1|||
156705909|NCT02245412|565668371|FG002|Treatment Period|Physician Decision|0|||
156705910|NCT02245412|565668369|FG000|Treatment Period|Withdrawal by Subject|2|||
156705911|NCT02245412|565668370|FG001|Treatment Period|Withdrawal by Subject|1|||
156705912|NCT02245412|565668371|FG002|Treatment Period|Withdrawal by Subject|0|||
156705913|NCT02245412|565668369|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
156705914|NCT02245412|565668370|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
156705915|NCT02245412|565668371|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
156705916|NCT02245412|565668369|FG000|Follow-Up Period|Death|4|||
156705917|NCT02245412|565668370|FG001|Follow-Up Period|Death|2|||
156705918|NCT02245412|565668371|FG002|Follow-Up Period|Death|1|||
156705919|NCT02245412|565668369|FG000|Follow-Up Period|Physician Decision|1|||
156705920|NCT02245412|565668370|FG001|Follow-Up Period|Physician Decision|0|||
156705921|NCT02245412|565668371|FG002|Follow-Up Period|Physician Decision|0|||
156705922|NCT02245412|565668369|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
156705923|NCT02245412|565668370|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
156705924|NCT02245412|565668371|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
156705925|NCT01056289|565668372|FG000|Open-label Phase|Adverse Event|29|||
156705926|NCT01056289|565668373|FG001|Open-label Phase|Adverse Event|0|||
156705927|NCT01056289|565668374|FG002|Open-label Phase|Adverse Event|0|||
156705928|NCT01056289|565668375|FG003|Open-label Phase|Adverse Event|0|||
156705929|NCT01056289|565668372|FG000|Open-label Phase|Lost to Follow-up|30|||
156705930|NCT01056289|565668373|FG001|Open-label Phase|Lost to Follow-up|0|||
156705931|NCT01056289|565668374|FG002|Open-label Phase|Lost to Follow-up|0|||
156705932|NCT01056289|565668375|FG003|Open-label Phase|Lost to Follow-up|0|||
156705933|NCT01056289|565668372|FG000|Open-label Phase|Other|9|||
156705934|NCT01056289|565668373|FG001|Open-label Phase|Other|0|||
156705935|NCT01056289|565668374|FG002|Open-label Phase|Other|0|||
156705936|NCT01056289|565668375|FG003|Open-label Phase|Other|0|||
156705937|NCT01056289|565668372|FG000|Open-label Phase|Protocol Violation|6|||
156705938|NCT01056289|565668373|FG001|Open-label Phase|Protocol Violation|0|||
156705939|NCT01056289|565668374|FG002|Open-label Phase|Protocol Violation|0|||
156705940|NCT01056289|565668375|FG003|Open-label Phase|Protocol Violation|0|||
156705941|NCT01056289|565668372|FG000|Open-label Phase|Withdrawal by Subject|26|||
156705942|NCT01056289|565668373|FG001|Open-label Phase|Withdrawal by Subject|0|||
156705943|NCT01056289|565668374|FG002|Open-label Phase|Withdrawal by Subject|0|||
156705944|NCT01056289|565668375|FG003|Open-label Phase|Withdrawal by Subject|0|||
156705945|NCT01056289|565668372|FG000|Open-label Phase|Lack of Efficacy|18|||
156705946|NCT01056289|565668373|FG001|Open-label Phase|Lack of Efficacy|0|||
156705947|NCT01056289|565668374|FG002|Open-label Phase|Lack of Efficacy|0|||
156705948|NCT01056289|565668375|FG003|Open-label Phase|Lack of Efficacy|0|||
156705949|NCT01056289|565668372|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
156705950|NCT01056289|565668373|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
156705951|NCT01056289|565668374|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
156705952|NCT01056289|565668375|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
156705953|NCT01056289|565668372|FG000|Double-blind Phase|Adverse Event|0|||
156705954|NCT01056289|565668373|FG001|Double-blind Phase|Adverse Event|1|||
156705955|NCT01056289|565668374|FG002|Double-blind Phase|Adverse Event|2|||
156705956|NCT01056289|565668375|FG003|Double-blind Phase|Adverse Event|1|||
156705957|NCT01056289|565668372|FG000|Double-blind Phase|Lost to Follow-up|0|||
156705958|NCT01056289|565668373|FG001|Double-blind Phase|Lost to Follow-up|2|||
156705959|NCT01056289|565668374|FG002|Double-blind Phase|Lost to Follow-up|2|||
156705960|NCT01056289|565668375|FG003|Double-blind Phase|Lost to Follow-up|2|||
156705961|NCT01056289|565668372|FG000|Double-blind Phase|Other|0|||
156705962|NCT01056289|565668373|FG001|Double-blind Phase|Other|0|||
156705963|NCT01056289|565668374|FG002|Double-blind Phase|Other|1|||
156705964|NCT01056289|565668375|FG003|Double-blind Phase|Other|2|||
156705965|NCT01056289|565668372|FG000|Double-blind Phase|Protocol Violation|0|||
156705966|NCT01056289|565668373|FG001|Double-blind Phase|Protocol Violation|0|||
156705967|NCT01056289|565668374|FG002|Double-blind Phase|Protocol Violation|1|||
156705968|NCT01056289|565668375|FG003|Double-blind Phase|Protocol Violation|1|||
156705969|NCT01056289|565668372|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156705970|NCT01056289|565668373|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156705971|NCT01056289|565668374|FG002|Double-blind Phase|Withdrawal by Subject|4|||
156705972|NCT01056289|565668375|FG003|Double-blind Phase|Withdrawal by Subject|2|||
156705973|NCT01056289|565668372|FG000|Double-blind Phase|Discontinuation symptom|0|||
156705974|NCT01056289|565668373|FG001|Double-blind Phase|Discontinuation symptom|1|||
156705975|NCT01056289|565668374|FG002|Double-blind Phase|Discontinuation symptom|2|||
156705976|NCT01056289|565668375|FG003|Double-blind Phase|Discontinuation symptom|2|||
156705977|NCT01056289|565668372|FG000|Double-blind Phase|Physician Decision|0|||
156705978|NCT01056289|565668373|FG001|Double-blind Phase|Physician Decision|0|||
156705979|NCT01056289|565668374|FG002|Double-blind Phase|Physician Decision|1|||
156705980|NCT01056289|565668375|FG003|Double-blind Phase|Physician Decision|0|||
156705981|NCT00459043|565668382|FG000|Overall Study|Withdrawal by Subject|1|||
156705982|NCT00459043|565668383|FG001|Overall Study|Withdrawal by Subject|0|||
156705983|NCT00270855|565668386|FG000|Overall Study|Withdrawal by Subject|8|||
156705984|NCT00270855|565668387|FG001|Overall Study|Withdrawal by Subject|8|||
156705985|NCT05048329|565668390|FG000|Overall Study|Withdrawal by Subject|1|||
157215529|NCT01165242|567537326|FG002|Overall Study|Unreachable Subjects|0|||
157215530|NCT01165242|567537324|FG000|Overall Study|Incarcerated Subjects|0|||
157215531|NCT01165242|567537325|FG001|Overall Study|Incarcerated Subjects|1|||
157215532|NCT01165242|567537326|FG002|Overall Study|Incarcerated Subjects|0|||
157215533|NCT01165242|567537324|FG000|Overall Study|Visit 2 Declined by Subject|0|||
157215534|NCT01165242|567537325|FG001|Overall Study|Visit 2 Declined by Subject|0|||
157215535|NCT01165242|567537326|FG002|Overall Study|Visit 2 Declined by Subject|1|||
156791142|NCT02614066|565987172|FG002|Overall Study|Full consent withdrawn|0|||
156791143|NCT02614066|565987173|FG003|Overall Study|Full consent withdrawn|8|||
156791144|NCT02614066|565987170|FG000|Overall Study|Lost to Follow-up|0|||
157215536|NCT01165242|567537324|FG000|Overall Study|Withdrawal by Subject|0|||
157215537|NCT01165242|567537325|FG001|Overall Study|Withdrawal by Subject|2|||
157215538|NCT01165242|567537326|FG002|Overall Study|Withdrawal by Subject|2|||
157215539|NCT01165242|567537324|FG000|Overall Study|Extended Holiday|0|||
157215540|NCT01165242|567537325|FG001|Overall Study|Extended Holiday|0|||
157215541|NCT01165242|567537326|FG002|Overall Study|Extended Holiday|1|||
157215542|NCT01165242|567537324|FG000|Overall Study|Lost to Follow-up|9|||
157215543|NCT01165242|567537325|FG001|Overall Study|Lost to Follow-up|7|||
156705986|NCT05048329|565668390|FG000|Overall Study|Screenfail|1|||
156705987|NCT03301649|565668391|FG000|Overall Study|Need alternate therapy due to live lice|17|||
156705988|NCT03301649|565668392|FG001|Overall Study|Need alternate therapy due to live lice|25|||
156705989|NCT03301649|565668393|FG002|Overall Study|Need alternate therapy due to live lice|81|||
156705990|NCT03301649|565668391|FG000|Overall Study|Lost to Follow-up|11|||
156705991|NCT03301649|565668392|FG001|Overall Study|Lost to Follow-up|11|||
156705992|NCT03301649|565668393|FG002|Overall Study|Lost to Follow-up|3|||
156705993|NCT03301649|565668391|FG000|Overall Study|Protocol Violation|0|||
156705994|NCT03301649|565668392|FG001|Overall Study|Protocol Violation|1|||
156705995|NCT03301649|565668393|FG002|Overall Study|Protocol Violation|1|||
156705996|NCT03301649|565668391|FG000|Overall Study|Withdrawal by Subject|10|||
156705997|NCT03301649|565668392|FG001|Overall Study|Withdrawal by Subject|4|||
156705998|NCT03301649|565668393|FG002|Overall Study|Withdrawal by Subject|0|||
156705999|NCT03301649|565668391|FG000|Overall Study|Other than specified|5|||
156706000|NCT03301649|565668392|FG001|Overall Study|Other than specified|3|||
156706001|NCT03301649|565668393|FG002|Overall Study|Other than specified|0|||
156706002|NCT01403051|565668394|FG000|Overall Study|Protocol Violation|2|||
156706003|NCT01403051|565668395|FG001|Overall Study|Protocol Violation|0|||
156706004|NCT01403051|565668394|FG000|Overall Study|Death|1|||
156706005|NCT01403051|565668395|FG001|Overall Study|Death|0|||
156706006|NCT01403051|565668394|FG000|Overall Study|Withdrawal by Subject|2|||
156706007|NCT01403051|565668395|FG001|Overall Study|Withdrawal by Subject|1|||
156706008|NCT01403051|565668394|FG000|Overall Study|Lost to Follow-up|5|||
156706009|NCT01403051|565668395|FG001|Overall Study|Lost to Follow-up|5|||
156706010|NCT00887289|565668396|FG000|Overall Study|Lack of Efficacy|14|||
156706011|NCT00887289|565668396|FG000|Overall Study|Adverse Event|27|||
156706012|NCT00887289|565668396|FG000|Overall Study|Withdrawal by Subject|26|||
157215544|NCT01165242|567537326|FG002|Overall Study|Lost to Follow-up|10|||
157215545|NCT03877237|567537327|FG000|Overall Study|Adverse Event|1|||
156706013|NCT00887289|565668396|FG000|Overall Study|Lost to Follow-up|8|||
156706014|NCT00887289|565668396|FG000|Overall Study|Other|20|||
156706015|NCT00591773|565668397|FG000|Overall Study|Adverse Event|9|||
156706016|NCT00591773|565668398|FG001|Overall Study|Adverse Event|9|||
156706017|NCT00591773|565668399|FG002|Overall Study|Adverse Event|6|||
156706018|NCT00591773|565668397|FG000|Overall Study|Protocol Violation|2|||
156706019|NCT00591773|565668398|FG001|Overall Study|Protocol Violation|3|||
156706020|NCT00591773|565668399|FG002|Overall Study|Protocol Violation|0|||
156706021|NCT00591773|565668397|FG000|Overall Study|Lost to Follow-up|1|||
156706022|NCT00591773|565668398|FG001|Overall Study|Lost to Follow-up|4|||
156706023|NCT00591773|565668399|FG002|Overall Study|Lost to Follow-up|1|||
156791145|NCT02614066|565987171|FG001|Overall Study|Lost to Follow-up|2|||
156791146|NCT02614066|565987172|FG002|Overall Study|Lost to Follow-up|2|||
157015792|NCT00774852|566808955|FG000|Overall Study|Physician Decision|2|||
157215546|NCT03877237|567537328|FG001|Overall Study|Adverse Event|2|||
157215547|NCT03877237|567537327|FG000|Overall Study|Death|3|||
156791147|NCT02614066|565987173|FG003|Overall Study|Lost to Follow-up|2|||
157215548|NCT03877237|567537328|FG001|Overall Study|Death|2|||
156791148|NCT02614066|565987170|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
157215549|NCT03877237|567537327|FG000|Overall Study|Physician Decision|1|||
156706024|NCT00591773|565668397|FG000|Overall Study|Withdrawal by Subject|2|||
156706025|NCT00591773|565668398|FG001|Overall Study|Withdrawal by Subject|5|||
156706026|NCT00591773|565668399|FG002|Overall Study|Withdrawal by Subject|3|||
156706027|NCT00591773|565668397|FG000|Overall Study|Lack of Efficacy|1|||
156706028|NCT00591773|565668398|FG001|Overall Study|Lack of Efficacy|2|||
156706029|NCT00591773|565668399|FG002|Overall Study|Lack of Efficacy|2|||
156791149|NCT02614066|565987171|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
157215550|NCT03877237|567537328|FG001|Overall Study|Physician Decision|0|||
157215551|NCT03877237|567537327|FG000|Overall Study|Withdrawal by Subject|0|||
157215552|NCT03877237|567537328|FG001|Overall Study|Withdrawal by Subject|2|||
157215553|NCT03372083|567537330|FG000|Overall Study|Adverse Event|3|||
156706030|NCT00591773|565668397|FG000|Overall Study|Other|1|||
156706031|NCT00591773|565668398|FG001|Overall Study|Other|1|||
156706032|NCT00591773|565668399|FG002|Overall Study|Other|4|||
156706033|NCT02135614|565668400|FG000|Overall Study|Randomized but Not Treated|2|||
156706034|NCT02135614|565668401|FG001|Overall Study|Randomized but Not Treated|1|||
156706035|NCT02135614|565668400|FG000|Overall Study|Adverse Event|0|||
156706036|NCT02135614|565668401|FG001|Overall Study|Adverse Event|1|||
156706037|NCT02135614|565668400|FG000|Overall Study|Death|1|||
156706038|NCT02135614|565668401|FG001|Overall Study|Death|0|||
156706039|NCT02135614|565668400|FG000|Overall Study|Investigator's Discretion|0|||
156706040|NCT02135614|565668401|FG001|Overall Study|Investigator's Discretion|1|||
156706041|NCT02135614|565668400|FG000|Overall Study|Withdrew Consent|2|||
156706042|NCT02135614|565668401|FG001|Overall Study|Withdrew Consent|2|||
156706043|NCT02135614|565668400|FG000|Overall Study|Lost to Follow-up|3|||
156706044|NCT02135614|565668401|FG001|Overall Study|Lost to Follow-up|0|||
156706045|NCT03022084|565668402|FG000|Overall Study|Lost to Follow-up|2|||
156706046|NCT03022084|565668403|FG001|Overall Study|Lost to Follow-up|3|||
156706047|NCT00554606|565668404|FG000|Overall Study|Adverse Event|3|||
156706048|NCT00554606|565668404|FG000|Overall Study|Abnormal laboratory values|1|||
156706049|NCT00554606|565668404|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
156706050|NCT00554606|565668404|FG000|Overall Study|Subject withdrew consent|2|||
156706051|NCT00554606|565668404|FG000|Overall Study|Lost to Follow-up|2|||
156706052|NCT00554606|565668404|FG000|Overall Study|Administrative problems|60|||
156706053|NCT00554606|565668404|FG000|Overall Study|Death|1|||
156706054|NCT00554606|565668404|FG000|Overall Study|Protocol deviation|2|||
157124894|NCT00848354|567206337|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
157124895|NCT00848354|567206338|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
157124896|NCT00848354|567206337|FG000|Phase 2 Year 1|Unspecified Reason|3|||
157124897|NCT00848354|567206338|FG001|Phase 2 Year 1|Unspecified Reason|0|||
157124898|NCT00848354|567206337|FG000|Phase 2 Year 1|Protocol Violation|4|||
157124899|NCT00848354|567206338|FG001|Phase 2 Year 1|Protocol Violation|1|||
157124900|NCT00848354|567206337|FG000|Phase 2 Year 1|Subject Request|1|||
157124901|NCT00848354|567206338|FG001|Phase 2 Year 1|Subject Request|2|||
157124902|NCT00848354|567206337|FG000|Phase 2 Year 2|Adverse Event|12|||
157124903|NCT00848354|567206338|FG001|Phase 2 Year 2|Adverse Event|2|||
157124904|NCT00848354|567206337|FG000|Phase 2 Year 2|Death|2|||
157124905|NCT00848354|567206338|FG001|Phase 2 Year 2|Death|0|||
157124906|NCT00848354|567206337|FG000|Phase 2 Year 2|Failed to return|3|||
157124907|NCT00848354|567206338|FG001|Phase 2 Year 2|Failed to return|0|||
157124908|NCT00848354|567206337|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
157124909|NCT00848354|567206338|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
157124910|NCT00848354|567206337|FG000|Phase 2 Year 2|Unspecified Reason|1|||
157124911|NCT00848354|567206338|FG001|Phase 2 Year 2|Unspecified Reason|0|||
157124912|NCT00848354|567206337|FG000|Phase 2 Year 2|Protocol Violation|1|||
157124913|NCT00848354|567206338|FG001|Phase 2 Year 2|Protocol Violation|1|||
157124914|NCT00848354|567206337|FG000|Phase 2 Year 2|Subject Request|1|||
157124915|NCT00848354|567206338|FG001|Phase 2 Year 2|Subject Request|1|||
157124916|NCT00848354|567206337|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
157124917|NCT00848354|567206338|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
157124918|NCT00512798|567206339|FG000|Overall Study|Death|0|||
157124919|NCT00512798|567206340|FG001|Overall Study|Death|3|||
157124920|NCT00512798|567206339|FG000|Overall Study|Adverse Event|2|||
157124921|NCT00512798|567206340|FG001|Overall Study|Adverse Event|4|||
157124922|NCT00512798|567206339|FG000|Overall Study|Progression of disease|14|||
157124923|NCT00512798|567206340|FG001|Overall Study|Progression of disease|20|||
157124924|NCT00512798|567206339|FG000|Overall Study|Withdrawal by Subject|3|||
156706055|NCT00605540|565668406|FG000|Overall Study|Death|15|||
156706056|NCT00605540|565668406|FG000|Overall Study|Lost to Follow-up|23|||
156706057|NCT00509366|565668407|FG000|Overall Study|Not Treated (Screen Failure)|1|||
156706058|NCT00509366|565668408|FG001|Overall Study|Not Treated (Screen Failure)|1|||
156706059|NCT00509366|565668409|FG002|Overall Study|Not Treated (Screen Failure)|1|||
156706060|NCT00509366|565668410|FG003|Overall Study|Not Treated (Screen Failure)|0|||
157124925|NCT00512798|567206340|FG001|Overall Study|Withdrawal by Subject|0|||
157124926|NCT00915343|567206341|FG000|Part B - Open Label Period|Treatment switch|0|||
157124927|NCT00915343|567206342|FG001|Part B - Open Label Period|Treatment switch|0|||
157124928|NCT00915343|567206343|FG002|Part B - Open Label Period|Treatment switch|1|||
157124929|NCT00915343|567206341|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
157124930|NCT00915343|567206342|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
157215554|NCT03372083|567537330|FG000|Overall Study|Physician Decision|1|||
156706061|NCT00509366|565668411|FG004|Overall Study|Not Treated (Screen Failure)|0|||
156706062|NCT02119819|565668414|FG000|Overall Study|Adverse Event|3|||
156706063|NCT02119819|565668415|FG001|Overall Study|Adverse Event|1|||
156706064|NCT02119819|565668416|FG002|Overall Study|Adverse Event|2|||
156706065|NCT02119819|565668417|FG003|Overall Study|Adverse Event|3|||
156706066|NCT02119819|565668418|FG004|Overall Study|Adverse Event|0|||
156706067|NCT02119819|565668419|FG005|Overall Study|Adverse Event|1|||
156706068|NCT02119819|565668414|FG000|Overall Study|Lack of Efficacy|0|||
156706069|NCT02119819|565668415|FG001|Overall Study|Lack of Efficacy|0|||
157124931|NCT00915343|567206343|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
156706070|NCT02119819|565668416|FG002|Overall Study|Lack of Efficacy|0|||
157124932|NCT00911989|567206344|FG000|Overall Study|Adverse Event|1|||
157124933|NCT03064841|567206345|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
157124934|NCT03064841|567206345|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
157124935|NCT03064841|567206345|FG000|Overall Study|Screen failure|2|||
157124936|NCT01250379|567206346|FG000|Overall Study|Death|141|||
157124937|NCT01250379|567206347|FG001|Overall Study|Death|148|||
157124938|NCT01250379|567206346|FG000|Overall Study|Withdrawal by Subject|32|||
157124939|NCT01250379|567206347|FG001|Overall Study|Withdrawal by Subject|20|||
157124940|NCT01250379|567206346|FG000|Overall Study|Physician Decision|11|||
157124941|NCT01250379|567206347|FG001|Overall Study|Physician Decision|3|||
157124942|NCT01250379|567206346|FG000|Overall Study|Protocol Violation|2|||
157124943|NCT01250379|567206347|FG001|Overall Study|Protocol Violation|8|||
157124944|NCT01250379|567206346|FG000|Overall Study|Lost to Follow-up|9|||
157124945|NCT01250379|567206347|FG001|Overall Study|Lost to Follow-up|6|||
157124946|NCT01250379|567206346|FG000|Overall Study|Adverse Event|5|||
157124947|NCT01250379|567206347|FG001|Overall Study|Adverse Event|4|||
157124948|NCT01250379|567206346|FG000|Overall Study|Other|0|||
157124949|NCT01250379|567206347|FG001|Overall Study|Other|4|||
157124950|NCT01250379|567206346|FG000|Overall Study|Participant noncompliance|2|||
157124951|NCT01250379|567206347|FG001|Overall Study|Participant noncompliance|0|||
157124952|NCT04899232|567206348|FG000|Screening Period|Physician Decision|1|||
157124953|NCT04899232|567206349|FG001|Screening Period|Physician Decision|0|||
157124954|NCT04899232|567206350|FG002|Screening Period|Physician Decision|0|||
157124955|NCT04899232|567206348|FG000|Screening Period|Withdrawal by Subject|1|||
157124956|NCT04899232|567206349|FG001|Screening Period|Withdrawal by Subject|0|||
157124957|NCT04899232|567206350|FG002|Screening Period|Withdrawal by Subject|0|||
157124958|NCT04899232|567206348|FG000|Screening Period|Participant discharged before receiving intervention|3|||
156706071|NCT02119819|565668417|FG003|Overall Study|Lack of Efficacy|0|||
156706072|NCT02119819|565668418|FG004|Overall Study|Lack of Efficacy|0|||
157015793|NCT00774852|566808956|FG001|Overall Study|Physician Decision|6|||
157015794|NCT00774852|566808955|FG000|Overall Study|Pregnancy|1|||
157015795|NCT00774852|566808956|FG001|Overall Study|Pregnancy|2|||
157015796|NCT00774852|566808955|FG000|Overall Study|Withdrawal by Subject|2|||
157015797|NCT00774852|566808956|FG001|Overall Study|Withdrawal by Subject|2|||
157015798|NCT00774852|566808955|FG000|Overall Study|Non-responder|15|||
157015799|NCT00774852|566808956|FG001|Overall Study|Non-responder|11|||
157015800|NCT00774852|566808955|FG000|Overall Study|Subject non-compliance|0|||
157015801|NCT00774852|566808956|FG001|Overall Study|Subject non-compliance|1|||
157015802|NCT00774852|566808955|FG000|Overall Study|Protocol Violation|1|||
157015803|NCT00774852|566808956|FG001|Overall Study|Protocol Violation|0|||
157015804|NCT00774852|566808955|FG000|Overall Study|Subject received prohibited medication|1|||
157015805|NCT00774852|566808956|FG001|Overall Study|Subject received prohibited medication|0|||
157015806|NCT04428112|566808957|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
157015807|NCT04428112|566808958|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
157015808|NCT04428112|566808957|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
157015809|NCT04428112|566808958|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
157015810|NCT04428112|566808957|FG000|Overall Study|Withdrawal by Subject|9|||
157015811|NCT04428112|566808958|FG001|Overall Study|Withdrawal by Subject|4|||
157015812|NCT04428112|566808957|FG000|Overall Study|Lost to Follow-up|27|||
157015813|NCT04428112|566808958|FG001|Overall Study|Lost to Follow-up|7|||
157015814|NCT04459416|566811119|FG000|Overall Study|Lost to Follow-up|2|||
157015815|NCT04459416|566811120|FG001|Overall Study|Lost to Follow-up|0|||
157015816|NCT04459416|566811119|FG000|Overall Study|Withdrawal by Subject|8|||
157015817|NCT04459416|566811120|FG001|Overall Study|Withdrawal by Subject|10|||
157015818|NCT04459416|566811119|FG000|Overall Study|Disease progression|0|||
157015819|NCT04459416|566811120|FG001|Overall Study|Disease progression|3|||
157015820|NCT03744312|566811121|FG000|Overall Study|Withdrawal by Subject|0|||
157015821|NCT03744312|566811122|FG001|Overall Study|Withdrawal by Subject|1|||
157015822|NCT03744312|566811121|FG000|Overall Study|Screen fail|0|||
157015823|NCT03744312|566811122|FG001|Overall Study|Screen fail|1|||
157015824|NCT05134337|566811123|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
157015825|NCT05134337|566811124|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
157015826|NCT03725722|566811125|FG000|Overall Study|Lack of Efficacy|2|||
157015827|NCT03725722|566811126|FG001|Overall Study|Lack of Efficacy|1|||
157015828|NCT03725722|566811127|FG002|Overall Study|Lack of Efficacy|2|||
157015829|NCT03725722|566811128|FG003|Overall Study|Lack of Efficacy|0|||
157015830|NCT03725722|566811129|FG004|Overall Study|Lack of Efficacy|2|||
157015831|NCT03725722|566811125|FG000|Overall Study|Adverse Event|2|||
157015832|NCT03725722|566811126|FG001|Overall Study|Adverse Event|2|||
157015833|NCT03725722|566811127|FG002|Overall Study|Adverse Event|1|||
157015834|NCT03725722|566811128|FG003|Overall Study|Adverse Event|0|||
157015835|NCT03725722|566811129|FG004|Overall Study|Adverse Event|6|||
157015836|NCT03725722|566811125|FG000|Overall Study|Withdrawal by Subject|4|||
156706073|NCT02119819|565668419|FG005|Overall Study|Lack of Efficacy|1|||
156706074|NCT02119819|565668414|FG000|Overall Study|Lost to Follow-up|0|||
156706075|NCT02119819|565668415|FG001|Overall Study|Lost to Follow-up|0|||
156706076|NCT02119819|565668416|FG002|Overall Study|Lost to Follow-up|1|||
156706077|NCT02119819|565668417|FG003|Overall Study|Lost to Follow-up|2|||
156706078|NCT02119819|565668418|FG004|Overall Study|Lost to Follow-up|1|||
156706079|NCT02119819|565668419|FG005|Overall Study|Lost to Follow-up|2|||
156706080|NCT02119819|565668414|FG000|Overall Study|Physician Decision|1|||
156706081|NCT02119819|565668415|FG001|Overall Study|Physician Decision|1|||
156706082|NCT02119819|565668416|FG002|Overall Study|Physician Decision|0|||
156706083|NCT02119819|565668417|FG003|Overall Study|Physician Decision|0|||
156706084|NCT02119819|565668418|FG004|Overall Study|Physician Decision|0|||
156706085|NCT02119819|565668419|FG005|Overall Study|Physician Decision|1|||
156706086|NCT02119819|565668414|FG000|Overall Study|Withdrawal by Subject|5|||
156706087|NCT02119819|565668415|FG001|Overall Study|Withdrawal by Subject|3|||
156706088|NCT02119819|565668416|FG002|Overall Study|Withdrawal by Subject|0|||
156706089|NCT02119819|565668417|FG003|Overall Study|Withdrawal by Subject|0|||
156706090|NCT02119819|565668418|FG004|Overall Study|Withdrawal by Subject|6|||
156706091|NCT02119819|565668419|FG005|Overall Study|Withdrawal by Subject|10|||
156706092|NCT02119819|565668414|FG000|Overall Study|Jury Duty|0|||
156706093|NCT02119819|565668415|FG001|Overall Study|Jury Duty|0|||
156706094|NCT02119819|565668416|FG002|Overall Study|Jury Duty|1|||
156706095|NCT02119819|565668417|FG003|Overall Study|Jury Duty|0|||
156706096|NCT02119819|565668418|FG004|Overall Study|Jury Duty|0|||
156706097|NCT02119819|565668419|FG005|Overall Study|Jury Duty|0|||
156706098|NCT02119819|565668414|FG000|Overall Study|Protocol Violation|0|||
156706099|NCT02119819|565668415|FG001|Overall Study|Protocol Violation|0|||
156706100|NCT02119819|565668416|FG002|Overall Study|Protocol Violation|0|||
156706101|NCT02119819|565668417|FG003|Overall Study|Protocol Violation|1|||
156706102|NCT02119819|565668418|FG004|Overall Study|Protocol Violation|0|||
156706103|NCT02119819|565668419|FG005|Overall Study|Protocol Violation|0|||
156706104|NCT02119819|565668414|FG000|Overall Study|Left the city to get a job|0|||
156706105|NCT02119819|565668415|FG001|Overall Study|Left the city to get a job|0|||
156706106|NCT02119819|565668416|FG002|Overall Study|Left the city to get a job|0|||
156706107|NCT02119819|565668417|FG003|Overall Study|Left the city to get a job|1|||
156706108|NCT02119819|565668418|FG004|Overall Study|Left the city to get a job|0|||
156706109|NCT02119819|565668419|FG005|Overall Study|Left the city to get a job|0|||
156706110|NCT00282919|565668421|FG000|Overall Study|Lack of Efficacy|4|||
156706111|NCT00282919|565668421|FG000|Overall Study|Withdrawal by Subject|1|||
156706112|NCT00282919|565668421|FG000|Overall Study|Asymptomatic Parasitemia|2|||
156706113|NCT01433549|565668422|FG000|Phase 2: Second Study Product|Adverse Event|0|||
156706114|NCT01433549|565668423|FG001|Phase 2: Second Study Product|Adverse Event|1|||
156706115|NCT04497948|565668428|FG000|Overall Study|Death|2|||
156706116|NCT03257865|565668433|FG000|Overall Study|Adverse Event|4|||
156706117|NCT03257865|565668434|FG001|Overall Study|Adverse Event|8|||
156706118|NCT03257865|565668433|FG000|Overall Study|Lack of Efficacy|1|||
156706119|NCT03257865|565668434|FG001|Overall Study|Lack of Efficacy|2|||
156706120|NCT03257865|565668433|FG000|Overall Study|Non-compliance with Study Drug|0|||
156706121|NCT03257865|565668434|FG001|Overall Study|Non-compliance with Study Drug|2|||
156706122|NCT03257865|565668433|FG000|Overall Study|Withdrawal by Subject|23|||
156706123|NCT03257865|565668434|FG001|Overall Study|Withdrawal by Subject|17|||
156706124|NCT03257865|565668433|FG000|Overall Study|Physician Decision|3|||
156706125|NCT03257865|565668434|FG001|Overall Study|Physician Decision|1|||
156706126|NCT03257865|565668433|FG000|Overall Study|Other|0|||
156706127|NCT03257865|565668434|FG001|Overall Study|Other|1|||
156706128|NCT03257865|565668433|FG000|Overall Study|Lost to Follow-up|4|||
156791150|NCT02614066|565987172|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
156791151|NCT02614066|565987173|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
156791152|NCT02614066|565987170|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
156791153|NCT02614066|565987171|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
156791154|NCT02614066|565987172|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
156791155|NCT02614066|565987173|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
156791156|NCT02614066|565987170|FG000|Overall Study|Reason not specified|0|||
156791157|NCT02614066|565987171|FG001|Overall Study|Reason not specified|2|||
156791158|NCT02614066|565987172|FG002|Overall Study|Reason not specified|1|||
156791159|NCT02614066|565987173|FG003|Overall Study|Reason not specified|1|||
156791160|NCT04565756|565987174|FG000|Overall Study|Withdrawal by Subject|0|||
156791161|NCT04565756|565987175|FG001|Overall Study|Withdrawal by Subject|0|||
156791162|NCT04565756|565987176|FG002|Overall Study|Withdrawal by Subject|0|||
156706129|NCT03257865|565668434|FG001|Overall Study|Lost to Follow-up|4|||
156706130|NCT02549027|565668435|FG000|Washout After Period 4|Withdrawal by Subject|0|||
156706131|NCT02549027|565668436|FG001|Washout After Period 4|Withdrawal by Subject|1|||
156706132|NCT02549027|565668437|FG002|Washout After Period 4|Withdrawal by Subject|1|||
156706133|NCT02549027|565668438|FG003|Washout After Period 4|Withdrawal by Subject|1|||
156706134|NCT02549027|565668439|FG004|Washout After Period 4|Withdrawal by Subject|0|||
156706135|NCT02549027|565668440|FG005|Washout After Period 4|Withdrawal by Subject|0|||
157124959|NCT04899232|567206349|FG001|Screening Period|Participant discharged before receiving intervention|0|||
157124960|NCT04899232|567206350|FG002|Screening Period|Participant discharged before receiving intervention|0|||
157124961|NCT00700271|567206352|FG000|Overall Study|Adverse Event|4|||
157124962|NCT00700271|567206353|FG001|Overall Study|Adverse Event|6|||
157124963|NCT00700271|567206352|FG000|Overall Study|Protocol Violation|1|||
156706136|NCT02549027|565668435|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706137|NCT02549027|565668436|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706138|NCT02549027|565668437|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706139|NCT02549027|565668438|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706140|NCT02549027|565668439|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
156706141|NCT02549027|565668440|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
156706142|NCT05384171|565668446|FG000|Overall Study|Lost to Follow-up|9|||
156706143|NCT05384171|565668447|FG001|Overall Study|Lost to Follow-up|9|||
156706144|NCT05384171|565668446|FG000|Overall Study|Withdrawal by Subject|3|||
156706145|NCT05384171|565668447|FG001|Overall Study|Withdrawal by Subject|0|||
156706146|NCT01421511|565668448|FG000|Overall Study|Lost to Follow-up|11|||
156706147|NCT01421511|565668449|FG001|Overall Study|Lost to Follow-up|14|||
156706148|NCT01421511|565668448|FG000|Overall Study|Randomized but didn't receive study drug|1|||
156706149|NCT01421511|565668449|FG001|Overall Study|Randomized but didn't receive study drug|7|||
156706150|NCT01421511|565668448|FG000|Overall Study|Physician Decision|0|||
156706151|NCT01421511|565668449|FG001|Overall Study|Physician Decision|1|||
156706152|NCT01421511|565668448|FG000|Overall Study|Withdrawal by Subject|6|||
156706153|NCT01421511|565668449|FG001|Overall Study|Withdrawal by Subject|5|||
156706154|NCT01421511|565668448|FG000|Overall Study|Death|1|||
156706155|NCT01421511|565668449|FG001|Overall Study|Death|1|||
156706156|NCT04853992|565668453|FG000|Treatment Period A|Adverse Event|0|||
156706157|NCT04853992|565668454|FG001|Treatment Period A|Adverse Event|1|||
156706158|NCT04853992|565668453|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
156706159|NCT04853992|565668454|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
156706160|NCT01094886|565668455|FG000|Overall Study|Adverse Event|2|||
156706161|NCT01094886|565668455|FG000|Overall Study|Withdrawal by Subject|5|||
156706162|NCT00402116|565670565|FG000|Overall Study|Jaw infection after surgery-other|1|||
156706163|NCT00402116|565670566|FG001|Overall Study|Jaw infection after surgery-other|0|||
156706164|NCT00402116|565670567|FG002|Overall Study|Jaw infection after surgery-other|0|||
156706165|NCT00402116|565670565|FG000|Overall Study|Withdrawal by Subject|1|||
156706166|NCT00402116|565670566|FG001|Overall Study|Withdrawal by Subject|0|||
156706167|NCT00402116|565670567|FG002|Overall Study|Withdrawal by Subject|5|||
156706168|NCT00402116|565670565|FG000|Overall Study|Treatment completed per protocol|1|||
156706169|NCT00402116|565670566|FG001|Overall Study|Treatment completed per protocol|1|||
156706170|NCT00402116|565670567|FG002|Overall Study|Treatment completed per protocol|2|||
156706171|NCT00402116|565670565|FG000|Overall Study|other complicating disease|0|||
156706172|NCT00402116|565670566|FG001|Overall Study|other complicating disease|0|||
156706173|NCT00402116|565670567|FG002|Overall Study|other complicating disease|2|||
156706174|NCT00402116|565670565|FG000|Overall Study|Disease Progression|0|||
156706175|NCT00402116|565670566|FG001|Overall Study|Disease Progression|4|||
156706176|NCT00402116|565670567|FG002|Overall Study|Disease Progression|38|||
156706177|NCT00402116|565670565|FG000|Overall Study|mistaken thrombocytopenia|0|||
156706178|NCT00402116|565670566|FG001|Overall Study|mistaken thrombocytopenia|0|||
156706179|NCT00402116|565670567|FG002|Overall Study|mistaken thrombocytopenia|1|||
156706180|NCT00402116|565670565|FG000|Overall Study|decline related hyponatremia/tumor|0|||
156706181|NCT00402116|565670566|FG001|Overall Study|decline related hyponatremia/tumor|0|||
156706182|NCT00402116|565670567|FG002|Overall Study|decline related hyponatremia/tumor|1|||
156706183|NCT00402116|565670565|FG000|Overall Study|Adverse Event|0|||
156706184|NCT00402116|565670566|FG001|Overall Study|Adverse Event|1|||
156706185|NCT00402116|565670567|FG002|Overall Study|Adverse Event|6|||
156706186|NCT02899195|565670568|FG000|Concurrent Durvalumab|Adverse Event|4|||
156706187|NCT02899195|565670568|FG000|Concurrent Durvalumab|Physician Decision|1|||
156706188|NCT02899195|565670568|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
156706189|NCT02899195|565670568|FG000|Concurrent Durvalumab|Progressive Disease|5|||
157124964|NCT00700271|567206353|FG001|Overall Study|Protocol Violation|0|||
156706190|NCT02899195|565670568|FG000|Maintenance Durvalumab|Adverse Event|1|||
156791163|NCT04565756|565987177|FG003|Overall Study|Withdrawal by Subject|0|||
157124965|NCT00700271|567206352|FG000|Overall Study|Administrative Reasons|1|||
157124966|NCT00700271|567206353|FG001|Overall Study|Administrative Reasons|0|||
157124967|NCT00700271|567206352|FG000|Overall Study|Withdrawal by Subject|6|||
157124968|NCT00700271|567206353|FG001|Overall Study|Withdrawal by Subject|4|||
157124969|NCT00700271|567206352|FG000|Overall Study|Lost to Follow-up|2|||
156706191|NCT02899195|565670568|FG000|Maintenance Durvalumab|Physician Decision|1|||
156706192|NCT02899195|565670568|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
156706193|NCT02899195|565670568|FG000|Maintenance Durvalumab|Progressive Disease|31|||
156706194|NCT04778904|565670570|FG000|Overall Study|Protocol Violation|1|||
156706195|NCT04778904|565670571|FG001|Overall Study|Protocol Violation|0|||
156706196|NCT04778904|565670572|FG002|Overall Study|Protocol Violation|0|||
157124970|NCT00700271|567206353|FG001|Overall Study|Lost to Follow-up|2|||
156706197|NCT04778904|565670573|FG003|Overall Study|Protocol Violation|0|||
156706198|NCT04778904|565670570|FG000|Overall Study|Withdrawal by Subject|0|||
156706199|NCT04778904|565670571|FG001|Overall Study|Withdrawal by Subject|0|||
156706200|NCT04778904|565670572|FG002|Overall Study|Withdrawal by Subject|1|||
156706201|NCT04778904|565670573|FG003|Overall Study|Withdrawal by Subject|0|||
156706202|NCT03156504|565670574|FG000|Overall Study|Withdrawal by Subject|1|||
156706203|NCT03452137|565670575|FG000|Overall Study|Death|67|||
156706204|NCT03452137|565670576|FG001|Overall Study|Death|70|||
156706205|NCT03452137|565670575|FG000|Overall Study|Lost to Follow-up|4|||
156706206|NCT03452137|565670576|FG001|Overall Study|Lost to Follow-up|2|||
156706207|NCT03452137|565670575|FG000|Overall Study|Physician Decision|0|||
156706208|NCT03452137|565670576|FG001|Overall Study|Physician Decision|1|||
156706209|NCT03452137|565670575|FG000|Overall Study|Study Terminated by Sponsor|120|||
156706210|NCT03452137|565670576|FG001|Overall Study|Study Terminated by Sponsor|121|||
156706211|NCT03452137|565670575|FG000|Overall Study|Withdrawal by Subject|12|||
156706212|NCT03452137|565670576|FG001|Overall Study|Withdrawal by Subject|9|||
156706213|NCT04138043|565670577|FG000|Overall Study|Withdrawal by Subject|0|||
156706214|NCT04138043|565670578|FG001|Overall Study|Withdrawal by Subject|1|||
156706215|NCT03772717|565670579|FG000|Overall Study|Withdrawal by Subject|2|||
156706216|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
156706217|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
156706218|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
156706219|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
156706220|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
156706221|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
156706222|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
156706223|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
156706224|NCT02856802|565670580|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
156706225|NCT02856802|565670581|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
156706226|NCT02856802|565670580|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
156706227|NCT02856802|565670581|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
156706228|NCT00587860|565670582|FG000|Overall Study|Lost to Follow-up|2|||
156706229|NCT00587860|565670583|FG001|Overall Study|Lost to Follow-up|2|||
156706230|NCT00587860|565670582|FG000|Overall Study|Withdrawal by Subject|3|||
156706231|NCT00587860|565670583|FG001|Overall Study|Withdrawal by Subject|3|||
156706232|NCT01659125|565670584|FG000|Overall Study|Withdrawal by Subject|2|||
156706233|NCT01659125|565670584|FG000|Overall Study|Lost to Follow-up|7|||
156706234|NCT01659125|565670584|FG000|Overall Study|Technical Problem|1|||
156706235|NCT01659125|565670584|FG000|Overall Study|Time Constraints|2|||
156706236|NCT01659125|565670584|FG000|Overall Study|Failed to Start Treatment|2|||
156706237|NCT02242045|565670585|FG000|Overall Study|Investigator's Discretion|1|||
156706238|NCT02242045|565670585|FG000|Overall Study|Progressive Disease|2|||
156706239|NCT02242045|565670585|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
156706240|NCT02242045|565670585|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
156706241|NCT00749892|565670586|FG000|Overall Study|Withdrawal by Subject|3|||
156706242|NCT04581369|565670587|FG000|Overall Study|Death|7|||
156706243|NCT04581369|565670588|FG001|Overall Study|Death|6|||
157124971|NCT01928381|567206356|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
156706244|NCT04581369|565670589|FG002|Overall Study|Death|0|||
156706245|NCT04581369|565670587|FG000|Overall Study|Lost to Follow-up|7|||
156706246|NCT04581369|565670588|FG001|Overall Study|Lost to Follow-up|3|||
156706247|NCT04581369|565670589|FG002|Overall Study|Lost to Follow-up|0|||
156706248|NCT04581369|565670587|FG000|Overall Study|liver transplant|2|||
156706249|NCT04581369|565670588|FG001|Overall Study|liver transplant|2|||
156706250|NCT04581369|565670589|FG002|Overall Study|liver transplant|0|||
156706251|NCT04581369|565670587|FG000|Overall Study|transitioned to hospice care|0|||
156706252|NCT04581369|565670588|FG001|Overall Study|transitioned to hospice care|5|||
156706253|NCT04581369|565670589|FG002|Overall Study|transitioned to hospice care|0|||
156706254|NCT00780910|565670590|FG000|Overall Study|Adverse Event|2|||
156706255|NCT00106964|565670592|FG000|Overall Study|Lost to Follow-up|8|||
156791164|NCT04565756|565987178|FG004|Overall Study|Withdrawal by Subject|1|||
156791165|NCT04565756|565987179|FG005|Overall Study|Withdrawal by Subject|0|||
156791166|NCT04565756|565987174|FG000|Overall Study|Protocol Violation|0|||
156706256|NCT00106964|565670593|FG001|Overall Study|Lost to Follow-up|6|||
156706257|NCT00106964|565670594|FG002|Overall Study|Lost to Follow-up|2|||
156706258|NCT00106964|565670592|FG000|Overall Study|Pregnancy|2|||
156706259|NCT00106964|565670593|FG001|Overall Study|Pregnancy|3|||
156706260|NCT00106964|565670594|FG002|Overall Study|Pregnancy|2|||
156706261|NCT00106964|565670592|FG000|Overall Study|Death|1|||
156706262|NCT00106964|565670593|FG001|Overall Study|Death|1|||
156706263|NCT00106964|565670594|FG002|Overall Study|Death|0|||
156706264|NCT00106964|565670592|FG000|Overall Study|Incarceration|0|||
156706265|NCT00106964|565670593|FG001|Overall Study|Incarceration|1|||
156706266|NCT00106964|565670594|FG002|Overall Study|Incarceration|0|||
156706267|NCT00106964|565670592|FG000|Overall Study|Site Funding Terminated|0|||
156706268|NCT00106964|565670593|FG001|Overall Study|Site Funding Terminated|1|||
156791167|NCT04565756|565987175|FG001|Overall Study|Protocol Violation|0|||
156706269|NCT00106964|565670594|FG002|Overall Study|Site Funding Terminated|1|||
156706270|NCT00106964|565670592|FG000|Overall Study|Failure to adhere|2|||
156706271|NCT00106964|565670593|FG001|Overall Study|Failure to adhere|0|||
156706272|NCT00106964|565670594|FG002|Overall Study|Failure to adhere|0|||
156706273|NCT00106964|565670592|FG000|Overall Study|Did not meet eligibility criteria|0|||
156706274|NCT00106964|565670593|FG001|Overall Study|Did not meet eligibility criteria|2|||
156706275|NCT00106964|565670594|FG002|Overall Study|Did not meet eligibility criteria|2|||
156706276|NCT00106964|565670592|FG000|Overall Study|Required disallowed medication|0|||
156706277|NCT00106964|565670593|FG001|Overall Study|Required disallowed medication|1|||
156706278|NCT00106964|565670594|FG002|Overall Study|Required disallowed medication|0|||
156706279|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
156706280|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
156706281|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
156706282|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
156706283|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
156706284|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
156706285|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
156706286|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
156706287|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
156706288|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
156706289|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
156706290|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
156706291|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
156706292|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
156706293|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
156706294|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
156706295|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
156706296|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
156706297|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
156706298|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
156706299|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
156706300|NCT04040192|565670595|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
156706301|NCT04040192|565670596|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
156706302|NCT04040192|565670597|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
156706303|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
156706304|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
156706305|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
156706306|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
156706307|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
156706308|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
156706309|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
156706310|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
156706311|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
156706312|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
156706313|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
156706314|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
156706315|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156706316|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
156706317|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
156706318|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
156706319|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
156791168|NCT04565756|565987176|FG002|Overall Study|Protocol Violation|0|||
156791169|NCT04565756|565987177|FG003|Overall Study|Protocol Violation|0|||
156791170|NCT04565756|565987178|FG004|Overall Study|Protocol Violation|0|||
156791171|NCT04565756|565987179|FG005|Overall Study|Protocol Violation|1|||
156791172|NCT03378635|565987187|FG000|Overall Study|Adverse Event|1|||
157124972|NCT01928381|567206357|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
156791173|NCT03378635|565987188|FG001|Overall Study|Adverse Event|0|||
156791174|NCT03378635|565987189|FG002|Overall Study|Adverse Event|0|||
157124973|NCT01928381|567206358|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
157124974|NCT01928381|567206359|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
157124975|NCT01928381|567206360|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
157124976|NCT01928381|567206361|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
157124977|NCT01928381|567206362|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
157215555|NCT03372083|567537330|FG000|Overall Study|Withdrawal by Subject|1|||
157215556|NCT00566098|567537331|FG000|Collection of MILs|Withdrawal by Subject|1|||
156706320|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
156706321|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
156706322|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
156706323|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
156706324|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
156706325|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
156706326|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
156706327|NCT04040192|565670595|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
156706328|NCT04040192|565670596|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
156706329|NCT04040192|565670597|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
156706330|NCT03207243|565670598|FG000|Overall Study|Adverse Event|2|||
156872183|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
156872184|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
156872185|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
156872186|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
156872187|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
156872188|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
156872189|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
156872190|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
157124978|NCT01928381|567206356|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
157124979|NCT01928381|567206357|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
156706331|NCT03207243|565670599|FG001|Overall Study|Adverse Event|2|||
156706332|NCT03207243|565670598|FG000|Overall Study|Loss of Asthma Control|47|||
156706333|NCT03207243|565670599|FG001|Overall Study|Loss of Asthma Control|31|||
156706334|NCT03207243|565670598|FG000|Overall Study|Withdrawal by Subject|2|||
156706335|NCT03207243|565670599|FG001|Overall Study|Withdrawal by Subject|4|||
156706336|NCT03207243|565670598|FG000|Overall Study|Physician Decision|1|||
156706337|NCT03207243|565670599|FG001|Overall Study|Physician Decision|1|||
156706338|NCT03207243|565670598|FG000|Overall Study|Lost to Follow-up|0|||
156706339|NCT03207243|565670599|FG001|Overall Study|Lost to Follow-up|1|||
156706340|NCT03207243|565670598|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
156706341|NCT03207243|565670599|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
156706342|NCT03207243|565670598|FG000|Overall Study|Protocol Violation|0|||
156706343|NCT03207243|565670599|FG001|Overall Study|Protocol Violation|3|||
156706344|NCT00168818|565670606|FG000|Overall Study|Adverse Event|23|||
156706345|NCT00168818|565670607|FG001|Overall Study|Adverse Event|29|||
156706346|NCT00168818|565670608|FG002|Overall Study|Adverse Event|31|||
156706347|NCT00168818|565670606|FG000|Overall Study|Protocol Violation|16|||
156706348|NCT00168818|565670607|FG001|Overall Study|Protocol Violation|11|||
156706349|NCT00168818|565670608|FG002|Overall Study|Protocol Violation|11|||
156706350|NCT00168818|565670606|FG000|Overall Study|Lost to Follow-up|13|||
156706351|NCT00168818|565670607|FG001|Overall Study|Lost to Follow-up|4|||
156706352|NCT00168818|565670608|FG002|Overall Study|Lost to Follow-up|15|||
156706353|NCT00168818|565670606|FG000|Overall Study|Withdrawal by Subject|43|||
157124980|NCT01928381|567206358|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
157124981|NCT01928381|567206359|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
157124982|NCT01928381|567206360|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
157124983|NCT01928381|567206361|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
157124984|NCT01928381|567206362|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
157124985|NCT01928381|567206356|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
157124986|NCT01928381|567206357|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
157124987|NCT01928381|567206358|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
156706354|NCT00168818|565670607|FG001|Overall Study|Withdrawal by Subject|41|||
156706355|NCT00168818|565670608|FG002|Overall Study|Withdrawal by Subject|37|||
156706356|NCT00168818|565670606|FG000|Overall Study|Other|22|||
156706357|NCT00168818|565670607|FG001|Overall Study|Other|24|||
156706358|NCT00168818|565670608|FG002|Overall Study|Other|30|||
156706359|NCT00168818|565670606|FG000|Treatment|Adverse Event|77|||
156706360|NCT00168818|565670607|FG001|Treatment|Adverse Event|89|||
156706361|NCT00168818|565670608|FG002|Treatment|Adverse Event|68|||
156706362|NCT00168818|565670606|FG000|Treatment|Protocol Violation|8|||
156706363|NCT00168818|565670607|FG001|Treatment|Protocol Violation|11|||
156706364|NCT00168818|565670608|FG002|Treatment|Protocol Violation|11|||
156706365|NCT00168818|565670606|FG000|Treatment|Lost to Follow-up|0|||
156706366|NCT00168818|565670607|FG001|Treatment|Lost to Follow-up|2|||
156706367|NCT00168818|565670608|FG002|Treatment|Lost to Follow-up|1|||
156706368|NCT00168818|565670606|FG000|Treatment|Withdrawal by Subject|25|||
156706369|NCT00168818|565670607|FG001|Treatment|Withdrawal by Subject|20|||
156872191|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
156872192|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
157124988|NCT01928381|567206359|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
157124989|NCT01928381|567206360|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
156706370|NCT00168818|565670608|FG002|Treatment|Withdrawal by Subject|22|||
156706371|NCT00168818|565670606|FG000|Treatment|Other|23|||
157124990|NCT01928381|567206361|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
157124991|NCT01928381|567206362|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
157124992|NCT01928381|567206356|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
157124993|NCT01928381|567206357|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
157124994|NCT01928381|567206358|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
157124995|NCT01928381|567206359|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
157124996|NCT01928381|567206360|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
157124997|NCT01928381|567206361|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
157124998|NCT01928381|567206362|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
157124999|NCT01928381|567206356|FG000|Part 1 - Pain Training|Protocol Violation|1|||
157125000|NCT01928381|567206357|FG001|Part 1 - Pain Training|Protocol Violation|0|||
157125001|NCT01928381|567206358|FG002|Part 1 - Pain Training|Protocol Violation|0|||
157125002|NCT01928381|567206359|FG003|Part 1 - Pain Training|Protocol Violation|0|||
157125003|NCT01928381|567206360|FG004|Part 1 - Pain Training|Protocol Violation|0|||
157125004|NCT01928381|567206361|FG005|Part 1 - Pain Training|Protocol Violation|0|||
157125005|NCT01928381|567206362|FG006|Part 1 - Pain Training|Protocol Violation|0|||
157125006|NCT01928381|567206356|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
157125007|NCT01928381|567206357|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125008|NCT01928381|567206358|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125009|NCT01928381|567206359|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125010|NCT01928381|567206360|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125011|NCT01928381|567206361|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125012|NCT01928381|567206362|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
157125013|NCT01928381|567206356|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
157125014|NCT01928381|567206357|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156706372|NCT00168818|565670607|FG001|Treatment|Other|29|||
156706373|NCT00168818|565670608|FG002|Treatment|Other|31|||
156706374|NCT00603837|565670611|FG000|Overall Study|Physician Decision|3|||
156706375|NCT00603837|565670612|FG001|Overall Study|Physician Decision|0|||
156706376|NCT00856375|565670673|FG000|Overall Study|Other|0|||
156706377|NCT00856375|565670674|FG001|Overall Study|Other|1|||
156706378|NCT00856375|565670673|FG000|Overall Study|Death|32|||
156706379|NCT00856375|565670674|FG001|Overall Study|Death|30|||
156706380|NCT00856375|565670673|FG000|Overall Study|Sponsor Terminated Study|7|||
156706381|NCT00856375|565670674|FG001|Overall Study|Sponsor Terminated Study|7|||
156706382|NCT00856375|565670673|FG000|Overall Study|Withdrawal by Subject|2|||
156706383|NCT00856375|565670674|FG001|Overall Study|Withdrawal by Subject|1|||
156706384|NCT00856375|565670673|FG000|Overall Study|Lost to Follow-up|1|||
156706385|NCT00856375|565670674|FG001|Overall Study|Lost to Follow-up|2|||
156706386|NCT02538965|565670675|FG000|Treatment Period|Other = Death due to disease progression|1|||
156706387|NCT02538965|565670675|FG000|Treatment Period|Adverse Event|2|||
156706388|NCT02538965|565670675|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
156706389|NCT02538965|565670675|FG000|Treatment Period|Treatment Failure|9|||
156706390|NCT02538965|565670675|FG000|Treatment Period|Disease Progression|1|||
156706391|NCT02538965|565670675|FG000|Treatment Period|Physician Decision|2|||
156706392|NCT02538965|565670675|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
156706393|NCT02538965|565670675|FG000|Follow-Up Period|Withdrawal by Parent|4|||
156706394|NCT00875797|565670676|FG000|Overall Study|Protocol Violation|6|||
156706395|NCT00875797|565670677|FG001|Overall Study|Protocol Violation|3|||
156706396|NCT01590797|565670680|FG000|Overall Study|Adverse Event|4|||
156706397|NCT01590797|565670681|FG001|Overall Study|Adverse Event|3|||
156706398|NCT01590797|565670680|FG000|Overall Study|Lack of Efficacy|0|||
156706399|NCT01590797|565670681|FG001|Overall Study|Lack of Efficacy|2|||
156706400|NCT01590797|565670680|FG000|Overall Study|Lost to Follow-up|0|||
156706401|NCT01590797|565670681|FG001|Overall Study|Lost to Follow-up|1|||
156706402|NCT01590797|565670680|FG000|Overall Study|Protocol Violation|4|||
156706403|NCT01590797|565670681|FG001|Overall Study|Protocol Violation|1|||
157125015|NCT01928381|567206358|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156706404|NCT01590797|565670680|FG000|Overall Study|Withdrawal by Subject|7|||
156791175|NCT03378635|565987187|FG000|Overall Study|Withdrawal by Subject|1|||
156791176|NCT03378635|565987188|FG001|Overall Study|Withdrawal by Subject|0|||
157125016|NCT01928381|567206359|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
157125017|NCT01928381|567206360|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
157125018|NCT01928381|567206361|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
156706405|NCT01590797|565670681|FG001|Overall Study|Withdrawal by Subject|5|||
157125019|NCT01928381|567206362|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
157215557|NCT00566098|567537331|FG000|Collection of MILs|Relapsed|1|||
156791177|NCT03378635|565987189|FG002|Overall Study|Withdrawal by Subject|0|||
157125020|NCT01928381|567206356|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
157215558|NCT00566098|567537331|FG000|Generation of MILs Product|Relapsed|1|||
156706406|NCT01590797|565670680|FG000|Overall Study|Other Protocol Specified Criteria|2|||
156706407|NCT01590797|565670681|FG001|Overall Study|Other Protocol Specified Criteria|4|||
156706408|NCT04893018|565670682|FG000|Overall Study|Lost to Follow-up|1|||
157125021|NCT01928381|567206357|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156706409|NCT04893018|565670683|FG001|Overall Study|Lost to Follow-up|0|||
156706410|NCT04893018|565670682|FG000|Overall Study|Withdrawal by Subject|2|||
156706411|NCT04893018|565670683|FG001|Overall Study|Withdrawal by Subject|0|||
156706412|NCT04893018|565670682|FG000|Overall Study|Study Terminated|1|||
156706413|NCT04893018|565670683|FG001|Overall Study|Study Terminated|2|||
156706414|NCT03106987|565670684|FG000|Overall Study|Death|37|||
156706415|NCT03106987|565670685|FG001|Overall Study|Death|22|||
156706416|NCT03106987|565670686|FG002|Overall Study|Death|12|||
156706417|NCT03106987|565670687|FG003|Overall Study|Death|8|||
156706418|NCT03106987|565670684|FG000|Overall Study|Lost to Follow-up|2|||
156706419|NCT03106987|565670685|FG001|Overall Study|Lost to Follow-up|0|||
156706420|NCT03106987|565670686|FG002|Overall Study|Lost to Follow-up|2|||
156706421|NCT03106987|565670687|FG003|Overall Study|Lost to Follow-up|2|||
156706422|NCT03106987|565670684|FG000|Overall Study|Withdrawal by Subject|5|||
156706423|NCT03106987|565670685|FG001|Overall Study|Withdrawal by Subject|1|||
156706424|NCT03106987|565670686|FG002|Overall Study|Withdrawal by Subject|4|||
156706425|NCT03106987|565670687|FG003|Overall Study|Withdrawal by Subject|1|||
156706426|NCT03336528|565670689|FG000|Overall Study|Protocol Violation|1|||
156706427|NCT03336528|565670690|FG001|Overall Study|Protocol Violation|1|||
156706428|NCT03336528|565670689|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
156706429|NCT03336528|565670690|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
156706430|NCT03336528|565670689|FG000|Overall Study|Did not receive study medication|1|||
156706431|NCT03336528|565670690|FG001|Overall Study|Did not receive study medication|2|||
156706432|NCT00195338|565670696|FG000|Overall Study|Lost to Follow-up|2|||
156706433|NCT00195338|565670696|FG000|Overall Study|Adverse Event|5|||
156706434|NCT00195338|565670696|FG000|Overall Study|Lack of Efficacy|1|||
156706435|NCT00195338|565670696|FG000|Overall Study|Early closure of the site|4|||
156706436|NCT00811928|565670697|FG000|Overall Study|AEs and SAEs Including Death|7|||
156706437|NCT00811928|565670698|FG001|Overall Study|AEs and SAEs Including Death|11|||
156706438|NCT00811928|565670697|FG000|Overall Study|Withdrawal by Subject|18|||
156706439|NCT00811928|565670698|FG001|Overall Study|Withdrawal by Subject|12|||
156706440|NCT00811928|565670697|FG000|Overall Study|Did Not Take Study Drug|3|||
156706441|NCT00811928|565670698|FG001|Overall Study|Did Not Take Study Drug|0|||
156706442|NCT00811928|565670697|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
156706443|NCT00811928|565670698|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
156706444|NCT00811928|565670697|FG000|Overall Study|Investigator Decision|2|||
156706445|NCT00811928|565670698|FG001|Overall Study|Investigator Decision|1|||
156706446|NCT00811928|565670697|FG000|Overall Study|Poor Compliance|2|||
156706447|NCT00811928|565670698|FG001|Overall Study|Poor Compliance|5|||
156706448|NCT01085357|565670699|FG000|Overall Study|Adverse Event|1|||
156706449|NCT01085357|565670700|FG001|Overall Study|Adverse Event|1|||
156706450|NCT01085357|565670699|FG000|Overall Study|Subject Decision|4|||
156706451|NCT01085357|565670700|FG001|Overall Study|Subject Decision|3|||
156706452|NCT01085357|565670699|FG000|Overall Study|Investigator Decision|1|||
156706453|NCT01085357|565670700|FG001|Overall Study|Investigator Decision|1|||
156706454|NCT01085357|565670699|FG000|Overall Study|Death|11|||
156706455|NCT01085357|565670700|FG001|Overall Study|Death|1|||
156706456|NCT01085357|565670699|FG000|Overall Study|Lost to Follow-up|2|||
156706457|NCT01085357|565670700|FG001|Overall Study|Lost to Follow-up|0|||
156706458|NCT00314951|565670703|FG000|Treatment|Didn't meet criteria for mITT population|16|||
156706459|NCT00314951|565670704|FG001|Treatment|Didn't meet criteria for mITT population|11|||
156706460|NCT00314951|565670703|FG000|Follow-up|mITT failure|44|||
156706461|NCT00314951|565670704|FG001|Follow-up|mITT failure|34|||
156706462|NCT02910011|565670705|FG000|Overall Study|Physician Decision|2|||
156706463|NCT00920790|565670706|FG000|Overall Study|aggravation of general condition|14|||
156706464|NCT04411914|565670707|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
156706465|NCT04411914|565670708|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
156706466|NCT00182325|565670714|FG000|Overall Study|Lost to Follow-up|7|||
156706467|NCT00182325|565670715|FG001|Overall Study|Lost to Follow-up|7|||
156706468|NCT00182325|565670714|FG000|Overall Study|Miscarriage|5|||
156706469|NCT00182325|565670715|FG001|Overall Study|Miscarriage|3|||
156706470|NCT00182325|565670714|FG000|Overall Study|Did not complete survey|22|||
156706471|NCT00182325|565670715|FG001|Overall Study|Did not complete survey|43|||
157015837|NCT03725722|566811126|FG001|Overall Study|Withdrawal by Subject|1|||
157015838|NCT03725722|566811127|FG002|Overall Study|Withdrawal by Subject|0|||
156706472|NCT01420965|565670719|FG000|Overall Study|Withdrawal by Subject|1|||
156706473|NCT01420965|565670720|FG001|Overall Study|Withdrawal by Subject|0|||
156706474|NCT01420965|565670721|FG002|Overall Study|Withdrawal by Subject|0|||
156706475|NCT01420965|565670719|FG000|Overall Study|Adverse Event|0|||
157015839|NCT03725722|566811128|FG003|Overall Study|Withdrawal by Subject|4|||
157015840|NCT03725722|566811129|FG004|Overall Study|Withdrawal by Subject|4|||
157015841|NCT03725722|566811125|FG000|Overall Study|Lost to Follow-up|3|||
157015842|NCT03725722|566811126|FG001|Overall Study|Lost to Follow-up|1|||
157015843|NCT03725722|566811127|FG002|Overall Study|Lost to Follow-up|2|||
157015844|NCT03725722|566811128|FG003|Overall Study|Lost to Follow-up|2|||
157015845|NCT03725722|566811129|FG004|Overall Study|Lost to Follow-up|1|||
157015846|NCT03725722|566811125|FG000|Overall Study|Personal reasons|0|||
157015847|NCT03725722|566811126|FG001|Overall Study|Personal reasons|0|||
157015848|NCT03725722|566811127|FG002|Overall Study|Personal reasons|1|||
156706476|NCT01420965|565670720|FG001|Overall Study|Adverse Event|1|||
156706477|NCT01420965|565670721|FG002|Overall Study|Adverse Event|0|||
156706478|NCT02015065|565670722|FG000|Overall Study|Death on study|1|||
156706479|NCT02015065|565670723|FG001|Overall Study|Death on study|2|||
156706480|NCT02015065|565670724|FG002|Overall Study|Death on study|1|||
156706481|NCT01292226|565670757|FG000|Overall Study|Adverse Event|5|||
156706482|NCT01292226|565670757|FG000|Overall Study|Death|1|||
156706483|NCT01292226|565670757|FG000|Overall Study|Graft loss|1|||
156706484|NCT01292226|565670757|FG000|Overall Study|Protocol Violation|3|||
156706485|NCT01292226|565670757|FG000|Overall Study|Withdrawal by Subject|1|||
156706486|NCT01292226|565670757|FG000|Overall Study|Other|2|||
156706487|NCT04106661|565670758|FG000|Overall Study|Protocol Violation|3|||
156706488|NCT04106661|565670759|FG001|Overall Study|Protocol Violation|0|||
156706489|NCT04106661|565670758|FG000|Overall Study|Scheduling difficulties|1|||
156706490|NCT04106661|565670759|FG001|Overall Study|Scheduling difficulties|1|||
156706491|NCT00233402|565670760|FG000|Overall Study|No pathology data|12|||
156706492|NCT00233402|565670761|FG001|Overall Study|No pathology data|9|||
156706493|NCT00233402|565670760|FG000|Overall Study|No Ta/T1|89|||
156706494|NCT00233402|565670761|FG001|Overall Study|No Ta/T1|94|||
156706495|NCT00233402|565670760|FG000|Overall Study|Lost to follow up etc|3|||
156706496|NCT00233402|565670761|FG001|Overall Study|Lost to follow up etc|21|||
156706497|NCT03280381|565670762|FG000|Overall Study|Physician Decision|0|||
156706498|NCT03280381|565670763|FG001|Overall Study|Physician Decision|2|||
156706499|NCT03503864|565670766|FG000|Overall Study|Protocol Violation|6|||
156706500|NCT03503864|565670766|FG000|Overall Study|Withdrawal by Subject|7|||
156706501|NCT00468650|565670767|FG000|Overall Study|Lost to Follow-up|4|||
156706502|NCT00468650|565670767|FG000|Overall Study|Withdrawal by Subject|2|||
156706503|NCT00468650|565670767|FG000|Overall Study|Protocol Violation|1|||
156706504|NCT00423319|565670768|FG000|Overall Study|Death|2|||
156706505|NCT00423319|565670769|FG001|Overall Study|Death|0|||
156706506|NCT00423319|565670768|FG000|Overall Study|Adverse Event|93|||
156706507|NCT00423319|565670769|FG001|Overall Study|Adverse Event|112|||
156706508|NCT00423319|565670768|FG000|Overall Study|Withdrawal by Subject|86|||
156706509|NCT00423319|565670769|FG001|Overall Study|Withdrawal by Subject|99|||
156706510|NCT00423319|565670768|FG000|Overall Study|Lost to Follow-up|4|||
156706511|NCT00423319|565670769|FG001|Overall Study|Lost to Follow-up|3|||
156706512|NCT00423319|565670768|FG000|Overall Study|Poor compliance or noncompliance|1|||
156706513|NCT00423319|565670769|FG001|Overall Study|Poor compliance or noncompliance|1|||
156706514|NCT00423319|565670768|FG000|Overall Study|No longer meets study criteria|15|||
156706515|NCT00423319|565670769|FG001|Overall Study|No longer meets study criteria|15|||
156706516|NCT00423319|565670768|FG000|Overall Study|Other|23|||
156706517|NCT00423319|565670769|FG001|Overall Study|Other|22|||
156706518|NCT02639052|565670770|FG000|Overall Study|Lost to Follow-up|1|||
156706519|NCT02655666|565670772|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
156706520|NCT00895414|565670773|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
156706521|NCT00895414|565670774|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
156706522|NCT00895414|565670773|FG000|First Intervention (14 Days)|Physician Decision|0|||
156706523|NCT00895414|565670774|FG001|First Intervention (14 Days)|Physician Decision|1|||
156706524|NCT00478426|565670775|FG000|Overall Study|Withdrawal by Subject|1|||
156706525|NCT00789737|565670780|FG000|Overall Study|Withdrawal by Subject|13|||
156706526|NCT00789737|565670781|FG001|Overall Study|Withdrawal by Subject|22|||
156706527|NCT00789737|565670780|FG000|Overall Study|Lost to Follow-up|10|||
156706528|NCT00789737|565670781|FG001|Overall Study|Lost to Follow-up|14|||
156706529|NCT00789737|565670780|FG000|Overall Study|Adverse Event|8|||
156706530|NCT00789737|565670781|FG001|Overall Study|Adverse Event|8|||
157125022|NCT01928381|567206358|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
157125023|NCT01928381|567206359|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156706531|NCT00789737|565670780|FG000|Overall Study|Protocol Violation|3|||
156706532|NCT00789737|565670781|FG001|Overall Study|Protocol Violation|0|||
157125024|NCT01928381|567206360|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156706533|NCT00789737|565670780|FG000|Overall Study|Lack of Efficacy|3|||
156706534|NCT00789737|565670781|FG001|Overall Study|Lack of Efficacy|0|||
156706535|NCT00789737|565670780|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
157125025|NCT01928381|567206361|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
156706536|NCT00789737|565670781|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
156706537|NCT00789737|565670780|FG000|Overall Study|Other|11|||
156706538|NCT00789737|565670781|FG001|Overall Study|Other|7|||
156706539|NCT01189487|565670782|FG000|Overall Study|Lack of Efficacy|2|||
156706540|NCT01189487|565670782|FG000|Overall Study|Adverse Event|1|||
156706541|NCT04630158|565670783|FG000|Overall Study|Adverse Event|1|||
156706542|NCT04630158|565670784|FG001|Overall Study|Adverse Event|1|||
156706543|NCT04630158|565670785|FG002|Overall Study|Adverse Event|1|||
156706544|NCT04630158|565670783|FG000|Overall Study|Physician Decision|0|||
156706545|NCT04630158|565670784|FG001|Overall Study|Physician Decision|2|||
156706546|NCT04630158|565670785|FG002|Overall Study|Physician Decision|0|||
156706547|NCT04630158|565670783|FG000|Overall Study|Protocol Violation|1|||
156706548|NCT04630158|565670784|FG001|Overall Study|Protocol Violation|0|||
156706549|NCT04630158|565670785|FG002|Overall Study|Protocol Violation|1|||
156706550|NCT04630158|565670783|FG000|Overall Study|Withdrawal by Subject|2|||
156706551|NCT04630158|565670784|FG001|Overall Study|Withdrawal by Subject|1|||
156706552|NCT04630158|565670785|FG002|Overall Study|Withdrawal by Subject|2|||
156706553|NCT03136965|565670789|FG000|Overall Study|Lost to Follow-up|0|||
156706554|NCT03136965|565670790|FG001|Overall Study|Lost to Follow-up|1|||
156706555|NCT03136965|565670791|FG002|Overall Study|Lost to Follow-up|0|||
156706556|NCT01210612|565670793|FG000|Overall Study|Withdrawal by Subject|0|||
156706557|NCT01210612|565670794|FG001|Overall Study|Withdrawal by Subject|2|||
156706558|NCT02752087|565670795|FG000|Washout|Physician Decision|1|||
156706559|NCT02752087|565670796|FG001|Washout|Physician Decision|0|||
156706560|NCT02458287|565670797|FG000|Overall Study|Adverse Event|0|||
156706561|NCT02458287|565670798|FG001|Overall Study|Adverse Event|0|||
156706562|NCT02458287|565670799|FG002|Overall Study|Adverse Event|0|||
156706563|NCT02458287|565670800|FG003|Overall Study|Adverse Event|1|||
156706564|NCT02458287|565670797|FG000|Overall Study|Lost to Follow-up|0|||
156706565|NCT02458287|565670798|FG001|Overall Study|Lost to Follow-up|1|||
156706566|NCT02458287|565670799|FG002|Overall Study|Lost to Follow-up|1|||
156706567|NCT02458287|565670800|FG003|Overall Study|Lost to Follow-up|0|||
156706568|NCT02458287|565670797|FG000|Overall Study|Protocol Violation|0|||
156706569|NCT02458287|565670798|FG001|Overall Study|Protocol Violation|1|||
156706570|NCT02458287|565670799|FG002|Overall Study|Protocol Violation|0|||
156706571|NCT02458287|565670800|FG003|Overall Study|Protocol Violation|0|||
156706572|NCT02458287|565670797|FG000|Overall Study|Withdrawal by Subject|0|||
156706573|NCT02458287|565670798|FG001|Overall Study|Withdrawal by Subject|2|||
156706574|NCT02458287|565670799|FG002|Overall Study|Withdrawal by Subject|2|||
156706575|NCT02458287|565670800|FG003|Overall Study|Withdrawal by Subject|1|||
156706576|NCT02458287|565670797|FG000|Overall Study|Relocated Out of State|0|||
156706577|NCT02458287|565670798|FG001|Overall Study|Relocated Out of State|0|||
156706578|NCT02458287|565670799|FG002|Overall Study|Relocated Out of State|0|||
156706579|NCT02458287|565670800|FG003|Overall Study|Relocated Out of State|1|||
156706580|NCT00843635|565670801|FG000|Overall Study|Adverse Event|2|||
156706581|NCT00843635|565670802|FG001|Overall Study|Adverse Event|2|||
156706582|NCT00843635|565670803|FG002|Overall Study|Adverse Event|0|||
156706583|NCT02290223|565670804|FG000|6 Months|Lost to Follow-up|9|||
156706584|NCT02290223|565670805|FG001|6 Months|Lost to Follow-up|6|||
156706585|NCT02290223|565670804|FG000|6 Months|Withdrawal by Subject|5|||
156706586|NCT02290223|565670805|FG001|6 Months|Withdrawal by Subject|0|||
156706587|NCT02290223|565670804|FG000|6 Months|deceased (not related to study)|2|||
156706588|NCT02290223|565670805|FG001|6 Months|deceased (not related to study)|0|||
156706589|NCT02290223|565670804|FG000|12 Months|Lost to Follow-up|16|||
156706590|NCT02290223|565670805|FG001|12 Months|Lost to Follow-up|10|||
156706591|NCT02290223|565670804|FG000|12 Months|Refusal|0|||
156706592|NCT02290223|565670805|FG001|12 Months|Refusal|1|||
156706593|NCT05293639|565670806|FG000|Overall Study|Withdrawal by Subject|1|||
156706594|NCT05293639|565670807|FG001|Overall Study|Withdrawal by Subject|1|||
156706595|NCT05293639|565670808|FG002|Overall Study|Withdrawal by Subject|2|||
156706596|NCT05293639|565670806|FG000|Overall Study|Death|0|||
156706597|NCT05293639|565670807|FG001|Overall Study|Death|1|||
156706598|NCT05293639|565670808|FG002|Overall Study|Death|0|||
156706599|NCT05293639|565670806|FG000|Overall Study|Lost to Follow-up|0|||
156706600|NCT05293639|565670807|FG001|Overall Study|Lost to Follow-up|0|||
156706601|NCT05293639|565670808|FG002|Overall Study|Lost to Follow-up|5|||
156706602|NCT05293639|565670806|FG000|Overall Study|Other|0|||
156706603|NCT05293639|565670807|FG001|Overall Study|Other|0|||
156706604|NCT05293639|565670808|FG002|Overall Study|Other|1|||
156706605|NCT00813800|565670812|FG000|Overall Study|Screen Failure after Consent|2|||
156706606|NCT00813800|565670812|FG000|Overall Study|Adverse Event|1|||
156706607|NCT00813800|565670812|FG000|Overall Study|Worsening of depression|2|||
156706608|NCT00813800|565670812|FG000|Overall Study|Physician Decision|1|||
156706609|NCT01860677|565670813|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
156706610|NCT01860677|565670814|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
157125026|NCT01928381|567206362|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
157125027|NCT01928381|567206356|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
156706611|NCT00418821|565670816|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
156706612|NCT02823652|565670817|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
156706613|NCT02823652|565670818|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
156706614|NCT02823652|565670819|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
156706615|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
156706616|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
156706617|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
156706618|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
156706619|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
156706620|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
156706621|NCT02823652|565670817|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
156706622|NCT02823652|565670818|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
157215559|NCT00566098|567537331|FG000|Administration of ASCT+MILs|Death|10|||
156706623|NCT02823652|565670819|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
157215560|NCT00566098|567537331|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
157215561|NCT01690520|567537332|FG000|Overall Study|Death|25|||
157215562|NCT01690520|567537333|FG001|Overall Study|Death|21|||
157215563|NCT01690520|567537332|FG000|Overall Study|Lost to Follow-up|2|||
157215564|NCT01690520|567537333|FG001|Overall Study|Lost to Follow-up|3|||
157215565|NCT01690520|567537332|FG000|Overall Study|Withdrawal by Subject|2|||
157215566|NCT01690520|567537333|FG001|Overall Study|Withdrawal by Subject|0|||
157215567|NCT01690520|567537332|FG000|Overall Study|Relapse|0|||
156706624|NCT03155945|565670820|FG000|Overall Study|Lost to Follow-up|0|||
156706625|NCT03155945|565670821|FG001|Overall Study|Lost to Follow-up|1|||
156706626|NCT03155945|565670820|FG000|Overall Study|Withdrawal by Subject|0|||
157215568|NCT01690520|567537333|FG001|Overall Study|Relapse|1|||
156706627|NCT03155945|565670821|FG001|Overall Study|Withdrawal by Subject|1|||
156706628|NCT03155945|565670820|FG000|Overall Study|Other Reason|0|||
156706629|NCT03155945|565670821|FG001|Overall Study|Other Reason|1|||
156706630|NCT02013674|565670822|FG000|Overall Study|Death|0|||
156706631|NCT02013674|565670823|FG001|Overall Study|Death|1|||
156706632|NCT02013674|565670822|FG000|Overall Study|Lost to Follow-up|1|||
156706633|NCT02013674|565670823|FG001|Overall Study|Lost to Follow-up|0|||
156706634|NCT03408639|565673143|FG000|Overall Study|Death|5|||
156706635|NCT03408639|565673144|FG001|Overall Study|Death|5|||
156706636|NCT03408639|565673143|FG000|Overall Study|Lost to Follow-up|1|||
156706637|NCT03408639|565673144|FG001|Overall Study|Lost to Follow-up|4|||
156706638|NCT03408639|565673143|FG000|Overall Study|Withdrawal by Subject|2|||
156706639|NCT03408639|565673144|FG001|Overall Study|Withdrawal by Subject|7|||
156706640|NCT03408639|565673143|FG000|Overall Study|Physician Decision|3|||
156706641|NCT03408639|565673144|FG001|Overall Study|Physician Decision|6|||
156706642|NCT01924754|565673153|FG000|Overall Study|Lost to Follow-up|1|||
156706643|NCT01924754|565673154|FG001|Overall Study|Lost to Follow-up|2|||
156706644|NCT01924754|565673155|FG002|Overall Study|Lost to Follow-up|1|||
156706645|NCT01924754|565673153|FG000|Overall Study|Pregnancy|0|||
156706646|NCT01924754|565673154|FG001|Overall Study|Pregnancy|1|||
156706647|NCT01924754|565673155|FG002|Overall Study|Pregnancy|2|||
156706648|NCT03132155|565673156|FG000|Overall Study|Lack of Efficacy|6|||
156706649|NCT03132155|565673156|FG000|Overall Study|Lost to Follow-up|1|||
156706650|NCT03132155|565673156|FG000|Overall Study|Withdrawal by Subject|1|||
156706651|NCT02925403|565673159|FG000|Overall Study|Lost to Follow-up|0|||
156706652|NCT02925403|565673160|FG001|Overall Study|Lost to Follow-up|1|||
156706653|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
156706654|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
156706655|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
156706656|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
156706657|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
156706658|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
156706659|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
156706660|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
156706661|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
156706662|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
156706663|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
156706664|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
156706665|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
156706666|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
156706667|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
156706668|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
156706669|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
156706670|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
156706671|NCT00261443|565673161|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
156791178|NCT02413346|565987192|FG000|Overall Study|Adverse Event|6|||
156791179|NCT02413346|565987193|FG001|Overall Study|Adverse Event|6|||
157215569|NCT01690520|567537332|FG000|Overall Study|Other|0|||
156706672|NCT00261443|565673162|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
156706673|NCT00261443|565673163|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
156706674|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
156706675|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
156706676|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
156706677|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
156706678|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
157215570|NCT01690520|567537333|FG001|Overall Study|Other|1|||
156706679|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
156706680|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
156706681|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
156791180|NCT02413346|565987192|FG000|Overall Study|Withdrawal by Subject|30|||
157215571|NCT01690520|567537332|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
156791181|NCT02413346|565987193|FG001|Overall Study|Withdrawal by Subject|40|||
157015849|NCT03725722|566811128|FG003|Overall Study|Personal reasons|0|||
156706682|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
156706683|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
156706684|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
156706685|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
156706686|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
156706687|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
156706688|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
156706689|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
156706690|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
156706691|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
156706692|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
156706693|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
156706694|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
156706695|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
156706696|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
156706697|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
156706698|NCT00261443|565673161|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
156706699|NCT00261443|565673162|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
156706700|NCT00261443|565673163|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
156706701|NCT00261443|565673161|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
156706702|NCT00261443|565673162|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
156706703|NCT00261443|565673163|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
156706704|NCT00261443|565673161|FG000|3: Assessment of Relapse|Adverse Event|0|||
156706705|NCT00261443|565673162|FG001|3: Assessment of Relapse|Adverse Event|15|||
156706706|NCT00261443|565673163|FG002|3: Assessment of Relapse|Adverse Event|19|||
156706707|NCT00261443|565673161|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
156706708|NCT00261443|565673162|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
156706709|NCT00261443|565673163|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
156706710|NCT00261443|565673161|FG000|3: Assessment of Relapse|Death|0|||
156706711|NCT00261443|565673162|FG001|3: Assessment of Relapse|Death|0|||
156706712|NCT00261443|565673163|FG002|3: Assessment of Relapse|Death|1|||
156706713|NCT00261443|565673161|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
156706714|NCT00261443|565673162|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
156706715|NCT00261443|565673163|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
156706716|NCT00261443|565673161|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
156706717|NCT00261443|565673162|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
156706718|NCT00261443|565673163|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
156706719|NCT00261443|565673161|FG000|3: Assessment of Relapse|Pregnancy|0|||
156706720|NCT00261443|565673162|FG001|3: Assessment of Relapse|Pregnancy|2|||
156706721|NCT00261443|565673163|FG002|3: Assessment of Relapse|Pregnancy|1|||
156706722|NCT00261443|565673161|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
156706723|NCT00261443|565673162|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
156706724|NCT00261443|565673163|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
156706725|NCT00261443|565673161|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
156706726|NCT00261443|565673162|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
156706727|NCT00261443|565673163|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
156706728|NCT00261443|565673161|FG000|3: Assessment of Relapse|Other Reasons|0|||
156706729|NCT00261443|565673162|FG001|3: Assessment of Relapse|Other Reasons|4|||
156706730|NCT00261443|565673163|FG002|3: Assessment of Relapse|Other Reasons|3|||
156706731|NCT00261443|565673161|FG000|4: Extension Phase|Adverse Event|0|||
156706732|NCT00261443|565673162|FG001|4: Extension Phase|Adverse Event|1|||
156706733|NCT00261443|565673163|FG002|4: Extension Phase|Adverse Event|0|||
156706734|NCT00261443|565673161|FG000|4: Extension Phase|Withdrawal by Subject|0|||
156706735|NCT00261443|565673162|FG001|4: Extension Phase|Withdrawal by Subject|1|||
156706736|NCT00261443|565673163|FG002|4: Extension Phase|Withdrawal by Subject|2|||
156706737|NCT00261443|565673161|FG000|4: Extension Phase|Lost to Follow-up|0|||
156706738|NCT00261443|565673162|FG001|4: Extension Phase|Lost to Follow-up|1|||
156706739|NCT00261443|565673163|FG002|4: Extension Phase|Lost to Follow-up|0|||
156706740|NCT02755649|565673164|FG000|Overall Study|Transitioned into OLE study|99|||
156706741|NCT02755649|565673165|FG001|Overall Study|Transitioned into OLE study|98|||
157015850|NCT03725722|566811129|FG004|Overall Study|Personal reasons|1|||
157015851|NCT03725722|566811125|FG000|Overall Study|COVID-19 situation|0|||
157015852|NCT03725722|566811126|FG001|Overall Study|COVID-19 situation|1|||
157015853|NCT03725722|566811127|FG002|Overall Study|COVID-19 situation|0|||
157015854|NCT03725722|566811128|FG003|Overall Study|COVID-19 situation|0|||
157015855|NCT03725722|566811129|FG004|Overall Study|COVID-19 situation|0|||
156791182|NCT02413346|565987192|FG000|Overall Study|Lost to Follow-up|17|||
156791183|NCT02413346|565987193|FG001|Overall Study|Lost to Follow-up|21|||
157015856|NCT01259401|566811133|FG000|4-month Follow-up|Death|0|||
156706742|NCT02755649|565673166|FG002|Overall Study|Transitioned into OLE study|100|||
156706743|NCT02755649|565673164|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
156706744|NCT02755649|565673165|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
156706745|NCT02755649|565673166|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
156706746|NCT02755649|565673164|FG000|Overall Study|Physician Decision|0|||
156706747|NCT02755649|565673165|FG001|Overall Study|Physician Decision|0|||
156706748|NCT02755649|565673166|FG002|Overall Study|Physician Decision|2|||
156706749|NCT02755649|565673164|FG000|Overall Study|Withdrawal by Subject|0|||
156706750|NCT02755649|565673165|FG001|Overall Study|Withdrawal by Subject|1|||
156706751|NCT02755649|565673166|FG002|Overall Study|Withdrawal by Subject|0|||
156706752|NCT02755649|565673164|FG000|Overall Study|Undecided|1|||
156706753|NCT02755649|565673165|FG001|Overall Study|Undecided|0|||
156706754|NCT02755649|565673166|FG002|Overall Study|Undecided|0|||
156706755|NCT01286753|565673167|FG000|Overall Study|Adverse Event|7|||
156706756|NCT01286753|565673168|FG001|Overall Study|Adverse Event|6|||
156706757|NCT01286753|565673167|FG000|Overall Study|Progression|11|||
156706758|NCT01286753|565673168|FG001|Overall Study|Progression|13|||
156706759|NCT01286753|565673167|FG000|Overall Study|Refused Treatment|1|||
156706760|NCT01286753|565673168|FG001|Overall Study|Refused Treatment|0|||
156706761|NCT01286753|565673167|FG000|Overall Study|Withdrawal of Consent|0|||
156706762|NCT01286753|565673168|FG001|Overall Study|Withdrawal of Consent|2|||
156706763|NCT01286753|565673167|FG000|Overall Study|Discontinued to Join Extension Study|6|||
156706764|NCT01286753|565673168|FG001|Overall Study|Discontinued to Join Extension Study|4|||
156706765|NCT01286753|565673167|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
156706766|NCT01286753|565673168|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
156706767|NCT02126826|565673172|FG000|Overall Study|Withdrawal by Subject|0|||
156706768|NCT02126826|565673173|FG001|Overall Study|Withdrawal by Subject|0|||
156706769|NCT02126826|565673174|FG002|Overall Study|Withdrawal by Subject|0|||
156706770|NCT02126826|565673175|FG003|Overall Study|Withdrawal by Subject|1|||
156706771|NCT02126826|565673176|FG004|Overall Study|Withdrawal by Subject|0|||
156706772|NCT02126826|565673177|FG005|Overall Study|Withdrawal by Subject|0|||
156706773|NCT02126826|565673178|FG006|Overall Study|Withdrawal by Subject|0|||
156706774|NCT01371747|565673179|FG000|Overall Study|Adverse Event|4|||
156706775|NCT01371747|565673180|FG001|Overall Study|Adverse Event|2|||
156706776|NCT01371747|565673181|FG002|Overall Study|Adverse Event|7|||
156706777|NCT01371747|565673182|FG003|Overall Study|Adverse Event|2|||
156706778|NCT01371747|565673183|FG004|Overall Study|Adverse Event|2|||
156706779|NCT01371747|565673184|FG005|Overall Study|Adverse Event|2|||
156706780|NCT01371747|565673179|FG000|Overall Study|Death|1|||
156706781|NCT01371747|565673180|FG001|Overall Study|Death|0|||
156706782|NCT01371747|565673181|FG002|Overall Study|Death|4|||
156706783|NCT01371747|565673182|FG003|Overall Study|Death|1|||
156706784|NCT01371747|565673183|FG004|Overall Study|Death|2|||
156706785|NCT01371747|565673184|FG005|Overall Study|Death|0|||
156706786|NCT01371747|565673179|FG000|Overall Study|Abnormal Renal Function|0|||
156706787|NCT01371747|565673180|FG001|Overall Study|Abnormal Renal Function|2|||
156706788|NCT01371747|565673181|FG002|Overall Study|Abnormal Renal Function|0|||
156706789|NCT01371747|565673182|FG003|Overall Study|Abnormal Renal Function|1|||
156706790|NCT01371747|565673183|FG004|Overall Study|Abnormal Renal Function|0|||
156706791|NCT01371747|565673184|FG005|Overall Study|Abnormal Renal Function|1|||
156706792|NCT01371747|565673179|FG000|Overall Study|High Serum Potassium Results|1|||
156706793|NCT01371747|565673180|FG001|Overall Study|High Serum Potassium Results|1|||
156706794|NCT01371747|565673181|FG002|Overall Study|High Serum Potassium Results|1|||
156706795|NCT01371747|565673182|FG003|Overall Study|High Serum Potassium Results|2|||
156706796|NCT01371747|565673183|FG004|Overall Study|High Serum Potassium Results|0|||
156706797|NCT01371747|565673184|FG005|Overall Study|High Serum Potassium Results|2|||
156706798|NCT01371747|565673179|FG000|Overall Study|Low Serum Potassium Results|1|||
156706799|NCT01371747|565673180|FG001|Overall Study|Low Serum Potassium Results|1|||
157125028|NCT01928381|567206357|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
157125029|NCT01928381|567206358|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
157125030|NCT01928381|567206359|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
157125031|NCT01928381|567206360|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
157125032|NCT01928381|567206361|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
156706800|NCT01371747|565673181|FG002|Overall Study|Low Serum Potassium Results|1|||
156706801|NCT01371747|565673182|FG003|Overall Study|Low Serum Potassium Results|1|||
156706802|NCT01371747|565673183|FG004|Overall Study|Low Serum Potassium Results|0|||
156706803|NCT01371747|565673184|FG005|Overall Study|Low Serum Potassium Results|3|||
156706804|NCT01371747|565673179|FG000|Overall Study|Protocol Violation|0|||
156706805|NCT01371747|565673180|FG001|Overall Study|Protocol Violation|0|||
156706806|NCT01371747|565673181|FG002|Overall Study|Protocol Violation|1|||
156706807|NCT01371747|565673182|FG003|Overall Study|Protocol Violation|0|||
156706808|NCT01371747|565673183|FG004|Overall Study|Protocol Violation|0|||
156706809|NCT01371747|565673184|FG005|Overall Study|Protocol Violation|0|||
156706810|NCT01371747|565673179|FG000|Overall Study|Non-Compliance|3|||
156872193|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
156706811|NCT01371747|565673180|FG001|Overall Study|Non-Compliance|4|||
156706812|NCT01371747|565673181|FG002|Overall Study|Non-Compliance|3|||
156706813|NCT01371747|565673182|FG003|Overall Study|Non-Compliance|0|||
156706814|NCT01371747|565673183|FG004|Overall Study|Non-Compliance|0|||
156706815|NCT01371747|565673184|FG005|Overall Study|Non-Compliance|1|||
156706816|NCT01371747|565673179|FG000|Overall Study|Physician Decision|0|||
156706817|NCT01371747|565673180|FG001|Overall Study|Physician Decision|0|||
156706818|NCT01371747|565673181|FG002|Overall Study|Physician Decision|0|||
156706819|NCT01371747|565673182|FG003|Overall Study|Physician Decision|0|||
156706820|NCT01371747|565673183|FG004|Overall Study|Physician Decision|1|||
156706821|NCT01371747|565673184|FG005|Overall Study|Physician Decision|0|||
156706822|NCT01371747|565673179|FG000|Overall Study|Withdrawal by Subject|6|||
156706823|NCT01371747|565673180|FG001|Overall Study|Withdrawal by Subject|12|||
156706824|NCT01371747|565673181|FG002|Overall Study|Withdrawal by Subject|5|||
156706825|NCT01371747|565673182|FG003|Overall Study|Withdrawal by Subject|2|||
156706826|NCT01371747|565673183|FG004|Overall Study|Withdrawal by Subject|2|||
156706827|NCT01371747|565673184|FG005|Overall Study|Withdrawal by Subject|4|||
156706828|NCT01371747|565673179|FG000|Overall Study|Other Reasons|2|||
156706829|NCT01371747|565673180|FG001|Overall Study|Other Reasons|1|||
156706830|NCT01371747|565673181|FG002|Overall Study|Other Reasons|2|||
156706831|NCT01371747|565673182|FG003|Overall Study|Other Reasons|0|||
156706832|NCT01371747|565673183|FG004|Overall Study|Other Reasons|0|||
156706833|NCT01371747|565673184|FG005|Overall Study|Other Reasons|1|||
156706834|NCT03092219|565673185|FG000|Overall Study|Protocol Violation|7|||
156706835|NCT03092219|565673186|FG001|Overall Study|Protocol Violation|4|||
156706836|NCT03278626|565673189|FG000|Overall Study|Death|2|||
156706837|NCT03278626|565673189|FG000|Overall Study|Toxicity|1|||
156706838|NCT03278626|565673189|FG000|Overall Study|Disease Progression|2|||
156706839|NCT02856555|565673190|FG000|Overall Study|Adverse Event|1|||
156706840|NCT02856555|565673191|FG001|Overall Study|Adverse Event|0|||
156706841|NCT02856555|565673192|FG002|Overall Study|Adverse Event|0|||
156706842|NCT02856555|565673190|FG000|Overall Study|Lost to Follow-up|1|||
156706843|NCT02856555|565673191|FG001|Overall Study|Lost to Follow-up|3|||
156706844|NCT02856555|565673192|FG002|Overall Study|Lost to Follow-up|0|||
156706845|NCT02856555|565673190|FG000|Overall Study|Withdrawal by Subject|3|||
156706846|NCT02856555|565673191|FG001|Overall Study|Withdrawal by Subject|0|||
156706847|NCT02856555|565673192|FG002|Overall Study|Withdrawal by Subject|0|||
156706848|NCT02856555|565673190|FG000|Overall Study|Randomized but Never Treated|0|||
156706849|NCT02856555|565673191|FG001|Overall Study|Randomized but Never Treated|1|||
156706850|NCT02856555|565673192|FG002|Overall Study|Randomized but Never Treated|0|||
156706851|NCT05013008|565673193|FG000|Overall Study|Exclusion from mBFAS|5|||
156706852|NCT05013008|565673194|FG001|Overall Study|Exclusion from mBFAS|25|||
156706853|NCT02842073|565673195|FG000|Overall Study|Withdrawal by Subject|1|||
156706854|NCT01333397|565673198|FG000|Overall Study|Lost to Follow-up|1|||
156706855|NCT01333397|565673199|FG001|Overall Study|Lost to Follow-up|0|||
156706856|NCT01333397|565673200|FG002|Overall Study|Lost to Follow-up|0|||
156706857|NCT01333397|565673201|FG003|Overall Study|Lost to Follow-up|1|||
156706858|NCT01333397|565673202|FG004|Overall Study|Lost to Follow-up|0|||
156706859|NCT02460679|565673203|FG000|Overall Study|Investigator Decision|1|||
156706860|NCT02460679|565673203|FG000|Overall Study|Withdrawal by Subject|4|||
156706861|NCT01994850|565673213|FG000|Overall Study|Physician Decision|1|||
156706862|NCT01994850|565673213|FG000|Overall Study|Withdrawal by Subject|1|||
156706863|NCT02785952|565673221|FG000|Overall Study|Adverse Event|31|||
156706864|NCT02785952|565673222|FG001|Overall Study|Adverse Event|19|||
156706865|NCT02785952|565673221|FG000|Overall Study|Refusal unrelated to adverse events|10|||
156706866|NCT02785952|565673222|FG001|Overall Study|Refusal unrelated to adverse events|5|||
156706867|NCT02785952|565673221|FG000|Overall Study|Disease progression/relapse|61|||
156706868|NCT02785952|565673222|FG001|Overall Study|Disease progression/relapse|89|||
156706869|NCT02785952|565673221|FG000|Overall Study|Death|11|||
156706870|NCT02785952|565673222|FG001|Overall Study|Death|7|||
156706871|NCT02785952|565673221|FG000|Overall Study|Other- not protocol specified|6|||
156706872|NCT02785952|565673222|FG001|Overall Study|Other- not protocol specified|4|||
157145167|NCT05755438|567278013|FG001|40-week OLE Period|Physician Decision|1|||
156706873|NCT02785952|565673221|FG000|Overall Study|On protocol treatment|6|||
156706874|NCT02785952|565673222|FG001|Overall Study|On protocol treatment|3|||
156706875|NCT00642278|565673225|FG000|Overall Study|Adverse Event|2|||
156706876|NCT00642278|565673226|FG001|Overall Study|Adverse Event|1|||
156706877|NCT00642278|565673227|FG002|Overall Study|Adverse Event|3|||
156706878|NCT00642278|565673228|FG003|Overall Study|Adverse Event|1|||
156706879|NCT00642278|565673229|FG004|Overall Study|Adverse Event|2|||
156706880|NCT00642278|565673230|FG005|Overall Study|Adverse Event|2|||
156706881|NCT00642278|565673231|FG006|Overall Study|Adverse Event|0|||
156706882|NCT00642278|565673225|FG000|Overall Study|Lack of Efficacy|0|||
156706883|NCT00642278|565673226|FG001|Overall Study|Lack of Efficacy|1|||
156706884|NCT00642278|565673227|FG002|Overall Study|Lack of Efficacy|0|||
156706885|NCT00642278|565673228|FG003|Overall Study|Lack of Efficacy|0|||
156706886|NCT00642278|565673229|FG004|Overall Study|Lack of Efficacy|0|||
156706887|NCT00642278|565673230|FG005|Overall Study|Lack of Efficacy|0|||
156706888|NCT00642278|565673231|FG006|Overall Study|Lack of Efficacy|0|||
156706889|NCT00642278|565673225|FG000|Overall Study|Lost to Follow-up|5|||
156706890|NCT00642278|565673226|FG001|Overall Study|Lost to Follow-up|1|||
156706891|NCT00642278|565673227|FG002|Overall Study|Lost to Follow-up|0|||
156706892|NCT00642278|565673228|FG003|Overall Study|Lost to Follow-up|1|||
157125033|NCT01928381|567206362|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
157125034|NCT01928381|567206356|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
157125035|NCT01928381|567206357|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
156706893|NCT00642278|565673229|FG004|Overall Study|Lost to Follow-up|0|||
156706894|NCT00642278|565673230|FG005|Overall Study|Lost to Follow-up|1|||
156706895|NCT00642278|565673231|FG006|Overall Study|Lost to Follow-up|1|||
156706896|NCT00642278|565673225|FG000|Overall Study|Physician Decision|0|||
156706897|NCT00642278|565673226|FG001|Overall Study|Physician Decision|0|||
156706898|NCT00642278|565673227|FG002|Overall Study|Physician Decision|0|||
156706899|NCT00642278|565673228|FG003|Overall Study|Physician Decision|1|||
156706900|NCT00642278|565673229|FG004|Overall Study|Physician Decision|0|||
156706901|NCT00642278|565673230|FG005|Overall Study|Physician Decision|0|||
156706902|NCT00642278|565673231|FG006|Overall Study|Physician Decision|0|||
156706903|NCT00642278|565673225|FG000|Overall Study|Protocol Violation|0|||
156706904|NCT00642278|565673226|FG001|Overall Study|Protocol Violation|0|||
156706905|NCT00642278|565673227|FG002|Overall Study|Protocol Violation|1|||
156706906|NCT00642278|565673228|FG003|Overall Study|Protocol Violation|1|||
156706907|NCT00642278|565673229|FG004|Overall Study|Protocol Violation|0|||
156706908|NCT00642278|565673230|FG005|Overall Study|Protocol Violation|1|||
156706909|NCT00642278|565673231|FG006|Overall Study|Protocol Violation|2|||
156706910|NCT00642278|565673225|FG000|Overall Study|Withdrawal by Subject|1|||
156706911|NCT00642278|565673226|FG001|Overall Study|Withdrawal by Subject|1|||
156706912|NCT00642278|565673227|FG002|Overall Study|Withdrawal by Subject|1|||
156706913|NCT00642278|565673228|FG003|Overall Study|Withdrawal by Subject|3|||
156706914|NCT00642278|565673229|FG004|Overall Study|Withdrawal by Subject|6|||
156706915|NCT00642278|565673230|FG005|Overall Study|Withdrawal by Subject|2|||
156706916|NCT00642278|565673231|FG006|Overall Study|Withdrawal by Subject|2|||
156706917|NCT00642278|565673225|FG000|Overall Study|Noncompliance with study drug regimen|0|||
156706918|NCT00642278|565673226|FG001|Overall Study|Noncompliance with study drug regimen|0|||
156706919|NCT00642278|565673227|FG002|Overall Study|Noncompliance with study drug regimen|0|||
156706920|NCT00642278|565673228|FG003|Overall Study|Noncompliance with study drug regimen|1|||
156706921|NCT00642278|565673229|FG004|Overall Study|Noncompliance with study drug regimen|0|||
156706922|NCT00642278|565673230|FG005|Overall Study|Noncompliance with study drug regimen|0|||
156706923|NCT00642278|565673231|FG006|Overall Study|Noncompliance with study drug regimen|0|||
156706924|NCT00642278|565673225|FG000|Overall Study|Other|2|||
156706925|NCT00642278|565673226|FG001|Overall Study|Other|1|||
156706926|NCT00642278|565673227|FG002|Overall Study|Other|0|||
156706927|NCT00642278|565673228|FG003|Overall Study|Other|1|||
156706928|NCT00642278|565673229|FG004|Overall Study|Other|0|||
156706929|NCT00642278|565673230|FG005|Overall Study|Other|1|||
156706930|NCT00642278|565673231|FG006|Overall Study|Other|0|||
156706931|NCT00090363|565673232|FG000|Overall Study|Lost to Follow-up|1|||
156706932|NCT00090363|565673233|FG001|Overall Study|Lost to Follow-up|2|||
156706933|NCT00090363|565673234|FG002|Overall Study|Lost to Follow-up|1|||
156706934|NCT00090363|565673232|FG000|Overall Study|Withdrawal by Subject|7|||
156706935|NCT00090363|565673233|FG001|Overall Study|Withdrawal by Subject|7|||
157125036|NCT01928381|567206358|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
157125037|NCT01928381|567206359|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
156706936|NCT00090363|565673234|FG002|Overall Study|Withdrawal by Subject|6|||
156706937|NCT00090363|565673232|FG000|Overall Study|Study-specific discontinuation criteria|75|||
156706938|NCT00090363|565673233|FG001|Overall Study|Study-specific discontinuation criteria|74|||
156706939|NCT00090363|565673234|FG002|Overall Study|Study-specific discontinuation criteria|62|||
156706940|NCT00090363|565673232|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156706941|NCT00090363|565673233|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156706942|NCT00090363|565673234|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156706943|NCT00090363|565673232|FG000|Overall Study|Consent expired|7|||
156706944|NCT00090363|565673233|FG001|Overall Study|Consent expired|10|||
156706945|NCT00090363|565673234|FG002|Overall Study|Consent expired|9|||
156706946|NCT00090363|565673232|FG000|Overall Study|Reasons not specified|2|||
156706947|NCT00090363|565673233|FG001|Overall Study|Reasons not specified|1|||
156706948|NCT00090363|565673234|FG002|Overall Study|Reasons not specified|1|||
156706949|NCT00090363|565673232|FG000|Overall Study|Continuing on study off treatment|14|||
156706950|NCT00090363|565673233|FG001|Overall Study|Continuing on study off treatment|13|||
156706951|NCT00090363|565673234|FG002|Overall Study|Continuing on study off treatment|16|||
156706952|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156706953|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706954|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
156706955|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706956|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156706957|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
156706958|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156706959|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156706960|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156706961|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156706962|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706963|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706964|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
156706965|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
156706966|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
156706967|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156706968|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706969|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706970|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706971|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156706972|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
156706973|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
156706974|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
156706975|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156706976|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156706977|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706978|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706979|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
156706980|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706981|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
156706982|NCT03713619|565673237|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
156706983|NCT03713619|565673238|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
156706984|NCT03713619|565673239|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706985|NCT03713619|565673240|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706986|NCT03713619|565673241|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
156706987|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
156706988|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
156706989|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
156706990|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
156706991|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
156706992|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156706993|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706994|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706995|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156706996|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156706997|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
156706998|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
156706999|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
156707000|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
156707001|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
156707002|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
156707003|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
156707004|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
156707005|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
156707006|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
156707007|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
156707008|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
156707009|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156707010|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
156707011|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
156707012|NCT03713619|565673237|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156707013|NCT03713619|565673238|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156707014|NCT03713619|565673239|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156707015|NCT03713619|565673240|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156707016|NCT03713619|565673241|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156707017|NCT04642365|565673243|FG000|Overall Study|Death|3|||
156707018|NCT04642365|565673244|FG001|Overall Study|Death|2|||
156707019|NCT04642365|565673245|FG002|Overall Study|Death|4|||
156707020|NCT04642365|565673246|FG003|Overall Study|Death|5|||
156707021|NCT04642365|565673247|FG004|Overall Study|Death|5|||
156707022|NCT04642365|565673248|FG005|Overall Study|Death|3|||
156707023|NCT04642365|565673249|FG006|Overall Study|Death|2|||
156707024|NCT04642365|565673250|FG007|Overall Study|Death|1|||
156707025|NCT04642365|565673243|FG000|Overall Study|Physician Decision|1|||
156707026|NCT04642365|565673244|FG001|Overall Study|Physician Decision|0|||
156707027|NCT04642365|565673245|FG002|Overall Study|Physician Decision|0|||
156707028|NCT04642365|565673246|FG003|Overall Study|Physician Decision|0|||
157125038|NCT01928381|567206360|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
156707029|NCT04642365|565673247|FG004|Overall Study|Physician Decision|0|||
156707030|NCT04642365|565673248|FG005|Overall Study|Physician Decision|0|||
156707031|NCT04642365|565673249|FG006|Overall Study|Physician Decision|0|||
156707032|NCT04642365|565673250|FG007|Overall Study|Physician Decision|0|||
156707033|NCT04642365|565673243|FG000|Overall Study|Progressive Disease|1|||
156707034|NCT04642365|565673244|FG001|Overall Study|Progressive Disease|1|||
156707035|NCT04642365|565673245|FG002|Overall Study|Progressive Disease|1|||
156707036|NCT04642365|565673246|FG003|Overall Study|Progressive Disease|0|||
156707037|NCT04642365|565673247|FG004|Overall Study|Progressive Disease|0|||
156707038|NCT04642365|565673248|FG005|Overall Study|Progressive Disease|0|||
156707039|NCT04642365|565673249|FG006|Overall Study|Progressive Disease|1|||
156707040|NCT04642365|565673250|FG007|Overall Study|Progressive Disease|0|||
156707041|NCT04642365|565673243|FG000|Overall Study|Study Terminated By Sponsor|0|||
156707042|NCT04642365|565673244|FG001|Overall Study|Study Terminated By Sponsor|2|||
156707043|NCT04642365|565673245|FG002|Overall Study|Study Terminated By Sponsor|1|||
156707044|NCT04642365|565673246|FG003|Overall Study|Study Terminated By Sponsor|1|||
156707045|NCT04642365|565673247|FG004|Overall Study|Study Terminated By Sponsor|1|||
156707046|NCT04642365|565673248|FG005|Overall Study|Study Terminated By Sponsor|2|||
156707047|NCT04642365|565673249|FG006|Overall Study|Study Terminated By Sponsor|2|||
156707048|NCT04642365|565673250|FG007|Overall Study|Study Terminated By Sponsor|1|||
156707049|NCT04642365|565673243|FG000|Overall Study|Symptomatic Deterioration|1|||
156707050|NCT04642365|565673244|FG001|Overall Study|Symptomatic Deterioration|1|||
156707051|NCT04642365|565673245|FG002|Overall Study|Symptomatic Deterioration|0|||
156707052|NCT04642365|565673246|FG003|Overall Study|Symptomatic Deterioration|0|||
156707053|NCT04642365|565673247|FG004|Overall Study|Symptomatic Deterioration|0|||
156707054|NCT04642365|565673248|FG005|Overall Study|Symptomatic Deterioration|1|||
156707055|NCT04642365|565673249|FG006|Overall Study|Symptomatic Deterioration|0|||
156707056|NCT04642365|565673250|FG007|Overall Study|Symptomatic Deterioration|0|||
156707057|NCT04642365|565673243|FG000|Overall Study|Withdrawal by Subject|0|||
156707058|NCT04642365|565673244|FG001|Overall Study|Withdrawal by Subject|0|||
156707059|NCT04642365|565673245|FG002|Overall Study|Withdrawal by Subject|1|||
156707060|NCT04642365|565673246|FG003|Overall Study|Withdrawal by Subject|1|||
156707061|NCT04642365|565673247|FG004|Overall Study|Withdrawal by Subject|0|||
156707062|NCT04642365|565673248|FG005|Overall Study|Withdrawal by Subject|0|||
156707063|NCT04642365|565673249|FG006|Overall Study|Withdrawal by Subject|2|||
156707064|NCT04642365|565673250|FG007|Overall Study|Withdrawal by Subject|0|||
156707065|NCT04642365|565673243|FG000|Overall Study|Adverse Event|0|||
156707066|NCT04642365|565673244|FG001|Overall Study|Adverse Event|0|||
156707067|NCT04642365|565673245|FG002|Overall Study|Adverse Event|0|||
156707068|NCT04642365|565673246|FG003|Overall Study|Adverse Event|0|||
156707069|NCT04642365|565673247|FG004|Overall Study|Adverse Event|0|||
156707070|NCT04642365|565673248|FG005|Overall Study|Adverse Event|0|||
156707071|NCT04642365|565673249|FG006|Overall Study|Adverse Event|0|||
156707072|NCT04642365|565673250|FG007|Overall Study|Adverse Event|1|||
156707073|NCT01144715|565673251|FG000|Overall Study|Lost to Follow-up|2|||
156707074|NCT01144715|565673252|FG001|Overall Study|Lost to Follow-up|1|||
156707075|NCT01144715|565673251|FG000|Overall Study|Withdrawal by Subject|2|||
156707076|NCT01144715|565673252|FG001|Overall Study|Withdrawal by Subject|1|||
156707077|NCT01144715|565673251|FG000|Overall Study|Adverse Event|0|||
156707078|NCT01144715|565673252|FG001|Overall Study|Adverse Event|1|||
156707079|NCT03553576|565673253|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
156707080|NCT03553576|565673254|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
156707081|NCT03553576|565673253|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
156707082|NCT03553576|565673254|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
156707083|NCT03553576|565673253|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
156707084|NCT03553576|565673254|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
156707085|NCT03553576|565673253|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
156707086|NCT03553576|565673254|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
156707087|NCT03553576|565673253|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
156707088|NCT03553576|565673254|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
156707089|NCT03553576|565673253|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
156707090|NCT03553576|565673254|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
156707091|NCT03553576|565673253|FG000|Overall Study|Physician Decision|2|||
156707092|NCT03553576|565673254|FG001|Overall Study|Physician Decision|5|||
156707093|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
156707094|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
156707095|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
156707096|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
157125039|NCT01928381|567206361|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
157125040|NCT01928381|567206362|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
156707097|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
156707098|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
156707099|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
156707100|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
156707101|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
156707102|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
156707103|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
156707104|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
156707105|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
156707106|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
156707107|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
156707108|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
156707109|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
156707110|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
156707111|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
156707112|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
156707113|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
156707114|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
156707115|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
156707116|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
156707117|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
156707118|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
156707119|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
156707120|NCT02552212|565673255|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
156707121|NCT02552212|565673256|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
156707122|NCT02552212|565673257|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
156707123|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
156707124|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
156707125|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
156707126|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
156707127|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
156707128|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
156707129|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
156707130|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
156707131|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
156707132|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
156707133|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
156707134|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
156707135|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
156707136|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
156707137|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
156707138|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
156707139|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
156707140|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
156707141|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
156707142|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
156707143|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
156707144|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
156707145|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
156707146|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
156707147|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
156707148|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
156707149|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
156707150|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
156707151|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
156707152|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
156707153|NCT02552212|565673255|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
156707154|NCT02552212|565673256|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
156707155|NCT02552212|565673257|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
156707156|NCT02728843|565673258|FG000|Overall Study|Adverse Event|0|||
157015857|NCT01259401|566811134|FG001|4-month Follow-up|Death|1|||
156707157|NCT02728843|565673259|FG001|Overall Study|Adverse Event|2|||
156707158|NCT02728843|565673260|FG002|Overall Study|Adverse Event|3|||
156707159|NCT02728843|565673261|FG003|Overall Study|Adverse Event|1|||
156707160|NCT02728843|565673262|FG004|Overall Study|Adverse Event|2|||
157015858|NCT01259401|566811133|FG000|4-month Follow-up|Lost to Follow-up|0|||
157015859|NCT01259401|566811134|FG001|4-month Follow-up|Lost to Follow-up|1|||
156707161|NCT02728843|565673258|FG000|Overall Study|Lack of Efficacy|0|||
156707162|NCT02728843|565673259|FG001|Overall Study|Lack of Efficacy|1|||
156707163|NCT02728843|565673260|FG002|Overall Study|Lack of Efficacy|1|||
156707164|NCT02728843|565673261|FG003|Overall Study|Lack of Efficacy|0|||
156707165|NCT02728843|565673262|FG004|Overall Study|Lack of Efficacy|0|||
156707166|NCT02728843|565673258|FG000|Overall Study|Protocol Violation|2|||
156707167|NCT02728843|565673259|FG001|Overall Study|Protocol Violation|0|||
156707168|NCT02728843|565673260|FG002|Overall Study|Protocol Violation|4|||
156707169|NCT02728843|565673261|FG003|Overall Study|Protocol Violation|2|||
156707170|NCT02728843|565673262|FG004|Overall Study|Protocol Violation|2|||
156707171|NCT02728843|565673258|FG000|Overall Study|Withdrawal by Subject|1|||
156707172|NCT02728843|565673259|FG001|Overall Study|Withdrawal by Subject|0|||
156707173|NCT02728843|565673260|FG002|Overall Study|Withdrawal by Subject|0|||
156707174|NCT02728843|565673261|FG003|Overall Study|Withdrawal by Subject|1|||
156707175|NCT02728843|565673262|FG004|Overall Study|Withdrawal by Subject|0|||
156707176|NCT02728843|565673258|FG000|Overall Study|Use of rescue medication|0|||
156707177|NCT02728843|565673259|FG001|Overall Study|Use of rescue medication|2|||
156707178|NCT02728843|565673260|FG002|Overall Study|Use of rescue medication|0|||
156707179|NCT02728843|565673261|FG003|Overall Study|Use of rescue medication|2|||
156707180|NCT02728843|565673262|FG004|Overall Study|Use of rescue medication|1|||
156707181|NCT05038800|565673263|FG000|Overall Study|Death|1|||
156707182|NCT05038800|565673264|FG001|Overall Study|Death|1|||
156707183|NCT05038800|565673265|FG002|Overall Study|Death|5|||
156707184|NCT05038800|565673266|FG003|Overall Study|Death|3|||
156707185|NCT05038800|565673267|FG004|Overall Study|Death|1|||
156707186|NCT05038800|565673263|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707187|NCT05038800|565673264|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707188|NCT05038800|565673265|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707189|NCT05038800|565673266|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156707190|NCT05038800|565673267|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156707191|NCT05038800|565673263|FG000|Overall Study|Lack of Efficacy|0|||
156707192|NCT05038800|565673264|FG001|Overall Study|Lack of Efficacy|0|||
156707193|NCT05038800|565673265|FG002|Overall Study|Lack of Efficacy|0|||
156707194|NCT05038800|565673266|FG003|Overall Study|Lack of Efficacy|0|||
156707195|NCT05038800|565673267|FG004|Overall Study|Lack of Efficacy|1|||
156707196|NCT00121134|565673268|FG000|Overall Study|Progression of Disease|5|||
156707197|NCT00121134|565673269|FG001|Overall Study|Progression of Disease|3|||
156707198|NCT00121134|565673270|FG002|Overall Study|Progression of Disease|4|||
156707199|NCT00121134|565673271|FG003|Overall Study|Progression of Disease|2|||
156707200|NCT00121134|565673268|FG000|Overall Study|Toxicity|4|||
156707201|NCT00121134|565673269|FG001|Overall Study|Toxicity|7|||
156707202|NCT00121134|565673270|FG002|Overall Study|Toxicity|13|||
156707203|NCT00121134|565673271|FG003|Overall Study|Toxicity|5|||
156707204|NCT00121134|565673268|FG000|Overall Study|Physician Decision|6|||
156707205|NCT00121134|565673269|FG001|Overall Study|Physician Decision|4|||
156707206|NCT00121134|565673270|FG002|Overall Study|Physician Decision|4|||
156707207|NCT00121134|565673271|FG003|Overall Study|Physician Decision|1|||
156707208|NCT00121134|565673268|FG000|Overall Study|Treatment Delay|1|||
156707209|NCT00121134|565673269|FG001|Overall Study|Treatment Delay|0|||
156707210|NCT00121134|565673270|FG002|Overall Study|Treatment Delay|0|||
156707211|NCT00121134|565673271|FG003|Overall Study|Treatment Delay|0|||
156707212|NCT00121134|565673268|FG000|Overall Study|Intercurrent Illness|0|||
156707213|NCT00121134|565673269|FG001|Overall Study|Intercurrent Illness|0|||
156707214|NCT00121134|565673270|FG002|Overall Study|Intercurrent Illness|0|||
156707215|NCT00121134|565673271|FG003|Overall Study|Intercurrent Illness|1|||
156707216|NCT00121134|565673268|FG000|Overall Study|Patient Personal Reasons|0|||
156707217|NCT00121134|565673269|FG001|Overall Study|Patient Personal Reasons|1|||
156707218|NCT00121134|565673270|FG002|Overall Study|Patient Personal Reasons|0|||
156707219|NCT00121134|565673271|FG003|Overall Study|Patient Personal Reasons|0|||
156707220|NCT02478320|565673277|FG000|Overall Study|Adverse Event|2|||
156707221|NCT02478320|565673278|FG001|Overall Study|Adverse Event|0|||
156707222|NCT02478320|565673277|FG000|Overall Study|Death|1|||
156707223|NCT02478320|565673278|FG001|Overall Study|Death|0|||
156707224|NCT02478320|565673277|FG000|Overall Study|Lack of Efficacy|4|||
156707225|NCT02478320|565673278|FG001|Overall Study|Lack of Efficacy|0|||
157125041|NCT01928381|567206356|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
157125042|NCT01928381|567206357|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
156707226|NCT02478320|565673277|FG000|Overall Study|Withdrawal by Subject|2|||
156707227|NCT02478320|565673278|FG001|Overall Study|Withdrawal by Subject|0|||
156707228|NCT02478320|565673277|FG000|Overall Study|Screen Failure|3|||
156707229|NCT02478320|565673278|FG001|Overall Study|Screen Failure|0|||
156707230|NCT00197496|565673282|FG000|Baseline to Discharge|not interested|1|||
156707231|NCT00197496|565673283|FG001|Baseline to Discharge|not interested|0|||
156707232|NCT00197496|565673282|FG000|Baseline to Discharge|MRSA|1|||
156707233|NCT00197496|565673283|FG001|Baseline to Discharge|MRSA|0|||
156707234|NCT00197496|565673282|FG000|Baseline to Discharge|Physician Decision|0|||
156707235|NCT00197496|565673283|FG001|Baseline to Discharge|Physician Decision|1|||
157125043|NCT01928381|567206358|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
157125044|NCT01928381|567206359|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
157125045|NCT01928381|567206360|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
157125046|NCT01928381|567206361|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
157125047|NCT01928381|567206362|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
157125048|NCT01928381|567206356|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
157125049|NCT01928381|567206357|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
157125050|NCT01928381|567206358|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
157125051|NCT01928381|567206359|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
157125052|NCT01928381|567206360|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
157125053|NCT01928381|567206361|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
157125054|NCT01928381|567206362|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
157125055|NCT01928381|567206356|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
157125056|NCT01928381|567206357|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
157125057|NCT01928381|567206358|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
157125058|NCT01928381|567206359|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
157125059|NCT01928381|567206360|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
157125060|NCT01928381|567206361|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
157125061|NCT01928381|567206362|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
157125062|NCT01928381|567206356|FG000|Washout First Intervention|Protocol Violation|0|||
157125063|NCT01928381|567206357|FG001|Washout First Intervention|Protocol Violation|0|||
157125064|NCT01928381|567206358|FG002|Washout First Intervention|Protocol Violation|0|||
157125065|NCT01928381|567206359|FG003|Washout First Intervention|Protocol Violation|0|||
157125066|NCT01928381|567206360|FG004|Washout First Intervention|Protocol Violation|1|||
157125067|NCT01928381|567206361|FG005|Washout First Intervention|Protocol Violation|0|||
157125068|NCT01928381|567206362|FG006|Washout First Intervention|Protocol Violation|0|||
157125069|NCT01928381|567206356|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
157125070|NCT01928381|567206357|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
157125071|NCT01928381|567206358|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
157125072|NCT01928381|567206359|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
157125073|NCT01928381|567206360|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
157125074|NCT01928381|567206361|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
157125075|NCT01928381|567206362|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
157125076|NCT01928381|567206356|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125077|NCT01928381|567206357|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125078|NCT01928381|567206358|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
157125079|NCT01928381|567206359|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125080|NCT01928381|567206360|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125081|NCT01928381|567206361|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125082|NCT01928381|567206362|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
157125083|NCT02406781|567206366|FG000|Overall Study|Protocol Violation|2|||
157125084|NCT02406781|567206367|FG001|Overall Study|Protocol Violation|2|||
157125085|NCT02406781|567206368|FG002|Overall Study|Protocol Violation|2|||
157125086|NCT02406781|567206369|FG003|Overall Study|Protocol Violation|2|||
157125087|NCT02406781|567206370|FG004|Overall Study|Protocol Violation|1|||
157125088|NCT02406781|567206371|FG005|Overall Study|Protocol Violation|5|||
157125089|NCT02406781|567206372|FG006|Overall Study|Protocol Violation|3|||
157125090|NCT03087955|567208028|FG000|Overall Study|Death|4|||
157125091|NCT03087955|567208029|FG001|Overall Study|Death|0|||
157125092|NCT03087955|567208028|FG000|Overall Study|Lack of Efficacy|2|||
157125093|NCT03087955|567208029|FG001|Overall Study|Lack of Efficacy|0|||
157125094|NCT03087955|567208028|FG000|Overall Study|Lost to Follow-up|1|||
157125095|NCT03087955|567208029|FG001|Overall Study|Lost to Follow-up|0|||
157125096|NCT03266016|567208036|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
157125097|NCT03266016|567208037|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
157125098|NCT03266016|567208038|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
157125099|NCT03266016|567208039|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
157125100|NCT03266016|567208036|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
157125101|NCT03266016|567208037|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
157125102|NCT03266016|567208038|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
157125103|NCT03266016|567208039|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
157125104|NCT05280756|567208040|FG000|Overall Study|Lost to Follow-up|1|||
157125105|NCT05280756|567208041|FG001|Overall Study|Lost to Follow-up|1|||
157125106|NCT00768898|567208042|FG000|Overall Study|Unrelated injury|1|||
157125107|NCT00768898|567208042|FG000|Overall Study|Headache|1|||
157125108|NCT00542997|567208047|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
157125109|NCT00542997|567208047|FG000|Wash in / Wash Out Period|Adverse Event|3|||
157125110|NCT00542997|567208047|FG000|Efficacy Period|Adverse Event|3|||
157125111|NCT03160560|567208050|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
157125112|NCT03160560|567208051|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156707236|NCT00197496|565673282|FG000|Baseline to Discharge|Protocol Violation|0|||
156707237|NCT00197496|565673283|FG001|Baseline to Discharge|Protocol Violation|1|||
156707238|NCT00197496|565673282|FG000|Follow-up|Lost to Follow-up|2|||
156707239|NCT00197496|565673283|FG001|Follow-up|Lost to Follow-up|1|||
156707240|NCT00857584|565673284|FG000|Overall Study|Lack of Efficacy|1|||
156707241|NCT00857584|565673285|FG001|Overall Study|Lack of Efficacy|2|||
156707242|NCT00857584|565673284|FG000|Overall Study|Adverse Event|2|||
156707243|NCT00857584|565673285|FG001|Overall Study|Adverse Event|2|||
156707244|NCT00857584|565673284|FG000|Overall Study|Physician Decision|1|||
156707245|NCT00857584|565673285|FG001|Overall Study|Physician Decision|1|||
156707246|NCT02533375|565673286|FG000|Overall Study|Lack of Efficacy|3|||
156707247|NCT02533375|565673286|FG000|Overall Study|Adverse Event|2|||
156707248|NCT00673387|565673287|FG000|Overall Study|Withdrawal by Subject|15|||
156707249|NCT00673387|565673288|FG001|Overall Study|Withdrawal by Subject|16|||
156707250|NCT00673387|565673289|FG002|Overall Study|Withdrawal by Subject|20|||
156707251|NCT00673387|565673290|FG003|Overall Study|Withdrawal by Subject|16|||
156707252|NCT00673387|565673291|FG004|Overall Study|Withdrawal by Subject|18|||
156707253|NCT00673387|565673292|FG005|Overall Study|Withdrawal by Subject|21|||
156707254|NCT00673387|565673293|FG006|Overall Study|Withdrawal by Subject|15|||
156707255|NCT00673387|565673294|FG007|Overall Study|Withdrawal by Subject|21|||
156707256|NCT00673387|565673287|FG000|Overall Study|Adverse Event|3|||
156707257|NCT00673387|565673288|FG001|Overall Study|Adverse Event|1|||
156707258|NCT00673387|565673289|FG002|Overall Study|Adverse Event|5|||
156707259|NCT00673387|565673290|FG003|Overall Study|Adverse Event|2|||
156707260|NCT00673387|565673291|FG004|Overall Study|Adverse Event|6|||
156707261|NCT00673387|565673292|FG005|Overall Study|Adverse Event|2|||
156707262|NCT00673387|565673293|FG006|Overall Study|Adverse Event|5|||
156707263|NCT00673387|565673294|FG007|Overall Study|Adverse Event|5|||
156707264|NCT00673387|565673287|FG000|Overall Study|Physician Decision|0|||
156707265|NCT00673387|565673288|FG001|Overall Study|Physician Decision|0|||
156707266|NCT00673387|565673289|FG002|Overall Study|Physician Decision|0|||
156707267|NCT00673387|565673290|FG003|Overall Study|Physician Decision|0|||
156707268|NCT00673387|565673291|FG004|Overall Study|Physician Decision|0|||
156707269|NCT00673387|565673292|FG005|Overall Study|Physician Decision|5|||
156707270|NCT00673387|565673293|FG006|Overall Study|Physician Decision|1|||
156707271|NCT00673387|565673294|FG007|Overall Study|Physician Decision|1|||
156707272|NCT00673387|565673287|FG000|Overall Study|Protocol Violation|3|||
156707273|NCT00673387|565673288|FG001|Overall Study|Protocol Violation|0|||
156707274|NCT00673387|565673289|FG002|Overall Study|Protocol Violation|1|||
156707275|NCT00673387|565673290|FG003|Overall Study|Protocol Violation|2|||
156707276|NCT00673387|565673291|FG004|Overall Study|Protocol Violation|0|||
156707277|NCT00673387|565673292|FG005|Overall Study|Protocol Violation|1|||
156707278|NCT00673387|565673293|FG006|Overall Study|Protocol Violation|1|||
156707279|NCT00673387|565673294|FG007|Overall Study|Protocol Violation|3|||
156707280|NCT00673387|565673287|FG000|Overall Study|Lost to Follow-up|8|||
156707281|NCT00673387|565673288|FG001|Overall Study|Lost to Follow-up|6|||
156707282|NCT00673387|565673289|FG002|Overall Study|Lost to Follow-up|5|||
156707283|NCT00673387|565673290|FG003|Overall Study|Lost to Follow-up|6|||
156707284|NCT00673387|565673291|FG004|Overall Study|Lost to Follow-up|6|||
156707285|NCT00673387|565673292|FG005|Overall Study|Lost to Follow-up|5|||
156707286|NCT00673387|565673293|FG006|Overall Study|Lost to Follow-up|8|||
156707287|NCT00673387|565673294|FG007|Overall Study|Lost to Follow-up|5|||
156707288|NCT00960115|565673295|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
156707289|NCT00960115|565673296|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
156707290|NCT01102374|565673297|FG000|Overall Study|Death|9|||
156707291|NCT01102374|565673298|FG001|Overall Study|Death|13|||
156707292|NCT01102374|565673297|FG000|Overall Study|Lost to Follow-up|7|||
156707293|NCT01102374|565673298|FG001|Overall Study|Lost to Follow-up|6|||
156707294|NCT03014180|565673304|FG000|Overall Study|Protocol Violation|2|||
156707295|NCT02952898|565673307|FG000|Overall Study|Withdrawal by Subject|10|||
156707296|NCT02952898|565673308|FG001|Overall Study|Withdrawal by Subject|8|||
156707297|NCT02952898|565673309|FG002|Overall Study|Withdrawal by Subject|8|||
156791184|NCT02413346|565987192|FG000|Overall Study|Protocol Violation|2|||
156791185|NCT02413346|565987193|FG001|Overall Study|Protocol Violation|0|||
156791186|NCT02413346|565987192|FG000|Overall Study|Other Miscellaneous Reasons|4|||
156791187|NCT02413346|565987193|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156791188|NCT01835431|565987194|FG000|Overall Study|Adverse Event|1|||
156791189|NCT01835431|565987195|FG001|Overall Study|Adverse Event|0|||
156707298|NCT02952898|565673307|FG000|Overall Study|Adverse Event|8|||
156791190|NCT01835431|565987194|FG000|Overall Study|other|0|||
156791191|NCT01835431|565987195|FG001|Overall Study|other|2|||
156707299|NCT02952898|565673308|FG001|Overall Study|Adverse Event|8|||
156707300|NCT02952898|565673309|FG002|Overall Study|Adverse Event|3|||
156707301|NCT02952898|565673307|FG000|Overall Study|Lost to Follow-up|3|||
156707302|NCT02952898|565673308|FG001|Overall Study|Lost to Follow-up|2|||
156707303|NCT02952898|565673309|FG002|Overall Study|Lost to Follow-up|2|||
156707304|NCT02952898|565673307|FG000|Overall Study|Non-compliance with study drug|1|||
156791192|NCT01835431|565987194|FG000|Overall Study|Withdrawal by Subject|6|||
156791193|NCT01835431|565987195|FG001|Overall Study|Withdrawal by Subject|10|||
156791194|NCT01835431|565987194|FG000|Overall Study|Protocol Violation|1|||
156707305|NCT02952898|565673308|FG001|Overall Study|Non-compliance with study drug|1|||
156707306|NCT02952898|565673309|FG002|Overall Study|Non-compliance with study drug|2|||
156707307|NCT02099682|565673310|FG000|Overall Study|Data Not Available|51|||
156707308|NCT02099682|565673310|FG000|Overall Study|Lost to Follow-up|31|||
156707309|NCT02099682|565673310|FG000|Overall Study|Other|29|||
156707310|NCT02802631|565673311|FG000|Overall Study|Withdrawal by Subject|1|||
156707311|NCT02802631|565673312|FG001|Overall Study|Withdrawal by Subject|0|||
156707312|NCT02802631|565673313|FG002|Overall Study|Withdrawal by Subject|0|||
156707313|NCT02802631|565673314|FG003|Overall Study|Withdrawal by Subject|0|||
156707314|NCT02802631|565673315|FG004|Overall Study|Withdrawal by Subject|0|||
156707315|NCT02802631|565673316|FG005|Overall Study|Withdrawal by Subject|0|||
156707316|NCT02802631|565673317|FG006|Overall Study|Withdrawal by Subject|0|||
156707317|NCT02802631|565673318|FG007|Overall Study|Withdrawal by Subject|0|||
156707318|NCT02802631|565673311|FG000|Overall Study|Physician Decision|1|||
156707319|NCT02802631|565673312|FG001|Overall Study|Physician Decision|0|||
156707320|NCT02802631|565673313|FG002|Overall Study|Physician Decision|0|||
156707321|NCT02802631|565673314|FG003|Overall Study|Physician Decision|0|||
156707322|NCT02802631|565673315|FG004|Overall Study|Physician Decision|0|||
156707323|NCT02802631|565673316|FG005|Overall Study|Physician Decision|0|||
156707324|NCT02802631|565673317|FG006|Overall Study|Physician Decision|1|||
156707325|NCT02802631|565673318|FG007|Overall Study|Physician Decision|0|||
156707326|NCT02802631|565673311|FG000|Overall Study|Adverse Event|0|||
156707327|NCT02802631|565673312|FG001|Overall Study|Adverse Event|2|||
156707328|NCT02802631|565673313|FG002|Overall Study|Adverse Event|0|||
156707329|NCT02802631|565673314|FG003|Overall Study|Adverse Event|1|||
156707330|NCT02802631|565673315|FG004|Overall Study|Adverse Event|6|||
156707331|NCT02802631|565673316|FG005|Overall Study|Adverse Event|1|||
156707332|NCT02802631|565673317|FG006|Overall Study|Adverse Event|4|||
156707333|NCT02802631|565673318|FG007|Overall Study|Adverse Event|0|||
156707334|NCT02802631|565673311|FG000|Overall Study|Sponsor Decision|0|||
156707335|NCT02802631|565673312|FG001|Overall Study|Sponsor Decision|0|||
156707336|NCT02802631|565673313|FG002|Overall Study|Sponsor Decision|6|||
156707337|NCT02802631|565673314|FG003|Overall Study|Sponsor Decision|0|||
156707338|NCT02802631|565673315|FG004|Overall Study|Sponsor Decision|2|||
156707339|NCT02802631|565673316|FG005|Overall Study|Sponsor Decision|0|||
156707340|NCT02802631|565673317|FG006|Overall Study|Sponsor Decision|0|||
156707341|NCT02802631|565673318|FG007|Overall Study|Sponsor Decision|4|||
156707342|NCT02212379|565673319|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
156707343|NCT02212379|565673319|FG000|From Baseline to Week 48|Adverse Event|7|||
156707344|NCT02212379|565673319|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
156707345|NCT02212379|565673319|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
156707346|NCT02212379|565673319|FG000|From Week 48 to Week 96|Adverse Event|1|||
156707347|NCT02212379|565673319|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
156707348|NCT02105974|565673320|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
156707349|NCT02105974|565673321|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
156707350|NCT02105974|565673322|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
156707351|NCT02105974|565673320|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
156707352|NCT02105974|565673321|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
156707353|NCT02105974|565673322|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
156707354|NCT02105974|565673320|FG000|2 Week Run-in Period|Adverse Event|6|||
156707355|NCT02105974|565673321|FG001|2 Week Run-in Period|Adverse Event|0|||
156707356|NCT02105974|565673322|FG002|2 Week Run-in Period|Adverse Event|0|||
156707357|NCT02105974|565673320|FG000|2 Week Run-in Period|Study closed/terminated|1|||
156707358|NCT02105974|565673321|FG001|2 Week Run-in Period|Study closed/terminated|0|||
156707359|NCT02105974|565673322|FG002|2 Week Run-in Period|Study closed/terminated|0|||
156707360|NCT02105974|565673320|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
156707361|NCT02105974|565673321|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
156707362|NCT02105974|565673322|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
156707363|NCT02105974|565673320|FG000|2 Week Run-in Period|Withdrew consent|23|||
156707364|NCT02105974|565673321|FG001|2 Week Run-in Period|Withdrew consent|0|||
156707365|NCT02105974|565673322|FG002|2 Week Run-in Period|Withdrew consent|0|||
156707366|NCT02105974|565673320|FG000|2 Week Run-in Period|Investigator discretion|8|||
156707367|NCT02105974|565673321|FG001|2 Week Run-in Period|Investigator discretion|0|||
156791195|NCT01835431|565987195|FG001|Overall Study|Protocol Violation|0|||
156707368|NCT02105974|565673322|FG002|2 Week Run-in Period|Investigator discretion|0|||
156707369|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
156707370|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
156707371|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
156707372|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
156791196|NCT02205359|565987198|FG000|Overall Study|Death|293|||
156707373|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
156707374|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
156707375|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
156707376|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
156791197|NCT02205359|565987199|FG001|Overall Study|Death|327|||
156707377|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
156707378|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
156707379|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
156707380|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
156707381|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
156707382|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
156707383|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
156707384|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
156707385|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
156707386|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
156707387|NCT02105974|565673320|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
156707388|NCT02105974|565673321|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
156707389|NCT02105974|565673322|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
156707390|NCT02968849|565673323|FG000|Overall Study|Death|8|||
156707391|NCT02968849|565673324|FG001|Overall Study|Death|10|||
156707392|NCT02968849|565673323|FG000|Overall Study|Lost to Follow-up|31|||
156707393|NCT02968849|565673324|FG001|Overall Study|Lost to Follow-up|29|||
156707394|NCT02968849|565673323|FG000|Overall Study|Withdrawal by Subject|73|||
156707395|NCT02968849|565673324|FG001|Overall Study|Withdrawal by Subject|64|||
156707396|NCT02968849|565673323|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
156707397|NCT02968849|565673324|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
156707398|NCT02968849|565673323|FG000|Overall Study|Physician Decision|6|||
156707399|NCT02968849|565673324|FG001|Overall Study|Physician Decision|9|||
156707400|NCT02968849|565673323|FG000|Overall Study|Other|16|||
156707401|NCT02968849|565673324|FG001|Overall Study|Other|10|||
156707402|NCT00704730|565673327|FG000|Overall Study|Adverse Event|35|||
156707403|NCT00704730|565673328|FG001|Overall Study|Adverse Event|9|||
156707404|NCT00704730|565673327|FG000|Overall Study|Death|11|||
156707405|NCT00704730|565673328|FG001|Overall Study|Death|5|||
156707406|NCT00704730|565673327|FG000|Overall Study|Physician Decision|2|||
156707407|NCT00704730|565673328|FG001|Overall Study|Physician Decision|0|||
156707408|NCT00704730|565673327|FG000|Overall Study|Did not receive drug|5|||
156707409|NCT00704730|565673328|FG001|Overall Study|Did not receive drug|2|||
156707410|NCT00704730|565673327|FG000|Overall Study|Disease progression per PI|58|||
156707411|NCT00704730|565673328|FG001|Overall Study|Disease progression per PI|67|||
156707412|NCT00704730|565673327|FG000|Overall Study|data unavailable|1|||
156707413|NCT00704730|565673328|FG001|Overall Study|data unavailable|0|||
156707414|NCT00704730|565673327|FG000|Overall Study|Withdrawal by Subject|9|||
156707415|NCT00704730|565673328|FG001|Overall Study|Withdrawal by Subject|13|||
156707416|NCT05833139|565675151|FG000|Study Period 2|Adverse Event|1|||
156707417|NCT03996447|565675152|FG000|First MRI Examination|Adverse Event|2|||
156707418|NCT03996447|565675153|FG001|First MRI Examination|Adverse Event|0|||
156707419|NCT03996447|565675152|FG000|First MRI Examination|Withdrawal by Subject|1|||
156707420|NCT03996447|565675153|FG001|First MRI Examination|Withdrawal by Subject|2|||
156707421|NCT03996447|565675152|FG000|First MRI Examination|Protocol Violation|0|||
156707422|NCT03996447|565675153|FG001|First MRI Examination|Protocol Violation|1|||
156707423|NCT03996447|565675152|FG000|Washout|Adverse Event|2|||
156707424|NCT03996447|565675153|FG001|Washout|Adverse Event|0|||
156707425|NCT03996447|565675152|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
157125113|NCT03160560|567208052|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
157125114|NCT03160560|567208053|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156791198|NCT02205359|565987198|FG000|Overall Study|Lost to Follow-up|182|||
156791199|NCT02205359|565987199|FG001|Overall Study|Lost to Follow-up|162|||
156791200|NCT02205359|565987198|FG000|Overall Study|Physician Decision|51|||
156791201|NCT02205359|565987199|FG001|Overall Study|Physician Decision|53|||
156791202|NCT02205359|565987198|FG000|Overall Study|Withdrawal by Subject|167|||
156791203|NCT02205359|565987199|FG001|Overall Study|Withdrawal by Subject|169|||
156791204|NCT02792257|565987204|FG000|Overall Study|Lost to Follow-up|3|||
156791205|NCT02792257|565987205|FG001|Overall Study|Lost to Follow-up|4|||
156791206|NCT02792257|565987204|FG000|Overall Study|Allergy|0|||
156791207|NCT02792257|565987205|FG001|Overall Study|Allergy|1|||
156791208|NCT02792257|565987204|FG000|Overall Study|Protocol Violation|2|||
156791209|NCT02792257|565987205|FG001|Overall Study|Protocol Violation|0|||
156791210|NCT02792257|565987204|FG000|Overall Study|Excessive Agitation|0|||
156791211|NCT02792257|565987205|FG001|Overall Study|Excessive Agitation|1|||
156707426|NCT03996447|565675153|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
156707427|NCT03996447|565675152|FG000|Washout|Withdrawal by Subject|0|||
156707428|NCT03996447|565675153|FG001|Washout|Withdrawal by Subject|1|||
156707429|NCT03996447|565675152|FG000|Washout|Other reason|1|||
156707430|NCT03996447|565675153|FG001|Washout|Other reason|1|||
156707431|NCT02094417|565675157|FG000|Overall Study|Adverse Event|0|||
156791212|NCT02792257|565987204|FG000|Overall Study|Not Feeling Well|0|||
156791213|NCT02792257|565987205|FG001|Overall Study|Not Feeling Well|1|||
156791214|NCT02766478|565987207|FG000|Overall Study|Withdrawal by Subject|1|||
156791215|NCT02766478|565987208|FG001|Overall Study|Withdrawal by Subject|1|||
157215572|NCT01690520|567537333|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
157215573|NCT01270841|567537334|FG000|Overall Study|Adverse Event|0|||
157215574|NCT01270841|567537335|FG001|Overall Study|Adverse Event|1|||
157215575|NCT01270841|567537336|FG002|Overall Study|Adverse Event|0|||
157015860|NCT03683069|566811135|FG000|Overall Study|see limitations|12|||
157215576|NCT01270841|567537337|FG003|Overall Study|Adverse Event|3|||
157215577|NCT01270841|567537334|FG000|Overall Study|Withdrawal by Subject|3|||
157215578|NCT01270841|567537335|FG001|Overall Study|Withdrawal by Subject|2|||
157215579|NCT01270841|567537336|FG002|Overall Study|Withdrawal by Subject|3|||
157215580|NCT01270841|567537337|FG003|Overall Study|Withdrawal by Subject|3|||
157215581|NCT01270841|567537334|FG000|Overall Study|Lost to Follow-up|3|||
157215582|NCT01270841|567537335|FG001|Overall Study|Lost to Follow-up|1|||
157215583|NCT01270841|567537336|FG002|Overall Study|Lost to Follow-up|4|||
157215584|NCT01270841|567537337|FG003|Overall Study|Lost to Follow-up|2|||
157215585|NCT01270841|567537334|FG000|Overall Study|Physician Decision|0|||
157215586|NCT01270841|567537335|FG001|Overall Study|Physician Decision|1|||
157215587|NCT01270841|567537336|FG002|Overall Study|Physician Decision|0|||
157215588|NCT01270841|567537337|FG003|Overall Study|Physician Decision|0|||
157215589|NCT01270841|567537334|FG000|Overall Study|Did not qualify|6|||
157215590|NCT01270841|567537335|FG001|Overall Study|Did not qualify|3|||
157215591|NCT01270841|567537336|FG002|Overall Study|Did not qualify|4|||
157215592|NCT01270841|567537337|FG003|Overall Study|Did not qualify|5|||
157215593|NCT01270841|567537334|FG000|Overall Study|Protocol Violation|1|||
157215594|NCT01270841|567537335|FG001|Overall Study|Protocol Violation|5|||
157215595|NCT01270841|567537336|FG002|Overall Study|Protocol Violation|0|||
157215596|NCT01270841|567537337|FG003|Overall Study|Protocol Violation|0|||
157215597|NCT01270841|567537334|FG000|Overall Study|Enrolled in error|0|||
157015861|NCT03683069|566811136|FG001|Overall Study|see limitations|13|||
157015862|NCT05478525|566811137|FG000|Overall Study|Withdrawal by Subject|0|||
157015863|NCT05478525|566811138|FG001|Overall Study|Withdrawal by Subject|1|||
157015864|NCT05478525|566811139|FG002|Overall Study|Withdrawal by Subject|2|||
157015865|NCT05478525|566811140|FG003|Overall Study|Withdrawal by Subject|0|||
157015866|NCT05478525|566811137|FG000|Overall Study|COVID-19 Infection|2|||
157015867|NCT05478525|566811138|FG001|Overall Study|COVID-19 Infection|0|||
157015868|NCT05478525|566811139|FG002|Overall Study|COVID-19 Infection|1|||
157015869|NCT05478525|566811140|FG003|Overall Study|COVID-19 Infection|1|||
157015870|NCT01649271|566811141|FG000|Overall Study|Progressive disease|4|||
157015871|NCT01649271|566811142|FG001|Overall Study|Progressive disease|5|||
157015872|NCT01649271|566811141|FG000|Overall Study|Other Adverse Event|0|||
157015873|NCT01649271|566811142|FG001|Overall Study|Other Adverse Event|2|||
157015874|NCT01649271|566811141|FG000|Overall Study|Withdrawal by Subject|1|||
157015875|NCT01649271|566811142|FG001|Overall Study|Withdrawal by Subject|0|||
157015876|NCT01649271|566811141|FG000|Overall Study|Other than stated above|1|||
157015877|NCT01649271|566811142|FG001|Overall Study|Other than stated above|0|||
157015878|NCT05644002|566811145|FG000|Overall Study|Lost to Follow-up|1|||
157015879|NCT05644002|566811146|FG001|Overall Study|Lost to Follow-up|2|||
157015880|NCT05644002|566811145|FG000|Overall Study|Withdrawal by Subject|0|||
157015881|NCT05644002|566811146|FG001|Overall Study|Withdrawal by Subject|1|||
157015882|NCT04038957|566811148|FG000|Overall Study|Withdrawal by Subject|1|||
157015883|NCT04038957|566811148|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
157015884|NCT03821844|566811149|FG000|Overall Study|Death|37|||
157125115|NCT03160560|567208050|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
157125116|NCT03160560|567208051|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
157125117|NCT03160560|567208052|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
157125118|NCT03160560|567208053|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
157125119|NCT01777763|567208064|FG000|Overall Study|Adverse Event|2|||
157125120|NCT01777763|567208065|FG001|Overall Study|Adverse Event|32|||
157125121|NCT01777763|567208064|FG000|Overall Study|Protocol Violation|1|||
157125122|NCT01777763|567208065|FG001|Overall Study|Protocol Violation|7|||
157125123|NCT01777763|567208064|FG000|Overall Study|Withdrawal by Subject|0|||
157125124|NCT01777763|567208065|FG001|Overall Study|Withdrawal by Subject|2|||
157125125|NCT01777763|567208064|FG000|Overall Study|Treatment Failure|1|||
157125126|NCT01777763|567208065|FG001|Overall Study|Treatment Failure|6|||
157125127|NCT02968810|567208069|FG000|Overall Study|Lost to Follow-up|1|||
157125128|NCT02968810|567208070|FG001|Overall Study|Lost to Follow-up|0|||
157125129|NCT02968810|567208069|FG000|Overall Study|Physician Decision|1|||
157125130|NCT02968810|567208070|FG001|Overall Study|Physician Decision|0|||
157125131|NCT02968810|567208069|FG000|Overall Study|Withdrawal by Subject|1|||
157125132|NCT02968810|567208070|FG001|Overall Study|Withdrawal by Subject|3|||
157125133|NCT02968810|567208069|FG000|Overall Study|Disease Progression|0|||
157125134|NCT02968810|567208070|FG001|Overall Study|Disease Progression|1|||
157125135|NCT01535729|567208072|FG000|Overall Study|Withdrawal by Subject|2|||
157125136|NCT01535729|567208072|FG000|Overall Study|Disease progression|230|||
157125137|NCT01535729|567208072|FG000|Overall Study|Discontinued treatment|25|||
157125138|NCT01535729|567208072|FG000|Overall Study|Lost to Follow-up|8|||
157125139|NCT01535729|567208072|FG000|Overall Study|Death|52|||
157215598|NCT01270841|567537335|FG001|Overall Study|Enrolled in error|1|||
157215599|NCT01270841|567537336|FG002|Overall Study|Enrolled in error|0|||
156791216|NCT00089583|565987209|FG000|Overall Study|Adverse Event|0|||
156791217|NCT00089583|565987210|FG001|Overall Study|Adverse Event|3|||
156791218|NCT00089583|565987209|FG000|Overall Study|Insufficient Viral Load Response|5|||
156791219|NCT00089583|565987210|FG001|Overall Study|Insufficient Viral Load Response|5|||
156791220|NCT00089583|565987209|FG000|Overall Study|Withdrawal by Subject|0|||
156791221|NCT00089583|565987210|FG001|Overall Study|Withdrawal by Subject|4|||
156791222|NCT00089583|565987209|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
157015885|NCT03821844|566811150|FG001|Overall Study|Death|31|||
157015886|NCT03821844|566811149|FG000|Overall Study|Discharged|10|||
157015887|NCT03821844|566811150|FG001|Overall Study|Discharged|14|||
157125140|NCT01535729|567208072|FG000|Overall Study|Other|19|||
157125141|NCT01535729|567208072|FG000|Overall Study|Did not sign informed consent|1|||
157125142|NCT01535729|567208072|FG000|Overall Study|No previous chemotherapy|33|||
157215600|NCT01270841|567537337|FG003|Overall Study|Enrolled in error|0|||
157215601|NCT02092961|567537338|FG000|Overall Study|Not reported|1|||
157215602|NCT02092961|567537339|FG001|Overall Study|Not reported|0|||
157215603|NCT02092961|567537340|FG002|Overall Study|Not reported|1|||
157215604|NCT02092961|567537338|FG000|Overall Study|Study stopped|13|||
157215605|NCT02092961|567537339|FG001|Overall Study|Study stopped|9|||
157215606|NCT02092961|567537340|FG002|Overall Study|Study stopped|12|||
157215607|NCT02092961|567537338|FG000|Overall Study|Lack of therapeutic response|2|||
157215608|NCT02092961|567537339|FG001|Overall Study|Lack of therapeutic response|1|||
157215609|NCT02092961|567537340|FG002|Overall Study|Lack of therapeutic response|3|||
157015888|NCT03821844|566811149|FG000|Overall Study|Not present in facility at followup|2|||
157125143|NCT01535729|567208072|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
157125144|NCT01535729|567208072|FG000|Overall Study|Protocol Violation|11|||
157125145|NCT01535729|567208072|FG000|Overall Study|Screening failure|1|||
157125146|NCT01535729|567208072|FG000|Overall Study|Not treated|9|||
157125147|NCT01535729|567208072|FG000|Overall Study|No participant record available|5|||
157125148|NCT02787850|567208073|FG000|Overall Study|Withdrawal by Subject|0|||
157125149|NCT02787850|567208074|FG001|Overall Study|Withdrawal by Subject|1|||
157125150|NCT03718143|567208075|FG000|Overall Study|Death|1|||
157125151|NCT03718143|567208076|FG001|Overall Study|Death|0|||
157125152|NCT03718143|567208077|FG002|Overall Study|Death|0|||
157125153|NCT03718143|567208075|FG000|Overall Study|Progression of Disease|1|||
157125154|NCT03718143|567208076|FG001|Overall Study|Progression of Disease|0|||
157125155|NCT03718143|567208077|FG002|Overall Study|Progression of Disease|0|||
157125156|NCT03718143|567208075|FG000|Overall Study|Withdrawal of Informed Consent|1|||
157125157|NCT03718143|567208076|FG001|Overall Study|Withdrawal of Informed Consent|2|||
157125158|NCT03718143|567208077|FG002|Overall Study|Withdrawal of Informed Consent|1|||
157125159|NCT03905863|567208078|FG000|Overall Study|Adverse Event|2|||
157125160|NCT03905863|567208079|FG001|Overall Study|Adverse Event|4|||
157125161|NCT03905863|567208078|FG000|Overall Study|Withdrawal by Subject|2|||
157125162|NCT03905863|567208079|FG001|Overall Study|Withdrawal by Subject|2|||
157215610|NCT02092961|567537338|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
157215611|NCT02092961|567537339|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
157015889|NCT03821844|566811150|FG001|Overall Study|Not present in facility at followup|3|||
157015890|NCT02605837|566811151|FG000|Overall Study|Adverse Event|3|||
157015891|NCT02605837|566811152|FG001|Overall Study|Adverse Event|1|||
157015892|NCT02605837|566811151|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157015893|NCT02605837|566811152|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157015894|NCT02605837|566811151|FG000|Overall Study|Withdrawal by Subject|8|||
157015895|NCT02605837|566811152|FG001|Overall Study|Withdrawal by Subject|8|||
157015896|NCT02605837|566811151|FG000|Overall Study|Physician Decision|0|||
157015897|NCT02605837|566811152|FG001|Overall Study|Physician Decision|1|||
157015898|NCT05656911|566811155|FG000|Treatment Phase|Physician Decision|2|||
157015899|NCT05656911|566811156|FG001|Treatment Phase|Physician Decision|0|||
157015900|NCT05656911|566811155|FG000|Treatment Phase|Lack of Efficacy|6|||
157015901|NCT05656911|566811156|FG001|Treatment Phase|Lack of Efficacy|3|||
157015902|NCT05656911|566811155|FG000|Treatment Phase|Subject Decision|4|||
157015903|NCT05656911|566811156|FG001|Treatment Phase|Subject Decision|2|||
157015904|NCT05656911|566811155|FG000|Treatment Phase|Other Reasons|1|||
157015905|NCT05656911|566811156|FG001|Treatment Phase|Other Reasons|0|||
157015906|NCT05656911|566811155|FG000|Treatment Phase|Adverse Event|3|||
157015907|NCT05656911|566811156|FG001|Treatment Phase|Adverse Event|1|||
157015908|NCT05656911|566811155|FG000|Follow-up Phase|Subject Decision|0|||
157015909|NCT05656911|566811156|FG001|Follow-up Phase|Subject Decision|1|||
157015910|NCT05656911|566811155|FG000|Follow-up Phase|Missing|1|||
157015911|NCT05656911|566811156|FG001|Follow-up Phase|Missing|0|||
157015912|NCT05419505|566811161|FG000|Overall Study|Adverse Event|0|||
157125163|NCT03905863|567208078|FG000|Overall Study|Physician Decision|0|||
157125164|NCT03905863|567208079|FG001|Overall Study|Physician Decision|3|||
157125165|NCT03905863|567208078|FG000|Overall Study|Lost to Follow-up|1|||
157125166|NCT03905863|567208079|FG001|Overall Study|Lost to Follow-up|0|||
157125167|NCT03905863|567208078|FG000|Overall Study|Protocol Violation|0|||
157125168|NCT03905863|567208079|FG001|Overall Study|Protocol Violation|2|||
157125169|NCT03905863|567208078|FG000|Overall Study|Death|0|||
157125170|NCT03905863|567208079|FG001|Overall Study|Death|1|||
157125171|NCT02944448|567208083|FG000|Overall Study|Adverse Event|37|||
157125172|NCT02944448|567208084|FG001|Overall Study|Adverse Event|6|||
157125173|NCT02944448|567208083|FG000|Overall Study|Lack of Efficacy|8|||
157125174|NCT02944448|567208084|FG001|Overall Study|Lack of Efficacy|5|||
157125175|NCT02944448|567208083|FG000|Overall Study|Lost to Follow-up|3|||
156707432|NCT02094417|565675158|FG001|Overall Study|Adverse Event|0|||
156707433|NCT02094417|565675159|FG002|Overall Study|Adverse Event|0|||
156707434|NCT02094417|565675160|FG003|Overall Study|Adverse Event|1|||
156707435|NCT02094417|565675157|FG000|Overall Study|Eligibility criteria|0|||
156707436|NCT02094417|565675158|FG001|Overall Study|Eligibility criteria|1|||
156707437|NCT02094417|565675159|FG002|Overall Study|Eligibility criteria|0|||
156707438|NCT02094417|565675160|FG003|Overall Study|Eligibility criteria|0|||
156707439|NCT02094417|565675157|FG000|Overall Study|No responder|4|||
156707440|NCT02094417|565675158|FG001|Overall Study|No responder|4|||
156707441|NCT02094417|565675159|FG002|Overall Study|No responder|4|||
156707442|NCT02094417|565675160|FG003|Overall Study|No responder|3|||
156707443|NCT02094417|565675157|FG000|Overall Study|Unable to conduct observations or assess|0|||
156707444|NCT02094417|565675158|FG001|Overall Study|Unable to conduct observations or assess|1|||
156707445|NCT02094417|565675159|FG002|Overall Study|Unable to conduct observations or assess|0|||
156707446|NCT02094417|565675160|FG003|Overall Study|Unable to conduct observations or assess|0|||
156707447|NCT02094417|565675157|FG000|Overall Study|Withdrawal by Subject|1|||
156707448|NCT02094417|565675158|FG001|Overall Study|Withdrawal by Subject|2|||
156707449|NCT02094417|565675159|FG002|Overall Study|Withdrawal by Subject|1|||
156707450|NCT02094417|565675160|FG003|Overall Study|Withdrawal by Subject|3|||
156707451|NCT03333941|565675161|FG000|Overall Study|Lost to Follow-up|10|||
156707452|NCT03333941|565675161|FG000|Overall Study|Death|2|||
156707453|NCT03333941|565675161|FG000|Overall Study|Adverse Event|1|||
156707454|NCT01443728|565675164|FG000|Overall Study|Lost to Follow-up|2|||
156707455|NCT01443728|565675165|FG001|Overall Study|Lost to Follow-up|0|||
156707456|NCT01443728|565675164|FG000|Overall Study|Withdrawal by Subject|1|||
156707457|NCT01443728|565675165|FG001|Overall Study|Withdrawal by Subject|1|||
156707458|NCT01443728|565675164|FG000|Overall Study|Adverse Event|0|||
156707459|NCT01443728|565675165|FG001|Overall Study|Adverse Event|2|||
156707460|NCT04971187|565675166|FG000|Overall Study|Screen failures|2|||
156707461|NCT01207583|565675174|FG000|Overall Study|Withdrawal by Subject|0|||
156707462|NCT01207583|565675175|FG001|Overall Study|Withdrawal by Subject|3|||
156707463|NCT01207583|565675176|FG002|Overall Study|Withdrawal by Subject|1|||
156707464|NCT01207583|565675174|FG000|Overall Study|Participant failed to return|1|||
156707465|NCT01207583|565675175|FG001|Overall Study|Participant failed to return|0|||
156707466|NCT01207583|565675176|FG002|Overall Study|Participant failed to return|0|||
156707467|NCT01207583|565675174|FG000|Overall Study|Lost to Follow-up|0|||
156707468|NCT01207583|565675175|FG001|Overall Study|Lost to Follow-up|2|||
156707469|NCT01207583|565675176|FG002|Overall Study|Lost to Follow-up|0|||
156707470|NCT01696058|565675178|FG000|Overall Study|Adverse Event|21|||
156707471|NCT01696058|565675179|FG001|Overall Study|Adverse Event|11|||
156707472|NCT01696058|565675178|FG000|Overall Study|Lack of Efficacy|2|||
156707473|NCT01696058|565675179|FG001|Overall Study|Lack of Efficacy|3|||
156707474|NCT01696058|565675178|FG000|Overall Study|Protocol Violation|9|||
156707475|NCT01696058|565675179|FG001|Overall Study|Protocol Violation|3|||
156707476|NCT01696058|565675178|FG000|Overall Study|Lost to Follow-up|2|||
156707477|NCT01696058|565675179|FG001|Overall Study|Lost to Follow-up|5|||
156707478|NCT01696058|565675178|FG000|Overall Study|Withdrawal by Subject|4|||
156707479|NCT01696058|565675179|FG001|Overall Study|Withdrawal by Subject|6|||
156707480|NCT01696058|565675178|FG000|Overall Study|Other reason prematurely discontinued|5|||
156707481|NCT01696058|565675179|FG001|Overall Study|Other reason prematurely discontinued|3|||
156707482|NCT02186834|565675181|FG000|Dose Escalation|Death|0|||
156707483|NCT02186834|565675182|FG001|Dose Escalation|Death|0|||
156707484|NCT02186834|565675183|FG002|Dose Escalation|Death|0|||
156707485|NCT02186834|565675184|FG003|Dose Escalation|Death|1|||
157125176|NCT02944448|567208084|FG001|Overall Study|Lost to Follow-up|1|||
157125177|NCT02944448|567208083|FG000|Overall Study|Protocol Violation|25|||
157215612|NCT02092961|567537340|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
157215613|NCT02092961|567537338|FG000|Overall Study|Adverse Event|2|||
157215614|NCT02092961|567537339|FG001|Overall Study|Adverse Event|4|||
156707486|NCT02186834|565675185|FG004|Dose Escalation|Death|0|||
156707487|NCT02186834|565675186|FG005|Dose Escalation|Death|0|||
156707488|NCT02186834|565675181|FG000|Treatment at RP2D|Died prior to treatment|0|||
156707489|NCT02186834|565675182|FG001|Treatment at RP2D|Died prior to treatment|0|||
156707490|NCT02186834|565675183|FG002|Treatment at RP2D|Died prior to treatment|0|||
156707491|NCT02186834|565675184|FG003|Treatment at RP2D|Died prior to treatment|0|||
156707492|NCT02186834|565675185|FG004|Treatment at RP2D|Died prior to treatment|0|||
156707493|NCT02186834|565675186|FG005|Treatment at RP2D|Died prior to treatment|1|||
156707494|NCT04746794|565675189|FG000|Overall Study|Did not complete any study assessment|50303|||
156707495|NCT04746794|565675190|FG001|Overall Study|Did not complete any study assessment|44997|||
156707496|NCT01422187|565675191|FG000|Overall Study|Personal reason|1|||
157125178|NCT02944448|567208084|FG001|Overall Study|Protocol Violation|7|||
156707497|NCT01422187|565675192|FG001|Overall Study|Personal reason|0|||
156707498|NCT01422187|565675193|FG002|Overall Study|Personal reason|0|||
156707499|NCT01422187|565675191|FG000|Overall Study|Lost to Follow-up|0|||
156707500|NCT01422187|565675192|FG001|Overall Study|Lost to Follow-up|1|||
156707501|NCT01422187|565675193|FG002|Overall Study|Lost to Follow-up|0|||
156707502|NCT04611529|565675195|FG000|2-day Follow up|Lost to Follow-up|5|||
156707503|NCT04611529|565675196|FG001|2-day Follow up|Lost to Follow-up|6|||
156707504|NCT04611529|565675197|FG002|2-day Follow up|Lost to Follow-up|3|||
156707505|NCT00741286|565675203|FG000|Overall Study|Lost to Follow-up|15|||
156707506|NCT00741286|565675204|FG001|Overall Study|Lost to Follow-up|10|||
156707507|NCT00741286|565675203|FG000|Overall Study|Adverse Event|1|||
156707508|NCT00741286|565675204|FG001|Overall Study|Adverse Event|6|||
156707509|NCT00741286|565675203|FG000|Overall Study|Protocol Violation|3|||
156707510|NCT00741286|565675204|FG001|Overall Study|Protocol Violation|2|||
156707511|NCT00741286|565675203|FG000|Overall Study|Primary Outcome|1|||
156707512|NCT00741286|565675204|FG001|Overall Study|Primary Outcome|1|||
156707513|NCT00425373|565675215|FG000|Overall Study|Adverse Event|2|||
156707514|NCT00425373|565675216|FG001|Overall Study|Adverse Event|2|||
156707515|NCT00425373|565675217|FG002|Overall Study|Adverse Event|0|||
156707516|NCT00425373|565675218|FG003|Overall Study|Adverse Event|1|||
156707517|NCT00425373|565675219|FG004|Overall Study|Adverse Event|4|||
156707518|NCT00425373|565675220|FG005|Overall Study|Adverse Event|6|||
156707519|NCT00425373|565675221|FG006|Overall Study|Adverse Event|2|||
156707520|NCT00425373|565675222|FG007|Overall Study|Adverse Event|3|||
156707521|NCT00425373|565675223|FG008|Overall Study|Adverse Event|8|||
156707522|NCT00425373|565675215|FG000|Overall Study|Lost to Follow-up|0|||
156707523|NCT00425373|565675216|FG001|Overall Study|Lost to Follow-up|1|||
156707524|NCT00425373|565675217|FG002|Overall Study|Lost to Follow-up|0|||
156707525|NCT00425373|565675218|FG003|Overall Study|Lost to Follow-up|0|||
156707526|NCT00425373|565675219|FG004|Overall Study|Lost to Follow-up|1|||
156707527|NCT00425373|565675220|FG005|Overall Study|Lost to Follow-up|0|||
156707528|NCT00425373|565675221|FG006|Overall Study|Lost to Follow-up|0|||
156707529|NCT00425373|565675222|FG007|Overall Study|Lost to Follow-up|0|||
156707530|NCT00425373|565675223|FG008|Overall Study|Lost to Follow-up|0|||
156707531|NCT00425373|565675215|FG000|Overall Study|Protocol Violation|1|||
156707532|NCT00425373|565675216|FG001|Overall Study|Protocol Violation|0|||
156707533|NCT00425373|565675217|FG002|Overall Study|Protocol Violation|1|||
156707534|NCT00425373|565675218|FG003|Overall Study|Protocol Violation|0|||
156707535|NCT00425373|565675219|FG004|Overall Study|Protocol Violation|0|||
156707536|NCT00425373|565675220|FG005|Overall Study|Protocol Violation|0|||
156707537|NCT00425373|565675221|FG006|Overall Study|Protocol Violation|0|||
156707538|NCT00425373|565675222|FG007|Overall Study|Protocol Violation|5|||
156707539|NCT00425373|565675223|FG008|Overall Study|Protocol Violation|3|||
156707540|NCT00425373|565675215|FG000|Overall Study|Withdrawal by Subject|2|||
156707541|NCT00425373|565675216|FG001|Overall Study|Withdrawal by Subject|0|||
156707542|NCT00425373|565675217|FG002|Overall Study|Withdrawal by Subject|2|||
156707543|NCT00425373|565675218|FG003|Overall Study|Withdrawal by Subject|1|||
156707544|NCT00425373|565675219|FG004|Overall Study|Withdrawal by Subject|4|||
156707545|NCT00425373|565675220|FG005|Overall Study|Withdrawal by Subject|0|||
156707546|NCT00425373|565675221|FG006|Overall Study|Withdrawal by Subject|2|||
156707547|NCT00425373|565675222|FG007|Overall Study|Withdrawal by Subject|2|||
156707548|NCT00425373|565675223|FG008|Overall Study|Withdrawal by Subject|2|||
156707549|NCT00425373|565675215|FG000|Overall Study|Lack of Efficacy|0|||
156707550|NCT00425373|565675216|FG001|Overall Study|Lack of Efficacy|0|||
156707551|NCT00425373|565675217|FG002|Overall Study|Lack of Efficacy|0|||
156707552|NCT00425373|565675218|FG003|Overall Study|Lack of Efficacy|0|||
156707553|NCT00425373|565675219|FG004|Overall Study|Lack of Efficacy|1|||
156707554|NCT00425373|565675220|FG005|Overall Study|Lack of Efficacy|3|||
156707555|NCT00425373|565675221|FG006|Overall Study|Lack of Efficacy|3|||
156707556|NCT00425373|565675222|FG007|Overall Study|Lack of Efficacy|0|||
156707557|NCT00425373|565675223|FG008|Overall Study|Lack of Efficacy|5|||
156707558|NCT00253448|565675224|FG000|Overall Study|Withdrawal by Subject|1|||
156707559|NCT02564887|565675227|FG000|Overall Study|Lost to Follow-up|6|||
156707560|NCT02564887|565675228|FG001|Overall Study|Lost to Follow-up|0|||
156707561|NCT02052011|565675229|FG000|Overall Study|Lost to Follow-up|3|||
156707562|NCT02052011|565675230|FG001|Overall Study|Lost to Follow-up|0|||
156707563|NCT02052011|565675229|FG000|Overall Study|Withdrawal by Subject|1|||
156707564|NCT02052011|565675230|FG001|Overall Study|Withdrawal by Subject|2|||
156707565|NCT00000620|565675231|FG000|Overall Study|Death|86|||
156707566|NCT00000620|565675232|FG001|Overall Study|Death|67|||
156707567|NCT00000620|565675233|FG002|Overall Study|Death|112|||
156707568|NCT00000620|565675234|FG003|Overall Study|Death|126|||
156707569|NCT00000620|565675235|FG004|Overall Study|Death|64|||
156707570|NCT00000620|565675236|FG005|Overall Study|Death|77|||
156707571|NCT00000620|565675237|FG006|Overall Study|Death|91|||
156707572|NCT00000620|565675238|FG007|Overall Study|Death|95|||
156707573|NCT00000620|565675231|FG000|Overall Study|Lost to Follow-up|14|||
156707574|NCT00000620|565675232|FG001|Overall Study|Lost to Follow-up|14|||
156707575|NCT00000620|565675233|FG002|Overall Study|Lost to Follow-up|14|||
156707576|NCT00000620|565675234|FG003|Overall Study|Lost to Follow-up|14|||
156707577|NCT00000620|565675235|FG004|Overall Study|Lost to Follow-up|15|||
156707578|NCT00000620|565675236|FG005|Overall Study|Lost to Follow-up|15|||
156707579|NCT00000620|565675237|FG006|Overall Study|Lost to Follow-up|13|||
156707580|NCT00000620|565675238|FG007|Overall Study|Lost to Follow-up|14|||
156707581|NCT00000620|565675231|FG000|Overall Study|Withdrawal by Subject|40|||
156707582|NCT00000620|565675232|FG001|Overall Study|Withdrawal by Subject|27|||
156707583|NCT00000620|565675233|FG002|Overall Study|Withdrawal by Subject|28|||
156707584|NCT00000620|565675234|FG003|Overall Study|Withdrawal by Subject|27|||
156707585|NCT00000620|565675235|FG004|Overall Study|Withdrawal by Subject|30|||
156707586|NCT00000620|565675236|FG005|Overall Study|Withdrawal by Subject|32|||
156707587|NCT00000620|565675237|FG006|Overall Study|Withdrawal by Subject|32|||
156707588|NCT00000620|565675238|FG007|Overall Study|Withdrawal by Subject|21|||
156707589|NCT00000620|565675231|FG000|Overall Study|missed closeout visit|22|||
156707590|NCT00000620|565675232|FG001|Overall Study|missed closeout visit|28|||
156707591|NCT00000620|565675233|FG002|Overall Study|missed closeout visit|16|||
156707592|NCT00000620|565675234|FG003|Overall Study|missed closeout visit|11|||
156707593|NCT00000620|565675235|FG004|Overall Study|missed closeout visit|26|||
156707594|NCT00000620|565675236|FG005|Overall Study|missed closeout visit|28|||
156707595|NCT00000620|565675237|FG006|Overall Study|missed closeout visit|13|||
156707596|NCT00000620|565675238|FG007|Overall Study|missed closeout visit|16|||
156707597|NCT01851330|565675239|FG000|Overall Study|Lack of Efficacy|10|||
156707598|NCT01851330|565675240|FG001|Overall Study|Lack of Efficacy|9|||
156707599|NCT01851330|565675241|FG002|Overall Study|Lack of Efficacy|2|||
156707600|NCT01851330|565675239|FG000|Overall Study|Lost to Follow-up|1|||
156707601|NCT01851330|565675240|FG001|Overall Study|Lost to Follow-up|6|||
156707602|NCT01851330|565675241|FG002|Overall Study|Lost to Follow-up|9|||
156707603|NCT01851330|565675239|FG000|Overall Study|Withdrew Consent|2|||
156707604|NCT01851330|565675240|FG001|Overall Study|Withdrew Consent|1|||
156707605|NCT01851330|565675241|FG002|Overall Study|Withdrew Consent|0|||
156707606|NCT01851330|565675239|FG000|Overall Study|Investigator's Discretion|0|||
156707607|NCT01851330|565675240|FG001|Overall Study|Investigator's Discretion|0|||
156707608|NCT01851330|565675241|FG002|Overall Study|Investigator's Discretion|1|||
156707609|NCT02648932|565675242|FG000|Overall Study|No transplant|3|||
156707610|NCT02648932|565675243|FG001|Overall Study|No transplant|1|||
156707611|NCT01199016|565675244|FG000|Overall Study|No longer meets eligibility criteria|4|||
156707612|NCT01199016|565675244|FG000|Overall Study|Entrance criteria|5|||
156707613|NCT01199016|565675244|FG000|Overall Study|Protocol Violation|9|||
156707614|NCT01199016|565675244|FG000|Overall Study|Other|13|||
156707615|NCT01199016|565675244|FG000|Overall Study|Withdrawal by Subject|21|||
156707616|NCT01199016|565675244|FG000|Overall Study|Lost to Follow-up|25|||
156707617|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
156707618|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
156707619|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707620|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707621|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707622|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707623|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707624|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707625|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707626|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
156707627|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707628|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
156707629|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707630|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707631|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707632|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707633|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707634|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707635|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
157215615|NCT02092961|567537340|FG002|Overall Study|Adverse Event|0|||
156707636|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
156707637|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
156707638|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
156707639|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707640|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707641|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
157015913|NCT05419505|566811162|FG001|Overall Study|Adverse Event|0|||
157015914|NCT05419505|566811163|FG002|Overall Study|Adverse Event|0|||
157015915|NCT05419505|566811164|FG003|Overall Study|Adverse Event|1|||
157015916|NCT05419505|566811165|FG004|Overall Study|Adverse Event|0|||
157015917|NCT05419505|566811166|FG005|Overall Study|Adverse Event|0|||
157015918|NCT05419505|566811167|FG006|Overall Study|Adverse Event|0|||
157015919|NCT05419505|566811168|FG007|Overall Study|Adverse Event|0|||
157015920|NCT05419505|566811161|FG000|Overall Study|Withdrawal by Subject|1|||
156707642|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707643|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707644|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707645|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707646|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
156707647|NCT02960490|565675253|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
156707648|NCT02960490|565675254|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
156707649|NCT02960490|565675255|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707650|NCT02960490|565675256|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707651|NCT02960490|565675257|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707652|NCT02960490|565675258|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156791223|NCT00089583|565987210|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
156791224|NCT00089583|565987209|FG000|Overall Study|Participant Refused Study Medication|0|||
156791225|NCT00089583|565987210|FG001|Overall Study|Participant Refused Study Medication|2|||
157125179|NCT02944448|567208083|FG000|Overall Study|Withdrawal by Subject|14|||
157125180|NCT02944448|567208084|FG001|Overall Study|Withdrawal by Subject|4|||
156791226|NCT00089583|565987209|FG000|Overall Study|Non-Compliance|0|||
156791227|NCT00089583|565987210|FG001|Overall Study|Non-Compliance|4|||
156791228|NCT00089583|565987209|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
156791229|NCT00089583|565987210|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
156791230|NCT00089583|565987209|FG000|Overall Study|Participant Management Criteria Met|0|||
156791231|NCT00089583|565987210|FG001|Overall Study|Participant Management Criteria Met|1|||
156791232|NCT00089583|565987209|FG000|Overall Study|Reason Not Provided|0|||
156791233|NCT00089583|565987210|FG001|Overall Study|Reason Not Provided|1|||
156791234|NCT00089583|565987209|FG000|Overall Study|Protocol Violation|0|||
156791235|NCT00089583|565987210|FG001|Overall Study|Protocol Violation|3|||
156791236|NCT00089583|565987209|FG000|Overall Study|Principal Investigator Decision|0|||
156791237|NCT00089583|565987210|FG001|Overall Study|Principal Investigator Decision|10|||
156791238|NCT00089583|565987209|FG000|Overall Study|Start of Disallowed Medication|0|||
156791239|NCT00089583|565987210|FG001|Overall Study|Start of Disallowed Medication|1|||
156791240|NCT00089583|565987209|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
156791241|NCT00089583|565987210|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
156791242|NCT00089583|565987209|FG000|Overall Study|Participant Incarcerated|0|||
156791243|NCT00089583|565987210|FG001|Overall Study|Participant Incarcerated|1|||
156791244|NCT01623154|565987211|FG000|Overall Study|Did not drink Pranactin Citric|4|||
156791245|NCT01412983|565987212|FG000|1st Period|Ineligible|0|||
156791246|NCT01412983|565987213|FG001|1st Period|Ineligible|1|||
156791247|NCT01412983|565987212|FG000|1st Period|Positive slit lamp finding|0|||
156791248|NCT01412983|565987213|FG001|1st Period|Positive slit lamp finding|1|||
156791249|NCT01412983|565987212|FG000|1st Period|Unacceptable lens movement|0|||
156791250|NCT01412983|565987213|FG001|1st Period|Unacceptable lens movement|1|||
156791251|NCT01412983|565987212|FG000|1st Period|Inability to maintain wear|0|||
156791252|NCT01412983|565987213|FG001|1st Period|Inability to maintain wear|1|||
156791253|NCT04349098|565987214|FG000|Overall Study|Death|16|||
156791254|NCT04349098|565987215|FG001|Overall Study|Death|8|||
156791255|NCT04349098|565987214|FG000|Overall Study|Lost to Follow-up|11|||
156791256|NCT04349098|565987215|FG001|Overall Study|Lost to Follow-up|8|||
156791257|NCT04349098|565987214|FG000|Overall Study|Withdrawal by Subject|8|||
156791258|NCT04349098|565987215|FG001|Overall Study|Withdrawal by Subject|5|||
156791259|NCT04349098|565987214|FG000|Overall Study|Other|3|||
156791260|NCT04349098|565987215|FG001|Overall Study|Other|5|||
156791261|NCT00800384|565987216|FG000|Overall Study|Withdrawal by Subject|24|||
156791262|NCT00800384|565987217|FG001|Overall Study|Withdrawal by Subject|17|||
156791263|NCT00800384|565987216|FG000|Overall Study|Lost to Follow-up|17|||
156791264|NCT00800384|565987217|FG001|Overall Study|Lost to Follow-up|26|||
156791265|NCT02946996|565987218|FG000|Overall Study|non-evaluable|3|||
156791266|NCT02946996|565987219|FG001|Overall Study|non-evaluable|6|||
156791267|NCT02946996|565987220|FG002|Overall Study|non-evaluable|5|||
156791268|NCT01245049|565987224|FG000|Overall Study|Migrated/moved from study area|0|||
156791269|NCT01245049|565987225|FG001|Overall Study|Migrated/moved from study area|1|||
156791270|NCT01245049|565987224|FG000|Overall Study|Withdrawal by Subject|0|||
156791271|NCT01245049|565987225|FG001|Overall Study|Withdrawal by Subject|1|||
156791272|NCT01245049|565987224|FG000|Overall Study|Lost to Follow-up|1|||
156791273|NCT01245049|565987225|FG001|Overall Study|Lost to Follow-up|2|||
156791274|NCT00450749|565987226|FG000|Overall Study|Withdrawal by Subject|0|||
156791275|NCT00450749|565987227|FG001|Overall Study|Withdrawal by Subject|0|||
156791276|NCT00450749|565987228|FG002|Overall Study|Withdrawal by Subject|2|||
156791277|NCT00450749|565987226|FG000|Overall Study|Noncompliant|0|||
156791278|NCT00450749|565987227|FG001|Overall Study|Noncompliant|1|||
156791279|NCT00450749|565987228|FG002|Overall Study|Noncompliant|0|||
156791280|NCT02151604|565987229|FG000|Overall Study|Lost to Follow-up|3|||
156791281|NCT02151604|565987229|FG000|Overall Study|Withdrawal by Subject|2|||
156791282|NCT02151604|565987229|FG000|Overall Study|Physician Decision|3|||
157125181|NCT02944448|567208083|FG000|Overall Study|Sponsor did not supply drug in time|0|||
156707653|NCT02960490|565675259|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707654|NCT02960490|565675260|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707655|NCT02960490|565675261|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707656|NCT02960490|565675262|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
156707657|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707658|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707659|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
156707660|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
156707661|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707662|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
156707663|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707664|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707665|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707666|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
156707667|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707668|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707669|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
156707670|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707671|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
156707672|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707673|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707674|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
157015921|NCT05419505|566811162|FG001|Overall Study|Withdrawal by Subject|2|||
157015922|NCT05419505|566811163|FG002|Overall Study|Withdrawal by Subject|0|||
157015923|NCT05419505|566811164|FG003|Overall Study|Withdrawal by Subject|0|||
157015924|NCT05419505|566811165|FG004|Overall Study|Withdrawal by Subject|0|||
157015925|NCT05419505|566811166|FG005|Overall Study|Withdrawal by Subject|0|||
157015926|NCT05419505|566811167|FG006|Overall Study|Withdrawal by Subject|1|||
157015927|NCT05419505|566811168|FG007|Overall Study|Withdrawal by Subject|0|||
156707675|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707676|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
156707677|NCT02960490|565675253|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
156707678|NCT02960490|565675254|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
156707679|NCT02960490|565675255|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
156707680|NCT02960490|565675256|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
156707681|NCT02960490|565675257|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
156707682|NCT02960490|565675258|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
156707683|NCT02960490|565675259|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
156707684|NCT02960490|565675260|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
156707685|NCT02960490|565675261|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
156707686|NCT02960490|565675262|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
156707687|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707688|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707689|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707690|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707691|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707692|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707693|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
156707694|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
156707695|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
156707696|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
156707697|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707698|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707699|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707700|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707701|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707702|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707703|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707704|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
156707705|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707706|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
156707707|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707708|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707709|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707710|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156791283|NCT02151604|565987229|FG000|Overall Study|Death|1|||
157015928|NCT05419505|566811161|FG000|Overall Study|Lost to Follow-up|2|||
157125182|NCT02944448|567208084|FG001|Overall Study|Sponsor did not supply drug in time|1|||
157125183|NCT02944448|567208083|FG000|Overall Study|Noncompliant with dosing|1|||
157125184|NCT02944448|567208084|FG001|Overall Study|Noncompliant with dosing|0|||
157125185|NCT02944448|567208083|FG000|Overall Study|Abnormal laboratory values|1|||
156707711|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707712|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
156707713|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
156707714|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
156707715|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
156707716|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
156707717|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707718|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707719|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
157125186|NCT02944448|567208084|FG001|Overall Study|Abnormal laboratory values|0|||
157125187|NCT00716976|567208087|FG000|Overall Study|Adverse Event|2|||
157125188|NCT00716976|567208088|FG001|Overall Study|Adverse Event|0|||
157125189|NCT00716976|567208087|FG000|Overall Study|Death|1|||
157125190|NCT00716976|567208088|FG001|Overall Study|Death|0|||
156707720|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707721|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707722|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707723|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
156707724|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707725|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707726|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
156707727|NCT02960490|565675253|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707728|NCT02960490|565675254|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707729|NCT02960490|565675255|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707730|NCT02960490|565675256|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707731|NCT02960490|565675257|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707732|NCT02960490|565675258|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707733|NCT02960490|565675259|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707734|NCT02960490|565675260|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
156707735|NCT02960490|565675261|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707736|NCT02960490|565675262|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
156707737|NCT02368314|565675267|FG000|Overall Study|Withdrawal by Subject|2|||
156707738|NCT02368314|565675268|FG001|Overall Study|Withdrawal by Subject|1|||
156707739|NCT02368314|565675267|FG000|Overall Study|Adverse Event|1|||
156707740|NCT02368314|565675268|FG001|Overall Study|Adverse Event|2|||
156707741|NCT01266031|565675269|FG000|Overall Study|Not treated|0|||
156707742|NCT01266031|565675270|FG001|Overall Study|Not treated|3|||
156707743|NCT01266031|565675271|FG002|Overall Study|Not treated|2|||
156707744|NCT01307111|565675274|FG000|IUD Insertion|Lost to Follow-up|2|||
156707745|NCT01307111|565675275|FG001|IUD Insertion|Lost to Follow-up|0|||
156707746|NCT01307111|565675274|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
156707747|NCT01307111|565675275|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
156707748|NCT02114385|565675277|FG000|Overall Study|Withdrawal by Subject|3|||
156707749|NCT02114385|565675278|FG001|Overall Study|Withdrawal by Subject|2|||
156707750|NCT02114385|565675277|FG000|Overall Study|Lost to Follow-up|0|||
156707751|NCT02114385|565675278|FG001|Overall Study|Lost to Follow-up|6|||
156707752|NCT02047734|565675282|FG000|Overall Study|Adverse Event|18|||
156707753|NCT02047734|565675283|FG001|Overall Study|Adverse Event|13|||
156707754|NCT02047734|565675284|FG002|Overall Study|Adverse Event|13|||
156707755|NCT02047734|565675282|FG000|Overall Study|Lack of Efficacy|4|||
156707756|NCT02047734|565675283|FG001|Overall Study|Lack of Efficacy|5|||
156707757|NCT02047734|565675284|FG002|Overall Study|Lack of Efficacy|1|||
156707758|NCT02047734|565675282|FG000|Overall Study|Protocol Violation|3|||
156707759|NCT02047734|565675283|FG001|Overall Study|Protocol Violation|1|||
156707760|NCT02047734|565675284|FG002|Overall Study|Protocol Violation|1|||
156707761|NCT02047734|565675282|FG000|Overall Study|Lost to Follow-up|1|||
156707762|NCT02047734|565675283|FG001|Overall Study|Lost to Follow-up|4|||
156707763|NCT02047734|565675284|FG002|Overall Study|Lost to Follow-up|0|||
156707764|NCT02047734|565675282|FG000|Overall Study|Death|0|||
156707765|NCT02047734|565675283|FG001|Overall Study|Death|1|||
156707766|NCT02047734|565675284|FG002|Overall Study|Death|0|||
156707767|NCT02047734|565675282|FG000|Overall Study|Withdrawal by Subject|30|||
156707768|NCT02047734|565675283|FG001|Overall Study|Withdrawal by Subject|31|||
156707769|NCT02047734|565675284|FG002|Overall Study|Withdrawal by Subject|19|||
156707770|NCT02047734|565675282|FG000|Overall Study|Physician Decision|7|||
156707771|NCT02047734|565675283|FG001|Overall Study|Physician Decision|6|||
156707772|NCT02047734|565675284|FG002|Overall Study|Physician Decision|5|||
156707773|NCT02047734|565675282|FG000|Overall Study|Miscellaneous|2|||
156707774|NCT02047734|565675283|FG001|Overall Study|Miscellaneous|4|||
156707775|NCT02047734|565675284|FG002|Overall Study|Miscellaneous|6|||
156707776|NCT02047734|565675282|FG000|Overall Study|Did Not Receive Study Drug|2|||
156791284|NCT00537082|565987230|FG000|Overall Study|Adverse Event|6|||
156791285|NCT00537082|565987231|FG001|Overall Study|Adverse Event|6|||
156791286|NCT00537082|565987232|FG002|Overall Study|Adverse Event|3|||
156791287|NCT00537082|565987230|FG000|Overall Study|Protocol Violation|0|||
156791288|NCT00537082|565987231|FG001|Overall Study|Protocol Violation|2|||
157125191|NCT00716976|567208087|FG000|Overall Study|Physician Decision|2|||
157125192|NCT00716976|567208088|FG001|Overall Study|Physician Decision|2|||
157125193|NCT00716976|567208087|FG000|Overall Study|Withdrawal by Subject|5|||
157125194|NCT00716976|567208088|FG001|Overall Study|Withdrawal by Subject|1|||
157125195|NCT00716976|567208087|FG000|Overall Study|Premature discontinuation cisplatin|5|||
157125196|NCT00716976|567208088|FG001|Overall Study|Premature discontinuation cisplatin|4|||
157125197|NCT00716976|567208087|FG000|Overall Study|Radiation during protocol|1|||
157125198|NCT00716976|567208088|FG001|Overall Study|Radiation during protocol|0|||
157125199|NCT00716976|567208087|FG000|Overall Study|Ineligibles|4|||
157125200|NCT00716976|567208088|FG001|Overall Study|Ineligibles|2|||
157125201|NCT00805740|567208093|FG000|Overall Study|Death|7|||
157125202|NCT00805740|567208094|FG001|Overall Study|Death|4|||
156707777|NCT02047734|565675283|FG001|Overall Study|Did Not Receive Study Drug|4|||
156707778|NCT02047734|565675284|FG002|Overall Study|Did Not Receive Study Drug|1|||
156707779|NCT00582010|565675285|FG000|Overall Study|Death|0|||
156707780|NCT00582010|565675286|FG001|Overall Study|Death|1|||
156707781|NCT05320887|565675291|FG000|Overall Study|Lost to Follow-up|0|||
156707782|NCT05320887|565675292|FG001|Overall Study|Lost to Follow-up|3|||
156707783|NCT05320887|565675293|FG002|Overall Study|Lost to Follow-up|0|||
156707784|NCT05320887|565675294|FG003|Overall Study|Lost to Follow-up|0|||
156707785|NCT02463357|565675297|FG000|Overall Study|Withdrawal by Subject|1|||
156707786|NCT02463357|565675298|FG001|Overall Study|Withdrawal by Subject|0|||
157125203|NCT00805740|567208093|FG000|Overall Study|Withdrawal by Subject|1|||
157125204|NCT00805740|567208094|FG001|Overall Study|Withdrawal by Subject|0|||
157125205|NCT00805740|567208093|FG000|Overall Study|Lost to Follow-up|1|||
157125206|NCT00805740|567208094|FG001|Overall Study|Lost to Follow-up|0|||
156707787|NCT02463357|565675299|FG002|Overall Study|Withdrawal by Subject|0|||
156707788|NCT02463357|565675300|FG003|Overall Study|Withdrawal by Subject|0|||
156707789|NCT02463357|565675301|FG004|Overall Study|Withdrawal by Subject|0|||
156707790|NCT02463357|565675297|FG000|Overall Study|Withdrawal by Subject|0|||
156707791|NCT02463357|565675298|FG001|Overall Study|Withdrawal by Subject|0|||
156707792|NCT02463357|565675299|FG002|Overall Study|Withdrawal by Subject|0|||
156707793|NCT02463357|565675300|FG003|Overall Study|Withdrawal by Subject|0|||
156707794|NCT02463357|565675301|FG004|Overall Study|Withdrawal by Subject|1|||
156707795|NCT01721317|565675302|FG000|Overall Study|Study Closed / Terminated|2|||
156707796|NCT01721317|565675303|FG001|Overall Study|Study Closed / Terminated|2|||
156707797|NCT01721317|565675302|FG000|Overall Study|Physician Decision|0|||
156707798|NCT01721317|565675303|FG001|Overall Study|Physician Decision|1|||
156707799|NCT01721317|565675302|FG000|Overall Study|Withdrawal by Subject|0|||
156707800|NCT01721317|565675303|FG001|Overall Study|Withdrawal by Subject|1|||
156707801|NCT00378573|565675306|FG000|Treatment Period|Adverse Event|9|||
156707802|NCT00378573|565675306|FG000|Treatment Period|Physician Decision|1|||
156707803|NCT00378573|565675306|FG000|Treatment Period|Withdrawal by Subject|2|||
156707804|NCT00378573|565675306|FG000|Treatment Period|Disease Progression|4|||
156707805|NCT00378573|565675306|FG000|Treatment Period|Sponsor decision to close study|1|||
157125207|NCT00805740|567208093|FG000|Overall Study|Randomized, but not treated|2|||
157125208|NCT00805740|567208094|FG001|Overall Study|Randomized, but not treated|0|||
157125209|NCT04033367|567208097|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
157125210|NCT04033367|567208098|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
157125211|NCT04033367|567208097|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
157125212|NCT04033367|567208098|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
157125213|NCT04033367|567208097|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
157125214|NCT04033367|567208098|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
157125215|NCT04033367|567208097|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
157125216|NCT04033367|567208098|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
156707806|NCT00378573|565675306|FG000|Follow-up|Death|12|||
156791289|NCT00537082|565987232|FG002|Overall Study|Protocol Violation|1|||
156791290|NCT00537082|565987230|FG000|Overall Study|Lack of Efficacy|0|||
156791291|NCT00537082|565987231|FG001|Overall Study|Lack of Efficacy|0|||
156791292|NCT00537082|565987232|FG002|Overall Study|Lack of Efficacy|2|||
156707807|NCT00378573|565675306|FG000|Follow-up|Lost to Follow-up|1|||
156791293|NCT00537082|565987230|FG000|Overall Study|Withdrawal by Subject|0|||
157125217|NCT01191697|567208099|FG000|Overall Study|Death|1|||
156707808|NCT00378573|565675306|FG000|Follow-up|Withdrawal by Subject|1|||
156707809|NCT03348163|565675312|FG000|Overall Study|Withdrawal by Subject|2|||
156707810|NCT03348163|565675313|FG001|Overall Study|Withdrawal by Subject|0|||
156707811|NCT00339144|565675314|FG000|Overall Study|Disease progression|5|||
156791294|NCT00537082|565987231|FG001|Overall Study|Withdrawal by Subject|1|||
156707812|NCT00339144|565675315|FG001|Overall Study|Disease progression|2|||
156707813|NCT00339144|565675316|FG002|Overall Study|Disease progression|2|||
156791295|NCT00537082|565987232|FG002|Overall Study|Withdrawal by Subject|0|||
156791296|NCT00537082|565987230|FG000|Overall Study|Discontinued before initiating treatment|3|||
156707814|NCT00339144|565675314|FG000|Overall Study|Study drug toxicity|3|||
156707815|NCT00339144|565675315|FG001|Overall Study|Study drug toxicity|1|||
156707816|NCT00339144|565675316|FG002|Overall Study|Study drug toxicity|1|||
156707817|NCT00339144|565675314|FG000|Overall Study|Participant's request to discontinuation|1|||
156707818|NCT00339144|565675315|FG001|Overall Study|Participant's request to discontinuation|0|||
156707819|NCT00339144|565675316|FG002|Overall Study|Participant's request to discontinuation|1|||
156707820|NCT03485365|565675323|FG000|Overall Study|Protocol Violation|0|||
156707821|NCT03485365|565675324|FG001|Overall Study|Protocol Violation|0|||
156707822|NCT03485365|565675325|FG002|Overall Study|Protocol Violation|0|||
156707823|NCT03485365|565675326|FG003|Overall Study|Protocol Violation|1|||
156707824|NCT03485365|565675327|FG004|Overall Study|Protocol Violation|0|||
156707825|NCT03485365|565675328|FG005|Overall Study|Protocol Violation|0|||
156707826|NCT03485365|565675329|FG006|Overall Study|Protocol Violation|1|||
156707827|NCT03485365|565675330|FG007|Overall Study|Protocol Violation|0|||
156707828|NCT03485365|565675331|FG008|Overall Study|Protocol Violation|0|||
156707829|NCT02181790|565675332|FG000|Overall Study|study terminated|2|||
156707830|NCT02181790|565675333|FG001|Overall Study|study terminated|0|||
156707831|NCT01275430|565675338|FG000|Overall Study|Adverse Event|1|||
156707832|NCT01275430|565675338|FG000|Overall Study|No Contrast Injection|6|||
156707833|NCT01275430|565675338|FG000|Overall Study|Device Malfunction|1|||
156707834|NCT01275430|565675338|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
156707835|NCT04988087|565675339|FG000|Overall Study|Adverse Event|4|||
156707836|NCT04988087|565675340|FG001|Overall Study|Adverse Event|0|||
156707837|NCT04988087|565675341|FG002|Overall Study|Adverse Event|0|||
156707838|NCT04988087|565675342|FG003|Overall Study|Adverse Event|0|||
156707839|NCT04988087|565675339|FG000|Overall Study|Withdrawal by Subject|1|||
156707840|NCT04988087|565675340|FG001|Overall Study|Withdrawal by Subject|1|||
156707841|NCT04988087|565675341|FG002|Overall Study|Withdrawal by Subject|0|||
156707842|NCT04988087|565675342|FG003|Overall Study|Withdrawal by Subject|0|||
156707843|NCT04988087|565675339|FG000|Overall Study|Technical problems|7|||
156707844|NCT04988087|565675340|FG001|Overall Study|Technical problems|9|||
156707845|NCT04988087|565675341|FG002|Overall Study|Technical problems|1|||
156707846|NCT04988087|565675342|FG003|Overall Study|Technical problems|2|||
156707847|NCT02613182|565675343|FG000|Overall Study|Death|6|||
156707848|NCT02613182|565675343|FG000|Overall Study|Physician Decision|1|||
156707849|NCT02613182|565675343|FG000|Overall Study|Study Terminated by Sponsor|21|||
156707850|NCT02613182|565675343|FG000|Overall Study|Withdrawal by Subject|6|||
156707851|NCT01810302|565676922|FG000|Overall Study|Death|1|||
156707852|NCT01810302|565676923|FG001|Overall Study|Death|0|||
156707853|NCT01810302|565676922|FG000|Overall Study|Physician Decision|0|||
156707854|NCT01810302|565676923|FG001|Overall Study|Physician Decision|1|||
156707855|NCT04981717|565676925|FG000|Overall Study|Protocol Violation|0|||
156707856|NCT04981717|565676926|FG001|Overall Study|Protocol Violation|3|||
157015929|NCT05419505|566811162|FG001|Overall Study|Lost to Follow-up|1|||
157015930|NCT05419505|566811163|FG002|Overall Study|Lost to Follow-up|0|||
157015931|NCT05419505|566811164|FG003|Overall Study|Lost to Follow-up|0|||
157015932|NCT05419505|566811165|FG004|Overall Study|Lost to Follow-up|1|||
157015933|NCT05419505|566811166|FG005|Overall Study|Lost to Follow-up|2|||
157015934|NCT05419505|566811167|FG006|Overall Study|Lost to Follow-up|0|||
157015935|NCT05419505|566811168|FG007|Overall Study|Lost to Follow-up|1|||
157015936|NCT02780388|566811169|FG000|Overall Study|Lost to Follow-up|0|||
157015937|NCT02780388|566811170|FG001|Overall Study|Lost to Follow-up|1|||
157015938|NCT02780388|566811171|FG002|Overall Study|Lost to Follow-up|0|||
157015939|NCT02780388|566811172|FG003|Overall Study|Lost to Follow-up|0|||
157015940|NCT02780388|566811173|FG004|Overall Study|Lost to Follow-up|0|||
157015941|NCT02780388|566811169|FG000|Overall Study|Withdrawal by Subject|1|||
157015942|NCT02780388|566811170|FG001|Overall Study|Withdrawal by Subject|1|||
157015943|NCT02780388|566811171|FG002|Overall Study|Withdrawal by Subject|0|||
157015944|NCT02780388|566811172|FG003|Overall Study|Withdrawal by Subject|0|||
157015945|NCT02780388|566811173|FG004|Overall Study|Withdrawal by Subject|0|||
157015946|NCT04527146|566811174|FG000|Overall Study|Withdrawal by Subject|12|||
157015947|NCT04527146|566811175|FG001|Overall Study|Withdrawal by Subject|15|||
157015948|NCT04527146|566811176|FG002|Overall Study|Withdrawal by Subject|7|||
157015949|NCT04527146|566811177|FG003|Overall Study|Withdrawal by Subject|16|||
157015950|NCT04527146|566811174|FG000|Overall Study|Lost to Follow-up|13|||
157015951|NCT04527146|566811175|FG001|Overall Study|Lost to Follow-up|9|||
157015952|NCT04527146|566811176|FG002|Overall Study|Lost to Follow-up|16|||
157015953|NCT04527146|566811177|FG003|Overall Study|Lost to Follow-up|13|||
157015954|NCT04527146|566811174|FG000|Overall Study|Death|0|||
157015955|NCT04527146|566811175|FG001|Overall Study|Death|1|||
157015956|NCT04527146|566811176|FG002|Overall Study|Death|1|||
157015957|NCT04527146|566811177|FG003|Overall Study|Death|0|||
157015958|NCT04527146|566811174|FG000|Overall Study|Adverse Event|0|||
157015959|NCT04527146|566811175|FG001|Overall Study|Adverse Event|0|||
157015960|NCT04527146|566811176|FG002|Overall Study|Adverse Event|1|||
157015961|NCT04527146|566811177|FG003|Overall Study|Adverse Event|0|||
157015962|NCT04527146|566811174|FG000|Overall Study|Ineligible after randomization|2|||
157015963|NCT04527146|566811175|FG001|Overall Study|Ineligible after randomization|0|||
157015964|NCT04527146|566811176|FG002|Overall Study|Ineligible after randomization|2|||
156707857|NCT04981717|565676925|FG000|Overall Study|Adverse Event|1|||
156707858|NCT04981717|565676926|FG001|Overall Study|Adverse Event|3|||
156707859|NCT04981717|565676925|FG000|Overall Study|Pregnancy|1|||
156707860|NCT04981717|565676926|FG001|Overall Study|Pregnancy|0|||
156707861|NCT04981717|565676925|FG000|Overall Study|Physician Decision|1|||
156707862|NCT04981717|565676926|FG001|Overall Study|Physician Decision|0|||
156707863|NCT04981717|565676925|FG000|Overall Study|Sponsor Request|157|||
156707864|NCT04981717|565676926|FG001|Overall Study|Sponsor Request|172|||
156707865|NCT04981717|565676925|FG000|Overall Study|Lost to Follow-up|4|||
156707866|NCT04981717|565676926|FG001|Overall Study|Lost to Follow-up|5|||
156707867|NCT04981717|565676925|FG000|Overall Study|Withdrawal by Subject|50|||
156707868|NCT04981717|565676926|FG001|Overall Study|Withdrawal by Subject|37|||
156707869|NCT02207634|565676927|FG000|Overall Study|Withdrawal by Subject|21|||
156707870|NCT02207634|565676928|FG001|Overall Study|Withdrawal by Subject|31|||
156707871|NCT02207634|565676927|FG000|Overall Study|Lost to Follow-up|1|||
156707872|NCT02207634|565676928|FG001|Overall Study|Lost to Follow-up|0|||
156707873|NCT02585778|565676932|FG000|Overall Study|Adverse Event|17|||
156707874|NCT02585778|565676933|FG001|Overall Study|Adverse Event|4|||
156707875|NCT02585778|565676932|FG000|Overall Study|Participant did not wish to continue|9|||
156707876|NCT02585778|565676933|FG001|Overall Study|Participant did not wish to continue|4|||
156707877|NCT02585778|565676932|FG000|Overall Study|Poor compliance to study protocol|0|||
156707878|NCT02585778|565676933|FG001|Overall Study|Poor compliance to study protocol|2|||
156707879|NCT02585778|565676932|FG000|Overall Study|Death|0|||
156707880|NCT02585778|565676933|FG001|Overall Study|Death|1|||
156707881|NCT02585778|565676932|FG000|Overall Study|Randomized but not treated|1|||
156707882|NCT02585778|565676933|FG001|Overall Study|Randomized but not treated|2|||
156707883|NCT02585778|565676932|FG000|Overall Study|Other than specified above|6|||
156707884|NCT02585778|565676933|FG001|Overall Study|Other than specified above|2|||
156707885|NCT05211726|565676934|FG000|Overall Study|Withdrawal by Subject|2|||
156707886|NCT05211726|565676935|FG001|Overall Study|Withdrawal by Subject|3|||
156707887|NCT05211726|565676934|FG000|Overall Study|Protocol Violation|0|||
156707888|NCT05211726|565676935|FG001|Overall Study|Protocol Violation|1|||
156791297|NCT00537082|565987231|FG001|Overall Study|Discontinued before initiating treatment|0|||
156791298|NCT00537082|565987232|FG002|Overall Study|Discontinued before initiating treatment|0|||
156791299|NCT02568254|565987233|FG000|Period 2|Adverse Event|0|||
156791300|NCT02568254|565987234|FG001|Period 2|Adverse Event|0|||
156791301|NCT02568254|565987235|FG002|Period 2|Adverse Event|1|||
156791302|NCT02568254|565987236|FG003|Period 2|Adverse Event|0|||
156791303|NCT02568254|565987237|FG004|Period 2|Adverse Event|0|||
156791304|NCT02568254|565987238|FG005|Period 2|Adverse Event|0|||
156791305|NCT02568254|565987233|FG000|Period 3|Unstatisfactory Lens fitting|0|||
156791306|NCT02568254|565987234|FG001|Period 3|Unstatisfactory Lens fitting|0|||
156791307|NCT02568254|565987235|FG002|Period 3|Unstatisfactory Lens fitting|0|||
156791308|NCT02568254|565987236|FG003|Period 3|Unstatisfactory Lens fitting|0|||
156791309|NCT02568254|565987237|FG004|Period 3|Unstatisfactory Lens fitting|1|||
156791310|NCT02568254|565987238|FG005|Period 3|Unstatisfactory Lens fitting|0|||
156791311|NCT04495478|565987239|FG000|Overall Study|Withdrawal by Subject|0|||
156791312|NCT04495478|565987240|FG001|Overall Study|Withdrawal by Subject|0|||
156791313|NCT04495478|565987241|FG002|Overall Study|Withdrawal by Subject|0|||
156791314|NCT04495478|565987242|FG003|Overall Study|Withdrawal by Subject|1|||
156791315|NCT04495478|565987243|FG004|Overall Study|Withdrawal by Subject|0|||
156791316|NCT04495478|565987244|FG005|Overall Study|Withdrawal by Subject|0|||
156791317|NCT04495478|565987245|FG006|Overall Study|Withdrawal by Subject|0|||
156791318|NCT04495478|565987239|FG000|Overall Study|Physician Decision|0|||
156791319|NCT04495478|565987240|FG001|Overall Study|Physician Decision|1|||
156791320|NCT04495478|565987241|FG002|Overall Study|Physician Decision|0|||
156791321|NCT04495478|565987242|FG003|Overall Study|Physician Decision|0|||
156791322|NCT04495478|565987243|FG004|Overall Study|Physician Decision|1|||
156791323|NCT04495478|565987244|FG005|Overall Study|Physician Decision|0|||
156791324|NCT04495478|565987245|FG006|Overall Study|Physician Decision|0|||
156791325|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
156791326|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
157125218|NCT01191697|567208099|FG000|Overall Study|Physician Decision|2|||
156707889|NCT02714426|565676939|FG000|Overall Study|Withdrawal by Subject|2|||
156707890|NCT02714426|565676940|FG001|Overall Study|Withdrawal by Subject|2|||
156707891|NCT00863772|565676941|FG000|Overall Study|Adverse Event|1|||
156707892|NCT00863772|565676942|FG001|Overall Study|Adverse Event|4|||
156707893|NCT00863772|565676943|FG002|Overall Study|Adverse Event|0|||
156707894|NCT00863772|565676941|FG000|Overall Study|Lack of Efficacy|4|||
156707895|NCT00863772|565676942|FG001|Overall Study|Lack of Efficacy|2|||
156707896|NCT00863772|565676943|FG002|Overall Study|Lack of Efficacy|4|||
156791327|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
156791328|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Adverse Event|5|||
156791329|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Adverse Event|1|||
156791330|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Adverse Event|0|||
156791331|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
156791332|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
157125219|NCT01191697|567208099|FG000|Overall Study|Pursue chemoradiation|2|||
156707897|NCT00863772|565676941|FG000|Overall Study|Lost to Follow-up|5|||
156707898|NCT00863772|565676942|FG001|Overall Study|Lost to Follow-up|1|||
156707899|NCT00863772|565676943|FG002|Overall Study|Lost to Follow-up|1|||
156707900|NCT00863772|565676941|FG000|Overall Study|Protocol Violation|2|||
156707901|NCT00863772|565676942|FG001|Overall Study|Protocol Violation|0|||
156707902|NCT00863772|565676943|FG002|Overall Study|Protocol Violation|2|||
156707903|NCT00863772|565676941|FG000|Overall Study|Withdrawal by Subject|4|||
156707904|NCT00863772|565676942|FG001|Overall Study|Withdrawal by Subject|7|||
156707905|NCT00863772|565676943|FG002|Overall Study|Withdrawal by Subject|5|||
156707906|NCT00863772|565676941|FG000|Overall Study|Study terminated by sponsor|44|||
156707907|NCT00863772|565676942|FG001|Overall Study|Study terminated by sponsor|45|||
156707908|NCT00863772|565676943|FG002|Overall Study|Study terminated by sponsor|36|||
156707909|NCT00863772|565676941|FG000|Overall Study|Entered extension study|6|||
156707910|NCT00863772|565676942|FG001|Overall Study|Entered extension study|4|||
156707911|NCT00863772|565676943|FG002|Overall Study|Entered extension study|9|||
156707912|NCT00863772|565676941|FG000|Overall Study|Other|1|||
156707913|NCT00863772|565676942|FG001|Overall Study|Other|2|||
156707914|NCT00863772|565676943|FG002|Overall Study|Other|4|||
156707915|NCT00863772|565676941|FG000|Overall Study|Randomized but not Treated|1|||
156707916|NCT00863772|565676942|FG001|Overall Study|Randomized but not Treated|0|||
156707917|NCT00863772|565676943|FG002|Overall Study|Randomized but not Treated|0|||
156707918|NCT00205803|565676947|FG000|Infant Series|Lost to Follow-up|10|||
156707919|NCT00205803|565676948|FG001|Infant Series|Lost to Follow-up|4|||
156707920|NCT00205803|565676947|FG000|Infant Series|Withdrawal by Subject|2|||
156707921|NCT00205803|565676948|FG001|Infant Series|Withdrawal by Subject|5|||
156707922|NCT00205803|565676947|FG000|Infant Series|Physician Decision|3|||
156707923|NCT00205803|565676948|FG001|Infant Series|Physician Decision|1|||
156707924|NCT00205803|565676947|FG000|Infant Series|Protocol Violation|1|||
156707925|NCT00205803|565676948|FG001|Infant Series|Protocol Violation|0|||
156707926|NCT00205803|565676947|FG000|Infant Series|Lost Kaiser coverage|0|||
156707927|NCT00205803|565676948|FG001|Infant Series|Lost Kaiser coverage|1|||
156707928|NCT00205803|565676947|FG000|Infant Series|Non-compliant|1|||
156707929|NCT00205803|565676948|FG001|Infant Series|Non-compliant|0|||
156707930|NCT00205803|565676947|FG000|Infant Series|Sponsor request|1|||
156707931|NCT00205803|565676948|FG001|Infant Series|Sponsor request|0|||
156707932|NCT00205803|565676947|FG000|After Infant Series|Adverse Event|1|||
156707933|NCT00205803|565676948|FG001|After Infant Series|Adverse Event|1|||
156707934|NCT00205803|565676947|FG000|After Infant Series|Protocol Violation|1|||
156707935|NCT00205803|565676948|FG001|After Infant Series|Protocol Violation|1|||
156707936|NCT00205803|565676947|FG000|After Infant Series|Lost to Follow-up|2|||
156707937|NCT00205803|565676948|FG001|After Infant Series|Lost to Follow-up|1|||
156707938|NCT00205803|565676947|FG000|After Infant Series|Physician Decision|3|||
156707939|NCT00205803|565676948|FG001|After Infant Series|Physician Decision|2|||
156707940|NCT00205803|565676947|FG000|After Infant Series|Withdrawal by Subject|1|||
156707941|NCT00205803|565676948|FG001|After Infant Series|Withdrawal by Subject|4|||
156707942|NCT00205803|565676947|FG000|After Infant Series|Other|10|||
156707943|NCT00205803|565676948|FG001|After Infant Series|Other|4|||
156707944|NCT00205803|565676947|FG000|Toddler Dose|Lost to Follow-up|2|||
156707945|NCT00205803|565676948|FG001|Toddler Dose|Lost to Follow-up|3|||
156707946|NCT03185013|565676951|FG000|Overall Study|Withdrawal by Subject|5|||
156707947|NCT03185013|565676952|FG001|Overall Study|Withdrawal by Subject|3|||
156707948|NCT03185013|565676951|FG000|Overall Study|Adverse Event|1|||
156707949|NCT03185013|565676952|FG001|Overall Study|Adverse Event|0|||
156707950|NCT03185013|565676951|FG000|Overall Study|Progressive Disease|1|||
156707951|NCT03185013|565676952|FG001|Overall Study|Progressive Disease|0|||
156707952|NCT03185013|565676951|FG000|Overall Study|Lost to Follow-up|8|||
156707953|NCT03185013|565676952|FG001|Overall Study|Lost to Follow-up|2|||
156707954|NCT03185013|565676951|FG000|Overall Study|Physician Decision|1|||
156707955|NCT03185013|565676952|FG001|Overall Study|Physician Decision|0|||
156707956|NCT03185013|565676951|FG000|Overall Study|Protocol Deviation|2|||
156707957|NCT03185013|565676952|FG001|Overall Study|Protocol Deviation|0|||
156707958|NCT03185013|565676951|FG000|Overall Study|Reason not Specified|3|||
156707959|NCT03185013|565676952|FG001|Overall Study|Reason not Specified|2|||
156707960|NCT03185013|565676951|FG000|Overall Study|Death|1|||
156707961|NCT03185013|565676952|FG001|Overall Study|Death|0|||
156872194|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
156707962|NCT02071849|565676956|FG000|6-month Primary Endpoint|Did not receive device|4|||
156707963|NCT02071849|565676956|FG000|6-month Primary Endpoint|Adverse Event|1|||
156707964|NCT02071849|565676956|FG000|2-year Extended Follow-up|Adverse Event|1|||
156707965|NCT03255655|565676957|FG000|Overall Study|Lost to Follow-up|7|||
156707966|NCT03255655|565676958|FG001|Overall Study|Lost to Follow-up|4|||
156707967|NCT02056392|565676961|FG000|Overall Study|Lost to Follow-up|0|||
156707968|NCT02056392|565676962|FG001|Overall Study|Lost to Follow-up|1|||
156707969|NCT02056392|565676963|FG002|Overall Study|Lost to Follow-up|2|||
156707970|NCT02056392|565676964|FG003|Overall Study|Lost to Follow-up|0|||
156707971|NCT02056392|565676965|FG004|Overall Study|Lost to Follow-up|0|||
156707972|NCT02056392|565676966|FG005|Overall Study|Lost to Follow-up|0|||
156707973|NCT02056392|565676961|FG000|Overall Study|Protocol Violation|1|||
156707974|NCT02056392|565676962|FG001|Overall Study|Protocol Violation|0|||
156707975|NCT02056392|565676963|FG002|Overall Study|Protocol Violation|1|||
156707976|NCT02056392|565676964|FG003|Overall Study|Protocol Violation|0|||
156707977|NCT02056392|565676965|FG004|Overall Study|Protocol Violation|0|||
156707978|NCT02056392|565676966|FG005|Overall Study|Protocol Violation|0|||
156707979|NCT02056392|565676961|FG000|Overall Study|Withdrawal by Subject|1|||
156707980|NCT02056392|565676962|FG001|Overall Study|Withdrawal by Subject|0|||
156707981|NCT02056392|565676963|FG002|Overall Study|Withdrawal by Subject|0|||
156707982|NCT02056392|565676964|FG003|Overall Study|Withdrawal by Subject|0|||
156707983|NCT02056392|565676965|FG004|Overall Study|Withdrawal by Subject|1|||
156707984|NCT02056392|565676966|FG005|Overall Study|Withdrawal by Subject|0|||
156707985|NCT00658021|565676967|FG000|28-Week Treatment Period|Adverse Event|3|||
156707986|NCT00658021|565676968|FG001|28-Week Treatment Period|Adverse Event|1|||
156707987|NCT00658021|565676969|FG002|28-Week Treatment Period|Adverse Event|0|||
156707988|NCT00658021|565676967|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
156707989|NCT00658021|565676968|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
157125220|NCT01191697|567208099|FG000|Overall Study|Break from chemotherapy|2|||
156707990|NCT00658021|565676969|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
156707991|NCT00658021|565676967|FG000|28-Week Treatment Period|Protocol Violation|0|||
156707992|NCT00658021|565676968|FG001|28-Week Treatment Period|Protocol Violation|2|||
156707993|NCT00658021|565676969|FG002|28-Week Treatment Period|Protocol Violation|1|||
156707994|NCT00658021|565676967|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
157125221|NCT01191697|567208099|FG000|Overall Study|Withdrawal by Subject|1|||
157125222|NCT01191697|567208099|FG000|Overall Study|Surveillance|1|||
157125223|NCT01191697|567208099|FG000|Overall Study|Adverse Event|2|||
157125224|NCT01191697|567208099|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
156707995|NCT00658021|565676968|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
156707996|NCT00658021|565676969|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
156707997|NCT00658021|565676967|FG000|28-Week Treatment Period|Physician Decision|1|||
156707998|NCT00658021|565676968|FG001|28-Week Treatment Period|Physician Decision|2|||
156707999|NCT00658021|565676969|FG002|28-Week Treatment Period|Physician Decision|1|||
156708000|NCT00658021|565676967|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708001|NCT00658021|565676968|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708002|NCT00658021|565676969|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
156708003|NCT00658021|565676967|FG000|28-Week Treatment Period|Loss of glucose control|1|||
156708004|NCT00658021|565676968|FG001|28-Week Treatment Period|Loss of glucose control|1|||
156708005|NCT00658021|565676969|FG002|28-Week Treatment Period|Loss of glucose control|10|||
156708006|NCT00658021|565676967|FG000|28-Week Treatment Period|Other|2|||
156708007|NCT00658021|565676968|FG001|28-Week Treatment Period|Other|3|||
156708008|NCT00658021|565676969|FG002|28-Week Treatment Period|Other|1|||
156708009|NCT00658021|565676967|FG000|28-Week Treatment Period|Did not receive treatment|2|||
156708010|NCT00658021|565676968|FG001|28-Week Treatment Period|Did not receive treatment|0|||
156708011|NCT00658021|565676969|FG002|28-Week Treatment Period|Did not receive treatment|0|||
156708012|NCT00658021|565676967|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
156708013|NCT00658021|565676968|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
156708014|NCT00658021|565676969|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
156708015|NCT00658021|565676967|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
156708016|NCT00658021|565676968|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
156708017|NCT00658021|565676969|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
156708018|NCT01806506|565676970|FG000|Overall Study|Lost to Follow-up|2|||
156791333|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
156791334|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Death|8|||
156791335|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Death|24|||
156791336|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Death|0|||
156791337|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
156791338|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
156791339|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
156791340|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
156791341|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
156791342|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
156791343|NCT02931539|565987246|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
156791344|NCT02931539|565987247|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
156791345|NCT02931539|565987248|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
156791346|NCT02931539|565987246|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
156791347|NCT02931539|565987247|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
156791348|NCT02931539|565987248|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
157125225|NCT01191697|567208099|FG000|Overall Study|Not completed but analyzed|25|||
157125226|NCT01534676|567208100|FG000|Overall Study|Study closed due to poor enrollment|2|||
156708019|NCT01806506|565676971|FG001|Overall Study|Lost to Follow-up|1|||
156708020|NCT00725205|565676978|FG000|Overall Study|Adverse Event|22|||
156708021|NCT00725205|565676978|FG000|Overall Study|Investigator Discontinued|1|||
156708022|NCT00725205|565676978|FG000|Overall Study|Non-compliance With Protocol|14|||
156708023|NCT00725205|565676978|FG000|Overall Study|Other|8|||
156708024|NCT00725205|565676978|FG000|Overall Study|Protocol Defined Clinical Event|1|||
156708025|NCT00725205|565676978|FG000|Overall Study|Treatment Failure|41|||
156708026|NCT05819203|565676982|FG000|Overall Study|Protocol Violation|1|||
156708027|NCT05819203|565676983|FG001|Overall Study|Protocol Violation|2|||
156708028|NCT05819203|565676982|FG000|Overall Study|Withdrawal by Subject|1|||
156708029|NCT05819203|565676983|FG001|Overall Study|Withdrawal by Subject|0|||
156708030|NCT04844762|565676986|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708031|NCT04844762|565676987|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708032|NCT04844762|565676988|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
156708033|NCT04844762|565676989|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708034|NCT04844762|565676990|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708035|NCT04844762|565676991|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708036|NCT04844762|565676986|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708037|NCT04844762|565676987|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708038|NCT04844762|565676988|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708039|NCT04844762|565676989|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708040|NCT04844762|565676990|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
156708041|NCT04844762|565676991|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
156708042|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708043|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708044|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708045|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
156708046|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708047|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708048|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708049|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708050|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708051|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708052|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
156708053|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708054|NCT04844762|565676986|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
156708055|NCT04844762|565676987|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
156708056|NCT04844762|565676988|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708057|NCT04844762|565676989|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708058|NCT04844762|565676990|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708059|NCT04844762|565676991|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708060|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708061|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708062|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708063|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708064|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708065|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708066|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708067|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708068|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708069|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708070|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
156708071|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
156708072|NCT04844762|565676986|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
156708073|NCT04844762|565676987|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708074|NCT04844762|565676988|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708075|NCT04844762|565676989|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708076|NCT04844762|565676990|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708077|NCT04844762|565676991|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
156708078|NCT04844762|565676986|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708079|NCT04844762|565676987|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708080|NCT04844762|565676988|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708081|NCT04844762|565676989|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708082|NCT04844762|565676990|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
156708083|NCT04844762|565676991|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
156708084|NCT04844762|565676986|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708085|NCT04844762|565676987|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
156708086|NCT04844762|565676988|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156872195|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
156872196|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
156872197|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
156872198|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
156872199|NCT02952820|566289531|FG000|Active Treatment Period (6 Months)|Not treated|0|||
156872200|NCT02952820|566289532|FG001|Active Treatment Period (6 Months)|Not treated|0|||
156872201|NCT02952820|566289533|FG002|Active Treatment Period (6 Months)|Not treated|1|||
156872202|NCT03614156|566289534|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
156872203|NCT03614156|566289535|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872204|NCT03614156|566289536|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872205|NCT03614156|566289537|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
156872206|NCT03614156|566289534|FG000|Open-Label Treatment Period|Adverse Event|7|||
156872207|NCT03614156|566289535|FG001|Open-Label Treatment Period|Adverse Event|0|||
156872208|NCT03614156|566289536|FG002|Open-Label Treatment Period|Adverse Event|0|||
156872209|NCT03614156|566289537|FG003|Open-Label Treatment Period|Adverse Event|0|||
156872210|NCT03614156|566289534|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
156872211|NCT03614156|566289535|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
156872212|NCT03614156|566289536|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
156872213|NCT03614156|566289537|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
156872214|NCT03614156|566289534|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
156872215|NCT03614156|566289535|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872216|NCT03614156|566289536|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872217|NCT03614156|566289537|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
156872218|NCT03614156|566289534|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
156872219|NCT03614156|566289535|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
156872220|NCT03614156|566289536|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
156872221|NCT03614156|566289537|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
156872222|NCT03614156|566289534|FG000|Open-Label Treatment Period|Protocol Violation|2|||
156872223|NCT03614156|566289535|FG001|Open-Label Treatment Period|Protocol Violation|0|||
156708087|NCT04844762|565676989|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708088|NCT04844762|565676990|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708089|NCT04844762|565676991|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
156708090|NCT04844762|565676986|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708091|NCT04844762|565676987|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708092|NCT04844762|565676988|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708093|NCT04844762|565676989|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
156708094|NCT04844762|565676990|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708095|NCT04844762|565676991|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
156708096|NCT04400682|565676994|FG000|Period 1|Withdrawal by Subject|1|||
156708097|NCT04400682|565676995|FG001|Period 1|Withdrawal by Subject|4|||
156708098|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
156708099|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
156708100|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708101|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708102|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708103|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708104|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708105|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708106|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708107|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
156708108|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
156708109|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
156708110|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708111|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708112|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708113|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708114|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708115|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708116|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708117|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
156708118|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708119|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
156708120|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708121|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708122|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708123|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708124|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708125|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708126|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708127|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
156708128|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
156708129|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708130|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708131|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708132|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708133|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708134|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708135|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708136|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708137|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
156708138|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
156708139|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
156708140|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708141|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708142|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708143|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708144|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708145|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708146|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708147|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
156708148|NCT04784533|565676996|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
156708149|NCT04784533|565676997|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
156708150|NCT04784533|565676998|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708151|NCT04784533|565676999|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708152|NCT04784533|565677000|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708153|NCT04784533|565677001|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708154|NCT04784533|565677002|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708155|NCT04784533|565677003|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708156|NCT04784533|565677004|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708157|NCT04784533|565677005|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
156708158|NCT04784533|565676996|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708159|NCT04784533|565676997|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708160|NCT04784533|565676998|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
156708161|NCT04784533|565676999|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708162|NCT04784533|565677000|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708163|NCT04784533|565677001|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
157015965|NCT04527146|566811177|FG003|Overall Study|Ineligible after randomization|2|||
157015966|NCT04527146|566811174|FG000|Overall Study|Moved to a different group|6|||
157015967|NCT04527146|566811175|FG001|Overall Study|Moved to a different group|3|||
156708164|NCT04784533|565677002|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708165|NCT04784533|565677003|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708166|NCT04784533|565677004|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708167|NCT04784533|565677005|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
156708168|NCT04784533|565676996|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708169|NCT04784533|565676997|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708170|NCT04784533|565676998|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708171|NCT04784533|565676999|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708172|NCT04784533|565677000|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708173|NCT04784533|565677001|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708174|NCT04784533|565677002|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708175|NCT04784533|565677003|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708176|NCT04784533|565677004|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
156708177|NCT04784533|565677005|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
156708178|NCT04784533|565676996|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708179|NCT04784533|565676997|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708180|NCT04784533|565676998|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708181|NCT04784533|565676999|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708182|NCT04784533|565677000|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708183|NCT04784533|565677001|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
157015968|NCT04527146|566811176|FG002|Overall Study|Moved to a different group|0|||
157015969|NCT04527146|566811177|FG003|Overall Study|Moved to a different group|2|||
156708184|NCT04784533|565677002|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708185|NCT04784533|565677003|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
156708186|NCT04784533|565677004|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
156708187|NCT04784533|565677005|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
156708188|NCT00477633|565677006|FG000|Overall Study|Did not receive treatment|23|||
156708189|NCT00477633|565677006|FG000|Overall Study|Adverse Event|143|||
156708190|NCT00477633|565677006|FG000|Overall Study|Pregnancy|23|||
156708191|NCT00477633|565677006|FG000|Overall Study|Lost to Follow-up|271|||
156708192|NCT00477633|565677006|FG000|Overall Study|Withdrawal by Subject|149|||
156708193|NCT00477633|565677006|FG000|Overall Study|Protocol Violation|25|||
156708194|NCT00477633|565677006|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
156708195|NCT02203331|565677013|FG000|Overall Study|Pregnancy|1|||
156708196|NCT02203331|565677014|FG001|Overall Study|Pregnancy|0|||
156708197|NCT02203331|565677015|FG002|Overall Study|Pregnancy|0|||
156708198|NCT02203331|565677016|FG003|Overall Study|Pregnancy|0|||
156708199|NCT02203331|565677017|FG004|Overall Study|Pregnancy|2|||
156708200|NCT02203331|565677018|FG005|Overall Study|Pregnancy|0|||
156708201|NCT02203331|565677013|FG000|Overall Study|Withdrawal by Subject|1|||
156708202|NCT02203331|565677014|FG001|Overall Study|Withdrawal by Subject|0|||
156708203|NCT02203331|565677015|FG002|Overall Study|Withdrawal by Subject|1|||
156708204|NCT02203331|565677016|FG003|Overall Study|Withdrawal by Subject|0|||
156708205|NCT02203331|565677017|FG004|Overall Study|Withdrawal by Subject|0|||
156708206|NCT02203331|565677018|FG005|Overall Study|Withdrawal by Subject|3|||
156708207|NCT02203331|565677013|FG000|Overall Study|Adverse Event|4|||
156708208|NCT02203331|565677014|FG001|Overall Study|Adverse Event|8|||
156708209|NCT02203331|565677015|FG002|Overall Study|Adverse Event|3|||
156708210|NCT02203331|565677016|FG003|Overall Study|Adverse Event|4|||
156708211|NCT02203331|565677017|FG004|Overall Study|Adverse Event|3|||
156708212|NCT02203331|565677018|FG005|Overall Study|Adverse Event|3|||
156708213|NCT02203331|565677013|FG000|Overall Study|Other Reasons|1|||
156708214|NCT02203331|565677014|FG001|Overall Study|Other Reasons|2|||
156708215|NCT02203331|565677015|FG002|Overall Study|Other Reasons|0|||
156708216|NCT02203331|565677016|FG003|Overall Study|Other Reasons|2|||
156708217|NCT02203331|565677017|FG004|Overall Study|Other Reasons|0|||
156708218|NCT02203331|565677018|FG005|Overall Study|Other Reasons|0|||
156708219|NCT02203331|565677013|FG000|Overall Study|Lack of Efficacy|0|||
156708220|NCT02203331|565677014|FG001|Overall Study|Lack of Efficacy|2|||
156708221|NCT02203331|565677015|FG002|Overall Study|Lack of Efficacy|1|||
156708222|NCT02203331|565677016|FG003|Overall Study|Lack of Efficacy|0|||
156708223|NCT02203331|565677017|FG004|Overall Study|Lack of Efficacy|0|||
156708224|NCT02203331|565677018|FG005|Overall Study|Lack of Efficacy|1|||
156708225|NCT02203331|565677013|FG000|Overall Study|Protocol Violation|0|||
156708226|NCT02203331|565677014|FG001|Overall Study|Protocol Violation|2|||
156708227|NCT02203331|565677015|FG002|Overall Study|Protocol Violation|0|||
156708228|NCT02203331|565677016|FG003|Overall Study|Protocol Violation|1|||
156708229|NCT02203331|565677017|FG004|Overall Study|Protocol Violation|1|||
156708230|NCT02203331|565677018|FG005|Overall Study|Protocol Violation|0|||
156708231|NCT02203331|565677013|FG000|Overall Study|Lost to Follow-up|0|||
156708232|NCT02203331|565677014|FG001|Overall Study|Lost to Follow-up|0|||
156708233|NCT02203331|565677015|FG002|Overall Study|Lost to Follow-up|0|||
156708234|NCT02203331|565677016|FG003|Overall Study|Lost to Follow-up|0|||
156708235|NCT02203331|565677017|FG004|Overall Study|Lost to Follow-up|1|||
156708236|NCT02203331|565677018|FG005|Overall Study|Lost to Follow-up|0|||
156708237|NCT03597464|565677019|FG000|Overall Study|Withdrawal by Subject|4|||
156708238|NCT03597464|565677020|FG001|Overall Study|Withdrawal by Subject|5|||
156708239|NCT03597464|565677019|FG000|Overall Study|Lost to Follow-up|3|||
156708240|NCT03597464|565677020|FG001|Overall Study|Lost to Follow-up|1|||
156708241|NCT03597464|565677019|FG000|Overall Study|Pregnancy|3|||
156708242|NCT03597464|565677020|FG001|Overall Study|Pregnancy|1|||
156872224|NCT03614156|566289536|FG002|Open-Label Treatment Period|Protocol Violation|0|||
157015970|NCT04840199|566811178|FG000|Overall Study|Study Terminated by Sponsor|8|||
156708243|NCT03597464|565677019|FG000|Overall Study|Lack of Efficacy|2|||
156708244|NCT03597464|565677020|FG001|Overall Study|Lack of Efficacy|0|||
156708245|NCT03597464|565677019|FG000|Overall Study|Physician Decision|2|||
156708246|NCT03597464|565677020|FG001|Overall Study|Physician Decision|2|||
156708247|NCT03597464|565677019|FG000|Overall Study|Protocol Violation|1|||
156708248|NCT03597464|565677020|FG001|Overall Study|Protocol Violation|1|||
156708249|NCT03597464|565677019|FG000|Overall Study|Adverse Event|0|||
156708250|NCT03597464|565677020|FG001|Overall Study|Adverse Event|2|||
156708251|NCT03597464|565677019|FG000|Overall Study|Death|0|||
156708252|NCT03597464|565677020|FG001|Overall Study|Death|3|||
156708253|NCT02542605|565677025|FG000|Part B: Challenge Phase|Sponsor decision|1|||
156708254|NCT02542605|565677026|FG001|Part B: Challenge Phase|Sponsor decision|0|||
156708255|NCT02542605|565677027|FG002|Part B: Challenge Phase|Sponsor decision|0|||
156708256|NCT02542605|565677025|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
156708257|NCT02542605|565677026|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
156708258|NCT02542605|565677027|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
156708259|NCT02682927|565677028|FG000|Overall Study|Adverse Event|0|||
156708260|NCT02682927|565677029|FG001|Overall Study|Adverse Event|0|||
157125227|NCT01534676|567208101|FG001|Overall Study|Study closed due to poor enrollment|1|||
157125228|NCT02634580|567208102|FG000|Double-blind Treatment Period|Subject Request|1|||
157125229|NCT02634580|567208103|FG001|Double-blind Treatment Period|Subject Request|0|||
157125230|NCT02634580|567208104|FG002|Double-blind Treatment Period|Subject Request|1|||
157125231|NCT02634580|567208105|FG003|Double-blind Treatment Period|Subject Request|1|||
157125232|NCT02634580|567208102|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
157125233|NCT02634580|567208103|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
157125234|NCT02634580|567208104|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
157125235|NCT02634580|567208105|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
157125236|NCT00424827|567208106|FG000|Overall Study|Adverse Event|1|||
157125237|NCT02397473|567208109|FG000|Treatment Phase|Adverse Event|1|||
157125238|NCT02397473|567208110|FG001|Treatment Phase|Adverse Event|2|||
157125239|NCT02397473|567208109|FG000|Treatment Phase|Lack of Efficacy|8|||
157125240|NCT02397473|567208110|FG001|Treatment Phase|Lack of Efficacy|1|||
157125241|NCT02397473|567208109|FG000|Treatment Phase|Lost to Follow-up|1|||
157125242|NCT02397473|567208110|FG001|Treatment Phase|Lost to Follow-up|0|||
157125243|NCT02397473|567208109|FG000|Treatment Phase|Withdrawal by Subject|2|||
157125244|NCT02397473|567208110|FG001|Treatment Phase|Withdrawal by Subject|1|||
157125245|NCT02397473|567208109|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
157125246|NCT02397473|567208110|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
157125247|NCT02397473|567208109|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
157125248|NCT02397473|567208110|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
157125249|NCT02397473|567208109|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
157125250|NCT02397473|567208110|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
157125251|NCT02397473|567208109|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
157125252|NCT02397473|567208110|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
157125253|NCT02397473|567208109|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
157125254|NCT02397473|567208110|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
157125255|NCT00491179|567208111|FG000|Overall Study|Adverse Event|5|||
157125256|NCT00491179|567208112|FG001|Overall Study|Adverse Event|1|||
157125257|NCT00491179|567208111|FG000|Overall Study|Withdrawal by Subject|2|||
157125258|NCT00491179|567208112|FG001|Overall Study|Withdrawal by Subject|1|||
157125259|NCT02009878|567208114|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
157125260|NCT02009878|567208115|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
157125261|NCT02009878|567208116|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
157125262|NCT01790048|567208118|FG000|Overall Study|Incorrect Age|9|||
157125263|NCT01790048|567208119|FG001|Overall Study|Incorrect Age|14|||
157125264|NCT01790048|567208118|FG000|Overall Study|data entry error|0|||
157125265|NCT01790048|567208119|FG001|Overall Study|data entry error|1|||
157125266|NCT01790048|567208118|FG000|Overall Study|Other|0|||
157125267|NCT01790048|567208119|FG001|Overall Study|Other|2|||
157125268|NCT01790048|567208118|FG000|Overall Study|SAM at Enrollment|2|||
157125269|NCT01790048|567208119|FG001|Overall Study|SAM at Enrollment|0|||
157125270|NCT01790048|567208118|FG000|Overall Study|Measurement error|1|||
157125271|NCT01790048|567208119|FG001|Overall Study|Measurement error|0|||
157125272|NCT03178487|567208120|FG000|Period 1|Adverse Event|1|||
157125273|NCT03178487|567208121|FG001|Period 1|Adverse Event|2|||
156708261|NCT02682927|565677030|FG002|Overall Study|Adverse Event|5|||
156708262|NCT02682927|565677031|FG003|Overall Study|Adverse Event|1|||
156708263|NCT02682927|565677032|FG004|Overall Study|Adverse Event|0|||
156708264|NCT02682927|565677033|FG005|Overall Study|Adverse Event|2|||
156708265|NCT02682927|565677028|FG000|Overall Study|Death|0|||
156708266|NCT02682927|565677029|FG001|Overall Study|Death|0|||
157125274|NCT03178487|567208120|FG000|Period 1|Withdrawal by Subject|2|||
157125275|NCT03178487|567208121|FG001|Period 1|Withdrawal by Subject|1|||
157125276|NCT03178487|567208120|FG000|Period 1|Lost to Follow-up|1|||
157125277|NCT03178487|567208121|FG001|Period 1|Lost to Follow-up|0|||
157125278|NCT03178487|567208120|FG000|Period 1|Other|0|||
157125279|NCT03178487|567208121|FG001|Period 1|Other|1|||
157125280|NCT03178487|567208120|FG000|Period 2|Adverse Event|4|||
156708267|NCT02682927|565677030|FG002|Overall Study|Death|0|||
157125281|NCT03178487|567208121|FG001|Period 2|Adverse Event|4|||
156708268|NCT02682927|565677031|FG003|Overall Study|Death|1|||
157125282|NCT03178487|567208120|FG000|Period 2|Withdrawal by Subject|6|||
157125283|NCT03178487|567208121|FG001|Period 2|Withdrawal by Subject|6|||
157125284|NCT03178487|567208120|FG000|Period 2|Lost to Follow-up|2|||
156708269|NCT02682927|565677032|FG004|Overall Study|Death|0|||
156791349|NCT00655746|565987249|FG000|Overall Study|Withdrawal by Subject|1|||
157125285|NCT03178487|567208121|FG001|Period 2|Lost to Follow-up|2|||
157125286|NCT03178487|567208120|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
157125287|NCT03178487|567208121|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
157125288|NCT03178487|567208120|FG000|Period 2|Other|8|||
156791350|NCT03178942|565987252|FG000|Overall Study|Withdrawal by Subject|2|||
156791351|NCT03178942|565987253|FG001|Overall Study|Withdrawal by Subject|0|||
156791352|NCT03178942|565987252|FG000|Overall Study|Lost to Follow-up|1|||
156791353|NCT03178942|565987253|FG001|Overall Study|Lost to Follow-up|2|||
156708270|NCT02682927|565677033|FG005|Overall Study|Death|0|||
157125289|NCT03178487|567208121|FG001|Period 2|Other|7|||
157125290|NCT03237065|567208124|FG000|Overall Study|Adverse Event|0|||
157125291|NCT03237065|567208125|FG001|Overall Study|Adverse Event|2|||
157125292|NCT03237065|567208124|FG000|Overall Study|Protocol Violation|0|||
157125293|NCT03237065|567208125|FG001|Overall Study|Protocol Violation|1|||
157125294|NCT03237065|567208124|FG000|Overall Study|Withdrawal by Subject|3|||
157125295|NCT03237065|567208125|FG001|Overall Study|Withdrawal by Subject|0|||
157125296|NCT03237065|567208124|FG000|Overall Study|Lost to Follow-up|1|||
156708271|NCT02682927|565677028|FG000|Overall Study|Lack of Efficacy|1|||
156708272|NCT02682927|565677029|FG001|Overall Study|Lack of Efficacy|0|||
156708273|NCT02682927|565677030|FG002|Overall Study|Lack of Efficacy|0|||
156708274|NCT02682927|565677031|FG003|Overall Study|Lack of Efficacy|1|||
156708275|NCT02682927|565677032|FG004|Overall Study|Lack of Efficacy|0|||
156708276|NCT02682927|565677033|FG005|Overall Study|Lack of Efficacy|0|||
156708277|NCT02682927|565677028|FG000|Overall Study|Other|0|||
156708278|NCT02682927|565677029|FG001|Overall Study|Other|0|||
156708279|NCT02682927|565677030|FG002|Overall Study|Other|0|||
156708280|NCT02682927|565677031|FG003|Overall Study|Other|2|||
156708281|NCT02682927|565677032|FG004|Overall Study|Other|0|||
156791354|NCT03061214|565987258|FG000|Overall Study|Withdrawal by Subject|21|||
156791355|NCT03061214|565987259|FG001|Overall Study|Withdrawal by Subject|26|||
156791356|NCT03061214|565987260|FG002|Overall Study|Withdrawal by Subject|9|||
156791357|NCT03061214|565987258|FG000|Overall Study|Lost to Follow-up|3|||
156791358|NCT03061214|565987259|FG001|Overall Study|Lost to Follow-up|1|||
156791359|NCT03061214|565987260|FG002|Overall Study|Lost to Follow-up|1|||
156791360|NCT03061214|565987258|FG000|Overall Study|Death|1|||
156791361|NCT03061214|565987259|FG001|Overall Study|Death|1|||
156791362|NCT03061214|565987260|FG002|Overall Study|Death|0|||
156791363|NCT01197300|565988854|FG000|Overall Study|Lost to Follow-up|0|||
156791364|NCT01197300|565988855|FG001|Overall Study|Lost to Follow-up|1|||
156791365|NCT01197300|565988854|FG000|Overall Study|Protocol Violation|0|||
156791366|NCT01197300|565988855|FG001|Overall Study|Protocol Violation|1|||
156791367|NCT02113878|565988856|FG000|Overall Study|Adverse Event|1|||
156791368|NCT02113878|565988857|FG001|Overall Study|Adverse Event|0|||
156791369|NCT02113878|565988856|FG000|Overall Study|Withdrawal by Subject|1|||
156791370|NCT02113878|565988857|FG001|Overall Study|Withdrawal by Subject|0|||
156791371|NCT02113878|565988856|FG000|Overall Study|patient non-compliance|1|||
156791372|NCT02113878|565988857|FG001|Overall Study|patient non-compliance|0|||
156791373|NCT00530257|565988865|FG000|Overall Study|Lost to Follow-up|1|||
156791374|NCT05130281|565988869|FG000|Overall Study|Withdrawal by Subject|0|||
156791375|NCT05130281|565988870|FG001|Overall Study|Withdrawal by Subject|0|||
156791376|NCT05130281|565988871|FG002|Overall Study|Withdrawal by Subject|1|||
156791377|NCT06844812|565988872|FG000|Overall Study|Lost to Follow-up|5|||
156791378|NCT06844812|565988872|FG000|Overall Study|stigmatization concerns|2|||
156791379|NCT06844812|565988872|FG000|Overall Study|medication refusal|2|||
156791380|NCT06844812|565988872|FG000|Overall Study|concerns about possible side effects|2|||
156791381|NCT06844812|565988872|FG000|Overall Study|wanting to seek another specialist opinion|2|||
156791382|NCT06844812|565988872|FG000|Overall Study|side effects (dizziness)|1|||
156791383|NCT03142451|565988901|FG000|Overall Study|Adverse Event|5|||
156791384|NCT03142451|565988902|FG001|Overall Study|Adverse Event|2|||
156791385|NCT03142451|565988901|FG000|Overall Study|Lost to Follow-up|25|||
156791386|NCT03142451|565988902|FG001|Overall Study|Lost to Follow-up|8|||
156791387|NCT03142451|565988901|FG000|Overall Study|Participant request|24|||
156791388|NCT03142451|565988902|FG001|Overall Study|Participant request|12|||
156791389|NCT03142451|565988901|FG000|Overall Study|Protocol Violation|3|||
156791390|NCT03142451|565988902|FG001|Overall Study|Protocol Violation|1|||
156791391|NCT03142451|565988901|FG000|Overall Study|Other|1|||
156791392|NCT03142451|565988902|FG001|Overall Study|Other|1|||
156791393|NCT05333965|565988903|FG000|First Intervention|Adverse Event|0|||
157125297|NCT03237065|567208125|FG001|Overall Study|Lost to Follow-up|0|||
157215616|NCT01623830|567537343|FG000|Overall Study|Withdrawal by Subject|6|||
156708282|NCT02682927|565677033|FG005|Overall Study|Other|0|||
156708283|NCT02682927|565677028|FG000|Overall Study|Withdrawal by Subject|2|||
156708284|NCT02682927|565677029|FG001|Overall Study|Withdrawal by Subject|0|||
156708285|NCT02682927|565677030|FG002|Overall Study|Withdrawal by Subject|1|||
156791394|NCT05333965|565988904|FG001|First Intervention|Adverse Event|1|||
156791395|NCT05333965|565988903|FG000|First Intervention|Withdrawal by Subject|0|||
156791396|NCT05333965|565988904|FG001|First Intervention|Withdrawal by Subject|1|||
156791397|NCT03048019|565988905|FG000|Overall Study|Adverse Event|1|||
156791398|NCT03048019|565988906|FG001|Overall Study|Adverse Event|0|||
156791399|NCT01730729|565988907|FG000|Overall Study|Adverse Event|1|||
156791400|NCT01730729|565988907|FG000|Overall Study|Death|1|||
156791401|NCT01730729|565988907|FG000|Overall Study|Progressive Disease|12|||
156791402|NCT00203242|565988910|FG000|Overall Study|Lost to Follow-up|1|||
156791403|NCT02837952|565988912|FG000|Overall Study|Adverse Event|0|||
156791404|NCT02837952|565988913|FG001|Overall Study|Adverse Event|1|||
156791405|NCT02837952|565988912|FG000|Overall Study|Withdrawal by Subject|4|||
156791406|NCT02837952|565988913|FG001|Overall Study|Withdrawal by Subject|5|||
156708286|NCT02682927|565677031|FG003|Overall Study|Withdrawal by Subject|0|||
157215617|NCT01623830|567537344|FG001|Overall Study|Withdrawal by Subject|7|||
157125298|NCT03237065|567208124|FG000|Overall Study|Unable to obtain venous access|0|||
157125299|NCT03237065|567208125|FG001|Overall Study|Unable to obtain venous access|1|||
156708287|NCT02682927|565677032|FG004|Overall Study|Withdrawal by Subject|1|||
156708288|NCT02682927|565677033|FG005|Overall Study|Withdrawal by Subject|1|||
156708289|NCT03316547|565677036|FG000|Overall Study|Death|3|||
156708290|NCT03316547|565677037|FG001|Overall Study|Death|1|||
156708291|NCT03316547|565677036|FG000|Overall Study|Lost to Follow-up|6|||
156708292|NCT03316547|565677037|FG001|Overall Study|Lost to Follow-up|6|||
156708293|NCT03316547|565677036|FG000|Overall Study|Withdrawal by Subject|3|||
156708294|NCT03316547|565677037|FG001|Overall Study|Withdrawal by Subject|2|||
156708295|NCT03316547|565677036|FG000|Overall Study|Transfer to another hospital|6|||
156708296|NCT03316547|565677037|FG001|Overall Study|Transfer to another hospital|4|||
156708297|NCT00278889|565677038|FG000|Overall Study|Withdrawal by Subject|0|||
156708298|NCT00278889|565677039|FG001|Overall Study|Withdrawal by Subject|5|||
156708299|NCT00278889|565677040|FG002|Overall Study|Withdrawal by Subject|3|||
156708300|NCT00278889|565677038|FG000|Overall Study|Lost to Follow-up|1|||
156708301|NCT00278889|565677039|FG001|Overall Study|Lost to Follow-up|1|||
156708302|NCT00278889|565677040|FG002|Overall Study|Lost to Follow-up|0|||
156708303|NCT00278889|565677038|FG000|Overall Study|Death|24|||
156708304|NCT00278889|565677039|FG001|Overall Study|Death|21|||
156708305|NCT00278889|565677040|FG002|Overall Study|Death|17|||
156708306|NCT03462459|565677041|FG000|Overall Study|Death|1|||
156708307|NCT03462459|565677042|FG001|Overall Study|Death|0|||
156708308|NCT03462459|565677041|FG000|Overall Study|Lack of Efficacy|2|||
156708309|NCT03462459|565677042|FG001|Overall Study|Lack of Efficacy|4|||
156708310|NCT03462459|565677041|FG000|Overall Study|Lost to Follow-up|1|||
157125300|NCT00662792|567208130|FG000|Period 1|Personal Reasons|0|||
156708311|NCT03462459|565677042|FG001|Overall Study|Lost to Follow-up|3|||
156708312|NCT03462459|565677041|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
156708313|NCT03462459|565677042|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
156708314|NCT03462459|565677041|FG000|Overall Study|Withdrawal by Subject|3|||
156708315|NCT03462459|565677042|FG001|Overall Study|Withdrawal by Subject|2|||
156708316|NCT03462459|565677041|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
156708317|NCT03462459|565677042|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
156708318|NCT01243775|565677043|FG000|Overall Study|Withdrawal by Subject|2|||
156708319|NCT01177059|565677044|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
156708320|NCT01177059|565677044|FG000|Overall Study|Withdrew consent|2|||
156708321|NCT01177059|565677044|FG000|Overall Study|Lost to Follow-up|18|||
156708322|NCT04051619|565677045|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
156708323|NCT04051619|565677046|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
156708324|NCT04051619|565677045|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
156708325|NCT04051619|565677046|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
156708326|NCT00974922|565678522|FG000|Overall Study|study terminated|24|||
156708327|NCT00287586|565678523|FG000|Overall Study|Withdrew Consent|19|||
156708328|NCT00287586|565678524|FG001|Overall Study|Withdrew Consent|30|||
156708329|NCT00287586|565678523|FG000|Overall Study|Lost to Follow-up|5|||
156708330|NCT00287586|565678524|FG001|Overall Study|Lost to Follow-up|4|||
156708331|NCT00287586|565678523|FG000|Overall Study|Death|2|||
156708332|NCT00287586|565678524|FG001|Overall Study|Death|3|||
156708333|NCT00287586|565678523|FG000|Overall Study|Elevated Hematocrit|3|||
156708334|NCT00287586|565678524|FG001|Overall Study|Elevated Hematocrit|0|||
156708335|NCT00287586|565678523|FG000|Overall Study|Rash|3|||
156708336|NCT00287586|565678524|FG001|Overall Study|Rash|0|||
156708337|NCT00287586|565678523|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
156708338|NCT00287586|565678524|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
156708339|NCT00287586|565678523|FG000|Overall Study|Stroke|2|||
156708340|NCT00287586|565678524|FG001|Overall Study|Stroke|0|||
156708341|NCT00287586|565678523|FG000|Overall Study|Myocardial Infarction|1|||
156708342|NCT00287586|565678524|FG001|Overall Study|Myocardial Infarction|0|||
156708343|NCT00287586|565678523|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
156708344|NCT00287586|565678524|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
156708345|NCT00287586|565678523|FG000|Overall Study|Cognitive Impairment|1|||
156708346|NCT00287586|565678524|FG001|Overall Study|Cognitive Impairment|0|||
157125301|NCT00662792|567208131|FG001|Period 1|Personal Reasons|0|||
157125302|NCT00662792|567208132|FG002|Period 1|Personal Reasons|1|||
157125303|NCT00662792|567208133|FG003|Period 1|Personal Reasons|0|||
157125304|NCT00662792|567208130|FG000|Period 1|Refused continuing medication|0|||
156708347|NCT00287586|565678523|FG000|Overall Study|Pancreatic Cancer|1|||
156708348|NCT00287586|565678524|FG001|Overall Study|Pancreatic Cancer|3|||
156708349|NCT00287586|565678523|FG000|Overall Study|Sleep Apnea|1|||
156708350|NCT00287586|565678524|FG001|Overall Study|Sleep Apnea|0|||
156708351|NCT00287586|565678523|FG000|Overall Study|Shoulder Pain|1|||
156708352|NCT00287586|565678524|FG001|Overall Study|Shoulder Pain|0|||
156708353|NCT00287586|565678523|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
156708354|NCT00287586|565678524|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
156708355|NCT00287586|565678523|FG000|Overall Study|Nonadherence|1|||
157125305|NCT00662792|567208131|FG001|Period 1|Refused continuing medication|1|||
157125306|NCT00662792|567208132|FG002|Period 1|Refused continuing medication|1|||
157125307|NCT00662792|567208133|FG003|Period 1|Refused continuing medication|0|||
156708356|NCT00287586|565678524|FG001|Overall Study|Nonadherence|1|||
156708357|NCT00287586|565678523|FG000|Overall Study|Enrolled in Another Study|1|||
156708358|NCT00287586|565678524|FG001|Overall Study|Enrolled in Another Study|0|||
156708359|NCT00287586|565678523|FG000|Overall Study|Major Depression|0|||
156708360|NCT00287586|565678524|FG001|Overall Study|Major Depression|2|||
156708361|NCT00287586|565678523|FG000|Overall Study|Lung Cancer|0|||
156708362|NCT00287586|565678524|FG001|Overall Study|Lung Cancer|2|||
156708363|NCT00287586|565678523|FG000|Overall Study|Elevated IPSS Score|0|||
156708364|NCT00287586|565678524|FG001|Overall Study|Elevated IPSS Score|1|||
156872225|NCT03614156|566289537|FG003|Open-Label Treatment Period|Protocol Violation|0|||
156872226|NCT03614156|566289534|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
156872227|NCT03614156|566289535|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872228|NCT03614156|566289536|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872229|NCT03614156|566289537|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
156872230|NCT03614156|566289534|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
156872231|NCT03614156|566289535|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872232|NCT03614156|566289536|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872233|NCT03614156|566289537|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
156872234|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
156872235|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
156872236|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
156872237|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
156872238|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156872239|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
157125308|NCT00662792|567208130|FG000|Period 1|Lost to Follow-up|1|||
157125309|NCT00662792|567208131|FG001|Period 1|Lost to Follow-up|0|||
157125310|NCT00662792|567208132|FG002|Period 1|Lost to Follow-up|0|||
157125311|NCT00662792|567208133|FG003|Period 1|Lost to Follow-up|0|||
157125312|NCT00662792|567208130|FG000|Period 1|Other adverse event (AE)|0|||
157125313|NCT00662792|567208131|FG001|Period 1|Other adverse event (AE)|2|||
157125314|NCT00662792|567208132|FG002|Period 1|Other adverse event (AE)|0|||
157125315|NCT00662792|567208133|FG003|Period 1|Other adverse event (AE)|0|||
157125316|NCT00662792|567208130|FG000|Period 1|Worsening of disease under study (AE)|1|||
157125317|NCT00662792|567208131|FG001|Period 1|Worsening of disease under study (AE)|3|||
157125318|NCT00662792|567208132|FG002|Period 1|Worsening of disease under study (AE)|2|||
157125319|NCT00662792|567208133|FG003|Period 1|Worsening of disease under study (AE)|0|||
157125320|NCT00662792|567208130|FG000|Period 1|Not treated|0|||
157125321|NCT00662792|567208131|FG001|Period 1|Not treated|1|||
157125322|NCT00662792|567208132|FG002|Period 1|Not treated|0|||
157125323|NCT00662792|567208133|FG003|Period 1|Not treated|0|||
157125324|NCT00662792|567208130|FG000|Period 2|Worsening of disease under study|1|||
157125325|NCT00662792|567208131|FG001|Period 2|Worsening of disease under study|0|||
157125326|NCT00662792|567208132|FG002|Period 2|Worsening of disease under study|0|||
157125327|NCT00662792|567208133|FG003|Period 2|Worsening of disease under study|3|||
157125328|NCT00662792|567208130|FG000|Period 3|Refused continuing medication|1|||
157125329|NCT00662792|567208131|FG001|Period 3|Refused continuing medication|0|||
157125330|NCT00662792|567208132|FG002|Period 3|Refused continuing medication|1|||
157125331|NCT00662792|567208133|FG003|Period 3|Refused continuing medication|0|||
157125332|NCT00662792|567208130|FG000|Period 3|Other adverse event (AE)|0|||
157125333|NCT00662792|567208131|FG001|Period 3|Other adverse event (AE)|0|||
157125334|NCT00662792|567208132|FG002|Period 3|Other adverse event (AE)|1|||
157125335|NCT00662792|567208133|FG003|Period 3|Other adverse event (AE)|1|||
157125336|NCT00662792|567208130|FG000|Period 4|Refused continuing medication|0|||
157125337|NCT00662792|567208131|FG001|Period 4|Refused continuing medication|1|||
157125338|NCT00662792|567208132|FG002|Period 4|Refused continuing medication|0|||
157125339|NCT00662792|567208133|FG003|Period 4|Refused continuing medication|0|||
157125340|NCT00662792|567208130|FG000|Period 4|Other adverse event (AE)|1|||
157125341|NCT00662792|567208131|FG001|Period 4|Other adverse event (AE)|0|||
157125342|NCT00662792|567208132|FG002|Period 4|Other adverse event (AE)|0|||
157125343|NCT00662792|567208133|FG003|Period 4|Other adverse event (AE)|0|||
157125344|NCT00662792|567208130|FG000|Period 4|Worsening of disease under study (AE)|0|||
157125345|NCT00662792|567208131|FG001|Period 4|Worsening of disease under study (AE)|0|||
157125346|NCT00662792|567208132|FG002|Period 4|Worsening of disease under study (AE)|0|||
157125347|NCT00662792|567208133|FG003|Period 4|Worsening of disease under study (AE)|1|||
157125348|NCT04029519|567208134|FG000|Overall Study|Protocol Violation|1|||
157125349|NCT04029519|567208134|FG000|Overall Study|Withdrawal by Subject|3|||
157125350|NCT04029519|567208134|FG000|Overall Study|Lost to Follow-up|1|||
157125351|NCT02347176|567208141|FG000|Overall Study|Lost to Follow-up|2|||
157125352|NCT02347176|567208142|FG001|Overall Study|Lost to Follow-up|3|||
156708365|NCT00287586|565678523|FG000|Overall Study|Retroperitoneal Cancer|0|||
156708366|NCT00287586|565678524|FG001|Overall Study|Retroperitoneal Cancer|1|||
157125353|NCT02347176|567208143|FG002|Overall Study|Lost to Follow-up|1|||
157125354|NCT02347176|567208144|FG003|Overall Study|Lost to Follow-up|1|||
156791407|NCT02837952|565988912|FG000|Overall Study|Medication Error|1|||
156791408|NCT02837952|565988913|FG001|Overall Study|Medication Error|0|||
156791409|NCT01517178|565988914|FG000|Period 1|Adverse Event|1|||
156791410|NCT01517178|565988915|FG001|Period 1|Adverse Event|2|||
156791411|NCT01517178|565988914|FG000|Period 1|Lack of Efficacy|0|||
156791412|NCT01517178|565988915|FG001|Period 1|Lack of Efficacy|1|||
156791413|NCT01517178|565988914|FG000|Period 1|E.g. study termination|3|||
156791414|NCT01517178|565988915|FG001|Period 1|E.g. study termination|1|||
156791415|NCT01517178|565988914|FG000|Period 1|Withdrawal by Subject|0|||
156791416|NCT01517178|565988915|FG001|Period 1|Withdrawal by Subject|1|||
156791417|NCT01517178|565988914|FG000|Period 2|Adverse Event|1|||
156791418|NCT01517178|565988915|FG001|Period 2|Adverse Event|0|||
156791419|NCT01517178|565988914|FG000|Period 2|Withdrawal by Subject|3|||
156791420|NCT01517178|565988915|FG001|Period 2|Withdrawal by Subject|0|||
156791421|NCT01517178|565988914|FG000|Period 2|E.g. study termination|2|||
156791422|NCT01517178|565988915|FG001|Period 2|E.g. study termination|2|||
156791423|NCT01959919|565988916|FG000|Overall Study|Did not meet the eligibility criteria|2|||
156791424|NCT03439072|565988919|FG000|Overall Study|Withdrawal by Subject|2|||
156791425|NCT03439072|565988920|FG001|Overall Study|Withdrawal by Subject|3|||
156791426|NCT03439072|565988919|FG000|Overall Study|Physician Decision|0|||
156791427|NCT03439072|565988920|FG001|Overall Study|Physician Decision|1|||
156791428|NCT01537432|565988923|FG000|Overall Study|Lost to Follow-up|3|||
156791429|NCT01537432|565988924|FG001|Overall Study|Lost to Follow-up|1|||
156791430|NCT01537432|565988923|FG000|Overall Study|Withdrawal by Subject|0|||
156791431|NCT01537432|565988924|FG001|Overall Study|Withdrawal by Subject|1|||
156791432|NCT01537432|565988923|FG000|Overall Study|Administrative problems|1|||
156791433|NCT01537432|565988924|FG001|Overall Study|Administrative problems|0|||
156791434|NCT01537432|565988923|FG000|Overall Study|Adverse Event|1|||
156791435|NCT01537432|565988924|FG001|Overall Study|Adverse Event|0|||
156791436|NCT01537432|565988923|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156791437|NCT01537432|565988924|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156791438|NCT00128492|565988927|FG000|Overall Study|AE unrelated to study|2|||
156791439|NCT00128492|565988928|FG001|Overall Study|AE unrelated to study|9|||
156791440|NCT00128492|565988927|FG000|Overall Study|Study drug intolerance (AE)|2|||
156791441|NCT00128492|565988928|FG001|Overall Study|Study drug intolerance (AE)|8|||
156791442|NCT00128492|565988927|FG000|Overall Study|AE related to study|1|||
156791443|NCT00128492|565988928|FG001|Overall Study|AE related to study|4|||
156791444|NCT00128492|565988927|FG000|Overall Study|Death|1|||
156791445|NCT00128492|565988928|FG001|Overall Study|Death|0|||
156791446|NCT00128492|565988927|FG000|Overall Study|Lost to Follow-up|1|||
156791447|NCT00128492|565988928|FG001|Overall Study|Lost to Follow-up|5|||
156791448|NCT00128492|565988927|FG000|Overall Study|Noncompliance|0|||
156791449|NCT00128492|565988928|FG001|Overall Study|Noncompliance|5|||
156872240|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
157125355|NCT02347176|567208141|FG000|Overall Study|Withdrawal by Subject|9|||
157125356|NCT02347176|567208142|FG001|Overall Study|Withdrawal by Subject|5|||
157125357|NCT02347176|567208143|FG002|Overall Study|Withdrawal by Subject|5|||
157125358|NCT02347176|567208144|FG003|Overall Study|Withdrawal by Subject|3|||
156791450|NCT00128492|565988927|FG000|Overall Study|Personal or administrative|10|||
156791451|NCT00128492|565988928|FG001|Overall Study|Personal or administrative|22|||
156791452|NCT00128492|565988927|FG000|Overall Study|Withdrawal by Subject|3|||
156791453|NCT00128492|565988928|FG001|Overall Study|Withdrawal by Subject|5|||
156791454|NCT00128492|565988927|FG000|Overall Study|Pregnancy|0|||
156791455|NCT00128492|565988928|FG001|Overall Study|Pregnancy|1|||
156791456|NCT01550965|565988936|FG000|Overall Study|Adverse Event|26|||
156791457|NCT01550965|565988936|FG000|Overall Study|Withdrawal by Subject|10|||
156791458|NCT01550965|565988936|FG000|Overall Study|Lost to Follow-up|2|||
156791459|NCT01550965|565988936|FG000|Overall Study|Lack of Efficacy|59|||
156791460|NCT01550965|565988936|FG000|Overall Study|Other|13|||
156791461|NCT01347086|565988943|FG000|Overall Study|failed screening visit|0|||
156791462|NCT01347086|565988944|FG001|Overall Study|failed screening visit|0|||
156791463|NCT01347086|565988945|FG002|Overall Study|failed screening visit|1|||
156791464|NCT01347086|565988946|FG003|Overall Study|failed screening visit|0|||
156791465|NCT01347086|565988947|FG004|Overall Study|failed screening visit|0|||
156791466|NCT01347086|565988948|FG005|Overall Study|failed screening visit|0|||
156791467|NCT01347086|565988949|FG006|Overall Study|failed screening visit|1|||
156791468|NCT01347086|565988950|FG007|Overall Study|failed screening visit|1|||
156791469|NCT01347086|565988951|FG008|Overall Study|failed screening visit|0|||
156791470|NCT01347086|565988952|FG009|Overall Study|failed screening visit|1|||
156791471|NCT02624687|565988953|FG000|Overall Study|Withdrawal by Subject|1|||
156791472|NCT02624687|565988954|FG001|Overall Study|Withdrawal by Subject|1|||
156791473|NCT02624687|565988953|FG000|Overall Study|medical leave from work|0|||
156791474|NCT02624687|565988954|FG001|Overall Study|medical leave from work|1|||
156791475|NCT03111108|565988955|FG000|Overall Study|Death|0|||
156791476|NCT03111108|565988956|FG001|Overall Study|Death|1|||
156791477|NCT03111108|565988955|FG000|Overall Study|Withdrawal by Subject|1|||
157125359|NCT02347176|567208141|FG000|Overall Study|Other|1|||
156791478|NCT03111108|565988956|FG001|Overall Study|Withdrawal by Subject|0|||
156791479|NCT01514357|565988957|FG000|Overall Study|Screen failure|2|||
156791480|NCT01514357|565988958|FG001|Overall Study|Screen failure|0|||
156791481|NCT01514357|565988957|FG000|Overall Study|Withdrawal by Subject|2|||
156791482|NCT01514357|565988958|FG001|Overall Study|Withdrawal by Subject|0|||
156791483|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|0|||
156791484|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|1|||
156791485|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|1|||
156791486|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|0|||
156791487|NCT00867334|565988959|FG000|Overall Study|Withdrawal by Subject|1|||
156791488|NCT00867334|565988960|FG001|Overall Study|Withdrawal by Subject|0|||
156791489|NCT00347269|565988965|FG000|Overall Study|Lost to Follow-up|74|||
156791490|NCT00347269|565988966|FG001|Overall Study|Lost to Follow-up|65|||
156791491|NCT00347269|565988965|FG000|Overall Study|Withdrawal by Subject|18|||
156791492|NCT00347269|565988966|FG001|Overall Study|Withdrawal by Subject|38|||
156791493|NCT00347269|565988965|FG000|Overall Study|Death|2|||
156791494|NCT00347269|565988966|FG001|Overall Study|Death|3|||
156791495|NCT04893811|565988967|FG000|Vaccination Phase|Death|1|||
156791496|NCT04893811|565988968|FG001|Vaccination Phase|Death|0|||
156791497|NCT04893811|565988967|FG000|Vaccination Phase|Lost to Follow-up|1|||
156791498|NCT04893811|565988968|FG001|Vaccination Phase|Lost to Follow-up|1|||
156791499|NCT04893811|565988967|FG000|Vaccination Phase|Protocol Violation|2|||
156791500|NCT04893811|565988968|FG001|Vaccination Phase|Protocol Violation|0|||
156791501|NCT04893811|565988967|FG000|Vaccination Phase|Withdrawal by Subject|2|||
156791502|NCT04893811|565988968|FG001|Vaccination Phase|Withdrawal by Subject|1|||
156791503|NCT04893811|565988967|FG000|Vaccination Phase|Other|0|||
156791504|NCT04893811|565988968|FG001|Vaccination Phase|Other|1|||
156791505|NCT04893811|565988967|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
156791506|NCT04893811|565988968|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
156791507|NCT04893811|565988967|FG000|Follow-up Phase|Lost to Follow-up|0|||
156791508|NCT04893811|565988968|FG001|Follow-up Phase|Lost to Follow-up|1|||
156791509|NCT02739828|565988969|FG000|Overall Study|Adverse Event|1|||
156791510|NCT02739828|565988969|FG000|Overall Study|Lost to Follow-up|4|||
156791511|NCT04191733|565988977|FG000|Overall Study|Withdrawn due to study closure|13|||
156791512|NCT04191733|565988978|FG001|Overall Study|Withdrawn due to study closure|14|||
156791513|NCT04191733|565988977|FG000|Overall Study|Withdrawal by Subject|2|||
156791514|NCT04191733|565988978|FG001|Overall Study|Withdrawal by Subject|4|||
156791515|NCT04191733|565988977|FG000|Overall Study|Physician Decision|1|||
156791516|NCT04191733|565988978|FG001|Overall Study|Physician Decision|1|||
156791517|NCT04191733|565988977|FG000|Overall Study|Lost to Follow-up|5|||
156791518|NCT04191733|565988978|FG001|Overall Study|Lost to Follow-up|6|||
156791519|NCT04191733|565988977|FG000|Overall Study|Death|0|||
156791520|NCT04191733|565988978|FG001|Overall Study|Death|1|||
156791521|NCT02202577|565988979|FG000|Overall Study|Lost to Follow-up|6|||
156791522|NCT02202577|565988980|FG001|Overall Study|Lost to Follow-up|16|||
156791523|NCT02202577|565988979|FG000|Overall Study|Protocol Violation|7|||
156791524|NCT02202577|565988980|FG001|Overall Study|Protocol Violation|3|||
156791525|NCT03878602|565988981|FG000|Overall Study|cord blood donation|7|||
156791526|NCT03878602|565988982|FG001|Overall Study|cord blood donation|1|||
156791527|NCT03878602|565988981|FG000|Overall Study|incomplete data collection|2|||
156791528|NCT03878602|565988982|FG001|Overall Study|incomplete data collection|0|||
156791529|NCT06091956|565988983|FG000|Overall Study|Withdrawal by Subject|1|||
156791530|NCT06091956|565988983|FG000|Overall Study|Complicating Disease|1|||
156791531|NCT02176525|565988985|FG000|Overall Study|Adverse Event|0|||
156791532|NCT02176525|565988986|FG001|Overall Study|Adverse Event|0|||
156791533|NCT02176525|565988987|FG002|Overall Study|Adverse Event|0|||
156791534|NCT02176525|565988988|FG003|Overall Study|Adverse Event|1|||
156791535|NCT02176525|565988989|FG004|Overall Study|Adverse Event|1|||
156791536|NCT02176525|565988990|FG005|Overall Study|Adverse Event|0|||
156791537|NCT02176525|565988991|FG006|Overall Study|Adverse Event|1|||
156791538|NCT02176525|565988992|FG007|Overall Study|Adverse Event|0|||
156791539|NCT02176525|565988985|FG000|Overall Study|not treated|1|||
156791540|NCT02176525|565988986|FG001|Overall Study|not treated|0|||
157125360|NCT02347176|567208142|FG001|Overall Study|Other|2|||
157125361|NCT02347176|567208143|FG002|Overall Study|Other|2|||
157125362|NCT02347176|567208144|FG003|Overall Study|Other|0|||
157125363|NCT00939692|567208151|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
157125364|NCT00939692|567208152|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
157125365|NCT00939692|567208151|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
157125366|NCT00939692|567208152|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
157125367|NCT04317274|567208153|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
157125368|NCT04317274|567208154|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
157125369|NCT04317274|567208155|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
157125370|NCT04317274|567208156|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
156791541|NCT02176525|565988987|FG002|Overall Study|not treated|0|||
156791542|NCT02176525|565988988|FG003|Overall Study|not treated|0|||
156791543|NCT02176525|565988989|FG004|Overall Study|not treated|0|||
156791544|NCT02176525|565988990|FG005|Overall Study|not treated|1|||
157015971|NCT04840199|566811179|FG001|Overall Study|Study Terminated by Sponsor|9|||
157015972|NCT04840199|566811178|FG000|Overall Study|Lost to Follow-up|0|||
157015973|NCT04840199|566811179|FG001|Overall Study|Lost to Follow-up|2|||
157015974|NCT04840199|566811178|FG000|Overall Study|Withdrawal by Subject|2|||
157015975|NCT04840199|566811179|FG001|Overall Study|Withdrawal by Subject|0|||
157015976|NCT04840199|566811178|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
157015977|NCT04840199|566811179|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
157015978|NCT03271151|566811180|FG000|Overall Study|Lost to Follow-up|1|||
157015979|NCT03271151|566811181|FG001|Overall Study|Lost to Follow-up|3|||
157015980|NCT03271151|566811180|FG000|Overall Study|Withdrawal by Subject|1|||
157015981|NCT03271151|566811181|FG001|Overall Study|Withdrawal by Subject|0|||
157015982|NCT02201108|566811184|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
157015983|NCT02201108|566811185|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
157015984|NCT02201108|566811186|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
157015985|NCT02201108|566811184|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
157015986|NCT02201108|566811185|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
157015987|NCT02201108|566811186|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
157015988|NCT02201108|566811184|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
157015989|NCT02201108|566811185|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
157015990|NCT02201108|566811186|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
157015991|NCT02201108|566811184|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
157015992|NCT02201108|566811185|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
157015993|NCT02201108|566811186|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
157015994|NCT02201108|566811184|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
157015995|NCT02201108|566811185|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
157015996|NCT02201108|566811186|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
157015997|NCT02201108|566811184|FG000|Open Label Period (up to Week 192)|Other reason|4|||
157015998|NCT02201108|566811185|FG001|Open Label Period (up to Week 192)|Other reason|7|||
157015999|NCT02201108|566811186|FG002|Open Label Period (up to Week 192)|Other reason|0|||
157016000|NCT02201108|566811184|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
157016001|NCT02201108|566811185|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
157016002|NCT02201108|566811186|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
157016003|NCT02201108|566811184|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
157016004|NCT02201108|566811185|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
157016005|NCT02201108|566811186|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
157016006|NCT02201108|566811184|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
157016007|NCT02201108|566811185|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
157016008|NCT02201108|566811186|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
157016009|NCT03438188|566811187|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
157016010|NCT03438188|566811188|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
157016011|NCT03438188|566811189|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
157016012|NCT03438188|566811187|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
157125371|NCT00699907|567208157|FG000|Overall Study|Withdrawal by Subject|2|||
157125372|NCT00699907|567208158|FG001|Overall Study|Withdrawal by Subject|1|||
156708367|NCT00287586|565678523|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
156708368|NCT00287586|565678524|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
156708369|NCT00287586|565678523|FG000|Overall Study|Mood Swings and Irritability|0|||
156708370|NCT00287586|565678524|FG001|Overall Study|Mood Swings and Irritability|1|||
156708371|NCT00287586|565678523|FG000|Overall Study|Bradycardia|0|||
156708372|NCT00287586|565678524|FG001|Overall Study|Bradycardia|1|||
156708373|NCT00287586|565678523|FG000|Overall Study|Itchy Swollen Eyes|0|||
156708374|NCT00287586|565678524|FG001|Overall Study|Itchy Swollen Eyes|1|||
156708375|NCT00287586|565678523|FG000|Overall Study|Recurrent Melanoma|0|||
156708376|NCT00287586|565678524|FG001|Overall Study|Recurrent Melanoma|1|||
157125373|NCT00699907|567208159|FG002|Overall Study|Withdrawal by Subject|0|||
157125374|NCT00699907|567208157|FG000|Overall Study|No usable sample|0|||
157125375|NCT00699907|567208158|FG001|Overall Study|No usable sample|9|||
157125376|NCT00699907|567208159|FG002|Overall Study|No usable sample|8|||
157125377|NCT02161211|567208160|FG000|Overall Study|Lost to Follow-up|21|||
157125378|NCT02161211|567208161|FG001|Overall Study|Lost to Follow-up|27|||
157125379|NCT02161211|567208162|FG002|Overall Study|Lost to Follow-up|21|||
157125380|NCT02161211|567208160|FG000|Overall Study|Dropped|12|||
157125381|NCT02161211|567208161|FG001|Overall Study|Dropped|5|||
156791545|NCT02176525|565988991|FG006|Overall Study|not treated|0|||
156791546|NCT02176525|565988992|FG007|Overall Study|not treated|0|||
157016013|NCT03438188|566811188|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
157016014|NCT03438188|566811189|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
157016015|NCT03438188|566811187|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
157125382|NCT02161211|567208162|FG002|Overall Study|Dropped|9|||
157125383|NCT00430508|567208164|FG000|Overall Study|Adverse Event|2|||
156708377|NCT01762800|565678526|FG000|Overall Study|Adverse Event|8|||
157125384|NCT00430508|567208165|FG001|Overall Study|Adverse Event|3|||
157125385|NCT00430508|567208166|FG002|Overall Study|Adverse Event|5|||
157125386|NCT00430508|567208167|FG003|Overall Study|Adverse Event|3|||
157125387|NCT00430508|567208164|FG000|Overall Study|Withdrawal by Subject|0|||
156708378|NCT01762800|565678527|FG001|Overall Study|Adverse Event|13|||
156708379|NCT01762800|565678526|FG000|Overall Study|Lack of Efficacy|3|||
156708380|NCT01762800|565678527|FG001|Overall Study|Lack of Efficacy|2|||
156708381|NCT01762800|565678526|FG000|Overall Study|Study Closed/Terminated|0|||
156708382|NCT01762800|565678527|FG001|Overall Study|Study Closed/Terminated|1|||
156708383|NCT01762800|565678526|FG000|Overall Study|Physician Decision|1|||
156708384|NCT01762800|565678527|FG001|Overall Study|Physician Decision|1|||
156708385|NCT01762800|565678526|FG000|Overall Study|Withdrawal by Subject|7|||
156708386|NCT01762800|565678527|FG001|Overall Study|Withdrawal by Subject|4|||
156708387|NCT02640482|565678528|FG000|Overall Study|Lost to Follow-up|3|||
156708388|NCT02640482|565678529|FG001|Overall Study|Lost to Follow-up|0|||
156708389|NCT00517881|565678530|FG000|Overall Study|Protocol Violation|2|||
156708390|NCT00517881|565678530|FG000|Overall Study|Adverse Event|1|||
156708391|NCT00517881|565678530|FG000|Overall Study|Renal transplantation|2|||
156708392|NCT00113763|565678531|FG000|Overall Study|Adverse Event|5|||
156708393|NCT00113763|565678532|FG001|Overall Study|Adverse Event|2|||
156708394|NCT00113763|565678531|FG000|Overall Study|Disease Progression|28|||
156708395|NCT00113763|565678532|FG001|Overall Study|Disease Progression|14|||
156708396|NCT00113763|565678531|FG000|Overall Study|Lost to Follow-up|10|||
156708397|NCT00113763|565678532|FG001|Overall Study|Lost to Follow-up|0|||
156708398|NCT00113763|565678531|FG000|Overall Study|Withdrawal by Subject|1|||
156708399|NCT00113763|565678532|FG001|Overall Study|Withdrawal by Subject|4|||
156708400|NCT00113763|565678531|FG000|Overall Study|Other|27|||
156708401|NCT00113763|565678532|FG001|Overall Study|Other|6|||
156708402|NCT00113763|565678531|FG000|Overall Study|Non-compliance|1|||
156708403|NCT00113763|565678532|FG001|Overall Study|Non-compliance|0|||
156708404|NCT00113763|565678531|FG000|Overall Study|Ongoing|1|||
156708405|NCT00113763|565678532|FG001|Overall Study|Ongoing|0|||
156708406|NCT03743415|565678533|FG000|Overall Study|Death|5|||
156708407|NCT03743415|565678534|FG001|Overall Study|Death|3|||
156708408|NCT03743415|565678535|FG002|Overall Study|Death|1|||
156708409|NCT03743415|565678536|FG003|Overall Study|Death|4|||
156708410|NCT03743415|565678537|FG004|Overall Study|Death|0|||
156708411|NCT03743415|565678538|FG005|Overall Study|Death|0|||
156708412|NCT03743415|565678539|FG006|Overall Study|Death|0|||
156708413|NCT03743415|565678540|FG007|Overall Study|Death|0|||
156708414|NCT03743415|565678541|FG008|Overall Study|Death|1|||
156708415|NCT03743415|565678542|FG009|Overall Study|Death|0|||
156708416|NCT03743415|565678533|FG000|Overall Study|Withdrawal by Subject|1|||
156708417|NCT03743415|565678534|FG001|Overall Study|Withdrawal by Subject|0|||
156708418|NCT03743415|565678535|FG002|Overall Study|Withdrawal by Subject|4|||
156708419|NCT03743415|565678536|FG003|Overall Study|Withdrawal by Subject|5|||
156708420|NCT03743415|565678537|FG004|Overall Study|Withdrawal by Subject|5|||
156708421|NCT03743415|565678538|FG005|Overall Study|Withdrawal by Subject|2|||
156708422|NCT03743415|565678539|FG006|Overall Study|Withdrawal by Subject|2|||
156708423|NCT03743415|565678540|FG007|Overall Study|Withdrawal by Subject|5|||
156708424|NCT03743415|565678541|FG008|Overall Study|Withdrawal by Subject|9|||
156708425|NCT03743415|565678542|FG009|Overall Study|Withdrawal by Subject|10|||
156708426|NCT03743415|565678533|FG000|Overall Study|Lost to Follow-up|2|||
156708427|NCT03743415|565678534|FG001|Overall Study|Lost to Follow-up|0|||
156708428|NCT03743415|565678535|FG002|Overall Study|Lost to Follow-up|2|||
156708429|NCT03743415|565678536|FG003|Overall Study|Lost to Follow-up|1|||
156708430|NCT03743415|565678537|FG004|Overall Study|Lost to Follow-up|1|||
156708431|NCT03743415|565678538|FG005|Overall Study|Lost to Follow-up|0|||
156708432|NCT03743415|565678539|FG006|Overall Study|Lost to Follow-up|1|||
156708433|NCT03743415|565678540|FG007|Overall Study|Lost to Follow-up|4|||
156708434|NCT03743415|565678541|FG008|Overall Study|Lost to Follow-up|13|||
156708435|NCT03743415|565678542|FG009|Overall Study|Lost to Follow-up|13|||
157125388|NCT00430508|567208165|FG001|Overall Study|Withdrawal by Subject|1|||
156708436|NCT02847260|565678543|FG000|Overall Study|Adverse Event|3|||
156708437|NCT02847260|565678543|FG000|Overall Study|Withdrawal by Subject|2|||
156708438|NCT02847260|565678543|FG000|Overall Study|Clinical Deterioration|1|||
156708439|NCT02847260|565678543|FG000|Overall Study|Physician Decision|1|||
157125389|NCT00430508|567208166|FG002|Overall Study|Withdrawal by Subject|1|||
156708440|NCT00264550|565678544|FG000|Overall Study|Death|0|||
156708441|NCT00264550|565678545|FG001|Overall Study|Death|3|||
156708442|NCT00264550|565678546|FG002|Overall Study|Death|0|||
156708443|NCT00264550|565678547|FG003|Overall Study|Death|0|||
157125390|NCT00430508|567208167|FG003|Overall Study|Withdrawal by Subject|1|||
157125391|NCT00430508|567208164|FG000|Overall Study|responder at visit 4|0|||
156708444|NCT00264550|565678544|FG000|Overall Study|Lost to Follow-up|3|||
156708445|NCT00264550|565678545|FG001|Overall Study|Lost to Follow-up|1|||
156708446|NCT00264550|565678546|FG002|Overall Study|Lost to Follow-up|1|||
156708447|NCT00264550|565678547|FG003|Overall Study|Lost to Follow-up|1|||
156708448|NCT00264550|565678544|FG000|Overall Study|Adverse Event|23|||
156708449|NCT00264550|565678545|FG001|Overall Study|Adverse Event|18|||
156708450|NCT00264550|565678546|FG002|Overall Study|Adverse Event|9|||
156708451|NCT00264550|565678547|FG003|Overall Study|Adverse Event|14|||
156708452|NCT00264550|565678544|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156708453|NCT00264550|565678545|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
156708454|NCT00264550|565678546|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156708455|NCT00264550|565678547|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
156708456|NCT00264550|565678544|FG000|Overall Study|Discontinued oral study agent|0|||
156708457|NCT00264550|565678545|FG001|Overall Study|Discontinued oral study agent|1|||
156708458|NCT00264550|565678546|FG002|Overall Study|Discontinued oral study agent|0|||
156708459|NCT00264550|565678547|FG003|Overall Study|Discontinued oral study agent|0|||
156708460|NCT00264550|565678544|FG000|Overall Study|Other|13|||
156708461|NCT00264550|565678545|FG001|Overall Study|Other|7|||
156708462|NCT00264550|565678546|FG002|Overall Study|Other|3|||
156708463|NCT00264550|565678547|FG003|Overall Study|Other|9|||
156708464|NCT02129608|565678548|FG000|Overall Study|Lost to Follow-up|0|||
156708465|NCT02129608|565678549|FG001|Overall Study|Lost to Follow-up|1|||
156708466|NCT02129608|565678550|FG002|Overall Study|Lost to Follow-up|1|||
156708467|NCT02129608|565678548|FG000|Overall Study|Withdrawal by Subject|0|||
156708468|NCT02129608|565678549|FG001|Overall Study|Withdrawal by Subject|0|||
156708469|NCT02129608|565678550|FG002|Overall Study|Withdrawal by Subject|2|||
156708470|NCT00129389|565678551|FG000|Overall Study|Adverse Event|19|||
156708471|NCT00129389|565678552|FG001|Overall Study|Adverse Event|87|||
156708472|NCT00129389|565678551|FG000|Overall Study|Death|0|||
156708473|NCT00129389|565678552|FG001|Overall Study|Death|1|||
156708474|NCT00129389|565678551|FG000|Overall Study|Lost to Follow-up|2|||
156708475|NCT00129389|565678552|FG001|Overall Study|Lost to Follow-up|1|||
156708476|NCT00129389|565678551|FG000|Overall Study|Physician Decision|0|||
156708477|NCT00129389|565678552|FG001|Overall Study|Physician Decision|4|||
156791547|NCT02100644|565988993|FG000|LTG Escalation Phase|Adverse Event|9|||
156791548|NCT02100644|565988994|FG001|LTG Escalation Phase|Adverse Event|0|||
156791549|NCT02100644|565988995|FG002|LTG Escalation Phase|Adverse Event|0|||
156791550|NCT02100644|565988993|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
156791551|NCT02100644|565988994|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
156791552|NCT02100644|565988995|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
156791553|NCT02100644|565988993|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
156791554|NCT02100644|565988994|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
156791555|NCT02100644|565988995|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
156791556|NCT00478140|565988996|FG000|Overall Study|Clinical Disease Progression|1|||
156791557|NCT00728182|565988997|FG000|Overall Study|Adverse Event|1|||
156791558|NCT00728182|565988998|FG001|Overall Study|Adverse Event|0|||
156791559|NCT00728182|565988997|FG000|Overall Study|Lost to Follow-up|2|||
156791560|NCT00728182|565988998|FG001|Overall Study|Lost to Follow-up|0|||
156791561|NCT00728182|565988997|FG000|Overall Study|Death|0|||
156791562|NCT00728182|565988998|FG001|Overall Study|Death|2|||
156791563|NCT00728182|565988997|FG000|Overall Study|Protocol Noncompliance|0|||
156791564|NCT00728182|565988998|FG001|Overall Study|Protocol Noncompliance|1|||
156791565|NCT02369159|565989002|FG000|Overall Study|Adverse Event|0|||
156791566|NCT02369159|565989003|FG001|Overall Study|Adverse Event|1|||
156791567|NCT02369159|565989002|FG000|Overall Study|Lost to Follow-up|1|||
156791568|NCT02369159|565989003|FG001|Overall Study|Lost to Follow-up|1|||
156791569|NCT02369159|565989002|FG000|Overall Study|Withdrawal by Subject|7|||
156791570|NCT02369159|565989003|FG001|Overall Study|Withdrawal by Subject|0|||
156791571|NCT00425854|565989013|FG000|Overall Study|Progressive Disease|19|||
156791572|NCT00425854|565989014|FG001|Overall Study|Progressive Disease|12|||
156791573|NCT00425854|565989013|FG000|Overall Study|Dose reduction toxicity AE|8|||
156791574|NCT00425854|565989014|FG001|Overall Study|Dose reduction toxicity AE|7|||
156791575|NCT00425854|565989013|FG000|Overall Study|Other Adverse Event|2|||
156791576|NCT00425854|565989014|FG001|Overall Study|Other Adverse Event|2|||
156791577|NCT01514422|565989015|FG000|Overall Study|Lost to Follow-up|1|||
156791578|NCT00176254|565989016|FG000|Overall Study|Lost to Follow-up|1|||
156791579|NCT03289741|565989017|FG000|Overall Study|Adverse Event|1|||
156791580|NCT03289741|565989018|FG001|Overall Study|Adverse Event|1|||
156791581|NCT03289741|565989017|FG000|Overall Study|Physician Decision|2|||
156791582|NCT03289741|565989018|FG001|Overall Study|Physician Decision|2|||
156791583|NCT03289741|565989017|FG000|Overall Study|Withdrawal by Subject|1|||
156791584|NCT03289741|565989018|FG001|Overall Study|Withdrawal by Subject|0|||
156791585|NCT00561821|565989021|FG000|Overall Study|Not treated|0|||
156791586|NCT00561821|565989022|FG001|Overall Study|Not treated|0|||
156791587|NCT00561821|565989023|FG002|Overall Study|Not treated|1|||
156791588|NCT00561821|565989024|FG003|Overall Study|Not treated|0|||
156791589|NCT00561821|565989021|FG000|Overall Study|Withdrawal by Subject|0|||
157016016|NCT03438188|566811188|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
157016017|NCT03438188|566811189|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
156708478|NCT00129389|565678551|FG000|Overall Study|Protocol Violation|0|||
156708479|NCT00129389|565678552|FG001|Overall Study|Protocol Violation|6|||
156708480|NCT00129389|565678551|FG000|Overall Study|Withdrawal by Subject|9|||
156708481|NCT00129389|565678552|FG001|Overall Study|Withdrawal by Subject|23|||
156708482|NCT00129389|565678551|FG000|Overall Study|Relapse|1|||
156708483|NCT00129389|565678552|FG001|Overall Study|Relapse|0|||
156708484|NCT00129389|565678551|FG000|Overall Study|Not eligible|1|||
156708485|NCT00129389|565678552|FG001|Overall Study|Not eligible|2|||
156708486|NCT00129389|565678551|FG000|Overall Study|Crossed to the other arm|1|||
156708487|NCT00129389|565678552|FG001|Overall Study|Crossed to the other arm|16|||
156708488|NCT01174043|565678554|FG000|Overall Study|Disease progression|5|||
156708489|NCT01174043|565678554|FG000|Overall Study|Adverse Event|3|||
156708490|NCT01174043|565678554|FG000|Overall Study|Death|1|||
156708491|NCT01174043|565678554|FG000|Overall Study|Withdrawal by Subject|2|||
156708492|NCT00789035|565678562|FG000|Overall Study|Adverse Event|0|||
156708493|NCT00789035|565678563|FG001|Overall Study|Adverse Event|2|||
156708494|NCT00789035|565678564|FG002|Overall Study|Adverse Event|0|||
156708495|NCT00789035|565678565|FG003|Overall Study|Adverse Event|1|||
156708496|NCT00789035|565678566|FG004|Overall Study|Adverse Event|3|||
156708497|NCT00789035|565678562|FG000|Overall Study|Lack of Efficacy|3|||
156708498|NCT00789035|565678563|FG001|Overall Study|Lack of Efficacy|0|||
156708499|NCT00789035|565678564|FG002|Overall Study|Lack of Efficacy|0|||
156708500|NCT00789035|565678565|FG003|Overall Study|Lack of Efficacy|0|||
156708501|NCT00789035|565678566|FG004|Overall Study|Lack of Efficacy|2|||
156708502|NCT00789035|565678562|FG000|Overall Study|Protocol Violation|1|||
156708503|NCT00789035|565678563|FG001|Overall Study|Protocol Violation|0|||
156708504|NCT00789035|565678564|FG002|Overall Study|Protocol Violation|0|||
156708505|NCT00789035|565678565|FG003|Overall Study|Protocol Violation|0|||
156708506|NCT00789035|565678566|FG004|Overall Study|Protocol Violation|0|||
156708507|NCT00789035|565678562|FG000|Overall Study|Withdrawal by Subject|0|||
156708508|NCT00789035|565678563|FG001|Overall Study|Withdrawal by Subject|2|||
156708509|NCT00789035|565678564|FG002|Overall Study|Withdrawal by Subject|0|||
156708510|NCT00789035|565678565|FG003|Overall Study|Withdrawal by Subject|0|||
156708511|NCT00789035|565678566|FG004|Overall Study|Withdrawal by Subject|0|||
156708512|NCT00789035|565678562|FG000|Overall Study|Other reason not defined above|2|||
156708513|NCT00789035|565678563|FG001|Overall Study|Other reason not defined above|3|||
156708514|NCT00789035|565678564|FG002|Overall Study|Other reason not defined above|1|||
156708515|NCT00789035|565678565|FG003|Overall Study|Other reason not defined above|0|||
156708516|NCT00789035|565678566|FG004|Overall Study|Other reason not defined above|1|||
156708517|NCT01520870|565678567|FG000|Overall Study|Withdrawal by Subject|2|||
156708518|NCT02289456|565678568|FG000|Induction Period|Death|2|||
156708519|NCT02289456|565678568|FG000|Induction Period|Adverse Event|11|||
156708520|NCT02289456|565678568|FG000|Induction Period|Progressive Disease (PD)|4|||
156708521|NCT02289456|565678568|FG000|Induction Period|Symptomatic Deterioration|4|||
156872241|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
156872242|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156872243|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
156872244|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
156872245|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
156872246|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
156872247|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872248|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872249|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
156872250|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
156872251|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
156872252|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
156872253|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
156872254|NCT03614156|566289534|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872255|NCT03614156|566289535|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
156872256|NCT03614156|566289536|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872257|NCT03614156|566289537|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
156872258|NCT03614156|566289534|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
156872259|NCT03614156|566289535|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872260|NCT03614156|566289536|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872261|NCT03614156|566289537|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
156872262|NCT03614156|566289534|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872263|NCT03614156|566289535|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872264|NCT03614156|566289536|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
156872265|NCT03614156|566289537|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
156872266|NCT03614156|566289534|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
157016018|NCT03438188|566811187|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
156708522|NCT02289456|565678568|FG000|Induction Period|Withdrawal by Subject|2|||
156708523|NCT02289456|565678568|FG000|Induction Period|Miscellaneous|1|||
156708524|NCT02289456|565678568|FG000|Monotherapy Period|Death|1|||
156708525|NCT02289456|565678568|FG000|Monotherapy Period|Adverse Event|1|||
156708526|NCT02289456|565678568|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
156708527|NCT02289456|565678568|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
156708528|NCT02289456|565678568|FG000|Monotherapy Period|Withdrawal by Subject|2|||
156791590|NCT00561821|565989022|FG001|Overall Study|Withdrawal by Subject|1|||
156791591|NCT00561821|565989023|FG002|Overall Study|Withdrawal by Subject|0|||
156791592|NCT00561821|565989024|FG003|Overall Study|Withdrawal by Subject|2|||
156791593|NCT00561821|565989021|FG000|Overall Study|Reasons not related to trial|2|||
156791594|NCT00561821|565989022|FG001|Overall Study|Reasons not related to trial|1|||
156791595|NCT00561821|565989023|FG002|Overall Study|Reasons not related to trial|0|||
156791596|NCT00561821|565989024|FG003|Overall Study|Reasons not related to trial|0|||
156791597|NCT00561821|565989021|FG000|Overall Study|Other (reason not specified)|1|||
156791598|NCT00561821|565989022|FG001|Overall Study|Other (reason not specified)|1|||
156791599|NCT00561821|565989023|FG002|Overall Study|Other (reason not specified)|0|||
156791600|NCT00561821|565989024|FG003|Overall Study|Other (reason not specified)|0|||
156791601|NCT00561821|565989021|FG000|Overall Study|Adverse Event|2|||
156791602|NCT00561821|565989022|FG001|Overall Study|Adverse Event|3|||
156791603|NCT00561821|565989023|FG002|Overall Study|Adverse Event|1|||
156791604|NCT00561821|565989024|FG003|Overall Study|Adverse Event|1|||
156791605|NCT04744831|565990922|FG000|Overall Study|Progressive Disease|31|||
156791606|NCT04744831|565990923|FG001|Overall Study|Progressive Disease|27|||
156791607|NCT04744831|565990924|FG002|Overall Study|Progressive Disease|25|||
156791608|NCT04744831|565990922|FG000|Overall Study|Adverse Event|3|||
156791609|NCT04744831|565990923|FG001|Overall Study|Adverse Event|3|||
156791610|NCT04744831|565990924|FG002|Overall Study|Adverse Event|3|||
156791611|NCT04744831|565990922|FG000|Overall Study|Clinical Progression|3|||
156791612|NCT04744831|565990923|FG001|Overall Study|Clinical Progression|2|||
156791613|NCT04744831|565990924|FG002|Overall Study|Clinical Progression|5|||
156872267|NCT03614156|566289535|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
156872268|NCT03614156|566289536|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
156872269|NCT03614156|566289537|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
156872270|NCT03857867|566289538|FG000|Overall Study|Physician Decision|1|||
156872271|NCT03070964|566289539|FG000|Overall Study|Progressive disease|8|||
156872272|NCT03070964|566289539|FG000|Overall Study|Treatment-unrelated adverse event|2|||
156872273|NCT03070964|566289539|FG000|Overall Study|Never treated|1|||
156872274|NCT03070964|566289539|FG000|Overall Study|Physician Decision|1|||
156872275|NCT03070964|566289539|FG000|Overall Study|Withdrawal by Subject|1|||
156872276|NCT03070964|566289539|FG000|Overall Study|Adverse Event|1|||
156872277|NCT01094119|566289540|FG000|Overall Study|Lack of Efficacy|2|||
156872278|NCT01094119|566289541|FG001|Overall Study|Lack of Efficacy|4|||
156872279|NCT01626872|566289542|FG000|Overall Study|Physician Decision|13|||
156872280|NCT01626872|566289543|FG001|Overall Study|Physician Decision|9|||
156872281|NCT01626872|566289544|FG002|Overall Study|Physician Decision|6|||
156872282|NCT01626872|566289542|FG000|Overall Study|Withdrawal by Subject|19|||
156872283|NCT01626872|566289543|FG001|Overall Study|Withdrawal by Subject|27|||
156872284|NCT01626872|566289544|FG002|Overall Study|Withdrawal by Subject|8|||
156872285|NCT01626872|566289542|FG000|Overall Study|Adverse Event (including Death)|20|||
156872286|NCT01626872|566289543|FG001|Overall Study|Adverse Event (including Death)|28|||
156872287|NCT01626872|566289544|FG002|Overall Study|Adverse Event (including Death)|8|||
156872288|NCT01626872|566289542|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
156872289|NCT01626872|566289543|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
156872290|NCT01626872|566289544|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
156872291|NCT01587924|566289545|FG000|Overall Study|Adverse Event|0|||
156872292|NCT01587924|566289546|FG001|Overall Study|Adverse Event|2|||
156872293|NCT01587924|566289547|FG002|Overall Study|Adverse Event|0|||
156872294|NCT01587924|566289548|FG003|Overall Study|Adverse Event|0|||
156872295|NCT01587924|566289545|FG000|Overall Study|Protocol Violation|2|||
156872296|NCT01587924|566289546|FG001|Overall Study|Protocol Violation|1|||
156872297|NCT01587924|566289547|FG002|Overall Study|Protocol Violation|2|||
156872298|NCT01587924|566289548|FG003|Overall Study|Protocol Violation|1|||
156872299|NCT01587924|566289545|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
156872300|NCT01587924|566289546|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
156872301|NCT01587924|566289547|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
156872302|NCT01587924|566289548|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
157125392|NCT00430508|567208165|FG001|Overall Study|responder at visit 4|0|||
157125393|NCT00430508|567208166|FG002|Overall Study|responder at visit 4|2|||
156791614|NCT04744831|565990922|FG000|Overall Study|Other|0|||
156872303|NCT01587924|566289545|FG000|Overall Study|Withdrawal by Subject|0|||
156872304|NCT01587924|566289546|FG001|Overall Study|Withdrawal by Subject|1|||
156872305|NCT01587924|566289547|FG002|Overall Study|Withdrawal by Subject|1|||
156872306|NCT01587924|566289548|FG003|Overall Study|Withdrawal by Subject|0|||
156872307|NCT01578486|566289549|FG000|Overall Study|Physician Decision|3|||
156872308|NCT01578486|566289549|FG000|Overall Study|Withdrawal by Subject|2|||
157125394|NCT00430508|567208167|FG003|Overall Study|responder at visit 4|0|||
156791615|NCT04744831|565990923|FG001|Overall Study|Other|2|||
156791616|NCT04744831|565990924|FG002|Overall Study|Other|1|||
156791617|NCT04744831|565990922|FG000|Overall Study|Death|0|||
156791618|NCT04744831|565990923|FG001|Overall Study|Death|2|||
156791619|NCT04744831|565990924|FG002|Overall Study|Death|1|||
156791620|NCT05401409|565990927|FG000|Overall Study|Lost to Follow-up|1|||
156872309|NCT02425943|566289550|FG000|Overall Study|Adverse Event|3|||
156872310|NCT02425943|566289551|FG001|Overall Study|Adverse Event|1|||
156872311|NCT02425943|566289550|FG000|Overall Study|Lost to Follow-up|59|||
156872312|NCT02425943|566289551|FG001|Overall Study|Lost to Follow-up|37|||
156872313|NCT02425943|566289550|FG000|Overall Study|Protocol Violation|4|||
156872314|NCT02425943|566289551|FG001|Overall Study|Protocol Violation|1|||
157016019|NCT03438188|566811188|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
157016020|NCT03438188|566811189|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
157016021|NCT03438188|566811187|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
157016022|NCT03438188|566811188|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
157016023|NCT03438188|566811189|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
157016024|NCT01673984|566811190|FG000|Overall Study|Adverse Event|1|||
157016025|NCT01673984|566811191|FG001|Overall Study|Adverse Event|0|||
157016026|NCT01673984|566811190|FG000|Overall Study|Study termination|9|||
157016027|NCT01673984|566811191|FG001|Overall Study|Study termination|6|||
157016028|NCT00150813|566811193|FG000|Overall Study|Adverse Event|1|||
157016029|NCT00150813|566811193|FG000|Overall Study|Lack of Efficacy|1|||
157016030|NCT00150813|566811193|FG000|Overall Study|Lost to Follow-up|5|||
157016031|NCT00150813|566811193|FG000|Overall Study|Withdrawal by Subject|5|||
157016032|NCT00150813|566811193|FG000|Overall Study|Remission|3|||
157016033|NCT00150813|566811193|FG000|Overall Study|Planned pregancy|1|||
157016034|NCT00150813|566811193|FG000|Overall Study|Switch to commercially available LEV|2|||
157016035|NCT01046136|566811202|FG000|Overall Study|Withdrawal by Subject|0|||
157016036|NCT01046136|566811203|FG001|Overall Study|Withdrawal by Subject|4|||
157016037|NCT01046136|566811202|FG000|Overall Study|Physician Decision|1|||
157016038|NCT01046136|566811203|FG001|Overall Study|Physician Decision|1|||
157016039|NCT01046136|566811202|FG000|Overall Study|Lost to Follow-up|3|||
157016040|NCT01046136|566811203|FG001|Overall Study|Lost to Follow-up|3|||
157016041|NCT04579250|566811204|FG000|Overall Study|Withdrawal by Subject|1|||
157016042|NCT04579250|566811205|FG001|Overall Study|Withdrawal by Subject|1|||
157016043|NCT04579250|566811206|FG002|Overall Study|Withdrawal by Subject|0|||
157016044|NCT04579250|566811204|FG000|Overall Study|Lost to Follow-up|1|||
157016045|NCT04579250|566811205|FG001|Overall Study|Lost to Follow-up|1|||
157016046|NCT04579250|566811206|FG002|Overall Study|Lost to Follow-up|0|||
157016047|NCT04579250|566811204|FG000|Overall Study|Moved from area|0|||
157016048|NCT04579250|566811205|FG001|Overall Study|Moved from area|1|||
157016049|NCT04579250|566811206|FG002|Overall Study|Moved from area|2|||
157016050|NCT02919449|566811207|FG000|Overall Study|Withdrawal by Subject|1|||
157016051|NCT02919449|566811207|FG000|Overall Study|Investigator decision|1|||
157016052|NCT02058108|566811208|FG000|Overall Study|Abnormal Laboratory Values|0|||
156708529|NCT02289456|565678568|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
156708530|NCT02289456|565678568|FG000|Monotherapy Period|Miscellaneous|1|||
156708531|NCT01371539|565678571|FG000|Period One: One Week|Lost to Follow-up|0|||
156708532|NCT01371539|565678572|FG001|Period One: One Week|Lost to Follow-up|1|||
156872315|NCT02425943|566289550|FG000|Overall Study|Withdrawal by Subject|64|||
156872316|NCT02425943|566289551|FG001|Overall Study|Withdrawal by Subject|31|||
156872317|NCT02425943|566289550|FG000|Overall Study|Other|6|||
156872318|NCT02425943|566289551|FG001|Overall Study|Other|0|||
156872319|NCT01106248|566289553|FG000|Overall Study|Adverse Event|1|||
156872320|NCT01106248|566289553|FG000|Overall Study|Administrative|2|||
156872321|NCT00357903|566289554|FG000|Overall Study|Adverse Event|87|||
156872322|NCT00357903|566289555|FG001|Overall Study|Adverse Event|4|||
156872323|NCT00357903|566289554|FG000|Overall Study|Death|33|||
156872324|NCT00357903|566289555|FG001|Overall Study|Death|0|||
156872325|NCT00357903|566289554|FG000|Overall Study|Lost to Follow-up|23|||
156872326|NCT00357903|566289555|FG001|Overall Study|Lost to Follow-up|4|||
156872327|NCT00357903|566289554|FG000|Overall Study|Physician Decision|39|||
156872328|NCT00357903|566289555|FG001|Overall Study|Physician Decision|5|||
157016053|NCT02058108|566811209|FG001|Overall Study|Abnormal Laboratory Values|1|||
156708533|NCT01371539|565678571|FG000|Period Two: One Week|Lost to Follow-up|0|||
156872329|NCT00357903|566289554|FG000|Overall Study|Withdrawal by Subject|57|||
157016054|NCT02058108|566811208|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
157016055|NCT02058108|566811209|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
157016056|NCT02058108|566811208|FG000|Overall Study|No longer requires study drug|0|||
157016057|NCT02058108|566811209|FG001|Overall Study|No longer requires study drug|1|||
156872330|NCT00357903|566289555|FG001|Overall Study|Withdrawal by Subject|7|||
156872331|NCT00357903|566289554|FG000|Overall Study|Completed month 12 only|0|||
156872332|NCT00357903|566289555|FG001|Overall Study|Completed month 12 only|1|||
156872333|NCT00357903|566289554|FG000|Overall Study|Protocol issues|14|||
157016058|NCT02058108|566811208|FG000|Overall Study|Withdrawal by Subject|1|||
156708534|NCT01371539|565678572|FG001|Period Two: One Week|Lost to Follow-up|1|||
156872334|NCT00357903|566289555|FG001|Overall Study|Protocol issues|3|||
156872335|NCT00357903|566289554|FG000|Overall Study|Response status|61|||
156872336|NCT00357903|566289555|FG001|Overall Study|Response status|9|||
156872337|NCT00357903|566289554|FG000|Overall Study|Other|49|||
156872338|NCT00357903|566289555|FG001|Overall Study|Other|10|||
157016059|NCT02058108|566811209|FG001|Overall Study|Withdrawal by Subject|0|||
157016060|NCT02058108|566811208|FG000|Overall Study|Administrative problems|3|||
156708535|NCT01371539|565678571|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
156708536|NCT01371539|565678572|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
156708537|NCT01371539|565678571|FG000|Period Two: One Week|Time/job conflict|0|||
156708538|NCT01371539|565678572|FG001|Period Two: One Week|Time/job conflict|1|||
156872339|NCT03181529|566289556|FG000|Overall Study|Withdrawal by Subject|1|||
156872340|NCT03181529|566289557|FG001|Overall Study|Withdrawal by Subject|1|||
156872341|NCT03181529|566289556|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
156872342|NCT03181529|566289557|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
156872343|NCT00607373|566289560|FG000|Treatment Period|Adverse Event|0|||
156872344|NCT00607373|566289561|FG001|Treatment Period|Adverse Event|4|||
156872345|NCT00607373|566289560|FG000|Treatment Period|Physician Decision|0|||
156872346|NCT00607373|566289561|FG001|Treatment Period|Physician Decision|1|||
156872347|NCT00607373|566289560|FG000|Treatment Period|Withdrawal by Subject|0|||
156872348|NCT00607373|566289561|FG001|Treatment Period|Withdrawal by Subject|1|||
156872349|NCT00607373|566289560|FG000|Follow-up Period|Other|0|||
156872350|NCT00607373|566289561|FG001|Follow-up Period|Other|1|||
156872351|NCT00607373|566289560|FG000|Follow-up Period|Protocol Violation|0|||
156872352|NCT00607373|566289561|FG001|Follow-up Period|Protocol Violation|1|||
156872353|NCT00607373|566289560|FG000|Follow-up Period|Withdrawal by Subject|1|||
156872354|NCT00607373|566289561|FG001|Follow-up Period|Withdrawal by Subject|3|||
156872355|NCT01918306|566289562|FG000|Overall Study|progresive disease|4|||
156872356|NCT01918306|566289563|FG001|Overall Study|progresive disease|0|||
156872357|NCT01918306|566289564|FG002|Overall Study|progresive disease|1|||
156872358|NCT01918306|566289565|FG003|Overall Study|progresive disease|1|||
156872359|NCT01918306|566289562|FG000|Overall Study|Withdrawal by Subject|0|||
156872360|NCT01918306|566289563|FG001|Overall Study|Withdrawal by Subject|0|||
156872361|NCT01918306|566289564|FG002|Overall Study|Withdrawal by Subject|0|||
156872362|NCT01918306|566289565|FG003|Overall Study|Withdrawal by Subject|2|||
156872363|NCT01918306|566289562|FG000|Overall Study|neutropenia|1|||
156872364|NCT01918306|566289563|FG001|Overall Study|neutropenia|0|||
156872365|NCT01918306|566289564|FG002|Overall Study|neutropenia|0|||
156872366|NCT01918306|566289565|FG003|Overall Study|neutropenia|0|||
156872367|NCT01918306|566289562|FG000|Overall Study|Lack of Efficacy|1|||
156872368|NCT01918306|566289563|FG001|Overall Study|Lack of Efficacy|0|||
156872369|NCT01918306|566289564|FG002|Overall Study|Lack of Efficacy|0|||
156872370|NCT01918306|566289565|FG003|Overall Study|Lack of Efficacy|0|||
156872371|NCT01918306|566289562|FG000|Overall Study|progress disease, crossover|0|||
156872372|NCT01918306|566289563|FG001|Overall Study|progress disease, crossover|0|||
156872373|NCT01918306|566289564|FG002|Overall Study|progress disease, crossover|1|||
156872374|NCT01918306|566289565|FG003|Overall Study|progress disease, crossover|0|||
156872375|NCT00314795|566289571|FG000|Overall Study|Adverse Event|8|||
156872376|NCT00314795|566289571|FG000|Overall Study|Death|4|||
156872377|NCT00314795|566289571|FG000|Overall Study|Reason not Specified|3|||
156872378|NCT00314795|566289571|FG000|Overall Study|Renal Transplant|3|||
156872379|NCT00314795|566289571|FG000|Overall Study|Participants Withdrew Consent|2|||
156872380|NCT02170077|566289576|FG000|Overall Study|Withdrawal by Subject|3|||
157016061|NCT02058108|566811209|FG001|Overall Study|Administrative problems|3|||
157016062|NCT02058108|566811208|FG000|Overall Study|Protocol Violation|0|||
157016063|NCT02058108|566811209|FG001|Overall Study|Protocol Violation|1|||
157016064|NCT01376700|566811213|FG000|Overall Study|Sponsor terminated study early|8|||
157016065|NCT01376700|566811213|FG000|Overall Study|Low or high titer inhibitor|8|||
157016066|NCT00727909|566811214|FG000|Overall Study|Withdrawal by Subject|5|||
157016067|NCT00727909|566811215|FG001|Overall Study|Withdrawal by Subject|11|||
157016068|NCT00727909|566811216|FG002|Overall Study|Withdrawal by Subject|8|||
157016069|NCT00727909|566811217|FG003|Overall Study|Withdrawal by Subject|5|||
157016070|NCT00727909|566811214|FG000|Overall Study|Death|0|||
157016071|NCT00727909|566811215|FG001|Overall Study|Death|0|||
157016072|NCT00727909|566811216|FG002|Overall Study|Death|1|||
157016073|NCT00727909|566811217|FG003|Overall Study|Death|0|||
157016074|NCT01696773|566811218|FG000|Days 15-27, Washout|Adverse Event|1|||
157016075|NCT01696773|566811219|FG001|Days 15-27, Washout|Adverse Event|0|||
157016076|NCT05623345|566811220|FG000|Overall Study|Withdrawal by Subject|14|||
157016077|NCT05623345|566811221|FG001|Overall Study|Withdrawal by Subject|0|||
157016078|NCT05623345|566811222|FG002|Overall Study|Withdrawal by Subject|9|||
157016079|NCT05623345|566811223|FG003|Overall Study|Withdrawal by Subject|20|||
157016080|NCT05623345|566811220|FG000|Overall Study|Lost to Follow-up|3|||
157016081|NCT05623345|566811221|FG001|Overall Study|Lost to Follow-up|0|||
157016082|NCT05623345|566811222|FG002|Overall Study|Lost to Follow-up|7|||
157016083|NCT05623345|566811223|FG003|Overall Study|Lost to Follow-up|2|||
157016084|NCT05623345|566811220|FG000|Overall Study|Termination of Study By Sponsor|37|||
157016085|NCT05623345|566811221|FG001|Overall Study|Termination of Study By Sponsor|4|||
157016086|NCT05623345|566811222|FG002|Overall Study|Termination of Study By Sponsor|40|||
157016087|NCT05623345|566811223|FG003|Overall Study|Termination of Study By Sponsor|38|||
157016088|NCT00411151|566811224|FG000|Overall Study|Death|38|||
157016089|NCT00411151|566811224|FG000|Overall Study|Withdrawal by Subject|2|||
157016090|NCT00411151|566811224|FG000|Overall Study|Lost to Follow-up|2|||
157125395|NCT00430508|567208164|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
157125396|NCT00430508|567208165|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
157125397|NCT00430508|567208166|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
157125398|NCT00430508|567208167|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
157125399|NCT00430508|567208164|FG000|Overall Study|Other|1|||
157125400|NCT00430508|567208165|FG001|Overall Study|Other|1|||
157125401|NCT00430508|567208166|FG002|Overall Study|Other|3|||
157125402|NCT00430508|567208167|FG003|Overall Study|Other|0|||
157125403|NCT02971670|567208169|FG000|Overall Study|Withdrawal by Subject|4|||
157125404|NCT02971670|567208170|FG001|Overall Study|Withdrawal by Subject|1|||
157125405|NCT02971670|567208171|FG002|Overall Study|Withdrawal by Subject|1|||
157125406|NCT02971670|567208172|FG003|Overall Study|Withdrawal by Subject|2|||
157125407|NCT02340663|567208176|FG000|Overall Study|Lost to Follow-up|1|||
157125408|NCT02340663|567208177|FG001|Overall Study|Lost to Follow-up|0|||
157125409|NCT02340663|567208176|FG000|Overall Study|Protocol Violation|1|||
157125410|NCT02340663|567208177|FG001|Overall Study|Protocol Violation|0|||
157125411|NCT02340663|567208176|FG000|Overall Study|Withdrawal by Subject|3|||
157125412|NCT02340663|567208177|FG001|Overall Study|Withdrawal by Subject|1|||
156708539|NCT02620579|565678575|FG000|Overall Study|Physician Decision|0|||
156708540|NCT02620579|565678576|FG001|Overall Study|Physician Decision|0|||
156708541|NCT02620579|565678577|FG002|Overall Study|Physician Decision|0|||
156708542|NCT02620579|565678578|FG003|Overall Study|Physician Decision|1|||
156708543|NCT02620579|565678575|FG000|Overall Study|Withdrawal by Subject|0|||
156708544|NCT02620579|565678576|FG001|Overall Study|Withdrawal by Subject|1|||
156708545|NCT02620579|565678577|FG002|Overall Study|Withdrawal by Subject|1|||
156708546|NCT02620579|565678578|FG003|Overall Study|Withdrawal by Subject|0|||
156708547|NCT00958893|565678581|FG000|Overall Study|Study prematurely terminated|4|||
156708548|NCT02892149|565678584|FG000|Overall Study|Death|262|||
156708549|NCT02892149|565678585|FG001|Overall Study|Death|278|||
156708550|NCT02892149|565678584|FG000|Overall Study|Withdrawal by Subject|53|||
156708551|NCT02892149|565678585|FG001|Overall Study|Withdrawal by Subject|47|||
156708552|NCT02892149|565678584|FG000|Overall Study|Lost to Follow-up|37|||
156708553|NCT02892149|565678585|FG001|Overall Study|Lost to Follow-up|31|||
156708554|NCT02165735|565678590|FG000|Overall Study|Lost to Follow-up|12|||
156708555|NCT02165735|565678591|FG001|Overall Study|Lost to Follow-up|10|||
156708556|NCT02165735|565678590|FG000|Overall Study|Withdrawal by Subject|3|||
156708557|NCT02165735|565678591|FG001|Overall Study|Withdrawal by Subject|0|||
156708558|NCT02165735|565678590|FG000|Overall Study|Participant indicated lack of time|1|||
156708559|NCT02165735|565678591|FG001|Overall Study|Participant indicated lack of time|3|||
156708560|NCT02165735|565678590|FG000|Overall Study|Protocol Violation|0|||
156708561|NCT02165735|565678591|FG001|Overall Study|Protocol Violation|1|||
156708562|NCT03066258|565678592|FG000|Overall Study|Death|1|||
156708563|NCT03066258|565678593|FG001|Overall Study|Death|0|||
156708564|NCT03066258|565678594|FG002|Overall Study|Death|0|||
156708565|NCT03066258|565678595|FG003|Overall Study|Death|0|||
156708566|NCT03066258|565678596|FG004|Overall Study|Death|1|||
156708567|NCT02784795|565678597|FG000|Overall Study|Progressive Disease|2|||
156708568|NCT02784795|565678598|FG001|Overall Study|Progressive Disease|1|||
156708569|NCT02784795|565678599|FG002|Overall Study|Progressive Disease|1|||
156708570|NCT02784795|565678600|FG003|Overall Study|Progressive Disease|0|||
156708571|NCT02784795|565678601|FG004|Overall Study|Progressive Disease|2|||
156708572|NCT02784795|565678602|FG005|Overall Study|Progressive Disease|0|||
156708573|NCT02784795|565678603|FG006|Overall Study|Progressive Disease|2|||
156708574|NCT02784795|565678604|FG007|Overall Study|Progressive Disease|0|||
156708575|NCT02784795|565678605|FG008|Overall Study|Progressive Disease|0|||
156708576|NCT02784795|565678606|FG009|Overall Study|Progressive Disease|0|||
156708577|NCT02784795|565678607|FG010|Overall Study|Progressive Disease|1|||
156708578|NCT02784795|565678608|FG011|Overall Study|Progressive Disease|0|||
156708579|NCT02784795|565678597|FG000|Overall Study|Adverse Event|1|||
156708580|NCT02784795|565678598|FG001|Overall Study|Adverse Event|0|||
156708581|NCT02784795|565678599|FG002|Overall Study|Adverse Event|0|||
156708582|NCT02784795|565678600|FG003|Overall Study|Adverse Event|1|||
157125413|NCT01353703|567208178|FG000|Overall Study|Migrated/moved from study area|1|||
157125414|NCT01353703|567208179|FG001|Overall Study|Migrated/moved from study area|0|||
157125415|NCT03033875|567208187|FG000|Overall Study|Withdrawal by Subject|5|||
157125416|NCT03033875|567208188|FG001|Overall Study|Withdrawal by Subject|9|||
156708583|NCT02784795|565678601|FG004|Overall Study|Adverse Event|0|||
156708584|NCT02784795|565678602|FG005|Overall Study|Adverse Event|0|||
156708585|NCT02784795|565678603|FG006|Overall Study|Adverse Event|1|||
156708586|NCT02784795|565678604|FG007|Overall Study|Adverse Event|0|||
156708587|NCT02784795|565678605|FG008|Overall Study|Adverse Event|0|||
156708588|NCT02784795|565678606|FG009|Overall Study|Adverse Event|0|||
156708589|NCT02784795|565678607|FG010|Overall Study|Adverse Event|0|||
156708590|NCT02784795|565678608|FG011|Overall Study|Adverse Event|2|||
156708591|NCT02784795|565678597|FG000|Overall Study|Withdrawal by Subject|1|||
156708592|NCT02784795|565678598|FG001|Overall Study|Withdrawal by Subject|0|||
156708593|NCT02784795|565678599|FG002|Overall Study|Withdrawal by Subject|2|||
156708594|NCT02784795|565678600|FG003|Overall Study|Withdrawal by Subject|1|||
156708595|NCT02784795|565678601|FG004|Overall Study|Withdrawal by Subject|3|||
156708596|NCT02784795|565678602|FG005|Overall Study|Withdrawal by Subject|0|||
156708597|NCT02784795|565678603|FG006|Overall Study|Withdrawal by Subject|0|||
156708598|NCT02784795|565678604|FG007|Overall Study|Withdrawal by Subject|1|||
156708599|NCT02784795|565678605|FG008|Overall Study|Withdrawal by Subject|0|||
156708600|NCT02784795|565678606|FG009|Overall Study|Withdrawal by Subject|0|||
156708601|NCT02784795|565678607|FG010|Overall Study|Withdrawal by Subject|0|||
156708602|NCT02784795|565678608|FG011|Overall Study|Withdrawal by Subject|2|||
156708603|NCT02784795|565678597|FG000|Overall Study|Death|0|||
156708604|NCT02784795|565678598|FG001|Overall Study|Death|0|||
156708605|NCT02784795|565678599|FG002|Overall Study|Death|0|||
156708606|NCT02784795|565678600|FG003|Overall Study|Death|0|||
156708607|NCT02784795|565678601|FG004|Overall Study|Death|1|||
156708608|NCT02784795|565678602|FG005|Overall Study|Death|0|||
156708609|NCT02784795|565678603|FG006|Overall Study|Death|0|||
156708610|NCT02784795|565678604|FG007|Overall Study|Death|0|||
156708611|NCT02784795|565678605|FG008|Overall Study|Death|0|||
156708612|NCT02784795|565678606|FG009|Overall Study|Death|0|||
156708613|NCT02784795|565678607|FG010|Overall Study|Death|0|||
156708614|NCT02784795|565678608|FG011|Overall Study|Death|0|||
156708615|NCT02784795|565678597|FG000|Overall Study|Physician Decision|0|||
156708616|NCT02784795|565678598|FG001|Overall Study|Physician Decision|0|||
156708617|NCT02784795|565678599|FG002|Overall Study|Physician Decision|0|||
156708618|NCT02784795|565678600|FG003|Overall Study|Physician Decision|0|||
156708619|NCT02784795|565678601|FG004|Overall Study|Physician Decision|0|||
156708620|NCT02784795|565678602|FG005|Overall Study|Physician Decision|0|||
156708621|NCT02784795|565678603|FG006|Overall Study|Physician Decision|1|||
156708622|NCT02784795|565678604|FG007|Overall Study|Physician Decision|0|||
156708623|NCT02784795|565678605|FG008|Overall Study|Physician Decision|0|||
156708624|NCT02784795|565678606|FG009|Overall Study|Physician Decision|0|||
156708625|NCT02784795|565678607|FG010|Overall Study|Physician Decision|0|||
156708626|NCT02784795|565678608|FG011|Overall Study|Physician Decision|0|||
156708627|NCT00595309|565678609|FG000|Overall Study|Lost to Follow-up|1|||
156708628|NCT00595309|565678609|FG000|Overall Study|planned vaccination against yellow fever|1|||
156708629|NCT00595309|565678609|FG000|Overall Study|acute infection after V0|1|||
156708630|NCT00595309|565678609|FG000|Overall Study|personal reason|1|||
156708631|NCT02797171|565678610|FG000|Overall Study|Lost to Follow-up|2|||
156708632|NCT02797171|565678611|FG001|Overall Study|Lost to Follow-up|0|||
156708633|NCT02797171|565678612|FG002|Overall Study|Lost to Follow-up|2|||
156708634|NCT02797171|565678613|FG003|Overall Study|Lost to Follow-up|1|||
156708635|NCT02797171|565678614|FG004|Overall Study|Lost to Follow-up|2|||
156708636|NCT02797171|565678615|FG005|Overall Study|Lost to Follow-up|0|||
156708637|NCT02797171|565678610|FG000|Overall Study|Withdrawal by Subject|1|||
156708638|NCT02797171|565678611|FG001|Overall Study|Withdrawal by Subject|1|||
156708639|NCT02797171|565678612|FG002|Overall Study|Withdrawal by Subject|0|||
156708640|NCT02797171|565678613|FG003|Overall Study|Withdrawal by Subject|0|||
156708641|NCT02797171|565678614|FG004|Overall Study|Withdrawal by Subject|0|||
156708642|NCT02797171|565678615|FG005|Overall Study|Withdrawal by Subject|0|||
156708643|NCT02797171|565678610|FG000|Overall Study|Protocol Violation|1|||
156708644|NCT02797171|565678611|FG001|Overall Study|Protocol Violation|0|||
156708645|NCT02797171|565678612|FG002|Overall Study|Protocol Violation|0|||
156708646|NCT02797171|565678613|FG003|Overall Study|Protocol Violation|0|||
156708647|NCT02797171|565678614|FG004|Overall Study|Protocol Violation|0|||
156708648|NCT02797171|565678615|FG005|Overall Study|Protocol Violation|0|||
156708649|NCT02797171|565678610|FG000|Overall Study|Participant unable to adhere|0|||
156708650|NCT02797171|565678611|FG001|Overall Study|Participant unable to adhere|1|||
156708651|NCT02797171|565678612|FG002|Overall Study|Participant unable to adhere|0|||
156708652|NCT02797171|565678613|FG003|Overall Study|Participant unable to adhere|0|||
156708653|NCT02797171|565678614|FG004|Overall Study|Participant unable to adhere|0|||
156708654|NCT02797171|565678615|FG005|Overall Study|Participant unable to adhere|0|||
156708655|NCT02797171|565678610|FG000|Overall Study|Not Randomized|0|||
156708656|NCT02797171|565678611|FG001|Overall Study|Not Randomized|0|||
156708657|NCT02797171|565678612|FG002|Overall Study|Not Randomized|0|||
156872381|NCT02170077|566289577|FG001|Overall Study|Withdrawal by Subject|4|||
156708658|NCT02797171|565678613|FG003|Overall Study|Not Randomized|0|||
156708659|NCT02797171|565678614|FG004|Overall Study|Not Randomized|0|||
156708660|NCT02797171|565678615|FG005|Overall Study|Not Randomized|1|||
156708661|NCT00101283|565678616|FG000|Overall Study|Withdrawal by Subject|0|||
156708662|NCT00101283|565678617|FG001|Overall Study|Withdrawal by Subject|1|||
156708663|NCT00101283|565678616|FG000|Overall Study|Insurance Refusal|0|||
156708664|NCT00101283|565678617|FG001|Overall Study|Insurance Refusal|1|||
156708665|NCT00101283|565678616|FG000|Overall Study|Prostate Cancer Recurrence|0|||
156708666|NCT00101283|565678617|FG001|Overall Study|Prostate Cancer Recurrence|1|||
156708667|NCT00711880|565678618|FG000|Overall Study|Adverse Event|11|||
156708668|NCT00711880|565678619|FG001|Overall Study|Adverse Event|2|||
156708669|NCT00711880|565678618|FG000|Overall Study|Patient non-compliance|1|||
156708670|NCT00711880|565678619|FG001|Overall Study|Patient non-compliance|0|||
156708671|NCT00711880|565678618|FG000|Overall Study|Lack of Efficacy|1|||
156708672|NCT00711880|565678619|FG001|Overall Study|Lack of Efficacy|5|||
156708673|NCT00704132|565678620|FG000|Overall Study|Clinical Adverse Experience|1|||
157125417|NCT03033875|567208189|FG002|Overall Study|Withdrawal by Subject|4|||
157125418|NCT03033875|567208187|FG000|Overall Study|Other|14|||
156872382|NCT02170077|566289578|FG002|Overall Study|Withdrawal by Subject|2|||
156872383|NCT02170077|566289576|FG000|Overall Study|Adverse Event|4|||
156872384|NCT02170077|566289577|FG001|Overall Study|Adverse Event|4|||
156872385|NCT02170077|566289578|FG002|Overall Study|Adverse Event|4|||
156872386|NCT02170077|566289576|FG000|Overall Study|Lost to Follow-up|0|||
156872387|NCT02170077|566289577|FG001|Overall Study|Lost to Follow-up|1|||
156872388|NCT02170077|566289578|FG002|Overall Study|Lost to Follow-up|0|||
156872389|NCT02170077|566289576|FG000|Overall Study|Exclusion criteria|2|||
156872390|NCT02170077|566289577|FG001|Overall Study|Exclusion criteria|2|||
156872391|NCT02170077|566289578|FG002|Overall Study|Exclusion criteria|5|||
156872392|NCT02170077|566289576|FG000|Overall Study|Exacerbation of seizures|0|||
156872393|NCT02170077|566289577|FG001|Overall Study|Exacerbation of seizures|2|||
156872394|NCT02170077|566289578|FG002|Overall Study|Exacerbation of seizures|1|||
156872395|NCT01780974|566289583|FG000|Overall Study|Death|1|||
156872396|NCT01780974|566289584|FG001|Overall Study|Death|0|||
156872397|NCT01780974|566289583|FG000|Overall Study|Adverse Event|1|||
156872398|NCT01780974|566289584|FG001|Overall Study|Adverse Event|3|||
156872399|NCT00525161|566289585|FG000|Overall Study|Adverse Event|1|||
156872400|NCT01076361|566289586|FG000|Overall Study|22 leads were excluded from analysis|21|||
156872401|NCT01642589|566289591|FG000|Overall Study|Withdrawal by Subject|1|||
156872402|NCT01642589|566289592|FG001|Overall Study|Withdrawal by Subject|1|||
156872403|NCT00759941|566289597|FG000|Overall Study|Use of medication|1|||
156872404|NCT00759941|566289598|FG001|Overall Study|Use of medication|0|||
156872405|NCT00759941|566289597|FG000|Overall Study|Adverse Event|1|||
156872406|NCT00759941|566289598|FG001|Overall Study|Adverse Event|0|||
156872407|NCT00759941|566289597|FG000|Overall Study|Exited in error by site|1|||
156872408|NCT00759941|566289598|FG001|Overall Study|Exited in error by site|1|||
156872409|NCT02736578|566289599|FG000|Overall Study|Adverse Event|1|||
156872410|NCT02736578|566289600|FG001|Overall Study|Adverse Event|0|||
156872411|NCT00802945|566289601|FG000|Overall Study|Death|27|||
156872412|NCT00802945|566289602|FG001|Overall Study|Death|23|||
156872413|NCT00802945|566289601|FG000|Overall Study|Terminated by sponsor|8|||
156872414|NCT00802945|566289602|FG001|Overall Study|Terminated by sponsor|12|||
156872415|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872416|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
156872417|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872418|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
156872419|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872420|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
156872421|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872422|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
156872423|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
156872424|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
156872425|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
156872426|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
156872427|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
156872428|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
156872429|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
156872430|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
156872431|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872432|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
156872433|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872434|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
156872435|NCT05307692|566289603|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
156872436|NCT05307692|566289604|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
156872437|NCT05307692|566289605|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
156872438|NCT05307692|566289606|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
157125419|NCT03033875|567208188|FG001|Overall Study|Other|15|||
157125420|NCT03033875|567208189|FG002|Overall Study|Other|8|||
157125421|NCT03434977|567208190|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
157125422|NCT03434977|567208191|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
156872439|NCT05307692|566289603|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
157125423|NCT01145066|567208192|FG000|Overall Study|To resume NSAIDs|2|||
156708674|NCT00704132|565678621|FG001|Overall Study|Clinical Adverse Experience|0|||
156872440|NCT05307692|566289604|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
156872441|NCT05307692|566289605|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
156872442|NCT05307692|566289606|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
157125424|NCT01145066|567208193|FG001|Overall Study|To resume NSAIDs|2|||
157125425|NCT01145066|567208194|FG002|Overall Study|To resume NSAIDs|1|||
157125426|NCT01145066|567208192|FG000|Overall Study|Non-related surgery|0|||
157125427|NCT01145066|567208193|FG001|Overall Study|Non-related surgery|0|||
157125428|NCT01145066|567208194|FG002|Overall Study|Non-related surgery|1|||
157125429|NCT01145066|567208192|FG000|Overall Study|Withdrawal by Subject|0|||
157125430|NCT01145066|567208193|FG001|Overall Study|Withdrawal by Subject|0|||
157125431|NCT01145066|567208194|FG002|Overall Study|Withdrawal by Subject|2|||
157125432|NCT01145066|567208192|FG000|Overall Study|To start new med|1|||
157125433|NCT01145066|567208193|FG001|Overall Study|To start new med|0|||
157125434|NCT01145066|567208194|FG002|Overall Study|To start new med|0|||
157125435|NCT01145066|567208192|FG000|Overall Study|problems swallowing capsule|1|||
157125436|NCT01145066|567208193|FG001|Overall Study|problems swallowing capsule|0|||
157125437|NCT01145066|567208194|FG002|Overall Study|problems swallowing capsule|0|||
157125438|NCT01145066|567208192|FG000|Overall Study|Abdominal discomfort|0|||
157125439|NCT01145066|567208193|FG001|Overall Study|Abdominal discomfort|1|||
157125440|NCT01145066|567208194|FG002|Overall Study|Abdominal discomfort|0|||
157125441|NCT01145066|567208192|FG000|Overall Study|Low platelet count|0|||
157125442|NCT01145066|567208193|FG001|Overall Study|Low platelet count|1|||
157125443|NCT01145066|567208194|FG002|Overall Study|Low platelet count|0|||
157125444|NCT01314716|567208201|FG000|Double-Blind Phase|Randomized but not treated|1|||
157125445|NCT01314716|567208202|FG001|Double-Blind Phase|Randomized but not treated|1|||
157125446|NCT01314716|567208201|FG000|Double-Blind Phase|Adverse Event|10|||
157125447|NCT01314716|567208202|FG001|Double-Blind Phase|Adverse Event|4|||
157125448|NCT01314716|567208201|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
157125449|NCT01314716|567208202|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
157125450|NCT01314716|567208201|FG000|Double-Blind Phase|Lost to Follow-up|0|||
157125451|NCT01314716|567208202|FG001|Double-Blind Phase|Lost to Follow-up|1|||
157125452|NCT01314716|567208201|FG000|Double-Blind Phase|Sponsor request|1|||
157125453|NCT01314716|567208202|FG001|Double-Blind Phase|Sponsor request|2|||
157125454|NCT01314716|567208201|FG000|Double-Blind Phase|Physician Decision|0|||
157125455|NCT01314716|567208202|FG001|Double-Blind Phase|Physician Decision|1|||
157125456|NCT01314716|567208201|FG000|Open-Label Phase|Adverse Event|4|||
157125457|NCT01314716|567208202|FG001|Open-Label Phase|Adverse Event|6|||
157125458|NCT01314716|567208201|FG000|Open-Label Phase|Withdrawal by Subject|1|||
157125459|NCT01314716|567208202|FG001|Open-Label Phase|Withdrawal by Subject|2|||
157125460|NCT01314716|567208201|FG000|Open-Label Phase|Physician Decision|5|||
157125461|NCT01314716|567208202|FG001|Open-Label Phase|Physician Decision|4|||
157125462|NCT04484285|567210256|FG000|Overall Study|Unable to operate stimulator|3|||
157125463|NCT04484285|567210257|FG001|Overall Study|Unable to operate stimulator|0|||
157125464|NCT02527707|567210258|FG000|Overall Study|Adverse Event|1|||
157125465|NCT02527707|567210258|FG000|Overall Study|Adverse Event|1|||
156708675|NCT00704132|565678620|FG000|Overall Study|Lack of Efficacy|0|||
156708676|NCT00704132|565678621|FG001|Overall Study|Lack of Efficacy|1|||
156708677|NCT00704132|565678620|FG000|Overall Study|Withdrawal by Subject|0|||
156708678|NCT00704132|565678621|FG001|Overall Study|Withdrawal by Subject|1|||
156708679|NCT00442962|565678622|FG000|Overall Study|Pregnancy|1|||
156708680|NCT00442962|565678622|FG000|Overall Study|Lost to Follow-up|7|||
156708681|NCT04238650|565678623|FG000|Overall Study|Withdrawal by Subject|0|||
156708682|NCT04238650|565678624|FG001|Overall Study|Withdrawal by Subject|1|||
156708683|NCT02756208|565678625|FG000|Overall Study|Withdrawal by Subject|1|||
156708684|NCT02756208|565678626|FG001|Overall Study|Withdrawal by Subject|0|||
156708685|NCT02756208|565678627|FG002|Overall Study|Withdrawal by Subject|1|||
156708686|NCT02756208|565678628|FG003|Overall Study|Withdrawal by Subject|3|||
156708687|NCT02756208|565678625|FG000|Overall Study|Lost to Follow-up|3|||
157016091|NCT00411151|566811224|FG000|Overall Study|Protocol Violation|1|||
157016092|NCT00411151|566811224|FG000|Overall Study|Trial prematurely closed|4|||
157016093|NCT03732820|566811232|FG000|Overall Study|Death|168|||
157016094|NCT03732820|566811233|FG001|Overall Study|Death|203|||
157016095|NCT03732820|566811232|FG000|Overall Study|Other|2|||
157016096|NCT03732820|566811233|FG001|Overall Study|Other|2|||
157016097|NCT03732820|566811232|FG000|Overall Study|Failure to meet randomisation criteria|1|||
157016098|NCT03732820|566811233|FG001|Overall Study|Failure to meet randomisation criteria|1|||
157016099|NCT03732820|566811232|FG000|Overall Study|Patient decision|14|||
157016100|NCT03732820|566811233|FG001|Overall Study|Patient decision|10|||
157016101|NCT03732820|566811232|FG000|Overall Study|Screen failure|0|||
157016102|NCT03732820|566811233|FG001|Overall Study|Screen failure|1|||
157016103|NCT03732820|566811232|FG000|Overall Study|Patients ongoing study at data cut off|210|||
157016104|NCT03732820|566811233|FG001|Overall Study|Patients ongoing study at data cut off|178|||
157016105|NCT03732820|566811232|FG000|Overall Study|Lost to Follow-up|4|||
157016106|NCT03732820|566811233|FG001|Overall Study|Lost to Follow-up|2|||
157016107|NCT02374307|566811234|FG000|3-months Follow-up|Lost to Follow-up|1|||
157125466|NCT02090855|567210259|FG000|Overall Study|no evaluable Standard of Truth results|2|||
157125467|NCT01354028|567210260|FG000|Overall Study|Physician Decision|0|||
157125468|NCT01354028|567210261|FG001|Overall Study|Physician Decision|2|||
156708688|NCT02756208|565678626|FG001|Overall Study|Lost to Follow-up|1|||
156708689|NCT02756208|565678627|FG002|Overall Study|Lost to Follow-up|1|||
156708690|NCT02756208|565678628|FG003|Overall Study|Lost to Follow-up|1|||
156708691|NCT02756208|565678625|FG000|Overall Study|Physician Decision|1|||
157125469|NCT01354028|567210260|FG000|Overall Study|Discharged before study start|2|||
157125470|NCT01354028|567210261|FG001|Overall Study|Discharged before study start|2|||
157125471|NCT01354028|567210260|FG000|Overall Study|No quiet alert state|0|||
157125472|NCT01354028|567210261|FG001|Overall Study|No quiet alert state|1|||
157125473|NCT00935883|567210264|FG000|Treatment Period|Physician Decision|1|||
157125474|NCT00935883|567210265|FG001|Treatment Period|Physician Decision|0|||
157125475|NCT00935883|567210264|FG000|Treatment Period|Withdrawal by Subject|0|||
157125476|NCT00935883|567210265|FG001|Treatment Period|Withdrawal by Subject|2|||
157125477|NCT01641939|567210266|FG000|Overall Study|Death|90|||
157125478|NCT01641939|567210267|FG001|Overall Study|Death|187|||
157125479|NCT01641939|567210268|FG002|Overall Study|Death|61|||
157125480|NCT01641939|567210266|FG000|Overall Study|Lost to Follow-up|3|||
157125481|NCT01641939|567210267|FG001|Overall Study|Lost to Follow-up|2|||
157125482|NCT01641939|567210268|FG002|Overall Study|Lost to Follow-up|1|||
157125483|NCT01641939|567210266|FG000|Overall Study|Withdrawal by Subject|14|||
157125484|NCT01641939|567210267|FG001|Overall Study|Withdrawal by Subject|11|||
157125485|NCT01641939|567210268|FG002|Overall Study|Withdrawal by Subject|5|||
157125486|NCT01641939|567210266|FG000|Overall Study|Study Terminated by Sponsor|10|||
157125487|NCT01641939|567210267|FG001|Overall Study|Study Terminated by Sponsor|28|||
157125488|NCT01641939|567210268|FG002|Overall Study|Study Terminated by Sponsor|3|||
157125489|NCT01072344|567210273|FG000|Overall Study|Relasped-reached end point|7|||
157125490|NCT01072344|567210274|FG001|Overall Study|Relasped-reached end point|12|||
157125491|NCT01072344|567210273|FG000|Overall Study|Protocol Violation|1|||
157125492|NCT01072344|567210274|FG001|Overall Study|Protocol Violation|2|||
157125493|NCT01072344|567210273|FG000|Overall Study|Lost to Follow-up|3|||
157125494|NCT01072344|567210274|FG001|Overall Study|Lost to Follow-up|4|||
157125495|NCT05227690|567210282|FG000|Overall Study|Adverse Event|5|||
157125496|NCT05227690|567210283|FG001|Overall Study|Adverse Event|6|||
157125497|NCT05227690|567210284|FG002|Overall Study|Adverse Event|10|||
157125498|NCT05227690|567210282|FG000|Overall Study|Lack of Efficacy|2|||
157125499|NCT05227690|567210283|FG001|Overall Study|Lack of Efficacy|4|||
157125500|NCT05227690|567210284|FG002|Overall Study|Lack of Efficacy|1|||
157125501|NCT05227690|567210282|FG000|Overall Study|Physician Decision|6|||
157125502|NCT05227690|567210283|FG001|Overall Study|Physician Decision|0|||
157125503|NCT05227690|567210284|FG002|Overall Study|Physician Decision|4|||
157125504|NCT05227690|567210282|FG000|Overall Study|Withdrawal of consent|28|||
157125505|NCT05227690|567210283|FG001|Overall Study|Withdrawal of consent|27|||
157125506|NCT05227690|567210284|FG002|Overall Study|Withdrawal of consent|21|||
157125507|NCT05227690|567210282|FG000|Overall Study|Other, not specified|2|||
157125508|NCT05227690|567210283|FG001|Overall Study|Other, not specified|2|||
157125509|NCT05227690|567210284|FG002|Overall Study|Other, not specified|1|||
157125510|NCT00975156|567210285|FG000|Overall Study|Protocol Violation|0|||
157125511|NCT00975156|567210286|FG001|Overall Study|Protocol Violation|1|||
157125512|NCT05499559|567210287|FG000|Overall Study|Lost to Follow-up|467|||
157125513|NCT02971202|567210292|FG000|Overall Study|Pregnancy|1|||
157125514|NCT02971202|567210293|FG001|Overall Study|Pregnancy|0|||
157125515|NCT02971202|567210294|FG002|Overall Study|Pregnancy|0|||
157125516|NCT02971202|567210292|FG000|Overall Study|screen fail after consent|1|||
157125517|NCT02971202|567210293|FG001|Overall Study|screen fail after consent|0|||
157125518|NCT02971202|567210294|FG002|Overall Study|screen fail after consent|1|||
157125519|NCT02723201|567210297|FG000|Second Intervention Period|Protocol Violation|1|||
157125520|NCT02723201|567210298|FG001|Second Intervention Period|Protocol Violation|0|||
157125521|NCT02723201|567210299|FG002|Second Intervention Period|Protocol Violation|0|||
157125522|NCT02723201|567210297|FG000|Second Intervention Period|Adverse Event|1|||
157125523|NCT02723201|567210298|FG001|Second Intervention Period|Adverse Event|0|||
157125524|NCT02723201|567210299|FG002|Second Intervention Period|Adverse Event|0|||
157125525|NCT03472560|567210300|FG000|Overall Study|Subject transfer to continuation protocol|0|||
157125526|NCT03472560|567210301|FG001|Overall Study|Subject transfer to continuation protocol|1|||
157125527|NCT03472560|567210300|FG000|Overall Study|Withdrawal by Subject|4|||
157125528|NCT03472560|567210301|FG001|Overall Study|Withdrawal by Subject|0|||
157125529|NCT03472560|567210300|FG000|Overall Study|Progressive disease|24|||
157125530|NCT03472560|567210301|FG001|Overall Study|Progressive disease|8|||
157215618|NCT01623830|567537343|FG000|Overall Study|Exclusion from Study|1|||
157125531|NCT03472560|567210300|FG000|Overall Study|Physician Decision|1|||
157125532|NCT03472560|567210301|FG001|Overall Study|Physician Decision|0|||
157125533|NCT03472560|567210300|FG000|Overall Study|Death|7|||
157215619|NCT01623830|567537344|FG001|Overall Study|Exclusion from Study|2|||
157215620|NCT01859390|567537345|FG000|Overall Study|Insufficient Sputum Collected|1|||
157125534|NCT03472560|567210301|FG001|Overall Study|Death|4|||
157125535|NCT03472560|567210300|FG000|Overall Study|Adverse Event|5|||
157215621|NCT01859390|567537346|FG001|Overall Study|Insufficient Sputum Collected|3|||
156872443|NCT05307692|566289603|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
157125536|NCT03472560|567210301|FG001|Overall Study|Adverse Event|3|||
157125537|NCT03472560|567210300|FG000|Overall Study|Global deterioration of health status|0|||
157125538|NCT03472560|567210301|FG001|Overall Study|Global deterioration of health status|4|||
157125539|NCT01946178|567210302|FG000|Overall Study|Pregnancy|1|||
157125540|NCT01946178|567210302|FG000|Overall Study|Lost to Follow-up|1|||
156872444|NCT05307692|566289604|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
156872445|NCT05307692|566289605|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
156872446|NCT05307692|566289606|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
156872447|NCT02656693|566291195|FG000|Overall Study|Pregnancy|1|||
156872448|NCT02656693|566291196|FG001|Overall Study|Pregnancy|1|||
156872449|NCT02656693|566291197|FG002|Overall Study|Pregnancy|1|||
156872450|NCT02656693|566291195|FG000|Overall Study|Bariatric surgery|0|||
156872451|NCT02656693|566291196|FG001|Overall Study|Bariatric surgery|1|||
156872452|NCT02656693|566291197|FG002|Overall Study|Bariatric surgery|2|||
156872453|NCT01596062|566291198|FG000|Overall Study|Adverse Event|1|||
156872454|NCT01596062|566291199|FG001|Overall Study|Adverse Event|0|||
156872455|NCT01596062|566291200|FG002|Overall Study|Adverse Event|2|||
156872456|NCT01596062|566291198|FG000|Overall Study|Lack of Efficacy|0|||
156872457|NCT01596062|566291199|FG001|Overall Study|Lack of Efficacy|0|||
156872458|NCT01596062|566291200|FG002|Overall Study|Lack of Efficacy|1|||
156872459|NCT01255436|566291207|FG000|Overall Study|Lost to Follow-up|178|||
156872460|NCT01255436|566291208|FG001|Overall Study|Lost to Follow-up|191|||
156872461|NCT01255436|566291207|FG000|Overall Study|Death, stroke, or MI|4|||
156872462|NCT01255436|566291208|FG001|Overall Study|Death, stroke, or MI|3|||
156872463|NCT00808080|566291210|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
156872464|NCT01837823|566291211|FG000|Overall Study|Lost to Follow-up|6|||
156872465|NCT03052400|566291212|FG000|Overall Study|Lost to Follow-up|1|||
156872466|NCT03052400|566291213|FG001|Overall Study|Lost to Follow-up|0|||
156872467|NCT03052400|566291212|FG000|Overall Study|Withdrawal by Subject|0|||
156872468|NCT03052400|566291213|FG001|Overall Study|Withdrawal by Subject|1|||
156872469|NCT00372593|566291214|FG000|Overall Study|Adverse Event|43|||
156872470|NCT00372593|566291215|FG001|Overall Study|Adverse Event|45|||
156872471|NCT00372593|566291216|FG002|Overall Study|Adverse Event|0|||
156872472|NCT00372593|566291214|FG000|Overall Study|Death|16|||
156872473|NCT00372593|566291215|FG001|Overall Study|Death|20|||
156872474|NCT00372593|566291216|FG002|Overall Study|Death|1|||
156872475|NCT00372593|566291214|FG000|Overall Study|Lack of Efficacy|82|||
156872476|NCT00372593|566291215|FG001|Overall Study|Lack of Efficacy|71|||
156872477|NCT00372593|566291216|FG002|Overall Study|Lack of Efficacy|2|||
156872478|NCT00372593|566291214|FG000|Overall Study|Lost to Follow-up|1|||
156872479|NCT00372593|566291215|FG001|Overall Study|Lost to Follow-up|0|||
156872480|NCT00372593|566291216|FG002|Overall Study|Lost to Follow-up|0|||
156872481|NCT00372593|566291214|FG000|Overall Study|Physician Decision|42|||
156872482|NCT00372593|566291215|FG001|Overall Study|Physician Decision|41|||
156872483|NCT00372593|566291216|FG002|Overall Study|Physician Decision|0|||
156872484|NCT00372593|566291214|FG000|Overall Study|Ineligible|20|||
156872485|NCT00372593|566291215|FG001|Overall Study|Ineligible|21|||
156872486|NCT00372593|566291216|FG002|Overall Study|Ineligible|1|||
156872487|NCT01237899|566291217|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
156872488|NCT01237899|566291218|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
156872489|NCT01237899|566291219|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
156872490|NCT01237899|566291220|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
156872491|NCT01237899|566291221|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
156872492|NCT01237899|566291222|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
156872493|NCT01237899|566291223|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
156872494|NCT01237899|566291224|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
156872495|NCT01237899|566291225|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
156872496|NCT01237899|566291226|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
156872497|NCT01237899|566291227|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
156872498|NCT00859456|566291228|FG000|Overall Study|Adverse Event|3|||
156872499|NCT00859456|566291228|FG000|Overall Study|Progressive disease|2|||
156872500|NCT00859456|566291228|FG000|Overall Study|Non-compliance|3|||
156872501|NCT02910986|566291232|FG000|Overall Study|non-Latina|14|||
156872502|NCT02910986|566291233|FG001|Overall Study|non-Latina|13|||
156872503|NCT02910986|566291234|FG002|Overall Study|non-Latina|12|||
156872504|NCT02910986|566291232|FG000|Overall Study|Failure to return T! survey|72|||
156872505|NCT02910986|566291233|FG001|Overall Study|Failure to return T! survey|84|||
156872506|NCT02910986|566291234|FG002|Overall Study|Failure to return T! survey|72|||
157016108|NCT02374307|566811235|FG001|3-months Follow-up|Lost to Follow-up|2|||
156708692|NCT02756208|565678626|FG001|Overall Study|Physician Decision|0|||
156708693|NCT02756208|565678627|FG002|Overall Study|Physician Decision|0|||
156872507|NCT02910986|566291232|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
156872508|NCT02910986|566291233|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
156872509|NCT02910986|566291234|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
156872510|NCT02910986|566291232|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
156872511|NCT02910986|566291233|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
156872512|NCT02910986|566291234|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
156872513|NCT02304367|566291238|FG000|Overall Study|Lack of Response to Bruosumab|1|||
156872514|NCT02304367|566291238|FG000|Overall Study|Sponsor Decision|3|||
156872515|NCT02304367|566291238|FG000|Overall Study|Death|2|||
156872516|NCT02304367|566291238|FG000|Overall Study|Physician Decision|1|||
156708694|NCT02756208|565678628|FG003|Overall Study|Physician Decision|0|||
156708695|NCT02756208|565678625|FG000|Overall Study|Protocol Violation|0|||
156708696|NCT02756208|565678626|FG001|Overall Study|Protocol Violation|1|||
156708697|NCT02756208|565678627|FG002|Overall Study|Protocol Violation|0|||
156708698|NCT02756208|565678628|FG003|Overall Study|Protocol Violation|0|||
156708699|NCT04841577|565678629|FG000|Overall Study|Adverse Event|5|||
156708700|NCT04841577|565678630|FG001|Overall Study|Adverse Event|10|||
156708701|NCT04841577|565678629|FG000|Overall Study|Lost to Follow-up|8|||
156708702|NCT04841577|565678630|FG001|Overall Study|Lost to Follow-up|7|||
156708703|NCT04841577|565678629|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156708704|NCT04841577|565678630|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
156708705|NCT04841577|565678629|FG000|Overall Study|Other|0|||
156708706|NCT04841577|565678630|FG001|Overall Study|Other|1|||
156708707|NCT01267994|565678640|FG000|Overall Study|Adverse Event|2|||
156708708|NCT00252239|565678641|FG000|Overall Study|Withdrawal by Subject|1|||
156708709|NCT00252239|565678642|FG001|Overall Study|Withdrawal by Subject|0|||
156708710|NCT00252239|565678643|FG002|Overall Study|Withdrawal by Subject|0|||
156708711|NCT00252239|565678644|FG003|Overall Study|Withdrawal by Subject|1|||
156708712|NCT00252239|565678641|FG000|Overall Study|Lost to Follow-up|0|||
156708713|NCT00252239|565678642|FG001|Overall Study|Lost to Follow-up|0|||
156708714|NCT00252239|565678643|FG002|Overall Study|Lost to Follow-up|2|||
156708715|NCT00252239|565678644|FG003|Overall Study|Lost to Follow-up|0|||
156708716|NCT03276078|565678648|FG000|Overall Study|Adverse Event|1|||
156708717|NCT03968978|565678649|FG000|Overall Study|Adverse Event|1|||
156708718|NCT03968978|565678650|FG001|Overall Study|Adverse Event|0|||
156708719|NCT00086281|565678654|FG000|Phase 1|Adverse Event|0|||
156791621|NCT05401409|565990928|FG001|Overall Study|Lost to Follow-up|0|||
156791622|NCT02410200|565990930|FG000|Overall Study|Adverse Event|2|||
156791623|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
156791624|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
156791625|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
156791626|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
156791627|NCT02144337|565990931|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
156791628|NCT02144337|565990932|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
156791629|NCT02144337|565990931|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
156791630|NCT02144337|565990932|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
156791631|NCT02144337|565990931|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
156791632|NCT02144337|565990932|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
156791633|NCT02402907|565990933|FG000|Overall Study|Delivered vaginally|9|||
156791634|NCT02402907|565990934|FG001|Overall Study|Delivered vaginally|3|||
156791635|NCT02402907|565990933|FG000|Overall Study|Delivered outside of Sinai|1|||
156791636|NCT02402907|565990934|FG001|Overall Study|Delivered outside of Sinai|1|||
156791637|NCT02402907|565990933|FG000|Overall Study|Lost to follow up after C-Section|10|||
156791638|NCT02402907|565990934|FG001|Overall Study|Lost to follow up after C-Section|23|||
156791639|NCT03701074|565990935|FG000|Overall Study|Physician Decision|1|||
156791640|NCT03701074|565990936|FG001|Overall Study|Physician Decision|0|||
156791641|NCT01661595|565990941|FG000|Phase 1: Week 0-4|Adverse Event|1|||
156791642|NCT01661595|565990942|FG001|Phase 1: Week 0-4|Adverse Event|0|||
156791643|NCT01661595|565990943|FG002|Phase 1: Week 0-4|Adverse Event|0|||
156791644|NCT01661595|565990944|FG003|Phase 1: Week 0-4|Adverse Event|0|||
156791645|NCT01661595|565990941|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
156791646|NCT01661595|565990942|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
156791647|NCT01661595|565990943|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
156791648|NCT01661595|565990944|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
156791649|NCT01500135|565990945|FG000|Overall Study|Withdrawal of Consent|4|||
156791650|NCT01500135|565990946|FG001|Overall Study|Withdrawal of Consent|0|||
156791651|NCT01500135|565990945|FG000|Overall Study|Lost to Follow-up|6|||
156791652|NCT01500135|565990946|FG001|Overall Study|Lost to Follow-up|4|||
156872517|NCT02304367|566291238|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
156872518|NCT00594815|566291239|FG000|Overall Study|Never Treated|3|||
156872519|NCT00594815|566291239|FG000|Overall Study|Withdrawal by Subject|2|||
156872520|NCT00594815|566291239|FG000|Overall Study|Toxicity|4|||
156872521|NCT03527732|566291240|FG000|Overall Study|Lost to Follow-up|21|||
156791653|NCT01500135|565990945|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
156791654|NCT01500135|565990946|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
156791655|NCT01500135|565990945|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
156708720|NCT00086281|565678655|FG001|Phase 1|Adverse Event|0|||
156708721|NCT00086281|565678656|FG002|Phase 1|Adverse Event|0|||
156708722|NCT00086281|565678657|FG003|Phase 1|Adverse Event|0|||
156708723|NCT00086281|565678658|FG004|Phase 1|Adverse Event|0|||
156708724|NCT00086281|565678659|FG005|Phase 1|Adverse Event|0|||
156708725|NCT00086281|565678660|FG006|Phase 1|Adverse Event|0|||
156708726|NCT00086281|565678661|FG007|Phase 1|Adverse Event|0|||
156708727|NCT00086281|565678662|FG008|Phase 1|Adverse Event|0|||
156708728|NCT00086281|565678663|FG009|Phase 1|Adverse Event|1|||
156791656|NCT01500135|565990946|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
156791657|NCT01500135|565990945|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
156872522|NCT03527732|566291241|FG001|Overall Study|Lost to Follow-up|23|||
157125541|NCT03655756|567210310|FG000|Overall Study|Death|1|||
157125542|NCT02475655|567210314|FG000|Overall Study|Lost to Follow-up|0|||
157125543|NCT02475655|567210315|FG001|Overall Study|Lost to Follow-up|1|||
157125544|NCT00257010|567210316|FG000|Overall Study|Lack of Efficacy|11|||
157125545|NCT00257010|567210316|FG000|Overall Study|Lost to Follow-up|53|||
157125546|NCT00257010|567210316|FG000|Overall Study|Withdrawal by Subject|34|||
157125547|NCT00257010|567210316|FG000|Overall Study|Adverse Event|10|||
157125548|NCT00257010|567210316|FG000|Overall Study|various|11|||
157125549|NCT00257010|567210316|FG000|Overall Study|no headache reported|9|||
157125550|NCT02474082|567210319|FG000|Overall Study|Adverse Event|2|||
157125551|NCT02474082|567210320|FG001|Overall Study|Adverse Event|32|||
157125552|NCT02474082|567210319|FG000|Overall Study|Withdrawal of informed consent|1|||
157125553|NCT02474082|567210320|FG001|Overall Study|Withdrawal of informed consent|11|||
157125554|NCT02474082|567210319|FG000|Overall Study|Lost to Follow-up|2|||
157125555|NCT02474082|567210320|FG001|Overall Study|Lost to Follow-up|2|||
157125556|NCT02474082|567210319|FG000|Overall Study|Dose tapering not achieved|0|||
157125557|NCT02474082|567210320|FG001|Overall Study|Dose tapering not achieved|4|||
157125558|NCT02474082|567210319|FG000|Overall Study|Participant/guardian decision|1|||
157125559|NCT02474082|567210320|FG001|Overall Study|Participant/guardian decision|2|||
157125560|NCT02474082|567210319|FG000|Overall Study|Non-compliance with study treatment|0|||
157125561|NCT02474082|567210320|FG001|Overall Study|Non-compliance with study treatment|2|||
157125562|NCT02474082|567210319|FG000|Overall Study|Protocol deviation|0|||
157125563|NCT02474082|567210320|FG001|Overall Study|Protocol deviation|1|||
157125564|NCT01463098|567210323|FG000|Part A (11 Days)|Participant Choice|2|||
157125565|NCT01463098|567210324|FG001|Part A (11 Days)|Participant Choice|0|||
157125566|NCT01463098|567210325|FG002|Part A (11 Days)|Participant Choice|0|||
157125567|NCT01463098|567210326|FG003|Part A (11 Days)|Participant Choice|0|||
157125568|NCT01463098|567210327|FG004|Part A (11 Days)|Participant Choice|0|||
157125569|NCT01463098|567210328|FG005|Part A (11 Days)|Participant Choice|0|||
157125570|NCT01463098|567210329|FG006|Part A (11 Days)|Participant Choice|0|||
157125571|NCT01463098|567210330|FG007|Part A (11 Days)|Participant Choice|0|||
157125572|NCT01463098|567210331|FG008|Part A (11 Days)|Participant Choice|1|||
157125573|NCT01463098|567210332|FG009|Part A (11 Days)|Participant Choice|0|||
157125574|NCT01463098|567210333|FG010|Part A (11 Days)|Participant Choice|0|||
157125575|NCT01463098|567210334|FG011|Part A (11 Days)|Participant Choice|0|||
157125576|NCT01463098|567210335|FG012|Part A (11 Days)|Participant Choice|0|||
157125577|NCT01463098|567210336|FG013|Part A (11 Days)|Participant Choice|0|||
157125578|NCT01463098|567210323|FG000|Part A (11 Days)|Lost to Follow-up|0|||
157125579|NCT01463098|567210324|FG001|Part A (11 Days)|Lost to Follow-up|0|||
157125580|NCT01463098|567210325|FG002|Part A (11 Days)|Lost to Follow-up|0|||
157125581|NCT01463098|567210326|FG003|Part A (11 Days)|Lost to Follow-up|0|||
157125582|NCT01463098|567210327|FG004|Part A (11 Days)|Lost to Follow-up|1|||
157125583|NCT01463098|567210328|FG005|Part A (11 Days)|Lost to Follow-up|0|||
157125584|NCT01463098|567210329|FG006|Part A (11 Days)|Lost to Follow-up|0|||
157125585|NCT01463098|567210330|FG007|Part A (11 Days)|Lost to Follow-up|0|||
157125586|NCT01463098|567210331|FG008|Part A (11 Days)|Lost to Follow-up|0|||
157125587|NCT01463098|567210332|FG009|Part A (11 Days)|Lost to Follow-up|0|||
157125588|NCT01463098|567210333|FG010|Part A (11 Days)|Lost to Follow-up|0|||
157125589|NCT01463098|567210334|FG011|Part A (11 Days)|Lost to Follow-up|0|||
157125590|NCT01463098|567210335|FG012|Part A (11 Days)|Lost to Follow-up|0|||
157125591|NCT01463098|567210336|FG013|Part A (11 Days)|Lost to Follow-up|0|||
157125592|NCT01463098|567210323|FG000|Part B (11 Days)|Participant Choice|0|||
157125593|NCT01463098|567210324|FG001|Part B (11 Days)|Participant Choice|0|||
157215622|NCT01859390|567537345|FG000|Overall Study|Sample Missing Collection Date|0|||
157215623|NCT01859390|567537346|FG001|Overall Study|Sample Missing Collection Date|1|||
156791658|NCT01500135|565990946|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
156791659|NCT01500135|565990945|FG000|Overall Study|Participant was a Safety Concern|1|||
156791660|NCT01500135|565990946|FG001|Overall Study|Participant was a Safety Concern|0|||
156791661|NCT01500135|565990945|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
156791662|NCT01500135|565990946|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
156791663|NCT00661687|565990947|FG000|Overall Study|Study related symptoms and complaints|5|||
156791664|NCT00661687|565990947|FG000|Overall Study|Positive slit lamp findings|4|||
156791665|NCT00661687|565990947|FG000|Overall Study|Inability to maintain wearing schedule|3|||
156791666|NCT00661687|565990947|FG000|Overall Study|Physician Decision|1|||
156791667|NCT00661687|565990947|FG000|Overall Study|Adverse Event|2|||
156872523|NCT03527732|566291242|FG002|Overall Study|Lost to Follow-up|80|||
156872524|NCT03527732|566291243|FG003|Overall Study|Lost to Follow-up|62|||
156872525|NCT03527732|566291244|FG004|Overall Study|Lost to Follow-up|12|||
157125594|NCT01463098|567210325|FG002|Part B (11 Days)|Participant Choice|0|||
157125595|NCT01463098|567210326|FG003|Part B (11 Days)|Participant Choice|0|||
157125596|NCT01463098|567210327|FG004|Part B (11 Days)|Participant Choice|0|||
156872526|NCT03527732|566291245|FG005|Overall Study|Lost to Follow-up|20|||
157125597|NCT01463098|567210328|FG005|Part B (11 Days)|Participant Choice|0|||
157125598|NCT01463098|567210329|FG006|Part B (11 Days)|Participant Choice|0|||
157125599|NCT01463098|567210330|FG007|Part B (11 Days)|Participant Choice|0|||
157125600|NCT01463098|567210331|FG008|Part B (11 Days)|Participant Choice|0|||
157125601|NCT01463098|567210332|FG009|Part B (11 Days)|Participant Choice|0|||
157125602|NCT01463098|567210333|FG010|Part B (11 Days)|Participant Choice|0|||
157125603|NCT01463098|567210334|FG011|Part B (11 Days)|Participant Choice|1|||
157125604|NCT01463098|567210335|FG012|Part B (11 Days)|Participant Choice|0|||
157125605|NCT01463098|567210336|FG013|Part B (11 Days)|Participant Choice|0|||
157125606|NCT00523991|567210344|FG000|Overall Study|Adverse Event|6|||
157125607|NCT00523991|567210345|FG001|Overall Study|Adverse Event|5|||
157125608|NCT00523991|567210344|FG000|Overall Study|Protocol Violation|1|||
157125609|NCT00523991|567210345|FG001|Overall Study|Protocol Violation|4|||
157125610|NCT00523991|567210344|FG000|Overall Study|Lost to Follow-up|4|||
157215624|NCT01859390|567537345|FG000|Overall Study|Tube Cracked|0|||
157215625|NCT01859390|567537346|FG001|Overall Study|Tube Cracked|2|||
156708729|NCT00086281|565678664|FG010|Phase 1|Adverse Event|2|||
156708730|NCT00086281|565678665|FG011|Phase 1|Adverse Event|1|||
156708731|NCT00086281|565678666|FG012|Phase 1|Adverse Event|1|||
156708732|NCT00086281|565678667|FG013|Phase 1|Adverse Event|1|||
156708733|NCT00086281|565678668|FG014|Phase 1|Adverse Event|2|||
156708734|NCT00086281|565678654|FG000|Phase 1|Protocol Violation|0|||
156708735|NCT00086281|565678655|FG001|Phase 1|Protocol Violation|0|||
156708736|NCT00086281|565678656|FG002|Phase 1|Protocol Violation|0|||
156708737|NCT00086281|565678657|FG003|Phase 1|Protocol Violation|0|||
156708738|NCT00086281|565678658|FG004|Phase 1|Protocol Violation|0|||
156708739|NCT00086281|565678659|FG005|Phase 1|Protocol Violation|0|||
156708740|NCT00086281|565678660|FG006|Phase 1|Protocol Violation|0|||
156708741|NCT00086281|565678661|FG007|Phase 1|Protocol Violation|0|||
156708742|NCT00086281|565678662|FG008|Phase 1|Protocol Violation|0|||
156708743|NCT00086281|565678663|FG009|Phase 1|Protocol Violation|0|||
156708744|NCT00086281|565678664|FG010|Phase 1|Protocol Violation|1|||
156708745|NCT00086281|565678665|FG011|Phase 1|Protocol Violation|0|||
156708746|NCT00086281|565678666|FG012|Phase 1|Protocol Violation|0|||
156708747|NCT00086281|565678667|FG013|Phase 1|Protocol Violation|0|||
156708748|NCT00086281|565678668|FG014|Phase 1|Protocol Violation|0|||
156708749|NCT00086281|565678654|FG000|Phase 1|Serious Adverse Event|0|||
156708750|NCT00086281|565678655|FG001|Phase 1|Serious Adverse Event|0|||
156708751|NCT00086281|565678656|FG002|Phase 1|Serious Adverse Event|0|||
156708752|NCT00086281|565678657|FG003|Phase 1|Serious Adverse Event|0|||
156708753|NCT00086281|565678658|FG004|Phase 1|Serious Adverse Event|0|||
156708754|NCT00086281|565678659|FG005|Phase 1|Serious Adverse Event|0|||
156708755|NCT00086281|565678660|FG006|Phase 1|Serious Adverse Event|0|||
156708756|NCT00086281|565678661|FG007|Phase 1|Serious Adverse Event|0|||
156708757|NCT00086281|565678662|FG008|Phase 1|Serious Adverse Event|0|||
156872527|NCT03599089|566291246|FG000|Overall Study|Lost to Follow-up|1|||
156872528|NCT03599089|566291247|FG001|Overall Study|Lost to Follow-up|0|||
156872529|NCT03599089|566291248|FG002|Overall Study|Lost to Follow-up|0|||
156872530|NCT03599089|566291249|FG003|Overall Study|Lost to Follow-up|0|||
156872531|NCT03599089|566291246|FG000|Overall Study|Withdrawal by Subject|2|||
156872532|NCT03599089|566291247|FG001|Overall Study|Withdrawal by Subject|1|||
156872533|NCT03599089|566291248|FG002|Overall Study|Withdrawal by Subject|0|||
156872534|NCT03599089|566291249|FG003|Overall Study|Withdrawal by Subject|0|||
156872535|NCT03599089|566291246|FG000|Overall Study|Lack of Efficacy|0|||
156872536|NCT03599089|566291247|FG001|Overall Study|Lack of Efficacy|0|||
156872537|NCT03599089|566291248|FG002|Overall Study|Lack of Efficacy|1|||
156872538|NCT03599089|566291249|FG003|Overall Study|Lack of Efficacy|2|||
156872539|NCT03214666|566291250|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872540|NCT03214666|566291251|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872541|NCT03214666|566291252|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872542|NCT03214666|566291253|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872543|NCT03214666|566291254|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
156872544|NCT03214666|566291255|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
156872545|NCT02207088|566291261|FG000|Overall Study|Adverse Event|2|||
156872546|NCT02500797|566291264|FG000|Overall Study|Cancel (rapid disease progression)|0|||
156872547|NCT02500797|566291265|FG001|Overall Study|Cancel (rapid disease progression)|0|||
156872548|NCT02500797|566291266|FG002|Overall Study|Cancel (rapid disease progression)|0|||
156872549|NCT02500797|566291267|FG003|Overall Study|Cancel (rapid disease progression)|0|||
156872550|NCT02500797|566291268|FG004|Overall Study|Cancel (rapid disease progression)|1|||
157125611|NCT00523991|567210345|FG001|Overall Study|Lost to Follow-up|1|||
157125612|NCT00523991|567210344|FG000|Overall Study|Withdrawal by Subject|7|||
157125613|NCT00523991|567210345|FG001|Overall Study|Withdrawal by Subject|17|||
157215626|NCT01859390|567537345|FG000|Overall Study|Shipment Error|0|||
156708758|NCT00086281|565678663|FG009|Phase 1|Serious Adverse Event|0|||
156708759|NCT00086281|565678664|FG010|Phase 1|Serious Adverse Event|0|||
156708760|NCT00086281|565678665|FG011|Phase 1|Serious Adverse Event|0|||
156708761|NCT00086281|565678666|FG012|Phase 1|Serious Adverse Event|0|||
156708762|NCT00086281|565678667|FG013|Phase 1|Serious Adverse Event|0|||
156708763|NCT00086281|565678668|FG014|Phase 1|Serious Adverse Event|1|||
156708764|NCT00086281|565678654|FG000|Phase 2|Adverse Event|0|||
156708765|NCT00086281|565678655|FG001|Phase 2|Adverse Event|0|||
156708766|NCT00086281|565678656|FG002|Phase 2|Adverse Event|0|||
156708767|NCT00086281|565678657|FG003|Phase 2|Adverse Event|0|||
156708768|NCT00086281|565678658|FG004|Phase 2|Adverse Event|0|||
156708769|NCT00086281|565678659|FG005|Phase 2|Adverse Event|0|||
156708770|NCT00086281|565678660|FG006|Phase 2|Adverse Event|0|||
156708771|NCT00086281|565678661|FG007|Phase 2|Adverse Event|0|||
156708772|NCT00086281|565678662|FG008|Phase 2|Adverse Event|0|||
156708773|NCT00086281|565678663|FG009|Phase 2|Adverse Event|0|||
156708774|NCT00086281|565678664|FG010|Phase 2|Adverse Event|0|||
156708775|NCT00086281|565678665|FG011|Phase 2|Adverse Event|0|||
156708776|NCT00086281|565678666|FG012|Phase 2|Adverse Event|1|||
156708777|NCT00086281|565678667|FG013|Phase 2|Adverse Event|1|||
156708778|NCT00086281|565678668|FG014|Phase 2|Adverse Event|0|||
156708779|NCT00908310|565678671|FG000|Overall Study|Death|37|||
156708780|NCT00908310|565678671|FG000|Overall Study|Withdrawal by Subject|7|||
156708781|NCT00908310|565678671|FG000|Overall Study|Lost to Follow-up|7|||
156708782|NCT00908310|565678671|FG000|Overall Study|Screening failure|5|||
156708783|NCT00908310|565678671|FG000|Overall Study|Other reasons|4|||
156708784|NCT03456453|565678672|FG000|Overall Study|Withdrawal by Subject|2|||
156708785|NCT03456453|565678673|FG001|Overall Study|Withdrawal by Subject|0|||
156708786|NCT03456453|565678672|FG000|Overall Study|Not released to community|1|||
156708787|NCT03456453|565678673|FG001|Overall Study|Not released to community|5|||
156708788|NCT03456453|565678672|FG000|Overall Study|Lost to Follow-up|0|||
156708789|NCT03456453|565678673|FG001|Overall Study|Lost to Follow-up|2|||
156708790|NCT00896480|565678674|FG000|Overall Study|Disease progression/recurrence|21|||
156708791|NCT00351533|565678675|FG000|Overall Study|Extubated before first BAL|1|||
156708792|NCT00351533|565678676|FG001|Overall Study|Extubated before first BAL|0|||
156708793|NCT00351533|565678675|FG000|Overall Study|Lost to Follow-up|1|||
156708794|NCT00351533|565678676|FG001|Overall Study|Lost to Follow-up|3|||
156708795|NCT00351533|565678675|FG000|Overall Study|Physician Decision|0|||
156708796|NCT00351533|565678676|FG001|Overall Study|Physician Decision|1|||
156708797|NCT00351533|565678675|FG000|Overall Study|Withdrawal by Subject|0|||
156708798|NCT00351533|565678676|FG001|Overall Study|Withdrawal by Subject|1|||
156708799|NCT01104792|565678680|FG000|Overall Study|Adverse Event|77|||
156708800|NCT01104792|565678680|FG000|Overall Study|Insufficient Therapeutic Response|22|||
156708801|NCT01104792|565678680|FG000|Overall Study|Protocol Violation|45|||
156708802|NCT01104792|565678680|FG000|Overall Study|Withdrawal of Consent|179|||
156708803|NCT01104792|565678680|FG000|Overall Study|Lost to Follow-up|43|||
156708804|NCT01104792|565678680|FG000|Overall Study|Reasons Not Specified|27|||
156791668|NCT00912509|565990948|FG000|Overall Study|Lost to Follow-up|1|||
156791669|NCT00912509|565990949|FG001|Overall Study|Lost to Follow-up|0|||
156791670|NCT00912509|565990948|FG000|Overall Study|Lack of Efficacy|4|||
156791671|NCT00912509|565990949|FG001|Overall Study|Lack of Efficacy|3|||
156791672|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Adverse Event|2|||
156791673|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Adverse Event|0|||
156791674|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Physician Decision|0|||
156791675|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Physician Decision|1|||
156791676|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
156791677|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
156791678|NCT01362530|565990951|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
156791679|NCT01362530|565990952|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
156791680|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
156791681|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
156791682|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
156791683|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
156791684|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
156791685|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
156791686|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
156791687|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
156791688|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
156791689|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
156791690|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
156791691|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
156791692|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
156791693|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
156791694|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
156708805|NCT01104792|565678680|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
156708806|NCT00103610|565678681|FG000|Overall Study|Entered Rescue Procedure|10|||
156708807|NCT00103610|565678682|FG001|Overall Study|Entered Rescue Procedure|52|||
156708808|NCT00103610|565678681|FG000|Overall Study|Death|16|||
156708809|NCT00103610|565678682|FG001|Overall Study|Death|12|||
156708810|NCT00103610|565678681|FG000|Overall Study|Elective Withdrawal|4|||
156708811|NCT00103610|565678682|FG001|Overall Study|Elective Withdrawal|0|||
156708812|NCT00103610|565678681|FG000|Overall Study|Lost to Follow-up|3|||
156708813|NCT00103610|565678682|FG001|Overall Study|Lost to Follow-up|1|||
156708814|NCT00103610|565678681|FG000|Overall Study|Adverse Event|2|||
156708815|NCT00103610|565678682|FG001|Overall Study|Adverse Event|2|||
157016109|NCT02374307|566811234|FG000|3-months Follow-up|Withdrawal by Subject|1|||
157016110|NCT02374307|566811235|FG001|3-months Follow-up|Withdrawal by Subject|4|||
157016111|NCT02374307|566811234|FG000|3-months Follow-up|Death|1|||
157016112|NCT02374307|566811235|FG001|3-months Follow-up|Death|2|||
157016113|NCT02374307|566811234|FG000|3-months Follow-up|Missed first follow-up|5|||
157016114|NCT02374307|566811235|FG001|3-months Follow-up|Missed first follow-up|1|||
157016115|NCT02374307|566811234|FG000|6-months Follow-up|Lost to Follow-up|1|||
157016116|NCT02374307|566811235|FG001|6-months Follow-up|Lost to Follow-up|2|||
157016117|NCT02374307|566811234|FG000|6-months Follow-up|Death|2|||
157016118|NCT02374307|566811235|FG001|6-months Follow-up|Death|1|||
157016119|NCT02374307|566811234|FG000|6-months Follow-up|Withdrawal by Subject|0|||
157016120|NCT02374307|566811235|FG001|6-months Follow-up|Withdrawal by Subject|3|||
157016121|NCT01989455|566811236|FG000|Overall Study|Adverse Event|0|||
157016122|NCT01989455|566811237|FG001|Overall Study|Adverse Event|1|||
157016123|NCT01989455|566811238|FG002|Overall Study|Adverse Event|0|||
157016124|NCT01989455|566811239|FG003|Overall Study|Adverse Event|0|||
157016125|NCT01989455|566811240|FG004|Overall Study|Adverse Event|0|||
157016126|NCT01989455|566811236|FG000|Overall Study|Withdrawal by Subject|0|||
157016127|NCT01989455|566811237|FG001|Overall Study|Withdrawal by Subject|1|||
157016128|NCT01989455|566811238|FG002|Overall Study|Withdrawal by Subject|0|||
157016129|NCT01989455|566811239|FG003|Overall Study|Withdrawal by Subject|0|||
157016130|NCT01989455|566811240|FG004|Overall Study|Withdrawal by Subject|0|||
157016131|NCT01989455|566811236|FG000|Overall Study|Technical problems with infusion|0|||
157016132|NCT01989455|566811237|FG001|Overall Study|Technical problems with infusion|0|||
157016133|NCT01989455|566811238|FG002|Overall Study|Technical problems with infusion|1|||
157125614|NCT00523991|567210344|FG000|Overall Study|Other reason (not specified)|3|||
157125615|NCT00523991|567210345|FG001|Overall Study|Other reason (not specified)|0|||
156708816|NCT00103610|565678681|FG000|Overall Study|Other|2|||
156708817|NCT00103610|565678682|FG001|Overall Study|Other|7|||
156708818|NCT00103610|565678681|FG000|Overall Study|Failed mobilization|1|||
156708819|NCT00103610|565678682|FG001|Overall Study|Failed mobilization|5|||
156708820|NCT00103610|565678681|FG000|Overall Study|Noncompliance|0|||
156708821|NCT00103610|565678682|FG001|Overall Study|Noncompliance|1|||
156708822|NCT00315731|565678683|FG000|Overall Study|Lost to Follow-up|1|||
156708823|NCT00315731|565678683|FG000|Overall Study|Death|5|||
157125616|NCT00288080|567210352|FG000|Overall Study|Withdrawal by Subject|1|||
156708824|NCT01680497|565678685|FG000|Overall Study|Lost to Follow-up|2|||
156708825|NCT04123561|565678688|FG000|Overall Study|Lost to Follow-up|20|||
156708826|NCT04123561|565678689|FG001|Overall Study|Lost to Follow-up|12|||
156708827|NCT04123561|565678690|FG002|Overall Study|Lost to Follow-up|5|||
156708828|NCT04123561|565678688|FG000|Overall Study|Withdrawal by Subject|9|||
156708829|NCT04123561|565678689|FG001|Overall Study|Withdrawal by Subject|7|||
156708830|NCT04123561|565678690|FG002|Overall Study|Withdrawal by Subject|9|||
156708831|NCT04123561|565678688|FG000|Overall Study|Lack of Efficacy|7|||
156708832|NCT04123561|565678689|FG001|Overall Study|Lack of Efficacy|8|||
156708833|NCT04123561|565678690|FG002|Overall Study|Lack of Efficacy|6|||
156708834|NCT04123561|565678688|FG000|Overall Study|Adverse Event|5|||
156708835|NCT04123561|565678689|FG001|Overall Study|Adverse Event|2|||
156708836|NCT04123561|565678690|FG002|Overall Study|Adverse Event|3|||
156708837|NCT04123561|565678688|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
156708838|NCT04123561|565678689|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
156708839|NCT04123561|565678690|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
156708840|NCT04123561|565678688|FG000|Overall Study|Death|0|||
156708841|NCT04123561|565678689|FG001|Overall Study|Death|0|||
156708842|NCT04123561|565678690|FG002|Overall Study|Death|1|||
156708843|NCT04123561|565678688|FG000|Overall Study|Protocol Violation|0|||
156708844|NCT04123561|565678689|FG001|Overall Study|Protocol Violation|1|||
156708845|NCT04123561|565678690|FG002|Overall Study|Protocol Violation|0|||
156708846|NCT02551666|565678706|FG000|Overall Study|Withdrawal by Subject|1|||
156708847|NCT02551666|565678707|FG001|Overall Study|Withdrawal by Subject|3|||
156708848|NCT02017015|565680500|FG000|Overall Study|Adverse Event|9|||
156708849|NCT02017015|565680500|FG000|Overall Study|Withdrawal by Subject|21|||
157016134|NCT01989455|566811239|FG003|Overall Study|Technical problems with infusion|0|||
157016135|NCT01989455|566811240|FG004|Overall Study|Technical problems with infusion|1|||
157125617|NCT00288080|567210353|FG001|Overall Study|Withdrawal by Subject|3|||
156708850|NCT02017015|565680500|FG000|Overall Study|Death|4|||
156708851|NCT02017015|565680500|FG000|Overall Study|Progressive Disease|31|||
156708852|NCT02017015|565680500|FG000|Overall Study|Non-compliance with study drug|2|||
157016136|NCT00448669|566811248|FG000|Overall Study|Lost to Follow-up|52|||
157125618|NCT00288080|567210352|FG000|Overall Study|Protocol Violation|25|||
157125619|NCT00288080|567210353|FG001|Overall Study|Protocol Violation|20|||
156708853|NCT02017015|565680500|FG000|Overall Study|Physician Decision|2|||
156708854|NCT01277601|565680503|FG000|Overall Study|Adverse Event|5|||
156708855|NCT01277601|565680504|FG001|Overall Study|Adverse Event|3|||
156708856|NCT01277601|565680505|FG002|Overall Study|Adverse Event|0|||
156708857|NCT01277601|565680506|FG003|Overall Study|Adverse Event|7|||
156708858|NCT01277601|565680503|FG000|Overall Study|Withdrawal by Subject|18|||
156708859|NCT01277601|565680504|FG001|Overall Study|Withdrawal by Subject|21|||
156791695|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
156791696|NCT01362530|565990951|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
156791697|NCT01362530|565990952|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
156791698|NCT01034657|565990953|FG000|Core Phase|Withdrawal by Subject|1|||
156791699|NCT01034657|565990954|FG001|Core Phase|Withdrawal by Subject|0|||
156791700|NCT01034657|565990955|FG002|Core Phase|Withdrawal by Subject|0|||
156791701|NCT01034657|565990953|FG000|Core Phase|Lack of Efficacy|2|||
156791702|NCT01034657|565990954|FG001|Core Phase|Lack of Efficacy|0|||
156791703|NCT01034657|565990955|FG002|Core Phase|Lack of Efficacy|0|||
156791704|NCT01034657|565990953|FG000|Core Phase|Abnormal laboratory value|1|||
156791705|NCT01034657|565990954|FG001|Core Phase|Abnormal laboratory value|0|||
156791706|NCT01034657|565990955|FG002|Core Phase|Abnormal laboratory value|0|||
156791707|NCT01034657|565990953|FG000|Core Phase|Adverse Event|8|||
156791708|NCT01034657|565990954|FG001|Core Phase|Adverse Event|0|||
156791709|NCT01034657|565990955|FG002|Core Phase|Adverse Event|0|||
156791710|NCT01034657|565990953|FG000|Core Phase|Protocol Violation|2|||
156791711|NCT01034657|565990954|FG001|Core Phase|Protocol Violation|0|||
156791712|NCT01034657|565990955|FG002|Core Phase|Protocol Violation|0|||
156791713|NCT01034657|565990953|FG000|Randomized Phase|Withdrawal by Subject|0|||
156791714|NCT01034657|565990954|FG001|Randomized Phase|Withdrawal by Subject|2|||
156791715|NCT01034657|565990955|FG002|Randomized Phase|Withdrawal by Subject|0|||
156791716|NCT01034657|565990953|FG000|Randomized Phase|Lack of Efficacy|5|||
156791717|NCT01034657|565990954|FG001|Randomized Phase|Lack of Efficacy|1|||
156791718|NCT01034657|565990955|FG002|Randomized Phase|Lack of Efficacy|0|||
156791719|NCT01034657|565990953|FG000|Randomized Phase|Abnormal laboratory value|0|||
156791720|NCT01034657|565990954|FG001|Randomized Phase|Abnormal laboratory value|1|||
156791721|NCT01034657|565990955|FG002|Randomized Phase|Abnormal laboratory value|0|||
156791722|NCT01034657|565990953|FG000|Randomized Phase|Adverse Event|0|||
156791723|NCT01034657|565990954|FG001|Randomized Phase|Adverse Event|2|||
156791724|NCT01034657|565990955|FG002|Randomized Phase|Adverse Event|1|||
156791725|NCT02715856|565990956|FG000|Overall Study|Software Issues|12|||
156791726|NCT02715856|565990957|FG001|Overall Study|Software Issues|7|||
156791727|NCT02715856|565990956|FG000|Overall Study|Death|6|||
156791728|NCT02715856|565990957|FG001|Overall Study|Death|5|||
156791729|NCT02715856|565990956|FG000|Overall Study|Non- Compliant|0|||
156791730|NCT02715856|565990957|FG001|Overall Study|Non- Compliant|40|||
156791731|NCT01557569|565990958|FG000|Overall Study|Adverse Event|2|||
156791732|NCT01557569|565990959|FG001|Overall Study|Adverse Event|0|||
156791733|NCT01557569|565990958|FG000|Overall Study|high blood pressure|0|||
156791734|NCT01557569|565990959|FG001|Overall Study|high blood pressure|1|||
156791735|NCT01557569|565990958|FG000|Overall Study|Withdrawal by Subject|3|||
156791736|NCT01557569|565990959|FG001|Overall Study|Withdrawal by Subject|5|||
156791737|NCT01557569|565990958|FG000|Overall Study|noncompliance with rules of residential|0|||
156791738|NCT01557569|565990959|FG001|Overall Study|noncompliance with rules of residential|1|||
156791739|NCT01050218|565990960|FG000|Overall Study|Adverse Event|37|||
156791740|NCT01050218|565990960|FG000|Overall Study|Lack of Efficacy|8|||
156791741|NCT01050218|565990960|FG000|Overall Study|Protocol Violation|3|||
156791742|NCT01050218|565990960|FG000|Overall Study|Withdrawal by Subject|18|||
156791743|NCT01050218|565990960|FG000|Overall Study|Discontinued by sponsor|18|||
156791744|NCT01050218|565990960|FG000|Overall Study|Compliance|2|||
156791745|NCT01050218|565990960|FG000|Overall Study|Failed to return|7|||
156791746|NCT01050218|565990960|FG000|Overall Study|Serious Adverse Event|1|||
156791747|NCT01050218|565990960|FG000|Overall Study|Family emergency|1|||
156791748|NCT03682367|565990963|FG000|Overall Study|Protocol Violation|2|||
156791749|NCT03682367|565990964|FG001|Overall Study|Protocol Violation|1|||
156791750|NCT03682367|565990963|FG000|Overall Study|Closed Study Early|0|||
156791751|NCT03682367|565990964|FG001|Overall Study|Closed Study Early|3|||
156791752|NCT00889005|565990965|FG000|Overall Study|Lost to Follow-up|4|||
156791753|NCT00889005|565990966|FG001|Overall Study|Lost to Follow-up|2|||
156791754|NCT00889005|565990965|FG000|Overall Study|Withdrawal by Subject|4|||
156791755|NCT00889005|565990966|FG001|Overall Study|Withdrawal by Subject|0|||
156791756|NCT01998477|565990967|FG000|Overall Study|Lost to Follow-up|4|||
156791757|NCT01998477|565990968|FG001|Overall Study|Lost to Follow-up|5|||
156791758|NCT01998477|565990967|FG000|Overall Study|Withdrawal by Subject|6|||
156791759|NCT01998477|565990968|FG001|Overall Study|Withdrawal by Subject|0|||
156791760|NCT00129974|565990969|FG000|Overall Study|Other|1|||
156791761|NCT00756314|565990970|FG000|Overall Study|Lost to Follow-up|2|||
156791762|NCT00756314|565990971|FG001|Overall Study|Lost to Follow-up|59|||
156791763|NCT02872142|565990972|FG000|Overall Study|Adverse Event|2|||
156791764|NCT02872142|565990972|FG000|Overall Study|Death|1|||
156791765|NCT02872142|565990972|FG000|Overall Study|Participant Decision|3|||
156791766|NCT00309946|565990973|FG000|Overall Study|Withdrawal by Subject|1|||
156791767|NCT02244957|565990974|FG000|Overall Study|Lack of Efficacy|1|||
156791768|NCT02244957|565990975|FG001|Overall Study|Lack of Efficacy|0|||
156791769|NCT04691115|565990978|FG000|Overall Study|Withdrawal by Subject|0|||
156791770|NCT04691115|565990979|FG001|Overall Study|Withdrawal by Subject|0|||
156791771|NCT04691115|565990980|FG002|Overall Study|Withdrawal by Subject|0|||
156791772|NCT04691115|565990981|FG003|Overall Study|Withdrawal by Subject|0|||
157125620|NCT00379795|567210354|FG000|Overall Study|Death|31|||
157125621|NCT00379795|567210355|FG001|Overall Study|Death|8|||
157125622|NCT00379795|567210356|FG002|Overall Study|Death|6|||
156708860|NCT01277601|565680505|FG002|Overall Study|Withdrawal by Subject|8|||
156708861|NCT01277601|565680506|FG003|Overall Study|Withdrawal by Subject|17|||
156708862|NCT01277601|565680503|FG000|Overall Study|Lost to Follow-up|7|||
156708863|NCT01277601|565680504|FG001|Overall Study|Lost to Follow-up|9|||
156708864|NCT01277601|565680505|FG002|Overall Study|Lost to Follow-up|4|||
156708865|NCT01277601|565680506|FG003|Overall Study|Lost to Follow-up|2|||
156708866|NCT01277601|565680503|FG000|Overall Study|Physician Decision|3|||
156708867|NCT01277601|565680504|FG001|Overall Study|Physician Decision|5|||
156708868|NCT01277601|565680505|FG002|Overall Study|Physician Decision|1|||
156708869|NCT01277601|565680506|FG003|Overall Study|Physician Decision|6|||
156708870|NCT01277601|565680503|FG000|Overall Study|Pregnancy|2|||
156708871|NCT01277601|565680504|FG001|Overall Study|Pregnancy|2|||
156708872|NCT01277601|565680505|FG002|Overall Study|Pregnancy|4|||
156708873|NCT01277601|565680506|FG003|Overall Study|Pregnancy|1|||
156708874|NCT01277601|565680503|FG000|Overall Study|Noncompliance with Study Drug|1|||
156708875|NCT01277601|565680504|FG001|Overall Study|Noncompliance with Study Drug|3|||
156708876|NCT01277601|565680505|FG002|Overall Study|Noncompliance with Study Drug|2|||
156708877|NCT01277601|565680506|FG003|Overall Study|Noncompliance with Study Drug|0|||
156708878|NCT01277601|565680503|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
156708879|NCT01277601|565680504|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
156708880|NCT01277601|565680505|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
156708881|NCT01277601|565680506|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
156708882|NCT01277601|565680503|FG000|Overall Study|Protocol Violation|0|||
156708883|NCT01277601|565680504|FG001|Overall Study|Protocol Violation|2|||
156708884|NCT01277601|565680505|FG002|Overall Study|Protocol Violation|5|||
156708885|NCT01277601|565680506|FG003|Overall Study|Protocol Violation|0|||
156708886|NCT01277601|565680503|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
156708887|NCT01277601|565680504|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
156708888|NCT01277601|565680505|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
157125623|NCT00379795|567210357|FG003|Overall Study|Death|4|||
157125624|NCT00379795|567210358|FG004|Overall Study|Death|7|||
157125625|NCT00379795|567210354|FG000|Overall Study|Adverse Event|17|||
157125626|NCT00379795|567210355|FG001|Overall Study|Adverse Event|3|||
157125627|NCT00379795|567210356|FG002|Overall Study|Adverse Event|3|||
157125628|NCT00379795|567210357|FG003|Overall Study|Adverse Event|1|||
157125629|NCT00379795|567210358|FG004|Overall Study|Adverse Event|4|||
157125630|NCT00379795|567210354|FG000|Overall Study|Lost to Follow-up|8|||
157125631|NCT00379795|567210355|FG001|Overall Study|Lost to Follow-up|1|||
157125632|NCT00379795|567210356|FG002|Overall Study|Lost to Follow-up|2|||
157125633|NCT00379795|567210357|FG003|Overall Study|Lost to Follow-up|1|||
157125634|NCT00379795|567210358|FG004|Overall Study|Lost to Follow-up|4|||
157125635|NCT00379795|567210354|FG000|Overall Study|Physician Decision|25|||
157125636|NCT00379795|567210355|FG001|Overall Study|Physician Decision|0|||
157125637|NCT00379795|567210356|FG002|Overall Study|Physician Decision|2|||
157125638|NCT00379795|567210357|FG003|Overall Study|Physician Decision|2|||
157125639|NCT00379795|567210358|FG004|Overall Study|Physician Decision|2|||
157125640|NCT00379795|567210354|FG000|Overall Study|Withdrawal by Subject|94|||
157125641|NCT00379795|567210355|FG001|Overall Study|Withdrawal by Subject|11|||
157125642|NCT00379795|567210356|FG002|Overall Study|Withdrawal by Subject|19|||
157125643|NCT00379795|567210357|FG003|Overall Study|Withdrawal by Subject|7|||
157125644|NCT00379795|567210358|FG004|Overall Study|Withdrawal by Subject|14|||
157125645|NCT00379795|567210354|FG000|Overall Study|Subject non-compliance|7|||
157125646|NCT00379795|567210355|FG001|Overall Study|Subject non-compliance|2|||
157125647|NCT00379795|567210356|FG002|Overall Study|Subject non-compliance|0|||
157125648|NCT00379795|567210357|FG003|Overall Study|Subject non-compliance|0|||
157125649|NCT00379795|567210358|FG004|Overall Study|Subject non-compliance|1|||
157125650|NCT00379795|567210354|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
157125651|NCT00379795|567210355|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
157125652|NCT00379795|567210356|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
157125653|NCT00379795|567210357|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
157125654|NCT00379795|567210358|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
157125655|NCT00379795|567210354|FG000|Overall Study|Subjects condition mandated intervention|34|||
157125656|NCT00379795|567210355|FG001|Overall Study|Subjects condition mandated intervention|9|||
156791773|NCT04691115|565990982|FG004|Overall Study|Withdrawal by Subject|0|||
156791774|NCT04691115|565990983|FG005|Overall Study|Withdrawal by Subject|1|||
156791775|NCT04691115|565990984|FG006|Overall Study|Withdrawal by Subject|0|||
157125657|NCT00379795|567210356|FG002|Overall Study|Subjects condition mandated intervention|7|||
157125658|NCT00379795|567210357|FG003|Overall Study|Subjects condition mandated intervention|5|||
156791776|NCT04691115|565990985|FG007|Overall Study|Withdrawal by Subject|0|||
156708889|NCT01277601|565680506|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
156708890|NCT02260570|565680508|FG000|Overall Study|Withdrawal by Subject|2|||
156708891|NCT02260570|565680509|FG001|Overall Study|Withdrawal by Subject|1|||
156708892|NCT02260570|565680508|FG000|Overall Study|Physician Decision|1|||
157125659|NCT00379795|567210358|FG004|Overall Study|Subjects condition mandated intervention|7|||
157125660|NCT00379795|567210354|FG000|Overall Study|Sponsor's decision|257|||
157125661|NCT00379795|567210355|FG001|Overall Study|Sponsor's decision|17|||
157125662|NCT00379795|567210356|FG002|Overall Study|Sponsor's decision|54|||
156708893|NCT02260570|565680509|FG001|Overall Study|Physician Decision|1|||
156708894|NCT04034927|565680510|FG000|Overall Study|Adverse Event|4|||
156708895|NCT04034927|565680511|FG001|Overall Study|Adverse Event|9|||
156708896|NCT04034927|565680510|FG000|Overall Study|Death|0|||
156708897|NCT04034927|565680511|FG001|Overall Study|Death|1|||
156708898|NCT04034927|565680510|FG000|Overall Study|Withdrawal by Subject|0|||
156708899|NCT04034927|565680511|FG001|Overall Study|Withdrawal by Subject|3|||
156708900|NCT04034927|565680510|FG000|Overall Study|Still on Treatment|2|||
156708901|NCT04034927|565680511|FG001|Overall Study|Still on Treatment|1|||
156708902|NCT04034927|565680510|FG000|Overall Study|Other|1|||
156708903|NCT04034927|565680511|FG001|Overall Study|Other|1|||
156708904|NCT00369486|565680513|FG000|4-Week Visit|Missed visit|2|||
156708905|NCT00369486|565680514|FG001|4-Week Visit|Missed visit|2|||
156708906|NCT00369486|565680515|FG002|4-Week Visit|Missed visit|0|||
156708907|NCT00369486|565680516|FG003|4-Week Visit|Missed visit|2|||
156708908|NCT00369486|565680517|FG004|4-Week Visit|Missed visit|1|||
156708909|NCT00369486|565680513|FG000|4-Week Visit|Dropped|0|||
156708910|NCT00369486|565680514|FG001|4-Week Visit|Dropped|0|||
156708911|NCT00369486|565680515|FG002|4-Week Visit|Dropped|1|||
156708912|NCT00369486|565680516|FG003|4-Week Visit|Dropped|0|||
156708913|NCT00369486|565680517|FG004|4-Week Visit|Dropped|0|||
156708914|NCT00369486|565680513|FG000|8-Week Visit|Missed visit|0|||
156708915|NCT00369486|565680514|FG001|8-Week Visit|Missed visit|1|||
156708916|NCT00369486|565680515|FG002|8-Week Visit|Missed visit|0|||
156708917|NCT00369486|565680516|FG003|8-Week Visit|Missed visit|0|||
156708918|NCT00369486|565680517|FG004|8-Week Visit|Missed visit|1|||
156708919|NCT00369486|565680513|FG000|8-Week Visit|Dropped|0|||
156708920|NCT00369486|565680514|FG001|8-Week Visit|Dropped|0|||
156708921|NCT00369486|565680515|FG002|8-Week Visit|Dropped|0|||
156708922|NCT00369486|565680516|FG003|8-Week Visit|Dropped|1|||
156708923|NCT00369486|565680517|FG004|8-Week Visit|Dropped|0|||
156708924|NCT00369486|565680513|FG000|17-Week Visit|Missed visit|0|||
156708925|NCT00369486|565680514|FG001|17-Week Visit|Missed visit|0|||
156708926|NCT00369486|565680515|FG002|17-Week Visit|Missed visit|1|||
156708927|NCT00369486|565680516|FG003|17-Week Visit|Missed visit|1|||
156708928|NCT00369486|565680517|FG004|17-Week Visit|Missed visit|1|||
156708929|NCT00369486|565680513|FG000|34-Week Visit|Dropped|0|||
156872551|NCT02500797|566291269|FG005|Overall Study|Cancel (rapid disease progression)|1|||
156872552|NCT02500797|566291270|FG006|Overall Study|Cancel (rapid disease progression)|0|||
156872553|NCT02500797|566291271|FG007|Overall Study|Cancel (rapid disease progression)|0|||
156872554|NCT02500797|566291264|FG000|Overall Study|Withdrawal by Subject|1|||
156872555|NCT02500797|566291265|FG001|Overall Study|Withdrawal by Subject|0|||
156872556|NCT02500797|566291266|FG002|Overall Study|Withdrawal by Subject|0|||
156872557|NCT02500797|566291267|FG003|Overall Study|Withdrawal by Subject|0|||
156872558|NCT02500797|566291268|FG004|Overall Study|Withdrawal by Subject|0|||
156708930|NCT00369486|565680514|FG001|34-Week Visit|Dropped|1|||
156708931|NCT00369486|565680515|FG002|34-Week Visit|Dropped|1|||
157125663|NCT00379795|567210357|FG003|Overall Study|Sponsor's decision|47|||
157125664|NCT00379795|567210358|FG004|Overall Study|Sponsor's decision|10|||
156708932|NCT00369486|565680516|FG003|34-Week Visit|Dropped|3|||
156708933|NCT00369486|565680517|FG004|34-Week Visit|Dropped|3|||
156708934|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1|24|||
156708935|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1|0|||
156708936|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
156708937|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
156872559|NCT02500797|566291269|FG005|Overall Study|Withdrawal by Subject|0|||
156872560|NCT02500797|566291270|FG006|Overall Study|Withdrawal by Subject|0|||
156872561|NCT02500797|566291271|FG007|Overall Study|Withdrawal by Subject|0|||
156872562|NCT00357006|566291278|FG000|Overall Study|Lost to Follow-up|1|||
156708938|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708939|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708940|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
156872563|NCT00357006|566291279|FG001|Overall Study|Lost to Follow-up|2|||
157125665|NCT00763321|567210359|FG000|Open-label Period|Adverse Event|24|||
156708941|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
156708942|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
156708943|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
156708944|NCT03888066|565680518|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708945|NCT03888066|565680519|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708946|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708947|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156872564|NCT00357006|566291280|FG002|Overall Study|Lost to Follow-up|1|||
157125666|NCT00763321|567210360|FG001|Open-label Period|Adverse Event|0|||
156708948|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
156708949|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
156708950|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708951|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708952|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
156708953|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708954|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #2|5|||
156708955|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #2|0|||
156708956|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
156708957|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
156708958|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
156708959|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
156708960|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
156708961|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
156708962|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3|11|||
156708963|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3|0|||
156708964|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
156708965|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
156708966|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
156708967|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708968|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708969|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708970|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4|3|||
156708971|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4|0|||
156708972|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
156708973|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
156708974|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
156708975|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
156708976|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
156708977|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708978|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
156708979|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
156708980|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
156708981|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708982|NCT03888066|565680518|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
156708983|NCT03888066|565680519|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708984|NCT03888066|565680518|FG000|Run-in Phase|AE (Adverse Event)|17|||
156708985|NCT03888066|565680519|FG001|Run-in Phase|AE (Adverse Event)|0|||
156708986|NCT03888066|565680518|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
156708987|NCT03888066|565680519|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
156708988|NCT03888066|565680518|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708989|NCT03888066|565680519|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708990|NCT03888066|565680518|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
156708991|NCT03888066|565680519|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156708992|NCT03888066|565680518|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
156708993|NCT03888066|565680519|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156708994|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal by Subject|43|||
156708995|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal by Subject|0|||
156708996|NCT03888066|565680518|FG000|Run-in Phase|AE; Physician Decision|1|||
156708997|NCT03888066|565680519|FG001|Run-in Phase|AE; Physician Decision|0|||
156708998|NCT03888066|565680518|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
156708999|NCT03888066|565680519|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
156709000|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
156709001|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
156709002|NCT03888066|565680518|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
156872565|NCT00357006|566291278|FG000|Overall Study|Withdrawal by Subject|1|||
156872566|NCT00357006|566291279|FG001|Overall Study|Withdrawal by Subject|3|||
156872567|NCT00357006|566291280|FG002|Overall Study|Withdrawal by Subject|2|||
156872568|NCT03710161|566291281|FG000|Overall Study|Study halted due to COVID pandemic|3|||
157215627|NCT01859390|567537346|FG001|Overall Study|Shipment Error|1|||
157215628|NCT00472446|567537357|FG000|Overall Study|Protocol Violation|0|||
157215629|NCT00472446|567537358|FG001|Overall Study|Protocol Violation|0|||
157215630|NCT00472446|567537359|FG002|Overall Study|Protocol Violation|0|||
156709003|NCT03888066|565680519|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
156709004|NCT03888066|565680518|FG000|Run-in Phase|Death|1|||
156709005|NCT03888066|565680519|FG001|Run-in Phase|Death|0|||
156709006|NCT03888066|565680518|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
156709007|NCT03888066|565680519|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
156709008|NCT03888066|565680518|FG000|Run-in Phase|Physician Decision|1|||
156709009|NCT03888066|565680519|FG001|Run-in Phase|Physician Decision|0|||
156709010|NCT03888066|565680518|FG000|Run-in Phase|Protocol Violation|13|||
156709011|NCT03888066|565680519|FG001|Run-in Phase|Protocol Violation|0|||
156709012|NCT03888066|565680518|FG000|Run-in Phase|Sponsor Request|34|||
156709013|NCT03888066|565680519|FG001|Run-in Phase|Sponsor Request|0|||
156709014|NCT03888066|565680518|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
156709015|NCT03888066|565680519|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
156709016|NCT03888066|565680518|FG000|Run-in Phase|Withdrawal Of Consent|1|||
156709017|NCT03888066|565680519|FG001|Run-in Phase|Withdrawal Of Consent|0|||
156709018|NCT03888066|565680518|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
156709019|NCT03888066|565680519|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
156709020|NCT03888066|565680518|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
156709021|NCT03888066|565680519|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
156709022|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
156709023|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
156709024|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
156709025|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
156709026|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
156709027|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
156709028|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
156709029|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
156709030|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
156709031|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
156709032|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
156709033|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
156709034|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
156709035|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
156709036|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
156709037|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
156709038|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
156709039|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
156709040|NCT03888066|565680518|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
156709041|NCT03888066|565680519|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
156709042|NCT02077140|565680520|FG000|Overall Study|Lost to Follow-up|4|||
156709043|NCT02077140|565680521|FG001|Overall Study|Lost to Follow-up|1|||
156709044|NCT02077140|565680522|FG002|Overall Study|Lost to Follow-up|2|||
156709045|NCT02077140|565680523|FG003|Overall Study|Lost to Follow-up|2|||
156709046|NCT02077140|565680524|FG004|Overall Study|Lost to Follow-up|3|||
156709047|NCT02077140|565680520|FG000|Overall Study|Withdrawal by Subject|0|||
156709048|NCT02077140|565680521|FG001|Overall Study|Withdrawal by Subject|1|||
156709049|NCT02077140|565680522|FG002|Overall Study|Withdrawal by Subject|0|||
156709050|NCT02077140|565680523|FG003|Overall Study|Withdrawal by Subject|2|||
156709051|NCT02077140|565680524|FG004|Overall Study|Withdrawal by Subject|2|||
156709052|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
156709053|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
156709054|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
156709055|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
156709056|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
156709057|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709058|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709059|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709060|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709061|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
156709062|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
156709063|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
156709064|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
156709065|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
156709066|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
156709067|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156709068|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156709069|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156709070|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156791777|NCT04691115|565990986|FG008|Overall Study|Withdrawal by Subject|0|||
156791778|NCT04691115|565990987|FG009|Overall Study|Withdrawal by Subject|0|||
156791779|NCT04691115|565990988|FG010|Overall Study|Withdrawal by Subject|0|||
156709071|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
156872569|NCT03710161|566291282|FG001|Overall Study|Study halted due to COVID pandemic|2|||
156872570|NCT02637037|566291285|FG000|Overall Study|Positive drug screen at admission|1|||
156872571|NCT02637037|566291286|FG001|Overall Study|Positive drug screen at admission|0|||
156872572|NCT02637037|566291285|FG000|Overall Study|Withdrawal by Subject|2|||
156872573|NCT02637037|566291286|FG001|Overall Study|Withdrawal by Subject|1|||
156872574|NCT02637037|566291285|FG000|Overall Study|Adverse Event|1|||
156872575|NCT02637037|566291286|FG001|Overall Study|Adverse Event|0|||
156872576|NCT03339219|566291287|FG000|Overall Study|Death|12|||
156872577|NCT03339219|566291287|FG000|Overall Study|Site Terminated by Sponsor|22|||
156872578|NCT03339219|566291287|FG000|Overall Study|Withdrawal by Subject|1|||
156872579|NCT02023697|566291291|FG000|Treatment Period|Radiological progression|13|||
156872580|NCT02023697|566291292|FG001|Treatment Period|Radiological progression|17|||
156872581|NCT02023697|566291293|FG002|Treatment Period|Radiological progression|26|||
156872582|NCT02023697|566291291|FG000|Treatment Period|Never Treated|5|||
156872583|NCT02023697|566291292|FG001|Treatment Period|Never Treated|6|||
156872584|NCT02023697|566291293|FG002|Treatment Period|Never Treated|10|||
156872585|NCT02023697|566291291|FG000|Treatment Period|Adverse Event|13|||
156872586|NCT02023697|566291292|FG001|Treatment Period|Adverse Event|25|||
156872587|NCT02023697|566291293|FG002|Treatment Period|Adverse Event|23|||
156872588|NCT02023697|566291291|FG000|Treatment Period|Logistical difficulties|1|||
156872589|NCT02023697|566291292|FG001|Treatment Period|Logistical difficulties|1|||
156872590|NCT02023697|566291293|FG002|Treatment Period|Logistical difficulties|1|||
156872591|NCT02023697|566291291|FG000|Treatment Period|Clinical progression|10|||
156872592|NCT02023697|566291292|FG001|Treatment Period|Clinical progression|8|||
156872593|NCT02023697|566291293|FG002|Treatment Period|Clinical progression|28|||
156872594|NCT02023697|566291291|FG000|Treatment Period|Withdrawal by Subject|4|||
156872595|NCT02023697|566291292|FG001|Treatment Period|Withdrawal by Subject|5|||
156872596|NCT02023697|566291293|FG002|Treatment Period|Withdrawal by Subject|13|||
156872597|NCT02023697|566291291|FG000|Treatment Period|Safety outcome reached|0|||
156872598|NCT02023697|566291292|FG001|Treatment Period|Safety outcome reached|1|||
157125667|NCT00763321|567210361|FG002|Open-label Period|Adverse Event|0|||
156709072|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
157125668|NCT00763321|567210359|FG000|Open-label Period|Lost to Follow-up|14|||
157125669|NCT00763321|567210360|FG001|Open-label Period|Lost to Follow-up|0|||
157125670|NCT00763321|567210361|FG002|Open-label Period|Lost to Follow-up|0|||
157125671|NCT00763321|567210359|FG000|Open-label Period|Withdrawal by Subject|7|||
157125672|NCT00763321|567210360|FG001|Open-label Period|Withdrawal by Subject|0|||
157125673|NCT00763321|567210361|FG002|Open-label Period|Withdrawal by Subject|0|||
156709073|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
156709074|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
156709075|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
156709076|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
156709077|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709078|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709079|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709080|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709081|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
156709082|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
156709083|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
156709084|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
156709085|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
156709086|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
156709087|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709088|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709089|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709090|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709091|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
156709092|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709093|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709094|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156872599|NCT02023697|566291293|FG002|Treatment Period|Safety outcome reached|0|||
157125674|NCT00763321|567210359|FG000|Open-label Period|Subject noncompliant|7|||
157125675|NCT00763321|567210360|FG001|Open-label Period|Subject noncompliant|0|||
157125676|NCT00763321|567210361|FG002|Open-label Period|Subject noncompliant|0|||
156709095|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
156709096|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
157125677|NCT00763321|567210359|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
157125678|NCT00763321|567210360|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
156709097|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709098|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156872600|NCT02023697|566291291|FG000|Treatment Period|Physician Decision|0|||
156872601|NCT02023697|566291292|FG001|Treatment Period|Physician Decision|0|||
156872602|NCT02023697|566291293|FG002|Treatment Period|Physician Decision|1|||
156709099|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709100|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709101|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
156709102|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
156709103|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
156709104|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
156709105|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
156872603|NCT02023697|566291291|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
156872604|NCT02023697|566291292|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
156872605|NCT02023697|566291293|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
156872606|NCT02023697|566291291|FG000|Active Follow-up Period|Lost to Follow-up|1|||
156872607|NCT02023697|566291292|FG001|Active Follow-up Period|Lost to Follow-up|1|||
156872608|NCT02023697|566291293|FG002|Active Follow-up Period|Lost to Follow-up|1|||
156872609|NCT02023697|566291291|FG000|Active Follow-up Period|Deterioration of general condition|1|||
156872610|NCT02023697|566291292|FG001|Active Follow-up Period|Deterioration of general condition|1|||
156872611|NCT02023697|566291293|FG002|Active Follow-up Period|Deterioration of general condition|1|||
156872612|NCT02023697|566291291|FG000|Active Follow-up Period|Other unspecified|2|||
156872613|NCT02023697|566291292|FG001|Active Follow-up Period|Other unspecified|0|||
156872614|NCT02023697|566291293|FG002|Active Follow-up Period|Other unspecified|1|||
156872615|NCT02023697|566291291|FG000|Active Follow-up Period|Clinical progression|0|||
156872616|NCT02023697|566291292|FG001|Active Follow-up Period|Clinical progression|2|||
156872617|NCT02023697|566291293|FG002|Active Follow-up Period|Clinical progression|1|||
156872618|NCT02023697|566291291|FG000|Active Follow-up Period|Radiological progression|0|||
156872619|NCT02023697|566291292|FG001|Active Follow-up Period|Radiological progression|0|||
156872620|NCT02023697|566291293|FG002|Active Follow-up Period|Radiological progression|1|||
156872621|NCT02023697|566291291|FG000|Active Follow-up Period|Death|83|||
156872622|NCT02023697|566291292|FG001|Active Follow-up Period|Death|82|||
156872623|NCT02023697|566291293|FG002|Active Follow-up Period|Death|87|||
156872624|NCT02023697|566291291|FG000|Long-term Follow-up Period|Death|9|||
156872625|NCT02023697|566291292|FG001|Long-term Follow-up Period|Death|6|||
156872626|NCT02023697|566291293|FG002|Long-term Follow-up Period|Death|4|||
156872627|NCT02023697|566291291|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
156872628|NCT02023697|566291292|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
156872629|NCT02023697|566291293|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
156872630|NCT02023697|566291291|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
156872631|NCT02023697|566291292|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
156872632|NCT02023697|566291293|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
156872633|NCT02023697|566291291|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
156872634|NCT02023697|566291292|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
156872635|NCT02023697|566291293|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
156872636|NCT02023697|566291291|FG000|Long-term Follow-up Period|Technical problems|0|||
156872637|NCT02023697|566291292|FG001|Long-term Follow-up Period|Technical problems|0|||
156872638|NCT02023697|566291293|FG002|Long-term Follow-up Period|Technical problems|1|||
156872639|NCT02023697|566291291|FG000|Long-term Follow-up Period|Other unspecified|6|||
156872640|NCT02023697|566291292|FG001|Long-term Follow-up Period|Other unspecified|3|||
156872641|NCT02023697|566291293|FG002|Long-term Follow-up Period|Other unspecified|5|||
156872642|NCT00541385|566291294|FG000|Overall Study|Adverse Event|6|||
156872643|NCT00541385|566291295|FG001|Overall Study|Adverse Event|3|||
156872644|NCT00541385|566291294|FG000|Overall Study|Withdrawal by Subject|2|||
156872645|NCT00541385|566291295|FG001|Overall Study|Withdrawal by Subject|2|||
156872646|NCT00541385|566291294|FG000|Overall Study|Lost to Follow-up|6|||
156872647|NCT00541385|566291295|FG001|Overall Study|Lost to Follow-up|1|||
156872648|NCT00541385|566291294|FG000|Overall Study|Parasite reappearance/malaria|67|||
156872649|NCT00541385|566291295|FG001|Overall Study|Parasite reappearance/malaria|32|||
156872650|NCT01469377|566291301|FG000|Overall Study|Protocol Deviation|7|||
156872651|NCT01469377|566291302|FG001|Overall Study|Protocol Deviation|10|||
156872652|NCT01469377|566291303|FG002|Overall Study|Protocol Deviation|10|||
156872653|NCT01469377|566291301|FG000|Overall Study|Lost to Follow-up|3|||
157016137|NCT00448669|566811249|FG001|Overall Study|Lost to Follow-up|63|||
156872654|NCT01469377|566291302|FG001|Overall Study|Lost to Follow-up|2|||
157016138|NCT00448669|566811248|FG000|Overall Study|Withdrawal by Subject|90|||
157016139|NCT00448669|566811249|FG001|Overall Study|Withdrawal by Subject|74|||
157016140|NCT00448669|566811248|FG000|Overall Study|Relocated|49|||
157016141|NCT00448669|566811249|FG001|Overall Study|Relocated|36|||
157016142|NCT00448669|566811248|FG000|Overall Study|Were withdrawn by investigator|10|||
157016143|NCT00448669|566811249|FG001|Overall Study|Were withdrawn by investigator|6|||
157016144|NCT00448669|566811248|FG000|Overall Study|Death|2|||
157016145|NCT00448669|566811249|FG001|Overall Study|Death|4|||
157016146|NCT00448669|566811248|FG000|Overall Study|Had other reasons|5|||
157016147|NCT00448669|566811249|FG001|Overall Study|Had other reasons|6|||
157016148|NCT00448669|566811248|FG000|Overall Study|HIV-infected at enrollment|1|||
157016149|NCT00448669|566811249|FG001|Overall Study|HIV-infected at enrollment|2|||
156709106|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
156872655|NCT01469377|566291303|FG002|Overall Study|Lost to Follow-up|5|||
156872656|NCT01469377|566291301|FG000|Overall Study|Withdrawal of Consent|12|||
156872657|NCT01469377|566291302|FG001|Overall Study|Withdrawal of Consent|14|||
156872658|NCT01469377|566291303|FG002|Overall Study|Withdrawal of Consent|15|||
156872659|NCT01469377|566291301|FG000|Overall Study|Adverse Event|8|||
156872660|NCT01469377|566291302|FG001|Overall Study|Adverse Event|18|||
156872661|NCT01469377|566291303|FG002|Overall Study|Adverse Event|36|||
156872662|NCT01469377|566291301|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156872663|NCT01469377|566291302|FG001|Overall Study|Insufficient Therapeutic Response|4|||
156872664|NCT01469377|566291303|FG002|Overall Study|Insufficient Therapeutic Response|0|||
156872665|NCT01469377|566291301|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156872666|NCT01469377|566291302|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156872667|NCT01469377|566291303|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156872668|NCT00074490|566291304|FG000|Overall Study|Progressive malignancy|0|||
156872669|NCT00074490|566291305|FG001|Overall Study|Progressive malignancy|7|||
156872670|NCT00074490|566291306|FG002|Overall Study|Progressive malignancy|0|||
156872671|NCT00074490|566291307|FG003|Overall Study|Progressive malignancy|0|||
156872672|NCT00074490|566291308|FG004|Overall Study|Progressive malignancy|3|||
156872673|NCT00074490|566291309|FG005|Overall Study|Progressive malignancy|0|||
156872674|NCT04139798|566291314|FG000|Overall Study|Withdrawal by Subject|6|||
156872675|NCT04139798|566291315|FG001|Overall Study|Withdrawal by Subject|5|||
156872676|NCT04139798|566291314|FG000|Overall Study|Lost to Follow-up|2|||
156872677|NCT04139798|566291315|FG001|Overall Study|Lost to Follow-up|5|||
156872678|NCT04139798|566291314|FG000|Overall Study|Discontinued|4|||
156872679|NCT04139798|566291315|FG001|Overall Study|Discontinued|2|||
156872680|NCT04139798|566291314|FG000|Overall Study|Adverse Event|1|||
156872681|NCT04139798|566291315|FG001|Overall Study|Adverse Event|3|||
156872682|NCT04139798|566291314|FG000|Overall Study|Protocol Violation|1|||
156872683|NCT04139798|566291315|FG001|Overall Study|Protocol Violation|0|||
156872684|NCT04939415|566291316|FG000|Overall Study|Withdrawal by Subject|1|||
156872685|NCT04939415|566291317|FG001|Overall Study|Withdrawal by Subject|3|||
156872686|NCT04939415|566291316|FG000|Overall Study|Lost to Follow-up|0|||
156872687|NCT04939415|566291317|FG001|Overall Study|Lost to Follow-up|2|||
156872688|NCT03155841|566291320|FG000|Overall Study|Protocol Violation|3|||
156872689|NCT03155841|566291321|FG001|Overall Study|Protocol Violation|4|||
156872690|NCT04308291|566291322|FG000|Run-In Phase|Withdrawal by Subject|4|||
157125679|NCT00763321|567210361|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
157125680|NCT00763321|567210359|FG000|Open-label Period|Lack of Efficacy|2|||
157125681|NCT00763321|567210360|FG001|Open-label Period|Lack of Efficacy|0|||
157125682|NCT00763321|567210361|FG002|Open-label Period|Lack of Efficacy|0|||
157125683|NCT00763321|567210359|FG000|Open-label Period|Other|4|||
157125684|NCT00763321|567210360|FG001|Open-label Period|Other|0|||
157125685|NCT00763321|567210361|FG002|Open-label Period|Other|0|||
157125686|NCT00763321|567210359|FG000|Double-blind Period|Lack of Efficacy|0|||
157125687|NCT00763321|567210360|FG001|Double-blind Period|Lack of Efficacy|9|||
157125688|NCT00763321|567210361|FG002|Double-blind Period|Lack of Efficacy|17|||
157125689|NCT00763321|567210359|FG000|Double-blind Period|Adverse Event|0|||
157125690|NCT00763321|567210360|FG001|Double-blind Period|Adverse Event|4|||
157125691|NCT00763321|567210361|FG002|Double-blind Period|Adverse Event|4|||
157125692|NCT00763321|567210359|FG000|Double-blind Period|Lost to Follow-up|0|||
157125693|NCT00763321|567210360|FG001|Double-blind Period|Lost to Follow-up|4|||
157125694|NCT00763321|567210361|FG002|Double-blind Period|Lost to Follow-up|2|||
157125695|NCT00763321|567210359|FG000|Double-blind Period|Withdrawal by Subject|0|||
157125696|NCT00763321|567210360|FG001|Double-blind Period|Withdrawal by Subject|2|||
157125697|NCT00763321|567210361|FG002|Double-blind Period|Withdrawal by Subject|3|||
157125698|NCT00763321|567210359|FG000|Double-blind Period|Other|0|||
157125699|NCT00763321|567210360|FG001|Double-blind Period|Other|2|||
157125700|NCT00763321|567210361|FG002|Double-blind Period|Other|3|||
157125701|NCT03175549|567210362|FG000|Overall Study|Lost to Follow-up|2|||
157125702|NCT03175549|567210363|FG001|Overall Study|Lost to Follow-up|2|||
157125703|NCT03175549|567210362|FG000|Overall Study|Medication non-compliance|2|||
157125704|NCT03175549|567210363|FG001|Overall Study|Medication non-compliance|2|||
157125705|NCT02486757|567210364|FG000|Overall Study|Lost to Follow-up|1|||
157125706|NCT02793232|567210365|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156872691|NCT04308291|566291322|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
157125707|NCT02793232|567210366|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
157125708|NCT02793232|567210367|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156872692|NCT04308291|566291322|FG000|Study Phase 6-M|Physician Decision|2|||
156872693|NCT04308291|566291322|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
156872694|NCT04308291|566291322|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
157125709|NCT02793232|567210368|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
157125710|NCT02793232|567210369|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
157125711|NCT02793232|567210370|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
157125712|NCT02793232|567210371|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
156872695|NCT04308291|566291322|FG000|Study Phase 12-M|Physician Decision|2|||
157125713|NCT02793232|567210372|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
156709107|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709108|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709109|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
156709110|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
157125714|NCT02793232|567210373|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
157125715|NCT02387580|567210374|FG000|Overall Study|Withdrawal by Subject|0|||
157125716|NCT02387580|567210375|FG001|Overall Study|Withdrawal by Subject|0|||
157125717|NCT02387580|567210376|FG002|Overall Study|Withdrawal by Subject|0|||
157125718|NCT02387580|567210377|FG003|Overall Study|Withdrawal by Subject|1|||
157125719|NCT02387580|567210378|FG004|Overall Study|Withdrawal by Subject|0|||
157125720|NCT02387580|567210379|FG005|Overall Study|Withdrawal by Subject|0|||
157125721|NCT04849780|567210380|FG000|Period 1|Covid-19 Related|1|||
157125722|NCT04849780|567210381|FG001|Period 1|Covid-19 Related|0|||
157125723|NCT04849780|567210380|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
157125724|NCT04849780|567210381|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
157125725|NCT04849780|567210380|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
157125726|NCT04849780|567210381|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
157125727|NCT00725075|567210382|FG000|Overall Study|Use of Excluded Medication|0|||
157125728|NCT00725075|567210383|FG001|Overall Study|Use of Excluded Medication|1|||
157125729|NCT00725075|567210384|FG002|Overall Study|Use of Excluded Medication|0|||
157125730|NCT00725075|567210382|FG000|Overall Study|Protocol Violation|0|||
157125731|NCT00725075|567210383|FG001|Overall Study|Protocol Violation|0|||
157125732|NCT00725075|567210384|FG002|Overall Study|Protocol Violation|1|||
157125733|NCT00725075|567210382|FG000|Overall Study|Lost to Follow-up|1|||
157125734|NCT00725075|567210383|FG001|Overall Study|Lost to Follow-up|0|||
157125735|NCT00725075|567210384|FG002|Overall Study|Lost to Follow-up|0|||
157125736|NCT00725075|567210382|FG000|Overall Study|Withdrawal by Subject|4|||
157125737|NCT00725075|567210383|FG001|Overall Study|Withdrawal by Subject|5|||
157125738|NCT00725075|567210384|FG002|Overall Study|Withdrawal by Subject|4|||
157125739|NCT00725075|567210382|FG000|Overall Study|Adverse Event|2|||
157125740|NCT00725075|567210383|FG001|Overall Study|Adverse Event|1|||
157125741|NCT00725075|567210384|FG002|Overall Study|Adverse Event|1|||
157125742|NCT00725075|567210382|FG000|Overall Study|Worsening of Disease|2|||
157125743|NCT00725075|567210383|FG001|Overall Study|Worsening of Disease|1|||
157125744|NCT00725075|567210384|FG002|Overall Study|Worsening of Disease|2|||
157125745|NCT00725075|567210382|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
157125746|NCT00725075|567210383|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
157125747|NCT00725075|567210384|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
157125748|NCT00725075|567210382|FG000|Overall Study|Other|1|||
157125749|NCT00725075|567210383|FG001|Overall Study|Other|0|||
157125750|NCT00725075|567210384|FG002|Overall Study|Other|0|||
157125751|NCT02286947|567210391|FG000|Overall Study|Withdrawal by Subject|2|||
157125752|NCT03920670|567210392|FG000|Overall Study|Protocol Violation|2|||
157125753|NCT03920670|567210393|FG001|Overall Study|Protocol Violation|2|||
157125754|NCT03920670|567210392|FG000|Overall Study|Adverse Event|1|||
157125755|NCT03920670|567210393|FG001|Overall Study|Adverse Event|0|||
157125756|NCT00573794|567210394|FG000|Overall Study|Adverse Event|81|||
157125757|NCT00573794|567210394|FG000|Overall Study|Withdrew Consent|90|||
157125758|NCT00573794|567210394|FG000|Overall Study|Lost to Follow-up|13|||
157125759|NCT00573794|567210394|FG000|Overall Study|Protocol Violation|6|||
157125760|NCT00573794|567210394|FG000|Overall Study|Lack of Efficacy|94|||
157125761|NCT00573794|567210394|FG000|Overall Study|Other|46|||
157125762|NCT04820309|567210403|FG000|Overall Study|Adverse Event|96|||
157125763|NCT04820309|567210403|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
157125764|NCT04820309|567210403|FG000|Overall Study|Consent Withdrawn|93|||
157125765|NCT04820309|567210403|FG000|Overall Study|failure to adhere to protocol|32|||
157125766|NCT04820309|567210403|FG000|Overall Study|alcohol or drug use|6|||
157125767|NCT04820309|567210403|FG000|Overall Study|Lost to Follow-up|46|||
157125768|NCT04820309|567210403|FG000|Overall Study|Death|2|||
157125769|NCT04820309|567210403|FG000|Overall Study|Pregnancy|1|||
157125770|NCT04820309|567210403|FG000|Overall Study|Other reasons|12|||
157125771|NCT04202679|567210406|FG000|Overall Study|Adverse Event|2|||
157125772|NCT04202679|567210407|FG001|Overall Study|Adverse Event|0|||
157125773|NCT04202679|567210406|FG000|Overall Study|Poor compliance to protocol|1|||
157125774|NCT04202679|567210407|FG001|Overall Study|Poor compliance to protocol|0|||
157125775|NCT04202679|567210406|FG000|Overall Study|Withdrawal by Subject|23|||
157125776|NCT04202679|567210407|FG001|Overall Study|Withdrawal by Subject|6|||
157125777|NCT05902364|567210408|FG000|Overall Study|Adverse Event|1|||
157125778|NCT05902364|567210409|FG001|Overall Study|Adverse Event|0|||
157125779|NCT02270242|567210410|FG000|Overall Study|Withdrawal by Subject|18|||
157125780|NCT02270242|567210411|FG001|Overall Study|Withdrawal by Subject|25|||
157125781|NCT02270242|567210410|FG000|Overall Study|Lost to Follow-up|41|||
157125782|NCT02270242|567210411|FG001|Overall Study|Lost to Follow-up|27|||
157125783|NCT02270242|567210410|FG000|Overall Study|Physician Decision|0|||
157125784|NCT02270242|567210411|FG001|Overall Study|Physician Decision|1|||
157125785|NCT03864653|567210412|FG000|Overall Study|Withdrawal by Subject|1|||
156709111|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
156872696|NCT04308291|566291322|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
157125786|NCT01984268|567210413|FG000|Overall Study|Study Terminated|15|||
157125787|NCT06272370|567212283|FG000|Overall Study|Lost to Follow-up|0|||
157125788|NCT06272370|567212284|FG001|Overall Study|Lost to Follow-up|3|||
157125789|NCT06272370|567212285|FG002|Overall Study|Lost to Follow-up|1|||
157125790|NCT06272370|567212286|FG003|Overall Study|Lost to Follow-up|1|||
157125791|NCT01227902|567212288|FG000|Overall Study|Adverse Event|12|||
157125792|NCT01227902|567212289|FG001|Overall Study|Adverse Event|8|||
157125793|NCT01227902|567212290|FG002|Overall Study|Adverse Event|11|||
157125794|NCT01227902|567212291|FG003|Overall Study|Adverse Event|4|||
157125795|NCT01227902|567212288|FG000|Overall Study|Lack of Efficacy|1|||
157125796|NCT01227902|567212289|FG001|Overall Study|Lack of Efficacy|2|||
157125797|NCT01227902|567212290|FG002|Overall Study|Lack of Efficacy|2|||
157125798|NCT01227902|567212291|FG003|Overall Study|Lack of Efficacy|1|||
157125799|NCT01227902|567212288|FG000|Overall Study|Protocol Violation|1|||
157125800|NCT01227902|567212289|FG001|Overall Study|Protocol Violation|0|||
157125801|NCT01227902|567212290|FG002|Overall Study|Protocol Violation|0|||
157125802|NCT01227902|567212291|FG003|Overall Study|Protocol Violation|0|||
157125803|NCT01227902|567212288|FG000|Overall Study|Lost to Follow-up|0|||
157125804|NCT01227902|567212289|FG001|Overall Study|Lost to Follow-up|0|||
157125805|NCT01227902|567212290|FG002|Overall Study|Lost to Follow-up|1|||
157125806|NCT01227902|567212291|FG003|Overall Study|Lost to Follow-up|2|||
157125807|NCT01227902|567212288|FG000|Overall Study|Physician Decision|0|||
157125808|NCT01227902|567212289|FG001|Overall Study|Physician Decision|1|||
157125809|NCT01227902|567212290|FG002|Overall Study|Physician Decision|1|||
157125810|NCT01227902|567212291|FG003|Overall Study|Physician Decision|0|||
157125811|NCT01227902|567212288|FG000|Overall Study|Withdrawal by Subject|4|||
157125812|NCT01227902|567212289|FG001|Overall Study|Withdrawal by Subject|2|||
157125813|NCT01227902|567212290|FG002|Overall Study|Withdrawal by Subject|4|||
157125814|NCT01227902|567212291|FG003|Overall Study|Withdrawal by Subject|3|||
157125815|NCT02363478|567212297|FG000|Overall Study|Lost to Follow-up|4|||
157125816|NCT02363478|567212297|FG000|Overall Study|Adverse Event|4|||
157125817|NCT00930059|567212298|FG000|Overall Study|Death|1|||
157125818|NCT00930059|567212299|FG001|Overall Study|Death|0|||
157125819|NCT00930059|567212298|FG000|Overall Study|Did not meet entrance criteria|1|||
157125820|NCT00930059|567212299|FG001|Overall Study|Did not meet entrance criteria|1|||
157125821|NCT00930059|567212298|FG000|Overall Study|Withdrawal by Subject|3|||
157125822|NCT00930059|567212299|FG001|Overall Study|Withdrawal by Subject|4|||
157125823|NCT00930059|567212298|FG000|Overall Study|Other|1|||
157125824|NCT00930059|567212299|FG001|Overall Study|Other|0|||
156709112|NCT03104400|565680527|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709113|NCT03104400|565680528|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709114|NCT03104400|565680529|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709115|NCT03104400|565680530|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
156709116|NCT03104400|565680531|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709117|NCT03104400|565680532|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709118|NCT03104400|565680533|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709119|NCT03104400|565680534|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709120|NCT03104400|565680535|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709121|NCT03104400|565680536|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
156709122|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
157125825|NCT00930059|567212298|FG000|Overall Study|1 site terminated by sponsor|1|||
157125826|NCT00930059|567212299|FG001|Overall Study|1 site terminated by sponsor|1|||
157125827|NCT00930059|567212298|FG000|Overall Study|Adverse Event|1|||
157125828|NCT00930059|567212299|FG001|Overall Study|Adverse Event|6|||
157125829|NCT01299766|567212301|FG000|Overall Study|Death|5|||
157125830|NCT01299766|567212302|FG001|Overall Study|Death|4|||
157125831|NCT01299766|567212301|FG000|Overall Study|Withdrawal by Subject|29|||
157125832|NCT01299766|567212302|FG001|Overall Study|Withdrawal by Subject|19|||
157125833|NCT04002310|567212303|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
157125834|NCT04002310|567212304|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
157125835|NCT04002310|567212305|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
157125836|NCT04002310|567212306|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
157125837|NCT04002310|567212307|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
157125838|NCT00352534|567212308|FG000|Initial Staging|Ineligible|8|||
157125839|NCT00352534|567212309|FG001|Initial Staging|Ineligible|9|||
157125840|NCT00352534|567212310|FG002|Initial Staging|Ineligible|0|||
157125841|NCT00352534|567212311|FG003|Initial Staging|Ineligible|0|||
157125842|NCT00352534|567212312|FG004|Initial Staging|Ineligible|0|||
157125843|NCT00352534|567212313|FG005|Initial Staging|Ineligible|0|||
157125844|NCT00352534|567212314|FG006|Initial Staging|Ineligible|0|||
157125845|NCT00352534|567212308|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
157125846|NCT00352534|567212309|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
157125847|NCT00352534|567212310|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
157125848|NCT00352534|567212311|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
156709123|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
157215631|NCT00472446|567537360|FG003|Overall Study|Protocol Violation|1|||
157215632|NCT00472446|567537357|FG000|Overall Study|Reintervention|0|||
157215633|NCT00472446|567537358|FG001|Overall Study|Reintervention|0|||
157215634|NCT00472446|567537359|FG002|Overall Study|Reintervention|1|||
157215635|NCT00472446|567537360|FG003|Overall Study|Reintervention|1|||
157215636|NCT00472446|567537357|FG000|Overall Study|Questionnaires not returned|5|||
157215637|NCT00472446|567537358|FG001|Overall Study|Questionnaires not returned|6|||
157215638|NCT00472446|567537359|FG002|Overall Study|Questionnaires not returned|6|||
157215639|NCT00472446|567537360|FG003|Overall Study|Questionnaires not returned|4|||
157215640|NCT00295854|567537362|FG000|Overall Study|Adverse Event|7|||
156709124|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
156709125|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
156709126|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
156709127|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
156709128|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
156709129|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
156709130|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
156872697|NCT04411667|566291323|FG000|Overall Study|Physician Decision|1|||
156872698|NCT04411667|566291324|FG001|Overall Study|Physician Decision|0|||
156872699|NCT00949702|566291327|FG000|Overall Study|Death|40|||
156872700|NCT00949702|566291327|FG000|Overall Study|Disease progression|7|||
156872701|NCT00949702|566291327|FG000|Overall Study|Withdrawal of consent|1|||
156872702|NCT03399552|566291329|FG000|Overall Study|No evidence of disease|1|||
156872703|NCT03399552|566291329|FG000|Overall Study|Unevaluable|1|||
156872704|NCT01286480|566291331|FG000|Overall Study|Withdrawal by Subject|5|||
156872705|NCT01286480|566291332|FG001|Overall Study|Withdrawal by Subject|3|||
156872706|NCT00834093|566291333|FG000|Overall Study|Progressive Disease|3|||
156872707|NCT00834093|566291333|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
156872708|NCT00606593|566291334|FG000|Overall Study|Adverse Event|0|||
157215641|NCT00295854|567537363|FG001|Overall Study|Adverse Event|7|||
157215642|NCT00295854|567537364|FG002|Overall Study|Adverse Event|6|||
157215643|NCT00295854|567537362|FG000|Overall Study|Protocol Violation|1|||
157215644|NCT00295854|567537363|FG001|Overall Study|Protocol Violation|1|||
157215645|NCT00295854|567537364|FG002|Overall Study|Protocol Violation|1|||
157215646|NCT00295854|567537362|FG000|Overall Study|Lost to Follow-up|2|||
157215647|NCT00295854|567537363|FG001|Overall Study|Lost to Follow-up|0|||
157215648|NCT00295854|567537364|FG002|Overall Study|Lost to Follow-up|1|||
156709131|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
157215649|NCT00295854|567537362|FG000|Overall Study|Withdrawal by Subject|3|||
157215650|NCT00295854|567537363|FG001|Overall Study|Withdrawal by Subject|7|||
157215651|NCT00295854|567537364|FG002|Overall Study|Withdrawal by Subject|4|||
157215652|NCT00295854|567537362|FG000|Overall Study|did not continue to meet criteria|1|||
157215653|NCT00295854|567537363|FG001|Overall Study|did not continue to meet criteria|1|||
157215654|NCT00295854|567537364|FG002|Overall Study|did not continue to meet criteria|2|||
157215655|NCT00295854|567537362|FG000|Overall Study|required a prohibited medication|1|||
157215656|NCT00295854|567537363|FG001|Overall Study|required a prohibited medication|0|||
156709132|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709133|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709134|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
157215657|NCT00295854|567537364|FG002|Overall Study|required a prohibited medication|0|||
157215658|NCT00295854|567537362|FG000|Overall Study|Other|3|||
157215659|NCT00295854|567537363|FG001|Overall Study|Other|5|||
157215660|NCT00295854|567537364|FG002|Overall Study|Other|1|||
157215661|NCT03211156|567537365|FG000|Overall Study|Withdrawal by Subject|0|||
157215662|NCT03211156|567537366|FG001|Overall Study|Withdrawal by Subject|2|||
157215663|NCT03211156|567537365|FG000|Overall Study|Lost to Follow-up|1|||
157215664|NCT03211156|567537366|FG001|Overall Study|Lost to Follow-up|1|||
157215665|NCT03211156|567537365|FG000|Overall Study|Adverse Event|1|||
157215666|NCT03211156|567537366|FG001|Overall Study|Adverse Event|0|||
157215667|NCT00738673|567537368|FG000|Overall Study|Adverse Event|1|||
157215668|NCT00738673|567537369|FG001|Overall Study|Adverse Event|0|||
157215669|NCT00738673|567537368|FG000|Overall Study|Lack of Efficacy|19|||
157215670|NCT00738673|567537369|FG001|Overall Study|Lack of Efficacy|8|||
157215671|NCT00738673|567537368|FG000|Overall Study|Protocol Violation|1|||
157215672|NCT00738673|567537369|FG001|Overall Study|Protocol Violation|2|||
157215673|NCT00738673|567537368|FG000|Overall Study|Withdrawal by Subject|3|||
156872709|NCT00606593|566291335|FG001|Overall Study|Adverse Event|0|||
156872710|NCT00606593|566291336|FG002|Overall Study|Adverse Event|0|||
157215674|NCT00738673|567537369|FG001|Overall Study|Withdrawal by Subject|1|||
157215675|NCT02736227|567537370|FG000|Overall Study|Withdrawal by Subject|0|||
157215676|NCT02736227|567537371|FG001|Overall Study|Withdrawal by Subject|0|||
157215677|NCT02736227|567537372|FG002|Overall Study|Withdrawal by Subject|1|||
156709135|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156709136|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
156872711|NCT00606593|566291337|FG003|Overall Study|Adverse Event|1|||
156872712|NCT00606593|566291338|FG004|Overall Study|Adverse Event|1|||
157215678|NCT02736227|567537370|FG000|Overall Study|Physician Decision|0|||
157215679|NCT02736227|567537371|FG001|Overall Study|Physician Decision|0|||
157125849|NCT00352534|567212312|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
157125850|NCT00352534|567212313|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
156709137|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
156709138|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
156709139|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
156709140|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
156709141|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
156709142|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709143|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709144|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709145|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709146|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
156709147|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
156709148|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
156709149|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
156709150|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
156709151|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
156709152|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709153|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709154|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709155|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709156|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
156709157|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
156709158|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
156791780|NCT04691115|565990989|FG011|Overall Study|Withdrawal by Subject|0|||
156791781|NCT04691115|565990990|FG012|Overall Study|Withdrawal by Subject|0|||
157125851|NCT00352534|567212314|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
157125852|NCT00352534|567212308|FG000|Final Risk Group Assignment|Physician Decision|0|||
157125853|NCT00352534|567212309|FG001|Final Risk Group Assignment|Physician Decision|0|||
157125854|NCT00352534|567212310|FG002|Final Risk Group Assignment|Physician Decision|0|||
157125855|NCT00352534|567212311|FG003|Final Risk Group Assignment|Physician Decision|0|||
157125856|NCT00352534|567212312|FG004|Final Risk Group Assignment|Physician Decision|0|||
157125857|NCT00352534|567212313|FG005|Final Risk Group Assignment|Physician Decision|8|||
157125858|NCT00352534|567212314|FG006|Final Risk Group Assignment|Physician Decision|0|||
157125859|NCT00352534|567212308|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125860|NCT00352534|567212309|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125861|NCT00352534|567212310|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125862|NCT00352534|567212311|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125863|NCT00352534|567212312|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125864|NCT00352534|567212313|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
157125865|NCT00352534|567212314|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
157125866|NCT00352534|567212308|FG000|Final Risk Group Assignment|Ineligible|0|||
157125867|NCT00352534|567212309|FG001|Final Risk Group Assignment|Ineligible|0|||
157125868|NCT00352534|567212310|FG002|Final Risk Group Assignment|Ineligible|3|||
157125869|NCT00352534|567212311|FG003|Final Risk Group Assignment|Ineligible|1|||
157125870|NCT00352534|567212312|FG004|Final Risk Group Assignment|Ineligible|0|||
157125871|NCT00352534|567212313|FG005|Final Risk Group Assignment|Ineligible|13|||
157125872|NCT00352534|567212314|FG006|Final Risk Group Assignment|Ineligible|0|||
157125873|NCT00352534|567212308|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125874|NCT00352534|567212309|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125875|NCT00352534|567212310|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125876|NCT00352534|567212311|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125877|NCT00352534|567212312|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125878|NCT00352534|567212313|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
157125879|NCT00352534|567212314|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
157125880|NCT00352534|567212308|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125881|NCT00352534|567212309|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125882|NCT00352534|567212310|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125883|NCT00352534|567212311|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125884|NCT00352534|567212312|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125885|NCT00352534|567212313|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
157125886|NCT00352534|567212314|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
157125887|NCT00352534|567212308|FG000|Final Risk Group Assignment|Death|0|||
157125888|NCT00352534|567212309|FG001|Final Risk Group Assignment|Death|0|||
157125889|NCT00352534|567212310|FG002|Final Risk Group Assignment|Death|0|||
157125890|NCT00352534|567212311|FG003|Final Risk Group Assignment|Death|0|||
157125891|NCT00352534|567212312|FG004|Final Risk Group Assignment|Death|0|||
157125892|NCT00352534|567212313|FG005|Final Risk Group Assignment|Death|2|||
156709159|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
156709160|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
156791782|NCT04691115|565990991|FG013|Overall Study|Withdrawal by Subject|0|||
157125893|NCT00352534|567212314|FG006|Final Risk Group Assignment|Death|0|||
157125894|NCT00544869|567212318|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
157125895|NCT00544869|567212319|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
157125896|NCT00544869|567212320|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
157125897|NCT00544869|567212318|FG000|Overall Study|Adverse Event|6|||
157125898|NCT00544869|567212319|FG001|Overall Study|Adverse Event|1|||
157125899|NCT00544869|567212320|FG002|Overall Study|Adverse Event|0|||
157125900|NCT00544869|567212318|FG000|Overall Study|Lack of Efficacy|1|||
157125901|NCT00544869|567212319|FG001|Overall Study|Lack of Efficacy|1|||
157125902|NCT00544869|567212320|FG002|Overall Study|Lack of Efficacy|0|||
157125903|NCT00544869|567212318|FG000|Overall Study|Physician Decision|2|||
157125904|NCT00544869|567212319|FG001|Overall Study|Physician Decision|0|||
157125905|NCT00544869|567212320|FG002|Overall Study|Physician Decision|0|||
156709161|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
156709162|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709163|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709164|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709165|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709166|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709167|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
156709168|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
156709169|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
157125906|NCT00619502|567212321|FG000|Overall Study|Lost to Follow-up|8|||
157125907|NCT00619502|567212322|FG001|Overall Study|Lost to Follow-up|10|||
157125908|NCT03968419|567212323|FG000|Treatment Period|Adverse Event|0|||
157125909|NCT03968419|567212324|FG001|Treatment Period|Adverse Event|0|||
157125910|NCT03968419|567212325|FG002|Treatment Period|Adverse Event|1|||
156709170|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
156709171|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
156709172|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709173|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709174|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709175|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709176|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709177|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709178|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709179|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
156709180|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
156709181|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
156709182|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
156709183|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
156709184|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
157016150|NCT00448669|566811248|FG000|Overall Study|Never started drug|9|||
157016151|NCT00448669|566811249|FG001|Overall Study|Never started drug|7|||
157016152|NCT04287985|566811250|FG000|Overall Study|Adverse Event|1|||
157016153|NCT04287985|566811251|FG001|Overall Study|Adverse Event|0|||
157016154|NCT04287985|566811252|FG002|Overall Study|Adverse Event|0|||
157016155|NCT04287985|566811253|FG003|Overall Study|Adverse Event|0|||
157016156|NCT04287985|566811250|FG000|Overall Study|Protocol Violation|0|||
157016157|NCT04287985|566811251|FG001|Overall Study|Protocol Violation|1|||
157016158|NCT04287985|566811252|FG002|Overall Study|Protocol Violation|0|||
157016159|NCT04287985|566811253|FG003|Overall Study|Protocol Violation|0|||
157016160|NCT04287985|566811250|FG000|Overall Study|Physician Decision|0|||
157016161|NCT04287985|566811251|FG001|Overall Study|Physician Decision|0|||
157016162|NCT04287985|566811252|FG002|Overall Study|Physician Decision|0|||
157016163|NCT04287985|566811253|FG003|Overall Study|Physician Decision|1|||
157016164|NCT04287985|566811250|FG000|Overall Study|Withdrawal by Subject|2|||
157016165|NCT04287985|566811251|FG001|Overall Study|Withdrawal by Subject|1|||
157016166|NCT04287985|566811252|FG002|Overall Study|Withdrawal by Subject|1|||
157016167|NCT04287985|566811253|FG003|Overall Study|Withdrawal by Subject|2|||
157016168|NCT01340066|566811254|FG000|Placebo Run in Period|Screen Failures|27|||
157016169|NCT01340066|566811255|FG001|Placebo Run in Period|Screen Failures|0|||
157016170|NCT01340066|566811256|FG002|Placebo Run in Period|Screen Failures|0|||
157016171|NCT01340066|566811254|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
157016172|NCT01340066|566811255|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
157016173|NCT01340066|566811256|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
157016174|NCT01340066|566811254|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
157016175|NCT01340066|566811255|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
157016176|NCT01340066|566811256|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
157016177|NCT01340066|566811254|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
157016178|NCT01340066|566811255|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
157016179|NCT01340066|566811256|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
157016180|NCT03771352|566811259|FG000|Overall Study|Screen failure|2|||
156709185|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
156709186|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
157215680|NCT02736227|567537372|FG002|Overall Study|Physician Decision|5|||
157215681|NCT02736227|567537370|FG000|Overall Study|Non Compliant|0|||
156709187|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
156709188|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
156709189|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
156709190|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
156709191|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
156709192|NCT03104400|565680527|FG000|Period 2 Week 56 - 260)|Other|0|||
156709193|NCT03104400|565680528|FG001|Period 2 Week 56 - 260)|Other|0|||
157215682|NCT02736227|567537371|FG001|Overall Study|Non Compliant|0|||
157215683|NCT02736227|567537372|FG002|Overall Study|Non Compliant|2|||
157215684|NCT04120194|567537373|FG000|Overall Study|Lost to Follow-up|11|||
157215685|NCT04120194|567537374|FG001|Overall Study|Lost to Follow-up|8|||
156709194|NCT03104400|565680529|FG002|Period 2 Week 56 - 260)|Other|0|||
156709195|NCT03104400|565680530|FG003|Period 2 Week 56 - 260)|Other|0|||
157125911|NCT03968419|567212323|FG000|Safety Follow-up Period|Death|3|||
157125912|NCT03968419|567212324|FG001|Safety Follow-up Period|Death|2|||
157125913|NCT03968419|567212325|FG002|Safety Follow-up Period|Death|1|||
157125914|NCT03968419|567212323|FG000|Safety Follow-up Period|Subject Decision|2|||
157125915|NCT03968419|567212324|FG001|Safety Follow-up Period|Subject Decision|1|||
157125916|NCT03968419|567212325|FG002|Safety Follow-up Period|Subject Decision|0|||
157125917|NCT02894840|567212328|FG000|Overall Study|Lost to Follow-up|1|||
157125918|NCT02894840|567212329|FG001|Overall Study|Lost to Follow-up|0|||
157125919|NCT02894840|567212330|FG002|Overall Study|Lost to Follow-up|3|||
157125920|NCT02894840|567212331|FG003|Overall Study|Lost to Follow-up|0|||
157125921|NCT00804687|567212332|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
157125922|NCT00804687|567212333|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
157125923|NCT00804687|567212334|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
157125924|NCT00804687|567212335|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
157125925|NCT00804687|567212336|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
157125926|NCT00804687|567212337|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
157125927|NCT00804687|567212332|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
157125928|NCT00804687|567212333|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
157125929|NCT00804687|567212334|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
157125930|NCT00804687|567212335|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
157125931|NCT00804687|567212336|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
157125932|NCT00804687|567212337|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
157125933|NCT00804687|567212332|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
157125934|NCT00804687|567212333|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
157125935|NCT00804687|567212334|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
157125936|NCT00804687|567212335|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
157125937|NCT00804687|567212336|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
157125938|NCT00804687|567212337|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
157125939|NCT00804687|567212332|FG000|Period 5: Treatment Period|Positive drug test|1|||
157125940|NCT00804687|567212333|FG001|Period 5: Treatment Period|Positive drug test|0|||
157125941|NCT00804687|567212334|FG002|Period 5: Treatment Period|Positive drug test|0|||
157125942|NCT00804687|567212335|FG003|Period 5: Treatment Period|Positive drug test|0|||
157125943|NCT00804687|567212336|FG004|Period 5: Treatment Period|Positive drug test|0|||
157125944|NCT00804687|567212337|FG005|Period 5: Treatment Period|Positive drug test|0|||
157125945|NCT02908880|567212340|FG000|Overall Study|Lost to Follow-up|4|||
157125946|NCT02908880|567212340|FG000|Overall Study|Explantation of the device|1|||
157125947|NCT02908880|567212340|FG000|Overall Study|Withdrawal by Subject|17|||
157125948|NCT02908880|567212340|FG000|Overall Study|Death|5|||
157125949|NCT05425563|567212343|FG000|Overall Study|Withdrawal by Subject|17|||
157215686|NCT04120194|567537373|FG000|Overall Study|Adverse Event|4|||
157215687|NCT04120194|567537374|FG001|Overall Study|Adverse Event|5|||
157215688|NCT04120194|567537373|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
156709196|NCT03104400|565680531|FG004|Period 2 Week 56 - 260)|Other|0|||
156709197|NCT03104400|565680532|FG005|Period 2 Week 56 - 260)|Other|0|||
156709198|NCT03104400|565680533|FG006|Period 2 Week 56 - 260)|Other|0|||
156709199|NCT03104400|565680534|FG007|Period 2 Week 56 - 260)|Other|0|||
156709200|NCT03104400|565680535|FG008|Period 2 Week 56 - 260)|Other|1|||
157125950|NCT01001702|567212344|FG000|Overall Study|Lost to Follow-up|7|||
157125951|NCT01001702|567212344|FG000|Overall Study|Adverse Event|7|||
157125952|NCT01001702|567212344|FG000|Overall Study|Sponsor Discontinued Study|4|||
157125953|NCT01001702|567212344|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
157125954|NCT01001702|567212344|FG000|Overall Study|Investigator withdrew Subject|10|||
157215689|NCT04120194|567537374|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
157215690|NCT04120194|567537373|FG000|Overall Study|Miscellaneous|4|||
157215691|NCT04120194|567537374|FG001|Overall Study|Miscellaneous|5|||
156709201|NCT03104400|565680536|FG009|Period 2 Week 56 - 260)|Other|1|||
156709202|NCT00094861|565680539|FG000|Overall Study|Adverse Event|5|||
157125955|NCT01001702|567212344|FG000|Overall Study|Withdrawal by Subject|19|||
157125956|NCT01001702|567212344|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
157125957|NCT00584233|567212347|FG000|Overall Study|Withdrawal by Subject|5|||
157125958|NCT00584233|567212347|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
157125959|NCT02494596|567212348|FG000|Overall Study|Insufficient Therapeutic Response|3|||
157125960|NCT02494596|567212349|FG001|Overall Study|Insufficient Therapeutic Response|3|||
157125961|NCT02494596|567212350|FG002|Overall Study|Insufficient Therapeutic Response|1|||
157125962|NCT02494596|567212348|FG000|Overall Study|Adverse Event|0|||
157125963|NCT02494596|567212349|FG001|Overall Study|Adverse Event|1|||
157125964|NCT02494596|567212350|FG002|Overall Study|Adverse Event|0|||
157125965|NCT02494596|567212348|FG000|Overall Study|Refused Treatment|0|||
157125966|NCT02494596|567212349|FG001|Overall Study|Refused Treatment|1|||
157125967|NCT02494596|567212350|FG002|Overall Study|Refused Treatment|0|||
157125968|NCT02222714|567212351|FG000|Overall Study|Death|0|||
157125969|NCT02222714|567212352|FG001|Overall Study|Death|2|||
157125970|NCT02222714|567212353|FG002|Overall Study|Death|3|||
157125971|NCT02222714|567212354|FG003|Overall Study|Death|4|||
157125972|NCT02222714|567212355|FG004|Overall Study|Death|6|||
157125973|NCT02222714|567212351|FG000|Overall Study|Withdrawal by Subject|0|||
157125974|NCT02222714|567212352|FG001|Overall Study|Withdrawal by Subject|0|||
157125975|NCT02222714|567212353|FG002|Overall Study|Withdrawal by Subject|1|||
157125976|NCT02222714|567212354|FG003|Overall Study|Withdrawal by Subject|0|||
157125977|NCT02222714|567212355|FG004|Overall Study|Withdrawal by Subject|1|||
157125978|NCT00159432|567212356|FG000|Overall Study|Adverse Event|1|||
157125979|NCT00159432|567212356|FG000|Overall Study|Death|1|||
157125980|NCT00159432|567212356|FG000|Overall Study|Lack of Efficacy|8|||
157125981|NCT04537208|567212361|FG000|Overall Study|Adverse Event|0|||
157125982|NCT04537208|567212362|FG001|Overall Study|Adverse Event|0|||
157125983|NCT04537208|567212363|FG002|Overall Study|Adverse Event|0|||
157125984|NCT04537208|567212364|FG003|Overall Study|Adverse Event|0|||
157125985|NCT04537208|567212365|FG004|Overall Study|Adverse Event|0|||
157125986|NCT04537208|567212366|FG005|Overall Study|Adverse Event|0|||
157125987|NCT04537208|567212367|FG006|Overall Study|Adverse Event|0|||
157125988|NCT04537208|567212368|FG007|Overall Study|Adverse Event|0|||
157125989|NCT04537208|567212369|FG008|Overall Study|Adverse Event|1|||
157125990|NCT04537208|567212370|FG009|Overall Study|Adverse Event|0|||
157125991|NCT04537208|567212371|FG010|Overall Study|Adverse Event|0|||
157125992|NCT04537208|567212361|FG000|Overall Study|Protocol deviation|0|||
157125993|NCT04537208|567212362|FG001|Overall Study|Protocol deviation|0|||
157125994|NCT04537208|567212363|FG002|Overall Study|Protocol deviation|2|||
157125995|NCT04537208|567212364|FG003|Overall Study|Protocol deviation|0|||
157125996|NCT04537208|567212365|FG004|Overall Study|Protocol deviation|0|||
157125997|NCT04537208|567212366|FG005|Overall Study|Protocol deviation|2|||
157125998|NCT04537208|567212367|FG006|Overall Study|Protocol deviation|4|||
157125999|NCT04537208|567212368|FG007|Overall Study|Protocol deviation|0|||
157126000|NCT04537208|567212369|FG008|Overall Study|Protocol deviation|1|||
157126001|NCT04537208|567212370|FG009|Overall Study|Protocol deviation|0|||
157126002|NCT04537208|567212371|FG010|Overall Study|Protocol deviation|2|||
157126003|NCT04537208|567212361|FG000|Overall Study|Withdrawal by Subject|4|||
157126004|NCT04537208|567212362|FG001|Overall Study|Withdrawal by Subject|2|||
157126005|NCT04537208|567212363|FG002|Overall Study|Withdrawal by Subject|1|||
157126006|NCT04537208|567212364|FG003|Overall Study|Withdrawal by Subject|3|||
157126007|NCT04537208|567212365|FG004|Overall Study|Withdrawal by Subject|5|||
157126008|NCT04537208|567212366|FG005|Overall Study|Withdrawal by Subject|1|||
157126009|NCT04537208|567212367|FG006|Overall Study|Withdrawal by Subject|6|||
157126010|NCT04537208|567212368|FG007|Overall Study|Withdrawal by Subject|1|||
157126011|NCT04537208|567212369|FG008|Overall Study|Withdrawal by Subject|7|||
157126012|NCT04537208|567212370|FG009|Overall Study|Withdrawal by Subject|2|||
157126013|NCT04537208|567212371|FG010|Overall Study|Withdrawal by Subject|4|||
157126014|NCT04537208|567212361|FG000|Overall Study|Lost to Follow-up|4|||
157126015|NCT04537208|567212362|FG001|Overall Study|Lost to Follow-up|1|||
157126016|NCT04537208|567212363|FG002|Overall Study|Lost to Follow-up|3|||
157126017|NCT04537208|567212364|FG003|Overall Study|Lost to Follow-up|4|||
157215692|NCT02622074|567537376|FG000|Overall Study|Death|4|||
157215693|NCT02622074|567537377|FG001|Overall Study|Death|0|||
157126018|NCT04537208|567212365|FG004|Overall Study|Lost to Follow-up|3|||
157126019|NCT04537208|567212366|FG005|Overall Study|Lost to Follow-up|2|||
157126020|NCT04537208|567212367|FG006|Overall Study|Lost to Follow-up|3|||
157215694|NCT02622074|567537378|FG002|Overall Study|Death|0|||
157126021|NCT04537208|567212368|FG007|Overall Study|Lost to Follow-up|2|||
157126022|NCT04537208|567212369|FG008|Overall Study|Lost to Follow-up|7|||
157126023|NCT04537208|567212370|FG009|Overall Study|Lost to Follow-up|2|||
157126024|NCT04537208|567212371|FG010|Overall Study|Lost to Follow-up|2|||
157215695|NCT02622074|567537379|FG003|Overall Study|Death|1|||
157126025|NCT01537211|567212376|FG000|Overall Study|Lost to Follow-up|0|||
157126026|NCT01537211|567212377|FG001|Overall Study|Lost to Follow-up|1|||
157126027|NCT00704964|567212378|FG000|Overall Study|Not completed on time|328|||
157126028|NCT02161562|567212379|FG000|Overall Study|Withdrawal by Subject|5|||
157215696|NCT02622074|567537380|FG004|Overall Study|Death|1|||
157215697|NCT02622074|567537381|FG005|Overall Study|Death|0|||
157215698|NCT02622074|567537376|FG000|Overall Study|Withdrawal by Subject|0|||
157215699|NCT02622074|567537377|FG001|Overall Study|Withdrawal by Subject|1|||
157215700|NCT02622074|567537378|FG002|Overall Study|Withdrawal by Subject|0|||
157215701|NCT02622074|567537379|FG003|Overall Study|Withdrawal by Subject|0|||
157215702|NCT02622074|567537380|FG004|Overall Study|Withdrawal by Subject|0|||
156791783|NCT00830336|565990995|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
156791784|NCT00830336|565990996|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
156791785|NCT01630811|565990997|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
156791786|NCT01630811|565990998|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156791787|NCT01725308|565991001|FG000|Treatment Period I|Did Not Receive Drug|1|||
156791788|NCT01725308|565991002|FG001|Treatment Period I|Did Not Receive Drug|0|||
156791789|NCT01725308|565991003|FG002|Treatment Period I|Did Not Receive Drug|0|||
156791790|NCT01725308|565991001|FG000|Treatment Period I|Adverse Event|5|||
156791791|NCT01725308|565991002|FG001|Treatment Period I|Adverse Event|4|||
156791792|NCT01725308|565991003|FG002|Treatment Period I|Adverse Event|21|||
156791793|NCT01725308|565991001|FG000|Treatment Period I|Insufficient Response|7|||
156791794|NCT01725308|565991002|FG001|Treatment Period I|Insufficient Response|0|||
156791795|NCT01725308|565991003|FG002|Treatment Period I|Insufficient Response|5|||
156791796|NCT01725308|565991001|FG000|Treatment Period I|Worsening of the Target Disease|8|||
156791797|NCT01725308|565991002|FG001|Treatment Period I|Worsening of the Target Disease|0|||
156791798|NCT01725308|565991003|FG002|Treatment Period I|Worsening of the Target Disease|2|||
156791799|NCT01725308|565991001|FG000|Treatment Period I|Changes in the Episodes|3|||
156791800|NCT01725308|565991002|FG001|Treatment Period I|Changes in the Episodes|0|||
156791801|NCT01725308|565991003|FG002|Treatment Period I|Changes in the Episodes|2|||
156791802|NCT01725308|565991001|FG000|Treatment Period I|Withdrawal of Consent|12|||
156791803|NCT01725308|565991002|FG001|Treatment Period I|Withdrawal of Consent|7|||
156791804|NCT01725308|565991003|FG002|Treatment Period I|Withdrawal of Consent|5|||
156791805|NCT01725308|565991001|FG000|Treatment Period I|Lost to Follow-up|3|||
156791806|NCT01725308|565991002|FG001|Treatment Period I|Lost to Follow-up|2|||
156791807|NCT01725308|565991003|FG002|Treatment Period I|Lost to Follow-up|2|||
156791808|NCT01725308|565991001|FG000|Treatment Period I|Protocol Deviations|3|||
156791809|NCT01725308|565991002|FG001|Treatment Period I|Protocol Deviations|1|||
156791810|NCT01725308|565991003|FG002|Treatment Period I|Protocol Deviations|1|||
156791811|NCT01725308|565991001|FG000|Treatment Period I|Miscellaneous|2|||
156791812|NCT01725308|565991002|FG001|Treatment Period I|Miscellaneous|0|||
156791813|NCT01725308|565991003|FG002|Treatment Period I|Miscellaneous|3|||
156791814|NCT01725308|565991001|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
156791815|NCT01725308|565991002|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
156791816|NCT01725308|565991003|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
156791817|NCT01725308|565991001|FG000|Treatment Period II|Did Not Receive Drug|4|||
156791818|NCT01725308|565991002|FG001|Treatment Period II|Did Not Receive Drug|0|||
156791819|NCT01725308|565991003|FG002|Treatment Period II|Did Not Receive Drug|0|||
156791820|NCT01725308|565991001|FG000|Treatment Period II|Adverse Event|13|||
156791821|NCT01725308|565991002|FG001|Treatment Period II|Adverse Event|8|||
156791822|NCT01725308|565991003|FG002|Treatment Period II|Adverse Event|20|||
156791823|NCT01725308|565991001|FG000|Treatment Period II|Insufficient Response|2|||
156791824|NCT01725308|565991002|FG001|Treatment Period II|Insufficient Response|4|||
156791825|NCT01725308|565991003|FG002|Treatment Period II|Insufficient Response|6|||
156791826|NCT01725308|565991001|FG000|Treatment Period II|Worsening of the Target Disease|1|||
156791827|NCT01725308|565991002|FG001|Treatment Period II|Worsening of the Target Disease|4|||
156791828|NCT01725308|565991003|FG002|Treatment Period II|Worsening of the Target Disease|2|||
156791829|NCT01725308|565991001|FG000|Treatment Period II|Changes in the Episodes|1|||
156791830|NCT01725308|565991002|FG001|Treatment Period II|Changes in the Episodes|0|||
156791831|NCT01725308|565991003|FG002|Treatment Period II|Changes in the Episodes|5|||
156791832|NCT01725308|565991001|FG000|Treatment Period II|Withdrawal of Consent|28|||
157016181|NCT03771352|566811259|FG000|Overall Study|Withdrawal by Subject|2|||
157016182|NCT00274469|566811265|FG000|Overall Study|Death|63|||
157016183|NCT00274469|566811266|FG001|Overall Study|Death|74|||
157016184|NCT00274469|566811265|FG000|Overall Study|Did not consent to OS follow-up|16|||
157016185|NCT00274469|566811266|FG001|Overall Study|Did not consent to OS follow-up|19|||
157016186|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
157016187|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
157016188|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
157016189|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
156791833|NCT01725308|565991002|FG001|Treatment Period II|Withdrawal of Consent|2|||
156791834|NCT01725308|565991003|FG002|Treatment Period II|Withdrawal of Consent|16|||
156791835|NCT01725308|565991001|FG000|Treatment Period II|Lost to Follow-up|1|||
156791836|NCT01725308|565991002|FG001|Treatment Period II|Lost to Follow-up|5|||
156791837|NCT01725308|565991003|FG002|Treatment Period II|Lost to Follow-up|3|||
156791838|NCT01725308|565991001|FG000|Treatment Period II|Protocol Deviations|0|||
156791839|NCT01725308|565991002|FG001|Treatment Period II|Protocol Deviations|0|||
156791840|NCT01725308|565991003|FG002|Treatment Period II|Protocol Deviations|1|||
156709203|NCT00094861|565680540|FG001|Overall Study|Adverse Event|2|||
156709204|NCT00094861|565680539|FG000|Overall Study|Withdrawal by Subject|5|||
156709205|NCT00094861|565680540|FG001|Overall Study|Withdrawal by Subject|3|||
156709206|NCT00094861|565680539|FG000|Overall Study|Physician Decision|1|||
156709207|NCT00094861|565680540|FG001|Overall Study|Physician Decision|1|||
157016190|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
157016191|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
157016192|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
157016193|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
157016194|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
157016195|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
157016196|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
157016197|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
157016198|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
157016199|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
156709208|NCT00094861|565680539|FG000|Overall Study|Lost to Follow-up|0|||
156709209|NCT00094861|565680540|FG001|Overall Study|Lost to Follow-up|1|||
156709210|NCT00094861|565680539|FG000|Overall Study|Death|4|||
156709211|NCT00094861|565680540|FG001|Overall Study|Death|2|||
156709212|NCT00094861|565680539|FG000|Overall Study|Other|3|||
156709213|NCT00094861|565680540|FG001|Overall Study|Other|0|||
156709214|NCT00451204|565680541|FG000|Overall Study|Adverse Event|4|||
156709215|NCT00451204|565680542|FG001|Overall Study|Adverse Event|6|||
156709216|NCT00451204|565680541|FG000|Overall Study|Lack of Efficacy|4|||
156709217|NCT00451204|565680542|FG001|Overall Study|Lack of Efficacy|4|||
156709218|NCT00451204|565680541|FG000|Overall Study|Lost to Follow-up|4|||
156709219|NCT00451204|565680542|FG001|Overall Study|Lost to Follow-up|4|||
156709220|NCT00451204|565680541|FG000|Overall Study|Protocol Violation|1|||
156709221|NCT00451204|565680542|FG001|Overall Study|Protocol Violation|0|||
156709222|NCT00451204|565680541|FG000|Overall Study|Patient refusal|8|||
156709223|NCT00451204|565680542|FG001|Overall Study|Patient refusal|4|||
156709224|NCT00451204|565680541|FG000|Overall Study|Other|1|||
156709225|NCT00451204|565680542|FG001|Overall Study|Other|2|||
156709226|NCT03760185|565680543|FG000|Overall Study|Lost to Follow-up|1|||
156791841|NCT01725308|565991001|FG000|Treatment Period II|Miscellaneous|5|||
156791842|NCT01725308|565991002|FG001|Treatment Period II|Miscellaneous|3|||
156791843|NCT01725308|565991003|FG002|Treatment Period II|Miscellaneous|7|||
156791844|NCT03511209|565991004|FG000|Overall Study|Withdrawal by Subject|2|||
156791845|NCT03511209|565991005|FG001|Overall Study|Withdrawal by Subject|4|||
156791846|NCT03511209|565991004|FG000|Overall Study|Death|1|||
156791847|NCT03511209|565991005|FG001|Overall Study|Death|0|||
156791848|NCT03511209|565991004|FG000|Overall Study|Lost to Follow-up|0|||
156791849|NCT03511209|565991005|FG001|Overall Study|Lost to Follow-up|2|||
156791850|NCT02971137|565991011|FG000|Overall Study|Lost to Follow-up|44|||
156791851|NCT02971137|565991012|FG001|Overall Study|Lost to Follow-up|56|||
156791852|NCT00215657|565991013|FG000|Overall Study|Adverse Event|5|||
156791853|NCT00215657|565991014|FG001|Overall Study|Adverse Event|1|||
156791854|NCT00215657|565991015|FG002|Overall Study|Adverse Event|3|||
156791855|NCT00215657|565991016|FG003|Overall Study|Adverse Event|0|||
156791856|NCT00215657|565991017|FG004|Overall Study|Adverse Event|3|||
156791857|NCT00215657|565991018|FG005|Overall Study|Adverse Event|1|||
156791858|NCT00215657|565991019|FG006|Overall Study|Adverse Event|0|||
156791859|NCT00215657|565991020|FG007|Overall Study|Adverse Event|3|||
156791860|NCT00215657|565991013|FG000|Overall Study|Withdrawal by Subject|6|||
156791861|NCT00215657|565991014|FG001|Overall Study|Withdrawal by Subject|3|||
156791862|NCT00215657|565991015|FG002|Overall Study|Withdrawal by Subject|3|||
156791863|NCT00215657|565991016|FG003|Overall Study|Withdrawal by Subject|1|||
156791864|NCT00215657|565991017|FG004|Overall Study|Withdrawal by Subject|6|||
156791865|NCT00215657|565991018|FG005|Overall Study|Withdrawal by Subject|1|||
156791866|NCT00215657|565991019|FG006|Overall Study|Withdrawal by Subject|10|||
156791867|NCT00215657|565991020|FG007|Overall Study|Withdrawal by Subject|3|||
156791868|NCT00215657|565991013|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
156791869|NCT00215657|565991014|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
156791870|NCT00215657|565991015|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
156791871|NCT00215657|565991016|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
156791872|NCT00215657|565991017|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
156791873|NCT00215657|565991018|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
156791874|NCT00215657|565991019|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
156791875|NCT00215657|565991020|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
156791876|NCT00215657|565991013|FG000|Overall Study|Insufficient testosterone response|5|||
156791877|NCT00215657|565991014|FG001|Overall Study|Insufficient testosterone response|4|||
156791878|NCT00215657|565991015|FG002|Overall Study|Insufficient testosterone response|1|||
156709227|NCT03760185|565680544|FG001|Overall Study|Lost to Follow-up|1|||
156709228|NCT02473523|565680545|FG000|Overall Study|Death|1|||
156709229|NCT02473523|565680545|FG000|Overall Study|Lost to Follow-up|1|||
156872713|NCT00606593|566291339|FG005|Overall Study|Adverse Event|0|||
156872714|NCT00606593|566291340|FG006|Overall Study|Adverse Event|1|||
156872715|NCT00606593|566291341|FG007|Overall Study|Adverse Event|2|||
156872716|NCT00606593|566291342|FG008|Overall Study|Adverse Event|1|||
156872717|NCT00606593|566291343|FG009|Overall Study|Adverse Event|0|||
156872718|NCT00606593|566291334|FG000|Overall Study|Withdrawal of consent|1|||
156872719|NCT00606593|566291335|FG001|Overall Study|Withdrawal of consent|0|||
157016200|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
157016201|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
157016202|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
157016203|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
157016204|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
157016205|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
157016206|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
157016207|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
157016208|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
157016209|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
157016210|NCT03338816|566811267|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
157016211|NCT03338816|566811268|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
157016212|NCT03338816|566811269|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
157016213|NCT03338816|566811270|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
157016214|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Adverse Event|4|||
157016215|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Adverse Event|1|||
157126029|NCT02161562|567212380|FG001|Overall Study|Withdrawal by Subject|8|||
157126030|NCT02161562|567212379|FG000|Overall Study|Protocol Violation|9|||
157126031|NCT02161562|567212380|FG001|Overall Study|Protocol Violation|4|||
157126032|NCT02161562|567212379|FG000|Overall Study|Pregnancy|1|||
157126033|NCT02161562|567212380|FG001|Overall Study|Pregnancy|2|||
157126034|NCT02161562|567212379|FG000|Overall Study|Lost to Follow-up|3|||
157126035|NCT02161562|567212380|FG001|Overall Study|Lost to Follow-up|1|||
157126036|NCT02161562|567212379|FG000|Overall Study|Lack of Efficacy|4|||
157126037|NCT02161562|567212380|FG001|Overall Study|Lack of Efficacy|1|||
157126038|NCT02161562|567212379|FG000|Overall Study|Adverse Event|1|||
157126039|NCT02161562|567212380|FG001|Overall Study|Adverse Event|1|||
157126040|NCT02161562|567212379|FG000|Overall Study|Participant moved back to home country|1|||
157126041|NCT02161562|567212380|FG001|Overall Study|Participant moved back to home country|0|||
157126042|NCT02161562|567212379|FG000|Overall Study|Withdrew due to being out of the country|1|||
157126043|NCT02161562|567212380|FG001|Overall Study|Withdrew due to being out of the country|0|||
157126044|NCT02161562|567212379|FG000|Overall Study|Participant moved out of province|1|||
157126045|NCT02161562|567212380|FG001|Overall Study|Participant moved out of province|0|||
157126046|NCT00323557|567212396|FG000|Overall Study|Physician Decision|1|||
157126047|NCT00323557|567212397|FG001|Overall Study|Physician Decision|0|||
157126048|NCT00684515|567212398|FG000|Overall Study|Adverse Event|3|||
157126049|NCT00684515|567212399|FG001|Overall Study|Adverse Event|3|||
157126050|NCT00684515|567212400|FG002|Overall Study|Adverse Event|1|||
157126051|NCT00684515|567212398|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
157126052|NCT00684515|567212399|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
157126053|NCT00684515|567212400|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
157126054|NCT02450578|567212401|FG000|Overall Study|ECG abnormality so not treated|1|||
157126055|NCT02450578|567212402|FG001|Overall Study|ECG abnormality so not treated|0|||
157126056|NCT02450578|567212403|FG002|Overall Study|ECG abnormality so not treated|0|||
157126057|NCT02450578|567212404|FG003|Overall Study|ECG abnormality so not treated|0|||
157126058|NCT00094757|567212406|FG000|Overall Study|Adverse Event|11|||
157126059|NCT00094757|567212407|FG001|Overall Study|Adverse Event|9|||
157126060|NCT00094757|567212408|FG002|Overall Study|Adverse Event|6|||
157126061|NCT00094757|567212406|FG000|Overall Study|Lack of Efficacy|11|||
157126062|NCT00094757|567212407|FG001|Overall Study|Lack of Efficacy|15|||
157126063|NCT00094757|567212408|FG002|Overall Study|Lack of Efficacy|8|||
157126064|NCT00094757|567212406|FG000|Overall Study|Lost to Follow-up|3|||
157126065|NCT00094757|567212407|FG001|Overall Study|Lost to Follow-up|5|||
156872720|NCT00606593|566291336|FG002|Overall Study|Withdrawal of consent|1|||
156872721|NCT00606593|566291337|FG003|Overall Study|Withdrawal of consent|0|||
157016216|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
157126066|NCT00094757|567212408|FG002|Overall Study|Lost to Follow-up|6|||
157126067|NCT00094757|567212406|FG000|Overall Study|Patient Moved|2|||
157126068|NCT00094757|567212407|FG001|Overall Study|Patient Moved|1|||
157126069|NCT00094757|567212408|FG002|Overall Study|Patient Moved|1|||
157126070|NCT00094757|567212406|FG000|Overall Study|Protocol Violation|8|||
157126071|NCT00094757|567212407|FG001|Overall Study|Protocol Violation|5|||
157126072|NCT00094757|567212408|FG002|Overall Study|Protocol Violation|3|||
157126073|NCT00094757|567212406|FG000|Overall Study|Withdrawal by Subject|14|||
157126074|NCT00094757|567212407|FG001|Overall Study|Withdrawal by Subject|21|||
157126075|NCT00094757|567212408|FG002|Overall Study|Withdrawal by Subject|5|||
157126076|NCT00094757|567212406|FG000|Overall Study|Other|3|||
157126077|NCT00094757|567212407|FG001|Overall Study|Other|3|||
157126078|NCT00094757|567212408|FG002|Overall Study|Other|1|||
157126079|NCT00094757|567212406|FG000|Overall Study|Protocol specified discontinuation|1|||
157126080|NCT00094757|567212407|FG001|Overall Study|Protocol specified discontinuation|3|||
157126081|NCT00094757|567212408|FG002|Overall Study|Protocol specified discontinuation|0|||
157126082|NCT03021642|567212412|FG000|Washout Period (21 Days)|Adverse Event|1|||
157126083|NCT03021642|567212413|FG001|Washout Period (21 Days)|Adverse Event|1|||
157126084|NCT01192347|567212414|FG000|Overall Study|Death|3|||
157126085|NCT01192347|567212414|FG000|Overall Study|Lost to Follow-up|3|||
157126086|NCT01192347|567212414|FG000|Overall Study|Withdrawal by Subject|1|||
157215703|NCT02622074|567537381|FG005|Overall Study|Withdrawal by Subject|0|||
157215704|NCT02114931|567537382|FG000|Overall Study|Withdrawal by Subject|15|||
157215705|NCT02114931|567537383|FG001|Overall Study|Withdrawal by Subject|18|||
157215706|NCT02114931|567537382|FG000|Overall Study|Adverse Event|4|||
157215707|NCT02114931|567537383|FG001|Overall Study|Adverse Event|6|||
157215708|NCT02114931|567537382|FG000|Overall Study|Lost to Follow-up|3|||
157215709|NCT02114931|567537383|FG001|Overall Study|Lost to Follow-up|3|||
157215710|NCT02114931|567537382|FG000|Overall Study|Physician Decision|1|||
157215711|NCT02114931|567537383|FG001|Overall Study|Physician Decision|2|||
157215712|NCT02114931|567537382|FG000|Overall Study|Other|2|||
157215713|NCT02114931|567537383|FG001|Overall Study|Other|1|||
157215714|NCT03565211|567537387|FG000|Overall Study|Withdrawal by Subject|2|||
157215715|NCT03565211|567537387|FG000|Overall Study|Lost to Follow-up|1|||
157215716|NCT03565211|567537387|FG000|Overall Study|Adverse Event|44|||
157215717|NCT03565211|567537387|FG000|Overall Study|Personal issues|1|||
157215718|NCT00986154|567537388|FG000|Overall Study|Death|136|||
157215719|NCT00986154|567537389|FG001|Overall Study|Death|127|||
157215720|NCT00986154|567537388|FG000|Overall Study|Lost to Follow-up|7|||
157215721|NCT00986154|567537389|FG001|Overall Study|Lost to Follow-up|4|||
157215722|NCT00986154|567537388|FG000|Overall Study|Withdrawal by Subject|32|||
157215723|NCT00986154|567537389|FG001|Overall Study|Withdrawal by Subject|33|||
157215724|NCT00986154|567537388|FG000|Overall Study|investigator/subject decide not continue|6|||
157215725|NCT00986154|567537389|FG001|Overall Study|investigator/subject decide not continue|3|||
157215726|NCT00986154|567537388|FG000|Overall Study|never received study drug|25|||
157215727|NCT00986154|567537389|FG001|Overall Study|never received study drug|27|||
157215728|NCT01205529|567537392|FG000|Overall Study|Procedure Cancelled|4|||
157215729|NCT01205529|567537392|FG000|Overall Study|Withdrawal by Subject|2|||
157215730|NCT01205529|567537392|FG000|Overall Study|Physician Decision|4|||
157215731|NCT01205529|567537392|FG000|Overall Study|Unstable post op|15|||
157215732|NCT01205529|567537392|FG000|Overall Study|No longer met criteria|30|||
157215733|NCT00667719|567537393|FG000|Overall Study|Adverse Event|39|||
157215734|NCT00667719|567537393|FG000|Overall Study|Abnormal Test Procedure|1|||
157215735|NCT00667719|567537393|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
157215736|NCT00667719|567537393|FG000|Overall Study|Protocol Violation|3|||
157215737|NCT00667719|567537393|FG000|Overall Study|Withdrawal by Subject|17|||
156791879|NCT00215657|565991016|FG003|Overall Study|Insufficient testosterone response|12|||
156791880|NCT00215657|565991017|FG004|Overall Study|Insufficient testosterone response|8|||
156791881|NCT00215657|565991018|FG005|Overall Study|Insufficient testosterone response|12|||
156791882|NCT00215657|565991019|FG006|Overall Study|Insufficient testosterone response|4|||
156791883|NCT00215657|565991020|FG007|Overall Study|Insufficient testosterone response|7|||
156791884|NCT00215657|565991013|FG000|Overall Study|Other|3|||
156791885|NCT00215657|565991014|FG001|Overall Study|Other|1|||
156791886|NCT00215657|565991015|FG002|Overall Study|Other|2|||
156791887|NCT00215657|565991016|FG003|Overall Study|Other|3|||
156791888|NCT00215657|565991017|FG004|Overall Study|Other|5|||
156791889|NCT00215657|565991018|FG005|Overall Study|Other|4|||
156791890|NCT00215657|565991019|FG006|Overall Study|Other|6|||
156791891|NCT00215657|565991020|FG007|Overall Study|Other|1|||
156791892|NCT01887600|565991023|FG000|Overall Study|Death|39|||
156791893|NCT01887600|565991024|FG001|Overall Study|Death|16|||
156791894|NCT01887600|565991023|FG000|Overall Study|Lack of Efficacy|3|||
156791895|NCT01887600|565991024|FG001|Overall Study|Lack of Efficacy|26|||
156791896|NCT01887600|565991023|FG000|Overall Study|Lost to Follow-up|5|||
156791897|NCT01887600|565991024|FG001|Overall Study|Lost to Follow-up|1|||
156791898|NCT01887600|565991023|FG000|Overall Study|Physician Decision|7|||
156791899|NCT01887600|565991024|FG001|Overall Study|Physician Decision|8|||
156791900|NCT01887600|565991023|FG000|Overall Study|Protocol Deviation|3|||
156791901|NCT01887600|565991024|FG001|Overall Study|Protocol Deviation|0|||
156791902|NCT01887600|565991023|FG000|Overall Study|Withdrawal by Subject|58|||
156791903|NCT01887600|565991024|FG001|Overall Study|Withdrawal by Subject|52|||
157215738|NCT00667719|567537393|FG000|Overall Study|Lost to Follow-up|8|||
157215739|NCT03840135|567537394|FG000|Overall Study|Protocol Violation|6|||
157215740|NCT03840135|567537395|FG001|Overall Study|Protocol Violation|1|||
157126087|NCT01192347|567212414|FG000|Overall Study|Adverse Event|1|||
157126088|NCT01192347|567212414|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
157215741|NCT03840135|567537394|FG000|Overall Study|Withdrawal by Subject|1|||
157215742|NCT03840135|567537395|FG001|Overall Study|Withdrawal by Subject|0|||
157215743|NCT00323609|567537396|FG000|Overall Study|Death|16|||
157215744|NCT00323609|567537397|FG001|Overall Study|Death|21|||
156872722|NCT00606593|566291338|FG004|Overall Study|Withdrawal of consent|0|||
156872723|NCT00606593|566291339|FG005|Overall Study|Withdrawal of consent|0|||
156872724|NCT00606593|566291340|FG006|Overall Study|Withdrawal of consent|0|||
156872725|NCT00606593|566291341|FG007|Overall Study|Withdrawal of consent|0|||
156872726|NCT00606593|566291342|FG008|Overall Study|Withdrawal of consent|0|||
156872727|NCT00606593|566291343|FG009|Overall Study|Withdrawal of consent|0|||
156872728|NCT00606593|566291334|FG000|Overall Study|Administrative/Other|0|||
156872729|NCT00606593|566291335|FG001|Overall Study|Administrative/Other|0|||
156872730|NCT00606593|566291336|FG002|Overall Study|Administrative/Other|1|||
156872731|NCT00606593|566291337|FG003|Overall Study|Administrative/Other|0|||
156872732|NCT00606593|566291338|FG004|Overall Study|Administrative/Other|0|||
156872733|NCT00606593|566291339|FG005|Overall Study|Administrative/Other|0|||
156872734|NCT00606593|566291340|FG006|Overall Study|Administrative/Other|0|||
156872735|NCT00606593|566291341|FG007|Overall Study|Administrative/Other|0|||
156872736|NCT00606593|566291342|FG008|Overall Study|Administrative/Other|0|||
156872737|NCT00606593|566291343|FG009|Overall Study|Administrative/Other|0|||
156872738|NCT01724346|566291344|FG000|Overall Study|Death|42|||
156872739|NCT01724346|566291345|FG001|Overall Study|Death|42|||
156872740|NCT01724346|566291344|FG000|Overall Study|Lost to Follow-up|5|||
156872741|NCT01724346|566291345|FG001|Overall Study|Lost to Follow-up|1|||
156872742|NCT01724346|566291344|FG000|Overall Study|Withdrawal by Subject|27|||
156872743|NCT01724346|566291345|FG001|Overall Study|Withdrawal by Subject|19|||
156872744|NCT01724346|566291344|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
156872745|NCT01724346|566291345|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
156872746|NCT01006291|566293215|FG000|Overall Study|Adverse Event|2|||
156872747|NCT01006291|566293216|FG001|Overall Study|Adverse Event|1|||
156872748|NCT01006291|566293217|FG002|Overall Study|Adverse Event|2|||
156872749|NCT01006291|566293215|FG000|Overall Study|Lack of Efficacy|2|||
156872750|NCT01006291|566293216|FG001|Overall Study|Lack of Efficacy|2|||
156872751|NCT01006291|566293217|FG002|Overall Study|Lack of Efficacy|1|||
156872752|NCT01006291|566293215|FG000|Overall Study|Protocol Violation|3|||
156872753|NCT01006291|566293216|FG001|Overall Study|Protocol Violation|3|||
156872754|NCT01006291|566293217|FG002|Overall Study|Protocol Violation|3|||
156872755|NCT01006291|566293215|FG000|Overall Study|Withdrawal criteria|5|||
156872756|NCT01006291|566293216|FG001|Overall Study|Withdrawal criteria|4|||
156872757|NCT01006291|566293217|FG002|Overall Study|Withdrawal criteria|4|||
156872758|NCT01006291|566293215|FG000|Overall Study|Other|14|||
156872759|NCT01006291|566293216|FG001|Overall Study|Other|14|||
156872760|NCT01006291|566293217|FG002|Overall Study|Other|17|||
156872761|NCT00684060|566293218|FG000|Overall Study|Lost to Follow-up|1|||
156872762|NCT00684060|566293219|FG001|Overall Study|Lost to Follow-up|0|||
156872763|NCT00684060|566293218|FG000|Overall Study|New stenosis identified|1|||
156872764|NCT00684060|566293219|FG001|Overall Study|New stenosis identified|0|||
156872765|NCT00684060|566293218|FG000|Overall Study|Unable to collect MRI|1|||
156872766|NCT00684060|566293219|FG001|Overall Study|Unable to collect MRI|2|||
156872767|NCT00684060|566293218|FG000|Overall Study|Death|0|||
156872768|NCT00684060|566293219|FG001|Overall Study|Death|1|||
156872769|NCT00702715|566293220|FG000|Overall Study|Lost to Follow-up|1|||
156872770|NCT00702715|566293221|FG001|Overall Study|Lost to Follow-up|0|||
156872771|NCT01677377|566293226|FG000|Overall Study|Protocol Violation|1|||
156872772|NCT01677377|566293227|FG001|Overall Study|Protocol Violation|0|||
156872773|NCT01677377|566293228|FG002|Overall Study|Protocol Violation|0|||
156872774|NCT01677377|566293226|FG000|Overall Study|Lost to Follow-up|0|||
156872775|NCT01677377|566293227|FG001|Overall Study|Lost to Follow-up|1|||
156872776|NCT01677377|566293228|FG002|Overall Study|Lost to Follow-up|1|||
156872777|NCT01677377|566293226|FG000|Overall Study|Withdrawal by Subject|0|||
156872778|NCT01677377|566293227|FG001|Overall Study|Withdrawal by Subject|0|||
156872779|NCT01677377|566293228|FG002|Overall Study|Withdrawal by Subject|3|||
156872780|NCT01677377|566293226|FG000|Overall Study|Lack of Efficacy|0|||
157126089|NCT01192347|567212414|FG000|Overall Study|Patient seen in different hospital|1|||
157126090|NCT01192347|567212414|FG000|Overall Study|Patient not visiting hospital regularly|1|||
157126091|NCT01192347|567212414|FG000|Overall Study|Patient did not show up for visits|1|||
157126092|NCT02623335|567212415|FG000|Overall Study|Death|8|||
157126093|NCT02623335|567212416|FG001|Overall Study|Death|7|||
156709230|NCT00976911|565680551|FG000|Overall Study|Withdrawal by Subject|4|||
156872781|NCT01677377|566293227|FG001|Overall Study|Lack of Efficacy|0|||
156872782|NCT01677377|566293228|FG002|Overall Study|Lack of Efficacy|1|||
156872783|NCT01677377|566293226|FG000|Overall Study|Pregnancy|0|||
156872784|NCT01677377|566293227|FG001|Overall Study|Pregnancy|0|||
156872785|NCT01677377|566293228|FG002|Overall Study|Pregnancy|1|||
156872786|NCT02260180|566293229|FG000|Overall Study|Adverse Event|2|||
156872787|NCT02260180|566293230|FG001|Overall Study|Adverse Event|0|||
156872788|NCT02260180|566293231|FG002|Overall Study|Adverse Event|1|||
156872789|NCT03180840|566293232|FG000|Overall Study|Withdrawal by Subject|1|||
156872790|NCT00753649|566293243|FG000|Overall Study|Migrated/moved from study area|1|||
156709231|NCT00976911|565680552|FG001|Overall Study|Withdrawal by Subject|6|||
156872791|NCT00753649|566293244|FG001|Overall Study|Migrated/moved from study area|0|||
156872792|NCT00753649|566293243|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
157126094|NCT02623335|567212415|FG000|Overall Study|Lost to Follow-up|15|||
157126095|NCT02623335|567212416|FG001|Overall Study|Lost to Follow-up|23|||
157215745|NCT00323609|567537398|FG002|Overall Study|Death|0|||
157215746|NCT00323609|567537399|FG003|Overall Study|Death|0|||
157215747|NCT00323609|567537396|FG000|Overall Study|Lost to Follow-up|9|||
157126096|NCT02623335|567212415|FG000|Overall Study|Withdrawal by Subject|2|||
157126097|NCT02623335|567212416|FG001|Overall Study|Withdrawal by Subject|5|||
157126098|NCT02623335|567212415|FG000|Overall Study|Protocol Violation|2|||
157126099|NCT02623335|567212416|FG001|Overall Study|Protocol Violation|1|||
157126100|NCT00090545|567212417|FG000|Overall Study|Disease progression on study|21|||
157126101|NCT00090545|567212418|FG001|Overall Study|Disease progression on study|17|||
157126102|NCT00090545|567212417|FG000|Overall Study|Refused further treatment|1|||
157126103|NCT00090545|567212418|FG001|Overall Study|Refused further treatment|4|||
157126104|NCT00090545|567212417|FG000|Overall Study|Death|0|||
157126105|NCT00090545|567212418|FG001|Overall Study|Death|1|||
157126106|NCT00090545|567212417|FG000|Overall Study|Adverse Event|0|||
157126107|NCT00090545|567212418|FG001|Overall Study|Adverse Event|2|||
157126108|NCT03433781|567212420|FG000|Overall Study|Progression of Disease|1|||
157126109|NCT03433781|567212421|FG001|Overall Study|Progression of Disease|0|||
157126110|NCT03433781|567212422|FG002|Overall Study|Progression of Disease|0|||
157126111|NCT03433781|567212420|FG000|Overall Study|Physician Decision|0|||
157126112|NCT03433781|567212421|FG001|Overall Study|Physician Decision|1|||
157126113|NCT03433781|567212422|FG002|Overall Study|Physician Decision|0|||
157126114|NCT00408694|567212423|FG000|Overall Study|Ineligible|1|||
157126115|NCT00408694|567212423|FG000|Overall Study|No protocol treatment|1|||
157126116|NCT00087646|567212426|FG000|Overall Study|Adverse Event|37|||
157126117|NCT00087646|567212427|FG001|Overall Study|Adverse Event|6|||
157126118|NCT00087646|567212428|FG002|Overall Study|Adverse Event|18|||
157126119|NCT00087646|567212429|FG003|Overall Study|Adverse Event|20|||
157126120|NCT00087646|567212426|FG000|Overall Study|Death|0|||
157215748|NCT00323609|567537397|FG001|Overall Study|Lost to Follow-up|10|||
157215749|NCT00323609|567537398|FG002|Overall Study|Lost to Follow-up|0|||
157215750|NCT00323609|567537399|FG003|Overall Study|Lost to Follow-up|0|||
156791904|NCT01887600|565991023|FG000|Overall Study|Adverse Event|21|||
156791905|NCT01887600|565991024|FG001|Overall Study|Adverse Event|9|||
156791906|NCT01887600|565991023|FG000|Overall Study|Non-compliance with study drug|3|||
156791907|NCT01887600|565991024|FG001|Overall Study|Non-compliance with study drug|0|||
156791908|NCT01887600|565991023|FG000|Overall Study|Miscellaneous|6|||
156791909|NCT01887600|565991024|FG001|Overall Study|Miscellaneous|2|||
156791910|NCT01887600|565991023|FG000|Overall Study|Progressive Disease|1|||
156791911|NCT01887600|565991024|FG001|Overall Study|Progressive Disease|0|||
156791912|NCT03688139|565991025|FG000|Overall Study|Lost to Follow-up|2|||
156791913|NCT03688139|565991026|FG001|Overall Study|Lost to Follow-up|0|||
156791914|NCT03688139|565991025|FG000|Overall Study|Physician Decision|0|||
156791915|NCT03688139|565991026|FG001|Overall Study|Physician Decision|1|||
156791916|NCT03688139|565991025|FG000|Overall Study|Withdrawal by Subject|2|||
156791917|NCT03688139|565991026|FG001|Overall Study|Withdrawal by Subject|3|||
156791918|NCT01185366|565991027|FG000|First Line Therapy|Insurance Coverage Denied|1|||
156791919|NCT01185366|565991028|FG001|First Line Therapy|Insurance Coverage Denied|1|||
156791920|NCT01185366|565991027|FG000|First Line Therapy|Withdrawal by Subject|1|||
156791921|NCT01185366|565991028|FG001|First Line Therapy|Withdrawal by Subject|0|||
156791922|NCT01185366|565991027|FG000|First Line Therapy|Lack of Metastatic Site|1|||
156791923|NCT01185366|565991028|FG001|First Line Therapy|Lack of Metastatic Site|0|||
156791924|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
156791925|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
156791926|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
156791927|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
156791928|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
157126121|NCT00087646|567212427|FG001|Overall Study|Death|1|||
157126122|NCT00087646|567212428|FG002|Overall Study|Death|0|||
157126123|NCT00087646|567212429|FG003|Overall Study|Death|0|||
156791929|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
156872793|NCT00753649|566293244|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
156872794|NCT00753649|566293243|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
157126124|NCT00087646|567212426|FG000|Overall Study|Withdrawal by Subject|6|||
157126125|NCT00087646|567212427|FG001|Overall Study|Withdrawal by Subject|1|||
157126126|NCT00087646|567212428|FG002|Overall Study|Withdrawal by Subject|2|||
157126127|NCT00087646|567212429|FG003|Overall Study|Withdrawal by Subject|2|||
157215751|NCT00323609|567537396|FG000|Overall Study|Physician Decision|2|||
157215752|NCT00323609|567537397|FG001|Overall Study|Physician Decision|0|||
156791930|NCT01185366|565991027|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
156791931|NCT01185366|565991028|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
157126128|NCT00087646|567212426|FG000|Overall Study|Insufficient therapeutic response|64|||
157126129|NCT00087646|567212427|FG001|Overall Study|Insufficient therapeutic response|24|||
157215753|NCT00323609|567537398|FG002|Overall Study|Physician Decision|0|||
157215754|NCT00323609|567537399|FG003|Overall Study|Physician Decision|1|||
157215755|NCT00323609|567537396|FG000|Overall Study|Withdrawal by Subject|11|||
157126130|NCT00087646|567212428|FG002|Overall Study|Insufficient therapeutic response|38|||
157126131|NCT00087646|567212429|FG003|Overall Study|Insufficient therapeutic response|51|||
157126132|NCT00087646|567212426|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
157126133|NCT00087646|567212427|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
157126134|NCT00087646|567212428|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
157126135|NCT00087646|567212429|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
157126136|NCT00087646|567212426|FG000|Overall Study|Failure to Return|5|||
157126137|NCT00087646|567212427|FG001|Overall Study|Failure to Return|2|||
157126138|NCT00087646|567212428|FG002|Overall Study|Failure to Return|2|||
157126139|NCT00087646|567212429|FG003|Overall Study|Failure to Return|3|||
157126140|NCT00087646|567212426|FG000|Overall Study|Administrative/Other|6|||
157126141|NCT00087646|567212427|FG001|Overall Study|Administrative/Other|1|||
157126142|NCT00087646|567212428|FG002|Overall Study|Administrative/Other|1|||
157126143|NCT00087646|567212429|FG003|Overall Study|Administrative/Other|2|||
157126144|NCT00087646|567212426|FG000|Overall Study|Other Protocol Violation|3|||
157126145|NCT00087646|567212427|FG001|Overall Study|Other Protocol Violation|1|||
157126146|NCT00087646|567212428|FG002|Overall Study|Other Protocol Violation|0|||
157126147|NCT00087646|567212429|FG003|Overall Study|Other Protocol Violation|0|||
157126148|NCT00087646|567212426|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
157126149|NCT00087646|567212427|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
157126150|NCT00087646|567212428|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
157126151|NCT00087646|567212429|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
157126152|NCT03979274|567212432|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157126153|NCT03979274|567212433|FG001|Treatment Period 2|Withdrawal by Subject|1|||
157126154|NCT01060059|567212434|FG000|Overall Study|Adverse Event|1|||
157126155|NCT01060059|567212435|FG001|Overall Study|Adverse Event|1|||
157126156|NCT01060059|567212434|FG000|Overall Study|Death|2|||
157126157|NCT01060059|567212435|FG001|Overall Study|Death|3|||
157126158|NCT01060059|567212434|FG000|Overall Study|Lost to Follow-up|18|||
157126159|NCT01060059|567212435|FG001|Overall Study|Lost to Follow-up|34|||
157126160|NCT01060059|567212434|FG000|Overall Study|entry criteria not met|4|||
157126161|NCT01060059|567212435|FG001|Overall Study|entry criteria not met|3|||
157126162|NCT01060059|567212434|FG000|Overall Study|Withdrawal by Subject|35|||
157126163|NCT01060059|567212435|FG001|Overall Study|Withdrawal by Subject|23|||
157126164|NCT01060059|567212434|FG000|Overall Study|lack of glycemic control|2|||
157126165|NCT01060059|567212435|FG001|Overall Study|lack of glycemic control|1|||
157126166|NCT01060059|567212434|FG000|Overall Study|lack of compliance|5|||
157126167|NCT01060059|567212435|FG001|Overall Study|lack of compliance|2|||
157126168|NCT02302963|567212438|FG000|Overall Study|Withdrawal by Subject|2|||
157126169|NCT02302963|567212439|FG001|Overall Study|Withdrawal by Subject|1|||
157126170|NCT02302963|567212438|FG000|Overall Study|Steroid injection|0|||
157126171|NCT02302963|567212439|FG001|Overall Study|Steroid injection|1|||
157126172|NCT02302963|567212438|FG000|Overall Study|Physician Decision|1|||
157126173|NCT02302963|567212439|FG001|Overall Study|Physician Decision|0|||
157126174|NCT01614093|567212440|FG000|Overall Study|Withdrawal by Subject|1|||
157126175|NCT03551743|567212441|FG000|Overall Study|Adverse Event|1|||
157126176|NCT03551743|567212442|FG001|Overall Study|Adverse Event|0|||
157126177|NCT03551743|567212443|FG002|Overall Study|Adverse Event|0|||
157126178|NCT03551743|567212444|FG003|Overall Study|Adverse Event|0|||
157126179|NCT03551743|567212441|FG000|Overall Study|Withdrawal by Subject|1|||
157126180|NCT03551743|567212442|FG001|Overall Study|Withdrawal by Subject|0|||
157126181|NCT03551743|567212443|FG002|Overall Study|Withdrawal by Subject|0|||
157126182|NCT03551743|567212444|FG003|Overall Study|Withdrawal by Subject|0|||
157126183|NCT02317562|567212445|FG000|Overall Study|Physician Decision|1|||
157126184|NCT02317562|567212445|FG000|Overall Study|early termination of the study|8|||
157126185|NCT02317562|567212445|FG000|Overall Study|Lack of Efficacy|4|||
157126186|NCT02317562|567212445|FG000|Overall Study|Withdrawal by Subject|1|||
157126187|NCT00603915|567212446|FG000|Overall Study|Physician Decision|1|||
157126188|NCT03891901|567212447|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
157126189|NCT03891901|567212448|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
157126190|NCT03891901|567212449|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156709232|NCT00976911|565680551|FG000|Overall Study|Death|138|||
156709233|NCT00976911|565680552|FG001|Overall Study|Death|126|||
157126191|NCT03891901|567212450|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
157126192|NCT03891901|567212451|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156709234|NCT00976911|565680551|FG000|Overall Study|Adverse Event|0|||
156709235|NCT00976911|565680552|FG001|Overall Study|Adverse Event|1|||
156709236|NCT00976911|565680551|FG000|Overall Study|Protocol Violation|2|||
156709237|NCT00976911|565680552|FG001|Overall Study|Protocol Violation|0|||
156709238|NCT00976911|565680551|FG000|Overall Study|Other|8|||
156709239|NCT00976911|565680552|FG001|Overall Study|Other|9|||
156709240|NCT00976911|565680551|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
156709241|NCT00976911|565680552|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
156709242|NCT01191944|565680553|FG000|Overall Study|Adverse Event|11|||
156709243|NCT01191944|565680554|FG001|Overall Study|Adverse Event|12|||
157215756|NCT00323609|567537397|FG001|Overall Study|Withdrawal by Subject|23|||
157215757|NCT00323609|567537398|FG002|Overall Study|Withdrawal by Subject|4|||
156709244|NCT01191944|565680553|FG000|Overall Study|Protocol Violation|1|||
156709245|NCT01191944|565680554|FG001|Overall Study|Protocol Violation|2|||
156709246|NCT01191944|565680553|FG000|Overall Study|Withdrawal by Subject|4|||
156709247|NCT01191944|565680554|FG001|Overall Study|Withdrawal by Subject|2|||
156709248|NCT01191944|565680553|FG000|Overall Study|Other|1|||
156709249|NCT01191944|565680554|FG001|Overall Study|Other|3|||
156709250|NCT02954991|565680557|FG000|Overall Study|Death|92|||
156709251|NCT02954991|565680558|FG001|Overall Study|Death|11|||
156709252|NCT02954991|565680559|FG002|Overall Study|Death|2|||
156709253|NCT02954991|565680557|FG000|Overall Study|Lost to Follow-up|3|||
156709254|NCT02954991|565680558|FG001|Overall Study|Lost to Follow-up|2|||
156709255|NCT02954991|565680559|FG002|Overall Study|Lost to Follow-up|0|||
156709256|NCT02954991|565680557|FG000|Overall Study|Withdrawal by Subject|9|||
156709257|NCT02954991|565680558|FG001|Overall Study|Withdrawal by Subject|8|||
156709258|NCT02954991|565680559|FG002|Overall Study|Withdrawal by Subject|1|||
156709259|NCT02954991|565680557|FG000|Overall Study|Study Terminated by Sponsor|18|||
156709260|NCT02954991|565680558|FG001|Overall Study|Study Terminated by Sponsor|10|||
156709261|NCT02954991|565680559|FG002|Overall Study|Study Terminated by Sponsor|1|||
156709262|NCT02954991|565680557|FG000|Overall Study|Miscellaneous|2|||
156709263|NCT02954991|565680558|FG001|Overall Study|Miscellaneous|1|||
156709264|NCT02954991|565680559|FG002|Overall Study|Miscellaneous|1|||
156709265|NCT00576316|565680560|FG000|Overall Study|Adverse Event|9|||
156709266|NCT00576316|565680560|FG000|Overall Study|Withdrawal by Subject|2|||
156709267|NCT00576316|565680560|FG000|Overall Study|Protocol Violation|9|||
156709268|NCT02552303|565680567|FG000|Allocation|Withdrawal by Subject|2|||
156709269|NCT02552303|565680568|FG001|Allocation|Withdrawal by Subject|1|||
156709270|NCT02552303|565680569|FG002|Allocation|Withdrawal by Subject|1|||
156709271|NCT02552303|565680570|FG003|Allocation|Withdrawal by Subject|1|||
156709272|NCT02552303|565680567|FG000|Allocation|ineligible|1|||
156709273|NCT02552303|565680568|FG001|Allocation|ineligible|1|||
156791932|NCT01783938|565991034|FG000|Overall Study|Disease Progression|18|||
156791933|NCT01783938|565991035|FG001|Overall Study|Disease Progression|41|||
156791934|NCT01783938|565991034|FG000|Overall Study|Study Drug Toxicity|27|||
156791935|NCT01783938|565991035|FG001|Overall Study|Study Drug Toxicity|14|||
156791936|NCT01783938|565991034|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
156791937|NCT01783938|565991035|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
156791938|NCT01783938|565991034|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
156791939|NCT01783938|565991035|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
156791940|NCT01783938|565991034|FG000|Overall Study|Participant Withdrew Consent|2|||
156791941|NCT01783938|565991035|FG001|Overall Study|Participant Withdrew Consent|0|||
156791942|NCT01783938|565991034|FG000|Overall Study|Maximum Clinical Benefit|1|||
156791943|NCT01783938|565991035|FG001|Overall Study|Maximum Clinical Benefit|0|||
156791944|NCT01783938|565991034|FG000|Overall Study|Other Reasons|3|||
156791945|NCT01783938|565991035|FG001|Overall Study|Other Reasons|1|||
156791946|NCT00498485|565991036|FG000|Overall Study|Adverse Event|1|||
156791947|NCT00498485|565991037|FG001|Overall Study|Adverse Event|5|||
156791948|NCT00452400|565991040|FG000|Overall Study|Adverse Event|1|||
156791949|NCT00452400|565991041|FG001|Overall Study|Adverse Event|1|||
156791950|NCT00452400|565991042|FG002|Overall Study|Adverse Event|5|||
156791951|NCT00452400|565991043|FG003|Overall Study|Adverse Event|0|||
156791952|NCT00452400|565991044|FG004|Overall Study|Adverse Event|2|||
156791953|NCT00452400|565991040|FG000|Overall Study|Protocol Violation|0|||
156791954|NCT00452400|565991041|FG001|Overall Study|Protocol Violation|0|||
157016217|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
157016218|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
157016219|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
157016220|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
157016221|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
157016222|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
157016223|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
157016224|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Other|6|||
157016225|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Other|1|||
157016226|NCT03271489|566811276|FG000|Double-Blind (DB) Period|Missing|1|||
157016227|NCT03271489|566811277|FG001|Double-Blind (DB) Period|Missing|0|||
157016228|NCT03271489|566811276|FG000|Open-Label (OL) Period|Adverse Event|2|||
157016229|NCT03271489|566811277|FG001|Open-Label (OL) Period|Adverse Event|0|||
157016230|NCT03271489|566811276|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
157016231|NCT03271489|566811277|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
157016232|NCT03271489|566811276|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
156709274|NCT02552303|565680569|FG002|Allocation|ineligible|0|||
156709275|NCT02552303|565680570|FG003|Allocation|ineligible|0|||
156791955|NCT00452400|565991042|FG002|Overall Study|Protocol Violation|1|||
156791956|NCT00452400|565991043|FG003|Overall Study|Protocol Violation|0|||
156709276|NCT02552303|565680567|FG000|Follow-Up|Lost to Follow-up|0|||
156709277|NCT02552303|565680568|FG001|Follow-Up|Lost to Follow-up|0|||
157126193|NCT03891901|567212452|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
157126194|NCT03891901|567212453|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
157126195|NCT03891901|567212454|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
157126196|NCT03891901|567212455|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
156709278|NCT02552303|565680569|FG002|Follow-Up|Lost to Follow-up|1|||
156709279|NCT02552303|565680570|FG003|Follow-Up|Lost to Follow-up|0|||
156709280|NCT02552303|565680567|FG000|Follow-Up|ineligible|0|||
156709281|NCT02552303|565680568|FG001|Follow-Up|ineligible|2|||
156709282|NCT02552303|565680569|FG002|Follow-Up|ineligible|0|||
156709283|NCT02552303|565680570|FG003|Follow-Up|ineligible|0|||
156709284|NCT02794246|565680571|FG000|Overall Study|Withdrawal by Subject|2|||
156709285|NCT02794246|565680571|FG000|Overall Study|Physician Decision|4|||
157126197|NCT03891901|567212447|FG000|Overall Study|Adverse Event|2|||
157126198|NCT03891901|567212448|FG001|Overall Study|Adverse Event|2|||
157126199|NCT03891901|567212449|FG002|Overall Study|Adverse Event|0|||
157126200|NCT03891901|567212450|FG003|Overall Study|Adverse Event|0|||
157126201|NCT03891901|567212451|FG004|Overall Study|Adverse Event|0|||
157126202|NCT03891901|567212452|FG005|Overall Study|Adverse Event|0|||
157126203|NCT03891901|567212453|FG006|Overall Study|Adverse Event|0|||
157126204|NCT03891901|567212454|FG007|Overall Study|Adverse Event|0|||
157126205|NCT03891901|567212455|FG008|Overall Study|Adverse Event|0|||
157126206|NCT03891901|567212447|FG000|Overall Study|Poor venous access|1|||
157126207|NCT03891901|567212448|FG001|Overall Study|Poor venous access|0|||
157126208|NCT03891901|567212449|FG002|Overall Study|Poor venous access|0|||
157126209|NCT03891901|567212450|FG003|Overall Study|Poor venous access|0|||
157126210|NCT03891901|567212451|FG004|Overall Study|Poor venous access|0|||
157126211|NCT03891901|567212452|FG005|Overall Study|Poor venous access|0|||
157126212|NCT03891901|567212453|FG006|Overall Study|Poor venous access|0|||
157126213|NCT03891901|567212454|FG007|Overall Study|Poor venous access|0|||
157126214|NCT03891901|567212455|FG008|Overall Study|Poor venous access|0|||
157126215|NCT03891901|567212447|FG000|Overall Study|Withdrawal by Subject|0|||
157126216|NCT03891901|567212448|FG001|Overall Study|Withdrawal by Subject|2|||
157126217|NCT03891901|567212449|FG002|Overall Study|Withdrawal by Subject|0|||
156709286|NCT04602546|565680572|FG000|Overall Study|Training|2|||
156709287|NCT04602546|565680573|FG001|Overall Study|Training|2|||
157126218|NCT03891901|567212450|FG003|Overall Study|Withdrawal by Subject|0|||
157126219|NCT03891901|567212451|FG004|Overall Study|Withdrawal by Subject|0|||
157126220|NCT03891901|567212452|FG005|Overall Study|Withdrawal by Subject|0|||
156709288|NCT04602546|565680574|FG002|Overall Study|Training|1|||
156709289|NCT04602546|565680575|FG003|Overall Study|Training|2|||
156709290|NCT04602546|565680576|FG004|Overall Study|Training|0|||
156791957|NCT00452400|565991044|FG004|Overall Study|Protocol Violation|0|||
156791958|NCT00452400|565991040|FG000|Overall Study|Lost to Follow-up|1|||
156791959|NCT00452400|565991041|FG001|Overall Study|Lost to Follow-up|0|||
156791960|NCT00452400|565991042|FG002|Overall Study|Lost to Follow-up|0|||
156791961|NCT00452400|565991043|FG003|Overall Study|Lost to Follow-up|0|||
156791962|NCT00452400|565991044|FG004|Overall Study|Lost to Follow-up|0|||
156791963|NCT00452400|565991040|FG000|Overall Study|Withdrawal by Subject|1|||
156791964|NCT00452400|565991041|FG001|Overall Study|Withdrawal by Subject|0|||
156791965|NCT00452400|565991042|FG002|Overall Study|Withdrawal by Subject|1|||
156791966|NCT00452400|565991043|FG003|Overall Study|Withdrawal by Subject|0|||
156791967|NCT00452400|565991044|FG004|Overall Study|Withdrawal by Subject|0|||
156791968|NCT00452400|565991040|FG000|Overall Study|Lack of Efficacy|2|||
156791969|NCT00452400|565991041|FG001|Overall Study|Lack of Efficacy|0|||
156791970|NCT00452400|565991042|FG002|Overall Study|Lack of Efficacy|0|||
156791971|NCT00452400|565991043|FG003|Overall Study|Lack of Efficacy|0|||
156791972|NCT00452400|565991044|FG004|Overall Study|Lack of Efficacy|0|||
156791973|NCT00452400|565991040|FG000|Overall Study|Other reasons not listed above|0|||
156791974|NCT00452400|565991041|FG001|Overall Study|Other reasons not listed above|0|||
156791975|NCT00452400|565991042|FG002|Overall Study|Other reasons not listed above|0|||
156791976|NCT00452400|565991043|FG003|Overall Study|Other reasons not listed above|1|||
156791977|NCT00452400|565991044|FG004|Overall Study|Other reasons not listed above|1|||
156791978|NCT01712074|565991047|FG000|Placebo Run-in Period|Adverse Event|2|||
156791979|NCT01712074|565991048|FG001|Placebo Run-in Period|Adverse Event|0|||
156791980|NCT01712074|565991049|FG002|Placebo Run-in Period|Adverse Event|0|||
156791981|NCT01712074|565991047|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
156791982|NCT01712074|565991048|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
156791983|NCT01712074|565991049|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
156791984|NCT01712074|565991047|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
156791985|NCT01712074|565991048|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
156791986|NCT01712074|565991049|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
156791987|NCT01712074|565991047|FG000|Placebo Run-in Period|Other|1|||
156791988|NCT01712074|565991048|FG001|Placebo Run-in Period|Other|0|||
156791989|NCT01712074|565991049|FG002|Placebo Run-in Period|Other|0|||
156791990|NCT01712074|565991047|FG000|Placebo Run-in Period|No longer willing to participate|1|||
156791991|NCT01712074|565991048|FG001|Placebo Run-in Period|No longer willing to participate|0|||
156872795|NCT00753649|566293244|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
156872796|NCT00753649|566293243|FG000|Overall Study|Protocol Violation|2|||
156872797|NCT00753649|566293244|FG001|Overall Study|Protocol Violation|0|||
156872798|NCT03544333|566293245|FG000|Overall Study|Withdrawal by Subject|1|||
156872799|NCT03544333|566293246|FG001|Overall Study|Withdrawal by Subject|0|||
156872800|NCT00423917|566293247|FG000|Overall Study|Cancel|2|||
156872801|NCT00423917|566293247|FG000|Overall Study|Ineligible|1|||
156872802|NCT00555061|566293248|FG000|Overall Study|Adverse Event|3|||
156872803|NCT00555061|566293248|FG000|Overall Study|Protocol Violation|1|||
156872804|NCT00555061|566293248|FG000|Overall Study|Lost to Follow-up|2|||
156872805|NCT00555061|566293248|FG000|Overall Study|Withdrawal by Subject|2|||
156872806|NCT00555061|566293248|FG000|Overall Study|Participant enrolled, but never treated|1|||
156872807|NCT00475306|566293249|FG000|Overall Study|Protocol Violation|1|||
156872808|NCT00475306|566293250|FG001|Overall Study|Protocol Violation|1|||
156872809|NCT00475306|566293251|FG002|Overall Study|Protocol Violation|0|||
156872810|NCT00475306|566293252|FG003|Overall Study|Protocol Violation|1|||
156872811|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
156872812|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
156872813|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
156872814|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
156872815|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
156872816|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
156872817|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
156872818|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
156872819|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
156872820|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
156872821|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
156872822|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
156872823|NCT02405442|566293254|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872824|NCT02405442|566293255|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
156872825|NCT02405442|566293256|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872826|NCT02405442|566293257|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
156872827|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
156872828|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
156872829|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
156872830|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
156872831|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
156872832|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
156872833|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
156872834|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
156872835|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
156872836|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
156872837|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
156872838|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
156872839|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
156872840|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
156872841|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
156872842|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
156872843|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872844|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
156872845|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872846|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
156872847|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872848|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
156872849|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872850|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
156872851|NCT02405442|566293254|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872852|NCT02405442|566293255|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
156872853|NCT02405442|566293256|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872854|NCT02405442|566293257|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
156872855|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
156872856|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
156872857|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
157016233|NCT03271489|566811277|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
157016234|NCT03271489|566811276|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
157016235|NCT03271489|566811277|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
156872858|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
157215758|NCT00323609|567537399|FG003|Overall Study|Withdrawal by Subject|4|||
157215759|NCT00323609|567537396|FG000|Overall Study|Other non-VCF-related medical condition|3|||
157215760|NCT00323609|567537397|FG001|Overall Study|Other non-VCF-related medical condition|2|||
157215761|NCT00323609|567537398|FG002|Overall Study|Other non-VCF-related medical condition|0|||
157215762|NCT00323609|567537399|FG003|Overall Study|Other non-VCF-related medical condition|0|||
157215763|NCT00323609|567537396|FG000|Overall Study|Sponsor discontinued trial|29|||
157215764|NCT00323609|567537397|FG001|Overall Study|Sponsor discontinued trial|29|||
157215765|NCT00323609|567537398|FG002|Overall Study|Sponsor discontinued trial|0|||
157215766|NCT00323609|567537399|FG003|Overall Study|Sponsor discontinued trial|0|||
157215767|NCT00323609|567537396|FG000|Overall Study|Unrelenting or severe back pain|1|||
157215768|NCT00323609|567537397|FG001|Overall Study|Unrelenting or severe back pain|1|||
157215769|NCT00323609|567537398|FG002|Overall Study|Unrelenting or severe back pain|0|||
157215770|NCT00323609|567537399|FG003|Overall Study|Unrelenting or severe back pain|0|||
157215771|NCT00323609|567537396|FG000|Overall Study|Logistical withdrawal|9|||
157215772|NCT00323609|567537397|FG001|Overall Study|Logistical withdrawal|5|||
157215773|NCT00323609|567537398|FG002|Overall Study|Logistical withdrawal|0|||
157215774|NCT00323609|567537399|FG003|Overall Study|Logistical withdrawal|1|||
157215775|NCT00323609|567537396|FG000|Overall Study|Other reason|11|||
157215776|NCT00323609|567537397|FG001|Overall Study|Other reason|8|||
157215777|NCT00323609|567537398|FG002|Overall Study|Other reason|4|||
157215778|NCT00323609|567537399|FG003|Overall Study|Other reason|9|||
157215779|NCT01827371|567537400|FG000|Overall Study|Adverse Event|0|||
157215780|NCT01827371|567537401|FG001|Overall Study|Adverse Event|0|||
157215781|NCT01827371|567537402|FG002|Overall Study|Adverse Event|4|||
156872859|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872860|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
156872861|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872862|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
156872863|NCT02405442|566293254|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
156872864|NCT02405442|566293255|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872865|NCT02405442|566293256|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872866|NCT02405442|566293257|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
156872867|NCT03830892|566293259|FG000|Overall Study|Physician Decision|2|||
156872868|NCT03830892|566293260|FG001|Overall Study|Physician Decision|3|||
156872869|NCT03830892|566293259|FG000|Overall Study|Study terminated due to COVID|4|||
156872870|NCT03830892|566293260|FG001|Overall Study|Study terminated due to COVID|0|||
156872871|NCT03830892|566293259|FG000|Overall Study|Protocol Violation|0|||
156872872|NCT03830892|566293260|FG001|Overall Study|Protocol Violation|1|||
156872873|NCT03830892|566293259|FG000|Overall Study|Withdrawal by Subject|0|||
156872874|NCT03830892|566293260|FG001|Overall Study|Withdrawal by Subject|2|||
156872875|NCT00975689|566293261|FG000|Overall Study|Adverse Event|0|||
156872876|NCT00975689|566293262|FG001|Overall Study|Adverse Event|3|||
156872877|NCT00975689|566293261|FG000|Overall Study|Withdrawal by Subject|1|||
156872878|NCT00975689|566293262|FG001|Overall Study|Withdrawal by Subject|0|||
156872879|NCT00975689|566293261|FG000|Overall Study|Physician Decision|1|||
156872880|NCT00975689|566293262|FG001|Overall Study|Physician Decision|0|||
156872881|NCT02974543|566293263|FG000|Overall Study|Withdrawal by Subject|1|||
156872882|NCT02974543|566293264|FG001|Overall Study|Withdrawal by Subject|0|||
156872883|NCT03534180|566293265|FG000|Overall Study|Withdrawal by Subject|1|||
156872884|NCT00220636|566293266|FG000|Overall Study|Withdrawal by Subject|4|||
156872885|NCT00330967|566293267|FG000|Overall Study|Withdrawal by Subject|0|||
156872886|NCT00330967|566293268|FG001|Overall Study|Withdrawal by Subject|5|||
156872887|NCT00330967|566293267|FG000|Overall Study|Physician Decision|0|||
156872888|NCT00330967|566293268|FG001|Overall Study|Physician Decision|9|||
156872889|NCT00337675|566293271|FG000|Overall Study|Adverse Event|10|||
156872890|NCT00337675|566293272|FG001|Overall Study|Adverse Event|9|||
156872891|NCT00337675|566293273|FG002|Overall Study|Adverse Event|19|||
156872892|NCT00337675|566293271|FG000|Overall Study|Lack of Efficacy|10|||
157215782|NCT01827371|567537403|FG003|Overall Study|Adverse Event|2|||
157215783|NCT01827371|567537400|FG000|Overall Study|Lost to Follow-up|0|||
157215784|NCT01827371|567537401|FG001|Overall Study|Lost to Follow-up|2|||
157215785|NCT01827371|567537402|FG002|Overall Study|Lost to Follow-up|0|||
157215786|NCT01827371|567537403|FG003|Overall Study|Lost to Follow-up|4|||
156872893|NCT00337675|566293272|FG001|Overall Study|Lack of Efficacy|7|||
156872894|NCT00337675|566293273|FG002|Overall Study|Lack of Efficacy|9|||
156872895|NCT00337675|566293271|FG000|Overall Study|Lost to Follow-up|22|||
156872896|NCT00337675|566293272|FG001|Overall Study|Lost to Follow-up|19|||
157215787|NCT01827371|567537400|FG000|Overall Study|Protocol Violation|1|||
157215788|NCT01827371|567537401|FG001|Overall Study|Protocol Violation|0|||
157215789|NCT01827371|567537402|FG002|Overall Study|Protocol Violation|0|||
157215790|NCT01827371|567537403|FG003|Overall Study|Protocol Violation|0|||
157215791|NCT01827371|567537400|FG000|Overall Study|Withdrawal by Subject|1|||
157215792|NCT01827371|567537401|FG001|Overall Study|Withdrawal by Subject|2|||
157215793|NCT01827371|567537402|FG002|Overall Study|Withdrawal by Subject|2|||
157215794|NCT01827371|567537403|FG003|Overall Study|Withdrawal by Subject|3|||
157215795|NCT01827371|567537400|FG000|Overall Study|Physician Decision|0|||
157215796|NCT01827371|567537401|FG001|Overall Study|Physician Decision|1|||
157215797|NCT01827371|567537402|FG002|Overall Study|Physician Decision|0|||
157215798|NCT01827371|567537403|FG003|Overall Study|Physician Decision|1|||
157215799|NCT01827371|567537400|FG000|Overall Study|Temporary study halt to vaccinations|11|||
157215800|NCT01827371|567537401|FG001|Overall Study|Temporary study halt to vaccinations|2|||
157215801|NCT01827371|567537402|FG002|Overall Study|Temporary study halt to vaccinations|5|||
157215802|NCT01827371|567537403|FG003|Overall Study|Temporary study halt to vaccinations|13|||
157215803|NCT03063632|567537411|FG000|Overall Study|Death|4|||
157215804|NCT03063632|567537412|FG001|Overall Study|Death|6|||
157215805|NCT03063632|567537411|FG000|Overall Study|Lost to Follow-up|0|||
157215806|NCT03063632|567537412|FG001|Overall Study|Lost to Follow-up|1|||
157215807|NCT03063632|567537411|FG000|Overall Study|Withdrawal by Subject|0|||
157215808|NCT03063632|567537412|FG001|Overall Study|Withdrawal by Subject|2|||
157215809|NCT03063632|567537411|FG000|Overall Study|Physician Decision|2|||
157215810|NCT03063632|567537412|FG001|Overall Study|Physician Decision|0|||
157215811|NCT03063632|567537411|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
157215812|NCT03063632|567537412|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
157215813|NCT02741271|567537417|FG000|Overall Study|Lost to Follow-up|2|||
157215814|NCT02741271|567537418|FG001|Overall Study|Lost to Follow-up|0|||
157215815|NCT02741271|567537417|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157215816|NCT02741271|567537418|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
157215817|NCT03652961|567537419|FG000|Overall Study|Lost to Follow-up|3|||
157215818|NCT03652961|567537419|FG000|Overall Study|Screen Failure|1|||
157215819|NCT00373685|567537420|FG000|Overall Study|Death|2|||
157215820|NCT00373685|567537421|FG001|Overall Study|Death|1|||
157215821|NCT00373685|567537420|FG000|Overall Study|Adverse Event|278|||
157215822|NCT00373685|567537421|FG001|Overall Study|Adverse Event|253|||
157215823|NCT00373685|567537420|FG000|Overall Study|Insufficient clinical response|169|||
157215824|NCT00373685|567537421|FG001|Overall Study|Insufficient clinical response|119|||
157215825|NCT00373685|567537420|FG000|Overall Study|Did not meet entrance criteria|167|||
157215826|NCT00373685|567537421|FG001|Overall Study|Did not meet entrance criteria|184|||
157215827|NCT00373685|567537420|FG000|Overall Study|Lost to follow up|83|||
157215828|NCT00373685|567537421|FG001|Overall Study|Lost to follow up|103|||
157215829|NCT00373685|567537420|FG000|Overall Study|No longer willing to participate|337|||
157215830|NCT00373685|567537421|FG001|Overall Study|No longer willing to participate|352|||
157215831|NCT00373685|567537420|FG000|Overall Study|Other|149|||
157215832|NCT00373685|567537421|FG001|Overall Study|Other|146|||
157215833|NCT00373685|567537420|FG000|Overall Study|Protocol Violation|191|||
157215834|NCT00373685|567537421|FG001|Overall Study|Protocol Violation|182|||
157215835|NCT00373685|567537420|FG000|Overall Study|Final Status Unknown|12|||
157215836|NCT00373685|567537421|FG001|Overall Study|Final Status Unknown|4|||
157215837|NCT00373685|567537420|FG000|Overall Study|Randomized, not treated|51|||
157215838|NCT00373685|567537421|FG001|Overall Study|Randomized, not treated|77|||
157215839|NCT01612156|567537422|FG000|Overall Study|Protocol Violation|2|||
157215840|NCT01612156|567537423|FG001|Overall Study|Protocol Violation|0|||
157215841|NCT00410410|567537424|FG000|Induction Period (IP)|Death|1|||
157215842|NCT00410410|567537425|FG001|Induction Period (IP)|Death|0|||
157215843|NCT00410410|567537426|FG002|Induction Period (IP)|Death|0|||
157215844|NCT00410410|567537427|FG003|Induction Period (IP)|Death|0|||
157215845|NCT00410410|567537428|FG004|Induction Period (IP)|Death|0|||
157215846|NCT00410410|567537429|FG005|Induction Period (IP)|Death|0|||
157215847|NCT00410410|567537430|FG006|Induction Period (IP)|Death|0|||
157215848|NCT00410410|567537431|FG007|Induction Period (IP)|Death|0|||
157215849|NCT00410410|567537432|FG008|Induction Period (IP)|Death|0|||
157215850|NCT00410410|567537424|FG000|Induction Period (IP)|Adverse Event|3|||
157215851|NCT00410410|567537425|FG001|Induction Period (IP)|Adverse Event|4|||
156709291|NCT04602546|565680572|FG000|Overall Study|Randomized with disqualified data|2|||
156709292|NCT04602546|565680573|FG001|Overall Study|Randomized with disqualified data|0|||
156709293|NCT04602546|565680574|FG002|Overall Study|Randomized with disqualified data|2|||
157215852|NCT00410410|567537426|FG002|Induction Period (IP)|Adverse Event|2|||
157215853|NCT00410410|567537427|FG003|Induction Period (IP)|Adverse Event|4|||
157215854|NCT00410410|567537428|FG004|Induction Period (IP)|Adverse Event|1|||
157215855|NCT00410410|567537429|FG005|Induction Period (IP)|Adverse Event|0|||
157215856|NCT00410410|567537430|FG006|Induction Period (IP)|Adverse Event|0|||
157215857|NCT00410410|567537431|FG007|Induction Period (IP)|Adverse Event|0|||
157215858|NCT00410410|567537432|FG008|Induction Period (IP)|Adverse Event|0|||
157215859|NCT00410410|567537424|FG000|Induction Period (IP)|Lack of Efficacy|26|||
157215860|NCT00410410|567537425|FG001|Induction Period (IP)|Lack of Efficacy|24|||
157215861|NCT00410410|567537426|FG002|Induction Period (IP)|Lack of Efficacy|8|||
157215862|NCT00410410|567537427|FG003|Induction Period (IP)|Lack of Efficacy|8|||
157215863|NCT00410410|567537428|FG004|Induction Period (IP)|Lack of Efficacy|7|||
156709294|NCT04602546|565680575|FG003|Overall Study|Randomized with disqualified data|5|||
157215864|NCT00410410|567537429|FG005|Induction Period (IP)|Lack of Efficacy|7|||
156709295|NCT04602546|565680576|FG004|Overall Study|Randomized with disqualified data|3|||
156709296|NCT01831258|565680579|FG000|Overall Study|Withdrawal by Subject|2|||
156709297|NCT01831258|565680580|FG001|Overall Study|Withdrawal by Subject|1|||
156709298|NCT01831258|565680579|FG000|Overall Study|Lost to Follow-up|3|||
156709299|NCT01831258|565680580|FG001|Overall Study|Lost to Follow-up|2|||
156709300|NCT01753297|565680590|FG000|Overall Study|Lost to Follow-up|7|||
156709301|NCT01753297|565680591|FG001|Overall Study|Lost to Follow-up|2|||
156709302|NCT01753297|565680590|FG000|Overall Study|Withdrawal by Subject|26|||
156709303|NCT01753297|565680591|FG001|Overall Study|Withdrawal by Subject|23|||
156709304|NCT01753297|565680590|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
156709305|NCT01753297|565680591|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
156709306|NCT01753297|565680590|FG000|Overall Study|Death|0|||
156709307|NCT01753297|565680591|FG001|Overall Study|Death|2|||
156709308|NCT01753297|565680590|FG000|Overall Study|Did not attend end of study visit|7|||
156709309|NCT01753297|565680591|FG001|Overall Study|Did not attend end of study visit|8|||
156709310|NCT01275729|565680592|FG000|Overall Study|Death|3|||
156709311|NCT01275729|565680592|FG000|Overall Study|Withdrawal by Subject|1|||
156709312|NCT00447876|565680593|FG000|Overall Study|Withdrawal by Subject|1|||
156709313|NCT00447876|565680594|FG001|Overall Study|Withdrawal by Subject|4|||
156709314|NCT00447876|565680593|FG000|Overall Study|Lost to Follow-up|1|||
156709315|NCT00447876|565680594|FG001|Overall Study|Lost to Follow-up|0|||
156709316|NCT00447876|565680593|FG000|Overall Study|Deterioration of symptomology|1|||
156709317|NCT00447876|565680594|FG001|Overall Study|Deterioration of symptomology|0|||
156709318|NCT02533180|565680595|FG000|Overall Study|Death|0|||
156791992|NCT01712074|565991049|FG002|Placebo Run-in Period|No longer willing to participate|0|||
156791993|NCT01712074|565991047|FG000|Double Blind Period|Adverse Event|0|||
156791994|NCT01712074|565991048|FG001|Double Blind Period|Adverse Event|2|||
156791995|NCT01712074|565991049|FG002|Double Blind Period|Adverse Event|1|||
156791996|NCT01712074|565991047|FG000|Double Blind Period|No longer willing to participate|0|||
156791997|NCT01712074|565991048|FG001|Double Blind Period|No longer willing to participate|2|||
156791998|NCT01712074|565991049|FG002|Double Blind Period|No longer willing to participate|4|||
156791999|NCT01712074|565991047|FG000|Double Blind Period|Death|0|||
156792000|NCT01712074|565991048|FG001|Double Blind Period|Death|1|||
156792001|NCT01712074|565991049|FG002|Double Blind Period|Death|0|||
156872897|NCT00337675|566293273|FG002|Overall Study|Lost to Follow-up|17|||
156872898|NCT00337675|566293271|FG000|Overall Study|Physician Decision|9|||
156872899|NCT00337675|566293272|FG001|Overall Study|Physician Decision|17|||
156872900|NCT00337675|566293273|FG002|Overall Study|Physician Decision|14|||
156872901|NCT00337675|566293271|FG000|Overall Study|Protocol Violation|21|||
156872902|NCT00337675|566293272|FG001|Overall Study|Protocol Violation|24|||
156872903|NCT00337675|566293273|FG002|Overall Study|Protocol Violation|19|||
157126221|NCT03891901|567212453|FG006|Overall Study|Withdrawal by Subject|0|||
157126222|NCT03891901|567212454|FG007|Overall Study|Withdrawal by Subject|0|||
157126223|NCT03891901|567212455|FG008|Overall Study|Withdrawal by Subject|0|||
157126224|NCT01724528|567212459|FG000|Overall Study|Death|3|||
157126225|NCT01724528|567212460|FG001|Overall Study|Death|0|||
157126226|NCT01724528|567212459|FG000|Overall Study|Withdrawal by Subject|0|||
157126227|NCT01724528|567212460|FG001|Overall Study|Withdrawal by Subject|2|||
157126228|NCT01724528|567212459|FG000|Overall Study|Protocol Violation|0|||
157126229|NCT01724528|567212460|FG001|Overall Study|Protocol Violation|1|||
157126230|NCT01724528|567212459|FG000|Overall Study|Patient refused to attend last visit|1|||
157126231|NCT01724528|567212460|FG001|Overall Study|Patient refused to attend last visit|0|||
157126232|NCT05574062|567212461|FG000|Pre Run-In|Screening failure|3|||
157126233|NCT05574062|567212462|FG001|Pre Run-In|Screening failure|0|||
157126234|NCT05574062|567212463|FG002|Pre Run-In|Screening failure|0|||
157126235|NCT05574062|567212464|FG003|Pre Run-In|Screening failure|0|||
157126236|NCT05574062|567212465|FG004|Pre Run-In|Screening failure|0|||
157126237|NCT05574062|567212461|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
157126238|NCT05574062|567212462|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
157126239|NCT05574062|567212463|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
157126240|NCT05574062|567212464|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
157126241|NCT05574062|567212465|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
157126242|NCT05574062|567212461|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
157126243|NCT05574062|567212462|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
157126244|NCT05574062|567212463|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
157126245|NCT05574062|567212464|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
157126246|NCT05574062|567212465|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
157126247|NCT05574062|567212461|FG000|Continuation Phase Period 1|Physician Decision|1|||
157126248|NCT05574062|567212462|FG001|Continuation Phase Period 1|Physician Decision|0|||
157126249|NCT05574062|567212463|FG002|Continuation Phase Period 1|Physician Decision|0|||
157126250|NCT05574062|567212464|FG003|Continuation Phase Period 1|Physician Decision|0|||
157126251|NCT05574062|567212465|FG004|Continuation Phase Period 1|Physician Decision|0|||
157126252|NCT05574062|567212461|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
157126253|NCT05574062|567212462|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
156792002|NCT01712074|565991047|FG000|Double Blind Period|Lost to Follow-up|0|||
156792003|NCT01712074|565991048|FG001|Double Blind Period|Lost to Follow-up|2|||
156872904|NCT00337675|566293271|FG000|Overall Study|Withdrawal by Subject|25|||
156872905|NCT00337675|566293272|FG001|Overall Study|Withdrawal by Subject|25|||
156872906|NCT00337675|566293273|FG002|Overall Study|Withdrawal by Subject|19|||
156872907|NCT00337675|566293271|FG000|Overall Study|Progressive Disease|0|||
156872908|NCT00337675|566293272|FG001|Overall Study|Progressive Disease|2|||
156872909|NCT00337675|566293273|FG002|Overall Study|Progressive Disease|0|||
156872910|NCT00337675|566293271|FG000|Overall Study|Trial Terminated|0|||
156872911|NCT00337675|566293272|FG001|Overall Study|Trial Terminated|0|||
156872912|NCT00337675|566293273|FG002|Overall Study|Trial Terminated|2|||
156872913|NCT04269265|566293274|FG000|Overall Study|Physician Decision|1|||
156872914|NCT04269265|566293274|FG000|Overall Study|Withdrawal by Subject|1|||
156872915|NCT04269265|566293274|FG000|Overall Study|Overenrolled (sample size reached)|4|||
156872916|NCT04439136|566293275|FG000|Overall Study|Ineligible|1|||
156872917|NCT04439136|566293275|FG000|Overall Study|Never Started Treatment|2|||
156872918|NCT04439136|566293275|FG000|Overall Study|Adverse Event|4|||
156872919|NCT04439136|566293275|FG000|Overall Study|Death|3|||
156872920|NCT04439136|566293275|FG000|Overall Study|Disease Progression|27|||
156872921|NCT04439136|566293275|FG000|Overall Study|Alternative Therapy|1|||
156872922|NCT04439136|566293275|FG000|Overall Study|Increased Tumor Burden|1|||
156872923|NCT04439136|566293275|FG000|Overall Study|Symptomatic Detrioration|1|||
156872924|NCT04693234|566293276|FG000|Overall Study|Death|79|||
156872925|NCT04693234|566293277|FG001|Overall Study|Death|19|||
156872926|NCT04693234|566293276|FG000|Overall Study|Sponsor Ended Study|47|||
156872927|NCT04693234|566293277|FG001|Overall Study|Sponsor Ended Study|18|||
156872928|NCT04693234|566293276|FG000|Overall Study|Withdrawal by Subject|10|||
156872929|NCT04693234|566293277|FG001|Overall Study|Withdrawal by Subject|2|||
156872930|NCT04693234|566293276|FG000|Overall Study|Lost to Follow-up|2|||
156872931|NCT04693234|566293277|FG001|Overall Study|Lost to Follow-up|1|||
156872932|NCT02578706|566293280|FG000|Overall Study|Withdrawal by Subject|1|||
156872933|NCT02578706|566293281|FG001|Overall Study|Withdrawal by Subject|0|||
156872934|NCT02578706|566293282|FG002|Overall Study|Withdrawal by Subject|0|||
156872935|NCT02578706|566293280|FG000|Overall Study|Lost to Follow-up|0|||
156872936|NCT02578706|566293281|FG001|Overall Study|Lost to Follow-up|4|||
156872937|NCT02578706|566293282|FG002|Overall Study|Lost to Follow-up|0|||
156872938|NCT02578706|566293280|FG000|Overall Study|Physician Decision|0|||
156872939|NCT02578706|566293281|FG001|Overall Study|Physician Decision|1|||
156872940|NCT02578706|566293282|FG002|Overall Study|Physician Decision|0|||
156872941|NCT04849559|566293283|FG000|Overall Study|Withdrawal by Subject|2|||
156872942|NCT04849559|566293284|FG001|Overall Study|Withdrawal by Subject|1|||
156872943|NCT01662102|566293296|FG000|Overall Study|Sponsor's decision|1|||
156872944|NCT01662102|566293297|FG001|Overall Study|Sponsor's decision|0|||
156872945|NCT02357368|566293298|FG000|Overall Study|Lost to Follow-up|0|||
156872946|NCT02357368|566293299|FG001|Overall Study|Lost to Follow-up|0|||
156872947|NCT02357368|566293300|FG002|Overall Study|Lost to Follow-up|0|||
156872948|NCT02357368|566293301|FG003|Overall Study|Lost to Follow-up|1|||
156872949|NCT02357368|566293298|FG000|Overall Study|Pregnancy|3|||
156872950|NCT02357368|566293299|FG001|Overall Study|Pregnancy|2|||
156872951|NCT02357368|566293300|FG002|Overall Study|Pregnancy|0|||
156872952|NCT02357368|566293301|FG003|Overall Study|Pregnancy|0|||
156872953|NCT02357368|566293298|FG000|Overall Study|Withdrawal by Subject|3|||
156872954|NCT02357368|566293299|FG001|Overall Study|Withdrawal by Subject|1|||
156872955|NCT02357368|566293300|FG002|Overall Study|Withdrawal by Subject|1|||
156872956|NCT02357368|566293301|FG003|Overall Study|Withdrawal by Subject|2|||
156872957|NCT01931566|566293302|FG000|Overall Study|Randomized But Not Treated|6|||
156872958|NCT01931566|566293303|FG001|Overall Study|Randomized But Not Treated|9|||
156872959|NCT01931566|566293304|FG002|Overall Study|Randomized But Not Treated|14|||
156872960|NCT01931566|566293302|FG000|Overall Study|Adverse Event|37|||
157215865|NCT00410410|567537430|FG006|Induction Period (IP)|Lack of Efficacy|0|||
156709319|NCT02533180|565680596|FG001|Overall Study|Death|2|||
156709320|NCT02533180|565680595|FG000|Overall Study|Lost to Follow-up|0|||
156709321|NCT02533180|565680596|FG001|Overall Study|Lost to Follow-up|1|||
156709322|NCT02533180|565680595|FG000|Overall Study|Physician Decision|0|||
156709323|NCT02533180|565680596|FG001|Overall Study|Physician Decision|1|||
156709324|NCT02533180|565680595|FG000|Overall Study|Withdrawal by Subject|2|||
156872961|NCT01931566|566293303|FG001|Overall Study|Adverse Event|167|||
156872962|NCT01931566|566293304|FG002|Overall Study|Adverse Event|132|||
156872963|NCT01931566|566293302|FG000|Overall Study|Major Protocol Deviation|5|||
156872964|NCT01931566|566293303|FG001|Overall Study|Major Protocol Deviation|14|||
156709325|NCT02533180|565680596|FG001|Overall Study|Withdrawal by Subject|5|||
156709326|NCT02533180|565680595|FG000|Overall Study|Screen Failure|37|||
156872965|NCT01931566|566293304|FG002|Overall Study|Major Protocol Deviation|21|||
156872966|NCT01931566|566293302|FG000|Overall Study|Lost to Follow-up|3|||
156872967|NCT01931566|566293303|FG001|Overall Study|Lost to Follow-up|26|||
156872968|NCT01931566|566293304|FG002|Overall Study|Lost to Follow-up|23|||
156872969|NCT01931566|566293302|FG000|Overall Study|Voluntary Withdrawal|78|||
156872970|NCT01931566|566293303|FG001|Overall Study|Voluntary Withdrawal|245|||
156872971|NCT01931566|566293304|FG002|Overall Study|Voluntary Withdrawal|225|||
156872972|NCT01931566|566293302|FG000|Overall Study|Study Termination|289|||
156709327|NCT02533180|565680596|FG001|Overall Study|Screen Failure|0|||
156872973|NCT01931566|566293303|FG001|Overall Study|Study Termination|968|||
156872974|NCT01931566|566293304|FG002|Overall Study|Study Termination|1037|||
156872975|NCT01931566|566293302|FG000|Overall Study|Reason Not Specified|11|||
156872976|NCT01931566|566293303|FG001|Overall Study|Reason Not Specified|47|||
156872977|NCT01931566|566293304|FG002|Overall Study|Reason Not Specified|53|||
156872978|NCT01931566|566293302|FG000|Overall Study|Missing|0|||
156872979|NCT01931566|566293303|FG001|Overall Study|Missing|0|||
156872980|NCT01931566|566293304|FG002|Overall Study|Missing|1|||
156872981|NCT00611026|566293306|FG000|Randomized to Double-blind Treatment|Not treated|2|||
156872982|NCT00611026|566293307|FG001|Randomized to Double-blind Treatment|Not treated|1|||
156872983|NCT00611026|566293308|FG002|Randomized to Double-blind Treatment|Not treated|3|||
156872984|NCT00611026|566293306|FG000|Double-blind Treatment Period|Death|1|||
156872985|NCT00611026|566293307|FG001|Double-blind Treatment Period|Death|0|||
156872986|NCT00611026|566293308|FG002|Double-blind Treatment Period|Death|0|||
156872987|NCT00611026|566293306|FG000|Double-blind Treatment Period|Adverse Event|9|||
156872988|NCT00611026|566293307|FG001|Double-blind Treatment Period|Adverse Event|28|||
156872989|NCT00611026|566293308|FG002|Double-blind Treatment Period|Adverse Event|46|||
156872990|NCT00611026|566293306|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
156872991|NCT00611026|566293307|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
156872992|NCT00611026|566293308|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
156872993|NCT00611026|566293306|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
156872994|NCT00611026|566293307|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
156872995|NCT00611026|566293308|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
156872996|NCT00611026|566293306|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156872997|NCT00611026|566293307|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
156872998|NCT00611026|566293308|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
156872999|NCT00611026|566293306|FG000|Double-blind Treatment Period|Other|13|||
156873000|NCT00611026|566293307|FG001|Double-blind Treatment Period|Other|20|||
156873001|NCT00611026|566293308|FG002|Double-blind Treatment Period|Other|18|||
156873002|NCT00760617|566293309|FG000|Overall Study|Adverse Event|5|||
156873003|NCT00760617|566293310|FG001|Overall Study|Adverse Event|2|||
156873004|NCT00760617|566293311|FG002|Overall Study|Adverse Event|0|||
156873005|NCT00760617|566293309|FG000|Overall Study|Lost to Follow-up|0|||
156873006|NCT00760617|566293310|FG001|Overall Study|Lost to Follow-up|0|||
157126254|NCT05574062|567212463|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
157126255|NCT05574062|567212464|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
157126256|NCT05574062|567212465|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
157126257|NCT05574062|567212461|FG000|Continuation Phase Period 1|Adverse Event|1|||
157126258|NCT05574062|567212462|FG001|Continuation Phase Period 1|Adverse Event|0|||
157126259|NCT05574062|567212463|FG002|Continuation Phase Period 1|Adverse Event|0|||
157126260|NCT05574062|567212464|FG003|Continuation Phase Period 1|Adverse Event|0|||
157126261|NCT05574062|567212465|FG004|Continuation Phase Period 1|Adverse Event|0|||
157126262|NCT05574062|567212461|FG000|Continuation Phase Period 1|Death|1|||
157126263|NCT05574062|567212462|FG001|Continuation Phase Period 1|Death|0|||
157126264|NCT05574062|567212463|FG002|Continuation Phase Period 1|Death|0|||
157126265|NCT05574062|567212464|FG003|Continuation Phase Period 1|Death|0|||
157126266|NCT05574062|567212465|FG004|Continuation Phase Period 1|Death|0|||
157126267|NCT05574062|567212461|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
157126268|NCT05574062|567212462|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
157126269|NCT05574062|567212463|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
157126270|NCT05574062|567212464|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
157126271|NCT05574062|567212465|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
157126272|NCT02482129|567212468|FG000|Overall Study|Adverse Event-prior to treatment|0|||
157126273|NCT02482129|567212469|FG001|Overall Study|Adverse Event-prior to treatment|1|||
157126274|NCT02482129|567212468|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
157126275|NCT02482129|567212469|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
157126276|NCT02482129|567212468|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
156709328|NCT02533180|565680595|FG000|Overall Study|Protocol Deviation|0|||
156709329|NCT02533180|565680596|FG001|Overall Study|Protocol Deviation|1|||
156709330|NCT02533180|565680595|FG000|Overall Study|Non-compliance|0|||
156709331|NCT02533180|565680596|FG001|Overall Study|Non-compliance|1|||
156709332|NCT00005957|565680597|FG000|Overall Study|No treated|3|||
156709333|NCT00005957|565680598|FG001|Overall Study|No treated|9|||
156709334|NCT00005957|565680597|FG000|Overall Study|Crossover to the other arm|5|||
156709335|NCT00005957|565680598|FG001|Overall Study|Crossover to the other arm|19|||
156709336|NCT01609023|565680599|FG000|Overall Study|Lack of Efficacy|3|||
156873007|NCT00760617|566293311|FG002|Overall Study|Lost to Follow-up|5|||
156873008|NCT01147874|566293315|FG000|Overall Study|Adverse Event|5|||
156873009|NCT01147874|566293315|FG000|Overall Study|Investigator's Request|1|||
156873010|NCT01147874|566293315|FG000|Overall Study|Lost to Follow-up|25|||
157126277|NCT02482129|567212469|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
157215866|NCT00410410|567537431|FG007|Induction Period (IP)|Lack of Efficacy|0|||
156709337|NCT01609023|565680599|FG000|Overall Study|Withdrawal by Subject|4|||
156709338|NCT01609023|565680599|FG000|Overall Study|Lost to Follow-up|8|||
156709339|NCT01609023|565680599|FG000|Overall Study|Toxicity|3|||
156709340|NCT01609023|565680599|FG000|Overall Study|Disease progression|10|||
156709341|NCT01609023|565680599|FG000|Overall Study|Physician Decision|2|||
156709342|NCT01609023|565680599|FG000|Overall Study|Death|2|||
156709343|NCT01609023|565680599|FG000|Overall Study|Personal reasons|1|||
156709344|NCT04172597|565680601|FG000|Overall Study|Disease Progression|0|||
156709345|NCT04172597|565680602|FG001|Overall Study|Disease Progression|0|||
156709346|NCT04172597|565680603|FG002|Overall Study|Disease Progression|0|||
156709347|NCT04172597|565680604|FG003|Overall Study|Disease Progression|0|||
156709348|NCT04172597|565680605|FG004|Overall Study|Disease Progression|1|||
156709349|NCT00794339|565680606|FG000|Overall Study|Withdrawal by Subject|3|||
156709350|NCT00794339|565680606|FG000|Overall Study|Ineligible|4|||
156709351|NCT00794339|565680606|FG000|Overall Study|Tx prior to ATSM|3|||
156709352|NCT00794339|565680606|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
156709353|NCT00794339|565680606|FG000|Overall Study|Tx not per protocol|1|||
156709354|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Death|0|||
156709355|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Death|1|||
156709356|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
157215867|NCT00410410|567537432|FG008|Induction Period (IP)|Lack of Efficacy|0|||
157215868|NCT00410410|567537424|FG000|Induction Period (IP)|Lost to Follow-up|2|||
157215869|NCT00410410|567537425|FG001|Induction Period (IP)|Lost to Follow-up|2|||
157215870|NCT00410410|567537426|FG002|Induction Period (IP)|Lost to Follow-up|2|||
157215871|NCT00410410|567537427|FG003|Induction Period (IP)|Lost to Follow-up|3|||
157215872|NCT00410410|567537428|FG004|Induction Period (IP)|Lost to Follow-up|0|||
157215873|NCT00410410|567537429|FG005|Induction Period (IP)|Lost to Follow-up|1|||
157215874|NCT00410410|567537430|FG006|Induction Period (IP)|Lost to Follow-up|0|||
157215875|NCT00410410|567537431|FG007|Induction Period (IP)|Lost to Follow-up|0|||
157215876|NCT00410410|567537432|FG008|Induction Period (IP)|Lost to Follow-up|0|||
157215877|NCT00410410|567537424|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
157215878|NCT00410410|567537425|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
157215879|NCT00410410|567537426|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
157215880|NCT00410410|567537427|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
157215881|NCT00410410|567537428|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
157215882|NCT00410410|567537429|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
157215883|NCT00410410|567537430|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
157215884|NCT00410410|567537431|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
157215885|NCT00410410|567537432|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
157215886|NCT00410410|567537424|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215887|NCT00410410|567537425|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215888|NCT00410410|567537426|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
157215889|NCT00410410|567537427|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215890|NCT00410410|567537428|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215891|NCT00410410|567537429|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215892|NCT00410410|567537430|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215893|NCT00410410|567537431|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215894|NCT00410410|567537432|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
157215895|NCT00410410|567537424|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215896|NCT00410410|567537425|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215897|NCT00410410|567537426|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215898|NCT00410410|567537427|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215899|NCT00410410|567537428|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
157215900|NCT00410410|567537429|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
157215901|NCT00410410|567537430|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215902|NCT00410410|567537431|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215903|NCT00410410|567537432|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
157215904|NCT00410410|567537424|FG000|Induction Period (IP)|Other|0|||
157215905|NCT00410410|567537425|FG001|Induction Period (IP)|Other|0|||
156709357|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
156709358|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
157016236|NCT03271489|566811276|FG000|Open-Label (OL) Period|No Specified|2|||
157016237|NCT03271489|566811277|FG001|Open-Label (OL) Period|No Specified|2|||
156709359|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
156709360|NCT02952586|565680609|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
156709361|NCT02952586|565680610|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
156709362|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
156709363|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
156709364|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
156709365|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
157215906|NCT00410410|567537426|FG002|Induction Period (IP)|Other|1|||
157215907|NCT00410410|567537427|FG003|Induction Period (IP)|Other|0|||
157215908|NCT00410410|567537428|FG004|Induction Period (IP)|Other|0|||
157215909|NCT00410410|567537429|FG005|Induction Period (IP)|Other|0|||
157215910|NCT00410410|567537430|FG006|Induction Period (IP)|Other|0|||
156709366|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
156709367|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
156709368|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
156709369|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
156709370|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
156709371|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
156709372|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
156709373|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
156709374|NCT02952586|565680609|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
156709375|NCT02952586|565680610|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
156709376|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Death|3|||
156709377|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Death|8|||
156709378|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
156709379|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
156709380|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
156709381|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
156792004|NCT01712074|565991049|FG002|Double Blind Period|Lost to Follow-up|1|||
156792005|NCT01712074|565991047|FG000|Double Blind Period|Other|0|||
156792006|NCT01712074|565991048|FG001|Double Blind Period|Other|4|||
156792007|NCT01712074|565991049|FG002|Double Blind Period|Other|1|||
156792008|NCT01712074|565991047|FG000|Double Blind Period|Protocol Violation|0|||
156792009|NCT01712074|565991048|FG001|Double Blind Period|Protocol Violation|0|||
156792010|NCT01712074|565991049|FG002|Double Blind Period|Protocol Violation|1|||
156792011|NCT01712074|565991047|FG000|Double Blind Period|No longer met eligibility criteria|0|||
156792012|NCT01712074|565991048|FG001|Double Blind Period|No longer met eligibility criteria|3|||
156792013|NCT01712074|565991049|FG002|Double Blind Period|No longer met eligibility criteria|0|||
156792014|NCT03478787|565991050|FG000|Overall Study|Adverse Event|5|||
156792015|NCT03478787|565991051|FG001|Overall Study|Adverse Event|1|||
156792016|NCT03478787|565991050|FG000|Overall Study|Protocol Violation|3|||
156792017|NCT03478787|565991051|FG001|Overall Study|Protocol Violation|0|||
156792018|NCT03478787|565991050|FG000|Overall Study|Lack of Efficacy|7|||
156792019|NCT03478787|565991051|FG001|Overall Study|Lack of Efficacy|1|||
156792020|NCT03478787|565991050|FG000|Overall Study|Lost to Follow-up|9|||
156792021|NCT03478787|565991051|FG001|Overall Study|Lost to Follow-up|5|||
156792022|NCT03478787|565991050|FG000|Overall Study|Withdrawal by Subject|2|||
156792023|NCT03478787|565991051|FG001|Overall Study|Withdrawal by Subject|6|||
156792024|NCT03478787|565991050|FG000|Overall Study|Other, Not Specified|3|||
156792025|NCT03478787|565991051|FG001|Overall Study|Other, Not Specified|0|||
157016238|NCT03271489|566811276|FG000|Open-Label (OL) Period|Missing|2|||
157016239|NCT03271489|566811277|FG001|Open-Label (OL) Period|Missing|0|||
157016240|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
157016241|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
157016242|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
157016243|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
157016244|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
157016245|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
157016246|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
157016247|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
157016248|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
157016249|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
157016250|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
157016251|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
157016252|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
157016253|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
157016254|NCT03271489|566811276|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
157016255|NCT03271489|566811277|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
157016256|NCT01127373|566811278|FG000|Overall Study|Not Treated|3|||
157016257|NCT01127373|566811278|FG000|Overall Study|Lost to Follow-up|7|||
157016258|NCT01127373|566811278|FG000|Overall Study|Withdrawal by Subject|1|||
157016259|NCT01127373|566811278|FG000|Overall Study|Disease progression|1|||
157016260|NCT05450458|566811281|FG000|Overall Study|Lost to Follow-up|4|||
157016261|NCT05494788|566811284|FG000|Initial Treatment Period|Adverse Event|2|||
157016262|NCT05494788|566811284|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
157016263|NCT05494788|566811284|FG000|Extension Period|Adverse Event|1|||
157016264|NCT05494788|566811284|FG000|Extension Period|Withdrawal by Subject|1|||
157016265|NCT00136435|566811285|FG000|Overall Study|Ineligible|8|||
157016266|NCT00136435|566811285|FG000|Overall Study|Induction Death|1|||
157016267|NCT00136435|566811285|FG000|Overall Study|Induction Failure|10|||
157016268|NCT00136435|566811285|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
157016269|NCT00136435|566811285|FG000|Overall Study|Withdrawal by Subject|3|||
156709382|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
156709383|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
156709384|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
156709385|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
156709386|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
156709387|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
156709388|NCT02952586|565680609|FG000|CRT for Cisplatin (63 Days)|Other|1|||
156709389|NCT02952586|565680610|FG001|CRT for Cisplatin (63 Days)|Other|1|||
157126278|NCT02482129|567212468|FG000|Overall Study|Criteria not met-prior to treatment|1|||
157126279|NCT02482129|567212469|FG001|Overall Study|Criteria not met-prior to treatment|0|||
157126280|NCT02482129|567212468|FG000|Overall Study|Adverse Event|1|||
157126281|NCT02482129|567212469|FG001|Overall Study|Adverse Event|0|||
157126282|NCT02482129|567212468|FG000|Overall Study|Withdrawal by Subject|2|||
157126283|NCT02482129|567212469|FG001|Overall Study|Withdrawal by Subject|0|||
157126284|NCT02482129|567212468|FG000|Overall Study|Criteria not met|1|||
157126285|NCT02482129|567212469|FG001|Overall Study|Criteria not met|0|||
157126286|NCT01877083|567212470|FG000|Treatment Phase|Disease Progression|10|||
157126287|NCT01877083|567212470|FG000|Treatment Phase|Clinical Progression|1|||
157126288|NCT01877083|567212470|FG000|Treatment Phase|Adverse Event|6|||
157126289|NCT01877083|567212470|FG000|Treatment Phase|Withdrawal by Subject|2|||
157126290|NCT01877083|567212470|FG000|Treatment Phase|Lost to Follow-up|1|||
157126291|NCT01877083|567212470|FG000|Extension Phase|Disease Progression|3|||
157126292|NCT01877083|567212470|FG000|Extension Phase|Adverse Event|2|||
157126293|NCT00429585|567212473|FG000|Overall Study|Death|1|||
157126294|NCT00429585|567212474|FG001|Overall Study|Death|0|||
157126295|NCT00429585|567212473|FG000|Overall Study|Lost to Follow-up|27|||
157126296|NCT00429585|567212474|FG001|Overall Study|Lost to Follow-up|20|||
157126297|NCT00429585|567212473|FG000|Overall Study|Physician Decision|2|||
157126298|NCT00429585|567212474|FG001|Overall Study|Physician Decision|0|||
157126299|NCT01582308|567212475|FG000|Period 1|Withdrawal by Subject|0|||
157126300|NCT01582308|567212476|FG001|Period 1|Withdrawal by Subject|0|||
157126301|NCT01582308|567212477|FG002|Period 1|Withdrawal by Subject|0|||
157126302|NCT01582308|567212478|FG003|Period 1|Withdrawal by Subject|0|||
157126303|NCT01582308|567212479|FG004|Period 1|Withdrawal by Subject|0|||
157126304|NCT01582308|567212480|FG005|Period 1|Withdrawal by Subject|0|||
157126305|NCT01582308|567212481|FG006|Period 1|Withdrawal by Subject|1|||
157126306|NCT01582308|567212482|FG007|Period 1|Withdrawal by Subject|0|||
157126307|NCT01582308|567212483|FG008|Period 1|Withdrawal by Subject|0|||
157126308|NCT01582308|567212484|FG009|Period 1|Withdrawal by Subject|0|||
157126309|NCT01582308|567212475|FG000|10-day Washout Following Period 1|Physician Decision|0|||
157126310|NCT01582308|567212476|FG001|10-day Washout Following Period 1|Physician Decision|0|||
157126311|NCT01582308|567212477|FG002|10-day Washout Following Period 1|Physician Decision|0|||
157126312|NCT01582308|567212478|FG003|10-day Washout Following Period 1|Physician Decision|0|||
157126313|NCT01582308|567212479|FG004|10-day Washout Following Period 1|Physician Decision|1|||
157126314|NCT01582308|567212480|FG005|10-day Washout Following Period 1|Physician Decision|0|||
157126315|NCT01582308|567212481|FG006|10-day Washout Following Period 1|Physician Decision|0|||
157126316|NCT01582308|567212482|FG007|10-day Washout Following Period 1|Physician Decision|0|||
157126317|NCT01582308|567212483|FG008|10-day Washout Following Period 1|Physician Decision|0|||
157126318|NCT01582308|567212484|FG009|10-day Washout Following Period 1|Physician Decision|0|||
157126319|NCT01582308|567212475|FG000|Period 4|Physician Decision|1|||
157126320|NCT01582308|567212476|FG001|Period 4|Physician Decision|0|||
157126321|NCT01582308|567212477|FG002|Period 4|Physician Decision|0|||
156709390|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Death|5|||
156709391|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Death|8|||
156709392|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
156709393|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
156709394|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
156792026|NCT02539394|565991052|FG000|Overall Study|Protocol Violation|1|||
156792027|NCT02539394|565991053|FG001|Overall Study|Protocol Violation|3|||
156792028|NCT02539394|565991052|FG000|Overall Study|Lost to Follow-up|1|||
156792029|NCT02539394|565991053|FG001|Overall Study|Lost to Follow-up|2|||
156792030|NCT02539394|565991052|FG000|Overall Study|Incomplete dataset|6|||
156792031|NCT02539394|565991053|FG001|Overall Study|Incomplete dataset|6|||
156792032|NCT01316900|565991074|FG000|Overall Study|Adverse Event|10|||
156792033|NCT01316900|565991075|FG001|Overall Study|Adverse Event|10|||
156792034|NCT01316900|565991076|FG002|Overall Study|Adverse Event|15|||
156792035|NCT01316900|565991077|FG003|Overall Study|Adverse Event|9|||
156792036|NCT01316900|565991074|FG000|Overall Study|Lack of Efficacy|17|||
156792037|NCT01316900|565991075|FG001|Overall Study|Lack of Efficacy|9|||
156792038|NCT01316900|565991076|FG002|Overall Study|Lack of Efficacy|5|||
156792039|NCT01316900|565991077|FG003|Overall Study|Lack of Efficacy|7|||
156792040|NCT01316900|565991074|FG000|Overall Study|Protocol Violation|7|||
156792041|NCT01316900|565991075|FG001|Overall Study|Protocol Violation|1|||
157126322|NCT01582308|567212478|FG003|Period 4|Physician Decision|0|||
157126323|NCT01582308|567212479|FG004|Period 4|Physician Decision|0|||
157126324|NCT01582308|567212480|FG005|Period 4|Physician Decision|1|||
156873011|NCT01147874|566293315|FG000|Overall Study|Other|5|||
156873012|NCT01147874|566293315|FG000|Overall Study|Protocol Violation|5|||
156873013|NCT01147874|566293315|FG000|Overall Study|Sponsor's Decision|2|||
156873014|NCT01147874|566293315|FG000|Overall Study|Withdrawal by Subject|24|||
156873015|NCT04625101|566293316|FG000|Overall Study|Withdrawal by Subject|0|||
156873016|NCT04625101|566293317|FG001|Overall Study|Withdrawal by Subject|1|||
156873017|NCT04625101|566293316|FG000|Overall Study|Protocol Deviation|1|||
156873018|NCT04625101|566293317|FG001|Overall Study|Protocol Deviation|0|||
156873019|NCT02991040|566293318|FG000|Overall Study|Withdrawal by Subject|2|||
156873020|NCT02991040|566293318|FG000|Overall Study|Lost to Follow-up|2|||
156873021|NCT04287517|566293319|FG000|Overall Study|Withdrawal by Subject|1|||
156873022|NCT04287517|566293320|FG001|Overall Study|Withdrawal by Subject|1|||
156873023|NCT01869764|566293327|FG000|Overall Study|Withdrawal by Subject|0|||
156873024|NCT01869764|566293328|FG001|Overall Study|Withdrawal by Subject|2|||
156873025|NCT02175030|566293329|FG000|Overall Study|Failed screen after consent|7|||
156873026|NCT02175030|566293330|FG001|Overall Study|Failed screen after consent|6|||
156873027|NCT02175030|566293329|FG000|Overall Study|Failed IUD Insertion|20|||
156873028|NCT02175030|566293330|FG001|Overall Study|Failed IUD Insertion|21|||
156873029|NCT02175030|566293329|FG000|Overall Study|Physician Decision|1|||
156873030|NCT02175030|566293330|FG001|Overall Study|Physician Decision|1|||
156873031|NCT02175030|566293329|FG000|Overall Study|Lost to Follow-up|6|||
156873032|NCT02175030|566293330|FG001|Overall Study|Lost to Follow-up|6|||
156873033|NCT02175030|566293329|FG000|Overall Study|Withdrawal by Subject|1|||
156873034|NCT02175030|566293330|FG001|Overall Study|Withdrawal by Subject|4|||
156873035|NCT02533453|566293331|FG000|Overall Study|Adverse Event|6|||
156873036|NCT02533453|566293331|FG000|Overall Study|Protocol Violation|1|||
156873037|NCT02533453|566293331|FG000|Overall Study|Withdrawal by Subject|2|||
156873038|NCT00885534|566293332|FG000|Overall Study|Patient deemed ineligible|1|||
156873039|NCT02453711|566293333|FG000|Overall Study|Withdrawal by Subject|5|||
156873040|NCT02453711|566293334|FG001|Overall Study|Withdrawal by Subject|4|||
156873041|NCT02453711|566293335|FG002|Overall Study|Withdrawal by Subject|6|||
156873042|NCT02453711|566293336|FG003|Overall Study|Withdrawal by Subject|4|||
156873043|NCT02453711|566293337|FG004|Overall Study|Withdrawal by Subject|1|||
156873044|NCT02453711|566293338|FG005|Overall Study|Withdrawal by Subject|1|||
156873045|NCT02453711|566293339|FG006|Overall Study|Withdrawal by Subject|0|||
156873046|NCT02453711|566293340|FG007|Overall Study|Withdrawal by Subject|1|||
156873047|NCT02453711|566293341|FG008|Overall Study|Withdrawal by Subject|7|||
156873048|NCT02453711|566293333|FG000|Overall Study|Lost to Follow-up|5|||
156873049|NCT02453711|566293334|FG001|Overall Study|Lost to Follow-up|3|||
156873050|NCT02453711|566293335|FG002|Overall Study|Lost to Follow-up|2|||
156873051|NCT02453711|566293336|FG003|Overall Study|Lost to Follow-up|3|||
156873052|NCT02453711|566293337|FG004|Overall Study|Lost to Follow-up|1|||
156873053|NCT02453711|566293338|FG005|Overall Study|Lost to Follow-up|5|||
156873054|NCT02453711|566293339|FG006|Overall Study|Lost to Follow-up|2|||
156873055|NCT02453711|566293340|FG007|Overall Study|Lost to Follow-up|6|||
156873056|NCT02453711|566293341|FG008|Overall Study|Lost to Follow-up|6|||
156873057|NCT02453711|566293333|FG000|Overall Study|Death|0|||
156873058|NCT02453711|566293334|FG001|Overall Study|Death|0|||
156873059|NCT02453711|566293335|FG002|Overall Study|Death|0|||
156873060|NCT02453711|566293336|FG003|Overall Study|Death|0|||
156873061|NCT02453711|566293337|FG004|Overall Study|Death|0|||
156873062|NCT02453711|566293338|FG005|Overall Study|Death|0|||
156873063|NCT02453711|566293339|FG006|Overall Study|Death|1|||
156873064|NCT02453711|566293340|FG007|Overall Study|Death|0|||
156873065|NCT02453711|566293341|FG008|Overall Study|Death|0|||
156873066|NCT02453711|566293333|FG000|Overall Study|Unclassified|1|||
156873067|NCT02453711|566293334|FG001|Overall Study|Unclassified|0|||
156873068|NCT02453711|566293335|FG002|Overall Study|Unclassified|1|||
156873069|NCT02453711|566293336|FG003|Overall Study|Unclassified|0|||
156873070|NCT02453711|566293337|FG004|Overall Study|Unclassified|0|||
156873071|NCT02453711|566293338|FG005|Overall Study|Unclassified|0|||
156873072|NCT02453711|566293339|FG006|Overall Study|Unclassified|0|||
156873073|NCT02453711|566293340|FG007|Overall Study|Unclassified|0|||
156873074|NCT02453711|566293341|FG008|Overall Study|Unclassified|0|||
156873075|NCT03695367|566293344|FG000|Overall Study|Missed the Day 28 visit.|1|||
156873076|NCT03695367|566293345|FG001|Overall Study|Missed the Day 28 visit.|0|||
156873077|NCT03695367|566293344|FG000|Overall Study|Lost to Follow-up|0|||
156873078|NCT03695367|566293345|FG001|Overall Study|Lost to Follow-up|1|||
156873079|NCT03695367|566293344|FG000|Overall Study|Withdrawal by Subject|0|||
156873080|NCT03695367|566293345|FG001|Overall Study|Withdrawal by Subject|1|||
156873081|NCT03695367|566293344|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
156873082|NCT03695367|566293345|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
156873083|NCT02506244|566293346|FG000|Overall Study|Did not undergo active monitoring|458|||
156873084|NCT02506244|566293347|FG001|Overall Study|Did not undergo active monitoring|459|||
156873085|NCT02506244|566293348|FG002|Overall Study|Did not undergo active monitoring|0|||
156873086|NCT01958164|566293350|FG000|Overall Study|Adverse Event|0|||
157016270|NCT00136435|566811285|FG000|Overall Study|Adverse Event|19|||
156873087|NCT01958164|566293351|FG001|Overall Study|Adverse Event|2|||
156873088|NCT01958164|566293350|FG000|Overall Study|Lost to Follow-up|2|||
156873089|NCT01958164|566293351|FG001|Overall Study|Lost to Follow-up|3|||
156873090|NCT00740857|566293353|FG000|Overall Study|Withdrawal by Subject|1|||
156873091|NCT00740857|566293354|FG001|Overall Study|Withdrawal by Subject|0|||
156873092|NCT00740857|566293355|FG002|Overall Study|Withdrawal by Subject|0|||
156873093|NCT02963506|566293356|FG000|Double-Blind Period|Adverse Event|0|||
156873094|NCT02963506|566293357|FG001|Double-Blind Period|Adverse Event|0|||
156873095|NCT02963506|566293358|FG002|Double-Blind Period|Adverse Event|1|||
157215911|NCT00410410|567537431|FG007|Induction Period (IP)|Other|0|||
157215912|NCT00410410|567537432|FG008|Induction Period (IP)|Other|0|||
157215913|NCT00410410|567537424|FG000|Maintenance Period (MP)|Death|0|||
156873096|NCT02963506|566293359|FG003|Double-Blind Period|Adverse Event|0|||
156873097|NCT02963506|566293360|FG004|Double-Blind Period|Adverse Event|0|||
156873098|NCT02963506|566293361|FG005|Double-Blind Period|Adverse Event|0|||
156873099|NCT02963506|566293362|FG006|Double-Blind Period|Adverse Event|0|||
156873100|NCT02963506|566293363|FG007|Double-Blind Period|Adverse Event|0|||
156873101|NCT02963506|566293364|FG008|Double-Blind Period|Adverse Event|0|||
156873102|NCT02963506|566293365|FG009|Double-Blind Period|Adverse Event|0|||
156873103|NCT02963506|566293366|FG010|Double-Blind Period|Adverse Event|0|||
156873104|NCT02963506|566293367|FG011|Double-Blind Period|Adverse Event|0|||
156873105|NCT02963506|566293368|FG012|Double-Blind Period|Adverse Event|0|||
156873106|NCT02963506|566293356|FG000|Double-Blind Period|Death|0|||
156873107|NCT02963506|566293357|FG001|Double-Blind Period|Death|0|||
156873108|NCT02963506|566293358|FG002|Double-Blind Period|Death|0|||
156873109|NCT02963506|566293359|FG003|Double-Blind Period|Death|1|||
156873110|NCT02963506|566293360|FG004|Double-Blind Period|Death|0|||
156873111|NCT02963506|566293361|FG005|Double-Blind Period|Death|0|||
156873112|NCT02963506|566293362|FG006|Double-Blind Period|Death|0|||
156873113|NCT02963506|566293363|FG007|Double-Blind Period|Death|0|||
156873114|NCT02963506|566293364|FG008|Double-Blind Period|Death|0|||
156873115|NCT02963506|566293365|FG009|Double-Blind Period|Death|0|||
156873116|NCT02963506|566293366|FG010|Double-Blind Period|Death|0|||
156873117|NCT02963506|566293367|FG011|Double-Blind Period|Death|0|||
156873118|NCT02963506|566293368|FG012|Double-Blind Period|Death|0|||
156873119|NCT02963506|566293356|FG000|Double-Blind Period|Lost to Follow-up|0|||
156873120|NCT02963506|566293357|FG001|Double-Blind Period|Lost to Follow-up|1|||
156873121|NCT02963506|566293358|FG002|Double-Blind Period|Lost to Follow-up|0|||
156873122|NCT02963506|566293359|FG003|Double-Blind Period|Lost to Follow-up|0|||
156873123|NCT02963506|566293360|FG004|Double-Blind Period|Lost to Follow-up|0|||
156873124|NCT02963506|566293361|FG005|Double-Blind Period|Lost to Follow-up|0|||
156873125|NCT02963506|566293362|FG006|Double-Blind Period|Lost to Follow-up|0|||
156873126|NCT02963506|566293363|FG007|Double-Blind Period|Lost to Follow-up|0|||
156873127|NCT02963506|566293364|FG008|Double-Blind Period|Lost to Follow-up|0|||
156873128|NCT02963506|566293365|FG009|Double-Blind Period|Lost to Follow-up|0|||
156873129|NCT02963506|566293366|FG010|Double-Blind Period|Lost to Follow-up|0|||
156873130|NCT02963506|566293367|FG011|Double-Blind Period|Lost to Follow-up|0|||
156873131|NCT02963506|566293368|FG012|Double-Blind Period|Lost to Follow-up|0|||
156873132|NCT02963506|566293356|FG000|Double-Blind Period|Withdrawal by Subject|0|||
156873133|NCT02963506|566293357|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156873134|NCT02963506|566293358|FG002|Double-Blind Period|Withdrawal by Subject|1|||
156873135|NCT02963506|566293359|FG003|Double-Blind Period|Withdrawal by Subject|1|||
156873136|NCT02963506|566293360|FG004|Double-Blind Period|Withdrawal by Subject|0|||
156873137|NCT02963506|566293361|FG005|Double-Blind Period|Withdrawal by Subject|0|||
156873138|NCT02963506|566293362|FG006|Double-Blind Period|Withdrawal by Subject|0|||
156873139|NCT02963506|566293363|FG007|Double-Blind Period|Withdrawal by Subject|0|||
156873140|NCT02963506|566293364|FG008|Double-Blind Period|Withdrawal by Subject|0|||
156873141|NCT02963506|566293365|FG009|Double-Blind Period|Withdrawal by Subject|0|||
156873142|NCT02963506|566293366|FG010|Double-Blind Period|Withdrawal by Subject|0|||
156873143|NCT02963506|566293367|FG011|Double-Blind Period|Withdrawal by Subject|0|||
156873144|NCT02963506|566293368|FG012|Double-Blind Period|Withdrawal by Subject|0|||
156873145|NCT02963506|566293356|FG000|Double-Blind Period|No compliance|0|||
156873146|NCT02963506|566293357|FG001|Double-Blind Period|No compliance|1|||
156873147|NCT02963506|566293358|FG002|Double-Blind Period|No compliance|0|||
156873148|NCT02963506|566293359|FG003|Double-Blind Period|No compliance|0|||
156873149|NCT02963506|566293360|FG004|Double-Blind Period|No compliance|0|||
157016271|NCT00136435|566811285|FG000|Overall Study|Relapse|4|||
157016272|NCT00136435|566811285|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
157016273|NCT02965846|566811290|FG000|Overall Study|Lost to Follow-up|1|||
157016274|NCT02965846|566811291|FG001|Overall Study|Lost to Follow-up|0|||
157016275|NCT02965846|566811292|FG002|Overall Study|Lost to Follow-up|0|||
157016276|NCT02965846|566811290|FG000|Overall Study|Withdrawal by Subject|0|||
157016277|NCT02965846|566811291|FG001|Overall Study|Withdrawal by Subject|1|||
156873150|NCT02963506|566293361|FG005|Double-Blind Period|No compliance|0|||
156873151|NCT02963506|566293362|FG006|Double-Blind Period|No compliance|0|||
156873152|NCT02963506|566293363|FG007|Double-Blind Period|No compliance|0|||
156873153|NCT02963506|566293364|FG008|Double-Blind Period|No compliance|0|||
157016278|NCT02965846|566811292|FG002|Overall Study|Withdrawal by Subject|0|||
157016279|NCT02965846|566811290|FG000|Overall Study|Study Terminated By Sponsor|4|||
157016280|NCT02965846|566811291|FG001|Overall Study|Study Terminated By Sponsor|4|||
156792042|NCT01316900|565991076|FG002|Overall Study|Protocol Violation|4|||
156873154|NCT02963506|566293365|FG009|Double-Blind Period|No compliance|0|||
156873155|NCT02963506|566293366|FG010|Double-Blind Period|No compliance|0|||
156873156|NCT02963506|566293367|FG011|Double-Blind Period|No compliance|0|||
156873157|NCT02963506|566293368|FG012|Double-Blind Period|No compliance|0|||
156873158|NCT02963506|566293356|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873159|NCT02963506|566293357|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
156873160|NCT02963506|566293358|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873161|NCT02963506|566293359|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873162|NCT02963506|566293360|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873163|NCT02963506|566293361|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873164|NCT02963506|566293362|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873165|NCT02963506|566293363|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873166|NCT02963506|566293364|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873167|NCT02963506|566293365|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873168|NCT02963506|566293366|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873169|NCT02963506|566293367|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873170|NCT02963506|566293368|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
156873171|NCT02963506|566293356|FG000|Dose-Blind Period|Adverse Event|0|||
156873172|NCT02963506|566293357|FG001|Dose-Blind Period|Adverse Event|0|||
156873173|NCT02963506|566293358|FG002|Dose-Blind Period|Adverse Event|0|||
156873174|NCT02963506|566293359|FG003|Dose-Blind Period|Adverse Event|0|||
156873175|NCT02963506|566293360|FG004|Dose-Blind Period|Adverse Event|0|||
156873176|NCT02963506|566293361|FG005|Dose-Blind Period|Adverse Event|1|||
156873177|NCT02963506|566293362|FG006|Dose-Blind Period|Adverse Event|3|||
156792043|NCT01316900|565991077|FG003|Overall Study|Protocol Violation|0|||
156792044|NCT01316900|565991074|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
156792045|NCT01316900|565991075|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
156792046|NCT01316900|565991076|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
156792047|NCT01316900|565991077|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
156873178|NCT02963506|566293363|FG007|Dose-Blind Period|Adverse Event|2|||
156873179|NCT02963506|566293364|FG008|Dose-Blind Period|Adverse Event|2|||
156873180|NCT02963506|566293365|FG009|Dose-Blind Period|Adverse Event|2|||
156873181|NCT02963506|566293366|FG010|Dose-Blind Period|Adverse Event|1|||
156873182|NCT02963506|566293367|FG011|Dose-Blind Period|Adverse Event|1|||
156873183|NCT02963506|566293368|FG012|Dose-Blind Period|Adverse Event|6|||
156873184|NCT02963506|566293356|FG000|Dose-Blind Period|Lack of Efficacy|0|||
156873185|NCT02963506|566293357|FG001|Dose-Blind Period|Lack of Efficacy|0|||
156792048|NCT01316900|565991074|FG000|Overall Study|Lost to Follow-up|1|||
156792049|NCT01316900|565991075|FG001|Overall Study|Lost to Follow-up|0|||
156792050|NCT01316900|565991076|FG002|Overall Study|Lost to Follow-up|1|||
156792051|NCT01316900|565991077|FG003|Overall Study|Lost to Follow-up|1|||
156792052|NCT01316900|565991074|FG000|Overall Study|Withdrawal by Subject|7|||
156792053|NCT01316900|565991075|FG001|Overall Study|Withdrawal by Subject|8|||
156792054|NCT01316900|565991076|FG002|Overall Study|Withdrawal by Subject|6|||
156792055|NCT01316900|565991077|FG003|Overall Study|Withdrawal by Subject|9|||
156792056|NCT00562861|565991078|FG000|Overall Study|Adverse Event|1|||
156792057|NCT00562861|565991079|FG001|Overall Study|Adverse Event|1|||
156792058|NCT00562861|565991078|FG000|Overall Study|Lack of Efficacy|5|||
156792059|NCT00562861|565991079|FG001|Overall Study|Lack of Efficacy|5|||
156792060|NCT00562861|565991078|FG000|Overall Study|noncompliance, moved|7|||
156792061|NCT00562861|565991079|FG001|Overall Study|noncompliance, moved|2|||
156792062|NCT00562861|565991078|FG000|Overall Study|Lost to Follow-up|7|||
156792063|NCT00562861|565991079|FG001|Overall Study|Lost to Follow-up|3|||
156792064|NCT00655356|565991080|FG000|Overall Study|Withdrawal by Subject|3|||
156792065|NCT00655356|565991081|FG001|Overall Study|Withdrawal by Subject|4|||
156792066|NCT00655356|565991080|FG000|Overall Study|Sponsor Request|10|||
156792067|NCT00655356|565991081|FG001|Overall Study|Sponsor Request|4|||
156792068|NCT00655356|565991080|FG000|Overall Study|Adverse Event|1|||
156792069|NCT00655356|565991081|FG001|Overall Study|Adverse Event|1|||
156873186|NCT02963506|566293358|FG002|Dose-Blind Period|Lack of Efficacy|0|||
156873187|NCT02963506|566293359|FG003|Dose-Blind Period|Lack of Efficacy|0|||
156873188|NCT02963506|566293360|FG004|Dose-Blind Period|Lack of Efficacy|0|||
156873189|NCT02963506|566293361|FG005|Dose-Blind Period|Lack of Efficacy|0|||
156873190|NCT02963506|566293362|FG006|Dose-Blind Period|Lack of Efficacy|0|||
156873191|NCT02963506|566293363|FG007|Dose-Blind Period|Lack of Efficacy|1|||
156873192|NCT02963506|566293364|FG008|Dose-Blind Period|Lack of Efficacy|0|||
157016281|NCT02965846|566811292|FG002|Overall Study|Study Terminated By Sponsor|0|||
157016282|NCT02965846|566811290|FG000|Overall Study|Participants not randomized|0|||
157016283|NCT02965846|566811291|FG001|Overall Study|Participants not randomized|0|||
157016284|NCT02965846|566811292|FG002|Overall Study|Participants not randomized|33|||
157016285|NCT00539734|566811293|FG000|Overall Study|Protocol Violation|1|||
157016286|NCT01017146|566811294|FG000|Overall Study|Adverse Event|11|||
156792070|NCT00655356|565991080|FG000|Overall Study|Protocol Violation|2|||
156792071|NCT00655356|565991081|FG001|Overall Study|Protocol Violation|1|||
157016287|NCT01017146|566811295|FG001|Overall Study|Adverse Event|1|||
156873193|NCT02963506|566293365|FG009|Dose-Blind Period|Lack of Efficacy|1|||
156873194|NCT02963506|566293366|FG010|Dose-Blind Period|Lack of Efficacy|0|||
157126325|NCT01582308|567212481|FG006|Period 4|Physician Decision|0|||
157126326|NCT01582308|567212482|FG007|Period 4|Physician Decision|0|||
157126327|NCT01582308|567212483|FG008|Period 4|Physician Decision|0|||
157126328|NCT01582308|567212484|FG009|Period 4|Physician Decision|1|||
157126329|NCT00684957|567212485|FG000|Overall Study|Withdrawal by Subject|1|||
157126330|NCT00684957|567212486|FG001|Overall Study|Withdrawal by Subject|1|||
157126331|NCT00684957|567212485|FG000|Overall Study|Lost to Follow-up|1|||
157126332|NCT00684957|567212486|FG001|Overall Study|Lost to Follow-up|0|||
157126333|NCT04341948|567212487|FG000|Overall Study|Adverse Event|0|||
157126334|NCT04341948|567212488|FG001|Overall Study|Adverse Event|1|||
157126335|NCT04341948|567212487|FG000|Overall Study|Lost to Follow-up|6|||
157126336|NCT04341948|567212488|FG001|Overall Study|Lost to Follow-up|1|||
157126337|NCT04341948|567212487|FG000|Overall Study|Physician Decision|1|||
157126338|NCT04341948|567212488|FG001|Overall Study|Physician Decision|2|||
157126339|NCT04341948|567212487|FG000|Overall Study|Withdrawal by Participant|6|||
157126340|NCT04341948|567212488|FG001|Overall Study|Withdrawal by Participant|3|||
156709395|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
156709396|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
156709397|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
156709398|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
156709399|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
156709400|NCT02952586|565680609|FG000|CRT for IMRT (63 Days)|Other|1|||
156709401|NCT02952586|565680610|FG001|CRT for IMRT (63 Days)|Other|0|||
156709402|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Death|17|||
156709403|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Death|11|||
156709404|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
156709405|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
156709406|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
157126341|NCT04341948|567212487|FG000|Overall Study|Lack of compliance by Participant|1|||
157126342|NCT04341948|567212488|FG001|Overall Study|Lack of compliance by Participant|0|||
157126343|NCT03406897|567212489|FG000|Overall Study|Lost to Follow-up|1|||
157126344|NCT03406897|567212490|FG001|Overall Study|Lost to Follow-up|2|||
157126345|NCT03406897|567212489|FG000|Overall Study|Withdrawal by Subject|4|||
157126346|NCT03406897|567212490|FG001|Overall Study|Withdrawal by Subject|4|||
157126347|NCT03406897|567212489|FG000|Overall Study|Physician Decision|0|||
157126348|NCT03406897|567212490|FG001|Overall Study|Physician Decision|1|||
157126349|NCT03064763|567214106|FG000|Overall Study|Lost to Follow-up|1|||
157126350|NCT03064763|567214106|FG000|Overall Study|Death|8|||
157126351|NCT02624492|567214111|FG000|Overall Study|Adverse Event|2|||
157126352|NCT02624492|567214112|FG001|Overall Study|Adverse Event|2|||
157126353|NCT02624492|567214113|FG002|Overall Study|Adverse Event|2|||
157126354|NCT02624492|567214111|FG000|Overall Study|Progressive disease|0|||
157126355|NCT02624492|567214112|FG001|Overall Study|Progressive disease|2|||
157126356|NCT02624492|567214113|FG002|Overall Study|Progressive disease|3|||
157126357|NCT00343512|567214119|FG000|Overall Study|Withdrawal by Subject|2|||
157126358|NCT00197054|567214120|FG000|Overall Study|Withdrawal by Subject|9|||
157126359|NCT00197054|567214121|FG001|Overall Study|Withdrawal by Subject|3|||
157126360|NCT00197054|567214122|FG002|Overall Study|Withdrawal by Subject|3|||
157126361|NCT00197054|567214120|FG000|Overall Study|Moved from area|7|||
157126362|NCT00197054|567214121|FG001|Overall Study|Moved from area|14|||
156709407|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
156792072|NCT00655356|565991080|FG000|Overall Study|Other Reason|1|||
156792073|NCT00655356|565991081|FG001|Overall Study|Other Reason|0|||
156792074|NCT01684033|565991082|FG000|Period 1, First 30 Days|Adverse Event|1|||
156792075|NCT01684033|565991083|FG001|Period 1, First 30 Days|Adverse Event|1|||
156792076|NCT01684033|565991082|FG000|Period 1, First 30 Days|Noncompliance|1|||
156792077|NCT01684033|565991083|FG001|Period 1, First 30 Days|Noncompliance|0|||
156792078|NCT01684033|565991082|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
156792079|NCT01684033|565991083|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
156792080|NCT01684033|565991082|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
156792081|NCT01684033|565991083|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
156792082|NCT01684033|565991082|FG000|Period 2, Second 30 Days|Adverse Event|1|||
156792083|NCT01684033|565991083|FG001|Period 2, Second 30 Days|Adverse Event|0|||
156792084|NCT01093573|565991088|FG000|Overall Study|Physician Decision|0|||
156792085|NCT01093573|565991089|FG001|Overall Study|Physician Decision|0|||
156792086|NCT01093573|565991090|FG002|Overall Study|Physician Decision|1|||
156792087|NCT01093573|565991088|FG000|Overall Study|Insurance Denied|0|||
156792088|NCT01093573|565991089|FG001|Overall Study|Insurance Denied|0|||
156792089|NCT01093573|565991090|FG002|Overall Study|Insurance Denied|1|||
156792090|NCT05626686|565991091|FG000|Overall Study|Protocol Violation|3|||
156792091|NCT05626686|565991091|FG000|Overall Study|Withdrawal by Subject|3|||
156792092|NCT02496156|565991092|FG000|Overall Study|Lost to Follow-up|5|||
157126363|NCT00197054|567214122|FG002|Overall Study|Moved from area|9|||
157126364|NCT00197054|567214120|FG000|Overall Study|Lost to Follow-up|1|||
157126365|NCT00197054|567214121|FG001|Overall Study|Lost to Follow-up|4|||
157126366|NCT00197054|567214122|FG002|Overall Study|Lost to Follow-up|0|||
157126367|NCT01163786|567214123|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
157126368|NCT01163786|567214123|FG000|Treatment With Bortezomib|Adverse Event|2|||
157126369|NCT01163786|567214123|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
157126370|NCT01699087|567214127|FG000|Overall Study|Lost to Follow-up|7|||
157126371|NCT01699087|567214127|FG000|Overall Study|Screen failure (prior to treatment)|15|||
157126372|NCT01699087|567214127|FG000|Overall Study|Unable to make future visits|2|||
157126373|NCT02167945|567214128|FG000|Overall Study|Adverse Event|16|||
157126374|NCT02167945|567214128|FG000|Overall Study|Withdrew Consent|42|||
157126375|NCT02167945|567214128|FG000|Overall Study|Lost to Follow-up|122|||
157126376|NCT02167945|567214128|FG000|Overall Study|COVID-19 logistical restrictions|6|||
157126377|NCT02167945|567214128|FG000|Overall Study|Other, not specified|63|||
157126378|NCT00132730|567214129|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
157126379|NCT00132730|567214130|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
157126380|NCT00132730|567214131|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
157126381|NCT00132730|567214132|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
157126382|NCT00132730|567214133|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
157126383|NCT00132730|567214134|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
157126384|NCT00132730|567214129|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
157126385|NCT00132730|567214130|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
157126386|NCT00132730|567214131|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
157126387|NCT00132730|567214132|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
157126388|NCT00132730|567214133|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
157126389|NCT00132730|567214134|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
157126390|NCT00132730|567214129|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
157126391|NCT00132730|567214130|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
157126392|NCT00132730|567214131|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
157126393|NCT00132730|567214132|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
157126394|NCT00132730|567214133|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
157215914|NCT00410410|567537425|FG001|Maintenance Period (MP)|Death|0|||
156709408|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
156709409|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
156709410|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
156709411|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
156709412|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
156709413|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
156709414|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
156709415|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
156709416|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
156709417|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
156709418|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Other|2|||
156709419|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Other|1|||
156709420|NCT02952586|565680609|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
156709421|NCT02952586|565680610|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
156709422|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Death|12|||
156709423|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Death|10|||
156709424|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
156709425|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
156709426|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
156709427|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
156709428|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Other|7|||
156709429|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Other|5|||
156709430|NCT02952586|565680609|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
156709431|NCT02952586|565680610|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
156709432|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Death|51|||
156709433|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Death|31|||
156709434|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
156709435|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
156709436|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
156709437|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
156709438|NCT02952586|565680609|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
156709439|NCT02952586|565680610|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
156709440|NCT00492778|565680611|FG000|Overall Study|Ineligible by Pathology Review|8|||
156709441|NCT00492778|565680612|FG001|Overall Study|Ineligible by Pathology Review|1|||
156709442|NCT03717012|565680625|FG000|Overall Study|Due to trial termination|1|||
156709443|NCT03717012|565680626|FG001|Overall Study|Due to trial termination|2|||
156709444|NCT03717012|565680625|FG000|Overall Study|Protocol Violation|0|||
156709445|NCT03717012|565680626|FG001|Overall Study|Protocol Violation|2|||
157016288|NCT01017146|566811294|FG000|Overall Study|Lost to Follow-up|14|||
157016289|NCT01017146|566811295|FG001|Overall Study|Lost to Follow-up|14|||
156792093|NCT02496156|565991093|FG001|Overall Study|Lost to Follow-up|0|||
156792094|NCT02496156|565991092|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
156792095|NCT02496156|565991093|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
156792096|NCT00289900|565991094|FG000|Overall Study|Adverse Event|28|||
156792097|NCT00289900|565991095|FG001|Overall Study|Adverse Event|40|||
156792098|NCT00289900|565991096|FG002|Overall Study|Adverse Event|13|||
156792099|NCT00289900|565991097|FG003|Overall Study|Adverse Event|19|||
156792100|NCT00289900|565991098|FG004|Overall Study|Adverse Event|20|||
157016290|NCT01017146|566811294|FG000|Overall Study|Noncompliance with Study Product|1|||
156709446|NCT03717012|565680625|FG000|Overall Study|Adverse Event|0|||
156709447|NCT03717012|565680626|FG001|Overall Study|Adverse Event|1|||
156709448|NCT03717012|565680625|FG000|Overall Study|Lung transplant|0|||
156709449|NCT03717012|565680626|FG001|Overall Study|Lung transplant|1|||
156709450|NCT00658879|565680627|FG000|Overall Study|Protocol Violation|1|||
156709451|NCT02640690|565680628|FG000|Overall Study|Lost to Follow-up|7|||
156709452|NCT02640690|565680629|FG001|Overall Study|Lost to Follow-up|7|||
156709453|NCT02640690|565680628|FG000|Overall Study|Withdrawal by Subject|16|||
156709454|NCT02640690|565680629|FG001|Overall Study|Withdrawal by Subject|20|||
156709455|NCT02640690|565680628|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
156709456|NCT02640690|565680629|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
156709457|NCT01118975|565680630|FG000|Overall Study|Adverse Event|0|||
156709458|NCT01118975|565680631|FG001|Overall Study|Adverse Event|1|||
156709459|NCT01645787|565680632|FG000|Washout (2 Weeks)|Adverse Event|1|||
156709460|NCT01645787|565680633|FG001|Washout (2 Weeks)|Adverse Event|0|||
156709461|NCT04315506|565680635|FG000|Overall Study|Lost to Follow-up|74|||
156709462|NCT04315506|565680636|FG001|Overall Study|Lost to Follow-up|82|||
156709463|NCT04315506|565680635|FG000|Overall Study|Withdrawal by Subject|8|||
156709464|NCT04315506|565680636|FG001|Overall Study|Withdrawal by Subject|8|||
156709465|NCT04315506|565680635|FG000|Overall Study|Physician Decision|0|||
156709466|NCT04315506|565680636|FG001|Overall Study|Physician Decision|1|||
156709467|NCT02661217|565680641|FG000|Overall Study|Physician Decision|12|||
156709468|NCT02661217|565680642|FG001|Overall Study|Physician Decision|15|||
156709469|NCT02661217|565680641|FG000|Overall Study|Lost to Follow-up|1|||
156709470|NCT02661217|565680642|FG001|Overall Study|Lost to Follow-up|4|||
156709471|NCT02661217|565680641|FG000|Overall Study|Protocol Deviation|0|||
156709472|NCT02661217|565680642|FG001|Overall Study|Protocol Deviation|4|||
156709473|NCT02661217|565680641|FG000|Overall Study|Non-compliance with study treatment|5|||
156709474|NCT02661217|565680642|FG001|Overall Study|Non-compliance with study treatment|5|||
156709475|NCT02661217|565680641|FG000|Overall Study|Death|21|||
156709476|NCT02661217|565680642|FG001|Overall Study|Death|15|||
156709477|NCT02661217|565680641|FG000|Overall Study|Adverse Event|10|||
156709478|NCT02661217|565680642|FG001|Overall Study|Adverse Event|8|||
156709479|NCT02661217|565680641|FG000|Overall Study|Withdrawal by Subject|15|||
156709480|NCT02661217|565680642|FG001|Overall Study|Withdrawal by Subject|19|||
156709481|NCT02661217|565680641|FG000|Overall Study|Did not enter follow-up epoch|7|||
156709482|NCT02661217|565680642|FG001|Overall Study|Did not enter follow-up epoch|10|||
156709483|NCT02661217|565680641|FG000|Overall Study|Death - no study drug received|1|||
156709484|NCT02661217|565680642|FG001|Overall Study|Death - no study drug received|2|||
156709485|NCT02661217|565680641|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
156709486|NCT02661217|565680642|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
156709487|NCT02075515|565680643|FG000|Overall Study|Serious Adverse Event|1|||
156709488|NCT02075515|565680644|FG001|Overall Study|Serious Adverse Event|1|||
156709489|NCT02075515|565680645|FG002|Overall Study|Serious Adverse Event|1|||
156709490|NCT02075515|565680643|FG000|Overall Study|Non-Serious Adverse Event|0|||
156709491|NCT02075515|565680644|FG001|Overall Study|Non-Serious Adverse Event|1|||
156709492|NCT02075515|565680645|FG002|Overall Study|Non-Serious Adverse Event|0|||
156709493|NCT02075515|565680643|FG000|Overall Study|Withdrawal by Subject|2|||
156709494|NCT02075515|565680644|FG001|Overall Study|Withdrawal by Subject|0|||
156709495|NCT02075515|565680645|FG002|Overall Study|Withdrawal by Subject|1|||
156709496|NCT02075515|565680643|FG000|Overall Study|Lost to Follow-up|1|||
156709497|NCT02075515|565680644|FG001|Overall Study|Lost to Follow-up|3|||
156709498|NCT02075515|565680645|FG002|Overall Study|Lost to Follow-up|6|||
156709499|NCT01098474|565680646|FG000|Active Phase|Other|0|||
156709500|NCT01098474|565680647|FG001|Active Phase|Other|0|||
156709501|NCT01098474|565680648|FG002|Active Phase|Other|3|||
156709502|NCT01098474|565680649|FG003|Active Phase|Other|0|||
156709503|NCT01098474|565680650|FG004|Active Phase|Other|0|||
156709504|NCT01098474|565680651|FG005|Active Phase|Other|0|||
156709505|NCT01098474|565680646|FG000|Active Phase|Withdrawal by Subject|1|||
156709506|NCT01098474|565680647|FG001|Active Phase|Withdrawal by Subject|1|||
156709507|NCT01098474|565680648|FG002|Active Phase|Withdrawal by Subject|2|||
156709508|NCT01098474|565680649|FG003|Active Phase|Withdrawal by Subject|0|||
156709509|NCT01098474|565680650|FG004|Active Phase|Withdrawal by Subject|0|||
156709510|NCT01098474|565680651|FG005|Active Phase|Withdrawal by Subject|0|||
156709511|NCT01098474|565680646|FG000|Active Phase|Lost to Follow-up|1|||
157215915|NCT00410410|567537426|FG002|Maintenance Period (MP)|Death|0|||
156709512|NCT01098474|565680647|FG001|Active Phase|Lost to Follow-up|0|||
156709513|NCT01098474|565680648|FG002|Active Phase|Lost to Follow-up|0|||
156873195|NCT02963506|566293367|FG011|Dose-Blind Period|Lack of Efficacy|0|||
156873196|NCT02963506|566293368|FG012|Dose-Blind Period|Lack of Efficacy|0|||
156873197|NCT02963506|566293356|FG000|Dose-Blind Period|Lost to Follow-up|0|||
156873198|NCT02963506|566293357|FG001|Dose-Blind Period|Lost to Follow-up|0|||
157215916|NCT00410410|567537427|FG003|Maintenance Period (MP)|Death|0|||
157215917|NCT00410410|567537428|FG004|Maintenance Period (MP)|Death|0|||
157215918|NCT00410410|567537429|FG005|Maintenance Period (MP)|Death|0|||
157215919|NCT00410410|567537430|FG006|Maintenance Period (MP)|Death|1|||
157215920|NCT00410410|567537431|FG007|Maintenance Period (MP)|Death|0|||
157215921|NCT00410410|567537432|FG008|Maintenance Period (MP)|Death|0|||
157215922|NCT00410410|567537424|FG000|Maintenance Period (MP)|Adverse Event|0|||
157215923|NCT00410410|567537425|FG001|Maintenance Period (MP)|Adverse Event|0|||
157215924|NCT00410410|567537426|FG002|Maintenance Period (MP)|Adverse Event|0|||
157215925|NCT00410410|567537427|FG003|Maintenance Period (MP)|Adverse Event|0|||
156709514|NCT01098474|565680649|FG003|Active Phase|Lost to Follow-up|0|||
156709515|NCT01098474|565680650|FG004|Active Phase|Lost to Follow-up|0|||
156873199|NCT02963506|566293358|FG002|Dose-Blind Period|Lost to Follow-up|0|||
156873200|NCT02963506|566293359|FG003|Dose-Blind Period|Lost to Follow-up|0|||
156873201|NCT02963506|566293360|FG004|Dose-Blind Period|Lost to Follow-up|0|||
156873202|NCT02963506|566293361|FG005|Dose-Blind Period|Lost to Follow-up|1|||
157016291|NCT01017146|566811295|FG001|Overall Study|Noncompliance with Study Product|1|||
157016292|NCT01017146|566811294|FG000|Overall Study|Withdrawal by Subject|32|||
157016293|NCT01017146|566811295|FG001|Overall Study|Withdrawal by Subject|16|||
157016294|NCT01017146|566811294|FG000|Overall Study|Relocation|0|||
157016295|NCT01017146|566811295|FG001|Overall Study|Relocation|4|||
157215926|NCT00410410|567537428|FG004|Maintenance Period (MP)|Adverse Event|0|||
156709516|NCT01098474|565680651|FG005|Active Phase|Lost to Follow-up|0|||
156709517|NCT01098474|565680646|FG000|Follow Up Phase|Travelled out of study area|0|||
156709518|NCT01098474|565680647|FG001|Follow Up Phase|Travelled out of study area|0|||
156709519|NCT01098474|565680648|FG002|Follow Up Phase|Travelled out of study area|0|||
156709520|NCT01098474|565680649|FG003|Follow Up Phase|Travelled out of study area|0|||
156709521|NCT01098474|565680650|FG004|Follow Up Phase|Travelled out of study area|1|||
156709522|NCT01098474|565680651|FG005|Follow Up Phase|Travelled out of study area|0|||
156709523|NCT01098474|565680646|FG000|Follow Up Phase|Other|0|||
156709524|NCT01098474|565680647|FG001|Follow Up Phase|Other|0|||
156709525|NCT01098474|565680648|FG002|Follow Up Phase|Other|0|||
156709526|NCT01098474|565680649|FG003|Follow Up Phase|Other|0|||
156709527|NCT01098474|565680650|FG004|Follow Up Phase|Other|0|||
156709528|NCT01098474|565680651|FG005|Follow Up Phase|Other|4|||
156709529|NCT01098474|565680646|FG000|Follow Up Phase|Withdrawal by Subject|0|||
156709530|NCT01098474|565680647|FG001|Follow Up Phase|Withdrawal by Subject|0|||
156709531|NCT01098474|565680648|FG002|Follow Up Phase|Withdrawal by Subject|0|||
156709532|NCT01098474|565680649|FG003|Follow Up Phase|Withdrawal by Subject|2|||
156709533|NCT01098474|565680650|FG004|Follow Up Phase|Withdrawal by Subject|0|||
156709534|NCT01098474|565680651|FG005|Follow Up Phase|Withdrawal by Subject|1|||
156709535|NCT01098474|565680646|FG000|Follow Up Phase|Lost to Follow-up|0|||
156709536|NCT01098474|565680647|FG001|Follow Up Phase|Lost to Follow-up|0|||
156709537|NCT01098474|565680648|FG002|Follow Up Phase|Lost to Follow-up|0|||
156709538|NCT01098474|565680649|FG003|Follow Up Phase|Lost to Follow-up|0|||
156709539|NCT01098474|565680650|FG004|Follow Up Phase|Lost to Follow-up|1|||
156709540|NCT01098474|565680651|FG005|Follow Up Phase|Lost to Follow-up|0|||
156709541|NCT05292183|565682306|FG000|Overall Study|Adverse Event|1|||
156709542|NCT03922529|565682311|FG000|Overall Study|Withdrawal by Subject|13|||
156709543|NCT03922529|565682312|FG001|Overall Study|Withdrawal by Subject|12|||
156709544|NCT03922529|565682311|FG000|Overall Study|Death|7|||
157016296|NCT01017146|566811294|FG000|Overall Study|Pregnancy|2|||
157016297|NCT01017146|566811295|FG001|Overall Study|Pregnancy|1|||
157016298|NCT01017146|566811294|FG000|Overall Study|Protocol Violation|2|||
157016299|NCT01017146|566811295|FG001|Overall Study|Protocol Violation|0|||
157016300|NCT01017146|566811294|FG000|Overall Study|Took Excluded Medication|2|||
157016301|NCT01017146|566811295|FG001|Overall Study|Took Excluded Medication|0|||
157016302|NCT01017146|566811294|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
157016303|NCT01017146|566811295|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
157016304|NCT01017146|566811294|FG000|Overall Study|Change in Work Situation|1|||
157016305|NCT01017146|566811295|FG001|Overall Study|Change in Work Situation|0|||
157016306|NCT00087139|566811296|FG000|Overall Study|Adverse Event|18|||
157016307|NCT00087139|566811297|FG001|Overall Study|Adverse Event|17|||
157016308|NCT00087139|566811298|FG002|Overall Study|Adverse Event|13|||
157016309|NCT00087139|566811296|FG000|Overall Study|Death|2|||
157215927|NCT00410410|567537429|FG005|Maintenance Period (MP)|Adverse Event|0|||
156709545|NCT03922529|565682312|FG001|Overall Study|Death|12|||
156709546|NCT03922529|565682311|FG000|Overall Study|Lost to Follow-up|12|||
157016310|NCT00087139|566811297|FG001|Overall Study|Death|1|||
157016311|NCT00087139|566811298|FG002|Overall Study|Death|0|||
157016312|NCT00087139|566811296|FG000|Overall Study|Withdrawal by Subject|3|||
157016313|NCT00087139|566811297|FG001|Overall Study|Withdrawal by Subject|2|||
156709547|NCT03922529|565682312|FG001|Overall Study|Lost to Follow-up|19|||
156709548|NCT03922529|565682311|FG000|Overall Study|Adverse Event|1|||
156709549|NCT03922529|565682312|FG001|Overall Study|Adverse Event|0|||
156709550|NCT03922529|565682311|FG000|Overall Study|Death after withdrawal|1|||
156709551|NCT03922529|565682312|FG001|Overall Study|Death after withdrawal|0|||
156709552|NCT03922529|565682311|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
156709553|NCT03922529|565682312|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
156873203|NCT02963506|566293362|FG006|Dose-Blind Period|Lost to Follow-up|0|||
156873204|NCT02963506|566293363|FG007|Dose-Blind Period|Lost to Follow-up|0|||
156873205|NCT02963506|566293364|FG008|Dose-Blind Period|Lost to Follow-up|1|||
156873206|NCT02963506|566293365|FG009|Dose-Blind Period|Lost to Follow-up|0|||
156873207|NCT02963506|566293366|FG010|Dose-Blind Period|Lost to Follow-up|0|||
156873208|NCT02963506|566293367|FG011|Dose-Blind Period|Lost to Follow-up|1|||
156873209|NCT02963506|566293368|FG012|Dose-Blind Period|Lost to Follow-up|0|||
156873210|NCT02963506|566293356|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
156873211|NCT02963506|566293357|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
156873212|NCT02963506|566293358|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
156873213|NCT02963506|566293359|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
156873214|NCT02963506|566293360|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
156873215|NCT02963506|566293361|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
156873216|NCT02963506|566293362|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
156873217|NCT02963506|566293363|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
156873218|NCT02963506|566293364|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
156873219|NCT02963506|566293365|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
156873220|NCT02963506|566293366|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
156873221|NCT02963506|566293367|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
156873222|NCT02963506|566293368|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
156873223|NCT02963506|566293356|FG000|Dose-Blind Period|Sponsor decision|0|||
156873224|NCT02963506|566293357|FG001|Dose-Blind Period|Sponsor decision|0|||
156873225|NCT02963506|566293358|FG002|Dose-Blind Period|Sponsor decision|0|||
156873226|NCT02963506|566293359|FG003|Dose-Blind Period|Sponsor decision|0|||
156873227|NCT02963506|566293360|FG004|Dose-Blind Period|Sponsor decision|0|||
156873228|NCT02963506|566293361|FG005|Dose-Blind Period|Sponsor decision|1|||
156873229|NCT02963506|566293362|FG006|Dose-Blind Period|Sponsor decision|0|||
156873230|NCT02963506|566293363|FG007|Dose-Blind Period|Sponsor decision|0|||
156873231|NCT02963506|566293364|FG008|Dose-Blind Period|Sponsor decision|0|||
156873232|NCT02963506|566293365|FG009|Dose-Blind Period|Sponsor decision|0|||
156873233|NCT02963506|566293366|FG010|Dose-Blind Period|Sponsor decision|0|||
156873234|NCT02963506|566293367|FG011|Dose-Blind Period|Sponsor decision|0|||
156873235|NCT02963506|566293368|FG012|Dose-Blind Period|Sponsor decision|0|||
156873236|NCT02963506|566293356|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873237|NCT02963506|566293357|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873238|NCT02963506|566293358|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873239|NCT02963506|566293359|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873240|NCT02963506|566293360|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873241|NCT02963506|566293361|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873242|NCT02963506|566293362|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873243|NCT02963506|566293363|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873244|NCT02963506|566293364|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873245|NCT02963506|566293365|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873246|NCT02963506|566293366|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873247|NCT02963506|566293367|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
156873248|NCT02963506|566293368|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
156873249|NCT00354432|566293371|FG000|Overall Study|Adverse Event|3|||
157016314|NCT00087139|566811298|FG002|Overall Study|Withdrawal by Subject|2|||
156709554|NCT03922529|565682311|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
156709555|NCT03922529|565682312|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
156709556|NCT03355469|565682315|FG000|Overall Study|COVID-19|3|||
156709557|NCT03355469|565682316|FG001|Overall Study|COVID-19|2|||
156709558|NCT03355469|565682317|FG002|Overall Study|COVID-19|3|||
156709559|NCT03355469|565682318|FG003|Overall Study|COVID-19|3|||
156709560|NCT03355469|565682315|FG000|Overall Study|Lost to Follow-up|1|||
156709561|NCT03355469|565682316|FG001|Overall Study|Lost to Follow-up|0|||
156709562|NCT03355469|565682317|FG002|Overall Study|Lost to Follow-up|1|||
156709563|NCT03355469|565682318|FG003|Overall Study|Lost to Follow-up|0|||
156709564|NCT03355469|565682315|FG000|Overall Study|Withdrawal by Subject|2|||
156709565|NCT03355469|565682316|FG001|Overall Study|Withdrawal by Subject|1|||
156709566|NCT03355469|565682317|FG002|Overall Study|Withdrawal by Subject|0|||
156709567|NCT03355469|565682318|FG003|Overall Study|Withdrawal by Subject|3|||
156709568|NCT02731638|565682319|FG000|Overall Study|Lost to Follow-up|6|||
156709569|NCT02731638|565682320|FG001|Overall Study|Lost to Follow-up|9|||
156709570|NCT04158245|565682321|FG000|Overall Study|Lost to Follow-up|1|||
156709571|NCT02291510|565682322|FG000|Overall Study|Adverse Event|0|||
156709572|NCT02291510|565682323|FG001|Overall Study|Adverse Event|0|||
156873250|NCT00354432|566293372|FG001|Overall Study|Adverse Event|1|||
156873251|NCT00354432|566293373|FG002|Overall Study|Adverse Event|5|||
156873252|NCT00354432|566293374|FG003|Overall Study|Adverse Event|5|||
156873253|NCT00354432|566293371|FG000|Overall Study|Off/Toxicity|3|||
156873254|NCT00354432|566293372|FG001|Overall Study|Off/Toxicity|7|||
156873255|NCT00354432|566293373|FG002|Overall Study|Off/Toxicity|5|||
156873256|NCT00354432|566293374|FG003|Overall Study|Off/Toxicity|5|||
156873257|NCT03843541|566293375|FG000|Overall Study|Adverse Event|4|||
156873258|NCT03843541|566293376|FG001|Overall Study|Adverse Event|2|||
156873259|NCT03843541|566293377|FG002|Overall Study|Adverse Event|3|||
156873260|NCT03843541|566293375|FG000|Overall Study|Death|1|||
156873261|NCT03843541|566293376|FG001|Overall Study|Death|0|||
156873262|NCT03843541|566293377|FG002|Overall Study|Death|0|||
156873263|NCT03843541|566293375|FG000|Overall Study|Lack of adherence to study medication|0|||
156873264|NCT03843541|566293376|FG001|Overall Study|Lack of adherence to study medication|0|||
156873265|NCT03843541|566293377|FG002|Overall Study|Lack of adherence to study medication|1|||
156873266|NCT03843541|566293375|FG000|Overall Study|Physician Decision|1|||
156873267|NCT03843541|566293376|FG001|Overall Study|Physician Decision|2|||
156873268|NCT03843541|566293377|FG002|Overall Study|Physician Decision|2|||
156873269|NCT03843541|566293375|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
156873270|NCT03843541|566293376|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
156873271|NCT03843541|566293377|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
156873272|NCT03843541|566293375|FG000|Overall Study|Withdrawal by Subject|6|||
156873273|NCT03843541|566293376|FG001|Overall Study|Withdrawal by Subject|9|||
156873274|NCT03843541|566293377|FG002|Overall Study|Withdrawal by Subject|7|||
156873275|NCT03843541|566293375|FG000|Overall Study|Administration of rescue mucolytic|0|||
156873276|NCT03843541|566293376|FG001|Overall Study|Administration of rescue mucolytic|0|||
156873277|NCT03843541|566293377|FG002|Overall Study|Administration of rescue mucolytic|1|||
156873278|NCT03843541|566293375|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
156873279|NCT03843541|566293376|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
156873280|NCT03843541|566293377|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
156873281|NCT02930018|566293379|FG000|Overall Study|Lost to Follow-up|1|||
156873282|NCT02930018|566293380|FG001|Overall Study|Lost to Follow-up|1|||
156873283|NCT02930018|566293379|FG000|Overall Study|Withdrawal by Subject|5|||
156873284|NCT02930018|566293380|FG001|Overall Study|Withdrawal by Subject|2|||
156873285|NCT03493464|566293381|FG000|Overall Study|Surgery not performed|1|||
156873286|NCT02807402|566293382|FG000|Overall Study|Failure to Return|1|||
156873287|NCT02807402|566293382|FG000|Overall Study|Death|3|||
156873288|NCT02807402|566293382|FG000|Overall Study|Other|2|||
156873289|NCT01077050|566294303|FG000|Overall Study|Subjects signed ICF could not be located|1|||
156873290|NCT01077050|566294303|FG000|Overall Study|Screen failure|8|||
156873291|NCT02565784|566294307|FG000|First Treatment|Adverse Event|1|||
156873292|NCT02565784|566294307|FG000|First Treatment|Withdrawal by Subject|1|||
156873293|NCT02565784|566294307|FG000|Second Treatment|Withdrawal by Subject|2|||
156873294|NCT01193257|566294311|FG000|Overall Study|Death|202|||
156873295|NCT01193257|566294312|FG001|Overall Study|Death|391|||
156873296|NCT01193257|566294311|FG000|Overall Study|Study termination by sponsor|0|||
156873297|NCT01193257|566294312|FG001|Overall Study|Study termination by sponsor|3|||
156873298|NCT01193257|566294311|FG000|Overall Study|Withdrawal by Subject|26|||
156873299|NCT01193257|566294312|FG001|Overall Study|Withdrawal by Subject|86|||
156873300|NCT01193257|566294311|FG000|Overall Study|Lost to Follow-up|2|||
156873301|NCT01193257|566294312|FG001|Overall Study|Lost to Follow-up|3|||
156873302|NCT01193257|566294311|FG000|Overall Study|Unblinded due to futility|135|||
156873303|NCT01193257|566294312|FG001|Overall Study|Unblinded due to futility|251|||
156873304|NCT03126344|566294326|FG000|Overall Study|Lost to Follow-up|0|||
156873305|NCT03126344|566294327|FG001|Overall Study|Lost to Follow-up|0|||
156873306|NCT03126344|566294328|FG002|Overall Study|Lost to Follow-up|5|||
156873307|NCT01715857|566294329|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
156873308|NCT02563067|566294331|FG000|Overall Study|Subject/guardian decision|14|||
156709573|NCT02291510|565682324|FG002|Overall Study|Adverse Event|0|||
156709574|NCT02291510|565682325|FG003|Overall Study|Adverse Event|1|||
156709575|NCT02454608|565682326|FG000|Double-Blind Period|Lack of Efficacy|0|||
156873309|NCT02563067|566294332|FG001|Overall Study|Subject/guardian decision|20|||
156873310|NCT02563067|566294333|FG002|Overall Study|Subject/guardian decision|16|||
156709576|NCT02454608|565682327|FG001|Double-Blind Period|Lack of Efficacy|2|||
156709577|NCT02454608|565682328|FG002|Double-Blind Period|Lack of Efficacy|0|||
156709578|NCT02454608|565682326|FG000|Open Label Period|Lost to Follow-up|0|||
156709579|NCT02454608|565682327|FG001|Open Label Period|Lost to Follow-up|0|||
156709580|NCT02454608|565682328|FG002|Open Label Period|Lost to Follow-up|11|||
156873311|NCT02563067|566294331|FG000|Overall Study|Physician Decision|0|||
156873312|NCT02563067|566294332|FG001|Overall Study|Physician Decision|1|||
156873313|NCT02563067|566294333|FG002|Overall Study|Physician Decision|3|||
156873314|NCT02563067|566294331|FG000|Overall Study|Lost to Follow-up|1|||
156873315|NCT02563067|566294332|FG001|Overall Study|Lost to Follow-up|2|||
156873316|NCT02563067|566294333|FG002|Overall Study|Lost to Follow-up|0|||
156709581|NCT02454608|565682326|FG000|Open Label Period|Withdrawal by Subject|0|||
156709582|NCT02454608|565682327|FG001|Open Label Period|Withdrawal by Subject|0|||
156709583|NCT02454608|565682328|FG002|Open Label Period|Withdrawal by Subject|8|||
156709584|NCT02465398|565682329|FG000|Overall Study|Death|7|||
156709585|NCT02465398|565682329|FG000|Overall Study|Revision|7|||
156709586|NCT02465398|565682329|FG000|Overall Study|did not receive study device|1|||
156709587|NCT02465398|565682329|FG000|Overall Study|Withdrawal by Subject|1|||
156709588|NCT02465398|565682329|FG000|Overall Study|Lost to Follow-up|14|||
156709589|NCT02906358|565682330|FG000|Overall Study|Withdrawal by Subject|10|||
156709590|NCT02906358|565682331|FG001|Overall Study|Withdrawal by Subject|7|||
156709591|NCT02906358|565682330|FG000|Overall Study|Lost to Follow-up|12|||
156709592|NCT02906358|565682331|FG001|Overall Study|Lost to Follow-up|15|||
156709593|NCT02699684|565682332|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
156709594|NCT02699684|565682333|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
156709595|NCT02540850|565682336|FG000|Overall Study|Lost to Follow-up|69|||
156709596|NCT02540850|565682337|FG001|Overall Study|Lost to Follow-up|66|||
156709597|NCT02540850|565682338|FG002|Overall Study|Lost to Follow-up|34|||
156709598|NCT02111603|565682343|FG000|Overall Study|Withdrawal by Subject|1|||
156709599|NCT01582152|565682344|FG000|Overall Study|Disease Progression|4|||
156709600|NCT01582152|565682345|FG001|Overall Study|Disease Progression|5|||
156709601|NCT01582152|565682344|FG000|Overall Study|Adverse Event|2|||
156709602|NCT01582152|565682345|FG001|Overall Study|Adverse Event|1|||
156709603|NCT00230178|565682346|FG000|Overall Study|Adverse Event|1|||
156709604|NCT00230178|565682347|FG001|Overall Study|Adverse Event|5|||
156709605|NCT00230178|565682348|FG002|Overall Study|Adverse Event|2|||
156709606|NCT00230178|565682346|FG000|Overall Study|Withdrawal by Subject|0|||
156709607|NCT00230178|565682347|FG001|Overall Study|Withdrawal by Subject|0|||
156709608|NCT00230178|565682348|FG002|Overall Study|Withdrawal by Subject|1|||
156709609|NCT00230178|565682346|FG000|Overall Study|Various other reasons|3|||
156709610|NCT00230178|565682347|FG001|Overall Study|Various other reasons|2|||
156709611|NCT00230178|565682348|FG002|Overall Study|Various other reasons|4|||
156709612|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
156709613|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
156709614|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
156709615|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
156709616|NCT02252406|565682355|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
156709617|NCT02252406|565682356|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
156709618|NCT02252406|565682355|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
156709619|NCT02252406|565682356|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
156709620|NCT02252406|565682355|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
156709621|NCT02252406|565682356|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
156709622|NCT04974749|565682366|FG000|Overall Study|Withdrawal by Subject|2|||
156709623|NCT04974749|565682366|FG000|Overall Study|Gestation|1|||
156709624|NCT00362336|565682367|FG000|Overall Study|Serious Adverse Event|1|||
156709625|NCT00362336|565682368|FG001|Overall Study|Serious Adverse Event|0|||
156709626|NCT00362336|565682369|FG002|Overall Study|Serious Adverse Event|1|||
156709627|NCT00362336|565682367|FG000|Overall Study|Protocol Violation|0|||
156709628|NCT00362336|565682368|FG001|Overall Study|Protocol Violation|0|||
156709629|NCT00362336|565682369|FG002|Overall Study|Protocol Violation|1|||
156709630|NCT00362336|565682367|FG000|Overall Study|Lost to Follow-up|6|||
156709631|NCT00362336|565682368|FG001|Overall Study|Lost to Follow-up|4|||
156709632|NCT00362336|565682369|FG002|Overall Study|Lost to Follow-up|0|||
156709633|NCT00362336|565682367|FG000|Overall Study|Withdrawal by Subject|3|||
156709634|NCT00362336|565682368|FG001|Overall Study|Withdrawal by Subject|3|||
156709635|NCT00362336|565682369|FG002|Overall Study|Withdrawal by Subject|1|||
156709636|NCT04414618|565682370|FG000|Overall Study|Death|3|||
156709637|NCT04414618|565682371|FG001|Overall Study|Death|3|||
156709638|NCT04414618|565682370|FG000|Overall Study|Withdrawal by Subject|2|||
156709639|NCT04414618|565682371|FG001|Overall Study|Withdrawal by Subject|1|||
156709640|NCT04414618|565682370|FG000|Overall Study|Lost to Follow-up|2|||
156709641|NCT04414618|565682371|FG001|Overall Study|Lost to Follow-up|3|||
156709642|NCT04414618|565682370|FG000|Overall Study|Physician Decision|1|||
156709643|NCT04414618|565682371|FG001|Overall Study|Physician Decision|0|||
156709644|NCT01399658|565682372|FG000|Overall Study|Ineligible|1|||
156709645|NCT01399658|565682372|FG000|Overall Study|Machine Technical Issue|3|||
156709646|NCT01399658|565682372|FG000|Overall Study|Alternative therapy|1|||
156709647|NCT01399658|565682372|FG000|Overall Study|No reason given|1|||
156709648|NCT00796107|565682378|FG000|Overall Study|Lack of Efficacy|1|||
156709649|NCT00796107|565682378|FG000|Overall Study|Progressive Disease|5|||
156709650|NCT02681510|565682383|FG000|Overall Study|Withdrawal by Subject|1|||
156709651|NCT02681510|565682383|FG000|Overall Study|Lost to Follow-up|9|||
156709652|NCT03593395|565682397|FG000|Overall Study|Lost to Follow-up|48|||
156709653|NCT03593395|565682398|FG001|Overall Study|Lost to Follow-up|3|||
156709654|NCT03593395|565682397|FG000|Overall Study|Withdrawal by Subject|5|||
156709655|NCT03593395|565682398|FG001|Overall Study|Withdrawal by Subject|24|||
156709656|NCT03593395|565682397|FG000|Overall Study|Death|2|||
156709657|NCT03593395|565682398|FG001|Overall Study|Death|3|||
156873317|NCT02563067|566294331|FG000|Overall Study|Technical problems|0|||
156873318|NCT02563067|566294332|FG001|Overall Study|Technical problems|1|||
156873319|NCT02563067|566294333|FG002|Overall Study|Technical problems|0|||
156873320|NCT02563067|566294331|FG000|Overall Study|Lack of Efficacy|1|||
156873321|NCT02563067|566294332|FG001|Overall Study|Lack of Efficacy|0|||
156873322|NCT02563067|566294333|FG002|Overall Study|Lack of Efficacy|0|||
156873323|NCT02563067|566294331|FG000|Overall Study|Death|0|||
156873324|NCT02563067|566294332|FG001|Overall Study|Death|1|||
156873325|NCT02563067|566294333|FG002|Overall Study|Death|1|||
156873326|NCT02563067|566294331|FG000|Overall Study|Adverse Event|2|||
156873327|NCT02563067|566294332|FG001|Overall Study|Adverse Event|1|||
156873328|NCT02563067|566294333|FG002|Overall Study|Adverse Event|0|||
156873329|NCT02563067|566294331|FG000|Overall Study|Death post Treatment/safety period|1|||
156873330|NCT02563067|566294332|FG001|Overall Study|Death post Treatment/safety period|0|||
156873331|NCT02563067|566294333|FG002|Overall Study|Death post Treatment/safety period|0|||
156873332|NCT01039519|566294346|FG000|Treatment|Progressive disease|20|||
156873333|NCT01039519|566294346|FG000|Treatment|Treatment failure|2|||
156873334|NCT01039519|566294346|FG000|Treatment|Adverse Event|3|||
156873335|NCT01039519|566294346|FG000|Treatment|Physician Decision|2|||
156873336|NCT01039519|566294346|FG000|Survival Follow-up|Death|23|||
156873337|NCT01039519|566294346|FG000|Survival Follow-up|Sponsor decision|4|||
156873338|NCT01330108|566294347|FG000|Overall Study|Withdrawal by Subject|4|||
156873339|NCT00392769|566294350|FG000|Overall Study|Clinical Deterioration|9|||
156873340|NCT00392769|566294350|FG000|Overall Study|Adverse Event|1|||
156873341|NCT00439517|566294352|FG000|Overall Study|Subject on treatment|1|||
156873342|NCT00439517|566294353|FG001|Overall Study|Subject on treatment|0|||
156709658|NCT03593395|565682397|FG000|Overall Study|Physician Decision|0|||
156709659|NCT03593395|565682398|FG001|Overall Study|Physician Decision|6|||
156709660|NCT03593395|565682397|FG000|Overall Study|Participant Relocated|19|||
156709661|NCT03593395|565682398|FG001|Overall Study|Participant Relocated|3|||
156709662|NCT03593395|565682397|FG000|Overall Study|No Information|1|||
156709663|NCT03593395|565682398|FG001|Overall Study|No Information|7|||
156709664|NCT02806024|565682399|FG000|Overall Study|Night Delivery|1|||
156709665|NCT02806024|565682400|FG001|Overall Study|Night Delivery|1|||
156709666|NCT02806024|565682399|FG000|Overall Study|DVT during antepartum admission|0|||
156709667|NCT02806024|565682400|FG001|Overall Study|DVT during antepartum admission|1|||
156709668|NCT00626561|565682403|FG000|Overall Study|Withdrawal by Subject|2|||
156709669|NCT00626561|565682403|FG000|Overall Study|Disease Progression|2|||
156709670|NCT01372748|565682406|FG000|Overall Study|Lost to Follow-up|16|||
156709671|NCT01372748|565682407|FG001|Overall Study|Lost to Follow-up|34|||
156709672|NCT01372748|565682406|FG000|Overall Study|Withdrawal by Subject|7|||
156709673|NCT01372748|565682407|FG001|Overall Study|Withdrawal by Subject|5|||
156709674|NCT00134901|565682408|FG000|Overall Study|Lost to Follow-up|5|||
156709675|NCT00134901|565682409|FG001|Overall Study|Lost to Follow-up|5|||
156709676|NCT00134901|565682408|FG000|Overall Study|discontinued intervention|12|||
156709677|NCT00134901|565682409|FG001|Overall Study|discontinued intervention|10|||
156709678|NCT00606632|565682410|FG000|Overall Study|Withdrawal by Subject|13|||
156709679|NCT00606632|565682410|FG000|Overall Study|Miscellaneous reasons|9|||
156709680|NCT03908437|565682411|FG000|Overall Study|Death|0|||
156709681|NCT03908437|565682412|FG001|Overall Study|Death|1|||
156709682|NCT03908437|565682411|FG000|Overall Study|Lost to Follow-up|31|||
156709683|NCT03908437|565682412|FG001|Overall Study|Lost to Follow-up|24|||
156709684|NCT03633825|565682413|FG000|Enrollment|Did not post on network|5066|||
156709685|NCT03633825|565682414|FG001|Enrollment|Did not post on network|5080|||
156709686|NCT03633825|565682413|FG000|Enrollment|Post not classified as crisis|13967|||
156709687|NCT03633825|565682414|FG001|Enrollment|Post not classified as crisis|13757|||
156709688|NCT03633825|565682413|FG000|Follow up|Lost to Follow-up|478|||
156709689|NCT03633825|565682414|FG001|Follow up|Lost to Follow-up|450|||
156709690|NCT05246670|565682415|FG000|Overall Study|Withdrawal by Subject|2|||
156709691|NCT05246670|565682416|FG001|Overall Study|Withdrawal by Subject|3|||
156709692|NCT05246670|565682417|FG002|Overall Study|Withdrawal by Subject|0|||
156873343|NCT00439517|566294352|FG000|Overall Study|Subject in survival follow-up|1|||
156873344|NCT00439517|566294353|FG001|Overall Study|Subject in survival follow-up|0|||
156709693|NCT05246670|565682418|FG003|Overall Study|Withdrawal by Subject|1|||
156709694|NCT05246670|565682415|FG000|Overall Study|Adverse Event|0|||
156709695|NCT05246670|565682416|FG001|Overall Study|Adverse Event|0|||
156709696|NCT05246670|565682417|FG002|Overall Study|Adverse Event|1|||
156709697|NCT05246670|565682418|FG003|Overall Study|Adverse Event|0|||
156709698|NCT05246670|565682415|FG000|Overall Study|Physician Decision|1|||
156709699|NCT05246670|565682416|FG001|Overall Study|Physician Decision|0|||
156873345|NCT01262989|566294356|FG000|Period 1|Lost to Follow-up|1|||
156873346|NCT01262989|566294357|FG001|Period 1|Lost to Follow-up|1|||
156709700|NCT05246670|565682417|FG002|Overall Study|Physician Decision|0|||
156709701|NCT05246670|565682418|FG003|Overall Study|Physician Decision|0|||
156873347|NCT01262989|566294356|FG000|Period 1|Intercurrent disease|0|||
156873348|NCT01262989|566294357|FG001|Period 1|Intercurrent disease|1|||
156709702|NCT05246670|565682415|FG000|Overall Study|Protocol Violation|1|||
156873349|NCT01262989|566294356|FG000|Period 1|Positive answer for exclusion criteria|0|||
156873350|NCT01262989|566294357|FG001|Period 1|Positive answer for exclusion criteria|1|||
156709703|NCT05246670|565682416|FG001|Overall Study|Protocol Violation|0|||
156709704|NCT05246670|565682417|FG002|Overall Study|Protocol Violation|0|||
156709705|NCT05246670|565682418|FG003|Overall Study|Protocol Violation|0|||
156709706|NCT00356525|565682419|FG000|Overall Study|Progressive Disease|8|||
156709707|NCT00356525|565682420|FG001|Overall Study|Progressive Disease|5|||
156709708|NCT00356525|565682421|FG002|Overall Study|Progressive Disease|4|||
156709709|NCT00356525|565682422|FG003|Overall Study|Progressive Disease|2|||
156709710|NCT00356525|565682419|FG000|Overall Study|Adverse Event|1|||
156709711|NCT00356525|565682420|FG001|Overall Study|Adverse Event|3|||
156709712|NCT00356525|565682421|FG002|Overall Study|Adverse Event|1|||
156709713|NCT00356525|565682422|FG003|Overall Study|Adverse Event|1|||
156709714|NCT00356525|565682419|FG000|Overall Study|Lost to Follow-up|1|||
156709715|NCT00356525|565682420|FG001|Overall Study|Lost to Follow-up|0|||
156709716|NCT00356525|565682421|FG002|Overall Study|Lost to Follow-up|0|||
156709717|NCT00356525|565682422|FG003|Overall Study|Lost to Follow-up|0|||
156709718|NCT00356525|565682419|FG000|Overall Study|Physician Decision|2|||
156709719|NCT00356525|565682420|FG001|Overall Study|Physician Decision|2|||
156709720|NCT00356525|565682421|FG002|Overall Study|Physician Decision|2|||
156709721|NCT00356525|565682422|FG003|Overall Study|Physician Decision|1|||
156709722|NCT00356525|565682419|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
156709723|NCT00356525|565682420|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
156709724|NCT00356525|565682421|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
156709725|NCT00356525|565682422|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
156709726|NCT00356525|565682419|FG000|Overall Study|Withdrawal by Subject|1|||
156709727|NCT00356525|565682420|FG001|Overall Study|Withdrawal by Subject|1|||
156709728|NCT00356525|565682421|FG002|Overall Study|Withdrawal by Subject|0|||
156709729|NCT00356525|565682422|FG003|Overall Study|Withdrawal by Subject|3|||
156709730|NCT00356525|565682419|FG000|Overall Study|Death|0|||
156709731|NCT00356525|565682420|FG001|Overall Study|Death|0|||
156709732|NCT00356525|565682421|FG002|Overall Study|Death|0|||
156709733|NCT00356525|565682422|FG003|Overall Study|Death|1|||
156709734|NCT00356525|565682419|FG000|Overall Study|Sponsor Decision|0|||
156709735|NCT00356525|565682420|FG001|Overall Study|Sponsor Decision|0|||
156709736|NCT00356525|565682421|FG002|Overall Study|Sponsor Decision|0|||
156709737|NCT00356525|565682422|FG003|Overall Study|Sponsor Decision|1|||
156709738|NCT00652340|565682423|FG000|Overall Study|Had not progressed.|4|||
156709739|NCT00652340|565682424|FG001|Overall Study|Had not progressed.|3|||
156709740|NCT03682107|565682425|FG000|Overall Study|Withdrawal by Subject|0|||
156709741|NCT03682107|565682426|FG001|Overall Study|Withdrawal by Subject|1|||
156709742|NCT03682107|565682427|FG002|Overall Study|Withdrawal by Subject|0|||
156709743|NCT03682107|565682428|FG003|Overall Study|Withdrawal by Subject|0|||
156709744|NCT03682107|565682429|FG004|Overall Study|Withdrawal by Subject|0|||
156709745|NCT00214383|565682432|FG000|Overall Study|Lost to Follow-up|16|||
156709746|NCT00214383|565682433|FG001|Overall Study|Lost to Follow-up|26|||
156709747|NCT04152291|565682434|FG000|Overall Study|Covid-19 restrictions|27|||
156709748|NCT04152291|565682434|FG000|Overall Study|Withdrawal by Subject|3|||
156709749|NCT03597295|565682435|FG000|Overall Study|Death|70|||
156709750|NCT03597295|565682435|FG000|Overall Study|Lost to Follow-up|7|||
156709751|NCT00879411|565682436|FG000|Overall Study|lost to follow-up (non-AE)|162|||
156709752|NCT05124691|565682437|FG000|Phase II|Eligibility criteria|0|||
156709753|NCT05124691|565682438|FG001|Phase II|Eligibility criteria|1|||
156709754|NCT05124691|565682439|FG002|Phase II|Eligibility criteria|0|||
156709755|NCT05124691|565682437|FG000|Phase II|Withdrawal by Subject|6|||
156709756|NCT05124691|565682438|FG001|Phase II|Withdrawal by Subject|2|||
156709757|NCT05124691|565682439|FG002|Phase II|Withdrawal by Subject|3|||
156709758|NCT05124691|565682437|FG000|Phase III|Withdrawal by Subject|6|||
156709759|NCT05124691|565682438|FG001|Phase III|Withdrawal by Subject|4|||
156709760|NCT05124691|565682439|FG002|Phase III|Withdrawal by Subject|4|||
156709761|NCT05124691|565682437|FG000|Phase III|Lost to Follow-up|1|||
156709762|NCT05124691|565682438|FG001|Phase III|Lost to Follow-up|0|||
156709763|NCT05124691|565682439|FG002|Phase III|Lost to Follow-up|0|||
156709764|NCT01890434|565682440|FG000|Overall Study|Adverse Event|8|||
156709765|NCT01890434|565682440|FG000|Overall Study|PCI at external hospital|1|||
156709766|NCT01890434|565682440|FG000|Overall Study|Assessment discrepancy|1|||
156792101|NCT00289900|565991099|FG005|Overall Study|Adverse Event|33|||
156709767|NCT01890434|565682440|FG000|Overall Study|CRC didn't contact participant for FU|1|||
156709768|NCT01890434|565682440|FG000|Overall Study|Could not get whole set of images|1|||
156709769|NCT01890434|565682440|FG000|Overall Study|Decline to return for GSPECT|1|||
156792102|NCT00289900|565991094|FG000|Overall Study|Lost to Follow-up|7|||
156792103|NCT00289900|565991095|FG001|Overall Study|Lost to Follow-up|7|||
156709770|NCT01890434|565682440|FG000|Overall Study|GSPECT at rest was not done|1|||
156709771|NCT01890434|565682440|FG000|Overall Study|Participant didn't complete MRI|1|||
156709772|NCT01890434|565682440|FG000|Overall Study|Uncontactable by phone|1|||
156709773|NCT01890434|565682440|FG000|Overall Study|Moved out of position|1|||
156709774|NCT01890434|565682440|FG000|Overall Study|Unable to contact|1|||
156709775|NCT01890434|565682440|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
156709776|NCT00428116|565682441|FG000|Overall Study|Death|1|||
156709777|NCT00428116|565682442|FG001|Overall Study|Death|0|||
156709778|NCT00428116|565682441|FG000|Overall Study|Withdrawal by Subject|1|||
156709779|NCT00428116|565682442|FG001|Overall Study|Withdrawal by Subject|0|||
156709780|NCT00428116|565682441|FG000|Overall Study|Lost to Follow-up|1|||
156709781|NCT00428116|565682442|FG001|Overall Study|Lost to Follow-up|0|||
156709782|NCT01038297|565682443|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
156709783|NCT01038297|565682444|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
156709784|NCT01038297|565682445|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
157016315|NCT00087139|566811296|FG000|Overall Study|Physician Decision|1|||
157016316|NCT00087139|566811297|FG001|Overall Study|Physician Decision|1|||
157016317|NCT00087139|566811298|FG002|Overall Study|Physician Decision|1|||
157016318|NCT00087139|566811296|FG000|Overall Study|Disease progression|9|||
157016319|NCT00087139|566811297|FG001|Overall Study|Disease progression|19|||
157016320|NCT00087139|566811298|FG002|Overall Study|Disease progression|12|||
157016321|NCT00087139|566811296|FG000|Overall Study|Ineligible|4|||
157016322|NCT00087139|566811297|FG001|Overall Study|Ineligible|7|||
156709793|NCT03837743|565682458|FG000|Overall Study|Adverse Event|1|||
156709794|NCT03837743|565682458|FG000|Overall Study|Withdrawal by Subject|2|||
156709795|NCT02257385|565682459|FG000|Overall Study|Adverse Event|12|||
156709796|NCT02257385|565682460|FG001|Overall Study|Adverse Event|8|||
156709797|NCT02257385|565682459|FG000|Overall Study|Lack of Efficacy|1|||
156709798|NCT02257385|565682460|FG001|Overall Study|Lack of Efficacy|2|||
156709799|NCT02257385|565682459|FG000|Overall Study|Protocol Violation|5|||
156709800|NCT02257385|565682460|FG001|Overall Study|Protocol Violation|7|||
156709801|NCT02257385|565682459|FG000|Overall Study|Lost to Follow-up|0|||
156709802|NCT02257385|565682460|FG001|Overall Study|Lost to Follow-up|1|||
156709803|NCT02257385|565682459|FG000|Overall Study|Withdrawal by Subject|4|||
156709804|NCT02257385|565682460|FG001|Overall Study|Withdrawal by Subject|4|||
156709805|NCT01449370|565682469|FG000|Overall Study|Disease Progression|5|||
156709806|NCT01449370|565682470|FG001|Overall Study|Disease Progression|4|||
156709807|NCT01449370|565682471|FG002|Overall Study|Disease Progression|8|||
156709808|NCT01449370|565682472|FG003|Overall Study|Disease Progression|3|||
156709809|NCT01449370|565682473|FG004|Overall Study|Disease Progression|3|||
156709810|NCT01449370|565682474|FG005|Overall Study|Disease Progression|3|||
156709811|NCT01449370|565682475|FG006|Overall Study|Disease Progression|3|||
156709812|NCT01449370|565682476|FG007|Overall Study|Disease Progression|2|||
156709813|NCT01449370|565682477|FG008|Overall Study|Disease Progression|9|||
156709814|NCT01449370|565682478|FG009|Overall Study|Disease Progression|1|||
156709815|NCT01449370|565682479|FG010|Overall Study|Disease Progression|3|||
156709816|NCT01449370|565682480|FG011|Overall Study|Disease Progression|3|||
156709817|NCT01449370|565682481|FG012|Overall Study|Disease Progression|2|||
156709818|NCT01449370|565682482|FG013|Overall Study|Disease Progression|8|||
156709819|NCT01449370|565682483|FG014|Overall Study|Disease Progression|3|||
156709820|NCT01449370|565682484|FG015|Overall Study|Disease Progression|1|||
156709821|NCT01449370|565682485|FG016|Overall Study|Disease Progression|4|||
156709822|NCT01449370|565682486|FG017|Overall Study|Disease Progression|3|||
156709823|NCT01449370|565682487|FG018|Overall Study|Disease Progression|1|||
156709824|NCT01449370|565682488|FG019|Overall Study|Disease Progression|2|||
156709825|NCT01449370|565682489|FG020|Overall Study|Disease Progression|5|||
156709826|NCT01449370|565682490|FG021|Overall Study|Disease Progression|2|||
156709827|NCT01449370|565682491|FG022|Overall Study|Disease Progression|3|||
156709828|NCT01449370|565682492|FG023|Overall Study|Disease Progression|7|||
156709829|NCT01449370|565682493|FG024|Overall Study|Disease Progression|3|||
156709830|NCT01449370|565682469|FG000|Overall Study|Adverse Event|1|||
156709831|NCT01449370|565682470|FG001|Overall Study|Adverse Event|2|||
156709832|NCT01449370|565682471|FG002|Overall Study|Adverse Event|0|||
156709833|NCT01449370|565682472|FG003|Overall Study|Adverse Event|1|||
156709834|NCT01449370|565682473|FG004|Overall Study|Adverse Event|0|||
156709835|NCT01449370|565682474|FG005|Overall Study|Adverse Event|0|||
156709836|NCT01449370|565682475|FG006|Overall Study|Adverse Event|0|||
156709837|NCT01449370|565682476|FG007|Overall Study|Adverse Event|0|||
156709838|NCT01449370|565682477|FG008|Overall Study|Adverse Event|1|||
156709839|NCT01449370|565682478|FG009|Overall Study|Adverse Event|1|||
156709840|NCT01449370|565682479|FG010|Overall Study|Adverse Event|0|||
156792104|NCT00289900|565991096|FG002|Overall Study|Lost to Follow-up|8|||
156792105|NCT00289900|565991097|FG003|Overall Study|Lost to Follow-up|8|||
156792106|NCT00289900|565991098|FG004|Overall Study|Lost to Follow-up|4|||
156792107|NCT00289900|565991099|FG005|Overall Study|Lost to Follow-up|8|||
156792108|NCT00289900|565991094|FG000|Overall Study|Participant had flushing|18|||
156709841|NCT01449370|565682480|FG011|Overall Study|Adverse Event|0|||
156709842|NCT01449370|565682481|FG012|Overall Study|Adverse Event|0|||
156709843|NCT01449370|565682482|FG013|Overall Study|Adverse Event|2|||
156709844|NCT01449370|565682483|FG014|Overall Study|Adverse Event|0|||
156709845|NCT01449370|565682484|FG015|Overall Study|Adverse Event|1|||
156709846|NCT01449370|565682485|FG016|Overall Study|Adverse Event|0|||
156792109|NCT00289900|565991095|FG001|Overall Study|Participant had flushing|42|||
156792110|NCT00289900|565991096|FG002|Overall Study|Participant had flushing|1|||
156792111|NCT00289900|565991097|FG003|Overall Study|Participant had flushing|2|||
156709847|NCT01449370|565682486|FG017|Overall Study|Adverse Event|0|||
156709848|NCT01449370|565682487|FG018|Overall Study|Adverse Event|1|||
156709849|NCT01449370|565682488|FG019|Overall Study|Adverse Event|1|||
156709850|NCT01449370|565682489|FG020|Overall Study|Adverse Event|0|||
157215928|NCT00410410|567537430|FG006|Maintenance Period (MP)|Adverse Event|1|||
156709851|NCT01449370|565682490|FG021|Overall Study|Adverse Event|1|||
156709852|NCT01449370|565682491|FG022|Overall Study|Adverse Event|0|||
156709853|NCT01449370|565682492|FG023|Overall Study|Adverse Event|1|||
156709854|NCT01449370|565682493|FG024|Overall Study|Adverse Event|3|||
156709855|NCT01449370|565682469|FG000|Overall Study|Participant Decision|0|||
156709856|NCT01449370|565682470|FG001|Overall Study|Participant Decision|0|||
156709857|NCT01449370|565682471|FG002|Overall Study|Participant Decision|0|||
156709858|NCT01449370|565682472|FG003|Overall Study|Participant Decision|0|||
156709859|NCT01449370|565682473|FG004|Overall Study|Participant Decision|0|||
156709860|NCT01449370|565682474|FG005|Overall Study|Participant Decision|0|||
156709861|NCT01449370|565682475|FG006|Overall Study|Participant Decision|0|||
156709862|NCT01449370|565682476|FG007|Overall Study|Participant Decision|1|||
156709863|NCT01449370|565682477|FG008|Overall Study|Participant Decision|1|||
156709864|NCT01449370|565682478|FG009|Overall Study|Participant Decision|0|||
156709865|NCT01449370|565682479|FG010|Overall Study|Participant Decision|0|||
156709866|NCT01449370|565682480|FG011|Overall Study|Participant Decision|0|||
156709867|NCT01449370|565682481|FG012|Overall Study|Participant Decision|1|||
156709868|NCT01449370|565682482|FG013|Overall Study|Participant Decision|1|||
156709869|NCT01449370|565682483|FG014|Overall Study|Participant Decision|0|||
156709870|NCT01449370|565682484|FG015|Overall Study|Participant Decision|1|||
156709871|NCT01449370|565682485|FG016|Overall Study|Participant Decision|3|||
156709872|NCT01449370|565682486|FG017|Overall Study|Participant Decision|0|||
156792112|NCT00289900|565991098|FG004|Overall Study|Participant had flushing|0|||
156792113|NCT00289900|565991099|FG005|Overall Study|Participant had flushing|4|||
156792114|NCT00289900|565991094|FG000|Overall Study|Other|0|||
156792115|NCT00289900|565991095|FG001|Overall Study|Other|0|||
156792116|NCT00289900|565991096|FG002|Overall Study|Other|0|||
156792117|NCT00289900|565991097|FG003|Overall Study|Other|5|||
156792118|NCT00289900|565991098|FG004|Overall Study|Other|1|||
156792119|NCT00289900|565991099|FG005|Overall Study|Other|0|||
156792120|NCT00289900|565991094|FG000|Overall Study|Participant moved|1|||
156792121|NCT00289900|565991095|FG001|Overall Study|Participant moved|0|||
156792122|NCT00289900|565991096|FG002|Overall Study|Participant moved|0|||
156792123|NCT00289900|565991097|FG003|Overall Study|Participant moved|1|||
156792124|NCT00289900|565991098|FG004|Overall Study|Participant moved|1|||
156792125|NCT00289900|565991099|FG005|Overall Study|Participant moved|1|||
156792126|NCT00289900|565991094|FG000|Overall Study|Withdrawal by Subject|10|||
156792127|NCT00289900|565991095|FG001|Overall Study|Withdrawal by Subject|21|||
156792128|NCT00289900|565991096|FG002|Overall Study|Withdrawal by Subject|8|||
156792129|NCT00289900|565991097|FG003|Overall Study|Withdrawal by Subject|18|||
156792130|NCT00289900|565991098|FG004|Overall Study|Withdrawal by Subject|12|||
156792131|NCT00289900|565991099|FG005|Overall Study|Withdrawal by Subject|11|||
156792132|NCT00289900|565991094|FG000|Overall Study|Protocol Violation|3|||
156792133|NCT00289900|565991095|FG001|Overall Study|Protocol Violation|9|||
156792134|NCT00289900|565991096|FG002|Overall Study|Protocol Violation|2|||
156792135|NCT00289900|565991097|FG003|Overall Study|Protocol Violation|6|||
156792136|NCT00289900|565991098|FG004|Overall Study|Protocol Violation|7|||
156792137|NCT00289900|565991099|FG005|Overall Study|Protocol Violation|4|||
156792138|NCT00289900|565991094|FG000|Overall Study|site terminated|1|||
156792139|NCT00289900|565991095|FG001|Overall Study|site terminated|0|||
156792140|NCT00289900|565991096|FG002|Overall Study|site terminated|1|||
156792141|NCT00289900|565991097|FG003|Overall Study|site terminated|0|||
156792142|NCT00289900|565991098|FG004|Overall Study|site terminated|0|||
156792143|NCT00289900|565991099|FG005|Overall Study|site terminated|0|||
156792144|NCT00289900|565991094|FG000|Overall Study|Not treated|0|||
156792145|NCT00289900|565991095|FG001|Overall Study|Not treated|1|||
156792146|NCT00289900|565991096|FG002|Overall Study|Not treated|0|||
156792147|NCT00289900|565991097|FG003|Overall Study|Not treated|0|||
156792148|NCT00289900|565991098|FG004|Overall Study|Not treated|0|||
156792149|NCT00289900|565991099|FG005|Overall Study|Not treated|0|||
156792150|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
156792151|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
156792152|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
156792153|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
156792154|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
156792155|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
156792156|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
156792157|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156792158|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
156709873|NCT01449370|565682487|FG018|Overall Study|Participant Decision|1|||
156709874|NCT01449370|565682488|FG019|Overall Study|Participant Decision|0|||
156709875|NCT01449370|565682489|FG020|Overall Study|Participant Decision|0|||
156709876|NCT01449370|565682490|FG021|Overall Study|Participant Decision|1|||
156709877|NCT01449370|565682491|FG022|Overall Study|Participant Decision|0|||
156709878|NCT01449370|565682492|FG023|Overall Study|Participant Decision|0|||
156792159|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
156792160|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
156709879|NCT01449370|565682493|FG024|Overall Study|Participant Decision|1|||
156709880|NCT01449370|565682469|FG000|Overall Study|Lost to Follow-up|0|||
156709881|NCT01449370|565682470|FG001|Overall Study|Lost to Follow-up|0|||
156709882|NCT01449370|565682471|FG002|Overall Study|Lost to Follow-up|0|||
156709883|NCT01449370|565682472|FG003|Overall Study|Lost to Follow-up|0|||
156709884|NCT01449370|565682473|FG004|Overall Study|Lost to Follow-up|0|||
156709885|NCT01449370|565682474|FG005|Overall Study|Lost to Follow-up|0|||
156709886|NCT01449370|565682475|FG006|Overall Study|Lost to Follow-up|0|||
156709887|NCT01449370|565682476|FG007|Overall Study|Lost to Follow-up|0|||
156709888|NCT01449370|565682477|FG008|Overall Study|Lost to Follow-up|0|||
156709889|NCT01449370|565682478|FG009|Overall Study|Lost to Follow-up|0|||
156709890|NCT01449370|565682479|FG010|Overall Study|Lost to Follow-up|0|||
156709891|NCT01449370|565682480|FG011|Overall Study|Lost to Follow-up|0|||
156709892|NCT01449370|565682481|FG012|Overall Study|Lost to Follow-up|0|||
156709893|NCT01449370|565682482|FG013|Overall Study|Lost to Follow-up|0|||
156792161|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
156792162|NCT01703221|565991100|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156792163|NCT01703221|565991101|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
156792164|NCT01703221|565991102|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
156792165|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
156792166|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
156792167|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
156792168|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
156792169|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
156792170|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
156792171|NCT01703221|565991100|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
156792172|NCT01703221|565991101|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
156792173|NCT01703221|565991102|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
156792174|NCT03927846|565991104|FG000|Overall Study|Lost to Follow-up|10|||
156792175|NCT03927846|565991105|FG001|Overall Study|Lost to Follow-up|11|||
156792176|NCT00992394|565991106|FG000|Overall Study|Lack of Efficacy|6|||
156792177|NCT00992394|565991107|FG001|Overall Study|Lack of Efficacy|3|||
156792178|NCT00992394|565991106|FG000|Overall Study|Adverse Event|4|||
156792179|NCT00992394|565991107|FG001|Overall Study|Adverse Event|5|||
156792180|NCT00992394|565991106|FG000|Overall Study|Withdrawal by Subject|8|||
156792181|NCT00992394|565991107|FG001|Overall Study|Withdrawal by Subject|2|||
156792182|NCT00992394|565991106|FG000|Overall Study|Physician Decision|1|||
156792183|NCT00992394|565991107|FG001|Overall Study|Physician Decision|0|||
156792184|NCT00992394|565991106|FG000|Overall Study|Protocol Violation|2|||
156792185|NCT00992394|565991107|FG001|Overall Study|Protocol Violation|4|||
156792186|NCT00992394|565991106|FG000|Overall Study|Lost to Follow-up|2|||
156792187|NCT00992394|565991107|FG001|Overall Study|Lost to Follow-up|0|||
156792188|NCT00992394|565991106|FG000|Overall Study|Other event|1|||
156792189|NCT00992394|565991107|FG001|Overall Study|Other event|0|||
156792190|NCT04280783|565992682|FG000|Overall Study|Family issues unrelated to the study.|1|||
156792191|NCT04280783|565992683|FG001|Overall Study|Family issues unrelated to the study.|0|||
156792192|NCT04280783|565992682|FG000|Overall Study|Withdrawal by Subject|0|||
156792193|NCT04280783|565992683|FG001|Overall Study|Withdrawal by Subject|1|||
156792194|NCT03443401|565992690|FG000|Overall Study|Lost to Follow-up|13|||
156792195|NCT03443401|565992690|FG000|Overall Study|Influential outlier|1|||
156792196|NCT02363283|565992691|FG000|Overall Study|Withdrawal by Subject|1|||
156792197|NCT02363283|565992691|FG000|Overall Study|Not eligible due to transaminitis|1|||
156792198|NCT01394185|565992692|FG000|Overall Study|Withdrawal by Subject|2|||
156792199|NCT01394185|565992693|FG001|Overall Study|Withdrawal by Subject|0|||
156792200|NCT01394185|565992694|FG002|Overall Study|Withdrawal by Subject|0|||
156792201|NCT01394185|565992695|FG003|Overall Study|Withdrawal by Subject|0|||
156792202|NCT01394185|565992696|FG004|Overall Study|Withdrawal by Subject|1|||
156792203|NCT01394185|565992697|FG005|Overall Study|Withdrawal by Subject|0|||
156792204|NCT01394185|565992692|FG000|Overall Study|Change in protocol|3|||
156792205|NCT01394185|565992693|FG001|Overall Study|Change in protocol|0|||
156792206|NCT01394185|565992694|FG002|Overall Study|Change in protocol|0|||
156792207|NCT01394185|565992695|FG003|Overall Study|Change in protocol|0|||
156792208|NCT01394185|565992696|FG004|Overall Study|Change in protocol|3|||
156792209|NCT01394185|565992697|FG005|Overall Study|Change in protocol|0|||
156792210|NCT01394185|565992692|FG000|Overall Study|Protocol Violation|1|||
156792211|NCT01394185|565992693|FG001|Overall Study|Protocol Violation|0|||
156792212|NCT01394185|565992694|FG002|Overall Study|Protocol Violation|0|||
157016323|NCT00087139|566811298|FG002|Overall Study|Ineligible|4|||
156709894|NCT01449370|565682483|FG014|Overall Study|Lost to Follow-up|0|||
156709895|NCT01449370|565682484|FG015|Overall Study|Lost to Follow-up|0|||
156709896|NCT01449370|565682485|FG016|Overall Study|Lost to Follow-up|0|||
156709897|NCT01449370|565682486|FG017|Overall Study|Lost to Follow-up|0|||
156709898|NCT01449370|565682487|FG018|Overall Study|Lost to Follow-up|0|||
156792213|NCT01394185|565992695|FG003|Overall Study|Protocol Violation|1|||
156792214|NCT01394185|565992696|FG004|Overall Study|Protocol Violation|0|||
156792215|NCT01394185|565992697|FG005|Overall Study|Protocol Violation|1|||
156808760|NCT00620373|566054455|FG000|Overall Study|Unverified cancer status|33|||
156709899|NCT01449370|565682488|FG019|Overall Study|Lost to Follow-up|0|||
156709900|NCT01449370|565682489|FG020|Overall Study|Lost to Follow-up|1|||
156709901|NCT01449370|565682490|FG021|Overall Study|Lost to Follow-up|0|||
156709902|NCT01449370|565682491|FG022|Overall Study|Lost to Follow-up|0|||
156709903|NCT01449370|565682492|FG023|Overall Study|Lost to Follow-up|0|||
156709904|NCT01449370|565682493|FG024|Overall Study|Lost to Follow-up|0|||
156709905|NCT01449370|565682469|FG000|Overall Study|Other|0|||
156709906|NCT01449370|565682470|FG001|Overall Study|Other|0|||
156709907|NCT01449370|565682471|FG002|Overall Study|Other|0|||
156709908|NCT01449370|565682472|FG003|Overall Study|Other|0|||
156709909|NCT01449370|565682473|FG004|Overall Study|Other|0|||
156709910|NCT01449370|565682474|FG005|Overall Study|Other|0|||
156709911|NCT01449370|565682475|FG006|Overall Study|Other|0|||
156709912|NCT01449370|565682476|FG007|Overall Study|Other|0|||
156709913|NCT01449370|565682477|FG008|Overall Study|Other|1|||
156709914|NCT01449370|565682478|FG009|Overall Study|Other|1|||
156709915|NCT01449370|565682479|FG010|Overall Study|Other|0|||
156709916|NCT01449370|565682480|FG011|Overall Study|Other|0|||
156709917|NCT01449370|565682481|FG012|Overall Study|Other|0|||
156709918|NCT01449370|565682482|FG013|Overall Study|Other|0|||
156709919|NCT01449370|565682483|FG014|Overall Study|Other|0|||
156709920|NCT01449370|565682484|FG015|Overall Study|Other|0|||
156709921|NCT01449370|565682485|FG016|Overall Study|Other|0|||
156709922|NCT01449370|565682486|FG017|Overall Study|Other|0|||
156709923|NCT01449370|565682487|FG018|Overall Study|Other|0|||
156709924|NCT01449370|565682488|FG019|Overall Study|Other|0|||
156709925|NCT01449370|565682489|FG020|Overall Study|Other|0|||
156709926|NCT01449370|565682490|FG021|Overall Study|Other|0|||
156709927|NCT01449370|565682491|FG022|Overall Study|Other|1|||
156709928|NCT01449370|565682492|FG023|Overall Study|Other|1|||
156709929|NCT01449370|565682493|FG024|Overall Study|Other|0|||
156709930|NCT01449370|565682469|FG000|Overall Study|Medication Prohibited by Protocol|0|||
156709931|NCT01449370|565682470|FG001|Overall Study|Medication Prohibited by Protocol|0|||
156709932|NCT01449370|565682471|FG002|Overall Study|Medication Prohibited by Protocol|0|||
156709933|NCT01449370|565682472|FG003|Overall Study|Medication Prohibited by Protocol|0|||
156709934|NCT01449370|565682473|FG004|Overall Study|Medication Prohibited by Protocol|0|||
156709935|NCT01449370|565682474|FG005|Overall Study|Medication Prohibited by Protocol|0|||
156709936|NCT01449370|565682475|FG006|Overall Study|Medication Prohibited by Protocol|0|||
156709937|NCT01449370|565682476|FG007|Overall Study|Medication Prohibited by Protocol|0|||
156709938|NCT01449370|565682477|FG008|Overall Study|Medication Prohibited by Protocol|0|||
156709939|NCT01449370|565682478|FG009|Overall Study|Medication Prohibited by Protocol|0|||
156709940|NCT01449370|565682479|FG010|Overall Study|Medication Prohibited by Protocol|0|||
156709941|NCT01449370|565682480|FG011|Overall Study|Medication Prohibited by Protocol|0|||
156709942|NCT01449370|565682481|FG012|Overall Study|Medication Prohibited by Protocol|0|||
156709943|NCT01449370|565682482|FG013|Overall Study|Medication Prohibited by Protocol|0|||
156709944|NCT01449370|565682483|FG014|Overall Study|Medication Prohibited by Protocol|0|||
156709945|NCT01449370|565682484|FG015|Overall Study|Medication Prohibited by Protocol|0|||
156709946|NCT01449370|565682485|FG016|Overall Study|Medication Prohibited by Protocol|0|||
156709947|NCT01449370|565682486|FG017|Overall Study|Medication Prohibited by Protocol|0|||
156709948|NCT01449370|565682487|FG018|Overall Study|Medication Prohibited by Protocol|0|||
156709949|NCT01449370|565682488|FG019|Overall Study|Medication Prohibited by Protocol|0|||
156709950|NCT01449370|565682489|FG020|Overall Study|Medication Prohibited by Protocol|0|||
156709951|NCT01449370|565682490|FG021|Overall Study|Medication Prohibited by Protocol|0|||
156709952|NCT01449370|565682491|FG022|Overall Study|Medication Prohibited by Protocol|0|||
156709953|NCT01449370|565682492|FG023|Overall Study|Medication Prohibited by Protocol|1|||
156709954|NCT01449370|565682493|FG024|Overall Study|Medication Prohibited by Protocol|0|||
156709955|NCT01449370|565682469|FG000|Overall Study|Death|0|||
156709956|NCT01449370|565682470|FG001|Overall Study|Death|0|||
156709957|NCT01449370|565682471|FG002|Overall Study|Death|0|||
157016324|NCT00087139|566811296|FG000|Overall Study|Symptomatic deterioration|1|||
157016325|NCT00087139|566811297|FG001|Overall Study|Symptomatic deterioration|1|||
157016326|NCT00087139|566811298|FG002|Overall Study|Symptomatic deterioration|3|||
157016327|NCT00087139|566811296|FG000|Overall Study|Use of coumadin|1|||
157016328|NCT00087139|566811297|FG001|Overall Study|Use of coumadin|0|||
156709958|NCT01449370|565682472|FG003|Overall Study|Death|0|||
156709959|NCT01449370|565682473|FG004|Overall Study|Death|0|||
156709960|NCT01449370|565682474|FG005|Overall Study|Death|0|||
156709961|NCT01449370|565682475|FG006|Overall Study|Death|0|||
157016329|NCT00087139|566811298|FG002|Overall Study|Use of coumadin|0|||
156709962|NCT01449370|565682476|FG007|Overall Study|Death|0|||
156709963|NCT01449370|565682477|FG008|Overall Study|Death|0|||
156709964|NCT01449370|565682478|FG009|Overall Study|Death|0|||
156709965|NCT01449370|565682479|FG010|Overall Study|Death|0|||
156709966|NCT01449370|565682480|FG011|Overall Study|Death|0|||
156709967|NCT01449370|565682481|FG012|Overall Study|Death|0|||
156709968|NCT01449370|565682482|FG013|Overall Study|Death|0|||
156709969|NCT01449370|565682483|FG014|Overall Study|Death|0|||
156709970|NCT01449370|565682484|FG015|Overall Study|Death|0|||
156709971|NCT01449370|565682485|FG016|Overall Study|Death|0|||
156709972|NCT01449370|565682486|FG017|Overall Study|Death|0|||
156709973|NCT01449370|565682487|FG018|Overall Study|Death|0|||
156709974|NCT01449370|565682488|FG019|Overall Study|Death|0|||
156709975|NCT01449370|565682489|FG020|Overall Study|Death|0|||
156709976|NCT01449370|565682490|FG021|Overall Study|Death|0|||
156709977|NCT01449370|565682491|FG022|Overall Study|Death|0|||
156709978|NCT01449370|565682492|FG023|Overall Study|Death|0|||
156709979|NCT01449370|565682493|FG024|Overall Study|Death|1|||
156709980|NCT00710866|565682494|FG000|Overall Study|Protocol Violation|5|||
156709981|NCT00710866|565682495|FG001|Overall Study|Protocol Violation|4|||
156709982|NCT00710866|565682494|FG000|Overall Study|Withdrawal by Subject|2|||
156709983|NCT00710866|565682495|FG001|Overall Study|Withdrawal by Subject|1|||
156709984|NCT00710866|565682494|FG000|Overall Study|Lost to Follow-up|1|||
156709985|NCT00710866|565682495|FG001|Overall Study|Lost to Follow-up|0|||
156873351|NCT01262989|566294356|FG000|Period 2|Intercurrent disease|0|||
156873352|NCT01262989|566294357|FG001|Period 2|Intercurrent disease|1|||
156873353|NCT00470275|566294358|FG000|Overall Study|Death|1|||
157126395|NCT00132730|567214134|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
157126396|NCT00132730|567214129|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
156709986|NCT00710866|565682494|FG000|Overall Study|Failed to meet eligibility|1|||
156709987|NCT00710866|565682495|FG001|Overall Study|Failed to meet eligibility|1|||
156709988|NCT00246324|565682499|FG000|Overall Study|Withdrawal by Subject|1|||
156709989|NCT01383707|565684101|FG000|Overall Study|Consent withdrawal|6|||
156709990|NCT01383707|565684101|FG000|Overall Study|Death|19|||
156709991|NCT01383707|565684101|FG000|Overall Study|Other|8|||
156709992|NCT01383707|565684101|FG000|Overall Study|Sponsor's decision|2|||
156709993|NCT01383707|565684101|FG000|Overall Study|Adverse Event|14|||
156709994|NCT01383707|565684101|FG000|Overall Study|Progressive disease|23|||
156709995|NCT00799825|565684104|FG000|Overall Study|Adverse Event|1|||
156709996|NCT00799825|565684104|FG000|Overall Study|Withdrawal by Subject|6|||
156709997|NCT00799825|565684104|FG000|Overall Study|Lost to Follow-up|38|||
156709998|NCT00799825|565684104|FG000|Overall Study|Pregnancy|3|||
156709999|NCT01611857|565684105|FG000|Overall Study|Withdrawal by Subject|0|||
156710000|NCT01611857|565684106|FG001|Overall Study|Withdrawal by Subject|2|||
156710001|NCT02439970|565684107|FG000|Overall Study|Study Terminated|2|||
156710002|NCT02439970|565684108|FG001|Overall Study|Study Terminated|3|||
156710003|NCT00741338|565684111|FG000|Overall Study|Adverse Event|0|||
156710004|NCT00741338|565684112|FG001|Overall Study|Adverse Event|1|||
156710005|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
156710006|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
156710007|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
156710008|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156710009|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
156710010|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
156710011|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156710012|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
156710013|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156710014|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
156710015|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710016|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710017|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
156710018|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156710019|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
156710020|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
156710021|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710022|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
156710023|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710024|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
156710025|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156710026|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710027|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
156710028|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710029|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
156710030|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710031|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710032|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
156710033|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710034|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
156710035|NCT03713632|565684113|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
156710036|NCT03713632|565684114|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710037|NCT03713632|565684115|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710038|NCT03713632|565684116|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710039|NCT03713632|565684117|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
156710040|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
156710041|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
156710042|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
156710043|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
156710044|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
156710045|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
156873354|NCT00470275|566294358|FG000|Overall Study|Lack of Efficacy|7|||
156873355|NCT00470275|566294358|FG000|Overall Study|Withdrawal by Subject|2|||
156873356|NCT00459186|566294359|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
156873357|NCT00459186|566294359|FG000|PET Imaging and Assessment|Adverse Event|3|||
156873358|NCT03306173|566294361|FG000|Overall Study|Lost to Follow-up|16|||
156873359|NCT03306173|566294362|FG001|Overall Study|Lost to Follow-up|23|||
156873360|NCT03306173|566294361|FG000|Overall Study|Withdrawal by Subject|4|||
156873361|NCT03306173|566294362|FG001|Overall Study|Withdrawal by Subject|3|||
156873362|NCT03306173|566294361|FG000|Overall Study|Discontinued|4|||
156873363|NCT03306173|566294362|FG001|Overall Study|Discontinued|4|||
156873364|NCT00573144|566294363|FG000|Overall Study|Withdrawal by Subject|2|||
156873365|NCT00573144|566294364|FG001|Overall Study|Withdrawal by Subject|3|||
156710046|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
156710047|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
156710048|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
156710049|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
156710050|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
156710051|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
156710052|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
156710053|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
156710054|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
156710055|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
156710056|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
156710057|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156710058|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
156710059|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
156710060|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
156710061|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156710062|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156710063|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
156710064|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
156710065|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
156710066|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710067|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710068|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710069|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
156710070|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Death|0|||
156710071|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Death|1|||
156710072|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Death|0|||
156710073|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Death|0|||
156710074|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Death|0|||
156710075|NCT03713632|565684113|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710076|NCT03713632|565684114|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
156710077|NCT03713632|565684115|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710078|NCT03713632|565684116|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710079|NCT03713632|565684117|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
156710080|NCT02370238|565684124|FG000|Overall Study|Death|42|||
156710081|NCT02370238|565684125|FG001|Overall Study|Death|35|||
156710082|NCT02370238|565684124|FG000|Overall Study|Lost to Follow-up|1|||
156710083|NCT02370238|565684125|FG001|Overall Study|Lost to Follow-up|3|||
156710084|NCT02370238|565684124|FG000|Overall Study|Withdrawal by Subject|2|||
156710085|NCT02370238|565684125|FG001|Overall Study|Withdrawal by Subject|6|||
156710086|NCT02370238|565684124|FG000|Overall Study|Other|2|||
156710087|NCT02370238|565684125|FG001|Overall Study|Other|1|||
156710088|NCT01295320|565684126|FG000|Overall Study|Adverse Event|2|||
156710089|NCT01295320|565684126|FG000|Overall Study|Lost to Follow-up|4|||
156710090|NCT01295320|565684126|FG000|Overall Study|Withdrawal by Subject|2|||
156710091|NCT01295320|565684126|FG000|Overall Study|Subject was bedridden|1|||
156710092|NCT01295320|565684126|FG000|Overall Study|Unable to travel|1|||
156710093|NCT00462904|565684127|FG000|Overall Study|Lost to Follow-up|1|||
156710094|NCT02125877|565684128|FG000|Overall Study|Physician Decision|1|||
156710095|NCT02125877|565684129|FG001|Overall Study|Physician Decision|0|||
156710096|NCT02125877|565684128|FG000|Overall Study|Death|0|||
156710097|NCT02125877|565684129|FG001|Overall Study|Death|1|||
156710098|NCT02125877|565684128|FG000|Overall Study|Administrative problems|0|||
156873366|NCT00478023|566294368|FG000|Overall Study|Adverse Event|11|||
156873367|NCT00478023|566294369|FG001|Overall Study|Adverse Event|7|||
156710099|NCT02125877|565684129|FG001|Overall Study|Administrative problems|1|||
156710100|NCT02125877|565684128|FG000|Overall Study|Participant/guardian decision|0|||
156710101|NCT02125877|565684129|FG001|Overall Study|Participant/guardian decision|2|||
156710102|NCT02125877|565684128|FG000|Overall Study|Withdrawal by Subject|2|||
156710103|NCT02125877|565684129|FG001|Overall Study|Withdrawal by Subject|1|||
156710104|NCT02125877|565684128|FG000|Overall Study|Protocol deviation|4|||
156710105|NCT02125877|565684129|FG001|Overall Study|Protocol deviation|1|||
156710106|NCT02125877|565684128|FG000|Overall Study|Adverse Event|6|||
156710107|NCT02125877|565684129|FG001|Overall Study|Adverse Event|4|||
156710108|NCT01973595|565684130|FG000|Washout|Withdrawal by Subject|1|||
156710109|NCT01973595|565684131|FG001|Washout|Withdrawal by Subject|0|||
156710110|NCT01973595|565684132|FG002|Washout|Withdrawal by Subject|1|||
156710111|NCT01973595|565684133|FG003|Washout|Withdrawal by Subject|0|||
156710112|NCT01822366|565684134|FG000|Overall Study|Lost to Follow-up|5|||
156710113|NCT01822366|565684135|FG001|Overall Study|Lost to Follow-up|1|||
156710114|NCT01822366|565684136|FG002|Overall Study|Lost to Follow-up|5|||
156710115|NCT01822366|565684137|FG003|Overall Study|Lost to Follow-up|1|||
156710116|NCT01822366|565684134|FG000|Overall Study|Withdrawal by Subject|0|||
156710117|NCT01822366|565684135|FG001|Overall Study|Withdrawal by Subject|6|||
156710118|NCT01822366|565684136|FG002|Overall Study|Withdrawal by Subject|0|||
156710119|NCT01822366|565684137|FG003|Overall Study|Withdrawal by Subject|6|||
156710120|NCT01822366|565684134|FG000|Overall Study|Partial Intervention Completion|0|||
156710121|NCT01822366|565684135|FG001|Overall Study|Partial Intervention Completion|15|||
156710122|NCT01822366|565684136|FG002|Overall Study|Partial Intervention Completion|0|||
156710123|NCT01822366|565684137|FG003|Overall Study|Partial Intervention Completion|15|||
156710124|NCT05199090|565684138|FG000|Overall Study|Adverse Event|1|||
156710125|NCT05199090|565684139|FG001|Overall Study|Adverse Event|4|||
156710126|NCT05199090|565684140|FG002|Overall Study|Adverse Event|0|||
156710127|NCT05199090|565684141|FG003|Overall Study|Adverse Event|0|||
156710128|NCT05199090|565684142|FG004|Overall Study|Adverse Event|0|||
156710129|NCT05199090|565684143|FG005|Overall Study|Adverse Event|0|||
156710130|NCT05199090|565684138|FG000|Overall Study|Lost to Follow-up|1|||
156710131|NCT05199090|565684139|FG001|Overall Study|Lost to Follow-up|0|||
156710132|NCT05199090|565684140|FG002|Overall Study|Lost to Follow-up|1|||
156710133|NCT05199090|565684141|FG003|Overall Study|Lost to Follow-up|4|||
156710134|NCT05199090|565684142|FG004|Overall Study|Lost to Follow-up|0|||
156710135|NCT05199090|565684143|FG005|Overall Study|Lost to Follow-up|5|||
156710136|NCT05199090|565684138|FG000|Overall Study|Physician Decision|0|||
156710137|NCT05199090|565684139|FG001|Overall Study|Physician Decision|0|||
156710138|NCT05199090|565684140|FG002|Overall Study|Physician Decision|0|||
156710139|NCT05199090|565684141|FG003|Overall Study|Physician Decision|0|||
156710140|NCT05199090|565684142|FG004|Overall Study|Physician Decision|0|||
156710141|NCT05199090|565684143|FG005|Overall Study|Physician Decision|1|||
156710142|NCT05199090|565684138|FG000|Overall Study|Study terminated by sponsor|0|||
156710143|NCT05199090|565684139|FG001|Overall Study|Study terminated by sponsor|6|||
156710144|NCT05199090|565684140|FG002|Overall Study|Study terminated by sponsor|0|||
156710145|NCT05199090|565684141|FG003|Overall Study|Study terminated by sponsor|0|||
156710146|NCT05199090|565684142|FG004|Overall Study|Study terminated by sponsor|0|||
156710147|NCT05199090|565684143|FG005|Overall Study|Study terminated by sponsor|5|||
156710148|NCT05199090|565684138|FG000|Overall Study|Subject decision|0|||
156710149|NCT05199090|565684139|FG001|Overall Study|Subject decision|4|||
156710150|NCT05199090|565684140|FG002|Overall Study|Subject decision|0|||
156710151|NCT05199090|565684141|FG003|Overall Study|Subject decision|2|||
156710152|NCT05199090|565684142|FG004|Overall Study|Subject decision|5|||
156710153|NCT05199090|565684143|FG005|Overall Study|Subject decision|2|||
156710154|NCT03489109|565684144|FG000|Overall Study|Lost to Follow-up|1|||
156710155|NCT03489109|565684145|FG001|Overall Study|Lost to Follow-up|2|||
156710156|NCT04868968|565684146|FG000|Overall Study|Lost to Follow-up|1|||
156710157|NCT00384930|565684149|FG000|Overall Study|Adverse Event|5|||
156710158|NCT00384930|565684150|FG001|Overall Study|Adverse Event|4|||
156710159|NCT00384930|565684151|FG002|Overall Study|Adverse Event|12|||
156710160|NCT00384930|565684152|FG003|Overall Study|Adverse Event|11|||
156710161|NCT00384930|565684153|FG004|Overall Study|Adverse Event|14|||
156710162|NCT00384930|565684149|FG000|Overall Study|Entry Criteria Not Met|2|||
156792216|NCT04110145|565992698|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792217|NCT04110145|565992699|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792218|NCT04110145|565992700|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
157016330|NCT00087139|566811296|FG000|Overall Study|Response achieved|0|||
156710163|NCT00384930|565684150|FG001|Overall Study|Entry Criteria Not Met|6|||
156710164|NCT00384930|565684151|FG002|Overall Study|Entry Criteria Not Met|7|||
156710165|NCT00384930|565684152|FG003|Overall Study|Entry Criteria Not Met|8|||
156710166|NCT00384930|565684153|FG004|Overall Study|Entry Criteria Not Met|4|||
156710167|NCT00384930|565684149|FG000|Overall Study|Lack of Efficacy|1|||
156710168|NCT00384930|565684150|FG001|Overall Study|Lack of Efficacy|1|||
156710169|NCT00384930|565684151|FG002|Overall Study|Lack of Efficacy|2|||
156710170|NCT00384930|565684152|FG003|Overall Study|Lack of Efficacy|1|||
156710171|NCT00384930|565684153|FG004|Overall Study|Lack of Efficacy|2|||
156710172|NCT00384930|565684149|FG000|Overall Study|Lost to Follow-up|5|||
156710173|NCT00384930|565684150|FG001|Overall Study|Lost to Follow-up|3|||
157016331|NCT00087139|566811297|FG001|Overall Study|Response achieved|1|||
156710174|NCT00384930|565684151|FG002|Overall Study|Lost to Follow-up|0|||
156710175|NCT00384930|565684152|FG003|Overall Study|Lost to Follow-up|4|||
156710176|NCT00384930|565684153|FG004|Overall Study|Lost to Follow-up|6|||
156710177|NCT00384930|565684149|FG000|Overall Study|Physician Decision|0|||
156710178|NCT00384930|565684150|FG001|Overall Study|Physician Decision|1|||
156710179|NCT00384930|565684151|FG002|Overall Study|Physician Decision|1|||
156710180|NCT00384930|565684152|FG003|Overall Study|Physician Decision|0|||
156710181|NCT00384930|565684153|FG004|Overall Study|Physician Decision|1|||
156710182|NCT00384930|565684149|FG000|Overall Study|Protocol Violation|1|||
156710183|NCT00384930|565684150|FG001|Overall Study|Protocol Violation|0|||
156710184|NCT00384930|565684151|FG002|Overall Study|Protocol Violation|1|||
156710185|NCT00384930|565684152|FG003|Overall Study|Protocol Violation|6|||
156710186|NCT00384930|565684153|FG004|Overall Study|Protocol Violation|4|||
156710187|NCT00384930|565684149|FG000|Overall Study|Sponsor Decision|3|||
156710188|NCT00384930|565684150|FG001|Overall Study|Sponsor Decision|4|||
156710189|NCT00384930|565684151|FG002|Overall Study|Sponsor Decision|0|||
156710190|NCT00384930|565684152|FG003|Overall Study|Sponsor Decision|5|||
156710191|NCT00384930|565684153|FG004|Overall Study|Sponsor Decision|0|||
156710192|NCT00384930|565684149|FG000|Overall Study|Withdrawal by Subject|9|||
156710193|NCT00384930|565684150|FG001|Overall Study|Withdrawal by Subject|7|||
156710194|NCT00384930|565684151|FG002|Overall Study|Withdrawal by Subject|7|||
156710195|NCT00384930|565684152|FG003|Overall Study|Withdrawal by Subject|6|||
156710196|NCT00384930|565684153|FG004|Overall Study|Withdrawal by Subject|16|||
156710197|NCT00384930|565684149|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
156710198|NCT00384930|565684150|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
156710199|NCT00384930|565684151|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710200|NCT00384930|565684152|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710201|NCT00384930|565684153|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
156710202|NCT02552732|565684156|FG000|Overall Study|Lost to Follow-up|2|||
156710203|NCT02552732|565684156|FG000|Overall Study|Physician Decision|1|||
156710204|NCT02552732|565684156|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
156710205|NCT02552732|565684156|FG000|Overall Study|Withdrawal by Subject|6|||
156710206|NCT01547130|565684159|FG000|Overall Study|Lost to Follow-up|9|||
156710207|NCT01547130|565684160|FG001|Overall Study|Lost to Follow-up|5|||
156710208|NCT00025259|565684162|FG000|Overall Study|Death|1|||
156710209|NCT00025259|565684163|FG001|Overall Study|Death|3|||
156710210|NCT00025259|565684164|FG002|Overall Study|Death|0|||
156710211|NCT00025259|565684165|FG003|Overall Study|Death|3|||
156710212|NCT00025259|565684166|FG004|Overall Study|Death|0|||
156710213|NCT00025259|565684167|FG005|Overall Study|Death|1|||
156710214|NCT00025259|565684168|FG006|Overall Study|Death|2|||
156710215|NCT00025259|565684162|FG000|Overall Study|Lack of Efficacy|2|||
156710216|NCT00025259|565684163|FG001|Overall Study|Lack of Efficacy|46|||
156710217|NCT00025259|565684164|FG002|Overall Study|Lack of Efficacy|60|||
156710218|NCT00025259|565684165|FG003|Overall Study|Lack of Efficacy|78|||
156710219|NCT00025259|565684166|FG004|Overall Study|Lack of Efficacy|11|||
156710220|NCT00025259|565684167|FG005|Overall Study|Lack of Efficacy|30|||
156710221|NCT00025259|565684168|FG006|Overall Study|Lack of Efficacy|38|||
156710222|NCT00025259|565684162|FG000|Overall Study|Lost to Follow-up|2|||
156710223|NCT00025259|565684163|FG001|Overall Study|Lost to Follow-up|9|||
157016332|NCT00087139|566811298|FG002|Overall Study|Response achieved|0|||
157016333|NCT00087139|566811296|FG000|Overall Study|Extradural disease|0|||
156710224|NCT00025259|565684164|FG002|Overall Study|Lost to Follow-up|13|||
156710225|NCT00025259|565684165|FG003|Overall Study|Lost to Follow-up|13|||
156710226|NCT00025259|565684166|FG004|Overall Study|Lost to Follow-up|1|||
156710227|NCT00025259|565684167|FG005|Overall Study|Lost to Follow-up|3|||
156710228|NCT00025259|565684168|FG006|Overall Study|Lost to Follow-up|1|||
156710229|NCT00025259|565684162|FG000|Overall Study|Physician Decision|12|||
156710230|NCT00025259|565684163|FG001|Overall Study|Physician Decision|1|||
156710231|NCT00025259|565684164|FG002|Overall Study|Physician Decision|0|||
156710232|NCT00025259|565684165|FG003|Overall Study|Physician Decision|5|||
156710233|NCT00025259|565684166|FG004|Overall Study|Physician Decision|4|||
156710234|NCT00025259|565684167|FG005|Overall Study|Physician Decision|2|||
156710235|NCT00025259|565684168|FG006|Overall Study|Physician Decision|1|||
156710236|NCT00025259|565684162|FG000|Overall Study|Protocol Violation|3|||
156710237|NCT00025259|565684163|FG001|Overall Study|Protocol Violation|2|||
157016334|NCT00087139|566811297|FG001|Overall Study|Extradural disease|0|||
156710238|NCT00025259|565684164|FG002|Overall Study|Protocol Violation|2|||
156710239|NCT00025259|565684165|FG003|Overall Study|Protocol Violation|1|||
156710240|NCT00025259|565684166|FG004|Overall Study|Protocol Violation|2|||
156710241|NCT00025259|565684167|FG005|Overall Study|Protocol Violation|1|||
156710242|NCT00025259|565684168|FG006|Overall Study|Protocol Violation|3|||
156710243|NCT00025259|565684162|FG000|Overall Study|Withdrawal by Subject|9|||
156710244|NCT00025259|565684163|FG001|Overall Study|Withdrawal by Subject|27|||
156710245|NCT00025259|565684164|FG002|Overall Study|Withdrawal by Subject|6|||
156710246|NCT00025259|565684165|FG003|Overall Study|Withdrawal by Subject|14|||
156710247|NCT00025259|565684166|FG004|Overall Study|Withdrawal by Subject|11|||
156710248|NCT00025259|565684167|FG005|Overall Study|Withdrawal by Subject|8|||
156873368|NCT00478023|566294370|FG002|Overall Study|Adverse Event|8|||
156873369|NCT00478023|566294371|FG003|Overall Study|Adverse Event|14|||
156873370|NCT00478023|566294372|FG004|Overall Study|Adverse Event|6|||
156873371|NCT00478023|566294368|FG000|Overall Study|Death|1|||
156873372|NCT00478023|566294369|FG001|Overall Study|Death|0|||
156873373|NCT00478023|566294370|FG002|Overall Study|Death|0|||
156873374|NCT00478023|566294371|FG003|Overall Study|Death|0|||
156873375|NCT00478023|566294372|FG004|Overall Study|Death|0|||
156873376|NCT00478023|566294368|FG000|Overall Study|Lack of Efficacy|11|||
156873377|NCT00478023|566294369|FG001|Overall Study|Lack of Efficacy|10|||
156873378|NCT00478023|566294370|FG002|Overall Study|Lack of Efficacy|4|||
156873379|NCT00478023|566294371|FG003|Overall Study|Lack of Efficacy|5|||
156873380|NCT00478023|566294372|FG004|Overall Study|Lack of Efficacy|41|||
156873381|NCT00478023|566294368|FG000|Overall Study|Lost to Follow-up|3|||
156873382|NCT00478023|566294369|FG001|Overall Study|Lost to Follow-up|1|||
156873383|NCT00478023|566294370|FG002|Overall Study|Lost to Follow-up|1|||
156873384|NCT00478023|566294371|FG003|Overall Study|Lost to Follow-up|1|||
156873385|NCT00478023|566294372|FG004|Overall Study|Lost to Follow-up|0|||
157126397|NCT00132730|567214130|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
157126398|NCT00132730|567214131|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
157126399|NCT00132730|567214132|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
157126400|NCT00132730|567214133|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
157126401|NCT00132730|567214134|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
157126402|NCT00132730|567214129|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
156710249|NCT00025259|565684168|FG006|Overall Study|Withdrawal by Subject|3|||
156873386|NCT00478023|566294368|FG000|Overall Study|Withdrawal by Subject|2|||
156873387|NCT00478023|566294369|FG001|Overall Study|Withdrawal by Subject|3|||
156873388|NCT00478023|566294370|FG002|Overall Study|Withdrawal by Subject|2|||
156873389|NCT00478023|566294371|FG003|Overall Study|Withdrawal by Subject|4|||
156873390|NCT00478023|566294372|FG004|Overall Study|Withdrawal by Subject|5|||
156873391|NCT00478023|566294368|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
156873392|NCT00478023|566294369|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
156873393|NCT00478023|566294370|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
156873394|NCT00478023|566294371|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
156873395|NCT00478023|566294372|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
156873396|NCT03895840|566294373|FG000|Overall Study|Withdrawal by Subject|21|||
156873397|NCT02395081|566294374|FG000|Overall Study|Withdrawal by Subject|1|||
156873398|NCT02395081|566294375|FG001|Overall Study|Withdrawal by Subject|1|||
156873399|NCT02395081|566294376|FG002|Overall Study|Withdrawal by Subject|0|||
156873400|NCT02395081|566294374|FG000|Overall Study|Moved where blood couldn't be collected|4|||
156873401|NCT02395081|566294375|FG001|Overall Study|Moved where blood couldn't be collected|1|||
156873402|NCT02395081|566294376|FG002|Overall Study|Moved where blood couldn't be collected|3|||
156873403|NCT02395081|566294374|FG000|Overall Study|Fetal Loss|2|||
156873404|NCT02395081|566294375|FG001|Overall Study|Fetal Loss|3|||
156873405|NCT02395081|566294376|FG002|Overall Study|Fetal Loss|1|||
156710250|NCT00025259|565684162|FG000|Overall Study|Ineligible|14|||
156710251|NCT00025259|565684163|FG001|Overall Study|Ineligible|1|||
156710252|NCT00025259|565684164|FG002|Overall Study|Ineligible|0|||
156710253|NCT00025259|565684165|FG003|Overall Study|Ineligible|0|||
156710254|NCT00025259|565684166|FG004|Overall Study|Ineligible|6|||
156710255|NCT00025259|565684167|FG005|Overall Study|Ineligible|0|||
156710256|NCT00025259|565684168|FG006|Overall Study|Ineligible|1|||
156710257|NCT00025259|565684162|FG000|Overall Study|Randomization error|1|||
156873406|NCT00068419|566294377|FG000|Overall Study|Adverse Event|3|||
156873407|NCT00068419|566294377|FG000|Overall Study|Lack of Efficacy|24|||
156873408|NCT00068419|566294377|FG000|Overall Study|Lost to Follow-up|1|||
156873409|NCT00068419|566294377|FG000|Overall Study|Physician Decision|7|||
156873410|NCT00068419|566294377|FG000|Overall Study|Withdrawal by Subject|14|||
156873411|NCT00068419|566294377|FG000|Overall Study|Ineligible|11|||
156710258|NCT00025259|565684163|FG001|Overall Study|Randomization error|0|||
156873412|NCT00630838|566294389|FG000|Overall Study|Death|0|||
156873413|NCT00630838|566294390|FG001|Overall Study|Death|1|||
156873414|NCT00630838|566294389|FG000|Overall Study|Lost to Follow-up|0|||
156873415|NCT00630838|566294390|FG001|Overall Study|Lost to Follow-up|1|||
156873416|NCT00928408|566294391|FG000|Overall Study|Other|2|||
156873417|NCT00928408|566294391|FG000|Overall Study|Withdrawal by Subject|4|||
156873418|NCT00928408|566294391|FG000|Overall Study|Death|5|||
156710259|NCT00025259|565684164|FG002|Overall Study|Randomization error|0|||
156710260|NCT00025259|565684165|FG003|Overall Study|Randomization error|0|||
156710261|NCT00025259|565684166|FG004|Overall Study|Randomization error|1|||
156710262|NCT00025259|565684167|FG005|Overall Study|Randomization error|7|||
156873419|NCT00928408|566294391|FG000|Overall Study|Lost to Follow-up|12|||
156873420|NCT00256997|566294396|FG000|Overall Study|Protocol Violation|1|||
156873421|NCT00256997|566294397|FG001|Overall Study|Protocol Violation|4|||
156710263|NCT00025259|565684168|FG006|Overall Study|Randomization error|2|||
156873422|NCT00256997|566294396|FG000|Overall Study|Lack of Efficacy|1|||
156873423|NCT00256997|566294397|FG001|Overall Study|Lack of Efficacy|4|||
156873424|NCT00256997|566294396|FG000|Overall Study|Death|2|||
156710264|NCT00025259|565684162|FG000|Overall Study|Adverse Event|1|||
156710265|NCT00025259|565684163|FG001|Overall Study|Adverse Event|0|||
156792219|NCT04110145|565992701|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
156792220|NCT04110145|565992702|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
156792221|NCT02371889|565992703|FG000|Overall Study|Adverse medication effect|11|||
156792222|NCT02371889|565992704|FG001|Overall Study|Adverse medication effect|2|||
156792223|NCT02371889|565992703|FG000|Overall Study|Lost to Follow-up|6|||
156792224|NCT02371889|565992704|FG001|Overall Study|Lost to Follow-up|5|||
156792225|NCT02371889|565992703|FG000|Overall Study|Personal time constraints|2|||
156792226|NCT02371889|565992704|FG001|Overall Study|Personal time constraints|4|||
156792227|NCT02371889|565992703|FG000|Overall Study|Lack of Efficacy|0|||
156792228|NCT02371889|565992704|FG001|Overall Study|Lack of Efficacy|2|||
156792229|NCT02371889|565992703|FG000|Overall Study|Relapse|0|||
156792230|NCT02371889|565992704|FG001|Overall Study|Relapse|1|||
156792231|NCT05520333|565992705|FG000|Overall Study|Lost to Follow-up|3|||
156792232|NCT05520333|565992706|FG001|Overall Study|Lost to Follow-up|6|||
156792233|NCT05538728|565992707|FG000|Overall Study|Withdrawal by Subject|1|||
156792234|NCT05538728|565992708|FG001|Overall Study|Withdrawal by Subject|1|||
157126403|NCT00132730|567214130|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
157126404|NCT00132730|567214131|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
157126405|NCT00132730|567214132|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
157126406|NCT00132730|567214133|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
157126407|NCT00132730|567214134|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
157126408|NCT00132730|567214129|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
157126409|NCT00132730|567214130|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
157126410|NCT00132730|567214131|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
157126411|NCT00132730|567214132|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
157126412|NCT00132730|567214133|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
157126413|NCT00132730|567214134|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
157126414|NCT00132730|567214129|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
157126415|NCT00132730|567214130|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
157126416|NCT00132730|567214131|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
157126417|NCT00132730|567214132|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
157126418|NCT00132730|567214133|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
157126419|NCT00132730|567214134|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
157126420|NCT00132730|567214129|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
157126421|NCT00132730|567214130|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
157126422|NCT00132730|567214131|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
157126423|NCT00132730|567214132|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
157126424|NCT00132730|567214133|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
157126425|NCT00132730|567214134|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
156710266|NCT00025259|565684164|FG002|Overall Study|Adverse Event|0|||
156710267|NCT00025259|565684165|FG003|Overall Study|Adverse Event|0|||
156710268|NCT00025259|565684166|FG004|Overall Study|Adverse Event|0|||
156710269|NCT00025259|565684167|FG005|Overall Study|Adverse Event|0|||
156710270|NCT00025259|565684168|FG006|Overall Study|Adverse Event|0|||
156710271|NCT01685840|565684169|FG000|Overall Study|Death|77|||
156710272|NCT01685840|565684170|FG001|Overall Study|Death|66|||
156710273|NCT01685840|565684169|FG000|Overall Study|Lost to Follow-up|27|||
156710274|NCT01685840|565684170|FG001|Overall Study|Lost to Follow-up|25|||
156710275|NCT01685840|565684169|FG000|Overall Study|Physician Decision|3|||
156710276|NCT01685840|565684170|FG001|Overall Study|Physician Decision|7|||
156710277|NCT01685840|565684169|FG000|Overall Study|Withdrawal by Subject|14|||
156710278|NCT01685840|565684170|FG001|Overall Study|Withdrawal by Subject|17|||
156710279|NCT01685840|565684169|FG000|Overall Study|Futility|197|||
156710280|NCT01685840|565684170|FG001|Overall Study|Futility|200|||
156710281|NCT01685840|565684169|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
156710282|NCT01685840|565684170|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
156710283|NCT01004003|565684172|FG000|Overall Study|Progressive disease|2|||
156710284|NCT01004003|565684173|FG001|Overall Study|Progressive disease|1|||
156710285|NCT01004003|565684174|FG002|Overall Study|Progressive disease|1|||
156710286|NCT01004003|565684175|FG003|Overall Study|Progressive disease|0|||
156710287|NCT01004003|565684176|FG004|Overall Study|Progressive disease|2|||
156710288|NCT01004003|565684177|FG005|Overall Study|Progressive disease|1|||
156710289|NCT01004003|565684178|FG006|Overall Study|Progressive disease|1|||
156710290|NCT01004003|565684179|FG007|Overall Study|Progressive disease|39|||
156710291|NCT01004003|565684180|FG008|Overall Study|Progressive disease|22|||
156710292|NCT01004003|565684172|FG000|Overall Study|Adverse Event|4|||
156792235|NCT02254460|565992709|FG000|Overall Study|Adverse Event|1|||
156792236|NCT02254460|565992710|FG001|Overall Study|Adverse Event|0|||
156710293|NCT01004003|565684173|FG001|Overall Study|Adverse Event|2|||
156710294|NCT01004003|565684174|FG002|Overall Study|Adverse Event|3|||
156792237|NCT02336555|565992711|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156873425|NCT00256997|566294397|FG001|Overall Study|Death|0|||
157126426|NCT00132730|567214129|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
157126427|NCT00132730|567214130|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
157126428|NCT00132730|567214131|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
157126429|NCT00132730|567214132|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
157126430|NCT00132730|567214133|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
157126431|NCT00132730|567214134|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
156710295|NCT01004003|565684175|FG003|Overall Study|Adverse Event|3|||
156710296|NCT01004003|565684176|FG004|Overall Study|Adverse Event|2|||
156873426|NCT00256997|566294396|FG000|Overall Study|Adverse Event|4|||
156873427|NCT00256997|566294397|FG001|Overall Study|Adverse Event|0|||
156873428|NCT00256997|566294396|FG000|Overall Study|Lost to Follow-up|3|||
156873429|NCT00256997|566294397|FG001|Overall Study|Lost to Follow-up|5|||
156873430|NCT00256997|566294396|FG000|Overall Study|Withdrawal by Subject|13|||
156873431|NCT00256997|566294397|FG001|Overall Study|Withdrawal by Subject|3|||
156873432|NCT00256997|566294396|FG000|Overall Study|Started but not treated|2|||
156873433|NCT00256997|566294397|FG001|Overall Study|Started but not treated|0|||
156873434|NCT00256997|566294396|FG000|Overall Study|Other|5|||
156873435|NCT00256997|566294397|FG001|Overall Study|Other|8|||
156873436|NCT00256997|566294396|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
156873437|NCT00256997|566294397|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
156873438|NCT00256997|566294396|FG000|Overall Study|Participant Non-compliant|3|||
156873439|NCT00256997|566294397|FG001|Overall Study|Participant Non-compliant|6|||
156873440|NCT00256997|566294396|FG000|Overall Study|Investigator Withdrew Participant|2|||
156873441|NCT00256997|566294397|FG001|Overall Study|Investigator Withdrew Participant|1|||
156873442|NCT01287741|566294400|FG000|Overall Study|Withdrawal by Subject|35|||
156873443|NCT01287741|566294401|FG001|Overall Study|Withdrawal by Subject|38|||
156873444|NCT01287741|566294400|FG000|Overall Study|Protocol Violation|2|||
156873445|NCT01287741|566294401|FG001|Overall Study|Protocol Violation|0|||
156873446|NCT01287741|566294400|FG000|Overall Study|Physician Decision|15|||
156873447|NCT01287741|566294401|FG001|Overall Study|Physician Decision|23|||
156873448|NCT01287741|566294400|FG000|Overall Study|Non-compliance|8|||
156873449|NCT01287741|566294401|FG001|Overall Study|Non-compliance|6|||
156873450|NCT01287741|566294400|FG000|Overall Study|Lost to Follow-up|10|||
156873451|NCT01287741|566294401|FG001|Overall Study|Lost to Follow-up|8|||
156873452|NCT01287741|566294400|FG000|Overall Study|Death|32|||
156873453|NCT01287741|566294401|FG001|Overall Study|Death|44|||
156873454|NCT01287741|566294400|FG000|Overall Study|Adverse Event|4|||
156873455|NCT01287741|566294401|FG001|Overall Study|Adverse Event|6|||
156873456|NCT01287741|566294400|FG000|Overall Study|Study terminated by Sponsor|307|||
156873457|NCT01287741|566294401|FG001|Overall Study|Study terminated by Sponsor|315|||
156873458|NCT01287741|566294400|FG000|Overall Study|Progressive disease|190|||
156873459|NCT01287741|566294401|FG001|Overall Study|Progressive disease|166|||
156873460|NCT01287741|566294400|FG000|Overall Study|Reason not specified|23|||
156873461|NCT01287741|566294401|FG001|Overall Study|Reason not specified|9|||
156873462|NCT04163016|566294403|FG000|Enrollment|Adverse Event|1|||
156873463|NCT04163016|566294404|FG001|Enrollment|Adverse Event|0|||
156873464|NCT04163016|566294405|FG002|Enrollment|Adverse Event|0|||
156873465|NCT04163016|566294406|FG003|Enrollment|Adverse Event|0|||
156873466|NCT04163016|566294403|FG000|Treatment|Adverse Event|0|||
156873467|NCT04163016|566294404|FG001|Treatment|Adverse Event|1|||
156873468|NCT04163016|566294405|FG002|Treatment|Adverse Event|0|||
156873469|NCT04163016|566294406|FG003|Treatment|Adverse Event|0|||
156873470|NCT04163016|566294403|FG000|Treatment|Withdrawal by Subject|0|||
156873471|NCT04163016|566294404|FG001|Treatment|Withdrawal by Subject|2|||
156710297|NCT01004003|565684177|FG005|Overall Study|Adverse Event|2|||
156710298|NCT01004003|565684178|FG006|Overall Study|Adverse Event|7|||
156710299|NCT01004003|565684179|FG007|Overall Study|Adverse Event|21|||
156710300|NCT01004003|565684180|FG008|Overall Study|Adverse Event|6|||
156710301|NCT01004003|565684172|FG000|Overall Study|Refused to continue taking trial med.|0|||
156710302|NCT01004003|565684173|FG001|Overall Study|Refused to continue taking trial med.|0|||
156710303|NCT01004003|565684174|FG002|Overall Study|Refused to continue taking trial med.|0|||
156873472|NCT04163016|566294405|FG002|Treatment|Withdrawal by Subject|0|||
156873473|NCT04163016|566294406|FG003|Treatment|Withdrawal by Subject|0|||
156873474|NCT04163016|566294403|FG000|Treatment|Indeterminate TB-test|0|||
156873475|NCT04163016|566294404|FG001|Treatment|Indeterminate TB-test|0|||
156873476|NCT04163016|566294405|FG002|Treatment|Indeterminate TB-test|0|||
156873477|NCT04163016|566294406|FG003|Treatment|Indeterminate TB-test|1|||
156873478|NCT04163016|566294403|FG000|Treatment|Participant did not want to continue in study|0|||
156873479|NCT04163016|566294404|FG001|Treatment|Participant did not want to continue in study|0|||
156873480|NCT04163016|566294405|FG002|Treatment|Participant did not want to continue in study|0|||
156873481|NCT04163016|566294406|FG003|Treatment|Participant did not want to continue in study|1|||
156873482|NCT01104311|566294411|FG000|Overall Study|Withdrawal by Subject|6|||
156873483|NCT01104311|566294412|FG001|Overall Study|Withdrawal by Subject|6|||
157126432|NCT00132730|567214129|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
157126433|NCT00132730|567214130|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
156873484|NCT01104311|566294411|FG000|Overall Study|Protocol Violation|0|||
156873485|NCT01104311|566294412|FG001|Overall Study|Protocol Violation|1|||
156873486|NCT01104311|566294411|FG000|Overall Study|Physician Decision|2|||
156873487|NCT01104311|566294412|FG001|Overall Study|Physician Decision|2|||
156873488|NCT01104311|566294411|FG000|Overall Study|low compliance|1|||
156873489|NCT01104311|566294412|FG001|Overall Study|low compliance|1|||
156873490|NCT01104311|566294411|FG000|Overall Study|Adverse Event|1|||
156873491|NCT01104311|566294412|FG001|Overall Study|Adverse Event|2|||
156873492|NCT04193189|566294413|FG000|Overall Study|Lost to Follow-up|9|||
156873493|NCT04193189|566294414|FG001|Overall Study|Lost to Follow-up|7|||
156873494|NCT04193189|566294415|FG002|Overall Study|Lost to Follow-up|9|||
156710304|NCT01004003|565684175|FG003|Overall Study|Refused to continue taking trial med.|0|||
156710305|NCT01004003|565684176|FG004|Overall Study|Refused to continue taking trial med.|0|||
156710306|NCT01004003|565684177|FG005|Overall Study|Refused to continue taking trial med.|0|||
156710307|NCT01004003|565684178|FG006|Overall Study|Refused to continue taking trial med.|0|||
156710308|NCT01004003|565684179|FG007|Overall Study|Refused to continue taking trial med.|0|||
156710309|NCT01004003|565684180|FG008|Overall Study|Refused to continue taking trial med.|2|||
156710310|NCT01004003|565684172|FG000|Overall Study|Other|0|||
156710311|NCT01004003|565684173|FG001|Overall Study|Other|0|||
156873495|NCT04193189|566294416|FG003|Overall Study|Lost to Follow-up|0|||
156873496|NCT04193189|566294413|FG000|Overall Study|Withdrawal by Subject|1|||
156873497|NCT04193189|566294414|FG001|Overall Study|Withdrawal by Subject|2|||
156873498|NCT04193189|566294415|FG002|Overall Study|Withdrawal by Subject|2|||
156710312|NCT01004003|565684174|FG002|Overall Study|Other|0|||
156710313|NCT01004003|565684175|FG003|Overall Study|Other|0|||
156710314|NCT01004003|565684176|FG004|Overall Study|Other|0|||
156710315|NCT01004003|565684177|FG005|Overall Study|Other|1|||
156710316|NCT01004003|565684178|FG006|Overall Study|Other|0|||
156873499|NCT04193189|566294416|FG003|Overall Study|Withdrawal by Subject|0|||
156873500|NCT04193189|566294413|FG000|Overall Study|Death|1|||
156873501|NCT04193189|566294414|FG001|Overall Study|Death|1|||
156873502|NCT04193189|566294415|FG002|Overall Study|Death|0|||
156873503|NCT04193189|566294416|FG003|Overall Study|Death|0|||
157016335|NCT00087139|566811298|FG002|Overall Study|Extradural disease|1|||
157016336|NCT02671435|566811307|FG000|Overall Study|Death|1|||
157016337|NCT02671435|566811308|FG001|Overall Study|Death|3|||
156710317|NCT01004003|565684179|FG007|Overall Study|Other|0|||
156710318|NCT01004003|565684180|FG008|Overall Study|Other|0|||
157016338|NCT02671435|566811309|FG002|Overall Study|Death|0|||
157016339|NCT02671435|566811310|FG003|Overall Study|Death|16|||
156710319|NCT00345631|565684181|FG000|Overall Study|Withdrawal by Subject|1|||
156710320|NCT00345631|565684182|FG001|Overall Study|Withdrawal by Subject|0|||
156710321|NCT00345631|565684183|FG002|Overall Study|Withdrawal by Subject|1|||
156710322|NCT00345631|565684181|FG000|Overall Study|Adverse Event|0|||
156710323|NCT00345631|565684182|FG001|Overall Study|Adverse Event|1|||
156710324|NCT00345631|565684183|FG002|Overall Study|Adverse Event|0|||
156710325|NCT00345631|565684181|FG000|Overall Study|Lost to Follow-up|3|||
156710326|NCT00345631|565684182|FG001|Overall Study|Lost to Follow-up|7|||
156710327|NCT00345631|565684183|FG002|Overall Study|Lost to Follow-up|4|||
156710328|NCT00345631|565684181|FG000|Overall Study|Other reasons|0|||
156710329|NCT00345631|565684182|FG001|Overall Study|Other reasons|0|||
156710330|NCT00345631|565684183|FG002|Overall Study|Other reasons|1|||
156710331|NCT03371459|565684191|FG000|Washout|Lost to Follow-up|0|||
156873504|NCT04193189|566294413|FG000|Overall Study|Protocol Violation|0|||
156873505|NCT04193189|566294414|FG001|Overall Study|Protocol Violation|0|||
156873506|NCT04193189|566294415|FG002|Overall Study|Protocol Violation|0|||
157016340|NCT02671435|566811311|FG004|Overall Study|Death|14|||
157016341|NCT02671435|566811312|FG005|Overall Study|Death|29|||
157016342|NCT02671435|566811313|FG006|Overall Study|Death|34|||
157016343|NCT02671435|566811314|FG007|Overall Study|Death|28|||
157016344|NCT02671435|566811315|FG008|Overall Study|Death|19|||
157016345|NCT02671435|566811316|FG009|Overall Study|Death|10|||
157016346|NCT02671435|566811317|FG010|Overall Study|Death|8|||
157016347|NCT02671435|566811318|FG011|Overall Study|Death|29|||
157016348|NCT02671435|566811319|FG012|Overall Study|Death|29|||
157016349|NCT02671435|566811320|FG013|Overall Study|Death|29|||
157016350|NCT02671435|566811321|FG014|Overall Study|Death|27|||
157016351|NCT02671435|566811307|FG000|Overall Study|Lost to Follow-up|0|||
157016352|NCT02671435|566811308|FG001|Overall Study|Lost to Follow-up|0|||
157016353|NCT02671435|566811309|FG002|Overall Study|Lost to Follow-up|1|||
157016354|NCT02671435|566811310|FG003|Overall Study|Lost to Follow-up|0|||
157016355|NCT02671435|566811311|FG004|Overall Study|Lost to Follow-up|1|||
157016356|NCT02671435|566811312|FG005|Overall Study|Lost to Follow-up|1|||
157016357|NCT02671435|566811313|FG006|Overall Study|Lost to Follow-up|2|||
156710332|NCT03371459|565684192|FG001|Washout|Lost to Follow-up|1|||
156710333|NCT01589497|565684195|FG000|Overall Study|Withdrawal by Subject|0|||
156873507|NCT04193189|566294416|FG003|Overall Study|Protocol Violation|1|||
156873508|NCT01864603|566296036|FG000|Stage 2|DSMB design modification|86056|||
156873509|NCT01864603|566296037|FG001|Stage 2|DSMB design modification|92558|||
157016358|NCT02671435|566811314|FG007|Overall Study|Lost to Follow-up|2|||
157016359|NCT02671435|566811315|FG008|Overall Study|Lost to Follow-up|0|||
157016360|NCT02671435|566811316|FG009|Overall Study|Lost to Follow-up|2|||
156873510|NCT03901469|566296038|FG000|Overall Study|Radiographic Progression|4|||
156873511|NCT03901469|566296039|FG001|Overall Study|Radiographic Progression|6|||
156873512|NCT03901469|566296040|FG002|Overall Study|Radiographic Progression|3|||
156873513|NCT03901469|566296041|FG003|Overall Study|Radiographic Progression|30|||
156873514|NCT03901469|566296042|FG004|Overall Study|Radiographic Progression|7|||
156873515|NCT03901469|566296043|FG005|Overall Study|Radiographic Progression|2|||
156873516|NCT03901469|566296044|FG006|Overall Study|Radiographic Progression|11|||
156873517|NCT03901469|566296038|FG000|Overall Study|Clinical Progression|0|||
156873518|NCT03901469|566296039|FG001|Overall Study|Clinical Progression|2|||
156873519|NCT03901469|566296040|FG002|Overall Study|Clinical Progression|0|||
156873520|NCT03901469|566296041|FG003|Overall Study|Clinical Progression|7|||
156873521|NCT03901469|566296042|FG004|Overall Study|Clinical Progression|6|||
156873522|NCT03901469|566296043|FG005|Overall Study|Clinical Progression|0|||
156873523|NCT03901469|566296044|FG006|Overall Study|Clinical Progression|2|||
156873524|NCT03901469|566296038|FG000|Overall Study|Adverse Event|1|||
156873525|NCT03901469|566296039|FG001|Overall Study|Adverse Event|0|||
156873526|NCT03901469|566296040|FG002|Overall Study|Adverse Event|0|||
156873527|NCT03901469|566296041|FG003|Overall Study|Adverse Event|0|||
156873528|NCT03901469|566296042|FG004|Overall Study|Adverse Event|0|||
156873529|NCT03901469|566296043|FG005|Overall Study|Adverse Event|0|||
156873530|NCT03901469|566296044|FG006|Overall Study|Adverse Event|9|||
156873531|NCT03901469|566296038|FG000|Overall Study|Physician Decision|0|||
156873532|NCT03901469|566296039|FG001|Overall Study|Physician Decision|0|||
156873533|NCT03901469|566296040|FG002|Overall Study|Physician Decision|0|||
156710334|NCT01589497|565684196|FG001|Overall Study|Withdrawal by Subject|1|||
156710335|NCT01589497|565684197|FG002|Overall Study|Withdrawal by Subject|0|||
156710336|NCT01589497|565684198|FG003|Overall Study|Withdrawal by Subject|1|||
156873534|NCT03901469|566296041|FG003|Overall Study|Physician Decision|1|||
156873535|NCT03901469|566296042|FG004|Overall Study|Physician Decision|0|||
156873536|NCT03901469|566296043|FG005|Overall Study|Physician Decision|0|||
156873537|NCT03901469|566296044|FG006|Overall Study|Physician Decision|0|||
156873538|NCT03901469|566296038|FG000|Overall Study|Withdrawal by Subject|0|||
156873539|NCT03901469|566296039|FG001|Overall Study|Withdrawal by Subject|0|||
156710337|NCT01589497|565684195|FG000|Overall Study|Death|1|||
156710338|NCT01589497|565684196|FG001|Overall Study|Death|0|||
156710339|NCT01589497|565684197|FG002|Overall Study|Death|0|||
156873540|NCT03901469|566296040|FG002|Overall Study|Withdrawal by Subject|0|||
156873541|NCT03901469|566296041|FG003|Overall Study|Withdrawal by Subject|0|||
156873542|NCT03901469|566296042|FG004|Overall Study|Withdrawal by Subject|2|||
156873543|NCT03901469|566296043|FG005|Overall Study|Withdrawal by Subject|0|||
156873544|NCT03901469|566296044|FG006|Overall Study|Withdrawal by Subject|8|||
156873545|NCT03901469|566296038|FG000|Overall Study|Death|0|||
156873546|NCT03901469|566296039|FG001|Overall Study|Death|0|||
156873547|NCT03901469|566296040|FG002|Overall Study|Death|0|||
156873548|NCT03901469|566296041|FG003|Overall Study|Death|3|||
156873549|NCT03901469|566296042|FG004|Overall Study|Death|5|||
156873550|NCT03901469|566296043|FG005|Overall Study|Death|0|||
156873551|NCT03901469|566296044|FG006|Overall Study|Death|1|||
156873552|NCT03901469|566296038|FG000|Overall Study|Termination of study by sponsor|0|||
156873553|NCT03901469|566296039|FG001|Overall Study|Termination of study by sponsor|0|||
156873554|NCT03901469|566296040|FG002|Overall Study|Termination of study by sponsor|0|||
157016361|NCT02671435|566811317|FG010|Overall Study|Lost to Follow-up|0|||
157016362|NCT02671435|566811318|FG011|Overall Study|Lost to Follow-up|3|||
156710340|NCT01589497|565684198|FG003|Overall Study|Death|0|||
156710341|NCT01589497|565684195|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710342|NCT01589497|565684196|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710343|NCT01589497|565684197|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
156710344|NCT01589497|565684198|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
156710345|NCT01885195|565684199|FG000|Overall Study|Adverse Event|29|||
156710346|NCT01885195|565684199|FG000|Overall Study|Death|1|||
156710347|NCT01885195|565684199|FG000|Overall Study|Disease Progression|67|||
156873555|NCT03901469|566296041|FG003|Overall Study|Termination of study by sponsor|0|||
156873556|NCT03901469|566296042|FG004|Overall Study|Termination of study by sponsor|1|||
156873557|NCT03901469|566296043|FG005|Overall Study|Termination of study by sponsor|1|||
156873558|NCT03901469|566296044|FG006|Overall Study|Termination of study by sponsor|0|||
156873559|NCT03901469|566296038|FG000|Overall Study|Not Reported|1|||
156873560|NCT03901469|566296039|FG001|Overall Study|Not Reported|0|||
156873561|NCT03901469|566296040|FG002|Overall Study|Not Reported|0|||
157016363|NCT02671435|566811319|FG012|Overall Study|Lost to Follow-up|3|||
156873562|NCT03901469|566296041|FG003|Overall Study|Not Reported|1|||
156873563|NCT03901469|566296042|FG004|Overall Study|Not Reported|0|||
156873564|NCT03901469|566296043|FG005|Overall Study|Not Reported|0|||
156873565|NCT03901469|566296044|FG006|Overall Study|Not Reported|1|||
156873566|NCT02586207|566296045|FG000|Overall Study|Physician Decision|1|||
157016364|NCT02671435|566811320|FG013|Overall Study|Lost to Follow-up|2|||
156710348|NCT01885195|565684199|FG000|Overall Study|Protocol Deviation|2|||
156710349|NCT01885195|565684199|FG000|Overall Study|Physician Decision|3|||
156710350|NCT01885195|565684199|FG000|Overall Study|Patient/guardian decision|8|||
157145168|NCT05755438|567278012|FG000|40-week OLE Period|Protocol Violation|1|||
156710351|NCT03390426|565684202|FG000|Overall Study|Protocol Violation|0|||
156710352|NCT03390426|565684203|FG001|Overall Study|Protocol Violation|1|||
156710353|NCT00259272|565684210|FG000|Overall Study|Adverse Event|2|||
156710354|NCT00259272|565684211|FG001|Overall Study|Adverse Event|1|||
156710355|NCT00259272|565684212|FG002|Overall Study|Adverse Event|0|||
156710356|NCT00259272|565684213|FG003|Overall Study|Adverse Event|3|||
156710357|NCT00259272|565684210|FG000|Overall Study|Lack of Efficacy|5|||
156710358|NCT00259272|565684211|FG001|Overall Study|Lack of Efficacy|1|||
156710359|NCT00259272|565684212|FG002|Overall Study|Lack of Efficacy|2|||
156710360|NCT00259272|565684213|FG003|Overall Study|Lack of Efficacy|6|||
156710361|NCT00259272|565684210|FG000|Overall Study|Physician Decision|1|||
156710362|NCT00259272|565684211|FG001|Overall Study|Physician Decision|2|||
156710363|NCT00259272|565684212|FG002|Overall Study|Physician Decision|1|||
156710364|NCT00259272|565684213|FG003|Overall Study|Physician Decision|3|||
156710365|NCT00259272|565684210|FG000|Overall Study|Protocol Violation|2|||
156710366|NCT00259272|565684211|FG001|Overall Study|Protocol Violation|0|||
156710367|NCT00259272|565684212|FG002|Overall Study|Protocol Violation|0|||
156710368|NCT00259272|565684213|FG003|Overall Study|Protocol Violation|1|||
156710369|NCT00259272|565684210|FG000|Overall Study|Sponsor Decision|0|||
156710370|NCT00259272|565684211|FG001|Overall Study|Sponsor Decision|1|||
156710371|NCT00259272|565684212|FG002|Overall Study|Sponsor Decision|0|||
156710372|NCT00259272|565684213|FG003|Overall Study|Sponsor Decision|0|||
156710373|NCT00259272|565684210|FG000|Overall Study|Withdrawal by Subject|4|||
156710374|NCT00259272|565684211|FG001|Overall Study|Withdrawal by Subject|2|||
156710375|NCT00259272|565684212|FG002|Overall Study|Withdrawal by Subject|2|||
156710376|NCT00259272|565684213|FG003|Overall Study|Withdrawal by Subject|7|||
156710377|NCT00259272|565684210|FG000|Overall Study|Lost to Follow-up|1|||
156710378|NCT00259272|565684211|FG001|Overall Study|Lost to Follow-up|0|||
156710379|NCT00259272|565684212|FG002|Overall Study|Lost to Follow-up|0|||
156710380|NCT00259272|565684213|FG003|Overall Study|Lost to Follow-up|1|||
156710381|NCT03301623|565684216|FG000|Overall Study|Death|3|||
156710382|NCT03301623|565684217|FG001|Overall Study|Death|1|||
156710383|NCT03301623|565684216|FG000|Overall Study|Withdrawal by Subject|11|||
156710384|NCT03301623|565684217|FG001|Overall Study|Withdrawal by Subject|13|||
156710385|NCT03301623|565684216|FG000|Overall Study|Lost to Follow-up|3|||
156710386|NCT03301623|565684217|FG001|Overall Study|Lost to Follow-up|1|||
156710387|NCT02185053|565684219|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
156710388|NCT02185053|565684220|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
156710389|NCT02185053|565684221|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
156710390|NCT02185053|565684219|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
156710391|NCT02185053|565684220|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710392|NCT02185053|565684221|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710393|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
156710394|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
156710395|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
156710396|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
156710397|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
156710398|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
156710399|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710400|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
156710401|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
156710402|NCT02185053|565684219|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
156710403|NCT02185053|565684220|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
156710404|NCT02185053|565684221|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
156710405|NCT02185053|565684219|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
156710406|NCT02185053|565684220|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
156710407|NCT02185053|565684221|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
156710408|NCT02185053|565684219|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
156710409|NCT02185053|565684220|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
156710410|NCT02185053|565684221|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
156710411|NCT02521376|565684229|FG000|Overall Study|Enrolled, But Not Treated|1|||
156792238|NCT02336555|565992712|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
156710412|NCT02521376|565684230|FG001|Overall Study|Enrolled, But Not Treated|0|||
156710413|NCT02521376|565684231|FG002|Overall Study|Enrolled, But Not Treated|0|||
156710414|NCT02521376|565684232|FG003|Overall Study|Enrolled, But Not Treated|0|||
156710415|NCT01374269|565684234|FG000|Overall Study|Withdrawal by Subject|4|||
156710416|NCT01374269|565684235|FG001|Overall Study|Withdrawal by Subject|0|||
156710417|NCT01374269|565684234|FG000|Overall Study|Lost to Follow-up|1|||
156710418|NCT01374269|565684235|FG001|Overall Study|Lost to Follow-up|3|||
156710419|NCT01374269|565684234|FG000|Overall Study|closed research|1|||
156808761|NCT04245449|566054456|FG000|Overall Study|COVID shutdown|7|||
156710420|NCT01374269|565684235|FG001|Overall Study|closed research|2|||
157145169|NCT05755438|567278013|FG001|40-week OLE Period|Protocol Violation|1|||
156873567|NCT02586207|566296045|FG000|Overall Study|Withdrawal by Subject|1|||
156873568|NCT03048578|566296046|FG000|Overall Study|Withdrawal by Subject|5|||
156873569|NCT03048578|566296047|FG001|Overall Study|Withdrawal by Subject|6|||
156873570|NCT03048578|566296046|FG000|Overall Study|Lost to Follow-up|22|||
156873571|NCT03048578|566296047|FG001|Overall Study|Lost to Follow-up|10|||
156873572|NCT03048578|566296046|FG000|Overall Study|Adverse Event|1|||
156873573|NCT03048578|566296047|FG001|Overall Study|Adverse Event|2|||
156873574|NCT03048578|566296046|FG000|Overall Study|Terminated|3|||
156873575|NCT03048578|566296047|FG001|Overall Study|Terminated|2|||
156873576|NCT00526071|566296048|FG000|Overall Study|Adverse Event|1|||
156873577|NCT00526071|566296048|FG000|Overall Study|Withdrawal by Subject|1|||
156873578|NCT00526071|566296048|FG000|Overall Study|Lack of Response to Study Drug|4|||
156873579|NCT02920242|566296049|FG000|Overall Study|Withdrawal by Subject|1|||
156873580|NCT02920242|566296050|FG001|Overall Study|Withdrawal by Subject|0|||
156873581|NCT02920242|566296051|FG002|Overall Study|Withdrawal by Subject|1|||
156873582|NCT02920242|566296049|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
156873583|NCT02920242|566296050|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
156873584|NCT02920242|566296051|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
156873585|NCT01409811|566296052|FG000|Overall Study|Insurance denial|1|||
156873586|NCT00634101|566296053|FG000|Overall Study|Study Terminated|3|||
156873587|NCT00634101|566296054|FG001|Overall Study|Study Terminated|3|||
156873588|NCT00634101|566296053|FG000|Overall Study|Lost to Follow-up|2|||
156873589|NCT00634101|566296054|FG001|Overall Study|Lost to Follow-up|0|||
156873590|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
156873591|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
156873592|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
156873593|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
156873594|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
156873595|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
156873596|NCT00139477|566296058|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
156873597|NCT00139477|566296059|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
156873598|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
156873599|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
156873600|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
156873601|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
156873602|NCT00139477|566296058|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
156873603|NCT00139477|566296059|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
156873604|NCT00441064|566296062|FG000|Overall Study|Adverse Event|1|||
156873605|NCT00441064|566296063|FG001|Overall Study|Adverse Event|0|||
156873606|NCT00441064|566296062|FG000|Overall Study|Abnormal laboratory values|0|||
156873607|NCT00441064|566296063|FG001|Overall Study|Abnormal laboratory values|2|||
156873608|NCT00441064|566296062|FG000|Overall Study|Abnormal test procedure results|0|||
156710421|NCT01653912|565684236|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710422|NCT01653912|565684237|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
156710423|NCT01653912|565684238|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710424|NCT01653912|565684239|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
157016365|NCT02671435|566811321|FG014|Overall Study|Lost to Follow-up|0|||
157016366|NCT02671435|566811307|FG000|Overall Study|Withdrawal by Subject|2|||
157016367|NCT02671435|566811308|FG001|Overall Study|Withdrawal by Subject|0|||
157016368|NCT02671435|566811309|FG002|Overall Study|Withdrawal by Subject|2|||
157016369|NCT02671435|566811310|FG003|Overall Study|Withdrawal by Subject|2|||
156710425|NCT01653912|565684240|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710426|NCT01653912|565684241|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
156710427|NCT01653912|565684236|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710428|NCT01653912|565684237|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710429|NCT01653912|565684238|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
156873609|NCT00441064|566296063|FG001|Overall Study|Abnormal test procedure results|1|||
156873610|NCT00441064|566296062|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156873611|NCT00441064|566296063|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157016370|NCT02671435|566811311|FG004|Overall Study|Withdrawal by Subject|2|||
157016371|NCT02671435|566811312|FG005|Overall Study|Withdrawal by Subject|7|||
156710430|NCT01653912|565684239|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710431|NCT01653912|565684240|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156873612|NCT00441064|566296062|FG000|Overall Study|Protocol Deviation|3|||
156873613|NCT00441064|566296063|FG001|Overall Study|Protocol Deviation|2|||
156873614|NCT00441064|566296062|FG000|Overall Study|Patient withdrew consent|5|||
156873615|NCT00441064|566296063|FG001|Overall Study|Patient withdrew consent|2|||
156873616|NCT03051178|566296064|FG000|Overall Study|Withdrawal by Subject|5|||
156873617|NCT00953056|566296065|FG000|Overall Study|Withdrew Consent|0|||
156873618|NCT00953056|566296066|FG001|Overall Study|Withdrew Consent|0|||
157016372|NCT02671435|566811313|FG006|Overall Study|Withdrawal by Subject|2|||
157016373|NCT02671435|566811314|FG007|Overall Study|Withdrawal by Subject|7|||
156873619|NCT00953056|566296067|FG002|Overall Study|Withdrew Consent|0|||
156873620|NCT00953056|566296068|FG003|Overall Study|Withdrew Consent|0|||
156873621|NCT00953056|566296069|FG004|Overall Study|Withdrew Consent|2|||
156710432|NCT01653912|565684241|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
156710433|NCT01653912|565684236|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710434|NCT01653912|565684237|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710435|NCT01653912|565684238|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710436|NCT01653912|565684239|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
156710437|NCT01653912|565684240|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710438|NCT01653912|565684241|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
156710439|NCT01653912|565684236|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710440|NCT01653912|565684237|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710441|NCT01653912|565684238|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710442|NCT01653912|565684239|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
156710443|NCT01653912|565684240|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710444|NCT01653912|565684241|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710445|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710446|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710447|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710448|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710449|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
156710450|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
156710451|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156873622|NCT00953056|566296070|FG005|Overall Study|Withdrew Consent|3|||
156873623|NCT00953056|566296065|FG000|Overall Study|Serious Adverse Event|0|||
157016374|NCT02671435|566811315|FG008|Overall Study|Withdrawal by Subject|1|||
157016375|NCT02671435|566811316|FG009|Overall Study|Withdrawal by Subject|1|||
156710452|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710453|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710454|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710455|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
156710456|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
156710457|NCT01653912|565684236|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710458|NCT01653912|565684237|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710459|NCT01653912|565684238|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710460|NCT01653912|565684239|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710461|NCT01653912|565684240|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
156710462|NCT01653912|565684241|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
156710463|NCT00708227|565684242|FG000|Overall Study|Physician Decision|0|||
156710464|NCT00708227|565684243|FG001|Overall Study|Physician Decision|3|||
156710465|NCT00708227|565684244|FG002|Overall Study|Physician Decision|1|||
156710466|NCT00708227|565684245|FG003|Overall Study|Physician Decision|2|||
156710467|NCT00708227|565684242|FG000|Overall Study|Withdrawal by Subject|1|||
156710468|NCT00708227|565684243|FG001|Overall Study|Withdrawal by Subject|2|||
156710469|NCT00708227|565684244|FG002|Overall Study|Withdrawal by Subject|0|||
156710470|NCT00708227|565684245|FG003|Overall Study|Withdrawal by Subject|1|||
156710471|NCT01987479|565684246|FG000|Overall Study|Protocol Violation|1|||
156710472|NCT01987479|565684246|FG000|Overall Study|Physician Decision|2|||
156710473|NCT01987479|565684246|FG000|Overall Study|Participant/legal guardian decision|1|||
156710474|NCT01987479|565684246|FG000|Overall Study|Other|5|||
156710475|NCT01987479|565684246|FG000|Overall Study|Lost to Follow-up|1|||
156710476|NCT01987479|565684246|FG000|Overall Study|Adverse Event|7|||
156710477|NCT04007991|565684247|FG000|Overall Study|Withdrawal by Subject|1|||
156710478|NCT04007991|565684248|FG001|Overall Study|Withdrawal by Subject|1|||
156710479|NCT04007991|565684247|FG000|Overall Study|Physician Decision|1|||
156710480|NCT04007991|565684248|FG001|Overall Study|Physician Decision|1|||
156710481|NCT04007991|565684247|FG000|Overall Study|Non-compliance with Study Drug|0|||
156710482|NCT04007991|565684248|FG001|Overall Study|Non-compliance with Study Drug|1|||
156710483|NCT04007991|565684247|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
156710484|NCT04007991|565684248|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
156710485|NCT04007991|565684247|FG000|Overall Study|Adverse event, non-fatal|5|||
156710486|NCT04007991|565684248|FG001|Overall Study|Adverse event, non-fatal|0|||
156710487|NCT04007991|565684247|FG000|Overall Study|Lost to Follow-up|2|||
156710488|NCT04007991|565684248|FG001|Overall Study|Lost to Follow-up|1|||
156710489|NCT01954745|565684249|FG000|Overall Study|Radiological Progression|11|||
156710490|NCT01954745|565684249|FG000|Overall Study|Clinical Progression|5|||
156710491|NCT01954745|565684249|FG000|Overall Study|Adverse Event|2|||
156710492|NCT01954745|565684249|FG000|Overall Study|Death|1|||
157016376|NCT02671435|566811317|FG010|Overall Study|Withdrawal by Subject|2|||
156710493|NCT03654599|565684252|FG000|Overall Study|Lost to Follow-up|14|||
156710494|NCT03654599|565684253|FG001|Overall Study|Lost to Follow-up|12|||
156710495|NCT03654599|565684252|FG000|Overall Study|Death|8|||
156710496|NCT03654599|565684253|FG001|Overall Study|Death|6|||
156710497|NCT03654599|565684252|FG000|Overall Study|Withdrawal by Subject|6|||
157126434|NCT00132730|567214131|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
157126435|NCT00132730|567214132|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
157126436|NCT00132730|567214133|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
157126437|NCT00132730|567214134|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
157126438|NCT00132730|567214129|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
157126439|NCT00132730|567214130|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156710498|NCT03654599|565684253|FG001|Overall Study|Withdrawal by Subject|4|||
156710499|NCT05314816|565684254|FG000|Overall Study|Lost to Follow-up|5|||
156710500|NCT05314816|565684255|FG001|Overall Study|Lost to Follow-up|0|||
156710501|NCT05314816|565684256|FG002|Overall Study|Lost to Follow-up|1|||
156710502|NCT05314816|565684254|FG000|Overall Study|Protocol Violation|13|||
156710503|NCT05314816|565684255|FG001|Overall Study|Protocol Violation|8|||
156710504|NCT05314816|565684256|FG002|Overall Study|Protocol Violation|0|||
156710505|NCT01290302|565686236|FG000|Overall Study|Adverse Event|2|||
156710506|NCT01290302|565686237|FG001|Overall Study|Adverse Event|0|||
156710507|NCT01290302|565686236|FG000|Overall Study|Withdrawal by Subject|1|||
156710508|NCT01290302|565686237|FG001|Overall Study|Withdrawal by Subject|0|||
156710509|NCT01290302|565686236|FG000|Overall Study|Physician Decision|0|||
156710510|NCT01290302|565686237|FG001|Overall Study|Physician Decision|2|||
156710511|NCT01290302|565686236|FG000|Overall Study|Expiration of time for screening window|1|||
156710512|NCT01290302|565686237|FG001|Overall Study|Expiration of time for screening window|0|||
156710513|NCT05938621|565686238|FG000|Overall Study|Lost to Follow-up|1|||
156710514|NCT05938621|565686239|FG001|Overall Study|Lost to Follow-up|5|||
156710515|NCT05938621|565686240|FG002|Overall Study|Lost to Follow-up|2|||
156710516|NCT05938621|565686241|FG003|Overall Study|Lost to Follow-up|2|||
156710517|NCT03816878|565686242|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
156710518|NCT03816878|565686243|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
156710519|NCT03816878|565686242|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
156710520|NCT03816878|565686243|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
156710521|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
156710522|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
156710523|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
156710524|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
156710525|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
156710526|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
156710527|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
156710528|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
156710529|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
156710530|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
156710531|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
156710532|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
156710533|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
156710534|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
156710535|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
156710536|NCT04856930|565686248|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710537|NCT04856930|565686249|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
156710538|NCT04856930|565686250|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710539|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
156710540|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
156710541|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
156710542|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
156710543|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
156710544|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
156710545|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
156710546|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
156710547|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
156710548|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
156710549|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
156710550|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
156710551|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
156710552|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710553|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
156710554|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
156710555|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
156710556|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
156792239|NCT02336555|565992711|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
156808762|NCT01408277|566054457|FG000|Overall Study|Adverse Event|3|||
156710557|NCT04856930|565686248|FG000|Extension Period (16 Weeks)|Other than specified|0|||
156710558|NCT04856930|565686249|FG001|Extension Period (16 Weeks)|Other than specified|0|||
156710559|NCT04856930|565686250|FG002|Extension Period (16 Weeks)|Other than specified|1|||
156710560|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
156710561|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
156710562|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
156710563|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
156710564|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
156710565|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
156710566|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
156710567|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
156710568|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
156710569|NCT04856930|565686248|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
156710570|NCT04856930|565686249|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
156710571|NCT04856930|565686250|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
156710572|NCT00678210|565686252|FG000|Overall Study|Adverse Event|1|||
156710573|NCT00678210|565686253|FG001|Overall Study|Adverse Event|2|||
156710574|NCT00678210|565686254|FG002|Overall Study|Adverse Event|3|||
156710575|NCT00678210|565686255|FG003|Overall Study|Adverse Event|3|||
156710576|NCT00678210|565686252|FG000|Overall Study|Lack of Efficacy|2|||
156710577|NCT00678210|565686253|FG001|Overall Study|Lack of Efficacy|3|||
156710578|NCT00678210|565686254|FG002|Overall Study|Lack of Efficacy|1|||
156710579|NCT00678210|565686255|FG003|Overall Study|Lack of Efficacy|9|||
156710580|NCT00678210|565686252|FG000|Overall Study|Lost to Follow-up|4|||
156710581|NCT00678210|565686253|FG001|Overall Study|Lost to Follow-up|2|||
156710582|NCT00678210|565686254|FG002|Overall Study|Lost to Follow-up|0|||
156710583|NCT00678210|565686255|FG003|Overall Study|Lost to Follow-up|1|||
156710584|NCT00678210|565686252|FG000|Overall Study|Withdrawal by Subject|3|||
156710585|NCT00678210|565686253|FG001|Overall Study|Withdrawal by Subject|4|||
156710586|NCT00678210|565686254|FG002|Overall Study|Withdrawal by Subject|1|||
156710587|NCT00678210|565686255|FG003|Overall Study|Withdrawal by Subject|7|||
156710588|NCT00678210|565686252|FG000|Overall Study|Other|1|||
156710589|NCT00678210|565686253|FG001|Overall Study|Other|0|||
156710590|NCT00678210|565686254|FG002|Overall Study|Other|1|||
156710591|NCT00678210|565686255|FG003|Overall Study|Other|0|||
156710592|NCT04825912|565686256|FG000|Overall Study|Death|3|||
156710593|NCT04825912|565686256|FG000|Overall Study|Withdrawal by Subject|1|||
156710594|NCT00459355|565686257|FG000|Overall Study|Subject no longer met inc criteria|20|||
156710595|NCT00459355|565686258|FG001|Overall Study|Subject no longer met inc criteria|18|||
156710596|NCT00618371|565686261|FG000|Overall Study|Withdrawal by Subject|2|||
156710597|NCT02437903|565686273|FG000|Overall Study|Adverse Event|1|||
156710598|NCT02437903|565686273|FG000|Overall Study|Withdrawal by Subject|1|||
156710599|NCT02437903|565686273|FG000|Overall Study|Lost to Follow-up|3|||
156710600|NCT05445492|565686277|FG000|Overall Study|Physician Decision|1|||
156710601|NCT01141205|565686278|FG000|Overall Study|Physician Decision|1|||
156710602|NCT01141205|565686279|FG001|Overall Study|Physician Decision|1|||
156710603|NCT01141205|565686278|FG000|Overall Study|Lost to Follow-up|1|||
156710604|NCT01141205|565686279|FG001|Overall Study|Lost to Follow-up|0|||
156710605|NCT01141205|565686278|FG000|Overall Study|Withdrawal by Subject|1|||
156710606|NCT01141205|565686279|FG001|Overall Study|Withdrawal by Subject|1|||
156710607|NCT00534404|565686290|FG000|Overall Study|Death|0|||
156710608|NCT00534404|565686291|FG001|Overall Study|Death|0|||
156710609|NCT00534404|565686292|FG002|Overall Study|Death|2|||
156710610|NCT00534404|565686290|FG000|Overall Study|Withdrawal by Subject|8|||
156710611|NCT00534404|565686291|FG001|Overall Study|Withdrawal by Subject|2|||
156710612|NCT00534404|565686292|FG002|Overall Study|Withdrawal by Subject|38|||
156710613|NCT00534404|565686290|FG000|Overall Study|Removed by study staff|2|||
156710614|NCT00534404|565686291|FG001|Overall Study|Removed by study staff|3|||
156710615|NCT00534404|565686292|FG002|Overall Study|Removed by study staff|1|||
156710616|NCT00534404|565686290|FG000|Overall Study|Lost to Follow-up|170|||
156710617|NCT00534404|565686291|FG001|Overall Study|Lost to Follow-up|138|||
156710618|NCT00534404|565686292|FG002|Overall Study|Lost to Follow-up|201|||
156710619|NCT04759768|565686293|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156710620|NCT04759768|565686294|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156710621|NCT04759768|565686293|FG000|Washout (7 Days)|Physician Decision|0|||
156710622|NCT04759768|565686294|FG001|Washout (7 Days)|Physician Decision|1|||
156710623|NCT02996487|565686295|FG000|Overall Study|Lost to Follow-up|1|||
156710624|NCT02996487|565686296|FG001|Overall Study|Lost to Follow-up|1|||
156710625|NCT02996487|565686297|FG002|Overall Study|Lost to Follow-up|0|||
156710626|NCT02996487|565686295|FG000|Overall Study|Death|0|||
156710627|NCT02996487|565686296|FG001|Overall Study|Death|1|||
156792240|NCT02336555|565992712|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
156710628|NCT02996487|565686297|FG002|Overall Study|Death|0|||
156710629|NCT02996487|565686295|FG000|Overall Study|Withdrawal by Subject|2|||
156710630|NCT02996487|565686296|FG001|Overall Study|Withdrawal by Subject|3|||
156710631|NCT02996487|565686297|FG002|Overall Study|Withdrawal by Subject|0|||
156710632|NCT02027428|565686298|FG000|Induction|Never treated|7|||
157126440|NCT00132730|567214131|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
157126441|NCT00132730|567214132|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
156710633|NCT02027428|565686299|FG001|Induction|Never treated|0|||
156710634|NCT02027428|565686300|FG002|Induction|Never treated|0|||
157126442|NCT00132730|567214133|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
157126443|NCT00132730|567214134|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
157126444|NCT00132730|567214129|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
157126445|NCT00132730|567214130|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
157126446|NCT00132730|567214131|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
157126447|NCT00132730|567214132|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
157126448|NCT00132730|567214133|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
157126449|NCT00132730|567214134|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
157126450|NCT00395967|567214135|FG000|Treatment Period|Failed Mobilization|1|||
157126451|NCT00395967|567214135|FG000|Follow-up Period|Death|1|||
157126452|NCT00395967|567214135|FG000|Follow-up Period|Lost to Follow-up|1|||
156710635|NCT02027428|565686298|FG000|Induction|Progressive disease|77|||
156710636|NCT02027428|565686299|FG001|Induction|Progressive disease|0|||
156710637|NCT02027428|565686300|FG002|Induction|Progressive disease|0|||
156710638|NCT02027428|565686298|FG000|Induction|Adverse Event|51|||
156710639|NCT02027428|565686299|FG001|Induction|Adverse Event|0|||
156710640|NCT02027428|565686300|FG002|Induction|Adverse Event|0|||
156710641|NCT02027428|565686298|FG000|Induction|Withdrawal by Subject|22|||
156710642|NCT02027428|565686299|FG001|Induction|Withdrawal by Subject|0|||
156710643|NCT02027428|565686300|FG002|Induction|Withdrawal by Subject|0|||
156710644|NCT02027428|565686298|FG000|Induction|Death|21|||
156710645|NCT02027428|565686299|FG001|Induction|Death|0|||
156710646|NCT02027428|565686300|FG002|Induction|Death|0|||
156710647|NCT02027428|565686298|FG000|Induction|Symptomatic deterioration|16|||
156710648|NCT02027428|565686299|FG001|Induction|Symptomatic deterioration|0|||
156710649|NCT02027428|565686300|FG002|Induction|Symptomatic deterioration|0|||
156710650|NCT02027428|565686298|FG000|Induction|Study terminated by sponsor|12|||
156710651|NCT02027428|565686299|FG001|Induction|Study terminated by sponsor|0|||
156710652|NCT02027428|565686300|FG002|Induction|Study terminated by sponsor|0|||
156710653|NCT02027428|565686298|FG000|Induction|Protocol Violation|1|||
156710654|NCT02027428|565686299|FG001|Induction|Protocol Violation|0|||
156710655|NCT02027428|565686300|FG002|Induction|Protocol Violation|0|||
156710656|NCT02027428|565686298|FG000|Induction|Miscellaneous|14|||
156710657|NCT02027428|565686299|FG001|Induction|Miscellaneous|0|||
156710658|NCT02027428|565686300|FG002|Induction|Miscellaneous|0|||
156710659|NCT02027428|565686298|FG000|Induction|Induction Treatment Ongoing|4|||
156710660|NCT02027428|565686299|FG001|Induction|Induction Treatment Ongoing|0|||
156710661|NCT02027428|565686300|FG002|Induction|Induction Treatment Ongoing|0|||
156710662|NCT02027428|565686298|FG000|Maintenance|Death|0|||
156710663|NCT02027428|565686299|FG001|Maintenance|Death|3|||
156710664|NCT02027428|565686300|FG002|Maintenance|Death|2|||
156873624|NCT00953056|566296066|FG001|Overall Study|Serious Adverse Event|0|||
156873625|NCT00953056|566296067|FG002|Overall Study|Serious Adverse Event|0|||
156873626|NCT00953056|566296068|FG003|Overall Study|Serious Adverse Event|0|||
156873627|NCT00953056|566296069|FG004|Overall Study|Serious Adverse Event|0|||
156873628|NCT00953056|566296070|FG005|Overall Study|Serious Adverse Event|1|||
156873629|NCT02813577|566296071|FG000|Overall Study|Study terminated|4|||
156873630|NCT01077076|566296072|FG000|First Intervention|Withdrawal by Subject|1|||
156873631|NCT01077076|566296073|FG001|First Intervention|Withdrawal by Subject|0|||
156873632|NCT01077076|566296074|FG002|First Intervention|Withdrawal by Subject|0|||
157215929|NCT00410410|567537431|FG007|Maintenance Period (MP)|Adverse Event|3|||
156873633|NCT01077076|566296075|FG003|First Intervention|Withdrawal by Subject|0|||
156873634|NCT01077076|566296076|FG004|First Intervention|Withdrawal by Subject|0|||
156873635|NCT01077076|566296077|FG005|First Intervention|Withdrawal by Subject|0|||
156873636|NCT01077076|566296072|FG000|Third Intervention|Death in the participant's family|0|||
156873637|NCT01077076|566296073|FG001|Third Intervention|Death in the participant's family|0|||
156873638|NCT01077076|566296074|FG002|Third Intervention|Death in the participant's family|0|||
156873639|NCT01077076|566296075|FG003|Third Intervention|Death in the participant's family|0|||
156873640|NCT01077076|566296076|FG004|Third Intervention|Death in the participant's family|0|||
156873641|NCT01077076|566296077|FG005|Third Intervention|Death in the participant's family|1|||
156873642|NCT00060840|566296080|FG000|Overall Study|Change in surgical plan|2|||
156873643|NCT00060840|566296081|FG001|Overall Study|Change in surgical plan|6|||
156873644|NCT00060840|566296080|FG000|Overall Study|Death|0|||
156710665|NCT02027428|565686298|FG000|Maintenance|Adverse Event|0|||
156710666|NCT02027428|565686299|FG001|Maintenance|Adverse Event|21|||
156710667|NCT02027428|565686300|FG002|Maintenance|Adverse Event|1|||
156710668|NCT02027428|565686298|FG000|Maintenance|Progressive disease|0|||
156873645|NCT00060840|566296081|FG001|Overall Study|Death|1|||
156873646|NCT00060840|566296080|FG000|Overall Study|Withdrawal by Subject|0|||
156873647|NCT00060840|566296081|FG001|Overall Study|Withdrawal by Subject|1|||
156710669|NCT02027428|565686299|FG001|Maintenance|Progressive disease|84|||
156710670|NCT02027428|565686300|FG002|Maintenance|Progressive disease|47|||
156710671|NCT02027428|565686298|FG000|Maintenance|Symptomatic deterioration|0|||
157016377|NCT02671435|566811318|FG011|Overall Study|Withdrawal by Subject|4|||
157016378|NCT02671435|566811319|FG012|Overall Study|Withdrawal by Subject|4|||
157016379|NCT02671435|566811320|FG013|Overall Study|Withdrawal by Subject|4|||
157016380|NCT02671435|566811321|FG014|Overall Study|Withdrawal by Subject|2|||
157016381|NCT02671435|566811307|FG000|Overall Study|Un-specified|0|||
157016382|NCT02671435|566811308|FG001|Overall Study|Un-specified|0|||
157016383|NCT02671435|566811309|FG002|Overall Study|Un-specified|0|||
157016384|NCT02671435|566811310|FG003|Overall Study|Un-specified|0|||
157016385|NCT02671435|566811311|FG004|Overall Study|Un-specified|1|||
157016386|NCT02671435|566811312|FG005|Overall Study|Un-specified|3|||
157016387|NCT02671435|566811313|FG006|Overall Study|Un-specified|2|||
157016388|NCT02671435|566811314|FG007|Overall Study|Un-specified|3|||
157016389|NCT02671435|566811315|FG008|Overall Study|Un-specified|0|||
157016390|NCT02671435|566811316|FG009|Overall Study|Un-specified|5|||
157016391|NCT02671435|566811317|FG010|Overall Study|Un-specified|8|||
157016392|NCT02671435|566811318|FG011|Overall Study|Un-specified|4|||
157016393|NCT02671435|566811319|FG012|Overall Study|Un-specified|5|||
157016394|NCT02671435|566811320|FG013|Overall Study|Un-specified|9|||
157016395|NCT02671435|566811321|FG014|Overall Study|Un-specified|8|||
157016396|NCT02269475|566811322|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
157016397|NCT02269475|566811323|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
157016398|NCT02269475|566811322|FG000|Overall Study|Withdrawal by Subject|0|||
157016399|NCT02269475|566811323|FG001|Overall Study|Withdrawal by Subject|1|||
157126453|NCT01262976|567214136|FG000|Up to Month 2|Serious Adverse Event|0|||
157126454|NCT01262976|567214137|FG001|Up to Month 2|Serious Adverse Event|0|||
157126455|NCT01262976|567214138|FG002|Up to Month 2|Serious Adverse Event|1|||
157126456|NCT01262976|567214139|FG003|Up to Month 2|Serious Adverse Event|0|||
157126457|NCT01262976|567214140|FG004|Up to Month 2|Serious Adverse Event|0|||
156873648|NCT00060840|566296080|FG000|Overall Study|Subinvestigator unavailable|0|||
156873649|NCT00060840|566296081|FG001|Overall Study|Subinvestigator unavailable|1|||
156873650|NCT00060840|566296080|FG000|Overall Study|Physician Decision|1|||
156873651|NCT00060840|566296081|FG001|Overall Study|Physician Decision|0|||
156873652|NCT00060840|566296080|FG000|Overall Study|Other|1|||
156873653|NCT00060840|566296081|FG001|Overall Study|Other|0|||
156873654|NCT01388335|566296082|FG000|Period 1|Progressive Disease|1|||
156873655|NCT01388335|566296082|FG000|Period 2|Progressive Disease|2|||
156873656|NCT01388335|566296082|FG000|Period 2|Sponsor Decision|1|||
156873657|NCT01388335|566296082|FG000|Safety Extension|Progressive Disease|7|||
156873658|NCT01415882|566296083|FG000|Overall Study|Ineligible|1|||
156873659|NCT01415882|566296084|FG001|Overall Study|Ineligible|0|||
156873660|NCT01415882|566296085|FG002|Overall Study|Ineligible|0|||
156873661|NCT01415882|566296086|FG003|Overall Study|Ineligible|3|||
156873662|NCT01415882|566296087|FG004|Overall Study|Ineligible|0|||
156873663|NCT01415882|566296083|FG000|Overall Study|Withdrawal by Subject|0|||
156873664|NCT01415882|566296084|FG001|Overall Study|Withdrawal by Subject|1|||
156873665|NCT01415882|566296085|FG002|Overall Study|Withdrawal by Subject|0|||
156873666|NCT01415882|566296086|FG003|Overall Study|Withdrawal by Subject|1|||
156873667|NCT01415882|566296087|FG004|Overall Study|Withdrawal by Subject|0|||
156873668|NCT00976560|566296088|FG000|Overall Study|Adverse Event|5|||
156873669|NCT00976560|566296089|FG001|Overall Study|Adverse Event|5|||
156873670|NCT00976560|566296088|FG000|Overall Study|Lack of Efficacy|3|||
156873671|NCT00976560|566296089|FG001|Overall Study|Lack of Efficacy|5|||
157016400|NCT02730871|566811326|FG000|Overall Study|Adverse Event|6|||
157016401|NCT02730871|566811327|FG001|Overall Study|Adverse Event|0|||
157016402|NCT05368558|566811328|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
157016403|NCT05368558|566811329|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
157016404|NCT05368558|566811330|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
157016405|NCT05368558|566811331|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016406|NCT05368558|566811332|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157126458|NCT01262976|567214141|FG005|Up to Month 2|Serious Adverse Event|0|||
157126459|NCT01262976|567214136|FG000|Up to Month 2|Withdrawal by Subject|1|||
156873672|NCT00976560|566296088|FG000|Overall Study|Protocol Violation|1|||
156873673|NCT00976560|566296089|FG001|Overall Study|Protocol Violation|0|||
156873674|NCT00976560|566296088|FG000|Overall Study|Lost to Follow-up|1|||
156873675|NCT00976560|566296089|FG001|Overall Study|Lost to Follow-up|0|||
156873676|NCT00976560|566296088|FG000|Overall Study|Physician Decision|2|||
156873677|NCT00976560|566296089|FG001|Overall Study|Physician Decision|0|||
156873678|NCT00976560|566296088|FG000|Overall Study|Withdrawal by Subject|2|||
157016407|NCT05368558|566811333|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016408|NCT05368558|566811334|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016409|NCT05368558|566811335|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016410|NCT05368558|566811336|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016411|NCT05368558|566811337|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016412|NCT05368558|566811338|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157016413|NCT05368558|566811339|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
157126460|NCT01262976|567214137|FG001|Up to Month 2|Withdrawal by Subject|0|||
156873679|NCT00976560|566296089|FG001|Overall Study|Withdrawal by Subject|3|||
156873680|NCT00125164|566296092|FG000|Overall Study|Adverse Event|0|||
157016414|NCT05368558|566811328|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016415|NCT05368558|566811329|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156710672|NCT02027428|565686299|FG001|Maintenance|Symptomatic deterioration|4|||
156710673|NCT02027428|565686300|FG002|Maintenance|Symptomatic deterioration|1|||
156710674|NCT02027428|565686298|FG000|Maintenance|Withdrawal by Subject|0|||
156710675|NCT02027428|565686299|FG001|Maintenance|Withdrawal by Subject|6|||
157126461|NCT01262976|567214138|FG002|Up to Month 2|Withdrawal by Subject|0|||
156710676|NCT02027428|565686300|FG002|Maintenance|Withdrawal by Subject|5|||
156710677|NCT02027428|565686298|FG000|Maintenance|Protocol Violation|0|||
156710678|NCT02027428|565686299|FG001|Maintenance|Protocol Violation|0|||
156710679|NCT02027428|565686300|FG002|Maintenance|Protocol Violation|1|||
156710680|NCT02027428|565686298|FG000|Maintenance|Other|0|||
156710681|NCT02027428|565686299|FG001|Maintenance|Other|6|||
156710682|NCT02027428|565686300|FG002|Maintenance|Other|3|||
156710683|NCT02027428|565686298|FG000|Survival Follow-up|Death|0|||
156710684|NCT02027428|565686299|FG001|Survival Follow-up|Death|78|||
156710685|NCT02027428|565686300|FG002|Survival Follow-up|Death|45|||
156710686|NCT02027428|565686298|FG000|Survival Follow-up|Lost to Follow-up|0|||
156710687|NCT02027428|565686299|FG001|Survival Follow-up|Lost to Follow-up|1|||
156710688|NCT02027428|565686300|FG002|Survival Follow-up|Lost to Follow-up|1|||
156710689|NCT02859142|565686301|FG000|Overall Study|Adverse Event|1|||
156710690|NCT02859142|565686302|FG001|Overall Study|Adverse Event|2|||
156710691|NCT02859142|565686301|FG000|Overall Study|Lost to Follow-up|1|||
156710692|NCT02859142|565686302|FG001|Overall Study|Lost to Follow-up|4|||
156710693|NCT02859142|565686301|FG000|Overall Study|Withdrawal by Subject|2|||
156710694|NCT02859142|565686302|FG001|Overall Study|Withdrawal by Subject|0|||
156710695|NCT02859142|565686301|FG000|Overall Study|Scheduling difficulties|0|||
156710696|NCT02859142|565686302|FG001|Overall Study|Scheduling difficulties|3|||
156710697|NCT01128543|565686306|FG000|Overall Study|Withdrawal by Subject|3|||
156710698|NCT01128543|565686306|FG000|Overall Study|Protocol Violation|1|||
156710699|NCT02676765|565686307|FG000|Overall Study|Lost to Follow-up|0|||
156710700|NCT02676765|565686308|FG001|Overall Study|Lost to Follow-up|1|||
156710701|NCT02374346|565686312|FG000|Overall Study|operated or discharged during weekend|48|||
156710702|NCT04487067|565686318|FG000|Overall Study|Adverse Event|3|||
156710703|NCT04487067|565686318|FG000|Overall Study|Death Other Than Progressive Disease|60|||
156710704|NCT04487067|565686318|FG000|Overall Study|Death Due To Progressive Disease|40|||
156710705|NCT04487067|565686318|FG000|Overall Study|Lost to Follow-up|3|||
156710706|NCT04487067|565686318|FG000|Overall Study|Progressive Disease|1|||
156710707|NCT04487067|565686318|FG000|Overall Study|Protocol Violation|3|||
156710708|NCT04487067|565686318|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
156710709|NCT04487067|565686318|FG000|Overall Study|Withdrawal by Subject|15|||
156710710|NCT05299528|565686319|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710711|NCT05299528|565686320|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
156710712|NCT05299528|565686321|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710713|NCT05299528|565686322|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710714|NCT05299528|565686323|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710715|NCT05299528|565686324|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710716|NCT05299528|565686325|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
156710717|NCT05299528|565686319|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710718|NCT05299528|565686320|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710719|NCT05299528|565686321|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710720|NCT05299528|565686322|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156792241|NCT02336555|565992711|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
156792242|NCT02336555|565992712|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
156792243|NCT01772693|565992713|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
156710721|NCT05299528|565686323|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710722|NCT05299528|565686324|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
156710723|NCT05299528|565686325|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
156710724|NCT05299528|565686319|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
156710725|NCT05299528|565686320|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
157016416|NCT05368558|566811330|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016417|NCT05368558|566811331|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
157016418|NCT05368558|566811332|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016419|NCT05368558|566811333|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
157016420|NCT05368558|566811334|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016421|NCT05368558|566811335|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016422|NCT05368558|566811336|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016423|NCT05368558|566811337|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
157016424|NCT05368558|566811338|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156710726|NCT05299528|565686321|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
156710727|NCT05299528|565686322|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
156710728|NCT05299528|565686323|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
156710729|NCT05299528|565686324|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
156710730|NCT05299528|565686325|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
156710731|NCT04324021|565686326|FG000|Overall Study|Adverse Event|1|||
156710732|NCT04324021|565686327|FG001|Overall Study|Adverse Event|0|||
156710733|NCT04324021|565686328|FG002|Overall Study|Adverse Event|0|||
156710734|NCT04324021|565686326|FG000|Overall Study|Lack of Efficacy|0|||
156710735|NCT04324021|565686327|FG001|Overall Study|Lack of Efficacy|0|||
156710736|NCT04324021|565686328|FG002|Overall Study|Lack of Efficacy|1|||
156710737|NCT04324021|565686326|FG000|Overall Study|Death|1|||
156710738|NCT04324021|565686327|FG001|Overall Study|Death|1|||
156710739|NCT04324021|565686328|FG002|Overall Study|Death|0|||
156710740|NCT04877457|565686329|FG000|Overall Study|Early termination of study due to low enrollment|2|||
156710741|NCT04877457|565686330|FG001|Overall Study|Early termination of study due to low enrollment|1|||
156710742|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
156710743|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
156710744|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
156710745|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Death|1|||
156710746|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Death|3|||
156710747|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Death|1|||
156710748|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
156710749|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
156710750|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
156710751|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
156710752|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
156710753|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
156710754|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
156710755|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
156710756|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
156710757|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
156710758|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
156710759|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
156710760|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
156710761|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
156710762|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
156710763|NCT00299130|565686331|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
156710764|NCT00299130|565686332|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
156710765|NCT00299130|565686333|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
156710766|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
156710767|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
156710768|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
156710769|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
156710770|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
156710771|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
156710772|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
156710773|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
156710774|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
156710775|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
156710776|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
156710777|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
156710778|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
156710779|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
156710780|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
156710781|NCT00299130|565686331|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
156710782|NCT00299130|565686332|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
156710783|NCT00299130|565686333|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
156710784|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
156710785|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
156710786|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
156710787|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
156710788|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
156710789|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
156710790|NCT00299130|565686331|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
156710791|NCT00299130|565686332|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
156710792|NCT00299130|565686333|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
156710793|NCT02211417|565686334|FG000|Overall Study|Withdrawal by Subject|11|||
156873681|NCT00125164|566296093|FG001|Overall Study|Adverse Event|0|||
156873682|NCT00125164|566296094|FG002|Overall Study|Adverse Event|2|||
156873683|NCT00125164|566296095|FG003|Overall Study|Adverse Event|4|||
156873684|NCT00125164|566296092|FG000|Overall Study|Lost to Follow-up|0|||
156873685|NCT00125164|566296093|FG001|Overall Study|Lost to Follow-up|0|||
156873686|NCT00125164|566296094|FG002|Overall Study|Lost to Follow-up|1|||
156873687|NCT00125164|566296095|FG003|Overall Study|Lost to Follow-up|1|||
156873688|NCT00125164|566296092|FG000|Overall Study|Withdrawal by Subject|2|||
156873689|NCT00125164|566296093|FG001|Overall Study|Withdrawal by Subject|0|||
156873690|NCT00125164|566296094|FG002|Overall Study|Withdrawal by Subject|1|||
156873691|NCT00125164|566296095|FG003|Overall Study|Withdrawal by Subject|1|||
156873692|NCT00670306|566296096|FG000|Overall Study|Adverse Event|8|||
156873693|NCT00670306|566296096|FG000|Overall Study|Lack of Efficacy|10|||
156873694|NCT00670306|566296096|FG000|Overall Study|Withdrawal by Subject|9|||
156873695|NCT00670306|566296096|FG000|Overall Study|Physician Decision|1|||
156873696|NCT00670306|566296096|FG000|Overall Study|Lost to Follow-up|8|||
156873697|NCT00670306|566296096|FG000|Overall Study|incl/excl criterias did not meet|19|||
156873698|NCT01339052|566296100|FG000|Overall Study|Disease progression|13|||
156873699|NCT01339052|566296101|FG001|Overall Study|Disease progression|46|||
156710794|NCT02211417|565686335|FG001|Overall Study|Withdrawal by Subject|8|||
156710795|NCT02211417|565686334|FG000|Overall Study|Protocol Violation|1|||
156710796|NCT02211417|565686335|FG001|Overall Study|Protocol Violation|0|||
156710797|NCT02211417|565686334|FG000|Overall Study|Pregnancy|0|||
156710798|NCT02211417|565686335|FG001|Overall Study|Pregnancy|1|||
156710799|NCT02211417|565686334|FG000|Overall Study|Lost to Follow-up|2|||
156710800|NCT02211417|565686335|FG001|Overall Study|Lost to Follow-up|3|||
156710801|NCT02211417|565686334|FG000|Overall Study|Adverse Event|1|||
156710802|NCT02211417|565686335|FG001|Overall Study|Adverse Event|4|||
156710803|NCT01198132|565686336|FG000|Overall Study|Withdrawal by Subject|4|||
156710804|NCT01198132|565686337|FG001|Overall Study|Withdrawal by Subject|5|||
156710805|NCT01198132|565686336|FG000|Overall Study|Physician Decision|5|||
156710806|NCT01198132|565686337|FG001|Overall Study|Physician Decision|4|||
156710807|NCT01198132|565686336|FG000|Overall Study|Other Unspecified|3|||
156710808|NCT01198132|565686337|FG001|Overall Study|Other Unspecified|6|||
156710809|NCT01198132|565686336|FG000|Overall Study|Lack of Efficacy|2|||
156710810|NCT01198132|565686337|FG001|Overall Study|Lack of Efficacy|3|||
156710811|NCT01198132|565686336|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
156710812|NCT01198132|565686337|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
156710813|NCT01198132|565686336|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
156710814|NCT01198132|565686337|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
156710815|NCT01198132|565686336|FG000|Overall Study|Adverse Event|0|||
156710816|NCT01198132|565686337|FG001|Overall Study|Adverse Event|1|||
156710817|NCT01198132|565686336|FG000|Overall Study|Protocol Violation|1|||
156710818|NCT01198132|565686337|FG001|Overall Study|Protocol Violation|0|||
156710819|NCT00490841|565686338|FG000|Overall Study|Death|5|||
156710820|NCT00490841|565686338|FG000|Overall Study|Withdrawal by Subject|4|||
156710821|NCT00490841|565686338|FG000|Overall Study|Lost to Follow-up|1|||
156710822|NCT00490841|565686338|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
156710823|NCT01277211|565686339|FG000|Overall Study|Adverse Event|60|||
156710824|NCT01277211|565686340|FG001|Overall Study|Adverse Event|22|||
156710825|NCT01277211|565686339|FG000|Overall Study|Pregnancy|9|||
156710826|NCT01277211|565686340|FG001|Overall Study|Pregnancy|4|||
156710827|NCT01277211|565686339|FG000|Overall Study|Lost to Follow-up|14|||
156710828|NCT01277211|565686340|FG001|Overall Study|Lost to Follow-up|9|||
156710829|NCT01277211|565686339|FG000|Overall Study|Did not wish to continue|17|||
156710830|NCT01277211|565686340|FG001|Overall Study|Did not wish to continue|0|||
156710831|NCT01277211|565686339|FG000|Overall Study|Withdrew Consent|9|||
156873700|NCT01339052|566296100|FG000|Overall Study|Adverse Event|1|||
156873701|NCT01339052|566296101|FG001|Overall Study|Adverse Event|1|||
156873702|NCT01339052|566296100|FG000|Overall Study|Withdrawal by Subject|0|||
156873703|NCT01339052|566296101|FG001|Overall Study|Withdrawal by Subject|3|||
156873704|NCT01339052|566296100|FG000|Overall Study|Physician Decision|1|||
156873705|NCT01339052|566296101|FG001|Overall Study|Physician Decision|0|||
156710832|NCT01277211|565686340|FG001|Overall Study|Withdrew Consent|9|||
156710833|NCT01277211|565686339|FG000|Overall Study|Non-compliance with protocol|13|||
156873706|NCT01301027|566296104|FG000|Overall Study|Physician Decision|2|||
156710834|NCT01277211|565686340|FG001|Overall Study|Non-compliance with protocol|4|||
156710835|NCT01277211|565686339|FG000|Overall Study|Did not meet protocol eligibility|1|||
156710836|NCT01277211|565686340|FG001|Overall Study|Did not meet protocol eligibility|0|||
156873707|NCT01301027|566296105|FG001|Overall Study|Physician Decision|0|||
156873708|NCT01301027|566296104|FG000|Overall Study|Withdrawal by Subject|2|||
156873709|NCT01301027|566296105|FG001|Overall Study|Withdrawal by Subject|3|||
156873710|NCT01301027|566296104|FG000|Overall Study|Adverse Event|0|||
156873711|NCT01301027|566296105|FG001|Overall Study|Adverse Event|2|||
156710837|NCT01277211|565686339|FG000|Overall Study|Administrative|3|||
156710838|NCT01277211|565686340|FG001|Overall Study|Administrative|0|||
156710839|NCT01277211|565686339|FG000|Overall Study|Pregnancy wish|0|||
156710840|NCT01277211|565686340|FG001|Overall Study|Pregnancy wish|2|||
156873712|NCT01301027|566296104|FG000|Overall Study|Fracture|1|||
156873713|NCT01301027|566296105|FG001|Overall Study|Fracture|3|||
156873714|NCT01301027|566296104|FG000|Overall Study|Transplant|0|||
156873715|NCT01301027|566296105|FG001|Overall Study|Transplant|2|||
156873716|NCT01301027|566296104|FG000|Overall Study|Volume Overload|3|||
156873717|NCT01301027|566296105|FG001|Overall Study|Volume Overload|0|||
156873718|NCT00845897|566296106|FG000|Overall Study|Lost to Follow-up|1|||
156873719|NCT00845897|566296107|FG001|Overall Study|Lost to Follow-up|1|||
156873720|NCT00845897|566296108|FG002|Overall Study|Lost to Follow-up|0|||
156873721|NCT00845897|566296106|FG000|Overall Study|Withdrawal by Subject|0|||
156873722|NCT00845897|566296107|FG001|Overall Study|Withdrawal by Subject|3|||
156873723|NCT00845897|566296108|FG002|Overall Study|Withdrawal by Subject|2|||
156873724|NCT00845897|566296106|FG000|Overall Study|Ulcer did not heal|1|||
156873725|NCT00845897|566296107|FG001|Overall Study|Ulcer did not heal|0|||
156873726|NCT00845897|566296108|FG002|Overall Study|Ulcer did not heal|1|||
156873727|NCT00845897|566296106|FG000|Overall Study|Too ill to participate|0|||
156873728|NCT00845897|566296107|FG001|Overall Study|Too ill to participate|1|||
156873729|NCT00845897|566296108|FG002|Overall Study|Too ill to participate|0|||
156873730|NCT02722499|566296110|FG000|Overall Study|Lost to Follow-up|2|||
156873731|NCT02722499|566296111|FG001|Overall Study|Lost to Follow-up|0|||
156710841|NCT01277211|565686339|FG000|Overall Study|Discontinued prior to treatment|24|||
156710842|NCT01277211|565686340|FG001|Overall Study|Discontinued prior to treatment|13|||
156710843|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
156710844|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
156710845|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
156710846|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
156710847|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
156710848|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
156710849|NCT03452943|565686341|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
156873732|NCT02722499|566296112|FG002|Overall Study|Lost to Follow-up|1|||
156873733|NCT03566485|566296123|FG000|Overall Study|Disease progression|5|||
156873734|NCT03566485|566296124|FG001|Overall Study|Disease progression|4|||
156873735|NCT03566485|566296123|FG000|Overall Study|Clinical progression|0|||
156873736|NCT03566485|566296124|FG001|Overall Study|Clinical progression|1|||
156873737|NCT03566485|566296123|FG000|Overall Study|Toxicity|0|||
156873738|NCT03566485|566296124|FG001|Overall Study|Toxicity|2|||
156873739|NCT03610269|566296127|FG000|Overall Study|Physician Decision|10|||
156873740|NCT03610269|566296127|FG000|Overall Study|Protocol Violation|1|||
156873741|NCT03610269|566296127|FG000|Overall Study|Unable to draw blood|1|||
156873742|NCT03610269|566296127|FG000|Overall Study|Screen fail|4|||
156873743|NCT00067002|566296128|FG000|Overall Study|Early Death|1|||
156873744|NCT00067002|566296129|FG001|Overall Study|Early Death|2|||
156873745|NCT00067002|566296128|FG000|Overall Study|Delayed|1|||
156873746|NCT00067002|566296129|FG001|Overall Study|Delayed|1|||
156873747|NCT00067002|566296128|FG000|Overall Study|Graft Failure|5|||
156873748|NCT00067002|566296129|FG001|Overall Study|Graft Failure|6|||
156873749|NCT01354314|566296130|FG000|Overall Study|Lost to Follow-up|1|||
156873750|NCT01354314|566296131|FG001|Overall Study|Lost to Follow-up|0|||
156873751|NCT01354314|566296132|FG002|Overall Study|Lost to Follow-up|1|||
156873752|NCT01354314|566296133|FG003|Overall Study|Lost to Follow-up|1|||
156873753|NCT01354314|566296130|FG000|Overall Study|Withdrawal by Subject|0|||
156710850|NCT03452943|565686342|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
156710851|NCT03452943|565686341|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
156710852|NCT03452943|565686342|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
156873754|NCT01354314|566296131|FG001|Overall Study|Withdrawal by Subject|0|||
156710853|NCT03452943|565686341|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
156710854|NCT03452943|565686342|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
156710855|NCT03516513|565686348|FG000|Overall Study|Withdrawal by Subject|2|||
156710856|NCT03516513|565686349|FG001|Overall Study|Withdrawal by Subject|2|||
156710857|NCT03516513|565686350|FG002|Overall Study|Withdrawal by Subject|0|||
156710858|NCT03516513|565686351|FG003|Overall Study|Withdrawal by Subject|0|||
156710859|NCT04697069|565686352|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
156710860|NCT04697069|565686353|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
156873755|NCT01354314|566296132|FG002|Overall Study|Withdrawal by Subject|1|||
156873756|NCT01354314|566296133|FG003|Overall Study|Withdrawal by Subject|0|||
156873757|NCT01354314|566296130|FG000|Overall Study|Adverse Event|0|||
156873758|NCT01354314|566296131|FG001|Overall Study|Adverse Event|0|||
156873759|NCT01354314|566296132|FG002|Overall Study|Adverse Event|0|||
156873760|NCT01354314|566296133|FG003|Overall Study|Adverse Event|1|||
156873761|NCT01354314|566296130|FG000|Overall Study|Protocol Violation|1|||
156873762|NCT01354314|566296131|FG001|Overall Study|Protocol Violation|1|||
156710861|NCT04697069|565686352|FG000|Overall Study|Study termination|2|||
156873763|NCT01354314|566296132|FG002|Overall Study|Protocol Violation|0|||
156873764|NCT01354314|566296133|FG003|Overall Study|Protocol Violation|0|||
156873765|NCT01354314|566296130|FG000|Overall Study|Less than 90% Adherence|4|||
156873766|NCT01354314|566296131|FG001|Overall Study|Less than 90% Adherence|2|||
156873767|NCT01354314|566296132|FG002|Overall Study|Less than 90% Adherence|6|||
157016425|NCT05368558|566811339|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
156873768|NCT01354314|566296133|FG003|Overall Study|Less than 90% Adherence|4|||
156873769|NCT00369265|566296135|FG000|Overall Study|Study terminated|4|||
156873770|NCT00369265|566296136|FG001|Overall Study|Study terminated|7|||
156873771|NCT00714870|566296137|FG000|Overall Study|Lost to Follow-up|22|||
156873772|NCT00714870|566296138|FG001|Overall Study|Lost to Follow-up|5|||
156873773|NCT00714870|566296137|FG000|Overall Study|patient unable to come b/c back pain|1|||
156873774|NCT00714870|566296138|FG001|Overall Study|patient unable to come b/c back pain|0|||
156873775|NCT00714870|566296137|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
156873776|NCT00714870|566296138|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
156873777|NCT01599637|566296141|FG000|Overall Study|administrative problems|0|||
156873778|NCT01599637|566296142|FG001|Overall Study|administrative problems|2|||
156873779|NCT01599637|566296143|FG002|Overall Study|administrative problems|0|||
156873780|NCT01599637|566296141|FG000|Overall Study|Adverse Event|1|||
156873781|NCT01599637|566296142|FG001|Overall Study|Adverse Event|0|||
156873782|NCT01599637|566296143|FG002|Overall Study|Adverse Event|0|||
156873783|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
156873784|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
156873785|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
156873786|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
156873787|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873788|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873789|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873790|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873791|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873792|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873793|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
156873794|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873795|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873796|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873797|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
156873798|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
156873799|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
156873800|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
156873801|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873802|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873803|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873804|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
156873805|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873806|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
156873807|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873808|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873809|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873810|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
156873811|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
156873812|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
156873813|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
156873814|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
156873815|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
156873816|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
156873817|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
156873818|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
156710862|NCT04697069|565686353|FG001|Overall Study|Study termination|1|||
156710863|NCT05180227|565686354|FG000|Overall Study|Hypertension at screening|1|||
156710864|NCT05180227|565686354|FG000|Overall Study|Lost to Follow-up|1|||
156710865|NCT01098487|565686355|FG000|Overall Study|Adverse Event|22|||
156710866|NCT01098487|565686355|FG000|Overall Study|Lack of Efficacy|11|||
156710867|NCT01098487|565686355|FG000|Overall Study|Withdrawal by Subject|7|||
156710868|NCT01098487|565686355|FG000|Overall Study|Lost to Follow-up|3|||
156710869|NCT01098487|565686355|FG000|Overall Study|Physician Decision|1|||
156710870|NCT01130597|565686356|FG000|Overall Study|Protocol-specified (High K+)|1|||
156710871|NCT01130597|565686356|FG000|Overall Study|Adverse Event|4|||
156710872|NCT01130597|565686356|FG000|Overall Study|Death|1|||
157016426|NCT05368558|566811328|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156710873|NCT01130597|565686356|FG000|Overall Study|Protocol Violation|1|||
156710874|NCT02516553|565686357|FG000|Overall Study|Progressive disease|2|||
156873819|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873820|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
157016427|NCT05368558|566811329|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156710875|NCT02516553|565686358|FG001|Overall Study|Progressive disease|2|||
156710876|NCT02516553|565686359|FG002|Overall Study|Progressive disease|3|||
156710877|NCT02516553|565686360|FG003|Overall Study|Progressive disease|5|||
156710878|NCT02516553|565686361|FG004|Overall Study|Progressive disease|3|||
156710879|NCT02516553|565686362|FG005|Overall Study|Progressive disease|0|||
156710880|NCT02516553|565686363|FG006|Overall Study|Progressive disease|5|||
156710881|NCT02516553|565686364|FG007|Overall Study|Progressive disease|5|||
156710882|NCT02516553|565686365|FG008|Overall Study|Progressive disease|11|||
156710883|NCT02516553|565686366|FG009|Overall Study|Progressive disease|3|||
156710884|NCT02516553|565686367|FG010|Overall Study|Progressive disease|10|||
156710885|NCT02516553|565686368|FG011|Overall Study|Progressive disease|8|||
156710886|NCT02516553|565686369|FG012|Overall Study|Progressive disease|8|||
156710887|NCT02516553|565686370|FG013|Overall Study|Progressive disease|2|||
156710888|NCT02516553|565686371|FG014|Overall Study|Progressive disease|2|||
156710889|NCT02516553|565686372|FG015|Overall Study|Progressive disease|2|||
156710890|NCT02516553|565686373|FG016|Overall Study|Progressive disease|1|||
156710891|NCT02516553|565686374|FG017|Overall Study|Progressive disease|9|||
156710892|NCT02516553|565686375|FG018|Overall Study|Progressive disease|12|||
156710893|NCT02516553|565686376|FG019|Overall Study|Progressive disease|7|||
156710894|NCT02516553|565686377|FG020|Overall Study|Progressive disease|16|||
156710895|NCT02516553|565686378|FG021|Overall Study|Progressive disease|18|||
156710896|NCT02516553|565686357|FG000|Overall Study|Dose limiting toxicity|0|||
156710897|NCT02516553|565686358|FG001|Overall Study|Dose limiting toxicity|0|||
156710898|NCT02516553|565686359|FG002|Overall Study|Dose limiting toxicity|0|||
156710899|NCT02516553|565686360|FG003|Overall Study|Dose limiting toxicity|0|||
156710900|NCT02516553|565686361|FG004|Overall Study|Dose limiting toxicity|3|||
156710901|NCT02516553|565686362|FG005|Overall Study|Dose limiting toxicity|1|||
156710902|NCT02516553|565686363|FG006|Overall Study|Dose limiting toxicity|1|||
156710903|NCT02516553|565686364|FG007|Overall Study|Dose limiting toxicity|0|||
156710904|NCT02516553|565686365|FG008|Overall Study|Dose limiting toxicity|1|||
156710905|NCT02516553|565686366|FG009|Overall Study|Dose limiting toxicity|0|||
156710906|NCT02516553|565686367|FG010|Overall Study|Dose limiting toxicity|0|||
156710907|NCT02516553|565686368|FG011|Overall Study|Dose limiting toxicity|1|||
156710908|NCT02516553|565686369|FG012|Overall Study|Dose limiting toxicity|0|||
156710909|NCT02516553|565686370|FG013|Overall Study|Dose limiting toxicity|1|||
156710910|NCT02516553|565686371|FG014|Overall Study|Dose limiting toxicity|0|||
156710911|NCT02516553|565686372|FG015|Overall Study|Dose limiting toxicity|0|||
156710912|NCT02516553|565686373|FG016|Overall Study|Dose limiting toxicity|1|||
156710913|NCT02516553|565686374|FG017|Overall Study|Dose limiting toxicity|1|||
156710914|NCT02516553|565686375|FG018|Overall Study|Dose limiting toxicity|0|||
156710915|NCT02516553|565686376|FG019|Overall Study|Dose limiting toxicity|2|||
156710916|NCT02516553|565686377|FG020|Overall Study|Dose limiting toxicity|0|||
156710917|NCT02516553|565686378|FG021|Overall Study|Dose limiting toxicity|0|||
156710918|NCT02516553|565686357|FG000|Overall Study|Other Adverse Events|0|||
156710919|NCT02516553|565686358|FG001|Overall Study|Other Adverse Events|0|||
156710920|NCT02516553|565686359|FG002|Overall Study|Other Adverse Events|0|||
156710921|NCT02516553|565686360|FG003|Overall Study|Other Adverse Events|1|||
156710922|NCT02516553|565686361|FG004|Overall Study|Other Adverse Events|0|||
156710923|NCT02516553|565686362|FG005|Overall Study|Other Adverse Events|1|||
156710924|NCT02516553|565686363|FG006|Overall Study|Other Adverse Events|0|||
156710925|NCT02516553|565686364|FG007|Overall Study|Other Adverse Events|0|||
156710926|NCT02516553|565686365|FG008|Overall Study|Other Adverse Events|0|||
156710927|NCT02516553|565686366|FG009|Overall Study|Other Adverse Events|1|||
156873821|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873822|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873823|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156710928|NCT02516553|565686367|FG010|Overall Study|Other Adverse Events|3|||
156710929|NCT02516553|565686368|FG011|Overall Study|Other Adverse Events|2|||
156710930|NCT02516553|565686369|FG012|Overall Study|Other Adverse Events|0|||
156873824|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156710931|NCT02516553|565686370|FG013|Overall Study|Other Adverse Events|1|||
156710932|NCT02516553|565686371|FG014|Overall Study|Other Adverse Events|0|||
156710933|NCT02516553|565686372|FG015|Overall Study|Other Adverse Events|0|||
156710934|NCT02516553|565686373|FG016|Overall Study|Other Adverse Events|0|||
156710935|NCT02516553|565686374|FG017|Overall Study|Other Adverse Events|2|||
156710936|NCT02516553|565686375|FG018|Overall Study|Other Adverse Events|1|||
156710937|NCT02516553|565686376|FG019|Overall Study|Other Adverse Events|2|||
156710938|NCT02516553|565686377|FG020|Overall Study|Other Adverse Events|2|||
156710939|NCT02516553|565686378|FG021|Overall Study|Other Adverse Events|1|||
156710940|NCT02516553|565686357|FG000|Overall Study|Refused to continue trial medication|0|||
156710941|NCT02516553|565686358|FG001|Overall Study|Refused to continue trial medication|0|||
156710942|NCT02516553|565686359|FG002|Overall Study|Refused to continue trial medication|0|||
156710943|NCT02516553|565686360|FG003|Overall Study|Refused to continue trial medication|0|||
156710944|NCT02516553|565686361|FG004|Overall Study|Refused to continue trial medication|0|||
157016428|NCT05368558|566811330|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016429|NCT05368558|566811331|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
157016430|NCT05368558|566811332|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016431|NCT05368558|566811333|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156710945|NCT02516553|565686362|FG005|Overall Study|Refused to continue trial medication|0|||
156710946|NCT02516553|565686363|FG006|Overall Study|Refused to continue trial medication|0|||
156710947|NCT02516553|565686364|FG007|Overall Study|Refused to continue trial medication|0|||
156710948|NCT02516553|565686365|FG008|Overall Study|Refused to continue trial medication|0|||
156710949|NCT02516553|565686366|FG009|Overall Study|Refused to continue trial medication|0|||
156710950|NCT02516553|565686367|FG010|Overall Study|Refused to continue trial medication|1|||
156710951|NCT02516553|565686368|FG011|Overall Study|Refused to continue trial medication|0|||
156710952|NCT02516553|565686369|FG012|Overall Study|Refused to continue trial medication|0|||
156710953|NCT02516553|565686370|FG013|Overall Study|Refused to continue trial medication|0|||
156710954|NCT02516553|565686371|FG014|Overall Study|Refused to continue trial medication|0|||
156710955|NCT02516553|565686372|FG015|Overall Study|Refused to continue trial medication|0|||
156710956|NCT02516553|565686373|FG016|Overall Study|Refused to continue trial medication|0|||
156710957|NCT02516553|565686374|FG017|Overall Study|Refused to continue trial medication|0|||
156710958|NCT02516553|565686375|FG018|Overall Study|Refused to continue trial medication|1|||
156710959|NCT02516553|565686376|FG019|Overall Study|Refused to continue trial medication|0|||
156710960|NCT02516553|565686377|FG020|Overall Study|Refused to continue trial medication|0|||
156710961|NCT02516553|565686378|FG021|Overall Study|Refused to continue trial medication|1|||
156710962|NCT02516553|565686357|FG000|Overall Study|other reasons than listed|0|||
156710963|NCT02516553|565686358|FG001|Overall Study|other reasons than listed|0|||
156710964|NCT02516553|565686359|FG002|Overall Study|other reasons than listed|0|||
156710965|NCT02516553|565686360|FG003|Overall Study|other reasons than listed|0|||
156710966|NCT02516553|565686361|FG004|Overall Study|other reasons than listed|0|||
156710967|NCT02516553|565686362|FG005|Overall Study|other reasons than listed|0|||
156710968|NCT02516553|565686363|FG006|Overall Study|other reasons than listed|0|||
156710969|NCT02516553|565686364|FG007|Overall Study|other reasons than listed|1|||
156710970|NCT02516553|565686365|FG008|Overall Study|other reasons than listed|1|||
156710971|NCT02516553|565686366|FG009|Overall Study|other reasons than listed|0|||
156710972|NCT02516553|565686367|FG010|Overall Study|other reasons than listed|1|||
156710973|NCT02516553|565686368|FG011|Overall Study|other reasons than listed|1|||
156710974|NCT02516553|565686369|FG012|Overall Study|other reasons than listed|0|||
156710975|NCT02516553|565686370|FG013|Overall Study|other reasons than listed|0|||
156710976|NCT02516553|565686371|FG014|Overall Study|other reasons than listed|0|||
156710977|NCT02516553|565686372|FG015|Overall Study|other reasons than listed|0|||
156710978|NCT02516553|565686373|FG016|Overall Study|other reasons than listed|0|||
156710979|NCT02516553|565686374|FG017|Overall Study|other reasons than listed|0|||
156710980|NCT02516553|565686375|FG018|Overall Study|other reasons than listed|0|||
156710981|NCT02516553|565686376|FG019|Overall Study|other reasons than listed|0|||
156710982|NCT02516553|565686377|FG020|Overall Study|other reasons than listed|2|||
156710983|NCT02516553|565686378|FG021|Overall Study|other reasons than listed|2|||
156710984|NCT04614246|565686379|FG000|Overall Study|Adverse Event|0|||
156710985|NCT04614246|565686380|FG001|Overall Study|Adverse Event|1|||
157016432|NCT05368558|566811334|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016433|NCT05368558|566811335|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016434|NCT05368558|566811336|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156710986|NCT04614246|565686381|FG002|Overall Study|Adverse Event|1|||
156710987|NCT04614246|565686382|FG003|Overall Study|Adverse Event|2|||
156710988|NCT04614246|565686383|FG004|Overall Study|Adverse Event|1|||
156710989|NCT04614246|565686379|FG000|Overall Study|Lost to Follow-up|0|||
156710990|NCT04614246|565686380|FG001|Overall Study|Lost to Follow-up|1|||
156710991|NCT04614246|565686381|FG002|Overall Study|Lost to Follow-up|0|||
156710992|NCT04614246|565686382|FG003|Overall Study|Lost to Follow-up|1|||
156710993|NCT04614246|565686383|FG004|Overall Study|Lost to Follow-up|3|||
156710994|NCT04614246|565686379|FG000|Overall Study|Other reason|0|||
156710995|NCT04614246|565686380|FG001|Overall Study|Other reason|1|||
156710996|NCT04614246|565686381|FG002|Overall Study|Other reason|2|||
156710997|NCT04614246|565686382|FG003|Overall Study|Other reason|0|||
156792244|NCT01772693|565992714|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
156792245|NCT01772693|565992713|FG000|Overall Study|Withdrawal by Subject|2|||
156792246|NCT01772693|565992714|FG001|Overall Study|Withdrawal by Subject|0|||
156792247|NCT01772693|565992713|FG000|Overall Study|Alternative Treatment|2|||
156792248|NCT01772693|565992714|FG001|Overall Study|Alternative Treatment|0|||
156792249|NCT01633112|565992717|FG000|Overall Study|Lack of Efficacy|1|||
156792250|NCT01633112|565992718|FG001|Overall Study|Lack of Efficacy|6|||
156792251|NCT01633112|565992719|FG002|Overall Study|Lack of Efficacy|13|||
156792252|NCT01633112|565992717|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156792253|NCT01633112|565992718|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156792254|NCT01633112|565992719|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156792255|NCT01633112|565992717|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156873825|NCT05019521|566296146|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156710998|NCT04614246|565686383|FG004|Overall Study|Other reason|0|||
156710999|NCT04614246|565686379|FG000|Overall Study|Withdrawal by Subject|4|||
156711000|NCT04614246|565686380|FG001|Overall Study|Withdrawal by Subject|2|||
156711001|NCT04614246|565686381|FG002|Overall Study|Withdrawal by Subject|4|||
156711002|NCT04614246|565686382|FG003|Overall Study|Withdrawal by Subject|3|||
156711003|NCT04614246|565686383|FG004|Overall Study|Withdrawal by Subject|4|||
156711004|NCT04614246|565686379|FG000|Overall Study|Physician Decision|0|||
156711005|NCT04614246|565686380|FG001|Overall Study|Physician Decision|2|||
156711006|NCT04614246|565686381|FG002|Overall Study|Physician Decision|1|||
156711007|NCT04614246|565686382|FG003|Overall Study|Physician Decision|0|||
156711008|NCT04614246|565686383|FG004|Overall Study|Physician Decision|0|||
156711009|NCT04614246|565686379|FG000|Overall Study|Study terminated by sponsor|10|||
156711010|NCT04614246|565686380|FG001|Overall Study|Study terminated by sponsor|15|||
156711011|NCT04614246|565686381|FG002|Overall Study|Study terminated by sponsor|12|||
156711012|NCT04614246|565686382|FG003|Overall Study|Study terminated by sponsor|13|||
156711013|NCT04614246|565686383|FG004|Overall Study|Study terminated by sponsor|9|||
156711014|NCT04614246|565686379|FG000|Overall Study|Pregnancy|2|||
156711015|NCT04614246|565686380|FG001|Overall Study|Pregnancy|0|||
156711016|NCT04614246|565686381|FG002|Overall Study|Pregnancy|1|||
156711017|NCT04614246|565686382|FG003|Overall Study|Pregnancy|0|||
156711018|NCT04614246|565686383|FG004|Overall Study|Pregnancy|0|||
156711019|NCT00340678|565686384|FG000|Overall Study|Lost to Follow-up|1|||
156711020|NCT00340678|565686385|FG001|Overall Study|Lost to Follow-up|0|||
156711021|NCT00340678|565686386|FG002|Overall Study|Lost to Follow-up|0|||
156711022|NCT00340678|565686387|FG003|Overall Study|Lost to Follow-up|0|||
156711023|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
156711024|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
156711025|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
156711026|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
156711027|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
156711028|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
156711029|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
156711030|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
156711031|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
156711032|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
156711033|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
156711034|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
156711035|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
156711036|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
156711037|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
156711038|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
156711039|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
156711040|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
156711041|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
156711042|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
156711043|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Death|1|||
156711044|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Death|0|||
156711045|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Death|0|||
156711046|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Death|0|||
156711047|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Death|0|||
156711048|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Death|1|||
156711049|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Death|0|||
156711050|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Death|0|||
156711051|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Death|0|||
156711052|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Death|0|||
156711053|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Death|0|||
156711054|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Death|0|||
156711055|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Death|0|||
156873826|NCT05019521|566296147|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873827|NCT05019521|566296148|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873828|NCT05019521|566296149|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
156873829|NCT05019521|566296150|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873830|NCT05019521|566296151|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873831|NCT05019521|566296152|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156711056|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Death|0|||
156711057|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Death|0|||
156711058|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Death|0|||
156711059|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Death|0|||
156711060|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Death|0|||
156711061|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Death|0|||
156711062|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Death|0|||
156711063|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
156711064|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
156711065|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
156873832|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
156873833|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
156873834|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
156873835|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873836|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873837|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
156873838|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
156873839|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873840|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
156873841|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873842|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873843|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873844|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
156873845|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
156873846|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
156873847|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873848|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873849|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
156873850|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
156873851|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
156873852|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
156873853|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873854|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
156873855|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
156873856|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873857|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873858|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873859|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
156873860|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873861|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873862|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873863|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
156711066|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
156711067|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
156711068|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
156711069|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
156711070|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
156711071|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
156711072|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
156711073|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
156711074|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
156711075|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
156711076|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
156711077|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
156711078|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
156711079|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
156711080|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
156711081|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
156711082|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
156711083|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711084|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711085|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711086|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
156711087|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711088|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156711089|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
156873864|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
156873865|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873866|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
156873867|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873868|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
157215930|NCT00410410|567537432|FG008|Maintenance Period (MP)|Adverse Event|0|||
157215931|NCT00410410|567537424|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
156711090|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711091|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711092|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711093|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
157215932|NCT00410410|567537425|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
156711094|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711095|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711096|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156873869|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873870|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873871|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156711097|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711098|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711099|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711100|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711101|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711102|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
156711103|NCT00996892|565686391|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
156711104|NCT00996892|565686392|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
156711105|NCT00996892|565686393|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
156711106|NCT00996892|565686394|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
156711107|NCT00996892|565686395|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
156711108|NCT00996892|565686396|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
156711109|NCT00996892|565686397|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
156711110|NCT00996892|565686398|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
156711111|NCT00996892|565686399|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
156711112|NCT00996892|565686400|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
156711113|NCT00996892|565686401|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
156711114|NCT00996892|565686402|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
156711115|NCT00996892|565686403|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
156873872|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
156873873|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
156873874|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873875|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
156873876|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
156873877|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873878|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873879|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
156873880|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
156873881|NCT05019521|566296146|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
156873882|NCT05019521|566296147|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
156873883|NCT05019521|566296148|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
156873884|NCT05019521|566296149|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
156711116|NCT00996892|565686404|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
156711117|NCT00996892|565686405|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
156711118|NCT00996892|565686406|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
156711119|NCT00996892|565686407|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
156711120|NCT00996892|565686408|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
156711121|NCT00996892|565686409|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
156711122|NCT00996892|565686410|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
156711123|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
156711124|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
156711125|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
156711126|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
156711127|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
156711128|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
156711129|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
156711130|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
156711131|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
156711132|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
156711133|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
156711134|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
156873885|NCT05019521|566296150|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
156883104|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
156711135|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
156711136|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
156711137|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
156711138|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
156711139|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
156711140|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
156711141|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
156711142|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
156711143|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Death|0|||
156873886|NCT05019521|566296151|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
156873887|NCT05019521|566296152|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
156711144|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Death|0|||
156711145|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Death|0|||
156711146|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Death|0|||
156711147|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Death|0|||
156711148|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Death|0|||
156711149|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Death|0|||
156711150|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Death|0|||
156711151|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Death|0|||
156711152|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Death|2|||
156711153|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Death|0|||
156873888|NCT04476797|566296153|FG000|Overall Study|Withdrawal by Subject|1|||
156873889|NCT04476797|566296154|FG001|Overall Study|Withdrawal by Subject|0|||
156873890|NCT04476797|566296155|FG002|Overall Study|Withdrawal by Subject|0|||
156873891|NCT04476797|566296153|FG000|Overall Study|Death|0|||
156873892|NCT04476797|566296154|FG001|Overall Study|Death|1|||
156873893|NCT04476797|566296155|FG002|Overall Study|Death|2|||
156873894|NCT04476797|566296153|FG000|Overall Study|Sponsor Terminated Study|0|||
156873895|NCT04476797|566296154|FG001|Overall Study|Sponsor Terminated Study|18|||
156873896|NCT04476797|566296155|FG002|Overall Study|Sponsor Terminated Study|17|||
156873897|NCT02721966|566296157|FG000|Overall Study|Protocol Violation|1|||
156711154|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Death|1|||
156711155|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Death|1|||
156711156|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Death|0|||
156711157|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Death|0|||
156711158|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Death|0|||
156711159|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Death|0|||
156711160|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Death|0|||
156711161|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Death|0|||
156711162|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Death|0|||
156711163|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
156711164|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
156711165|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
156711166|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
156711167|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
156711168|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
156711169|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
156711170|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
156711171|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
156711172|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
156711173|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
156711174|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
156711175|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
156711176|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
156873898|NCT02721966|566296158|FG001|Overall Study|Protocol Violation|0|||
156873899|NCT02721966|566296159|FG002|Overall Study|Protocol Violation|0|||
156873900|NCT02721966|566296160|FG003|Overall Study|Protocol Violation|0|||
156873901|NCT02721966|566296161|FG004|Overall Study|Protocol Violation|0|||
156873902|NCT02721966|566296157|FG000|Overall Study|Withdrawal by Subject|9|||
156873903|NCT02721966|566296158|FG001|Overall Study|Withdrawal by Subject|2|||
156873904|NCT02721966|566296159|FG002|Overall Study|Withdrawal by Subject|3|||
156873905|NCT02721966|566296160|FG003|Overall Study|Withdrawal by Subject|7|||
156873906|NCT02721966|566296161|FG004|Overall Study|Withdrawal by Subject|0|||
156873907|NCT02721966|566296157|FG000|Overall Study|Adverse Event|4|||
156873908|NCT02721966|566296158|FG001|Overall Study|Adverse Event|4|||
156873909|NCT02721966|566296159|FG002|Overall Study|Adverse Event|3|||
156873910|NCT02721966|566296160|FG003|Overall Study|Adverse Event|0|||
156873911|NCT02721966|566296161|FG004|Overall Study|Adverse Event|0|||
156873912|NCT02721966|566296157|FG000|Overall Study|Death|1|||
156873913|NCT02721966|566296158|FG001|Overall Study|Death|0|||
156711177|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
156873914|NCT02721966|566296159|FG002|Overall Study|Death|0|||
156711178|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
156711179|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
156711180|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
156873915|NCT02721966|566296160|FG003|Overall Study|Death|0|||
157016435|NCT05368558|566811337|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
156873916|NCT02721966|566296161|FG004|Overall Study|Death|0|||
156873917|NCT02721966|566296157|FG000|Overall Study|Lack of Efficacy|7|||
156873918|NCT02721966|566296158|FG001|Overall Study|Lack of Efficacy|4|||
156711181|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
156711182|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
156711183|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711184|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711185|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711186|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711187|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711188|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711189|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711190|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711191|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711192|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711193|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711194|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711195|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
156711196|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711197|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711198|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711199|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711200|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711201|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711202|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
156711203|NCT00996892|565686391|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
156711204|NCT00996892|565686392|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
156711205|NCT00996892|565686393|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
156711206|NCT00996892|565686394|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
156711207|NCT00996892|565686395|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
156711208|NCT00996892|565686396|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
156711209|NCT00996892|565686397|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
156711210|NCT00996892|565686398|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
156711211|NCT00996892|565686399|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
156711212|NCT00996892|565686400|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
156711213|NCT00996892|565686401|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
156711214|NCT00996892|565686402|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
156711215|NCT00996892|565686403|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
156711216|NCT00996892|565686404|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
156711217|NCT00996892|565686405|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
156711218|NCT00996892|565686406|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
156711219|NCT00996892|565686407|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
156711220|NCT00996892|565686408|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
156711221|NCT00996892|565686409|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
156711222|NCT00996892|565686410|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
156711223|NCT00996892|565686391|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
156711224|NCT00996892|565686392|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
156711225|NCT00996892|565686393|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
156711226|NCT00996892|565686394|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
156711227|NCT00996892|565686395|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
156711228|NCT00996892|565686396|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
156711229|NCT00996892|565686397|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
156711230|NCT00996892|565686398|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
156711231|NCT00996892|565686399|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
156711232|NCT00996892|565686400|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
156711233|NCT00996892|565686401|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
156711234|NCT00996892|565686402|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
156711235|NCT00996892|565686403|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
156711236|NCT00996892|565686404|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
156711237|NCT00996892|565686405|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
156711238|NCT00996892|565686406|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
156711239|NCT00996892|565686407|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
156711240|NCT00996892|565686408|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
156711241|NCT00996892|565686409|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
156711242|NCT00996892|565686410|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
156711243|NCT00996892|565686391|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
156711244|NCT00996892|565686392|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
156873919|NCT02721966|566296159|FG002|Overall Study|Lack of Efficacy|0|||
156873920|NCT02721966|566296160|FG003|Overall Study|Lack of Efficacy|0|||
156873921|NCT02721966|566296161|FG004|Overall Study|Lack of Efficacy|0|||
156873922|NCT02721966|566296157|FG000|Overall Study|Lost to Follow-up|0|||
156873923|NCT02721966|566296158|FG001|Overall Study|Lost to Follow-up|0|||
156873924|NCT02721966|566296159|FG002|Overall Study|Lost to Follow-up|3|||
156873925|NCT02721966|566296160|FG003|Overall Study|Lost to Follow-up|0|||
156873926|NCT02721966|566296161|FG004|Overall Study|Lost to Follow-up|0|||
156711245|NCT00996892|565686393|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
156711246|NCT00996892|565686394|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
156711247|NCT00996892|565686395|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
156711248|NCT00996892|565686396|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
157126462|NCT01262976|567214139|FG003|Up to Month 2|Withdrawal by Subject|0|||
157126463|NCT01262976|567214140|FG004|Up to Month 2|Withdrawal by Subject|0|||
156711249|NCT00996892|565686397|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
156711250|NCT00996892|565686398|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
156711251|NCT00996892|565686399|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
156711252|NCT00996892|565686400|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
156711253|NCT00996892|565686401|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
156711254|NCT00996892|565686402|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
156711255|NCT00996892|565686403|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
156711256|NCT00996892|565686404|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
157126464|NCT01262976|567214141|FG005|Up to Month 2|Withdrawal by Subject|0|||
157126465|NCT01262976|567214136|FG000|Up to Month 2|Migrated/moved from study area|0|||
157126466|NCT01262976|567214137|FG001|Up to Month 2|Migrated/moved from study area|1|||
157126467|NCT01262976|567214138|FG002|Up to Month 2|Migrated/moved from study area|0|||
157126468|NCT01262976|567214139|FG003|Up to Month 2|Migrated/moved from study area|0|||
157126469|NCT01262976|567214140|FG004|Up to Month 2|Migrated/moved from study area|1|||
157126470|NCT01262976|567214141|FG005|Up to Month 2|Migrated/moved from study area|1|||
157126471|NCT01262976|567214136|FG000|Up to Month 2|Lost to Follow-up|1|||
157126472|NCT01262976|567214137|FG001|Up to Month 2|Lost to Follow-up|0|||
157126473|NCT01262976|567214138|FG002|Up to Month 2|Lost to Follow-up|0|||
157126474|NCT01262976|567214139|FG003|Up to Month 2|Lost to Follow-up|1|||
157126475|NCT01262976|567214140|FG004|Up to Month 2|Lost to Follow-up|1|||
157126476|NCT01262976|567214141|FG005|Up to Month 2|Lost to Follow-up|1|||
157126477|NCT01262976|567214136|FG000|Up to Month 2|Other|1|||
157126478|NCT01262976|567214137|FG001|Up to Month 2|Other|0|||
157126479|NCT01262976|567214138|FG002|Up to Month 2|Other|0|||
157126480|NCT01262976|567214139|FG003|Up to Month 2|Other|1|||
157126481|NCT01262976|567214140|FG004|Up to Month 2|Other|0|||
157126482|NCT01262976|567214141|FG005|Up to Month 2|Other|2|||
157126483|NCT01262976|567214136|FG000|Up to Month 7|Serious Adverse Event|0|||
157126484|NCT01262976|567214137|FG001|Up to Month 7|Serious Adverse Event|0|||
157126485|NCT01262976|567214138|FG002|Up to Month 7|Serious Adverse Event|2|||
157126486|NCT01262976|567214139|FG003|Up to Month 7|Serious Adverse Event|0|||
157126487|NCT01262976|567214140|FG004|Up to Month 7|Serious Adverse Event|0|||
157126488|NCT01262976|567214141|FG005|Up to Month 7|Serious Adverse Event|0|||
157126489|NCT01262976|567214136|FG000|Up to Month 7|Withdrawal by Subject|1|||
157126490|NCT01262976|567214137|FG001|Up to Month 7|Withdrawal by Subject|0|||
157126491|NCT01262976|567214138|FG002|Up to Month 7|Withdrawal by Subject|0|||
157126492|NCT01262976|567214139|FG003|Up to Month 7|Withdrawal by Subject|0|||
157126493|NCT01262976|567214140|FG004|Up to Month 7|Withdrawal by Subject|0|||
157126494|NCT01262976|567214141|FG005|Up to Month 7|Withdrawal by Subject|0|||
157126495|NCT01262976|567214136|FG000|Up to Month 7|Migrated/moved from study area|0|||
157126496|NCT01262976|567214137|FG001|Up to Month 7|Migrated/moved from study area|0|||
157126497|NCT01262976|567214138|FG002|Up to Month 7|Migrated/moved from study area|1|||
157126498|NCT01262976|567214139|FG003|Up to Month 7|Migrated/moved from study area|3|||
157126499|NCT01262976|567214140|FG004|Up to Month 7|Migrated/moved from study area|1|||
157126500|NCT01262976|567214141|FG005|Up to Month 7|Migrated/moved from study area|1|||
157126501|NCT01262976|567214136|FG000|Up to Month 7|Lost to Follow-up|1|||
157126502|NCT01262976|567214137|FG001|Up to Month 7|Lost to Follow-up|0|||
157126503|NCT01262976|567214138|FG002|Up to Month 7|Lost to Follow-up|1|||
157126504|NCT01262976|567214139|FG003|Up to Month 7|Lost to Follow-up|3|||
157126505|NCT01262976|567214140|FG004|Up to Month 7|Lost to Follow-up|1|||
156711257|NCT00996892|565686405|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
156792256|NCT01633112|565992718|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156792257|NCT01633112|565992719|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156792258|NCT01633112|565992717|FG000|Overall Study|Administrative problems|1|||
156792259|NCT01633112|565992718|FG001|Overall Study|Administrative problems|2|||
156792260|NCT01633112|565992719|FG002|Overall Study|Administrative problems|5|||
156792261|NCT01633112|565992717|FG000|Overall Study|Adverse Event|16|||
156792262|NCT01633112|565992718|FG001|Overall Study|Adverse Event|18|||
156792263|NCT01633112|565992719|FG002|Overall Study|Adverse Event|20|||
156792264|NCT01633112|565992717|FG000|Overall Study|Lost to Follow-up|7|||
156792265|NCT01633112|565992718|FG001|Overall Study|Lost to Follow-up|19|||
156792266|NCT01633112|565992719|FG002|Overall Study|Lost to Follow-up|6|||
156792267|NCT01633112|565992717|FG000|Overall Study|Protocol Violation|4|||
156792268|NCT01633112|565992718|FG001|Overall Study|Protocol Violation|0|||
156792269|NCT01633112|565992719|FG002|Overall Study|Protocol Violation|2|||
157126506|NCT01262976|567214141|FG005|Up to Month 7|Lost to Follow-up|3|||
157126507|NCT01262976|567214136|FG000|Up to Month 7|Other|3|||
157126508|NCT01262976|567214137|FG001|Up to Month 7|Other|0|||
157126509|NCT01262976|567214138|FG002|Up to Month 7|Other|2|||
157126510|NCT01262976|567214139|FG003|Up to Month 7|Other|0|||
157126511|NCT01262976|567214140|FG004|Up to Month 7|Other|0|||
157126512|NCT01262976|567214141|FG005|Up to Month 7|Other|0|||
157126513|NCT01262976|567214136|FG000|Up to Year 1|Serious Adverse Event|0|||
157126514|NCT01262976|567214137|FG001|Up to Year 1|Serious Adverse Event|0|||
157126515|NCT01262976|567214138|FG002|Up to Year 1|Serious Adverse Event|2|||
156711258|NCT00996892|565686406|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
156711259|NCT00996892|565686407|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
156711260|NCT00996892|565686408|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
156711261|NCT00996892|565686409|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
156711262|NCT00996892|565686410|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
156711263|NCT00996892|565686391|FG000|Expansion Stage 2|Adverse Event|0|||
156711264|NCT00996892|565686392|FG001|Expansion Stage 2|Adverse Event|0|||
156711265|NCT00996892|565686393|FG002|Expansion Stage 2|Adverse Event|0|||
156711266|NCT00996892|565686394|FG003|Expansion Stage 2|Adverse Event|0|||
156711267|NCT00996892|565686395|FG004|Expansion Stage 2|Adverse Event|0|||
156711268|NCT00996892|565686396|FG005|Expansion Stage 2|Adverse Event|0|||
156711269|NCT00996892|565686397|FG006|Expansion Stage 2|Adverse Event|0|||
156711270|NCT00996892|565686398|FG007|Expansion Stage 2|Adverse Event|0|||
156711271|NCT00996892|565686399|FG008|Expansion Stage 2|Adverse Event|0|||
156711272|NCT00996892|565686400|FG009|Expansion Stage 2|Adverse Event|0|||
156711273|NCT00996892|565686401|FG010|Expansion Stage 2|Adverse Event|0|||
156711274|NCT00996892|565686402|FG011|Expansion Stage 2|Adverse Event|0|||
156711275|NCT00996892|565686403|FG012|Expansion Stage 2|Adverse Event|0|||
156711276|NCT00996892|565686404|FG013|Expansion Stage 2|Adverse Event|0|||
156711277|NCT00996892|565686405|FG014|Expansion Stage 2|Adverse Event|0|||
156711278|NCT00996892|565686406|FG015|Expansion Stage 2|Adverse Event|0|||
156711279|NCT00996892|565686407|FG016|Expansion Stage 2|Adverse Event|0|||
156711280|NCT00996892|565686408|FG017|Expansion Stage 2|Adverse Event|0|||
156711281|NCT00996892|565686409|FG018|Expansion Stage 2|Adverse Event|3|||
156711282|NCT00996892|565686410|FG019|Expansion Stage 2|Adverse Event|0|||
156711283|NCT00996892|565686391|FG000|Expansion Stage 2|Death|0|||
156711284|NCT00996892|565686392|FG001|Expansion Stage 2|Death|0|||
156711285|NCT00996892|565686393|FG002|Expansion Stage 2|Death|0|||
156711286|NCT00996892|565686394|FG003|Expansion Stage 2|Death|0|||
156711287|NCT00996892|565686395|FG004|Expansion Stage 2|Death|0|||
156711288|NCT00996892|565686396|FG005|Expansion Stage 2|Death|0|||
156711289|NCT00996892|565686397|FG006|Expansion Stage 2|Death|0|||
156711290|NCT00996892|565686398|FG007|Expansion Stage 2|Death|0|||
156711291|NCT00996892|565686399|FG008|Expansion Stage 2|Death|0|||
156711292|NCT00996892|565686400|FG009|Expansion Stage 2|Death|0|||
156711293|NCT00996892|565686401|FG010|Expansion Stage 2|Death|0|||
156711294|NCT00996892|565686402|FG011|Expansion Stage 2|Death|0|||
156711295|NCT00996892|565686403|FG012|Expansion Stage 2|Death|0|||
156711296|NCT00996892|565686404|FG013|Expansion Stage 2|Death|0|||
156711297|NCT00996892|565686405|FG014|Expansion Stage 2|Death|0|||
156711298|NCT00996892|565686406|FG015|Expansion Stage 2|Death|0|||
156711299|NCT00996892|565686407|FG016|Expansion Stage 2|Death|0|||
156711300|NCT00996892|565686408|FG017|Expansion Stage 2|Death|0|||
156711301|NCT00996892|565686409|FG018|Expansion Stage 2|Death|2|||
156711302|NCT00996892|565686410|FG019|Expansion Stage 2|Death|0|||
156711303|NCT00996892|565686391|FG000|Expansion Stage 2|Physician Decision|0|||
156711304|NCT00996892|565686392|FG001|Expansion Stage 2|Physician Decision|0|||
156711305|NCT00996892|565686393|FG002|Expansion Stage 2|Physician Decision|0|||
156711306|NCT00996892|565686394|FG003|Expansion Stage 2|Physician Decision|0|||
156711307|NCT00996892|565686395|FG004|Expansion Stage 2|Physician Decision|0|||
156711308|NCT00996892|565686396|FG005|Expansion Stage 2|Physician Decision|0|||
156711309|NCT00996892|565686397|FG006|Expansion Stage 2|Physician Decision|0|||
157126516|NCT01262976|567214139|FG003|Up to Year 1|Serious Adverse Event|0|||
157126517|NCT01262976|567214140|FG004|Up to Year 1|Serious Adverse Event|0|||
157126518|NCT01262976|567214141|FG005|Up to Year 1|Serious Adverse Event|0|||
157126519|NCT01262976|567214136|FG000|Up to Year 1|Withdrawal by Subject|1|||
157126520|NCT01262976|567214137|FG001|Up to Year 1|Withdrawal by Subject|0|||
157126521|NCT01262976|567214138|FG002|Up to Year 1|Withdrawal by Subject|0|||
157126522|NCT01262976|567214139|FG003|Up to Year 1|Withdrawal by Subject|0|||
157126523|NCT01262976|567214140|FG004|Up to Year 1|Withdrawal by Subject|0|||
157126524|NCT01262976|567214141|FG005|Up to Year 1|Withdrawal by Subject|0|||
157126525|NCT01262976|567214136|FG000|Up to Year 1|Migrated/moved from study area|1|||
157126526|NCT01262976|567214137|FG001|Up to Year 1|Migrated/moved from study area|0|||
157126527|NCT01262976|567214138|FG002|Up to Year 1|Migrated/moved from study area|0|||
157126528|NCT01262976|567214139|FG003|Up to Year 1|Migrated/moved from study area|3|||
157126529|NCT01262976|567214140|FG004|Up to Year 1|Migrated/moved from study area|3|||
157126530|NCT01262976|567214141|FG005|Up to Year 1|Migrated/moved from study area|2|||
157126531|NCT01262976|567214136|FG000|Up to Year 1|Lost to Follow-up|4|||
157126532|NCT01262976|567214137|FG001|Up to Year 1|Lost to Follow-up|0|||
157126533|NCT01262976|567214138|FG002|Up to Year 1|Lost to Follow-up|0|||
156711310|NCT00996892|565686398|FG007|Expansion Stage 2|Physician Decision|0|||
156711311|NCT00996892|565686399|FG008|Expansion Stage 2|Physician Decision|0|||
156711312|NCT00996892|565686400|FG009|Expansion Stage 2|Physician Decision|0|||
156711313|NCT00996892|565686401|FG010|Expansion Stage 2|Physician Decision|0|||
156711314|NCT00996892|565686402|FG011|Expansion Stage 2|Physician Decision|0|||
156711315|NCT00996892|565686403|FG012|Expansion Stage 2|Physician Decision|0|||
157126534|NCT01262976|567214139|FG003|Up to Year 1|Lost to Follow-up|1|||
157126535|NCT01262976|567214140|FG004|Up to Year 1|Lost to Follow-up|6|||
157126536|NCT01262976|567214141|FG005|Up to Year 1|Lost to Follow-up|5|||
156711316|NCT00996892|565686404|FG013|Expansion Stage 2|Physician Decision|0|||
156711317|NCT00996892|565686405|FG014|Expansion Stage 2|Physician Decision|0|||
156711318|NCT00996892|565686406|FG015|Expansion Stage 2|Physician Decision|0|||
156711319|NCT00996892|565686407|FG016|Expansion Stage 2|Physician Decision|0|||
156711320|NCT00996892|565686408|FG017|Expansion Stage 2|Physician Decision|0|||
156711321|NCT00996892|565686409|FG018|Expansion Stage 2|Physician Decision|1|||
157126537|NCT01262976|567214136|FG000|Up to Year 1|Other|3|||
157126538|NCT01262976|567214137|FG001|Up to Year 1|Other|1|||
157126539|NCT01262976|567214138|FG002|Up to Year 1|Other|0|||
157126540|NCT01262976|567214139|FG003|Up to Year 1|Other|0|||
156711322|NCT00996892|565686410|FG019|Expansion Stage 2|Physician Decision|0|||
156711323|NCT00996892|565686391|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
156711324|NCT00996892|565686392|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
156711325|NCT00996892|565686393|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
156711326|NCT00996892|565686394|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
156711327|NCT00996892|565686395|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
157126541|NCT01262976|567214140|FG004|Up to Year 1|Other|2|||
157126542|NCT01262976|567214141|FG005|Up to Year 1|Other|1|||
157126543|NCT01262976|567214136|FG000|Up to Year 1|Subjects with unknown completion status|0|||
157126544|NCT01262976|567214137|FG001|Up to Year 1|Subjects with unknown completion status|0|||
157126545|NCT01262976|567214138|FG002|Up to Year 1|Subjects with unknown completion status|1|||
157126546|NCT01262976|567214139|FG003|Up to Year 1|Subjects with unknown completion status|0|||
157126547|NCT01262976|567214140|FG004|Up to Year 1|Subjects with unknown completion status|0|||
157126548|NCT01262976|567214141|FG005|Up to Year 1|Subjects with unknown completion status|1|||
157126549|NCT01262976|567214136|FG000|Up to Year 2|Serious Adverse Event|0|||
157126550|NCT01262976|567214137|FG001|Up to Year 2|Serious Adverse Event|0|||
157126551|NCT01262976|567214138|FG002|Up to Year 2|Serious Adverse Event|2|||
156711328|NCT00996892|565686396|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
156711329|NCT00996892|565686397|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
156711330|NCT00996892|565686398|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
156711331|NCT00996892|565686399|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
156711332|NCT00996892|565686400|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
156711333|NCT00996892|565686401|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
156711334|NCT00996892|565686402|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
156711335|NCT00996892|565686403|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
156711336|NCT00996892|565686404|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
156711337|NCT00996892|565686405|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
156711338|NCT00996892|565686406|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
156711339|NCT00996892|565686407|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
156711340|NCT00996892|565686408|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
156711341|NCT00996892|565686409|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
156711342|NCT00996892|565686410|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
156711343|NCT00996892|565686391|FG000|Expansion Stage 2|Disease Progression|0|||
156711344|NCT00996892|565686392|FG001|Expansion Stage 2|Disease Progression|0|||
156711345|NCT00996892|565686393|FG002|Expansion Stage 2|Disease Progression|0|||
157126552|NCT01262976|567214139|FG003|Up to Year 2|Serious Adverse Event|0|||
157126553|NCT01262976|567214140|FG004|Up to Year 2|Serious Adverse Event|0|||
156873927|NCT02721966|566296157|FG000|Overall Study|Physician Decision|1|||
156873928|NCT02721966|566296158|FG001|Overall Study|Physician Decision|1|||
157126554|NCT01262976|567214141|FG005|Up to Year 2|Serious Adverse Event|0|||
157126555|NCT01262976|567214136|FG000|Up to Year 2|Withdrawal by Subject|1|||
157126556|NCT01262976|567214137|FG001|Up to Year 2|Withdrawal by Subject|0|||
157126557|NCT01262976|567214138|FG002|Up to Year 2|Withdrawal by Subject|0|||
157126558|NCT01262976|567214139|FG003|Up to Year 2|Withdrawal by Subject|0|||
157126559|NCT01262976|567214140|FG004|Up to Year 2|Withdrawal by Subject|0|||
157126560|NCT01262976|567214141|FG005|Up to Year 2|Withdrawal by Subject|0|||
156711346|NCT00996892|565686394|FG003|Expansion Stage 2|Disease Progression|0|||
156711347|NCT00996892|565686395|FG004|Expansion Stage 2|Disease Progression|0|||
156711348|NCT00996892|565686396|FG005|Expansion Stage 2|Disease Progression|0|||
156711349|NCT00996892|565686397|FG006|Expansion Stage 2|Disease Progression|0|||
156873929|NCT02721966|566296159|FG002|Overall Study|Physician Decision|0|||
157126561|NCT01262976|567214136|FG000|Up to Year 2|Migrated/moved from study area|0|||
157126562|NCT01262976|567214137|FG001|Up to Year 2|Migrated/moved from study area|0|||
157126563|NCT01262976|567214138|FG002|Up to Year 2|Migrated/moved from study area|0|||
157126564|NCT01262976|567214139|FG003|Up to Year 2|Migrated/moved from study area|2|||
157126565|NCT01262976|567214140|FG004|Up to Year 2|Migrated/moved from study area|1|||
157126566|NCT01262976|567214141|FG005|Up to Year 2|Migrated/moved from study area|2|||
157126567|NCT01262976|567214136|FG000|Up to Year 2|Lost to Follow-up|1|||
156711350|NCT00996892|565686398|FG007|Expansion Stage 2|Disease Progression|0|||
156711351|NCT00996892|565686399|FG008|Expansion Stage 2|Disease Progression|0|||
156711352|NCT00996892|565686400|FG009|Expansion Stage 2|Disease Progression|0|||
156711353|NCT00996892|565686401|FG010|Expansion Stage 2|Disease Progression|0|||
157126568|NCT01262976|567214137|FG001|Up to Year 2|Lost to Follow-up|1|||
157126569|NCT01262976|567214138|FG002|Up to Year 2|Lost to Follow-up|2|||
157126570|NCT01262976|567214139|FG003|Up to Year 2|Lost to Follow-up|2|||
156873930|NCT02721966|566296160|FG003|Overall Study|Physician Decision|0|||
156873931|NCT02721966|566296161|FG004|Overall Study|Physician Decision|0|||
156873932|NCT02721966|566296157|FG000|Overall Study|Pregnancy|1|||
156711354|NCT00996892|565686402|FG011|Expansion Stage 2|Disease Progression|0|||
156711355|NCT00996892|565686403|FG012|Expansion Stage 2|Disease Progression|0|||
156711356|NCT00996892|565686404|FG013|Expansion Stage 2|Disease Progression|0|||
156711357|NCT00996892|565686405|FG014|Expansion Stage 2|Disease Progression|0|||
156711358|NCT00996892|565686406|FG015|Expansion Stage 2|Disease Progression|0|||
156711359|NCT00996892|565686407|FG016|Expansion Stage 2|Disease Progression|0|||
156711360|NCT00996892|565686408|FG017|Expansion Stage 2|Disease Progression|0|||
156711361|NCT00996892|565686409|FG018|Expansion Stage 2|Disease Progression|28|||
156711362|NCT00996892|565686410|FG019|Expansion Stage 2|Disease Progression|0|||
156711363|NCT00996892|565686391|FG000|Expansion Stage 2A|Adverse Event|0|||
156711364|NCT00996892|565686392|FG001|Expansion Stage 2A|Adverse Event|0|||
156711365|NCT00996892|565686393|FG002|Expansion Stage 2A|Adverse Event|0|||
156711366|NCT00996892|565686394|FG003|Expansion Stage 2A|Adverse Event|0|||
156711367|NCT00996892|565686395|FG004|Expansion Stage 2A|Adverse Event|0|||
156711368|NCT00996892|565686396|FG005|Expansion Stage 2A|Adverse Event|0|||
156711369|NCT00996892|565686397|FG006|Expansion Stage 2A|Adverse Event|0|||
156711370|NCT00996892|565686398|FG007|Expansion Stage 2A|Adverse Event|0|||
156711371|NCT00996892|565686399|FG008|Expansion Stage 2A|Adverse Event|0|||
156711372|NCT00996892|565686400|FG009|Expansion Stage 2A|Adverse Event|0|||
156711373|NCT00996892|565686401|FG010|Expansion Stage 2A|Adverse Event|0|||
156711374|NCT00996892|565686402|FG011|Expansion Stage 2A|Adverse Event|0|||
156711375|NCT00996892|565686403|FG012|Expansion Stage 2A|Adverse Event|0|||
156711376|NCT00996892|565686404|FG013|Expansion Stage 2A|Adverse Event|0|||
156711377|NCT00996892|565686405|FG014|Expansion Stage 2A|Adverse Event|0|||
156711378|NCT00996892|565686406|FG015|Expansion Stage 2A|Adverse Event|0|||
156711379|NCT00996892|565686407|FG016|Expansion Stage 2A|Adverse Event|0|||
156711380|NCT00996892|565686408|FG017|Expansion Stage 2A|Adverse Event|0|||
156711381|NCT00996892|565686409|FG018|Expansion Stage 2A|Adverse Event|0|||
156711382|NCT00996892|565686410|FG019|Expansion Stage 2A|Adverse Event|8|||
156711383|NCT00996892|565686391|FG000|Expansion Stage 2A|Physician Decision|0|||
156711384|NCT00996892|565686392|FG001|Expansion Stage 2A|Physician Decision|0|||
156711385|NCT00996892|565686393|FG002|Expansion Stage 2A|Physician Decision|0|||
156711386|NCT00996892|565686394|FG003|Expansion Stage 2A|Physician Decision|0|||
156711387|NCT00996892|565686395|FG004|Expansion Stage 2A|Physician Decision|0|||
156711388|NCT00996892|565686396|FG005|Expansion Stage 2A|Physician Decision|0|||
156711389|NCT00996892|565686397|FG006|Expansion Stage 2A|Physician Decision|0|||
156711390|NCT00996892|565686398|FG007|Expansion Stage 2A|Physician Decision|0|||
156711391|NCT00996892|565686399|FG008|Expansion Stage 2A|Physician Decision|0|||
156711392|NCT00996892|565686400|FG009|Expansion Stage 2A|Physician Decision|0|||
156873933|NCT02721966|566296158|FG001|Overall Study|Pregnancy|0|||
156873934|NCT02721966|566296159|FG002|Overall Study|Pregnancy|0|||
156873935|NCT02721966|566296160|FG003|Overall Study|Pregnancy|0|||
156873936|NCT02721966|566296161|FG004|Overall Study|Pregnancy|0|||
156873937|NCT02721966|566296157|FG000|Overall Study|Did not continue to period 2|5|||
156873938|NCT02721966|566296158|FG001|Overall Study|Did not continue to period 2|12|||
156873939|NCT02721966|566296159|FG002|Overall Study|Did not continue to period 2|0|||
156873940|NCT02721966|566296160|FG003|Overall Study|Did not continue to period 2|0|||
156873941|NCT02721966|566296161|FG004|Overall Study|Did not continue to period 2|5|||
156873942|NCT01192191|566296162|FG000|Overall Study|Adverse Event|7|||
156873943|NCT01192191|566296163|FG001|Overall Study|Adverse Event|12|||
156873944|NCT01192191|566296162|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
156873945|NCT01192191|566296163|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
156873946|NCT01192191|566296162|FG000|Overall Study|Lost to Follow-up|0|||
156873947|NCT01192191|566296163|FG001|Overall Study|Lost to Follow-up|1|||
156873948|NCT01192191|566296162|FG000|Overall Study|Withdrawal by Subject|1|||
156873949|NCT01192191|566296163|FG001|Overall Study|Withdrawal by Subject|6|||
156873950|NCT00467753|566296164|FG000|Overall Study|Lost to Follow-up|1|||
156873951|NCT00467753|566296165|FG001|Overall Study|Lost to Follow-up|2|||
156711393|NCT00996892|565686401|FG010|Expansion Stage 2A|Physician Decision|0|||
156711394|NCT00996892|565686402|FG011|Expansion Stage 2A|Physician Decision|0|||
156711395|NCT00996892|565686403|FG012|Expansion Stage 2A|Physician Decision|0|||
156711396|NCT00996892|565686404|FG013|Expansion Stage 2A|Physician Decision|0|||
156711397|NCT00996892|565686405|FG014|Expansion Stage 2A|Physician Decision|0|||
156711398|NCT00996892|565686406|FG015|Expansion Stage 2A|Physician Decision|0|||
156711399|NCT00996892|565686407|FG016|Expansion Stage 2A|Physician Decision|0|||
156711400|NCT00996892|565686408|FG017|Expansion Stage 2A|Physician Decision|0|||
156711401|NCT00996892|565686409|FG018|Expansion Stage 2A|Physician Decision|0|||
156711402|NCT00996892|565686410|FG019|Expansion Stage 2A|Physician Decision|2|||
156711403|NCT00996892|565686391|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
156873952|NCT00467753|566296164|FG000|Overall Study|Adverse Event|2|||
156873953|NCT00467753|566296165|FG001|Overall Study|Adverse Event|0|||
156873954|NCT01047553|566296166|FG000|Overall Study|Adverse Event|10|||
157126571|NCT01262976|567214140|FG004|Up to Year 2|Lost to Follow-up|3|||
156711404|NCT00996892|565686392|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
156873955|NCT01047553|566296167|FG001|Overall Study|Adverse Event|5|||
156792270|NCT01633112|565992717|FG000|Overall Study|Subject no longer requires study drug|0|||
156792271|NCT01633112|565992718|FG001|Overall Study|Subject no longer requires study drug|0|||
157126572|NCT01262976|567214141|FG005|Up to Year 2|Lost to Follow-up|3|||
157126573|NCT01262976|567214136|FG000|Up to Year 2|Subjects with unknown completion status|0|||
157126574|NCT01262976|567214137|FG001|Up to Year 2|Subjects with unknown completion status|0|||
157126575|NCT01262976|567214138|FG002|Up to Year 2|Subjects with unknown completion status|1|||
156792272|NCT01633112|565992719|FG002|Overall Study|Subject no longer requires study drug|1|||
156792273|NCT01633112|565992717|FG000|Overall Study|Withdrawal by Subject|20|||
156792274|NCT01633112|565992718|FG001|Overall Study|Withdrawal by Subject|12|||
156792275|NCT01633112|565992719|FG002|Overall Study|Withdrawal by Subject|41|||
156792276|NCT01633112|565992717|FG000|Overall Study|missing Study Completion CRF|1|||
156792277|NCT01633112|565992718|FG001|Overall Study|missing Study Completion CRF|1|||
156792278|NCT01633112|565992719|FG002|Overall Study|missing Study Completion CRF|4|||
156792279|NCT02605967|565992728|FG000|Overall Study|subject / guardian decision|1|||
156792280|NCT02605967|565992729|FG001|Overall Study|subject / guardian decision|2|||
156792281|NCT02605967|565992728|FG000|Overall Study|Physician Decision|10|||
156792282|NCT02605967|565992729|FG001|Overall Study|Physician Decision|1|||
156792283|NCT02605967|565992728|FG000|Overall Study|Death|4|||
156792284|NCT02605967|565992729|FG001|Overall Study|Death|2|||
156792285|NCT02605967|565992728|FG000|Overall Study|Adverse Event|1|||
156792286|NCT02605967|565992729|FG001|Overall Study|Adverse Event|0|||
156792287|NCT02605967|565992728|FG000|Overall Study|progressive disease|66|||
156792288|NCT02605967|565992729|FG001|Overall Study|progressive disease|35|||
156792289|NCT05122143|565992735|FG000|Overall Study|Adverse Event|1|||
156792290|NCT05122143|565992736|FG001|Overall Study|Adverse Event|0|||
156792291|NCT05122143|565992737|FG002|Overall Study|Adverse Event|0|||
156792292|NCT05122143|565992738|FG003|Overall Study|Adverse Event|0|||
156792293|NCT05122143|565992739|FG004|Overall Study|Adverse Event|1|||
156792294|NCT05122143|565992740|FG005|Overall Study|Adverse Event|0|||
157126576|NCT01262976|567214139|FG003|Up to Year 2|Subjects with unknown completion status|0|||
157126577|NCT01262976|567214140|FG004|Up to Year 2|Subjects with unknown completion status|0|||
157126578|NCT01262976|567214141|FG005|Up to Year 2|Subjects with unknown completion status|0|||
157126579|NCT01262976|567214136|FG000|Up to Year 2|Other|3|||
157215933|NCT00410410|567537426|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
157215934|NCT00410410|567537427|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
157215935|NCT00410410|567537428|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
157215936|NCT00410410|567537429|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
157215937|NCT00410410|567537430|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
157215938|NCT00410410|567537431|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
157215939|NCT00410410|567537432|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
157215940|NCT00410410|567537424|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
157215941|NCT00410410|567537425|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
157215942|NCT00410410|567537426|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
157215943|NCT00410410|567537427|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
157215944|NCT00410410|567537428|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
157215945|NCT00410410|567537429|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
157215946|NCT00410410|567537430|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
157215947|NCT00410410|567537431|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
157215948|NCT00410410|567537432|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
157215949|NCT00410410|567537424|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215950|NCT00410410|567537425|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215951|NCT00410410|567537426|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215952|NCT00410410|567537427|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215953|NCT00410410|567537428|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215954|NCT00410410|567537429|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215955|NCT00410410|567537430|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
157215956|NCT00410410|567537431|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
157215957|NCT00410410|567537432|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
157215958|NCT00410410|567537424|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215959|NCT00410410|567537425|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215960|NCT00410410|567537426|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215961|NCT00410410|567537427|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215962|NCT00410410|567537428|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215963|NCT00410410|567537429|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215964|NCT00410410|567537430|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
157215965|NCT00410410|567537431|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
157215966|NCT00410410|567537432|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
157215967|NCT00410410|567537424|FG000|Open-Label Period (OL)|Death|0|||
156792295|NCT05122143|565992735|FG000|Overall Study|Protocol non-compliance|0|||
157215968|NCT00410410|567537425|FG001|Open-Label Period (OL)|Death|0|||
156792296|NCT05122143|565992736|FG001|Overall Study|Protocol non-compliance|0|||
156792297|NCT05122143|565992737|FG002|Overall Study|Protocol non-compliance|1|||
156792298|NCT05122143|565992738|FG003|Overall Study|Protocol non-compliance|0|||
157215969|NCT00410410|567537426|FG002|Open-Label Period (OL)|Death|0|||
157215970|NCT00410410|567537427|FG003|Open-Label Period (OL)|Death|0|||
157215971|NCT00410410|567537428|FG004|Open-Label Period (OL)|Death|0|||
157215972|NCT00410410|567537429|FG005|Open-Label Period (OL)|Death|0|||
157215973|NCT00410410|567537430|FG006|Open-Label Period (OL)|Death|0|||
157215974|NCT00410410|567537431|FG007|Open-Label Period (OL)|Death|0|||
157215975|NCT00410410|567537432|FG008|Open-Label Period (OL)|Death|1|||
157215976|NCT00410410|567537424|FG000|Open-Label Period (OL)|Adverse Event|0|||
157215977|NCT00410410|567537425|FG001|Open-Label Period (OL)|Adverse Event|0|||
157215978|NCT00410410|567537426|FG002|Open-Label Period (OL)|Adverse Event|0|||
157215979|NCT00410410|567537427|FG003|Open-Label Period (OL)|Adverse Event|0|||
157215980|NCT00410410|567537428|FG004|Open-Label Period (OL)|Adverse Event|0|||
156711405|NCT00996892|565686393|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
156711406|NCT00996892|565686394|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
156711407|NCT00996892|565686395|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
156711408|NCT00996892|565686396|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
156711409|NCT00996892|565686397|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
157215981|NCT00410410|567537429|FG005|Open-Label Period (OL)|Adverse Event|0|||
157215982|NCT00410410|567537430|FG006|Open-Label Period (OL)|Adverse Event|0|||
156711410|NCT00996892|565686398|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
156711411|NCT00996892|565686399|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
156711412|NCT00996892|565686400|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
156711413|NCT00996892|565686401|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
156711414|NCT00996892|565686402|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
156711415|NCT00996892|565686403|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
156711416|NCT00996892|565686404|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
156711417|NCT00996892|565686405|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
156711418|NCT00996892|565686406|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
156711419|NCT00996892|565686407|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
156711420|NCT00996892|565686408|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
156711421|NCT00996892|565686409|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
156711422|NCT00996892|565686410|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
156711423|NCT00996892|565686391|FG000|Expansion Stage 2A|Disease Progression|0|||
156711424|NCT00996892|565686392|FG001|Expansion Stage 2A|Disease Progression|0|||
156711425|NCT00996892|565686393|FG002|Expansion Stage 2A|Disease Progression|0|||
156711426|NCT00996892|565686394|FG003|Expansion Stage 2A|Disease Progression|0|||
156711427|NCT00996892|565686395|FG004|Expansion Stage 2A|Disease Progression|0|||
156711428|NCT00996892|565686396|FG005|Expansion Stage 2A|Disease Progression|0|||
156711429|NCT00996892|565686397|FG006|Expansion Stage 2A|Disease Progression|0|||
156711430|NCT00996892|565686398|FG007|Expansion Stage 2A|Disease Progression|0|||
156711431|NCT00996892|565686399|FG008|Expansion Stage 2A|Disease Progression|0|||
156711432|NCT00996892|565686400|FG009|Expansion Stage 2A|Disease Progression|0|||
156711433|NCT00996892|565686401|FG010|Expansion Stage 2A|Disease Progression|0|||
156711434|NCT00996892|565686402|FG011|Expansion Stage 2A|Disease Progression|0|||
156711435|NCT00996892|565686403|FG012|Expansion Stage 2A|Disease Progression|0|||
156711436|NCT00996892|565686404|FG013|Expansion Stage 2A|Disease Progression|0|||
156711437|NCT00996892|565686405|FG014|Expansion Stage 2A|Disease Progression|0|||
156711438|NCT00996892|565686406|FG015|Expansion Stage 2A|Disease Progression|0|||
156711439|NCT00996892|565686407|FG016|Expansion Stage 2A|Disease Progression|0|||
156711440|NCT00996892|565686408|FG017|Expansion Stage 2A|Disease Progression|0|||
156711441|NCT00996892|565686409|FG018|Expansion Stage 2A|Disease Progression|0|||
156711442|NCT00996892|565686410|FG019|Expansion Stage 2A|Disease Progression|31|||
156711443|NCT02759692|565686411|FG000|Period 1|Test article no longer available|1|||
156711444|NCT02759692|565686412|FG001|Period 1|Test article no longer available|1|||
156711445|NCT02759692|565686411|FG000|Period 1|No longer meets eligibility criteria.|1|||
156792299|NCT05122143|565992739|FG004|Overall Study|Protocol non-compliance|0|||
156792300|NCT05122143|565992740|FG005|Overall Study|Protocol non-compliance|0|||
156792301|NCT05122143|565992735|FG000|Overall Study|Covid contact|0|||
157016436|NCT05368558|566811338|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016437|NCT05368558|566811339|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
157016438|NCT05368558|566811328|FG000|Blinded Extension Period (BEP)|other|0|||
157016439|NCT05368558|566811329|FG001|Blinded Extension Period (BEP)|other|0|||
157016440|NCT05368558|566811330|FG002|Blinded Extension Period (BEP)|other|0|||
157016441|NCT05368558|566811331|FG003|Blinded Extension Period (BEP)|other|0|||
157016442|NCT05368558|566811332|FG004|Blinded Extension Period (BEP)|other|0|||
157016443|NCT05368558|566811333|FG005|Blinded Extension Period (BEP)|other|1|||
157016444|NCT05368558|566811334|FG006|Blinded Extension Period (BEP)|other|0|||
157016445|NCT05368558|566811335|FG007|Blinded Extension Period (BEP)|other|0|||
157016446|NCT05368558|566811336|FG008|Blinded Extension Period (BEP)|other|0|||
157016447|NCT05368558|566811337|FG009|Blinded Extension Period (BEP)|other|0|||
157016448|NCT05368558|566811338|FG010|Blinded Extension Period (BEP)|other|0|||
157016449|NCT05368558|566811339|FG011|Blinded Extension Period (BEP)|other|0|||
157215983|NCT00410410|567537431|FG007|Open-Label Period (OL)|Adverse Event|0|||
157215984|NCT00410410|567537432|FG008|Open-Label Period (OL)|Adverse Event|10|||
157215985|NCT00410410|567537424|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
157215986|NCT00410410|567537425|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
157215987|NCT00410410|567537426|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
157215988|NCT00410410|567537427|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
157215989|NCT00410410|567537428|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
157215990|NCT00410410|567537429|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
156711446|NCT02759692|565686412|FG001|Period 1|No longer meets eligibility criteria.|0|||
156711447|NCT02759692|565686411|FG000|Period 1|Miss-Randomized|1|||
156711448|NCT02759692|565686412|FG001|Period 1|Miss-Randomized|1|||
156711449|NCT02759692|565686411|FG000|Period 2|Lost to Follow-up|1|||
156711450|NCT02759692|565686412|FG001|Period 2|Lost to Follow-up|0|||
156711451|NCT02759692|565686411|FG000|Period 2|Test article no longer available|0|||
156711452|NCT02759692|565686412|FG001|Period 2|Test article no longer available|1|||
156711453|NCT04042376|565686418|FG000|Overall Study|Withdrawal by Subject|1|||
156711454|NCT04042376|565686418|FG000|Overall Study|Death|3|||
156711455|NCT01059786|565688769|FG000|Overall Study|Did not receive 6 cycles.|0|||
156711456|NCT01059786|565688770|FG001|Overall Study|Did not receive 6 cycles.|0|||
156711457|NCT01059786|565688771|FG002|Overall Study|Did not receive 6 cycles.|4|||
156711458|NCT01059786|565688772|FG003|Overall Study|Did not receive 6 cycles.|1|||
156711459|NCT01059786|565688773|FG004|Overall Study|Did not receive 6 cycles.|0|||
156711460|NCT04205812|565688774|FG000|Randomized Treatment Period|Ongoing|28|||
156711461|NCT04205812|565688775|FG001|Randomized Treatment Period|Ongoing|138|||
156711462|NCT04205812|565688774|FG000|Randomized Treatment Period|Death|94|||
156711463|NCT04205812|565688775|FG001|Randomized Treatment Period|Death|226|||
156711464|NCT04205812|565688774|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
156711465|NCT04205812|565688775|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
156711466|NCT04205812|565688774|FG000|Randomized Treatment Period|Physician Decision|1|||
156711467|NCT04205812|565688775|FG001|Randomized Treatment Period|Physician Decision|4|||
156711468|NCT04205812|565688774|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
156711469|NCT04205812|565688775|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
156711470|NCT04205812|565688774|FG000|Randomized Treatment Period|Progressive Disease|0|||
156711471|NCT04205812|565688775|FG001|Randomized Treatment Period|Progressive Disease|1|||
156711472|NCT04205812|565688774|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
156711473|NCT04205812|565688775|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
156711474|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Ongoing|17|||
156711475|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Ongoing|0|||
156711476|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Death|39|||
156711477|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Death|0|||
156711478|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
156711479|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
156711480|NCT04205812|565688774|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
156711481|NCT04205812|565688775|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
156711482|NCT04559347|565688776|FG000|Overall Study|Death|1|||
156711483|NCT04559347|565688777|FG001|Overall Study|Death|0|||
156711484|NCT04559347|565688776|FG000|Overall Study|Thoracotomy conversion|1|||
156711485|NCT04559347|565688777|FG001|Overall Study|Thoracotomy conversion|1|||
156711486|NCT04559347|565688776|FG000|Overall Study|Provider unavailable|2|||
156711487|NCT04559347|565688777|FG001|Overall Study|Provider unavailable|1|||
156792302|NCT05122143|565992736|FG001|Overall Study|Covid contact|0|||
156792303|NCT05122143|565992737|FG002|Overall Study|Covid contact|0|||
156792304|NCT05122143|565992738|FG003|Overall Study|Covid contact|0|||
156792305|NCT05122143|565992739|FG004|Overall Study|Covid contact|1|||
156792306|NCT05122143|565992740|FG005|Overall Study|Covid contact|0|||
156792307|NCT01475825|565992741|FG000|Overall Study|Adverse Event|41|||
156792308|NCT01475825|565992742|FG001|Overall Study|Adverse Event|15|||
156792309|NCT01475825|565992743|FG002|Overall Study|Adverse Event|27|||
156792310|NCT01475825|565992744|FG003|Overall Study|Adverse Event|11|||
156792311|NCT01475825|565992741|FG000|Overall Study|Death|1|||
156792312|NCT01475825|565992742|FG001|Overall Study|Death|0|||
156792313|NCT01475825|565992743|FG002|Overall Study|Death|1|||
156792314|NCT01475825|565992744|FG003|Overall Study|Death|0|||
156792315|NCT01475825|565992741|FG000|Overall Study|Lack of Efficacy|0|||
156792316|NCT01475825|565992742|FG001|Overall Study|Lack of Efficacy|0|||
156792317|NCT01475825|565992743|FG002|Overall Study|Lack of Efficacy|1|||
156792318|NCT01475825|565992744|FG003|Overall Study|Lack of Efficacy|0|||
156792319|NCT01475825|565992741|FG000|Overall Study|Lost to Follow-up|0|||
156792320|NCT01475825|565992742|FG001|Overall Study|Lost to Follow-up|0|||
156792321|NCT01475825|565992743|FG002|Overall Study|Lost to Follow-up|3|||
156792322|NCT01475825|565992744|FG003|Overall Study|Lost to Follow-up|1|||
156792323|NCT01475825|565992741|FG000|Overall Study|Non-compliance with Study Drug|1|||
156792324|NCT01475825|565992742|FG001|Overall Study|Non-compliance with Study Drug|2|||
156792325|NCT01475825|565992743|FG002|Overall Study|Non-compliance with Study Drug|4|||
156792326|NCT01475825|565992744|FG003|Overall Study|Non-compliance with Study Drug|0|||
156792327|NCT01475825|565992741|FG000|Overall Study|Other: Not available|0|||
156792328|NCT01475825|565992742|FG001|Overall Study|Other: Not available|0|||
156792329|NCT01475825|565992743|FG002|Overall Study|Other: Not available|2|||
156792330|NCT01475825|565992744|FG003|Overall Study|Other: Not available|0|||
156711488|NCT04559347|565688776|FG000|Overall Study|Other|2|||
156711489|NCT04559347|565688777|FG001|Overall Study|Other|1|||
156711490|NCT00371033|565688778|FG000|Overall Study|Lost to Follow-up|3|||
156711491|NCT00371033|565688779|FG001|Overall Study|Lost to Follow-up|2|||
156711492|NCT00371033|565688778|FG000|Overall Study|No longer interested|2|||
156711493|NCT00371033|565688779|FG001|Overall Study|No longer interested|0|||
156711494|NCT00371033|565688778|FG000|Overall Study|Uknown|3|||
157016450|NCT01303445|566811342|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
157215991|NCT00410410|567537430|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
156711495|NCT00371033|565688779|FG001|Overall Study|Uknown|1|||
156711496|NCT05929651|565688786|FG000|Overall Study|Protocol Deviation|1|||
156711497|NCT05929651|565688786|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
156711498|NCT05026177|565688787|FG000|Overall Study|Adverse Event|33|||
156711499|NCT05026177|565688788|FG001|Overall Study|Adverse Event|33|||
156711500|NCT05026177|565688789|FG002|Overall Study|Adverse Event|17|||
156711501|NCT05026177|565688787|FG000|Overall Study|Lost to Follow-up|7|||
156711502|NCT05026177|565688788|FG001|Overall Study|Lost to Follow-up|6|||
156711503|NCT05026177|565688789|FG002|Overall Study|Lost to Follow-up|8|||
156711504|NCT05026177|565688787|FG000|Overall Study|Noncompliance with study drug|6|||
156711505|NCT05026177|565688788|FG001|Overall Study|Noncompliance with study drug|2|||
156711506|NCT05026177|565688789|FG002|Overall Study|Noncompliance with study drug|1|||
156711507|NCT05026177|565688787|FG000|Overall Study|Physician Decision|4|||
156711508|NCT05026177|565688788|FG001|Overall Study|Physician Decision|1|||
156711509|NCT05026177|565688789|FG002|Overall Study|Physician Decision|0|||
156711510|NCT05026177|565688787|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
156711511|NCT05026177|565688788|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
156711512|NCT05026177|565688789|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
156711513|NCT05026177|565688787|FG000|Overall Study|Withdrawal by Subject|53|||
156711514|NCT05026177|565688788|FG001|Overall Study|Withdrawal by Subject|51|||
156711515|NCT05026177|565688789|FG002|Overall Study|Withdrawal by Subject|55|||
156711516|NCT05026177|565688787|FG000|Overall Study|Protocol Violation|0|||
156711517|NCT05026177|565688788|FG001|Overall Study|Protocol Violation|1|||
156711518|NCT05026177|565688789|FG002|Overall Study|Protocol Violation|0|||
156711519|NCT05026177|565688787|FG000|Overall Study|Study terminated by sponsor|70|||
156711520|NCT05026177|565688788|FG001|Overall Study|Study terminated by sponsor|74|||
156711521|NCT05026177|565688789|FG002|Overall Study|Study terminated by sponsor|67|||
156711522|NCT05026177|565688787|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
156711523|NCT05026177|565688788|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
156711524|NCT05026177|565688789|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
156711525|NCT05026177|565688787|FG000|Overall Study|Starting alternative treatment|0|||
156711526|NCT05026177|565688788|FG001|Overall Study|Starting alternative treatment|1|||
156711527|NCT05026177|565688789|FG002|Overall Study|Starting alternative treatment|1|||
156711528|NCT05026177|565688787|FG000|Overall Study|Noncompliance with study procedures|0|||
156711529|NCT05026177|565688788|FG001|Overall Study|Noncompliance with study procedures|1|||
156711530|NCT05026177|565688789|FG002|Overall Study|Noncompliance with study procedures|1|||
156711531|NCT05026177|565688787|FG000|Overall Study|Met stopping criteria|0|||
156711532|NCT05026177|565688788|FG001|Overall Study|Met stopping criteria|0|||
156711533|NCT05026177|565688789|FG002|Overall Study|Met stopping criteria|1|||
156711534|NCT05026177|565688787|FG000|Overall Study|Health issues preventing continuation|0|||
156711535|NCT05026177|565688788|FG001|Overall Study|Health issues preventing continuation|0|||
156711536|NCT05026177|565688789|FG002|Overall Study|Health issues preventing continuation|1|||
156711537|NCT05026177|565688787|FG000|Overall Study|Randomized in error, not treated|0|||
156711538|NCT05026177|565688788|FG001|Overall Study|Randomized in error, not treated|0|||
156711539|NCT05026177|565688789|FG002|Overall Study|Randomized in error, not treated|2|||
156711540|NCT01433055|565688792|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
156711541|NCT01433055|565688793|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
156711542|NCT01433055|565688792|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
156711543|NCT01433055|565688793|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
156711544|NCT00733005|565688799|FG000|Overall Study|Adverse Event|0|||
156711545|NCT00733005|565688800|FG001|Overall Study|Adverse Event|1|||
156711546|NCT00733005|565688799|FG000|Overall Study|Treatment Failure|0|||
156711547|NCT00733005|565688800|FG001|Overall Study|Treatment Failure|1|||
156711548|NCT00733005|565688799|FG000|Overall Study|Withdrawal by Subject|0|||
156711549|NCT00733005|565688800|FG001|Overall Study|Withdrawal by Subject|1|||
156711550|NCT00733005|565688799|FG000|Overall Study|Protocol Violation|2|||
156711551|NCT00733005|565688800|FG001|Overall Study|Protocol Violation|0|||
156711552|NCT05244122|565688805|FG000|Overall Study|Withdrawal by Subject|318|||
156711553|NCT00615199|565688810|FG000|Overall Study|Adverse Event|3|||
156711554|NCT00615199|565688811|FG001|Overall Study|Adverse Event|1|||
156711555|NCT00615199|565688812|FG002|Overall Study|Adverse Event|1|||
156711556|NCT00615199|565688813|FG003|Overall Study|Adverse Event|0|||
157215992|NCT00410410|567537431|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
157215993|NCT00410410|567537432|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
157215994|NCT00410410|567537424|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
156711557|NCT00615199|565688810|FG000|Overall Study|Lack of Efficacy|2|||
156711558|NCT00615199|565688811|FG001|Overall Study|Lack of Efficacy|0|||
156711559|NCT00615199|565688812|FG002|Overall Study|Lack of Efficacy|0|||
156711560|NCT00615199|565688813|FG003|Overall Study|Lack of Efficacy|1|||
156711561|NCT00615199|565688810|FG000|Overall Study|Lost to Follow-up|1|||
156711562|NCT00615199|565688811|FG001|Overall Study|Lost to Follow-up|0|||
156711563|NCT00615199|565688812|FG002|Overall Study|Lost to Follow-up|0|||
156711564|NCT00615199|565688813|FG003|Overall Study|Lost to Follow-up|0|||
156711565|NCT00615199|565688810|FG000|Overall Study|Other|0|||
156711566|NCT00615199|565688811|FG001|Overall Study|Other|0|||
156711567|NCT00615199|565688812|FG002|Overall Study|Other|0|||
156711568|NCT00615199|565688813|FG003|Overall Study|Other|1|||
156711569|NCT00615199|565688810|FG000|Overall Study|Withdrawal by Subject|2|||
156711570|NCT00615199|565688811|FG001|Overall Study|Withdrawal by Subject|1|||
156711571|NCT00615199|565688812|FG002|Overall Study|Withdrawal by Subject|0|||
156711572|NCT00615199|565688813|FG003|Overall Study|Withdrawal by Subject|0|||
156711573|NCT01009814|565688816|FG000|Overall Study|No longer met study criteria|1|||
156711574|NCT01009814|565688817|FG001|Overall Study|No longer met study criteria|1|||
156711575|NCT01009814|565688818|FG002|Overall Study|No longer met study criteria|0|||
156711576|NCT01009814|565688819|FG003|Overall Study|No longer met study criteria|0|||
156711577|NCT01009814|565688820|FG004|Overall Study|No longer met study criteria|0|||
156711578|NCT02653625|565688821|FG000|Overall Study|Adverse Event|1|||
156711579|NCT02653625|565688821|FG000|Overall Study|Non-compliance with Study Drug|1|||
156711580|NCT02653625|565688821|FG000|Overall Study|Protocol Violation|1|||
156711581|NCT02653625|565688821|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
156711582|NCT03965689|565688822|FG000|Overall Study|Too sick to get study intervention|2|||
156711583|NCT01173120|565688824|FG000|Overall Study|Lack of Efficacy|2|||
156711584|NCT01173120|565688824|FG000|Overall Study|Lost to Follow-up|1|||
156711585|NCT01173120|565688824|FG000|Overall Study|Participant Decision|2|||
156711586|NCT01173120|565688824|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
156711587|NCT01173120|565688824|FG000|Overall Study|Switch-Participant Decision|12|||
156711588|NCT01173120|565688824|FG000|Overall Study|Switch-Difficulty With Device|12|||
156711589|NCT01214655|565688825|FG000|Part A|Progressive Disease|7|||
156711590|NCT01214655|565688826|FG001|Part A|Progressive Disease|0|||
156711591|NCT01214655|565688827|FG002|Part A|Progressive Disease|0|||
156711592|NCT01214655|565688825|FG000|Part A|Physician Decision|1|||
156711593|NCT01214655|565688826|FG001|Part A|Physician Decision|0|||
156711594|NCT01214655|565688827|FG002|Part A|Physician Decision|0|||
156711595|NCT01214655|565688825|FG000|Part B|Progressive disease|0|||
156711596|NCT01214655|565688826|FG001|Part B|Progressive disease|10|||
156711597|NCT01214655|565688827|FG002|Part B|Progressive disease|0|||
156711598|NCT01214655|565688825|FG000|Part B|Death|0|||
156711599|NCT01214655|565688826|FG001|Part B|Death|1|||
156711600|NCT01214655|565688827|FG002|Part B|Death|0|||
156711601|NCT01214655|565688825|FG000|Part B|Withdrawal by Subject|0|||
156711602|NCT01214655|565688826|FG001|Part B|Withdrawal by Subject|2|||
156711603|NCT01214655|565688827|FG002|Part B|Withdrawal by Subject|0|||
156711604|NCT01214655|565688825|FG000|Part C|Progressive Disease|0|||
156711605|NCT01214655|565688826|FG001|Part C|Progressive Disease|0|||
156711606|NCT01214655|565688827|FG002|Part C|Progressive Disease|5|||
156711607|NCT01214655|565688825|FG000|Part C|Death|0|||
156711608|NCT01214655|565688826|FG001|Part C|Death|0|||
156711609|NCT01214655|565688827|FG002|Part C|Death|1|||
156711610|NCT01214655|565688825|FG000|Part C|Physician Decision|0|||
156711611|NCT01214655|565688826|FG001|Part C|Physician Decision|0|||
156711612|NCT01214655|565688827|FG002|Part C|Physician Decision|1|||
156711613|NCT00764881|565688828|FG000|Overall Study|Adverse Event|5|||
156711614|NCT00764881|565688829|FG001|Overall Study|Adverse Event|1|||
156711615|NCT00764881|565688828|FG000|Overall Study|Withdrawal by Subject|1|||
156711616|NCT00764881|565688829|FG001|Overall Study|Withdrawal by Subject|3|||
156711617|NCT00764881|565688828|FG000|Overall Study|Protocol Violation|2|||
156711618|NCT00764881|565688829|FG001|Overall Study|Protocol Violation|2|||
156711619|NCT00764881|565688828|FG000|Overall Study|Lost to Follow-up|2|||
156711620|NCT00764881|565688829|FG001|Overall Study|Lost to Follow-up|0|||
156711621|NCT00764881|565688828|FG000|Overall Study|Noncompliant|1|||
156711622|NCT00764881|565688829|FG001|Overall Study|Noncompliant|0|||
157016451|NCT01303445|566811343|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
157215995|NCT00410410|567537425|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
156711623|NCT00764881|565688828|FG000|Overall Study|Accidentally discontinued study drug|1|||
156711624|NCT00764881|565688829|FG001|Overall Study|Accidentally discontinued study drug|0|||
156711625|NCT00764881|565688828|FG000|Overall Study|Wished to become pregnant|1|||
156711626|NCT00764881|565688829|FG001|Overall Study|Wished to become pregnant|0|||
156711627|NCT00764881|565688828|FG000|Overall Study|Carcinoma detected|1|||
156711628|NCT00764881|565688829|FG001|Overall Study|Carcinoma detected|0|||
156711629|NCT00764881|565688828|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
156711630|NCT00764881|565688829|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
156711631|NCT00764881|565688828|FG000|Overall Study|no treatment or no observation|2|||
156711632|NCT00764881|565688829|FG001|Overall Study|no treatment or no observation|2|||
156711633|NCT05256134|565688832|FG000|Overall Study|Study Terminated by Sponsor|11|||
157126580|NCT01262976|567214137|FG001|Up to Year 2|Other|0|||
157126581|NCT01262976|567214138|FG002|Up to Year 2|Other|0|||
157126582|NCT01262976|567214139|FG003|Up to Year 2|Other|0|||
157126583|NCT01262976|567214140|FG004|Up to Year 2|Other|0|||
157126584|NCT01262976|567214141|FG005|Up to Year 2|Other|0|||
157126585|NCT01262976|567214136|FG000|Up to Year 3|Serious Adverse Event|0|||
157126586|NCT01262976|567214137|FG001|Up to Year 3|Serious Adverse Event|0|||
157126587|NCT01262976|567214138|FG002|Up to Year 3|Serious Adverse Event|2|||
157126588|NCT01262976|567214139|FG003|Up to Year 3|Serious Adverse Event|0|||
157126589|NCT01262976|567214140|FG004|Up to Year 3|Serious Adverse Event|0|||
157126590|NCT01262976|567214141|FG005|Up to Year 3|Serious Adverse Event|0|||
157126591|NCT01262976|567214136|FG000|Up to Year 3|Withdrawal by Subject|1|||
157126592|NCT01262976|567214137|FG001|Up to Year 3|Withdrawal by Subject|0|||
157126593|NCT01262976|567214138|FG002|Up to Year 3|Withdrawal by Subject|0|||
157126594|NCT01262976|567214139|FG003|Up to Year 3|Withdrawal by Subject|0|||
156711634|NCT05256134|565688833|FG001|Overall Study|Study Terminated by Sponsor|10|||
156711635|NCT05256134|565688832|FG000|Overall Study|Withdrawal by Subject|1|||
156711636|NCT05256134|565688833|FG001|Overall Study|Withdrawal by Subject|3|||
156711637|NCT02013817|565688841|FG000|Overall Study|Adverse Event|12|||
156711638|NCT02013817|565688841|FG000|Overall Study|Withdrawal by Subject|4|||
156711639|NCT02013817|565688841|FG000|Overall Study|Death|2|||
157126595|NCT01262976|567214140|FG004|Up to Year 3|Withdrawal by Subject|0|||
157126596|NCT01262976|567214141|FG005|Up to Year 3|Withdrawal by Subject|0|||
156711640|NCT02013817|565688841|FG000|Overall Study|Other|9|||
156711641|NCT01977417|565688842|FG000|Overall Study|Adverse Event|1|||
156711642|NCT01977417|565688843|FG001|Overall Study|Adverse Event|0|||
156711643|NCT01977417|565688842|FG000|Overall Study|Withdrawal by Subject|2|||
156711644|NCT01977417|565688843|FG001|Overall Study|Withdrawal by Subject|4|||
156711645|NCT01977417|565688842|FG000|Overall Study|Female enrollment goal met|0|||
156711646|NCT01977417|565688843|FG001|Overall Study|Female enrollment goal met|2|||
156711647|NCT01145508|565688844|FG000|Overall Study|Adverse Event|1|||
156711648|NCT01145508|565688845|FG001|Overall Study|Adverse Event|0|||
156711649|NCT01145508|565688844|FG000|Overall Study|Death|1|||
156711650|NCT01145508|565688845|FG001|Overall Study|Death|0|||
156711651|NCT01145508|565688844|FG000|Overall Study|Physician Decision|2|||
156711652|NCT01145508|565688845|FG001|Overall Study|Physician Decision|1|||
156711653|NCT01145508|565688844|FG000|Overall Study|Never started treatment|1|||
156711654|NCT01145508|565688845|FG001|Overall Study|Never started treatment|1|||
156711655|NCT03055624|565688848|FG000|Overall Study|Study closed|9|||
156711656|NCT01434810|565688850|FG000|Overall Study|Did not receive treatment|11|||
156711657|NCT01434810|565688851|FG001|Overall Study|Did not receive treatment|3|||
156711658|NCT01434810|565688850|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
156711659|NCT01434810|565688851|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
156711660|NCT01625988|565688854|FG000|Overall Study|Lost to Follow-up|5|||
156711661|NCT01625988|565688855|FG001|Overall Study|Lost to Follow-up|6|||
156711662|NCT01625988|565688854|FG000|Overall Study|Withdrawal by Subject|8|||
156711663|NCT01625988|565688855|FG001|Overall Study|Withdrawal by Subject|3|||
156711664|NCT01625988|565688854|FG000|Overall Study|Adverse Event|0|||
156711665|NCT01625988|565688855|FG001|Overall Study|Adverse Event|1|||
156711666|NCT01625988|565688854|FG000|Overall Study|Lack of Efficacy|0|||
156711667|NCT01625988|565688855|FG001|Overall Study|Lack of Efficacy|1|||
156711668|NCT01625988|565688854|FG000|Overall Study|Randomized Inappropriately|1|||
156711669|NCT01625988|565688855|FG001|Overall Study|Randomized Inappropriately|0|||
156711670|NCT01625988|565688854|FG000|Overall Study|Protocol Violation|0|||
156711671|NCT01625988|565688855|FG001|Overall Study|Protocol Violation|2|||
156711672|NCT01121562|565688856|FG000|Overall Study|Objective progression or relapse|8|||
156711673|NCT01121562|565688856|FG000|Overall Study|Withdrawal by Subject|1|||
156711674|NCT01121562|565688856|FG000|Overall Study|Adverse Event|1|||
156711675|NCT01121562|565688856|FG000|Overall Study|Sponsor Decision|1|||
156711676|NCT01121562|565688856|FG000|Overall Study|Met study discontinuation criteria|1|||
156711677|NCT00616421|565688857|FG000|Overall Study|Withdrawal by Subject|9|||
156711678|NCT00616421|565688858|FG001|Overall Study|Withdrawal by Subject|11|||
156711679|NCT00616421|565688859|FG002|Overall Study|Withdrawal by Subject|8|||
156711680|NCT00616421|565688857|FG000|Overall Study|Lost to Follow-up|12|||
157126597|NCT01262976|567214136|FG000|Up to Year 3|Migrated/moved from study area|0|||
157126598|NCT01262976|567214137|FG001|Up to Year 3|Migrated/moved from study area|0|||
157126599|NCT01262976|567214138|FG002|Up to Year 3|Migrated/moved from study area|0|||
157126600|NCT01262976|567214139|FG003|Up to Year 3|Migrated/moved from study area|2|||
157126601|NCT01262976|567214140|FG004|Up to Year 3|Migrated/moved from study area|1|||
157126602|NCT01262976|567214141|FG005|Up to Year 3|Migrated/moved from study area|1|||
156711681|NCT00616421|565688858|FG001|Overall Study|Lost to Follow-up|26|||
156711682|NCT00616421|565688859|FG002|Overall Study|Lost to Follow-up|30|||
156711683|NCT00616421|565688857|FG000|Overall Study|Inappropriate enrollment|3|||
156711684|NCT00616421|565688858|FG001|Overall Study|Inappropriate enrollment|0|||
156711685|NCT00616421|565688859|FG002|Overall Study|Inappropriate enrollment|1|||
156711686|NCT00616421|565688857|FG000|Overall Study|Administrative reason|1|||
156711687|NCT00616421|565688858|FG001|Overall Study|Administrative reason|0|||
156711688|NCT00616421|565688859|FG002|Overall Study|Administrative reason|0|||
156711689|NCT00616421|565688857|FG000|Overall Study|Protocol Violation|0|||
156711690|NCT00616421|565688858|FG001|Overall Study|Protocol Violation|1|||
156711691|NCT00616421|565688859|FG002|Overall Study|Protocol Violation|2|||
156711692|NCT00616421|565688857|FG000|Overall Study|Unable to classify|1|||
156711693|NCT00616421|565688858|FG001|Overall Study|Unable to classify|0|||
156711694|NCT00616421|565688859|FG002|Overall Study|Unable to classify|0|||
156711695|NCT01495702|565688860|FG000|Randomized Phase|Randomized But Not Treated|1|||
156711696|NCT01495702|565688861|FG001|Randomized Phase|Randomized But Not Treated|4|||
156711697|NCT01495702|565688860|FG000|Randomized Phase|Adverse Event|2|||
156711698|NCT01495702|565688861|FG001|Randomized Phase|Adverse Event|2|||
156711699|NCT01495702|565688860|FG000|Randomized Phase|Death|1|||
156711700|NCT01495702|565688861|FG001|Randomized Phase|Death|0|||
156711701|NCT01495702|565688860|FG000|Randomized Phase|Lack of Efficacy|2|||
156711702|NCT01495702|565688861|FG001|Randomized Phase|Lack of Efficacy|0|||
156711703|NCT01495702|565688860|FG000|Randomized Phase|Investigators Discretion|2|||
156711704|NCT01495702|565688861|FG001|Randomized Phase|Investigators Discretion|0|||
156711705|NCT01495702|565688860|FG000|Randomized Phase|Withdrew Consent|10|||
156711706|NCT01495702|565688861|FG001|Randomized Phase|Withdrew Consent|18|||
156711707|NCT01495702|565688860|FG000|Randomized Phase|Lost to Follow-up|4|||
156711708|NCT01495702|565688861|FG001|Randomized Phase|Lost to Follow-up|3|||
156711709|NCT01495702|565688860|FG000|Randomized Phase|Participant Noncompliance|1|||
156711710|NCT01495702|565688861|FG001|Randomized Phase|Participant Noncompliance|0|||
156711711|NCT01495702|565688860|FG000|Randomized Phase|Protocol Violation|3|||
156711712|NCT01495702|565688861|FG001|Randomized Phase|Protocol Violation|1|||
156711713|NCT04152863|565688862|FG000|Overall Study|Death|13|||
156711714|NCT04152863|565688863|FG001|Overall Study|Death|12|||
156711715|NCT04152863|565688864|FG002|Overall Study|Death|7|||
156711716|NCT04152863|565688862|FG000|Overall Study|Physician Decision|1|||
156711717|NCT04152863|565688863|FG001|Overall Study|Physician Decision|1|||
156711718|NCT04152863|565688864|FG002|Overall Study|Physician Decision|1|||
156711719|NCT04152863|565688862|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
156711720|NCT04152863|565688863|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
156711721|NCT04152863|565688864|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
156711722|NCT04152863|565688862|FG000|Overall Study|Withdrawal by Subject|2|||
156711723|NCT04152863|565688863|FG001|Overall Study|Withdrawal by Subject|1|||
156711724|NCT04152863|565688864|FG002|Overall Study|Withdrawal by Subject|3|||
156711725|NCT01644617|565688868|FG000|Overall Study|Withdrawal by Subject|3|||
156711726|NCT01644617|565688869|FG001|Overall Study|Withdrawal by Subject|4|||
156711727|NCT01644617|565688870|FG002|Overall Study|Withdrawal by Subject|1|||
156711728|NCT01644617|565688868|FG000|Overall Study|Lost to Follow-up|0|||
156711729|NCT01644617|565688869|FG001|Overall Study|Lost to Follow-up|1|||
156711730|NCT01644617|565688870|FG002|Overall Study|Lost to Follow-up|0|||
156711731|NCT01644617|565688868|FG000|Overall Study|Adverse Event|3|||
156711732|NCT01644617|565688869|FG001|Overall Study|Adverse Event|0|||
156711733|NCT01644617|565688870|FG002|Overall Study|Adverse Event|6|||
157126603|NCT01262976|567214136|FG000|Up to Year 3|Lost to Follow-up|2|||
157126604|NCT01262976|567214137|FG001|Up to Year 3|Lost to Follow-up|2|||
157126605|NCT01262976|567214138|FG002|Up to Year 3|Lost to Follow-up|4|||
157126606|NCT01262976|567214139|FG003|Up to Year 3|Lost to Follow-up|3|||
157126607|NCT01262976|567214140|FG004|Up to Year 3|Lost to Follow-up|1|||
157126608|NCT01262976|567214141|FG005|Up to Year 3|Lost to Follow-up|3|||
157126609|NCT01262976|567214136|FG000|Up to Year 3|Subjects with unknown completion status|0|||
157126610|NCT01262976|567214137|FG001|Up to Year 3|Subjects with unknown completion status|0|||
157126611|NCT01262976|567214138|FG002|Up to Year 3|Subjects with unknown completion status|1|||
157126612|NCT01262976|567214139|FG003|Up to Year 3|Subjects with unknown completion status|0|||
157126613|NCT01262976|567214140|FG004|Up to Year 3|Subjects with unknown completion status|0|||
157126614|NCT01262976|567214141|FG005|Up to Year 3|Subjects with unknown completion status|0|||
156711734|NCT01524978|565688874|FG000|Overall Study|Other|16|||
156711735|NCT01524978|565688875|FG001|Overall Study|Other|2|||
156711736|NCT01524978|565688876|FG002|Overall Study|Other|1|||
156792331|NCT01475825|565992741|FG000|Overall Study|Protocol Violation|1|||
156792332|NCT01475825|565992742|FG001|Overall Study|Protocol Violation|0|||
156792333|NCT01475825|565992743|FG002|Overall Study|Protocol Violation|0|||
156792334|NCT01475825|565992744|FG003|Overall Study|Protocol Violation|0|||
156711737|NCT01524978|565688877|FG003|Overall Study|Other|2|||
156711738|NCT01524978|565688878|FG004|Overall Study|Other|1|||
156711739|NCT01524978|565688879|FG005|Overall Study|Other|3|||
156711740|NCT01524978|565688880|FG006|Overall Study|Other|17|||
156711741|NCT01524978|565688881|FG007|Overall Study|Other|1|||
156711742|NCT01524978|565688882|FG008|Overall Study|Other|2|||
157126615|NCT01262976|567214136|FG000|Up to Year 3|Other|3|||
156711743|NCT01524978|565688883|FG009|Overall Study|Other|2|||
156711744|NCT01524978|565688884|FG010|Overall Study|Other|5|||
156792335|NCT01475825|565992741|FG000|Overall Study|Physician Decision|0|||
157126616|NCT01262976|567214137|FG001|Up to Year 3|Other|0|||
157126617|NCT01262976|567214138|FG002|Up to Year 3|Other|0|||
157126618|NCT01262976|567214139|FG003|Up to Year 3|Other|0|||
157126619|NCT01262976|567214140|FG004|Up to Year 3|Other|0|||
157126620|NCT01262976|567214141|FG005|Up to Year 3|Other|0|||
157126621|NCT01528787|567214142|FG000|Overall Study|Withdrawal by Subject|0|||
157126622|NCT01528787|567214143|FG001|Overall Study|Withdrawal by Subject|0|||
157126623|NCT01528787|567214144|FG002|Overall Study|Withdrawal by Subject|0|||
157126624|NCT01528787|567214145|FG003|Overall Study|Withdrawal by Subject|1|||
157126625|NCT01528787|567214142|FG000|Overall Study|Family Emergency|0|||
157126626|NCT01528787|567214143|FG001|Overall Study|Family Emergency|0|||
157126627|NCT01528787|567214144|FG002|Overall Study|Family Emergency|1|||
157126628|NCT01528787|567214145|FG003|Overall Study|Family Emergency|0|||
157126629|NCT00797823|567214148|FG000|First Period (Initial Randomization)|Physician Decision|1|||
157126630|NCT00797823|567214149|FG001|First Period (Initial Randomization)|Physician Decision|0|||
157126631|NCT00797823|567214150|FG002|First Period (Initial Randomization)|Physician Decision|0|||
157126632|NCT02400255|567214151|FG000|Overall Study|Relapse|4|||
157126633|NCT02400255|567214152|FG001|Overall Study|Relapse|1|||
157126634|NCT02400255|567214153|FG002|Overall Study|Relapse|1|||
157126635|NCT02400255|567214154|FG003|Overall Study|Relapse|2|||
157126636|NCT02400255|567214151|FG000|Overall Study|Adverse Event|6|||
157126637|NCT02400255|567214152|FG001|Overall Study|Adverse Event|3|||
157126638|NCT02400255|567214153|FG002|Overall Study|Adverse Event|0|||
157126639|NCT02400255|567214154|FG003|Overall Study|Adverse Event|0|||
157126640|NCT02400255|567214151|FG000|Overall Study|Physician Decision|6|||
157126641|NCT02400255|567214152|FG001|Overall Study|Physician Decision|0|||
157126642|NCT02400255|567214153|FG002|Overall Study|Physician Decision|0|||
157126643|NCT02400255|567214154|FG003|Overall Study|Physician Decision|0|||
157126644|NCT02400255|567214151|FG000|Overall Study|Loss of insurance|1|||
157126645|NCT02400255|567214152|FG001|Overall Study|Loss of insurance|0|||
157126646|NCT02400255|567214153|FG002|Overall Study|Loss of insurance|0|||
157126647|NCT02400255|567214154|FG003|Overall Study|Loss of insurance|0|||
157126648|NCT02568046|567214155|FG000|Overall Study|Adverse Event|0|||
157126649|NCT02568046|567214156|FG001|Overall Study|Adverse Event|1|||
157126650|NCT02568046|567214155|FG000|Overall Study|Death|2|||
157126651|NCT02568046|567214156|FG001|Overall Study|Death|0|||
157126652|NCT02568046|567214155|FG000|Overall Study|Progressive Disease|1|||
157126653|NCT02568046|567214156|FG001|Overall Study|Progressive Disease|0|||
157126654|NCT02568046|567214155|FG000|Overall Study|Withdrawal by Subject|2|||
157126655|NCT02568046|567214156|FG001|Overall Study|Withdrawal by Subject|1|||
157126656|NCT02568046|567214155|FG000|Overall Study|Other Events|0|||
157126657|NCT02568046|567214156|FG001|Overall Study|Other Events|1|||
157126658|NCT02809833|567214157|FG000|Overall Study|Death|3|||
157126659|NCT02809833|567214157|FG000|Overall Study|Intolerance|54|||
157126660|NCT02809833|567214157|FG000|Overall Study|Lack of Efficacy|89|||
157126661|NCT02809833|567214157|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
157126662|NCT02809833|567214157|FG000|Overall Study|Noncompliance|1|||
157126663|NCT02809833|567214157|FG000|Overall Study|Withdrawal by Subject|34|||
157126664|NCT02809833|567214157|FG000|Overall Study|Lost to Follow-up|35|||
157126665|NCT02809833|567214157|FG000|Overall Study|Adverse Event (AE)|24|||
157126666|NCT02809833|567214157|FG000|Overall Study|Other|5|||
157126667|NCT02809833|567214157|FG000|Overall Study|Missing Information|52|||
157126668|NCT00193063|567214159|FG000|Overall Study|Lack of Efficacy|3|||
157126669|NCT00193063|567214159|FG000|Overall Study|Adverse Event|1|||
156711745|NCT01524978|565688874|FG000|Overall Study|Withdrawal by Subject|12|||
156711746|NCT01524978|565688875|FG001|Overall Study|Withdrawal by Subject|0|||
156711747|NCT01524978|565688876|FG002|Overall Study|Withdrawal by Subject|1|||
156711748|NCT01524978|565688877|FG003|Overall Study|Withdrawal by Subject|1|||
157126670|NCT03261531|567214160|FG000|Overall Study|Withdrawal by Subject|4|||
156711749|NCT01524978|565688878|FG004|Overall Study|Withdrawal by Subject|3|||
156711750|NCT01524978|565688879|FG005|Overall Study|Withdrawal by Subject|1|||
156711751|NCT01524978|565688880|FG006|Overall Study|Withdrawal by Subject|6|||
156711752|NCT01524978|565688881|FG007|Overall Study|Withdrawal by Subject|2|||
156711753|NCT01524978|565688882|FG008|Overall Study|Withdrawal by Subject|4|||
156711754|NCT01524978|565688883|FG009|Overall Study|Withdrawal by Subject|0|||
156711755|NCT01524978|565688884|FG010|Overall Study|Withdrawal by Subject|5|||
156711756|NCT01524978|565688874|FG000|Overall Study|Lost to Follow-up|0|||
156711757|NCT01524978|565688875|FG001|Overall Study|Lost to Follow-up|0|||
157126671|NCT01700192|567214161|FG000|Overall Study|Adverse Event|73|||
157126672|NCT01700192|567214162|FG001|Overall Study|Adverse Event|18|||
156711758|NCT01524978|565688876|FG002|Overall Study|Lost to Follow-up|3|||
156711759|NCT01524978|565688877|FG003|Overall Study|Lost to Follow-up|0|||
157126673|NCT01700192|567214161|FG000|Overall Study|Lack of Efficacy|1|||
157126674|NCT01700192|567214162|FG001|Overall Study|Lack of Efficacy|0|||
157126675|NCT01700192|567214161|FG000|Overall Study|Lost to Follow-up|42|||
157126676|NCT01700192|567214162|FG001|Overall Study|Lost to Follow-up|29|||
157126677|NCT01700192|567214161|FG000|Overall Study|Noncompliance with study drug|0|||
157126678|NCT01700192|567214162|FG001|Overall Study|Noncompliance with study drug|5|||
157126679|NCT01700192|567214161|FG000|Overall Study|Physician Decision|2|||
157126680|NCT01700192|567214162|FG001|Overall Study|Physician Decision|3|||
157126681|NCT01700192|567214161|FG000|Overall Study|Pregnancy|1|||
157126682|NCT01700192|567214162|FG001|Overall Study|Pregnancy|4|||
156711760|NCT01524978|565688878|FG004|Overall Study|Lost to Follow-up|1|||
156711761|NCT01524978|565688879|FG005|Overall Study|Lost to Follow-up|1|||
156711762|NCT01524978|565688880|FG006|Overall Study|Lost to Follow-up|2|||
156711763|NCT01524978|565688881|FG007|Overall Study|Lost to Follow-up|0|||
156711764|NCT01524978|565688882|FG008|Overall Study|Lost to Follow-up|1|||
156711765|NCT01524978|565688883|FG009|Overall Study|Lost to Follow-up|1|||
156711766|NCT01524978|565688884|FG010|Overall Study|Lost to Follow-up|1|||
156711767|NCT01524978|565688874|FG000|Overall Study|Death|34|||
156711768|NCT01524978|565688875|FG001|Overall Study|Death|2|||
156711769|NCT01524978|565688876|FG002|Overall Study|Death|5|||
156711770|NCT01524978|565688877|FG003|Overall Study|Death|24|||
156711771|NCT01524978|565688878|FG004|Overall Study|Death|4|||
156711772|NCT01524978|565688879|FG005|Overall Study|Death|4|||
156711773|NCT01524978|565688880|FG006|Overall Study|Death|1|||
156711774|NCT01524978|565688881|FG007|Overall Study|Death|9|||
156711775|NCT01524978|565688882|FG008|Overall Study|Death|5|||
156711776|NCT01524978|565688883|FG009|Overall Study|Death|6|||
156711777|NCT01524978|565688884|FG010|Overall Study|Death|17|||
156711778|NCT04289363|565688892|FG000|Overall Study|Lost to Follow-up|14|||
156711779|NCT04289363|565688893|FG001|Overall Study|Lost to Follow-up|0|||
156711780|NCT03126435|565688897|FG000|Overall Study|Death|90|||
156711781|NCT03126435|565688898|FG001|Overall Study|Death|84|||
156711782|NCT03126435|565688897|FG000|Overall Study|Lost to Follow-up|4|||
156711783|NCT03126435|565688898|FG001|Overall Study|Lost to Follow-up|3|||
156711784|NCT03126435|565688897|FG000|Overall Study|Physician Decision|0|||
156711785|NCT03126435|565688898|FG001|Overall Study|Physician Decision|1|||
156711786|NCT03126435|565688897|FG000|Overall Study|Withdrawal by Subject|6|||
156711787|NCT03126435|565688898|FG001|Overall Study|Withdrawal by Subject|12|||
156711788|NCT03126435|565688897|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
156711789|NCT03126435|565688898|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
156711790|NCT03971474|565688899|FG000|Overall Study|Adverse Event|11|||
156711791|NCT03971474|565688900|FG001|Overall Study|Adverse Event|7|||
156711792|NCT03971474|565688899|FG000|Overall Study|Refusal unrelated to adverse event|5|||
156711793|NCT03971474|565688900|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156711794|NCT03971474|565688899|FG000|Overall Study|Progression/relapse|40|||
156711795|NCT03971474|565688900|FG001|Overall Study|Progression/relapse|47|||
156711796|NCT03971474|565688899|FG000|Overall Study|Death|6|||
156711797|NCT03971474|565688900|FG001|Overall Study|Death|3|||
156711798|NCT03971474|565688899|FG000|Overall Study|Other - not protocol specified|5|||
156711799|NCT03971474|565688900|FG001|Overall Study|Other - not protocol specified|4|||
156711800|NCT03971474|565688899|FG000|Overall Study|On treatment|0|||
156711801|NCT03971474|565688900|FG001|Overall Study|On treatment|7|||
156711802|NCT01807065|565688901|FG000|Overall Study|Receive no sip-T due to IV access|1|||
156711803|NCT01807065|565688902|FG001|Overall Study|Receive no sip-T due to IV access|1|||
156711804|NCT01153425|565688904|FG000|Overall Study|Withdrawal by Subject|3|||
156711805|NCT01153425|565688905|FG001|Overall Study|Withdrawal by Subject|3|||
157126683|NCT01700192|567214161|FG000|Overall Study|Progressive disease|1|||
157126684|NCT01700192|567214162|FG001|Overall Study|Progressive disease|0|||
157126685|NCT01700192|567214161|FG000|Overall Study|Protocol Violation|3|||
157126686|NCT01700192|567214162|FG001|Overall Study|Protocol Violation|4|||
157126687|NCT01700192|567214161|FG000|Overall Study|Technical problems|0|||
156711806|NCT01937871|565688906|FG000|Overall Study|Adverse Event|6|||
156711807|NCT01937871|565688907|FG001|Overall Study|Adverse Event|6|||
156711808|NCT01937871|565688908|FG002|Overall Study|Adverse Event|2|||
156711809|NCT01937871|565688906|FG000|Overall Study|Lost to Follow-up|8|||
156711810|NCT01937871|565688907|FG001|Overall Study|Lost to Follow-up|2|||
156711811|NCT01937871|565688908|FG002|Overall Study|Lost to Follow-up|4|||
156711812|NCT01937871|565688906|FG000|Overall Study|Withdrawal by Subject|9|||
156711813|NCT01937871|565688907|FG001|Overall Study|Withdrawal by Subject|6|||
157126688|NCT01700192|567214162|FG001|Overall Study|Technical problems|1|||
156711814|NCT01937871|565688908|FG002|Overall Study|Withdrawal by Subject|4|||
156711815|NCT01937871|565688906|FG000|Overall Study|Physician Decision|0|||
156711816|NCT01937871|565688907|FG001|Overall Study|Physician Decision|1|||
156711817|NCT01937871|565688908|FG002|Overall Study|Physician Decision|0|||
157126689|NCT01700192|567214161|FG000|Overall Study|Withdrawal by Subject|56|||
156711818|NCT01937871|565688906|FG000|Overall Study|Entry Criteria Not Met|1|||
156711819|NCT01937871|565688907|FG001|Overall Study|Entry Criteria Not Met|2|||
156711820|NCT01937871|565688908|FG002|Overall Study|Entry Criteria Not Met|1|||
156711821|NCT01482312|565688909|FG000|Period 1, 90 Minutes of Wear|Other|1|||
156711822|NCT01482312|565688910|FG001|Period 1, 90 Minutes of Wear|Other|0|||
156711823|NCT01482312|565688911|FG002|Period 1, 90 Minutes of Wear|Other|0|||
156711824|NCT01482312|565688909|FG000|Period 2, 90 Minutes of Wear|Other|1|||
156711825|NCT01482312|565688910|FG001|Period 2, 90 Minutes of Wear|Other|0|||
156711826|NCT01482312|565688911|FG002|Period 2, 90 Minutes of Wear|Other|0|||
156711827|NCT01699815|565688912|FG000|Overall Study|Protocol Violation|4|||
156711828|NCT01699815|565688913|FG001|Overall Study|Protocol Violation|7|||
157126690|NCT01700192|567214162|FG001|Overall Study|Withdrawal by Subject|64|||
156711829|NCT01699815|565688912|FG000|Overall Study|record could not be located|1|||
156711830|NCT01699815|565688913|FG001|Overall Study|record could not be located|0|||
156711831|NCT01699815|565688912|FG000|Overall Study|Adverse Event|0|||
156711832|NCT01699815|565688913|FG001|Overall Study|Adverse Event|1|||
156711833|NCT03154125|565688914|FG000|Overall Study|Lost to Follow-up|11|||
156711834|NCT03154125|565688915|FG001|Overall Study|Lost to Follow-up|11|||
156711835|NCT03154125|565688916|FG002|Overall Study|Lost to Follow-up|0|||
156711836|NCT03154125|565688914|FG000|Overall Study|Withdrawal by Subject|49|||
156711837|NCT03154125|565688915|FG001|Overall Study|Withdrawal by Subject|55|||
156711838|NCT03154125|565688916|FG002|Overall Study|Withdrawal by Subject|8|||
156711839|NCT03154125|565688914|FG000|Overall Study|Physician Decision|13|||
156711840|NCT03154125|565688915|FG001|Overall Study|Physician Decision|6|||
156711841|NCT03154125|565688916|FG002|Overall Study|Physician Decision|0|||
156711842|NCT03154125|565688914|FG000|Overall Study|Protocol Violation|3|||
156711843|NCT03154125|565688915|FG001|Overall Study|Protocol Violation|5|||
156711844|NCT03154125|565688916|FG002|Overall Study|Protocol Violation|0|||
156711845|NCT00810511|565688917|FG000|Overall Study|Protocol Violation|0|||
156711846|NCT00810511|565688918|FG001|Overall Study|Protocol Violation|1|||
156711847|NCT00810511|565688917|FG000|Overall Study|Lack of Efficacy|9|||
156711848|NCT00810511|565688918|FG001|Overall Study|Lack of Efficacy|1|||
156711849|NCT00810511|565688917|FG000|Overall Study|death in the family|0|||
156711850|NCT00810511|565688918|FG001|Overall Study|death in the family|1|||
156711851|NCT00810511|565688917|FG000|Overall Study|Lost to Follow-up|1|||
156711852|NCT00810511|565688918|FG001|Overall Study|Lost to Follow-up|0|||
156711853|NCT00810511|565688917|FG000|Overall Study|deposits on contact lens|0|||
156711854|NCT00810511|565688918|FG001|Overall Study|deposits on contact lens|1|||
156711855|NCT02652949|565688919|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
156711856|NCT02652949|565688919|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
156711857|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
156711858|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
156711859|NCT02652949|565688919|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
156711860|NCT02652949|565688919|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
156711861|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
156711862|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
156711863|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
156711864|NCT02652949|565688919|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
156711865|NCT02652949|565688919|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
156711866|NCT02652949|565688919|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
156711867|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
156711868|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
156711869|NCT02652949|565688919|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156711870|NCT02652949|565688919|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
156711871|NCT02652949|565688919|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
156711872|NCT00911300|565688920|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
156711873|NCT00911300|565688921|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
157016452|NCT01303445|566811342|FG000|Second Intervention (7 Days)|Adverse Event|0|||
156711874|NCT00911300|565688920|FG000|Overall Study|Death|1|||
156711875|NCT00911300|565688921|FG001|Overall Study|Death|0|||
156711876|NCT00911300|565688920|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
156711877|NCT00911300|565688921|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
156711878|NCT00911300|565688920|FG000|Overall Study|Adverse Event|14|||
156711879|NCT00911300|565688921|FG001|Overall Study|Adverse Event|6|||
156711880|NCT00911300|565688920|FG000|Overall Study|Protocol Violation|3|||
156711881|NCT00911300|565688921|FG001|Overall Study|Protocol Violation|2|||
156711882|NCT00911300|565688920|FG000|Overall Study|Consent Withdrawn|4|||
156711883|NCT00911300|565688921|FG001|Overall Study|Consent Withdrawn|12|||
157016453|NCT01303445|566811343|FG001|Second Intervention (7 Days)|Adverse Event|2|||
157016454|NCT01303445|566811342|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
157016455|NCT01303445|566811343|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
156711884|NCT00911300|565688920|FG000|Overall Study|Coronary Angiography Performed|1|||
156711885|NCT00911300|565688921|FG001|Overall Study|Coronary Angiography Performed|0|||
156711886|NCT00911300|565688920|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
156711887|NCT00911300|565688921|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
156711888|NCT00911300|565688920|FG000|Overall Study|Received Commercial Treatment|1|||
156711889|NCT00911300|565688921|FG001|Overall Study|Received Commercial Treatment|0|||
156711890|NCT00911300|565688920|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
156711891|NCT00911300|565688921|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
157016456|NCT01303445|566811342|FG000|Washout (14 Days)|Protocol Violation|1|||
157016457|NCT01303445|566811343|FG001|Washout (14 Days)|Protocol Violation|0|||
157016458|NCT01303445|566811342|FG000|Washout (14 Days)|Lost to Follow-up|0|||
157016459|NCT01303445|566811343|FG001|Washout (14 Days)|Lost to Follow-up|2|||
156711892|NCT00911300|565688920|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
156711893|NCT00911300|565688921|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
156711894|NCT00911300|565688920|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
156711895|NCT00911300|565688921|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
156711896|NCT00911300|565688920|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
156711897|NCT00911300|565688921|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
156711898|NCT00911300|565688920|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
156711899|NCT00911300|565688921|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
156711900|NCT00911300|565688920|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
156711901|NCT00911300|565688921|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
156711902|NCT00911300|565688920|FG000|Overall Study|International Normalized Ratio Too High|0|||
156711903|NCT00911300|565688921|FG001|Overall Study|International Normalized Ratio Too High|1|||
156711904|NCT00911300|565688920|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
156711905|NCT00911300|565688921|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
156711906|NCT00911300|565688920|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
156711907|NCT00911300|565688921|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
156711908|NCT00911300|565688920|FG000|Overall Study|Physician Decision|0|||
156711909|NCT00911300|565688921|FG001|Overall Study|Physician Decision|1|||
156711910|NCT00911300|565688920|FG000|Overall Study|Treatment Stopped by Mistake|0|||
156711911|NCT00911300|565688921|FG001|Overall Study|Treatment Stopped by Mistake|1|||
156711912|NCT00911300|565688920|FG000|Overall Study|Randomized; No Study Medication Received|0|||
156711913|NCT00911300|565688921|FG001|Overall Study|Randomized; No Study Medication Received|2|||
156711914|NCT00699816|565688922|FG000|Overall Study|Protocol Violation|1|||
156711915|NCT00699816|565688923|FG001|Overall Study|Protocol Violation|3|||
156711916|NCT01569295|565688924|FG000|Overall Study|Progressive Disease|75|||
156711917|NCT01569295|565688925|FG001|Overall Study|Progressive Disease|139|||
156711918|NCT01569295|565688924|FG000|Overall Study|Adverse Event|39|||
156711919|NCT01569295|565688925|FG001|Overall Study|Adverse Event|14|||
156711920|NCT01569295|565688924|FG000|Overall Study|Withdrawal by Subject|25|||
156711921|NCT01569295|565688925|FG001|Overall Study|Withdrawal by Subject|12|||
156711922|NCT01569295|565688924|FG000|Overall Study|Death|19|||
156711923|NCT01569295|565688925|FG001|Overall Study|Death|15|||
156711924|NCT01569295|565688924|FG000|Overall Study|Physician Decision|13|||
156711925|NCT01569295|565688925|FG001|Overall Study|Physician Decision|18|||
156711926|NCT01569295|565688924|FG000|Overall Study|Study Terminated by Sponsor|24|||
156711927|NCT01569295|565688925|FG001|Overall Study|Study Terminated by Sponsor|2|||
156711928|NCT01569295|565688924|FG000|Overall Study|Other Reason not Specified|3|||
156711929|NCT01569295|565688925|FG001|Overall Study|Other Reason not Specified|5|||
156711930|NCT01569295|565688924|FG000|Overall Study|Non-Compliance with Study Drug|6|||
156711931|NCT01569295|565688925|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156792336|NCT01475825|565992742|FG001|Overall Study|Physician Decision|1|||
156792337|NCT01475825|565992743|FG002|Overall Study|Physician Decision|0|||
156792338|NCT01475825|565992744|FG003|Overall Study|Physician Decision|0|||
156792339|NCT01475825|565992741|FG000|Overall Study|Withdrawal by Subject|8|||
156792340|NCT01475825|565992742|FG001|Overall Study|Withdrawal by Subject|3|||
156792341|NCT01475825|565992743|FG002|Overall Study|Withdrawal by Subject|11|||
156792342|NCT01475825|565992744|FG003|Overall Study|Withdrawal by Subject|7|||
156792343|NCT01475825|565992741|FG000|Overall Study|Did not enter OLC|15|||
156792344|NCT01475825|565992742|FG001|Overall Study|Did not enter OLC|11|||
156792345|NCT01475825|565992743|FG002|Overall Study|Did not enter OLC|15|||
156792346|NCT01475825|565992744|FG003|Overall Study|Did not enter OLC|11|||
156792347|NCT00160563|565992745|FG000|Overall Study|Adverse Event|1|||
156792348|NCT00160563|565992746|FG001|Overall Study|Adverse Event|1|||
157126691|NCT01700192|567214161|FG000|Overall Study|Never received study drug|1|||
157126692|NCT01700192|567214162|FG001|Overall Study|Never received study drug|0|||
157126693|NCT00744874|567214164|FG000|Overall Study|Lost to Follow-up|1|||
157126694|NCT00744874|567214164|FG000|Overall Study|Withdrawal by Subject|1|||
157126695|NCT00744874|567214164|FG000|Overall Study|Study Device not available at procedure|1|||
157126696|NCT00744874|567214164|FG000|Overall Study|Unable to accomodate schedule|1|||
157126697|NCT01818726|567214182|FG000|Overall Study|Administrative reasons|5|||
157126698|NCT01818726|567214183|FG001|Overall Study|Administrative reasons|1|||
157126699|NCT01818726|567214182|FG000|Overall Study|Withdrawal by Subject|0|||
157126700|NCT01818726|567214183|FG001|Overall Study|Withdrawal by Subject|1|||
157126701|NCT01818726|567214182|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
157126702|NCT01818726|567214183|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
157126703|NCT00357500|567214186|FG000|Overall Study|Adverse Event|3|||
157126704|NCT00357500|567214186|FG000|Overall Study|Withdrawal by Subject|5|||
157126705|NCT00357500|567214186|FG000|Overall Study|Progressive Disease|65|||
157126706|NCT00357500|567214186|FG000|Overall Study|Not Started Protocol Therapy|4|||
157126707|NCT02301403|567214190|FG000|Overall Study|Withdrawal by Subject|28|||
157126708|NCT02301403|567214191|FG001|Overall Study|Withdrawal by Subject|41|||
157126709|NCT01816243|567214194|FG000|Overall Study|Adverse Event|6|||
157126710|NCT01816243|567214194|FG000|Overall Study|Lost to Follow-up|1|||
157126711|NCT01816243|567214194|FG000|Overall Study|Lack of Efficacy|1|||
157126712|NCT01816243|567214194|FG000|Overall Study|Not eligible for the study|1|||
157126713|NCT01816243|567214194|FG000|Overall Study|Amputation|3|||
157126714|NCT01920711|567214195|FG000|Overall Study|Death|347|||
156792349|NCT00160563|565992747|FG002|Overall Study|Adverse Event|1|||
156792350|NCT00160563|565992745|FG000|Overall Study|Lost to Follow-up|1|||
157126715|NCT01920711|567214196|FG001|Overall Study|Death|356|||
157126716|NCT01920711|567214195|FG000|Overall Study|Lost to Follow-up|13|||
157126717|NCT01920711|567214196|FG001|Overall Study|Lost to Follow-up|14|||
157126718|NCT01920711|567214195|FG000|Overall Study|Withdrawal by Subject|4|||
157126719|NCT01920711|567214196|FG001|Overall Study|Withdrawal by Subject|3|||
157126720|NCT04556617|567214207|FG000|Overall Study|progressive disease|0|||
157126721|NCT04556617|567214208|FG001|Overall Study|progressive disease|2|||
157126722|NCT04556617|567214209|FG002|Overall Study|progressive disease|2|||
157126723|NCT04556617|567214210|FG003|Overall Study|progressive disease|1|||
157126724|NCT04556617|567214211|FG004|Overall Study|progressive disease|1|||
157126725|NCT04556617|567214207|FG000|Overall Study|Physician Decision|0|||
157126726|NCT04556617|567214208|FG001|Overall Study|Physician Decision|0|||
157126727|NCT04556617|567214209|FG002|Overall Study|Physician Decision|2|||
157126728|NCT04556617|567214210|FG003|Overall Study|Physician Decision|0|||
157126729|NCT04556617|567214211|FG004|Overall Study|Physician Decision|0|||
157126730|NCT04556617|567214207|FG000|Overall Study|Adverse Event|0|||
157126731|NCT04556617|567214208|FG001|Overall Study|Adverse Event|0|||
157126732|NCT04556617|567214209|FG002|Overall Study|Adverse Event|2|||
157126733|NCT04556617|567214210|FG003|Overall Study|Adverse Event|3|||
157126734|NCT04556617|567214211|FG004|Overall Study|Adverse Event|0|||
157126735|NCT04556617|567214207|FG000|Overall Study|Withdrawal by Subject|0|||
157126736|NCT04556617|567214208|FG001|Overall Study|Withdrawal by Subject|2|||
157126737|NCT04556617|567214209|FG002|Overall Study|Withdrawal by Subject|1|||
157126738|NCT04556617|567214210|FG003|Overall Study|Withdrawal by Subject|1|||
157126739|NCT04556617|567214211|FG004|Overall Study|Withdrawal by Subject|0|||
157126740|NCT04556617|567214207|FG000|Overall Study|PSA increase|0|||
157126741|NCT04556617|567214208|FG001|Overall Study|PSA increase|1|||
157126742|NCT04556617|567214209|FG002|Overall Study|PSA increase|0|||
157126743|NCT04556617|567214210|FG003|Overall Study|PSA increase|0|||
157126744|NCT04556617|567214211|FG004|Overall Study|PSA increase|0|||
157126745|NCT04556617|567214207|FG000|Overall Study|Sponsor study termination|1|||
157126746|NCT04556617|567214208|FG001|Overall Study|Sponsor study termination|0|||
157126747|NCT04556617|567214209|FG002|Overall Study|Sponsor study termination|0|||
157126748|NCT04556617|567214210|FG003|Overall Study|Sponsor study termination|0|||
157126749|NCT04556617|567214211|FG004|Overall Study|Sponsor study termination|0|||
157126750|NCT04949841|567214212|FG000|Overall Study|Adverse Event|7|||
157126751|NCT04949841|567214212|FG000|Overall Study|Death|1|||
157126752|NCT04949841|567214212|FG000|Overall Study|Withdrawal by Subject|52|||
157126753|NCT04949841|567214212|FG000|Overall Study|Pregnancy|4|||
157126754|NCT04949841|567214212|FG000|Overall Study|Lost to Follow-up|9|||
157126755|NCT04949841|567214212|FG000|Overall Study|Lack of Efficacy|55|||
157126756|NCT04949841|567214212|FG000|Overall Study|Various reasons|9|||
157215996|NCT00410410|567537426|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
157215997|NCT00410410|567537427|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
157215998|NCT00410410|567537428|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
157215999|NCT00410410|567537429|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
156711932|NCT01569295|565688924|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
157126757|NCT00546052|567214227|FG000|Overall Study|Adverse Event|47|||
157126758|NCT00546052|567214227|FG000|Overall Study|Lost to Follow-up|144|||
157126759|NCT00546052|567214227|FG000|Overall Study|Protocol Violation|9|||
157126760|NCT00546052|567214227|FG000|Overall Study|Withdrawal by Subject|20|||
157126761|NCT00546052|567214227|FG000|Overall Study|Non Compliance|7|||
157126762|NCT03048422|567214228|FG000|Overall Study|Death|1|||
157126763|NCT03048422|567214229|FG001|Overall Study|Death|0|||
157126764|NCT03048422|567214230|FG002|Overall Study|Death|0|||
157126765|NCT03048422|567214228|FG000|Overall Study|Lost to Follow-up|5|||
157126766|NCT03048422|567214229|FG001|Overall Study|Lost to Follow-up|0|||
157126767|NCT03048422|567214230|FG002|Overall Study|Lost to Follow-up|1|||
157126768|NCT03048422|567214228|FG000|Overall Study|Withdrawal by Subject|5|||
157126769|NCT03048422|567214229|FG001|Overall Study|Withdrawal by Subject|7|||
156711933|NCT01569295|565688925|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
156711934|NCT01569295|565688924|FG000|Overall Study|Lost to Follow-up|1|||
156711935|NCT01569295|565688925|FG001|Overall Study|Lost to Follow-up|1|||
156711936|NCT01895777|565688926|FG000|Overall Study|Adverse Event|1|||
156711937|NCT01895777|565688927|FG001|Overall Study|Adverse Event|2|||
157126770|NCT03048422|567214230|FG002|Overall Study|Withdrawal by Subject|4|||
157126771|NCT03048422|567214228|FG000|Overall Study|Moved|3|||
157126772|NCT03048422|567214229|FG001|Overall Study|Moved|2|||
157126773|NCT03048422|567214230|FG002|Overall Study|Moved|2|||
157126774|NCT03048422|567214228|FG000|Overall Study|Noncompliant with Study Requirements|2|||
157126775|NCT03048422|567214229|FG001|Overall Study|Noncompliant with Study Requirements|1|||
157126776|NCT03048422|567214230|FG002|Overall Study|Noncompliant with Study Requirements|2|||
157126777|NCT03048422|567214228|FG000|Overall Study|Not Able to Get to Clinic|1|||
157126778|NCT03048422|567214229|FG001|Overall Study|Not Able to Get to Clinic|0|||
157126779|NCT03048422|567214230|FG002|Overall Study|Not Able to Get to Clinic|0|||
157126780|NCT01031446|567214231|FG000|Overall Study|Disease Progression|38|||
157126781|NCT01031446|567214231|FG000|Overall Study|Adverse Event|9|||
157126782|NCT01031446|567214231|FG000|Overall Study|Physician Decision|4|||
157126783|NCT01031446|567214231|FG000|Overall Study|Withdrawal by Subject|3|||
157126784|NCT01031446|567214231|FG000|Overall Study|Still on treatment|1|||
157126785|NCT00500682|567214232|FG000|Overall Study|Adverse Event|37|||
157126786|NCT00500682|567214233|FG001|Overall Study|Adverse Event|29|||
157126787|NCT00500682|567214232|FG000|Overall Study|Death|25|||
157126788|NCT00500682|567214233|FG001|Overall Study|Death|16|||
157126789|NCT00500682|567214232|FG000|Overall Study|Lost to Follow-up|11|||
157126790|NCT00500682|567214233|FG001|Overall Study|Lost to Follow-up|11|||
157126791|NCT00500682|567214232|FG000|Overall Study|Physician Decision|6|||
157126792|NCT00500682|567214233|FG001|Overall Study|Physician Decision|10|||
157126793|NCT00500682|567214232|FG000|Overall Study|Pregnancy|2|||
157126794|NCT00500682|567214233|FG001|Overall Study|Pregnancy|0|||
157126795|NCT00500682|567214232|FG000|Overall Study|Protocol Violation|1|||
157126796|NCT00500682|567214233|FG001|Overall Study|Protocol Violation|3|||
157126797|NCT00500682|567214232|FG000|Overall Study|Withdrawal by Subject|80|||
157126798|NCT00500682|567214233|FG001|Overall Study|Withdrawal by Subject|74|||
157126799|NCT00500682|567214232|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
157126800|NCT00500682|567214233|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
157126801|NCT02531646|567214234|FG000|Overall Study|equip. image processing issue|5|||
157126802|NCT02531646|567214235|FG001|Overall Study|equip. image processing issue|1|||
157126803|NCT02531646|567214236|FG002|Overall Study|equip. image processing issue|0|||
157126804|NCT00772668|567214241|FG000|Overall Study|Physician Decision|3|||
157126805|NCT01182428|567214242|FG000|Overall Study|Physician Decision|1|||
157126806|NCT01182428|567214243|FG001|Overall Study|Physician Decision|0|||
157126807|NCT01182428|567214242|FG000|Overall Study|Lost to Follow-up|9|||
157126808|NCT01182428|567214243|FG001|Overall Study|Lost to Follow-up|1|||
157126809|NCT01182428|567214242|FG000|Overall Study|Withdrawal by Subject|1|||
157126810|NCT01182428|567214243|FG001|Overall Study|Withdrawal by Subject|0|||
157126811|NCT03631706|567214245|FG000|Overall Study|Randomized, not treated|1|||
157126812|NCT03631706|567214246|FG001|Overall Study|Randomized, not treated|0|||
157126813|NCT01916980|567215724|FG000|Overall Study|Adverse Event|4|||
157126814|NCT01916980|567215725|FG001|Overall Study|Adverse Event|2|||
157126815|NCT01916980|567215724|FG000|Overall Study|Lack of Efficacy|2|||
157126816|NCT01916980|567215725|FG001|Overall Study|Lack of Efficacy|2|||
157126817|NCT01916980|567215724|FG000|Overall Study|Withdrawal by Subject|1|||
157126818|NCT01916980|567215725|FG001|Overall Study|Withdrawal by Subject|0|||
157126819|NCT00546364|567215726|FG000|Overall Study|Disease progression|5|||
157126820|NCT00546364|567215727|FG001|Overall Study|Disease progression|11|||
157126821|NCT00546364|567215728|FG002|Overall Study|Disease progression|8|||
157126822|NCT00546364|567215726|FG000|Overall Study|Completed and off treatment|1|||
157126823|NCT00546364|567215727|FG001|Overall Study|Completed and off treatment|0|||
157126824|NCT00546364|567215728|FG002|Overall Study|Completed and off treatment|2|||
157126825|NCT00546364|567215726|FG000|Overall Study|Administrative reason by sponsor|1|||
157126826|NCT00546364|567215727|FG001|Overall Study|Administrative reason by sponsor|0|||
157126827|NCT00546364|567215728|FG002|Overall Study|Administrative reason by sponsor|0|||
157126828|NCT00546364|567215726|FG000|Overall Study|Poor compliance/noncompliance|0|||
157126829|NCT00546364|567215727|FG001|Overall Study|Poor compliance/noncompliance|0|||
157126830|NCT00546364|567215728|FG002|Overall Study|Poor compliance/noncompliance|1|||
156711938|NCT01895777|565688926|FG000|Overall Study|Lost to Follow-up|2|||
156711939|NCT01895777|565688927|FG001|Overall Study|Lost to Follow-up|0|||
156711940|NCT01895777|565688926|FG000|Overall Study|Not treated|1|||
156711941|NCT01895777|565688927|FG001|Overall Study|Not treated|0|||
157126831|NCT00546364|567215726|FG000|Overall Study|No longer meets study criteria|1|||
157126832|NCT00546364|567215727|FG001|Overall Study|No longer meets study criteria|1|||
156711942|NCT01895777|565688926|FG000|Overall Study|Other reasons|3|||
156711943|NCT01895777|565688927|FG001|Overall Study|Other reasons|2|||
156711944|NCT01895777|565688926|FG000|Overall Study|Non-compliance with the CTP|2|||
156711945|NCT01895777|565688927|FG001|Overall Study|Non-compliance with the CTP|1|||
157126833|NCT00546364|567215728|FG002|Overall Study|No longer meets study criteria|0|||
157126834|NCT00546364|567215726|FG000|Overall Study|Withdrawal by Subject|5|||
157126835|NCT00546364|567215727|FG001|Overall Study|Withdrawal by Subject|6|||
157126836|NCT00546364|567215728|FG002|Overall Study|Withdrawal by Subject|3|||
157126837|NCT00546364|567215726|FG000|Overall Study|Prior taxotere|1|||
157126838|NCT00546364|567215727|FG001|Overall Study|Prior taxotere|0|||
157126839|NCT00546364|567215728|FG002|Overall Study|Prior taxotere|0|||
157126840|NCT00546364|567215726|FG000|Overall Study|Mixed response|1|||
157126841|NCT00546364|567215727|FG001|Overall Study|Mixed response|0|||
157126842|NCT00546364|567215728|FG002|Overall Study|Mixed response|0|||
157126843|NCT00546364|567215726|FG000|Overall Study|Palliative treatment|1|||
157126844|NCT00546364|567215727|FG001|Overall Study|Palliative treatment|0|||
157126845|NCT00546364|567215728|FG002|Overall Study|Palliative treatment|1|||
157126846|NCT00546364|567215726|FG000|Overall Study|Target lesions resected|1|||
157126847|NCT00546364|567215727|FG001|Overall Study|Target lesions resected|0|||
157126848|NCT00546364|567215728|FG002|Overall Study|Target lesions resected|0|||
157126849|NCT00546364|567215726|FG000|Overall Study|Physician Decision|0|||
157126850|NCT00546364|567215727|FG001|Overall Study|Physician Decision|0|||
157126851|NCT00546364|567215728|FG002|Overall Study|Physician Decision|1|||
157126852|NCT00546364|567215726|FG000|Overall Study|Sponsor decision|0|||
157126853|NCT00546364|567215727|FG001|Overall Study|Sponsor decision|0|||
156711946|NCT02508935|565688932|FG000|Overall Study|Withdrawal by Subject|1|||
156711947|NCT02508935|565688932|FG000|Overall Study|Withdrawal by Caregiver|8|||
156711948|NCT02508935|565688932|FG000|Overall Study|Pain Score <4|1|||
156711949|NCT02508935|565688932|FG000|Overall Study|Emesis|3|||
156711950|NCT02508935|565688932|FG000|Overall Study|Adverse Event|3|||
156711951|NCT02508935|565688932|FG000|Overall Study|Protocol Violation|1|||
156711952|NCT02508935|565688932|FG000|Overall Study|Physician Decision|1|||
156711953|NCT02508935|565688932|FG000|Overall Study|Trial terminated by sponsor|5|||
156711954|NCT04223752|565688935|FG000|Overall Study|Participant enrolled in error|0|||
156711955|NCT04223752|565688936|FG001|Overall Study|Participant enrolled in error|0|||
156711956|NCT04223752|565688937|FG002|Overall Study|Participant enrolled in error|0|||
156711957|NCT04223752|565688938|FG003|Overall Study|Participant enrolled in error|0|||
156711958|NCT04223752|565688939|FG004|Overall Study|Participant enrolled in error|1|||
156711959|NCT04223752|565688935|FG000|Overall Study|Death|0|||
156711960|NCT04223752|565688936|FG001|Overall Study|Death|0|||
156711961|NCT04223752|565688937|FG002|Overall Study|Death|0|||
156711962|NCT04223752|565688938|FG003|Overall Study|Death|2|||
156711963|NCT04223752|565688939|FG004|Overall Study|Death|1|||
156711964|NCT04759703|565688940|FG000|Overall Study|Withdrawal by Subject|4|||
156711965|NCT04759703|565688941|FG001|Overall Study|Withdrawal by Subject|9|||
156711966|NCT04759703|565688940|FG000|Overall Study|Adverse Event|1|||
156711967|NCT04759703|565688941|FG001|Overall Study|Adverse Event|0|||
156711968|NCT04759703|565688940|FG000|Overall Study|Lost to Follow-up|2|||
156711969|NCT04759703|565688941|FG001|Overall Study|Lost to Follow-up|0|||
156711970|NCT03138655|565688951|FG000|Overall Study|Adverse Event|2|||
156711971|NCT03138655|565688952|FG001|Overall Study|Adverse Event|1|||
156711972|NCT03138655|565688953|FG002|Overall Study|Adverse Event|2|||
156711973|NCT03138655|565688954|FG003|Overall Study|Adverse Event|1|||
156711974|NCT03138655|565688955|FG004|Overall Study|Adverse Event|1|||
156711975|NCT03138655|565688956|FG005|Overall Study|Adverse Event|4|||
156711976|NCT03138655|565688957|FG006|Overall Study|Adverse Event|2|||
156711977|NCT03138655|565688958|FG007|Overall Study|Adverse Event|2|||
156711978|NCT03138655|565688951|FG000|Overall Study|Withdrawal by Subject|0|||
156711979|NCT03138655|565688952|FG001|Overall Study|Withdrawal by Subject|1|||
156711980|NCT03138655|565688953|FG002|Overall Study|Withdrawal by Subject|0|||
156711981|NCT03138655|565688954|FG003|Overall Study|Withdrawal by Subject|0|||
156711982|NCT03138655|565688955|FG004|Overall Study|Withdrawal by Subject|0|||
156711983|NCT03138655|565688956|FG005|Overall Study|Withdrawal by Subject|0|||
156711984|NCT03138655|565688957|FG006|Overall Study|Withdrawal by Subject|1|||
156711985|NCT03138655|565688958|FG007|Overall Study|Withdrawal by Subject|0|||
156711986|NCT03138655|565688951|FG000|Overall Study|Reason not Specified|1|||
156711987|NCT03138655|565688952|FG001|Overall Study|Reason not Specified|0|||
156711988|NCT03138655|565688953|FG002|Overall Study|Reason not Specified|0|||
156711989|NCT03138655|565688954|FG003|Overall Study|Reason not Specified|2|||
156711990|NCT03138655|565688955|FG004|Overall Study|Reason not Specified|1|||
156711991|NCT03138655|565688956|FG005|Overall Study|Reason not Specified|1|||
156711992|NCT03138655|565688957|FG006|Overall Study|Reason not Specified|0|||
156711993|NCT03138655|565688958|FG007|Overall Study|Reason not Specified|0|||
156711994|NCT02800642|565688959|FG000|Overall Study|Death|3|||
156711995|NCT02800642|565688959|FG000|Overall Study|Other|10|||
156711996|NCT02800642|565688959|FG000|Overall Study|Physician Decision|2|||
156711997|NCT02800642|565688959|FG000|Overall Study|Adverse Event|6|||
156711998|NCT02800642|565688959|FG000|Overall Study|Withdrawal by Subject|3|||
156711999|NCT02800642|565688959|FG000|Overall Study|Lost to Follow-up|1|||
156712000|NCT04868500|565688960|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
156712001|NCT04868500|565688961|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
156712002|NCT04868500|565688960|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
156712003|NCT04868500|565688961|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
156712004|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Death|8|||
156712005|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Death|5|||
156712006|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Death|5|||
156712007|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Death|7|||
156712008|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
156712009|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
156712010|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
156712011|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
157016460|NCT01303445|566811342|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
156712012|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
156712013|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
156712014|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
156712015|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
157016461|NCT01303445|566811343|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
157016462|NCT01303445|566811342|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
157016463|NCT01303445|566811343|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
156712016|NCT03340974|565688962|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
156712017|NCT03340974|565688963|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
156712018|NCT03340974|565688964|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
156712019|NCT03340974|565688965|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
156712020|NCT00396565|565688972|FG000|Overall Study|Physician Decision|3|||
156712021|NCT00396565|565688973|FG001|Overall Study|Physician Decision|1|||
156712022|NCT00396565|565688974|FG002|Overall Study|Physician Decision|2|||
156712023|NCT00396565|565688972|FG000|Overall Study|Adverse Event|5|||
156712024|NCT00396565|565688973|FG001|Overall Study|Adverse Event|13|||
156712025|NCT00396565|565688974|FG002|Overall Study|Adverse Event|3|||
156712026|NCT00396565|565688972|FG000|Overall Study|Withdrawal by Subject|8|||
156712027|NCT00396565|565688973|FG001|Overall Study|Withdrawal by Subject|13|||
156712028|NCT00396565|565688974|FG002|Overall Study|Withdrawal by Subject|1|||
156712029|NCT00396565|565688972|FG000|Overall Study|Lack of Efficacy|32|||
156712030|NCT00396565|565688973|FG001|Overall Study|Lack of Efficacy|64|||
156712031|NCT00396565|565688974|FG002|Overall Study|Lack of Efficacy|11|||
156712032|NCT05109611|565690803|FG000|Overall Study|Adverse Event|13|||
156712033|NCT05109611|565690804|FG001|Overall Study|Adverse Event|10|||
156712034|NCT05109611|565690803|FG000|Overall Study|Withdrawal by Subject|1|||
156712035|NCT05109611|565690804|FG001|Overall Study|Withdrawal by Subject|0|||
156712036|NCT05109611|565690803|FG000|Overall Study|Lost to Follow-up|1|||
156712037|NCT05109611|565690804|FG001|Overall Study|Lost to Follow-up|2|||
156712038|NCT05109611|565690803|FG000|Overall Study|Protocol Violation|0|||
156712039|NCT05109611|565690804|FG001|Overall Study|Protocol Violation|4|||
156712040|NCT05109611|565690803|FG000|Overall Study|Information unavailable|1|||
156712041|NCT05109611|565690804|FG001|Overall Study|Information unavailable|1|||
156712042|NCT03203850|565690808|FG000|Overall Study|Subject/guardian decision|4|||
156712043|NCT03203850|565690809|FG001|Overall Study|Subject/guardian decision|3|||
156712044|NCT03203850|565690808|FG000|Overall Study|Adverse Event|3|||
156712045|NCT03203850|565690809|FG001|Overall Study|Adverse Event|0|||
156712046|NCT03203850|565690808|FG000|Overall Study|Death|1|||
156712047|NCT03203850|565690809|FG001|Overall Study|Death|0|||
156712048|NCT02717455|565690810|FG000|Overall Study|Adverse Event|1|||
156712049|NCT02717455|565690811|FG001|Overall Study|Adverse Event|0|||
156712050|NCT02717455|565690812|FG002|Overall Study|Adverse Event|0|||
156712051|NCT02717455|565690813|FG003|Overall Study|Adverse Event|2|||
156712052|NCT02717455|565690814|FG004|Overall Study|Adverse Event|2|||
156712053|NCT02717455|565690815|FG005|Overall Study|Adverse Event|2|||
156712054|NCT02717455|565690810|FG000|Overall Study|Withdrawal by Subject|1|||
156712055|NCT02717455|565690811|FG001|Overall Study|Withdrawal by Subject|1|||
156712056|NCT02717455|565690812|FG002|Overall Study|Withdrawal by Subject|0|||
156712057|NCT02717455|565690813|FG003|Overall Study|Withdrawal by Subject|2|||
156712058|NCT02717455|565690814|FG004|Overall Study|Withdrawal by Subject|2|||
156712059|NCT02717455|565690815|FG005|Overall Study|Withdrawal by Subject|1|||
156712060|NCT02717455|565690810|FG000|Overall Study|Death|1|||
156712061|NCT02717455|565690811|FG001|Overall Study|Death|0|||
156712062|NCT02717455|565690812|FG002|Overall Study|Death|0|||
156712063|NCT02717455|565690813|FG003|Overall Study|Death|0|||
156712064|NCT02717455|565690814|FG004|Overall Study|Death|1|||
156712065|NCT02717455|565690815|FG005|Overall Study|Death|0|||
156712066|NCT02717455|565690810|FG000|Overall Study|Did not receive study drug|0|||
156712067|NCT02717455|565690811|FG001|Overall Study|Did not receive study drug|0|||
156712068|NCT02717455|565690812|FG002|Overall Study|Did not receive study drug|0|||
156712069|NCT02717455|565690813|FG003|Overall Study|Did not receive study drug|1|||
156712070|NCT02717455|565690814|FG004|Overall Study|Did not receive study drug|0|||
156712071|NCT02717455|565690815|FG005|Overall Study|Did not receive study drug|1|||
156712072|NCT02717455|565690810|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712073|NCT02717455|565690811|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712074|NCT02717455|565690812|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
157126854|NCT00546364|567215728|FG002|Overall Study|Sponsor decision|1|||
156712075|NCT02717455|565690813|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712076|NCT02717455|565690814|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
156712077|NCT02717455|565690815|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
156712078|NCT02717455|565690810|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
156792351|NCT00160563|565992746|FG001|Overall Study|Lost to Follow-up|1|||
157126855|NCT00388947|567215730|FG000|Overall Study|Protocol Violation|47|||
156712079|NCT02717455|565690811|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
156712080|NCT02717455|565690812|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
156712081|NCT02717455|565690813|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
157126856|NCT04187092|567215731|FG000|Overall Study|Lost to Follow-up|1|||
157126857|NCT04187092|567215732|FG001|Overall Study|Lost to Follow-up|1|||
157126858|NCT04187092|567215731|FG000|Overall Study|Withdrawal by Subject|1|||
156712082|NCT02717455|565690814|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
156792352|NCT00160563|565992747|FG002|Overall Study|Lost to Follow-up|2|||
156712083|NCT02717455|565690815|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
156712084|NCT00886015|565690820|FG000|Overall Study|Death|0|||
156712085|NCT00886015|565690821|FG001|Overall Study|Death|2|||
156712086|NCT01692626|565690822|FG000|Overall Study|Death|0|||
156712087|NCT01692626|565690823|FG001|Overall Study|Death|1|||
156712088|NCT01692626|565690822|FG000|Overall Study|Adverse Event|2|||
156712089|NCT01692626|565690823|FG001|Overall Study|Adverse Event|3|||
156712090|NCT01692626|565690822|FG000|Overall Study|Protocol Violation|1|||
156712091|NCT01692626|565690823|FG001|Overall Study|Protocol Violation|2|||
156712092|NCT01692626|565690822|FG000|Overall Study|Withdrawal by Subject|1|||
156712093|NCT01692626|565690823|FG001|Overall Study|Withdrawal by Subject|0|||
156712094|NCT00855894|565690824|FG000|Overall Study|Death|31|||
156712095|NCT00855894|565690824|FG000|Overall Study|Patient's decision|1|||
156712096|NCT00855894|565690824|FG000|Overall Study|Disease progression|1|||
156712097|NCT02794870|565690836|FG000|Overall Study|Withdrawal by Subject|2|||
156712098|NCT02794870|565690837|FG001|Overall Study|Withdrawal by Subject|0|||
156712099|NCT02540083|565690838|FG000|Overall Study|Withdrawal by Subject|16|||
156712100|NCT02301390|565690839|FG000|Overall Study|Withdrawal by Subject|3|||
156712101|NCT02301390|565690840|FG001|Overall Study|Withdrawal by Subject|5|||
156712102|NCT02301390|565690839|FG000|Overall Study|Protocol Violation|1|||
156712103|NCT02301390|565690840|FG001|Overall Study|Protocol Violation|0|||
156712104|NCT02301390|565690839|FG000|Overall Study|Physician Decision|1|||
156712105|NCT02301390|565690840|FG001|Overall Study|Physician Decision|0|||
156712106|NCT02301390|565690839|FG000|Overall Study|Lost to Follow-up|0|||
156712107|NCT02301390|565690840|FG001|Overall Study|Lost to Follow-up|1|||
156712108|NCT02301390|565690839|FG000|Overall Study|Death|2|||
156712109|NCT02301390|565690840|FG001|Overall Study|Death|2|||
156712110|NCT02301390|565690839|FG000|Overall Study|Procedure not completed|0|||
156712111|NCT02301390|565690840|FG001|Overall Study|Procedure not completed|4|||
156712112|NCT02301390|565690839|FG000|Overall Study|Missed multiple visits|1|||
156712113|NCT02301390|565690840|FG001|Overall Study|Missed multiple visits|1|||
156712114|NCT02301390|565690839|FG000|Overall Study|study terminated|2|||
156712115|NCT02301390|565690840|FG001|Overall Study|study terminated|0|||
156712116|NCT02604407|565690841|FG000|Overall Study|Adverse Event|0|||
156712117|NCT02604407|565690842|FG001|Overall Study|Adverse Event|7|||
156712118|NCT02604407|565690843|FG002|Overall Study|Adverse Event|5|||
156712119|NCT02604407|565690841|FG000|Overall Study|Protocol Violation|2|||
156712120|NCT02604407|565690842|FG001|Overall Study|Protocol Violation|0|||
156712121|NCT02604407|565690843|FG002|Overall Study|Protocol Violation|0|||
156712122|NCT02604407|565690841|FG000|Overall Study|Withdrawal by Subject|3|||
156712123|NCT02604407|565690842|FG001|Overall Study|Withdrawal by Subject|3|||
156712124|NCT02604407|565690843|FG002|Overall Study|Withdrawal by Subject|5|||
156712125|NCT02604407|565690841|FG000|Overall Study|Lost to Follow-up|2|||
156712126|NCT02604407|565690842|FG001|Overall Study|Lost to Follow-up|1|||
156712127|NCT02604407|565690843|FG002|Overall Study|Lost to Follow-up|2|||
156712128|NCT02604407|565690841|FG000|Overall Study|Lack of Efficacy|1|||
156712129|NCT02604407|565690842|FG001|Overall Study|Lack of Efficacy|0|||
156712130|NCT02604407|565690843|FG002|Overall Study|Lack of Efficacy|0|||
156712131|NCT02604407|565690841|FG000|Overall Study|Other|3|||
156712132|NCT02604407|565690842|FG001|Overall Study|Other|1|||
156712133|NCT02604407|565690843|FG002|Overall Study|Other|4|||
156712134|NCT00185588|565690844|FG000|Overall Study|Adverse Event|3|||
156712135|NCT00185588|565690845|FG001|Overall Study|Adverse Event|1|||
156712136|NCT00185588|565690846|FG002|Overall Study|Adverse Event|4|||
156712137|NCT00185588|565690847|FG003|Overall Study|Adverse Event|2|||
156712138|NCT00185588|565690844|FG000|Overall Study|Lost to Follow-up|0|||
156712139|NCT00185588|565690845|FG001|Overall Study|Lost to Follow-up|0|||
156792353|NCT00160563|565992745|FG000|Overall Study|Protocol Violation|0|||
156792354|NCT00160563|565992746|FG001|Overall Study|Protocol Violation|0|||
157126859|NCT04187092|567215732|FG001|Overall Study|Withdrawal by Subject|1|||
157126860|NCT04187092|567215731|FG000|Overall Study|Adverse Event|0|||
157126861|NCT04187092|567215732|FG001|Overall Study|Adverse Event|1|||
157126862|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
157126863|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
156712140|NCT00185588|565690846|FG002|Overall Study|Lost to Follow-up|1|||
156712141|NCT00185588|565690847|FG003|Overall Study|Lost to Follow-up|2|||
156712142|NCT00185588|565690844|FG000|Overall Study|Withdrawal by Subject|0|||
156712143|NCT00185588|565690845|FG001|Overall Study|Withdrawal by Subject|1|||
156712144|NCT00185588|565690846|FG002|Overall Study|Withdrawal by Subject|0|||
156712145|NCT00185588|565690847|FG003|Overall Study|Withdrawal by Subject|0|||
156712146|NCT00185588|565690844|FG000|Overall Study|Physician Decision|0|||
156712147|NCT00185588|565690845|FG001|Overall Study|Physician Decision|0|||
156712148|NCT00185588|565690846|FG002|Overall Study|Physician Decision|1|||
156712149|NCT00185588|565690847|FG003|Overall Study|Physician Decision|0|||
156712150|NCT00398866|565690848|FG000|Overall Study|Adverse Event|1|||
156712151|NCT00398866|565690849|FG001|Overall Study|Adverse Event|0|||
156712152|NCT00398866|565690850|FG002|Overall Study|Adverse Event|0|||
156712153|NCT00398866|565690848|FG000|Overall Study|Lack of Efficacy|0|||
156792355|NCT00160563|565992747|FG002|Overall Study|Protocol Violation|3|||
156712154|NCT00398866|565690849|FG001|Overall Study|Lack of Efficacy|0|||
156712155|NCT00398866|565690850|FG002|Overall Study|Lack of Efficacy|1|||
156712156|NCT00398866|565690848|FG000|Overall Study|Lost to Follow-up|7|||
156712157|NCT00398866|565690849|FG001|Overall Study|Lost to Follow-up|6|||
156712158|NCT00398866|565690850|FG002|Overall Study|Lost to Follow-up|4|||
156712159|NCT00398866|565690848|FG000|Overall Study|Withdrawal by Subject|5|||
156712160|NCT00398866|565690849|FG001|Overall Study|Withdrawal by Subject|1|||
156712161|NCT00398866|565690850|FG002|Overall Study|Withdrawal by Subject|2|||
156712162|NCT00398866|565690848|FG000|Overall Study|Unable to complete requirements of study|1|||
156712163|NCT00398866|565690849|FG001|Overall Study|Unable to complete requirements of study|1|||
156712164|NCT00398866|565690850|FG002|Overall Study|Unable to complete requirements of study|1|||
156712165|NCT02481869|565690853|FG000|Overall Study|Lost to Follow-up|3|||
156712166|NCT02481869|565690854|FG001|Overall Study|Lost to Follow-up|4|||
156712167|NCT02481869|565690853|FG000|Overall Study|Withdrawal by Subject|2|||
156712168|NCT02481869|565690854|FG001|Overall Study|Withdrawal by Subject|0|||
156712169|NCT00191191|565690857|FG000|Overall Study|Entry Criteria Exclusion|2|||
156712170|NCT00191191|565690858|FG001|Overall Study|Entry Criteria Exclusion|0|||
156712171|NCT00191191|565690857|FG000|Overall Study|Treated with Another Systemic Agent|1|||
156712172|NCT00191191|565690858|FG001|Overall Study|Treated with Another Systemic Agent|1|||
156712173|NCT00191191|565690857|FG000|Overall Study|Adverse Event|11|||
156712174|NCT00191191|565690858|FG001|Overall Study|Adverse Event|21|||
156712175|NCT00191191|565690857|FG000|Overall Study|Progressive Disease|84|||
156712176|NCT00191191|565690858|FG001|Overall Study|Progressive Disease|72|||
156712177|NCT00191191|565690857|FG000|Overall Study|Toxicity After Dose Reduction|7|||
156712178|NCT00191191|565690858|FG001|Overall Study|Toxicity After Dose Reduction|8|||
156712179|NCT00191191|565690857|FG000|Overall Study|Family/Caregiver Decision|5|||
156712180|NCT00191191|565690858|FG001|Overall Study|Family/Caregiver Decision|7|||
156712181|NCT00191191|565690857|FG000|Overall Study|Lost to Follow-up|1|||
156712182|NCT00191191|565690858|FG001|Overall Study|Lost to Follow-up|0|||
156712183|NCT00191191|565690857|FG000|Overall Study|Physician Decision|3|||
156712184|NCT00191191|565690858|FG001|Overall Study|Physician Decision|2|||
156712185|NCT00191191|565690857|FG000|Overall Study|Good Clinical Practice Violation|0|||
156712186|NCT00191191|565690858|FG001|Overall Study|Good Clinical Practice Violation|1|||
156712187|NCT03790657|565690859|FG000|Overall Study|Adverse Event|1|||
156712188|NCT03790657|565690860|FG001|Overall Study|Adverse Event|1|||
156712189|NCT03790657|565690859|FG000|Overall Study|Withdrawal by Subject|1|||
156712190|NCT03790657|565690860|FG001|Overall Study|Withdrawal by Subject|1|||
156712191|NCT01023035|565690862|FG000|Treatment Period|Adverse Event|27|||
156712192|NCT01023035|565690863|FG001|Treatment Period|Adverse Event|32|||
156712193|NCT01023035|565690864|FG002|Treatment Period|Adverse Event|50|||
156712194|NCT01023035|565690862|FG000|Treatment Period|Non-Medical Reasons|19|||
156712195|NCT01023035|565690863|FG001|Treatment Period|Non-Medical Reasons|22|||
156712196|NCT01023035|565690864|FG002|Treatment Period|Non-Medical Reasons|44|||
156712197|NCT01023035|565690862|FG000|Treatment Period|Treatment Failure|26|||
156712198|NCT01023035|565690863|FG001|Treatment Period|Treatment Failure|31|||
156712199|NCT01023035|565690864|FG002|Treatment Period|Treatment Failure|24|||
156712200|NCT01023035|565690862|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
156712201|NCT01023035|565690863|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
156712202|NCT01023035|565690864|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
156712203|NCT01023035|565690862|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
156712204|NCT01023035|565690863|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
156712205|NCT01023035|565690864|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
156712206|NCT04342819|565690865|FG000|Overall Study|Declined|4|||
156712207|NCT04342819|565690865|FG000|Overall Study|Not meeeting selection criteria|1|||
156712208|NCT00560391|565690869|FG000|Overall Study|Still on treatment|0|||
156712209|NCT00560391|565690870|FG001|Overall Study|Still on treatment|0|||
156712210|NCT00560391|565690871|FG002|Overall Study|Still on treatment|0|||
156712211|NCT00560391|565690872|FG003|Overall Study|Still on treatment|1|||
156792356|NCT00160563|565992745|FG000|Overall Study|Withdrawal by Subject|1|||
156792357|NCT00160563|565992746|FG001|Overall Study|Withdrawal by Subject|2|||
156792358|NCT00160563|565992747|FG002|Overall Study|Withdrawal by Subject|3|||
156792359|NCT00160563|565992745|FG000|Overall Study|Other (listed in the study report)|48|||
156792360|NCT00160563|565992746|FG001|Overall Study|Other (listed in the study report)|40|||
156712212|NCT00560391|565690873|FG004|Overall Study|Still on treatment|2|||
156712213|NCT03607487|565690874|FG000|Overall Study|Withdrawal by Subject|2|||
156712214|NCT03607487|565690875|FG001|Overall Study|Withdrawal by Subject|0|||
156712215|NCT03607487|565690876|FG002|Overall Study|Withdrawal by Subject|0|||
156712216|NCT03607487|565690877|FG003|Overall Study|Withdrawal by Subject|1|||
156712217|NCT05061420|565690878|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
156712218|NCT05061420|565690879|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156712219|NCT05061420|565690880|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
156712220|NCT05061420|565690878|FG000|Overall Study|Progressive disease|11|||
156712221|NCT05061420|565690879|FG001|Overall Study|Progressive disease|15|||
156712222|NCT05061420|565690880|FG002|Overall Study|Progressive disease|14|||
156808763|NCT01408277|566054458|FG001|Overall Study|Adverse Event|4|||
156712223|NCT05061420|565690878|FG000|Overall Study|Withdrawal by Subject|2|||
156712224|NCT05061420|565690879|FG001|Overall Study|Withdrawal by Subject|0|||
157126864|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
157126865|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
157126866|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
157126867|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
157126868|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
157126869|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
157126870|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
157126871|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
157126872|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
157126873|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
157216000|NCT00410410|567537430|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
156712225|NCT05061420|565690880|FG002|Overall Study|Withdrawal by Subject|1|||
156712226|NCT05061420|565690878|FG000|Overall Study|Not related to COVID-19|2|||
156712227|NCT05061420|565690879|FG001|Overall Study|Not related to COVID-19|0|||
157016464|NCT06024174|566811344|FG000|Overall Study|Other Reasons|1|||
157016465|NCT06024174|566811344|FG000|Overall Study|Study terminated by Sponsor|4|||
157016466|NCT04994509|566811345|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
157016467|NCT04994509|566811346|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
157016468|NCT04994509|566811347|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
157016469|NCT04994509|566811345|FG000|Overall Study|Withdrew Consent|73|||
157016470|NCT04994509|566811346|FG001|Overall Study|Withdrew Consent|72|||
157016471|NCT04994509|566811347|FG002|Overall Study|Withdrew Consent|46|||
157016472|NCT04994509|566811345|FG000|Overall Study|Lost to Follow-up|39|||
157016473|NCT04994509|566811346|FG001|Overall Study|Lost to Follow-up|36|||
157016474|NCT04994509|566811347|FG002|Overall Study|Lost to Follow-up|26|||
157016475|NCT04994509|566811345|FG000|Overall Study|HIV-1 Infection|4|||
157016476|NCT04994509|566811346|FG001|Overall Study|HIV-1 Infection|20|||
157016477|NCT04994509|566811347|FG002|Overall Study|HIV-1 Infection|12|||
157016478|NCT04994509|566811345|FG000|Overall Study|Investigator's Discretion|9|||
157016479|NCT04994509|566811346|FG001|Overall Study|Investigator's Discretion|8|||
157016480|NCT04994509|566811347|FG002|Overall Study|Investigator's Discretion|11|||
157016481|NCT04994509|566811345|FG000|Overall Study|Randomized but Never Treated|10|||
157016482|NCT04994509|566811346|FG001|Overall Study|Randomized but Never Treated|10|||
157016483|NCT04994509|566811347|FG002|Overall Study|Randomized but Never Treated|3|||
157016484|NCT04994509|566811345|FG000|Overall Study|Pregnancy|5|||
157016485|NCT04994509|566811346|FG001|Overall Study|Pregnancy|5|||
157016486|NCT04994509|566811347|FG002|Overall Study|Pregnancy|0|||
157016487|NCT04994509|566811345|FG000|Overall Study|Death|0|||
157016488|NCT04994509|566811346|FG001|Overall Study|Death|5|||
157016489|NCT04994509|566811347|FG002|Overall Study|Death|0|||
157016490|NCT04994509|566811345|FG000|Overall Study|Adverse Event|2|||
157016491|NCT04994509|566811346|FG001|Overall Study|Adverse Event|1|||
157016492|NCT04994509|566811347|FG002|Overall Study|Adverse Event|0|||
157016493|NCT04994509|566811345|FG000|Overall Study|Non-compliance With Study Drug|1|||
157016494|NCT04994509|566811346|FG001|Overall Study|Non-compliance With Study Drug|1|||
157016495|NCT04994509|566811347|FG002|Overall Study|Non-compliance With Study Drug|1|||
157016496|NCT04994509|566811345|FG000|Overall Study|Withdrew Assent|3|||
157016497|NCT04994509|566811346|FG001|Overall Study|Withdrew Assent|0|||
157016498|NCT04994509|566811347|FG002|Overall Study|Withdrew Assent|0|||
157016499|NCT04994509|566811345|FG000|Overall Study|Protocol Violation|1|||
157016500|NCT04994509|566811346|FG001|Overall Study|Protocol Violation|0|||
157016501|NCT04994509|566811347|FG002|Overall Study|Protocol Violation|0|||
157016502|NCT04402294|566811348|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
157016503|NCT04402294|566811349|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
157016504|NCT04402294|566811348|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
157016505|NCT04402294|566811349|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
157016506|NCT04923347|566813127|FG000|Overall Study|Withdrawal by Subject|14|||
157016507|NCT01991977|566813132|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
157016508|NCT01991977|566813132|FG000|Overall Study|Withdrew after start of treatment|5|||
157016509|NCT03845465|566813134|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
157016510|NCT03845465|566813135|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
157016511|NCT03845465|566813134|FG000|6-month Data Collection|Withdrawal by Subject|0|||
157016512|NCT03845465|566813135|FG001|6-month Data Collection|Withdrawal by Subject|2|||
157016513|NCT03845465|566813134|FG000|12-month Data Collection|Withdrawal by Subject|0|||
157016514|NCT03845465|566813135|FG001|12-month Data Collection|Withdrawal by Subject|2|||
157016515|NCT00979576|566813138|FG000|Combination Treatment Phase|Progressive disease|3|||
157016516|NCT00979576|566813139|FG001|Combination Treatment Phase|Progressive disease|1|||
157016517|NCT00979576|566813140|FG002|Combination Treatment Phase|Progressive disease|5|||
157016518|NCT00979576|566813138|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
157016519|NCT00979576|566813139|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
157216001|NCT00410410|567537431|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
157216002|NCT00410410|567537432|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
157216003|NCT00410410|567537424|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216004|NCT00410410|567537425|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216005|NCT00410410|567537426|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216006|NCT00410410|567537427|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216007|NCT00410410|567537428|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216008|NCT00410410|567537429|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216009|NCT00410410|567537430|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216010|NCT00410410|567537431|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
157216011|NCT00410410|567537432|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
157216012|NCT00410410|567537424|FG000|Open-Label Period (OL)|Pregnancy|0|||
156712228|NCT05061420|565690880|FG002|Overall Study|Not related to COVID-19|0|||
156712229|NCT01814553|565690881|FG000|Overall Study|PD per clinical progression|6|||
156712230|NCT01814553|565690882|FG001|Overall Study|PD per clinical progression|8|||
156712231|NCT01814553|565690881|FG000|Overall Study|Other Adverse Event|4|||
156712232|NCT01814553|565690882|FG001|Overall Study|Other Adverse Event|5|||
156712233|NCT01814553|565690881|FG000|Overall Study|Withdrawal by Subject|1|||
156712234|NCT01814553|565690882|FG001|Overall Study|Withdrawal by Subject|1|||
156712235|NCT01814553|565690881|FG000|Overall Study|Other than stated|7|||
156712236|NCT01814553|565690882|FG001|Overall Study|Other than stated|8|||
156712237|NCT04036110|565690883|FG000|Overall Study|Lost to Follow-up|3|||
156712238|NCT04036110|565690884|FG001|Overall Study|Lost to Follow-up|2|||
156712239|NCT04036110|565690885|FG002|Overall Study|Lost to Follow-up|1|||
156712240|NCT04036110|565690883|FG000|Overall Study|Study Suspended|4|||
156712241|NCT04036110|565690884|FG001|Overall Study|Study Suspended|5|||
156712242|NCT04036110|565690885|FG002|Overall Study|Study Suspended|1|||
156712243|NCT01941498|565690886|FG000|Overall Study|Relocated out of state|1|||
156712244|NCT03097991|565690887|FG000|Overall Study|Didn't meet study criteria|8|||
156712245|NCT03097991|565690888|FG001|Overall Study|Didn't meet study criteria|0|||
156712246|NCT03097991|565690887|FG000|Overall Study|Withdrawal by Subject|12|||
157126874|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
157126875|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
157126876|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
157126877|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
157126878|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
157126879|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
157126880|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
157126881|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
157126882|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
157126883|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
157126884|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
157126885|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
157126886|NCT04660643|567215733|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
157126887|NCT04660643|567215734|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
157126888|NCT04660643|567215735|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
157216013|NCT00410410|567537425|FG001|Open-Label Period (OL)|Pregnancy|0|||
157216014|NCT00410410|567537426|FG002|Open-Label Period (OL)|Pregnancy|0|||
156712247|NCT03097991|565690888|FG001|Overall Study|Withdrawal by Subject|6|||
156712248|NCT03097991|565690887|FG000|Overall Study|Death of Baby|3|||
156712249|NCT03097991|565690888|FG001|Overall Study|Death of Baby|1|||
156712250|NCT03097991|565690887|FG000|Overall Study|Lost to Follow-up|24|||
156712251|NCT03097991|565690888|FG001|Overall Study|Lost to Follow-up|38|||
156712252|NCT03097991|565690887|FG000|Overall Study|Adverse Event|3|||
156712253|NCT03097991|565690888|FG001|Overall Study|Adverse Event|5|||
156712254|NCT02006732|565690889|FG000|Overall Study|Adverse Event|10|||
156712255|NCT02006732|565690890|FG001|Overall Study|Adverse Event|7|||
156712256|NCT02006732|565690891|FG002|Overall Study|Adverse Event|4|||
156712257|NCT02006732|565690892|FG003|Overall Study|Adverse Event|2|||
156712258|NCT02006732|565690889|FG000|Overall Study|Lack of Efficacy|6|||
156712259|NCT02006732|565690890|FG001|Overall Study|Lack of Efficacy|3|||
156712260|NCT02006732|565690891|FG002|Overall Study|Lack of Efficacy|1|||
156712261|NCT02006732|565690892|FG003|Overall Study|Lack of Efficacy|1|||
156712262|NCT02006732|565690889|FG000|Overall Study|Protocol Violation|1|||
156712263|NCT02006732|565690890|FG001|Overall Study|Protocol Violation|1|||
156712264|NCT02006732|565690891|FG002|Overall Study|Protocol Violation|0|||
156712265|NCT02006732|565690892|FG003|Overall Study|Protocol Violation|0|||
156712266|NCT02006732|565690889|FG000|Overall Study|Lost to Follow-up|0|||
156712267|NCT02006732|565690890|FG001|Overall Study|Lost to Follow-up|1|||
156712268|NCT02006732|565690891|FG002|Overall Study|Lost to Follow-up|0|||
156712269|NCT02006732|565690892|FG003|Overall Study|Lost to Follow-up|0|||
156712270|NCT02006732|565690889|FG000|Overall Study|Withdrawal by Subject|3|||
156712271|NCT02006732|565690890|FG001|Overall Study|Withdrawal by Subject|0|||
156712272|NCT02006732|565690891|FG002|Overall Study|Withdrawal by Subject|4|||
156712273|NCT02006732|565690892|FG003|Overall Study|Withdrawal by Subject|1|||
156712274|NCT01755091|565690893|FG000|Overall Study|Withdrawal by Subject|6|||
156712275|NCT01755091|565690894|FG001|Overall Study|Withdrawal by Subject|1|||
156712276|NCT01755091|565690895|FG002|Overall Study|Withdrawal by Subject|3|||
156712277|NCT01755091|565690893|FG000|Overall Study|Adverse Event|1|||
156712278|NCT01755091|565690894|FG001|Overall Study|Adverse Event|1|||
156712279|NCT01755091|565690895|FG002|Overall Study|Adverse Event|1|||
156712280|NCT01755091|565690893|FG000|Overall Study|Lost to Follow-up|1|||
156712281|NCT01755091|565690894|FG001|Overall Study|Lost to Follow-up|0|||
156712282|NCT01755091|565690895|FG002|Overall Study|Lost to Follow-up|1|||
156712283|NCT01755091|565690893|FG000|Overall Study|Physician Decision|1|||
156712284|NCT01755091|565690894|FG001|Overall Study|Physician Decision|1|||
156712285|NCT01755091|565690895|FG002|Overall Study|Physician Decision|2|||
156712286|NCT01107197|565690897|FG000|Overall Study|Death|12|||
156712287|NCT01107197|565690898|FG001|Overall Study|Death|10|||
156712288|NCT01107197|565690897|FG000|Overall Study|Lost to Follow-up|5|||
156712289|NCT01107197|565690898|FG001|Overall Study|Lost to Follow-up|8|||
156712290|NCT01107197|565690897|FG000|Overall Study|Withdrawal by Subject|3|||
156712291|NCT01107197|565690898|FG001|Overall Study|Withdrawal by Subject|5|||
156712292|NCT01301729|565690899|FG000|Overall Study|Withdrawal by Subject|2|||
156712293|NCT01301729|565690899|FG000|Overall Study|Participant did not Return for Treatment|1|||
156712294|NCT01301729|565690899|FG000|Overall Study|Violated Selection Criteria|1|||
156712295|NCT03071276|565690900|FG000|Overall Study|Adverse Event|1|||
156712296|NCT03071276|565690900|FG000|Overall Study|Lack of Efficacy|14|||
156712297|NCT05794503|565690901|FG000|Overall Study|Operation Cancelled|2|||
156712298|NCT05794503|565690902|FG001|Overall Study|Operation Cancelled|0|||
156712299|NCT05794503|565690901|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
156712300|NCT05794503|565690902|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
156712301|NCT05794503|565690901|FG000|Overall Study|Protocol Violation|1|||
156712302|NCT05794503|565690902|FG001|Overall Study|Protocol Violation|0|||
156712303|NCT00447993|565690903|FG000|Overall Study|Lost to Follow-up|0|||
156712304|NCT00447993|565690904|FG001|Overall Study|Lost to Follow-up|0|||
156712305|NCT00447993|565690905|FG002|Overall Study|Lost to Follow-up|2|||
156712306|NCT00447993|565690906|FG003|Overall Study|Lost to Follow-up|2|||
156792361|NCT00160563|565992747|FG002|Overall Study|Other (listed in the study report)|81|||
156792362|NCT00160563|565992745|FG000|Overall Study|Missing reason|0|||
156792363|NCT00160563|565992746|FG001|Overall Study|Missing reason|1|||
156792364|NCT00160563|565992747|FG002|Overall Study|Missing reason|0|||
156792365|NCT04157738|565992748|FG000|Overall Study|Moved out of state|0|||
156792366|NCT04157738|565992749|FG001|Overall Study|Moved out of state|2|||
157126889|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
157126890|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
157126891|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
157126892|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
157126893|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
157126894|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
157126895|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
157126896|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
156712307|NCT00447993|565690903|FG000|Overall Study|Withdrawal by Subject|0|||
156712308|NCT00447993|565690904|FG001|Overall Study|Withdrawal by Subject|0|||
156712309|NCT00447993|565690905|FG002|Overall Study|Withdrawal by Subject|2|||
156712310|NCT00447993|565690906|FG003|Overall Study|Withdrawal by Subject|2|||
156792367|NCT04157738|565992748|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
156792368|NCT04157738|565992749|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
156792369|NCT00395447|565992756|FG000|Overall Study|Death|37|||
156792370|NCT00395447|565992757|FG001|Overall Study|Death|32|||
156792371|NCT00395447|565992756|FG000|Overall Study|Lost to Follow-up|52|||
157016520|NCT00979576|566813140|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
157016521|NCT00979576|566813138|FG000|Combination Treatment Phase|Adverse Event|0|||
157016522|NCT00979576|566813139|FG001|Combination Treatment Phase|Adverse Event|2|||
157016523|NCT00979576|566813140|FG002|Combination Treatment Phase|Adverse Event|2|||
157016524|NCT00979576|566813138|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
157016525|NCT00979576|566813139|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
157016526|NCT00979576|566813140|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
157016527|NCT04855760|566813141|FG000|Overall Study|Adverse Event|21|||
157016528|NCT04855760|566813141|FG000|Overall Study|Withdrawal by Subject|116|||
157016529|NCT04855760|566813141|FG000|Overall Study|Lack of Efficacy|21|||
157016530|NCT04855760|566813141|FG000|Overall Study|Lost to Follow-up|49|||
157016531|NCT04855760|566813141|FG000|Overall Study|Protocol Violation|2|||
157016532|NCT04855760|566813141|FG000|Overall Study|Physician Decision|5|||
157216015|NCT00410410|567537427|FG003|Open-Label Period (OL)|Pregnancy|0|||
157216016|NCT00410410|567537428|FG004|Open-Label Period (OL)|Pregnancy|0|||
156712311|NCT02924727|565690907|FG000|Overall Study|Withdrawal by Subject|2|||
156712312|NCT02924727|565690908|FG001|Overall Study|Withdrawal by Subject|4|||
156712313|NCT02924727|565690907|FG000|Overall Study|Lost to Follow-up|2|||
156712314|NCT02924727|565690908|FG001|Overall Study|Lost to Follow-up|5|||
156712315|NCT02924727|565690907|FG000|Overall Study|Death|221|||
156712316|NCT02924727|565690908|FG001|Overall Study|Death|247|||
156712317|NCT02924727|565690907|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
156712318|NCT02924727|565690908|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
156712319|NCT03052127|565690909|FG000|Overall Study|Withdrawal by Subject|0|||
156712320|NCT03052127|565690910|FG001|Overall Study|Withdrawal by Subject|0|||
156712321|NCT03052127|565690911|FG002|Overall Study|Withdrawal by Subject|0|||
156712322|NCT03052127|565690912|FG003|Overall Study|Withdrawal by Subject|0|||
156712323|NCT03052127|565690913|FG004|Overall Study|Withdrawal by Subject|0|||
156712324|NCT03052127|565690914|FG005|Overall Study|Withdrawal by Subject|0|||
156712325|NCT03052127|565690915|FG006|Overall Study|Withdrawal by Subject|0|||
156712326|NCT03052127|565690916|FG007|Overall Study|Withdrawal by Subject|1|||
156712327|NCT03052127|565690917|FG008|Overall Study|Withdrawal by Subject|1|||
156712328|NCT03052127|565690918|FG009|Overall Study|Withdrawal by Subject|1|||
156712329|NCT03052127|565690919|FG010|Overall Study|Withdrawal by Subject|0|||
156712330|NCT03052127|565690920|FG011|Overall Study|Withdrawal by Subject|0|||
156712331|NCT03052127|565690909|FG000|Overall Study|Discontinuation by Sponsor|0|||
156712332|NCT03052127|565690910|FG001|Overall Study|Discontinuation by Sponsor|0|||
156712333|NCT03052127|565690911|FG002|Overall Study|Discontinuation by Sponsor|0|||
156712334|NCT03052127|565690912|FG003|Overall Study|Discontinuation by Sponsor|0|||
156712335|NCT03052127|565690913|FG004|Overall Study|Discontinuation by Sponsor|0|||
156712336|NCT03052127|565690914|FG005|Overall Study|Discontinuation by Sponsor|0|||
156712337|NCT03052127|565690915|FG006|Overall Study|Discontinuation by Sponsor|0|||
156712338|NCT03052127|565690916|FG007|Overall Study|Discontinuation by Sponsor|0|||
156712339|NCT03052127|565690917|FG008|Overall Study|Discontinuation by Sponsor|4|||
156712340|NCT03052127|565690918|FG009|Overall Study|Discontinuation by Sponsor|2|||
156712341|NCT03052127|565690919|FG010|Overall Study|Discontinuation by Sponsor|5|||
156712342|NCT03052127|565690920|FG011|Overall Study|Discontinuation by Sponsor|13|||
156712343|NCT03052127|565690909|FG000|Overall Study|Inability to comply with trial requirements|0|||
156712344|NCT03052127|565690910|FG001|Overall Study|Inability to comply with trial requirements|0|||
156712345|NCT03052127|565690911|FG002|Overall Study|Inability to comply with trial requirements|1|||
156712346|NCT03052127|565690912|FG003|Overall Study|Inability to comply with trial requirements|0|||
156712347|NCT03052127|565690913|FG004|Overall Study|Inability to comply with trial requirements|0|||
156712348|NCT03052127|565690914|FG005|Overall Study|Inability to comply with trial requirements|0|||
156712349|NCT03052127|565690915|FG006|Overall Study|Inability to comply with trial requirements|0|||
156712350|NCT03052127|565690916|FG007|Overall Study|Inability to comply with trial requirements|0|||
156712351|NCT03052127|565690917|FG008|Overall Study|Inability to comply with trial requirements|0|||
156712352|NCT03052127|565690918|FG009|Overall Study|Inability to comply with trial requirements|0|||
156712353|NCT03052127|565690919|FG010|Overall Study|Inability to comply with trial requirements|0|||
156712354|NCT03052127|565690920|FG011|Overall Study|Inability to comply with trial requirements|0|||
156712355|NCT03052127|565690909|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712356|NCT03052127|565690910|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712357|NCT03052127|565690911|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712358|NCT03052127|565690912|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712359|NCT03052127|565690913|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712360|NCT03052127|565690914|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712361|NCT03052127|565690915|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
156712362|NCT03052127|565690916|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712363|NCT03052127|565690917|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712364|NCT03052127|565690918|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712365|NCT03052127|565690919|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712366|NCT03052127|565690920|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
156712367|NCT03694327|565690921|FG000|Overall Study|Lost to Follow-up|13|||
156712368|NCT03694327|565690922|FG001|Overall Study|Lost to Follow-up|23|||
156712369|NCT01464931|565690925|FG000|Overall Study|Withdrawal by Subject|1|||
156712370|NCT01464931|565690926|FG001|Overall Study|Withdrawal by Subject|0|||
156712371|NCT01982812|565690927|FG000|Overall Study|Death|1|||
156712372|NCT01982812|565690928|FG001|Overall Study|Death|5|||
156712373|NCT01982812|565690927|FG000|Overall Study|Adverse Event|0|||
156712374|NCT01982812|565690928|FG001|Overall Study|Adverse Event|5|||
156712375|NCT00338728|565690930|FG000|Overall Study|Screen Failure|14|||
156712376|NCT04380961|565690933|FG000|Overall Study|Lost to Follow-up|17|||
156792372|NCT00395447|565992757|FG001|Overall Study|Lost to Follow-up|43|||
156792373|NCT00395447|565992756|FG000|Overall Study|Withdrawal by Subject|24|||
156792374|NCT00395447|565992757|FG001|Overall Study|Withdrawal by Subject|19|||
156712377|NCT04380961|565690934|FG001|Overall Study|Lost to Follow-up|11|||
156712378|NCT04380961|565690933|FG000|Overall Study|Withdrawal by Subject|3|||
156712379|NCT04380961|565690934|FG001|Overall Study|Withdrawal by Subject|0|||
156712380|NCT04380961|565690933|FG000|Overall Study|Death|22|||
156712381|NCT04380961|565690934|FG001|Overall Study|Death|16|||
156808764|NCT01408277|566054457|FG000|Overall Study|Lost to Follow-up|1|||
156712382|NCT04380961|565690933|FG000|Overall Study|Other|1|||
156712383|NCT04380961|565690934|FG001|Overall Study|Other|0|||
156712384|NCT04380961|565690933|FG000|Overall Study|Randomized but Not Treated|1|||
156712385|NCT04380961|565690934|FG001|Overall Study|Randomized but Not Treated|2|||
156712386|NCT01862484|565690935|FG000|Overall Study|Lack of Efficacy|1|||
156712387|NCT01862484|565690936|FG001|Overall Study|Lack of Efficacy|1|||
156712388|NCT01862484|565690935|FG000|Overall Study|Lost to Follow-up|1|||
156712389|NCT01862484|565690936|FG001|Overall Study|Lost to Follow-up|2|||
156712390|NCT01862484|565690935|FG000|Overall Study|Protocol Violation|0|||
156712391|NCT01862484|565690936|FG001|Overall Study|Protocol Violation|2|||
156712392|NCT01862484|565690935|FG000|Overall Study|Withdrawal by Subject|0|||
156712393|NCT01862484|565690936|FG001|Overall Study|Withdrawal by Subject|3|||
156712394|NCT00993421|565690937|FG000|Overall Study|Adverse Event|2|||
156712395|NCT00993421|565690938|FG001|Overall Study|Adverse Event|7|||
156712396|NCT00993421|565690939|FG002|Overall Study|Adverse Event|6|||
156712397|NCT00993421|565690940|FG003|Overall Study|Adverse Event|9|||
156712398|NCT00993421|565690941|FG004|Overall Study|Adverse Event|5|||
156712399|NCT00993421|565690942|FG005|Overall Study|Adverse Event|7|||
156712400|NCT00993421|565690943|FG006|Overall Study|Adverse Event|1|||
156712401|NCT00993421|565690937|FG000|Overall Study|Sponsor Decision|36|||
156712402|NCT00993421|565690938|FG001|Overall Study|Sponsor Decision|31|||
156712403|NCT00993421|565690939|FG002|Overall Study|Sponsor Decision|28|||
156712404|NCT00993421|565690940|FG003|Overall Study|Sponsor Decision|30|||
156712405|NCT00993421|565690941|FG004|Overall Study|Sponsor Decision|38|||
156712406|NCT00993421|565690942|FG005|Overall Study|Sponsor Decision|30|||
156712407|NCT00993421|565690943|FG006|Overall Study|Sponsor Decision|29|||
156712408|NCT00993421|565690937|FG000|Overall Study|Lost to Follow-up|3|||
156712409|NCT00993421|565690938|FG001|Overall Study|Lost to Follow-up|5|||
156712410|NCT00993421|565690939|FG002|Overall Study|Lost to Follow-up|5|||
156712411|NCT00993421|565690940|FG003|Overall Study|Lost to Follow-up|0|||
156712412|NCT00993421|565690941|FG004|Overall Study|Lost to Follow-up|0|||
156712413|NCT00993421|565690942|FG005|Overall Study|Lost to Follow-up|0|||
156712414|NCT00993421|565690943|FG006|Overall Study|Lost to Follow-up|6|||
156712415|NCT00993421|565690937|FG000|Overall Study|Withdrawal by Subject|3|||
156712416|NCT00993421|565690938|FG001|Overall Study|Withdrawal by Subject|2|||
156712417|NCT00993421|565690939|FG002|Overall Study|Withdrawal by Subject|3|||
156712418|NCT00993421|565690940|FG003|Overall Study|Withdrawal by Subject|3|||
156712419|NCT00993421|565690941|FG004|Overall Study|Withdrawal by Subject|3|||
156712420|NCT00993421|565690942|FG005|Overall Study|Withdrawal by Subject|5|||
156712421|NCT00993421|565690943|FG006|Overall Study|Withdrawal by Subject|3|||
156712422|NCT00993421|565690937|FG000|Overall Study|Death|0|||
156712423|NCT00993421|565690938|FG001|Overall Study|Death|0|||
156712424|NCT00993421|565690939|FG002|Overall Study|Death|0|||
156712425|NCT00993421|565690940|FG003|Overall Study|Death|0|||
156712426|NCT00993421|565690941|FG004|Overall Study|Death|0|||
156712427|NCT00993421|565690942|FG005|Overall Study|Death|0|||
156712428|NCT00993421|565690943|FG006|Overall Study|Death|1|||
156712429|NCT00993421|565690937|FG000|Overall Study|Entry Criteria Exclusion|0|||
156712430|NCT00993421|565690938|FG001|Overall Study|Entry Criteria Exclusion|0|||
156712431|NCT00993421|565690939|FG002|Overall Study|Entry Criteria Exclusion|1|||
156712432|NCT00993421|565690940|FG003|Overall Study|Entry Criteria Exclusion|3|||
156712433|NCT00993421|565690941|FG004|Overall Study|Entry Criteria Exclusion|0|||
156792375|NCT00395447|565992756|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
156792376|NCT00395447|565992757|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
156792377|NCT03766906|565992758|FG000|Overall Study|Withdrawal by Subject|6|||
156792378|NCT01437189|565992760|FG000|Overall Study|Adverse Event|3|||
156792379|NCT01437189|565992760|FG000|Overall Study|Lack of Efficacy|4|||
156792380|NCT01437189|565992760|FG000|Overall Study|Withdrawal by Subject|8|||
156712434|NCT00993421|565690942|FG005|Overall Study|Entry Criteria Exclusion|1|||
156712435|NCT00993421|565690943|FG006|Overall Study|Entry Criteria Exclusion|0|||
156792381|NCT03032484|565992761|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
156712436|NCT00993421|565690937|FG000|Overall Study|Physician Decision|0|||
156712437|NCT00993421|565690938|FG001|Overall Study|Physician Decision|0|||
156712438|NCT00993421|565690939|FG002|Overall Study|Physician Decision|0|||
156792382|NCT03032484|565992762|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
156792383|NCT03032484|565992761|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
156808765|NCT01408277|566054458|FG001|Overall Study|Lost to Follow-up|0|||
156712439|NCT00993421|565690940|FG003|Overall Study|Physician Decision|0|||
156712440|NCT00993421|565690941|FG004|Overall Study|Physician Decision|0|||
156712441|NCT00993421|565690942|FG005|Overall Study|Physician Decision|1|||
156712442|NCT00993421|565690943|FG006|Overall Study|Physician Decision|1|||
156712443|NCT00993421|565690937|FG000|Overall Study|Protocol Violation|0|||
156712444|NCT00993421|565690938|FG001|Overall Study|Protocol Violation|0|||
156712445|NCT00993421|565690939|FG002|Overall Study|Protocol Violation|0|||
156808766|NCT01408277|566054457|FG000|Overall Study|Withdrawal by Subject|2|||
156808767|NCT01408277|566054458|FG001|Overall Study|Withdrawal by Subject|0|||
156808768|NCT01408277|566054457|FG000|Overall Study|Protocol Violation|2|||
156808769|NCT01408277|566054458|FG001|Overall Study|Protocol Violation|0|||
156808770|NCT03801928|566054459|FG000|Overall Study|Adverse Event|1|||
157216017|NCT00410410|567537429|FG005|Open-Label Period (OL)|Pregnancy|0|||
157216018|NCT00410410|567537430|FG006|Open-Label Period (OL)|Pregnancy|0|||
157216019|NCT00410410|567537431|FG007|Open-Label Period (OL)|Pregnancy|0|||
157216020|NCT00410410|567537432|FG008|Open-Label Period (OL)|Pregnancy|1|||
157216021|NCT00410410|567537424|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216022|NCT00410410|567537425|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216023|NCT00410410|567537426|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216024|NCT00410410|567537427|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216025|NCT00410410|567537428|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216026|NCT00410410|567537429|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216027|NCT00410410|567537430|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216028|NCT00410410|567537431|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
157216029|NCT00410410|567537432|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
157216030|NCT00410410|567537424|FG000|Open-Label Period (OL)|Other|0|||
157216031|NCT00410410|567537425|FG001|Open-Label Period (OL)|Other|0|||
157216032|NCT00410410|567537426|FG002|Open-Label Period (OL)|Other|0|||
157216033|NCT00410410|567537427|FG003|Open-Label Period (OL)|Other|0|||
157216034|NCT00410410|567537428|FG004|Open-Label Period (OL)|Other|0|||
157216035|NCT00410410|567537429|FG005|Open-Label Period (OL)|Other|0|||
157216036|NCT00410410|567537430|FG006|Open-Label Period (OL)|Other|0|||
157216037|NCT00410410|567537431|FG007|Open-Label Period (OL)|Other|0|||
157216038|NCT00410410|567537432|FG008|Open-Label Period (OL)|Other|7|||
157216039|NCT01783496|567537433|FG000|Overall Study|Lost to Follow-up|0|||
157216040|NCT01783496|567537434|FG001|Overall Study|Lost to Follow-up|0|||
157216041|NCT01783496|567537435|FG002|Overall Study|Lost to Follow-up|0|||
157216042|NCT01783496|567537436|FG003|Overall Study|Lost to Follow-up|2|||
157216043|NCT01783496|567537437|FG004|Overall Study|Lost to Follow-up|0|||
157216044|NCT01783496|567537438|FG005|Overall Study|Lost to Follow-up|1|||
157216045|NCT01783496|567537433|FG000|Overall Study|Withdrawal by Subject|1|||
157216046|NCT01783496|567537434|FG001|Overall Study|Withdrawal by Subject|0|||
157216047|NCT01783496|567537435|FG002|Overall Study|Withdrawal by Subject|0|||
157216048|NCT01783496|567537436|FG003|Overall Study|Withdrawal by Subject|0|||
157216049|NCT01783496|567537437|FG004|Overall Study|Withdrawal by Subject|0|||
157216050|NCT01783496|567537438|FG005|Overall Study|Withdrawal by Subject|0|||
157216051|NCT01953783|567537439|FG000|Overall Study|Progressive disease|2|||
157216052|NCT01789281|567537440|FG000|Overall Study|Disease progression|15|||
157216053|NCT01789281|567537441|FG001|Overall Study|Disease progression|4|||
157216054|NCT01789281|567537440|FG000|Overall Study|Adverse Event|5|||
157216055|NCT01789281|567537441|FG001|Overall Study|Adverse Event|5|||
157216056|NCT01789281|567537440|FG000|Overall Study|Withdrawal by Subject|1|||
156712446|NCT00993421|565690940|FG003|Overall Study|Protocol Violation|0|||
156712447|NCT00993421|565690941|FG004|Overall Study|Protocol Violation|0|||
156712448|NCT00993421|565690942|FG005|Overall Study|Protocol Violation|2|||
156712449|NCT00993421|565690943|FG006|Overall Study|Protocol Violation|1|||
156712450|NCT02447744|565690945|FG000|Overall Study|Withdrawal by Subject|3|||
156712451|NCT02447744|565690946|FG001|Overall Study|Withdrawal by Subject|1|||
156712452|NCT02447744|565690945|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
156712453|NCT02447744|565690946|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
156712454|NCT00912912|565690947|FG000|Overall Study|Withdrawal by Subject|1|||
156712455|NCT00912912|565690947|FG000|Overall Study|Disease Progression|3|||
156712456|NCT00306995|565690948|FG000|Study Part I|Withdrawal by Subject|0|||
156712457|NCT00306995|565690949|FG001|Study Part I|Withdrawal by Subject|0|||
156712458|NCT00306995|565690950|FG002|Study Part I|Withdrawal by Subject|0|||
156712459|NCT00306995|565690951|FG003|Study Part I|Withdrawal by Subject|0|||
156712460|NCT00306995|565690952|FG004|Study Part I|Withdrawal by Subject|0|||
156712461|NCT00306995|565690953|FG005|Study Part I|Withdrawal by Subject|0|||
156712462|NCT00306995|565690954|FG006|Study Part I|Withdrawal by Subject|1|||
156712463|NCT00306995|565690948|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
156712464|NCT00306995|565690949|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
156712465|NCT00306995|565690950|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
156712466|NCT00306995|565690951|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
156712467|NCT00306995|565690952|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
156712468|NCT00306995|565690953|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
156712469|NCT00306995|565690954|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
156712470|NCT05422625|565690955|FG000|Overall Study|Withdrawal by Subject|1|||
156712471|NCT05422625|565690956|FG001|Overall Study|Withdrawal by Subject|0|||
156712472|NCT01769456|565692729|FG000|Overall Study|Lost to Follow-up|19|||
156712473|NCT01769456|565692729|FG000|Overall Study|Withdrawal by Subject|3|||
156712474|NCT01769456|565692729|FG000|Overall Study|Did not receive PCC intervention|6|||
156712475|NCT01769456|565692729|FG000|Overall Study|Moved out of the area|3|||
157216057|NCT01789281|567537441|FG001|Overall Study|Withdrawal by Subject|0|||
157216058|NCT01789281|567537440|FG000|Overall Study|Lost to Follow-up|1|||
157216059|NCT01789281|567537441|FG001|Overall Study|Lost to Follow-up|0|||
157216060|NCT01789281|567537440|FG000|Overall Study|Administrative problems|0|||
157216061|NCT01789281|567537441|FG001|Overall Study|Administrative problems|1|||
156873956|NCT01047553|566296166|FG000|Overall Study|Withdrawal by Subject|4|||
156712476|NCT01769456|565692729|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
156712477|NCT01769456|565692729|FG000|Overall Study|Parental request to youth to withdraw|1|||
156712478|NCT05377749|565692732|FG000|3 Weeks|Lost to Follow-up|2|||
156712479|NCT05377749|565692733|FG001|3 Weeks|Lost to Follow-up|4|||
156712480|NCT05377749|565692732|FG000|3 Weeks|Withdrawal by Subject|1|||
156712481|NCT05377749|565692733|FG001|3 Weeks|Withdrawal by Subject|1|||
156712482|NCT02969382|565692734|FG000|Overall Study|Adverse Event|8|||
156712483|NCT02969382|565692735|FG001|Overall Study|Adverse Event|10|||
156712484|NCT02969382|565692734|FG000|Overall Study|Lack of Efficacy|4|||
156712485|NCT02969382|565692735|FG001|Overall Study|Lack of Efficacy|5|||
156712486|NCT02969382|565692734|FG000|Overall Study|Death|0|||
156712487|NCT02969382|565692735|FG001|Overall Study|Death|1|||
156712488|NCT02969382|565692734|FG000|Overall Study|PROTOCOL DEVIATION|0|||
156712489|NCT02969382|565692735|FG001|Overall Study|PROTOCOL DEVIATION|1|||
156712490|NCT02969382|565692734|FG000|Overall Study|Withdrawal by Subject|14|||
156712491|NCT02969382|565692735|FG001|Overall Study|Withdrawal by Subject|9|||
156712492|NCT02090725|565692736|FG000|Overall Study|Withdrawal by Subject|1|||
156712493|NCT02090725|565692736|FG000|Overall Study|participants moved from area|3|||
156712494|NCT00403585|565692741|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
156712495|NCT00403585|565692741|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
156712496|NCT00403585|565692741|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
156712497|NCT03685344|565692746|FG000|Overall Study|Withdrawal by Subject|1|||
156712498|NCT03685344|565692747|FG001|Overall Study|Withdrawal by Subject|1|||
156712499|NCT03685344|565692748|FG002|Overall Study|Withdrawal by Subject|2|||
156712500|NCT03685344|565692749|FG003|Overall Study|Withdrawal by Subject|0|||
156712501|NCT03685344|565692746|FG000|Overall Study|Physician Decision|1|||
156712502|NCT03685344|565692747|FG001|Overall Study|Physician Decision|1|||
156712503|NCT03685344|565692748|FG002|Overall Study|Physician Decision|5|||
156712504|NCT03685344|565692749|FG003|Overall Study|Physician Decision|0|||
156712505|NCT03685344|565692746|FG000|Overall Study|Death|1|||
156712506|NCT03685344|565692747|FG001|Overall Study|Death|1|||
156712507|NCT03685344|565692748|FG002|Overall Study|Death|0|||
156712508|NCT03685344|565692749|FG003|Overall Study|Death|0|||
156712509|NCT02121652|565692752|FG000|Overall Study|Lost to Follow-up|2|||
156712510|NCT02121652|565692753|FG001|Overall Study|Lost to Follow-up|1|||
156712511|NCT02121652|565692752|FG000|Overall Study|Death|1|||
156712512|NCT02121652|565692753|FG001|Overall Study|Death|0|||
156712513|NCT02121652|565692752|FG000|Overall Study|Withdrawal by Subject|3|||
156712514|NCT02121652|565692753|FG001|Overall Study|Withdrawal by Subject|3|||
156712515|NCT00799058|565692757|FG000|Overall Study|Withdrawal by Subject|2|||
156712516|NCT00799058|565692758|FG001|Overall Study|Withdrawal by Subject|2|||
156712517|NCT00799058|565692759|FG002|Overall Study|Withdrawal by Subject|2|||
156712518|NCT00799058|565692757|FG000|Overall Study|Lost to Follow-up|1|||
156712519|NCT00799058|565692758|FG001|Overall Study|Lost to Follow-up|2|||
156712520|NCT00799058|565692759|FG002|Overall Study|Lost to Follow-up|1|||
156712521|NCT00799058|565692757|FG000|Overall Study|Adverse Event|0|||
156712522|NCT00799058|565692758|FG001|Overall Study|Adverse Event|2|||
156712523|NCT00799058|565692759|FG002|Overall Study|Adverse Event|0|||
156712524|NCT00799058|565692757|FG000|Overall Study|Pregnancy|1|||
156712525|NCT00799058|565692758|FG001|Overall Study|Pregnancy|0|||
156712526|NCT00799058|565692759|FG002|Overall Study|Pregnancy|0|||
156712527|NCT00799058|565692757|FG000|Overall Study|Not adherent|3|||
157126897|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
156712528|NCT00799058|565692758|FG001|Overall Study|Not adherent|2|||
156712529|NCT00799058|565692759|FG002|Overall Study|Not adherent|1|||
157126898|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
157126899|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
157126900|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
156712530|NCT00799058|565692757|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
156712531|NCT00799058|565692758|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
156712532|NCT00799058|565692759|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
157126901|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
156712533|NCT00799058|565692757|FG000|Overall Study|IP dispensing error|1|||
156712534|NCT00799058|565692758|FG001|Overall Study|IP dispensing error|0|||
156712535|NCT00799058|565692759|FG002|Overall Study|IP dispensing error|0|||
156712536|NCT00799058|565692757|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
156712537|NCT00799058|565692758|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
156712538|NCT00799058|565692759|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
156712539|NCT00799058|565692757|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
156712540|NCT00799058|565692758|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
156712541|NCT00799058|565692759|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
156712542|NCT00799058|565692757|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
156873957|NCT01047553|566296167|FG001|Overall Study|Withdrawal by Subject|2|||
156792384|NCT03032484|565992762|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
157126902|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
157126903|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
157126904|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
157126905|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
157126906|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
157126907|NCT04660643|567215733|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
157126908|NCT04660643|567215734|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
157126909|NCT04660643|567215735|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
157126910|NCT05162066|567215739|FG000|Overall Study|Adverse Event|1|||
157126911|NCT05162066|567215740|FG001|Overall Study|Adverse Event|0|||
157126912|NCT05162066|567215741|FG002|Overall Study|Adverse Event|0|||
157126913|NCT05162066|567215739|FG000|Overall Study|Perceived lack of efficacy|1|||
157126914|NCT05162066|567215740|FG001|Overall Study|Perceived lack of efficacy|0|||
157126915|NCT05162066|567215741|FG002|Overall Study|Perceived lack of efficacy|0|||
157126916|NCT00568555|567215742|FG000|Overall Study|Withdrawal by Subject|1|||
157126917|NCT00568555|567215743|FG001|Overall Study|Withdrawal by Subject|1|||
157126918|NCT01231555|567215744|FG000|Overall Study|Study terminated|8|||
157126919|NCT01231555|567215745|FG001|Overall Study|Study terminated|5|||
157126920|NCT01231555|567215746|FG002|Overall Study|Study terminated|8|||
157126921|NCT01231555|567215744|FG000|Overall Study|Withdrawal by Subject|0|||
157126922|NCT01231555|567215745|FG001|Overall Study|Withdrawal by Subject|2|||
157126923|NCT01231555|567215746|FG002|Overall Study|Withdrawal by Subject|0|||
157126924|NCT01220414|567215747|FG000|Overall Study|Withdrawal by Subject|1|||
157126925|NCT01220414|567215748|FG001|Overall Study|Withdrawal by Subject|0|||
157126926|NCT01220414|567215749|FG002|Overall Study|Withdrawal by Subject|0|||
157126927|NCT01220414|567215750|FG003|Overall Study|Withdrawal by Subject|1|||
157126928|NCT00669617|567215753|FG000|Period 1|Withdrawal by Subject|0|||
157126929|NCT00669617|567215754|FG001|Period 1|Withdrawal by Subject|0|||
157126930|NCT00669617|567215755|FG002|Period 1|Withdrawal by Subject|1|||
157126931|NCT00669617|567215756|FG003|Period 1|Withdrawal by Subject|0|||
157126932|NCT00669617|567215757|FG004|Period 1|Withdrawal by Subject|0|||
157126933|NCT00669617|567215753|FG000|Period 1|Protocol Deviation|0|||
157126934|NCT00669617|567215754|FG001|Period 1|Protocol Deviation|0|||
157126935|NCT00669617|567215755|FG002|Period 1|Protocol Deviation|0|||
157126936|NCT00669617|567215756|FG003|Period 1|Protocol Deviation|0|||
157126937|NCT00669617|567215757|FG004|Period 1|Protocol Deviation|1|||
157126938|NCT00669617|567215753|FG000|Period 3|Lost to Follow-up|1|||
157126939|NCT00669617|567215754|FG001|Period 3|Lost to Follow-up|0|||
157126940|NCT00669617|567215755|FG002|Period 3|Lost to Follow-up|0|||
157126941|NCT00669617|567215756|FG003|Period 3|Lost to Follow-up|0|||
157126942|NCT00669617|567215757|FG004|Period 3|Lost to Follow-up|0|||
157126943|NCT00623831|567215758|FG000|Overall Study|Withdrawal by Subject|1|||
157126944|NCT00623831|567215759|FG001|Overall Study|Withdrawal by Subject|0|||
157126945|NCT00623831|567215758|FG000|Overall Study|Progressive Disease|0|||
157126946|NCT00623831|567215759|FG001|Overall Study|Progressive Disease|1|||
157126947|NCT01276821|567215760|FG000|Overall Study|Protocol Violation|0|||
157126948|NCT01276821|567215761|FG001|Overall Study|Protocol Violation|1|||
157126949|NCT01748071|567215762|FG000|Overall Study|Adverse Event|2|||
157126950|NCT01748071|567215763|FG001|Overall Study|Adverse Event|2|||
157126951|NCT01748071|567215764|FG002|Overall Study|Adverse Event|0|||
157126952|NCT03068325|567215765|FG000|Overall Study|Lost to Follow-up|5|||
157126953|NCT00066690|567215768|FG000|Overall Study|Adverse Event|145|||
157126954|NCT00066690|567215769|FG001|Overall Study|Adverse Event|58|||
157126955|NCT00066690|567215770|FG002|Overall Study|Adverse Event|126|||
157126956|NCT00066690|567215768|FG000|Overall Study|Death|3|||
157126957|NCT00066690|567215769|FG001|Overall Study|Death|0|||
157126958|NCT00066690|567215770|FG002|Overall Study|Death|2|||
156792385|NCT01689649|565992763|FG000|Overall Study|Lack of Efficacy|3|||
156792386|NCT01689649|565992763|FG000|Overall Study|Non-compliance|11|||
156792387|NCT01689649|565992763|FG000|Overall Study|Protocol Violation|3|||
156792388|NCT01689649|565992763|FG000|Overall Study|Lost to Follow-up|5|||
156792389|NCT01725282|565992766|FG000|Overall Study|Adverse Event|1|||
156792390|NCT01725282|565992767|FG001|Overall Study|Adverse Event|3|||
157126959|NCT00066690|567215768|FG000|Overall Study|Lack of Efficacy|114|||
157126960|NCT00066690|567215769|FG001|Overall Study|Lack of Efficacy|110|||
157126961|NCT00066690|567215770|FG002|Overall Study|Lack of Efficacy|76|||
157126962|NCT00066690|567215768|FG000|Overall Study|Lost to Follow-up|40|||
157126963|NCT00066690|567215769|FG001|Overall Study|Lost to Follow-up|21|||
157126964|NCT00066690|567215770|FG002|Overall Study|Lost to Follow-up|29|||
157126965|NCT00066690|567215768|FG000|Overall Study|Withdrawal by Subject|50|||
157126966|NCT00066690|567215769|FG001|Overall Study|Withdrawal by Subject|55|||
157126967|NCT00066690|567215770|FG002|Overall Study|Withdrawal by Subject|49|||
157126968|NCT00066690|567215768|FG000|Overall Study|Treatment Ongoing|246|||
156792391|NCT01725282|565992768|FG002|Overall Study|Adverse Event|6|||
156792392|NCT01725282|565992769|FG003|Overall Study|Adverse Event|4|||
156792393|NCT01725282|565992766|FG000|Overall Study|Exacerbation of Target Disease|1|||
156792394|NCT01725282|565992767|FG001|Overall Study|Exacerbation of Target Disease|0|||
156792395|NCT01725282|565992768|FG002|Overall Study|Exacerbation of Target Disease|0|||
156792396|NCT01725282|565992769|FG003|Overall Study|Exacerbation of Target Disease|1|||
156792397|NCT01725282|565992766|FG000|Overall Study|Met Exclusion Criteria|0|||
156792398|NCT01725282|565992767|FG001|Overall Study|Met Exclusion Criteria|0|||
156792399|NCT01725282|565992768|FG002|Overall Study|Met Exclusion Criteria|1|||
157126969|NCT00066690|567215769|FG001|Overall Study|Treatment Ongoing|278|||
157126970|NCT00066690|567215770|FG002|Overall Study|Treatment Ongoing|282|||
157126971|NCT00223496|567215771|FG000|Overall Study|screen failure|9|||
156712543|NCT00799058|565692758|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
156712544|NCT00799058|565692759|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
156712545|NCT00799058|565692757|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
156712546|NCT00799058|565692758|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
156712547|NCT00799058|565692759|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
156712548|NCT02088697|565692764|FG000|Period I|Physician Decision|1|||
156712549|NCT02088697|565692765|FG001|Period I|Physician Decision|4|||
156712550|NCT02088697|565692764|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
156712551|NCT02088697|565692765|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
156712552|NCT00247676|565692766|FG000|Overall Study|Death|5|||
156712553|NCT00247676|565692766|FG000|Overall Study|Adverse Event|11|||
156712554|NCT00247676|565692766|FG000|Overall Study|Lack of Efficacy|15|||
156712555|NCT00247676|565692766|FG000|Overall Study|Other|3|||
156712556|NCT00247676|565692766|FG000|Overall Study|Withdrawal by Subject|2|||
156712557|NCT03594071|565692767|FG000|Overall Study|Re-operation|3|||
156712558|NCT03594071|565692767|FG000|Overall Study|Missed visit|2|||
156712559|NCT02287922|565692768|FG000|Overall Study|Adverse Event|1|||
156712560|NCT02287922|565692769|FG001|Overall Study|Adverse Event|1|||
156712561|NCT02287922|565692770|FG002|Overall Study|Adverse Event|3|||
156712562|NCT02287922|565692771|FG003|Overall Study|Adverse Event|4|||
156712563|NCT02287922|565692768|FG000|Overall Study|Withdrawal by Subject|1|||
156712564|NCT02287922|565692769|FG001|Overall Study|Withdrawal by Subject|1|||
156712565|NCT02287922|565692770|FG002|Overall Study|Withdrawal by Subject|1|||
156712566|NCT02287922|565692771|FG003|Overall Study|Withdrawal by Subject|2|||
156712567|NCT02287922|565692768|FG000|Overall Study|Lost to Follow-up|0|||
156712568|NCT02287922|565692769|FG001|Overall Study|Lost to Follow-up|0|||
156712569|NCT02287922|565692770|FG002|Overall Study|Lost to Follow-up|1|||
156712570|NCT02287922|565692771|FG003|Overall Study|Lost to Follow-up|0|||
156712571|NCT02287922|565692768|FG000|Overall Study|Sponsor's decision|0|||
156712572|NCT02287922|565692769|FG001|Overall Study|Sponsor's decision|0|||
156712573|NCT02287922|565692770|FG002|Overall Study|Sponsor's decision|0|||
156712574|NCT02287922|565692771|FG003|Overall Study|Sponsor's decision|1|||
156712575|NCT02287922|565692768|FG000|Overall Study|Other|1|||
156712576|NCT02287922|565692769|FG001|Overall Study|Other|0|||
156712577|NCT02287922|565692770|FG002|Overall Study|Other|2|||
156712578|NCT02287922|565692771|FG003|Overall Study|Other|0|||
156712579|NCT03022370|565692772|FG000|Overall Study|Death|6|||
156712580|NCT03022370|565692773|FG001|Overall Study|Death|12|||
156712581|NCT03022370|565692772|FG000|Overall Study|Lost to Follow-up|174|||
156712582|NCT03022370|565692773|FG001|Overall Study|Lost to Follow-up|109|||
156792400|NCT01725282|565992769|FG003|Overall Study|Met Exclusion Criteria|0|||
156792401|NCT01725282|565992766|FG000|Overall Study|Study Site Withdrawal|0|||
156792402|NCT01725282|565992767|FG001|Overall Study|Study Site Withdrawal|1|||
157126972|NCT00223496|567215771|FG000|Overall Study|Lost to Follow-up|4|||
157126973|NCT00223496|567215771|FG000|Overall Study|Lack of Efficacy|6|||
157126974|NCT00223496|567215771|FG000|Overall Study|Withdrawal by Subject|1|||
157126975|NCT00223496|567215771|FG000|Overall Study|Physician Decision|2|||
157216062|NCT03712228|567537442|FG000|Treatment Period 1|Lack of Efficacy|0|||
156712583|NCT00668317|565692774|FG000|Overall Study|Adverse Event|2|||
156712584|NCT03668808|565692778|FG000|First Intervention|Withdrawal by Subject|2|||
156712585|NCT03668808|565692779|FG001|First Intervention|Withdrawal by Subject|2|||
156712586|NCT01526655|565692782|FG000|Overall Study|Withdrawal by Subject|0|||
156712587|NCT01526655|565692783|FG001|Overall Study|Withdrawal by Subject|1|||
156712588|NCT00280735|565692784|FG000|Overall Study|Adverse Event|5|||
156712589|NCT00280735|565692784|FG000|Overall Study|Lack of Efficacy|3|||
156712590|NCT00280735|565692784|FG000|Overall Study|Withdrawal by Subject|8|||
156792403|NCT01725282|565992768|FG002|Overall Study|Study Site Withdrawal|0|||
156873958|NCT01047553|566296166|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
157126976|NCT02939131|567215774|FG000|Overall Study|Unable to get to clinic|6|||
157126977|NCT02939131|567215775|FG001|Overall Study|Unable to get to clinic|4|||
156712591|NCT00280735|565692784|FG000|Overall Study|Intercurrent Illness|2|||
156712592|NCT04753216|565692785|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
156712593|NCT04753216|565692785|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
156712594|NCT04753216|565692785|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
156792404|NCT01725282|565992769|FG003|Overall Study|Study Site Withdrawal|0|||
157126978|NCT02939131|567215774|FG000|Overall Study|Lost to Follow-up|2|||
156712595|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
156712596|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Death|1|||
156712597|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
156712598|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
156712599|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
156712600|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
156873959|NCT01047553|566296167|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
156873960|NCT01047553|566296166|FG000|Overall Study|Lost to Follow-up|1|||
156873961|NCT01047553|566296167|FG001|Overall Study|Lost to Follow-up|0|||
156873962|NCT01047553|566296166|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
156873963|NCT01047553|566296167|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
156873964|NCT01047553|566296166|FG000|Overall Study|PI's decision|0|||
156873965|NCT01047553|566296167|FG001|Overall Study|PI's decision|1|||
157126979|NCT02939131|567215775|FG001|Overall Study|Lost to Follow-up|4|||
157126980|NCT02939131|567215774|FG000|Overall Study|severe debilitation|1|||
156712601|NCT02001987|565692787|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
156712602|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
156712603|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
156712604|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
156712605|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
156712606|NCT02001987|565692787|FG000|LTE Period (52 Weeks)|Other|3|||
156712607|NCT01965860|565692788|FG000|Overall Study|Pregnancy|1|||
156712608|NCT01965860|565692789|FG001|Overall Study|Pregnancy|0|||
156712609|NCT01965860|565692790|FG002|Overall Study|Pregnancy|1|||
156712610|NCT01965860|565692788|FG000|Overall Study|Logistics|1|||
156712611|NCT01965860|565692789|FG001|Overall Study|Logistics|0|||
156712612|NCT01965860|565692790|FG002|Overall Study|Logistics|0|||
156712613|NCT02064296|565692794|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
156712614|NCT02064296|565692795|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
156712615|NCT02064296|565692796|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
156792405|NCT01725282|565992766|FG000|Overall Study|Withdrawal by Subject|0|||
157126981|NCT02939131|567215775|FG001|Overall Study|severe debilitation|0|||
157126982|NCT02939131|567215774|FG000|Overall Study|Other|0|||
156792406|NCT01725282|565992767|FG001|Overall Study|Withdrawal by Subject|0|||
156792407|NCT01725282|565992768|FG002|Overall Study|Withdrawal by Subject|1|||
156792408|NCT01725282|565992769|FG003|Overall Study|Withdrawal by Subject|1|||
156792409|NCT01725282|565992766|FG000|Overall Study|Lack of Efficacy|0|||
156792410|NCT01725282|565992767|FG001|Overall Study|Lack of Efficacy|1|||
156792411|NCT01725282|565992768|FG002|Overall Study|Lack of Efficacy|0|||
156792412|NCT01725282|565992769|FG003|Overall Study|Lack of Efficacy|1|||
156792413|NCT01646216|565992777|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
156792414|NCT01646216|565992778|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
156792415|NCT01646216|565992777|FG000|Overall Study|Did not complete training|0|||
156792416|NCT01646216|565992778|FG001|Overall Study|Did not complete training|2|||
156792417|NCT01646216|565992777|FG000|Overall Study|Investigator decision|1|||
156792418|NCT01646216|565992778|FG001|Overall Study|Investigator decision|1|||
156792419|NCT00113373|565992779|FG000|Overall Study|Ineligible: wrong primary|1|||
156792420|NCT00113373|565992779|FG000|Overall Study|Ineligible: second primary|1|||
156792421|NCT00113373|565992779|FG000|Overall Study|Never Treated|1|||
156792422|NCT02395627|565992780|FG000|Overall Study|Withdrawal by Subject|0|||
156792423|NCT02395627|565992781|FG001|Overall Study|Withdrawal by Subject|2|||
156873966|NCT02817464|566296173|FG000|Overall Study|Lost to Follow-up|1|||
156873967|NCT02817464|566296174|FG001|Overall Study|Lost to Follow-up|0|||
156873968|NCT02817464|566296173|FG000|Overall Study|Discontinued early due to personal decision|1|||
156873969|NCT02817464|566296174|FG001|Overall Study|Discontinued early due to personal decision|1|||
157126983|NCT02939131|567215775|FG001|Overall Study|Other|1|||
157126984|NCT02939131|567215774|FG000|Overall Study|not willing to adhere to protocol|2|||
157126985|NCT02939131|567215775|FG001|Overall Study|not willing to adhere to protocol|0|||
157126986|NCT03569202|567215779|FG000|Part 3|Physician Decision|1|||
157126987|NCT03569202|567215780|FG001|Part 3|Physician Decision|0|||
157126988|NCT03569202|567215779|FG000|Part 3|Other|1|||
156712616|NCT02064296|565692794|FG000|Intervention|Withdrawal by Subject|0|||
156712617|NCT02064296|565692795|FG001|Intervention|Withdrawal by Subject|1|||
156792424|NCT02395627|565992782|FG002|Overall Study|Withdrawal by Subject|0|||
156792425|NCT02395627|565992780|FG000|Overall Study|Did not receive pembrolizumab|3|||
156792426|NCT02395627|565992781|FG001|Overall Study|Did not receive pembrolizumab|1|||
156792427|NCT02395627|565992782|FG002|Overall Study|Did not receive pembrolizumab|0|||
157126989|NCT03569202|567215780|FG001|Part 3|Other|1|||
156712618|NCT02064296|565692796|FG002|Intervention|Withdrawal by Subject|2|||
156712619|NCT00666328|565692810|FG000|Overall Study|Death|2|||
156712620|NCT00666328|565692810|FG000|Overall Study|Lost to Follow-up|2|||
156792428|NCT02757963|565992785|FG000|Overall Study|Adverse Event|3|||
156792429|NCT02757963|565992785|FG000|Overall Study|Reached Stopping Criteria|1054|||
156792430|NCT02757963|565992785|FG000|Overall Study|Lost to Follow-up|5|||
156873970|NCT01273519|566296176|FG000|Overall Study|Adverse Event|3|||
157126990|NCT00420511|567215781|FG000|Overall Study|Adverse Event|1|||
157126991|NCT00420511|567215782|FG001|Overall Study|Adverse Event|1|||
157126992|NCT00420511|567215781|FG000|Overall Study|Lost to Follow-up|1|||
157126993|NCT00420511|567215782|FG001|Overall Study|Lost to Follow-up|0|||
157126994|NCT02415712|567215783|FG000|Overall Study|Protocol Violation|16|||
157126995|NCT04428411|567215787|FG000|Overall Study|Lost to Follow-up|114|||
157126996|NCT00634569|567215788|FG000|Overall Study|Withdrawal by Subject|0|||
157126997|NCT00634569|567215789|FG001|Overall Study|Withdrawal by Subject|4|||
156712621|NCT00666328|565692810|FG000|Overall Study|No longer met eligibility criteria|1|||
156712622|NCT02288325|565692811|FG000|Run-in Period|Adverse Event|48|||
156712623|NCT02288325|565692812|FG001|Run-in Period|Adverse Event|0|||
156712624|NCT02288325|565692813|FG002|Run-in Period|Adverse Event|0|||
156712625|NCT02288325|565692811|FG000|Run-in Period|Lack of Efficacy|16|||
156712626|NCT02288325|565692812|FG001|Run-in Period|Lack of Efficacy|0|||
156712627|NCT02288325|565692813|FG002|Run-in Period|Lack of Efficacy|0|||
156712628|NCT02288325|565692811|FG000|Run-in Period|Withdrawal of Consent|28|||
156712629|NCT02288325|565692812|FG001|Run-in Period|Withdrawal of Consent|0|||
156712630|NCT02288325|565692813|FG002|Run-in Period|Withdrawal of Consent|0|||
156712631|NCT02288325|565692811|FG000|Run-in Period|Lost to Follow-up|25|||
156712632|NCT02288325|565692812|FG001|Run-in Period|Lost to Follow-up|0|||
156712633|NCT02288325|565692813|FG002|Run-in Period|Lost to Follow-up|0|||
156712634|NCT02288325|565692811|FG000|Run-in Period|Protocol Violation|17|||
156712635|NCT02288325|565692812|FG001|Run-in Period|Protocol Violation|0|||
156712636|NCT02288325|565692813|FG002|Run-in Period|Protocol Violation|0|||
156712637|NCT02288325|565692811|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
156712638|NCT02288325|565692812|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
156712639|NCT02288325|565692813|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
156712640|NCT02288325|565692811|FG000|Run-in Period|Reason not Specified|8|||
156712641|NCT02288325|565692812|FG001|Run-in Period|Reason not Specified|0|||
156712642|NCT02288325|565692813|FG002|Run-in Period|Reason not Specified|0|||
156712643|NCT02288325|565692811|FG000|Stabilization Period|Adverse Event|13|||
156712644|NCT02288325|565692812|FG001|Stabilization Period|Adverse Event|0|||
156712645|NCT02288325|565692813|FG002|Stabilization Period|Adverse Event|0|||
156712646|NCT02288325|565692811|FG000|Stabilization Period|Lack of Efficacy|22|||
156712647|NCT02288325|565692812|FG001|Stabilization Period|Lack of Efficacy|0|||
156712648|NCT02288325|565692813|FG002|Stabilization Period|Lack of Efficacy|0|||
156712649|NCT02288325|565692811|FG000|Stabilization Period|Withdrawal of Consent|23|||
156712650|NCT02288325|565692812|FG001|Stabilization Period|Withdrawal of Consent|0|||
156712651|NCT02288325|565692813|FG002|Stabilization Period|Withdrawal of Consent|0|||
156712652|NCT02288325|565692811|FG000|Stabilization Period|Lost to Follow-up|12|||
156712653|NCT02288325|565692812|FG001|Stabilization Period|Lost to Follow-up|0|||
156712654|NCT02288325|565692813|FG002|Stabilization Period|Lost to Follow-up|0|||
157126998|NCT00634569|567215788|FG000|Overall Study|Physician Decision|0|||
157126999|NCT00634569|567215789|FG001|Overall Study|Physician Decision|1|||
157127000|NCT02918019|567215790|FG000|Overall Study|Death|0|||
157127001|NCT02918019|567215791|FG001|Overall Study|Death|0|||
157127002|NCT02918019|567215792|FG002|Overall Study|Death|1|||
157127003|NCT02918019|567215793|FG003|Overall Study|Death|0|||
157127004|NCT02918019|567215790|FG000|Overall Study|Lost to Follow-up|1|||
157127005|NCT02918019|567215791|FG001|Overall Study|Lost to Follow-up|1|||
157127006|NCT02918019|567215792|FG002|Overall Study|Lost to Follow-up|0|||
157127007|NCT02918019|567215793|FG003|Overall Study|Lost to Follow-up|1|||
157127008|NCT02918019|567215790|FG000|Overall Study|Principal investigator request|0|||
157127009|NCT02918019|567215791|FG001|Overall Study|Principal investigator request|0|||
157127010|NCT02918019|567215792|FG002|Overall Study|Principal investigator request|0|||
157127011|NCT02918019|567215793|FG003|Overall Study|Principal investigator request|1|||
157127012|NCT02918019|567215790|FG000|Overall Study|Physician Decision|1|||
157127013|NCT02918019|567215791|FG001|Overall Study|Physician Decision|3|||
157127014|NCT02918019|567215792|FG002|Overall Study|Physician Decision|2|||
157127015|NCT02918019|567215793|FG003|Overall Study|Physician Decision|0|||
157127016|NCT02918019|567215790|FG000|Overall Study|Protocol deviation|1|||
157127017|NCT02918019|567215791|FG001|Overall Study|Protocol deviation|1|||
157127018|NCT02918019|567215792|FG002|Overall Study|Protocol deviation|0|||
157127019|NCT02918019|567215793|FG003|Overall Study|Protocol deviation|2|||
157127020|NCT02918019|567215790|FG000|Overall Study|Withdrawal by Subject|3|||
157127021|NCT02918019|567215791|FG001|Overall Study|Withdrawal by Subject|4|||
157127022|NCT02918019|567215792|FG002|Overall Study|Withdrawal by Subject|6|||
157216063|NCT03712228|567537443|FG001|Treatment Period 1|Lack of Efficacy|0|||
156712655|NCT02288325|565692811|FG000|Stabilization Period|Protocol Violation|8|||
156712656|NCT02288325|565692812|FG001|Stabilization Period|Protocol Violation|0|||
156712657|NCT02288325|565692813|FG002|Stabilization Period|Protocol Violation|0|||
156712658|NCT02288325|565692811|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
156712659|NCT02288325|565692812|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
157216064|NCT03712228|567537444|FG002|Treatment Period 1|Lack of Efficacy|0|||
156712660|NCT02288325|565692813|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
156792431|NCT02757963|565992785|FG000|Overall Study|Physician Decision|1|||
157127023|NCT02918019|567215793|FG003|Overall Study|Withdrawal by Subject|4|||
157216065|NCT03712228|567537445|FG003|Treatment Period 1|Lack of Efficacy|0|||
156712661|NCT02288325|565692811|FG000|Stabilization Period|Reason not Specified|15|||
156873971|NCT01273519|566296177|FG001|Overall Study|Adverse Event|0|||
156873972|NCT01273519|566296178|FG002|Overall Study|Adverse Event|0|||
156873973|NCT01273519|566296176|FG000|Overall Study|Lost to Follow-up|2|||
156873974|NCT01273519|566296177|FG001|Overall Study|Lost to Follow-up|1|||
156873975|NCT01273519|566296178|FG002|Overall Study|Lost to Follow-up|3|||
156873976|NCT01273519|566296176|FG000|Overall Study|Lack of Efficacy|8|||
156873977|NCT01273519|566296177|FG001|Overall Study|Lack of Efficacy|3|||
156873978|NCT01273519|566296178|FG002|Overall Study|Lack of Efficacy|4|||
156873979|NCT01273519|566296176|FG000|Overall Study|Other|6|||
156873980|NCT01273519|566296177|FG001|Overall Study|Other|1|||
156873981|NCT01273519|566296178|FG002|Overall Study|Other|1|||
156712662|NCT02288325|565692812|FG001|Stabilization Period|Reason not Specified|0|||
156712663|NCT02288325|565692813|FG002|Stabilization Period|Reason not Specified|0|||
156712664|NCT02288325|565692811|FG000|Double-blind Treatment Period|Adverse Event|0|||
156712665|NCT02288325|565692812|FG001|Double-blind Treatment Period|Adverse Event|2|||
156712666|NCT02288325|565692813|FG002|Double-blind Treatment Period|Adverse Event|5|||
156712667|NCT02288325|565692811|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
156712668|NCT02288325|565692812|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
156712669|NCT02288325|565692813|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
156712670|NCT02288325|565692811|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156712671|NCT02288325|565692812|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
156712672|NCT02288325|565692813|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156712673|NCT02288325|565692811|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156712674|NCT02288325|565692812|FG001|Double-blind Treatment Period|Protocol Violation|1|||
156712675|NCT02288325|565692813|FG002|Double-blind Treatment Period|Protocol Violation|2|||
156712676|NCT02288325|565692811|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
156712677|NCT02288325|565692812|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
156712678|NCT02288325|565692813|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
156712679|NCT02288325|565692811|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
156712680|NCT02288325|565692812|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
156712681|NCT02288325|565692813|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
156712682|NCT01884337|565692816|FG000|Treatment|Adverse Event|2|||
156712683|NCT01884337|565692817|FG001|Treatment|Adverse Event|2|||
156712684|NCT01884337|565692816|FG000|Treatment|Subj. request to discont. treatment|2|||
156712685|NCT01884337|565692817|FG001|Treatment|Subj. request to discont. treatment|0|||
156712686|NCT01884337|565692816|FG000|Follow-up Period|Lost to Follow-up|1|||
156712687|NCT01884337|565692817|FG001|Follow-up Period|Lost to Follow-up|1|||
156712688|NCT02455518|565692818|FG000|Overall Study|Protocol Violation|0|||
156712689|NCT02455518|565692819|FG001|Overall Study|Protocol Violation|1|||
156712690|NCT02455518|565692820|FG002|Overall Study|Protocol Violation|1|||
156712691|NCT02455518|565692821|FG003|Overall Study|Protocol Violation|3|||
156712692|NCT04186845|565692823|FG000|Overall Study|Death|2|||
156712693|NCT04186845|565692823|FG000|Overall Study|Lost to Follow-up|1|||
156712694|NCT04186845|565692823|FG000|Overall Study|Physician Decision|1|||
156712695|NCT04186845|565692823|FG000|Overall Study|Protocol Violation|1|||
156712696|NCT04186845|565692823|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
156712697|NCT04186845|565692823|FG000|Overall Study|Biopsy ordered but not done|1|||
156712698|NCT04186845|565692823|FG000|Overall Study|It was previously confirmed|1|||
156712699|NCT04186845|565692823|FG000|Overall Study|Patient cancelled scheduled scans|2|||
156712700|NCT04186845|565692823|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
156712701|NCT04186845|565692823|FG000|Overall Study|Subject refused confirmatory imaging|1|||
156712702|NCT04186845|565692823|FG000|Overall Study|Too small to biopsy|1|||
156712703|NCT03151304|565692824|FG000|Overall Study|Termination of study by Sponsor|23|||
156873982|NCT04292899|566296179|FG000|Overall Study|Death|21|||
156873983|NCT04292899|566296180|FG001|Overall Study|Death|28|||
156873984|NCT04292899|566296181|FG002|Overall Study|Death|188|||
156873985|NCT04292899|566296182|FG003|Overall Study|Death|371|||
156873986|NCT04292899|566296179|FG000|Overall Study|Lost to Follow-up|8|||
156873987|NCT04292899|566296180|FG001|Overall Study|Lost to Follow-up|4|||
156873988|NCT04292899|566296181|FG002|Overall Study|Lost to Follow-up|22|||
156873989|NCT04292899|566296182|FG003|Overall Study|Lost to Follow-up|235|||
156873990|NCT04292899|566296179|FG000|Overall Study|Withdrew consent|1|||
156873991|NCT04292899|566296180|FG001|Overall Study|Withdrew consent|0|||
156712704|NCT03151304|565692824|FG000|Overall Study|missing|3|||
156712705|NCT03151304|565692824|FG000|Overall Study|Withdrawal by Subject|8|||
156712706|NCT03151304|565692824|FG000|Overall Study|multiple reasons|30|||
156712707|NCT01332292|565692826|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
157127024|NCT02918019|567215790|FG000|Overall Study|Adverse Event|0|||
156712708|NCT01332292|565692827|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156712709|NCT01332292|565692826|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156712710|NCT01332292|565692827|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
156873992|NCT04292899|566296181|FG002|Overall Study|Withdrew consent|11|||
156873993|NCT04292899|566296182|FG003|Overall Study|Withdrew consent|32|||
156873994|NCT04292899|566296179|FG000|Overall Study|Adverse Event|2|||
156873995|NCT04292899|566296180|FG001|Overall Study|Adverse Event|1|||
157127025|NCT02918019|567215791|FG001|Overall Study|Adverse Event|1|||
157127026|NCT02918019|567215792|FG002|Overall Study|Adverse Event|0|||
157127027|NCT02918019|567215793|FG003|Overall Study|Adverse Event|1|||
157127028|NCT01212185|567215794|FG000|Overall Study|Protocol Violation|2|||
157127029|NCT01212185|567215795|FG001|Overall Study|Protocol Violation|1|||
157127030|NCT03555266|567215796|FG000|Overall Study|Protocol Violation|6|||
157127031|NCT03555266|567215797|FG001|Overall Study|Protocol Violation|4|||
157127032|NCT03370770|567215798|FG000|Overall Study|Patient was followed in another hospital center|1|||
157127033|NCT03370770|567215798|FG000|Overall Study|Progressive Disease|98|||
157127034|NCT03370770|567215798|FG000|Overall Study|Adverse Event|2|||
157127035|NCT03370770|567215798|FG000|Overall Study|Death|5|||
157127036|NCT01127165|567215799|FG000|Overall Study|Adverse Event|2|||
157127037|NCT01127165|567215800|FG001|Overall Study|Adverse Event|2|||
157127038|NCT01127165|567215799|FG000|Overall Study|Lack of Efficacy|10|||
157127039|NCT01127165|567215800|FG001|Overall Study|Lack of Efficacy|8|||
157127040|NCT01127165|567215799|FG000|Overall Study|Lost to Follow-up|3|||
157127041|NCT01127165|567215800|FG001|Overall Study|Lost to Follow-up|5|||
157127042|NCT01127165|567215799|FG000|Overall Study|Withdrawal by Subject|1|||
157127043|NCT01127165|567215800|FG001|Overall Study|Withdrawal by Subject|3|||
157127044|NCT01127165|567215799|FG000|Overall Study|Protocol Violation|0|||
157127045|NCT01127165|567215800|FG001|Overall Study|Protocol Violation|1|||
157127046|NCT02435849|567215801|FG000|Overall Study|Death|23|||
157127047|NCT02435849|567215802|FG001|Overall Study|Death|0|||
157127048|NCT02435849|567215801|FG000|Overall Study|Lack of Efficacy|10|||
157127049|NCT02435849|567215802|FG001|Overall Study|Lack of Efficacy|0|||
157127050|NCT02435849|567215801|FG000|Overall Study|New therapy for study indication|8|||
157127051|NCT02435849|567215802|FG001|Overall Study|New therapy for study indication|0|||
157127052|NCT02435849|567215801|FG000|Overall Study|Subject/guardian decision|5|||
157127053|NCT02435849|567215802|FG001|Overall Study|Subject/guardian decision|1|||
157127054|NCT02435849|567215801|FG000|Overall Study|Lost to Follow-up|1|||
157127055|NCT02435849|567215802|FG001|Overall Study|Lost to Follow-up|0|||
157127056|NCT02435849|567215801|FG000|Overall Study|Physician Decision|1|||
157127057|NCT02435849|567215802|FG001|Overall Study|Physician Decision|0|||
157127058|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
157127059|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157127060|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157127061|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157127062|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157127063|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
157127064|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
157127065|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
157127066|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
157127067|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
157127068|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
157127069|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
157127070|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
157127071|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
157127072|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
157127073|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
157127074|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157127075|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157127076|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157127077|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157127078|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
157127079|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
157127080|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
156712711|NCT01332292|565692826|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
156712712|NCT01332292|565692827|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
156712713|NCT00098774|565692828|FG000|Overall Study|Adverse Event|2|||
156712714|NCT00098774|565692828|FG000|Overall Study|Disease Progression|9|||
156712715|NCT00098774|565692828|FG000|Overall Study|Withdrawal by Subject|1|||
156712716|NCT00098774|565692828|FG000|Overall Study|Failed (to respond) during induction|4|||
157127081|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
157127082|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
157127083|NCT01017952|567215803|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
157127084|NCT01017952|567215804|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157127085|NCT01017952|567215805|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157127086|NCT01017952|567215806|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157127087|NCT01017952|567215807|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157127088|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
157127089|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
157127090|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
156712717|NCT00098774|565692828|FG000|Overall Study|Physician Decision|2|||
156712718|NCT01330303|565692829|FG000|Period 1|Adverse Event|1|||
156712719|NCT01330303|565692830|FG001|Period 1|Adverse Event|0|||
156712720|NCT01330303|565692829|FG000|Period 1|Protocol Violation|0|||
156712721|NCT01330303|565692830|FG001|Period 1|Protocol Violation|1|||
156712722|NCT01330303|565692829|FG000|Period 1|Withdrawal by Subject|0|||
156712723|NCT01330303|565692830|FG001|Period 1|Withdrawal by Subject|1|||
156712724|NCT00796757|565692831|FG000|Overall Study|Withdrawal by Subject|14|||
156712725|NCT00796757|565692831|FG000|Overall Study|Death|61|||
156712726|NCT00796757|565692831|FG000|Overall Study|Protocol Violation|1|||
156712727|NCT00796757|565692831|FG000|Overall Study|Participant noncompliance|1|||
156712728|NCT00796757|565692831|FG000|Overall Study|Investigator's decision|2|||
156712729|NCT00796757|565692831|FG000|Overall Study|Other|7|||
156712730|NCT02593110|565692833|FG000|Overall Study|Withdrawal by Subject|0|||
156712731|NCT02593110|565692834|FG001|Overall Study|Withdrawal by Subject|3|||
156712732|NCT02593110|565692835|FG002|Overall Study|Withdrawal by Subject|3|||
156712733|NCT02593110|565692836|FG003|Overall Study|Withdrawal by Subject|2|||
156712734|NCT02593110|565692833|FG000|Overall Study|Death|0|||
156712735|NCT02593110|565692834|FG001|Overall Study|Death|0|||
156712736|NCT02593110|565692835|FG002|Overall Study|Death|1|||
156712737|NCT02593110|565692836|FG003|Overall Study|Death|0|||
156712738|NCT03548337|565692837|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
156712739|NCT03548337|565692838|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
156712740|NCT03548337|565692837|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
156712741|NCT03548337|565692838|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
156712742|NCT03548337|565692837|FG000|Infant Series|Lost to Follow-up|2|||
156712743|NCT03548337|565692838|FG001|Infant Series|Lost to Follow-up|1|||
156712744|NCT03548337|565692837|FG000|Infant Series|Adverse Event|0|||
156712745|NCT03548337|565692838|FG001|Infant Series|Adverse Event|2|||
156712746|NCT03548337|565692837|FG000|Infant Series|Randomized but Not Vaccinated|1|||
156712747|NCT03548337|565692838|FG001|Infant Series|Randomized but Not Vaccinated|0|||
156712748|NCT03548337|565692837|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
156712749|NCT03548337|565692838|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
156712750|NCT04502212|565692841|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
156712751|NCT04502212|565692841|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
156712752|NCT01911273|565692843|FG000|Overall Study|Progression of Disease|1|||
156712753|NCT01911273|565692844|FG001|Overall Study|Progression of Disease|0|||
156712754|NCT01911273|565692843|FG000|Overall Study|Withdrawal by Subject|0|||
156712755|NCT01911273|565692844|FG001|Overall Study|Withdrawal by Subject|2|||
156712756|NCT00307437|565692846|FG000|Controlled Period|Adverse Event|7|||
156712757|NCT00307437|565692847|FG001|Controlled Period|Adverse Event|2|||
156712758|NCT00307437|565692848|FG002|Controlled Period|Adverse Event|5|||
156712759|NCT00307437|565692849|FG003|Controlled Period|Adverse Event|0|||
156712760|NCT00307437|565692850|FG004|Controlled Period|Adverse Event|0|||
156792432|NCT02757963|565992785|FG000|Overall Study|Withdrawal by Subject|34|||
156792433|NCT00911157|565992786|FG000|Overall Study|Adverse Event|4|||
156792434|NCT00911157|565992787|FG001|Overall Study|Adverse Event|1|||
156792435|NCT00911157|565992786|FG000|Overall Study|Withdrawal by Subject|1|||
156792436|NCT00911157|565992787|FG001|Overall Study|Withdrawal by Subject|1|||
156792437|NCT00911157|565992786|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
156792438|NCT00911157|565992787|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
156792439|NCT00911157|565992786|FG000|Overall Study|Need to treat for lung cancer|1|||
156792440|NCT00911157|565992787|FG001|Overall Study|Need to treat for lung cancer|0|||
156792441|NCT03769467|565992791|FG000|Overall Study|Adverse Event|1|||
156792442|NCT03769467|565992792|FG001|Overall Study|Adverse Event|1|||
156792443|NCT03769467|565992793|FG002|Overall Study|Adverse Event|0|||
156792444|NCT03769467|565992791|FG000|Overall Study|Death|3|||
156792445|NCT03769467|565992792|FG001|Overall Study|Death|3|||
156792446|NCT03769467|565992793|FG002|Overall Study|Death|0|||
156792447|NCT03769467|565992791|FG000|Overall Study|Study Terminated By Sponsor|2|||
156792448|NCT03769467|565992792|FG001|Overall Study|Study Terminated By Sponsor|1|||
156792449|NCT03769467|565992793|FG002|Overall Study|Study Terminated By Sponsor|0|||
157016533|NCT04855760|566813141|FG000|Overall Study|Pregnancy|1|||
156712761|NCT00307437|565692851|FG005|Controlled Period|Adverse Event|0|||
156712762|NCT00307437|565692852|FG006|Controlled Period|Adverse Event|0|||
157016534|NCT04855760|566813141|FG000|Overall Study|Non-Compliance with Study Drug|11|||
157016535|NCT04855760|566813141|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
156712763|NCT00307437|565692846|FG000|Controlled Period|Death|0|||
156712764|NCT00307437|565692847|FG001|Controlled Period|Death|0|||
156712765|NCT00307437|565692848|FG002|Controlled Period|Death|1|||
156712766|NCT00307437|565692849|FG003|Controlled Period|Death|0|||
156712767|NCT00307437|565692850|FG004|Controlled Period|Death|0|||
156712768|NCT00307437|565692851|FG005|Controlled Period|Death|0|||
156792450|NCT03769467|565992791|FG000|Overall Study|Withdrawal by Subject|0|||
156792451|NCT03769467|565992792|FG001|Overall Study|Withdrawal by Subject|1|||
156792452|NCT03769467|565992793|FG002|Overall Study|Withdrawal by Subject|0|||
156792453|NCT05259722|565992796|FG000|Overall Study|Adverse Event|2|||
156712769|NCT00307437|565692852|FG006|Controlled Period|Death|0|||
156712770|NCT00307437|565692846|FG000|Controlled Period|Lack of Efficacy|2|||
156712771|NCT00307437|565692847|FG001|Controlled Period|Lack of Efficacy|0|||
156712772|NCT00307437|565692848|FG002|Controlled Period|Lack of Efficacy|0|||
156712773|NCT00307437|565692849|FG003|Controlled Period|Lack of Efficacy|0|||
156712774|NCT00307437|565692850|FG004|Controlled Period|Lack of Efficacy|0|||
156712775|NCT00307437|565692851|FG005|Controlled Period|Lack of Efficacy|0|||
156712776|NCT00307437|565692852|FG006|Controlled Period|Lack of Efficacy|0|||
156712777|NCT00307437|565692846|FG000|Controlled Period|Lost to Follow-up|2|||
156712778|NCT00307437|565692847|FG001|Controlled Period|Lost to Follow-up|3|||
156712779|NCT00307437|565692848|FG002|Controlled Period|Lost to Follow-up|0|||
156712780|NCT00307437|565692849|FG003|Controlled Period|Lost to Follow-up|0|||
156712781|NCT00307437|565692850|FG004|Controlled Period|Lost to Follow-up|0|||
156712782|NCT00307437|565692851|FG005|Controlled Period|Lost to Follow-up|0|||
156712783|NCT00307437|565692852|FG006|Controlled Period|Lost to Follow-up|0|||
156712784|NCT00307437|565692846|FG000|Controlled Period|Other|5|||
156712785|NCT00307437|565692847|FG001|Controlled Period|Other|1|||
156712786|NCT00307437|565692848|FG002|Controlled Period|Other|3|||
156712787|NCT00307437|565692849|FG003|Controlled Period|Other|0|||
156712788|NCT00307437|565692850|FG004|Controlled Period|Other|0|||
156712789|NCT00307437|565692851|FG005|Controlled Period|Other|0|||
156712790|NCT00307437|565692852|FG006|Controlled Period|Other|0|||
156712791|NCT00307437|565692846|FG000|After Controlled Period|Adverse Event|0|||
156712792|NCT00307437|565692847|FG001|After Controlled Period|Adverse Event|0|||
156712793|NCT00307437|565692848|FG002|After Controlled Period|Adverse Event|0|||
156712794|NCT00307437|565692849|FG003|After Controlled Period|Adverse Event|18|||
156712795|NCT00307437|565692850|FG004|After Controlled Period|Adverse Event|16|||
156712796|NCT00307437|565692851|FG005|After Controlled Period|Adverse Event|31|||
156712797|NCT00307437|565692852|FG006|After Controlled Period|Adverse Event|40|||
156712798|NCT00307437|565692846|FG000|After Controlled Period|Death|0|||
156712799|NCT00307437|565692847|FG001|After Controlled Period|Death|0|||
156712800|NCT00307437|565692848|FG002|After Controlled Period|Death|0|||
156712801|NCT00307437|565692849|FG003|After Controlled Period|Death|3|||
156712802|NCT00307437|565692850|FG004|After Controlled Period|Death|1|||
156712803|NCT00307437|565692851|FG005|After Controlled Period|Death|1|||
156712804|NCT00307437|565692852|FG006|After Controlled Period|Death|3|||
156712805|NCT00307437|565692846|FG000|After Controlled Period|Lack of Efficacy|0|||
156712806|NCT00307437|565692847|FG001|After Controlled Period|Lack of Efficacy|0|||
156712807|NCT00307437|565692848|FG002|After Controlled Period|Lack of Efficacy|0|||
156712808|NCT00307437|565692849|FG003|After Controlled Period|Lack of Efficacy|15|||
156712809|NCT00307437|565692850|FG004|After Controlled Period|Lack of Efficacy|17|||
156712810|NCT00307437|565692851|FG005|After Controlled Period|Lack of Efficacy|37|||
156712811|NCT00307437|565692852|FG006|After Controlled Period|Lack of Efficacy|24|||
156712812|NCT00307437|565692846|FG000|After Controlled Period|Lost to Follow-up|0|||
156712813|NCT00307437|565692847|FG001|After Controlled Period|Lost to Follow-up|0|||
156712814|NCT00307437|565692848|FG002|After Controlled Period|Lost to Follow-up|0|||
156712815|NCT00307437|565692849|FG003|After Controlled Period|Lost to Follow-up|7|||
156712816|NCT00307437|565692850|FG004|After Controlled Period|Lost to Follow-up|12|||
156712817|NCT00307437|565692851|FG005|After Controlled Period|Lost to Follow-up|13|||
156712818|NCT00307437|565692852|FG006|After Controlled Period|Lost to Follow-up|18|||
156712819|NCT00307437|565692846|FG000|After Controlled Period|Other|0|||
156712820|NCT00307437|565692847|FG001|After Controlled Period|Other|0|||
156712821|NCT00307437|565692848|FG002|After Controlled Period|Other|0|||
156712822|NCT00307437|565692849|FG003|After Controlled Period|Other|15|||
156712823|NCT00307437|565692850|FG004|After Controlled Period|Other|9|||
156712824|NCT00307437|565692851|FG005|After Controlled Period|Other|40|||
156712825|NCT00307437|565692852|FG006|After Controlled Period|Other|28|||
156712826|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
156712827|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
156712828|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
156792454|NCT05259722|565992797|FG001|Overall Study|Adverse Event|24|||
156712829|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
156712830|NCT04803305|565692853|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
156712831|NCT04803305|565692854|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
156712832|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
156712833|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
156712834|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
156712835|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
156712836|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
156712837|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
156712838|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
156712839|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
156712840|NCT04803305|565692853|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
156712841|NCT04803305|565692854|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
156792455|NCT05259722|565992796|FG000|Overall Study|Lost to Follow-up|5|||
156792456|NCT05259722|565992797|FG001|Overall Study|Lost to Follow-up|1|||
156712842|NCT00721227|565692855|FG000|Overall Study|Lost to Follow-up|3|||
156712843|NCT00721227|565692856|FG001|Overall Study|Lost to Follow-up|0|||
156712844|NCT00721227|565692855|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
156712845|NCT00721227|565692856|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
156712846|NCT00352417|565692861|FG000|Overall Study|Adverse Event|1|||
156712847|NCT00352417|565692862|FG001|Overall Study|Adverse Event|0|||
156712848|NCT00352417|565692861|FG000|Overall Study|Protocol Violation|0|||
156712849|NCT00352417|565692862|FG001|Overall Study|Protocol Violation|2|||
156712850|NCT00352417|565692861|FG000|Overall Study|Withdrawal by Subject|1|||
156712851|NCT00352417|565692862|FG001|Overall Study|Withdrawal by Subject|2|||
156712852|NCT00352417|565692861|FG000|Overall Study|Lost to Follow-up|1|||
156712853|NCT00352417|565692862|FG001|Overall Study|Lost to Follow-up|0|||
156712854|NCT00352417|565692861|FG000|Overall Study|Schedule Change|2|||
156712855|NCT00352417|565692862|FG001|Overall Study|Schedule Change|1|||
156712856|NCT03207867|565692863|FG000|Overall Study|Adverse Event|1|||
156712857|NCT03207867|565692864|FG001|Overall Study|Adverse Event|0|||
156712858|NCT03207867|565692865|FG002|Overall Study|Adverse Event|1|||
156712859|NCT03207867|565692866|FG003|Overall Study|Adverse Event|0|||
156712860|NCT03207867|565692867|FG004|Overall Study|Adverse Event|0|||
156712861|NCT03207867|565692868|FG005|Overall Study|Adverse Event|2|||
156712862|NCT03207867|565692869|FG006|Overall Study|Adverse Event|1|||
156712863|NCT03207867|565692870|FG007|Overall Study|Adverse Event|1|||
156712864|NCT03207867|565692871|FG008|Overall Study|Adverse Event|2|||
156712865|NCT03207867|565692872|FG009|Overall Study|Adverse Event|2|||
156712866|NCT03207867|565692873|FG010|Overall Study|Adverse Event|0|||
156712867|NCT03207867|565692874|FG011|Overall Study|Adverse Event|0|||
156712868|NCT03207867|565692875|FG012|Overall Study|Adverse Event|0|||
156712869|NCT03207867|565692876|FG013|Overall Study|Adverse Event|0|||
156712870|NCT03207867|565692877|FG014|Overall Study|Adverse Event|0|||
156712871|NCT03207867|565692878|FG015|Overall Study|Adverse Event|0|||
156712872|NCT03207867|565692879|FG016|Overall Study|Adverse Event|3|||
156712873|NCT03207867|565692880|FG017|Overall Study|Adverse Event|1|||
156712874|NCT03207867|565692881|FG018|Overall Study|Adverse Event|2|||
156712875|NCT03207867|565692882|FG019|Overall Study|Adverse Event|1|||
156712876|NCT03207867|565692883|FG020|Overall Study|Adverse Event|0|||
156712877|NCT03207867|565692884|FG021|Overall Study|Adverse Event|0|||
156712878|NCT03207867|565692885|FG022|Overall Study|Adverse Event|0|||
156712879|NCT03207867|565692886|FG023|Overall Study|Adverse Event|0|||
156712880|NCT03207867|565692863|FG000|Overall Study|Death|0|||
156712881|NCT03207867|565692864|FG001|Overall Study|Death|0|||
156712882|NCT03207867|565692865|FG002|Overall Study|Death|0|||
156712883|NCT03207867|565692866|FG003|Overall Study|Death|0|||
156712884|NCT03207867|565692867|FG004|Overall Study|Death|0|||
156712885|NCT03207867|565692868|FG005|Overall Study|Death|1|||
156712886|NCT03207867|565692869|FG006|Overall Study|Death|0|||
156712887|NCT03207867|565692870|FG007|Overall Study|Death|3|||
156712888|NCT03207867|565692871|FG008|Overall Study|Death|1|||
156712889|NCT03207867|565692872|FG009|Overall Study|Death|2|||
156712890|NCT03207867|565692873|FG010|Overall Study|Death|0|||
156712891|NCT03207867|565692874|FG011|Overall Study|Death|1|||
156712892|NCT03207867|565692875|FG012|Overall Study|Death|0|||
156712893|NCT03207867|565692876|FG013|Overall Study|Death|1|||
156712894|NCT03207867|565692877|FG014|Overall Study|Death|0|||
156712895|NCT03207867|565692878|FG015|Overall Study|Death|0|||
156712896|NCT03207867|565692879|FG016|Overall Study|Death|0|||
156712897|NCT03207867|565692880|FG017|Overall Study|Death|2|||
156712898|NCT03207867|565692881|FG018|Overall Study|Death|0|||
156712899|NCT03207867|565692882|FG019|Overall Study|Death|1|||
156712900|NCT03207867|565692883|FG020|Overall Study|Death|0|||
156712901|NCT03207867|565692884|FG021|Overall Study|Death|0|||
156712902|NCT03207867|565692885|FG022|Overall Study|Death|0|||
156712903|NCT03207867|565692886|FG023|Overall Study|Death|0|||
156712904|NCT03207867|565692863|FG000|Overall Study|Physician Decision|3|||
156712905|NCT03207867|565692864|FG001|Overall Study|Physician Decision|5|||
156712906|NCT03207867|565692865|FG002|Overall Study|Physician Decision|0|||
156712907|NCT03207867|565692866|FG003|Overall Study|Physician Decision|3|||
156712908|NCT03207867|565692867|FG004|Overall Study|Physician Decision|2|||
156712909|NCT03207867|565692868|FG005|Overall Study|Physician Decision|0|||
156712910|NCT03207867|565692869|FG006|Overall Study|Physician Decision|0|||
156712911|NCT03207867|565692870|FG007|Overall Study|Physician Decision|0|||
156712912|NCT03207867|565692871|FG008|Overall Study|Physician Decision|4|||
156712913|NCT03207867|565692872|FG009|Overall Study|Physician Decision|2|||
156712914|NCT03207867|565692873|FG010|Overall Study|Physician Decision|0|||
156712915|NCT03207867|565692874|FG011|Overall Study|Physician Decision|4|||
156792457|NCT05259722|565992796|FG000|Overall Study|Lack of Efficacy|8|||
156792458|NCT05259722|565992797|FG001|Overall Study|Lack of Efficacy|26|||
156792459|NCT05259722|565992796|FG000|Overall Study|Withdrawal by Subject|15|||
156792460|NCT05259722|565992797|FG001|Overall Study|Withdrawal by Subject|33|||
156792461|NCT05259722|565992796|FG000|Overall Study|Various reasons|3|||
156792462|NCT05259722|565992797|FG001|Overall Study|Various reasons|9|||
156792463|NCT05259722|565992796|FG000|Overall Study|Not exposed to IMP|1|||
156792464|NCT05259722|565992797|FG001|Overall Study|Not exposed to IMP|12|||
156712916|NCT03207867|565692875|FG012|Overall Study|Physician Decision|0|||
156712917|NCT03207867|565692876|FG013|Overall Study|Physician Decision|0|||
156712918|NCT03207867|565692877|FG014|Overall Study|Physician Decision|2|||
156712919|NCT03207867|565692878|FG015|Overall Study|Physician Decision|1|||
156712920|NCT03207867|565692879|FG016|Overall Study|Physician Decision|1|||
156712921|NCT03207867|565692880|FG017|Overall Study|Physician Decision|2|||
156712922|NCT03207867|565692881|FG018|Overall Study|Physician Decision|1|||
156712923|NCT03207867|565692882|FG019|Overall Study|Physician Decision|3|||
156712924|NCT03207867|565692883|FG020|Overall Study|Physician Decision|0|||
156712925|NCT03207867|565692884|FG021|Overall Study|Physician Decision|0|||
156712926|NCT03207867|565692885|FG022|Overall Study|Physician Decision|0|||
156712927|NCT03207867|565692886|FG023|Overall Study|Physician Decision|0|||
156712928|NCT03207867|565692863|FG000|Overall Study|Progressive Disease|7|||
156712929|NCT03207867|565692864|FG001|Overall Study|Progressive Disease|7|||
156712930|NCT03207867|565692865|FG002|Overall Study|Progressive Disease|9|||
156712931|NCT03207867|565692866|FG003|Overall Study|Progressive Disease|10|||
156712932|NCT03207867|565692867|FG004|Overall Study|Progressive Disease|11|||
156712933|NCT03207867|565692868|FG005|Overall Study|Progressive Disease|10|||
156712934|NCT03207867|565692869|FG006|Overall Study|Progressive Disease|9|||
156712935|NCT03207867|565692870|FG007|Overall Study|Progressive Disease|8|||
156712936|NCT03207867|565692871|FG008|Overall Study|Progressive Disease|19|||
156712937|NCT03207867|565692872|FG009|Overall Study|Progressive Disease|23|||
156712938|NCT03207867|565692873|FG010|Overall Study|Progressive Disease|2|||
156712939|NCT03207867|565692874|FG011|Overall Study|Progressive Disease|24|||
156712940|NCT03207867|565692875|FG012|Overall Study|Progressive Disease|3|||
156712941|NCT03207867|565692876|FG013|Overall Study|Progressive Disease|11|||
156712942|NCT03207867|565692877|FG014|Overall Study|Progressive Disease|9|||
156712943|NCT03207867|565692878|FG015|Overall Study|Progressive Disease|5|||
156712944|NCT03207867|565692879|FG016|Overall Study|Progressive Disease|10|||
156712945|NCT03207867|565692880|FG017|Overall Study|Progressive Disease|14|||
156712946|NCT03207867|565692881|FG018|Overall Study|Progressive Disease|13|||
156712947|NCT03207867|565692882|FG019|Overall Study|Progressive Disease|14|||
156712948|NCT03207867|565692883|FG020|Overall Study|Progressive Disease|6|||
156712949|NCT03207867|565692884|FG021|Overall Study|Progressive Disease|3|||
156712950|NCT03207867|565692885|FG022|Overall Study|Progressive Disease|3|||
156712951|NCT03207867|565692886|FG023|Overall Study|Progressive Disease|3|||
156712952|NCT03207867|565692863|FG000|Overall Study|Patient/guardian Decision|0|||
156712953|NCT03207867|565692864|FG001|Overall Study|Patient/guardian Decision|0|||
156712954|NCT03207867|565692865|FG002|Overall Study|Patient/guardian Decision|1|||
156712955|NCT03207867|565692866|FG003|Overall Study|Patient/guardian Decision|1|||
156712956|NCT03207867|565692867|FG004|Overall Study|Patient/guardian Decision|1|||
156712957|NCT03207867|565692868|FG005|Overall Study|Patient/guardian Decision|2|||
156712958|NCT03207867|565692869|FG006|Overall Study|Patient/guardian Decision|1|||
156712959|NCT03207867|565692870|FG007|Overall Study|Patient/guardian Decision|0|||
156712960|NCT03207867|565692871|FG008|Overall Study|Patient/guardian Decision|1|||
156712961|NCT03207867|565692872|FG009|Overall Study|Patient/guardian Decision|0|||
156712962|NCT03207867|565692873|FG010|Overall Study|Patient/guardian Decision|0|||
156712963|NCT03207867|565692874|FG011|Overall Study|Patient/guardian Decision|1|||
156712964|NCT03207867|565692875|FG012|Overall Study|Patient/guardian Decision|0|||
156712965|NCT03207867|565692876|FG013|Overall Study|Patient/guardian Decision|1|||
156712966|NCT03207867|565692877|FG014|Overall Study|Patient/guardian Decision|2|||
156712967|NCT03207867|565692878|FG015|Overall Study|Patient/guardian Decision|0|||
156712968|NCT03207867|565692879|FG016|Overall Study|Patient/guardian Decision|1|||
156712969|NCT03207867|565692880|FG017|Overall Study|Patient/guardian Decision|3|||
156712970|NCT03207867|565692881|FG018|Overall Study|Patient/guardian Decision|4|||
156712971|NCT03207867|565692882|FG019|Overall Study|Patient/guardian Decision|1|||
156712972|NCT03207867|565692883|FG020|Overall Study|Patient/guardian Decision|0|||
156712973|NCT03207867|565692884|FG021|Overall Study|Patient/guardian Decision|0|||
156712974|NCT03207867|565692885|FG022|Overall Study|Patient/guardian Decision|0|||
157127091|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
156712975|NCT03207867|565692886|FG023|Overall Study|Patient/guardian Decision|0|||
156712976|NCT06419907|565694655|FG000|Overall Study|Protocol Violation|0|||
156712977|NCT06419907|565694656|FG001|Overall Study|Protocol Violation|3|||
156712978|NCT06419907|565694657|FG002|Overall Study|Protocol Violation|0|||
156712979|NCT06419907|565694658|FG003|Overall Study|Protocol Violation|1|||
156712980|NCT06419907|565694655|FG000|Overall Study|Lost to Follow-up|0|||
156712981|NCT06419907|565694656|FG001|Overall Study|Lost to Follow-up|0|||
156712982|NCT06419907|565694657|FG002|Overall Study|Lost to Follow-up|2|||
156712983|NCT06419907|565694658|FG003|Overall Study|Lost to Follow-up|1|||
156712984|NCT03130777|565694659|FG000|Overall Study|Death|0|||
156712985|NCT03130777|565694660|FG001|Overall Study|Death|1|||
156712986|NCT03130777|565694659|FG000|Overall Study|Did not meet eligibility criteria|1|||
156712987|NCT03130777|565694660|FG001|Overall Study|Did not meet eligibility criteria|0|||
156712988|NCT02586688|565694661|FG000|Overall Study|Lost to Follow-up|2|||
156712989|NCT02586688|565694662|FG001|Overall Study|Lost to Follow-up|1|||
156712990|NCT02586688|565694661|FG000|Overall Study|Withdrawal by Subject|1|||
156712991|NCT02586688|565694662|FG001|Overall Study|Withdrawal by Subject|1|||
156712992|NCT02586688|565694661|FG000|Overall Study|Adverse Event|3|||
157016536|NCT04855760|566813141|FG000|Overall Study|Study Completed by Sponsor|202|||
157016537|NCT04855760|566813141|FG000|Overall Study|Other|13|||
157216066|NCT03712228|567537446|FG004|Treatment Period 1|Lack of Efficacy|0|||
157216067|NCT03712228|567537447|FG005|Treatment Period 1|Lack of Efficacy|1|||
157216068|NCT03712228|567537442|FG000|Treatment Period 2|Pregnancy|0|||
157216069|NCT03712228|567537443|FG001|Treatment Period 2|Pregnancy|0|||
157216070|NCT03712228|567537444|FG002|Treatment Period 2|Pregnancy|0|||
157216071|NCT03712228|567537445|FG003|Treatment Period 2|Pregnancy|1|||
157216072|NCT03712228|567537446|FG004|Treatment Period 2|Pregnancy|0|||
157216073|NCT03712228|567537447|FG005|Treatment Period 2|Pregnancy|0|||
157216074|NCT03712228|567537442|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157216075|NCT03712228|567537443|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157216076|NCT03712228|567537444|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157216077|NCT03712228|567537445|FG003|Treatment Period 2|Withdrawal by Subject|1|||
157216078|NCT03712228|567537446|FG004|Treatment Period 2|Withdrawal by Subject|0|||
157216079|NCT03712228|567537447|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157216080|NCT01964105|567537448|FG000|Overall Study|Lost to Follow-up|2|||
157216081|NCT01964105|567537449|FG001|Overall Study|Lost to Follow-up|13|||
157216082|NCT01964105|567537450|FG002|Overall Study|Lost to Follow-up|0|||
157216083|NCT02295280|567537452|FG000|Overall Study|Adverse Event|0|||
157216084|NCT02295280|567537453|FG001|Overall Study|Adverse Event|1|||
157216085|NCT02875067|567537454|FG000|Overall Study|Withdrawal by Subject|1|||
157216086|NCT02875067|567537454|FG000|Overall Study|Withdrawal by Termination of Study|5|||
157216087|NCT01430104|567537455|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
157216088|NCT02713243|567537457|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
157216089|NCT02713243|567537458|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
157216090|NCT02713243|567537457|FG000|Overall Study|Administrative problems|0|||
157216091|NCT02713243|567537458|FG001|Overall Study|Administrative problems|1|||
156873996|NCT04292899|566296181|FG002|Overall Study|Adverse Event|2|||
156873997|NCT04292899|566296182|FG003|Overall Study|Adverse Event|2|||
157216092|NCT02713243|567537457|FG000|Overall Study|Protocol deviation|0|||
157216093|NCT02713243|567537458|FG001|Overall Study|Protocol deviation|1|||
157216094|NCT03056352|567537459|FG000|Overall Study|Lost to Follow-up|1|||
156873998|NCT04292899|566296179|FG000|Overall Study|Investigator's Discretion|0|||
156873999|NCT04292899|566296180|FG001|Overall Study|Investigator's Discretion|0|||
156874000|NCT04292899|566296181|FG002|Overall Study|Investigator's Discretion|0|||
156874001|NCT04292899|566296182|FG003|Overall Study|Investigator's Discretion|3|||
156874002|NCT04292899|566296179|FG000|Overall Study|Non-compliance With Study Drug|0|||
156874003|NCT04292899|566296180|FG001|Overall Study|Non-compliance With Study Drug|0|||
156874004|NCT04292899|566296181|FG002|Overall Study|Non-compliance With Study Drug|0|||
156874005|NCT04292899|566296182|FG003|Overall Study|Non-compliance With Study Drug|1|||
157016538|NCT03424811|566813148|FG000|Overall Study|Lost to Follow-up|9|||
157016539|NCT03424811|566813149|FG001|Overall Study|Lost to Follow-up|0|||
157016540|NCT00567398|566813151|FG000|Overall Study|Adverse Event|6|||
157216095|NCT02971605|567537462|FG000|Overall Study|Withdrawal by Subject|1|||
157216096|NCT03185949|567537467|FG000|ITT Analysis|Withdrawal by Subject|4|||
157216097|NCT03185949|567537468|FG001|ITT Analysis|Withdrawal by Subject|3|||
156712993|NCT02586688|565694662|FG001|Overall Study|Adverse Event|1|||
156712994|NCT04856917|565694663|FG000|Overall Study|Withdrawal by Subject|4|||
156712995|NCT04856917|565694664|FG001|Overall Study|Withdrawal by Subject|3|||
156712996|NCT04856917|565694665|FG002|Overall Study|Withdrawal by Subject|1|||
156712997|NCT04856917|565694663|FG000|Overall Study|Lost to Follow-up|3|||
156712998|NCT04856917|565694664|FG001|Overall Study|Lost to Follow-up|1|||
156712999|NCT04856917|565694665|FG002|Overall Study|Lost to Follow-up|1|||
156713000|NCT04856917|565694663|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
156713001|NCT04856917|565694664|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
156713002|NCT04856917|565694665|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
156713003|NCT04856917|565694663|FG000|Overall Study|Other|1|||
156713004|NCT04856917|565694664|FG001|Overall Study|Other|1|||
156713005|NCT04856917|565694665|FG002|Overall Study|Other|0|||
156713006|NCT00233948|565694666|FG000|Overall Study|Adverse Event|1|||
156713007|NCT00233948|565694667|FG001|Overall Study|Adverse Event|0|||
156713008|NCT00233948|565694668|FG002|Overall Study|Adverse Event|0|||
156713009|NCT00233948|565694669|FG003|Overall Study|Adverse Event|0|||
157216098|NCT03185949|567537467|FG000|PP Analysis|Protocol Violation|2|||
157216099|NCT03185949|567537468|FG001|PP Analysis|Protocol Violation|2|||
157216100|NCT03185949|567537467|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
157216101|NCT03185949|567537468|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
156713010|NCT00233948|565694670|FG004|Overall Study|Adverse Event|0|||
156713011|NCT00233948|565694671|FG005|Overall Study|Adverse Event|0|||
156713012|NCT01427608|565694672|FG000|Overall Study|Death|1|||
156874006|NCT04292899|566296179|FG000|Overall Study|Protocol Violation|0|||
157016541|NCT00567398|566813152|FG001|Overall Study|Adverse Event|14|||
156713013|NCT01427608|565694673|FG001|Overall Study|Death|0|||
156874007|NCT04292899|566296180|FG001|Overall Study|Protocol Violation|0|||
157016542|NCT00567398|566813151|FG000|Overall Study|Physician Decision|0|||
157016543|NCT00567398|566813152|FG001|Overall Study|Physician Decision|4|||
157127092|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
157127093|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
157127094|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
157127095|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
157127096|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
157127097|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
157127098|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
157127099|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
157127100|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
157127101|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
157127102|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
157127103|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
157127104|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
157127105|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
157127106|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
157127107|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
157127108|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
157127109|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
157127110|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
157127111|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
157127112|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
157127113|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157127114|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
157127115|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
157127116|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157127117|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157127118|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157127119|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
157127120|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
157127121|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
157127122|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
157127123|NCT01017952|567215803|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
157127124|NCT01017952|567215804|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
157127125|NCT01017952|567215805|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
157127126|NCT01017952|567215806|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
157127127|NCT01017952|567215807|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
157127128|NCT01064167|567215808|FG000|Overall Study|Protocol Violation|14|||
157127129|NCT01064167|567215809|FG001|Overall Study|Protocol Violation|15|||
157127130|NCT03984305|567215812|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
157127131|NCT03984305|567215813|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
157127132|NCT03984305|567215812|FG000|Overall Study|Withdrawal by Subject|3|||
157127133|NCT03984305|567215813|FG001|Overall Study|Withdrawal by Subject|3|||
157127134|NCT03984305|567215812|FG000|Overall Study|Lost to Follow-up|1|||
157127135|NCT03984305|567215813|FG001|Overall Study|Lost to Follow-up|0|||
157127136|NCT00352105|567215814|FG000|Overall Study|Death|5|||
157127137|NCT00352105|567215814|FG000|Overall Study|Withdrawal by Subject|5|||
157127138|NCT00352105|567215814|FG000|Overall Study|Lack of Efficacy|9|||
157127139|NCT00352105|567215814|FG000|Overall Study|Adverse Event|19|||
157127140|NCT00352105|567215814|FG000|Overall Study|Protocol Violation|2|||
157127141|NCT02979431|567215815|FG000|Overall Study|Parent/guardian withdrew consent|2|||
157127142|NCT02979431|567215816|FG001|Overall Study|Parent/guardian withdrew consent|1|||
157127143|NCT02979431|567215817|FG002|Overall Study|Parent/guardian withdrew consent|1|||
157127144|NCT02979431|567215818|FG003|Overall Study|Parent/guardian withdrew consent|1|||
157127145|NCT02979431|567215815|FG000|Overall Study|Randomized but received no study drug|1|||
157127146|NCT02979431|567215816|FG001|Overall Study|Randomized but received no study drug|1|||
157127147|NCT02979431|567215817|FG002|Overall Study|Randomized but received no study drug|0|||
157127148|NCT02979431|567215818|FG003|Overall Study|Randomized but received no study drug|0|||
157127149|NCT02979431|567215815|FG000|Overall Study|Adverse Event|0|||
157127150|NCT02979431|567215816|FG001|Overall Study|Adverse Event|0|||
157127151|NCT02979431|567215817|FG002|Overall Study|Adverse Event|1|||
157127152|NCT02979431|567215818|FG003|Overall Study|Adverse Event|0|||
157127153|NCT02979431|567215815|FG000|Overall Study|Subject left country after Day14|1|||
157127154|NCT02979431|567215816|FG001|Overall Study|Subject left country after Day14|0|||
157127155|NCT02979431|567215817|FG002|Overall Study|Subject left country after Day14|0|||
157127156|NCT02979431|567215818|FG003|Overall Study|Subject left country after Day14|0|||
157127157|NCT01656434|567215819|FG000|Overall Study|Adverse Event|199|||
157127158|NCT01656434|567215820|FG001|Overall Study|Adverse Event|63|||
157216102|NCT00343642|567539200|FG000|Overall Study|Lost to Follow-up|0|||
157127159|NCT01656434|567215819|FG000|Overall Study|Enrollment terminated at trial site|2|||
157127160|NCT01656434|567215820|FG001|Overall Study|Enrollment terminated at trial site|0|||
157127161|NCT01656434|567215819|FG000|Overall Study|Lost to Follow-up|309|||
157127162|NCT01656434|567215820|FG001|Overall Study|Lost to Follow-up|76|||
157127163|NCT01656434|567215819|FG000|Overall Study|Site discontinued study participation|24|||
157127164|NCT01656434|567215820|FG001|Overall Study|Site discontinued study participation|9|||
157127165|NCT01656434|567215819|FG000|Overall Study|Screen failure|2|||
157127166|NCT01656434|567215820|FG001|Overall Study|Screen failure|0|||
157127167|NCT01656434|567215819|FG000|Overall Study|Protocol Violation|7|||
157127168|NCT01656434|567215820|FG001|Overall Study|Protocol Violation|0|||
157127169|NCT01656434|567215819|FG000|Overall Study|Pregnancy wish|18|||
157127170|NCT01656434|567215820|FG001|Overall Study|Pregnancy wish|6|||
157127171|NCT01656434|567215819|FG000|Overall Study|Pregnancy|45|||
157127172|NCT01656434|567215820|FG001|Overall Study|Pregnancy|10|||
157127173|NCT01656434|567215819|FG000|Overall Study|Physician Decision|7|||
157127174|NCT01656434|567215820|FG001|Overall Study|Physician Decision|2|||
157127175|NCT01656434|567215819|FG000|Overall Study|Non-compliance with study drug|48|||
157127176|NCT01656434|567215820|FG001|Overall Study|Non-compliance with study drug|9|||
157127177|NCT01656434|567215819|FG000|Overall Study|Study terminated by sponsor|1501|||
157127178|NCT01656434|567215820|FG001|Overall Study|Study terminated by sponsor|348|||
157127179|NCT01656434|567215819|FG000|Overall Study|Participant discontinued; drug related|13|||
157127180|NCT01656434|567215820|FG001|Overall Study|Participant discontinued; drug related|4|||
157127181|NCT01656434|567215819|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
157127182|NCT01656434|567215820|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
157127183|NCT01656434|567215819|FG000|Overall Study|Non-compliance with protocol|39|||
157127184|NCT01656434|567215820|FG001|Overall Study|Non-compliance with protocol|15|||
157127185|NCT01656434|567215819|FG000|Overall Study|Participant moved|40|||
157127186|NCT01656434|567215820|FG001|Overall Study|Participant moved|12|||
157127187|NCT01656434|567215819|FG000|Overall Study|Participant withdrew consent|28|||
157127188|NCT01656434|567215820|FG001|Overall Study|Participant withdrew consent|9|||
157127189|NCT01656434|567215819|FG000|Overall Study|Withdrawal by Subject|64|||
157127190|NCT01656434|567215820|FG001|Overall Study|Withdrawal by Subject|7|||
157127191|NCT01580397|567215821|FG000|Overall Study|Lack of Efficacy|14|||
157127192|NCT02883244|567215822|FG000|Overall Study|Lost to Follow-up|0|||
157127193|NCT02883244|567215823|FG001|Overall Study|Lost to Follow-up|1|||
157127194|NCT02435914|567215824|FG000|Overall Study|Ocular Adverse Event|1|||
157127195|NCT02435914|567215825|FG001|Overall Study|Ocular Adverse Event|0|||
157127196|NCT02435914|567215826|FG002|Overall Study|Ocular Adverse Event|0|||
157127197|NCT02435914|567215827|FG003|Overall Study|Ocular Adverse Event|0|||
157127198|NCT02435914|567215824|FG000|Overall Study|Withdrawal by Subject|0|||
157127199|NCT02435914|567215825|FG001|Overall Study|Withdrawal by Subject|1|||
157127200|NCT02435914|567215826|FG002|Overall Study|Withdrawal by Subject|0|||
157216103|NCT00343642|567539201|FG001|Overall Study|Lost to Follow-up|1|||
157216104|NCT00343642|567539202|FG002|Overall Study|Lost to Follow-up|0|||
157216105|NCT00343642|567539200|FG000|Overall Study|Pregnancy|1|||
157216106|NCT00343642|567539201|FG001|Overall Study|Pregnancy|0|||
157216107|NCT00343642|567539202|FG002|Overall Study|Pregnancy|2|||
157216108|NCT00343642|567539200|FG000|Overall Study|Withdrawal by Subject|2|||
157216109|NCT00343642|567539201|FG001|Overall Study|Withdrawal by Subject|3|||
157216110|NCT00343642|567539202|FG002|Overall Study|Withdrawal by Subject|4|||
157216111|NCT00343642|567539200|FG000|Overall Study|Adverse Event|0|||
157216112|NCT00343642|567539201|FG001|Overall Study|Adverse Event|0|||
157216113|NCT00343642|567539202|FG002|Overall Study|Adverse Event|1|||
157216114|NCT00343642|567539200|FG000|Overall Study|Flare up|6|||
157216115|NCT00343642|567539201|FG001|Overall Study|Flare up|4|||
157216116|NCT00343642|567539202|FG002|Overall Study|Flare up|0|||
157216117|NCT00860574|567539205|FG000|Overall Study|Death|2|||
157216118|NCT00860574|567539205|FG000|Overall Study|Relapse|1|||
157216119|NCT02496221|567539207|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
157216120|NCT02496221|567539208|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
157216121|NCT02496221|567539207|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
157216122|NCT02496221|567539208|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
157216123|NCT02496221|567539207|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
157216124|NCT02496221|567539208|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
157127201|NCT02435914|567215827|FG003|Overall Study|Withdrawal by Subject|0|||
157127202|NCT02435914|567215824|FG000|Overall Study|Other Miscellaneous Reason|0|||
157127203|NCT02435914|567215825|FG001|Overall Study|Other Miscellaneous Reason|0|||
157127204|NCT02435914|567215826|FG002|Overall Study|Other Miscellaneous Reason|1|||
157127205|NCT02435914|567215827|FG003|Overall Study|Other Miscellaneous Reason|0|||
157127206|NCT01727258|567215828|FG000|Overall Study|Adverse Event|0|||
157216125|NCT01335399|567539209|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
157216126|NCT01335399|567539210|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
157216127|NCT01335399|567539209|FG000|Pre-treatment Period|Participant request to discontinue|0|||
157216128|NCT01335399|567539210|FG001|Pre-treatment Period|Participant request to discontinue|1|||
157216129|NCT01335399|567539209|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
157216130|NCT01335399|567539210|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
157216131|NCT01335399|567539209|FG000|Pre-treatment Period|Consent withdrawal|3|||
156713014|NCT01427608|565694672|FG000|Overall Study|Withdrawal by Subject|7|||
156713015|NCT01427608|565694673|FG001|Overall Study|Withdrawal by Subject|3|||
156713016|NCT01427608|565694672|FG000|Overall Study|Relapsed-all cause|13|||
156713017|NCT01427608|565694673|FG001|Overall Study|Relapsed-all cause|34|||
156713018|NCT01427608|565694672|FG000|Overall Study|Events not attributed to study meds|0|||
156713019|NCT01427608|565694673|FG001|Overall Study|Events not attributed to study meds|1|||
156713020|NCT01473407|565694674|FG000|Overall Study|Physician Decision|1|||
156713021|NCT01473407|565694675|FG001|Overall Study|Physician Decision|4|||
156713022|NCT01473407|565694674|FG000|Overall Study|Lost to Follow-up|10|||
156713023|NCT01473407|565694675|FG001|Overall Study|Lost to Follow-up|4|||
156713024|NCT01473407|565694674|FG000|Overall Study|Adverse Event|8|||
156713025|NCT01473407|565694675|FG001|Overall Study|Adverse Event|8|||
156713026|NCT01473407|565694674|FG000|Overall Study|Randomization Error|3|||
156713027|NCT01473407|565694675|FG001|Overall Study|Randomization Error|1|||
156713028|NCT01473407|565694674|FG000|Overall Study|Withdrawal by Subject|4|||
156713029|NCT01473407|565694675|FG001|Overall Study|Withdrawal by Subject|7|||
156713030|NCT01473407|565694674|FG000|Overall Study|Kidney Transplant|7|||
156713031|NCT01473407|565694675|FG001|Overall Study|Kidney Transplant|6|||
156713032|NCT01473407|565694674|FG000|Overall Study|Vacation/Travel|1|||
156713033|NCT01473407|565694675|FG001|Overall Study|Vacation/Travel|1|||
156713034|NCT01473407|565694674|FG000|Overall Study|Elevated Hemoglobin|1|||
156713035|NCT01473407|565694675|FG001|Overall Study|Elevated Hemoglobin|0|||
156713036|NCT01473407|565694674|FG000|Overall Study|Patient Received Aranesp|1|||
156713037|NCT01473407|565694675|FG001|Overall Study|Patient Received Aranesp|0|||
156713038|NCT01473407|565694674|FG000|Overall Study|Patient Lost Green Card Status|1|||
156713039|NCT01473407|565694675|FG001|Overall Study|Patient Lost Green Card Status|0|||
156713040|NCT01473407|565694674|FG000|Overall Study|Temperature Excursion|2|||
156713041|NCT01473407|565694675|FG001|Overall Study|Temperature Excursion|3|||
156713042|NCT01473407|565694674|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
156713043|NCT01473407|565694675|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
156713044|NCT01473407|565694674|FG000|Overall Study|Sponsor's Decision|10|||
156713045|NCT01473407|565694675|FG001|Overall Study|Sponsor's Decision|10|||
156713046|NCT01473407|565694674|FG000|Overall Study|Site Closure|1|||
156713047|NCT01473407|565694675|FG001|Overall Study|Site Closure|0|||
156713048|NCT04071405|565694676|FG000|Overall Study|Protocol Violation|3|||
156713049|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
156713050|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
156713051|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
156713052|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
156713053|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
156713054|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
157216132|NCT01335399|567539210|FG001|Pre-treatment Period|Consent withdrawal|0|||
157216133|NCT01335399|567539209|FG000|Treatment Period|Disease progression|117|||
157216134|NCT01335399|567539210|FG001|Treatment Period|Disease progression|145|||
157216135|NCT01335399|567539209|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
156713055|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156713056|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156713057|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
156713058|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
156713059|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
156713060|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
156713061|NCT02422797|565694677|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
156713062|NCT02422797|565694678|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
156713063|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
156713064|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
156713065|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
156713066|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
156713067|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
156792465|NCT05259722|565992796|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
156713068|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
156792466|NCT05259722|565992797|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
157216136|NCT01335399|567539210|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
156713069|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
156713070|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
156713071|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
156713072|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
156713073|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
156713074|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
157216137|NCT01335399|567539209|FG000|Treatment Period|Study drug toxicity|52|||
157127207|NCT01727258|567215829|FG001|Overall Study|Adverse Event|2|||
157127208|NCT01727258|567215830|FG002|Overall Study|Adverse Event|0|||
157127209|NCT01727258|567215828|FG000|Overall Study|Noncompliance with Study Drug|0|||
157127210|NCT01727258|567215829|FG001|Overall Study|Noncompliance with Study Drug|0|||
157127211|NCT01727258|567215830|FG002|Overall Study|Noncompliance with Study Drug|1|||
157127212|NCT01727258|567215828|FG000|Overall Study|Withdrawal by Subject|1|||
157127213|NCT01727258|567215829|FG001|Overall Study|Withdrawal by Subject|1|||
157127214|NCT01727258|567215830|FG002|Overall Study|Withdrawal by Subject|0|||
157127215|NCT01727258|567215828|FG000|Overall Study|Lost to Follow-up|1|||
157127216|NCT01727258|567215829|FG001|Overall Study|Lost to Follow-up|0|||
157127217|NCT01727258|567215830|FG002|Overall Study|Lost to Follow-up|0|||
157127218|NCT01405053|567215831|FG000|Overall Study|Adverse Event|3|||
157127219|NCT01405053|567215832|FG001|Overall Study|Adverse Event|0|||
157127220|NCT01405053|567215831|FG000|Overall Study|Lost to Follow-up|0|||
157127221|NCT01405053|567215832|FG001|Overall Study|Lost to Follow-up|1|||
157127222|NCT01405053|567215831|FG000|Overall Study|Participant choice|2|||
157127223|NCT01405053|567215832|FG001|Overall Study|Participant choice|1|||
157127224|NCT01405053|567215831|FG000|Overall Study|Inadequate therapeutic effect|2|||
157127225|NCT01405053|567215832|FG001|Overall Study|Inadequate therapeutic effect|1|||
157127226|NCT01405053|567215831|FG000|Overall Study|Withdrawal by Subject|3|||
157127227|NCT01405053|567215832|FG001|Overall Study|Withdrawal by Subject|4|||
157127228|NCT01405053|567215831|FG000|Overall Study|Other|0|||
157127229|NCT01405053|567215832|FG001|Overall Study|Other|1|||
157127230|NCT00993928|567215836|FG000|Overall Study|Withdrawal by Subject|4|||
157127231|NCT00993928|567215837|FG001|Overall Study|Withdrawal by Subject|7|||
157127232|NCT00993928|567215836|FG000|Overall Study|ineligible|1|||
157127233|NCT00993928|567215837|FG001|Overall Study|ineligible|0|||
157127234|NCT04871711|567215838|FG000|Overall Study|Withdrawal by Subject|11|||
157127235|NCT04871711|567215839|FG001|Overall Study|Withdrawal by Subject|5|||
157127236|NCT04871711|567215838|FG000|Overall Study|Lack of Efficacy|5|||
157127237|NCT04871711|567215839|FG001|Overall Study|Lack of Efficacy|7|||
157127238|NCT04871711|567215838|FG000|Overall Study|Adverse Event|2|||
157127239|NCT04871711|567215839|FG001|Overall Study|Adverse Event|6|||
156792467|NCT00962650|565992798|FG000|Overall Study|Transgastric DP was not completed|2|||
156792468|NCT00420056|565992799|FG000|Overall Study|Objective progression or relapse|17|||
156792469|NCT00127933|565992805|FG000|Overall Study|Randomized but not dosed|1|||
156792470|NCT00127933|565992806|FG001|Overall Study|Randomized but not dosed|0|||
156792471|NCT03072875|565992811|FG000|Overall Study|Lost to Follow-up|1|||
156792472|NCT03111732|565992812|FG000|Overall Study|Enrolled in different study|1|||
156792473|NCT03111732|565992812|FG000|Overall Study|Progressive disease|3|||
156792474|NCT03111732|565992812|FG000|Overall Study|Withdrawal by Subject|1|||
156792475|NCT00401830|565992813|FG000|Overall Study|Adverse Event|10|||
156792476|NCT00401830|565992814|FG001|Overall Study|Adverse Event|18|||
156792477|NCT00401830|565992813|FG000|Overall Study|Lack of Efficacy|11|||
156792478|NCT00401830|565992814|FG001|Overall Study|Lack of Efficacy|5|||
156792479|NCT00401830|565992813|FG000|Overall Study|Withdrawal by Subject|4|||
156792480|NCT00401830|565992814|FG001|Overall Study|Withdrawal by Subject|3|||
156792481|NCT00401830|565992813|FG000|Overall Study|Protocol Violation|3|||
156792482|NCT00401830|565992814|FG001|Overall Study|Protocol Violation|3|||
156792483|NCT00401830|565992813|FG000|Overall Study|Non-compliance with drug study|1|||
156792484|NCT00401830|565992814|FG001|Overall Study|Non-compliance with drug study|0|||
156792485|NCT00401830|565992813|FG000|Overall Study|Lost to Follow-up|1|||
156792486|NCT00401830|565992814|FG001|Overall Study|Lost to Follow-up|3|||
156792487|NCT00401830|565992813|FG000|Overall Study|Other: Personal / Family problems|1|||
156792488|NCT00401830|565992814|FG001|Overall Study|Other: Personal / Family problems|0|||
156792489|NCT01943825|565992815|FG000|Overall Study|Lost to Follow-up|9|||
156792490|NCT01943825|565992816|FG001|Overall Study|Lost to Follow-up|3|||
156792491|NCT01943825|565992817|FG002|Overall Study|Lost to Follow-up|12|||
156874008|NCT04292899|566296181|FG002|Overall Study|Protocol Violation|0|||
157127240|NCT04871711|567215838|FG000|Overall Study|Various reasons|2|||
156792492|NCT01943825|565992818|FG003|Overall Study|Lost to Follow-up|8|||
157127241|NCT04871711|567215839|FG001|Overall Study|Various reasons|1|||
157127242|NCT04871711|567215838|FG000|Overall Study|Lost to Follow-up|0|||
157127243|NCT04871711|567215839|FG001|Overall Study|Lost to Follow-up|2|||
157127244|NCT02319044|567215840|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
157127245|NCT02319044|567215841|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
157127246|NCT02319044|567215842|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
157127247|NCT02319044|567215840|FG000|Overall Study|Withdrawal by Subject|3|||
157127248|NCT02319044|567215841|FG001|Overall Study|Withdrawal by Subject|3|||
156792493|NCT01943825|565992815|FG000|Overall Study|Withdrawal by Subject|1|||
156792494|NCT01943825|565992816|FG001|Overall Study|Withdrawal by Subject|0|||
156792495|NCT01943825|565992817|FG002|Overall Study|Withdrawal by Subject|3|||
156792496|NCT01943825|565992818|FG003|Overall Study|Withdrawal by Subject|2|||
156792497|NCT01943825|565992815|FG000|Overall Study|Other than specified above|0|||
156792498|NCT01943825|565992816|FG001|Overall Study|Other than specified above|1|||
156792499|NCT01943825|565992817|FG002|Overall Study|Other than specified above|0|||
157127249|NCT02319044|567215842|FG002|Overall Study|Withdrawal by Subject|6|||
157016544|NCT00567398|566813151|FG000|Overall Study|Withdrawal by Subject|0|||
157016545|NCT00567398|566813152|FG001|Overall Study|Withdrawal by Subject|2|||
157016546|NCT00567398|566813151|FG000|Overall Study|Renal Transplantation|0|||
157016547|NCT00567398|566813152|FG001|Overall Study|Renal Transplantation|3|||
157016548|NCT00567398|566813151|FG000|Overall Study|Other|1|||
157016549|NCT00567398|566813152|FG001|Overall Study|Other|0|||
157016550|NCT03517553|566813153|FG000|Overall Study|Withdrawal by Subject|2|||
157016551|NCT04093362|566813156|FG000|Overall Study|Study Termination|1|||
157016552|NCT04093362|566813157|FG001|Overall Study|Study Termination|1|||
157016553|NCT04093362|566813156|FG000|Overall Study|Withdrawal of Consent|1|||
157016554|NCT04093362|566813157|FG001|Overall Study|Withdrawal of Consent|0|||
157016555|NCT04093362|566813156|FG000|Overall Study|Death|1|||
157016556|NCT04093362|566813157|FG001|Overall Study|Death|3|||
157016557|NCT04093362|566813156|FG000|Overall Study|Reason not Specified|1|||
157016558|NCT04093362|566813157|FG001|Overall Study|Reason not Specified|2|||
157016559|NCT04247542|566813158|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
157016560|NCT04247542|566813159|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
157016561|NCT04247542|566813160|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
157016562|NCT04247542|566813158|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
157016563|NCT04247542|566813159|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
157016564|NCT04247542|566813160|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
157016565|NCT03055377|566813161|FG000|Treatment Phase|Lost to Follow-up|28|||
157016566|NCT03055377|566813162|FG001|Treatment Phase|Lost to Follow-up|24|||
157016567|NCT03055377|566813161|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
157016568|NCT03055377|566813162|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
157016569|NCT03157167|566813163|FG000|Overall Study|Withdrawal by Subject|1|||
157016570|NCT03157167|566813164|FG001|Overall Study|Withdrawal by Subject|0|||
157016571|NCT03157167|566813165|FG002|Overall Study|Withdrawal by Subject|0|||
157016572|NCT02597946|566813166|FG000|Overall Study|Withdrawal by Subject|1|||
157016573|NCT02597946|566813166|FG000|Overall Study|Progressive disease|16|||
157016574|NCT02597946|566813166|FG000|Overall Study|Other than above|1|||
157016575|NCT04905407|566813167|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
157016576|NCT04905407|566813168|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
157016577|NCT04905407|566813169|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
157016578|NCT04905407|566813170|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
157127250|NCT02319044|567215840|FG000|Overall Study|Condition under investigation worsened|100|||
157127251|NCT02319044|567215841|FG001|Overall Study|Condition under investigation worsened|50|||
157016579|NCT04905407|566813167|FG000|Part 1 and Part 2|Death|7|||
157016580|NCT04905407|566813168|FG001|Part 1 and Part 2|Death|7|||
157016581|NCT04905407|566813169|FG002|Part 1 and Part 2|Death|7|||
156713075|NCT02422797|565694677|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156713076|NCT02422797|565694678|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
156713077|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
156713078|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
156713079|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
156713080|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
156713081|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
156713082|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
156713083|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
156713084|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
156713085|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
156713086|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
156713087|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
156713088|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
157016582|NCT04905407|566813170|FG003|Part 1 and Part 2|Death|0|||
157016583|NCT04905407|566813167|FG000|Part 1 and Part 2|Other than specified|0|||
157127252|NCT02319044|567215842|FG002|Overall Study|Condition under investigation worsened|46|||
157127253|NCT02319044|567215840|FG000|Overall Study|Adverse Event|17|||
157127254|NCT02319044|567215841|FG001|Overall Study|Adverse Event|2|||
157127255|NCT02319044|567215842|FG002|Overall Study|Adverse Event|8|||
157127256|NCT02319044|567215840|FG000|Overall Study|Study specific discontinuation criteria|2|||
157127257|NCT02319044|567215841|FG001|Overall Study|Study specific discontinuation criteria|2|||
157016584|NCT04905407|566813168|FG001|Part 1 and Part 2|Other than specified|0|||
157016585|NCT04905407|566813169|FG002|Part 1 and Part 2|Other than specified|1|||
157016586|NCT04905407|566813170|FG003|Part 1 and Part 2|Other than specified|0|||
157016587|NCT04905407|566813167|FG000|Part 3|Death|0|||
157016588|NCT04905407|566813168|FG001|Part 3|Death|0|||
157016589|NCT04905407|566813169|FG002|Part 3|Death|0|||
157016590|NCT04905407|566813170|FG003|Part 3|Death|2|||
157016591|NCT04868110|566813173|FG000|Overall Study|Withdrawal by Subject|3|||
157127258|NCT02319044|567215842|FG002|Overall Study|Study specific discontinuation criteria|1|||
157127259|NCT02319044|567215840|FG000|Overall Study|Not treated|0|||
156713089|NCT02422797|565694677|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
156713090|NCT02422797|565694678|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
156713091|NCT01027702|565694683|FG000|Overall Study|Received subsequent therapy|1|||
156713092|NCT01027702|565694684|FG001|Overall Study|Received subsequent therapy|2|||
156713093|NCT01027702|565694685|FG002|Overall Study|Received subsequent therapy|0|||
156713094|NCT01027702|565694686|FG003|Overall Study|Received subsequent therapy|4|||
156713095|NCT01027702|565694687|FG004|Overall Study|Received subsequent therapy|1|||
156713096|NCT01027702|565694688|FG005|Overall Study|Received subsequent therapy|0|||
156713097|NCT01027702|565694689|FG006|Overall Study|Received subsequent therapy|1|||
156713098|NCT01027702|565694683|FG000|Overall Study|Death|0|||
156713099|NCT01027702|565694684|FG001|Overall Study|Death|0|||
156713100|NCT01027702|565694685|FG002|Overall Study|Death|1|||
156713101|NCT01027702|565694686|FG003|Overall Study|Death|0|||
156713102|NCT01027702|565694687|FG004|Overall Study|Death|0|||
156713103|NCT01027702|565694688|FG005|Overall Study|Death|0|||
156713104|NCT01027702|565694689|FG006|Overall Study|Death|0|||
156713105|NCT02862730|565694690|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713106|NCT02862730|565694691|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713107|NCT02862730|565694692|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
156713108|NCT02862730|565694693|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713109|NCT02862730|565694694|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713110|NCT02862730|565694695|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713111|NCT02862730|565694696|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
156713112|NCT02862730|565694690|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
156713113|NCT02862730|565694691|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713114|NCT02862730|565694692|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713115|NCT02862730|565694693|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713116|NCT02862730|565694694|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713117|NCT02862730|565694695|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713118|NCT02862730|565694696|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
156713119|NCT02862730|565694690|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713120|NCT02862730|565694691|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
157127260|NCT02319044|567215841|FG001|Overall Study|Not treated|2|||
157127261|NCT02319044|567215842|FG002|Overall Study|Not treated|2|||
157127262|NCT02026063|567215845|FG000|Overall Study|Physician Decision|0|||
156713121|NCT02862730|565694692|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
156713122|NCT02862730|565694693|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713123|NCT02862730|565694694|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
156713124|NCT02862730|565694695|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713125|NCT02862730|565694696|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
156713126|NCT02862730|565694690|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713127|NCT02862730|565694691|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713128|NCT02862730|565694692|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713129|NCT02862730|565694693|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
156713130|NCT02862730|565694694|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713131|NCT02862730|565694695|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713132|NCT02862730|565694696|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
156713133|NCT02276807|565694697|FG000|Overall Study|Withdrawal by Subject|8|||
156713134|NCT02276807|565694698|FG001|Overall Study|Withdrawal by Subject|7|||
156713135|NCT02276807|565694697|FG000|Overall Study|Lost to Follow-up|10|||
156713136|NCT02276807|565694698|FG001|Overall Study|Lost to Follow-up|10|||
156713137|NCT00261950|565694699|FG000|Overall Study|Lost to Follow-up|2|||
156713138|NCT00261950|565694699|FG000|Overall Study|Death|6|||
156713139|NCT00261950|565694699|FG000|Overall Study|Withdrawal by Subject|5|||
156713140|NCT00261950|565694699|FG000|Overall Study|Other|1|||
156713141|NCT00261950|565694699|FG000|Overall Study|Physician Decision|1|||
156713142|NCT00261950|565694699|FG000|Overall Study|Protocol specified Criteria|11|||
156713143|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
156713144|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
156713145|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
156713146|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
156713147|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713148|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713149|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
156713150|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
156713151|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
156713152|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
156713153|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
156713154|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
157127263|NCT02026063|567215846|FG001|Overall Study|Physician Decision|10|||
156713155|NCT00445432|565694702|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
156713156|NCT00445432|565694703|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
156713157|NCT00445432|565694704|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
156713158|NCT00445432|565694705|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
156713159|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
156713160|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
156713161|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
157127264|NCT02026063|567215845|FG000|Overall Study|Noncompliance with Study Drug|1|||
157127265|NCT02026063|567215846|FG001|Overall Study|Noncompliance with Study Drug|1|||
157127266|NCT02026063|567215845|FG000|Overall Study|Withdrawal of Consent|1|||
157127267|NCT02026063|567215846|FG001|Overall Study|Withdrawal of Consent|6|||
157127268|NCT02026063|567215845|FG000|Overall Study|Adverse Event|5|||
157127269|NCT02026063|567215846|FG001|Overall Study|Adverse Event|20|||
157127270|NCT02026063|567215845|FG000|Overall Study|Lack of Efficacy|0|||
157127271|NCT02026063|567215846|FG001|Overall Study|Lack of Efficacy|4|||
157127272|NCT02026063|567215845|FG000|Overall Study|Lost to Follow-up|0|||
157127273|NCT02026063|567215846|FG001|Overall Study|Lost to Follow-up|1|||
157127274|NCT02026063|567215845|FG000|Overall Study|Reason not Specified|2|||
157127275|NCT02026063|567215846|FG001|Overall Study|Reason not Specified|7|||
157127276|NCT02154087|567215848|FG000|Overall Study|Study Termination|1|||
157127277|NCT05702736|567215851|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
157127278|NCT05702736|567215852|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
157127279|NCT05702736|567215851|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
157127280|NCT05702736|567215852|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
157127281|NCT04811716|567215855|FG000|Overall Study|Withdrawal by Subject|2|||
157127282|NCT04811716|567215856|FG001|Overall Study|Withdrawal by Subject|0|||
157127283|NCT00865020|567215862|FG000|Overall Study|Withdrawal by Subject|22|||
157127284|NCT00865020|567215863|FG001|Overall Study|Withdrawal by Subject|16|||
157127285|NCT00865020|567215862|FG000|Overall Study|Adverse Event|9|||
157127286|NCT00865020|567215863|FG001|Overall Study|Adverse Event|14|||
157127287|NCT00865020|567215862|FG000|Overall Study|Abnormal test procedure result(s)|6|||
157127288|NCT00865020|567215863|FG001|Overall Study|Abnormal test procedure result(s)|8|||
157127289|NCT00865020|567215862|FG000|Overall Study|Lost to Follow-up|6|||
157127290|NCT00865020|567215863|FG001|Overall Study|Lost to Follow-up|4|||
157127291|NCT00865020|567215862|FG000|Overall Study|Protocol deviation|4|||
157127292|NCT00865020|567215863|FG001|Overall Study|Protocol deviation|1|||
157127293|NCT00865020|567215862|FG000|Overall Study|Administrative problems|0|||
157127294|NCT00865020|567215863|FG001|Overall Study|Administrative problems|2|||
157127295|NCT00865020|567215862|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157127296|NCT00865020|567215863|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157127297|NCT00865020|567215862|FG000|Overall Study|Death|0|||
157127298|NCT00865020|567215863|FG001|Overall Study|Death|1|||
157127299|NCT00865020|567215862|FG000|Overall Study|Randomized but discontinued|2|||
157127300|NCT00865020|567215863|FG001|Overall Study|Randomized but discontinued|4|||
157127301|NCT05888103|567217041|FG000|Overall Study|Participant decision|3|||
157127302|NCT05888103|567217042|FG001|Overall Study|Participant decision|3|||
157127303|NCT05900115|567217043|FG000|Overall Study|Lost to Follow-up|129|||
157127304|NCT05900115|567217044|FG001|Overall Study|Lost to Follow-up|98|||
156713162|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
156713163|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156713164|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156713165|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
156792500|NCT01943825|565992818|FG003|Overall Study|Other than specified above|1|||
156792501|NCT01472835|565992819|FG000|Overall Study|Lost to Follow-up|2|||
156792502|NCT01472835|565992820|FG001|Overall Study|Lost to Follow-up|0|||
156792503|NCT03425188|565992822|FG000|Overall Study|Withdrawal by Subject|1|||
156792504|NCT01044459|565992823|FG000|Overall Study|Withdrawal by Subject|21|||
156792505|NCT01044459|565992824|FG001|Overall Study|Withdrawal by Subject|28|||
156792506|NCT01044459|565992823|FG000|Overall Study|Terminated by Sponsor|22|||
156792507|NCT01044459|565992824|FG001|Overall Study|Terminated by Sponsor|21|||
157127305|NCT02554929|567217045|FG000|Overall Study|Lost to Follow-up|4|||
157127306|NCT02554929|567217046|FG001|Overall Study|Lost to Follow-up|4|||
157127307|NCT02554929|567217045|FG000|Overall Study|Withdrawal by Subject|2|||
157127308|NCT02554929|567217046|FG001|Overall Study|Withdrawal by Subject|8|||
157127309|NCT02324270|567217047|FG000|Overall Study|Withdrawal by Subject|0|||
157127310|NCT02324270|567217048|FG001|Overall Study|Withdrawal by Subject|1|||
156713166|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
156713167|NCT00445432|565694702|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
156792508|NCT01044459|565992823|FG000|Overall Study|Adverse Event|22|||
157127311|NCT02324270|567217049|FG002|Overall Study|Withdrawal by Subject|0|||
156792509|NCT01044459|565992824|FG001|Overall Study|Adverse Event|20|||
157127312|NCT02324270|567217047|FG000|Overall Study|Lost to Follow-up|4|||
157127313|NCT02324270|567217048|FG001|Overall Study|Lost to Follow-up|3|||
157127314|NCT02324270|567217049|FG002|Overall Study|Lost to Follow-up|4|||
157127315|NCT02324270|567217047|FG000|Overall Study|Protocol Violation|0|||
157127316|NCT02324270|567217048|FG001|Overall Study|Protocol Violation|1|||
157127317|NCT02324270|567217049|FG002|Overall Study|Protocol Violation|1|||
157127318|NCT02324270|567217047|FG000|Overall Study|Non Compliance with Study Drug|1|||
157127319|NCT02324270|567217048|FG001|Overall Study|Non Compliance with Study Drug|2|||
157127320|NCT02324270|567217049|FG002|Overall Study|Non Compliance with Study Drug|0|||
156713168|NCT00445432|565694703|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
156713169|NCT00445432|565694704|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
156713170|NCT00445432|565694705|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
156713171|NCT02789137|565694706|FG000|Overall Study|Dropped out/Died|58|||
156713172|NCT01090414|565694707|FG000|Study 101-99|Progressive Disease|28|||
156713173|NCT01090414|565694708|FG001|Study 101-99|Progressive Disease|48|||
156713174|NCT01090414|565694709|FG002|Study 101-99|Progressive Disease|10|||
156713175|NCT01090414|565694710|FG003|Study 101-99|Progressive Disease|4|||
156713176|NCT01090414|565694707|FG000|Study 101-99|Adverse Event|10|||
156713177|NCT01090414|565694708|FG001|Study 101-99|Adverse Event|28|||
156713178|NCT01090414|565694709|FG002|Study 101-99|Adverse Event|18|||
156713179|NCT01090414|565694710|FG003|Study 101-99|Adverse Event|0|||
156713180|NCT01090414|565694707|FG000|Study 101-99|Investigator Request|1|||
156713181|NCT01090414|565694708|FG001|Study 101-99|Investigator Request|11|||
156713182|NCT01090414|565694709|FG002|Study 101-99|Investigator Request|4|||
156713183|NCT01090414|565694710|FG003|Study 101-99|Investigator Request|0|||
156713184|NCT01090414|565694707|FG000|Study 101-99|Death|3|||
156713185|NCT01090414|565694708|FG001|Study 101-99|Death|8|||
156713186|NCT01090414|565694709|FG002|Study 101-99|Death|1|||
156713187|NCT01090414|565694710|FG003|Study 101-99|Death|0|||
156713188|NCT01090414|565694707|FG000|Study 101-99|Sponsor Discontinued Study|0|||
156713189|NCT01090414|565694708|FG001|Study 101-99|Sponsor Discontinued Study|7|||
156713190|NCT01090414|565694709|FG002|Study 101-99|Sponsor Discontinued Study|5|||
156713191|NCT01090414|565694710|FG003|Study 101-99|Sponsor Discontinued Study|0|||
156713192|NCT01090414|565694707|FG000|Study 101-99|Other (Unknown Reasons)|3|||
156713193|NCT01090414|565694708|FG001|Study 101-99|Other (Unknown Reasons)|3|||
156713194|NCT01090414|565694709|FG002|Study 101-99|Other (Unknown Reasons)|0|||
156713195|NCT01090414|565694710|FG003|Study 101-99|Other (Unknown Reasons)|0|||
156713196|NCT01090414|565694707|FG000|Study 101-99|Withdrew Consent|0|||
156713197|NCT01090414|565694708|FG001|Study 101-99|Withdrew Consent|2|||
156713198|NCT01090414|565694709|FG002|Study 101-99|Withdrew Consent|3|||
156713199|NCT01090414|565694710|FG003|Study 101-99|Withdrew Consent|1|||
156713200|NCT01090414|565694707|FG000|Study 101-99|Participant Request|3|||
156713201|NCT01090414|565694708|FG001|Study 101-99|Participant Request|1|||
156713202|NCT01090414|565694709|FG002|Study 101-99|Participant Request|0|||
156713203|NCT01090414|565694710|FG003|Study 101-99|Participant Request|0|||
156713204|NCT04138823|565694729|FG000|Overall Study|Clinical disease progression|0|||
156713205|NCT04138823|565694730|FG001|Overall Study|Clinical disease progression|0|||
156713206|NCT04138823|565694731|FG002|Overall Study|Clinical disease progression|1|||
156713207|NCT04138823|565694729|FG000|Overall Study|Objective disease progression|3|||
156713208|NCT04138823|565694730|FG001|Overall Study|Objective disease progression|2|||
156713209|NCT04138823|565694731|FG002|Overall Study|Objective disease progression|5|||
156713210|NCT02466685|565694733|FG000|Overall Study|Adverse Event|5|||
156713211|NCT02466685|565694734|FG001|Overall Study|Adverse Event|2|||
156713212|NCT02466685|565694733|FG000|Overall Study|Lost to Follow-up|1|||
156713213|NCT02466685|565694734|FG001|Overall Study|Lost to Follow-up|1|||
156713214|NCT02466685|565694733|FG000|Overall Study|Withdrawal by Subject|1|||
156713215|NCT02466685|565694734|FG001|Overall Study|Withdrawal by Subject|0|||
156713216|NCT02466685|565694733|FG000|Overall Study|Physician Decision|1|||
156713217|NCT02466685|565694734|FG001|Overall Study|Physician Decision|1|||
156713218|NCT02565511|565694735|FG000|Overall Study|Study terminated by Sponsor|35|||
156713219|NCT02565511|565694736|FG001|Overall Study|Study terminated by Sponsor|22|||
157127321|NCT03521791|567217050|FG000|Overall Study|Protocol Violation|7|||
157127322|NCT03521791|567217051|FG001|Overall Study|Protocol Violation|17|||
156713220|NCT02565511|565694737|FG002|Overall Study|Study terminated by Sponsor|235|||
156713221|NCT02565511|565694738|FG003|Overall Study|Study terminated by Sponsor|156|||
156713222|NCT02565511|565694735|FG000|Overall Study|Withdrawal by Subject|3|||
156713223|NCT02565511|565694736|FG001|Overall Study|Withdrawal by Subject|0|||
156713224|NCT02565511|565694737|FG002|Overall Study|Withdrawal by Subject|12|||
156713225|NCT02565511|565694738|FG003|Overall Study|Withdrawal by Subject|5|||
156713226|NCT02565511|565694735|FG000|Overall Study|Adverse Event|0|||
156713227|NCT02565511|565694736|FG001|Overall Study|Adverse Event|0|||
156713228|NCT02565511|565694737|FG002|Overall Study|Adverse Event|1|||
156713229|NCT02565511|565694738|FG003|Overall Study|Adverse Event|1|||
156713230|NCT02565511|565694735|FG000|Overall Study|Lost to Follow-up|4|||
156713231|NCT02565511|565694736|FG001|Overall Study|Lost to Follow-up|1|||
156713232|NCT02565511|565694737|FG002|Overall Study|Lost to Follow-up|0|||
157127323|NCT03786432|567217052|FG000|Overall Study|Screen Failure after consent|1|||
157127324|NCT03786432|567217052|FG000|Overall Study|Lost to Follow-up|4|||
157127325|NCT03786432|567217052|FG000|Overall Study|did not complete 12 month CT scan|1|||
157127326|NCT03038308|567217053|FG000|Overall Study|Surgical resection|1|||
157127327|NCT03038308|567217053|FG000|Overall Study|Withdrawal by Subject|2|||
157127328|NCT03038308|567217053|FG000|Overall Study|Lost to Follow-up|1|||
157127329|NCT00771472|567217055|FG000|Overall Study|Physician Decision|2|||
157127330|NCT00771472|567217056|FG001|Overall Study|Physician Decision|3|||
157127331|NCT00771472|567217055|FG000|Overall Study|Progressive Disease|3|||
157127332|NCT00771472|567217056|FG001|Overall Study|Progressive Disease|1|||
157127333|NCT00771472|567217055|FG000|Overall Study|Protocol Violation|1|||
157127334|NCT00771472|567217056|FG001|Overall Study|Protocol Violation|0|||
157127335|NCT02002975|567217057|FG000|Overall Study|Case Report Forms Uncollected|135|||
157127336|NCT02002975|567217057|FG000|Overall Study|Protocol Deviation|437|||
157127337|NCT03988907|567217058|FG000|Overall Study|Unable to complete visit|0|||
157127338|NCT03988907|567217059|FG001|Overall Study|Unable to complete visit|1|||
157127339|NCT03609619|567217063|FG000|Overall Study|Adverse Event|1|||
157127340|NCT03609619|567217064|FG001|Overall Study|Adverse Event|0|||
157216138|NCT01335399|567539210|FG001|Treatment Period|Study drug toxicity|64|||
156713233|NCT02565511|565694738|FG003|Overall Study|Lost to Follow-up|1|||
156713234|NCT02565511|565694735|FG000|Overall Study|Physician Decision|0|||
156713235|NCT02565511|565694736|FG001|Overall Study|Physician Decision|0|||
156713236|NCT02565511|565694737|FG002|Overall Study|Physician Decision|0|||
156713237|NCT02565511|565694738|FG003|Overall Study|Physician Decision|1|||
156713238|NCT02565511|565694735|FG000|Overall Study|Protocol deviation|0|||
156713239|NCT02565511|565694736|FG001|Overall Study|Protocol deviation|0|||
156713240|NCT02565511|565694737|FG002|Overall Study|Protocol deviation|3|||
156713241|NCT02565511|565694738|FG003|Overall Study|Protocol deviation|0|||
156713242|NCT00104572|565694739|FG000|Overall Study|Withdrawal by Subject|3|||
156713243|NCT00104572|565694740|FG001|Overall Study|Withdrawal by Subject|3|||
156713244|NCT00104572|565694741|FG002|Overall Study|Withdrawal by Subject|0|||
156713245|NCT02969044|565694743|FG000|Overall Study|Withdrawal by Subject|2|||
156713246|NCT02969044|565694744|FG001|Overall Study|Withdrawal by Subject|6|||
156713247|NCT02969044|565694743|FG000|Overall Study|Adverse Event|3|||
156713248|NCT02969044|565694744|FG001|Overall Study|Adverse Event|0|||
156713249|NCT04650204|565694745|FG000|Overall Study|Study was Terminated|2|||
156713250|NCT04650204|565694746|FG001|Overall Study|Study was Terminated|1|||
156713251|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
156713252|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Off-label use|283|||
156713253|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
156713254|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
156713255|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
156713256|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
156713257|NCT01070953|565694755|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
156713258|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
156713259|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
156713260|NCT01070953|565694755|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
156713261|NCT04700137|565694756|FG000|Overall Study|Lost to Follow-up|1|||
156713262|NCT04700137|565694757|FG001|Overall Study|Lost to Follow-up|6|||
156713263|NCT04700137|565694758|FG002|Overall Study|Lost to Follow-up|1|||
156792510|NCT01044459|565992823|FG000|Overall Study|Lack of Efficacy|23|||
156792511|NCT01044459|565992824|FG001|Overall Study|Lack of Efficacy|12|||
156792512|NCT01044459|565992823|FG000|Overall Study|Protocol Violation|11|||
156792513|NCT01044459|565992824|FG001|Overall Study|Protocol Violation|16|||
156792514|NCT01044459|565992823|FG000|Overall Study|Other Reason|7|||
156792515|NCT01044459|565992824|FG001|Overall Study|Other Reason|14|||
156792516|NCT01044459|565992823|FG000|Overall Study|COPD exacerbation|9|||
156792517|NCT01044459|565992824|FG001|Overall Study|COPD exacerbation|8|||
156792518|NCT01044459|565992823|FG000|Overall Study|Lost to Follow-up|18|||
156792519|NCT01044459|565992824|FG001|Overall Study|Lost to Follow-up|12|||
156792520|NCT05346640|565992825|FG000|Overall Study|Lack of Efficacy|2|||
156792521|NCT05346640|565992825|FG000|Overall Study|Lost to Follow-up|14|||
156792522|NCT05346640|565992825|FG000|Overall Study|Protocol Violation|4|||
156792523|NCT05346640|565992825|FG000|Overall Study|Withdrawal by Subject|2|||
156792524|NCT05346640|565992825|FG000|Overall Study|Physiological Complications|3|||
156792525|NCT05346640|565992825|FG000|Overall Study|Other Reason|3|||
156792526|NCT04634331|565992826|FG000|Overall Study|Withdrawal by Subject|2|||
156792527|NCT04634331|565992827|FG001|Overall Study|Withdrawal by Subject|2|||
156792528|NCT03726879|565992828|FG000|Overall Study|Death|11|||
156874009|NCT04292899|566296182|FG003|Overall Study|Protocol Violation|1|||
156874010|NCT00948441|566296183|FG000|Overall Study|no longer meet inclusion criteria|1|||
156792529|NCT03726879|565992829|FG001|Overall Study|Death|13|||
156792530|NCT03726879|565992828|FG000|Overall Study|Physician Decision|0|||
157016592|NCT04868110|566813174|FG001|Overall Study|Withdrawal by Subject|4|||
157016593|NCT01938547|566813181|FG000|Overall Study|Physician Decision|1|||
157016594|NCT02287311|566813184|FG000|Cohort 1: Dose Level 1|Death|2|||
157016595|NCT02287311|566813185|FG001|Cohort 1: Dose Level 1|Death|0|||
157016596|NCT02287311|566813186|FG002|Cohort 1: Dose Level 1|Death|0|||
157016597|NCT02287311|566813187|FG003|Cohort 1: Dose Level 1|Death|3|||
157016598|NCT02287311|566813188|FG004|Cohort 1: Dose Level 1|Death|0|||
157016599|NCT02287311|566813189|FG005|Cohort 1: Dose Level 1|Death|0|||
157127341|NCT03609619|567217063|FG000|Overall Study|Lack of Efficacy|1|||
156713264|NCT04700137|565694759|FG003|Overall Study|Lost to Follow-up|1|||
156874011|NCT00948441|566296184|FG001|Overall Study|no longer meet inclusion criteria|4|||
156874012|NCT00396253|566296185|FG000|Overall Study|Protocol Violation|1|||
156713265|NCT04700137|565694756|FG000|Overall Study|Withdrawal by Subject|0|||
156713266|NCT04700137|565694757|FG001|Overall Study|Withdrawal by Subject|0|||
156713267|NCT04700137|565694758|FG002|Overall Study|Withdrawal by Subject|1|||
156713268|NCT04700137|565694759|FG003|Overall Study|Withdrawal by Subject|0|||
156713269|NCT04700137|565694756|FG000|Overall Study|Death|0|||
156713270|NCT04700137|565694757|FG001|Overall Study|Death|0|||
156713271|NCT04700137|565694758|FG002|Overall Study|Death|1|||
156713272|NCT04700137|565694759|FG003|Overall Study|Death|0|||
156713273|NCT02503787|565694760|FG000|Enrollment|Withdrawal by Subject|6|||
156713274|NCT02503787|565694760|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
156713275|NCT02503787|565694760|FG000|Enrollment|Physician Decision|2|||
156713276|NCT02503787|565694760|FG000|Enrollment|Insurance issue|2|||
156713277|NCT02503787|565694760|FG000|Enrollment|Lost to Follow-up|1|||
156713278|NCT02503787|565694760|FG000|Enrollment|Study closure|1|||
156713279|NCT02503787|565694760|FG000|Enrollment|Adverse Event|1|||
156713280|NCT02503787|565694760|FG000|Enrollment|Protocol Violation|1|||
156713281|NCT02503787|565694760|FG000|Enrollment|Inability to implant system|1|||
156713282|NCT02503787|565694760|FG000|Enrollment|Unable to be programmed|1|||
156713283|NCT02503787|565694760|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
156713284|NCT02503787|565694760|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
156713285|NCT02503787|565694760|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
156713286|NCT02503787|565694760|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
156713287|NCT02503787|565694760|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
156713288|NCT02503787|565694760|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
156713289|NCT04787627|565694761|FG000|Overall Study|Withdrawal by Subject|3|||
156713290|NCT04787627|565694762|FG001|Overall Study|Withdrawal by Subject|0|||
156713291|NCT04787627|565694761|FG000|Overall Study|Physician Decision|2|||
156713292|NCT04787627|565694762|FG001|Overall Study|Physician Decision|0|||
156713293|NCT04787627|565694761|FG000|Overall Study|Excluded|0|||
156713294|NCT04787627|565694762|FG001|Overall Study|Excluded|1|||
156713295|NCT00548093|565694763|FG000|Overall Study|Death|33|||
156713296|NCT00548093|565694764|FG001|Overall Study|Death|13|||
156713297|NCT00548093|565694763|FG000|Overall Study|Lost to Follow-up|3|||
156713298|NCT00548093|565694764|FG001|Overall Study|Lost to Follow-up|1|||
156713299|NCT00548093|565694763|FG000|Overall Study|Objective progression or relapse|1|||
156713300|NCT00548093|565694764|FG001|Overall Study|Objective progression or relapse|1|||
156713301|NCT00548093|565694763|FG000|Overall Study|Other|11|||
156713302|NCT00548093|565694764|FG001|Overall Study|Other|1|||
156713303|NCT00548093|565694763|FG000|Overall Study|Withdrawal by Subject|1|||
156713304|NCT00548093|565694764|FG001|Overall Study|Withdrawal by Subject|0|||
156713305|NCT00548093|565694763|FG000|Overall Study|Completed post-treatment follow-up|1|||
156713306|NCT00548093|565694764|FG001|Overall Study|Completed post-treatment follow-up|0|||
156713307|NCT00174954|565694767|FG000|Overall Study|Adverse Event|2|||
156713308|NCT00174954|565694767|FG000|Overall Study|No tophi found in MRI|1|||
156713309|NCT00174954|565694767|FG000|Overall Study|Physician Decision|1|||
156713310|NCT00839254|565694768|FG000|Overall Study|Protocol Violation|0|||
156713311|NCT00839254|565694769|FG001|Overall Study|Protocol Violation|1|||
156713312|NCT00839254|565694770|FG002|Overall Study|Protocol Violation|1|||
156713313|NCT00839254|565694771|FG003|Overall Study|Protocol Violation|1|||
156713314|NCT00839254|565694772|FG004|Overall Study|Protocol Violation|0|||
156713315|NCT00839254|565694773|FG005|Overall Study|Protocol Violation|0|||
156713316|NCT00839254|565694774|FG006|Overall Study|Protocol Violation|1|||
156713317|NCT00839254|565694775|FG007|Overall Study|Protocol Violation|2|||
156713318|NCT00839254|565694768|FG000|Overall Study|Physician Decision|0|||
156713319|NCT00839254|565694769|FG001|Overall Study|Physician Decision|1|||
156713320|NCT00839254|565694770|FG002|Overall Study|Physician Decision|0|||
156713321|NCT00839254|565694771|FG003|Overall Study|Physician Decision|0|||
156713322|NCT00839254|565694772|FG004|Overall Study|Physician Decision|0|||
156713323|NCT00839254|565694773|FG005|Overall Study|Physician Decision|0|||
156713324|NCT00839254|565694774|FG006|Overall Study|Physician Decision|0|||
156713325|NCT00839254|565694775|FG007|Overall Study|Physician Decision|1|||
157127342|NCT03609619|567217064|FG001|Overall Study|Lack of Efficacy|2|||
156713326|NCT00839254|565694768|FG000|Overall Study|Wrong treatment number allocation|0|||
156713327|NCT00839254|565694769|FG001|Overall Study|Wrong treatment number allocation|1|||
156713328|NCT00839254|565694770|FG002|Overall Study|Wrong treatment number allocation|0|||
156713329|NCT00839254|565694771|FG003|Overall Study|Wrong treatment number allocation|0|||
156713330|NCT00839254|565694772|FG004|Overall Study|Wrong treatment number allocation|0|||
156713331|NCT00839254|565694773|FG005|Overall Study|Wrong treatment number allocation|1|||
156713332|NCT00839254|565694774|FG006|Overall Study|Wrong treatment number allocation|0|||
156713333|NCT00839254|565694775|FG007|Overall Study|Wrong treatment number allocation|0|||
156874013|NCT00396253|566296185|FG000|Overall Study|Withdrawal by Subject|7|||
156713334|NCT00839254|565694768|FG000|Overall Study|Adverse Event|12|||
156713335|NCT00839254|565694769|FG001|Overall Study|Adverse Event|6|||
156713336|NCT00839254|565694770|FG002|Overall Study|Adverse Event|3|||
156713337|NCT00839254|565694771|FG003|Overall Study|Adverse Event|5|||
157216139|NCT01335399|567539209|FG000|Treatment Period|Participant request to discontinue|30|||
157216140|NCT01335399|567539210|FG001|Treatment Period|Participant request to discontinue|22|||
157216141|NCT01335399|567539209|FG000|Treatment Period|Other reasons|30|||
157216142|NCT01335399|567539210|FG001|Treatment Period|Other reasons|30|||
157216143|NCT01335399|567539209|FG000|Treatment Period|Consent withdrawal|10|||
157216144|NCT01335399|567539210|FG001|Treatment Period|Consent withdrawal|7|||
157216145|NCT01335399|567539209|FG000|Treatment Period|Death|7|||
157216146|NCT01335399|567539210|FG001|Treatment Period|Death|6|||
157216147|NCT01335399|567539209|FG000|Treatment Period|Poor/Non-compliance|3|||
157216148|NCT01335399|567539210|FG001|Treatment Period|Poor/Non-compliance|4|||
157216149|NCT01335399|567539209|FG000|Treatment Period|Lost to Follow-up|2|||
157216150|NCT01335399|567539210|FG001|Treatment Period|Lost to Follow-up|2|||
157216151|NCT01335399|567539209|FG000|Treatment Period|Maximum clinical benefit|1|||
157216152|NCT01335399|567539210|FG001|Treatment Period|Maximum clinical benefit|1|||
157216153|NCT01335399|567539209|FG000|Treatment Period|No longer meet study criteria|1|||
157216154|NCT01335399|567539210|FG001|Treatment Period|No longer meet study criteria|1|||
157216155|NCT01335399|567539209|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
157216156|NCT01335399|567539210|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
157216157|NCT01120600|567539213|FG000|Overall Study|Adverse Event|7|||
157216158|NCT01120600|567539214|FG001|Overall Study|Adverse Event|7|||
157216159|NCT01120600|567539213|FG000|Overall Study|Excessive Bone Loss|0|||
157216160|NCT01120600|567539214|FG001|Overall Study|Excessive Bone Loss|4|||
157216161|NCT01120600|567539213|FG000|Overall Study|Lost to Follow-up|1|||
157216162|NCT01120600|567539214|FG001|Overall Study|Lost to Follow-up|3|||
157216163|NCT01120600|567539213|FG000|Overall Study|Physician Decision|1|||
157216164|NCT01120600|567539214|FG001|Overall Study|Physician Decision|3|||
157216165|NCT01120600|567539213|FG000|Overall Study|Protocol Violation|0|||
157216166|NCT01120600|567539214|FG001|Overall Study|Protocol Violation|4|||
157216167|NCT01120600|567539213|FG000|Overall Study|Withdrawal by Subject|10|||
157216168|NCT01120600|567539214|FG001|Overall Study|Withdrawal by Subject|11|||
157216169|NCT02544633|567539219|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
156792531|NCT03726879|565992829|FG001|Overall Study|Physician Decision|2|||
156792532|NCT03726879|565992828|FG000|Overall Study|Protocol Violation|0|||
156792533|NCT03726879|565992829|FG001|Overall Study|Protocol Violation|1|||
156874014|NCT00396253|566296185|FG000|Overall Study|Death|3|||
156792534|NCT03726879|565992828|FG000|Overall Study|Withdrawal by Subject|5|||
156792535|NCT03726879|565992829|FG001|Overall Study|Withdrawal by Subject|6|||
156792536|NCT03726879|565992828|FG000|Overall Study|TSH result is unstable|0|||
156792537|NCT03726879|565992829|FG001|Overall Study|TSH result is unstable|1|||
156792538|NCT03726879|565992828|FG000|Overall Study|Disease relapse|1|||
156792539|NCT03726879|565992829|FG001|Overall Study|Disease relapse|0|||
156792540|NCT03726879|565992828|FG000|Overall Study|Lost to Follow-up|3|||
156792541|NCT03726879|565992829|FG001|Overall Study|Lost to Follow-up|0|||
156792542|NCT00553475|565992831|FG000|Overall Study|Adverse Event|7|||
156792543|NCT00553475|565992832|FG001|Overall Study|Adverse Event|17|||
156792544|NCT00553475|565992833|FG002|Overall Study|Adverse Event|13|||
156792545|NCT00553475|565992831|FG000|Overall Study|Lack of Efficacy|7|||
156792546|NCT00553475|565992832|FG001|Overall Study|Lack of Efficacy|1|||
157016600|NCT02287311|566813190|FG006|Cohort 1: Dose Level 1|Death|1|||
157016601|NCT02287311|566813191|FG007|Cohort 1: Dose Level 1|Death|0|||
157016602|NCT02287311|566813192|FG008|Cohort 1: Dose Level 1|Death|0|||
157016603|NCT02287311|566813184|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016604|NCT02287311|566813185|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016605|NCT02287311|566813186|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016606|NCT02287311|566813187|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
157016607|NCT02287311|566813188|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016608|NCT02287311|566813189|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016609|NCT02287311|566813190|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
157016610|NCT02287311|566813191|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016611|NCT02287311|566813192|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
157016612|NCT02287311|566813184|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
157016613|NCT02287311|566813185|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
157016614|NCT02287311|566813186|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
157016615|NCT02287311|566813187|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
157016616|NCT02287311|566813188|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
157016617|NCT02287311|566813189|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
157016618|NCT02287311|566813190|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
157016619|NCT02287311|566813191|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
157016620|NCT02287311|566813192|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
157016621|NCT02287311|566813184|FG000|Cohort 2: Dose Level 2|Death|0|||
157016622|NCT02287311|566813185|FG001|Cohort 2: Dose Level 2|Death|2|||
157016623|NCT02287311|566813186|FG002|Cohort 2: Dose Level 2|Death|0|||
157016624|NCT02287311|566813187|FG003|Cohort 2: Dose Level 2|Death|0|||
157016625|NCT02287311|566813188|FG004|Cohort 2: Dose Level 2|Death|2|||
157216170|NCT02544633|567539220|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
157216171|NCT02544633|567539221|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
157216172|NCT02544633|567539222|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
156713338|NCT00839254|565694772|FG004|Overall Study|Adverse Event|2|||
156713339|NCT00839254|565694773|FG005|Overall Study|Adverse Event|1|||
156713340|NCT00839254|565694774|FG006|Overall Study|Adverse Event|0|||
156713341|NCT00839254|565694775|FG007|Overall Study|Adverse Event|1|||
156713342|NCT00839254|565694768|FG000|Overall Study|Withdrawal by Subject|87|||
156713343|NCT00839254|565694769|FG001|Overall Study|Withdrawal by Subject|53|||
156713344|NCT00839254|565694770|FG002|Overall Study|Withdrawal by Subject|54|||
156713345|NCT00839254|565694771|FG003|Overall Study|Withdrawal by Subject|32|||
156713346|NCT00839254|565694772|FG004|Overall Study|Withdrawal by Subject|27|||
156713347|NCT00839254|565694773|FG005|Overall Study|Withdrawal by Subject|15|||
156713348|NCT00839254|565694774|FG006|Overall Study|Withdrawal by Subject|22|||
156713349|NCT00839254|565694775|FG007|Overall Study|Withdrawal by Subject|9|||
156713350|NCT00839254|565694768|FG000|Overall Study|Wrong group allocation|0|||
156713351|NCT00839254|565694769|FG001|Overall Study|Wrong group allocation|0|||
156713352|NCT00839254|565694770|FG002|Overall Study|Wrong group allocation|0|||
156713353|NCT00839254|565694771|FG003|Overall Study|Wrong group allocation|0|||
156713354|NCT00839254|565694772|FG004|Overall Study|Wrong group allocation|0|||
156713355|NCT00839254|565694773|FG005|Overall Study|Wrong group allocation|0|||
156713356|NCT00839254|565694774|FG006|Overall Study|Wrong group allocation|1|||
156713357|NCT00839254|565694775|FG007|Overall Study|Wrong group allocation|0|||
156713358|NCT00839254|565694768|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
156713359|NCT00839254|565694769|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713360|NCT00839254|565694770|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713361|NCT00839254|565694771|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713362|NCT00839254|565694772|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713363|NCT00839254|565694773|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
156713364|NCT00839254|565694774|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713365|NCT00839254|565694775|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
156713366|NCT00839254|565694768|FG000|Overall Study|Withdrawn due to non-compliance|2|||
156713367|NCT00839254|565694769|FG001|Overall Study|Withdrawn due to non-compliance|0|||
156713368|NCT00839254|565694770|FG002|Overall Study|Withdrawn due to non-compliance|0|||
156713369|NCT00839254|565694771|FG003|Overall Study|Withdrawn due to non-compliance|0|||
156713370|NCT00839254|565694772|FG004|Overall Study|Withdrawn due to non-compliance|0|||
156713371|NCT00839254|565694773|FG005|Overall Study|Withdrawn due to non-compliance|0|||
156713372|NCT00839254|565694774|FG006|Overall Study|Withdrawn due to non-compliance|0|||
156713373|NCT00839254|565694775|FG007|Overall Study|Withdrawn due to non-compliance|0|||
156713374|NCT00839254|565694768|FG000|Overall Study|Lost to Follow-up|51|||
156713375|NCT00839254|565694769|FG001|Overall Study|Lost to Follow-up|30|||
156713376|NCT00839254|565694770|FG002|Overall Study|Lost to Follow-up|32|||
156713377|NCT00839254|565694771|FG003|Overall Study|Lost to Follow-up|24|||
156713378|NCT00839254|565694772|FG004|Overall Study|Lost to Follow-up|8|||
156713379|NCT00839254|565694773|FG005|Overall Study|Lost to Follow-up|8|||
156713380|NCT00839254|565694774|FG006|Overall Study|Lost to Follow-up|4|||
156713381|NCT00839254|565694775|FG007|Overall Study|Lost to Follow-up|2|||
156713382|NCT02359994|565694779|FG000|Overall Population Study|Adverse Event|1|||
156713383|NCT02359994|565694780|FG001|Overall Population Study|Adverse Event|1|||
156713384|NCT02359994|565694779|FG000|Overall Population Study|Death|1|||
156713385|NCT02359994|565694780|FG001|Overall Population Study|Death|5|||
156713386|NCT02359994|565694779|FG000|Overall Population Study|Lost to Follow-up|1|||
156713387|NCT02359994|565694780|FG001|Overall Population Study|Lost to Follow-up|1|||
156713388|NCT02359994|565694779|FG000|Overall Population Study|Withdrawal by Subject|1|||
156713389|NCT02359994|565694780|FG001|Overall Population Study|Withdrawal by Subject|0|||
156713390|NCT02359994|565694779|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
156713391|NCT02359994|565694780|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
156713392|NCT02359994|565694779|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
156713393|NCT02359994|565694780|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
156713394|NCT02359994|565694779|FG000|Extended Oncology 24-Month Survival|Death|19|||
156713395|NCT02359994|565694780|FG001|Extended Oncology 24-Month Survival|Death|21|||
156713396|NCT02359994|565694779|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
156713397|NCT02359994|565694780|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
156713398|NCT01823835|565694781|FG000|Overall Study|Adverse Event|0|||
156713399|NCT01823835|565694782|FG001|Overall Study|Adverse Event|0|||
156713400|NCT01823835|565694783|FG002|Overall Study|Adverse Event|0|||
156713401|NCT01823835|565694784|FG003|Overall Study|Adverse Event|0|||
156713402|NCT01823835|565694785|FG004|Overall Study|Adverse Event|1|||
156713403|NCT01823835|565694786|FG005|Overall Study|Adverse Event|0|||
156713404|NCT01823835|565694787|FG006|Overall Study|Adverse Event|1|||
156713405|NCT01823835|565694788|FG007|Overall Study|Adverse Event|0|||
156713406|NCT01823835|565694789|FG008|Overall Study|Adverse Event|0|||
156713407|NCT01823835|565694790|FG009|Overall Study|Adverse Event|0|||
156713408|NCT01823835|565694791|FG010|Overall Study|Adverse Event|1|||
157016626|NCT02287311|566813189|FG005|Cohort 2: Dose Level 2|Death|0|||
157016627|NCT02287311|566813190|FG006|Cohort 2: Dose Level 2|Death|0|||
156713409|NCT01823835|565694792|FG011|Overall Study|Adverse Event|2|||
156713410|NCT01823835|565694793|FG012|Overall Study|Adverse Event|0|||
156713411|NCT01823835|565694794|FG013|Overall Study|Adverse Event|0|||
156713412|NCT01823835|565694795|FG014|Overall Study|Adverse Event|0|||
156713413|NCT01823835|565694781|FG000|Overall Study|Physician Decision|0|||
156713414|NCT01823835|565694782|FG001|Overall Study|Physician Decision|0|||
156713415|NCT01823835|565694783|FG002|Overall Study|Physician Decision|0|||
156713416|NCT01823835|565694784|FG003|Overall Study|Physician Decision|0|||
156713417|NCT01823835|565694785|FG004|Overall Study|Physician Decision|0|||
156713418|NCT01823835|565694786|FG005|Overall Study|Physician Decision|0|||
156713419|NCT01823835|565694787|FG006|Overall Study|Physician Decision|0|||
157127343|NCT03609619|567217063|FG000|Overall Study|Protocol Violation|5|||
157127344|NCT03609619|567217064|FG001|Overall Study|Protocol Violation|0|||
157127345|NCT03609619|567217063|FG000|Overall Study|Withdrawal by Subject|2|||
157127346|NCT03609619|567217064|FG001|Overall Study|Withdrawal by Subject|3|||
157127347|NCT03609619|567217063|FG000|Overall Study|Lost to Follow-up|1|||
157127348|NCT03609619|567217064|FG001|Overall Study|Lost to Follow-up|1|||
157127349|NCT00688909|567217065|FG000|Overall Study|Adverse Event|28|||
157127350|NCT00688909|567217065|FG000|Overall Study|Patient withdrew consent|2|||
157127351|NCT00688909|567217065|FG000|Overall Study|Administrative problems|1|||
157127352|NCT00688909|567217065|FG000|Overall Study|Protocol Violation|2|||
157127353|NCT01668654|567217066|FG000|Overall Study|Study Closed/Terminated|3|||
157127354|NCT01668654|567217066|FG000|Overall Study|Withdrawal by Subject|1|||
157127355|NCT03634800|567217067|FG000|Overall Study|Adverse Event|1|||
157127356|NCT03634800|567217067|FG000|Overall Study|Disease Progression|4|||
157127357|NCT03634800|567217067|FG000|Overall Study|Withdrawal by Subject|1|||
157127358|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
157127359|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
157127360|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
157127361|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
156713420|NCT01823835|565694788|FG007|Overall Study|Physician Decision|0|||
156713421|NCT01823835|565694789|FG008|Overall Study|Physician Decision|0|||
156713422|NCT01823835|565694790|FG009|Overall Study|Physician Decision|0|||
156713423|NCT01823835|565694791|FG010|Overall Study|Physician Decision|0|||
156713424|NCT01823835|565694792|FG011|Overall Study|Physician Decision|2|||
156713425|NCT01823835|565694793|FG012|Overall Study|Physician Decision|0|||
156713426|NCT01823835|565694794|FG013|Overall Study|Physician Decision|0|||
156713427|NCT01823835|565694795|FG014|Overall Study|Physician Decision|0|||
156713428|NCT01823835|565694781|FG000|Overall Study|Progressive Disease|3|||
156713429|NCT01823835|565694782|FG001|Overall Study|Progressive Disease|4|||
156713430|NCT01823835|565694783|FG002|Overall Study|Progressive Disease|3|||
156713431|NCT01823835|565694784|FG003|Overall Study|Progressive Disease|6|||
156713432|NCT01823835|565694785|FG004|Overall Study|Progressive Disease|4|||
156713433|NCT01823835|565694786|FG005|Overall Study|Progressive Disease|6|||
156713434|NCT01823835|565694787|FG006|Overall Study|Progressive Disease|5|||
156713435|NCT01823835|565694788|FG007|Overall Study|Progressive Disease|3|||
156713436|NCT01823835|565694789|FG008|Overall Study|Progressive Disease|3|||
156713437|NCT01823835|565694790|FG009|Overall Study|Progressive Disease|18|||
156713438|NCT01823835|565694791|FG010|Overall Study|Progressive Disease|8|||
156713439|NCT01823835|565694792|FG011|Overall Study|Progressive Disease|46|||
156713440|NCT01823835|565694793|FG012|Overall Study|Progressive Disease|18|||
156713441|NCT01823835|565694794|FG013|Overall Study|Progressive Disease|4|||
156713442|NCT01823835|565694795|FG014|Overall Study|Progressive Disease|6|||
156713443|NCT01823835|565694781|FG000|Overall Study|Study Termination|0|||
156874015|NCT00396253|566296185|FG000|Overall Study|Physician Decision|1|||
157127362|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
157127363|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
157127364|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
157127365|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
157127366|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
157127367|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
157127368|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
157216173|NCT02544633|567539219|FG000|Treatment Period|Adverse Event|7|||
156713444|NCT01823835|565694782|FG001|Overall Study|Study Termination|0|||
156713445|NCT01823835|565694783|FG002|Overall Study|Study Termination|0|||
156713446|NCT01823835|565694784|FG003|Overall Study|Study Termination|0|||
156713447|NCT01823835|565694785|FG004|Overall Study|Study Termination|1|||
156713448|NCT01823835|565694786|FG005|Overall Study|Study Termination|0|||
156713449|NCT01823835|565694787|FG006|Overall Study|Study Termination|0|||
156713450|NCT01823835|565694788|FG007|Overall Study|Study Termination|0|||
156713451|NCT01823835|565694789|FG008|Overall Study|Study Termination|0|||
156713452|NCT01823835|565694790|FG009|Overall Study|Study Termination|0|||
157127369|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
157127370|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
156713453|NCT01823835|565694791|FG010|Overall Study|Study Termination|0|||
156713454|NCT01823835|565694792|FG011|Overall Study|Study Termination|1|||
156713455|NCT01823835|565694793|FG012|Overall Study|Study Termination|0|||
156713456|NCT01823835|565694794|FG013|Overall Study|Study Termination|0|||
156713457|NCT01823835|565694795|FG014|Overall Study|Study Termination|0|||
156713458|NCT01823835|565694781|FG000|Overall Study|Withdrawal by Subject|0|||
156713459|NCT01823835|565694782|FG001|Overall Study|Withdrawal by Subject|0|||
156713460|NCT01823835|565694783|FG002|Overall Study|Withdrawal by Subject|1|||
156713461|NCT01823835|565694784|FG003|Overall Study|Withdrawal by Subject|0|||
156713462|NCT01823835|565694785|FG004|Overall Study|Withdrawal by Subject|0|||
156713463|NCT01823835|565694786|FG005|Overall Study|Withdrawal by Subject|0|||
156713464|NCT01823835|565694787|FG006|Overall Study|Withdrawal by Subject|0|||
156713465|NCT01823835|565694788|FG007|Overall Study|Withdrawal by Subject|0|||
156713466|NCT01823835|565694789|FG008|Overall Study|Withdrawal by Subject|0|||
156713467|NCT01823835|565694790|FG009|Overall Study|Withdrawal by Subject|1|||
156713468|NCT01823835|565694791|FG010|Overall Study|Withdrawal by Subject|1|||
156713469|NCT01823835|565694792|FG011|Overall Study|Withdrawal by Subject|2|||
156713470|NCT01823835|565694793|FG012|Overall Study|Withdrawal by Subject|1|||
156713471|NCT01823835|565694794|FG013|Overall Study|Withdrawal by Subject|0|||
156713472|NCT01823835|565694795|FG014|Overall Study|Withdrawal by Subject|0|||
156792547|NCT00553475|565992833|FG002|Overall Study|Lack of Efficacy|0|||
157127371|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
157127372|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
157127373|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
157127374|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
157127375|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
157127376|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
157127377|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
157127378|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
157127379|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
157127380|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
157127381|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
157127382|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Death|2|||
157127383|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Death|1|||
157127384|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Death|2|||
157127385|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Graft loss|0|||
157127386|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Graft loss|2|||
157127387|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Graft loss|0|||
156792548|NCT00553475|565992831|FG000|Overall Study|Withdrawal by Subject|1|||
156792549|NCT00553475|565992832|FG001|Overall Study|Withdrawal by Subject|1|||
156792550|NCT00553475|565992833|FG002|Overall Study|Withdrawal by Subject|0|||
156792551|NCT00553475|565992831|FG000|Overall Study|Physician Decision|1|||
156792552|NCT00553475|565992832|FG001|Overall Study|Physician Decision|0|||
156792553|NCT00553475|565992833|FG002|Overall Study|Physician Decision|0|||
156792554|NCT00553475|565992831|FG000|Overall Study|Due to moving|0|||
156792555|NCT00553475|565992832|FG001|Overall Study|Due to moving|1|||
156792556|NCT00553475|565992833|FG002|Overall Study|Due to moving|0|||
156792557|NCT00890097|565992834|FG000|Overall Study|Adverse Event|21|||
156792558|NCT00890097|565992835|FG001|Overall Study|Adverse Event|32|||
156792559|NCT00890097|565992836|FG002|Overall Study|Adverse Event|28|||
156792560|NCT00890097|565992834|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
156792561|NCT00890097|565992835|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
156792562|NCT00890097|565992836|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
156792563|NCT00890097|565992834|FG000|Overall Study|Withdrew Consent|9|||
156792564|NCT00890097|565992835|FG001|Overall Study|Withdrew Consent|6|||
156792565|NCT00890097|565992836|FG002|Overall Study|Withdrew Consent|9|||
156792566|NCT00890097|565992834|FG000|Overall Study|Lost to Follow-up|5|||
156792567|NCT00890097|565992835|FG001|Overall Study|Lost to Follow-up|5|||
156792568|NCT00890097|565992836|FG002|Overall Study|Lost to Follow-up|5|||
156792569|NCT00890097|565992834|FG000|Overall Study|Noncompliance|0|||
156792570|NCT00890097|565992835|FG001|Overall Study|Noncompliance|4|||
156792571|NCT00890097|565992836|FG002|Overall Study|Noncompliance|4|||
156792572|NCT00890097|565992834|FG000|Overall Study|Sponsor Decision|7|||
156713473|NCT00509795|565694798|FG000|Overall Study|Adverse Event|4|||
156713474|NCT00509795|565694799|FG001|Overall Study|Adverse Event|3|||
156713475|NCT00509795|565694800|FG002|Overall Study|Adverse Event|5|||
156713476|NCT00509795|565694801|FG003|Overall Study|Adverse Event|4|||
156713477|NCT00509795|565694798|FG000|Overall Study|Death|3|||
156713478|NCT00509795|565694799|FG001|Overall Study|Death|1|||
156713479|NCT00509795|565694800|FG002|Overall Study|Death|2|||
156792573|NCT00890097|565992835|FG001|Overall Study|Sponsor Decision|11|||
156792574|NCT00890097|565992836|FG002|Overall Study|Sponsor Decision|7|||
156792575|NCT00890097|565992834|FG000|Overall Study|Did not attend final visit|2|||
156792576|NCT00890097|565992835|FG001|Overall Study|Did not attend final visit|3|||
156792577|NCT00890097|565992836|FG002|Overall Study|Did not attend final visit|0|||
156792578|NCT00890097|565992834|FG000|Overall Study|Subject Decision|3|||
156713480|NCT00509795|565694801|FG003|Overall Study|Death|7|||
156713481|NCT00509795|565694798|FG000|Overall Study|Lack of Efficacy|0|||
156713482|NCT00509795|565694799|FG001|Overall Study|Lack of Efficacy|0|||
156713483|NCT00509795|565694800|FG002|Overall Study|Lack of Efficacy|2|||
156713484|NCT00509795|565694801|FG003|Overall Study|Lack of Efficacy|2|||
156713485|NCT00509795|565694798|FG000|Overall Study|Lost to Follow-up|1|||
156713486|NCT00509795|565694799|FG001|Overall Study|Lost to Follow-up|2|||
156713487|NCT00509795|565694800|FG002|Overall Study|Lost to Follow-up|4|||
156713488|NCT00509795|565694801|FG003|Overall Study|Lost to Follow-up|4|||
156713489|NCT00509795|565694798|FG000|Overall Study|OTHER|1|||
156713490|NCT00509795|565694799|FG001|Overall Study|OTHER|0|||
156713491|NCT00509795|565694800|FG002|Overall Study|OTHER|4|||
156713492|NCT00509795|565694801|FG003|Overall Study|OTHER|1|||
156713493|NCT00509795|565694798|FG000|Overall Study|Protocol Violation|3|||
156713494|NCT00509795|565694799|FG001|Overall Study|Protocol Violation|0|||
156713495|NCT00509795|565694800|FG002|Overall Study|Protocol Violation|3|||
156713496|NCT00509795|565694801|FG003|Overall Study|Protocol Violation|1|||
156713497|NCT00509795|565694798|FG000|Overall Study|Withdrawal by Subject|10|||
156713498|NCT00509795|565694799|FG001|Overall Study|Withdrawal by Subject|5|||
156713499|NCT00509795|565694800|FG002|Overall Study|Withdrawal by Subject|7|||
156713500|NCT00509795|565694801|FG003|Overall Study|Withdrawal by Subject|8|||
156713501|NCT03017612|565694802|FG000|Overall Study|Adverse Event|2|||
156713502|NCT01320150|565694803|FG000|Overall Study|Protocol Violation|15|||
156713503|NCT01320150|565694803|FG000|Overall Study|Withdrawal by Subject|5|||
156713504|NCT01320150|565694803|FG000|Overall Study|Death|2|||
156713505|NCT01320150|565694803|FG000|Overall Study|Lost to Follow-up|44|||
156713506|NCT00919854|565694806|FG000|Overall Study|Adverse Event|1|||
156713507|NCT01893346|565694808|FG000|Overall Study|Lost to Follow-up|0|||
156713508|NCT01893346|565694809|FG001|Overall Study|Lost to Follow-up|1|||
156713509|NCT01893346|565694810|FG002|Overall Study|Lost to Follow-up|0|||
156713510|NCT01893346|565694811|FG003|Overall Study|Lost to Follow-up|0|||
156713511|NCT01893346|565694808|FG000|Overall Study|Protocol Violation|1|||
156713512|NCT01893346|565694809|FG001|Overall Study|Protocol Violation|0|||
156713513|NCT01893346|565694810|FG002|Overall Study|Protocol Violation|0|||
156713514|NCT01893346|565694811|FG003|Overall Study|Protocol Violation|0|||
156713515|NCT01893346|565694808|FG000|Overall Study|Withdrawal by Subject|2|||
156713516|NCT01893346|565694809|FG001|Overall Study|Withdrawal by Subject|0|||
156713517|NCT01893346|565694810|FG002|Overall Study|Withdrawal by Subject|0|||
156713518|NCT01893346|565694811|FG003|Overall Study|Withdrawal by Subject|0|||
156713519|NCT00985491|565694812|FG000|Overall Study|Adverse Event|8|||
156713520|NCT00985491|565694812|FG000|Overall Study|device migration|7|||
156713521|NCT00985491|565694812|FG000|Overall Study|Withdrawal by Subject|1|||
156713522|NCT00985491|565694812|FG000|Overall Study|implant failure|3|||
156713523|NCT00143247|565694815|FG000|Overall Study|Death|8|||
156713524|NCT00143247|565694815|FG000|Overall Study|Adverse Event|19|||
156713525|NCT00143247|565694815|FG000|Overall Study|Lack of Efficacy|3|||
156713526|NCT00143247|565694815|FG000|Overall Study|Withdrawal by Subject|55|||
156713527|NCT00143247|565694815|FG000|Overall Study|Study terminated by sponsor|31|||
156713528|NCT00143247|565694815|FG000|Overall Study|Protocol Violation|15|||
156713529|NCT00143247|565694815|FG000|Overall Study|Lost to Follow-up|12|||
156713530|NCT00143247|565694815|FG000|Overall Study|following inaccurate lab adverse event|1|||
156792579|NCT00890097|565992835|FG001|Overall Study|Subject Decision|2|||
156792580|NCT00890097|565992836|FG002|Overall Study|Subject Decision|6|||
156792581|NCT00890097|565992834|FG000|Overall Study|Randomization Error|2|||
156792582|NCT00890097|565992835|FG001|Overall Study|Randomization Error|0|||
156792583|NCT00890097|565992836|FG002|Overall Study|Randomization Error|0|||
156792584|NCT00890097|565992834|FG000|Overall Study|Failed inclusion criteria|3|||
156792585|NCT00890097|565992835|FG001|Overall Study|Failed inclusion criteria|4|||
156792586|NCT00890097|565992836|FG002|Overall Study|Failed inclusion criteria|0|||
156792587|NCT00890097|565992834|FG000|Overall Study|Transportation|0|||
157016628|NCT02287311|566813191|FG007|Cohort 2: Dose Level 2|Death|2|||
156713531|NCT00143247|565694815|FG000|Overall Study|Other|12|||
156713532|NCT02933255|565694818|FG000|Overall Study|Discontinued due to study closure.|1|||
156713533|NCT02933255|565694819|FG001|Overall Study|Discontinued due to study closure.|0|||
156713534|NCT02766283|565694820|FG000|Overall Study|Lost to Follow-up|27|||
156713535|NCT00805961|565694821|FG000|Modality Therapy|Withdrawal by Subject|1|||
156713536|NCT00805961|565694821|FG000|Modality Therapy|Adverse Event|1|||
156713537|NCT00805961|565694821|FG000|Modality Therapy|Disease Progression|2|||
156713538|NCT00805961|565694821|FG000|Treatment-Free Interval|Adverse Event|3|||
156713539|NCT00805961|565694821|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
156713540|NCT00805961|565694821|FG000|Treatment-Free Interval|Physician Decision|1|||
156713541|NCT00805961|565694821|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
156713542|NCT00805961|565694821|FG000|Maintenance Treatment|Lack of Efficacy|13|||
157016629|NCT02287311|566813192|FG008|Cohort 2: Dose Level 2|Death|0|||
157016630|NCT02287311|566813184|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156792588|NCT00890097|565992835|FG001|Overall Study|Transportation|2|||
156792589|NCT00890097|565992836|FG002|Overall Study|Transportation|0|||
156792590|NCT00890097|565992834|FG000|Overall Study|Subject Moved|0|||
156792591|NCT00890097|565992835|FG001|Overall Study|Subject Moved|4|||
157127388|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
156713543|NCT00805961|565694821|FG000|Maintenance Treatment|Intercurrent Illness|7|||
156713544|NCT00805961|565694821|FG000|Maintenance Treatment|Adverse Event|6|||
156713545|NCT00805961|565694821|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
156713546|NCT00805961|565694821|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
156713547|NCT00805961|565694821|FG000|Maintenance Treatment|Withdrawn Consent|1|||
156713548|NCT03086551|565694822|FG000|First Intervention|Failure to meet inclusion criterion|1|||
157127389|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
157127390|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
157127391|NCT01114529|567217068|FG000|Completed Study Medication at Month 24|Missing|2|||
157127392|NCT01114529|567217069|FG001|Completed Study Medication at Month 24|Missing|0|||
157127393|NCT01114529|567217070|FG002|Completed Study Medication at Month 24|Missing|0|||
157127394|NCT01114529|567217068|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
157127395|NCT01114529|567217069|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
157127396|NCT01114529|567217070|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
156713549|NCT03086551|565694823|FG001|First Intervention|Failure to meet inclusion criterion|0|||
156713550|NCT03086551|565694822|FG000|First Intervention|Lost to Follow-up|0|||
156713551|NCT03086551|565694823|FG001|First Intervention|Lost to Follow-up|1|||
156713552|NCT03086551|565694822|FG000|Washout|Lost to Follow-up|1|||
156713553|NCT03086551|565694823|FG001|Washout|Lost to Follow-up|2|||
156713554|NCT03086551|565694822|FG000|Washout|Withdrawal by Subject|2|||
156713555|NCT03086551|565694823|FG001|Washout|Withdrawal by Subject|1|||
156713556|NCT02215967|565694824|FG000|Overall Study|Patient became ineligible for treatment|0|||
156713557|NCT02215967|565694825|FG001|Overall Study|Patient became ineligible for treatment|0|||
156713558|NCT02215967|565694826|FG002|Overall Study|Patient became ineligible for treatment|0|||
156713559|NCT02215967|565694827|FG003|Overall Study|Patient became ineligible for treatment|3|||
156713560|NCT02215967|565694824|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
156713561|NCT02215967|565694825|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
156713562|NCT02215967|565694826|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
156713563|NCT02215967|565694827|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
156713564|NCT06473519|565696688|FG000|Overall Study|Lost to Follow-up|2|||
156713565|NCT06473519|565696689|FG001|Overall Study|Lost to Follow-up|5|||
156713566|NCT06473519|565696688|FG000|Overall Study|Withdrawal by Subject|1|||
156713567|NCT06473519|565696689|FG001|Overall Study|Withdrawal by Subject|4|||
156713568|NCT06473519|565696688|FG000|Overall Study|Randomized but not vaccinated|1|||
156713569|NCT06473519|565696689|FG001|Overall Study|Randomized but not vaccinated|2|||
156713570|NCT02514447|565696693|FG000|Overall Study|Withdrawal by Subject|3|||
156713571|NCT02514447|565696694|FG001|Overall Study|Withdrawal by Subject|1|||
156713572|NCT02514447|565696695|FG002|Overall Study|Withdrawal by Subject|1|||
156713573|NCT02514447|565696696|FG003|Overall Study|Withdrawal by Subject|0|||
156713574|NCT02514447|565696697|FG004|Overall Study|Withdrawal by Subject|0|||
156713575|NCT02514447|565696698|FG005|Overall Study|Withdrawal by Subject|0|||
156713576|NCT02514447|565696699|FG006|Overall Study|Withdrawal by Subject|0|||
156713577|NCT02514447|565696700|FG007|Overall Study|Withdrawal by Subject|1|||
156713578|NCT02514447|565696701|FG008|Overall Study|Withdrawal by Subject|1|||
156713579|NCT02514447|565696693|FG000|Overall Study|Death|24|||
156713580|NCT02514447|565696694|FG001|Overall Study|Death|28|||
156713581|NCT02514447|565696695|FG002|Overall Study|Death|29|||
156792592|NCT00890097|565992836|FG002|Overall Study|Subject Moved|0|||
156792593|NCT00890097|565992834|FG000|Overall Study|Protocol Deviation|1|||
156792594|NCT00890097|565992835|FG001|Overall Study|Protocol Deviation|1|||
156792595|NCT00890097|565992836|FG002|Overall Study|Protocol Deviation|1|||
156792596|NCT01152385|565992837|FG000|Overall Study|Withdrawal by Subject|3|||
156792597|NCT01152385|565992838|FG001|Overall Study|Withdrawal by Subject|1|||
156792598|NCT01152385|565992839|FG002|Overall Study|Withdrawal by Subject|1|||
156792599|NCT01152385|565992840|FG003|Overall Study|Withdrawal by Subject|1|||
156792600|NCT01152385|565992837|FG000|Overall Study|Protocol Violation|0|||
156792601|NCT01152385|565992838|FG001|Overall Study|Protocol Violation|0|||
156792602|NCT01152385|565992839|FG002|Overall Study|Protocol Violation|0|||
156792603|NCT01152385|565992840|FG003|Overall Study|Protocol Violation|1|||
156792604|NCT01152385|565992837|FG000|Overall Study|Adverse Event|1|||
157127397|NCT01114529|567217068|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
157216174|NCT02544633|567539220|FG001|Treatment Period|Adverse Event|4|||
157216175|NCT02544633|567539221|FG002|Treatment Period|Adverse Event|0|||
156713582|NCT02514447|565696696|FG003|Overall Study|Death|0|||
156713583|NCT02514447|565696697|FG004|Overall Study|Death|3|||
156713584|NCT02514447|565696698|FG005|Overall Study|Death|4|||
156713585|NCT02514447|565696699|FG006|Overall Study|Death|8|||
156713586|NCT02514447|565696700|FG007|Overall Study|Death|6|||
156713587|NCT02514447|565696701|FG008|Overall Study|Death|5|||
156792605|NCT01152385|565992838|FG001|Overall Study|Adverse Event|1|||
156792606|NCT01152385|565992839|FG002|Overall Study|Adverse Event|0|||
156792607|NCT01152385|565992840|FG003|Overall Study|Adverse Event|0|||
156792608|NCT01152385|565992837|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156808771|NCT03801928|566054460|FG001|Overall Study|Adverse Event|0|||
156713588|NCT02514447|565696693|FG000|Overall Study|Lost to Follow-up|1|||
156713589|NCT02514447|565696694|FG001|Overall Study|Lost to Follow-up|0|||
156713590|NCT02514447|565696695|FG002|Overall Study|Lost to Follow-up|0|||
156713591|NCT02514447|565696696|FG003|Overall Study|Lost to Follow-up|0|||
156713592|NCT02514447|565696697|FG004|Overall Study|Lost to Follow-up|0|||
156713593|NCT02514447|565696698|FG005|Overall Study|Lost to Follow-up|0|||
156713594|NCT02514447|565696699|FG006|Overall Study|Lost to Follow-up|0|||
156713595|NCT02514447|565696700|FG007|Overall Study|Lost to Follow-up|0|||
156713596|NCT02514447|565696701|FG008|Overall Study|Lost to Follow-up|1|||
156713597|NCT02514447|565696693|FG000|Overall Study|Sponsor Termination of Study|0|||
156713598|NCT02514447|565696694|FG001|Overall Study|Sponsor Termination of Study|1|||
156713599|NCT02514447|565696695|FG002|Overall Study|Sponsor Termination of Study|1|||
156713600|NCT02514447|565696696|FG003|Overall Study|Sponsor Termination of Study|0|||
156713601|NCT02514447|565696697|FG004|Overall Study|Sponsor Termination of Study|0|||
156713602|NCT02514447|565696698|FG005|Overall Study|Sponsor Termination of Study|0|||
156713603|NCT02514447|565696699|FG006|Overall Study|Sponsor Termination of Study|0|||
156713604|NCT02514447|565696700|FG007|Overall Study|Sponsor Termination of Study|0|||
156713605|NCT02514447|565696701|FG008|Overall Study|Sponsor Termination of Study|0|||
156713606|NCT02514447|565696693|FG000|Overall Study|Study completion per Investigator|1|||
156713607|NCT02514447|565696694|FG001|Overall Study|Study completion per Investigator|0|||
156713608|NCT02514447|565696695|FG002|Overall Study|Study completion per Investigator|1|||
156713609|NCT02514447|565696696|FG003|Overall Study|Study completion per Investigator|2|||
156713610|NCT02514447|565696697|FG004|Overall Study|Study completion per Investigator|0|||
156713611|NCT02514447|565696698|FG005|Overall Study|Study completion per Investigator|0|||
156713612|NCT02514447|565696699|FG006|Overall Study|Study completion per Investigator|0|||
156713613|NCT02514447|565696700|FG007|Overall Study|Study completion per Investigator|0|||
156713614|NCT02514447|565696701|FG008|Overall Study|Study completion per Investigator|1|||
156713615|NCT03560037|565696702|FG000|Overall Study|Protocol Violation|1|||
156713616|NCT03560037|565696703|FG001|Overall Study|Protocol Violation|0|||
156713617|NCT03560037|565696702|FG000|Overall Study|Physician Decision|0|||
156713618|NCT03560037|565696703|FG001|Overall Study|Physician Decision|1|||
156713619|NCT03620708|565696704|FG000|Overall Study|Lost to Follow-up|1|||
156713620|NCT03620708|565696705|FG001|Overall Study|Lost to Follow-up|1|||
156713621|NCT03620708|565696706|FG002|Overall Study|Lost to Follow-up|2|||
156713622|NCT03620708|565696704|FG000|Overall Study|Withdrawal by Subject|0|||
156713623|NCT03620708|565696705|FG001|Overall Study|Withdrawal by Subject|0|||
156713624|NCT03620708|565696706|FG002|Overall Study|Withdrawal by Subject|1|||
156713625|NCT03631199|565696712|FG000|Overall Study|Progressive disease|9|||
156713626|NCT03631199|565696713|FG001|Overall Study|Progressive disease|5|||
156713627|NCT03631199|565696714|FG002|Overall Study|Progressive disease|5|||
156713628|NCT03631199|565696715|FG003|Overall Study|Progressive disease|149|||
156713629|NCT03631199|565696716|FG004|Overall Study|Progressive disease|148|||
156713630|NCT03631199|565696712|FG000|Overall Study|Physician Decision|0|||
156713631|NCT03631199|565696713|FG001|Overall Study|Physician Decision|2|||
156713632|NCT03631199|565696714|FG002|Overall Study|Physician Decision|3|||
156713633|NCT03631199|565696715|FG003|Overall Study|Physician Decision|19|||
156713634|NCT03631199|565696716|FG004|Overall Study|Physician Decision|13|||
156713635|NCT03631199|565696712|FG000|Overall Study|Adverse Event|1|||
156713636|NCT03631199|565696713|FG001|Overall Study|Adverse Event|1|||
156713637|NCT03631199|565696714|FG002|Overall Study|Adverse Event|0|||
156713638|NCT03631199|565696715|FG003|Overall Study|Adverse Event|28|||
156713639|NCT03631199|565696716|FG004|Overall Study|Adverse Event|29|||
156713640|NCT03631199|565696712|FG000|Overall Study|Death|0|||
156713641|NCT03631199|565696713|FG001|Overall Study|Death|1|||
156713642|NCT03631199|565696714|FG002|Overall Study|Death|0|||
156713643|NCT03631199|565696715|FG003|Overall Study|Death|35|||
156713644|NCT03631199|565696716|FG004|Overall Study|Death|48|||
156713645|NCT03631199|565696712|FG000|Overall Study|Subject decision|0|||
156713646|NCT03631199|565696713|FG001|Overall Study|Subject decision|1|||
156713647|NCT03631199|565696714|FG002|Overall Study|Subject decision|0|||
156713648|NCT03631199|565696715|FG003|Overall Study|Subject decision|12|||
156713649|NCT03631199|565696716|FG004|Overall Study|Subject decision|12|||
156713650|NCT03631199|565696712|FG000|Overall Study|No treated|0|||
156713651|NCT03631199|565696713|FG001|Overall Study|No treated|0|||
156713652|NCT03631199|565696714|FG002|Overall Study|No treated|0|||
156713653|NCT03631199|565696715|FG003|Overall Study|No treated|0|||
156713654|NCT03631199|565696716|FG004|Overall Study|No treated|1|||
156713655|NCT03631199|565696712|FG000|Overall Study|Treatment ongoing|0|||
156713656|NCT03631199|565696713|FG001|Overall Study|Treatment ongoing|1|||
156713657|NCT03631199|565696714|FG002|Overall Study|Treatment ongoing|1|||
156713658|NCT03631199|565696715|FG003|Overall Study|Treatment ongoing|76|||
156713659|NCT03631199|565696716|FG004|Overall Study|Treatment ongoing|71|||
156713660|NCT03631199|565696712|FG000|Overall Study|Guardian decision|0|||
156713661|NCT03631199|565696713|FG001|Overall Study|Guardian decision|0|||
156713662|NCT03631199|565696714|FG002|Overall Study|Guardian decision|0|||
156713663|NCT03631199|565696715|FG003|Overall Study|Guardian decision|1|||
156713664|NCT03631199|565696716|FG004|Overall Study|Guardian decision|1|||
156713665|NCT03765788|565696717|FG000|Overall Study|Subject decision|2|||
156713666|NCT03765788|565696718|FG001|Overall Study|Subject decision|3|||
156713667|NCT03765788|565696717|FG000|Overall Study|Physician Decision|2|||
156713668|NCT03765788|565696718|FG001|Overall Study|Physician Decision|4|||
156713669|NCT03765788|565696717|FG000|Overall Study|Death|0|||
156713670|NCT03765788|565696718|FG001|Overall Study|Death|1|||
156713671|NCT03765788|565696717|FG000|Overall Study|Lost to Follow-up|1|||
156713672|NCT03765788|565696718|FG001|Overall Study|Lost to Follow-up|0|||
156713673|NCT00064987|565696723|FG000|Overall Study|Physician Decision|3|||
156713674|NCT00064987|565696724|FG001|Overall Study|Physician Decision|0|||
156713675|NCT01567462|565696725|FG000|Overall Study|Withdrawal by Subject|4|||
156713676|NCT01567462|565696726|FG001|Overall Study|Withdrawal by Subject|7|||
156713677|NCT01720225|565696731|FG000|Overall Study|Withdrawal by Subject|0|||
156713678|NCT01720225|565696732|FG001|Overall Study|Withdrawal by Subject|1|||
156713679|NCT01720225|565696731|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
156713680|NCT01720225|565696732|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
156713681|NCT05223920|565696733|FG000|Overall Study|Adverse Event|6|||
156713682|NCT05223920|565696734|FG001|Overall Study|Adverse Event|3|||
156713683|NCT05223920|565696733|FG000|Overall Study|Death|2|||
156713684|NCT05223920|565696734|FG001|Overall Study|Death|0|||
156713685|NCT05223920|565696733|FG000|Overall Study|Disease Progression|1|||
156713686|NCT05223920|565696734|FG001|Overall Study|Disease Progression|2|||
156713687|NCT05223920|565696733|FG000|Overall Study|Physician Decision|1|||
156713688|NCT05223920|565696734|FG001|Overall Study|Physician Decision|2|||
156713689|NCT05223920|565696733|FG000|Overall Study|Sponsor decision|11|||
156713690|NCT05223920|565696734|FG001|Overall Study|Sponsor decision|9|||
156713691|NCT05223920|565696733|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
156713692|NCT05223920|565696734|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
156713693|NCT05223920|565696733|FG000|Overall Study|Subject decision|1|||
156713694|NCT05223920|565696734|FG001|Overall Study|Subject decision|0|||
156713695|NCT05223920|565696733|FG000|Overall Study|Withdrawal by Subject|1|||
156713696|NCT05223920|565696734|FG001|Overall Study|Withdrawal by Subject|6|||
156713697|NCT00369941|565696735|FG000|Overall Study|Never Treated|1|||
156713698|NCT00369941|565696736|FG001|Overall Study|Never Treated|2|||
156713699|NCT00369941|565696735|FG000|Overall Study|Adverse Event|14|||
156713700|NCT00369941|565696736|FG001|Overall Study|Adverse Event|28|||
156713701|NCT00369941|565696735|FG000|Overall Study|Lack of Efficacy|6|||
156713702|NCT00369941|565696736|FG001|Overall Study|Lack of Efficacy|10|||
156713703|NCT00369941|565696735|FG000|Overall Study|Lost to Follow-up|12|||
156713704|NCT00369941|565696736|FG001|Overall Study|Lost to Follow-up|22|||
156713705|NCT00369941|565696735|FG000|Overall Study|Protocol Violation|5|||
156713706|NCT00369941|565696736|FG001|Overall Study|Protocol Violation|3|||
156713707|NCT00369941|565696735|FG000|Overall Study|Withdrawal by Subject|5|||
156713708|NCT00369941|565696736|FG001|Overall Study|Withdrawal by Subject|18|||
156713709|NCT00369941|565696735|FG000|Overall Study|Pregnancy|4|||
156713710|NCT00369941|565696736|FG001|Overall Study|Pregnancy|2|||
156713711|NCT00369941|565696735|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
156713712|NCT00369941|565696736|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
156713713|NCT00369941|565696735|FG000|Overall Study|Moved|11|||
156713714|NCT00369941|565696736|FG001|Overall Study|Moved|5|||
156713715|NCT00369941|565696735|FG000|Overall Study|Treatment with Prohibited Medication|3|||
156713716|NCT00369941|565696736|FG001|Overall Study|Treatment with Prohibited Medication|1|||
156713717|NCT00369941|565696735|FG000|Overall Study|Employment Interfered with Study Visits|1|||
156713718|NCT00369941|565696736|FG001|Overall Study|Employment Interfered with Study Visits|0|||
156713719|NCT00369941|565696735|FG000|Overall Study|Study Site Terminated|2|||
156713720|NCT00369941|565696736|FG001|Overall Study|Study Site Terminated|0|||
156713721|NCT00369941|565696735|FG000|Overall Study|Miscellaneous|3|||
156713722|NCT00369941|565696736|FG001|Overall Study|Miscellaneous|3|||
156713723|NCT02964312|565696743|FG000|Overall Study|Lost to Follow-up|28|||
156713724|NCT02964312|565696743|FG000|Overall Study|Withdrawal by Subject|11|||
156713725|NCT02964312|565696743|FG000|Overall Study|Lack of Efficacy|10|||
156713726|NCT02964312|565696743|FG000|Overall Study|Did not consent to long-term FU|14|||
156713727|NCT02964312|565696743|FG000|Overall Study|Death|1|||
156713728|NCT02738138|565696744|FG000|Overall Study|Adverse Event|0|||
156874016|NCT00396253|566296185|FG000|Overall Study|Change in eligibility status|1|||
156874017|NCT05340478|566296186|FG000|Overall Study|Scheduling Issues|10|||
156874018|NCT05340478|566296187|FG001|Overall Study|Scheduling Issues|4|||
156874019|NCT05340478|566296186|FG000|Overall Study|Neither member of dyad started treatment|2|||
156874020|NCT05340478|566296187|FG001|Overall Study|Neither member of dyad started treatment|2|||
156874021|NCT05340478|566296186|FG000|Overall Study|Withdrawn from study|2|||
156713729|NCT02738138|565696745|FG001|Overall Study|Adverse Event|1|||
156874022|NCT05340478|566296187|FG001|Overall Study|Withdrawn from study|2|||
157216176|NCT02544633|567539222|FG003|Treatment Period|Adverse Event|5|||
156713730|NCT02738138|565696744|FG000|Overall Study|Lost to Follow-up|2|||
156713731|NCT02738138|565696745|FG001|Overall Study|Lost to Follow-up|0|||
156713732|NCT02738138|565696744|FG000|Overall Study|Other - not further specified|1|||
156713733|NCT02738138|565696745|FG001|Overall Study|Other - not further specified|0|||
156713734|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Other|34|||
156713735|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Other|0|||
156713736|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Other|0|||
156713737|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Other|0|||
156713738|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Death|14|||
156713739|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Death|0|||
156713740|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Death|0|||
156713741|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Death|0|||
156713742|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
156713743|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
156713744|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
156713745|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
156713746|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
156713747|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713748|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713749|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
156713750|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
156713751|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
156713752|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
156713753|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
156713754|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
156713755|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713756|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713757|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
156713758|NCT01995513|565696749|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
156713759|NCT01995513|565696750|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713760|NCT01995513|565696751|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713761|NCT01995513|565696752|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
156713762|NCT01995513|565696749|FG000|Period 1: Second Open Label Treatment|Other|0|||
156713763|NCT01995513|565696750|FG001|Period 1: Second Open Label Treatment|Other|2|||
156713764|NCT01995513|565696751|FG002|Period 1: Second Open Label Treatment|Other|0|||
156713765|NCT01995513|565696752|FG003|Period 1: Second Open Label Treatment|Other|0|||
156713766|NCT01995513|565696749|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713767|NCT01995513|565696750|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
156713768|NCT01995513|565696751|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713769|NCT01995513|565696752|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
156713770|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Death|0|||
156713771|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Death|0|||
156713772|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Death|0|||
156713773|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Death|1|||
156713774|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Other|0|||
156713775|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Other|0|||
156713776|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Other|3|||
156713777|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Other|3|||
156713778|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
156713779|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
156713780|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
156713781|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
156713782|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
156713783|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
156713784|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
156713785|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
156713786|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
156713787|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
156713788|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
156874023|NCT05340478|566296186|FG000|Overall Study|Lost to Follow-up|1|||
156874024|NCT05340478|566296187|FG001|Overall Study|Lost to Follow-up|4|||
156874025|NCT00092443|566296190|FG000|Overall Study|Adverse Event|9|||
156874026|NCT00092443|566296191|FG001|Overall Study|Adverse Event|13|||
156713789|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
156713790|NCT01995513|565696749|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713791|NCT01995513|565696750|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713792|NCT01995513|565696751|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
156713793|NCT01995513|565696752|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
156713794|NCT01232452|565696753|FG000|Overall Study|Adverse Event|17|||
156713795|NCT01232452|565696754|FG001|Overall Study|Adverse Event|15|||
156874027|NCT00092443|566296190|FG000|Overall Study|Lost to Follow-up|7|||
156874028|NCT00092443|566296191|FG001|Overall Study|Lost to Follow-up|3|||
156874029|NCT00092443|566296190|FG000|Overall Study|Protocol Violation|11|||
156874030|NCT00092443|566296191|FG001|Overall Study|Protocol Violation|9|||
156713796|NCT01232452|565696753|FG000|Overall Study|Withdrawal by Subject|11|||
156713797|NCT01232452|565696754|FG001|Overall Study|Withdrawal by Subject|8|||
156713798|NCT01232452|565696753|FG000|Overall Study|Physician Decision|8|||
156713799|NCT01232452|565696754|FG001|Overall Study|Physician Decision|12|||
156713800|NCT01232452|565696753|FG000|Overall Study|Protocol entry criterion not met|0|||
156713801|NCT01232452|565696754|FG001|Overall Study|Protocol entry criterion not met|2|||
156713802|NCT01232452|565696753|FG000|Overall Study|Sponsor Decision|3|||
156713803|NCT01232452|565696754|FG001|Overall Study|Sponsor Decision|1|||
156713804|NCT01232452|565696753|FG000|Overall Study|Protocol Violation|0|||
156713805|NCT01232452|565696754|FG001|Overall Study|Protocol Violation|1|||
156713806|NCT05219448|565696759|FG000|Overall Study|Lost to Follow-up|9|||
156713807|NCT05219448|565696760|FG001|Overall Study|Lost to Follow-up|0|||
156713808|NCT01750190|565696761|FG000|Overall Study|Adverse Event|47|||
156713809|NCT01750190|565696762|FG001|Overall Study|Adverse Event|19|||
156713810|NCT01750190|565696761|FG000|Overall Study|Death|38|||
156713811|NCT01750190|565696762|FG001|Overall Study|Death|11|||
156713812|NCT01750190|565696761|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
156713813|NCT01750190|565696762|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
156713814|NCT01750190|565696761|FG000|Overall Study|Lost to Follow-up|28|||
156713815|NCT01750190|565696762|FG001|Overall Study|Lost to Follow-up|7|||
156713816|NCT01750190|565696761|FG000|Overall Study|Physician Decision|16|||
156713817|NCT01750190|565696762|FG001|Overall Study|Physician Decision|17|||
156713818|NCT01750190|565696761|FG000|Overall Study|Protocol Violation|6|||
156713819|NCT01750190|565696762|FG001|Overall Study|Protocol Violation|5|||
156713820|NCT01750190|565696761|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
156713821|NCT01750190|565696762|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
156713822|NCT01750190|565696761|FG000|Overall Study|Withdrawal by Subject|83|||
156713823|NCT01750190|565696762|FG001|Overall Study|Withdrawal by Subject|89|||
156713824|NCT01750190|565696761|FG000|Overall Study|Kidney Transplant|8|||
156713825|NCT01750190|565696762|FG001|Overall Study|Kidney Transplant|4|||
156713826|NCT01750190|565696761|FG000|Overall Study|Dialysis|22|||
156713827|NCT01750190|565696762|FG001|Overall Study|Dialysis|8|||
156713828|NCT01750190|565696761|FG000|Overall Study|Other than Specified|13|||
156713829|NCT01750190|565696762|FG001|Overall Study|Other than Specified|4|||
156713830|NCT03571828|565696767|FG000|Overall Study|Withdrawal by Subject|1|||
156713831|NCT03571828|565696768|FG001|Overall Study|Withdrawal by Subject|0|||
156713832|NCT03571828|565696767|FG000|Overall Study|Decision by sponsor|5|||
156713833|NCT03571828|565696768|FG001|Overall Study|Decision by sponsor|1|||
156713834|NCT03571828|565696767|FG000|Overall Study|Death|2|||
156713835|NCT03571828|565696768|FG001|Overall Study|Death|0|||
156713836|NCT02232984|565696769|FG000|Overall Study|Withdrawal by Subject|5|||
156713837|NCT02232984|565696769|FG000|Overall Study|Death|1|||
156713838|NCT02232984|565696769|FG000|Overall Study|Investigator withdrawal|10|||
156713839|NCT02232984|565696769|FG000|Overall Study|Device implant unsuccessful|53|||
156713840|NCT02232984|565696769|FG000|Overall Study|not disclosed by site|7|||
156713841|NCT02232984|565696769|FG000|Overall Study|Protocol Violation|1|||
156713842|NCT00769379|565696774|FG000|Overall Study|No follow up data mapped to Other.|3|||
156713843|NCT00769379|565696775|FG001|Overall Study|No follow up data mapped to Other.|13|||
156713844|NCT03762239|565696784|FG000|Overall Study|Appointment to the doctor|1|||
156713845|NCT03762239|565696785|FG001|Overall Study|Appointment to the doctor|1|||
156713846|NCT04597632|565696786|FG000|Overall Study|Withdrawal by Subject|10|||
156713847|NCT04597632|565696786|FG000|Overall Study|Lost to Follow-up|1|||
156713848|NCT04597632|565696786|FG000|Overall Study|Death|1|||
156713849|NCT04597632|565696786|FG000|Overall Study|Adverse Event|5|||
156713850|NCT04895982|565696787|FG000|Overall Study|Withdrawal by Subject|0|||
156713851|NCT04895982|565696788|FG001|Overall Study|Withdrawal by Subject|0|||
156792609|NCT01152385|565992838|FG001|Overall Study|Study-specific withdrawal criteria|1|||
156792610|NCT01152385|565992839|FG002|Overall Study|Study-specific withdrawal criteria|2|||
156792611|NCT01152385|565992840|FG003|Overall Study|Study-specific withdrawal criteria|0|||
157016631|NCT02287311|566813185|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
157016632|NCT02287311|566813186|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
157016633|NCT02287311|566813187|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
157016634|NCT02287311|566813188|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
157016635|NCT02287311|566813189|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156713852|NCT04895982|565696789|FG002|Overall Study|Withdrawal by Subject|0|||
156713853|NCT04895982|565696790|FG003|Overall Study|Withdrawal by Subject|0|||
156713854|NCT04895982|565696791|FG004|Overall Study|Withdrawal by Subject|0|||
156713855|NCT04895982|565696792|FG005|Overall Study|Withdrawal by Subject|1|||
157016636|NCT02287311|566813190|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
157016637|NCT02287311|566813191|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
157016638|NCT02287311|566813192|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
156713856|NCT04895982|565696793|FG006|Overall Study|Withdrawal by Subject|1|||
156713857|NCT04895982|565696794|FG007|Overall Study|Withdrawal by Subject|0|||
156713858|NCT04895982|565696795|FG008|Overall Study|Withdrawal by Subject|0|||
156792612|NCT01152385|565992837|FG000|Overall Study|Other|4|||
157016639|NCT02287311|566813184|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016640|NCT02287311|566813185|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
156713859|NCT04895982|565696796|FG009|Overall Study|Withdrawal by Subject|1|||
156713860|NCT04895982|565696797|FG010|Overall Study|Withdrawal by Subject|0|||
156713861|NCT04895982|565696798|FG011|Overall Study|Withdrawal by Subject|1|||
156713862|NCT04895982|565696787|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156713863|NCT04895982|565696788|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156713864|NCT04895982|565696789|FG002|Overall Study|Withdrawal by parent/guardian|3|||
156713865|NCT04895982|565696790|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156713866|NCT04895982|565696791|FG004|Overall Study|Withdrawal by parent/guardian|3|||
156713867|NCT04895982|565696792|FG005|Overall Study|Withdrawal by parent/guardian|2|||
156713868|NCT04895982|565696793|FG006|Overall Study|Withdrawal by parent/guardian|1|||
156713869|NCT04895982|565696794|FG007|Overall Study|Withdrawal by parent/guardian|0|||
156713870|NCT04895982|565696795|FG008|Overall Study|Withdrawal by parent/guardian|3|||
156713871|NCT04895982|565696796|FG009|Overall Study|Withdrawal by parent/guardian|0|||
156713872|NCT04895982|565696797|FG010|Overall Study|Withdrawal by parent/guardian|0|||
156713873|NCT04895982|565696798|FG011|Overall Study|Withdrawal by parent/guardian|0|||
156713874|NCT04895982|565696787|FG000|Overall Study|Other|0|||
156713875|NCT04895982|565696788|FG001|Overall Study|Other|0|||
156713876|NCT04895982|565696789|FG002|Overall Study|Other|1|||
156713877|NCT04895982|565696790|FG003|Overall Study|Other|1|||
156713878|NCT04895982|565696791|FG004|Overall Study|Other|0|||
156713879|NCT04895982|565696792|FG005|Overall Study|Other|0|||
156713880|NCT04895982|565696793|FG006|Overall Study|Other|0|||
156713881|NCT04895982|565696794|FG007|Overall Study|Other|0|||
156713882|NCT04895982|565696795|FG008|Overall Study|Other|0|||
156713883|NCT04895982|565696796|FG009|Overall Study|Other|1|||
156713884|NCT04895982|565696797|FG010|Overall Study|Other|0|||
156713885|NCT04895982|565696798|FG011|Overall Study|Other|0|||
156713886|NCT04895982|565696787|FG000|Overall Study|Protocol Violation|0|||
156713887|NCT04895982|565696788|FG001|Overall Study|Protocol Violation|0|||
156713888|NCT04895982|565696789|FG002|Overall Study|Protocol Violation|1|||
156713889|NCT04895982|565696790|FG003|Overall Study|Protocol Violation|1|||
156713890|NCT04895982|565696791|FG004|Overall Study|Protocol Violation|1|||
156713891|NCT04895982|565696792|FG005|Overall Study|Protocol Violation|0|||
156713892|NCT04895982|565696793|FG006|Overall Study|Protocol Violation|0|||
156713893|NCT04895982|565696794|FG007|Overall Study|Protocol Violation|1|||
156713894|NCT04895982|565696795|FG008|Overall Study|Protocol Violation|0|||
156713895|NCT04895982|565696796|FG009|Overall Study|Protocol Violation|0|||
156713896|NCT04895982|565696797|FG010|Overall Study|Protocol Violation|0|||
156713897|NCT04895982|565696798|FG011|Overall Study|Protocol Violation|0|||
156713898|NCT04895982|565696787|FG000|Overall Study|Lost to Follow-up|0|||
156713899|NCT04895982|565696788|FG001|Overall Study|Lost to Follow-up|0|||
156713900|NCT04895982|565696789|FG002|Overall Study|Lost to Follow-up|1|||
156713901|NCT04895982|565696790|FG003|Overall Study|Lost to Follow-up|0|||
156713902|NCT04895982|565696791|FG004|Overall Study|Lost to Follow-up|0|||
156713903|NCT04895982|565696792|FG005|Overall Study|Lost to Follow-up|1|||
156713904|NCT04895982|565696793|FG006|Overall Study|Lost to Follow-up|0|||
156713905|NCT04895982|565696794|FG007|Overall Study|Lost to Follow-up|0|||
156713906|NCT04895982|565696795|FG008|Overall Study|Lost to Follow-up|1|||
156713907|NCT04895982|565696796|FG009|Overall Study|Lost to Follow-up|0|||
156713908|NCT04895982|565696797|FG010|Overall Study|Lost to Follow-up|0|||
156713909|NCT04895982|565696798|FG011|Overall Study|Lost to Follow-up|0|||
156713910|NCT04895982|565696787|FG000|Overall Study|Refused further study procedures|0|||
156713911|NCT04895982|565696788|FG001|Overall Study|Refused further study procedures|0|||
156713912|NCT04895982|565696789|FG002|Overall Study|Refused further study procedures|1|||
156713913|NCT04895982|565696790|FG003|Overall Study|Refused further study procedures|0|||
156713914|NCT04895982|565696791|FG004|Overall Study|Refused further study procedures|0|||
156713915|NCT04895982|565696792|FG005|Overall Study|Refused further study procedures|0|||
156713916|NCT04895982|565696793|FG006|Overall Study|Refused further study procedures|0|||
156713917|NCT04895982|565696794|FG007|Overall Study|Refused further study procedures|0|||
156713918|NCT04895982|565696795|FG008|Overall Study|Refused further study procedures|0|||
156713919|NCT04895982|565696796|FG009|Overall Study|Refused further study procedures|0|||
156792613|NCT01152385|565992838|FG001|Overall Study|Other|3|||
156792614|NCT01152385|565992839|FG002|Overall Study|Other|2|||
156713920|NCT04895982|565696797|FG010|Overall Study|Refused further study procedures|0|||
156713921|NCT04895982|565696798|FG011|Overall Study|Refused further study procedures|0|||
156713922|NCT02517463|565696804|FG000|Overall Study|Lost to Follow-up|5|||
156713923|NCT02517463|565696805|FG001|Overall Study|Lost to Follow-up|2|||
156713924|NCT00489827|565696813|FG000|Overall Study|Intraoperative exclusion criteria|1|||
156792615|NCT01152385|565992840|FG003|Overall Study|Other|3|||
156713925|NCT00489827|565696814|FG001|Overall Study|Intraoperative exclusion criteria|1|||
156713926|NCT00489827|565696813|FG000|Overall Study|Intraoperative exclusion criteria|1|||
156713927|NCT00489827|565696814|FG001|Overall Study|Intraoperative exclusion criteria|1|||
156713928|NCT02296931|565696815|FG000|Overall Study|Protocol Violation|0|||
156713929|NCT02296931|565696816|FG001|Overall Study|Protocol Violation|2|||
156713930|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|3|||
156713931|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|2|||
156792616|NCT02656173|565992841|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
156713932|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|1|||
156713933|NCT01590277|565696817|FG000|Overall Study|Withdrawal by Subject|1|||
156713934|NCT04386616|565696818|FG000|Overall Study|Death|22|||
156713935|NCT04386616|565696819|FG001|Overall Study|Death|22|||
156713936|NCT04386616|565696820|FG002|Overall Study|Death|21|||
156713937|NCT04386616|565696818|FG000|Overall Study|Lost to Follow-up|5|||
156713938|NCT04386616|565696819|FG001|Overall Study|Lost to Follow-up|8|||
156713939|NCT04386616|565696820|FG002|Overall Study|Lost to Follow-up|6|||
156713940|NCT04386616|565696818|FG000|Overall Study|Withdrawal by Subject|2|||
156713941|NCT04386616|565696819|FG001|Overall Study|Withdrawal by Subject|4|||
156713942|NCT04386616|565696820|FG002|Overall Study|Withdrawal by Subject|1|||
156713943|NCT04386616|565696818|FG000|Overall Study|Adverse Event|1|||
156713944|NCT04386616|565696819|FG001|Overall Study|Adverse Event|1|||
156713945|NCT04386616|565696820|FG002|Overall Study|Adverse Event|0|||
156713946|NCT01377012|565696821|FG000|Core Study|Study terminated by Sponsor|47|||
156713947|NCT01377012|565696822|FG001|Core Study|Study terminated by Sponsor|54|||
156713948|NCT01377012|565696823|FG002|Core Study|Study terminated by Sponsor|46|||
156713949|NCT01377012|565696821|FG000|Core Study|Technical problems|1|||
156713950|NCT01377012|565696822|FG001|Core Study|Technical problems|0|||
156713951|NCT01377012|565696823|FG002|Core Study|Technical problems|0|||
156713952|NCT01377012|565696821|FG000|Core Study|Withdrawal by Subject|15|||
156713953|NCT01377012|565696822|FG001|Core Study|Withdrawal by Subject|23|||
156713954|NCT01377012|565696823|FG002|Core Study|Withdrawal by Subject|18|||
156713955|NCT01377012|565696821|FG000|Core Study|Protocol Violation|7|||
156713956|NCT01377012|565696822|FG001|Core Study|Protocol Violation|3|||
156713957|NCT01377012|565696823|FG002|Core Study|Protocol Violation|2|||
156713958|NCT01377012|565696821|FG000|Core Study|Pregnancy|0|||
156713959|NCT01377012|565696822|FG001|Core Study|Pregnancy|0|||
156713960|NCT01377012|565696823|FG002|Core Study|Pregnancy|1|||
156713961|NCT01377012|565696821|FG000|Core Study|Physician Decision|5|||
156713962|NCT01377012|565696822|FG001|Core Study|Physician Decision|4|||
156713963|NCT01377012|565696823|FG002|Core Study|Physician Decision|10|||
156713964|NCT01377012|565696821|FG000|Core Study|Non-Compliant with study treatment|0|||
156713965|NCT01377012|565696822|FG001|Core Study|Non-Compliant with study treatment|0|||
156713966|NCT01377012|565696823|FG002|Core Study|Non-Compliant with study treatment|1|||
156713967|NCT01377012|565696821|FG000|Core Study|No Longer require treatment|0|||
156713968|NCT01377012|565696822|FG001|Core Study|No Longer require treatment|0|||
156713969|NCT01377012|565696823|FG002|Core Study|No Longer require treatment|1|||
156713970|NCT01377012|565696821|FG000|Core Study|Lost to Follow-up|7|||
156713971|NCT01377012|565696822|FG001|Core Study|Lost to Follow-up|5|||
156713972|NCT01377012|565696823|FG002|Core Study|Lost to Follow-up|4|||
156713973|NCT01377012|565696821|FG000|Core Study|Lack of Efficacy|41|||
156713974|NCT01377012|565696822|FG001|Core Study|Lack of Efficacy|28|||
156713975|NCT01377012|565696823|FG002|Core Study|Lack of Efficacy|37|||
156713976|NCT01377012|565696821|FG000|Core Study|Death|1|||
156713977|NCT01377012|565696822|FG001|Core Study|Death|1|||
156713978|NCT01377012|565696823|FG002|Core Study|Death|1|||
156713979|NCT01377012|565696821|FG000|Core Study|Adverse Event|10|||
156713980|NCT01377012|565696822|FG001|Core Study|Adverse Event|14|||
156713981|NCT01377012|565696823|FG002|Core Study|Adverse Event|13|||
156713982|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
156713983|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
156713984|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
156713985|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
156713986|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
156713987|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
156713988|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
156713989|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
156713990|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
156713991|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
156713992|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
156713993|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
156713994|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
156713995|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
156713996|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
156713997|NCT01377012|565696821|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
156713998|NCT01377012|565696822|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
156713999|NCT01377012|565696823|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
156714000|NCT01632280|565696850|FG000|Overall Study|Withdrawal by Subject|1|||
156714001|NCT01632280|565696851|FG001|Overall Study|Withdrawal by Subject|0|||
156714002|NCT03736031|565696854|FG000|Overall Study|Death|2|||
156714003|NCT03736031|565696855|FG001|Overall Study|Death|4|||
156714004|NCT03736031|565696854|FG000|Overall Study|Lost to Follow-up|21|||
156714005|NCT03736031|565696855|FG001|Overall Study|Lost to Follow-up|2|||
156714006|NCT03736031|565696854|FG000|Overall Study|Withdrawal by Subject|9|||
156714007|NCT03736031|565696855|FG001|Overall Study|Withdrawal by Subject|0|||
156714008|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
156714009|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
156714010|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
156714011|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
156714012|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
156714013|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
156714014|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
156714015|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
156714016|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
156714017|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
156714018|NCT00451178|565696858|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
156714019|NCT00451178|565696859|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
156714020|NCT00451178|565696858|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
156714021|NCT00451178|565696859|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
156714022|NCT00451178|565696858|FG000|Prior to Maintenance Therapy|PD|2|||
156714023|NCT00451178|565696859|FG001|Prior to Maintenance Therapy|PD|0|||
156714024|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
156714025|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
156714026|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
156714027|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
156714028|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
156714029|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
156714030|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
156714031|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
156714032|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
156714033|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
156714034|NCT00451178|565696858|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
156714035|NCT00451178|565696859|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
156714036|NCT00451178|565696858|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
156714037|NCT00451178|565696859|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
156714038|NCT05221320|565699266|FG000|Overall Study|Lack of Efficacy|3|||
156714039|NCT05221320|565699267|FG001|Overall Study|Lack of Efficacy|7|||
156714040|NCT05221320|565699268|FG002|Overall Study|Lack of Efficacy|10|||
156714041|NCT05221320|565699269|FG003|Overall Study|Lack of Efficacy|1|||
156714042|NCT05221320|565699270|FG004|Overall Study|Lack of Efficacy|0|||
156714043|NCT05221320|565699271|FG005|Overall Study|Lack of Efficacy|0|||
156714044|NCT05221320|565699266|FG000|Overall Study|Physician Decision|1|||
156714045|NCT05221320|565699267|FG001|Overall Study|Physician Decision|0|||
156714046|NCT05221320|565699268|FG002|Overall Study|Physician Decision|3|||
156714047|NCT05221320|565699269|FG003|Overall Study|Physician Decision|1|||
156714048|NCT05221320|565699270|FG004|Overall Study|Physician Decision|0|||
156714049|NCT05221320|565699271|FG005|Overall Study|Physician Decision|0|||
156714050|NCT05221320|565699266|FG000|Overall Study|Withdrawal by Subject|0|||
156714051|NCT05221320|565699267|FG001|Overall Study|Withdrawal by Subject|3|||
156714052|NCT05221320|565699268|FG002|Overall Study|Withdrawal by Subject|1|||
156714053|NCT05221320|565699269|FG003|Overall Study|Withdrawal by Subject|0|||
156714054|NCT05221320|565699270|FG004|Overall Study|Withdrawal by Subject|0|||
156714055|NCT05221320|565699271|FG005|Overall Study|Withdrawal by Subject|0|||
156714056|NCT05221320|565699266|FG000|Overall Study|Death|0|||
156714057|NCT05221320|565699267|FG001|Overall Study|Death|5|||
156714058|NCT05221320|565699268|FG002|Overall Study|Death|6|||
156714059|NCT05221320|565699269|FG003|Overall Study|Death|0|||
156714060|NCT05221320|565699270|FG004|Overall Study|Death|1|||
156714061|NCT05221320|565699271|FG005|Overall Study|Death|0|||
156714062|NCT03300817|565699272|FG000|Overall Study|Withdrawal by Subject|1|||
156714063|NCT03300817|565699272|FG000|Overall Study|Adverse Event|1|||
156714064|NCT03300817|565699272|FG000|Overall Study|Subject Found to be Ineligible|2|||
156714065|NCT03729596|565699274|FG000|Overall Study|Death|3|||
156714066|NCT03729596|565699275|FG001|Overall Study|Death|5|||
156714067|NCT03729596|565699276|FG002|Overall Study|Death|4|||
156714068|NCT03729596|565699277|FG003|Overall Study|Death|1|||
156714069|NCT03729596|565699278|FG004|Overall Study|Death|0|||
156714070|NCT03729596|565699279|FG005|Overall Study|Death|34|||
156714071|NCT03729596|565699280|FG006|Overall Study|Death|18|||
156714072|NCT03729596|565699281|FG007|Overall Study|Death|14|||
156714073|NCT03729596|565699282|FG008|Overall Study|Death|19|||
156714074|NCT03729596|565699283|FG009|Overall Study|Death|9|||
156714075|NCT03729596|565699274|FG000|Overall Study|Lost to Follow-up|0|||
156714076|NCT03729596|565699275|FG001|Overall Study|Lost to Follow-up|0|||
156714077|NCT03729596|565699276|FG002|Overall Study|Lost to Follow-up|0|||
156714078|NCT03729596|565699277|FG003|Overall Study|Lost to Follow-up|0|||
156714079|NCT03729596|565699278|FG004|Overall Study|Lost to Follow-up|0|||
156714080|NCT03729596|565699279|FG005|Overall Study|Lost to Follow-up|0|||
156714081|NCT03729596|565699280|FG006|Overall Study|Lost to Follow-up|1|||
157127398|NCT01114529|567217069|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
156714082|NCT03729596|565699281|FG007|Overall Study|Lost to Follow-up|0|||
156714083|NCT03729596|565699282|FG008|Overall Study|Lost to Follow-up|0|||
156714084|NCT03729596|565699283|FG009|Overall Study|Lost to Follow-up|1|||
156714085|NCT03729596|565699274|FG000|Overall Study|protocol amendment|0|||
156714086|NCT03729596|565699275|FG001|Overall Study|protocol amendment|1|||
156714087|NCT03729596|565699276|FG002|Overall Study|protocol amendment|3|||
156714088|NCT03729596|565699277|FG003|Overall Study|protocol amendment|6|||
156714089|NCT03729596|565699278|FG004|Overall Study|protocol amendment|5|||
156714090|NCT03729596|565699279|FG005|Overall Study|protocol amendment|0|||
156714091|NCT03729596|565699280|FG006|Overall Study|protocol amendment|0|||
156714092|NCT03729596|565699281|FG007|Overall Study|protocol amendment|0|||
156714093|NCT03729596|565699282|FG008|Overall Study|protocol amendment|0|||
156714094|NCT03729596|565699283|FG009|Overall Study|protocol amendment|0|||
156714095|NCT03729596|565699274|FG000|Overall Study|Withdrawal by Subject|0|||
156714096|NCT03729596|565699275|FG001|Overall Study|Withdrawal by Subject|0|||
156714097|NCT03729596|565699276|FG002|Overall Study|Withdrawal by Subject|0|||
156714098|NCT03729596|565699277|FG003|Overall Study|Withdrawal by Subject|0|||
156714099|NCT03729596|565699278|FG004|Overall Study|Withdrawal by Subject|0|||
156714100|NCT03729596|565699279|FG005|Overall Study|Withdrawal by Subject|4|||
156714101|NCT03729596|565699280|FG006|Overall Study|Withdrawal by Subject|2|||
156714102|NCT03729596|565699281|FG007|Overall Study|Withdrawal by Subject|3|||
156714103|NCT03729596|565699282|FG008|Overall Study|Withdrawal by Subject|2|||
156714104|NCT03729596|565699283|FG009|Overall Study|Withdrawal by Subject|3|||
156714105|NCT03729596|565699274|FG000|Overall Study|study terminated by sponsor|0|||
156714106|NCT03729596|565699275|FG001|Overall Study|study terminated by sponsor|0|||
156714107|NCT03729596|565699276|FG002|Overall Study|study terminated by sponsor|0|||
156714108|NCT03729596|565699277|FG003|Overall Study|study terminated by sponsor|0|||
156714109|NCT03729596|565699278|FG004|Overall Study|study terminated by sponsor|1|||
156714110|NCT03729596|565699279|FG005|Overall Study|study terminated by sponsor|3|||
156714111|NCT03729596|565699280|FG006|Overall Study|study terminated by sponsor|0|||
156714112|NCT03729596|565699281|FG007|Overall Study|study terminated by sponsor|1|||
156714113|NCT03729596|565699282|FG008|Overall Study|study terminated by sponsor|0|||
156714114|NCT03729596|565699283|FG009|Overall Study|study terminated by sponsor|0|||
156714115|NCT02498613|565699285|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
156714116|NCT02498613|565699286|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
156714117|NCT02498613|565699287|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
156714118|NCT02498613|565699288|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
156714119|NCT02498613|565699285|FG000|Overall Study|Withdrawal by Subject|3|||
156714120|NCT02498613|565699286|FG001|Overall Study|Withdrawal by Subject|1|||
157127399|NCT01114529|567217070|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
157127400|NCT01114529|567217068|FG000|Completed Study Phase at Month 24|Death|8|||
157127401|NCT01114529|567217069|FG001|Completed Study Phase at Month 24|Death|5|||
156714121|NCT02498613|565699287|FG002|Overall Study|Withdrawal by Subject|0|||
156714122|NCT02498613|565699288|FG003|Overall Study|Withdrawal by Subject|0|||
156714123|NCT05168202|565699289|FG000|Overall Study|Progressive Disease|4|||
157127402|NCT01114529|567217070|FG002|Completed Study Phase at Month 24|Death|4|||
157127403|NCT01114529|567217068|FG000|Completed Study Phase at Month 24|Other|2|||
157127404|NCT01114529|567217069|FG001|Completed Study Phase at Month 24|Other|0|||
157127405|NCT01114529|567217070|FG002|Completed Study Phase at Month 24|Other|0|||
157127406|NCT01114529|567217068|FG000|Completed Study Phase at Month 24|Missing|2|||
157127407|NCT01114529|567217069|FG001|Completed Study Phase at Month 24|Missing|0|||
157127408|NCT01114529|567217070|FG002|Completed Study Phase at Month 24|Missing|0|||
157127409|NCT01235962|567217075|FG000|Overall Study|Withdrawal by Subject|20|||
157127410|NCT01235962|567217076|FG001|Overall Study|Withdrawal by Subject|19|||
157127411|NCT01235962|567217077|FG002|Overall Study|Withdrawal by Subject|62|||
157127412|NCT01235962|567217078|FG003|Overall Study|Withdrawal by Subject|49|||
157127413|NCT01235962|567217075|FG000|Overall Study|Lost to Follow-up|21|||
157127414|NCT01235962|567217076|FG001|Overall Study|Lost to Follow-up|16|||
157127415|NCT01235962|567217077|FG002|Overall Study|Lost to Follow-up|47|||
157127416|NCT01235962|567217078|FG003|Overall Study|Lost to Follow-up|32|||
157127417|NCT01235962|567217075|FG000|Overall Study|Physician Decision|5|||
157127418|NCT01235962|567217076|FG001|Overall Study|Physician Decision|0|||
157127419|NCT01235962|567217077|FG002|Overall Study|Physician Decision|9|||
157127420|NCT01235962|567217078|FG003|Overall Study|Physician Decision|5|||
157127421|NCT00130286|567217079|FG000|Overall Study|Withdrawal by Subject|0|||
157127422|NCT00130286|567217080|FG001|Overall Study|Withdrawal by Subject|1|||
157127423|NCT00130286|567217081|FG002|Overall Study|Withdrawal by Subject|2|||
156714124|NCT05168202|565699290|FG001|Overall Study|Progressive Disease|4|||
156714125|NCT05168202|565699291|FG002|Overall Study|Progressive Disease|2|||
156714126|NCT05168202|565699292|FG003|Overall Study|Progressive Disease|3|||
156714127|NCT05168202|565699293|FG004|Overall Study|Progressive Disease|2|||
157127424|NCT00130286|567217082|FG003|Overall Study|Withdrawal by Subject|2|||
157127425|NCT00130286|567217079|FG000|Overall Study|Adverse Event|0|||
157127426|NCT00130286|567217080|FG001|Overall Study|Adverse Event|0|||
157127427|NCT00130286|567217081|FG002|Overall Study|Adverse Event|2|||
157127428|NCT00130286|567217082|FG003|Overall Study|Adverse Event|0|||
157127429|NCT00130286|567217079|FG000|Overall Study|Missing lab specimens|0|||
156714128|NCT05168202|565699294|FG005|Overall Study|Progressive Disease|3|||
156714129|NCT05168202|565699295|FG006|Overall Study|Progressive Disease|2|||
156874031|NCT00092443|566296190|FG000|Overall Study|Withdrawal by Subject|9|||
156874032|NCT00092443|566296191|FG001|Overall Study|Withdrawal by Subject|11|||
156874033|NCT00092443|566296190|FG000|Overall Study|Moved|5|||
156874034|NCT00092443|566296191|FG001|Overall Study|Moved|5|||
156874035|NCT00092443|566296190|FG000|Overall Study|Other|17|||
156874036|NCT00092443|566296191|FG001|Overall Study|Other|13|||
156874037|NCT04717336|566296192|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
156874038|NCT04717336|566296193|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
156874039|NCT04717336|566296192|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
156874040|NCT04717336|566296193|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
156874041|NCT02039843|566296194|FG000|Randomization and Observation Period|Adverse Event|2|||
156874042|NCT02039843|566296195|FG001|Randomization and Observation Period|Adverse Event|0|||
156874043|NCT02039843|566296194|FG000|Randomization and Observation Period|Death|1|||
156874044|NCT02039843|566296195|FG001|Randomization and Observation Period|Death|0|||
156874045|NCT02039843|566296194|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
156874046|NCT02039843|566296195|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
156874047|NCT02039843|566296194|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
156874048|NCT02039843|566296195|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
156874049|NCT02039843|566296194|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
156874050|NCT02039843|566296195|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
156874051|NCT02039843|566296194|FG000|Pairing With a Study Dog|Death|1|||
157127430|NCT00130286|567217080|FG001|Overall Study|Missing lab specimens|2|||
157127431|NCT00130286|567217081|FG002|Overall Study|Missing lab specimens|0|||
157127432|NCT00130286|567217082|FG003|Overall Study|Missing lab specimens|0|||
156874052|NCT02039843|566296195|FG001|Pairing With a Study Dog|Death|0|||
156874053|NCT02039843|566296194|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
156874054|NCT02039843|566296195|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
156874055|NCT02039843|566296194|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
156874056|NCT02039843|566296195|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
156874057|NCT02039843|566296194|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
156874058|NCT02039843|566296195|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
156874059|NCT01500720|566296199|FG000|Overall Study|Randomized But Not Treated|1|||
156874060|NCT01500720|566296200|FG001|Overall Study|Randomized But Not Treated|1|||
156874061|NCT01500720|566296199|FG000|Overall Study|Other|4|||
156874062|NCT01500720|566296200|FG001|Overall Study|Other|8|||
156874063|NCT04672655|566296201|FG000|Overall Study|Lost to Follow-up|12|||
156874064|NCT04672655|566296202|FG001|Overall Study|Lost to Follow-up|17|||
156874065|NCT04672655|566296201|FG000|Overall Study|Withdrawal by Subject|1|||
156874066|NCT04672655|566296202|FG001|Overall Study|Withdrawal by Subject|0|||
156874067|NCT04672655|566296201|FG000|Overall Study|Withdrawal by Study|1|||
156874068|NCT04672655|566296202|FG001|Overall Study|Withdrawal by Study|0|||
156874069|NCT03079102|566298538|FG000|Overall Study|Physician Decision|0|||
156874070|NCT03079102|566298539|FG001|Overall Study|Physician Decision|1|||
156874071|NCT02923921|566298540|FG000|Overall Study|Sponsor Decision|39|||
156874072|NCT02923921|566298541|FG001|Overall Study|Sponsor Decision|38|||
156874073|NCT02923921|566298540|FG000|Overall Study|Lost to Follow-up|1|||
156874074|NCT02923921|566298541|FG001|Overall Study|Lost to Follow-up|0|||
156874075|NCT02923921|566298540|FG000|Overall Study|Withdrawal by Subject|6|||
156874076|NCT02923921|566298541|FG001|Overall Study|Withdrawal by Subject|13|||
156874077|NCT02923921|566298540|FG000|Overall Study|Unknown, Not Collected|7|||
157127433|NCT01972074|567217091|FG000|Overall Study|Adverse Event|4|||
157127434|NCT01972074|567217092|FG001|Overall Study|Adverse Event|1|||
157127435|NCT01972074|567217093|FG002|Overall Study|Adverse Event|0|||
157127436|NCT01972074|567217091|FG000|Overall Study|Lack of Efficacy|1|||
157127437|NCT01972074|567217092|FG001|Overall Study|Lack of Efficacy|1|||
157127438|NCT01972074|567217093|FG002|Overall Study|Lack of Efficacy|0|||
157127439|NCT01972074|567217091|FG000|Overall Study|Lost to Follow-up|0|||
157127440|NCT01972074|567217092|FG001|Overall Study|Lost to Follow-up|1|||
157127441|NCT01972074|567217093|FG002|Overall Study|Lost to Follow-up|1|||
157127442|NCT01972074|567217091|FG000|Overall Study|Withdrawal by Subject|1|||
157127443|NCT01972074|567217092|FG001|Overall Study|Withdrawal by Subject|1|||
157127444|NCT01972074|567217093|FG002|Overall Study|Withdrawal by Subject|1|||
157127445|NCT01972074|567217091|FG000|Overall Study|Scanner Unavailable|0|||
157127446|NCT01972074|567217092|FG001|Overall Study|Scanner Unavailable|0|||
157127447|NCT01972074|567217093|FG002|Overall Study|Scanner Unavailable|1|||
156874078|NCT02923921|566298541|FG001|Overall Study|Unknown, Not Collected|6|||
156874079|NCT00854113|566298545|FG000|Overall Study|Adverse Event|0|||
156874080|NCT00854113|566298546|FG001|Overall Study|Adverse Event|0|||
156874081|NCT00854113|566298547|FG002|Overall Study|Adverse Event|0|||
156874082|NCT00854113|566298548|FG003|Overall Study|Adverse Event|0|||
156874083|NCT00854113|566298549|FG004|Overall Study|Adverse Event|0|||
156874084|NCT00854113|566298550|FG005|Overall Study|Adverse Event|0|||
157127448|NCT03687502|567217104|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
157216177|NCT02544633|567539219|FG000|Treatment Period|Lack of Efficacy|17|||
157127449|NCT03687502|567217104|FG000|Overall Study|Lumason not available|1|||
156874085|NCT00854113|566298551|FG006|Overall Study|Adverse Event|0|||
156874086|NCT00854113|566298552|FG007|Overall Study|Adverse Event|2|||
156874087|NCT00854113|566298553|FG008|Overall Study|Adverse Event|0|||
156874088|NCT00854113|566298554|FG009|Overall Study|Adverse Event|0|||
156874089|NCT00854113|566298555|FG010|Overall Study|Adverse Event|0|||
156874090|NCT00854113|566298545|FG000|Overall Study|Withdrawal by Subject|0|||
156874091|NCT00854113|566298546|FG001|Overall Study|Withdrawal by Subject|0|||
157216178|NCT02544633|567539220|FG001|Treatment Period|Lack of Efficacy|11|||
157216179|NCT02544633|567539221|FG002|Treatment Period|Lack of Efficacy|5|||
157216180|NCT02544633|567539222|FG003|Treatment Period|Lack of Efficacy|5|||
157216181|NCT02544633|567539219|FG000|Treatment Period|Global Deterioration of Health|3|||
157216182|NCT02544633|567539220|FG001|Treatment Period|Global Deterioration of Health|3|||
157216183|NCT02544633|567539221|FG002|Treatment Period|Global Deterioration of Health|0|||
157216184|NCT02544633|567539222|FG003|Treatment Period|Global Deterioration of Health|1|||
157216185|NCT02544633|567539219|FG000|Treatment Period|Withdrawal by Subject|1|||
157216186|NCT02544633|567539220|FG001|Treatment Period|Withdrawal by Subject|0|||
157216187|NCT02544633|567539221|FG002|Treatment Period|Withdrawal by Subject|0|||
157216188|NCT02544633|567539222|FG003|Treatment Period|Withdrawal by Subject|0|||
157216189|NCT02544633|567539219|FG000|Treatment Period|Lost to Follow-up|0|||
157216190|NCT02544633|567539220|FG001|Treatment Period|Lost to Follow-up|1|||
157216191|NCT02544633|567539221|FG002|Treatment Period|Lost to Follow-up|0|||
157216192|NCT02544633|567539222|FG003|Treatment Period|Lost to Follow-up|0|||
157216193|NCT02544633|567539219|FG000|Treatment Period|Death|0|||
157216194|NCT02544633|567539220|FG001|Treatment Period|Death|0|||
157216195|NCT02544633|567539221|FG002|Treatment Period|Death|1|||
157216196|NCT02544633|567539222|FG003|Treatment Period|Death|0|||
156874092|NCT00854113|566298547|FG002|Overall Study|Withdrawal by Subject|0|||
156874093|NCT00854113|566298548|FG003|Overall Study|Withdrawal by Subject|0|||
156874094|NCT00854113|566298549|FG004|Overall Study|Withdrawal by Subject|0|||
156874095|NCT00854113|566298550|FG005|Overall Study|Withdrawal by Subject|0|||
156874096|NCT00854113|566298551|FG006|Overall Study|Withdrawal by Subject|0|||
156874097|NCT00854113|566298552|FG007|Overall Study|Withdrawal by Subject|1|||
156874098|NCT00854113|566298553|FG008|Overall Study|Withdrawal by Subject|1|||
156874099|NCT00854113|566298554|FG009|Overall Study|Withdrawal by Subject|0|||
156874100|NCT00854113|566298555|FG010|Overall Study|Withdrawal by Subject|0|||
156874101|NCT00796419|566298557|FG000|Overall Study|Death|0|||
156874102|NCT00796419|566298558|FG001|Overall Study|Death|1|||
156874103|NCT00539864|566298559|FG000|Overall Study|Lost to Follow-up|0|||
156874104|NCT00539864|566298560|FG001|Overall Study|Lost to Follow-up|1|||
156874105|NCT00539864|566298559|FG000|Overall Study|Withdrawal by Subject|1|||
156874106|NCT00539864|566298560|FG001|Overall Study|Withdrawal by Subject|1|||
156874107|NCT01250145|566298563|FG000|Overall Study|Adverse Event|2|||
156874108|NCT01250145|566298564|FG001|Overall Study|Adverse Event|1|||
157127450|NCT00486278|567217106|FG000|Overall Study|Adverse Event|5|||
157127451|NCT00486278|567217106|FG000|Overall Study|Withdrawal by Subject|2|||
157127452|NCT00486278|567217106|FG000|Overall Study|Physician Decision|2|||
157127453|NCT02183519|567217112|FG000|Overall Study|computer error|3|||
157127454|NCT02183519|567217113|FG001|Overall Study|computer error|0|||
157127455|NCT02183519|567217112|FG000|Overall Study|Did not respond to cough inducter|0|||
157127456|NCT02183519|567217113|FG001|Overall Study|Did not respond to cough inducter|3|||
157127457|NCT01777581|567217115|FG000|Overall Study|Lost to Follow-up|1|||
157127458|NCT01777581|567217116|FG001|Overall Study|Lost to Follow-up|1|||
157127459|NCT01777581|567217115|FG000|Overall Study|Adverse Event|2|||
157127460|NCT01777581|567217116|FG001|Overall Study|Adverse Event|0|||
157127461|NCT01777581|567217115|FG000|Overall Study|Lack of Efficacy|0|||
157127462|NCT01777581|567217116|FG001|Overall Study|Lack of Efficacy|1|||
157127463|NCT05168267|567217117|FG000|Overall Study|Withdrawal by Subject|2|||
157127464|NCT05168267|567217118|FG001|Overall Study|Withdrawal by Subject|1|||
157127465|NCT05168267|567217117|FG000|Overall Study|Withdrawn by Therapist|1|||
157127466|NCT05168267|567217118|FG001|Overall Study|Withdrawn by Therapist|1|||
157127467|NCT05168267|567217117|FG000|Overall Study|Left Facility|1|||
157127468|NCT05168267|567217118|FG001|Overall Study|Left Facility|0|||
157127469|NCT02887521|567217119|FG000|Overall Study|Withdrawal by Subject|0|||
157127470|NCT02887521|567217120|FG001|Overall Study|Withdrawal by Subject|3|||
157127471|NCT00695565|567217121|FG000|Overall Study|Lost to Follow-up|4|||
157127472|NCT00695565|567217122|FG001|Overall Study|Lost to Follow-up|4|||
157127473|NCT00695565|567217121|FG000|Overall Study|Adverse Event|3|||
156874109|NCT01250145|566298563|FG000|Overall Study|Withdrawal by Subject|0|||
156874110|NCT01250145|566298564|FG001|Overall Study|Withdrawal by Subject|4|||
156874111|NCT02840799|566298565|FG000|Phase 1|Physician Decision|1|||
157127474|NCT00695565|567217122|FG001|Overall Study|Adverse Event|1|||
157127475|NCT00695565|567217121|FG000|Overall Study|Protocol Violation|3|||
157127476|NCT00695565|567217122|FG001|Overall Study|Protocol Violation|1|||
157127477|NCT00695565|567217121|FG000|Overall Study|Withdrawal by Subject|1|||
157127478|NCT00695565|567217122|FG001|Overall Study|Withdrawal by Subject|1|||
157127479|NCT00695565|567217121|FG000|Overall Study|Lack of Efficacy|1|||
157216197|NCT02544633|567539219|FG000|Treatment Period|Non-compliance|0|||
157216198|NCT02544633|567539220|FG001|Treatment Period|Non-compliance|0|||
157216199|NCT02544633|567539221|FG002|Treatment Period|Non-compliance|1|||
157216200|NCT02544633|567539222|FG003|Treatment Period|Non-compliance|0|||
157216201|NCT02544633|567539219|FG000|Treatment Period|Clinical Disease Progression|0|||
157216202|NCT02544633|567539220|FG001|Treatment Period|Clinical Disease Progression|0|||
157216203|NCT02544633|567539221|FG002|Treatment Period|Clinical Disease Progression|0|||
157216204|NCT02544633|567539222|FG003|Treatment Period|Clinical Disease Progression|1|||
157216205|NCT02544633|567539219|FG000|Survival Follow-up Period|Death|12|||
157216206|NCT02544633|567539220|FG001|Survival Follow-up Period|Death|14|||
157216207|NCT02544633|567539221|FG002|Survival Follow-up Period|Death|3|||
157216208|NCT02544633|567539222|FG003|Survival Follow-up Period|Death|9|||
157216209|NCT02544633|567539219|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
157216210|NCT02544633|567539220|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
157216211|NCT02544633|567539221|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
157216212|NCT02544633|567539222|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
157216213|NCT02544633|567539219|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
157216214|NCT02544633|567539220|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
157216215|NCT02544633|567539221|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
157216216|NCT02544633|567539222|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
157216217|NCT02544633|567539219|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
157216218|NCT02544633|567539220|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
157216219|NCT02544633|567539221|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
157216220|NCT02544633|567539222|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
157216221|NCT01605461|567539223|FG000|Overall Study|Lost to Follow-up|3|||
157216222|NCT01605461|567539223|FG000|Overall Study|Withdrawal by Subject|1|||
157216223|NCT01312779|567539226|FG000|Overall Study|Withdrawal by Subject|2|||
157216224|NCT01312779|567539226|FG000|Overall Study|Death|3|||
157216225|NCT01312779|567539226|FG000|Overall Study|Not Implanted with Device|27|||
157216226|NCT00506753|567539227|FG000|Overall Study|Lost to Follow-up|21|||
157216227|NCT00506753|567539228|FG001|Overall Study|Lost to Follow-up|15|||
157216228|NCT02451670|567539229|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
156714130|NCT05168202|565699289|FG000|Overall Study|Adverse Event|2|||
156714131|NCT05168202|565699290|FG001|Overall Study|Adverse Event|1|||
156714132|NCT05168202|565699291|FG002|Overall Study|Adverse Event|4|||
156714133|NCT05168202|565699292|FG003|Overall Study|Adverse Event|4|||
156714134|NCT05168202|565699293|FG004|Overall Study|Adverse Event|3|||
156714135|NCT05168202|565699294|FG005|Overall Study|Adverse Event|2|||
156714136|NCT05168202|565699295|FG006|Overall Study|Adverse Event|0|||
156714137|NCT05168202|565699289|FG000|Overall Study|Lack of Efficacy|0|||
156714138|NCT05168202|565699290|FG001|Overall Study|Lack of Efficacy|1|||
156714139|NCT05168202|565699291|FG002|Overall Study|Lack of Efficacy|1|||
156714140|NCT05168202|565699292|FG003|Overall Study|Lack of Efficacy|0|||
156714141|NCT05168202|565699293|FG004|Overall Study|Lack of Efficacy|1|||
156714142|NCT05168202|565699294|FG005|Overall Study|Lack of Efficacy|2|||
156714143|NCT05168202|565699295|FG006|Overall Study|Lack of Efficacy|2|||
156714144|NCT05168202|565699289|FG000|Overall Study|Withdrawal by Subject|0|||
156714145|NCT05168202|565699290|FG001|Overall Study|Withdrawal by Subject|0|||
156714146|NCT05168202|565699291|FG002|Overall Study|Withdrawal by Subject|1|||
156714147|NCT05168202|565699292|FG003|Overall Study|Withdrawal by Subject|1|||
156714148|NCT05168202|565699293|FG004|Overall Study|Withdrawal by Subject|1|||
156714149|NCT05168202|565699294|FG005|Overall Study|Withdrawal by Subject|1|||
156714150|NCT05168202|565699295|FG006|Overall Study|Withdrawal by Subject|0|||
156714151|NCT05168202|565699289|FG000|Overall Study|Disease Relapse|0|||
156714152|NCT05168202|565699290|FG001|Overall Study|Disease Relapse|1|||
156714153|NCT05168202|565699291|FG002|Overall Study|Disease Relapse|0|||
156714154|NCT05168202|565699292|FG003|Overall Study|Disease Relapse|1|||
156714155|NCT05168202|565699293|FG004|Overall Study|Disease Relapse|1|||
156714156|NCT05168202|565699294|FG005|Overall Study|Disease Relapse|0|||
156714157|NCT05168202|565699295|FG006|Overall Study|Disease Relapse|0|||
156714158|NCT05168202|565699289|FG000|Overall Study|Other Reasons|0|||
156714159|NCT05168202|565699290|FG001|Overall Study|Other Reasons|0|||
156714160|NCT05168202|565699291|FG002|Overall Study|Other Reasons|0|||
156714161|NCT05168202|565699292|FG003|Overall Study|Other Reasons|0|||
156714162|NCT05168202|565699293|FG004|Overall Study|Other Reasons|0|||
156714163|NCT05168202|565699294|FG005|Overall Study|Other Reasons|2|||
157216229|NCT02451670|567539230|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
156714164|NCT05168202|565699295|FG006|Overall Study|Other Reasons|1|||
156714165|NCT05168202|565699289|FG000|Overall Study|Physician Decision|0|||
156714166|NCT05168202|565699290|FG001|Overall Study|Physician Decision|1|||
156714167|NCT05168202|565699291|FG002|Overall Study|Physician Decision|1|||
157216230|NCT03549130|567539236|FG000|Overall Study|Adverse Event|0|||
157216231|NCT03549130|567539237|FG001|Overall Study|Adverse Event|1|||
157216232|NCT03549130|567539236|FG000|Overall Study|Lost to Follow-up|0|||
157216233|NCT03549130|567539237|FG001|Overall Study|Lost to Follow-up|1|||
157216234|NCT01078623|567539238|FG000|Treatment Period 1|Adverse Event|1|||
156714168|NCT05168202|565699292|FG003|Overall Study|Physician Decision|0|||
156714169|NCT05168202|565699293|FG004|Overall Study|Physician Decision|0|||
156714170|NCT05168202|565699294|FG005|Overall Study|Physician Decision|0|||
156714171|NCT05168202|565699295|FG006|Overall Study|Physician Decision|0|||
156714172|NCT05168202|565699289|FG000|Overall Study|Study Terminated by Sponsor|0|||
156714173|NCT05168202|565699290|FG001|Overall Study|Study Terminated by Sponsor|0|||
156714174|NCT05168202|565699291|FG002|Overall Study|Study Terminated by Sponsor|0|||
156714175|NCT05168202|565699292|FG003|Overall Study|Study Terminated by Sponsor|1|||
156714176|NCT05168202|565699293|FG004|Overall Study|Study Terminated by Sponsor|0|||
156714177|NCT05168202|565699294|FG005|Overall Study|Study Terminated by Sponsor|0|||
156714178|NCT05168202|565699295|FG006|Overall Study|Study Terminated by Sponsor|0|||
156714179|NCT04011722|565699297|FG000|30 Days|Death|5|||
156714180|NCT04011722|565699298|FG001|30 Days|Death|1|||
156714181|NCT04011722|565699297|FG000|1 Year|Death|13|||
156714182|NCT04011722|565699298|FG001|1 Year|Death|5|||
156714183|NCT04011722|565699297|FG000|1 Year|Withdrawal by Subject|8|||
156714184|NCT04011722|565699298|FG001|1 Year|Withdrawal by Subject|2|||
156714185|NCT04011722|565699297|FG000|1 Year|Missed Visit|6|||
156714186|NCT04011722|565699298|FG001|1 Year|Missed Visit|1|||
156714187|NCT04011722|565699297|FG000|1 Year|Pending Visit|0|||
156714188|NCT04011722|565699298|FG001|1 Year|Pending Visit|11|||
156714189|NCT04011722|565699297|FG000|1 Year|Not Yet Due|0|||
156714190|NCT04011722|565699298|FG001|1 Year|Not Yet Due|9|||
156714191|NCT04011722|565699297|FG000|2 Year|Death|16|||
156714192|NCT04011722|565699298|FG001|2 Year|Death|1|||
156714193|NCT04011722|565699297|FG000|2 Year|Withdrawal by Subject|10|||
156714194|NCT04011722|565699298|FG001|2 Year|Withdrawal by Subject|1|||
156714195|NCT04011722|565699297|FG000|2 Year|Missed Visit|9|||
156714196|NCT04011722|565699298|FG001|2 Year|Missed Visit|0|||
156714197|NCT04011722|565699297|FG000|2 Year|Visit Pending|1|||
156714198|NCT04011722|565699298|FG001|2 Year|Visit Pending|3|||
156714199|NCT04011722|565699297|FG000|2 Year|Not Yet Due|43|||
156714200|NCT04011722|565699298|FG001|2 Year|Not Yet Due|54|||
156714201|NCT04011722|565699297|FG000|3 Year|Death|10|||
156714202|NCT04011722|565699298|FG001|3 Year|Death|0|||
156714203|NCT04011722|565699297|FG000|3 Year|Withdrawal by Subject|2|||
156714204|NCT04011722|565699298|FG001|3 Year|Withdrawal by Subject|0|||
156714205|NCT04011722|565699297|FG000|3 Year|Missed Visit|2|||
156714206|NCT04011722|565699298|FG001|3 Year|Missed Visit|0|||
156714207|NCT04011722|565699297|FG000|3 Year|Pending Visit|34|||
156714208|NCT04011722|565699298|FG001|3 Year|Pending Visit|0|||
156714209|NCT04011722|565699297|FG000|3 Year|Not Yet Due|99|||
156714210|NCT04011722|565699298|FG001|3 Year|Not Yet Due|0|||
156714211|NCT05626231|565699299|FG000|Provider Enrollment|Worked part-time|4|||
156714212|NCT05626231|565699299|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
156714213|NCT05626231|565699299|FG000|Provider Enrollment|Non-clinical employee|1|||
156714214|NCT05626231|565699299|FG000|Provider Enrollment|Provider does not see clients|3|||
156714215|NCT05626231|565699299|FG000|Provider Enrollment|Other|5|||
156714216|NCT06195930|565699303|FG000|Overall Study|Adverse Event|4|||
156714217|NCT03999996|565699304|FG000|Prior to Booster|Adverse Event|2|||
156714218|NCT03999996|565699305|FG001|Prior to Booster|Adverse Event|0|||
156714219|NCT03999996|565699306|FG002|Prior to Booster|Adverse Event|0|||
156714220|NCT03999996|565699307|FG003|Prior to Booster|Adverse Event|0|||
156714221|NCT03999996|565699304|FG000|Prior to Booster|Lost to Follow-up|17|||
156714222|NCT03999996|565699305|FG001|Prior to Booster|Lost to Follow-up|22|||
156714223|NCT03999996|565699306|FG002|Prior to Booster|Lost to Follow-up|0|||
156714224|NCT03999996|565699307|FG003|Prior to Booster|Lost to Follow-up|0|||
156714225|NCT03999996|565699304|FG000|Prior to Booster|Withdrawal of Consent|51|||
156714226|NCT03999996|565699305|FG001|Prior to Booster|Withdrawal of Consent|8|||
156714227|NCT03999996|565699306|FG002|Prior to Booster|Withdrawal of Consent|0|||
156714228|NCT03999996|565699307|FG003|Prior to Booster|Withdrawal of Consent|0|||
156714229|NCT03999996|565699304|FG000|Prior to Booster|Death|0|||
156792617|NCT02656173|565992842|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
156792618|NCT02656173|565992841|FG000|Overall Study|Adverse Event|7|||
156792619|NCT02656173|565992842|FG001|Overall Study|Adverse Event|5|||
156792620|NCT02656173|565992841|FG000|Overall Study|Withdrawal by Subject|1|||
156792621|NCT02656173|565992842|FG001|Overall Study|Withdrawal by Subject|3|||
156792622|NCT02656173|565992841|FG000|Overall Study|Protocol Violation|0|||
156792623|NCT02656173|565992842|FG001|Overall Study|Protocol Violation|1|||
156714230|NCT03999996|565699305|FG001|Prior to Booster|Death|1|||
156714231|NCT03999996|565699306|FG002|Prior to Booster|Death|0|||
156714232|NCT03999996|565699307|FG003|Prior to Booster|Death|0|||
156714233|NCT03999996|565699304|FG000|Prior to Booster|Reason Not Specified|27|||
156714234|NCT03999996|565699305|FG001|Prior to Booster|Reason Not Specified|4|||
156714235|NCT03999996|565699306|FG002|Prior to Booster|Reason Not Specified|0|||
156714236|NCT03999996|565699307|FG003|Prior to Booster|Reason Not Specified|0|||
156714237|NCT03999996|565699304|FG000|Booster Phase|Lost to Follow-up|0|||
156714238|NCT03999996|565699305|FG001|Booster Phase|Lost to Follow-up|0|||
156714239|NCT03999996|565699306|FG002|Booster Phase|Lost to Follow-up|3|||
156714240|NCT03999996|565699307|FG003|Booster Phase|Lost to Follow-up|3|||
156714241|NCT03999996|565699304|FG000|Booster Phase|Withdrawal of Consent|0|||
156714242|NCT03999996|565699305|FG001|Booster Phase|Withdrawal of Consent|0|||
156714243|NCT03999996|565699306|FG002|Booster Phase|Withdrawal of Consent|0|||
156792624|NCT02656173|565992841|FG000|Overall Study|Miscellaneous|2|||
156792625|NCT02656173|565992842|FG001|Overall Study|Miscellaneous|0|||
156714244|NCT03999996|565699307|FG003|Booster Phase|Withdrawal of Consent|1|||
156714245|NCT03999996|565699304|FG000|Booster Phase|Reason Not Specified|0|||
156714246|NCT03999996|565699305|FG001|Booster Phase|Reason Not Specified|0|||
156714247|NCT03999996|565699306|FG002|Booster Phase|Reason Not Specified|0|||
156714248|NCT03999996|565699307|FG003|Booster Phase|Reason Not Specified|1|||
156714249|NCT03690388|565699308|FG000|Overall Study|Adverse Event|8|||
156714250|NCT03690388|565699309|FG001|Overall Study|Adverse Event|1|||
156714251|NCT03690388|565699308|FG000|Overall Study|Radiographic Progression|14|||
156714252|NCT03690388|565699309|FG001|Overall Study|Radiographic Progression|29|||
156714253|NCT03690388|565699308|FG000|Overall Study|Clinical deterioration|10|||
156714254|NCT03690388|565699309|FG001|Overall Study|Clinical deterioration|6|||
156714255|NCT03690388|565699308|FG000|Overall Study|Withdrawal by Subject|2|||
156714256|NCT03690388|565699309|FG001|Overall Study|Withdrawal by Subject|0|||
156714257|NCT03690388|565699308|FG000|Overall Study|Lack of Efficacy|1|||
156714258|NCT03690388|565699309|FG001|Overall Study|Lack of Efficacy|0|||
156714259|NCT03690388|565699308|FG000|Overall Study|Lost to Follow-up|1|||
156714260|NCT03690388|565699309|FG001|Overall Study|Lost to Follow-up|0|||
156714261|NCT00001521|565699310|FG000|Overall Study|Withdrawal by Subject|3|||
156714262|NCT00001521|565699311|FG001|Overall Study|Withdrawal by Subject|3|||
156714263|NCT00001521|565699310|FG000|Overall Study|Physician Decision|1|||
156714264|NCT00001521|565699311|FG001|Overall Study|Physician Decision|1|||
156714265|NCT00001521|565699310|FG000|Overall Study|Noncompliant|6|||
156714266|NCT00001521|565699311|FG001|Overall Study|Noncompliant|3|||
156714267|NCT03573830|565699316|FG000|Overall Study|Dropped without completing treatment|0|||
156714268|NCT03573830|565699317|FG001|Overall Study|Dropped without completing treatment|7|||
156714269|NCT03573830|565699316|FG000|Overall Study|Lost to Follow-up|4|||
156714270|NCT03573830|565699317|FG001|Overall Study|Lost to Follow-up|0|||
156714271|NCT00266630|565699318|FG000|Overall Study|Adverse Event|8|||
156714272|NCT00266630|565699319|FG001|Overall Study|Adverse Event|6|||
156714273|NCT00266630|565699318|FG000|Overall Study|Lack of Efficacy|1|||
156714274|NCT00266630|565699319|FG001|Overall Study|Lack of Efficacy|4|||
156714275|NCT00266630|565699318|FG000|Overall Study|Entry Criteria not met|1|||
156714276|NCT00266630|565699319|FG001|Overall Study|Entry Criteria not met|0|||
156714277|NCT00266630|565699318|FG000|Overall Study|Protocol Violation|1|||
156714278|NCT00266630|565699319|FG001|Overall Study|Protocol Violation|3|||
156714279|NCT00266630|565699318|FG000|Overall Study|Physician Decision|1|||
156714280|NCT00266630|565699319|FG001|Overall Study|Physician Decision|2|||
156714281|NCT00266630|565699318|FG000|Overall Study|Withdrawal by Subject|10|||
156714282|NCT00266630|565699319|FG001|Overall Study|Withdrawal by Subject|2|||
156714283|NCT00266630|565699318|FG000|Overall Study|Lost to Follow-up|1|||
156714284|NCT00266630|565699319|FG001|Overall Study|Lost to Follow-up|0|||
156714285|NCT00266630|565699318|FG000|Overall Study|Other|19|||
156714286|NCT00266630|565699319|FG001|Overall Study|Other|11|||
156714287|NCT03284723|565699324|FG000|Overall Study|Death|0|||
156714288|NCT03284723|565699325|FG001|Overall Study|Death|0|||
156714289|NCT03284723|565699326|FG002|Overall Study|Death|0|||
156714290|NCT03284723|565699327|FG003|Overall Study|Death|1|||
156714291|NCT03284723|565699328|FG004|Overall Study|Death|0|||
156714292|NCT03284723|565699329|FG005|Overall Study|Death|0|||
156714293|NCT03284723|565699330|FG006|Overall Study|Death|1|||
156714294|NCT03284723|565699331|FG007|Overall Study|Death|0|||
156792626|NCT00834587|565992845|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
157127480|NCT00695565|567217122|FG001|Overall Study|Lack of Efficacy|1|||
156792627|NCT00834587|565992846|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156792628|NCT03810495|565992847|FG000|Overall Study|Lost to Follow-up|2|||
156792629|NCT03810495|565992847|FG000|Overall Study|Withdrawal by Subject|1|||
156792630|NCT03449147|565992848|FG000|52-week Treatment Period|Death|0|||
156792631|NCT03449147|565992849|FG001|52-week Treatment Period|Death|1|||
156792632|NCT03449147|565992850|FG002|52-week Treatment Period|Death|0|||
156792633|NCT03449147|565992848|FG000|52-week Treatment Period|Lost to Follow-up|6|||
156792634|NCT03449147|565992849|FG001|52-week Treatment Period|Lost to Follow-up|2|||
157127481|NCT00695565|567217121|FG000|Overall Study|Subject did not follow instructions|1|||
157127482|NCT00695565|567217122|FG001|Overall Study|Subject did not follow instructions|1|||
157127483|NCT02937350|567217123|FG000|Overall Study|Withdrawal by Subject|0|||
156792635|NCT03449147|565992850|FG002|52-week Treatment Period|Lost to Follow-up|5|||
156792636|NCT03449147|565992848|FG000|52-week Treatment Period|Other|0|||
156874112|NCT02840799|566298566|FG001|Phase 1|Physician Decision|3|||
156714295|NCT03284723|565699332|FG008|Overall Study|Death|0|||
156714296|NCT03284723|565699333|FG009|Overall Study|Death|2|||
156714297|NCT03284723|565699334|FG010|Overall Study|Death|1|||
156714298|NCT03284723|565699335|FG011|Overall Study|Death|0|||
156714299|NCT03284723|565699324|FG000|Overall Study|Lost to Follow-up|0|||
156714300|NCT03284723|565699325|FG001|Overall Study|Lost to Follow-up|0|||
156714301|NCT03284723|565699326|FG002|Overall Study|Lost to Follow-up|0|||
156714302|NCT03284723|565699327|FG003|Overall Study|Lost to Follow-up|0|||
156714303|NCT03284723|565699328|FG004|Overall Study|Lost to Follow-up|0|||
156714304|NCT03284723|565699329|FG005|Overall Study|Lost to Follow-up|2|||
156714305|NCT03284723|565699330|FG006|Overall Study|Lost to Follow-up|1|||
156792637|NCT03449147|565992849|FG001|52-week Treatment Period|Other|1|||
156714306|NCT03284723|565699331|FG007|Overall Study|Lost to Follow-up|0|||
156714307|NCT03284723|565699332|FG008|Overall Study|Lost to Follow-up|0|||
156714308|NCT03284723|565699333|FG009|Overall Study|Lost to Follow-up|2|||
156714309|NCT03284723|565699334|FG010|Overall Study|Lost to Follow-up|0|||
156714310|NCT03284723|565699335|FG011|Overall Study|Lost to Follow-up|0|||
156714311|NCT03284723|565699324|FG000|Overall Study|Study Terminated By Sponsor|0|||
156714312|NCT03284723|565699325|FG001|Overall Study|Study Terminated By Sponsor|0|||
156714313|NCT03284723|565699326|FG002|Overall Study|Study Terminated By Sponsor|0|||
156714314|NCT03284723|565699327|FG003|Overall Study|Study Terminated By Sponsor|0|||
156714315|NCT03284723|565699328|FG004|Overall Study|Study Terminated By Sponsor|1|||
156714316|NCT03284723|565699329|FG005|Overall Study|Study Terminated By Sponsor|0|||
156714317|NCT03284723|565699330|FG006|Overall Study|Study Terminated By Sponsor|0|||
156714318|NCT03284723|565699331|FG007|Overall Study|Study Terminated By Sponsor|0|||
156714319|NCT03284723|565699332|FG008|Overall Study|Study Terminated By Sponsor|1|||
156714320|NCT03284723|565699333|FG009|Overall Study|Study Terminated By Sponsor|1|||
156714321|NCT03284723|565699334|FG010|Overall Study|Study Terminated By Sponsor|1|||
156714322|NCT03284723|565699335|FG011|Overall Study|Study Terminated By Sponsor|1|||
156714323|NCT03284723|565699324|FG000|Overall Study|Withdrawal by Subject|0|||
156714324|NCT03284723|565699325|FG001|Overall Study|Withdrawal by Subject|0|||
156714325|NCT03284723|565699326|FG002|Overall Study|Withdrawal by Subject|0|||
156714326|NCT03284723|565699327|FG003|Overall Study|Withdrawal by Subject|0|||
156714327|NCT03284723|565699328|FG004|Overall Study|Withdrawal by Subject|5|||
156714328|NCT03284723|565699329|FG005|Overall Study|Withdrawal by Subject|3|||
156714329|NCT03284723|565699330|FG006|Overall Study|Withdrawal by Subject|1|||
156714330|NCT03284723|565699331|FG007|Overall Study|Withdrawal by Subject|0|||
156714331|NCT03284723|565699332|FG008|Overall Study|Withdrawal by Subject|6|||
156714332|NCT03284723|565699333|FG009|Overall Study|Withdrawal by Subject|0|||
156714333|NCT03284723|565699334|FG010|Overall Study|Withdrawal by Subject|3|||
156714334|NCT03284723|565699335|FG011|Overall Study|Withdrawal by Subject|1|||
156714335|NCT03284723|565699324|FG000|Overall Study|Other|1|||
156714336|NCT03284723|565699325|FG001|Overall Study|Other|0|||
156714337|NCT03284723|565699326|FG002|Overall Study|Other|1|||
156714338|NCT03284723|565699327|FG003|Overall Study|Other|0|||
156714339|NCT03284723|565699328|FG004|Overall Study|Other|1|||
156714340|NCT03284723|565699329|FG005|Overall Study|Other|0|||
156714341|NCT03284723|565699330|FG006|Overall Study|Other|0|||
156714342|NCT03284723|565699331|FG007|Overall Study|Other|0|||
156714343|NCT03284723|565699332|FG008|Overall Study|Other|0|||
156714344|NCT03284723|565699333|FG009|Overall Study|Other|0|||
156714345|NCT03284723|565699334|FG010|Overall Study|Other|1|||
156714346|NCT03284723|565699335|FG011|Overall Study|Other|0|||
156714347|NCT03284723|565699324|FG000|Overall Study|Adverse Event|0|||
156714348|NCT03284723|565699325|FG001|Overall Study|Adverse Event|0|||
156714349|NCT03284723|565699326|FG002|Overall Study|Adverse Event|0|||
156714350|NCT03284723|565699327|FG003|Overall Study|Adverse Event|0|||
156714351|NCT03284723|565699328|FG004|Overall Study|Adverse Event|0|||
156714352|NCT03284723|565699329|FG005|Overall Study|Adverse Event|0|||
156714353|NCT03284723|565699330|FG006|Overall Study|Adverse Event|0|||
156714354|NCT03284723|565699331|FG007|Overall Study|Adverse Event|0|||
156714355|NCT03284723|565699332|FG008|Overall Study|Adverse Event|1|||
156714356|NCT03284723|565699333|FG009|Overall Study|Adverse Event|0|||
156714357|NCT03284723|565699334|FG010|Overall Study|Adverse Event|0|||
156714358|NCT03284723|565699335|FG011|Overall Study|Adverse Event|0|||
156714359|NCT01499095|565699340|FG000|Overall Study|Randomized But Not Treated|1|||
156714360|NCT01499095|565699341|FG001|Overall Study|Randomized But Not Treated|1|||
156714361|NCT01499095|565699340|FG000|Overall Study|Adverse Event|12|||
156714362|NCT01499095|565699341|FG001|Overall Study|Adverse Event|7|||
156714363|NCT01499095|565699340|FG000|Overall Study|Lack of Efficacy|2|||
157127484|NCT02937350|567217124|FG001|Overall Study|Withdrawal by Subject|1|||
156714364|NCT01499095|565699341|FG001|Overall Study|Lack of Efficacy|1|||
156714365|NCT01499095|565699340|FG000|Overall Study|Protocol Violation|6|||
156714366|NCT01499095|565699341|FG001|Overall Study|Protocol Violation|7|||
156714367|NCT01499095|565699340|FG000|Overall Study|Received Rescue Therapy|32|||
156714368|NCT01499095|565699341|FG001|Overall Study|Received Rescue Therapy|40|||
156714369|NCT01499095|565699340|FG000|Overall Study|Diverse Reasons|22|||
156714370|NCT01499095|565699341|FG001|Overall Study|Diverse Reasons|25|||
156714371|NCT01499095|565699340|FG000|Overall Study|Lost to Follow-up|6|||
156714372|NCT01499095|565699341|FG001|Overall Study|Lost to Follow-up|4|||
156714373|NCT01499095|565699340|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
156714374|NCT01499095|565699341|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
156714375|NCT01499095|565699340|FG000|Overall Study|Hypoglycemia|3|||
156714376|NCT01499095|565699341|FG001|Overall Study|Hypoglycemia|1|||
156714377|NCT01499095|565699340|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
156714378|NCT01499095|565699341|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
156714379|NCT01499095|565699340|FG000|Overall Study|Change in Injection Schedule|2|||
156714380|NCT01499095|565699341|FG001|Overall Study|Change in Injection Schedule|0|||
156714381|NCT01499095|565699340|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156714382|NCT01499095|565699341|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156714383|NCT01368497|565699345|FG000|Overall Study|Lost to Follow-up|2|||
156714384|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
156714385|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
156714386|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
156714387|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
156714388|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
156714389|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
156714390|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
156714391|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
156714392|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
156714393|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
156714394|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
156714395|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
156714396|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
156714397|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
156714398|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
156714399|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
156714400|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
156714401|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
156714402|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
156714403|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
156714404|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
156714405|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
156714406|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
156714407|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
156714408|NCT01130532|565699346|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
156714409|NCT01130532|565699347|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
156714410|NCT01130532|565699348|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
156714411|NCT01130532|565699349|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
156714412|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
156714413|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
156714414|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
156714415|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
156714416|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714417|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714418|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
156714419|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
156714420|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714421|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714422|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
156714423|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
156714424|NCT01130532|565699346|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714425|NCT01130532|565699347|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714426|NCT01130532|565699348|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
156714427|NCT01130532|565699349|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
156714428|NCT02762929|565699350|FG000|Overall Study|Adverse Event|0|||
156714429|NCT02762929|565699351|FG001|Overall Study|Adverse Event|0|||
156714430|NCT02762929|565699352|FG002|Overall Study|Adverse Event|0|||
156714431|NCT02762929|565699353|FG003|Overall Study|Adverse Event|1|||
156714432|NCT02762929|565699354|FG004|Overall Study|Adverse Event|0|||
156714433|NCT02762929|565699355|FG005|Overall Study|Adverse Event|0|||
156792638|NCT03449147|565992850|FG002|52-week Treatment Period|Other|2|||
156792639|NCT03449147|565992848|FG000|52-week Treatment Period|Physician Decision|1|||
156792640|NCT03449147|565992849|FG001|52-week Treatment Period|Physician Decision|0|||
156792641|NCT03449147|565992850|FG002|52-week Treatment Period|Physician Decision|3|||
156792642|NCT03449147|565992848|FG000|52-week Treatment Period|Screen Failure|1|||
156792643|NCT03449147|565992849|FG001|52-week Treatment Period|Screen Failure|2|||
156792644|NCT03449147|565992850|FG002|52-week Treatment Period|Screen Failure|0|||
156792645|NCT03449147|565992848|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
156792646|NCT03449147|565992849|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
156792647|NCT03449147|565992850|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
156792648|NCT03449147|565992848|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
156714434|NCT02762929|565699350|FG000|Overall Study|Lost to Follow-up|1|||
156792649|NCT03449147|565992849|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
156792650|NCT03449147|565992850|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
156714435|NCT02762929|565699351|FG001|Overall Study|Lost to Follow-up|2|||
156714436|NCT02762929|565699352|FG002|Overall Study|Lost to Follow-up|0|||
156714437|NCT02762929|565699353|FG003|Overall Study|Lost to Follow-up|1|||
156714438|NCT02762929|565699354|FG004|Overall Study|Lost to Follow-up|0|||
156808772|NCT03801928|566054461|FG002|Overall Study|Adverse Event|1|||
156714439|NCT02762929|565699355|FG005|Overall Study|Lost to Follow-up|0|||
156714440|NCT02762929|565699350|FG000|Overall Study|Withdrawal by Subject|0|||
156714441|NCT02762929|565699351|FG001|Overall Study|Withdrawal by Subject|1|||
156714442|NCT02762929|565699352|FG002|Overall Study|Withdrawal by Subject|0|||
156714443|NCT02762929|565699353|FG003|Overall Study|Withdrawal by Subject|0|||
156714444|NCT02762929|565699354|FG004|Overall Study|Withdrawal by Subject|0|||
156714445|NCT02762929|565699355|FG005|Overall Study|Withdrawal by Subject|0|||
156714446|NCT02762929|565699350|FG000|Overall Study|exclusionary medication disclosed late|0|||
156714447|NCT02762929|565699351|FG001|Overall Study|exclusionary medication disclosed late|0|||
156714448|NCT02762929|565699352|FG002|Overall Study|exclusionary medication disclosed late|0|||
156714449|NCT02762929|565699353|FG003|Overall Study|exclusionary medication disclosed late|1|||
156714450|NCT02762929|565699354|FG004|Overall Study|exclusionary medication disclosed late|0|||
156714451|NCT02762929|565699355|FG005|Overall Study|exclusionary medication disclosed late|0|||
156714452|NCT02656303|565699357|FG000|Overall Study|Adverse Event|3|||
156714453|NCT02656303|565699358|FG001|Overall Study|Adverse Event|2|||
156714454|NCT02656303|565699359|FG002|Overall Study|Adverse Event|0|||
156714455|NCT02656303|565699357|FG000|Overall Study|Death|12|||
156714456|NCT02656303|565699358|FG001|Overall Study|Death|4|||
156714457|NCT02656303|565699359|FG002|Overall Study|Death|1|||
156714458|NCT02656303|565699357|FG000|Overall Study|Lack of Efficacy|1|||
156714459|NCT02656303|565699358|FG001|Overall Study|Lack of Efficacy|0|||
156714460|NCT02656303|565699359|FG002|Overall Study|Lack of Efficacy|0|||
156714461|NCT02656303|565699357|FG000|Overall Study|Non-Compliance with Study|1|||
156714462|NCT02656303|565699358|FG001|Overall Study|Non-Compliance with Study|1|||
156714463|NCT02656303|565699359|FG002|Overall Study|Non-Compliance with Study|0|||
156714464|NCT02656303|565699357|FG000|Overall Study|Investigator Decision|2|||
156714465|NCT02656303|565699358|FG001|Overall Study|Investigator Decision|1|||
156714466|NCT02656303|565699359|FG002|Overall Study|Investigator Decision|0|||
156714467|NCT02656303|565699357|FG000|Overall Study|Progressive Disease|25|||
156714468|NCT02656303|565699358|FG001|Overall Study|Progressive Disease|14|||
156714469|NCT02656303|565699359|FG002|Overall Study|Progressive Disease|10|||
156714470|NCT02656303|565699357|FG000|Overall Study|Study Terminated by Sponsor|20|||
156714471|NCT02656303|565699358|FG001|Overall Study|Study Terminated by Sponsor|7|||
156714472|NCT02656303|565699359|FG002|Overall Study|Study Terminated by Sponsor|5|||
156714473|NCT02656303|565699357|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
156714474|NCT02656303|565699358|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
156714475|NCT02656303|565699359|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
156714476|NCT02656303|565699357|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
156714477|NCT02656303|565699358|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
156714478|NCT02656303|565699359|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
156714479|NCT02656303|565699357|FG000|Overall Study|Reason not Specified|1|||
156714480|NCT02656303|565699358|FG001|Overall Study|Reason not Specified|1|||
156714481|NCT02656303|565699359|FG002|Overall Study|Reason not Specified|2|||
156714482|NCT03041311|565699364|FG000|Overall Study|Death|39|||
156714483|NCT03041311|565699365|FG001|Overall Study|Death|42|||
156714484|NCT03041311|565699364|FG000|Overall Study|Lost to Follow-up|0|||
156714485|NCT03041311|565699365|FG001|Overall Study|Lost to Follow-up|1|||
156714486|NCT03041311|565699364|FG000|Overall Study|Withdrawal by Subject|8|||
156714487|NCT03041311|565699365|FG001|Overall Study|Withdrawal by Subject|5|||
156714488|NCT03041311|565699364|FG000|Overall Study|Sponsor Terminated Study|2|||
156714489|NCT03041311|565699365|FG001|Overall Study|Sponsor Terminated Study|4|||
156714490|NCT03041311|565699364|FG000|Overall Study|Disease Progression|3|||
156714491|NCT03041311|565699365|FG001|Overall Study|Disease Progression|1|||
156714492|NCT03041311|565699364|FG000|Overall Study|Randomized in error, did not receive drug|2|||
156714493|NCT03041311|565699365|FG001|Overall Study|Randomized in error, did not receive drug|0|||
156714494|NCT01842438|565699366|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
156714495|NCT01842438|565699367|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
156714496|NCT01842438|565699366|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
156714497|NCT01842438|565699367|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
156714498|NCT01842438|565699366|FG000|T2: 6month Follow-up|Death|0|||
156714499|NCT01842438|565699367|FG001|T2: 6month Follow-up|Death|1|||
156714500|NCT00782626|565699371|FG000|Overall Study|Adverse Event|1|||
156714501|NCT00782626|565699371|FG000|Overall Study|Progressive Disease|5|||
156714502|NCT00782626|565699371|FG000|Overall Study|Other Complicating Disease|1|||
156714503|NCT04909853|565699372|FG000|Part 1|Assigned but not treated|0|||
156714504|NCT04909853|565699373|FG001|Part 1|Assigned but not treated|0|||
157016641|NCT02287311|566813186|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
156714505|NCT04909853|565699374|FG002|Part 1|Assigned but not treated|1|||
156714506|NCT04909853|565699375|FG003|Part 1|Assigned but not treated|0|||
156714507|NCT04909853|565699372|FG000|Part 2|Adverse Event|0|||
157016642|NCT02287311|566813187|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016643|NCT02287311|566813188|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016644|NCT02287311|566813189|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
156714508|NCT04909853|565699373|FG001|Part 2|Adverse Event|0|||
156714509|NCT04909853|565699374|FG002|Part 2|Adverse Event|0|||
156714510|NCT04909853|565699375|FG003|Part 2|Adverse Event|1|||
156714511|NCT00077207|565699378|FG000|Overall Study|Adverse Event|5|||
156714512|NCT00077207|565699378|FG000|Overall Study|Lack of Efficacy|12|||
156714513|NCT00077207|565699378|FG000|Overall Study|Physician Decision|6|||
156714514|NCT00077207|565699378|FG000|Overall Study|Withdrawal by Subject|6|||
156714515|NCT00077207|565699378|FG000|Overall Study|Ineligible|1|||
156714516|NCT03052751|565699381|FG000|Dosing Period 1|Adverse Event|0|||
156714517|NCT03052751|565699382|FG001|Dosing Period 1|Adverse Event|1|||
156714518|NCT03052751|565699383|FG002|Dosing Period 1|Adverse Event|0|||
156714519|NCT03052751|565699384|FG003|Dosing Period 1|Adverse Event|0|||
156714520|NCT03052751|565699385|FG004|Dosing Period 1|Adverse Event|0|||
156714521|NCT03052751|565699386|FG005|Dosing Period 1|Adverse Event|0|||
156714522|NCT03052751|565699381|FG000|Dosing Period 2|Adverse Event|0|||
156714523|NCT03052751|565699382|FG001|Dosing Period 2|Adverse Event|0|||
156714524|NCT03052751|565699383|FG002|Dosing Period 2|Adverse Event|3|||
156714525|NCT03052751|565699384|FG003|Dosing Period 2|Adverse Event|0|||
156714526|NCT03052751|565699385|FG004|Dosing Period 2|Adverse Event|0|||
156714527|NCT03052751|565699386|FG005|Dosing Period 2|Adverse Event|0|||
156714528|NCT03052751|565699381|FG000|Observation Period|Adverse Event|0|||
156714529|NCT03052751|565699382|FG001|Observation Period|Adverse Event|0|||
156714530|NCT03052751|565699383|FG002|Observation Period|Adverse Event|0|||
156714531|NCT03052751|565699384|FG003|Observation Period|Adverse Event|0|||
156714532|NCT03052751|565699385|FG004|Observation Period|Adverse Event|1|||
156714533|NCT03052751|565699386|FG005|Observation Period|Adverse Event|0|||
156714534|NCT00444587|565699397|FG000|Overall Study|Death|2|||
156714535|NCT00444587|565699398|FG001|Overall Study|Death|1|||
156714536|NCT00444587|565699397|FG000|Overall Study|Progression of the disease|73|||
156714537|NCT00444587|565699398|FG001|Overall Study|Progression of the disease|8|||
156714538|NCT00444587|565699397|FG000|Overall Study|Refused treatment/did not cooperate|4|||
156714539|NCT00444587|565699398|FG001|Overall Study|Refused treatment/did not cooperate|1|||
156714540|NCT00444587|565699397|FG000|Overall Study|Investigator decision|3|||
156714541|NCT00444587|565699398|FG001|Overall Study|Investigator decision|0|||
156714542|NCT00444587|565699397|FG000|Overall Study|Protocol Violation|1|||
156714543|NCT00444587|565699398|FG001|Overall Study|Protocol Violation|0|||
156714544|NCT00444587|565699397|FG000|Overall Study|Missing|0|||
156714545|NCT00444587|565699398|FG001|Overall Study|Missing|5|||
156714546|NCT00196326|565699399|FG000|Overall Study|Did not meet protocol requirements|64|||
156714547|NCT00196326|565699399|FG000|Overall Study|Non-compliance with the protocol|81|||
156714548|NCT00196326|565699399|FG000|Overall Study|Physician Decision|3|||
156714549|NCT00196326|565699399|FG000|Overall Study|Withdrawal by Subject|225|||
156714550|NCT00196326|565699399|FG000|Overall Study|Adverse Event|253|||
156714551|NCT00196326|565699399|FG000|Overall Study|Pregnancy|34|||
156714552|NCT00196326|565699399|FG000|Overall Study|Lost to Follow-up|304|||
156714553|NCT00196326|565699399|FG000|Overall Study|Other|22|||
156714554|NCT00524420|565699406|FG000|Overall Study|Lack of Efficacy|1|||
156714555|NCT00524420|565699407|FG001|Overall Study|Lack of Efficacy|0|||
156714556|NCT00577863|565699408|FG000|Overall Study|Adverse Event|4|||
156714557|NCT00577863|565699409|FG001|Overall Study|Adverse Event|2|||
156714558|NCT00577863|565699408|FG000|Overall Study|Death|1|||
156714559|NCT00577863|565699409|FG001|Overall Study|Death|0|||
156714560|NCT00577863|565699408|FG000|Overall Study|Lost to Follow-up|2|||
156714561|NCT00577863|565699409|FG001|Overall Study|Lost to Follow-up|2|||
156714562|NCT00577863|565699408|FG000|Overall Study|Entry Criteria Exclusion|1|||
156714563|NCT00577863|565699409|FG001|Overall Study|Entry Criteria Exclusion|0|||
156714564|NCT00577863|565699408|FG000|Overall Study|Withdrawal by Subject|0|||
156714565|NCT00577863|565699409|FG001|Overall Study|Withdrawal by Subject|2|||
156714566|NCT00577863|565699408|FG000|Overall Study|Sponsor Decision|2|||
156714567|NCT00577863|565699409|FG001|Overall Study|Sponsor Decision|7|||
156714568|NCT00577863|565699408|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
156714569|NCT00577863|565699409|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
156714570|NCT03639779|565699417|FG000|Overall Study|Lost to Follow-up|1|||
156714571|NCT02413229|565699420|FG000|Overall Study|Adverse Event|0|||
156714572|NCT02413229|565699421|FG001|Overall Study|Adverse Event|0|||
156714573|NCT02413229|565699422|FG002|Overall Study|Adverse Event|0|||
156714574|NCT02413229|565699423|FG003|Overall Study|Adverse Event|1|||
157127485|NCT02937350|567217125|FG002|Overall Study|Withdrawal by Subject|0|||
157127486|NCT01462266|567217126|FG000|Overall Study|Adverse Event|7|||
157127487|NCT01462266|567217127|FG001|Overall Study|Adverse Event|6|||
157127488|NCT01462266|567217126|FG000|Overall Study|Death|2|||
156714575|NCT02413229|565699424|FG004|Overall Study|Adverse Event|0|||
156792651|NCT03449147|565992848|FG000|12-Week Off-Treatment Durability Period|Other|0|||
157127489|NCT01462266|567217127|FG001|Overall Study|Death|1|||
156714576|NCT02413229|565699425|FG005|Overall Study|Adverse Event|0|||
156714577|NCT02413229|565699426|FG006|Overall Study|Adverse Event|0|||
156714578|NCT02413229|565699427|FG007|Overall Study|Adverse Event|1|||
156714579|NCT02413229|565699420|FG000|Overall Study|Lost to Follow-up|0|||
156714580|NCT02413229|565699421|FG001|Overall Study|Lost to Follow-up|0|||
156714581|NCT02413229|565699422|FG002|Overall Study|Lost to Follow-up|1|||
156714582|NCT02413229|565699423|FG003|Overall Study|Lost to Follow-up|0|||
156714583|NCT02413229|565699424|FG004|Overall Study|Lost to Follow-up|2|||
156714584|NCT02413229|565699425|FG005|Overall Study|Lost to Follow-up|0|||
157127490|NCT01462266|567217126|FG000|Overall Study|Lack of Efficacy|0|||
156714585|NCT02413229|565699426|FG006|Overall Study|Lost to Follow-up|0|||
156714586|NCT02413229|565699427|FG007|Overall Study|Lost to Follow-up|0|||
156714587|NCT02413229|565699420|FG000|Overall Study|Withdrawal by Subject|1|||
156714588|NCT02413229|565699421|FG001|Overall Study|Withdrawal by Subject|1|||
156714589|NCT02413229|565699422|FG002|Overall Study|Withdrawal by Subject|0|||
156714590|NCT02413229|565699423|FG003|Overall Study|Withdrawal by Subject|0|||
156714591|NCT02413229|565699424|FG004|Overall Study|Withdrawal by Subject|1|||
156714592|NCT02413229|565699425|FG005|Overall Study|Withdrawal by Subject|0|||
156714593|NCT02413229|565699426|FG006|Overall Study|Withdrawal by Subject|0|||
156714594|NCT02413229|565699427|FG007|Overall Study|Withdrawal by Subject|2|||
156714595|NCT02413229|565699420|FG000|Overall Study|Progressive Disease|0|||
156714596|NCT02413229|565699421|FG001|Overall Study|Progressive Disease|0|||
156714597|NCT02413229|565699422|FG002|Overall Study|Progressive Disease|0|||
156714598|NCT02413229|565699423|FG003|Overall Study|Progressive Disease|0|||
156714599|NCT02413229|565699424|FG004|Overall Study|Progressive Disease|0|||
156714600|NCT02413229|565699425|FG005|Overall Study|Progressive Disease|0|||
156714601|NCT02413229|565699426|FG006|Overall Study|Progressive Disease|0|||
156714602|NCT02413229|565699427|FG007|Overall Study|Progressive Disease|1|||
156714603|NCT02932462|565699428|FG000|Overall Study|Adverse Event|1|||
156714604|NCT02932462|565699429|FG001|Overall Study|Adverse Event|2|||
156714605|NCT02932462|565699428|FG000|Overall Study|Lost to Follow-up|4|||
156714606|NCT02932462|565699429|FG001|Overall Study|Lost to Follow-up|1|||
156714607|NCT02932462|565699428|FG000|Overall Study|Protocol Violation|0|||
156714608|NCT02932462|565699429|FG001|Overall Study|Protocol Violation|5|||
156714609|NCT02932462|565699428|FG000|Overall Study|Withdrawal by Subject|1|||
156714610|NCT02932462|565699429|FG001|Overall Study|Withdrawal by Subject|4|||
156714611|NCT02932462|565699428|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156714612|NCT02932462|565699429|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156714613|NCT02932462|565699428|FG000|Overall Study|Progressive Disease|1|||
156714614|NCT02932462|565699429|FG001|Overall Study|Progressive Disease|0|||
156714615|NCT02009722|565699436|FG000|Overall Study|Protocol Violation|1|||
156714616|NCT02009722|565699437|FG001|Overall Study|Protocol Violation|2|||
156714617|NCT02009722|565699436|FG000|Overall Study|Did not receive intervention|0|||
156714618|NCT02009722|565699437|FG001|Overall Study|Did not receive intervention|1|||
156714619|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
156714620|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
156714621|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
156714622|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
156714623|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
156714624|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
156714625|NCT02955212|565699438|FG000|Period 1: Double-blind Treatment Period|Other|3|||
156714626|NCT02955212|565699439|FG001|Period 1: Double-blind Treatment Period|Other|2|||
156714627|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Adverse Event|11|||
156714628|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Adverse Event|7|||
156714629|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
156714630|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
156714631|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
156714632|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
156714633|NCT02955212|565699438|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
156714634|NCT02955212|565699439|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
156714635|NCT02955212|565699438|FG000|Period 2: Open-label Extension|Other|2|||
156714636|NCT02955212|565699439|FG001|Period 2: Open-label Extension|Other|4|||
156714637|NCT02454933|565699440|FG000|Overall Study|Progressive disease|10|||
156714638|NCT02454933|565699441|FG001|Overall Study|Progressive disease|7|||
156714639|NCT02454933|565699440|FG000|Overall Study|Adverse Event|1|||
156714640|NCT02454933|565699441|FG001|Overall Study|Adverse Event|1|||
156714641|NCT02454933|565699440|FG000|Overall Study|Withdrawal by Subject|0|||
156714642|NCT02454933|565699441|FG001|Overall Study|Withdrawal by Subject|3|||
156714643|NCT02454933|565699440|FG000|Overall Study|Lost to Follow-up|1|||
156714644|NCT02454933|565699441|FG001|Overall Study|Lost to Follow-up|0|||
156714645|NCT02071225|565699447|FG000|Overall Study|Withdrawal of Consent|2|||
156714646|NCT02071225|565699447|FG000|Overall Study|Protocol Deviation|1|||
156714647|NCT02071225|565699447|FG000|Overall Study|Lost to Follow-up|2|||
156714648|NCT02071225|565699447|FG000|Overall Study|Death|25|||
156714649|NCT03164616|565699466|FG000|Overall Study|Death|250|||
156714650|NCT03164616|565699467|FG001|Overall Study|Death|264|||
156714651|NCT03164616|565699468|FG002|Overall Study|Death|279|||
156714652|NCT03164616|565699466|FG000|Overall Study|Lost to Follow-up|2|||
156714653|NCT03164616|565699467|FG001|Overall Study|Lost to Follow-up|2|||
156714654|NCT03164616|565699468|FG002|Overall Study|Lost to Follow-up|2|||
156714655|NCT03164616|565699466|FG000|Overall Study|Withdrawal by Subject|6|||
156714656|NCT03164616|565699467|FG001|Overall Study|Withdrawal by Subject|7|||
156714657|NCT03164616|565699468|FG002|Overall Study|Withdrawal by Subject|16|||
156714658|NCT04388553|565699469|FG000|Overall Study|Protocol Violation|1|||
156714659|NCT04388553|565699470|FG001|Overall Study|Protocol Violation|0|||
156714660|NCT04604795|565699471|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
156714661|NCT04604795|565699472|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
156714662|NCT04604795|565699473|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714663|NCT04604795|565699474|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714664|NCT04604795|565699475|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714665|NCT04604795|565699476|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714666|NCT04604795|565699477|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714667|NCT04604795|565699478|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714668|NCT04604795|565699479|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714669|NCT04604795|565699480|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
156714670|NCT04604795|565699471|FG000|Part B: Up to Day 14|Adverse Event|0|||
156714671|NCT04604795|565699472|FG001|Part B: Up to Day 14|Adverse Event|0|||
156714672|NCT04604795|565699473|FG002|Part B: Up to Day 14|Adverse Event|0|||
156714673|NCT04604795|565699474|FG003|Part B: Up to Day 14|Adverse Event|0|||
156714674|NCT04604795|565699475|FG004|Part B: Up to Day 14|Adverse Event|2|||
156714675|NCT04604795|565699476|FG005|Part B: Up to Day 14|Adverse Event|1|||
156714676|NCT04604795|565699477|FG006|Part B: Up to Day 14|Adverse Event|0|||
156714677|NCT04604795|565699478|FG007|Part B: Up to Day 14|Adverse Event|0|||
156714678|NCT04604795|565699479|FG008|Part B: Up to Day 14|Adverse Event|0|||
156714679|NCT04604795|565699480|FG009|Part B: Up to Day 14|Adverse Event|0|||
156714680|NCT04604795|565699471|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714681|NCT04604795|565699472|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714682|NCT04604795|565699473|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714683|NCT04604795|565699474|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714684|NCT04604795|565699475|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714685|NCT04604795|565699476|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714686|NCT04604795|565699477|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714687|NCT04604795|565699478|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714688|NCT04604795|565699479|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
156714689|NCT04604795|565699480|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
156714690|NCT04604795|565699471|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714691|NCT04604795|565699472|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714692|NCT04604795|565699473|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714693|NCT04604795|565699474|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714694|NCT04604795|565699475|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714695|NCT04604795|565699476|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714696|NCT04604795|565699477|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714697|NCT04604795|565699478|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714698|NCT04604795|565699479|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
156714699|NCT04604795|565699480|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
156714700|NCT04604795|565699471|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714701|NCT04604795|565699472|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714702|NCT04604795|565699473|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714703|NCT04604795|565699474|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714704|NCT04604795|565699475|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714705|NCT04604795|565699476|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714706|NCT04604795|565699477|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714707|NCT04604795|565699478|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714708|NCT04604795|565699479|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
156714709|NCT04604795|565699480|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
156714710|NCT04604795|565699471|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714711|NCT04604795|565699472|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714712|NCT04604795|565699473|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714713|NCT04604795|565699474|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714714|NCT04604795|565699475|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714715|NCT04604795|565699476|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714716|NCT04604795|565699477|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714717|NCT04604795|565699478|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714718|NCT04604795|565699479|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
156714719|NCT04604795|565699480|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
156714720|NCT01260701|565699489|FG000|Overall Study|Adverse Event|9|||
156714721|NCT01260701|565699489|FG000|Overall Study|Withdrawal by Subject|2|||
156714722|NCT01260701|565699489|FG000|Overall Study|Progression|53|||
156792652|NCT03449147|565992849|FG001|12-Week Off-Treatment Durability Period|Other|1|||
156792653|NCT03449147|565992850|FG002|12-Week Off-Treatment Durability Period|Other|0|||
156792654|NCT00954538|565992853|FG000|Part III|Withdrawal by Subject|0|||
156792655|NCT00954538|565992854|FG001|Part III|Withdrawal by Subject|0|||
156792656|NCT00954538|565992855|FG002|Part III|Withdrawal by Subject|0|||
156792657|NCT00954538|565992856|FG003|Part III|Withdrawal by Subject|0|||
156792658|NCT00954538|565992857|FG004|Part III|Withdrawal by Subject|1|||
156792659|NCT00954538|565992858|FG005|Part III|Withdrawal by Subject|0|||
156792660|NCT01657942|565992860|FG000|Overall Study|Alternative Treatment|7|||
157216235|NCT01078623|567539239|FG001|Treatment Period 1|Adverse Event|1|||
156714723|NCT01260701|565699489|FG000|Overall Study|Death|2|||
156714724|NCT01260701|565699489|FG000|Overall Study|Not protocol specified|3|||
156714725|NCT01260701|565699489|FG000|Overall Study|Under review|1|||
156714726|NCT01260701|565699489|FG000|Overall Study|Ineligible|4|||
156714727|NCT01260701|565699489|FG000|Overall Study|Did not begin protocol therapy|1|||
156714728|NCT00443729|565700776|FG000|Overall Study|Never Treated|0|||
156714729|NCT00443729|565700777|FG001|Overall Study|Never Treated|1|||
156714730|NCT00443729|565700776|FG000|Overall Study|Lack of Efficacy|4|||
156714731|NCT00443729|565700777|FG001|Overall Study|Lack of Efficacy|2|||
156714732|NCT00443729|565700776|FG000|Overall Study|Lost to Follow-up|0|||
156714733|NCT00443729|565700777|FG001|Overall Study|Lost to Follow-up|1|||
156714734|NCT00443729|565700776|FG000|Overall Study|Physician Decision|2|||
156714735|NCT00443729|565700777|FG001|Overall Study|Physician Decision|1|||
156714736|NCT00443729|565700776|FG000|Overall Study|Protocol Violation|1|||
156714737|NCT00443729|565700777|FG001|Overall Study|Protocol Violation|1|||
156714738|NCT00443729|565700776|FG000|Overall Study|Withdrawal by Subject|3|||
156714739|NCT00443729|565700777|FG001|Overall Study|Withdrawal by Subject|1|||
156714740|NCT03718832|565700778|FG000|Analysis Sample|Withdrawal by Subject|18|||
156714741|NCT03718832|565700779|FG001|Analysis Sample|Withdrawal by Subject|15|||
156714742|NCT03718832|565700778|FG000|Analysis Sample|Legal hold on data|1|||
156714743|NCT03718832|565700779|FG001|Analysis Sample|Legal hold on data|0|||
156714744|NCT03718832|565700778|FG000|Analysis Sample|Participant from treated household|0|||
156714745|NCT03718832|565700779|FG001|Analysis Sample|Participant from treated household|1|||
156714746|NCT03718832|565700778|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
156714747|NCT03718832|565700779|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
156714748|NCT02548156|565700781|FG000|Washout Period 1|Lost to Follow-up|0|||
156714749|NCT02548156|565700782|FG001|Washout Period 1|Lost to Follow-up|0|||
156714750|NCT02548156|565700783|FG002|Washout Period 1|Lost to Follow-up|0|||
156714751|NCT02548156|565700784|FG003|Washout Period 1|Lost to Follow-up|0|||
156714752|NCT02548156|565700785|FG004|Washout Period 1|Lost to Follow-up|1|||
156714753|NCT02548156|565700786|FG005|Washout Period 1|Lost to Follow-up|0|||
156714754|NCT03288714|565700787|FG000|Overall Study|Lost to Follow-up|2|||
156714755|NCT03288714|565700788|FG001|Overall Study|Lost to Follow-up|1|||
156714756|NCT03288714|565700787|FG000|Overall Study|Non-compliance with study schedule|2|||
156714757|NCT03288714|565700788|FG001|Overall Study|Non-compliance with study schedule|0|||
156714758|NCT03288714|565700787|FG000|Overall Study|Withdrawal by Subject|3|||
156714759|NCT03288714|565700788|FG001|Overall Study|Withdrawal by Subject|1|||
156714760|NCT03288714|565700787|FG000|Overall Study|Clinical Worsening|2|||
156714761|NCT03288714|565700788|FG001|Overall Study|Clinical Worsening|1|||
156714762|NCT03288714|565700787|FG000|Overall Study|Adverse Event|1|||
156714763|NCT03288714|565700788|FG001|Overall Study|Adverse Event|0|||
156714764|NCT03280264|565700789|FG000|Overall Study|Adverse Event|1|||
156714765|NCT03280264|565700789|FG000|Overall Study|Physician Decision|1|||
156714766|NCT03280264|565700789|FG000|Overall Study|Withdrawal by Subject|1|||
156714767|NCT01342081|565700800|FG000|Overall Study|Did not receive allocated intervention|0|||
156714768|NCT01342081|565700801|FG001|Overall Study|Did not receive allocated intervention|0|||
156714769|NCT01342081|565700802|FG002|Overall Study|Did not receive allocated intervention|1|||
156714770|NCT01342081|565700800|FG000|Overall Study|Adverse Event|1|||
156714771|NCT01342081|565700801|FG001|Overall Study|Adverse Event|0|||
156714772|NCT01342081|565700802|FG002|Overall Study|Adverse Event|0|||
156714773|NCT01342081|565700800|FG000|Overall Study|Physician Decision|0|||
156714774|NCT01342081|565700801|FG001|Overall Study|Physician Decision|1|||
156714775|NCT01342081|565700802|FG002|Overall Study|Physician Decision|0|||
156714776|NCT01342081|565700800|FG000|Overall Study|Withdrawal by Subject|1|||
156714777|NCT01342081|565700801|FG001|Overall Study|Withdrawal by Subject|1|||
156714778|NCT01342081|565700802|FG002|Overall Study|Withdrawal by Subject|0|||
156714779|NCT04720053|565700807|FG000|Overall Study|Lost to Follow-up|12|||
156714780|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
156714781|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
156714782|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
156714783|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
156714784|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
156714785|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
156714786|NCT01960257|565700808|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
156714787|NCT01960257|565700809|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
156714788|NCT01960257|565700810|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
156714789|NCT01942993|565700811|FG000|Overall Study|Lost to Follow-up|1|||
156714790|NCT01942993|565700811|FG000|Overall Study|Physician Decision|1|||
156792661|NCT01657942|565992860|FG000|Overall Study|Lost to Follow-up|1|||
156714791|NCT01350271|565700812|FG000|Overall Study|Lost to Follow-up|21|||
156714792|NCT01350271|565700813|FG001|Overall Study|Lost to Follow-up|17|||
156714793|NCT01350271|565700814|FG002|Overall Study|Lost to Follow-up|26|||
156714794|NCT02906670|565700818|FG000|Cohort 1, QW|Radiological Progression|1|||
156714795|NCT02906670|565700819|FG001|Cohort 1, QW|Radiological Progression|0|||
156714796|NCT02906670|565700820|FG002|Cohort 1, QW|Radiological Progression|0|||
156714797|NCT02906670|565700821|FG003|Cohort 1, QW|Radiological Progression|0|||
156714798|NCT02906670|565700822|FG004|Cohort 1, QW|Radiological Progression|0|||
156714799|NCT02906670|565700823|FG005|Cohort 1, QW|Radiological Progression|0|||
156714800|NCT02906670|565700824|FG006|Cohort 1, QW|Radiological Progression|0|||
156714801|NCT02906670|565700825|FG007|Cohort 1, QW|Radiological Progression|0|||
156714802|NCT02906670|565700826|FG008|Cohort 1, QW|Radiological Progression|0|||
156714803|NCT02906670|565700827|FG009|Cohort 1, QW|Radiological Progression|0|||
156714804|NCT02906670|565700818|FG000|Cohort 2, QW|Radiological Progression|0|||
156714805|NCT02906670|565700819|FG001|Cohort 2, QW|Radiological Progression|1|||
156714806|NCT02906670|565700820|FG002|Cohort 2, QW|Radiological Progression|0|||
156714807|NCT02906670|565700821|FG003|Cohort 2, QW|Radiological Progression|0|||
156714808|NCT02906670|565700822|FG004|Cohort 2, QW|Radiological Progression|0|||
156714809|NCT02906670|565700823|FG005|Cohort 2, QW|Radiological Progression|0|||
156714810|NCT02906670|565700824|FG006|Cohort 2, QW|Radiological Progression|0|||
156714811|NCT02906670|565700825|FG007|Cohort 2, QW|Radiological Progression|0|||
156714812|NCT02906670|565700826|FG008|Cohort 2, QW|Radiological Progression|0|||
156714813|NCT02906670|565700827|FG009|Cohort 2, QW|Radiological Progression|0|||
156714814|NCT02906670|565700818|FG000|Cohort 3, QW|Radiological Progression|0|||
156714815|NCT02906670|565700819|FG001|Cohort 3, QW|Radiological Progression|0|||
156714816|NCT02906670|565700820|FG002|Cohort 3, QW|Radiological Progression|2|||
156792662|NCT00993473|565994682|FG000|Overall Study|Adverse Event|0|||
156792663|NCT00993473|565994683|FG001|Overall Study|Adverse Event|2|||
156792664|NCT00993473|565994682|FG000|Overall Study|Protocol Violation|1|||
156792665|NCT00993473|565994683|FG001|Overall Study|Protocol Violation|2|||
156792666|NCT00993473|565994682|FG000|Overall Study|Lost to Follow-up|1|||
156792667|NCT00993473|565994683|FG001|Overall Study|Lost to Follow-up|0|||
156792668|NCT00993473|565994682|FG000|Overall Study|Withdrawal by Subject|1|||
156714817|NCT02906670|565700821|FG003|Cohort 3, QW|Radiological Progression|0|||
156714818|NCT02906670|565700822|FG004|Cohort 3, QW|Radiological Progression|0|||
156792669|NCT00993473|565994683|FG001|Overall Study|Withdrawal by Subject|5|||
156792670|NCT00993473|565994682|FG000|Overall Study|Technical problem with CGM device|0|||
156792671|NCT00993473|565994683|FG001|Overall Study|Technical problem with CGM device|1|||
156792672|NCT00993473|565994682|FG000|Overall Study|Family event|1|||
156792673|NCT00993473|565994683|FG001|Overall Study|Family event|0|||
157016645|NCT02287311|566813190|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016646|NCT02287311|566813191|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016647|NCT02287311|566813192|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
157016648|NCT02287311|566813184|FG000|Cohort 3: Dose Level 3|Death|0|||
157016649|NCT02287311|566813185|FG001|Cohort 3: Dose Level 3|Death|0|||
157016650|NCT02287311|566813186|FG002|Cohort 3: Dose Level 3|Death|4|||
157016651|NCT02287311|566813187|FG003|Cohort 3: Dose Level 3|Death|0|||
157016652|NCT02287311|566813188|FG004|Cohort 3: Dose Level 3|Death|0|||
157016653|NCT02287311|566813189|FG005|Cohort 3: Dose Level 3|Death|4|||
157016654|NCT02287311|566813190|FG006|Cohort 3: Dose Level 3|Death|0|||
157016655|NCT02287311|566813191|FG007|Cohort 3: Dose Level 3|Death|0|||
157016656|NCT02287311|566813192|FG008|Cohort 3: Dose Level 3|Death|2|||
157016657|NCT02287311|566813184|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016658|NCT02287311|566813185|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016659|NCT02287311|566813186|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
157016660|NCT02287311|566813187|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016661|NCT02287311|566813188|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016662|NCT02287311|566813189|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
157016663|NCT02287311|566813190|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016664|NCT02287311|566813191|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016665|NCT02287311|566813192|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
157016666|NCT02287311|566813184|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016667|NCT02287311|566813185|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016668|NCT02287311|566813186|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016669|NCT02287311|566813187|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016670|NCT02287311|566813188|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016671|NCT02287311|566813189|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
157016672|NCT02287311|566813190|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016673|NCT02287311|566813191|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
157016674|NCT02287311|566813192|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
157016675|NCT02724956|566813194|FG000|Overall Study|Physician Decision|1|||
157016676|NCT02724956|566813195|FG001|Overall Study|Physician Decision|0|||
157016677|NCT02724956|566813194|FG000|Overall Study|Lack of Efficacy|0|||
157016678|NCT02724956|566813195|FG001|Overall Study|Lack of Efficacy|1|||
157016679|NCT02724956|566813194|FG000|Overall Study|Withdrawal by Subject|0|||
157016680|NCT02724956|566813195|FG001|Overall Study|Withdrawal by Subject|1|||
157016681|NCT04600752|566813196|FG000|Overall Study|Physician Decision|0|||
157016682|NCT04600752|566813197|FG001|Overall Study|Physician Decision|0|||
157016683|NCT04600752|566813198|FG002|Overall Study|Physician Decision|1|||
157127491|NCT01462266|567217127|FG001|Overall Study|Lack of Efficacy|2|||
157127492|NCT01462266|567217126|FG000|Overall Study|Lost to Follow-up|4|||
157127493|NCT01462266|567217127|FG001|Overall Study|Lost to Follow-up|3|||
157127494|NCT01462266|567217126|FG000|Overall Study|Non-compliance with study drug|3|||
157127495|NCT01462266|567217127|FG001|Overall Study|Non-compliance with study drug|0|||
157127496|NCT01462266|567217126|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
157127497|NCT01462266|567217127|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
157127498|NCT01462266|567217126|FG000|Overall Study|Physician Decision|2|||
157127499|NCT01462266|567217127|FG001|Overall Study|Physician Decision|5|||
157127500|NCT01462266|567217126|FG000|Overall Study|Protocol Violation|1|||
157127501|NCT01462266|567217127|FG001|Overall Study|Protocol Violation|3|||
157127502|NCT01462266|567217126|FG000|Overall Study|Withdrawal by Subject|7|||
157127503|NCT01462266|567217127|FG001|Overall Study|Withdrawal by Subject|2|||
157127504|NCT01462266|567217126|FG000|Overall Study|Screen failure|1|||
157127505|NCT01462266|567217127|FG001|Overall Study|Screen failure|1|||
157127506|NCT01106846|567217128|FG000|Overall Study|Change in surgical procedure|0|||
157127507|NCT01106846|567217129|FG001|Overall Study|Change in surgical procedure|1|||
157127508|NCT03110900|567217131|FG000|Overall Study|Sponsor withdrew|1|||
157127509|NCT03110900|567217132|FG001|Overall Study|Sponsor withdrew|1|||
157127510|NCT02321436|567217133|FG000|Overall Study|Withdrawal by Subject|1|||
157127511|NCT02321436|567217134|FG001|Overall Study|Withdrawal by Subject|0|||
157127512|NCT02321436|567217133|FG000|Overall Study|Lost to Follow-up|0|||
157127513|NCT02321436|567217134|FG001|Overall Study|Lost to Follow-up|1|||
157127514|NCT00644787|567217135|FG000|Period 1: Titration Phase|Adverse Event|11|||
157127515|NCT00644787|567217136|FG001|Period 1: Titration Phase|Adverse Event|0|||
157127516|NCT00644787|567217137|FG002|Period 1: Titration Phase|Adverse Event|0|||
157127517|NCT00644787|567217135|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
157127518|NCT00644787|567217136|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
157127519|NCT00644787|567217137|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
157127520|NCT00644787|567217135|FG000|Period 1: Titration Phase|Physician Decision|1|||
157127521|NCT00644787|567217136|FG001|Period 1: Titration Phase|Physician Decision|0|||
157127522|NCT00644787|567217137|FG002|Period 1: Titration Phase|Physician Decision|0|||
157127523|NCT00644787|567217135|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
157127524|NCT00644787|567217136|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
157127525|NCT00644787|567217137|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
157127526|NCT00644787|567217135|FG000|Period 1: Titration Phase|Worsening of complications|1|||
157127527|NCT00644787|567217136|FG001|Period 1: Titration Phase|Worsening of complications|0|||
157127528|NCT00644787|567217137|FG002|Period 1: Titration Phase|Worsening of complications|0|||
157127529|NCT00644787|567217135|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
157127530|NCT00644787|567217136|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
157127531|NCT00644787|567217137|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
157127532|NCT00644787|567217135|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
157127533|NCT00644787|567217136|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
157127534|NCT00644787|567217137|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
157127535|NCT00644787|567217135|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
157127536|NCT00644787|567217136|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
157127537|NCT00644787|567217137|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
157127538|NCT00644787|567217135|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
157127539|NCT00644787|567217136|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
157127540|NCT00644787|567217137|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
157127541|NCT00644787|567217135|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
157127542|NCT00644787|567217136|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
157127543|NCT00644787|567217137|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
157127544|NCT00644787|567217135|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
157127545|NCT00644787|567217136|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
157127546|NCT00644787|567217137|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
157127547|NCT00644787|567217135|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
157127548|NCT00644787|567217136|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
157127549|NCT00644787|567217137|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
157127550|NCT03355300|567217138|FG000|Overall Study|Physician Decision|0|||
157127551|NCT03355300|567217139|FG001|Overall Study|Physician Decision|1|||
157127552|NCT03355300|567217138|FG000|Overall Study|Lack of Efficacy|2|||
156874113|NCT02840799|566298565|FG000|Phase 1|Withdrawal by Subject|4|||
156874114|NCT02840799|566298566|FG001|Phase 1|Withdrawal by Subject|0|||
156874115|NCT02840799|566298565|FG000|Phase 2 (Crossover)|Adverse Event|0|||
156874116|NCT02840799|566298566|FG001|Phase 2 (Crossover)|Adverse Event|1|||
156874117|NCT02840799|566298565|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
156874118|NCT02840799|566298566|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
157127553|NCT03355300|567217139|FG001|Overall Study|Lack of Efficacy|1|||
157127554|NCT03355300|567217138|FG000|Overall Study|Other reason|1|||
157127555|NCT03355300|567217139|FG001|Overall Study|Other reason|0|||
157127556|NCT03344003|567217155|FG000|Overall Study|Switched to alternative treatment|1|||
157127557|NCT03344003|567217156|FG001|Overall Study|Switched to alternative treatment|0|||
157127558|NCT03344003|567217155|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
157216236|NCT01078623|567539240|FG002|Treatment Period 1|Adverse Event|1|||
157127559|NCT03344003|567217156|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
157127560|NCT02949128|567218569|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
157127561|NCT02949128|567218569|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
157127562|NCT02949128|567218569|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
157127563|NCT02949128|567218569|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
157127564|NCT02949128|567218569|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
157127565|NCT02949128|567218569|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
157127566|NCT02949128|567218569|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
157127567|NCT02949128|567218569|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
157127568|NCT02949128|567218569|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
157127569|NCT02949128|567218569|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
157127570|NCT01602341|567218570|FG000|Overall Study|Adverse Event|0|||
157127571|NCT01602341|567218571|FG001|Overall Study|Adverse Event|1|||
157127572|NCT02152345|567218572|FG000|Overall Study|Case Cancellations|2|||
157127573|NCT02152345|567218573|FG001|Overall Study|Case Cancellations|4|||
157127574|NCT02152345|567218572|FG000|Overall Study|Withdrawal by Subject|2|||
157127575|NCT02152345|567218573|FG001|Overall Study|Withdrawal by Subject|1|||
157127576|NCT00680836|567218575|FG000|Overall Study|Withdrawal by Subject|3|||
157127577|NCT00680836|567218576|FG001|Overall Study|Withdrawal by Subject|0|||
157127578|NCT00680836|567218575|FG000|Overall Study|Lost to Follow-up|3|||
157127579|NCT00680836|567218576|FG001|Overall Study|Lost to Follow-up|1|||
157127580|NCT00680836|567218575|FG000|Overall Study|Physician Decision|2|||
157127581|NCT00680836|567218576|FG001|Overall Study|Physician Decision|1|||
157127582|NCT01475734|567218579|FG000|Overall Study|Withdrawal by Subject|1|||
157127583|NCT01475734|567218580|FG001|Overall Study|Withdrawal by Subject|0|||
157127584|NCT01475734|567218579|FG000|Overall Study|Protocol Violation|1|||
157127585|NCT01475734|567218580|FG001|Overall Study|Protocol Violation|0|||
157127586|NCT01475734|567218579|FG000|Overall Study|Physician Decision|0|||
157127587|NCT01475734|567218580|FG001|Overall Study|Physician Decision|1|||
157127588|NCT00880750|567218586|FG000|First Intervention|Adverse Event|1|||
157127589|NCT00880750|567218587|FG001|First Intervention|Adverse Event|0|||
157127590|NCT00880750|567218586|FG000|First Intervention|Unable to collect urine|4|||
157127591|NCT00880750|567218587|FG001|First Intervention|Unable to collect urine|0|||
157127592|NCT00880750|567218586|FG000|First Intervention|Non-compliance with meals|0|||
157127593|NCT00880750|567218587|FG001|First Intervention|Non-compliance with meals|1|||
157127594|NCT00880750|567218586|FG000|First Intervention|Withdrawal by Subject|2|||
157127595|NCT00880750|567218587|FG001|First Intervention|Withdrawal by Subject|0|||
157127596|NCT00880750|567218586|FG000|First Intervention|Lost to Follow-up|2|||
157127597|NCT00880750|567218587|FG001|First Intervention|Lost to Follow-up|0|||
157127598|NCT00880750|567218586|FG000|Second Intervention|Withdrawal by Subject|2|||
157127599|NCT00880750|567218587|FG001|Second Intervention|Withdrawal by Subject|2|||
157127600|NCT00880750|567218586|FG000|Second Intervention|Protocol Violation|1|||
157127601|NCT00880750|567218587|FG001|Second Intervention|Protocol Violation|0|||
157127602|NCT00880750|567218586|FG000|Second Intervention|Unable to collect urine|1|||
157127603|NCT00880750|567218587|FG001|Second Intervention|Unable to collect urine|0|||
157127604|NCT00667576|567218588|FG000|Overall Study|Withdrawal by Subject|1|||
157127605|NCT00667576|567218589|FG001|Overall Study|Withdrawal by Subject|0|||
157127606|NCT00667576|567218590|FG002|Overall Study|Withdrawal by Subject|1|||
157127607|NCT00667576|567218591|FG003|Overall Study|Withdrawal by Subject|1|||
157127608|NCT00667576|567218592|FG004|Overall Study|Withdrawal by Subject|1|||
157127609|NCT00667576|567218588|FG000|Overall Study|Adverse Event|1|||
157127610|NCT00667576|567218589|FG001|Overall Study|Adverse Event|1|||
157127611|NCT00667576|567218590|FG002|Overall Study|Adverse Event|0|||
157127612|NCT00667576|567218591|FG003|Overall Study|Adverse Event|0|||
156714819|NCT02906670|565700823|FG005|Cohort 3, QW|Radiological Progression|0|||
156714820|NCT02906670|565700824|FG006|Cohort 3, QW|Radiological Progression|0|||
156714821|NCT02906670|565700825|FG007|Cohort 3, QW|Radiological Progression|0|||
156714822|NCT02906670|565700826|FG008|Cohort 3, QW|Radiological Progression|0|||
156714823|NCT02906670|565700827|FG009|Cohort 3, QW|Radiological Progression|0|||
156714824|NCT02906670|565700818|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714825|NCT02906670|565700819|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
157127613|NCT00667576|567218592|FG004|Overall Study|Adverse Event|0|||
157127614|NCT00667576|567218588|FG000|Overall Study|Lost to Follow-up|0|||
157127615|NCT00667576|567218589|FG001|Overall Study|Lost to Follow-up|0|||
157127616|NCT00667576|567218590|FG002|Overall Study|Lost to Follow-up|1|||
156714826|NCT02906670|565700820|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
157127617|NCT00667576|567218591|FG003|Overall Study|Lost to Follow-up|0|||
157127618|NCT00667576|567218592|FG004|Overall Study|Lost to Follow-up|0|||
157127619|NCT00667576|567218588|FG000|Overall Study|Protocol Violation|0|||
157127620|NCT00667576|567218589|FG001|Overall Study|Protocol Violation|0|||
157127621|NCT00667576|567218590|FG002|Overall Study|Protocol Violation|0|||
157127622|NCT00667576|567218591|FG003|Overall Study|Protocol Violation|1|||
157127623|NCT00667576|567218592|FG004|Overall Study|Protocol Violation|0|||
157127624|NCT00667576|567218588|FG000|Overall Study|Physician Decision|0|||
156714827|NCT02906670|565700821|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
157127625|NCT00667576|567218589|FG001|Overall Study|Physician Decision|0|||
157127626|NCT00667576|567218590|FG002|Overall Study|Physician Decision|0|||
157127627|NCT00667576|567218591|FG003|Overall Study|Physician Decision|1|||
157127628|NCT00667576|567218592|FG004|Overall Study|Physician Decision|0|||
157127629|NCT00667576|567218588|FG000|Overall Study|Missed Visit|0|||
157127630|NCT00667576|567218589|FG001|Overall Study|Missed Visit|0|||
157127631|NCT00667576|567218590|FG002|Overall Study|Missed Visit|0|||
157127632|NCT00667576|567218591|FG003|Overall Study|Missed Visit|1|||
157127633|NCT00667576|567218592|FG004|Overall Study|Missed Visit|0|||
157127634|NCT00483327|567218596|FG000|Overall Study|Adverse Event|1|||
157127635|NCT00483327|567218596|FG000|Overall Study|Withdrawal by Subject|3|||
157127636|NCT00483327|567218596|FG000|Overall Study|Lost to Follow-up|4|||
157127637|NCT00483327|567218596|FG000|Overall Study|Patient Non Compliance|2|||
157127638|NCT01390389|567218597|FG000|Overall Study|Withdrawal by Subject|2|||
157127639|NCT01390389|567218598|FG001|Overall Study|Withdrawal by Subject|0|||
157127640|NCT01390389|567218597|FG000|Overall Study|Screen Fail|2|||
157127641|NCT01390389|567218598|FG001|Overall Study|Screen Fail|1|||
157127642|NCT03593915|567218599|FG000|Overall Study|Adverse Event|0|||
157127643|NCT03593915|567218600|FG001|Overall Study|Adverse Event|0|||
157127644|NCT03593915|567218601|FG002|Overall Study|Adverse Event|0|||
157127645|NCT03593915|567218602|FG003|Overall Study|Adverse Event|1|||
157127646|NCT03593915|567218603|FG004|Overall Study|Adverse Event|0|||
157127647|NCT03593915|567218604|FG005|Overall Study|Adverse Event|0|||
157127648|NCT03593915|567218599|FG000|Overall Study|Physician Decision|0|||
157127649|NCT03593915|567218600|FG001|Overall Study|Physician Decision|0|||
157127650|NCT03593915|567218601|FG002|Overall Study|Physician Decision|0|||
157127651|NCT03593915|567218602|FG003|Overall Study|Physician Decision|0|||
157127652|NCT03593915|567218603|FG004|Overall Study|Physician Decision|0|||
157127653|NCT03593915|567218604|FG005|Overall Study|Physician Decision|1|||
157127654|NCT01583179|567218605|FG000|Overall Study|Screen failure|1|||
157127655|NCT01583179|567218606|FG001|Overall Study|Screen failure|2|||
157127656|NCT01246206|567218607|FG000|Overall Study|Patient did not receive study regiments.|1|||
157127657|NCT02810964|567218608|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
157127658|NCT02810964|567218609|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
157127659|NCT02810964|567218608|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
157127660|NCT02810964|567218609|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
157127661|NCT02810964|567218608|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
157127662|NCT02810964|567218609|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
157016684|NCT04600752|566813196|FG000|Overall Study|Adverse Event|0|||
157016685|NCT04600752|566813197|FG001|Overall Study|Adverse Event|1|||
157016686|NCT04600752|566813198|FG002|Overall Study|Adverse Event|0|||
157016687|NCT04600752|566813196|FG000|Overall Study|Withdrawal by Subject|2|||
157016688|NCT04600752|566813197|FG001|Overall Study|Withdrawal by Subject|1|||
157016689|NCT04600752|566813198|FG002|Overall Study|Withdrawal by Subject|0|||
157016690|NCT04600752|566813196|FG000|Overall Study|Lack of Efficacy|1|||
157016691|NCT04600752|566813197|FG001|Overall Study|Lack of Efficacy|0|||
157016692|NCT04600752|566813198|FG002|Overall Study|Lack of Efficacy|0|||
157016693|NCT04436107|566813199|FG000|Overall Study|Sponsor Ended Study|2|||
157016694|NCT04436107|566813200|FG001|Overall Study|Sponsor Ended Study|4|||
157016695|NCT04436107|566813201|FG002|Overall Study|Sponsor Ended Study|8|||
157016696|NCT04436107|566813202|FG003|Overall Study|Sponsor Ended Study|20|||
157127663|NCT02810964|567218608|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
157127664|NCT02810964|567218609|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
157127665|NCT03523351|567218612|FG000|Overall Study|Death|13|||
156714828|NCT02906670|565700822|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714829|NCT02906670|565700823|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714830|NCT02906670|565700824|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714831|NCT02906670|565700825|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714832|NCT02906670|565700826|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
156714833|NCT02906670|565700827|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
157127666|NCT03523351|567218613|FG001|Overall Study|Death|11|||
157127667|NCT03523351|567218612|FG000|Overall Study|Lost to Follow-up|2|||
157127668|NCT03523351|567218613|FG001|Overall Study|Lost to Follow-up|3|||
156714834|NCT02906670|565700818|FG000|Cohort 4, Q2W|Radiological Progression|0|||
156714835|NCT02906670|565700819|FG001|Cohort 4, Q2W|Radiological Progression|0|||
157016697|NCT04436107|566813199|FG000|Overall Study|Death|3|||
157016698|NCT04436107|566813200|FG001|Overall Study|Death|5|||
157127669|NCT03523351|567218612|FG000|Overall Study|Withdrawal by Subject|4|||
157127670|NCT03523351|567218613|FG001|Overall Study|Withdrawal by Subject|0|||
157127671|NCT03523351|567218612|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
157127672|NCT03523351|567218613|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
157127673|NCT01430442|567218615|FG000|Overall Study|Subject Withdrew Consent|3|||
157016699|NCT04436107|566813201|FG002|Overall Study|Death|3|||
157016700|NCT04436107|566813202|FG003|Overall Study|Death|18|||
156714836|NCT02906670|565700820|FG002|Cohort 4, Q2W|Radiological Progression|0|||
157016701|NCT04436107|566813199|FG000|Overall Study|Withdrawal by Subject|1|||
157127674|NCT01430442|567218616|FG001|Overall Study|Subject Withdrew Consent|0|||
157127675|NCT01430442|567218617|FG002|Overall Study|Subject Withdrew Consent|1|||
157127676|NCT01430442|567218618|FG003|Overall Study|Subject Withdrew Consent|0|||
157127677|NCT01430442|567218619|FG004|Overall Study|Subject Withdrew Consent|2|||
156874119|NCT02687191|566298570|FG000|Overall Study|Death|0|||
157127678|NCT01430442|567218620|FG005|Overall Study|Subject Withdrew Consent|1|||
157127679|NCT01430442|567218621|FG006|Overall Study|Subject Withdrew Consent|5|||
157127680|NCT01430442|567218622|FG007|Overall Study|Subject Withdrew Consent|2|||
157127681|NCT01430442|567218615|FG000|Overall Study|Lost to Follow-up|2|||
157127682|NCT01430442|567218616|FG001|Overall Study|Lost to Follow-up|0|||
157127683|NCT01430442|567218617|FG002|Overall Study|Lost to Follow-up|1|||
157127684|NCT01430442|567218618|FG003|Overall Study|Lost to Follow-up|2|||
157127685|NCT01430442|567218619|FG004|Overall Study|Lost to Follow-up|2|||
157127686|NCT01430442|567218620|FG005|Overall Study|Lost to Follow-up|1|||
157127687|NCT01430442|567218621|FG006|Overall Study|Lost to Follow-up|5|||
157127688|NCT01430442|567218622|FG007|Overall Study|Lost to Follow-up|1|||
156714837|NCT02906670|565700821|FG003|Cohort 4, Q2W|Radiological Progression|0|||
156714838|NCT02906670|565700822|FG004|Cohort 4, Q2W|Radiological Progression|0|||
156714839|NCT02906670|565700823|FG005|Cohort 4, Q2W|Radiological Progression|1|||
156714840|NCT02906670|565700824|FG006|Cohort 4, Q2W|Radiological Progression|0|||
156714841|NCT02906670|565700825|FG007|Cohort 4, Q2W|Radiological Progression|0|||
156714842|NCT02906670|565700826|FG008|Cohort 4, Q2W|Radiological Progression|0|||
156714843|NCT02906670|565700827|FG009|Cohort 4, Q2W|Radiological Progression|0|||
156714844|NCT02906670|565700818|FG000|Cohort 4, Q2W|Clinical Progression|0|||
156714845|NCT02906670|565700819|FG001|Cohort 4, Q2W|Clinical Progression|0|||
156714846|NCT02906670|565700820|FG002|Cohort 4, Q2W|Clinical Progression|0|||
156714847|NCT02906670|565700821|FG003|Cohort 4, Q2W|Clinical Progression|0|||
156714848|NCT02906670|565700822|FG004|Cohort 4, Q2W|Clinical Progression|0|||
156714849|NCT02906670|565700823|FG005|Cohort 4, Q2W|Clinical Progression|2|||
156714850|NCT02906670|565700824|FG006|Cohort 4, Q2W|Clinical Progression|0|||
156714851|NCT02906670|565700825|FG007|Cohort 4, Q2W|Clinical Progression|0|||
156714852|NCT02906670|565700826|FG008|Cohort 4, Q2W|Clinical Progression|0|||
156714853|NCT02906670|565700827|FG009|Cohort 4, Q2W|Clinical Progression|0|||
156714854|NCT02906670|565700818|FG000|Cohort 5, Q2W|Radiological Progression|0|||
156714855|NCT02906670|565700819|FG001|Cohort 5, Q2W|Radiological Progression|0|||
156714856|NCT02906670|565700820|FG002|Cohort 5, Q2W|Radiological Progression|0|||
156714857|NCT02906670|565700821|FG003|Cohort 5, Q2W|Radiological Progression|0|||
156792674|NCT00836901|565994684|FG000|First Intervention|Withdrawal by Subject|1|||
156792675|NCT00836901|565994685|FG001|First Intervention|Withdrawal by Subject|0|||
156792676|NCT01148771|565994688|FG000|Washout Period|Withdrawal by Subject|0|||
156792677|NCT01148771|565994689|FG001|Washout Period|Withdrawal by Subject|1|||
156792678|NCT01047540|565994690|FG000|Overall Study|Protocol Violation|1|||
156792679|NCT01047540|565994691|FG001|Overall Study|Protocol Violation|0|||
156792680|NCT01047540|565994692|FG002|Overall Study|Protocol Violation|0|||
156792681|NCT01047540|565994693|FG003|Overall Study|Protocol Violation|0|||
156792682|NCT01047540|565994694|FG004|Overall Study|Protocol Violation|0|||
156792683|NCT01047540|565994690|FG000|Overall Study|Lost to Follow-up|1|||
156792684|NCT01047540|565994691|FG001|Overall Study|Lost to Follow-up|0|||
156792685|NCT01047540|565994692|FG002|Overall Study|Lost to Follow-up|0|||
156792686|NCT01047540|565994693|FG003|Overall Study|Lost to Follow-up|0|||
156792687|NCT01047540|565994694|FG004|Overall Study|Lost to Follow-up|0|||
156792688|NCT01047540|565994690|FG000|Overall Study|Withdrawal by Subject|1|||
156792689|NCT01047540|565994691|FG001|Overall Study|Withdrawal by Subject|0|||
156792690|NCT01047540|565994692|FG002|Overall Study|Withdrawal by Subject|3|||
156792691|NCT01047540|565994693|FG003|Overall Study|Withdrawal by Subject|0|||
156792692|NCT01047540|565994694|FG004|Overall Study|Withdrawal by Subject|1|||
156792693|NCT01047540|565994690|FG000|Overall Study|Pregnancy|1|||
156792694|NCT01047540|565994691|FG001|Overall Study|Pregnancy|0|||
156792695|NCT01047540|565994692|FG002|Overall Study|Pregnancy|0|||
156792696|NCT01047540|565994693|FG003|Overall Study|Pregnancy|0|||
156792697|NCT01047540|565994694|FG004|Overall Study|Pregnancy|0|||
156792698|NCT01047540|565994690|FG000|Overall Study|Adverse Event|1|||
156792699|NCT01047540|565994691|FG001|Overall Study|Adverse Event|0|||
156792700|NCT01047540|565994692|FG002|Overall Study|Adverse Event|0|||
156792701|NCT01047540|565994693|FG003|Overall Study|Adverse Event|0|||
156792702|NCT01047540|565994694|FG004|Overall Study|Adverse Event|0|||
156792703|NCT03268499|565994700|FG000|Overall Study|Withdrawal by Subject|2|||
156792704|NCT03268499|565994701|FG001|Overall Study|Withdrawal by Subject|1|||
156792705|NCT04064567|565994705|FG000|Overall Study|Lost to Follow-up|23|||
156792706|NCT04064567|565994706|FG001|Overall Study|Lost to Follow-up|22|||
156792707|NCT04064567|565994705|FG000|Overall Study|Withdrawal by Subject|0|||
156792708|NCT04064567|565994706|FG001|Overall Study|Withdrawal by Subject|1|||
156792709|NCT04064567|565994705|FG000|Overall Study|Reincarcerated|7|||
156714858|NCT02906670|565700822|FG004|Cohort 5, Q2W|Radiological Progression|0|||
156792710|NCT04064567|565994706|FG001|Overall Study|Reincarcerated|10|||
156792711|NCT04064567|565994705|FG000|Overall Study|Moved out of U.S.|0|||
157127689|NCT01430442|567218615|FG000|Overall Study|Pregnancy|1|||
157127690|NCT01430442|567218616|FG001|Overall Study|Pregnancy|0|||
157127691|NCT01430442|567218617|FG002|Overall Study|Pregnancy|0|||
157127692|NCT01430442|567218618|FG003|Overall Study|Pregnancy|0|||
157127693|NCT01430442|567218619|FG004|Overall Study|Pregnancy|0|||
157127694|NCT01430442|567218620|FG005|Overall Study|Pregnancy|1|||
157127695|NCT01430442|567218621|FG006|Overall Study|Pregnancy|0|||
157127696|NCT01430442|567218622|FG007|Overall Study|Pregnancy|0|||
157127697|NCT01430442|567218615|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
157127698|NCT01430442|567218616|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
157127699|NCT01430442|567218617|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
157127700|NCT01430442|567218618|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
157127701|NCT01430442|567218619|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
157127702|NCT01430442|567218620|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
157127703|NCT01430442|567218621|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
157127704|NCT01430442|567218622|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
157127705|NCT00700180|567218629|FG000|Overall Study|Death|99|||
157127706|NCT00700180|567218630|FG001|Overall Study|Death|114|||
157127707|NCT00700180|567218629|FG000|Overall Study|Alive on treatment|5|||
157127708|NCT00700180|567218630|FG001|Overall Study|Alive on treatment|3|||
157127709|NCT00700180|567218629|FG000|Overall Study|Alive in follow-up|46|||
157127710|NCT00700180|567218630|FG001|Overall Study|Alive in follow-up|27|||
157127711|NCT00700180|567218629|FG000|Overall Study|Lost to Follow-up|4|||
157127712|NCT00700180|567218630|FG001|Overall Study|Lost to Follow-up|5|||
157127713|NCT03588741|567218631|FG000|Overall Study|Withdrawal by Subject|1|||
157127714|NCT01445535|567218632|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
157127715|NCT01445535|567218633|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
157127716|NCT01445535|567218634|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
157127717|NCT01445535|567218635|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
157127718|NCT01445535|567218632|FG000|Overall Study|Disease progression|1|||
157127719|NCT01445535|567218633|FG001|Overall Study|Disease progression|0|||
157127720|NCT01445535|567218634|FG002|Overall Study|Disease progression|1|||
157127721|NCT01445535|567218635|FG003|Overall Study|Disease progression|0|||
157127722|NCT01445535|567218632|FG000|Overall Study|PI discretion|0|||
156874120|NCT02687191|566298571|FG001|Overall Study|Death|1|||
156874121|NCT02687191|566298572|FG002|Overall Study|Death|1|||
156874122|NCT02687191|566298573|FG003|Overall Study|Death|0|||
156874123|NCT02687191|566298574|FG004|Overall Study|Death|1|||
157127723|NCT01445535|567218633|FG001|Overall Study|PI discretion|0|||
157127724|NCT01445535|567218634|FG002|Overall Study|PI discretion|0|||
157127725|NCT01445535|567218635|FG003|Overall Study|PI discretion|1|||
157127726|NCT00454779|567218640|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
157127727|NCT00454779|567218641|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
157127728|NCT00454779|567218640|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
157127729|NCT00454779|567218641|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
157127730|NCT00454779|567218640|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
157127731|NCT00454779|567218641|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
157127732|NCT00454779|567218640|FG000|First-line Treatment Phase|Protocol Violation|0|||
157127733|NCT00454779|567218641|FG001|First-line Treatment Phase|Protocol Violation|1|||
157127734|NCT00454779|567218640|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
157127735|NCT00454779|567218641|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
157127736|NCT00454779|567218640|FG000|First-line Treatment Phase|Ongoing|1|||
157127737|NCT00454779|567218641|FG001|First-line Treatment Phase|Ongoing|0|||
157127738|NCT00454779|567218640|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
157127739|NCT00454779|567218641|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
157127740|NCT00454779|567218640|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
157127741|NCT00454779|567218641|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
157127742|NCT00454779|567218640|FG000|Second-line Treatment Phase|Ongoing|0|||
157127743|NCT00454779|567218641|FG001|Second-line Treatment Phase|Ongoing|1|||
157127744|NCT01337973|567218643|FG000|Overall Study|Lost to Follow-up|2|||
157127745|NCT01337973|567218644|FG001|Overall Study|Lost to Follow-up|4|||
157127746|NCT01337973|567218645|FG002|Overall Study|Lost to Follow-up|3|||
157127747|NCT01337973|567218643|FG000|Overall Study|Death|1|||
157127748|NCT01337973|567218644|FG001|Overall Study|Death|2|||
157127749|NCT01337973|567218645|FG002|Overall Study|Death|1|||
157127750|NCT01337973|567218643|FG000|Overall Study|Withdrawal by Subject|10|||
157216237|NCT01078623|567539241|FG003|Treatment Period 1|Adverse Event|0|||
157127751|NCT01337973|567218644|FG001|Overall Study|Withdrawal by Subject|8|||
157127752|NCT01337973|567218645|FG002|Overall Study|Withdrawal by Subject|4|||
157127753|NCT01337973|567218643|FG000|Overall Study|missing data on primary outcome|3|||
157127754|NCT01337973|567218644|FG001|Overall Study|missing data on primary outcome|1|||
156874124|NCT02687191|566298575|FG005|Overall Study|Death|1|||
157127755|NCT01337973|567218645|FG002|Overall Study|missing data on primary outcome|3|||
157127756|NCT02522767|567218647|FG000|Double-blind|Withdrawal by Subject|8|||
157127757|NCT02522767|567218648|FG001|Double-blind|Withdrawal by Subject|11|||
157127758|NCT02522767|567218647|FG000|Double-blind|Lost to Follow-up|1|||
157127759|NCT02522767|567218648|FG001|Double-blind|Lost to Follow-up|0|||
157127760|NCT02522767|567218647|FG000|Double-blind|Adverse Event|1|||
157127761|NCT02522767|567218648|FG001|Double-blind|Adverse Event|10|||
157127762|NCT02522767|567218647|FG000|Double-blind|Protocol Violation|0|||
157127763|NCT02522767|567218648|FG001|Double-blind|Protocol Violation|1|||
157127764|NCT02522767|567218647|FG000|Double-blind|Lack of Efficacy|0|||
157127765|NCT02522767|567218648|FG001|Double-blind|Lack of Efficacy|2|||
157127766|NCT02522767|567218647|FG000|Double-blind|Protocol Deviation|1|||
157127767|NCT02522767|567218648|FG001|Double-blind|Protocol Deviation|0|||
157127768|NCT02522767|567218647|FG000|Open-label|Withdrawal by Subject|2|||
157127769|NCT02522767|567218648|FG001|Open-label|Withdrawal by Subject|3|||
157127770|NCT02522767|567218647|FG000|Open-label|Lost to Follow-up|0|||
157127771|NCT02522767|567218648|FG001|Open-label|Lost to Follow-up|1|||
157127772|NCT02522767|567218647|FG000|Open-label|Adverse Event|2|||
157127773|NCT02522767|567218648|FG001|Open-label|Adverse Event|1|||
157127774|NCT02522767|567218647|FG000|Open-label|Lack of Efficacy|1|||
157127775|NCT02522767|567218648|FG001|Open-label|Lack of Efficacy|1|||
157127776|NCT02522767|567218647|FG000|Open-label|Protocol Violation|0|||
156714859|NCT02906670|565700823|FG005|Cohort 5, Q2W|Radiological Progression|0|||
156714860|NCT02906670|565700824|FG006|Cohort 5, Q2W|Radiological Progression|4|||
156714861|NCT02906670|565700825|FG007|Cohort 5, Q2W|Radiological Progression|0|||
156714862|NCT02906670|565700826|FG008|Cohort 5, Q2W|Radiological Progression|0|||
156714863|NCT02906670|565700827|FG009|Cohort 5, Q2W|Radiological Progression|0|||
156714864|NCT02906670|565700818|FG000|Cohort 5, Q2W|Clinical Progression|0|||
156714865|NCT02906670|565700819|FG001|Cohort 5, Q2W|Clinical Progression|0|||
156714866|NCT02906670|565700820|FG002|Cohort 5, Q2W|Clinical Progression|0|||
156714867|NCT02906670|565700821|FG003|Cohort 5, Q2W|Clinical Progression|0|||
156714868|NCT02906670|565700822|FG004|Cohort 5, Q2W|Clinical Progression|0|||
156714869|NCT02906670|565700823|FG005|Cohort 5, Q2W|Clinical Progression|0|||
156714870|NCT02906670|565700824|FG006|Cohort 5, Q2W|Clinical Progression|1|||
156714871|NCT02906670|565700825|FG007|Cohort 5, Q2W|Clinical Progression|0|||
156714872|NCT02906670|565700826|FG008|Cohort 5, Q2W|Clinical Progression|0|||
156714873|NCT02906670|565700827|FG009|Cohort 5, Q2W|Clinical Progression|0|||
156714874|NCT02906670|565700818|FG000|Cohort 5, Q2W|Adverse Event|0|||
156714875|NCT02906670|565700819|FG001|Cohort 5, Q2W|Adverse Event|0|||
156714876|NCT02906670|565700820|FG002|Cohort 5, Q2W|Adverse Event|0|||
156714877|NCT02906670|565700821|FG003|Cohort 5, Q2W|Adverse Event|0|||
156714878|NCT02906670|565700822|FG004|Cohort 5, Q2W|Adverse Event|0|||
156714879|NCT02906670|565700823|FG005|Cohort 5, Q2W|Adverse Event|0|||
156714880|NCT02906670|565700824|FG006|Cohort 5, Q2W|Adverse Event|1|||
156714881|NCT02906670|565700825|FG007|Cohort 5, Q2W|Adverse Event|0|||
156714882|NCT02906670|565700826|FG008|Cohort 5, Q2W|Adverse Event|0|||
156714883|NCT02906670|565700827|FG009|Cohort 5, Q2W|Adverse Event|0|||
156714884|NCT02906670|565700818|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714885|NCT02906670|565700819|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714886|NCT02906670|565700820|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714887|NCT02906670|565700821|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714888|NCT02906670|565700822|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714889|NCT02906670|565700823|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714890|NCT02906670|565700824|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
156714891|NCT02906670|565700825|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714892|NCT02906670|565700826|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714893|NCT02906670|565700827|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
156714894|NCT02906670|565700818|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
157127777|NCT02522767|567218648|FG001|Open-label|Protocol Violation|1|||
157127778|NCT00548548|567218650|FG000|Overall Study|Death|345|||
157127779|NCT00548548|567218651|FG001|Overall Study|Death|348|||
157127780|NCT00548548|567218650|FG000|Overall Study|Lost to Follow-up|17|||
157127781|NCT00548548|567218651|FG001|Overall Study|Lost to Follow-up|18|||
157127782|NCT02658448|567218653|FG000|Overall Study|Lost to Follow-up|1|||
157127783|NCT00191451|567218654|FG000|Overall Study|Withdrawal by Subject|2|||
157127784|NCT00191451|567218655|FG001|Overall Study|Withdrawal by Subject|3|||
157127785|NCT00191451|567218656|FG002|Overall Study|Withdrawal by Subject|5|||
157127786|NCT00191451|567218654|FG000|Overall Study|Physician Decision|2|||
157127787|NCT00191451|567218655|FG001|Overall Study|Physician Decision|9|||
157127788|NCT00191451|567218656|FG002|Overall Study|Physician Decision|6|||
157127789|NCT00191451|567218654|FG000|Overall Study|Sponsor Decision|1|||
157127790|NCT00191451|567218655|FG001|Overall Study|Sponsor Decision|0|||
157127791|NCT00191451|567218656|FG002|Overall Study|Sponsor Decision|0|||
157127792|NCT00191451|567218654|FG000|Overall Study|Ineligible|0|||
157127793|NCT00191451|567218655|FG001|Overall Study|Ineligible|1|||
157127794|NCT00191451|567218656|FG002|Overall Study|Ineligible|0|||
156714895|NCT02906670|565700819|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
156714896|NCT02906670|565700820|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
156714897|NCT02906670|565700821|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
156714898|NCT02906670|565700822|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
156792712|NCT04064567|565994706|FG001|Overall Study|Moved out of U.S.|1|||
157127795|NCT00191451|567218654|FG000|Overall Study|Reason Not Specified|2|||
157127796|NCT00191451|567218655|FG001|Overall Study|Reason Not Specified|1|||
157127797|NCT00191451|567218656|FG002|Overall Study|Reason Not Specified|3|||
156874125|NCT02687191|566298570|FG000|Overall Study|Withdrawal by Subject|0|||
156874126|NCT02687191|566298571|FG001|Overall Study|Withdrawal by Subject|0|||
156874127|NCT02687191|566298572|FG002|Overall Study|Withdrawal by Subject|0|||
156874128|NCT02687191|566298573|FG003|Overall Study|Withdrawal by Subject|1|||
156874129|NCT02687191|566298574|FG004|Overall Study|Withdrawal by Subject|0|||
156874130|NCT02687191|566298575|FG005|Overall Study|Withdrawal by Subject|0|||
156874131|NCT00943072|566298576|FG000|Overall Study|Adverse Event|0|||
156874132|NCT00943072|566298577|FG001|Overall Study|Adverse Event|3|||
156874133|NCT00943072|566298576|FG000|Overall Study|Death|0|||
156874134|NCT00943072|566298577|FG001|Overall Study|Death|2|||
156874135|NCT00943072|566298576|FG000|Overall Study|Withdrawal by Subject|3|||
157216238|NCT01078623|567539242|FG004|Treatment Period 1|Adverse Event|0|||
157216239|NCT01078623|567539243|FG005|Treatment Period 1|Adverse Event|0|||
157216240|NCT01078623|567539244|FG006|Treatment Period 1|Adverse Event|1|||
157216241|NCT01078623|567539245|FG007|Treatment Period 1|Adverse Event|0|||
156874136|NCT00943072|566298577|FG001|Overall Study|Withdrawal by Subject|1|||
156874137|NCT00943072|566298576|FG000|Overall Study|Protocol Violation|0|||
156874138|NCT00943072|566298577|FG001|Overall Study|Protocol Violation|1|||
156874139|NCT00943072|566298576|FG000|Overall Study|Lost to Follow-up|1|||
156874140|NCT00943072|566298577|FG001|Overall Study|Lost to Follow-up|2|||
156874141|NCT00943072|566298576|FG000|Overall Study|Lack of Efficacy|0|||
157016702|NCT04436107|566813200|FG001|Overall Study|Withdrawal by Subject|1|||
157016703|NCT04436107|566813201|FG002|Overall Study|Withdrawal by Subject|0|||
157016704|NCT04436107|566813202|FG003|Overall Study|Withdrawal by Subject|1|||
157016705|NCT01095796|566813203|FG000|Overall Study|Randomized but Not Treated|5|||
157016706|NCT01095796|566813204|FG001|Overall Study|Randomized but Not Treated|2|||
157016707|NCT01095796|566813203|FG000|Overall Study|Adverse Event|9|||
157016708|NCT01095796|566813204|FG001|Overall Study|Adverse Event|19|||
157016709|NCT01095796|566813203|FG000|Overall Study|Death|3|||
157016710|NCT01095796|566813204|FG001|Overall Study|Death|2|||
157016711|NCT01095796|566813203|FG000|Overall Study|Pregnancy|2|||
157016712|NCT01095796|566813204|FG001|Overall Study|Pregnancy|0|||
157016713|NCT01095796|566813203|FG000|Overall Study|Lack of Efficacy|5|||
157016714|NCT01095796|566813204|FG001|Overall Study|Lack of Efficacy|3|||
157016715|NCT01095796|566813203|FG000|Overall Study|Investigator's Discretion|7|||
157016716|NCT01095796|566813204|FG001|Overall Study|Investigator's Discretion|2|||
157016717|NCT01095796|566813203|FG000|Overall Study|Withdrew Consent|16|||
157016718|NCT01095796|566813204|FG001|Overall Study|Withdrew Consent|22|||
157016719|NCT01095796|566813203|FG000|Overall Study|Lost to Follow-up|27|||
157016720|NCT01095796|566813204|FG001|Overall Study|Lost to Follow-up|29|||
157016721|NCT01095796|566813203|FG000|Overall Study|Participant Noncompliance|5|||
157016722|NCT01095796|566813204|FG001|Overall Study|Participant Noncompliance|10|||
157016723|NCT01095796|566813203|FG000|Overall Study|Protocol Violation|1|||
157016724|NCT01095796|566813204|FG001|Overall Study|Protocol Violation|0|||
157016725|NCT01095796|566813203|FG000|Overall Study|Participant Transferred to Another Study|215|||
157016726|NCT01095796|566813204|FG001|Overall Study|Participant Transferred to Another Study|200|||
157016727|NCT00632203|566813205|FG000|Overall Study|Did not start study treatment|1|||
157016728|NCT00632203|566813206|FG001|Overall Study|Did not start study treatment|0|||
157016729|NCT05512962|566813211|FG000|Overall Study|Withdrawal by Subject|1|||
157016730|NCT05512962|566813212|FG001|Overall Study|Withdrawal by Subject|0|||
157016731|NCT04950127|566813213|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
157016732|NCT04950127|566813214|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
157016733|NCT04950127|566813215|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
157016734|NCT04950127|566813216|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
157016735|NCT04950127|566813217|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
157016736|NCT04950127|566813218|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
157016737|NCT04950127|566813213|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
157016738|NCT04950127|566813214|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
157016739|NCT04950127|566813215|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
157016740|NCT04950127|566813216|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
157016741|NCT04950127|566813217|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
157016742|NCT04950127|566813218|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
157016743|NCT04950127|566813213|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
157016744|NCT04950127|566813214|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
157016745|NCT04950127|566813215|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
157016746|NCT04950127|566813216|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
157016747|NCT04950127|566813217|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
157016748|NCT04950127|566813218|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
157016749|NCT04950127|566813213|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
157016750|NCT04950127|566813214|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
157016751|NCT04950127|566813215|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
157016752|NCT04950127|566813216|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
157016753|NCT04950127|566813217|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
157016754|NCT04950127|566813218|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
156874142|NCT00943072|566298577|FG001|Overall Study|Lack of Efficacy|4|||
156874143|NCT00943072|566298576|FG000|Overall Study|Other|1|||
157127798|NCT00272987|567218661|FG000|Overall Study|Adverse Event|1|||
157127799|NCT00272987|567218662|FG001|Overall Study|Adverse Event|0|||
157127800|NCT00272987|567218663|FG002|Overall Study|Adverse Event|0|||
157127801|NCT00272987|567218661|FG000|Overall Study|Lost to Follow-up|3|||
157127802|NCT00272987|567218662|FG001|Overall Study|Lost to Follow-up|1|||
157127803|NCT00272987|567218663|FG002|Overall Study|Lost to Follow-up|1|||
157127804|NCT00272987|567218661|FG000|Overall Study|Withdrawal by Subject|1|||
157127805|NCT00272987|567218662|FG001|Overall Study|Withdrawal by Subject|0|||
157127806|NCT00272987|567218663|FG002|Overall Study|Withdrawal by Subject|3|||
157127807|NCT00272987|567218661|FG000|Overall Study|Sponsor Terminated study|0|||
157127808|NCT00272987|567218662|FG001|Overall Study|Sponsor Terminated study|1|||
157127809|NCT00272987|567218663|FG002|Overall Study|Sponsor Terminated study|1|||
157127810|NCT00272987|567218661|FG000|Overall Study|Disease progression|1|||
157127811|NCT00272987|567218662|FG001|Overall Study|Disease progression|1|||
157127812|NCT00272987|567218663|FG002|Overall Study|Disease progression|2|||
157127813|NCT00272987|567218661|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
157127814|NCT00272987|567218662|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
157127815|NCT00272987|567218663|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
157127816|NCT00272987|567218661|FG000|Overall Study|Death|1|||
157127817|NCT00272987|567218662|FG001|Overall Study|Death|0|||
157127818|NCT00272987|567218663|FG002|Overall Study|Death|0|||
157127819|NCT02614079|567218664|FG000|Overall Study|Withdrawal by Subject|1|||
157127820|NCT00236080|567218665|FG000|Overall Study|Adverse Event|0|||
157127821|NCT00236080|567218666|FG001|Overall Study|Adverse Event|0|||
157127822|NCT00236080|567218667|FG002|Overall Study|Adverse Event|3|||
157127823|NCT00236080|567218668|FG003|Overall Study|Adverse Event|1|||
157127824|NCT00236080|567218669|FG004|Overall Study|Adverse Event|0|||
157127825|NCT00236080|567218665|FG000|Overall Study|Lost to Follow-up|0|||
157127826|NCT00236080|567218666|FG001|Overall Study|Lost to Follow-up|1|||
157127827|NCT00236080|567218667|FG002|Overall Study|Lost to Follow-up|0|||
157127828|NCT00236080|567218668|FG003|Overall Study|Lost to Follow-up|0|||
157127829|NCT00236080|567218669|FG004|Overall Study|Lost to Follow-up|0|||
157127830|NCT00236080|567218665|FG000|Overall Study|Physician Decision|1|||
157127831|NCT00236080|567218666|FG001|Overall Study|Physician Decision|0|||
157127832|NCT00236080|567218667|FG002|Overall Study|Physician Decision|1|||
157127833|NCT00236080|567218668|FG003|Overall Study|Physician Decision|1|||
157127834|NCT00236080|567218669|FG004|Overall Study|Physician Decision|1|||
157127835|NCT00236080|567218665|FG000|Overall Study|Withdrawal by Subject|1|||
157127836|NCT00236080|567218666|FG001|Overall Study|Withdrawal by Subject|0|||
157127837|NCT00236080|567218667|FG002|Overall Study|Withdrawal by Subject|0|||
157127838|NCT00236080|567218668|FG003|Overall Study|Withdrawal by Subject|0|||
157127839|NCT00236080|567218669|FG004|Overall Study|Withdrawal by Subject|0|||
157127840|NCT00236080|567218665|FG000|Overall Study|Miscellaneous|0|||
157127841|NCT00236080|567218666|FG001|Overall Study|Miscellaneous|0|||
157127842|NCT00236080|567218667|FG002|Overall Study|Miscellaneous|1|||
157127843|NCT00236080|567218668|FG003|Overall Study|Miscellaneous|0|||
157127844|NCT00236080|567218669|FG004|Overall Study|Miscellaneous|0|||
157127845|NCT01214044|567218670|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
157127846|NCT01214044|567218670|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
157127847|NCT01214044|567218670|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
157127848|NCT01214044|567218670|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
157127849|NCT01214044|567218670|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
157127850|NCT01214044|567218670|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
157127851|NCT04698525|567218671|FG000|Overall Study|Lost to Follow-up|1|||
157127852|NCT04698525|567218672|FG001|Overall Study|Lost to Follow-up|2|||
157127853|NCT04698525|567218671|FG000|Overall Study|Three suffered of Covid-19|2|||
156714899|NCT02906670|565700823|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
156714900|NCT02906670|565700824|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
156714901|NCT02906670|565700825|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
156714902|NCT02906670|565700826|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
156714903|NCT02906670|565700827|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
156714904|NCT02906670|565700818|FG000|Cohort 5P, Q2W|Adverse Event|0|||
157127854|NCT04698525|567218672|FG001|Overall Study|Three suffered of Covid-19|1|||
157127855|NCT03604445|567218674|FG000|Overall Study|Death|0|||
157127856|NCT03604445|567218675|FG001|Overall Study|Death|0|||
157127857|NCT03604445|567218676|FG002|Overall Study|Death|0|||
157127858|NCT03604445|567218677|FG003|Overall Study|Death|0|||
157127859|NCT03604445|567218678|FG004|Overall Study|Death|0|||
157127860|NCT03604445|567218679|FG005|Overall Study|Death|0|||
157127861|NCT03604445|567218680|FG006|Overall Study|Death|0|||
157127862|NCT03604445|567218681|FG007|Overall Study|Death|0|||
157127863|NCT03604445|567218682|FG008|Overall Study|Death|1|||
157127864|NCT03604445|567218674|FG000|Overall Study|Withdrawal by Subject|0|||
157127865|NCT03604445|567218675|FG001|Overall Study|Withdrawal by Subject|0|||
157127866|NCT03604445|567218676|FG002|Overall Study|Withdrawal by Subject|0|||
157127867|NCT03604445|567218677|FG003|Overall Study|Withdrawal by Subject|0|||
157127868|NCT03604445|567218678|FG004|Overall Study|Withdrawal by Subject|0|||
157127869|NCT03604445|567218679|FG005|Overall Study|Withdrawal by Subject|0|||
157127870|NCT03604445|567218680|FG006|Overall Study|Withdrawal by Subject|1|||
157127871|NCT03604445|567218681|FG007|Overall Study|Withdrawal by Subject|0|||
157127872|NCT03604445|567218682|FG008|Overall Study|Withdrawal by Subject|0|||
157127873|NCT03604445|567218674|FG000|Overall Study|Missing visit|0|||
157127874|NCT03604445|567218675|FG001|Overall Study|Missing visit|0|||
157127875|NCT03604445|567218676|FG002|Overall Study|Missing visit|0|||
157127876|NCT03604445|567218677|FG003|Overall Study|Missing visit|0|||
157127877|NCT03604445|567218678|FG004|Overall Study|Missing visit|0|||
157127878|NCT03604445|567218679|FG005|Overall Study|Missing visit|1|||
157127879|NCT03604445|567218680|FG006|Overall Study|Missing visit|0|||
157127880|NCT03604445|567218681|FG007|Overall Study|Missing visit|1|||
157127881|NCT03604445|567218682|FG008|Overall Study|Missing visit|0|||
157127882|NCT03604445|567218674|FG000|Overall Study|Adverse Event|0|||
157127883|NCT03604445|567218675|FG001|Overall Study|Adverse Event|0|||
157127884|NCT03604445|567218676|FG002|Overall Study|Adverse Event|0|||
157127885|NCT03604445|567218677|FG003|Overall Study|Adverse Event|1|||
157127886|NCT03604445|567218678|FG004|Overall Study|Adverse Event|0|||
157127887|NCT03604445|567218679|FG005|Overall Study|Adverse Event|0|||
157127888|NCT03604445|567218680|FG006|Overall Study|Adverse Event|0|||
157127889|NCT03604445|567218681|FG007|Overall Study|Adverse Event|0|||
157127890|NCT03604445|567218682|FG008|Overall Study|Adverse Event|1|||
157127891|NCT02817087|567218683|FG000|Overall Study|Withdrawal by Subject|2|||
157127892|NCT02817087|567218684|FG001|Overall Study|Withdrawal by Subject|0|||
157127893|NCT00611247|567218687|FG000|Overall Study|Death|1|||
157127894|NCT00611247|567218688|FG001|Overall Study|Death|5|||
157127895|NCT00611247|567218687|FG000|Overall Study|Lack of Efficacy|1|||
157127896|NCT00611247|567218688|FG001|Overall Study|Lack of Efficacy|16|||
157127897|NCT02551159|567218691|FG000|Overall Study|Death|352|||
157127898|NCT02551159|567218692|FG001|Overall Study|Death|174|||
157127899|NCT02551159|567218693|FG002|Overall Study|Death|161|||
157127900|NCT02551159|567218691|FG000|Overall Study|Withdrawal by Subject|8|||
157127901|NCT02551159|567218692|FG001|Overall Study|Withdrawal by Subject|5|||
157127902|NCT02551159|567218693|FG002|Overall Study|Withdrawal by Subject|16|||
157127903|NCT02551159|567218691|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
157127904|NCT02551159|567218692|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
157127905|NCT02551159|567218693|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
157127906|NCT00243659|567218694|FG000|Overall Study|Withdrawal by Subject|1|||
157127907|NCT00243659|567218695|FG001|Overall Study|Withdrawal by Subject|1|||
157127908|NCT00243659|567218694|FG000|Overall Study|Protocol Violation|1|||
157127909|NCT00243659|567218695|FG001|Overall Study|Protocol Violation|2|||
157127910|NCT06098729|567218696|FG000|Overall Study|Withdrawal by Subject|1|||
157127911|NCT01890421|567218697|FG000|Overall Study|Adverse Event|1|||
157127912|NCT01890421|567218697|FG000|Overall Study|Other reason|10|||
157127913|NCT00268242|567218698|FG000|Overall Study|Death|1|||
157127914|NCT01665144|567218699|FG000|Core Part|Withdrawal by Subject|96|||
157127915|NCT01665144|567218700|FG001|Core Part|Withdrawal by Subject|77|||
157127916|NCT01665144|567218701|FG002|Core Part|Withdrawal by Subject|0|||
157127917|NCT01665144|567218699|FG000|Core Part|Adverse Event|45|||
157127918|NCT01665144|567218700|FG001|Core Part|Adverse Event|18|||
157127919|NCT01665144|567218701|FG002|Core Part|Adverse Event|0|||
157127920|NCT01665144|567218699|FG000|Core Part|Lack of Efficacy|16|||
157127921|NCT01665144|567218700|FG001|Core Part|Lack of Efficacy|11|||
157127922|NCT01665144|567218701|FG002|Core Part|Lack of Efficacy|0|||
157127923|NCT01665144|567218699|FG000|Core Part|Lost to Follow-up|9|||
157127924|NCT01665144|567218700|FG001|Core Part|Lost to Follow-up|8|||
157216242|NCT01078623|567539246|FG008|Treatment Period 1|Adverse Event|1|||
156792713|NCT05071027|565994707|FG000|Overall Study|Lost to Follow-up|1|||
156792714|NCT05071027|565994708|FG001|Overall Study|Lost to Follow-up|4|||
156792715|NCT04576481|565994710|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
156792716|NCT04576481|565994711|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
156792717|NCT04576481|565994712|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
156792718|NCT04576481|565994713|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
157127925|NCT01665144|567218701|FG002|Core Part|Lost to Follow-up|0|||
157127926|NCT01665144|567218699|FG000|Core Part|Physician Decision|13|||
157127927|NCT01665144|567218700|FG001|Core Part|Physician Decision|1|||
157127928|NCT01665144|567218701|FG002|Core Part|Physician Decision|0|||
157127929|NCT01665144|567218699|FG000|Core Part|Progressive disease|8|||
157216243|NCT01078623|567539247|FG009|Treatment Period 1|Adverse Event|1|||
156792719|NCT03464461|565994721|FG000|Overall Study|exclusionary medication given ,|1|||
156808773|NCT03801928|566054462|FG003|Overall Study|Adverse Event|2|||
157127930|NCT01665144|567218700|FG001|Core Part|Progressive disease|4|||
157127931|NCT01665144|567218701|FG002|Core Part|Progressive disease|0|||
157127932|NCT01665144|567218699|FG000|Core Part|Non-compliance with study treatment|5|||
157127933|NCT01665144|567218700|FG001|Core Part|Non-compliance with study treatment|0|||
157127934|NCT01665144|567218701|FG002|Core Part|Non-compliance with study treatment|0|||
157127935|NCT01665144|567218699|FG000|Core Part|Death|3|||
157127936|NCT01665144|567218700|FG001|Core Part|Death|1|||
157127937|NCT01665144|567218701|FG002|Core Part|Death|0|||
157127938|NCT01665144|567218699|FG000|Core Part|Protocol deviation|3|||
157127939|NCT01665144|567218700|FG001|Core Part|Protocol deviation|1|||
157127940|NCT01665144|567218701|FG002|Core Part|Protocol deviation|0|||
157127941|NCT01665144|567218699|FG000|Core Part|New therapy for study indication|2|||
157127942|NCT01665144|567218700|FG001|Core Part|New therapy for study indication|1|||
157127943|NCT01665144|567218701|FG002|Core Part|New therapy for study indication|0|||
157127944|NCT01665144|567218699|FG000|Core Part|Technical problems|2|||
157127945|NCT01665144|567218700|FG001|Core Part|Technical problems|0|||
157127946|NCT01665144|567218701|FG002|Core Part|Technical problems|0|||
157127947|NCT01665144|567218699|FG000|Extension Part|Patient/guardian decision|180|||
157127948|NCT01665144|567218700|FG001|Extension Part|Patient/guardian decision|0|||
157127949|NCT01665144|567218701|FG002|Extension Part|Patient/guardian decision|98|||
157127950|NCT01665144|567218699|FG000|Extension Part|Adverse Event|104|||
157127951|NCT01665144|567218700|FG001|Extension Part|Adverse Event|0|||
157127952|NCT01665144|567218701|FG002|Extension Part|Adverse Event|59|||
157127953|NCT01665144|567218699|FG000|Extension Part|Study closed early|42|||
157127954|NCT01665144|567218700|FG001|Extension Part|Study closed early|0|||
157127955|NCT01665144|567218701|FG002|Extension Part|Study closed early|19|||
157127956|NCT01665144|567218699|FG000|Extension Part|Progressive disease|36|||
157127957|NCT01665144|567218700|FG001|Extension Part|Progressive disease|0|||
157127958|NCT01665144|567218701|FG002|Extension Part|Progressive disease|14|||
157127959|NCT01665144|567218699|FG000|Extension Part|Lack of Efficacy|37|||
157127960|NCT01665144|567218700|FG001|Extension Part|Lack of Efficacy|0|||
157127961|NCT01665144|567218701|FG002|Extension Part|Lack of Efficacy|12|||
157127962|NCT01665144|567218699|FG000|Extension Part|Physician Decision|29|||
157127963|NCT01665144|567218700|FG001|Extension Part|Physician Decision|0|||
157127964|NCT01665144|567218701|FG002|Extension Part|Physician Decision|13|||
157127965|NCT01665144|567218699|FG000|Extension Part|Technical problems|20|||
157127966|NCT01665144|567218700|FG001|Extension Part|Technical problems|0|||
157127967|NCT01665144|567218701|FG002|Extension Part|Technical problems|8|||
157127968|NCT01665144|567218699|FG000|Extension Part|Death|20|||
157127969|NCT01665144|567218700|FG001|Extension Part|Death|0|||
157127970|NCT01665144|567218701|FG002|Extension Part|Death|4|||
157127971|NCT01665144|567218699|FG000|Extension Part|Missing|12|||
157127972|NCT01665144|567218700|FG001|Extension Part|Missing|0|||
157127973|NCT01665144|567218701|FG002|Extension Part|Missing|6|||
157127974|NCT01665144|567218699|FG000|Extension Part|Lost to Follow-up|9|||
157127975|NCT01665144|567218700|FG001|Extension Part|Lost to Follow-up|0|||
157127976|NCT01665144|567218701|FG002|Extension Part|Lost to Follow-up|5|||
157127977|NCT01665144|567218699|FG000|Extension Part|New therapy for study indication|3|||
157127978|NCT01665144|567218700|FG001|Extension Part|New therapy for study indication|0|||
157127979|NCT01665144|567218701|FG002|Extension Part|New therapy for study indication|2|||
157127980|NCT01665144|567218699|FG000|Extension Part|Protocol deviation|3|||
157127981|NCT01665144|567218700|FG001|Extension Part|Protocol deviation|0|||
157127982|NCT01665144|567218701|FG002|Extension Part|Protocol deviation|0|||
157127983|NCT01913483|567218702|FG000|Overall Study|Withdrawal by Subject|1|||
157127984|NCT01913483|567218703|FG001|Overall Study|Withdrawal by Subject|2|||
157127985|NCT01913483|567218702|FG000|Overall Study|Lost to Follow-up|6|||
157127986|NCT01913483|567218703|FG001|Overall Study|Lost to Follow-up|3|||
157127987|NCT01913483|567218702|FG000|Overall Study|Death|14|||
157127988|NCT01913483|567218703|FG001|Overall Study|Death|17|||
157127989|NCT03969888|567218704|FG000|Overall Study|Never Received Study Drug|0|||
157127990|NCT03969888|567218705|FG001|Overall Study|Never Received Study Drug|0|||
157127991|NCT03969888|567218706|FG002|Overall Study|Never Received Study Drug|1|||
157127992|NCT03969888|567218707|FG003|Overall Study|Never Received Study Drug|0|||
157127993|NCT03969888|567218708|FG004|Overall Study|Never Received Study Drug|0|||
157127994|NCT03969888|567218709|FG005|Overall Study|Never Received Study Drug|0|||
157127995|NCT03969888|567218710|FG006|Overall Study|Never Received Study Drug|1|||
156792720|NCT03464461|565994722|FG001|Overall Study|exclusionary medication given ,|2|||
156792721|NCT03464461|565994723|FG002|Overall Study|exclusionary medication given ,|0|||
156792722|NCT03464461|565994721|FG000|Overall Study|Physician Decision|0|||
156792723|NCT03464461|565994722|FG001|Overall Study|Physician Decision|1|||
156792724|NCT03464461|565994723|FG002|Overall Study|Physician Decision|0|||
157127996|NCT03969888|567218711|FG007|Overall Study|Never Received Study Drug|0|||
157127997|NCT03969888|567218704|FG000|Overall Study|Reason Not Specified|0|||
157127998|NCT03969888|567218705|FG001|Overall Study|Reason Not Specified|0|||
157216244|NCT01078623|567539248|FG010|Treatment Period 1|Adverse Event|0|||
156792725|NCT05524948|565994724|FG000|Overall Study|Withdrawal by Subject|1|||
156792726|NCT05524948|565994725|FG001|Overall Study|Withdrawal by Subject|0|||
157127999|NCT03969888|567218706|FG002|Overall Study|Reason Not Specified|0|||
157128000|NCT03969888|567218707|FG003|Overall Study|Reason Not Specified|0|||
157128001|NCT03969888|567218708|FG004|Overall Study|Reason Not Specified|0|||
157128002|NCT03969888|567218709|FG005|Overall Study|Reason Not Specified|0|||
157128003|NCT03969888|567218710|FG006|Overall Study|Reason Not Specified|0|||
157128004|NCT03969888|567218711|FG007|Overall Study|Reason Not Specified|1|||
157128005|NCT00464178|567218716|FG000|Overall Study|Protocol Violation|1|||
157128006|NCT00464178|567218716|FG000|Overall Study|Withdrawal by Subject|1|||
157128007|NCT04506294|567218717|FG000|Overall Study|Lost to Follow-up|70|||
157128008|NCT04506294|567218718|FG001|Overall Study|Lost to Follow-up|20|||
157128009|NCT04506294|567218717|FG000|Overall Study|Withdrawal by Subject|16|||
157128010|NCT04506294|567218718|FG001|Overall Study|Withdrawal by Subject|2|||
157128011|NCT01469000|567218719|FG000|Overall Study|Withdrawal by Subject|16|||
157128012|NCT01469000|567218720|FG001|Overall Study|Withdrawal by Subject|3|||
157128013|NCT01469000|567218719|FG000|Overall Study|Sponsor Decision|4|||
157128014|NCT01469000|567218720|FG001|Overall Study|Sponsor Decision|1|||
157128015|NCT00769119|567218722|FG000|Overall Study|Voluntary discontinuation|0|||
157128016|NCT00769119|567218723|FG001|Overall Study|Voluntary discontinuation|2|||
157128017|NCT00769119|567218722|FG000|Overall Study|Adverse Event|1|||
157128018|NCT00769119|567218723|FG001|Overall Study|Adverse Event|1|||
157128019|NCT00769119|567218722|FG000|Overall Study|Disallowed medication|1|||
156792727|NCT05524948|565994724|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
156792728|NCT05524948|565994725|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
156792729|NCT05463952|565994728|FG000|Treatment|Progressive disease|4|||
156792730|NCT05463952|565994728|FG000|Treatment|Ongoing|2|||
156792731|NCT00595075|565994729|FG000|Overall Study|Withdrawal by Subject|1|||
156792732|NCT00595075|565994730|FG001|Overall Study|Withdrawal by Subject|0|||
156792733|NCT05261490|565994733|FG000|Overall Study|Other|1|||
157128020|NCT00769119|567218723|FG001|Overall Study|Disallowed medication|0|||
157128021|NCT04698629|567218728|FG000|Overall Study|Adverse Event|1|||
157128022|NCT02320487|567218731|FG000|Overall Study|Reason not Specified|1|||
157128023|NCT02320487|567218731|FG000|Overall Study|Physician Decision|5|||
157128024|NCT02320487|567218731|FG000|Overall Study|Withdrawal by Subject|1|||
157128025|NCT02320487|567218731|FG000|Overall Study|Death|3|||
157128026|NCT02320487|567218731|FG000|Overall Study|Adverse Event|11|||
157128027|NCT06228586|567218732|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
157128028|NCT06228586|567218733|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
157128029|NCT00618722|567221381|FG000|Overall Study|Refusal of Treatment|0|||
157128030|NCT00618722|567221382|FG001|Overall Study|Refusal of Treatment|0|||
157128031|NCT00618722|567221383|FG002|Overall Study|Refusal of Treatment|1|||
157128032|NCT00618722|567221384|FG003|Overall Study|Refusal of Treatment|0|||
156874144|NCT00943072|566298577|FG001|Overall Study|Other|1|||
156874145|NCT01349049|566298578|FG000|Overall Study|Disease progression|3|||
156874146|NCT01349049|566298579|FG001|Overall Study|Disease progression|5|||
156874147|NCT01349049|566298580|FG002|Overall Study|Disease progression|3|||
157128033|NCT00618722|567221381|FG000|Overall Study|Patient Request|1|||
157128034|NCT00618722|567221382|FG001|Overall Study|Patient Request|1|||
157128035|NCT00618722|567221383|FG002|Overall Study|Patient Request|1|||
157128036|NCT00618722|567221384|FG003|Overall Study|Patient Request|1|||
157128037|NCT00618722|567221381|FG000|Overall Study|Inability to Complete Study Procedure|0|||
157128038|NCT00618722|567221382|FG001|Overall Study|Inability to Complete Study Procedure|1|||
156792734|NCT05261490|565994734|FG001|Overall Study|Other|0|||
156792735|NCT05261490|565994735|FG002|Overall Study|Other|0|||
156792736|NCT05261490|565994733|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874148|NCT01349049|566298581|FG003|Overall Study|Disease progression|2|||
157016755|NCT04950127|566813213|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
157016756|NCT04950127|566813214|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
157016757|NCT04950127|566813215|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
157016758|NCT04950127|566813216|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
157016759|NCT04950127|566813217|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
157016760|NCT04950127|566813218|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
157016761|NCT04315181|566813219|FG000|Overall Study|Non-responsive to drug conditions.|1|||
157016762|NCT01948661|566813220|FG000|Overall Study|Withdrawal by Subject|2|||
157016763|NCT01948661|566813221|FG001|Overall Study|Withdrawal by Subject|4|||
157016764|NCT00522951|566813224|FG000|Period 1|body motion|0|||
157016765|NCT00522951|566813225|FG001|Period 1|body motion|1|||
157016766|NCT00522951|566813224|FG000|Washout Period|Adverse Event|0|||
157016767|NCT00522951|566813225|FG001|Washout Period|Adverse Event|1|||
157016768|NCT00522951|566813224|FG000|Washout Period|Death|0|||
157016769|NCT00522951|566813225|FG001|Washout Period|Death|1|||
157016770|NCT00522951|566813224|FG000|Period 2|Withdrawal by Subject|1|||
157016771|NCT00522951|566813225|FG001|Period 2|Withdrawal by Subject|0|||
157016772|NCT00522951|566813224|FG000|Period 2|residual contrast medium|1|||
157016773|NCT00522951|566813225|FG001|Period 2|residual contrast medium|1|||
157016774|NCT01101451|566813229|FG000|Overall Study|Eligible and never treated|0|||
157016775|NCT01101451|566813230|FG001|Overall Study|Eligible and never treated|5|||
157016776|NCT01101451|566813229|FG000|Overall Study|Ineligible and treated|12|||
157016777|NCT01101451|566813230|FG001|Overall Study|Ineligible and treated|8|||
157016778|NCT01101451|566813229|FG000|Overall Study|Ineligible and never treated|2|||
157016779|NCT01101451|566813230|FG001|Overall Study|Ineligible and never treated|2|||
157128039|NCT00618722|567221383|FG002|Overall Study|Inability to Complete Study Procedure|0|||
157128040|NCT00618722|567221384|FG003|Overall Study|Inability to Complete Study Procedure|0|||
157128041|NCT00618722|567221381|FG000|Overall Study|Lost to Follow-up|2|||
157128042|NCT00618722|567221382|FG001|Overall Study|Lost to Follow-up|0|||
157128043|NCT00618722|567221383|FG002|Overall Study|Lost to Follow-up|0|||
157128044|NCT00618722|567221384|FG003|Overall Study|Lost to Follow-up|2|||
157128045|NCT00618722|567221381|FG000|Overall Study|Miscellaneous Reasons|0|||
157128046|NCT00618722|567221382|FG001|Overall Study|Miscellaneous Reasons|0|||
157128047|NCT00618722|567221383|FG002|Overall Study|Miscellaneous Reasons|1|||
157128048|NCT00618722|567221384|FG003|Overall Study|Miscellaneous Reasons|1|||
157128049|NCT05512949|567221386|FG000|Overall Study|Lost to Follow-up|4|||
157128050|NCT05512949|567221387|FG001|Overall Study|Lost to Follow-up|6|||
157128051|NCT05512949|567221388|FG002|Overall Study|Lost to Follow-up|2|||
157128052|NCT05512949|567221386|FG000|Overall Study|Protocol Violation|0|||
157128053|NCT05512949|567221387|FG001|Overall Study|Protocol Violation|0|||
157128054|NCT05512949|567221388|FG002|Overall Study|Protocol Violation|1|||
157128055|NCT05512949|567221386|FG000|Overall Study|Withdrawal by Subject|1|||
157128056|NCT05512949|567221387|FG001|Overall Study|Withdrawal by Subject|1|||
157128057|NCT05512949|567221388|FG002|Overall Study|Withdrawal by Subject|2|||
156792737|NCT05261490|565994734|FG001|Overall Study|Study Terminated by Sponsor|1|||
156792738|NCT05261490|565994735|FG002|Overall Study|Study Terminated by Sponsor|4|||
156792739|NCT05261490|565994733|FG000|Overall Study|Death|1|||
156792740|NCT05261490|565994734|FG001|Overall Study|Death|2|||
156792741|NCT05261490|565994735|FG002|Overall Study|Death|0|||
156792742|NCT01682720|565994740|FG000|Overall Study|Randomized but Not Treated|0|||
156792743|NCT01682720|565994741|FG001|Overall Study|Randomized but Not Treated|1|||
156792744|NCT01682720|565994742|FG002|Overall Study|Randomized but Not Treated|1|||
156792745|NCT01682720|565994743|FG003|Overall Study|Randomized but Not Treated|0|||
156792746|NCT01682720|565994740|FG000|Overall Study|Terminated by Sponsor|83|||
156792747|NCT01682720|565994741|FG001|Overall Study|Terminated by Sponsor|0|||
156792748|NCT01682720|565994742|FG002|Overall Study|Terminated by Sponsor|0|||
156792749|NCT01682720|565994743|FG003|Overall Study|Terminated by Sponsor|0|||
156792750|NCT01682720|565994740|FG000|Overall Study|Efficacy Failure|0|||
156792751|NCT01682720|565994741|FG001|Overall Study|Efficacy Failure|3|||
156792752|NCT01682720|565994742|FG002|Overall Study|Efficacy Failure|3|||
156792753|NCT01682720|565994743|FG003|Overall Study|Efficacy Failure|30|||
156792754|NCT01682720|565994740|FG000|Overall Study|Lost to Follow-up|1|||
156792755|NCT01682720|565994741|FG001|Overall Study|Lost to Follow-up|1|||
156792756|NCT01682720|565994742|FG002|Overall Study|Lost to Follow-up|0|||
156792757|NCT01682720|565994743|FG003|Overall Study|Lost to Follow-up|6|||
156792758|NCT01682720|565994740|FG000|Overall Study|Subject Withdrew Consent|0|||
156792759|NCT01682720|565994741|FG001|Overall Study|Subject Withdrew Consent|0|||
156792760|NCT01682720|565994742|FG002|Overall Study|Subject Withdrew Consent|2|||
156792761|NCT01682720|565994743|FG003|Overall Study|Subject Withdrew Consent|2|||
156792762|NCT01682720|565994740|FG000|Overall Study|Adverse Event|1|||
156792763|NCT01682720|565994741|FG001|Overall Study|Adverse Event|0|||
156792764|NCT01682720|565994742|FG002|Overall Study|Adverse Event|1|||
156792765|NCT01682720|565994743|FG003|Overall Study|Adverse Event|1|||
156792766|NCT01687595|565994744|FG000|Overall Study|Withdrawal by Subject|8|||
156792767|NCT01687595|565994745|FG001|Overall Study|Withdrawal by Subject|0|||
156792768|NCT01687595|565994744|FG000|Overall Study|Lost to Follow-up|3|||
156792769|NCT01687595|565994745|FG001|Overall Study|Lost to Follow-up|1|||
156792770|NCT01687595|565994744|FG000|Overall Study|Investigator's decision|1|||
156792771|NCT01687595|565994745|FG001|Overall Study|Investigator's decision|0|||
156792772|NCT01687595|565994744|FG000|Overall Study|Sponsor's decision|1|||
156792773|NCT01687595|565994745|FG001|Overall Study|Sponsor's decision|0|||
156792774|NCT01687595|565994744|FG000|Overall Study|Noncompliance|1|||
156792775|NCT01687595|565994745|FG001|Overall Study|Noncompliance|2|||
156792776|NCT01687595|565994744|FG000|Overall Study|Other than specified|56|||
156792777|NCT01687595|565994745|FG001|Overall Study|Other than specified|7|||
156792778|NCT04204902|565994746|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
156792779|NCT04204902|565994747|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
156792780|NCT05451329|565994748|FG000|Overall Study|Adverse Event|1|||
156792781|NCT05451329|565994749|FG001|Overall Study|Adverse Event|1|||
156792782|NCT05451329|565994750|FG002|Overall Study|Adverse Event|0|||
156792783|NCT05451329|565994748|FG000|Overall Study|Withdrawal by Subject|1|||
156792784|NCT05451329|565994749|FG001|Overall Study|Withdrawal by Subject|0|||
156792785|NCT05451329|565994750|FG002|Overall Study|Withdrawal by Subject|0|||
156792786|NCT05451329|565994748|FG000|Overall Study|Investigational Product Lot exchange|1|||
156792787|NCT05451329|565994749|FG001|Overall Study|Investigational Product Lot exchange|1|||
156792788|NCT05451329|565994750|FG002|Overall Study|Investigational Product Lot exchange|0|||
156792789|NCT00069953|565994751|FG000|Overall Study|Protocol Violation|2|||
156792790|NCT03253627|565994754|FG000|Overall Study|Lost to Follow-up|1|||
156792791|NCT03253627|565994755|FG001|Overall Study|Lost to Follow-up|2|||
156792792|NCT03253627|565994754|FG000|Overall Study|Withdrawal by Subject|0|||
156792793|NCT03253627|565994755|FG001|Overall Study|Withdrawal by Subject|2|||
156792794|NCT03253627|565994754|FG000|Overall Study|Inability to complete MRI|1|||
156792795|NCT03253627|565994755|FG001|Overall Study|Inability to complete MRI|0|||
156792796|NCT03829683|565994756|FG000|Overall Study|Lost to Follow-up|1|||
156792797|NCT03829683|565994757|FG001|Overall Study|Lost to Follow-up|0|||
157128058|NCT05512949|567221386|FG000|Overall Study|Completion status unknown|1|||
157128059|NCT05512949|567221387|FG001|Overall Study|Completion status unknown|3|||
157128060|NCT05512949|567221388|FG002|Overall Study|Completion status unknown|0|||
157128061|NCT00772629|567221389|FG000|Overall Study|Subject was not vaccinated|1|||
157128062|NCT00772629|567221390|FG001|Overall Study|Subject was not vaccinated|0|||
157128063|NCT01871090|567221392|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
157128064|NCT01871090|567221393|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
157128065|NCT01871090|567221392|FG000|Overall Study|Interrogation not completed correctly|1|||
157128066|NCT01871090|567221393|FG001|Overall Study|Interrogation not completed correctly|0|||
157128067|NCT01871090|567221392|FG000|Overall Study|Subject Non-Compliance|0|||
157128068|NCT01871090|567221393|FG001|Overall Study|Subject Non-Compliance|1|||
157128069|NCT02911688|567221397|FG000|Washout|Lost to Follow-up|1|||
157128070|NCT02911688|567221398|FG001|Washout|Lost to Follow-up|1|||
157128071|NCT02911688|567221397|FG000|Washout|Withdrawal by Subject|0|||
157128072|NCT02911688|567221398|FG001|Washout|Withdrawal by Subject|1|||
157128073|NCT01307033|567221399|FG000|8-week Double-blind Period|Adverse Event|2|||
157128074|NCT01307033|567221400|FG001|8-week Double-blind Period|Adverse Event|0|||
157128075|NCT01307033|567221401|FG002|8-week Double-blind Period|Adverse Event|0|||
157128076|NCT01307033|567221402|FG003|8-week Double-blind Period|Adverse Event|0|||
157128077|NCT01307033|567221399|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
157128078|NCT01307033|567221400|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
157128079|NCT01307033|567221401|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
157128080|NCT01307033|567221402|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
157128081|NCT01307033|567221399|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
157128082|NCT01307033|567221400|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
157128083|NCT01307033|567221401|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
157128084|NCT01307033|567221402|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
157128085|NCT01307033|567221399|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
157128086|NCT01307033|567221400|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
157128087|NCT01307033|567221401|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
157128088|NCT01307033|567221402|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
157128089|NCT01307033|567221399|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
157128090|NCT01307033|567221400|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
157128091|NCT01307033|567221401|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
157128092|NCT01307033|567221402|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
157128093|NCT01307033|567221399|FG000|44-week Open-label Extension|Adverse Event|0|||
157128094|NCT01307033|567221400|FG001|44-week Open-label Extension|Adverse Event|0|||
157128095|NCT01307033|567221401|FG002|44-week Open-label Extension|Adverse Event|2|||
157128096|NCT01307033|567221402|FG003|44-week Open-label Extension|Adverse Event|1|||
157128097|NCT01307033|567221399|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
157128098|NCT01307033|567221400|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
157128099|NCT01307033|567221401|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
157128100|NCT01307033|567221402|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
157128101|NCT01307033|567221399|FG000|44-week Open-label Extension|Physician Decision|0|||
157128102|NCT01307033|567221400|FG001|44-week Open-label Extension|Physician Decision|0|||
157128103|NCT01307033|567221401|FG002|44-week Open-label Extension|Physician Decision|1|||
157128104|NCT01307033|567221402|FG003|44-week Open-label Extension|Physician Decision|0|||
157128105|NCT01307033|567221399|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
157128106|NCT01307033|567221400|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
157128107|NCT01307033|567221401|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
157128108|NCT01307033|567221402|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
157128109|NCT01307033|567221399|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
157128110|NCT01307033|567221400|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
157128111|NCT01307033|567221401|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
157128112|NCT01307033|567221402|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
157128113|NCT01307033|567221399|FG000|44-week Open-label Extension|Death|0|||
157128114|NCT01307033|567221400|FG001|44-week Open-label Extension|Death|0|||
157128115|NCT01307033|567221401|FG002|44-week Open-label Extension|Death|0|||
157128116|NCT01307033|567221402|FG003|44-week Open-label Extension|Death|1|||
157128117|NCT02804763|567221407|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
157128118|NCT02804763|567221408|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
157128119|NCT02804763|567221409|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
157128120|NCT02804763|567221410|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
157128121|NCT02804763|567221407|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
157128122|NCT02804763|567221408|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
157128123|NCT02804763|567221409|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
157128124|NCT02804763|567221410|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
157128125|NCT02804763|567221407|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
157128126|NCT02804763|567221408|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
157128127|NCT02804763|567221409|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
157128128|NCT02804763|567221410|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
157128129|NCT02804763|567221407|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
157128130|NCT02804763|567221408|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
157128131|NCT02804763|567221409|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
157128132|NCT02804763|567221410|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
157128133|NCT02804763|567221407|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
157128134|NCT02804763|567221408|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
157128135|NCT02804763|567221409|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
157128136|NCT02804763|567221410|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
157128137|NCT02804763|567221407|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
157016780|NCT05480943|566813231|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
157128138|NCT02804763|567221408|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
157128139|NCT02804763|567221409|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
157128140|NCT02804763|567221410|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
157128141|NCT02472847|567221411|FG000|Overall Study|Withdrawal by Subject|1|||
157128142|NCT02472847|567221412|FG001|Overall Study|Withdrawal by Subject|5|||
157016781|NCT05480943|566813231|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
157016782|NCT05480943|566813231|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
157016783|NCT05480943|566813231|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
157016784|NCT02272816|566813232|FG000|Overall Study|Adverse Event|1|||
157016785|NCT04095104|566813233|FG000|Overall Study|Withdrawal by Subject|0|||
157016786|NCT04095104|566813234|FG001|Overall Study|Withdrawal by Subject|1|||
157016787|NCT05048186|566813237|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
157016788|NCT05048186|566813238|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
157016789|NCT05048186|566813237|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
157016790|NCT05048186|566813238|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
157016791|NCT02412748|566813239|FG000|Overall Study|Lost to Follow-up|38|||
157016792|NCT02412748|566813240|FG001|Overall Study|Lost to Follow-up|39|||
157016793|NCT00976937|566813241|FG000|Overall Study|Adverse Event|4|||
157016794|NCT00976937|566813242|FG001|Overall Study|Adverse Event|5|||
157016795|NCT00976937|566813241|FG000|Overall Study|Lost to Follow-up|2|||
157016796|NCT00976937|566813242|FG001|Overall Study|Lost to Follow-up|1|||
157016797|NCT00976937|566813241|FG000|Overall Study|Withdrawal by Subject|5|||
157016798|NCT00976937|566813242|FG001|Overall Study|Withdrawal by Subject|3|||
157016799|NCT00976937|566813241|FG000|Overall Study|Poor compliance to protocol|3|||
157016800|NCT00976937|566813242|FG001|Overall Study|Poor compliance to protocol|0|||
157016801|NCT00976937|566813241|FG000|Overall Study|Personal and Familial Reason|2|||
157016802|NCT00976937|566813242|FG001|Overall Study|Personal and Familial Reason|2|||
157016803|NCT04218266|566813243|FG000|Overall Study|Death|1|||
157016804|NCT04218266|566813244|FG001|Overall Study|Death|2|||
157016805|NCT04218266|566813245|FG002|Overall Study|Death|3|||
157016806|NCT04218266|566813243|FG000|Overall Study|Adverse Event|13|||
157016807|NCT04218266|566813244|FG001|Overall Study|Adverse Event|14|||
157016808|NCT04218266|566813245|FG002|Overall Study|Adverse Event|11|||
157016809|NCT04218266|566813243|FG000|Overall Study|Other|7|||
157128143|NCT04656990|567221413|FG000|Baseline|pandemic|20|||
157128144|NCT04656990|567221414|FG001|Baseline|pandemic|24|||
157128145|NCT04656990|567221413|FG000|Follow Up Period|Lost to Follow-up|61|||
157128146|NCT04656990|567221414|FG001|Follow Up Period|Lost to Follow-up|73|||
157128147|NCT03244059|567221415|FG000|Specific Aim 1|Physician Decision|1|||
157128148|NCT03244059|567221416|FG001|Specific Aim 1|Physician Decision|0|||
157128149|NCT03244059|567221415|FG000|Specific Aim 2|Physician Decision|1|||
157128150|NCT03244059|567221416|FG001|Specific Aim 2|Physician Decision|0|||
157128151|NCT05499520|567221417|FG000|Overall Study|Lost to Follow-up|0|||
157128152|NCT05499520|567221418|FG001|Overall Study|Lost to Follow-up|0|||
157128153|NCT05499520|567221419|FG002|Overall Study|Lost to Follow-up|38|||
157128154|NCT05499520|567221420|FG003|Overall Study|Lost to Follow-up|41|||
157128155|NCT05499520|567221421|FG004|Overall Study|Lost to Follow-up|46|||
157128156|NCT05499520|567221422|FG005|Overall Study|Lost to Follow-up|0|||
157128157|NCT05499520|567221423|FG006|Overall Study|Lost to Follow-up|31|||
157128158|NCT05499520|567221424|FG007|Overall Study|Lost to Follow-up|45|||
157128159|NCT05499520|567221425|FG008|Overall Study|Lost to Follow-up|42|||
157128160|NCT05499520|567221426|FG009|Overall Study|Lost to Follow-up|0|||
157128161|NCT05499520|567221427|FG010|Overall Study|Lost to Follow-up|0|||
157128162|NCT05499520|567221428|FG011|Overall Study|Lost to Follow-up|37|||
157016810|NCT04218266|566813244|FG001|Overall Study|Other|5|||
157016811|NCT04218266|566813245|FG002|Overall Study|Other|14|||
157016812|NCT04218266|566813243|FG000|Overall Study|Physician Decision|1|||
157016813|NCT04218266|566813244|FG001|Overall Study|Physician Decision|3|||
157016814|NCT04218266|566813245|FG002|Overall Study|Physician Decision|2|||
157128163|NCT05499520|567221429|FG012|Overall Study|Lost to Follow-up|53|||
157128164|NCT05499520|567221430|FG013|Overall Study|Lost to Follow-up|49|||
157128165|NCT05499520|567221431|FG014|Overall Study|Lost to Follow-up|0|||
157016815|NCT04218266|566813243|FG000|Overall Study|Non-compliance with study drug|0|||
157128166|NCT05499520|567221432|FG015|Overall Study|Lost to Follow-up|36|||
157128167|NCT05499520|567221433|FG016|Overall Study|Lost to Follow-up|58|||
157128168|NCT05499520|567221434|FG017|Overall Study|Lost to Follow-up|53|||
157128169|NCT01613326|567221435|FG000|Overall Study|Adverse Event|7|||
157128170|NCT01613326|567221436|FG001|Overall Study|Adverse Event|5|||
157128171|NCT01613326|567221435|FG000|Overall Study|Withdrawal by Subject|3|||
157128172|NCT01613326|567221436|FG001|Overall Study|Withdrawal by Subject|4|||
157128173|NCT01613326|567221435|FG000|Overall Study|Abnormal test procedure result(s)|2|||
157128174|NCT01613326|567221436|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157128175|NCT01613326|567221435|FG000|Overall Study|inability to use device|1|||
157128176|NCT01613326|567221436|FG001|Overall Study|inability to use device|0|||
157128177|NCT01613326|567221435|FG000|Overall Study|Lack of Efficacy|0|||
157128178|NCT01613326|567221436|FG001|Overall Study|Lack of Efficacy|1|||
157128179|NCT01613326|567221435|FG000|Overall Study|Lost to Follow-up|0|||
157128180|NCT01613326|567221436|FG001|Overall Study|Lost to Follow-up|1|||
157128181|NCT01613326|567221435|FG000|Overall Study|Administrative|0|||
157128182|NCT01613326|567221436|FG001|Overall Study|Administrative|2|||
157128183|NCT01613326|567221435|FG000|Overall Study|Protocol Violation|0|||
157128184|NCT01613326|567221436|FG001|Overall Study|Protocol Violation|1|||
157128185|NCT00605267|567221439|FG000|Overall Study|Adverse Event|0|||
157128186|NCT00605267|567221440|FG001|Overall Study|Adverse Event|1|||
157128187|NCT00605267|567221439|FG000|Overall Study|Lack of Efficacy|1|||
157128188|NCT00605267|567221440|FG001|Overall Study|Lack of Efficacy|5|||
157128189|NCT00605267|567221439|FG000|Overall Study|Withdrawal by Subject|2|||
157128190|NCT00605267|567221440|FG001|Overall Study|Withdrawal by Subject|3|||
157128191|NCT00793793|567221441|FG000|Overall Study|Adverse Event|0|||
157128192|NCT00793793|567221442|FG001|Overall Study|Adverse Event|0|||
157128193|NCT00793793|567221443|FG002|Overall Study|Adverse Event|1|||
157128194|NCT00793793|567221444|FG003|Overall Study|Adverse Event|1|||
157128195|NCT00793793|567221445|FG004|Overall Study|Adverse Event|0|||
157128196|NCT00793793|567221446|FG005|Overall Study|Adverse Event|1|||
157128197|NCT00793793|567221447|FG006|Overall Study|Adverse Event|2|||
157128198|NCT00793793|567221448|FG007|Overall Study|Adverse Event|0|||
157128199|NCT00793793|567221449|FG008|Overall Study|Adverse Event|0|||
157128200|NCT00793793|567221450|FG009|Overall Study|Adverse Event|0|||
157128201|NCT00793793|567221451|FG010|Overall Study|Adverse Event|0|||
157128202|NCT00793793|567221452|FG011|Overall Study|Adverse Event|2|||
157128203|NCT00793793|567221441|FG000|Overall Study|Protocol Violation|0|||
157128204|NCT00793793|567221442|FG001|Overall Study|Protocol Violation|0|||
157128205|NCT00793793|567221443|FG002|Overall Study|Protocol Violation|0|||
157128206|NCT00793793|567221444|FG003|Overall Study|Protocol Violation|1|||
157128207|NCT00793793|567221445|FG004|Overall Study|Protocol Violation|0|||
157128208|NCT00793793|567221446|FG005|Overall Study|Protocol Violation|0|||
157128209|NCT00793793|567221447|FG006|Overall Study|Protocol Violation|0|||
157128210|NCT00793793|567221448|FG007|Overall Study|Protocol Violation|0|||
157128211|NCT00793793|567221449|FG008|Overall Study|Protocol Violation|0|||
157128212|NCT00793793|567221450|FG009|Overall Study|Protocol Violation|0|||
157128213|NCT00793793|567221451|FG010|Overall Study|Protocol Violation|0|||
157128214|NCT00793793|567221452|FG011|Overall Study|Protocol Violation|0|||
157128215|NCT00793793|567221441|FG000|Overall Study|Lost to Follow-up|0|||
157128216|NCT00793793|567221442|FG001|Overall Study|Lost to Follow-up|0|||
157128217|NCT00793793|567221443|FG002|Overall Study|Lost to Follow-up|1|||
157128218|NCT00793793|567221444|FG003|Overall Study|Lost to Follow-up|0|||
157128219|NCT00793793|567221445|FG004|Overall Study|Lost to Follow-up|0|||
157128220|NCT00793793|567221446|FG005|Overall Study|Lost to Follow-up|0|||
157128221|NCT00793793|567221447|FG006|Overall Study|Lost to Follow-up|0|||
157128222|NCT00793793|567221448|FG007|Overall Study|Lost to Follow-up|0|||
157128223|NCT00793793|567221449|FG008|Overall Study|Lost to Follow-up|1|||
157128224|NCT00793793|567221450|FG009|Overall Study|Lost to Follow-up|3|||
157128225|NCT00793793|567221451|FG010|Overall Study|Lost to Follow-up|1|||
157128226|NCT00793793|567221452|FG011|Overall Study|Lost to Follow-up|0|||
157128227|NCT00793793|567221441|FG000|Overall Study|Withdrawal by Subject|0|||
157128228|NCT00793793|567221442|FG001|Overall Study|Withdrawal by Subject|0|||
157128229|NCT00793793|567221443|FG002|Overall Study|Withdrawal by Subject|0|||
157128230|NCT00793793|567221444|FG003|Overall Study|Withdrawal by Subject|0|||
157128231|NCT00793793|567221445|FG004|Overall Study|Withdrawal by Subject|1|||
157128232|NCT00793793|567221446|FG005|Overall Study|Withdrawal by Subject|0|||
157128233|NCT00793793|567221447|FG006|Overall Study|Withdrawal by Subject|0|||
157128234|NCT00793793|567221448|FG007|Overall Study|Withdrawal by Subject|0|||
157128235|NCT00793793|567221449|FG008|Overall Study|Withdrawal by Subject|1|||
157128236|NCT00793793|567221450|FG009|Overall Study|Withdrawal by Subject|0|||
157128237|NCT00793793|567221451|FG010|Overall Study|Withdrawal by Subject|0|||
157128238|NCT00793793|567221452|FG011|Overall Study|Withdrawal by Subject|0|||
157128239|NCT00793793|567221441|FG000|Overall Study|reason not specified|0|||
157128240|NCT00793793|567221442|FG001|Overall Study|reason not specified|1|||
157128241|NCT00793793|567221443|FG002|Overall Study|reason not specified|0|||
157216245|NCT01078623|567539249|FG011|Treatment Period 1|Adverse Event|0|||
157128242|NCT00793793|567221444|FG003|Overall Study|reason not specified|1|||
157128243|NCT00793793|567221445|FG004|Overall Study|reason not specified|1|||
157128244|NCT00793793|567221446|FG005|Overall Study|reason not specified|1|||
157128245|NCT00793793|567221447|FG006|Overall Study|reason not specified|2|||
157128246|NCT00793793|567221448|FG007|Overall Study|reason not specified|0|||
157128247|NCT00793793|567221449|FG008|Overall Study|reason not specified|7|||
157128248|NCT00793793|567221450|FG009|Overall Study|reason not specified|6|||
157128249|NCT00793793|567221451|FG010|Overall Study|reason not specified|2|||
157128250|NCT00793793|567221452|FG011|Overall Study|reason not specified|4|||
157128251|NCT00840827|567221453|FG000|Overall Study|Adverse Event|1|||
157128252|NCT00840827|567221453|FG000|Overall Study|Lack of Efficacy|4|||
157128253|NCT00840827|567221453|FG000|Overall Study|Physician Decision|1|||
157128254|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
157128255|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
157128256|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
157128257|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
157128258|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
157128259|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
157128260|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
157128261|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
157128262|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157128263|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157128264|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157128265|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
157128266|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
157128267|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157128268|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157128269|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
157128270|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
157128271|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
157128272|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
157128273|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
157128274|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
157128275|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
157128276|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
157128277|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
157128278|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
157128279|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
157128280|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
157128281|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
157128282|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
157128283|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
157128284|NCT05195528|567221455|FG000|Placebo-controlled Treatment Period|Other|0|||
157128285|NCT05195528|567221456|FG001|Placebo-controlled Treatment Period|Other|0|||
157128286|NCT05195528|567221457|FG002|Placebo-controlled Treatment Period|Other|1|||
157128287|NCT05195528|567221458|FG003|Placebo-controlled Treatment Period|Other|0|||
157128288|NCT05195528|567221459|FG004|Placebo-controlled Treatment Period|Other|0|||
157128289|NCT05195528|567221455|FG000|Extension Period|PTE or AE or SAE|0|||
157128290|NCT05195528|567221456|FG001|Extension Period|PTE or AE or SAE|4|||
157128291|NCT05195528|567221457|FG002|Extension Period|PTE or AE or SAE|5|||
157128292|NCT05195528|567221458|FG003|Extension Period|PTE or AE or SAE|4|||
157128293|NCT05195528|567221459|FG004|Extension Period|PTE or AE or SAE|4|||
157128294|NCT05195528|567221455|FG000|Extension Period|Protocol Violation|0|||
157128295|NCT05195528|567221456|FG001|Extension Period|Protocol Violation|2|||
157128296|NCT05195528|567221457|FG002|Extension Period|Protocol Violation|1|||
157128297|NCT05195528|567221458|FG003|Extension Period|Protocol Violation|0|||
157128298|NCT05195528|567221459|FG004|Extension Period|Protocol Violation|1|||
157128299|NCT05195528|567221455|FG000|Extension Period|Lost to Follow-up|0|||
157128300|NCT05195528|567221456|FG001|Extension Period|Lost to Follow-up|6|||
157128301|NCT05195528|567221457|FG002|Extension Period|Lost to Follow-up|13|||
157128302|NCT05195528|567221458|FG003|Extension Period|Lost to Follow-up|3|||
157128303|NCT05195528|567221459|FG004|Extension Period|Lost to Follow-up|7|||
157128304|NCT05195528|567221455|FG000|Extension Period|Withdrawal by Subject|0|||
157128305|NCT05195528|567221456|FG001|Extension Period|Withdrawal by Subject|12|||
157128306|NCT05195528|567221457|FG002|Extension Period|Withdrawal by Subject|9|||
157128307|NCT05195528|567221458|FG003|Extension Period|Withdrawal by Subject|6|||
157128308|NCT05195528|567221459|FG004|Extension Period|Withdrawal by Subject|5|||
157128309|NCT05195528|567221455|FG000|Extension Period|Lack of Efficacy|0|||
157128310|NCT05195528|567221456|FG001|Extension Period|Lack of Efficacy|3|||
157128311|NCT05195528|567221457|FG002|Extension Period|Lack of Efficacy|0|||
157128312|NCT05195528|567221458|FG003|Extension Period|Lack of Efficacy|0|||
157128313|NCT05195528|567221459|FG004|Extension Period|Lack of Efficacy|2|||
157128314|NCT05195528|567221455|FG000|Extension Period|Not Treated|0|||
157128315|NCT05195528|567221456|FG001|Extension Period|Not Treated|0|||
157128316|NCT05195528|567221457|FG002|Extension Period|Not Treated|2|||
157128317|NCT05195528|567221458|FG003|Extension Period|Not Treated|3|||
157128318|NCT05195528|567221459|FG004|Extension Period|Not Treated|0|||
157128319|NCT05195528|567221455|FG000|Extension Period|Other|0|||
157128320|NCT05195528|567221456|FG001|Extension Period|Other|1|||
157128321|NCT05195528|567221457|FG002|Extension Period|Other|1|||
157128322|NCT05195528|567221458|FG003|Extension Period|Other|0|||
157128323|NCT05195528|567221459|FG004|Extension Period|Other|0|||
157128324|NCT01552902|567221460|FG000|Overall Study|Adverse Event|1|||
157128325|NCT01552902|567221461|FG001|Overall Study|Adverse Event|15|||
157128326|NCT01552902|567221462|FG002|Overall Study|Adverse Event|14|||
157128327|NCT01552902|567221460|FG000|Overall Study|Protocol Violation|3|||
157128328|NCT01552902|567221461|FG001|Overall Study|Protocol Violation|3|||
157128329|NCT01552902|567221462|FG002|Overall Study|Protocol Violation|3|||
157128330|NCT01552902|567221460|FG000|Overall Study|Lack of Efficacy|4|||
157128331|NCT01552902|567221461|FG001|Overall Study|Lack of Efficacy|3|||
157128332|NCT01552902|567221462|FG002|Overall Study|Lack of Efficacy|1|||
157128333|NCT01552902|567221460|FG000|Overall Study|Withdrawal by Subject|1|||
157128334|NCT01552902|567221461|FG001|Overall Study|Withdrawal by Subject|9|||
157128335|NCT01552902|567221462|FG002|Overall Study|Withdrawal by Subject|6|||
157128336|NCT01552902|567221460|FG000|Overall Study|Lost to Follow-up|1|||
157128337|NCT01552902|567221461|FG001|Overall Study|Lost to Follow-up|3|||
157128338|NCT01552902|567221462|FG002|Overall Study|Lost to Follow-up|6|||
157128339|NCT01552902|567221460|FG000|Overall Study|Other|3|||
157128340|NCT01552902|567221461|FG001|Overall Study|Other|4|||
157128341|NCT01552902|567221462|FG002|Overall Study|Other|3|||
157128342|NCT00883493|567221463|FG000|Overall Study|Adverse Event|11|||
157128343|NCT00883493|567221464|FG001|Overall Study|Adverse Event|12|||
157128344|NCT00883493|567221463|FG000|Overall Study|Lack of Efficacy|4|||
157128345|NCT00883493|567221464|FG001|Overall Study|Lack of Efficacy|3|||
157128346|NCT00883493|567221463|FG000|Overall Study|Lost to Follow-up|7|||
157128347|NCT00883493|567221464|FG001|Overall Study|Lost to Follow-up|6|||
157016816|NCT04218266|566813244|FG001|Overall Study|Non-compliance with study drug|0|||
157016817|NCT04218266|566813245|FG002|Overall Study|Non-compliance with study drug|1|||
157016818|NCT04218266|566813243|FG000|Overall Study|Withdrawal by Subject|1|||
157016819|NCT04218266|566813244|FG001|Overall Study|Withdrawal by Subject|3|||
157016820|NCT04218266|566813245|FG002|Overall Study|Withdrawal by Subject|1|||
157016821|NCT04218266|566813243|FG000|Overall Study|Study drug never administered|2|||
157016822|NCT04218266|566813244|FG001|Overall Study|Study drug never administered|0|||
157016823|NCT04218266|566813245|FG002|Overall Study|Study drug never administered|0|||
157016824|NCT00761189|566813247|FG000|Overall Study|Adverse Event|42|||
157128348|NCT00883493|567221463|FG000|Overall Study|Withdrawal by Subject|11|||
157128349|NCT00883493|567221464|FG001|Overall Study|Withdrawal by Subject|20|||
157128350|NCT00883493|567221463|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
157128351|NCT00883493|567221464|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
157128352|NCT00883493|567221463|FG000|Overall Study|Study specific disc. criteria|2|||
157128353|NCT00883493|567221464|FG001|Overall Study|Study specific disc. criteria|0|||
157128354|NCT00883493|567221463|FG000|Overall Study|Other|5|||
157128355|NCT00883493|567221464|FG001|Overall Study|Other|3|||
157128356|NCT04557384|567221465|FG000|Overall Study|Study Terminated by Sponsor|1|||
157128357|NCT04557384|567221465|FG000|Overall Study|Death|1|||
157128358|NCT00168831|567221467|FG000|Overall Study|Adverse Event|36|||
157128359|NCT00168831|567221468|FG001|Overall Study|Adverse Event|47|||
157128360|NCT00168831|567221469|FG002|Overall Study|Adverse Event|74|||
157128361|NCT00168831|567221467|FG000|Overall Study|Lost to Follow-up|5|||
157128362|NCT00168831|567221468|FG001|Overall Study|Lost to Follow-up|6|||
157128363|NCT00168831|567221469|FG002|Overall Study|Lost to Follow-up|4|||
157128364|NCT00168831|567221467|FG000|Overall Study|Withdrawal by Subject|7|||
157128365|NCT00168831|567221468|FG001|Overall Study|Withdrawal by Subject|14|||
157128366|NCT00168831|567221469|FG002|Overall Study|Withdrawal by Subject|19|||
157128367|NCT00168831|567221467|FG000|Overall Study|Protocol Violation|6|||
157128368|NCT00168831|567221468|FG001|Overall Study|Protocol Violation|11|||
157128369|NCT00168831|567221469|FG002|Overall Study|Protocol Violation|11|||
157128370|NCT00168831|567221467|FG000|Overall Study|Other|6|||
156714905|NCT02906670|565700819|FG001|Cohort 5P, Q2W|Adverse Event|0|||
156874149|NCT01349049|566298582|FG004|Overall Study|Disease progression|2|||
157128371|NCT00168831|567221468|FG001|Overall Study|Other|3|||
157128372|NCT00168831|567221469|FG002|Overall Study|Other|6|||
157128373|NCT01622569|567221470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
157128374|NCT01622569|567221471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
157128375|NCT01622569|567221472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
157128376|NCT01622569|567221473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
157128377|NCT01622569|567221470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
157128378|NCT01622569|567221471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
157128379|NCT01622569|567221472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
157128380|NCT01622569|567221473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
157128381|NCT01622569|567221470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
157128382|NCT01622569|567221471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
157128383|NCT01622569|567221472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
157128384|NCT01622569|567221473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
157128385|NCT01622569|567221470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
157128386|NCT01622569|567221471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
157128387|NCT01622569|567221472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
157128388|NCT01622569|567221473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
157128389|NCT01622569|567221470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
157128390|NCT01622569|567221471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
157128391|NCT01622569|567221472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
157128392|NCT01622569|567221473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
157128393|NCT01622569|567221470|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
157128394|NCT01622569|567221471|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
157128395|NCT01622569|567221472|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
157128396|NCT01622569|567221473|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
157128397|NCT01622569|567221470|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
157128398|NCT01622569|567221471|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
157216246|NCT01078623|567539250|FG012|Treatment Period 1|Adverse Event|0|||
157216247|NCT01078623|567539251|FG013|Treatment Period 1|Adverse Event|0|||
157216248|NCT01078623|567539252|FG014|Treatment Period 1|Adverse Event|0|||
157216249|NCT01078623|567539253|FG015|Treatment Period 1|Adverse Event|0|||
157216250|NCT01078623|567539254|FG016|Treatment Period 1|Adverse Event|0|||
157216251|NCT01078623|567539255|FG017|Treatment Period 1|Adverse Event|0|||
157216252|NCT01078623|567539256|FG018|Treatment Period 1|Adverse Event|0|||
157216253|NCT01078623|567539257|FG019|Treatment Period 1|Adverse Event|0|||
157216254|NCT01078623|567539238|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157216255|NCT01078623|567539239|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157216256|NCT01078623|567539240|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157216257|NCT01078623|567539241|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157216258|NCT01078623|567539242|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157216259|NCT01078623|567539243|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157216260|NCT01078623|567539244|FG006|Treatment Period 1|Withdrawal by Subject|0|||
157216261|NCT01078623|567539245|FG007|Treatment Period 1|Withdrawal by Subject|1|||
157216262|NCT01078623|567539246|FG008|Treatment Period 1|Withdrawal by Subject|0|||
157216263|NCT01078623|567539247|FG009|Treatment Period 1|Withdrawal by Subject|0|||
157216264|NCT01078623|567539248|FG010|Treatment Period 1|Withdrawal by Subject|1|||
157216265|NCT01078623|567539249|FG011|Treatment Period 1|Withdrawal by Subject|0|||
157216266|NCT01078623|567539250|FG012|Treatment Period 1|Withdrawal by Subject|0|||
157216267|NCT01078623|567539251|FG013|Treatment Period 1|Withdrawal by Subject|0|||
157216268|NCT01078623|567539252|FG014|Treatment Period 1|Withdrawal by Subject|0|||
157216269|NCT01078623|567539253|FG015|Treatment Period 1|Withdrawal by Subject|0|||
157216270|NCT01078623|567539254|FG016|Treatment Period 1|Withdrawal by Subject|0|||
157216271|NCT01078623|567539255|FG017|Treatment Period 1|Withdrawal by Subject|0|||
157216272|NCT01078623|567539256|FG018|Treatment Period 1|Withdrawal by Subject|0|||
157216273|NCT01078623|567539257|FG019|Treatment Period 1|Withdrawal by Subject|0|||
157216274|NCT01078623|567539238|FG000|Treatment Period 1|Protocol Violation|0|||
157216275|NCT01078623|567539239|FG001|Treatment Period 1|Protocol Violation|0|||
157216276|NCT01078623|567539240|FG002|Treatment Period 1|Protocol Violation|0|||
157216277|NCT01078623|567539241|FG003|Treatment Period 1|Protocol Violation|0|||
157216278|NCT01078623|567539242|FG004|Treatment Period 1|Protocol Violation|0|||
157216279|NCT01078623|567539243|FG005|Treatment Period 1|Protocol Violation|1|||
157216280|NCT01078623|567539244|FG006|Treatment Period 1|Protocol Violation|0|||
157216281|NCT01078623|567539245|FG007|Treatment Period 1|Protocol Violation|0|||
157216282|NCT01078623|567539246|FG008|Treatment Period 1|Protocol Violation|0|||
157216283|NCT01078623|567539247|FG009|Treatment Period 1|Protocol Violation|0|||
157216284|NCT01078623|567539248|FG010|Treatment Period 1|Protocol Violation|0|||
157216285|NCT01078623|567539249|FG011|Treatment Period 1|Protocol Violation|0|||
157216286|NCT01078623|567539250|FG012|Treatment Period 1|Protocol Violation|0|||
157216287|NCT01078623|567539251|FG013|Treatment Period 1|Protocol Violation|0|||
157216288|NCT01078623|567539252|FG014|Treatment Period 1|Protocol Violation|0|||
157216289|NCT01078623|567539253|FG015|Treatment Period 1|Protocol Violation|0|||
157216290|NCT01078623|567539254|FG016|Treatment Period 1|Protocol Violation|0|||
157216291|NCT01078623|567539255|FG017|Treatment Period 1|Protocol Violation|0|||
157216292|NCT01078623|567539256|FG018|Treatment Period 1|Protocol Violation|0|||
157216293|NCT01078623|567539257|FG019|Treatment Period 1|Protocol Violation|0|||
157216294|NCT01078623|567539238|FG000|Treatment Period 2|Adverse Event|0|||
157216295|NCT01078623|567539239|FG001|Treatment Period 2|Adverse Event|0|||
157216296|NCT01078623|567539240|FG002|Treatment Period 2|Adverse Event|0|||
157216297|NCT01078623|567539241|FG003|Treatment Period 2|Adverse Event|0|||
157216298|NCT01078623|567539242|FG004|Treatment Period 2|Adverse Event|0|||
157216299|NCT01078623|567539243|FG005|Treatment Period 2|Adverse Event|0|||
157128399|NCT01622569|567221472|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
157128400|NCT01622569|567221473|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
157128401|NCT01622569|567221470|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
157128402|NCT01622569|567221471|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
156874150|NCT01349049|566298583|FG005|Overall Study|Disease progression|2|||
156874151|NCT01349049|566298584|FG006|Overall Study|Disease progression|3|||
156874152|NCT01349049|566298585|FG007|Overall Study|Disease progression|2|||
157128403|NCT01622569|567221472|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
157128404|NCT01622569|567221473|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
157128405|NCT01505894|567221474|FG000|Overall Study|Adverse Event|1|||
157128406|NCT01505894|567221475|FG001|Overall Study|Adverse Event|0|||
157128407|NCT01505894|567221476|FG002|Overall Study|Adverse Event|0|||
157128408|NCT01505894|567221477|FG003|Overall Study|Adverse Event|0|||
157128409|NCT01505894|567221478|FG004|Overall Study|Adverse Event|0|||
157128410|NCT01505894|567221479|FG005|Overall Study|Adverse Event|0|||
157128411|NCT01505894|567221480|FG006|Overall Study|Adverse Event|0|||
157128412|NCT01505894|567221481|FG007|Overall Study|Adverse Event|0|||
157128413|NCT01505894|567221482|FG008|Overall Study|Adverse Event|0|||
157128414|NCT01505894|567221474|FG000|Overall Study|Other than specified|0|||
157128415|NCT01505894|567221475|FG001|Overall Study|Other than specified|0|||
157128416|NCT01505894|567221476|FG002|Overall Study|Other than specified|0|||
157128417|NCT01505894|567221477|FG003|Overall Study|Other than specified|0|||
157128418|NCT01505894|567221478|FG004|Overall Study|Other than specified|1|||
157128419|NCT01505894|567221479|FG005|Overall Study|Other than specified|0|||
157128420|NCT01505894|567221480|FG006|Overall Study|Other than specified|0|||
157128421|NCT01505894|567221481|FG007|Overall Study|Other than specified|0|||
157128422|NCT01505894|567221482|FG008|Overall Study|Other than specified|0|||
157128423|NCT04173741|567221484|FG000|Overall Study|IVC measurement cannot be done|1|||
157128424|NCT04173741|567221485|FG001|Overall Study|IVC measurement cannot be done|1|||
157128425|NCT00254566|567221486|FG000|Overall Study|Death|1|||
157128426|NCT00254566|567221487|FG001|Overall Study|Death|0|||
157128427|NCT00254566|567221486|FG000|Overall Study|Adverse Event|5|||
157128428|NCT00254566|567221487|FG001|Overall Study|Adverse Event|4|||
157128429|NCT00254566|567221486|FG000|Overall Study|Lack of Efficacy|12|||
157128430|NCT00254566|567221487|FG001|Overall Study|Lack of Efficacy|9|||
157128431|NCT00254566|567221486|FG000|Overall Study|Other|1|||
157128432|NCT00254566|567221487|FG001|Overall Study|Other|5|||
157128433|NCT00254566|567221486|FG000|Overall Study|Withdrawal by Subject|5|||
157128434|NCT00254566|567221487|FG001|Overall Study|Withdrawal by Subject|6|||
157128435|NCT00254566|567221486|FG000|Overall Study|Lost to Follow-up|7|||
157128436|NCT00254566|567221487|FG001|Overall Study|Lost to Follow-up|2|||
157128437|NCT00059202|567221488|FG000|Overall Study|Withdrawal by Subject|5|||
157128438|NCT00059202|567221489|FG001|Overall Study|Withdrawal by Subject|9|||
157128439|NCT00059202|567221488|FG000|Overall Study|Protocol Violation|1|||
157128440|NCT00059202|567221489|FG001|Overall Study|Protocol Violation|3|||
157128441|NCT00059202|567221488|FG000|Overall Study|drug toxicity|0|||
157128442|NCT00059202|567221489|FG001|Overall Study|drug toxicity|3|||
157128443|NCT01940484|567221493|FG000|Overall Study|Withdrawal by Subject|3|||
157128444|NCT01940484|567221493|FG000|Overall Study|Underwent transplantation|4|||
157128445|NCT01940484|567221493|FG000|Overall Study|Death|2|||
157128446|NCT01940484|567221493|FG000|Overall Study|Adverse Event|1|||
157128447|NCT01705691|567221494|FG000|Overall Study|Death|1|||
157128448|NCT01705691|567221495|FG001|Overall Study|Death|2|||
157128449|NCT01705691|567221494|FG000|Overall Study|Withdrawal by Subject|1|||
157128450|NCT01705691|567221495|FG001|Overall Study|Withdrawal by Subject|2|||
157128451|NCT01705691|567221494|FG000|Overall Study|Lost to Follow-up|1|||
157128452|NCT01705691|567221495|FG001|Overall Study|Lost to Follow-up|1|||
157128453|NCT01705691|567221494|FG000|Overall Study|Other|0|||
157128454|NCT01705691|567221495|FG001|Overall Study|Other|1|||
157128455|NCT03106779|567221496|FG000|Overall Study|Lack of Efficacy|33|||
157128456|NCT03106779|567221497|FG001|Overall Study|Lack of Efficacy|24|||
157128457|NCT03106779|567221496|FG000|Overall Study|Adverse Event|8|||
157128458|NCT03106779|567221497|FG001|Overall Study|Adverse Event|16|||
157128459|NCT03106779|567221496|FG000|Overall Study|Physician Decision|10|||
156714906|NCT02906670|565700820|FG002|Cohort 5P, Q2W|Adverse Event|0|||
157128460|NCT03106779|567221497|FG001|Overall Study|Physician Decision|6|||
156714907|NCT02906670|565700821|FG003|Cohort 5P, Q2W|Adverse Event|0|||
156714908|NCT02906670|565700822|FG004|Cohort 5P, Q2W|Adverse Event|0|||
157128461|NCT03106779|567221496|FG000|Overall Study|Patient/guardian decision|4|||
157128462|NCT03106779|567221497|FG001|Overall Study|Patient/guardian decision|3|||
157128463|NCT03106779|567221496|FG000|Overall Study|Progressive disease|1|||
157128464|NCT03106779|567221497|FG001|Overall Study|Progressive disease|3|||
157128465|NCT03106779|567221496|FG000|Overall Study|Lost to Follow-up|1|||
157128466|NCT03106779|567221497|FG001|Overall Study|Lost to Follow-up|2|||
157128467|NCT03106779|567221496|FG000|Overall Study|Death|1|||
157128468|NCT03106779|567221497|FG001|Overall Study|Death|0|||
157128469|NCT03106779|567221496|FG000|Overall Study|Protocol Violation|1|||
156874153|NCT01349049|566298586|FG008|Overall Study|Disease progression|33|||
157128470|NCT03106779|567221497|FG001|Overall Study|Protocol Violation|0|||
157128471|NCT03106779|567221496|FG000|Overall Study|Not treated|1|||
157128472|NCT03106779|567221497|FG001|Overall Study|Not treated|0|||
157128473|NCT04233229|567221498|FG000|Overall Study|Withdrawal by Subject|0|||
157128474|NCT04233229|567221499|FG001|Overall Study|Withdrawal by Subject|1|||
157128475|NCT04233229|567221498|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
157128476|NCT04233229|567221499|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
157128477|NCT04233229|567221498|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
157128478|NCT04233229|567221499|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
157128479|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
157128480|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
157128481|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
157128482|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
157128483|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
157128484|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
157128485|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
157128486|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
157128487|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
157128488|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
157128489|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
156874154|NCT01349049|566298578|FG000|Overall Study|Adverse Event|0|||
156874155|NCT01349049|566298579|FG001|Overall Study|Adverse Event|1|||
156874156|NCT01349049|566298580|FG002|Overall Study|Adverse Event|0|||
156874157|NCT01349049|566298581|FG003|Overall Study|Adverse Event|0|||
156874158|NCT01349049|566298582|FG004|Overall Study|Adverse Event|0|||
156874159|NCT01349049|566298583|FG005|Overall Study|Adverse Event|3|||
156874160|NCT01349049|566298584|FG006|Overall Study|Adverse Event|1|||
156874161|NCT01349049|566298585|FG007|Overall Study|Adverse Event|0|||
156874162|NCT01349049|566298586|FG008|Overall Study|Adverse Event|4|||
156874163|NCT01349049|566298578|FG000|Overall Study|Physician Decision|0|||
156874164|NCT01349049|566298579|FG001|Overall Study|Physician Decision|1|||
156874165|NCT01349049|566298580|FG002|Overall Study|Physician Decision|0|||
156874166|NCT01349049|566298581|FG003|Overall Study|Physician Decision|0|||
156874167|NCT01349049|566298582|FG004|Overall Study|Physician Decision|0|||
156874168|NCT01349049|566298583|FG005|Overall Study|Physician Decision|0|||
156874169|NCT01349049|566298584|FG006|Overall Study|Physician Decision|0|||
156874170|NCT01349049|566298585|FG007|Overall Study|Physician Decision|0|||
156874171|NCT01349049|566298586|FG008|Overall Study|Physician Decision|2|||
156874172|NCT01349049|566298578|FG000|Overall Study|Protocol Violation|0|||
156874173|NCT01349049|566298579|FG001|Overall Study|Protocol Violation|0|||
156874174|NCT01349049|566298580|FG002|Overall Study|Protocol Violation|0|||
156874175|NCT01349049|566298581|FG003|Overall Study|Protocol Violation|0|||
156874176|NCT01349049|566298582|FG004|Overall Study|Protocol Violation|0|||
156874177|NCT01349049|566298583|FG005|Overall Study|Protocol Violation|0|||
157128490|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
157128491|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
157128492|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
157128493|NCT02288247|567221500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
157128494|NCT02288247|567221501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
157128495|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
157128496|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
157128497|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
157128498|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
157128499|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
157128500|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
157128501|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
156874178|NCT01349049|566298584|FG006|Overall Study|Protocol Violation|0|||
157128502|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
157128503|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
157128504|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
157128505|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
157128506|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
157128507|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
156874179|NCT01349049|566298585|FG007|Overall Study|Protocol Violation|0|||
156874180|NCT01349049|566298586|FG008|Overall Study|Protocol Violation|1|||
156874181|NCT01349049|566298578|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
156874182|NCT01349049|566298579|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
156874183|NCT01349049|566298580|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
156874184|NCT01349049|566298581|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
156874185|NCT01349049|566298582|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
157128508|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
157128509|NCT02288247|567221500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
157128510|NCT02288247|567221501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
157128511|NCT04652804|567221502|FG000|Overall Study|Ineligible post randomization|1|||
157128512|NCT04652804|567221503|FG001|Overall Study|Ineligible post randomization|0|||
157128513|NCT04652804|567221504|FG002|Overall Study|Ineligible post randomization|1|||
157128514|NCT04652804|567221505|FG003|Overall Study|Ineligible post randomization|0|||
157128515|NCT04652804|567221506|FG004|Overall Study|Ineligible post randomization|1|||
157128516|NCT04652804|567221507|FG005|Overall Study|Ineligible post randomization|1|||
157128517|NCT04652804|567221502|FG000|Overall Study|Missing SVR lab results|2|||
157128518|NCT04652804|567221503|FG001|Overall Study|Missing SVR lab results|0|||
157128519|NCT04652804|567221504|FG002|Overall Study|Missing SVR lab results|0|||
157128520|NCT04652804|567221505|FG003|Overall Study|Missing SVR lab results|0|||
157128521|NCT04652804|567221506|FG004|Overall Study|Missing SVR lab results|0|||
157128522|NCT04652804|567221507|FG005|Overall Study|Missing SVR lab results|0|||
157128523|NCT00584194|567221508|FG000|Overall Study|Other|135|||
157128524|NCT04093531|567221509|FG000|Overall Study|failed screening|4|||
157128525|NCT00841763|567221510|FG000|Overall Study|Withdrawal by Subject|60|||
157128526|NCT00841763|567221511|FG001|Overall Study|Withdrawal by Subject|17|||
157128527|NCT00841763|567221512|FG002|Overall Study|Withdrawal by Subject|4|||
157128528|NCT00841763|567221513|FG003|Overall Study|Withdrawal by Subject|1|||
157128529|NCT00841763|567221510|FG000|Overall Study|Adverse Event|9|||
157128530|NCT00841763|567221511|FG001|Overall Study|Adverse Event|10|||
157128531|NCT00841763|567221512|FG002|Overall Study|Adverse Event|3|||
157128532|NCT00841763|567221513|FG003|Overall Study|Adverse Event|2|||
157128533|NCT00841763|567221510|FG000|Overall Study|Lost to Follow-up|63|||
157128534|NCT00841763|567221511|FG001|Overall Study|Lost to Follow-up|25|||
157128535|NCT00841763|567221512|FG002|Overall Study|Lost to Follow-up|0|||
157128536|NCT00841763|567221513|FG003|Overall Study|Lost to Follow-up|0|||
157128537|NCT00841763|567221510|FG000|Overall Study|Protocol Violation|20|||
157128538|NCT00841763|567221511|FG001|Overall Study|Protocol Violation|3|||
157128539|NCT00841763|567221512|FG002|Overall Study|Protocol Violation|1|||
157128540|NCT00841763|567221513|FG003|Overall Study|Protocol Violation|0|||
157128541|NCT00841763|567221510|FG000|Overall Study|Administrative Reasons|3|||
157128542|NCT00841763|567221511|FG001|Overall Study|Administrative Reasons|1|||
157128543|NCT00841763|567221512|FG002|Overall Study|Administrative Reasons|0|||
157128544|NCT00841763|567221513|FG003|Overall Study|Administrative Reasons|0|||
157128545|NCT00841763|567221510|FG000|Overall Study|Unable to Classify|7|||
157128546|NCT00841763|567221511|FG001|Overall Study|Unable to Classify|1|||
157128547|NCT00841763|567221512|FG002|Overall Study|Unable to Classify|0|||
157128548|NCT00841763|567221513|FG003|Overall Study|Unable to Classify|0|||
157128549|NCT00648167|567221514|FG000|Overall Study|Adverse Event|6|||
157128550|NCT00648167|567221514|FG000|Overall Study|unable to swallow tablets|1|||
156874186|NCT01349049|566298583|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
156874187|NCT01349049|566298584|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
156874188|NCT01349049|566298585|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
156874189|NCT01349049|566298586|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
156874190|NCT01349049|566298578|FG000|Overall Study|Other|0|||
156874191|NCT01349049|566298579|FG001|Overall Study|Other|0|||
156874192|NCT01349049|566298580|FG002|Overall Study|Other|0|||
156874193|NCT01349049|566298581|FG003|Overall Study|Other|0|||
156874194|NCT01349049|566298582|FG004|Overall Study|Other|0|||
156874195|NCT01349049|566298583|FG005|Overall Study|Other|1|||
156874196|NCT01349049|566298584|FG006|Overall Study|Other|0|||
156874197|NCT01349049|566298585|FG007|Overall Study|Other|0|||
156874198|NCT01349049|566298586|FG008|Overall Study|Other|4|||
156874199|NCT01349049|566298578|FG000|Overall Study|Death|0|||
156874200|NCT01349049|566298579|FG001|Overall Study|Death|0|||
156874201|NCT01349049|566298580|FG002|Overall Study|Death|0|||
156874202|NCT01349049|566298581|FG003|Overall Study|Death|0|||
156874203|NCT01349049|566298582|FG004|Overall Study|Death|0|||
156874204|NCT01349049|566298583|FG005|Overall Study|Death|0|||
156874205|NCT01349049|566298584|FG006|Overall Study|Death|0|||
156714909|NCT02906670|565700823|FG005|Cohort 5P, Q2W|Adverse Event|0|||
156714910|NCT02906670|565700824|FG006|Cohort 5P, Q2W|Adverse Event|0|||
156874206|NCT01349049|566298585|FG007|Overall Study|Death|1|||
156874207|NCT01349049|566298586|FG008|Overall Study|Death|5|||
156714911|NCT02906670|565700825|FG007|Cohort 5P, Q2W|Adverse Event|1|||
156874208|NCT01349049|566298578|FG000|Overall Study|Non-compliance|0|||
156874209|NCT01349049|566298579|FG001|Overall Study|Non-compliance|0|||
156874210|NCT01349049|566298580|FG002|Overall Study|Non-compliance|0|||
157128551|NCT00927368|567221515|FG000|Overall Study|enrollment in another study|1|||
157128552|NCT00927368|567221516|FG001|Overall Study|enrollment in another study|1|||
157128553|NCT00927368|567221517|FG002|Overall Study|enrollment in another study|2|||
157128554|NCT00927368|567221515|FG000|Overall Study|Lost to Follow-up|4|||
157128555|NCT00927368|567221516|FG001|Overall Study|Lost to Follow-up|0|||
156874211|NCT01349049|566298581|FG003|Overall Study|Non-compliance|1|||
156874212|NCT01349049|566298582|FG004|Overall Study|Non-compliance|0|||
156874213|NCT01349049|566298583|FG005|Overall Study|Non-compliance|0|||
156714912|NCT02906670|565700826|FG008|Cohort 5P, Q2W|Adverse Event|0|||
156714913|NCT02906670|565700827|FG009|Cohort 5P, Q2W|Adverse Event|0|||
156714914|NCT02906670|565700818|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
157016825|NCT00761189|566813247|FG000|Overall Study|Lack of Efficacy|45|||
157016826|NCT00761189|566813247|FG000|Overall Study|Lost to Follow-up|36|||
157016827|NCT00761189|566813247|FG000|Overall Study|Withdrawal by Subject|49|||
157016828|NCT00761189|566813247|FG000|Overall Study|Other|13|||
157016829|NCT01494922|566813248|FG000|Overall Study|Adverse Event|1|||
157016830|NCT04377308|566813249|FG000|Overall Study|Withdrawal by Subject|0|||
157016831|NCT04377308|566813250|FG001|Overall Study|Withdrawal by Subject|1|||
157016832|NCT00709098|566813260|FG000|Double-blind Period|Withdrawal of consent|3|||
157016833|NCT00709098|566813261|FG001|Double-blind Period|Withdrawal of consent|3|||
157016834|NCT00709098|566813262|FG002|Double-blind Period|Withdrawal of consent|0|||
157016835|NCT00709098|566813260|FG000|Double-blind Period|Administrative reason|1|||
157016836|NCT00709098|566813261|FG001|Double-blind Period|Administrative reason|3|||
157016837|NCT00709098|566813262|FG002|Double-blind Period|Administrative reason|0|||
157016838|NCT00709098|566813260|FG000|Double-blind Period|Death|1|||
157016839|NCT00709098|566813261|FG001|Double-blind Period|Death|1|||
157016840|NCT00709098|566813262|FG002|Double-blind Period|Death|0|||
157016841|NCT00709098|566813260|FG000|Double-blind Period|Lost to Follow-up|1|||
157016842|NCT00709098|566813261|FG001|Double-blind Period|Lost to Follow-up|1|||
157016843|NCT00709098|566813262|FG002|Double-blind Period|Lost to Follow-up|0|||
157016844|NCT00709098|566813260|FG000|Open-label Period|Withdrawal of consent|0|||
157016845|NCT00709098|566813261|FG001|Open-label Period|Withdrawal of consent|0|||
157016846|NCT00709098|566813262|FG002|Open-label Period|Withdrawal of consent|7|||
157016847|NCT00709098|566813260|FG000|Open-label Period|Administrative reason|0|||
157016848|NCT00709098|566813261|FG001|Open-label Period|Administrative reason|0|||
157016849|NCT00709098|566813262|FG002|Open-label Period|Administrative reason|5|||
157016850|NCT00709098|566813260|FG000|Open-label Period|Death|0|||
157016851|NCT00709098|566813261|FG001|Open-label Period|Death|0|||
157016852|NCT00709098|566813262|FG002|Open-label Period|Death|1|||
157016853|NCT00709098|566813260|FG000|Open-label Period|Lost to Follow-up|0|||
157016854|NCT00709098|566813261|FG001|Open-label Period|Lost to Follow-up|0|||
157016855|NCT00709098|566813262|FG002|Open-label Period|Lost to Follow-up|1|||
157016856|NCT01227265|566813263|FG000|Overall Study|Did Not Receive Treatment|1|||
157016857|NCT01227265|566813264|FG001|Overall Study|Did Not Receive Treatment|2|||
157016858|NCT01227265|566813265|FG002|Overall Study|Did Not Receive Treatment|0|||
157016859|NCT01227265|566813263|FG000|Overall Study|Administrative|1|||
157016860|NCT01227265|566813264|FG001|Overall Study|Administrative|0|||
157016861|NCT01227265|566813265|FG002|Overall Study|Administrative|2|||
157016862|NCT01227265|566813263|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
157016863|NCT01227265|566813264|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
157016864|NCT01227265|566813265|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
157016865|NCT01227265|566813263|FG000|Overall Study|Protocol Violation|2|||
157016866|NCT01227265|566813264|FG001|Overall Study|Protocol Violation|1|||
157016867|NCT01227265|566813265|FG002|Overall Study|Protocol Violation|0|||
157016868|NCT01227265|566813263|FG000|Overall Study|Withdrawal by Subject|7|||
157016869|NCT01227265|566813264|FG001|Overall Study|Withdrawal by Subject|7|||
157016870|NCT01227265|566813265|FG002|Overall Study|Withdrawal by Subject|3|||
157016871|NCT01227265|566813263|FG000|Overall Study|Lost to Follow-up|2|||
157016872|NCT01227265|566813264|FG001|Overall Study|Lost to Follow-up|0|||
157016873|NCT01227265|566813265|FG002|Overall Study|Lost to Follow-up|3|||
157016874|NCT01227265|566813263|FG000|Overall Study|Adverse Event|6|||
157016875|NCT01227265|566813264|FG001|Overall Study|Adverse Event|10|||
157016876|NCT01227265|566813265|FG002|Overall Study|Adverse Event|5|||
157016877|NCT01037985|566813267|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
157016878|NCT01037985|566813268|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
157016879|NCT01037985|566813267|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
157016880|NCT01037985|566813268|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
157016881|NCT01037985|566813267|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
157016882|NCT01037985|566813268|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
157016883|NCT01037985|566813267|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
157016884|NCT01037985|566813268|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
157016885|NCT04924062|566815093|FG000|Overall Study|Death|49|||
157016886|NCT04924062|566815094|FG001|Overall Study|Death|63|||
157016887|NCT04924062|566815093|FG000|Overall Study|Participant On-going|26|||
157016888|NCT04924062|566815094|FG001|Overall Study|Participant On-going|20|||
157016889|NCT03547908|566815095|FG000|Blinded Phase|Lost to Follow-up|3|||
157016890|NCT03547908|566815096|FG001|Blinded Phase|Lost to Follow-up|3|||
157016891|NCT03547908|566815097|FG002|Blinded Phase|Lost to Follow-up|0|||
157016892|NCT03547908|566815098|FG003|Blinded Phase|Lost to Follow-up|0|||
157016893|NCT03547908|566815095|FG000|Blinded Phase|Withdrew Consent|2|||
157016894|NCT03547908|566815096|FG001|Blinded Phase|Withdrew Consent|3|||
157016895|NCT03547908|566815097|FG002|Blinded Phase|Withdrew Consent|0|||
157016896|NCT03547908|566815098|FG003|Blinded Phase|Withdrew Consent|0|||
157016897|NCT03547908|566815095|FG000|Blinded Phase|Investigator's Discretion|2|||
157016898|NCT03547908|566815096|FG001|Blinded Phase|Investigator's Discretion|1|||
156874214|NCT01349049|566298584|FG006|Overall Study|Non-compliance|0|||
156874215|NCT01349049|566298585|FG007|Overall Study|Non-compliance|0|||
156874216|NCT01349049|566298586|FG008|Overall Study|Non-compliance|0|||
156874217|NCT01349049|566298578|FG000|Overall Study|Withdrawal by Subject|0|||
156874218|NCT01349049|566298579|FG001|Overall Study|Withdrawal by Subject|0|||
156874219|NCT01349049|566298580|FG002|Overall Study|Withdrawal by Subject|0|||
156874220|NCT01349049|566298581|FG003|Overall Study|Withdrawal by Subject|0|||
156874221|NCT01349049|566298582|FG004|Overall Study|Withdrawal by Subject|0|||
156874222|NCT01349049|566298583|FG005|Overall Study|Withdrawal by Subject|0|||
156874223|NCT01349049|566298584|FG006|Overall Study|Withdrawal by Subject|0|||
156874224|NCT01349049|566298585|FG007|Overall Study|Withdrawal by Subject|0|||
156874225|NCT01349049|566298586|FG008|Overall Study|Withdrawal by Subject|6|||
156874226|NCT00970684|566298592|FG000|Overall Study|Lack of Efficacy|5|||
156874227|NCT00970684|566298592|FG000|Overall Study|Adverse Event|4|||
156874228|NCT00970684|566298592|FG000|Overall Study|Withdrawal by Subject|1|||
156874229|NCT01175083|566298593|FG000|Primary Epoch|Withdrawal by Subject|0|||
156874230|NCT01175083|566298594|FG001|Primary Epoch|Withdrawal by Subject|0|||
156874231|NCT01175083|566298595|FG002|Primary Epoch|Withdrawal by Subject|0|||
156874232|NCT01175083|566298596|FG003|Primary Epoch|Withdrawal by Subject|0|||
156874233|NCT01175083|566298597|FG004|Primary Epoch|Withdrawal by Subject|0|||
156874234|NCT01175083|566298598|FG005|Primary Epoch|Withdrawal by Subject|2|||
156874235|NCT01175083|566298593|FG000|Primary Epoch|Lost to Follow-up|0|||
156874236|NCT01175083|566298594|FG001|Primary Epoch|Lost to Follow-up|0|||
156874237|NCT01175083|566298595|FG002|Primary Epoch|Lost to Follow-up|0|||
156874238|NCT01175083|566298596|FG003|Primary Epoch|Lost to Follow-up|0|||
156874239|NCT01175083|566298597|FG004|Primary Epoch|Lost to Follow-up|0|||
156874240|NCT01175083|566298598|FG005|Primary Epoch|Lost to Follow-up|1|||
156874241|NCT01175083|566298593|FG000|Booster Epoch|Death|0|||
156874242|NCT01175083|566298594|FG001|Booster Epoch|Death|0|||
156874243|NCT01175083|566298595|FG002|Booster Epoch|Death|1|||
156874244|NCT01175083|566298596|FG003|Booster Epoch|Death|0|||
156874245|NCT01175083|566298597|FG004|Booster Epoch|Death|0|||
156874246|NCT01175083|566298598|FG005|Booster Epoch|Death|0|||
156874247|NCT01175083|566298593|FG000|Booster Epoch|Withdrawal by Subject|0|||
156874248|NCT01175083|566298594|FG001|Booster Epoch|Withdrawal by Subject|0|||
156874249|NCT01175083|566298595|FG002|Booster Epoch|Withdrawal by Subject|0|||
156874250|NCT01175083|566298596|FG003|Booster Epoch|Withdrawal by Subject|1|||
156874251|NCT01175083|566298597|FG004|Booster Epoch|Withdrawal by Subject|0|||
156874252|NCT01175083|566298598|FG005|Booster Epoch|Withdrawal by Subject|0|||
156874253|NCT00481091|566298599|FG000|Overall Study|Withdrawal by Subject|0|||
156874254|NCT00481091|566298600|FG001|Overall Study|Withdrawal by Subject|1|||
156874255|NCT00481091|566298601|FG002|Overall Study|Withdrawal by Subject|1|||
156874256|NCT00481091|566298602|FG003|Overall Study|Withdrawal by Subject|0|||
156874257|NCT00481091|566298603|FG004|Overall Study|Withdrawal by Subject|0|||
156874258|NCT00481091|566298604|FG005|Overall Study|Withdrawal by Subject|0|||
156874259|NCT00481091|566298605|FG006|Overall Study|Withdrawal by Subject|0|||
156874260|NCT00481091|566298606|FG007|Overall Study|Withdrawal by Subject|0|||
156874261|NCT00481091|566298607|FG008|Overall Study|Withdrawal by Subject|1|||
156874262|NCT00481091|566298608|FG009|Overall Study|Withdrawal by Subject|6|||
156714915|NCT02906670|565700819|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
156714916|NCT02906670|565700820|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
156714917|NCT02906670|565700821|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
156714918|NCT02906670|565700822|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
156714919|NCT02906670|565700823|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
156714920|NCT02906670|565700824|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
156714921|NCT02906670|565700825|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
156714922|NCT02906670|565700826|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
156714923|NCT02906670|565700827|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
156714924|NCT02906670|565700818|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
156714925|NCT02906670|565700819|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
156714926|NCT02906670|565700820|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
156714927|NCT02906670|565700821|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
156874263|NCT00481091|566298599|FG000|Overall Study|Other, Not Specified|0|||
156874264|NCT00481091|566298600|FG001|Overall Study|Other, Not Specified|1|||
156874265|NCT00481091|566298601|FG002|Overall Study|Other, Not Specified|1|||
156874266|NCT00481091|566298602|FG003|Overall Study|Other, Not Specified|0|||
156874267|NCT00481091|566298603|FG004|Overall Study|Other, Not Specified|0|||
156874268|NCT00481091|566298604|FG005|Overall Study|Other, Not Specified|1|||
156874269|NCT00481091|566298605|FG006|Overall Study|Other, Not Specified|0|||
156874270|NCT00481091|566298606|FG007|Overall Study|Other, Not Specified|0|||
156874271|NCT00481091|566298607|FG008|Overall Study|Other, Not Specified|0|||
156874272|NCT00481091|566298608|FG009|Overall Study|Other, Not Specified|4|||
156874273|NCT00481091|566298599|FG000|Overall Study|Adverse Event|1|||
156874274|NCT00481091|566298600|FG001|Overall Study|Adverse Event|2|||
156874275|NCT00481091|566298601|FG002|Overall Study|Adverse Event|0|||
156874276|NCT00481091|566298602|FG003|Overall Study|Adverse Event|1|||
156874277|NCT00481091|566298603|FG004|Overall Study|Adverse Event|1|||
156874278|NCT00481091|566298604|FG005|Overall Study|Adverse Event|1|||
156874279|NCT00481091|566298605|FG006|Overall Study|Adverse Event|2|||
156874280|NCT00481091|566298606|FG007|Overall Study|Adverse Event|1|||
156874281|NCT00481091|566298607|FG008|Overall Study|Adverse Event|1|||
156874282|NCT00481091|566298608|FG009|Overall Study|Adverse Event|6|||
156874283|NCT00481091|566298599|FG000|Overall Study|Progressive disease clinical|0|||
156874284|NCT00481091|566298600|FG001|Overall Study|Progressive disease clinical|0|||
156874285|NCT00481091|566298601|FG002|Overall Study|Progressive disease clinical|0|||
156874286|NCT00481091|566298602|FG003|Overall Study|Progressive disease clinical|0|||
156874287|NCT00481091|566298603|FG004|Overall Study|Progressive disease clinical|0|||
156874288|NCT00481091|566298604|FG005|Overall Study|Progressive disease clinical|0|||
156874289|NCT00481091|566298605|FG006|Overall Study|Progressive disease clinical|0|||
156874290|NCT00481091|566298606|FG007|Overall Study|Progressive disease clinical|0|||
156874291|NCT00481091|566298607|FG008|Overall Study|Progressive disease clinical|1|||
156874292|NCT00481091|566298608|FG009|Overall Study|Progressive disease clinical|7|||
156874293|NCT00481091|566298599|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874294|NCT00481091|566298600|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874295|NCT00481091|566298601|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874296|NCT00481091|566298602|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874297|NCT00481091|566298603|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874298|NCT00481091|566298604|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
156874299|NCT00481091|566298605|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874300|NCT00481091|566298606|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
157016899|NCT03547908|566815097|FG002|Blinded Phase|Investigator's Discretion|0|||
157016900|NCT03547908|566815098|FG003|Blinded Phase|Investigator's Discretion|0|||
157016901|NCT03547908|566815095|FG000|Blinded Phase|Death|2|||
157016902|NCT03547908|566815096|FG001|Blinded Phase|Death|0|||
157016903|NCT03547908|566815097|FG002|Blinded Phase|Death|0|||
157016904|NCT03547908|566815098|FG003|Blinded Phase|Death|0|||
157016905|NCT03547908|566815095|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
157016906|NCT03547908|566815096|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
157016907|NCT03547908|566815097|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
157016908|NCT03547908|566815098|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
157016909|NCT03547908|566815095|FG000|Blinded Phase|Adverse Event|1|||
157016910|NCT03547908|566815096|FG001|Blinded Phase|Adverse Event|0|||
157016911|NCT03547908|566815097|FG002|Blinded Phase|Adverse Event|0|||
157016912|NCT03547908|566815098|FG003|Blinded Phase|Adverse Event|0|||
157016913|NCT03547908|566815095|FG000|Blinded Phase|Randomized But Never Treated|1|||
157016914|NCT03547908|566815096|FG001|Blinded Phase|Randomized But Never Treated|0|||
157016915|NCT03547908|566815097|FG002|Blinded Phase|Randomized But Never Treated|0|||
157016916|NCT03547908|566815098|FG003|Blinded Phase|Randomized But Never Treated|0|||
157016917|NCT03547908|566815095|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
157016918|NCT03547908|566815096|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
157016919|NCT03547908|566815097|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
157016920|NCT03547908|566815098|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
157016921|NCT03547908|566815095|FG000|Open-label Extension Phase|Death|0|||
157016922|NCT03547908|566815096|FG001|Open-label Extension Phase|Death|0|||
157016923|NCT03547908|566815097|FG002|Open-label Extension Phase|Death|1|||
157016924|NCT03547908|566815098|FG003|Open-label Extension Phase|Death|0|||
157016925|NCT04059354|566815101|FG000|Overall Study|COVID-19 pandemic|3|||
157016926|NCT02525692|566815102|FG000|Overall Study|Withdrawal by Subject|1|||
157016927|NCT02525692|566815103|FG001|Overall Study|Withdrawal by Subject|1|||
157016928|NCT02525692|566815104|FG002|Overall Study|Withdrawal by Subject|0|||
157016929|NCT02525692|566815105|FG003|Overall Study|Withdrawal by Subject|5|||
157016930|NCT02525692|566815106|FG004|Overall Study|Withdrawal by Subject|0|||
157016931|NCT02525692|566815107|FG005|Overall Study|Withdrawal by Subject|1|||
157016932|NCT02525692|566815102|FG000|Overall Study|Death|16|||
157016933|NCT02525692|566815103|FG001|Overall Study|Death|18|||
157016934|NCT02525692|566815104|FG002|Overall Study|Death|7|||
157016935|NCT02525692|566815105|FG003|Overall Study|Death|20|||
157016936|NCT02525692|566815106|FG004|Overall Study|Death|3|||
157016937|NCT02525692|566815107|FG005|Overall Study|Death|6|||
157016938|NCT02525692|566815102|FG000|Overall Study|Lost to Follow-up|0|||
157016939|NCT02525692|566815103|FG001|Overall Study|Lost to Follow-up|0|||
157016940|NCT02525692|566815104|FG002|Overall Study|Lost to Follow-up|1|||
157016941|NCT02525692|566815105|FG003|Overall Study|Lost to Follow-up|5|||
157016942|NCT02525692|566815106|FG004|Overall Study|Lost to Follow-up|0|||
157016943|NCT02525692|566815107|FG005|Overall Study|Lost to Follow-up|0|||
157016944|NCT02396199|566815108|FG000|Overall Study|Lost to Follow-up|1|||
157016945|NCT02396199|566815108|FG000|Overall Study|Death|4|||
157016946|NCT02349412|566815109|FG000|Overall Study|Withdrawal by Subject|7|||
157016947|NCT02349412|566815110|FG001|Overall Study|Withdrawal by Subject|7|||
157016948|NCT03263026|566815115|FG000|Overall Study|Withdrawal by Subject|1|||
157016949|NCT03263026|566815116|FG001|Overall Study|Withdrawal by Subject|0|||
157016950|NCT03263026|566815115|FG000|Overall Study|Death|1|||
157016951|NCT03263026|566815116|FG001|Overall Study|Death|0|||
157016952|NCT03263026|566815115|FG000|Overall Study|Other/ Various|41|||
157016953|NCT03263026|566815116|FG001|Overall Study|Other/ Various|29|||
157016954|NCT04823611|566815121|FG000|Overall Study|Adverse Event|2|||
157016955|NCT04823611|566815122|FG001|Overall Study|Adverse Event|0|||
157016956|NCT04823611|566815123|FG002|Overall Study|Adverse Event|1|||
157016957|NCT04823611|566815124|FG003|Overall Study|Adverse Event|0|||
157016958|NCT04823611|566815125|FG004|Overall Study|Adverse Event|0|||
157016959|NCT04823611|566815126|FG005|Overall Study|Adverse Event|0|||
157016960|NCT04823611|566815127|FG006|Overall Study|Adverse Event|0|||
157016961|NCT04178733|566815133|FG000|Overall Study|Investigator Decision|0|||
157016962|NCT04178733|566815134|FG001|Overall Study|Investigator Decision|0|||
157016963|NCT04178733|566815135|FG002|Overall Study|Investigator Decision|0|||
157016964|NCT04178733|566815136|FG003|Overall Study|Investigator Decision|1|||
157016965|NCT04178733|566815137|FG004|Overall Study|Investigator Decision|2|||
157016966|NCT03655132|566815140|FG000|Overall Study|Lost to Follow-up|2|||
157016967|NCT03655132|566815141|FG001|Overall Study|Lost to Follow-up|1|||
157016968|NCT03655132|566815140|FG000|Overall Study|Withdrawal by Subject|0|||
157016969|NCT03655132|566815141|FG001|Overall Study|Withdrawal by Subject|1|||
157016970|NCT03655132|566815140|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
157016971|NCT03655132|566815141|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
157016972|NCT02651324|566815143|FG000|Overall Study|drug not administered, due dispensing issue|1|||
157016973|NCT02651324|566815144|FG001|Overall Study|drug not administered, due dispensing issue|0|||
157016974|NCT05919082|566815147|FG000|Overall Study|Adverse Event|3|||
157016975|NCT05919082|566815148|FG001|Overall Study|Adverse Event|0|||
157016976|NCT05919082|566815147|FG000|Overall Study|Lost to Follow-up|0|||
157016977|NCT05919082|566815148|FG001|Overall Study|Lost to Follow-up|1|||
157016978|NCT05919082|566815147|FG000|Overall Study|Withdrawal by Subject|8|||
157016979|NCT05919082|566815148|FG001|Overall Study|Withdrawal by Subject|9|||
157016980|NCT05919082|566815147|FG000|Overall Study|Lack of Efficacy|0|||
157016981|NCT05919082|566815148|FG001|Overall Study|Lack of Efficacy|1|||
157016982|NCT05919082|566815147|FG000|Overall Study|Investigator Decision|1|||
157016983|NCT05919082|566815148|FG001|Overall Study|Investigator Decision|0|||
157016984|NCT05415410|566815156|FG000|Overall Study|Death|3|||
157016985|NCT05415410|566815157|FG001|Overall Study|Death|6|||
157016986|NCT05415410|566815158|FG002|Overall Study|Death|1|||
157016987|NCT05415410|566815156|FG000|Overall Study|Trial Terminated by Sponsor|1|||
157016988|NCT05415410|566815157|FG001|Overall Study|Trial Terminated by Sponsor|5|||
157016989|NCT05415410|566815158|FG002|Overall Study|Trial Terminated by Sponsor|0|||
157016990|NCT05415410|566815156|FG000|Overall Study|Adverse Event|2|||
157016991|NCT05415410|566815157|FG001|Overall Study|Adverse Event|1|||
157016992|NCT05415410|566815158|FG002|Overall Study|Adverse Event|0|||
157016993|NCT05415410|566815156|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
157016994|NCT05415410|566815157|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
157016995|NCT05415410|566815158|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
157016996|NCT05415410|566815156|FG000|Overall Study|Withdrawal by Subject|1|||
157016997|NCT05415410|566815157|FG001|Overall Study|Withdrawal by Subject|0|||
157016998|NCT05415410|566815158|FG002|Overall Study|Withdrawal by Subject|0|||
157016999|NCT05415410|566815156|FG000|Overall Study|Pregnancy|5|||
157017000|NCT05415410|566815157|FG001|Overall Study|Pregnancy|2|||
157017001|NCT05415410|566815158|FG002|Overall Study|Pregnancy|0|||
157017002|NCT04437433|566815159|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
157017003|NCT04437433|566815160|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
157017004|NCT04437433|566815159|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
157017005|NCT04437433|566815160|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
157017006|NCT04437433|566815159|FG000|Overall Study|Adverse Event|9|||
157017007|NCT04437433|566815160|FG001|Overall Study|Adverse Event|0|||
157017008|NCT04437433|566815159|FG000|Overall Study|Lack of Efficacy|4|||
157017009|NCT04437433|566815160|FG001|Overall Study|Lack of Efficacy|0|||
157017010|NCT04437433|566815159|FG000|Overall Study|Withdrawal by Subject|4|||
157017011|NCT04437433|566815160|FG001|Overall Study|Withdrawal by Subject|1|||
157017012|NCT04437433|566815159|FG000|Overall Study|Protocol Deviation|0|||
157017013|NCT04437433|566815160|FG001|Overall Study|Protocol Deviation|1|||
156714928|NCT02906670|565700822|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
157017014|NCT04437433|566815159|FG000|Overall Study|Other, not specified|0|||
157017015|NCT04437433|566815160|FG001|Overall Study|Other, not specified|1|||
157017016|NCT02365766|566815161|FG000|Overall Study|Withdrawal by Subject|0|||
157017017|NCT02365766|566815162|FG001|Overall Study|Withdrawal by Subject|0|||
157017018|NCT02365766|566815163|FG002|Overall Study|Withdrawal by Subject|1|||
157017019|NCT02365766|566815161|FG000|Overall Study|Eligibility Criteria Not Met|0|||
157017020|NCT02365766|566815162|FG001|Overall Study|Eligibility Criteria Not Met|0|||
157017021|NCT02365766|566815163|FG002|Overall Study|Eligibility Criteria Not Met|1|||
157017022|NCT04791709|566815169|FG000|Overall Study|Withdrawal by Subject|3|||
157017023|NCT03385629|566815170|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
157128556|NCT00927368|567221517|FG002|Overall Study|Lost to Follow-up|0|||
157128557|NCT00927368|567221515|FG000|Overall Study|equipment failure|1|||
157128558|NCT00927368|567221516|FG001|Overall Study|equipment failure|0|||
157128559|NCT00927368|567221517|FG002|Overall Study|equipment failure|0|||
157128560|NCT00927368|567221515|FG000|Overall Study|ineligible post randomization|0|||
157128561|NCT00927368|567221516|FG001|Overall Study|ineligible post randomization|3|||
157128562|NCT00927368|567221517|FG002|Overall Study|ineligible post randomization|1|||
157128563|NCT00927368|567221515|FG000|Overall Study|cancellation of surgery|0|||
157128564|NCT00927368|567221516|FG001|Overall Study|cancellation of surgery|1|||
156874301|NCT00481091|566298607|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874302|NCT00481091|566298608|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
156874303|NCT00481091|566298599|FG000|Overall Study|Progressive disease other|1|||
156874304|NCT00481091|566298600|FG001|Overall Study|Progressive disease other|1|||
156874305|NCT00481091|566298601|FG002|Overall Study|Progressive disease other|0|||
156874306|NCT00481091|566298602|FG003|Overall Study|Progressive disease other|1|||
156874307|NCT00481091|566298603|FG004|Overall Study|Progressive disease other|1|||
156874308|NCT00481091|566298604|FG005|Overall Study|Progressive disease other|1|||
156874309|NCT00481091|566298605|FG006|Overall Study|Progressive disease other|0|||
156874310|NCT00481091|566298606|FG007|Overall Study|Progressive disease other|2|||
156874311|NCT00481091|566298607|FG008|Overall Study|Progressive disease other|0|||
156874312|NCT00481091|566298608|FG009|Overall Study|Progressive disease other|0|||
156874313|NCT00481091|566298599|FG000|Overall Study|No reason given|0|||
156874314|NCT00481091|566298600|FG001|Overall Study|No reason given|0|||
157017024|NCT03385629|566815171|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
157017025|NCT03385629|566815170|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
157017026|NCT03385629|566815171|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
157017027|NCT03385629|566815170|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
157017028|NCT03385629|566815171|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
157017029|NCT01532388|566815172|FG000|3-month Follow-up|Lost to Follow-up|68|||
157017030|NCT01532388|566815173|FG001|3-month Follow-up|Lost to Follow-up|68|||
157017031|NCT01532388|566815172|FG000|6-month Follow-up|Lost to Follow-up|74|||
157017032|NCT01532388|566815173|FG001|6-month Follow-up|Lost to Follow-up|66|||
157017033|NCT01532388|566815172|FG000|12-month Follow-up|Lost to Follow-up|69|||
157017034|NCT01532388|566815173|FG001|12-month Follow-up|Lost to Follow-up|67|||
157017035|NCT00792636|566815174|FG000|Overall Study|Protocol Violation|17|||
157017036|NCT00792636|566815175|FG001|Overall Study|Protocol Violation|23|||
157017037|NCT00792636|566815176|FG002|Overall Study|Protocol Violation|20|||
157017038|NCT00792636|566815174|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
157017039|NCT00792636|566815175|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
157017040|NCT00792636|566815176|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
157017041|NCT00792636|566815174|FG000|Overall Study|Lost to Follow-up|13|||
157017042|NCT00792636|566815175|FG001|Overall Study|Lost to Follow-up|19|||
157017043|NCT00792636|566815176|FG002|Overall Study|Lost to Follow-up|14|||
157017044|NCT00792636|566815174|FG000|Overall Study|Withdrew Consent|10|||
157017045|NCT00792636|566815175|FG001|Overall Study|Withdrew Consent|13|||
157017046|NCT00792636|566815176|FG002|Overall Study|Withdrew Consent|9|||
157017047|NCT00792636|566815174|FG000|Overall Study|Lack of Efficacy|3|||
157017048|NCT00792636|566815175|FG001|Overall Study|Lack of Efficacy|4|||
157017049|NCT00792636|566815176|FG002|Overall Study|Lack of Efficacy|13|||
157017050|NCT00792636|566815174|FG000|Overall Study|Adverse Event|4|||
157017051|NCT00792636|566815175|FG001|Overall Study|Adverse Event|2|||
157017052|NCT00792636|566815176|FG002|Overall Study|Adverse Event|3|||
157017053|NCT00792636|566815174|FG000|Overall Study|Investigator Discretion|2|||
157017054|NCT00792636|566815175|FG001|Overall Study|Investigator Discretion|0|||
157017055|NCT00792636|566815176|FG002|Overall Study|Investigator Discretion|2|||
157017056|NCT04711135|566815180|FG000|Overall Study|Physician Decision|0|||
157017057|NCT04711135|566815181|FG001|Overall Study|Physician Decision|1|||
157017058|NCT04711135|566815180|FG000|Overall Study|Ongoing treatment|0|||
157017059|NCT04711135|566815181|FG001|Overall Study|Ongoing treatment|1|||
157017060|NCT03578536|566815187|FG000|Overall Study|Lost to Follow-up|1|||
157017061|NCT02538900|566815188|FG000|Overall Study|Death|2|||
157017062|NCT02538900|566815189|FG001|Overall Study|Death|2|||
157017063|NCT02538900|566815190|FG002|Overall Study|Death|2|||
157017064|NCT02538900|566815188|FG000|Overall Study|Withdrawal by Subject|18|||
157017065|NCT02538900|566815189|FG001|Overall Study|Withdrawal by Subject|16|||
157017066|NCT02538900|566815190|FG002|Overall Study|Withdrawal by Subject|15|||
157017067|NCT04431726|566815191|FG000|Overall Study|Ongoing in the Study|55|||
157017068|NCT00999167|566815194|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
157017069|NCT00999167|566815195|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
157017070|NCT00999167|566815196|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
157017071|NCT00999167|566815194|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
157017072|NCT00999167|566815195|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
157017073|NCT00999167|566815196|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
157017074|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
157017075|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
157017076|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
157017077|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
157017078|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
157017079|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
157017080|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
157017081|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
157017082|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
157017083|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
157017084|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
157017085|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
157017086|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
157017087|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
157017088|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
157017089|NCT00999167|566815194|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
157017090|NCT00999167|566815195|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
157017091|NCT00999167|566815196|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
157017092|NCT02789020|566815197|FG000|Overall Study|Withdrawal by Subject|6|||
157017093|NCT02789020|566815198|FG001|Overall Study|Withdrawal by Subject|5|||
157017094|NCT04238247|566815201|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
157017095|NCT04238247|566815202|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
157017096|NCT04238247|566815203|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
157017097|NCT04238247|566815204|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
157017098|NCT04238247|566815201|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
157017099|NCT04238247|566815202|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
157017100|NCT04238247|566815203|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
157017101|NCT04238247|566815204|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
157017102|NCT04238247|566815201|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
157017103|NCT04238247|566815202|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
157017104|NCT04238247|566815203|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
157017105|NCT04238247|566815204|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
157017106|NCT04238247|566815201|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
157017107|NCT04238247|566815202|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
157017108|NCT04238247|566815203|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
157017109|NCT04238247|566815204|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
157017110|NCT01711632|566815205|FG000|Overall Study|Adverse Event|4|||
157017111|NCT01711632|566815205|FG000|Overall Study|Death|3|||
157017112|NCT01711632|566815205|FG000|Overall Study|Lost to Follow-up|3|||
157017113|NCT01711632|566815205|FG000|Overall Study|Withdrawal by Subject|4|||
157017114|NCT01711632|566815205|FG000|Overall Study|Progressive disease|2|||
157017115|NCT01711632|566815205|FG000|Overall Study|No follow up required in re-treatment|3|||
157017116|NCT01711632|566815205|FG000|Overall Study|No follow up required in re-treatment|3|||
157017117|NCT03517969|566815206|FG000|Overall Study|Never started protocol treatment|3|||
157017118|NCT03517969|566815207|FG001|Overall Study|Never started protocol treatment|5|||
157017119|NCT03517969|566815206|FG000|Overall Study|Disease progression|11|||
157017120|NCT03517969|566815207|FG001|Overall Study|Disease progression|16|||
157017121|NCT03517969|566815206|FG000|Overall Study|PSA progression|8|||
157017122|NCT03517969|566815207|FG001|Overall Study|PSA progression|1|||
157017123|NCT03517969|566815206|FG000|Overall Study|Clinical progression|4|||
157017124|NCT03517969|566815207|FG001|Overall Study|Clinical progression|2|||
157017125|NCT03517969|566815206|FG000|Overall Study|Adverse Event|5|||
157017126|NCT03517969|566815207|FG001|Overall Study|Adverse Event|4|||
157017127|NCT03517969|566815206|FG000|Overall Study|Intercurrent illness|1|||
157017128|NCT03517969|566815207|FG001|Overall Study|Intercurrent illness|2|||
157017129|NCT03517969|566815206|FG000|Overall Study|Death|1|||
157017130|NCT03517969|566815207|FG001|Overall Study|Death|1|||
157017131|NCT03517969|566815206|FG000|Overall Study|Withdrawal by Subject|1|||
157017132|NCT03517969|566815207|FG001|Overall Study|Withdrawal by Subject|2|||
157017133|NCT03517969|566815206|FG000|Overall Study|Physician Decision|1|||
157017134|NCT03517969|566815207|FG001|Overall Study|Physician Decision|1|||
157017135|NCT03517969|566815206|FG000|Overall Study|No clinical benefit|1|||
157017136|NCT03517969|566815207|FG001|Overall Study|No clinical benefit|0|||
157017137|NCT03517969|566815206|FG000|Overall Study|Delayed treatment for dental treatment|1|||
157017138|NCT03517969|566815207|FG001|Overall Study|Delayed treatment for dental treatment|0|||
157017139|NCT03517969|566815206|FG000|Overall Study|Difficult to maintain appointment|0|||
157017140|NCT03517969|566815207|FG001|Overall Study|Difficult to maintain appointment|1|||
157017141|NCT03517969|566815206|FG000|Overall Study|Protocol Violation|0|||
157017142|NCT03517969|566815207|FG001|Overall Study|Protocol Violation|1|||
157017143|NCT02860130|566815208|FG000|Overall Study|Adverse Event|2|||
157017144|NCT02860130|566815209|FG001|Overall Study|Adverse Event|3|||
157017145|NCT02860130|566815208|FG000|Overall Study|Protocol Violation|1|||
157128565|NCT00927368|567221517|FG002|Overall Study|cancellation of surgery|2|||
157128566|NCT01482910|567221525|FG000|Overall Study|Adverse Event|6|||
157128567|NCT01482910|567221526|FG001|Overall Study|Adverse Event|5|||
157128568|NCT01482910|567221525|FG000|Overall Study|Lost to Follow-up|0|||
157128569|NCT01482910|567221526|FG001|Overall Study|Lost to Follow-up|1|||
157128570|NCT01482910|567221525|FG000|Overall Study|Protocol Violation|1|||
157128571|NCT01482910|567221526|FG001|Overall Study|Protocol Violation|1|||
157128572|NCT01482910|567221525|FG000|Overall Study|Withdrawal by Subject|7|||
156874315|NCT00481091|566298601|FG002|Overall Study|No reason given|1|||
156874316|NCT00481091|566298602|FG003|Overall Study|No reason given|1|||
156874317|NCT00481091|566298603|FG004|Overall Study|No reason given|1|||
156874318|NCT00481091|566298604|FG005|Overall Study|No reason given|0|||
156874319|NCT00481091|566298605|FG006|Overall Study|No reason given|1|||
156874320|NCT00481091|566298606|FG007|Overall Study|No reason given|1|||
156874321|NCT00481091|566298607|FG008|Overall Study|No reason given|1|||
156874322|NCT00481091|566298608|FG009|Overall Study|No reason given|4|||
157128573|NCT01482910|567221526|FG001|Overall Study|Withdrawal by Subject|2|||
157128574|NCT01482910|567221525|FG000|Overall Study|Death|1|||
157128575|NCT01482910|567221526|FG001|Overall Study|Death|0|||
157128576|NCT00331409|567221527|FG000|Overall Study|Lack of Efficacy|4|||
157128577|NCT03222349|567221530|FG000|Overall Study|Treatment B not done|5|||
157128578|NCT03222349|567221531|FG001|Overall Study|Treatment B not done|0|||
157128579|NCT03222349|567221530|FG000|Overall Study|Lost to Follow-up|1|||
157128580|NCT03222349|567221531|FG001|Overall Study|Lost to Follow-up|2|||
157128581|NCT03222349|567221530|FG000|Overall Study|Withdrawal by Subject|1|||
157128582|NCT03222349|567221531|FG001|Overall Study|Withdrawal by Subject|0|||
157128583|NCT03222349|567221530|FG000|Overall Study|Treatment A not done|0|||
157128584|NCT03222349|567221531|FG001|Overall Study|Treatment A not done|5|||
157128585|NCT03222349|567221530|FG000|Overall Study|Study terminated by sponsor|1|||
157128586|NCT03222349|567221531|FG001|Overall Study|Study terminated by sponsor|0|||
157128587|NCT03739528|567221534|FG000|Overall Study|Not treated|8|||
157128588|NCT03739528|567221535|FG001|Overall Study|Not treated|12|||
157128589|NCT03739528|567221534|FG000|Overall Study|Treatment and study discontinued|6|||
157128590|NCT03739528|567221535|FG001|Overall Study|Treatment and study discontinued|2|||
157128591|NCT03739528|567221534|FG000|Overall Study|Treatment discontinued + study completed|1|||
157128592|NCT03739528|567221535|FG001|Overall Study|Treatment discontinued + study completed|3|||
157128593|NCT01109940|567221538|FG000|Overall Study|Administrative problems|2|||
157128594|NCT01109940|567221539|FG001|Overall Study|Administrative problems|0|||
157128595|NCT01109940|567221540|FG002|Overall Study|Administrative problems|0|||
157128596|NCT01109940|567221541|FG003|Overall Study|Administrative problems|0|||
157128597|NCT01109940|567221538|FG000|Overall Study|Serious Adverse Event|2|||
157128598|NCT01109940|567221539|FG001|Overall Study|Serious Adverse Event|1|||
157128599|NCT01109940|567221540|FG002|Overall Study|Serious Adverse Event|0|||
157128600|NCT01109940|567221541|FG003|Overall Study|Serious Adverse Event|0|||
157128601|NCT01109940|567221538|FG000|Overall Study|Lost to Follow-up|1|||
157128602|NCT01109940|567221539|FG001|Overall Study|Lost to Follow-up|0|||
156714929|NCT02906670|565700823|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
156874323|NCT02881567|566298609|FG000|Overall Study|Adverse Event|1|||
156874324|NCT02881567|566298609|FG000|Overall Study|Lost to Follow-up|3|||
156714930|NCT02906670|565700824|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
156714931|NCT02906670|565700825|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
156874325|NCT02881567|566298609|FG000|Overall Study|Consent withdrawn|1|||
156874326|NCT02881567|566298609|FG000|Overall Study|Investigator decision|1|||
156874327|NCT02881567|566298609|FG000|Overall Study|Study terminated by sponsor|9|||
156874328|NCT02881567|566298609|FG000|Overall Study|Reason not Specified|3|||
156874329|NCT00373113|566298611|FG000|Overall Study|Death|1|||
156874330|NCT00373113|566298612|FG001|Overall Study|Death|7|||
156874331|NCT00373113|566298611|FG000|Overall Study|Adverse Event|38|||
156874332|NCT00373113|566298612|FG001|Overall Study|Adverse Event|24|||
156874333|NCT00373113|566298611|FG000|Overall Study|Study terminated by sponsor|9|||
156874334|NCT00373113|566298612|FG001|Overall Study|Study terminated by sponsor|1|||
156874335|NCT00373113|566298611|FG000|Overall Study|Global deterioration of health status|10|||
156874336|NCT00373113|566298612|FG001|Overall Study|Global deterioration of health status|7|||
156874337|NCT00373113|566298611|FG000|Overall Study|Lost to Follow-up|1|||
156874338|NCT00373113|566298612|FG001|Overall Study|Lost to Follow-up|3|||
156874339|NCT00373113|566298611|FG000|Overall Study|Objective progression or relapse|150|||
156874340|NCT00373113|566298612|FG001|Overall Study|Objective progression or relapse|169|||
156874341|NCT00373113|566298611|FG000|Overall Study|Other|14|||
156874342|NCT00373113|566298612|FG001|Overall Study|Other|17|||
156874343|NCT00373113|566298611|FG000|Overall Study|Protocol Violation|5|||
156874344|NCT00373113|566298612|FG001|Overall Study|Protocol Violation|1|||
156874345|NCT00373113|566298611|FG000|Overall Study|Withdrawal by Subject|10|||
156874346|NCT00373113|566298612|FG001|Overall Study|Withdrawal by Subject|15|||
156874347|NCT03275350|566298613|FG000|Overall Study|Lost to Follow-up|4|||
156874348|NCT03275350|566298614|FG001|Overall Study|Lost to Follow-up|6|||
157128603|NCT01109940|567221540|FG002|Overall Study|Lost to Follow-up|0|||
157128604|NCT01109940|567221541|FG003|Overall Study|Lost to Follow-up|0|||
157128605|NCT01109940|567221538|FG000|Overall Study|Patient withdrew consent|1|||
156874349|NCT03275350|566298613|FG000|Overall Study|Death|2|||
156874350|NCT03275350|566298614|FG001|Overall Study|Death|1|||
156874351|NCT03275350|566298613|FG000|Overall Study|Physician Decision|1|||
156874352|NCT03275350|566298614|FG001|Overall Study|Physician Decision|0|||
156874353|NCT03275350|566298613|FG000|Overall Study|Incarcerated|1|||
156874354|NCT03275350|566298614|FG001|Overall Study|Incarcerated|1|||
156874355|NCT04661579|566298618|FG000|Overall Study|Lost to Follow-up|19|||
156874356|NCT04661579|566298619|FG001|Overall Study|Lost to Follow-up|10|||
156874357|NCT04661579|566298620|FG002|Overall Study|Lost to Follow-up|2|||
156874358|NCT04661579|566298621|FG003|Overall Study|Lost to Follow-up|7|||
156874359|NCT04661579|566298622|FG004|Overall Study|Lost to Follow-up|11|||
156874360|NCT04661579|566298618|FG000|Overall Study|Physician Decision|2|||
156874361|NCT04661579|566298619|FG001|Overall Study|Physician Decision|0|||
156874362|NCT04661579|566298620|FG002|Overall Study|Physician Decision|0|||
156874363|NCT04661579|566298621|FG003|Overall Study|Physician Decision|1|||
156874364|NCT04661579|566298622|FG004|Overall Study|Physician Decision|0|||
156874365|NCT04661579|566298618|FG000|Overall Study|Withdrawal by Subject|1|||
156874366|NCT04661579|566298619|FG001|Overall Study|Withdrawal by Subject|4|||
156874367|NCT04661579|566298620|FG002|Overall Study|Withdrawal by Subject|0|||
156874368|NCT04661579|566298621|FG003|Overall Study|Withdrawal by Subject|2|||
156874369|NCT04661579|566298622|FG004|Overall Study|Withdrawal by Subject|0|||
156874370|NCT04661579|566298618|FG000|Overall Study|Death|1|||
156874371|NCT04661579|566298619|FG001|Overall Study|Death|0|||
156874372|NCT04661579|566298620|FG002|Overall Study|Death|0|||
156874373|NCT04661579|566298621|FG003|Overall Study|Death|0|||
156874374|NCT04661579|566298622|FG004|Overall Study|Death|0|||
156874375|NCT04661579|566298618|FG000|Overall Study|Other|1|||
156874376|NCT04661579|566298619|FG001|Overall Study|Other|2|||
156874377|NCT04661579|566298620|FG002|Overall Study|Other|1|||
156874378|NCT04661579|566298621|FG003|Overall Study|Other|1|||
156874379|NCT04661579|566298622|FG004|Overall Study|Other|1|||
156874380|NCT04661579|566298618|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
156874381|NCT04661579|566298619|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
156874382|NCT04661579|566298620|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
156874383|NCT04661579|566298621|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
156874384|NCT04661579|566298622|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
156874385|NCT03656562|566298623|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
156874386|NCT03656562|566298624|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
156874387|NCT03656562|566298625|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
156874388|NCT03656562|566298626|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
156874389|NCT03656562|566298623|FG000|Overall Study|Physician Decision|1|||
156874390|NCT03656562|566298624|FG001|Overall Study|Physician Decision|2|||
156874391|NCT03656562|566298625|FG002|Overall Study|Physician Decision|0|||
156874392|NCT03656562|566298626|FG003|Overall Study|Physician Decision|0|||
156874393|NCT03656562|566298623|FG000|Overall Study|Subject Decision|3|||
156874394|NCT03656562|566298624|FG001|Overall Study|Subject Decision|5|||
156874395|NCT03656562|566298625|FG002|Overall Study|Subject Decision|0|||
156874396|NCT03656562|566298626|FG003|Overall Study|Subject Decision|2|||
156874397|NCT04335136|566298627|FG000|Overall Study|Death|8|||
156874398|NCT04335136|566298628|FG001|Overall Study|Death|4|||
156874399|NCT04335136|566298627|FG000|Overall Study|Lost to Follow-up|2|||
156874400|NCT04335136|566298628|FG001|Overall Study|Lost to Follow-up|0|||
156874401|NCT04335136|566298627|FG000|Overall Study|Protocol Violation|1|||
157128606|NCT01109940|567221539|FG001|Overall Study|Patient withdrew consent|1|||
157128607|NCT01109940|567221540|FG002|Overall Study|Patient withdrew consent|0|||
157128608|NCT01109940|567221541|FG003|Overall Study|Patient withdrew consent|0|||
157128609|NCT01109940|567221538|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156874402|NCT04335136|566298628|FG001|Overall Study|Protocol Violation|0|||
157128610|NCT01109940|567221539|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157128611|NCT01109940|567221540|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
157128612|NCT01109940|567221541|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
157128613|NCT02769624|567221542|FG000|Overall Study|Lost to Follow-up|0|||
157128614|NCT02769624|567221543|FG001|Overall Study|Lost to Follow-up|1|||
157128615|NCT05099640|567221544|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
157128616|NCT05099640|567221545|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
157128617|NCT05099640|567221546|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
157128618|NCT05099640|567221544|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
157128619|NCT05099640|567221545|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
157128620|NCT05099640|567221546|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
157128621|NCT05099640|567221544|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
157216300|NCT01078623|567539244|FG006|Treatment Period 2|Adverse Event|1|||
156874403|NCT04335136|566298627|FG000|Overall Study|Withdrawal by Subject|1|||
156874404|NCT04335136|566298628|FG001|Overall Study|Withdrawal by Subject|1|||
156874405|NCT04335136|566298627|FG000|Overall Study|Health-threatening condition|0|||
156874406|NCT04335136|566298628|FG001|Overall Study|Health-threatening condition|1|||
156874407|NCT04335136|566298627|FG000|Overall Study|Adverse Event|0|||
157128622|NCT05099640|567221545|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
157128623|NCT05099640|567221546|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
157128624|NCT05099640|567221544|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
157128625|NCT05099640|567221545|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
157128626|NCT05099640|567221546|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
157128627|NCT05099640|567221544|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
157128628|NCT05099640|567221545|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
157128629|NCT05099640|567221546|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
157128630|NCT05099640|567221544|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
157128631|NCT05099640|567221545|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
157128632|NCT05099640|567221546|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
157128633|NCT00179959|567221547|FG000|Overall Study|Lost to Follow-up|3|||
157128634|NCT00179959|567221548|FG001|Overall Study|Lost to Follow-up|1|||
157128635|NCT00179959|567221547|FG000|Overall Study|Withdrawal by Subject|3|||
157128636|NCT00179959|567221548|FG001|Overall Study|Withdrawal by Subject|2|||
157128637|NCT01552681|567221549|FG000|Overall Study|Withdrawal by Subject|4|||
157128638|NCT01552681|567221550|FG001|Overall Study|Withdrawal by Subject|0|||
157128639|NCT01552681|567221549|FG000|Overall Study|Physician Decision|1|||
157128640|NCT01552681|567221550|FG001|Overall Study|Physician Decision|0|||
157128641|NCT01552681|567221549|FG000|Overall Study|Subject moved away|0|||
157128642|NCT01552681|567221550|FG001|Overall Study|Subject moved away|1|||
157128643|NCT03075163|567221551|FG000|Overall Study|not eligible for treatment limb|138|||
157128644|NCT03075163|567221552|FG001|Overall Study|not eligible for treatment limb|138|||
157128645|NCT01961544|567221553|FG000|Overall Study|Protocol Violation|1|||
157128646|NCT01961544|567221553|FG000|Overall Study|Withdrawal by Subject|7|||
157128647|NCT01961544|567221553|FG000|Overall Study|Adverse Event|1|||
157128648|NCT01961544|567221553|FG000|Overall Study|Physician Decision|2|||
157128649|NCT01961544|567221553|FG000|Overall Study|Poor Tolerance|1|||
157128650|NCT01961544|567221553|FG000|Overall Study|Aggravation of Steral Pain|1|||
157128651|NCT03665285|567221556|FG000|Overall Study|Started New Anticancer Treatment|1|||
157128652|NCT03665285|567221557|FG001|Overall Study|Started New Anticancer Treatment|1|||
157128653|NCT03665285|567221558|FG002|Overall Study|Started New Anticancer Treatment|2|||
157128654|NCT03665285|567221559|FG003|Overall Study|Started New Anticancer Treatment|4|||
157128655|NCT03665285|567221560|FG004|Overall Study|Started New Anticancer Treatment|1|||
157128656|NCT03665285|567221561|FG005|Overall Study|Started New Anticancer Treatment|1|||
157128657|NCT03665285|567221562|FG006|Overall Study|Started New Anticancer Treatment|2|||
157128658|NCT03665285|567221563|FG007|Overall Study|Started New Anticancer Treatment|15|||
157128659|NCT03665285|567221564|FG008|Overall Study|Started New Anticancer Treatment|1|||
157128660|NCT03665285|567221556|FG000|Overall Study|Disease Progression|0|||
157128661|NCT03665285|567221557|FG001|Overall Study|Disease Progression|0|||
157128662|NCT03665285|567221558|FG002|Overall Study|Disease Progression|3|||
157128663|NCT03665285|567221559|FG003|Overall Study|Disease Progression|1|||
157128664|NCT03665285|567221560|FG004|Overall Study|Disease Progression|0|||
157128665|NCT03665285|567221561|FG005|Overall Study|Disease Progression|0|||
157128666|NCT03665285|567221562|FG006|Overall Study|Disease Progression|0|||
156874408|NCT04335136|566298628|FG001|Overall Study|Adverse Event|1|||
156874409|NCT04335136|566298627|FG000|Overall Study|Erroneously randomized|2|||
156874410|NCT04335136|566298628|FG001|Overall Study|Erroneously randomized|0|||
156874411|NCT01396447|566298629|FG000|Overall Study|Did Not Receive Treatment|3|||
156874412|NCT01396447|566298630|FG001|Overall Study|Did Not Receive Treatment|2|||
156874413|NCT01396447|566298631|FG002|Overall Study|Did Not Receive Treatment|1|||
156874414|NCT01396447|566298632|FG003|Overall Study|Did Not Receive Treatment|0|||
156874415|NCT01396447|566298629|FG000|Overall Study|Adverse Event|15|||
156874416|NCT01396447|566298630|FG001|Overall Study|Adverse Event|12|||
156874417|NCT01396447|566298631|FG002|Overall Study|Adverse Event|12|||
156874418|NCT01396447|566298632|FG003|Overall Study|Adverse Event|17|||
156874419|NCT01396447|566298629|FG000|Overall Study|Insufficient Therapeutic Response|5|||
156874420|NCT01396447|566298630|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156874421|NCT01396447|566298631|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156874422|NCT01396447|566298632|FG003|Overall Study|Insufficient Therapeutic Response|4|||
156874423|NCT01396447|566298629|FG000|Overall Study|Protocol Violation|5|||
156874424|NCT01396447|566298630|FG001|Overall Study|Protocol Violation|2|||
157128667|NCT03665285|567221563|FG007|Overall Study|Disease Progression|7|||
157128668|NCT03665285|567221564|FG008|Overall Study|Disease Progression|1|||
157128669|NCT03665285|567221556|FG000|Overall Study|Hospice|0|||
157128670|NCT03665285|567221557|FG001|Overall Study|Hospice|0|||
157128671|NCT03665285|567221558|FG002|Overall Study|Hospice|0|||
157128672|NCT03665285|567221559|FG003|Overall Study|Hospice|0|||
157128673|NCT03665285|567221560|FG004|Overall Study|Hospice|0|||
157128674|NCT03665285|567221561|FG005|Overall Study|Hospice|0|||
157128675|NCT03665285|567221562|FG006|Overall Study|Hospice|0|||
157128676|NCT03665285|567221563|FG007|Overall Study|Hospice|2|||
156714932|NCT02906670|565700826|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
156874425|NCT01396447|566298631|FG002|Overall Study|Protocol Violation|3|||
156874426|NCT01396447|566298632|FG003|Overall Study|Protocol Violation|7|||
156874427|NCT01396447|566298629|FG000|Overall Study|Withdrawal of Consent|11|||
157017146|NCT02860130|566815209|FG001|Overall Study|Protocol Violation|1|||
157017147|NCT02860130|566815208|FG000|Overall Study|Withdrawal by Subject|0|||
157017148|NCT02860130|566815209|FG001|Overall Study|Withdrawal by Subject|2|||
157017149|NCT02860130|566815208|FG000|Overall Study|Physician Decision|2|||
157017150|NCT02860130|566815209|FG001|Overall Study|Physician Decision|2|||
157017151|NCT02860130|566815208|FG000|Overall Study|Other|2|||
157128677|NCT03665285|567221564|FG008|Overall Study|Hospice|0|||
157128678|NCT03665285|567221556|FG000|Overall Study|Withdrawal by Subject|0|||
157128679|NCT03665285|567221557|FG001|Overall Study|Withdrawal by Subject|0|||
157128680|NCT03665285|567221558|FG002|Overall Study|Withdrawal by Subject|0|||
157128681|NCT03665285|567221559|FG003|Overall Study|Withdrawal by Subject|0|||
157128682|NCT03665285|567221560|FG004|Overall Study|Withdrawal by Subject|1|||
157128683|NCT03665285|567221561|FG005|Overall Study|Withdrawal by Subject|0|||
157128684|NCT03665285|567221562|FG006|Overall Study|Withdrawal by Subject|0|||
157128685|NCT03665285|567221563|FG007|Overall Study|Withdrawal by Subject|2|||
157128686|NCT03665285|567221564|FG008|Overall Study|Withdrawal by Subject|0|||
157128687|NCT03665285|567221556|FG000|Overall Study|Physician Decision|0|||
157128688|NCT03665285|567221557|FG001|Overall Study|Physician Decision|0|||
157128689|NCT03665285|567221558|FG002|Overall Study|Physician Decision|0|||
157128690|NCT03665285|567221559|FG003|Overall Study|Physician Decision|0|||
157128691|NCT03665285|567221560|FG004|Overall Study|Physician Decision|0|||
157128692|NCT03665285|567221561|FG005|Overall Study|Physician Decision|0|||
157128693|NCT03665285|567221562|FG006|Overall Study|Physician Decision|0|||
157128694|NCT03665285|567221563|FG007|Overall Study|Physician Decision|2|||
157128695|NCT03665285|567221564|FG008|Overall Study|Physician Decision|0|||
157128696|NCT03543410|567221565|FG000|Overall Study|Adverse Event|10|||
157128697|NCT03543410|567221566|FG001|Overall Study|Adverse Event|8|||
157128698|NCT03543410|567221567|FG002|Overall Study|Adverse Event|2|||
157128699|NCT03543410|567221565|FG000|Overall Study|Lack of Efficacy|0|||
157128700|NCT03543410|567221566|FG001|Overall Study|Lack of Efficacy|1|||
157128701|NCT03543410|567221567|FG002|Overall Study|Lack of Efficacy|0|||
157128702|NCT03543410|567221565|FG000|Overall Study|Lost to Follow-up|0|||
157128703|NCT03543410|567221566|FG001|Overall Study|Lost to Follow-up|1|||
157128704|NCT03543410|567221567|FG002|Overall Study|Lost to Follow-up|0|||
157128705|NCT03543410|567221565|FG000|Overall Study|Withdrawal by Subject|5|||
157128706|NCT03543410|567221566|FG001|Overall Study|Withdrawal by Subject|2|||
157128707|NCT03543410|567221567|FG002|Overall Study|Withdrawal by Subject|8|||
157128708|NCT03543410|567221565|FG000|Overall Study|Protocol Violation|0|||
157128709|NCT03543410|567221566|FG001|Overall Study|Protocol Violation|1|||
157128710|NCT03543410|567221567|FG002|Overall Study|Protocol Violation|0|||
157128711|NCT03543410|567221565|FG000|Overall Study|Due to COVID-19|4|||
157216301|NCT01078623|567539245|FG007|Treatment Period 2|Adverse Event|0|||
157216302|NCT01078623|567539246|FG008|Treatment Period 2|Adverse Event|0|||
157216303|NCT01078623|567539247|FG009|Treatment Period 2|Adverse Event|0|||
156792798|NCT03829683|565994756|FG000|Overall Study|Physician Decision|3|||
157017152|NCT02860130|566815209|FG001|Overall Study|Other|1|||
157017153|NCT02140645|566815212|FG000|Overall Study|Not linked|5489|||
157017154|NCT02140645|566815213|FG001|Overall Study|Not linked|61654|||
157017155|NCT02140645|566815214|FG002|Overall Study|Not linked|4236|||
157017156|NCT02140645|566815215|FG003|Overall Study|Not linked|13833|||
157128712|NCT03543410|567221566|FG001|Overall Study|Due to COVID-19|0|||
157128713|NCT03543410|567221567|FG002|Overall Study|Due to COVID-19|2|||
157128714|NCT03543410|567221565|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
157128715|NCT03543410|567221566|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
157128716|NCT03543410|567221567|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
157128717|NCT03543410|567221565|FG000|Overall Study|Not Due to COVID-19|2|||
157128718|NCT03543410|567221566|FG001|Overall Study|Not Due to COVID-19|0|||
157128719|NCT03543410|567221567|FG002|Overall Study|Not Due to COVID-19|1|||
157128720|NCT02211261|567221568|FG000|Overall Study|Withdrawal by Subject|0|||
157128721|NCT02211261|567221569|FG001|Overall Study|Withdrawal by Subject|0|||
157128722|NCT02211261|567221570|FG002|Overall Study|Withdrawal by Subject|1|||
157128723|NCT02211261|567221571|FG003|Overall Study|Withdrawal by Subject|0|||
157128724|NCT02211261|567221572|FG004|Overall Study|Withdrawal by Subject|2|||
157128725|NCT02211261|567221573|FG005|Overall Study|Withdrawal by Subject|0|||
157128726|NCT02211261|567221574|FG006|Overall Study|Withdrawal by Subject|0|||
157128727|NCT02211261|567221575|FG007|Overall Study|Withdrawal by Subject|0|||
157128728|NCT02211261|567221576|FG008|Overall Study|Withdrawal by Subject|0|||
157128729|NCT02211261|567221577|FG009|Overall Study|Withdrawal by Subject|0|||
157128730|NCT02211261|567221578|FG010|Overall Study|Withdrawal by Subject|0|||
157216304|NCT01078623|567539248|FG010|Treatment Period 2|Adverse Event|0|||
156792799|NCT03829683|565994757|FG001|Overall Study|Physician Decision|1|||
156792800|NCT03829683|565994756|FG000|Overall Study|Withdrawal by Subject|0|||
156792801|NCT03829683|565994757|FG001|Overall Study|Withdrawal by Subject|1|||
156792802|NCT03829683|565994756|FG000|Overall Study|Discharge from hospital|1|||
156792803|NCT03829683|565994757|FG001|Overall Study|Discharge from hospital|0|||
156792804|NCT04629521|565994766|FG000|Overall Study|Death|1|||
156792805|NCT04629521|565994766|FG000|Overall Study|Lost to Follow-up|3|||
156792806|NCT04629521|565994766|FG000|Overall Study|Subject withdrew consent|3|||
156792807|NCT04629521|565994766|FG000|Overall Study|Enrolled in error|1|||
156792808|NCT03163667|565994767|FG000|Overall Study|Death|15|||
156792809|NCT03163667|565994768|FG001|Overall Study|Death|27|||
156792810|NCT03163667|565994767|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
156792811|NCT03163667|565994768|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
156792812|NCT01335685|565994769|FG000|Overall Study|Study Terminated by Sponsor|2|||
157017157|NCT02140645|566815216|FG004|Overall Study|Not linked|3286|||
157017158|NCT02140645|566815217|FG005|Overall Study|Not linked|70896|||
157017159|NCT02794480|566815218|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
157017160|NCT02794480|566815219|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
157017161|NCT02794480|566815220|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
157017162|NCT02794480|566815221|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
157017163|NCT02794480|566815218|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
157017164|NCT02794480|566815219|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
157017165|NCT02794480|566815220|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
157017166|NCT02794480|566815221|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
157017167|NCT02794480|566815218|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157017168|NCT02794480|566815219|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157017169|NCT02794480|566815220|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157017170|NCT02794480|566815221|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
157017171|NCT02794480|566815218|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157017172|NCT02794480|566815219|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
157017173|NCT02794480|566815220|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157017174|NCT02794480|566815221|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
157017175|NCT02794480|566815218|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
157017176|NCT02794480|566815219|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157017177|NCT02794480|566815220|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157017178|NCT02794480|566815221|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
157017179|NCT00593489|566815222|FG000|Allocation|did not attend workshop; allocation not|2|||
157017180|NCT00593489|566815223|FG001|Allocation|did not attend workshop; allocation not|1|||
157017181|NCT01747486|566815227|FG000|Stage 1|Physician Decision|3|||
157017182|NCT01747486|566815228|FG001|Stage 1|Physician Decision|0|||
157017183|NCT01747486|566815227|FG000|Stage 1|Withdrawal by Subject|4|||
157017184|NCT01747486|566815228|FG001|Stage 1|Withdrawal by Subject|3|||
157017185|NCT01747486|566815227|FG000|Stage 1|Disease progression|4|||
157017186|NCT01747486|566815228|FG001|Stage 1|Disease progression|9|||
157017187|NCT01747486|566815227|FG000|Stage 1|Death|1|||
157017188|NCT01747486|566815228|FG001|Stage 1|Death|1|||
157017189|NCT01747486|566815227|FG000|Stage 2|Physician Decision|2|||
157017190|NCT01747486|566815228|FG001|Stage 2|Physician Decision|0|||
157017191|NCT01747486|566815227|FG000|Stage 2|Withdrawal by Subject|1|||
157017192|NCT01747486|566815228|FG001|Stage 2|Withdrawal by Subject|0|||
157017193|NCT01747486|566815227|FG000|Stage 2|New Cancer Therapy|3|||
157017194|NCT01747486|566815228|FG001|Stage 2|New Cancer Therapy|0|||
157017195|NCT01747486|566815227|FG000|Stage 2|Disease Progression|3|||
157017196|NCT01747486|566815228|FG001|Stage 2|Disease Progression|0|||
157017197|NCT00632749|566815229|FG000|Overall Study|Progressive disease|3|||
157017198|NCT00632749|566815230|FG001|Overall Study|Progressive disease|2|||
157017199|NCT00632749|566815231|FG002|Overall Study|Progressive disease|2|||
157017200|NCT00632749|566815232|FG003|Overall Study|Progressive disease|2|||
157017201|NCT00632749|566815233|FG004|Overall Study|Progressive disease|4|||
157017202|NCT00632749|566815234|FG005|Overall Study|Progressive disease|4|||
157017203|NCT00632749|566815235|FG006|Overall Study|Progressive disease|3|||
157017204|NCT00632749|566815236|FG007|Overall Study|Progressive disease|2|||
157017205|NCT00632749|566815237|FG008|Overall Study|Progressive disease|3|||
157017206|NCT00632749|566815238|FG009|Overall Study|Progressive disease|2|||
157017207|NCT00632749|566815239|FG010|Overall Study|Progressive disease|4|||
157017208|NCT00632749|566815240|FG011|Overall Study|Progressive disease|3|||
157017209|NCT00632749|566815241|FG012|Overall Study|Progressive disease|2|||
157017210|NCT00632749|566815242|FG013|Overall Study|Progressive disease|4|||
157017211|NCT00632749|566815229|FG000|Overall Study|Other Adverse event|1|||
157017212|NCT00632749|566815230|FG001|Overall Study|Other Adverse event|1|||
157017213|NCT00632749|566815231|FG002|Overall Study|Other Adverse event|1|||
157017214|NCT00632749|566815232|FG003|Overall Study|Other Adverse event|1|||
157017215|NCT00632749|566815233|FG004|Overall Study|Other Adverse event|2|||
157017216|NCT00632749|566815234|FG005|Overall Study|Other Adverse event|4|||
157017217|NCT00632749|566815235|FG006|Overall Study|Other Adverse event|1|||
157017218|NCT00632749|566815236|FG007|Overall Study|Other Adverse event|2|||
157017219|NCT00632749|566815237|FG008|Overall Study|Other Adverse event|2|||
157017220|NCT00632749|566815238|FG009|Overall Study|Other Adverse event|0|||
157017221|NCT00632749|566815239|FG010|Overall Study|Other Adverse event|1|||
157017222|NCT00632749|566815240|FG011|Overall Study|Other Adverse event|0|||
157017223|NCT00632749|566815241|FG012|Overall Study|Other Adverse event|1|||
157017224|NCT00632749|566815242|FG013|Overall Study|Other Adverse event|0|||
157017225|NCT00632749|566815229|FG000|Overall Study|Refuse to continue medication|0|||
157017226|NCT00632749|566815230|FG001|Overall Study|Refuse to continue medication|0|||
157017227|NCT00632749|566815231|FG002|Overall Study|Refuse to continue medication|0|||
157017228|NCT00632749|566815232|FG003|Overall Study|Refuse to continue medication|1|||
157017229|NCT00632749|566815233|FG004|Overall Study|Refuse to continue medication|0|||
157017230|NCT00632749|566815234|FG005|Overall Study|Refuse to continue medication|0|||
157017231|NCT00632749|566815235|FG006|Overall Study|Refuse to continue medication|0|||
157017232|NCT00632749|566815236|FG007|Overall Study|Refuse to continue medication|0|||
157017233|NCT00632749|566815237|FG008|Overall Study|Refuse to continue medication|0|||
157017234|NCT00632749|566815238|FG009|Overall Study|Refuse to continue medication|1|||
157017235|NCT00632749|566815239|FG010|Overall Study|Refuse to continue medication|0|||
157017236|NCT00632749|566815240|FG011|Overall Study|Refuse to continue medication|0|||
157017237|NCT00632749|566815241|FG012|Overall Study|Refuse to continue medication|0|||
157017238|NCT00632749|566815242|FG013|Overall Study|Refuse to continue medication|0|||
157017239|NCT00632749|566815229|FG000|Overall Study|Reason other than those specified above|0|||
157017240|NCT00632749|566815230|FG001|Overall Study|Reason other than those specified above|2|||
157017241|NCT00632749|566815231|FG002|Overall Study|Reason other than those specified above|0|||
157017242|NCT00632749|566815232|FG003|Overall Study|Reason other than those specified above|0|||
157017243|NCT00632749|566815233|FG004|Overall Study|Reason other than those specified above|1|||
157017244|NCT00632749|566815234|FG005|Overall Study|Reason other than those specified above|0|||
157017245|NCT00632749|566815235|FG006|Overall Study|Reason other than those specified above|1|||
157017246|NCT00632749|566815236|FG007|Overall Study|Reason other than those specified above|0|||
157017247|NCT00632749|566815237|FG008|Overall Study|Reason other than those specified above|0|||
157017248|NCT00632749|566815238|FG009|Overall Study|Reason other than those specified above|0|||
157017249|NCT00632749|566815239|FG010|Overall Study|Reason other than those specified above|2|||
157017250|NCT00632749|566815240|FG011|Overall Study|Reason other than those specified above|1|||
157017251|NCT00632749|566815241|FG012|Overall Study|Reason other than those specified above|0|||
157017252|NCT00632749|566815242|FG013|Overall Study|Reason other than those specified above|2|||
157017253|NCT00611559|566815243|FG000|Overall Study|Lost to Follow-up|0|||
157017254|NCT00611559|566815244|FG001|Overall Study|Lost to Follow-up|1|||
157017255|NCT00611559|566815245|FG002|Overall Study|Lost to Follow-up|0|||
157017256|NCT00611559|566815243|FG000|Overall Study|Protocol Violation|1|||
157017257|NCT00611559|566815244|FG001|Overall Study|Protocol Violation|0|||
157017258|NCT00611559|566815245|FG002|Overall Study|Protocol Violation|1|||
157017259|NCT04999592|566815246|FG000|Overall Study|Withdrawal by Subject|1|||
157017260|NCT04999592|566815247|FG001|Overall Study|Withdrawal by Subject|0|||
157017261|NCT00879333|566815248|FG000|Overall Study|Adverse Event|94|||
157128731|NCT02211261|567221568|FG000|Overall Study|Other|0|||
156874428|NCT01396447|566298630|FG001|Overall Study|Withdrawal of Consent|9|||
156874429|NCT01396447|566298631|FG002|Overall Study|Withdrawal of Consent|4|||
156874430|NCT01396447|566298632|FG003|Overall Study|Withdrawal of Consent|15|||
156874431|NCT01396447|566298629|FG000|Overall Study|Lost to Follow-up|4|||
156874432|NCT01396447|566298630|FG001|Overall Study|Lost to Follow-up|8|||
156874433|NCT01396447|566298631|FG002|Overall Study|Lost to Follow-up|7|||
156874434|NCT01396447|566298632|FG003|Overall Study|Lost to Follow-up|9|||
156874435|NCT01396447|566298629|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156874436|NCT01396447|566298630|FG001|Overall Study|Other Miscellaneous Reasons|2|||
156874437|NCT01396447|566298631|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156874438|NCT01396447|566298632|FG003|Overall Study|Other Miscellaneous Reasons|0|||
156874439|NCT01402102|566298634|FG000|Overall Study|Protocol Violation|1|||
156874440|NCT01402102|566298635|FG001|Overall Study|Protocol Violation|0|||
156874441|NCT01402102|566298634|FG000|Overall Study|Insufficiency of compliance|1|||
156874442|NCT01402102|566298635|FG001|Overall Study|Insufficiency of compliance|1|||
156874443|NCT01402102|566298634|FG000|Overall Study|Withdrawal by Subject|0|||
156874444|NCT01402102|566298635|FG001|Overall Study|Withdrawal by Subject|2|||
156874445|NCT00905645|566298636|FG000|Overall Study|Death (not device related)|10|||
156874446|NCT00905645|566298637|FG001|Overall Study|Death (not device related)|4|||
157128732|NCT02211261|567221569|FG001|Overall Study|Other|0|||
157128733|NCT02211261|567221570|FG002|Overall Study|Other|0|||
157128734|NCT02211261|567221571|FG003|Overall Study|Other|0|||
157128735|NCT02211261|567221572|FG004|Overall Study|Other|0|||
157128736|NCT02211261|567221573|FG005|Overall Study|Other|1|||
157128737|NCT02211261|567221574|FG006|Overall Study|Other|0|||
156874447|NCT00905645|566298638|FG002|Overall Study|Death (not device related)|15|||
156874448|NCT00905645|566298639|FG003|Overall Study|Death (not device related)|8|||
157017262|NCT00879333|566815249|FG001|Overall Study|Adverse Event|34|||
157017263|NCT00879333|566815248|FG000|Overall Study|Abnormal Laboratory Value|1|||
157017264|NCT00879333|566815249|FG001|Overall Study|Abnormal Laboratory Value|0|||
157017265|NCT00879333|566815248|FG000|Overall Study|Withdrawal by Subject|20|||
157128738|NCT02211261|567221575|FG007|Overall Study|Other|0|||
157017266|NCT00879333|566815249|FG001|Overall Study|Withdrawal by Subject|7|||
157017267|NCT00879333|566815248|FG000|Overall Study|Lost to Follow-up|2|||
156874449|NCT00905645|566298636|FG000|Overall Study|Explantation of study device(s)|78|||
156874450|NCT00905645|566298637|FG001|Overall Study|Explantation of study device(s)|47|||
157017268|NCT00879333|566815249|FG001|Overall Study|Lost to Follow-up|1|||
157128739|NCT02211261|567221576|FG008|Overall Study|Other|0|||
157128740|NCT02211261|567221577|FG009|Overall Study|Other|2|||
157128741|NCT02211261|567221578|FG010|Overall Study|Other|0|||
157128742|NCT02211261|567221568|FG000|Overall Study|Lost to Follow-up|0|||
157128743|NCT02211261|567221569|FG001|Overall Study|Lost to Follow-up|0|||
157128744|NCT02211261|567221570|FG002|Overall Study|Lost to Follow-up|0|||
157128745|NCT02211261|567221571|FG003|Overall Study|Lost to Follow-up|0|||
157128746|NCT02211261|567221572|FG004|Overall Study|Lost to Follow-up|0|||
157128747|NCT02211261|567221573|FG005|Overall Study|Lost to Follow-up|0|||
157128748|NCT02211261|567221574|FG006|Overall Study|Lost to Follow-up|0|||
157128749|NCT02211261|567221575|FG007|Overall Study|Lost to Follow-up|1|||
157128750|NCT02211261|567221576|FG008|Overall Study|Lost to Follow-up|0|||
157128751|NCT02211261|567221577|FG009|Overall Study|Lost to Follow-up|0|||
157128752|NCT02211261|567221578|FG010|Overall Study|Lost to Follow-up|0|||
157128753|NCT00480857|567221579|FG000|Overall Study|Lack of Efficacy|2|||
157128754|NCT02175680|567221588|FG000|Overall Study|non-compliance|1|||
157128755|NCT02175680|567221588|FG000|Overall Study|other non-medical reason|1|||
157128756|NCT01116544|567221592|FG000|Overall Study|Protocol Violation|1|||
157128757|NCT01116544|567221593|FG001|Overall Study|Protocol Violation|0|||
157128758|NCT01116544|567221592|FG000|Overall Study|Withdrawal by Subject|1|||
157128759|NCT01116544|567221593|FG001|Overall Study|Withdrawal by Subject|1|||
157128760|NCT02419508|567221594|FG000|Overall Study|Adverse Event|9|||
157128761|NCT02419508|567221595|FG001|Overall Study|Adverse Event|3|||
157128762|NCT02419508|567221594|FG000|Overall Study|Withdrawal by Subject|1|||
157128763|NCT02419508|567221595|FG001|Overall Study|Withdrawal by Subject|0|||
157128764|NCT02419508|567221594|FG000|Overall Study|Other - Reason not specified|0|||
157128765|NCT02419508|567221595|FG001|Overall Study|Other - Reason not specified|1|||
157128766|NCT01738971|567221604|FG000|Overall Study|Lost to Follow-up|19|||
157128767|NCT01738971|567221605|FG001|Overall Study|Lost to Follow-up|30|||
157128768|NCT01738971|567221606|FG002|Overall Study|Lost to Follow-up|17|||
157128769|NCT00670007|567223854|FG000|Overall Study|Drug abuse|1|||
157128770|NCT00670007|567223854|FG000|Overall Study|Lung transplant|1|||
157128771|NCT00670007|567223854|FG000|Overall Study|Travel/Vacation|1|||
157128772|NCT00670007|567223854|FG000|Overall Study|Adverse event, serious fatal|1|||
157128773|NCT00670007|567223854|FG000|Overall Study|Adverse Event|1|||
157128774|NCT00670007|567223854|FG000|Overall Study|Withdrawal by Subject|4|||
157128775|NCT00925600|567223855|FG000|Overall Study|Withdrawal by Subject|16|||
157128776|NCT00925600|567223856|FG001|Overall Study|Withdrawal by Subject|14|||
157128777|NCT00925600|567223855|FG000|Overall Study|Death|4|||
157128778|NCT00925600|567223856|FG001|Overall Study|Death|3|||
157128779|NCT00925600|567223855|FG000|Overall Study|Lost to Follow-up|2|||
157128780|NCT00925600|567223856|FG001|Overall Study|Lost to Follow-up|2|||
157128781|NCT00925600|567223855|FG000|Overall Study|Disease Progression|1|||
157128782|NCT00925600|567223856|FG001|Overall Study|Disease Progression|3|||
157128783|NCT00925600|567223855|FG000|Overall Study|Administrative Decision|1|||
157128784|NCT00925600|567223856|FG001|Overall Study|Administrative Decision|1|||
157128785|NCT00925600|567223855|FG000|Overall Study|Noncompliance|2|||
157128786|NCT00925600|567223856|FG001|Overall Study|Noncompliance|0|||
157128787|NCT00925600|567223855|FG000|Overall Study|Ineligibility Determined|2|||
157128788|NCT00925600|567223856|FG001|Overall Study|Ineligibility Determined|0|||
157128789|NCT00925600|567223855|FG000|Overall Study|Protocol Deviation|0|||
157128790|NCT00925600|567223856|FG001|Overall Study|Protocol Deviation|1|||
157128791|NCT00925600|567223855|FG000|Overall Study|Requirement for Alternative Therapy|0|||
157128792|NCT00925600|567223856|FG001|Overall Study|Requirement for Alternative Therapy|1|||
156714933|NCT02906670|565700827|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
156808774|NCT03801928|566054463|FG004|Overall Study|Adverse Event|0|||
156808775|NCT03801928|566054464|FG005|Overall Study|Adverse Event|2|||
156808776|NCT03801928|566054459|FG000|Overall Study|Lack of Efficacy|0|||
156808777|NCT03801928|566054460|FG001|Overall Study|Lack of Efficacy|0|||
156808778|NCT03801928|566054461|FG002|Overall Study|Lack of Efficacy|1|||
156808779|NCT03801928|566054462|FG003|Overall Study|Lack of Efficacy|0|||
156808780|NCT03801928|566054463|FG004|Overall Study|Lack of Efficacy|0|||
156808781|NCT03801928|566054464|FG005|Overall Study|Lack of Efficacy|0|||
156808782|NCT03801928|566054459|FG000|Overall Study|Lost to Follow-up|5|||
156808783|NCT03801928|566054460|FG001|Overall Study|Lost to Follow-up|1|||
156808784|NCT03801928|566054461|FG002|Overall Study|Lost to Follow-up|1|||
156808785|NCT03801928|566054462|FG003|Overall Study|Lost to Follow-up|4|||
156808786|NCT03801928|566054463|FG004|Overall Study|Lost to Follow-up|4|||
156808787|NCT03801928|566054464|FG005|Overall Study|Lost to Follow-up|2|||
156808788|NCT03801928|566054459|FG000|Overall Study|Withdrawal by Subject|0|||
156808789|NCT03801928|566054460|FG001|Overall Study|Withdrawal by Subject|0|||
156808790|NCT03801928|566054461|FG002|Overall Study|Withdrawal by Subject|2|||
156808791|NCT03801928|566054462|FG003|Overall Study|Withdrawal by Subject|1|||
156808792|NCT03801928|566054463|FG004|Overall Study|Withdrawal by Subject|0|||
156808793|NCT03801928|566054464|FG005|Overall Study|Withdrawal by Subject|0|||
156808794|NCT03801928|566054459|FG000|Overall Study|Other|0|||
156808795|NCT03801928|566054460|FG001|Overall Study|Other|2|||
156808796|NCT03801928|566054461|FG002|Overall Study|Other|0|||
156808797|NCT03801928|566054462|FG003|Overall Study|Other|1|||
156808798|NCT03801928|566054463|FG004|Overall Study|Other|0|||
156808799|NCT03801928|566054464|FG005|Overall Study|Other|1|||
156874451|NCT00905645|566298638|FG002|Overall Study|Explantation of study device(s)|28|||
156874452|NCT00905645|566298639|FG003|Overall Study|Explantation of study device(s)|21|||
156874453|NCT00905645|566298636|FG000|Overall Study|Subject Request|41|||
156874454|NCT00905645|566298637|FG001|Overall Study|Subject Request|17|||
156874455|NCT00905645|566298638|FG002|Overall Study|Subject Request|13|||
156874456|NCT00905645|566298639|FG003|Overall Study|Subject Request|11|||
156874457|NCT00905645|566298636|FG000|Overall Study|Lost to Follow-up|299|||
156874458|NCT00905645|566298637|FG001|Overall Study|Lost to Follow-up|103|||
156874459|NCT00905645|566298638|FG002|Overall Study|Lost to Follow-up|51|||
156874460|NCT00905645|566298639|FG003|Overall Study|Lost to Follow-up|12|||
156874461|NCT01386970|566298640|FG000|Overall Study|Withdrawal by Subject|0|||
156874462|NCT01386970|566298641|FG001|Overall Study|Withdrawal by Subject|1|||
156874463|NCT01386970|566298640|FG000|Overall Study|Adverse Event|4|||
156874464|NCT01386970|566298641|FG001|Overall Study|Adverse Event|1|||
156874465|NCT04881942|566298643|FG000|Overall Study|Adverse Event|0|||
156874466|NCT04881942|566298644|FG001|Overall Study|Adverse Event|0|||
156874467|NCT04881942|566298645|FG002|Overall Study|Adverse Event|0|||
156874468|NCT04881942|566298646|FG003|Overall Study|Adverse Event|0|||
156874469|NCT04881942|566298647|FG004|Overall Study|Adverse Event|1|||
156874470|NCT04881942|566298643|FG000|Overall Study|Alternates|0|||
156874471|NCT04881942|566298644|FG001|Overall Study|Alternates|0|||
156874472|NCT04881942|566298645|FG002|Overall Study|Alternates|0|||
156874473|NCT04881942|566298646|FG003|Overall Study|Alternates|0|||
156874474|NCT04881942|566298647|FG004|Overall Study|Alternates|2|||
156874475|NCT02423902|566298648|FG000|Overall Study|Disease progression|1|||
156874476|NCT02423902|566298649|FG001|Overall Study|Disease progression|4|||
156874477|NCT02136069|566298650|FG000|Overall Study|UC flare-up|1|||
156874478|NCT02136069|566298651|FG001|Overall Study|UC flare-up|0|||
156874479|NCT02136069|566298650|FG000|Overall Study|Adverse Event|6|||
156874480|NCT02136069|566298651|FG001|Overall Study|Adverse Event|8|||
156874481|NCT02136069|566298650|FG000|Overall Study|Death|0|||
156874482|NCT02136069|566298651|FG001|Overall Study|Death|1|||
156874483|NCT02136069|566298650|FG000|Overall Study|Lack of Efficacy|10|||
156874484|NCT02136069|566298651|FG001|Overall Study|Lack of Efficacy|4|||
156874485|NCT02136069|566298650|FG000|Overall Study|Lost to Follow-up|1|||
156874486|NCT02136069|566298651|FG001|Overall Study|Lost to Follow-up|0|||
156874487|NCT02136069|566298650|FG000|Overall Study|Non-Compliance|1|||
156874488|NCT02136069|566298651|FG001|Overall Study|Non-Compliance|0|||
156874489|NCT02136069|566298650|FG000|Overall Study|Physician Decision|5|||
156874490|NCT02136069|566298651|FG001|Overall Study|Physician Decision|4|||
156874491|NCT02136069|566298650|FG000|Overall Study|Withdrawal by Subject|10|||
156874492|NCT02136069|566298651|FG001|Overall Study|Withdrawal by Subject|11|||
156874493|NCT04838626|566298652|FG000|Overall Study|Adverse Event|2|||
156874494|NCT04838626|566298652|FG000|Overall Study|Physician Decision|6|||
156874495|NCT04838626|566298652|FG000|Overall Study|Protocol Violation|3|||
156874496|NCT04838626|566298652|FG000|Overall Study|Withdrawal by Subject|9|||
156874497|NCT04838626|566298652|FG000|Overall Study|Technical Problems|2|||
156874498|NCT00578292|566298655|FG000|Overall Study|Death|1|||
156874499|NCT00578292|566298655|FG000|Overall Study|Graft failure|2|||
156874500|NCT01026324|566298656|FG000|Follow up/Survival|Withdrawal by Subject|1|||
156874501|NCT01026324|566298657|FG001|Follow up/Survival|Withdrawal by Subject|0|||
156874502|NCT01026324|566298658|FG002|Follow up/Survival|Withdrawal by Subject|0|||
156874503|NCT01032889|566298663|FG000|Overall Study|Adverse Event|2|||
156874504|NCT01032889|566298664|FG001|Overall Study|Adverse Event|2|||
156874505|NCT01032889|566298665|FG002|Overall Study|Adverse Event|0|||
156874506|NCT01032889|566298663|FG000|Overall Study|Withdrawal of Consent|1|||
156874507|NCT01032889|566298664|FG001|Overall Study|Withdrawal of Consent|2|||
156874508|NCT01032889|566298665|FG002|Overall Study|Withdrawal of Consent|1|||
156874509|NCT01032889|566298663|FG000|Overall Study|Patient Request|0|||
156874510|NCT01032889|566298664|FG001|Overall Study|Patient Request|1|||
156874511|NCT01032889|566298665|FG002|Overall Study|Patient Request|0|||
156874512|NCT01032889|566298663|FG000|Overall Study|Lost to Follow-up|1|||
156874513|NCT01032889|566298664|FG001|Overall Study|Lost to Follow-up|1|||
157017269|NCT00879333|566815248|FG000|Overall Study|Administrative Problems|2|||
157017270|NCT00879333|566815249|FG001|Overall Study|Administrative Problems|0|||
157017271|NCT00879333|566815248|FG000|Overall Study|Death|16|||
157017272|NCT00879333|566815249|FG001|Overall Study|Death|5|||
156874514|NCT01032889|566298665|FG002|Overall Study|Lost to Follow-up|0|||
156874515|NCT01032889|566298663|FG000|Overall Study|Lack of Submental Fat|2|||
156874516|NCT01032889|566298664|FG001|Overall Study|Lack of Submental Fat|8|||
156874517|NCT01032889|566298665|FG002|Overall Study|Lack of Submental Fat|1|||
156874518|NCT01032889|566298663|FG000|Overall Study|Miscellaneous Reasons|2|||
156874519|NCT01032889|566298664|FG001|Overall Study|Miscellaneous Reasons|1|||
156874520|NCT01032889|566298665|FG002|Overall Study|Miscellaneous Reasons|1|||
156874521|NCT02442804|566298666|FG000|Overall Study|Withdrawal by Subject|0|||
156874522|NCT02442804|566298667|FG001|Overall Study|Withdrawal by Subject|1|||
157017273|NCT00879333|566815248|FG000|Overall Study|Disease Progression|292|||
156874523|NCT02442804|566298666|FG000|Overall Study|Adverse Event|1|||
156874524|NCT02442804|566298667|FG001|Overall Study|Adverse Event|0|||
157017274|NCT00879333|566815249|FG001|Overall Study|Disease Progression|169|||
156714934|NCT02906670|565700818|FG000|Cohort 4P, QW|Radiological Progression|0|||
156874525|NCT02624986|566298671|FG000|Overall Study|Death|0|||
156874526|NCT02624986|566298672|FG001|Overall Study|Death|1|||
156874527|NCT02624986|566298673|FG002|Overall Study|Death|2|||
156874528|NCT02624986|566298674|FG003|Overall Study|Death|2|||
156874529|NCT02624986|566298675|FG004|Overall Study|Death|2|||
156874530|NCT02624986|566298676|FG005|Overall Study|Death|0|||
156874531|NCT02624986|566298677|FG006|Overall Study|Death|0|||
156874532|NCT02624986|566298678|FG007|Overall Study|Death|1|||
156874533|NCT02624986|566298671|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874534|NCT02624986|566298672|FG001|Overall Study|Study Terminated by Sponsor|1|||
156874535|NCT02624986|566298673|FG002|Overall Study|Study Terminated by Sponsor|0|||
156874536|NCT02624986|566298674|FG003|Overall Study|Study Terminated by Sponsor|1|||
156874537|NCT02624986|566298675|FG004|Overall Study|Study Terminated by Sponsor|2|||
156874538|NCT02624986|566298676|FG005|Overall Study|Study Terminated by Sponsor|2|||
156874539|NCT02624986|566298677|FG006|Overall Study|Study Terminated by Sponsor|4|||
156874540|NCT02624986|566298678|FG007|Overall Study|Study Terminated by Sponsor|3|||
156874541|NCT02624986|566298671|FG000|Overall Study|Progressive Disease|0|||
156874542|NCT02624986|566298672|FG001|Overall Study|Progressive Disease|1|||
156874543|NCT02624986|566298673|FG002|Overall Study|Progressive Disease|0|||
156874544|NCT02624986|566298674|FG003|Overall Study|Progressive Disease|0|||
156874545|NCT02624986|566298675|FG004|Overall Study|Progressive Disease|0|||
156874546|NCT02624986|566298676|FG005|Overall Study|Progressive Disease|0|||
156874547|NCT02624986|566298677|FG006|Overall Study|Progressive Disease|0|||
156874548|NCT02624986|566298678|FG007|Overall Study|Progressive Disease|0|||
156874549|NCT02624986|566298671|FG000|Overall Study|Protocol Violation|1|||
156874550|NCT02624986|566298672|FG001|Overall Study|Protocol Violation|0|||
156874551|NCT02624986|566298673|FG002|Overall Study|Protocol Violation|0|||
156874552|NCT02624986|566298674|FG003|Overall Study|Protocol Violation|0|||
156874553|NCT02624986|566298675|FG004|Overall Study|Protocol Violation|0|||
156874554|NCT02624986|566298676|FG005|Overall Study|Protocol Violation|0|||
156874555|NCT02624986|566298677|FG006|Overall Study|Protocol Violation|0|||
156874556|NCT02624986|566298678|FG007|Overall Study|Protocol Violation|0|||
156874557|NCT02624986|566298671|FG000|Overall Study|Withdrawal by Subject|0|||
156874558|NCT02624986|566298672|FG001|Overall Study|Withdrawal by Subject|0|||
156874559|NCT02624986|566298673|FG002|Overall Study|Withdrawal by Subject|0|||
156874560|NCT02624986|566298674|FG003|Overall Study|Withdrawal by Subject|0|||
156874561|NCT02624986|566298675|FG004|Overall Study|Withdrawal by Subject|0|||
156874562|NCT02624986|566298676|FG005|Overall Study|Withdrawal by Subject|0|||
156874563|NCT02624986|566298677|FG006|Overall Study|Withdrawal by Subject|0|||
156874564|NCT02624986|566298678|FG007|Overall Study|Withdrawal by Subject|1|||
156874565|NCT03532451|566298682|FG000|Overall Study|Withdrawal by Subject|0|||
156874566|NCT03532451|566298683|FG001|Overall Study|Withdrawal by Subject|1|||
156874567|NCT03532451|566298682|FG000|Overall Study|Did not undergo surgery|1|||
156874568|NCT03532451|566298683|FG001|Overall Study|Did not undergo surgery|1|||
156874569|NCT02527421|566298684|FG000|Overall Study|Withdrawal by Subject|1|||
156874570|NCT02527421|566298685|FG001|Overall Study|Withdrawal by Subject|0|||
156874571|NCT02116205|566298686|FG000|Overall Study|Withdrawal by Subject|2|||
156874572|NCT02116205|566298687|FG001|Overall Study|Withdrawal by Subject|4|||
156874573|NCT02116205|566298688|FG002|Overall Study|Withdrawal by Subject|1|||
156874574|NCT02116205|566298689|FG003|Overall Study|Withdrawal by Subject|3|||
156874575|NCT02116205|566298686|FG000|Overall Study|Lost to Follow-up|0|||
156874576|NCT02116205|566298687|FG001|Overall Study|Lost to Follow-up|2|||
156874577|NCT02116205|566298688|FG002|Overall Study|Lost to Follow-up|1|||
156874578|NCT02116205|566298689|FG003|Overall Study|Lost to Follow-up|2|||
156874579|NCT02116205|566298686|FG000|Overall Study|Physician Decision|0|||
156874580|NCT02116205|566298687|FG001|Overall Study|Physician Decision|1|||
156874581|NCT02116205|566298688|FG002|Overall Study|Physician Decision|1|||
157017275|NCT00879333|566815248|FG000|Overall Study|Protocol Violation|1|||
156874582|NCT02116205|566298689|FG003|Overall Study|Physician Decision|1|||
156874583|NCT02116205|566298686|FG000|Overall Study|Exclusion criteria|0|||
156874584|NCT02116205|566298687|FG001|Overall Study|Exclusion criteria|0|||
157017276|NCT00879333|566815249|FG001|Overall Study|Protocol Violation|1|||
157017277|NCT03069313|566815250|FG000|Overall Study|Adverse Event|5|||
157017278|NCT02910713|566815252|FG000|Overall Study|Protocol Violation|2|||
157017279|NCT02910713|566815252|FG000|Overall Study|Subject Choice|4|||
157017280|NCT02910713|566815252|FG000|Overall Study|Received One Application|10|||
156874585|NCT02116205|566298688|FG002|Overall Study|Exclusion criteria|1|||
156874586|NCT02116205|566298689|FG003|Overall Study|Exclusion criteria|0|||
156874587|NCT04200352|566298695|FG000|Overall Study|Death|1|||
156874588|NCT04200352|566298695|FG000|Overall Study|Adverse Event|6|||
156874589|NCT04200352|566298695|FG000|Overall Study|Withdrawal by parent/guardian|6|||
156874590|NCT04200352|566298695|FG000|Overall Study|Lack of Efficacy|1|||
156874591|NCT04200352|566298695|FG000|Overall Study|Other than specified|6|||
156874592|NCT02541604|566298696|FG000|Overall Study|Death|6|||
156874593|NCT02541604|566298697|FG001|Overall Study|Death|5|||
157017281|NCT02910713|566815252|FG000|Overall Study|Received Neither Application|18|||
157017282|NCT02910713|566815252|FG000|Overall Study|Enrollment cap|7|||
157017283|NCT02910713|566815252|FG000|Overall Study|Investigator Discretion|1|||
157128793|NCT00925600|567223855|FG000|Overall Study|Other|3|||
157128794|NCT00925600|567223856|FG001|Overall Study|Other|1|||
157128795|NCT00925600|567223855|FG000|Overall Study|Adverse Event|1|||
157128796|NCT00925600|567223856|FG001|Overall Study|Adverse Event|2|||
157128797|NCT00127127|567223861|FG000|Overall Study|Adverse Event|0|||
157128798|NCT00127127|567223862|FG001|Overall Study|Adverse Event|2|||
157128799|NCT00127127|567223863|FG002|Overall Study|Adverse Event|0|||
157128800|NCT00127127|567223864|FG003|Overall Study|Adverse Event|1|||
157128801|NCT00127127|567223861|FG000|Overall Study|Lack of Efficacy|1|||
157128802|NCT00127127|567223862|FG001|Overall Study|Lack of Efficacy|3|||
157128803|NCT00127127|567223863|FG002|Overall Study|Lack of Efficacy|0|||
157128804|NCT00127127|567223864|FG003|Overall Study|Lack of Efficacy|2|||
157128805|NCT00200057|567223865|FG000|Overall Study|Lack of Efficacy|3|||
157128806|NCT00200057|567223865|FG000|Overall Study|Exited due to terminal illness of PI|2|||
157128807|NCT00200057|567223865|FG000|Overall Study|Withdrawal by Subject|1|||
157128808|NCT00200057|567223865|FG000|Overall Study|Change in medical condition|1|||
157128809|NCT00200057|567223865|FG000|Overall Study|Infection|1|||
157128810|NCT00200057|567223865|FG000|Overall Study|Death|1|||
157128811|NCT01059448|567223866|FG000|Overall Study|Adverse Event|1|||
157128812|NCT01059448|567223867|FG001|Overall Study|Adverse Event|3|||
157128813|NCT01059448|567223868|FG002|Overall Study|Adverse Event|0|||
157128814|NCT01059448|567223869|FG003|Overall Study|Adverse Event|1|||
157128815|NCT01059448|567223866|FG000|Overall Study|Withdrawal by Subject|2|||
157128816|NCT01059448|567223867|FG001|Overall Study|Withdrawal by Subject|0|||
157128817|NCT01059448|567223868|FG002|Overall Study|Withdrawal by Subject|2|||
157128818|NCT01059448|567223869|FG003|Overall Study|Withdrawal by Subject|4|||
157128819|NCT01059448|567223866|FG000|Overall Study|Disease Progression|2|||
157128820|NCT01059448|567223867|FG001|Overall Study|Disease Progression|1|||
157128821|NCT01059448|567223868|FG002|Overall Study|Disease Progression|4|||
157128822|NCT01059448|567223869|FG003|Overall Study|Disease Progression|2|||
157128823|NCT01059448|567223866|FG000|Overall Study|Administrative Decision|43|||
157128824|NCT01059448|567223867|FG001|Overall Study|Administrative Decision|49|||
157128825|NCT01059448|567223868|FG002|Overall Study|Administrative Decision|45|||
157128826|NCT01059448|567223869|FG003|Overall Study|Administrative Decision|46|||
157128827|NCT01059448|567223866|FG000|Overall Study|Lost to Follow-up|0|||
157128828|NCT01059448|567223867|FG001|Overall Study|Lost to Follow-up|0|||
157128829|NCT01059448|567223868|FG002|Overall Study|Lost to Follow-up|2|||
157128830|NCT01059448|567223869|FG003|Overall Study|Lost to Follow-up|0|||
157128831|NCT01059448|567223866|FG000|Overall Study|Death|0|||
157128832|NCT01059448|567223867|FG001|Overall Study|Death|1|||
157128833|NCT01059448|567223868|FG002|Overall Study|Death|0|||
157128834|NCT01059448|567223869|FG003|Overall Study|Death|0|||
157128835|NCT01059448|567223866|FG000|Overall Study|Other|1|||
157128836|NCT01059448|567223867|FG001|Overall Study|Other|1|||
157128837|NCT01059448|567223868|FG002|Overall Study|Other|0|||
157128838|NCT01059448|567223869|FG003|Overall Study|Other|1|||
157128839|NCT00778830|567223870|FG000|Overall Study|Ongoing at data cut-off|0|||
157128840|NCT00778830|567223871|FG001|Overall Study|Ongoing at data cut-off|1|||
157128841|NCT01891643|567223872|FG000|Overall Study|Adverse event unrelated to study drug|2|||
157128842|NCT01891643|567223873|FG001|Overall Study|Adverse event unrelated to study drug|5|||
157128843|NCT01891643|567223872|FG000|Overall Study|Disease Progression|4|||
157128844|NCT01891643|567223873|FG001|Overall Study|Disease Progression|3|||
157128845|NCT01891643|567223872|FG000|Overall Study|Study Drug Toxicity|3|||
156714935|NCT02906670|565700819|FG001|Cohort 4P, QW|Radiological Progression|0|||
157017284|NCT04442126|566815256|FG000|Overall Study|Withdrawal by Subject|0|||
157017285|NCT04442126|566815257|FG001|Overall Study|Withdrawal by Subject|0|||
157017286|NCT04442126|566815258|FG002|Overall Study|Withdrawal by Subject|0|||
157017287|NCT04442126|566815259|FG003|Overall Study|Withdrawal by Subject|2|||
157017288|NCT04442126|566815260|FG004|Overall Study|Withdrawal by Subject|1|||
157017289|NCT04442126|566815261|FG005|Overall Study|Withdrawal by Subject|0|||
157017290|NCT04442126|566815262|FG006|Overall Study|Withdrawal by Subject|1|||
157017291|NCT04442126|566815263|FG007|Overall Study|Withdrawal by Subject|1|||
157017292|NCT04442126|566815264|FG008|Overall Study|Withdrawal by Subject|3|||
157017293|NCT04442126|566815256|FG000|Overall Study|Death|1|||
157017294|NCT04442126|566815257|FG001|Overall Study|Death|0|||
157017295|NCT04442126|566815258|FG002|Overall Study|Death|0|||
157017296|NCT04442126|566815259|FG003|Overall Study|Death|1|||
157017297|NCT04442126|566815260|FG004|Overall Study|Death|2|||
157128846|NCT01891643|567223873|FG001|Overall Study|Study Drug Toxicity|0|||
157128847|NCT01891643|567223872|FG000|Overall Study|Maximum Clinical Benefit|0|||
157128848|NCT01891643|567223873|FG001|Overall Study|Maximum Clinical Benefit|1|||
157128849|NCT01891643|567223872|FG000|Overall Study|Poor/Non-compliance|0|||
157128850|NCT01891643|567223873|FG001|Overall Study|Poor/Non-compliance|1|||
157128851|NCT01891643|567223872|FG000|Overall Study|Participant request to discontinue|1|||
157017298|NCT04442126|566815261|FG005|Overall Study|Death|2|||
157017299|NCT04442126|566815262|FG006|Overall Study|Death|4|||
157017300|NCT04442126|566815263|FG007|Overall Study|Death|1|||
157017301|NCT04442126|566815264|FG008|Overall Study|Death|5|||
157128852|NCT01891643|567223873|FG001|Overall Study|Participant request to discontinue|0|||
157128853|NCT04047797|567223876|FG000|Overall Study|Progressive Disease|1|||
156714936|NCT02906670|565700820|FG002|Cohort 4P, QW|Radiological Progression|0|||
156714937|NCT02906670|565700821|FG003|Cohort 4P, QW|Radiological Progression|3|||
156714938|NCT02906670|565700822|FG004|Cohort 4P, QW|Radiological Progression|0|||
156714939|NCT02906670|565700823|FG005|Cohort 4P, QW|Radiological Progression|0|||
156714940|NCT02906670|565700824|FG006|Cohort 4P, QW|Radiological Progression|0|||
156714941|NCT02906670|565700825|FG007|Cohort 4P, QW|Radiological Progression|0|||
156714942|NCT02906670|565700826|FG008|Cohort 4P, QW|Radiological Progression|0|||
156714943|NCT02906670|565700827|FG009|Cohort 4P, QW|Radiological Progression|0|||
156714944|NCT02906670|565700818|FG000|Cohort 7P, Q2W|Adverse Event|0|||
156714945|NCT02906670|565700819|FG001|Cohort 7P, Q2W|Adverse Event|0|||
156714946|NCT02906670|565700820|FG002|Cohort 7P, Q2W|Adverse Event|0|||
156714947|NCT02906670|565700821|FG003|Cohort 7P, Q2W|Adverse Event|0|||
157017302|NCT04442126|566815256|FG000|Overall Study|Study Terminated by Sponsor|0|||
157017303|NCT04442126|566815257|FG001|Overall Study|Study Terminated by Sponsor|0|||
157017304|NCT04442126|566815258|FG002|Overall Study|Study Terminated by Sponsor|0|||
157017305|NCT04442126|566815259|FG003|Overall Study|Study Terminated by Sponsor|0|||
157017306|NCT04442126|566815260|FG004|Overall Study|Study Terminated by Sponsor|0|||
157017307|NCT04442126|566815261|FG005|Overall Study|Study Terminated by Sponsor|1|||
157017308|NCT04442126|566815262|FG006|Overall Study|Study Terminated by Sponsor|4|||
157017309|NCT04442126|566815263|FG007|Overall Study|Study Terminated by Sponsor|2|||
157017310|NCT04442126|566815264|FG008|Overall Study|Study Terminated by Sponsor|10|||
157017311|NCT04442126|566815256|FG000|Overall Study|Lost to Follow-up|0|||
157017312|NCT04442126|566815257|FG001|Overall Study|Lost to Follow-up|0|||
157017313|NCT04442126|566815258|FG002|Overall Study|Lost to Follow-up|0|||
157017314|NCT04442126|566815259|FG003|Overall Study|Lost to Follow-up|0|||
157017315|NCT04442126|566815260|FG004|Overall Study|Lost to Follow-up|0|||
157017316|NCT04442126|566815261|FG005|Overall Study|Lost to Follow-up|0|||
157017317|NCT04442126|566815262|FG006|Overall Study|Lost to Follow-up|0|||
157017318|NCT04442126|566815263|FG007|Overall Study|Lost to Follow-up|1|||
157017319|NCT04442126|566815264|FG008|Overall Study|Lost to Follow-up|2|||
157017320|NCT04442126|566815256|FG000|Overall Study|Progressive Disease|0|||
157017321|NCT04442126|566815257|FG001|Overall Study|Progressive Disease|1|||
157017322|NCT04442126|566815258|FG002|Overall Study|Progressive Disease|3|||
157017323|NCT04442126|566815259|FG003|Overall Study|Progressive Disease|0|||
157017324|NCT04442126|566815260|FG004|Overall Study|Progressive Disease|3|||
157017325|NCT04442126|566815261|FG005|Overall Study|Progressive Disease|0|||
157017326|NCT04442126|566815262|FG006|Overall Study|Progressive Disease|0|||
157017327|NCT04442126|566815263|FG007|Overall Study|Progressive Disease|0|||
157017328|NCT04442126|566815264|FG008|Overall Study|Progressive Disease|0|||
157017329|NCT04442126|566815256|FG000|Overall Study|Other|0|||
157017330|NCT04442126|566815257|FG001|Overall Study|Other|0|||
157017331|NCT04442126|566815258|FG002|Overall Study|Other|0|||
157017332|NCT04442126|566815259|FG003|Overall Study|Other|0|||
157017333|NCT04442126|566815260|FG004|Overall Study|Other|0|||
157017334|NCT04442126|566815261|FG005|Overall Study|Other|0|||
157017335|NCT04442126|566815262|FG006|Overall Study|Other|0|||
157017336|NCT04442126|566815263|FG007|Overall Study|Other|0|||
157017337|NCT04442126|566815264|FG008|Overall Study|Other|1|||
157017338|NCT06450405|566815265|FG000|Overall Study|Study funding terminated.|0|||
157017339|NCT06450405|566815266|FG001|Overall Study|Study funding terminated.|2|||
157017340|NCT03767517|566815267|FG000|Overall Study|Lost to Follow-up|16|||
157017341|NCT03767517|566815268|FG001|Overall Study|Lost to Follow-up|10|||
157017342|NCT03767517|566815267|FG000|Overall Study|Death|2|||
157017343|NCT03767517|566815268|FG001|Overall Study|Death|3|||
157017344|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
157017345|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
157017346|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
157017347|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
157017348|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
157017349|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
157017350|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
157017351|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
157017352|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
157017353|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
157017354|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
157017355|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
157017356|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
157017357|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
157017358|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
157017359|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
157017360|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
157017361|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
157017362|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
156714948|NCT02906670|565700822|FG004|Cohort 7P, Q2W|Adverse Event|0|||
157017363|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
157017364|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
157017365|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
157017366|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
157017367|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
157017368|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
157128854|NCT00132041|567223882|FG000|Baseline|Ineligible|6|||
157128855|NCT00132041|567223882|FG000|3 Months Post Ablation|Transplant|1|||
157128856|NCT00132041|567223882|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
157128857|NCT00132041|567223882|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
157128858|NCT00132041|567223882|FG000|6 Months Post Ablation|Death|2|||
157128859|NCT00132041|567223882|FG000|6 Months Post Ablation|Transplant|6|||
157128860|NCT00132041|567223882|FG000|9 Months Post Ablation|Death|1|||
157128861|NCT00132041|567223882|FG000|9 Months Post Ablation|Transplant|1|||
157128862|NCT00132041|567223882|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
157128863|NCT00132041|567223882|FG000|12 Months Post Ablation|Death|1|||
157128864|NCT00132041|567223882|FG000|12 Months Post Ablation|Transplant|1|||
157128865|NCT00132041|567223882|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
157128866|NCT00132041|567223882|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
157128867|NCT00132041|567223882|FG000|15 Months Post Ablation|Death|1|||
157128868|NCT00132041|567223882|FG000|15 Months Post Ablation|Transplant|5|||
157128869|NCT00132041|567223882|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
157128870|NCT00132041|567223882|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
157128871|NCT00132041|567223882|FG000|18 Months Post Ablation|Transplant|1|||
157128872|NCT00132041|567223882|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
157128873|NCT00132041|567223882|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
157128874|NCT01171820|567223883|FG000|Overall Study|Death|3|||
157128875|NCT01171820|567223884|FG001|Overall Study|Death|3|||
157128876|NCT01171820|567223883|FG000|Overall Study|Lost to Follow-up|0|||
157128877|NCT01171820|567223884|FG001|Overall Study|Lost to Follow-up|1|||
157128878|NCT01171820|567223883|FG000|Overall Study|Withdrawal by Subject|2|||
157128879|NCT01171820|567223884|FG001|Overall Study|Withdrawal by Subject|0|||
157128880|NCT01171820|567223883|FG000|Overall Study|Physician Decision|0|||
157128881|NCT01171820|567223884|FG001|Overall Study|Physician Decision|1|||
157128882|NCT01171820|567223883|FG000|Overall Study|1-Year Missed Visit|1|||
157128883|NCT01171820|567223884|FG001|Overall Study|1-Year Missed Visit|1|||
157128884|NCT00167245|567223885|FG000|Overall Study|Lost to Follow-up|20|||
157128885|NCT00167245|567223886|FG001|Overall Study|Lost to Follow-up|31|||
157128886|NCT00167245|567223885|FG000|Overall Study|Withdrawal by Subject|5|||
157128887|NCT00167245|567223886|FG001|Overall Study|Withdrawal by Subject|8|||
157128888|NCT00167245|567223885|FG000|Overall Study|Incarcerated|3|||
157128889|NCT00167245|567223886|FG001|Overall Study|Incarcerated|2|||
157128890|NCT00167245|567223885|FG000|Overall Study|Drowsy|1|||
157128891|NCT00167245|567223886|FG001|Overall Study|Drowsy|0|||
157128892|NCT03969875|567223887|FG000|Overall Study|did not receive allocated intervention|3|||
157128893|NCT03969875|567223888|FG001|Overall Study|did not receive allocated intervention|3|||
157128894|NCT03969875|567223889|FG002|Overall Study|did not receive allocated intervention|4|||
157128895|NCT03969875|567223887|FG000|Overall Study|Protocol Violation|4|||
157128896|NCT03969875|567223888|FG001|Overall Study|Protocol Violation|2|||
157128897|NCT03969875|567223889|FG002|Overall Study|Protocol Violation|2|||
157128898|NCT00947531|567223894|FG000|Overall Study|Withdrawal by Subject|10|||
156714949|NCT02906670|565700823|FG005|Cohort 7P, Q2W|Adverse Event|0|||
156714950|NCT02906670|565700824|FG006|Cohort 7P, Q2W|Adverse Event|0|||
156874594|NCT02541604|566298698|FG002|Overall Study|Death|7|||
157128899|NCT00947531|567223895|FG001|Overall Study|Withdrawal by Subject|7|||
157128900|NCT00947531|567223894|FG000|Overall Study|Administrative Reason|0|||
157128901|NCT00947531|567223895|FG001|Overall Study|Administrative Reason|1|||
157128902|NCT00947531|567223894|FG000|Overall Study|Adverse Event|2|||
157128903|NCT00947531|567223895|FG001|Overall Study|Adverse Event|2|||
157128904|NCT00947531|567223894|FG000|Overall Study|Lack of Efficacy|1|||
157128905|NCT00947531|567223895|FG001|Overall Study|Lack of Efficacy|0|||
157128906|NCT00947531|567223894|FG000|Overall Study|Other|1|||
157128907|NCT00947531|567223895|FG001|Overall Study|Other|1|||
157128908|NCT01773421|567223897|FG000|Treatment Phase|Other|0|||
157128909|NCT01773421|567223898|FG001|Treatment Phase|Other|0|||
157128910|NCT01773421|567223899|FG002|Treatment Phase|Other|2|||
157128911|NCT01773421|567223900|FG003|Treatment Phase|Other|0|||
157128912|NCT01773421|567223901|FG004|Treatment Phase|Other|0|||
157128913|NCT01773421|567223902|FG005|Treatment Phase|Other|0|||
157128914|NCT01773421|567223903|FG006|Treatment Phase|Other|0|||
156714951|NCT02906670|565700825|FG007|Cohort 7P, Q2W|Adverse Event|0|||
157128915|NCT01773421|567223897|FG000|Treatment Phase|Adverse Event|0|||
157128916|NCT01773421|567223898|FG001|Treatment Phase|Adverse Event|0|||
157128917|NCT01773421|567223899|FG002|Treatment Phase|Adverse Event|3|||
157128918|NCT01773421|567223900|FG003|Treatment Phase|Adverse Event|1|||
157017369|NCT05338086|566816156|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
157017370|NCT05338086|566816157|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
157017371|NCT05338086|566816158|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
157017372|NCT05338086|566816159|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
157017373|NCT05338086|566816160|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
157017374|NCT05338086|566816156|FG000|Transition Period (M12 to M18)|Death|0|||
157017375|NCT05338086|566816157|FG001|Transition Period (M12 to M18)|Death|0|||
157017376|NCT05338086|566816158|FG002|Transition Period (M12 to M18)|Death|1|||
157017377|NCT05338086|566816159|FG003|Transition Period (M12 to M18)|Death|0|||
157017378|NCT05338086|566816160|FG004|Transition Period (M12 to M18)|Death|0|||
157017379|NCT05338086|566816156|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
157017380|NCT05338086|566816157|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
157017381|NCT05338086|566816158|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
157017382|NCT05338086|566816159|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
157017383|NCT05338086|566816160|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
157017384|NCT05338086|566816156|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
157128919|NCT01773421|567223901|FG004|Treatment Phase|Adverse Event|0|||
157128920|NCT01773421|567223902|FG005|Treatment Phase|Adverse Event|0|||
157128921|NCT01773421|567223903|FG006|Treatment Phase|Adverse Event|0|||
157128922|NCT01773421|567223897|FG000|Treatment Phase|Withdrawal by Subject|0|||
157128923|NCT01773421|567223898|FG001|Treatment Phase|Withdrawal by Subject|0|||
157128924|NCT01773421|567223899|FG002|Treatment Phase|Withdrawal by Subject|1|||
157128925|NCT01773421|567223900|FG003|Treatment Phase|Withdrawal by Subject|1|||
157128926|NCT01773421|567223901|FG004|Treatment Phase|Withdrawal by Subject|0|||
157128927|NCT01773421|567223902|FG005|Treatment Phase|Withdrawal by Subject|0|||
157128928|NCT01773421|567223903|FG006|Treatment Phase|Withdrawal by Subject|0|||
157128929|NCT01773421|567223897|FG000|Extension Phase|Other|0|||
157128930|NCT01773421|567223898|FG001|Extension Phase|Other|0|||
157128931|NCT01773421|567223899|FG002|Extension Phase|Other|0|||
157128932|NCT01773421|567223900|FG003|Extension Phase|Other|0|||
157128933|NCT01773421|567223901|FG004|Extension Phase|Other|1|||
157128934|NCT01773421|567223902|FG005|Extension Phase|Other|2|||
157128935|NCT01773421|567223903|FG006|Extension Phase|Other|0|||
157128936|NCT01773421|567223897|FG000|Extension Phase|Adverse Event|0|||
157128937|NCT01773421|567223898|FG001|Extension Phase|Adverse Event|0|||
157128938|NCT01773421|567223899|FG002|Extension Phase|Adverse Event|0|||
157128939|NCT01773421|567223900|FG003|Extension Phase|Adverse Event|0|||
157128940|NCT01773421|567223901|FG004|Extension Phase|Adverse Event|2|||
157128941|NCT01773421|567223902|FG005|Extension Phase|Adverse Event|0|||
157128942|NCT01773421|567223903|FG006|Extension Phase|Adverse Event|0|||
157128943|NCT02327260|567223904|FG000|Overall Study|Lost to Follow-up|2|||
157128944|NCT02327260|567223905|FG001|Overall Study|Lost to Follow-up|3|||
157128945|NCT02327260|567223906|FG002|Overall Study|Lost to Follow-up|2|||
157128946|NCT02327260|567223904|FG000|Overall Study|invalid phone number|1|||
157128947|NCT02327260|567223905|FG001|Overall Study|invalid phone number|1|||
157128948|NCT02327260|567223906|FG002|Overall Study|invalid phone number|0|||
157128949|NCT02327260|567223904|FG000|Overall Study|non-adherence to protocol|2|||
157128950|NCT02327260|567223905|FG001|Overall Study|non-adherence to protocol|0|||
157128951|NCT02327260|567223906|FG002|Overall Study|non-adherence to protocol|0|||
156714952|NCT02906670|565700826|FG008|Cohort 7P, Q2W|Adverse Event|0|||
156714953|NCT02906670|565700827|FG009|Cohort 7P, Q2W|Adverse Event|1|||
157017385|NCT05338086|566816157|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
157017386|NCT05338086|566816158|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
157017387|NCT05338086|566816159|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
157128952|NCT02327260|567223904|FG000|Overall Study|cognitive concerns|1|||
157128953|NCT02327260|567223905|FG001|Overall Study|cognitive concerns|0|||
157128954|NCT02327260|567223906|FG002|Overall Study|cognitive concerns|0|||
157128955|NCT03502330|567223907|FG000|Overall Study|Adverse Event|2|||
157128956|NCT03502330|567223908|FG001|Overall Study|Adverse Event|1|||
157128957|NCT03502330|567223909|FG002|Overall Study|Adverse Event|0|||
157128958|NCT03502330|567223910|FG003|Overall Study|Adverse Event|0|||
157128959|NCT03502330|567223911|FG004|Overall Study|Adverse Event|1|||
157128960|NCT03502330|567223912|FG005|Overall Study|Adverse Event|0|||
157128961|NCT03502330|567223913|FG006|Overall Study|Adverse Event|1|||
157128962|NCT03502330|567223914|FG007|Overall Study|Adverse Event|1|||
157128963|NCT03502330|567223915|FG008|Overall Study|Adverse Event|0|||
157128964|NCT03502330|567223907|FG000|Overall Study|Lack of Efficacy|1|||
157128965|NCT03502330|567223908|FG001|Overall Study|Lack of Efficacy|5|||
157128966|NCT03502330|567223909|FG002|Overall Study|Lack of Efficacy|3|||
157128967|NCT03502330|567223910|FG003|Overall Study|Lack of Efficacy|5|||
157128968|NCT03502330|567223911|FG004|Overall Study|Lack of Efficacy|1|||
157128969|NCT03502330|567223912|FG005|Overall Study|Lack of Efficacy|5|||
157128970|NCT03502330|567223913|FG006|Overall Study|Lack of Efficacy|5|||
157128971|NCT03502330|567223914|FG007|Overall Study|Lack of Efficacy|6|||
157128972|NCT03502330|567223915|FG008|Overall Study|Lack of Efficacy|0|||
157128973|NCT03502330|567223907|FG000|Overall Study|Physician Decision|0|||
157128974|NCT03502330|567223908|FG001|Overall Study|Physician Decision|0|||
157128975|NCT03502330|567223909|FG002|Overall Study|Physician Decision|0|||
157128976|NCT03502330|567223910|FG003|Overall Study|Physician Decision|0|||
157128977|NCT03502330|567223911|FG004|Overall Study|Physician Decision|1|||
157128978|NCT03502330|567223912|FG005|Overall Study|Physician Decision|0|||
157128979|NCT03502330|567223913|FG006|Overall Study|Physician Decision|0|||
157128980|NCT03502330|567223914|FG007|Overall Study|Physician Decision|0|||
157128981|NCT03502330|567223915|FG008|Overall Study|Physician Decision|0|||
157128982|NCT03502330|567223907|FG000|Overall Study|Withdrawal by Subject|0|||
157128983|NCT03502330|567223908|FG001|Overall Study|Withdrawal by Subject|0|||
157128984|NCT03502330|567223909|FG002|Overall Study|Withdrawal by Subject|0|||
157128985|NCT03502330|567223910|FG003|Overall Study|Withdrawal by Subject|0|||
157128986|NCT03502330|567223911|FG004|Overall Study|Withdrawal by Subject|0|||
157128987|NCT03502330|567223912|FG005|Overall Study|Withdrawal by Subject|1|||
157128988|NCT03502330|567223913|FG006|Overall Study|Withdrawal by Subject|0|||
157128989|NCT03502330|567223914|FG007|Overall Study|Withdrawal by Subject|1|||
157128990|NCT03502330|567223915|FG008|Overall Study|Withdrawal by Subject|0|||
157128991|NCT03502330|567223907|FG000|Overall Study|Death|0|||
157128992|NCT03502330|567223908|FG001|Overall Study|Death|0|||
157128993|NCT03502330|567223909|FG002|Overall Study|Death|0|||
157128994|NCT03502330|567223910|FG003|Overall Study|Death|0|||
157128995|NCT03502330|567223911|FG004|Overall Study|Death|0|||
157128996|NCT03502330|567223912|FG005|Overall Study|Death|0|||
157128997|NCT03502330|567223913|FG006|Overall Study|Death|2|||
157128998|NCT03502330|567223914|FG007|Overall Study|Death|0|||
157128999|NCT03502330|567223915|FG008|Overall Study|Death|0|||
157129000|NCT01400932|567223921|FG000|Overall Study|Adverse Event|10|||
157129001|NCT01400932|567223922|FG001|Overall Study|Adverse Event|5|||
157129002|NCT01400932|567223921|FG000|Overall Study|Lack of Efficacy|0|||
156714954|NCT02906670|565700818|FG000|Cohort 7P, Q2W|Physician Decision|0|||
156714955|NCT02906670|565700819|FG001|Cohort 7P, Q2W|Physician Decision|0|||
156714956|NCT02906670|565700820|FG002|Cohort 7P, Q2W|Physician Decision|0|||
156714957|NCT02906670|565700821|FG003|Cohort 7P, Q2W|Physician Decision|0|||
156714958|NCT02906670|565700822|FG004|Cohort 7P, Q2W|Physician Decision|0|||
156714959|NCT02906670|565700823|FG005|Cohort 7P, Q2W|Physician Decision|0|||
156714960|NCT02906670|565700824|FG006|Cohort 7P, Q2W|Physician Decision|0|||
156714961|NCT02906670|565700825|FG007|Cohort 7P, Q2W|Physician Decision|0|||
156714962|NCT02906670|565700826|FG008|Cohort 7P, Q2W|Physician Decision|0|||
156714963|NCT02906670|565700827|FG009|Cohort 7P, Q2W|Physician Decision|1|||
156714964|NCT02906670|565700818|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714965|NCT02906670|565700819|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714966|NCT02906670|565700820|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714967|NCT02906670|565700821|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714968|NCT02906670|565700822|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714969|NCT02906670|565700823|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714970|NCT02906670|565700824|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714971|NCT02906670|565700825|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156714972|NCT02906670|565700826|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
156792813|NCT01335685|565994770|FG001|Overall Study|Study Terminated by Sponsor|1|||
156714973|NCT02906670|565700827|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
156714974|NCT02906670|565700818|FG000|Cohort 5P, QW|Radiological Progression|0|||
156714975|NCT02906670|565700819|FG001|Cohort 5P, QW|Radiological Progression|0|||
156792814|NCT01335685|565994771|FG002|Overall Study|Study Terminated by Sponsor|1|||
156792815|NCT01335685|565994772|FG003|Overall Study|Study Terminated by Sponsor|10|||
156792816|NCT01335685|565994773|FG004|Overall Study|Study Terminated by Sponsor|0|||
156792817|NCT01335685|565994774|FG005|Overall Study|Study Terminated by Sponsor|4|||
157129003|NCT01400932|567223922|FG001|Overall Study|Lack of Efficacy|3|||
157129004|NCT01400932|567223921|FG000|Overall Study|Withdrawal by Subject|2|||
157129005|NCT01400932|567223922|FG001|Overall Study|Withdrawal by Subject|6|||
157129006|NCT01400932|567223921|FG000|Overall Study|Lost to Follow-up|1|||
157129007|NCT01400932|567223922|FG001|Overall Study|Lost to Follow-up|0|||
157129008|NCT01400932|567223921|FG000|Overall Study|Protocol Deviation|0|||
157129009|NCT01400932|567223922|FG001|Overall Study|Protocol Deviation|1|||
157129010|NCT01400932|567223921|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156792818|NCT01335685|565994775|FG006|Overall Study|Study Terminated by Sponsor|2|||
157129011|NCT01400932|567223922|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157129012|NCT00860158|567223923|FG000|Overall Study|Study Terminated|1|||
157129013|NCT02487108|567223926|FG000|Overall Study|Adverse Event|1|||
157129014|NCT02487108|567223927|FG001|Overall Study|Adverse Event|6|||
157129015|NCT02487108|567223928|FG002|Overall Study|Adverse Event|12|||
156714976|NCT02906670|565700820|FG002|Cohort 5P, QW|Radiological Progression|0|||
156714977|NCT02906670|565700821|FG003|Cohort 5P, QW|Radiological Progression|0|||
156714978|NCT02906670|565700822|FG004|Cohort 5P, QW|Radiological Progression|3|||
156792819|NCT01335685|565994776|FG007|Overall Study|Study Terminated by Sponsor|3|||
157129016|NCT02487108|567223929|FG003|Overall Study|Adverse Event|6|||
157129017|NCT02487108|567223926|FG000|Overall Study|Withdrawal by Subject|8|||
157129018|NCT02487108|567223927|FG001|Overall Study|Withdrawal by Subject|5|||
157129019|NCT02487108|567223928|FG002|Overall Study|Withdrawal by Subject|5|||
156714979|NCT02906670|565700823|FG005|Cohort 5P, QW|Radiological Progression|0|||
156874595|NCT02541604|566298699|FG003|Overall Study|Death|2|||
156874596|NCT02541604|566298700|FG004|Overall Study|Death|9|||
156874597|NCT02541604|566298701|FG005|Overall Study|Death|8|||
156874598|NCT02541604|566298702|FG006|Overall Study|Death|9|||
157129020|NCT02487108|567223929|FG003|Overall Study|Withdrawal by Subject|0|||
157129021|NCT02487108|567223926|FG000|Overall Study|Non-compliance to study medication|3|||
157129022|NCT02487108|567223927|FG001|Overall Study|Non-compliance to study medication|2|||
157129023|NCT02487108|567223928|FG002|Overall Study|Non-compliance to study medication|5|||
157129024|NCT02487108|567223929|FG003|Overall Study|Non-compliance to study medication|4|||
157129025|NCT02487108|567223926|FG000|Overall Study|Protocol Violation|1|||
157129026|NCT02487108|567223927|FG001|Overall Study|Protocol Violation|1|||
157129027|NCT02487108|567223928|FG002|Overall Study|Protocol Violation|2|||
157129028|NCT02487108|567223929|FG003|Overall Study|Protocol Violation|0|||
157129029|NCT02487108|567223926|FG000|Overall Study|Non-compliance to study procedures|0|||
157129030|NCT02487108|567223927|FG001|Overall Study|Non-compliance to study procedures|0|||
157129031|NCT02487108|567223928|FG002|Overall Study|Non-compliance to study procedures|0|||
157129032|NCT02487108|567223929|FG003|Overall Study|Non-compliance to study procedures|1|||
157129033|NCT02487108|567223926|FG000|Overall Study|Other than specified|3|||
157129034|NCT02487108|567223927|FG001|Overall Study|Other than specified|2|||
157129035|NCT02487108|567223928|FG002|Overall Study|Other than specified|2|||
157129036|NCT02487108|567223929|FG003|Overall Study|Other than specified|0|||
157129037|NCT02720757|567223930|FG000|Overall Study|Other reason|5|||
157129038|NCT02720757|567223930|FG000|Overall Study|Loss of contact|4|||
157129039|NCT02720757|567223930|FG000|Overall Study|Informed consent withdrawal|1|||
157129040|NCT02720757|567223930|FG000|Overall Study|Patients wish to withdraw|2|||
157129041|NCT02720757|567223930|FG000|Overall Study|Missing|3|||
157129042|NCT02720757|567223930|FG000|Overall Study|General exclusion|3|||
157129043|NCT04088409|567223931|FG000|Part A|Withdrawal by Subject|2|||
157129044|NCT04088409|567223932|FG001|Part A|Withdrawal by Subject|1|||
157129045|NCT04088409|567223931|FG000|Part A|Did Not Meet Randomization Criteria|2|||
157129046|NCT04088409|567223932|FG001|Part A|Did Not Meet Randomization Criteria|0|||
157129047|NCT04088409|567223931|FG000|Part A|Lack of Efficacy|9|||
157129048|NCT04088409|567223932|FG001|Part A|Lack of Efficacy|0|||
157129049|NCT04088409|567223931|FG000|Part A|Lost to Follow-up|1|||
157129050|NCT04088409|567223932|FG001|Part A|Lost to Follow-up|0|||
157129051|NCT04088409|567223931|FG000|Part A|Adverse Event|1|||
157129052|NCT04088409|567223932|FG001|Part A|Adverse Event|0|||
157129053|NCT04088409|567223931|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
157129054|NCT04088409|567223932|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
157129055|NCT04088409|567223931|FG000|Part B|Ongoing Treatment|10|||
157129056|NCT04088409|567223932|FG001|Part B|Ongoing Treatment|0|||
157129057|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Adverse Event|11|||
157129058|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Adverse Event|15|||
157129059|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
157129060|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
157129061|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
157129062|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
157129063|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
157129064|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
157129065|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
157129066|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
157129067|NCT01058096|567223938|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
157129068|NCT01058096|567223939|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
157129069|NCT05655377|567223940|FG000|Overall Study|Withdrawal by Subject|2|||
157129070|NCT03653390|567223941|FG000|Overall Study|Lost to Follow-up|12|||
157129071|NCT03653390|567223942|FG001|Overall Study|Lost to Follow-up|8|||
157129072|NCT03653390|567223943|FG002|Overall Study|Lost to Follow-up|7|||
157129073|NCT03653390|567223941|FG000|Overall Study|Withdrawal by Subject|6|||
157129074|NCT03653390|567223942|FG001|Overall Study|Withdrawal by Subject|1|||
157129075|NCT03653390|567223943|FG002|Overall Study|Withdrawal by Subject|1|||
156714980|NCT02906670|565700824|FG006|Cohort 5P, QW|Radiological Progression|0|||
156714981|NCT02906670|565700825|FG007|Cohort 5P, QW|Radiological Progression|0|||
156714982|NCT02906670|565700826|FG008|Cohort 5P, QW|Radiological Progression|0|||
156714983|NCT02906670|565700827|FG009|Cohort 5P, QW|Radiological Progression|0|||
156874599|NCT02541604|566298703|FG007|Overall Study|Death|9|||
156874600|NCT02541604|566298704|FG008|Overall Study|Death|3|||
156874601|NCT02541604|566298705|FG009|Overall Study|Death|4|||
157129076|NCT03653390|567223941|FG000|Overall Study|Death|1|||
157129077|NCT03653390|567223942|FG001|Overall Study|Death|0|||
157129078|NCT03653390|567223943|FG002|Overall Study|Death|0|||
157129079|NCT03653390|567223941|FG000|Overall Study|Paper Survey Lost|1|||
157129080|NCT03653390|567223942|FG001|Overall Study|Paper Survey Lost|0|||
157129081|NCT03653390|567223943|FG002|Overall Study|Paper Survey Lost|0|||
157129082|NCT03118947|567223944|FG000|Overall Study|Adverse Event|7|||
157129083|NCT03118947|567223944|FG000|Overall Study|Death|3|||
157129084|NCT03118947|567223944|FG000|Overall Study|Lack of Efficacy|4|||
157216305|NCT01078623|567539249|FG011|Treatment Period 2|Adverse Event|0|||
157216306|NCT01078623|567539250|FG012|Treatment Period 2|Adverse Event|0|||
157216307|NCT01078623|567539251|FG013|Treatment Period 2|Adverse Event|0|||
157216308|NCT01078623|567539252|FG014|Treatment Period 2|Adverse Event|0|||
157216309|NCT01078623|567539253|FG015|Treatment Period 2|Adverse Event|0|||
157216310|NCT01078623|567539254|FG016|Treatment Period 2|Adverse Event|0|||
157216311|NCT01078623|567539255|FG017|Treatment Period 2|Adverse Event|0|||
157216312|NCT01078623|567539256|FG018|Treatment Period 2|Adverse Event|1|||
157216313|NCT01078623|567539257|FG019|Treatment Period 2|Adverse Event|0|||
157216314|NCT01078623|567539238|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157216315|NCT01078623|567539239|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157216316|NCT01078623|567539240|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157216317|NCT01078623|567539241|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156714984|NCT01349192|565700828|FG000|Overall Study|Protocol Violation|0|||
156714985|NCT01349192|565700829|FG001|Overall Study|Protocol Violation|1|||
156714986|NCT01349192|565700828|FG000|Overall Study|Withdrawal by Subject|0|||
156714987|NCT01349192|565700829|FG001|Overall Study|Withdrawal by Subject|2|||
156714988|NCT01349192|565700828|FG000|Overall Study|Lost to Follow-up|1|||
156714989|NCT01349192|565700829|FG001|Overall Study|Lost to Follow-up|3|||
156714990|NCT01349192|565700828|FG000|Overall Study|Failure to adhere to Protocol|2|||
156714991|NCT01349192|565700829|FG001|Overall Study|Failure to adhere to Protocol|0|||
156714992|NCT03749330|565700830|FG000|Overall Study|Clinicians left work in the CICU|0|||
156714993|NCT03749330|565700831|FG001|Overall Study|Clinicians left work in the CICU|2|||
156714994|NCT03749330|565700832|FG002|Overall Study|Clinicians left work in the CICU|0|||
156714995|NCT03749330|565700833|FG003|Overall Study|Clinicians left work in the CICU|0|||
156714996|NCT03749330|565700834|FG004|Overall Study|Clinicians left work in the CICU|0|||
156714997|NCT03749330|565700835|FG005|Overall Study|Clinicians left work in the CICU|0|||
156714998|NCT01973439|565700836|FG000|Overall Study|Lost samples from one PK Day|2|||
156714999|NCT01973439|565700836|FG000|Overall Study|Vomiting after commencing once daily|1|||
156715000|NCT01973439|565700836|FG000|Overall Study|PK curve incomplete|2|||
156715001|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715002|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
156715003|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715004|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
156715005|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
156715006|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715007|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715008|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
156715009|NCT02038010|565700837|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715010|NCT02038010|565700838|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
156715011|NCT02038010|565700839|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715012|NCT02038010|565700840|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
156715013|NCT02038010|565700837|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
156715014|NCT02038010|565700838|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
156715015|NCT02038010|565700839|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
156715016|NCT02038010|565700840|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
156715017|NCT02038010|565700837|FG000|Follow Up|Death|4|||
156715018|NCT02038010|565700838|FG001|Follow Up|Death|3|||
156715019|NCT02038010|565700839|FG002|Follow Up|Death|0|||
156715020|NCT02038010|565700840|FG003|Follow Up|Death|0|||
156715021|NCT02038010|565700837|FG000|Follow Up|Other|3|||
156715022|NCT02038010|565700838|FG001|Follow Up|Other|0|||
156715023|NCT02038010|565700839|FG002|Follow Up|Other|0|||
156715024|NCT02038010|565700840|FG003|Follow Up|Other|0|||
156715025|NCT00958828|565700844|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
156715026|NCT00958828|565700845|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
156715027|NCT00958828|565700844|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
156715028|NCT00958828|565700845|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
156715029|NCT00344448|565700850|FG000|Screening|Withdrawal by Subject|0|||
156874602|NCT02541604|566298706|FG010|Overall Study|Death|2|||
156874603|NCT02541604|566298707|FG011|Overall Study|Death|3|||
156874604|NCT02541604|566298696|FG000|Overall Study|Lost to Follow-up|2|||
157216318|NCT01078623|567539242|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156715030|NCT00344448|565700851|FG001|Screening|Withdrawal by Subject|1|||
156715031|NCT00344448|565700850|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
156715032|NCT00344448|565700851|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
157216319|NCT01078623|567539243|FG005|Treatment Period 2|Withdrawal by Subject|1|||
157216320|NCT01078623|567539244|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156715033|NCT00344448|565700850|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
156715034|NCT00344448|565700851|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
156715035|NCT00344448|565700850|FG000|Open Label|Withdrawal by Subject|1|||
157216321|NCT01078623|567539245|FG007|Treatment Period 2|Withdrawal by Subject|0|||
157216322|NCT01078623|567539246|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156715036|NCT00344448|565700851|FG001|Open Label|Withdrawal by Subject|1|||
156715037|NCT00344448|565700850|FG000|Open Label|Study terminated|1|||
156715038|NCT00344448|565700851|FG001|Open Label|Study terminated|0|||
156715039|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
156715040|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
156715041|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
156715042|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
156715043|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
156715044|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
156715045|NCT02673775|565700852|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
156715046|NCT02673775|565700853|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
156715047|NCT02441686|565700854|FG000|Induction|Adverse Event|4|||
156715048|NCT02441686|565700854|FG000|Induction|Complicating disease|1|||
156715049|NCT02441686|565700854|FG000|Induction|Physician Decision|1|||
156715050|NCT02441686|565700854|FG000|Induction|Withdrawal by Subject|1|||
156715051|NCT02441686|565700854|FG000|Induction|Did not receive treatment|1|||
156715052|NCT02441686|565700854|FG000|Maintenance|Remaining on Treatment|23|||
156715053|NCT02441686|565700854|FG000|Maintenance|Physician Decision|1|||
156715054|NCT02441686|565700854|FG000|Maintenance|Adverse Event|3|||
156715055|NCT02441686|565700854|FG000|Maintenance|Progressive Disease|10|||
156715056|NCT02441686|565700854|FG000|Maintenance|Withdrawal by Subject|1|||
156715057|NCT00535405|565700855|FG000|Overall Study|Adverse Event|6|||
156715058|NCT00535405|565700856|FG001|Overall Study|Adverse Event|8|||
156715059|NCT00535405|565700857|FG002|Overall Study|Adverse Event|3|||
156715060|NCT00535405|565700858|FG003|Overall Study|Adverse Event|8|||
156715061|NCT00535405|565700859|FG004|Overall Study|Adverse Event|6|||
156715062|NCT00535405|565700855|FG000|Overall Study|Lost to Follow-up|1|||
156715063|NCT00535405|565700856|FG001|Overall Study|Lost to Follow-up|3|||
156715064|NCT00535405|565700857|FG002|Overall Study|Lost to Follow-up|3|||
156715065|NCT00535405|565700858|FG003|Overall Study|Lost to Follow-up|2|||
156715066|NCT00535405|565700859|FG004|Overall Study|Lost to Follow-up|1|||
156715067|NCT00535405|565700855|FG000|Overall Study|Physician Decision|3|||
156715068|NCT00535405|565700856|FG001|Overall Study|Physician Decision|2|||
156715069|NCT00535405|565700857|FG002|Overall Study|Physician Decision|0|||
156715070|NCT00535405|565700858|FG003|Overall Study|Physician Decision|1|||
156715071|NCT00535405|565700859|FG004|Overall Study|Physician Decision|1|||
156715072|NCT00535405|565700855|FG000|Overall Study|Protocol Violation|2|||
156715073|NCT00535405|565700856|FG001|Overall Study|Protocol Violation|2|||
156715074|NCT00535405|565700857|FG002|Overall Study|Protocol Violation|2|||
156715075|NCT00535405|565700858|FG003|Overall Study|Protocol Violation|1|||
156715076|NCT00535405|565700859|FG004|Overall Study|Protocol Violation|0|||
156715077|NCT00535405|565700855|FG000|Overall Study|Withdrawal by Subject|5|||
156715078|NCT00535405|565700856|FG001|Overall Study|Withdrawal by Subject|11|||
156715079|NCT00535405|565700857|FG002|Overall Study|Withdrawal by Subject|10|||
156715080|NCT00535405|565700858|FG003|Overall Study|Withdrawal by Subject|10|||
156715081|NCT00535405|565700859|FG004|Overall Study|Withdrawal by Subject|8|||
156715082|NCT03910673|565700862|FG000|Overall Study|Adverse Event|0|||
156715083|NCT03910673|565700863|FG001|Overall Study|Adverse Event|0|||
156715084|NCT03910673|565700864|FG002|Overall Study|Adverse Event|0|||
156715085|NCT03910673|565700865|FG003|Overall Study|Adverse Event|2|||
156715086|NCT03910673|565700866|FG004|Overall Study|Adverse Event|0|||
156715087|NCT02290405|565700867|FG000|Overall Study|Withdrawal by Subject|1|||
156715088|NCT02290405|565700868|FG001|Overall Study|Withdrawal by Subject|0|||
156715089|NCT02016183|565700869|FG000|Overall Study|Case Report Forms Uncollected|13|||
156715090|NCT02016183|565700869|FG000|Overall Study|Protocol Violation|52|||
156715091|NCT03142191|565700870|FG000|Placebo Controlled Period|Death|0|||
156715092|NCT03142191|565700871|FG001|Placebo Controlled Period|Death|1|||
156792820|NCT01335685|565994769|FG000|Overall Study|Withdrawal by Subject|1|||
156792821|NCT01335685|565994770|FG001|Overall Study|Withdrawal by Subject|0|||
156792822|NCT01335685|565994771|FG002|Overall Study|Withdrawal by Subject|0|||
156792823|NCT01335685|565994772|FG003|Overall Study|Withdrawal by Subject|1|||
156792824|NCT01335685|565994773|FG004|Overall Study|Withdrawal by Subject|0|||
156792825|NCT01335685|565994774|FG005|Overall Study|Withdrawal by Subject|0|||
156792826|NCT01335685|565994775|FG006|Overall Study|Withdrawal by Subject|0|||
156792827|NCT01335685|565994776|FG007|Overall Study|Withdrawal by Subject|0|||
156715093|NCT03142191|565700872|FG002|Placebo Controlled Period|Death|1|||
156715094|NCT03142191|565700873|FG003|Placebo Controlled Period|Death|0|||
156792828|NCT01335685|565994769|FG000|Overall Study|Reason not Specified|0|||
156792829|NCT01335685|565994770|FG001|Overall Study|Reason not Specified|0|||
156715095|NCT03142191|565700874|FG004|Placebo Controlled Period|Death|0|||
156715096|NCT03142191|565700870|FG000|Placebo Controlled Period|Adverse Event|4|||
156715097|NCT03142191|565700871|FG001|Placebo Controlled Period|Adverse Event|5|||
156715098|NCT03142191|565700872|FG002|Placebo Controlled Period|Adverse Event|1|||
156715099|NCT03142191|565700873|FG003|Placebo Controlled Period|Adverse Event|0|||
156715100|NCT03142191|565700874|FG004|Placebo Controlled Period|Adverse Event|0|||
156715101|NCT03142191|565700870|FG000|Placebo Controlled Period|Progressive Disease|1|||
156715102|NCT03142191|565700871|FG001|Placebo Controlled Period|Progressive Disease|0|||
156715103|NCT03142191|565700872|FG002|Placebo Controlled Period|Progressive Disease|1|||
156715104|NCT03142191|565700873|FG003|Placebo Controlled Period|Progressive Disease|0|||
156715105|NCT03142191|565700874|FG004|Placebo Controlled Period|Progressive Disease|0|||
156715106|NCT03142191|565700870|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
156715107|NCT03142191|565700871|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
156715108|NCT03142191|565700872|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
156715109|NCT03142191|565700873|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
156715110|NCT03142191|565700874|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
156715111|NCT03142191|565700870|FG000|Placebo Controlled Period|Other Reasons|1|||
156715112|NCT03142191|565700871|FG001|Placebo Controlled Period|Other Reasons|0|||
156715113|NCT03142191|565700872|FG002|Placebo Controlled Period|Other Reasons|0|||
156715114|NCT03142191|565700873|FG003|Placebo Controlled Period|Other Reasons|0|||
156715115|NCT03142191|565700874|FG004|Placebo Controlled Period|Other Reasons|0|||
156715116|NCT03142191|565700870|FG000|Active Treatment Extension Period|Death|2|||
156715117|NCT03142191|565700871|FG001|Active Treatment Extension Period|Death|1|||
156715118|NCT03142191|565700872|FG002|Active Treatment Extension Period|Death|1|||
156715119|NCT03142191|565700873|FG003|Active Treatment Extension Period|Death|1|||
156715120|NCT03142191|565700874|FG004|Active Treatment Extension Period|Death|0|||
156715121|NCT03142191|565700870|FG000|Active Treatment Extension Period|Adverse Event|6|||
156715122|NCT03142191|565700871|FG001|Active Treatment Extension Period|Adverse Event|5|||
156715123|NCT03142191|565700872|FG002|Active Treatment Extension Period|Adverse Event|4|||
156715124|NCT03142191|565700873|FG003|Active Treatment Extension Period|Adverse Event|1|||
156715125|NCT03142191|565700874|FG004|Active Treatment Extension Period|Adverse Event|0|||
156715126|NCT03142191|565700870|FG000|Active Treatment Extension Period|Progressive Disease|10|||
156715127|NCT03142191|565700871|FG001|Active Treatment Extension Period|Progressive Disease|5|||
156715128|NCT03142191|565700872|FG002|Active Treatment Extension Period|Progressive Disease|4|||
156715129|NCT03142191|565700873|FG003|Active Treatment Extension Period|Progressive Disease|1|||
156715130|NCT03142191|565700874|FG004|Active Treatment Extension Period|Progressive Disease|2|||
156715131|NCT03142191|565700870|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
156715132|NCT03142191|565700871|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
156715133|NCT03142191|565700872|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
156715134|NCT03142191|565700873|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
156715135|NCT03142191|565700874|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
156715136|NCT03142191|565700870|FG000|Active Treatment Extension Period|Physician Decision|2|||
156715137|NCT03142191|565700871|FG001|Active Treatment Extension Period|Physician Decision|0|||
156715138|NCT03142191|565700872|FG002|Active Treatment Extension Period|Physician Decision|0|||
156715139|NCT03142191|565700873|FG003|Active Treatment Extension Period|Physician Decision|0|||
156715140|NCT03142191|565700874|FG004|Active Treatment Extension Period|Physician Decision|0|||
156715141|NCT03142191|565700870|FG000|Active Treatment Extension Period|Other Reasons|3|||
156715142|NCT03142191|565700871|FG001|Active Treatment Extension Period|Other Reasons|3|||
156715143|NCT03142191|565700872|FG002|Active Treatment Extension Period|Other Reasons|3|||
156715144|NCT03142191|565700873|FG003|Active Treatment Extension Period|Other Reasons|8|||
156715145|NCT03142191|565700874|FG004|Active Treatment Extension Period|Other Reasons|3|||
156715146|NCT03142191|565700870|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
156715147|NCT03142191|565700871|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
156715148|NCT03142191|565700872|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
156715149|NCT03142191|565700873|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
156715150|NCT03142191|565700874|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
156715151|NCT00770328|565700879|FG000|Overall Study|Adverse Event|11|||
156715152|NCT00770328|565700880|FG001|Overall Study|Adverse Event|2|||
156715153|NCT00770328|565700879|FG000|Overall Study|Lost to Follow-up|2|||
156715154|NCT00770328|565700880|FG001|Overall Study|Lost to Follow-up|2|||
156715155|NCT01512160|565700883|FG000|Overall Study|Lost to Follow-up|1|||
156715156|NCT01512160|565700884|FG001|Overall Study|Lost to Follow-up|0|||
156715157|NCT01512160|565700885|FG002|Overall Study|Lost to Follow-up|0|||
156715158|NCT01512160|565700886|FG003|Overall Study|Lost to Follow-up|0|||
156715159|NCT01512160|565700883|FG000|Overall Study|Withdrawal by Subject|1|||
156715160|NCT01512160|565700884|FG001|Overall Study|Withdrawal by Subject|0|||
156715161|NCT01512160|565700885|FG002|Overall Study|Withdrawal by Subject|0|||
156715162|NCT01512160|565700886|FG003|Overall Study|Withdrawal by Subject|1|||
156715163|NCT05022212|565700889|FG000|Overall Study|Lost to Follow-up|0|||
156715164|NCT05022212|565700890|FG001|Overall Study|Lost to Follow-up|2|||
156715165|NCT02905032|565700891|FG000|Overall Study|Withdrawal by Subject|2|||
156715166|NCT02905032|565700892|FG001|Overall Study|Withdrawal by Subject|0|||
156715167|NCT02905032|565700893|FG002|Overall Study|Withdrawal by Subject|0|||
156715168|NCT02905032|565700891|FG000|Overall Study|Protocol Violation|6|||
156715169|NCT02905032|565700892|FG001|Overall Study|Protocol Violation|12|||
156715170|NCT02905032|565700893|FG002|Overall Study|Protocol Violation|0|||
156715171|NCT02729909|565700894|FG000|Overall Study|Lost to Follow-up|0|||
156715172|NCT02729909|565700895|FG001|Overall Study|Lost to Follow-up|1|||
156715173|NCT02729909|565700894|FG000|Overall Study|Lack of Efficacy|0|||
156715174|NCT02729909|565700895|FG001|Overall Study|Lack of Efficacy|2|||
156715175|NCT02729909|565700894|FG000|Overall Study|Significant Protocol Deviation|0|||
156715176|NCT02729909|565700895|FG001|Overall Study|Significant Protocol Deviation|2|||
156715177|NCT02729909|565700894|FG000|Overall Study|Voluntary Withdrawal|1|||
156715178|NCT02729909|565700895|FG001|Overall Study|Voluntary Withdrawal|0|||
156715179|NCT00739063|565700897|FG000|Overall Study|Screen failures|8|||
156715180|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
156715181|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
156715182|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
156715183|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
156715184|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
156715185|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715186|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715187|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
156715188|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
156715189|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
156715190|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
157216323|NCT01078623|567539247|FG009|Treatment Period 2|Withdrawal by Subject|0|||
157216324|NCT01078623|567539248|FG010|Treatment Period 2|Withdrawal by Subject|0|||
157216325|NCT01078623|567539249|FG011|Treatment Period 2|Withdrawal by Subject|0|||
157216326|NCT01078623|567539250|FG012|Treatment Period 2|Withdrawal by Subject|0|||
157216327|NCT01078623|567539251|FG013|Treatment Period 2|Withdrawal by Subject|0|||
157216328|NCT01078623|567539252|FG014|Treatment Period 2|Withdrawal by Subject|0|||
157216329|NCT01078623|567539253|FG015|Treatment Period 2|Withdrawal by Subject|0|||
157216330|NCT01078623|567539254|FG016|Treatment Period 2|Withdrawal by Subject|0|||
157216331|NCT01078623|567539255|FG017|Treatment Period 2|Withdrawal by Subject|0|||
157216332|NCT01078623|567539256|FG018|Treatment Period 2|Withdrawal by Subject|0|||
157216333|NCT01078623|567539257|FG019|Treatment Period 2|Withdrawal by Subject|0|||
157216334|NCT01078623|567539238|FG000|Treatment Period 3|Adverse Event|0|||
157216335|NCT01078623|567539239|FG001|Treatment Period 3|Adverse Event|0|||
157216336|NCT01078623|567539240|FG002|Treatment Period 3|Adverse Event|0|||
157216337|NCT01078623|567539241|FG003|Treatment Period 3|Adverse Event|0|||
157216338|NCT01078623|567539242|FG004|Treatment Period 3|Adverse Event|1|||
157216339|NCT01078623|567539243|FG005|Treatment Period 3|Adverse Event|0|||
157216340|NCT01078623|567539244|FG006|Treatment Period 3|Adverse Event|0|||
157216341|NCT01078623|567539245|FG007|Treatment Period 3|Adverse Event|0|||
157216342|NCT01078623|567539246|FG008|Treatment Period 3|Adverse Event|0|||
157216343|NCT01078623|567539247|FG009|Treatment Period 3|Adverse Event|0|||
157216344|NCT01078623|567539248|FG010|Treatment Period 3|Adverse Event|0|||
157216345|NCT01078623|567539249|FG011|Treatment Period 3|Adverse Event|0|||
157216346|NCT01078623|567539250|FG012|Treatment Period 3|Adverse Event|0|||
157216347|NCT01078623|567539251|FG013|Treatment Period 3|Adverse Event|1|||
157216348|NCT01078623|567539252|FG014|Treatment Period 3|Adverse Event|0|||
157216349|NCT01078623|567539253|FG015|Treatment Period 3|Adverse Event|0|||
157216350|NCT01078623|567539254|FG016|Treatment Period 3|Adverse Event|0|||
157216351|NCT01078623|567539255|FG017|Treatment Period 3|Adverse Event|0|||
157216352|NCT01078623|567539256|FG018|Treatment Period 3|Adverse Event|0|||
157216353|NCT01078623|567539257|FG019|Treatment Period 3|Adverse Event|0|||
157216354|NCT01078623|567539238|FG000|Treatment Period 4|Adverse Event|0|||
156715191|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
156715192|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
156715193|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
156715194|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
156715195|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
156715196|NCT00866359|565700898|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
156715197|NCT00866359|565700899|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
156715198|NCT00866359|565700900|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
156715199|NCT00866359|565700901|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
157216355|NCT01078623|567539239|FG001|Treatment Period 4|Adverse Event|0|||
157216356|NCT01078623|567539240|FG002|Treatment Period 4|Adverse Event|1|||
156715200|NCT00866359|565700898|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
156715201|NCT00866359|565700899|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
156715202|NCT00866359|565700900|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
156715203|NCT00866359|565700901|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
156715204|NCT01625091|565700902|FG000|Intervention|Death|1|||
156715205|NCT01625091|565700903|FG001|Intervention|Death|1|||
156874605|NCT02541604|566298697|FG001|Overall Study|Lost to Follow-up|0|||
156874606|NCT02541604|566298698|FG002|Overall Study|Lost to Follow-up|1|||
156874607|NCT02541604|566298699|FG003|Overall Study|Lost to Follow-up|0|||
157216357|NCT01078623|567539241|FG003|Treatment Period 4|Adverse Event|0|||
156874608|NCT02541604|566298700|FG004|Overall Study|Lost to Follow-up|0|||
157017388|NCT05338086|566816160|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
157216358|NCT01078623|567539242|FG004|Treatment Period 4|Adverse Event|0|||
157216359|NCT01078623|567539243|FG005|Treatment Period 4|Adverse Event|0|||
156874609|NCT02541604|566298701|FG005|Overall Study|Lost to Follow-up|1|||
157216360|NCT01078623|567539244|FG006|Treatment Period 4|Adverse Event|0|||
156715206|NCT01625091|565700902|FG000|Intervention|Withdrawal by Subject|4|||
156715207|NCT01625091|565700903|FG001|Intervention|Withdrawal by Subject|1|||
156715208|NCT01625091|565700902|FG000|Intervention|Adverse Event|0|||
156715209|NCT01625091|565700903|FG001|Intervention|Adverse Event|2|||
156715210|NCT01625091|565700902|FG000|Intervention|Lost to Follow-up|4|||
156715211|NCT01625091|565700903|FG001|Intervention|Lost to Follow-up|4|||
156715212|NCT01625091|565700902|FG000|Intervention|Study termination|2|||
156715213|NCT01625091|565700903|FG001|Intervention|Study termination|3|||
156715214|NCT01625091|565700902|FG000|Post-intervention|Death|0|||
156715215|NCT01625091|565700903|FG001|Post-intervention|Death|1|||
156715216|NCT01625091|565700902|FG000|Post-intervention|Lost to Follow-up|2|||
156715217|NCT01625091|565700903|FG001|Post-intervention|Lost to Follow-up|0|||
156715218|NCT01625091|565700902|FG000|Post-intervention|Study termination|2|||
156715219|NCT01625091|565700903|FG001|Post-intervention|Study termination|1|||
156715220|NCT02163057|565700904|FG000|Overall Study|Participant Refusal to Continue|2|||
156715221|NCT02163057|565700905|FG001|Overall Study|Participant Refusal to Continue|2|||
156715222|NCT02163057|565700904|FG000|Overall Study|Participant Significant Noncompliance|0|||
156715223|NCT02163057|565700905|FG001|Overall Study|Participant Significant Noncompliance|1|||
156715224|NCT02163057|565700904|FG000|Overall Study|Progression of Disease|1|||
156715225|NCT02163057|565700905|FG001|Overall Study|Progression of Disease|2|||
156715226|NCT01547390|565700909|FG000|Overall Study|Withdrawal by Subject|10|||
156715227|NCT01547390|565700910|FG001|Overall Study|Withdrawal by Subject|7|||
156715228|NCT01547390|565700909|FG000|Overall Study|termination of pregnancy|0|||
156715229|NCT01547390|565700910|FG001|Overall Study|termination of pregnancy|1|||
156715230|NCT01547390|565700909|FG000|Overall Study|Lost to Follow-up|0|||
156715231|NCT01547390|565700910|FG001|Overall Study|Lost to Follow-up|2|||
157129085|NCT03118947|567223944|FG000|Overall Study|Non-compliance with study drug|1|||
156715232|NCT01547390|565700909|FG000|Overall Study|Adverse Event|3|||
156715233|NCT01547390|565700910|FG001|Overall Study|Adverse Event|0|||
156715234|NCT00720382|565700916|FG000|Overall Study|Adverse Event|54|||
156715235|NCT00720382|565700917|FG001|Overall Study|Adverse Event|17|||
156715236|NCT00720382|565700916|FG000|Overall Study|Lack of Efficacy|18|||
156715237|NCT00720382|565700917|FG001|Overall Study|Lack of Efficacy|7|||
156715238|NCT00720382|565700916|FG000|Overall Study|Non-Compliance|15|||
156715239|NCT00720382|565700917|FG001|Overall Study|Non-Compliance|5|||
156715240|NCT00720382|565700916|FG000|Overall Study|Withdrawal by Subject|47|||
156715241|NCT00720382|565700917|FG001|Overall Study|Withdrawal by Subject|11|||
156715242|NCT00720382|565700916|FG000|Overall Study|Lost to Follow-up|28|||
156715243|NCT00720382|565700917|FG001|Overall Study|Lost to Follow-up|14|||
156715244|NCT00720382|565700916|FG000|Overall Study|administrative|14|||
156715245|NCT00720382|565700917|FG001|Overall Study|administrative|5|||
156715246|NCT05192889|565700918|FG000|Block 1: All Eligible Patients|Death|2|||
156715247|NCT05192889|565700919|FG001|Block 1: All Eligible Patients|Death|0|||
156792830|NCT01335685|565994771|FG002|Overall Study|Reason not Specified|1|||
156792831|NCT01335685|565994772|FG003|Overall Study|Reason not Specified|0|||
156792832|NCT01335685|565994773|FG004|Overall Study|Reason not Specified|0|||
156792833|NCT01335685|565994774|FG005|Overall Study|Reason not Specified|1|||
156792834|NCT01335685|565994775|FG006|Overall Study|Reason not Specified|0|||
156792835|NCT01335685|565994776|FG007|Overall Study|Reason not Specified|0|||
156792836|NCT02554474|565994779|FG000|Overall Study|Protocol Violation|1|||
156792837|NCT02554474|565994780|FG001|Overall Study|Protocol Violation|1|||
156792838|NCT02554474|565994779|FG000|Overall Study|Health issue not related to the study|1|||
156792839|NCT02554474|565994780|FG001|Overall Study|Health issue not related to the study|0|||
156792840|NCT02554474|565994779|FG000|Overall Study|Withdrawal by Subject|1|||
156792841|NCT02554474|565994780|FG001|Overall Study|Withdrawal by Subject|1|||
156792842|NCT03211832|565994781|FG000|Overall Study|No longer with agency|32|||
156792843|NCT03211832|565994782|FG001|Overall Study|No longer with agency|49|||
156792844|NCT03211832|565994783|FG002|Overall Study|No longer with agency|30|||
156792845|NCT03211832|565994781|FG000|Overall Study|Declined survey|3|||
156792846|NCT03211832|565994782|FG001|Overall Study|Declined survey|3|||
156792847|NCT03211832|565994783|FG002|Overall Study|Declined survey|2|||
156792848|NCT03211832|565994781|FG000|Overall Study|Not available during data collection|1|||
156792849|NCT03211832|565994782|FG001|Overall Study|Not available during data collection|0|||
156792850|NCT03211832|565994783|FG002|Overall Study|Not available during data collection|2|||
156874610|NCT02541604|566298702|FG006|Overall Study|Lost to Follow-up|1|||
156874611|NCT02541604|566298703|FG007|Overall Study|Lost to Follow-up|0|||
157129086|NCT03118947|567223944|FG000|Overall Study|Protocol Violation|2|||
156715248|NCT05192889|565700920|FG002|Block 1: All Eligible Patients|Death|0|||
156715249|NCT05192889|565700918|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
156792851|NCT00855166|565994784|FG000|Overall Study|Adverse Event|0|||
156792852|NCT00855166|565994785|FG001|Overall Study|Adverse Event|2|||
156792853|NCT00855166|565994784|FG000|Overall Study|Death|0|||
156874612|NCT02541604|566298704|FG008|Overall Study|Lost to Follow-up|0|||
156715250|NCT05192889|565700919|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
156715251|NCT05192889|565700920|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
156715252|NCT05192889|565700918|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
156715253|NCT05192889|565700919|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
156792854|NCT00855166|565994785|FG001|Overall Study|Death|1|||
156792855|NCT00855166|565994784|FG000|Overall Study|Withdrawal by Subject|1|||
156792856|NCT00855166|565994785|FG001|Overall Study|Withdrawal by Subject|4|||
156792857|NCT00855166|565994784|FG000|Overall Study|Poor/non-compliance|2|||
156792858|NCT00855166|565994785|FG001|Overall Study|Poor/non-compliance|0|||
156792859|NCT00855166|565994784|FG000|Overall Study|Administrative reasons by sponsor|1|||
156792860|NCT00855166|565994785|FG001|Overall Study|Administrative reasons by sponsor|0|||
156792861|NCT00855166|565994784|FG000|Overall Study|Subject no longer meets study criteria|1|||
156792862|NCT00855166|565994785|FG001|Overall Study|Subject no longer meets study criteria|1|||
156792863|NCT03777020|565994789|FG000|Overall Study|Withdrawal by Subject|4|||
156792864|NCT03777020|565994790|FG001|Overall Study|Withdrawal by Subject|4|||
156792865|NCT03777020|565994789|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
156792866|NCT03777020|565994790|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
156792867|NCT00489476|565994791|FG000|Overall Study|Lost to Follow-up|0|||
156792868|NCT00489476|565994792|FG001|Overall Study|Lost to Follow-up|1|||
156792869|NCT00489476|565994793|FG002|Overall Study|Lost to Follow-up|0|||
156792870|NCT00489476|565994794|FG003|Overall Study|Lost to Follow-up|0|||
156792871|NCT03460704|565994795|FG000|Overall Study|Withdrawal by Subject|11|||
156792872|NCT03460704|565994796|FG001|Overall Study|Withdrawal by Subject|14|||
156792873|NCT03460704|565994795|FG000|Overall Study|Study terminated by the Sponsor|29|||
156792874|NCT03460704|565994796|FG001|Overall Study|Study terminated by the Sponsor|19|||
156792875|NCT03460704|565994795|FG000|Overall Study|Adverse Event|10|||
156792876|NCT03460704|565994796|FG001|Overall Study|Adverse Event|5|||
156792877|NCT03460704|565994795|FG000|Overall Study|Death|3|||
156792878|NCT03460704|565994796|FG001|Overall Study|Death|2|||
156792879|NCT03460704|565994795|FG000|Overall Study|Non-Compliance with Study Drug|3|||
156792880|NCT03460704|565994796|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156792881|NCT03460704|565994795|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156792882|NCT03460704|565994796|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
156792883|NCT03460704|565994795|FG000|Overall Study|Other|2|||
156792884|NCT03460704|565994796|FG001|Overall Study|Other|1|||
156792885|NCT02913326|565994797|FG000|Overall Study|Reason not listed|0|||
156792886|NCT02913326|565994798|FG001|Overall Study|Reason not listed|1|||
157129087|NCT03118947|567223944|FG000|Overall Study|Withdrawal by Subject|3|||
157129088|NCT03118947|567223944|FG000|Overall Study|Withdrawal by caregiver|3|||
157129089|NCT03118947|567223944|FG000|Overall Study|Change in patient's living situation|4|||
157129090|NCT03118947|567223944|FG000|Overall Study|Lost to Follow-up|2|||
157129091|NCT04451330|567223945|FG000|Overall Study|Adverse Event|1|||
157129092|NCT04451330|567223946|FG001|Overall Study|Adverse Event|2|||
157129093|NCT04451330|567223945|FG000|Overall Study|Lost to Follow-up|5|||
157129094|NCT04451330|567223946|FG001|Overall Study|Lost to Follow-up|0|||
157129095|NCT04451330|567223945|FG000|Overall Study|Withdrawal by Subject|3|||
157129096|NCT04451330|567223946|FG001|Overall Study|Withdrawal by Subject|1|||
157129097|NCT04451330|567223945|FG000|Overall Study|Withdrawal by parent/guardian|1|||
157129098|NCT04451330|567223946|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157129099|NCT04451330|567223945|FG000|Overall Study|Other than specified|0|||
157129100|NCT04451330|567223946|FG001|Overall Study|Other than specified|1|||
157129101|NCT01987908|567223959|FG000|Placebo Lead-in Period|Adverse Event|2|||
157129102|NCT01987908|567223960|FG001|Placebo Lead-in Period|Adverse Event|0|||
157129103|NCT01987908|567223961|FG002|Placebo Lead-in Period|Adverse Event|0|||
157129104|NCT01987908|567223959|FG000|Placebo Lead-in Period|Physician Decision|2|||
157129105|NCT01987908|567223960|FG001|Placebo Lead-in Period|Physician Decision|0|||
157129106|NCT01987908|567223961|FG002|Placebo Lead-in Period|Physician Decision|0|||
157129107|NCT01987908|567223959|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
157129108|NCT01987908|567223960|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
157129109|NCT01987908|567223961|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
157129110|NCT01987908|567223959|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
157129111|NCT01987908|567223960|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
157129112|NCT01987908|567223961|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
157129113|NCT01987908|567223959|FG000|Treatment Period|Adverse Event|0|||
157129114|NCT01987908|567223960|FG001|Treatment Period|Adverse Event|1|||
157129115|NCT01987908|567223961|FG002|Treatment Period|Adverse Event|1|||
157129116|NCT01987908|567223959|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
157129117|NCT01987908|567223960|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
157129118|NCT01987908|567223961|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
157129119|NCT01987908|567223959|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
157129120|NCT01987908|567223960|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
156792887|NCT02913326|565994797|FG000|Overall Study|Lost to Follow-up|0|||
156792888|NCT02913326|565994798|FG001|Overall Study|Lost to Follow-up|1|||
156792889|NCT02913326|565994797|FG000|Overall Study|Adverse Event|1|||
156792890|NCT02913326|565994798|FG001|Overall Study|Adverse Event|0|||
156792891|NCT01767857|565994799|FG000|Overall Study|Adverse Event|27|||
156792892|NCT01767857|565994800|FG001|Overall Study|Adverse Event|7|||
156792893|NCT01767857|565994799|FG000|Overall Study|Death|28|||
156715254|NCT05192889|565700920|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
156715255|NCT03713593|565703065|FG000|Overall Study|Sponsor Decision|73|||
156715256|NCT03713593|565703066|FG001|Overall Study|Sponsor Decision|41|||
156715257|NCT03713593|565703065|FG000|Overall Study|Lost to Follow-up|2|||
156715258|NCT03713593|565703066|FG001|Overall Study|Lost to Follow-up|1|||
156715259|NCT03713593|565703065|FG000|Overall Study|Death|314|||
156715260|NCT03713593|565703066|FG001|Overall Study|Death|349|||
156715261|NCT03713593|565703065|FG000|Overall Study|Withdrawal by Subject|6|||
156715262|NCT03713593|565703066|FG001|Overall Study|Withdrawal by Subject|8|||
156715263|NCT05061134|565703067|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
156715264|NCT05061134|565703068|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
156715265|NCT05061134|565703069|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
156715266|NCT05061134|565703067|FG000|Overall Study|Subject not treated|0|||
156715267|NCT05061134|565703068|FG001|Overall Study|Subject not treated|0|||
156715268|NCT05061134|565703069|FG002|Overall Study|Subject not treated|2|||
156715269|NCT05061134|565703067|FG000|Overall Study|Other|0|||
156715270|NCT05061134|565703068|FG001|Overall Study|Other|0|||
156715271|NCT05061134|565703069|FG002|Overall Study|Other|9|||
156715272|NCT05061134|565703067|FG000|Overall Study|Withdrawal by Subject|9|||
156715273|NCT05061134|565703068|FG001|Overall Study|Withdrawal by Subject|8|||
156715274|NCT05061134|565703069|FG002|Overall Study|Withdrawal by Subject|5|||
156715275|NCT05061134|565703067|FG000|Overall Study|Study Terminated by Sponsor|22|||
156715276|NCT05061134|565703068|FG001|Overall Study|Study Terminated by Sponsor|14|||
156715277|NCT05061134|565703069|FG002|Overall Study|Study Terminated by Sponsor|7|||
156715278|NCT05061134|565703067|FG000|Overall Study|Progressive Disease|1|||
156715279|NCT05061134|565703068|FG001|Overall Study|Progressive Disease|2|||
156715280|NCT05061134|565703069|FG002|Overall Study|Progressive Disease|0|||
156715281|NCT05061134|565703067|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
156715282|NCT05061134|565703068|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
156715283|NCT05061134|565703069|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
156715284|NCT05061134|565703067|FG000|Overall Study|Lost to Follow-up|1|||
156715285|NCT05061134|565703068|FG001|Overall Study|Lost to Follow-up|0|||
156715286|NCT05061134|565703069|FG002|Overall Study|Lost to Follow-up|0|||
156715287|NCT05061134|565703067|FG000|Overall Study|Physician Decision|1|||
156715288|NCT05061134|565703068|FG001|Overall Study|Physician Decision|1|||
156715289|NCT05061134|565703069|FG002|Overall Study|Physician Decision|0|||
156715290|NCT05061134|565703067|FG000|Overall Study|Disease progression|1|||
156715291|NCT05061134|565703068|FG001|Overall Study|Disease progression|0|||
156715292|NCT05061134|565703069|FG002|Overall Study|Disease progression|0|||
156715293|NCT05061134|565703067|FG000|Overall Study|Death|43|||
156715294|NCT05061134|565703068|FG001|Overall Study|Death|23|||
156715295|NCT05061134|565703069|FG002|Overall Study|Death|14|||
156715296|NCT05061134|565703067|FG000|Overall Study|Database lock|2|||
156715297|NCT05061134|565703068|FG001|Overall Study|Database lock|0|||
156715298|NCT05061134|565703069|FG002|Overall Study|Database lock|0|||
156715299|NCT03176134|565703070|FG000|Overall Study|Lost to Follow-up|0|||
156715300|NCT03176134|565703071|FG001|Overall Study|Lost to Follow-up|2|||
156715301|NCT03176134|565703072|FG002|Overall Study|Lost to Follow-up|0|||
156715302|NCT03176134|565703073|FG003|Overall Study|Lost to Follow-up|0|||
156715303|NCT03176134|565703074|FG004|Overall Study|Lost to Follow-up|0|||
156715304|NCT03176134|565703075|FG005|Overall Study|Lost to Follow-up|0|||
156715305|NCT03176134|565703076|FG006|Overall Study|Lost to Follow-up|0|||
156715306|NCT03176134|565703077|FG007|Overall Study|Lost to Follow-up|0|||
156715307|NCT03176134|565703070|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156715308|NCT03176134|565703071|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156715309|NCT03176134|565703072|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156715310|NCT03176134|565703073|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156715311|NCT03176134|565703074|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156715312|NCT03176134|565703075|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156715313|NCT03176134|565703076|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
156715314|NCT03176134|565703077|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
156715315|NCT03410056|565703082|FG000|Overall Study|Decision by Sponsor|0|||
156715316|NCT03410056|565703083|FG001|Overall Study|Decision by Sponsor|0|||
156715317|NCT03410056|565703084|FG002|Overall Study|Decision by Sponsor|3|||
157017389|NCT05338086|566816156|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
157017390|NCT05338086|566816157|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
157017391|NCT05338086|566816158|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
157017392|NCT05338086|566816159|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
156715318|NCT03410056|565703085|FG003|Overall Study|Decision by Sponsor|0|||
156715319|NCT03410056|565703086|FG004|Overall Study|Decision by Sponsor|0|||
156715320|NCT03410056|565703087|FG005|Overall Study|Decision by Sponsor|0|||
156715321|NCT03410056|565703088|FG006|Overall Study|Decision by Sponsor|0|||
156715322|NCT03410056|565703082|FG000|Overall Study|Withdrawal by Subject|0|||
156715323|NCT03410056|565703083|FG001|Overall Study|Withdrawal by Subject|2|||
156715324|NCT03410056|565703084|FG002|Overall Study|Withdrawal by Subject|5|||
156715325|NCT03410056|565703085|FG003|Overall Study|Withdrawal by Subject|5|||
156715326|NCT03410056|565703086|FG004|Overall Study|Withdrawal by Subject|0|||
156715327|NCT03410056|565703087|FG005|Overall Study|Withdrawal by Subject|0|||
156715328|NCT03410056|565703088|FG006|Overall Study|Withdrawal by Subject|0|||
156715329|NCT04182490|565703095|FG000|Overall Study|Withdrawal by Subject|3|||
156715330|NCT04182490|565703096|FG001|Overall Study|Withdrawal by Subject|3|||
156715331|NCT04182490|565703095|FG000|Overall Study|Lost to Follow-up|0|||
156715332|NCT04182490|565703096|FG001|Overall Study|Lost to Follow-up|1|||
156715333|NCT04182490|565703095|FG000|Overall Study|Physician Decision|0|||
156715334|NCT04182490|565703096|FG001|Overall Study|Physician Decision|1|||
156715335|NCT00661193|565703108|FG000|Overall Study|Adverse Event|2|||
156715336|NCT00661193|565703109|FG001|Overall Study|Adverse Event|1|||
156715337|NCT00661193|565703108|FG000|Overall Study|Withdrawal by Subject|3|||
156715338|NCT00661193|565703109|FG001|Overall Study|Withdrawal by Subject|1|||
156715339|NCT00661193|565703108|FG000|Overall Study|Progression|27|||
156715340|NCT00661193|565703109|FG001|Overall Study|Progression|24|||
156715341|NCT00661193|565703108|FG000|Overall Study|Not protocol specified|1|||
156715342|NCT00661193|565703109|FG001|Overall Study|Not protocol specified|0|||
156715343|NCT01811472|565703110|FG000|Overall Study|Adverse Event|1|||
156715344|NCT01811472|565703111|FG001|Overall Study|Adverse Event|0|||
156715345|NCT01811472|565703112|FG002|Overall Study|Adverse Event|4|||
156715346|NCT01811472|565703110|FG000|Overall Study|Lost to Follow-up|0|||
156715347|NCT01811472|565703111|FG001|Overall Study|Lost to Follow-up|0|||
156715348|NCT01811472|565703112|FG002|Overall Study|Lost to Follow-up|1|||
156715349|NCT01811472|565703110|FG000|Overall Study|Subject/guardian decision|1|||
156715350|NCT01811472|565703111|FG001|Overall Study|Subject/guardian decision|0|||
156715351|NCT01811472|565703112|FG002|Overall Study|Subject/guardian decision|0|||
156715352|NCT04882241|565703117|FG000|Overall Study|Ongoing in study|46|||
156715353|NCT04882241|565703118|FG001|Overall Study|Ongoing in study|48|||
156715354|NCT04882241|565703119|FG002|Overall Study|Ongoing in study|0|||
156715355|NCT04882241|565703120|FG003|Overall Study|Ongoing in study|0|||
156715356|NCT04882241|565703117|FG000|Overall Study|Death|13|||
156715357|NCT04882241|565703118|FG001|Overall Study|Death|13|||
156715358|NCT04882241|565703119|FG002|Overall Study|Death|0|||
156715359|NCT04882241|565703120|FG003|Overall Study|Death|0|||
156715360|NCT02719184|565703128|FG000|Overall Study|Other than listed|1|||
156715361|NCT02719184|565703129|FG001|Overall Study|Other than listed|12|||
156715362|NCT02719184|565703130|FG002|Overall Study|Other than listed|13|||
156715363|NCT02719184|565703131|FG003|Overall Study|Other than listed|22|||
156715364|NCT02719184|565703132|FG004|Overall Study|Other than listed|9|||
156715365|NCT02719184|565703128|FG000|Overall Study|Withdrawal by Subject|5|||
156715366|NCT02719184|565703129|FG001|Overall Study|Withdrawal by Subject|3|||
156715367|NCT02719184|565703130|FG002|Overall Study|Withdrawal by Subject|6|||
156874613|NCT02541604|566298705|FG009|Overall Study|Lost to Follow-up|0|||
156874614|NCT02541604|566298706|FG010|Overall Study|Lost to Follow-up|0|||
156874615|NCT02541604|566298707|FG011|Overall Study|Lost to Follow-up|0|||
156874616|NCT02541604|566298696|FG000|Overall Study|Withdrawal by Subject|2|||
156874617|NCT02541604|566298697|FG001|Overall Study|Withdrawal by Subject|0|||
156874618|NCT02541604|566298698|FG002|Overall Study|Withdrawal by Subject|1|||
156874619|NCT02541604|566298699|FG003|Overall Study|Withdrawal by Subject|0|||
156874620|NCT02541604|566298700|FG004|Overall Study|Withdrawal by Subject|1|||
156874621|NCT02541604|566298701|FG005|Overall Study|Withdrawal by Subject|1|||
156874622|NCT02541604|566298702|FG006|Overall Study|Withdrawal by Subject|0|||
156874623|NCT02541604|566298703|FG007|Overall Study|Withdrawal by Subject|0|||
156874624|NCT02541604|566298704|FG008|Overall Study|Withdrawal by Subject|1|||
156874625|NCT02541604|566298705|FG009|Overall Study|Withdrawal by Subject|0|||
156874626|NCT02541604|566298706|FG010|Overall Study|Withdrawal by Subject|0|||
156874627|NCT02541604|566298707|FG011|Overall Study|Withdrawal by Subject|0|||
156715368|NCT02719184|565703131|FG003|Overall Study|Withdrawal by Subject|6|||
156715369|NCT02719184|565703132|FG004|Overall Study|Withdrawal by Subject|0|||
156715370|NCT02719184|565703128|FG000|Overall Study|Lost to Follow-up|0|||
156715371|NCT02719184|565703129|FG001|Overall Study|Lost to Follow-up|4|||
156715372|NCT02719184|565703130|FG002|Overall Study|Lost to Follow-up|1|||
156715373|NCT02719184|565703131|FG003|Overall Study|Lost to Follow-up|3|||
156715374|NCT02719184|565703132|FG004|Overall Study|Lost to Follow-up|0|||
156715375|NCT02719184|565703128|FG000|Overall Study|Protocol Violation|0|||
156715376|NCT02719184|565703129|FG001|Overall Study|Protocol Violation|3|||
156715377|NCT02719184|565703130|FG002|Overall Study|Protocol Violation|0|||
156874628|NCT02541604|566298696|FG000|Overall Study|Study Terminated by Sponsor|1|||
156874629|NCT02541604|566298697|FG001|Overall Study|Study Terminated by Sponsor|4|||
157129121|NCT01987908|567223961|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
157129122|NCT00189462|567223962|FG000|Overall Study|Lack of Efficacy|5|||
157129123|NCT00189462|567223963|FG001|Overall Study|Lack of Efficacy|1|||
156715378|NCT02719184|565703131|FG003|Overall Study|Protocol Violation|2|||
156715379|NCT02719184|565703132|FG004|Overall Study|Protocol Violation|0|||
156715380|NCT02719184|565703128|FG000|Overall Study|Adverse Event|0|||
156715381|NCT02719184|565703129|FG001|Overall Study|Adverse Event|0|||
156874630|NCT02541604|566298698|FG002|Overall Study|Study Terminated by Sponsor|2|||
156874631|NCT02541604|566298699|FG003|Overall Study|Study Terminated by Sponsor|1|||
157129124|NCT00189462|567223962|FG000|Overall Study|Lost to Follow-up|18|||
156715382|NCT02719184|565703130|FG002|Overall Study|Adverse Event|0|||
156715383|NCT02719184|565703131|FG003|Overall Study|Adverse Event|3|||
156715384|NCT02719184|565703132|FG004|Overall Study|Adverse Event|0|||
156715385|NCT04108299|565703134|FG000|Overall Study|Not interested in participating|2|||
156715386|NCT04108299|565703135|FG001|Overall Study|Not interested in participating|1|||
156715387|NCT04108299|565703136|FG002|Overall Study|Not interested in participating|2|||
156715388|NCT04108299|565703137|FG003|Overall Study|Not interested in participating|1|||
156715389|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
156715390|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
156715391|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
156715392|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
156715393|NCT05024747|565703141|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
156715394|NCT05024747|565703142|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
156715395|NCT00662649|565703143|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
156715396|NCT00662649|565703144|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
156715397|NCT00662649|565703145|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
156715398|NCT00662649|565703146|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
156715399|NCT00662649|565703147|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
156715400|NCT00662649|565703143|FG000|Core Study (24 Months)|Adverse Event|22|||
156715401|NCT00662649|565703144|FG001|Core Study (24 Months)|Adverse Event|13|||
156715402|NCT00662649|565703145|FG002|Core Study (24 Months)|Adverse Event|18|||
156715403|NCT00662649|565703146|FG003|Core Study (24 Months)|Adverse Event|0|||
156715404|NCT00662649|565703147|FG004|Core Study (24 Months)|Adverse Event|0|||
156715405|NCT00662649|565703143|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
156715406|NCT00662649|565703144|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
156715407|NCT00662649|565703145|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
156715408|NCT00662649|565703146|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
156715409|NCT00662649|565703147|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
156715410|NCT00662649|565703143|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
156715411|NCT00662649|565703144|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
156715412|NCT00662649|565703145|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
156715413|NCT00662649|565703146|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
156715414|NCT00662649|565703147|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
156715415|NCT00662649|565703143|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
156715416|NCT00662649|565703144|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
156715417|NCT00662649|565703145|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
156715418|NCT00662649|565703146|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
156715419|NCT00662649|565703147|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
156715420|NCT00662649|565703143|FG000|Core Study (24 Months)|Protocol Violation|5|||
156715421|NCT00662649|565703144|FG001|Core Study (24 Months)|Protocol Violation|5|||
156715422|NCT00662649|565703145|FG002|Core Study (24 Months)|Protocol Violation|4|||
156715423|NCT00662649|565703146|FG003|Core Study (24 Months)|Protocol Violation|0|||
156715424|NCT00662649|565703147|FG004|Core Study (24 Months)|Protocol Violation|0|||
156715425|NCT00662649|565703143|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
156715426|NCT00662649|565703144|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
156715427|NCT00662649|565703145|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
156715428|NCT00662649|565703146|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
156715429|NCT00662649|565703147|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
156715430|NCT00662649|565703143|FG000|Core Study (24 Months)|Death|1|||
156715431|NCT00662649|565703144|FG001|Core Study (24 Months)|Death|0|||
156715432|NCT00662649|565703145|FG002|Core Study (24 Months)|Death|2|||
156715433|NCT00662649|565703146|FG003|Core Study (24 Months)|Death|0|||
156715434|NCT00662649|565703147|FG004|Core Study (24 Months)|Death|0|||
156715435|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
156715436|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
156715437|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
156792894|NCT01767857|565994800|FG001|Overall Study|Death|13|||
156792895|NCT01767857|565994799|FG000|Overall Study|Lack of Efficacy|299|||
156792896|NCT01767857|565994800|FG001|Overall Study|Lack of Efficacy|151|||
156792897|NCT01767857|565994799|FG000|Overall Study|Lost to Follow-up|1|||
156792898|NCT01767857|565994800|FG001|Overall Study|Lost to Follow-up|1|||
156792899|NCT01767857|565994799|FG000|Overall Study|Withdrawal by Subject|38|||
156792900|NCT01767857|565994800|FG001|Overall Study|Withdrawal by Subject|18|||
156792901|NCT01767857|565994799|FG000|Overall Study|Physician Decision|17|||
156792902|NCT01767857|565994800|FG001|Overall Study|Physician Decision|10|||
157216361|NCT01078623|567539245|FG007|Treatment Period 4|Adverse Event|0|||
156715438|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
156715439|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
156715440|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
156792903|NCT01767857|565994799|FG000|Overall Study|Protocol Terminated|1|||
156792904|NCT01767857|565994800|FG001|Overall Study|Protocol Terminated|0|||
156715441|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
156715442|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
156715443|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
156715444|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
156715445|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715446|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715447|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715448|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
156715449|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
156715450|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
156715451|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
156715452|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
156715453|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
156715454|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
156715455|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
156715456|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
156715457|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
156715458|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
156715459|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
156715460|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
156715461|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
156715462|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715463|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715464|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
156715465|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
156715466|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
156715467|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
156715468|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
156715469|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
156715470|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715471|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
156715472|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715473|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715474|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
156715475|NCT00662649|565703143|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
156715476|NCT00662649|565703144|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
156715477|NCT00662649|565703145|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
156715478|NCT00662649|565703146|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
156715479|NCT00662649|565703147|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
156715480|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Adverse Event|2|||
156715481|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Adverse Event|1|||
156715482|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
156715483|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
156715484|NCT01026194|565703149|FG000|Period 1：Double Blind Period|Physician Decision|0|||
156715485|NCT01026194|565703150|FG001|Period 1：Double Blind Period|Physician Decision|4|||
156715486|NCT01026194|565703149|FG000|Period 2：Open-label Period|Adverse Event|4|||
156715487|NCT01026194|565703150|FG001|Period 2：Open-label Period|Adverse Event|5|||
156715488|NCT01026194|565703149|FG000|Period 2：Open-label Period|Physician Decision|3|||
156715489|NCT01026194|565703150|FG001|Period 2：Open-label Period|Physician Decision|1|||
156715490|NCT01026194|565703149|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
156715491|NCT01026194|565703150|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
156715492|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
156715493|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
156715494|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
156715495|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
157017393|NCT05338086|566816160|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
157017394|NCT06066541|566816170|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
157017395|NCT06066541|566816171|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
157017396|NCT06066541|566816172|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
157017397|NCT06066541|566816173|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
157017398|NCT06066541|566816174|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
157017399|NCT06066541|566816175|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
157017400|NCT06066541|566816176|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
157017401|NCT06066541|566816170|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
156715496|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
156715497|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
156715498|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715499|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715500|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715501|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715502|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715503|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715504|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715505|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715506|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715507|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715508|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
156715509|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715510|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715511|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
156715512|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715513|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
156715514|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
156715515|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715516|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715517|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715518|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715519|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715520|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715521|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715522|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715523|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715524|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715525|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
156715526|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
156715527|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715528|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715529|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
156715530|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
156715531|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
156715532|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715533|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715534|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715535|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715536|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715537|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715538|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715539|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715540|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715541|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715542|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
156715543|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715544|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
156715545|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
156715546|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
157129125|NCT00189462|567223963|FG001|Overall Study|Lost to Follow-up|20|||
157129126|NCT00849667|567223964|FG000|Overall Study|Withdrawal by Subject|16|||
157129127|NCT00849667|567223965|FG001|Overall Study|Withdrawal by Subject|33|||
157129128|NCT00849667|567223966|FG002|Overall Study|Withdrawal by Subject|35|||
157129129|NCT00849667|567223964|FG000|Overall Study|Lost to Follow-up|8|||
157129130|NCT00849667|567223965|FG001|Overall Study|Lost to Follow-up|8|||
157129131|NCT00849667|567223966|FG002|Overall Study|Lost to Follow-up|8|||
157129132|NCT00849667|567223964|FG000|Overall Study|Adverse Event|1|||
157129133|NCT00849667|567223965|FG001|Overall Study|Adverse Event|2|||
157129134|NCT00849667|567223966|FG002|Overall Study|Adverse Event|0|||
157129135|NCT00849667|567223964|FG000|Overall Study|Other|18|||
157129136|NCT00849667|567223965|FG001|Overall Study|Other|19|||
157129137|NCT00849667|567223966|FG002|Overall Study|Other|18|||
157129138|NCT00849667|567223964|FG000|Overall Study|Progressive disease|119|||
156715547|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
156715548|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
156715549|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715550|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
157129139|NCT00849667|567223965|FG001|Overall Study|Progressive disease|100|||
157129140|NCT00849667|567223966|FG002|Overall Study|Progressive disease|112|||
156715551|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715552|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715553|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715554|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715555|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715556|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715557|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715558|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715559|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
156715560|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715561|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715562|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
156715563|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
156715564|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715565|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715566|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715567|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715568|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715569|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715570|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715571|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715572|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715573|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715574|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715575|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715576|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
156715577|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715578|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715579|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715580|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715581|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
156715582|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715583|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715584|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715585|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715586|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715587|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715588|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715589|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715590|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715591|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715592|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715593|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
156715594|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715595|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
156715596|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715597|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715598|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715599|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715600|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715601|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715602|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715603|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715604|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715605|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715606|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156792905|NCT01767857|565994799|FG000|Overall Study|Randomized But Never Treated|19|||
156792906|NCT01767857|565994800|FG001|Overall Study|Randomized But Never Treated|13|||
156792907|NCT01421459|565994801|FG000|Overall Study|Adverse Event|6|||
156792908|NCT01421459|565994802|FG001|Overall Study|Adverse Event|10|||
156792909|NCT01421459|565994801|FG000|Overall Study|Death|1|||
156792910|NCT01421459|565994802|FG001|Overall Study|Death|1|||
156715607|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156792911|NCT01421459|565994801|FG000|Overall Study|Lack of Efficacy|1|||
156792912|NCT01421459|565994802|FG001|Overall Study|Lack of Efficacy|2|||
156792913|NCT01421459|565994801|FG000|Overall Study|Lost to Follow-up|8|||
156792914|NCT01421459|565994802|FG001|Overall Study|Lost to Follow-up|9|||
157216362|NCT01078623|567539246|FG008|Treatment Period 4|Adverse Event|0|||
157216363|NCT01078623|567539247|FG009|Treatment Period 4|Adverse Event|0|||
157216364|NCT01078623|567539248|FG010|Treatment Period 4|Adverse Event|0|||
157216365|NCT01078623|567539249|FG011|Treatment Period 4|Adverse Event|0|||
157216366|NCT01078623|567539250|FG012|Treatment Period 4|Adverse Event|0|||
157216367|NCT01078623|567539251|FG013|Treatment Period 4|Adverse Event|0|||
157216368|NCT01078623|567539252|FG014|Treatment Period 4|Adverse Event|0|||
157216369|NCT01078623|567539253|FG015|Treatment Period 4|Adverse Event|0|||
157216370|NCT01078623|567539254|FG016|Treatment Period 4|Adverse Event|0|||
157216371|NCT01078623|567539255|FG017|Treatment Period 4|Adverse Event|0|||
157216372|NCT01078623|567539256|FG018|Treatment Period 4|Adverse Event|0|||
157216373|NCT01078623|567539257|FG019|Treatment Period 4|Adverse Event|0|||
157216374|NCT01078623|567539238|FG000|Treatment Period 4|Withdrawal by Subject|0|||
157216375|NCT01078623|567539239|FG001|Treatment Period 4|Withdrawal by Subject|0|||
157216376|NCT01078623|567539240|FG002|Treatment Period 4|Withdrawal by Subject|0|||
157216377|NCT01078623|567539241|FG003|Treatment Period 4|Withdrawal by Subject|0|||
157216378|NCT01078623|567539242|FG004|Treatment Period 4|Withdrawal by Subject|0|||
157216379|NCT01078623|567539243|FG005|Treatment Period 4|Withdrawal by Subject|0|||
157216380|NCT01078623|567539244|FG006|Treatment Period 4|Withdrawal by Subject|0|||
157216381|NCT01078623|567539245|FG007|Treatment Period 4|Withdrawal by Subject|0|||
157216382|NCT01078623|567539246|FG008|Treatment Period 4|Withdrawal by Subject|0|||
157216383|NCT01078623|567539247|FG009|Treatment Period 4|Withdrawal by Subject|0|||
157216384|NCT01078623|567539248|FG010|Treatment Period 4|Withdrawal by Subject|0|||
157216385|NCT01078623|567539249|FG011|Treatment Period 4|Withdrawal by Subject|0|||
157216386|NCT01078623|567539250|FG012|Treatment Period 4|Withdrawal by Subject|0|||
157216387|NCT01078623|567539251|FG013|Treatment Period 4|Withdrawal by Subject|0|||
157216388|NCT01078623|567539252|FG014|Treatment Period 4|Withdrawal by Subject|0|||
157216389|NCT01078623|567539253|FG015|Treatment Period 4|Withdrawal by Subject|1|||
157216390|NCT01078623|567539254|FG016|Treatment Period 4|Withdrawal by Subject|0|||
157216391|NCT01078623|567539255|FG017|Treatment Period 4|Withdrawal by Subject|0|||
157216392|NCT01078623|567539256|FG018|Treatment Period 4|Withdrawal by Subject|0|||
157216393|NCT01078623|567539257|FG019|Treatment Period 4|Withdrawal by Subject|0|||
157216394|NCT00463866|567539258|FG000|Overall Study|Adverse Event|70|||
157216395|NCT00463866|567539259|FG001|Overall Study|Adverse Event|93|||
157216396|NCT00463866|567539258|FG000|Overall Study|Withdrawal by Subject|81|||
157216397|NCT00463866|567539259|FG001|Overall Study|Withdrawal by Subject|79|||
157216398|NCT00463866|567539258|FG000|Overall Study|Lost to Follow-up|46|||
157216399|NCT00463866|567539259|FG001|Overall Study|Lost to Follow-up|55|||
157216400|NCT00463866|567539258|FG000|Overall Study|Incorrect Enrolment|64|||
157216401|NCT00463866|567539259|FG001|Overall Study|Incorrect Enrolment|66|||
157216402|NCT00463866|567539258|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
157216403|NCT00463866|567539259|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
157216404|NCT00463866|567539258|FG000|Overall Study|Safety Reason|1|||
157216405|NCT00463866|567539259|FG001|Overall Study|Safety Reason|3|||
157216406|NCT00463866|567539258|FG000|Overall Study|Mis-Randomization of subject|0|||
156715608|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715609|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715610|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
156715611|NCT00758524|565703151|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715612|NCT00758524|565703152|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
156715613|NCT00758524|565703153|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715614|NCT00758524|565703154|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715615|NCT00758524|565703155|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715616|NCT00758524|565703156|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715617|NCT00758524|565703157|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715618|NCT00758524|565703158|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715619|NCT00758524|565703159|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715620|NCT00758524|565703160|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715621|NCT00758524|565703161|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156792915|NCT01421459|565994801|FG000|Overall Study|Physician Decision|9|||
156792916|NCT01421459|565994802|FG001|Overall Study|Physician Decision|9|||
156792917|NCT01421459|565994801|FG000|Overall Study|Protocol Violation|8|||
156792918|NCT01421459|565994802|FG001|Overall Study|Protocol Violation|5|||
156792919|NCT01421459|565994801|FG000|Overall Study|Withdrawal by Subject|12|||
157216407|NCT00463866|567539259|FG001|Overall Study|Mis-Randomization of subject|1|||
157216408|NCT00463866|567539258|FG000|Overall Study|Other|22|||
157216409|NCT00463866|567539259|FG001|Overall Study|Other|22|||
156792920|NCT01421459|565994802|FG001|Overall Study|Withdrawal by Subject|16|||
157216410|NCT01706198|567539260|FG000|Overall Study|Adverse Event|12|||
156792921|NCT01422382|565994805|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
157216411|NCT01706198|567539261|FG001|Overall Study|Adverse Event|15|||
157216412|NCT01706198|567539260|FG000|Overall Study|Protocol Violation|7|||
157216413|NCT01706198|567539261|FG001|Overall Study|Protocol Violation|5|||
157216414|NCT01706198|567539260|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
157216415|NCT01706198|567539261|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
156715622|NCT00758524|565703162|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715623|NCT00758524|565703163|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715624|NCT00758524|565703164|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715625|NCT00758524|565703165|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715626|NCT00758524|565703166|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715627|NCT00758524|565703167|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
156715628|NCT00758524|565703151|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715629|NCT00758524|565703152|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715630|NCT00758524|565703153|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715631|NCT00758524|565703154|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715632|NCT00758524|565703155|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715633|NCT00758524|565703156|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715634|NCT00758524|565703157|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715635|NCT00758524|565703158|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715636|NCT00758524|565703159|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
156715637|NCT00758524|565703160|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715638|NCT00758524|565703161|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715639|NCT00758524|565703162|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715640|NCT00758524|565703163|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715641|NCT00758524|565703164|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715642|NCT00758524|565703165|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715643|NCT00758524|565703166|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715644|NCT00758524|565703167|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
156715645|NCT00758524|565703151|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715646|NCT00758524|565703152|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715647|NCT00758524|565703153|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715648|NCT00758524|565703154|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715649|NCT00758524|565703155|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715650|NCT00758524|565703156|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715651|NCT00758524|565703157|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
156715652|NCT00758524|565703158|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715653|NCT00758524|565703159|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715654|NCT00758524|565703160|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715655|NCT00758524|565703161|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715656|NCT00758524|565703162|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715657|NCT00758524|565703163|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
157129141|NCT00849667|567223964|FG000|Overall Study|Sponsor decision|208|||
157129142|NCT00849667|567223965|FG001|Overall Study|Sponsor decision|204|||
157129143|NCT00849667|567223966|FG002|Overall Study|Sponsor decision|190|||
157129144|NCT00849667|567223964|FG000|Overall Study|Investigator discretion|0|||
157129145|NCT00849667|567223965|FG001|Overall Study|Investigator discretion|0|||
157129146|NCT00849667|567223966|FG002|Overall Study|Investigator discretion|1|||
157129147|NCT01869348|567223967|FG000|Overall Study|Withdrawal by Subject|1|||
157129148|NCT01869348|567223968|FG001|Overall Study|Withdrawal by Subject|1|||
157129149|NCT02789657|567223969|FG000|Overall Study|Withdrawal by Subject|2|||
157129150|NCT02789657|567223970|FG001|Overall Study|Withdrawal by Subject|0|||
157129151|NCT02789657|567223971|FG002|Overall Study|Withdrawal by Subject|0|||
157129152|NCT02789657|567223972|FG003|Overall Study|Withdrawal by Subject|0|||
157129153|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Adverse Event|21|||
157129154|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Adverse Event|6|||
157129155|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
157129156|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
157129157|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
157129158|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
157129159|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
157129160|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
157129161|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Physician Decision|0|||
157129162|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Physician Decision|3|||
157129163|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
157129164|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
157129165|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
157129166|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
157129167|NCT00510276|567223983|FG000|Acute Double-Blind Phase|Subject Decision|26|||
157129168|NCT00510276|567223984|FG001|Acute Double-Blind Phase|Subject Decision|28|||
157129169|NCT00510276|567223983|FG000|Extension Open-Label Phase|Adverse Event|9|||
157216416|NCT01706198|567539260|FG000|Overall Study|Lost to Follow-up|97|||
156874632|NCT02541604|566298700|FG004|Overall Study|Study Terminated by Sponsor|0|||
156874633|NCT02541604|566298701|FG005|Overall Study|Study Terminated by Sponsor|0|||
156715658|NCT00758524|565703164|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715659|NCT00758524|565703165|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715660|NCT00758524|565703166|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715661|NCT00758524|565703167|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
156715662|NCT03519087|565703182|FG000|Clinic Evaluation|Physician Decision|15|||
156715663|NCT03519087|565703183|FG001|Clinic Evaluation|Physician Decision|18|||
156715664|NCT03519087|565703184|FG002|Clinic Evaluation|Physician Decision|0|||
156715665|NCT03519087|565703185|FG003|Clinic Evaluation|Physician Decision|0|||
156715666|NCT03519087|565703186|FG004|Clinic Evaluation|Physician Decision|0|||
156715667|NCT03519087|565703182|FG000|Clinic Evaluation|Protocol Violation|1|||
156715668|NCT03519087|565703183|FG001|Clinic Evaluation|Protocol Violation|0|||
156715669|NCT03519087|565703184|FG002|Clinic Evaluation|Protocol Violation|0|||
156715670|NCT03519087|565703185|FG003|Clinic Evaluation|Protocol Violation|0|||
156715671|NCT03519087|565703186|FG004|Clinic Evaluation|Protocol Violation|0|||
156715672|NCT03519087|565703182|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
156715673|NCT03519087|565703183|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
156715674|NCT03519087|565703184|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715675|NCT03519087|565703185|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715676|NCT03519087|565703186|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
156715677|NCT03519087|565703182|FG000|Re-randomization for Treatment|Not appropriate|2|||
156715678|NCT03519087|565703183|FG001|Re-randomization for Treatment|Not appropriate|3|||
156715679|NCT03519087|565703184|FG002|Re-randomization for Treatment|Not appropriate|0|||
156715680|NCT03519087|565703185|FG003|Re-randomization for Treatment|Not appropriate|0|||
156715681|NCT03519087|565703186|FG004|Re-randomization for Treatment|Not appropriate|0|||
156715682|NCT03519087|565703182|FG000|Laboratory Testing|Lost to Follow-up|0|||
156715683|NCT03519087|565703183|FG001|Laboratory Testing|Lost to Follow-up|0|||
156715684|NCT03519087|565703184|FG002|Laboratory Testing|Lost to Follow-up|2|||
156715685|NCT03519087|565703185|FG003|Laboratory Testing|Lost to Follow-up|3|||
156874634|NCT02541604|566298702|FG006|Overall Study|Study Terminated by Sponsor|0|||
156874635|NCT02541604|566298703|FG007|Overall Study|Study Terminated by Sponsor|0|||
156715686|NCT03519087|565703186|FG004|Laboratory Testing|Lost to Follow-up|6|||
156715687|NCT03519087|565703182|FG000|Laboratory Testing|Protocol Violation|0|||
156715688|NCT03519087|565703183|FG001|Laboratory Testing|Protocol Violation|0|||
156715689|NCT03519087|565703184|FG002|Laboratory Testing|Protocol Violation|0|||
156715690|NCT03519087|565703185|FG003|Laboratory Testing|Protocol Violation|1|||
156715691|NCT03519087|565703186|FG004|Laboratory Testing|Protocol Violation|0|||
156715692|NCT01137071|565703187|FG000|Overall Study|Disease Progression|11|||
156715693|NCT01137071|565703187|FG000|Overall Study|Withdrawal by Subject|2|||
156715694|NCT01137071|565703187|FG000|Overall Study|Wrongly Included|1|||
156715695|NCT04807400|565703188|FG000|Overall Study|Adverse Event|2|||
156715696|NCT04807400|565703189|FG001|Overall Study|Adverse Event|3|||
156715697|NCT04807400|565703190|FG002|Overall Study|Adverse Event|3|||
156715698|NCT04807400|565703188|FG000|Overall Study|Death|2|||
156715699|NCT04807400|565703189|FG001|Overall Study|Death|0|||
156715700|NCT04807400|565703190|FG002|Overall Study|Death|0|||
156715701|NCT04807400|565703188|FG000|Overall Study|Lost to Follow-up|8|||
156715702|NCT04807400|565703189|FG001|Overall Study|Lost to Follow-up|6|||
156715703|NCT04807400|565703190|FG002|Overall Study|Lost to Follow-up|6|||
156715704|NCT04807400|565703188|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156715705|NCT04807400|565703189|FG001|Overall Study|Non-Compliance With Study Drug|4|||
156874636|NCT02541604|566298704|FG008|Overall Study|Study Terminated by Sponsor|0|||
156715706|NCT04807400|565703190|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156874637|NCT02541604|566298705|FG009|Overall Study|Study Terminated by Sponsor|0|||
156874638|NCT02541604|566298706|FG010|Overall Study|Study Terminated by Sponsor|0|||
156874639|NCT02541604|566298707|FG011|Overall Study|Study Terminated by Sponsor|0|||
156874640|NCT02541604|566298696|FG000|Overall Study|Medical condition may jeopardize safety|0|||
156715707|NCT04807400|565703188|FG000|Overall Study|Participant Decision|20|||
156715708|NCT04807400|565703189|FG001|Overall Study|Participant Decision|19|||
156715709|NCT04807400|565703190|FG002|Overall Study|Participant Decision|26|||
156715710|NCT04807400|565703188|FG000|Overall Study|Physician Decision|0|||
156715711|NCT04807400|565703189|FG001|Overall Study|Physician Decision|1|||
156715712|NCT04807400|565703190|FG002|Overall Study|Physician Decision|0|||
156715713|NCT04807400|565703188|FG000|Overall Study|Protocol Violation|4|||
156715714|NCT04807400|565703189|FG001|Overall Study|Protocol Violation|3|||
156715715|NCT04807400|565703190|FG002|Overall Study|Protocol Violation|7|||
156715716|NCT04807400|565703188|FG000|Overall Study|Withdrawal by Subject|13|||
156715717|NCT04807400|565703189|FG001|Overall Study|Withdrawal by Subject|9|||
156715718|NCT04807400|565703190|FG002|Overall Study|Withdrawal by Subject|20|||
156715719|NCT04807400|565703188|FG000|Overall Study|Mis-randomized|1|||
156715720|NCT04807400|565703189|FG001|Overall Study|Mis-randomized|0|||
156715721|NCT04807400|565703190|FG002|Overall Study|Mis-randomized|0|||
156715722|NCT04194645|565703191|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156874641|NCT02541604|566298697|FG001|Overall Study|Medical condition may jeopardize safety|0|||
156874642|NCT02541604|566298698|FG002|Overall Study|Medical condition may jeopardize safety|0|||
156874643|NCT02541604|566298699|FG003|Overall Study|Medical condition may jeopardize safety|0|||
156874644|NCT02541604|566298700|FG004|Overall Study|Medical condition may jeopardize safety|0|||
156874645|NCT02541604|566298701|FG005|Overall Study|Medical condition may jeopardize safety|0|||
156874646|NCT02541604|566298702|FG006|Overall Study|Medical condition may jeopardize safety|0|||
156874647|NCT02541604|566298703|FG007|Overall Study|Medical condition may jeopardize safety|1|||
156874648|NCT02541604|566298704|FG008|Overall Study|Medical condition may jeopardize safety|0|||
156874649|NCT02541604|566298705|FG009|Overall Study|Medical condition may jeopardize safety|0|||
156874650|NCT02541604|566298706|FG010|Overall Study|Medical condition may jeopardize safety|0|||
156874651|NCT02541604|566298707|FG011|Overall Study|Medical condition may jeopardize safety|0|||
156874652|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
156874653|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
156874654|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
156874655|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
156874656|NCT00828204|566298708|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
156874657|NCT00828204|566298709|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
156874658|NCT00828204|566298708|FG000|Main Study: After Study Restart|Adverse Event|0|||
156874659|NCT00828204|566298709|FG001|Main Study: After Study Restart|Adverse Event|2|||
156874660|NCT00828204|566298708|FG000|Main Study: After Study Restart|Noncompliance|0|||
156874661|NCT00828204|566298709|FG001|Main Study: After Study Restart|Noncompliance|1|||
156874662|NCT00828204|566298708|FG000|Extension Study|Lost to Follow-up|0|||
156874663|NCT00828204|566298709|FG001|Extension Study|Lost to Follow-up|1|||
156874664|NCT00828204|566298708|FG000|Extension Study|Physician Decision|0|||
156874665|NCT00828204|566298709|FG001|Extension Study|Physician Decision|2|||
156874666|NCT00806819|566298710|FG000|Overall Study|progressive disease (modified RECIST )|217|||
156874667|NCT00806819|566298711|FG001|Overall Study|progressive disease (modified RECIST )|216|||
156874668|NCT00806819|566298710|FG000|Overall Study|Worsening or AE of underlying disease|18|||
156874669|NCT00806819|566298711|FG001|Overall Study|Worsening or AE of underlying disease|25|||
156874670|NCT00806819|566298710|FG000|Overall Study|Other AE|38|||
156715723|NCT04194645|565703192|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715724|NCT04194645|565703193|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715725|NCT04194645|565703194|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715726|NCT04194645|565703195|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715727|NCT04194645|565703196|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715728|NCT04194645|565703197|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715729|NCT04194645|565703198|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715730|NCT04194645|565703199|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715731|NCT04194645|565703200|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
156715732|NCT04194645|565703201|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715733|NCT04194645|565703202|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715734|NCT04194645|565703203|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715735|NCT04194645|565703204|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715736|NCT04194645|565703205|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
156715737|NCT03656744|565703206|FG000|Overall Study|Adverse Event|1|||
156715738|NCT03656744|565703207|FG001|Overall Study|Adverse Event|4|||
156715739|NCT03656744|565703208|FG002|Overall Study|Adverse Event|1|||
156715740|NCT03656744|565703206|FG000|Overall Study|Protocol Violation|1|||
156715741|NCT03656744|565703207|FG001|Overall Study|Protocol Violation|0|||
156715742|NCT03656744|565703208|FG002|Overall Study|Protocol Violation|0|||
156715743|NCT03656744|565703206|FG000|Overall Study|Lost to Follow-up|2|||
156715744|NCT03656744|565703207|FG001|Overall Study|Lost to Follow-up|2|||
156715745|NCT03656744|565703208|FG002|Overall Study|Lost to Follow-up|0|||
156715746|NCT03656744|565703206|FG000|Overall Study|Withdrawal by Subject|0|||
156715747|NCT03656744|565703207|FG001|Overall Study|Withdrawal by Subject|1|||
156715748|NCT03656744|565703208|FG002|Overall Study|Withdrawal by Subject|0|||
156874671|NCT00806819|566298711|FG001|Overall Study|Other AE|40|||
157216417|NCT01706198|567539261|FG001|Overall Study|Lost to Follow-up|93|||
157216418|NCT01706198|567539260|FG000|Overall Study|Physician Decision|23|||
157216419|NCT01706198|567539261|FG001|Overall Study|Physician Decision|37|||
157216420|NCT01706198|567539260|FG000|Overall Study|Withdrawal by Subject|23|||
157216421|NCT01706198|567539261|FG001|Overall Study|Withdrawal by Subject|31|||
157216422|NCT02480010|567539267|FG000|Overall Study|Adverse Event|3|||
156715749|NCT03656744|565703206|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
156715750|NCT03656744|565703207|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
156715751|NCT03656744|565703208|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
156715752|NCT03076775|565703209|FG000|Overall Study|Lost to Follow-up|1|||
156874672|NCT00806819|566298710|FG000|Overall Study|Protocol Violation|9|||
156874673|NCT00806819|566298711|FG001|Overall Study|Protocol Violation|4|||
156874674|NCT00806819|566298710|FG000|Overall Study|Lost to Follow-up|1|||
156874675|NCT00806819|566298711|FG001|Overall Study|Lost to Follow-up|0|||
157216423|NCT02480010|567539268|FG001|Overall Study|Adverse Event|1|||
156874676|NCT00806819|566298710|FG000|Overall Study|Withdrawal by Subject|32|||
156715753|NCT03076775|565703210|FG001|Overall Study|Lost to Follow-up|0|||
156715754|NCT00940316|565703211|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
156715755|NCT00940316|565703212|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
156715756|NCT00940316|565703213|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
156715757|NCT00940316|565703211|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
156715758|NCT00940316|565703212|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
156715759|NCT00940316|565703213|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
156715760|NCT00940316|565703211|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
156715761|NCT00940316|565703212|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
156715762|NCT00940316|565703213|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
156715763|NCT00940316|565703211|FG000|Treated After Cycle 5|Adverse Event|0|||
156715764|NCT00940316|565703212|FG001|Treated After Cycle 5|Adverse Event|0|||
156715765|NCT00940316|565703213|FG002|Treated After Cycle 5|Adverse Event|1|||
156715766|NCT00940316|565703211|FG000|Treated After Cycle 5|Progressive disease|0|||
156715767|NCT00940316|565703212|FG001|Treated After Cycle 5|Progressive disease|1|||
156715768|NCT00940316|565703213|FG002|Treated After Cycle 5|Progressive disease|0|||
156715769|NCT00996489|565703216|FG000|Overall Study|Device failure|45|||
156715770|NCT00996489|565703216|FG000|Overall Study|Discontinued|116|||
156715771|NCT00129545|565703219|FG000|Overall Study|Death|5|||
156715772|NCT00129545|565703220|FG001|Overall Study|Death|60|||
156715773|NCT00129545|565703221|FG002|Overall Study|Death|44|||
156715774|NCT00129545|565703219|FG000|Overall Study|Withdrawal by Subject|3|||
156715775|NCT00129545|565703220|FG001|Overall Study|Withdrawal by Subject|18|||
156715776|NCT00129545|565703221|FG002|Overall Study|Withdrawal by Subject|44|||
156715777|NCT00129545|565703219|FG000|Overall Study|Lost to Follow-up|2|||
156715778|NCT00129545|565703220|FG001|Overall Study|Lost to Follow-up|22|||
156715779|NCT00129545|565703221|FG002|Overall Study|Lost to Follow-up|13|||
156715780|NCT00129545|565703219|FG000|Overall Study|Physician Decision|0|||
156715781|NCT00129545|565703220|FG001|Overall Study|Physician Decision|3|||
156874677|NCT00806819|566298711|FG001|Overall Study|Withdrawal by Subject|29|||
156874678|NCT00806819|566298710|FG000|Overall Study|Not treated|6|||
156874679|NCT00806819|566298711|FG001|Overall Study|Not treated|3|||
156874680|NCT00806819|566298710|FG000|Overall Study|Reasons other than stated above|25|||
156874681|NCT00806819|566298711|FG001|Overall Study|Reasons other than stated above|41|||
156874682|NCT02840461|566298715|FG000|Overall Study|Adverse Event|1|||
156874683|NCT02840461|566298716|FG001|Overall Study|Adverse Event|5|||
157129170|NCT00510276|567223984|FG001|Extension Open-Label Phase|Adverse Event|18|||
157129171|NCT00510276|567223983|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
157129172|NCT00510276|567223984|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
157129173|NCT00510276|567223983|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
156715782|NCT00129545|565703221|FG002|Overall Study|Physician Decision|10|||
156715783|NCT00129545|565703219|FG000|Overall Study|Device not implanted|16|||
156715784|NCT00129545|565703220|FG001|Overall Study|Device not implanted|61|||
156715785|NCT00129545|565703221|FG002|Overall Study|Device not implanted|0|||
156715786|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
156715787|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
156715788|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
156715789|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
156715790|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
156715791|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
156715792|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
156715793|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
156715794|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
156715795|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
156715796|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
156715797|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
156715798|NCT01130493|565703226|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
156874684|NCT02840461|566298717|FG002|Overall Study|Adverse Event|3|||
156874685|NCT02840461|566298715|FG000|Overall Study|Lost to Follow-up|10|||
156874686|NCT02840461|566298716|FG001|Overall Study|Lost to Follow-up|7|||
157129174|NCT00510276|567223984|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
157129175|NCT00510276|567223983|FG000|Extension Open-Label Phase|Physician Decision|2|||
157129176|NCT00510276|567223984|FG001|Extension Open-Label Phase|Physician Decision|3|||
157129177|NCT00510276|567223983|FG000|Extension Open-Label Phase|Protocol Violation|0|||
157216424|NCT02480010|567539267|FG000|Overall Study|Death|1|||
156715799|NCT01130493|565703227|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
156715800|NCT01130493|565703228|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
156715801|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
156715802|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
156715803|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
156715804|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
157216425|NCT02480010|567539268|FG001|Overall Study|Death|0|||
157216426|NCT02480010|567539267|FG000|Overall Study|Insufficient therapeutic response|31|||
157216427|NCT02480010|567539268|FG001|Overall Study|Insufficient therapeutic response|29|||
156715805|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
156715806|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
156715807|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
156792922|NCT02899754|565994806|FG000|Overall Study|Lost to Follow-up|7|||
156792923|NCT02899754|565994807|FG001|Overall Study|Lost to Follow-up|9|||
156792924|NCT04082364|565994808|FG000|Overall Study|Death|23|||
156792925|NCT04082364|565994809|FG001|Overall Study|Death|1|||
156792926|NCT04082364|565994810|FG002|Overall Study|Death|1|||
156792927|NCT04082364|565994811|FG003|Overall Study|Death|2|||
156792928|NCT04082364|565994812|FG004|Overall Study|Death|1|||
156792929|NCT04082364|565994808|FG000|Overall Study|Lost to Follow-up|1|||
156792930|NCT04082364|565994809|FG001|Overall Study|Lost to Follow-up|0|||
156792931|NCT04082364|565994810|FG002|Overall Study|Lost to Follow-up|0|||
156792932|NCT04082364|565994811|FG003|Overall Study|Lost to Follow-up|0|||
156792933|NCT04082364|565994812|FG004|Overall Study|Lost to Follow-up|1|||
156715808|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
156715809|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
156715810|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
156715811|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
156715812|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
156715813|NCT01130493|565703226|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
156715814|NCT01130493|565703227|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
156792934|NCT04082364|565994808|FG000|Overall Study|Physician Decision|1|||
156792935|NCT04082364|565994809|FG001|Overall Study|Physician Decision|1|||
156792936|NCT04082364|565994810|FG002|Overall Study|Physician Decision|0|||
156792937|NCT04082364|565994811|FG003|Overall Study|Physician Decision|2|||
156874687|NCT02840461|566298717|FG002|Overall Study|Lost to Follow-up|6|||
157017402|NCT06066541|566816171|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
157017403|NCT06066541|566816172|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
157017404|NCT06066541|566816173|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
157017405|NCT06066541|566816174|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
157017406|NCT06066541|566816175|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
157017407|NCT06066541|566816176|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
157017408|NCT04533022|566816177|FG000|Overall Study|Withdrawal by Subject|15|||
157017409|NCT04533022|566816177|FG000|Overall Study|Adverse Event|6|||
157017410|NCT04533022|566816177|FG000|Overall Study|Death|1|||
157017411|NCT04533022|566816177|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
157017412|NCT04533022|566816177|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
157017413|NCT02163447|566816178|FG000|Overall Study|Withdrawal by Subject|2|||
157017414|NCT02163447|566816179|FG001|Overall Study|Withdrawal by Subject|0|||
157017415|NCT02163447|566816180|FG002|Overall Study|Withdrawal by Subject|1|||
157017416|NCT02163447|566816178|FG000|Overall Study|Lost to Follow-up|1|||
157017417|NCT02163447|566816179|FG001|Overall Study|Lost to Follow-up|3|||
157017418|NCT02163447|566816180|FG002|Overall Study|Lost to Follow-up|0|||
157017419|NCT02163447|566816178|FG000|Overall Study|Moved out of study area|2|||
157017420|NCT02163447|566816179|FG001|Overall Study|Moved out of study area|3|||
157017421|NCT02163447|566816180|FG002|Overall Study|Moved out of study area|2|||
157017422|NCT02163447|566816178|FG000|Overall Study|Became HIV infected at time of delivery|1|||
157017423|NCT02163447|566816179|FG001|Overall Study|Became HIV infected at time of delivery|0|||
157017424|NCT02163447|566816180|FG002|Overall Study|Became HIV infected at time of delivery|0|||
157017425|NCT05320432|566816186|FG000|Overall Study|Withdrawal by Subject|0|||
157017426|NCT05320432|566816187|FG001|Overall Study|Withdrawal by Subject|2|||
157017427|NCT05038566|566816188|FG000|Overall Study|Technical Difficulties with the Device|0|||
157017428|NCT05038566|566816189|FG001|Overall Study|Technical Difficulties with the Device|1|||
157017429|NCT04850807|566816196|FG000|Overall Study|Death|50|||
157017430|NCT04850807|566816197|FG001|Overall Study|Death|55|||
157017431|NCT04850807|566816196|FG000|Overall Study|Discharged|17|||
157017432|NCT04850807|566816197|FG001|Overall Study|Discharged|13|||
157017433|NCT04850807|566816196|FG000|Overall Study|Incomplete baseline data|3|||
157017434|NCT04850807|566816197|FG001|Overall Study|Incomplete baseline data|2|||
157017435|NCT03739996|566816198|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
157017436|NCT03739996|566816198|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
157017437|NCT03739996|566816198|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
157017438|NCT03739996|566816198|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
157017439|NCT03739996|566816198|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
157017440|NCT03739996|566816198|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
157216428|NCT02480010|567539267|FG000|Overall Study|Refused Treatment|0|||
156715815|NCT01130493|565703228|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
156792938|NCT04082364|565994812|FG004|Overall Study|Physician Decision|1|||
157017441|NCT03739996|566816198|FG000|Step 3 (SOC ART)|Death|1|||
156715816|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
156715817|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
156715818|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
156792939|NCT04082364|565994808|FG000|Overall Study|Withdrawal by Subject|1|||
156715819|NCT01130493|565703226|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
156715820|NCT01130493|565703227|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
156715821|NCT01130493|565703228|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
156715822|NCT01130493|565703226|FG000|Part 2: OLE|Adverse Event|0|||
156715823|NCT01130493|565703227|FG001|Part 2: OLE|Adverse Event|2|||
156715824|NCT01130493|565703228|FG002|Part 2: OLE|Adverse Event|1|||
156715825|NCT01130493|565703226|FG000|Part 2: OLE|Withdrawal by Subject|0|||
156715826|NCT01130493|565703227|FG001|Part 2: OLE|Withdrawal by Subject|1|||
156715827|NCT01130493|565703228|FG002|Part 2: OLE|Withdrawal by Subject|4|||
156715828|NCT03541317|565703232|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
156715829|NCT03541317|565703233|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715830|NCT03541317|565703234|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715831|NCT03541317|565703235|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715832|NCT03541317|565703236|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715833|NCT03541317|565703237|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
156715834|NCT00879086|565703238|FG000|Overall Study|Adverse Event|3|||
156792940|NCT04082364|565994809|FG001|Overall Study|Withdrawal by Subject|1|||
156792941|NCT04082364|565994810|FG002|Overall Study|Withdrawal by Subject|0|||
156792942|NCT04082364|565994811|FG003|Overall Study|Withdrawal by Subject|0|||
156792943|NCT04082364|565994812|FG004|Overall Study|Withdrawal by Subject|1|||
156792944|NCT04082364|565994808|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
156792945|NCT04082364|565994809|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
156792946|NCT04082364|565994810|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
156792947|NCT04082364|565994811|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
156792948|NCT04082364|565994812|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
156792949|NCT04082364|565994808|FG000|Overall Study|Disease progression|0|||
156792950|NCT04082364|565994809|FG001|Overall Study|Disease progression|0|||
156792951|NCT04082364|565994810|FG002|Overall Study|Disease progression|0|||
156792952|NCT04082364|565994811|FG003|Overall Study|Disease progression|1|||
156792953|NCT04082364|565994812|FG004|Overall Study|Disease progression|0|||
156792954|NCT02514746|565994818|FG000|Overall Study|Chronically Ill|1|||
156792955|NCT02514746|565994819|FG001|Overall Study|Chronically Ill|2|||
156792956|NCT02514746|565994818|FG000|Overall Study|Physician Decision|4|||
156792957|NCT02514746|565994819|FG001|Overall Study|Physician Decision|2|||
156792958|NCT02514746|565994818|FG000|Overall Study|Withdrawal by Subject|12|||
156792959|NCT02514746|565994819|FG001|Overall Study|Withdrawal by Subject|10|||
156792960|NCT02514746|565994818|FG000|Overall Study|Other|5|||
156792961|NCT02514746|565994819|FG001|Overall Study|Other|1|||
156792962|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
156792963|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
157129178|NCT00510276|567223984|FG001|Extension Open-Label Phase|Protocol Violation|1|||
157129179|NCT00510276|567223983|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
157129180|NCT00510276|567223984|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
157129181|NCT00510276|567223983|FG000|Extension Open-Label Phase|Subject Decision|7|||
157129182|NCT00510276|567223984|FG001|Extension Open-Label Phase|Subject Decision|9|||
157129183|NCT01731678|567223985|FG000|Overall Study|Withdrawal by Subject|3|||
157129184|NCT01731678|567223985|FG000|Overall Study|Did not meet inclusion criteria|1|||
157129185|NCT01731678|567223985|FG000|Overall Study|RMT too high, making TMS difficult|3|||
157129186|NCT00354601|567223986|FG000|Overall Study|Protocol Violation|1|||
157129187|NCT00354601|567223986|FG000|Overall Study|progression|1|||
157216429|NCT02480010|567539268|FG001|Overall Study|Refused Treatment|3|||
157216430|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
157216431|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216432|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216433|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216434|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216435|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216436|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
157216437|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
156792964|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
156792965|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
156792966|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
156792967|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156792968|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
157129188|NCT00666926|567223987|FG000|Overall Study|Adverse Event|0|||
156715835|NCT00879086|565703239|FG001|Overall Study|Adverse Event|15|||
156715836|NCT00879086|565703238|FG000|Overall Study|Participant choice|2|||
156715837|NCT00879086|565703239|FG001|Overall Study|Participant choice|2|||
157216438|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
156715838|NCT00879086|565703238|FG000|Overall Study|Progression of disease|40|||
156715839|NCT00879086|565703239|FG001|Overall Study|Progression of disease|26|||
156715840|NCT00879086|565703238|FG000|Overall Study|Withdrawal of consent|2|||
156715841|NCT00879086|565703239|FG001|Overall Study|Withdrawal of consent|1|||
156715842|NCT00879086|565703238|FG000|Overall Study|Other|4|||
156715843|NCT00879086|565703239|FG001|Overall Study|Other|6|||
156715844|NCT00879086|565703238|FG000|Overall Study|Death|1|||
156715845|NCT00879086|565703239|FG001|Overall Study|Death|2|||
156715846|NCT04728802|565703242|FG000|Overall Study|Withdrawal by Subject|4|||
156715847|NCT04728802|565703243|FG001|Overall Study|Withdrawal by Subject|20|||
156715848|NCT04728802|565703242|FG000|Overall Study|Physician Decision|7|||
156715849|NCT04728802|565703243|FG001|Overall Study|Physician Decision|7|||
156715850|NCT04728802|565703242|FG000|Overall Study|Protocol Violation|10|||
156715851|NCT04728802|565703243|FG001|Overall Study|Protocol Violation|4|||
156715852|NCT04728802|565703242|FG000|Overall Study|Transfer|1|||
156715853|NCT04728802|565703243|FG001|Overall Study|Transfer|0|||
156715854|NCT04728802|565703242|FG000|Overall Study|Death|4|||
156715855|NCT04728802|565703243|FG001|Overall Study|Death|5|||
156715856|NCT04728802|565703242|FG000|Overall Study|Other|3|||
156715857|NCT04728802|565703243|FG001|Overall Study|Other|0|||
156715858|NCT02286843|565703246|FG000|Overall Study|Not Treated|4|||
156715859|NCT02286843|565703246|FG000|Overall Study|Protocol Violation|1|||
156715860|NCT02286843|565703246|FG000|Overall Study|Withdrawal by Subject|1|||
156715861|NCT02536846|565703247|FG000|Overall Study|Withdrawal by Subject|1|||
156715862|NCT02123446|565703248|FG000|Washout Period (1 Day)|Physician Decision|1|||
156715863|NCT02123446|565703249|FG001|Washout Period (1 Day)|Physician Decision|0|||
156715864|NCT00111241|565703251|FG000|Overall Study|Lost to Follow-up|1|||
156715865|NCT00111241|565703252|FG001|Overall Study|Lost to Follow-up|0|||
156715866|NCT00111241|565703251|FG000|Overall Study|Withdrawal by Subject|4|||
156792969|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156792970|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
157017442|NCT03739996|566816198|FG000|Step 3 (SOC ART)|Participant moved|1|||
157017443|NCT05141903|566816199|FG000|Overall Study|Withdrawal by Subject|0|||
157017444|NCT05141903|566816200|FG001|Overall Study|Withdrawal by Subject|1|||
157017445|NCT05141903|566816201|FG002|Overall Study|Withdrawal by Subject|1|||
157017446|NCT05141903|566816202|FG003|Overall Study|Withdrawal by Subject|0|||
157017447|NCT05141903|566816203|FG004|Overall Study|Withdrawal by Subject|0|||
157017448|NCT05141903|566816199|FG000|Overall Study|Other|1|||
157017449|NCT05141903|566816200|FG001|Overall Study|Other|1|||
157017450|NCT05141903|566816201|FG002|Overall Study|Other|0|||
157017451|NCT05141903|566816202|FG003|Overall Study|Other|0|||
157017452|NCT05141903|566816203|FG004|Overall Study|Other|0|||
157017453|NCT05387447|566816207|FG000|Overall Study|Participants changed their minds about study participation.|3|||
157017454|NCT05387447|566816208|FG001|Overall Study|Participants changed their minds about study participation.|5|||
157017455|NCT05439603|566816209|FG000|Overall Study|met withdrawal criteria|2|||
157017456|NCT05461131|566816210|FG000|Overall Study|Lost to Follow-up|0|||
157017457|NCT05461131|566816211|FG001|Overall Study|Lost to Follow-up|2|||
157017458|NCT03896516|566816212|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
157017459|NCT03896516|566816213|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
157017460|NCT03896516|566816212|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
157017461|NCT03896516|566816213|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
157017462|NCT03896516|566816212|FG000|Washout Period|Physician Decision|3|||
157017463|NCT03896516|566816213|FG001|Washout Period|Physician Decision|1|||
157017464|NCT03896516|566816212|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
157017465|NCT03896516|566816213|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
157017466|NCT04549168|566816221|FG000|Randomization Phase|Adverse Event|0|||
157017467|NCT04549168|566816222|FG001|Randomization Phase|Adverse Event|0|||
157017468|NCT04549168|566816223|FG002|Randomization Phase|Adverse Event|1|||
157017469|NCT04549168|566816221|FG000|Randomization Phase|Other|0|||
157017470|NCT04549168|566816222|FG001|Randomization Phase|Other|2|||
157017471|NCT04549168|566816223|FG002|Randomization Phase|Other|0|||
157017472|NCT04549168|566816221|FG000|Randomization Phase|Withdrawal by Subject|0|||
157017473|NCT04549168|566816222|FG001|Randomization Phase|Withdrawal by Subject|2|||
157017474|NCT04549168|566816223|FG002|Randomization Phase|Withdrawal by Subject|1|||
157017475|NCT01707030|566816226|FG000|Overall Study|Death|1|||
157017476|NCT01707030|566816227|FG001|Overall Study|Death|1|||
157017477|NCT01707030|566816226|FG000|Overall Study|Withdrawal by Subject|2|||
157017478|NCT01707030|566816227|FG001|Overall Study|Withdrawal by Subject|3|||
157017479|NCT01707030|566816226|FG000|Overall Study|Lost to Follow-up|8|||
157017480|NCT01707030|566816227|FG001|Overall Study|Lost to Follow-up|13|||
157017481|NCT00650104|566816228|FG000|Overall Study|Adverse Event|17|||
157017482|NCT00650104|566816228|FG000|Overall Study|Death|2|||
156715867|NCT00111241|565703252|FG001|Overall Study|Withdrawal by Subject|0|||
156715868|NCT00111241|565703251|FG000|Overall Study|Protocol Violation|9|||
156715869|NCT00111241|565703252|FG001|Overall Study|Protocol Violation|8|||
156715870|NCT00111241|565703251|FG000|Overall Study|Adverse Event|1|||
156715871|NCT00111241|565703252|FG001|Overall Study|Adverse Event|0|||
157129189|NCT00666926|567223988|FG001|Overall Study|Adverse Event|0|||
157129190|NCT00666926|567223989|FG002|Overall Study|Adverse Event|0|||
157129191|NCT00666926|567223990|FG003|Overall Study|Adverse Event|0|||
157129192|NCT00666926|567223991|FG004|Overall Study|Adverse Event|0|||
157129193|NCT00666926|567223992|FG005|Overall Study|Adverse Event|0|||
157129194|NCT00666926|567223993|FG006|Overall Study|Adverse Event|0|||
157129195|NCT00666926|567223994|FG007|Overall Study|Adverse Event|0|||
157129196|NCT00666926|567223995|FG008|Overall Study|Adverse Event|0|||
157129197|NCT00666926|567223996|FG009|Overall Study|Adverse Event|2|||
157129198|NCT00666926|567223997|FG010|Overall Study|Adverse Event|2|||
157129199|NCT00666926|567223998|FG011|Overall Study|Adverse Event|2|||
157129200|NCT00666926|567223999|FG012|Overall Study|Adverse Event|0|||
157129201|NCT00666926|567224000|FG013|Overall Study|Adverse Event|1|||
157129202|NCT00666926|567224001|FG014|Overall Study|Adverse Event|0|||
157129203|NCT00666926|567224002|FG015|Overall Study|Adverse Event|0|||
157129204|NCT00666926|567223987|FG000|Overall Study|Laboratory abnormality|0|||
157129205|NCT00666926|567223988|FG001|Overall Study|Laboratory abnormality|0|||
157129206|NCT00666926|567223989|FG002|Overall Study|Laboratory abnormality|0|||
157129207|NCT00666926|567223990|FG003|Overall Study|Laboratory abnormality|0|||
157129208|NCT00666926|567223991|FG004|Overall Study|Laboratory abnormality|0|||
157129209|NCT00666926|567223992|FG005|Overall Study|Laboratory abnormality|0|||
157129210|NCT00666926|567223993|FG006|Overall Study|Laboratory abnormality|0|||
157129211|NCT00666926|567223994|FG007|Overall Study|Laboratory abnormality|0|||
157129212|NCT00666926|567223995|FG008|Overall Study|Laboratory abnormality|0|||
157129213|NCT00666926|567223996|FG009|Overall Study|Laboratory abnormality|0|||
157129214|NCT00666926|567223997|FG010|Overall Study|Laboratory abnormality|1|||
157129215|NCT00666926|567223998|FG011|Overall Study|Laboratory abnormality|0|||
157129216|NCT00666926|567223999|FG012|Overall Study|Laboratory abnormality|0|||
157129217|NCT00666926|567224000|FG013|Overall Study|Laboratory abnormality|0|||
157129218|NCT00666926|567224001|FG014|Overall Study|Laboratory abnormality|0|||
157129219|NCT00666926|567224002|FG015|Overall Study|Laboratory abnormality|1|||
156715872|NCT02096744|565703263|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
156808800|NCT03688919|566054465|FG000|Overall Study|Lost to Follow-up|2|||
156808801|NCT03688919|566054466|FG001|Overall Study|Lost to Follow-up|1|||
157017483|NCT00650104|566816228|FG000|Overall Study|Withdrawal by Subject|11|||
157017484|NCT00650104|566816228|FG000|Overall Study|Physician Decision|7|||
157017485|NCT00650104|566816228|FG000|Overall Study|Lost to Follow-up|1|||
157017486|NCT00650104|566816228|FG000|Overall Study|Non-compliance|2|||
157017487|NCT00650104|566816228|FG000|Overall Study|Sponsor Terminated Dosing|1|||
157017488|NCT01011946|566816229|FG000|Overall Study|Transferred to another hospital|2|||
157017489|NCT01011946|566816229|FG000|Overall Study|No pathological lab value|1|||
157017490|NCT01872078|566816231|FG000|Overall Study|Adverse Event|0|||
157017491|NCT01872078|566816232|FG001|Overall Study|Adverse Event|0|||
157017492|NCT01872078|566816233|FG002|Overall Study|Adverse Event|1|||
157017493|NCT01872078|566816234|FG003|Overall Study|Adverse Event|0|||
157017494|NCT01872078|566816231|FG000|Overall Study|Dose administration non-compliance|0|||
157017495|NCT01872078|566816232|FG001|Overall Study|Dose administration non-compliance|0|||
157017496|NCT01872078|566816233|FG002|Overall Study|Dose administration non-compliance|0|||
157017497|NCT01872078|566816234|FG003|Overall Study|Dose administration non-compliance|1|||
157017498|NCT01872078|566816231|FG000|Overall Study|Protocol Violation|0|||
157017499|NCT01872078|566816232|FG001|Overall Study|Protocol Violation|0|||
157017500|NCT01872078|566816233|FG002|Overall Study|Protocol Violation|1|||
157017501|NCT01872078|566816234|FG003|Overall Study|Protocol Violation|0|||
157017502|NCT01872078|566816231|FG000|Overall Study|Withdrawal by Subject|0|||
157017503|NCT01872078|566816232|FG001|Overall Study|Withdrawal by Subject|0|||
157017504|NCT01872078|566816233|FG002|Overall Study|Withdrawal by Subject|1|||
157017505|NCT01872078|566816234|FG003|Overall Study|Withdrawal by Subject|0|||
157017506|NCT01872078|566816231|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
157017507|NCT01872078|566816232|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
157017508|NCT01872078|566816233|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
157017509|NCT01872078|566816234|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
157017510|NCT04623775|566816244|FG000|Randomization|No Longer Meets Study Criteria|2|||
157017511|NCT04623775|566816245|FG001|Randomization|No Longer Meets Study Criteria|1|||
157017512|NCT04623775|566816246|FG002|Randomization|No Longer Meets Study Criteria|0|||
157017513|NCT04623775|566816247|FG003|Randomization|No Longer Meets Study Criteria|0|||
157017514|NCT04623775|566816244|FG000|Randomization|Withdrew Consent|0|||
157017515|NCT04623775|566816245|FG001|Randomization|Withdrew Consent|0|||
157017516|NCT04623775|566816246|FG002|Randomization|Withdrew Consent|0|||
157017517|NCT04623775|566816247|FG003|Randomization|Withdrew Consent|1|||
157017518|NCT04623775|566816244|FG000|Randomization|Other Reasons|0|||
157017519|NCT04623775|566816245|FG001|Randomization|Other Reasons|0|||
157017520|NCT04623775|566816246|FG002|Randomization|Other Reasons|0|||
157017521|NCT04623775|566816247|FG003|Randomization|Other Reasons|1|||
157129220|NCT00666926|567223987|FG000|Overall Study|Lack of Efficacy|0|||
157129221|NCT00666926|567223988|FG001|Overall Study|Lack of Efficacy|0|||
157129222|NCT00666926|567223989|FG002|Overall Study|Lack of Efficacy|0|||
157129223|NCT00666926|567223990|FG003|Overall Study|Lack of Efficacy|0|||
157017522|NCT04623775|566816244|FG000|Treatment Period|participant withdrew consent|4|||
157017523|NCT04623775|566816245|FG001|Treatment Period|participant withdrew consent|0|||
157017524|NCT04623775|566816246|FG002|Treatment Period|participant withdrew consent|1|||
157017525|NCT04623775|566816247|FG003|Treatment Period|participant withdrew consent|2|||
157017526|NCT04623775|566816244|FG000|Treatment Period|Death|3|||
157017527|NCT04623775|566816245|FG001|Treatment Period|Death|1|||
157017528|NCT04623775|566816246|FG002|Treatment Period|Death|4|||
157017529|NCT04623775|566816247|FG003|Treatment Period|Death|2|||
157017530|NCT04623775|566816244|FG000|Treatment Period|Lost to Follow-up|0|||
157017531|NCT04623775|566816245|FG001|Treatment Period|Lost to Follow-up|2|||
157017532|NCT04623775|566816246|FG002|Treatment Period|Lost to Follow-up|0|||
156715873|NCT02096744|565703264|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
156715874|NCT02096744|565703263|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
156715875|NCT02096744|565703264|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
156715876|NCT02096744|565703263|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
156715877|NCT02096744|565703264|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
156715878|NCT02445963|565703266|FG000|Overall Study|Lost to Follow-up|1|||
156715879|NCT02445963|565703267|FG001|Overall Study|Lost to Follow-up|0|||
156715880|NCT02445963|565703268|FG002|Overall Study|Lost to Follow-up|0|||
156715881|NCT02445963|565703269|FG003|Overall Study|Lost to Follow-up|0|||
156715882|NCT02445963|565703266|FG000|Overall Study|Change in employment|1|||
156792971|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
156792972|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
156792973|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
156792974|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
157017533|NCT04623775|566816247|FG003|Treatment Period|Lost to Follow-up|0|||
157017534|NCT04623775|566816244|FG000|Treatment Period|poor/non compliance|0|||
157017535|NCT04623775|566816245|FG001|Treatment Period|poor/non compliance|0|||
156792975|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
157017536|NCT04623775|566816246|FG002|Treatment Period|poor/non compliance|1|||
157017537|NCT04623775|566816247|FG003|Treatment Period|poor/non compliance|0|||
157017538|NCT04623775|566816244|FG000|Treatment Period|participant no longer meets study criteria|0|||
157017539|NCT04623775|566816245|FG001|Treatment Period|participant no longer meets study criteria|1|||
157017540|NCT04623775|566816246|FG002|Treatment Period|participant no longer meets study criteria|0|||
157017541|NCT04623775|566816247|FG003|Treatment Period|participant no longer meets study criteria|0|||
157017542|NCT04623775|566816244|FG000|Treatment Period|administrative reasons by sponsor|3|||
157129224|NCT00666926|567223991|FG004|Overall Study|Lack of Efficacy|0|||
157129225|NCT00666926|567223992|FG005|Overall Study|Lack of Efficacy|1|||
157129226|NCT00666926|567223993|FG006|Overall Study|Lack of Efficacy|0|||
157129227|NCT00666926|567223994|FG007|Overall Study|Lack of Efficacy|0|||
157129228|NCT00666926|567223995|FG008|Overall Study|Lack of Efficacy|0|||
157129229|NCT00666926|567223996|FG009|Overall Study|Lack of Efficacy|0|||
157129230|NCT00666926|567223997|FG010|Overall Study|Lack of Efficacy|0|||
157129231|NCT00666926|567223998|FG011|Overall Study|Lack of Efficacy|1|||
157129232|NCT00666926|567223999|FG012|Overall Study|Lack of Efficacy|0|||
157129233|NCT00666926|567224000|FG013|Overall Study|Lack of Efficacy|0|||
157129234|NCT00666926|567224001|FG014|Overall Study|Lack of Efficacy|0|||
157129235|NCT00666926|567224002|FG015|Overall Study|Lack of Efficacy|0|||
157129236|NCT00666926|567223987|FG000|Overall Study|Lost to Follow-up|0|||
157129237|NCT00666926|567223988|FG001|Overall Study|Lost to Follow-up|0|||
157129238|NCT00666926|567223989|FG002|Overall Study|Lost to Follow-up|0|||
157129239|NCT00666926|567223990|FG003|Overall Study|Lost to Follow-up|1|||
157129240|NCT00666926|567223991|FG004|Overall Study|Lost to Follow-up|0|||
157129241|NCT00666926|567223992|FG005|Overall Study|Lost to Follow-up|0|||
157129242|NCT00666926|567223993|FG006|Overall Study|Lost to Follow-up|0|||
157129243|NCT00666926|567223994|FG007|Overall Study|Lost to Follow-up|0|||
157129244|NCT00666926|567223995|FG008|Overall Study|Lost to Follow-up|0|||
157129245|NCT00666926|567223996|FG009|Overall Study|Lost to Follow-up|0|||
157129246|NCT00666926|567223997|FG010|Overall Study|Lost to Follow-up|0|||
157129247|NCT00666926|567223998|FG011|Overall Study|Lost to Follow-up|0|||
157017543|NCT04623775|566816245|FG001|Treatment Period|administrative reasons by sponsor|2|||
157017544|NCT04623775|566816246|FG002|Treatment Period|administrative reasons by sponsor|0|||
157017545|NCT04623775|566816247|FG003|Treatment Period|administrative reasons by sponsor|0|||
157129248|NCT00666926|567223999|FG012|Overall Study|Lost to Follow-up|0|||
157129249|NCT00666926|567224000|FG013|Overall Study|Lost to Follow-up|0|||
157129250|NCT00666926|567224001|FG014|Overall Study|Lost to Follow-up|0|||
157129251|NCT00666926|567224002|FG015|Overall Study|Lost to Follow-up|0|||
157129252|NCT00666926|567223987|FG000|Overall Study|Other|2|||
157129253|NCT00666926|567223988|FG001|Overall Study|Other|4|||
157129254|NCT00666926|567223989|FG002|Overall Study|Other|3|||
157129255|NCT00666926|567223990|FG003|Overall Study|Other|3|||
156715883|NCT02445963|565703267|FG001|Overall Study|Change in employment|0|||
156792976|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
157129256|NCT00666926|567223991|FG004|Overall Study|Other|3|||
157129257|NCT00666926|567223992|FG005|Overall Study|Other|3|||
157129258|NCT00666926|567223993|FG006|Overall Study|Other|4|||
156715884|NCT02445963|565703268|FG002|Overall Study|Change in employment|0|||
156715885|NCT02445963|565703269|FG003|Overall Study|Change in employment|0|||
156715886|NCT02445963|565703266|FG000|Overall Study|Symptoms post-vaccination|0|||
156715887|NCT02445963|565703267|FG001|Overall Study|Symptoms post-vaccination|0|||
156715888|NCT02445963|565703268|FG002|Overall Study|Symptoms post-vaccination|1|||
156715889|NCT02445963|565703269|FG003|Overall Study|Symptoms post-vaccination|0|||
156715890|NCT01957176|565703273|FG000|Overall Study|Adverse Event|2|||
156715891|NCT01957176|565703274|FG001|Overall Study|Adverse Event|0|||
156715892|NCT01957176|565703273|FG000|Overall Study|Physician Decision|2|||
156715893|NCT01957176|565703274|FG001|Overall Study|Physician Decision|1|||
156715894|NCT01957176|565703273|FG000|Overall Study|Withdrawal by Subject|1|||
156715895|NCT01957176|565703274|FG001|Overall Study|Withdrawal by Subject|0|||
156715896|NCT01449812|565703275|FG000|Overall Study|Migrated/moved from study area|1|||
156715897|NCT01449812|565703276|FG001|Overall Study|Migrated/moved from study area|0|||
156715898|NCT01449812|565703277|FG002|Overall Study|Migrated/moved from study area|0|||
156715899|NCT01449812|565703275|FG000|Overall Study|Withdrawal by Subject|0|||
156715900|NCT01449812|565703276|FG001|Overall Study|Withdrawal by Subject|0|||
156715901|NCT01449812|565703277|FG002|Overall Study|Withdrawal by Subject|1|||
156715902|NCT01449812|565703275|FG000|Overall Study|Lost to Follow-up|1|||
156715903|NCT01449812|565703276|FG001|Overall Study|Lost to Follow-up|0|||
156715904|NCT01449812|565703277|FG002|Overall Study|Lost to Follow-up|0|||
156715905|NCT03449446|565703278|FG000|Overall Study|Randomized but Never Treated|0|||
156715906|NCT03449446|565703279|FG001|Overall Study|Randomized but Never Treated|0|||
156715907|NCT03449446|565703280|FG002|Overall Study|Randomized but Never Treated|1|||
156715908|NCT03449446|565703281|FG003|Overall Study|Randomized but Never Treated|1|||
156715909|NCT03449446|565703282|FG004|Overall Study|Randomized but Never Treated|1|||
156715910|NCT03449446|565703283|FG005|Overall Study|Randomized but Never Treated|0|||
156715911|NCT03449446|565703284|FG006|Overall Study|Randomized but Never Treated|0|||
156715912|NCT03449446|565703278|FG000|Overall Study|Unknown Reason|33|||
156715913|NCT03449446|565703279|FG001|Overall Study|Unknown Reason|1|||
156715914|NCT03449446|565703280|FG002|Overall Study|Unknown Reason|1|||
156715915|NCT03449446|565703281|FG003|Overall Study|Unknown Reason|1|||
156874688|NCT02840461|566298715|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
156874689|NCT02840461|566298716|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
156874690|NCT02840461|566298717|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
156874691|NCT02840461|566298715|FG000|Overall Study|Protocol Violation|2|||
157017546|NCT04623775|566816244|FG000|Treatment Period|other reasons|2|||
157017547|NCT04623775|566816245|FG001|Treatment Period|other reasons|0|||
156715916|NCT03449446|565703282|FG004|Overall Study|Unknown Reason|2|||
156715917|NCT03449446|565703283|FG005|Overall Study|Unknown Reason|2|||
156715918|NCT03449446|565703284|FG006|Overall Study|Unknown Reason|0|||
156715919|NCT03449446|565703278|FG000|Overall Study|Withdrew Consent|1|||
157017548|NCT04623775|566816246|FG002|Treatment Period|other reasons|1|||
157017549|NCT04623775|566816247|FG003|Treatment Period|other reasons|1|||
157017550|NCT04623775|566816244|FG000|Treatment Period|disease progression|40|||
157017551|NCT04623775|566816245|FG001|Treatment Period|disease progression|35|||
157017552|NCT04623775|566816246|FG002|Treatment Period|disease progression|63|||
157017553|NCT04623775|566816247|FG003|Treatment Period|disease progression|63|||
157017554|NCT04623775|566816244|FG000|Treatment Period|study drug toxicity|12|||
157017555|NCT04623775|566816245|FG001|Treatment Period|study drug toxicity|15|||
157017556|NCT04623775|566816246|FG002|Treatment Period|study drug toxicity|13|||
157017557|NCT04623775|566816247|FG003|Treatment Period|study drug toxicity|12|||
157017558|NCT04623775|566816244|FG000|Treatment Period|AE unrelated to study drug|4|||
157017559|NCT04623775|566816245|FG001|Treatment Period|AE unrelated to study drug|9|||
157017560|NCT04623775|566816246|FG002|Treatment Period|AE unrelated to study drug|12|||
157017561|NCT04623775|566816247|FG003|Treatment Period|AE unrelated to study drug|9|||
157017562|NCT04623775|566816244|FG000|Treatment Period|participant request to discontinue treatment|0|||
157017563|NCT04623775|566816245|FG001|Treatment Period|participant request to discontinue treatment|2|||
157017564|NCT04623775|566816246|FG002|Treatment Period|participant request to discontinue treatment|2|||
157017565|NCT04623775|566816247|FG003|Treatment Period|participant request to discontinue treatment|0|||
157017566|NCT03978637|566816251|FG000|Overall Study|Death|0|||
157017567|NCT03978637|566816252|FG001|Overall Study|Death|2|||
157017568|NCT03978637|566816253|FG002|Overall Study|Death|2|||
157017569|NCT03978637|566816254|FG003|Overall Study|Death|0|||
157017570|NCT03978637|566816251|FG000|Overall Study|Withdrawal by Subject|0|||
157017571|NCT03978637|566816252|FG001|Overall Study|Withdrawal by Subject|0|||
157017572|NCT03978637|566816253|FG002|Overall Study|Withdrawal by Subject|1|||
157017573|NCT03978637|566816254|FG003|Overall Study|Withdrawal by Subject|0|||
157017574|NCT03978637|566816251|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
157017575|NCT03978637|566816252|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
157017576|NCT03978637|566816253|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
157017577|NCT03978637|566816254|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
157017578|NCT03152786|566817827|FG000|Overall Study|Withdrawal by Subject|2|||
157017579|NCT03152786|566817828|FG001|Overall Study|Withdrawal by Subject|1|||
156792977|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
156792978|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
156792979|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
156792980|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
156792981|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
156792982|NCT04003142|565994822|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
156792983|NCT04003142|565994823|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
156874692|NCT02840461|566298716|FG001|Overall Study|Protocol Violation|3|||
156874693|NCT02840461|566298717|FG002|Overall Study|Protocol Violation|1|||
156874694|NCT02840461|566298715|FG000|Overall Study|Withdrawal by Subject|10|||
156874695|NCT02840461|566298716|FG001|Overall Study|Withdrawal by Subject|6|||
156874696|NCT02840461|566298717|FG002|Overall Study|Withdrawal by Subject|2|||
157216439|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
157216440|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
157216441|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
157216442|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
157216443|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
157216444|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
157216445|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216446|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216447|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216448|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216449|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216450|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
157216451|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
157216452|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216453|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216454|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216455|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216456|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216457|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
157216458|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
157216459|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216460|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216461|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216462|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216463|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216464|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
157216465|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
157216466|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216467|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216468|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216469|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216470|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216471|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
157216472|NCT00606684|567539269|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
157216473|NCT00606684|567539270|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216474|NCT00606684|567539271|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216475|NCT00606684|567539272|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216476|NCT00606684|567539273|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216477|NCT00606684|567539274|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216478|NCT00606684|567539275|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
157216479|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157216480|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Adverse Event|3|||
157216481|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Adverse Event|2|||
156874697|NCT02840461|566298715|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
156874698|NCT02840461|566298716|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
156874699|NCT02840461|566298717|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
156874700|NCT01737502|566298720|FG000|Phase I|Disease progression|2|||
157216482|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Adverse Event|4|||
156874701|NCT01737502|566298721|FG001|Phase I|Disease progression|3|||
156874702|NCT01737502|566298720|FG000|Phase I|Complicating disease|1|||
156874703|NCT01737502|566298721|FG001|Phase I|Complicating disease|0|||
156874704|NCT01737502|566298720|FG000|Phase II|Adverse Event|0|||
157216483|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Adverse Event|2|||
156874705|NCT01737502|566298721|FG001|Phase II|Adverse Event|3|||
156874706|NCT01737502|566298720|FG000|Phase II|Disease progression|0|||
157017580|NCT04112316|566817829|FG000|First Period (8 Weeks)|Protocol Violation|1|||
156715920|NCT03449446|565703279|FG001|Overall Study|Withdrew Consent|3|||
156715921|NCT03449446|565703280|FG002|Overall Study|Withdrew Consent|1|||
156715922|NCT03449446|565703281|FG003|Overall Study|Withdrew Consent|4|||
156715923|NCT03449446|565703282|FG004|Overall Study|Withdrew Consent|4|||
156715924|NCT03449446|565703283|FG005|Overall Study|Withdrew Consent|4|||
156715925|NCT03449446|565703284|FG006|Overall Study|Withdrew Consent|1|||
156715926|NCT03449446|565703278|FG000|Overall Study|Adverse Event|1|||
156715927|NCT03449446|565703279|FG001|Overall Study|Adverse Event|2|||
156715928|NCT03449446|565703280|FG002|Overall Study|Adverse Event|1|||
156715929|NCT03449446|565703281|FG003|Overall Study|Adverse Event|0|||
156715930|NCT03449446|565703282|FG004|Overall Study|Adverse Event|0|||
156715931|NCT03449446|565703283|FG005|Overall Study|Adverse Event|2|||
156715932|NCT03449446|565703284|FG006|Overall Study|Adverse Event|0|||
156715933|NCT03449446|565703278|FG000|Overall Study|Lost to Follow-up|0|||
156715934|NCT03449446|565703279|FG001|Overall Study|Lost to Follow-up|0|||
156715935|NCT03449446|565703280|FG002|Overall Study|Lost to Follow-up|2|||
156715936|NCT03449446|565703281|FG003|Overall Study|Lost to Follow-up|1|||
156715937|NCT03449446|565703282|FG004|Overall Study|Lost to Follow-up|3|||
156715938|NCT03449446|565703283|FG005|Overall Study|Lost to Follow-up|0|||
156715939|NCT03449446|565703284|FG006|Overall Study|Lost to Follow-up|0|||
156715940|NCT03449446|565703278|FG000|Overall Study|Investigator's Discretion|0|||
156715941|NCT03449446|565703279|FG001|Overall Study|Investigator's Discretion|1|||
156715942|NCT03449446|565703280|FG002|Overall Study|Investigator's Discretion|1|||
156715943|NCT03449446|565703281|FG003|Overall Study|Investigator's Discretion|2|||
156715944|NCT03449446|565703282|FG004|Overall Study|Investigator's Discretion|0|||
156715945|NCT03449446|565703283|FG005|Overall Study|Investigator's Discretion|0|||
156715946|NCT03449446|565703284|FG006|Overall Study|Investigator's Discretion|0|||
156715947|NCT03449446|565703278|FG000|Overall Study|Non Compliance with Study Drug|1|||
156715948|NCT03449446|565703279|FG001|Overall Study|Non Compliance with Study Drug|0|||
156715949|NCT03449446|565703280|FG002|Overall Study|Non Compliance with Study Drug|0|||
156715950|NCT03449446|565703281|FG003|Overall Study|Non Compliance with Study Drug|0|||
156715951|NCT03449446|565703282|FG004|Overall Study|Non Compliance with Study Drug|0|||
156715952|NCT03449446|565703283|FG005|Overall Study|Non Compliance with Study Drug|0|||
156715953|NCT03449446|565703284|FG006|Overall Study|Non Compliance with Study Drug|0|||
156715954|NCT03449446|565703278|FG000|Overall Study|Protocol Violation|0|||
156715955|NCT03449446|565703279|FG001|Overall Study|Protocol Violation|0|||
156715956|NCT03449446|565703280|FG002|Overall Study|Protocol Violation|0|||
156715957|NCT03449446|565703281|FG003|Overall Study|Protocol Violation|0|||
156715958|NCT03449446|565703282|FG004|Overall Study|Protocol Violation|1|||
156715959|NCT03449446|565703283|FG005|Overall Study|Protocol Violation|1|||
156792984|NCT04003142|565994824|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
156792985|NCT04003142|565994825|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
156792986|NCT04003142|565994826|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
156792987|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
156792988|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
156792989|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
156792990|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
156792991|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
156792992|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Death|0|||
156792993|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Death|0|||
156792994|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Death|0|||
156792995|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Death|0|||
156792996|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Death|1|||
156792997|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
156792998|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
156792999|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
156793000|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
156793001|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
156793002|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793003|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793004|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
156793005|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793006|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
156793007|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
156874707|NCT01737502|566298721|FG001|Phase II|Disease progression|18|||
156874708|NCT01737502|566298720|FG000|Phase II|Death|0|||
156715960|NCT03449446|565703284|FG006|Overall Study|Protocol Violation|0|||
156715961|NCT03449446|565703278|FG000|Overall Study|Death|0|||
156715962|NCT03449446|565703279|FG001|Overall Study|Death|0|||
156715963|NCT03449446|565703280|FG002|Overall Study|Death|0|||
156715964|NCT03449446|565703281|FG003|Overall Study|Death|0|||
156715965|NCT03449446|565703282|FG004|Overall Study|Death|1|||
156715966|NCT03449446|565703283|FG005|Overall Study|Death|0|||
156715967|NCT03449446|565703284|FG006|Overall Study|Death|0|||
156715968|NCT03180645|565703289|FG000|Overall Study|Adverse Event|0|||
156715969|NCT03180645|565703290|FG001|Overall Study|Adverse Event|1|||
156874709|NCT01737502|566298721|FG001|Phase II|Death|1|||
156715970|NCT03180645|565703291|FG002|Overall Study|Adverse Event|2|||
156715971|NCT00625872|565703292|FG000|Overall Study|Withdrawal by Subject|1|||
156715972|NCT00625872|565703293|FG001|Overall Study|Withdrawal by Subject|0|||
156715973|NCT00625872|565703292|FG000|Overall Study|Does not meet inclusion criteria|1|||
156715974|NCT00625872|565703293|FG001|Overall Study|Does not meet inclusion criteria|0|||
156715975|NCT00625872|565703292|FG000|Overall Study|Terminated by sponsor|2|||
156715976|NCT00625872|565703293|FG001|Overall Study|Terminated by sponsor|5|||
156715977|NCT00625872|565703292|FG000|Overall Study|Randomized but not treated|0|||
156715978|NCT00625872|565703293|FG001|Overall Study|Randomized but not treated|1|||
156715979|NCT04208750|565703294|FG000|Overall Study|Lost to Follow-up|16|||
156715980|NCT04208750|565703295|FG001|Overall Study|Lost to Follow-up|15|||
156715981|NCT02201277|565703299|FG000|Overall Study|Death|3|||
156715982|NCT02201277|565703300|FG001|Overall Study|Death|4|||
156715983|NCT02201277|565703299|FG000|Overall Study|Lost to Follow-up|2|||
156715984|NCT02201277|565703300|FG001|Overall Study|Lost to Follow-up|1|||
156715985|NCT02201277|565703299|FG000|Overall Study|Failed retrieval|1|||
156715986|NCT02201277|565703300|FG001|Overall Study|Failed retrieval|0|||
156715987|NCT02201277|565703299|FG000|Overall Study|Physician Decision|1|||
156715988|NCT02201277|565703300|FG001|Overall Study|Physician Decision|0|||
156715989|NCT04917861|565703301|FG000|Main Study (196 Days)|Adverse Event|0|||
156715990|NCT04917861|565703302|FG001|Main Study (196 Days)|Adverse Event|1|||
156715991|NCT04917861|565703303|FG002|Main Study (196 Days)|Adverse Event|0|||
157129259|NCT00666926|567223994|FG007|Overall Study|Other|0|||
157129260|NCT00666926|567223995|FG008|Overall Study|Other|3|||
157129261|NCT00666926|567223996|FG009|Overall Study|Other|5|||
157129262|NCT00666926|567223997|FG010|Overall Study|Other|3|||
157129263|NCT00666926|567223998|FG011|Overall Study|Other|26|||
157129264|NCT00666926|567223999|FG012|Overall Study|Other|3|||
157129265|NCT00666926|567224000|FG013|Overall Study|Other|2|||
157129266|NCT00666926|567224001|FG014|Overall Study|Other|4|||
157129267|NCT00666926|567224002|FG015|Overall Study|Other|4|||
157129268|NCT00666926|567223987|FG000|Overall Study|Withdrawal by Subject|0|||
157129269|NCT00666926|567223988|FG001|Overall Study|Withdrawal by Subject|0|||
157129270|NCT00666926|567223989|FG002|Overall Study|Withdrawal by Subject|0|||
157129271|NCT00666926|567223990|FG003|Overall Study|Withdrawal by Subject|0|||
157129272|NCT00666926|567223991|FG004|Overall Study|Withdrawal by Subject|0|||
157129273|NCT00666926|567223992|FG005|Overall Study|Withdrawal by Subject|0|||
157129274|NCT00666926|567223993|FG006|Overall Study|Withdrawal by Subject|0|||
157129275|NCT00666926|567223994|FG007|Overall Study|Withdrawal by Subject|1|||
157129276|NCT00666926|567223995|FG008|Overall Study|Withdrawal by Subject|0|||
157129277|NCT00666926|567223996|FG009|Overall Study|Withdrawal by Subject|3|||
157129278|NCT00666926|567223997|FG010|Overall Study|Withdrawal by Subject|0|||
157129279|NCT00666926|567223998|FG011|Overall Study|Withdrawal by Subject|3|||
157129280|NCT00666926|567223999|FG012|Overall Study|Withdrawal by Subject|0|||
157129281|NCT00666926|567224000|FG013|Overall Study|Withdrawal by Subject|1|||
157129282|NCT00666926|567224001|FG014|Overall Study|Withdrawal by Subject|3|||
157129283|NCT00666926|567224002|FG015|Overall Study|Withdrawal by Subject|3|||
157129284|NCT00666926|567223987|FG000|Overall Study|Death|0|||
157129285|NCT00666926|567223988|FG001|Overall Study|Death|0|||
157129286|NCT00666926|567223989|FG002|Overall Study|Death|0|||
157129287|NCT00666926|567223990|FG003|Overall Study|Death|0|||
157129288|NCT00666926|567223991|FG004|Overall Study|Death|0|||
157129289|NCT00666926|567223992|FG005|Overall Study|Death|0|||
157129290|NCT00666926|567223993|FG006|Overall Study|Death|0|||
157129291|NCT00666926|567223994|FG007|Overall Study|Death|0|||
157129292|NCT00666926|567223995|FG008|Overall Study|Death|0|||
157129293|NCT00666926|567223996|FG009|Overall Study|Death|0|||
157129294|NCT00666926|567223997|FG010|Overall Study|Death|0|||
157129295|NCT00666926|567223998|FG011|Overall Study|Death|1|||
156715992|NCT04917861|565703304|FG003|Main Study (196 Days)|Adverse Event|0|||
156715993|NCT04917861|565703301|FG000|Main Study (196 Days)|Death|0|||
156715994|NCT04917861|565703302|FG001|Main Study (196 Days)|Death|0|||
156715995|NCT04917861|565703303|FG002|Main Study (196 Days)|Death|0|||
156715996|NCT04917861|565703304|FG003|Main Study (196 Days)|Death|1|||
156715997|NCT04917861|565703301|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
156715998|NCT04917861|565703302|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
156715999|NCT04917861|565703303|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
156716000|NCT04917861|565703304|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
156716001|NCT04917861|565703301|FG000|Main Study (196 Days)|Physician Decision|0|||
156716002|NCT04917861|565703302|FG001|Main Study (196 Days)|Physician Decision|0|||
156716003|NCT04917861|565703303|FG002|Main Study (196 Days)|Physician Decision|0|||
156716004|NCT04917861|565703304|FG003|Main Study (196 Days)|Physician Decision|1|||
157129296|NCT00666926|567223999|FG012|Overall Study|Death|0|||
157129297|NCT00666926|567224000|FG013|Overall Study|Death|0|||
157129298|NCT00666926|567224001|FG014|Overall Study|Death|0|||
157129299|NCT00666926|567224002|FG015|Overall Study|Death|0|||
156716005|NCT04917861|565703301|FG000|Main Study (196 Days)|Pregnancy|1|||
157129300|NCT01960855|567224003|FG000|Overall Study|Subject noncompliant|1|||
157129301|NCT01960855|567224004|FG001|Overall Study|Subject noncompliant|0|||
157129302|NCT01960855|567224005|FG002|Overall Study|Subject noncompliant|0|||
157129303|NCT01960855|567224006|FG003|Overall Study|Subject noncompliant|0|||
157129304|NCT01960855|567224007|FG004|Overall Study|Subject noncompliant|0|||
157129305|NCT01960855|567224003|FG000|Overall Study|Adverse Event|2|||
157129306|NCT01960855|567224004|FG001|Overall Study|Adverse Event|0|||
157129307|NCT01960855|567224005|FG002|Overall Study|Adverse Event|6|||
157129308|NCT01960855|567224006|FG003|Overall Study|Adverse Event|2|||
157129309|NCT01960855|567224007|FG004|Overall Study|Adverse Event|2|||
157129310|NCT01960855|567224003|FG000|Overall Study|Lack of Efficacy|1|||
157129311|NCT01960855|567224004|FG001|Overall Study|Lack of Efficacy|1|||
157129312|NCT01960855|567224005|FG002|Overall Study|Lack of Efficacy|0|||
157129313|NCT01960855|567224006|FG003|Overall Study|Lack of Efficacy|0|||
157129314|NCT01960855|567224007|FG004|Overall Study|Lack of Efficacy|0|||
157129315|NCT01960855|567224003|FG000|Overall Study|Other|2|||
157129316|NCT01960855|567224004|FG001|Overall Study|Other|1|||
157129317|NCT01960855|567224005|FG002|Overall Study|Other|1|||
157129318|NCT01960855|567224006|FG003|Overall Study|Other|1|||
157129319|NCT01960855|567224007|FG004|Overall Study|Other|0|||
157129320|NCT01960855|567224003|FG000|Overall Study|Consent withdrawn by subject|3|||
157129321|NCT01960855|567224004|FG001|Overall Study|Consent withdrawn by subject|1|||
157129322|NCT01960855|567224005|FG002|Overall Study|Consent withdrawn by subject|2|||
157129323|NCT01960855|567224006|FG003|Overall Study|Consent withdrawn by subject|1|||
157129324|NCT01960855|567224007|FG004|Overall Study|Consent withdrawn by subject|1|||
157129325|NCT01960855|567224003|FG000|Overall Study|Lost to Follow-up|2|||
157129326|NCT01960855|567224004|FG001|Overall Study|Lost to Follow-up|1|||
157129327|NCT01960855|567224005|FG002|Overall Study|Lost to Follow-up|0|||
157129328|NCT01960855|567224006|FG003|Overall Study|Lost to Follow-up|0|||
157129329|NCT01960855|567224007|FG004|Overall Study|Lost to Follow-up|2|||
157129330|NCT01318122|567224010|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157129331|NCT01318122|567224011|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157129332|NCT01318122|567224012|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
157129333|NCT01318122|567224013|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
157129334|NCT01318122|567224010|FG000|Enrolled - Long-Term Extension Study|Other|1|||
157129335|NCT01318122|567224011|FG001|Enrolled - Long-Term Extension Study|Other|0|||
157129336|NCT01318122|567224012|FG002|Enrolled - Long-Term Extension Study|Other|0|||
157129337|NCT01318122|567224013|FG003|Enrolled - Long-Term Extension Study|Other|0|||
157129338|NCT01318122|567224010|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
157129339|NCT01318122|567224011|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
157129340|NCT01318122|567224012|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
157129341|NCT01318122|567224013|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
157129342|NCT01318122|567224010|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
157129343|NCT01318122|567224011|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157129344|NCT01318122|567224012|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157129345|NCT01318122|567224013|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157129346|NCT01318122|567224010|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
157129347|NCT01318122|567224011|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
157129348|NCT01318122|567224012|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157129349|NCT01318122|567224013|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
157129350|NCT01318122|567224010|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157129351|NCT01318122|567224011|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
157129352|NCT01318122|567224012|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
157129353|NCT01318122|567224013|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157129354|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
157129355|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
157129356|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
157129357|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Death|28|||
157216484|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Adverse Event|0|||
156716006|NCT04917861|565703302|FG001|Main Study (196 Days)|Pregnancy|1|||
156716007|NCT04917861|565703303|FG002|Main Study (196 Days)|Pregnancy|0|||
156716008|NCT04917861|565703304|FG003|Main Study (196 Days)|Pregnancy|0|||
156716009|NCT04917861|565703301|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
156716010|NCT04917861|565703302|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
156716011|NCT04917861|565703303|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
156716012|NCT04917861|565703304|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
156716013|NCT04917861|565703301|FG000|Main Study (196 Days)|Other Than Specified|1|||
156716014|NCT04917861|565703302|FG001|Main Study (196 Days)|Other Than Specified|0|||
156716015|NCT04917861|565703303|FG002|Main Study (196 Days)|Other Than Specified|1|||
156716016|NCT04917861|565703304|FG003|Main Study (196 Days)|Other Than Specified|2|||
156716017|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
156716018|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
157129358|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Death|0|||
157129359|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Death|0|||
157129360|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
157129361|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
157129362|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
157129363|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
157129364|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
157129365|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
157129366|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
157129367|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
157129368|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
157129369|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
157129370|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
157129371|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
157129372|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
157129373|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
157129374|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
157129375|NCT00820755|567224014|FG000|Period 1: Combination Therapy Phase|Other|11|||
157129376|NCT00820755|567224015|FG001|Period 1: Combination Therapy Phase|Other|0|||
157129377|NCT00820755|567224016|FG002|Period 1: Combination Therapy Phase|Other|0|||
157129378|NCT00820755|567224014|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
157129379|NCT00820755|567224015|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
157129380|NCT00820755|567224016|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
157129381|NCT01486199|567224017|FG000|Two Year Period Between Study Days|Physician Decision|1|||
157129382|NCT01486199|567224018|FG001|Two Year Period Between Study Days|Physician Decision|0|||
157129383|NCT02154425|567224024|FG000|Screening Period|Adverse Event|1|||
157129384|NCT02251912|567224025|FG000|Overall Study|Withdrawal by Subject|2|||
157129385|NCT02251912|567224026|FG001|Overall Study|Withdrawal by Subject|3|||
157129386|NCT02251912|567224025|FG000|Overall Study|Adverse Event|0|||
157129387|NCT02251912|567224026|FG001|Overall Study|Adverse Event|2|||
157129388|NCT01133171|567224028|FG000|Overall Study|Withdrawal by Subject|1|||
157129389|NCT01133171|567224029|FG001|Overall Study|Withdrawal by Subject|2|||
157129390|NCT01133171|567224030|FG002|Overall Study|Withdrawal by Subject|0|||
157129391|NCT04062214|567224032|FG000|Week 12|Death|1|||
157129392|NCT04062214|567224033|FG001|Week 12|Death|1|||
157129393|NCT04062214|567224032|FG000|Week 12|Withdrawal by Subject|14|||
157129394|NCT04062214|567224033|FG001|Week 12|Withdrawal by Subject|13|||
157129395|NCT04062214|567224032|FG000|Week 12|Lost to Follow-up|55|||
157129396|NCT04062214|567224033|FG001|Week 12|Lost to Follow-up|68|||
157129397|NCT04062214|567224032|FG000|Week 12|Intermittent missing|31|||
157129398|NCT04062214|567224033|FG001|Week 12|Intermittent missing|29|||
157129399|NCT04062214|567224032|FG000|Week 36|Withdrawal by Subject|4|||
157129400|NCT04062214|567224033|FG001|Week 36|Withdrawal by Subject|5|||
157129401|NCT04062214|567224032|FG000|Week 36|Lost to Follow-up|50|||
157129402|NCT04062214|567224033|FG001|Week 36|Lost to Follow-up|46|||
157129403|NCT04062214|567224032|FG000|Week 36|Death|0|||
157129404|NCT04062214|567224033|FG001|Week 36|Death|1|||
157129405|NCT00091832|567224034|FG000|Overall Study|Physician Decision|1|||
157129406|NCT00091832|567224035|FG001|Overall Study|Physician Decision|0|||
157129407|NCT00091832|567224036|FG002|Overall Study|Physician Decision|0|||
157129408|NCT00091832|567224037|FG003|Overall Study|Physician Decision|0|||
157129409|NCT00091832|567224038|FG004|Overall Study|Physician Decision|0|||
157129410|NCT00091832|567224039|FG005|Overall Study|Physician Decision|0|||
157129411|NCT00091832|567224034|FG000|Overall Study|Adverse Event|0|||
157129412|NCT00091832|567224035|FG001|Overall Study|Adverse Event|0|||
157129413|NCT00091832|567224036|FG002|Overall Study|Adverse Event|0|||
157129414|NCT00091832|567224037|FG003|Overall Study|Adverse Event|1|||
157129415|NCT00091832|567224038|FG004|Overall Study|Adverse Event|3|||
157129416|NCT00091832|567224039|FG005|Overall Study|Adverse Event|0|||
157129417|NCT00091832|567224034|FG000|Overall Study|Withdrawal by Subject|4|||
157129418|NCT00091832|567224035|FG001|Overall Study|Withdrawal by Subject|5|||
157129419|NCT00091832|567224036|FG002|Overall Study|Withdrawal by Subject|0|||
157129420|NCT00091832|567224037|FG003|Overall Study|Withdrawal by Subject|1|||
157129421|NCT00091832|567224038|FG004|Overall Study|Withdrawal by Subject|3|||
157129422|NCT00091832|567224039|FG005|Overall Study|Withdrawal by Subject|1|||
157129423|NCT00091832|567224034|FG000|Overall Study|Death|6|||
157129424|NCT00091832|567224035|FG001|Overall Study|Death|4|||
157129425|NCT00091832|567224036|FG002|Overall Study|Death|5|||
157129426|NCT00091832|567224037|FG003|Overall Study|Death|8|||
157129427|NCT00091832|567224038|FG004|Overall Study|Death|5|||
157129428|NCT00091832|567224039|FG005|Overall Study|Death|6|||
157129429|NCT00091832|567224034|FG000|Overall Study|Disease Progression|2|||
157129430|NCT00091832|567224035|FG001|Overall Study|Disease Progression|0|||
156716019|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
157129431|NCT00091832|567224036|FG002|Overall Study|Disease Progression|0|||
157129432|NCT00091832|567224037|FG003|Overall Study|Disease Progression|1|||
157129433|NCT00091832|567224038|FG004|Overall Study|Disease Progression|1|||
156716020|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
157216485|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Adverse Event|1|||
157216486|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
157216487|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
157216488|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
157216489|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
156716021|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716022|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
156716023|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716024|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
156716025|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716026|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
156716027|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716028|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
156716029|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
156716030|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
156716031|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
156716032|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
156716033|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716034|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
156716035|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716036|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
156716037|NCT04917861|565703301|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
156716038|NCT04917861|565703302|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
156716039|NCT04917861|565703303|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
156716040|NCT04917861|565703304|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
156716041|NCT01128179|565703305|FG000|Overall Study|Death|1|||
156716042|NCT01128179|565703306|FG001|Overall Study|Death|0|||
156716043|NCT01128179|565703305|FG000|Overall Study|Protocol Violation|1|||
156716044|NCT01128179|565703306|FG001|Overall Study|Protocol Violation|0|||
156716045|NCT02694328|565703307|FG000|Overall Study|Adverse Event|27|||
156716046|NCT02694328|565703308|FG001|Overall Study|Adverse Event|33|||
156716047|NCT02694328|565703307|FG000|Overall Study|Withdrawal by Subject|27|||
156716048|NCT02694328|565703308|FG001|Overall Study|Withdrawal by Subject|23|||
156716049|NCT02694328|565703307|FG000|Overall Study|Lost to Follow-up|26|||
156716050|NCT02694328|565703308|FG001|Overall Study|Lost to Follow-up|22|||
156716051|NCT02694328|565703307|FG000|Overall Study|Noncompliant with study drug|11|||
156716052|NCT02694328|565703308|FG001|Overall Study|Noncompliant with study drug|8|||
156716053|NCT02694328|565703307|FG000|Overall Study|Incarceration|1|||
156716054|NCT02694328|565703308|FG001|Overall Study|Incarceration|1|||
156716055|NCT02694328|565703307|FG000|Overall Study|Lack of Efficacy|1|||
156716056|NCT02694328|565703308|FG001|Overall Study|Lack of Efficacy|2|||
156716057|NCT02694328|565703307|FG000|Overall Study|Pregnancy|1|||
156716058|NCT02694328|565703308|FG001|Overall Study|Pregnancy|1|||
156716059|NCT02694328|565703307|FG000|Overall Study|Protocol Violation|6|||
156716060|NCT02694328|565703308|FG001|Overall Study|Protocol Violation|5|||
156716061|NCT02694328|565703307|FG000|Overall Study|Abnormal Laboratory Value|0|||
156716062|NCT02694328|565703308|FG001|Overall Study|Abnormal Laboratory Value|3|||
156716063|NCT02603146|565705239|FG000|Overall Study|Lost to Follow-up|5|||
156716064|NCT02603146|565705240|FG001|Overall Study|Lost to Follow-up|6|||
156716065|NCT02603146|565705239|FG000|Overall Study|Withdrawal by Subject|8|||
156716066|NCT02603146|565705240|FG001|Overall Study|Withdrawal by Subject|10|||
156716067|NCT02603146|565705239|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
156716068|NCT02603146|565705240|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
156716069|NCT02603146|565705239|FG000|Overall Study|Participant moved|2|||
156716070|NCT02603146|565705240|FG001|Overall Study|Participant moved|0|||
156716071|NCT02603146|565705239|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
156874710|NCT01737502|566298720|FG000|Phase II|Transition to hospice care|0|||
156874711|NCT01737502|566298721|FG001|Phase II|Transition to hospice care|1|||
156874712|NCT01326104|566298726|FG000|Overall Study|progressed prior to vaccine|0|||
156874713|NCT01326104|566298727|FG001|Overall Study|progressed prior to vaccine|2|||
157017581|NCT04112316|566817830|FG001|First Period (8 Weeks)|Protocol Violation|0|||
156716072|NCT02603146|565705240|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
156716073|NCT00265759|565705244|FG000|Overall Study|Withdrawal by Subject|0|||
156716074|NCT00265759|565705245|FG001|Overall Study|Withdrawal by Subject|1|||
156716075|NCT00265759|565705246|FG002|Overall Study|Withdrawal by Subject|2|||
156716076|NCT00265759|565705247|FG003|Overall Study|Withdrawal by Subject|2|||
156716077|NCT00265759|565705244|FG000|Overall Study|Cancel|0|||
156716078|NCT00265759|565705245|FG001|Overall Study|Cancel|0|||
156716079|NCT00265759|565705246|FG002|Overall Study|Cancel|0|||
156716080|NCT00265759|565705247|FG003|Overall Study|Cancel|3|||
156716081|NCT00265759|565705244|FG000|Overall Study|Ineligible|0|||
156716082|NCT00265759|565705245|FG001|Overall Study|Ineligible|0|||
157216490|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
156874714|NCT01326104|566298726|FG000|Overall Study|unable to make vaccine|0|||
157129434|NCT00091832|567224039|FG005|Overall Study|Disease Progression|2|||
157129435|NCT00091832|567224034|FG000|Overall Study|Ineligibility Determined|0|||
157129436|NCT00091832|567224035|FG001|Overall Study|Ineligibility Determined|0|||
157129437|NCT00091832|567224036|FG002|Overall Study|Ineligibility Determined|1|||
157129438|NCT00091832|567224037|FG003|Overall Study|Ineligibility Determined|0|||
157129439|NCT00091832|567224038|FG004|Overall Study|Ineligibility Determined|1|||
157129440|NCT00091832|567224039|FG005|Overall Study|Ineligibility Determined|0|||
157129441|NCT00091832|567224034|FG000|Overall Study|Lost to Follow-up|1|||
156793008|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
157129442|NCT00091832|567224035|FG001|Overall Study|Lost to Follow-up|0|||
157129443|NCT00091832|567224036|FG002|Overall Study|Lost to Follow-up|3|||
157129444|NCT00091832|567224037|FG003|Overall Study|Lost to Follow-up|3|||
157129445|NCT00091832|567224038|FG004|Overall Study|Lost to Follow-up|2|||
157129446|NCT00091832|567224039|FG005|Overall Study|Lost to Follow-up|1|||
157129447|NCT00091832|567224034|FG000|Overall Study|Noncompliance|0|||
157129448|NCT00091832|567224035|FG001|Overall Study|Noncompliance|1|||
157129449|NCT00091832|567224036|FG002|Overall Study|Noncompliance|0|||
157129450|NCT00091832|567224037|FG003|Overall Study|Noncompliance|0|||
157129451|NCT00091832|567224038|FG004|Overall Study|Noncompliance|0|||
157129452|NCT00091832|567224039|FG005|Overall Study|Noncompliance|0|||
157129453|NCT00091832|567224034|FG000|Overall Study|Other|0|||
157129454|NCT00091832|567224035|FG001|Overall Study|Other|1|||
157129455|NCT00091832|567224036|FG002|Overall Study|Other|2|||
157129456|NCT00091832|567224037|FG003|Overall Study|Other|0|||
157129457|NCT00091832|567224038|FG004|Overall Study|Other|0|||
157129458|NCT00091832|567224039|FG005|Overall Study|Other|0|||
157129459|NCT00091832|567224034|FG000|Overall Study|Protocol Violation|0|||
157129460|NCT00091832|567224035|FG001|Overall Study|Protocol Violation|0|||
157129461|NCT00091832|567224036|FG002|Overall Study|Protocol Violation|1|||
156793009|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
156793010|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
156793011|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
156793012|NCT04003142|565994822|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
156793013|NCT04003142|565994823|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
156793014|NCT04003142|565994824|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
156793015|NCT04003142|565994825|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
156793016|NCT04003142|565994826|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
156793017|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
156793018|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793019|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793020|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793021|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
156793022|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793023|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793024|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
156793025|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793026|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793027|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793028|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
156793029|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
156793030|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793031|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793032|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
156793033|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793034|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793035|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793036|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793037|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
156793038|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
156793039|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
157129462|NCT00091832|567224037|FG003|Overall Study|Protocol Violation|0|||
157216491|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
157216492|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
157216493|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
157216494|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
157216495|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
157216496|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
156793040|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
157129463|NCT00091832|567224038|FG004|Overall Study|Protocol Violation|0|||
157129464|NCT00091832|567224039|FG005|Overall Study|Protocol Violation|1|||
157129465|NCT03434379|567224043|FG000|Global Period|Lost to Follow-up|3|||
157129466|NCT03434379|567224044|FG001|Global Period|Lost to Follow-up|6|||
157129467|NCT03434379|567224045|FG002|Global Period|Lost to Follow-up|0|||
157216497|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
157216498|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
157216499|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
157216500|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
157216501|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
157216502|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
157216503|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
157216504|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
157216505|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
157216506|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
157216507|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Physician Decision|0|||
157216508|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Physician Decision|5|||
157216509|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Physician Decision|1|||
157216510|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Physician Decision|0|||
157216511|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Physician Decision|3|||
157216512|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Physician Decision|1|||
157216513|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Physician Decision|2|||
157216514|NCT00606684|567539269|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157216515|NCT00606684|567539270|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157216516|NCT00606684|567539271|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157216517|NCT00606684|567539272|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
157216518|NCT00606684|567539273|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157216519|NCT00606684|567539274|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
157216520|NCT00606684|567539275|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157216521|NCT03377556|567539280|FG000|Overall Study|Adverse Event|5|||
157216522|NCT03377556|567539280|FG000|Overall Study|Refusal unrelated to adverse events|1|||
157216523|NCT03377556|567539280|FG000|Overall Study|Progression/relapse|38|||
157216524|NCT03377556|567539280|FG000|Overall Study|Death|3|||
157216525|NCT00827827|567539281|FG000|Overall Study|Lost to Follow-up|3|||
157216526|NCT00827827|567539282|FG001|Overall Study|Lost to Follow-up|0|||
157216527|NCT00827827|567539281|FG000|Overall Study|Fall at home- hospitalization|1|||
157216528|NCT00827827|567539282|FG001|Overall Study|Fall at home- hospitalization|0|||
157216529|NCT00827827|567539281|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
157216530|NCT00827827|567539282|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
157216531|NCT00827827|567539281|FG000|Overall Study|Gout|1|||
157216532|NCT00827827|567539282|FG001|Overall Study|Gout|0|||
157216533|NCT00827827|567539281|FG000|Overall Study|Transportation issues|1|||
157216534|NCT00827827|567539282|FG001|Overall Study|Transportation issues|0|||
157216535|NCT00827827|567539281|FG000|Overall Study|Burned with water at home|1|||
157216536|NCT00827827|567539282|FG001|Overall Study|Burned with water at home|0|||
157216537|NCT00447603|567539287|FG000|Screening|Withdrawal by Subject|1|||
157216538|NCT00447603|567539288|FG001|Screening|Withdrawal by Subject|0|||
157216539|NCT00447603|567539289|FG002|Screening|Withdrawal by Subject|0|||
157216540|NCT00447603|567539287|FG000|Screening|Protocol Violation|1|||
157216541|NCT00447603|567539288|FG001|Screening|Protocol Violation|0|||
157216542|NCT00447603|567539289|FG002|Screening|Protocol Violation|0|||
157216543|NCT00447603|567539287|FG000|Screening|Screen Failure|4|||
157216544|NCT00447603|567539288|FG001|Screening|Screen Failure|0|||
157216545|NCT00447603|567539289|FG002|Screening|Screen Failure|0|||
157216546|NCT00447603|567539287|FG000|Screening|Study Terminated by Sponsor|15|||
157216547|NCT00447603|567539288|FG001|Screening|Study Terminated by Sponsor|0|||
157216548|NCT00447603|567539289|FG002|Screening|Study Terminated by Sponsor|0|||
157216549|NCT00447603|567539287|FG000|Filter Period|Adverse Event|0|||
156716083|NCT00265759|565705246|FG002|Overall Study|Ineligible|0|||
156716084|NCT00265759|565705247|FG003|Overall Study|Ineligible|1|||
156716085|NCT00265759|565705244|FG000|Overall Study|Bilateral disease|0|||
156716086|NCT00265759|565705245|FG001|Overall Study|Bilateral disease|0|||
156716087|NCT00265759|565705246|FG002|Overall Study|Bilateral disease|0|||
156716088|NCT00265759|565705247|FG003|Overall Study|Bilateral disease|2|||
156716089|NCT00265759|565705244|FG000|Overall Study|Discontinued due to intolerability|0|||
156874715|NCT01326104|566298727|FG001|Overall Study|unable to make vaccine|2|||
156874716|NCT05064358|566298728|FG000|Overall Study|Death|23|||
157216550|NCT00447603|567539288|FG001|Filter Period|Adverse Event|0|||
157216551|NCT00447603|567539289|FG002|Filter Period|Adverse Event|1|||
157216552|NCT00447603|567539287|FG000|Filter Period|Screen Failure|0|||
156716090|NCT00265759|565705245|FG001|Overall Study|Discontinued due to intolerability|0|||
156716091|NCT00265759|565705246|FG002|Overall Study|Discontinued due to intolerability|0|||
156716092|NCT00265759|565705247|FG003|Overall Study|Discontinued due to intolerability|1|||
156874717|NCT05064358|566298729|FG001|Overall Study|Death|23|||
156874718|NCT05064358|566298730|FG002|Overall Study|Death|25|||
156716093|NCT06082843|565705248|FG000|Overall Study|Withdrawal by Subject|0|||
156716094|NCT06082843|565705249|FG001|Overall Study|Withdrawal by Subject|2|||
156716095|NCT06082843|565705248|FG000|Overall Study|Study terminated by sponsor|12|||
156874719|NCT05064358|566298731|FG003|Overall Study|Death|21|||
157129468|NCT03434379|567224046|FG003|Global Period|Lost to Follow-up|0|||
157129469|NCT03434379|567224043|FG000|Global Period|Death|115|||
157129470|NCT03434379|567224044|FG001|Global Period|Death|228|||
157129471|NCT03434379|567224045|FG002|Global Period|Death|0|||
157129472|NCT03434379|567224046|FG003|Global Period|Death|0|||
157129473|NCT03434379|567224043|FG000|Global Period|Withdrawal by Subject|20|||
157129474|NCT03434379|567224044|FG001|Global Period|Withdrawal by Subject|21|||
157129475|NCT03434379|567224045|FG002|Global Period|Withdrawal by Subject|0|||
157129476|NCT03434379|567224046|FG003|Global Period|Withdrawal by Subject|0|||
157129477|NCT03434379|567224043|FG000|Global Period|Reason Unspecified|0|||
157129478|NCT03434379|567224044|FG001|Global Period|Reason Unspecified|1|||
157129479|NCT03434379|567224045|FG002|Global Period|Reason Unspecified|0|||
157129480|NCT03434379|567224046|FG003|Global Period|Reason Unspecified|0|||
157129481|NCT03434379|567224043|FG000|Global Period|Study Ended by Sponsor|26|||
157129482|NCT03434379|567224044|FG001|Global Period|Study Ended by Sponsor|80|||
157129483|NCT03434379|567224045|FG002|Global Period|Study Ended by Sponsor|0|||
157129484|NCT03434379|567224046|FG003|Global Period|Study Ended by Sponsor|0|||
157129485|NCT03434379|567224043|FG000|Global Period|Physician Decision|1|||
157129486|NCT03434379|567224044|FG001|Global Period|Physician Decision|0|||
157129487|NCT03434379|567224045|FG002|Global Period|Physician Decision|0|||
157129488|NCT03434379|567224046|FG003|Global Period|Physician Decision|0|||
157129489|NCT03434379|567224043|FG000|China Extension Period|Lost to Follow-up|0|||
157129490|NCT03434379|567224044|FG001|China Extension Period|Lost to Follow-up|0|||
157129491|NCT03434379|567224045|FG002|China Extension Period|Lost to Follow-up|2|||
157129492|NCT03434379|567224046|FG003|China Extension Period|Lost to Follow-up|3|||
157129493|NCT03434379|567224043|FG000|China Extension Period|Death|0|||
157129494|NCT03434379|567224044|FG001|China Extension Period|Death|0|||
156874720|NCT05064358|566298732|FG004|Overall Study|Death|5|||
156874721|NCT05064358|566298728|FG000|Overall Study|Lost to Follow-up|1|||
156874722|NCT05064358|566298729|FG001|Overall Study|Lost to Follow-up|2|||
157017582|NCT04112316|566817829|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
157017583|NCT04112316|566817830|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
157017584|NCT05415436|566817840|FG000|Overall Study|Surgeon cancelled procedure|1|||
157017585|NCT05415436|566817841|FG001|Overall Study|Surgeon cancelled procedure|0|||
157017586|NCT05415436|566817840|FG000|Overall Study|Death|1|||
157017587|NCT05415436|566817841|FG001|Overall Study|Death|0|||
157017588|NCT05386355|566817852|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
157017589|NCT05386355|566817853|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
157017590|NCT05386355|566817854|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
157017591|NCT05386355|566817855|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
157017592|NCT03775109|566817860|FG000|Overall Study|Adverse Event|1|||
157017593|NCT03775109|566817861|FG001|Overall Study|Adverse Event|0|||
157017594|NCT03775109|566817860|FG000|Overall Study|COVID-19 outbreak|2|||
157017595|NCT03775109|566817861|FG001|Overall Study|COVID-19 outbreak|0|||
157017596|NCT03775109|566817860|FG000|Overall Study|Lost to Follow-up|0|||
157017597|NCT03775109|566817861|FG001|Overall Study|Lost to Follow-up|2|||
157017598|NCT03775109|566817860|FG000|Overall Study|Withdrawal by Subject|1|||
157017599|NCT03775109|566817861|FG001|Overall Study|Withdrawal by Subject|1|||
157017600|NCT03775109|566817860|FG000|Overall Study|Death|0|||
157017601|NCT03775109|566817861|FG001|Overall Study|Death|1|||
157017602|NCT03775109|566817860|FG000|Overall Study|Lack of Efficacy|1|||
157017603|NCT03775109|566817861|FG001|Overall Study|Lack of Efficacy|0|||
157017604|NCT02840474|566817866|FG000|Overall Study|Lost to Follow-up|1|||
157017605|NCT02840474|566817867|FG001|Overall Study|Lost to Follow-up|0|||
157017606|NCT04716634|566817868|FG000|Overall Study|Death|24|||
157017607|NCT04716634|566817869|FG001|Overall Study|Death|24|||
157017608|NCT04716634|566817870|FG002|Overall Study|Death|8|||
157017609|NCT04716634|566817868|FG000|Overall Study|Closed by Sponsor|4|||
157017610|NCT04716634|566817869|FG001|Overall Study|Closed by Sponsor|4|||
157017611|NCT04716634|566817870|FG002|Overall Study|Closed by Sponsor|5|||
157017612|NCT04716634|566817868|FG000|Overall Study|Lost to Follow-up|1|||
157017613|NCT04716634|566817869|FG001|Overall Study|Lost to Follow-up|0|||
157017614|NCT04716634|566817870|FG002|Overall Study|Lost to Follow-up|1|||
157017615|NCT04716634|566817868|FG000|Overall Study|Withdrawal by Subject|0|||
157017616|NCT04716634|566817869|FG001|Overall Study|Withdrawal by Subject|0|||
157017617|NCT04716634|566817870|FG002|Overall Study|Withdrawal by Subject|1|||
157017618|NCT04737772|566817886|FG000|Phase 2 Study|Lost to Follow-up|15|||
157017619|NCT04737772|566817887|FG001|Phase 2 Study|Lost to Follow-up|15|||
157017620|NCT04737772|566817886|FG000|Phase 2 Study|Withdrawal by Subject|0|||
157017621|NCT04737772|566817887|FG001|Phase 2 Study|Withdrawal by Subject|1|||
157017622|NCT04737772|566817886|FG000|Phase 2 Study|Did not take any coaching calls|4|||
157017623|NCT04737772|566817887|FG001|Phase 2 Study|Did not take any coaching calls|0|||
157017624|NCT04737772|566817886|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
157017625|NCT04737772|566817887|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
157129495|NCT03434379|567224045|FG002|China Extension Period|Death|46|||
157129496|NCT03434379|567224046|FG003|China Extension Period|Death|88|||
156793041|NCT03973489|565994829|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
156793042|NCT03973489|565994830|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793043|NCT03973489|565994831|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793044|NCT03973489|565994832|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
156793045|NCT03973489|565994833|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793046|NCT03973489|565994834|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793047|NCT03973489|565994835|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793048|NCT03973489|565994836|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
156793049|NCT03973489|565994829|FG000|Second Intervention (1 Day)|Adverse Event|0|||
156793050|NCT03973489|565994830|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156793051|NCT03973489|565994831|FG002|Second Intervention (1 Day)|Adverse Event|0|||
156793052|NCT03973489|565994832|FG003|Second Intervention (1 Day)|Adverse Event|1|||
156793053|NCT03973489|565994833|FG004|Second Intervention (1 Day)|Adverse Event|0|||
156793054|NCT03973489|565994834|FG005|Second Intervention (1 Day)|Adverse Event|0|||
157017626|NCT04737772|566817886|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
157017627|NCT04737772|566817887|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
157017628|NCT02549339|566817888|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
157017629|NCT02549339|566817889|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
157017630|NCT02549339|566817888|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
157017631|NCT02549339|566817889|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
157017632|NCT02549339|566817888|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
157017633|NCT02549339|566817889|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
157017634|NCT02549339|566817888|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
157017635|NCT02549339|566817889|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
157017636|NCT02549339|566817888|FG000|12-month Follow-up|Lack of Efficacy|0|||
157017637|NCT02549339|566817889|FG001|12-month Follow-up|Lack of Efficacy|2|||
157017638|NCT02549339|566817888|FG000|12-month Follow-up|Withdrawal by Subject|8|||
157017639|NCT02549339|566817889|FG001|12-month Follow-up|Withdrawal by Subject|3|||
157017640|NCT02549339|566817888|FG000|12-month Follow-up|Lost to Follow-up|1|||
157017641|NCT02549339|566817889|FG001|12-month Follow-up|Lost to Follow-up|3|||
157017642|NCT02549339|566817888|FG000|12-month Follow-up|Other|0|||
157017643|NCT02549339|566817889|FG001|12-month Follow-up|Other|3|||
157017644|NCT05054374|566817906|FG000|Overall Study|Withdrawal by Subject|1|||
157017645|NCT05054374|566817907|FG001|Overall Study|Withdrawal by Subject|0|||
157017646|NCT05054374|566817908|FG002|Overall Study|Withdrawal by Subject|0|||
157017647|NCT05054374|566817909|FG003|Overall Study|Withdrawal by Subject|0|||
157017648|NCT05054374|566817906|FG000|Overall Study|Progressive Disease|5|||
157017649|NCT05054374|566817907|FG001|Overall Study|Progressive Disease|0|||
157017650|NCT05054374|566817908|FG002|Overall Study|Progressive Disease|0|||
157017651|NCT05054374|566817909|FG003|Overall Study|Progressive Disease|0|||
157017652|NCT05691309|566817910|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
157017653|NCT05691309|566817910|FG000|Overall Study|vancomycin levels not evaluable|2|||
157017654|NCT04820855|566817912|FG000|Overall Study|Lost to Follow-up|6|||
157017655|NCT04820855|566817913|FG001|Overall Study|Lost to Follow-up|9|||
157017656|NCT04838262|566817914|FG000|Overall Study|Withdrawal by Subject|9|||
157017657|NCT04838262|566817915|FG001|Overall Study|Withdrawal by Subject|4|||
157017658|NCT02697136|566817922|FG000|Overall Study|Adverse Event|3|||
157017659|NCT02697136|566817923|FG001|Overall Study|Adverse Event|0|||
157017660|NCT02323321|566817927|FG000|Overall Study|Re-Transplant|1|||
157017661|NCT02323321|566817927|FG000|Overall Study|Death|12|||
157017662|NCT04093752|566817930|FG000|Overall Study|Adverse Event|7|||
157017663|NCT04093752|566817931|FG001|Overall Study|Adverse Event|19|||
157017664|NCT04093752|566817932|FG002|Overall Study|Adverse Event|18|||
157017665|NCT04093752|566817933|FG003|Overall Study|Adverse Event|4|||
157017666|NCT04093752|566817930|FG000|Overall Study|Withdrawal by Subject|6|||
157017667|NCT04093752|566817931|FG001|Overall Study|Withdrawal by Subject|6|||
157017668|NCT04093752|566817932|FG002|Overall Study|Withdrawal by Subject|8|||
157017669|NCT04093752|566817933|FG003|Overall Study|Withdrawal by Subject|20|||
157017670|NCT04093752|566817930|FG000|Overall Study|Lost to Follow-up|2|||
157017671|NCT04093752|566817931|FG001|Overall Study|Lost to Follow-up|1|||
157017672|NCT04093752|566817932|FG002|Overall Study|Lost to Follow-up|1|||
157017673|NCT04093752|566817933|FG003|Overall Study|Lost to Follow-up|1|||
157017674|NCT04093752|566817930|FG000|Overall Study|Death|0|||
157017675|NCT04093752|566817931|FG001|Overall Study|Death|0|||
157017676|NCT04093752|566817932|FG002|Overall Study|Death|1|||
157017677|NCT04093752|566817933|FG003|Overall Study|Death|2|||
157017678|NCT04093752|566817930|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
157017679|NCT04093752|566817931|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
157017680|NCT04093752|566817932|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
157017681|NCT04093752|566817933|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
157017682|NCT04093752|566817930|FG000|Overall Study|Covid 19|0|||
157017683|NCT04093752|566817931|FG001|Overall Study|Covid 19|0|||
157017684|NCT04093752|566817932|FG002|Overall Study|Covid 19|0|||
157017685|NCT04093752|566817933|FG003|Overall Study|Covid 19|1|||
156874723|NCT05064358|566298730|FG002|Overall Study|Lost to Follow-up|0|||
157129497|NCT03434379|567224043|FG000|China Extension Period|Withdrawal by Subject|0|||
157129498|NCT03434379|567224044|FG001|China Extension Period|Withdrawal by Subject|0|||
157129499|NCT03434379|567224045|FG002|China Extension Period|Withdrawal by Subject|8|||
157129500|NCT03434379|567224046|FG003|China Extension Period|Withdrawal by Subject|6|||
157129501|NCT03434379|567224043|FG000|China Extension Period|Study Ended by Sponsor|0|||
157129502|NCT03434379|567224044|FG001|China Extension Period|Study Ended by Sponsor|0|||
157129503|NCT03434379|567224045|FG002|China Extension Period|Study Ended by Sponsor|5|||
156874724|NCT05064358|566298731|FG003|Overall Study|Lost to Follow-up|2|||
156874725|NCT05064358|566298732|FG004|Overall Study|Lost to Follow-up|0|||
156874726|NCT05064358|566298728|FG000|Overall Study|Physician Decision|1|||
156874727|NCT05064358|566298729|FG001|Overall Study|Physician Decision|1|||
156874728|NCT05064358|566298730|FG002|Overall Study|Physician Decision|2|||
156874729|NCT05064358|566298731|FG003|Overall Study|Physician Decision|0|||
156874730|NCT05064358|566298732|FG004|Overall Study|Physician Decision|0|||
156874731|NCT05064358|566298728|FG000|Overall Study|Withdrawal by Subject|4|||
156874732|NCT05064358|566298729|FG001|Overall Study|Withdrawal by Subject|5|||
156874733|NCT05064358|566298730|FG002|Overall Study|Withdrawal by Subject|3|||
156874734|NCT05064358|566298731|FG003|Overall Study|Withdrawal by Subject|6|||
156874735|NCT05064358|566298732|FG004|Overall Study|Withdrawal by Subject|3|||
156874736|NCT05064358|566298728|FG000|Overall Study|Ongoing at the time of analysis|1|||
156874737|NCT05064358|566298729|FG001|Overall Study|Ongoing at the time of analysis|2|||
156874738|NCT05064358|566298730|FG002|Overall Study|Ongoing at the time of analysis|2|||
156874739|NCT05064358|566298731|FG003|Overall Study|Ongoing at the time of analysis|2|||
157129504|NCT03434379|567224046|FG003|China Extension Period|Study Ended by Sponsor|36|||
157129505|NCT02591615|567225902|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
157129506|NCT02591615|567225903|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
157129507|NCT02591615|567225904|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
157129508|NCT02591615|567225905|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
157129509|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
157129510|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
157129511|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
157129512|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
157129513|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
157129514|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
157129515|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
157129516|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
157129517|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
157129518|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
157129519|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
157129520|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
157129521|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
157129522|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
157129523|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
157129524|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
157129525|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
157129526|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
157129527|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
157129528|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
157129529|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
157129530|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
157129531|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
157129532|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
157129533|NCT02591615|567225902|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
157129534|NCT02591615|567225903|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
157129535|NCT02591615|567225904|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
157129536|NCT02591615|567225905|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
157129537|NCT02591615|567225902|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
157129538|NCT02591615|567225903|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
157129539|NCT02591615|567225904|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
157129540|NCT02591615|567225905|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
157129541|NCT02591615|567225902|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
157129542|NCT02591615|567225903|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
157129543|NCT02591615|567225904|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
157129544|NCT02591615|567225905|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
156874740|NCT05064358|566298732|FG004|Overall Study|Ongoing at the time of analysis|2|||
156874741|NCT04421027|566298733|FG000|Treatment Period|Adverse Event|5|||
156874742|NCT04421027|566298734|FG001|Treatment Period|Adverse Event|3|||
156874743|NCT04421027|566298735|FG002|Treatment Period|Adverse Event|0|||
157129545|NCT02591615|567225902|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
157129546|NCT02591615|567225903|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
157129547|NCT02591615|567225904|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
157129548|NCT02591615|567225905|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
157129549|NCT02591615|567225902|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
157129550|NCT02591615|567225903|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
157129551|NCT02591615|567225904|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
157129552|NCT02591615|567225905|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
157129553|NCT02591615|567225902|FG000|Maintenance MK-3475|Adverse Event|0|||
157129554|NCT02591615|567225903|FG001|Maintenance MK-3475|Adverse Event|3|||
157129555|NCT02591615|567225904|FG002|Maintenance MK-3475|Adverse Event|1|||
157129556|NCT02591615|567225905|FG003|Maintenance MK-3475|Adverse Event|2|||
157129557|NCT02591615|567225902|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
157129558|NCT02591615|567225903|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
157129559|NCT02591615|567225904|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
157129560|NCT02591615|567225905|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
157129561|NCT02591615|567225902|FG000|Maintenance MK-3475|Death|0|||
157129562|NCT02591615|567225903|FG001|Maintenance MK-3475|Death|1|||
157129563|NCT02591615|567225904|FG002|Maintenance MK-3475|Death|1|||
157129564|NCT02591615|567225905|FG003|Maintenance MK-3475|Death|0|||
157129565|NCT02591615|567225902|FG000|Maintenance MK-3475|Physician discretion|0|||
157129566|NCT02591615|567225903|FG001|Maintenance MK-3475|Physician discretion|0|||
157129567|NCT02591615|567225904|FG002|Maintenance MK-3475|Physician discretion|1|||
157129568|NCT02591615|567225905|FG003|Maintenance MK-3475|Physician discretion|0|||
157129569|NCT02591615|567225902|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
157129570|NCT02591615|567225903|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
157129571|NCT02591615|567225904|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
157129572|NCT02591615|567225905|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
157129573|NCT02591615|567225902|FG000|Maintenance MK-3475|In active treatment|2|||
157129574|NCT02591615|567225903|FG001|Maintenance MK-3475|In active treatment|0|||
157129575|NCT02591615|567225904|FG002|Maintenance MK-3475|In active treatment|0|||
157129576|NCT02591615|567225905|FG003|Maintenance MK-3475|In active treatment|1|||
157129577|NCT00809328|567225906|FG000|Overall Study|Lack of Efficacy|18|||
157129578|NCT00809328|567225906|FG000|Overall Study|Adverse Event|6|||
156793055|NCT03973489|565994835|FG006|Second Intervention (1 Day)|Adverse Event|0|||
156793056|NCT03973489|565994836|FG007|Second Intervention (1 Day)|Adverse Event|0|||
156793057|NCT03247673|565994837|FG000|Overall Study|Withdrawal by Subject|1|||
156793058|NCT03247673|565994838|FG001|Overall Study|Withdrawal by Subject|0|||
156793059|NCT03247673|565994839|FG002|Overall Study|Withdrawal by Subject|3|||
156793060|NCT03247673|565994837|FG000|Overall Study|Lost to Follow-up|0|||
156793061|NCT03247673|565994838|FG001|Overall Study|Lost to Follow-up|0|||
156793062|NCT03247673|565994839|FG002|Overall Study|Lost to Follow-up|1|||
156793063|NCT04754399|565994845|FG000|Overall Study|Adverse Event|5|||
156793064|NCT04754399|565994845|FG000|Overall Study|Withdrawal by Subject|6|||
156793065|NCT00231465|565994846|FG000|Overall Study|Completed only one cycle|1|||
156793066|NCT00231465|565994846|FG000|Overall Study|Did not have follow up CT scans|1|||
156793067|NCT03624036|565994847|FG000|Overall Study|Death|2|||
156793068|NCT03624036|565994848|FG001|Overall Study|Death|3|||
156793069|NCT03624036|565994849|FG002|Overall Study|Death|0|||
156793070|NCT03624036|565994850|FG003|Overall Study|Death|1|||
156793071|NCT03624036|565994847|FG000|Overall Study|Withdrawal by Subject|1|||
156793072|NCT03624036|565994848|FG001|Overall Study|Withdrawal by Subject|0|||
156793073|NCT03624036|565994849|FG002|Overall Study|Withdrawal by Subject|1|||
156793074|NCT03624036|565994850|FG003|Overall Study|Withdrawal by Subject|0|||
156793075|NCT03624036|565994847|FG000|Overall Study|Enrolled but Never Treated|1|||
156793076|NCT03624036|565994848|FG001|Overall Study|Enrolled but Never Treated|0|||
156793077|NCT03624036|565994849|FG002|Overall Study|Enrolled but Never Treated|0|||
156793078|NCT03624036|565994850|FG003|Overall Study|Enrolled but Never Treated|0|||
156793079|NCT03624036|565994847|FG000|Overall Study|Reason not Specified|3|||
157129579|NCT00809328|567225906|FG000|Overall Study|Protocol Violation|3|||
157129580|NCT00809328|567225906|FG000|Overall Study|Withdrawal by Subject|2|||
157129581|NCT00282243|567225907|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
157129582|NCT00282243|567225907|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
157129583|NCT00282243|567225907|FG000|Extension Treatment Period|Adverse Event|15|||
157129584|NCT00282243|567225907|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
156793080|NCT03624036|565994848|FG001|Overall Study|Reason not Specified|0|||
156793081|NCT03624036|565994849|FG002|Overall Study|Reason not Specified|2|||
156793082|NCT03624036|565994850|FG003|Overall Study|Reason not Specified|2|||
157129585|NCT00282243|567225907|FG000|Extension Treatment Period|Non-compliance|2|||
156793083|NCT01390584|565994858|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
156793084|NCT01390584|565994859|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
156793085|NCT01390584|565994860|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
156793086|NCT01539525|565994861|FG000|Overall Study|Lost to Follow-up|19|||
157129586|NCT00282243|567225907|FG000|Extension Treatment Period|Physician Decision|1|||
157129587|NCT00270894|567225908|FG000|Overall Study|Adverse Event|1|||
157129588|NCT00270894|567225908|FG000|Overall Study|Withdrawal by Subject|1|||
157129589|NCT01070329|567225909|FG000|Overall Study|Adverse Event|13|||
157129590|NCT01070329|567225910|FG001|Overall Study|Adverse Event|10|||
157129591|NCT01070329|567225909|FG000|Overall Study|Lost to Follow-up|22|||
157129592|NCT01070329|567225910|FG001|Overall Study|Lost to Follow-up|12|||
157129593|NCT01070329|567225909|FG000|Overall Study|Withdrawal by Subject|9|||
157129594|NCT01070329|567225910|FG001|Overall Study|Withdrawal by Subject|11|||
157129595|NCT01070329|567225909|FG000|Overall Study|Protocol Violation|3|||
157129596|NCT01070329|567225910|FG001|Overall Study|Protocol Violation|8|||
157129597|NCT01070329|567225909|FG000|Overall Study|Lack of Efficacy|2|||
157129598|NCT01070329|567225910|FG001|Overall Study|Lack of Efficacy|6|||
157129599|NCT01070329|567225909|FG000|Overall Study|Physician Decision|2|||
157129600|NCT01070329|567225910|FG001|Overall Study|Physician Decision|1|||
157129601|NCT01070329|567225909|FG000|Overall Study|Entry Criteria Not Met|1|||
157129602|NCT01070329|567225910|FG001|Overall Study|Entry Criteria Not Met|0|||
157129603|NCT01070329|567225909|FG000|Overall Study|Sponsor Decision|0|||
157129604|NCT01070329|567225910|FG001|Overall Study|Sponsor Decision|1|||
157129605|NCT02863848|567225911|FG000|Overall Study|Lost to Follow-up|1|||
157129606|NCT02863848|567225912|FG001|Overall Study|Lost to Follow-up|1|||
157129607|NCT02863848|567225911|FG000|Overall Study|Protocol Violation|1|||
157129608|NCT02863848|567225912|FG001|Overall Study|Protocol Violation|2|||
157129609|NCT00686127|567225913|FG000|Overall Study|Withdrawal by Subject|14|||
157129610|NCT00686127|567225914|FG001|Overall Study|Withdrawal by Subject|6|||
157129611|NCT03980938|567225921|FG000|Treatment Period 1|Study Terminated|1|||
157129612|NCT03980938|567225922|FG001|Treatment Period 1|Study Terminated|1|||
157129613|NCT03980938|567225921|FG000|Treatment Period 2|Study Terminated|2|||
157129614|NCT03980938|567225922|FG001|Treatment Period 2|Study Terminated|2|||
157129615|NCT00400400|567225927|FG000|Overall Study|Adverse Event|9|||
157129616|NCT00400400|567225928|FG001|Overall Study|Adverse Event|8|||
157129617|NCT00400400|567225927|FG000|Overall Study|Protocol Violation|2|||
157129618|NCT00400400|567225928|FG001|Overall Study|Protocol Violation|0|||
157129619|NCT00400400|567225927|FG000|Overall Study|Withdrawal by Subject|1|||
157129620|NCT00400400|567225928|FG001|Overall Study|Withdrawal by Subject|3|||
157129621|NCT00400400|567225927|FG000|Overall Study|Administrative Problem|1|||
157129622|NCT00400400|567225928|FG001|Overall Study|Administrative Problem|0|||
157129623|NCT00400400|567225927|FG000|Overall Study|Lost to Follow-up|0|||
157129624|NCT00400400|567225928|FG001|Overall Study|Lost to Follow-up|1|||
156716096|NCT06082843|565705249|FG001|Overall Study|Study terminated by sponsor|8|||
156716097|NCT02366689|565705254|FG000|Overall Study|Withdrawal by Subject|1|||
156716098|NCT02366689|565705255|FG001|Overall Study|Withdrawal by Subject|0|||
156716099|NCT02366689|565705256|FG002|Overall Study|Withdrawal by Subject|1|||
156716100|NCT02366689|565705254|FG000|Overall Study|Lost to Follow-up|3|||
156716101|NCT02366689|565705255|FG001|Overall Study|Lost to Follow-up|2|||
156716102|NCT02366689|565705256|FG002|Overall Study|Lost to Follow-up|0|||
156716103|NCT02366689|565705254|FG000|Overall Study|Pregnancy|0|||
156716104|NCT02366689|565705255|FG001|Overall Study|Pregnancy|1|||
156716105|NCT02366689|565705256|FG002|Overall Study|Pregnancy|1|||
156716106|NCT01996241|565705257|FG000|Overall Study|Lost to Follow-up|252|||
156716107|NCT01996241|565705258|FG001|Overall Study|Lost to Follow-up|235|||
156716108|NCT01068262|565705262|FG000|Overall Study|Adverse Event|2|||
156716109|NCT01068262|565705263|FG001|Overall Study|Adverse Event|0|||
156716110|NCT01068262|565705264|FG002|Overall Study|Adverse Event|1|||
156716111|NCT01068262|565705265|FG003|Overall Study|Adverse Event|0|||
156716112|NCT01068262|565705262|FG000|Overall Study|Protocol Violation|1|||
156716113|NCT01068262|565705263|FG001|Overall Study|Protocol Violation|0|||
156716114|NCT01068262|565705264|FG002|Overall Study|Protocol Violation|0|||
156716115|NCT01068262|565705265|FG003|Overall Study|Protocol Violation|0|||
156716116|NCT01068262|565705262|FG000|Overall Study|Withdrawal by Subject|0|||
156716117|NCT01068262|565705263|FG001|Overall Study|Withdrawal by Subject|1|||
156716118|NCT01068262|565705264|FG002|Overall Study|Withdrawal by Subject|0|||
157129625|NCT00400400|567225927|FG000|Overall Study|Did not receive study drug|1|||
157129626|NCT00400400|567225928|FG001|Overall Study|Did not receive study drug|3|||
157129627|NCT01848145|567225929|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
157129628|NCT01848145|567225929|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
157129629|NCT01848145|567225929|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
157129630|NCT01848145|567225929|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
156716119|NCT01068262|565705265|FG003|Overall Study|Withdrawal by Subject|0|||
156716120|NCT04428034|565705268|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
156716121|NCT02556801|565705271|FG000|Overall Study|Lost to Follow-up|1|||
156716122|NCT02556801|565705272|FG001|Overall Study|Lost to Follow-up|0|||
156716123|NCT02556801|565705273|FG002|Overall Study|Lost to Follow-up|2|||
156716124|NCT02556801|565705274|FG003|Overall Study|Lost to Follow-up|0|||
156716125|NCT02556801|565705271|FG000|Overall Study|Withdrawal by Subject|1|||
156716126|NCT02556801|565705272|FG001|Overall Study|Withdrawal by Subject|1|||
156716127|NCT02556801|565705273|FG002|Overall Study|Withdrawal by Subject|1|||
156716128|NCT02556801|565705274|FG003|Overall Study|Withdrawal by Subject|0|||
156716129|NCT02556801|565705271|FG000|Overall Study|Protocol Violation|0|||
157129631|NCT01848145|567225929|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
157216553|NCT00447603|567539288|FG001|Filter Period|Screen Failure|3|||
156716130|NCT02556801|565705272|FG001|Overall Study|Protocol Violation|3|||
156874744|NCT04421027|566298736|FG003|Treatment Period|Adverse Event|0|||
156874745|NCT04421027|566298733|FG000|Treatment Period|Death|98|||
156874746|NCT04421027|566298734|FG001|Treatment Period|Death|61|||
157017686|NCT04093752|566817930|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
156716131|NCT02556801|565705273|FG002|Overall Study|Protocol Violation|1|||
156716132|NCT02556801|565705274|FG003|Overall Study|Protocol Violation|1|||
156716133|NCT02556801|565705271|FG000|Overall Study|Adverse Event|0|||
156716134|NCT02556801|565705272|FG001|Overall Study|Adverse Event|2|||
156716135|NCT02556801|565705273|FG002|Overall Study|Adverse Event|0|||
156716136|NCT02556801|565705274|FG003|Overall Study|Adverse Event|3|||
156716137|NCT02556801|565705271|FG000|Overall Study|Pregnancy|0|||
156716138|NCT02556801|565705272|FG001|Overall Study|Pregnancy|1|||
156716139|NCT02556801|565705273|FG002|Overall Study|Pregnancy|0|||
156716140|NCT02556801|565705274|FG003|Overall Study|Pregnancy|0|||
156874747|NCT04421027|566298735|FG002|Treatment Period|Death|0|||
157017687|NCT04093752|566817931|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
157017688|NCT04093752|566817932|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
157017689|NCT04093752|566817933|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
157017690|NCT04093752|566817930|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
157017691|NCT04093752|566817931|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
157017692|NCT04093752|566817932|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
157017693|NCT04093752|566817933|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
157017694|NCT04093752|566817930|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
157017695|NCT04093752|566817931|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
157017696|NCT04093752|566817932|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
157017697|NCT04093752|566817933|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
157017698|NCT04838613|566817936|FG000|Overall Study|Withdrawal by Subject|3|||
157017699|NCT04838613|566817937|FG001|Overall Study|Withdrawal by Subject|6|||
157017700|NCT04838613|566817936|FG000|Overall Study|Protocol Deviation|3|||
157017701|NCT04838613|566817937|FG001|Overall Study|Protocol Deviation|2|||
157017702|NCT04838613|566817936|FG000|Overall Study|Technical Problems|0|||
157017703|NCT04838613|566817937|FG001|Overall Study|Technical Problems|5|||
157017704|NCT04838613|566817936|FG000|Overall Study|Physician Decision|2|||
157017705|NCT04838613|566817937|FG001|Overall Study|Physician Decision|0|||
157017706|NCT04970654|566817938|FG000|Overall Study|Withdrawal by parents/guardian|1|||
157017707|NCT04970654|566817939|FG001|Overall Study|Withdrawal by parents/guardian|2|||
157017708|NCT04970654|566817938|FG000|Overall Study|Unclassified|2|||
157017709|NCT04970654|566817939|FG001|Overall Study|Unclassified|1|||
157017710|NCT04970654|566817938|FG000|Overall Study|Lost to Follow-up|1|||
157017711|NCT04970654|566817939|FG001|Overall Study|Lost to Follow-up|0|||
157017712|NCT00901901|566817940|FG000|Treatment Period|Adverse Event|120|||
157017713|NCT00901901|566817941|FG001|Treatment Period|Adverse Event|128|||
157017714|NCT00901901|566817940|FG000|Treatment Period|Withdrawal by Subject|26|||
157017715|NCT00901901|566817941|FG001|Treatment Period|Withdrawal by Subject|24|||
157017716|NCT00901901|566817940|FG000|Treatment Period|Physician Decision|2|||
157017717|NCT00901901|566817941|FG001|Treatment Period|Physician Decision|2|||
157017718|NCT00901901|566817940|FG000|Treatment Period|Lost to Follow-up|3|||
157017719|NCT00901901|566817941|FG001|Treatment Period|Lost to Follow-up|5|||
157017720|NCT00901901|566817940|FG000|Treatment Period|Noncompliance with study medication|4|||
157017721|NCT00901901|566817941|FG001|Treatment Period|Noncompliance with study medication|1|||
157017722|NCT00901901|566817940|FG000|Treatment Period|Missing|1|||
157017723|NCT00901901|566817941|FG001|Treatment Period|Missing|0|||
157017724|NCT00901901|566817940|FG000|Treatment Period|Never treated|0|||
157017725|NCT00901901|566817941|FG001|Treatment Period|Never treated|3|||
157017726|NCT00901901|566817940|FG000|Treatment Period|Protocol driven decision point|0|||
157017727|NCT00901901|566817941|FG001|Treatment Period|Protocol driven decision point|2|||
157017728|NCT00901901|566817940|FG000|Treatment Period|Study terminated by sponsor|2|||
157017729|NCT00901901|566817941|FG001|Treatment Period|Study terminated by sponsor|0|||
157017730|NCT00901901|566817940|FG000|Treatment Period|Protocol Violation|5|||
157017731|NCT00901901|566817941|FG001|Treatment Period|Protocol Violation|9|||
157017732|NCT00901901|566817940|FG000|Treatment Period|Switch to commercial drug|1|||
157017733|NCT00901901|566817941|FG001|Treatment Period|Switch to commercial drug|1|||
157017734|NCT00901901|566817940|FG000|Treatment Period|Transfer to treatment continuation study|5|||
157017735|NCT00901901|566817941|FG001|Treatment Period|Transfer to treatment continuation study|2|||
157017736|NCT00901901|566817940|FG000|Follow-up Period|Death|181|||
157017737|NCT00901901|566817941|FG001|Follow-up Period|Death|208|||
157017738|NCT00901901|566817940|FG000|Follow-up Period|Protocol driven decision point|47|||
157017739|NCT00901901|566817941|FG001|Follow-up Period|Protocol driven decision point|36|||
156716141|NCT02556801|565705271|FG000|Overall Study|Personal reasons patient|0|||
156716142|NCT02556801|565705272|FG001|Overall Study|Personal reasons patient|0|||
156874748|NCT04421027|566298736|FG003|Treatment Period|Death|0|||
157017740|NCT00901901|566817940|FG000|Follow-up Period|Withdrawal by Subject|6|||
157017741|NCT00901901|566817941|FG001|Follow-up Period|Withdrawal by Subject|9|||
157017742|NCT00901901|566817940|FG000|Follow-up Period|Lost to Follow-up|12|||
157129632|NCT01848145|567225929|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
157129633|NCT01848145|567225929|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
157129634|NCT00364689|567225930|FG000|Overall Study|Lost to Follow-up|1|||
157129635|NCT00234039|567225932|FG000|Overall Study|Adverse Event|2|||
157129636|NCT00234039|567225932|FG000|Overall Study|Progression/relapse|34|||
157129637|NCT00234039|567225932|FG000|Overall Study|Other - Not Protocol Specified|3|||
157129638|NCT00234039|567225932|FG000|Overall Study|Ineligible|9|||
157129639|NCT00234039|567225932|FG000|Overall Study|No Protocol Treatment Received|2|||
157129640|NCT04426695|567225933|FG000|Overall Study|Death|2|||
157129641|NCT04426695|567225934|FG001|Overall Study|Death|0|||
157129642|NCT04426695|567225935|FG002|Overall Study|Death|1|||
157129643|NCT04426695|567225936|FG003|Overall Study|Death|27|||
157129644|NCT04426695|567225937|FG004|Overall Study|Death|25|||
157129645|NCT04426695|567225938|FG005|Overall Study|Death|21|||
157129646|NCT04426695|567225939|FG006|Overall Study|Death|42|||
157129647|NCT04426695|567225940|FG007|Overall Study|Death|23|||
157129648|NCT04426695|567225941|FG008|Overall Study|Death|37|||
157129649|NCT04426695|567225942|FG009|Overall Study|Death|14|||
157129650|NCT04426695|567225943|FG010|Overall Study|Death|8|||
157129651|NCT04426695|567225944|FG011|Overall Study|Death|7|||
157129652|NCT04426695|567225945|FG012|Overall Study|Death|13|||
157129653|NCT04426695|567225946|FG013|Overall Study|Death|25|||
157129654|NCT04426695|567225947|FG014|Overall Study|Death|19|||
156716143|NCT02556801|565705273|FG002|Overall Study|Personal reasons patient|0|||
156716144|NCT02556801|565705274|FG003|Overall Study|Personal reasons patient|1|||
157129655|NCT04426695|567225948|FG015|Overall Study|Death|7|||
157129656|NCT04426695|567225949|FG016|Overall Study|Death|8|||
157129657|NCT04426695|567225950|FG017|Overall Study|Death|4|||
157129658|NCT04426695|567225933|FG000|Overall Study|Lost to Follow-up|2|||
157129659|NCT04426695|567225934|FG001|Overall Study|Lost to Follow-up|4|||
157129660|NCT04426695|567225935|FG002|Overall Study|Lost to Follow-up|1|||
157129661|NCT04426695|567225936|FG003|Overall Study|Lost to Follow-up|19|||
157129662|NCT04426695|567225937|FG004|Overall Study|Lost to Follow-up|10|||
157129663|NCT04426695|567225938|FG005|Overall Study|Lost to Follow-up|14|||
157129664|NCT04426695|567225939|FG006|Overall Study|Lost to Follow-up|5|||
157129665|NCT04426695|567225940|FG007|Overall Study|Lost to Follow-up|14|||
157129666|NCT04426695|567225941|FG008|Overall Study|Lost to Follow-up|10|||
157129667|NCT04426695|567225942|FG009|Overall Study|Lost to Follow-up|11|||
157129668|NCT04426695|567225943|FG010|Overall Study|Lost to Follow-up|12|||
157129669|NCT04426695|567225944|FG011|Overall Study|Lost to Follow-up|6|||
157129670|NCT04426695|567225945|FG012|Overall Study|Lost to Follow-up|2|||
157129671|NCT04426695|567225946|FG013|Overall Study|Lost to Follow-up|2|||
157129672|NCT04426695|567225947|FG014|Overall Study|Lost to Follow-up|2|||
157129673|NCT04426695|567225948|FG015|Overall Study|Lost to Follow-up|0|||
157129674|NCT04426695|567225949|FG016|Overall Study|Lost to Follow-up|0|||
157129675|NCT04426695|567225950|FG017|Overall Study|Lost to Follow-up|0|||
157129676|NCT04426695|567225933|FG000|Overall Study|Participant Decision|1|||
157129677|NCT04426695|567225934|FG001|Overall Study|Participant Decision|2|||
157129678|NCT04426695|567225935|FG002|Overall Study|Participant Decision|2|||
157129679|NCT04426695|567225936|FG003|Overall Study|Participant Decision|12|||
157129680|NCT04426695|567225937|FG004|Overall Study|Participant Decision|18|||
157129681|NCT04426695|567225938|FG005|Overall Study|Participant Decision|22|||
157129682|NCT04426695|567225939|FG006|Overall Study|Participant Decision|13|||
157129683|NCT04426695|567225940|FG007|Overall Study|Participant Decision|13|||
157129684|NCT04426695|567225941|FG008|Overall Study|Participant Decision|10|||
157129685|NCT04426695|567225942|FG009|Overall Study|Participant Decision|15|||
157129686|NCT04426695|567225943|FG010|Overall Study|Participant Decision|16|||
157216554|NCT00447603|567539289|FG002|Filter Period|Screen Failure|4|||
156716145|NCT02515331|565705279|FG000|Overall Study|Withdrawal by Subject|0|||
156716146|NCT02515331|565705280|FG001|Overall Study|Withdrawal by Subject|0|||
156716147|NCT02515331|565705281|FG002|Overall Study|Withdrawal by Subject|1|||
156716148|NCT02515331|565705279|FG000|Overall Study|Protocol deviation|0|||
156716149|NCT02515331|565705280|FG001|Overall Study|Protocol deviation|0|||
156716150|NCT02515331|565705281|FG002|Overall Study|Protocol deviation|3|||
156716151|NCT02515331|565705279|FG000|Overall Study|Adverse Event|2|||
156716152|NCT02515331|565705280|FG001|Overall Study|Adverse Event|0|||
156716153|NCT02515331|565705281|FG002|Overall Study|Adverse Event|0|||
156716154|NCT00124748|565705282|FG000|Overall Study|Adverse Event|8|||
156716155|NCT00124748|565705283|FG001|Overall Study|Adverse Event|39|||
156716156|NCT00124748|565705282|FG000|Overall Study|Abnormal laboratory Value|2|||
157129687|NCT04426695|567225944|FG011|Overall Study|Participant Decision|17|||
157129688|NCT04426695|567225945|FG012|Overall Study|Participant Decision|2|||
157129689|NCT04426695|567225946|FG013|Overall Study|Participant Decision|1|||
157129690|NCT04426695|567225947|FG014|Overall Study|Participant Decision|2|||
157216555|NCT00447603|567539287|FG000|Filter Period|Study terminated by Sponsor|0|||
157129691|NCT04426695|567225948|FG015|Overall Study|Participant Decision|0|||
157129692|NCT04426695|567225949|FG016|Overall Study|Participant Decision|0|||
156716157|NCT00124748|565705283|FG001|Overall Study|Abnormal laboratory Value|2|||
157129693|NCT04426695|567225950|FG017|Overall Study|Participant Decision|0|||
157129694|NCT04426695|567225933|FG000|Overall Study|Adverse Event|0|||
157129695|NCT04426695|567225934|FG001|Overall Study|Adverse Event|0|||
157129696|NCT04426695|567225935|FG002|Overall Study|Adverse Event|0|||
157129697|NCT04426695|567225936|FG003|Overall Study|Adverse Event|0|||
157129698|NCT04426695|567225937|FG004|Overall Study|Adverse Event|0|||
157129699|NCT04426695|567225938|FG005|Overall Study|Adverse Event|0|||
157129700|NCT04426695|567225939|FG006|Overall Study|Adverse Event|0|||
157129701|NCT04426695|567225940|FG007|Overall Study|Adverse Event|1|||
157129702|NCT04426695|567225941|FG008|Overall Study|Adverse Event|0|||
157129703|NCT04426695|567225942|FG009|Overall Study|Adverse Event|0|||
157129704|NCT04426695|567225943|FG010|Overall Study|Adverse Event|1|||
157129705|NCT04426695|567225944|FG011|Overall Study|Adverse Event|1|||
157129706|NCT04426695|567225945|FG012|Overall Study|Adverse Event|0|||
157129707|NCT04426695|567225946|FG013|Overall Study|Adverse Event|0|||
157129708|NCT04426695|567225947|FG014|Overall Study|Adverse Event|0|||
157129709|NCT04426695|567225948|FG015|Overall Study|Adverse Event|0|||
157129710|NCT04426695|567225949|FG016|Overall Study|Adverse Event|0|||
157129711|NCT04426695|567225950|FG017|Overall Study|Adverse Event|0|||
157129712|NCT04426695|567225933|FG000|Overall Study|Sponsor Request|0|||
157129713|NCT04426695|567225934|FG001|Overall Study|Sponsor Request|0|||
157129714|NCT04426695|567225935|FG002|Overall Study|Sponsor Request|0|||
157129715|NCT04426695|567225936|FG003|Overall Study|Sponsor Request|0|||
157129716|NCT04426695|567225937|FG004|Overall Study|Sponsor Request|0|||
157129717|NCT04426695|567225938|FG005|Overall Study|Sponsor Request|0|||
157129718|NCT04426695|567225939|FG006|Overall Study|Sponsor Request|1|||
157129719|NCT04426695|567225940|FG007|Overall Study|Sponsor Request|0|||
157129720|NCT04426695|567225941|FG008|Overall Study|Sponsor Request|0|||
157129721|NCT04426695|567225942|FG009|Overall Study|Sponsor Request|0|||
157129722|NCT04426695|567225943|FG010|Overall Study|Sponsor Request|0|||
157129723|NCT04426695|567225944|FG011|Overall Study|Sponsor Request|0|||
157129724|NCT04426695|567225945|FG012|Overall Study|Sponsor Request|0|||
157129725|NCT04426695|567225946|FG013|Overall Study|Sponsor Request|0|||
157129726|NCT04426695|567225947|FG014|Overall Study|Sponsor Request|0|||
157129727|NCT04426695|567225948|FG015|Overall Study|Sponsor Request|0|||
157129728|NCT04426695|567225949|FG016|Overall Study|Sponsor Request|0|||
157129729|NCT04426695|567225950|FG017|Overall Study|Sponsor Request|0|||
157129730|NCT04426695|567225933|FG000|Overall Study|Physician Decision|0|||
157129731|NCT04426695|567225934|FG001|Overall Study|Physician Decision|0|||
157129732|NCT04426695|567225935|FG002|Overall Study|Physician Decision|0|||
157129733|NCT04426695|567225936|FG003|Overall Study|Physician Decision|0|||
157129734|NCT04426695|567225937|FG004|Overall Study|Physician Decision|0|||
157129735|NCT04426695|567225938|FG005|Overall Study|Physician Decision|0|||
157129736|NCT04426695|567225939|FG006|Overall Study|Physician Decision|0|||
157129737|NCT04426695|567225940|FG007|Overall Study|Physician Decision|0|||
157129738|NCT04426695|567225941|FG008|Overall Study|Physician Decision|0|||
157129739|NCT04426695|567225942|FG009|Overall Study|Physician Decision|1|||
157129740|NCT04426695|567225943|FG010|Overall Study|Physician Decision|0|||
157129741|NCT04426695|567225944|FG011|Overall Study|Physician Decision|0|||
157129742|NCT04426695|567225945|FG012|Overall Study|Physician Decision|1|||
157129743|NCT04426695|567225946|FG013|Overall Study|Physician Decision|0|||
157216556|NCT00447603|567539288|FG001|Filter Period|Study terminated by Sponsor|1|||
157216557|NCT00447603|567539289|FG002|Filter Period|Study terminated by Sponsor|10|||
156716158|NCT00124748|565705282|FG000|Overall Study|Abnormal Procedure|0|||
156716159|NCT00124748|565705283|FG001|Overall Study|Abnormal Procedure|1|||
156716160|NCT00124748|565705282|FG000|Overall Study|Lack of Efficacy|20|||
156716161|NCT00124748|565705283|FG001|Overall Study|Lack of Efficacy|41|||
156716162|NCT00124748|565705282|FG000|Overall Study|No longer requires study drug|1|||
156716163|NCT00124748|565705283|FG001|Overall Study|No longer requires study drug|1|||
156716164|NCT00124748|565705282|FG000|Overall Study|Protocol Violation|3|||
156716165|NCT00124748|565705283|FG001|Overall Study|Protocol Violation|1|||
156716166|NCT00124748|565705282|FG000|Overall Study|Withdrawal by Subject|5|||
156716167|NCT00124748|565705283|FG001|Overall Study|Withdrawal by Subject|15|||
156716168|NCT00124748|565705282|FG000|Overall Study|Lost to Follow-up|2|||
156793087|NCT01539525|565994862|FG001|Overall Study|Lost to Follow-up|12|||
156793088|NCT01539525|565994863|FG002|Overall Study|Lost to Follow-up|11|||
157129744|NCT04426695|567225947|FG014|Overall Study|Physician Decision|0|||
157129745|NCT04426695|567225948|FG015|Overall Study|Physician Decision|0|||
157129746|NCT04426695|567225949|FG016|Overall Study|Physician Decision|0|||
157129747|NCT04426695|567225950|FG017|Overall Study|Physician Decision|0|||
157129748|NCT04426695|567225933|FG000|Overall Study|Randomized but Never Treated|3|||
157129749|NCT04426695|567225934|FG001|Overall Study|Randomized but Never Treated|1|||
157129750|NCT04426695|567225935|FG002|Overall Study|Randomized but Never Treated|0|||
157129751|NCT04426695|567225936|FG003|Overall Study|Randomized but Never Treated|4|||
157129752|NCT04426695|567225937|FG004|Overall Study|Randomized but Never Treated|5|||
157129753|NCT04426695|567225938|FG005|Overall Study|Randomized but Never Treated|5|||
157129754|NCT04426695|567225939|FG006|Overall Study|Randomized but Never Treated|4|||
157129755|NCT04426695|567225940|FG007|Overall Study|Randomized but Never Treated|6|||
156793089|NCT01539525|565994861|FG000|Overall Study|Withdrawal by Subject|0|||
157129756|NCT04426695|567225941|FG008|Overall Study|Randomized but Never Treated|6|||
157129757|NCT04426695|567225942|FG009|Overall Study|Randomized but Never Treated|3|||
157129758|NCT04426695|567225943|FG010|Overall Study|Randomized but Never Treated|3|||
157129759|NCT04426695|567225944|FG011|Overall Study|Randomized but Never Treated|6|||
157129760|NCT04426695|567225945|FG012|Overall Study|Randomized but Never Treated|1|||
157129761|NCT04426695|567225946|FG013|Overall Study|Randomized but Never Treated|2|||
157129762|NCT04426695|567225947|FG014|Overall Study|Randomized but Never Treated|0|||
157129763|NCT04426695|567225948|FG015|Overall Study|Randomized but Never Treated|0|||
157129764|NCT04426695|567225949|FG016|Overall Study|Randomized but Never Treated|0|||
157129765|NCT04426695|567225950|FG017|Overall Study|Randomized but Never Treated|0|||
157129766|NCT02772757|567225958|FG000|Overall Study|Withdrawal by Subject|1|||
157129767|NCT02772757|567225959|FG001|Overall Study|Withdrawal by Subject|0|||
157129768|NCT02772757|567225960|FG002|Overall Study|Withdrawal by Subject|1|||
156716169|NCT00124748|565705283|FG001|Overall Study|Lost to Follow-up|7|||
156716170|NCT00124748|565705282|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
156716171|NCT00124748|565705283|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
156716172|NCT00124748|565705282|FG000|Overall Study|Death|1|||
156716173|NCT00124748|565705283|FG001|Overall Study|Death|3|||
156716174|NCT00322712|565705284|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
156716175|NCT04176250|565705287|FG000|Overall Study|Adverse Event|0|||
156716176|NCT04176250|565705288|FG001|Overall Study|Adverse Event|1|||
156716177|NCT04176250|565705289|FG002|Overall Study|Adverse Event|0|||
156716178|NCT04176250|565705290|FG003|Overall Study|Adverse Event|1|||
156716179|NCT04176250|565705291|FG004|Overall Study|Adverse Event|0|||
156716180|NCT04176250|565705292|FG005|Overall Study|Adverse Event|1|||
156716181|NCT04176250|565705287|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716182|NCT04176250|565705288|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716183|NCT04176250|565705289|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
156716184|NCT04176250|565705290|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
156716185|NCT04176250|565705291|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716186|NCT04176250|565705292|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
156716187|NCT04176250|565705287|FG000|Overall Study|Withdrawal by Subject|0|||
156716188|NCT04176250|565705288|FG001|Overall Study|Withdrawal by Subject|0|||
156716189|NCT04176250|565705289|FG002|Overall Study|Withdrawal by Subject|0|||
156716190|NCT04176250|565705290|FG003|Overall Study|Withdrawal by Subject|0|||
156716191|NCT04176250|565705291|FG004|Overall Study|Withdrawal by Subject|0|||
156716192|NCT04176250|565705292|FG005|Overall Study|Withdrawal by Subject|1|||
156716193|NCT04176250|565705287|FG000|Overall Study|Randomized in error|0|||
156716194|NCT04176250|565705288|FG001|Overall Study|Randomized in error|0|||
156716195|NCT04176250|565705289|FG002|Overall Study|Randomized in error|0|||
156793090|NCT01539525|565994862|FG001|Overall Study|Withdrawal by Subject|3|||
156793091|NCT01539525|565994863|FG002|Overall Study|Withdrawal by Subject|2|||
156793092|NCT01539525|565994861|FG000|Overall Study|Protocol Violation|1|||
156793093|NCT01539525|565994862|FG001|Overall Study|Protocol Violation|1|||
156793094|NCT01539525|565994863|FG002|Overall Study|Protocol Violation|4|||
156793095|NCT02268851|565994864|FG000|Overall Study|Death|0|||
156793096|NCT02268851|565994865|FG001|Overall Study|Death|0|||
156793097|NCT02268851|565994866|FG002|Overall Study|Death|0|||
156793098|NCT02268851|565994867|FG003|Overall Study|Death|1|||
156793099|NCT02268851|565994868|FG004|Overall Study|Death|2|||
156793100|NCT02268851|565994869|FG005|Overall Study|Death|1|||
156793101|NCT02268851|565994864|FG000|Overall Study|Adverse Event|0|||
156793102|NCT02268851|565994865|FG001|Overall Study|Adverse Event|0|||
156793103|NCT02268851|565994866|FG002|Overall Study|Adverse Event|0|||
156793104|NCT02268851|565994867|FG003|Overall Study|Adverse Event|0|||
156793105|NCT02268851|565994868|FG004|Overall Study|Adverse Event|2|||
156793106|NCT02268851|565994869|FG005|Overall Study|Adverse Event|2|||
156793107|NCT02268851|565994864|FG000|Overall Study|Withdrawal by Subject|0|||
156793108|NCT02268851|565994865|FG001|Overall Study|Withdrawal by Subject|0|||
156793109|NCT02268851|565994866|FG002|Overall Study|Withdrawal by Subject|0|||
156793110|NCT02268851|565994867|FG003|Overall Study|Withdrawal by Subject|2|||
156793111|NCT02268851|565994868|FG004|Overall Study|Withdrawal by Subject|0|||
156793112|NCT02268851|565994869|FG005|Overall Study|Withdrawal by Subject|1|||
156793113|NCT02268851|565994864|FG000|Overall Study|Progressive Disease|1|||
157129769|NCT02772757|567225958|FG000|Overall Study|Protocol Violation|0|||
157129770|NCT02772757|567225959|FG001|Overall Study|Protocol Violation|0|||
157129771|NCT02772757|567225960|FG002|Overall Study|Protocol Violation|1|||
157129772|NCT02772757|567225958|FG000|Overall Study|Physician Decision|0|||
157129773|NCT02772757|567225959|FG001|Overall Study|Physician Decision|3|||
157129774|NCT02772757|567225960|FG002|Overall Study|Physician Decision|3|||
157129775|NCT01500057|567225963|FG000|Overall Study|Lost to Follow-up|6|||
157129776|NCT01500057|567225964|FG001|Overall Study|Lost to Follow-up|4|||
157129777|NCT00441792|567225965|FG000|Overall Study|Lost to Follow-up|0|||
157129778|NCT00441792|567225966|FG001|Overall Study|Lost to Follow-up|2|||
157129779|NCT00888355|567225971|FG000|Overall Study|Adverse Event|10|||
157216558|NCT01023269|567539301|FG000|Overall Study|early termination of the study|2|||
157216559|NCT01023269|567539302|FG001|Overall Study|early termination of the study|0|||
157216560|NCT00106028|567539303|FG000|Overall Study|Adverse Event|3|||
157216561|NCT00106028|567539304|FG001|Overall Study|Adverse Event|2|||
157216562|NCT00106028|567539303|FG000|Overall Study|Protocol Violation|1|||
157216563|NCT00106028|567539304|FG001|Overall Study|Protocol Violation|1|||
157216564|NCT00106028|567539303|FG000|Overall Study|Withdrawal by Subject|2|||
157216565|NCT00106028|567539304|FG001|Overall Study|Withdrawal by Subject|8|||
157216566|NCT00106028|567539303|FG000|Overall Study|Lost to Follow-up|0|||
157216567|NCT00106028|567539304|FG001|Overall Study|Lost to Follow-up|1|||
157216568|NCT00947011|567539305|FG000|Overall Study|Study was terminated,PI left institution|12|||
157216569|NCT05266456|567539306|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
157216570|NCT05266456|567539307|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
157216571|NCT05266456|567539308|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
157216572|NCT05266456|567539309|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
157216573|NCT05266456|567539306|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
157216574|NCT05266456|567539307|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
157216575|NCT05266456|567539308|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
157216576|NCT05266456|567539309|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
157216577|NCT05266456|567539306|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
157216578|NCT05266456|567539307|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
157216579|NCT05266456|567539308|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
157216580|NCT05266456|567539309|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
157216581|NCT05266456|567539306|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
157216582|NCT05266456|567539307|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
157216583|NCT05266456|567539308|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
157216584|NCT05266456|567539309|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
157216585|NCT05266456|567539306|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
157216586|NCT05266456|567539307|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
157216587|NCT05266456|567539308|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
157216588|NCT05266456|567539309|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
157216589|NCT00068237|567539310|FG000|Overall Study|Ineligible|3|||
157216590|NCT00068237|567539310|FG000|Overall Study|No protocol treatment received|2|||
157216591|NCT01504867|567539314|FG000|Overall Study|Inclusion criteria not met|2|||
157216592|NCT01504867|567539315|FG001|Overall Study|Inclusion criteria not met|2|||
157216593|NCT01504867|567539314|FG000|Overall Study|Consent revoked|5|||
157216594|NCT01504867|567539315|FG001|Overall Study|Consent revoked|1|||
157216595|NCT00571922|567539321|FG000|Overall Study|Completion unknown|36|||
156874749|NCT04421027|566298733|FG000|Treatment Period|Lost to Follow-up|22|||
157216596|NCT00571922|567539322|FG001|Overall Study|Completion unknown|36|||
156874750|NCT04421027|566298734|FG001|Treatment Period|Lost to Follow-up|20|||
156874751|NCT04421027|566298735|FG002|Treatment Period|Lost to Follow-up|0|||
156874752|NCT04421027|566298736|FG003|Treatment Period|Lost to Follow-up|0|||
156874753|NCT04421027|566298733|FG000|Treatment Period|Other-Unknown|15|||
156874754|NCT04421027|566298734|FG001|Treatment Period|Other-Unknown|9|||
156874755|NCT04421027|566298735|FG002|Treatment Period|Other-Unknown|0|||
156874756|NCT04421027|566298736|FG003|Treatment Period|Other-Unknown|0|||
156874757|NCT04421027|566298733|FG000|Treatment Period|Physician Decision|1|||
156874758|NCT04421027|566298734|FG001|Treatment Period|Physician Decision|1|||
156874759|NCT04421027|566298735|FG002|Treatment Period|Physician Decision|0|||
156874760|NCT04421027|566298736|FG003|Treatment Period|Physician Decision|0|||
157216597|NCT03124381|567539323|FG000|Overall Study|Lost to Follow-up|1|||
157216598|NCT03124381|567539324|FG001|Overall Study|Lost to Follow-up|1|||
157216599|NCT03124381|567539323|FG000|Overall Study|Withdrawal by Subject|6|||
157216600|NCT03124381|567539324|FG001|Overall Study|Withdrawal by Subject|3|||
157216601|NCT03124381|567539323|FG000|Overall Study|Protocol Violation|0|||
157216602|NCT03124381|567539324|FG001|Overall Study|Protocol Violation|1|||
156874761|NCT04421027|566298733|FG000|Treatment Period|Withdrawal by Subject|7|||
156874762|NCT04421027|566298734|FG001|Treatment Period|Withdrawal by Subject|12|||
156874763|NCT04421027|566298735|FG002|Treatment Period|Withdrawal by Subject|0|||
156874764|NCT04421027|566298736|FG003|Treatment Period|Withdrawal by Subject|0|||
156874765|NCT04421027|566298733|FG000|Treatment Period|Randomized Not Dosed|9|||
156874766|NCT04421027|566298734|FG001|Treatment Period|Randomized Not Dosed|14|||
156874767|NCT04421027|566298735|FG002|Treatment Period|Randomized Not Dosed|0|||
156874768|NCT04421027|566298736|FG003|Treatment Period|Randomized Not Dosed|0|||
156874769|NCT04421027|566298733|FG000|Follow-Up Period|Adverse Event|0|||
157216603|NCT03124381|567539323|FG000|Overall Study|Adverse Event|1|||
157216604|NCT03124381|567539324|FG001|Overall Study|Adverse Event|1|||
157216605|NCT03124381|567539323|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
157216606|NCT03124381|567539324|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
157216607|NCT02533999|567539330|FG000|Overall Study|Lost to Follow-up|3|||
157216608|NCT02533999|567539331|FG001|Overall Study|Lost to Follow-up|5|||
157216609|NCT02533999|567539330|FG000|Overall Study|Protocol Violation|3|||
156874770|NCT04421027|566298734|FG001|Follow-Up Period|Adverse Event|0|||
157129780|NCT00888355|567225972|FG001|Overall Study|Adverse Event|0|||
157129781|NCT00888355|567225973|FG002|Overall Study|Adverse Event|3|||
157129782|NCT00888355|567225974|FG003|Overall Study|Adverse Event|3|||
157129783|NCT00888355|567225971|FG000|Overall Study|Lack of Efficacy|9|||
157129784|NCT00888355|567225972|FG001|Overall Study|Lack of Efficacy|2|||
157129785|NCT00888355|567225973|FG002|Overall Study|Lack of Efficacy|5|||
157129786|NCT00888355|567225974|FG003|Overall Study|Lack of Efficacy|2|||
157129787|NCT00888355|567225971|FG000|Overall Study|Lost to Follow-up|0|||
157129788|NCT00888355|567225972|FG001|Overall Study|Lost to Follow-up|2|||
157129789|NCT00888355|567225973|FG002|Overall Study|Lost to Follow-up|2|||
157129790|NCT00888355|567225974|FG003|Overall Study|Lost to Follow-up|0|||
157129791|NCT00888355|567225971|FG000|Overall Study|Protocol Violation|3|||
157129792|NCT00888355|567225972|FG001|Overall Study|Protocol Violation|2|||
157129793|NCT00888355|567225973|FG002|Overall Study|Protocol Violation|1|||
157129794|NCT00888355|567225974|FG003|Overall Study|Protocol Violation|2|||
157129795|NCT00888355|567225971|FG000|Overall Study|Withdrawal by Subject|0|||
157129796|NCT00888355|567225972|FG001|Overall Study|Withdrawal by Subject|3|||
157129797|NCT00888355|567225973|FG002|Overall Study|Withdrawal by Subject|1|||
157129798|NCT00888355|567225974|FG003|Overall Study|Withdrawal by Subject|3|||
157129799|NCT03157531|567225981|FG000|Overall Study|Death|2|||
157129800|NCT03157531|567225981|FG000|Overall Study|Lost to Follow-up|4|||
157129801|NCT03603652|567225982|FG000|Overall Study|Death|2|||
157129802|NCT03213366|567225987|FG000|Overall Study|Lost to Follow-up|9|||
157129803|NCT03213366|567225988|FG001|Overall Study|Lost to Follow-up|4|||
157129804|NCT02532855|567225989|FG000|Overall Study|Lost to Follow-up|4|||
157129805|NCT02532855|567225990|FG001|Overall Study|Lost to Follow-up|3|||
157129806|NCT02532855|567225989|FG000|Overall Study|Withdrawal by Subject|4|||
157129807|NCT02532855|567225990|FG001|Overall Study|Withdrawal by Subject|8|||
157129808|NCT02058147|567225993|FG000|Overall Study|Randomized but not treated|0|||
157129809|NCT02058147|567225994|FG001|Overall Study|Randomized but not treated|0|||
157129810|NCT02058147|567225995|FG002|Overall Study|Randomized but not treated|1|||
157129811|NCT02058147|567225993|FG000|Overall Study|Adverse Event|12|||
157129812|NCT02058147|567225994|FG001|Overall Study|Adverse Event|9|||
157129813|NCT02058147|567225995|FG002|Overall Study|Adverse Event|21|||
157129814|NCT02058147|567225993|FG000|Overall Study|Lack of Efficacy|1|||
157129815|NCT02058147|567225994|FG001|Overall Study|Lack of Efficacy|0|||
157129816|NCT02058147|567225995|FG002|Overall Study|Lack of Efficacy|3|||
157129817|NCT02058147|567225993|FG000|Overall Study|Poor compliance to protocol|8|||
157129818|NCT02058147|567225994|FG001|Overall Study|Poor compliance to protocol|9|||
157129819|NCT02058147|567225995|FG002|Overall Study|Poor compliance to protocol|4|||
157129820|NCT02058147|567225993|FG000|Overall Study|Other than specified|8|||
157129821|NCT02058147|567225994|FG001|Overall Study|Other than specified|9|||
157129822|NCT02058147|567225995|FG002|Overall Study|Other than specified|0|||
157129823|NCT02471716|567225996|FG000|Overall Study|Withdrawal by Subject|0|||
156716196|NCT04176250|565705290|FG003|Overall Study|Randomized in error|0|||
156874771|NCT04421027|566298735|FG002|Follow-Up Period|Adverse Event|0|||
157129824|NCT02471716|567225997|FG001|Overall Study|Withdrawal by Subject|1|||
157129825|NCT02471716|567225998|FG002|Overall Study|Withdrawal by Subject|0|||
157129826|NCT02471716|567225999|FG003|Overall Study|Withdrawal by Subject|2|||
157129827|NCT02471716|567226000|FG004|Overall Study|Withdrawal by Subject|5|||
157129828|NCT02471716|567225996|FG000|Overall Study|Study Terminiated by sponsor|0|||
157129829|NCT02471716|567225997|FG001|Overall Study|Study Terminiated by sponsor|0|||
157129830|NCT02471716|567225998|FG002|Overall Study|Study Terminiated by sponsor|0|||
157129831|NCT02471716|567225999|FG003|Overall Study|Study Terminiated by sponsor|1|||
157129832|NCT02471716|567226000|FG004|Overall Study|Study Terminiated by sponsor|0|||
157129833|NCT02471716|567225996|FG000|Overall Study|Lost to Follow-up|0|||
157129834|NCT02471716|567225997|FG001|Overall Study|Lost to Follow-up|0|||
157129835|NCT02471716|567225998|FG002|Overall Study|Lost to Follow-up|0|||
157129836|NCT02471716|567225999|FG003|Overall Study|Lost to Follow-up|3|||
157129837|NCT02471716|567226000|FG004|Overall Study|Lost to Follow-up|2|||
156716197|NCT04176250|565705291|FG004|Overall Study|Randomized in error|1|||
156874772|NCT04421027|566298736|FG003|Follow-Up Period|Adverse Event|3|||
157129838|NCT02471716|567225996|FG000|Overall Study|Death|0|||
157129839|NCT02471716|567225997|FG001|Overall Study|Death|0|||
157129840|NCT02471716|567225998|FG002|Overall Study|Death|0|||
157129841|NCT02471716|567225999|FG003|Overall Study|Death|1|||
156874773|NCT04421027|566298733|FG000|Follow-Up Period|Death|0|||
157129842|NCT02471716|567226000|FG004|Overall Study|Death|0|||
157129843|NCT02471716|567225996|FG000|Overall Study|Other|0|||
157129844|NCT02471716|567225997|FG001|Overall Study|Other|0|||
157129845|NCT02471716|567225998|FG002|Overall Study|Other|0|||
157129846|NCT02471716|567225999|FG003|Overall Study|Other|8|||
157129847|NCT02471716|567226000|FG004|Overall Study|Other|9|||
157129848|NCT00773279|567226007|FG000|Period 1|Adverse Event|2|||
157129849|NCT00773279|567226008|FG001|Period 1|Adverse Event|1|||
157129850|NCT00773279|567226007|FG000|Period 1|Lack of Efficacy|0|||
157129851|NCT00773279|567226008|FG001|Period 1|Lack of Efficacy|2|||
157129852|NCT00773279|567226007|FG000|Period 1|Unclassified|5|||
157129853|NCT00773279|567226008|FG001|Period 1|Unclassified|1|||
157129854|NCT00773279|567226007|FG000|Period 2|Adverse Event|0|||
156716198|NCT04176250|565705292|FG005|Overall Study|Randomized in error|0|||
156716199|NCT04747470|565705293|FG000|Overall Study|Death|0|||
157017743|NCT00901901|566817941|FG001|Follow-up Period|Lost to Follow-up|8|||
157017744|NCT00901901|566817940|FG000|Follow-up Period|Missing|94|||
157017745|NCT00901901|566817941|FG001|Follow-up Period|Missing|80|||
157017746|NCT00951379|566817942|FG000|Overall Study|Adverse Event|4|||
156716200|NCT04747470|565705294|FG001|Overall Study|Death|3|||
156716201|NCT04747470|565705295|FG002|Overall Study|Death|2|||
156716202|NCT04747470|565705296|FG003|Overall Study|Death|2|||
156716203|NCT04747470|565705297|FG004|Overall Study|Death|2|||
156716204|NCT04747470|565705298|FG005|Overall Study|Death|0|||
156716205|NCT04747470|565705299|FG006|Overall Study|Death|0|||
156716206|NCT04747470|565705300|FG007|Overall Study|Death|0|||
156716207|NCT04747470|565705301|FG008|Overall Study|Death|0|||
156716208|NCT04747470|565705302|FG009|Overall Study|Death|0|||
156716209|NCT04747470|565705303|FG010|Overall Study|Death|0|||
156716210|NCT04747470|565705293|FG000|Overall Study|Withdrew Consent|0|||
156716211|NCT04747470|565705294|FG001|Overall Study|Withdrew Consent|0|||
156716212|NCT04747470|565705295|FG002|Overall Study|Withdrew Consent|0|||
156716213|NCT04747470|565705296|FG003|Overall Study|Withdrew Consent|1|||
156716214|NCT04747470|565705297|FG004|Overall Study|Withdrew Consent|0|||
156716215|NCT04747470|565705298|FG005|Overall Study|Withdrew Consent|0|||
156716216|NCT04747470|565705299|FG006|Overall Study|Withdrew Consent|0|||
156716217|NCT04747470|565705300|FG007|Overall Study|Withdrew Consent|0|||
156716218|NCT04747470|565705301|FG008|Overall Study|Withdrew Consent|0|||
157129855|NCT00773279|567226008|FG001|Period 2|Adverse Event|1|||
157129856|NCT00773279|567226007|FG000|Period 2|Lack of Efficacy|1|||
157129857|NCT00773279|567226008|FG001|Period 2|Lack of Efficacy|0|||
156716219|NCT04747470|565705302|FG009|Overall Study|Withdrew Consent|0|||
156716220|NCT04747470|565705303|FG010|Overall Study|Withdrew Consent|0|||
156716221|NCT04747470|565705293|FG000|Overall Study|Study Terminated by Sponsor|0|||
156716222|NCT04747470|565705294|FG001|Overall Study|Study Terminated by Sponsor|0|||
156716223|NCT04747470|565705295|FG002|Overall Study|Study Terminated by Sponsor|1|||
156716224|NCT04747470|565705296|FG003|Overall Study|Study Terminated by Sponsor|0|||
156716225|NCT04747470|565705297|FG004|Overall Study|Study Terminated by Sponsor|2|||
156716226|NCT04747470|565705298|FG005|Overall Study|Study Terminated by Sponsor|0|||
156716227|NCT04747470|565705299|FG006|Overall Study|Study Terminated by Sponsor|0|||
156716228|NCT04747470|565705300|FG007|Overall Study|Study Terminated by Sponsor|0|||
156716229|NCT04747470|565705301|FG008|Overall Study|Study Terminated by Sponsor|0|||
156716230|NCT04747470|565705302|FG009|Overall Study|Study Terminated by Sponsor|0|||
156716231|NCT04747470|565705303|FG010|Overall Study|Study Terminated by Sponsor|0|||
156716232|NCT02105467|565705306|FG000|Period 1|Lost to Follow-up|1|||
156716233|NCT02105467|565705307|FG001|Period 1|Lost to Follow-up|0|||
156716234|NCT02105467|565705306|FG000|Period 1|Death|1|||
156716235|NCT02105467|565705307|FG001|Period 1|Death|0|||
156716236|NCT02105467|565705306|FG000|Period 2|Lost to Follow-up|1|||
156716237|NCT02105467|565705307|FG001|Period 2|Lost to Follow-up|0|||
157017747|NCT00951379|566817943|FG001|Overall Study|Adverse Event|1|||
157017748|NCT00951379|566817942|FG000|Overall Study|Withdrawal by Subject|1|||
157017749|NCT00951379|566817943|FG001|Overall Study|Withdrawal by Subject|0|||
157017750|NCT00951379|566817942|FG000|Overall Study|Noncompliance|1|||
157017751|NCT00951379|566817943|FG001|Overall Study|Noncompliance|0|||
157017752|NCT00951379|566817942|FG000|Overall Study|Disease Progression|0|||
157017753|NCT00951379|566817943|FG001|Overall Study|Disease Progression|1|||
157017754|NCT02742519|566817946|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
157017755|NCT02742519|566817947|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
157017756|NCT02742519|566817948|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
157017757|NCT02742519|566817946|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
157017758|NCT02742519|566817947|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
157017759|NCT02742519|566817948|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
157017760|NCT02742519|566817946|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
157017761|NCT02742519|566817947|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
157017762|NCT02742519|566817948|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
157017763|NCT03432858|566817950|FG000|Overall Study|Protocol Violation|2|||
157017764|NCT03432858|566817951|FG001|Overall Study|Protocol Violation|1|||
157017765|NCT03432858|566817952|FG002|Overall Study|Protocol Violation|9|||
157017766|NCT03432858|566817950|FG000|Overall Study|Withdrawal by Subject|0|||
157017767|NCT03432858|566817951|FG001|Overall Study|Withdrawal by Subject|1|||
157017768|NCT03432858|566817952|FG002|Overall Study|Withdrawal by Subject|1|||
157129858|NCT00773279|567226007|FG000|Period 2|Protocol Violation|0|||
156716238|NCT02105467|565705306|FG000|Period 2|Death|1|||
156716239|NCT02105467|565705307|FG001|Period 2|Death|0|||
156716240|NCT02105467|565705306|FG000|Period 2|Withdrawal by Subject|0|||
156716241|NCT02105467|565705307|FG001|Period 2|Withdrawal by Subject|2|||
156716242|NCT02105467|565705306|FG000|Period 3|Lost to Follow-up|0|||
156716243|NCT02105467|565705307|FG001|Period 3|Lost to Follow-up|1|||
156716244|NCT03908125|565705308|FG000|Overall Study|Withdrawal by Subject|92|||
156716245|NCT03908125|565705308|FG000|Overall Study|Lost to Follow-up|8|||
156716246|NCT02262325|565705309|FG000|Overall Study|Death|16|||
157129859|NCT00773279|567226008|FG001|Period 2|Protocol Violation|3|||
157129860|NCT00773279|567226007|FG000|Period 2|Unclassified|2|||
157129861|NCT00773279|567226008|FG001|Period 2|Unclassified|2|||
157129862|NCT04178772|567226015|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
157129863|NCT04178772|567226015|FG000|Overall Study|study terminated early due to COVID-19|7|||
157129864|NCT00330187|567226018|FG000|Overall Study|Lost to Follow-up|12|||
157129865|NCT00330187|567226019|FG001|Overall Study|Lost to Follow-up|13|||
157129866|NCT00330187|567226020|FG002|Overall Study|Lost to Follow-up|14|||
157129867|NCT00330187|567226021|FG003|Overall Study|Lost to Follow-up|10|||
157129868|NCT00330187|567226018|FG000|Overall Study|Withdrawal by Subject|8|||
157129869|NCT00330187|567226019|FG001|Overall Study|Withdrawal by Subject|5|||
157129870|NCT00330187|567226020|FG002|Overall Study|Withdrawal by Subject|4|||
157129871|NCT00330187|567226021|FG003|Overall Study|Withdrawal by Subject|4|||
157129872|NCT01481896|567226027|FG000|Overall Study|Lost to Follow-up|12|||
157129873|NCT01573910|567226028|FG000|Overall Study|Adverse Event|4|||
157129874|NCT01573910|567226029|FG001|Overall Study|Adverse Event|4|||
157129875|NCT01573910|567226028|FG000|Overall Study|Lost to Follow-up|2|||
157129876|NCT01573910|567226029|FG001|Overall Study|Lost to Follow-up|1|||
157129877|NCT01573910|567226028|FG000|Overall Study|Withdrawal by Subject|0|||
157129878|NCT01573910|567226029|FG001|Overall Study|Withdrawal by Subject|1|||
157129879|NCT01573910|567226028|FG000|Overall Study|Protocol Violation|3|||
156716247|NCT02262325|565705309|FG000|Overall Study|Lost to Follow-up|1|||
156716248|NCT02815995|565705310|FG000|Overall Study|Disease Progression|3|||
156716249|NCT02815995|565705311|FG001|Overall Study|Disease Progression|7|||
156716250|NCT02815995|565705312|FG002|Overall Study|Disease Progression|2|||
156716251|NCT02815995|565705313|FG003|Overall Study|Disease Progression|4|||
156716252|NCT02815995|565705314|FG004|Overall Study|Disease Progression|3|||
156716253|NCT02815995|565705315|FG005|Overall Study|Disease Progression|9|||
156716254|NCT02815995|565705316|FG006|Overall Study|Disease Progression|3|||
156716255|NCT02815995|565705317|FG007|Overall Study|Disease Progression|1|||
156716256|NCT02815995|565705310|FG000|Overall Study|Adverse Event|1|||
156716257|NCT02815995|565705311|FG001|Overall Study|Adverse Event|2|||
156716258|NCT02815995|565705312|FG002|Overall Study|Adverse Event|2|||
156716259|NCT02815995|565705313|FG003|Overall Study|Adverse Event|0|||
156716260|NCT02815995|565705314|FG004|Overall Study|Adverse Event|0|||
156716261|NCT02815995|565705315|FG005|Overall Study|Adverse Event|1|||
156716262|NCT02815995|565705316|FG006|Overall Study|Adverse Event|0|||
156716263|NCT02815995|565705317|FG007|Overall Study|Adverse Event|0|||
156716264|NCT02815995|565705310|FG000|Overall Study|Pregnancy|0|||
157129880|NCT01573910|567226029|FG001|Overall Study|Protocol Violation|0|||
157129881|NCT01573910|567226028|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
157129882|NCT01573910|567226029|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
157129883|NCT00364182|567226030|FG000|First Intervention|Secondary prophylaxis|1|||
157129884|NCT00364182|567226031|FG001|First Intervention|Secondary prophylaxis|0|||
157129885|NCT00364182|567226032|FG002|First Intervention|Secondary prophylaxis|0|||
157129886|NCT00364182|567226030|FG000|First Intervention|Withdrawal by Subject|2|||
157129887|NCT00364182|567226031|FG001|First Intervention|Withdrawal by Subject|0|||
157129888|NCT00364182|567226032|FG002|First Intervention|Withdrawal by Subject|0|||
157129889|NCT00364182|567226030|FG000|Second Intervention|non-compliance|0|||
157129890|NCT00364182|567226031|FG001|Second Intervention|non-compliance|1|||
157129891|NCT00364182|567226032|FG002|Second Intervention|non-compliance|1|||
157129892|NCT00364182|567226030|FG000|Second Intervention|Protocol Violation|0|||
157129893|NCT00364182|567226031|FG001|Second Intervention|Protocol Violation|1|||
157129894|NCT00364182|567226032|FG002|Second Intervention|Protocol Violation|0|||
157129895|NCT00364182|567226030|FG000|Second Intervention|Adverse Event|0|||
157129896|NCT00364182|567226031|FG001|Second Intervention|Adverse Event|0|||
157129897|NCT00364182|567226032|FG002|Second Intervention|Adverse Event|1|||
157129898|NCT00364182|567226030|FG000|Third Intervention|non-compliance|0|||
157216610|NCT02533999|567539331|FG001|Overall Study|Protocol Violation|0|||
157129899|NCT00364182|567226031|FG001|Third Intervention|non-compliance|1|||
157129900|NCT00364182|567226032|FG002|Third Intervention|non-compliance|0|||
157129901|NCT00364182|567226030|FG000|Third Intervention|Lost to Follow-up|0|||
157129902|NCT00364182|567226031|FG001|Third Intervention|Lost to Follow-up|0|||
157129903|NCT00364182|567226032|FG002|Third Intervention|Lost to Follow-up|1|||
157129904|NCT01162421|567226036|FG000|Overall Study|Did not receive study drug|2|||
157129905|NCT01162421|567226037|FG001|Overall Study|Did not receive study drug|1|||
157129906|NCT01162421|567226036|FG000|Overall Study|Adverse Event|2|||
156716265|NCT02815995|565705311|FG001|Overall Study|Pregnancy|0|||
157129907|NCT01162421|567226037|FG001|Overall Study|Adverse Event|5|||
157216611|NCT02533999|567539330|FG000|Overall Study|Adverse Event|0|||
156716266|NCT02815995|565705312|FG002|Overall Study|Pregnancy|0|||
157129908|NCT01162421|567226036|FG000|Overall Study|Lost to Follow-up|0|||
157129909|NCT01162421|567226037|FG001|Overall Study|Lost to Follow-up|2|||
157216612|NCT02533999|567539331|FG001|Overall Study|Adverse Event|1|||
156716267|NCT02815995|565705313|FG003|Overall Study|Pregnancy|0|||
156716268|NCT02815995|565705314|FG004|Overall Study|Pregnancy|0|||
156716269|NCT02815995|565705315|FG005|Overall Study|Pregnancy|0|||
156716270|NCT02815995|565705316|FG006|Overall Study|Pregnancy|1|||
156716271|NCT02815995|565705317|FG007|Overall Study|Pregnancy|0|||
157129910|NCT01162421|567226036|FG000|Overall Study|Lack of Efficacy|2|||
157129911|NCT01162421|567226037|FG001|Overall Study|Lack of Efficacy|2|||
157129912|NCT01162421|567226036|FG000|Overall Study|Other|2|||
157129913|NCT01162421|567226037|FG001|Overall Study|Other|3|||
157129914|NCT02526550|567226041|FG000|Overall Study|Lost to Follow-up|1|||
157129915|NCT01557166|567226044|FG000|Overall Study|Adverse Event|20|||
157129916|NCT01557166|567226045|FG001|Overall Study|Adverse Event|6|||
157129917|NCT01557166|567226044|FG000|Overall Study|Lack of Efficacy|2|||
157129918|NCT01557166|567226045|FG001|Overall Study|Lack of Efficacy|1|||
157129919|NCT01557166|567226044|FG000|Overall Study|Protocol Violation|8|||
157129920|NCT01557166|567226045|FG001|Overall Study|Protocol Violation|5|||
157129921|NCT01557166|567226044|FG000|Overall Study|Withdrawn consent|12|||
157129922|NCT01557166|567226045|FG001|Overall Study|Withdrawn consent|20|||
157129923|NCT01557166|567226044|FG000|Overall Study|Target dose not tolerated|1|||
157129924|NCT01557166|567226045|FG001|Overall Study|Target dose not tolerated|0|||
156793114|NCT02268851|565994865|FG001|Overall Study|Progressive Disease|3|||
156793115|NCT02268851|565994866|FG002|Overall Study|Progressive Disease|0|||
156793116|NCT02268851|565994867|FG003|Overall Study|Progressive Disease|0|||
156793117|NCT02268851|565994868|FG004|Overall Study|Progressive Disease|1|||
156793118|NCT02268851|565994869|FG005|Overall Study|Progressive Disease|4|||
156793119|NCT02268851|565994864|FG000|Overall Study|Physician Decision|0|||
156793120|NCT02268851|565994865|FG001|Overall Study|Physician Decision|0|||
156793121|NCT02268851|565994866|FG002|Overall Study|Physician Decision|1|||
156793122|NCT02268851|565994867|FG003|Overall Study|Physician Decision|0|||
156793123|NCT02268851|565994868|FG004|Overall Study|Physician Decision|0|||
156793124|NCT02268851|565994869|FG005|Overall Study|Physician Decision|1|||
156793125|NCT02268851|565994864|FG000|Overall Study|Patient Compliance|0|||
156793126|NCT02268851|565994865|FG001|Overall Study|Patient Compliance|0|||
156793127|NCT02268851|565994866|FG002|Overall Study|Patient Compliance|0|||
156793128|NCT02268851|565994867|FG003|Overall Study|Patient Compliance|0|||
157129925|NCT01557166|567226044|FG000|Overall Study|Psychiatric disorder|1|||
157129926|NCT01557166|567226045|FG001|Overall Study|Psychiatric disorder|0|||
157129927|NCT01557166|567226044|FG000|Overall Study|Unclassified|2|||
157129928|NCT01557166|567226045|FG001|Overall Study|Unclassified|5|||
157129929|NCT00946309|567226046|FG000|Overall Study|Protocol Violation|1|||
157129930|NCT00946309|567226047|FG001|Overall Study|Protocol Violation|0|||
157129931|NCT00946309|567226046|FG000|Overall Study|Lost to Follow-up|0|||
157129932|NCT00946309|567226047|FG001|Overall Study|Lost to Follow-up|1|||
157129933|NCT00946309|567226046|FG000|Overall Study|Procedure cancelled/discontinued|0|||
157129934|NCT00946309|567226047|FG001|Overall Study|Procedure cancelled/discontinued|3|||
157129935|NCT01465659|567226051|FG000|Completed 1 Cycle of Treatment|Death|0|||
157129936|NCT01465659|567226052|FG001|Completed 1 Cycle of Treatment|Death|1|||
157129937|NCT01465659|567226053|FG002|Completed 1 Cycle of Treatment|Death|0|||
157129938|NCT01465659|567226054|FG003|Completed 1 Cycle of Treatment|Death|0|||
157129939|NCT01465659|567226051|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
157129940|NCT01465659|567226052|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
157129941|NCT01465659|567226053|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
157129942|NCT01465659|567226054|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
157129943|NCT01465659|567226051|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
157129944|NCT01465659|567226052|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
156793129|NCT02268851|565994868|FG004|Overall Study|Patient Compliance|1|||
156793130|NCT02268851|565994869|FG005|Overall Study|Patient Compliance|1|||
156793131|NCT02268851|565994864|FG000|Overall Study|Co-Morbid Condition|0|||
156793132|NCT02268851|565994865|FG001|Overall Study|Co-Morbid Condition|0|||
156793133|NCT02268851|565994866|FG002|Overall Study|Co-Morbid Condition|0|||
157129945|NCT01465659|567226053|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
157129946|NCT01465659|567226054|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
157129947|NCT01465659|567226051|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
157129948|NCT01465659|567226052|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
157129949|NCT01465659|567226053|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
157129950|NCT01465659|567226054|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
157129951|NCT01465659|567226051|FG000|Completed Follow for 1 Year|Death|6|||
157129952|NCT01465659|567226052|FG001|Completed Follow for 1 Year|Death|3|||
157129953|NCT01465659|567226053|FG002|Completed Follow for 1 Year|Death|2|||
157129954|NCT01465659|567226054|FG003|Completed Follow for 1 Year|Death|4|||
157129955|NCT00686647|567226059|FG000|Overall Study|Lost to Follow-up|1|||
157129956|NCT00686647|567226059|FG000|Overall Study|Death|1|||
157129957|NCT00578643|567226062|FG000|Overall Study|Death|1|||
157129958|NCT00578643|567226062|FG000|Overall Study|Lost to Follow-up|1|||
157129959|NCT01725750|567226063|FG000|Overall Study|Adverse Event|1|||
157129960|NCT01725750|567226064|FG001|Overall Study|Adverse Event|0|||
157129961|NCT01725750|567226063|FG000|Overall Study|Lost to Follow-up|1|||
157129962|NCT01725750|567226064|FG001|Overall Study|Lost to Follow-up|1|||
157129963|NCT01725750|567226063|FG000|Overall Study|Withdrawal by Subject|0|||
156793134|NCT02268851|565994867|FG003|Overall Study|Co-Morbid Condition|0|||
156793135|NCT02268851|565994868|FG004|Overall Study|Co-Morbid Condition|1|||
156793136|NCT02268851|565994869|FG005|Overall Study|Co-Morbid Condition|1|||
157129964|NCT01725750|567226064|FG001|Overall Study|Withdrawal by Subject|9|||
157129965|NCT03828487|567226067|FG000|Overall Study|Physician Decision|1|||
157129966|NCT03179436|567226069|FG000|Overall Study|Withdrawal by Subject|1|||
157129967|NCT03179436|567226070|FG001|Overall Study|Withdrawal by Subject|0|||
157129968|NCT03179436|567226071|FG002|Overall Study|Withdrawal by Subject|0|||
157129969|NCT03179436|567226072|FG003|Overall Study|Withdrawal by Subject|4|||
157129970|NCT03179436|567226073|FG004|Overall Study|Withdrawal by Subject|2|||
157129971|NCT03179436|567226074|FG005|Overall Study|Withdrawal by Subject|2|||
157129972|NCT03179436|567226075|FG006|Overall Study|Withdrawal by Subject|5|||
157129973|NCT03179436|567226076|FG007|Overall Study|Withdrawal by Subject|0|||
157129974|NCT03179436|567226077|FG008|Overall Study|Withdrawal by Subject|3|||
157129975|NCT03179436|567226078|FG009|Overall Study|Withdrawal by Subject|0|||
157129976|NCT03179436|567226079|FG010|Overall Study|Withdrawal by Subject|0|||
157129977|NCT03179436|567226080|FG011|Overall Study|Withdrawal by Subject|0|||
157129978|NCT03179436|567226069|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157129979|NCT03179436|567226070|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157129980|NCT03179436|567226071|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157129981|NCT03179436|567226072|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
157129982|NCT03179436|567226073|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
157129983|NCT03179436|567226074|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
157129984|NCT03179436|567226075|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
157129985|NCT03179436|567226076|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
157129986|NCT03179436|567226077|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
157129987|NCT03179436|567226078|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
157129988|NCT03179436|567226079|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
157129989|NCT03179436|567226080|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
157129990|NCT03179436|567226069|FG000|Overall Study|Sponsor Decision|0|||
157129991|NCT03179436|567226070|FG001|Overall Study|Sponsor Decision|0|||
157129992|NCT03179436|567226071|FG002|Overall Study|Sponsor Decision|1|||
157129993|NCT03179436|567226072|FG003|Overall Study|Sponsor Decision|3|||
157129994|NCT03179436|567226073|FG004|Overall Study|Sponsor Decision|9|||
157129995|NCT03179436|567226074|FG005|Overall Study|Sponsor Decision|7|||
157129996|NCT03179436|567226075|FG006|Overall Study|Sponsor Decision|2|||
157129997|NCT03179436|567226076|FG007|Overall Study|Sponsor Decision|4|||
157129998|NCT03179436|567226077|FG008|Overall Study|Sponsor Decision|23|||
157129999|NCT03179436|567226078|FG009|Overall Study|Sponsor Decision|6|||
157130000|NCT03179436|567226079|FG010|Overall Study|Sponsor Decision|7|||
157130001|NCT03179436|567226080|FG011|Overall Study|Sponsor Decision|5|||
157130002|NCT03179436|567226069|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130003|NCT03179436|567226070|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
157130004|NCT03179436|567226071|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130005|NCT03179436|567226072|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130006|NCT03179436|567226073|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
156793137|NCT01694771|565994872|FG000|Overall Study|Adverse Event|18|||
156793138|NCT01694771|565994873|FG001|Overall Study|Adverse Event|16|||
156793139|NCT01694771|565994872|FG000|Overall Study|Lack of Efficacy|1|||
156793140|NCT01694771|565994873|FG001|Overall Study|Lack of Efficacy|0|||
157130007|NCT03179436|567226074|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
157130008|NCT03179436|567226075|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130009|NCT03179436|567226076|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130010|NCT03179436|567226077|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130011|NCT03179436|567226078|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130012|NCT03179436|567226079|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130013|NCT03179436|567226080|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
157130014|NCT03179436|567226069|FG000|Overall Study|Lost to Follow-up|1|||
157130015|NCT03179436|567226070|FG001|Overall Study|Lost to Follow-up|0|||
157130016|NCT03179436|567226071|FG002|Overall Study|Lost to Follow-up|0|||
157130017|NCT03179436|567226072|FG003|Overall Study|Lost to Follow-up|1|||
157130018|NCT03179436|567226073|FG004|Overall Study|Lost to Follow-up|0|||
157130019|NCT03179436|567226074|FG005|Overall Study|Lost to Follow-up|1|||
157130020|NCT03179436|567226075|FG006|Overall Study|Lost to Follow-up|0|||
157130021|NCT03179436|567226076|FG007|Overall Study|Lost to Follow-up|0|||
157130022|NCT03179436|567226077|FG008|Overall Study|Lost to Follow-up|1|||
157130023|NCT03179436|567226078|FG009|Overall Study|Lost to Follow-up|1|||
157130024|NCT03179436|567226079|FG010|Overall Study|Lost to Follow-up|0|||
157130025|NCT03179436|567226080|FG011|Overall Study|Lost to Follow-up|0|||
157130026|NCT03179436|567226069|FG000|Overall Study|Death|12|||
157130027|NCT03179436|567226070|FG001|Overall Study|Death|17|||
157130028|NCT03179436|567226071|FG002|Overall Study|Death|7|||
157130029|NCT03179436|567226072|FG003|Overall Study|Death|32|||
157130030|NCT03179436|567226073|FG004|Overall Study|Death|29|||
157130031|NCT03179436|567226074|FG005|Overall Study|Death|30|||
157130032|NCT03179436|567226075|FG006|Overall Study|Death|33|||
157130033|NCT03179436|567226076|FG007|Overall Study|Death|9|||
157130034|NCT03179436|567226077|FG008|Overall Study|Death|84|||
157130035|NCT03179436|567226078|FG009|Overall Study|Death|33|||
157130036|NCT03179436|567226079|FG010|Overall Study|Death|22|||
157130037|NCT03179436|567226080|FG011|Overall Study|Death|15|||
157216613|NCT02533999|567539330|FG000|Overall Study|Randomized but intervention not received|0|||
157216614|NCT02533999|567539331|FG001|Overall Study|Randomized but intervention not received|1|||
157216615|NCT05017493|567539334|FG000|Overall Study|Withdrawal by Subject|26|||
157216616|NCT05017493|567539335|FG001|Overall Study|Withdrawal by Subject|0|||
157216617|NCT05017493|567539334|FG000|Overall Study|Physician Decision|15|||
157216618|NCT05017493|567539335|FG001|Overall Study|Physician Decision|0|||
157216619|NCT05017493|567539334|FG000|Overall Study|Protocol Violation|81|||
157216620|NCT05017493|567539335|FG001|Overall Study|Protocol Violation|0|||
157216621|NCT01154153|567539336|FG000|Overall Study|Poor compliance to protocol|2|||
157216622|NCT01154153|567539337|FG001|Overall Study|Poor compliance to protocol|0|||
157216623|NCT01154153|567539336|FG000|Overall Study|Unable to use labs|2|||
157216624|NCT01154153|567539337|FG001|Overall Study|Unable to use labs|3|||
157216625|NCT01154153|567539336|FG000|Overall Study|Withdrew consent|1|||
157216626|NCT01154153|567539337|FG001|Overall Study|Withdrew consent|0|||
157216627|NCT02473510|567539338|FG000|Overall Study|Lost to Follow-up|1|||
157216628|NCT02473510|567539339|FG001|Overall Study|Lost to Follow-up|2|||
157216629|NCT03940586|567539343|FG000|Overall Study|Death|3|||
157216630|NCT03940586|567539344|FG001|Overall Study|Death|2|||
157216631|NCT03940586|567539345|FG002|Overall Study|Death|0|||
157216632|NCT03940586|567539343|FG000|Overall Study|Physician Decision|1|||
157216633|NCT03940586|567539344|FG001|Overall Study|Physician Decision|0|||
157216634|NCT03940586|567539345|FG002|Overall Study|Physician Decision|1|||
157216635|NCT03940586|567539343|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
157216636|NCT03940586|567539344|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
157216637|NCT03940586|567539345|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
157216638|NCT03940586|567539343|FG000|Overall Study|Not Treated|0|||
157216639|NCT03940586|567539344|FG001|Overall Study|Not Treated|2|||
157216640|NCT03940586|567539345|FG002|Overall Study|Not Treated|0|||
157216641|NCT00964223|567539346|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
157216642|NCT03439293|567539347|FG000|Overall Study|Death|22|||
157216643|NCT03439293|567539347|FG000|Overall Study|Withdrawal by Subject|8|||
157216644|NCT03439293|567539347|FG000|Overall Study|Lost to Follow-up|2|||
157216645|NCT03439293|567539347|FG000|Overall Study|Reason Not Specified|28|||
157216646|NCT03439293|567539347|FG000|Overall Study|Missing|1|||
157216647|NCT02006147|567539348|FG000|Overall Study|Protocol Violation|1|||
157216648|NCT02006147|567539349|FG001|Overall Study|Protocol Violation|1|||
157216649|NCT02006147|567539350|FG002|Overall Study|Protocol Violation|0|||
157216650|NCT02006147|567539351|FG003|Overall Study|Protocol Violation|0|||
157216651|NCT02006147|567539348|FG000|Overall Study|Withdrawal by Subject|0|||
157216652|NCT02006147|567539349|FG001|Overall Study|Withdrawal by Subject|1|||
157216653|NCT02006147|567539350|FG002|Overall Study|Withdrawal by Subject|0|||
157216654|NCT02006147|567539351|FG003|Overall Study|Withdrawal by Subject|0|||
157216655|NCT02006147|567539348|FG000|Overall Study|Withdrawal by Sponsor|1|||
157216656|NCT02006147|567539349|FG001|Overall Study|Withdrawal by Sponsor|0|||
157216657|NCT02006147|567539350|FG002|Overall Study|Withdrawal by Sponsor|0|||
157216658|NCT02006147|567539351|FG003|Overall Study|Withdrawal by Sponsor|0|||
157216659|NCT03404206|567539352|FG000|Overall Study|Withdrawal by Subject|1|||
157130038|NCT01634555|567226081|FG000|Overall Study|Adverse Event|3|||
157130039|NCT01634555|567226081|FG000|Overall Study|Physician Decision|1|||
157130040|NCT04025632|567227478|FG000|Overall Study|Adverse Event|1|||
157130041|NCT04025632|567227479|FG001|Overall Study|Adverse Event|1|||
157130042|NCT04025632|567227478|FG000|Overall Study|Withdrawal by Subject|1|||
157130043|NCT04025632|567227479|FG001|Overall Study|Withdrawal by Subject|1|||
157130044|NCT04025632|567227478|FG000|Overall Study|Study Terminated by Sponsor|10|||
157130045|NCT04025632|567227479|FG001|Overall Study|Study Terminated by Sponsor|9|||
157130046|NCT04025632|567227478|FG000|Overall Study|Physician Decision|3|||
157130047|NCT04025632|567227479|FG001|Overall Study|Physician Decision|1|||
157130048|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
157130049|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
157216660|NCT03404206|567539353|FG001|Overall Study|Withdrawal by Subject|1|||
157216661|NCT03404206|567539354|FG002|Overall Study|Withdrawal by Subject|0|||
157130050|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
157216662|NCT03404206|567539352|FG000|Overall Study|Lost to Follow-up|3|||
157216663|NCT03404206|567539353|FG001|Overall Study|Lost to Follow-up|1|||
157216664|NCT03404206|567539354|FG002|Overall Study|Lost to Follow-up|0|||
157216665|NCT05478603|567539355|FG000|Overall Study|Withdrawal by Subject|0|||
157216666|NCT05478603|567539356|FG001|Overall Study|Withdrawal by Subject|1|||
157216667|NCT05478603|567539357|FG002|Overall Study|Withdrawal by Subject|0|||
157130051|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157130052|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157216668|NCT05478603|567539358|FG003|Overall Study|Withdrawal by Subject|0|||
157216669|NCT00990093|567539361|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
157216670|NCT00990093|567539362|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
157216671|NCT00990093|567539361|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
157130053|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157130054|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157130055|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157130056|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
157130057|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
157130058|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
157130059|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157130060|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157130061|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157130062|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157130063|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157130064|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
157130065|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
157130066|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
157130067|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157130068|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157130069|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157130070|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157130071|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157130072|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
157130073|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
157130074|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
157130075|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157130076|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157130077|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157130078|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157130079|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157130080|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
157130081|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
157130082|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
157130083|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157130084|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157130085|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157130086|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157130087|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157130088|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
157130089|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
157130090|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130091|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130092|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130093|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130094|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130095|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157130096|NCT01097629|567227487|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
157130097|NCT01097629|567227488|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
157130098|NCT01097629|567227489|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
157130099|NCT01097629|567227490|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157130100|NCT01097629|567227491|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156793141|NCT01694771|565994872|FG000|Overall Study|Non compliance protocol|7|||
156793142|NCT01694771|565994873|FG001|Overall Study|Non compliance protocol|6|||
156793143|NCT01694771|565994872|FG000|Overall Study|Lost to Follow-up|2|||
156793144|NCT01694771|565994873|FG001|Overall Study|Lost to Follow-up|3|||
156793145|NCT01694771|565994872|FG000|Overall Study|Consent withdrawn|7|||
156793146|NCT01694771|565994873|FG001|Overall Study|Consent withdrawn|9|||
156793147|NCT01694771|565994872|FG000|Overall Study|Other reasons|5|||
156793148|NCT01694771|565994873|FG001|Overall Study|Other reasons|6|||
156793149|NCT02536339|565994875|FG000|Overall Study|Death|20|||
156793150|NCT02536339|565994875|FG000|Overall Study|Withdrawal by Subject|3|||
156793151|NCT02536339|565994875|FG000|Overall Study|Lost to Follow-up|2|||
156793152|NCT02536339|565994875|FG000|Overall Study|Treatment discontinued|2|||
156793153|NCT02536339|565994875|FG000|Overall Study|Physician Decision|1|||
156793154|NCT01905683|565994876|FG000|Overall Study|Protocol Violation|1|||
156793155|NCT01905683|565994876|FG000|Overall Study|Re-injection criteria not met; others|13|||
156793156|NCT01905683|565994876|FG000|Overall Study|Physician Decision|1|||
156793157|NCT01905683|565994876|FG000|Overall Study|Lack of Efficacy|8|||
156793158|NCT01905683|565994876|FG000|Overall Study|Withdrawal by Subject|20|||
156793159|NCT01905683|565994876|FG000|Overall Study|Adverse Event|4|||
157130101|NCT01097629|567227492|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
156874774|NCT04421027|566298734|FG001|Follow-Up Period|Death|0|||
156874775|NCT04421027|566298735|FG002|Follow-Up Period|Death|16|||
156874776|NCT04421027|566298736|FG003|Follow-Up Period|Death|17|||
156874777|NCT04421027|566298733|FG000|Follow-Up Period|Lost to Follow-up|0|||
156874778|NCT04421027|566298734|FG001|Follow-Up Period|Lost to Follow-up|0|||
156874779|NCT04421027|566298735|FG002|Follow-Up Period|Lost to Follow-up|7|||
156874780|NCT04421027|566298736|FG003|Follow-Up Period|Lost to Follow-up|7|||
156874781|NCT04421027|566298733|FG000|Follow-Up Period|Protocol Deviation|0|||
156874782|NCT04421027|566298734|FG001|Follow-Up Period|Protocol Deviation|0|||
156874783|NCT04421027|566298735|FG002|Follow-Up Period|Protocol Deviation|1|||
156874784|NCT04421027|566298736|FG003|Follow-Up Period|Protocol Deviation|0|||
156874785|NCT04421027|566298733|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874786|NCT04421027|566298734|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874787|NCT04421027|566298735|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
156874788|NCT04421027|566298736|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
156874789|NCT04421027|566298733|FG000|Follow-Up Period|Left message, participant did not call back|0|||
156874790|NCT04421027|566298734|FG001|Follow-Up Period|Left message, participant did not call back|0|||
156874791|NCT04421027|566298735|FG002|Follow-Up Period|Left message, participant did not call back|0|||
156874792|NCT04421027|566298736|FG003|Follow-Up Period|Left message, participant did not call back|1|||
156874793|NCT04421027|566298733|FG000|Follow-Up Period|Participant died|0|||
156874794|NCT04421027|566298734|FG001|Follow-Up Period|Participant died|0|||
156874795|NCT04421027|566298735|FG002|Follow-Up Period|Participant died|0|||
156874796|NCT04421027|566298736|FG003|Follow-Up Period|Participant died|1|||
156874797|NCT04421027|566298733|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
156874798|NCT04421027|566298734|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
157130102|NCT01097629|567227493|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157130103|NCT01097629|567227494|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157130104|NCT01097629|567227487|FG000|DB RO Phase|Withdrawal by Subject|0|||
157130105|NCT01097629|567227488|FG001|DB RO Phase|Withdrawal by Subject|0|||
157130106|NCT01097629|567227489|FG002|DB RO Phase|Withdrawal by Subject|0|||
157130107|NCT01097629|567227490|FG003|DB RO Phase|Withdrawal by Subject|0|||
157130108|NCT01097629|567227491|FG004|DB RO Phase|Withdrawal by Subject|0|||
157130109|NCT01097629|567227492|FG005|DB RO Phase|Withdrawal by Subject|0|||
157130110|NCT01097629|567227493|FG006|DB RO Phase|Withdrawal by Subject|0|||
157130111|NCT01097629|567227494|FG007|DB RO Phase|Withdrawal by Subject|1|||
157130112|NCT01097629|567227487|FG000|DB RO Phase|Protocol Violation|0|||
157130113|NCT01097629|567227488|FG001|DB RO Phase|Protocol Violation|0|||
157130114|NCT01097629|567227489|FG002|DB RO Phase|Protocol Violation|0|||
157130115|NCT01097629|567227490|FG003|DB RO Phase|Protocol Violation|1|||
157130116|NCT01097629|567227491|FG004|DB RO Phase|Protocol Violation|0|||
157130117|NCT01097629|567227492|FG005|DB RO Phase|Protocol Violation|1|||
157130118|NCT01097629|567227493|FG006|DB RO Phase|Protocol Violation|1|||
157130119|NCT01097629|567227494|FG007|DB RO Phase|Protocol Violation|0|||
157130120|NCT01097629|567227487|FG000|DB RO Phase|Lost to Follow-up|0|||
157130121|NCT01097629|567227488|FG001|DB RO Phase|Lost to Follow-up|0|||
157130122|NCT01097629|567227489|FG002|DB RO Phase|Lost to Follow-up|0|||
157130123|NCT01097629|567227490|FG003|DB RO Phase|Lost to Follow-up|0|||
157130124|NCT01097629|567227491|FG004|DB RO Phase|Lost to Follow-up|0|||
157130125|NCT01097629|567227492|FG005|DB RO Phase|Lost to Follow-up|0|||
157130126|NCT01097629|567227493|FG006|DB RO Phase|Lost to Follow-up|2|||
157130127|NCT01097629|567227494|FG007|DB RO Phase|Lost to Follow-up|0|||
157130128|NCT00956943|567227495|FG000|Overall Study|Lost to Follow-up|9|||
157130129|NCT00956943|567227496|FG001|Overall Study|Lost to Follow-up|10|||
156874799|NCT04421027|566298735|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
156874800|NCT04421027|566298736|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
157130130|NCT02663895|567227497|FG000|Overall Study|Adverse Event|3|||
157130131|NCT02663895|567227497|FG000|Overall Study|Physician Decision|2|||
157130132|NCT02663895|567227497|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
157130133|NCT02663895|567227497|FG000|Overall Study|Withdrawal by Subject|1|||
157130134|NCT01793792|567227498|FG000|Overall Study|Death|5|||
156874801|NCT00560352|566298739|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156874802|NCT00560352|566298740|FG001|Overall Study|Adverse event unrelated to study drug|1|||
157130135|NCT01793792|567227498|FG000|Overall Study|Lost to Follow-up|5|||
157130136|NCT01793792|567227498|FG000|Overall Study|Withdrawal by Subject|1|||
157130137|NCT01793792|567227498|FG000|Overall Study|Device Not Implanted|1|||
157130138|NCT00851903|567227503|FG000|Overall Study|Withdrawal by Subject|2|||
157130139|NCT03706365|567227504|FG000|Overall Study|Lost to Follow-up|7|||
157130140|NCT03706365|567227505|FG001|Overall Study|Lost to Follow-up|0|||
157130141|NCT03706365|567227504|FG000|Overall Study|Withdrawal by Subject|17|||
157130142|NCT03706365|567227505|FG001|Overall Study|Withdrawal by Subject|15|||
157130143|NCT03706365|567227504|FG000|Overall Study|On Study Treatment|51|||
157130144|NCT03706365|567227505|FG001|Overall Study|On Study Treatment|51|||
157130145|NCT00469612|567227506|FG000|Overall Study|Study terminated before data collected|2|||
156874803|NCT00560352|566298741|FG002|Overall Study|Adverse event unrelated to study drug|1|||
156874804|NCT00560352|566298739|FG000|Overall Study|Study drug toxicity|3|||
156874805|NCT00560352|566298740|FG001|Overall Study|Study drug toxicity|0|||
156874806|NCT00560352|566298741|FG002|Overall Study|Study drug toxicity|1|||
156874807|NCT00560352|566298739|FG000|Overall Study|Disease progression|0|||
156874808|NCT00560352|566298740|FG001|Overall Study|Disease progression|1|||
156874809|NCT00560352|566298741|FG002|Overall Study|Disease progression|1|||
156874810|NCT00560352|566298739|FG000|Overall Study|Withdrawal by Subject|1|||
156874811|NCT00560352|566298740|FG001|Overall Study|Withdrawal by Subject|1|||
156874812|NCT00560352|566298741|FG002|Overall Study|Withdrawal by Subject|1|||
156874813|NCT00560352|566298739|FG000|Overall Study|Maximum clinical benefit|1|||
157130146|NCT00469612|567227507|FG001|Overall Study|Study terminated before data collected|0|||
157130147|NCT00542191|567227508|FG000|Overall Study|Death|3|||
157130148|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130149|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
157130150|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130151|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130152|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130153|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
157130154|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
157130155|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
157130156|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
157130157|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
157130158|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
157130159|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
157130160|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130161|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
157130162|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
157130163|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
157130164|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
157130165|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
157130166|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
157130167|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
157130168|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130169|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130170|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130171|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
157130172|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130173|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
157130174|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
157130175|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
157130176|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
157130177|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
157130178|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
157130179|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
157130180|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
157130181|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
157130182|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
157130183|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
157130184|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
157130185|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
157130186|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
157130187|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
157130188|NCT00289913|567227509|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
157130189|NCT00289913|567227510|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130190|NCT00289913|567227511|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
157130191|NCT00289913|567227512|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130192|NCT00289913|567227513|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130193|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130194|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130195|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
157130196|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
156874814|NCT00560352|566298740|FG001|Overall Study|Maximum clinical benefit|0|||
156874815|NCT00560352|566298741|FG002|Overall Study|Maximum clinical benefit|0|||
157130197|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130198|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
157130199|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
157130200|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
157130201|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
157130202|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
157130203|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
157130204|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
157130205|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
157130206|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
157130207|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
157130208|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
157130209|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
157130210|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
157130211|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130212|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130213|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
157130214|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130215|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
157130216|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130217|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130218|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
157130219|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
157130220|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
157130221|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
157130222|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
157130223|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
157130224|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
157130225|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
157130226|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
157130227|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
157130228|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
157130229|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
157130230|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
157130231|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
157130232|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
157130233|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
157130234|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
157130235|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
157130236|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
157130237|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
157130238|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
157130239|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
157130240|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
157130241|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
157130242|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
157130243|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
157130244|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
157130245|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
157130246|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
157130247|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
157130248|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
157130249|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
157130250|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
157130251|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
157130252|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
157130253|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
157130254|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
157130255|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
157130256|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
157130257|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
157130258|NCT00289913|567227509|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
157216672|NCT00990093|567539362|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
157130259|NCT00289913|567227510|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
157130260|NCT00289913|567227511|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
157130261|NCT00289913|567227512|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
157130262|NCT00289913|567227513|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
157130263|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130264|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
157130265|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130266|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130267|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
157130268|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
157130269|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
157130270|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
157130271|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
157130272|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
157130273|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130274|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130275|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130276|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
157130277|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
157130278|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130279|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130280|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130281|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
157130282|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
157130283|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
157130284|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
157130285|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
157130286|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
157130287|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
157130288|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
157130289|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
157130290|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
157130291|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
157130292|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
157130293|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
157130294|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
157130295|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
157130296|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
157130297|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
157130298|NCT00289913|567227509|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130299|NCT00289913|567227510|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
157130300|NCT00289913|567227511|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130301|NCT00289913|567227512|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130302|NCT00289913|567227513|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
157130303|NCT03822884|567227514|FG000|Overall Study|Withdrawal by Subject|0|||
157130304|NCT03822884|567227515|FG001|Overall Study|Withdrawal by Subject|0|||
157130305|NCT03822884|567227516|FG002|Overall Study|Withdrawal by Subject|0|||
157130306|NCT03822884|567227517|FG003|Overall Study|Withdrawal by Subject|0|||
157130307|NCT03822884|567227518|FG004|Overall Study|Withdrawal by Subject|1|||
157130308|NCT03822884|567227519|FG005|Overall Study|Withdrawal by Subject|0|||
157130309|NCT02357420|567227526|FG000|Overall Study|Adverse Event|3|||
157130310|NCT02357420|567227527|FG001|Overall Study|Adverse Event|3|||
157130311|NCT02357420|567227528|FG002|Overall Study|Adverse Event|8|||
157130312|NCT02357420|567227529|FG003|Overall Study|Adverse Event|9|||
157130313|NCT02357420|567227526|FG000|Overall Study|Investigator Decision|1|||
157130314|NCT02357420|567227527|FG001|Overall Study|Investigator Decision|0|||
157130315|NCT02357420|567227528|FG002|Overall Study|Investigator Decision|0|||
157130316|NCT02357420|567227529|FG003|Overall Study|Investigator Decision|0|||
157130317|NCT02357420|567227526|FG000|Overall Study|Prohibited Medication|1|||
157130318|NCT02357420|567227527|FG001|Overall Study|Prohibited Medication|1|||
157130319|NCT02357420|567227528|FG002|Overall Study|Prohibited Medication|0|||
157130320|NCT02357420|567227529|FG003|Overall Study|Prohibited Medication|0|||
157130321|NCT02357420|567227526|FG000|Overall Study|Protocol Non-compliance|0|||
157130322|NCT02357420|567227527|FG001|Overall Study|Protocol Non-compliance|0|||
157130323|NCT02357420|567227528|FG002|Overall Study|Protocol Non-compliance|0|||
156793160|NCT01905683|565994876|FG000|Overall Study|Lost to Follow-up|4|||
156793161|NCT02037984|565994879|FG000|Overall Study|Lack of Efficacy|0|||
157130324|NCT02357420|567227529|FG003|Overall Study|Protocol Non-compliance|1|||
157130325|NCT02357420|567227526|FG000|Overall Study|Withdrawn Consent|4|||
157130326|NCT02357420|567227527|FG001|Overall Study|Withdrawn Consent|8|||
157130327|NCT02357420|567227528|FG002|Overall Study|Withdrawn Consent|6|||
157130328|NCT02357420|567227529|FG003|Overall Study|Withdrawn Consent|6|||
157130329|NCT02357420|567227526|FG000|Overall Study|Lost to Follow-up|3|||
157130330|NCT02357420|567227527|FG001|Overall Study|Lost to Follow-up|0|||
157130331|NCT02357420|567227528|FG002|Overall Study|Lost to Follow-up|2|||
157130332|NCT02357420|567227529|FG003|Overall Study|Lost to Follow-up|3|||
157130333|NCT03617705|567227530|FG000|Overall Study|Withdrawal by Subject|2|||
157130334|NCT03617705|567227530|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
156793162|NCT02037984|565994880|FG001|Overall Study|Lack of Efficacy|0|||
157130335|NCT03617705|567227530|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
157130336|NCT00214461|567227531|FG000|Overall Study|Adverse Event|0|||
157130337|NCT00214461|567227532|FG001|Overall Study|Adverse Event|0|||
157130338|NCT00214461|567227533|FG002|Overall Study|Adverse Event|1|||
157130339|NCT00214461|567227534|FG003|Overall Study|Adverse Event|1|||
157130340|NCT00214461|567227531|FG000|Overall Study|Withdrawal by Subject|0|||
157130341|NCT00214461|567227532|FG001|Overall Study|Withdrawal by Subject|0|||
157130342|NCT00214461|567227533|FG002|Overall Study|Withdrawal by Subject|1|||
157130343|NCT00214461|567227534|FG003|Overall Study|Withdrawal by Subject|0|||
157130344|NCT02411448|567227536|FG000|Overall Study|Withdrawal by Subject|1|||
157130345|NCT02411448|567227537|FG001|Overall Study|Withdrawal by Subject|14|||
157130346|NCT02411448|567227538|FG002|Overall Study|Withdrawal by Subject|9|||
157130347|NCT02411448|567227536|FG000|Overall Study|Other|0|||
157130348|NCT02411448|567227537|FG001|Overall Study|Other|2|||
157130349|NCT02411448|567227538|FG002|Overall Study|Other|0|||
157130350|NCT02411448|567227536|FG000|Overall Study|Did not receive study treatment|0|||
156793163|NCT02037984|565994881|FG002|Overall Study|Lack of Efficacy|3|||
156793164|NCT02037984|565994882|FG003|Overall Study|Lack of Efficacy|10|||
156793165|NCT02037984|565994883|FG004|Overall Study|Lack of Efficacy|2|||
156793166|NCT02037984|565994884|FG005|Overall Study|Lack of Efficacy|2|||
156793167|NCT02037984|565994885|FG006|Overall Study|Lack of Efficacy|4|||
156793168|NCT02037984|565994886|FG007|Overall Study|Lack of Efficacy|3|||
156793169|NCT02037984|565994879|FG000|Overall Study|Lost to Follow-up|1|||
156793170|NCT02037984|565994880|FG001|Overall Study|Lost to Follow-up|0|||
156793171|NCT02037984|565994881|FG002|Overall Study|Lost to Follow-up|3|||
156793172|NCT02037984|565994882|FG003|Overall Study|Lost to Follow-up|5|||
156793173|NCT02037984|565994883|FG004|Overall Study|Lost to Follow-up|2|||
156793174|NCT02037984|565994884|FG005|Overall Study|Lost to Follow-up|2|||
156793175|NCT02037984|565994885|FG006|Overall Study|Lost to Follow-up|2|||
156793176|NCT02037984|565994886|FG007|Overall Study|Lost to Follow-up|4|||
156793177|NCT02037984|565994879|FG000|Overall Study|Physician Decision|0|||
156793178|NCT02037984|565994880|FG001|Overall Study|Physician Decision|0|||
156793179|NCT02037984|565994881|FG002|Overall Study|Physician Decision|0|||
156793180|NCT02037984|565994882|FG003|Overall Study|Physician Decision|0|||
156793181|NCT02037984|565994883|FG004|Overall Study|Physician Decision|0|||
156793182|NCT02037984|565994884|FG005|Overall Study|Physician Decision|0|||
156793183|NCT02037984|565994885|FG006|Overall Study|Physician Decision|1|||
156793184|NCT02037984|565994886|FG007|Overall Study|Physician Decision|0|||
156793185|NCT02037984|565994879|FG000|Overall Study|Protocol Violation|0|||
156793186|NCT02037984|565994880|FG001|Overall Study|Protocol Violation|0|||
156793187|NCT02037984|565994881|FG002|Overall Study|Protocol Violation|0|||
156793188|NCT02037984|565994882|FG003|Overall Study|Protocol Violation|0|||
156793189|NCT02037984|565994883|FG004|Overall Study|Protocol Violation|0|||
156793190|NCT02037984|565994884|FG005|Overall Study|Protocol Violation|1|||
156793191|NCT02037984|565994885|FG006|Overall Study|Protocol Violation|2|||
156793192|NCT02037984|565994886|FG007|Overall Study|Protocol Violation|0|||
156793193|NCT02037984|565994879|FG000|Overall Study|Technical Problems|0|||
156793194|NCT02037984|565994880|FG001|Overall Study|Technical Problems|0|||
156793195|NCT02037984|565994881|FG002|Overall Study|Technical Problems|3|||
156793196|NCT02037984|565994882|FG003|Overall Study|Technical Problems|3|||
156793197|NCT02037984|565994883|FG004|Overall Study|Technical Problems|2|||
156793198|NCT02037984|565994884|FG005|Overall Study|Technical Problems|3|||
156793199|NCT02037984|565994885|FG006|Overall Study|Technical Problems|4|||
156793200|NCT02037984|565994886|FG007|Overall Study|Technical Problems|2|||
156793201|NCT02037984|565994879|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156793202|NCT02037984|565994880|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156793203|NCT02037984|565994881|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
156793204|NCT02037984|565994882|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
156793205|NCT02037984|565994883|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
156793206|NCT02037984|565994884|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
156793207|NCT02037984|565994885|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
157130351|NCT02411448|567227537|FG001|Overall Study|Did not receive study treatment|3|||
157130352|NCT02411448|567227538|FG002|Overall Study|Did not receive study treatment|0|||
157130353|NCT02411448|567227536|FG000|Overall Study|Alive on study treatment|3|||
157130354|NCT02411448|567227537|FG001|Overall Study|Alive on study treatment|64|||
157130355|NCT02411448|567227538|FG002|Overall Study|Alive on study treatment|43|||
157130356|NCT02631538|567227541|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
157130357|NCT02631538|567227542|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
157130358|NCT02631538|567227543|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
157130359|NCT02631538|567227544|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
157130360|NCT02631538|567227541|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
157130361|NCT02631538|567227542|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
157130362|NCT02631538|567227543|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
157130363|NCT02631538|567227544|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
157130364|NCT02631538|567227541|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
157130365|NCT02631538|567227542|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
157130366|NCT02631538|567227543|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
157130367|NCT02631538|567227544|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
157130368|NCT02631538|567227541|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
157130369|NCT02631538|567227542|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
157130370|NCT02631538|567227543|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
157130371|NCT02631538|567227544|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
157130372|NCT02631538|567227541|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
157130373|NCT02631538|567227542|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
157130374|NCT02631538|567227543|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
157130375|NCT02631538|567227544|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
157130376|NCT02631538|567227541|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
157130377|NCT02631538|567227542|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
157130378|NCT02631538|567227543|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
157130379|NCT02631538|567227544|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
157130380|NCT01688050|567227545|FG000|Overall Study|Death|7|||
157130381|NCT01688050|567227545|FG000|Overall Study|Conversion to open repair|1|||
157130382|NCT01688050|567227545|FG000|Overall Study|Lost to Follow-up|13|||
157130383|NCT01688050|567227545|FG000|Overall Study|Withdrawal by Subject|10|||
157130384|NCT00440726|567227546|FG000|Phase 1|Dose-Limiting Toxicity|0|||
157130385|NCT00440726|567227547|FG001|Phase 1|Dose-Limiting Toxicity|1|||
157130386|NCT00440726|567227548|FG002|Phase 1|Dose-Limiting Toxicity|0|||
157130387|NCT00440726|567227546|FG000|Phase 1|Physician Decision|1|||
157130388|NCT00440726|567227547|FG001|Phase 1|Physician Decision|0|||
157130389|NCT00440726|567227548|FG002|Phase 1|Physician Decision|0|||
157130390|NCT00440726|567227546|FG000|Phase 2|Death|0|||
157130391|NCT00440726|567227547|FG001|Phase 2|Death|0|||
157130392|NCT00440726|567227548|FG002|Phase 2|Death|1|||
157130393|NCT00440726|567227546|FG000|Phase 2|Adverse Event|0|||
157130394|NCT00440726|567227547|FG001|Phase 2|Adverse Event|0|||
157130395|NCT00440726|567227548|FG002|Phase 2|Adverse Event|1|||
157130396|NCT01554579|567227549|FG000|Overall Study|Adverse Event|6|||
157130397|NCT01554579|567227550|FG001|Overall Study|Adverse Event|25|||
157130398|NCT01554579|567227549|FG000|Overall Study|Lack of Efficacy|2|||
157130399|NCT01554579|567227550|FG001|Overall Study|Lack of Efficacy|1|||
157130400|NCT01554579|567227549|FG000|Overall Study|Withdrawal by Subject|2|||
157130401|NCT01554579|567227550|FG001|Overall Study|Withdrawal by Subject|1|||
157130402|NCT01808612|567227551|FG000|Treatment Period|Adverse Event|8|||
157130403|NCT01808612|567227552|FG001|Treatment Period|Adverse Event|4|||
157130404|NCT01808612|567227553|FG002|Treatment Period|Adverse Event|3|||
157130405|NCT01808612|567227551|FG000|Treatment Period|Lost to Follow-up|2|||
157130406|NCT01808612|567227552|FG001|Treatment Period|Lost to Follow-up|2|||
157130407|NCT01808612|567227553|FG002|Treatment Period|Lost to Follow-up|1|||
157130408|NCT01808612|567227551|FG000|Treatment Period|Protocol Violation|1|||
157130409|NCT01808612|567227552|FG001|Treatment Period|Protocol Violation|0|||
157130410|NCT01808612|567227553|FG002|Treatment Period|Protocol Violation|0|||
157130411|NCT01808612|567227551|FG000|Treatment Period|Withdrawal by Subject|1|||
157130412|NCT01808612|567227552|FG001|Treatment Period|Withdrawal by Subject|0|||
157130413|NCT01808612|567227553|FG002|Treatment Period|Withdrawal by Subject|4|||
157130414|NCT01808612|567227551|FG000|Treatment Period|Physician Decision|1|||
157130415|NCT01808612|567227552|FG001|Treatment Period|Physician Decision|0|||
157130416|NCT01808612|567227553|FG002|Treatment Period|Physician Decision|4|||
157130417|NCT01808612|567227551|FG000|Treatment Period|Sponsor Decision|1|||
157130418|NCT01808612|567227552|FG001|Treatment Period|Sponsor Decision|0|||
157130419|NCT01808612|567227553|FG002|Treatment Period|Sponsor Decision|0|||
157130420|NCT01808612|567227551|FG000|Treatment Period|Lack of Efficacy|1|||
157130421|NCT01808612|567227552|FG001|Treatment Period|Lack of Efficacy|1|||
157130422|NCT01808612|567227553|FG002|Treatment Period|Lack of Efficacy|2|||
157130423|NCT01808612|567227551|FG000|Discontinuation Period|Adverse Event|1|||
157130424|NCT01808612|567227552|FG001|Discontinuation Period|Adverse Event|0|||
157130425|NCT01808612|567227553|FG002|Discontinuation Period|Adverse Event|0|||
157130426|NCT01808612|567227551|FG000|Discontinuation Period|Physician Decision|1|||
157130427|NCT01808612|567227552|FG001|Discontinuation Period|Physician Decision|0|||
157130428|NCT01808612|567227553|FG002|Discontinuation Period|Physician Decision|0|||
156716272|NCT02676882|565705318|FG000|Overall Study|Adverse Event|1|||
157130429|NCT01808612|567227551|FG000|Discontinuation Period|Lost to Follow-up|0|||
157130430|NCT01808612|567227552|FG001|Discontinuation Period|Lost to Follow-up|1|||
157130431|NCT01808612|567227553|FG002|Discontinuation Period|Lost to Follow-up|0|||
157130432|NCT03683394|567227554|FG000|Overall Study|Withdrawal by Subject|4|||
157130433|NCT03683394|567227555|FG001|Overall Study|Withdrawal by Subject|8|||
157130434|NCT03683394|567227554|FG000|Overall Study|Lost to Follow-up|7|||
157017769|NCT03432858|566817950|FG000|Overall Study|Procedure canceled/rescheduled|0|||
157017770|NCT03432858|566817951|FG001|Overall Study|Procedure canceled/rescheduled|9|||
157130435|NCT03683394|567227555|FG001|Overall Study|Lost to Follow-up|0|||
157130436|NCT03683394|567227554|FG000|Overall Study|Death|3|||
157130437|NCT03683394|567227555|FG001|Overall Study|Death|1|||
157130438|NCT00110019|567227556|FG000|Overall Study|Lack of Efficacy|253|||
157130439|NCT00110019|567227557|FG001|Overall Study|Lack of Efficacy|285|||
157130440|NCT00110019|567227556|FG000|Overall Study|Adverse Event|61|||
157130441|NCT00110019|567227557|FG001|Overall Study|Adverse Event|40|||
157130442|NCT00110019|567227556|FG000|Overall Study|Death|13|||
157130443|NCT00110019|567227557|FG001|Overall Study|Death|15|||
157130444|NCT00110019|567227556|FG000|Overall Study|Withdrawal by Subject|21|||
157130445|NCT00110019|567227557|FG001|Overall Study|Withdrawal by Subject|9|||
157130446|NCT00110019|567227556|FG000|Overall Study|alternative therapy|5|||
157130447|NCT00110019|567227557|FG001|Overall Study|alternative therapy|1|||
157130448|NCT00110019|567227556|FG000|Overall Study|complicating disease|1|||
157130449|NCT00110019|567227557|FG001|Overall Study|complicating disease|1|||
157017771|NCT03432858|566817952|FG002|Overall Study|Procedure canceled/rescheduled|6|||
157017772|NCT03432858|566817950|FG000|Overall Study|Required postop mobilization with splinting|0|||
157017773|NCT03432858|566817951|FG001|Overall Study|Required postop mobilization with splinting|0|||
157017774|NCT03432858|566817952|FG002|Overall Study|Required postop mobilization with splinting|1|||
157017775|NCT03580369|566817955|FG000|Overall Study|No treatment due to mis-randomization|1|||
157017776|NCT03580369|566817956|FG001|Overall Study|No treatment due to mis-randomization|0|||
157017777|NCT03580369|566817957|FG002|Overall Study|No treatment due to mis-randomization|0|||
157017778|NCT03580369|566817958|FG003|Overall Study|No treatment due to mis-randomization|0|||
157017779|NCT03580369|566817959|FG004|Overall Study|No treatment due to mis-randomization|3|||
157017780|NCT03580369|566817960|FG005|Overall Study|No treatment due to mis-randomization|0|||
157017781|NCT03580369|566817961|FG006|Overall Study|No treatment due to mis-randomization|0|||
157017782|NCT03580369|566817962|FG007|Overall Study|No treatment due to mis-randomization|0|||
157017783|NCT03580369|566817955|FG000|Overall Study|Reason unknown|0|||
157017784|NCT03580369|566817956|FG001|Overall Study|Reason unknown|0|||
157017785|NCT03580369|566817957|FG002|Overall Study|Reason unknown|1|||
157017786|NCT03580369|566817958|FG003|Overall Study|Reason unknown|0|||
157017787|NCT03580369|566817959|FG004|Overall Study|Reason unknown|0|||
157017788|NCT03580369|566817960|FG005|Overall Study|Reason unknown|0|||
157017789|NCT03580369|566817961|FG006|Overall Study|Reason unknown|0|||
157017790|NCT03580369|566817962|FG007|Overall Study|Reason unknown|0|||
157017791|NCT03580369|566817955|FG000|Overall Study|Technical problems|0|||
157017792|NCT03580369|566817956|FG001|Overall Study|Technical problems|0|||
157017793|NCT03580369|566817957|FG002|Overall Study|Technical problems|0|||
157017794|NCT03580369|566817958|FG003|Overall Study|Technical problems|0|||
157017795|NCT03580369|566817959|FG004|Overall Study|Technical problems|1|||
157017796|NCT03580369|566817960|FG005|Overall Study|Technical problems|0|||
157017797|NCT03580369|566817961|FG006|Overall Study|Technical problems|2|||
157017798|NCT03580369|566817962|FG007|Overall Study|Technical problems|0|||
157017799|NCT03580369|566817955|FG000|Overall Study|Pregnancy|2|||
157017800|NCT03580369|566817956|FG001|Overall Study|Pregnancy|0|||
157017801|NCT03580369|566817957|FG002|Overall Study|Pregnancy|3|||
157017802|NCT03580369|566817958|FG003|Overall Study|Pregnancy|0|||
157017803|NCT03580369|566817959|FG004|Overall Study|Pregnancy|2|||
157017804|NCT03580369|566817960|FG005|Overall Study|Pregnancy|0|||
157017805|NCT03580369|566817961|FG006|Overall Study|Pregnancy|0|||
157130450|NCT00110019|567227556|FG000|Overall Study|symptom deterioration|13|||
157130451|NCT00110019|567227557|FG001|Overall Study|symptom deterioration|16|||
157130452|NCT00110019|567227556|FG000|Overall Study|Not start protocol therapy|17|||
157017806|NCT03580369|566817962|FG007|Overall Study|Pregnancy|0|||
157017807|NCT03580369|566817955|FG000|Overall Study|Lost to Follow-up|2|||
157017808|NCT03580369|566817956|FG001|Overall Study|Lost to Follow-up|0|||
157017809|NCT03580369|566817957|FG002|Overall Study|Lost to Follow-up|2|||
157130453|NCT00110019|567227557|FG001|Overall Study|Not start protocol therapy|16|||
157130454|NCT00110019|567227556|FG000|Overall Study|other reasons|22|||
157130455|NCT00110019|567227557|FG001|Overall Study|other reasons|30|||
157130456|NCT02239263|567227560|FG000|Overall Study|Protocol Violation|6|||
157130457|NCT01046695|567227561|FG000|Overall Study|Subject had a pacemaker|0|||
157130458|NCT01046695|567227562|FG001|Overall Study|Subject had a pacemaker|1|||
157017810|NCT03580369|566817958|FG003|Overall Study|Lost to Follow-up|0|||
157130459|NCT01046695|567227561|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
157130460|NCT01046695|567227562|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
157130461|NCT03072160|567227563|FG000|Overall Study|Adverse Event|3|||
157130462|NCT03072160|567227564|FG001|Overall Study|Adverse Event|1|||
157017811|NCT03580369|566817959|FG004|Overall Study|Lost to Follow-up|3|||
157017812|NCT03580369|566817960|FG005|Overall Study|Lost to Follow-up|0|||
156874816|NCT03892967|566298745|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
156874817|NCT03892967|566298746|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
156874818|NCT03892967|566298747|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
156874819|NCT03892967|566298748|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
156874820|NCT03892967|566298749|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
156874821|NCT03892967|566298745|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
156874822|NCT03892967|566298746|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
156874823|NCT03892967|566298747|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
156874824|NCT03892967|566298748|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
156874825|NCT03892967|566298749|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
156874826|NCT03892967|566298745|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
156874827|NCT03892967|566298746|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
157130463|NCT03072160|567227563|FG000|Overall Study|Refused further treatment|6|||
157130464|NCT03072160|567227564|FG001|Overall Study|Refused further treatment|1|||
157130465|NCT03072160|567227563|FG000|Overall Study|Physician Decision|1|||
157130466|NCT03072160|567227564|FG001|Overall Study|Physician Decision|0|||
157130467|NCT03072160|567227563|FG000|Overall Study|Disease progression on study|1|||
157130468|NCT03072160|567227564|FG001|Overall Study|Disease progression on study|1|||
157130469|NCT03072160|567227563|FG000|Overall Study|No contact|0|||
157130470|NCT03072160|567227564|FG001|Overall Study|No contact|1|||
157130471|NCT04303000|567227565|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
157130472|NCT04303000|567227566|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
157130473|NCT04303000|567227567|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
157130474|NCT00553462|567227570|FG000|Overall Study|Adverse Event|4|||
157130475|NCT00553462|567227570|FG000|Overall Study|Progression|4|||
157130476|NCT00553462|567227570|FG000|Overall Study|Withdrawal by Subject|5|||
157130477|NCT00553462|567227570|FG000|Overall Study|Physician Decision|1|||
157130478|NCT01262625|567227571|FG000|Overall Study|Administrative Error|1|||
157130479|NCT01262625|567227572|FG001|Overall Study|Administrative Error|1|||
157130480|NCT01262625|567227571|FG000|Overall Study|Site Closed|1|||
157130481|NCT01262625|567227572|FG001|Overall Study|Site Closed|0|||
157130482|NCT01728779|567227574|FG000|Overall Study|Withdrawal by Subject|1|||
157130483|NCT00448708|567227575|FG000|Overall Study|Death|21|||
157130484|NCT00448708|567227576|FG001|Overall Study|Death|17|||
157130485|NCT00448708|567227575|FG000|Overall Study|Withdrawal by Subject|8|||
157130486|NCT00448708|567227576|FG001|Overall Study|Withdrawal by Subject|4|||
157130487|NCT00448708|567227575|FG000|Overall Study|Lost to Follow-up|6|||
157130488|NCT00448708|567227576|FG001|Overall Study|Lost to Follow-up|8|||
157130489|NCT00448708|567227575|FG000|Overall Study|not listed|0|||
157130490|NCT00448708|567227576|FG001|Overall Study|not listed|2|||
157130491|NCT01925209|567227577|FG000|Treatment Epoch|Physician Decision|1|||
157130492|NCT01925209|567227578|FG001|Treatment Epoch|Physician Decision|0|||
157130493|NCT01925209|567227579|FG002|Treatment Epoch|Physician Decision|0|||
157130494|NCT01925209|567227580|FG003|Treatment Epoch|Physician Decision|0|||
157130495|NCT01925209|567227577|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
157130496|NCT01925209|567227578|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
157130497|NCT01925209|567227579|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
156874828|NCT03892967|566298747|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
156874829|NCT03892967|566298748|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
156874830|NCT03892967|566298749|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
156874831|NCT03892967|566298745|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
156874832|NCT03892967|566298746|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
156874833|NCT03892967|566298747|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
157130498|NCT01925209|567227580|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
157130499|NCT01925209|567227577|FG000|Treatment Epoch|Death|1|||
157130500|NCT01925209|567227578|FG001|Treatment Epoch|Death|0|||
157130501|NCT01925209|567227579|FG002|Treatment Epoch|Death|0|||
157130502|NCT01925209|567227580|FG003|Treatment Epoch|Death|0|||
157130503|NCT01925209|567227577|FG000|Treatment Epoch|Protocol deviation|0|||
157130504|NCT01925209|567227578|FG001|Treatment Epoch|Protocol deviation|0|||
157130505|NCT01925209|567227579|FG002|Treatment Epoch|Protocol deviation|1|||
157130506|NCT01925209|567227580|FG003|Treatment Epoch|Protocol deviation|1|||
157130507|NCT01925209|567227577|FG000|Treatment Epoch|Withdrawal by Subject|4|||
157017813|NCT03580369|566817961|FG006|Overall Study|Lost to Follow-up|1|||
157017814|NCT03580369|566817962|FG007|Overall Study|Lost to Follow-up|0|||
157017815|NCT03580369|566817955|FG000|Overall Study|Physician Decision|4|||
157017816|NCT03580369|566817956|FG001|Overall Study|Physician Decision|0|||
157017817|NCT03580369|566817957|FG002|Overall Study|Physician Decision|4|||
157017818|NCT03580369|566817958|FG003|Overall Study|Physician Decision|1|||
157017819|NCT03580369|566817959|FG004|Overall Study|Physician Decision|1|||
157017820|NCT03580369|566817960|FG005|Overall Study|Physician Decision|0|||
157017821|NCT03580369|566817961|FG006|Overall Study|Physician Decision|0|||
157017822|NCT03580369|566817962|FG007|Overall Study|Physician Decision|0|||
157017823|NCT03580369|566817955|FG000|Overall Study|Lack of Efficacy|3|||
157017824|NCT03580369|566817956|FG001|Overall Study|Lack of Efficacy|0|||
157017825|NCT03580369|566817957|FG002|Overall Study|Lack of Efficacy|7|||
157017826|NCT03580369|566817958|FG003|Overall Study|Lack of Efficacy|0|||
157017827|NCT03580369|566817959|FG004|Overall Study|Lack of Efficacy|2|||
157017828|NCT03580369|566817960|FG005|Overall Study|Lack of Efficacy|0|||
157017829|NCT03580369|566817961|FG006|Overall Study|Lack of Efficacy|3|||
157017830|NCT03580369|566817962|FG007|Overall Study|Lack of Efficacy|0|||
157017831|NCT03580369|566817955|FG000|Overall Study|Protocol Violation|6|||
157017832|NCT03580369|566817956|FG001|Overall Study|Protocol Violation|0|||
157017833|NCT03580369|566817957|FG002|Overall Study|Protocol Violation|6|||
157017834|NCT03580369|566817958|FG003|Overall Study|Protocol Violation|1|||
157017835|NCT03580369|566817959|FG004|Overall Study|Protocol Violation|8|||
157017836|NCT03580369|566817960|FG005|Overall Study|Protocol Violation|2|||
157017837|NCT03580369|566817961|FG006|Overall Study|Protocol Violation|1|||
157017838|NCT03580369|566817962|FG007|Overall Study|Protocol Violation|0|||
157017839|NCT03580369|566817955|FG000|Overall Study|Adverse Event|7|||
157017840|NCT03580369|566817956|FG001|Overall Study|Adverse Event|0|||
157017841|NCT03580369|566817957|FG002|Overall Study|Adverse Event|14|||
157017842|NCT03580369|566817958|FG003|Overall Study|Adverse Event|1|||
157017843|NCT03580369|566817959|FG004|Overall Study|Adverse Event|6|||
157017844|NCT03580369|566817960|FG005|Overall Study|Adverse Event|0|||
157017845|NCT03580369|566817961|FG006|Overall Study|Adverse Event|1|||
157017846|NCT03580369|566817962|FG007|Overall Study|Adverse Event|0|||
157017847|NCT03580369|566817955|FG000|Overall Study|Withdrawal by Subject|19|||
157017848|NCT03580369|566817956|FG001|Overall Study|Withdrawal by Subject|0|||
157017849|NCT03580369|566817957|FG002|Overall Study|Withdrawal by Subject|17|||
157017850|NCT03580369|566817958|FG003|Overall Study|Withdrawal by Subject|0|||
157017851|NCT03580369|566817959|FG004|Overall Study|Withdrawal by Subject|16|||
157017852|NCT03580369|566817960|FG005|Overall Study|Withdrawal by Subject|1|||
157017853|NCT03580369|566817961|FG006|Overall Study|Withdrawal by Subject|7|||
157017854|NCT03580369|566817962|FG007|Overall Study|Withdrawal by Subject|0|||
157017855|NCT03912831|566817963|FG000|Overall Study|Death|1|||
157017856|NCT03912831|566817964|FG001|Overall Study|Death|1|||
157017857|NCT03912831|566817965|FG002|Overall Study|Death|1|||
157017858|NCT03912831|566817966|FG003|Overall Study|Death|1|||
157017859|NCT03912831|566817967|FG004|Overall Study|Death|1|||
157017860|NCT03912831|566817968|FG005|Overall Study|Death|1|||
157017861|NCT03912831|566817963|FG000|Overall Study|Reason not Specified|0|||
157017862|NCT03912831|566817964|FG001|Overall Study|Reason not Specified|0|||
157017863|NCT03912831|566817965|FG002|Overall Study|Reason not Specified|0|||
157017864|NCT03912831|566817966|FG003|Overall Study|Reason not Specified|0|||
157017865|NCT03912831|566817967|FG004|Overall Study|Reason not Specified|1|||
157017866|NCT03912831|566817968|FG005|Overall Study|Reason not Specified|0|||
157017867|NCT03912831|566817963|FG000|Overall Study|Withdrawal by Participant|0|||
157017868|NCT03912831|566817964|FG001|Overall Study|Withdrawal by Participant|0|||
157017869|NCT03912831|566817965|FG002|Overall Study|Withdrawal by Participant|0|||
157017870|NCT03912831|566817966|FG003|Overall Study|Withdrawal by Participant|0|||
157017871|NCT03912831|566817967|FG004|Overall Study|Withdrawal by Participant|1|||
157017872|NCT03912831|566817968|FG005|Overall Study|Withdrawal by Participant|0|||
157017873|NCT03527160|566817969|FG000|Overall Study|No urine collected|13|||
157017874|NCT03527160|566817969|FG000|Overall Study|No clinical serum creatinine collected|6|||
157017875|NCT03527160|566817969|FG000|Overall Study|Did not meet inclusion|2|||
157017876|NCT01721291|566817971|FG000|Overall Study|Withdrawal by Subject|1|||
157017877|NCT01721291|566817972|FG001|Overall Study|Withdrawal by Subject|0|||
157017878|NCT01721291|566817971|FG000|Overall Study|did not like the treatment|1|||
157017879|NCT01721291|566817972|FG001|Overall Study|did not like the treatment|0|||
157017880|NCT05239039|566817974|FG000|Overall Study|Withdrawal by Subject|0|||
157017881|NCT05239039|566817975|FG001|Overall Study|Withdrawal by Subject|1|||
157017882|NCT03690206|566817976|FG000|Overall Study|Withdrawal by Subject|2|||
157017883|NCT03690206|566817977|FG001|Overall Study|Withdrawal by Subject|0|||
157017884|NCT03690206|566817978|FG002|Overall Study|Withdrawal by Subject|0|||
157017885|NCT03690206|566817976|FG000|Overall Study|ICF withdrawal|2|||
157017886|NCT03690206|566817977|FG001|Overall Study|ICF withdrawal|0|||
157017887|NCT03690206|566817978|FG002|Overall Study|ICF withdrawal|0|||
157017888|NCT03897686|566819400|FG000|Overall Study|Protocol Violation|1|||
157017889|NCT03897686|566819401|FG001|Overall Study|Protocol Violation|1|||
157017890|NCT03897686|566819400|FG000|Overall Study|Withdrawal by Subject|1|||
157017891|NCT03897686|566819401|FG001|Overall Study|Withdrawal by Subject|1|||
157017892|NCT03484702|566819402|FG000|Treatment Period|Death|3|||
157130508|NCT01925209|567227578|FG001|Treatment Epoch|Withdrawal by Subject|3|||
157017893|NCT03484702|566819403|FG001|Treatment Period|Death|1|||
157130509|NCT01925209|567227579|FG002|Treatment Epoch|Withdrawal by Subject|3|||
157130510|NCT01925209|567227580|FG003|Treatment Epoch|Withdrawal by Subject|2|||
157130511|NCT01925209|567227577|FG000|Treatment Epoch|Adverse Event|3|||
157130512|NCT01925209|567227578|FG001|Treatment Epoch|Adverse Event|5|||
157130513|NCT01925209|567227579|FG002|Treatment Epoch|Adverse Event|3|||
157130514|NCT01925209|567227580|FG003|Treatment Epoch|Adverse Event|1|||
157130515|NCT01925209|567227577|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
157130516|NCT01925209|567227578|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
157130517|NCT01925209|567227579|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
157130518|NCT01925209|567227580|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
157130519|NCT01925209|567227577|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
157130520|NCT01925209|567227578|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
157130521|NCT01925209|567227579|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
157130522|NCT01925209|567227580|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
157130523|NCT01925209|567227577|FG000|Follow-up|Adverse Event|1|||
157130524|NCT01925209|567227578|FG001|Follow-up|Adverse Event|4|||
157130525|NCT01925209|567227579|FG002|Follow-up|Adverse Event|0|||
157130526|NCT01925209|567227580|FG003|Follow-up|Adverse Event|1|||
157130527|NCT01925209|567227577|FG000|Follow-up|Physician Decision|0|||
157130528|NCT01925209|567227578|FG001|Follow-up|Physician Decision|0|||
157130529|NCT01925209|567227579|FG002|Follow-up|Physician Decision|1|||
157130530|NCT01925209|567227580|FG003|Follow-up|Physician Decision|0|||
157130531|NCT01925209|567227577|FG000|Follow-up|Non-compliance with study treatment|0|||
157130532|NCT01925209|567227578|FG001|Follow-up|Non-compliance with study treatment|0|||
157130533|NCT01925209|567227579|FG002|Follow-up|Non-compliance with study treatment|0|||
157130534|NCT01925209|567227580|FG003|Follow-up|Non-compliance with study treatment|1|||
157130535|NCT01925209|567227577|FG000|Follow-up|Withdrawal by Subject|0|||
157130536|NCT01925209|567227578|FG001|Follow-up|Withdrawal by Subject|2|||
157130537|NCT01925209|567227579|FG002|Follow-up|Withdrawal by Subject|0|||
157130538|NCT01925209|567227580|FG003|Follow-up|Withdrawal by Subject|2|||
157130539|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
157130540|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
157130541|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|Death|1|||
157130542|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|Death|0|||
157130543|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
157130544|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
157130545|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
157130546|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
157130547|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
157130548|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
157130549|NCT00110994|567227581|FG000|Double-blind (DB) Treatment|other reasons|2|||
157130550|NCT00110994|567227582|FG001|Double-blind (DB) Treatment|other reasons|3|||
157130551|NCT00110994|567227581|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
157130552|NCT00110994|567227582|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
157130553|NCT00110994|567227581|FG000|Active Follow-up|Other reasons|0|||
157130554|NCT00110994|567227582|FG001|Active Follow-up|Other reasons|2|||
157130555|NCT00110994|567227581|FG000|Long Term Follow-up|Death|19|||
157130556|NCT00110994|567227582|FG001|Long Term Follow-up|Death|17|||
157130557|NCT04398732|567227583|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
157130558|NCT01299727|567227584|FG000|Overall Study|Withdrawal by Subject|1|||
156716273|NCT02676882|565705319|FG001|Overall Study|Adverse Event|0|||
157017894|NCT03484702|566819404|FG002|Treatment Period|Death|0|||
157017895|NCT03484702|566819405|FG003|Treatment Period|Death|0|||
157017896|NCT03484702|566819406|FG004|Treatment Period|Death|0|||
157017897|NCT03484702|566819407|FG005|Treatment Period|Death|0|||
157017898|NCT03484702|566819402|FG000|Treatment Period|Adverse Event|1|||
157017899|NCT03484702|566819403|FG001|Treatment Period|Adverse Event|0|||
157130559|NCT01299727|567227585|FG001|Overall Study|Withdrawal by Subject|0|||
157130560|NCT01299727|567227586|FG002|Overall Study|Withdrawal by Subject|0|||
157130561|NCT01299727|567227584|FG000|Overall Study|Adverse Event|0|||
157130562|NCT01299727|567227585|FG001|Overall Study|Adverse Event|0|||
157130563|NCT01299727|567227586|FG002|Overall Study|Adverse Event|1|||
157130564|NCT01299727|567227584|FG000|Overall Study|Completed the Treatment Period|3|||
157130565|NCT01299727|567227585|FG001|Overall Study|Completed the Treatment Period|4|||
157130566|NCT01299727|567227586|FG002|Overall Study|Completed the Treatment Period|3|||
157130567|NCT03882424|567227587|FG000|Overall Study|Lost to Follow-up|3|||
157130568|NCT03882424|567227588|FG001|Overall Study|Lost to Follow-up|0|||
157130569|NCT03882424|567227589|FG002|Overall Study|Lost to Follow-up|0|||
157130570|NCT03882424|567227587|FG000|Overall Study|schedule conflict|1|||
156716274|NCT02676882|565705318|FG000|Overall Study|Lost to Follow-up|1|||
157017900|NCT03484702|566819404|FG002|Treatment Period|Adverse Event|0|||
157017901|NCT03484702|566819405|FG003|Treatment Period|Adverse Event|0|||
157017902|NCT03484702|566819406|FG004|Treatment Period|Adverse Event|0|||
157017903|NCT03484702|566819407|FG005|Treatment Period|Adverse Event|0|||
157017904|NCT03484702|566819402|FG000|Treatment Period|Participant Withdrew from Study|0|||
157017905|NCT03484702|566819403|FG001|Treatment Period|Participant Withdrew from Study|1|||
157017906|NCT03484702|566819404|FG002|Treatment Period|Participant Withdrew from Study|0|||
157017907|NCT03484702|566819405|FG003|Treatment Period|Participant Withdrew from Study|0|||
157017908|NCT03484702|566819406|FG004|Treatment Period|Participant Withdrew from Study|0|||
157017909|NCT03484702|566819407|FG005|Treatment Period|Participant Withdrew from Study|0|||
157017910|NCT03484702|566819402|FG000|Treatment Period|Physician Decision|0|||
157017911|NCT03484702|566819403|FG001|Treatment Period|Physician Decision|1|||
157130571|NCT03882424|567227588|FG001|Overall Study|schedule conflict|0|||
157130572|NCT03882424|567227589|FG002|Overall Study|schedule conflict|0|||
157130573|NCT00531960|567227594|FG000|Overall Study|Adverse Event|5|||
157130574|NCT00531960|567227595|FG001|Overall Study|Adverse Event|4|||
157130575|NCT00531960|567227594|FG000|Overall Study|Death|3|||
157130576|NCT00531960|567227595|FG001|Overall Study|Death|2|||
157130577|NCT00531960|567227594|FG000|Overall Study|Lack of Efficacy|42|||
157130578|NCT00531960|567227595|FG001|Overall Study|Lack of Efficacy|41|||
157130579|NCT00531960|567227594|FG000|Overall Study|Violation of Selection Criteria|2|||
157130580|NCT00531960|567227595|FG001|Overall Study|Violation of Selection Criteria|0|||
157130581|NCT00531960|567227594|FG000|Overall Study|Refused Treatment|5|||
157130582|NCT00531960|567227595|FG001|Overall Study|Refused Treatment|6|||
157130583|NCT00531960|567227594|FG000|Overall Study|Other|4|||
157130584|NCT00531960|567227595|FG001|Overall Study|Other|10|||
157130585|NCT03336502|567227599|FG000|Overall Study|Physician Decision|0|||
157130586|NCT03336502|567227600|FG001|Overall Study|Physician Decision|1|||
157130587|NCT03336502|567227599|FG000|Overall Study|Prohibited Drugs|1|||
157130588|NCT03336502|567227600|FG001|Overall Study|Prohibited Drugs|1|||
157130589|NCT03336502|567227599|FG000|Overall Study|Death|1|||
157130590|NCT03336502|567227600|FG001|Overall Study|Death|2|||
157130591|NCT03336502|567227599|FG000|Overall Study|Adverse Event|2|||
157130592|NCT03336502|567227600|FG001|Overall Study|Adverse Event|5|||
157130593|NCT02921425|567227601|FG000|Overall Study|Protocol Violation|9|||
157130594|NCT01227967|567227602|FG000|Overall Study|Protocol Violation|3|||
157130595|NCT01227967|567227603|FG001|Overall Study|Protocol Violation|1|||
157130596|NCT01227967|567227602|FG000|Overall Study|Death|0|||
157130597|NCT01227967|567227603|FG001|Overall Study|Death|1|||
157130598|NCT01227967|567227602|FG000|Overall Study|Lost to Follow-up|8|||
157130599|NCT01227967|567227603|FG001|Overall Study|Lost to Follow-up|3|||
157130600|NCT01227967|567227602|FG000|Overall Study|Withdrawal by Subject|4|||
157130601|NCT01227967|567227603|FG001|Overall Study|Withdrawal by Subject|3|||
157130602|NCT01227967|567227602|FG000|Overall Study|Physician Decision|0|||
157130603|NCT01227967|567227603|FG001|Overall Study|Physician Decision|1|||
157130604|NCT01227967|567227602|FG000|Overall Study|Never Started Treatment|0|||
157130605|NCT01227967|567227603|FG001|Overall Study|Never Started Treatment|4|||
157130606|NCT01227967|567227602|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
157130607|NCT01227967|567227603|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
157130608|NCT01107444|567227607|FG000|Overall Study|Withdrawal by Subject|8|||
157130609|NCT01107444|567227608|FG001|Overall Study|Withdrawal by Subject|12|||
157130610|NCT01107444|567227607|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
157130611|NCT01107444|567227608|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
157130612|NCT03310970|567227612|FG000|Overall Study|Withdrawal by Subject|0|||
157130613|NCT03310970|567227613|FG001|Overall Study|Withdrawal by Subject|1|||
157130614|NCT01446419|567227614|FG000|Overall Study|Death|1|||
157130615|NCT01446419|567227615|FG001|Overall Study|Death|0|||
157130616|NCT01446419|567227614|FG000|Overall Study|Withdrawal by Subject|1|||
157130617|NCT01446419|567227615|FG001|Overall Study|Withdrawal by Subject|1|||
157130618|NCT01446419|567227614|FG000|Overall Study|Terminated per protocol|3|||
157130619|NCT01446419|567227615|FG001|Overall Study|Terminated per protocol|0|||
157130620|NCT02445586|567227620|FG000|Overall Study|Death|14|||
157130621|NCT02445586|567227620|FG000|Overall Study|Withdrawal by Subject|13|||
157017912|NCT03484702|566819404|FG002|Treatment Period|Physician Decision|0|||
157130622|NCT02445586|567227620|FG000|Overall Study|Disease Progression|10|||
157130623|NCT02445586|567227620|FG000|Overall Study|Protocol Violation|1|||
157130624|NCT02445586|567227620|FG000|Overall Study|Medical Condition|1|||
157130625|NCT02149810|567227621|FG000|Overall Study|Physician Decision|1|||
157130626|NCT02149810|567227622|FG001|Overall Study|Physician Decision|2|||
157130627|NCT02149810|567227621|FG000|Overall Study|Lost to Follow-up|2|||
157130628|NCT02149810|567227622|FG001|Overall Study|Lost to Follow-up|1|||
157130629|NCT02149810|567227621|FG000|Overall Study|Withdrawal by Subject|5|||
157130630|NCT02149810|567227622|FG001|Overall Study|Withdrawal by Subject|1|||
157130631|NCT00428597|567227623|FG000|Overall Study|Randomized but not treated|3|||
157130632|NCT00428597|567227624|FG001|Overall Study|Randomized but not treated|3|||
157130633|NCT00428597|567227623|FG000|Overall Study|Objective Progression or Relapse|19|||
157130634|NCT00428597|567227624|FG001|Overall Study|Objective Progression or Relapse|47|||
157130635|NCT00428597|567227623|FG000|Overall Study|Study Terminated by Sponsor|41|||
157130636|NCT00428597|567227624|FG001|Overall Study|Study Terminated by Sponsor|16|||
157130637|NCT00428597|567227623|FG000|Overall Study|Adverse Event|15|||
157130638|NCT00428597|567227624|FG001|Overall Study|Adverse Event|7|||
157130639|NCT00428597|567227623|FG000|Overall Study|Global Deterioration of Health Status|1|||
157130640|NCT00428597|567227624|FG001|Overall Study|Global Deterioration of Health Status|5|||
157017913|NCT03484702|566819405|FG003|Treatment Period|Physician Decision|0|||
157130641|NCT00428597|567227623|FG000|Overall Study|Protocol Violation|2|||
157130642|NCT00428597|567227624|FG001|Overall Study|Protocol Violation|1|||
157130643|NCT00428597|567227623|FG000|Overall Study|Withdrawal by Subject|2|||
157130644|NCT00428597|567227624|FG001|Overall Study|Withdrawal by Subject|1|||
157130645|NCT00428597|567227623|FG000|Overall Study|Other|1|||
157130646|NCT00428597|567227624|FG001|Overall Study|Other|1|||
157130647|NCT00428597|567227623|FG000|Overall Study|Lost to Follow-up|0|||
157130648|NCT00428597|567227624|FG001|Overall Study|Lost to Follow-up|1|||
157130649|NCT00428597|567227623|FG000|Overall Study|Pregnancy|1|||
157130650|NCT00428597|567227624|FG001|Overall Study|Pregnancy|0|||
157130651|NCT00428597|567227623|FG000|Overall Study|Death|1|||
157130652|NCT00428597|567227624|FG001|Overall Study|Death|3|||
157130653|NCT05032950|567227626|FG000|Overall Study|Adverse Event|0|||
157130654|NCT05032950|567227627|FG001|Overall Study|Adverse Event|0|||
157130655|NCT05032950|567227628|FG002|Overall Study|Adverse Event|1|||
157017914|NCT03484702|566819406|FG004|Treatment Period|Physician Decision|0|||
157017915|NCT03484702|566819407|FG005|Treatment Period|Physician Decision|1|||
157017916|NCT01894061|566819411|FG000|Overall Study|Screen failure|1|||
157017917|NCT01894061|566819411|FG000|Overall Study|Withdrawal by Subject|1|||
157017918|NCT00739648|566819412|FG000|Overall Study|Adverse Event|3|||
157017919|NCT00739648|566819413|FG001|Overall Study|Adverse Event|15|||
157017920|NCT00739648|566819412|FG000|Overall Study|Withdrawal by Subject|13|||
157017921|NCT00739648|566819413|FG001|Overall Study|Withdrawal by Subject|25|||
157017922|NCT00739648|566819412|FG000|Overall Study|Lost to Follow-up|4|||
157017923|NCT00739648|566819413|FG001|Overall Study|Lost to Follow-up|7|||
157017924|NCT00739648|566819412|FG000|Overall Study|Death|2|||
157017925|NCT00739648|566819413|FG001|Overall Study|Death|0|||
157017926|NCT00739648|566819412|FG000|Overall Study|Do not know|4|||
157017927|NCT00739648|566819413|FG001|Overall Study|Do not know|6|||
157017928|NCT05110495|566819414|FG000|Overall Study|Lost to Follow-up|1|||
157017929|NCT05110495|566819414|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
157017930|NCT04173663|566819415|FG000|Overall Study|Withdrawal by Subject|1|||
157017931|NCT04173663|566819416|FG001|Overall Study|Withdrawal by Subject|6|||
157017932|NCT04173663|566819415|FG000|Overall Study|Lost to Follow-up|17|||
157017933|NCT04173663|566819416|FG001|Overall Study|Lost to Follow-up|24|||
157017934|NCT05418296|566819421|FG000|Overall Study|Withdrawal by Subject|4|||
157017935|NCT05418296|566819422|FG001|Overall Study|Withdrawal by Subject|1|||
157017936|NCT04419168|566819425|FG000|Overall Study|Protocol Violation|1|||
157017937|NCT04419168|566819426|FG001|Overall Study|Protocol Violation|1|||
157017938|NCT04419168|566819425|FG000|Overall Study|Lost to Follow-up|7|||
157017939|NCT04419168|566819426|FG001|Overall Study|Lost to Follow-up|7|||
157017940|NCT04419168|566819425|FG000|Overall Study|Missed 6-month Visit|48|||
157017941|NCT04419168|566819426|FG001|Overall Study|Missed 6-month Visit|45|||
157017942|NCT02249949|566819434|FG000|Overall Study|Cancelled prior to treatment|2|||
157017943|NCT02097420|566819437|FG000|Overall Study|Death|6|||
157017944|NCT02097420|566819437|FG000|Overall Study|Valve explanted|13|||
157017945|NCT02097420|566819437|FG000|Overall Study|Other Reason|1|||
157017946|NCT05059262|566819438|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
157017947|NCT05059262|566819439|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
157017948|NCT05059262|566819438|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
157017949|NCT05059262|566819439|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
157017950|NCT05059262|566819438|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
157017951|NCT05059262|566819439|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
157017952|NCT05059262|566819438|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
157017953|NCT05059262|566819439|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
157017954|NCT05059262|566819438|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
157017955|NCT05059262|566819439|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
157130656|NCT05032950|567227629|FG003|Overall Study|Adverse Event|1|||
157130657|NCT05032950|567227630|FG004|Overall Study|Adverse Event|0|||
157130658|NCT05032950|567227631|FG005|Overall Study|Adverse Event|0|||
157130659|NCT02474329|567227635|FG000|Overall Study|Withdraw or did not contribute data.|13|||
157130660|NCT01356589|567227636|FG000|Overall Study|Enrolled, but not treated|3|||
157130661|NCT01356589|567227636|FG000|Overall Study|Dose data not recorded|2|||
157130662|NCT02447848|567227637|FG000|Overall Study|Patient discharged|3|||
157017956|NCT05059262|566819438|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
157017957|NCT05059262|566819439|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
157017958|NCT05059262|566819438|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
157017959|NCT05059262|566819439|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
157017960|NCT05059262|566819438|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
157130663|NCT02447848|567227637|FG000|Overall Study|Lack of Efficacy|4|||
157130664|NCT02447848|567227637|FG000|Overall Study|Withdrawal by Subject|4|||
157130665|NCT02307370|567227638|FG000|Overall Study|Death|5|||
157130666|NCT02307370|567227638|FG000|Overall Study|Lost to Follow-up|1|||
157130667|NCT02307370|567227638|FG000|Overall Study|Withdrawal by Subject|1|||
157130668|NCT02307370|567227638|FG000|Overall Study|Declined Addendum ICF|6|||
157130669|NCT02307370|567227638|FG000|Overall Study|No response during telephone contact|5|||
157130670|NCT02307370|567227638|FG000|Overall Study|Protocol Violation|1|||
157130671|NCT01506882|567227639|FG000|Overall Study|Lack of Efficacy|4|||
157130672|NCT01506882|567227640|FG001|Overall Study|Lack of Efficacy|3|||
157130673|NCT01506882|567227639|FG000|Overall Study|Lost to Follow-up|1|||
157130674|NCT01506882|567227640|FG001|Overall Study|Lost to Follow-up|0|||
157130675|NCT01506882|567227639|FG000|Overall Study|Withdrawal by Subject|9|||
157130676|NCT01506882|567227640|FG001|Overall Study|Withdrawal by Subject|3|||
157130677|NCT01506882|567227639|FG000|Overall Study|SAE, non-fatal|2|||
157130678|NCT01506882|567227640|FG001|Overall Study|SAE, non-fatal|0|||
157130679|NCT01506882|567227639|FG000|Overall Study|AE, non-serious non-fatal|3|||
157130680|NCT01506882|567227640|FG001|Overall Study|AE, non-serious non-fatal|1|||
157130681|NCT01506882|567227639|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
157130682|NCT01506882|567227640|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
157130683|NCT01506882|567227639|FG000|Overall Study|Other Reason|2|||
157130684|NCT01506882|567227640|FG001|Overall Study|Other Reason|0|||
157130685|NCT00376961|567229358|FG000|Initial Registration|Adverse Event|1|||
157130686|NCT00376961|567229359|FG001|Initial Registration|Adverse Event|0|||
157130687|NCT00376961|567229358|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
157130688|NCT00376961|567229359|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157130689|NCT00376961|567229358|FG000|Initial Registration|Progression/relapse|1|||
157130690|NCT00376961|567229359|FG001|Initial Registration|Progression/relapse|0|||
157130691|NCT00376961|567229358|FG000|Initial Registration|Ineligible|3|||
157130692|NCT00376961|567229359|FG001|Initial Registration|Ineligible|0|||
157130693|NCT00376961|567229358|FG000|Maintenance|Adverse Event|0|||
157130694|NCT00376961|567229359|FG001|Maintenance|Adverse Event|1|||
157130695|NCT00376961|567229358|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
157130696|NCT00376961|567229359|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
157130697|NCT00376961|567229358|FG000|Maintenance|Progression/relapse|0|||
157130698|NCT00376961|567229359|FG001|Maintenance|Progression/relapse|18|||
157130699|NCT00376961|567229358|FG000|Maintenance|Ineligible|0|||
157130700|NCT00376961|567229359|FG001|Maintenance|Ineligible|3|||
157130701|NCT04188197|567229366|FG000|Overall Study|Lost to Follow-up|4|||
157130702|NCT04188197|567229367|FG001|Overall Study|Lost to Follow-up|1|||
157130703|NCT04188197|567229366|FG000|Overall Study|Withdrawal by Subject|1|||
157130704|NCT04188197|567229367|FG001|Overall Study|Withdrawal by Subject|1|||
157130705|NCT04188197|567229366|FG000|Overall Study|Pregnancy|0|||
157130706|NCT04188197|567229367|FG001|Overall Study|Pregnancy|1|||
157130707|NCT02613208|567229368|FG000|Overall Study|Withdrawal by Subject|1|||
157130708|NCT02613208|567229368|FG000|Overall Study|Change of address|2|||
157130709|NCT02613208|567229368|FG000|Overall Study|Physician Decision|2|||
157130710|NCT02613208|567229368|FG000|Overall Study|Lost to Follow-up|5|||
157130711|NCT02613208|567229368|FG000|Overall Study|Death|37|||
157130712|NCT00008385|567229369|FG000|Overall Study|Off treatment reasons not reported|79|||
157130713|NCT00008385|567229370|FG001|Overall Study|Off treatment reasons not reported|70|||
157130714|NCT00008385|567229369|FG000|Overall Study|Progressive disease|52|||
157130715|NCT00008385|567229370|FG001|Overall Study|Progressive disease|117|||
157130716|NCT00008385|567229369|FG000|Overall Study|Adverse Event|8|||
157130717|NCT00008385|567229370|FG001|Overall Study|Adverse Event|20|||
157130718|NCT00008385|567229369|FG000|Overall Study|Death|12|||
157130719|NCT00008385|567229370|FG001|Overall Study|Death|18|||
157130720|NCT00008385|567229369|FG000|Overall Study|Withdrawal by Subject|67|||
157130721|NCT00008385|567229370|FG001|Overall Study|Withdrawal by Subject|157|||
157130722|NCT00008385|567229369|FG000|Overall Study|Start non-protocol therapy|3|||
157130723|NCT00008385|567229370|FG001|Overall Study|Start non-protocol therapy|1|||
157130724|NCT00008385|567229369|FG000|Overall Study|Other complicating disease|17|||
157130725|NCT00008385|567229370|FG001|Overall Study|Other complicating disease|30|||
157130726|NCT00008385|567229369|FG000|Overall Study|Maximum dose reached|0|||
157130727|NCT00008385|567229370|FG001|Overall Study|Maximum dose reached|2|||
157130728|NCT00008385|567229369|FG000|Overall Study|Other|105|||
157130729|NCT00008385|567229370|FG001|Overall Study|Other|212|||
157130730|NCT00008385|567229369|FG000|Overall Study|Not start protocol therapy|44|||
157130731|NCT00008385|567229370|FG001|Overall Study|Not start protocol therapy|175|||
157130732|NCT01719757|567229373|FG000|Overall Study|Adverse Event|38|||
157130733|NCT01719757|567229373|FG000|Overall Study|Withdrawal by Subject|15|||
157130734|NCT01719757|567229373|FG000|Overall Study|Lost to Follow-up|20|||
157130735|NCT01719757|567229373|FG000|Overall Study|Protocol Violation|1|||
157130736|NCT01719757|567229373|FG000|Overall Study|well controlled pain|27|||
157130737|NCT06441877|567229374|FG000|Overall Study|Withdrawal by Subject|0|||
157130738|NCT06441877|567229375|FG001|Overall Study|Withdrawal by Subject|2|||
157130739|NCT06441877|567229376|FG002|Overall Study|Withdrawal by Subject|0|||
157130740|NCT06441877|567229377|FG003|Overall Study|Withdrawal by Subject|0|||
157130741|NCT05742984|567229378|FG000|Overall Study|Adverse Event|0|||
157130742|NCT05742984|567229379|FG001|Overall Study|Adverse Event|0|||
157130743|NCT05742984|567229380|FG002|Overall Study|Adverse Event|1|||
157130744|NCT05742984|567229381|FG003|Overall Study|Adverse Event|0|||
157130745|NCT05742984|567229382|FG004|Overall Study|Adverse Event|1|||
157130746|NCT05742984|567229383|FG005|Overall Study|Adverse Event|1|||
157130747|NCT05742984|567229378|FG000|Overall Study|Withdrawal by Subject|0|||
157130748|NCT05742984|567229379|FG001|Overall Study|Withdrawal by Subject|1|||
157130749|NCT05742984|567229380|FG002|Overall Study|Withdrawal by Subject|0|||
157130750|NCT05742984|567229381|FG003|Overall Study|Withdrawal by Subject|0|||
157130751|NCT05742984|567229382|FG004|Overall Study|Withdrawal by Subject|0|||
157130752|NCT05742984|567229383|FG005|Overall Study|Withdrawal by Subject|2|||
157130753|NCT02162862|567229384|FG000|Overall Study|Lost to Follow-up|0|||
157130754|NCT02162862|567229385|FG001|Overall Study|Lost to Follow-up|11|||
157130755|NCT02162862|567229386|FG002|Overall Study|Lost to Follow-up|0|||
157130756|NCT02162862|567229384|FG000|Overall Study|Subject did not feel the med was needed|0|||
157130757|NCT02162862|567229385|FG001|Overall Study|Subject did not feel the med was needed|0|||
157130758|NCT02162862|567229386|FG002|Overall Study|Subject did not feel the med was needed|4|||
157130759|NCT03116113|567229387|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130760|NCT03116113|567229388|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130761|NCT03116113|567229389|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130762|NCT03116113|567229390|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130763|NCT03116113|567229391|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130764|NCT03116113|567229392|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130765|NCT03116113|567229393|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
157130766|NCT03116113|567229394|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
157130767|NCT03116113|567229395|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
157130768|NCT02159807|567229396|FG000|Overall Study|Adverse Event|0|||
157130769|NCT02159807|567229397|FG001|Overall Study|Adverse Event|0|||
157130770|NCT02159807|567229398|FG002|Overall Study|Adverse Event|1|||
157130771|NCT02159807|567229396|FG000|Overall Study|No CSF|1|||
157130772|NCT02159807|567229397|FG001|Overall Study|No CSF|1|||
157130773|NCT02159807|567229398|FG002|Overall Study|No CSF|1|||
157130774|NCT02159807|567229396|FG000|Overall Study|elevated blood pressure|0|||
157130775|NCT02159807|567229397|FG001|Overall Study|elevated blood pressure|0|||
157130776|NCT02159807|567229398|FG002|Overall Study|elevated blood pressure|1|||
157130777|NCT00950170|567229399|FG000|Overall Study|Parent/Legal Guardian Request|1|||
157130778|NCT00950170|567229399|FG000|Overall Study|Adverse Event|2|||
157130779|NCT00950170|567229399|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
157130780|NCT00600171|567229405|FG000|Overall Study|Adverse Event|0|||
157130781|NCT00600171|567229406|FG001|Overall Study|Adverse Event|1|||
157130782|NCT00600171|567229407|FG002|Overall Study|Adverse Event|0|||
157130783|NCT00600171|567229408|FG003|Overall Study|Adverse Event|0|||
157130784|NCT00600171|567229409|FG004|Overall Study|Adverse Event|1|||
157130785|NCT00600171|567229410|FG005|Overall Study|Adverse Event|0|||
157130786|NCT00600171|567229405|FG000|Overall Study|Lack of Efficacy|9|||
157130787|NCT00600171|567229406|FG001|Overall Study|Lack of Efficacy|12|||
157130788|NCT00600171|567229407|FG002|Overall Study|Lack of Efficacy|3|||
157130789|NCT00600171|567229408|FG003|Overall Study|Lack of Efficacy|5|||
157130790|NCT00600171|567229409|FG004|Overall Study|Lack of Efficacy|4|||
157130791|NCT00600171|567229410|FG005|Overall Study|Lack of Efficacy|0|||
156883105|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
157130792|NCT00600171|567229405|FG000|Overall Study|Protocol Violation|1|||
157130793|NCT00600171|567229406|FG001|Overall Study|Protocol Violation|2|||
157130794|NCT00600171|567229407|FG002|Overall Study|Protocol Violation|0|||
157130795|NCT00600171|567229408|FG003|Overall Study|Protocol Violation|1|||
157130796|NCT00600171|567229409|FG004|Overall Study|Protocol Violation|0|||
157130797|NCT00600171|567229410|FG005|Overall Study|Protocol Violation|0|||
157130798|NCT00600171|567229405|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
157130799|NCT00600171|567229406|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157130800|NCT00600171|567229407|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
157130801|NCT00600171|567229408|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
157130802|NCT00600171|567229409|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
157130803|NCT00600171|567229410|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
157130804|NCT00600171|567229405|FG000|Overall Study|Withdrawal by Subject|3|||
157130805|NCT00600171|567229406|FG001|Overall Study|Withdrawal by Subject|0|||
157130806|NCT00600171|567229407|FG002|Overall Study|Withdrawal by Subject|0|||
157130807|NCT00600171|567229408|FG003|Overall Study|Withdrawal by Subject|1|||
157130808|NCT00600171|567229409|FG004|Overall Study|Withdrawal by Subject|1|||
157130809|NCT00600171|567229410|FG005|Overall Study|Withdrawal by Subject|1|||
157130810|NCT00600171|567229405|FG000|Overall Study|Physician Decision|0|||
156716275|NCT02676882|565705319|FG001|Overall Study|Lost to Follow-up|0|||
156716276|NCT02676882|565705318|FG000|Overall Study|Withdrawal by Subject|1|||
156716277|NCT02676882|565705319|FG001|Overall Study|Withdrawal by Subject|2|||
156716278|NCT01071915|565705320|FG000|Overall Study|Adverse Event|3|||
156716279|NCT01071915|565705320|FG000|Overall Study|Physician Decision|2|||
156716280|NCT01071915|565705320|FG000|Overall Study|Withdrawal by Subject|2|||
156716281|NCT01071915|565705320|FG000|Overall Study|Miscellaneous Reasons|2|||
157216673|NCT00990093|567539361|FG000|Test Period 1 (1-14 Days)|Other|1|||
157216674|NCT00990093|567539362|FG001|Test Period 1 (1-14 Days)|Other|0|||
157216675|NCT00990093|567539361|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
157216676|NCT00990093|567539362|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
157216677|NCT00990093|567539361|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
157216678|NCT00990093|567539362|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
157216679|NCT00990093|567539361|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
157216680|NCT00990093|567539362|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
157216681|NCT00990093|567539361|FG000|Test Period 2 (15-28 Days)|Other|0|||
157216682|NCT00990093|567539362|FG001|Test Period 2 (15-28 Days)|Other|1|||
157216683|NCT04147611|567539364|FG000|Overall Study|Physician Decision|0|||
157216684|NCT04147611|567539365|FG001|Overall Study|Physician Decision|1|||
157216685|NCT01010230|567539366|FG000|Overall Study|Withdrawal by Subject|6|||
157216686|NCT01010230|567539367|FG001|Overall Study|Withdrawal by Subject|5|||
157216687|NCT01010230|567539366|FG000|Overall Study|Lost to Follow-up|4|||
157216688|NCT01010230|567539367|FG001|Overall Study|Lost to Follow-up|2|||
157216689|NCT00530439|567539368|FG000|Overall Study|GDM|9|||
157216690|NCT00530439|567539369|FG001|Overall Study|GDM|3|||
157216691|NCT00530439|567539368|FG000|Overall Study|Withdraw|18|||
157216692|NCT00530439|567539369|FG001|Overall Study|Withdraw|14|||
157017961|NCT05059262|566819439|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
157017962|NCT05059262|566819438|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
157017963|NCT05059262|566819439|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
157216693|NCT00530439|567539368|FG000|Overall Study|Missed abortion|1|||
157216694|NCT00530439|567539369|FG001|Overall Study|Missed abortion|4|||
157216695|NCT00530439|567539368|FG000|Overall Study|Misclassification|2|||
157216696|NCT00530439|567539369|FG001|Overall Study|Misclassification|0|||
157216697|NCT00530439|567539368|FG000|Overall Study|Twin pregnancy|0|||
157216698|NCT00530439|567539369|FG001|Overall Study|Twin pregnancy|2|||
157216699|NCT00530439|567539368|FG000|Overall Study|Severe malformation/abortion|0|||
157216700|NCT00530439|567539369|FG001|Overall Study|Severe malformation/abortion|3|||
157216701|NCT01585831|567539376|FG000|Overall Study|Physician Decision|0|||
157216702|NCT01585831|567539377|FG001|Overall Study|Physician Decision|1|||
157216703|NCT01585831|567539376|FG000|Overall Study|Withdrawal by Subject|2|||
157216704|NCT01585831|567539377|FG001|Overall Study|Withdrawal by Subject|1|||
157216705|NCT01123980|567539378|FG000|Overall Study|Adverse Event|1|||
157216706|NCT01123980|567539379|FG001|Overall Study|Adverse Event|1|||
157216707|NCT01123980|567539378|FG000|Overall Study|Lack of Efficacy|1|||
157216708|NCT01123980|567539379|FG001|Overall Study|Lack of Efficacy|0|||
157216709|NCT01123980|567539378|FG000|Overall Study|Physician Decision|0|||
157017964|NCT02728076|566819441|FG000|Overall Study|Physician Decision|4|||
157017965|NCT04263311|566819442|FG000|Overall Study|Lost to Follow-up|1|||
157017966|NCT04263311|566819443|FG001|Overall Study|Lost to Follow-up|2|||
157017967|NCT04263311|566819444|FG002|Overall Study|Lost to Follow-up|0|||
157017968|NCT04263311|566819442|FG000|Overall Study|Health Issues|1|||
157017969|NCT04263311|566819443|FG001|Overall Study|Health Issues|0|||
157017970|NCT04263311|566819444|FG002|Overall Study|Health Issues|0|||
157017971|NCT04263311|566819442|FG000|Overall Study|Left the country|1|||
157017972|NCT04263311|566819443|FG001|Overall Study|Left the country|0|||
157017973|NCT04263311|566819444|FG002|Overall Study|Left the country|0|||
157017974|NCT04263311|566819442|FG000|Overall Study|Unable to maintain time commitment|1|||
157017975|NCT04263311|566819443|FG001|Overall Study|Unable to maintain time commitment|0|||
157017976|NCT04263311|566819444|FG002|Overall Study|Unable to maintain time commitment|0|||
157017977|NCT04263311|566819442|FG000|Overall Study|No longer interested|1|||
157017978|NCT04263311|566819443|FG001|Overall Study|No longer interested|0|||
157017979|NCT04263311|566819444|FG002|Overall Study|No longer interested|0|||
157017980|NCT04263311|566819442|FG000|Overall Study|Ineligible post consent|0|||
157017981|NCT04263311|566819443|FG001|Overall Study|Ineligible post consent|0|||
157017982|NCT04263311|566819444|FG002|Overall Study|Ineligible post consent|5|||
157017983|NCT02927769|566819445|FG000|Induction Phase|Study drug toxicity|1|||
157017984|NCT02927769|566819446|FG001|Induction Phase|Study drug toxicity|1|||
157017985|NCT02927769|566819445|FG000|Induction Phase|Disease progression|0|||
157017986|NCT02927769|566819446|FG001|Induction Phase|Disease progression|1|||
157017987|NCT02927769|566819445|FG000|Intensification Phase|Study drug toxicity|1|||
157017988|NCT02927769|566819446|FG001|Intensification Phase|Study drug toxicity|0|||
157017989|NCT03526861|566819464|FG000|Initial Treatment Period|Not dosed|1|||
157017990|NCT03526861|566819465|FG001|Initial Treatment Period|Not dosed|1|||
157017991|NCT03526861|566819466|FG002|Initial Treatment Period|Not dosed|1|||
157017992|NCT03526861|566819467|FG003|Initial Treatment Period|Not dosed|0|||
157017993|NCT03526861|566819468|FG004|Initial Treatment Period|Not dosed|0|||
157017994|NCT03526861|566819469|FG005|Initial Treatment Period|Not dosed|0|||
157017995|NCT03526861|566819470|FG006|Initial Treatment Period|Not dosed|0|||
157017996|NCT03526861|566819471|FG007|Initial Treatment Period|Not dosed|0|||
157017997|NCT03526861|566819472|FG008|Initial Treatment Period|Not dosed|0|||
157017998|NCT03526861|566819464|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
157216710|NCT01123980|567539379|FG001|Overall Study|Physician Decision|1|||
157216711|NCT01123980|567539378|FG000|Overall Study|Lost to Follow-up|0|||
157130811|NCT00600171|567229406|FG001|Overall Study|Physician Decision|1|||
157130812|NCT00600171|567229407|FG002|Overall Study|Physician Decision|0|||
157130813|NCT00600171|567229408|FG003|Overall Study|Physician Decision|1|||
157130814|NCT00600171|567229409|FG004|Overall Study|Physician Decision|0|||
157130815|NCT00600171|567229410|FG005|Overall Study|Physician Decision|2|||
157130816|NCT00600171|567229405|FG000|Overall Study|Lost to Follow-up|0|||
157130817|NCT00600171|567229406|FG001|Overall Study|Lost to Follow-up|0|||
157130818|NCT00600171|567229407|FG002|Overall Study|Lost to Follow-up|0|||
157130819|NCT00600171|567229408|FG003|Overall Study|Lost to Follow-up|1|||
157130820|NCT00600171|567229409|FG004|Overall Study|Lost to Follow-up|0|||
157130821|NCT00600171|567229410|FG005|Overall Study|Lost to Follow-up|0|||
157130822|NCT02367521|567229411|FG000|Overall Study|severe headache after intervention|2|||
157130823|NCT02367521|567229412|FG001|Overall Study|severe headache after intervention|0|||
157130824|NCT02367521|567229411|FG000|Overall Study|unable to find transportation|2|||
157130825|NCT02367521|567229412|FG001|Overall Study|unable to find transportation|0|||
157130826|NCT00434967|567229416|FG000|Overall Study|Adverse Event|2|||
157130827|NCT00434967|567229417|FG001|Overall Study|Adverse Event|4|||
157130828|NCT00434967|567229418|FG002|Overall Study|Adverse Event|3|||
157130829|NCT00434967|567229419|FG003|Overall Study|Adverse Event|3|||
157130830|NCT00434967|567229416|FG000|Overall Study|Lost to Follow-up|0|||
157130831|NCT00434967|567229417|FG001|Overall Study|Lost to Follow-up|0|||
157130832|NCT00434967|567229418|FG002|Overall Study|Lost to Follow-up|1|||
157130833|NCT00434967|567229419|FG003|Overall Study|Lost to Follow-up|0|||
157130834|NCT00434967|567229416|FG000|Overall Study|Withdrawal by Subject|2|||
157130835|NCT00434967|567229417|FG001|Overall Study|Withdrawal by Subject|2|||
157130836|NCT00434967|567229418|FG002|Overall Study|Withdrawal by Subject|4|||
157130837|NCT00434967|567229419|FG003|Overall Study|Withdrawal by Subject|6|||
157130838|NCT00434967|567229416|FG000|Overall Study|Randomized in error|0|||
157130839|NCT00434967|567229417|FG001|Overall Study|Randomized in error|0|||
157130840|NCT00434967|567229418|FG002|Overall Study|Randomized in error|0|||
157130841|NCT00434967|567229419|FG003|Overall Study|Randomized in error|1|||
157130842|NCT00434967|567229416|FG000|Overall Study|Protocol Violation|0|||
157130843|NCT00434967|567229417|FG001|Overall Study|Protocol Violation|1|||
157130844|NCT00434967|567229418|FG002|Overall Study|Protocol Violation|0|||
157130845|NCT00434967|567229419|FG003|Overall Study|Protocol Violation|1|||
157130846|NCT00434967|567229416|FG000|Overall Study|Physician Decision|1|||
157130847|NCT00434967|567229417|FG001|Overall Study|Physician Decision|1|||
157130848|NCT00434967|567229418|FG002|Overall Study|Physician Decision|1|||
157130849|NCT00434967|567229419|FG003|Overall Study|Physician Decision|0|||
157130850|NCT00434967|567229416|FG000|Overall Study|Patient Disposition Challenges|2|||
157130851|NCT00434967|567229417|FG001|Overall Study|Patient Disposition Challenges|0|||
157130852|NCT00434967|567229418|FG002|Overall Study|Patient Disposition Challenges|0|||
157130853|NCT00434967|567229419|FG003|Overall Study|Patient Disposition Challenges|3|||
157130854|NCT00559273|567229423|FG000|Correction Period (20 Weeks)|Death|3|||
157130855|NCT00559273|567229424|FG001|Correction Period (20 Weeks)|Death|4|||
157130856|NCT00559273|567229423|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
157130857|NCT00559273|567229424|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
157130858|NCT00559273|567229423|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
157130859|NCT00559273|567229424|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
157130860|NCT00559273|567229423|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
157130861|NCT00559273|567229424|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
157130862|NCT00559273|567229423|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
157130863|NCT00559273|567229424|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
157130864|NCT00559273|567229423|FG000|Evaluation Period (8 Weeks)|Death|1|||
157130865|NCT00559273|567229424|FG001|Evaluation Period (8 Weeks)|Death|3|||
157130866|NCT00559273|567229423|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
157130867|NCT00559273|567229424|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
157130868|NCT00559273|567229423|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
157130869|NCT00559273|567229424|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
156716282|NCT01125189|565705321|FG000|Treatment Period|Lack of Efficacy|15|||
156716283|NCT01125189|565705322|FG001|Treatment Period|Lack of Efficacy|18|||
156716284|NCT01125189|565705323|FG002|Treatment Period|Lack of Efficacy|25|||
157130870|NCT00559273|567229423|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
157130871|NCT00559273|567229424|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
157130872|NCT01256177|567229425|FG000|Overall Study|Withdrawal by Subject|23|||
157130873|NCT01256177|567229426|FG001|Overall Study|Withdrawal by Subject|22|||
157130874|NCT01256177|567229425|FG000|Overall Study|Lost to Follow-up|2|||
157130875|NCT01256177|567229426|FG001|Overall Study|Lost to Follow-up|2|||
157130876|NCT01256177|567229425|FG000|Overall Study|Adverse Event|8|||
157130877|NCT01256177|567229426|FG001|Overall Study|Adverse Event|9|||
157130878|NCT01256177|567229425|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
157130879|NCT01256177|567229426|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
157130880|NCT01256177|567229425|FG000|Overall Study|Condition under Investigation Worsened|1|||
157130881|NCT01256177|567229426|FG001|Overall Study|Condition under Investigation Worsened|0|||
156716285|NCT01125189|565705321|FG000|Treatment Period|Adverse Event|7|||
157130882|NCT01256177|567229425|FG000|Overall Study|Lack of Efficacy|11|||
157130883|NCT01256177|567229426|FG001|Overall Study|Lack of Efficacy|2|||
157130884|NCT01256177|567229425|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
157130885|NCT01256177|567229426|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
157130886|NCT01596257|567229431|FG000|Overall Study|Inadequate Collection|23|||
157130887|NCT01596257|567229432|FG001|Overall Study|Inadequate Collection|19|||
157130888|NCT01570244|567229436|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
157130889|NCT01879410|567229440|FG000|Overall Study|Adverse Event|9|||
157130890|NCT01879410|567229441|FG001|Overall Study|Adverse Event|14|||
157130891|NCT01879410|567229440|FG000|Overall Study|Lack of Efficacy|4|||
157130892|NCT01879410|567229441|FG001|Overall Study|Lack of Efficacy|6|||
157130893|NCT01879410|567229440|FG000|Overall Study|Protocol Violation|1|||
157130894|NCT01879410|567229441|FG001|Overall Study|Protocol Violation|7|||
157130895|NCT01879410|567229440|FG000|Overall Study|Lost to Follow-up|2|||
157130896|NCT01879410|567229441|FG001|Overall Study|Lost to Follow-up|1|||
157130897|NCT01879410|567229440|FG000|Overall Study|Withdrawal by Subject|7|||
157130898|NCT01879410|567229441|FG001|Overall Study|Withdrawal by Subject|8|||
157130899|NCT01879410|567229440|FG000|Overall Study|Randomised in Error|1|||
157130900|NCT01879410|567229441|FG001|Overall Study|Randomised in Error|2|||
157130901|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
157130902|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
157130903|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
157130904|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
157130905|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
157130906|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
157130907|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
157130908|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
157130909|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
157130910|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
157130911|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
157130912|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
157216712|NCT01123980|567539379|FG001|Overall Study|Lost to Follow-up|6|||
157216713|NCT01123980|567539378|FG000|Overall Study|Protocol Violation|6|||
157216714|NCT01123980|567539379|FG001|Overall Study|Protocol Violation|6|||
157216715|NCT01123980|567539378|FG000|Overall Study|Withdrawal by Subject|5|||
157216716|NCT01123980|567539379|FG001|Overall Study|Withdrawal by Subject|3|||
157216717|NCT01123980|567539378|FG000|Overall Study|Unclassified|6|||
156793208|NCT02037984|565994886|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
156793209|NCT02037984|565994879|FG000|Overall Study|Withdrawal by Subject|0|||
156793210|NCT02037984|565994880|FG001|Overall Study|Withdrawal by Subject|0|||
156793211|NCT02037984|565994881|FG002|Overall Study|Withdrawal by Subject|0|||
156793212|NCT02037984|565994882|FG003|Overall Study|Withdrawal by Subject|1|||
157216718|NCT01123980|567539379|FG001|Overall Study|Unclassified|7|||
157216719|NCT04385199|567539380|FG000|Overall Study|Withdrawal by Subject|1|||
157216720|NCT04385199|567539381|FG001|Overall Study|Withdrawal by Subject|0|||
157216721|NCT01225991|567539382|FG000|Overall Study|Withdrawal by Subject|6|||
157216722|NCT04444752|567539383|FG000|Overall Study|Adverse Event|1|||
157216723|NCT04444752|567539384|FG001|Overall Study|Adverse Event|0|||
157216724|NCT04444752|567539385|FG002|Overall Study|Adverse Event|0|||
157216725|NCT04444752|567539386|FG003|Overall Study|Adverse Event|2|||
157216726|NCT04444752|567539383|FG000|Overall Study|Lost to Follow-up|2|||
157216727|NCT04444752|567539384|FG001|Overall Study|Lost to Follow-up|6|||
157216728|NCT04444752|567539385|FG002|Overall Study|Lost to Follow-up|2|||
157216729|NCT04444752|567539386|FG003|Overall Study|Lost to Follow-up|5|||
157216730|NCT04444752|567539383|FG000|Overall Study|Physician Decision|0|||
157216731|NCT04444752|567539384|FG001|Overall Study|Physician Decision|0|||
156793213|NCT02037984|565994883|FG004|Overall Study|Withdrawal by Subject|1|||
156793214|NCT02037984|565994884|FG005|Overall Study|Withdrawal by Subject|3|||
156793215|NCT02037984|565994885|FG006|Overall Study|Withdrawal by Subject|0|||
156793216|NCT02037984|565994886|FG007|Overall Study|Withdrawal by Subject|1|||
156874834|NCT03892967|566298748|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
156883106|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
157017999|NCT03526861|566819465|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
157018000|NCT03526861|566819466|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
157216732|NCT04444752|567539385|FG002|Overall Study|Physician Decision|0|||
157216733|NCT04444752|567539386|FG003|Overall Study|Physician Decision|2|||
157018001|NCT03526861|566819467|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018002|NCT03526861|566819468|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018003|NCT03526861|566819469|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
156793217|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Death|2|||
157130913|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
157130914|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
157130915|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
157130916|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
157130917|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
157130918|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
157130919|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
157216734|NCT04444752|567539383|FG000|Overall Study|Pregnancy|0|||
157130920|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
157216735|NCT04444752|567539384|FG001|Overall Study|Pregnancy|0|||
157216736|NCT04444752|567539385|FG002|Overall Study|Pregnancy|0|||
157216737|NCT04444752|567539386|FG003|Overall Study|Pregnancy|1|||
157216738|NCT04444752|567539383|FG000|Overall Study|Withdrawal by Subject|6|||
157216739|NCT04444752|567539384|FG001|Overall Study|Withdrawal by Subject|5|||
157216740|NCT04444752|567539385|FG002|Overall Study|Withdrawal by Subject|3|||
157216741|NCT04444752|567539386|FG003|Overall Study|Withdrawal by Subject|4|||
157216742|NCT04444752|567539383|FG000|Overall Study|Protocol Violation|1|||
157216743|NCT04444752|567539384|FG001|Overall Study|Protocol Violation|1|||
157216744|NCT04444752|567539385|FG002|Overall Study|Protocol Violation|0|||
157216745|NCT04444752|567539386|FG003|Overall Study|Protocol Violation|0|||
157216746|NCT04444752|567539383|FG000|Overall Study|Patient moving out of town|1|||
157216747|NCT04444752|567539384|FG001|Overall Study|Patient moving out of town|0|||
157216748|NCT04444752|567539385|FG002|Overall Study|Patient moving out of town|0|||
157216749|NCT04444752|567539386|FG003|Overall Study|Patient moving out of town|1|||
157216750|NCT04444752|567539383|FG000|Overall Study|Lack of Efficacy|0|||
157216751|NCT04444752|567539384|FG001|Overall Study|Lack of Efficacy|0|||
157130921|NCT01360645|567229442|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
157130922|NCT01360645|567229443|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
157130923|NCT01360645|567229444|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
157130924|NCT01360645|567229445|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
157130925|NCT01360645|567229442|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
157130926|NCT01360645|567229443|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
157130927|NCT01360645|567229444|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
157130928|NCT01360645|567229445|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
157130929|NCT01360645|567229442|FG000|Phase B (6 Weeks)|Adverse Event|0|||
157130930|NCT01360645|567229443|FG001|Phase B (6 Weeks)|Adverse Event|6|||
157130931|NCT01360645|567229444|FG002|Phase B (6 Weeks)|Adverse Event|0|||
157216752|NCT04444752|567539385|FG002|Overall Study|Lack of Efficacy|0|||
157216753|NCT04444752|567539386|FG003|Overall Study|Lack of Efficacy|1|||
157216754|NCT04444752|567539383|FG000|Overall Study|Death|0|||
157216755|NCT04444752|567539384|FG001|Overall Study|Death|0|||
157216756|NCT04444752|567539385|FG002|Overall Study|Death|1|||
157216757|NCT04444752|567539386|FG003|Overall Study|Death|0|||
157216758|NCT00579254|567539387|FG000|Overall Study|Lost to Follow-up|39|||
157216759|NCT00579254|567539387|FG000|Overall Study|Discontinued when study terminated|73|||
157216760|NCT02557672|567539388|FG000|Overall Study|Withdrawal by Subject|4|||
157216761|NCT02557672|567539389|FG001|Overall Study|Withdrawal by Subject|2|||
157216762|NCT03705169|567539390|FG000|Overall Study|Lost to Follow-up|0|||
157216763|NCT03705169|567539391|FG001|Overall Study|Lost to Follow-up|0|||
157216764|NCT03705169|567539392|FG002|Overall Study|Lost to Follow-up|0|||
157216765|NCT03705169|567539393|FG003|Overall Study|Lost to Follow-up|2|||
157216766|NCT03705169|567539394|FG004|Overall Study|Lost to Follow-up|0|||
157216767|NCT03705169|567539395|FG005|Overall Study|Lost to Follow-up|2|||
157216768|NCT03705169|567539396|FG006|Overall Study|Lost to Follow-up|1|||
157216769|NCT03705169|567539397|FG007|Overall Study|Lost to Follow-up|0|||
157216770|NCT03705169|567539398|FG008|Overall Study|Lost to Follow-up|0|||
157216771|NCT03705169|567539399|FG009|Overall Study|Lost to Follow-up|1|||
157216772|NCT03705169|567539390|FG000|Overall Study|Adverse Event|0|||
157216773|NCT03705169|567539391|FG001|Overall Study|Adverse Event|0|||
157216774|NCT03705169|567539392|FG002|Overall Study|Adverse Event|0|||
157216775|NCT03705169|567539393|FG003|Overall Study|Adverse Event|1|||
156716286|NCT01125189|565705322|FG001|Treatment Period|Adverse Event|8|||
156716287|NCT01125189|565705323|FG002|Treatment Period|Adverse Event|8|||
156716288|NCT01125189|565705321|FG000|Treatment Period|Withdrawal by Subject|3|||
156716289|NCT01125189|565705322|FG001|Treatment Period|Withdrawal by Subject|1|||
156716290|NCT01125189|565705323|FG002|Treatment Period|Withdrawal by Subject|1|||
156716291|NCT01125189|565705321|FG000|Treatment Period|Death|1|||
156716292|NCT01125189|565705322|FG001|Treatment Period|Death|0|||
156716293|NCT01125189|565705323|FG002|Treatment Period|Death|0|||
156716294|NCT01125189|565705321|FG000|Treatment Period|Lost to Follow-up|1|||
156716295|NCT01125189|565705322|FG001|Treatment Period|Lost to Follow-up|2|||
157216776|NCT03705169|567539394|FG004|Overall Study|Adverse Event|0|||
157216777|NCT03705169|567539395|FG005|Overall Study|Adverse Event|0|||
157216778|NCT03705169|567539396|FG006|Overall Study|Adverse Event|0|||
157216779|NCT03705169|567539397|FG007|Overall Study|Adverse Event|0|||
156716296|NCT01125189|565705323|FG002|Treatment Period|Lost to Follow-up|1|||
157018004|NCT03526861|566819470|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018005|NCT03526861|566819471|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018006|NCT03526861|566819472|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018007|NCT03526861|566819464|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
157018008|NCT03526861|566819465|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
157018009|NCT03526861|566819466|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
157018010|NCT03526861|566819467|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157130932|NCT01360645|567229445|FG003|Phase B (6 Weeks)|Adverse Event|0|||
157130933|NCT01360645|567229442|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
157130934|NCT01360645|567229443|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
157130935|NCT01360645|567229444|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
157130936|NCT01360645|567229445|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
157130937|NCT01360645|567229442|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
157130938|NCT01360645|567229443|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
157130939|NCT01360645|567229444|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
157130940|NCT01360645|567229445|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
157130941|NCT01360645|567229442|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
157130942|NCT01360645|567229443|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
157130943|NCT01360645|567229444|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
157130944|NCT01360645|567229445|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
157130945|NCT01360645|567229442|FG000|Phase A+|Lost to Follow-up|0|||
157130946|NCT01360645|567229443|FG001|Phase A+|Lost to Follow-up|0|||
157130947|NCT01360645|567229444|FG002|Phase A+|Lost to Follow-up|0|||
157130948|NCT01360645|567229445|FG003|Phase A+|Lost to Follow-up|7|||
157130949|NCT01360645|567229442|FG000|Phase A+|Adverse Event|0|||
157130950|NCT01360645|567229443|FG001|Phase A+|Adverse Event|0|||
157018011|NCT03526861|566819468|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157018012|NCT03526861|566819469|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157018013|NCT03526861|566819470|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157018014|NCT03526861|566819471|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157018015|NCT03526861|566819472|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
157018016|NCT03526861|566819464|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018017|NCT03526861|566819465|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018018|NCT03526861|566819466|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018019|NCT03526861|566819467|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
157018020|NCT03526861|566819468|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
157018021|NCT03526861|566819469|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018022|NCT03526861|566819470|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
157018023|NCT03526861|566819471|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018024|NCT03526861|566819472|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157130951|NCT01360645|567229444|FG002|Phase A+|Adverse Event|0|||
157130952|NCT01360645|567229445|FG003|Phase A+|Adverse Event|2|||
157130953|NCT01360645|567229442|FG000|Phase A+|Met Withdrawal Criteria|0|||
157130954|NCT01360645|567229443|FG001|Phase A+|Met Withdrawal Criteria|0|||
157130955|NCT01360645|567229444|FG002|Phase A+|Met Withdrawal Criteria|0|||
157130956|NCT01360645|567229445|FG003|Phase A+|Met Withdrawal Criteria|4|||
157130957|NCT01360645|567229442|FG000|Phase A+|Physician Decision|0|||
157130958|NCT01360645|567229443|FG001|Phase A+|Physician Decision|0|||
157130959|NCT01360645|567229444|FG002|Phase A+|Physician Decision|0|||
157130960|NCT01360645|567229445|FG003|Phase A+|Physician Decision|2|||
157130961|NCT01360645|567229442|FG000|Phase A+|Withdrawal by Subject|0|||
157130962|NCT01360645|567229443|FG001|Phase A+|Withdrawal by Subject|0|||
157130963|NCT01360645|567229444|FG002|Phase A+|Withdrawal by Subject|0|||
157130964|NCT01360645|567229445|FG003|Phase A+|Withdrawal by Subject|5|||
157130965|NCT01360645|567229442|FG000|Phase A+|Protocol Deviation|0|||
157130966|NCT01360645|567229443|FG001|Phase A+|Protocol Deviation|0|||
157130967|NCT01360645|567229444|FG002|Phase A+|Protocol Deviation|0|||
157130968|NCT01360645|567229445|FG003|Phase A+|Protocol Deviation|4|||
157130969|NCT01014585|567229446|FG000|Overall Study|Adverse Event|0|||
157130970|NCT01014585|567229447|FG001|Overall Study|Adverse Event|2|||
157130971|NCT01014585|567229448|FG002|Overall Study|Adverse Event|0|||
157130972|NCT01014585|567229449|FG003|Overall Study|Adverse Event|3|||
157130973|NCT01014585|567229446|FG000|Overall Study|Withdrawal by Subject|2|||
157130974|NCT01014585|567229447|FG001|Overall Study|Withdrawal by Subject|0|||
157130975|NCT01014585|567229448|FG002|Overall Study|Withdrawal by Subject|1|||
157130976|NCT01014585|567229449|FG003|Overall Study|Withdrawal by Subject|3|||
157130977|NCT01014585|567229446|FG000|Overall Study|Lost to Follow-up|0|||
157130978|NCT01014585|567229447|FG001|Overall Study|Lost to Follow-up|0|||
157130979|NCT01014585|567229448|FG002|Overall Study|Lost to Follow-up|0|||
157130980|NCT01014585|567229449|FG003|Overall Study|Lost to Follow-up|2|||
157216780|NCT03705169|567539398|FG008|Overall Study|Adverse Event|0|||
157216781|NCT03705169|567539399|FG009|Overall Study|Adverse Event|0|||
157216782|NCT03705169|567539390|FG000|Overall Study|Site Closure|0|||
157216783|NCT03705169|567539391|FG001|Overall Study|Site Closure|0|||
157216784|NCT03705169|567539392|FG002|Overall Study|Site Closure|0|||
157216785|NCT03705169|567539393|FG003|Overall Study|Site Closure|1|||
157130981|NCT01014585|567229446|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
157130982|NCT01014585|567229447|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
157130983|NCT01014585|567229448|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
157130984|NCT01014585|567229449|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
157130985|NCT00508391|567229453|FG000|First Treatment|Withdrawal by Subject|6|||
157130986|NCT00508391|567229454|FG001|First Treatment|Withdrawal by Subject|3|||
157130987|NCT00508391|567229453|FG000|Second Treatment|Withdrawal by Subject|2|||
157130988|NCT00508391|567229454|FG001|Second Treatment|Withdrawal by Subject|0|||
157130989|NCT00880256|567229458|FG000|Overall Study|Lost to Follow-up|28|||
157130990|NCT02041962|567229459|FG000|Overall Study|Lost Aetna Coverage|43|||
157130991|NCT02041962|567229460|FG001|Overall Study|Lost Aetna Coverage|40|||
157130992|NCT02041962|567229459|FG000|Overall Study|Death|1|||
157130993|NCT02041962|567229460|FG001|Overall Study|Death|1|||
157130994|NCT02041962|567229459|FG000|Overall Study|Lost to Follow-up|37|||
157130995|NCT02041962|567229460|FG001|Overall Study|Lost to Follow-up|32|||
157130996|NCT02041962|567229459|FG000|Overall Study|Withdrawal by Subject|0|||
157130997|NCT02041962|567229460|FG001|Overall Study|Withdrawal by Subject|11|||
157130998|NCT01686568|567229461|FG000|Main Study|Withdrawal by Subject|1|||
157130999|NCT01686568|567229462|FG001|Main Study|Withdrawal by Subject|3|||
157131000|NCT01686568|567229461|FG000|Main Study|Noncompliance with protocol|0|||
157131001|NCT01686568|567229462|FG001|Main Study|Noncompliance with protocol|1|||
157131002|NCT01686568|567229461|FG000|Main Study|Liver enzymes above range of exclusion|1|||
157131003|NCT01686568|567229462|FG001|Main Study|Liver enzymes above range of exclusion|0|||
157131004|NCT01686568|567229461|FG000|Sub-Study|Not consented for sub-study|2|||
157131005|NCT01686568|567229462|FG001|Sub-Study|Not consented for sub-study|2|||
157131006|NCT02601573|567229463|FG000|Overall Study|Lost to Follow-up|0|||
157131007|NCT02601573|567229464|FG001|Overall Study|Lost to Follow-up|3|||
157131008|NCT02601573|567229465|FG002|Overall Study|Lost to Follow-up|1|||
157131009|NCT02601573|567229466|FG003|Overall Study|Lost to Follow-up|0|||
157131010|NCT02601573|567229467|FG004|Overall Study|Lost to Follow-up|2|||
157131011|NCT02601573|567229463|FG000|Overall Study|Withdrawal by Subject|0|||
157131012|NCT02601573|567229464|FG001|Overall Study|Withdrawal by Subject|1|||
157131013|NCT02601573|567229465|FG002|Overall Study|Withdrawal by Subject|0|||
157131014|NCT02601573|567229466|FG003|Overall Study|Withdrawal by Subject|1|||
157131015|NCT02601573|567229467|FG004|Overall Study|Withdrawal by Subject|0|||
157131016|NCT01850615|567229468|FG000|Overall Study|Protocol Violation|4|||
157131017|NCT01850615|567229469|FG001|Overall Study|Protocol Violation|1|||
157131018|NCT01850615|567229468|FG000|Overall Study|Adverse Event|2|||
157131019|NCT01850615|567229469|FG001|Overall Study|Adverse Event|1|||
157131020|NCT01850615|567229468|FG000|Overall Study|Withdrawal by Subject|3|||
157131021|NCT01850615|567229469|FG001|Overall Study|Withdrawal by Subject|1|||
157131022|NCT01850615|567229468|FG000|Overall Study|Lost to Follow-up|0|||
157131023|NCT01850615|567229469|FG001|Overall Study|Lost to Follow-up|1|||
157131024|NCT01850615|567229468|FG000|Overall Study|Unclassified|0|||
157131025|NCT01850615|567229469|FG001|Overall Study|Unclassified|1|||
157131026|NCT00974220|567229470|FG000|Treatment Period 1|Adverse Event|2|||
157131027|NCT00974220|567229471|FG001|Treatment Period 1|Adverse Event|1|||
157131028|NCT00974220|567229470|FG000|Treatment Period 1|noncompliant subjects|0|||
157131029|NCT00974220|567229471|FG001|Treatment Period 1|noncompliant subjects|1|||
157131030|NCT00706628|567229472|FG000|Overall Study|Other Adverse Event|16|||
157131031|NCT00706628|567229473|FG001|Overall Study|Other Adverse Event|5|||
157131032|NCT00706628|567229474|FG002|Overall Study|Other Adverse Event|5|||
157131033|NCT00706628|567229475|FG003|Overall Study|Other Adverse Event|2|||
157131034|NCT00706628|567229472|FG000|Overall Study|Non compliant with protocol|0|||
157131035|NCT00706628|567229473|FG001|Overall Study|Non compliant with protocol|1|||
157216786|NCT03705169|567539394|FG004|Overall Study|Site Closure|0|||
157216787|NCT03705169|567539395|FG005|Overall Study|Site Closure|0|||
157131036|NCT00706628|567229474|FG002|Overall Study|Non compliant with protocol|0|||
157216788|NCT03705169|567539396|FG006|Overall Study|Site Closure|0|||
157131037|NCT00706628|567229475|FG003|Overall Study|Non compliant with protocol|0|||
157131038|NCT00706628|567229472|FG000|Overall Study|Consent withdrawn|6|||
157131039|NCT00706628|567229473|FG001|Overall Study|Consent withdrawn|1|||
157131040|NCT00706628|567229474|FG002|Overall Study|Consent withdrawn|3|||
157131041|NCT00706628|567229475|FG003|Overall Study|Consent withdrawn|0|||
157131042|NCT00706628|567229472|FG000|Overall Study|Progressive disease|20|||
157131043|NCT00706628|567229473|FG001|Overall Study|Progressive disease|13|||
157131044|NCT00706628|567229474|FG002|Overall Study|Progressive disease|8|||
157216789|NCT03705169|567539397|FG007|Overall Study|Site Closure|0|||
157216790|NCT03705169|567539398|FG008|Overall Study|Site Closure|0|||
157131045|NCT00706628|567229475|FG003|Overall Study|Progressive disease|1|||
157131046|NCT00706628|567229472|FG000|Overall Study|Other than those stated above|4|||
157131047|NCT00706628|567229473|FG001|Overall Study|Other than those stated above|0|||
157216791|NCT03705169|567539399|FG009|Overall Study|Site Closure|0|||
157131048|NCT00706628|567229474|FG002|Overall Study|Other than those stated above|0|||
157131049|NCT00706628|567229475|FG003|Overall Study|Other than those stated above|0|||
157131050|NCT00706628|567229472|FG000|Overall Study|Not treated|1|||
157131051|NCT00706628|567229473|FG001|Overall Study|Not treated|1|||
157131052|NCT00706628|567229474|FG002|Overall Study|Not treated|0|||
157131053|NCT00706628|567229475|FG003|Overall Study|Not treated|0|||
157018025|NCT03526861|566819464|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
157018026|NCT03526861|566819465|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
157018027|NCT03526861|566819466|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
157018028|NCT03526861|566819467|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
157018029|NCT03526861|566819468|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
157018030|NCT03526861|566819469|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
157018031|NCT03526861|566819470|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
157018032|NCT03526861|566819471|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
157018033|NCT03526861|566819472|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
157018034|NCT03526861|566819464|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018035|NCT03526861|566819465|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018036|NCT03526861|566819466|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018037|NCT03526861|566819467|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
157018038|NCT03526861|566819468|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018039|NCT03526861|566819469|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018040|NCT03526861|566819470|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018041|NCT03526861|566819471|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018042|NCT03526861|566819472|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018043|NCT03526861|566819464|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018044|NCT03526861|566819465|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018045|NCT03526861|566819466|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018046|NCT03526861|566819467|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018047|NCT03526861|566819468|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018048|NCT03526861|566819469|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018049|NCT03526861|566819470|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018050|NCT03526861|566819471|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
157018051|NCT03526861|566819472|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
157018052|NCT03526861|566819464|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018053|NCT03526861|566819465|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018054|NCT03526861|566819466|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018055|NCT03526861|566819467|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018056|NCT03526861|566819468|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018057|NCT03526861|566819469|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018058|NCT03526861|566819470|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018059|NCT03526861|566819471|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
157018060|NCT03526861|566819472|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
157018061|NCT03526861|566819464|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018062|NCT03526861|566819465|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018063|NCT03526861|566819466|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018064|NCT03526861|566819467|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018065|NCT03526861|566819468|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157131054|NCT03403400|567229476|FG000|Overall Study|Lost to Follow-up|1|||
157131055|NCT03403400|567229477|FG001|Overall Study|Lost to Follow-up|0|||
156716297|NCT01125189|565705321|FG000|Treatment Period|Poor compliance/noncompliance|0|||
156716298|NCT01125189|565705322|FG001|Treatment Period|Poor compliance/noncompliance|1|||
156793218|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
157216792|NCT03705169|567539390|FG000|Overall Study|Did not receive study treatment|0|||
157216793|NCT03705169|567539391|FG001|Overall Study|Did not receive study treatment|0|||
157216794|NCT03705169|567539392|FG002|Overall Study|Did not receive study treatment|0|||
157216795|NCT03705169|567539393|FG003|Overall Study|Did not receive study treatment|1|||
157216796|NCT03705169|567539394|FG004|Overall Study|Did not receive study treatment|0|||
157216797|NCT03705169|567539395|FG005|Overall Study|Did not receive study treatment|0|||
157216798|NCT03705169|567539396|FG006|Overall Study|Did not receive study treatment|0|||
157216799|NCT03705169|567539397|FG007|Overall Study|Did not receive study treatment|0|||
157216800|NCT03705169|567539398|FG008|Overall Study|Did not receive study treatment|0|||
157216801|NCT03705169|567539399|FG009|Overall Study|Did not receive study treatment|0|||
157216802|NCT03705169|567539390|FG000|Overall Study|Concerns about study visit compliance|0|||
157216803|NCT03705169|567539391|FG001|Overall Study|Concerns about study visit compliance|0|||
157216804|NCT03705169|567539392|FG002|Overall Study|Concerns about study visit compliance|0|||
157216805|NCT03705169|567539393|FG003|Overall Study|Concerns about study visit compliance|1|||
157216806|NCT03705169|567539394|FG004|Overall Study|Concerns about study visit compliance|0|||
157216807|NCT03705169|567539395|FG005|Overall Study|Concerns about study visit compliance|0|||
157216808|NCT03705169|567539396|FG006|Overall Study|Concerns about study visit compliance|0|||
157216809|NCT03705169|567539397|FG007|Overall Study|Concerns about study visit compliance|0|||
157216810|NCT03705169|567539398|FG008|Overall Study|Concerns about study visit compliance|0|||
157216811|NCT03705169|567539399|FG009|Overall Study|Concerns about study visit compliance|0|||
157216812|NCT00928252|567540925|FG000|Overall Study|Physician Decision|3|||
157216813|NCT02257632|567540926|FG000|Overall Study|Withdrawal by Subject|0|||
157216814|NCT02257632|567540927|FG001|Overall Study|Withdrawal by Subject|1|||
157216815|NCT02257632|567540926|FG000|Overall Study|Adverse Event|1|||
157216816|NCT02257632|567540927|FG001|Overall Study|Adverse Event|2|||
157216817|NCT02468557|567540928|FG000|Overall Study|Adverse Event|1|||
157216818|NCT02468557|567540928|FG000|Overall Study|Death|1|||
157216819|NCT02468557|567540928|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
157216820|NCT02468557|567540928|FG000|Overall Study|All Enrolled but Never Dosed|4|||
157216821|NCT02024698|567540932|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
157216822|NCT02024698|567540933|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
157216823|NCT03322462|567540934|FG000|Overall Study|Technical difficulties|2|||
157216824|NCT03322462|567540934|FG000|Overall Study|Other|1|||
157216825|NCT01393990|567540935|FG000|Overall Study|Adverse Event|0|||
156793219|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
156793220|NCT00974233|565994892|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
156793221|NCT00974233|565994892|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
156793222|NCT00974233|565994892|FG000|Maintenance Lenalidomide|Adverse Event|8|||
156793223|NCT01691092|565994893|FG000|Overall Study|Lost to Follow-up|10|||
156793224|NCT01691092|565994893|FG000|Overall Study|Physician Decision|4|||
156793225|NCT01691092|565994893|FG000|Overall Study|Withdrawal by Subject|3|||
156793226|NCT01691092|565994893|FG000|Overall Study|non-compliance|3|||
157216826|NCT01393990|567540936|FG001|Overall Study|Adverse Event|0|||
157216827|NCT01393990|567540937|FG002|Overall Study|Adverse Event|0|||
157216828|NCT01393990|567540938|FG003|Overall Study|Adverse Event|0|||
157216829|NCT01393990|567540939|FG004|Overall Study|Adverse Event|0|||
157216830|NCT01393990|567540940|FG005|Overall Study|Adverse Event|0|||
157216831|NCT01393990|567540941|FG006|Overall Study|Adverse Event|0|||
157216832|NCT01393990|567540942|FG007|Overall Study|Adverse Event|0|||
157216833|NCT01393990|567540943|FG008|Overall Study|Adverse Event|0|||
157216834|NCT01393990|567540944|FG009|Overall Study|Adverse Event|0|||
157216835|NCT01393990|567540945|FG010|Overall Study|Adverse Event|0|||
157216836|NCT01393990|567540946|FG011|Overall Study|Adverse Event|0|||
157216837|NCT01393990|567540947|FG012|Overall Study|Adverse Event|0|||
157216838|NCT01393990|567540948|FG013|Overall Study|Adverse Event|0|||
157216839|NCT01393990|567540949|FG014|Overall Study|Adverse Event|1|||
157216840|NCT01393990|567540950|FG015|Overall Study|Adverse Event|1|||
157216841|NCT01393990|567540951|FG016|Overall Study|Adverse Event|0|||
157216842|NCT01393990|567540952|FG017|Overall Study|Adverse Event|0|||
157216843|NCT01393990|567540935|FG000|Overall Study|Progressive Disease|1|||
157216844|NCT01393990|567540936|FG001|Overall Study|Progressive Disease|0|||
156793227|NCT01691092|565994893|FG000|Overall Study|used for different study|2|||
157216845|NCT01393990|567540937|FG002|Overall Study|Progressive Disease|0|||
157216846|NCT01393990|567540938|FG003|Overall Study|Progressive Disease|1|||
156793228|NCT01691092|565994893|FG000|Overall Study|screen fail|19|||
157216847|NCT01393990|567540939|FG004|Overall Study|Progressive Disease|1|||
157216848|NCT01393990|567540940|FG005|Overall Study|Progressive Disease|1|||
157216849|NCT01393990|567540941|FG006|Overall Study|Progressive Disease|1|||
157216850|NCT01393990|567540942|FG007|Overall Study|Progressive Disease|1|||
156793229|NCT00581100|565996189|FG000|Overall Study|Death|1|||
156793230|NCT00581100|565996190|FG001|Overall Study|Death|0|||
157216851|NCT01393990|567540943|FG008|Overall Study|Progressive Disease|3|||
157216852|NCT01393990|567540944|FG009|Overall Study|Progressive Disease|1|||
157216853|NCT01393990|567540945|FG010|Overall Study|Progressive Disease|0|||
157131056|NCT03403400|567229478|FG002|Overall Study|Lost to Follow-up|1|||
157131057|NCT03403400|567229476|FG000|Overall Study|Hospitalization|1|||
157131058|NCT03403400|567229477|FG001|Overall Study|Hospitalization|0|||
157018066|NCT03526861|566819469|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018067|NCT03526861|566819470|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018068|NCT03526861|566819471|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
157018069|NCT03526861|566819472|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
157131059|NCT03403400|567229478|FG002|Overall Study|Hospitalization|0|||
157131060|NCT03403400|567229476|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
157131061|NCT03403400|567229477|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
157131062|NCT03403400|567229478|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
157131063|NCT01948830|567229479|FG000|Overall Study|Physician Decision|1|||
157131064|NCT01948830|567229480|FG001|Overall Study|Physician Decision|3|||
157131065|NCT01948830|567229479|FG000|Overall Study|Protocol deviation|1|||
157131066|NCT01948830|567229480|FG001|Overall Study|Protocol deviation|2|||
157131067|NCT01948830|567229479|FG000|Overall Study|Lost to Follow-up|5|||
157131068|NCT01948830|567229480|FG001|Overall Study|Lost to Follow-up|4|||
157131069|NCT01948830|567229479|FG000|Overall Study|Withdrawal by Subject|14|||
157131070|NCT01948830|567229480|FG001|Overall Study|Withdrawal by Subject|17|||
157131071|NCT01948830|567229479|FG000|Overall Study|Adverse Event|9|||
157131072|NCT01948830|567229480|FG001|Overall Study|Adverse Event|2|||
157131073|NCT01948830|567229479|FG000|Overall Study|Death|3|||
157131074|NCT01948830|567229480|FG001|Overall Study|Death|4|||
157131075|NCT01145560|567229481|FG000|Overall Study|Withdrawal by Subject|2|||
157131076|NCT01145560|567229482|FG001|Overall Study|Withdrawal by Subject|1|||
157131077|NCT01145560|567229483|FG002|Overall Study|Withdrawal by Subject|0|||
157131078|NCT01145560|567229481|FG000|Overall Study|Lost to Follow-up|1|||
157131079|NCT01145560|567229482|FG001|Overall Study|Lost to Follow-up|1|||
157131080|NCT01145560|567229483|FG002|Overall Study|Lost to Follow-up|1|||
157131081|NCT01145560|567229481|FG000|Overall Study|No study drug by 24h after organ failure|1|||
157131082|NCT01145560|567229482|FG001|Overall Study|No study drug by 24h after organ failure|0|||
157131083|NCT01145560|567229483|FG002|Overall Study|No study drug by 24h after organ failure|0|||
157131084|NCT01145560|567229481|FG000|Overall Study|Accidental unblinding of study treatment|0|||
157131085|NCT01145560|567229482|FG001|Overall Study|Accidental unblinding of study treatment|1|||
157131086|NCT01145560|567229483|FG002|Overall Study|Accidental unblinding of study treatment|0|||
157131087|NCT01145560|567229481|FG000|Overall Study|False insurance information|0|||
157131088|NCT01145560|567229482|FG001|Overall Study|False insurance information|1|||
157131089|NCT01145560|567229483|FG002|Overall Study|False insurance information|0|||
157131090|NCT01145560|567229481|FG000|Overall Study|Withdrawal of therapy|0|||
157131091|NCT01145560|567229482|FG001|Overall Study|Withdrawal of therapy|0|||
157131092|NCT01145560|567229483|FG002|Overall Study|Withdrawal of therapy|1|||
157131093|NCT02411747|567229485|FG000|Overall Study|Withdrawal by Subject|1|||
157131094|NCT02411747|567229486|FG001|Overall Study|Withdrawal by Subject|0|||
157131095|NCT02411747|567229485|FG000|Overall Study|Protocol Violation|2|||
157131096|NCT02411747|567229486|FG001|Overall Study|Protocol Violation|4|||
157131097|NCT00675597|567229487|FG000|Overall Study|Withdrawal by Subject|3|||
157131098|NCT00560755|567229489|FG000|Overall Study|Protocol Violation|15|||
157131099|NCT00560755|567229489|FG000|Overall Study|Withdrawal by Subject|26|||
157131100|NCT00560755|567229489|FG000|Overall Study|Lost to Follow-up|9|||
157018070|NCT05524233|566819475|FG000|Overall Study|Lost to Follow-up|2|||
157018071|NCT05524233|566819475|FG000|Overall Study|Adverse Event|2|||
157018072|NCT05524233|566819475|FG000|Overall Study|Withdrawal by Subject|1|||
157018073|NCT04382898|566819476|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
157018074|NCT04382898|566819477|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
157018075|NCT04382898|566819478|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
157018076|NCT04382898|566819479|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
157018077|NCT04382898|566819480|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
157018078|NCT04382898|566819476|FG000|Part 1: Dose Titration|Death|6|||
157018079|NCT04382898|566819477|FG001|Part 1: Dose Titration|Death|0|||
157018080|NCT04382898|566819478|FG002|Part 1: Dose Titration|Death|0|||
157018081|NCT04382898|566819479|FG003|Part 1: Dose Titration|Death|0|||
157018082|NCT04382898|566819480|FG004|Part 1: Dose Titration|Death|0|||
157131101|NCT00560755|567229489|FG000|Overall Study|Adverse Event|8|||
157131102|NCT00560755|567229489|FG000|Overall Study|Physician Decision|2|||
157018083|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157018084|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157131103|NCT01439945|567229494|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
157131104|NCT01439945|567229495|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
157131105|NCT01439945|567229496|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
157018085|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
157131106|NCT01439945|567229497|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
157131107|NCT01439945|567229494|FG000|Double-Blind Treatment Phase|Ineligible|1|||
156793231|NCT00581100|565996189|FG000|Overall Study|Adverse Event|2|||
157131108|NCT01439945|567229495|FG001|Double-Blind Treatment Phase|Ineligible|2|||
157131109|NCT01439945|567229496|FG002|Double-Blind Treatment Phase|Ineligible|0|||
157131110|NCT01439945|567229497|FG003|Double-Blind Treatment Phase|Ineligible|1|||
157131111|NCT04082663|567229510|FG000|Overall Study|Adverse Event|6|||
157131112|NCT04082663|567229510|FG000|Overall Study|Lost to Follow-up|1|||
157131113|NCT02542072|567229511|FG000|First Intervention (1 Month)|Adverse Event|1|||
157131114|NCT02542072|567229512|FG001|First Intervention (1 Month)|Adverse Event|1|||
157131115|NCT02542072|567229511|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
157131116|NCT02542072|567229512|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
157131117|NCT02542072|567229511|FG000|First Intervention (1 Month)|Lens discomfort|1|||
157131118|NCT02542072|567229512|FG001|First Intervention (1 Month)|Lens discomfort|2|||
157131119|NCT02542072|567229511|FG000|First Intervention (1 Month)|Protocol Violation|1|||
157131120|NCT02542072|567229512|FG001|First Intervention (1 Month)|Protocol Violation|0|||
157131121|NCT02542072|567229511|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
157131122|NCT02542072|567229512|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
157131123|NCT02542072|567229511|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
157131124|NCT02542072|567229512|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
157131125|NCT02959814|567229513|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
157131126|NCT02959814|567229513|FG000|Overall Study|Excluded based on anatomical criteria|2|||
157131127|NCT02959814|567229513|FG000|Overall Study|Protocol Violation|7|||
157131128|NCT02959814|567229513|FG000|Overall Study|FFR not measured|2|||
157131129|NCT02959814|567229513|FG000|Overall Study|In-procedure QFR not computed|6|||
157131130|NCT02959814|567229513|FG000|Overall Study|Excluded by FFR core-lab|24|||
157131131|NCT01990261|567229514|FG000|Overall Study|Death Before Treatment Start|2|||
157131132|NCT01990261|567229514|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
157131133|NCT01990261|567229514|FG000|Overall Study|Death From other Causes|1|||
157131134|NCT01990261|567229514|FG000|Overall Study|Disease Progression (PD)|8|||
157131135|NCT01990261|567229514|FG000|Overall Study|PD Before Treatment Start|1|||
157131136|NCT01990261|567229514|FG000|Overall Study|Dossier not Approved|1|||
157131137|NCT01990261|567229514|FG000|Overall Study|Lost to Follow-up|2|||
157131138|NCT04343651|567229518|FG000|Overall Study|Physician Decision|2|||
157131139|NCT04343651|567229519|FG001|Overall Study|Physician Decision|1|||
157131140|NCT04343651|567229518|FG000|Overall Study|Lost to Follow-up|2|||
157131141|NCT04343651|567229519|FG001|Overall Study|Lost to Follow-up|1|||
157131142|NCT04343651|567229518|FG000|Overall Study|Protocol Violation|4|||
157131143|NCT04343651|567229519|FG001|Overall Study|Protocol Violation|6|||
157131144|NCT04343651|567229518|FG000|Overall Study|Missing|3|||
157131145|NCT04343651|567229519|FG001|Overall Study|Missing|9|||
157131146|NCT04343651|567229518|FG000|Overall Study|Withdrawal by Subject|0|||
157131147|NCT04343651|567229519|FG001|Overall Study|Withdrawal by Subject|4|||
157131148|NCT04343651|567229518|FG000|Overall Study|Death|0|||
157131149|NCT04343651|567229519|FG001|Overall Study|Death|1|||
157131150|NCT04343651|567229518|FG000|Overall Study|Did not start treatment|1|||
157131151|NCT04343651|567229519|FG001|Overall Study|Did not start treatment|1|||
157131152|NCT04343651|567229518|FG000|Overall Study|Patient did not complete visits 3-6|0|||
157131153|NCT04343651|567229519|FG001|Overall Study|Patient did not complete visits 3-6|1|||
157131154|NCT03219164|567231912|FG000|Overall Study|Study Terminated by Sponsor|16|||
157131155|NCT03219164|567231913|FG001|Overall Study|Study Terminated by Sponsor|12|||
157131156|NCT03219164|567231912|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
157131157|NCT03219164|567231913|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
157131158|NCT03219164|567231912|FG000|Overall Study|Lost to Follow-up|1|||
157131159|NCT03219164|567231913|FG001|Overall Study|Lost to Follow-up|1|||
157131160|NCT03219164|567231912|FG000|Overall Study|Adverse Event|1|||
157131161|NCT03219164|567231913|FG001|Overall Study|Adverse Event|0|||
157131162|NCT03219164|567231912|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157131163|NCT03219164|567231913|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157131164|NCT03219164|567231912|FG000|Overall Study|Protocol Violation|0|||
157131165|NCT03219164|567231913|FG001|Overall Study|Protocol Violation|1|||
157131166|NCT03219164|567231912|FG000|Overall Study|Withdrew Assent|1|||
157131167|NCT03219164|567231913|FG001|Overall Study|Withdrew Assent|0|||
157131168|NCT04574999|567231917|FG000|Overall Study|Adverse Event|1|||
157131169|NCT04574999|567231918|FG001|Overall Study|Adverse Event|0|||
157131170|NCT04574999|567231917|FG000|Overall Study|Lack of Efficacy|2|||
157131171|NCT04574999|567231918|FG001|Overall Study|Lack of Efficacy|3|||
157131172|NCT04574999|567231917|FG000|Overall Study|Protocol Violation|1|||
157131173|NCT04574999|567231918|FG001|Overall Study|Protocol Violation|0|||
156793232|NCT00581100|565996190|FG001|Overall Study|Adverse Event|1|||
157131174|NCT04574999|567231917|FG000|Overall Study|Withdrawal by Subject|2|||
157131175|NCT04574999|567231918|FG001|Overall Study|Withdrawal by Subject|2|||
157216854|NCT01393990|567540946|FG011|Overall Study|Progressive Disease|0|||
157131176|NCT04574999|567231917|FG000|Overall Study|Lost to Follow-up|1|||
156793233|NCT00581100|565996189|FG000|Overall Study|Withdrawal by Subject|1|||
157131177|NCT04574999|567231918|FG001|Overall Study|Lost to Follow-up|0|||
157131178|NCT04574999|567231917|FG000|Overall Study|Personal problems|1|||
157131179|NCT04574999|567231918|FG001|Overall Study|Personal problems|0|||
157131180|NCT04574999|567231917|FG000|Overall Study|Previous planned surgery|1|||
157131181|NCT04574999|567231918|FG001|Overall Study|Previous planned surgery|0|||
157131182|NCT00206726|567231920|FG000|Overall Study|Delayed recovery of blood counts|1|||
157131183|NCT00206726|567231920|FG000|Overall Study|Progressive disease or relapsed disease|18|||
157131184|NCT00206726|567231920|FG000|Overall Study|Placed on new protocol|1|||
157131185|NCT00206726|567231920|FG000|Overall Study|Bone marrow transplant|1|||
157018086|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157018087|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
157018088|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
157018089|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
157018090|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
157018091|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
157018092|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
157018093|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Death|0|||
157018094|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Death|17|||
157018095|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Death|13|||
157018096|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Death|1|||
157018097|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Death|0|||
157018098|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
157018099|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
157018100|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
157131186|NCT00206726|567231920|FG000|Overall Study|Adverse Event|17|||
157131187|NCT00206726|567231920|FG000|Overall Study|Death|4|||
157131188|NCT00206726|567231920|FG000|Overall Study|Protocol Violation|1|||
157018101|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
157018102|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
157018103|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
157018104|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
157018105|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
157018106|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
157018107|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
157018108|NCT04382898|566819476|FG000|Part 2: Dose Expansion|Other|0|||
157018109|NCT04382898|566819477|FG001|Part 2: Dose Expansion|Other|0|||
157018110|NCT04382898|566819478|FG002|Part 2: Dose Expansion|Other|1|||
157018111|NCT04382898|566819479|FG003|Part 2: Dose Expansion|Other|0|||
157018112|NCT04382898|566819480|FG004|Part 2: Dose Expansion|Other|0|||
157018113|NCT05956002|566819481|FG000|Treatment Period 3|Adverse Event|0|||
157018114|NCT05956002|566819482|FG001|Treatment Period 3|Adverse Event|0|||
157018115|NCT05956002|566819483|FG002|Treatment Period 3|Adverse Event|1|||
157018116|NCT05956002|566819484|FG003|Treatment Period 3|Adverse Event|0|||
157018117|NCT02307565|566819485|FG000|Overall Study|Adverse Event|3|||
157018118|NCT02307565|566819486|FG001|Overall Study|Adverse Event|2|||
157018119|NCT02307565|566819485|FG000|Overall Study|Withdrawal by Subject|2|||
157018120|NCT02307565|566819486|FG001|Overall Study|Withdrawal by Subject|2|||
157018121|NCT01772472|566819487|FG000|Overall Study|Death|126|||
157018122|NCT01772472|566819488|FG001|Overall Study|Death|94|||
157018123|NCT01772472|566819487|FG000|Overall Study|Lost to Follow-up|51|||
157018124|NCT01772472|566819488|FG001|Overall Study|Lost to Follow-up|50|||
157018125|NCT01772472|566819487|FG000|Overall Study|Other|9|||
157018126|NCT01772472|566819488|FG001|Overall Study|Other|7|||
157018127|NCT01772472|566819487|FG000|Overall Study|Physician Decision|1|||
157018128|NCT01772472|566819488|FG001|Overall Study|Physician Decision|7|||
157018129|NCT01772472|566819487|FG000|Overall Study|Withdrawal by Subject|115|||
157018130|NCT01772472|566819488|FG001|Overall Study|Withdrawal by Subject|90|||
157018131|NCT01772472|566819487|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
157018132|NCT01772472|566819488|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
157018133|NCT00446225|566819489|FG000|Overall Study|Protocol Violation|1|||
157018134|NCT00446225|566819490|FG001|Overall Study|Protocol Violation|0|||
157018135|NCT04450342|566819491|FG000|Overall Study|Adverse Event|1|||
157018136|NCT04450342|566819492|FG001|Overall Study|Adverse Event|1|||
157131189|NCT00206726|567231920|FG000|Overall Study|Withdrawal by Subject|8|||
157131190|NCT05148884|567231921|FG000|Overall Study|Withdrawal by Subject|3|||
157131191|NCT05148884|567231922|FG001|Overall Study|Withdrawal by Subject|0|||
157131192|NCT05148884|567231921|FG000|Overall Study|Deep brain stimulation operation|0|||
157018137|NCT04450342|566819493|FG002|Overall Study|Adverse Event|0|||
157018138|NCT04450342|566819491|FG000|Overall Study|Device not used|1|||
157018139|NCT04450342|566819492|FG001|Overall Study|Device not used|0|||
157018140|NCT04450342|566819493|FG002|Overall Study|Device not used|0|||
157018141|NCT04450342|566819491|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
157018142|NCT04450342|566819492|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
157018143|NCT04450342|566819493|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
157018144|NCT04450342|566819491|FG000|Overall Study|Physician Decision|1|||
157018145|NCT04450342|566819492|FG001|Overall Study|Physician Decision|0|||
157018146|NCT04450342|566819493|FG002|Overall Study|Physician Decision|1|||
157131193|NCT05148884|567231922|FG001|Overall Study|Deep brain stimulation operation|1|||
157131194|NCT01341457|567231925|FG000|Overall Study|Adverse Event|2|||
156716299|NCT01125189|565705323|FG002|Treatment Period|Poor compliance/noncompliance|0|||
156716300|NCT01125189|565705321|FG000|Treatment Period|Participants requested to discontinue|1|||
156716301|NCT01125189|565705322|FG001|Treatment Period|Participants requested to discontinue|3|||
156716302|NCT01125189|565705323|FG002|Treatment Period|Participants requested to discontinue|4|||
157131195|NCT01341457|567231926|FG001|Overall Study|Adverse Event|0|||
157131196|NCT00365989|567231927|FG000|Overall Study|Withdrawal by Subject|1|||
157131197|NCT00365989|567231927|FG000|Overall Study|Non-compliance|1|||
157131198|NCT00832819|567231930|FG000|Overall Study|Adverse Event|0|||
157131199|NCT00832819|567231931|FG001|Overall Study|Adverse Event|1|||
157131200|NCT00832819|567231932|FG002|Overall Study|Adverse Event|0|||
157131201|NCT00832819|567231930|FG000|Overall Study|Protocol Violation|0|||
157131202|NCT00832819|567231931|FG001|Overall Study|Protocol Violation|0|||
157131203|NCT00832819|567231932|FG002|Overall Study|Protocol Violation|1|||
157131204|NCT00317044|567231933|FG000|Overall Study|Protocol Violation|28|||
157131205|NCT00317044|567231934|FG001|Overall Study|Protocol Violation|22|||
157131206|NCT00317044|567231935|FG002|Overall Study|Protocol Violation|20|||
157131207|NCT00317044|567231933|FG000|Overall Study|Adverse Event|4|||
157131208|NCT00317044|567231934|FG001|Overall Study|Adverse Event|7|||
157131209|NCT00317044|567231935|FG002|Overall Study|Adverse Event|4|||
157131210|NCT00317044|567231933|FG000|Overall Study|Withdrawal by Subject|10|||
157131211|NCT00317044|567231934|FG001|Overall Study|Withdrawal by Subject|7|||
157131212|NCT00317044|567231935|FG002|Overall Study|Withdrawal by Subject|12|||
157131213|NCT00317044|567231933|FG000|Overall Study|Lost to Follow-up|0|||
157131214|NCT00317044|567231934|FG001|Overall Study|Lost to Follow-up|2|||
157131215|NCT00317044|567231935|FG002|Overall Study|Lost to Follow-up|3|||
157131216|NCT00317044|567231933|FG000|Overall Study|Multiple Reasons|6|||
157131217|NCT00317044|567231934|FG001|Overall Study|Multiple Reasons|2|||
157131218|NCT00317044|567231935|FG002|Overall Study|Multiple Reasons|6|||
157131219|NCT04317690|567231938|FG000|Overall Study|did not have complete information for primary outcome|0|||
157131220|NCT04317690|567231939|FG001|Overall Study|did not have complete information for primary outcome|4|||
157131221|NCT04317690|567231940|FG002|Overall Study|did not have complete information for primary outcome|0|||
157131222|NCT04317690|567231941|FG003|Overall Study|did not have complete information for primary outcome|2|||
157131223|NCT04317690|567231942|FG004|Overall Study|did not have complete information for primary outcome|0|||
157131224|NCT02318095|567231943|FG000|Overall Study|Adverse Event|1|||
157131225|NCT01717638|567231944|FG000|Overall Study|Lost to Follow-up|0|||
157131226|NCT01717638|567231945|FG001|Overall Study|Lost to Follow-up|0|||
157131227|NCT01717638|567231946|FG002|Overall Study|Lost to Follow-up|0|||
157131228|NCT01717638|567231947|FG003|Overall Study|Lost to Follow-up|0|||
157131229|NCT01717638|567231948|FG004|Overall Study|Lost to Follow-up|0|||
157131230|NCT01717638|567231949|FG005|Overall Study|Lost to Follow-up|1|||
157131231|NCT01717638|567231950|FG006|Overall Study|Lost to Follow-up|0|||
157131232|NCT01717638|567231951|FG007|Overall Study|Lost to Follow-up|0|||
157131233|NCT01717638|567231952|FG008|Overall Study|Lost to Follow-up|0|||
157131234|NCT01717638|567231953|FG009|Overall Study|Lost to Follow-up|0|||
157131235|NCT01717638|567231954|FG010|Overall Study|Lost to Follow-up|0|||
157131236|NCT01717638|567231955|FG011|Overall Study|Lost to Follow-up|0|||
157131237|NCT01717638|567231956|FG012|Overall Study|Lost to Follow-up|0|||
157131238|NCT01717638|567231944|FG000|Overall Study|Father in hospital|0|||
157131239|NCT01717638|567231945|FG001|Overall Study|Father in hospital|0|||
157131240|NCT01717638|567231946|FG002|Overall Study|Father in hospital|0|||
157131241|NCT01717638|567231947|FG003|Overall Study|Father in hospital|0|||
157131242|NCT01717638|567231948|FG004|Overall Study|Father in hospital|0|||
157131243|NCT01717638|567231949|FG005|Overall Study|Father in hospital|0|||
157131244|NCT01717638|567231950|FG006|Overall Study|Father in hospital|0|||
157131245|NCT01717638|567231951|FG007|Overall Study|Father in hospital|0|||
157131246|NCT01717638|567231952|FG008|Overall Study|Father in hospital|0|||
157131247|NCT01717638|567231953|FG009|Overall Study|Father in hospital|0|||
157131248|NCT01717638|567231954|FG010|Overall Study|Father in hospital|0|||
157131249|NCT01717638|567231955|FG011|Overall Study|Father in hospital|0|||
157131250|NCT01717638|567231956|FG012|Overall Study|Father in hospital|1|||
157131251|NCT01717638|567231944|FG000|Overall Study|Withdrawal by Subject|0|||
157131252|NCT01717638|567231945|FG001|Overall Study|Withdrawal by Subject|1|||
157131253|NCT01717638|567231946|FG002|Overall Study|Withdrawal by Subject|1|||
157131254|NCT01717638|567231947|FG003|Overall Study|Withdrawal by Subject|0|||
157131255|NCT01717638|567231948|FG004|Overall Study|Withdrawal by Subject|1|||
157131256|NCT01717638|567231949|FG005|Overall Study|Withdrawal by Subject|0|||
157131257|NCT01717638|567231950|FG006|Overall Study|Withdrawal by Subject|2|||
157131258|NCT01717638|567231951|FG007|Overall Study|Withdrawal by Subject|1|||
157131259|NCT01717638|567231952|FG008|Overall Study|Withdrawal by Subject|2|||
157131260|NCT01717638|567231953|FG009|Overall Study|Withdrawal by Subject|1|||
157131261|NCT01717638|567231954|FG010|Overall Study|Withdrawal by Subject|0|||
157131262|NCT01717638|567231955|FG011|Overall Study|Withdrawal by Subject|0|||
157131263|NCT01717638|567231956|FG012|Overall Study|Withdrawal by Subject|18|||
157131264|NCT02626338|567231957|FG000|Overall Study|Lack of Efficacy|3|||
157131265|NCT02626338|567231958|FG001|Overall Study|Lack of Efficacy|2|||
157131266|NCT02626338|567231959|FG002|Overall Study|Lack of Efficacy|0|||
157131267|NCT03312218|567231965|FG000|Overall Study|Never signed in to access the app|54|||
157131268|NCT03312218|567231966|FG001|Overall Study|Never signed in to access the app|58|||
157131269|NCT01901224|567231967|FG000|Overall Study|study was not funded and terminated|2|||
157131270|NCT01279057|567231968|FG000|Overall Study|Adverse Event|1|||
157131271|NCT01279057|567231969|FG001|Overall Study|Adverse Event|0|||
157131272|NCT01279057|567231970|FG002|Overall Study|Adverse Event|1|||
157131273|NCT01279057|567231968|FG000|Overall Study|Insufficient therapeutic response|0|||
157131274|NCT01279057|567231969|FG001|Overall Study|Insufficient therapeutic response|0|||
157131275|NCT01279057|567231970|FG002|Overall Study|Insufficient therapeutic response|1|||
157131276|NCT01279057|567231968|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
157131277|NCT01279057|567231969|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
157131278|NCT01279057|567231970|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
156716303|NCT01125189|565705321|FG000|Treatment Period|Other reasons|1|||
156716304|NCT01125189|565705322|FG001|Treatment Period|Other reasons|1|||
156716305|NCT01125189|565705323|FG002|Treatment Period|Other reasons|0|||
156793234|NCT00581100|565996190|FG001|Overall Study|Withdrawal by Subject|4|||
156793235|NCT00581100|565996189|FG000|Overall Study|Other|3|||
156793236|NCT00581100|565996190|FG001|Overall Study|Other|0|||
156793237|NCT04129398|565996191|FG000|Overall Study|Physician Decision|2|||
156793238|NCT00590317|565996192|FG000|Overall Study|Lack of Efficacy|1|||
156793239|NCT00590317|565996193|FG001|Overall Study|Lack of Efficacy|5|||
156793240|NCT02904265|565996194|FG000|Overall Study|Physician Decision|1|||
156793241|NCT02904265|565996195|FG001|Overall Study|Physician Decision|2|||
156793242|NCT00185614|565996198|FG000|Inter-treatment Period|Physician Decision|1|||
156793243|NCT00185614|565996198|FG000|Inter-treatment Period|Relapse|2|||
156793244|NCT00185614|565996198|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
156793245|NCT00866775|565996208|FG000|Overall Study|Adverse Event|5|||
156793246|NCT00866775|565996209|FG001|Overall Study|Adverse Event|19|||
156793247|NCT00866775|565996208|FG000|Overall Study|Death|1|||
156793248|NCT00866775|565996209|FG001|Overall Study|Death|0|||
156793249|NCT00866775|565996208|FG000|Overall Study|Lost to Follow-up|0|||
156793250|NCT00866775|565996209|FG001|Overall Study|Lost to Follow-up|4|||
156793251|NCT00866775|565996208|FG000|Overall Study|Physician Decision|0|||
156793252|NCT00866775|565996209|FG001|Overall Study|Physician Decision|3|||
156793253|NCT00866775|565996208|FG000|Overall Study|Protocol Violation|3|||
156793254|NCT00866775|565996209|FG001|Overall Study|Protocol Violation|4|||
156793255|NCT00866775|565996208|FG000|Overall Study|Withdrawal by Subject|4|||
156793256|NCT00866775|565996209|FG001|Overall Study|Withdrawal by Subject|4|||
156793257|NCT00866775|565996208|FG000|Overall Study|met exit criteria|23|||
156793258|NCT00866775|565996209|FG001|Overall Study|met exit criteria|17|||
156793259|NCT00866775|565996208|FG000|Overall Study|discontinued due to communication error|0|||
156793260|NCT00866775|565996209|FG001|Overall Study|discontinued due to communication error|1|||
156793261|NCT00003907|565996210|FG000|Overall Study|Adverse Event|2|||
156793262|NCT00003907|565996211|FG001|Overall Study|Adverse Event|11|||
156793263|NCT00003907|565996210|FG000|Overall Study|Death|2|||
156793264|NCT00003907|565996211|FG001|Overall Study|Death|0|||
156793265|NCT00003907|565996210|FG000|Overall Study|Withdrawal by Subject|1|||
156793266|NCT00003907|565996211|FG001|Overall Study|Withdrawal by Subject|3|||
156793267|NCT00003907|565996210|FG000|Overall Study|Progressive disease|4|||
156793268|NCT00003907|565996211|FG001|Overall Study|Progressive disease|4|||
156793269|NCT00003907|565996210|FG000|Overall Study|Complicating disease|1|||
156793270|NCT00003907|565996211|FG001|Overall Study|Complicating disease|0|||
156793271|NCT00003907|565996210|FG000|Overall Study|Other|1|||
156793272|NCT00003907|565996211|FG001|Overall Study|Other|3|||
156793273|NCT00003907|565996210|FG000|Overall Study|ineligible or not treated|2|||
156793274|NCT00003907|565996211|FG001|Overall Study|ineligible or not treated|2|||
156793275|NCT02439957|565996214|FG000|Overall Study|Study Terminated|3|||
157131279|NCT01279057|567231968|FG000|Overall Study|Withdrew consent|2|||
157131280|NCT01279057|567231969|FG001|Overall Study|Withdrew consent|0|||
156716306|NCT01125189|565705321|FG000|Treatment Period|Completed 24 week treatment period only|2|||
156716307|NCT01125189|565705322|FG001|Treatment Period|Completed 24 week treatment period only|1|||
156716308|NCT01125189|565705323|FG002|Treatment Period|Completed 24 week treatment period only|2|||
156716309|NCT01125189|565705321|FG000|Follow up Period|Withdrawal by Subject|3|||
156716310|NCT01125189|565705322|FG001|Follow up Period|Withdrawal by Subject|2|||
156716311|NCT01125189|565705323|FG002|Follow up Period|Withdrawal by Subject|5|||
156716312|NCT01125189|565705321|FG000|Follow up Period|Death|1|||
156716313|NCT01125189|565705322|FG001|Follow up Period|Death|0|||
156716314|NCT01125189|565705323|FG002|Follow up Period|Death|0|||
156716315|NCT01125189|565705321|FG000|Follow up Period|Lost to Follow-up|12|||
156716316|NCT01125189|565705322|FG001|Follow up Period|Lost to Follow-up|9|||
156716317|NCT01125189|565705323|FG002|Follow up Period|Lost to Follow-up|6|||
156793276|NCT02439957|565996215|FG001|Overall Study|Study Terminated|3|||
156793277|NCT00586157|565996216|FG000|First Intervention|Worsening behavior|1|||
156793278|NCT00586157|565996217|FG001|First Intervention|Worsening behavior|0|||
156793279|NCT00586157|565996216|FG000|Second Intervention|Withdrawal by Subject|1|||
156793280|NCT00586157|565996217|FG001|Second Intervention|Withdrawal by Subject|0|||
156793281|NCT00586157|565996216|FG000|Second Intervention|Worsening behavior|1|||
157131281|NCT01279057|567231970|FG002|Overall Study|Withdrew consent|1|||
157131282|NCT01279057|567231968|FG000|Overall Study|Pregnancy|0|||
157131283|NCT01279057|567231969|FG001|Overall Study|Pregnancy|1|||
157131284|NCT01279057|567231970|FG002|Overall Study|Pregnancy|0|||
157131285|NCT01279057|567231968|FG000|Overall Study|Other|3|||
157131286|NCT01279057|567231969|FG001|Overall Study|Other|3|||
157131287|NCT01279057|567231970|FG002|Overall Study|Other|0|||
157131288|NCT01427309|567231971|FG000|Overall Study|Lost to Follow-up|130|||
157131289|NCT01427309|567231972|FG001|Overall Study|Lost to Follow-up|145|||
157131290|NCT01427309|567231973|FG002|Overall Study|Lost to Follow-up|122|||
157131291|NCT01427309|567231974|FG003|Overall Study|Lost to Follow-up|135|||
157131292|NCT01427309|567231971|FG000|Overall Study|Protocol Violation|42|||
157131293|NCT01427309|567231972|FG001|Overall Study|Protocol Violation|69|||
157131294|NCT01427309|567231973|FG002|Overall Study|Protocol Violation|125|||
157131295|NCT01427309|567231974|FG003|Overall Study|Protocol Violation|124|||
157131296|NCT01427309|567231971|FG000|Overall Study|Adverse Event|0|||
157131297|NCT01427309|567231972|FG001|Overall Study|Adverse Event|0|||
157131298|NCT01427309|567231973|FG002|Overall Study|Adverse Event|3|||
157131299|NCT01427309|567231974|FG003|Overall Study|Adverse Event|1|||
157131300|NCT01427309|567231971|FG000|Overall Study|Serious adverse event|52|||
157131301|NCT01427309|567231972|FG001|Overall Study|Serious adverse event|45|||
157131302|NCT01427309|567231973|FG002|Overall Study|Serious adverse event|50|||
157131303|NCT01427309|567231974|FG003|Overall Study|Serious adverse event|61|||
157131304|NCT01427309|567231971|FG000|Overall Study|Withdrawal by Subject|148|||
157131305|NCT01427309|567231972|FG001|Overall Study|Withdrawal by Subject|148|||
157131306|NCT01427309|567231973|FG002|Overall Study|Withdrawal by Subject|61|||
157131307|NCT01427309|567231974|FG003|Overall Study|Withdrawal by Subject|55|||
157131308|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
157131309|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
157131310|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
157131311|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
157131312|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
157131313|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
157018147|NCT04450342|566819491|FG000|Overall Study|Protocol Deviation|0|||
157018148|NCT04450342|566819492|FG001|Overall Study|Protocol Deviation|1|||
157018149|NCT04450342|566819493|FG002|Overall Study|Protocol Deviation|0|||
157018150|NCT04450342|566819491|FG000|Overall Study|Reoperation|1|||
157018151|NCT04450342|566819492|FG001|Overall Study|Reoperation|1|||
157018152|NCT04450342|566819493|FG002|Overall Study|Reoperation|0|||
157018153|NCT04450342|566819491|FG000|Overall Study|Screen Failures|0|||
157018154|NCT04450342|566819492|FG001|Overall Study|Screen Failures|0|||
157018155|NCT04450342|566819493|FG002|Overall Study|Screen Failures|2|||
157018156|NCT04450342|566819491|FG000|Overall Study|Site Terminated by Sponsor|1|||
157018157|NCT04450342|566819492|FG001|Overall Study|Site Terminated by Sponsor|1|||
157131314|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
157131315|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
157131316|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
157131317|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
157131318|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
157131319|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
157131320|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
157018158|NCT04450342|566819493|FG002|Overall Study|Site Terminated by Sponsor|1|||
157018159|NCT04450342|566819491|FG000|Overall Study|Study Terminated by Sponsor|31|||
157018160|NCT04450342|566819492|FG001|Overall Study|Study Terminated by Sponsor|29|||
157018161|NCT04450342|566819493|FG002|Overall Study|Study Terminated by Sponsor|6|||
157018162|NCT04450342|566819491|FG000|Overall Study|Withdrawal by Subject|0|||
157018163|NCT04450342|566819492|FG001|Overall Study|Withdrawal by Subject|1|||
157018164|NCT04450342|566819493|FG002|Overall Study|Withdrawal by Subject|2|||
157131321|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
156793282|NCT00586157|565996217|FG001|Second Intervention|Worsening behavior|0|||
156793283|NCT00586157|565996216|FG000|Second Intervention|Adverse Event|0|||
156793284|NCT00586157|565996217|FG001|Second Intervention|Adverse Event|1|||
157018165|NCT00220740|566819494|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
157131322|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
157018166|NCT00220740|566819495|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
157018167|NCT00220740|566819494|FG000|Efficacy Period|Adverse Event|1|||
157131323|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
157131324|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
157131325|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
157018168|NCT00220740|566819495|FG001|Efficacy Period|Adverse Event|1|||
157131326|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
157018169|NCT00220740|566819494|FG000|Efficacy Period|Withdrawal by Subject|1|||
157018170|NCT00220740|566819495|FG001|Efficacy Period|Withdrawal by Subject|0|||
157018171|NCT00220740|566819494|FG000|Efficacy Period|Protocol Violation|1|||
157131327|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
157131328|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
157216855|NCT01393990|567540947|FG012|Overall Study|Progressive Disease|0|||
157131329|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
157131330|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
157131331|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
157131332|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
157131333|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
157131334|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
157131335|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
157131336|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
157131337|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
157131338|NCT00849017|567231977|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
157131339|NCT00849017|567231978|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
157131340|NCT00849017|567231979|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
157131341|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
157131342|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
157131343|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
157131344|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
157131345|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
157131346|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
157131347|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
157131348|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
157131349|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
157131350|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
157131351|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
157131352|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
157131353|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
157131354|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
157131355|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
157131356|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
157131357|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
157131358|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
157131359|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
157131360|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
157131361|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
157131362|NCT00849017|567231977|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
157131363|NCT00849017|567231978|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
157131364|NCT00849017|567231979|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
157131365|NCT03502187|567231980|FG000|Overall Study|Withdrawal by Subject|4|||
157131366|NCT03502187|567231981|FG001|Overall Study|Withdrawal by Subject|3|||
157131367|NCT03502187|567231982|FG002|Overall Study|Withdrawal by Subject|3|||
157131368|NCT03502187|567231980|FG000|Overall Study|Lost to Follow-up|5|||
157131369|NCT03502187|567231981|FG001|Overall Study|Lost to Follow-up|4|||
157131370|NCT03502187|567231982|FG002|Overall Study|Lost to Follow-up|5|||
157131371|NCT02913313|567231983|FG000|Overall Study|DISEASE PROGRESSION|1|||
157131372|NCT02913313|567231984|FG001|Overall Study|DISEASE PROGRESSION|2|||
157131373|NCT02913313|567231985|FG002|Overall Study|DISEASE PROGRESSION|2|||
157131374|NCT02913313|567231986|FG003|Overall Study|DISEASE PROGRESSION|4|||
157131375|NCT02913313|567231987|FG004|Overall Study|DISEASE PROGRESSION|6|||
157131376|NCT02913313|567231988|FG005|Overall Study|DISEASE PROGRESSION|4|||
157131377|NCT02913313|567231989|FG006|Overall Study|DISEASE PROGRESSION|19|||
157131378|NCT02913313|567231990|FG007|Overall Study|DISEASE PROGRESSION|3|||
157131379|NCT02913313|567231991|FG008|Overall Study|DISEASE PROGRESSION|4|||
157131380|NCT02913313|567231992|FG009|Overall Study|DISEASE PROGRESSION|4|||
157131381|NCT02913313|567231993|FG010|Overall Study|DISEASE PROGRESSION|11|||
157131382|NCT02913313|567231994|FG011|Overall Study|DISEASE PROGRESSION|5|||
157131383|NCT02913313|567231995|FG012|Overall Study|DISEASE PROGRESSION|14|||
157131384|NCT02913313|567231996|FG013|Overall Study|DISEASE PROGRESSION|3|||
157131385|NCT02913313|567231983|FG000|Overall Study|Not Reported|0|||
157131386|NCT02913313|567231984|FG001|Overall Study|Not Reported|0|||
157131387|NCT02913313|567231985|FG002|Overall Study|Not Reported|0|||
157131388|NCT02913313|567231986|FG003|Overall Study|Not Reported|0|||
157131389|NCT02913313|567231987|FG004|Overall Study|Not Reported|1|||
157131390|NCT02913313|567231988|FG005|Overall Study|Not Reported|0|||
157131391|NCT02913313|567231989|FG006|Overall Study|Not Reported|0|||
157131392|NCT02913313|567231990|FG007|Overall Study|Not Reported|0|||
157131393|NCT02913313|567231991|FG008|Overall Study|Not Reported|0|||
157131394|NCT02913313|567231992|FG009|Overall Study|Not Reported|0|||
157131395|NCT02913313|567231993|FG010|Overall Study|Not Reported|4|||
157131396|NCT02913313|567231994|FG011|Overall Study|Not Reported|0|||
156716318|NCT01125189|565705321|FG000|Follow up Period|Other reasons|4|||
157131397|NCT02913313|567231995|FG012|Overall Study|Not Reported|0|||
157131398|NCT02913313|567231996|FG013|Overall Study|Not Reported|0|||
157131399|NCT02913313|567231983|FG000|Overall Study|Other reasons|0|||
157131400|NCT02913313|567231984|FG001|Overall Study|Other reasons|0|||
157131401|NCT02913313|567231985|FG002|Overall Study|Other reasons|0|||
157131402|NCT02913313|567231986|FG003|Overall Study|Other reasons|0|||
157131403|NCT02913313|567231987|FG004|Overall Study|Other reasons|1|||
157131404|NCT02913313|567231988|FG005|Overall Study|Other reasons|0|||
157131405|NCT02913313|567231989|FG006|Overall Study|Other reasons|0|||
157131406|NCT02913313|567231990|FG007|Overall Study|Other reasons|0|||
157131407|NCT02913313|567231991|FG008|Overall Study|Other reasons|0|||
157131408|NCT02913313|567231992|FG009|Overall Study|Other reasons|0|||
157131409|NCT02913313|567231993|FG010|Overall Study|Other reasons|1|||
157131410|NCT02913313|567231994|FG011|Overall Study|Other reasons|0|||
157131411|NCT02913313|567231995|FG012|Overall Study|Other reasons|0|||
157131412|NCT02913313|567231996|FG013|Overall Study|Other reasons|0|||
157131413|NCT02913313|567231983|FG000|Overall Study|Withdrawal by Subject|0|||
157131414|NCT02913313|567231984|FG001|Overall Study|Withdrawal by Subject|0|||
157131415|NCT02913313|567231985|FG002|Overall Study|Withdrawal by Subject|1|||
157131416|NCT02913313|567231986|FG003|Overall Study|Withdrawal by Subject|0|||
157131417|NCT02913313|567231987|FG004|Overall Study|Withdrawal by Subject|0|||
157131418|NCT02913313|567231988|FG005|Overall Study|Withdrawal by Subject|0|||
157131419|NCT02913313|567231989|FG006|Overall Study|Withdrawal by Subject|1|||
157131420|NCT02913313|567231990|FG007|Overall Study|Withdrawal by Subject|1|||
157131421|NCT02913313|567231991|FG008|Overall Study|Withdrawal by Subject|0|||
157131422|NCT02913313|567231992|FG009|Overall Study|Withdrawal by Subject|0|||
157131423|NCT02913313|567231993|FG010|Overall Study|Withdrawal by Subject|1|||
157131424|NCT02913313|567231994|FG011|Overall Study|Withdrawal by Subject|0|||
157131425|NCT02913313|567231995|FG012|Overall Study|Withdrawal by Subject|0|||
157131426|NCT02913313|567231996|FG013|Overall Study|Withdrawal by Subject|0|||
157131427|NCT02913313|567231983|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131428|NCT02913313|567231984|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131429|NCT02913313|567231985|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131430|NCT02913313|567231986|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131431|NCT02913313|567231987|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131432|NCT02913313|567231988|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131433|NCT02913313|567231989|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131434|NCT02913313|567231990|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131435|NCT02913313|567231991|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131436|NCT02913313|567231992|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131437|NCT02913313|567231993|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
157131438|NCT02913313|567231994|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
157131439|NCT02913313|567231995|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
157131440|NCT02913313|567231996|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
157131441|NCT02913313|567231983|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
157131442|NCT02913313|567231984|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
157131443|NCT02913313|567231985|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
157131444|NCT02913313|567231986|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
157131445|NCT02913313|567231987|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
157131446|NCT02913313|567231988|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
157131447|NCT02913313|567231989|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
157131448|NCT02913313|567231990|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
157131449|NCT02913313|567231991|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
157131450|NCT02913313|567231992|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
157131451|NCT02913313|567231993|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
157131452|NCT02913313|567231994|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
157131453|NCT02913313|567231995|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
157131454|NCT02913313|567231996|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
157131455|NCT02024971|567231999|FG000|Overall Study|Data Not Available|30|||
157131456|NCT02024971|567231999|FG000|Overall Study|Lost to Follow-up|6|||
157131457|NCT02908100|567232000|FG000|Overall Study|Adverse Event|7|||
157131458|NCT02908100|567232001|FG001|Overall Study|Adverse Event|6|||
157131459|NCT02908100|567232002|FG002|Overall Study|Adverse Event|9|||
157131460|NCT02908100|567232000|FG000|Overall Study|Death|2|||
157131461|NCT02908100|567232001|FG001|Overall Study|Death|0|||
157131462|NCT02908100|567232002|FG002|Overall Study|Death|0|||
156716319|NCT01125189|565705322|FG001|Follow up Period|Other reasons|4|||
156716320|NCT01125189|565705323|FG002|Follow up Period|Other reasons|5|||
156716321|NCT00114140|565705324|FG000|Overall Study|Protocol Violation|7|||
156716322|NCT02414958|565705325|FG000|Overall Study|Adverse Event|6|||
156716323|NCT02414958|565705326|FG001|Overall Study|Adverse Event|6|||
156716324|NCT02414958|565705327|FG002|Overall Study|Adverse Event|3|||
156716325|NCT02414958|565705325|FG000|Overall Study|Protocol Violation|10|||
156716326|NCT02414958|565705326|FG001|Overall Study|Protocol Violation|3|||
156716327|NCT02414958|565705327|FG002|Overall Study|Protocol Violation|1|||
156716328|NCT02414958|565705325|FG000|Overall Study|Lost to Follow-up|7|||
157131463|NCT02908100|567232000|FG000|Overall Study|Lack of Efficacy|2|||
157131464|NCT02908100|567232001|FG001|Overall Study|Lack of Efficacy|3|||
157131465|NCT02908100|567232002|FG002|Overall Study|Lack of Efficacy|3|||
157131466|NCT02908100|567232000|FG000|Overall Study|Lost to Follow-up|0|||
156716329|NCT02414958|565705326|FG001|Overall Study|Lost to Follow-up|4|||
156716330|NCT02414958|565705327|FG002|Overall Study|Lost to Follow-up|0|||
156716331|NCT02414958|565705325|FG000|Overall Study|Withdrawal by Subject|5|||
156716332|NCT02414958|565705326|FG001|Overall Study|Withdrawal by Subject|3|||
156716333|NCT02414958|565705327|FG002|Overall Study|Withdrawal by Subject|5|||
156716334|NCT02414958|565705325|FG000|Overall Study|Other than specified|4|||
156716335|NCT02414958|565705326|FG001|Overall Study|Other than specified|4|||
156716336|NCT02414958|565705327|FG002|Overall Study|Other than specified|5|||
157018172|NCT00220740|566819495|FG001|Efficacy Period|Protocol Violation|0|||
157018173|NCT00220740|566819494|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
157018174|NCT00220740|566819495|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
157018175|NCT01057433|566819496|FG000|Overall Study|Adverse Event|1|||
157018176|NCT02874534|566819498|FG000|Overall Study|Withdrawal by Subject|5|||
157018177|NCT02874534|566819499|FG001|Overall Study|Withdrawal by Subject|8|||
157018178|NCT02874534|566819498|FG000|Overall Study|Lost to Follow-up|2|||
157018179|NCT02874534|566819499|FG001|Overall Study|Lost to Follow-up|2|||
157018180|NCT02874534|566819498|FG000|Overall Study|Ongoing in study|1|||
157018181|NCT02874534|566819499|FG001|Overall Study|Ongoing in study|1|||
157018182|NCT02923180|566819500|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
157018183|NCT02923180|566819500|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
157018184|NCT05198310|566819501|FG000|Overall Study|Lost to Follow-up|0|||
157018185|NCT05198310|566819502|FG001|Overall Study|Lost to Follow-up|1|||
157018186|NCT05198310|566819503|FG002|Overall Study|Lost to Follow-up|0|||
157018187|NCT05198310|566819504|FG003|Overall Study|Lost to Follow-up|0|||
157018188|NCT05198310|566819505|FG004|Overall Study|Lost to Follow-up|0|||
157018189|NCT05198310|566819506|FG005|Overall Study|Lost to Follow-up|0|||
157018190|NCT05198310|566819507|FG006|Overall Study|Lost to Follow-up|0|||
157018191|NCT05198310|566819508|FG007|Overall Study|Lost to Follow-up|0|||
157018192|NCT05198310|566819501|FG000|Overall Study|Withdrawal by Subject|0|||
156716337|NCT01269918|565705328|FG000|Overall Study|Did not receive study drug|0|||
156716338|NCT01269918|565705329|FG001|Overall Study|Did not receive study drug|3|||
156716339|NCT02500589|565705330|FG000|Overall Study|Withdrawal by Subject|11|||
156716340|NCT02500589|565705331|FG001|Overall Study|Withdrawal by Subject|14|||
156716341|NCT02500589|565705330|FG000|Overall Study|Lost to Follow-up|10|||
156716342|NCT02500589|565705331|FG001|Overall Study|Lost to Follow-up|12|||
156716343|NCT02500589|565705330|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
156716344|NCT02500589|565705331|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
156716345|NCT02500589|565705330|FG000|Overall Study|Death|7|||
156716346|NCT02500589|565705331|FG001|Overall Study|Death|5|||
156716347|NCT03885661|565705332|FG000|Overall Study|Withdrawal by Subject|0|||
156716348|NCT03885661|565705333|FG001|Overall Study|Withdrawal by Subject|1|||
156716349|NCT03885661|565705332|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
156716350|NCT03885661|565705333|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
156716351|NCT05064397|565705334|FG000|Overall Study|Adverse Event|4|||
156716352|NCT05064397|565705334|FG000|Overall Study|Lack of Efficacy|12|||
156716353|NCT05064397|565705334|FG000|Overall Study|Withdrawal by Subject|3|||
156716354|NCT05064397|565705334|FG000|Overall Study|Lost to Follow-up|1|||
156716355|NCT05064397|565705334|FG000|Overall Study|Other reasons|3|||
156716356|NCT03934541|565705337|FG000|Overall Study|Study Terminated by Sponsor|0|||
156716357|NCT03934541|565705338|FG001|Overall Study|Study Terminated by Sponsor|1|||
156716358|NCT03934541|565705339|FG002|Overall Study|Study Terminated by Sponsor|0|||
156716359|NCT03934541|565705340|FG003|Overall Study|Study Terminated by Sponsor|0|||
156716360|NCT01783886|565705345|FG000|Overall Study|Lost to Follow-up|0|||
156716361|NCT01783886|565705346|FG001|Overall Study|Lost to Follow-up|3|||
156716362|NCT01783886|565705347|FG002|Overall Study|Lost to Follow-up|0|||
156716363|NCT01783886|565705345|FG000|Overall Study|Protocol deviation|0|||
156716364|NCT01783886|565705346|FG001|Overall Study|Protocol deviation|0|||
156716365|NCT01783886|565705347|FG002|Overall Study|Protocol deviation|2|||
156716366|NCT01783886|565705345|FG000|Overall Study|Withdrawal of consent by participant|1|||
156716367|NCT01783886|565705346|FG001|Overall Study|Withdrawal of consent by participant|3|||
156716368|NCT01783886|565705347|FG002|Overall Study|Withdrawal of consent by participant|4|||
156716369|NCT01783886|565705345|FG000|Overall Study|Adverse Event|4|||
156716370|NCT01783886|565705346|FG001|Overall Study|Adverse Event|5|||
156716371|NCT01783886|565705347|FG002|Overall Study|Adverse Event|4|||
156716372|NCT02324582|565705348|FG000|Overall Study|Screen Failures|0|||
156716373|NCT02324582|565705349|FG001|Overall Study|Screen Failures|5|||
156716374|NCT04660331|565705350|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
156716375|NCT04660331|565705351|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
156716376|NCT04660331|565705352|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
156716377|NCT03624192|565705353|FG000|Overall Study|Lost to Follow-up|1|||
156716378|NCT03624192|565705354|FG001|Overall Study|Lost to Follow-up|1|||
156716379|NCT00838526|565705357|FG000|Overall Study|Adverse Event|3|||
156716380|NCT00838526|565705358|FG001|Overall Study|Adverse Event|12|||
156716381|NCT00838526|565705357|FG000|Overall Study|Lost to Follow-up|4|||
156716382|NCT00838526|565705358|FG001|Overall Study|Lost to Follow-up|12|||
156716383|NCT00838526|565705357|FG000|Overall Study|Withdrawal by Subject|4|||
157018193|NCT05198310|566819502|FG001|Overall Study|Withdrawal by Subject|0|||
157018194|NCT05198310|566819503|FG002|Overall Study|Withdrawal by Subject|0|||
157018195|NCT05198310|566819504|FG003|Overall Study|Withdrawal by Subject|2|||
157018196|NCT05198310|566819505|FG004|Overall Study|Withdrawal by Subject|0|||
157018197|NCT05198310|566819506|FG005|Overall Study|Withdrawal by Subject|2|||
157018198|NCT05198310|566819507|FG006|Overall Study|Withdrawal by Subject|1|||
157018199|NCT05198310|566819508|FG007|Overall Study|Withdrawal by Subject|3|||
157018200|NCT04116736|566819509|FG000|Overall Study|Withdrew consent during study|3|||
157018201|NCT04116736|566819510|FG001|Overall Study|Withdrew consent during study|1|||
157018202|NCT04116736|566819509|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
157018203|NCT04116736|566819510|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
157018204|NCT04116736|566819509|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
157018205|NCT04116736|566819510|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
157018206|NCT04116736|566819509|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
157018207|NCT04116736|566819510|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
157018208|NCT04116736|566819509|FG000|Overall Study|Subject was enrolled in error|2|||
157018209|NCT04116736|566819510|FG001|Overall Study|Subject was enrolled in error|0|||
157018210|NCT04116736|566819509|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
157018211|NCT04116736|566819510|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
157018212|NCT04116736|566819509|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
157018213|NCT04116736|566819510|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
157018214|NCT04116736|566819509|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
157018215|NCT04116736|566819510|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
157018216|NCT03361748|566819516|FG000|Overall Study|Death|77|||
157018217|NCT03361748|566819516|FG000|Overall Study|Lost to Follow-up|4|||
157018218|NCT03361748|566819516|FG000|Overall Study|Withdrawal by Subject|20|||
157018219|NCT04854096|566819517|FG000|Overall Study|Adverse Event|1|||
157018220|NCT04854096|566819518|FG001|Overall Study|Adverse Event|0|||
157018221|NCT04854096|566819517|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
157018222|NCT04854096|566819518|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
157018223|NCT04854096|566819517|FG000|Overall Study|Withdrawal by Subject|1|||
157018224|NCT04854096|566819518|FG001|Overall Study|Withdrawal by Subject|0|||
157018225|NCT04854096|566819517|FG000|Overall Study|Other reasons|1|||
157018226|NCT04854096|566819518|FG001|Overall Study|Other reasons|0|||
157018227|NCT01084707|566819524|FG000|Overall Study|Withdrawal by Subject|6|||
157018228|NCT01091168|566819525|FG000|Overall Study|Progressive disease|250|||
157018229|NCT01091168|566819526|FG001|Overall Study|Progressive disease|234|||
157018230|NCT01091168|566819525|FG000|Overall Study|Adverse Event|21|||
157018231|NCT01091168|566819526|FG001|Overall Study|Adverse Event|24|||
157018232|NCT01091168|566819525|FG000|Overall Study|Lost to Follow-up|0|||
157018233|NCT01091168|566819526|FG001|Overall Study|Lost to Follow-up|1|||
157018234|NCT01091168|566819525|FG000|Overall Study|Physician, patient's decision, other|27|||
157018235|NCT01091168|566819526|FG001|Overall Study|Physician, patient's decision, other|37|||
157018236|NCT01959698|566819527|FG000|Overall Study|Adverse Event|0|||
157018237|NCT01959698|566819528|FG001|Overall Study|Adverse Event|0|||
157018238|NCT01959698|566819529|FG002|Overall Study|Adverse Event|0|||
157018239|NCT01959698|566819530|FG003|Overall Study|Adverse Event|0|||
157018240|NCT01959698|566819531|FG004|Overall Study|Adverse Event|0|||
157018241|NCT01959698|566819532|FG005|Overall Study|Adverse Event|0|||
157018242|NCT01959698|566819533|FG006|Overall Study|Adverse Event|1|||
157018243|NCT01959698|566819527|FG000|Overall Study|Physician Decision|1|||
157018244|NCT01959698|566819528|FG001|Overall Study|Physician Decision|0|||
157018245|NCT01959698|566819529|FG002|Overall Study|Physician Decision|1|||
157018246|NCT01959698|566819530|FG003|Overall Study|Physician Decision|2|||
157018247|NCT01959698|566819531|FG004|Overall Study|Physician Decision|0|||
157018248|NCT01959698|566819532|FG005|Overall Study|Physician Decision|3|||
157018249|NCT01959698|566819533|FG006|Overall Study|Physician Decision|3|||
157018250|NCT04052516|566821223|FG000|Overall Study|Withdrawal by Subject|4|||
157018251|NCT04052516|566821224|FG001|Overall Study|Withdrawal by Subject|5|||
157018252|NCT04052516|566821225|FG002|Overall Study|Withdrawal by Subject|6|||
157018253|NCT04052516|566821223|FG000|Overall Study|Adverse Event|3|||
157018254|NCT04052516|566821224|FG001|Overall Study|Adverse Event|2|||
157018255|NCT04052516|566821225|FG002|Overall Study|Adverse Event|8|||
157018256|NCT04052516|566821223|FG000|Overall Study|Lost to Follow-up|2|||
157018257|NCT04052516|566821224|FG001|Overall Study|Lost to Follow-up|5|||
157018258|NCT04052516|566821225|FG002|Overall Study|Lost to Follow-up|3|||
157018259|NCT04052516|566821223|FG000|Overall Study|Protocol Violation|1|||
157018260|NCT04052516|566821224|FG001|Overall Study|Protocol Violation|1|||
157018261|NCT04052516|566821225|FG002|Overall Study|Protocol Violation|0|||
157018262|NCT04052516|566821223|FG000|Overall Study|Death|1|||
157018263|NCT04052516|566821224|FG001|Overall Study|Death|0|||
157018264|NCT04052516|566821225|FG002|Overall Study|Death|0|||
157018265|NCT04052516|566821223|FG000|Overall Study|Physician Decision|0|||
157018266|NCT04052516|566821224|FG001|Overall Study|Physician Decision|1|||
157131467|NCT02908100|567232001|FG001|Overall Study|Lost to Follow-up|1|||
157131468|NCT02908100|567232002|FG002|Overall Study|Lost to Follow-up|2|||
157131469|NCT02908100|567232000|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157216856|NCT01393990|567540948|FG013|Overall Study|Progressive Disease|1|||
157216857|NCT01393990|567540949|FG014|Overall Study|Progressive Disease|6|||
157216858|NCT01393990|567540950|FG015|Overall Study|Progressive Disease|1|||
157216859|NCT01393990|567540951|FG016|Overall Study|Progressive Disease|0|||
157216860|NCT01393990|567540952|FG017|Overall Study|Progressive Disease|0|||
157216861|NCT01393990|567540935|FG000|Overall Study|Death|0|||
157216862|NCT01393990|567540936|FG001|Overall Study|Death|0|||
157216863|NCT01393990|567540937|FG002|Overall Study|Death|0|||
157216864|NCT01393990|567540938|FG003|Overall Study|Death|0|||
157216865|NCT01393990|567540939|FG004|Overall Study|Death|1|||
157216866|NCT01393990|567540940|FG005|Overall Study|Death|0|||
157216867|NCT01393990|567540941|FG006|Overall Study|Death|0|||
157131470|NCT02908100|567232001|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157131471|NCT02908100|567232002|FG002|Overall Study|Non-Compliance With Study Drug|2|||
157131472|NCT02908100|567232000|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
157131473|NCT02908100|567232001|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
157131474|NCT02908100|567232002|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
157216868|NCT01393990|567540942|FG007|Overall Study|Death|0|||
157216869|NCT01393990|567540943|FG008|Overall Study|Death|0|||
157216870|NCT01393990|567540944|FG009|Overall Study|Death|0|||
157216871|NCT01393990|567540945|FG010|Overall Study|Death|0|||
157216872|NCT01393990|567540946|FG011|Overall Study|Death|0|||
157216873|NCT01393990|567540947|FG012|Overall Study|Death|0|||
157216874|NCT01393990|567540948|FG013|Overall Study|Death|1|||
157216875|NCT01393990|567540949|FG014|Overall Study|Death|1|||
157216876|NCT01393990|567540950|FG015|Overall Study|Death|0|||
157216877|NCT01393990|567540951|FG016|Overall Study|Death|0|||
157216878|NCT01393990|567540952|FG017|Overall Study|Death|0|||
157216879|NCT01393990|567540935|FG000|Overall Study|Withdrawal by Subject|0|||
157216880|NCT01393990|567540936|FG001|Overall Study|Withdrawal by Subject|0|||
157216881|NCT01393990|567540937|FG002|Overall Study|Withdrawal by Subject|0|||
157216882|NCT01393990|567540938|FG003|Overall Study|Withdrawal by Subject|0|||
157216883|NCT01393990|567540939|FG004|Overall Study|Withdrawal by Subject|0|||
157216884|NCT01393990|567540940|FG005|Overall Study|Withdrawal by Subject|0|||
157216885|NCT01393990|567540941|FG006|Overall Study|Withdrawal by Subject|0|||
157216886|NCT01393990|567540942|FG007|Overall Study|Withdrawal by Subject|0|||
157216887|NCT01393990|567540943|FG008|Overall Study|Withdrawal by Subject|0|||
157216888|NCT01393990|567540944|FG009|Overall Study|Withdrawal by Subject|0|||
157216889|NCT01393990|567540945|FG010|Overall Study|Withdrawal by Subject|0|||
157216890|NCT01393990|567540946|FG011|Overall Study|Withdrawal by Subject|0|||
157216891|NCT01393990|567540947|FG012|Overall Study|Withdrawal by Subject|0|||
157216892|NCT01393990|567540948|FG013|Overall Study|Withdrawal by Subject|0|||
157216893|NCT01393990|567540949|FG014|Overall Study|Withdrawal by Subject|1|||
157216894|NCT01393990|567540950|FG015|Overall Study|Withdrawal by Subject|1|||
157216895|NCT01393990|567540951|FG016|Overall Study|Withdrawal by Subject|0|||
157131475|NCT02908100|567232000|FG000|Overall Study|Physician Decision|0|||
157131476|NCT02908100|567232001|FG001|Overall Study|Physician Decision|1|||
157131477|NCT02908100|567232002|FG002|Overall Study|Physician Decision|0|||
157131478|NCT02908100|567232000|FG000|Overall Study|Pregnancy|1|||
157131479|NCT02908100|567232001|FG001|Overall Study|Pregnancy|2|||
157131480|NCT02908100|567232002|FG002|Overall Study|Pregnancy|0|||
157131481|NCT02908100|567232000|FG000|Overall Study|Withdrawal by Subject|8|||
157131482|NCT02908100|567232001|FG001|Overall Study|Withdrawal by Subject|7|||
157131483|NCT02908100|567232002|FG002|Overall Study|Withdrawal by Subject|5|||
157131484|NCT02908100|567232000|FG000|Overall Study|Randomised in Error|1|||
157131485|NCT02908100|567232001|FG001|Overall Study|Randomised in Error|0|||
157131486|NCT02908100|567232002|FG002|Overall Study|Randomised in Error|0|||
157131487|NCT05254418|567232003|FG000|Overall Study|Adverse Event|2|||
157216896|NCT01393990|567540952|FG017|Overall Study|Withdrawal by Subject|0|||
156874835|NCT03892967|566298749|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
157131488|NCT06118385|567232005|FG000|Overall Study|Protocol Violation|0|||
157131489|NCT06118385|567232006|FG001|Overall Study|Protocol Violation|0|||
157131490|NCT06118385|567232007|FG002|Overall Study|Protocol Violation|0|||
157131491|NCT06118385|567232008|FG003|Overall Study|Protocol Violation|0|||
157131492|NCT06118385|567232009|FG004|Overall Study|Protocol Violation|0|||
157216897|NCT00720798|567540958|FG000|Overall Study|Adverse Event|304|||
157216898|NCT00720798|567540958|FG000|Overall Study|Death|39|||
157216899|NCT00720798|567540958|FG000|Overall Study|Insufficient Therapeutic Response|129|||
157216900|NCT00720798|567540958|FG000|Overall Study|Protocol Violation|4|||
157216901|NCT00720798|567540958|FG000|Overall Study|Refused Treatment|151|||
157216902|NCT00720798|567540958|FG000|Overall Study|Failure to Return|46|||
157216903|NCT00720798|567540958|FG000|Overall Study|Reason not Specified|83|||
157216904|NCT02806232|567540962|FG000|Overall Study|Lost to Follow-up|1|||
157216905|NCT02806232|567540963|FG001|Overall Study|Lost to Follow-up|2|||
157216906|NCT02806232|567540964|FG002|Overall Study|Lost to Follow-up|1|||
157216907|NCT02806232|567540965|FG003|Overall Study|Lost to Follow-up|0|||
157131493|NCT06118385|567232010|FG005|Overall Study|Protocol Violation|0|||
157131494|NCT06118385|567232011|FG006|Overall Study|Protocol Violation|0|||
157131495|NCT06118385|567232012|FG007|Overall Study|Protocol Violation|0|||
157131496|NCT06118385|567232013|FG008|Overall Study|Protocol Violation|1|||
157131497|NCT06118385|567232014|FG009|Overall Study|Protocol Violation|0|||
157131498|NCT06118385|567232015|FG010|Overall Study|Protocol Violation|0|||
157131499|NCT06118385|567232016|FG011|Overall Study|Protocol Violation|0|||
157131500|NCT06118385|567232005|FG000|Overall Study|Out-of-range blood tests|0|||
157131501|NCT06118385|567232006|FG001|Overall Study|Out-of-range blood tests|0|||
157131502|NCT06118385|567232007|FG002|Overall Study|Out-of-range blood tests|0|||
157131503|NCT06118385|567232008|FG003|Overall Study|Out-of-range blood tests|0|||
157131504|NCT06118385|567232009|FG004|Overall Study|Out-of-range blood tests|0|||
157131505|NCT06118385|567232010|FG005|Overall Study|Out-of-range blood tests|0|||
157131506|NCT06118385|567232011|FG006|Overall Study|Out-of-range blood tests|0|||
157131507|NCT06118385|567232012|FG007|Overall Study|Out-of-range blood tests|0|||
157131508|NCT06118385|567232013|FG008|Overall Study|Out-of-range blood tests|1|||
157131509|NCT06118385|567232014|FG009|Overall Study|Out-of-range blood tests|0|||
157131510|NCT06118385|567232015|FG010|Overall Study|Out-of-range blood tests|0|||
157131511|NCT06118385|567232016|FG011|Overall Study|Out-of-range blood tests|0|||
157131512|NCT04276207|567232017|FG000|Period 1|Withdrawal by Subject|0|||
157131513|NCT04276207|567232018|FG001|Period 1|Withdrawal by Subject|1|||
157131514|NCT02690194|567232019|FG000|Overall Study|Withdrawal by Subject|1|||
157131515|NCT02690194|567232020|FG001|Overall Study|Withdrawal by Subject|4|||
157131516|NCT02690194|567232021|FG002|Overall Study|Withdrawal by Subject|0|||
157131517|NCT03624946|567232022|FG000|Overall Study|Lost to Follow-up|0|||
157131518|NCT03624946|567232023|FG001|Overall Study|Lost to Follow-up|1|||
157131519|NCT00624520|567232024|FG000|Overall Study|Withdrawal by Subject|12|||
157131520|NCT00624520|567232025|FG001|Overall Study|Withdrawal by Subject|7|||
157131521|NCT00624520|567232024|FG000|Overall Study|Death|0|||
157131522|NCT00624520|567232025|FG001|Overall Study|Death|1|||
157131523|NCT00944034|567232027|FG000|Overall Study|Inappropriate enrollment|0|||
157131524|NCT00944034|567232028|FG001|Overall Study|Inappropriate enrollment|1|||
157131525|NCT00944034|567232029|FG002|Overall Study|Inappropriate enrollment|0|||
157131526|NCT00944034|567232030|FG003|Overall Study|Inappropriate enrollment|1|||
157131527|NCT00944034|567232031|FG004|Overall Study|Inappropriate enrollment|2|||
157131528|NCT00944034|567232032|FG005|Overall Study|Inappropriate enrollment|1|||
157131529|NCT00944034|567232033|FG006|Overall Study|Inappropriate enrollment|0|||
157131530|NCT00944034|567232034|FG007|Overall Study|Inappropriate enrollment|0|||
157131531|NCT00944034|567232035|FG008|Overall Study|Inappropriate enrollment|1|||
157131532|NCT00944034|567232036|FG009|Overall Study|Inappropriate enrollment|1|||
157131533|NCT00944034|567232037|FG010|Overall Study|Inappropriate enrollment|0|||
157131534|NCT00944034|567232038|FG011|Overall Study|Inappropriate enrollment|0|||
157131535|NCT00944034|567232027|FG000|Overall Study|Withdrawal by Subject|3|||
157131536|NCT00944034|567232028|FG001|Overall Study|Withdrawal by Subject|2|||
157131537|NCT00944034|567232029|FG002|Overall Study|Withdrawal by Subject|6|||
157131538|NCT00944034|567232030|FG003|Overall Study|Withdrawal by Subject|2|||
157131539|NCT00944034|567232031|FG004|Overall Study|Withdrawal by Subject|5|||
157131540|NCT00944034|567232032|FG005|Overall Study|Withdrawal by Subject|8|||
157131541|NCT00944034|567232033|FG006|Overall Study|Withdrawal by Subject|2|||
157131542|NCT00944034|567232034|FG007|Overall Study|Withdrawal by Subject|2|||
157131543|NCT00944034|567232035|FG008|Overall Study|Withdrawal by Subject|3|||
157131544|NCT00944034|567232036|FG009|Overall Study|Withdrawal by Subject|4|||
157131545|NCT00944034|567232037|FG010|Overall Study|Withdrawal by Subject|0|||
157131546|NCT00944034|567232038|FG011|Overall Study|Withdrawal by Subject|4|||
157131547|NCT00944034|567232027|FG000|Overall Study|Lost to Follow-up|0|||
157131548|NCT00944034|567232028|FG001|Overall Study|Lost to Follow-up|4|||
157131549|NCT00944034|567232029|FG002|Overall Study|Lost to Follow-up|2|||
157131550|NCT00944034|567232030|FG003|Overall Study|Lost to Follow-up|0|||
157131551|NCT00944034|567232031|FG004|Overall Study|Lost to Follow-up|5|||
157131552|NCT00944034|567232032|FG005|Overall Study|Lost to Follow-up|7|||
157131553|NCT00944034|567232033|FG006|Overall Study|Lost to Follow-up|0|||
157131554|NCT00944034|567232034|FG007|Overall Study|Lost to Follow-up|1|||
157131555|NCT00944034|567232035|FG008|Overall Study|Lost to Follow-up|5|||
157131556|NCT00944034|567232036|FG009|Overall Study|Lost to Follow-up|1|||
157131557|NCT00944034|567232037|FG010|Overall Study|Lost to Follow-up|1|||
157131558|NCT00944034|567232038|FG011|Overall Study|Lost to Follow-up|0|||
157131559|NCT00944034|567232027|FG000|Overall Study|Death|0|||
157131560|NCT00944034|567232028|FG001|Overall Study|Death|0|||
157131561|NCT00944034|567232029|FG002|Overall Study|Death|1|||
157131562|NCT00944034|567232030|FG003|Overall Study|Death|0|||
157131563|NCT00944034|567232031|FG004|Overall Study|Death|0|||
157131564|NCT00944034|567232032|FG005|Overall Study|Death|0|||
157131565|NCT00944034|567232033|FG006|Overall Study|Death|0|||
157131566|NCT00944034|567232034|FG007|Overall Study|Death|0|||
157131567|NCT00944034|567232035|FG008|Overall Study|Death|0|||
157131568|NCT00944034|567232036|FG009|Overall Study|Death|0|||
157131569|NCT00944034|567232037|FG010|Overall Study|Death|0|||
157131570|NCT00944034|567232038|FG011|Overall Study|Death|0|||
157131571|NCT00944034|567232027|FG000|Overall Study|Protocol Violation|2|||
156793285|NCT01225952|565996219|FG000|Overall Study|Lost to Follow-up|1|||
156793286|NCT01225952|565996220|FG001|Overall Study|Lost to Follow-up|0|||
156793287|NCT01225952|565996221|FG002|Overall Study|Lost to Follow-up|0|||
156793288|NCT01225952|565996219|FG000|Overall Study|Study Eye Explanted|0|||
156793289|NCT01225952|565996220|FG001|Overall Study|Study Eye Explanted|0|||
156793290|NCT01225952|565996221|FG002|Overall Study|Study Eye Explanted|1|||
156793291|NCT01225952|565996219|FG000|Overall Study|Withdrawal by Subject|4|||
156793292|NCT01225952|565996220|FG001|Overall Study|Withdrawal by Subject|4|||
156793293|NCT01225952|565996221|FG002|Overall Study|Withdrawal by Subject|5|||
156793294|NCT01225952|565996219|FG000|Overall Study|Surgical complications|1|||
156793295|NCT01225952|565996220|FG001|Overall Study|Surgical complications|0|||
156793296|NCT01225952|565996221|FG002|Overall Study|Surgical complications|0|||
156793297|NCT00770679|565996224|FG000|Overall Study|Lost to Follow-up|3|||
156793298|NCT00770679|565996224|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
156793299|NCT00831389|565996225|FG000|Overall Study|Withdrawal by Subject|0|||
156793300|NCT00831389|565996226|FG001|Overall Study|Withdrawal by Subject|1|||
156793301|NCT00278161|565996228|FG000|Overall Study|Death|11|||
156793302|NCT01817777|565996229|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
156793303|NCT01817777|565996230|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
156793304|NCT01817777|565996231|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
156793305|NCT01817777|565996229|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
156793306|NCT01817777|565996230|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
156793307|NCT01817777|565996231|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
156793308|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
156793309|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
156793310|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
156793311|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
156793312|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
156793313|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
156793314|NCT01817777|565996229|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
156793315|NCT01817777|565996230|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
156793316|NCT01817777|565996231|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
156793317|NCT01935947|565996233|FG000|Overall Study|Adverse Event|0|||
156793318|NCT01935947|565996234|FG001|Overall Study|Adverse Event|2|||
156793319|NCT01935947|565996235|FG002|Overall Study|Adverse Event|0|||
156793320|NCT01935947|565996233|FG000|Overall Study|Diease Progression|2|||
156793321|NCT01935947|565996234|FG001|Overall Study|Diease Progression|2|||
156793322|NCT01935947|565996235|FG002|Overall Study|Diease Progression|2|||
156793323|NCT01935947|565996233|FG000|Overall Study|Death|1|||
156793324|NCT01935947|565996234|FG001|Overall Study|Death|0|||
156793325|NCT01935947|565996235|FG002|Overall Study|Death|0|||
156793326|NCT00692237|565996236|FG000|Overall Study|Withdrawal by Subject|1|||
156793327|NCT00692237|565996237|FG001|Overall Study|Withdrawal by Subject|3|||
156793328|NCT00692237|565996236|FG000|Overall Study|Adverse Event|0|||
156793329|NCT00692237|565996237|FG001|Overall Study|Adverse Event|1|||
156793330|NCT00752219|565996238|FG000|Overall Study|Clinical failure|0|||
156793331|NCT00752219|565996239|FG001|Overall Study|Clinical failure|1|||
156793332|NCT00752219|565996238|FG000|Overall Study|Adverse Event|5|||
156793333|NCT00752219|565996239|FG001|Overall Study|Adverse Event|3|||
156793334|NCT00752219|565996238|FG000|Overall Study|Protocol deviation|1|||
156793335|NCT00752219|565996239|FG001|Overall Study|Protocol deviation|0|||
156793336|NCT00752219|565996238|FG000|Overall Study|Lost to Follow-up|1|||
156793337|NCT00752219|565996239|FG001|Overall Study|Lost to Follow-up|2|||
156793338|NCT00752219|565996238|FG000|Overall Study|Randomized but not treated|1|||
156793339|NCT00752219|565996239|FG001|Overall Study|Randomized but not treated|0|||
156793340|NCT00752219|565996238|FG000|Overall Study|Other|3|||
156793341|NCT00752219|565996239|FG001|Overall Study|Other|0|||
157018267|NCT04052516|566821225|FG002|Overall Study|Physician Decision|0|||
157018268|NCT04052516|566821223|FG000|Overall Study|Pregnancy|1|||
157018269|NCT04052516|566821224|FG001|Overall Study|Pregnancy|0|||
157018270|NCT04052516|566821225|FG002|Overall Study|Pregnancy|0|||
157018271|NCT04052516|566821223|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
157018272|NCT04052516|566821224|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
157018273|NCT04052516|566821225|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
157018274|NCT04052516|566821223|FG000|Overall Study|Reason not recorded|0|||
157018275|NCT04052516|566821224|FG001|Overall Study|Reason not recorded|1|||
157018276|NCT04052516|566821225|FG002|Overall Study|Reason not recorded|0|||
157018277|NCT03819686|566821227|FG000|Overall Study|Lost to Follow-up|2|||
157018278|NCT03819686|566821228|FG001|Overall Study|Lost to Follow-up|3|||
157018279|NCT03625882|566821229|FG000|Overall Study|Protocol Violation|3|||
157018280|NCT05058391|566821230|FG000|Overall Study|Adverse Event|1|||
157018281|NCT05691452|566821232|FG000|Overall Study|Withdrawal by Subject|1|||
157018282|NCT05691452|566821233|FG001|Overall Study|Withdrawal by Subject|1|||
157018283|NCT05691452|566821234|FG002|Overall Study|Withdrawal by Subject|0|||
157018284|NCT05691452|566821232|FG000|Overall Study|Physician Decision|1|||
157018285|NCT05691452|566821233|FG001|Overall Study|Physician Decision|0|||
156793342|NCT02758626|565996247|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
156793343|NCT02758626|565996248|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
157131572|NCT00944034|567232028|FG001|Overall Study|Protocol Violation|0|||
157131573|NCT00944034|567232029|FG002|Overall Study|Protocol Violation|0|||
157131574|NCT00944034|567232030|FG003|Overall Study|Protocol Violation|1|||
157131575|NCT00944034|567232031|FG004|Overall Study|Protocol Violation|2|||
157131576|NCT00944034|567232032|FG005|Overall Study|Protocol Violation|3|||
157131577|NCT00944034|567232033|FG006|Overall Study|Protocol Violation|0|||
157131578|NCT00944034|567232034|FG007|Overall Study|Protocol Violation|1|||
157131579|NCT00944034|567232035|FG008|Overall Study|Protocol Violation|1|||
157131580|NCT00944034|567232036|FG009|Overall Study|Protocol Violation|4|||
157131581|NCT00944034|567232037|FG010|Overall Study|Protocol Violation|0|||
157131582|NCT00944034|567232038|FG011|Overall Study|Protocol Violation|0|||
157131583|NCT00944034|567232027|FG000|Overall Study|Unable to classify|0|||
157131584|NCT00944034|567232028|FG001|Overall Study|Unable to classify|0|||
157131585|NCT00944034|567232029|FG002|Overall Study|Unable to classify|0|||
157131586|NCT00944034|567232030|FG003|Overall Study|Unable to classify|0|||
157131587|NCT00944034|567232031|FG004|Overall Study|Unable to classify|0|||
157131588|NCT00944034|567232032|FG005|Overall Study|Unable to classify|1|||
157131589|NCT00944034|567232033|FG006|Overall Study|Unable to classify|1|||
157131590|NCT00944034|567232034|FG007|Overall Study|Unable to classify|1|||
157018286|NCT05691452|566821234|FG002|Overall Study|Physician Decision|0|||
157018287|NCT05691452|566821232|FG000|Overall Study|Lost to Follow-up|0|||
157018288|NCT05691452|566821233|FG001|Overall Study|Lost to Follow-up|0|||
157018289|NCT05691452|566821234|FG002|Overall Study|Lost to Follow-up|1|||
157131591|NCT00944034|567232035|FG008|Overall Study|Unable to classify|0|||
157131592|NCT00944034|567232036|FG009|Overall Study|Unable to classify|0|||
157131593|NCT00944034|567232037|FG010|Overall Study|Unable to classify|0|||
157131594|NCT00944034|567232038|FG011|Overall Study|Unable to classify|0|||
157131595|NCT00944034|567232027|FG000|Overall Study|Administrative reason|0|||
157131596|NCT00944034|567232028|FG001|Overall Study|Administrative reason|0|||
157131597|NCT00944034|567232029|FG002|Overall Study|Administrative reason|0|||
157131598|NCT00944034|567232030|FG003|Overall Study|Administrative reason|0|||
157131599|NCT00944034|567232031|FG004|Overall Study|Administrative reason|0|||
157131600|NCT00944034|567232032|FG005|Overall Study|Administrative reason|0|||
157131601|NCT00944034|567232033|FG006|Overall Study|Administrative reason|1|||
157131602|NCT00944034|567232034|FG007|Overall Study|Administrative reason|0|||
157131603|NCT00944034|567232035|FG008|Overall Study|Administrative reason|0|||
157131604|NCT00944034|567232036|FG009|Overall Study|Administrative reason|0|||
157131605|NCT00944034|567232037|FG010|Overall Study|Administrative reason|0|||
157131606|NCT00944034|567232038|FG011|Overall Study|Administrative reason|0|||
157131607|NCT03486392|567232039|FG000|Overall Study|Lost to Follow-up|0|||
157131608|NCT03486392|567232040|FG001|Overall Study|Lost to Follow-up|0|||
157131609|NCT03486392|567232041|FG002|Overall Study|Lost to Follow-up|8|||
157131610|NCT03486392|567232042|FG003|Overall Study|Lost to Follow-up|5|||
157131611|NCT03486392|567232043|FG004|Overall Study|Lost to Follow-up|2|||
157131612|NCT03486392|567232039|FG000|Overall Study|Withdrawal by Subject|3|||
157131613|NCT03486392|567232040|FG001|Overall Study|Withdrawal by Subject|0|||
157131614|NCT03486392|567232041|FG002|Overall Study|Withdrawal by Subject|6|||
157131615|NCT03486392|567232042|FG003|Overall Study|Withdrawal by Subject|4|||
157131616|NCT03486392|567232043|FG004|Overall Study|Withdrawal by Subject|1|||
157131617|NCT03486392|567232039|FG000|Overall Study|Death|0|||
157131618|NCT03486392|567232040|FG001|Overall Study|Death|0|||
157131619|NCT03486392|567232041|FG002|Overall Study|Death|0|||
157131620|NCT03486392|567232042|FG003|Overall Study|Death|0|||
157131621|NCT03486392|567232043|FG004|Overall Study|Death|1|||
157131622|NCT02318784|567232044|FG000|Overall Study|Adverse Event|13|||
157131623|NCT02318784|567232044|FG000|Overall Study|Death|2|||
157131624|NCT02318784|567232044|FG000|Overall Study|Progressive Disease|37|||
157131625|NCT02318784|567232044|FG000|Overall Study|Withdrawal by Subject|10|||
157131626|NCT00331006|567232045|FG000|Screening Phase|Withdrawal by Subject|1|||
157131627|NCT00331006|567232045|FG000|Screening Phase|enrollment halted|1|||
157131628|NCT00331006|567232045|FG000|Screening Phase|Lost to Follow-up|1|||
157131629|NCT00331006|567232045|FG000|Screening Phase|Ineligible for treatment phase|4|||
157131630|NCT00331006|567232045|FG000|Treatment Phase|Withdrawal by Subject|1|||
157131631|NCT00331006|567232045|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
157131632|NCT00331006|567232045|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
157131633|NCT01950819|567232048|FG000|Overall Study|Graft Loss|35|||
157131634|NCT01950819|567232049|FG001|Overall Study|Graft Loss|30|||
157131635|NCT01950819|567232048|FG000|Overall Study|Death|29|||
157131636|NCT01950819|567232049|FG001|Overall Study|Death|34|||
157131637|NCT01950819|567232048|FG000|Overall Study|Subject / Gardian decision|54|||
156793344|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
157018290|NCT05691452|566821232|FG000|Overall Study|Adverse Event|0|||
157018291|NCT05691452|566821233|FG001|Overall Study|Adverse Event|0|||
157018292|NCT05691452|566821234|FG002|Overall Study|Adverse Event|1|||
157018293|NCT04842643|566821237|FG000|Overall Study|Physician Decision|1|||
157018294|NCT04842643|566821237|FG000|Overall Study|Other|1|||
157018295|NCT03089398|566821238|FG000|Overall Study|Death|4|||
157216908|NCT02806232|567540966|FG004|Overall Study|Lost to Follow-up|0|||
157216909|NCT02806232|567540967|FG005|Overall Study|Lost to Follow-up|1|||
157216910|NCT02806232|567540968|FG006|Overall Study|Lost to Follow-up|0|||
157216911|NCT02806232|567540969|FG007|Overall Study|Lost to Follow-up|0|||
157216912|NCT02806232|567540970|FG008|Overall Study|Lost to Follow-up|0|||
157216913|NCT02806232|567540962|FG000|Overall Study|Withdrawal by Subject|0|||
157216914|NCT02806232|567540963|FG001|Overall Study|Withdrawal by Subject|2|||
157216915|NCT02806232|567540964|FG002|Overall Study|Withdrawal by Subject|0|||
157216916|NCT02806232|567540965|FG003|Overall Study|Withdrawal by Subject|0|||
157216917|NCT02806232|567540966|FG004|Overall Study|Withdrawal by Subject|2|||
157216918|NCT02806232|567540967|FG005|Overall Study|Withdrawal by Subject|1|||
157216919|NCT02806232|567540968|FG006|Overall Study|Withdrawal by Subject|0|||
157216920|NCT02806232|567540969|FG007|Overall Study|Withdrawal by Subject|0|||
157216921|NCT02806232|567540970|FG008|Overall Study|Withdrawal by Subject|0|||
157216922|NCT00434161|567540973|FG000|Overall Study|Adverse Event|5|||
156793345|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
156793346|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
157131638|NCT01950819|567232049|FG001|Overall Study|Subject / Gardian decision|51|||
157131639|NCT01950819|567232048|FG000|Overall Study|technical problems|2|||
157131640|NCT01950819|567232049|FG001|Overall Study|technical problems|0|||
157131641|NCT01950819|567232048|FG000|Overall Study|Pregnancy|0|||
157131642|NCT01950819|567232049|FG001|Overall Study|Pregnancy|2|||
157131643|NCT01950819|567232048|FG000|Overall Study|Lost to Follow-up|9|||
156874836|NCT03892967|566298745|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
156874837|NCT03892967|566298746|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
156874838|NCT03892967|566298747|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
156874839|NCT03892967|566298748|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
156874840|NCT03892967|566298749|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
156874841|NCT03892967|566298745|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
156874842|NCT03892967|566298746|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
156874843|NCT03892967|566298747|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
156874844|NCT03892967|566298748|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
156874845|NCT03892967|566298749|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
157131644|NCT01950819|567232049|FG001|Overall Study|Lost to Follow-up|17|||
157131645|NCT00238264|567232054|FG000|Overall Study|Death|7|||
157131646|NCT00238264|567232054|FG000|Overall Study|Lost to Follow-up|18|||
157131647|NCT00238264|567232054|FG000|Overall Study|Withdrawal by Subject|4|||
157131648|NCT00238264|567232054|FG000|Overall Study|Ineligible|7|||
157131649|NCT00713219|567232058|FG000|Overall Study|Death|1|||
157131650|NCT00713219|567232058|FG000|Overall Study|Protocol Violation|1|||
157131651|NCT01737931|567232059|FG000|Overall Study|Withdrawal by Subject|0|||
156793347|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
156874846|NCT04434937|566298750|FG000|Overall Study|Death|4|||
156793348|NCT02758626|565996247|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
156793349|NCT02758626|565996248|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
156793350|NCT00456365|565996256|FG000|Overall Study|Lost to Follow-up|1|||
156793351|NCT00456365|565996257|FG001|Overall Study|Lost to Follow-up|3|||
156793352|NCT00456365|565996256|FG000|Overall Study|Withdrawal by Subject|4|||
156874847|NCT04434937|566298750|FG000|Overall Study|Withdrawal by Subject|1|||
156874848|NCT04434937|566298750|FG000|Overall Study|Transitioned to Rollover Study|19|||
156874849|NCT04434937|566298750|FG000|Overall Study|Progressive Disease|18|||
156874850|NCT04549545|566300561|FG000|Initial Period|Withdrawal by Subject|4|||
156874851|NCT04549545|566300562|FG001|Initial Period|Withdrawal by Subject|0|||
156874852|NCT04549545|566300561|FG000|Initial Period|Additional ENT Procedure|3|||
156874853|NCT04549545|566300562|FG001|Initial Period|Additional ENT Procedure|0|||
156874854|NCT04549545|566300561|FG000|Initial Period|Lost to Follow-up|3|||
156874855|NCT04549545|566300562|FG001|Initial Period|Lost to Follow-up|1|||
156874856|NCT04549545|566300561|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
156874857|NCT04549545|566300562|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
157131652|NCT01737931|567232060|FG001|Overall Study|Withdrawal by Subject|1|||
157131653|NCT01737931|567232061|FG002|Overall Study|Withdrawal by Subject|1|||
156793353|NCT00456365|565996257|FG001|Overall Study|Withdrawal by Subject|7|||
157131654|NCT01737931|567232059|FG000|Overall Study|Physician Decision|0|||
157131655|NCT01737931|567232060|FG001|Overall Study|Physician Decision|1|||
157131656|NCT01737931|567232061|FG002|Overall Study|Physician Decision|0|||
157216923|NCT00434161|567540974|FG001|Overall Study|Adverse Event|1|||
157216924|NCT00434161|567540975|FG002|Overall Study|Adverse Event|4|||
157216925|NCT00434161|567540973|FG000|Overall Study|Lost to Follow-up|0|||
157131657|NCT04897867|567232062|FG000|Overall Study|Withdrawal of Consent|1|||
156874858|NCT04549545|566300561|FG000|Crossover Period|Additional ENT Procedure|0|||
157131658|NCT04897867|567232062|FG000|Overall Study|Pregnancy|1|||
157131659|NCT04897867|567232062|FG000|Overall Study|Lost to Follow-up|7|||
157131660|NCT04897867|567232062|FG000|Overall Study|Reason not Specified|2|||
157131661|NCT01838044|567232063|FG000|Overall Study|Adverse Event|4|||
157131662|NCT01838044|567232064|FG001|Overall Study|Adverse Event|6|||
157131663|NCT01838044|567232063|FG000|Overall Study|Protocol Violation|3|||
157131664|NCT01838044|567232064|FG001|Overall Study|Protocol Violation|3|||
157131665|NCT01838044|567232063|FG000|Overall Study|Withdrawal by Subject|0|||
157131666|NCT01838044|567232064|FG001|Overall Study|Withdrawal by Subject|2|||
157131667|NCT01838044|567232063|FG000|Overall Study|Insufficient clinical response|1|||
157131668|NCT01838044|567232064|FG001|Overall Study|Insufficient clinical response|2|||
157131669|NCT01838044|567232063|FG000|Overall Study|Medication error without associated AE|0|||
157131670|NCT01838044|567232064|FG001|Overall Study|Medication error without associated AE|1|||
157131671|NCT01838044|567232063|FG000|Overall Study|Lost to Follow-up|0|||
157131672|NCT01838044|567232064|FG001|Overall Study|Lost to Follow-up|2|||
157131673|NCT01413958|567232065|FG000|Overall Study|Lost to Follow-up|0|||
157131674|NCT01413958|567232066|FG001|Overall Study|Lost to Follow-up|1|||
157131675|NCT02908516|567232067|FG000|Overall Study|Study Terminated|3|||
157131676|NCT02908516|567232068|FG001|Overall Study|Study Terminated|3|||
157131677|NCT01225562|567232071|FG000|Overall Study|Withdrawal by Subject|52|||
157131678|NCT01225562|567232072|FG001|Overall Study|Withdrawal by Subject|50|||
157131679|NCT01225562|567232073|FG002|Overall Study|Withdrawal by Subject|52|||
157131680|NCT01225562|567232071|FG000|Overall Study|Lost to Follow-up|3|||
157131681|NCT01225562|567232072|FG001|Overall Study|Lost to Follow-up|6|||
157131682|NCT01225562|567232073|FG002|Overall Study|Lost to Follow-up|1|||
157131683|NCT02928952|567232075|FG000|Overall Study|Lost to Follow-up|5|||
157131684|NCT02928952|567232076|FG001|Overall Study|Lost to Follow-up|5|||
157131685|NCT02928952|567232075|FG000|Overall Study|Withdrawal by Subject|5|||
157131686|NCT02928952|567232076|FG001|Overall Study|Withdrawal by Subject|1|||
157131687|NCT02928952|567232075|FG000|Overall Study|Physician Decision|0|||
157131688|NCT02928952|567232076|FG001|Overall Study|Physician Decision|1|||
157131689|NCT00712348|567232080|FG000|Overall Study|Withdrawal by Subject|1|||
157131690|NCT01273064|567232083|FG000|Overall Study|Adverse Event|5|||
157131691|NCT01273064|567232084|FG001|Overall Study|Adverse Event|1|||
157131692|NCT01273064|567232085|FG002|Overall Study|Adverse Event|3|||
157131693|NCT01273064|567232086|FG003|Overall Study|Adverse Event|2|||
157131694|NCT01273064|567232087|FG004|Overall Study|Adverse Event|1|||
157131695|NCT01273064|567232083|FG000|Overall Study|Withdrawal by Subject|4|||
157131696|NCT01273064|567232084|FG001|Overall Study|Withdrawal by Subject|2|||
157131697|NCT01273064|567232085|FG002|Overall Study|Withdrawal by Subject|2|||
157131698|NCT01273064|567232086|FG003|Overall Study|Withdrawal by Subject|2|||
157131699|NCT01273064|567232087|FG004|Overall Study|Withdrawal by Subject|0|||
157131700|NCT01273064|567232083|FG000|Overall Study|Study Termination|13|||
157131701|NCT01273064|567232084|FG001|Overall Study|Study Termination|27|||
157131702|NCT01273064|567232085|FG002|Overall Study|Study Termination|26|||
157131703|NCT01273064|567232086|FG003|Overall Study|Study Termination|16|||
157131704|NCT01273064|567232087|FG004|Overall Study|Study Termination|8|||
157131705|NCT01273064|567232083|FG000|Overall Study|Lost to Follow-up|1|||
157131706|NCT01273064|567232084|FG001|Overall Study|Lost to Follow-up|0|||
157131707|NCT01273064|567232085|FG002|Overall Study|Lost to Follow-up|0|||
157131708|NCT01273064|567232086|FG003|Overall Study|Lost to Follow-up|0|||
157131709|NCT01273064|567232087|FG004|Overall Study|Lost to Follow-up|0|||
157131710|NCT01273064|567232083|FG000|Overall Study|Physician Decision|0|||
157131711|NCT01273064|567232084|FG001|Overall Study|Physician Decision|0|||
157131712|NCT01273064|567232085|FG002|Overall Study|Physician Decision|0|||
157131713|NCT01273064|567232086|FG003|Overall Study|Physician Decision|0|||
157131714|NCT01273064|567232087|FG004|Overall Study|Physician Decision|1|||
157131715|NCT04666038|567232088|FG000|Overall Study|Progressive Disease|2|||
157131716|NCT04666038|567232089|FG001|Overall Study|Progressive Disease|0|||
157131717|NCT04666038|567232088|FG000|Overall Study|Death|38|||
157131718|NCT04666038|567232089|FG001|Overall Study|Death|32|||
157131719|NCT04666038|567232088|FG000|Overall Study|Withdrawal by Subject|10|||
157131720|NCT04666038|567232089|FG001|Overall Study|Withdrawal by Subject|19|||
157131721|NCT04666038|567232088|FG000|Overall Study|Lost to Follow-up|0|||
157131722|NCT04666038|567232089|FG001|Overall Study|Lost to Follow-up|2|||
157131723|NCT04666038|567232088|FG000|Overall Study|On Study Treatment|46|||
157131724|NCT04666038|567232089|FG001|Overall Study|On Study Treatment|5|||
157131725|NCT04666038|567232088|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
157131726|NCT04666038|567232089|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
157131727|NCT04957290|567232091|FG000|Overall Study|Progressive disease|3|||
157131728|NCT04957290|567232092|FG001|Overall Study|Progressive disease|3|||
157131729|NCT04957290|567232093|FG002|Overall Study|Progressive disease|2|||
157131730|NCT04957290|567232094|FG003|Overall Study|Progressive disease|0|||
157131731|NCT04957290|567232095|FG004|Overall Study|Progressive disease|0|||
157131732|NCT04957290|567232096|FG005|Overall Study|Progressive disease|0|||
157131733|NCT04957290|567232091|FG000|Overall Study|Withdrawal by Subject|1|||
157131734|NCT04957290|567232092|FG001|Overall Study|Withdrawal by Subject|0|||
157131735|NCT04957290|567232093|FG002|Overall Study|Withdrawal by Subject|1|||
157131736|NCT04957290|567232094|FG003|Overall Study|Withdrawal by Subject|0|||
157131737|NCT04957290|567232095|FG004|Overall Study|Withdrawal by Subject|0|||
157131738|NCT04957290|567232096|FG005|Overall Study|Withdrawal by Subject|0|||
157131739|NCT04957290|567232091|FG000|Overall Study|Death|0|||
157131740|NCT04957290|567232092|FG001|Overall Study|Death|2|||
157131741|NCT04957290|567232093|FG002|Overall Study|Death|1|||
157131742|NCT04957290|567232094|FG003|Overall Study|Death|0|||
157131743|NCT04957290|567232095|FG004|Overall Study|Death|0|||
157131744|NCT04957290|567232096|FG005|Overall Study|Death|0|||
157131745|NCT04957290|567232091|FG000|Overall Study|non compliance with study drug|0|||
157131746|NCT04957290|567232092|FG001|Overall Study|non compliance with study drug|1|||
157131747|NCT04957290|567232093|FG002|Overall Study|non compliance with study drug|0|||
156793354|NCT00456365|565996256|FG000|Overall Study|Pregnancy|1|||
156793355|NCT00456365|565996257|FG001|Overall Study|Pregnancy|1|||
156793356|NCT00456365|565996256|FG000|Overall Study|oncologic diagnosis|1|||
156793357|NCT00456365|565996257|FG001|Overall Study|oncologic diagnosis|1|||
156793358|NCT00803049|565996263|FG000|Overall Study|Adverse Event|21|||
156793359|NCT00803049|565996264|FG001|Overall Study|Adverse Event|33|||
156793360|NCT00803049|565996265|FG002|Overall Study|Adverse Event|13|||
156793361|NCT00803049|565996266|FG003|Overall Study|Adverse Event|27|||
156793362|NCT00803049|565996263|FG000|Overall Study|Lack of Efficacy|10|||
156793363|NCT00803049|565996264|FG001|Overall Study|Lack of Efficacy|19|||
156793364|NCT00803049|565996265|FG002|Overall Study|Lack of Efficacy|6|||
156793365|NCT00803049|565996266|FG003|Overall Study|Lack of Efficacy|13|||
156793366|NCT00803049|565996263|FG000|Overall Study|Lost to Follow-up|0|||
156793367|NCT00803049|565996264|FG001|Overall Study|Lost to Follow-up|2|||
156793368|NCT00803049|565996265|FG002|Overall Study|Lost to Follow-up|0|||
156793369|NCT00803049|565996266|FG003|Overall Study|Lost to Follow-up|3|||
156793370|NCT00803049|565996263|FG000|Overall Study|Death|2|||
156793371|NCT00803049|565996264|FG001|Overall Study|Death|1|||
156793372|NCT00803049|565996265|FG002|Overall Study|Death|0|||
156793373|NCT00803049|565996266|FG003|Overall Study|Death|2|||
156793374|NCT00803049|565996263|FG000|Overall Study|Progressive Disease|6|||
156793375|NCT00803049|565996264|FG001|Overall Study|Progressive Disease|10|||
156793376|NCT00803049|565996265|FG002|Overall Study|Progressive Disease|6|||
156793377|NCT00803049|565996266|FG003|Overall Study|Progressive Disease|6|||
156793378|NCT00803049|565996263|FG000|Overall Study|Withdrawal by Subject|19|||
156793379|NCT00803049|565996264|FG001|Overall Study|Withdrawal by Subject|43|||
156793380|NCT00803049|565996265|FG002|Overall Study|Withdrawal by Subject|16|||
156793381|NCT00803049|565996266|FG003|Overall Study|Withdrawal by Subject|44|||
156793382|NCT00803049|565996263|FG000|Overall Study|Protocol Violation|0|||
156793383|NCT00803049|565996264|FG001|Overall Study|Protocol Violation|1|||
156793384|NCT00803049|565996265|FG002|Overall Study|Protocol Violation|1|||
156793385|NCT00803049|565996266|FG003|Overall Study|Protocol Violation|0|||
156793386|NCT00803049|565996263|FG000|Overall Study|Randomized and Not Treated|0|||
156793387|NCT00803049|565996264|FG001|Overall Study|Randomized and Not Treated|0|||
156793388|NCT00803049|565996265|FG002|Overall Study|Randomized and Not Treated|0|||
156793389|NCT00803049|565996266|FG003|Overall Study|Randomized and Not Treated|2|||
156793390|NCT00803049|565996263|FG000|Overall Study|Other than Specified Above|3|||
156793391|NCT00803049|565996264|FG001|Overall Study|Other than Specified Above|9|||
156793392|NCT00803049|565996265|FG002|Overall Study|Other than Specified Above|2|||
156793393|NCT00803049|565996266|FG003|Overall Study|Other than Specified Above|5|||
156793394|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
156793395|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
156793396|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
156793397|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
156793398|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
156793399|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
156793400|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
156793401|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
156793402|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
156793403|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
156793404|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
156793405|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
156793406|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
156793407|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
156793408|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
156793409|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
156793410|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
156793411|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
156793412|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
157131748|NCT04957290|567232094|FG003|Overall Study|non compliance with study drug|0|||
157216926|NCT00434161|567540974|FG001|Overall Study|Lost to Follow-up|1|||
156793413|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
156793414|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
157216927|NCT00434161|567540975|FG002|Overall Study|Lost to Follow-up|0|||
157216928|NCT00434161|567540973|FG000|Overall Study|Death|1|||
157216929|NCT00434161|567540974|FG001|Overall Study|Death|0|||
157018296|NCT03089398|566821239|FG001|Overall Study|Death|9|||
157018297|NCT03089398|566821238|FG000|Overall Study|Lost to Follow-up|21|||
157018298|NCT03089398|566821239|FG001|Overall Study|Lost to Follow-up|30|||
157018299|NCT03089398|566821238|FG000|Overall Study|Withdrawal by Subject|2|||
157018300|NCT03089398|566821239|FG001|Overall Study|Withdrawal by Subject|2|||
157018301|NCT04703322|566821241|FG000|Overall Study|Ongoing|8|||
157018302|NCT04703322|566821241|FG000|Overall Study|Withdrawal by Subject|1|||
157018303|NCT04638998|566821242|FG000|Overall Study|Withdrawal by Subject|1|||
157018304|NCT04638998|566821243|FG001|Overall Study|Withdrawal by Subject|3|||
157018305|NCT03713086|566821244|FG000|Overall Study|Withdrawal by Subject|0|||
157018306|NCT03713086|566821245|FG001|Overall Study|Withdrawal by Subject|2|||
157018307|NCT03713086|566821246|FG002|Overall Study|Withdrawal by Subject|1|||
157018308|NCT03713086|566821247|FG003|Overall Study|Withdrawal by Subject|0|||
157018309|NCT03713086|566821244|FG000|Overall Study|Lost to Follow-up|0|||
157018310|NCT03713086|566821245|FG001|Overall Study|Lost to Follow-up|1|||
157018311|NCT03713086|566821246|FG002|Overall Study|Lost to Follow-up|0|||
157018312|NCT03713086|566821247|FG003|Overall Study|Lost to Follow-up|1|||
157018313|NCT05009251|566821248|FG000|Overall Study|Protocol Violation|100|||
157018314|NCT05009251|566821249|FG001|Overall Study|Protocol Violation|105|||
157018315|NCT05009251|566821250|FG002|Overall Study|Protocol Violation|119|||
157018316|NCT05009251|566821251|FG003|Overall Study|Protocol Violation|120|||
157018317|NCT05009251|566821252|FG004|Overall Study|Protocol Violation|119|||
157018318|NCT05009251|566821248|FG000|Overall Study|Death|25|||
157018319|NCT05009251|566821249|FG001|Overall Study|Death|22|||
157018320|NCT05009251|566821250|FG002|Overall Study|Death|24|||
157018321|NCT05009251|566821251|FG003|Overall Study|Death|19|||
157018322|NCT05009251|566821252|FG004|Overall Study|Death|15|||
157018323|NCT05406921|566821256|FG000|Overall Study|Withdrawal by Subject|25|||
157018324|NCT05406921|566821257|FG001|Overall Study|Withdrawal by Subject|0|||
157018325|NCT05406921|566821258|FG002|Overall Study|Withdrawal by Subject|25|||
157018326|NCT05406921|566821256|FG000|Overall Study|Protocol Violation|0|||
157018327|NCT05406921|566821257|FG001|Overall Study|Protocol Violation|12|||
157018328|NCT05406921|566821258|FG002|Overall Study|Protocol Violation|0|||
157018329|NCT04831281|566821261|FG000|Overall Study|Adverse Event|1|||
157018330|NCT04831281|566821262|FG001|Overall Study|Adverse Event|0|||
157018331|NCT04831281|566821263|FG002|Overall Study|Adverse Event|3|||
157018332|NCT04831281|566821261|FG000|Overall Study|Withdrawal by Subject|0|||
157018333|NCT04831281|566821262|FG001|Overall Study|Withdrawal by Subject|1|||
157018334|NCT04831281|566821263|FG002|Overall Study|Withdrawal by Subject|2|||
157018335|NCT04831281|566821261|FG000|Overall Study|Undetermined|1|||
157018336|NCT04831281|566821262|FG001|Overall Study|Undetermined|1|||
157018337|NCT04831281|566821263|FG002|Overall Study|Undetermined|0|||
157018338|NCT05249439|566821264|FG000|Overall Study|Withdrawal by Subject|2|||
157018339|NCT05249439|566821265|FG001|Overall Study|Withdrawal by Subject|5|||
157018340|NCT05249439|566821264|FG000|Overall Study|Physician Decision|3|||
157018341|NCT05249439|566821265|FG001|Overall Study|Physician Decision|1|||
157018342|NCT00616967|566821266|FG000|Overall Study|Withdrawal by Subject|0|||
157018343|NCT00616967|566821267|FG001|Overall Study|Withdrawal by Subject|0|||
157018344|NCT00616967|566821268|FG002|Overall Study|Withdrawal by Subject|1|||
157018345|NCT02910583|566821269|FG000|Overall Study|Death|7|||
157018346|NCT02910583|566821270|FG001|Overall Study|Death|3|||
157018347|NCT02910583|566821269|FG000|Overall Study|Lost to Follow-up|1|||
157018348|NCT02910583|566821270|FG001|Overall Study|Lost to Follow-up|0|||
157018349|NCT02910583|566821269|FG000|Overall Study|Withdrawal by Subject|12|||
157018350|NCT02910583|566821270|FG001|Overall Study|Withdrawal by Subject|8|||
157018351|NCT02910583|566821269|FG000|Overall Study|Other, Not Specified|6|||
157018352|NCT02910583|566821270|FG001|Overall Study|Other, Not Specified|3|||
157018353|NCT03393975|566821271|FG000|Urgent Treatment Period|Physician Decision|0|||
157018354|NCT03393975|566821272|FG001|Urgent Treatment Period|Physician Decision|0|||
157018355|NCT03393975|566821273|FG002|Urgent Treatment Period|Physician Decision|0|||
157018356|NCT03393975|566821274|FG003|Urgent Treatment Period|Physician Decision|1|||
157018357|NCT03393975|566821271|FG000|Prophylaxis Period 1|Reason not Specified|0|||
157018358|NCT03393975|566821272|FG001|Prophylaxis Period 1|Reason not Specified|1|||
157018359|NCT03393975|566821273|FG002|Prophylaxis Period 1|Reason not Specified|0|||
157018360|NCT03393975|566821274|FG003|Prophylaxis Period 1|Reason not Specified|0|||
157018361|NCT03393975|566821271|FG000|Prophylaxis Period 2|Reason not Specified|0|||
157018362|NCT03393975|566821272|FG001|Prophylaxis Period 2|Reason not Specified|1|||
157018363|NCT03393975|566821273|FG002|Prophylaxis Period 2|Reason not Specified|0|||
157018364|NCT03393975|566821274|FG003|Prophylaxis Period 2|Reason not Specified|0|||
157018365|NCT05021640|566821275|FG000|Overall Study|Lost to Follow-up|0|||
157018366|NCT05021640|566821276|FG001|Overall Study|Lost to Follow-up|0|||
157018367|NCT05021640|566821277|FG002|Overall Study|Lost to Follow-up|0|||
157018368|NCT05021640|566821278|FG003|Overall Study|Lost to Follow-up|0|||
157018369|NCT05021640|566821279|FG004|Overall Study|Lost to Follow-up|1|||
157018370|NCT02312960|566821280|FG000|Overall Study|Death|24|||
157216930|NCT00434161|567540975|FG002|Overall Study|Death|1|||
157131749|NCT04957290|567232095|FG004|Overall Study|non compliance with study drug|0|||
157131750|NCT04957290|567232096|FG005|Overall Study|non compliance with study drug|0|||
157131751|NCT04957290|567232091|FG000|Overall Study|none specified.|0|||
157131752|NCT04957290|567232092|FG001|Overall Study|none specified.|1|||
157131753|NCT04957290|567232093|FG002|Overall Study|none specified.|2|||
157131754|NCT04957290|567232094|FG003|Overall Study|none specified.|0|||
157216931|NCT00434161|567540973|FG000|Overall Study|Non-Compliance|1|||
157216932|NCT00434161|567540974|FG001|Overall Study|Non-Compliance|1|||
157216933|NCT00434161|567540975|FG002|Overall Study|Non-Compliance|0|||
157216934|NCT00434161|567540973|FG000|Overall Study|Withdrawal by Subject|2|||
157216935|NCT00434161|567540974|FG001|Overall Study|Withdrawal by Subject|0|||
157216936|NCT00434161|567540975|FG002|Overall Study|Withdrawal by Subject|3|||
157216937|NCT00434161|567540973|FG000|Overall Study|Logistical error study assessments|1|||
157216938|NCT00434161|567540974|FG001|Overall Study|Logistical error study assessments|0|||
157216939|NCT00434161|567540975|FG002|Overall Study|Logistical error study assessments|3|||
157216940|NCT01084005|567540976|FG000|Overall Study|Adverse Event|1|||
157216941|NCT01084005|567540977|FG001|Overall Study|Adverse Event|8|||
157216942|NCT01084005|567540976|FG000|Overall Study|Protocol Violation|3|||
157216943|NCT01084005|567540977|FG001|Overall Study|Protocol Violation|7|||
157216944|NCT01084005|567540976|FG000|Overall Study|Withdrawal by Subject|1|||
157216945|NCT01084005|567540977|FG001|Overall Study|Withdrawal by Subject|1|||
157216946|NCT03568500|567540978|FG000|Overall Study|Lost to Follow-up|1|||
157216947|NCT03568500|567540979|FG001|Overall Study|Lost to Follow-up|1|||
157216948|NCT03568500|567540980|FG002|Overall Study|Lost to Follow-up|2|||
157216949|NCT03568500|567540978|FG000|Overall Study|Adverse Event|1|||
157018371|NCT02312960|566821281|FG001|Overall Study|Death|32|||
157018372|NCT02312960|566821282|FG002|Overall Study|Death|25|||
157018373|NCT02312960|566821283|FG003|Overall Study|Death|11|||
157018374|NCT02312960|566821284|FG004|Overall Study|Death|5|||
157018375|NCT02312960|566821285|FG005|Overall Study|Death|5|||
157018376|NCT02312960|566821286|FG006|Overall Study|Death|8|||
157018377|NCT02312960|566821287|FG007|Overall Study|Death|5|||
157018378|NCT02312960|566821288|FG008|Overall Study|Death|7|||
157131755|NCT04957290|567232095|FG004|Overall Study|none specified.|0|||
157131756|NCT04957290|567232096|FG005|Overall Study|none specified.|0|||
157131757|NCT04957290|567232091|FG000|Overall Study|unacceptable toxicity|0|||
157131758|NCT04957290|567232092|FG001|Overall Study|unacceptable toxicity|0|||
157216950|NCT03568500|567540979|FG001|Overall Study|Adverse Event|1|||
157216951|NCT03568500|567540980|FG002|Overall Study|Adverse Event|2|||
157216952|NCT03568500|567540978|FG000|Overall Study|Physician Decision|1|||
157216953|NCT03568500|567540979|FG001|Overall Study|Physician Decision|0|||
157216954|NCT03568500|567540980|FG002|Overall Study|Physician Decision|0|||
157216955|NCT03568500|567540978|FG000|Overall Study|Withdrawal by Subject|4|||
157216956|NCT03568500|567540979|FG001|Overall Study|Withdrawal by Subject|2|||
157216957|NCT03568500|567540980|FG002|Overall Study|Withdrawal by Subject|0|||
157216958|NCT03568500|567540978|FG000|Overall Study|Technical Problems|2|||
157216959|NCT03568500|567540979|FG001|Overall Study|Technical Problems|1|||
157216960|NCT03568500|567540980|FG002|Overall Study|Technical Problems|0|||
157131759|NCT04957290|567232093|FG002|Overall Study|unacceptable toxicity|1|||
157216961|NCT03568500|567540978|FG000|Overall Study|Participant Noncompliance|1|||
157216962|NCT03568500|567540979|FG001|Overall Study|Participant Noncompliance|1|||
157216963|NCT03568500|567540980|FG002|Overall Study|Participant Noncompliance|0|||
157216964|NCT01759381|567540983|FG000|Overall Study|Death|1|||
157216965|NCT01759381|567540984|FG001|Overall Study|Death|0|||
157216966|NCT00910858|567540985|FG000|Pharmacokinetic Phase|Adverse Event|1|||
157216967|NCT00910858|567540986|FG001|Pharmacokinetic Phase|Adverse Event|0|||
157216968|NCT00910858|567540987|FG002|Pharmacokinetic Phase|Adverse Event|0|||
157018379|NCT02312960|566821289|FG009|Overall Study|Death|3|||
157131760|NCT04957290|567232094|FG003|Overall Study|unacceptable toxicity|0|||
157131761|NCT04957290|567232095|FG004|Overall Study|unacceptable toxicity|0|||
157131762|NCT04957290|567232096|FG005|Overall Study|unacceptable toxicity|0|||
157131763|NCT04957290|567232091|FG000|Overall Study|Adverse Event|0|||
157131764|NCT04957290|567232092|FG001|Overall Study|Adverse Event|0|||
157216969|NCT00910858|567540985|FG000|Monotherapy Phase|Adverse Event|3|||
157216970|NCT00910858|567540986|FG001|Monotherapy Phase|Adverse Event|2|||
157018380|NCT02312960|566821290|FG010|Overall Study|Death|3|||
157018381|NCT02312960|566821291|FG011|Overall Study|Death|1|||
157018382|NCT02312960|566821292|FG012|Overall Study|Death|25|||
157018383|NCT02312960|566821293|FG013|Overall Study|Death|19|||
157131765|NCT04957290|567232093|FG002|Overall Study|Adverse Event|1|||
157131766|NCT04957290|567232094|FG003|Overall Study|Adverse Event|0|||
157131767|NCT04957290|567232095|FG004|Overall Study|Adverse Event|0|||
157131768|NCT04957290|567232096|FG005|Overall Study|Adverse Event|0|||
157216971|NCT00910858|567540987|FG002|Monotherapy Phase|Adverse Event|0|||
157216972|NCT00910858|567540985|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
157216973|NCT00910858|567540986|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
157216974|NCT00910858|567540987|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
157216975|NCT00910858|567540985|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
157216976|NCT00910858|567540986|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
157131769|NCT04957290|567232091|FG000|Overall Study|study terminated by sponsor|0|||
157131770|NCT04957290|567232092|FG001|Overall Study|study terminated by sponsor|0|||
157131771|NCT04957290|567232093|FG002|Overall Study|study terminated by sponsor|2|||
157131772|NCT04957290|567232094|FG003|Overall Study|study terminated by sponsor|0|||
157131773|NCT04957290|567232095|FG004|Overall Study|study terminated by sponsor|0|||
157131774|NCT04957290|567232096|FG005|Overall Study|study terminated by sponsor|0|||
157131775|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131776|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131777|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131778|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
157131779|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131780|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
157131781|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131782|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131783|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131784|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131785|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131786|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131787|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131788|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131789|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131790|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131791|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131792|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131793|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131794|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131795|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131796|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131797|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
157131798|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
157131799|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
157131800|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
157131801|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
157131802|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
157131803|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
157131804|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
157131805|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131806|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131807|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131808|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131809|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131810|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131811|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131812|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131813|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131814|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131815|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131816|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131817|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131818|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131819|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131820|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
157131821|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
157131822|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
157131823|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
157131824|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
157131825|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
157131826|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
157131827|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
157131828|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
156716384|NCT00838526|565705358|FG001|Overall Study|Withdrawal by Subject|5|||
156716385|NCT00838526|565705357|FG000|Overall Study|Lack of Efficacy|2|||
156716386|NCT00838526|565705358|FG001|Overall Study|Lack of Efficacy|3|||
156716387|NCT00838526|565705357|FG000|Overall Study|Other|11|||
157131829|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131830|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131831|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131832|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131833|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131834|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131835|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131836|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131837|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131838|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131839|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131840|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131841|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131842|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131843|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
157131844|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131845|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131846|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
157131847|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131848|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
157131849|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131850|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131851|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131852|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131853|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131854|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131855|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131856|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131857|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131858|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131859|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131860|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131861|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131862|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131863|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131864|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131865|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131866|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
157131867|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
157131868|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131869|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131870|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
157131871|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131872|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131873|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131874|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131875|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131876|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131877|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131878|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131879|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156874859|NCT04549545|566300562|FG001|Crossover Period|Additional ENT Procedure|6|||
156874860|NCT04549545|566300561|FG000|Crossover Period|Lost to Follow-up|0|||
156874861|NCT04549545|566300562|FG001|Crossover Period|Lost to Follow-up|1|||
156874862|NCT04549545|566300561|FG000|Crossover Period|Withdrawal by Subject|0|||
157018384|NCT02312960|566821280|FG000|Overall Study|Missing|0|||
157018385|NCT02312960|566821281|FG001|Overall Study|Missing|0|||
157018386|NCT02312960|566821282|FG002|Overall Study|Missing|2|||
157018387|NCT02312960|566821283|FG003|Overall Study|Missing|0|||
157018388|NCT02312960|566821284|FG004|Overall Study|Missing|0|||
157018389|NCT02312960|566821285|FG005|Overall Study|Missing|0|||
157018390|NCT02312960|566821286|FG006|Overall Study|Missing|0|||
157131880|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
156874863|NCT04549545|566300562|FG001|Crossover Period|Withdrawal by Subject|4|||
157018391|NCT02312960|566821287|FG007|Overall Study|Missing|0|||
157018392|NCT02312960|566821288|FG008|Overall Study|Missing|0|||
157018393|NCT02312960|566821289|FG009|Overall Study|Missing|0|||
157131881|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131882|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131883|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131884|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131885|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131886|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131887|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131888|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131889|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
157131890|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131891|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131892|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
157131893|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131894|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131895|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131896|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131897|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131898|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131899|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131900|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131901|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131902|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131903|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131904|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131905|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131906|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131907|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131908|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131909|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131910|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131911|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131912|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
157131913|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131914|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131915|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
157131916|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131917|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131918|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131919|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131920|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131921|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131922|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131923|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131924|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131925|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131926|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131927|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131928|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131929|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131930|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131931|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131932|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131933|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131934|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131935|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
157131936|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131937|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131938|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131939|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
157131940|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131941|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131942|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
156716388|NCT00838526|565705358|FG001|Overall Study|Other|7|||
157131943|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131944|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131945|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131946|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131947|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131948|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131949|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131950|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131951|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131952|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131953|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131954|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131955|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131956|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131957|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131958|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
157131959|NCT00896532|567232097|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131960|NCT00896532|567232098|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
157131961|NCT00896532|567232099|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131962|NCT00896532|567232100|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
157131963|NCT00896532|567232101|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
157131964|NCT00896532|567232102|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131965|NCT00896532|567232103|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131966|NCT00896532|567232104|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131967|NCT00896532|567232105|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131968|NCT00896532|567232106|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131969|NCT00896532|567232107|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131970|NCT00896532|567232108|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131971|NCT00896532|567232109|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131972|NCT00896532|567232110|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131973|NCT00896532|567232111|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131974|NCT00896532|567232112|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131975|NCT00896532|567232113|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131976|NCT00896532|567232114|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131977|NCT00896532|567232115|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131978|NCT00896532|567232116|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131979|NCT00896532|567232117|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131980|NCT00896532|567232118|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131981|NCT00896532|567232119|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
157131982|NCT00896532|567232097|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131983|NCT00896532|567232098|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131984|NCT00896532|567232099|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131985|NCT00896532|567232100|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131986|NCT00896532|567232101|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131987|NCT00896532|567232102|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131988|NCT00896532|567232103|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131989|NCT00896532|567232104|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131990|NCT00896532|567232105|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
157131991|NCT00896532|567232106|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131992|NCT00896532|567232107|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131993|NCT00896532|567232108|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131994|NCT00896532|567232109|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131995|NCT00896532|567232110|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131996|NCT00896532|567232111|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131997|NCT00896532|567232112|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131998|NCT00896532|567232113|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157131999|NCT00896532|567232114|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132000|NCT00896532|567232115|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132001|NCT00896532|567232116|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132002|NCT00896532|567232117|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132003|NCT00896532|567232118|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132004|NCT00896532|567232119|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
157132005|NCT00896532|567232097|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132006|NCT00896532|567232098|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132007|NCT00896532|567232099|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132008|NCT00896532|567232100|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132009|NCT00896532|567232101|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132010|NCT00896532|567232102|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132011|NCT00896532|567232103|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132012|NCT00896532|567232104|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157018394|NCT02312960|566821290|FG010|Overall Study|Missing|0|||
157018395|NCT02312960|566821291|FG011|Overall Study|Missing|0|||
157018396|NCT02312960|566821292|FG012|Overall Study|Missing|0|||
157132013|NCT00896532|567232105|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132014|NCT00896532|567232106|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132015|NCT00896532|567232107|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132016|NCT00896532|567232108|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132017|NCT00896532|567232109|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
157132018|NCT00896532|567232110|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132019|NCT00896532|567232111|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132020|NCT00896532|567232112|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132021|NCT00896532|567232113|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132022|NCT00896532|567232114|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132023|NCT00896532|567232115|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132024|NCT00896532|567232116|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132025|NCT00896532|567232117|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132026|NCT00896532|567232118|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132027|NCT00896532|567232119|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
157132028|NCT00896532|567232097|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132029|NCT00896532|567232098|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132030|NCT00896532|567232099|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132031|NCT00896532|567232100|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132032|NCT00896532|567232101|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132033|NCT00896532|567232102|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132034|NCT00896532|567232103|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132035|NCT00896532|567232104|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132036|NCT00896532|567232105|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132037|NCT00896532|567232106|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132038|NCT00896532|567232107|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
157132039|NCT00896532|567232108|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132040|NCT00896532|567232109|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
157132041|NCT00896532|567232110|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132042|NCT00896532|567232111|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132043|NCT00896532|567232112|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132044|NCT00896532|567232113|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132045|NCT00896532|567232114|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132046|NCT00896532|567232115|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132047|NCT00896532|567232116|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
156716389|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
156716390|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
156716391|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
156716392|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
156716393|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
156716394|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
156716395|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
156716396|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
156716397|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
156716398|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
156716399|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
156716400|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
156716401|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
156874864|NCT01865552|566300565|FG000|Period 1|Adverse Event|1|||
156874865|NCT01865552|566300566|FG001|Period 1|Adverse Event|0|||
157018397|NCT02312960|566821293|FG013|Overall Study|Missing|0|||
157018398|NCT02312960|566821280|FG000|Overall Study|Lost to Follow-up|0|||
157018399|NCT02312960|566821281|FG001|Overall Study|Lost to Follow-up|0|||
157018400|NCT02312960|566821282|FG002|Overall Study|Lost to Follow-up|1|||
157018401|NCT02312960|566821283|FG003|Overall Study|Lost to Follow-up|0|||
157018402|NCT02312960|566821284|FG004|Overall Study|Lost to Follow-up|0|||
157018403|NCT02312960|566821285|FG005|Overall Study|Lost to Follow-up|0|||
157018404|NCT02312960|566821286|FG006|Overall Study|Lost to Follow-up|1|||
157018405|NCT02312960|566821287|FG007|Overall Study|Lost to Follow-up|1|||
157216977|NCT00910858|567540987|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
157018406|NCT02312960|566821288|FG008|Overall Study|Lost to Follow-up|0|||
157018407|NCT02312960|566821289|FG009|Overall Study|Lost to Follow-up|1|||
157018408|NCT02312960|566821290|FG010|Overall Study|Lost to Follow-up|0|||
157018409|NCT02312960|566821291|FG011|Overall Study|Lost to Follow-up|0|||
157018410|NCT02312960|566821292|FG012|Overall Study|Lost to Follow-up|1|||
157018411|NCT02312960|566821293|FG013|Overall Study|Lost to Follow-up|0|||
157018412|NCT02312960|566821280|FG000|Overall Study|Withdrawal by Subject|1|||
157018413|NCT02312960|566821281|FG001|Overall Study|Withdrawal by Subject|2|||
157018414|NCT02312960|566821282|FG002|Overall Study|Withdrawal by Subject|0|||
157018415|NCT02312960|566821283|FG003|Overall Study|Withdrawal by Subject|0|||
157018416|NCT02312960|566821284|FG004|Overall Study|Withdrawal by Subject|1|||
157018417|NCT02312960|566821285|FG005|Overall Study|Withdrawal by Subject|0|||
157018418|NCT02312960|566821286|FG006|Overall Study|Withdrawal by Subject|1|||
157018419|NCT02312960|566821287|FG007|Overall Study|Withdrawal by Subject|2|||
157018420|NCT02312960|566821288|FG008|Overall Study|Withdrawal by Subject|2|||
157018421|NCT02312960|566821289|FG009|Overall Study|Withdrawal by Subject|3|||
157018422|NCT02312960|566821290|FG010|Overall Study|Withdrawal by Subject|0|||
157018423|NCT02312960|566821291|FG011|Overall Study|Withdrawal by Subject|0|||
157018424|NCT02312960|566821292|FG012|Overall Study|Withdrawal by Subject|2|||
157018425|NCT02312960|566821293|FG013|Overall Study|Withdrawal by Subject|0|||
157018426|NCT03315754|566821298|FG000|Overall Study|COVID-19 complications leading to death|1|||
157018427|NCT03315754|566821298|FG000|Overall Study|insurance coverage issue|1|||
157018428|NCT02954341|566821299|FG000|Overall Study|Attempted Implant unsuccessful|5|||
157018429|NCT02954341|566821299|FG000|Overall Study|Death|90|||
157018430|NCT02954341|566821299|FG000|Overall Study|Withdrawal by Subject|4|||
157018431|NCT02954341|566821299|FG000|Overall Study|Physician Decision|13|||
157018432|NCT02954341|566821299|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
157018433|NCT02954341|566821299|FG000|Overall Study|Not implanted due to physician's decision|1|||
157018434|NCT02954341|566821299|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
157018435|NCT05227209|566821300|FG000|Overall Study|Adverse Event|11|||
157018436|NCT05227209|566821300|FG000|Overall Study|Lost to Follow-up|1|||
157018437|NCT05227209|566821300|FG000|Overall Study|Withdrawal by Subject|7|||
157018438|NCT05227209|566821300|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
157018439|NCT05633953|566821301|FG000|Overall Study|Adverse Event|7|||
157018440|NCT05633953|566821301|FG000|Overall Study|Death|30|||
157018441|NCT05633953|566821301|FG000|Overall Study|Lost to Follow-up|1|||
157018442|NCT05633953|566821301|FG000|Overall Study|Osilodrostat discontinued|4|||
157018443|NCT05633953|566821301|FG000|Overall Study|Physician Decision|1|||
157018444|NCT05633953|566821301|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
157018445|NCT05633953|566821301|FG000|Overall Study|Progressive disease|2|||
157018446|NCT04245501|566821303|FG000|Overall Study|Adverse Event|2|||
157018447|NCT04245501|566821304|FG001|Overall Study|Adverse Event|0|||
157018448|NCT04245501|566821303|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
157018449|NCT04245501|566821304|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
157018450|NCT05337748|566821306|FG000|Overall Study|Withdrawal by Subject|1|||
157018451|NCT05337748|566821307|FG001|Overall Study|Withdrawal by Subject|0|||
157018452|NCT05337748|566821306|FG000|Overall Study|Death|1|||
157018453|NCT05337748|566821307|FG001|Overall Study|Death|0|||
157018454|NCT03453619|566821312|FG000|Core Study (Part A)|Physician Decision|0|||
157018455|NCT03453619|566821313|FG001|Core Study (Part A)|Physician Decision|0|||
157018456|NCT03453619|566821314|FG002|Core Study (Part A)|Physician Decision|2|||
157018457|NCT03453619|566821315|FG003|Core Study (Part A)|Physician Decision|0|||
157018458|NCT03453619|566821312|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
157018459|NCT03453619|566821313|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
157018460|NCT03453619|566821314|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
157018461|NCT03453619|566821315|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
157018462|NCT03453619|566821312|FG000|Core Study (Part A)|Other|0|||
157018463|NCT03453619|566821313|FG001|Core Study (Part A)|Other|1|||
157018464|NCT03453619|566821314|FG002|Core Study (Part A)|Other|0|||
157018465|NCT03453619|566821315|FG003|Core Study (Part A)|Other|0|||
157018466|NCT03453619|566821312|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
157018467|NCT03453619|566821313|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
157018468|NCT03453619|566821314|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
157018469|NCT03453619|566821315|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
157018470|NCT03453619|566821312|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
157018471|NCT03453619|566821313|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
157018472|NCT03453619|566821314|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
157018473|NCT03453619|566821315|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
157018474|NCT03453619|566821312|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
157018475|NCT03453619|566821313|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
157018476|NCT03453619|566821314|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
157018477|NCT03453619|566821315|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
157018478|NCT03453619|566821312|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
157216978|NCT00910858|567540985|FG000|Monotherapy Phase|Protocol Violation|1|||
156874866|NCT01865552|566300567|FG002|Period 1|Adverse Event|0|||
156874867|NCT01865552|566300568|FG003|Period 1|Adverse Event|1|||
156874868|NCT01865552|566300569|FG004|Period 1|Adverse Event|1|||
156874869|NCT01865552|566300570|FG005|Period 1|Adverse Event|1|||
156874870|NCT01865552|566300565|FG000|Period 1|Pathological lab|0|||
156874871|NCT01865552|566300566|FG001|Period 1|Pathological lab|0|||
157132048|NCT00896532|567232117|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132049|NCT00896532|567232118|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132050|NCT00896532|567232119|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
157132051|NCT00896532|567232097|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132052|NCT00896532|567232098|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132053|NCT00896532|567232099|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132054|NCT00896532|567232100|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132055|NCT00896532|567232101|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132056|NCT00896532|567232102|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132057|NCT00896532|567232103|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132058|NCT00896532|567232104|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132059|NCT00896532|567232105|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132060|NCT00896532|567232106|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132061|NCT00896532|567232107|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132062|NCT00896532|567232108|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132063|NCT00896532|567232109|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
157132064|NCT00896532|567232110|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
157132065|NCT00896532|567232111|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132066|NCT00896532|567232112|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132067|NCT00896532|567232113|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132068|NCT00896532|567232114|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132069|NCT00896532|567232115|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132070|NCT00896532|567232116|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132071|NCT00896532|567232117|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132072|NCT00896532|567232118|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132073|NCT00896532|567232119|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
157132074|NCT00896532|567232097|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
157132075|NCT00896532|567232098|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
157132076|NCT00896532|567232099|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
157132077|NCT00896532|567232100|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
157132078|NCT00896532|567232101|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
157132079|NCT00896532|567232102|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
157132080|NCT00896532|567232103|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
157132081|NCT00896532|567232104|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
157132082|NCT00896532|567232105|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
157132083|NCT00896532|567232106|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
157132084|NCT00896532|567232107|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
157132085|NCT00896532|567232108|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
157132086|NCT00896532|567232109|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
157132087|NCT00896532|567232110|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
157132088|NCT00896532|567232111|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
157132089|NCT00896532|567232112|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
157132090|NCT00896532|567232113|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
157132091|NCT00896532|567232114|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
157132092|NCT00896532|567232115|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
157132093|NCT00896532|567232116|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
157132094|NCT00896532|567232117|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
157132095|NCT00896532|567232118|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
157132096|NCT00896532|567232119|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
157132097|NCT00896532|567232097|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132098|NCT00896532|567232098|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156874872|NCT01865552|566300567|FG002|Period 1|Pathological lab|0|||
156874873|NCT01865552|566300568|FG003|Period 1|Pathological lab|0|||
156874874|NCT01865552|566300569|FG004|Period 1|Pathological lab|1|||
156874875|NCT01865552|566300570|FG005|Period 1|Pathological lab|0|||
157132099|NCT00896532|567232099|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132100|NCT00896532|567232100|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132101|NCT00896532|567232101|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
156716402|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
156716403|NCT04338022|565705361|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
156874876|NCT01865552|566300565|FG000|Period 1|Other|0|||
156874877|NCT01865552|566300566|FG001|Period 1|Other|0|||
157132102|NCT00896532|567232102|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132103|NCT00896532|567232103|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132104|NCT00896532|567232104|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132105|NCT00896532|567232105|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132106|NCT00896532|567232106|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132107|NCT00896532|567232107|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132108|NCT00896532|567232108|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132109|NCT00896532|567232109|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132110|NCT00896532|567232110|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132111|NCT00896532|567232111|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132112|NCT00896532|567232112|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
157132113|NCT00896532|567232113|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
157132114|NCT00896532|567232114|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132115|NCT00896532|567232115|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132116|NCT00896532|567232116|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132117|NCT00896532|567232117|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132118|NCT00896532|567232118|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132119|NCT00896532|567232119|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
157132120|NCT00896532|567232097|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132121|NCT00896532|567232098|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132122|NCT00896532|567232099|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132123|NCT00896532|567232100|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132124|NCT00896532|567232101|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132125|NCT00896532|567232102|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132126|NCT00896532|567232103|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132127|NCT00896532|567232104|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132128|NCT00896532|567232105|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132129|NCT00896532|567232106|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132130|NCT00896532|567232107|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132131|NCT00896532|567232108|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132132|NCT00896532|567232109|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132133|NCT00896532|567232110|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132134|NCT00896532|567232111|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132135|NCT00896532|567232112|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
157132136|NCT00896532|567232113|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
157132137|NCT00896532|567232114|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
157132138|NCT00896532|567232115|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132139|NCT00896532|567232116|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132140|NCT00896532|567232117|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132141|NCT00896532|567232118|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132142|NCT00896532|567232119|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
157132143|NCT00896532|567232097|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132144|NCT00896532|567232098|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
156716404|NCT04338022|565705362|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
156716405|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
156716406|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
156716407|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
156716408|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
156716409|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
156716410|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
156716411|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
156716412|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
156874878|NCT01865552|566300567|FG002|Period 1|Other|0|||
156874879|NCT01865552|566300568|FG003|Period 1|Other|0|||
156874880|NCT01865552|566300569|FG004|Period 1|Other|1|||
156874881|NCT01865552|566300570|FG005|Period 1|Other|0|||
156874882|NCT03083873|566300573|FG000|Overall Study|Death|6|||
157132145|NCT00896532|567232099|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132146|NCT00896532|567232100|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132147|NCT00896532|567232101|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132148|NCT00896532|567232102|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132149|NCT00896532|567232103|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132150|NCT00896532|567232104|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132151|NCT00896532|567232105|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132152|NCT00896532|567232106|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132153|NCT00896532|567232107|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132154|NCT00896532|567232108|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132155|NCT00896532|567232109|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132156|NCT00896532|567232110|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132157|NCT00896532|567232111|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132158|NCT00896532|567232112|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132159|NCT00896532|567232113|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
157132160|NCT00896532|567232114|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132161|NCT00896532|567232115|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132162|NCT00896532|567232116|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132163|NCT00896532|567232117|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132164|NCT00896532|567232118|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132165|NCT00896532|567232119|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
157132166|NCT00896532|567232097|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
157132167|NCT00896532|567232098|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
157132168|NCT00896532|567232099|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
157132169|NCT00896532|567232100|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
157132170|NCT00896532|567232101|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
157132171|NCT00896532|567232102|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
157132172|NCT00896532|567232103|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
157132173|NCT00896532|567232104|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
157132174|NCT00896532|567232105|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
157132175|NCT00896532|567232106|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
157132176|NCT00896532|567232107|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
157132177|NCT00896532|567232108|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
157132178|NCT00896532|567232109|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
157132179|NCT00896532|567232110|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
157132180|NCT00896532|567232111|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
157132181|NCT00896532|567232112|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
157132182|NCT00896532|567232113|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
157132183|NCT00896532|567232114|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
157132184|NCT00896532|567232115|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
157132185|NCT00896532|567232116|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
157132186|NCT00896532|567232117|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
157132187|NCT00896532|567232118|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
157132188|NCT00896532|567232119|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
157132189|NCT00896532|567232097|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132190|NCT00896532|567232098|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132191|NCT00896532|567232099|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
156716413|NCT04338022|565705361|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
156716414|NCT04338022|565705362|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
156716415|NCT04338022|565705361|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
156716416|NCT04338022|565705362|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
156716417|NCT05724589|565705367|FG000|Overall Study|Lost to Follow-up|1|||
156716418|NCT02466321|565705368|FG000|Overall Study|Death|26|||
156716419|NCT02466321|565705368|FG000|Overall Study|Revision|6|||
156716420|NCT02466321|565705368|FG000|Overall Study|Lost to Follow-up|60|||
156716421|NCT02466321|565705368|FG000|Overall Study|Did not receive study device|1|||
156716422|NCT00786409|565705369|FG000|Overall Study|Withdrawal by Subject|2|||
156716423|NCT00786409|565705369|FG000|Overall Study|Adverse Event|2|||
156716424|NCT00786409|565705369|FG000|Overall Study|Pregnancy|2|||
156716425|NCT00786409|565705369|FG000|Overall Study|Lost to Follow-up|1|||
156716426|NCT00610129|565705370|FG000|Overall Study|Not treated since patients ineligible|3|||
156716427|NCT01184079|565705377|FG000|Overall Study|Lost to Follow-up|14|||
156716428|NCT01184079|565705378|FG001|Overall Study|Lost to Follow-up|2|||
156716429|NCT04779879|565705381|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
157132192|NCT00896532|567232100|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132193|NCT00896532|567232101|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132194|NCT00896532|567232102|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132195|NCT00896532|567232103|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132196|NCT00896532|567232104|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132197|NCT00896532|567232105|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132198|NCT00896532|567232106|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132199|NCT00896532|567232107|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132200|NCT00896532|567232108|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132201|NCT00896532|567232109|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132202|NCT00896532|567232110|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132203|NCT00896532|567232111|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132204|NCT00896532|567232112|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132205|NCT00896532|567232113|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
157132206|NCT00896532|567232114|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132207|NCT00896532|567232115|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132208|NCT00896532|567232116|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132209|NCT00896532|567232117|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132210|NCT00896532|567232118|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132211|NCT00896532|567232119|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
157132212|NCT00896532|567232097|FG000|Months 48-72: Follow-on Phase|Death|0|||
157132213|NCT00896532|567232098|FG001|Months 48-72: Follow-on Phase|Death|0|||
157132214|NCT00896532|567232099|FG002|Months 48-72: Follow-on Phase|Death|0|||
157132215|NCT00896532|567232100|FG003|Months 48-72: Follow-on Phase|Death|0|||
157132216|NCT00896532|567232101|FG004|Months 48-72: Follow-on Phase|Death|0|||
157132217|NCT00896532|567232102|FG005|Months 48-72: Follow-on Phase|Death|0|||
157132218|NCT00896532|567232103|FG006|Months 48-72: Follow-on Phase|Death|0|||
157132219|NCT00896532|567232104|FG007|Months 48-72: Follow-on Phase|Death|0|||
157132220|NCT00896532|567232105|FG008|Months 48-72: Follow-on Phase|Death|0|||
157132221|NCT00896532|567232106|FG009|Months 48-72: Follow-on Phase|Death|0|||
157132222|NCT00896532|567232107|FG010|Months 48-72: Follow-on Phase|Death|0|||
157132223|NCT00896532|567232108|FG011|Months 48-72: Follow-on Phase|Death|0|||
157132224|NCT00896532|567232109|FG012|Months 48-72: Follow-on Phase|Death|0|||
157132225|NCT00896532|567232110|FG013|Months 48-72: Follow-on Phase|Death|0|||
157132226|NCT00896532|567232111|FG014|Months 48-72: Follow-on Phase|Death|0|||
157132227|NCT00896532|567232112|FG015|Months 48-72: Follow-on Phase|Death|0|||
157132228|NCT00896532|567232113|FG016|Months 48-72: Follow-on Phase|Death|0|||
157132229|NCT00896532|567232114|FG017|Months 48-72: Follow-on Phase|Death|0|||
157132230|NCT00896532|567232115|FG018|Months 48-72: Follow-on Phase|Death|1|||
157132231|NCT00896532|567232116|FG019|Months 48-72: Follow-on Phase|Death|0|||
157132232|NCT00896532|567232117|FG020|Months 48-72: Follow-on Phase|Death|0|||
157132233|NCT00896532|567232118|FG021|Months 48-72: Follow-on Phase|Death|0|||
157132234|NCT00896532|567232119|FG022|Months 48-72: Follow-on Phase|Death|0|||
157132235|NCT00896532|567232097|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132236|NCT00896532|567232098|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132237|NCT00896532|567232099|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132238|NCT00896532|567232100|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132239|NCT00896532|567232101|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132240|NCT00896532|567232102|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132241|NCT00896532|567232103|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132242|NCT00896532|567232104|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132243|NCT00896532|567232105|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132244|NCT00896532|567232106|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132245|NCT00896532|567232107|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132246|NCT00896532|567232108|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132247|NCT00896532|567232109|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132248|NCT00896532|567232110|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132249|NCT00896532|567232111|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132250|NCT00896532|567232112|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132251|NCT00896532|567232113|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132252|NCT00896532|567232114|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132253|NCT00896532|567232115|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132254|NCT00896532|567232116|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132255|NCT00896532|567232117|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132256|NCT00896532|567232118|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
157132257|NCT00896532|567232119|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
157132258|NCT00896532|567232097|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132259|NCT00896532|567232098|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132260|NCT00896532|567232099|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132261|NCT00896532|567232100|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132262|NCT00896532|567232101|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132263|NCT00896532|567232102|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132264|NCT00896532|567232103|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157216979|NCT00910858|567540986|FG001|Monotherapy Phase|Protocol Violation|0|||
157216980|NCT00910858|567540987|FG002|Monotherapy Phase|Protocol Violation|0|||
157132265|NCT00896532|567232104|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132266|NCT00896532|567232105|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132267|NCT00896532|567232106|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132268|NCT00896532|567232107|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157216981|NCT00910858|567540985|FG000|Monotherapy Phase|Other|3|||
157132269|NCT00896532|567232108|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132270|NCT00896532|567232109|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132271|NCT00896532|567232110|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132272|NCT00896532|567232111|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132273|NCT00896532|567232112|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132274|NCT00896532|567232113|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132275|NCT00896532|567232114|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132276|NCT00896532|567232115|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132277|NCT00896532|567232116|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132278|NCT00896532|567232117|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132279|NCT00896532|567232118|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
157132280|NCT00896532|567232119|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
157132281|NCT03186989|567232122|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132282|NCT03186989|567232123|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132283|NCT03186989|567232124|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
157132284|NCT03186989|567232125|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
157132285|NCT03186989|567232126|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
157132286|NCT03186989|567232127|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132287|NCT03186989|567232128|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132288|NCT03186989|567232129|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132289|NCT03186989|567232130|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132290|NCT03186989|567232131|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132291|NCT03186989|567232132|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
157132292|NCT03186989|567232122|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132293|NCT03186989|567232123|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132294|NCT03186989|567232124|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132295|NCT03186989|567232125|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132296|NCT03186989|567232126|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132297|NCT03186989|567232127|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
157132298|NCT03186989|567232128|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132299|NCT03186989|567232129|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132300|NCT03186989|567232130|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132301|NCT03186989|567232131|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132302|NCT03186989|567232132|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
157132303|NCT03186989|567232122|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132304|NCT03186989|567232123|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132305|NCT03186989|567232124|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132306|NCT03186989|567232125|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132307|NCT03186989|567232126|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132308|NCT03186989|567232127|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132309|NCT03186989|567232128|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
157132310|NCT03186989|567232129|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132311|NCT03186989|567232130|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132312|NCT03186989|567232131|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132313|NCT03186989|567232132|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
157132314|NCT03186989|567232122|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132315|NCT03186989|567232123|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132316|NCT03186989|567232124|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132317|NCT03186989|567232125|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132318|NCT03186989|567232126|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132319|NCT03186989|567232127|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
157132320|NCT03186989|567232128|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
157132321|NCT03186989|567232129|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132322|NCT03186989|567232130|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
157132323|NCT03186989|567232131|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132324|NCT03186989|567232132|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
157132325|NCT00821678|567232135|FG000|Overall Study|Withdrawal by Subject|8|||
157132326|NCT00821678|567232136|FG001|Overall Study|Withdrawal by Subject|0|||
156793415|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
156793416|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
156793417|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
156793418|NCT01272219|565996267|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
156793419|NCT01272219|565996268|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
156793420|NCT01272219|565996269|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
157132327|NCT00821678|567232135|FG000|Overall Study|Lost to Follow-up|13|||
157132328|NCT00821678|567232136|FG001|Overall Study|Lost to Follow-up|12|||
157132329|NCT00821678|567232135|FG000|Overall Study|Death|0|||
157132330|NCT00821678|567232136|FG001|Overall Study|Death|2|||
157132331|NCT01254669|567234057|FG000|Overall Study|Withdrawal by Subject|0|||
157132332|NCT01254669|567234058|FG001|Overall Study|Withdrawal by Subject|1|||
157132333|NCT01254669|567234057|FG000|Overall Study|time constraint|2|||
157132334|NCT01254669|567234058|FG001|Overall Study|time constraint|2|||
157132335|NCT01254669|567234057|FG000|Overall Study|called to clinic during intervention|1|||
156874883|NCT03083873|566300574|FG001|Overall Study|Death|15|||
156874884|NCT03083873|566300575|FG002|Overall Study|Death|13|||
156874885|NCT03083873|566300576|FG003|Overall Study|Death|9|||
156874886|NCT03083873|566300577|FG004|Overall Study|Death|0|||
156874887|NCT03083873|566300573|FG000|Overall Study|Sponsor Terminated Study|0|||
156874888|NCT03083873|566300574|FG001|Overall Study|Sponsor Terminated Study|1|||
156874889|NCT03083873|566300575|FG002|Overall Study|Sponsor Terminated Study|2|||
156874890|NCT03083873|566300576|FG003|Overall Study|Sponsor Terminated Study|3|||
156874891|NCT03083873|566300577|FG004|Overall Study|Sponsor Terminated Study|0|||
156874892|NCT03083873|566300573|FG000|Overall Study|Lost to Follow-up|0|||
156874893|NCT03083873|566300574|FG001|Overall Study|Lost to Follow-up|1|||
156874894|NCT03083873|566300575|FG002|Overall Study|Lost to Follow-up|1|||
156874895|NCT03083873|566300576|FG003|Overall Study|Lost to Follow-up|0|||
156874896|NCT03083873|566300577|FG004|Overall Study|Lost to Follow-up|0|||
156874897|NCT03083873|566300573|FG000|Overall Study|Withdrawal by Subject|2|||
156874898|NCT03083873|566300574|FG001|Overall Study|Withdrawal by Subject|0|||
156874899|NCT03083873|566300575|FG002|Overall Study|Withdrawal by Subject|0|||
156874900|NCT03083873|566300576|FG003|Overall Study|Withdrawal by Subject|0|||
156874901|NCT03083873|566300577|FG004|Overall Study|Withdrawal by Subject|0|||
156874902|NCT03083873|566300573|FG000|Overall Study|Did Not Receive TIL|2|||
156874903|NCT03083873|566300574|FG001|Overall Study|Did Not Receive TIL|5|||
156874904|NCT03083873|566300575|FG002|Overall Study|Did Not Receive TIL|3|||
156874905|NCT03083873|566300576|FG003|Overall Study|Did Not Receive TIL|1|||
156874906|NCT03083873|566300577|FG004|Overall Study|Did Not Receive TIL|0|||
156874907|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
156874908|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
156874909|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
156874910|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
156874911|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
156874912|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
156874913|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
156874914|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
156874915|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
156874916|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
156874917|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
156874918|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
156874919|NCT00479687|566300578|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
156874920|NCT00479687|566300579|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
156874921|NCT00479687|566300580|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
156874922|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
157132336|NCT01254669|567234058|FG001|Overall Study|called to clinic during intervention|1|||
157132337|NCT00103012|567234059|FG000|Overall Study|Withdrawal by Subject|2|||
157132338|NCT00103012|567234060|FG001|Overall Study|Withdrawal by Subject|1|||
157132339|NCT00103012|567234061|FG002|Overall Study|Withdrawal by Subject|2|||
157132340|NCT00103012|567234059|FG000|Overall Study|Pregnancy|1|||
156716430|NCT04779879|565705382|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716431|NCT04779879|565705383|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716432|NCT04779879|565705384|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
156716433|NCT04779879|565705385|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716434|NCT04779879|565705386|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
156716435|NCT04779879|565705381|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716436|NCT04779879|565705382|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716437|NCT04779879|565705383|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716438|NCT04779879|565705384|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
156716439|NCT04779879|565705385|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716440|NCT04779879|565705386|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
156716441|NCT04779879|565705381|FG000|Part C: Up to Week 36|Death|0|||
156716442|NCT04779879|565705382|FG001|Part C: Up to Week 36|Death|0|||
156716443|NCT04779879|565705383|FG002|Part C: Up to Week 36|Death|0|||
156716444|NCT04779879|565705384|FG003|Part C: Up to Week 36|Death|0|||
156716445|NCT04779879|565705385|FG004|Part C: Up to Week 36|Death|0|||
156716446|NCT04779879|565705386|FG005|Part C: Up to Week 36|Death|1|||
156716447|NCT04779879|565705381|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716448|NCT04779879|565705382|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
157132341|NCT00103012|567234060|FG001|Overall Study|Pregnancy|0|||
157132342|NCT00103012|567234061|FG002|Overall Study|Pregnancy|0|||
157132343|NCT00103012|567234059|FG000|Overall Study|Adverse Event|0|||
157132344|NCT00103012|567234060|FG001|Overall Study|Adverse Event|0|||
157132345|NCT00103012|567234061|FG002|Overall Study|Adverse Event|1|||
157132346|NCT00103012|567234059|FG000|Overall Study|Subject non-compliant with medications|0|||
157132347|NCT00103012|567234060|FG001|Overall Study|Subject non-compliant with medications|0|||
157132348|NCT00103012|567234061|FG002|Overall Study|Subject non-compliant with medications|1|||
157132349|NCT05211336|567234064|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
157132350|NCT05211336|567234065|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
157132351|NCT05211336|567234064|FG000|Overall Study|Progressive disease|0|||
157132352|NCT05211336|567234065|FG001|Overall Study|Progressive disease|4|||
157132353|NCT05211336|567234064|FG000|Overall Study|Death due to myocardial infarction|0|||
157132354|NCT05211336|567234065|FG001|Overall Study|Death due to myocardial infarction|1|||
157132355|NCT05211336|567234064|FG000|Overall Study|Death due to unknown cause|0|||
157132356|NCT05211336|567234065|FG001|Overall Study|Death due to unknown cause|1|||
157132357|NCT05211336|567234064|FG000|Overall Study|Worsening kidney function and quality of response|0|||
156874923|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
156874924|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
156874925|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
156874926|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
156874927|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
156874928|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
156874929|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
156874930|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
156874931|NCT00479687|566300578|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
156874932|NCT00479687|566300579|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
156874933|NCT00479687|566300580|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
156874934|NCT01474239|566300581|FG000|Overall Study|Disease Progression|37|||
156874935|NCT01474239|566300582|FG001|Overall Study|Disease Progression|25|||
156874936|NCT01474239|566300581|FG000|Overall Study|Adverse Event|12|||
156874937|NCT01474239|566300582|FG001|Overall Study|Adverse Event|3|||
156874938|NCT01474239|566300581|FG000|Overall Study|Withdrawal by Subject|1|||
156874939|NCT01474239|566300582|FG001|Overall Study|Withdrawal by Subject|2|||
157132358|NCT05211336|567234065|FG001|Overall Study|Worsening kidney function and quality of response|1|||
157132359|NCT00393718|567234070|FG000|Overall Study|Adverse Event|20|||
157132360|NCT00393718|567234071|FG001|Overall Study|Adverse Event|8|||
157132361|NCT00393718|567234070|FG000|Overall Study|Protocol Violation|1|||
157132362|NCT00393718|567234071|FG001|Overall Study|Protocol Violation|2|||
157132363|NCT00393718|567234070|FG000|Overall Study|Lack of Efficacy|10|||
156874940|NCT01474239|566300581|FG000|Overall Study|Death|1|||
156874941|NCT01474239|566300582|FG001|Overall Study|Death|1|||
157132364|NCT00393718|567234071|FG001|Overall Study|Lack of Efficacy|9|||
157132365|NCT00393718|567234070|FG000|Overall Study|Hypoglycaemia|3|||
157132366|NCT00393718|567234071|FG001|Overall Study|Hypoglycaemia|2|||
157132367|NCT00393718|567234070|FG000|Overall Study|Subject decision|5|||
157132368|NCT00393718|567234071|FG001|Overall Study|Subject decision|0|||
157132369|NCT00393718|567234070|FG000|Overall Study|Withdrawal of consent|2|||
157132370|NCT00393718|567234071|FG001|Overall Study|Withdrawal of consent|1|||
157132371|NCT00393718|567234070|FG000|Overall Study|Missed measurement|1|||
157132372|NCT00393718|567234071|FG001|Overall Study|Missed measurement|0|||
157132373|NCT00393718|567234070|FG000|Overall Study|Move|1|||
157132374|NCT00393718|567234071|FG001|Overall Study|Move|0|||
157132375|NCT01084551|567234076|FG000|Overall Study|Adverse Event|2|||
157132376|NCT01084551|567234077|FG001|Overall Study|Adverse Event|9|||
157216982|NCT00910858|567540986|FG001|Monotherapy Phase|Other|4|||
156716449|NCT04779879|565705383|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716450|NCT04779879|565705384|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
156716451|NCT04779879|565705385|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
156716452|NCT04779879|565705386|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
156716453|NCT05101343|565705387|FG000|Overall Study|Withdrawal by Subject|2|||
156716454|NCT05101343|565705388|FG001|Overall Study|Withdrawal by Subject|1|||
156716455|NCT02854527|565705389|FG000|Overall Study|Adverse Event|0|||
156716456|NCT02854527|565705390|FG001|Overall Study|Adverse Event|0|||
156716457|NCT02854527|565705391|FG002|Overall Study|Adverse Event|0|||
156716458|NCT02854527|565705392|FG003|Overall Study|Adverse Event|0|||
156716459|NCT02854527|565705393|FG004|Overall Study|Adverse Event|1|||
157132377|NCT01084551|567234078|FG002|Overall Study|Adverse Event|4|||
157132378|NCT01084551|567234076|FG000|Overall Study|Lack of Efficacy|2|||
157132379|NCT01084551|567234077|FG001|Overall Study|Lack of Efficacy|0|||
157132380|NCT01084551|567234078|FG002|Overall Study|Lack of Efficacy|1|||
157132381|NCT01084551|567234076|FG000|Overall Study|Withdrawal by Subject|2|||
157132382|NCT01084551|567234077|FG001|Overall Study|Withdrawal by Subject|1|||
156716460|NCT02854527|565705394|FG005|Overall Study|Adverse Event|0|||
157132383|NCT01084551|567234078|FG002|Overall Study|Withdrawal by Subject|0|||
157132384|NCT01084551|567234076|FG000|Overall Study|Protocol Violation|2|||
157132385|NCT01084551|567234077|FG001|Overall Study|Protocol Violation|4|||
157132386|NCT01084551|567234078|FG002|Overall Study|Protocol Violation|0|||
157132387|NCT01084551|567234076|FG000|Overall Study|Lost to Follow-up|0|||
157132388|NCT01084551|567234077|FG001|Overall Study|Lost to Follow-up|0|||
157132389|NCT01084551|567234078|FG002|Overall Study|Lost to Follow-up|3|||
157132390|NCT01084551|567234076|FG000|Overall Study|Physician Decision|1|||
157132391|NCT01084551|567234077|FG001|Overall Study|Physician Decision|0|||
157132392|NCT01084551|567234078|FG002|Overall Study|Physician Decision|0|||
157132393|NCT03902080|567234079|FG000|Overall Study|Adverse Event|17|||
157132394|NCT03902080|567234080|FG001|Overall Study|Adverse Event|15|||
157132395|NCT03902080|567234079|FG000|Overall Study|Withdrawal by Subject|28|||
157132396|NCT03902080|567234080|FG001|Overall Study|Withdrawal by Subject|35|||
157132397|NCT03902080|567234079|FG000|Overall Study|Lost to Follow-up|6|||
157132398|NCT03902080|567234080|FG001|Overall Study|Lost to Follow-up|7|||
157132399|NCT03902080|567234079|FG000|Overall Study|Other|3|||
157132400|NCT03902080|567234080|FG001|Overall Study|Other|5|||
157132401|NCT03902080|567234079|FG000|Overall Study|Non compliance|4|||
157132402|NCT03902080|567234080|FG001|Overall Study|Non compliance|3|||
157132403|NCT03902080|567234079|FG000|Overall Study|Physician Decision|5|||
157132404|NCT03902080|567234080|FG001|Overall Study|Physician Decision|1|||
157132405|NCT03902080|567234079|FG000|Overall Study|Protocol Violation|3|||
157132406|NCT03902080|567234080|FG001|Overall Study|Protocol Violation|3|||
157132407|NCT03902080|567234079|FG000|Overall Study|Lack of Efficacy|1|||
157132408|NCT03902080|567234080|FG001|Overall Study|Lack of Efficacy|3|||
157132409|NCT03902080|567234079|FG000|Overall Study|Withdrawn prior to dosing|0|||
157132410|NCT03902080|567234080|FG001|Overall Study|Withdrawn prior to dosing|1|||
157132411|NCT04684420|567234081|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157132412|NCT04684420|567234082|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157132413|NCT04684420|567234083|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
157132414|NCT04684420|567234084|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
157132415|NCT04684420|567234081|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
157132416|NCT04684420|567234082|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
157132417|NCT04684420|567234083|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
157132418|NCT04684420|567234084|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
157132419|NCT00463476|567234085|FG000|Overall Study|Withdrawal by Subject|1|||
157132420|NCT00463476|567234086|FG001|Overall Study|Withdrawal by Subject|2|||
157132421|NCT00463476|567234085|FG000|Overall Study|Lost to Follow-up|1|||
157132422|NCT00463476|567234086|FG001|Overall Study|Lost to Follow-up|1|||
157132423|NCT01703000|567234088|FG000|Overall Study|Death|1|||
157132424|NCT01061008|567234089|FG000|Overall Study|Badiocephalic fistula failed|3|||
157132425|NCT01061008|567234090|FG001|Overall Study|Badiocephalic fistula failed|2|||
157132426|NCT01061008|567234089|FG000|Overall Study|Death|1|||
157132427|NCT01061008|567234090|FG001|Overall Study|Death|0|||
156716461|NCT02854527|565705395|FG006|Overall Study|Adverse Event|0|||
156716462|NCT02854527|565705396|FG007|Overall Study|Adverse Event|0|||
156716463|NCT02854527|565705397|FG008|Overall Study|Adverse Event|0|||
156716464|NCT02854527|565705398|FG009|Overall Study|Adverse Event|0|||
156716465|NCT02854527|565705389|FG000|Overall Study|Lost to Follow-up|0|||
156716466|NCT02854527|565705390|FG001|Overall Study|Lost to Follow-up|0|||
156716467|NCT02854527|565705391|FG002|Overall Study|Lost to Follow-up|0|||
156716468|NCT02854527|565705392|FG003|Overall Study|Lost to Follow-up|1|||
156716469|NCT02854527|565705393|FG004|Overall Study|Lost to Follow-up|0|||
156716470|NCT02854527|565705394|FG005|Overall Study|Lost to Follow-up|0|||
156716471|NCT02854527|565705395|FG006|Overall Study|Lost to Follow-up|0|||
156716472|NCT02854527|565705396|FG007|Overall Study|Lost to Follow-up|0|||
156716473|NCT02854527|565705397|FG008|Overall Study|Lost to Follow-up|0|||
156716474|NCT02854527|565705398|FG009|Overall Study|Lost to Follow-up|0|||
156716475|NCT04075487|565707489|FG000|Overall Study|Withdrawal by Subject|1|||
156716476|NCT05016960|565707492|FG000|Overall Study|Withdrawal by Subject|1|||
156716477|NCT05016960|565707493|FG001|Overall Study|Withdrawal by Subject|9|||
156716478|NCT04467840|565707496|FG000|Overall Study|Death|35|||
156716479|NCT04467840|565707497|FG001|Overall Study|Death|39|||
156716480|NCT04467840|565707496|FG000|Overall Study|Withdrawal by Subject|8|||
156716481|NCT04467840|565707497|FG001|Overall Study|Withdrawal by Subject|4|||
156716482|NCT04467840|565707496|FG000|Overall Study|Adverse Event|2|||
156874942|NCT01474239|566300581|FG000|Overall Study|Clinical Disease Progression|7|||
157132428|NCT01061008|567234089|FG000|Overall Study|Withdrawal by Subject|1|||
157132429|NCT01061008|567234090|FG001|Overall Study|Withdrawal by Subject|3|||
157132430|NCT01061008|567234089|FG000|Overall Study|Unable to exercise following surgery|1|||
157132431|NCT01061008|567234090|FG001|Overall Study|Unable to exercise following surgery|0|||
157132432|NCT01061008|567234089|FG000|Overall Study|Adverse Event|0|||
157132433|NCT01061008|567234090|FG001|Overall Study|Adverse Event|1|||
157132434|NCT04067518|567234091|FG000|Overall Study|Adverse Event|1|||
157132435|NCT04067518|567234092|FG001|Overall Study|Adverse Event|3|||
156716483|NCT04467840|565707497|FG001|Overall Study|Adverse Event|0|||
156716484|NCT04467840|565707496|FG000|Overall Study|Lost to Follow-up|1|||
156716485|NCT04467840|565707497|FG001|Overall Study|Lost to Follow-up|3|||
156716486|NCT04467840|565707496|FG000|Overall Study|Physician Decision|1|||
157132436|NCT04067518|567234091|FG000|Overall Study|Screen failures|0|||
157132437|NCT04067518|567234092|FG001|Overall Study|Screen failures|1|||
157132438|NCT04067518|567234091|FG000|Overall Study|Enrolled but not treated|0|||
157132439|NCT04067518|567234092|FG001|Overall Study|Enrolled but not treated|1|||
157132440|NCT00675025|567234093|FG000|Overall Study|Study Terminated by Sponsor|38|||
157132441|NCT00675025|567234094|FG001|Overall Study|Study Terminated by Sponsor|42|||
157132442|NCT00675025|567234093|FG000|Overall Study|Adverse Event|6|||
157132443|NCT00675025|567234094|FG001|Overall Study|Adverse Event|11|||
157132444|NCT00675025|567234093|FG000|Overall Study|Lost to Follow-up|6|||
157132445|NCT00675025|567234094|FG001|Overall Study|Lost to Follow-up|4|||
157132446|NCT00675025|567234093|FG000|Overall Study|Withdrawal by Subject|4|||
157132447|NCT00675025|567234094|FG001|Overall Study|Withdrawal by Subject|6|||
157132448|NCT00556426|567234098|FG000|Overall Study|Withdrawal by Subject|3|||
157132449|NCT00556426|567234098|FG000|Overall Study|Death|6|||
157132450|NCT02347631|567234107|FG000|First Intervention (2 Months)|Adverse Event|1|||
157132451|NCT02347631|567234108|FG001|First Intervention (2 Months)|Adverse Event|1|||
157132452|NCT02347631|567234107|FG000|First Intervention (2 Months)|Pregnancy|1|||
157132453|NCT02347631|567234108|FG001|First Intervention (2 Months)|Pregnancy|0|||
157132454|NCT02347631|567234107|FG000|First Intervention (2 Months)|Moved out of area|0|||
157132455|NCT02347631|567234108|FG001|First Intervention (2 Months)|Moved out of area|2|||
157132456|NCT02347631|567234107|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
157132457|NCT02347631|567234108|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
157132458|NCT02347631|567234107|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
157132459|NCT02347631|567234108|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
157132460|NCT02347631|567234107|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
157132461|NCT02347631|567234108|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
157132462|NCT02347631|567234107|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
157132463|NCT02347631|567234108|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
157132464|NCT02347631|567234107|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
157132465|NCT02347631|567234108|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
157132466|NCT03804684|567234110|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
157132467|NCT03804684|567234111|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
157132468|NCT03183128|567234115|FG000|Overall Study|Adverse Event|1|||
157132469|NCT03183128|567234116|FG001|Overall Study|Adverse Event|2|||
157132470|NCT03183128|567234115|FG000|Overall Study|Withdrawal by Subject|1|||
157132471|NCT03183128|567234116|FG001|Overall Study|Withdrawal by Subject|8|||
157132472|NCT03183128|567234115|FG000|Overall Study|Protocol Violation|2|||
157132473|NCT03183128|567234116|FG001|Overall Study|Protocol Violation|0|||
157132474|NCT03183128|567234115|FG000|Overall Study|Lack of Efficacy|4|||
157132475|NCT03183128|567234116|FG001|Overall Study|Lack of Efficacy|27|||
157132476|NCT03183128|567234115|FG000|Overall Study|Lost to Follow-up|1|||
157132477|NCT03183128|567234116|FG001|Overall Study|Lost to Follow-up|0|||
157132478|NCT03183128|567234115|FG000|Overall Study|Death|2|||
157132479|NCT03183128|567234116|FG001|Overall Study|Death|0|||
157132480|NCT03183128|567234115|FG000|Overall Study|Physician Decision|1|||
157132481|NCT03183128|567234116|FG001|Overall Study|Physician Decision|0|||
157132482|NCT00802360|567234117|FG000|Overall Study|Stimulation failure|4|||
157132483|NCT00802360|567234118|FG001|Overall Study|Stimulation failure|0|||
157132484|NCT00802360|567234119|FG002|Overall Study|Stimulation failure|3|||
157132485|NCT00802360|567234120|FG003|Overall Study|Stimulation failure|3|||
157132486|NCT00802360|567234117|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
157132487|NCT00802360|567234118|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
157132488|NCT00802360|567234119|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
157132489|NCT00802360|567234120|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
157132490|NCT00802360|567234117|FG000|Overall Study|Cycle cancelled|0|||
157132491|NCT00802360|567234118|FG001|Overall Study|Cycle cancelled|1|||
157132492|NCT00802360|567234119|FG002|Overall Study|Cycle cancelled|1|||
157132493|NCT00802360|567234120|FG003|Overall Study|Cycle cancelled|1|||
156793421|NCT01272219|565996270|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
156793422|NCT01272219|565996271|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
156793423|NCT01272219|565996272|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
156793424|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
157132494|NCT00802360|567234117|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
157132495|NCT00802360|567234118|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
157132496|NCT00802360|567234119|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
157132497|NCT00802360|567234120|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
157132498|NCT00802360|567234117|FG000|Overall Study|No positive serum pregnancy|17|||
157132499|NCT00802360|567234118|FG001|Overall Study|No positive serum pregnancy|20|||
157132500|NCT00802360|567234119|FG002|Overall Study|No positive serum pregnancy|14|||
157132501|NCT00802360|567234120|FG003|Overall Study|No positive serum pregnancy|10|||
157132502|NCT00802360|567234117|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
157132503|NCT00802360|567234118|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
157132504|NCT00802360|567234119|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
157018479|NCT03453619|566821313|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
156793425|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
156793426|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
156793427|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
156793428|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
156793429|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
156793430|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793431|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
157018480|NCT03453619|566821314|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
157018481|NCT03453619|566821315|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
157018482|NCT04089371|566821318|FG000|Overall Study|Withdrawal by Subject|0|||
157018483|NCT04089371|566821319|FG001|Overall Study|Withdrawal by Subject|1|||
157018484|NCT04089371|566821318|FG000|Overall Study|Study terminated early|0|||
157018485|NCT04089371|566821319|FG001|Overall Study|Study terminated early|9|||
157018486|NCT05229120|566821320|FG000|Overall Study|Withdrawal by Subject|8|||
157018487|NCT03932682|566821323|FG000|Overall Study|Death|1|||
157018488|NCT03932682|566821324|FG001|Overall Study|Death|2|||
157018489|NCT03932682|566821323|FG000|Overall Study|Withdrawal by Subject|37|||
157018490|NCT03932682|566821324|FG001|Overall Study|Withdrawal by Subject|45|||
157018491|NCT03932682|566821323|FG000|Overall Study|Lost to Follow-up|19|||
157018492|NCT03932682|566821324|FG001|Overall Study|Lost to Follow-up|25|||
157018493|NCT03932682|566821323|FG000|Overall Study|Protocol Violation|0|||
157018494|NCT03932682|566821324|FG001|Overall Study|Protocol Violation|2|||
157018495|NCT03932682|566821323|FG000|Overall Study|Other|9|||
157018496|NCT03932682|566821324|FG001|Overall Study|Other|23|||
157018497|NCT04391894|566821336|FG000|Overall Study|Adverse Event|1|||
157018498|NCT04391894|566821337|FG001|Overall Study|Adverse Event|1|||
157018499|NCT04391894|566821338|FG002|Overall Study|Adverse Event|1|||
157018500|NCT04391894|566821339|FG003|Overall Study|Adverse Event|1|||
157018501|NCT04391894|566821340|FG004|Overall Study|Adverse Event|1|||
157018502|NCT04391894|566821336|FG000|Overall Study|Lost to Follow-up|1|||
157018503|NCT04391894|566821337|FG001|Overall Study|Lost to Follow-up|0|||
157018504|NCT04391894|566821338|FG002|Overall Study|Lost to Follow-up|0|||
157018505|NCT04391894|566821339|FG003|Overall Study|Lost to Follow-up|0|||
157018506|NCT04391894|566821340|FG004|Overall Study|Lost to Follow-up|0|||
157018507|NCT04391894|566821336|FG000|Overall Study|Protocol Violation|0|||
157018508|NCT04391894|566821337|FG001|Overall Study|Protocol Violation|0|||
157018509|NCT04391894|566821338|FG002|Overall Study|Protocol Violation|0|||
157018510|NCT04391894|566821339|FG003|Overall Study|Protocol Violation|1|||
157018511|NCT04391894|566821340|FG004|Overall Study|Protocol Violation|0|||
157018512|NCT04391894|566821336|FG000|Overall Study|Withdrawal by Subject|2|||
157018513|NCT04391894|566821337|FG001|Overall Study|Withdrawal by Subject|0|||
157018514|NCT04391894|566821338|FG002|Overall Study|Withdrawal by Subject|3|||
157018515|NCT04391894|566821339|FG003|Overall Study|Withdrawal by Subject|0|||
157018516|NCT04391894|566821340|FG004|Overall Study|Withdrawal by Subject|1|||
157018517|NCT04391894|566821336|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
157018518|NCT04391894|566821337|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
157018519|NCT04391894|566821338|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
157018520|NCT04391894|566821339|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
157018521|NCT04391894|566821340|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
157018522|NCT05633407|566821344|FG000|Overall Study|Physician Decision|2|||
157018523|NCT05633407|566821345|FG001|Overall Study|Physician Decision|0|||
157018524|NCT05633407|566821344|FG000|Overall Study|Adverse Event|1|||
157018525|NCT05633407|566821345|FG001|Overall Study|Adverse Event|0|||
157018526|NCT05633407|566821344|FG000|Overall Study|Withdrawal by Subject|1|||
157018527|NCT05633407|566821345|FG001|Overall Study|Withdrawal by Subject|0|||
157018528|NCT05633407|566821344|FG000|Overall Study|Other|1|||
157018529|NCT05633407|566821345|FG001|Overall Study|Other|1|||
157018530|NCT02500758|566821348|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
157018531|NCT02500758|566821349|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
157018532|NCT02500758|566821348|FG000|Washout (1 Week)|Lost to Follow-up|2|||
157018533|NCT02500758|566821349|FG001|Washout (1 Week)|Lost to Follow-up|2|||
157018534|NCT02500758|566821348|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
157018535|NCT02500758|566821349|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
157018536|NCT02500758|566821348|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
157018537|NCT02500758|566821349|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
157018538|NCT02500758|566821348|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
157018539|NCT02500758|566821349|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
157018540|NCT03941860|566821351|FG000|Overall Study|Withdrawal by Subject|0|||
157018541|NCT03941860|566821352|FG001|Overall Study|Withdrawal by Subject|1|||
157018542|NCT04757610|566821354|FG000|Overall Study|Adverse Event|13|||
157018543|NCT04757610|566821355|FG001|Overall Study|Adverse Event|10|||
157018544|NCT04757610|566821356|FG002|Overall Study|Adverse Event|5|||
157018545|NCT04757610|566821354|FG000|Overall Study|Death|5|||
157018546|NCT04757610|566821355|FG001|Overall Study|Death|13|||
157018547|NCT04757610|566821356|FG002|Overall Study|Death|8|||
157132505|NCT00802360|567234120|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
157132506|NCT00802360|567234117|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
157132507|NCT00802360|567234118|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
157132508|NCT00802360|567234119|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
157132509|NCT00802360|567234120|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
157132510|NCT00802360|567234117|FG000|Overall Study|Other|2|||
157132511|NCT00802360|567234118|FG001|Overall Study|Other|3|||
157132512|NCT00802360|567234119|FG002|Overall Study|Other|6|||
157132513|NCT00802360|567234120|FG003|Overall Study|Other|3|||
157132514|NCT03258814|567234125|FG000|Overall Study|Early Termination|4|||
157132515|NCT03258814|567234126|FG001|Overall Study|Early Termination|3|||
157132516|NCT03258814|567234127|FG002|Overall Study|Early Termination|10|||
157132517|NCT01900002|567234128|FG000|Overall Study|Withdrawal by Subject|2|||
157132518|NCT01900002|567234128|FG000|Overall Study|ineligible for Y-90|4|||
157132519|NCT00348140|567234133|FG000|Overall Study|Adverse Event|46|||
157132520|NCT00348140|567234134|FG001|Overall Study|Adverse Event|49|||
157132521|NCT00348140|567234135|FG002|Overall Study|Adverse Event|78|||
157132522|NCT00348140|567234133|FG000|Overall Study|Lost to Follow-up|4|||
157132523|NCT00348140|567234134|FG001|Overall Study|Lost to Follow-up|4|||
157132524|NCT00348140|567234135|FG002|Overall Study|Lost to Follow-up|4|||
157132525|NCT00348140|567234133|FG000|Overall Study|Protocol Violation|12|||
157132526|NCT00348140|567234134|FG001|Overall Study|Protocol Violation|13|||
157132527|NCT00348140|567234135|FG002|Overall Study|Protocol Violation|14|||
157132528|NCT00348140|567234133|FG000|Overall Study|Withdrawal by Subject|32|||
157132529|NCT00348140|567234134|FG001|Overall Study|Withdrawal by Subject|40|||
157132530|NCT00348140|567234135|FG002|Overall Study|Withdrawal by Subject|40|||
157132531|NCT00348140|567234133|FG000|Overall Study|Non-compliance|8|||
157132532|NCT00348140|567234134|FG001|Overall Study|Non-compliance|13|||
157132533|NCT00348140|567234135|FG002|Overall Study|Non-compliance|5|||
157132534|NCT00348140|567234133|FG000|Overall Study|Participant at risk due to study drug|2|||
157132535|NCT00348140|567234134|FG001|Overall Study|Participant at risk due to study drug|0|||
157132536|NCT00348140|567234135|FG002|Overall Study|Participant at risk due to study drug|0|||
157132537|NCT00348140|567234133|FG000|Overall Study|Conditional medication increased dose|1|||
157132538|NCT00348140|567234134|FG001|Overall Study|Conditional medication increased dose|0|||
157132539|NCT00348140|567234135|FG002|Overall Study|Conditional medication increased dose|0|||
157132540|NCT00348140|567234133|FG000|Overall Study|Caregiver related|4|||
157132541|NCT00348140|567234134|FG001|Overall Study|Caregiver related|7|||
157132542|NCT00348140|567234135|FG002|Overall Study|Caregiver related|3|||
157132543|NCT00348140|567234133|FG000|Overall Study|Participant hospitalised|3|||
157132544|NCT00348140|567234134|FG001|Overall Study|Participant hospitalised|0|||
157132545|NCT00348140|567234135|FG002|Overall Study|Participant hospitalised|0|||
157132546|NCT00348140|567234133|FG000|Overall Study|Efficacy related|1|||
157132547|NCT00348140|567234134|FG001|Overall Study|Efficacy related|1|||
157132548|NCT00348140|567234135|FG002|Overall Study|Efficacy related|0|||
157132549|NCT00348140|567234133|FG000|Overall Study|Administration related|3|||
157132550|NCT00348140|567234134|FG001|Overall Study|Administration related|1|||
157132551|NCT00348140|567234135|FG002|Overall Study|Administration related|1|||
157132552|NCT00348140|567234133|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
157132553|NCT00348140|567234134|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
157132554|NCT00348140|567234135|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
157132555|NCT00348140|567234133|FG000|Overall Study|Participant unwell|1|||
157132556|NCT00348140|567234134|FG001|Overall Study|Participant unwell|0|||
157132557|NCT00348140|567234135|FG002|Overall Study|Participant unwell|0|||
157132558|NCT00348140|567234133|FG000|Overall Study|Screen failure|1|||
157132559|NCT00348140|567234134|FG001|Overall Study|Screen failure|0|||
157132560|NCT00348140|567234135|FG002|Overall Study|Screen failure|0|||
156874943|NCT01474239|566300582|FG001|Overall Study|Clinical Disease Progression|1|||
156874944|NCT01474239|566300581|FG000|Overall Study|Withdrawal for Economic Reason|1|||
157132561|NCT00348140|567234133|FG000|Overall Study|Investigator decided to discontinue|4|||
157132562|NCT00348140|567234134|FG001|Overall Study|Investigator decided to discontinue|1|||
157132563|NCT00348140|567234135|FG002|Overall Study|Investigator decided to discontinue|4|||
157132564|NCT00348140|567234133|FG000|Overall Study|Decided to discontinue on their own|1|||
157132565|NCT00348140|567234134|FG001|Overall Study|Decided to discontinue on their own|4|||
157132566|NCT00348140|567234135|FG002|Overall Study|Decided to discontinue on their own|1|||
157132567|NCT00348140|567234133|FG000|Overall Study|Use of prohibited drug|1|||
157132568|NCT00348140|567234134|FG001|Overall Study|Use of prohibited drug|0|||
157132569|NCT00348140|567234135|FG002|Overall Study|Use of prohibited drug|2|||
157132570|NCT00348140|567234133|FG000|Overall Study|Disease progression|1|||
157132571|NCT00348140|567234134|FG001|Overall Study|Disease progression|2|||
157132572|NCT00348140|567234135|FG002|Overall Study|Disease progression|5|||
157132573|NCT00348140|567234133|FG000|Overall Study|Increased risk of cardiac infarction|0|||
157132574|NCT00348140|567234134|FG001|Overall Study|Increased risk of cardiac infarction|1|||
157132575|NCT00348140|567234135|FG002|Overall Study|Increased risk of cardiac infarction|0|||
157132576|NCT00348140|567234133|FG000|Overall Study|Serious adverse event|0|||
156874945|NCT01474239|566300582|FG001|Overall Study|Withdrawal for Economic Reason|0|||
157132577|NCT00348140|567234134|FG001|Overall Study|Serious adverse event|1|||
157132578|NCT00348140|567234135|FG002|Overall Study|Serious adverse event|0|||
157132579|NCT00348140|567234133|FG000|Overall Study|Abnormal ECG|0|||
157132580|NCT00348140|567234134|FG001|Overall Study|Abnormal ECG|1|||
157132581|NCT00348140|567234135|FG002|Overall Study|Abnormal ECG|3|||
157132582|NCT00348140|567234133|FG000|Overall Study|Participant died|0|||
157132583|NCT00348140|567234134|FG001|Overall Study|Participant died|1|||
157132584|NCT00348140|567234135|FG002|Overall Study|Participant died|0|||
157132585|NCT00348140|567234133|FG000|Overall Study|Exclusion criteria met|0|||
157132586|NCT00348140|567234134|FG001|Overall Study|Exclusion criteria met|0|||
157132587|NCT00348140|567234135|FG002|Overall Study|Exclusion criteria met|1|||
157132588|NCT00348140|567234133|FG000|Overall Study|Memory declined|0|||
157216983|NCT00910858|567540987|FG002|Monotherapy Phase|Other|2|||
157216984|NCT00910858|567540985|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
157216985|NCT00910858|567540986|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
157132589|NCT00348140|567234134|FG001|Overall Study|Memory declined|0|||
157132590|NCT00348140|567234135|FG002|Overall Study|Memory declined|1|||
157132591|NCT01662648|567234136|FG000|Overall Study|Death|1|||
157132592|NCT01662648|567234137|FG001|Overall Study|Death|3|||
157132593|NCT01662648|567234136|FG000|Overall Study|Adverse Event|40|||
157132594|NCT01662648|567234137|FG001|Overall Study|Adverse Event|37|||
157132595|NCT01662648|567234136|FG000|Overall Study|Lack of Efficacy|17|||
157132596|NCT01662648|567234137|FG001|Overall Study|Lack of Efficacy|16|||
157132597|NCT01662648|567234136|FG000|Overall Study|Participant ineligible to continue trial|1|||
157132598|NCT01662648|567234137|FG001|Overall Study|Participant ineligible to continue trial|1|||
157132599|NCT01662648|567234136|FG000|Overall Study|Lost to Follow-up|24|||
157132600|NCT01662648|567234137|FG001|Overall Study|Lost to Follow-up|36|||
157132601|NCT01662648|567234136|FG000|Overall Study|Withdrawal by Subject|36|||
157132602|NCT01662648|567234137|FG001|Overall Study|Withdrawal by Subject|53|||
157132603|NCT01662648|567234136|FG000|Overall Study|Participant non-compliant|16|||
157132604|NCT01662648|567234137|FG001|Overall Study|Participant non-compliant|20|||
156874946|NCT01675544|566300583|FG000|Overall Study|Withdrawal by Subject|2|||
156874947|NCT00505778|566300584|FG000|Overall Study|Adverse Event|2|||
156874948|NCT00505778|566300585|FG001|Overall Study|Adverse Event|7|||
156874949|NCT00505778|566300584|FG000|Overall Study|Physician Decision|8|||
156874950|NCT00505778|566300585|FG001|Overall Study|Physician Decision|14|||
156874951|NCT00505778|566300584|FG000|Overall Study|Lost to Follow-up|17|||
156874952|NCT00505778|566300585|FG001|Overall Study|Lost to Follow-up|23|||
156874953|NCT00505778|566300584|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
156874954|NCT00505778|566300585|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
156874955|NCT00505778|566300584|FG000|Overall Study|Protocol Violation|7|||
156874956|NCT00505778|566300585|FG001|Overall Study|Protocol Violation|9|||
156874957|NCT00505778|566300584|FG000|Overall Study|Withdrawal by Subject|29|||
156874958|NCT00505778|566300585|FG001|Overall Study|Withdrawal by Subject|14|||
156874959|NCT00505778|566300584|FG000|Overall Study|Relapse|65|||
156874960|NCT00505778|566300585|FG001|Overall Study|Relapse|65|||
156874961|NCT00505778|566300584|FG000|Overall Study|Took No Study Drug|2|||
156874962|NCT00505778|566300585|FG001|Overall Study|Took No Study Drug|2|||
156874963|NCT03790696|566300587|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
156874964|NCT03790696|566300588|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
156874965|NCT00243269|566300593|FG000|Overall Study|Protocol Violation|2|||
157132605|NCT01662648|567234136|FG000|Overall Study|Other|8|||
157132606|NCT01662648|567234137|FG001|Overall Study|Other|11|||
157216986|NCT00910858|567540987|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
157216987|NCT00910858|567540985|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
157132607|NCT01662648|567234136|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
157132608|NCT01662648|567234137|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
157132609|NCT01662648|567234136|FG000|Overall Study|LOE and other reason unspecified|1|||
157132610|NCT01662648|567234137|FG001|Overall Study|LOE and other reason unspecified|0|||
157132611|NCT01662648|567234136|FG000|Overall Study|LOE and Participant non-compliant|0|||
157132612|NCT01662648|567234137|FG001|Overall Study|LOE and Participant non-compliant|1|||
157132613|NCT00868790|567234140|FG000|Period 1|Adverse Event|1|||
157216988|NCT00910858|567540986|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
157132614|NCT00868790|567234141|FG001|Period 1|Adverse Event|0|||
157132615|NCT00868790|567234142|FG002|Period 1|Adverse Event|0|||
157132616|NCT00868790|567234143|FG003|Period 1|Adverse Event|0|||
157216989|NCT00910858|567540987|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
156874966|NCT00243269|566300594|FG001|Overall Study|Protocol Violation|1|||
156874967|NCT00243269|566300595|FG002|Overall Study|Protocol Violation|0|||
157132617|NCT00868790|567234144|FG004|Period 1|Adverse Event|0|||
157132618|NCT00868790|567234145|FG005|Period 1|Adverse Event|0|||
157132619|NCT00868790|567234146|FG006|Period 1|Adverse Event|0|||
157132620|NCT00868790|567234147|FG007|Period 1|Adverse Event|3|||
157132621|NCT00868790|567234148|FG008|Period 1|Adverse Event|1|||
157132622|NCT00868790|567234149|FG009|Period 1|Adverse Event|0|||
157132623|NCT00868790|567234150|FG010|Period 1|Adverse Event|0|||
157132624|NCT00868790|567234151|FG011|Period 1|Adverse Event|0|||
157132625|NCT00868790|567234152|FG012|Period 1|Adverse Event|0|||
157216990|NCT00910858|567540985|FG000|Combined Treatment Phase|Protocol Violation|1|||
157132626|NCT00868790|567234153|FG013|Period 1|Adverse Event|1|||
157132627|NCT00868790|567234140|FG000|Period 1|Protocol Violation|1|||
157132628|NCT00868790|567234141|FG001|Period 1|Protocol Violation|0|||
157132629|NCT00868790|567234142|FG002|Period 1|Protocol Violation|0|||
157132630|NCT00868790|567234143|FG003|Period 1|Protocol Violation|0|||
157132631|NCT00868790|567234144|FG004|Period 1|Protocol Violation|0|||
157132632|NCT00868790|567234145|FG005|Period 1|Protocol Violation|0|||
157132633|NCT00868790|567234146|FG006|Period 1|Protocol Violation|0|||
157132634|NCT00868790|567234147|FG007|Period 1|Protocol Violation|0|||
157132635|NCT00868790|567234148|FG008|Period 1|Protocol Violation|0|||
157132636|NCT00868790|567234149|FG009|Period 1|Protocol Violation|0|||
157132637|NCT00868790|567234150|FG010|Period 1|Protocol Violation|0|||
157132638|NCT00868790|567234151|FG011|Period 1|Protocol Violation|0|||
157132639|NCT00868790|567234152|FG012|Period 1|Protocol Violation|0|||
157132640|NCT00868790|567234153|FG013|Period 1|Protocol Violation|0|||
157132641|NCT00868790|567234140|FG000|Period 1|Withdrawal by Subject|0|||
157132642|NCT00868790|567234141|FG001|Period 1|Withdrawal by Subject|1|||
157132643|NCT00868790|567234142|FG002|Period 1|Withdrawal by Subject|0|||
157132644|NCT00868790|567234143|FG003|Period 1|Withdrawal by Subject|0|||
157132645|NCT00868790|567234144|FG004|Period 1|Withdrawal by Subject|0|||
157132646|NCT00868790|567234145|FG005|Period 1|Withdrawal by Subject|0|||
157132647|NCT00868790|567234146|FG006|Period 1|Withdrawal by Subject|0|||
157132648|NCT00868790|567234147|FG007|Period 1|Withdrawal by Subject|0|||
157132649|NCT00868790|567234148|FG008|Period 1|Withdrawal by Subject|0|||
157132650|NCT00868790|567234149|FG009|Period 1|Withdrawal by Subject|0|||
157132651|NCT00868790|567234150|FG010|Period 1|Withdrawal by Subject|0|||
157132652|NCT00868790|567234151|FG011|Period 1|Withdrawal by Subject|0|||
157132653|NCT00868790|567234152|FG012|Period 1|Withdrawal by Subject|0|||
157132654|NCT00868790|567234153|FG013|Period 1|Withdrawal by Subject|1|||
157132655|NCT00868790|567234140|FG000|Period 1|Abnormal Triglycerides|0|||
157132656|NCT00868790|567234141|FG001|Period 1|Abnormal Triglycerides|0|||
157132657|NCT00868790|567234142|FG002|Period 1|Abnormal Triglycerides|0|||
157132658|NCT00868790|567234143|FG003|Period 1|Abnormal Triglycerides|0|||
157132659|NCT00868790|567234144|FG004|Period 1|Abnormal Triglycerides|1|||
157132660|NCT00868790|567234145|FG005|Period 1|Abnormal Triglycerides|0|||
157132661|NCT00868790|567234146|FG006|Period 1|Abnormal Triglycerides|0|||
157132662|NCT00868790|567234147|FG007|Period 1|Abnormal Triglycerides|0|||
157132663|NCT00868790|567234148|FG008|Period 1|Abnormal Triglycerides|0|||
157132664|NCT00868790|567234149|FG009|Period 1|Abnormal Triglycerides|0|||
157132665|NCT00868790|567234150|FG010|Period 1|Abnormal Triglycerides|0|||
157132666|NCT00868790|567234151|FG011|Period 1|Abnormal Triglycerides|0|||
157132667|NCT00868790|567234152|FG012|Period 1|Abnormal Triglycerides|0|||
157132668|NCT00868790|567234153|FG013|Period 1|Abnormal Triglycerides|0|||
157132669|NCT00868790|567234140|FG000|Period 1|Lost to Follow-up|0|||
157132670|NCT00868790|567234141|FG001|Period 1|Lost to Follow-up|0|||
157132671|NCT00868790|567234142|FG002|Period 1|Lost to Follow-up|0|||
157132672|NCT00868790|567234143|FG003|Period 1|Lost to Follow-up|0|||
157132673|NCT00868790|567234144|FG004|Period 1|Lost to Follow-up|0|||
157132674|NCT00868790|567234145|FG005|Period 1|Lost to Follow-up|1|||
157132675|NCT00868790|567234146|FG006|Period 1|Lost to Follow-up|0|||
157132676|NCT00868790|567234147|FG007|Period 1|Lost to Follow-up|0|||
157132677|NCT00868790|567234148|FG008|Period 1|Lost to Follow-up|0|||
157132678|NCT00868790|567234149|FG009|Period 1|Lost to Follow-up|0|||
157132679|NCT00868790|567234150|FG010|Period 1|Lost to Follow-up|0|||
157132680|NCT00868790|567234151|FG011|Period 1|Lost to Follow-up|0|||
157132681|NCT00868790|567234152|FG012|Period 1|Lost to Follow-up|0|||
157132682|NCT00868790|567234153|FG013|Period 1|Lost to Follow-up|0|||
156793432|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793433|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
156793434|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793435|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
156793436|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
157132683|NCT00868790|567234140|FG000|Period 2|Adverse Event|0|||
157132684|NCT00868790|567234141|FG001|Period 2|Adverse Event|0|||
157132685|NCT00868790|567234142|FG002|Period 2|Adverse Event|0|||
157132686|NCT00868790|567234143|FG003|Period 2|Adverse Event|0|||
156793437|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
156874968|NCT00243269|566300596|FG003|Overall Study|Protocol Violation|1|||
157132687|NCT00868790|567234144|FG004|Period 2|Adverse Event|0|||
157132688|NCT00868790|567234145|FG005|Period 2|Adverse Event|0|||
157132689|NCT00868790|567234146|FG006|Period 2|Adverse Event|0|||
157132690|NCT00868790|567234147|FG007|Period 2|Adverse Event|0|||
157132691|NCT00868790|567234148|FG008|Period 2|Adverse Event|1|||
157132692|NCT00868790|567234149|FG009|Period 2|Adverse Event|0|||
157132693|NCT00868790|567234150|FG010|Period 2|Adverse Event|0|||
157132694|NCT00868790|567234151|FG011|Period 2|Adverse Event|0|||
157132695|NCT00868790|567234152|FG012|Period 2|Adverse Event|0|||
157132696|NCT00868790|567234153|FG013|Period 2|Adverse Event|0|||
157132697|NCT00868790|567234140|FG000|Period 2|Lost to Follow-up|0|||
157132698|NCT00868790|567234141|FG001|Period 2|Lost to Follow-up|1|||
156793438|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793439|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
156793440|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793441|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
156793442|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793443|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
156793444|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
156793445|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
156793446|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793447|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
156793448|NCT01272219|565996267|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793449|NCT01272219|565996268|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
156793450|NCT01272219|565996269|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
156793451|NCT01272219|565996270|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
156793452|NCT01272219|565996271|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793453|NCT01272219|565996272|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
156793454|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
157132699|NCT00868790|567234142|FG002|Period 2|Lost to Follow-up|0|||
157132700|NCT00868790|567234143|FG003|Period 2|Lost to Follow-up|0|||
157132701|NCT00868790|567234144|FG004|Period 2|Lost to Follow-up|0|||
157132702|NCT00868790|567234145|FG005|Period 2|Lost to Follow-up|1|||
157132703|NCT00868790|567234146|FG006|Period 2|Lost to Follow-up|0|||
157132704|NCT00868790|567234147|FG007|Period 2|Lost to Follow-up|0|||
157132705|NCT00868790|567234148|FG008|Period 2|Lost to Follow-up|0|||
157132706|NCT00868790|567234149|FG009|Period 2|Lost to Follow-up|0|||
157132707|NCT00868790|567234150|FG010|Period 2|Lost to Follow-up|0|||
157132708|NCT00868790|567234151|FG011|Period 2|Lost to Follow-up|0|||
157132709|NCT00868790|567234152|FG012|Period 2|Lost to Follow-up|0|||
157132710|NCT00868790|567234153|FG013|Period 2|Lost to Follow-up|0|||
157132711|NCT00868790|567234140|FG000|Period 2|Withdrawal by Subject|0|||
157132712|NCT00868790|567234141|FG001|Period 2|Withdrawal by Subject|0|||
157132713|NCT00868790|567234142|FG002|Period 2|Withdrawal by Subject|0|||
157132714|NCT00868790|567234143|FG003|Period 2|Withdrawal by Subject|0|||
157132715|NCT00868790|567234144|FG004|Period 2|Withdrawal by Subject|0|||
157132716|NCT00868790|567234145|FG005|Period 2|Withdrawal by Subject|0|||
157132717|NCT00868790|567234146|FG006|Period 2|Withdrawal by Subject|0|||
157132718|NCT00868790|567234147|FG007|Period 2|Withdrawal by Subject|0|||
157132719|NCT00868790|567234148|FG008|Period 2|Withdrawal by Subject|1|||
157132720|NCT00868790|567234149|FG009|Period 2|Withdrawal by Subject|0|||
157132721|NCT00868790|567234150|FG010|Period 2|Withdrawal by Subject|0|||
157132722|NCT00868790|567234151|FG011|Period 2|Withdrawal by Subject|0|||
157132723|NCT00868790|567234152|FG012|Period 2|Withdrawal by Subject|0|||
157132724|NCT00868790|567234153|FG013|Period 2|Withdrawal by Subject|1|||
157132725|NCT00868790|567234140|FG000|Period 3|Adverse Event|0|||
157132726|NCT00868790|567234141|FG001|Period 3|Adverse Event|0|||
157132727|NCT00868790|567234142|FG002|Period 3|Adverse Event|0|||
157132728|NCT00868790|567234143|FG003|Period 3|Adverse Event|0|||
157132729|NCT00868790|567234144|FG004|Period 3|Adverse Event|0|||
157132730|NCT00868790|567234145|FG005|Period 3|Adverse Event|0|||
157132731|NCT00868790|567234146|FG006|Period 3|Adverse Event|0|||
157132732|NCT00868790|567234147|FG007|Period 3|Adverse Event|0|||
157132733|NCT00868790|567234148|FG008|Period 3|Adverse Event|0|||
157132734|NCT00868790|567234149|FG009|Period 3|Adverse Event|1|||
157132735|NCT00868790|567234150|FG010|Period 3|Adverse Event|0|||
157132736|NCT00868790|567234151|FG011|Period 3|Adverse Event|0|||
157132737|NCT00868790|567234152|FG012|Period 3|Adverse Event|0|||
157132738|NCT00868790|567234153|FG013|Period 3|Adverse Event|0|||
157132739|NCT00868790|567234140|FG000|Period 3|Protocol Violation|0|||
157132740|NCT00868790|567234141|FG001|Period 3|Protocol Violation|0|||
156793455|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
156874969|NCT00243269|566300593|FG000|Overall Study|Lost to Follow-up|1|||
157132741|NCT00868790|567234142|FG002|Period 3|Protocol Violation|0|||
157132742|NCT00868790|567234143|FG003|Period 3|Protocol Violation|0|||
156793456|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
156874970|NCT00243269|566300594|FG001|Overall Study|Lost to Follow-up|0|||
157132743|NCT00868790|567234144|FG004|Period 3|Protocol Violation|0|||
157132744|NCT00868790|567234145|FG005|Period 3|Protocol Violation|0|||
157132745|NCT00868790|567234146|FG006|Period 3|Protocol Violation|0|||
157132746|NCT00868790|567234147|FG007|Period 3|Protocol Violation|0|||
157132747|NCT00868790|567234148|FG008|Period 3|Protocol Violation|0|||
157132748|NCT00868790|567234149|FG009|Period 3|Protocol Violation|0|||
156793457|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
157132749|NCT00868790|567234150|FG010|Period 3|Protocol Violation|1|||
157132750|NCT00868790|567234151|FG011|Period 3|Protocol Violation|0|||
157132751|NCT00868790|567234152|FG012|Period 3|Protocol Violation|0|||
157132752|NCT00868790|567234153|FG013|Period 3|Protocol Violation|0|||
157132753|NCT00868790|567234140|FG000|Period 3|Study Terminated by Sponsor|0|||
157132754|NCT00868790|567234141|FG001|Period 3|Study Terminated by Sponsor|0|||
157132755|NCT00868790|567234142|FG002|Period 3|Study Terminated by Sponsor|0|||
157132756|NCT00868790|567234143|FG003|Period 3|Study Terminated by Sponsor|1|||
157132757|NCT00868790|567234144|FG004|Period 3|Study Terminated by Sponsor|0|||
157132758|NCT00868790|567234145|FG005|Period 3|Study Terminated by Sponsor|0|||
157132759|NCT00868790|567234146|FG006|Period 3|Study Terminated by Sponsor|0|||
157132760|NCT00868790|567234147|FG007|Period 3|Study Terminated by Sponsor|0|||
157132761|NCT00868790|567234148|FG008|Period 3|Study Terminated by Sponsor|0|||
157132762|NCT00868790|567234149|FG009|Period 3|Study Terminated by Sponsor|0|||
157132763|NCT00868790|567234150|FG010|Period 3|Study Terminated by Sponsor|0|||
157132764|NCT00868790|567234151|FG011|Period 3|Study Terminated by Sponsor|0|||
157132765|NCT00868790|567234152|FG012|Period 3|Study Terminated by Sponsor|0|||
157132766|NCT00868790|567234153|FG013|Period 3|Study Terminated by Sponsor|0|||
157132767|NCT00868790|567234140|FG000|Period 4|Adverse Event|0|||
157132768|NCT00868790|567234141|FG001|Period 4|Adverse Event|0|||
157132769|NCT00868790|567234142|FG002|Period 4|Adverse Event|0|||
157132770|NCT00868790|567234143|FG003|Period 4|Adverse Event|0|||
157132771|NCT00868790|567234144|FG004|Period 4|Adverse Event|0|||
157132772|NCT00868790|567234145|FG005|Period 4|Adverse Event|0|||
157132773|NCT00868790|567234146|FG006|Period 4|Adverse Event|0|||
157132774|NCT00868790|567234147|FG007|Period 4|Adverse Event|1|||
157132775|NCT00868790|567234148|FG008|Period 4|Adverse Event|0|||
157132776|NCT00868790|567234149|FG009|Period 4|Adverse Event|0|||
157132777|NCT00868790|567234150|FG010|Period 4|Adverse Event|1|||
157132778|NCT00868790|567234151|FG011|Period 4|Adverse Event|0|||
157132779|NCT00868790|567234152|FG012|Period 4|Adverse Event|1|||
157132780|NCT00868790|567234153|FG013|Period 4|Adverse Event|0|||
157132781|NCT00868790|567234140|FG000|Period 4|Lost to Follow-up|0|||
157132782|NCT00868790|567234141|FG001|Period 4|Lost to Follow-up|0|||
157132783|NCT00868790|567234142|FG002|Period 4|Lost to Follow-up|0|||
157132784|NCT00868790|567234143|FG003|Period 4|Lost to Follow-up|0|||
157132785|NCT00868790|567234144|FG004|Period 4|Lost to Follow-up|0|||
157132786|NCT00868790|567234145|FG005|Period 4|Lost to Follow-up|0|||
157132787|NCT00868790|567234146|FG006|Period 4|Lost to Follow-up|0|||
157132788|NCT00868790|567234147|FG007|Period 4|Lost to Follow-up|1|||
157132789|NCT00868790|567234148|FG008|Period 4|Lost to Follow-up|0|||
157132790|NCT00868790|567234149|FG009|Period 4|Lost to Follow-up|0|||
157132791|NCT00868790|567234150|FG010|Period 4|Lost to Follow-up|0|||
157132792|NCT00868790|567234151|FG011|Period 4|Lost to Follow-up|0|||
157132793|NCT00868790|567234152|FG012|Period 4|Lost to Follow-up|0|||
157132794|NCT00868790|567234153|FG013|Period 4|Lost to Follow-up|0|||
157132795|NCT00868790|567234140|FG000|Period 4|Study Terminated by Sponsor|2|||
157132796|NCT00868790|567234141|FG001|Period 4|Study Terminated by Sponsor|0|||
157132797|NCT00868790|567234142|FG002|Period 4|Study Terminated by Sponsor|0|||
157132798|NCT00868790|567234143|FG003|Period 4|Study Terminated by Sponsor|0|||
157132799|NCT00868790|567234144|FG004|Period 4|Study Terminated by Sponsor|0|||
157132800|NCT00868790|567234145|FG005|Period 4|Study Terminated by Sponsor|0|||
157132801|NCT00868790|567234146|FG006|Period 4|Study Terminated by Sponsor|0|||
157132802|NCT00868790|567234147|FG007|Period 4|Study Terminated by Sponsor|1|||
157132803|NCT00868790|567234148|FG008|Period 4|Study Terminated by Sponsor|2|||
157132804|NCT00868790|567234149|FG009|Period 4|Study Terminated by Sponsor|0|||
157132805|NCT00868790|567234150|FG010|Period 4|Study Terminated by Sponsor|2|||
157132806|NCT00868790|567234151|FG011|Period 4|Study Terminated by Sponsor|1|||
157132807|NCT00868790|567234152|FG012|Period 4|Study Terminated by Sponsor|0|||
157132808|NCT00868790|567234153|FG013|Period 4|Study Terminated by Sponsor|1|||
157132809|NCT00868790|567234140|FG000|Period 4|Abnormal ALT/AST|0|||
157132810|NCT00868790|567234141|FG001|Period 4|Abnormal ALT/AST|0|||
157132811|NCT00868790|567234142|FG002|Period 4|Abnormal ALT/AST|1|||
157132812|NCT00868790|567234143|FG003|Period 4|Abnormal ALT/AST|0|||
157132813|NCT00868790|567234144|FG004|Period 4|Abnormal ALT/AST|0|||
157132814|NCT00868790|567234145|FG005|Period 4|Abnormal ALT/AST|0|||
156716487|NCT04467840|565707497|FG001|Overall Study|Physician Decision|0|||
157132815|NCT00868790|567234146|FG006|Period 4|Abnormal ALT/AST|0|||
157132816|NCT00868790|567234147|FG007|Period 4|Abnormal ALT/AST|0|||
157132817|NCT00868790|567234148|FG008|Period 4|Abnormal ALT/AST|0|||
157132818|NCT00868790|567234149|FG009|Period 4|Abnormal ALT/AST|0|||
157132819|NCT00868790|567234150|FG010|Period 4|Abnormal ALT/AST|0|||
157132820|NCT00868790|567234151|FG011|Period 4|Abnormal ALT/AST|0|||
157132821|NCT00868790|567234152|FG012|Period 4|Abnormal ALT/AST|0|||
157132822|NCT00868790|567234153|FG013|Period 4|Abnormal ALT/AST|0|||
157132823|NCT00868790|567234140|FG000|Post-study|Withdrawal by Subject|0|||
157132824|NCT00868790|567234141|FG001|Post-study|Withdrawal by Subject|0|||
157132825|NCT00868790|567234142|FG002|Post-study|Withdrawal by Subject|0|||
157132826|NCT00868790|567234143|FG003|Post-study|Withdrawal by Subject|0|||
157132827|NCT00868790|567234144|FG004|Post-study|Withdrawal by Subject|1|||
157132828|NCT00868790|567234145|FG005|Post-study|Withdrawal by Subject|0|||
157132829|NCT00868790|567234146|FG006|Post-study|Withdrawal by Subject|0|||
157132830|NCT00868790|567234147|FG007|Post-study|Withdrawal by Subject|0|||
157132831|NCT00868790|567234148|FG008|Post-study|Withdrawal by Subject|0|||
157132832|NCT00868790|567234149|FG009|Post-study|Withdrawal by Subject|0|||
157132833|NCT00868790|567234150|FG010|Post-study|Withdrawal by Subject|0|||
157132834|NCT00868790|567234151|FG011|Post-study|Withdrawal by Subject|0|||
157132835|NCT00868790|567234152|FG012|Post-study|Withdrawal by Subject|0|||
157132836|NCT00868790|567234153|FG013|Post-study|Withdrawal by Subject|0|||
157132837|NCT00868790|567234140|FG000|Post-study|Excluded Medication|0|||
157132838|NCT00868790|567234141|FG001|Post-study|Excluded Medication|0|||
157132839|NCT00868790|567234142|FG002|Post-study|Excluded Medication|0|||
157132840|NCT00868790|567234143|FG003|Post-study|Excluded Medication|0|||
157132841|NCT00868790|567234144|FG004|Post-study|Excluded Medication|0|||
157132842|NCT00868790|567234145|FG005|Post-study|Excluded Medication|0|||
157132843|NCT00868790|567234146|FG006|Post-study|Excluded Medication|0|||
157132844|NCT00868790|567234147|FG007|Post-study|Excluded Medication|2|||
157132845|NCT00868790|567234148|FG008|Post-study|Excluded Medication|0|||
157132846|NCT00868790|567234149|FG009|Post-study|Excluded Medication|1|||
157132847|NCT00868790|567234150|FG010|Post-study|Excluded Medication|0|||
157132848|NCT00868790|567234151|FG011|Post-study|Excluded Medication|0|||
157132849|NCT00868790|567234152|FG012|Post-study|Excluded Medication|0|||
157132850|NCT00868790|567234153|FG013|Post-study|Excluded Medication|0|||
157132851|NCT01264939|567234154|FG000|Overall Study|Adverse Event|1|||
157132852|NCT01264939|567234155|FG001|Overall Study|Adverse Event|3|||
157132853|NCT01264939|567234154|FG000|Overall Study|Lost to Follow-up|0|||
157132854|NCT01264939|567234155|FG001|Overall Study|Lost to Follow-up|3|||
157132855|NCT01264939|567234154|FG000|Overall Study|Physician Decision|1|||
157132856|NCT01264939|567234155|FG001|Overall Study|Physician Decision|1|||
157132857|NCT01264939|567234154|FG000|Overall Study|Patient/Guardian Decision|8|||
157132858|NCT01264939|567234155|FG001|Overall Study|Patient/Guardian Decision|10|||
157132859|NCT01264939|567234154|FG000|Overall Study|Disease Progression|8|||
157132860|NCT01264939|567234155|FG001|Overall Study|Disease Progression|11|||
157132861|NCT02266433|567234162|FG000|Overall Study|Lost to Follow-up|54|||
157132862|NCT02266433|567234163|FG001|Overall Study|Lost to Follow-up|46|||
157132863|NCT02266433|567234162|FG000|Overall Study|Withdrawal by Subject|5|||
157132864|NCT02266433|567234163|FG001|Overall Study|Withdrawal by Subject|7|||
157132865|NCT00737529|567234164|FG000|Overall Study|Disease Progression|95|||
157132866|NCT00737529|567234164|FG000|Overall Study|Adverse Event|24|||
157132867|NCT00737529|567234164|FG000|Overall Study|Withdrawal by Subject|5|||
157132868|NCT00737529|567234164|FG000|Overall Study|Death|4|||
157132869|NCT00737529|567234164|FG000|Overall Study|Protocol Violation|1|||
157132870|NCT00737529|567234164|FG000|Overall Study|Other|4|||
157132871|NCT01375764|567234170|FG000|Overall Study|Lost to Follow-up|0|||
157132872|NCT01375764|567234171|FG001|Overall Study|Lost to Follow-up|1|||
157132873|NCT01375764|567234172|FG002|Overall Study|Lost to Follow-up|0|||
157132874|NCT01375764|567234173|FG003|Overall Study|Lost to Follow-up|0|||
157132875|NCT01375764|567234174|FG004|Overall Study|Lost to Follow-up|0|||
157132876|NCT01375764|567234170|FG000|Overall Study|Withdrawal by Subject|2|||
157132877|NCT01375764|567234171|FG001|Overall Study|Withdrawal by Subject|0|||
157132878|NCT01375764|567234172|FG002|Overall Study|Withdrawal by Subject|0|||
157132879|NCT01375764|567234173|FG003|Overall Study|Withdrawal by Subject|0|||
157132880|NCT01375764|567234174|FG004|Overall Study|Withdrawal by Subject|1|||
157132881|NCT01375764|567234170|FG000|Overall Study|Other|0|||
157132882|NCT01375764|567234171|FG001|Overall Study|Other|0|||
157132883|NCT01375764|567234172|FG002|Overall Study|Other|0|||
157132884|NCT01375764|567234173|FG003|Overall Study|Other|1|||
157132885|NCT01375764|567234174|FG004|Overall Study|Other|0|||
157132886|NCT02867761|567234175|FG000|Overall Study|Participant withdrawn by investigator|0|||
157132887|NCT02867761|567234176|FG001|Overall Study|Participant withdrawn by investigator|1|||
157132888|NCT02867761|567234175|FG000|Overall Study|Lost to Follow-up|25|||
157132889|NCT02867761|567234176|FG001|Overall Study|Lost to Follow-up|18|||
157132890|NCT02867761|567234175|FG000|Overall Study|Unable to complete protocol|3|||
157132891|NCT02867761|567234176|FG001|Overall Study|Unable to complete protocol|7|||
157132892|NCT03595280|567234177|FG000|Overall Study|Lost to Follow-up|6|||
157132893|NCT03595280|567234178|FG001|Overall Study|Lost to Follow-up|9|||
157132894|NCT03595280|567234179|FG002|Overall Study|Lost to Follow-up|15|||
157132895|NCT01512264|567234180|FG000|Overall Study|Lost to Follow-up|0|||
157132896|NCT01512264|567234181|FG001|Overall Study|Lost to Follow-up|0|||
157132897|NCT01512264|567234182|FG002|Overall Study|Lost to Follow-up|0|||
157216991|NCT00910858|567540986|FG001|Combined Treatment Phase|Protocol Violation|0|||
157216992|NCT00910858|567540987|FG002|Combined Treatment Phase|Protocol Violation|0|||
157132898|NCT01512264|567234183|FG003|Overall Study|Lost to Follow-up|1|||
157132899|NCT01194440|567234184|FG000|Baseline (First Dose)|Reason not specified|4|||
157132900|NCT01194440|567234184|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
157132901|NCT01194440|567234184|FG000|Baseline (First Dose)|Change in therapy|1|||
157132902|NCT01194440|567234184|FG000|Baseline (First Dose)|Adverse Event|1|||
157132903|NCT01194440|567234184|FG000|6-months (2nd Dose)|Change in therapy|4|||
157132904|NCT01931059|567234185|FG000|Day 1|Pregnancy|0|||
157132905|NCT01931059|567234186|FG001|Day 1|Pregnancy|1|||
157132906|NCT01931059|567234185|FG000|Day3|Lost to Follow-up|1|||
157132907|NCT01931059|567234186|FG001|Day3|Lost to Follow-up|0|||
157132908|NCT02292212|567234196|FG000|ViE Phase|Withdrawal by Subject|1|||
157132909|NCT02292212|567234196|FG000|ViE Phase|Protocol Violation|2|||
157132910|NCT02675075|567234197|FG000|Overall Study|Lost to Follow-up|3|||
157132911|NCT02675075|567234198|FG001|Overall Study|Lost to Follow-up|0|||
156793458|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
156793459|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
156793460|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793461|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793462|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793463|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
156793464|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
156793465|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
156793466|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793467|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793468|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793469|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
156793470|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
156793471|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
156793472|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793473|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793474|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156716488|NCT04467840|565707496|FG000|Overall Study|Other|1|||
156716489|NCT04467840|565707497|FG001|Overall Study|Other|5|||
156716490|NCT04467840|565707496|FG000|Overall Study|Missing study completion status|3|||
156716491|NCT04467840|565707497|FG001|Overall Study|Missing study completion status|1|||
156716492|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
156716493|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
156716494|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
156716495|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
156716496|NCT05126693|565707500|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
156716497|NCT05126693|565707501|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
156716498|NCT04688671|565707502|FG000|Overall Study|Adverse Event|3|||
156716499|NCT04688671|565707503|FG001|Overall Study|Adverse Event|1|||
156716500|NCT04688671|565707502|FG000|Overall Study|Withdrawal by Subject|3|||
156716501|NCT04688671|565707503|FG001|Overall Study|Withdrawal by Subject|1|||
156716502|NCT04688671|565707502|FG000|Overall Study|Lack of Efficacy|1|||
156716503|NCT04688671|565707503|FG001|Overall Study|Lack of Efficacy|1|||
156716504|NCT04688671|565707502|FG000|Overall Study|Protocol Violation|1|||
156716505|NCT04688671|565707503|FG001|Overall Study|Protocol Violation|0|||
156716506|NCT04688671|565707502|FG000|Overall Study|Lost to Follow-up|0|||
156716507|NCT04688671|565707503|FG001|Overall Study|Lost to Follow-up|1|||
156716508|NCT00110396|565707508|FG000|Overall Study|Adverse Event|15|||
156716509|NCT00110396|565707508|FG000|Overall Study|Lost to Follow-up|1|||
156716510|NCT00110396|565707508|FG000|Overall Study|Administration of plasmapheresis|1|||
156716511|NCT00110396|565707508|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
156716512|NCT00110396|565707508|FG000|Overall Study|Lack of Efficacy|1|||
156716513|NCT00110396|565707508|FG000|Overall Study|Decided not to continue treatment|1|||
156716514|NCT00110396|565707508|FG000|Overall Study|Patient non-compliance|1|||
156716515|NCT00110396|565707508|FG000|Overall Study|Patient refused to continue|1|||
156716516|NCT00110396|565707508|FG000|Overall Study|Patient refused to participate|1|||
156716517|NCT00110396|565707508|FG000|Overall Study|Patient will|1|||
156716518|NCT00110396|565707508|FG000|Overall Study|Patient's decision|1|||
156716519|NCT00110396|565707508|FG000|Overall Study|Participation in MS vaccine study|1|||
156716520|NCT00110396|565707508|FG000|Overall Study|Pregnancy|1|||
156716521|NCT00110396|565707508|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
156716522|NCT00110396|565707508|FG000|Overall Study|Protocol Violation|2|||
156716523|NCT00110396|565707508|FG000|Overall Study|Patient refused to come back|1|||
156716524|NCT00110396|565707508|FG000|Overall Study|The patient has refused|2|||
156793475|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
156793476|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
156793477|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
156793478|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
157018548|NCT04757610|566821354|FG000|Overall Study|Lack of Efficacy|1|||
157018549|NCT04757610|566821355|FG001|Overall Study|Lack of Efficacy|2|||
156716525|NCT00110396|565707508|FG000|Overall Study|The patient has refused to visit site|1|||
156716526|NCT00110396|565707508|FG000|Overall Study|Patient is to be administered copaxone|1|||
156716527|NCT00811733|565707515|FG000|Overall Study|Investigator Discretion|10|||
156793479|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
157018550|NCT04757610|566821356|FG002|Overall Study|Lack of Efficacy|3|||
156716528|NCT00811733|565707516|FG001|Overall Study|Investigator Discretion|8|||
156716529|NCT00811733|565707515|FG000|Overall Study|Withdrawal by Subject|1|||
156716530|NCT00811733|565707516|FG001|Overall Study|Withdrawal by Subject|2|||
156716531|NCT00793871|565707517|FG000|Overall Study|Death|50|||
156716532|NCT00793871|565707517|FG000|Overall Study|Lost to Follow-up|3|||
156716533|NCT00793871|565707517|FG000|Overall Study|Study terminated by the Sponsor|7|||
156793480|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
157018551|NCT04757610|566821354|FG000|Overall Study|Lost to Follow-up|7|||
156716534|NCT00245466|565707518|FG000|Overall Study|Adverse Event|2|||
156716535|NCT00245466|565707519|FG001|Overall Study|Adverse Event|8|||
156716536|NCT00245466|565707520|FG002|Overall Study|Adverse Event|4|||
156716537|NCT00245466|565707518|FG000|Overall Study|Low prostate specific antigen suppr|16|||
156716538|NCT00245466|565707519|FG001|Overall Study|Low prostate specific antigen suppr|14|||
156716539|NCT00245466|565707520|FG002|Overall Study|Low prostate specific antigen suppr|5|||
156716540|NCT00245466|565707518|FG000|Overall Study|Insufficient testosterone suppr|12|||
156716541|NCT00245466|565707519|FG001|Overall Study|Insufficient testosterone suppr|12|||
156716542|NCT00245466|565707520|FG002|Overall Study|Insufficient testosterone suppr|21|||
156716543|NCT00245466|565707518|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
156716544|NCT00245466|565707519|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
156716545|NCT00245466|565707520|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
156716546|NCT00245466|565707518|FG000|Overall Study|Withdrawal by Subject|2|||
156716547|NCT00245466|565707519|FG001|Overall Study|Withdrawal by Subject|2|||
156716548|NCT00245466|565707520|FG002|Overall Study|Withdrawal by Subject|1|||
156716549|NCT00245466|565707518|FG000|Overall Study|Lost to Follow-up|3|||
156716550|NCT00245466|565707519|FG001|Overall Study|Lost to Follow-up|0|||
156716551|NCT00245466|565707520|FG002|Overall Study|Lost to Follow-up|0|||
156716552|NCT00245466|565707518|FG000|Overall Study|Disease progression|0|||
156716553|NCT00245466|565707519|FG001|Overall Study|Disease progression|3|||
156716554|NCT00245466|565707520|FG002|Overall Study|Disease progression|1|||
156716555|NCT00245466|565707518|FG000|Overall Study|Protocol Violation|1|||
156716556|NCT00245466|565707519|FG001|Overall Study|Protocol Violation|2|||
156716557|NCT00245466|565707520|FG002|Overall Study|Protocol Violation|2|||
156716558|NCT00245466|565707518|FG000|Overall Study|Death|0|||
156716559|NCT00245466|565707519|FG001|Overall Study|Death|2|||
156716560|NCT00245466|565707520|FG002|Overall Study|Death|0|||
156716561|NCT00245466|565707518|FG000|Overall Study|Administrative reasons|0|||
156716562|NCT00245466|565707519|FG001|Overall Study|Administrative reasons|1|||
156716563|NCT00245466|565707520|FG002|Overall Study|Administrative reasons|0|||
156716564|NCT00856193|565707521|FG000|Period 2|Abnormal test procedure results|0|||
156716565|NCT00856193|565707522|FG001|Period 2|Abnormal test procedure results|1|||
156716566|NCT00856193|565707521|FG000|Period 2|Lost to Follow-up|0|||
156716567|NCT00856193|565707522|FG001|Period 2|Lost to Follow-up|1|||
156716568|NCT01928472|565707523|FG000|Overall Study|Death|0|||
156716569|NCT01928472|565707524|FG001|Overall Study|Death|0|||
156716570|NCT01928472|565707525|FG002|Overall Study|Death|1|||
156716571|NCT01928472|565707526|FG003|Overall Study|Death|0|||
156716572|NCT01928472|565707523|FG000|Overall Study|Withdrawal by Subject|4|||
156716573|NCT01928472|565707524|FG001|Overall Study|Withdrawal by Subject|4|||
156716574|NCT01928472|565707525|FG002|Overall Study|Withdrawal by Subject|1|||
156716575|NCT01928472|565707526|FG003|Overall Study|Withdrawal by Subject|2|||
156716576|NCT01928472|565707523|FG000|Overall Study|Lost to Follow-up|2|||
156716577|NCT01928472|565707524|FG001|Overall Study|Lost to Follow-up|3|||
156716578|NCT01928472|565707525|FG002|Overall Study|Lost to Follow-up|4|||
156716579|NCT01928472|565707526|FG003|Overall Study|Lost to Follow-up|0|||
156716580|NCT01928472|565707523|FG000|Overall Study|Administrative Reason|2|||
156716581|NCT01928472|565707524|FG001|Overall Study|Administrative Reason|1|||
156716582|NCT01928472|565707525|FG002|Overall Study|Administrative Reason|0|||
156793481|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
156793482|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
156793483|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
156793484|NCT01272219|565996267|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
156793485|NCT01272219|565996268|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
156793486|NCT01272219|565996269|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
156793487|NCT01272219|565996270|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
156874971|NCT00243269|566300595|FG002|Overall Study|Lost to Follow-up|1|||
157132912|NCT01176916|567234199|FG000|Overall Study|Adverse Event|61|||
157132913|NCT01176916|567234199|FG000|Overall Study|Death|1|||
157132914|NCT01176916|567234199|FG000|Overall Study|Lost to Follow-up|15|||
157132915|NCT01176916|567234199|FG000|Overall Study|Objective progression or relapse|17|||
157132916|NCT01176916|567234199|FG000|Overall Study|Protocol Violation|24|||
157132917|NCT01176916|567234199|FG000|Overall Study|Withdrawal by Subject|37|||
157132918|NCT01176916|567234199|FG000|Overall Study|Other|6|||
156716583|NCT01928472|565707526|FG003|Overall Study|Administrative Reason|0|||
156716584|NCT01928472|565707523|FG000|Overall Study|Unclassified|0|||
156716585|NCT01928472|565707524|FG001|Overall Study|Unclassified|0|||
156716586|NCT01928472|565707525|FG002|Overall Study|Unclassified|1|||
156716587|NCT01928472|565707526|FG003|Overall Study|Unclassified|0|||
156716588|NCT04542057|565707531|FG000|Overall Study|Death|3|||
156716589|NCT04542057|565707532|FG001|Overall Study|Death|1|||
156716590|NCT04542057|565707531|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
156716591|NCT04542057|565707532|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
157216993|NCT00910858|567540985|FG000|Combined Treatment Phase|Other|0|||
156716592|NCT04542057|565707531|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
156716593|NCT04542057|565707532|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
156716594|NCT04542057|565707531|FG000|Overall Study|Adverse Event|15|||
156793488|NCT01272219|565996271|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
156793489|NCT01272219|565996272|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
156793490|NCT05305651|565996273|FG000|Overall Study|Death|1|||
156793491|NCT05305651|565996273|FG000|Overall Study|Withdrawal by Subject|4|||
156793492|NCT05305651|565996273|FG000|Overall Study|Lost to Follow-up|4|||
156716595|NCT04542057|565707532|FG001|Overall Study|Adverse Event|6|||
156716596|NCT04542057|565707531|FG000|Overall Study|COVID-19 adverse event|6|||
156716597|NCT04542057|565707532|FG001|Overall Study|COVID-19 adverse event|4|||
156716598|NCT04542057|565707531|FG000|Overall Study|Lack of Efficacy|2|||
156716599|NCT04542057|565707532|FG001|Overall Study|Lack of Efficacy|5|||
156716600|NCT04542057|565707531|FG000|Overall Study|Study terminated by sponsor|1|||
156716601|NCT04542057|565707532|FG001|Overall Study|Study terminated by sponsor|0|||
156716602|NCT04542057|565707531|FG000|Overall Study|Investigator discretion|2|||
156716603|NCT04542057|565707532|FG001|Overall Study|Investigator discretion|1|||
156716604|NCT04542057|565707531|FG000|Overall Study|Withdrawal by Subject|52|||
156716605|NCT04542057|565707532|FG001|Overall Study|Withdrawal by Subject|30|||
156716606|NCT04542057|565707531|FG000|Overall Study|Lost to Follow-up|8|||
156716607|NCT04542057|565707532|FG001|Overall Study|Lost to Follow-up|11|||
156716608|NCT04542057|565707531|FG000|Overall Study|Other|2|||
156716609|NCT04542057|565707532|FG001|Overall Study|Other|2|||
156716610|NCT00307086|565707535|FG000|Overall Study|ineligible|5|||
156716611|NCT00065156|565707536|FG000|Overall Study|Adverse Event|37|||
156716612|NCT00065156|565707536|FG000|Overall Study|Lack of Efficacy|52|||
156716613|NCT00065156|565707536|FG000|Overall Study|Withdrawal by Subject|8|||
156716614|NCT00065156|565707536|FG000|Overall Study|Lost to Follow-up|1|||
156716615|NCT00065156|565707536|FG000|Overall Study|Death|11|||
156716616|NCT00065156|565707536|FG000|Overall Study|Study Closed by Sponsor|2|||
156716617|NCT00065156|565707536|FG000|Overall Study|Disease Progression|7|||
156716618|NCT00065156|565707536|FG000|Overall Study|Investigator Decision|2|||
156716619|NCT00065156|565707536|FG000|Overall Study|Non-Compliance|2|||
156716620|NCT00065156|565707536|FG000|Overall Study|Loss of Response|1|||
156716621|NCT00065156|565707536|FG000|Overall Study|Secondary Malign Disease|1|||
156716622|NCT04583735|565707537|FG000|Double-masked Treatment Period|Adverse Event|0|||
156716623|NCT04583735|565707538|FG001|Double-masked Treatment Period|Adverse Event|1|||
156716624|NCT04583735|565707537|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
156716625|NCT04583735|565707538|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
156716626|NCT04583735|565707537|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
156716627|NCT04583735|565707538|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
156716628|NCT04583735|565707537|FG000|Open-label Treatment Period|Adverse Event|1|||
156716629|NCT04583735|565707538|FG001|Open-label Treatment Period|Adverse Event|1|||
156716630|NCT04583735|565707537|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
156716631|NCT04583735|565707538|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156716632|NCT04583735|565707537|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156716633|NCT04583735|565707538|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
156716634|NCT01176513|565707539|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
156716635|NCT01197911|565707540|FG000|Overall Study|Adverse Event|0|||
156716636|NCT01197911|565707541|FG001|Overall Study|Adverse Event|0|||
156716637|NCT01197911|565707542|FG002|Overall Study|Adverse Event|1|||
156716638|NCT02273388|565707546|FG000|Overall Study|Adverse Event|0|||
156716639|NCT02273388|565707547|FG001|Overall Study|Adverse Event|0|||
156716640|NCT02273388|565707548|FG002|Overall Study|Adverse Event|0|||
156716641|NCT02273388|565707549|FG003|Overall Study|Adverse Event|0|||
156793493|NCT01491919|565996276|FG000|Overall Study|Insufficient PK sampling|1|||
156793494|NCT01491919|565996277|FG001|Overall Study|Insufficient PK sampling|2|||
156793495|NCT01491919|565996278|FG002|Overall Study|Insufficient PK sampling|1|||
156793496|NCT00967499|565996279|FG000|Overall Study|Adverse Event|0|||
156793497|NCT00967499|565996280|FG001|Overall Study|Adverse Event|1|||
156793498|NCT00967499|565996279|FG000|Overall Study|Protocol Violation|1|||
156793499|NCT00967499|565996280|FG001|Overall Study|Protocol Violation|0|||
156793500|NCT00967499|565996279|FG000|Overall Study|Sponsor Decision|1|||
156793501|NCT00967499|565996280|FG001|Overall Study|Sponsor Decision|0|||
156793502|NCT00967499|565996279|FG000|Overall Study|Randomized but not treated|63|||
156793503|NCT00967499|565996280|FG001|Overall Study|Randomized but not treated|59|||
156874972|NCT00243269|566300596|FG003|Overall Study|Lost to Follow-up|3|||
156716642|NCT02273388|565707550|FG004|Overall Study|Adverse Event|0|||
156716643|NCT02273388|565707551|FG005|Overall Study|Adverse Event|0|||
156716644|NCT02273388|565707552|FG006|Overall Study|Adverse Event|1|||
156716645|NCT02273388|565707553|FG007|Overall Study|Adverse Event|2|||
156716646|NCT02273388|565707554|FG008|Overall Study|Adverse Event|0|||
156716647|NCT02273388|565707555|FG009|Overall Study|Adverse Event|0|||
156793504|NCT04003389|565996281|FG000|Overall Study|Adverse Event|27|||
156793505|NCT04003389|565996282|FG001|Overall Study|Adverse Event|34|||
156793506|NCT04003389|565996283|FG002|Overall Study|Adverse Event|28|||
156793507|NCT04003389|565996281|FG000|Overall Study|Lost to Follow-up|39|||
156874973|NCT00485134|566300599|FG000|Overall Study|Lost to Follow-up|1|||
156716648|NCT02273388|565707556|FG010|Overall Study|Adverse Event|0|||
156793508|NCT04003389|565996282|FG001|Overall Study|Lost to Follow-up|30|||
156793509|NCT04003389|565996283|FG002|Overall Study|Lost to Follow-up|33|||
156716649|NCT02273388|565707557|FG011|Overall Study|Adverse Event|0|||
156716650|NCT02273388|565707546|FG000|Overall Study|Adverse Event study disease worse|4|||
156716651|NCT02273388|565707547|FG001|Overall Study|Adverse Event study disease worse|3|||
156716652|NCT02273388|565707548|FG002|Overall Study|Adverse Event study disease worse|3|||
156716653|NCT02273388|565707549|FG003|Overall Study|Adverse Event study disease worse|2|||
156716654|NCT02273388|565707550|FG004|Overall Study|Adverse Event study disease worse|4|||
156716655|NCT02273388|565707551|FG005|Overall Study|Adverse Event study disease worse|3|||
156716656|NCT02273388|565707552|FG006|Overall Study|Adverse Event study disease worse|14|||
156716657|NCT02273388|565707553|FG007|Overall Study|Adverse Event study disease worse|6|||
156716658|NCT02273388|565707554|FG008|Overall Study|Adverse Event study disease worse|6|||
156716659|NCT02273388|565707555|FG009|Overall Study|Adverse Event study disease worse|5|||
156716660|NCT02273388|565707556|FG010|Overall Study|Adverse Event study disease worse|10|||
156716661|NCT02273388|565707557|FG011|Overall Study|Adverse Event study disease worse|1|||
156716662|NCT02273388|565707546|FG000|Overall Study|Sponsor decision|0|||
156716663|NCT02273388|565707547|FG001|Overall Study|Sponsor decision|0|||
156716664|NCT02273388|565707548|FG002|Overall Study|Sponsor decision|0|||
156716665|NCT02273388|565707549|FG003|Overall Study|Sponsor decision|0|||
156716666|NCT02273388|565707550|FG004|Overall Study|Sponsor decision|0|||
156716667|NCT02273388|565707551|FG005|Overall Study|Sponsor decision|0|||
156716668|NCT02273388|565707552|FG006|Overall Study|Sponsor decision|0|||
156716669|NCT02273388|565707553|FG007|Overall Study|Sponsor decision|0|||
156716670|NCT02273388|565707554|FG008|Overall Study|Sponsor decision|0|||
156716671|NCT02273388|565707555|FG009|Overall Study|Sponsor decision|0|||
156716672|NCT02273388|565707556|FG010|Overall Study|Sponsor decision|0|||
156716673|NCT02273388|565707557|FG011|Overall Study|Sponsor decision|1|||
156716674|NCT04331808|565707558|FG000|Overall Study|Withdrew consent|1|||
156716675|NCT04331808|565707559|FG001|Overall Study|Withdrew consent|0|||
156716676|NCT04331808|565707560|FG002|Overall Study|Withdrew consent|2|||
156716677|NCT04331808|565707561|FG003|Overall Study|Withdrew consent|3|||
156716678|NCT00952731|565707562|FG000|Overall Study|Drug supply expired|1|||
156716679|NCT00952731|565707563|FG001|Overall Study|Drug supply expired|0|||
156716680|NCT01329900|565707564|FG000|Overall Study|Elevated creatinine/renal function|1|||
156716681|NCT01855828|565707565|FG000|Overall Study|Adverse Event|1|||
156716682|NCT01855828|565707565|FG000|Overall Study|Withdrawal by Subject|1|||
156716683|NCT01866098|565707566|FG000|Overall Study|Lost to Follow-up|11|||
156716684|NCT01866098|565707567|FG001|Overall Study|Lost to Follow-up|18|||
156716685|NCT01866098|565707568|FG002|Overall Study|Lost to Follow-up|13|||
156716686|NCT01866098|565707566|FG000|Overall Study|Physician Decision|0|||
156716687|NCT01866098|565707567|FG001|Overall Study|Physician Decision|1|||
156716688|NCT01866098|565707568|FG002|Overall Study|Physician Decision|2|||
156716689|NCT01866098|565707566|FG000|Overall Study|Adverse Event|1|||
156716690|NCT01866098|565707567|FG001|Overall Study|Adverse Event|5|||
156716691|NCT01866098|565707568|FG002|Overall Study|Adverse Event|4|||
156716692|NCT01866098|565707566|FG000|Overall Study|Protocol Violation|1|||
156716693|NCT01866098|565707567|FG001|Overall Study|Protocol Violation|0|||
156716694|NCT01866098|565707568|FG002|Overall Study|Protocol Violation|0|||
156716695|NCT01866098|565707566|FG000|Overall Study|Withdrawal by Subject|1|||
156716696|NCT01866098|565707567|FG001|Overall Study|Withdrawal by Subject|2|||
156874974|NCT00485134|566300600|FG001|Overall Study|Lost to Follow-up|0|||
156874975|NCT00485134|566300601|FG002|Overall Study|Lost to Follow-up|0|||
157132919|NCT01176916|567234199|FG000|Overall Study|Withdrawal prior to Treatment|6|||
157132920|NCT03158220|567234200|FG000|Overall Study|Screen Failure|0|||
157132921|NCT03158220|567234201|FG001|Overall Study|Screen Failure|1|||
157132922|NCT03158220|567234200|FG000|Overall Study|Withdrawal by Subject|8|||
157132923|NCT03158220|567234201|FG001|Overall Study|Withdrawal by Subject|9|||
157132924|NCT03158220|567234200|FG000|Overall Study|Status unknown|0|||
157132925|NCT03158220|567234201|FG001|Overall Study|Status unknown|1|||
157132926|NCT03158220|567234200|FG000|Overall Study|Lost to Follow-up|8|||
157132927|NCT03158220|567234201|FG001|Overall Study|Lost to Follow-up|5|||
157132928|NCT03158220|567234200|FG000|Overall Study|Physician Decision|1|||
157132929|NCT03158220|567234201|FG001|Overall Study|Physician Decision|0|||
157132930|NCT00848120|567234202|FG000|Overall Study|Adverse Event|1|||
157132931|NCT01961115|567234211|FG000|Overall Study|Disease Progression|1|||
157132932|NCT01961115|567234212|FG001|Overall Study|Disease Progression|0|||
157132933|NCT01961115|567234213|FG002|Overall Study|Disease Progression|3|||
157132934|NCT01961115|567234211|FG000|Overall Study|Adverse Event|1|||
157132935|NCT01961115|567234212|FG001|Overall Study|Adverse Event|0|||
157132936|NCT01961115|567234213|FG002|Overall Study|Adverse Event|1|||
157132937|NCT00705263|567234218|FG000|Overall Study|Withdrawal by Subject|2|||
157132938|NCT05501119|567234219|FG000|Overall Study|Withdrawal by Subject|2|||
157132939|NCT05501119|567234219|FG000|Overall Study|Lost to Follow-up|5|||
157132940|NCT01752023|567234220|FG000|Overall Study|Physician Decision|2|||
157132941|NCT01752023|567234221|FG001|Overall Study|Physician Decision|1|||
157132942|NCT02899156|567234222|FG000|Overall Study|Death|1|||
156874976|NCT00485134|566300602|FG003|Overall Study|Lost to Follow-up|0|||
157132943|NCT02899156|567234223|FG001|Overall Study|Death|0|||
157132944|NCT02899156|567234222|FG000|Overall Study|Physician Decision|0|||
157132945|NCT02899156|567234223|FG001|Overall Study|Physician Decision|1|||
157132946|NCT02440581|567234226|FG000|Overall Study|Death|0|||
156716697|NCT01866098|565707568|FG002|Overall Study|Withdrawal by Subject|0|||
156716698|NCT01866098|565707566|FG000|Overall Study|Unrelated Hospitalization|2|||
156716699|NCT01866098|565707567|FG001|Overall Study|Unrelated Hospitalization|0|||
156716700|NCT01866098|565707568|FG002|Overall Study|Unrelated Hospitalization|1|||
156716701|NCT01866098|565707566|FG000|Overall Study|Non-compliance|1|||
156716702|NCT01866098|565707567|FG001|Overall Study|Non-compliance|0|||
156716703|NCT01866098|565707568|FG002|Overall Study|Non-compliance|1|||
156716704|NCT01866098|565707566|FG000|Overall Study|Pregnancy|2|||
156716705|NCT01866098|565707567|FG001|Overall Study|Pregnancy|0|||
156716706|NCT01866098|565707568|FG002|Overall Study|Pregnancy|0|||
156716707|NCT01866098|565707566|FG000|Overall Study|Death|0|||
156716708|NCT01866098|565707567|FG001|Overall Study|Death|1|||
156716709|NCT01866098|565707568|FG002|Overall Study|Death|0|||
156716710|NCT04239027|565707569|FG000|Overall Study|Adverse Event|4|||
156716711|NCT04239027|565707569|FG000|Overall Study|Withdrawal by Subject|9|||
156716712|NCT04239027|565707569|FG000|Overall Study|Death|1|||
156716713|NCT04239027|565707569|FG000|Overall Study|Physician Decision|9|||
156716714|NCT04239027|565707569|FG000|Overall Study|Lost to Follow-up|2|||
156716715|NCT04239027|565707569|FG000|Overall Study|Lack of Efficacy|1|||
156716716|NCT04233073|565707579|FG000|Overall Study|Death|5|||
156716717|NCT03172494|565707580|FG000|Overall Study|Adverse Event|5|||
156716718|NCT03172494|565707581|FG001|Overall Study|Adverse Event|1|||
156716719|NCT03172494|565707582|FG002|Overall Study|Adverse Event|15|||
156716720|NCT03172494|565707580|FG000|Overall Study|Protocol Violation|3|||
156716721|NCT03172494|565707581|FG001|Overall Study|Protocol Violation|2|||
156716722|NCT03172494|565707582|FG002|Overall Study|Protocol Violation|1|||
156716723|NCT03172494|565707580|FG000|Overall Study|Lack of Efficacy|0|||
156716724|NCT03172494|565707581|FG001|Overall Study|Lack of Efficacy|0|||
156716725|NCT03172494|565707582|FG002|Overall Study|Lack of Efficacy|4|||
156716726|NCT03172494|565707580|FG000|Overall Study|Pregnancy|0|||
156716727|NCT03172494|565707581|FG001|Overall Study|Pregnancy|1|||
156716728|NCT03172494|565707582|FG002|Overall Study|Pregnancy|0|||
156716729|NCT03172494|565707580|FG000|Overall Study|Withdrawal by Subject|10|||
156716730|NCT03172494|565707581|FG001|Overall Study|Withdrawal by Subject|8|||
156716731|NCT03172494|565707582|FG002|Overall Study|Withdrawal by Subject|8|||
156716732|NCT03172494|565707580|FG000|Overall Study|Severe hypoglycaemic episode|0|||
156716733|NCT03172494|565707581|FG001|Overall Study|Severe hypoglycaemic episode|0|||
156716734|NCT03172494|565707582|FG002|Overall Study|Severe hypoglycaemic episode|1|||
156716735|NCT03172494|565707580|FG000|Overall Study|Non-compliance towards treatment|2|||
156716736|NCT03172494|565707581|FG001|Overall Study|Non-compliance towards treatment|0|||
156716737|NCT03172494|565707582|FG002|Overall Study|Non-compliance towards treatment|0|||
156716738|NCT00143390|565707583|FG000|Overall Study|Death|2|||
156716739|NCT00143390|565707584|FG001|Overall Study|Death|0|||
156716740|NCT00143390|565707583|FG000|Overall Study|Not meeting entry criteria|2|||
156716741|NCT00143390|565707584|FG001|Overall Study|Not meeting entry criteria|5|||
156716742|NCT00143390|565707583|FG000|Overall Study|Withdrawal by Subject|4|||
156716743|NCT00143390|565707584|FG001|Overall Study|Withdrawal by Subject|4|||
156716744|NCT00143390|565707583|FG000|Overall Study|Progressive disease|119|||
156716745|NCT00143390|565707584|FG001|Overall Study|Progressive disease|115|||
156716746|NCT00143390|565707583|FG000|Overall Study|Protocol Violation|2|||
156716747|NCT00143390|565707584|FG001|Overall Study|Protocol Violation|0|||
156716748|NCT00143390|565707583|FG000|Overall Study|Study termination|10|||
156716749|NCT00143390|565707584|FG001|Overall Study|Study termination|15|||
156716750|NCT00143390|565707583|FG000|Overall Study|Adverse Event|9|||
156716751|NCT00143390|565707584|FG001|Overall Study|Adverse Event|8|||
156716752|NCT00143390|565707583|FG000|Overall Study|Other|1|||
156716753|NCT00143390|565707584|FG001|Overall Study|Other|2|||
156716754|NCT00243412|565707585|FG000|Overall Study|Death|0|||
156716755|NCT00243412|565707586|FG001|Overall Study|Death|1|||
156716756|NCT00243412|565707585|FG000|Overall Study|Adverse Event|4|||
156716757|NCT00243412|565707586|FG001|Overall Study|Adverse Event|2|||
156716758|NCT00243412|565707585|FG000|Overall Study|Lost to Follow-up|0|||
156716759|NCT00243412|565707586|FG001|Overall Study|Lost to Follow-up|1|||
156716760|NCT00243412|565707585|FG000|Overall Study|Physician Decision|1|||
156716761|NCT00243412|565707586|FG001|Overall Study|Physician Decision|1|||
156716762|NCT00243412|565707585|FG000|Overall Study|Withdrawal by Subject|4|||
156716763|NCT00243412|565707586|FG001|Overall Study|Withdrawal by Subject|5|||
156716764|NCT00243412|565707585|FG000|Overall Study|Other|1|||
156716765|NCT00243412|565707586|FG001|Overall Study|Other|1|||
156716766|NCT00041132|565707588|FG000|Overall Study|Adverse Event|19|||
156716767|NCT00041132|565707588|FG000|Overall Study|Death|1|||
156716768|NCT00041132|565707588|FG000|Overall Study|Not Eligible|7|||
156716769|NCT00041132|565707588|FG000|Overall Study|Withdrawal by Subject|1|||
156716770|NCT00041132|565707588|FG000|Overall Study|Physician Decision|2|||
156716771|NCT02764151|565707592|FG000|Overall Study|Subject refused further follow-up|0|||
156716772|NCT02764151|565707593|FG001|Overall Study|Subject refused further follow-up|0|||
156716773|NCT02764151|565707594|FG002|Overall Study|Subject refused further follow-up|0|||
156716774|NCT02764151|565707595|FG003|Overall Study|Subject refused further follow-up|1|||
156716775|NCT02764151|565707592|FG000|Overall Study|Other|0|||
156716776|NCT02764151|565707593|FG001|Overall Study|Other|0|||
156716777|NCT02764151|565707594|FG002|Overall Study|Other|0|||
156716778|NCT02764151|565707595|FG003|Overall Study|Other|2|||
156716779|NCT01450683|565707596|FG000|Overall Study|Adverse Event|2|||
156716780|NCT01523002|565707605|FG000|Period 1|Withdrawal by Subject|1|||
156716781|NCT01523002|565707606|FG001|Period 1|Withdrawal by Subject|3|||
156716782|NCT01523002|565707605|FG000|Period 1|Lost to Follow-up|1|||
156716783|NCT01523002|565707606|FG001|Period 1|Lost to Follow-up|0|||
156716784|NCT01523002|565707605|FG000|Period 1|Adverse Event|0|||
156716785|NCT01523002|565707606|FG001|Period 1|Adverse Event|8|||
156716786|NCT01523002|565707605|FG000|Period 2|Withdrawal by Subject|4|||
156716787|NCT01523002|565707606|FG001|Period 2|Withdrawal by Subject|1|||
156716788|NCT01523002|565707605|FG000|Period 2|Adverse Event|2|||
156716789|NCT01523002|565707606|FG001|Period 2|Adverse Event|5|||
156716790|NCT01523002|565707605|FG000|Period 3|Withdrawal by Subject|1|||
156716791|NCT01523002|565707606|FG001|Period 3|Withdrawal by Subject|0|||
156716792|NCT01523002|565707605|FG000|Period 3|Adverse Event|3|||
156716793|NCT01523002|565707606|FG001|Period 3|Adverse Event|0|||
156716794|NCT01256502|565707607|FG000|Overall Study|Had scaffold removed|4|||
157132947|NCT02440581|567234227|FG001|Overall Study|Death|0|||
157132948|NCT02440581|567234228|FG002|Overall Study|Death|7|||
157132949|NCT02440581|567234229|FG003|Overall Study|Death|5|||
156716795|NCT01256502|565707607|FG000|Overall Study|Personal reasons|5|||
156716796|NCT01256502|565707607|FG000|Overall Study|Protocol deviation|1|||
156716797|NCT00489255|565707608|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
156716798|NCT00489255|565707609|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
156716799|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
156716800|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
156716801|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
156716802|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
156716803|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
156716804|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
156716805|NCT00489255|565707608|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
156716806|NCT00489255|565707609|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
156716807|NCT00489255|565707608|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
156716808|NCT00489255|565707609|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
156716809|NCT00489255|565707608|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
156716810|NCT00489255|565707609|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
156716811|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
156716812|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
156716813|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
156716814|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
156716815|NCT00489255|565707608|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
156716816|NCT00489255|565707609|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
156716817|NCT03485352|565707610|FG000|Overall Study|Lost to Follow-up|9|||
156716818|NCT00852202|565707621|FG000|Overall Study|Adverse Event|2|||
156716819|NCT00852202|565707622|FG001|Overall Study|Adverse Event|3|||
156716820|NCT00852202|565707623|FG002|Overall Study|Adverse Event|7|||
156716821|NCT00852202|565707621|FG000|Overall Study|Lack of Efficacy|4|||
156716822|NCT00852202|565707622|FG001|Overall Study|Lack of Efficacy|1|||
156716823|NCT00852202|565707623|FG002|Overall Study|Lack of Efficacy|2|||
156716824|NCT00852202|565707621|FG000|Overall Study|Protocol Violation|2|||
156716825|NCT00852202|565707622|FG001|Overall Study|Protocol Violation|2|||
156716826|NCT00852202|565707623|FG002|Overall Study|Protocol Violation|7|||
156716827|NCT00852202|565707621|FG000|Overall Study|Withdrawal by Subject|3|||
156716828|NCT00852202|565707622|FG001|Overall Study|Withdrawal by Subject|1|||
156716829|NCT00852202|565707623|FG002|Overall Study|Withdrawal by Subject|2|||
156716830|NCT00852202|565707621|FG000|Overall Study|Lost to Follow-up|5|||
156716831|NCT00852202|565707622|FG001|Overall Study|Lost to Follow-up|5|||
156716832|NCT00852202|565707623|FG002|Overall Study|Lost to Follow-up|6|||
156716833|NCT00852202|565707621|FG000|Overall Study|pregnancy,moving away and surgery|1|||
156716834|NCT00852202|565707622|FG001|Overall Study|pregnancy,moving away and surgery|0|||
156716835|NCT00852202|565707623|FG002|Overall Study|pregnancy,moving away and surgery|2|||
156716836|NCT00141778|565707626|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
156716837|NCT00141778|565707627|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
156716838|NCT00141778|565707628|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
156716839|NCT00141778|565707626|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
156716840|NCT00141778|565707627|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
156716841|NCT00141778|565707628|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
156716842|NCT00141778|565707626|FG000|Started Study Medication|Withdrawal by Subject|0|||
156716843|NCT00141778|565707627|FG001|Started Study Medication|Withdrawal by Subject|2|||
156793510|NCT04003389|565996281|FG000|Overall Study|Protocol Violation|1|||
156793511|NCT04003389|565996282|FG001|Overall Study|Protocol Violation|6|||
156793512|NCT04003389|565996283|FG002|Overall Study|Protocol Violation|5|||
156793513|NCT04003389|565996281|FG000|Overall Study|Withdrawal by Subject|119|||
156793514|NCT04003389|565996282|FG001|Overall Study|Withdrawal by Subject|79|||
156716844|NCT00141778|565707628|FG002|Started Study Medication|Withdrawal by Subject|0|||
157132950|NCT02440581|567234226|FG000|Overall Study|Transplanted|1|||
157132951|NCT02440581|567234227|FG001|Overall Study|Transplanted|0|||
157132952|NCT02440581|567234228|FG002|Overall Study|Transplanted|3|||
156716845|NCT00141778|565707626|FG000|Started Study Medication|Difficulty Swallowing|0|||
156716846|NCT00141778|565707627|FG001|Started Study Medication|Difficulty Swallowing|1|||
156716847|NCT00141778|565707628|FG002|Started Study Medication|Difficulty Swallowing|0|||
156716848|NCT00141778|565707626|FG000|Started Study Medication|Chest Discomfort|0|||
156716849|NCT00141778|565707627|FG001|Started Study Medication|Chest Discomfort|0|||
156716850|NCT00141778|565707628|FG002|Started Study Medication|Chest Discomfort|1|||
156716851|NCT00768248|565707629|FG000|Overall Study|Research coordinator didn't collect data|1|||
156716852|NCT00768248|565707630|FG001|Overall Study|Research coordinator didn't collect data|1|||
156716853|NCT01959295|565707633|FG000|Overall Study|Adverse Event|2|||
156716854|NCT01959295|565707634|FG001|Overall Study|Adverse Event|0|||
156716855|NCT01959295|565707633|FG000|Overall Study|Lost to Follow-up|0|||
156716856|NCT01959295|565707634|FG001|Overall Study|Lost to Follow-up|2|||
156716857|NCT01959295|565707633|FG000|Overall Study|Physician Decision|2|||
156716858|NCT01959295|565707634|FG001|Overall Study|Physician Decision|3|||
156716859|NCT01959295|565707633|FG000|Overall Study|Protocol Violation|16|||
156716860|NCT01959295|565707634|FG001|Overall Study|Protocol Violation|5|||
156716861|NCT01959295|565707633|FG000|Overall Study|Withdrawal by Subject|3|||
156716862|NCT01959295|565707634|FG001|Overall Study|Withdrawal by Subject|1|||
156716863|NCT01959295|565707633|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
156716864|NCT01959295|565707634|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
156716865|NCT04100018|565709339|FG000|Pre-Treatment Period|Not Reported|0|||
156716866|NCT04100018|565709340|FG001|Pre-Treatment Period|Not Reported|4|||
156716867|NCT04100018|565709339|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
156716868|NCT04100018|565709340|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
156716869|NCT04100018|565709339|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
156716870|NCT04100018|565709340|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
156716871|NCT04100018|565709339|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
156716872|NCT04100018|565709340|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156716873|NCT04100018|565709339|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156716874|NCT04100018|565709340|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
156716875|NCT04100018|565709339|FG000|Treatment Period|Ongoing Treatment|1|||
156716876|NCT04100018|565709340|FG001|Treatment Period|Ongoing Treatment|0|||
156716877|NCT04100018|565709339|FG000|Treatment Period|Other Reason|26|||
156716878|NCT04100018|565709340|FG001|Treatment Period|Other Reason|37|||
156716879|NCT04100018|565709339|FG000|Treatment Period|Completed treatment as per protocol|1|||
156716880|NCT04100018|565709340|FG001|Treatment Period|Completed treatment as per protocol|2|||
156716881|NCT04100018|565709339|FG000|Treatment Period|Maximum clinical benefit|3|||
156716882|NCT04100018|565709340|FG001|Treatment Period|Maximum clinical benefit|0|||
156716883|NCT04100018|565709339|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
156716884|NCT04100018|565709340|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
156716885|NCT04100018|565709339|FG000|Treatment Period|Study drug toxicity|67|||
156716886|NCT04100018|565709340|FG001|Treatment Period|Study drug toxicity|28|||
156716887|NCT04100018|565709339|FG000|Treatment Period|Disease Progression|284|||
156716888|NCT04100018|565709340|FG001|Treatment Period|Disease Progression|327|||
156716889|NCT04100018|565709339|FG000|Treatment Period|Administrative reasons by sponsor|16|||
156716890|NCT04100018|565709340|FG001|Treatment Period|Administrative reasons by sponsor|30|||
156716891|NCT04100018|565709339|FG000|Treatment Period|Poor/Non-Compliance|1|||
156716892|NCT04100018|565709340|FG001|Treatment Period|Poor/Non-Compliance|0|||
156716893|NCT04100018|565709339|FG000|Treatment Period|Lost to Follow-up|2|||
156716894|NCT04100018|565709340|FG001|Treatment Period|Lost to Follow-up|2|||
156716895|NCT04100018|565709339|FG000|Treatment Period|Death|16|||
156716896|NCT04100018|565709340|FG001|Treatment Period|Death|11|||
156716897|NCT04100018|565709339|FG000|Treatment Period|Participant withdrew consent|10|||
156716898|NCT04100018|565709340|FG001|Treatment Period|Participant withdrew consent|10|||
156716899|NCT04100018|565709339|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
156716900|NCT04100018|565709340|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
156716901|NCT04100018|565709339|FG000|Treatment Period|Adverse Event|14|||
156716902|NCT04100018|565709340|FG001|Treatment Period|Adverse Event|6|||
156716903|NCT04100018|565709339|FG000|Treatment Period|Lack of Efficacy|4|||
156716904|NCT04100018|565709340|FG001|Treatment Period|Lack of Efficacy|2|||
156716905|NCT02848001|565709341|FG000|Overall Study|other reasons|0|||
156716906|NCT02848001|565709342|FG001|Overall Study|other reasons|0|||
156716907|NCT02848001|565709343|FG002|Overall Study|other reasons|1|||
156716908|NCT02848001|565709344|FG003|Overall Study|other reasons|0|||
156716909|NCT02848001|565709345|FG004|Overall Study|other reasons|4|||
156716910|NCT02848001|565709346|FG005|Overall Study|other reasons|1|||
156716911|NCT02848001|565709347|FG006|Overall Study|other reasons|0|||
156716912|NCT02848001|565709348|FG007|Overall Study|other reasons|2|||
156716913|NCT02848001|565709349|FG008|Overall Study|other reasons|2|||
156716914|NCT02848001|565709350|FG009|Overall Study|other reasons|3|||
156793515|NCT04003389|565996283|FG002|Overall Study|Withdrawal by Subject|85|||
156716915|NCT02848001|565709351|FG010|Overall Study|other reasons|0|||
156716916|NCT02848001|565709352|FG011|Overall Study|other reasons|1|||
156716917|NCT02848001|565709353|FG012|Overall Study|other reasons|1|||
156716918|NCT02848001|565709354|FG013|Overall Study|other reasons|0|||
156716919|NCT02848001|565709355|FG014|Overall Study|other reasons|0|||
156716920|NCT02848001|565709356|FG015|Overall Study|other reasons|2|||
156716921|NCT02848001|565709357|FG016|Overall Study|other reasons|1|||
156716922|NCT02848001|565709341|FG000|Overall Study|Lack of Efficacy|0|||
156716923|NCT02848001|565709342|FG001|Overall Study|Lack of Efficacy|1|||
156716924|NCT02848001|565709343|FG002|Overall Study|Lack of Efficacy|1|||
156716925|NCT02848001|565709344|FG003|Overall Study|Lack of Efficacy|2|||
156716926|NCT02848001|565709345|FG004|Overall Study|Lack of Efficacy|3|||
156716927|NCT02848001|565709346|FG005|Overall Study|Lack of Efficacy|0|||
156716928|NCT02848001|565709347|FG006|Overall Study|Lack of Efficacy|1|||
156716929|NCT02848001|565709348|FG007|Overall Study|Lack of Efficacy|0|||
156716930|NCT02848001|565709349|FG008|Overall Study|Lack of Efficacy|0|||
156716931|NCT02848001|565709350|FG009|Overall Study|Lack of Efficacy|1|||
156716932|NCT02848001|565709351|FG010|Overall Study|Lack of Efficacy|0|||
157132953|NCT02440581|567234229|FG003|Overall Study|Transplanted|2|||
157132954|NCT02440581|567234226|FG000|Overall Study|Withdrawal by Subject|4|||
156716933|NCT02848001|565709352|FG011|Overall Study|Lack of Efficacy|2|||
156716934|NCT02848001|565709353|FG012|Overall Study|Lack of Efficacy|0|||
156716935|NCT02848001|565709354|FG013|Overall Study|Lack of Efficacy|2|||
156716936|NCT02848001|565709355|FG014|Overall Study|Lack of Efficacy|2|||
156716937|NCT02848001|565709356|FG015|Overall Study|Lack of Efficacy|0|||
156716938|NCT02848001|565709357|FG016|Overall Study|Lack of Efficacy|0|||
156716939|NCT02848001|565709341|FG000|Overall Study|Progressive Disease|2|||
156716940|NCT02848001|565709342|FG001|Overall Study|Progressive Disease|1|||
156716941|NCT02848001|565709343|FG002|Overall Study|Progressive Disease|0|||
156716942|NCT02848001|565709344|FG003|Overall Study|Progressive Disease|4|||
156716943|NCT02848001|565709345|FG004|Overall Study|Progressive Disease|3|||
156716944|NCT02848001|565709346|FG005|Overall Study|Progressive Disease|0|||
156716945|NCT02848001|565709347|FG006|Overall Study|Progressive Disease|4|||
156716946|NCT02848001|565709348|FG007|Overall Study|Progressive Disease|1|||
156716947|NCT02848001|565709349|FG008|Overall Study|Progressive Disease|0|||
156716948|NCT02848001|565709350|FG009|Overall Study|Progressive Disease|2|||
156716949|NCT02848001|565709351|FG010|Overall Study|Progressive Disease|3|||
156716950|NCT02848001|565709352|FG011|Overall Study|Progressive Disease|2|||
156716951|NCT02848001|565709353|FG012|Overall Study|Progressive Disease|1|||
156716952|NCT02848001|565709354|FG013|Overall Study|Progressive Disease|0|||
156716953|NCT02848001|565709355|FG014|Overall Study|Progressive Disease|2|||
156716954|NCT02848001|565709356|FG015|Overall Study|Progressive Disease|4|||
156716955|NCT02848001|565709357|FG016|Overall Study|Progressive Disease|0|||
156716956|NCT02848001|565709341|FG000|Overall Study|Adverse Event|0|||
156716957|NCT02848001|565709342|FG001|Overall Study|Adverse Event|0|||
156716958|NCT02848001|565709343|FG002|Overall Study|Adverse Event|0|||
156716959|NCT02848001|565709344|FG003|Overall Study|Adverse Event|0|||
156716960|NCT02848001|565709345|FG004|Overall Study|Adverse Event|2|||
156716961|NCT02848001|565709346|FG005|Overall Study|Adverse Event|0|||
156716962|NCT02848001|565709347|FG006|Overall Study|Adverse Event|0|||
156716963|NCT02848001|565709348|FG007|Overall Study|Adverse Event|0|||
157132955|NCT02440581|567234227|FG001|Overall Study|Withdrawal by Subject|11|||
157132956|NCT02440581|567234228|FG002|Overall Study|Withdrawal by Subject|3|||
157132957|NCT02440581|567234229|FG003|Overall Study|Withdrawal by Subject|7|||
157132958|NCT01468987|567234230|FG000|Overall Study|Adverse Event|12|||
157132959|NCT01468987|567234231|FG001|Overall Study|Adverse Event|9|||
157132960|NCT01468987|567234230|FG000|Overall Study|Death|4|||
157132961|NCT01468987|567234231|FG001|Overall Study|Death|1|||
157132962|NCT01468987|567234230|FG000|Overall Study|Lost to Follow-up|10|||
157132963|NCT01468987|567234231|FG001|Overall Study|Lost to Follow-up|5|||
157132964|NCT01468987|567234230|FG000|Overall Study|Protocol Violation|8|||
157132965|NCT01468987|567234231|FG001|Overall Study|Protocol Violation|2|||
157132966|NCT01468987|567234230|FG000|Overall Study|Withdrawal by Subject|28|||
157132967|NCT01468987|567234231|FG001|Overall Study|Withdrawal by Subject|28|||
157216994|NCT00910858|567540986|FG001|Combined Treatment Phase|Other|2|||
156716964|NCT02848001|565709349|FG008|Overall Study|Adverse Event|0|||
156716965|NCT02848001|565709350|FG009|Overall Study|Adverse Event|1|||
156716966|NCT02848001|565709351|FG010|Overall Study|Adverse Event|0|||
156716967|NCT02848001|565709352|FG011|Overall Study|Adverse Event|1|||
156716968|NCT02848001|565709353|FG012|Overall Study|Adverse Event|1|||
156716969|NCT02848001|565709354|FG013|Overall Study|Adverse Event|0|||
156716970|NCT02848001|565709355|FG014|Overall Study|Adverse Event|2|||
156716971|NCT02848001|565709356|FG015|Overall Study|Adverse Event|0|||
156716972|NCT02848001|565709357|FG016|Overall Study|Adverse Event|0|||
157216995|NCT00910858|567540987|FG002|Combined Treatment Phase|Other|1|||
156716973|NCT02848001|565709341|FG000|Overall Study|Death|0|||
156716974|NCT02848001|565709342|FG001|Overall Study|Death|0|||
156716975|NCT02848001|565709343|FG002|Overall Study|Death|0|||
156716976|NCT02848001|565709344|FG003|Overall Study|Death|1|||
156716977|NCT02848001|565709345|FG004|Overall Study|Death|3|||
157132968|NCT01468987|567234230|FG000|Overall Study|Physician Decision|8|||
156874977|NCT00485134|566300603|FG004|Overall Study|Lost to Follow-up|0|||
156874978|NCT00485134|566300604|FG005|Overall Study|Lost to Follow-up|0|||
156874979|NCT00485134|566300605|FG006|Overall Study|Lost to Follow-up|0|||
156874980|NCT00485134|566300606|FG007|Overall Study|Lost to Follow-up|0|||
156874981|NCT00485134|566300599|FG000|Overall Study|Withdrawal by Subject|0|||
156874982|NCT00485134|566300600|FG001|Overall Study|Withdrawal by Subject|1|||
156874983|NCT00485134|566300601|FG002|Overall Study|Withdrawal by Subject|0|||
156874984|NCT00485134|566300602|FG003|Overall Study|Withdrawal by Subject|0|||
156874985|NCT00485134|566300603|FG004|Overall Study|Withdrawal by Subject|0|||
156716978|NCT02848001|565709346|FG005|Overall Study|Death|1|||
156716979|NCT02848001|565709347|FG006|Overall Study|Death|2|||
156716980|NCT02848001|565709348|FG007|Overall Study|Death|3|||
156716981|NCT02848001|565709349|FG008|Overall Study|Death|4|||
156716982|NCT02848001|565709350|FG009|Overall Study|Death|1|||
156716983|NCT02848001|565709351|FG010|Overall Study|Death|0|||
156716984|NCT02848001|565709352|FG011|Overall Study|Death|1|||
156716985|NCT02848001|565709353|FG012|Overall Study|Death|3|||
156716986|NCT02848001|565709354|FG013|Overall Study|Death|0|||
156716987|NCT02848001|565709355|FG014|Overall Study|Death|2|||
156716988|NCT02848001|565709356|FG015|Overall Study|Death|3|||
156716989|NCT02848001|565709357|FG016|Overall Study|Death|0|||
156716990|NCT02848001|565709341|FG000|Overall Study|Physician Decision|0|||
156716991|NCT02848001|565709342|FG001|Overall Study|Physician Decision|0|||
156716992|NCT02848001|565709343|FG002|Overall Study|Physician Decision|0|||
156716993|NCT02848001|565709344|FG003|Overall Study|Physician Decision|0|||
156716994|NCT02848001|565709345|FG004|Overall Study|Physician Decision|0|||
156716995|NCT02848001|565709346|FG005|Overall Study|Physician Decision|0|||
156716996|NCT02848001|565709347|FG006|Overall Study|Physician Decision|0|||
156716997|NCT02848001|565709348|FG007|Overall Study|Physician Decision|0|||
156716998|NCT02848001|565709349|FG008|Overall Study|Physician Decision|1|||
156716999|NCT02848001|565709350|FG009|Overall Study|Physician Decision|1|||
156793516|NCT04003389|565996281|FG000|Overall Study|Miscellaneous|14|||
156793517|NCT04003389|565996282|FG001|Overall Study|Miscellaneous|11|||
156793518|NCT04003389|565996283|FG002|Overall Study|Miscellaneous|14|||
156793519|NCT04003389|565996281|FG000|Overall Study|Participant did not receive study drug|1|||
156793520|NCT04003389|565996282|FG001|Overall Study|Participant did not receive study drug|0|||
156793521|NCT04003389|565996283|FG002|Overall Study|Participant did not receive study drug|0|||
156793522|NCT04818229|565996284|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
156793523|NCT04818229|565996285|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
156793524|NCT04818229|565996286|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
156793525|NCT04818229|565996284|FG000|Overall Study|Adverse Event|3|||
156874986|NCT00485134|566300604|FG005|Overall Study|Withdrawal by Subject|0|||
156874987|NCT00485134|566300605|FG006|Overall Study|Withdrawal by Subject|0|||
156874988|NCT00485134|566300606|FG007|Overall Study|Withdrawal by Subject|0|||
156874989|NCT00485134|566300599|FG000|Overall Study|Change in health status|0|||
156874990|NCT00485134|566300600|FG001|Overall Study|Change in health status|1|||
156874991|NCT00485134|566300601|FG002|Overall Study|Change in health status|2|||
156874992|NCT00485134|566300602|FG003|Overall Study|Change in health status|1|||
156874993|NCT00485134|566300603|FG004|Overall Study|Change in health status|0|||
156874994|NCT00485134|566300604|FG005|Overall Study|Change in health status|1|||
156874995|NCT00485134|566300605|FG006|Overall Study|Change in health status|0|||
156874996|NCT00485134|566300606|FG007|Overall Study|Change in health status|0|||
156874997|NCT00485134|566300599|FG000|Overall Study|Withdrew for adverse event|0|||
156874998|NCT00485134|566300600|FG001|Overall Study|Withdrew for adverse event|0|||
156874999|NCT00485134|566300601|FG002|Overall Study|Withdrew for adverse event|1|||
157132969|NCT01468987|567234231|FG001|Overall Study|Physician Decision|15|||
157132970|NCT01468987|567234230|FG000|Overall Study|Sponsor Decision|1|||
157132971|NCT01468987|567234231|FG001|Overall Study|Sponsor Decision|0|||
157132972|NCT01078805|567234236|FG000|Overall Study|Clinically significant abnormal lab|5|||
157132973|NCT01078805|567234236|FG000|Overall Study|Death|134|||
156717000|NCT02848001|565709351|FG010|Overall Study|Physician Decision|0|||
156717001|NCT02848001|565709352|FG011|Overall Study|Physician Decision|0|||
157132974|NCT01078805|567234236|FG000|Overall Study|Lost to Follow-up|676|||
157132975|NCT01078805|567234236|FG000|Overall Study|Physician Decision|169|||
156717002|NCT02848001|565709353|FG012|Overall Study|Physician Decision|2|||
156717003|NCT02848001|565709354|FG013|Overall Study|Physician Decision|0|||
156717004|NCT02848001|565709355|FG014|Overall Study|Physician Decision|0|||
156717005|NCT02848001|565709356|FG015|Overall Study|Physician Decision|0|||
157132976|NCT01078805|567234236|FG000|Overall Study|Serious adverse event|26|||
156717006|NCT02848001|565709357|FG016|Overall Study|Physician Decision|0|||
156717007|NCT02848001|565709341|FG000|Overall Study|Withdrawal by Subject|0|||
156717008|NCT02848001|565709342|FG001|Overall Study|Withdrawal by Subject|0|||
156717009|NCT02848001|565709343|FG002|Overall Study|Withdrawal by Subject|0|||
156793526|NCT04818229|565996285|FG001|Overall Study|Adverse Event|1|||
156793527|NCT04818229|565996286|FG002|Overall Study|Adverse Event|1|||
156793528|NCT04818229|565996284|FG000|Overall Study|Withdrawal by Subject|0|||
156717010|NCT02848001|565709344|FG003|Overall Study|Withdrawal by Subject|0|||
156717011|NCT02848001|565709345|FG004|Overall Study|Withdrawal by Subject|0|||
156875000|NCT00485134|566300602|FG003|Overall Study|Withdrew for adverse event|0|||
156875001|NCT00485134|566300603|FG004|Overall Study|Withdrew for adverse event|0|||
156875002|NCT00485134|566300604|FG005|Overall Study|Withdrew for adverse event|0|||
156875003|NCT00485134|566300605|FG006|Overall Study|Withdrew for adverse event|0|||
156875004|NCT00485134|566300606|FG007|Overall Study|Withdrew for adverse event|0|||
156875005|NCT00485134|566300599|FG000|Overall Study|Positive drug test|0|||
156875006|NCT00485134|566300600|FG001|Overall Study|Positive drug test|0|||
156717012|NCT02848001|565709346|FG005|Overall Study|Withdrawal by Subject|1|||
156717013|NCT02848001|565709347|FG006|Overall Study|Withdrawal by Subject|1|||
156717014|NCT02848001|565709348|FG007|Overall Study|Withdrawal by Subject|1|||
156717015|NCT02848001|565709349|FG008|Overall Study|Withdrawal by Subject|0|||
156717016|NCT02848001|565709350|FG009|Overall Study|Withdrawal by Subject|0|||
156717017|NCT02848001|565709351|FG010|Overall Study|Withdrawal by Subject|0|||
156717018|NCT02848001|565709352|FG011|Overall Study|Withdrawal by Subject|0|||
156717019|NCT02848001|565709353|FG012|Overall Study|Withdrawal by Subject|0|||
156717020|NCT02848001|565709354|FG013|Overall Study|Withdrawal by Subject|0|||
156717021|NCT02848001|565709355|FG014|Overall Study|Withdrawal by Subject|0|||
156717022|NCT02848001|565709356|FG015|Overall Study|Withdrawal by Subject|0|||
156717023|NCT02848001|565709357|FG016|Overall Study|Withdrawal by Subject|0|||
156717024|NCT04358081|565709358|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
156717025|NCT04358081|565709359|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
156717026|NCT04358081|565709360|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
156717027|NCT04358081|565709358|FG000|Treatment Phase of Study|Adverse Event|1|||
156717028|NCT04358081|565709359|FG001|Treatment Phase of Study|Adverse Event|0|||
156717029|NCT04358081|565709360|FG002|Treatment Phase of Study|Adverse Event|1|||
156717030|NCT04358081|565709358|FG000|Treatment Phase of Study|Physician Decision|2|||
156717031|NCT04358081|565709359|FG001|Treatment Phase of Study|Physician Decision|0|||
156717032|NCT04358081|565709360|FG002|Treatment Phase of Study|Physician Decision|1|||
156717033|NCT04358081|565709358|FG000|Treatment Phase of Study|Protocol Violation|1|||
156717034|NCT04358081|565709359|FG001|Treatment Phase of Study|Protocol Violation|0|||
156717035|NCT04358081|565709360|FG002|Treatment Phase of Study|Protocol Violation|0|||
156717036|NCT04358081|565709358|FG000|Study Completion Phase|Death|0|||
156717037|NCT04358081|565709359|FG001|Study Completion Phase|Death|0|||
156717038|NCT04358081|565709360|FG002|Study Completion Phase|Death|1|||
156717039|NCT04358081|565709358|FG000|Study Completion Phase|Lost to Follow-up|1|||
156717040|NCT04358081|565709359|FG001|Study Completion Phase|Lost to Follow-up|0|||
156717041|NCT04358081|565709360|FG002|Study Completion Phase|Lost to Follow-up|1|||
156717042|NCT00696423|565709364|FG000|Overall Study|Lost to Follow-up|0|||
156717043|NCT00696423|565709365|FG001|Overall Study|Lost to Follow-up|5|||
156717044|NCT03989102|565709366|FG000|Year 1|Withdrawal by Subject|6|||
156717045|NCT03989102|565709367|FG001|Year 1|Withdrawal by Subject|2|||
156717046|NCT03989102|565709368|FG002|Year 1|Withdrawal by Subject|7|||
156717047|NCT03989102|565709366|FG000|Year 1|Lost to Follow-up|5|||
156717048|NCT03989102|565709367|FG001|Year 1|Lost to Follow-up|2|||
156717049|NCT03989102|565709368|FG002|Year 1|Lost to Follow-up|5|||
156717050|NCT03989102|565709366|FG000|Year 1|Subject met withdrawal criteria|1|||
156717051|NCT03989102|565709367|FG001|Year 1|Subject met withdrawal criteria|0|||
156717052|NCT03989102|565709368|FG002|Year 1|Subject met withdrawal criteria|1|||
156717053|NCT03989102|565709366|FG000|Year 2|Lost to Follow-up|7|||
156717054|NCT03989102|565709367|FG001|Year 2|Lost to Follow-up|3|||
156717055|NCT03989102|565709368|FG002|Year 2|Lost to Follow-up|4|||
156717056|NCT03989102|565709366|FG000|Year 2|Withdrawal by Subject|3|||
156717057|NCT03989102|565709367|FG001|Year 2|Withdrawal by Subject|1|||
156717058|NCT03989102|565709368|FG002|Year 2|Withdrawal by Subject|2|||
156717059|NCT03989102|565709366|FG000|Year 2|Subject non-compliant|3|||
156717060|NCT03989102|565709367|FG001|Year 2|Subject non-compliant|2|||
156717061|NCT03989102|565709368|FG002|Year 2|Subject non-compliant|0|||
156717062|NCT03989102|565709366|FG000|Year 2|Travel|1|||
156717063|NCT03989102|565709367|FG001|Year 2|Travel|0|||
156717064|NCT03989102|565709368|FG002|Year 2|Travel|1|||
156717065|NCT03989102|565709366|FG000|Year 2|P16 missing|4|||
156717066|NCT03989102|565709367|FG001|Year 2|P16 missing|2|||
156875007|NCT00485134|566300601|FG002|Overall Study|Positive drug test|0|||
156875008|NCT00485134|566300602|FG003|Overall Study|Positive drug test|0|||
157018552|NCT04757610|566821355|FG001|Overall Study|Lost to Follow-up|2|||
157018553|NCT04757610|566821356|FG002|Overall Study|Lost to Follow-up|7|||
157018554|NCT04757610|566821354|FG000|Overall Study|Physician Decision|4|||
156717067|NCT03989102|565709368|FG002|Year 2|P16 missing|1|||
156717068|NCT03989102|565709366|FG000|Year 2|P11 missing|1|||
156717069|NCT03989102|565709367|FG001|Year 2|P11 missing|3|||
156717070|NCT03989102|565709368|FG002|Year 2|P11 missing|7|||
156717071|NCT03989102|565709366|FG000|Year 2|Definitive displacement outside the study site|0|||
156875009|NCT00485134|566300603|FG004|Overall Study|Positive drug test|2|||
156717072|NCT03989102|565709367|FG001|Year 2|Definitive displacement outside the study site|1|||
156717073|NCT03989102|565709368|FG002|Year 2|Definitive displacement outside the study site|0|||
156717074|NCT03989102|565709366|FG000|Year 2|Subject missed last study visit|0|||
156875010|NCT00485134|566300604|FG005|Overall Study|Positive drug test|1|||
156717075|NCT03989102|565709367|FG001|Year 2|Subject missed last study visit|1|||
157132977|NCT01078805|567234236|FG000|Overall Study|Sponsor decision|46|||
156717076|NCT03989102|565709368|FG002|Year 2|Subject missed last study visit|0|||
156717077|NCT03989102|565709366|FG000|Year 2|Death|0|||
156717078|NCT03989102|565709367|FG001|Year 2|Death|1|||
156717079|NCT03989102|565709368|FG002|Year 2|Death|0|||
156717080|NCT03989102|565709366|FG000|Year 2|Subject not reachable|0|||
156717081|NCT03989102|565709367|FG001|Year 2|Subject not reachable|0|||
156717082|NCT03989102|565709368|FG002|Year 2|Subject not reachable|1|||
156717083|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
156717084|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
156717085|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
156717086|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717087|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717088|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
156717089|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
156717090|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
156717091|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
156717092|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
156717093|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
156717094|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
156717095|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
156717096|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
156717097|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
156717098|NCT03989102|565709366|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
156717099|NCT03989102|565709367|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
156717100|NCT03989102|565709368|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
156717101|NCT04054765|565709369|FG000|Baseline|Withdrawal by Subject|5|||
156717102|NCT04054765|565709370|FG001|Baseline|Withdrawal by Subject|3|||
156717103|NCT04054765|565709369|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
156717104|NCT04054765|565709370|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
156717105|NCT04054765|565709369|FG000|3-month Follow up|Withdrawal by Subject|0|||
156717106|NCT04054765|565709370|FG001|3-month Follow up|Withdrawal by Subject|3|||
156717107|NCT04054765|565709369|FG000|6-month Follow up|Lost to Follow-up|32|||
156717108|NCT04054765|565709370|FG001|6-month Follow up|Lost to Follow-up|32|||
156717109|NCT01290068|565709371|FG000|Overall Study|Adverse Event|1|||
156717110|NCT01290068|565709372|FG001|Overall Study|Adverse Event|3|||
156717111|NCT01290068|565709371|FG000|Overall Study|Lost to Follow-up|3|||
156717112|NCT01290068|565709372|FG001|Overall Study|Lost to Follow-up|0|||
156717113|NCT01290068|565709371|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
156717114|NCT01290068|565709372|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
156717115|NCT01290068|565709371|FG000|Overall Study|Other|3|||
156717116|NCT01290068|565709372|FG001|Overall Study|Other|1|||
156717117|NCT03283566|565709375|FG000|Overall Study|Lost to Follow-up|1|||
156717118|NCT03283566|565709376|FG001|Overall Study|Lost to Follow-up|2|||
156717119|NCT04515147|565709377|FG000|Overall Study|Withdrawal by Subject|1|||
156717120|NCT04515147|565709378|FG001|Overall Study|Withdrawal by Subject|0|||
156717121|NCT04515147|565709379|FG002|Overall Study|Withdrawal by Subject|10|||
156717122|NCT04515147|565709380|FG003|Overall Study|Withdrawal by Subject|18|||
156717123|NCT04515147|565709381|FG004|Overall Study|Withdrawal by Subject|1|||
156717124|NCT04515147|565709382|FG005|Overall Study|Withdrawal by Subject|8|||
156717125|NCT04515147|565709377|FG000|Overall Study|Lost to Follow-up|0|||
156717126|NCT04515147|565709378|FG001|Overall Study|Lost to Follow-up|1|||
156717127|NCT04515147|565709379|FG002|Overall Study|Lost to Follow-up|5|||
156717128|NCT04515147|565709380|FG003|Overall Study|Lost to Follow-up|6|||
156717129|NCT04515147|565709381|FG004|Overall Study|Lost to Follow-up|2|||
156717130|NCT04515147|565709382|FG005|Overall Study|Lost to Follow-up|1|||
156717131|NCT04515147|565709377|FG000|Overall Study|Adverse Event|0|||
156717132|NCT04515147|565709378|FG001|Overall Study|Adverse Event|0|||
156717133|NCT04515147|565709379|FG002|Overall Study|Adverse Event|0|||
156717134|NCT04515147|565709380|FG003|Overall Study|Adverse Event|2|||
156717135|NCT04515147|565709381|FG004|Overall Study|Adverse Event|0|||
157018555|NCT04757610|566821355|FG001|Overall Study|Physician Decision|1|||
157018556|NCT04757610|566821356|FG002|Overall Study|Physician Decision|2|||
157018557|NCT04757610|566821354|FG000|Overall Study|Withdrawal by Subject|26|||
157018558|NCT04757610|566821355|FG001|Overall Study|Withdrawal by Subject|25|||
157018559|NCT04757610|566821356|FG002|Overall Study|Withdrawal by Subject|25|||
156717136|NCT04515147|565709382|FG005|Overall Study|Adverse Event|0|||
156717137|NCT04515147|565709377|FG000|Overall Study|Miscellaneous|0|||
156717138|NCT04515147|565709378|FG001|Overall Study|Miscellaneous|0|||
156717139|NCT04515147|565709379|FG002|Overall Study|Miscellaneous|0|||
156717140|NCT04515147|565709380|FG003|Overall Study|Miscellaneous|1|||
157018560|NCT04757610|566821354|FG000|Overall Study|Study Terminated by Sponsor|105|||
157018561|NCT04757610|566821355|FG001|Overall Study|Study Terminated by Sponsor|105|||
157018562|NCT04757610|566821356|FG002|Overall Study|Study Terminated by Sponsor|110|||
157018563|NCT04757610|566821354|FG000|Overall Study|Randomized in Error|1|||
157132978|NCT01078805|567234236|FG000|Overall Study|Withdrawal by Subject|739|||
157132979|NCT01078805|567234236|FG000|Overall Study|Other|173|||
156717141|NCT04515147|565709381|FG004|Overall Study|Miscellaneous|0|||
156717142|NCT04515147|565709382|FG005|Overall Study|Miscellaneous|1|||
156717143|NCT01431079|565709390|FG000|Overall Study|Lost to Follow-up|35|||
156717144|NCT01431079|565709391|FG001|Overall Study|Lost to Follow-up|39|||
156717145|NCT02790437|565709392|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
156717146|NCT02790437|565709393|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
156717147|NCT02790437|565709392|FG000|Overall Study|Adverse Event|1|||
156717148|NCT02790437|565709393|FG001|Overall Study|Adverse Event|0|||
156717149|NCT02790437|565709392|FG000|Overall Study|Withdrawal by Subject|1|||
156717150|NCT02790437|565709393|FG001|Overall Study|Withdrawal by Subject|0|||
156717151|NCT01202175|565709394|FG000|Overall Study|Lost to Follow-up|2|||
156717152|NCT01202175|565709394|FG000|Overall Study|Withdrawal by Subject|1|||
156717153|NCT01202175|565709394|FG000|Overall Study|Adverse Event|2|||
156717154|NCT01626690|565709397|FG000|Overall Study|Protocol Violation|1|||
156717155|NCT01626690|565709398|FG001|Overall Study|Protocol Violation|0|||
156717156|NCT01626690|565709397|FG000|Overall Study|Adverse Event|1|||
156717157|NCT01626690|565709398|FG001|Overall Study|Adverse Event|0|||
156717158|NCT00942357|565709399|FG000|Overall Study|Ineligible|37|||
156717159|NCT00942357|565709400|FG001|Overall Study|Ineligible|40|||
156717160|NCT01321879|565709404|FG000|Overall Study|Lack of Efficacy|5|||
156717161|NCT01321879|565709404|FG000|Overall Study|Adverse Event|5|||
156717162|NCT01321879|565709404|FG000|Overall Study|Death|3|||
156717163|NCT01321879|565709404|FG000|Overall Study|Withdrawal by Subject|1|||
156717164|NCT01518322|565709411|FG000|Overall Study|FeNO measurement was missing|13|||
156717165|NCT02108912|565709415|FG000|Overall Study|Lost to Follow-up|1|||
156717166|NCT02108912|565709416|FG001|Overall Study|Lost to Follow-up|1|||
156717167|NCT02108912|565709415|FG000|Overall Study|lack of transportation|1|||
156717168|NCT02108912|565709416|FG001|Overall Study|lack of transportation|0|||
157132980|NCT01078805|567234236|FG000|Overall Study|Didn't take study drug|82|||
157132981|NCT01609842|567234237|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
156717169|NCT02108912|565709415|FG000|Overall Study|high blood pressure|1|||
156717170|NCT02108912|565709416|FG001|Overall Study|high blood pressure|0|||
156717171|NCT01876446|565709417|FG000|Overall Study|Death|0|||
156717172|NCT01876446|565709418|FG001|Overall Study|Death|1|||
156717173|NCT01876446|565709417|FG000|Overall Study|Withdrawal by Subject|1|||
156717174|NCT01876446|565709418|FG001|Overall Study|Withdrawal by Subject|2|||
156717175|NCT01876446|565709417|FG000|Overall Study|Physician Decision|1|||
156717176|NCT01876446|565709418|FG001|Overall Study|Physician Decision|3|||
156717177|NCT01808573|565709419|FG000|Overall Study|Death|212|||
156717178|NCT01808573|565709420|FG001|Overall Study|Death|240|||
156717179|NCT01808573|565709419|FG000|Overall Study|Withdrawal by Subject|12|||
156717180|NCT01808573|565709420|FG001|Overall Study|Withdrawal by Subject|10|||
156717181|NCT01808573|565709419|FG000|Overall Study|Lost to Follow-up|3|||
156717182|NCT01808573|565709420|FG001|Overall Study|Lost to Follow-up|0|||
156717183|NCT01808573|565709419|FG000|Overall Study|Discontinuation of study by sponsor|79|||
156717184|NCT01808573|565709420|FG001|Overall Study|Discontinuation of study by sponsor|64|||
156717185|NCT01808573|565709419|FG000|Overall Study|Randomized in Error|1|||
156717186|NCT01808573|565709420|FG001|Overall Study|Randomized in Error|0|||
157132982|NCT01609842|567234238|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
156717187|NCT03953612|565709421|FG000|Overall Study|Randomized but did not start|1|||
156717188|NCT03953612|565709422|FG001|Overall Study|Randomized but did not start|1|||
156717189|NCT03953612|565709423|FG002|Overall Study|Randomized but did not start|1|||
156717190|NCT03953612|565709421|FG000|Overall Study|Withdrawal by Subject|2|||
156717191|NCT03953612|565709422|FG001|Overall Study|Withdrawal by Subject|1|||
156717192|NCT03953612|565709423|FG002|Overall Study|Withdrawal by Subject|0|||
156717193|NCT03629184|565709427|FG000|Overall Study|Withdrawal by Subject|2|||
156717194|NCT03629184|565709428|FG001|Overall Study|Withdrawal by Subject|1|||
156717195|NCT03629184|565709427|FG000|Overall Study|Physician Decision|1|||
157132983|NCT02246621|567234249|FG000|Overall Study|Withdrawal by Subject|28|||
156717196|NCT03629184|565709428|FG001|Overall Study|Physician Decision|0|||
156717197|NCT01982955|565709432|FG000|Overall Study|Randomized but not treated|0|||
156717198|NCT01982955|565709433|FG001|Overall Study|Randomized but not treated|0|||
156793529|NCT04818229|565996285|FG001|Overall Study|Withdrawal by Subject|0|||
156793530|NCT04818229|565996286|FG002|Overall Study|Withdrawal by Subject|2|||
156793531|NCT04818229|565996284|FG000|Overall Study|Lost to Follow-up|0|||
156793532|NCT04818229|565996285|FG001|Overall Study|Lost to Follow-up|0|||
157132984|NCT02246621|567234250|FG001|Overall Study|Withdrawal by Subject|16|||
156717199|NCT01982955|565709434|FG002|Overall Study|Randomized but not treated|0|||
156717200|NCT01982955|565709435|FG003|Overall Study|Randomized but not treated|1|||
156717201|NCT01982955|565709436|FG004|Overall Study|Randomized but not treated|0|||
156717202|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717203|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717204|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156793533|NCT04818229|565996286|FG002|Overall Study|Lost to Follow-up|1|||
157132985|NCT02246621|567234249|FG000|Overall Study|Lost to Follow-up|1|||
156793534|NCT03186378|565996287|FG000|Overall Study|Lost to Follow-up|1|||
156717205|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717206|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
156717207|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717208|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
156717209|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
156717210|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
156717211|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
156717212|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
156717213|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
156717214|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
156717215|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
156717216|NCT01682811|565709441|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717217|NCT01682811|565709442|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717218|NCT01682811|565709443|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717219|NCT01682811|565709444|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717220|NCT01682811|565709445|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
156717221|NCT01682811|565709446|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717222|NCT01682811|565709447|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
156717223|NCT01682811|565709441|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717224|NCT01682811|565709442|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717225|NCT01682811|565709443|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717226|NCT01682811|565709444|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717227|NCT01682811|565709445|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717228|NCT01682811|565709446|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
156717229|NCT01682811|565709447|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
156717230|NCT05525520|565711572|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
156717231|NCT05525520|565711573|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
156717232|NCT05525520|565711572|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
156717233|NCT05525520|565711573|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
156717234|NCT05878093|565711576|FG000|Overall Study|Withdrawal by Subject|3|||
156717235|NCT05878093|565711577|FG001|Overall Study|Withdrawal by Subject|1|||
156717236|NCT02721732|565711578|FG000|Overall Study|Adverse Event|2|||
156717237|NCT02721732|565711579|FG001|Overall Study|Adverse Event|0|||
156717238|NCT02721732|565711580|FG002|Overall Study|Adverse Event|2|||
156717239|NCT02721732|565711581|FG003|Overall Study|Adverse Event|0|||
156717240|NCT02721732|565711582|FG004|Overall Study|Adverse Event|1|||
156717241|NCT02721732|565711583|FG005|Overall Study|Adverse Event|0|||
156717242|NCT02721732|565711584|FG006|Overall Study|Adverse Event|1|||
156717243|NCT02721732|565711585|FG007|Overall Study|Adverse Event|0|||
156717244|NCT02721732|565711586|FG008|Overall Study|Adverse Event|1|||
156717245|NCT02721732|565711587|FG009|Overall Study|Adverse Event|1|||
156717246|NCT02721732|565711578|FG000|Overall Study|Death|0|||
156717247|NCT02721732|565711579|FG001|Overall Study|Death|0|||
156717248|NCT02721732|565711580|FG002|Overall Study|Death|0|||
156717249|NCT02721732|565711581|FG003|Overall Study|Death|0|||
156717250|NCT02721732|565711582|FG004|Overall Study|Death|1|||
156717251|NCT02721732|565711583|FG005|Overall Study|Death|0|||
156717252|NCT02721732|565711584|FG006|Overall Study|Death|1|||
156717253|NCT02721732|565711585|FG007|Overall Study|Death|0|||
156717254|NCT02721732|565711586|FG008|Overall Study|Death|0|||
156717255|NCT02721732|565711587|FG009|Overall Study|Death|1|||
156717256|NCT02721732|565711578|FG000|Overall Study|Lack of Efficacy|12|||
156717257|NCT02721732|565711579|FG001|Overall Study|Lack of Efficacy|11|||
156717258|NCT02721732|565711580|FG002|Overall Study|Lack of Efficacy|18|||
156717259|NCT02721732|565711581|FG003|Overall Study|Lack of Efficacy|5|||
156717260|NCT02721732|565711582|FG004|Overall Study|Lack of Efficacy|21|||
156717261|NCT02721732|565711583|FG005|Overall Study|Lack of Efficacy|2|||
156717262|NCT02721732|565711584|FG006|Overall Study|Lack of Efficacy|8|||
156717263|NCT02721732|565711585|FG007|Overall Study|Lack of Efficacy|11|||
156717264|NCT02721732|565711586|FG008|Overall Study|Lack of Efficacy|10|||
156717265|NCT02721732|565711587|FG009|Overall Study|Lack of Efficacy|20|||
157132986|NCT02246621|567234250|FG001|Overall Study|Lost to Follow-up|0|||
157132987|NCT02246621|567234249|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
157132988|NCT02246621|567234250|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
157132989|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
157132990|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
157132991|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
156717266|NCT02721732|565711578|FG000|Overall Study|Physician Decision|0|||
156717267|NCT02721732|565711579|FG001|Overall Study|Physician Decision|0|||
156717268|NCT02721732|565711580|FG002|Overall Study|Physician Decision|1|||
156717269|NCT02721732|565711581|FG003|Overall Study|Physician Decision|0|||
156717270|NCT02721732|565711582|FG004|Overall Study|Physician Decision|0|||
156717271|NCT02721732|565711583|FG005|Overall Study|Physician Decision|0|||
156717272|NCT02721732|565711584|FG006|Overall Study|Physician Decision|0|||
156717273|NCT02721732|565711585|FG007|Overall Study|Physician Decision|0|||
156717274|NCT02721732|565711586|FG008|Overall Study|Physician Decision|0|||
156717275|NCT02721732|565711587|FG009|Overall Study|Physician Decision|0|||
156717276|NCT02721732|565711578|FG000|Overall Study|Withdrawal by Subject|1|||
156717277|NCT02721732|565711579|FG001|Overall Study|Withdrawal by Subject|0|||
156717278|NCT02721732|565711580|FG002|Overall Study|Withdrawal by Subject|0|||
156717279|NCT02721732|565711581|FG003|Overall Study|Withdrawal by Subject|0|||
156717280|NCT02721732|565711582|FG004|Overall Study|Withdrawal by Subject|3|||
156717281|NCT02721732|565711583|FG005|Overall Study|Withdrawal by Subject|0|||
156717282|NCT02721732|565711584|FG006|Overall Study|Withdrawal by Subject|1|||
156717283|NCT02721732|565711585|FG007|Overall Study|Withdrawal by Subject|1|||
156717284|NCT02721732|565711586|FG008|Overall Study|Withdrawal by Subject|0|||
156717285|NCT02721732|565711587|FG009|Overall Study|Withdrawal by Subject|1|||
156717286|NCT02721732|565711578|FG000|Overall Study|Participant Choice|1|||
156717287|NCT02721732|565711579|FG001|Overall Study|Participant Choice|0|||
156717288|NCT02721732|565711580|FG002|Overall Study|Participant Choice|0|||
156717289|NCT02721732|565711581|FG003|Overall Study|Participant Choice|0|||
156717290|NCT02721732|565711582|FG004|Overall Study|Participant Choice|0|||
156717291|NCT02721732|565711583|FG005|Overall Study|Participant Choice|0|||
156717292|NCT02721732|565711584|FG006|Overall Study|Participant Choice|0|||
156717293|NCT02721732|565711585|FG007|Overall Study|Participant Choice|0|||
156717294|NCT02721732|565711586|FG008|Overall Study|Participant Choice|0|||
156717295|NCT02721732|565711587|FG009|Overall Study|Participant Choice|1|||
156717296|NCT02721732|565711578|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717297|NCT02721732|565711579|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717298|NCT02721732|565711580|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
156717299|NCT02721732|565711581|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717300|NCT02721732|565711582|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717301|NCT02721732|565711583|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717302|NCT02721732|565711584|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717303|NCT02721732|565711585|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717304|NCT02721732|565711586|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717305|NCT02721732|565711587|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
156717306|NCT02721732|565711578|FG000|Overall Study|Progression and withdrew consent|1|||
156717307|NCT02721732|565711579|FG001|Overall Study|Progression and withdrew consent|1|||
156717308|NCT02721732|565711580|FG002|Overall Study|Progression and withdrew consent|0|||
156717309|NCT02721732|565711581|FG003|Overall Study|Progression and withdrew consent|0|||
156717310|NCT02721732|565711582|FG004|Overall Study|Progression and withdrew consent|0|||
156717311|NCT02721732|565711583|FG005|Overall Study|Progression and withdrew consent|0|||
156717312|NCT02721732|565711584|FG006|Overall Study|Progression and withdrew consent|0|||
156717313|NCT02721732|565711585|FG007|Overall Study|Progression and withdrew consent|0|||
156717314|NCT02721732|565711586|FG008|Overall Study|Progression and withdrew consent|0|||
156717315|NCT02721732|565711587|FG009|Overall Study|Progression and withdrew consent|1|||
156717316|NCT02721732|565711578|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
156717317|NCT02721732|565711579|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
156717318|NCT02721732|565711580|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
156717319|NCT02721732|565711581|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
156717320|NCT02721732|565711582|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
156717321|NCT02721732|565711583|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
156717322|NCT02721732|565711584|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
156717323|NCT02721732|565711585|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
156717324|NCT02721732|565711586|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
156717325|NCT02721732|565711587|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
156717326|NCT00725283|565711588|FG000|Overall Study|Missing Code|3|||
156717327|NCT00725283|565711588|FG000|Overall Study|Death|5|||
156717328|NCT00725283|565711588|FG000|Overall Study|Other|6|||
156717329|NCT00725283|565711588|FG000|Overall Study|Withdrawal by Subject|10|||
156717330|NCT00118157|565711589|FG000|Overall Study|Adverse Event|2|||
156793535|NCT03186378|565996288|FG001|Overall Study|Lost to Follow-up|0|||
156793536|NCT03769116|565996289|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
156793537|NCT03769116|565996290|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
156793538|NCT03769116|565996289|FG000|Part 3 - Open Label|Physician Decision|1|||
156793539|NCT03769116|565996290|FG001|Part 3 - Open Label|Physician Decision|0|||
156793540|NCT03769116|565996289|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
156793541|NCT03769116|565996290|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
156793542|NCT03382873|565996291|FG000|Overall Study|Lost to Follow-up|9|||
156793543|NCT03382873|565996292|FG001|Overall Study|Lost to Follow-up|10|||
156717331|NCT00118157|565711589|FG000|Overall Study|Death|8|||
156717332|NCT00118157|565711589|FG000|Overall Study|Withdrawal by Subject|2|||
156875011|NCT00485134|566300605|FG006|Overall Study|Positive drug test|0|||
156717333|NCT01557504|565711592|FG000|Overall Study|Physician Decision|1|||
156717334|NCT01557504|565711593|FG001|Overall Study|Physician Decision|0|||
156793544|NCT03382873|565996291|FG000|Overall Study|Withdrawal by Subject|6|||
156875012|NCT00485134|566300606|FG007|Overall Study|Positive drug test|0|||
156717335|NCT01962103|565711597|FG000|Phase 1|Adverse Event|4|||
156717336|NCT01962103|565711598|FG001|Phase 1|Adverse Event|0|||
156717337|NCT01962103|565711599|FG002|Phase 1|Adverse Event|2|||
156717338|NCT01962103|565711600|FG003|Phase 1|Adverse Event|1|||
156717339|NCT01962103|565711601|FG004|Phase 1|Adverse Event|2|||
156717340|NCT01962103|565711602|FG005|Phase 1|Adverse Event|2|||
156717341|NCT01962103|565711603|FG006|Phase 1|Adverse Event|0|||
156717342|NCT01962103|565711604|FG007|Phase 1|Adverse Event|0|||
156717343|NCT01962103|565711605|FG008|Phase 1|Adverse Event|0|||
156717344|NCT01962103|565711597|FG000|Phase 1|Progressive Disease|8|||
156717345|NCT01962103|565711598|FG001|Phase 1|Progressive Disease|6|||
156717346|NCT01962103|565711599|FG002|Phase 1|Progressive Disease|8|||
156717347|NCT01962103|565711600|FG003|Phase 1|Progressive Disease|4|||
156717348|NCT01962103|565711601|FG004|Phase 1|Progressive Disease|5|||
156717349|NCT01962103|565711602|FG005|Phase 1|Progressive Disease|4|||
156717350|NCT01962103|565711603|FG006|Phase 1|Progressive Disease|0|||
156717351|NCT01962103|565711604|FG007|Phase 1|Progressive Disease|0|||
156717352|NCT01962103|565711605|FG008|Phase 1|Progressive Disease|0|||
156717353|NCT01962103|565711597|FG000|Phase 1|Withdrawal by Subject|0|||
156717354|NCT01962103|565711598|FG001|Phase 1|Withdrawal by Subject|0|||
156717355|NCT01962103|565711599|FG002|Phase 1|Withdrawal by Subject|0|||
156717356|NCT01962103|565711600|FG003|Phase 1|Withdrawal by Subject|2|||
156717357|NCT01962103|565711601|FG004|Phase 1|Withdrawal by Subject|0|||
156717358|NCT01962103|565711602|FG005|Phase 1|Withdrawal by Subject|0|||
156717359|NCT01962103|565711603|FG006|Phase 1|Withdrawal by Subject|0|||
156717360|NCT01962103|565711604|FG007|Phase 1|Withdrawal by Subject|0|||
156717361|NCT01962103|565711605|FG008|Phase 1|Withdrawal by Subject|0|||
156717362|NCT01962103|565711597|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
156717363|NCT01962103|565711598|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
156717364|NCT01962103|565711599|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
156717365|NCT01962103|565711600|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
156717366|NCT01962103|565711601|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
156717367|NCT01962103|565711602|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
156717368|NCT01962103|565711603|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
156717369|NCT01962103|565711604|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
156717370|NCT01962103|565711605|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
156717371|NCT01962103|565711597|FG000|Phase 1|Physician Decision|0|||
156717372|NCT01962103|565711598|FG001|Phase 1|Physician Decision|0|||
156717373|NCT01962103|565711599|FG002|Phase 1|Physician Decision|0|||
156717374|NCT01962103|565711600|FG003|Phase 1|Physician Decision|1|||
156717375|NCT01962103|565711601|FG004|Phase 1|Physician Decision|0|||
156717376|NCT01962103|565711602|FG005|Phase 1|Physician Decision|0|||
156717377|NCT01962103|565711603|FG006|Phase 1|Physician Decision|0|||
156717378|NCT01962103|565711604|FG007|Phase 1|Physician Decision|0|||
156717379|NCT01962103|565711605|FG008|Phase 1|Physician Decision|0|||
156717380|NCT01962103|565711597|FG000|Phase 1|Symptomatic Deterioration|3|||
156717381|NCT01962103|565711598|FG001|Phase 1|Symptomatic Deterioration|2|||
156717382|NCT01962103|565711599|FG002|Phase 1|Symptomatic Deterioration|2|||
156717383|NCT01962103|565711600|FG003|Phase 1|Symptomatic Deterioration|2|||
156717384|NCT01962103|565711601|FG004|Phase 1|Symptomatic Deterioration|1|||
156717385|NCT01962103|565711602|FG005|Phase 1|Symptomatic Deterioration|1|||
156717386|NCT01962103|565711603|FG006|Phase 1|Symptomatic Deterioration|0|||
156717387|NCT01962103|565711604|FG007|Phase 1|Symptomatic Deterioration|0|||
156717388|NCT01962103|565711605|FG008|Phase 1|Symptomatic Deterioration|0|||
156717389|NCT01962103|565711597|FG000|Phase 1|Miscellaneous|1|||
156717390|NCT01962103|565711598|FG001|Phase 1|Miscellaneous|0|||
156717391|NCT01962103|565711599|FG002|Phase 1|Miscellaneous|0|||
156717392|NCT01962103|565711600|FG003|Phase 1|Miscellaneous|0|||
156717393|NCT01962103|565711601|FG004|Phase 1|Miscellaneous|0|||
156717394|NCT01962103|565711602|FG005|Phase 1|Miscellaneous|0|||
156717395|NCT01962103|565711603|FG006|Phase 1|Miscellaneous|0|||
156717396|NCT01962103|565711604|FG007|Phase 1|Miscellaneous|0|||
156717397|NCT01962103|565711605|FG008|Phase 1|Miscellaneous|0|||
156717398|NCT01962103|565711597|FG000|Phase 2|Adverse Event|0|||
156717399|NCT01962103|565711598|FG001|Phase 2|Adverse Event|0|||
156717400|NCT01962103|565711599|FG002|Phase 2|Adverse Event|0|||
156717401|NCT01962103|565711600|FG003|Phase 2|Adverse Event|0|||
156717402|NCT01962103|565711601|FG004|Phase 2|Adverse Event|0|||
156717403|NCT01962103|565711602|FG005|Phase 2|Adverse Event|0|||
156717404|NCT01962103|565711603|FG006|Phase 2|Adverse Event|1|||
156717405|NCT01962103|565711604|FG007|Phase 2|Adverse Event|0|||
156717406|NCT01962103|565711605|FG008|Phase 2|Adverse Event|3|||
156717407|NCT01962103|565711597|FG000|Phase 2|Progressive Disease|0|||
156717408|NCT01962103|565711598|FG001|Phase 2|Progressive Disease|0|||
156717409|NCT01962103|565711599|FG002|Phase 2|Progressive Disease|0|||
156717410|NCT01962103|565711600|FG003|Phase 2|Progressive Disease|0|||
156717411|NCT01962103|565711601|FG004|Phase 2|Progressive Disease|0|||
156717412|NCT01962103|565711602|FG005|Phase 2|Progressive Disease|0|||
156717413|NCT01962103|565711603|FG006|Phase 2|Progressive Disease|11|||
156717414|NCT01962103|565711604|FG007|Phase 2|Progressive Disease|12|||
156717415|NCT01962103|565711605|FG008|Phase 2|Progressive Disease|11|||
156717416|NCT01962103|565711597|FG000|Phase 2|Symptomatic Deterioration|0|||
156717417|NCT01962103|565711598|FG001|Phase 2|Symptomatic Deterioration|0|||
156717418|NCT01962103|565711599|FG002|Phase 2|Symptomatic Deterioration|0|||
156717419|NCT01962103|565711600|FG003|Phase 2|Symptomatic Deterioration|0|||
156717420|NCT01962103|565711601|FG004|Phase 2|Symptomatic Deterioration|0|||
156717421|NCT01962103|565711602|FG005|Phase 2|Symptomatic Deterioration|0|||
156717422|NCT01962103|565711603|FG006|Phase 2|Symptomatic Deterioration|2|||
157216996|NCT01907737|567540990|FG000|Overall Study|Withdrawal by Subject|1|||
157216997|NCT01165684|567540991|FG000|Overall Study|Adverse Event|1|||
157216998|NCT01165684|567540992|FG001|Overall Study|Adverse Event|1|||
157216999|NCT01165684|567540991|FG000|Overall Study|Lack of Efficacy|2|||
157217000|NCT01165684|567540992|FG001|Overall Study|Lack of Efficacy|1|||
157217001|NCT01165684|567540991|FG000|Overall Study|Protocol Violation|7|||
157217002|NCT01165684|567540992|FG001|Overall Study|Protocol Violation|15|||
157217003|NCT01165684|567540991|FG000|Overall Study|Withdrawal Criteria|2|||
157217004|NCT01165684|567540992|FG001|Overall Study|Withdrawal Criteria|13|||
157217005|NCT01165684|567540991|FG000|Overall Study|Unclassified|16|||
157217006|NCT01165684|567540992|FG001|Overall Study|Unclassified|22|||
157217007|NCT01886300|567540997|FG000|Overall Study|Trial terminated by sponsor|16|||
157217008|NCT00608205|567540998|FG000|Overall Study|Adverse Event|3|||
157217009|NCT00608205|567540999|FG001|Overall Study|Adverse Event|2|||
157217010|NCT00608205|567540998|FG000|Overall Study|Patient non-compliant|0|||
157217011|NCT00608205|567540999|FG001|Overall Study|Patient non-compliant|1|||
157217012|NCT02008721|567541000|FG000|Overall Study|Withdrawal by Subject|5|||
157217013|NCT02008721|567541001|FG001|Overall Study|Withdrawal by Subject|1|||
157217014|NCT02008721|567541000|FG000|Overall Study|Death|4|||
157217015|NCT02008721|567541001|FG001|Overall Study|Death|2|||
157217016|NCT02008721|567541000|FG000|Overall Study|Adverse Event|3|||
156793545|NCT03382873|565996292|FG001|Overall Study|Withdrawal by Subject|11|||
156793546|NCT03382873|565996291|FG000|Overall Study|Visit not completed due to pandemic|16|||
156793547|NCT03382873|565996292|FG001|Overall Study|Visit not completed due to pandemic|41|||
156793548|NCT04105725|565996297|FG000|Primary Intervention|Lost to Follow-up|0|||
156793549|NCT04105725|565996298|FG001|Primary Intervention|Lost to Follow-up|2|||
156793550|NCT04105725|565996297|FG000|Primary Intervention|Withdrawal by Subject|0|||
156793551|NCT04105725|565996298|FG001|Primary Intervention|Withdrawal by Subject|1|||
156717423|NCT01962103|565711604|FG007|Phase 2|Symptomatic Deterioration|2|||
156717424|NCT01962103|565711605|FG008|Phase 2|Symptomatic Deterioration|0|||
156717425|NCT01321749|565711608|FG000|Overall Study|Lost to Follow-up|4|||
156717426|NCT01321749|565711609|FG001|Overall Study|Lost to Follow-up|11|||
156717427|NCT01321749|565711608|FG000|Overall Study|Protocol Violation|4|||
156717428|NCT01321749|565711609|FG001|Overall Study|Protocol Violation|7|||
156717429|NCT01321749|565711608|FG000|Overall Study|Withdrawal by Subject|5|||
156717430|NCT01321749|565711609|FG001|Overall Study|Withdrawal by Subject|4|||
156717431|NCT04179838|565711613|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156717432|NCT04179838|565711614|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
156717433|NCT04179838|565711613|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
156717434|NCT04179838|565711614|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
156717435|NCT02763046|565711621|FG000|Overall Study|Adverse Event|5|||
156717436|NCT02763046|565711622|FG001|Overall Study|Adverse Event|4|||
156717437|NCT02763046|565711623|FG002|Overall Study|Adverse Event|0|||
156717438|NCT02763046|565711621|FG000|Overall Study|Lack of Efficacy|1|||
156717439|NCT02763046|565711622|FG001|Overall Study|Lack of Efficacy|1|||
156717440|NCT02763046|565711623|FG002|Overall Study|Lack of Efficacy|3|||
156717441|NCT02763046|565711621|FG000|Overall Study|Physician Decision|1|||
156717442|NCT02763046|565711622|FG001|Overall Study|Physician Decision|0|||
156717443|NCT02763046|565711623|FG002|Overall Study|Physician Decision|1|||
156717444|NCT02763046|565711621|FG000|Overall Study|Subject/guardian decision|2|||
156717445|NCT02763046|565711622|FG001|Overall Study|Subject/guardian decision|0|||
156793552|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
156793553|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
156793554|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156793555|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156793556|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156793557|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
156793558|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Other|2|||
156793559|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Other|1|||
156793560|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Other|1|||
156793561|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
156793562|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
157217017|NCT02008721|567541001|FG001|Overall Study|Adverse Event|5|||
156717446|NCT02763046|565711623|FG002|Overall Study|Subject/guardian decision|4|||
156717447|NCT00818766|565711628|FG000|Overall Study|Could not be Contacted on Day 28|11|||
156717448|NCT00818766|565711629|FG001|Overall Study|Could not be Contacted on Day 28|10|||
157217018|NCT02008721|567541000|FG000|Overall Study|Protocol Violation|3|||
157217019|NCT02008721|567541001|FG001|Overall Study|Protocol Violation|2|||
157217020|NCT01797120|567541004|FG000|Overall Study|Disesae progression|37|||
157217021|NCT01797120|567541005|FG001|Overall Study|Disesae progression|49|||
157132992|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132993|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132994|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132995|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132996|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132997|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
157132998|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
157132999|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
157133000|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
156717449|NCT00818766|565711628|FG000|Overall Study|Death|1|||
156717450|NCT00818766|565711629|FG001|Overall Study|Death|0|||
156717451|NCT00818766|565711628|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
156717452|NCT00818766|565711629|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
156717453|NCT00086684|565711630|FG000|Overall Study|Adverse Event|12|||
156717454|NCT00086684|565711631|FG001|Overall Study|Adverse Event|17|||
157133001|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156717455|NCT00086684|565711632|FG002|Overall Study|Adverse Event|14|||
156717456|NCT00086684|565711630|FG000|Overall Study|Lack of Efficacy|6|||
156717457|NCT00086684|565711631|FG001|Overall Study|Lack of Efficacy|6|||
156717458|NCT00086684|565711632|FG002|Overall Study|Lack of Efficacy|5|||
156717459|NCT00086684|565711630|FG000|Overall Study|Lost to Follow-up|15|||
156717460|NCT00086684|565711631|FG001|Overall Study|Lost to Follow-up|8|||
156717461|NCT00086684|565711632|FG002|Overall Study|Lost to Follow-up|10|||
156717462|NCT00086684|565711630|FG000|Overall Study|Protocol Violation|8|||
156717463|NCT00086684|565711631|FG001|Overall Study|Protocol Violation|3|||
156717464|NCT00086684|565711632|FG002|Overall Study|Protocol Violation|0|||
156717465|NCT00086684|565711630|FG000|Overall Study|Withdrawal by Subject|0|||
156717466|NCT00086684|565711631|FG001|Overall Study|Withdrawal by Subject|4|||
156717467|NCT00086684|565711632|FG002|Overall Study|Withdrawal by Subject|10|||
156717468|NCT00086684|565711630|FG000|Overall Study|NONCOMPLIANCE|5|||
156793563|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
157133002|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
157133003|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
157133004|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
157133005|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
157133006|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
157133007|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
157133008|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
157133009|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133010|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133011|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133012|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133013|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133014|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133015|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157133016|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
157133017|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
157133018|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
157133019|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133020|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133021|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133022|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133023|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133024|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
157133025|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
157133026|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
157133027|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133028|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133029|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157217022|NCT01797120|567541004|FG000|Overall Study|Adverse Event|13|||
156717469|NCT00086684|565711631|FG001|Overall Study|NONCOMPLIANCE|7|||
156717470|NCT00086684|565711632|FG002|Overall Study|NONCOMPLIANCE|6|||
156793564|NCT02691494|565996301|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156717471|NCT00086684|565711630|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156793565|NCT02691494|565996302|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156793566|NCT02691494|565996303|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156875013|NCT00485134|566300599|FG000|Overall Study|Non-compliance|0|||
156717472|NCT00086684|565711631|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
156717473|NCT00086684|565711632|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
156717474|NCT00086684|565711630|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
156717475|NCT00086684|565711631|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
156717476|NCT00086684|565711632|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
156717477|NCT00086684|565711630|FG000|Overall Study|Other|4|||
156717478|NCT00086684|565711631|FG001|Overall Study|Other|2|||
156717479|NCT00086684|565711632|FG002|Overall Study|Other|3|||
156717480|NCT01103180|565711635|FG000|Overall Study|Withdrawal by Subject|8|||
156717481|NCT01103180|565711636|FG001|Overall Study|Withdrawal by Subject|13|||
156717482|NCT01103180|565711635|FG000|Overall Study|Lost to Follow-up|13|||
156717483|NCT01103180|565711636|FG001|Overall Study|Lost to Follow-up|7|||
156717484|NCT01103180|565711635|FG000|Overall Study|Physician Decision|1|||
156717485|NCT01103180|565711636|FG001|Overall Study|Physician Decision|0|||
156717486|NCT01103180|565711635|FG000|Overall Study|Protocol Violation|0|||
156717487|NCT01103180|565711636|FG001|Overall Study|Protocol Violation|1|||
156717488|NCT01067105|565711637|FG000|Overall Study|Adverse Event|14|||
156717489|NCT01067105|565711637|FG000|Overall Study|Protocol Violation|48|||
156717490|NCT01067105|565711637|FG000|Overall Study|Withdrawal by Subject|36|||
156717491|NCT01067105|565711637|FG000|Overall Study|Lost to Follow-up|6|||
156717492|NCT01067105|565711637|FG000|Overall Study|Physician Decision|6|||
156717493|NCT01067105|565711637|FG000|Overall Study|Other|31|||
156717494|NCT02760004|565711638|FG000|Overall Study|Lost to Follow-up|13|||
156717495|NCT02760004|565711639|FG001|Overall Study|Lost to Follow-up|22|||
156717496|NCT00970593|565711640|FG000|Overall Study|Adverse Event|1|||
156717497|NCT00970593|565711641|FG001|Overall Study|Adverse Event|1|||
157133030|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133031|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133032|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133033|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
157133034|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133035|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133036|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
157133037|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133038|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133039|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133040|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133041|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133042|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157133043|NCT01583374|567234254|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133044|NCT01583374|567234255|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
157133045|NCT01583374|567234256|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133046|NCT01583374|567234257|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133047|NCT01583374|567234258|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133048|NCT01583374|567234259|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133049|NCT01583374|567234260|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133050|NCT01583374|567234261|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133051|NCT01583374|567234262|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
157133052|NCT01583374|567234254|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133053|NCT01583374|567234255|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133054|NCT01583374|567234256|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133055|NCT01583374|567234257|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133056|NCT01583374|567234258|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133057|NCT01583374|567234259|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133058|NCT01583374|567234260|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133059|NCT01583374|567234261|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
157133060|NCT01583374|567234262|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
157133061|NCT01583374|567234254|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
157133062|NCT01583374|567234255|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
157133063|NCT01583374|567234256|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
157217023|NCT01797120|567541005|FG001|Overall Study|Adverse Event|5|||
156717498|NCT00970593|565711642|FG002|Overall Study|Adverse Event|0|||
156717499|NCT00970593|565711643|FG003|Overall Study|Adverse Event|0|||
156717500|NCT00970593|565711644|FG004|Overall Study|Adverse Event|0|||
156717501|NCT00970593|565711645|FG005|Overall Study|Adverse Event|0|||
156793567|NCT02916433|565996304|FG000|Overall Study|Withdrawal by Subject|1|||
157133064|NCT01583374|567234257|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
157133065|NCT01583374|567234258|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156717502|NCT00970593|565711646|FG006|Overall Study|Adverse Event|0|||
156717503|NCT00970593|565711640|FG000|Overall Study|Discontinuation of study by sponsor|0|||
156717504|NCT00970593|565711641|FG001|Overall Study|Discontinuation of study by sponsor|0|||
156717505|NCT00970593|565711642|FG002|Overall Study|Discontinuation of study by sponsor|5|||
156717506|NCT00970593|565711643|FG003|Overall Study|Discontinuation of study by sponsor|0|||
156717507|NCT00970593|565711644|FG004|Overall Study|Discontinuation of study by sponsor|0|||
156717508|NCT00970593|565711645|FG005|Overall Study|Discontinuation of study by sponsor|0|||
156717509|NCT00970593|565711646|FG006|Overall Study|Discontinuation of study by sponsor|2|||
156717510|NCT00970593|565711640|FG000|Overall Study|Withdrawal by Subject|0|||
156717511|NCT00970593|565711641|FG001|Overall Study|Withdrawal by Subject|0|||
157133066|NCT01583374|567234259|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
157133067|NCT01583374|567234260|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
157133068|NCT01583374|567234261|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
157133069|NCT01583374|567234262|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
157133070|NCT01583374|567234254|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
157133071|NCT01583374|567234255|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
157133072|NCT01583374|567234256|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
157133073|NCT01583374|567234257|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
157133074|NCT01583374|567234258|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
157133075|NCT01583374|567234259|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
157133076|NCT01583374|567234260|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
157133077|NCT01583374|567234261|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
157133078|NCT01583374|567234262|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
157133079|NCT01583374|567234254|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133080|NCT01583374|567234255|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
157133081|NCT01583374|567234256|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
157133082|NCT01583374|567234257|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133083|NCT01583374|567234258|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
157133084|NCT01583374|567234259|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133085|NCT01583374|567234260|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133086|NCT01583374|567234261|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133087|NCT01583374|567234262|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
157133088|NCT01583374|567234254|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133089|NCT01583374|567234255|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133090|NCT01583374|567234256|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
157133091|NCT01583374|567234257|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133092|NCT01583374|567234258|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
157133093|NCT01583374|567234259|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
157133094|NCT01583374|567234260|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133095|NCT01583374|567234261|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133096|NCT01583374|567234262|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
157133097|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
157133098|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
157133099|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
157133100|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
157133101|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
157133102|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
157133103|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
157133104|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
157133105|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
157133106|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
157133107|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
157133108|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
157133109|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
157133110|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
157133111|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
157133112|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
157133113|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
157133114|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
157133115|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133116|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133117|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133118|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133119|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
157133120|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133121|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
157133122|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
156717512|NCT00970593|565711642|FG002|Overall Study|Withdrawal by Subject|1|||
156717513|NCT00970593|565711643|FG003|Overall Study|Withdrawal by Subject|0|||
156717514|NCT00970593|565711644|FG004|Overall Study|Withdrawal by Subject|0|||
156717515|NCT00970593|565711645|FG005|Overall Study|Withdrawal by Subject|0|||
156717516|NCT00970593|565711646|FG006|Overall Study|Withdrawal by Subject|0|||
156717517|NCT02439216|565711653|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
156717518|NCT02439216|565711654|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717519|NCT02439216|565711655|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717520|NCT02439216|565711656|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717521|NCT02439216|565711657|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717522|NCT02439216|565711658|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717523|NCT02439216|565711659|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717524|NCT02439216|565711660|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717525|NCT02439216|565711661|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
156717526|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717527|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717528|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717529|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717530|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717531|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717532|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717533|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
156717534|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
156717535|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717536|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717537|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717538|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717539|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717540|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717541|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
156717542|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
156717543|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
156717544|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717545|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717546|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156793568|NCT02916433|565996305|FG001|Overall Study|Withdrawal by Subject|0|||
156793569|NCT02916433|565996304|FG000|Overall Study|Physician Decision|1|||
156793570|NCT02916433|565996305|FG001|Overall Study|Physician Decision|0|||
156793571|NCT04616196|565997393|FG000|Overall Study|Progressive Disease|3|||
156793572|NCT04616196|565997394|FG001|Overall Study|Progressive Disease|0|||
157133123|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
157133124|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
157133125|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
157133126|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
157133127|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
157133128|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
157133129|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
157133130|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
157133131|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
157133132|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
157133133|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133134|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133135|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133136|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133137|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
157133138|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133139|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
157133140|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133141|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
157133142|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
157133143|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
157133144|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
157133145|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
157133146|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
157217024|NCT01797120|567541004|FG000|Overall Study|Withdrawal by Subject|6|||
156793573|NCT04616196|565997395|FG002|Overall Study|Progressive Disease|4|||
156793574|NCT04616196|565997396|FG003|Overall Study|Progressive Disease|1|||
156793575|NCT04616196|565997393|FG000|Overall Study|Death|2|||
157133147|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
157217025|NCT01797120|567541005|FG001|Overall Study|Withdrawal by Subject|6|||
157217026|NCT01797120|567541004|FG000|Overall Study|Symptomatic progression|2|||
157217027|NCT01797120|567541005|FG001|Overall Study|Symptomatic progression|1|||
157217028|NCT01797120|567541004|FG000|Overall Study|Non-compliance|1|||
157217029|NCT01797120|567541005|FG001|Overall Study|Non-compliance|0|||
157217030|NCT01797120|567541004|FG000|Overall Study|Physician Decision|3|||
157217031|NCT01797120|567541005|FG001|Overall Study|Physician Decision|0|||
157217032|NCT01797120|567541004|FG000|Overall Study|still on treatment|2|||
157217033|NCT01797120|567541005|FG001|Overall Study|still on treatment|4|||
157217034|NCT01797120|567541004|FG000|Overall Study|never start protocol therapy|2|||
157217035|NCT01797120|567541005|FG001|Overall Study|never start protocol therapy|0|||
157217036|NCT00672620|567541006|FG000|Overall Study|Adverse Event|7|||
157217037|NCT00672620|567541007|FG001|Overall Study|Adverse Event|7|||
157217038|NCT00672620|567541008|FG002|Overall Study|Adverse Event|12|||
157217039|NCT00672620|567541009|FG003|Overall Study|Adverse Event|17|||
156717547|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717548|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717549|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717550|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717551|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
156717552|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
156717553|NCT02439216|565711653|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717554|NCT02439216|565711654|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717555|NCT02439216|565711655|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717556|NCT02439216|565711656|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717557|NCT02439216|565711657|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156793576|NCT04616196|565997394|FG001|Overall Study|Death|4|||
156793577|NCT04616196|565997395|FG002|Overall Study|Death|1|||
156793578|NCT04616196|565997396|FG003|Overall Study|Death|0|||
156793579|NCT04616196|565997393|FG000|Overall Study|Withdrawal by Subject|0|||
156793580|NCT04616196|565997394|FG001|Overall Study|Withdrawal by Subject|2|||
156793581|NCT04616196|565997395|FG002|Overall Study|Withdrawal by Subject|0|||
156793582|NCT04616196|565997396|FG003|Overall Study|Withdrawal by Subject|0|||
156793583|NCT04616196|565997393|FG000|Overall Study|Lost to Follow-up|1|||
156793584|NCT04616196|565997394|FG001|Overall Study|Lost to Follow-up|0|||
156793585|NCT04616196|565997395|FG002|Overall Study|Lost to Follow-up|0|||
156793586|NCT04616196|565997396|FG003|Overall Study|Lost to Follow-up|0|||
156793587|NCT04616196|565997393|FG000|Overall Study|Sponsor request|2|||
156793588|NCT04616196|565997394|FG001|Overall Study|Sponsor request|1|||
156793589|NCT04616196|565997395|FG002|Overall Study|Sponsor request|1|||
156717558|NCT02439216|565711658|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717559|NCT02439216|565711659|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
156717560|NCT02439216|565711660|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
156717561|NCT02439216|565711661|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
156717562|NCT02094300|565711665|FG000|Overall Study|Death|7|||
156717563|NCT02094300|565711665|FG000|Overall Study|Lost to Follow-up|10|||
156717564|NCT02094300|565711665|FG000|Overall Study|Still be eligible for follow-up|3|||
156717565|NCT00470535|565711670|FG000|Overall Study|Disease Progression|13|||
156717566|NCT00470535|565711670|FG000|Overall Study|Withdrawal by Subject|1|||
156717567|NCT00470535|565711670|FG000|Overall Study|Adverse Event|1|||
156717568|NCT00470535|565711670|FG000|Overall Study|Death|1|||
156717569|NCT00470535|565711670|FG000|Overall Study|Other|2|||
156717570|NCT04123405|565711671|FG000|Overall Study|Adverse Event|1|||
156717571|NCT04123405|565711672|FG001|Overall Study|Adverse Event|2|||
156717572|NCT04123405|565711673|FG002|Overall Study|Adverse Event|3|||
156717573|NCT04123405|565711674|FG003|Overall Study|Adverse Event|3|||
156717574|NCT04123405|565711671|FG000|Overall Study|Exclusion criteria met|1|||
156717575|NCT04123405|565711672|FG001|Overall Study|Exclusion criteria met|2|||
156717576|NCT04123405|565711673|FG002|Overall Study|Exclusion criteria met|0|||
156717577|NCT04123405|565711674|FG003|Overall Study|Exclusion criteria met|2|||
156717578|NCT04123405|565711671|FG000|Overall Study|Withdrawal by Subject|1|||
156717579|NCT04123405|565711672|FG001|Overall Study|Withdrawal by Subject|3|||
156717580|NCT04123405|565711673|FG002|Overall Study|Withdrawal by Subject|0|||
156717581|NCT04123405|565711674|FG003|Overall Study|Withdrawal by Subject|2|||
156793590|NCT04616196|565997396|FG003|Overall Study|Sponsor request|2|||
156793591|NCT06790303|565997397|FG000|Overall Study|Study Terminated by sponsor|4|||
156717582|NCT04123405|565711671|FG000|Overall Study|Contact to subject lost|0|||
156717583|NCT04123405|565711672|FG001|Overall Study|Contact to subject lost|0|||
156793592|NCT06790303|565997397|FG000|Overall Study|Death|4|||
156793593|NCT02579759|565997403|FG000|Overall Study|Protocol Violation|2|||
156793594|NCT02579759|565997404|FG001|Overall Study|Protocol Violation|0|||
156793595|NCT02579759|565997405|FG002|Overall Study|Protocol Violation|0|||
156793596|NCT02579759|565997403|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
157217040|NCT00672620|567541006|FG000|Overall Study|Lack of Efficacy|1|||
157217041|NCT00672620|567541007|FG001|Overall Study|Lack of Efficacy|2|||
157133148|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
157133149|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
157133150|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
157133151|NCT01583374|567234254|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
156717584|NCT04123405|565711673|FG002|Overall Study|Contact to subject lost|0|||
156717585|NCT04123405|565711674|FG003|Overall Study|Contact to subject lost|1|||
156717586|NCT04123405|565711671|FG000|Overall Study|screening failure|1|||
156717587|NCT04123405|565711672|FG001|Overall Study|screening failure|0|||
156717588|NCT04123405|565711673|FG002|Overall Study|screening failure|0|||
156717589|NCT04123405|565711674|FG003|Overall Study|screening failure|0|||
156717590|NCT01050530|565711675|FG000|Overall Study|Adverse Event|6|||
156717591|NCT01050530|565711676|FG001|Overall Study|Adverse Event|3|||
156717592|NCT01050530|565711675|FG000|Overall Study|Lack of Efficacy|1|||
156717593|NCT01050530|565711676|FG001|Overall Study|Lack of Efficacy|4|||
156717594|NCT01050530|565711675|FG000|Overall Study|Withdrawal by Subject|0|||
156717595|NCT01050530|565711676|FG001|Overall Study|Withdrawal by Subject|3|||
156717596|NCT01050530|565711675|FG000|Overall Study|Protocol Violation|1|||
156717597|NCT01050530|565711676|FG001|Overall Study|Protocol Violation|0|||
156717598|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Physician Decision|3|||
156717599|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
156717600|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Disease Progression|1|||
156717601|NCT00545714|565711677|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
156717602|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
156717603|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
156717604|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
156793597|NCT02579759|565997404|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
156793598|NCT02579759|565997405|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
156793599|NCT02579759|565997403|FG000|Overall Study|BfArM hold|13|||
156793600|NCT02579759|565997404|FG001|Overall Study|BfArM hold|12|||
156793601|NCT02579759|565997405|FG002|Overall Study|BfArM hold|12|||
156793602|NCT02579759|565997403|FG000|Overall Study|Sponsor stopped Dose 2|0|||
156793603|NCT02579759|565997404|FG001|Overall Study|Sponsor stopped Dose 2|41|||
156793604|NCT02579759|565997405|FG002|Overall Study|Sponsor stopped Dose 2|0|||
156793605|NCT02579759|565997403|FG000|Overall Study|Non compliance|0|||
156793606|NCT02579759|565997404|FG001|Overall Study|Non compliance|1|||
156793607|NCT02579759|565997405|FG002|Overall Study|Non compliance|0|||
156793608|NCT02579759|565997403|FG000|Overall Study|Pregnancy|0|||
156793609|NCT02579759|565997404|FG001|Overall Study|Pregnancy|1|||
156793610|NCT02579759|565997405|FG002|Overall Study|Pregnancy|0|||
156793611|NCT02579759|565997403|FG000|Overall Study|Inclusion/exclusion criteria|0|||
156793612|NCT02579759|565997404|FG001|Overall Study|Inclusion/exclusion criteria|0|||
156793613|NCT02579759|565997405|FG002|Overall Study|Inclusion/exclusion criteria|1|||
156793614|NCT02579759|565997403|FG000|Overall Study|Adverse Event|4|||
156793615|NCT02579759|565997404|FG001|Overall Study|Adverse Event|3|||
156793616|NCT02579759|565997405|FG002|Overall Study|Adverse Event|1|||
156793617|NCT02579759|565997403|FG000|Overall Study|Withdrawal by Subject|3|||
156793618|NCT02579759|565997404|FG001|Overall Study|Withdrawal by Subject|3|||
156793619|NCT02579759|565997405|FG002|Overall Study|Withdrawal by Subject|5|||
156793620|NCT02579759|565997403|FG000|Overall Study|Lost to Follow-up|2|||
156793621|NCT02579759|565997404|FG001|Overall Study|Lost to Follow-up|2|||
156793622|NCT02579759|565997405|FG002|Overall Study|Lost to Follow-up|2|||
156793623|NCT00833703|565997408|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
156793624|NCT00833703|565997409|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
156793625|NCT01904279|565997412|FG000|Overall Study|Lack of Efficacy|2|||
156793626|NCT01904279|565997413|FG001|Overall Study|Lack of Efficacy|3|||
156793627|NCT01904279|565997412|FG000|Overall Study|Withdrawal by Subject|1|||
156793628|NCT01904279|565997413|FG001|Overall Study|Withdrawal by Subject|0|||
156793629|NCT03283241|565997421|FG000|Overall Study|Adverse Event|4|||
156793630|NCT03283241|565997422|FG001|Overall Study|Adverse Event|1|||
156793631|NCT03283241|565997421|FG000|Overall Study|Withdrawal by Subject|0|||
156793632|NCT03283241|565997422|FG001|Overall Study|Withdrawal by Subject|1|||
157133152|NCT01583374|567234255|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
156717605|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
156717606|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
156717607|NCT00545714|565711677|FG000|Maintenance Phase (36 Months)|Death|2|||
156793633|NCT03283241|565997421|FG000|Overall Study|Subject relocated to Finland|0|||
156793634|NCT03283241|565997422|FG001|Overall Study|Subject relocated to Finland|1|||
156793635|NCT05418426|565997423|FG000|Overall Study|Adverse Event|0|||
156793636|NCT05418426|565997424|FG001|Overall Study|Adverse Event|1|||
156793637|NCT05418426|565997425|FG002|Overall Study|Adverse Event|0|||
156793638|NCT05418426|565997423|FG000|Overall Study|Withdrawal by Subject|0|||
156793639|NCT05418426|565997424|FG001|Overall Study|Withdrawal by Subject|1|||
156793640|NCT05418426|565997425|FG002|Overall Study|Withdrawal by Subject|0|||
156793641|NCT05418426|565997423|FG000|Overall Study|Protocol Violation|0|||
156793642|NCT05418426|565997424|FG001|Overall Study|Protocol Violation|0|||
156793643|NCT05418426|565997425|FG002|Overall Study|Protocol Violation|1|||
157133153|NCT01583374|567234256|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
157133154|NCT01583374|567234257|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
157133155|NCT01583374|567234258|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
157133156|NCT01583374|567234259|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
156717608|NCT03889886|565711679|FG000|Overall Study|Other|0|||
156717609|NCT03889886|565711680|FG001|Overall Study|Other|1|||
156717610|NCT03889886|565711681|FG002|Overall Study|Other|0|||
156717611|NCT03889886|565711682|FG003|Overall Study|Other|1|||
156717612|NCT03889886|565711679|FG000|Overall Study|Withdrawal by Subject|0|||
156717613|NCT03889886|565711680|FG001|Overall Study|Withdrawal by Subject|0|||
156717614|NCT03889886|565711681|FG002|Overall Study|Withdrawal by Subject|1|||
156717615|NCT03889886|565711682|FG003|Overall Study|Withdrawal by Subject|0|||
156717616|NCT03889886|565711679|FG000|Overall Study|Adverse Event|0|||
156717617|NCT03889886|565711680|FG001|Overall Study|Adverse Event|0|||
156717618|NCT03889886|565711681|FG002|Overall Study|Adverse Event|0|||
156717619|NCT03889886|565711682|FG003|Overall Study|Adverse Event|6|||
156717620|NCT00276484|565711683|FG000|Overall Study|Adverse Event|4|||
156717621|NCT00276484|565711684|FG001|Overall Study|Adverse Event|7|||
156717622|NCT00276484|565711683|FG000|Overall Study|Lost to Follow-up|1|||
156717623|NCT00276484|565711684|FG001|Overall Study|Lost to Follow-up|1|||
156717624|NCT00276484|565711683|FG000|Overall Study|Protocol Violation|0|||
156717625|NCT00276484|565711684|FG001|Overall Study|Protocol Violation|1|||
156717626|NCT00276484|565711683|FG000|Overall Study|Withdrawal by Subject|4|||
156717627|NCT00276484|565711684|FG001|Overall Study|Withdrawal by Subject|3|||
156717628|NCT00276484|565711683|FG000|Overall Study|Could not take time off work|0|||
156717629|NCT00276484|565711684|FG001|Overall Study|Could not take time off work|1|||
156717630|NCT03347110|565711698|FG000|Overall Study|Other (Participant is incarcerated)|1|||
156717631|NCT03347110|565711698|FG000|Overall Study|Withdrawal by Subject|9|||
156717632|NCT03347110|565711698|FG000|Overall Study|Lost to Follow-up|1|||
156717633|NCT03347110|565711698|FG000|Overall Study|Lack of Efficacy|2|||
156717634|NCT03347110|565711698|FG000|Overall Study|Adverse Event, non-fatal|9|||
156717635|NCT00116779|565711699|FG000|Overall Study|Adverse Event|4|||
156717636|NCT00116779|565711700|FG001|Overall Study|Adverse Event|2|||
156717637|NCT00116779|565711699|FG000|Overall Study|Protocol Violation|1|||
156717638|NCT00116779|565711700|FG001|Overall Study|Protocol Violation|4|||
156717639|NCT00116779|565711699|FG000|Overall Study|Withdrawal by Subject|4|||
156717640|NCT00116779|565711700|FG001|Overall Study|Withdrawal by Subject|1|||
156717641|NCT00116779|565711699|FG000|Overall Study|Inadequate testosterone suppression|7|||
156717642|NCT00116779|565711700|FG001|Overall Study|Inadequate testosterone suppression|9|||
156717643|NCT00116779|565711699|FG000|Overall Study|Physician Decision|3|||
156717644|NCT00116779|565711700|FG001|Overall Study|Physician Decision|1|||
156717645|NCT00116779|565711699|FG000|Overall Study|Elevated PSA levels|2|||
156717646|NCT00116779|565711700|FG001|Overall Study|Elevated PSA levels|2|||
156717647|NCT00707239|565711701|FG000|Overall Study|Adverse Event|5|||
156717648|NCT00707239|565711702|FG001|Overall Study|Adverse Event|3|||
156717649|NCT00707239|565711703|FG002|Overall Study|Adverse Event|2|||
156717650|NCT00707239|565711701|FG000|Overall Study|Death|3|||
156717651|NCT00707239|565711702|FG001|Overall Study|Death|1|||
156717652|NCT00707239|565711703|FG002|Overall Study|Death|3|||
156717653|NCT00707239|565711701|FG000|Overall Study|Physician Decision|1|||
156717654|NCT00707239|565711702|FG001|Overall Study|Physician Decision|1|||
156717655|NCT00707239|565711703|FG002|Overall Study|Physician Decision|2|||
156717656|NCT00707239|565711701|FG000|Overall Study|Protocol Violation|0|||
156717657|NCT00707239|565711702|FG001|Overall Study|Protocol Violation|0|||
156717658|NCT00707239|565711703|FG002|Overall Study|Protocol Violation|1|||
156717659|NCT00707239|565711701|FG000|Overall Study|Lack of Efficacy|1|||
156717660|NCT00707239|565711702|FG001|Overall Study|Lack of Efficacy|2|||
156717661|NCT00707239|565711703|FG002|Overall Study|Lack of Efficacy|0|||
156717662|NCT00707239|565711701|FG000|Overall Study|Randomized, but not treated|1|||
156717663|NCT00707239|565711702|FG001|Overall Study|Randomized, but not treated|1|||
156717664|NCT00707239|565711703|FG002|Overall Study|Randomized, but not treated|1|||
156717665|NCT00707239|565711701|FG000|Overall Study|Other|8|||
156717666|NCT00707239|565711702|FG001|Overall Study|Other|3|||
156717667|NCT00707239|565711703|FG002|Overall Study|Other|5|||
156717668|NCT03652051|565711704|FG000|Stage 1|Adverse Event|0|||
156717669|NCT03652051|565711705|FG001|Stage 1|Adverse Event|5|||
156875014|NCT00485134|566300600|FG001|Overall Study|Non-compliance|0|||
157133157|NCT01583374|567234260|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
157133158|NCT01583374|567234261|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
156717670|NCT03652051|565711706|FG002|Stage 1|Adverse Event|7|||
156717671|NCT03652051|565711707|FG003|Stage 1|Adverse Event|1|||
156717672|NCT03652051|565711704|FG000|Stage 1|Withdrawal by Subject|0|||
156717673|NCT03652051|565711705|FG001|Stage 1|Withdrawal by Subject|0|||
156717674|NCT03652051|565711706|FG002|Stage 1|Withdrawal by Subject|1|||
156717675|NCT03652051|565711707|FG003|Stage 1|Withdrawal by Subject|0|||
156717676|NCT03652051|565711704|FG000|Stage 2|Adverse Event|0|||
156717677|NCT03652051|565711705|FG001|Stage 2|Adverse Event|2|||
156717678|NCT03652051|565711706|FG002|Stage 2|Adverse Event|1|||
156717679|NCT03652051|565711707|FG003|Stage 2|Adverse Event|0|||
156717680|NCT03652051|565711704|FG000|Stage 2|Protocol Violation|0|||
156717681|NCT03652051|565711705|FG001|Stage 2|Protocol Violation|1|||
156717682|NCT03652051|565711706|FG002|Stage 2|Protocol Violation|6|||
156717683|NCT03652051|565711707|FG003|Stage 2|Protocol Violation|0|||
156717684|NCT03652051|565711704|FG000|Stage 2|Lost to Follow-up|0|||
156717685|NCT03652051|565711705|FG001|Stage 2|Lost to Follow-up|2|||
156717686|NCT03652051|565711706|FG002|Stage 2|Lost to Follow-up|0|||
156717687|NCT03652051|565711707|FG003|Stage 2|Lost to Follow-up|3|||
156717688|NCT03652051|565711704|FG000|Stage 2|Withdrawal by Subject|0|||
156717689|NCT03652051|565711705|FG001|Stage 2|Withdrawal by Subject|11|||
156717690|NCT03652051|565711706|FG002|Stage 2|Withdrawal by Subject|9|||
156717691|NCT03652051|565711707|FG003|Stage 2|Withdrawal by Subject|3|||
156717692|NCT02569801|565711708|FG000|Overall Study|Withdrawal by Subject|9|||
156717693|NCT02569801|565711709|FG001|Overall Study|Withdrawal by Subject|9|||
156717694|NCT02569801|565711708|FG000|Overall Study|Sponsor Decision|13|||
156717695|NCT02569801|565711709|FG001|Overall Study|Sponsor Decision|14|||
156717696|NCT02569801|565711708|FG000|Overall Study|Progressive Disease|2|||
156717697|NCT02569801|565711709|FG001|Overall Study|Progressive Disease|7|||
156717698|NCT02569801|565711708|FG000|Overall Study|Lost to Follow-up|0|||
156717699|NCT02569801|565711709|FG001|Overall Study|Lost to Follow-up|1|||
156717700|NCT02569801|565711708|FG000|Overall Study|Death|12|||
156717701|NCT02569801|565711709|FG001|Overall Study|Death|4|||
156717702|NCT00948155|565711712|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
156717703|NCT00948155|565711713|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
156717704|NCT00948155|565711712|FG000|Washout 14 Days|Lost to Follow-up|1|||
156717705|NCT00948155|565711713|FG001|Washout 14 Days|Lost to Follow-up|2|||
156717706|NCT03404674|565711714|FG000|Overall Study|Inability to Attend Future Visits|0|||
157217042|NCT00672620|567541008|FG002|Overall Study|Lack of Efficacy|2|||
157217043|NCT00672620|567541009|FG003|Overall Study|Lack of Efficacy|0|||
157217044|NCT00672620|567541006|FG000|Overall Study|Noncompliance with Study Drug|3|||
157217045|NCT00672620|567541007|FG001|Overall Study|Noncompliance with Study Drug|4|||
157217046|NCT00672620|567541008|FG002|Overall Study|Noncompliance with Study Drug|0|||
157217047|NCT00672620|567541009|FG003|Overall Study|Noncompliance with Study Drug|2|||
157217048|NCT00672620|567541006|FG000|Overall Study|Protocol Deviations|5|||
157217049|NCT00672620|567541007|FG001|Overall Study|Protocol Deviations|7|||
157217050|NCT00672620|567541008|FG002|Overall Study|Protocol Deviations|2|||
157217051|NCT00672620|567541009|FG003|Overall Study|Protocol Deviations|5|||
157217052|NCT00672620|567541006|FG000|Overall Study|Withdrawal of Consent|6|||
157217053|NCT00672620|567541007|FG001|Overall Study|Withdrawal of Consent|12|||
157217054|NCT00672620|567541008|FG002|Overall Study|Withdrawal of Consent|5|||
156717707|NCT03404674|565711715|FG001|Overall Study|Inability to Attend Future Visits|1|||
156717708|NCT03404674|565711716|FG002|Overall Study|Inability to Attend Future Visits|1|||
156717709|NCT03404674|565711717|FG003|Overall Study|Inability to Attend Future Visits|0|||
156717710|NCT03404674|565711718|FG004|Overall Study|Inability to Attend Future Visits|0|||
156717711|NCT03404674|565711719|FG005|Overall Study|Inability to Attend Future Visits|0|||
156717712|NCT03404674|565711714|FG000|Overall Study|Behavioral Problems|0|||
156717713|NCT03404674|565711715|FG001|Overall Study|Behavioral Problems|0|||
156717714|NCT03404674|565711716|FG002|Overall Study|Behavioral Problems|1|||
156717715|NCT03404674|565711717|FG003|Overall Study|Behavioral Problems|0|||
156717716|NCT03404674|565711718|FG004|Overall Study|Behavioral Problems|0|||
156717717|NCT03404674|565711719|FG005|Overall Study|Behavioral Problems|0|||
156717718|NCT03404674|565711714|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717719|NCT03404674|565711715|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717720|NCT03404674|565711716|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
156717721|NCT03404674|565711717|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
156717722|NCT03404674|565711718|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
156793644|NCT04126174|565997430|FG000|Overall Study|Lost to Follow-up|3|||
156793645|NCT04126174|565997431|FG001|Overall Study|Lost to Follow-up|3|||
156793646|NCT03131479|565997442|FG000|Overall Study|Adverse Event|0|||
156793647|NCT03131479|565997443|FG001|Overall Study|Adverse Event|0|||
156793648|NCT03131479|565997444|FG002|Overall Study|Adverse Event|1|||
156793649|NCT03131479|565997445|FG003|Overall Study|Adverse Event|1|||
157217055|NCT00672620|567541009|FG003|Overall Study|Withdrawal of Consent|6|||
156717723|NCT03404674|565711719|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
156717724|NCT02635984|565711724|FG000|Overall Study|Lost to Follow-up|2|||
156717725|NCT02635984|565711725|FG001|Overall Study|Lost to Follow-up|4|||
156717726|NCT02635984|565711724|FG000|Overall Study|Study Arm Closed|1|||
156717727|NCT02635984|565711725|FG001|Overall Study|Study Arm Closed|0|||
156793650|NCT03131479|565997446|FG004|Overall Study|Adverse Event|0|||
156793651|NCT03131479|565997442|FG000|Overall Study|Subject/Guardian Decision|0|||
156717728|NCT01487525|565711728|FG000|Overall Study|Withdrawal by Subject|0|||
156717729|NCT01487525|565711729|FG001|Overall Study|Withdrawal by Subject|1|||
156717730|NCT01640249|565711730|FG000|Period 1|Withdrawal by Subject|1|||
156793652|NCT03131479|565997443|FG001|Overall Study|Subject/Guardian Decision|0|||
156793653|NCT03131479|565997444|FG002|Overall Study|Subject/Guardian Decision|0|||
156793654|NCT03131479|565997445|FG003|Overall Study|Subject/Guardian Decision|1|||
157217056|NCT00672620|567541006|FG000|Overall Study|Lost to Follow-up|8|||
156717731|NCT01640249|565711731|FG001|Period 1|Withdrawal by Subject|0|||
156717732|NCT01640249|565711732|FG002|Period 1|Withdrawal by Subject|0|||
156717733|NCT01640249|565711733|FG003|Period 1|Withdrawal by Subject|0|||
156717734|NCT01640249|565711734|FG004|Period 1|Withdrawal by Subject|0|||
156717735|NCT01640249|565711735|FG005|Period 1|Withdrawal by Subject|1|||
156717736|NCT01640249|565711736|FG006|Period 1|Withdrawal by Subject|0|||
156717737|NCT01870778|565711738|FG000|Overall Study|Withdrawal by Subject|8|||
156717738|NCT01870778|565711739|FG001|Overall Study|Withdrawal by Subject|7|||
156717739|NCT01870778|565711738|FG000|Overall Study|Lost to Follow-up|0|||
156717740|NCT01870778|565711739|FG001|Overall Study|Lost to Follow-up|2|||
156717741|NCT00312338|565711740|FG000|Overall Study|Adverse Event|7|||
156717742|NCT00312338|565711741|FG001|Overall Study|Adverse Event|2|||
156717743|NCT00312338|565711740|FG000|Overall Study|Lost to Follow-up|9|||
156717744|NCT00312338|565711741|FG001|Overall Study|Lost to Follow-up|1|||
156717745|NCT00312338|565711740|FG000|Overall Study|Withdrawal by Subject|4|||
156717746|NCT00312338|565711741|FG001|Overall Study|Withdrawal by Subject|0|||
156717747|NCT00312338|565711740|FG000|Overall Study|Subsequent infection|2|||
156717748|NCT00312338|565711741|FG001|Overall Study|Subsequent infection|0|||
156717749|NCT00100828|565711742|FG000|Overall Study|Physician Decision|6|||
156717750|NCT03518008|565711743|FG000|Period 2, Second Week of Wear|Family emergency|0|||
156717751|NCT03518008|565711744|FG001|Period 2, Second Week of Wear|Family emergency|1|||
156717752|NCT01215136|565711745|FG000|Overall Study|Adverse Event|2|||
156717753|NCT01215136|565711746|FG001|Overall Study|Adverse Event|9|||
157133159|NCT01583374|567234262|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
157133160|NCT01292057|567234263|FG000|Overall Study|Protocol Violation|1|||
157133161|NCT01292057|567234264|FG001|Overall Study|Protocol Violation|1|||
157133162|NCT01292057|567234263|FG000|Overall Study|Lost to Follow-up|1|||
157133163|NCT01292057|567234264|FG001|Overall Study|Lost to Follow-up|1|||
157133164|NCT03641560|567234271|FG000|Overall Study|Withdrawal by Subject|6|||
157133165|NCT03641560|567234271|FG000|Overall Study|Progressive disease|40|||
157133166|NCT03641560|567234271|FG000|Overall Study|Death|6|||
156717754|NCT01215136|565711745|FG000|Overall Study|Disease Progression|3|||
156717755|NCT01215136|565711746|FG001|Overall Study|Disease Progression|14|||
156717756|NCT01215136|565711745|FG000|Overall Study|Symptomatic Deterioration|1|||
156717757|NCT01215136|565711746|FG001|Overall Study|Symptomatic Deterioration|1|||
156717758|NCT01215136|565711745|FG000|Overall Study|Death|0|||
156717759|NCT01215136|565711746|FG001|Overall Study|Death|2|||
156717760|NCT01215136|565711745|FG000|Overall Study|Withdrawal by Subject|0|||
156717761|NCT01215136|565711746|FG001|Overall Study|Withdrawal by Subject|1|||
156717762|NCT01125917|565711751|FG000|Overall Study|Adverse Event|43|||
156717763|NCT01125917|565711751|FG000|Overall Study|Lost to Follow-up|23|||
156717764|NCT01125917|565711751|FG000|Overall Study|Withdrawal by Subject|31|||
156717765|NCT01125917|565711751|FG000|Overall Study|Administrative|223|||
156717766|NCT01125917|565711751|FG000|Overall Study|Lack of Efficacy|19|||
156717767|NCT04421131|565711755|FG000|Overall Study|Lost to Follow-up|1|||
156717768|NCT04421131|565711755|FG000|Overall Study|Protocol Violation|2|||
156717769|NCT04421131|565711755|FG000|Overall Study|App crashed|5|||
156717770|NCT02308124|565711756|FG000|Overall Study|Lost to Follow-up|6|||
156717771|NCT02308124|565711757|FG001|Overall Study|Lost to Follow-up|6|||
156717772|NCT02308124|565711758|FG002|Overall Study|Lost to Follow-up|6|||
156717773|NCT02308124|565711756|FG000|Overall Study|Adverse Event|0|||
156717774|NCT02308124|565711757|FG001|Overall Study|Adverse Event|2|||
156717775|NCT02308124|565711758|FG002|Overall Study|Adverse Event|2|||
156717776|NCT02501928|565711763|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156717777|NCT02501928|565711764|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156717778|NCT02501928|565711765|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
156717779|NCT02501928|565711766|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
156717780|NCT02501928|565711767|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
156717781|NCT02501928|565711768|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
156717782|NCT01526057|565711772|FG000|Overall Study|Withdrawal by Subject|3|||
156717783|NCT01526057|565711773|FG001|Overall Study|Withdrawal by Subject|2|||
156717784|NCT01526057|565711774|FG002|Overall Study|Withdrawal by Subject|2|||
156717785|NCT01526057|565711772|FG000|Overall Study|Adverse Event|3|||
156717786|NCT01526057|565711773|FG001|Overall Study|Adverse Event|1|||
156717787|NCT01526057|565711774|FG002|Overall Study|Adverse Event|1|||
156717788|NCT01526057|565711772|FG000|Overall Study|Death|1|||
156717789|NCT01526057|565711773|FG001|Overall Study|Death|0|||
157133167|NCT04439279|567235977|FG000|Overall Study|Adverse Event|7|||
157133168|NCT04439279|567235977|FG000|Overall Study|Death|4|||
157133169|NCT04439279|567235977|FG000|Overall Study|Disease progression|17|||
156717790|NCT01526057|565711774|FG002|Overall Study|Death|0|||
156717791|NCT01526057|565711772|FG000|Overall Study|Lost to Follow-up|1|||
156717792|NCT01526057|565711773|FG001|Overall Study|Lost to Follow-up|0|||
156717793|NCT01526057|565711774|FG002|Overall Study|Lost to Follow-up|1|||
156717794|NCT01526057|565711772|FG000|Overall Study|Other|1|||
156717795|NCT01526057|565711773|FG001|Overall Study|Other|0|||
157133170|NCT04439279|567235977|FG000|Overall Study|Complicating disease|3|||
157133171|NCT04439279|567235977|FG000|Overall Study|Withdrawal by Subject|2|||
157133172|NCT04439279|567235977|FG000|Overall Study|Ineligible|1|||
156717796|NCT01526057|565711774|FG002|Overall Study|Other|1|||
156717797|NCT01526057|565711772|FG000|Overall Study|Protocol Violation|0|||
156717798|NCT01526057|565711773|FG001|Overall Study|Protocol Violation|0|||
156717799|NCT01526057|565711774|FG002|Overall Study|Protocol Violation|1|||
156717800|NCT02553772|565711776|FG000|Overall Study|Adverse Event|2|||
156717801|NCT02553772|565711777|FG001|Overall Study|Adverse Event|3|||
156717802|NCT02553772|565711776|FG000|Overall Study|Lost to Follow-up|2|||
156717803|NCT02553772|565711777|FG001|Overall Study|Lost to Follow-up|1|||
156717804|NCT02553772|565711776|FG000|Overall Study|Withdrawal of Consent|1|||
156717805|NCT02553772|565711777|FG001|Overall Study|Withdrawal of Consent|1|||
156717806|NCT02553772|565711776|FG000|Overall Study|Lack of Efficacy|1|||
156717807|NCT02553772|565711777|FG001|Overall Study|Lack of Efficacy|0|||
156717808|NCT02553772|565711776|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156717809|NCT02553772|565711777|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156717810|NCT02189837|565711783|FG000|Overall Study|Withdrawal by Subject|2|||
156717811|NCT02189837|565711784|FG001|Overall Study|Withdrawal by Subject|1|||
156717812|NCT02189837|565711785|FG002|Overall Study|Withdrawal by Subject|3|||
156717813|NCT02189837|565711786|FG003|Overall Study|Withdrawal by Subject|1|||
156717814|NCT02189837|565711783|FG000|Overall Study|Sponsor Decision|0|||
156717815|NCT02189837|565711784|FG001|Overall Study|Sponsor Decision|0|||
156717816|NCT02189837|565711785|FG002|Overall Study|Sponsor Decision|0|||
156717817|NCT02189837|565711786|FG003|Overall Study|Sponsor Decision|1|||
156717818|NCT01461538|565711790|FG000|Overall Study|Death|15|||
156717819|NCT01461538|565711791|FG001|Overall Study|Death|6|||
156717820|NCT01461538|565711792|FG002|Overall Study|Death|2|||
156717821|NCT01461538|565711790|FG000|Overall Study|Study Stopped by Sponsor|2|||
156717822|NCT01461538|565711791|FG001|Overall Study|Study Stopped by Sponsor|1|||
156717823|NCT01461538|565711792|FG002|Overall Study|Study Stopped by Sponsor|0|||
156717824|NCT01461538|565711790|FG000|Overall Study|Withdrawal by Subject|1|||
156717825|NCT01461538|565711791|FG001|Overall Study|Withdrawal by Subject|1|||
156717826|NCT01461538|565711792|FG002|Overall Study|Withdrawal by Subject|0|||
156717827|NCT04796961|565713307|FG000|Overall Study|Lost to Follow-up|10|||
156717828|NCT04796961|565713307|FG000|Overall Study|Withdrawal by Subject|3|||
156717829|NCT04796961|565713307|FG000|Overall Study|Left Organization|10|||
156717830|NCT05655546|565713308|FG000|Overall Study|Withdrawal by Subject|2|||
156717831|NCT05655546|565713309|FG001|Overall Study|Withdrawal by Subject|4|||
156717832|NCT03493685|565713310|FG000|Overall Study|Death|4|||
156717833|NCT03493685|565713311|FG001|Overall Study|Death|3|||
156717834|NCT03493685|565713310|FG000|Overall Study|Lost to Follow-up|3|||
156717835|NCT03493685|565713311|FG001|Overall Study|Lost to Follow-up|2|||
156717836|NCT03493685|565713310|FG000|Overall Study|Physician Decision|2|||
156717837|NCT03493685|565713311|FG001|Overall Study|Physician Decision|0|||
156717838|NCT03493685|565713310|FG000|Overall Study|Withdrawal by Subject|7|||
156717839|NCT03493685|565713311|FG001|Overall Study|Withdrawal by Subject|11|||
156717840|NCT04452669|565713312|FG000|Overall Study|Death|1|||
156717841|NCT04452669|565713313|FG001|Overall Study|Death|4|||
156717842|NCT04576507|565713317|FG000|Overall Study|Adverse Event|4|||
156717843|NCT04576507|565713317|FG000|Overall Study|Withdrawal by Subject|1|||
156717844|NCT04653454|565713322|FG000|Overall Study|Withdrawal by Subject|1|||
156717845|NCT04653454|565713322|FG000|Overall Study|Physician Decision|40|||
156717846|NCT03657797|565713323|FG000|Overall Study|Lost to Follow-up|0|||
156717847|NCT03657797|565713324|FG001|Overall Study|Lost to Follow-up|1|||
156717848|NCT03657797|565713325|FG002|Overall Study|Lost to Follow-up|1|||
156717849|NCT03657797|565713326|FG003|Overall Study|Lost to Follow-up|0|||
156717850|NCT03657797|565713323|FG000|Overall Study|Physician Decision|0|||
156717851|NCT03657797|565713324|FG001|Overall Study|Physician Decision|1|||
156717852|NCT03657797|565713325|FG002|Overall Study|Physician Decision|0|||
156717853|NCT03657797|565713326|FG003|Overall Study|Physician Decision|0|||
156717854|NCT03657797|565713323|FG000|Overall Study|Withdrawal by Subject|0|||
156717855|NCT03657797|565713324|FG001|Overall Study|Withdrawal by Subject|1|||
156717856|NCT03657797|565713325|FG002|Overall Study|Withdrawal by Subject|2|||
156717857|NCT03657797|565713326|FG003|Overall Study|Withdrawal by Subject|0|||
156717858|NCT03657797|565713323|FG000|Overall Study|Adverse Event|0|||
156717859|NCT03657797|565713324|FG001|Overall Study|Adverse Event|0|||
156717860|NCT03657797|565713325|FG002|Overall Study|Adverse Event|2|||
156717861|NCT03657797|565713326|FG003|Overall Study|Adverse Event|0|||
156717862|NCT03103087|565713327|FG000|Overall Study|Did not receive any study drug|1|||
156717863|NCT03103087|565713328|FG001|Overall Study|Did not receive any study drug|0|||
156717864|NCT03103087|565713329|FG002|Overall Study|Did not receive any study drug|0|||
156717865|NCT03103087|565713327|FG000|Overall Study|Protocol Violation|1|||
156717866|NCT03103087|565713328|FG001|Overall Study|Protocol Violation|2|||
156717867|NCT03103087|565713329|FG002|Overall Study|Protocol Violation|1|||
156717868|NCT03103087|565713327|FG000|Overall Study|Lack of Efficacy|2|||
156717869|NCT03103087|565713328|FG001|Overall Study|Lack of Efficacy|1|||
156717870|NCT03103087|565713329|FG002|Overall Study|Lack of Efficacy|1|||
156717871|NCT03103087|565713327|FG000|Overall Study|Pregnancy|0|||
156717872|NCT03103087|565713328|FG001|Overall Study|Pregnancy|0|||
156717873|NCT03103087|565713329|FG002|Overall Study|Pregnancy|1|||
156717874|NCT03103087|565713327|FG000|Overall Study|Adverse Event|2|||
156717875|NCT03103087|565713328|FG001|Overall Study|Adverse Event|15|||
156717876|NCT03103087|565713329|FG002|Overall Study|Adverse Event|6|||
156717877|NCT03103087|565713327|FG000|Overall Study|Withdrawal by Subject|13|||
156717878|NCT03103087|565713328|FG001|Overall Study|Withdrawal by Subject|6|||
156717879|NCT03103087|565713329|FG002|Overall Study|Withdrawal by Subject|6|||
156717880|NCT03103087|565713327|FG000|Overall Study|Lost to Follow-up|4|||
156717881|NCT03103087|565713328|FG001|Overall Study|Lost to Follow-up|2|||
156717882|NCT03103087|565713329|FG002|Overall Study|Lost to Follow-up|7|||
156717883|NCT03103087|565713327|FG000|Overall Study|Other reason not reported|1|||
156717884|NCT03103087|565713328|FG001|Overall Study|Other reason not reported|3|||
156717885|NCT03103087|565713329|FG002|Overall Study|Other reason not reported|5|||
156717886|NCT00413699|565713330|FG000|Initial Period|Death|25|||
156717887|NCT00413699|565713331|FG001|Initial Period|Death|30|||
156717888|NCT00413699|565713332|FG002|Initial Period|Death|0|||
156717889|NCT00413699|565713330|FG000|Initial Period|Lack of Efficacy|59|||
156717890|NCT00413699|565713331|FG001|Initial Period|Lack of Efficacy|115|||
156717891|NCT00413699|565713332|FG002|Initial Period|Lack of Efficacy|0|||
156717892|NCT00413699|565713330|FG000|Initial Period|Lost to Follow-up|31|||
156717893|NCT00413699|565713331|FG001|Initial Period|Lost to Follow-up|101|||
156717894|NCT00413699|565713332|FG002|Initial Period|Lost to Follow-up|0|||
156717895|NCT00413699|565713330|FG000|Initial Period|Protocol Violation|38|||
156717896|NCT00413699|565713331|FG001|Initial Period|Protocol Violation|89|||
156717897|NCT00413699|565713332|FG002|Initial Period|Protocol Violation|0|||
156717898|NCT00413699|565713330|FG000|Initial Period|Pregnancy|10|||
156717899|NCT00413699|565713331|FG001|Initial Period|Pregnancy|8|||
156717900|NCT00413699|565713332|FG002|Initial Period|Pregnancy|0|||
156717901|NCT00413699|565713330|FG000|Initial Period|Did not meet entrance criteria|2|||
156717902|NCT00413699|565713331|FG001|Initial Period|Did not meet entrance criteria|2|||
156717903|NCT00413699|565713332|FG002|Initial Period|Did not meet entrance criteria|0|||
156717904|NCT00413699|565713330|FG000|Initial Period|Medication error without adverse event|0|||
157133173|NCT04439279|567235977|FG000|Overall Study|Treatment still ongoing|1|||
157133174|NCT02689492|567235978|FG000|Overall Study|Lost to Follow-up|61|||
157133175|NCT02689492|567235978|FG000|Overall Study|Withdrawal by Subject|11|||
157133176|NCT02689492|567235978|FG000|Overall Study|Death|9|||
157133177|NCT02689492|567235978|FG000|Overall Study|Physician Decision|2|||
157133178|NCT02689492|567235978|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
157133179|NCT02689492|567235978|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
157133180|NCT02689492|567235978|FG000|Overall Study|Other than listed|1|||
157133181|NCT02732951|567235979|FG000|Overall Study|Other than listed|1|||
157133182|NCT02732951|567235980|FG001|Overall Study|Other than listed|0|||
157133183|NCT02732951|567235979|FG000|Overall Study|Lost to Follow-up|0|||
157133184|NCT02732951|567235980|FG001|Overall Study|Lost to Follow-up|1|||
157133185|NCT02732951|567235979|FG000|Overall Study|Adverse Event|4|||
157133186|NCT02732951|567235980|FG001|Overall Study|Adverse Event|4|||
157133187|NCT02732951|567235979|FG000|Overall Study|Protocol Violation|0|||
157133188|NCT02732951|567235980|FG001|Overall Study|Protocol Violation|1|||
157133189|NCT01750918|567235981|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
157133190|NCT01750918|567235982|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
157133191|NCT01750918|567235983|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
157133192|NCT01750918|567235984|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
157133193|NCT01750918|567235985|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
157133194|NCT01750918|567235986|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
157133195|NCT01750918|567235987|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
157133196|NCT01750918|567235988|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
157133197|NCT01750918|567235981|FG000|Overall Study|Lost to Follow-up|0|||
157133198|NCT01750918|567235982|FG001|Overall Study|Lost to Follow-up|0|||
157133199|NCT01750918|567235983|FG002|Overall Study|Lost to Follow-up|2|||
157133200|NCT01750918|567235984|FG003|Overall Study|Lost to Follow-up|2|||
157133201|NCT01750918|567235985|FG004|Overall Study|Lost to Follow-up|0|||
157133202|NCT01750918|567235986|FG005|Overall Study|Lost to Follow-up|0|||
157133203|NCT01750918|567235987|FG006|Overall Study|Lost to Follow-up|0|||
157133204|NCT01750918|567235988|FG007|Overall Study|Lost to Follow-up|1|||
157133205|NCT01750918|567235981|FG000|Overall Study|Withdrawal by Subject|0|||
157133206|NCT01750918|567235982|FG001|Overall Study|Withdrawal by Subject|0|||
157133207|NCT01750918|567235983|FG002|Overall Study|Withdrawal by Subject|1|||
156717905|NCT00413699|565713331|FG001|Initial Period|Medication error without adverse event|1|||
156717906|NCT00413699|565713332|FG002|Initial Period|Medication error without adverse event|0|||
156717907|NCT00413699|565713330|FG000|Initial Period|Study terminated by Sponsor|0|||
156717908|NCT00413699|565713331|FG001|Initial Period|Study terminated by Sponsor|1|||
156717909|NCT00413699|565713332|FG002|Initial Period|Study terminated by Sponsor|0|||
156717910|NCT00413699|565713330|FG000|Initial Period|Other|67|||
157133208|NCT01750918|567235984|FG003|Overall Study|Withdrawal by Subject|2|||
157133209|NCT01750918|567235985|FG004|Overall Study|Withdrawal by Subject|1|||
157133210|NCT01750918|567235986|FG005|Overall Study|Withdrawal by Subject|1|||
157133211|NCT01750918|567235987|FG006|Overall Study|Withdrawal by Subject|2|||
157133212|NCT01750918|567235988|FG007|Overall Study|Withdrawal by Subject|2|||
156717911|NCT00413699|565713331|FG001|Initial Period|Other|211|||
157133213|NCT02031679|567235989|FG000|Overall Study|Protocol Violation|0|||
157133214|NCT02031679|567235990|FG001|Overall Study|Protocol Violation|1|||
157133215|NCT02031679|567235989|FG000|Overall Study|Lack of Efficacy|0|||
157133216|NCT02031679|567235990|FG001|Overall Study|Lack of Efficacy|1|||
157133217|NCT01974817|567235991|FG000|Overall Study|Death|4|||
157133218|NCT01974817|567235991|FG000|Overall Study|Lost to Follow-up|2|||
157133219|NCT01974817|567235991|FG000|Overall Study|Protocol Violation|2|||
157133220|NCT03658889|567235996|FG000|Overall Study|Protocol Violation|2|||
157133221|NCT03658889|567235997|FG001|Overall Study|Protocol Violation|0|||
157133222|NCT01524991|567236002|FG000|Overall Study|Adverse Event|12|||
157133223|NCT01524991|567236002|FG000|Overall Study|Death|1|||
157133224|NCT01524991|567236002|FG000|Overall Study|Disease ProgressionDu|17|||
157133225|NCT01524991|567236002|FG000|Overall Study|Other complicating disease|1|||
157133226|NCT01524991|567236002|FG000|Overall Study|Withdrawal by Subject|2|||
156717912|NCT00413699|565713332|FG002|Initial Period|Other|0|||
156717913|NCT00413699|565713330|FG000|Initial Period|Adverse event related to study drug|178|||
156717914|NCT00413699|565713331|FG001|Initial Period|Adverse event related to study drug|527|||
156717915|NCT00413699|565713332|FG002|Initial Period|Adverse event related to study drug|0|||
156717916|NCT00413699|565713330|FG000|Initial Period|Adverse event not related to study drug|113|||
156717917|NCT00413699|565713331|FG001|Initial Period|Adverse event not related to study drug|248|||
156717918|NCT00413699|565713332|FG002|Initial Period|Adverse event not related to study drug|0|||
156717919|NCT00413699|565713330|FG000|Initial Period|Missing end of study page|0|||
156717920|NCT00413699|565713331|FG001|Initial Period|Missing end of study page|4|||
156717921|NCT00413699|565713332|FG002|Initial Period|Missing end of study page|0|||
156717922|NCT00413699|565713330|FG000|Initial Period|No longer willing to participate|116|||
156717923|NCT00413699|565713331|FG001|Initial Period|No longer willing to participate|368|||
156717924|NCT00413699|565713332|FG002|Initial Period|No longer willing to participate|0|||
156717925|NCT00413699|565713330|FG000|Extension Period|No Longer Willing to Participate|0|||
156717926|NCT00413699|565713331|FG001|Extension Period|No Longer Willing to Participate|0|||
156717927|NCT00413699|565713332|FG002|Extension Period|No Longer Willing to Participate|2|||
156717928|NCT00413699|565713330|FG000|Extension Period|Protocol Violation|0|||
156717929|NCT00413699|565713331|FG001|Extension Period|Protocol Violation|0|||
156717930|NCT00413699|565713332|FG002|Extension Period|Protocol Violation|1|||
156717931|NCT00413699|565713330|FG000|Extension Period|Adverse Event|0|||
156717932|NCT00413699|565713331|FG001|Extension Period|Adverse Event|0|||
156717933|NCT00413699|565713332|FG002|Extension Period|Adverse Event|2|||
156717934|NCT02115269|565713333|FG000|Overall Study|Lost to Follow-up|43|||
156717935|NCT02115269|565713333|FG000|Overall Study|Did not complete patient diary|3|||
156717936|NCT02115269|565713333|FG000|Overall Study|Moved to another city|7|||
156717937|NCT02115269|565713333|FG000|Overall Study|Withdrawal by Subject|2|||
156717938|NCT02115269|565713333|FG000|Overall Study|Didn't take study drug|2|||
156717939|NCT00711243|565713335|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
156717940|NCT00711243|565713336|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
156717941|NCT00711243|565713337|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
156717942|NCT00711243|565713338|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
156717943|NCT00711243|565713339|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
156717944|NCT00711243|565713340|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
156717945|NCT00711243|565713335|FG000|Reached First Response/4 Cycles|Death|0|||
156717946|NCT00711243|565713336|FG001|Reached First Response/4 Cycles|Death|0|||
156717947|NCT00711243|565713337|FG002|Reached First Response/4 Cycles|Death|0|||
156717948|NCT00711243|565713338|FG003|Reached First Response/4 Cycles|Death|0|||
156717949|NCT00711243|565713339|FG004|Reached First Response/4 Cycles|Death|0|||
156717950|NCT00711243|565713340|FG005|Reached First Response/4 Cycles|Death|2|||
156717951|NCT00711243|565713335|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
156717952|NCT00711243|565713336|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
156717953|NCT00711243|565713337|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
156717954|NCT00711243|565713338|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
156717955|NCT00711243|565713339|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
156717956|NCT00711243|565713340|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
156717957|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
156717958|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
156717959|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
156717960|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
156717961|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
156717962|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
156717963|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Death|0|||
156717964|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Death|0|||
156717965|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Death|0|||
156875015|NCT00485134|566300601|FG002|Overall Study|Non-compliance|0|||
157133227|NCT01524991|567236002|FG000|Overall Study|Symptomatic Deterioration|1|||
156717966|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Death|0|||
157133228|NCT01805180|567236003|FG000|Lead-in Donor Phase|screen failure|1|||
157217057|NCT00672620|567541007|FG001|Overall Study|Lost to Follow-up|19|||
157217058|NCT00672620|567541008|FG002|Overall Study|Lost to Follow-up|8|||
157217059|NCT00672620|567541009|FG003|Overall Study|Lost to Follow-up|11|||
157217060|NCT00672620|567541006|FG000|Overall Study|Reason not Specified|3|||
157217061|NCT00672620|567541007|FG001|Overall Study|Reason not Specified|3|||
157217062|NCT00672620|567541008|FG002|Overall Study|Reason not Specified|2|||
157217063|NCT00672620|567541009|FG003|Overall Study|Reason not Specified|1|||
157217064|NCT01684722|567541010|FG000|Overall Study|Lost to Follow-up|78|||
157217065|NCT01684722|567541011|FG001|Overall Study|Lost to Follow-up|56|||
157217066|NCT01684722|567541012|FG002|Overall Study|Lost to Follow-up|75|||
157217067|NCT01684722|567541013|FG003|Overall Study|Lost to Follow-up|89|||
157217068|NCT01684722|567541010|FG000|Overall Study|Death|19|||
157217069|NCT01684722|567541011|FG001|Overall Study|Death|21|||
157217070|NCT01684722|567541012|FG002|Overall Study|Death|19|||
157217071|NCT01684722|567541013|FG003|Overall Study|Death|21|||
157217072|NCT01664494|567541014|FG000|Overall Study|Withdrawal by Subject|27|||
157217073|NCT01664494|567541014|FG000|Overall Study|Death|18|||
157217074|NCT01664494|567541014|FG000|Overall Study|Other|49|||
157217075|NCT01664494|567541014|FG000|Overall Study|Lost to Follow-up|99|||
157217076|NCT00219557|567541015|FG000|Phase 1|Lack of Efficacy|3|||
157217077|NCT00219557|567541016|FG001|Phase 1|Lack of Efficacy|0|||
157217078|NCT00219557|567541017|FG002|Phase 1|Lack of Efficacy|0|||
157217079|NCT00219557|567541015|FG000|Phase 1|Adverse Event|2|||
157217080|NCT00219557|567541016|FG001|Phase 1|Adverse Event|0|||
157217081|NCT00219557|567541017|FG002|Phase 1|Adverse Event|0|||
157217082|NCT00219557|567541015|FG000|Phase 1|Withdrawal by Subject|1|||
157217083|NCT00219557|567541016|FG001|Phase 1|Withdrawal by Subject|0|||
157217084|NCT00219557|567541017|FG002|Phase 1|Withdrawal by Subject|0|||
157217085|NCT00219557|567541015|FG000|Phase 1|Started chemotherapy at other institute|1|||
157217086|NCT00219557|567541016|FG001|Phase 1|Started chemotherapy at other institute|0|||
157217087|NCT00219557|567541017|FG002|Phase 1|Started chemotherapy at other institute|0|||
157217088|NCT00219557|567541015|FG000|Phase 2|Lack of Efficacy|0|||
157217089|NCT00219557|567541016|FG001|Phase 2|Lack of Efficacy|21|||
157217090|NCT00219557|567541017|FG002|Phase 2|Lack of Efficacy|15|||
157217091|NCT00219557|567541015|FG000|Phase 2|Adverse Event|0|||
157217092|NCT00219557|567541016|FG001|Phase 2|Adverse Event|22|||
157217093|NCT00219557|567541017|FG002|Phase 2|Adverse Event|2|||
157217094|NCT00219557|567541015|FG000|Phase 2|Death|0|||
157217095|NCT00219557|567541016|FG001|Phase 2|Death|8|||
157217096|NCT00219557|567541017|FG002|Phase 2|Death|2|||
157217097|NCT00219557|567541015|FG000|Phase 2|Other|0|||
157217098|NCT00219557|567541016|FG001|Phase 2|Other|8|||
157217099|NCT00219557|567541017|FG002|Phase 2|Other|6|||
157217100|NCT00219557|567541015|FG000|Phase 2|Withdrawal by Subject|0|||
157217101|NCT00219557|567541016|FG001|Phase 2|Withdrawal by Subject|9|||
157217102|NCT00219557|567541017|FG002|Phase 2|Withdrawal by Subject|5|||
157217103|NCT00219557|567541015|FG000|Phase 2|Treatment not received|0|||
157217104|NCT00219557|567541016|FG001|Phase 2|Treatment not received|1|||
157217105|NCT00219557|567541017|FG002|Phase 2|Treatment not received|3|||
157217106|NCT00814658|567541023|FG000|Overall Study|Lost to Follow-up|0|||
157217107|NCT00814658|567541024|FG001|Overall Study|Lost to Follow-up|1|||
157217108|NCT00814658|567541023|FG000|Overall Study|Physician Decision|1|||
157217109|NCT00814658|567541024|FG001|Overall Study|Physician Decision|0|||
157217110|NCT00814658|567541023|FG000|Overall Study|Adverse Event|3|||
157217111|NCT00814658|567541024|FG001|Overall Study|Adverse Event|3|||
157217112|NCT01141283|567541026|FG000|Overall Study|Adverse Event|56|||
157217113|NCT01141283|567541026|FG000|Overall Study|Lost to Follow-up|4|||
157217114|NCT01141283|567541026|FG000|Overall Study|Withdrawal by Subject|14|||
157217115|NCT01141283|567541026|FG000|Overall Study|Administrative|4|||
157217116|NCT01141283|567541026|FG000|Overall Study|Lack of Efficacy|10|||
157217117|NCT00545233|567541030|FG000|Overall Study|Adverse Event|10|||
157217118|NCT00545233|567541031|FG001|Overall Study|Adverse Event|5|||
157217119|NCT00545233|567541030|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
156717967|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Death|0|||
157018564|NCT04757610|566821355|FG001|Overall Study|Randomized in Error|0|||
157018565|NCT04757610|566821356|FG002|Overall Study|Randomized in Error|0|||
157018566|NCT06143670|566822827|FG000|Overall Study|Lost to Follow-up|0|||
157018567|NCT06143670|566822828|FG001|Overall Study|Lost to Follow-up|1|||
157018568|NCT06143670|566822827|FG000|Overall Study|Withdrawal by Subject|3|||
157018569|NCT06143670|566822828|FG001|Overall Study|Withdrawal by Subject|0|||
157018570|NCT03747484|566822829|FG000|Overall Study|Lack of Efficacy|0|||
157018571|NCT03747484|566822830|FG001|Overall Study|Lack of Efficacy|1|||
157018572|NCT03747484|566822831|FG002|Overall Study|Lack of Efficacy|1|||
157018573|NCT03747484|566822832|FG003|Overall Study|Lack of Efficacy|2|||
157018574|NCT03747484|566822833|FG004|Overall Study|Lack of Efficacy|2|||
157217120|NCT00545233|567541031|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
157217121|NCT00545233|567541030|FG000|Overall Study|Protocol Violation|2|||
157217122|NCT00545233|567541031|FG001|Overall Study|Protocol Violation|0|||
157217123|NCT00545233|567541030|FG000|Overall Study|Refused Treatment|9|||
157217124|NCT00545233|567541031|FG001|Overall Study|Refused Treatment|7|||
157217125|NCT00545233|567541030|FG000|Overall Study|Failure to Return|4|||
157217126|NCT00545233|567541031|FG001|Overall Study|Failure to Return|6|||
157217127|NCT00545233|567541030|FG000|Overall Study|Insufficient response|14|||
157217128|NCT00545233|567541031|FG001|Overall Study|Insufficient response|15|||
157217129|NCT00545233|567541030|FG000|Overall Study|Physician Decision|2|||
157217130|NCT00545233|567541031|FG001|Overall Study|Physician Decision|1|||
157217131|NCT06371079|567541032|FG000|Overall Study|Missing data|88|||
157217132|NCT06371079|567541033|FG001|Overall Study|Missing data|247|||
156717968|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Death|2|||
156717969|NCT00711243|565713335|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717970|NCT00711243|565713336|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717971|NCT00711243|565713337|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717972|NCT00711243|565713338|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717973|NCT00711243|565713339|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
156717974|NCT00711243|565713340|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
156717975|NCT00711243|565713335|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717976|NCT00711243|565713336|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717977|NCT00711243|565713337|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717978|NCT00711243|565713338|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717979|NCT00711243|565713339|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
156717980|NCT00711243|565713340|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
156717981|NCT05989672|565713341|FG000|Overall Study|Adverse Event|3|||
156717982|NCT05989672|565713342|FG001|Overall Study|Adverse Event|0|||
156717983|NCT05989672|565713343|FG002|Overall Study|Adverse Event|0|||
156717984|NCT03511105|565713344|FG000|Overall Study|Adverse Event|1|||
156717985|NCT03511105|565713345|FG001|Overall Study|Adverse Event|0|||
156717986|NCT03511105|565713344|FG000|Overall Study|Withdrew consent|1|||
156717987|NCT03511105|565713345|FG001|Overall Study|Withdrew consent|0|||
156717988|NCT02810457|565713346|FG000|Overall Study|Randomised but no treatment received|2|||
157217133|NCT01238211|567541034|FG000|Overall Study|Continues active treatment|31|||
157217134|NCT01238211|567541034|FG000|Overall Study|Adverse Event|7|||
157217135|NCT01238211|567541034|FG000|Overall Study|Death|4|||
157217136|NCT01238211|567541034|FG000|Overall Study|Relapse/Progression|2|||
157217137|NCT01238211|567541034|FG000|Overall Study|Withdrawal by Subject|7|||
157217138|NCT01238211|567541034|FG000|Overall Study|Non-protocol treatment|4|||
157217139|NCT01238211|567541034|FG000|Overall Study|Investigator/Patient Decision|3|||
157217140|NCT00449930|567541035|FG000|Overall Study|Adverse Event|9|||
157217141|NCT00449930|567541036|FG001|Overall Study|Adverse Event|19|||
157217142|NCT00449930|567541035|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
157217143|NCT00449930|567541036|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
157217144|NCT00449930|567541035|FG000|Overall Study|Lack of Efficacy|10|||
157217145|NCT00449930|567541036|FG001|Overall Study|Lack of Efficacy|1|||
157217146|NCT00449930|567541035|FG000|Overall Study|Lost to Follow-up|9|||
157217147|NCT00449930|567541036|FG001|Overall Study|Lost to Follow-up|14|||
157217148|NCT00449930|567541035|FG000|Overall Study|Physician Decision|1|||
157217149|NCT00449930|567541036|FG001|Overall Study|Physician Decision|2|||
157217150|NCT00449930|567541035|FG000|Overall Study|Protocol Violation|14|||
157217151|NCT00449930|567541036|FG001|Overall Study|Protocol Violation|15|||
157217152|NCT00449930|567541035|FG000|Overall Study|Withdrawal by Subject|16|||
157217153|NCT00449930|567541036|FG001|Overall Study|Withdrawal by Subject|23|||
157217154|NCT00449930|567541035|FG000|Overall Study|Glycemic discontinuation criteria|1|||
157217155|NCT00449930|567541036|FG001|Overall Study|Glycemic discontinuation criteria|1|||
157217156|NCT02746705|567541039|FG000|Overall Study|Physician Decision|1|||
157217157|NCT02746705|567541040|FG001|Overall Study|Physician Decision|1|||
157217158|NCT02746705|567541039|FG000|Overall Study|Lost to Follow-up|1|||
157217159|NCT02746705|567541040|FG001|Overall Study|Lost to Follow-up|0|||
156717989|NCT02810457|565713347|FG001|Overall Study|Randomised but no treatment received|1|||
156717990|NCT02810457|565713346|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
156717991|NCT02810457|565713347|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
156717992|NCT02810457|565713346|FG000|Overall Study|Adverse Event|37|||
156717993|NCT02810457|565713347|FG001|Overall Study|Adverse Event|43|||
156717994|NCT02810457|565713346|FG000|Overall Study|Patient decision|31|||
156717995|NCT02810457|565713347|FG001|Overall Study|Patient decision|35|||
156717996|NCT02810457|565713346|FG000|Overall Study|Patient lost to follow-up|2|||
157217160|NCT02746705|567541039|FG000|Overall Study|outlier scores deemed not valid|0|||
157217161|NCT02746705|567541040|FG001|Overall Study|outlier scores deemed not valid|1|||
157217162|NCT00479401|567541041|FG000|Overall Study|Adverse Event|24|||
157217163|NCT00479401|567541042|FG001|Overall Study|Adverse Event|20|||
157217164|NCT00479401|567541043|FG002|Overall Study|Adverse Event|4|||
157217165|NCT00479401|567541041|FG000|Overall Study|Lack of Efficacy|2|||
157217166|NCT00479401|567541042|FG001|Overall Study|Lack of Efficacy|2|||
157217167|NCT00479401|567541043|FG002|Overall Study|Lack of Efficacy|4|||
157217168|NCT00479401|567541041|FG000|Overall Study|Protocol Violation|2|||
157217169|NCT00479401|567541042|FG001|Overall Study|Protocol Violation|1|||
157217170|NCT00479401|567541043|FG002|Overall Study|Protocol Violation|1|||
157217171|NCT00479401|567541041|FG000|Overall Study|Lost to Follow-up|1|||
157217172|NCT00479401|567541042|FG001|Overall Study|Lost to Follow-up|1|||
156793655|NCT03131479|565997446|FG004|Overall Study|Subject/Guardian Decision|0|||
156793656|NCT04439903|565997451|FG000|Overall Study|Withdrawal by Subject|2|||
156793657|NCT04439903|565997451|FG000|Overall Study|Screen Failure|1|||
156793658|NCT04806373|565997454|FG000|Overall Study|Withdrawal by Subject|1|||
156793659|NCT04806373|565997455|FG001|Overall Study|Withdrawal by Subject|1|||
156793660|NCT05810597|565997456|FG000|Period 1|Adverse Event|2|||
156793661|NCT05810597|565997457|FG001|Period 1|Adverse Event|0|||
156793662|NCT05810597|565997456|FG000|Period 1|Physician Decision|1|||
156793663|NCT05810597|565997457|FG001|Period 1|Physician Decision|0|||
156793664|NCT01450631|565997458|FG000|Overall Study|Lost to Follow-up|2|||
156793665|NCT01450631|565997459|FG001|Overall Study|Lost to Follow-up|4|||
156793666|NCT01450631|565997458|FG000|Overall Study|Withdrawal by Subject|1|||
156793667|NCT01450631|565997459|FG001|Overall Study|Withdrawal by Subject|0|||
156793668|NCT05021224|565997465|FG000|Overall Study|Did not complete all survey items|4|||
156793669|NCT05021224|565997466|FG001|Overall Study|Did not complete all survey items|1|||
156793670|NCT05021224|565997467|FG002|Overall Study|Did not complete all survey items|0|||
156793671|NCT05021224|565997468|FG003|Overall Study|Did not complete all survey items|2|||
156793672|NCT03996395|565997469|FG000|Overall Study|Lost to Follow-up|4|||
156793673|NCT03996395|565997469|FG000|Overall Study|Withdrawal by Subject|1|||
156793674|NCT03996395|565997469|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
156793675|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
156793676|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793677|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793678|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
156793679|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156793680|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156793681|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156793682|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156793683|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
156793684|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
156793685|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
156793686|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
156793687|NCT05375929|565997476|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793688|NCT05375929|565997477|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
156793689|NCT05375929|565997478|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793690|NCT05375929|565997479|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
156793691|NCT05375929|565997476|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
156793692|NCT05375929|565997477|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156717997|NCT02810457|565713347|FG001|Overall Study|Patient lost to follow-up|2|||
156717998|NCT02810457|565713346|FG000|Overall Study|Death|39|||
156717999|NCT02810457|565713347|FG001|Overall Study|Death|28|||
156718000|NCT02810457|565713346|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
156718001|NCT02810457|565713347|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
156718002|NCT02810457|565713346|FG000|Overall Study|Clinical progression|15|||
156718003|NCT02810457|565713347|FG001|Overall Study|Clinical progression|16|||
156718004|NCT02810457|565713346|FG000|Overall Study|Investigator decision|3|||
156718005|NCT02810457|565713347|FG001|Overall Study|Investigator decision|2|||
156718006|NCT02810457|565713346|FG000|Overall Study|Patient ineligibility|3|||
156718007|NCT02810457|565713347|FG001|Overall Study|Patient ineligibility|0|||
156718008|NCT02810457|565713346|FG000|Overall Study|Miscalculated PD|1|||
156718009|NCT02810457|565713347|FG001|Overall Study|Miscalculated PD|0|||
156718010|NCT02810457|565713346|FG000|Overall Study|Physician Decision|0|||
156718011|NCT02810457|565713347|FG001|Overall Study|Physician Decision|1|||
156718012|NCT02750618|565713348|FG000|Overall Study|Withdrawal by Subject|1|||
156718013|NCT00853099|565713349|FG000|Double-blind Period|Adverse Event|7|||
156718014|NCT00853099|565713350|FG001|Double-blind Period|Adverse Event|9|||
156718015|NCT00853099|565713351|FG002|Double-blind Period|Adverse Event|13|||
156718016|NCT00853099|565713352|FG003|Double-blind Period|Adverse Event|0|||
156718017|NCT00853099|565713349|FG000|Double-blind Period|Withdrawal by Subject|2|||
156718018|NCT00853099|565713350|FG001|Double-blind Period|Withdrawal by Subject|3|||
156718019|NCT00853099|565713351|FG002|Double-blind Period|Withdrawal by Subject|0|||
156718020|NCT00853099|565713352|FG003|Double-blind Period|Withdrawal by Subject|0|||
156718021|NCT00853099|565713349|FG000|Double-blind Period|Lack of Efficacy|14|||
156718022|NCT00853099|565713350|FG001|Double-blind Period|Lack of Efficacy|17|||
156793693|NCT05375929|565997478|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156793694|NCT05375929|565997479|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
156793695|NCT05375929|565997476|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156718023|NCT00853099|565713351|FG002|Double-blind Period|Lack of Efficacy|16|||
156875016|NCT00485134|566300602|FG003|Overall Study|Non-compliance|0|||
156718024|NCT00853099|565713352|FG003|Double-blind Period|Lack of Efficacy|0|||
156718025|NCT00853099|565713349|FG000|Double-blind Period|Other|0|||
156718026|NCT00853099|565713350|FG001|Double-blind Period|Other|0|||
156718027|NCT00853099|565713351|FG002|Double-blind Period|Other|1|||
157133229|NCT01805180|567236004|FG001|Lead-in Donor Phase|screen failure|0|||
156718028|NCT00853099|565713352|FG003|Double-blind Period|Other|0|||
156718029|NCT00853099|565713349|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
156718030|NCT00853099|565713350|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
156718031|NCT00853099|565713351|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
157133230|NCT01805180|567236005|FG002|Lead-in Donor Phase|screen failure|0|||
157133231|NCT00928070|567236011|FG000|Overall Study|Lost to Follow-up|1|||
157133232|NCT00928070|567236012|FG001|Overall Study|Lost to Follow-up|2|||
157133233|NCT00928070|567236011|FG000|Overall Study|Withdrawal by Subject|10|||
157133234|NCT00928070|567236012|FG001|Overall Study|Withdrawal by Subject|3|||
157133235|NCT00928070|567236011|FG000|Overall Study|Adverse Event|14|||
157133236|NCT00928070|567236012|FG001|Overall Study|Adverse Event|26|||
157133237|NCT00928070|567236011|FG000|Overall Study|Lack of Efficacy|9|||
157133238|NCT00928070|567236012|FG001|Overall Study|Lack of Efficacy|5|||
157133239|NCT00928070|567236011|FG000|Overall Study|Did not meet entrance criteria|16|||
157133240|NCT00928070|567236012|FG001|Overall Study|Did not meet entrance criteria|9|||
157133241|NCT00928070|567236011|FG000|Overall Study|Protocol Violation|6|||
157133242|NCT00928070|567236012|FG001|Overall Study|Protocol Violation|5|||
157133243|NCT00928070|567236011|FG000|Overall Study|Randomized but not treated|2|||
157133244|NCT00928070|567236012|FG001|Overall Study|Randomized but not treated|2|||
157133245|NCT00928070|567236011|FG000|Overall Study|Other|5|||
157133246|NCT00928070|567236012|FG001|Overall Study|Other|5|||
157133247|NCT00862251|567236016|FG000|Overall Study|Adverse Event|8|||
157133248|NCT00862251|567236017|FG001|Overall Study|Adverse Event|3|||
157133249|NCT00862251|567236018|FG002|Overall Study|Adverse Event|1|||
157133250|NCT00862251|567236016|FG000|Overall Study|Lost to Follow-up|0|||
157133251|NCT00862251|567236017|FG001|Overall Study|Lost to Follow-up|0|||
156718032|NCT00853099|565713352|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
156718033|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
157133252|NCT00862251|567236018|FG002|Overall Study|Lost to Follow-up|1|||
157133253|NCT00862251|567236016|FG000|Overall Study|Protocol Violation|2|||
157133254|NCT00862251|567236017|FG001|Overall Study|Protocol Violation|0|||
157133255|NCT00862251|567236018|FG002|Overall Study|Protocol Violation|1|||
157133256|NCT00862251|567236016|FG000|Overall Study|Withdrawal by Subject|9|||
157133257|NCT00862251|567236017|FG001|Overall Study|Withdrawal by Subject|2|||
157133258|NCT00862251|567236018|FG002|Overall Study|Withdrawal by Subject|6|||
157133259|NCT02796755|567236019|FG000|Overall Study|Adverse Event|2|||
157133260|NCT02796755|567236020|FG001|Overall Study|Adverse Event|0|||
157133261|NCT03049449|567236021|FG000|Overall Study|Did not receive treatment.|0|||
157133262|NCT03049449|567236022|FG001|Overall Study|Did not receive treatment.|0|||
157133263|NCT03049449|567236023|FG002|Overall Study|Did not receive treatment.|0|||
157133264|NCT03049449|567236024|FG003|Overall Study|Did not receive treatment.|0|||
157133265|NCT03049449|567236025|FG004|Overall Study|Did not receive treatment.|0|||
157133266|NCT03049449|567236026|FG005|Overall Study|Did not receive treatment.|0|||
157133267|NCT03049449|567236027|FG006|Overall Study|Did not receive treatment.|0|||
157133268|NCT03049449|567236028|FG007|Overall Study|Did not receive treatment.|0|||
157133269|NCT03049449|567236029|FG008|Overall Study|Did not receive treatment.|1|||
157133270|NCT03049449|567236030|FG009|Overall Study|Did not receive treatment.|0|||
157133271|NCT03049449|567236021|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
157133272|NCT03049449|567236022|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
157133273|NCT03049449|567236023|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
157133274|NCT03049449|567236024|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
157133275|NCT03049449|567236025|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
157133276|NCT03049449|567236026|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
157133277|NCT03049449|567236027|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
157133278|NCT03049449|567236028|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
157133279|NCT03049449|567236029|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
157133280|NCT03049449|567236030|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
157133281|NCT03049449|567236021|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133282|NCT03049449|567236022|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133283|NCT03049449|567236023|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133284|NCT03049449|567236024|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133285|NCT03049449|567236025|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133286|NCT03049449|567236026|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133287|NCT03049449|567236027|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133288|NCT03049449|567236028|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
157145170|NCT05755438|567278012|FG000|40-week OLE Period|Withdrawal by Subject|6|||
156718034|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
156793696|NCT05375929|565997477|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
156793697|NCT05375929|565997478|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156793698|NCT05375929|565997479|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
156793699|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793700|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793701|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
156793702|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
156793703|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793704|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793705|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
156793706|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
156793707|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793708|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793709|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
156793710|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
156793711|NCT05375929|565997476|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793712|NCT05375929|565997477|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793713|NCT05375929|565997478|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
156793714|NCT05375929|565997479|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
156793715|NCT03301415|565997480|FG000|Overall Study|Lost to Follow-up|2|||
156793716|NCT03301415|565997480|FG000|Overall Study|Unable to comply with visit schedule|2|||
156793717|NCT00392288|565997481|FG000|Overall Study|Adverse Event|17|||
156793718|NCT00392288|565997482|FG001|Overall Study|Adverse Event|7|||
156793719|NCT00392288|565997483|FG002|Overall Study|Adverse Event|8|||
156793720|NCT00392288|565997481|FG000|Overall Study|Lack of Efficacy|8|||
156793721|NCT00392288|565997482|FG001|Overall Study|Lack of Efficacy|5|||
156793722|NCT00392288|565997483|FG002|Overall Study|Lack of Efficacy|3|||
156793723|NCT00392288|565997481|FG000|Overall Study|Protocol Violation|1|||
156793724|NCT00392288|565997482|FG001|Overall Study|Protocol Violation|3|||
156793725|NCT00392288|565997483|FG002|Overall Study|Protocol Violation|1|||
156793726|NCT00392288|565997481|FG000|Overall Study|Lost to Follow-up|1|||
156793727|NCT00392288|565997482|FG001|Overall Study|Lost to Follow-up|1|||
157133289|NCT03049449|567236029|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
157133290|NCT03049449|567236030|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
157133291|NCT02304926|567236032|FG000|Overall Study|Lost to Follow-up|2|||
157133292|NCT02304926|567236033|FG001|Overall Study|Lost to Follow-up|1|||
157133293|NCT04007159|567236035|FG000|Induction Phase|(missed study visits)|16|||
157133294|NCT04007159|567236035|FG000|Induction Phase|Withdrawal by Subject|4|||
156793728|NCT00392288|565997483|FG002|Overall Study|Lost to Follow-up|1|||
156793729|NCT00392288|565997481|FG000|Overall Study|Withdrawal by Subject|1|||
156793730|NCT00392288|565997482|FG001|Overall Study|Withdrawal by Subject|0|||
156793731|NCT00392288|565997483|FG002|Overall Study|Withdrawal by Subject|2|||
156793732|NCT00392288|565997481|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
156793733|NCT00392288|565997482|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
156793734|NCT00392288|565997483|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
156793735|NCT00392288|565997481|FG000|Overall Study|Other|3|||
156793736|NCT00392288|565997482|FG001|Overall Study|Other|4|||
156793737|NCT00392288|565997483|FG002|Overall Study|Other|1|||
156793738|NCT04755231|565997486|FG000|Overall Study|Lost to Follow-up|5|||
156793739|NCT04755231|565997486|FG000|Overall Study|Withdrawal by Subject|5|||
156793740|NCT00025233|565997490|FG000|Overall Study|Ineligible: wrong cell type|1|||
156793741|NCT00025233|565997490|FG000|Overall Study|Ineligible: wrong primary|1|||
156793742|NCT00025233|565997490|FG000|Overall Study|Ineligible: improper prior treatment|1|||
156793743|NCT00025233|565997490|FG000|Overall Study|Never treated|1|||
156793744|NCT01720602|565997491|FG000|Overall Study|Adverse Event|3|||
156793745|NCT01720602|565997491|FG000|Overall Study|Progressive disease on therapy|2|||
156793746|NCT02184442|565997492|FG000|Overall Study|Death|61|||
156793747|NCT02184442|565997493|FG001|Overall Study|Death|65|||
156793748|NCT02184442|565997492|FG000|Overall Study|Withdrawal by Subject|3|||
156793749|NCT02184442|565997493|FG001|Overall Study|Withdrawal by Subject|11|||
157133295|NCT04007159|567236035|FG000|Induction Phase|Adverse Event|2|||
157133296|NCT04007159|567236035|FG000|Challenge Phase|missed study visits|3|||
157133297|NCT04258579|567236036|FG000|Overall Study|Withdrawal by Subject|7|||
157133298|NCT04258579|567236036|FG000|Overall Study|Lost to Follow-up|3|||
156793750|NCT00787800|565997495|FG000|Overall Study|Withdrawal by Subject|3|||
156793751|NCT00787800|565997496|FG001|Overall Study|Withdrawal by Subject|5|||
156793752|NCT00787800|565997495|FG000|Overall Study|Death|0|||
156793753|NCT00787800|565997496|FG001|Overall Study|Death|2|||
156793754|NCT00507507|565997502|FG000|Treatment Period|Lost to Follow-up|0|||
156793755|NCT00507507|565997503|FG001|Treatment Period|Lost to Follow-up|2|||
156793756|NCT00507507|565997502|FG000|Treatment Period|Physician Decision|4|||
156793757|NCT00507507|565997503|FG001|Treatment Period|Physician Decision|1|||
156793758|NCT00507507|565997502|FG000|Treatment Period|Protocol Violation|1|||
157217173|NCT00479401|567541043|FG002|Overall Study|Lost to Follow-up|1|||
157217174|NCT00479401|567541041|FG000|Overall Study|Withdrawal by Subject|16|||
157217175|NCT00479401|567541042|FG001|Overall Study|Withdrawal by Subject|10|||
157217176|NCT00479401|567541043|FG002|Overall Study|Withdrawal by Subject|2|||
157217177|NCT00479401|567541041|FG000|Overall Study|Exclusion criteria, relocation|4|||
157217178|NCT00479401|567541042|FG001|Overall Study|Exclusion criteria, relocation|3|||
157217179|NCT00479401|567541043|FG002|Overall Study|Exclusion criteria, relocation|0|||
157217180|NCT02124746|567541044|FG000|Overall Study|Adverse Event|2|||
157217181|NCT02124746|567541045|FG001|Overall Study|Adverse Event|1|||
157217182|NCT02124746|567541046|FG002|Overall Study|Adverse Event|2|||
157217183|NCT02124746|567541044|FG000|Overall Study|Death|2|||
157217184|NCT02124746|567541045|FG001|Overall Study|Death|1|||
157217185|NCT02124746|567541046|FG002|Overall Study|Death|3|||
157217186|NCT02124746|567541044|FG000|Overall Study|Lack of Efficacy|3|||
157217187|NCT02124746|567541045|FG001|Overall Study|Lack of Efficacy|2|||
157217188|NCT02124746|567541046|FG002|Overall Study|Lack of Efficacy|2|||
157217189|NCT02124746|567541044|FG000|Overall Study|Physician Decision|6|||
157217190|NCT02124746|567541045|FG001|Overall Study|Physician Decision|4|||
157217191|NCT02124746|567541046|FG002|Overall Study|Physician Decision|5|||
157217192|NCT02124746|567541044|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157217193|NCT02124746|567541045|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157217194|NCT02124746|567541046|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157217195|NCT02124746|567541044|FG000|Overall Study|Withdrawal by Subject|3|||
157217196|NCT02124746|567541045|FG001|Overall Study|Withdrawal by Subject|3|||
157217197|NCT02124746|567541046|FG002|Overall Study|Withdrawal by Subject|0|||
157217198|NCT02124746|567541044|FG000|Overall Study|Study Terminated by Sponsor|0|||
157217199|NCT02124746|567541045|FG001|Overall Study|Study Terminated by Sponsor|0|||
157217200|NCT02124746|567541046|FG002|Overall Study|Study Terminated by Sponsor|6|||
157217201|NCT02124746|567541044|FG000|Overall Study|Disease Progression|3|||
157217202|NCT02124746|567541045|FG001|Overall Study|Disease Progression|6|||
157217203|NCT02124746|567541046|FG002|Overall Study|Disease Progression|4|||
157217204|NCT05288673|567541047|FG000|Overall Study|Consent withdrawn by subject|0|||
157217205|NCT05288673|567541048|FG001|Overall Study|Consent withdrawn by subject|0|||
157217206|NCT05288673|567541049|FG002|Overall Study|Consent withdrawn by subject|1|||
157217207|NCT03210259|567541052|FG000|12-Week Run-in Period|Adverse Event|1|||
157217208|NCT03210259|567541053|FG001|12-Week Run-in Period|Adverse Event|0|||
157217209|NCT03210259|567541054|FG002|12-Week Run-in Period|Adverse Event|0|||
157217210|NCT03210259|567541052|FG000|12-Week Run-in Period|Death|1|||
157217211|NCT03210259|567541053|FG001|12-Week Run-in Period|Death|0|||
157217212|NCT03210259|567541054|FG002|12-Week Run-in Period|Death|0|||
157217213|NCT03210259|567541052|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
157217214|NCT03210259|567541053|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
157217215|NCT03210259|567541054|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
157217216|NCT03210259|567541052|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
157217217|NCT03210259|567541053|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
157217218|NCT03210259|567541054|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
157217219|NCT03210259|567541052|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
157217220|NCT03210259|567541053|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
157217221|NCT03210259|567541054|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
157217222|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
157217223|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
157217224|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
156718035|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
156718036|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
156718037|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
156718038|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
156718039|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
156718040|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
156718041|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
156718042|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
157217225|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
157217226|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
157217227|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
157217228|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
157217229|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
156793759|NCT00507507|565997503|FG001|Treatment Period|Protocol Violation|2|||
157217230|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
157217231|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
157217232|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
157217233|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
157217234|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
157217235|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
157217236|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
156718043|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
156718044|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
156718045|NCT00853099|565713349|FG000|Double-blind + Open-label Periods|Other|0|||
156718046|NCT00853099|565713350|FG001|Double-blind + Open-label Periods|Other|0|||
156718047|NCT00853099|565713351|FG002|Double-blind + Open-label Periods|Other|0|||
156718048|NCT00853099|565713352|FG003|Double-blind + Open-label Periods|Other|6|||
156718049|NCT02203357|565713356|FG000|Overall Study|Lost to Follow-up|58|||
156718050|NCT02203357|565713357|FG001|Overall Study|Lost to Follow-up|66|||
156718051|NCT02203357|565713358|FG002|Overall Study|Lost to Follow-up|70|||
156718052|NCT02687451|565713361|FG000|Overall Study|Withdrawal by Subject|1|||
156718053|NCT02687451|565713362|FG001|Overall Study|Withdrawal by Subject|0|||
156718054|NCT02687451|565713363|FG002|Overall Study|Withdrawal by Subject|0|||
156718055|NCT02687451|565713364|FG003|Overall Study|Withdrawal by Subject|0|||
156718056|NCT02687451|565713365|FG004|Overall Study|Withdrawal by Subject|0|||
156718057|NCT02687451|565713366|FG005|Overall Study|Withdrawal by Subject|1|||
156718058|NCT01778530|565713367|FG000|Overall Study|Progression on study|1|||
156718059|NCT01778530|565713367|FG000|Overall Study|Adverse event/side effect|1|||
156718060|NCT03472014|565713368|FG000|Overall Study|Lost to Follow-up|4|||
156718061|NCT00711087|565713369|FG000|Overall Study|Lost to Follow-up|1|||
157018575|NCT03833245|566822840|FG000|Overall Study|Death|0|||
157018576|NCT03833245|566822841|FG001|Overall Study|Death|1|||
157018577|NCT03347383|566822842|FG000|Overall Study|Death|39|||
157018578|NCT03347383|566822842|FG000|Overall Study|Withdrawal by Subject|3|||
157018579|NCT03347383|566822842|FG000|Overall Study|Lost to Follow-up|9|||
156718062|NCT00711087|565713370|FG001|Overall Study|Lost to Follow-up|0|||
156793760|NCT00507507|565997502|FG000|Treatment Period|Adverse Event|1|||
156793761|NCT00507507|565997503|FG001|Treatment Period|Adverse Event|1|||
156793762|NCT00507507|565997502|FG000|Treatment Period|Withdrawal by Subject|46|||
157018580|NCT02630823|566822847|FG000|Overall Study|Withdrawal by Subject|1|||
157018581|NCT02630823|566822847|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
157018582|NCT04833777|566822849|FG000|Overall Study|Lost to Follow-up|1|||
157018583|NCT04833777|566822850|FG001|Overall Study|Lost to Follow-up|0|||
157018584|NCT05062265|566822853|FG000|Overall Study|Withdrawal by Subject|1|||
157018585|NCT05062265|566822854|FG001|Overall Study|Withdrawal by Subject|0|||
157018586|NCT04630262|566822858|FG000|Overall Study|Intraoperative Screen Failure|5|||
157018587|NCT04630262|566822858|FG000|Overall Study|Study terminated prematurely|71|||
157018588|NCT04630262|566822858|FG000|Overall Study|Withdrawal by Subject|2|||
157018589|NCT04630262|566822858|FG000|Overall Study|Physician Decision|2|||
157018590|NCT02662062|566822859|FG000|Overall Study|Withdrawal by Subject|1|||
157018591|NCT03988634|566822860|FG000|Double-Blind|Adverse Event|4|||
157018592|NCT03988634|566822861|FG001|Double-Blind|Adverse Event|0|||
157018593|NCT03988634|566822862|FG002|Double-Blind|Adverse Event|0|||
157018594|NCT03988634|566822860|FG000|Double-Blind|Death|18|||
157018595|NCT03988634|566822861|FG001|Double-Blind|Death|26|||
157018596|NCT03988634|566822862|FG002|Double-Blind|Death|0|||
157018597|NCT03988634|566822860|FG000|Double-Blind|Lost to Follow-up|6|||
157018598|NCT03988634|566822861|FG001|Double-Blind|Lost to Follow-up|7|||
157018599|NCT03988634|566822862|FG002|Double-Blind|Lost to Follow-up|0|||
157018600|NCT03988634|566822860|FG000|Double-Blind|Physician Decision|9|||
157018601|NCT03988634|566822861|FG001|Double-Blind|Physician Decision|5|||
157018602|NCT03988634|566822862|FG002|Double-Blind|Physician Decision|0|||
157018603|NCT03988634|566822860|FG000|Double-Blind|Subject decision|24|||
157018604|NCT03988634|566822861|FG001|Double-Blind|Subject decision|13|||
157018605|NCT03988634|566822862|FG002|Double-Blind|Subject decision|0|||
157018606|NCT03988634|566822860|FG000|Open-Label|Adverse Event|0|||
157018607|NCT03988634|566822861|FG001|Open-Label|Adverse Event|0|||
157018608|NCT03988634|566822862|FG002|Open-Label|Adverse Event|7|||
157018609|NCT03988634|566822860|FG000|Open-Label|Physician Decision|0|||
157018610|NCT03988634|566822861|FG001|Open-Label|Physician Decision|0|||
157018611|NCT03988634|566822862|FG002|Open-Label|Physician Decision|1|||
157018612|NCT03988634|566822860|FG000|Open-Label|Technical problems|0|||
157018613|NCT03988634|566822861|FG001|Open-Label|Technical problems|0|||
157018614|NCT03988634|566822862|FG002|Open-Label|Technical problems|1|||
157018615|NCT05374837|566822863|FG000|Overall Study|Lost to Follow-up|17|||
157018616|NCT05374837|566822864|FG001|Overall Study|Lost to Follow-up|18|||
157018617|NCT00676715|566822872|FG000|Treatment Period (TP)|Adverse Event|0|||
157018618|NCT00676715|566822873|FG001|Treatment Period (TP)|Adverse Event|3|||
157018619|NCT00676715|566822874|FG002|Treatment Period (TP)|Adverse Event|2|||
157018620|NCT00676715|566822875|FG003|Treatment Period (TP)|Adverse Event|2|||
157018621|NCT00676715|566822872|FG000|Treatment Period (TP)|Death|0|||
157018622|NCT00676715|566822873|FG001|Treatment Period (TP)|Death|0|||
157018623|NCT00676715|566822874|FG002|Treatment Period (TP)|Death|1|||
157018624|NCT00676715|566822875|FG003|Treatment Period (TP)|Death|0|||
157018625|NCT00676715|566822872|FG000|Treatment Period (TP)|Failure to return|1|||
157018626|NCT00676715|566822873|FG001|Treatment Period (TP)|Failure to return|0|||
157018627|NCT00676715|566822874|FG002|Treatment Period (TP)|Failure to return|0|||
157018628|NCT00676715|566822875|FG003|Treatment Period (TP)|Failure to return|0|||
157018629|NCT00676715|566822872|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
156718063|NCT01930162|565713371|FG000|Overall Study|Abnormal test procedure result(s)|4|||
156718064|NCT01930162|565713371|FG000|Overall Study|Death|1|||
156718065|NCT01958437|565713372|FG000|Overall Study|Incidental MRI findings|0|||
156718066|NCT01958437|565713373|FG001|Overall Study|Incidental MRI findings|0|||
156718067|NCT01958437|565713374|FG002|Overall Study|Incidental MRI findings|1|||
156718068|NCT01958437|565713375|FG003|Overall Study|Incidental MRI findings|1|||
156718069|NCT02394600|565713378|FG000|Overall Study|Adverse Event|3|||
156718070|NCT02394600|565713379|FG001|Overall Study|Adverse Event|0|||
156718071|NCT02394600|565713378|FG000|Overall Study|Lost to Follow-up|0|||
156718072|NCT02394600|565713379|FG001|Overall Study|Lost to Follow-up|1|||
156718073|NCT02394600|565713378|FG000|Overall Study|Withdrawal by Subject|0|||
156718074|NCT02394600|565713379|FG001|Overall Study|Withdrawal by Subject|1|||
156718075|NCT02394600|565713378|FG000|Overall Study|Protocol Violation|1|||
156718076|NCT02394600|565713379|FG001|Overall Study|Protocol Violation|0|||
156718077|NCT00428246|565713380|FG000|Overall Study|Withdrawal by Subject|0|||
156875017|NCT00485134|566300603|FG004|Overall Study|Non-compliance|1|||
156875018|NCT00485134|566300604|FG005|Overall Study|Non-compliance|2|||
157133299|NCT04258579|567236036|FG000|Overall Study|Protocol Violation|2|||
157133300|NCT04258579|567236036|FG000|Overall Study|Adverse Event|1|||
157133301|NCT02076165|567236038|FG000|Overall Study|Lost to Follow-up|7|||
157133302|NCT02076165|567236039|FG001|Overall Study|Lost to Follow-up|5|||
157133303|NCT02076165|567236038|FG000|Overall Study|Refused follow-up assessment|1|||
157133304|NCT02076165|567236039|FG001|Overall Study|Refused follow-up assessment|1|||
157133305|NCT02429856|567236040|FG000|Overall Study|Death|12|||
157133306|NCT02429856|567236041|FG001|Overall Study|Death|13|||
157133307|NCT02429856|567236040|FG000|Overall Study|Lost to Follow-up|6|||
157133308|NCT02429856|567236041|FG001|Overall Study|Lost to Follow-up|5|||
157133309|NCT02429856|567236040|FG000|Overall Study|Withdrawal by Subject|1|||
157133310|NCT02429856|567236041|FG001|Overall Study|Withdrawal by Subject|1|||
157133311|NCT02978222|567236042|FG000|Overall Study|Withdrawal by Subject|2|||
157133312|NCT02978222|567236043|FG001|Overall Study|Withdrawal by Subject|2|||
157133313|NCT02978222|567236042|FG000|Overall Study|Physician Decision|2|||
157133314|NCT02978222|567236043|FG001|Overall Study|Physician Decision|0|||
157133315|NCT02978222|567236042|FG000|Overall Study|Adverse Event|0|||
157133316|NCT02978222|567236043|FG001|Overall Study|Adverse Event|1|||
157133317|NCT02978222|567236042|FG000|Overall Study|Death|1|||
157133318|NCT02978222|567236043|FG001|Overall Study|Death|0|||
157133319|NCT02978222|567236042|FG000|Overall Study|Disease Progression|32|||
157133320|NCT02978222|567236043|FG001|Overall Study|Disease Progression|32|||
157133321|NCT02978222|567236042|FG000|Overall Study|Early Study Termination|24|||
157133322|NCT02978222|567236043|FG001|Overall Study|Early Study Termination|21|||
157133323|NCT01384292|567236053|FG000|Part B|Severe non-compliance to protocol|1|||
157133324|NCT01384292|567236054|FG001|Part B|Severe non-compliance to protocol|0|||
157133325|NCT01384292|567236055|FG002|Part B|Severe non-compliance to protocol|0|||
157133326|NCT01171612|567236056|FG000|Overall Study|Lost to Follow-up|51|||
157133327|NCT01285349|567236057|FG000|Overall Study|Lost to Follow-up|27|||
157133328|NCT01285349|567236058|FG001|Overall Study|Lost to Follow-up|20|||
157133329|NCT01285349|567236059|FG002|Overall Study|Lost to Follow-up|27|||
157133330|NCT02909153|567236060|FG000|Overall Study|Withdrawal by Subject|0|||
157133331|NCT02909153|567236061|FG001|Overall Study|Withdrawal by Subject|1|||
157133332|NCT02909153|567236062|FG002|Overall Study|Withdrawal by Subject|0|||
157133333|NCT02909153|567236063|FG003|Overall Study|Withdrawal by Subject|0|||
157133334|NCT02909153|567236064|FG004|Overall Study|Withdrawal by Subject|0|||
157133335|NCT00565617|567236065|FG000|Overall Study|Withdrawal by Subject|1|||
156875019|NCT00485134|566300605|FG006|Overall Study|Non-compliance|2|||
156875020|NCT00485134|566300606|FG007|Overall Study|Non-compliance|0|||
156875021|NCT00485134|566300599|FG000|Overall Study|Unable to comply with study schedule|0|||
156875022|NCT00485134|566300600|FG001|Overall Study|Unable to comply with study schedule|0|||
156875023|NCT00485134|566300601|FG002|Overall Study|Unable to comply with study schedule|0|||
156875024|NCT00485134|566300602|FG003|Overall Study|Unable to comply with study schedule|0|||
156875025|NCT00485134|566300603|FG004|Overall Study|Unable to comply with study schedule|0|||
156875026|NCT00485134|566300604|FG005|Overall Study|Unable to comply with study schedule|0|||
156875027|NCT00485134|566300605|FG006|Overall Study|Unable to comply with study schedule|0|||
156875028|NCT00485134|566300606|FG007|Overall Study|Unable to comply with study schedule|1|||
156875029|NCT00485134|566300599|FG000|Overall Study|Pregnancy|0|||
157133336|NCT03040024|567236066|FG000|Overall Study|Adverse Event|0|||
157133337|NCT03040024|567236067|FG001|Overall Study|Adverse Event|1|||
157133338|NCT03040024|567236068|FG002|Overall Study|Adverse Event|0|||
157133339|NCT03040024|567236066|FG000|Overall Study|Death|0|||
157133340|NCT03040024|567236067|FG001|Overall Study|Death|1|||
157133341|NCT03040024|567236068|FG002|Overall Study|Death|0|||
157133342|NCT03040024|567236066|FG000|Overall Study|Physician Decision|0|||
157133343|NCT03040024|567236067|FG001|Overall Study|Physician Decision|0|||
157133344|NCT03040024|567236068|FG002|Overall Study|Physician Decision|1|||
157133345|NCT02658812|567236071|FG000|Overall Study|Disease Progression|7|||
157133346|NCT02658812|567236071|FG000|Overall Study|Unrelated to study treatment|1|||
157133347|NCT02658812|567236071|FG000|Overall Study|Adverse Event|1|||
157133348|NCT00854828|567236074|FG000|Overall Study|Death|1|||
156875030|NCT00485134|566300600|FG001|Overall Study|Pregnancy|0|||
156875031|NCT00485134|566300601|FG002|Overall Study|Pregnancy|0|||
156875032|NCT00485134|566300602|FG003|Overall Study|Pregnancy|0|||
156875033|NCT00485134|566300603|FG004|Overall Study|Pregnancy|0|||
156875034|NCT00485134|566300604|FG005|Overall Study|Pregnancy|0|||
156875035|NCT00485134|566300605|FG006|Overall Study|Pregnancy|1|||
156875036|NCT00485134|566300606|FG007|Overall Study|Pregnancy|0|||
156875037|NCT04294680|566300607|FG000|Overall Study|Withdrawal by Subject|2|||
156875038|NCT04294680|566300608|FG001|Overall Study|Withdrawal by Subject|1|||
156875039|NCT04294680|566300607|FG000|Overall Study|Follow-up visits completed outside of window|1|||
156875040|NCT04294680|566300608|FG001|Overall Study|Follow-up visits completed outside of window|0|||
156875041|NCT02675634|566300609|FG000|Test Period 1|Adverse Event|0|||
156875042|NCT02675634|566300610|FG001|Test Period 1|Adverse Event|1|||
156875043|NCT02675634|566300611|FG002|Test Period 1|Adverse Event|0|||
156875044|NCT02675634|566300612|FG003|Test Period 1|Adverse Event|1|||
156875045|NCT02675634|566300613|FG004|Test Period 1|Adverse Event|0|||
156875046|NCT02675634|566300614|FG005|Test Period 1|Adverse Event|0|||
156875047|NCT02675634|566300609|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
156875048|NCT02675634|566300610|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
156875049|NCT02675634|566300611|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
156875050|NCT02675634|566300612|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
156875051|NCT02675634|566300613|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
156875052|NCT02675634|566300614|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
156875053|NCT02675634|566300609|FG000|Test Period 2|Lack of Efficacy|1|||
156875054|NCT02675634|566300610|FG001|Test Period 2|Lack of Efficacy|0|||
156875055|NCT02675634|566300611|FG002|Test Period 2|Lack of Efficacy|0|||
156875056|NCT02675634|566300612|FG003|Test Period 2|Lack of Efficacy|0|||
156875057|NCT02675634|566300613|FG004|Test Period 2|Lack of Efficacy|0|||
156875058|NCT02675634|566300614|FG005|Test Period 2|Lack of Efficacy|0|||
156875059|NCT02675634|566300609|FG000|Test Period 2|Adverse Event|0|||
156875060|NCT02675634|566300610|FG001|Test Period 2|Adverse Event|0|||
156875061|NCT02675634|566300611|FG002|Test Period 2|Adverse Event|0|||
156875062|NCT02675634|566300612|FG003|Test Period 2|Adverse Event|0|||
156875063|NCT02675634|566300613|FG004|Test Period 2|Adverse Event|0|||
156875064|NCT02675634|566300614|FG005|Test Period 2|Adverse Event|1|||
156875065|NCT04380519|566300615|FG000|Overall Study|Withdrawal by Subject|4|||
156875066|NCT04380519|566300616|FG001|Overall Study|Withdrawal by Subject|0|||
156875067|NCT04380519|566300617|FG002|Overall Study|Withdrawal by Subject|1|||
156875068|NCT04380519|566300615|FG000|Overall Study|Death|14|||
156875069|NCT04380519|566300616|FG001|Overall Study|Death|9|||
156875070|NCT04380519|566300617|FG002|Overall Study|Death|6|||
156875071|NCT04380519|566300615|FG000|Overall Study|Adverse Event|0|||
156875072|NCT04380519|566300616|FG001|Overall Study|Adverse Event|1|||
156875073|NCT04380519|566300617|FG002|Overall Study|Adverse Event|0|||
156875074|NCT04380519|566300615|FG000|Overall Study|relatives' decision|0|||
156875075|NCT04380519|566300616|FG001|Overall Study|relatives' decision|1|||
156875076|NCT04380519|566300617|FG002|Overall Study|relatives' decision|0|||
156875077|NCT05300763|566300620|FG000|Overall Study|Adverse Event|0|||
156875078|NCT05300763|566300621|FG001|Overall Study|Adverse Event|1|||
156875079|NCT05300763|566300620|FG000|Overall Study|Major Protocol Deviation|1|||
156875080|NCT05300763|566300621|FG001|Overall Study|Major Protocol Deviation|0|||
156875081|NCT05300763|566300620|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
156875082|NCT05300763|566300621|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156875083|NCT01485172|566300622|FG000|Overall Study|Adverse Event|2|||
157133349|NCT00854828|567236075|FG001|Overall Study|Death|0|||
157133350|NCT00854828|567236076|FG002|Overall Study|Death|0|||
157133351|NCT00854828|567236077|FG003|Overall Study|Death|0|||
157133352|NCT00854828|567236074|FG000|Overall Study|Withdrawal by Subject|1|||
157133353|NCT00854828|567236075|FG001|Overall Study|Withdrawal by Subject|1|||
156875084|NCT01485172|566300623|FG001|Overall Study|Adverse Event|1|||
156875085|NCT01485172|566300624|FG002|Overall Study|Adverse Event|2|||
157133354|NCT00854828|567236076|FG002|Overall Study|Withdrawal by Subject|0|||
157133355|NCT00854828|567236077|FG003|Overall Study|Withdrawal by Subject|9|||
157133356|NCT00854828|567236074|FG000|Overall Study|Missed 24mo visit|1|||
156718078|NCT00428246|565713381|FG001|Overall Study|Withdrawal by Subject|0|||
156875086|NCT01485172|566300625|FG003|Overall Study|Adverse Event|2|||
156875087|NCT01485172|566300626|FG004|Overall Study|Adverse Event|1|||
156875088|NCT01485172|566300627|FG005|Overall Study|Adverse Event|2|||
156875089|NCT01485172|566300622|FG000|Overall Study|Lack of Efficacy|2|||
156875090|NCT01485172|566300623|FG001|Overall Study|Lack of Efficacy|0|||
156875091|NCT01485172|566300624|FG002|Overall Study|Lack of Efficacy|0|||
156875092|NCT01485172|566300625|FG003|Overall Study|Lack of Efficacy|0|||
156875093|NCT01485172|566300626|FG004|Overall Study|Lack of Efficacy|0|||
156875094|NCT01485172|566300627|FG005|Overall Study|Lack of Efficacy|0|||
156875095|NCT01485172|566300622|FG000|Overall Study|Protocol Violation|0|||
156875096|NCT01485172|566300623|FG001|Overall Study|Protocol Violation|0|||
156875097|NCT01485172|566300624|FG002|Overall Study|Protocol Violation|4|||
156875098|NCT01485172|566300625|FG003|Overall Study|Protocol Violation|5|||
157133357|NCT00854828|567236075|FG001|Overall Study|Missed 24mo visit|1|||
156875099|NCT01485172|566300626|FG004|Overall Study|Protocol Violation|1|||
156875100|NCT01485172|566300627|FG005|Overall Study|Protocol Violation|0|||
156875101|NCT01485172|566300622|FG000|Overall Study|Protocol defined stopping criteria|1|||
156875102|NCT01485172|566300623|FG001|Overall Study|Protocol defined stopping criteria|0|||
156875103|NCT01485172|566300624|FG002|Overall Study|Protocol defined stopping criteria|0|||
156875104|NCT01485172|566300625|FG003|Overall Study|Protocol defined stopping criteria|0|||
156875105|NCT01485172|566300626|FG004|Overall Study|Protocol defined stopping criteria|1|||
156875106|NCT01485172|566300627|FG005|Overall Study|Protocol defined stopping criteria|0|||
156875107|NCT01485172|566300622|FG000|Overall Study|Lost to Follow-up|0|||
156875108|NCT01485172|566300623|FG001|Overall Study|Lost to Follow-up|0|||
156875109|NCT01485172|566300624|FG002|Overall Study|Lost to Follow-up|1|||
156875110|NCT01485172|566300625|FG003|Overall Study|Lost to Follow-up|0|||
156875111|NCT01485172|566300626|FG004|Overall Study|Lost to Follow-up|0|||
156875112|NCT01485172|566300627|FG005|Overall Study|Lost to Follow-up|1|||
156875113|NCT01485172|566300622|FG000|Overall Study|Physician Decision|0|||
156875114|NCT01485172|566300623|FG001|Overall Study|Physician Decision|0|||
156875115|NCT01485172|566300624|FG002|Overall Study|Physician Decision|0|||
156875116|NCT01485172|566300625|FG003|Overall Study|Physician Decision|0|||
156875117|NCT01485172|566300626|FG004|Overall Study|Physician Decision|1|||
156875118|NCT01485172|566300627|FG005|Overall Study|Physician Decision|0|||
156875119|NCT01485172|566300622|FG000|Overall Study|Withdrawal by Subject|2|||
156875120|NCT01485172|566300623|FG001|Overall Study|Withdrawal by Subject|0|||
156875121|NCT01485172|566300624|FG002|Overall Study|Withdrawal by Subject|0|||
156875122|NCT01485172|566300625|FG003|Overall Study|Withdrawal by Subject|1|||
156875123|NCT01485172|566300626|FG004|Overall Study|Withdrawal by Subject|1|||
156875124|NCT01485172|566300627|FG005|Overall Study|Withdrawal by Subject|1|||
156875125|NCT04995419|566300633|FG000|Overall Study|Withdrawal by Subject|3|||
156875126|NCT04995419|566300633|FG000|Overall Study|Progressive Disease|19|||
156875127|NCT04995419|566300633|FG000|Overall Study|Adverse Event|2|||
156875128|NCT04995419|566300633|FG000|Overall Study|Ongoing|16|||
156875129|NCT02948088|566300634|FG000|Overall Study|Lost to Follow-up|8|||
156875130|NCT02948088|566300634|FG000|Overall Study|Death|1|||
156875131|NCT02948088|566300634|FG000|Overall Study|Withdrawal by Subject|4|||
156875132|NCT02948088|566300634|FG000|Overall Study|Other|2|||
156875133|NCT00838513|566300635|FG000|Screening Period|Screen Failure|3|||
156875134|NCT00838513|566300635|FG000|Extension Treatment Period|Death|1|||
156875135|NCT00838513|566300635|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
156875136|NCT00975780|566300636|FG000|Follow Up|Death|88|||
156875137|NCT00975780|566300637|FG001|Follow Up|Death|122|||
156875138|NCT00975780|566300636|FG000|Follow Up|Facility Withdrawal|7|||
156875139|NCT00975780|566300637|FG001|Follow Up|Facility Withdrawal|23|||
156875140|NCT00975780|566300636|FG000|Follow Up|Discharged from Facility|7|||
156875141|NCT00975780|566300637|FG001|Follow Up|Discharged from Facility|12|||
156875142|NCT01976741|566300638|FG000|Overall Study|Withdrawal by Subject|1|||
156875143|NCT01976741|566300639|FG001|Overall Study|Withdrawal by Subject|0|||
156875144|NCT01976741|566300640|FG002|Overall Study|Withdrawal by Subject|1|||
156875145|NCT01976741|566300641|FG003|Overall Study|Withdrawal by Subject|1|||
156875146|NCT01976741|566300642|FG004|Overall Study|Withdrawal by Subject|0|||
156875147|NCT01976741|566300643|FG005|Overall Study|Withdrawal by Subject|0|||
156875148|NCT01976741|566300644|FG006|Overall Study|Withdrawal by Subject|1|||
156875149|NCT01976741|566300645|FG007|Overall Study|Withdrawal by Subject|4|||
156875150|NCT01976741|566300646|FG008|Overall Study|Withdrawal by Subject|0|||
156875151|NCT01976741|566300647|FG009|Overall Study|Withdrawal by Subject|0|||
156875152|NCT01976741|566300638|FG000|Overall Study|Adverse Event|0|||
156875153|NCT01976741|566300639|FG001|Overall Study|Adverse Event|0|||
156875154|NCT01976741|566300640|FG002|Overall Study|Adverse Event|2|||
156875155|NCT01976741|566300641|FG003|Overall Study|Adverse Event|0|||
156875156|NCT01976741|566300642|FG004|Overall Study|Adverse Event|0|||
156875157|NCT01976741|566300643|FG005|Overall Study|Adverse Event|0|||
156875158|NCT01976741|566300644|FG006|Overall Study|Adverse Event|3|||
156875159|NCT01976741|566300645|FG007|Overall Study|Adverse Event|8|||
156875160|NCT01976741|566300646|FG008|Overall Study|Adverse Event|1|||
156875161|NCT01976741|566300647|FG009|Overall Study|Adverse Event|4|||
156875162|NCT04999852|566300648|FG000|Overall Study|Withdrawal by Subject|11|||
156875163|NCT04999852|566300649|FG001|Overall Study|Withdrawal by Subject|1|||
156875164|NCT04999852|566300648|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
156875165|NCT04999852|566300649|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
157133358|NCT00854828|567236076|FG002|Overall Study|Missed 24mo visit|8|||
156875166|NCT05626322|566300650|FG000|Overall Study|Death|2|||
156875167|NCT05626322|566300651|FG001|Overall Study|Death|0|||
156875168|NCT05626322|566300652|FG002|Overall Study|Death|0|||
156875169|NCT05626322|566300650|FG000|Overall Study|Physician Decision|1|||
156875170|NCT05626322|566300651|FG001|Overall Study|Physician Decision|0|||
156875171|NCT05626322|566300652|FG002|Overall Study|Physician Decision|0|||
156875172|NCT05626322|566300650|FG000|Overall Study|Progressive Disease|0|||
156875173|NCT05626322|566300651|FG001|Overall Study|Progressive Disease|1|||
156875174|NCT05626322|566300652|FG002|Overall Study|Progressive Disease|1|||
156875175|NCT05626322|566300650|FG000|Overall Study|Study terminated by sponsor|0|||
157133359|NCT00854828|567236077|FG003|Overall Study|Missed 24mo visit|8|||
157133360|NCT01282229|567236078|FG000|Overall Study|Protocol Violation|2|||
157133361|NCT00996203|567236079|FG000|Overall Study|Adverse Event|3|||
157133362|NCT00996203|567236079|FG000|Overall Study|Lost to Follow-up|1|||
157133363|NCT00996203|567236079|FG000|Overall Study|Lack of Efficacy|1|||
157133364|NCT00996203|567236079|FG000|Overall Study|Protocol Violation|2|||
157133365|NCT01671280|567236080|FG000|Overall Study|Withdrawal by Subject|2|||
156875176|NCT05626322|566300651|FG001|Overall Study|Study terminated by sponsor|1|||
156875177|NCT05626322|566300652|FG002|Overall Study|Study terminated by sponsor|0|||
156875178|NCT03776812|566300653|FG000|Overall Study|Death|53|||
156875179|NCT03776812|566300654|FG001|Overall Study|Death|49|||
156875180|NCT03776812|566300655|FG002|Overall Study|Death|56|||
156875181|NCT03776812|566300653|FG000|Overall Study|Withdrawal by Subject|1|||
156875182|NCT03776812|566300654|FG001|Overall Study|Withdrawal by Subject|7|||
156875183|NCT03776812|566300655|FG002|Overall Study|Withdrawal by Subject|2|||
156875184|NCT03776812|566300653|FG000|Overall Study|Lost to Follow-up|1|||
156875185|NCT03776812|566300654|FG001|Overall Study|Lost to Follow-up|1|||
156875186|NCT03776812|566300655|FG002|Overall Study|Lost to Follow-up|0|||
156875187|NCT03776812|566300653|FG000|Overall Study|Did not enter long-term follow-up|3|||
156875188|NCT03776812|566300654|FG001|Overall Study|Did not enter long-term follow-up|3|||
156875189|NCT03776812|566300655|FG002|Overall Study|Did not enter long-term follow-up|2|||
156875190|NCT04758637|566300658|FG000|Overall Study|Lost to Follow-up|0|||
156875191|NCT04758637|566300659|FG001|Overall Study|Lost to Follow-up|1|||
156875192|NCT04758637|566300660|FG002|Overall Study|Lost to Follow-up|0|||
156875193|NCT04758637|566300661|FG003|Overall Study|Lost to Follow-up|0|||
156875194|NCT03350672|566300664|FG000|Overall Study|Withdrawal by Subject|7|||
156875195|NCT03350672|566300665|FG001|Overall Study|Withdrawal by Subject|0|||
156875196|NCT03350672|566300666|FG002|Overall Study|Withdrawal by Subject|0|||
156875197|NCT00048074|566300670|FG000|Overall Study|Adverse Event|46|||
156875198|NCT00048074|566300671|FG001|Overall Study|Adverse Event|41|||
156875199|NCT00048074|566300672|FG002|Overall Study|Adverse Event|53|||
156875200|NCT00048074|566300670|FG000|Overall Study|Death|3|||
156875201|NCT00048074|566300671|FG001|Overall Study|Death|3|||
156875202|NCT00048074|566300672|FG002|Overall Study|Death|2|||
156875203|NCT00048074|566300670|FG000|Overall Study|Lost to Follow-up|2|||
156875204|NCT00048074|566300671|FG001|Overall Study|Lost to Follow-up|6|||
156875205|NCT00048074|566300672|FG002|Overall Study|Lost to Follow-up|6|||
156875206|NCT00048074|566300670|FG000|Overall Study|Withdrawal by Subject|28|||
156875207|NCT00048074|566300671|FG001|Overall Study|Withdrawal by Subject|30|||
156875208|NCT00048074|566300672|FG002|Overall Study|Withdrawal by Subject|35|||
156875209|NCT00048074|566300670|FG000|Overall Study|Protocol Violation|1|||
156875210|NCT00048074|566300671|FG001|Overall Study|Protocol Violation|3|||
156875211|NCT00048074|566300672|FG002|Overall Study|Protocol Violation|0|||
156875212|NCT00048074|566300670|FG000|Overall Study|Study participation was terminated|0|||
156875213|NCT00048074|566300671|FG001|Overall Study|Study participation was terminated|1|||
156718079|NCT00428246|565713382|FG002|Overall Study|Withdrawal by Subject|1|||
156718080|NCT00428246|565713380|FG000|Overall Study|Adverse Event|1|||
156718081|NCT00428246|565713381|FG001|Overall Study|Adverse Event|0|||
156875214|NCT00048074|566300672|FG002|Overall Study|Study participation was terminated|0|||
156875215|NCT00048074|566300670|FG000|Overall Study|Husband ill|0|||
156875216|NCT00048074|566300671|FG001|Overall Study|Husband ill|1|||
156875217|NCT00048074|566300672|FG002|Overall Study|Husband ill|0|||
156875218|NCT00048074|566300670|FG000|Overall Study|Poor compliance|0|||
156875219|NCT00048074|566300671|FG001|Overall Study|Poor compliance|1|||
156875220|NCT00048074|566300672|FG002|Overall Study|Poor compliance|0|||
156875221|NCT00048074|566300670|FG000|Overall Study|Out of station|0|||
156875222|NCT00048074|566300671|FG001|Overall Study|Out of station|1|||
157133366|NCT01959165|567236081|FG000|Overall Study|Adverse Event|0|||
157133367|NCT01959165|567236082|FG001|Overall Study|Adverse Event|0|||
157133368|NCT01959165|567236083|FG002|Overall Study|Adverse Event|0|||
156718082|NCT00428246|565713382|FG002|Overall Study|Adverse Event|0|||
156718083|NCT03442751|565713386|FG000|Overall Study|Withdrawal by Subject|3|||
156718084|NCT03442751|565713387|FG001|Overall Study|Withdrawal by Subject|1|||
156718085|NCT03442751|565713386|FG000|Overall Study|Lost to Follow-up|3|||
156718086|NCT03442751|565713387|FG001|Overall Study|Lost to Follow-up|0|||
156718087|NCT02603887|565713390|FG000|Stage 1|Adverse Event|4|||
156718088|NCT02603887|565713390|FG000|Stage 1|Disease progression|1|||
156718089|NCT02603887|565713390|FG000|Stage 2|FDA guidance|1|||
156718090|NCT01308424|565713391|FG000|Baseline Eligibility|Screen Failures|71|||
156718091|NCT01308424|565713392|FG001|Baseline Eligibility|Screen Failures|0|||
156718092|NCT01308424|565713393|FG002|Baseline Eligibility|Screen Failures|0|||
156718093|NCT01308424|565713391|FG000|Randomization|Adverse Event|0|||
156875223|NCT00048074|566300672|FG002|Overall Study|Out of station|1|||
156875224|NCT00048074|566300670|FG000|Overall Study|Social reasons|1|||
156875225|NCT00048074|566300671|FG001|Overall Study|Social reasons|0|||
156875226|NCT00048074|566300672|FG002|Overall Study|Social reasons|0|||
156875227|NCT02873377|566300673|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
156875228|NCT02873377|566300674|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
156875229|NCT02873377|566300673|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
156875230|NCT02873377|566300674|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
156875231|NCT00993148|566300679|FG000|Overall Study|Lost to Follow-up|2|||
156875232|NCT00993148|566300679|FG000|Overall Study|never initiated treatment|1|||
156875233|NCT03568461|566300699|FG000|Overall Study|Death|7|||
156875234|NCT03568461|566300699|FG000|Overall Study|Physician Decision|5|||
156875235|NCT03568461|566300699|FG000|Overall Study|Subject decision|5|||
156875236|NCT03568461|566300699|FG000|Overall Study|Lost to Follow-up|1|||
156875237|NCT03387085|566300703|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
156875238|NCT00295880|566301976|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
156875239|NCT00295880|566301976|FG000|Overall Study|Unit randomization did not occur|1|||
156875240|NCT01243242|566301977|FG000|Overall Study|Adverse Event|1|||
156875241|NCT01243242|566301978|FG001|Overall Study|Adverse Event|1|||
156875242|NCT01243242|566301977|FG000|Overall Study|Withdrawal by Subject|1|||
156875243|NCT01243242|566301978|FG001|Overall Study|Withdrawal by Subject|1|||
156875244|NCT01243242|566301977|FG000|Overall Study|Physician Decision|0|||
156875245|NCT01243242|566301978|FG001|Overall Study|Physician Decision|1|||
156875246|NCT01243242|566301977|FG000|Overall Study|sponsor decision|0|||
156875247|NCT01243242|566301978|FG001|Overall Study|sponsor decision|1|||
156875248|NCT01243242|566301977|FG000|Overall Study|non compliance|1|||
156875249|NCT01243242|566301978|FG001|Overall Study|non compliance|0|||
156875250|NCT03983317|566301983|FG000|Overall Study|Physician Decision|5|||
156875251|NCT00552188|566301990|FG000|Overall Study|Adverse Event|0|||
156875252|NCT00552188|566301991|FG001|Overall Study|Adverse Event|2|||
156875253|NCT00552188|566301990|FG000|Overall Study|Lost to Follow-up|2|||
156875254|NCT00552188|566301991|FG001|Overall Study|Lost to Follow-up|1|||
156875255|NCT00552188|566301990|FG000|Overall Study|Withdrawal of consent|0|||
156875256|NCT00552188|566301991|FG001|Overall Study|Withdrawal of consent|1|||
156875257|NCT00552188|566301990|FG000|Overall Study|Subject returned to home country|0|||
156875258|NCT00552188|566301991|FG001|Overall Study|Subject returned to home country|1|||
156875259|NCT01256294|566301992|FG000|Overall Study|Adverse Event|1|||
156875260|NCT01256294|566301993|FG001|Overall Study|Adverse Event|0|||
156875261|NCT01256294|566301992|FG000|Overall Study|Withdrawal by Subject|1|||
156875262|NCT01256294|566301993|FG001|Overall Study|Withdrawal by Subject|1|||
156875263|NCT01256294|566301992|FG000|Overall Study|Protocol deviation|2|||
156875264|NCT01256294|566301993|FG001|Overall Study|Protocol deviation|1|||
156875265|NCT04681352|566301994|FG000|Overall Study|Lost to Follow-up|2|||
156875266|NCT04681352|566301994|FG000|Overall Study|Withdrawal by Subject|22|||
156875267|NCT03887702|566301995|FG000|Overall Study|Study terminated|0|||
156875268|NCT03887702|566301996|FG001|Overall Study|Study terminated|0|||
156875269|NCT03887702|566301997|FG002|Overall Study|Study terminated|2|||
156875270|NCT03887702|566301998|FG003|Overall Study|Study terminated|2|||
156875271|NCT01643772|566301999|FG000|Overall Study|Protocol Violation|0|||
156875272|NCT01643772|566302000|FG001|Overall Study|Protocol Violation|0|||
156875273|NCT01643772|566302001|FG002|Overall Study|Protocol Violation|0|||
156875274|NCT01643772|566302002|FG003|Overall Study|Protocol Violation|1|||
156875275|NCT01643772|566301999|FG000|Overall Study|Adverse Event|0|||
156875276|NCT01643772|566302000|FG001|Overall Study|Adverse Event|0|||
156875277|NCT01643772|566302001|FG002|Overall Study|Adverse Event|0|||
156875278|NCT01643772|566302002|FG003|Overall Study|Adverse Event|1|||
156875279|NCT03860818|566302005|FG000|Overall Study|Death|144|||
156875280|NCT03860818|566302006|FG001|Overall Study|Death|195|||
156875281|NCT03860818|566302005|FG000|Overall Study|Graft Loss|32|||
156875282|NCT03860818|566302006|FG001|Overall Study|Graft Loss|45|||
156875283|NCT00792571|566302007|FG000|Overall Study|Death|1|||
156875284|NCT00792571|566302007|FG000|Overall Study|Adverse Event|4|||
156875285|NCT00792571|566302007|FG000|Overall Study|Withdrawal by Subject|1|||
156875286|NCT00792571|566302007|FG000|Overall Study|Other|4|||
156875287|NCT02600819|566302008|FG000|GEN Phase|Adverse Event|2|||
156875288|NCT02600819|566302009|FG001|GEN Phase|Adverse Event|0|||
156875289|NCT02600819|566302008|FG000|GEN Phase|Death|2|||
156875290|NCT02600819|566302009|FG001|GEN Phase|Death|0|||
156875291|NCT02600819|566302008|FG000|GEN Phase|Investigator's Discretion|4|||
156875292|NCT02600819|566302009|FG001|GEN Phase|Investigator's Discretion|0|||
156875293|NCT02600819|566302008|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
156875294|NCT02600819|566302009|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
156875295|NCT02600819|566302008|FG000|GEN Phase|Withdrew Consent|5|||
156875296|NCT02600819|566302009|FG001|GEN Phase|Withdrew Consent|0|||
156875297|NCT02600819|566302008|FG000|GEN Phase|Lost to Follow-up|2|||
156875298|NCT02600819|566302009|FG001|GEN Phase|Lost to Follow-up|0|||
156875299|NCT01621802|566302011|FG000|Overall Study|Protocol Violation|0|||
157133369|NCT01959165|567236084|FG003|Overall Study|Adverse Event|1|||
156875300|NCT01621802|566302012|FG001|Overall Study|Protocol Violation|0|||
156875301|NCT01621802|566302013|FG002|Overall Study|Protocol Violation|0|||
156875302|NCT01621802|566302014|FG003|Overall Study|Protocol Violation|0|||
156875303|NCT01621802|566302015|FG004|Overall Study|Protocol Violation|0|||
156875304|NCT01621802|566302016|FG005|Overall Study|Protocol Violation|1|||
156875305|NCT01621802|566302011|FG000|Overall Study|Withdrawal by Subject|8|||
156875306|NCT01621802|566302012|FG001|Overall Study|Withdrawal by Subject|4|||
156875307|NCT01621802|566302013|FG002|Overall Study|Withdrawal by Subject|4|||
157133370|NCT01959165|567236081|FG000|Overall Study|Lack of Efficacy|1|||
156718094|NCT01308424|565713392|FG001|Randomization|Adverse Event|1|||
156718095|NCT01308424|565713393|FG002|Randomization|Adverse Event|1|||
156718096|NCT01308424|565713391|FG000|Randomization|Lost to Follow-up|0|||
156718097|NCT01308424|565713392|FG001|Randomization|Lost to Follow-up|1|||
156875308|NCT01621802|566302014|FG003|Overall Study|Withdrawal by Subject|2|||
156875309|NCT01621802|566302015|FG004|Overall Study|Withdrawal by Subject|2|||
156875310|NCT01621802|566302016|FG005|Overall Study|Withdrawal by Subject|0|||
156875311|NCT01621802|566302011|FG000|Overall Study|Migrated/moved from study area|0|||
156875312|NCT01621802|566302012|FG001|Overall Study|Migrated/moved from study area|0|||
156875313|NCT01621802|566302013|FG002|Overall Study|Migrated/moved from study area|2|||
156875314|NCT01621802|566302014|FG003|Overall Study|Migrated/moved from study area|0|||
156875315|NCT01621802|566302015|FG004|Overall Study|Migrated/moved from study area|1|||
156718098|NCT01308424|565713393|FG002|Randomization|Lost to Follow-up|0|||
156718099|NCT01308424|565713391|FG000|Randomization|Physician Decision|0|||
156718100|NCT01308424|565713392|FG001|Randomization|Physician Decision|1|||
156718101|NCT01308424|565713393|FG002|Randomization|Physician Decision|1|||
156718102|NCT04620746|565713394|FG000|Overall Study|Adverse Event|2|||
156718103|NCT04620746|565713395|FG001|Overall Study|Adverse Event|0|||
156718104|NCT04620746|565713394|FG000|Overall Study|Uniterpretable skin test|1|||
156718105|NCT04620746|565713395|FG001|Overall Study|Uniterpretable skin test|0|||
156718106|NCT04620746|565713394|FG000|Overall Study|Withdrawal by Subject|0|||
156718107|NCT04620746|565713395|FG001|Overall Study|Withdrawal by Subject|1|||
156718108|NCT05767905|565713398|FG000|Overall Study|Adverse Event|0|||
156718109|NCT05767905|565713399|FG001|Overall Study|Adverse Event|0|||
156718110|NCT05767905|565713400|FG002|Overall Study|Adverse Event|1|||
156718111|NCT01841593|565713403|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
156718112|NCT01841593|565713404|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
156718113|NCT01841593|565713403|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
156718114|NCT01841593|565713404|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
156718115|NCT03125798|565713405|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
156718116|NCT03125798|565713406|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
156718117|NCT03125798|565713405|FG000|Overall Study|Conversion to thoracotomy|7|||
156718118|NCT03125798|565713406|FG001|Overall Study|Conversion to thoracotomy|7|||
156718119|NCT00262028|565713415|FG000|Overall Study|Withdrawal by Subject|6|||
156718120|NCT00262028|565713416|FG001|Overall Study|Withdrawal by Subject|3|||
156718121|NCT00262028|565713417|FG002|Overall Study|Withdrawal by Subject|6|||
156718122|NCT00262028|565713418|FG003|Overall Study|Withdrawal by Subject|5|||
156718123|NCT00262028|565713419|FG004|Overall Study|Withdrawal by Subject|2|||
156718124|NCT00262028|565713420|FG005|Overall Study|Withdrawal by Subject|3|||
156718125|NCT00262028|565713421|FG006|Overall Study|Withdrawal by Subject|5|||
156718126|NCT00262028|565713422|FG007|Overall Study|Withdrawal by Subject|7|||
156718127|NCT00262028|565713423|FG008|Overall Study|Withdrawal by Subject|2|||
156718128|NCT00262028|565713415|FG000|Overall Study|Lost to Follow-up|7|||
156718129|NCT00262028|565713416|FG001|Overall Study|Lost to Follow-up|7|||
156718130|NCT00262028|565713417|FG002|Overall Study|Lost to Follow-up|5|||
156718131|NCT00262028|565713418|FG003|Overall Study|Lost to Follow-up|5|||
156718132|NCT00262028|565713419|FG004|Overall Study|Lost to Follow-up|4|||
156718133|NCT00262028|565713420|FG005|Overall Study|Lost to Follow-up|3|||
156718134|NCT00262028|565713421|FG006|Overall Study|Lost to Follow-up|3|||
156718135|NCT00262028|565713422|FG007|Overall Study|Lost to Follow-up|5|||
156718136|NCT00262028|565713423|FG008|Overall Study|Lost to Follow-up|6|||
156718137|NCT00262028|565713415|FG000|Overall Study|Administrative Reason|11|||
156718138|NCT00262028|565713416|FG001|Overall Study|Administrative Reason|14|||
156718139|NCT00262028|565713417|FG002|Overall Study|Administrative Reason|9|||
156718140|NCT00262028|565713418|FG003|Overall Study|Administrative Reason|12|||
156718141|NCT00262028|565713419|FG004|Overall Study|Administrative Reason|6|||
156718142|NCT00262028|565713420|FG005|Overall Study|Administrative Reason|7|||
156718143|NCT00262028|565713421|FG006|Overall Study|Administrative Reason|4|||
156718144|NCT00262028|565713422|FG007|Overall Study|Administrative Reason|6|||
156718145|NCT00262028|565713423|FG008|Overall Study|Administrative Reason|10|||
156718146|NCT00262028|565713415|FG000|Overall Study|Protocol Violation|0|||
156718147|NCT00262028|565713416|FG001|Overall Study|Protocol Violation|0|||
156718148|NCT00262028|565713417|FG002|Overall Study|Protocol Violation|0|||
157018630|NCT00676715|566822873|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
156718149|NCT00262028|565713418|FG003|Overall Study|Protocol Violation|1|||
156718150|NCT00262028|565713419|FG004|Overall Study|Protocol Violation|0|||
156718151|NCT00262028|565713420|FG005|Overall Study|Protocol Violation|0|||
156875316|NCT01621802|566302016|FG005|Overall Study|Migrated/moved from study area|0|||
156875317|NCT01621802|566302011|FG000|Overall Study|Others|3|||
156875318|NCT01621802|566302012|FG001|Overall Study|Others|3|||
157018631|NCT00676715|566822874|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
157018632|NCT00676715|566822875|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
157018633|NCT00676715|566822872|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
157018634|NCT00676715|566822873|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
157018635|NCT00676715|566822874|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
156718152|NCT00262028|565713421|FG006|Overall Study|Protocol Violation|0|||
156718153|NCT00262028|565713422|FG007|Overall Study|Protocol Violation|0|||
156718154|NCT00262028|565713423|FG008|Overall Study|Protocol Violation|0|||
156718155|NCT00262028|565713415|FG000|Overall Study|Unable to classify|0|||
156718156|NCT00262028|565713416|FG001|Overall Study|Unable to classify|3|||
156718157|NCT00262028|565713417|FG002|Overall Study|Unable to classify|0|||
156718158|NCT00262028|565713418|FG003|Overall Study|Unable to classify|0|||
156718159|NCT00262028|565713419|FG004|Overall Study|Unable to classify|0|||
156718160|NCT00262028|565713420|FG005|Overall Study|Unable to classify|0|||
156718161|NCT00262028|565713421|FG006|Overall Study|Unable to classify|0|||
156718162|NCT00262028|565713422|FG007|Overall Study|Unable to classify|0|||
156718163|NCT00262028|565713423|FG008|Overall Study|Unable to classify|1|||
156718164|NCT01515423|565713424|FG000|Open Label Phase|Adverse Event|57|||
156718165|NCT01515423|565713425|FG001|Open Label Phase|Adverse Event|0|||
156718166|NCT01515423|565713426|FG002|Open Label Phase|Adverse Event|0|||
156718167|NCT01515423|565713424|FG000|Open Label Phase|Death|2|||
156718168|NCT01515423|565713425|FG001|Open Label Phase|Death|0|||
156718169|NCT01515423|565713426|FG002|Open Label Phase|Death|0|||
156718170|NCT01515423|565713424|FG000|Open Label Phase|Lack of Efficacy|117|||
156718171|NCT01515423|565713425|FG001|Open Label Phase|Lack of Efficacy|0|||
156718172|NCT01515423|565713426|FG002|Open Label Phase|Lack of Efficacy|0|||
156718173|NCT01515423|565713424|FG000|Open Label Phase|Lost to Follow-up|21|||
156718174|NCT01515423|565713425|FG001|Open Label Phase|Lost to Follow-up|0|||
156718175|NCT01515423|565713426|FG002|Open Label Phase|Lost to Follow-up|0|||
156718176|NCT01515423|565713424|FG000|Open Label Phase|Withdrawal by Subject|118|||
156718177|NCT01515423|565713425|FG001|Open Label Phase|Withdrawal by Subject|0|||
156718178|NCT01515423|565713426|FG002|Open Label Phase|Withdrawal by Subject|0|||
156718179|NCT01515423|565713424|FG000|Open Label Phase|excluded from DB Phase|70|||
156718180|NCT01515423|565713425|FG001|Open Label Phase|excluded from DB Phase|0|||
156718181|NCT01515423|565713426|FG002|Open Label Phase|excluded from DB Phase|0|||
156718182|NCT01515423|565713424|FG000|Open Label Phase|Other|28|||
156718183|NCT01515423|565713425|FG001|Open Label Phase|Other|0|||
156718184|NCT01515423|565713426|FG002|Open Label Phase|Other|0|||
156718185|NCT01515423|565713424|FG000|DOUBLE BLIND|Adverse Event|0|||
156718186|NCT01515423|565713425|FG001|DOUBLE BLIND|Adverse Event|15|||
156718187|NCT01515423|565713426|FG002|DOUBLE BLIND|Adverse Event|13|||
156718188|NCT01515423|565713424|FG000|DOUBLE BLIND|Death|0|||
156718189|NCT01515423|565713425|FG001|DOUBLE BLIND|Death|1|||
156718190|NCT01515423|565713426|FG002|DOUBLE BLIND|Death|2|||
156718191|NCT01515423|565713424|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
156718192|NCT01515423|565713425|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
156718193|NCT01515423|565713426|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
156718194|NCT01515423|565713424|FG000|DOUBLE BLIND|Pregnancy|0|||
156718195|NCT01515423|565713425|FG001|DOUBLE BLIND|Pregnancy|2|||
156718196|NCT01515423|565713426|FG002|DOUBLE BLIND|Pregnancy|0|||
156718197|NCT01515423|565713424|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
156718198|NCT01515423|565713425|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
156718199|NCT01515423|565713426|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
156718200|NCT01515423|565713424|FG000|DOUBLE BLIND|Other|0|||
156718201|NCT01515423|565713425|FG001|DOUBLE BLIND|Other|6|||
156718202|NCT01515423|565713426|FG002|DOUBLE BLIND|Other|12|||
156718203|NCT01515423|565713424|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
156718204|NCT01515423|565713425|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
156718205|NCT01515423|565713426|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
156718206|NCT00613171|565713431|FG000|Overall Study|Adverse Event|7|||
156718207|NCT00613171|565713431|FG000|Overall Study|Withdrawal by Subject|3|||
156718208|NCT00613171|565713431|FG000|Overall Study|Reason not Specified|4|||
156718209|NCT02860546|565713433|FG000|Overall Study|Clinical Progression|6|||
156793763|NCT00507507|565997503|FG001|Treatment Period|Withdrawal by Subject|47|||
156793764|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
156793765|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
156793766|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
156793767|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
156793768|NCT00507507|565997502|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
156718210|NCT02860546|565713433|FG000|Overall Study|Radiological Progression|12|||
156718211|NCT00995774|565713436|FG000|Training Period 2|Withdrawal by Subject|2|||
156718212|NCT00995774|565713437|FG001|Training Period 2|Withdrawal by Subject|0|||
157133371|NCT01959165|567236082|FG001|Overall Study|Lack of Efficacy|0|||
157133372|NCT01959165|567236083|FG002|Overall Study|Lack of Efficacy|0|||
157133373|NCT01959165|567236084|FG003|Overall Study|Lack of Efficacy|0|||
157133374|NCT01959165|567236081|FG000|Overall Study|overdose|0|||
157133375|NCT01959165|567236082|FG001|Overall Study|overdose|0|||
157133376|NCT01959165|567236083|FG002|Overall Study|overdose|0|||
157133377|NCT01959165|567236084|FG003|Overall Study|overdose|1|||
157133378|NCT01959165|567236081|FG000|Overall Study|Welfare recipient|0|||
157133379|NCT01959165|567236082|FG001|Overall Study|Welfare recipient|1|||
157133380|NCT01959165|567236083|FG002|Overall Study|Welfare recipient|0|||
157133381|NCT01959165|567236084|FG003|Overall Study|Welfare recipient|0|||
157133382|NCT03686969|567236085|FG000|Overall Study|Study terminated|1|||
157133383|NCT03686969|567236086|FG001|Overall Study|Study terminated|0|||
157133384|NCT01988090|567236091|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
156718213|NCT00683657|565713442|FG000|Overall Study|Adverse Event|0|||
156718214|NCT00683657|565713443|FG001|Overall Study|Adverse Event|1|||
156718215|NCT00683657|565713442|FG000|Overall Study|Subject Withdrew Consent|1|||
156718216|NCT00683657|565713443|FG001|Overall Study|Subject Withdrew Consent|0|||
156718217|NCT00972595|565713444|FG000|Period 1|Adverse Event|1|||
156718218|NCT00972595|565713445|FG001|Period 1|Adverse Event|0|||
156718219|NCT01112059|565713446|FG000|Overall Study|Withdrawal by Subject|1|||
156718220|NCT01112059|565713447|FG001|Overall Study|Withdrawal by Subject|0|||
156718221|NCT03567980|565713448|FG000|Overall Study|Adverse Event|1|||
156718222|NCT02575833|565713449|FG000|Overall Study|Withdrawal by Subject|0|||
156718223|NCT02575833|565713450|FG001|Overall Study|Withdrawal by Subject|1|||
156718224|NCT02575833|565713449|FG000|Overall Study|Lost to Follow-up|1|||
156718225|NCT02575833|565713450|FG001|Overall Study|Lost to Follow-up|0|||
156718226|NCT00967330|565713451|FG000|Overall Study|Protocol Violation|3|||
156718227|NCT00967330|565713452|FG001|Overall Study|Protocol Violation|4|||
156718228|NCT00967330|565713451|FG000|Overall Study|Regular|10|||
156718229|NCT00967330|565713452|FG001|Overall Study|Regular|3|||
156718230|NCT00967330|565713451|FG000|Overall Study|Withdrawal by Subject|6|||
156718231|NCT00967330|565713452|FG001|Overall Study|Withdrawal by Subject|0|||
156718232|NCT00967330|565713451|FG000|Overall Study|Lost to Follow-up|1|||
156718233|NCT00967330|565713452|FG001|Overall Study|Lost to Follow-up|1|||
156718234|NCT00967330|565713451|FG000|Overall Study|Death|102|||
156718235|NCT00967330|565713452|FG001|Overall Study|Death|51|||
156718236|NCT00967330|565713451|FG000|Overall Study|Severe protocol deviation|0|||
156718237|NCT00967330|565713452|FG001|Overall Study|Severe protocol deviation|1|||
156718238|NCT02698163|565713453|FG000|Overall Study|Lost to Follow-up|0|||
156718239|NCT02698163|565713454|FG001|Overall Study|Lost to Follow-up|1|||
156718240|NCT01133067|565713455|FG000|Overall Study|Death|136|||
156718241|NCT01133067|565713455|FG000|Overall Study|Lost to Follow-up|3|||
156718242|NCT00349973|565713456|FG000|Overall Study|Adverse Event|3|||
156718243|NCT00349973|565713457|FG001|Overall Study|Adverse Event|3|||
156718244|NCT00349973|565713456|FG000|Overall Study|Withdrawal by Subject|1|||
156718245|NCT00349973|565713457|FG001|Overall Study|Withdrawal by Subject|0|||
156718246|NCT02548143|565713458|FG000|Overall Study|Adverse Event|1|||
156718247|NCT02548143|565713459|FG001|Overall Study|Adverse Event|0|||
156718248|NCT02548143|565713458|FG000|Overall Study|Withdrawal by Subject|0|||
156718249|NCT02548143|565713459|FG001|Overall Study|Withdrawal by Subject|1|||
156718250|NCT05620082|565713463|FG000|Overall Study|Discharged before study end|1|||
156718251|NCT05620082|565713464|FG001|Overall Study|Discharged before study end|4|||
156718252|NCT05620082|565713465|FG002|Overall Study|Discharged before study end|0|||
156718253|NCT05620082|565713463|FG000|Overall Study|Moved to a different ward|1|||
156718254|NCT05620082|565713464|FG001|Overall Study|Moved to a different ward|0|||
156718255|NCT05620082|565713465|FG002|Overall Study|Moved to a different ward|0|||
156718256|NCT05620082|565713463|FG000|Overall Study|Feeling too unwell|1|||
156718257|NCT05620082|565713464|FG001|Overall Study|Feeling too unwell|0|||
156718258|NCT05620082|565713465|FG002|Overall Study|Feeling too unwell|0|||
156718259|NCT02019472|565715153|FG000|Overall Study|Adverse Event|14|||
156718260|NCT02019472|565715154|FG001|Overall Study|Adverse Event|23|||
156718261|NCT02019472|565715155|FG002|Overall Study|Adverse Event|17|||
156718262|NCT02019472|565715153|FG000|Overall Study|Death|0|||
156718263|NCT02019472|565715154|FG001|Overall Study|Death|1|||
156718264|NCT02019472|565715155|FG002|Overall Study|Death|1|||
156718265|NCT02019472|565715153|FG000|Overall Study|Lack of Efficacy|7|||
156718266|NCT02019472|565715154|FG001|Overall Study|Lack of Efficacy|4|||
156718267|NCT02019472|565715155|FG002|Overall Study|Lack of Efficacy|4|||
156718268|NCT02019472|565715153|FG000|Overall Study|Lost to Follow-up|0|||
156718269|NCT02019472|565715154|FG001|Overall Study|Lost to Follow-up|2|||
156718270|NCT02019472|565715155|FG002|Overall Study|Lost to Follow-up|1|||
156718271|NCT02019472|565715153|FG000|Overall Study|Physician Decision|1|||
156718272|NCT02019472|565715154|FG001|Overall Study|Physician Decision|2|||
156718273|NCT02019472|565715155|FG002|Overall Study|Physician Decision|0|||
156718274|NCT02019472|565715153|FG000|Overall Study|Pregnancy|1|||
156718275|NCT02019472|565715154|FG001|Overall Study|Pregnancy|2|||
156718276|NCT02019472|565715155|FG002|Overall Study|Pregnancy|2|||
156718277|NCT02019472|565715153|FG000|Overall Study|Withdrawal by Subject|11|||
156718278|NCT02019472|565715154|FG001|Overall Study|Withdrawal by Subject|10|||
157133385|NCT01988090|567236092|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
157133386|NCT01988090|567236091|FG000|Start Treament After Randomization|Protocol Violation|0|||
156875319|NCT01621802|566302013|FG002|Overall Study|Others|3|||
157133387|NCT01988090|567236092|FG001|Start Treament After Randomization|Protocol Violation|1|||
157133388|NCT01988090|567236091|FG000|Complete Study After Start|Withdrawal by Subject|2|||
156718279|NCT02019472|565715155|FG002|Overall Study|Withdrawal by Subject|11|||
156718280|NCT02019472|565715153|FG000|Overall Study|Other|3|||
156718281|NCT02019472|565715154|FG001|Overall Study|Other|8|||
156718282|NCT02019472|565715155|FG002|Overall Study|Other|6|||
156718283|NCT00513695|565715156|FG000|Overall Study|Discontinued therapy|2|||
156718284|NCT00513695|565715156|FG000|Overall Study|Progression prior to surgery|3|||
156718285|NCT01866826|565715157|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
156718286|NCT01866826|565715158|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
156718287|NCT01866826|565715157|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
156718288|NCT01866826|565715158|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
156718289|NCT01866826|565715157|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
156718290|NCT01866826|565715158|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
156718291|NCT02288312|565715159|FG000|Overall Study|Pregnancy|1|||
156718292|NCT02288312|565715160|FG001|Overall Study|Pregnancy|0|||
156718293|NCT02288312|565715161|FG002|Overall Study|Pregnancy|0|||
156718294|NCT01276041|565715162|FG000|Overall Study|Adverse Event|2|||
156718295|NCT01276041|565715162|FG000|Overall Study|Protocol Violation|1|||
156718296|NCT00725491|565715163|FG000|Overall Study|Adverse Event|3|||
156718297|NCT00725491|565715164|FG001|Overall Study|Adverse Event|2|||
156718298|NCT00725491|565715163|FG000|Overall Study|Pregnancy|0|||
156718299|NCT00725491|565715164|FG001|Overall Study|Pregnancy|3|||
156718300|NCT00725491|565715163|FG000|Overall Study|Risk for hyperstimulation|2|||
156718301|NCT00725491|565715164|FG001|Overall Study|Risk for hyperstimulation|9|||
156718302|NCT00725491|565715163|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
156718303|NCT00725491|565715164|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
156718304|NCT00725491|565715163|FG000|Overall Study|Fertilization failure|0|||
156718305|NCT00725491|565715164|FG001|Overall Study|Fertilization failure|1|||
156718306|NCT00725491|565715163|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
156718307|NCT00725491|565715164|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
156718308|NCT01495000|565715167|FG000|Overall Study|Lost to Follow-up|2|||
156718309|NCT01495000|565715168|FG001|Overall Study|Lost to Follow-up|2|||
156718310|NCT01495000|565715167|FG000|Overall Study|Protocol Violation|1|||
156718311|NCT01495000|565715168|FG001|Overall Study|Protocol Violation|0|||
156718312|NCT01495000|565715167|FG000|Overall Study|Withdrawal by Subject|10|||
156718313|NCT01495000|565715168|FG001|Overall Study|Withdrawal by Subject|10|||
156718314|NCT02070965|565715169|FG000|Overall Study|Lost to Follow-up|0|||
156718315|NCT02070965|565715170|FG001|Overall Study|Lost to Follow-up|1|||
156718316|NCT02070965|565715171|FG002|Overall Study|Lost to Follow-up|0|||
156718317|NCT02070965|565715169|FG000|Overall Study|Withdrawal by Subject|1|||
156718318|NCT02070965|565715170|FG001|Overall Study|Withdrawal by Subject|1|||
156718319|NCT02070965|565715171|FG002|Overall Study|Withdrawal by Subject|1|||
156718320|NCT02070965|565715169|FG000|Overall Study|Subject moved|1|||
156718321|NCT02070965|565715170|FG001|Overall Study|Subject moved|0|||
156718322|NCT02070965|565715171|FG002|Overall Study|Subject moved|0|||
156718323|NCT02968576|565715172|FG000|Overall Study|Pregnancy|0|||
156718324|NCT02968576|565715173|FG001|Overall Study|Pregnancy|1|||
156718325|NCT02058069|565715176|FG000|Overall Study|Exclusion due to implant size|5|||
156718326|NCT02058069|565715176|FG000|Overall Study|Withdrawal by Subject|6|||
156718327|NCT02222922|565715177|FG000|Overall Study|Death|0|||
156718328|NCT02222922|565715178|FG001|Overall Study|Death|0|||
156718329|NCT02222922|565715179|FG002|Overall Study|Death|0|||
156718330|NCT02222922|565715180|FG003|Overall Study|Death|0|||
156718331|NCT02222922|565715181|FG004|Overall Study|Death|13|||
156718332|NCT02222922|565715182|FG005|Overall Study|Death|0|||
156718333|NCT02222922|565715183|FG006|Overall Study|Death|0|||
156718334|NCT02222922|565715184|FG007|Overall Study|Death|0|||
156718335|NCT02222922|565715185|FG008|Overall Study|Death|2|||
156718336|NCT02222922|565715177|FG000|Overall Study|Lost to Follow-up|0|||
156718337|NCT02222922|565715178|FG001|Overall Study|Lost to Follow-up|0|||
156718338|NCT02222922|565715179|FG002|Overall Study|Lost to Follow-up|1|||
156718339|NCT02222922|565715180|FG003|Overall Study|Lost to Follow-up|0|||
156718340|NCT02222922|565715181|FG004|Overall Study|Lost to Follow-up|9|||
156718341|NCT02222922|565715182|FG005|Overall Study|Lost to Follow-up|1|||
156718342|NCT02222922|565715183|FG006|Overall Study|Lost to Follow-up|0|||
156718343|NCT02222922|565715184|FG007|Overall Study|Lost to Follow-up|0|||
156793769|NCT00507507|565997503|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
156793770|NCT03249558|565997504|FG000|Overall Study|Lost to Follow-up|2|||
156793771|NCT03249558|565997505|FG001|Overall Study|Lost to Follow-up|1|||
156793772|NCT03249558|565997506|FG002|Overall Study|Lost to Follow-up|4|||
156718344|NCT02222922|565715185|FG008|Overall Study|Lost to Follow-up|0|||
156718345|NCT02222922|565715177|FG000|Overall Study|Other|0|||
156718346|NCT02222922|565715178|FG001|Overall Study|Other|0|||
156718347|NCT02222922|565715179|FG002|Overall Study|Other|0|||
156718348|NCT02222922|565715180|FG003|Overall Study|Other|2|||
156718349|NCT02222922|565715181|FG004|Overall Study|Other|10|||
156718350|NCT02222922|565715182|FG005|Overall Study|Other|2|||
156718351|NCT02222922|565715183|FG006|Overall Study|Other|2|||
156718352|NCT02222922|565715184|FG007|Overall Study|Other|4|||
156718353|NCT02222922|565715185|FG008|Overall Study|Other|1|||
156718354|NCT02222922|565715177|FG000|Overall Study|Participant refused further follow-up|1|||
156793773|NCT03249558|565997504|FG000|Overall Study|Physician Decision|1|||
156718355|NCT02222922|565715178|FG001|Overall Study|Participant refused further follow-up|0|||
156718356|NCT02222922|565715179|FG002|Overall Study|Participant refused further follow-up|0|||
156718357|NCT02222922|565715180|FG003|Overall Study|Participant refused further follow-up|1|||
156793774|NCT03249558|565997505|FG001|Overall Study|Physician Decision|0|||
157133389|NCT01988090|567236092|FG001|Complete Study After Start|Withdrawal by Subject|0|||
157133390|NCT01988090|567236091|FG000|Complete Study After Start|Protocol Violation|1|||
157133391|NCT01988090|567236092|FG001|Complete Study After Start|Protocol Violation|1|||
157133392|NCT03887130|567236095|FG000|Overall Study|Progressive disease|23|||
157133393|NCT03887130|567236096|FG001|Overall Study|Progressive disease|14|||
156718358|NCT02222922|565715181|FG004|Overall Study|Participant refused further follow-up|6|||
156718359|NCT02222922|565715182|FG005|Overall Study|Participant refused further follow-up|0|||
156718360|NCT02222922|565715183|FG006|Overall Study|Participant refused further follow-up|0|||
156718361|NCT02222922|565715184|FG007|Overall Study|Participant refused further follow-up|0|||
156718362|NCT02222922|565715185|FG008|Overall Study|Participant refused further follow-up|3|||
156718363|NCT02002221|565715186|FG000|Overall Study|Adverse Event|2|||
156718364|NCT02002221|565715187|FG001|Overall Study|Adverse Event|1|||
156718365|NCT02002221|565715186|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156718366|NCT02002221|565715187|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156718367|NCT02002221|565715186|FG000|Overall Study|Patient withdrew consent|0|||
156718368|NCT02002221|565715187|FG001|Overall Study|Patient withdrew consent|1|||
156718369|NCT01998919|565715188|FG000|Overall Study|Death|2|||
156718370|NCT01998919|565715189|FG001|Overall Study|Death|2|||
156718371|NCT01998919|565715188|FG000|Overall Study|Adverse Event|0|||
156718372|NCT01998919|565715189|FG001|Overall Study|Adverse Event|5|||
156718373|NCT01998919|565715188|FG000|Overall Study|Disease progression|31|||
156718374|NCT01998919|565715189|FG001|Overall Study|Disease progression|22|||
156718375|NCT01998919|565715188|FG000|Overall Study|Withdrawal by Subject|2|||
156718376|NCT01998919|565715189|FG001|Overall Study|Withdrawal by Subject|4|||
156718377|NCT01998919|565715188|FG000|Overall Study|Lost to Follow-up|2|||
156718378|NCT01998919|565715189|FG001|Overall Study|Lost to Follow-up|0|||
156718379|NCT01998919|565715188|FG000|Overall Study|Other|5|||
156718380|NCT01998919|565715189|FG001|Overall Study|Other|2|||
156718381|NCT01068860|565715190|FG000|Overall Study|Withdrawal by Subject|0|||
156718382|NCT01068860|565715191|FG001|Overall Study|Withdrawal by Subject|0|||
156718383|NCT01068860|565715192|FG002|Overall Study|Withdrawal by Subject|0|||
156718384|NCT01068860|565715193|FG003|Overall Study|Withdrawal by Subject|0|||
156718385|NCT01068860|565715194|FG004|Overall Study|Withdrawal by Subject|0|||
156718386|NCT01068860|565715195|FG005|Overall Study|Withdrawal by Subject|2|||
156718387|NCT01068860|565715196|FG006|Overall Study|Withdrawal by Subject|0|||
156718388|NCT01068860|565715197|FG007|Overall Study|Withdrawal by Subject|0|||
156718389|NCT01068860|565715198|FG008|Overall Study|Withdrawal by Subject|0|||
156718390|NCT01068860|565715199|FG009|Overall Study|Withdrawal by Subject|3|||
156718391|NCT01068860|565715190|FG000|Overall Study|Administrative problems; misrandomized|0|||
156718392|NCT01068860|565715191|FG001|Overall Study|Administrative problems; misrandomized|0|||
156718393|NCT01068860|565715192|FG002|Overall Study|Administrative problems; misrandomized|0|||
156718394|NCT01068860|565715193|FG003|Overall Study|Administrative problems; misrandomized|1|||
156718395|NCT01068860|565715194|FG004|Overall Study|Administrative problems; misrandomized|0|||
156718396|NCT01068860|565715195|FG005|Overall Study|Administrative problems; misrandomized|0|||
156718397|NCT01068860|565715196|FG006|Overall Study|Administrative problems; misrandomized|0|||
156718398|NCT01068860|565715197|FG007|Overall Study|Administrative problems; misrandomized|0|||
156718399|NCT01068860|565715198|FG008|Overall Study|Administrative problems; misrandomized|0|||
156718400|NCT01068860|565715199|FG009|Overall Study|Administrative problems; misrandomized|1|||
156718401|NCT01068860|565715190|FG000|Overall Study|Lost to Follow-up|0|||
156718402|NCT01068860|565715191|FG001|Overall Study|Lost to Follow-up|1|||
156718403|NCT01068860|565715192|FG002|Overall Study|Lost to Follow-up|0|||
156718404|NCT01068860|565715193|FG003|Overall Study|Lost to Follow-up|0|||
156718405|NCT01068860|565715194|FG004|Overall Study|Lost to Follow-up|0|||
156718406|NCT01068860|565715195|FG005|Overall Study|Lost to Follow-up|0|||
156718407|NCT01068860|565715196|FG006|Overall Study|Lost to Follow-up|0|||
156718408|NCT01068860|565715197|FG007|Overall Study|Lost to Follow-up|0|||
156718409|NCT01068860|565715198|FG008|Overall Study|Lost to Follow-up|0|||
156718410|NCT01068860|565715199|FG009|Overall Study|Lost to Follow-up|0|||
156718411|NCT00897715|565715203|FG000|Overall Study|Lost to Follow-up|0|||
156718412|NCT00897715|565715204|FG001|Overall Study|Lost to Follow-up|1|||
156718413|NCT00897715|565715203|FG000|Overall Study|Physician Decision|1|||
156718414|NCT00897715|565715204|FG001|Overall Study|Physician Decision|0|||
156718415|NCT00897715|565715203|FG000|Overall Study|increased risk of infection|1|||
156718416|NCT00897715|565715204|FG001|Overall Study|increased risk of infection|0|||
156718417|NCT00513240|565715205|FG000|Overall Study|Did not have intended surgery|3|||
156718418|NCT00513240|565715206|FG001|Overall Study|Did not have intended surgery|0|||
156718419|NCT00513240|565715205|FG000|Overall Study|Death|3|||
156718420|NCT00513240|565715206|FG001|Overall Study|Death|3|||
156718421|NCT00513240|565715205|FG000|Overall Study|Withdrawal by Subject|7|||
156718422|NCT00513240|565715206|FG001|Overall Study|Withdrawal by Subject|4|||
156718423|NCT00882518|565715216|FG000|Overall Study|Adverse Event|9|||
156718424|NCT00882518|565715217|FG001|Overall Study|Adverse Event|18|||
156718425|NCT00882518|565715216|FG000|Overall Study|Withdrawal by Subject|9|||
156718426|NCT00882518|565715217|FG001|Overall Study|Withdrawal by Subject|13|||
156718427|NCT00882518|565715216|FG000|Overall Study|Lack of Efficacy|12|||
156718428|NCT00882518|565715217|FG001|Overall Study|Lack of Efficacy|9|||
156718429|NCT00882518|565715216|FG000|Overall Study|Severe non-compliance to protocol|3|||
156718430|NCT00882518|565715217|FG001|Overall Study|Severe non-compliance to protocol|1|||
156718431|NCT00882518|565715216|FG000|Overall Study|Incorrect enrolment|4|||
156718432|NCT00882518|565715217|FG001|Overall Study|Incorrect enrolment|2|||
156718433|NCT00882518|565715216|FG000|Overall Study|Central lab closure for National day|1|||
156718434|NCT00882518|565715217|FG001|Overall Study|Central lab closure for National day|0|||
156718435|NCT00882518|565715216|FG000|Overall Study|Allocating random number by mistake|0|||
156718436|NCT00882518|565715217|FG001|Overall Study|Allocating random number by mistake|1|||
156718437|NCT03238651|565715218|FG000|Overall Study|Other|0|||
156718438|NCT03238651|565715219|FG001|Overall Study|Other|0|||
156718439|NCT03238651|565715220|FG002|Overall Study|Other|0|||
156718440|NCT03238651|565715221|FG003|Overall Study|Other|0|||
156718441|NCT03238651|565715222|FG004|Overall Study|Other|1|||
156718442|NCT03238651|565715218|FG000|Overall Study|Progressive Disease|2|||
156718443|NCT03238651|565715219|FG001|Overall Study|Progressive Disease|2|||
156718444|NCT03238651|565715220|FG002|Overall Study|Progressive Disease|2|||
156718445|NCT03238651|565715221|FG003|Overall Study|Progressive Disease|2|||
156718446|NCT03238651|565715222|FG004|Overall Study|Progressive Disease|0|||
156718447|NCT03238651|565715218|FG000|Overall Study|Withdrawal by Subject|0|||
156718448|NCT03238651|565715219|FG001|Overall Study|Withdrawal by Subject|1|||
156718449|NCT03238651|565715220|FG002|Overall Study|Withdrawal by Subject|0|||
156718450|NCT03238651|565715221|FG003|Overall Study|Withdrawal by Subject|1|||
156718451|NCT03238651|565715222|FG004|Overall Study|Withdrawal by Subject|0|||
156718452|NCT03238651|565715218|FG000|Overall Study|Adverse Event|1|||
156718453|NCT03238651|565715219|FG001|Overall Study|Adverse Event|3|||
156718454|NCT03238651|565715220|FG002|Overall Study|Adverse Event|2|||
156718455|NCT03238651|565715221|FG003|Overall Study|Adverse Event|0|||
156718456|NCT03238651|565715222|FG004|Overall Study|Adverse Event|0|||
156718457|NCT03743051|565715223|FG000|Overall Study|Adverse Event|5|||
156718458|NCT03743051|565715224|FG001|Overall Study|Adverse Event|9|||
156718459|NCT03743051|565715223|FG000|Overall Study|Death|27|||
156718460|NCT03743051|565715224|FG001|Overall Study|Death|26|||
156718461|NCT03743051|565715223|FG000|Overall Study|Lost to Follow-up|4|||
156718462|NCT03743051|565715224|FG001|Overall Study|Lost to Follow-up|8|||
156718463|NCT03743051|565715223|FG000|Overall Study|Withdrawal by Subject|32|||
156718464|NCT03743051|565715224|FG001|Overall Study|Withdrawal by Subject|19|||
156718465|NCT03743051|565715223|FG000|Overall Study|Physician Decision|10|||
156718466|NCT03743051|565715224|FG001|Overall Study|Physician Decision|15|||
156718467|NCT03743051|565715223|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
156718468|NCT03743051|565715224|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
156718469|NCT02137252|565715225|FG000|Overall Study|trial terminated early|2|||
157217237|NCT03210259|567541052|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
156718470|NCT02137252|565715226|FG001|Overall Study|trial terminated early|1|||
156718471|NCT00840749|565715230|FG000|Overall Study|Death|1|||
156718472|NCT00840749|565715231|FG001|Overall Study|Death|2|||
156718473|NCT00840749|565715230|FG000|Overall Study|not treated on study arm|11|||
156718474|NCT00840749|565715231|FG001|Overall Study|not treated on study arm|11|||
156718475|NCT00840749|565715230|FG000|Overall Study|study closed|19|||
156718476|NCT00840749|565715231|FG001|Overall Study|study closed|14|||
156718477|NCT02550561|565715232|FG000|Overall Study|Lost to Follow-up|5|||
156718478|NCT02550561|565715232|FG000|Overall Study|Withdrawal by Subject|1|||
156718479|NCT03473925|565715233|FG000|Overall Study|Death|48|||
156718480|NCT03473925|565715234|FG001|Overall Study|Death|44|||
156718481|NCT03473925|565715233|FG000|Overall Study|Sponsor Decision|2|||
156718482|NCT03473925|565715234|FG001|Overall Study|Sponsor Decision|7|||
156718483|NCT03473925|565715233|FG000|Overall Study|Withdrawal by Subject|1|||
156718484|NCT03473925|565715234|FG001|Overall Study|Withdrawal by Subject|3|||
156718485|NCT03473925|565715233|FG000|Overall Study|Not Treated|1|||
156718486|NCT03473925|565715234|FG001|Overall Study|Not Treated|1|||
156718487|NCT03411863|565715235|FG000|Overall Study|Withdrawal by Subject|3|||
156718488|NCT03411863|565715236|FG001|Overall Study|Withdrawal by Subject|1|||
156718489|NCT03411863|565715235|FG000|Overall Study|Physician Decision|0|||
156718490|NCT03411863|565715236|FG001|Overall Study|Physician Decision|1|||
156718491|NCT03535740|565715237|FG000|Overall Study|Death|44|||
156718492|NCT03535740|565715237|FG000|Overall Study|Lost to Follow-up|1|||
156718493|NCT03535740|565715237|FG000|Overall Study|Withdrawal by Subject|13|||
156718494|NCT03535740|565715237|FG000|Overall Study|Site terminated by Sponsor|45|||
156718495|NCT05198518|565715241|FG000|Screening Visit|Deemed unable to participate|58|||
156718496|NCT05198518|565715242|FG001|Screening Visit|Deemed unable to participate|0|||
156718497|NCT05198518|565715243|FG002|Screening Visit|Deemed unable to participate|0|||
156718498|NCT03645863|565715245|FG000|Overall Study|Withdrawal by Subject|1|||
156718499|NCT03645863|565715246|FG001|Overall Study|Withdrawal by Subject|0|||
156718500|NCT03645863|565715247|FG002|Overall Study|Withdrawal by Subject|0|||
156718501|NCT02756611|565715249|FG000|Overall Study|Death|70|||
156793775|NCT03249558|565997506|FG002|Overall Study|Physician Decision|0|||
156718502|NCT02756611|565715249|FG000|Overall Study|Withdrawal by Subject|2|||
156718503|NCT02756611|565715249|FG000|Overall Study|Lost to Follow-up|3|||
156718504|NCT02756611|565715249|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
156718505|NCT02756611|565715249|FG000|Overall Study|Other|10|||
156718506|NCT05317312|565715250|FG000|Overall Study|Withdrawal by Subject|0|||
156718507|NCT05317312|565715251|FG001|Overall Study|Withdrawal by Subject|1|||
156718508|NCT05317312|565715252|FG002|Overall Study|Withdrawal by Subject|0|||
156718509|NCT05317312|565715253|FG003|Overall Study|Withdrawal by Subject|0|||
156718510|NCT05317312|565715250|FG000|Overall Study|Lost to Follow-up|0|||
156718511|NCT05317312|565715251|FG001|Overall Study|Lost to Follow-up|0|||
156718512|NCT05317312|565715252|FG002|Overall Study|Lost to Follow-up|0|||
156718513|NCT05317312|565715253|FG003|Overall Study|Lost to Follow-up|1|||
156718514|NCT05317312|565715250|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
156718515|NCT05317312|565715251|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
156718516|NCT05317312|565715252|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
156718517|NCT05317312|565715253|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
156718518|NCT00124917|565715254|FG000|Overall Study|Physician Decision|3|||
156718519|NCT03164551|565715255|FG000|Overall Study|Imaging discontinued prior completion|8|||
156718520|NCT03164551|565715256|FG001|Overall Study|Imaging discontinued prior completion|0|||
156718521|NCT03164551|565715255|FG000|Overall Study|Participant was non-compliant|1|||
156718522|NCT03164551|565715256|FG001|Overall Study|Participant was non-compliant|0|||
156718523|NCT03164551|565715255|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
156718524|NCT03164551|565715256|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
156718525|NCT03164551|565715255|FG000|Overall Study|Other|8|||
156718526|NCT03164551|565715256|FG001|Overall Study|Other|2|||
156718527|NCT01422213|565715257|FG000|Overall Study|Adverse Event|8|||
156718528|NCT01422213|565715258|FG001|Overall Study|Adverse Event|7|||
156718529|NCT01422213|565715259|FG002|Overall Study|Adverse Event|11|||
156718530|NCT01422213|565715257|FG000|Overall Study|Lack of Efficacy|10|||
156718531|NCT01422213|565715258|FG001|Overall Study|Lack of Efficacy|2|||
156718532|NCT01422213|565715259|FG002|Overall Study|Lack of Efficacy|2|||
156718533|NCT01422213|565715257|FG000|Overall Study|Non-compliance with study drug|0|||
156718534|NCT01422213|565715258|FG001|Overall Study|Non-compliance with study drug|1|||
156718535|NCT01422213|565715259|FG002|Overall Study|Non-compliance with study drug|0|||
156718536|NCT01422213|565715257|FG000|Overall Study|Protocol Violation|0|||
156718537|NCT01422213|565715258|FG001|Overall Study|Protocol Violation|2|||
156718538|NCT01422213|565715259|FG002|Overall Study|Protocol Violation|4|||
156718539|NCT01422213|565715257|FG000|Overall Study|Withdrawal of Consent|7|||
156718540|NCT01422213|565715258|FG001|Overall Study|Withdrawal of Consent|3|||
156718541|NCT01422213|565715259|FG002|Overall Study|Withdrawal of Consent|5|||
156718542|NCT01422213|565715257|FG000|Overall Study|Lost to Follow-up|3|||
156718543|NCT01422213|565715258|FG001|Overall Study|Lost to Follow-up|3|||
156718544|NCT01422213|565715259|FG002|Overall Study|Lost to Follow-up|5|||
156718545|NCT01422213|565715257|FG000|Overall Study|Administrative or Other Reason(s)|5|||
156718546|NCT01422213|565715258|FG001|Overall Study|Administrative or Other Reason(s)|4|||
156718547|NCT01422213|565715259|FG002|Overall Study|Administrative or Other Reason(s)|2|||
156718548|NCT00951496|565715266|FG000|Overall Study|Did not initiate study treatment|10|||
156718549|NCT00951496|565715267|FG001|Overall Study|Did not initiate study treatment|8|||
156718550|NCT00951496|565715268|FG002|Overall Study|Did not initiate study treatment|13|||
156718551|NCT01169350|565715279|FG000|Overall Study|Physician Decision|3|||
156718552|NCT01169350|565715279|FG000|Overall Study|Lost to Follow-up|2|||
156718553|NCT04870710|565715283|FG000|Overall Study|Lost to Follow-up|3|||
156718554|NCT00476190|565715284|FG000|Overall Study|Ineligible|1|||
156718555|NCT00476190|565715285|FG001|Overall Study|Ineligible|1|||
156718556|NCT00476190|565715284|FG000|Overall Study|Induction Death|2|||
156718557|NCT00476190|565715285|FG001|Overall Study|Induction Death|0|||
156718558|NCT00476190|565715284|FG000|Overall Study|Induction Failure|2|||
156718559|NCT00476190|565715285|FG001|Overall Study|Induction Failure|4|||
156718560|NCT00476190|565715284|FG000|Overall Study|Lost to Follow-up|1|||
156718561|NCT00476190|565715285|FG001|Overall Study|Lost to Follow-up|0|||
156718562|NCT00476190|565715284|FG000|Overall Study|Relapse/Progression|5|||
156718563|NCT00476190|565715285|FG001|Overall Study|Relapse/Progression|2|||
156718564|NCT00476190|565715284|FG000|Overall Study|Remission Death|0|||
156718565|NCT00476190|565715285|FG001|Overall Study|Remission Death|1|||
156718566|NCT00476190|565715284|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
156718567|NCT00476190|565715285|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
156718568|NCT00476190|565715284|FG000|Overall Study|Withdrawal by Subject|6|||
156718569|NCT00476190|565715285|FG001|Overall Study|Withdrawal by Subject|2|||
156718570|NCT00476190|565715284|FG000|Overall Study|Other|9|||
156718571|NCT00476190|565715285|FG001|Overall Study|Other|10|||
156718572|NCT04782076|565715286|FG000|Overall Study|Family Emergency|1|||
156718573|NCT01042093|565715287|FG000|Overall Study|Protocol Violation|2|||
156718574|NCT01042093|565715288|FG001|Overall Study|Protocol Violation|2|||
156718575|NCT01042093|565715289|FG002|Overall Study|Protocol Violation|2|||
156718576|NCT01042093|565715290|FG003|Overall Study|Protocol Violation|3|||
156718577|NCT01042093|565715287|FG000|Overall Study|Withdrawal by Subject|0|||
156718578|NCT01042093|565715288|FG001|Overall Study|Withdrawal by Subject|0|||
157018636|NCT00676715|566822875|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
156718579|NCT01042093|565715289|FG002|Overall Study|Withdrawal by Subject|0|||
156718580|NCT01042093|565715290|FG003|Overall Study|Withdrawal by Subject|1|||
156718581|NCT02198963|565715296|FG000|Overall Study|Adverse Event|1|||
156718582|NCT02198963|565715296|FG000|Overall Study|Withdrawal by Subject|6|||
156718583|NCT01998841|565715300|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
156718584|NCT01998841|565715301|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
156718585|NCT01998841|565715302|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
156718586|NCT01998841|565715303|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718587|NCT01998841|565715304|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718588|NCT01998841|565715300|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718589|NCT01998841|565715301|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718590|NCT01998841|565715302|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
156718591|NCT01998841|565715303|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
156718592|NCT01998841|565715304|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
156718593|NCT03447743|565715305|FG000|Overall Study|Withdrawal by Subject|2|||
156718594|NCT03447743|565715305|FG000|Overall Study|Lost to Follow-up|3|||
156718595|NCT03447743|565715305|FG000|Overall Study|Adverse Event|1|||
156718596|NCT03447743|565715305|FG000|Overall Study|Did not meet criteria to continue|1|||
156718597|NCT04211831|565715310|FG000|Overall Study|Withdrawal by Subject|4|||
156718598|NCT04211831|565715311|FG001|Overall Study|Withdrawal by Subject|1|||
156718599|NCT04211831|565715312|FG002|Overall Study|Withdrawal by Subject|1|||
156718600|NCT04211831|565715310|FG000|Overall Study|Protocol Violation|0|||
156718601|NCT04211831|565715311|FG001|Overall Study|Protocol Violation|0|||
156718602|NCT04211831|565715312|FG002|Overall Study|Protocol Violation|1|||
156718603|NCT04211831|565715310|FG000|Overall Study|Adverse Event|0|||
156718604|NCT04211831|565715311|FG001|Overall Study|Adverse Event|1|||
156875320|NCT01621802|566302014|FG003|Overall Study|Others|2|||
156875321|NCT01621802|566302015|FG004|Overall Study|Others|1|||
156875322|NCT01621802|566302016|FG005|Overall Study|Others|0|||
156875323|NCT01621802|566302011|FG000|Overall Study|Lost to Follow-up|36|||
156875324|NCT01621802|566302012|FG001|Overall Study|Lost to Follow-up|16|||
156875325|NCT01621802|566302013|FG002|Overall Study|Lost to Follow-up|24|||
156875326|NCT01621802|566302014|FG003|Overall Study|Lost to Follow-up|7|||
156875327|NCT01621802|566302015|FG004|Overall Study|Lost to Follow-up|31|||
156875328|NCT01621802|566302016|FG005|Overall Study|Lost to Follow-up|11|||
156875329|NCT01149148|566302017|FG000|Overall Study|Lost to Follow-up|1|||
156875330|NCT01149148|566302018|FG001|Overall Study|Lost to Follow-up|2|||
156875331|NCT01149148|566302017|FG000|Overall Study|Death|1|||
156875332|NCT01149148|566302018|FG001|Overall Study|Death|0|||
156875333|NCT03436082|566302019|FG000|Overall Study|Did not undergo procedure|1|||
156875334|NCT03436082|566302020|FG001|Overall Study|Did not undergo procedure|0|||
156875335|NCT04896086|566302021|FG000|Overall Study|Lost to Follow-up|0|||
156875336|NCT04896086|566302022|FG001|Overall Study|Lost to Follow-up|2|||
156875337|NCT04896086|566302023|FG002|Overall Study|Lost to Follow-up|1|||
156875338|NCT04896086|566302024|FG003|Overall Study|Lost to Follow-up|0|||
156875339|NCT04896086|566302025|FG004|Overall Study|Lost to Follow-up|0|||
156875340|NCT04896086|566302021|FG000|Overall Study|Physician Decision|0|||
156875341|NCT04896086|566302022|FG001|Overall Study|Physician Decision|1|||
156875342|NCT04896086|566302023|FG002|Overall Study|Physician Decision|0|||
156875343|NCT04896086|566302024|FG003|Overall Study|Physician Decision|0|||
156875344|NCT04896086|566302025|FG004|Overall Study|Physician Decision|0|||
156875345|NCT04896086|566302021|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156875346|NCT04896086|566302022|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156718605|NCT04211831|565715312|FG002|Overall Study|Adverse Event|0|||
156718606|NCT04211831|565715310|FG000|Overall Study|Lack of Efficacy|0|||
156718607|NCT04211831|565715311|FG001|Overall Study|Lack of Efficacy|0|||
156718608|NCT04211831|565715312|FG002|Overall Study|Lack of Efficacy|1|||
156718609|NCT04211831|565715310|FG000|Overall Study|Lost to Follow-up|0|||
156718610|NCT04211831|565715311|FG001|Overall Study|Lost to Follow-up|0|||
156718611|NCT04211831|565715312|FG002|Overall Study|Lost to Follow-up|2|||
156718612|NCT04211831|565715310|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
156718613|NCT04211831|565715311|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
156718614|NCT04211831|565715312|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
156718615|NCT04211831|565715310|FG000|Overall Study|Other|0|||
156718616|NCT04211831|565715311|FG001|Overall Study|Other|1|||
156718617|NCT04211831|565715312|FG002|Overall Study|Other|0|||
156718618|NCT00752128|565715316|FG000|Overall Study|Withdrawal by Subject|4|||
156718619|NCT04135937|565715317|FG000|Overall Study|Lost to Follow-up|2|||
156718620|NCT04135937|565715317|FG000|Overall Study|Withdrawal by Subject|1|||
156718621|NCT00625820|565715318|FG000|Overall Study|Withdrawal by Subject|1|||
156875347|NCT04896086|566302023|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
156875348|NCT04896086|566302024|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
156875349|NCT04896086|566302025|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
157133394|NCT03887130|567236097|FG002|Overall Study|Progressive disease|7|||
156718622|NCT05201794|565717187|FG000|Overall Study|Withdrawal by Subject|13|||
156718623|NCT05201794|565717188|FG001|Overall Study|Withdrawal by Subject|12|||
156718624|NCT05201794|565717189|FG002|Overall Study|Withdrawal by Subject|14|||
156718625|NCT05201794|565717190|FG003|Overall Study|Withdrawal by Subject|0|||
156718626|NCT05201794|565717187|FG000|Overall Study|Adverse Event|5|||
156718627|NCT05201794|565717188|FG001|Overall Study|Adverse Event|5|||
156718628|NCT05201794|565717189|FG002|Overall Study|Adverse Event|4|||
156718629|NCT05201794|565717190|FG003|Overall Study|Adverse Event|0|||
156718630|NCT05201794|565717187|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
156718631|NCT05201794|565717188|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156718632|NCT05201794|565717189|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
156718633|NCT05201794|565717190|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156718634|NCT05201794|565717187|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156718635|NCT05201794|565717188|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156718636|NCT05201794|565717189|FG002|Overall Study|Non-Compliance With Study Drug|3|||
156718637|NCT05201794|565717190|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156718638|NCT05201794|565717187|FG000|Overall Study|Physician Decision|1|||
156718639|NCT05201794|565717188|FG001|Overall Study|Physician Decision|3|||
156718640|NCT05201794|565717189|FG002|Overall Study|Physician Decision|2|||
156718641|NCT05201794|565717190|FG003|Overall Study|Physician Decision|0|||
156718642|NCT05201794|565717187|FG000|Overall Study|Lost to Follow-up|2|||
156718643|NCT05201794|565717188|FG001|Overall Study|Lost to Follow-up|2|||
156718644|NCT05201794|565717189|FG002|Overall Study|Lost to Follow-up|0|||
156718645|NCT05201794|565717190|FG003|Overall Study|Lost to Follow-up|0|||
156718646|NCT05201794|565717187|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
156718647|NCT05201794|565717188|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
156718648|NCT05201794|565717189|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
156718649|NCT05201794|565717190|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
156718650|NCT05201794|565717187|FG000|Overall Study|Protocol Violation|2|||
156718651|NCT05201794|565717188|FG001|Overall Study|Protocol Violation|0|||
156718652|NCT05201794|565717189|FG002|Overall Study|Protocol Violation|1|||
156718653|NCT05201794|565717190|FG003|Overall Study|Protocol Violation|0|||
156718654|NCT05201794|565717187|FG000|Overall Study|Death|1|||
156718655|NCT05201794|565717188|FG001|Overall Study|Death|0|||
156718656|NCT05201794|565717189|FG002|Overall Study|Death|0|||
156718657|NCT05201794|565717190|FG003|Overall Study|Death|0|||
156718658|NCT05201794|565717187|FG000|Overall Study|Site Terminated By Sponsor|0|||
156718659|NCT05201794|565717188|FG001|Overall Study|Site Terminated By Sponsor|1|||
156718660|NCT05201794|565717189|FG002|Overall Study|Site Terminated By Sponsor|0|||
156718661|NCT05201794|565717190|FG003|Overall Study|Site Terminated By Sponsor|0|||
156718662|NCT05201794|565717187|FG000|Overall Study|Other|3|||
156718663|NCT05201794|565717188|FG001|Overall Study|Other|3|||
156718664|NCT05201794|565717189|FG002|Overall Study|Other|3|||
156718665|NCT05201794|565717190|FG003|Overall Study|Other|0|||
156718666|NCT05201794|565717187|FG000|Overall Study|Randomized But Not Treated|1|||
156718667|NCT05201794|565717188|FG001|Overall Study|Randomized But Not Treated|2|||
156718668|NCT05201794|565717189|FG002|Overall Study|Randomized But Not Treated|1|||
156718669|NCT05201794|565717190|FG003|Overall Study|Randomized But Not Treated|0|||
156718670|NCT01490086|565717191|FG000|Overall Study|Consent withdrawn|4|||
156718671|NCT01490086|565717192|FG001|Overall Study|Consent withdrawn|4|||
156718672|NCT01490086|565717193|FG002|Overall Study|Consent withdrawn|3|||
156718673|NCT01490086|565717194|FG003|Overall Study|Consent withdrawn|0|||
156718674|NCT01490086|565717195|FG004|Overall Study|Consent withdrawn|1|||
156718675|NCT01490086|565717191|FG000|Overall Study|Non-compliance|0|||
156718676|NCT01490086|565717192|FG001|Overall Study|Non-compliance|1|||
156718677|NCT01490086|565717193|FG002|Overall Study|Non-compliance|0|||
156718678|NCT01490086|565717194|FG003|Overall Study|Non-compliance|0|||
156718679|NCT01490086|565717195|FG004|Overall Study|Non-compliance|0|||
156718680|NCT01490086|565717191|FG000|Overall Study|Abnormal laboratory findings|1|||
156718681|NCT01490086|565717192|FG001|Overall Study|Abnormal laboratory findings|0|||
156718682|NCT01490086|565717193|FG002|Overall Study|Abnormal laboratory findings|0|||
156718683|NCT01490086|565717194|FG003|Overall Study|Abnormal laboratory findings|0|||
156718684|NCT01490086|565717195|FG004|Overall Study|Abnormal laboratory findings|0|||
156718685|NCT01490086|565717191|FG000|Overall Study|Lost to Follow-up|0|||
156718686|NCT01490086|565717192|FG001|Overall Study|Lost to Follow-up|0|||
156718687|NCT01490086|565717193|FG002|Overall Study|Lost to Follow-up|0|||
156718688|NCT01490086|565717194|FG003|Overall Study|Lost to Follow-up|0|||
156718689|NCT01490086|565717195|FG004|Overall Study|Lost to Follow-up|1|||
156718690|NCT01490086|565717191|FG000|Overall Study|Physician Decision|3|||
156718691|NCT01490086|565717192|FG001|Overall Study|Physician Decision|4|||
156718692|NCT01490086|565717193|FG002|Overall Study|Physician Decision|2|||
156718693|NCT01490086|565717194|FG003|Overall Study|Physician Decision|3|||
156718694|NCT01490086|565717195|FG004|Overall Study|Physician Decision|1|||
156718695|NCT01490086|565717191|FG000|Overall Study|Adverse Event|0|||
156718696|NCT01490086|565717192|FG001|Overall Study|Adverse Event|0|||
156718697|NCT01490086|565717193|FG002|Overall Study|Adverse Event|1|||
157133395|NCT03887130|567236095|FG000|Overall Study|Protocol Violation|3|||
156718698|NCT01490086|565717194|FG003|Overall Study|Adverse Event|2|||
156718699|NCT01490086|565717195|FG004|Overall Study|Adverse Event|0|||
156718700|NCT01490086|565717191|FG000|Overall Study|Lack of Efficacy|0|||
156718701|NCT01490086|565717192|FG001|Overall Study|Lack of Efficacy|3|||
156718702|NCT01490086|565717193|FG002|Overall Study|Lack of Efficacy|1|||
156718703|NCT01490086|565717194|FG003|Overall Study|Lack of Efficacy|0|||
156718704|NCT01490086|565717195|FG004|Overall Study|Lack of Efficacy|8|||
156718705|NCT01490086|565717191|FG000|Overall Study|Worsening of symptoms|0|||
156718706|NCT01490086|565717192|FG001|Overall Study|Worsening of symptoms|1|||
156718707|NCT01490086|565717193|FG002|Overall Study|Worsening of symptoms|0|||
156718708|NCT01490086|565717194|FG003|Overall Study|Worsening of symptoms|1|||
156718709|NCT01490086|565717195|FG004|Overall Study|Worsening of symptoms|0|||
156718710|NCT01490086|565717191|FG000|Overall Study|Subject uncontrollable and abusive|0|||
156718711|NCT01490086|565717192|FG001|Overall Study|Subject uncontrollable and abusive|1|||
156718712|NCT01490086|565717193|FG002|Overall Study|Subject uncontrollable and abusive|0|||
156718713|NCT01490086|565717194|FG003|Overall Study|Subject uncontrollable and abusive|0|||
156718714|NCT01490086|565717195|FG004|Overall Study|Subject uncontrollable and abusive|0|||
156718715|NCT01490086|565717191|FG000|Overall Study|Subject left hospital|0|||
156718716|NCT01490086|565717192|FG001|Overall Study|Subject left hospital|1|||
156718717|NCT01490086|565717193|FG002|Overall Study|Subject left hospital|0|||
156718718|NCT01490086|565717194|FG003|Overall Study|Subject left hospital|1|||
156718719|NCT01490086|565717195|FG004|Overall Study|Subject left hospital|0|||
156718720|NCT04510090|565717198|FG000|FE-HS|Withdrawal by Subject|0|||
156718721|NCT04510090|565717199|FG001|FE-HS|Withdrawal by Subject|0|||
156718722|NCT04510090|565717200|FG002|FE-HS|Withdrawal by Subject|0|||
156718723|NCT04510090|565717201|FG003|FE-HS|Withdrawal by Subject|0|||
156718724|NCT04510090|565717202|FG004|FE-HS|Withdrawal by Subject|1|||
156718725|NCT04510090|565717203|FG005|FE-HS|Withdrawal by Subject|0|||
156718726|NCT04510090|565717204|FG006|FE-HS|Withdrawal by Subject|0|||
156718727|NCT04510090|565717205|FG007|FE-HS|Withdrawal by Subject|0|||
156718728|NCT05825404|565717206|FG000|First Intervention (Weeks 2-5)|Death|0|||
156718729|NCT05825404|565717207|FG001|First Intervention (Weeks 2-5)|Death|1|||
156718730|NCT05825404|565717206|FG000|Second Intervention (Weeks 8-11)|Death|0|||
156718731|NCT05825404|565717207|FG001|Second Intervention (Weeks 8-11)|Death|1|||
156718732|NCT01127256|565717208|FG000|Overall Study|Adverse Event|13|||
156718733|NCT01127256|565717209|FG001|Overall Study|Adverse Event|13|||
156718734|NCT01127256|565717208|FG000|Overall Study|Lack of Efficacy|4|||
156718735|NCT01127256|565717209|FG001|Overall Study|Lack of Efficacy|0|||
156718736|NCT01127256|565717208|FG000|Overall Study|Lost to Follow-up|16|||
156718737|NCT01127256|565717209|FG001|Overall Study|Lost to Follow-up|17|||
156718738|NCT01127256|565717208|FG000|Overall Study|Withdrawal by Subject|5|||
156718739|NCT01127256|565717209|FG001|Overall Study|Withdrawal by Subject|9|||
156718740|NCT01127256|565717208|FG000|Overall Study|Protocol Violation|1|||
156793776|NCT03249558|565997504|FG000|Overall Study|Withdrawal by Subject|6|||
156793777|NCT03249558|565997505|FG001|Overall Study|Withdrawal by Subject|5|||
156793778|NCT03249558|565997506|FG002|Overall Study|Withdrawal by Subject|7|||
156793779|NCT03249558|565997504|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
156793780|NCT03249558|565997505|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
156793781|NCT03249558|565997506|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
156793782|NCT03249558|565997504|FG000|Overall Study|Protocol Violation|1|||
156793783|NCT03249558|565997505|FG001|Overall Study|Protocol Violation|1|||
156793784|NCT03249558|565997506|FG002|Overall Study|Protocol Violation|2|||
156793785|NCT03878069|565997507|FG000|Overall Study|Death|0|||
156793786|NCT03878069|565997508|FG001|Overall Study|Death|1|||
156793787|NCT03878069|565997509|FG002|Overall Study|Death|0|||
156793788|NCT04101331|565999432|FG000|Overall Study|Adverse Event|9|||
156793789|NCT04101331|565999432|FG000|Overall Study|Disease progression|82|||
156793790|NCT04101331|565999432|FG000|Overall Study|Withdrawal by Subject|1|||
156793791|NCT04101331|565999432|FG000|Overall Study|Investigator decision|6|||
156793792|NCT04101331|565999432|FG000|Overall Study|Death|6|||
156793793|NCT04101331|565999432|FG000|Overall Study|Allogenic transplant|1|||
156793794|NCT01356940|565999442|FG000|First Intervention (28 Days)|Adverse Event|1|||
156793795|NCT01356940|565999443|FG001|First Intervention (28 Days)|Adverse Event|0|||
156793796|NCT01356940|565999442|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
156793797|NCT01356940|565999443|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
156793798|NCT03412591|565999449|FG000|Overall Study|Withdrawal by Subject|1|||
156718741|NCT01127256|565717209|FG001|Overall Study|Protocol Violation|0|||
156718742|NCT01749826|565717210|FG000|Overall Study|Study Terminated|20|||
156718743|NCT01749826|565717211|FG001|Overall Study|Study Terminated|0|||
156718744|NCT00679211|565717212|FG000|Overall Study|Progressive disease|82|||
156793799|NCT03412591|565999450|FG001|Overall Study|Withdrawal by Subject|8|||
156793800|NCT03412591|565999449|FG000|Overall Study|Adverse Event|0|||
156793801|NCT03412591|565999450|FG001|Overall Study|Adverse Event|1|||
156718745|NCT00679211|565717212|FG000|Overall Study|Adverse Event|7|||
156718746|NCT00679211|565717212|FG000|Overall Study|Withdrawal by Subject|2|||
156718747|NCT00679211|565717212|FG000|Overall Study|Physician Decision|5|||
156718748|NCT00679211|565717212|FG000|Overall Study|Refused to undergo protocol procedures|1|||
156793802|NCT02272985|565999451|FG000|Overall Study|Withdrawal by Subject|1|||
156718749|NCT00679211|565717212|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
156718750|NCT00679211|565717212|FG000|Overall Study|Other|1|||
156718751|NCT00931528|565717213|FG000|Overall Study|Protocol Violation|9|||
156718752|NCT00931528|565717214|FG001|Overall Study|Protocol Violation|12|||
156718753|NCT00931528|565717213|FG000|Overall Study|Withdrawal by Subject|4|||
156718754|NCT00931528|565717214|FG001|Overall Study|Withdrawal by Subject|12|||
156718755|NCT00931528|565717213|FG000|Overall Study|Lost to Follow-up|6|||
156718756|NCT00931528|565717214|FG001|Overall Study|Lost to Follow-up|13|||
156718757|NCT00931528|565717213|FG000|Overall Study|Assessment outside of Time Frame|22|||
156718758|NCT00931528|565717214|FG001|Overall Study|Assessment outside of Time Frame|23|||
156718759|NCT01470248|565717215|FG000|Overall Study|Withdrawal by Subject|1|||
156718760|NCT05085834|565717216|FG000|Overall Study|Lost to Follow-up|9|||
156718761|NCT05085834|565717217|FG001|Overall Study|Lost to Follow-up|2|||
156718762|NCT05085834|565717216|FG000|Overall Study|Adverse Event|6|||
156718763|NCT05085834|565717217|FG001|Overall Study|Adverse Event|0|||
156718764|NCT05085834|565717216|FG000|Overall Study|Death|1|||
156718765|NCT05085834|565717217|FG001|Overall Study|Death|0|||
156718766|NCT05085834|565717216|FG000|Overall Study|Inability to swallow the pill|0|||
156718767|NCT05085834|565717217|FG001|Overall Study|Inability to swallow the pill|1|||
156718768|NCT05842967|565717220|FG000|Period 1: SSA|Adverse Event|1|||
156718769|NCT05842967|565717221|FG001|Period 1: SSA|Adverse Event|1|||
156718770|NCT05842967|565717222|FG002|Period 1: SSA|Adverse Event|0|||
156718771|NCT05842967|565717223|FG003|Period 1: SSA|Adverse Event|0|||
156718772|NCT05842967|565717220|FG000|Period 1: SSA|Death|1|||
156718773|NCT05842967|565717221|FG001|Period 1: SSA|Death|0|||
156718774|NCT05842967|565717222|FG002|Period 1: SSA|Death|0|||
156718775|NCT05842967|565717223|FG003|Period 1: SSA|Death|0|||
156718776|NCT05842967|565717220|FG000|Period 1: SSA|Lost to Follow-up|16|||
156718777|NCT05842967|565717221|FG001|Period 1: SSA|Lost to Follow-up|4|||
156718778|NCT05842967|565717222|FG002|Period 1: SSA|Lost to Follow-up|0|||
156718779|NCT05842967|565717223|FG003|Period 1: SSA|Lost to Follow-up|0|||
156718780|NCT05842967|565717220|FG000|Period 1: SSA|Physician Decision|1|||
156718781|NCT05842967|565717221|FG001|Period 1: SSA|Physician Decision|0|||
156718782|NCT05842967|565717222|FG002|Period 1: SSA|Physician Decision|0|||
156718783|NCT05842967|565717223|FG003|Period 1: SSA|Physician Decision|0|||
156718784|NCT05842967|565717220|FG000|Period 1: SSA|Withdrawal by Subject|2|||
156718785|NCT05842967|565717221|FG001|Period 1: SSA|Withdrawal by Subject|2|||
156718786|NCT05842967|565717222|FG002|Period 1: SSA|Withdrawal by Subject|0|||
156718787|NCT05842967|565717223|FG003|Period 1: SSA|Withdrawal by Subject|0|||
156718788|NCT05842967|565717220|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
156718789|NCT05842967|565717221|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
156718790|NCT05842967|565717222|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
156718791|NCT05842967|565717223|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
156718792|NCT05842967|565717220|FG000|Period 2: SSB|Adverse Event|0|||
156718793|NCT05842967|565717221|FG001|Period 2: SSB|Adverse Event|0|||
156718794|NCT05842967|565717222|FG002|Period 2: SSB|Adverse Event|2|||
156718795|NCT05842967|565717223|FG003|Period 2: SSB|Adverse Event|0|||
156718796|NCT05842967|565717220|FG000|Period 2: SSB|Lost to Follow-up|0|||
156718797|NCT05842967|565717221|FG001|Period 2: SSB|Lost to Follow-up|0|||
156718798|NCT05842967|565717222|FG002|Period 2: SSB|Lost to Follow-up|4|||
156718799|NCT05842967|565717223|FG003|Period 2: SSB|Lost to Follow-up|3|||
156718800|NCT05842967|565717220|FG000|Period 2: SSB|Withdrawal by Subject|0|||
156718801|NCT05842967|565717221|FG001|Period 2: SSB|Withdrawal by Subject|0|||
156718802|NCT05842967|565717222|FG002|Period 2: SSB|Withdrawal by Subject|1|||
156718803|NCT05842967|565717223|FG003|Period 2: SSB|Withdrawal by Subject|0|||
156793803|NCT02272985|565999451|FG000|Overall Study|hip fracture|1|||
156793804|NCT02272985|565999451|FG000|Overall Study|kidney transplantation|1|||
156793805|NCT00505687|565999454|FG000|Overall Study|Important protocol violation|2|||
156793806|NCT00505687|565999454|FG000|Overall Study|Lack of Efficacy|15|||
157133396|NCT03887130|567236096|FG001|Overall Study|Protocol Violation|1|||
156718804|NCT05842967|565717220|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
156718805|NCT05842967|565717221|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
156718806|NCT05842967|565717222|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
156718807|NCT05842967|565717223|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
156718808|NCT05842967|565717220|FG000|Period 2: SSB|Protocol Violation|0|||
156718809|NCT05842967|565717221|FG001|Period 2: SSB|Protocol Violation|0|||
156718810|NCT05842967|565717222|FG002|Period 2: SSB|Protocol Violation|0|||
156718811|NCT05842967|565717223|FG003|Period 2: SSB|Protocol Violation|1|||
156718812|NCT01402570|565717231|FG000|Overall Study|Adverse Event|1|||
156718813|NCT03642262|565717234|FG000|Period 1|Withdrawal by Subject|1|||
156718814|NCT03642262|565717235|FG001|Period 1|Withdrawal by Subject|1|||
156718815|NCT03642262|565717234|FG000|Period 1|Adverse Event|0|||
156718816|NCT03642262|565717235|FG001|Period 1|Adverse Event|1|||
156718817|NCT02157935|565717236|FG000|Overall Study|Withdrawal by Subject|25|||
156718818|NCT02157935|565717237|FG001|Overall Study|Withdrawal by Subject|39|||
156793807|NCT00505687|565999454|FG000|Overall Study|Adverse Event|48|||
156718819|NCT02157935|565717236|FG000|Overall Study|Screen failure|1|||
156718820|NCT02157935|565717237|FG001|Overall Study|Screen failure|2|||
156793808|NCT00505687|565999454|FG000|Overall Study|Subject withdrew consent|15|||
157133397|NCT03887130|567236097|FG002|Overall Study|Protocol Violation|2|||
157133398|NCT03887130|567236095|FG000|Overall Study|Drug related toxicity|7|||
157133399|NCT03887130|567236096|FG001|Overall Study|Drug related toxicity|7|||
157133400|NCT03887130|567236097|FG002|Overall Study|Drug related toxicity|13|||
157133401|NCT03887130|567236095|FG000|Overall Study|Non drug related toxicity|3|||
157133402|NCT03887130|567236096|FG001|Overall Study|Non drug related toxicity|0|||
156718821|NCT02157935|565717236|FG000|Overall Study|Protocol Violation|1|||
156718822|NCT02157935|565717237|FG001|Overall Study|Protocol Violation|0|||
156718823|NCT02157935|565717236|FG000|Overall Study|Progressive disease|0|||
156718824|NCT02157935|565717237|FG001|Overall Study|Progressive disease|2|||
156718825|NCT02157935|565717236|FG000|Overall Study|Other|5|||
156718826|NCT02157935|565717237|FG001|Overall Study|Other|12|||
156718827|NCT02157935|565717236|FG000|Overall Study|Lack of Efficacy|0|||
156718828|NCT02157935|565717237|FG001|Overall Study|Lack of Efficacy|1|||
156718829|NCT02157935|565717236|FG000|Overall Study|Death|4|||
156718830|NCT02157935|565717237|FG001|Overall Study|Death|4|||
156718831|NCT02157935|565717236|FG000|Overall Study|Adverse Event|3|||
156718832|NCT02157935|565717237|FG001|Overall Study|Adverse Event|5|||
156718833|NCT01173523|565717238|FG000|Overall Study|Clinical Progression|1|||
156718834|NCT01173523|565717239|FG001|Overall Study|Clinical Progression|1|||
156718835|NCT01173523|565717238|FG000|Overall Study|Progressive Disease|10|||
156718836|NCT01173523|565717239|FG001|Overall Study|Progressive Disease|8|||
156718837|NCT01173523|565717238|FG000|Overall Study|Other|2|||
156718838|NCT01173523|565717239|FG001|Overall Study|Other|3|||
156718839|NCT02302833|565717246|FG000|Overall Study|Lost to Follow-up|3|||
156718840|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
156718841|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
156718842|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718843|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718844|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718845|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
156718846|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
156718847|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
156718848|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
156718849|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
156718850|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
156718851|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
156718852|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
156718853|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
156718854|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
156718855|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718856|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718857|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
156718858|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
156718859|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
156718860|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
156718861|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718862|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718863|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
156718864|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
156718865|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
156718866|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
156718867|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718868|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718869|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
156718870|NCT04429503|565717247|FG000|Main Study (Up to Wk 96)|Death|9|||
156718871|NCT04429503|565717248|FG001|Main Study (Up to Wk 96)|Death|18|||
156718872|NCT04429503|565717249|FG002|Main Study (Up to Wk 96)|Death|5|||
156718873|NCT04429503|565717250|FG003|Main Study (Up to Wk 96)|Death|0|||
156718874|NCT04429503|565717251|FG004|Main Study (Up to Wk 96)|Death|0|||
156718875|NCT04429503|565717252|FG005|Main Study (Up to Wk 96)|Death|0|||
156718876|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718877|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718878|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718879|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
156718880|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718881|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
156718882|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718883|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718884|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
156718885|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
157133403|NCT03887130|567236097|FG002|Overall Study|Non drug related toxicity|0|||
157217238|NCT03210259|567541053|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
157217239|NCT03210259|567541054|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
156718886|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
156718887|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
156718888|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718889|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718890|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718891|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
156718892|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
156718893|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
156718894|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718895|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718896|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
156718897|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
156718898|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
156718899|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
156718900|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718901|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718902|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
156718903|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
156718904|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
156718905|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
156718906|NCT04429503|565717247|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718907|NCT04429503|565717248|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718908|NCT04429503|565717249|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
156718909|NCT04429503|565717250|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
156718910|NCT04429503|565717251|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
156718911|NCT04429503|565717252|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
156718912|NCT05516108|565717253|FG000|Overall Study|Time Commitment|3|||
156718913|NCT05516108|565717254|FG001|Overall Study|Time Commitment|1|||
156718914|NCT05516108|565717253|FG000|Overall Study|Reason Unknown|2|||
156718915|NCT05516108|565717254|FG001|Overall Study|Reason Unknown|4|||
156718916|NCT02717507|565717255|FG000|Overall Study|Lost to Follow-up|5|||
156718917|NCT02717507|565717256|FG001|Overall Study|Lost to Follow-up|8|||
156718918|NCT02717507|565717255|FG000|Overall Study|Pregnancy|1|||
156718919|NCT02717507|565717256|FG001|Overall Study|Pregnancy|1|||
156718920|NCT02717507|565717255|FG000|Overall Study|Protocol Violation|2|||
156718921|NCT02717507|565717256|FG001|Overall Study|Protocol Violation|2|||
156718922|NCT02717507|565717255|FG000|Overall Study|Withdrawal by Subject|20|||
156718923|NCT02717507|565717256|FG001|Overall Study|Withdrawal by Subject|20|||
156718924|NCT02717507|565717255|FG000|Overall Study|Relapse|1|||
156718925|NCT02717507|565717256|FG001|Overall Study|Relapse|1|||
156718926|NCT02717507|565717255|FG000|Overall Study|Cardiac Event|2|||
156718927|NCT02717507|565717256|FG001|Overall Study|Cardiac Event|6|||
156718928|NCT05017246|565717257|FG000|Overall Study|Withdrawal by Subject|5|||
156718929|NCT05017246|565717258|FG001|Overall Study|Withdrawal by Subject|3|||
156718930|NCT05017246|565717257|FG000|Overall Study|Determined to be ineligible|0|||
156718931|NCT05017246|565717258|FG001|Overall Study|Determined to be ineligible|1|||
156718932|NCT05017246|565717257|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
156718933|NCT05017246|565717258|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
156718934|NCT05017246|565717257|FG000|Overall Study|Technical failure|1|||
156718935|NCT05017246|565717258|FG001|Overall Study|Technical failure|3|||
156718936|NCT02493660|565717261|FG000|Overall Study|Physician Decision|0|||
156718937|NCT02493660|565717262|FG001|Overall Study|Physician Decision|1|||
156718938|NCT02493660|565717261|FG000|Overall Study|Adverse Event|4|||
156718939|NCT02493660|565717262|FG001|Overall Study|Adverse Event|2|||
157217240|NCT00345683|567541055|FG000|Overall Study|Lost to Follow-up|19|||
156718940|NCT02493660|565717261|FG000|Overall Study|Withdrawal by Subject|2|||
156718941|NCT02493660|565717262|FG001|Overall Study|Withdrawal by Subject|3|||
157217241|NCT00345683|567541056|FG001|Overall Study|Lost to Follow-up|7|||
157217242|NCT00345683|567541055|FG000|Overall Study|Other|6|||
156718942|NCT02493660|565717261|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
156718943|NCT02493660|565717262|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
156718944|NCT02493660|565717261|FG000|Overall Study|Protocol Violation|0|||
157217243|NCT00345683|567541056|FG001|Overall Study|Other|2|||
156718945|NCT02493660|565717262|FG001|Overall Study|Protocol Violation|1|||
156718946|NCT02493660|565717261|FG000|Overall Study|Death|0|||
156718947|NCT02493660|565717262|FG001|Overall Study|Death|1|||
157217244|NCT03634488|567541057|FG000|Overall Study|Death|1|||
157217245|NCT03634488|567541058|FG001|Overall Study|Death|0|||
157217246|NCT03634488|567541059|FG002|Overall Study|Death|0|||
157217247|NCT03634488|567541057|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
157221654|NCT00094302|567558466|FG001|Overall Study|Withdrawal by Subject|111|||
156718948|NCT02493660|565717261|FG000|Overall Study|Lost to Follow-up|2|||
156718949|NCT02493660|565717262|FG001|Overall Study|Lost to Follow-up|4|||
156718950|NCT00709995|565717263|FG000|Overall Study|Adverse Event|4|||
156718951|NCT00709995|565717264|FG001|Overall Study|Adverse Event|2|||
156718952|NCT00709995|565717263|FG000|Overall Study|Withdrawal by Subject|1|||
156718953|NCT00709995|565717264|FG001|Overall Study|Withdrawal by Subject|3|||
156718954|NCT01037218|565717272|FG000|Overall Study|Adverse Event|4|||
156718955|NCT01037218|565717273|FG001|Overall Study|Adverse Event|2|||
156718956|NCT01037218|565717274|FG002|Overall Study|Adverse Event|2|||
156718957|NCT01037218|565717275|FG003|Overall Study|Adverse Event|1|||
156718958|NCT01037218|565717272|FG000|Overall Study|Lack of Efficacy|0|||
156718959|NCT01037218|565717273|FG001|Overall Study|Lack of Efficacy|2|||
156718960|NCT01037218|565717274|FG002|Overall Study|Lack of Efficacy|1|||
156718961|NCT01037218|565717275|FG003|Overall Study|Lack of Efficacy|5|||
156718962|NCT01037218|565717272|FG000|Overall Study|Lost to Follow-up|3|||
156718963|NCT01037218|565717273|FG001|Overall Study|Lost to Follow-up|5|||
156718964|NCT01037218|565717274|FG002|Overall Study|Lost to Follow-up|4|||
156718965|NCT01037218|565717275|FG003|Overall Study|Lost to Follow-up|2|||
156718966|NCT01037218|565717272|FG000|Overall Study|Withdrawal by Subject|6|||
156718967|NCT01037218|565717273|FG001|Overall Study|Withdrawal by Subject|7|||
156718968|NCT01037218|565717274|FG002|Overall Study|Withdrawal by Subject|7|||
156718969|NCT01037218|565717275|FG003|Overall Study|Withdrawal by Subject|4|||
156718970|NCT01037218|565717272|FG000|Overall Study|Partner Withdrew Consent|0|||
156718971|NCT01037218|565717273|FG001|Overall Study|Partner Withdrew Consent|3|||
156718972|NCT01037218|565717274|FG002|Overall Study|Partner Withdrew Consent|2|||
156718973|NCT01037218|565717275|FG003|Overall Study|Partner Withdrew Consent|1|||
156718974|NCT01037218|565717272|FG000|Overall Study|Protocol Violation|0|||
156718975|NCT01037218|565717273|FG001|Overall Study|Protocol Violation|0|||
156718976|NCT01037218|565717274|FG002|Overall Study|Protocol Violation|2|||
156718977|NCT01037218|565717275|FG003|Overall Study|Protocol Violation|2|||
156718978|NCT01037218|565717272|FG000|Overall Study|Various|3|||
156718979|NCT01037218|565717273|FG001|Overall Study|Various|2|||
156718980|NCT01037218|565717274|FG002|Overall Study|Various|3|||
156718981|NCT01037218|565717275|FG003|Overall Study|Various|1|||
156718982|NCT02568072|565717276|FG000|Overall Study|Unavailable for appointment|23|||
156718983|NCT02568072|565717276|FG000|Overall Study|Unable to contact|3|||
156718984|NCT02568072|565717276|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
156718985|NCT02568072|565717276|FG000|Overall Study|Withdrawal by Subject|1|||
156718986|NCT02568072|565717276|FG000|Overall Study|Sustained injury, marathon not run|24|||
156718987|NCT00927589|565717278|FG000|Overall Study|Death|1|||
156718988|NCT00927589|565717278|FG000|Overall Study|Physician Decision|1|||
156718989|NCT00927589|565717278|FG000|Overall Study|Withdrawal by Subject|3|||
156718990|NCT00927589|565717278|FG000|Overall Study|Adverse Event|2|||
156718991|NCT00927589|565717278|FG000|Overall Study|Disease Progression|8|||
156718992|NCT00927589|565717278|FG000|Overall Study|Non-compliance|1|||
156718993|NCT05263908|565717280|FG000|Overall Study|No informed consent for publication of study results|397|||
156718994|NCT05263908|565717280|FG000|Overall Study|CRF not collected|1|||
156718995|NCT02714218|565717281|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156718996|NCT02714218|565717282|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156718997|NCT02714218|565717283|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156718998|NCT02714218|565717281|FG000|Pre-Treatment Period|Other reasons|0|||
156718999|NCT02714218|565717282|FG001|Pre-Treatment Period|Other reasons|1|||
156719000|NCT02714218|565717283|FG002|Pre-Treatment Period|Other reasons|0|||
156719001|NCT02714218|565717281|FG000|Treatment Period|Disease Progression|55|||
156719002|NCT02714218|565717282|FG001|Treatment Period|Disease Progression|52|||
156719003|NCT02714218|565717283|FG002|Treatment Period|Disease Progression|14|||
156719004|NCT02714218|565717281|FG000|Treatment Period|Study drug toxicity|46|||
156719005|NCT02714218|565717282|FG001|Treatment Period|Study drug toxicity|70|||
156719006|NCT02714218|565717283|FG002|Treatment Period|Study drug toxicity|6|||
156719007|NCT02714218|565717281|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
156719008|NCT02714218|565717282|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
156719009|NCT02714218|565717283|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
156719010|NCT02714218|565717281|FG000|Treatment Period|Request to discontinue treatment|1|||
156719011|NCT02714218|565717282|FG001|Treatment Period|Request to discontinue treatment|4|||
156719012|NCT02714218|565717283|FG002|Treatment Period|Request to discontinue treatment|1|||
156719013|NCT02714218|565717281|FG000|Treatment Period|Participant withdrew consent|2|||
156719014|NCT02714218|565717282|FG001|Treatment Period|Participant withdrew consent|2|||
156793809|NCT00505687|565999454|FG000|Overall Study|Lost to Follow-up|1|||
157133404|NCT03887130|567236095|FG000|Overall Study|Death|2|||
156719015|NCT02714218|565717283|FG002|Treatment Period|Participant withdrew consent|0|||
156719016|NCT02714218|565717281|FG000|Treatment Period|Maximum clinical benefit|4|||
156719017|NCT02714218|565717282|FG001|Treatment Period|Maximum clinical benefit|2|||
156719018|NCT02714218|565717283|FG002|Treatment Period|Maximum clinical benefit|0|||
156719019|NCT02714218|565717281|FG000|Treatment Period|Administrative reason by sponsor|2|||
156719020|NCT02714218|565717282|FG001|Treatment Period|Administrative reason by sponsor|1|||
156719021|NCT02714218|565717283|FG002|Treatment Period|Administrative reason by sponsor|0|||
156719022|NCT02714218|565717281|FG000|Treatment Period|Other reasons|6|||
156719023|NCT02714218|565717282|FG001|Treatment Period|Other reasons|6|||
156719024|NCT02714218|565717283|FG002|Treatment Period|Other reasons|0|||
156719025|NCT02714218|565717281|FG000|Treatment Period|Completed treatment as per protocol|36|||
156719026|NCT02714218|565717282|FG001|Treatment Period|Completed treatment as per protocol|27|||
156719027|NCT02714218|565717283|FG002|Treatment Period|Completed treatment as per protocol|3|||
156719028|NCT02714218|565717281|FG000|Treatment Period|Not reported|9|||
156719029|NCT02714218|565717282|FG001|Treatment Period|Not reported|6|||
156719030|NCT02714218|565717283|FG002|Treatment Period|Not reported|0|||
156719031|NCT01641640|565717284|FG000|Overall Study|Enrolled but not treated|1|||
156719032|NCT01641640|565717284|FG000|Overall Study|Efficacy failure|29|||
156719033|NCT01641640|565717284|FG000|Overall Study|Lost to Follow-up|3|||
156719034|NCT01641640|565717284|FG000|Overall Study|Withdrawal by Subject|2|||
156719035|NCT01641640|565717284|FG000|Overall Study|Adverse Event|1|||
156719036|NCT01199939|565717286|FG000|Overall Study|Adverse Event|4|||
156719037|NCT01199939|565717286|FG000|Overall Study|Protocol Violation|3|||
156719038|NCT01199939|565717286|FG000|Overall Study|Lost to Follow-up|2|||
156719039|NCT01199939|565717286|FG000|Overall Study|Reached a virologic endpoint|4|||
156719040|NCT02792517|565717287|FG000|Overall Study|Withdrawal by Subject|10|||
156719041|NCT02792517|565717287|FG000|Overall Study|Decision by Sponsor|7|||
156719042|NCT02792517|565717287|FG000|Overall Study|Lost to Follow-up|3|||
156719043|NCT03875508|565717288|FG000|Overall Study|Adverse Event|1|||
156719044|NCT03875508|565717288|FG000|Overall Study|Lost to Follow-up|8|||
156719045|NCT03875508|565717288|FG000|Overall Study|Lack of Efficacy|1|||
156719046|NCT03875508|565717288|FG000|Overall Study|Other, not specified|2|||
156719047|NCT01113892|565717293|FG000|Overall Study|Lost to Follow-up|2|||
156719048|NCT01113892|565717294|FG001|Overall Study|Lost to Follow-up|2|||
156719049|NCT01113892|565717293|FG000|Overall Study|Withdrawal by Subject|1|||
156719050|NCT01113892|565717294|FG001|Overall Study|Withdrawal by Subject|1|||
156719051|NCT01113892|565717293|FG000|Overall Study|Death|2|||
156719052|NCT01113892|565717294|FG001|Overall Study|Death|4|||
156719053|NCT01113892|565717293|FG000|Overall Study|Graft no longer evaluable|9|||
156719054|NCT01113892|565717294|FG001|Overall Study|Graft no longer evaluable|9|||
156719055|NCT00789854|565717299|FG000|Overall Study|Adverse Event|28|||
156719056|NCT00789854|565717300|FG001|Overall Study|Adverse Event|23|||
156719057|NCT00789854|565717301|FG002|Overall Study|Adverse Event|18|||
156719058|NCT00789854|565717299|FG000|Overall Study|Lost to Follow-up|1|||
156719059|NCT00789854|565717300|FG001|Overall Study|Lost to Follow-up|1|||
156719060|NCT00789854|565717301|FG002|Overall Study|Lost to Follow-up|4|||
156719061|NCT00789854|565717299|FG000|Overall Study|Withdrawal by Subject|9|||
156719062|NCT00789854|565717300|FG001|Overall Study|Withdrawal by Subject|6|||
156719063|NCT00789854|565717301|FG002|Overall Study|Withdrawal by Subject|17|||
156719064|NCT00789854|565717299|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156719065|NCT00789854|565717300|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
156719066|NCT00789854|565717301|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156719067|NCT00789854|565717299|FG000|Overall Study|Severe non-compliance to the protocol|3|||
156719068|NCT00789854|565717300|FG001|Overall Study|Severe non-compliance to the protocol|0|||
156719069|NCT00789854|565717301|FG002|Overall Study|Severe non-compliance to the protocol|0|||
156719070|NCT00789854|565717299|FG000|Overall Study|Safety reasons|0|||
156719071|NCT00789854|565717300|FG001|Overall Study|Safety reasons|0|||
156719072|NCT00789854|565717301|FG002|Overall Study|Safety reasons|2|||
156719073|NCT00789854|565717299|FG000|Overall Study|Other|6|||
156719074|NCT00789854|565717300|FG001|Overall Study|Other|0|||
156719075|NCT00789854|565717301|FG002|Overall Study|Other|5|||
156719076|NCT02766335|565717302|FG000|Initial Registration|Adverse Event|6|||
156719077|NCT02766335|565717303|FG001|Initial Registration|Adverse Event|3|||
156719078|NCT02766335|565717304|FG002|Initial Registration|Adverse Event|0|||
156719079|NCT02766335|565717302|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
156719080|NCT02766335|565717303|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
156719081|NCT02766335|565717304|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
156719082|NCT02766335|565717302|FG000|Initial Registration|Progression/relapse|49|||
156719083|NCT02766335|565717303|FG001|Initial Registration|Progression/relapse|15|||
156719084|NCT02766335|565717304|FG002|Initial Registration|Progression/relapse|0|||
156719085|NCT02766335|565717302|FG000|Initial Registration|Death|1|||
156719086|NCT02766335|565717303|FG001|Initial Registration|Death|3|||
156719087|NCT02766335|565717304|FG002|Initial Registration|Death|0|||
156719088|NCT02766335|565717302|FG000|Initial Registration|not protocol specified|1|||
157221655|NCT00094302|567558465|FG000|Overall Study|Death|266|||
156719089|NCT02766335|565717303|FG001|Initial Registration|not protocol specified|9|||
156719090|NCT02766335|565717304|FG002|Initial Registration|not protocol specified|0|||
156719091|NCT02766335|565717302|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
156719092|NCT02766335|565717303|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
156719093|NCT02766335|565717304|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
156719094|NCT02766335|565717302|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
156719095|NCT02766335|565717303|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
156719096|NCT02766335|565717304|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
156719097|NCT02857816|565717305|FG000|Overall Study|Screen Failure|33|||
156719098|NCT02857816|565717305|FG000|Overall Study|Withdrawal by Subject|4|||
156719099|NCT02857816|565717305|FG000|Overall Study|Lost to Follow-up|1|||
156719100|NCT00729937|565717306|FG000|Overall Study|Lost to Follow-up|49|||
156719101|NCT00729937|565717307|FG001|Overall Study|Lost to Follow-up|58|||
156719102|NCT00729937|565717308|FG002|Overall Study|Lost to Follow-up|18|||
156719103|NCT00729937|565717309|FG003|Overall Study|Lost to Follow-up|33|||
156719104|NCT00729937|565717310|FG004|Overall Study|Lost to Follow-up|18|||
156719105|NCT00729937|565717311|FG005|Overall Study|Lost to Follow-up|23|||
156719106|NCT00729937|565717306|FG000|Overall Study|Physician Decision|7|||
156719107|NCT00729937|565717307|FG001|Overall Study|Physician Decision|16|||
156719108|NCT00729937|565717308|FG002|Overall Study|Physician Decision|2|||
156719109|NCT00729937|565717309|FG003|Overall Study|Physician Decision|0|||
156719110|NCT00729937|565717310|FG004|Overall Study|Physician Decision|5|||
156719111|NCT00729937|565717311|FG005|Overall Study|Physician Decision|8|||
156719112|NCT00729937|565717306|FG000|Overall Study|Death|1|||
156719113|NCT00729937|565717307|FG001|Overall Study|Death|0|||
156719114|NCT00729937|565717308|FG002|Overall Study|Death|1|||
156719115|NCT00729937|565717309|FG003|Overall Study|Death|0|||
156719116|NCT00729937|565717310|FG004|Overall Study|Death|0|||
156719117|NCT00729937|565717311|FG005|Overall Study|Death|1|||
156719118|NCT00729937|565717306|FG000|Overall Study|Withdrawal by Subject|3|||
156719119|NCT00729937|565717307|FG001|Overall Study|Withdrawal by Subject|5|||
156719120|NCT00729937|565717308|FG002|Overall Study|Withdrawal by Subject|6|||
156719121|NCT00729937|565717309|FG003|Overall Study|Withdrawal by Subject|0|||
156719122|NCT00729937|565717310|FG004|Overall Study|Withdrawal by Subject|4|||
156719123|NCT00729937|565717311|FG005|Overall Study|Withdrawal by Subject|2|||
156719124|NCT00729937|565717306|FG000|Overall Study|Randomized but not treated|12|||
156719125|NCT00729937|565717307|FG001|Overall Study|Randomized but not treated|6|||
156719126|NCT00729937|565717308|FG002|Overall Study|Randomized but not treated|1|||
156719127|NCT00729937|565717309|FG003|Overall Study|Randomized but not treated|0|||
156719128|NCT00729937|565717310|FG004|Overall Study|Randomized but not treated|1|||
156719129|NCT00729937|565717311|FG005|Overall Study|Randomized but not treated|3|||
156719130|NCT00729937|565717306|FG000|Overall Study|Did not meet eligibility criteria|2|||
156719131|NCT00729937|565717307|FG001|Overall Study|Did not meet eligibility criteria|1|||
156719132|NCT00729937|565717308|FG002|Overall Study|Did not meet eligibility criteria|0|||
156719133|NCT00729937|565717309|FG003|Overall Study|Did not meet eligibility criteria|0|||
156719134|NCT00729937|565717310|FG004|Overall Study|Did not meet eligibility criteria|0|||
156719135|NCT00729937|565717311|FG005|Overall Study|Did not meet eligibility criteria|0|||
156719136|NCT00729937|565717306|FG000|Overall Study|Incarcerated|0|||
156719137|NCT00729937|565717307|FG001|Overall Study|Incarcerated|2|||
156719138|NCT00729937|565717308|FG002|Overall Study|Incarcerated|1|||
156719139|NCT00729937|565717309|FG003|Overall Study|Incarcerated|1|||
156719140|NCT00729937|565717310|FG004|Overall Study|Incarcerated|0|||
156719141|NCT00729937|565717311|FG005|Overall Study|Incarcerated|0|||
156719142|NCT03200717|565717318|FG000|Overall Study|Progressive disease|24|||
156719143|NCT03200717|565717319|FG001|Overall Study|Progressive disease|5|||
156719144|NCT03200717|565717318|FG000|Overall Study|Adverse Event|11|||
156719145|NCT03200717|565717319|FG001|Overall Study|Adverse Event|8|||
156719146|NCT03200717|565717318|FG000|Overall Study|Physician Decision|3|||
156719147|NCT03200717|565717319|FG001|Overall Study|Physician Decision|2|||
156719148|NCT03200717|565717318|FG000|Overall Study|Death|2|||
156719149|NCT03200717|565717319|FG001|Overall Study|Death|0|||
156719150|NCT03200717|565717318|FG000|Overall Study|Subject/Guardian Decision|1|||
156719151|NCT03200717|565717319|FG001|Overall Study|Subject/Guardian Decision|0|||
156719152|NCT03552380|565717321|FG000|Study Treatment|Disease Progression|3|||
156719153|NCT03552380|565717322|FG001|Study Treatment|Disease Progression|4|||
156719154|NCT03552380|565717321|FG000|Study Treatment|Adverse Event|2|||
156719155|NCT03552380|565717322|FG001|Study Treatment|Adverse Event|2|||
156719156|NCT03552380|565717321|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
156719157|NCT03552380|565717322|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
156719158|NCT03552380|565717321|FG000|Follow up|Death|3|||
156719159|NCT03552380|565717322|FG001|Follow up|Death|4|||
156719160|NCT03552380|565717321|FG000|Follow up|Site IRB terminated|0|||
156719161|NCT03552380|565717322|FG001|Follow up|Site IRB terminated|1|||
156719162|NCT02461160|565717323|FG000|Overall Study|Lost to Follow-up|0|||
156719163|NCT02461160|565717324|FG001|Overall Study|Lost to Follow-up|0|||
156719164|NCT02461160|565717325|FG002|Overall Study|Lost to Follow-up|0|||
156719165|NCT02461160|565717326|FG003|Overall Study|Lost to Follow-up|0|||
156719166|NCT02461160|565717327|FG004|Overall Study|Lost to Follow-up|0|||
156719167|NCT02461160|565717328|FG005|Overall Study|Lost to Follow-up|0|||
156719168|NCT02461160|565717329|FG006|Overall Study|Lost to Follow-up|0|||
156719169|NCT02461160|565717330|FG007|Overall Study|Lost to Follow-up|1|||
156719170|NCT02461160|565717331|FG008|Overall Study|Lost to Follow-up|0|||
156719171|NCT02461160|565717332|FG009|Overall Study|Lost to Follow-up|0|||
156719172|NCT02461160|565717333|FG010|Overall Study|Lost to Follow-up|0|||
156719173|NCT02461160|565717334|FG011|Overall Study|Lost to Follow-up|0|||
156719174|NCT02461160|565717335|FG012|Overall Study|Lost to Follow-up|0|||
156719175|NCT02899962|565717336|FG000|Open-label Phase|Adverse Event|2|||
156719176|NCT02899962|565717337|FG001|Open-label Phase|Adverse Event|0|||
156719177|NCT02899962|565717338|FG002|Open-label Phase|Adverse Event|0|||
156719178|NCT02899962|565717336|FG000|Open-label Phase|Lost to Follow-up|9|||
156719179|NCT02899962|565717337|FG001|Open-label Phase|Lost to Follow-up|0|||
156719180|NCT02899962|565717338|FG002|Open-label Phase|Lost to Follow-up|0|||
156719181|NCT02899962|565717336|FG000|Open-label Phase|Other reasons|9|||
156719182|NCT02899962|565717337|FG001|Open-label Phase|Other reasons|0|||
156719183|NCT02899962|565717338|FG002|Open-label Phase|Other reasons|0|||
156719184|NCT02899962|565717336|FG000|Open-label Phase|Withdrawal by Subject|7|||
156719185|NCT02899962|565717337|FG001|Open-label Phase|Withdrawal by Subject|0|||
156719186|NCT02899962|565717338|FG002|Open-label Phase|Withdrawal by Subject|0|||
156719187|NCT02899962|565717336|FG000|Maintenance Phase|Adverse Event|0|||
156719188|NCT02899962|565717337|FG001|Maintenance Phase|Adverse Event|2|||
156719189|NCT02899962|565717338|FG002|Maintenance Phase|Adverse Event|1|||
156719190|NCT02899962|565717336|FG000|Maintenance Phase|Death|0|||
156719191|NCT02899962|565717337|FG001|Maintenance Phase|Death|0|||
156719192|NCT02899962|565717338|FG002|Maintenance Phase|Death|1|||
156719193|NCT02899962|565717336|FG000|Maintenance Phase|Lack of Efficacy|0|||
156719194|NCT02899962|565717337|FG001|Maintenance Phase|Lack of Efficacy|20|||
156719195|NCT02899962|565717338|FG002|Maintenance Phase|Lack of Efficacy|16|||
156719196|NCT02899962|565717336|FG000|Maintenance Phase|Lost to Follow-up|0|||
156719197|NCT02899962|565717337|FG001|Maintenance Phase|Lost to Follow-up|12|||
156719198|NCT02899962|565717338|FG002|Maintenance Phase|Lost to Follow-up|14|||
156719199|NCT02899962|565717336|FG000|Maintenance Phase|Other reasons|0|||
156719200|NCT02899962|565717337|FG001|Maintenance Phase|Other reasons|9|||
156719201|NCT02899962|565717338|FG002|Maintenance Phase|Other reasons|13|||
156719202|NCT02899962|565717336|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
156719203|NCT02899962|565717337|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
156719204|NCT02899962|565717338|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
156719205|NCT02899962|565717336|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
156719206|NCT02899962|565717337|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
156719207|NCT02899962|565717338|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
156719208|NCT02899962|565717336|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156719209|NCT02899962|565717337|FG001|Maintenance Phase|Withdrawal by Subject|30|||
156719210|NCT02899962|565717338|FG002|Maintenance Phase|Withdrawal by Subject|36|||
156719211|NCT02404805|565717339|FG000|Overall Study|Withdrawal by Subject|1|||
156719212|NCT02404805|565717340|FG001|Overall Study|Withdrawal by Subject|0|||
156719213|NCT02404805|565717341|FG002|Overall Study|Withdrawal by Subject|0|||
156719214|NCT02404805|565717342|FG003|Overall Study|Withdrawal by Subject|0|||
156719215|NCT02404805|565717343|FG004|Overall Study|Withdrawal by Subject|0|||
156719216|NCT02404805|565717344|FG005|Overall Study|Withdrawal by Subject|0|||
156719217|NCT04563754|565719714|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
156719218|NCT04563754|565719715|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
156719219|NCT04563754|565719716|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
156719220|NCT04563754|565719714|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
156719221|NCT04563754|565719715|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
156719222|NCT04563754|565719716|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
156719223|NCT04563754|565719714|FG000|Follow up|Lost to Follow-up|61|||
156719224|NCT04563754|565719715|FG001|Follow up|Lost to Follow-up|23|||
156719225|NCT04563754|565719716|FG002|Follow up|Lost to Follow-up|5|||
156719226|NCT04563754|565719714|FG000|Follow up|Death|0|||
156719227|NCT04563754|565719715|FG001|Follow up|Death|2|||
156719228|NCT04563754|565719716|FG002|Follow up|Death|0|||
156719229|NCT04563754|565719714|FG000|Follow up|Ongoing|0|||
156719230|NCT04563754|565719715|FG001|Follow up|Ongoing|28|||
156719231|NCT04563754|565719716|FG002|Follow up|Ongoing|0|||
156875350|NCT04896086|566302021|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
157133405|NCT03887130|567236096|FG001|Overall Study|Death|2|||
157133406|NCT03887130|567236097|FG002|Overall Study|Death|1|||
157133407|NCT03887130|567236095|FG000|Overall Study|Withdrawal by Subject|7|||
157133408|NCT03887130|567236096|FG001|Overall Study|Withdrawal by Subject|6|||
157133409|NCT03887130|567236097|FG002|Overall Study|Withdrawal by Subject|11|||
157133410|NCT03887130|567236095|FG000|Overall Study|other reason|6|||
157133411|NCT03887130|567236096|FG001|Overall Study|other reason|20|||
157133412|NCT03887130|567236097|FG002|Overall Study|other reason|17|||
157133413|NCT00927563|567236098|FG000|Overall Study|Lost to Follow-up|1|||
156719232|NCT00070564|565719717|FG000|Overall Study|Progression|2|||
156719233|NCT00070564|565719718|FG001|Overall Study|Progression|4|||
156719234|NCT00070564|565719719|FG002|Overall Study|Progression|7|||
156719235|NCT00070564|565719720|FG003|Overall Study|Progression|7|||
156719236|NCT00070564|565719721|FG004|Overall Study|Progression|1|||
156719237|NCT00070564|565719722|FG005|Overall Study|Progression|0|||
156719238|NCT00070564|565719717|FG000|Overall Study|Delinquent|1|||
156719239|NCT00070564|565719718|FG001|Overall Study|Delinquent|4|||
156719240|NCT00070564|565719719|FG002|Overall Study|Delinquent|2|||
156719241|NCT00070564|565719720|FG003|Overall Study|Delinquent|0|||
156719242|NCT00070564|565719721|FG004|Overall Study|Delinquent|0|||
156719243|NCT00070564|565719722|FG005|Overall Study|Delinquent|0|||
156719244|NCT00070564|565719717|FG000|Overall Study|Adverse Event|150|||
156719245|NCT00070564|565719718|FG001|Overall Study|Adverse Event|142|||
156719246|NCT00070564|565719719|FG002|Overall Study|Adverse Event|120|||
156719247|NCT00070564|565719720|FG003|Overall Study|Adverse Event|108|||
156719248|NCT00070564|565719721|FG004|Overall Study|Adverse Event|63|||
156719249|NCT00070564|565719722|FG005|Overall Study|Adverse Event|36|||
156719250|NCT00070564|565719717|FG000|Overall Study|Death|4|||
156719251|NCT00070564|565719718|FG001|Overall Study|Death|1|||
156719252|NCT00070564|565719719|FG002|Overall Study|Death|5|||
156719253|NCT00070564|565719720|FG003|Overall Study|Death|3|||
156719254|NCT00070564|565719721|FG004|Overall Study|Death|0|||
156719255|NCT00070564|565719722|FG005|Overall Study|Death|1|||
156719256|NCT00070564|565719717|FG000|Overall Study|Other, not protocol specified|17|||
156719257|NCT00070564|565719718|FG001|Overall Study|Other, not protocol specified|15|||
156719258|NCT00070564|565719719|FG002|Overall Study|Other, not protocol specified|14|||
156719259|NCT00070564|565719720|FG003|Overall Study|Other, not protocol specified|19|||
156719260|NCT00070564|565719721|FG004|Overall Study|Other, not protocol specified|6|||
156719261|NCT00070564|565719722|FG005|Overall Study|Other, not protocol specified|7|||
156719262|NCT00070564|565719717|FG000|Overall Study|Withdrawal by Subject|26|||
156719263|NCT00070564|565719718|FG001|Overall Study|Withdrawal by Subject|37|||
156719264|NCT00070564|565719719|FG002|Overall Study|Withdrawal by Subject|23|||
156719265|NCT00070564|565719720|FG003|Overall Study|Withdrawal by Subject|30|||
156719266|NCT00070564|565719721|FG004|Overall Study|Withdrawal by Subject|8|||
156719267|NCT00070564|565719722|FG005|Overall Study|Withdrawal by Subject|8|||
156719268|NCT00070564|565719717|FG000|Overall Study|Not reported|0|||
156719269|NCT00070564|565719718|FG001|Overall Study|Not reported|0|||
156719270|NCT00070564|565719719|FG002|Overall Study|Not reported|0|||
156719271|NCT00070564|565719720|FG003|Overall Study|Not reported|0|||
156719272|NCT00070564|565719721|FG004|Overall Study|Not reported|1|||
156719273|NCT00070564|565719722|FG005|Overall Study|Not reported|0|||
156719274|NCT03565900|565719724|FG000|Overall Study|Disposition Unknown|4|||
156719275|NCT03565900|565719725|FG001|Overall Study|Disposition Unknown|1|||
156719276|NCT03565900|565719724|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156719277|NCT03565900|565719725|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
156719278|NCT03565900|565719724|FG000|Overall Study|Withdrawal by Subject|4|||
156719279|NCT03565900|565719725|FG001|Overall Study|Withdrawal by Subject|5|||
156719280|NCT03565900|565719724|FG000|Overall Study|Randomized By Mistake|0|||
156719281|NCT03565900|565719725|FG001|Overall Study|Randomized By Mistake|2|||
156719282|NCT03565900|565719724|FG000|Overall Study|Physician Decision|7|||
156719283|NCT03565900|565719725|FG001|Overall Study|Physician Decision|11|||
156719284|NCT03565900|565719724|FG000|Overall Study|Death|9|||
156719285|NCT03565900|565719725|FG001|Overall Study|Death|7|||
156719286|NCT03359850|565719728|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
156719287|NCT03359850|565719729|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
156719288|NCT03359850|565719728|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
156719289|NCT03359850|565719729|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
156719290|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Death|2|||
156719291|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Death|4|||
156719292|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
156719293|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
156719294|NCT03359850|565719728|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
156719295|NCT03359850|565719729|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
156719296|NCT03817125|565719747|FG000|Overall Study|Adverse Event|1|||
156719297|NCT03817125|565719748|FG001|Overall Study|Adverse Event|0|||
156719298|NCT03817125|565719747|FG000|Overall Study|Physician Decision|0|||
156719299|NCT03817125|565719748|FG001|Overall Study|Physician Decision|1|||
156719300|NCT03817125|565719747|FG000|Overall Study|Lack of Efficacy|1|||
156719301|NCT03817125|565719748|FG001|Overall Study|Lack of Efficacy|5|||
156719302|NCT00942084|565719749|FG000|Overall Study|Death|2|||
156719303|NCT00281957|565719756|FG000|Overall Study|Adverse Event|7|||
156719304|NCT00281957|565719757|FG001|Overall Study|Adverse Event|2|||
156719305|NCT00281957|565719756|FG000|Overall Study|Death|1|||
156719306|NCT00281957|565719757|FG001|Overall Study|Death|0|||
156719307|NCT00281957|565719756|FG000|Overall Study|Progression/relapse|47|||
156719308|NCT00281957|565719757|FG001|Overall Study|Progression/relapse|35|||
156719309|NCT00281957|565719756|FG000|Overall Study|Not protocol specified|8|||
156719310|NCT00281957|565719757|FG001|Overall Study|Not protocol specified|1|||
156719311|NCT00281957|565719756|FG000|Overall Study|Not eligible|1|||
156719312|NCT00281957|565719757|FG001|Overall Study|Not eligible|2|||
156719313|NCT00281957|565719756|FG000|Overall Study|Did not start treatment|3|||
156719314|NCT00281957|565719757|FG001|Overall Study|Did not start treatment|1|||
156719315|NCT00281957|565719756|FG000|Overall Study|Refusal unrelated to adverse events|0|||
156719316|NCT00281957|565719757|FG001|Overall Study|Refusal unrelated to adverse events|1|||
156719317|NCT00822692|565719765|FG000|Overall Study|Lost to Follow-up|17|||
156719318|NCT00822692|565719766|FG001|Overall Study|Lost to Follow-up|25|||
156719319|NCT03281876|565719767|FG000|Overall Study|Adverse Event|4|||
157133414|NCT00927563|567236098|FG000|Overall Study|Withdrawal by Subject|1|||
157133415|NCT02497001|567236101|FG000|Overall Study|Lost to Follow-up|10|||
157133416|NCT02497001|567236102|FG001|Overall Study|Lost to Follow-up|2|||
157133417|NCT02497001|567236103|FG002|Overall Study|Lost to Follow-up|0|||
157133418|NCT02497001|567236104|FG003|Overall Study|Lost to Follow-up|2|||
157133419|NCT02497001|567236101|FG000|Overall Study|Adverse Event|28|||
156719320|NCT03281876|565719768|FG001|Overall Study|Adverse Event|15|||
156719321|NCT03281876|565719767|FG000|Overall Study|Lost to Follow-up|1|||
156719322|NCT03281876|565719768|FG001|Overall Study|Lost to Follow-up|4|||
156719323|NCT03281876|565719767|FG000|Overall Study|Withdrawal by Subject|11|||
156719324|NCT03281876|565719768|FG001|Overall Study|Withdrawal by Subject|15|||
156719325|NCT03281876|565719767|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156719326|NCT03281876|565719768|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156719327|NCT03281876|565719767|FG000|Overall Study|OTHER|5|||
156719328|NCT03281876|565719768|FG001|Overall Study|OTHER|5|||
156719329|NCT02208089|565719769|FG000|Overall Study|Withdrawal by Subject|1|||
156719330|NCT02208089|565719770|FG001|Overall Study|Withdrawal by Subject|0|||
156719331|NCT02208089|565719769|FG000|Overall Study|Lost to Follow-up|6|||
156719332|NCT02208089|565719770|FG001|Overall Study|Lost to Follow-up|0|||
156719333|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719334|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719335|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719336|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719337|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719338|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
156719339|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719340|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719341|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719342|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719343|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
156719344|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
156719345|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719346|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719347|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719348|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719349|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719350|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
156719351|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719352|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719353|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719354|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
156719355|NCT02443740|565719771|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719356|NCT02443740|565719772|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719357|NCT02443740|565719773|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719358|NCT02443740|565719774|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719359|NCT02443740|565719775|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719360|NCT02443740|565719776|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
156719361|NCT02443740|565719777|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719362|NCT02443740|565719778|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719363|NCT02443740|565719779|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719364|NCT02443740|565719780|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719365|NCT02443740|565719781|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
156719366|NCT00456300|565719782|FG000|Overall Study|Adverse Event|1|||
156719367|NCT00456300|565719783|FG001|Overall Study|Adverse Event|0|||
156719368|NCT01964976|565719784|FG000|Overall Study|Protocol Violation|31|||
156719369|NCT02452476|565719785|FG000|Overall Study|Death|4|||
156719370|NCT02452476|565719786|FG001|Overall Study|Death|7|||
156719371|NCT02452476|565719785|FG000|Overall Study|Lost to Follow-up|1|||
156719372|NCT02452476|565719786|FG001|Overall Study|Lost to Follow-up|1|||
156719373|NCT02452476|565719785|FG000|Overall Study|Physician Decision|1|||
156719374|NCT02452476|565719786|FG001|Overall Study|Physician Decision|1|||
156719375|NCT02452476|565719785|FG000|Overall Study|Not treated|5|||
156719376|NCT02452476|565719786|FG001|Overall Study|Not treated|1|||
156719377|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
156719378|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719379|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719380|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156793810|NCT00505687|565999454|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
156793811|NCT00505687|565999454|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
156793812|NCT00505687|565999454|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
156793813|NCT00505687|565999454|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
156793814|NCT00505687|565999454|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
156793815|NCT00505687|565999454|FG000|Overall Study|Other: Disease Progression|1|||
156719381|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
156719382|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
156719383|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719384|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719385|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719386|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
156719387|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
156719388|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719389|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719390|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719391|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
156719392|NCT01074944|565719790|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
156719393|NCT01074944|565719791|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719394|NCT01074944|565719792|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719395|NCT01074944|565719793|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719396|NCT01074944|565719794|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
156719397|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719398|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
156719399|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
156719400|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719401|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
156719402|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719403|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
156719404|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
156719405|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719406|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
156719407|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719408|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
156719409|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
156719410|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719411|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
156719412|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719413|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
156719414|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719415|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719416|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
156719417|NCT01074944|565719790|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719418|NCT01074944|565719791|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
156719419|NCT01074944|565719792|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
156719420|NCT01074944|565719793|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719421|NCT01074944|565719794|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
156719422|NCT01074944|565719790|FG000|Long Term Treatment|Adverse Event|0|||
156719423|NCT01074944|565719791|FG001|Long Term Treatment|Adverse Event|0|||
156719424|NCT01074944|565719792|FG002|Long Term Treatment|Adverse Event|0|||
156719425|NCT01074944|565719793|FG003|Long Term Treatment|Adverse Event|3|||
156719426|NCT01074944|565719794|FG004|Long Term Treatment|Adverse Event|0|||
156719427|NCT01074944|565719790|FG000|Long Term Treatment|Lost to Follow-up|0|||
156719428|NCT01074944|565719791|FG001|Long Term Treatment|Lost to Follow-up|0|||
156719429|NCT01074944|565719792|FG002|Long Term Treatment|Lost to Follow-up|0|||
156719430|NCT01074944|565719793|FG003|Long Term Treatment|Lost to Follow-up|2|||
156719431|NCT01074944|565719794|FG004|Long Term Treatment|Lost to Follow-up|0|||
156719432|NCT01074944|565719790|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719433|NCT01074944|565719791|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719434|NCT01074944|565719792|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719435|NCT01074944|565719793|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
156719436|NCT01074944|565719794|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
156719437|NCT01074944|565719790|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719438|NCT01074944|565719791|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719439|NCT01074944|565719792|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719440|NCT01074944|565719793|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
156719441|NCT01074944|565719794|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
156719442|NCT01074944|565719790|FG000|Long Term Treatment|Withdrawal by Subject|0|||
156719443|NCT01074944|565719791|FG001|Long Term Treatment|Withdrawal by Subject|0|||
156875351|NCT04896086|566302022|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
156875352|NCT04896086|566302023|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
157133420|NCT02497001|567236102|FG001|Overall Study|Adverse Event|30|||
156719444|NCT01074944|565719792|FG002|Long Term Treatment|Withdrawal by Subject|0|||
156719445|NCT01074944|565719793|FG003|Long Term Treatment|Withdrawal by Subject|2|||
156719446|NCT01074944|565719794|FG004|Long Term Treatment|Withdrawal by Subject|0|||
156719447|NCT01074944|565719790|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719448|NCT01074944|565719791|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719449|NCT01074944|565719792|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719450|NCT01074944|565719793|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
156719451|NCT01074944|565719794|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
156719452|NCT01074944|565719790|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719453|NCT01074944|565719791|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719454|NCT01074944|565719792|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719455|NCT01074944|565719793|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
156719456|NCT01074944|565719794|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
156719457|NCT02348112|565719796|FG000|Overall Study|Withdrawal by Subject|32|||
156719458|NCT02348112|565719797|FG001|Overall Study|Withdrawal by Subject|29|||
156719459|NCT02348112|565719796|FG000|Overall Study|Lost to Follow-up|24|||
156719460|NCT02348112|565719797|FG001|Overall Study|Lost to Follow-up|20|||
156719461|NCT02348112|565719796|FG000|Overall Study|Physician Decision|17|||
156719462|NCT02348112|565719797|FG001|Overall Study|Physician Decision|15|||
156719463|NCT02348112|565719796|FG000|Overall Study|Site closed due to PI leaving|0|||
156719464|NCT02348112|565719797|FG001|Overall Study|Site closed due to PI leaving|30|||
156719465|NCT02348112|565719796|FG000|Overall Study|Sponsor withdrawal|0|||
156719466|NCT02348112|565719797|FG001|Overall Study|Sponsor withdrawal|7|||
156719467|NCT02348112|565719796|FG000|Overall Study|Death|0|||
156719468|NCT02348112|565719797|FG001|Overall Study|Death|1|||
156719469|NCT02552121|565719803|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
156719470|NCT02552121|565719804|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719471|NCT02552121|565719805|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719472|NCT02552121|565719806|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719473|NCT02552121|565719807|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719474|NCT02552121|565719808|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719475|NCT02552121|565719809|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719476|NCT02552121|565719810|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
156719477|NCT02552121|565719803|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
156719478|NCT02552121|565719804|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719479|NCT02552121|565719805|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719480|NCT02552121|565719806|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719481|NCT02552121|565719807|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719482|NCT02552121|565719808|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719483|NCT02552121|565719809|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719484|NCT02552121|565719810|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
156719485|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719486|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
156719487|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719488|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719489|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719490|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719491|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719492|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
156719493|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719494|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
156719495|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719496|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719497|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719498|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719499|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719500|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
156719501|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719502|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
156719503|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719504|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719505|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719506|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719507|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719508|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
156719509|NCT02552121|565719803|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156793816|NCT00505687|565999454|FG000|Overall Study|Other: As Per Sponsor|8|||
156793817|NCT00666263|565999457|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
157133421|NCT02497001|567236103|FG002|Overall Study|Adverse Event|11|||
156719510|NCT02552121|565719804|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
156719511|NCT02552121|565719805|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719512|NCT02552121|565719806|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719513|NCT02552121|565719807|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719514|NCT02552121|565719808|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719515|NCT02552121|565719809|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719516|NCT02552121|565719810|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
156719517|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
156719518|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
156719519|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
156719520|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
156719521|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
156719522|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
156719523|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
156719524|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
156719525|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
156719526|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
156719527|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
156719528|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
156719529|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
156719530|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
156719531|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
156719532|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
156719533|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
156719534|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
156719535|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
156719536|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
156719537|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
156719538|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
156719539|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
156719540|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
156719541|NCT02552121|565719803|FG000|Part 2: Cohort Expansion|Death|0|||
156719542|NCT02552121|565719804|FG001|Part 2: Cohort Expansion|Death|0|||
156719543|NCT02552121|565719805|FG002|Part 2: Cohort Expansion|Death|1|||
156719544|NCT02552121|565719806|FG003|Part 2: Cohort Expansion|Death|0|||
156719545|NCT02552121|565719807|FG004|Part 2: Cohort Expansion|Death|0|||
156719546|NCT02552121|565719808|FG005|Part 2: Cohort Expansion|Death|0|||
156719547|NCT02552121|565719809|FG006|Part 2: Cohort Expansion|Death|0|||
156719548|NCT02552121|565719810|FG007|Part 2: Cohort Expansion|Death|0|||
156719549|NCT02586155|565719811|FG000|Overall Study|Adverse Event|2|||
156719550|NCT02586155|565719812|FG001|Overall Study|Adverse Event|3|||
156719551|NCT02586155|565719811|FG000|Overall Study|Withdrawal by Subject|31|||
156719552|NCT02586155|565719812|FG001|Overall Study|Withdrawal by Subject|24|||
156719553|NCT02586155|565719811|FG000|Overall Study|Lost to Follow-up|7|||
156719554|NCT02586155|565719812|FG001|Overall Study|Lost to Follow-up|13|||
156719555|NCT02586155|565719811|FG000|Overall Study|Death|61|||
156719556|NCT02586155|565719812|FG001|Overall Study|Death|72|||
156719557|NCT02586155|565719811|FG000|Overall Study|Other reasons|26|||
156719558|NCT02586155|565719812|FG001|Overall Study|Other reasons|15|||
156719559|NCT01522456|565719814|FG000|Overall Study|Adverse Event|2|||
156719560|NCT01522456|565719814|FG000|Overall Study|Lost to Follow-up|2|||
156719561|NCT01522456|565719814|FG000|Overall Study|Withdrawal by Subject|2|||
156719562|NCT01522456|565719814|FG000|Overall Study|Pregnancy|1|||
156719563|NCT01522456|565719814|FG000|Overall Study|Tolerability Assessment|1|||
156719564|NCT04052620|565719815|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
156719565|NCT04052620|565719816|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
156719566|NCT04052620|565719815|FG000|Overall Study|Withdrawal by Subject|1|||
156719567|NCT04052620|565719816|FG001|Overall Study|Withdrawal by Subject|0|||
156719568|NCT04052620|565719815|FG000|Overall Study|Lost to Follow-up|1|||
156719569|NCT04052620|565719816|FG001|Overall Study|Lost to Follow-up|1|||
156719570|NCT04052620|565719815|FG000|Overall Study|Adverse Event|1|||
156719571|NCT04052620|565719816|FG001|Overall Study|Adverse Event|0|||
156719572|NCT04052620|565719815|FG000|Overall Study|Subject did not meet study Criteria|0|||
156719573|NCT04052620|565719816|FG001|Overall Study|Subject did not meet study Criteria|1|||
156719574|NCT04052620|565719815|FG000|Overall Study|Screened failure, randomized by mistake|0|||
156719575|NCT04052620|565719816|FG001|Overall Study|Screened failure, randomized by mistake|1|||
156719576|NCT04052620|565719815|FG000|Overall Study|Personal reasons|2|||
157018637|NCT00676715|566822872|FG000|Treatment Period (TP)|Withdrew consent|3|||
156719577|NCT04052620|565719816|FG001|Overall Study|Personal reasons|4|||
157018638|NCT00676715|566822873|FG001|Treatment Period (TP)|Withdrew consent|3|||
157018639|NCT00676715|566822874|FG002|Treatment Period (TP)|Withdrew consent|3|||
157018640|NCT00676715|566822875|FG003|Treatment Period (TP)|Withdrew consent|3|||
157018641|NCT00676715|566822872|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
157018642|NCT00676715|566822873|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
157133422|NCT02497001|567236104|FG003|Overall Study|Adverse Event|11|||
156719578|NCT04052620|565719815|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
156719579|NCT04052620|565719816|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
156719580|NCT01406574|565719817|FG000|Overall Study|Adverse Event|0|||
156719581|NCT01406574|565719818|FG001|Overall Study|Adverse Event|0|||
156719582|NCT01406574|565719819|FG002|Overall Study|Adverse Event|1|||
156719583|NCT01406574|565719820|FG003|Overall Study|Adverse Event|3|||
156719584|NCT01406574|565719817|FG000|Overall Study|Physician Decision|0|||
156719585|NCT01406574|565719818|FG001|Overall Study|Physician Decision|0|||
156719586|NCT01406574|565719819|FG002|Overall Study|Physician Decision|0|||
156719587|NCT01406574|565719820|FG003|Overall Study|Physician Decision|1|||
156719588|NCT01406574|565719817|FG000|Overall Study|Withdrawal by Subject|0|||
156719589|NCT01406574|565719818|FG001|Overall Study|Withdrawal by Subject|1|||
156719590|NCT01406574|565719819|FG002|Overall Study|Withdrawal by Subject|0|||
156719591|NCT01406574|565719820|FG003|Overall Study|Withdrawal by Subject|0|||
156719592|NCT01406574|565719817|FG000|Overall Study|Definite progression of primary disease|1|||
156719593|NCT01406574|565719818|FG001|Overall Study|Definite progression of primary disease|0|||
156719594|NCT01406574|565719819|FG002|Overall Study|Definite progression of primary disease|0|||
156719595|NCT01406574|565719820|FG003|Overall Study|Definite progression of primary disease|0|||
156719596|NCT02201784|565719822|FG000|Overall Study|Failure to achieve adequate block|2|||
156719597|NCT02201784|565719823|FG001|Overall Study|Failure to achieve adequate block|0|||
156719598|NCT02046603|565719824|FG000|Overall Study|Other|11|||
156719599|NCT02046603|565719825|FG001|Overall Study|Other|66|||
156719600|NCT02046603|565719824|FG000|Overall Study|Protocol Violation|0|||
156719601|NCT02046603|565719825|FG001|Overall Study|Protocol Violation|1|||
156719602|NCT02046603|565719824|FG000|Overall Study|Participant/legal guardian decision|1|||
156719603|NCT02046603|565719825|FG001|Overall Study|Participant/legal guardian decision|3|||
156719604|NCT02046603|565719824|FG000|Overall Study|Physician Decision|2|||
156719605|NCT02046603|565719825|FG001|Overall Study|Physician Decision|1|||
156719606|NCT02046603|565719824|FG000|Overall Study|Lost to Follow-up|1|||
156719607|NCT02046603|565719825|FG001|Overall Study|Lost to Follow-up|2|||
156719608|NCT02046603|565719824|FG000|Overall Study|Death|0|||
156719609|NCT02046603|565719825|FG001|Overall Study|Death|1|||
156719610|NCT02046603|565719824|FG000|Overall Study|Adverse Event|0|||
156719611|NCT02046603|565719825|FG001|Overall Study|Adverse Event|1|||
156719612|NCT02072980|565719826|FG000|Period 2, Second Wear|Adverse Event|0|||
156719613|NCT02072980|565719827|FG001|Period 2, Second Wear|Adverse Event|1|||
156719614|NCT00946920|565719828|FG000|Overall Study|Withdrawal by Subject|28|||
156719615|NCT00946920|565719829|FG001|Overall Study|Withdrawal by Subject|15|||
156719616|NCT00946920|565719828|FG000|Overall Study|Lost to Follow-up|2|||
156719617|NCT00946920|565719829|FG001|Overall Study|Lost to Follow-up|2|||
156719618|NCT00946920|565719828|FG000|Overall Study|Physician Decision|5|||
156719619|NCT00946920|565719829|FG001|Overall Study|Physician Decision|2|||
156719620|NCT00946920|565719828|FG000|Overall Study|Adverse Event|41|||
156719621|NCT00946920|565719829|FG001|Overall Study|Adverse Event|14|||
156719622|NCT00946920|565719828|FG000|Overall Study|Protocol Violation|16|||
156719623|NCT00946920|565719829|FG001|Overall Study|Protocol Violation|8|||
156719624|NCT00946920|565719828|FG000|Overall Study|Miscellaneous reasons|18|||
156719625|NCT00946920|565719829|FG001|Overall Study|Miscellaneous reasons|3|||
156719626|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
156719627|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
156719628|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Physician Decision|2|||
156719629|NCT00193050|565719830|FG000|Neoadjuvant Treatment|Adverse Event|2|||
156719630|NCT00193050|565719830|FG000|Adjuvant|Physician Decision|5|||
156719631|NCT00193050|565719830|FG000|Adjuvant|Intercurrent Hospitalization|3|||
156719632|NCT00193050|565719830|FG000|Adjuvant|Lack of Efficacy|2|||
156719633|NCT02431364|565719831|FG000|Overall Study|Adverse Event|0|||
156719634|NCT02431364|565719832|FG001|Overall Study|Adverse Event|1|||
156719635|NCT02431364|565719833|FG002|Overall Study|Adverse Event|0|||
156719636|NCT02431364|565719834|FG003|Overall Study|Adverse Event|0|||
156719637|NCT02431364|565719835|FG004|Overall Study|Adverse Event|0|||
156719638|NCT02431364|565719831|FG000|Overall Study|Randomized but never treated|0|||
156719639|NCT02431364|565719832|FG001|Overall Study|Randomized but never treated|0|||
156719640|NCT02431364|565719833|FG002|Overall Study|Randomized but never treated|0|||
156719641|NCT02431364|565719834|FG003|Overall Study|Randomized but never treated|1|||
156719642|NCT02431364|565719835|FG004|Overall Study|Randomized but never treated|0|||
156719643|NCT00061932|565719836|FG000|Overall Study|Withdrawal by Subject|13|||
156719644|NCT00061932|565719837|FG001|Overall Study|Withdrawal by Subject|4|||
156719645|NCT00916383|565719838|FG000|Overall Study|Adverse Event|1|||
156719646|NCT00916383|565719838|FG000|Overall Study|Death|1|||
156719647|NCT00916383|565719838|FG000|Overall Study|Protocol Violation|1|||
156719648|NCT00258960|565719839|FG000|Overall Study|Death|2|||
156719649|NCT00258960|565719839|FG000|Overall Study|Disease Progression|7|||
156719650|NCT00258960|565719839|FG000|Overall Study|Adverse Event|4|||
156719651|NCT00258960|565719839|FG000|Overall Study|Physician Decision|1|||
156719652|NCT00258960|565719839|FG000|Overall Study|Withdrawal by Subject|1|||
156719653|NCT00258960|565719839|FG000|Overall Study|Mistake|2|||
156719654|NCT00473590|565719840|FG000|Overall Study|Adverse Event|3|||
156719655|NCT00473590|565719841|FG001|Overall Study|Adverse Event|3|||
156719656|NCT00473590|565719840|FG000|Overall Study|Death|4|||
156719657|NCT00473590|565719841|FG001|Overall Study|Death|2|||
156719658|NCT00473590|565719840|FG000|Overall Study|Progression not resulting in death|24|||
156719659|NCT00473590|565719841|FG001|Overall Study|Progression not resulting in death|20|||
156719660|NCT00473590|565719840|FG000|Overall Study|Non-protocol-specified therapy|7|||
156719661|NCT00473590|565719841|FG001|Overall Study|Non-protocol-specified therapy|5|||
156719662|NCT00473590|565719840|FG000|Overall Study|Physician Decision|2|||
156719663|NCT00473590|565719841|FG001|Overall Study|Physician Decision|4|||
156719664|NCT00473590|565719840|FG000|Overall Study|Withdrawal by Subject|5|||
156719665|NCT00473590|565719841|FG001|Overall Study|Withdrawal by Subject|3|||
156719666|NCT00473590|565719840|FG000|Overall Study|Other|0|||
156719667|NCT00473590|565719841|FG001|Overall Study|Other|1|||
156719668|NCT01245283|565719844|FG000|Overall Study|Lost to Follow-up|14|||
156719669|NCT01245283|565719845|FG001|Overall Study|Lost to Follow-up|11|||
156719670|NCT01245283|565719846|FG002|Overall Study|Lost to Follow-up|11|||
156719671|NCT01610492|565719855|FG000|Overall Study|Adverse Event|1|||
156719672|NCT01610492|565719855|FG000|Overall Study|Lack of Efficacy|3|||
156719673|NCT01610492|565719855|FG000|Overall Study|Other: Reached stopping criteria|1|||
156719674|NCT01610492|565719855|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
156719675|NCT03093259|565719857|FG000|Overall Study|Adverse Event|1|||
156719676|NCT03093259|565719858|FG001|Overall Study|Adverse Event|0|||
156719677|NCT03093259|565719857|FG000|Overall Study|Withdrawal by Subject|1|||
156719678|NCT03093259|565719858|FG001|Overall Study|Withdrawal by Subject|0|||
156719679|NCT01757275|565719859|FG000|Overall Study|Lost to Follow-up|1|||
156719680|NCT01757275|565719860|FG001|Overall Study|Lost to Follow-up|2|||
156719681|NCT01757275|565719859|FG000|Overall Study|Adverse Event|3|||
156719682|NCT01757275|565719860|FG001|Overall Study|Adverse Event|3|||
156719683|NCT01757275|565719859|FG000|Overall Study|Withdrawal by Subject|2|||
156719684|NCT01757275|565719860|FG001|Overall Study|Withdrawal by Subject|4|||
156719685|NCT01757275|565719859|FG000|Overall Study|Not treated|3|||
156719686|NCT01757275|565719860|FG001|Overall Study|Not treated|4|||
156719687|NCT01821807|565719863|FG000|Overall Study|Lost to Follow-up|3|||
156719688|NCT01821807|565719864|FG001|Overall Study|Lost to Follow-up|1|||
156719689|NCT03367819|565719866|FG000|Overall Study|Adverse Event|4|||
156719690|NCT03367819|565719867|FG001|Overall Study|Adverse Event|4|||
156719691|NCT03367819|565719866|FG000|Overall Study|Progressive Disease|15|||
156719692|NCT03367819|565719867|FG001|Overall Study|Progressive Disease|13|||
156719693|NCT03367819|565719866|FG000|Overall Study|Withdrawal by Subject|1|||
156719694|NCT03367819|565719867|FG001|Overall Study|Withdrawal by Subject|0|||
156719695|NCT03367819|565719866|FG000|Overall Study|Other|4|||
156719696|NCT03367819|565719867|FG001|Overall Study|Other|2|||
156719697|NCT02633787|565719868|FG000|Overall Study|Withdrawal by Subject|1|||
156719698|NCT01401452|565719869|FG000|Overall Study|Adverse reaction|9|||
156719699|NCT01401452|565719869|FG000|Overall Study|Lost to Follow-up|12|||
156719700|NCT01401452|565719869|FG000|Overall Study|Lack of Efficacy|30|||
156719701|NCT01401452|565719869|FG000|Overall Study|Participant developed breast cancer|1|||
156719702|NCT01401452|565719869|FG000|Overall Study|Tx stopped due to financial reasons|1|||
156719703|NCT01401452|565719869|FG000|Overall Study|Tx stopped by psychiatrist|1|||
156719704|NCT01401452|565719869|FG000|Overall Study|No more visits within the 36 wk followup|4|||
156719705|NCT01401452|565719869|FG000|Overall Study|Subject did not come to follow up visits|2|||
156719706|NCT01401452|565719869|FG000|Overall Study|Subject didn't return for routine visits|1|||
156719707|NCT01401452|565719869|FG000|Overall Study|Subject moved to another city|1|||
156719708|NCT01401452|565719869|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
156719709|NCT01401452|565719869|FG000|Overall Study|Psoriatic arthritis|1|||
156719710|NCT01401452|565719869|FG000|Overall Study|Participant stopped Tx|2|||
156719711|NCT01401452|565719869|FG000|Overall Study|Discontinuation for personal reasons|1|||
156719712|NCT01401452|565719869|FG000|Overall Study|Treatment failure|1|||
156719713|NCT01401452|565719869|FG000|Overall Study|Unsatisfactory output|1|||
156719714|NCT01401452|565719869|FG000|Overall Study|Subject withdrew because of Tx success|1|||
156719715|NCT01401452|565719869|FG000|Overall Study|Subject chose to discontinue treatment|1|||
156719716|NCT01401452|565719869|FG000|Overall Study|Participant withdrew consent|1|||
156719717|NCT00550459|565719870|FG000|Overall Study|Adverse Event|0|||
156719718|NCT00550459|565719871|FG001|Overall Study|Adverse Event|2|||
156719719|NCT00550459|565719870|FG000|Overall Study|Withdrawal by Subject|1|||
156719720|NCT00550459|565719871|FG001|Overall Study|Withdrawal by Subject|1|||
156719721|NCT00584454|565719872|FG000|Overall Study|Adverse Event|1|||
156719722|NCT00584454|565719872|FG000|Overall Study|Relocation|1|||
156793818|NCT00666263|565999458|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
156793819|NCT00666263|565999457|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
156793820|NCT00666263|565999458|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
156793821|NCT00666263|565999457|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
156719723|NCT00584454|565719872|FG000|Overall Study|Clinical Hold|2|||
156719724|NCT01742897|565719873|FG000|Overall Study|Adverse Event|3|||
156719725|NCT01742897|565719873|FG000|Overall Study|Withdrawal by Subject|1|||
156719726|NCT01742897|565719873|FG000|Overall Study|Other|1|||
156719727|NCT01459783|565719875|FG000|Baseline to 6 Months|Death|1|||
156719728|NCT01459783|565719876|FG001|Baseline to 6 Months|Death|0|||
156719729|NCT01459783|565719875|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
156719730|NCT01459783|565719876|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
156719731|NCT01459783|565719875|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
156719732|NCT01459783|565719876|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
156719733|NCT01459783|565719875|FG000|6 Months to 12 Months|Death|0|||
156719734|NCT01459783|565719876|FG001|6 Months to 12 Months|Death|1|||
156719735|NCT01459783|565719875|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
156719736|NCT01459783|565719876|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
156719737|NCT01459783|565719875|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
156719738|NCT01459783|565719876|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
156719739|NCT01459783|565719875|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
156719740|NCT01459783|565719876|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
156719741|NCT02601014|565719877|FG000|Overall Study|Adverse Event|3|||
156719742|NCT02601014|565719878|FG001|Overall Study|Adverse Event|3|||
156719743|NCT02601014|565719877|FG000|Overall Study|Death|3|||
156719744|NCT02601014|565719878|FG001|Overall Study|Death|1|||
156719745|NCT02601014|565719877|FG000|Overall Study|Disease progression|4|||
156719746|NCT02601014|565719878|FG001|Overall Study|Disease progression|8|||
156719747|NCT00445146|565719881|FG000|Overall Study|Withdrew Consent|29|||
156719748|NCT00445146|565719881|FG000|Overall Study|Lack of Efficacy|28|||
156719749|NCT00445146|565719881|FG000|Overall Study|Investigator's Discretion|22|||
156719750|NCT00445146|565719881|FG000|Overall Study|Adverse Event|13|||
156719751|NCT00445146|565719881|FG000|Overall Study|Lost to Follow-up|13|||
156719752|NCT00445146|565719881|FG000|Overall Study|Death|9|||
156719753|NCT00445146|565719881|FG000|Overall Study|Protocol Violation|4|||
156719754|NCT00445146|565719881|FG000|Overall Study|Pregnancy|1|||
156719755|NCT02623725|565719883|FG000|Overall Study|Non compliance with protocol|9|||
156719756|NCT02623725|565719884|FG001|Overall Study|Non compliance with protocol|3|||
156719757|NCT02623725|565719883|FG000|Overall Study|Serious adverse event|0|||
156719758|NCT02623725|565719884|FG001|Overall Study|Serious adverse event|2|||
156719759|NCT02623725|565719883|FG000|Overall Study|Withdrawal by Subject|7|||
156719760|NCT02623725|565719884|FG001|Overall Study|Withdrawal by Subject|1|||
156719761|NCT03918629|565719885|FG000|Overall Study|Adverse Event|19|||
156719762|NCT03918629|565719886|FG001|Overall Study|Adverse Event|20|||
156719763|NCT03918629|565719885|FG000|Overall Study|Death|14|||
156719764|NCT03918629|565719886|FG001|Overall Study|Death|7|||
156719765|NCT03918629|565719885|FG000|Overall Study|Lost to Follow-up|36|||
156719766|NCT03918629|565719886|FG001|Overall Study|Lost to Follow-up|28|||
156719767|NCT03918629|565719885|FG000|Overall Study|Physician Decision|1|||
156719768|NCT03918629|565719886|FG001|Overall Study|Physician Decision|0|||
156719769|NCT03918629|565719885|FG000|Overall Study|Protocol Violation|7|||
156719770|NCT03918629|565719886|FG001|Overall Study|Protocol Violation|4|||
156719771|NCT03918629|565719885|FG000|Overall Study|Withdrawal by Subject|47|||
156719772|NCT03918629|565719886|FG001|Overall Study|Withdrawal by Subject|47|||
156719773|NCT03918629|565719885|FG000|Overall Study|Other|7|||
156719774|NCT03918629|565719886|FG001|Overall Study|Other|11|||
156719775|NCT03918629|565719885|FG000|Overall Study|Randomized but not vaccinated|2|||
156719776|NCT03918629|565719886|FG001|Overall Study|Randomized but not vaccinated|1|||
156719777|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719778|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719779|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
156719780|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719781|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719782|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719783|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719784|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719785|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
156719786|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
156719787|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
156719788|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
156793822|NCT00666263|565999458|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
156719789|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156793823|NCT03242434|565999459|FG000|Overall Study|Death|0|||
156719790|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719791|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156793824|NCT03242434|565999460|FG001|Overall Study|Death|2|||
156719792|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719793|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719794|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
156719795|NCT02456740|565719887|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
156793825|NCT00414609|565999461|FG000|Core Study|Adverse Event|9|||
156793826|NCT00414609|565999462|FG001|Core Study|Adverse Event|11|||
156719796|NCT02456740|565719888|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
156719797|NCT02456740|565719889|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
156719798|NCT02456740|565719890|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719799|NCT02456740|565719891|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719800|NCT02456740|565719892|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719801|NCT02456740|565719893|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719802|NCT02456740|565719894|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719803|NCT02456740|565719895|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
156719804|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719805|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719806|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719807|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
156719808|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
156719809|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719810|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719811|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
156719812|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
156719813|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719814|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719815|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
156719816|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
156719817|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
156719818|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
156719819|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
156719820|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
156719821|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
156719822|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719823|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719824|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719825|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719826|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719827|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719828|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719829|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
156719830|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
156719831|NCT02456740|565719887|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719832|NCT02456740|565719888|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719833|NCT02456740|565719889|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
156719834|NCT02456740|565719890|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
156719835|NCT02456740|565719891|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
156719836|NCT02456740|565719892|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
156719837|NCT02456740|565719893|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
156719838|NCT02456740|565719894|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
156719839|NCT02456740|565719895|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
156719840|NCT01891864|565719898|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
156719841|NCT01891864|565719899|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
156719842|NCT01891864|565719900|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719843|NCT01891864|565719901|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719844|NCT01891864|565719902|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719845|NCT01891864|565719903|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
156719846|NCT01891864|565719898|FG000|Treatment Period 1|Physician Decision|0|||
156719847|NCT01891864|565719899|FG001|Treatment Period 1|Physician Decision|1|||
156719848|NCT01891864|565719900|FG002|Treatment Period 1|Physician Decision|0|||
156719849|NCT01891864|565719901|FG003|Treatment Period 1|Physician Decision|0|||
156719850|NCT01891864|565719902|FG004|Treatment Period 1|Physician Decision|0|||
156719851|NCT01891864|565719903|FG005|Treatment Period 1|Physician Decision|0|||
156719852|NCT01891864|565719898|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719853|NCT01891864|565719899|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
156719854|NCT01891864|565719900|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719855|NCT01891864|565719901|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719856|NCT01891864|565719902|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156793827|NCT00414609|565999463|FG002|Core Study|Adverse Event|0|||
156793828|NCT00414609|565999461|FG000|Core Study|Abnormal laboratory values|0|||
156793829|NCT00414609|565999462|FG001|Core Study|Abnormal laboratory values|1|||
156793830|NCT00414609|565999463|FG002|Core Study|Abnormal laboratory values|0|||
156793831|NCT00414609|565999461|FG000|Core Study|Abnormal test procedure results|1|||
156719857|NCT01891864|565719903|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
156719858|NCT01891864|565719898|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
156719859|NCT01891864|565719899|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
156719860|NCT01891864|565719900|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719861|NCT01891864|565719901|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719862|NCT01891864|565719902|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719863|NCT01891864|565719903|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
156719864|NCT01891864|565719898|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156719865|NCT01891864|565719899|FG001|Treatment Period 1|Withdrawal by Subject|5|||
156719866|NCT01891864|565719900|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156719867|NCT01891864|565719901|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156719868|NCT01891864|565719902|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156719869|NCT01891864|565719903|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156719870|NCT01891864|565719898|FG000|Treatment Period 1|Lost to Follow-up|1|||
156719871|NCT01891864|565719899|FG001|Treatment Period 1|Lost to Follow-up|0|||
156719872|NCT01891864|565719900|FG002|Treatment Period 1|Lost to Follow-up|0|||
156719873|NCT01891864|565719901|FG003|Treatment Period 1|Lost to Follow-up|0|||
156719874|NCT01891864|565719902|FG004|Treatment Period 1|Lost to Follow-up|0|||
156719875|NCT01891864|565719903|FG005|Treatment Period 1|Lost to Follow-up|0|||
156719876|NCT01891864|565719898|FG000|Treatment Period 2|Protocol Violation|0|||
156719877|NCT01891864|565719899|FG001|Treatment Period 2|Protocol Violation|0|||
156719878|NCT01891864|565719900|FG002|Treatment Period 2|Protocol Violation|0|||
156719879|NCT01891864|565719901|FG003|Treatment Period 2|Protocol Violation|1|||
156719880|NCT01891864|565719902|FG004|Treatment Period 2|Protocol Violation|0|||
156719881|NCT01891864|565719903|FG005|Treatment Period 2|Protocol Violation|0|||
156719882|NCT01891864|565719898|FG000|Treatment Period 2|Physician Decision|0|||
156719883|NCT01891864|565719899|FG001|Treatment Period 2|Physician Decision|0|||
156719884|NCT01891864|565719900|FG002|Treatment Period 2|Physician Decision|1|||
156719885|NCT01891864|565719901|FG003|Treatment Period 2|Physician Decision|0|||
156719886|NCT01891864|565719902|FG004|Treatment Period 2|Physician Decision|0|||
156719887|NCT01891864|565719903|FG005|Treatment Period 2|Physician Decision|0|||
156719888|NCT01891864|565719898|FG000|Treatment Period 2|Site Termination|0|||
156719889|NCT01891864|565719899|FG001|Treatment Period 2|Site Termination|0|||
156719890|NCT01891864|565719900|FG002|Treatment Period 2|Site Termination|1|||
156719891|NCT01891864|565719901|FG003|Treatment Period 2|Site Termination|2|||
156719892|NCT01891864|565719902|FG004|Treatment Period 2|Site Termination|0|||
156719893|NCT01891864|565719903|FG005|Treatment Period 2|Site Termination|0|||
156719894|NCT01891864|565719898|FG000|Treatment Period 2|Lack of Efficacy|0|||
156719895|NCT01891864|565719899|FG001|Treatment Period 2|Lack of Efficacy|0|||
156719896|NCT01891864|565719900|FG002|Treatment Period 2|Lack of Efficacy|1|||
156719897|NCT01891864|565719901|FG003|Treatment Period 2|Lack of Efficacy|0|||
156719898|NCT01891864|565719902|FG004|Treatment Period 2|Lack of Efficacy|1|||
156719899|NCT01891864|565719903|FG005|Treatment Period 2|Lack of Efficacy|0|||
156719900|NCT01891864|565719898|FG000|Treatment Period 2|Adverse Event|0|||
156719901|NCT01891864|565719899|FG001|Treatment Period 2|Adverse Event|0|||
156719902|NCT01891864|565719900|FG002|Treatment Period 2|Adverse Event|1|||
156719903|NCT01891864|565719901|FG003|Treatment Period 2|Adverse Event|2|||
156719904|NCT01891864|565719902|FG004|Treatment Period 2|Adverse Event|0|||
156719905|NCT01891864|565719903|FG005|Treatment Period 2|Adverse Event|4|||
156719906|NCT01891864|565719898|FG000|Treatment Period 2|Termination of Site|0|||
156719907|NCT01891864|565719899|FG001|Treatment Period 2|Termination of Site|0|||
156719908|NCT01891864|565719900|FG002|Treatment Period 2|Termination of Site|0|||
156719909|NCT01891864|565719901|FG003|Treatment Period 2|Termination of Site|0|||
156719910|NCT01891864|565719902|FG004|Treatment Period 2|Termination of Site|2|||
156719911|NCT01891864|565719903|FG005|Treatment Period 2|Termination of Site|0|||
156719912|NCT01891864|565719898|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156719913|NCT01891864|565719899|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156719914|NCT01891864|565719900|FG002|Treatment Period 2|Withdrawal by Subject|3|||
156719915|NCT01891864|565719901|FG003|Treatment Period 2|Withdrawal by Subject|4|||
156719916|NCT01891864|565719902|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156719917|NCT01891864|565719903|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156719918|NCT01891864|565719898|FG000|Extension Period|Lack of Efficacy|0|||
156719919|NCT01891864|565719899|FG001|Extension Period|Lack of Efficacy|0|||
156719920|NCT01891864|565719900|FG002|Extension Period|Lack of Efficacy|0|||
156719921|NCT01891864|565719901|FG003|Extension Period|Lack of Efficacy|1|||
156793832|NCT00414609|565999462|FG001|Core Study|Abnormal test procedure results|1|||
156793833|NCT00414609|565999463|FG002|Core Study|Abnormal test procedure results|0|||
156793834|NCT00414609|565999461|FG000|Core Study|Protocol deviation|0|||
156793835|NCT00414609|565999462|FG001|Core Study|Protocol deviation|1|||
156793836|NCT00414609|565999463|FG002|Core Study|Protocol deviation|0|||
156793837|NCT00414609|565999461|FG000|Core Study|Patient withdrew consent|10|||
156793838|NCT00414609|565999462|FG001|Core Study|Patient withdrew consent|11|||
156793839|NCT00414609|565999463|FG002|Core Study|Patient withdrew consent|0|||
156793840|NCT00414609|565999461|FG000|Core Study|Lost to Follow-up|7|||
156793841|NCT00414609|565999462|FG001|Core Study|Lost to Follow-up|4|||
156719922|NCT01891864|565719902|FG004|Extension Period|Lack of Efficacy|1|||
156719923|NCT01891864|565719903|FG005|Extension Period|Lack of Efficacy|0|||
156719924|NCT01891864|565719898|FG000|Extension Period|Pregnancy|0|||
156719925|NCT01891864|565719899|FG001|Extension Period|Pregnancy|0|||
156719926|NCT01891864|565719900|FG002|Extension Period|Pregnancy|1|||
156719927|NCT01891864|565719901|FG003|Extension Period|Pregnancy|0|||
156719928|NCT01891864|565719902|FG004|Extension Period|Pregnancy|0|||
156719929|NCT01891864|565719903|FG005|Extension Period|Pregnancy|0|||
156719930|NCT01891864|565719898|FG000|Extension Period|Adverse Event|0|||
156719931|NCT01891864|565719899|FG001|Extension Period|Adverse Event|0|||
156719932|NCT01891864|565719900|FG002|Extension Period|Adverse Event|4|||
156719933|NCT01891864|565719901|FG003|Extension Period|Adverse Event|2|||
156719934|NCT01891864|565719902|FG004|Extension Period|Adverse Event|2|||
156719935|NCT01891864|565719903|FG005|Extension Period|Adverse Event|0|||
156719936|NCT01891864|565719898|FG000|Extension Period|Withdrawal by Subject|0|||
156719937|NCT01891864|565719899|FG001|Extension Period|Withdrawal by Subject|0|||
156719938|NCT01891864|565719900|FG002|Extension Period|Withdrawal by Subject|1|||
156719939|NCT01891864|565719901|FG003|Extension Period|Withdrawal by Subject|2|||
156719940|NCT01891864|565719902|FG004|Extension Period|Withdrawal by Subject|4|||
156719941|NCT01891864|565719903|FG005|Extension Period|Withdrawal by Subject|0|||
156719942|NCT01891864|565719898|FG000|Extension Period|Lost to Follow-up|0|||
156719943|NCT01891864|565719899|FG001|Extension Period|Lost to Follow-up|0|||
156719944|NCT01891864|565719900|FG002|Extension Period|Lost to Follow-up|2|||
156719945|NCT01891864|565719901|FG003|Extension Period|Lost to Follow-up|0|||
156719946|NCT01891864|565719902|FG004|Extension Period|Lost to Follow-up|0|||
156719947|NCT01891864|565719903|FG005|Extension Period|Lost to Follow-up|0|||
156719948|NCT04720105|565719905|FG000|Overall Study|Lack of Efficacy|1|||
156719949|NCT04720105|565719905|FG000|Overall Study|Lost to Follow-up|1|||
156719950|NCT04720105|565719905|FG000|Overall Study|Withdrawal by Subject|3|||
156719951|NCT05373108|565719906|FG000|Overall Study|Withdrawal by Subject|2|||
156719952|NCT02892331|565719907|FG000|Overall Study|Withdrawal by Subject|0|||
156719953|NCT02892331|565719908|FG001|Overall Study|Withdrawal by Subject|1|||
156719954|NCT02892331|565719909|FG002|Overall Study|Withdrawal by Subject|1|||
156719955|NCT02892331|565719907|FG000|Overall Study|Sick family member|0|||
156719956|NCT02892331|565719908|FG001|Overall Study|Sick family member|0|||
156719957|NCT02892331|565719909|FG002|Overall Study|Sick family member|1|||
156719958|NCT02892331|565719907|FG000|Overall Study|Corona virus pandemic|1|||
156719959|NCT02892331|565719908|FG001|Overall Study|Corona virus pandemic|0|||
156719960|NCT02892331|565719909|FG002|Overall Study|Corona virus pandemic|1|||
156719961|NCT02892331|565719907|FG000|Overall Study|Lost to Follow-up|1|||
156719962|NCT02892331|565719908|FG001|Overall Study|Lost to Follow-up|0|||
156719963|NCT02892331|565719909|FG002|Overall Study|Lost to Follow-up|1|||
156719964|NCT02892331|565719907|FG000|Overall Study|Blood pressure was too elevated|0|||
156719965|NCT02892331|565719908|FG001|Overall Study|Blood pressure was too elevated|1|||
156719966|NCT02892331|565719909|FG002|Overall Study|Blood pressure was too elevated|0|||
156719967|NCT02892331|565719907|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
156719968|NCT02892331|565719908|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
156719969|NCT02892331|565719909|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
156719970|NCT04871776|565719911|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
156719971|NCT04871776|565719912|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
156719972|NCT04871776|565719913|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
156719973|NCT04871776|565719911|FG000|Overall Study|Did not meet eligibility criteria|1|||
156719974|NCT04871776|565719912|FG001|Overall Study|Did not meet eligibility criteria|1|||
156719975|NCT04871776|565719913|FG002|Overall Study|Did not meet eligibility criteria|1|||
156719976|NCT04023396|565721787|FG000|Overall Study|Adverse Event|16|||
156719977|NCT04023396|565721787|FG000|Overall Study|Death|1|||
156719978|NCT04023396|565721787|FG000|Overall Study|Lost to Follow-up|1|||
156719979|NCT04023396|565721787|FG000|Overall Study|Withdrawal by Subject|14|||
156719980|NCT04023396|565721787|FG000|Overall Study|Pregnancy|4|||
156793842|NCT00414609|565999463|FG002|Core Study|Lost to Follow-up|0|||
156793843|NCT00414609|565999461|FG000|Core Study|Administrative problems|0|||
156793844|NCT00414609|565999462|FG001|Core Study|Administrative problems|2|||
156793845|NCT00414609|565999463|FG002|Core Study|Administrative problems|0|||
156793846|NCT00414609|565999461|FG000|Core Study|Death|7|||
156719981|NCT04023396|565721787|FG000|Overall Study|Lack of Efficacy|3|||
156719982|NCT04023396|565721787|FG000|Overall Study|Physician Decision|4|||
156719983|NCT04023396|565721787|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
156719984|NCT02325973|565721792|FG000|Overall Study|Death|5|||
156719985|NCT02325973|565721792|FG000|Overall Study|Withdrawal by subject or investigator|16|||
156719986|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
156719987|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156793847|NCT00414609|565999462|FG001|Core Study|Death|14|||
156793848|NCT00414609|565999463|FG002|Core Study|Death|0|||
156793849|NCT00414609|565999461|FG000|Extension Study|Adverse Event|0|||
157018643|NCT00676715|566822874|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
157217248|NCT03634488|567541058|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
157217249|NCT03634488|567541059|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
157217250|NCT03182686|567541060|FG000|Overall Study|Lost to Follow-up|2|||
157217251|NCT03182686|567541061|FG001|Overall Study|Lost to Follow-up|0|||
157217252|NCT03182686|567541060|FG000|Overall Study|Adverse Event|2|||
157217253|NCT03182686|567541061|FG001|Overall Study|Adverse Event|0|||
157217254|NCT03182686|567541060|FG000|Overall Study|Withdrawal by Subject|3|||
157217255|NCT03182686|567541061|FG001|Overall Study|Withdrawal by Subject|0|||
157217256|NCT01154127|567541062|FG000|Period 1 (21 Days)|Adverse Event|3|||
157217257|NCT01154127|567541063|FG001|Period 1 (21 Days)|Adverse Event|4|||
157217258|NCT01154127|567541062|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
157217259|NCT01154127|567541063|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
156719988|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156719989|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
156719990|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
156719991|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719992|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719993|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
156719994|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
156719995|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719996|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719997|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
156719998|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
156719999|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720000|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720001|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
156720002|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
156720003|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720004|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720005|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
156720006|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
156720007|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720008|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720009|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
156720010|NCT02513160|565721793|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
156720011|NCT02513160|565721794|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720012|NCT02513160|565721795|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720013|NCT02513160|565721796|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
156720014|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
156720015|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
156720016|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
156720017|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
156720018|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
156720019|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156793850|NCT00414609|565999462|FG001|Extension Study|Adverse Event|0|||
156793851|NCT00414609|565999463|FG002|Extension Study|Adverse Event|14|||
156793852|NCT00414609|565999461|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
156793853|NCT00414609|565999462|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
156793854|NCT00414609|565999463|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
156793855|NCT00414609|565999461|FG000|Extension Study|Withdrawal by Subject|0|||
156793856|NCT00414609|565999462|FG001|Extension Study|Withdrawal by Subject|0|||
156793857|NCT00414609|565999463|FG002|Extension Study|Withdrawal by Subject|13|||
156793858|NCT00414609|565999461|FG000|Extension Study|Lost to Follow-up|0|||
156793859|NCT00414609|565999462|FG001|Extension Study|Lost to Follow-up|0|||
156793860|NCT00414609|565999463|FG002|Extension Study|Lost to Follow-up|10|||
156793861|NCT00414609|565999461|FG000|Extension Study|Administrative problems|0|||
156793862|NCT00414609|565999462|FG001|Extension Study|Administrative problems|0|||
156793863|NCT00414609|565999463|FG002|Extension Study|Administrative problems|1|||
156793864|NCT00414609|565999461|FG000|Extension Study|Death|0|||
156793865|NCT00414609|565999462|FG001|Extension Study|Death|0|||
156793866|NCT00414609|565999463|FG002|Extension Study|Death|17|||
156793867|NCT00266032|565999464|FG000|Treatment|Adverse Event|42|||
156793868|NCT00266032|565999465|FG001|Treatment|Adverse Event|26|||
157217260|NCT01154127|567541062|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
156793869|NCT00266032|565999466|FG002|Treatment|Adverse Event|10|||
156793870|NCT00266032|565999464|FG000|Treatment|Lost to Follow-up|19|||
156793871|NCT00266032|565999465|FG001|Treatment|Lost to Follow-up|4|||
156793872|NCT00266032|565999466|FG002|Treatment|Lost to Follow-up|2|||
157217261|NCT01154127|567541063|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
156720020|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156720021|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
156720022|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
156720023|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720024|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720025|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
156720026|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
156720027|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720028|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720029|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
156720030|NCT02513160|565721793|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720031|NCT02513160|565721794|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
156720032|NCT02513160|565721795|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720033|NCT02513160|565721796|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
156720034|NCT01168232|565721797|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
156720035|NCT01168232|565721797|FG000|Overall Study|Ineligible- Wrong cell type|6|||
156720036|NCT01168232|565721797|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
156720037|NCT02861586|565721807|FG000|Overall Study|Withdrawal by Subject|1|||
156720038|NCT02861586|565721808|FG001|Overall Study|Withdrawal by Subject|2|||
156720039|NCT02861586|565721809|FG002|Overall Study|Withdrawal by Subject|0|||
156720040|NCT02861586|565721810|FG003|Overall Study|Withdrawal by Subject|0|||
156720041|NCT02861586|565721811|FG004|Overall Study|Withdrawal by Subject|0|||
156720042|NCT02861586|565721812|FG005|Overall Study|Withdrawal by Subject|1|||
156720043|NCT02861586|565721813|FG006|Overall Study|Withdrawal by Subject|1|||
156720044|NCT02861586|565721814|FG007|Overall Study|Withdrawal by Subject|0|||
156720045|NCT02861586|565721807|FG000|Overall Study|Lost to Follow-up|3|||
156720046|NCT02861586|565721808|FG001|Overall Study|Lost to Follow-up|1|||
156720047|NCT02861586|565721809|FG002|Overall Study|Lost to Follow-up|1|||
156720048|NCT02861586|565721810|FG003|Overall Study|Lost to Follow-up|0|||
156720049|NCT02861586|565721811|FG004|Overall Study|Lost to Follow-up|0|||
156720050|NCT02861586|565721812|FG005|Overall Study|Lost to Follow-up|3|||
156720051|NCT02861586|565721813|FG006|Overall Study|Lost to Follow-up|0|||
156720052|NCT02861586|565721814|FG007|Overall Study|Lost to Follow-up|0|||
156720053|NCT02861586|565721807|FG000|Overall Study|Adverse Event|0|||
156720054|NCT02861586|565721808|FG001|Overall Study|Adverse Event|0|||
156720055|NCT02861586|565721809|FG002|Overall Study|Adverse Event|0|||
156720056|NCT02861586|565721810|FG003|Overall Study|Adverse Event|0|||
156720057|NCT02861586|565721811|FG004|Overall Study|Adverse Event|0|||
156720058|NCT02861586|565721812|FG005|Overall Study|Adverse Event|1|||
156720059|NCT02861586|565721813|FG006|Overall Study|Adverse Event|0|||
156720060|NCT02861586|565721814|FG007|Overall Study|Adverse Event|0|||
156720061|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
156720062|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
156720063|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
156720064|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
156720065|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156720066|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
157133423|NCT02497001|567236101|FG000|Overall Study|Withdrawal by Subject|14|||
157133424|NCT02497001|567236102|FG001|Overall Study|Withdrawal by Subject|37|||
157133425|NCT02497001|567236103|FG002|Overall Study|Withdrawal by Subject|19|||
157133426|NCT02497001|567236104|FG003|Overall Study|Withdrawal by Subject|15|||
157133427|NCT02497001|567236101|FG000|Overall Study|Physician Decision|5|||
157133428|NCT02497001|567236102|FG001|Overall Study|Physician Decision|11|||
157133429|NCT02497001|567236103|FG002|Overall Study|Physician Decision|5|||
157133430|NCT02497001|567236104|FG003|Overall Study|Physician Decision|1|||
157133431|NCT02497001|567236101|FG000|Overall Study|subjects that were not treated|1|||
157133432|NCT02497001|567236102|FG001|Overall Study|subjects that were not treated|2|||
157133433|NCT02497001|567236103|FG002|Overall Study|subjects that were not treated|2|||
157133434|NCT02497001|567236104|FG003|Overall Study|subjects that were not treated|1|||
157133435|NCT02497001|567236101|FG000|Overall Study|Major Protocol Deviation|3|||
157133436|NCT02497001|567236102|FG001|Overall Study|Major Protocol Deviation|4|||
157133437|NCT02497001|567236103|FG002|Overall Study|Major Protocol Deviation|4|||
157133438|NCT02497001|567236104|FG003|Overall Study|Major Protocol Deviation|4|||
157133439|NCT02497001|567236101|FG000|Overall Study|Lack of Efficacy|10|||
156720067|NCT03874117|565721816|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
156720068|NCT03874117|565721817|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
156720069|NCT03874117|565721816|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156720070|NCT03874117|565721817|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156720071|NCT05012098|565721818|FG000|Overall Study|Disease progression|5|||
156720072|NCT05012098|565721819|FG001|Overall Study|Disease progression|2|||
156720073|NCT05012098|565721818|FG000|Overall Study|Adverse Event|1|||
157133440|NCT02497001|567236102|FG001|Overall Study|Lack of Efficacy|16|||
157133441|NCT02497001|567236103|FG002|Overall Study|Lack of Efficacy|6|||
157133442|NCT02497001|567236104|FG003|Overall Study|Lack of Efficacy|6|||
157133443|NCT02497001|567236101|FG000|Overall Study|Protocol Violation|3|||
156720074|NCT05012098|565721819|FG001|Overall Study|Adverse Event|0|||
156720075|NCT05012098|565721818|FG000|Overall Study|Withdrawal by Subject|1|||
156720076|NCT05012098|565721819|FG001|Overall Study|Withdrawal by Subject|0|||
156720077|NCT05012098|565721818|FG000|Overall Study|Discontinuation per protocol|1|||
156720078|NCT05012098|565721819|FG001|Overall Study|Discontinuation per protocol|0|||
156720079|NCT03018288|565721820|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
156720080|NCT03018288|565721821|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
156720081|NCT03018288|565721822|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
156720082|NCT03018288|565721823|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
156720083|NCT03018288|565721820|FG000|Overall Study|Participant withdrew consent.|0|||
156720084|NCT03018288|565721821|FG001|Overall Study|Participant withdrew consent.|0|||
156720085|NCT03018288|565721822|FG002|Overall Study|Participant withdrew consent.|1|||
156720086|NCT03018288|565721823|FG003|Overall Study|Participant withdrew consent.|0|||
156720087|NCT03018288|565721820|FG000|Overall Study|Switched to alternative treatment.|0|||
156720088|NCT03018288|565721821|FG001|Overall Study|Switched to alternative treatment.|0|||
156720089|NCT03018288|565721822|FG002|Overall Study|Switched to alternative treatment.|1|||
156720090|NCT03018288|565721823|FG003|Overall Study|Switched to alternative treatment.|0|||
156720091|NCT03018288|565721820|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720092|NCT03018288|565721821|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720093|NCT03018288|565721822|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
156720094|NCT03018288|565721823|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
156720095|NCT03018288|565721820|FG000|Overall Study|Screen failures|0|||
156720096|NCT03018288|565721821|FG001|Overall Study|Screen failures|0|||
156720097|NCT03018288|565721822|FG002|Overall Study|Screen failures|0|||
156720098|NCT03018288|565721823|FG003|Overall Study|Screen failures|51|||
156720099|NCT03018288|565721820|FG000|Overall Study|Chose treatment outside of UNC|0|||
156720100|NCT03018288|565721821|FG001|Overall Study|Chose treatment outside of UNC|0|||
156720101|NCT03018288|565721822|FG002|Overall Study|Chose treatment outside of UNC|0|||
156720102|NCT03018288|565721823|FG003|Overall Study|Chose treatment outside of UNC|1|||
156720103|NCT03018288|565721820|FG000|Overall Study|Unable to comply with protocol requirements|1|||
156720104|NCT03018288|565721821|FG001|Overall Study|Unable to comply with protocol requirements|1|||
156720105|NCT03018288|565721822|FG002|Overall Study|Unable to comply with protocol requirements|0|||
156720106|NCT03018288|565721823|FG003|Overall Study|Unable to comply with protocol requirements|1|||
156720107|NCT03018288|565721820|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
156720108|NCT03018288|565721821|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
156720109|NCT03018288|565721822|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
156720110|NCT03018288|565721823|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
156720111|NCT03018288|565721820|FG000|Overall Study|Physician Decision|0|||
156720112|NCT03018288|565721821|FG001|Overall Study|Physician Decision|0|||
156720113|NCT03018288|565721822|FG002|Overall Study|Physician Decision|0|||
156720114|NCT03018288|565721823|FG003|Overall Study|Physician Decision|1|||
156720115|NCT04815083|565721827|FG000|Overall Study|Physician Decision|1|||
156720116|NCT04815083|565721827|FG000|Overall Study|Study pause|2|||
156720117|NCT04815083|565721827|FG000|Overall Study|Screening failure|4|||
156720118|NCT01922037|565721828|FG000|Overall Study|Withdrawal by Subject|2|||
156720119|NCT01922037|565721829|FG001|Overall Study|Withdrawal by Subject|44|||
156720120|NCT01922037|565721828|FG000|Overall Study|Adverse Event|1|||
156720121|NCT01922037|565721829|FG001|Overall Study|Adverse Event|7|||
156720122|NCT01922037|565721828|FG000|Overall Study|Death|0|||
156720123|NCT01922037|565721829|FG001|Overall Study|Death|5|||
156720124|NCT01922037|565721828|FG000|Overall Study|Pregnancy|0|||
156793873|NCT00266032|565999464|FG000|Treatment|Pregnancy|3|||
156793874|NCT00266032|565999465|FG001|Treatment|Pregnancy|2|||
157133444|NCT02497001|567236102|FG001|Overall Study|Protocol Violation|1|||
157133445|NCT02497001|567236103|FG002|Overall Study|Protocol Violation|3|||
156720125|NCT01922037|565721829|FG001|Overall Study|Pregnancy|2|||
156720126|NCT01922037|565721828|FG000|Overall Study|Participant non-compliance|4|||
156720127|NCT01922037|565721829|FG001|Overall Study|Participant non-compliance|46|||
156720128|NCT01922037|565721828|FG000|Overall Study|Investigator/Sponsor decision|1|||
156720129|NCT01922037|565721829|FG001|Overall Study|Investigator/Sponsor decision|4|||
156720130|NCT01922037|565721828|FG000|Overall Study|Other unspecified|2|||
156720131|NCT01922037|565721829|FG001|Overall Study|Other unspecified|66|||
156720132|NCT01730053|565721830|FG000|Overall Study|Participant moved|0|||
156720133|NCT01730053|565721831|FG001|Overall Study|Participant moved|0|||
156720134|NCT01730053|565721832|FG002|Overall Study|Participant moved|1|||
156720135|NCT01730053|565721833|FG003|Overall Study|Participant moved|0|||
156720136|NCT01730053|565721834|FG004|Overall Study|Participant moved|0|||
156793875|NCT00266032|565999466|FG002|Treatment|Pregnancy|2|||
157133446|NCT02497001|567236104|FG003|Overall Study|Protocol Violation|1|||
157133447|NCT00654498|567236110|FG000|Overall Study|Not Treated|1|||
157133448|NCT00654498|567236111|FG001|Overall Study|Not Treated|0|||
156720137|NCT01730053|565721835|FG005|Overall Study|Participant moved|0|||
156720138|NCT01730053|565721830|FG000|Overall Study|Physician Decision|0|||
156720139|NCT01730053|565721831|FG001|Overall Study|Physician Decision|0|||
156720140|NCT01730053|565721832|FG002|Overall Study|Physician Decision|0|||
156720141|NCT01730053|565721833|FG003|Overall Study|Physician Decision|1|||
156720142|NCT01730053|565721834|FG004|Overall Study|Physician Decision|0|||
156720143|NCT01730053|565721835|FG005|Overall Study|Physician Decision|0|||
156720144|NCT01730053|565721830|FG000|Overall Study|Adverse Event|2|||
156720145|NCT01730053|565721831|FG001|Overall Study|Adverse Event|6|||
156720146|NCT01730053|565721832|FG002|Overall Study|Adverse Event|3|||
156720147|NCT01730053|565721833|FG003|Overall Study|Adverse Event|3|||
156720148|NCT01730053|565721834|FG004|Overall Study|Adverse Event|2|||
156720149|NCT01730053|565721835|FG005|Overall Study|Adverse Event|2|||
156720150|NCT01730053|565721830|FG000|Overall Study|Poor compliance to protocol|1|||
156720151|NCT01730053|565721831|FG001|Overall Study|Poor compliance to protocol|2|||
156720152|NCT01730053|565721832|FG002|Overall Study|Poor compliance to protocol|2|||
156720153|NCT01730053|565721833|FG003|Overall Study|Poor compliance to protocol|0|||
156720154|NCT01730053|565721834|FG004|Overall Study|Poor compliance to protocol|0|||
156720155|NCT01730053|565721835|FG005|Overall Study|Poor compliance to protocol|2|||
156720156|NCT01730053|565721830|FG000|Overall Study|Other than specified|2|||
156720157|NCT01730053|565721831|FG001|Overall Study|Other than specified|6|||
156720158|NCT01730053|565721832|FG002|Overall Study|Other than specified|5|||
156720159|NCT01730053|565721833|FG003|Overall Study|Other than specified|4|||
156720160|NCT01730053|565721834|FG004|Overall Study|Other than specified|7|||
156720161|NCT01730053|565721835|FG005|Overall Study|Other than specified|9|||
156720162|NCT02243605|565721840|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
156720163|NCT02243605|565721841|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
156720164|NCT02243605|565721840|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
156720165|NCT02243605|565721841|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
156720166|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
156720167|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
156720168|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
156720169|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
156720170|NCT02243605|565721840|FG000|Stage 2 - Final Analysis Population|Progression|0|||
156720171|NCT02243605|565721841|FG001|Stage 2 - Final Analysis Population|Progression|1|||
156720172|NCT00075816|565721842|FG000|Overall Study|Did not undergo transplantation|14|||
156720173|NCT00075816|565721843|FG001|Overall Study|Did not undergo transplantation|11|||
156720174|NCT04173507|565721844|FG000|Overall Study|On Treatment|3|||
156720175|NCT04173507|565721844|FG000|Overall Study|Adverse Event|3|||
156720176|NCT04173507|565721844|FG000|Overall Study|Progression/Relapse|34|||
156720177|NCT04173507|565721844|FG000|Overall Study|Death|2|||
156720178|NCT01823328|565721845|FG000|Overall Study|Withdrawal by Subject|8|||
156720179|NCT01823328|565721846|FG001|Overall Study|Withdrawal by Subject|6|||
156720180|NCT02832687|565721847|FG000|Overall Study|Adverse Event|0|||
156720181|NCT02832687|565721848|FG001|Overall Study|Adverse Event|2|||
156720182|NCT02572570|565721849|FG000|Overall Study|Study Terminated|27|||
156720183|NCT01417156|565721852|FG000|Overall Study|Adverse Event|12|||
156720184|NCT01417156|565721852|FG000|Overall Study|Protocol Violation|2|||
156720185|NCT03192488|565721853|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
156720186|NCT03192488|565721854|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
156720187|NCT03192488|565721855|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
156720188|NCT03192488|565721856|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
156720189|NCT03192488|565721857|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
156720190|NCT03192488|565721858|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
156720191|NCT03192488|565721853|FG000|Third Intervention (d1)|Adverse Event|0|||
156720192|NCT03192488|565721854|FG001|Third Intervention (d1)|Adverse Event|0|||
156720193|NCT03192488|565721855|FG002|Third Intervention (d1)|Adverse Event|0|||
156720194|NCT03192488|565721856|FG003|Third Intervention (d1)|Adverse Event|0|||
156720195|NCT03192488|565721857|FG004|Third Intervention (d1)|Adverse Event|1|||
156720196|NCT03192488|565721858|FG005|Third Intervention (d1)|Adverse Event|0|||
156720197|NCT00611923|565721860|FG000|Overall Study|Withdrawal by Subject|2|||
156720198|NCT00611923|565721861|FG001|Overall Study|Withdrawal by Subject|2|||
156720199|NCT00471822|565721865|FG000|Overall Study|Protocol Violation|2|||
156720200|NCT03664232|565721877|FG000|Overall Study|Withdrawal by Subject|0|||
156720201|NCT03664232|565721878|FG001|Overall Study|Withdrawal by Subject|1|||
156720202|NCT03664232|565721879|FG002|Overall Study|Withdrawal by Subject|0|||
156720203|NCT03664232|565721880|FG003|Overall Study|Withdrawal by Subject|1|||
156720204|NCT03664232|565721877|FG000|Overall Study|Adverse Event|0|||
156720205|NCT03664232|565721878|FG001|Overall Study|Adverse Event|0|||
156720206|NCT03664232|565721879|FG002|Overall Study|Adverse Event|1|||
156720207|NCT03664232|565721880|FG003|Overall Study|Adverse Event|0|||
156720208|NCT03664232|565721877|FG000|Overall Study|Other-Non-compliance with study drug|0|||
156720209|NCT03664232|565721878|FG001|Overall Study|Other-Non-compliance with study drug|1|||
156720210|NCT03664232|565721879|FG002|Overall Study|Other-Non-compliance with study drug|0|||
156720211|NCT03664232|565721880|FG003|Overall Study|Other-Non-compliance with study drug|2|||
156720212|NCT03664232|565721877|FG000|Overall Study|Other-Unspecified|0|||
156720213|NCT03664232|565721878|FG001|Overall Study|Other-Unspecified|3|||
156720214|NCT03664232|565721879|FG002|Overall Study|Other-Unspecified|0|||
156720215|NCT03664232|565721880|FG003|Overall Study|Other-Unspecified|1|||
156720216|NCT03664232|565721877|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720217|NCT03664232|565721878|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720218|NCT03664232|565721879|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
156720219|NCT03664232|565721880|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
156720220|NCT01439802|565721881|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
156720221|NCT01439802|565721881|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
156720222|NCT00742209|565721882|FG000|Overall Study|Adverse Event|11|||
156720223|NCT00742209|565721883|FG001|Overall Study|Adverse Event|4|||
156720224|NCT00742209|565721884|FG002|Overall Study|Adverse Event|17|||
156720225|NCT00742209|565721885|FG003|Overall Study|Adverse Event|16|||
156720226|NCT00742209|565721886|FG004|Overall Study|Adverse Event|13|||
156720227|NCT00742209|565721882|FG000|Overall Study|Participant Withdrew Consent|8|||
156720228|NCT00742209|565721883|FG001|Overall Study|Participant Withdrew Consent|4|||
156720229|NCT00742209|565721884|FG002|Overall Study|Participant Withdrew Consent|14|||
156720230|NCT00742209|565721885|FG003|Overall Study|Participant Withdrew Consent|7|||
156720231|NCT00742209|565721886|FG004|Overall Study|Participant Withdrew Consent|4|||
156720232|NCT00742209|565721882|FG000|Overall Study|Protocol Violation|6|||
156720233|NCT00742209|565721883|FG001|Overall Study|Protocol Violation|5|||
156720234|NCT00742209|565721884|FG002|Overall Study|Protocol Violation|4|||
156720235|NCT00742209|565721885|FG003|Overall Study|Protocol Violation|5|||
156720236|NCT00742209|565721886|FG004|Overall Study|Protocol Violation|3|||
156720237|NCT00742209|565721882|FG000|Overall Study|Lost to Follow-up|3|||
156720238|NCT00742209|565721883|FG001|Overall Study|Lost to Follow-up|4|||
156720239|NCT00742209|565721884|FG002|Overall Study|Lost to Follow-up|5|||
156720240|NCT00742209|565721885|FG003|Overall Study|Lost to Follow-up|5|||
156720241|NCT00742209|565721886|FG004|Overall Study|Lost to Follow-up|3|||
156720242|NCT00742209|565721882|FG000|Overall Study|Lack of Efficacy|6|||
156720243|NCT00742209|565721883|FG001|Overall Study|Lack of Efficacy|1|||
156720244|NCT00742209|565721884|FG002|Overall Study|Lack of Efficacy|1|||
156720245|NCT00742209|565721885|FG003|Overall Study|Lack of Efficacy|3|||
156720246|NCT00742209|565721886|FG004|Overall Study|Lack of Efficacy|1|||
156720247|NCT00742209|565721882|FG000|Overall Study|Investigator Discretion|0|||
156720248|NCT00742209|565721883|FG001|Overall Study|Investigator Discretion|0|||
156720249|NCT00742209|565721884|FG002|Overall Study|Investigator Discretion|5|||
156720250|NCT00742209|565721885|FG003|Overall Study|Investigator Discretion|1|||
156720251|NCT00742209|565721886|FG004|Overall Study|Investigator Discretion|1|||
156720252|NCT02003209|565721890|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
156720253|NCT02003209|565721891|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
156720254|NCT00638508|565721892|FG000|Overall Study|Physician Decision|5|||
156720255|NCT00638508|565721893|FG001|Overall Study|Physician Decision|2|||
156720256|NCT00485264|565721896|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
156720257|NCT00485264|565721897|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
156720258|NCT00485264|565721898|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
156720259|NCT00485264|565721899|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
156720260|NCT00485264|565721900|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
156720261|NCT00485264|565721901|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
156720262|NCT00485264|565721896|FG000|Overall Study|Death|1|||
156720263|NCT00485264|565721897|FG001|Overall Study|Death|0|||
156720264|NCT00485264|565721898|FG002|Overall Study|Death|0|||
156720265|NCT00485264|565721899|FG003|Overall Study|Death|0|||
156720266|NCT00485264|565721900|FG004|Overall Study|Death|1|||
156793876|NCT00266032|565999464|FG000|Treatment|Protocol Violation|6|||
156793877|NCT00266032|565999465|FG001|Treatment|Protocol Violation|14|||
157018644|NCT00676715|566822875|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
156720267|NCT00485264|565721901|FG005|Overall Study|Death|0|||
156720268|NCT00485264|565721896|FG000|Overall Study|Adverse Event|1|||
156720269|NCT00485264|565721897|FG001|Overall Study|Adverse Event|0|||
156720270|NCT00485264|565721898|FG002|Overall Study|Adverse Event|2|||
156720271|NCT00485264|565721899|FG003|Overall Study|Adverse Event|3|||
156720272|NCT00485264|565721900|FG004|Overall Study|Adverse Event|1|||
156720273|NCT00485264|565721901|FG005|Overall Study|Adverse Event|3|||
156720274|NCT00485264|565721896|FG000|Overall Study|Pregnancy|4|||
156720275|NCT00485264|565721897|FG001|Overall Study|Pregnancy|0|||
156720276|NCT00485264|565721898|FG002|Overall Study|Pregnancy|0|||
156720277|NCT00485264|565721899|FG003|Overall Study|Pregnancy|0|||
156720278|NCT00485264|565721900|FG004|Overall Study|Pregnancy|0|||
156720279|NCT00485264|565721901|FG005|Overall Study|Pregnancy|0|||
156720280|NCT00485264|565721896|FG000|Overall Study|Disallowed Medication|0|||
156720281|NCT00485264|565721897|FG001|Overall Study|Disallowed Medication|0|||
156720282|NCT00485264|565721898|FG002|Overall Study|Disallowed Medication|0|||
156720283|NCT00485264|565721899|FG003|Overall Study|Disallowed Medication|0|||
156720284|NCT00485264|565721900|FG004|Overall Study|Disallowed Medication|0|||
157018645|NCT00676715|566822872|FG000|Treatment Period (TP)|Administrative|0|||
156720285|NCT00485264|565721901|FG005|Overall Study|Disallowed Medication|1|||
156720286|NCT00485264|565721896|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
156720287|NCT00485264|565721897|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
156720288|NCT00485264|565721898|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
156720289|NCT00485264|565721899|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720290|NCT00485264|565721900|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720291|NCT00485264|565721901|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
156720292|NCT00485264|565721896|FG000|Overall Study|Lack of Efficacy|0|||
156720293|NCT00485264|565721897|FG001|Overall Study|Lack of Efficacy|1|||
156720294|NCT00485264|565721898|FG002|Overall Study|Lack of Efficacy|0|||
156720295|NCT00485264|565721899|FG003|Overall Study|Lack of Efficacy|0|||
156720296|NCT00485264|565721900|FG004|Overall Study|Lack of Efficacy|0|||
156720297|NCT00485264|565721901|FG005|Overall Study|Lack of Efficacy|0|||
156720298|NCT00485264|565721896|FG000|Overall Study|Guardian Consent Withdrawn|1|||
156720299|NCT00485264|565721897|FG001|Overall Study|Guardian Consent Withdrawn|0|||
156720300|NCT00485264|565721898|FG002|Overall Study|Guardian Consent Withdrawn|0|||
156720301|NCT00485264|565721899|FG003|Overall Study|Guardian Consent Withdrawn|0|||
156720302|NCT00485264|565721900|FG004|Overall Study|Guardian Consent Withdrawn|1|||
156720303|NCT00485264|565721901|FG005|Overall Study|Guardian Consent Withdrawn|0|||
156720304|NCT00485264|565721896|FG000|Overall Study|Physician Decision|0|||
156720305|NCT00485264|565721897|FG001|Overall Study|Physician Decision|2|||
156720306|NCT00485264|565721898|FG002|Overall Study|Physician Decision|0|||
156720307|NCT00485264|565721899|FG003|Overall Study|Physician Decision|0|||
156720308|NCT00485264|565721900|FG004|Overall Study|Physician Decision|0|||
156720309|NCT00485264|565721901|FG005|Overall Study|Physician Decision|0|||
156720310|NCT00485264|565721896|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720311|NCT00485264|565721897|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720312|NCT00485264|565721898|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
156720313|NCT00485264|565721899|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720314|NCT00485264|565721900|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720315|NCT00485264|565721901|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
156720316|NCT00485264|565721896|FG000|Overall Study|Not Able to Attend Clinic|5|||
156720317|NCT00485264|565721897|FG001|Overall Study|Not Able to Attend Clinic|0|||
156720318|NCT00485264|565721898|FG002|Overall Study|Not Able to Attend Clinic|0|||
156720319|NCT00485264|565721899|FG003|Overall Study|Not Able to Attend Clinic|1|||
156720320|NCT00485264|565721900|FG004|Overall Study|Not Able to Attend Clinic|1|||
156720321|NCT00485264|565721901|FG005|Overall Study|Not Able to Attend Clinic|2|||
156720322|NCT00485264|565721896|FG000|Overall Study|Non-Compliant|17|||
156720323|NCT00485264|565721897|FG001|Overall Study|Non-Compliant|2|||
156720324|NCT00485264|565721898|FG002|Overall Study|Non-Compliant|1|||
156720325|NCT00485264|565721899|FG003|Overall Study|Non-Compliant|0|||
156720326|NCT00485264|565721900|FG004|Overall Study|Non-Compliant|1|||
156720327|NCT00485264|565721901|FG005|Overall Study|Non-Compliant|0|||
156720328|NCT00485264|565721896|FG000|Overall Study|Lost to Follow-up|2|||
156720329|NCT00485264|565721897|FG001|Overall Study|Lost to Follow-up|1|||
156720330|NCT00485264|565721898|FG002|Overall Study|Lost to Follow-up|1|||
156720331|NCT00485264|565721899|FG003|Overall Study|Lost to Follow-up|0|||
156720332|NCT00485264|565721900|FG004|Overall Study|Lost to Follow-up|0|||
156720333|NCT00485264|565721901|FG005|Overall Study|Lost to Follow-up|1|||
156720334|NCT00485264|565721896|FG000|Overall Study|Other Reason|3|||
156720335|NCT00485264|565721897|FG001|Overall Study|Other Reason|0|||
156720336|NCT00485264|565721898|FG002|Overall Study|Other Reason|0|||
156720337|NCT00485264|565721899|FG003|Overall Study|Other Reason|0|||
156720338|NCT00485264|565721900|FG004|Overall Study|Other Reason|0|||
156720339|NCT00485264|565721901|FG005|Overall Study|Other Reason|0|||
156720340|NCT03500198|565721902|FG000|Overall Study|Lost to Follow-up|0|||
156720341|NCT03500198|565721903|FG001|Overall Study|Lost to Follow-up|1|||
156720342|NCT01514461|565721904|FG000|Overall Study|Adverse Event|2|||
156720343|NCT01514461|565721905|FG001|Overall Study|Adverse Event|1|||
157133449|NCT00654498|567236110|FG000|Overall Study|Adverse Event|6|||
157133450|NCT00654498|567236111|FG001|Overall Study|Adverse Event|1|||
156720344|NCT01514461|565721906|FG002|Overall Study|Adverse Event|3|||
156720345|NCT01514461|565721904|FG000|Overall Study|Physician Decision|1|||
156720346|NCT01514461|565721905|FG001|Overall Study|Physician Decision|1|||
156720347|NCT01514461|565721906|FG002|Overall Study|Physician Decision|0|||
156793878|NCT00266032|565999466|FG002|Treatment|Protocol Violation|13|||
156720348|NCT01514461|565721904|FG000|Overall Study|Patient/guardian decision|1|||
156720349|NCT01514461|565721905|FG001|Overall Study|Patient/guardian decision|1|||
156720350|NCT01514461|565721906|FG002|Overall Study|Patient/guardian decision|1|||
156720351|NCT01514461|565721904|FG000|Overall Study|Death|1|||
156793879|NCT00266032|565999464|FG000|Treatment|Withdrawal by Subject|28|||
156793880|NCT00266032|565999465|FG001|Treatment|Withdrawal by Subject|13|||
156720352|NCT01514461|565721905|FG001|Overall Study|Death|0|||
156720353|NCT01514461|565721906|FG002|Overall Study|Death|0|||
156720354|NCT00654095|565721907|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
156720355|NCT00654095|565721907|FG000|Overall Study|Elevated triglyceride level (2)|1|||
156720356|NCT00654095|565721907|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
156720357|NCT00654095|565721907|FG000|Overall Study|Adverse Event|11|||
157133451|NCT00654498|567236110|FG000|Overall Study|Protocol Violation|1|||
156720358|NCT00654095|565721907|FG000|Overall Study|Withdrawal by Subject|5|||
156720359|NCT00654095|565721907|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
156720360|NCT00654095|565721907|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
156720361|NCT00654095|565721907|FG000|Overall Study|Did not meet inclusion criteria|1|||
156720362|NCT00595621|565721913|FG000|Open Label Run in|Adverse Event|1|||
156720363|NCT00595621|565721914|FG001|Open Label Run in|Adverse Event|0|||
156720364|NCT00595621|565721913|FG000|Open Label Run in|Physician Decision|1|||
156720365|NCT00595621|565721914|FG001|Open Label Run in|Physician Decision|0|||
156720366|NCT00595621|565721913|FG000|Open Label Run in|Withdrawal by Subject|1|||
156720367|NCT00595621|565721914|FG001|Open Label Run in|Withdrawal by Subject|0|||
156720368|NCT00595621|565721913|FG000|Randomization and Study|Adverse Event|2|||
156720369|NCT00595621|565721914|FG001|Randomization and Study|Adverse Event|0|||
156720370|NCT00595621|565721913|FG000|Randomization and Study|Withdrawal by Subject|0|||
156720371|NCT00595621|565721914|FG001|Randomization and Study|Withdrawal by Subject|1|||
156720372|NCT02440464|565721915|FG000|Overall Study|Withdrawal by Subject|3|||
156720373|NCT02440464|565721916|FG001|Overall Study|Withdrawal by Subject|2|||
156720374|NCT00324987|565721917|FG000|Overall Study|Adverse Event|2|||
156720375|NCT00324987|565721918|FG001|Overall Study|Adverse Event|1|||
156720376|NCT00324987|565721917|FG000|Overall Study|Withdrawal by Subject|1|||
156720377|NCT00324987|565721918|FG001|Overall Study|Withdrawal by Subject|1|||
156720378|NCT00324987|565721917|FG000|Overall Study|Progression|1|||
156720379|NCT00324987|565721918|FG001|Overall Study|Progression|1|||
156720380|NCT00324987|565721917|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
156720381|NCT00324987|565721918|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
156720382|NCT01254643|565721919|FG000|Overall Study|Withdrawal by Subject|1|||
156720383|NCT01062425|565721923|FG000|Overall Study|Protocol Violation|3|||
156720384|NCT01062425|565721924|FG001|Overall Study|Protocol Violation|6|||
156720385|NCT05366010|565721926|FG000|Overall Study|Withdrawal by Subject|1|||
156720386|NCT05366010|565721926|FG000|Overall Study|Protocol Violation|1|||
156720387|NCT05366010|565721926|FG000|Overall Study|Lost to Follow-up|2|||
156720388|NCT05366010|565721926|FG000|Overall Study|Screen Failure|2|||
156720389|NCT02224157|565721927|FG000|Overall Study|Severe non-compliance to protocol|2|||
156720390|NCT02224157|565721928|FG001|Overall Study|Severe non-compliance to protocol|2|||
156720391|NCT02224157|565721927|FG000|Overall Study|Other|13|||
156720392|NCT02224157|565721928|FG001|Overall Study|Other|10|||
156720393|NCT02224157|565721927|FG000|Overall Study|Subject decision|58|||
156720394|NCT02224157|565721928|FG001|Overall Study|Subject decision|50|||
156720395|NCT02224157|565721927|FG000|Overall Study|Prematurely closed site|4|||
156720396|NCT02224157|565721928|FG001|Overall Study|Prematurely closed site|2|||
156720397|NCT02224157|565721927|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
156720398|NCT02224157|565721928|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
156720399|NCT02224157|565721927|FG000|Overall Study|Lost to Follow-up|27|||
156720400|NCT02224157|565721928|FG001|Overall Study|Lost to Follow-up|35|||
156720401|NCT02224157|565721927|FG000|Overall Study|Death|1|||
156720402|NCT02224157|565721928|FG001|Overall Study|Death|1|||
156720403|NCT02224157|565721927|FG000|Overall Study|Adverse Event|1|||
156720404|NCT02224157|565721928|FG001|Overall Study|Adverse Event|3|||
156720405|NCT05906628|565721929|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
156720406|NCT05906628|565721930|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
156720407|NCT05906628|565721929|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
156720408|NCT05906628|565721930|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
156720409|NCT05906628|565721929|FG000|16-Week DBVC Period|Protocol Violation|4|||
156720410|NCT05906628|565721930|FG001|16-Week DBVC Period|Protocol Violation|2|||
157018646|NCT00676715|566822873|FG001|Treatment Period (TP)|Administrative|0|||
157018647|NCT00676715|566822874|FG002|Treatment Period (TP)|Administrative|0|||
156720411|NCT05906628|565721929|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
156720412|NCT05906628|565721930|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
156720413|NCT05906628|565721929|FG000|16-Week OLE Period|Death|1|||
156720414|NCT05906628|565721930|FG001|16-Week OLE Period|Death|0|||
156720415|NCT05906628|565721929|FG000|16-Week OLE Period|Lost to Follow-up|1|||
156720416|NCT05906628|565721930|FG001|16-Week OLE Period|Lost to Follow-up|1|||
156720417|NCT05906628|565721929|FG000|16-Week OLE Period|Protocol Violation|0|||
156720418|NCT05906628|565721930|FG001|16-Week OLE Period|Protocol Violation|1|||
156720419|NCT05906628|565721929|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
156720420|NCT05906628|565721930|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
156720421|NCT01108718|565721931|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
156793881|NCT00266032|565999466|FG002|Treatment|Withdrawal by Subject|12|||
156720422|NCT01108718|565721932|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
156720423|NCT01060072|565721935|FG000|Overall Study|Adverse Event|1|||
156720424|NCT01060072|565721936|FG001|Overall Study|Adverse Event|1|||
156720425|NCT01060072|565721935|FG000|Overall Study|Physician Decision|0|||
156720426|NCT01060072|565721936|FG001|Overall Study|Physician Decision|2|||
156720427|NCT01060072|565721935|FG000|Overall Study|Protocol Violation|0|||
156720428|NCT01060072|565721936|FG001|Overall Study|Protocol Violation|1|||
156720429|NCT01060072|565721935|FG000|Overall Study|Acute cholecystitis|1|||
156720430|NCT01060072|565721936|FG001|Overall Study|Acute cholecystitis|0|||
156720431|NCT01060072|565721935|FG000|Overall Study|Excluded Medications|0|||
157133452|NCT00654498|567236111|FG001|Overall Study|Protocol Violation|1|||
157133453|NCT00654498|567236110|FG000|Overall Study|Lost to Follow-up|1|||
157133454|NCT00654498|567236111|FG001|Overall Study|Lost to Follow-up|5|||
157133455|NCT00654498|567236110|FG000|Overall Study|Withdrawal by Subject|1|||
157133456|NCT00654498|567236111|FG001|Overall Study|Withdrawal by Subject|0|||
157133457|NCT00654498|567236110|FG000|Overall Study|Other reason not defined above|4|||
157133458|NCT00654498|567236111|FG001|Overall Study|Other reason not defined above|5|||
157133459|NCT00787787|567236112|FG000|Overall Study|Lack of Efficacy|4|||
157133460|NCT00787787|567236112|FG000|Overall Study|Adverse Event|3|||
157133461|NCT03430986|567236114|FG000|24-week Control Period|Adverse Event|1|||
157133462|NCT03430986|567236115|FG001|24-week Control Period|Adverse Event|0|||
157133463|NCT03430986|567236114|FG000|24-week Control Period|Lost to Follow-up|2|||
157133464|NCT03430986|567236115|FG001|24-week Control Period|Lost to Follow-up|2|||
157133465|NCT03430986|567236114|FG000|24-week Control Period|Withdrawal by Participant|5|||
157133466|NCT03430986|567236115|FG001|24-week Control Period|Withdrawal by Participant|0|||
157133467|NCT03430986|567236114|FG000|24-week Control Period|Protocol Deviation|0|||
157133468|NCT03430986|567236115|FG001|24-week Control Period|Protocol Deviation|2|||
157133469|NCT03430986|567236114|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
157133470|NCT03430986|567236115|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
157133471|NCT03430986|567236114|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
157133472|NCT03430986|567236115|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
157133473|NCT01889602|567236118|FG000|First Intervention|Adverse Event|1|||
157133474|NCT01889602|567236119|FG001|First Intervention|Adverse Event|1|||
157133475|NCT01889602|567236120|FG002|First Intervention|Adverse Event|1|||
156720432|NCT01060072|565721936|FG001|Overall Study|Excluded Medications|1|||
156720433|NCT02301169|565721937|FG000|Overall Study|Adverse Event|1|||
156720434|NCT02301169|565721938|FG001|Overall Study|Adverse Event|0|||
156720435|NCT01949662|565721939|FG000|Overall Study|Death|9|||
156720436|NCT01949662|565721940|FG001|Overall Study|Death|7|||
156720437|NCT01949662|565721939|FG000|Overall Study|Discharged before an agitation event|8|||
156720438|NCT01949662|565721940|FG001|Overall Study|Discharged before an agitation event|3|||
156720439|NCT01949662|565721939|FG000|Overall Study|Dropped out|1|||
156720440|NCT01949662|565721940|FG001|Overall Study|Dropped out|3|||
156720441|NCT01949662|565721939|FG000|Overall Study|Ineligible|0|||
156720442|NCT01949662|565721940|FG001|Overall Study|Ineligible|1|||
156720443|NCT02291237|565721941|FG000|Overall Study|Study Terminated by Sponsor|72|||
156720444|NCT02291237|565721942|FG001|Overall Study|Study Terminated by Sponsor|67|||
156720445|NCT02291237|565721941|FG000|Overall Study|Adverse Event|1|||
156720446|NCT02291237|565721942|FG001|Overall Study|Adverse Event|3|||
156720447|NCT02291237|565721941|FG000|Overall Study|Investigator's Discretion|0|||
156720448|NCT02291237|565721942|FG001|Overall Study|Investigator's Discretion|3|||
156720449|NCT02291237|565721941|FG000|Overall Study|Withdrew Consent|11|||
156720450|NCT02291237|565721942|FG001|Overall Study|Withdrew Consent|11|||
156720451|NCT02291237|565721941|FG000|Overall Study|Lost to Follow-up|0|||
156720452|NCT02291237|565721942|FG001|Overall Study|Lost to Follow-up|2|||
156720453|NCT02291237|565721941|FG000|Overall Study|Subject Required Prohibited Medication|2|||
156720454|NCT02291237|565721942|FG001|Overall Study|Subject Required Prohibited Medication|0|||
156720455|NCT01478373|565721946|FG000|Treatment Phase|Protocol Violation|1|||
156720456|NCT01478373|565721946|FG000|Survival Phase|Adverse Event|8|||
156720457|NCT01478373|565721946|FG000|Survival Phase|Protocol Violation|1|||
156720458|NCT01478373|565721946|FG000|Survival Phase|crossover to another study|2|||
156720459|NCT01478373|565721946|FG000|Survival Phase|Progressive Disease|27|||
156720460|NCT04199104|565723696|FG000|Overall Study|Death|148|||
156720461|NCT04199104|565723697|FG001|Overall Study|Death|134|||
157133476|NCT01889602|567236118|FG000|First Intervention|Protocol Violation|0|||
157133477|NCT01889602|567236119|FG001|First Intervention|Protocol Violation|1|||
157133478|NCT01889602|567236120|FG002|First Intervention|Protocol Violation|1|||
157133479|NCT01889602|567236118|FG000|First Intervention|Study ending|0|||
157133480|NCT01889602|567236119|FG001|First Intervention|Study ending|1|||
157133481|NCT01889602|567236120|FG002|First Intervention|Study ending|0|||
157133482|NCT01889602|567236118|FG000|Second Intervention|Adverse Event|0|||
156720462|NCT04199104|565723696|FG000|Overall Study|Lost to Follow-up|1|||
156720463|NCT04199104|565723697|FG001|Overall Study|Lost to Follow-up|1|||
156720464|NCT04199104|565723696|FG000|Overall Study|Withdrawal by Subject|4|||
157133483|NCT01889602|567236119|FG001|Second Intervention|Adverse Event|0|||
156720465|NCT04199104|565723697|FG001|Overall Study|Withdrawal by Subject|4|||
156720466|NCT04199104|565723696|FG000|Overall Study|Participants Ongoing|103|||
157133484|NCT01889602|567236120|FG002|Second Intervention|Adverse Event|1|||
157133485|NCT01889602|567236118|FG000|Second Intervention|Study ending|1|||
157133486|NCT01889602|567236119|FG001|Second Intervention|Study ending|0|||
157133487|NCT01889602|567236120|FG002|Second Intervention|Study ending|0|||
156720467|NCT04199104|565723697|FG001|Overall Study|Participants Ongoing|116|||
156720468|NCT04075825|565723698|FG000|Overall Study|Withdrawal by Subject|6|||
156720469|NCT04075825|565723699|FG001|Overall Study|Withdrawal by Subject|8|||
156720470|NCT04075825|565723698|FG000|Overall Study|Physician Decision|3|||
156720471|NCT04075825|565723699|FG001|Overall Study|Physician Decision|1|||
156720472|NCT04075825|565723698|FG000|Overall Study|Lost to Follow-up|5|||
157133488|NCT01889602|567236118|FG000|Second Intervention|Withdrawal by Subject|0|||
156720473|NCT04075825|565723699|FG001|Overall Study|Lost to Follow-up|1|||
156720474|NCT04075825|565723698|FG000|Overall Study|Participation in New Clinical Trial|1|||
156720475|NCT04075825|565723699|FG001|Overall Study|Participation in New Clinical Trial|1|||
156720476|NCT04075825|565723698|FG000|Overall Study|Reason Not Specified|2|||
156720477|NCT04075825|565723699|FG001|Overall Study|Reason Not Specified|2|||
156720478|NCT04581824|565723700|FG000|Overall Study|Lost to Follow-up|1|||
156720479|NCT04581824|565723701|FG001|Overall Study|Lost to Follow-up|0|||
156720480|NCT04581824|565723700|FG000|Overall Study|Withdrawal by Subject|2|||
156720481|NCT04581824|565723701|FG001|Overall Study|Withdrawal by Subject|7|||
156720482|NCT04581824|565723700|FG000|Overall Study|Study terminated by sponsor|37|||
156720483|NCT04581824|565723701|FG001|Overall Study|Study terminated by sponsor|23|||
156720484|NCT04796909|565723702|FG000|Overall Study|Withdrawal by Subject|1|||
156720485|NCT04796909|565723703|FG001|Overall Study|Withdrawal by Subject|1|||
156720486|NCT03879135|565723704|FG000|Overall Study|Physician Decision|0|||
156720487|NCT03879135|565723705|FG001|Overall Study|Physician Decision|0|||
156720488|NCT03879135|565723706|FG002|Overall Study|Physician Decision|0|||
156720489|NCT03879135|565723707|FG003|Overall Study|Physician Decision|1|||
156720490|NCT03879135|565723708|FG004|Overall Study|Physician Decision|0|||
156720491|NCT03879135|565723709|FG005|Overall Study|Physician Decision|0|||
156720492|NCT03879135|565723704|FG000|Overall Study|Withdrawal by Subject|0|||
156720493|NCT03879135|565723705|FG001|Overall Study|Withdrawal by Subject|0|||
156720494|NCT03879135|565723706|FG002|Overall Study|Withdrawal by Subject|0|||
156720495|NCT03879135|565723707|FG003|Overall Study|Withdrawal by Subject|0|||
156720496|NCT03879135|565723708|FG004|Overall Study|Withdrawal by Subject|0|||
156720497|NCT03879135|565723709|FG005|Overall Study|Withdrawal by Subject|1|||
156720498|NCT03879135|565723704|FG000|Overall Study|Site Closed by Sponsor|0|||
156720499|NCT03879135|565723705|FG001|Overall Study|Site Closed by Sponsor|0|||
156720500|NCT03879135|565723706|FG002|Overall Study|Site Closed by Sponsor|0|||
156720501|NCT03879135|565723707|FG003|Overall Study|Site Closed by Sponsor|1|||
156720502|NCT03879135|565723708|FG004|Overall Study|Site Closed by Sponsor|1|||
156720503|NCT03879135|565723709|FG005|Overall Study|Site Closed by Sponsor|0|||
156720504|NCT03428958|565723710|FG000|Overall Study|Adverse Event|0|||
156720505|NCT03428958|565723711|FG001|Overall Study|Adverse Event|0|||
156720506|NCT03428958|565723712|FG002|Overall Study|Adverse Event|0|||
156720507|NCT03428958|565723713|FG003|Overall Study|Adverse Event|1|||
156720508|NCT03428958|565723714|FG004|Overall Study|Adverse Event|0|||
156720509|NCT03428958|565723715|FG005|Overall Study|Adverse Event|2|||
156720510|NCT03428958|565723716|FG006|Overall Study|Adverse Event|1|||
156720511|NCT03428958|565723717|FG007|Overall Study|Adverse Event|0|||
156720512|NCT03428958|565723718|FG008|Overall Study|Adverse Event|0|||
156720513|NCT03428958|565723719|FG009|Overall Study|Adverse Event|0|||
156720514|NCT03428958|565723720|FG010|Overall Study|Adverse Event|0|||
156793882|NCT00266032|565999464|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
156793883|NCT00266032|565999465|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
156793884|NCT00266032|565999466|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
157018648|NCT00676715|566822875|FG003|Treatment Period (TP)|Administrative|1|||
157018649|NCT00676715|566822872|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
156720515|NCT03428958|565723721|FG011|Overall Study|Adverse Event|0|||
156720516|NCT03428958|565723722|FG012|Overall Study|Adverse Event|0|||
156720517|NCT03428958|565723723|FG013|Overall Study|Adverse Event|0|||
157018650|NCT00676715|566822873|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
157018651|NCT00676715|566822874|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
157018652|NCT00676715|566822875|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
157018653|NCT00676715|566822872|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
157018654|NCT00676715|566822873|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
157018655|NCT00676715|566822874|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
157018656|NCT00676715|566822875|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
157018657|NCT00676715|566822872|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
157018658|NCT00676715|566822873|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
157018659|NCT00676715|566822874|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
157018660|NCT00676715|566822875|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
157018661|NCT00676715|566822872|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
157018662|NCT00676715|566822873|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
157018663|NCT00676715|566822874|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
157018664|NCT00676715|566822875|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
157018665|NCT00676715|566822872|FG000|Treatment-free Period (TFP)|Death|1|||
157018666|NCT00676715|566822873|FG001|Treatment-free Period (TFP)|Death|1|||
157018667|NCT00676715|566822874|FG002|Treatment-free Period (TFP)|Death|1|||
157018668|NCT00676715|566822875|FG003|Treatment-free Period (TFP)|Death|0|||
157018669|NCT00676715|566822872|FG000|Open Label Extension (OLE)|Reason not provided|3|||
157018670|NCT00676715|566822873|FG001|Open Label Extension (OLE)|Reason not provided|4|||
157018671|NCT00676715|566822874|FG002|Open Label Extension (OLE)|Reason not provided|1|||
157018672|NCT00676715|566822875|FG003|Open Label Extension (OLE)|Reason not provided|4|||
157018673|NCT00676715|566822872|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
157133489|NCT01889602|567236119|FG001|Second Intervention|Withdrawal by Subject|0|||
157133490|NCT01889602|567236120|FG002|Second Intervention|Withdrawal by Subject|1|||
157133491|NCT01889602|567236118|FG000|Third Intervention|Protocol Violation|1|||
157133492|NCT01889602|567236119|FG001|Third Intervention|Protocol Violation|0|||
157133493|NCT01889602|567236120|FG002|Third Intervention|Protocol Violation|0|||
157133494|NCT01889602|567236118|FG000|Third Intervention|Withdrawal by Subject|2|||
157133495|NCT01889602|567236119|FG001|Third Intervention|Withdrawal by Subject|2|||
157133496|NCT01889602|567236120|FG002|Third Intervention|Withdrawal by Subject|0|||
157133497|NCT01412957|567236121|FG000|Overall Study|Withdrawal by Subject|6|||
157133498|NCT01412957|567236122|FG001|Overall Study|Withdrawal by Subject|22|||
157133499|NCT01412957|567236121|FG000|Overall Study|Lost to Follow-up|7|||
157133500|NCT01412957|567236122|FG001|Overall Study|Lost to Follow-up|2|||
157133501|NCT01412957|567236121|FG000|Overall Study|Death|136|||
157133502|NCT01412957|567236122|FG001|Overall Study|Death|133|||
157133503|NCT00484315|567236123|FG000|12-Month Clinical Follow-up|Death|6|||
157133504|NCT00484315|567236124|FG001|12-Month Clinical Follow-up|Death|2|||
157133505|NCT00484315|567236123|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
156720518|NCT03428958|565723724|FG014|Overall Study|Adverse Event|0|||
156720519|NCT03428958|565723725|FG015|Overall Study|Adverse Event|0|||
156720520|NCT03428958|565723726|FG016|Overall Study|Adverse Event|0|||
156720521|NCT03428958|565723710|FG000|Overall Study|Clinical Progression|2|||
156720522|NCT03428958|565723711|FG001|Overall Study|Clinical Progression|3|||
156720523|NCT03428958|565723712|FG002|Overall Study|Clinical Progression|2|||
156720524|NCT03428958|565723713|FG003|Overall Study|Clinical Progression|1|||
156720525|NCT03428958|565723714|FG004|Overall Study|Clinical Progression|0|||
156720526|NCT03428958|565723715|FG005|Overall Study|Clinical Progression|2|||
156720527|NCT03428958|565723716|FG006|Overall Study|Clinical Progression|0|||
156720528|NCT03428958|565723717|FG007|Overall Study|Clinical Progression|0|||
156720529|NCT03428958|565723718|FG008|Overall Study|Clinical Progression|0|||
156720530|NCT03428958|565723719|FG009|Overall Study|Clinical Progression|0|||
156720531|NCT03428958|565723720|FG010|Overall Study|Clinical Progression|0|||
156720532|NCT03428958|565723721|FG011|Overall Study|Clinical Progression|0|||
156720533|NCT03428958|565723722|FG012|Overall Study|Clinical Progression|0|||
156720534|NCT03428958|565723723|FG013|Overall Study|Clinical Progression|0|||
156720535|NCT03428958|565723724|FG014|Overall Study|Clinical Progression|0|||
156720536|NCT03428958|565723725|FG015|Overall Study|Clinical Progression|0|||
156720537|NCT03428958|565723726|FG016|Overall Study|Clinical Progression|0|||
156720538|NCT03428958|565723710|FG000|Overall Study|Progression per RECIST|6|||
156720539|NCT03428958|565723711|FG001|Overall Study|Progression per RECIST|6|||
156720540|NCT03428958|565723712|FG002|Overall Study|Progression per RECIST|7|||
156720541|NCT03428958|565723713|FG003|Overall Study|Progression per RECIST|4|||
156720542|NCT03428958|565723714|FG004|Overall Study|Progression per RECIST|0|||
156720543|NCT03428958|565723715|FG005|Overall Study|Progression per RECIST|7|||
156720544|NCT03428958|565723716|FG006|Overall Study|Progression per RECIST|8|||
156720545|NCT03428958|565723717|FG007|Overall Study|Progression per RECIST|0|||
156720546|NCT03428958|565723718|FG008|Overall Study|Progression per RECIST|0|||
156720547|NCT03428958|565723719|FG009|Overall Study|Progression per RECIST|0|||
156720548|NCT03428958|565723720|FG010|Overall Study|Progression per RECIST|0|||
156720549|NCT03428958|565723721|FG011|Overall Study|Progression per RECIST|0|||
156720550|NCT03428958|565723722|FG012|Overall Study|Progression per RECIST|1|||
156720551|NCT03428958|565723723|FG013|Overall Study|Progression per RECIST|0|||
156720552|NCT03428958|565723724|FG014|Overall Study|Progression per RECIST|0|||
156720553|NCT03428958|565723725|FG015|Overall Study|Progression per RECIST|0|||
156720554|NCT03428958|565723726|FG016|Overall Study|Progression per RECIST|0|||
156720555|NCT03428958|565723710|FG000|Overall Study|Death|2|||
156720556|NCT03428958|565723711|FG001|Overall Study|Death|2|||
156720557|NCT03428958|565723712|FG002|Overall Study|Death|0|||
157133506|NCT00484315|567236124|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
157133507|NCT00484315|567236123|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
157133508|NCT00484315|567236124|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
157217262|NCT01154127|567541062|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
157217263|NCT01154127|567541063|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
156720558|NCT03428958|565723713|FG003|Overall Study|Death|0|||
156720559|NCT03428958|565723714|FG004|Overall Study|Death|0|||
156720560|NCT03428958|565723715|FG005|Overall Study|Death|7|||
156720561|NCT03428958|565723716|FG006|Overall Study|Death|9|||
157217264|NCT01154127|567541062|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
156720562|NCT03428958|565723717|FG007|Overall Study|Death|6|||
156720563|NCT03428958|565723718|FG008|Overall Study|Death|0|||
156720564|NCT03428958|565723719|FG009|Overall Study|Death|0|||
156720565|NCT03428958|565723720|FG010|Overall Study|Death|3|||
156720566|NCT03428958|565723721|FG011|Overall Study|Death|0|||
156720567|NCT03428958|565723722|FG012|Overall Study|Death|4|||
156720568|NCT03428958|565723723|FG013|Overall Study|Death|0|||
156720569|NCT03428958|565723724|FG014|Overall Study|Death|0|||
156720570|NCT03428958|565723725|FG015|Overall Study|Death|0|||
156720571|NCT03428958|565723726|FG016|Overall Study|Death|0|||
156720572|NCT03428958|565723710|FG000|Overall Study|Lost to Follow-up|0|||
157133509|NCT00484315|567236123|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
157133510|NCT00484315|567236124|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
157133511|NCT00484315|567236123|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
157133512|NCT00484315|567236124|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
157133513|NCT00484315|567236123|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
157133514|NCT00484315|567236124|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
157133515|NCT00484315|567236123|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
157133516|NCT00484315|567236124|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
157133517|NCT00943683|567236125|FG000|Overall Study|Adverse Event|3|||
157133518|NCT00943683|567236126|FG001|Overall Study|Adverse Event|3|||
157133519|NCT00943683|567236125|FG000|Overall Study|Lost to Follow-up|1|||
157133520|NCT00943683|567236126|FG001|Overall Study|Lost to Follow-up|1|||
157133521|NCT00943683|567236125|FG000|Overall Study|Protocol Violation|1|||
157133522|NCT00943683|567236126|FG001|Overall Study|Protocol Violation|2|||
157133523|NCT00943683|567236125|FG000|Overall Study|Withdrawal by Subject|1|||
157133524|NCT00943683|567236126|FG001|Overall Study|Withdrawal by Subject|0|||
157133525|NCT00943683|567236125|FG000|Overall Study|Patient Moved|1|||
157133526|NCT00943683|567236126|FG001|Overall Study|Patient Moved|0|||
157133527|NCT01245673|567236127|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
157133528|NCT04722991|567236136|FG000|Overall Study|Adverse Event|12|||
157133529|NCT04722991|567236137|FG001|Overall Study|Adverse Event|4|||
157133530|NCT04722991|567236136|FG000|Overall Study|Death|2|||
157133531|NCT04722991|567236137|FG001|Overall Study|Death|0|||
156720573|NCT03428958|565723711|FG001|Overall Study|Lost to Follow-up|0|||
156720574|NCT03428958|565723712|FG002|Overall Study|Lost to Follow-up|0|||
156720575|NCT03428958|565723713|FG003|Overall Study|Lost to Follow-up|0|||
156720576|NCT03428958|565723714|FG004|Overall Study|Lost to Follow-up|0|||
156720577|NCT03428958|565723715|FG005|Overall Study|Lost to Follow-up|1|||
156720578|NCT03428958|565723716|FG006|Overall Study|Lost to Follow-up|1|||
156720579|NCT03428958|565723717|FG007|Overall Study|Lost to Follow-up|0|||
156720580|NCT03428958|565723718|FG008|Overall Study|Lost to Follow-up|0|||
156720581|NCT03428958|565723719|FG009|Overall Study|Lost to Follow-up|0|||
156720582|NCT03428958|565723720|FG010|Overall Study|Lost to Follow-up|0|||
156720583|NCT03428958|565723721|FG011|Overall Study|Lost to Follow-up|0|||
156720584|NCT03428958|565723722|FG012|Overall Study|Lost to Follow-up|0|||
156720585|NCT03428958|565723723|FG013|Overall Study|Lost to Follow-up|0|||
156720586|NCT03428958|565723724|FG014|Overall Study|Lost to Follow-up|0|||
156720587|NCT03428958|565723725|FG015|Overall Study|Lost to Follow-up|0|||
156720588|NCT03428958|565723726|FG016|Overall Study|Lost to Follow-up|0|||
156720589|NCT03428958|565723710|FG000|Overall Study|Physician/Sponsor Decision|1|||
156720590|NCT03428958|565723711|FG001|Overall Study|Physician/Sponsor Decision|0|||
157018674|NCT00676715|566822873|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
157018675|NCT00676715|566822874|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
157018676|NCT00676715|566822875|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
157018677|NCT00676715|566822872|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
157018678|NCT00676715|566822873|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
157018679|NCT00676715|566822874|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
157018680|NCT00676715|566822875|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
157018681|NCT00676715|566822872|FG000|Open Label Extension (OLE)|Adverse Event|0|||
157018682|NCT00676715|566822873|FG001|Open Label Extension (OLE)|Adverse Event|3|||
157018683|NCT00676715|566822874|FG002|Open Label Extension (OLE)|Adverse Event|1|||
157018684|NCT00676715|566822875|FG003|Open Label Extension (OLE)|Adverse Event|0|||
157018685|NCT00676715|566822872|FG000|Open Label Extension (OLE)|Death|2|||
157018686|NCT00676715|566822873|FG001|Open Label Extension (OLE)|Death|0|||
157018687|NCT00676715|566822874|FG002|Open Label Extension (OLE)|Death|2|||
157018688|NCT00676715|566822875|FG003|Open Label Extension (OLE)|Death|2|||
157018689|NCT01331005|566822879|FG000|Overall Study|Lost to Follow-up|2|||
157018690|NCT01331005|566822880|FG001|Overall Study|Lost to Follow-up|1|||
157018691|NCT01331005|566822879|FG000|Overall Study|Withdrawal by Subject|2|||
157018692|NCT01331005|566822880|FG001|Overall Study|Withdrawal by Subject|3|||
157018693|NCT03161379|566822890|FG000|Overall Study|Withdrawal by Subject|4|||
157018694|NCT03161379|566822890|FG000|Overall Study|disease progression during chemotherapy|5|||
157018695|NCT03161379|566822890|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
157018696|NCT03161379|566822890|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
157018697|NCT03131648|566822894|FG000|Initial Treatment Period|Not dosed|2|||
157018698|NCT03131648|566822895|FG001|Initial Treatment Period|Not dosed|2|||
157018699|NCT03131648|566822896|FG002|Initial Treatment Period|Not dosed|0|||
157018700|NCT03131648|566822897|FG003|Initial Treatment Period|Not dosed|0|||
157018701|NCT03131648|566822898|FG004|Initial Treatment Period|Not dosed|0|||
157018702|NCT03131648|566822899|FG005|Initial Treatment Period|Not dosed|0|||
157018703|NCT03131648|566822900|FG006|Initial Treatment Period|Not dosed|0|||
157018704|NCT03131648|566822901|FG007|Initial Treatment Period|Not dosed|0|||
157018705|NCT03131648|566822894|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
157018706|NCT03131648|566822895|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
157133532|NCT04722991|567236136|FG000|Overall Study|Lost to Follow-up|1|||
157133533|NCT04722991|567236137|FG001|Overall Study|Lost to Follow-up|1|||
157133534|NCT04722991|567236136|FG000|Overall Study|Withdrawal cirterion met|2|||
157133535|NCT04722991|567236137|FG001|Overall Study|Withdrawal cirterion met|2|||
157133536|NCT04722991|567236136|FG000|Overall Study|Other|1|||
157133537|NCT04722991|567236137|FG001|Overall Study|Other|0|||
157133538|NCT04722991|567236136|FG000|Overall Study|Non-compliance|0|||
157133539|NCT04722991|567236137|FG001|Overall Study|Non-compliance|1|||
157133540|NCT04722991|567236136|FG000|Overall Study|Withdrawal by Subject|0|||
157133541|NCT04722991|567236137|FG001|Overall Study|Withdrawal by Subject|1|||
157133542|NCT01445678|567236138|FG000|Overall Study|Adverse Event|12|||
157133543|NCT01445678|567236139|FG001|Overall Study|Adverse Event|8|||
157133544|NCT01445678|567236138|FG000|Overall Study|Lack of Efficacy|0|||
157133545|NCT01445678|567236139|FG001|Overall Study|Lack of Efficacy|2|||
157133546|NCT01445678|567236138|FG000|Overall Study|Lost to Follow-up|8|||
157133547|NCT01445678|567236139|FG001|Overall Study|Lost to Follow-up|5|||
157133548|NCT01445678|567236138|FG000|Overall Study|Protocol Violation|1|||
157133549|NCT01445678|567236139|FG001|Overall Study|Protocol Violation|1|||
157133550|NCT01445678|567236138|FG000|Overall Study|Withdrawal by Subject|9|||
157133551|NCT01445678|567236139|FG001|Overall Study|Withdrawal by Subject|5|||
157133552|NCT01459614|567236142|FG000|Overall Study|Adverse Event|1|||
157133553|NCT01459614|567236143|FG001|Overall Study|Adverse Event|0|||
157133554|NCT01565980|567236144|FG000|Overall Study|Death|1|||
157133555|NCT01565980|567236145|FG001|Overall Study|Death|0|||
157133556|NCT01565980|567236144|FG000|Overall Study|Lost to Follow-up|1|||
157133557|NCT01565980|567236145|FG001|Overall Study|Lost to Follow-up|0|||
157133558|NCT01565980|567236144|FG000|Overall Study|health complications|1|||
157133559|NCT01565980|567236145|FG001|Overall Study|health complications|1|||
157133560|NCT01565980|567236144|FG000|Overall Study|stopped medical treatment|1|||
157133561|NCT01565980|567236145|FG001|Overall Study|stopped medical treatment|0|||
157133562|NCT01565980|567236144|FG000|Overall Study|Withdrawal by Subject|0|||
157133563|NCT01565980|567236145|FG001|Overall Study|Withdrawal by Subject|3|||
157133564|NCT02078219|567236148|FG000|Overall Study|Other|2|||
157133565|NCT02078219|567236149|FG001|Overall Study|Other|2|||
157133566|NCT02078219|567236150|FG002|Overall Study|Other|3|||
157133567|NCT02078219|567236151|FG003|Overall Study|Other|0|||
157133568|NCT02078219|567236152|FG004|Overall Study|Other|1|||
157133569|NCT02078219|567236148|FG000|Overall Study|Withdrawal by Subject|0|||
157133570|NCT02078219|567236149|FG001|Overall Study|Withdrawal by Subject|1|||
157133571|NCT02078219|567236150|FG002|Overall Study|Withdrawal by Subject|0|||
157133572|NCT02078219|567236151|FG003|Overall Study|Withdrawal by Subject|1|||
157133573|NCT02078219|567236152|FG004|Overall Study|Withdrawal by Subject|1|||
157133574|NCT02078219|567236148|FG000|Overall Study|Protocol Violation|0|||
157133575|NCT02078219|567236149|FG001|Overall Study|Protocol Violation|0|||
157133576|NCT02078219|567236150|FG002|Overall Study|Protocol Violation|0|||
157133577|NCT02078219|567236151|FG003|Overall Study|Protocol Violation|1|||
156720591|NCT03428958|565723712|FG002|Overall Study|Physician/Sponsor Decision|1|||
156720592|NCT03428958|565723713|FG003|Overall Study|Physician/Sponsor Decision|0|||
156720593|NCT03428958|565723714|FG004|Overall Study|Physician/Sponsor Decision|0|||
156720594|NCT03428958|565723715|FG005|Overall Study|Physician/Sponsor Decision|2|||
156720595|NCT03428958|565723716|FG006|Overall Study|Physician/Sponsor Decision|2|||
156720596|NCT03428958|565723717|FG007|Overall Study|Physician/Sponsor Decision|2|||
156720597|NCT03428958|565723718|FG008|Overall Study|Physician/Sponsor Decision|0|||
156720598|NCT03428958|565723719|FG009|Overall Study|Physician/Sponsor Decision|0|||
156720599|NCT03428958|565723720|FG010|Overall Study|Physician/Sponsor Decision|2|||
156720600|NCT03428958|565723721|FG011|Overall Study|Physician/Sponsor Decision|0|||
156720601|NCT03428958|565723722|FG012|Overall Study|Physician/Sponsor Decision|4|||
156720602|NCT03428958|565723723|FG013|Overall Study|Physician/Sponsor Decision|0|||
156720603|NCT03428958|565723724|FG014|Overall Study|Physician/Sponsor Decision|0|||
156720604|NCT03428958|565723725|FG015|Overall Study|Physician/Sponsor Decision|0|||
156720605|NCT03428958|565723726|FG016|Overall Study|Physician/Sponsor Decision|0|||
157133578|NCT02078219|567236152|FG004|Overall Study|Protocol Violation|0|||
157133579|NCT02078219|567236148|FG000|Overall Study|Death|0|||
156720606|NCT03428958|565723710|FG000|Overall Study|Withdrawal by Subject|0|||
157133580|NCT02078219|567236149|FG001|Overall Study|Death|0|||
157133581|NCT02078219|567236150|FG002|Overall Study|Death|0|||
157133582|NCT02078219|567236151|FG003|Overall Study|Death|1|||
157133583|NCT02078219|567236152|FG004|Overall Study|Death|0|||
157133584|NCT02078219|567236148|FG000|Overall Study|Adverse Event|1|||
157133585|NCT02078219|567236149|FG001|Overall Study|Adverse Event|1|||
157133586|NCT02078219|567236150|FG002|Overall Study|Adverse Event|3|||
157133587|NCT02078219|567236151|FG003|Overall Study|Adverse Event|1|||
157133588|NCT02078219|567236152|FG004|Overall Study|Adverse Event|0|||
157133589|NCT01468311|567236153|FG000|Overall Study|mobilization failure|1|||
156720607|NCT03428958|565723711|FG001|Overall Study|Withdrawal by Subject|0|||
156793885|NCT00266032|565999464|FG000|Open-label Safety Extension|Adverse Event|5|||
157133590|NCT01468311|567236153|FG000|Overall Study|Withdrawal by Subject|1|||
157133591|NCT02338843|567237789|FG000|Overall Study|Adverse Event|2|||
157133592|NCT02338843|567237790|FG001|Overall Study|Adverse Event|1|||
156793886|NCT00266032|565999465|FG001|Open-label Safety Extension|Adverse Event|0|||
156793887|NCT00266032|565999466|FG002|Open-label Safety Extension|Adverse Event|4|||
156793888|NCT00266032|565999464|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
156793889|NCT00266032|565999465|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
156793890|NCT00266032|565999466|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
156793891|NCT00266032|565999464|FG000|Open-label Safety Extension|Pregnancy|4|||
156793892|NCT00266032|565999465|FG001|Open-label Safety Extension|Pregnancy|1|||
156793893|NCT00266032|565999466|FG002|Open-label Safety Extension|Pregnancy|2|||
156793894|NCT00266032|565999464|FG000|Open-label Safety Extension|Protocol Violation|1|||
156793895|NCT00266032|565999465|FG001|Open-label Safety Extension|Protocol Violation|3|||
156793896|NCT00266032|565999466|FG002|Open-label Safety Extension|Protocol Violation|2|||
156793897|NCT00266032|565999464|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
157133593|NCT02338843|567237789|FG000|Overall Study|Death|40|||
157133594|NCT02338843|567237790|FG001|Overall Study|Death|53|||
157133595|NCT02338843|567237789|FG000|Overall Study|Physician Decision|1|||
157133596|NCT02338843|567237790|FG001|Overall Study|Physician Decision|0|||
157133597|NCT02338843|567237789|FG000|Overall Study|Withdrawal by Subject|0|||
157133598|NCT02338843|567237790|FG001|Overall Study|Withdrawal by Subject|2|||
157133599|NCT02338843|567237789|FG000|Overall Study|Subject Recovered|0|||
156720608|NCT03428958|565723712|FG002|Overall Study|Withdrawal by Subject|2|||
156720609|NCT03428958|565723713|FG003|Overall Study|Withdrawal by Subject|0|||
156720610|NCT03428958|565723714|FG004|Overall Study|Withdrawal by Subject|0|||
156720611|NCT03428958|565723715|FG005|Overall Study|Withdrawal by Subject|2|||
156720612|NCT03428958|565723716|FG006|Overall Study|Withdrawal by Subject|4|||
156720613|NCT03428958|565723717|FG007|Overall Study|Withdrawal by Subject|1|||
156720614|NCT03428958|565723718|FG008|Overall Study|Withdrawal by Subject|0|||
156720615|NCT03428958|565723719|FG009|Overall Study|Withdrawal by Subject|0|||
156720616|NCT03428958|565723720|FG010|Overall Study|Withdrawal by Subject|0|||
156720617|NCT03428958|565723721|FG011|Overall Study|Withdrawal by Subject|0|||
156720618|NCT03428958|565723722|FG012|Overall Study|Withdrawal by Subject|0|||
156720619|NCT03428958|565723723|FG013|Overall Study|Withdrawal by Subject|0|||
156720620|NCT03428958|565723724|FG014|Overall Study|Withdrawal by Subject|0|||
156720621|NCT03428958|565723725|FG015|Overall Study|Withdrawal by Subject|0|||
156720622|NCT03428958|565723726|FG016|Overall Study|Withdrawal by Subject|0|||
156720623|NCT03985800|565723727|FG000|Overall Study|Death|1|||
156720624|NCT03985800|565723728|FG001|Overall Study|Death|2|||
156720625|NCT03985800|565723727|FG000|Overall Study|Withdrawal by Subject|3|||
156720626|NCT03985800|565723728|FG001|Overall Study|Withdrawal by Subject|6|||
156720627|NCT03985800|565723727|FG000|Overall Study|Protocol Violation|2|||
156720628|NCT03985800|565723728|FG001|Overall Study|Protocol Violation|0|||
156720629|NCT05258773|565723729|FG000|Overall Study|Screen Failure|1|||
156720630|NCT05258773|565723730|FG001|Overall Study|Screen Failure|1|||
156720631|NCT05258773|565723729|FG000|Overall Study|Adverse Event|1|||
156720632|NCT05258773|565723730|FG001|Overall Study|Adverse Event|0|||
156720633|NCT05258773|565723729|FG000|Overall Study|Withdrawal by Subject|0|||
156720634|NCT05258773|565723730|FG001|Overall Study|Withdrawal by Subject|1|||
156720635|NCT06025721|565723733|FG000|Overall Study|Physician Decision|1|||
156720636|NCT06025721|565723733|FG000|Overall Study|Protocol Violation|1|||
156720637|NCT06025721|565723733|FG000|Overall Study|Incarceration|1|||
156720638|NCT04231825|565723734|FG000|Overall Study|Protocol Violation|3|||
156720639|NCT04231825|565723735|FG001|Overall Study|Protocol Violation|3|||
156720640|NCT04231825|565723734|FG000|Overall Study|Lost to Follow-up|0|||
156720641|NCT04231825|565723735|FG001|Overall Study|Lost to Follow-up|1|||
156720642|NCT01662635|565723736|FG000|Overall Study|scarce samples for evaluation|30|||
156720643|NCT00595920|565723737|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
156720644|NCT00351468|565723738|FG000|Overall Study|Adverse Event|42|||
156720645|NCT00351468|565723738|FG000|Overall Study|Withdrawal by Subject|39|||
156720646|NCT00351468|565723738|FG000|Overall Study|Various -follow up w clinical team|39|||
156720647|NCT00351468|565723738|FG000|Overall Study|Lack of Efficacy|32|||
156793898|NCT00266032|565999465|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
156793899|NCT00266032|565999466|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
156875353|NCT04896086|566302024|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
156793900|NCT00266032|565999464|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
157133600|NCT02338843|567237790|FG001|Overall Study|Subject Recovered|2|||
157133601|NCT02338843|567237789|FG000|Overall Study|Discontinued prior to randomizat|1|||
156720648|NCT00351468|565723738|FG000|Overall Study|Non-compliance|8|||
156720649|NCT00351468|565723738|FG000|Overall Study|Lost to Follow-up|4|||
156720650|NCT00351468|565723738|FG000|Overall Study|Protocol Violation|3|||
156720651|NCT03588910|565723739|FG000|Overall Study|Withdrawal by Subject|1|||
156720652|NCT03588910|565723740|FG001|Overall Study|Withdrawal by Subject|0|||
156720653|NCT03588910|565723739|FG000|Overall Study|Allergy|2|||
156720654|NCT03588910|565723740|FG001|Overall Study|Allergy|0|||
156720655|NCT03588910|565723739|FG000|Overall Study|Protocol Violation|0|||
156720656|NCT03588910|565723740|FG001|Overall Study|Protocol Violation|3|||
156720657|NCT03588910|565723739|FG000|Overall Study|Did not complete Day 1 Survey|5|||
156720658|NCT03588910|565723740|FG001|Overall Study|Did not complete Day 1 Survey|10|||
157133602|NCT02338843|567237790|FG001|Overall Study|Discontinued prior to randomizat|0|||
157133603|NCT00110305|567237791|FG000|Overall Study|Adverse Event|46|||
157133604|NCT00110305|567237792|FG001|Overall Study|Adverse Event|13|||
157133605|NCT00110305|567237791|FG000|Overall Study|Sponsors Decision|1|||
157133606|NCT00110305|567237792|FG001|Overall Study|Sponsors Decision|0|||
157133607|NCT00110305|567237791|FG000|Overall Study|Subject Non-Compliant|9|||
157133608|NCT00110305|567237792|FG001|Overall Study|Subject Non-Compliant|2|||
156720659|NCT03588910|565723739|FG000|Overall Study|Did not complete Day 7 Survey|5|||
156720660|NCT03588910|565723740|FG001|Overall Study|Did not complete Day 7 Survey|2|||
156720661|NCT04565145|565723741|FG000|Overall Study|Withdrawal by Subject|1|||
156720662|NCT04565145|565723742|FG001|Overall Study|Withdrawal by Subject|1|||
157133609|NCT00110305|567237791|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
157133610|NCT00110305|567237792|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
157133611|NCT00110305|567237791|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
157133612|NCT00110305|567237792|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
157133613|NCT00110305|567237791|FG000|Overall Study|Protocol Violation|0|||
157133614|NCT00110305|567237792|FG001|Overall Study|Protocol Violation|1|||
157133615|NCT00110305|567237791|FG000|Overall Study|Withdrawal by Subject|7|||
157133616|NCT00110305|567237792|FG001|Overall Study|Withdrawal by Subject|7|||
157133617|NCT00110305|567237791|FG000|Overall Study|Lost to Follow-up|20|||
157133618|NCT00110305|567237792|FG001|Overall Study|Lost to Follow-up|3|||
157133619|NCT00110305|567237791|FG000|Overall Study|Other|8|||
157133620|NCT00110305|567237792|FG001|Overall Study|Other|2|||
157133621|NCT05047523|567237800|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
157133622|NCT05047523|567237801|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
157133623|NCT05047523|567237802|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
157133624|NCT05047523|567237803|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
157133625|NCT05047523|567237804|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
157133626|NCT05047523|567237805|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
157133627|NCT05047523|567237800|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157133628|NCT05047523|567237801|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
157133629|NCT05047523|567237802|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157133630|NCT05047523|567237803|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157133631|NCT05047523|567237804|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157133632|NCT05047523|567237805|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
157133633|NCT05047523|567237800|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
157133634|NCT05047523|567237801|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
157133635|NCT05047523|567237802|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
157133636|NCT05047523|567237803|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
157133637|NCT05047523|567237804|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
157133638|NCT05047523|567237805|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
157133639|NCT05047523|567237800|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
157133640|NCT05047523|567237801|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157133641|NCT05047523|567237802|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157133642|NCT05047523|567237803|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157133643|NCT05047523|567237804|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157133644|NCT05047523|567237805|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
157133645|NCT05047523|567237800|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
157133646|NCT05047523|567237801|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
157133647|NCT05047523|567237802|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
157133648|NCT05047523|567237803|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
157133649|NCT05047523|567237804|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
157133650|NCT05047523|567237805|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
157133651|NCT05047523|567237800|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
157133652|NCT05047523|567237801|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
157133653|NCT05047523|567237802|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
157133654|NCT05047523|567237803|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
157133655|NCT05047523|567237804|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
157133656|NCT05047523|567237805|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
157133657|NCT00224016|567237806|FG000|Titration Period|Withdrawal by Subject|0|||
156720663|NCT03096314|565723743|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
156720664|NCT03096314|565723744|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
156720665|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
156720666|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
156720667|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
157133658|NCT00224016|567237807|FG001|Titration Period|Withdrawal by Subject|1|||
157133659|NCT00224016|567237806|FG000|Titration Period|Lost to Follow-up|1|||
156720668|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
157133660|NCT00224016|567237807|FG001|Titration Period|Lost to Follow-up|0|||
157133661|NCT00224016|567237806|FG000|Maintenance Period|Withdrawal by Subject|2|||
156720669|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
156720670|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
156720671|NCT02547428|565723745|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
156720672|NCT02547428|565723746|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
156720673|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
157133662|NCT00224016|567237807|FG001|Maintenance Period|Withdrawal by Subject|0|||
157133663|NCT00224016|567237806|FG000|Maintenance Period|Lost to Follow-up|0|||
157133664|NCT00224016|567237807|FG001|Maintenance Period|Lost to Follow-up|1|||
157133665|NCT04854499|567237809|FG000|Overall Study|Study Terminated by Sponsor|5|||
157133666|NCT04854499|567237810|FG001|Overall Study|Study Terminated by Sponsor|27|||
157133667|NCT04854499|567237811|FG002|Overall Study|Study Terminated by Sponsor|28|||
157133668|NCT04854499|567237812|FG003|Overall Study|Study Terminated by Sponsor|19|||
157133669|NCT04854499|567237813|FG004|Overall Study|Study Terminated by Sponsor|1|||
157133670|NCT04854499|567237814|FG005|Overall Study|Study Terminated by Sponsor|10|||
157133671|NCT04854499|567237809|FG000|Overall Study|Death|1|||
157133672|NCT04854499|567237810|FG001|Overall Study|Death|23|||
157133673|NCT04854499|567237811|FG002|Overall Study|Death|21|||
157133674|NCT04854499|567237812|FG003|Overall Study|Death|7|||
157133675|NCT04854499|567237813|FG004|Overall Study|Death|6|||
157133676|NCT04854499|567237814|FG005|Overall Study|Death|24|||
157133677|NCT04854499|567237809|FG000|Overall Study|Investigator's Discretion|0|||
157133678|NCT04854499|567237810|FG001|Overall Study|Investigator's Discretion|1|||
157133679|NCT04854499|567237811|FG002|Overall Study|Investigator's Discretion|3|||
157133680|NCT04854499|567237812|FG003|Overall Study|Investigator's Discretion|4|||
157133681|NCT04854499|567237813|FG004|Overall Study|Investigator's Discretion|1|||
157133682|NCT04854499|567237814|FG005|Overall Study|Investigator's Discretion|5|||
157133683|NCT04854499|567237809|FG000|Overall Study|Withdrew Consent|0|||
157133684|NCT04854499|567237810|FG001|Overall Study|Withdrew Consent|1|||
157133685|NCT04854499|567237811|FG002|Overall Study|Withdrew Consent|2|||
157133686|NCT04854499|567237812|FG003|Overall Study|Withdrew Consent|2|||
157133687|NCT04854499|567237813|FG004|Overall Study|Withdrew Consent|0|||
157133688|NCT04854499|567237814|FG005|Overall Study|Withdrew Consent|1|||
157133689|NCT04854499|567237809|FG000|Overall Study|Lost to Follow-up|0|||
157133690|NCT04854499|567237810|FG001|Overall Study|Lost to Follow-up|0|||
157133691|NCT04854499|567237811|FG002|Overall Study|Lost to Follow-up|0|||
157133692|NCT04854499|567237812|FG003|Overall Study|Lost to Follow-up|0|||
157133693|NCT04854499|567237813|FG004|Overall Study|Lost to Follow-up|0|||
157133694|NCT04854499|567237814|FG005|Overall Study|Lost to Follow-up|1|||
157133695|NCT01993888|567237817|FG000|Overall Study|Death|1|||
157133696|NCT01993888|567237818|FG001|Overall Study|Death|1|||
157133697|NCT01993888|567237817|FG000|Overall Study|Lost to Follow-up|1|||
157133698|NCT01993888|567237818|FG001|Overall Study|Lost to Follow-up|1|||
157133699|NCT01993888|567237817|FG000|Overall Study|Withdrawal by Subject|0|||
157133700|NCT01993888|567237818|FG001|Overall Study|Withdrawal by Subject|1|||
157133701|NCT00522392|567237820|FG000|Overall Study|Disease progression|0|||
157133702|NCT00522392|567237821|FG001|Overall Study|Disease progression|3|||
157133703|NCT00522392|567237820|FG000|Overall Study|Adverse Event|7|||
157133704|NCT00522392|567237821|FG001|Overall Study|Adverse Event|7|||
157133705|NCT00522392|567237820|FG000|Overall Study|Withdrawal by Subject|1|||
157133706|NCT00522392|567237821|FG001|Overall Study|Withdrawal by Subject|1|||
157133707|NCT00522392|567237820|FG000|Overall Study|Physician Decision|0|||
157133708|NCT00522392|567237821|FG001|Overall Study|Physician Decision|1|||
157133709|NCT00522392|567237820|FG000|Overall Study|Non-compliance|0|||
157133710|NCT00522392|567237821|FG001|Overall Study|Non-compliance|1|||
157133711|NCT00430755|567237824|FG000|Overall Study|Withdrawal by Subject|53|||
157133712|NCT01154101|567237825|FG000|Overall Study|Adverse Event|0|||
157133713|NCT01154101|567237826|FG001|Overall Study|Adverse Event|2|||
157133714|NCT01154101|567237827|FG002|Overall Study|Adverse Event|1|||
157133715|NCT01154101|567237828|FG003|Overall Study|Adverse Event|1|||
157133716|NCT01154101|567237829|FG004|Overall Study|Adverse Event|0|||
157133717|NCT01154101|567237825|FG000|Overall Study|Lost to Follow-up|0|||
157133718|NCT01154101|567237826|FG001|Overall Study|Lost to Follow-up|1|||
157133719|NCT01154101|567237827|FG002|Overall Study|Lost to Follow-up|0|||
157133720|NCT01154101|567237828|FG003|Overall Study|Lost to Follow-up|1|||
157133721|NCT01154101|567237829|FG004|Overall Study|Lost to Follow-up|0|||
157133722|NCT01154101|567237825|FG000|Overall Study|Withdrawal by Subject|0|||
157133723|NCT01154101|567237826|FG001|Overall Study|Withdrawal by Subject|1|||
157133724|NCT01154101|567237827|FG002|Overall Study|Withdrawal by Subject|2|||
157133725|NCT01154101|567237828|FG003|Overall Study|Withdrawal by Subject|0|||
157133726|NCT01154101|567237829|FG004|Overall Study|Withdrawal by Subject|1|||
157133727|NCT05019131|567237830|FG000|Overall Study|Lost to Follow-up|0|||
157133728|NCT05019131|567237831|FG001|Overall Study|Lost to Follow-up|3|||
157133729|NCT03575104|567237832|FG000|Overall Study|Adverse Event|4|||
157133730|NCT03575104|567237833|FG001|Overall Study|Adverse Event|3|||
157133731|NCT03575104|567237834|FG002|Overall Study|Adverse Event|4|||
156720674|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
157133732|NCT03575104|567237832|FG000|Overall Study|Withdrawal by Subject|13|||
157133733|NCT03575104|567237833|FG001|Overall Study|Withdrawal by Subject|16|||
157133734|NCT03575104|567237834|FG002|Overall Study|Withdrawal by Subject|11|||
157133735|NCT03575104|567237832|FG000|Overall Study|Other reasons|6|||
157133736|NCT03575104|567237833|FG001|Overall Study|Other reasons|8|||
157133737|NCT03575104|567237834|FG002|Overall Study|Other reasons|6|||
157133738|NCT03575104|567237832|FG000|Overall Study|Lost to Follow-up|1|||
157133739|NCT03575104|567237833|FG001|Overall Study|Lost to Follow-up|2|||
157133740|NCT03575104|567237834|FG002|Overall Study|Lost to Follow-up|1|||
157133741|NCT01409928|567237835|FG000|Overall Study|Physician Decision|12|||
157133742|NCT00988247|567237836|FG000|Overall Study|Adverse Event|17|||
157133743|NCT00988247|567237837|FG001|Overall Study|Adverse Event|3|||
157133744|NCT00988247|567237836|FG000|Overall Study|Withdrawal by Subject|44|||
157133745|NCT00988247|567237837|FG001|Overall Study|Withdrawal by Subject|13|||
157133746|NCT00988247|567237836|FG000|Overall Study|Pregnancy|1|||
157133747|NCT00988247|567237837|FG001|Overall Study|Pregnancy|2|||
157133748|NCT00988247|567237836|FG000|Overall Study|Lost to Follow-up|11|||
157133749|NCT00988247|567237837|FG001|Overall Study|Lost to Follow-up|2|||
157133750|NCT00988247|567237836|FG000|Overall Study|Protocol Violation|4|||
157133751|NCT00988247|567237837|FG001|Overall Study|Protocol Violation|5|||
157133752|NCT00988247|567237836|FG000|Overall Study|Sponsor requested withdrawal|3|||
157133753|NCT00988247|567237837|FG001|Overall Study|Sponsor requested withdrawal|1|||
157133754|NCT00988247|567237836|FG000|Overall Study|Other|3|||
157133755|NCT00988247|567237837|FG001|Overall Study|Other|0|||
157133756|NCT02661594|567237838|FG000|Overall Study|Protocol Violation|1|||
157133757|NCT02661594|567237839|FG001|Overall Study|Protocol Violation|0|||
157133758|NCT02661594|567237840|FG002|Overall Study|Protocol Violation|1|||
157133759|NCT02661594|567237841|FG003|Overall Study|Protocol Violation|0|||
157133760|NCT00432237|567237842|FG000|Overall Study|Adverse Event|0|||
157133761|NCT00432237|567237843|FG001|Overall Study|Adverse Event|0|||
157133762|NCT00432237|567237844|FG002|Overall Study|Adverse Event|0|||
157133763|NCT00432237|567237845|FG003|Overall Study|Adverse Event|1|||
157133764|NCT00432237|567237842|FG000|Overall Study|Lack of Efficacy|0|||
157133765|NCT00432237|567237843|FG001|Overall Study|Lack of Efficacy|0|||
157133766|NCT00432237|567237844|FG002|Overall Study|Lack of Efficacy|0|||
157133767|NCT00432237|567237845|FG003|Overall Study|Lack of Efficacy|1|||
157133768|NCT00432237|567237842|FG000|Overall Study|Lost to Follow-up|10|||
157133769|NCT00432237|567237843|FG001|Overall Study|Lost to Follow-up|10|||
157133770|NCT00432237|567237844|FG002|Overall Study|Lost to Follow-up|18|||
157133771|NCT00432237|567237845|FG003|Overall Study|Lost to Follow-up|18|||
157133772|NCT00432237|567237842|FG000|Overall Study|Physician Decision|1|||
157133773|NCT00432237|567237843|FG001|Overall Study|Physician Decision|3|||
157133774|NCT00432237|567237844|FG002|Overall Study|Physician Decision|2|||
157133775|NCT00432237|567237845|FG003|Overall Study|Physician Decision|1|||
157133776|NCT00432237|567237842|FG000|Overall Study|Pregnancy|0|||
157133777|NCT00432237|567237843|FG001|Overall Study|Pregnancy|1|||
157133778|NCT00432237|567237844|FG002|Overall Study|Pregnancy|0|||
157133779|NCT00432237|567237845|FG003|Overall Study|Pregnancy|0|||
157133780|NCT00432237|567237842|FG000|Overall Study|Protocol Violation|13|||
157133781|NCT00432237|567237843|FG001|Overall Study|Protocol Violation|10|||
157133782|NCT00432237|567237844|FG002|Overall Study|Protocol Violation|11|||
157133783|NCT00432237|567237845|FG003|Overall Study|Protocol Violation|8|||
157133784|NCT00432237|567237842|FG000|Overall Study|Withdrawal by Subject|5|||
157133785|NCT00432237|567237843|FG001|Overall Study|Withdrawal by Subject|6|||
157133786|NCT00432237|567237844|FG002|Overall Study|Withdrawal by Subject|9|||
157133787|NCT00432237|567237845|FG003|Overall Study|Withdrawal by Subject|11|||
157133788|NCT00432237|567237842|FG000|Overall Study|Lack of Qualifying Event|38|||
157133789|NCT00432237|567237843|FG001|Overall Study|Lack of Qualifying Event|71|||
157133790|NCT00432237|567237844|FG002|Overall Study|Lack of Qualifying Event|69|||
157133791|NCT00432237|567237845|FG003|Overall Study|Lack of Qualifying Event|84|||
157133792|NCT01354132|567237846|FG000|Randomization|Physician Decision|1|||
157133793|NCT01354132|567237847|FG001|Randomization|Physician Decision|0|||
157133794|NCT01354132|567237846|FG000|Randomization|Withdrawal by Subject|0|||
157133795|NCT01354132|567237847|FG001|Randomization|Withdrawal by Subject|1|||
157133796|NCT01354132|567237846|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
157133797|NCT01354132|567237847|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
157133798|NCT01354132|567237846|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
157133799|NCT01354132|567237847|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
157133800|NCT01354132|567237846|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
157133801|NCT01354132|567237847|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
157133802|NCT02360098|567237848|FG000|Overall Study|Physician Decision|7|||
157133803|NCT01919307|567237854|FG000|Overall Study|Withdrawal by Subject|9|||
157133804|NCT05052723|567237856|FG000|Overall Study|Death|19|||
157133805|NCT02771522|567237857|FG000|Overall Study|Lost to Follow-up|3|||
157133806|NCT02771522|567237857|FG000|Overall Study|Withdrawal by Subject|2|||
157133807|NCT02771522|567237857|FG000|Overall Study|No white spot lesions|3|||
157133808|NCT02054702|567237862|FG000|Overall Study|Lost to Follow-up|3|||
157133809|NCT02054702|567237863|FG001|Overall Study|Lost to Follow-up|5|||
157133810|NCT02054702|567237862|FG000|Overall Study|Adverse Event|3|||
157133811|NCT02054702|567237863|FG001|Overall Study|Adverse Event|1|||
157133812|NCT02054702|567237862|FG000|Overall Study|Met Withdrawal Criteria|4|||
157133813|NCT02054702|567237863|FG001|Overall Study|Met Withdrawal Criteria|1|||
157133814|NCT02054702|567237862|FG000|Overall Study|Physician Decision|0|||
157133815|NCT02054702|567237863|FG001|Overall Study|Physician Decision|1|||
157133816|NCT02054702|567237862|FG000|Overall Study|Withdrawal by Subject|14|||
157133817|NCT02054702|567237863|FG001|Overall Study|Withdrawal by Subject|4|||
157133818|NCT01262898|567237864|FG000|Overall Study|Protocol Violation|1|||
157133819|NCT01262898|567237865|FG001|Overall Study|Protocol Violation|1|||
157133820|NCT01262898|567237866|FG002|Overall Study|Protocol Violation|0|||
157133821|NCT01262898|567237867|FG003|Overall Study|Protocol Violation|0|||
157133822|NCT01262898|567237864|FG000|Overall Study|Lost to Follow-up|1|||
157133823|NCT01262898|567237865|FG001|Overall Study|Lost to Follow-up|0|||
157133824|NCT01262898|567237866|FG002|Overall Study|Lost to Follow-up|0|||
157133825|NCT01262898|567237867|FG003|Overall Study|Lost to Follow-up|0|||
157133826|NCT01262898|567237864|FG000|Overall Study|Withdrawal by Subject|1|||
157133827|NCT01262898|567237865|FG001|Overall Study|Withdrawal by Subject|1|||
157133828|NCT01262898|567237866|FG002|Overall Study|Withdrawal by Subject|0|||
157133829|NCT01262898|567237867|FG003|Overall Study|Withdrawal by Subject|0|||
157133830|NCT02388295|567237873|FG000|Dose Escalation Week 1|Adverse Event|1|||
157133831|NCT02388295|567237874|FG001|Dose Escalation Week 1|Adverse Event|2|||
157133832|NCT02388295|567237875|FG002|Dose Escalation Week 1|Adverse Event|1|||
157133833|NCT02388295|567237873|FG000|Dose Escalation Week 1|Determined not eligible|1|||
157133834|NCT02388295|567237874|FG001|Dose Escalation Week 1|Determined not eligible|1|||
157133835|NCT02388295|567237875|FG002|Dose Escalation Week 1|Determined not eligible|1|||
157133836|NCT02388295|567237873|FG000|Dose Escalation Week 2|Protocol Violation|0|||
157133837|NCT02388295|567237874|FG001|Dose Escalation Week 2|Protocol Violation|1|||
157133838|NCT02388295|567237875|FG002|Dose Escalation Week 2|Protocol Violation|0|||
157133839|NCT02388295|567237873|FG000|Dose Escalation Week 2|Determined not eligible|1|||
157133840|NCT02388295|567237874|FG001|Dose Escalation Week 2|Determined not eligible|1|||
157133841|NCT02388295|567237875|FG002|Dose Escalation Week 2|Determined not eligible|1|||
157133842|NCT02388295|567237873|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
157133843|NCT02388295|567237874|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
157133844|NCT02388295|567237875|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
157133845|NCT01551693|567237876|FG000|Overall Study|Disease Progression|1|||
157133846|NCT01551693|567237877|FG001|Overall Study|Disease Progression|0|||
157133847|NCT01551693|567237876|FG000|Overall Study|Adverse Event|0|||
157133848|NCT01551693|567237877|FG001|Overall Study|Adverse Event|1|||
157133849|NCT01551693|567237876|FG000|Overall Study|Withdrawal by Subject|0|||
157133850|NCT01551693|567237877|FG001|Overall Study|Withdrawal by Subject|1|||
157133851|NCT04134494|567237881|FG000|Overall Study|Lost to Follow-up|2|||
157133852|NCT00781365|567237882|FG000|Overall Study|Withdrawal by Subject|13|||
157133853|NCT00781365|567237883|FG001|Overall Study|Withdrawal by Subject|8|||
157133854|NCT00781365|567237882|FG000|Overall Study|Did Not Attend Visit|20|||
157133855|NCT00781365|567237883|FG001|Overall Study|Did Not Attend Visit|28|||
157133856|NCT00781365|567237882|FG000|Overall Study|Language barrier|1|||
157133857|NCT00781365|567237883|FG001|Overall Study|Language barrier|0|||
157133858|NCT00723957|567237888|FG000|Overall Study|Adverse event unrelated to study drug|1|||
157133859|NCT00723957|567237889|FG001|Overall Study|Adverse event unrelated to study drug|4|||
157133860|NCT00723957|567237888|FG000|Overall Study|Death|3|||
157133861|NCT00723957|567237889|FG001|Overall Study|Death|4|||
157133862|NCT00723957|567237888|FG000|Overall Study|Disease progression|27|||
157133863|NCT00723957|567237889|FG001|Overall Study|Disease progression|25|||
157133864|NCT00723957|567237888|FG000|Overall Study|Maximum clinical benefit|4|||
157133865|NCT00723957|567237889|FG001|Overall Study|Maximum clinical benefit|5|||
157133866|NCT00723957|567237888|FG000|Overall Study|Investigator decision|1|||
157133867|NCT00723957|567237889|FG001|Overall Study|Investigator decision|1|||
157133868|NCT00723957|567237888|FG000|Overall Study|Study drug toxicity|4|||
157133869|NCT00723957|567237889|FG001|Overall Study|Study drug toxicity|6|||
157133870|NCT00723957|567237888|FG000|Overall Study|Withdrawal by Subject|7|||
157133871|NCT00723957|567237889|FG001|Overall Study|Withdrawal by Subject|5|||
157133872|NCT00723957|567237888|FG000|Overall Study|Reason not analyzed|1|||
157133873|NCT00723957|567237889|FG001|Overall Study|Reason not analyzed|0|||
157133874|NCT00723957|567237888|FG000|Overall Study|Never received treatment|3|||
157133875|NCT00723957|567237889|FG001|Overall Study|Never received treatment|3|||
157133876|NCT01360996|567237894|FG000|Overall Study|Withdrawal by Subject|4|||
157133877|NCT01360996|567237895|FG001|Overall Study|Withdrawal by Subject|3|||
157133878|NCT01360996|567237896|FG002|Overall Study|Withdrawal by Subject|2|||
157133879|NCT01360996|567237894|FG000|Overall Study|Noncompliant|2|||
157133880|NCT01360996|567237895|FG001|Overall Study|Noncompliant|0|||
157133881|NCT01360996|567237896|FG002|Overall Study|Noncompliant|0|||
157133882|NCT03377634|567237897|FG000|Study Period|Adverse Event|1|||
157133883|NCT03377634|567237898|FG001|Study Period|Adverse Event|0|||
157133884|NCT03377634|567237897|FG000|Study Period|Withdrawal by Subject|1|||
157133885|NCT03377634|567237898|FG001|Study Period|Withdrawal by Subject|0|||
157133886|NCT01454076|567237899|FG000|Overall Study|Other|2|||
157133887|NCT01454076|567237900|FG001|Overall Study|Other|0|||
157133888|NCT01454076|567237901|FG002|Overall Study|Other|0|||
157133889|NCT01454076|567237902|FG003|Overall Study|Other|1|||
157133890|NCT01454076|567237903|FG004|Overall Study|Other|2|||
157133891|NCT01454076|567237899|FG000|Overall Study|Withdrawal by Subject|3|||
157133892|NCT01454076|567237900|FG001|Overall Study|Withdrawal by Subject|4|||
157133893|NCT01454076|567237901|FG002|Overall Study|Withdrawal by Subject|2|||
157133894|NCT01454076|567237902|FG003|Overall Study|Withdrawal by Subject|1|||
157133895|NCT01454076|567237903|FG004|Overall Study|Withdrawal by Subject|2|||
157133896|NCT01454076|567237899|FG000|Overall Study|Adverse Event|8|||
157133897|NCT01454076|567237900|FG001|Overall Study|Adverse Event|2|||
157133898|NCT01454076|567237901|FG002|Overall Study|Adverse Event|7|||
157133899|NCT01454076|567237902|FG003|Overall Study|Adverse Event|0|||
157133900|NCT01454076|567237903|FG004|Overall Study|Adverse Event|2|||
157133901|NCT04964258|567237904|FG000|Overall Study|Lost to Follow-up|1|||
157133902|NCT04964258|567237905|FG001|Overall Study|Lost to Follow-up|0|||
157133903|NCT04964258|567237906|FG002|Overall Study|Lost to Follow-up|0|||
157133904|NCT04964258|567237907|FG003|Overall Study|Lost to Follow-up|0|||
157133905|NCT04964258|567237908|FG004|Overall Study|Lost to Follow-up|0|||
157133906|NCT04964258|567237909|FG005|Overall Study|Lost to Follow-up|1|||
157133907|NCT04964258|567237910|FG006|Overall Study|Lost to Follow-up|0|||
157133908|NCT04964258|567237911|FG007|Overall Study|Lost to Follow-up|0|||
157133909|NCT04964258|567237912|FG008|Overall Study|Lost to Follow-up|0|||
157133910|NCT04964258|567237913|FG009|Overall Study|Lost to Follow-up|0|||
157133911|NCT04964258|567237914|FG010|Overall Study|Lost to Follow-up|0|||
157133912|NCT02965378|567237915|FG000|Overall Study|Progression|16|||
157133913|NCT02965378|567237916|FG001|Overall Study|Progression|4|||
157133914|NCT02965378|567237915|FG000|Overall Study|Adverse Event|5|||
157133915|NCT02965378|567237916|FG001|Overall Study|Adverse Event|2|||
157133916|NCT02965378|567237915|FG000|Overall Study|Death|2|||
157133917|NCT02965378|567237916|FG001|Overall Study|Death|0|||
157133918|NCT02965378|567237915|FG000|Overall Study|Refusal|2|||
157133919|NCT02965378|567237916|FG001|Overall Study|Refusal|1|||
157133920|NCT02965378|567237915|FG000|Overall Study|Not protocol specified|0|||
157133921|NCT02965378|567237916|FG001|Overall Study|Not protocol specified|2|||
157133922|NCT04525703|567237919|FG000|Overall Study|Lost to Follow-up|6|||
157133923|NCT04525703|567237920|FG001|Overall Study|Lost to Follow-up|15|||
157133924|NCT04525703|567237921|FG002|Overall Study|Lost to Follow-up|8|||
157133925|NCT00961961|567237922|FG000|Phase I|Withdrawal by Subject|7|||
157133926|NCT00961961|567237923|FG001|Phase I|Withdrawal by Subject|0|||
157133927|NCT00961961|567237924|FG002|Phase I|Withdrawal by Subject|0|||
157133928|NCT00961961|567237925|FG003|Phase I|Withdrawal by Subject|0|||
157133929|NCT00961961|567237922|FG000|Phase I|Lost to Follow-up|10|||
157133930|NCT00961961|567237923|FG001|Phase I|Lost to Follow-up|0|||
157133931|NCT00961961|567237924|FG002|Phase I|Lost to Follow-up|0|||
157133932|NCT00961961|567237925|FG003|Phase I|Lost to Follow-up|0|||
157133933|NCT00961961|567237922|FG000|Phase I|Lack of Efficacy|94|||
157133934|NCT00961961|567237923|FG001|Phase I|Lack of Efficacy|0|||
157133935|NCT00961961|567237924|FG002|Phase I|Lack of Efficacy|0|||
157133936|NCT00961961|567237925|FG003|Phase I|Lack of Efficacy|0|||
157133937|NCT00961961|567237922|FG000|Phase I|Adverse Event|7|||
157133938|NCT00961961|567237923|FG001|Phase I|Adverse Event|0|||
157133939|NCT00961961|567237924|FG002|Phase I|Adverse Event|0|||
157133940|NCT00961961|567237925|FG003|Phase I|Adverse Event|0|||
157133941|NCT00961961|567237922|FG000|Phase I|Physician Decision|8|||
157133942|NCT00961961|567237923|FG001|Phase I|Physician Decision|0|||
157133943|NCT00961961|567237924|FG002|Phase I|Physician Decision|0|||
157133944|NCT00961961|567237925|FG003|Phase I|Physician Decision|0|||
157133945|NCT00961961|567237922|FG000|Phase II|Lost to Follow-up|0|||
157133946|NCT00961961|567237923|FG001|Phase II|Lost to Follow-up|0|||
157133947|NCT00961961|567237924|FG002|Phase II|Lost to Follow-up|10|||
157133948|NCT00961961|567237925|FG003|Phase II|Lost to Follow-up|7|||
157133949|NCT00961961|567237922|FG000|Phase II|Adverse Event|0|||
157133950|NCT00961961|567237923|FG001|Phase II|Adverse Event|0|||
157133951|NCT00961961|567237924|FG002|Phase II|Adverse Event|0|||
157133952|NCT00961961|567237925|FG003|Phase II|Adverse Event|1|||
156793901|NCT00266032|565999465|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
157133953|NCT00961961|567237922|FG000|Phase II|Physician Decision|0|||
157133954|NCT00961961|567237923|FG001|Phase II|Physician Decision|0|||
157133955|NCT00961961|567237924|FG002|Phase II|Physician Decision|1|||
157133956|NCT00961961|567237925|FG003|Phase II|Physician Decision|0|||
157133957|NCT00961961|567237922|FG000|Phase II|Withdrawal by Subject|0|||
157133958|NCT00961961|567237923|FG001|Phase II|Withdrawal by Subject|0|||
157133959|NCT00961961|567237924|FG002|Phase II|Withdrawal by Subject|1|||
157133960|NCT00961961|567237925|FG003|Phase II|Withdrawal by Subject|0|||
157133961|NCT01870739|567237926|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
157133962|NCT01870739|567237927|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
157133963|NCT01870739|567237926|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
157133964|NCT01870739|567237927|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
157133965|NCT01870739|567237926|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
157133966|NCT01870739|567237927|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
157133967|NCT01870739|567237926|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
157133968|NCT01870739|567237927|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
157133969|NCT01870739|567237926|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
157133970|NCT01870739|567237927|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
157133971|NCT01870739|567237926|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
157133972|NCT01870739|567237927|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
157133973|NCT01870739|567237926|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
157133974|NCT01870739|567237927|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
157133975|NCT00630331|567237930|FG000|Overall Study|Death|2|||
157133976|NCT00630331|567237931|FG001|Overall Study|Death|1|||
157133977|NCT00630331|567237932|FG002|Overall Study|Death|1|||
157133978|NCT00630331|567237930|FG000|Overall Study|Adverse Event|1|||
157133979|NCT00630331|567237931|FG001|Overall Study|Adverse Event|0|||
157133980|NCT00630331|567237932|FG002|Overall Study|Adverse Event|0|||
157133981|NCT00630331|567237930|FG000|Overall Study|Withdrawal by Subject|12|||
157133982|NCT00630331|567237931|FG001|Overall Study|Withdrawal by Subject|7|||
157133983|NCT00630331|567237932|FG002|Overall Study|Withdrawal by Subject|5|||
157133984|NCT00630331|567237930|FG000|Overall Study|Lost to Follow-up|175|||
157133985|NCT00630331|567237931|FG001|Overall Study|Lost to Follow-up|143|||
157133986|NCT00630331|567237932|FG002|Overall Study|Lost to Follow-up|170|||
157133987|NCT00630331|567237930|FG000|Overall Study|Inappropriate enrollment|3|||
157133988|NCT00630331|567237931|FG001|Overall Study|Inappropriate enrollment|6|||
157133989|NCT00630331|567237932|FG002|Overall Study|Inappropriate enrollment|3|||
157133990|NCT00630331|567237930|FG000|Overall Study|Unable to classify|9|||
157133991|NCT00630331|567237931|FG001|Overall Study|Unable to classify|4|||
157133992|NCT00630331|567237932|FG002|Overall Study|Unable to classify|3|||
157217265|NCT01154127|567541063|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
157217266|NCT01697449|567541070|FG000|Overall Study|Disease progression|47|||
156793902|NCT00266032|565999466|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
156793903|NCT00814983|565999469|FG000|Overall Study|Screen failure|1|||
156793904|NCT00814983|565999470|FG001|Overall Study|Screen failure|0|||
156793905|NCT00814983|565999469|FG000|Overall Study|Withdrawal by Subject|1|||
156793906|NCT00814983|565999470|FG001|Overall Study|Withdrawal by Subject|0|||
156793907|NCT00814983|565999469|FG000|Overall Study|Graft failure|1|||
156793908|NCT00814983|565999470|FG001|Overall Study|Graft failure|0|||
156793909|NCT01229111|565999471|FG000|Overall Study|Death|1|||
156793910|NCT04102514|565999472|FG000|Overall Study|Death|3|||
156793911|NCT04102514|565999473|FG001|Overall Study|Death|0|||
156793912|NCT04102514|565999474|FG002|Overall Study|Death|0|||
156793913|NCT04102514|565999475|FG003|Overall Study|Death|0|||
156793914|NCT04102514|565999472|FG000|Overall Study|Lost to Follow-up|0|||
156793915|NCT04102514|565999473|FG001|Overall Study|Lost to Follow-up|0|||
156793916|NCT04102514|565999474|FG002|Overall Study|Lost to Follow-up|3|||
156793917|NCT04102514|565999475|FG003|Overall Study|Lost to Follow-up|0|||
156793918|NCT04102514|565999472|FG000|Overall Study|Physician Decision|0|||
156793919|NCT04102514|565999473|FG001|Overall Study|Physician Decision|0|||
156793920|NCT04102514|565999474|FG002|Overall Study|Physician Decision|1|||
156793921|NCT04102514|565999475|FG003|Overall Study|Physician Decision|0|||
156793922|NCT04102514|565999472|FG000|Overall Study|Withdrawal by Subject|7|||
156793923|NCT04102514|565999473|FG001|Overall Study|Withdrawal by Subject|13|||
156793924|NCT04102514|565999474|FG002|Overall Study|Withdrawal by Subject|7|||
156793925|NCT04102514|565999475|FG003|Overall Study|Withdrawal by Subject|14|||
156793926|NCT04102514|565999472|FG000|Overall Study|Moved to longterm care facility|6|||
156793927|NCT04102514|565999473|FG001|Overall Study|Moved to longterm care facility|0|||
156793928|NCT04102514|565999474|FG002|Overall Study|Moved to longterm care facility|4|||
156793929|NCT04102514|565999475|FG003|Overall Study|Moved to longterm care facility|0|||
157018707|NCT03131648|566822896|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018708|NCT03131648|566822897|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018709|NCT03131648|566822898|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018710|NCT03131648|566822899|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018711|NCT03131648|566822900|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018712|NCT03131648|566822901|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157018713|NCT03131648|566822894|FG000|Open-label Treatment|Discontinued IMP|0|||
157018714|NCT03131648|566822895|FG001|Open-label Treatment|Discontinued IMP|0|||
157018715|NCT03131648|566822896|FG002|Open-label Treatment|Discontinued IMP|0|||
157018716|NCT03131648|566822897|FG003|Open-label Treatment|Discontinued IMP|0|||
157018717|NCT03131648|566822898|FG004|Open-label Treatment|Discontinued IMP|0|||
157018718|NCT03131648|566822899|FG005|Open-label Treatment|Discontinued IMP|0|||
157018719|NCT03131648|566822900|FG006|Open-label Treatment|Discontinued IMP|112|||
157018720|NCT03131648|566822901|FG007|Open-label Treatment|Discontinued IMP|0|||
157018721|NCT03131648|566822894|FG000|Open-label Treatment|Completed Week 50|0|||
157018722|NCT03131648|566822895|FG001|Open-label Treatment|Completed Week 50|0|||
157018723|NCT03131648|566822896|FG002|Open-label Treatment|Completed Week 50|0|||
157018724|NCT03131648|566822897|FG003|Open-label Treatment|Completed Week 50|0|||
157018725|NCT03131648|566822898|FG004|Open-label Treatment|Completed Week 50|0|||
157018726|NCT03131648|566822899|FG005|Open-label Treatment|Completed Week 50|0|||
157018727|NCT03131648|566822900|FG006|Open-label Treatment|Completed Week 50|6|||
157133993|NCT00630331|567237930|FG000|Overall Study|Protocol Violation|4|||
156793930|NCT02096354|565999488|FG000|Overall Study|Physician Decision|4|||
156793931|NCT02096354|565999489|FG001|Overall Study|Physician Decision|5|||
156793932|NCT02096354|565999490|FG002|Overall Study|Physician Decision|0|||
156793933|NCT02096354|565999488|FG000|Overall Study|Withdrawal by Subject|3|||
156793934|NCT02096354|565999489|FG001|Overall Study|Withdrawal by Subject|1|||
156793935|NCT02096354|565999490|FG002|Overall Study|Withdrawal by Subject|0|||
156875354|NCT04896086|566302025|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
156875355|NCT02249832|566302028|FG000|Overall Study|Withdrawal by Subject|3|||
156875356|NCT02249832|566302028|FG000|Overall Study|Lost to Follow-up|10|||
156875357|NCT02078960|566302031|FG000|Treatment Period|Other|0|||
156875358|NCT02078960|566302032|FG001|Treatment Period|Other|0|||
156875359|NCT02078960|566302033|FG002|Treatment Period|Other|1|||
156875360|NCT02078960|566302031|FG000|Treatment Period|Lack of Efficacy|0|||
156875361|NCT02078960|566302032|FG001|Treatment Period|Lack of Efficacy|1|||
156875362|NCT02078960|566302033|FG002|Treatment Period|Lack of Efficacy|0|||
156875363|NCT02078960|566302031|FG000|Treatment Period|Disease progression - accelerated phase|0|||
156875364|NCT02078960|566302032|FG001|Treatment Period|Disease progression - accelerated phase|1|||
156875365|NCT02078960|566302033|FG002|Treatment Period|Disease progression - accelerated phase|0|||
156875366|NCT02078960|566302031|FG000|Treatment Period|Disease progression - blast phase|1|||
156875367|NCT02078960|566302032|FG001|Treatment Period|Disease progression - blast phase|0|||
156875368|NCT02078960|566302033|FG002|Treatment Period|Disease progression - blast phase|0|||
156875369|NCT02078960|566302031|FG000|Treatment Period|Withdrawal by Subject|0|||
157133994|NCT00630331|567237931|FG001|Overall Study|Protocol Violation|5|||
157133995|NCT00630331|567237932|FG002|Overall Study|Protocol Violation|6|||
157133996|NCT02425098|567237940|FG000|Overall Study|Lost to Follow-up|7|||
157133997|NCT02425098|567237941|FG001|Overall Study|Lost to Follow-up|7|||
157133998|NCT02425098|567237940|FG000|Overall Study|Withdrawal by Subject|4|||
157133999|NCT02425098|567237941|FG001|Overall Study|Withdrawal by Subject|8|||
157134000|NCT02425098|567237940|FG000|Overall Study|Pregnancy|2|||
157134001|NCT02425098|567237941|FG001|Overall Study|Pregnancy|0|||
156793936|NCT02096354|565999488|FG000|Overall Study|Adverse Event|7|||
156793937|NCT02096354|565999489|FG001|Overall Study|Adverse Event|4|||
156793938|NCT02096354|565999490|FG002|Overall Study|Adverse Event|0|||
156793939|NCT02096354|565999488|FG000|Overall Study|Ineligible|0|||
156793940|NCT02096354|565999489|FG001|Overall Study|Ineligible|0|||
156793941|NCT02096354|565999490|FG002|Overall Study|Ineligible|11|||
156793942|NCT02951819|565999491|FG000|Overall Study|Death|9|||
156793943|NCT02951819|565999492|FG001|Overall Study|Death|7|||
156793944|NCT02951819|565999491|FG000|Overall Study|Withdrawal by Subject|3|||
156793945|NCT02951819|565999492|FG001|Overall Study|Withdrawal by Subject|0|||
156793946|NCT02951819|565999491|FG000|Overall Study|Adverse Event|1|||
156793947|NCT02951819|565999492|FG001|Overall Study|Adverse Event|0|||
156793948|NCT02951819|565999491|FG000|Overall Study|Lack of Efficacy|4|||
156793949|NCT02951819|565999492|FG001|Overall Study|Lack of Efficacy|0|||
156793950|NCT02951819|565999491|FG000|Overall Study|Lost to Follow-up|1|||
156793951|NCT02951819|565999492|FG001|Overall Study|Lost to Follow-up|0|||
156793952|NCT02951819|565999491|FG000|Overall Study|Progressive Disease|1|||
156793953|NCT02951819|565999492|FG001|Overall Study|Progressive Disease|0|||
156793954|NCT02951819|565999491|FG000|Overall Study|Other|9|||
156793955|NCT02951819|565999492|FG001|Overall Study|Other|0|||
156793956|NCT03715829|565999493|FG000|Dose Ranging Period|Adverse Event|2|||
156793957|NCT03715829|565999494|FG001|Dose Ranging Period|Adverse Event|4|||
156793958|NCT03715829|565999495|FG002|Dose Ranging Period|Adverse Event|5|||
156793959|NCT03715829|565999496|FG003|Dose Ranging Period|Adverse Event|2|||
156793960|NCT03715829|565999497|FG004|Dose Ranging Period|Adverse Event|3|||
156793961|NCT03715829|565999498|FG005|Dose Ranging Period|Adverse Event|3|||
156793962|NCT03715829|565999499|FG006|Dose Ranging Period|Adverse Event|0|||
156793963|NCT03715829|565999500|FG007|Dose Ranging Period|Adverse Event|0|||
156793964|NCT03715829|565999501|FG008|Dose Ranging Period|Adverse Event|0|||
156793965|NCT03715829|565999502|FG009|Dose Ranging Period|Adverse Event|0|||
156793966|NCT03715829|565999503|FG010|Dose Ranging Period|Adverse Event|0|||
156793967|NCT03715829|565999493|FG000|Dose Ranging Period|Lack of Efficacy|0|||
156793968|NCT03715829|565999494|FG001|Dose Ranging Period|Lack of Efficacy|1|||
156793969|NCT03715829|565999495|FG002|Dose Ranging Period|Lack of Efficacy|0|||
156793970|NCT03715829|565999496|FG003|Dose Ranging Period|Lack of Efficacy|1|||
156793971|NCT03715829|565999497|FG004|Dose Ranging Period|Lack of Efficacy|0|||
157134002|NCT02425098|567237940|FG000|Overall Study|Reason not Specified|0|||
156793972|NCT03715829|565999498|FG005|Dose Ranging Period|Lack of Efficacy|0|||
156793973|NCT03715829|565999499|FG006|Dose Ranging Period|Lack of Efficacy|0|||
156793974|NCT03715829|565999500|FG007|Dose Ranging Period|Lack of Efficacy|0|||
156793975|NCT03715829|565999501|FG008|Dose Ranging Period|Lack of Efficacy|0|||
156793976|NCT03715829|565999502|FG009|Dose Ranging Period|Lack of Efficacy|0|||
156793977|NCT03715829|565999503|FG010|Dose Ranging Period|Lack of Efficacy|0|||
156793978|NCT03715829|565999493|FG000|Dose Ranging Period|Lost to Follow-up|2|||
156793979|NCT03715829|565999494|FG001|Dose Ranging Period|Lost to Follow-up|0|||
156875370|NCT02078960|566302032|FG001|Treatment Period|Withdrawal by Subject|1|||
157134003|NCT02425098|567237941|FG001|Overall Study|Reason not Specified|1|||
157134004|NCT01929135|567237942|FG000|Overall Study|Lost to Follow-up|1|||
157134005|NCT01929135|567237943|FG001|Overall Study|Lost to Follow-up|1|||
157134006|NCT01926626|567237944|FG000|Overall Study|Withdrawal by Subject|15|||
157134007|NCT01926626|567237944|FG000|Overall Study|Lost to Follow-up|7|||
157134008|NCT03136107|567237947|FG000|Overall Study|Other (Not specified)|1|||
157134009|NCT03283085|567237948|FG000|Overall Study|Adverse Event|18|||
157134010|NCT03283085|567237949|FG001|Overall Study|Adverse Event|3|||
157134011|NCT03283085|567237950|FG002|Overall Study|Adverse Event|13|||
157134012|NCT03283085|567237951|FG003|Overall Study|Adverse Event|0|||
157134013|NCT03283085|567237952|FG004|Overall Study|Adverse Event|0|||
157134014|NCT03283085|567237953|FG005|Overall Study|Adverse Event|5|||
157134015|NCT03283085|567237948|FG000|Overall Study|Death|0|||
157134016|NCT03283085|567237949|FG001|Overall Study|Death|0|||
157134017|NCT03283085|567237950|FG002|Overall Study|Death|3|||
157134018|NCT03283085|567237951|FG003|Overall Study|Death|1|||
157134019|NCT03283085|567237952|FG004|Overall Study|Death|0|||
157134020|NCT03283085|567237953|FG005|Overall Study|Death|0|||
157134021|NCT03283085|567237948|FG000|Overall Study|Withdrawal by Subject|42|||
157134022|NCT03283085|567237949|FG001|Overall Study|Withdrawal by Subject|21|||
157134023|NCT03283085|567237950|FG002|Overall Study|Withdrawal by Subject|66|||
157134024|NCT03283085|567237951|FG003|Overall Study|Withdrawal by Subject|3|||
157134025|NCT03283085|567237952|FG004|Overall Study|Withdrawal by Subject|3|||
157134026|NCT03283085|567237953|FG005|Overall Study|Withdrawal by Subject|5|||
157134027|NCT03283085|567237948|FG000|Overall Study|Physician Decision|14|||
157134028|NCT03283085|567237949|FG001|Overall Study|Physician Decision|8|||
157134029|NCT03283085|567237950|FG002|Overall Study|Physician Decision|19|||
157018728|NCT03131648|566822901|FG007|Open-label Treatment|Completed Week 50|0|||
157018729|NCT03131648|566822894|FG000|Maintenance Treatment Period|Not dosed|0|||
157018730|NCT03131648|566822895|FG001|Maintenance Treatment Period|Not dosed|0|||
157018731|NCT03131648|566822896|FG002|Maintenance Treatment Period|Not dosed|3|||
157018732|NCT03131648|566822897|FG003|Maintenance Treatment Period|Not dosed|2|||
157018733|NCT03131648|566822898|FG004|Maintenance Treatment Period|Not dosed|1|||
157018734|NCT03131648|566822899|FG005|Maintenance Treatment Period|Not dosed|0|||
157018735|NCT03131648|566822900|FG006|Maintenance Treatment Period|Not dosed|0|||
157018736|NCT03131648|566822901|FG007|Maintenance Treatment Period|Not dosed|0|||
157018737|NCT03131648|566822894|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
157018738|NCT03131648|566822895|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
157018739|NCT03131648|566822896|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
157018740|NCT03131648|566822897|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
157018741|NCT03131648|566822898|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
157018742|NCT03131648|566822899|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
157018743|NCT03131648|566822900|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
157018744|NCT03131648|566822901|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
157018745|NCT03131648|566822894|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157018746|NCT03131648|566822895|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157018747|NCT03131648|566822896|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
157018748|NCT03131648|566822897|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
157018749|NCT03131648|566822898|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
157018750|NCT03131648|566822899|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
157018751|NCT03131648|566822900|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157018752|NCT03131648|566822901|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157018753|NCT03131648|566822894|FG000|Maintenance Treatment Period|Completed Week 50|0|||
157018754|NCT03131648|566822895|FG001|Maintenance Treatment Period|Completed Week 50|0|||
157018755|NCT03131648|566822896|FG002|Maintenance Treatment Period|Completed Week 50|0|||
157018756|NCT03131648|566822897|FG003|Maintenance Treatment Period|Completed Week 50|0|||
157018757|NCT03131648|566822898|FG004|Maintenance Treatment Period|Completed Week 50|1|||
157018758|NCT03131648|566822899|FG005|Maintenance Treatment Period|Completed Week 50|0|||
157018759|NCT03131648|566822900|FG006|Maintenance Treatment Period|Completed Week 50|0|||
157018760|NCT03131648|566822901|FG007|Maintenance Treatment Period|Completed Week 50|0|||
157018761|NCT03131648|566822894|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018762|NCT03131648|566822895|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018763|NCT03131648|566822896|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018764|NCT03131648|566822897|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018765|NCT03131648|566822898|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018766|NCT03131648|566822899|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018767|NCT03131648|566822900|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
157018768|NCT03131648|566822901|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
157134030|NCT03283085|567237951|FG003|Overall Study|Physician Decision|0|||
157134031|NCT03283085|567237952|FG004|Overall Study|Physician Decision|0|||
157134032|NCT03283085|567237953|FG005|Overall Study|Physician Decision|2|||
157134033|NCT03283085|567237948|FG000|Overall Study|Site Terminated by Sponsor|1|||
157134034|NCT03283085|567237949|FG001|Overall Study|Site Terminated by Sponsor|0|||
157134035|NCT03283085|567237950|FG002|Overall Study|Site Terminated by Sponsor|3|||
157134036|NCT03283085|567237951|FG003|Overall Study|Site Terminated by Sponsor|0|||
157134037|NCT03283085|567237952|FG004|Overall Study|Site Terminated by Sponsor|0|||
157134038|NCT03283085|567237953|FG005|Overall Study|Site Terminated by Sponsor|0|||
157134039|NCT03283085|567237948|FG000|Overall Study|Lost to Follow-up|2|||
157134040|NCT03283085|567237949|FG001|Overall Study|Lost to Follow-up|0|||
157134041|NCT03283085|567237950|FG002|Overall Study|Lost to Follow-up|2|||
157134042|NCT03283085|567237951|FG003|Overall Study|Lost to Follow-up|0|||
157134043|NCT03283085|567237952|FG004|Overall Study|Lost to Follow-up|0|||
157134044|NCT03283085|567237953|FG005|Overall Study|Lost to Follow-up|1|||
157134045|NCT03283085|567237948|FG000|Overall Study|Pregnancy|0|||
157134046|NCT03283085|567237949|FG001|Overall Study|Pregnancy|0|||
157134047|NCT03283085|567237950|FG002|Overall Study|Pregnancy|1|||
157134048|NCT03283085|567237951|FG003|Overall Study|Pregnancy|0|||
157134049|NCT03283085|567237952|FG004|Overall Study|Pregnancy|0|||
157134050|NCT03283085|567237953|FG005|Overall Study|Pregnancy|0|||
157134051|NCT03283085|567237948|FG000|Overall Study|Lack of Efficacy|12|||
157134052|NCT03283085|567237949|FG001|Overall Study|Lack of Efficacy|6|||
157134053|NCT03283085|567237950|FG002|Overall Study|Lack of Efficacy|24|||
157134054|NCT03283085|567237951|FG003|Overall Study|Lack of Efficacy|1|||
157134055|NCT03283085|567237952|FG004|Overall Study|Lack of Efficacy|1|||
157134056|NCT03283085|567237953|FG005|Overall Study|Lack of Efficacy|0|||
157134057|NCT03283085|567237948|FG000|Overall Study|Reason not Specified|0|||
157134058|NCT03283085|567237949|FG001|Overall Study|Reason not Specified|4|||
157134059|NCT03283085|567237950|FG002|Overall Study|Reason not Specified|8|||
157134060|NCT03283085|567237951|FG003|Overall Study|Reason not Specified|0|||
157134061|NCT03283085|567237952|FG004|Overall Study|Reason not Specified|0|||
157134062|NCT03283085|567237953|FG005|Overall Study|Reason not Specified|1|||
157134063|NCT00891202|567237954|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
157134064|NCT00891202|567237955|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
157134065|NCT00891202|567237956|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
157134066|NCT00891202|567237957|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
157134067|NCT00891202|567237954|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
157134068|NCT00891202|567237955|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
157134069|NCT00891202|567237956|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
157134070|NCT00891202|567237957|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
157134071|NCT00891202|567237954|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
157134072|NCT00891202|567237955|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
157134073|NCT00891202|567237956|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
157134074|NCT00891202|567237957|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
157134075|NCT00891202|567237954|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
157134076|NCT00891202|567237955|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
157134077|NCT00891202|567237956|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
157134078|NCT00891202|567237957|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
157134079|NCT02292771|567237961|FG000|Overall Study|Withdrawal by Subject|2|||
157134080|NCT02292771|567237962|FG001|Overall Study|Withdrawal by Subject|1|||
157134081|NCT02292771|567237961|FG000|Overall Study|Lost to Follow-up|2|||
157134082|NCT02292771|567237962|FG001|Overall Study|Lost to Follow-up|1|||
157134083|NCT04280081|567237963|FG000|Overall Study|Adverse Event|4|||
157134084|NCT04280081|567237963|FG000|Overall Study|Death|2|||
157134085|NCT04280081|567237963|FG000|Overall Study|Progressive Disease|6|||
156720675|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
156720676|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
156720677|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
156720678|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
156720679|NCT02547428|565723745|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
156720680|NCT02547428|565723746|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
156720681|NCT03318861|565723747|FG000|Overall Study|Death|2|||
156720682|NCT03318861|565723748|FG001|Overall Study|Death|3|||
156720683|NCT03318861|565723749|FG002|Overall Study|Death|3|||
156720684|NCT03318861|565723750|FG003|Overall Study|Death|2|||
156720685|NCT03318861|565723751|FG004|Overall Study|Death|2|||
156720686|NCT03318861|565723747|FG000|Overall Study|Enrolled But Never Treated|0|||
156720687|NCT03318861|565723748|FG001|Overall Study|Enrolled But Never Treated|1|||
156720688|NCT03318861|565723749|FG002|Overall Study|Enrolled But Never Treated|0|||
156720689|NCT03318861|565723750|FG003|Overall Study|Enrolled But Never Treated|1|||
156720690|NCT03318861|565723751|FG004|Overall Study|Enrolled But Never Treated|1|||
157134086|NCT01609933|567239805|FG000|Overall Study|Adverse Event|1|||
157134087|NCT01609933|567239805|FG000|Overall Study|Withdrawal by Subject|3|||
157134088|NCT01252966|567239806|FG000|Overall Study|Lost to Follow-up|16|||
157134089|NCT01252966|567239807|FG001|Overall Study|Lost to Follow-up|10|||
157134090|NCT01252966|567239806|FG000|Overall Study|Withdrawal by Subject|7|||
157134091|NCT01252966|567239807|FG001|Overall Study|Withdrawal by Subject|3|||
157134092|NCT00398112|567239826|FG000|Overall Study|Adverse Event|4|||
157134093|NCT00398112|567239826|FG000|Overall Study|Disease progression|9|||
157134094|NCT00398112|567239826|FG000|Overall Study|Alternative treatment|1|||
157134095|NCT00398112|567239826|FG000|Overall Study|Withdrawal by Subject|3|||
157134096|NCT00398112|567239826|FG000|Overall Study|Death|1|||
157134097|NCT00582556|567239827|FG000|Overall Study|Withdrawal by Subject|0|||
157134098|NCT00582556|567239828|FG001|Overall Study|Withdrawal by Subject|1|||
157134099|NCT00582556|567239829|FG002|Overall Study|Withdrawal by Subject|1|||
157134100|NCT00582556|567239827|FG000|Overall Study|Physician Decision|0|||
157134101|NCT00582556|567239828|FG001|Overall Study|Physician Decision|0|||
157134102|NCT00582556|567239829|FG002|Overall Study|Physician Decision|1|||
157134103|NCT02300129|567239833|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
157134104|NCT02300129|567239834|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
157134105|NCT02300129|567239835|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
157134106|NCT02300129|567239836|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
157134107|NCT02300129|567239833|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
157134108|NCT02300129|567239834|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
157134109|NCT02300129|567239835|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
157134110|NCT02300129|567239836|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
156720691|NCT03318861|565723747|FG000|Overall Study|Informed Consent Withdraw|0|||
156720692|NCT03318861|565723748|FG001|Overall Study|Informed Consent Withdraw|0|||
156720693|NCT03318861|565723749|FG002|Overall Study|Informed Consent Withdraw|0|||
156720694|NCT03318861|565723750|FG003|Overall Study|Informed Consent Withdraw|1|||
156720695|NCT03318861|565723751|FG004|Overall Study|Informed Consent Withdraw|0|||
156720696|NCT03318861|565723747|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
156720697|NCT03318861|565723748|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720698|NCT03318861|565723749|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720699|NCT03318861|565723750|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720700|NCT03318861|565723751|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
156720701|NCT00917852|565723752|FG000|Overall Study|Death|6|||
156720702|NCT03499067|565723753|FG000|First Intervention|Physician Decision|2|||
156720703|NCT03499067|565723754|FG001|First Intervention|Physician Decision|1|||
156720704|NCT03499067|565723753|FG000|First Intervention|Withdrawal by Subject|3|||
156720705|NCT03499067|565723754|FG001|First Intervention|Withdrawal by Subject|6|||
156720706|NCT02392481|565723755|FG000|Overall Study|Adverse Event|0|||
156720707|NCT02392481|565723756|FG001|Overall Study|Adverse Event|0|||
156720708|NCT02392481|565723757|FG002|Overall Study|Adverse Event|1|||
156720709|NCT02392481|565723758|FG003|Overall Study|Adverse Event|2|||
156720710|NCT02392481|565723755|FG000|Overall Study|Withdrawal by Subject|0|||
156720711|NCT02392481|565723756|FG001|Overall Study|Withdrawal by Subject|0|||
157134111|NCT02300129|567239833|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
157134112|NCT02300129|567239834|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
157134113|NCT02300129|567239835|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
157134114|NCT02300129|567239836|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
157134115|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
157134116|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
157134117|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
157134118|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
157134119|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
157134120|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
157134121|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
157134122|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
157134123|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
157134124|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
157134125|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
157134126|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
157134127|NCT02747927|567239838|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
157134128|NCT02747927|567239839|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
157134129|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
157134130|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
157134131|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
157217267|NCT01697449|567541070|FG000|Overall Study|Adverse Event|7|||
157217268|NCT01697449|567541070|FG000|Overall Study|Lost to Follow-up|5|||
156720712|NCT02392481|565723757|FG002|Overall Study|Withdrawal by Subject|1|||
156720713|NCT02392481|565723758|FG003|Overall Study|Withdrawal by Subject|0|||
157217269|NCT01697449|567541070|FG000|Overall Study|Withdrawal by Subject|2|||
156720714|NCT02502149|565723759|FG000|Intermediate|Discontinued prematurely|1|||
156720715|NCT02502149|565723760|FG001|Intermediate|Discontinued prematurely|0|||
156720716|NCT02502149|565723761|FG002|Intermediate|Discontinued prematurely|0|||
156720717|NCT02502149|565723762|FG003|Intermediate|Discontinued prematurely|0|||
157134132|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
157134133|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
157217270|NCT01697449|567541070|FG000|Overall Study|Physician Decision|1|||
157134134|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
157134135|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
157134136|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
157134137|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
157134138|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
157134139|NCT02747927|567239838|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
157134140|NCT02747927|567239839|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
157134141|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
157134142|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
157134143|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
157134144|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
157134145|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
157134146|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
157134147|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
157134148|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
157134149|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
157134150|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
157134151|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
157134152|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
157134153|NCT02747927|567239838|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
157134154|NCT02747927|567239839|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
157134155|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
157134156|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
157134157|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
157134158|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
157134159|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
157134160|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
157134161|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
157134162|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
157134163|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
157134164|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
157134165|NCT02747927|567239838|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
157134166|NCT02747927|567239839|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
157134167|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
157134168|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
157134169|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
156720718|NCT02502149|565723763|FG004|Intermediate|Discontinued prematurely|0|||
156720719|NCT02548832|565723764|FG000|Overall Study|Lost to Follow-up|2|||
156720720|NCT02548832|565723765|FG001|Overall Study|Lost to Follow-up|2|||
156720721|NCT02548832|565723766|FG002|Overall Study|Lost to Follow-up|2|||
156720722|NCT02383017|565723770|FG000|Overall Study|Injury Sustained Outside Study|1|||
156720723|NCT02383017|565723771|FG001|Overall Study|Injury Sustained Outside Study|0|||
156720724|NCT02383017|565723770|FG000|Overall Study|Compliance|3|||
157134170|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
157134171|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
157134172|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
157134173|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
157134174|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
157134175|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
157134176|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
157134177|NCT02747927|567239838|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
157134178|NCT02747927|567239839|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
157134179|NCT03932812|567239843|FG000|Overall Study|Lost to Follow-up|12|||
156793980|NCT03715829|565999495|FG002|Dose Ranging Period|Lost to Follow-up|1|||
156720725|NCT02383017|565723771|FG001|Overall Study|Compliance|2|||
157134180|NCT03932812|567239844|FG001|Overall Study|Lost to Follow-up|14|||
157134181|NCT03932812|567239843|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
157134182|NCT03932812|567239844|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
157134183|NCT00191854|567239851|FG000|Overall Study|Death|26|||
157134184|NCT00191854|567239852|FG001|Overall Study|Death|23|||
157134185|NCT00191854|567239853|FG002|Overall Study|Death|29|||
156720726|NCT02383017|565723770|FG000|Overall Study|Found to be Hypogonadal|1|||
156720727|NCT02383017|565723771|FG001|Overall Study|Found to be Hypogonadal|0|||
156720728|NCT02088177|565723778|FG000|Overall Study|Lost to Follow-up|3|||
156720729|NCT01234350|565723780|FG000|Overall Study|Adverse Event|277|||
156720730|NCT01234350|565723781|FG001|Overall Study|Adverse Event|92|||
156720731|NCT01234350|565723780|FG000|Overall Study|Withdrawal by Subject|61|||
156720732|NCT01234350|565723781|FG001|Overall Study|Withdrawal by Subject|36|||
156720733|NCT01234350|565723780|FG000|Overall Study|Lost to Follow-up|115|||
156720734|NCT01234350|565723781|FG001|Overall Study|Lost to Follow-up|47|||
156720735|NCT01234350|565723780|FG000|Overall Study|Covers a diverse set of reasons|234|||
156720736|NCT01234350|565723781|FG001|Overall Study|Covers a diverse set of reasons|92|||
156720737|NCT00289848|565723782|FG000|Overall Study|Adverse Event|6|||
156720738|NCT00289848|565723783|FG001|Overall Study|Adverse Event|4|||
156875371|NCT02078960|566302033|FG002|Treatment Period|Withdrawal by Subject|1|||
156720739|NCT00289848|565723782|FG000|Overall Study|Death|1|||
156720740|NCT00289848|565723783|FG001|Overall Study|Death|0|||
156720741|NCT00289848|565723782|FG000|Overall Study|Lack of Efficacy|20|||
156720742|NCT00289848|565723783|FG001|Overall Study|Lack of Efficacy|24|||
156720743|NCT00289848|565723782|FG000|Overall Study|Lost to Follow-up|3|||
156720744|NCT00289848|565723783|FG001|Overall Study|Lost to Follow-up|1|||
156720745|NCT00289848|565723782|FG000|Overall Study|Protocol Violation|5|||
156720746|NCT00289848|565723783|FG001|Overall Study|Protocol Violation|2|||
156720747|NCT00289848|565723782|FG000|Overall Study|Withdrawal by Subject|5|||
156720748|NCT00289848|565723783|FG001|Overall Study|Withdrawal by Subject|11|||
156720749|NCT00289848|565723782|FG000|Overall Study|Patient Moved|6|||
156720750|NCT00289848|565723783|FG001|Overall Study|Patient Moved|2|||
156720751|NCT00289848|565723782|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
156720752|NCT00289848|565723783|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
156720753|NCT01433471|565723784|FG000|Overall Study|Withdrawal by Subject|0|||
156720754|NCT01433471|565723785|FG001|Overall Study|Withdrawal by Subject|1|||
156720755|NCT03711188|565723786|FG000|Overall Study|Disease progression|11|||
156720756|NCT03711188|565723786|FG000|Overall Study|Adverse Event|1|||
156720757|NCT00063934|565723791|FG000|Overall Study|Ineligible|1|||
156720758|NCT00395629|565723792|FG000|Core Study|Adverse Event|0|||
156720759|NCT00395629|565723793|FG001|Core Study|Adverse Event|3|||
156720760|NCT00395629|565723794|FG002|Core Study|Adverse Event|4|||
156720761|NCT00395629|565723792|FG000|Core Study|Abnormal laboratory value(s)|0|||
156720762|NCT00395629|565723793|FG001|Core Study|Abnormal laboratory value(s)|0|||
156720763|NCT00395629|565723794|FG002|Core Study|Abnormal laboratory value(s)|1|||
156875372|NCT02078960|566302031|FG000|Treatment Period|Adverse Event|1|||
156875373|NCT02078960|566302032|FG001|Treatment Period|Adverse Event|0|||
156875374|NCT02078960|566302033|FG002|Treatment Period|Adverse Event|0|||
156875375|NCT02078960|566302031|FG000|Treatment Period|Death|0|||
156875376|NCT02078960|566302032|FG001|Treatment Period|Death|0|||
156875377|NCT02078960|566302033|FG002|Treatment Period|Death|1|||
156875378|NCT02078960|566302031|FG000|Follow-up Period|Death|2|||
156875379|NCT02078960|566302032|FG001|Follow-up Period|Death|0|||
156875380|NCT02078960|566302033|FG002|Follow-up Period|Death|0|||
156875381|NCT02078960|566302031|FG000|Follow-up Period|Lost to Follow-up|0|||
156875382|NCT02078960|566302032|FG001|Follow-up Period|Lost to Follow-up|1|||
156875383|NCT02078960|566302033|FG002|Follow-up Period|Lost to Follow-up|0|||
156875384|NCT00859638|566302034|FG000|Overall Study|Lost to Follow-up|6|||
156875385|NCT00859638|566302035|FG001|Overall Study|Lost to Follow-up|1|||
156875386|NCT00859638|566302034|FG000|Overall Study|Withdrawal by Subject|3|||
156875387|NCT00859638|566302035|FG001|Overall Study|Withdrawal by Subject|2|||
156875388|NCT00859638|566302034|FG000|Overall Study|Ill health|1|||
156875389|NCT00859638|566302035|FG001|Overall Study|Ill health|1|||
156875390|NCT04643158|566302039|FG000|Overall Study|Study terminated by sponsor|0|||
156875391|NCT04643158|566302040|FG001|Overall Study|Study terminated by sponsor|0|||
156875392|NCT04643158|566302041|FG002|Overall Study|Study terminated by sponsor|1|||
157018769|NCT02724878|566822902|FG000|Overall Study|Still on Active Therapy|15|||
157018770|NCT02724878|566822902|FG000|Overall Study|Disease Progression|31|||
157018771|NCT02724878|566822902|FG000|Overall Study|Toxicity|5|||
157018772|NCT02724878|566822902|FG000|Overall Study|Death|1|||
157018773|NCT02724878|566822902|FG000|Overall Study|Withdrawal by Subject|4|||
157018774|NCT02724878|566822902|FG000|Overall Study|Lost to Follow-up|2|||
157018775|NCT02724878|566822902|FG000|Overall Study|Protocol Violation|1|||
157018776|NCT02724878|566822902|FG000|Overall Study|Ineligible for Study Drug|5|||
157018777|NCT02724878|566822902|FG000|Overall Study|not started|1|||
157018778|NCT02807636|566822907|FG000|Overall Study|Lost to Follow-up|10|||
157018779|NCT02807636|566822908|FG001|Overall Study|Lost to Follow-up|13|||
157018780|NCT02807636|566822909|FG002|Overall Study|Lost to Follow-up|6|||
157018781|NCT02807636|566822907|FG000|Overall Study|Protocol Deviation|1|||
157018782|NCT02807636|566822908|FG001|Overall Study|Protocol Deviation|0|||
157018783|NCT02807636|566822909|FG002|Overall Study|Protocol Deviation|0|||
157018784|NCT02807636|566822907|FG000|Overall Study|Symptomatic Deterioration|0|||
157018785|NCT02807636|566822908|FG001|Overall Study|Symptomatic Deterioration|1|||
157018786|NCT02807636|566822909|FG002|Overall Study|Symptomatic Deterioration|0|||
157018787|NCT02807636|566822907|FG000|Overall Study|Withdrawal by Subject|39|||
157018788|NCT02807636|566822908|FG001|Overall Study|Withdrawal by Subject|28|||
157018789|NCT02807636|566822909|FG002|Overall Study|Withdrawal by Subject|24|||
157018790|NCT02807636|566822907|FG000|Overall Study|Death|303|||
157018791|NCT02807636|566822908|FG001|Overall Study|Death|332|||
157018792|NCT02807636|566822909|FG002|Overall Study|Death|272|||
157018793|NCT02807636|566822907|FG000|Overall Study|Study Terminated By Sponsor|47|||
157134186|NCT00191854|567239851|FG000|Overall Study|Lost to Follow-up|7|||
157134187|NCT00191854|567239852|FG001|Overall Study|Lost to Follow-up|5|||
156720764|NCT00395629|565723792|FG000|Core Study|Protocol Violation|1|||
156720765|NCT00395629|565723793|FG001|Core Study|Protocol Violation|0|||
156720766|NCT00395629|565723794|FG002|Core Study|Protocol Violation|0|||
156720767|NCT00395629|565723792|FG000|Core Study|Withdrawal by Subject|0|||
156720768|NCT00395629|565723793|FG001|Core Study|Withdrawal by Subject|1|||
156720769|NCT00395629|565723794|FG002|Core Study|Withdrawal by Subject|1|||
156720770|NCT00395629|565723792|FG000|Core Study|Lost to Follow-up|0|||
156720771|NCT00395629|565723793|FG001|Core Study|Lost to Follow-up|0|||
156720772|NCT00395629|565723794|FG002|Core Study|Lost to Follow-up|1|||
156720773|NCT00395629|565723792|FG000|Extension Study|Adverse Event|0|||
156720774|NCT00395629|565723793|FG001|Extension Study|Adverse Event|0|||
156720775|NCT00395629|565723794|FG002|Extension Study|Adverse Event|2|||
156720776|NCT00395629|565723792|FG000|Extension Study|Administrative problems|0|||
156720777|NCT00395629|565723793|FG001|Extension Study|Administrative problems|0|||
156720778|NCT00395629|565723794|FG002|Extension Study|Administrative problems|1|||
156720779|NCT03428152|565723795|FG000|Overall Study|Physician Decision|4|||
156720780|NCT03428152|565723796|FG001|Overall Study|Physician Decision|2|||
156720781|NCT03428152|565723795|FG000|Overall Study|Protocol Violation|3|||
156720782|NCT03428152|565723796|FG001|Overall Study|Protocol Violation|5|||
156720783|NCT03428152|565723795|FG000|Overall Study|Lack of Efficacy|0|||
156720784|NCT03428152|565723796|FG001|Overall Study|Lack of Efficacy|4|||
156720785|NCT01686373|565723797|FG000|Overall Study|Lost to Follow-up|3|||
156720786|NCT01686373|565723798|FG001|Overall Study|Lost to Follow-up|0|||
156720787|NCT01686373|565723797|FG000|Overall Study|Withdrawal by Subject|0|||
156720788|NCT01686373|565723798|FG001|Overall Study|Withdrawal by Subject|1|||
156720789|NCT01686373|565723797|FG000|Overall Study|Adverse Event|0|||
156720790|NCT01686373|565723798|FG001|Overall Study|Adverse Event|1|||
156720791|NCT01836471|565723805|FG000|Overall Study|Pregnancy|1|||
156720792|NCT01836471|565723806|FG001|Overall Study|Pregnancy|0|||
156720793|NCT01836471|565723807|FG002|Overall Study|Pregnancy|0|||
156720794|NCT01836471|565723808|FG003|Overall Study|Pregnancy|0|||
156720795|NCT01836471|565723809|FG004|Overall Study|Pregnancy|0|||
156720796|NCT01836471|565723805|FG000|Overall Study|Withdrawal by Subject|3|||
156720797|NCT01836471|565723806|FG001|Overall Study|Withdrawal by Subject|4|||
156720798|NCT01836471|565723807|FG002|Overall Study|Withdrawal by Subject|1|||
156720799|NCT01836471|565723808|FG003|Overall Study|Withdrawal by Subject|0|||
156720800|NCT01836471|565723809|FG004|Overall Study|Withdrawal by Subject|2|||
156720801|NCT01836471|565723805|FG000|Overall Study|Physician Decision|0|||
156720802|NCT01836471|565723806|FG001|Overall Study|Physician Decision|1|||
156720803|NCT01836471|565723807|FG002|Overall Study|Physician Decision|0|||
156720804|NCT01836471|565723808|FG003|Overall Study|Physician Decision|0|||
156720805|NCT01836471|565723809|FG004|Overall Study|Physician Decision|0|||
156720806|NCT01836471|565723805|FG000|Overall Study|Lost to Follow-up|0|||
156720807|NCT01836471|565723806|FG001|Overall Study|Lost to Follow-up|0|||
156720808|NCT01836471|565723807|FG002|Overall Study|Lost to Follow-up|0|||
156720809|NCT01836471|565723808|FG003|Overall Study|Lost to Follow-up|1|||
156720810|NCT01836471|565723809|FG004|Overall Study|Lost to Follow-up|1|||
157134188|NCT00191854|567239853|FG002|Overall Study|Lost to Follow-up|5|||
157134189|NCT00191854|567239851|FG000|Overall Study|Withdrawal by Subject|4|||
157134190|NCT00191854|567239852|FG001|Overall Study|Withdrawal by Subject|2|||
157134191|NCT00191854|567239853|FG002|Overall Study|Withdrawal by Subject|3|||
157134192|NCT00191854|567239851|FG000|Overall Study|Sponsor Decision|0|||
157134193|NCT00191854|567239852|FG001|Overall Study|Sponsor Decision|0|||
157134194|NCT00191854|567239853|FG002|Overall Study|Sponsor Decision|1|||
157134195|NCT00191854|567239851|FG000|Overall Study|Screen Failure|0|||
157134196|NCT00191854|567239852|FG001|Overall Study|Screen Failure|0|||
157134197|NCT00191854|567239853|FG002|Overall Study|Screen Failure|1|||
157134198|NCT01933932|567239854|FG000|Overall Study|Death|173|||
157134199|NCT01933932|567239855|FG001|Overall Study|Death|163|||
157134200|NCT01933932|567239854|FG000|Overall Study|Withdrawal by Subject|11|||
157217271|NCT01697449|567541070|FG000|Overall Study|Death|2|||
156720811|NCT01836471|565723805|FG000|Overall Study|Adverse Event|6|||
156720812|NCT01836471|565723806|FG001|Overall Study|Adverse Event|3|||
156720813|NCT01836471|565723807|FG002|Overall Study|Adverse Event|1|||
156720814|NCT01836471|565723808|FG003|Overall Study|Adverse Event|1|||
156720815|NCT01836471|565723809|FG004|Overall Study|Adverse Event|2|||
156720816|NCT01836471|565723805|FG000|Overall Study|Non compliance with tx|1|||
156720817|NCT01836471|565723806|FG001|Overall Study|Non compliance with tx|1|||
156720818|NCT01836471|565723807|FG002|Overall Study|Non compliance with tx|0|||
156720819|NCT01836471|565723808|FG003|Overall Study|Non compliance with tx|0|||
157217272|NCT01697449|567541070|FG000|Overall Study|Other|1|||
156720820|NCT01836471|565723809|FG004|Overall Study|Non compliance with tx|0|||
156720821|NCT02570308|565723815|FG000|Overall Study|Death|1|||
156720822|NCT02570308|565723816|FG001|Overall Study|Death|5|||
156720823|NCT02570308|565723817|FG002|Overall Study|Death|4|||
157134201|NCT01933932|567239855|FG001|Overall Study|Withdrawal by Subject|14|||
157134202|NCT01933932|567239854|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157134203|NCT01933932|567239855|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156793981|NCT03715829|565999496|FG003|Dose Ranging Period|Lost to Follow-up|1|||
156793982|NCT03715829|565999497|FG004|Dose Ranging Period|Lost to Follow-up|1|||
156793983|NCT03715829|565999498|FG005|Dose Ranging Period|Lost to Follow-up|2|||
156793984|NCT03715829|565999499|FG006|Dose Ranging Period|Lost to Follow-up|0|||
156793985|NCT03715829|565999500|FG007|Dose Ranging Period|Lost to Follow-up|0|||
156793986|NCT03715829|565999501|FG008|Dose Ranging Period|Lost to Follow-up|0|||
156793987|NCT03715829|565999502|FG009|Dose Ranging Period|Lost to Follow-up|0|||
156793988|NCT03715829|565999503|FG010|Dose Ranging Period|Lost to Follow-up|0|||
156793989|NCT03715829|565999493|FG000|Dose Ranging Period|Protocol Violation|0|||
156793990|NCT03715829|565999494|FG001|Dose Ranging Period|Protocol Violation|0|||
156793991|NCT03715829|565999495|FG002|Dose Ranging Period|Protocol Violation|0|||
156793992|NCT03715829|565999496|FG003|Dose Ranging Period|Protocol Violation|1|||
156793993|NCT03715829|565999497|FG004|Dose Ranging Period|Protocol Violation|0|||
156793994|NCT03715829|565999498|FG005|Dose Ranging Period|Protocol Violation|0|||
156793995|NCT03715829|565999499|FG006|Dose Ranging Period|Protocol Violation|0|||
156793996|NCT03715829|565999500|FG007|Dose Ranging Period|Protocol Violation|0|||
156793997|NCT03715829|565999501|FG008|Dose Ranging Period|Protocol Violation|0|||
156793998|NCT03715829|565999502|FG009|Dose Ranging Period|Protocol Violation|0|||
156793999|NCT03715829|565999503|FG010|Dose Ranging Period|Protocol Violation|0|||
156794000|NCT03715829|565999493|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
156794001|NCT03715829|565999494|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
156794002|NCT03715829|565999495|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
156794003|NCT03715829|565999496|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
156794004|NCT03715829|565999497|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
156794005|NCT03715829|565999498|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
156794006|NCT03715829|565999499|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
156794007|NCT03715829|565999500|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
156794008|NCT03715829|565999501|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
156794009|NCT03715829|565999502|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
156794010|NCT03715829|565999503|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
156794011|NCT03715829|565999493|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794012|NCT03715829|565999494|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794013|NCT03715829|565999495|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
156794014|NCT03715829|565999496|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794015|NCT03715829|565999497|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794016|NCT03715829|565999498|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794017|NCT03715829|565999499|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794018|NCT03715829|565999500|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794019|NCT03715829|565999501|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794020|NCT03715829|565999502|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794021|NCT03715829|565999503|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
156794022|NCT03715829|565999493|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794023|NCT03715829|565999494|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794024|NCT03715829|565999495|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
156794025|NCT03715829|565999496|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794026|NCT03715829|565999497|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
156794027|NCT03715829|565999498|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794028|NCT03715829|565999499|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794029|NCT03715829|565999500|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794030|NCT03715829|565999501|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794031|NCT03715829|565999502|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794032|NCT03715829|565999503|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
156794033|NCT03715829|565999493|FG000|Dose Ranging Period|Other|0|||
157018794|NCT02807636|566822908|FG001|Overall Study|Study Terminated By Sponsor|76|||
157018795|NCT02807636|566822909|FG002|Overall Study|Study Terminated By Sponsor|60|||
157018796|NCT02807636|566822907|FG000|Overall Study|Physician Decision|0|||
157018797|NCT02807636|566822908|FG001|Overall Study|Physician Decision|1|||
157018798|NCT02807636|566822909|FG002|Overall Study|Physician Decision|0|||
156794034|NCT03715829|565999494|FG001|Dose Ranging Period|Other|0|||
156794035|NCT03715829|565999495|FG002|Dose Ranging Period|Other|2|||
156794036|NCT03715829|565999496|FG003|Dose Ranging Period|Other|0|||
156794037|NCT03715829|565999497|FG004|Dose Ranging Period|Other|0|||
156794038|NCT03715829|565999498|FG005|Dose Ranging Period|Other|3|||
156794039|NCT03715829|565999499|FG006|Dose Ranging Period|Other|0|||
156794040|NCT03715829|565999500|FG007|Dose Ranging Period|Other|0|||
156794041|NCT03715829|565999501|FG008|Dose Ranging Period|Other|0|||
156794042|NCT03715829|565999502|FG009|Dose Ranging Period|Other|0|||
156794043|NCT03715829|565999503|FG010|Dose Ranging Period|Other|0|||
156794044|NCT03715829|565999493|FG000|Extension Period|Adverse Event|0|||
156794045|NCT03715829|565999494|FG001|Extension Period|Adverse Event|0|||
156794046|NCT03715829|565999495|FG002|Extension Period|Adverse Event|0|||
157018799|NCT02506959|566822911|FG000|Overall Study|Physician Decision|2|||
157134204|NCT00934102|567239860|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
157134205|NCT00934102|567239861|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
157134206|NCT00934102|567239862|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
157134207|NCT03304522|567239863|FG000|Overall Study|Adverse Event|0|||
157134208|NCT03304522|567239864|FG001|Overall Study|Adverse Event|4|||
157134209|NCT03304522|567239863|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
157134210|NCT03304522|567239864|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
157134211|NCT03304522|567239863|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
157134212|NCT03304522|567239864|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
157134213|NCT03304522|567239863|FG000|Overall Study|Other|0|||
157134214|NCT03304522|567239864|FG001|Overall Study|Other|1|||
157134215|NCT02649634|567239868|FG000|Overall Study|Withdrawal by Subject|3|||
157134216|NCT02649634|567239869|FG001|Overall Study|Withdrawal by Subject|5|||
157134217|NCT02649634|567239868|FG000|Overall Study|Lost to Follow-up|0|||
157134218|NCT02649634|567239869|FG001|Overall Study|Lost to Follow-up|1|||
157134219|NCT00763009|567239871|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
157134220|NCT01111604|567239872|FG000|Overall Study|Lost to Follow-up|0|||
157134221|NCT01111604|567239873|FG001|Overall Study|Lost to Follow-up|0|||
157134222|NCT01111604|567239874|FG002|Overall Study|Lost to Follow-up|1|||
157134223|NCT01111604|567239872|FG000|Overall Study|Withdrew Consent|3|||
157134224|NCT01111604|567239873|FG001|Overall Study|Withdrew Consent|0|||
157134225|NCT01111604|567239874|FG002|Overall Study|Withdrew Consent|2|||
157134226|NCT01111604|567239872|FG000|Overall Study|Withdrawal by Subject|2|||
157134227|NCT01111604|567239873|FG001|Overall Study|Withdrawal by Subject|0|||
157134228|NCT01111604|567239874|FG002|Overall Study|Withdrawal by Subject|0|||
157134229|NCT01111604|567239872|FG000|Overall Study|Death|1|||
157134230|NCT01111604|567239873|FG001|Overall Study|Death|0|||
157134231|NCT01111604|567239874|FG002|Overall Study|Death|0|||
157134232|NCT01111604|567239872|FG000|Overall Study|Met Exclusion Criteria|2|||
157134233|NCT01111604|567239873|FG001|Overall Study|Met Exclusion Criteria|0|||
157134234|NCT01111604|567239874|FG002|Overall Study|Met Exclusion Criteria|0|||
157134235|NCT01295125|567239876|FG000|Overall Study|Study stopped prematurely|9|||
157134236|NCT01355289|567239877|FG000|Core Study|Adverse Event, Non-Fatal|1|||
157134237|NCT01355289|567239878|FG001|Core Study|Adverse Event, Non-Fatal|0|||
157134238|NCT01355289|567239879|FG002|Core Study|Adverse Event, Non-Fatal|0|||
157134239|NCT01355289|567239880|FG003|Core Study|Adverse Event, Non-Fatal|0|||
157134240|NCT01355289|567239881|FG004|Core Study|Adverse Event, Non-Fatal|0|||
156720824|NCT02570308|565723818|FG003|Overall Study|Death|4|||
156720825|NCT02570308|565723819|FG004|Overall Study|Death|69|||
156720826|NCT02570308|565723815|FG000|Overall Study|Lost to Follow-up|0|||
156720827|NCT02570308|565723816|FG001|Overall Study|Lost to Follow-up|0|||
156720828|NCT02570308|565723817|FG002|Overall Study|Lost to Follow-up|0|||
156720829|NCT02570308|565723818|FG003|Overall Study|Lost to Follow-up|0|||
156720830|NCT02570308|565723819|FG004|Overall Study|Lost to Follow-up|2|||
156720831|NCT02570308|565723815|FG000|Overall Study|Withdrawal by Subject|0|||
156720832|NCT02570308|565723816|FG001|Overall Study|Withdrawal by Subject|0|||
156720833|NCT02570308|565723817|FG002|Overall Study|Withdrawal by Subject|0|||
156720834|NCT02570308|565723818|FG003|Overall Study|Withdrawal by Subject|0|||
156720835|NCT02570308|565723819|FG004|Overall Study|Withdrawal by Subject|1|||
156720836|NCT02570308|565723815|FG000|Overall Study|Other|0|||
156720837|NCT02570308|565723816|FG001|Overall Study|Other|0|||
156720838|NCT02570308|565723817|FG002|Overall Study|Other|0|||
156720839|NCT02570308|565723818|FG003|Overall Study|Other|0|||
156720840|NCT02570308|565723819|FG004|Overall Study|Other|2|||
156720841|NCT01960413|565723820|FG000|Overall Study|Withdrawal by Subject|1|||
156720842|NCT01960413|565723821|FG001|Overall Study|Withdrawal by Subject|1|||
156720843|NCT01960413|565723820|FG000|Overall Study|Physician Decision|1|||
156720844|NCT01960413|565723821|FG001|Overall Study|Physician Decision|0|||
156720845|NCT01960413|565723820|FG000|Overall Study|Lost to Follow-up|2|||
156720846|NCT01960413|565723821|FG001|Overall Study|Lost to Follow-up|0|||
157134241|NCT01355289|567239877|FG000|Core Study|Inadequate Therapeutic Effect|0|||
157134242|NCT01355289|567239878|FG001|Core Study|Inadequate Therapeutic Effect|0|||
157134243|NCT01355289|567239879|FG002|Core Study|Inadequate Therapeutic Effect|0|||
156720847|NCT00314340|565723823|FG000|Overall Study|lost interest|1|||
156720848|NCT00791778|565723824|FG000|Double-blind Treatment|Adverse Event|49|||
157134244|NCT01355289|567239880|FG003|Core Study|Inadequate Therapeutic Effect|1|||
156720849|NCT00791778|565723825|FG001|Double-blind Treatment|Adverse Event|9|||
157134245|NCT01355289|567239881|FG004|Core Study|Inadequate Therapeutic Effect|0|||
157134246|NCT01355289|567239877|FG000|Core Study|Other|0|||
156720850|NCT00791778|565723824|FG000|Double-blind Treatment|Physician Decision|6|||
156720851|NCT00791778|565723825|FG001|Double-blind Treatment|Physician Decision|26|||
156720852|NCT00791778|565723824|FG000|Double-blind Treatment|Protocol Violation|0|||
156720853|NCT00791778|565723825|FG001|Double-blind Treatment|Protocol Violation|4|||
157134247|NCT01355289|567239878|FG001|Core Study|Other|0|||
157134248|NCT01355289|567239879|FG002|Core Study|Other|0|||
157134249|NCT01355289|567239880|FG003|Core Study|Other|1|||
157134250|NCT01355289|567239881|FG004|Core Study|Other|0|||
157134251|NCT01355289|567239877|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
157217273|NCT01697449|567541070|FG000|Overall Study|Missing|25|||
156720854|NCT00791778|565723824|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
156720855|NCT00791778|565723825|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
156720856|NCT00791778|565723824|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
156720857|NCT00791778|565723825|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
156720858|NCT00791778|565723824|FG000|Follow-up|Withdrawal by Subject|3|||
156720859|NCT00791778|565723825|FG001|Follow-up|Withdrawal by Subject|0|||
156720860|NCT00791778|565723824|FG000|Follow-up|Lost to Follow-up|2|||
156720861|NCT00791778|565723825|FG001|Follow-up|Lost to Follow-up|1|||
157134252|NCT01355289|567239878|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
157134253|NCT01355289|567239879|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
157134254|NCT01355289|567239880|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
157134255|NCT01355289|567239881|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
156720862|NCT02285361|565723826|FG000|Overall Study|Protocol Violation|43|||
156720863|NCT02285361|565723826|FG000|Overall Study|Lost to Follow-up|5|||
156720864|NCT02285361|565723826|FG000|Overall Study|Not taken GIOTRIF|2|||
156720865|NCT02285361|565723826|FG000|Overall Study|Consented prior to the contract date|1|||
156720866|NCT01283464|565723827|FG000|Overall Study|Lost to Follow-up|0|||
156720867|NCT01283464|565723828|FG001|Overall Study|Lost to Follow-up|1|||
156720868|NCT01283464|565723827|FG000|Overall Study|Withdrawal by Subject|1|||
156720869|NCT01283464|565723828|FG001|Overall Study|Withdrawal by Subject|0|||
156720870|NCT01283464|565723827|FG000|Overall Study|Physician Decision|1|||
156720871|NCT01283464|565723828|FG001|Overall Study|Physician Decision|0|||
156720872|NCT03051100|565723829|FG000|Overall Study|Withdrawal by Subject|1|||
156720873|NCT03051100|565723830|FG001|Overall Study|Withdrawal by Subject|0|||
156720874|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
156720875|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
156720876|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
156794047|NCT03715829|565999496|FG003|Extension Period|Adverse Event|0|||
156794048|NCT03715829|565999497|FG004|Extension Period|Adverse Event|0|||
156794049|NCT03715829|565999498|FG005|Extension Period|Adverse Event|0|||
156794050|NCT03715829|565999499|FG006|Extension Period|Adverse Event|3|||
157134256|NCT01355289|567239877|FG000|Open Label Extension|Lost to Follow-up|0|||
157134257|NCT01355289|567239878|FG001|Open Label Extension|Lost to Follow-up|0|||
157134258|NCT01355289|567239879|FG002|Open Label Extension|Lost to Follow-up|0|||
157134259|NCT01355289|567239880|FG003|Open Label Extension|Lost to Follow-up|0|||
157134260|NCT01355289|567239881|FG004|Open Label Extension|Lost to Follow-up|1|||
157134261|NCT01355289|567239877|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
157134262|NCT01355289|567239878|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
157134263|NCT01355289|567239879|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
157134264|NCT01355289|567239880|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
157134265|NCT01355289|567239881|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
157134266|NCT01355289|567239877|FG000|Open Label Extension|Other|0|||
157134267|NCT01355289|567239878|FG001|Open Label Extension|Other|0|||
157134268|NCT01355289|567239879|FG002|Open Label Extension|Other|0|||
157134269|NCT01355289|567239880|FG003|Open Label Extension|Other|0|||
157134270|NCT01355289|567239881|FG004|Open Label Extension|Other|3|||
157134271|NCT01756456|567239891|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
157134272|NCT01756456|567239892|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
157134273|NCT01756456|567239893|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
157134274|NCT01756456|567239894|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
157134275|NCT01756456|567239895|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
157134276|NCT01756456|567239896|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
157134277|NCT01756456|567239891|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
157134278|NCT01756456|567239892|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
157134279|NCT01756456|567239893|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
157134280|NCT01756456|567239894|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
157134281|NCT01756456|567239895|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
157134282|NCT01756456|567239896|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
157134283|NCT01756456|567239891|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156720877|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
156720878|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
156720879|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
156720880|NCT02059135|565723831|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
156720881|NCT02059135|565723832|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
156720882|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
156720883|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
156794051|NCT03715829|565999500|FG007|Extension Period|Adverse Event|1|||
156720884|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
156794052|NCT03715829|565999501|FG008|Extension Period|Adverse Event|6|||
157134284|NCT01756456|567239892|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
157134285|NCT01756456|567239893|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
157134286|NCT01756456|567239894|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
157134287|NCT01756456|567239895|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
157134288|NCT01756456|567239896|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
156720885|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
156720886|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
156720887|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
156720888|NCT02059135|565723831|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
156720889|NCT02059135|565723832|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
156720890|NCT00191477|565723833|FG000|Overall Study|Tumor Recurrence|49|||
156720891|NCT00191477|565723834|FG001|Overall Study|Tumor Recurrence|48|||
156720892|NCT00191477|565723833|FG000|Overall Study|Death, Study Disease|1|||
156720893|NCT00191477|565723834|FG001|Overall Study|Death, Study Disease|1|||
156720894|NCT00191477|565723833|FG000|Overall Study|Death, Other Cause|3|||
156720895|NCT00191477|565723834|FG001|Overall Study|Death, Other Cause|6|||
156720896|NCT00191477|565723833|FG000|Overall Study|Lost to Follow-up|23|||
156720897|NCT00191477|565723834|FG001|Overall Study|Lost to Follow-up|21|||
156720898|NCT00191477|565723833|FG000|Overall Study|Protocol Violation|1|||
156720899|NCT00191477|565723834|FG001|Overall Study|Protocol Violation|1|||
156720900|NCT00191477|565723833|FG000|Overall Study|Treatment Change|2|||
156720901|NCT00191477|565723834|FG001|Overall Study|Treatment Change|0|||
156720902|NCT00191477|565723833|FG000|Overall Study|Withdrawal by Subject|2|||
156720903|NCT00191477|565723834|FG001|Overall Study|Withdrawal by Subject|0|||
156720904|NCT00191477|565723833|FG000|Overall Study|Other|2|||
156720905|NCT00191477|565723834|FG001|Overall Study|Other|0|||
156720906|NCT00191477|565723833|FG000|Overall Study|Not Eligible|41|||
156720907|NCT00191477|565723834|FG001|Overall Study|Not Eligible|38|||
156720908|NCT00191477|565723833|FG000|Overall Study|Pathological Specimen Lost|1|||
156720909|NCT00191477|565723834|FG001|Overall Study|Pathological Specimen Lost|0|||
156720910|NCT00191477|565723833|FG000|Overall Study|Discontinued Prior to Instillation|13|||
156720911|NCT00191477|565723834|FG001|Overall Study|Discontinued Prior to Instillation|14|||
156720912|NCT03335475|565723841|FG000|Overall Study|Did not wear accelerometer|4|||
156720913|NCT03335475|565723842|FG001|Overall Study|Did not wear accelerometer|0|||
156720914|NCT03335475|565723841|FG000|Overall Study|Withdrawal by Subject|0|||
156720915|NCT03335475|565723842|FG001|Overall Study|Withdrawal by Subject|1|||
156720916|NCT04886596|565723843|FG000|Overall Study|Adverse Event|442|||
156720917|NCT04886596|565723844|FG001|Overall Study|Adverse Event|441|||
156720918|NCT04886596|565723843|FG000|Overall Study|Lost to Follow-up|448|||
156720919|NCT04886596|565723844|FG001|Overall Study|Lost to Follow-up|465|||
156720920|NCT04886596|565723843|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
156720921|NCT04886596|565723844|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
156720922|NCT04886596|565723843|FG000|Overall Study|Migrated/moved from the study area|201|||
156720923|NCT04886596|565723844|FG001|Overall Study|Migrated/moved from the study area|184|||
156720924|NCT04886596|565723843|FG000|Overall Study|Other|298|||
156720925|NCT04886596|565723844|FG001|Overall Study|Other|326|||
156720926|NCT02411656|565723845|FG000|Overall Study|Adverse Event|4|||
156720927|NCT02411656|565723845|FG000|Overall Study|Clinical Progression|33|||
156720928|NCT06481709|565723846|FG000|Overall Study|Withdrawal by Subject|0|||
156720929|NCT06481709|565723847|FG001|Overall Study|Withdrawal by Subject|0|||
156720930|NCT06481709|565723848|FG002|Overall Study|Withdrawal by Subject|2|||
156720931|NCT06481709|565723849|FG003|Overall Study|Withdrawal by Subject|0|||
156720932|NCT05921903|565723850|FG000|Overall Study|Unsolicited non-SAE|0|||
156720933|NCT05921903|565723851|FG001|Overall Study|Unsolicited non-SAE|1|||
156720934|NCT05921903|565723852|FG002|Overall Study|Unsolicited non-SAE|0|||
156720935|NCT05921903|565723850|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
156720936|NCT05921903|565723851|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
156720937|NCT05921903|565723852|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
156720938|NCT05921903|565723850|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
156720939|NCT05921903|565723851|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
156720940|NCT05921903|565723852|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
156720941|NCT03305848|565723853|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
156720942|NCT03305848|565723853|FG000|Overall Study|Physician Decision|2|||
156720943|NCT00923013|565723854|FG000|Overall Study|Refused further treatment|0|||
156720944|NCT00923013|565723855|FG001|Overall Study|Refused further treatment|1|||
156720945|NCT00923013|565723856|FG002|Overall Study|Refused further treatment|2|||
156720946|NCT00923013|565723857|FG003|Overall Study|Refused further treatment|0|||
156720947|NCT00923013|565723858|FG004|Overall Study|Refused further treatment|0|||
156720948|NCT00923013|565723859|FG005|Overall Study|Refused further treatment|0|||
156720949|NCT00923013|565723854|FG000|Overall Study|Switched to alternative treatment|0|||
156720950|NCT00923013|565723855|FG001|Overall Study|Switched to alternative treatment|1|||
156720951|NCT00923013|565723856|FG002|Overall Study|Switched to alternative treatment|0|||
156720952|NCT00923013|565723857|FG003|Overall Study|Switched to alternative treatment|0|||
156720953|NCT00923013|565723858|FG004|Overall Study|Switched to alternative treatment|0|||
156720954|NCT00923013|565723859|FG005|Overall Study|Switched to alternative treatment|0|||
156720955|NCT00923013|565723854|FG000|Overall Study|Death on study|2|||
156720956|NCT00923013|565723855|FG001|Overall Study|Death on study|2|||
156720957|NCT00923013|565723856|FG002|Overall Study|Death on study|0|||
156720958|NCT00923013|565723857|FG003|Overall Study|Death on study|1|||
156720959|NCT00923013|565723858|FG004|Overall Study|Death on study|0|||
156720960|NCT00923013|565723859|FG005|Overall Study|Death on study|0|||
156720961|NCT03326193|565723861|FG000|Overall Study|Sponsor decision|35|||
156720962|NCT01408043|565723862|FG000|Overall Study|unable to collect cells|1|||
156720963|NCT00803790|565725747|FG000|Period 1|Adverse Event|0|||
156720964|NCT00803790|565725748|FG001|Period 1|Adverse Event|1|||
156720965|NCT00803790|565725749|FG002|Period 1|Adverse Event|0|||
156720966|NCT00803790|565725750|FG003|Period 1|Adverse Event|0|||
156875393|NCT04643158|566302042|FG003|Overall Study|Study terminated by sponsor|0|||
156875394|NCT04643158|566302043|FG004|Overall Study|Study terminated by sponsor|0|||
157134289|NCT01756456|567239891|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
157134290|NCT01756456|567239892|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
157134291|NCT01756456|567239893|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
157134292|NCT01756456|567239894|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
157134293|NCT01756456|567239895|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
157134294|NCT01756456|567239896|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
157134295|NCT01756456|567239891|FG000|Treatment Period: Phase I/II|Other causes|0|||
157134296|NCT01756456|567239892|FG001|Treatment Period: Phase I/II|Other causes|0|||
157134297|NCT01756456|567239893|FG002|Treatment Period: Phase I/II|Other causes|0|||
157134298|NCT01756456|567239894|FG003|Treatment Period: Phase I/II|Other causes|1|||
157134299|NCT01756456|567239895|FG004|Treatment Period: Phase I/II|Other causes|2|||
157134300|NCT01756456|567239896|FG005|Treatment Period: Phase I/II|Other causes|2|||
157134301|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
157134302|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
157134303|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
157134304|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
157134305|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
157134306|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
157134307|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
157134308|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
157134309|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
157134310|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
157134311|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
157134312|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
157134313|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
157134314|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
157134315|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
157134316|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
157134317|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
157134318|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
157134319|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
157134320|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
157134321|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
157134322|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
157134323|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
157134324|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
157134325|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
157134326|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
157134327|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
157134328|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
157134329|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
157134330|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
157134331|NCT01756456|567239891|FG000|Follow Up Period Phase I/II|Other causes|0|||
157134332|NCT01756456|567239892|FG001|Follow Up Period Phase I/II|Other causes|0|||
157134333|NCT01756456|567239893|FG002|Follow Up Period Phase I/II|Other causes|0|||
157134334|NCT01756456|567239894|FG003|Follow Up Period Phase I/II|Other causes|1|||
157134335|NCT01756456|567239895|FG004|Follow Up Period Phase I/II|Other causes|3|||
157134336|NCT01756456|567239896|FG005|Follow Up Period Phase I/II|Other causes|5|||
157134337|NCT02706938|567239897|FG000|First Period, 6 Weeks|Adverse Event|8|||
156720967|NCT00803790|565725747|FG000|Period 1|Lost to Follow-up|1|||
156720968|NCT00803790|565725748|FG001|Period 1|Lost to Follow-up|2|||
156720969|NCT00803790|565725749|FG002|Period 1|Lost to Follow-up|0|||
156720970|NCT00803790|565725750|FG003|Period 1|Lost to Follow-up|0|||
156720971|NCT00803790|565725747|FG000|Period 1|Withdrawal by Subject|8|||
157134338|NCT02706938|567239898|FG001|First Period, 6 Weeks|Adverse Event|0|||
157134339|NCT02706938|567239897|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
157134340|NCT02706938|567239898|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
157134341|NCT02706938|567239897|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
157217274|NCT01169844|567541071|FG000|Overall Study|Adverse Event|0|||
157134342|NCT02706938|567239898|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
157134343|NCT02706938|567239897|FG000|Second Period, 6 Weeks|Adverse Event|0|||
157134344|NCT02706938|567239898|FG001|Second Period, 6 Weeks|Adverse Event|7|||
157134345|NCT02706938|567239897|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
157134346|NCT02706938|567239898|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
157134347|NCT03838484|567239899|FG000|Overall Study|Lost to Follow-up|0|||
157134348|NCT03838484|567239900|FG001|Overall Study|Lost to Follow-up|1|||
157134349|NCT03838484|567239901|FG002|Overall Study|Lost to Follow-up|0|||
157134350|NCT03838484|567239902|FG003|Overall Study|Lost to Follow-up|0|||
157134351|NCT02507349|567239903|FG000|Overall Study|Death|12|||
157134352|NCT02507349|567239904|FG001|Overall Study|Death|16|||
157134353|NCT02507349|567239903|FG000|Overall Study|Withdrawal by Subject|1|||
157134354|NCT02507349|567239904|FG001|Overall Study|Withdrawal by Subject|1|||
156720972|NCT00803790|565725748|FG001|Period 1|Withdrawal by Subject|6|||
156720973|NCT00803790|565725749|FG002|Period 1|Withdrawal by Subject|0|||
157134355|NCT02507349|567239903|FG000|Overall Study|Lost to Follow-up|174|||
157134356|NCT02507349|567239904|FG001|Overall Study|Lost to Follow-up|144|||
157134357|NCT00813995|567239905|FG000|Overall Study|Clinical adverse event|9|||
157134358|NCT00813995|567239906|FG001|Overall Study|Clinical adverse event|3|||
157134359|NCT00813995|567239905|FG000|Overall Study|Laboratory adverse event|0|||
157134360|NCT00813995|567239906|FG001|Overall Study|Laboratory adverse event|2|||
157134361|NCT00813995|567239905|FG000|Overall Study|Lack of Efficacy|1|||
157134362|NCT00813995|567239906|FG001|Overall Study|Lack of Efficacy|0|||
157134363|NCT00813995|567239905|FG000|Overall Study|Lost to Follow-up|4|||
157134364|NCT00813995|567239906|FG001|Overall Study|Lost to Follow-up|2|||
157134365|NCT00813995|567239905|FG000|Overall Study|Other reason|2|||
157134366|NCT00813995|567239906|FG001|Overall Study|Other reason|2|||
157134367|NCT00813995|567239905|FG000|Overall Study|Protocol Violation|3|||
157134368|NCT00813995|567239906|FG001|Overall Study|Protocol Violation|2|||
157134369|NCT00813995|567239905|FG000|Overall Study|Subject moved|4|||
157134370|NCT00813995|567239906|FG001|Overall Study|Subject moved|0|||
156720974|NCT00803790|565725750|FG003|Period 1|Withdrawal by Subject|0|||
156720975|NCT00803790|565725747|FG000|Period 1|positive drug screen or personal reasons|0|||
156720976|NCT00803790|565725748|FG001|Period 1|positive drug screen or personal reasons|3|||
156720977|NCT00803790|565725749|FG002|Period 1|positive drug screen or personal reasons|0|||
156720978|NCT00803790|565725750|FG003|Period 1|positive drug screen or personal reasons|4|||
156720979|NCT00803790|565725747|FG000|Period 1|Protocol Violation|0|||
156720980|NCT00803790|565725748|FG001|Period 1|Protocol Violation|0|||
156720981|NCT00803790|565725749|FG002|Period 1|Protocol Violation|1|||
156720982|NCT00803790|565725750|FG003|Period 1|Protocol Violation|0|||
156720983|NCT00803790|565725747|FG000|Period 2|Adverse Event|0|||
156720984|NCT00803790|565725748|FG001|Period 2|Adverse Event|0|||
156720985|NCT00803790|565725749|FG002|Period 2|Adverse Event|1|||
156720986|NCT00803790|565725750|FG003|Period 2|Adverse Event|1|||
156720987|NCT00803790|565725747|FG000|Period 2|Withdrawal by Subject|1|||
156720988|NCT00803790|565725748|FG001|Period 2|Withdrawal by Subject|0|||
156720989|NCT00803790|565725749|FG002|Period 2|Withdrawal by Subject|0|||
156720990|NCT00803790|565725750|FG003|Period 2|Withdrawal by Subject|0|||
156720991|NCT00803790|565725747|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
157134371|NCT00813995|567239905|FG000|Overall Study|Withdrawal by Subject|0|||
157134372|NCT00813995|567239906|FG001|Overall Study|Withdrawal by Subject|5|||
156720992|NCT00803790|565725748|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720993|NCT00803790|565725749|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720994|NCT00803790|565725750|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
156720995|NCT04710576|565725751|FG000|Overall Study|Participants still in the study|73|||
156720996|NCT04710576|565725752|FG001|Overall Study|Participants still in the study|70|||
156720997|NCT04710576|565725753|FG002|Overall Study|Participants still in the study|60|||
156720998|NCT04710576|565725751|FG000|Overall Study|Death|2|||
157134373|NCT01614964|567239907|FG000|Overall Study|Withdrawal by Subject|2|||
157134374|NCT01614964|567239908|FG001|Overall Study|Withdrawal by Subject|0|||
156720999|NCT04710576|565725752|FG001|Overall Study|Death|7|||
157134375|NCT01614964|567239907|FG000|Overall Study|Lost to Follow-up|3|||
156721000|NCT04710576|565725753|FG002|Overall Study|Death|12|||
156721001|NCT04710576|565725751|FG000|Overall Study|Withdrawal by Subject|4|||
157134376|NCT01614964|567239908|FG001|Overall Study|Lost to Follow-up|0|||
156721002|NCT04710576|565725752|FG001|Overall Study|Withdrawal by Subject|3|||
156721003|NCT04710576|565725753|FG002|Overall Study|Withdrawal by Subject|7|||
156721004|NCT04710576|565725751|FG000|Overall Study|Sponsor decision|1|||
157134377|NCT00860470|567239917|FG000|Overall Study|Death|6|||
156721005|NCT04710576|565725752|FG001|Overall Study|Sponsor decision|0|||
156721006|NCT04710576|565725753|FG002|Overall Study|Sponsor decision|0|||
156794053|NCT03715829|565999502|FG009|Extension Period|Adverse Event|0|||
156794054|NCT03715829|565999503|FG010|Extension Period|Adverse Event|0|||
156794055|NCT03715829|565999493|FG000|Extension Period|Lack of Efficacy|0|||
156794056|NCT03715829|565999494|FG001|Extension Period|Lack of Efficacy|0|||
156794057|NCT03715829|565999495|FG002|Extension Period|Lack of Efficacy|0|||
157134378|NCT00860470|567239918|FG001|Overall Study|Death|10|||
157134379|NCT00860470|567239917|FG000|Overall Study|Moved away|8|||
157134380|NCT00860470|567239918|FG001|Overall Study|Moved away|10|||
156721007|NCT04162847|565725754|FG000|Overall Study|Withdrawal by Subject|7|||
156721008|NCT04162847|565725755|FG001|Overall Study|Withdrawal by Subject|1|||
156721009|NCT02068508|565725758|FG000|Overall Study|Case report forms uncollected|27|||
156721010|NCT02068508|565725758|FG000|Overall Study|Patient did not visit the study site|1|||
156721011|NCT02068508|565725758|FG000|Overall Study|Protocol Violation|4|||
156721012|NCT01217112|565725759|FG000|Overall Study|Adverse Event|0|||
156721013|NCT01217112|565725760|FG001|Overall Study|Adverse Event|2|||
156721014|NCT01217112|565725761|FG002|Overall Study|Adverse Event|0|||
156721015|NCT01217112|565725762|FG003|Overall Study|Adverse Event|2|||
156721016|NCT01217112|565725763|FG004|Overall Study|Adverse Event|0|||
156721017|NCT01217112|565725759|FG000|Overall Study|Withdrawal by Subject|0|||
156721018|NCT01217112|565725760|FG001|Overall Study|Withdrawal by Subject|0|||
156721019|NCT01217112|565725761|FG002|Overall Study|Withdrawal by Subject|1|||
156721020|NCT01217112|565725762|FG003|Overall Study|Withdrawal by Subject|0|||
156721021|NCT01217112|565725763|FG004|Overall Study|Withdrawal by Subject|0|||
156721022|NCT01217112|565725759|FG000|Overall Study|Physician Decision|0|||
156721023|NCT01217112|565725760|FG001|Overall Study|Physician Decision|0|||
156721024|NCT01217112|565725761|FG002|Overall Study|Physician Decision|0|||
156721025|NCT01217112|565725762|FG003|Overall Study|Physician Decision|0|||
156721026|NCT01217112|565725763|FG004|Overall Study|Physician Decision|1|||
156721027|NCT01401361|565725764|FG000|Overall Study|Withdrawal by Subject|16|||
156721028|NCT01401361|565725764|FG000|Overall Study|Lack of Efficacy|6|||
156721029|NCT01401361|565725764|FG000|Overall Study|Physician Decision|1|||
156721030|NCT01401361|565725764|FG000|Overall Study|Lost to Follow-up|3|||
156721031|NCT01401361|565725764|FG000|Overall Study|Subject/family decision post procedure|2|||
156721032|NCT02764762|565725767|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156721033|NCT02764762|565725767|FG000|Overall Study|Lost to Follow-up|4|||
156721034|NCT02764762|565725767|FG000|Overall Study|Voluntary Withdrawal|8|||
156721035|NCT02764762|565725767|FG000|Overall Study|Site Termination|1|||
156721036|NCT02764762|565725767|FG000|Overall Study|Lack of Efficacy|16|||
156794058|NCT03715829|565999496|FG003|Extension Period|Lack of Efficacy|0|||
156794059|NCT03715829|565999497|FG004|Extension Period|Lack of Efficacy|0|||
156794060|NCT03715829|565999498|FG005|Extension Period|Lack of Efficacy|0|||
156794061|NCT03715829|565999499|FG006|Extension Period|Lack of Efficacy|1|||
156794062|NCT03715829|565999500|FG007|Extension Period|Lack of Efficacy|9|||
156794063|NCT03715829|565999501|FG008|Extension Period|Lack of Efficacy|2|||
157018800|NCT02506959|566822912|FG001|Overall Study|Physician Decision|1|||
157018801|NCT01566695|566822913|FG000|Overall Study|Lack of Efficacy|1|||
157018802|NCT01566695|566822914|FG001|Overall Study|Lack of Efficacy|0|||
157018803|NCT01566695|566822913|FG000|Overall Study|Adverse Event|3|||
157018804|NCT01566695|566822914|FG001|Overall Study|Adverse Event|0|||
157018805|NCT01566695|566822913|FG000|Overall Study|Death|79|||
157018806|NCT01566695|566822914|FG001|Overall Study|Death|86|||
157018807|NCT01566695|566822913|FG000|Overall Study|Withdrawal by Subject|13|||
157018808|NCT01566695|566822914|FG001|Overall Study|Withdrawal by Subject|12|||
157018809|NCT01566695|566822913|FG000|Overall Study|Lost to Follow-up|0|||
157018810|NCT01566695|566822914|FG001|Overall Study|Lost to Follow-up|3|||
157018811|NCT01566695|566822913|FG000|Overall Study|Other reasons|11|||
157018812|NCT01566695|566822914|FG001|Overall Study|Other reasons|8|||
157018813|NCT05470400|566822915|FG000|Overall Study|Lost to Follow-up|0|||
157018814|NCT05470400|566822916|FG001|Overall Study|Lost to Follow-up|0|||
157018815|NCT05470400|566822917|FG002|Overall Study|Lost to Follow-up|0|||
157018816|NCT05470400|566822918|FG003|Overall Study|Lost to Follow-up|0|||
157018817|NCT05470400|566822919|FG004|Overall Study|Lost to Follow-up|0|||
157018818|NCT05470400|566822920|FG005|Overall Study|Lost to Follow-up|0|||
157018819|NCT05470400|566822921|FG006|Overall Study|Lost to Follow-up|0|||
157018820|NCT05470400|566822922|FG007|Overall Study|Lost to Follow-up|1|||
157018821|NCT05470400|566822915|FG000|Overall Study|Withdrawal by Subject|1|||
157018822|NCT05470400|566822916|FG001|Overall Study|Withdrawal by Subject|0|||
157018823|NCT05470400|566822917|FG002|Overall Study|Withdrawal by Subject|0|||
156721037|NCT02764762|565725767|FG000|Overall Study|Reason not Specified|1|||
156721038|NCT00471081|565725771|FG000|Active Phase|Protocol Violation|1|||
156721039|NCT00471081|565725772|FG001|Active Phase|Protocol Violation|1|||
156721040|NCT00471081|565725771|FG000|Active Phase|Withdrawal by Subject|0|||
156721041|NCT00471081|565725772|FG001|Active Phase|Withdrawal by Subject|3|||
156721042|NCT00471081|565725771|FG000|Active Phase|Lost to Follow-up|0|||
156721043|NCT00471081|565725772|FG001|Active Phase|Lost to Follow-up|1|||
156721044|NCT00471081|565725771|FG000|Active Phase|Lost health plan/insurance|1|||
156721045|NCT00471081|565725772|FG001|Active Phase|Lost health plan/insurance|8|||
156794064|NCT03715829|565999502|FG009|Extension Period|Lack of Efficacy|0|||
157018824|NCT05470400|566822918|FG003|Overall Study|Withdrawal by Subject|0|||
156721046|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
156721047|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
156721048|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
156721049|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
157018825|NCT05470400|566822919|FG004|Overall Study|Withdrawal by Subject|0|||
157018826|NCT05470400|566822920|FG005|Overall Study|Withdrawal by Subject|1|||
157018827|NCT05470400|566822921|FG006|Overall Study|Withdrawal by Subject|0|||
157018828|NCT05470400|566822922|FG007|Overall Study|Withdrawal by Subject|2|||
157018829|NCT05323084|566822924|FG000|Period 2 - Washout|Lost to Follow-up|0|||
157018830|NCT05323084|566822925|FG001|Period 2 - Washout|Lost to Follow-up|1|||
157018831|NCT04294225|566822926|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
157018832|NCT04294225|566822926|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
157018833|NCT04294225|566822926|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
157018834|NCT04294225|566822926|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
157018835|NCT04294225|566822926|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
157018836|NCT05592418|566822928|FG000|Overall Study|Adverse Event|1|||
157018837|NCT05592418|566822929|FG001|Overall Study|Adverse Event|0|||
157018838|NCT05592418|566822928|FG000|Overall Study|Lost to Follow-up|1|||
157018839|NCT05592418|566822929|FG001|Overall Study|Lost to Follow-up|3|||
157018840|NCT05592418|566822928|FG000|Overall Study|Withdrawal by Subject|2|||
157018841|NCT05592418|566822929|FG001|Overall Study|Withdrawal by Subject|7|||
157018842|NCT01494662|566822932|FG000|Overall Study|Withdrawal by Subject|0|||
157018843|NCT01494662|566822933|FG001|Overall Study|Withdrawal by Subject|0|||
157018844|NCT01494662|566822934|FG002|Overall Study|Withdrawal by Subject|1|||
157018845|NCT01494662|566822935|FG003|Overall Study|Withdrawal by Subject|0|||
157018846|NCT01494662|566822936|FG004|Overall Study|Withdrawal by Subject|0|||
157018847|NCT01494662|566822937|FG005|Overall Study|Withdrawal by Subject|0|||
157018848|NCT01494662|566822938|FG006|Overall Study|Withdrawal by Subject|0|||
157018849|NCT01494662|566822932|FG000|Overall Study|Physician Decision|0|||
157018850|NCT01494662|566822933|FG001|Overall Study|Physician Decision|0|||
157018851|NCT01494662|566822934|FG002|Overall Study|Physician Decision|1|||
157018852|NCT01494662|566822935|FG003|Overall Study|Physician Decision|0|||
157018853|NCT01494662|566822936|FG004|Overall Study|Physician Decision|0|||
157018854|NCT01494662|566822937|FG005|Overall Study|Physician Decision|0|||
157018855|NCT01494662|566822938|FG006|Overall Study|Physician Decision|0|||
157018856|NCT04072822|566822939|FG000|Treatment|Adverse Event|9|||
157018857|NCT04072822|566822940|FG001|Treatment|Adverse Event|5|||
157018858|NCT04072822|566822939|FG000|Treatment|Met Stopping Criteria|13|||
157018859|NCT04072822|566822940|FG001|Treatment|Met Stopping Criteria|24|||
157018860|NCT04072822|566822939|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
157018861|NCT04072822|566822940|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
157018862|NCT04072822|566822939|FG000|Treatment|Withdrawal by Subject|0|||
157018863|NCT04072822|566822940|FG001|Treatment|Withdrawal by Subject|2|||
157018864|NCT04072822|566822939|FG000|Treatment|Death|0|||
157018865|NCT04072822|566822940|FG001|Treatment|Death|2|||
157018866|NCT04072822|566822939|FG000|Treatment|Lost to Follow-up|11|||
157018867|NCT04072822|566822940|FG001|Treatment|Lost to Follow-up|3|||
157018868|NCT04072822|566822939|FG000|Treatment|Physician Decision|1|||
157018869|NCT04072822|566822940|FG001|Treatment|Physician Decision|0|||
157018870|NCT04072822|566822939|FG000|Treatment|Other|7|||
157018871|NCT04072822|566822940|FG001|Treatment|Other|9|||
157018872|NCT04072822|566822939|FG000|Follow-up|Withdrawal by Subject|1|||
157018873|NCT04072822|566822940|FG001|Follow-up|Withdrawal by Subject|0|||
157018874|NCT04072822|566822939|FG000|Follow-up|Lost to Follow-up|5|||
157018875|NCT04072822|566822940|FG001|Follow-up|Lost to Follow-up|4|||
157018876|NCT05481320|566822943|FG000|Overall Study|Withdrawal by Subject|1|||
157018877|NCT05481320|566822944|FG001|Overall Study|Withdrawal by Subject|1|||
157018878|NCT05481320|566822943|FG000|Overall Study|Care recipent passed away|0|||
157018879|NCT05481320|566822944|FG001|Overall Study|Care recipent passed away|1|||
157018880|NCT05481320|566822943|FG000|Overall Study|Out-of-window assessment|0|||
157018881|NCT05481320|566822944|FG001|Overall Study|Out-of-window assessment|1|||
157018882|NCT05481320|566822943|FG000|Overall Study|No longer a primary caregiver|3|||
157018883|NCT05481320|566822944|FG001|Overall Study|No longer a primary caregiver|0|||
156794065|NCT03715829|565999503|FG010|Extension Period|Lack of Efficacy|0|||
156794066|NCT03715829|565999493|FG000|Extension Period|Lost to Follow-up|0|||
156794067|NCT03715829|565999494|FG001|Extension Period|Lost to Follow-up|0|||
156794068|NCT03715829|565999495|FG002|Extension Period|Lost to Follow-up|0|||
156794069|NCT03715829|565999496|FG003|Extension Period|Lost to Follow-up|0|||
156794070|NCT03715829|565999497|FG004|Extension Period|Lost to Follow-up|0|||
156794071|NCT03715829|565999498|FG005|Extension Period|Lost to Follow-up|0|||
157018884|NCT05481320|566822943|FG000|Overall Study|Unable to contact|1|||
156794072|NCT03715829|565999499|FG006|Extension Period|Lost to Follow-up|0|||
157018885|NCT05481320|566822944|FG001|Overall Study|Unable to contact|0|||
157018886|NCT04314895|566822948|FG000|Overall Study|Lost to Follow-up|1|||
157018887|NCT04314895|566822948|FG000|Overall Study|Death|10|||
157018888|NCT04314895|566822948|FG000|Overall Study|Physician Decision|2|||
157018889|NCT03930342|566822952|FG000|Overall Study|Lost to Follow-up|70|||
156794073|NCT03715829|565999500|FG007|Extension Period|Lost to Follow-up|0|||
156794074|NCT03715829|565999501|FG008|Extension Period|Lost to Follow-up|2|||
157018890|NCT03930342|566822953|FG001|Overall Study|Lost to Follow-up|77|||
157018891|NCT02596126|566822954|FG000|Overall Study|Lost to Follow-up|12|||
157018892|NCT02596126|566822955|FG001|Overall Study|Lost to Follow-up|21|||
157018893|NCT02596126|566822954|FG000|Overall Study|Protocol Violation|7|||
157018894|NCT02596126|566822955|FG001|Overall Study|Protocol Violation|9|||
157018895|NCT04774237|566822960|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
157018896|NCT04774237|566822961|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
157018897|NCT04774237|566822962|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
157018898|NCT04774237|566822963|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
157018899|NCT04774237|566822964|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
157018900|NCT04774237|566822965|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
157018901|NCT05792423|566822966|FG000|Overall Study|Withdrawal by Subject|2|||
157018902|NCT02682316|566824644|FG000|Overall Study|Benign Final Pathology|27|||
157018903|NCT02682316|566824645|FG001|Overall Study|Benign Final Pathology|26|||
157018904|NCT02682316|566824644|FG000|Overall Study|Reoperation before 30 days|7|||
157018905|NCT02682316|566824645|FG001|Overall Study|Reoperation before 30 days|6|||
157018906|NCT02682316|566824644|FG000|Overall Study|Ineligible|1|||
157018907|NCT02682316|566824645|FG001|Overall Study|Ineligible|0|||
157018908|NCT02682316|566824644|FG000|Overall Study|Death|1|||
157018909|NCT02682316|566824645|FG001|Overall Study|Death|0|||
157018910|NCT02682316|566824644|FG000|Overall Study|Lost to Follow-up|7|||
157018911|NCT02682316|566824645|FG001|Overall Study|Lost to Follow-up|3|||
157018912|NCT03101904|566824646|FG000|Wash Out (10 Days)|Adverse Event|1|||
157018913|NCT03101904|566824647|FG001|Wash Out (10 Days)|Adverse Event|0|||
157018914|NCT03101904|566824646|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
157018915|NCT03101904|566824647|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
157018916|NCT04538417|566824648|FG000|Overall Study|Withdrawal by Subject|2|||
157018917|NCT06311084|566824650|FG000|Overall Study|Lost to Follow-up|14|||
157018918|NCT01140880|566824658|FG000|Overall Study|Death|0|||
157018919|NCT01140880|566824659|FG001|Overall Study|Death|1|||
157018920|NCT01140880|566824658|FG000|Overall Study|Withdrawal by Subject|6|||
157018921|NCT01140880|566824659|FG001|Overall Study|Withdrawal by Subject|3|||
157018922|NCT01140880|566824658|FG000|Overall Study|Lost to Follow-up|8|||
157018923|NCT01140880|566824659|FG001|Overall Study|Lost to Follow-up|10|||
157018924|NCT01140880|566824658|FG000|Overall Study|Protocol Violation|0|||
157018925|NCT01140880|566824659|FG001|Overall Study|Protocol Violation|30|||
157018926|NCT04421378|566824660|FG000|Overall Study|Adverse Event|2|||
157018927|NCT04421378|566824661|FG001|Overall Study|Adverse Event|7|||
157018928|NCT04421378|566824662|FG002|Overall Study|Adverse Event|0|||
157018929|NCT04421378|566824663|FG003|Overall Study|Adverse Event|1|||
157018930|NCT04421378|566824664|FG004|Overall Study|Adverse Event|0|||
157018931|NCT04421378|566824660|FG000|Overall Study|Physician Decision|1|||
157018932|NCT04421378|566824661|FG001|Overall Study|Physician Decision|2|||
157018933|NCT04421378|566824662|FG002|Overall Study|Physician Decision|0|||
157018934|NCT04421378|566824663|FG003|Overall Study|Physician Decision|0|||
157018935|NCT04421378|566824664|FG004|Overall Study|Physician Decision|0|||
157018936|NCT04421378|566824660|FG000|Overall Study|Progressive Disease|16|||
157018937|NCT04421378|566824661|FG001|Overall Study|Progressive Disease|4|||
157018938|NCT04421378|566824662|FG002|Overall Study|Progressive Disease|18|||
157018939|NCT04421378|566824663|FG003|Overall Study|Progressive Disease|11|||
157018940|NCT04421378|566824664|FG004|Overall Study|Progressive Disease|3|||
157018941|NCT04421378|566824660|FG000|Overall Study|Study Terminated by Sponsor|0|||
157018942|NCT04421378|566824661|FG001|Overall Study|Study Terminated by Sponsor|1|||
157018943|NCT04421378|566824662|FG002|Overall Study|Study Terminated by Sponsor|1|||
157018944|NCT04421378|566824663|FG003|Overall Study|Study Terminated by Sponsor|0|||
157018945|NCT04421378|566824664|FG004|Overall Study|Study Terminated by Sponsor|0|||
157018946|NCT04421378|566824660|FG000|Overall Study|Withdrawal by Subject|3|||
157018947|NCT04421378|566824661|FG001|Overall Study|Withdrawal by Subject|1|||
157018948|NCT04421378|566824662|FG002|Overall Study|Withdrawal by Subject|0|||
157018949|NCT04421378|566824663|FG003|Overall Study|Withdrawal by Subject|2|||
157018950|NCT04421378|566824664|FG004|Overall Study|Withdrawal by Subject|0|||
157217275|NCT01169844|567541072|FG001|Overall Study|Adverse Event|1|||
157217276|NCT01169844|567541071|FG000|Overall Study|Patient withdrew consent|4|||
156794075|NCT03715829|565999502|FG009|Extension Period|Lost to Follow-up|0|||
156794076|NCT03715829|565999503|FG010|Extension Period|Lost to Follow-up|0|||
156794077|NCT03715829|565999493|FG000|Extension Period|Protocol Violation|0|||
156794078|NCT03715829|565999494|FG001|Extension Period|Protocol Violation|0|||
156794079|NCT03715829|565999495|FG002|Extension Period|Protocol Violation|0|||
157217277|NCT01169844|567541072|FG001|Overall Study|Patient withdrew consent|0|||
156794080|NCT03715829|565999496|FG003|Extension Period|Protocol Violation|0|||
156794081|NCT03715829|565999497|FG004|Extension Period|Protocol Violation|0|||
156794082|NCT03715829|565999498|FG005|Extension Period|Protocol Violation|0|||
156794083|NCT03715829|565999499|FG006|Extension Period|Protocol Violation|0|||
156794084|NCT03715829|565999500|FG007|Extension Period|Protocol Violation|0|||
157018951|NCT04421378|566824660|FG000|Overall Study|Other|1|||
157018952|NCT04421378|566824661|FG001|Overall Study|Other|0|||
157018953|NCT04421378|566824662|FG002|Overall Study|Other|0|||
157018954|NCT04421378|566824663|FG003|Overall Study|Other|0|||
157018955|NCT04421378|566824664|FG004|Overall Study|Other|0|||
157018956|NCT04258709|566824665|FG000|Overall Study|Lost to Follow-up|10|||
157018957|NCT04258709|566824666|FG001|Overall Study|Lost to Follow-up|4|||
157018958|NCT04258709|566824665|FG000|Overall Study|Withdrawal by Subject|1|||
157018959|NCT04258709|566824666|FG001|Overall Study|Withdrawal by Subject|0|||
157018960|NCT04258709|566824665|FG000|Overall Study|Fetal demise|0|||
157221656|NCT00094302|567558466|FG001|Overall Study|Death|246|||
156721050|NCT00471081|565725771|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
156721051|NCT00471081|565725772|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
156721052|NCT02844933|565725773|FG000|Overall Study|Discontinued due to premature termination of study|3|||
156721053|NCT02844933|565725774|FG001|Overall Study|Discontinued due to premature termination of study|2|||
156721054|NCT01479465|565725775|FG000|Overall Study|Disease Progression|9|||
156721055|NCT01479465|565725776|FG001|Overall Study|Disease Progression|61|||
156721056|NCT01479465|565725777|FG002|Overall Study|Disease Progression|65|||
156721057|NCT01479465|565725778|FG003|Overall Study|Disease Progression|70|||
156721058|NCT01479465|565725775|FG000|Overall Study|Study Discontinued by Sponsor|0|||
156721059|NCT01479465|565725776|FG001|Overall Study|Study Discontinued by Sponsor|7|||
156721060|NCT01479465|565725777|FG002|Overall Study|Study Discontinued by Sponsor|5|||
156721061|NCT01479465|565725778|FG003|Overall Study|Study Discontinued by Sponsor|3|||
156721062|NCT01479465|565725775|FG000|Overall Study|Adverse Event|0|||
156721063|NCT01479465|565725776|FG001|Overall Study|Adverse Event|3|||
156721064|NCT01479465|565725777|FG002|Overall Study|Adverse Event|6|||
156721065|NCT01479465|565725778|FG003|Overall Study|Adverse Event|4|||
156721066|NCT01479465|565725775|FG000|Overall Study|Investigator Discretion|1|||
156721067|NCT01479465|565725776|FG001|Overall Study|Investigator Discretion|4|||
156721068|NCT01479465|565725777|FG002|Overall Study|Investigator Discretion|2|||
156721069|NCT01479465|565725778|FG003|Overall Study|Investigator Discretion|4|||
156721070|NCT01479465|565725775|FG000|Overall Study|Subject Request|1|||
156721071|NCT01479465|565725776|FG001|Overall Study|Subject Request|3|||
156721072|NCT01479465|565725777|FG002|Overall Study|Subject Request|4|||
156721073|NCT01479465|565725778|FG003|Overall Study|Subject Request|2|||
156721074|NCT01479465|565725775|FG000|Overall Study|Subject Withdrew Consent|0|||
156721075|NCT01479465|565725776|FG001|Overall Study|Subject Withdrew Consent|5|||
156721076|NCT01479465|565725777|FG002|Overall Study|Subject Withdrew Consent|2|||
156721077|NCT01479465|565725778|FG003|Overall Study|Subject Withdrew Consent|1|||
156721078|NCT01479465|565725775|FG000|Overall Study|Protocol Violation|0|||
156721079|NCT01479465|565725776|FG001|Overall Study|Protocol Violation|1|||
156721080|NCT01479465|565725777|FG002|Overall Study|Protocol Violation|1|||
156721081|NCT01479465|565725778|FG003|Overall Study|Protocol Violation|0|||
156721082|NCT01479465|565725775|FG000|Overall Study|Death|0|||
156721083|NCT01479465|565725776|FG001|Overall Study|Death|0|||
156721084|NCT01479465|565725777|FG002|Overall Study|Death|0|||
156721085|NCT01479465|565725778|FG003|Overall Study|Death|1|||
156721086|NCT01479465|565725775|FG000|Overall Study|Lost to Follow-up|0|||
156721087|NCT01479465|565725776|FG001|Overall Study|Lost to Follow-up|0|||
156721088|NCT01479465|565725777|FG002|Overall Study|Lost to Follow-up|1|||
156721089|NCT01479465|565725778|FG003|Overall Study|Lost to Follow-up|0|||
156721090|NCT01892501|565725779|FG000|Overall Study|Protocol Violation|2|||
156721091|NCT01892501|565725779|FG000|Overall Study|Puncture not carried out|9|||
156721092|NCT01892501|565725779|FG000|Overall Study|Radiological monitoring not carried out|5|||
156875395|NCT04643158|566302044|FG005|Overall Study|Study terminated by sponsor|1|||
156875396|NCT04643158|566302045|FG006|Overall Study|Study terminated by sponsor|0|||
156875397|NCT04643158|566302039|FG000|Overall Study|Global/country situation|0|||
156875398|NCT04643158|566302040|FG001|Overall Study|Global/country situation|0|||
156875399|NCT04643158|566302041|FG002|Overall Study|Global/country situation|1|||
156875400|NCT04643158|566302042|FG003|Overall Study|Global/country situation|0|||
156875401|NCT04643158|566302043|FG004|Overall Study|Global/country situation|0|||
156875402|NCT04643158|566302044|FG005|Overall Study|Global/country situation|0|||
156875403|NCT04643158|566302045|FG006|Overall Study|Global/country situation|0|||
156875404|NCT04643158|566302039|FG000|Overall Study|Withdrawal by Subject|0|||
156875405|NCT04643158|566302040|FG001|Overall Study|Withdrawal by Subject|0|||
156875406|NCT04643158|566302041|FG002|Overall Study|Withdrawal by Subject|0|||
156875407|NCT04643158|566302042|FG003|Overall Study|Withdrawal by Subject|0|||
156875408|NCT04643158|566302043|FG004|Overall Study|Withdrawal by Subject|0|||
156875409|NCT04643158|566302044|FG005|Overall Study|Withdrawal by Subject|1|||
156875410|NCT04643158|566302045|FG006|Overall Study|Withdrawal by Subject|0|||
156875411|NCT04329806|566302046|FG000|Overall Study|Physician Decision|3|||
156875412|NCT04329806|566302047|FG001|Overall Study|Physician Decision|4|||
156875413|NCT00622440|566302060|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
156721093|NCT01892501|565725779|FG000|Overall Study|Non-contributory histological result|12|||
156721094|NCT02393950|565725787|FG000|Overall Study|Adverse Event|1|||
156721095|NCT02393950|565725788|FG001|Overall Study|Adverse Event|0|||
156721096|NCT02393950|565725787|FG000|Overall Study|Withdrawal by Subject|0|||
156875414|NCT00622440|566302061|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
156875415|NCT00622440|566302060|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
156875416|NCT00622440|566302061|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
156721097|NCT02393950|565725788|FG001|Overall Study|Withdrawal by Subject|1|||
156721098|NCT04335123|565725789|FG000|Overall Study|Withdrawal by Subject|2|||
156721099|NCT04335123|565725790|FG001|Overall Study|Withdrawal by Subject|0|||
156721100|NCT04335123|565725789|FG000|Overall Study|Physician Decision|2|||
156721101|NCT04335123|565725790|FG001|Overall Study|Physician Decision|0|||
156721102|NCT05486091|565725791|FG000|Overall Study|Withdrawal by Subject|1|||
156721103|NCT05486091|565725791|FG000|Overall Study|Lost to Follow-up|2|||
157134381|NCT00860470|567239917|FG000|Overall Study|Lost to Follow-up|34|||
157134382|NCT00860470|567239918|FG001|Overall Study|Lost to Follow-up|39|||
157134383|NCT00888238|567239920|FG000|Washout Period After Period 2|Adverse Event|0|||
157134384|NCT00888238|567239921|FG001|Washout Period After Period 2|Adverse Event|0|||
157134385|NCT00888238|567239922|FG002|Washout Period After Period 2|Adverse Event|1|||
156721104|NCT00370552|565725792|FG000|Overall Study|Adverse Event|2|||
156721105|NCT00370552|565725793|FG001|Overall Study|Adverse Event|2|||
156721106|NCT00370552|565725794|FG002|Overall Study|Adverse Event|2|||
156721107|NCT00370552|565725792|FG000|Overall Study|Disease progression|23|||
156721108|NCT00370552|565725793|FG001|Overall Study|Disease progression|23|||
156721109|NCT00370552|565725794|FG002|Overall Study|Disease progression|15|||
156721110|NCT00370552|565725792|FG000|Overall Study|Maximum clinical benefit|3|||
156721111|NCT00370552|565725793|FG001|Overall Study|Maximum clinical benefit|5|||
156721112|NCT00370552|565725794|FG002|Overall Study|Maximum clinical benefit|5|||
156721113|NCT00370552|565725792|FG000|Overall Study|Poor or noncompliance|0|||
156721114|NCT00370552|565725793|FG001|Overall Study|Poor or noncompliance|0|||
156721115|NCT00370552|565725794|FG002|Overall Study|Poor or noncompliance|1|||
156721116|NCT00370552|565725792|FG000|Overall Study|Study drug toxicity|11|||
156721117|NCT00370552|565725793|FG001|Overall Study|Study drug toxicity|8|||
156721118|NCT00370552|565725794|FG002|Overall Study|Study drug toxicity|6|||
156721119|NCT00370552|565725792|FG000|Overall Study|Withdrawal by Subject|2|||
156721120|NCT00370552|565725793|FG001|Overall Study|Withdrawal by Subject|0|||
156721121|NCT00370552|565725794|FG002|Overall Study|Withdrawal by Subject|1|||
156721122|NCT00370552|565725792|FG000|Overall Study|Still on treatment|1|||
156721123|NCT00370552|565725793|FG001|Overall Study|Still on treatment|3|||
156721124|NCT00370552|565725794|FG002|Overall Study|Still on treatment|2|||
156721125|NCT00370552|565725792|FG000|Overall Study|Never treated|1|||
156721126|NCT00370552|565725793|FG001|Overall Study|Never treated|0|||
156721127|NCT00370552|565725794|FG002|Overall Study|Never treated|0|||
156721128|NCT00370552|565725792|FG000|Overall Study|Physician Decision|1|||
156721129|NCT00370552|565725793|FG001|Overall Study|Physician Decision|1|||
156721130|NCT00370552|565725794|FG002|Overall Study|Physician Decision|0|||
156721131|NCT00370552|565725792|FG000|Overall Study|Investigator decision|2|||
156721132|NCT00370552|565725793|FG001|Overall Study|Investigator decision|1|||
156721133|NCT00370552|565725794|FG002|Overall Study|Investigator decision|0|||
156721134|NCT00370552|565725792|FG000|Overall Study|High risk of allergic reaction|0|||
156721135|NCT00370552|565725793|FG001|Overall Study|High risk of allergic reaction|1|||
156721136|NCT00370552|565725794|FG002|Overall Study|High risk of allergic reaction|0|||
156794085|NCT03715829|565999501|FG008|Extension Period|Protocol Violation|1|||
156794086|NCT03715829|565999502|FG009|Extension Period|Protocol Violation|0|||
157134386|NCT02700984|567239923|FG000|Overall Study|Death|2|||
156794087|NCT03715829|565999503|FG010|Extension Period|Protocol Violation|0|||
157134387|NCT02700984|567239924|FG001|Overall Study|Death|1|||
157134388|NCT02700984|567239923|FG000|Overall Study|Lost to Follow-up|2|||
157134389|NCT02700984|567239924|FG001|Overall Study|Lost to Follow-up|1|||
157134390|NCT02700984|567239923|FG000|Overall Study|Physician Decision|0|||
157134391|NCT02700984|567239924|FG001|Overall Study|Physician Decision|1|||
157134392|NCT02700984|567239923|FG000|Overall Study|Withdrawal by Subject|8|||
157134393|NCT02700984|567239924|FG001|Overall Study|Withdrawal by Subject|9|||
157134394|NCT02700984|567239923|FG000|Overall Study|Reason not specified|3|||
157134395|NCT02700984|567239924|FG001|Overall Study|Reason not specified|2|||
157134396|NCT01032629|567239925|FG000|Overall Study|Closed Site|21|||
157134397|NCT01032629|567239926|FG001|Overall Study|Closed Site|18|||
157134398|NCT01032629|567239927|FG002|Overall Study|Closed Site|16|||
157134399|NCT01032629|567239925|FG000|Overall Study|Withdrawal by Subject|50|||
157134400|NCT01032629|567239926|FG001|Overall Study|Withdrawal by Subject|36|||
157134401|NCT01032629|567239927|FG002|Overall Study|Withdrawal by Subject|35|||
157134402|NCT01032629|567239925|FG000|Overall Study|Lost to Follow-up|74|||
157134403|NCT01032629|567239926|FG001|Overall Study|Lost to Follow-up|47|||
157134404|NCT01032629|567239927|FG002|Overall Study|Lost to Follow-up|37|||
157134405|NCT03371355|567239928|FG000|Overall Study|Investigator judgment|0|||
157134406|NCT03371355|567239929|FG001|Overall Study|Investigator judgment|0|||
157134407|NCT03371355|567239930|FG002|Overall Study|Investigator judgment|1|||
156721137|NCT00370552|565725792|FG000|Overall Study|Planned radiation for palliation|0|||
156721138|NCT00370552|565725793|FG001|Overall Study|Planned radiation for palliation|1|||
156721139|NCT00370552|565725794|FG002|Overall Study|Planned radiation for palliation|0|||
156721140|NCT01651117|565725806|FG000|Overall Study|Death|2|||
156721141|NCT01651117|565725807|FG001|Overall Study|Death|3|||
156721142|NCT01651117|565725808|FG002|Overall Study|Death|2|||
156794088|NCT03715829|565999493|FG000|Extension Period|Withdrawal by Subject|0|||
156794089|NCT03715829|565999494|FG001|Extension Period|Withdrawal by Subject|0|||
157134408|NCT03371355|567239931|FG003|Overall Study|Investigator judgment|1|||
157134409|NCT03371355|567239928|FG000|Overall Study|Voluntary withdrawal|1|||
157134410|NCT03371355|567239929|FG001|Overall Study|Voluntary withdrawal|0|||
157134411|NCT03371355|567239930|FG002|Overall Study|Voluntary withdrawal|1|||
157134412|NCT03371355|567239931|FG003|Overall Study|Voluntary withdrawal|2|||
157134413|NCT03371355|567239928|FG000|Overall Study|Adverse Event|0|||
157134414|NCT03371355|567239929|FG001|Overall Study|Adverse Event|1|||
157134415|NCT03371355|567239930|FG002|Overall Study|Adverse Event|2|||
157134416|NCT03371355|567239931|FG003|Overall Study|Adverse Event|3|||
157134417|NCT03371355|567239928|FG000|Overall Study|Reason not Specified|0|||
157134418|NCT03371355|567239929|FG001|Overall Study|Reason not Specified|1|||
157134419|NCT03371355|567239930|FG002|Overall Study|Reason not Specified|0|||
157134420|NCT03371355|567239931|FG003|Overall Study|Reason not Specified|1|||
157134421|NCT02868892|567239932|FG000|Overall Study|Investigator left site and no follow-up|6|||
157134422|NCT00619957|567239933|FG000|Month 24 Double-Blind|Adverse Event|9|||
157134423|NCT00619957|567239934|FG001|Month 24 Double-Blind|Adverse Event|7|||
157134424|NCT00619957|567239933|FG000|Month 24 Double-Blind|Protocol Violation|1|||
157134425|NCT00619957|567239934|FG001|Month 24 Double-Blind|Protocol Violation|0|||
157134426|NCT00619957|567239933|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
157134427|NCT00619957|567239934|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
157134428|NCT00619957|567239933|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
157134429|NCT00619957|567239934|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
157134430|NCT00619957|567239933|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
157134431|NCT00619957|567239934|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
157134432|NCT00619957|567239933|FG000|Month 48 Open-Label|Adverse Event|4|||
157134433|NCT00619957|567239934|FG001|Month 48 Open-Label|Adverse Event|4|||
157134434|NCT00619957|567239933|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
157134435|NCT00619957|567239934|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
157134436|NCT00619957|567239933|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
157134437|NCT00619957|567239934|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
157134438|NCT01763164|567239935|FG000|Treatment Phase|Participant/Guardian decision|26|||
157134439|NCT01763164|567239936|FG001|Treatment Phase|Participant/Guardian decision|14|||
157134440|NCT01763164|567239935|FG000|Treatment Phase|Protocol Violation|1|||
157217278|NCT01169844|567541071|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156721143|NCT01651117|565725809|FG003|Overall Study|Death|2|||
156721144|NCT03871543|565725810|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
156721145|NCT03871543|565725810|FG000|Period 1|Investigator Error|1|||
156721146|NCT03871543|565725810|FG000|Period 1|Protocol Violation|2|||
156721147|NCT03871543|565725810|FG000|Period 1|COVID-19 Related|1|||
156721148|NCT03871543|565725810|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
156721149|NCT03871543|565725810|FG000|Period 1|Withdrawal by Subject|10|||
156721150|NCT03871543|565725810|FG000|Period 2|Adverse Event|1|||
156721151|NCT03871543|565725810|FG000|Period 2|Withdrawal by Subject|1|||
156721152|NCT01894919|565725811|FG000|Overall Study|Withdrawal by Subject|1|||
156721153|NCT01894919|565725812|FG001|Overall Study|Withdrawal by Subject|0|||
156721154|NCT01894919|565725813|FG002|Overall Study|Withdrawal by Subject|0|||
156721155|NCT01894919|565725814|FG003|Overall Study|Withdrawal by Subject|0|||
156721156|NCT01894919|565725815|FG004|Overall Study|Withdrawal by Subject|1|||
156721157|NCT01894919|565725816|FG005|Overall Study|Withdrawal by Subject|0|||
156721158|NCT01894919|565725817|FG006|Overall Study|Withdrawal by Subject|0|||
156721159|NCT01894919|565725818|FG007|Overall Study|Withdrawal by Subject|0|||
156721160|NCT01894919|565725819|FG008|Overall Study|Withdrawal by Subject|0|||
156721161|NCT01894919|565725820|FG009|Overall Study|Withdrawal by Subject|1|||
156721162|NCT01894919|565725821|FG010|Overall Study|Withdrawal by Subject|1|||
156721163|NCT01894919|565725822|FG011|Overall Study|Withdrawal by Subject|0|||
156721164|NCT01894919|565725823|FG012|Overall Study|Withdrawal by Subject|0|||
156721165|NCT01894919|565725811|FG000|Overall Study|Adverse Event|0|||
156721166|NCT01894919|565725812|FG001|Overall Study|Adverse Event|0|||
156721167|NCT01894919|565725813|FG002|Overall Study|Adverse Event|0|||
156721168|NCT01894919|565725814|FG003|Overall Study|Adverse Event|0|||
156721169|NCT01894919|565725815|FG004|Overall Study|Adverse Event|0|||
156721170|NCT01894919|565725816|FG005|Overall Study|Adverse Event|0|||
156794090|NCT03715829|565999495|FG002|Extension Period|Withdrawal by Subject|0|||
156794091|NCT03715829|565999496|FG003|Extension Period|Withdrawal by Subject|0|||
156794092|NCT03715829|565999497|FG004|Extension Period|Withdrawal by Subject|0|||
156794093|NCT03715829|565999498|FG005|Extension Period|Withdrawal by Subject|0|||
156794094|NCT03715829|565999499|FG006|Extension Period|Withdrawal by Subject|3|||
156794095|NCT03715829|565999500|FG007|Extension Period|Withdrawal by Subject|3|||
156794096|NCT03715829|565999501|FG008|Extension Period|Withdrawal by Subject|12|||
156794097|NCT03715829|565999502|FG009|Extension Period|Withdrawal by Subject|3|||
156794098|NCT03715829|565999503|FG010|Extension Period|Withdrawal by Subject|0|||
156721171|NCT01894919|565725817|FG006|Overall Study|Adverse Event|0|||
156721172|NCT01894919|565725818|FG007|Overall Study|Adverse Event|0|||
156721173|NCT01894919|565725819|FG008|Overall Study|Adverse Event|0|||
156721174|NCT01894919|565725820|FG009|Overall Study|Adverse Event|0|||
156794099|NCT03715829|565999493|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
157134441|NCT01763164|567239936|FG001|Treatment Phase|Protocol Violation|1|||
157134442|NCT01763164|567239935|FG000|Treatment Phase|Progressive Disease|142|||
156721175|NCT01894919|565725821|FG010|Overall Study|Adverse Event|1|||
157134443|NCT01763164|567239936|FG001|Treatment Phase|Progressive Disease|76|||
157134444|NCT01763164|567239935|FG000|Treatment Phase|Physician Decision|24|||
157134445|NCT01763164|567239936|FG001|Treatment Phase|Physician Decision|13|||
157134446|NCT01763164|567239935|FG000|Treatment Phase|Death|10|||
156875417|NCT00622440|566302060|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
157018961|NCT04258709|566824666|FG001|Overall Study|Fetal demise|1|||
157018962|NCT04258709|566824665|FG000|Overall Study|Protocol Violation|1|||
157018963|NCT04258709|566824666|FG001|Overall Study|Protocol Violation|1|||
157018964|NCT02592330|566824667|FG000|Overall Study|Withdrawal by Subject|1|||
157018965|NCT02592330|566824668|FG001|Overall Study|Withdrawal by Subject|0|||
157018966|NCT02592330|566824667|FG000|Overall Study|Failed Biopsy|1|||
157018967|NCT02592330|566824668|FG001|Overall Study|Failed Biopsy|0|||
157018968|NCT03090152|566824669|FG000|Overall Study|Withdrawal by Subject|0|||
157018969|NCT03090152|566824670|FG001|Overall Study|Withdrawal by Subject|2|||
157018970|NCT03090152|566824671|FG002|Overall Study|Withdrawal by Subject|1|||
157018971|NCT03090152|566824669|FG000|Overall Study|Surgery Canceled|1|||
157018972|NCT03090152|566824670|FG001|Overall Study|Surgery Canceled|0|||
157018973|NCT03090152|566824671|FG002|Overall Study|Surgery Canceled|0|||
157018974|NCT03090152|566824669|FG000|Overall Study|Epidural catheter could not be placed|0|||
157018975|NCT03090152|566824670|FG001|Overall Study|Epidural catheter could not be placed|2|||
157018976|NCT03090152|566824671|FG002|Overall Study|Epidural catheter could not be placed|0|||
157018977|NCT03958955|566824672|FG000|Overall Study|Adverse Event|1|||
157018978|NCT03143153|566824673|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
157018979|NCT03143153|566824674|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
157018980|NCT03143153|566824675|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
157018981|NCT03143153|566824673|FG000|Pre-Treatment|Participant withdrew consent|0|||
157018982|NCT03143153|566824674|FG001|Pre-Treatment|Participant withdrew consent|1|||
157018983|NCT03143153|566824675|FG002|Pre-Treatment|Participant withdrew consent|12|||
157018984|NCT03143153|566824673|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
157018985|NCT03143153|566824674|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
157018986|NCT03143153|566824675|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
157018987|NCT03143153|566824673|FG000|Pre-Treatment|Other Reasons|1|||
157018988|NCT03143153|566824674|FG001|Pre-Treatment|Other Reasons|2|||
157018989|NCT03143153|566824675|FG002|Pre-Treatment|Other Reasons|1|||
157018990|NCT03143153|566824673|FG000|Pre-Treatment|Disease Progression|1|||
157018991|NCT03143153|566824674|FG001|Pre-Treatment|Disease Progression|1|||
157018992|NCT03143153|566824675|FG002|Pre-Treatment|Disease Progression|2|||
157018993|NCT03143153|566824673|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
157018994|NCT03143153|566824674|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
157018995|NCT03143153|566824675|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
157018996|NCT03143153|566824673|FG000|Treatment|Disease progression|174|||
157018997|NCT03143153|566824674|FG001|Treatment|Disease progression|184|||
157018998|NCT03143153|566824675|FG002|Treatment|Disease progression|193|||
157018999|NCT03143153|566824673|FG000|Treatment|Study drug toxicity|59|||
157019000|NCT03143153|566824674|FG001|Treatment|Study drug toxicity|33|||
157019001|NCT03143153|566824675|FG002|Treatment|Study drug toxicity|40|||
157019002|NCT03143153|566824673|FG000|Treatment|Death|5|||
157019003|NCT03143153|566824674|FG001|Treatment|Death|3|||
157019004|NCT03143153|566824675|FG002|Treatment|Death|4|||
157019005|NCT03143153|566824673|FG000|Treatment|Adverse event unrelated to study drug|19|||
157019006|NCT03143153|566824674|FG001|Treatment|Adverse event unrelated to study drug|28|||
157019007|NCT03143153|566824675|FG002|Treatment|Adverse event unrelated to study drug|12|||
157019008|NCT03143153|566824673|FG000|Treatment|Participant request to discontinue study treatment|13|||
157019009|NCT03143153|566824674|FG001|Treatment|Participant request to discontinue study treatment|15|||
157019010|NCT03143153|566824675|FG002|Treatment|Participant request to discontinue study treatment|20|||
157019011|NCT03143153|566824673|FG000|Treatment|Participant withdrew consent|3|||
157019012|NCT03143153|566824674|FG001|Treatment|Participant withdrew consent|4|||
157019013|NCT03143153|566824675|FG002|Treatment|Participant withdrew consent|12|||
157019014|NCT03143153|566824673|FG000|Treatment|Pregnancy|1|||
157019015|NCT03143153|566824674|FG001|Treatment|Pregnancy|0|||
157019016|NCT03143153|566824675|FG002|Treatment|Pregnancy|0|||
157019017|NCT03143153|566824673|FG000|Treatment|Maximum clinical benefit|1|||
157019018|NCT03143153|566824674|FG001|Treatment|Maximum clinical benefit|3|||
157019019|NCT03143153|566824675|FG002|Treatment|Maximum clinical benefit|4|||
157019020|NCT03143153|566824673|FG000|Treatment|Completed treatment as per Protocol|13|||
157019021|NCT03143153|566824674|FG001|Treatment|Completed treatment as per Protocol|8|||
157019022|NCT03143153|566824675|FG002|Treatment|Completed treatment as per Protocol|0|||
157019023|NCT03143153|566824673|FG000|Treatment|Other reasons|12|||
157019024|NCT03143153|566824674|FG001|Treatment|Other reasons|7|||
157019025|NCT03143153|566824675|FG002|Treatment|Other reasons|15|||
157019026|NCT03143153|566824673|FG000|Treatment|Not reported|1|||
157019027|NCT03143153|566824674|FG001|Treatment|Not reported|0|||
157019028|NCT03143153|566824675|FG002|Treatment|Not reported|0|||
157019029|NCT04237298|566824676|FG000|Overall Study|Lost to Follow-up|4|||
157019030|NCT04237298|566824677|FG001|Overall Study|Lost to Follow-up|5|||
157019031|NCT04556656|566824680|FG000|Overall Study|Withdrawal by Subject|14|||
157019032|NCT04556656|566824681|FG001|Overall Study|Withdrawal by Subject|12|||
157019033|NCT04556656|566824680|FG000|Overall Study|Physician Decision|1|||
157019034|NCT04556656|566824681|FG001|Overall Study|Physician Decision|0|||
157134447|NCT01763164|567239936|FG001|Treatment Phase|Death|1|||
157134448|NCT01763164|567239935|FG000|Treatment Phase|Adverse Event|66|||
157134449|NCT01763164|567239936|FG001|Treatment Phase|Adverse Event|8|||
157134450|NCT01763164|567239935|FG000|Treatment Phase|Randomized but not Treated|0|||
157134451|NCT01763164|567239936|FG001|Treatment Phase|Randomized but not Treated|19|||
157134452|NCT01763164|567239935|FG000|Treatment Phase|Other|0|||
157134453|NCT01763164|567239936|FG001|Treatment Phase|Other|1|||
157134454|NCT01763164|567239935|FG000|Follow up Phase|New therapy for study indication|12|||
157134455|NCT01763164|567239936|FG001|Follow up Phase|New therapy for study indication|3|||
157134456|NCT01763164|567239935|FG000|Follow up Phase|Death|21|||
157134457|NCT01763164|567239936|FG001|Follow up Phase|Death|4|||
157134458|NCT01763164|567239935|FG000|Follow up Phase|Subject/guardian decision|9|||
157217279|NCT01169844|567541072|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157019035|NCT04556656|566824680|FG000|Overall Study|Adverse Event|4|||
157019036|NCT04556656|566824681|FG001|Overall Study|Adverse Event|7|||
157019037|NCT04556656|566824680|FG000|Overall Study|Death|4|||
157019038|NCT04556656|566824681|FG001|Overall Study|Death|0|||
157019039|NCT04556656|566824680|FG000|Overall Study|Lost to Follow-up|3|||
157019040|NCT04556656|566824681|FG001|Overall Study|Lost to Follow-up|2|||
157019041|NCT04556656|566824680|FG000|Overall Study|Not further specified|2|||
157019042|NCT04556656|566824681|FG001|Overall Study|Not further specified|1|||
157019043|NCT04541706|566824682|FG000|Overall Study|Withdrawal by Subject|3|||
157019044|NCT04541706|566824682|FG000|Overall Study|Progressive disease|33|||
157019045|NCT04541706|566824682|FG000|Overall Study|Physician Decision|1|||
157019046|NCT04541706|566824682|FG000|Overall Study|Lost to Follow-up|2|||
157019047|NCT04541706|566824682|FG000|Overall Study|Death|5|||
157019048|NCT04541706|566824682|FG000|Overall Study|Adverse Event|1|||
157019049|NCT01416831|566824685|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
157019050|NCT01416831|566824686|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
157019051|NCT04812535|566824687|FG000|Overall Study|Withdrawal by Subject|0|||
157019052|NCT04812535|566824688|FG001|Overall Study|Withdrawal by Subject|0|||
157019053|NCT04812535|566824689|FG002|Overall Study|Withdrawal by Subject|0|||
157019054|NCT04812535|566824690|FG003|Overall Study|Withdrawal by Subject|1|||
157019055|NCT04812535|566824687|FG000|Overall Study|Death|7|||
157019056|NCT04812535|566824688|FG001|Overall Study|Death|2|||
157019057|NCT04812535|566824689|FG002|Overall Study|Death|4|||
157019058|NCT04812535|566824690|FG003|Overall Study|Death|1|||
157019059|NCT04812535|566824687|FG000|Overall Study|Due to premature study termination by sponsor|2|||
157019060|NCT04812535|566824688|FG001|Overall Study|Due to premature study termination by sponsor|0|||
157019061|NCT04812535|566824689|FG002|Overall Study|Due to premature study termination by sponsor|1|||
157019062|NCT04812535|566824690|FG003|Overall Study|Due to premature study termination by sponsor|3|||
157019063|NCT03436745|566824691|FG000|Overall Study|Ineligible|0|||
157019064|NCT03436745|566824692|FG001|Overall Study|Ineligible|0|||
157019065|NCT03436745|566824693|FG002|Overall Study|Ineligible|1|||
157019066|NCT00931710|566824698|FG000|Overall Study|Adverse Event|16|||
157019067|NCT00931710|566824699|FG001|Overall Study|Adverse Event|10|||
157019068|NCT00931710|566824698|FG000|Overall Study|Abnormal test procedure results|2|||
157019069|NCT00931710|566824699|FG001|Overall Study|Abnormal test procedure results|0|||
157019070|NCT00931710|566824698|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
157019071|NCT00931710|566824699|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
157019072|NCT00931710|566824698|FG000|Overall Study|Patient withdrew consent|4|||
157019073|NCT00931710|566824699|FG001|Overall Study|Patient withdrew consent|9|||
157019074|NCT00931710|566824698|FG000|Overall Study|Lost to Follow-up|6|||
157019075|NCT00931710|566824699|FG001|Overall Study|Lost to Follow-up|5|||
157019076|NCT00931710|566824698|FG000|Overall Study|Protocol deviation|1|||
157019077|NCT00931710|566824699|FG001|Overall Study|Protocol deviation|2|||
157019078|NCT04401800|566824700|FG000|Overall Study|Death|17|||
157019079|NCT04401800|566824700|FG000|Overall Study|Lost to Follow-up|5|||
157019080|NCT04401800|566824700|FG000|Overall Study|Withdrawal by Subject|4|||
157019081|NCT04927065|566824701|FG000|First Booster|Adverse Event|1|||
157019082|NCT04927065|566824702|FG001|First Booster|Adverse Event|0|||
157019083|NCT04927065|566824703|FG002|First Booster|Adverse Event|0|||
157019084|NCT04927065|566824704|FG003|First Booster|Adverse Event|0|||
157019085|NCT04927065|566824705|FG004|First Booster|Adverse Event|0|||
157019086|NCT04927065|566824706|FG005|First Booster|Adverse Event|0|||
157019087|NCT04927065|566824707|FG006|First Booster|Adverse Event|0|||
157019088|NCT04927065|566824708|FG007|First Booster|Adverse Event|1|||
157019089|NCT04927065|566824709|FG008|First Booster|Adverse Event|0|||
157019090|NCT04927065|566824710|FG009|First Booster|Adverse Event|0|||
157019091|NCT04927065|566824711|FG010|First Booster|Adverse Event|0|||
157019092|NCT04927065|566824712|FG011|First Booster|Adverse Event|0|||
157019093|NCT04927065|566824713|FG012|First Booster|Adverse Event|0|||
157019094|NCT04927065|566824714|FG013|First Booster|Adverse Event|0|||
157019095|NCT04927065|566824715|FG014|First Booster|Adverse Event|0|||
157019096|NCT04927065|566824716|FG015|First Booster|Adverse Event|0|||
157019097|NCT04927065|566824701|FG000|First Booster|Death|1|||
157019098|NCT04927065|566824702|FG001|First Booster|Death|0|||
157019099|NCT04927065|566824703|FG002|First Booster|Death|0|||
157019100|NCT04927065|566824704|FG003|First Booster|Death|1|||
157134459|NCT01763164|567239936|FG001|Follow up Phase|Subject/guardian decision|2|||
157134460|NCT01763164|567239935|FG000|Follow up Phase|Progressive disease|127|||
157134461|NCT01763164|567239936|FG001|Follow up Phase|Progressive disease|62|||
157134462|NCT01763164|567239935|FG000|Follow up Phase|Physician Decision|10|||
157134463|NCT01763164|567239936|FG001|Follow up Phase|Physician Decision|3|||
157134464|NCT01763164|567239935|FG000|Follow up Phase|Lost to Follow-up|1|||
157134465|NCT01763164|567239936|FG001|Follow up Phase|Lost to Follow-up|0|||
157134466|NCT01763164|567239935|FG000|Follow up Phase|Adverse Event|17|||
157134467|NCT01763164|567239936|FG001|Follow up Phase|Adverse Event|1|||
157134468|NCT01526148|567239942|FG000|Overall Study|Adverse Event|6|||
157134469|NCT01526148|567239943|FG001|Overall Study|Adverse Event|5|||
157134470|NCT01526148|567239942|FG000|Overall Study|Lost to Follow-up|3|||
157134471|NCT01526148|567239943|FG001|Overall Study|Lost to Follow-up|6|||
157134472|NCT01526148|567239942|FG000|Overall Study|Withdrawal by Subject|2|||
157134473|NCT01526148|567239943|FG001|Overall Study|Withdrawal by Subject|0|||
157134474|NCT01526148|567239942|FG000|Overall Study|Unstable Medical Condition|1|||
157134475|NCT01526148|567239943|FG001|Overall Study|Unstable Medical Condition|0|||
157134476|NCT01526148|567239942|FG000|Overall Study|Unable to discontinue concomitant med|1|||
157134477|NCT01526148|567239943|FG001|Overall Study|Unable to discontinue concomitant med|0|||
157134478|NCT01526148|567239942|FG000|Overall Study|Moved out of state|1|||
157134479|NCT01526148|567239943|FG001|Overall Study|Moved out of state|0|||
157134480|NCT01526148|567239942|FG000|Overall Study|Incarcerated|0|||
157134481|NCT01526148|567239943|FG001|Overall Study|Incarcerated|2|||
157134482|NCT01173653|567239944|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
157134483|NCT01173653|567239945|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
157134484|NCT03529409|567239954|FG000|Randomized|Lost to Follow-up|0|||
157134485|NCT03529409|567239955|FG001|Randomized|Lost to Follow-up|0|||
157134486|NCT03529409|567239956|FG002|Randomized|Lost to Follow-up|4|||
157134487|NCT03529409|567239954|FG000|Randomized|Excluded|0|||
157134488|NCT03529409|567239955|FG001|Randomized|Excluded|0|||
157134489|NCT03529409|567239956|FG002|Randomized|Excluded|1|||
157134490|NCT03529409|567239954|FG000|Post-treatment Assessment|Death|1|||
157134491|NCT03529409|567239955|FG001|Post-treatment Assessment|Death|0|||
157134492|NCT03529409|567239956|FG002|Post-treatment Assessment|Death|0|||
157134493|NCT03529409|567239954|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
157134494|NCT03529409|567239955|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
157134495|NCT03529409|567239956|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
157134496|NCT03529409|567239954|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
157134497|NCT03529409|567239955|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
157134498|NCT03529409|567239956|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
157134499|NCT03529409|567239954|FG000|Follow-up Assessment|Death|1|||
157134500|NCT03529409|567239955|FG001|Follow-up Assessment|Death|0|||
157134501|NCT03529409|567239956|FG002|Follow-up Assessment|Death|0|||
157134502|NCT03529409|567239954|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
157134503|NCT03529409|567239955|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
157134504|NCT03529409|567239956|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
157134505|NCT01497262|567239957|FG000|Overall Study|Abnormal Lab Values|4|||
157134506|NCT01497262|567239957|FG000|Overall Study|Abnormal Test Procedure Result|1|||
157134507|NCT01497262|567239957|FG000|Overall Study|Physician Decision|1|||
157134508|NCT01497262|567239957|FG000|Overall Study|Withdrawal by Subject|2|||
156721176|NCT01894919|565725822|FG011|Overall Study|Adverse Event|0|||
156721177|NCT01894919|565725823|FG012|Overall Study|Adverse Event|0|||
156721178|NCT01894919|565725811|FG000|Overall Study|Other-Unspecified|1|||
157134509|NCT01497262|567239957|FG000|Overall Study|Adverse Event|2|||
157134510|NCT01497262|567239957|FG000|Overall Study|Protocol Violation|1|||
157134511|NCT03898063|567239960|FG000|Overall Study|Withdrawal by Subject|10|||
157134512|NCT03898063|567239961|FG001|Overall Study|Withdrawal by Subject|8|||
157134513|NCT01817790|567239971|FG000|Overall Study|Adverse Event|0|||
157134514|NCT01817790|567239972|FG001|Overall Study|Adverse Event|2|||
157134515|NCT01817790|567239971|FG000|Overall Study|Lost to Follow-up|0|||
157134516|NCT01817790|567239972|FG001|Overall Study|Lost to Follow-up|1|||
156721179|NCT01894919|565725812|FG001|Overall Study|Other-Unspecified|0|||
156721180|NCT01894919|565725813|FG002|Overall Study|Other-Unspecified|0|||
156721181|NCT01894919|565725814|FG003|Overall Study|Other-Unspecified|0|||
156721182|NCT01894919|565725815|FG004|Overall Study|Other-Unspecified|0|||
156721183|NCT01894919|565725816|FG005|Overall Study|Other-Unspecified|0|||
156721184|NCT01894919|565725817|FG006|Overall Study|Other-Unspecified|0|||
156721185|NCT01894919|565725818|FG007|Overall Study|Other-Unspecified|0|||
156721186|NCT01894919|565725819|FG008|Overall Study|Other-Unspecified|0|||
156721187|NCT01894919|565725820|FG009|Overall Study|Other-Unspecified|0|||
156721188|NCT01894919|565725821|FG010|Overall Study|Other-Unspecified|0|||
156721189|NCT01894919|565725822|FG011|Overall Study|Other-Unspecified|0|||
157134517|NCT01817790|567239971|FG000|Overall Study|Protocol Violation|2|||
157134518|NCT01817790|567239972|FG001|Overall Study|Protocol Violation|1|||
157134519|NCT01817790|567239971|FG000|Overall Study|Withdrawal by Subject|1|||
157134520|NCT01817790|567239972|FG001|Overall Study|Withdrawal by Subject|3|||
157134521|NCT01817790|567239971|FG000|Overall Study|Other: Could not attend appointment|1|||
157134522|NCT01817790|567239972|FG001|Overall Study|Other: Could not attend appointment|1|||
157134523|NCT01671345|567239973|FG000|Overall Study|Lost to Follow-up|10|||
157134524|NCT01671345|567239974|FG001|Overall Study|Lost to Follow-up|6|||
157134525|NCT01671345|567239973|FG000|Overall Study|visit with non-participating physician|3|||
157134526|NCT01671345|567239974|FG001|Overall Study|visit with non-participating physician|3|||
157134527|NCT03636906|567239975|FG000|Overall Study|Adverse Event|0|||
157134528|NCT03636906|567239976|FG001|Overall Study|Adverse Event|0|||
157134529|NCT03636906|567239977|FG002|Overall Study|Adverse Event|1|||
157134530|NCT03636906|567239975|FG000|Overall Study|Lost to Follow-up|1|||
157134531|NCT03636906|567239976|FG001|Overall Study|Lost to Follow-up|0|||
157134532|NCT03636906|567239977|FG002|Overall Study|Lost to Follow-up|0|||
157134533|NCT03636906|567239975|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
157134534|NCT03636906|567239976|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
157134535|NCT03636906|567239977|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
157134536|NCT03636906|567239975|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
157134537|NCT03636906|567239976|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
157134538|NCT03636906|567239977|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
157134539|NCT03636906|567239975|FG000|Overall Study|Other|0|||
157134540|NCT03636906|567239976|FG001|Overall Study|Other|0|||
157134541|NCT03636906|567239977|FG002|Overall Study|Other|1|||
157134542|NCT03690869|567239981|FG000|Overall Study|Adverse Event|0|||
157134543|NCT03690869|567239982|FG001|Overall Study|Adverse Event|0|||
157134544|NCT03690869|567239983|FG002|Overall Study|Adverse Event|0|||
157134545|NCT03690869|567239984|FG003|Overall Study|Adverse Event|1|||
157134546|NCT03690869|567239985|FG004|Overall Study|Adverse Event|0|||
157134547|NCT03690869|567239986|FG005|Overall Study|Adverse Event|0|||
157134548|NCT03690869|567239987|FG006|Overall Study|Adverse Event|0|||
157134549|NCT03690869|567239988|FG007|Overall Study|Adverse Event|1|||
157134550|NCT03690869|567239989|FG008|Overall Study|Adverse Event|0|||
157134551|NCT03690869|567239990|FG009|Overall Study|Adverse Event|1|||
157134552|NCT03690869|567239981|FG000|Overall Study|Death|1|||
157134553|NCT03690869|567239982|FG001|Overall Study|Death|1|||
157134554|NCT03690869|567239983|FG002|Overall Study|Death|1|||
157134555|NCT03690869|567239984|FG003|Overall Study|Death|4|||
157134556|NCT03690869|567239985|FG004|Overall Study|Death|2|||
157134557|NCT03690869|567239986|FG005|Overall Study|Death|5|||
157134558|NCT03690869|567239987|FG006|Overall Study|Death|3|||
157134559|NCT03690869|567239988|FG007|Overall Study|Death|2|||
157134560|NCT03690869|567239989|FG008|Overall Study|Death|0|||
157134561|NCT03690869|567239990|FG009|Overall Study|Death|3|||
157134562|NCT03690869|567239981|FG000|Overall Study|Lost to Follow-up|0|||
157134563|NCT03690869|567239982|FG001|Overall Study|Lost to Follow-up|0|||
157134564|NCT03690869|567239983|FG002|Overall Study|Lost to Follow-up|1|||
157134565|NCT03690869|567239984|FG003|Overall Study|Lost to Follow-up|0|||
157134566|NCT03690869|567239985|FG004|Overall Study|Lost to Follow-up|0|||
157134567|NCT03690869|567239986|FG005|Overall Study|Lost to Follow-up|0|||
157134568|NCT03690869|567239987|FG006|Overall Study|Lost to Follow-up|0|||
157134569|NCT03690869|567239988|FG007|Overall Study|Lost to Follow-up|0|||
157134570|NCT03690869|567239989|FG008|Overall Study|Lost to Follow-up|0|||
157134571|NCT03690869|567239990|FG009|Overall Study|Lost to Follow-up|0|||
157134572|NCT03690869|567239981|FG000|Overall Study|Other Treatment|1|||
157134573|NCT03690869|567239982|FG001|Overall Study|Other Treatment|1|||
157134574|NCT03690869|567239983|FG002|Overall Study|Other Treatment|1|||
157134575|NCT03690869|567239984|FG003|Overall Study|Other Treatment|2|||
157134576|NCT03690869|567239985|FG004|Overall Study|Other Treatment|3|||
157134577|NCT03690869|567239986|FG005|Overall Study|Other Treatment|1|||
157134578|NCT03690869|567239987|FG006|Overall Study|Other Treatment|2|||
156875418|NCT00622440|566302061|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
156875419|NCT00622440|566302060|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
156875420|NCT00622440|566302061|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
156875421|NCT00771953|566302064|FG000|Overall Study|Adverse Event|5|||
157134579|NCT03690869|567239988|FG007|Overall Study|Other Treatment|7|||
157134580|NCT03690869|567239989|FG008|Overall Study|Other Treatment|0|||
157134581|NCT03690869|567239990|FG009|Overall Study|Other Treatment|3|||
156875422|NCT00771953|566302065|FG001|Overall Study|Adverse Event|3|||
157134582|NCT03690869|567239981|FG000|Overall Study|Physician Decision|0|||
157134583|NCT03690869|567239982|FG001|Overall Study|Physician Decision|1|||
157134584|NCT03690869|567239983|FG002|Overall Study|Physician Decision|0|||
157134585|NCT03690869|567239984|FG003|Overall Study|Physician Decision|0|||
157134586|NCT03690869|567239985|FG004|Overall Study|Physician Decision|0|||
157134587|NCT03690869|567239986|FG005|Overall Study|Physician Decision|0|||
157134588|NCT03690869|567239987|FG006|Overall Study|Physician Decision|0|||
156875423|NCT00771953|566302064|FG000|Overall Study|Death|2|||
157134589|NCT03690869|567239988|FG007|Overall Study|Physician Decision|0|||
157134590|NCT03690869|567239989|FG008|Overall Study|Physician Decision|0|||
157134591|NCT03690869|567239990|FG009|Overall Study|Physician Decision|0|||
157134592|NCT03690869|567239981|FG000|Overall Study|Progressive Disease|1|||
156875424|NCT00771953|566302065|FG001|Overall Study|Death|2|||
157019101|NCT04927065|566824705|FG004|First Booster|Death|0|||
157019102|NCT04927065|566824706|FG005|First Booster|Death|1|||
157134593|NCT03690869|567239982|FG001|Overall Study|Progressive Disease|2|||
157134594|NCT03690869|567239983|FG002|Overall Study|Progressive Disease|0|||
157134595|NCT03690869|567239984|FG003|Overall Study|Progressive Disease|1|||
156721190|NCT01894919|565725823|FG012|Overall Study|Other-Unspecified|0|||
156721191|NCT01894919|565725811|FG000|Overall Study|Lost to Follow-up|0|||
156721192|NCT01894919|565725812|FG001|Overall Study|Lost to Follow-up|0|||
156721193|NCT01894919|565725813|FG002|Overall Study|Lost to Follow-up|0|||
156721194|NCT01894919|565725814|FG003|Overall Study|Lost to Follow-up|0|||
156721195|NCT01894919|565725815|FG004|Overall Study|Lost to Follow-up|2|||
156721196|NCT01894919|565725816|FG005|Overall Study|Lost to Follow-up|0|||
156721197|NCT01894919|565725817|FG006|Overall Study|Lost to Follow-up|0|||
156721198|NCT01894919|565725818|FG007|Overall Study|Lost to Follow-up|0|||
156721199|NCT01894919|565725819|FG008|Overall Study|Lost to Follow-up|0|||
156721200|NCT01894919|565725820|FG009|Overall Study|Lost to Follow-up|0|||
156721201|NCT01894919|565725821|FG010|Overall Study|Lost to Follow-up|0|||
156721202|NCT01894919|565725822|FG011|Overall Study|Lost to Follow-up|0|||
156721203|NCT01894919|565725823|FG012|Overall Study|Lost to Follow-up|0|||
156721204|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
156721205|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
156721206|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
156721207|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
156721208|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
156721209|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
156721210|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
156721211|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
156721212|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
156721213|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
156721214|NCT03762265|565725828|FG000|BT Period: Weeks 1 to 37|Other|0|||
156721215|NCT03762265|565725829|FG001|BT Period: Weeks 1 to 37|Other|1|||
156721216|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
156721217|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
156721218|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
156721219|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
156721220|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
156721221|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
156721222|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
156721223|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
156721224|NCT03762265|565725828|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
156875425|NCT00771953|566302064|FG000|Overall Study|Progression before active Tx|1|||
157019103|NCT04927065|566824707|FG006|First Booster|Death|0|||
157019104|NCT04927065|566824708|FG007|First Booster|Death|0|||
157019105|NCT04927065|566824709|FG008|First Booster|Death|0|||
157019106|NCT04927065|566824710|FG009|First Booster|Death|0|||
157019107|NCT04927065|566824711|FG010|First Booster|Death|0|||
157019108|NCT04927065|566824712|FG011|First Booster|Death|0|||
157019109|NCT04927065|566824713|FG012|First Booster|Death|0|||
157019110|NCT04927065|566824714|FG013|First Booster|Death|0|||
157019111|NCT04927065|566824715|FG014|First Booster|Death|0|||
157019112|NCT04927065|566824716|FG015|First Booster|Death|0|||
157019113|NCT04927065|566824701|FG000|First Booster|Lost to Follow-up|8|||
157019114|NCT04927065|566824702|FG001|First Booster|Lost to Follow-up|20|||
157019115|NCT04927065|566824703|FG002|First Booster|Lost to Follow-up|0|||
157019116|NCT04927065|566824704|FG003|First Booster|Lost to Follow-up|11|||
157019117|NCT04927065|566824705|FG004|First Booster|Lost to Follow-up|43|||
157019118|NCT04927065|566824706|FG005|First Booster|Lost to Follow-up|30|||
157019119|NCT04927065|566824707|FG006|First Booster|Lost to Follow-up|28|||
157019120|NCT04927065|566824708|FG007|First Booster|Lost to Follow-up|23|||
157019121|NCT04927065|566824709|FG008|First Booster|Lost to Follow-up|4|||
157019122|NCT04927065|566824710|FG009|First Booster|Lost to Follow-up|15|||
157019123|NCT04927065|566824711|FG010|First Booster|Lost to Follow-up|0|||
157019124|NCT04927065|566824712|FG011|First Booster|Lost to Follow-up|0|||
157019125|NCT04927065|566824713|FG012|First Booster|Lost to Follow-up|0|||
157019126|NCT04927065|566824714|FG013|First Booster|Lost to Follow-up|0|||
157019127|NCT04927065|566824715|FG014|First Booster|Lost to Follow-up|0|||
157019128|NCT04927065|566824716|FG015|First Booster|Lost to Follow-up|0|||
157019129|NCT04927065|566824701|FG000|First Booster|Physician Decision|1|||
157019130|NCT04927065|566824702|FG001|First Booster|Physician Decision|0|||
157019131|NCT04927065|566824703|FG002|First Booster|Physician Decision|0|||
157019132|NCT04927065|566824704|FG003|First Booster|Physician Decision|3|||
157019133|NCT04927065|566824705|FG004|First Booster|Physician Decision|1|||
157019134|NCT04927065|566824706|FG005|First Booster|Physician Decision|1|||
157019135|NCT04927065|566824707|FG006|First Booster|Physician Decision|0|||
157019136|NCT04927065|566824708|FG007|First Booster|Physician Decision|3|||
157019137|NCT04927065|566824709|FG008|First Booster|Physician Decision|0|||
157019138|NCT04927065|566824710|FG009|First Booster|Physician Decision|0|||
157019139|NCT04927065|566824711|FG010|First Booster|Physician Decision|0|||
157134596|NCT03690869|567239985|FG004|Overall Study|Progressive Disease|0|||
157134597|NCT03690869|567239986|FG005|Overall Study|Progressive Disease|0|||
157134598|NCT03690869|567239987|FG006|Overall Study|Progressive Disease|0|||
157134599|NCT03690869|567239988|FG007|Overall Study|Progressive Disease|0|||
157134600|NCT03690869|567239989|FG008|Overall Study|Progressive Disease|1|||
157134601|NCT03690869|567239990|FG009|Overall Study|Progressive Disease|1|||
157134602|NCT03690869|567239981|FG000|Overall Study|Subject Decision|0|||
157134603|NCT03690869|567239982|FG001|Overall Study|Subject Decision|0|||
157134604|NCT03690869|567239983|FG002|Overall Study|Subject Decision|0|||
157134605|NCT03690869|567239984|FG003|Overall Study|Subject Decision|1|||
157134606|NCT03690869|567239985|FG004|Overall Study|Subject Decision|0|||
157134607|NCT03690869|567239986|FG005|Overall Study|Subject Decision|0|||
157134608|NCT03690869|567239987|FG006|Overall Study|Subject Decision|0|||
157134609|NCT03690869|567239988|FG007|Overall Study|Subject Decision|1|||
157134610|NCT03690869|567239989|FG008|Overall Study|Subject Decision|0|||
157134611|NCT03690869|567239990|FG009|Overall Study|Subject Decision|0|||
157134612|NCT06001307|567241722|FG000|Overall Study|Lost to Follow-up|1|||
157134613|NCT06001307|567241723|FG001|Overall Study|Lost to Follow-up|2|||
157134614|NCT03263806|567241725|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
157134615|NCT03263806|567241726|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
157134616|NCT03263806|567241725|FG000|Overall Study|Withdrawal by Subject|0|||
157134617|NCT03263806|567241726|FG001|Overall Study|Withdrawal by Subject|1|||
157134618|NCT03263806|567241725|FG000|Overall Study|Study Termination|5|||
157134619|NCT03263806|567241726|FG001|Overall Study|Study Termination|6|||
157217280|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
157217281|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
157217282|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
157217283|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
156721225|NCT03762265|565725829|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
157134620|NCT04840667|567241727|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
157134621|NCT00023322|567241734|FG000|Overall Study|Lost to Follow-up|1|||
157134622|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
157217284|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
157217285|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
157217286|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
157217287|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
156721226|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
156721227|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
157134623|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
157134624|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
157134625|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
157134626|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
157134627|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
157134628|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
157134629|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
157134630|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
157134631|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
157134632|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
157134633|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
157134634|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
157134635|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
157134636|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
157134637|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
157134638|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
157134639|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
156721228|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
156721229|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
156721230|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
156721231|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
156721232|NCT03762265|565725828|FG000|LTE Period: Weeks 61 to 109|Other|1|||
156721233|NCT03762265|565725829|FG001|LTE Period: Weeks 61 to 109|Other|0|||
157134640|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
157134641|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
157134642|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
157134643|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
157134644|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
157134645|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
157134646|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
156721234|NCT02289729|565725830|FG000|Overall Study|Lack of Efficacy|3|||
157134647|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
157134648|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
157134649|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
157134650|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
157134651|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
157134652|NCT02660580|567241739|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
157134653|NCT02660580|567241740|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
156721235|NCT02289729|565725830|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
156721236|NCT02289729|565725830|FG000|Overall Study|Withdrawal by Subject|1|||
156721237|NCT02289729|565725830|FG000|Overall Study|Death|1|||
156721238|NCT00470470|565725831|FG000|Overall Study|Adverse Event|2|||
156721239|NCT00470470|565725831|FG000|Overall Study|Death|2|||
156721240|NCT00470470|565725831|FG000|Overall Study|Not treated|1|||
156721241|NCT01149863|565725834|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
156721242|NCT01256879|565725835|FG000|Overall Study|Withdrawal by Subject|1|||
156721243|NCT00640315|565725836|FG000|Overall Study|Withdrawal by Subject|0|||
156721244|NCT00640315|565725837|FG001|Overall Study|Withdrawal by Subject|1|||
156721245|NCT00397514|565725838|FG000|Overall Study|Withdrawal by Subject|1|||
156721246|NCT00397514|565725838|FG000|Overall Study|Pacing wire malfunction|1|||
156721247|NCT00397514|565725838|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
156721248|NCT00397514|565725838|FG000|Overall Study|early extubation|2|||
156721249|NCT00397514|565725838|FG000|Overall Study|poor echocardiographic windows|1|||
156721250|NCT00725920|565725839|FG000|Overall Study|Lack of Efficacy|3|||
156721251|NCT00725920|565725840|FG001|Overall Study|Lack of Efficacy|6|||
156721252|NCT02286713|565725841|FG000|One Week Follow-Up|Death|1|||
156721253|NCT02286713|565725842|FG001|One Week Follow-Up|Death|0|||
156721254|NCT02286713|565725841|FG000|One Week Follow-Up|Lost to Follow-up|17|||
156721255|NCT02286713|565725842|FG001|One Week Follow-Up|Lost to Follow-up|21|||
156721256|NCT02286713|565725841|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
156721257|NCT02286713|565725842|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
156721258|NCT02286713|565725841|FG000|Three Month Follow-Up|Death|1|||
156721259|NCT02286713|565725842|FG001|Three Month Follow-Up|Death|1|||
156721260|NCT02286713|565725841|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
156721261|NCT02286713|565725842|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
156721262|NCT02286713|565725841|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
156721263|NCT02286713|565725842|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
156721264|NCT02286713|565725841|FG000|Six Month Follow-Up|Death|2|||
156721265|NCT02286713|565725842|FG001|Six Month Follow-Up|Death|0|||
156721266|NCT02286713|565725841|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
156721267|NCT02286713|565725842|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
156721268|NCT04314037|565725844|FG000|Treatment Period 2|Adverse Event|1|||
156721269|NCT04314037|565725845|FG001|Treatment Period 2|Adverse Event|0|||
156721270|NCT04314037|565725844|FG000|Treatment Period 3|Protocol Violation|1|||
156721271|NCT04314037|565725845|FG001|Treatment Period 3|Protocol Violation|0|||
156721272|NCT04314037|565725844|FG000|Treatment Period 3|Adverse Event|0|||
156721273|NCT04314037|565725845|FG001|Treatment Period 3|Adverse Event|1|||
156721274|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
156721275|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
156721276|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
156721277|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156721278|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
156721279|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
156721280|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721281|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721282|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
156721283|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Other|1|||
156721284|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Other|0|||
156721285|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Other|4|||
156721286|NCT02654054|565725846|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156721287|NCT02654054|565725847|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156721288|NCT02654054|565725848|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
156721289|NCT00856492|565725852|FG000|Overall Study|Ineligible or withdrew consent|1|||
156721290|NCT00856492|565725853|FG001|Overall Study|Ineligible or withdrew consent|1|||
156721291|NCT00856492|565725854|FG002|Overall Study|Ineligible or withdrew consent|2|||
156721292|NCT06018129|565725855|FG000|Overall Study|Death|1|||
156721293|NCT06018129|565725856|FG001|Overall Study|Death|1|||
156721294|NCT06018129|565725857|FG002|Overall Study|Death|2|||
156721295|NCT06018129|565725855|FG000|Overall Study|Sponsor Decision|2|||
156721296|NCT06018129|565725856|FG001|Overall Study|Sponsor Decision|2|||
156721297|NCT06018129|565725857|FG002|Overall Study|Sponsor Decision|1|||
156721298|NCT03832686|565725858|FG000|Overall Study|Lost to Follow-up|6|||
156721299|NCT03832686|565725859|FG001|Overall Study|Lost to Follow-up|9|||
157019140|NCT04927065|566824712|FG011|First Booster|Physician Decision|0|||
156721300|NCT03832686|565725858|FG000|Overall Study|Discontinued Intervention|5|||
157019141|NCT04927065|566824713|FG012|First Booster|Physician Decision|0|||
157134654|NCT02660580|567241741|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
157134655|NCT02660580|567241742|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
157134656|NCT02660580|567241743|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
157134657|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
157134658|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
157134659|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
157134660|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
157134661|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
157134662|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
157134663|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
157134664|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
157134665|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
157134666|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
157134667|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
157134668|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
156721301|NCT03832686|565725859|FG001|Overall Study|Discontinued Intervention|4|||
156721302|NCT03323398|565725860|FG000|Overall Study|Other than Specified|0|||
156721303|NCT03323398|565725861|FG001|Overall Study|Other than Specified|1|||
156721304|NCT03323398|565725862|FG002|Overall Study|Other than Specified|2|||
156721305|NCT03323398|565725863|FG003|Overall Study|Other than Specified|0|||
156721306|NCT03323398|565725864|FG004|Overall Study|Other than Specified|0|||
156721307|NCT03323398|565725865|FG005|Overall Study|Other than Specified|0|||
156721308|NCT03323398|565725866|FG006|Overall Study|Other than Specified|1|||
156721309|NCT03323398|565725867|FG007|Overall Study|Other than Specified|0|||
156721310|NCT03323398|565725868|FG008|Overall Study|Other than Specified|2|||
156721311|NCT03323398|565725860|FG000|Overall Study|Lost to Follow-up|1|||
156721312|NCT03323398|565725861|FG001|Overall Study|Lost to Follow-up|2|||
156721313|NCT03323398|565725862|FG002|Overall Study|Lost to Follow-up|1|||
156721314|NCT03323398|565725863|FG003|Overall Study|Lost to Follow-up|0|||
156721315|NCT03323398|565725864|FG004|Overall Study|Lost to Follow-up|0|||
156721316|NCT03323398|565725865|FG005|Overall Study|Lost to Follow-up|0|||
156721317|NCT03323398|565725866|FG006|Overall Study|Lost to Follow-up|0|||
156721318|NCT03323398|565725867|FG007|Overall Study|Lost to Follow-up|0|||
156721319|NCT03323398|565725868|FG008|Overall Study|Lost to Follow-up|0|||
156721320|NCT03323398|565725860|FG000|Overall Study|Death|4|||
156721321|NCT03323398|565725861|FG001|Overall Study|Death|6|||
156721322|NCT03323398|565725862|FG002|Overall Study|Death|2|||
156721323|NCT03323398|565725863|FG003|Overall Study|Death|2|||
156721324|NCT03323398|565725864|FG004|Overall Study|Death|1|||
156721325|NCT03323398|565725865|FG005|Overall Study|Death|2|||
156721326|NCT03323398|565725866|FG006|Overall Study|Death|0|||
156721327|NCT03323398|565725867|FG007|Overall Study|Death|0|||
156721328|NCT03323398|565725868|FG008|Overall Study|Death|6|||
156721329|NCT03323398|565725860|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
156721330|NCT03323398|565725861|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
156721331|NCT03323398|565725862|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
156721332|NCT03323398|565725863|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
156721333|NCT03323398|565725864|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
156721334|NCT03323398|565725865|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
156721335|NCT03323398|565725866|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
156721336|NCT03323398|565725867|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
156721337|NCT03323398|565725868|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
156721338|NCT03323398|565725860|FG000|Overall Study|Withdrawal by Subject|2|||
156721339|NCT03323398|565725861|FG001|Overall Study|Withdrawal by Subject|1|||
156721340|NCT03323398|565725862|FG002|Overall Study|Withdrawal by Subject|3|||
156721341|NCT03323398|565725863|FG003|Overall Study|Withdrawal by Subject|0|||
156721342|NCT03323398|565725864|FG004|Overall Study|Withdrawal by Subject|0|||
156721343|NCT03323398|565725865|FG005|Overall Study|Withdrawal by Subject|1|||
156721344|NCT03323398|565725866|FG006|Overall Study|Withdrawal by Subject|0|||
156721345|NCT03323398|565725867|FG007|Overall Study|Withdrawal by Subject|0|||
156721346|NCT03323398|565725868|FG008|Overall Study|Withdrawal by Subject|0|||
156721347|NCT03323398|565725860|FG000|Overall Study|Participant was Put on Hospice|0|||
156721348|NCT03323398|565725861|FG001|Overall Study|Participant was Put on Hospice|0|||
156721349|NCT03323398|565725862|FG002|Overall Study|Participant was Put on Hospice|0|||
156721350|NCT03323398|565725863|FG003|Overall Study|Participant was Put on Hospice|0|||
157019142|NCT04927065|566824714|FG013|First Booster|Physician Decision|0|||
157134669|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
156721351|NCT03323398|565725864|FG004|Overall Study|Participant was Put on Hospice|0|||
156721352|NCT03323398|565725865|FG005|Overall Study|Participant was Put on Hospice|0|||
156721353|NCT03323398|565725866|FG006|Overall Study|Participant was Put on Hospice|1|||
156721354|NCT03323398|565725867|FG007|Overall Study|Participant was Put on Hospice|0|||
156721355|NCT03323398|565725868|FG008|Overall Study|Participant was Put on Hospice|0|||
157134670|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
157134671|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
157134672|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
157134673|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
157134674|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
157134675|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
157134676|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
157134677|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
157134678|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
157134679|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
157134680|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
157134681|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
157134682|NCT02660580|567241739|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
157134683|NCT02660580|567241740|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
157134684|NCT02660580|567241741|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
157134685|NCT02660580|567241742|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
157134686|NCT02660580|567241743|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
157134687|NCT05415449|567241744|FG000|Overall Study|Lost to Follow-up|2|||
157134688|NCT05415449|567241744|FG000|Overall Study|Withdrawal by Subject|4|||
157134689|NCT02185521|567241748|FG000|Overall Study|Withdrawal by Subject|1|||
157134690|NCT02185521|567241748|FG000|Overall Study|Protocol Violation|1|||
157134691|NCT01028352|567241750|FG000|Overall Study|Ineligible due to baseline average pain|5|||
157134692|NCT01028352|567241750|FG000|Overall Study|Withdrawal by Subject|1|||
157134693|NCT03124459|567241751|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
157134694|NCT03124459|567241752|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
157134695|NCT03124459|567241753|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
157134696|NCT03124459|567241754|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
157134697|NCT03124459|567241755|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
157134698|NCT03124459|567241756|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
157134699|NCT03124459|567241751|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
157134700|NCT03124459|567241752|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
157134701|NCT03124459|567241753|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
157134702|NCT03124459|567241754|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
157134703|NCT03124459|567241755|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
157134704|NCT03124459|567241756|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
157134705|NCT03124459|567241751|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
157134706|NCT03124459|567241752|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
157134707|NCT03124459|567241753|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
157134708|NCT03124459|567241754|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
157134709|NCT03124459|567241755|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
157134710|NCT03124459|567241756|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
157134711|NCT03124459|567241751|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
157134712|NCT03124459|567241752|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
157134713|NCT03124459|567241753|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
157134714|NCT03124459|567241754|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
157134715|NCT03124459|567241755|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
157134716|NCT03124459|567241756|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
157134717|NCT03124459|567241751|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
157134718|NCT03124459|567241752|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
157134719|NCT03124459|567241753|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
157134720|NCT03124459|567241754|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
157134721|NCT03124459|567241755|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
157134722|NCT03124459|567241756|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
157134723|NCT03124459|567241751|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
157134724|NCT03124459|567241752|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
157134725|NCT03124459|567241753|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
156794100|NCT03715829|565999494|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794101|NCT03715829|565999495|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794102|NCT03715829|565999496|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794103|NCT03715829|565999497|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794104|NCT03715829|565999498|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794105|NCT03715829|565999499|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
157019143|NCT04927065|566824715|FG014|First Booster|Physician Decision|0|||
157134726|NCT03124459|567241754|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
157134727|NCT03124459|567241755|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
157134728|NCT03124459|567241756|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
157134729|NCT01903876|567241757|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
157134730|NCT01903876|567241758|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
157134731|NCT01903876|567241757|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
157134732|NCT01903876|567241758|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
157134733|NCT00826748|567241768|FG000|Overall Study|Withdrawal by Subject|0|||
157134734|NCT00826748|567241769|FG001|Overall Study|Withdrawal by Subject|0|||
157134735|NCT00826748|567241770|FG002|Overall Study|Withdrawal by Subject|2|||
157134736|NCT00826748|567241768|FG000|Overall Study|Physician Decision|0|||
157134737|NCT00826748|567241769|FG001|Overall Study|Physician Decision|0|||
157134738|NCT00826748|567241770|FG002|Overall Study|Physician Decision|1|||
157134739|NCT00826748|567241768|FG000|Overall Study|Samples Did Not pass QC|0|||
157134740|NCT00826748|567241769|FG001|Overall Study|Samples Did Not pass QC|0|||
157134741|NCT00826748|567241770|FG002|Overall Study|Samples Did Not pass QC|1|||
157134742|NCT01887912|567241771|FG000|Overall Study|Serious adverse event|400|||
157134743|NCT01887912|567241772|FG001|Overall Study|Serious adverse event|198|||
157134744|NCT01887912|567241771|FG000|Overall Study|Other Adverse Event|34|||
157134745|NCT01887912|567241772|FG001|Overall Study|Other Adverse Event|15|||
157134746|NCT01887912|567241771|FG000|Overall Study|Protocol Violation|67|||
157134747|NCT01887912|567241772|FG001|Overall Study|Protocol Violation|37|||
157134748|NCT01887912|567241771|FG000|Overall Study|Lost to Follow-up|163|||
157134749|NCT01887912|567241772|FG001|Overall Study|Lost to Follow-up|74|||
157134750|NCT01887912|567241771|FG000|Overall Study|Withdrawal by Subject|606|||
157134751|NCT01887912|567241772|FG001|Overall Study|Withdrawal by Subject|349|||
157134752|NCT01887912|567241771|FG000|Overall Study|Other|122|||
157134753|NCT01887912|567241772|FG001|Overall Study|Other|58|||
157134754|NCT04462536|567241773|FG000|Overall Study|Withdrawal by Subject|3|||
157134755|NCT04462536|567241774|FG001|Overall Study|Withdrawal by Subject|9|||
157134756|NCT04462536|567241773|FG000|Overall Study|Lost to Follow-up|2|||
156721356|NCT03323398|565725860|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
156721357|NCT03323398|565725861|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
156721358|NCT03323398|565725862|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
156721359|NCT03323398|565725863|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
156721360|NCT03323398|565725864|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
156721361|NCT03323398|565725865|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
156721362|NCT03323398|565725866|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
156794106|NCT03715829|565999500|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
156794107|NCT03715829|565999501|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
157134757|NCT04462536|567241774|FG001|Overall Study|Lost to Follow-up|4|||
157134758|NCT00450580|567241777|FG000|Overall Study|Adverse Event|5|||
157134759|NCT00450580|567241778|FG001|Overall Study|Adverse Event|7|||
157134760|NCT00450580|567241777|FG000|Overall Study|Lost to Follow-up|4|||
157134761|NCT00450580|567241778|FG001|Overall Study|Lost to Follow-up|5|||
157134762|NCT00450580|567241777|FG000|Overall Study|Withdrawal by Subject|2|||
157134763|NCT00450580|567241778|FG001|Overall Study|Withdrawal by Subject|2|||
157134764|NCT00450580|567241777|FG000|Overall Study|Protocol Violation|1|||
157134765|NCT00450580|567241778|FG001|Overall Study|Protocol Violation|1|||
157134766|NCT00450580|567241777|FG000|Overall Study|Protocol-defined virologic failure|1|||
157134767|NCT00450580|567241778|FG001|Overall Study|Protocol-defined virologic failure|0|||
157134768|NCT00450580|567241777|FG000|Overall Study|Could not comply with scheduled visits|1|||
157134769|NCT00450580|567241778|FG001|Overall Study|Could not comply with scheduled visits|0|||
157134770|NCT00450580|567241777|FG000|Overall Study|Patient went to Brazil|1|||
157134771|NCT00450580|567241778|FG001|Overall Study|Patient went to Brazil|0|||
157134772|NCT00450580|567241777|FG000|Overall Study|Patient could not swallow Norvir|1|||
157134773|NCT00450580|567241778|FG001|Overall Study|Patient could not swallow Norvir|0|||
157134774|NCT00450580|567241777|FG000|Overall Study|Withdrawal due to pregnancy|0|||
157134775|NCT00450580|567241778|FG001|Overall Study|Withdrawal due to pregnancy|1|||
157134776|NCT00332709|567241783|FG000|Overall Study|Adverse Event|11|||
157134777|NCT00332709|567241784|FG001|Overall Study|Adverse Event|14|||
157217288|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
157217289|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
157134778|NCT00332709|567241783|FG000|Overall Study|Withdrawal by Subject|2|||
157134779|NCT00332709|567241784|FG001|Overall Study|Withdrawal by Subject|3|||
157134780|NCT00332709|567241783|FG000|Overall Study|Lost to Follow-up|2|||
157134781|NCT00332709|567241784|FG001|Overall Study|Lost to Follow-up|0|||
157134782|NCT00332709|567241783|FG000|Overall Study|Administrative Problems|0|||
157134783|NCT00332709|567241784|FG001|Overall Study|Administrative Problems|3|||
157134784|NCT00332709|567241783|FG000|Overall Study|Abnormal test procedure result|1|||
157134785|NCT00332709|567241784|FG001|Overall Study|Abnormal test procedure result|0|||
157134786|NCT01169779|567241787|FG000|Overall Study|Adverse Event|3|||
157134787|NCT01169779|567241788|FG001|Overall Study|Adverse Event|11|||
157134788|NCT01169779|567241787|FG000|Overall Study|Lack of Efficacy|1|||
157217290|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
156721363|NCT03323398|565725867|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
156721364|NCT03323398|565725868|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
156721365|NCT02235454|565725869|FG000|Overall Study|Withdrawal by Subject|2|||
156721366|NCT03641469|565725870|FG000|Overall Study|Ineligible|2|||
156721367|NCT03641469|565725870|FG000|Overall Study|Withdrawal by Subject|5|||
156721368|NCT03641469|565725870|FG000|Overall Study|Physician Decision|1|||
156721369|NCT03641469|565725870|FG000|Overall Study|Protocol Violation|1|||
156721370|NCT03641469|565725870|FG000|Overall Study|Lost to Follow-up|2|||
156721371|NCT06389487|565725871|FG000|Overall Study|Lost to Follow-up|9|||
156721372|NCT06389487|565725872|FG001|Overall Study|Lost to Follow-up|5|||
156721373|NCT06389487|565725873|FG002|Overall Study|Lost to Follow-up|13|||
156721374|NCT06389487|565725871|FG000|Overall Study|Protocol Violation|0|||
156721375|NCT06389487|565725872|FG001|Overall Study|Protocol Violation|0|||
156721376|NCT06389487|565725873|FG002|Overall Study|Protocol Violation|2|||
156721377|NCT06389487|565725871|FG000|Overall Study|Withdrawal by Subject|2|||
156721378|NCT06389487|565725872|FG001|Overall Study|Withdrawal by Subject|2|||
156721379|NCT06389487|565725873|FG002|Overall Study|Withdrawal by Subject|1|||
156721380|NCT06389487|565725871|FG000|Overall Study|Other|1|||
156721381|NCT06389487|565725872|FG001|Overall Study|Other|0|||
156721382|NCT06389487|565725873|FG002|Overall Study|Other|1|||
156721383|NCT05479435|565725874|FG000|Overall Study|Withdrawal by Subject|1|||
156721384|NCT05479435|565725875|FG001|Overall Study|Withdrawal by Subject|0|||
156721385|NCT05479435|565725876|FG002|Overall Study|Withdrawal by Subject|0|||
156721386|NCT05479435|565725874|FG000|Overall Study|Covid 19|0|||
156721387|NCT05479435|565725875|FG001|Overall Study|Covid 19|0|||
156721388|NCT05479435|565725876|FG002|Overall Study|Covid 19|2|||
156721389|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
156721390|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
156721391|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
156721392|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
156721393|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
156721394|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
156721395|NCT00955617|565725880|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
156721396|NCT00955617|565725881|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
156721397|NCT00982657|565725883|FG000|Overall Study|Death|1|||
156721398|NCT00982657|565725884|FG001|Overall Study|Death|0|||
156721399|NCT00982657|565725885|FG002|Overall Study|Death|1|||
156721400|NCT00982657|565725886|FG003|Overall Study|Death|1|||
156721401|NCT00982657|565725883|FG000|Overall Study|Withdrawal by Subject|0|||
156721402|NCT00982657|565725884|FG001|Overall Study|Withdrawal by Subject|0|||
156721403|NCT00982657|565725885|FG002|Overall Study|Withdrawal by Subject|1|||
156721404|NCT00982657|565725886|FG003|Overall Study|Withdrawal by Subject|3|||
156721405|NCT00982657|565725883|FG000|Overall Study|Other|0|||
156794108|NCT03715829|565999502|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794109|NCT03715829|565999503|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
156794110|NCT03715829|565999493|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
157134789|NCT01169779|567241788|FG001|Overall Study|Lack of Efficacy|0|||
157134790|NCT01169779|567241787|FG000|Overall Study|Protocol Violation|1|||
157134791|NCT01169779|567241788|FG001|Overall Study|Protocol Violation|1|||
157134792|NCT01169779|567241787|FG000|Overall Study|Withdrawal by Subject|3|||
157134793|NCT01169779|567241788|FG001|Overall Study|Withdrawal by Subject|2|||
157134794|NCT01169779|567241787|FG000|Overall Study|Familial and personal reasons|3|||
156721406|NCT00982657|565725884|FG001|Overall Study|Other|0|||
156721407|NCT00982657|565725885|FG002|Overall Study|Other|0|||
156721408|NCT00982657|565725886|FG003|Overall Study|Other|4|||
156721409|NCT00982657|565725883|FG000|Overall Study|On going at date of cut-off|0|||
156721410|NCT00982657|565725884|FG001|Overall Study|On going at date of cut-off|0|||
156721411|NCT00982657|565725885|FG002|Overall Study|On going at date of cut-off|0|||
156721412|NCT00982657|565725886|FG003|Overall Study|On going at date of cut-off|1|||
156721413|NCT02141438|565727387|FG000|Overall Study|Death|1308|||
156721414|NCT02141438|565727387|FG000|Overall Study|Lost to Follow-up|84|||
156721415|NCT02141438|565727387|FG000|Overall Study|Withdrawal by Subject|52|||
156721416|NCT02141438|565727387|FG000|Overall Study|Physician Decision|1|||
156721417|NCT02141438|565727387|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
157134795|NCT01169779|567241788|FG001|Overall Study|Familial and personal reasons|3|||
156721418|NCT02546986|565727390|FG000|Treatment Period|Progressive Disease|20|||
156721419|NCT02546986|565727391|FG001|Treatment Period|Progressive Disease|22|||
156721420|NCT02546986|565727390|FG000|Treatment Period|Adverse Event|14|||
156721421|NCT02546986|565727391|FG001|Treatment Period|Adverse Event|6|||
156721422|NCT02546986|565727390|FG000|Treatment Period|Symptomatic Deterioration|4|||
156721423|NCT02546986|565727391|FG001|Treatment Period|Symptomatic Deterioration|3|||
156721424|NCT02546986|565727390|FG000|Treatment Period|Death|3|||
156721425|NCT02546986|565727391|FG001|Treatment Period|Death|4|||
156721426|NCT02546986|565727390|FG000|Treatment Period|Physician Decision|1|||
156721427|NCT02546986|565727391|FG001|Treatment Period|Physician Decision|2|||
157134796|NCT03293654|567241791|FG000|Overall Study|Lost to Follow-up|0|||
156721428|NCT02546986|565727390|FG000|Treatment Period|Protocol Violation|1|||
156721429|NCT02546986|565727391|FG001|Treatment Period|Protocol Violation|0|||
156721430|NCT02546986|565727390|FG000|Treatment Period|Withdrawal by Subject|1|||
156721431|NCT02546986|565727391|FG001|Treatment Period|Withdrawal by Subject|1|||
156721432|NCT02546986|565727390|FG000|Treatment Period|Non-compliance with Study Drug|0|||
156721433|NCT02546986|565727391|FG001|Treatment Period|Non-compliance with Study Drug|1|||
156721434|NCT02546986|565727390|FG000|Treatment Period|Study Terminated by Sponsor|0|||
156721435|NCT02546986|565727391|FG001|Treatment Period|Study Terminated by Sponsor|1|||
156721436|NCT02546986|565727390|FG000|Treatment Period|Miscellaneous|7|||
156721437|NCT02546986|565727391|FG001|Treatment Period|Miscellaneous|9|||
156721438|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Missing Status|3|||
156721439|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Missing Status|5|||
156721440|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Death|18|||
156721441|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Death|12|||
156721442|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Alive|13|||
156721443|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Alive|16|||
156721444|NCT02546986|565727390|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
156721445|NCT02546986|565727391|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
156721446|NCT00739882|565727392|FG000|Double-blind Period|Adverse Event|1|||
156721447|NCT00739882|565727393|FG001|Double-blind Period|Adverse Event|2|||
156721448|NCT00739882|565727392|FG000|Double-blind Period|Protocol Violation|1|||
156721449|NCT00739882|565727393|FG001|Double-blind Period|Protocol Violation|0|||
156721450|NCT00739882|565727392|FG000|Double-blind Period|Lack of Efficacy|1|||
156721451|NCT00739882|565727393|FG001|Double-blind Period|Lack of Efficacy|1|||
156721452|NCT00739882|565727392|FG000|Double-blind Period|Other|16|||
156721453|NCT00739882|565727393|FG001|Double-blind Period|Other|8|||
156721454|NCT00739882|565727392|FG000|Open-label Period|Adverse Event|1|||
156721455|NCT00739882|565727393|FG001|Open-label Period|Adverse Event|0|||
156721456|NCT00739882|565727392|FG000|Open-label Period|Other|9|||
156721457|NCT00739882|565727393|FG001|Open-label Period|Other|5|||
156721458|NCT04021914|565727394|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
156721459|NCT02844543|565727395|FG000|Overall Study|Withdrawal by Subject|4|||
156721460|NCT02844543|565727395|FG000|Overall Study|Did not meet eligibility criteria|1|||
156721461|NCT03349060|565727396|FG000|Overall Study|Adverse Event|9|||
156721462|NCT03349060|565727397|FG001|Overall Study|Adverse Event|9|||
156721463|NCT03349060|565727398|FG002|Overall Study|Adverse Event|7|||
156721464|NCT03349060|565727396|FG000|Overall Study|Lack of Efficacy|1|||
156721465|NCT03349060|565727397|FG001|Overall Study|Lack of Efficacy|0|||
156721466|NCT03349060|565727398|FG002|Overall Study|Lack of Efficacy|2|||
156721467|NCT03349060|565727396|FG000|Overall Study|Lost to Follow-up|2|||
156721468|NCT03349060|565727397|FG001|Overall Study|Lost to Follow-up|1|||
156721469|NCT03349060|565727398|FG002|Overall Study|Lost to Follow-up|1|||
156721470|NCT03349060|565727396|FG000|Overall Study|Protocol Violation|2|||
156721471|NCT03349060|565727397|FG001|Overall Study|Protocol Violation|2|||
156721472|NCT03349060|565727398|FG002|Overall Study|Protocol Violation|1|||
157134797|NCT03293654|567241792|FG001|Overall Study|Lost to Follow-up|1|||
157134798|NCT03293654|567241793|FG002|Overall Study|Lost to Follow-up|0|||
157134799|NCT03155997|567241795|FG000|Overall Study|Withdrawal by Subject|119|||
157134800|NCT03155997|567241796|FG001|Overall Study|Withdrawal by Subject|134|||
157134801|NCT03155997|567241795|FG000|Overall Study|Lost to Follow-up|12|||
156721473|NCT03349060|565727396|FG000|Overall Study|Withdrawal by Subject|5|||
156721474|NCT03349060|565727397|FG001|Overall Study|Withdrawal by Subject|3|||
156721475|NCT03349060|565727398|FG002|Overall Study|Withdrawal by Subject|4|||
156794111|NCT03715829|565999494|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
156721476|NCT03349060|565727396|FG000|Overall Study|Medication error,no linked adverse event|0|||
156721477|NCT03349060|565727397|FG001|Overall Study|Medication error,no linked adverse event|0|||
156721478|NCT03349060|565727398|FG002|Overall Study|Medication error,no linked adverse event|1|||
156721479|NCT03349060|565727396|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156721480|NCT03349060|565727397|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
156721481|NCT03349060|565727398|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
156721482|NCT03349060|565727396|FG000|Overall Study|Other|2|||
156721483|NCT03349060|565727397|FG001|Overall Study|Other|1|||
156721484|NCT03349060|565727398|FG002|Overall Study|Other|0|||
156721485|NCT00955409|565727399|FG000|Overall Study|Lack of Efficacy|1|||
156721486|NCT00955409|565727400|FG001|Overall Study|Lack of Efficacy|0|||
156721487|NCT00955409|565727401|FG002|Overall Study|Lack of Efficacy|0|||
156721488|NCT00955409|565727402|FG003|Overall Study|Lack of Efficacy|0|||
156721489|NCT00955409|565727403|FG004|Overall Study|Lack of Efficacy|0|||
156721490|NCT00955409|565727404|FG005|Overall Study|Lack of Efficacy|0|||
156721491|NCT00955409|565727405|FG006|Overall Study|Lack of Efficacy|0|||
156721492|NCT00955409|565727406|FG007|Overall Study|Lack of Efficacy|0|||
156721493|NCT00955409|565727407|FG008|Overall Study|Lack of Efficacy|0|||
156721494|NCT00955409|565727408|FG009|Overall Study|Lack of Efficacy|0|||
156721495|NCT00955409|565727399|FG000|Overall Study|Withdrawal by Subject|1|||
156721496|NCT00955409|565727400|FG001|Overall Study|Withdrawal by Subject|0|||
157019144|NCT04927065|566824716|FG015|First Booster|Physician Decision|0|||
157134802|NCT03155997|567241796|FG001|Overall Study|Lost to Follow-up|13|||
157134803|NCT03155997|567241795|FG000|Overall Study|Missing disposition data|0|||
157134804|NCT03155997|567241796|FG001|Overall Study|Missing disposition data|1|||
157134805|NCT03155997|567241795|FG000|Overall Study|On study treatment|2027|||
157134806|NCT03155997|567241796|FG001|Overall Study|On study treatment|2074|||
157134807|NCT00792298|567241797|FG000|Treatment Period 1|Adverse Event|0|||
157134808|NCT00792298|567241798|FG001|Treatment Period 1|Adverse Event|1|||
157134809|NCT00792298|567241799|FG002|Treatment Period 1|Adverse Event|0|||
157134810|NCT00792298|567241800|FG003|Treatment Period 1|Adverse Event|1|||
157134811|NCT00792298|567241801|FG004|Treatment Period 1|Adverse Event|0|||
157134812|NCT00792298|567241802|FG005|Treatment Period 1|Adverse Event|1|||
157134813|NCT00792298|567241803|FG006|Treatment Period 1|Adverse Event|1|||
157134814|NCT00792298|567241804|FG007|Treatment Period 1|Adverse Event|0|||
157134815|NCT00792298|567241797|FG000|Treatment Period 1|Lack of Efficacy|0|||
157134816|NCT00792298|567241798|FG001|Treatment Period 1|Lack of Efficacy|0|||
157134817|NCT00792298|567241799|FG002|Treatment Period 1|Lack of Efficacy|1|||
157134818|NCT00792298|567241800|FG003|Treatment Period 1|Lack of Efficacy|0|||
157134819|NCT00792298|567241801|FG004|Treatment Period 1|Lack of Efficacy|0|||
156721497|NCT00955409|565727401|FG002|Overall Study|Withdrawal by Subject|5|||
156721498|NCT00955409|565727402|FG003|Overall Study|Withdrawal by Subject|2|||
156721499|NCT00955409|565727403|FG004|Overall Study|Withdrawal by Subject|0|||
156721500|NCT00955409|565727404|FG005|Overall Study|Withdrawal by Subject|0|||
156721501|NCT00955409|565727405|FG006|Overall Study|Withdrawal by Subject|2|||
156721502|NCT00955409|565727406|FG007|Overall Study|Withdrawal by Subject|0|||
156721503|NCT00955409|565727407|FG008|Overall Study|Withdrawal by Subject|1|||
156721504|NCT00955409|565727408|FG009|Overall Study|Withdrawal by Subject|0|||
156721505|NCT00955409|565727399|FG000|Overall Study|Caregiver Request|2|||
156721506|NCT00955409|565727400|FG001|Overall Study|Caregiver Request|0|||
156721507|NCT00955409|565727401|FG002|Overall Study|Caregiver Request|6|||
157134820|NCT00792298|567241802|FG005|Treatment Period 1|Lack of Efficacy|0|||
157134821|NCT00792298|567241803|FG006|Treatment Period 1|Lack of Efficacy|0|||
157134822|NCT00792298|567241804|FG007|Treatment Period 1|Lack of Efficacy|0|||
157134823|NCT00792298|567241797|FG000|Treatment Period 1|Withdrawal by Subject|1|||
157134824|NCT00792298|567241798|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157134825|NCT00792298|567241799|FG002|Treatment Period 1|Withdrawal by Subject|1|||
157134826|NCT00792298|567241800|FG003|Treatment Period 1|Withdrawal by Subject|2|||
157134827|NCT00792298|567241801|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157134828|NCT00792298|567241802|FG005|Treatment Period 1|Withdrawal by Subject|2|||
157134829|NCT00792298|567241803|FG006|Treatment Period 1|Withdrawal by Subject|1|||
157134830|NCT00792298|567241804|FG007|Treatment Period 1|Withdrawal by Subject|0|||
157134831|NCT00792298|567241797|FG000|Treatment Period 1|Lost to Follow-up|0|||
157134832|NCT00792298|567241798|FG001|Treatment Period 1|Lost to Follow-up|0|||
157134833|NCT00792298|567241799|FG002|Treatment Period 1|Lost to Follow-up|0|||
157134834|NCT00792298|567241800|FG003|Treatment Period 1|Lost to Follow-up|0|||
157134835|NCT00792298|567241801|FG004|Treatment Period 1|Lost to Follow-up|0|||
157134836|NCT00792298|567241802|FG005|Treatment Period 1|Lost to Follow-up|0|||
157134837|NCT00792298|567241803|FG006|Treatment Period 1|Lost to Follow-up|1|||
157134838|NCT00792298|567241804|FG007|Treatment Period 1|Lost to Follow-up|0|||
157134839|NCT00792298|567241797|FG000|Treatment Period 1|Physician Decision|0|||
157134840|NCT00792298|567241798|FG001|Treatment Period 1|Physician Decision|0|||
157134841|NCT00792298|567241799|FG002|Treatment Period 1|Physician Decision|0|||
157134842|NCT00792298|567241800|FG003|Treatment Period 1|Physician Decision|1|||
157134843|NCT00792298|567241801|FG004|Treatment Period 1|Physician Decision|0|||
157134844|NCT00792298|567241802|FG005|Treatment Period 1|Physician Decision|0|||
157134845|NCT00792298|567241803|FG006|Treatment Period 1|Physician Decision|1|||
157134846|NCT00792298|567241804|FG007|Treatment Period 1|Physician Decision|0|||
157134847|NCT00792298|567241797|FG000|Treatment Period 1|Protocol Violation|0|||
157134848|NCT00792298|567241798|FG001|Treatment Period 1|Protocol Violation|0|||
157134849|NCT00792298|567241799|FG002|Treatment Period 1|Protocol Violation|0|||
157134850|NCT00792298|567241800|FG003|Treatment Period 1|Protocol Violation|0|||
157134851|NCT00792298|567241801|FG004|Treatment Period 1|Protocol Violation|0|||
157134852|NCT00792298|567241802|FG005|Treatment Period 1|Protocol Violation|0|||
157134853|NCT00792298|567241803|FG006|Treatment Period 1|Protocol Violation|0|||
157134854|NCT00792298|567241804|FG007|Treatment Period 1|Protocol Violation|1|||
156721508|NCT00955409|565727402|FG003|Overall Study|Caregiver Request|5|||
156721509|NCT00955409|565727403|FG004|Overall Study|Caregiver Request|0|||
156721510|NCT00955409|565727404|FG005|Overall Study|Caregiver Request|2|||
157134855|NCT00792298|567241797|FG000|Washout|Adverse Event|0|||
157134856|NCT00792298|567241798|FG001|Washout|Adverse Event|0|||
157134857|NCT00792298|567241799|FG002|Washout|Adverse Event|0|||
157134858|NCT00792298|567241800|FG003|Washout|Adverse Event|0|||
157134859|NCT00792298|567241801|FG004|Washout|Adverse Event|0|||
157134860|NCT00792298|567241802|FG005|Washout|Adverse Event|1|||
156721511|NCT00955409|565727405|FG006|Overall Study|Caregiver Request|3|||
156721512|NCT00955409|565727406|FG007|Overall Study|Caregiver Request|1|||
156721513|NCT00955409|565727407|FG008|Overall Study|Caregiver Request|3|||
157134861|NCT00792298|567241803|FG006|Washout|Adverse Event|0|||
157134862|NCT00792298|567241804|FG007|Washout|Adverse Event|0|||
157134863|NCT00792298|567241797|FG000|Washout|Withdrawal by Subject|0|||
157134864|NCT00792298|567241798|FG001|Washout|Withdrawal by Subject|0|||
157134865|NCT00792298|567241799|FG002|Washout|Withdrawal by Subject|1|||
157134866|NCT00792298|567241800|FG003|Washout|Withdrawal by Subject|0|||
157134867|NCT00792298|567241801|FG004|Washout|Withdrawal by Subject|0|||
157134868|NCT00792298|567241802|FG005|Washout|Withdrawal by Subject|1|||
157134869|NCT00792298|567241803|FG006|Washout|Withdrawal by Subject|0|||
157134870|NCT00792298|567241804|FG007|Washout|Withdrawal by Subject|0|||
157134871|NCT00792298|567241797|FG000|Treatment Period 2|Lack of Efficacy|0|||
157134872|NCT00792298|567241798|FG001|Treatment Period 2|Lack of Efficacy|0|||
157134873|NCT00792298|567241799|FG002|Treatment Period 2|Lack of Efficacy|0|||
157134874|NCT00792298|567241800|FG003|Treatment Period 2|Lack of Efficacy|0|||
157134875|NCT00792298|567241801|FG004|Treatment Period 2|Lack of Efficacy|1|||
157134876|NCT00792298|567241802|FG005|Treatment Period 2|Lack of Efficacy|0|||
157134877|NCT00792298|567241803|FG006|Treatment Period 2|Lack of Efficacy|0|||
157134878|NCT00792298|567241804|FG007|Treatment Period 2|Lack of Efficacy|0|||
157134879|NCT00792298|567241797|FG000|Treatment Period 2|Physician Decision|0|||
157134880|NCT00792298|567241798|FG001|Treatment Period 2|Physician Decision|0|||
157134881|NCT00792298|567241799|FG002|Treatment Period 2|Physician Decision|0|||
157134882|NCT00792298|567241800|FG003|Treatment Period 2|Physician Decision|0|||
157134883|NCT00792298|567241801|FG004|Treatment Period 2|Physician Decision|0|||
157134884|NCT00792298|567241802|FG005|Treatment Period 2|Physician Decision|0|||
157134885|NCT00792298|567241803|FG006|Treatment Period 2|Physician Decision|1|||
157134886|NCT00792298|567241804|FG007|Treatment Period 2|Physician Decision|0|||
157134887|NCT00792298|567241797|FG000|Treatment Period 2|Pregnancy|0|||
157134888|NCT00792298|567241798|FG001|Treatment Period 2|Pregnancy|0|||
157134889|NCT00792298|567241799|FG002|Treatment Period 2|Pregnancy|1|||
157134890|NCT00792298|567241800|FG003|Treatment Period 2|Pregnancy|0|||
157134891|NCT00792298|567241801|FG004|Treatment Period 2|Pregnancy|0|||
157134892|NCT00792298|567241802|FG005|Treatment Period 2|Pregnancy|0|||
157134893|NCT00792298|567241803|FG006|Treatment Period 2|Pregnancy|0|||
157134894|NCT00792298|567241804|FG007|Treatment Period 2|Pregnancy|0|||
157134895|NCT00792298|567241797|FG000|Treatment Period 2|Withdrawal by Subject|1|||
157134896|NCT00792298|567241798|FG001|Treatment Period 2|Withdrawal by Subject|1|||
157134897|NCT00792298|567241799|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157134898|NCT00792298|567241800|FG003|Treatment Period 2|Withdrawal by Subject|2|||
157134899|NCT00792298|567241801|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157134900|NCT00792298|567241802|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157134901|NCT00792298|567241803|FG006|Treatment Period 2|Withdrawal by Subject|0|||
157134902|NCT00792298|567241804|FG007|Treatment Period 2|Withdrawal by Subject|2|||
157134903|NCT00486603|567241807|FG000|Overall Study|Withdrawal by Subject|1|||
157134904|NCT00486603|567241808|FG001|Overall Study|Withdrawal by Subject|0|||
157134905|NCT00486603|567241809|FG002|Overall Study|Withdrawal by Subject|0|||
157134906|NCT00486603|567241810|FG003|Overall Study|Withdrawal by Subject|0|||
157134907|NCT00486603|567241811|FG004|Overall Study|Withdrawal by Subject|0|||
157134908|NCT00486603|567241807|FG000|Overall Study|Physician Decision|0|||
157134909|NCT00486603|567241808|FG001|Overall Study|Physician Decision|1|||
157134910|NCT00486603|567241809|FG002|Overall Study|Physician Decision|0|||
157134911|NCT00486603|567241810|FG003|Overall Study|Physician Decision|0|||
157134912|NCT00486603|567241811|FG004|Overall Study|Physician Decision|0|||
157134913|NCT01670994|567241813|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
157134914|NCT01670994|567241814|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
157134915|NCT01670994|567241813|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
157134916|NCT01670994|567241814|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
157134917|NCT01670994|567241813|FG000|Overall Study|Patient experienced DLT|0|||
157134918|NCT01670994|567241814|FG001|Overall Study|Patient experienced DLT|1|||
157134919|NCT02013544|567241815|FG000|Overall Study|Adverse Event|5|||
157134920|NCT02013544|567241816|FG001|Overall Study|Adverse Event|5|||
157134921|NCT02013544|567241815|FG000|Overall Study|Lost to Follow-up|2|||
157134922|NCT02013544|567241816|FG001|Overall Study|Lost to Follow-up|3|||
157134923|NCT02013544|567241815|FG000|Overall Study|Withdrawal by Subject|2|||
157134924|NCT02013544|567241816|FG001|Overall Study|Withdrawal by Subject|8|||
157134925|NCT02013544|567241815|FG000|Overall Study|Physician Decision|0|||
157134926|NCT02013544|567241816|FG001|Overall Study|Physician Decision|1|||
157134927|NCT02013544|567241815|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
157134928|NCT02013544|567241816|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
157134929|NCT00891735|567241817|FG000|Overall Study|Adverse Event|2|||
157134930|NCT00891735|567241818|FG001|Overall Study|Adverse Event|0|||
157134931|NCT00891735|567241819|FG002|Overall Study|Adverse Event|2|||
157134932|NCT00891735|567241820|FG003|Overall Study|Adverse Event|0|||
157134933|NCT00891735|567241817|FG000|Overall Study|Death|8|||
157217291|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
157134934|NCT00891735|567241818|FG001|Overall Study|Death|5|||
157134935|NCT00891735|567241819|FG002|Overall Study|Death|4|||
157134936|NCT00891735|567241820|FG003|Overall Study|Death|5|||
157134937|NCT00891735|567241817|FG000|Overall Study|Lost to Follow-up|2|||
157134938|NCT00891735|567241818|FG001|Overall Study|Lost to Follow-up|2|||
157134939|NCT00891735|567241819|FG002|Overall Study|Lost to Follow-up|2|||
157134940|NCT00891735|567241820|FG003|Overall Study|Lost to Follow-up|2|||
157134941|NCT00891735|567241817|FG000|Overall Study|Physician's decision to withdraw patient|1|||
157134942|NCT00891735|567241818|FG001|Overall Study|Physician's decision to withdraw patient|0|||
157134943|NCT00891735|567241819|FG002|Overall Study|Physician's decision to withdraw patient|0|||
157134944|NCT00891735|567241820|FG003|Overall Study|Physician's decision to withdraw patient|0|||
157134945|NCT00891735|567241817|FG000|Overall Study|Patient's decision to withdraw|4|||
157134946|NCT00891735|567241818|FG001|Overall Study|Patient's decision to withdraw|9|||
157134947|NCT00891735|567241819|FG002|Overall Study|Patient's decision to withdraw|4|||
157134948|NCT00891735|567241820|FG003|Overall Study|Patient's decision to withdraw|8|||
157134949|NCT00291551|567241823|FG000|Overall Study|Death|7|||
157134950|NCT00291551|567241823|FG000|Overall Study|Withdrawal by Subject|6|||
157134951|NCT02452762|567241824|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
156721514|NCT00955409|565727408|FG009|Overall Study|Caregiver Request|0|||
156721515|NCT00955409|565727399|FG000|Overall Study|Investigator Request|0|||
156721516|NCT00955409|565727400|FG001|Overall Study|Investigator Request|0|||
156721517|NCT00955409|565727401|FG002|Overall Study|Investigator Request|1|||
156721518|NCT00955409|565727402|FG003|Overall Study|Investigator Request|0|||
156721519|NCT00955409|565727403|FG004|Overall Study|Investigator Request|0|||
156721520|NCT00955409|565727404|FG005|Overall Study|Investigator Request|0|||
156721521|NCT00955409|565727405|FG006|Overall Study|Investigator Request|0|||
157134952|NCT02452762|567241825|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
157134953|NCT02452762|567241824|FG000|Overall Study|Withdrawal by Subject|1|||
157134954|NCT02452762|567241825|FG001|Overall Study|Withdrawal by Subject|0|||
157134955|NCT00584870|567241826|FG000|Overall Study|Adverse Event|4|||
157134956|NCT00584870|567241827|FG001|Overall Study|Adverse Event|3|||
157134957|NCT00584870|567241828|FG002|Overall Study|Adverse Event|2|||
157134958|NCT00584870|567241826|FG000|Overall Study|Lost to Follow-up|4|||
157134959|NCT00584870|567241827|FG001|Overall Study|Lost to Follow-up|1|||
157134960|NCT00584870|567241828|FG002|Overall Study|Lost to Follow-up|1|||
157134961|NCT00584870|567241826|FG000|Overall Study|Lack of Efficacy|7|||
157134962|NCT00584870|567241827|FG001|Overall Study|Lack of Efficacy|14|||
157134963|NCT00584870|567241828|FG002|Overall Study|Lack of Efficacy|8|||
157134964|NCT00584870|567241826|FG000|Overall Study|Withdrawal by Subject|10|||
157134965|NCT00584870|567241827|FG001|Overall Study|Withdrawal by Subject|5|||
157134966|NCT00584870|567241828|FG002|Overall Study|Withdrawal by Subject|3|||
156721522|NCT00955409|565727406|FG007|Overall Study|Investigator Request|0|||
156721523|NCT00955409|565727407|FG008|Overall Study|Investigator Request|0|||
157134967|NCT00584870|567241826|FG000|Overall Study|Protocol Violation|1|||
157134968|NCT00584870|567241827|FG001|Overall Study|Protocol Violation|1|||
157134969|NCT00584870|567241828|FG002|Overall Study|Protocol Violation|2|||
157134970|NCT00584870|567241826|FG000|Overall Study|Did not met entrance criteria|1|||
157134971|NCT00584870|567241827|FG001|Overall Study|Did not met entrance criteria|0|||
157134972|NCT00584870|567241828|FG002|Overall Study|Did not met entrance criteria|0|||
157134973|NCT00584870|567241826|FG000|Overall Study|Other|2|||
157134974|NCT00584870|567241827|FG001|Overall Study|Other|0|||
157134975|NCT00584870|567241828|FG002|Overall Study|Other|0|||
157134976|NCT00584870|567241826|FG000|Overall Study|Randomized but not treated|0|||
157134977|NCT00584870|567241827|FG001|Overall Study|Randomized but not treated|1|||
157134978|NCT00584870|567241828|FG002|Overall Study|Randomized but not treated|2|||
157134979|NCT00631137|567241829|FG000|Overall Study|Withdrawal by Subject|1|||
157134980|NCT00631137|567241830|FG001|Overall Study|Withdrawal by Subject|0|||
156721524|NCT00955409|565727408|FG009|Overall Study|Investigator Request|0|||
156721525|NCT00955409|565727399|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
156721526|NCT00955409|565727400|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
157134981|NCT03682120|567241831|FG000|Overall Study|Lost to Follow-up|11|||
157134982|NCT03682120|567241832|FG001|Overall Study|Lost to Follow-up|4|||
157134983|NCT03682120|567241833|FG002|Overall Study|Lost to Follow-up|5|||
157134984|NCT03682120|567241834|FG003|Overall Study|Lost to Follow-up|2|||
156721527|NCT00955409|565727401|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
156721528|NCT00955409|565727402|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
156721529|NCT00955409|565727403|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
156721530|NCT00955409|565727404|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
156721531|NCT00955409|565727405|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
157134985|NCT03682120|567241831|FG000|Overall Study|Physician Decision|1|||
157134986|NCT03682120|567241832|FG001|Overall Study|Physician Decision|0|||
157134987|NCT03682120|567241833|FG002|Overall Study|Physician Decision|0|||
157134988|NCT03682120|567241834|FG003|Overall Study|Physician Decision|0|||
157134989|NCT03682120|567241831|FG000|Overall Study|Withdrawal by Subject|1|||
157134990|NCT03682120|567241832|FG001|Overall Study|Withdrawal by Subject|2|||
157134991|NCT03682120|567241833|FG002|Overall Study|Withdrawal by Subject|3|||
157134992|NCT03682120|567241834|FG003|Overall Study|Withdrawal by Subject|0|||
157134993|NCT03682120|567241831|FG000|Overall Study|Death|0|||
157134994|NCT03682120|567241832|FG001|Overall Study|Death|1|||
157134995|NCT03682120|567241833|FG002|Overall Study|Death|0|||
157134996|NCT03682120|567241834|FG003|Overall Study|Death|0|||
157134997|NCT03682120|567241831|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
157134998|NCT03682120|567241832|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
157134999|NCT03682120|567241833|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
157135000|NCT03682120|567241834|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
157135001|NCT01015833|567241835|FG000|Overall Study|Death|1|||
157135002|NCT01015833|567241836|FG001|Overall Study|Death|0|||
157135003|NCT01015833|567241835|FG000|Overall Study|Withdrawal by Subject|3|||
157135004|NCT01015833|567241836|FG001|Overall Study|Withdrawal by Subject|2|||
157135005|NCT01015833|567241835|FG000|Overall Study|Adverse Event|0|||
157135006|NCT01015833|567241836|FG001|Overall Study|Adverse Event|1|||
157135007|NCT01015833|567241835|FG000|Overall Study|Physician Decision|2|||
157135008|NCT01015833|567241836|FG001|Overall Study|Physician Decision|0|||
157135009|NCT01015833|567241835|FG000|Overall Study|Symptomatic deterioration|0|||
157135010|NCT01015833|567241836|FG001|Overall Study|Symptomatic deterioration|1|||
157135011|NCT01015833|567241835|FG000|Overall Study|Other|5|||
157135012|NCT01015833|567241836|FG001|Overall Study|Other|1|||
157135013|NCT01015833|567241835|FG000|Overall Study|Motor Vehicle Accidents|1|||
157135014|NCT01015833|567241836|FG001|Overall Study|Motor Vehicle Accidents|0|||
157135015|NCT01015833|567241835|FG000|Overall Study|Did not start treatment|1|||
157135016|NCT01015833|567241836|FG001|Overall Study|Did not start treatment|0|||
157135017|NCT01651780|567241837|FG000|Overall Study|Physician decision: No 30-day visit|2|||
157135018|NCT01651780|567241838|FG001|Overall Study|Physician decision: No 30-day visit|1|||
157135019|NCT01651780|567241837|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
157135020|NCT01651780|567241838|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
157135021|NCT01651780|567241837|FG000|Overall Study|Withdrawal by Subject|2|||
157135022|NCT01651780|567241838|FG001|Overall Study|Withdrawal by Subject|0|||
157135023|NCT01651780|567241837|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
157135024|NCT01651780|567241838|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157135025|NCT01651780|567241837|FG000|Overall Study|Lost to Follow-up|1|||
157135026|NCT01651780|567241838|FG001|Overall Study|Lost to Follow-up|2|||
157135027|NCT01651780|567241837|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
157135028|NCT01651780|567241838|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
157135029|NCT02949830|567241839|FG000|Overall Study|Adverse Event|1|||
157135030|NCT02949830|567241839|FG000|Overall Study|Withdrawal by Subject|1|||
157135031|NCT01290887|567241840|FG000|Overall Study|Adverse Event|6|||
157135032|NCT01290887|567241841|FG001|Overall Study|Adverse Event|11|||
157135033|NCT01290887|567241840|FG000|Overall Study|Lack of Efficacy|4|||
157135034|NCT01290887|567241841|FG001|Overall Study|Lack of Efficacy|5|||
157135035|NCT01290887|567241840|FG000|Overall Study|Withdrawal by Subject|26|||
157135036|NCT01290887|567241841|FG001|Overall Study|Withdrawal by Subject|32|||
157135037|NCT01290887|567241840|FG000|Overall Study|Protocol Violation|2|||
157135038|NCT01290887|567241841|FG001|Overall Study|Protocol Violation|1|||
157135039|NCT01290887|567241840|FG000|Overall Study|Lost to Follow-up|4|||
157135040|NCT01290887|567241841|FG001|Overall Study|Lost to Follow-up|4|||
157135041|NCT01290887|567241840|FG000|Overall Study|Non-compliance to study procedures|0|||
157135042|NCT01290887|567241841|FG001|Overall Study|Non-compliance to study procedures|1|||
157135043|NCT01290887|567241840|FG000|Overall Study|Non-compliance to study medications|1|||
157135044|NCT01290887|567241841|FG001|Overall Study|Non-compliance to study medications|0|||
157135045|NCT01290887|567241840|FG000|Overall Study|Sponsor closure of study|420|||
157135046|NCT01290887|567241841|FG001|Overall Study|Sponsor closure of study|476|||
157135047|NCT01290887|567241840|FG000|Overall Study|Other|3|||
157135048|NCT01290887|567241841|FG001|Overall Study|Other|6|||
157135049|NCT01628926|567241842|FG000|Overall Study|Adverse Event|13|||
156721532|NCT00955409|565727406|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
156721533|NCT00955409|565727407|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
156721534|NCT00955409|565727408|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
156721535|NCT00955409|565727399|FG000|Overall Study|Lost to Follow-up|0|||
156721536|NCT00955409|565727400|FG001|Overall Study|Lost to Follow-up|0|||
156721537|NCT00955409|565727401|FG002|Overall Study|Lost to Follow-up|1|||
156721538|NCT00955409|565727402|FG003|Overall Study|Lost to Follow-up|0|||
156721539|NCT00955409|565727403|FG004|Overall Study|Lost to Follow-up|0|||
156721540|NCT00955409|565727404|FG005|Overall Study|Lost to Follow-up|0|||
157135050|NCT01628926|567241843|FG001|Overall Study|Adverse Event|11|||
157135051|NCT01628926|567241844|FG002|Overall Study|Adverse Event|9|||
157135052|NCT01628926|567241842|FG000|Overall Study|Lack of Efficacy|2|||
157135053|NCT01628926|567241843|FG001|Overall Study|Lack of Efficacy|1|||
157135054|NCT01628926|567241844|FG002|Overall Study|Lack of Efficacy|5|||
157135055|NCT01628926|567241842|FG000|Overall Study|Withdrawal by Subject|6|||
157135056|NCT01628926|567241843|FG001|Overall Study|Withdrawal by Subject|4|||
157135057|NCT01628926|567241844|FG002|Overall Study|Withdrawal by Subject|2|||
157135058|NCT01628926|567241842|FG000|Overall Study|Protocol Violation|0|||
157135059|NCT01628926|567241843|FG001|Overall Study|Protocol Violation|1|||
157135060|NCT01628926|567241844|FG002|Overall Study|Protocol Violation|0|||
157135061|NCT01628926|567241842|FG000|Overall Study|Discontinuation criteria|3|||
157135062|NCT01628926|567241843|FG001|Overall Study|Discontinuation criteria|4|||
156721541|NCT00955409|565727405|FG006|Overall Study|Lost to Follow-up|1|||
157135063|NCT01628926|567241844|FG002|Overall Study|Discontinuation criteria|0|||
157135064|NCT01628926|567241842|FG000|Overall Study|Physician Decision|2|||
157135065|NCT01628926|567241843|FG001|Overall Study|Physician Decision|2|||
157135066|NCT01628926|567241844|FG002|Overall Study|Physician Decision|1|||
157135067|NCT02116621|567241845|FG000|Baseline|Withdrawal by Subject|0|||
156721542|NCT00955409|565727406|FG007|Overall Study|Lost to Follow-up|0|||
157135068|NCT02116621|567241846|FG001|Baseline|Withdrawal by Subject|4|||
157135069|NCT02116621|567241845|FG000|Three Month Follow-up|Death|1|||
157135070|NCT02116621|567241846|FG001|Three Month Follow-up|Death|1|||
157135071|NCT02116621|567241845|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
157135072|NCT02116621|567241846|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
157135073|NCT02116621|567241845|FG000|Three Month Follow-up|Lost to Follow-up|0|||
157135074|NCT02116621|567241846|FG001|Three Month Follow-up|Lost to Follow-up|1|||
157135075|NCT02116621|567241845|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
157135076|NCT02116621|567241846|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
157135077|NCT02116621|567241845|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
157135078|NCT02116621|567241846|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
157135079|NCT02116621|567241845|FG000|Six Month Follow-up|Lost to Follow-up|2|||
157135080|NCT02116621|567241846|FG001|Six Month Follow-up|Lost to Follow-up|1|||
157135081|NCT02116621|567241845|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
157135082|NCT02116621|567241846|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
157135083|NCT02116621|567241845|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
157135084|NCT02116621|567241846|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
157135085|NCT02116621|567241845|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
156721543|NCT00955409|565727407|FG008|Overall Study|Lost to Follow-up|0|||
156721544|NCT00955409|565727408|FG009|Overall Study|Lost to Follow-up|0|||
156721545|NCT00955409|565727399|FG000|Overall Study|Failed to Return|2|||
156721546|NCT00955409|565727400|FG001|Overall Study|Failed to Return|0|||
156721547|NCT00955409|565727401|FG002|Overall Study|Failed to Return|0|||
156721548|NCT00955409|565727402|FG003|Overall Study|Failed to Return|0|||
156721549|NCT00955409|565727403|FG004|Overall Study|Failed to Return|0|||
156721550|NCT00955409|565727404|FG005|Overall Study|Failed to Return|0|||
156721551|NCT00955409|565727405|FG006|Overall Study|Failed to Return|0|||
156721552|NCT00955409|565727406|FG007|Overall Study|Failed to Return|2|||
156721553|NCT00955409|565727407|FG008|Overall Study|Failed to Return|0|||
156721554|NCT00955409|565727408|FG009|Overall Study|Failed to Return|0|||
156721555|NCT00955409|565727399|FG000|Overall Study|Adverse Event (AE)|2|||
156721556|NCT00955409|565727400|FG001|Overall Study|Adverse Event (AE)|0|||
156721557|NCT00955409|565727401|FG002|Overall Study|Adverse Event (AE)|0|||
156721558|NCT00955409|565727402|FG003|Overall Study|Adverse Event (AE)|0|||
156721559|NCT00955409|565727403|FG004|Overall Study|Adverse Event (AE)|0|||
156721560|NCT00955409|565727404|FG005|Overall Study|Adverse Event (AE)|1|||
157135086|NCT02116621|567241846|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
156721561|NCT00955409|565727405|FG006|Overall Study|Adverse Event (AE)|2|||
156794112|NCT03715829|565999495|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794113|NCT03715829|565999496|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794114|NCT03715829|565999497|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794115|NCT03715829|565999498|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794116|NCT03715829|565999499|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794117|NCT03715829|565999500|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794118|NCT03715829|565999501|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
156794119|NCT03715829|565999502|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794120|NCT03715829|565999503|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
156794121|NCT03715829|565999493|FG000|Extension Period|Other|0|||
156794122|NCT03715829|565999494|FG001|Extension Period|Other|0|||
156794123|NCT03715829|565999495|FG002|Extension Period|Other|0|||
156794124|NCT03715829|565999496|FG003|Extension Period|Other|0|||
156794125|NCT03715829|565999497|FG004|Extension Period|Other|0|||
157135087|NCT02116621|567241845|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
157135088|NCT02116621|567241846|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
157135089|NCT02116621|567241845|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
157135090|NCT02116621|567241846|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
157217292|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
156721562|NCT00955409|565727406|FG007|Overall Study|Adverse Event (AE)|0|||
156721563|NCT00955409|565727407|FG008|Overall Study|Adverse Event (AE)|2|||
156721564|NCT00955409|565727408|FG009|Overall Study|Adverse Event (AE)|0|||
157019145|NCT04927065|566824701|FG000|First Booster|Protocol Violation|4|||
157135091|NCT03437447|567241847|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157135092|NCT03437447|567241848|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157135093|NCT03437447|567241849|FG002|Treatment Period 1|Withdrawal by Subject|1|||
157135094|NCT02040142|567241851|FG000|Overall Study|Lost to Follow-up|5|||
157217293|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
156721565|NCT00955409|565727399|FG000|Overall Study|Reason not Specified|2|||
156721566|NCT00955409|565727400|FG001|Overall Study|Reason not Specified|1|||
156721567|NCT00955409|565727401|FG002|Overall Study|Reason not Specified|13|||
156794126|NCT03715829|565999498|FG005|Extension Period|Other|0|||
156794127|NCT03715829|565999499|FG006|Extension Period|Other|1|||
156794128|NCT03715829|565999500|FG007|Extension Period|Other|2|||
156794129|NCT03715829|565999501|FG008|Extension Period|Other|4|||
156794130|NCT03715829|565999502|FG009|Extension Period|Other|0|||
156794131|NCT03715829|565999503|FG010|Extension Period|Other|0|||
156794132|NCT03647137|565999504|FG000|Overall Study|Scan Limitation|2|||
156794133|NCT03647137|565999505|FG001|Overall Study|Scan Limitation|1|||
156794134|NCT03647137|565999506|FG002|Overall Study|Scan Limitation|1|||
156794135|NCT03647137|565999507|FG003|Overall Study|Scan Limitation|2|||
156794136|NCT03579719|565999508|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
156794137|NCT01443026|565999509|FG000|Overall Study|Physician Decision|1|||
156794138|NCT01443026|565999510|FG001|Overall Study|Physician Decision|0|||
156794139|NCT01443026|565999509|FG000|Overall Study|Death|0|||
156794140|NCT01443026|565999510|FG001|Overall Study|Death|1|||
156794141|NCT01443026|565999509|FG000|Overall Study|Withdrawal by Subject|0|||
156794142|NCT01443026|565999510|FG001|Overall Study|Withdrawal by Subject|3|||
156794143|NCT01443026|565999509|FG000|Overall Study|Lost to Follow-up|2|||
156794144|NCT01443026|565999510|FG001|Overall Study|Lost to Follow-up|1|||
156794145|NCT00829868|565999511|FG000|Washout|Physician Decision|1|||
156794146|NCT00829868|565999512|FG001|Washout|Physician Decision|0|||
156794147|NCT01969409|565999513|FG000|Overall Study|Death|2|||
156794148|NCT01969409|565999514|FG001|Overall Study|Death|2|||
156794149|NCT01969409|565999513|FG000|Overall Study|Transplant|1|||
156794150|NCT01969409|565999514|FG001|Overall Study|Transplant|1|||
156794151|NCT01969409|565999513|FG000|Overall Study|Withdrawal by Subject|0|||
156794152|NCT01969409|565999514|FG001|Overall Study|Withdrawal by Subject|1|||
156794153|NCT02799043|565999516|FG000|Overall Study|Adverse Event|0|||
156794154|NCT02799043|565999517|FG001|Overall Study|Adverse Event|1|||
156794155|NCT02799043|565999516|FG000|Overall Study|Death|1|||
156794156|NCT02799043|565999517|FG001|Overall Study|Death|1|||
156794157|NCT02799043|565999516|FG000|Overall Study|Lost to Follow-up|3|||
156794158|NCT02799043|565999517|FG001|Overall Study|Lost to Follow-up|6|||
156794159|NCT02799043|565999516|FG000|Overall Study|Withdrawal by Subject|4|||
156794160|NCT02799043|565999517|FG001|Overall Study|Withdrawal by Subject|4|||
156794161|NCT02799043|565999516|FG000|Overall Study|Moved to different country|0|||
156794162|NCT02799043|565999517|FG001|Overall Study|Moved to different country|1|||
156794163|NCT02799043|565999516|FG000|Overall Study|Trial Screen Failure|1|||
156794164|NCT02799043|565999517|FG001|Overall Study|Trial Screen Failure|0|||
156794165|NCT02799043|565999516|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
156794166|NCT02799043|565999517|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
156794167|NCT01554904|565999520|FG000|Overall Study|Withdrawal by Subject|3|||
156794168|NCT01554904|565999520|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
156794169|NCT01051661|565999521|FG000|Overall Study|Adverse Event|1|||
156794170|NCT01051661|565999522|FG001|Overall Study|Adverse Event|1|||
156794171|NCT01051661|565999523|FG002|Overall Study|Adverse Event|1|||
156794172|NCT01051661|565999524|FG003|Overall Study|Adverse Event|1|||
156794173|NCT01051661|565999525|FG004|Overall Study|Adverse Event|0|||
156794174|NCT01051661|565999526|FG005|Overall Study|Adverse Event|0|||
156794175|NCT01051661|565999521|FG000|Overall Study|Lost to Follow-up|13|||
156794176|NCT01051661|565999522|FG001|Overall Study|Lost to Follow-up|22|||
156794177|NCT01051661|565999523|FG002|Overall Study|Lost to Follow-up|15|||
156794178|NCT01051661|565999524|FG003|Overall Study|Lost to Follow-up|17|||
157135095|NCT02040142|567241851|FG000|Overall Study|Death|17|||
157135096|NCT02040142|567241851|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
157135097|NCT04752384|567241852|FG000|Overall Study|Withdrawal by Subject|1|||
157135098|NCT04752384|567241852|FG000|Overall Study|Death|1|||
157135099|NCT04439331|567241859|FG000|Overall Study|Never Start Protocol Therapy|2|||
157135100|NCT04439331|567241859|FG000|Overall Study|Ineligible|2|||
157135101|NCT04439331|567241859|FG000|Overall Study|Mutation Status Not Confirmed|1|||
156794179|NCT01051661|565999525|FG004|Overall Study|Lost to Follow-up|10|||
156794180|NCT01051661|565999526|FG005|Overall Study|Lost to Follow-up|24|||
156794181|NCT01051661|565999521|FG000|Overall Study|Migrated/moved from study area|1|||
156794182|NCT01051661|565999522|FG001|Overall Study|Migrated/moved from study area|6|||
156794183|NCT01051661|565999523|FG002|Overall Study|Migrated/moved from study area|6|||
156794184|NCT01051661|565999524|FG003|Overall Study|Migrated/moved from study area|8|||
156794185|NCT01051661|565999525|FG004|Overall Study|Migrated/moved from study area|7|||
157135102|NCT04439331|567241859|FG000|Overall Study|Adverse Event|1|||
156794186|NCT01051661|565999526|FG005|Overall Study|Migrated/moved from study area|3|||
156794187|NCT01051661|565999521|FG000|Overall Study|Refused blood sampling|0|||
156794188|NCT01051661|565999522|FG001|Overall Study|Refused blood sampling|0|||
157135103|NCT04439331|567241859|FG000|Overall Study|Death|1|||
157135104|NCT04439331|567241859|FG000|Overall Study|Disease Progression|20|||
157135105|NCT04439331|567241859|FG000|Overall Study|Withdrawal by Subject|6|||
156794189|NCT01051661|565999523|FG002|Overall Study|Refused blood sampling|0|||
156794190|NCT01051661|565999524|FG003|Overall Study|Refused blood sampling|0|||
156794191|NCT01051661|565999525|FG004|Overall Study|Refused blood sampling|0|||
156794192|NCT01051661|565999526|FG005|Overall Study|Refused blood sampling|1|||
157135106|NCT04439331|567241859|FG000|Overall Study|Physician Decision|1|||
156794193|NCT01051661|565999521|FG000|Overall Study|Data not reliable|1|||
156794194|NCT01051661|565999522|FG001|Overall Study|Data not reliable|0|||
156794195|NCT01051661|565999523|FG002|Overall Study|Data not reliable|0|||
156794196|NCT01051661|565999524|FG003|Overall Study|Data not reliable|0|||
156794197|NCT01051661|565999525|FG004|Overall Study|Data not reliable|0|||
156794198|NCT01051661|565999526|FG005|Overall Study|Data not reliable|1|||
156794199|NCT01051661|565999521|FG000|Overall Study|Unable to attend visit(s)|2|||
156794200|NCT01051661|565999522|FG001|Overall Study|Unable to attend visit(s)|4|||
156794201|NCT01051661|565999523|FG002|Overall Study|Unable to attend visit(s)|2|||
156794202|NCT01051661|565999524|FG003|Overall Study|Unable to attend visit(s)|1|||
156794203|NCT01051661|565999525|FG004|Overall Study|Unable to attend visit(s)|3|||
156794204|NCT01051661|565999526|FG005|Overall Study|Unable to attend visit(s)|2|||
156794205|NCT01051661|565999521|FG000|Overall Study|Consent not received from both parents|0|||
156794206|NCT01051661|565999522|FG001|Overall Study|Consent not received from both parents|0|||
156794207|NCT01051661|565999523|FG002|Overall Study|Consent not received from both parents|0|||
156794208|NCT01051661|565999524|FG003|Overall Study|Consent not received from both parents|0|||
156794209|NCT01051661|565999525|FG004|Overall Study|Consent not received from both parents|0|||
156794210|NCT01051661|565999526|FG005|Overall Study|Consent not received from both parents|1|||
156794211|NCT01051661|565999521|FG000|Overall Study|Failure to comply with protocol|0|||
156794212|NCT01051661|565999522|FG001|Overall Study|Failure to comply with protocol|0|||
156794213|NCT01051661|565999523|FG002|Overall Study|Failure to comply with protocol|2|||
156794214|NCT01051661|565999524|FG003|Overall Study|Failure to comply with protocol|0|||
156794215|NCT01051661|565999525|FG004|Overall Study|Failure to comply with protocol|0|||
156794216|NCT01051661|565999526|FG005|Overall Study|Failure to comply with protocol|0|||
156794217|NCT01051661|565999521|FG000|Overall Study|Subject lost legal representation|0|||
156794218|NCT01051661|565999522|FG001|Overall Study|Subject lost legal representation|0|||
156794219|NCT01051661|565999523|FG002|Overall Study|Subject lost legal representation|0|||
156794220|NCT01051661|565999524|FG003|Overall Study|Subject lost legal representation|0|||
156794221|NCT01051661|565999525|FG004|Overall Study|Subject lost legal representation|1|||
156794222|NCT01051661|565999526|FG005|Overall Study|Subject lost legal representation|0|||
156794223|NCT01051661|565999521|FG000|Overall Study|Protocol Violation|0|||
156794224|NCT01051661|565999522|FG001|Overall Study|Protocol Violation|0|||
156794225|NCT01051661|565999523|FG002|Overall Study|Protocol Violation|0|||
156794226|NCT01051661|565999524|FG003|Overall Study|Protocol Violation|1|||
156721568|NCT00955409|565727402|FG003|Overall Study|Reason not Specified|1|||
156721569|NCT00955409|565727403|FG004|Overall Study|Reason not Specified|2|||
156721570|NCT00955409|565727404|FG005|Overall Study|Reason not Specified|0|||
156721571|NCT00955409|565727405|FG006|Overall Study|Reason not Specified|16|||
156721572|NCT00955409|565727406|FG007|Overall Study|Reason not Specified|0|||
156721573|NCT00955409|565727407|FG008|Overall Study|Reason not Specified|8|||
156721574|NCT00955409|565727408|FG009|Overall Study|Reason not Specified|1|||
156721575|NCT00485732|565727409|FG000|Overall Study|Protocol Violation|1|||
156721576|NCT00485732|565727410|FG001|Overall Study|Protocol Violation|3|||
156721577|NCT00485732|565727409|FG000|Overall Study|Withdrawal by Subject|5|||
156721578|NCT00485732|565727410|FG001|Overall Study|Withdrawal by Subject|4|||
156721579|NCT00485732|565727409|FG000|Overall Study|Lost to Follow-up|2|||
156721580|NCT00485732|565727410|FG001|Overall Study|Lost to Follow-up|2|||
156721581|NCT00437021|565727411|FG000|Overall Study|Adverse Event|0|||
156721582|NCT00437021|565727412|FG001|Overall Study|Adverse Event|0|||
156721583|NCT00437021|565727413|FG002|Overall Study|Adverse Event|0|||
156721584|NCT00437021|565727414|FG003|Overall Study|Adverse Event|0|||
156721585|NCT00437021|565727415|FG004|Overall Study|Adverse Event|0|||
156721586|NCT00437021|565727416|FG005|Overall Study|Adverse Event|0|||
156721587|NCT00437021|565727417|FG006|Overall Study|Adverse Event|1|||
156721588|NCT00437021|565727418|FG007|Overall Study|Adverse Event|0|||
156721589|NCT00437021|565727419|FG008|Overall Study|Adverse Event|0|||
156721590|NCT00437021|565727420|FG009|Overall Study|Adverse Event|0|||
156721591|NCT00437021|565727421|FG010|Overall Study|Adverse Event|0|||
156721592|NCT00437021|565727422|FG011|Overall Study|Adverse Event|0|||
156794227|NCT01051661|565999525|FG004|Overall Study|Protocol Violation|2|||
156794228|NCT01051661|565999526|FG005|Overall Study|Protocol Violation|1|||
156794229|NCT01051661|565999521|FG000|Overall Study|Withdrawal by Subject|16|||
156794230|NCT01051661|565999522|FG001|Overall Study|Withdrawal by Subject|30|||
156794231|NCT01051661|565999523|FG002|Overall Study|Withdrawal by Subject|13|||
156794232|NCT01051661|565999524|FG003|Overall Study|Withdrawal by Subject|28|||
156794233|NCT01051661|565999525|FG004|Overall Study|Withdrawal by Subject|12|||
156794234|NCT01051661|565999526|FG005|Overall Study|Withdrawal by Subject|34|||
156721593|NCT00437021|565727411|FG000|Overall Study|Lost to Follow-up|0|||
156721594|NCT00437021|565727412|FG001|Overall Study|Lost to Follow-up|3|||
156721595|NCT00437021|565727413|FG002|Overall Study|Lost to Follow-up|0|||
156721596|NCT00437021|565727414|FG003|Overall Study|Lost to Follow-up|0|||
156721597|NCT00437021|565727415|FG004|Overall Study|Lost to Follow-up|0|||
156721598|NCT00437021|565727416|FG005|Overall Study|Lost to Follow-up|2|||
156794235|NCT01681849|565999527|FG000|Overall Study|Protocol Violation|2|||
156794236|NCT01681849|565999528|FG001|Overall Study|Protocol Violation|0|||
156794237|NCT01681849|565999529|FG002|Overall Study|Protocol Violation|0|||
156721599|NCT00437021|565727417|FG006|Overall Study|Lost to Follow-up|0|||
156721600|NCT00437021|565727418|FG007|Overall Study|Lost to Follow-up|1|||
156721601|NCT00437021|565727419|FG008|Overall Study|Lost to Follow-up|0|||
156721602|NCT00437021|565727420|FG009|Overall Study|Lost to Follow-up|0|||
156721603|NCT00437021|565727421|FG010|Overall Study|Lost to Follow-up|0|||
156721604|NCT00437021|565727422|FG011|Overall Study|Lost to Follow-up|0|||
156721605|NCT00437021|565727411|FG000|Overall Study|Withdrawal by Subject|2|||
156721606|NCT00437021|565727412|FG001|Overall Study|Withdrawal by Subject|1|||
156721607|NCT00437021|565727413|FG002|Overall Study|Withdrawal by Subject|0|||
156721608|NCT00437021|565727414|FG003|Overall Study|Withdrawal by Subject|0|||
156721609|NCT00437021|565727415|FG004|Overall Study|Withdrawal by Subject|0|||
156721610|NCT00437021|565727416|FG005|Overall Study|Withdrawal by Subject|0|||
156721611|NCT00437021|565727417|FG006|Overall Study|Withdrawal by Subject|0|||
156721612|NCT00437021|565727418|FG007|Overall Study|Withdrawal by Subject|0|||
156721613|NCT00437021|565727419|FG008|Overall Study|Withdrawal by Subject|0|||
156721614|NCT00437021|565727420|FG009|Overall Study|Withdrawal by Subject|0|||
156721615|NCT00437021|565727421|FG010|Overall Study|Withdrawal by Subject|0|||
156721616|NCT00437021|565727422|FG011|Overall Study|Withdrawal by Subject|0|||
156721617|NCT05573464|565727423|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
156721618|NCT05573464|565727424|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
156721619|NCT05573464|565727423|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
156721620|NCT05573464|565727424|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
156721621|NCT05573464|565727423|FG000|12-week Treatment Period|Protocol Violation|3|||
156721622|NCT05573464|565727424|FG001|12-week Treatment Period|Protocol Violation|1|||
156721623|NCT05573464|565727423|FG000|12-week Treatment Period|Physician Decision|1|||
156721624|NCT05573464|565727424|FG001|12-week Treatment Period|Physician Decision|2|||
156721625|NCT05573464|565727423|FG000|12-week Treatment Period|Lost to Follow-up|2|||
156721626|NCT05573464|565727424|FG001|12-week Treatment Period|Lost to Follow-up|0|||
156721627|NCT05573464|565727423|FG000|12-week Treatment Period|Adverse Event|20|||
156721628|NCT05573464|565727424|FG001|12-week Treatment Period|Adverse Event|9|||
156721629|NCT05573464|565727423|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
156721630|NCT05573464|565727424|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
157217294|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
157217295|NCT00529568|567541074|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
156721631|NCT05573464|565727423|FG000|12-week Treatment Period|Randomised, not treated|0|||
156721632|NCT05573464|565727424|FG001|12-week Treatment Period|Randomised, not treated|1|||
156721633|NCT05573464|565727423|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
157135107|NCT04439331|567241859|FG000|Overall Study|Other Complicating Disease|1|||
157135108|NCT03726268|567241861|FG000|Overall Study|Physician Decision|2|||
157135109|NCT03726268|567241862|FG001|Overall Study|Physician Decision|8|||
157135110|NCT03726268|567241863|FG002|Overall Study|Physician Decision|6|||
157135111|NCT03726268|567241864|FG003|Overall Study|Physician Decision|3|||
157135112|NCT03726268|567241861|FG000|Overall Study|Withdrawal by Subject|11|||
157135113|NCT03726268|567241862|FG001|Overall Study|Withdrawal by Subject|5|||
157135114|NCT03726268|567241863|FG002|Overall Study|Withdrawal by Subject|9|||
157135115|NCT03726268|567241864|FG003|Overall Study|Withdrawal by Subject|8|||
157135116|NCT00413959|567241866|FG000|Overall Study|Pt had only one cycle.|1|||
157135117|NCT01986062|567241867|FG000|Overall Study|Lost to Follow-up|1|||
157135118|NCT01986062|567241868|FG001|Overall Study|Lost to Follow-up|0|||
157135119|NCT01986062|567241867|FG000|Overall Study|Withdrawal by Subject|0|||
157135120|NCT01986062|567241868|FG001|Overall Study|Withdrawal by Subject|1|||
157135121|NCT03538743|567241869|FG000|Overall Study|Adverse Event|0|||
157135122|NCT03538743|567241870|FG001|Overall Study|Adverse Event|0|||
157135123|NCT03538743|567241871|FG002|Overall Study|Adverse Event|1|||
157135124|NCT03538743|567241872|FG003|Overall Study|Adverse Event|1|||
157135125|NCT03538743|567241873|FG004|Overall Study|Adverse Event|0|||
157135126|NCT03538743|567241874|FG005|Overall Study|Adverse Event|0|||
157135127|NCT03538743|567241875|FG006|Overall Study|Adverse Event|0|||
157135128|NCT03538743|567241876|FG007|Overall Study|Adverse Event|0|||
157135129|NCT03538743|567241877|FG008|Overall Study|Adverse Event|0|||
157221657|NCT02207621|567558474|FG000|Overall Study|Adverse Event|71|||
156721634|NCT05573464|565727424|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
156721635|NCT05573464|565727423|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
156721636|NCT05573464|565727424|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
156721637|NCT05573464|565727423|FG000|52-week Treatment Period|Protocol Violation|1|||
156721638|NCT05573464|565727424|FG001|52-week Treatment Period|Protocol Violation|1|||
156721639|NCT05573464|565727423|FG000|52-week Treatment Period|Physician Decision|2|||
156721640|NCT05573464|565727424|FG001|52-week Treatment Period|Physician Decision|2|||
156721641|NCT05573464|565727423|FG000|52-week Treatment Period|Lost to Follow-up|1|||
156721642|NCT05573464|565727424|FG001|52-week Treatment Period|Lost to Follow-up|1|||
156721643|NCT05573464|565727423|FG000|52-week Treatment Period|Adverse Event|11|||
156721644|NCT05573464|565727424|FG001|52-week Treatment Period|Adverse Event|8|||
156721645|NCT05573464|565727423|FG000|52-week Treatment Period|Death|1|||
156721646|NCT05573464|565727424|FG001|52-week Treatment Period|Death|1|||
156721647|NCT05734157|565727425|FG000|Overall Study|Death|3|||
156721648|NCT05734157|565727425|FG000|Overall Study|Withdrawal by Subject|2|||
156721649|NCT05734157|565727425|FG000|Overall Study|Lost to Follow-up|1|||
156721650|NCT05734157|565727425|FG000|Overall Study|Telephone call|3|||
156721651|NCT01415518|565727426|FG000|Overall Study|Withdrawal by Subject|2|||
156721652|NCT01415518|565727427|FG001|Overall Study|Withdrawal by Subject|12|||
156721653|NCT01415518|565727426|FG000|Overall Study|Protocol Violation|6|||
156721654|NCT01415518|565727427|FG001|Overall Study|Protocol Violation|8|||
156721655|NCT01415518|565727426|FG000|Overall Study|Lost to Follow-up|3|||
156721656|NCT01415518|565727427|FG001|Overall Study|Lost to Follow-up|5|||
156721657|NCT01415518|565727426|FG000|Overall Study|Adverse Event|3|||
156721658|NCT01415518|565727427|FG001|Overall Study|Adverse Event|4|||
157019146|NCT04927065|566824702|FG001|First Booster|Protocol Violation|4|||
157135130|NCT03538743|567241869|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
157135131|NCT03538743|567241870|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
157135132|NCT03538743|567241871|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
157135133|NCT03538743|567241872|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
157135134|NCT03538743|567241873|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
157135135|NCT03538743|567241874|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
157135136|NCT03538743|567241875|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
157135137|NCT03538743|567241876|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
157135138|NCT03538743|567241877|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
157135139|NCT03538743|567241869|FG000|Overall Study|Withdrawal by Subject|0|||
157135140|NCT03538743|567241870|FG001|Overall Study|Withdrawal by Subject|0|||
157135141|NCT03538743|567241871|FG002|Overall Study|Withdrawal by Subject|0|||
157135142|NCT03538743|567241872|FG003|Overall Study|Withdrawal by Subject|1|||
157019147|NCT04927065|566824703|FG002|First Booster|Protocol Violation|0|||
157135143|NCT03538743|567241873|FG004|Overall Study|Withdrawal by Subject|0|||
157135144|NCT03538743|567241874|FG005|Overall Study|Withdrawal by Subject|0|||
157135145|NCT03538743|567241875|FG006|Overall Study|Withdrawal by Subject|0|||
157135146|NCT03538743|567241876|FG007|Overall Study|Withdrawal by Subject|0|||
157135147|NCT03538743|567241877|FG008|Overall Study|Withdrawal by Subject|0|||
157135148|NCT01955707|567241880|FG000|Overall Study|Adverse Event|1|||
157019148|NCT04927065|566824704|FG003|First Booster|Protocol Violation|3|||
157135149|NCT01955707|567241881|FG001|Overall Study|Adverse Event|2|||
157135150|NCT01955707|567241880|FG000|Overall Study|Lost to Follow-up|2|||
157135151|NCT01955707|567241881|FG001|Overall Study|Lost to Follow-up|1|||
157135152|NCT01955707|567241880|FG000|Overall Study|Withdrawal by Subject|0|||
157217296|NCT00529568|567541075|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
157217297|NCT00529568|567541076|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
157217298|NCT00529568|567541074|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
157217299|NCT00529568|567541075|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
157217300|NCT00529568|567541076|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
157217301|NCT00529568|567541074|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
157217302|NCT00529568|567541075|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
157135153|NCT01955707|567241881|FG001|Overall Study|Withdrawal by Subject|3|||
157135154|NCT01955707|567241880|FG000|Overall Study|Death|13|||
157217303|NCT00529568|567541076|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
157217304|NCT00529568|567541074|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
157217305|NCT00529568|567541075|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
156721659|NCT01415518|565727426|FG000|Overall Study|Death|1|||
156721660|NCT01415518|565727427|FG001|Overall Study|Death|1|||
156721661|NCT01415518|565727426|FG000|Overall Study|Condition under Investigation Worsened|1|||
156721662|NCT01415518|565727427|FG001|Overall Study|Condition under Investigation Worsened|1|||
156721663|NCT00813150|565727429|FG000|Treatment Period|Adverse Event|16|||
156721664|NCT00813150|565727430|FG001|Treatment Period|Adverse Event|15|||
156721665|NCT00813150|565727429|FG000|Treatment Period|Death|2|||
156721666|NCT00813150|565727430|FG001|Treatment Period|Death|0|||
156721667|NCT00813150|565727429|FG000|Treatment Period|Progressive disease|1|||
156721668|NCT00813150|565727430|FG001|Treatment Period|Progressive disease|0|||
156721669|NCT00813150|565727429|FG000|Treatment Period|Complete response|0|||
156721670|NCT00813150|565727430|FG001|Treatment Period|Complete response|1|||
156721671|NCT00813150|565727429|FG000|Treatment Period|Stable disease|1|||
156721672|NCT00813150|565727430|FG001|Treatment Period|Stable disease|2|||
156721673|NCT00813150|565727429|FG000|Treatment Period|Protocol Violation|3|||
156721674|NCT00813150|565727430|FG001|Treatment Period|Protocol Violation|4|||
156721675|NCT00813150|565727429|FG000|Treatment Period|Withdrawal by Subject|5|||
156721676|NCT00813150|565727430|FG001|Treatment Period|Withdrawal by Subject|3|||
156721677|NCT00813150|565727429|FG000|Treatment Period|Non compliance|0|||
156721678|NCT00813150|565727430|FG001|Treatment Period|Non compliance|1|||
156721679|NCT00813150|565727429|FG000|Treatment Period|Reason not specified|3|||
156721680|NCT00813150|565727430|FG001|Treatment Period|Reason not specified|4|||
156721681|NCT00813150|565727429|FG000|Treatment Period|Data not available|1|||
156721682|NCT00813150|565727430|FG001|Treatment Period|Data not available|2|||
157135155|NCT01955707|567241881|FG001|Overall Study|Death|14|||
156721683|NCT00813150|565727429|FG000|Long Term Follow-up|Death|0|||
156721684|NCT00813150|565727430|FG001|Long Term Follow-up|Death|4|||
156721685|NCT00813150|565727429|FG000|Long Term Follow-up|Other|0|||
156721686|NCT00813150|565727430|FG001|Long Term Follow-up|Other|3|||
156721687|NCT00813150|565727429|FG000|Long Term Follow-up|Lost to Follow-up|2|||
156721688|NCT00813150|565727430|FG001|Long Term Follow-up|Lost to Follow-up|0|||
156721689|NCT00813150|565727429|FG000|Long Term Follow-up|Progression/Relapse|22|||
156721690|NCT00813150|565727430|FG001|Long Term Follow-up|Progression/Relapse|24|||
156721691|NCT00210210|565727438|FG000|Overall Study|Withdrawal by Subject|3|||
156721692|NCT00210210|565727439|FG001|Overall Study|Withdrawal by Subject|2|||
156721693|NCT00210210|565727438|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
156721694|NCT00210210|565727439|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
156721695|NCT02445248|565727440|FG000|Overall Study|Death|45|||
156721696|NCT02445248|565727441|FG001|Overall Study|Death|12|||
156721697|NCT02445248|565727440|FG000|Overall Study|Progressive disease|13|||
156721698|NCT02445248|565727441|FG001|Overall Study|Progressive disease|1|||
156721699|NCT02445248|565727440|FG000|Overall Study|Subject decision|8|||
156721700|NCT02445248|565727441|FG001|Overall Study|Subject decision|0|||
156721701|NCT02445248|565727440|FG000|Overall Study|Physician Decision|5|||
156721702|NCT02445248|565727441|FG001|Overall Study|Physician Decision|0|||
156721703|NCT02445248|565727440|FG000|Overall Study|Adverse Event|1|||
156721704|NCT02445248|565727441|FG001|Overall Study|Adverse Event|0|||
156721705|NCT02445248|565727440|FG000|Overall Study|Lost to Follow-up|1|||
156721706|NCT02445248|565727441|FG001|Overall Study|Lost to Follow-up|0|||
156721707|NCT02596971|565727444|FG000|Overall Study|Death|5|||
156721708|NCT02596971|565727445|FG001|Overall Study|Death|1|||
156721709|NCT02596971|565727446|FG002|Overall Study|Death|5|||
156721710|NCT02596971|565727444|FG000|Overall Study|Withdrawal by Subject|5|||
156721711|NCT02596971|565727445|FG001|Overall Study|Withdrawal by Subject|1|||
156721712|NCT02596971|565727446|FG002|Overall Study|Withdrawal by Subject|4|||
156721713|NCT04067050|565727447|FG000|One Month|Lost to Follow-up|4|||
156721714|NCT04067050|565727448|FG001|One Month|Lost to Follow-up|0|||
156721715|NCT04067050|565727447|FG000|Two Month|Lost to Follow-up|1|||
156721716|NCT04067050|565727448|FG001|Two Month|Lost to Follow-up|0|||
156721717|NCT04067050|565727447|FG000|Two Month|Adverse Event|1|||
156721718|NCT04067050|565727448|FG001|Two Month|Adverse Event|0|||
156721719|NCT04341363|565727451|FG000|Overall Study|Adverse Event|1|||
156721720|NCT04341363|565727451|FG000|Overall Study|Withdrawal by Subject|1|||
156721721|NCT03534687|565727453|FG000|Overall Study|Lost to Follow-up|7|||
156721722|NCT03534687|565727454|FG001|Overall Study|Lost to Follow-up|2|||
156721723|NCT01293695|565727455|FG000|Overall Study|Withdrawal by Subject|7|||
156721724|NCT01293695|565727456|FG001|Overall Study|Withdrawal by Subject|1|||
157135156|NCT01955707|567241880|FG000|Overall Study|Other|4|||
157135157|NCT01955707|567241881|FG001|Overall Study|Other|2|||
157135158|NCT03532100|567243030|FG000|Overall Study|Intervention malfunction|1|||
157135159|NCT03896581|567243031|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
157135160|NCT03896581|567243032|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
157135161|NCT03896581|567243031|FG000|Overall Study|Withdrawal by Subject|4|||
157135162|NCT03896581|567243032|FG001|Overall Study|Withdrawal by Subject|1|||
157135163|NCT03896581|567243031|FG000|Overall Study|Lost to Follow-up|1|||
157135164|NCT03896581|567243032|FG001|Overall Study|Lost to Follow-up|0|||
157135165|NCT03896581|567243031|FG000|Overall Study|Lack of Efficacy|2|||
157135166|NCT03896581|567243032|FG001|Overall Study|Lack of Efficacy|1|||
157135167|NCT03896581|567243031|FG000|Overall Study|Adverse event, non-fatal|0|||
157135168|NCT03896581|567243032|FG001|Overall Study|Adverse event, non-fatal|2|||
157135169|NCT00960076|567243033|FG000|Overall Study|Adverse Event|1|||
157135170|NCT00960076|567243034|FG001|Overall Study|Adverse Event|7|||
157135171|NCT00960076|567243033|FG000|Overall Study|No longer met study criteria|1|||
157135172|NCT00960076|567243034|FG001|Overall Study|No longer met study criteria|5|||
157135173|NCT00960076|567243033|FG000|Overall Study|Withdrawal by Subject|1|||
157135174|NCT00960076|567243034|FG001|Overall Study|Withdrawal by Subject|2|||
157135175|NCT00960076|567243033|FG000|Overall Study|Lost to Follow-up|3|||
156721725|NCT01293695|565727455|FG000|Overall Study|Lost to Follow-up|8|||
156721726|NCT01293695|565727456|FG001|Overall Study|Lost to Follow-up|6|||
156721727|NCT02069015|565727459|FG000|Overall Study|Lost to Follow-up|39|||
156721728|NCT02069015|565727460|FG001|Overall Study|Lost to Follow-up|32|||
156721729|NCT02069015|565727459|FG000|Overall Study|Withdrawal by Subject|1|||
156721730|NCT02069015|565727460|FG001|Overall Study|Withdrawal by Subject|1|||
156721731|NCT01778855|565727461|FG000|Overall Study|Death|0|||
156721732|NCT01778855|565727462|FG001|Overall Study|Death|1|||
156721733|NCT03776357|565727463|FG000|Overall Study|Lost to Follow-up|3|||
156721734|NCT03751098|565727466|FG000|Overall Study|Withdrawal by Subject|0|||
156721735|NCT03751098|565727467|FG001|Overall Study|Withdrawal by Subject|1|||
156721736|NCT00837148|565727470|FG000|Overall Study|Adverse Event|1|||
156721737|NCT00837148|565727470|FG000|Overall Study|Death|1|||
156721738|NCT00931411|565727478|FG000|First Intervention - 42 Days|Adverse Event|2|||
157135176|NCT00960076|567243034|FG001|Overall Study|Lost to Follow-up|3|||
157135177|NCT00960076|567243033|FG000|Overall Study|Severe non-compliance to protocol|1|||
157135178|NCT00960076|567243034|FG001|Overall Study|Severe non-compliance to protocol|2|||
157135179|NCT00960076|567243033|FG000|Overall Study|Hyperglycemia|1|||
157135180|NCT00960076|567243034|FG001|Overall Study|Hyperglycemia|5|||
157135181|NCT00960076|567243033|FG000|Overall Study|Did not attend the termination visit|0|||
157135182|NCT00960076|567243034|FG001|Overall Study|Did not attend the termination visit|1|||
157135183|NCT02029976|567243035|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
157135184|NCT02029976|567243036|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
157135185|NCT02029976|567243035|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
157135186|NCT02029976|567243036|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
157135187|NCT02029976|567243035|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
157135188|NCT02029976|567243036|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
157135189|NCT02029976|567243035|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
157135190|NCT02029976|567243036|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
157135191|NCT01445171|567243037|FG000|Overall Study|Lost to Follow-up|11|||
157135192|NCT01445171|567243037|FG000|Overall Study|Withdrawal by Subject|16|||
157135193|NCT01445171|567243037|FG000|Overall Study|Death|51|||
157135194|NCT01445171|567243037|FG000|Overall Study|Subjects declined to return for followup|9|||
157135195|NCT01445171|567243037|FG000|Overall Study|Consented but did not receive device|8|||
157135196|NCT00162773|567243038|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
157135197|NCT05194345|567243041|FG000|Overall Study|Withdrawal by Subject|6|||
157135198|NCT05194345|567243042|FG001|Overall Study|Withdrawal by Subject|4|||
157135199|NCT05194345|567243043|FG002|Overall Study|Withdrawal by Subject|0|||
157135200|NCT05194345|567243041|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
157135201|NCT05194345|567243042|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
157135202|NCT05194345|567243043|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
157135203|NCT02612909|567243046|FG000|Phase 2|Withdrawal by Subject|2|||
157135204|NCT02612909|567243047|FG001|Phase 2|Withdrawal by Subject|5|||
157135205|NCT02612909|567243048|FG002|Phase 2|Withdrawal by Subject|0|||
157135206|NCT02612909|567243049|FG003|Phase 2|Withdrawal by Subject|0|||
157135207|NCT02612909|567243050|FG004|Phase 2|Withdrawal by Subject|0|||
157135208|NCT02612909|567243046|FG000|Phase 2|Pregnancy|0|||
157135209|NCT02612909|567243047|FG001|Phase 2|Pregnancy|0|||
157135210|NCT02612909|567243048|FG002|Phase 2|Pregnancy|1|||
157135211|NCT02612909|567243049|FG003|Phase 2|Pregnancy|0|||
157135212|NCT02612909|567243050|FG004|Phase 2|Pregnancy|0|||
157135213|NCT02612909|567243046|FG000|Phase 3|Withdrawal by Subject|0|||
157135214|NCT02612909|567243047|FG001|Phase 3|Withdrawal by Subject|0|||
157135215|NCT02612909|567243048|FG002|Phase 3|Withdrawal by Subject|0|||
157135216|NCT02612909|567243049|FG003|Phase 3|Withdrawal by Subject|1|||
157135217|NCT02612909|567243050|FG004|Phase 3|Withdrawal by Subject|0|||
157135218|NCT05067127|567243055|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
157135219|NCT05067127|567243056|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
157135220|NCT05067127|567243057|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
157135221|NCT05067127|567243058|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
157135222|NCT05067127|567243055|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
157135223|NCT05067127|567243056|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
157135224|NCT05067127|567243057|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
157135225|NCT05067127|567243058|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
157135226|NCT05067127|567243055|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
157135227|NCT05067127|567243056|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
157135228|NCT05067127|567243057|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
157135229|NCT05067127|567243058|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
157135230|NCT05067127|567243055|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
157135231|NCT05067127|567243056|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
157135232|NCT05067127|567243057|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
157135233|NCT05067127|567243058|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
157135234|NCT05067127|567243055|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
157135235|NCT05067127|567243056|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
157135236|NCT05067127|567243057|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
157135237|NCT05067127|567243058|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
157135238|NCT05067127|567243055|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
157135239|NCT05067127|567243056|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
157135240|NCT05067127|567243057|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
157135241|NCT05067127|567243058|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
157135242|NCT05067127|567243055|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
157135243|NCT05067127|567243056|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
157135244|NCT05067127|567243057|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
157135245|NCT05067127|567243058|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
157135246|NCT03615222|567243062|FG000|Overall Study|Ineligible|26|||
156794238|NCT01681849|565999527|FG000|Overall Study|Withdrawal by Subject|3|||
157135247|NCT03615222|567243062|FG000|Overall Study|Withdrawal by Subject|7|||
157135248|NCT03615222|567243062|FG000|Overall Study|Death|1|||
157135249|NCT04572633|567243065|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
157135250|NCT03480802|567243066|FG000|Overall Study|Lost to Follow-up|5|||
157135251|NCT03480802|567243067|FG001|Overall Study|Lost to Follow-up|1|||
157135252|NCT03480802|567243066|FG000|Overall Study|Withdrawal by Subject|2|||
157135253|NCT03480802|567243067|FG001|Overall Study|Withdrawal by Subject|1|||
157135254|NCT03480802|567243066|FG000|Overall Study|Relocated|0|||
157135255|NCT03480802|567243067|FG001|Overall Study|Relocated|1|||
157135256|NCT02601950|567243072|FG000|Overall Study|Participant enrolled in rollover study|0|||
157135257|NCT02601950|567243073|FG001|Overall Study|Participant enrolled in rollover study|0|||
157135258|NCT02601950|567243074|FG002|Overall Study|Participant enrolled in rollover study|1|||
157135259|NCT02601950|567243075|FG003|Overall Study|Participant enrolled in rollover study|0|||
157135260|NCT02601950|567243076|FG004|Overall Study|Participant enrolled in rollover study|1|||
157135261|NCT02601950|567243077|FG005|Overall Study|Participant enrolled in rollover study|1|||
157135262|NCT02601950|567243078|FG006|Overall Study|Participant enrolled in rollover study|1|||
157135263|NCT02601950|567243079|FG007|Overall Study|Participant enrolled in rollover study|0|||
157135264|NCT02601950|567243072|FG000|Overall Study|Disease progression - radiological|21|||
157135265|NCT02601950|567243073|FG001|Overall Study|Disease progression - radiological|26|||
157135266|NCT02601950|567243074|FG002|Overall Study|Disease progression - radiological|22|||
157135267|NCT02601950|567243075|FG003|Overall Study|Disease progression - radiological|11|||
157135268|NCT02601950|567243076|FG004|Overall Study|Disease progression - radiological|46|||
157135269|NCT02601950|567243077|FG005|Overall Study|Disease progression - radiological|52|||
157135270|NCT02601950|567243078|FG006|Overall Study|Disease progression - radiological|7|||
157135271|NCT02601950|567243079|FG007|Overall Study|Disease progression - radiological|5|||
157135272|NCT02601950|567243072|FG000|Overall Study|Disease progression - clinical|3|||
157135273|NCT02601950|567243073|FG001|Overall Study|Disease progression - clinical|5|||
157135274|NCT02601950|567243074|FG002|Overall Study|Disease progression - clinical|4|||
157135275|NCT02601950|567243075|FG003|Overall Study|Disease progression - clinical|2|||
157135276|NCT02601950|567243076|FG004|Overall Study|Disease progression - clinical|6|||
157135277|NCT02601950|567243077|FG005|Overall Study|Disease progression - clinical|6|||
157135278|NCT02601950|567243078|FG006|Overall Study|Disease progression - clinical|5|||
157135279|NCT02601950|567243079|FG007|Overall Study|Disease progression - clinical|1|||
157135280|NCT02601950|567243072|FG000|Overall Study|Death|6|||
157135281|NCT02601950|567243073|FG001|Overall Study|Death|0|||
157135282|NCT02601950|567243074|FG002|Overall Study|Death|3|||
157135283|NCT02601950|567243075|FG003|Overall Study|Death|1|||
157135284|NCT02601950|567243076|FG004|Overall Study|Death|4|||
157135285|NCT02601950|567243077|FG005|Overall Study|Death|1|||
157135286|NCT02601950|567243078|FG006|Overall Study|Death|0|||
157135287|NCT02601950|567243079|FG007|Overall Study|Death|0|||
156721739|NCT00931411|565727479|FG001|First Intervention - 42 Days|Adverse Event|3|||
156721740|NCT00931411|565727478|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
156721741|NCT00931411|565727479|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
156721742|NCT00931411|565727478|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
156721743|NCT00931411|565727479|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
156721744|NCT01306305|565727486|FG000|Overall Study|Lost to Follow-up|1|||
156721745|NCT01306305|565727487|FG001|Overall Study|Lost to Follow-up|0|||
156721746|NCT01306305|565727486|FG000|Overall Study|Withdrew consent|1|||
156721747|NCT01306305|565727487|FG001|Overall Study|Withdrew consent|0|||
156721748|NCT04030299|565727488|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
156721749|NCT04030299|565727488|FG000|Overall Study|Withdrawal by Subject|3|||
156721750|NCT00699998|565727489|FG000|Overall Study|Withdrawal by Subject|194|||
156721751|NCT00699998|565727490|FG001|Overall Study|Withdrawal by Subject|83|||
156721752|NCT00699998|565727491|FG002|Overall Study|Withdrawal by Subject|202|||
156721753|NCT00699998|565727492|FG003|Overall Study|Withdrawal by Subject|80|||
156721754|NCT00699998|565727489|FG000|Overall Study|Physician Decision|3|||
156721755|NCT00699998|565727490|FG001|Overall Study|Physician Decision|2|||
156721756|NCT00699998|565727491|FG002|Overall Study|Physician Decision|1|||
156721757|NCT00699998|565727492|FG003|Overall Study|Physician Decision|1|||
156721758|NCT00699998|565727489|FG000|Overall Study|Lost to Follow-up|2|||
156721759|NCT00699998|565727490|FG001|Overall Study|Lost to Follow-up|1|||
156721760|NCT00699998|565727491|FG002|Overall Study|Lost to Follow-up|3|||
156721761|NCT00699998|565727492|FG003|Overall Study|Lost to Follow-up|1|||
156721762|NCT04616612|565727499|FG000|Overall Study|Lost to Follow-up|6|||
156721763|NCT04616612|565727500|FG001|Overall Study|Lost to Follow-up|3|||
156721764|NCT04740918|565727502|FG000|Overall Study|Study Terminated by Sponsor|41|||
157135288|NCT02601950|567243072|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135289|NCT02601950|567243073|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135290|NCT02601950|567243074|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
156721765|NCT04740918|565727503|FG001|Overall Study|Study Terminated by Sponsor|32|||
156721766|NCT04740918|565727502|FG000|Overall Study|Death|3|||
156721767|NCT04740918|565727503|FG001|Overall Study|Death|6|||
156721768|NCT04740918|565727502|FG000|Overall Study|Withdrawal by Subject|5|||
157135291|NCT02601950|567243075|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135292|NCT02601950|567243076|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135293|NCT02601950|567243077|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
157135294|NCT02601950|567243078|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135295|NCT02601950|567243079|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
157135296|NCT02601950|567243072|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
157135297|NCT02601950|567243073|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
157135298|NCT02601950|567243074|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
157135299|NCT02601950|567243075|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
157135300|NCT02601950|567243076|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
157135301|NCT02601950|567243077|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
157135302|NCT02601950|567243078|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
157135303|NCT02601950|567243079|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
157135304|NCT02601950|567243072|FG000|Overall Study|Non-compliance|0|||
157135305|NCT02601950|567243073|FG001|Overall Study|Non-compliance|1|||
157135306|NCT02601950|567243074|FG002|Overall Study|Non-compliance|0|||
157135307|NCT02601950|567243075|FG003|Overall Study|Non-compliance|0|||
157135308|NCT02601950|567243076|FG004|Overall Study|Non-compliance|0|||
157135309|NCT02601950|567243077|FG005|Overall Study|Non-compliance|1|||
157135310|NCT02601950|567243078|FG006|Overall Study|Non-compliance|1|||
157135311|NCT02601950|567243079|FG007|Overall Study|Non-compliance|0|||
157135312|NCT02601950|567243072|FG000|Overall Study|Participant refused further study treatment|0|||
157135313|NCT02601950|567243073|FG001|Overall Study|Participant refused further study treatment|1|||
157135314|NCT02601950|567243074|FG002|Overall Study|Participant refused further study treatment|1|||
157135315|NCT02601950|567243075|FG003|Overall Study|Participant refused further study treatment|0|||
157135316|NCT02601950|567243076|FG004|Overall Study|Participant refused further study treatment|2|||
157135317|NCT02601950|567243077|FG005|Overall Study|Participant refused further study treatment|2|||
157135318|NCT02601950|567243078|FG006|Overall Study|Participant refused further study treatment|2|||
157135319|NCT02601950|567243079|FG007|Overall Study|Participant refused further study treatment|1|||
157135320|NCT02601950|567243072|FG000|Overall Study|Investigator discretion|1|||
157135321|NCT02601950|567243073|FG001|Overall Study|Investigator discretion|0|||
157135322|NCT02601950|567243074|FG002|Overall Study|Investigator discretion|1|||
157135323|NCT02601950|567243075|FG003|Overall Study|Investigator discretion|0|||
157135324|NCT02601950|567243076|FG004|Overall Study|Investigator discretion|1|||
157135325|NCT02601950|567243077|FG005|Overall Study|Investigator discretion|1|||
157135326|NCT02601950|567243078|FG006|Overall Study|Investigator discretion|1|||
157135327|NCT02601950|567243079|FG007|Overall Study|Investigator discretion|0|||
157135328|NCT02601950|567243072|FG000|Overall Study|Other|0|||
157135329|NCT02601950|567243073|FG001|Overall Study|Other|0|||
157135330|NCT02601950|567243074|FG002|Overall Study|Other|0|||
157135331|NCT02601950|567243075|FG003|Overall Study|Other|0|||
157135332|NCT02601950|567243076|FG004|Overall Study|Other|2|||
156721769|NCT04740918|565727503|FG001|Overall Study|Withdrawal by Subject|4|||
156721770|NCT04740918|565727502|FG000|Overall Study|Lost to Follow-up|1|||
156721771|NCT04740918|565727503|FG001|Overall Study|Lost to Follow-up|3|||
156721772|NCT04740918|565727502|FG000|Overall Study|Progressive disease|0|||
156721773|NCT04740918|565727503|FG001|Overall Study|Progressive disease|1|||
156721774|NCT01168427|565727504|FG000|Overall Study|Patient exited prior to implant|1|||
156721775|NCT02964247|565727506|FG000|Overall Study|Lost to Follow-up|2|||
156721776|NCT02964247|565727507|FG001|Overall Study|Lost to Follow-up|0|||
156721777|NCT02964247|565727506|FG000|Overall Study|Withdrawal by Subject|1|||
156721778|NCT02964247|565727507|FG001|Overall Study|Withdrawal by Subject|2|||
156721779|NCT03759392|565727508|FG000|Overall Study|Adverse Event|12|||
156721780|NCT03759392|565727509|FG001|Overall Study|Adverse Event|4|||
156721781|NCT03759392|565727508|FG000|Overall Study|Death|2|||
156721782|NCT03759392|565727509|FG001|Overall Study|Death|1|||
157135333|NCT02601950|567243077|FG005|Overall Study|Other|2|||
157135334|NCT02601950|567243078|FG006|Overall Study|Other|1|||
156721783|NCT03759392|565727508|FG000|Overall Study|Withdrawal by Subject|2|||
156875426|NCT00771953|566302065|FG001|Overall Study|Progression before active Tx|2|||
157135335|NCT02601950|567243079|FG007|Overall Study|Other|0|||
157135336|NCT02157883|567243080|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
157135337|NCT02157883|567243080|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
157135338|NCT02157883|567243080|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
157135339|NCT02157883|567243080|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
157135340|NCT02157883|567243080|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
157135341|NCT01701258|567243081|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
157135342|NCT01701258|567243082|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
157135343|NCT01701258|567243083|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
157135344|NCT01701258|567243084|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
156721784|NCT03759392|565727509|FG001|Overall Study|Withdrawal by Subject|0|||
156721785|NCT03759392|565727508|FG000|Overall Study|Protocol Violation|2|||
156721786|NCT03759392|565727509|FG001|Overall Study|Protocol Violation|0|||
157135345|NCT01701258|567243085|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
157135346|NCT01701258|567243086|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
157135347|NCT01701258|567243087|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
157135348|NCT01701258|567243088|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
157135349|NCT01701258|567243089|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
157135350|NCT01701258|567243090|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
157135351|NCT01701258|567243091|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
157135352|NCT01701258|567243092|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
157135353|NCT01701258|567243093|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
157135354|NCT01701258|567243081|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
157135355|NCT01701258|567243082|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
157135356|NCT01701258|567243083|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
157135357|NCT01701258|567243084|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
157135358|NCT01701258|567243085|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
157135359|NCT01701258|567243086|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
157135360|NCT01701258|567243087|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
157135361|NCT01701258|567243088|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
157135362|NCT01701258|567243089|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
157135363|NCT01701258|567243090|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
157135364|NCT01701258|567243091|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
157135365|NCT01701258|567243092|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
157135366|NCT01701258|567243093|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
157135367|NCT01701258|567243081|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
157135368|NCT01701258|567243082|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
157135369|NCT01701258|567243083|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
157135370|NCT01701258|567243084|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
157135371|NCT01701258|567243085|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
157135372|NCT01701258|567243086|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
157135373|NCT01701258|567243087|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
157135374|NCT01701258|567243088|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
157135375|NCT01701258|567243089|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
157135376|NCT01701258|567243090|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
157135377|NCT01701258|567243091|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
157135378|NCT01701258|567243092|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
157135379|NCT01701258|567243093|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
157135380|NCT01701258|567243081|FG000|Assessment and Scheduling|Investigator Terminated|2|||
157135381|NCT01701258|567243082|FG001|Assessment and Scheduling|Investigator Terminated|0|||
157135382|NCT01701258|567243083|FG002|Assessment and Scheduling|Investigator Terminated|0|||
157135383|NCT01701258|567243084|FG003|Assessment and Scheduling|Investigator Terminated|0|||
157135384|NCT01701258|567243085|FG004|Assessment and Scheduling|Investigator Terminated|0|||
157135385|NCT01701258|567243086|FG005|Assessment and Scheduling|Investigator Terminated|0|||
157135386|NCT01701258|567243087|FG006|Assessment and Scheduling|Investigator Terminated|0|||
157135387|NCT01701258|567243088|FG007|Assessment and Scheduling|Investigator Terminated|0|||
157135388|NCT01701258|567243089|FG008|Assessment and Scheduling|Investigator Terminated|0|||
157135389|NCT01701258|567243090|FG009|Assessment and Scheduling|Investigator Terminated|0|||
157135390|NCT01701258|567243091|FG010|Assessment and Scheduling|Investigator Terminated|0|||
157135391|NCT01701258|567243092|FG011|Assessment and Scheduling|Investigator Terminated|0|||
157135392|NCT01701258|567243093|FG012|Assessment and Scheduling|Investigator Terminated|0|||
157135393|NCT01323478|567243094|FG000|Overall Study|Adverse Event|7|||
157135394|NCT01323478|567243094|FG000|Overall Study|Lack of Efficacy|4|||
157135395|NCT01323478|567243094|FG000|Overall Study|Non-compliance With Study Product|3|||
157135396|NCT01323478|567243094|FG000|Overall Study|Protocol Violation|1|||
157135397|NCT01323478|567243094|FG000|Overall Study|Withdrawal of Consent|1|||
157135398|NCT01323478|567243094|FG000|Overall Study|Administrative or Other Reasons|8|||
156875427|NCT00771953|566302064|FG000|Overall Study|Sponsor decision|1|||
156875428|NCT00771953|566302065|FG001|Overall Study|Sponsor decision|0|||
156875429|NCT00771953|566302064|FG000|Overall Study|Other complicating disease|1|||
156875430|NCT00771953|566302065|FG001|Overall Study|Other complicating disease|0|||
156875431|NCT00771953|566302064|FG000|Overall Study|Withdrawal by Subject|0|||
156875432|NCT00771953|566302065|FG001|Overall Study|Withdrawal by Subject|3|||
157135399|NCT03367871|567243098|FG000|Overall Study|Lost to Follow-up|1|||
157135400|NCT00885365|567243102|FG000|4 Weeks ON Treatment|Adverse Event|2|||
157135401|NCT00885365|567243103|FG001|4 Weeks ON Treatment|Adverse Event|4|||
157135402|NCT00885365|567243102|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
157135403|NCT00885365|567243103|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
157135404|NCT00885365|567243102|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
157135405|NCT00885365|567243103|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
157217306|NCT00529568|567541076|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
156875433|NCT00947193|566302068|FG000|Overall Study|Lost to Follow-up|1|||
156875434|NCT00947193|566302069|FG001|Overall Study|Lost to Follow-up|0|||
157135406|NCT01824979|567243104|FG000|Overall Study|Withdrawal by Subject|5|||
157135407|NCT01824979|567243105|FG001|Overall Study|Withdrawal by Subject|0|||
157135408|NCT01824979|567243104|FG000|Overall Study|Physician Decision|2|||
157135409|NCT01824979|567243105|FG001|Overall Study|Physician Decision|0|||
157135410|NCT01824979|567243104|FG000|Overall Study|Protocol Violation|6|||
157135411|NCT01824979|567243105|FG001|Overall Study|Protocol Violation|13|||
157135412|NCT03094195|567243109|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
157135413|NCT03094195|567243110|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
157135414|NCT03094195|567243111|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
157135415|NCT03094195|567243112|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
157135416|NCT03094195|567243113|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
157135417|NCT03094195|567243114|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
157135418|NCT03094195|567243115|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
157135419|NCT03094195|567243116|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
157135420|NCT03094195|567243109|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
157135421|NCT03094195|567243110|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
157135422|NCT03094195|567243111|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
157135423|NCT03094195|567243112|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
157135424|NCT03094195|567243113|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
157135425|NCT03094195|567243114|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
157135426|NCT03094195|567243115|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
157135427|NCT03094195|567243116|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
157135428|NCT03094195|567243109|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135429|NCT03094195|567243110|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135430|NCT03094195|567243111|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
157135431|NCT03094195|567243112|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
156721787|NCT03759392|565727508|FG000|Overall Study|Physician Decision|0|||
156721788|NCT03759392|565727509|FG001|Overall Study|Physician Decision|1|||
157135432|NCT03094195|567243113|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135433|NCT03094195|567243114|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135434|NCT03094195|567243115|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135435|NCT03094195|567243116|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
157135436|NCT03094195|567243109|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
157135437|NCT03094195|567243110|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
157135438|NCT03094195|567243111|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
157135439|NCT03094195|567243112|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
157135440|NCT03094195|567243113|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
157135441|NCT03094195|567243114|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
156721789|NCT03759392|565727508|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
156721790|NCT03759392|565727509|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
156721791|NCT03759392|565727508|FG000|Overall Study|No longer able to take medicines|1|||
157135442|NCT03094195|567243115|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
157135443|NCT03094195|567243116|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
157135444|NCT00054132|567243117|FG000|Overall Study|Not Treated|1|||
157135445|NCT01795547|567243120|FG000|Overall Study|Adverse Event|16|||
157135446|NCT01795547|567243121|FG001|Overall Study|Adverse Event|27|||
157135447|NCT01795547|567243120|FG000|Overall Study|Lack of Efficacy|8|||
157135448|NCT01795547|567243121|FG001|Overall Study|Lack of Efficacy|3|||
157135449|NCT01795547|567243120|FG000|Overall Study|Protocol Violation|6|||
157135450|NCT01795547|567243121|FG001|Overall Study|Protocol Violation|4|||
157135451|NCT01795547|567243120|FG000|Overall Study|Lost to Follow-up|2|||
157135452|NCT01795547|567243121|FG001|Overall Study|Lost to Follow-up|5|||
157135453|NCT01795547|567243120|FG000|Overall Study|Withdrawal of consent|7|||
157135454|NCT01795547|567243121|FG001|Overall Study|Withdrawal of consent|12|||
157135455|NCT01795547|567243120|FG000|Overall Study|Not Treated|4|||
157135456|NCT01795547|567243121|FG001|Overall Study|Not Treated|10|||
157135457|NCT01795547|567243120|FG000|Overall Study|Non-compliance with IMP|1|||
157135458|NCT01795547|567243121|FG001|Overall Study|Non-compliance with IMP|1|||
157135459|NCT01795547|567243120|FG000|Overall Study|Others|4|||
157135460|NCT01795547|567243121|FG001|Overall Study|Others|1|||
157135461|NCT01795547|567243120|FG000|Overall Study|Not stated|0|||
157135462|NCT01795547|567243121|FG001|Overall Study|Not stated|1|||
157135463|NCT02901431|567243122|FG000|PK Part|Adverse Event|0|||
157135464|NCT02901431|567243123|FG001|PK Part|Adverse Event|1|||
157221658|NCT02207621|567558475|FG001|Overall Study|Adverse Event|15|||
156721792|NCT03759392|565727509|FG001|Overall Study|No longer able to take medicines|0|||
156721793|NCT03759392|565727508|FG000|Overall Study|Stopped taking study drug|1|||
156721794|NCT03759392|565727509|FG001|Overall Study|Stopped taking study drug|0|||
157135465|NCT02901431|567243124|FG002|PK Part|Adverse Event|0|||
157135466|NCT02901431|567243125|FG003|PK Part|Adverse Event|0|||
157135467|NCT02901431|567243126|FG004|PK Part|Adverse Event|0|||
157135468|NCT02901431|567243127|FG005|PK Part|Adverse Event|0|||
157135469|NCT02901431|567243128|FG006|PK Part|Adverse Event|0|||
157135470|NCT02901431|567243129|FG007|PK Part|Adverse Event|0|||
157135471|NCT02901431|567243130|FG008|PK Part|Adverse Event|0|||
157217307|NCT00529568|567541074|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
157217308|NCT00529568|567541075|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
157217309|NCT00529568|567541076|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
157135472|NCT02901431|567243131|FG009|PK Part|Adverse Event|0|||
157135473|NCT02901431|567243132|FG010|PK Part|Adverse Event|0|||
157135474|NCT02901431|567243133|FG011|PK Part|Adverse Event|0|||
157135475|NCT02901431|567243134|FG012|PK Part|Adverse Event|0|||
157135476|NCT02901431|567243122|FG000|PK Part|Lost to Follow-up|0|||
157135477|NCT02901431|567243123|FG001|PK Part|Lost to Follow-up|0|||
157135478|NCT02901431|567243124|FG002|PK Part|Lost to Follow-up|1|||
157135479|NCT02901431|567243125|FG003|PK Part|Lost to Follow-up|0|||
157135480|NCT02901431|567243126|FG004|PK Part|Lost to Follow-up|0|||
157135481|NCT02901431|567243127|FG005|PK Part|Lost to Follow-up|0|||
157135482|NCT02901431|567243128|FG006|PK Part|Lost to Follow-up|0|||
157135483|NCT02901431|567243129|FG007|PK Part|Lost to Follow-up|0|||
157135484|NCT02901431|567243130|FG008|PK Part|Lost to Follow-up|0|||
157135485|NCT02901431|567243131|FG009|PK Part|Lost to Follow-up|0|||
157135486|NCT02901431|567243132|FG010|PK Part|Lost to Follow-up|0|||
157135487|NCT02901431|567243133|FG011|PK Part|Lost to Follow-up|0|||
157135488|NCT02901431|567243134|FG012|PK Part|Lost to Follow-up|0|||
157135489|NCT02901431|567243122|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
157135490|NCT02901431|567243123|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135491|NCT02901431|567243124|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135492|NCT02901431|567243125|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135493|NCT02901431|567243126|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135494|NCT02901431|567243127|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135495|NCT02901431|567243128|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135496|NCT02901431|567243129|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135497|NCT02901431|567243130|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135498|NCT02901431|567243131|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135499|NCT02901431|567243132|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135500|NCT02901431|567243133|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135501|NCT02901431|567243134|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
157135502|NCT02901431|567243122|FG000|PK Part|Pending dose confirmation|0|||
157135503|NCT02901431|567243123|FG001|PK Part|Pending dose confirmation|1|||
157135504|NCT02901431|567243124|FG002|PK Part|Pending dose confirmation|0|||
157135505|NCT02901431|567243125|FG003|PK Part|Pending dose confirmation|0|||
157135506|NCT02901431|567243126|FG004|PK Part|Pending dose confirmation|0|||
157135507|NCT02901431|567243127|FG005|PK Part|Pending dose confirmation|0|||
157135508|NCT02901431|567243128|FG006|PK Part|Pending dose confirmation|0|||
157135509|NCT02901431|567243129|FG007|PK Part|Pending dose confirmation|0|||
157135510|NCT02901431|567243130|FG008|PK Part|Pending dose confirmation|0|||
157135511|NCT02901431|567243131|FG009|PK Part|Pending dose confirmation|0|||
157135512|NCT02901431|567243132|FG010|PK Part|Pending dose confirmation|0|||
157135513|NCT02901431|567243133|FG011|PK Part|Pending dose confirmation|0|||
157135514|NCT02901431|567243134|FG012|PK Part|Pending dose confirmation|0|||
157135515|NCT02901431|567243122|FG000|PK Part|8 weeks of treatment ran out|2|||
157135516|NCT02901431|567243123|FG001|PK Part|8 weeks of treatment ran out|0|||
157135517|NCT02901431|567243124|FG002|PK Part|8 weeks of treatment ran out|0|||
157217310|NCT00529568|567541074|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
157217311|NCT00529568|567541075|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
157217312|NCT00529568|567541076|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
157217313|NCT04049552|567541077|FG000|Overall Study|Lost to Follow-up|1|||
157217314|NCT00738920|567541079|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
157217315|NCT00738920|567541080|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
157217316|NCT00738920|567541081|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
157217317|NCT00738920|567541079|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
157217318|NCT00738920|567541080|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
157217319|NCT00738920|567541081|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
157217320|NCT00738920|567541079|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
157221659|NCT02207621|567558476|FG002|Overall Study|Adverse Event|132|||
157019149|NCT04927065|566824705|FG004|First Booster|Protocol Violation|0|||
157135518|NCT02901431|567243125|FG003|PK Part|8 weeks of treatment ran out|0|||
157135519|NCT02901431|567243126|FG004|PK Part|8 weeks of treatment ran out|0|||
157135520|NCT02901431|567243127|FG005|PK Part|8 weeks of treatment ran out|0|||
157135521|NCT02901431|567243128|FG006|PK Part|8 weeks of treatment ran out|0|||
157135522|NCT02901431|567243129|FG007|PK Part|8 weeks of treatment ran out|0|||
157135523|NCT02901431|567243130|FG008|PK Part|8 weeks of treatment ran out|0|||
157135524|NCT02901431|567243131|FG009|PK Part|8 weeks of treatment ran out|0|||
157135525|NCT02901431|567243132|FG010|PK Part|8 weeks of treatment ran out|0|||
157135526|NCT02901431|567243133|FG011|PK Part|8 weeks of treatment ran out|0|||
157135527|NCT02901431|567243134|FG012|PK Part|8 weeks of treatment ran out|0|||
157135528|NCT02901431|567243122|FG000|PK Part|Stopped treatment after 8 weeks|1|||
157135529|NCT02901431|567243123|FG001|PK Part|Stopped treatment after 8 weeks|0|||
157135530|NCT02901431|567243124|FG002|PK Part|Stopped treatment after 8 weeks|1|||
157135531|NCT02901431|567243125|FG003|PK Part|Stopped treatment after 8 weeks|0|||
157135532|NCT02901431|567243126|FG004|PK Part|Stopped treatment after 8 weeks|0|||
157135533|NCT02901431|567243127|FG005|PK Part|Stopped treatment after 8 weeks|0|||
157135534|NCT02901431|567243128|FG006|PK Part|Stopped treatment after 8 weeks|0|||
157135535|NCT02901431|567243129|FG007|PK Part|Stopped treatment after 8 weeks|0|||
157135536|NCT02901431|567243130|FG008|PK Part|Stopped treatment after 8 weeks|0|||
157135537|NCT02901431|567243131|FG009|PK Part|Stopped treatment after 8 weeks|0|||
157135538|NCT02901431|567243132|FG010|PK Part|Stopped treatment after 8 weeks|0|||
157135539|NCT02901431|567243133|FG011|PK Part|Stopped treatment after 8 weeks|0|||
157135540|NCT02901431|567243134|FG012|PK Part|Stopped treatment after 8 weeks|0|||
157135541|NCT02901431|567243122|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
157135542|NCT02901431|567243123|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135543|NCT02901431|567243124|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
157135544|NCT02901431|567243125|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135545|NCT02901431|567243126|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
156721795|NCT01288079|565727510|FG000|Overall Study|Withdrawal by Subject|2|||
156721796|NCT01288079|565727511|FG001|Overall Study|Withdrawal by Subject|4|||
156721797|NCT01288079|565727512|FG002|Overall Study|Withdrawal by Subject|1|||
156721798|NCT01288079|565727513|FG003|Overall Study|Withdrawal by Subject|0|||
156721799|NCT01288079|565727510|FG000|Overall Study|Adverse Event|2|||
156721800|NCT01288079|565727511|FG001|Overall Study|Adverse Event|1|||
156721801|NCT01288079|565727512|FG002|Overall Study|Adverse Event|2|||
156721802|NCT01288079|565727513|FG003|Overall Study|Adverse Event|3|||
157135546|NCT02901431|567243127|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135547|NCT02901431|567243128|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135548|NCT02901431|567243129|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135549|NCT02901431|567243130|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135550|NCT02901431|567243131|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135551|NCT02901431|567243132|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135552|NCT02901431|567243133|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135553|NCT02901431|567243134|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
157135554|NCT02901431|567243122|FG000|PK Part|Discontinued per Sponsor|0|||
157135555|NCT02901431|567243123|FG001|PK Part|Discontinued per Sponsor|3|||
157135556|NCT02901431|567243124|FG002|PK Part|Discontinued per Sponsor|0|||
157135557|NCT02901431|567243125|FG003|PK Part|Discontinued per Sponsor|0|||
157135558|NCT02901431|567243126|FG004|PK Part|Discontinued per Sponsor|0|||
157135559|NCT02901431|567243127|FG005|PK Part|Discontinued per Sponsor|0|||
157135560|NCT02901431|567243128|FG006|PK Part|Discontinued per Sponsor|0|||
157135561|NCT02901431|567243129|FG007|PK Part|Discontinued per Sponsor|0|||
157135562|NCT02901431|567243130|FG008|PK Part|Discontinued per Sponsor|0|||
157135563|NCT02901431|567243131|FG009|PK Part|Discontinued per Sponsor|0|||
157135564|NCT02901431|567243132|FG010|PK Part|Discontinued per Sponsor|0|||
157135565|NCT02901431|567243133|FG011|PK Part|Discontinued per Sponsor|0|||
157135566|NCT02901431|567243134|FG012|PK Part|Discontinued per Sponsor|0|||
157135567|NCT02901431|567243122|FG000|PK Part|Withdrawal by Subject|1|||
157135568|NCT02901431|567243123|FG001|PK Part|Withdrawal by Subject|1|||
157135569|NCT02901431|567243124|FG002|PK Part|Withdrawal by Subject|3|||
157135570|NCT02901431|567243125|FG003|PK Part|Withdrawal by Subject|0|||
157135571|NCT02901431|567243126|FG004|PK Part|Withdrawal by Subject|0|||
157135572|NCT02901431|567243127|FG005|PK Part|Withdrawal by Subject|0|||
157135573|NCT02901431|567243128|FG006|PK Part|Withdrawal by Subject|0|||
157135574|NCT02901431|567243129|FG007|PK Part|Withdrawal by Subject|0|||
157135575|NCT02901431|567243130|FG008|PK Part|Withdrawal by Subject|0|||
157135576|NCT02901431|567243131|FG009|PK Part|Withdrawal by Subject|0|||
157135577|NCT02901431|567243132|FG010|PK Part|Withdrawal by Subject|0|||
157135578|NCT02901431|567243133|FG011|PK Part|Withdrawal by Subject|0|||
157135579|NCT02901431|567243134|FG012|PK Part|Withdrawal by Subject|0|||
157135580|NCT02901431|567243122|FG000|Main Treatment Part|Adverse Event|0|||
157135581|NCT02901431|567243123|FG001|Main Treatment Part|Adverse Event|0|||
157135582|NCT02901431|567243124|FG002|Main Treatment Part|Adverse Event|0|||
157135583|NCT02901431|567243125|FG003|Main Treatment Part|Adverse Event|3|||
157135584|NCT02901431|567243126|FG004|Main Treatment Part|Adverse Event|3|||
157135585|NCT02901431|567243127|FG005|Main Treatment Part|Adverse Event|4|||
157135586|NCT02901431|567243128|FG006|Main Treatment Part|Adverse Event|1|||
156721803|NCT01288079|565727510|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156721804|NCT01288079|565727511|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
156721805|NCT01288079|565727512|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
157135587|NCT02901431|567243129|FG007|Main Treatment Part|Adverse Event|0|||
157135588|NCT02901431|567243130|FG008|Main Treatment Part|Adverse Event|0|||
157135589|NCT02901431|567243131|FG009|Main Treatment Part|Adverse Event|0|||
157135590|NCT02901431|567243132|FG010|Main Treatment Part|Adverse Event|0|||
157135591|NCT02901431|567243133|FG011|Main Treatment Part|Adverse Event|0|||
157135592|NCT02901431|567243134|FG012|Main Treatment Part|Adverse Event|0|||
157135593|NCT02901431|567243122|FG000|Main Treatment Part|Lack of Efficacy|0|||
157135594|NCT02901431|567243123|FG001|Main Treatment Part|Lack of Efficacy|0|||
157135595|NCT02901431|567243124|FG002|Main Treatment Part|Lack of Efficacy|0|||
157135596|NCT02901431|567243125|FG003|Main Treatment Part|Lack of Efficacy|1|||
157135597|NCT02901431|567243126|FG004|Main Treatment Part|Lack of Efficacy|0|||
157135598|NCT02901431|567243127|FG005|Main Treatment Part|Lack of Efficacy|0|||
157135599|NCT02901431|567243128|FG006|Main Treatment Part|Lack of Efficacy|0|||
157135600|NCT02901431|567243129|FG007|Main Treatment Part|Lack of Efficacy|0|||
157135601|NCT02901431|567243130|FG008|Main Treatment Part|Lack of Efficacy|0|||
157135602|NCT02901431|567243131|FG009|Main Treatment Part|Lack of Efficacy|0|||
157135603|NCT02901431|567243132|FG010|Main Treatment Part|Lack of Efficacy|0|||
157135604|NCT02901431|567243133|FG011|Main Treatment Part|Lack of Efficacy|0|||
157135605|NCT02901431|567243134|FG012|Main Treatment Part|Lack of Efficacy|0|||
157135606|NCT02901431|567243122|FG000|Main Treatment Part|Lost to Follow-up|0|||
157135607|NCT02901431|567243123|FG001|Main Treatment Part|Lost to Follow-up|0|||
157135608|NCT02901431|567243124|FG002|Main Treatment Part|Lost to Follow-up|0|||
157135609|NCT02901431|567243125|FG003|Main Treatment Part|Lost to Follow-up|3|||
157135610|NCT02901431|567243126|FG004|Main Treatment Part|Lost to Follow-up|1|||
157135611|NCT02901431|567243127|FG005|Main Treatment Part|Lost to Follow-up|2|||
157135612|NCT02901431|567243128|FG006|Main Treatment Part|Lost to Follow-up|3|||
157135613|NCT02901431|567243129|FG007|Main Treatment Part|Lost to Follow-up|0|||
157135614|NCT02901431|567243130|FG008|Main Treatment Part|Lost to Follow-up|0|||
157135615|NCT02901431|567243131|FG009|Main Treatment Part|Lost to Follow-up|0|||
157135616|NCT02901431|567243132|FG010|Main Treatment Part|Lost to Follow-up|0|||
157135617|NCT02901431|567243133|FG011|Main Treatment Part|Lost to Follow-up|0|||
157135618|NCT02901431|567243134|FG012|Main Treatment Part|Lost to Follow-up|0|||
157135619|NCT02901431|567243122|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
157135620|NCT02901431|567243123|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
157135621|NCT02901431|567243124|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
157135622|NCT02901431|567243125|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
157135623|NCT02901431|567243126|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
157135624|NCT02901431|567243127|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
157135625|NCT02901431|567243128|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
157135626|NCT02901431|567243129|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
157135627|NCT02901431|567243130|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
157135628|NCT02901431|567243131|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
157135629|NCT02901431|567243132|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
157135630|NCT02901431|567243133|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
157135631|NCT02901431|567243134|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
157135632|NCT02901431|567243122|FG000|Main Treatment Part|Physician Decision|0|||
157135633|NCT02901431|567243123|FG001|Main Treatment Part|Physician Decision|0|||
157135634|NCT02901431|567243124|FG002|Main Treatment Part|Physician Decision|0|||
157135635|NCT02901431|567243125|FG003|Main Treatment Part|Physician Decision|1|||
157135636|NCT02901431|567243126|FG004|Main Treatment Part|Physician Decision|0|||
157135637|NCT02901431|567243127|FG005|Main Treatment Part|Physician Decision|0|||
157135638|NCT02901431|567243128|FG006|Main Treatment Part|Physician Decision|1|||
157135639|NCT02901431|567243129|FG007|Main Treatment Part|Physician Decision|0|||
157135640|NCT02901431|567243130|FG008|Main Treatment Part|Physician Decision|0|||
157135641|NCT02901431|567243131|FG009|Main Treatment Part|Physician Decision|0|||
157135642|NCT02901431|567243132|FG010|Main Treatment Part|Physician Decision|0|||
157135643|NCT02901431|567243133|FG011|Main Treatment Part|Physician Decision|0|||
157135644|NCT02901431|567243134|FG012|Main Treatment Part|Physician Decision|0|||
157135645|NCT02901431|567243122|FG000|Main Treatment Part|Withdrawal by Subject|0|||
157135646|NCT02901431|567243123|FG001|Main Treatment Part|Withdrawal by Subject|0|||
157135647|NCT02901431|567243124|FG002|Main Treatment Part|Withdrawal by Subject|0|||
157135648|NCT02901431|567243125|FG003|Main Treatment Part|Withdrawal by Subject|18|||
157135649|NCT02901431|567243126|FG004|Main Treatment Part|Withdrawal by Subject|3|||
157135650|NCT02901431|567243127|FG005|Main Treatment Part|Withdrawal by Subject|5|||
157135651|NCT02901431|567243128|FG006|Main Treatment Part|Withdrawal by Subject|6|||
157135652|NCT02901431|567243129|FG007|Main Treatment Part|Withdrawal by Subject|0|||
157135653|NCT02901431|567243130|FG008|Main Treatment Part|Withdrawal by Subject|0|||
157135654|NCT02901431|567243131|FG009|Main Treatment Part|Withdrawal by Subject|0|||
157135655|NCT02901431|567243132|FG010|Main Treatment Part|Withdrawal by Subject|0|||
157135656|NCT02901431|567243133|FG011|Main Treatment Part|Withdrawal by Subject|0|||
157217321|NCT00738920|567541080|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
156794239|NCT01681849|565999528|FG001|Overall Study|Withdrawal by Subject|5|||
157135657|NCT02901431|567243134|FG012|Main Treatment Part|Withdrawal by Subject|0|||
157135658|NCT02901431|567243122|FG000|Open Label Part|Adverse Event|0|||
157135659|NCT02901431|567243123|FG001|Open Label Part|Adverse Event|0|||
157135660|NCT02901431|567243124|FG002|Open Label Part|Adverse Event|0|||
157135661|NCT02901431|567243125|FG003|Open Label Part|Adverse Event|0|||
157135662|NCT02901431|567243126|FG004|Open Label Part|Adverse Event|0|||
157135663|NCT02901431|567243127|FG005|Open Label Part|Adverse Event|0|||
157135664|NCT02901431|567243128|FG006|Open Label Part|Adverse Event|0|||
157135665|NCT02901431|567243129|FG007|Open Label Part|Adverse Event|0|||
157135666|NCT02901431|567243130|FG008|Open Label Part|Adverse Event|4|||
157135667|NCT02901431|567243131|FG009|Open Label Part|Adverse Event|4|||
157135668|NCT02901431|567243132|FG010|Open Label Part|Adverse Event|0|||
157135669|NCT02901431|567243133|FG011|Open Label Part|Adverse Event|4|||
157135670|NCT02901431|567243134|FG012|Open Label Part|Adverse Event|1|||
157135671|NCT02901431|567243122|FG000|Open Label Part|Lost to Follow-up|0|||
157135672|NCT02901431|567243123|FG001|Open Label Part|Lost to Follow-up|0|||
157135673|NCT02901431|567243124|FG002|Open Label Part|Lost to Follow-up|0|||
157135674|NCT02901431|567243125|FG003|Open Label Part|Lost to Follow-up|0|||
157135675|NCT02901431|567243126|FG004|Open Label Part|Lost to Follow-up|0|||
157135676|NCT02901431|567243127|FG005|Open Label Part|Lost to Follow-up|0|||
157135677|NCT02901431|567243128|FG006|Open Label Part|Lost to Follow-up|0|||
157135678|NCT02901431|567243129|FG007|Open Label Part|Lost to Follow-up|0|||
157135679|NCT02901431|567243130|FG008|Open Label Part|Lost to Follow-up|2|||
157135680|NCT02901431|567243131|FG009|Open Label Part|Lost to Follow-up|2|||
157135681|NCT02901431|567243132|FG010|Open Label Part|Lost to Follow-up|1|||
157135682|NCT02901431|567243133|FG011|Open Label Part|Lost to Follow-up|1|||
157135683|NCT02901431|567243134|FG012|Open Label Part|Lost to Follow-up|1|||
157135684|NCT02901431|567243122|FG000|Open Label Part|Physician Decision|0|||
157135685|NCT02901431|567243123|FG001|Open Label Part|Physician Decision|0|||
157135686|NCT02901431|567243124|FG002|Open Label Part|Physician Decision|0|||
157135687|NCT02901431|567243125|FG003|Open Label Part|Physician Decision|0|||
157135688|NCT02901431|567243126|FG004|Open Label Part|Physician Decision|0|||
157135689|NCT02901431|567243127|FG005|Open Label Part|Physician Decision|0|||
157135690|NCT02901431|567243128|FG006|Open Label Part|Physician Decision|0|||
157135691|NCT02901431|567243129|FG007|Open Label Part|Physician Decision|0|||
157135692|NCT02901431|567243130|FG008|Open Label Part|Physician Decision|1|||
157135693|NCT02901431|567243131|FG009|Open Label Part|Physician Decision|1|||
157135694|NCT02901431|567243132|FG010|Open Label Part|Physician Decision|0|||
157135695|NCT02901431|567243133|FG011|Open Label Part|Physician Decision|0|||
157135696|NCT02901431|567243134|FG012|Open Label Part|Physician Decision|0|||
157135697|NCT02901431|567243122|FG000|Open Label Part|Study Terminated By Sponsor|0|||
157135698|NCT02901431|567243123|FG001|Open Label Part|Study Terminated By Sponsor|0|||
157135699|NCT02901431|567243124|FG002|Open Label Part|Study Terminated By Sponsor|0|||
157135700|NCT02901431|567243125|FG003|Open Label Part|Study Terminated By Sponsor|0|||
157135701|NCT02901431|567243126|FG004|Open Label Part|Study Terminated By Sponsor|0|||
157135702|NCT02901431|567243127|FG005|Open Label Part|Study Terminated By Sponsor|0|||
157135703|NCT02901431|567243128|FG006|Open Label Part|Study Terminated By Sponsor|0|||
157135704|NCT02901431|567243129|FG007|Open Label Part|Study Terminated By Sponsor|0|||
157135705|NCT02901431|567243130|FG008|Open Label Part|Study Terminated By Sponsor|35|||
157135706|NCT02901431|567243131|FG009|Open Label Part|Study Terminated By Sponsor|12|||
157135707|NCT02901431|567243132|FG010|Open Label Part|Study Terminated By Sponsor|21|||
157135708|NCT02901431|567243133|FG011|Open Label Part|Study Terminated By Sponsor|31|||
157135709|NCT02901431|567243134|FG012|Open Label Part|Study Terminated By Sponsor|0|||
157135710|NCT02901431|567243122|FG000|Open Label Part|Withdrawal by Subject|0|||
157135711|NCT02901431|567243123|FG001|Open Label Part|Withdrawal by Subject|0|||
157135712|NCT02901431|567243124|FG002|Open Label Part|Withdrawal by Subject|0|||
157135713|NCT02901431|567243125|FG003|Open Label Part|Withdrawal by Subject|0|||
157135714|NCT02901431|567243126|FG004|Open Label Part|Withdrawal by Subject|0|||
157135715|NCT02901431|567243127|FG005|Open Label Part|Withdrawal by Subject|0|||
157135716|NCT02901431|567243128|FG006|Open Label Part|Withdrawal by Subject|0|||
157135717|NCT02901431|567243129|FG007|Open Label Part|Withdrawal by Subject|0|||
157135718|NCT02901431|567243130|FG008|Open Label Part|Withdrawal by Subject|6|||
157135719|NCT02901431|567243131|FG009|Open Label Part|Withdrawal by Subject|5|||
157135720|NCT02901431|567243132|FG010|Open Label Part|Withdrawal by Subject|7|||
157135721|NCT02901431|567243133|FG011|Open Label Part|Withdrawal by Subject|3|||
157135722|NCT02901431|567243134|FG012|Open Label Part|Withdrawal by Subject|1|||
157135723|NCT00591734|567243139|FG000|Overall Study|Lack of Efficacy|35|||
157135724|NCT00591734|567243139|FG000|Overall Study|Adverse Event|5|||
157135725|NCT00591734|567243139|FG000|Overall Study|Physician Decision|5|||
157135726|NCT00591734|567243139|FG000|Overall Study|Intercurrent Illness|8|||
157135727|NCT01661790|567243140|FG000|Overall Study|Lost to Follow-up|0|||
157135728|NCT01661790|567243141|FG001|Overall Study|Lost to Follow-up|2|||
157135729|NCT00784758|567243144|FG000|Overall Study|Withdrawal by Subject|3|||
157135730|NCT00784758|567243145|FG001|Overall Study|Withdrawal by Subject|0|||
157135731|NCT00784758|567243144|FG000|Overall Study|Adverse Event|1|||
157135732|NCT00784758|567243145|FG001|Overall Study|Adverse Event|0|||
157135733|NCT01827384|567243146|FG000|Overall Study|Switched to alternative treatment|0|||
157135734|NCT01827384|567243147|FG001|Overall Study|Switched to alternative treatment|0|||
157135735|NCT01827384|567243148|FG002|Overall Study|Switched to alternative treatment|0|||
157217322|NCT00738920|567541081|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
157217323|NCT00738920|567541079|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
157135736|NCT01827384|567243149|FG003|Overall Study|Switched to alternative treatment|0|||
157135737|NCT01827384|567243150|FG004|Overall Study|Switched to alternative treatment|0|||
157135738|NCT01827384|567243151|FG005|Overall Study|Switched to alternative treatment|0|||
157135739|NCT01827384|567243152|FG006|Overall Study|Switched to alternative treatment|0|||
157135740|NCT01827384|567243153|FG007|Overall Study|Switched to alternative treatment|0|||
157135741|NCT01827384|567243154|FG008|Overall Study|Switched to alternative treatment|0|||
157135742|NCT01827384|567243155|FG009|Overall Study|Switched to alternative treatment|0|||
157135743|NCT01827384|567243156|FG010|Overall Study|Switched to alternative treatment|0|||
157135744|NCT01827384|567243157|FG011|Overall Study|Switched to alternative treatment|0|||
157135745|NCT01827384|567243158|FG012|Overall Study|Switched to alternative treatment|0|||
157135746|NCT01827384|567243159|FG013|Overall Study|Switched to alternative treatment|2|||
157135747|NCT01827384|567243146|FG000|Overall Study|Disease progression before treatment|0|||
157135748|NCT01827384|567243147|FG001|Overall Study|Disease progression before treatment|0|||
157135749|NCT01827384|567243148|FG002|Overall Study|Disease progression before treatment|0|||
157135750|NCT01827384|567243149|FG003|Overall Study|Disease progression before treatment|0|||
157135751|NCT01827384|567243150|FG004|Overall Study|Disease progression before treatment|0|||
157135752|NCT01827384|567243151|FG005|Overall Study|Disease progression before treatment|0|||
157135753|NCT01827384|567243152|FG006|Overall Study|Disease progression before treatment|0|||
157135754|NCT01827384|567243153|FG007|Overall Study|Disease progression before treatment|0|||
157135755|NCT01827384|567243154|FG008|Overall Study|Disease progression before treatment|0|||
157135756|NCT01827384|567243155|FG009|Overall Study|Disease progression before treatment|0|||
157135757|NCT01827384|567243156|FG010|Overall Study|Disease progression before treatment|0|||
157135758|NCT01827384|567243157|FG011|Overall Study|Disease progression before treatment|0|||
157135759|NCT01827384|567243158|FG012|Overall Study|Disease progression before treatment|0|||
157135760|NCT01827384|567243159|FG013|Overall Study|Disease progression before treatment|4|||
157135761|NCT01827384|567243146|FG000|Overall Study|Ineligible|0|||
157135762|NCT01827384|567243147|FG001|Overall Study|Ineligible|0|||
157135763|NCT01827384|567243148|FG002|Overall Study|Ineligible|0|||
157135764|NCT01827384|567243149|FG003|Overall Study|Ineligible|0|||
157135765|NCT01827384|567243150|FG004|Overall Study|Ineligible|0|||
157135766|NCT01827384|567243151|FG005|Overall Study|Ineligible|0|||
157135767|NCT01827384|567243152|FG006|Overall Study|Ineligible|0|||
157135768|NCT01827384|567243153|FG007|Overall Study|Ineligible|0|||
157135769|NCT01827384|567243154|FG008|Overall Study|Ineligible|0|||
157135770|NCT01827384|567243155|FG009|Overall Study|Ineligible|0|||
157135771|NCT01827384|567243156|FG010|Overall Study|Ineligible|0|||
157135772|NCT01827384|567243157|FG011|Overall Study|Ineligible|0|||
157135773|NCT01827384|567243158|FG012|Overall Study|Ineligible|0|||
157135774|NCT01827384|567243159|FG013|Overall Study|Ineligible|19|||
157135775|NCT01827384|567243146|FG000|Overall Study|Participant died before treatment|0|||
157135776|NCT01827384|567243147|FG001|Overall Study|Participant died before treatment|0|||
157135777|NCT01827384|567243148|FG002|Overall Study|Participant died before treatment|0|||
157135778|NCT01827384|567243149|FG003|Overall Study|Participant died before treatment|0|||
157135779|NCT01827384|567243150|FG004|Overall Study|Participant died before treatment|0|||
157135780|NCT01827384|567243151|FG005|Overall Study|Participant died before treatment|0|||
157135781|NCT01827384|567243152|FG006|Overall Study|Participant died before treatment|0|||
157135782|NCT01827384|567243153|FG007|Overall Study|Participant died before treatment|0|||
157135783|NCT01827384|567243154|FG008|Overall Study|Participant died before treatment|0|||
157135784|NCT01827384|567243155|FG009|Overall Study|Participant died before treatment|0|||
157135785|NCT01827384|567243156|FG010|Overall Study|Participant died before treatment|0|||
157135786|NCT01827384|567243157|FG011|Overall Study|Participant died before treatment|0|||
157135787|NCT01827384|567243158|FG012|Overall Study|Participant died before treatment|0|||
157135788|NCT01827384|567243159|FG013|Overall Study|Participant died before treatment|5|||
157135789|NCT01827384|567243146|FG000|Overall Study|Insufficient tumor cells|0|||
157135790|NCT01827384|567243147|FG001|Overall Study|Insufficient tumor cells|0|||
157135791|NCT01827384|567243148|FG002|Overall Study|Insufficient tumor cells|0|||
157135792|NCT01827384|567243149|FG003|Overall Study|Insufficient tumor cells|0|||
157135793|NCT01827384|567243150|FG004|Overall Study|Insufficient tumor cells|0|||
157135794|NCT01827384|567243151|FG005|Overall Study|Insufficient tumor cells|0|||
157135795|NCT01827384|567243152|FG006|Overall Study|Insufficient tumor cells|0|||
157135796|NCT01827384|567243153|FG007|Overall Study|Insufficient tumor cells|0|||
157135797|NCT01827384|567243154|FG008|Overall Study|Insufficient tumor cells|0|||
157135798|NCT01827384|567243155|FG009|Overall Study|Insufficient tumor cells|0|||
157135799|NCT01827384|567243156|FG010|Overall Study|Insufficient tumor cells|0|||
156875435|NCT00947193|566302068|FG000|Overall Study|Withdrawal by Subject|1|||
156875436|NCT00947193|566302069|FG001|Overall Study|Withdrawal by Subject|0|||
157019150|NCT04927065|566824706|FG005|First Booster|Protocol Violation|0|||
157135800|NCT01827384|567243157|FG011|Overall Study|Insufficient tumor cells|0|||
157135801|NCT01827384|567243158|FG012|Overall Study|Insufficient tumor cells|0|||
157135802|NCT01827384|567243159|FG013|Overall Study|Insufficient tumor cells|13|||
157135803|NCT01827384|567243146|FG000|Overall Study|No actionable mutation|0|||
157135804|NCT01827384|567243147|FG001|Overall Study|No actionable mutation|0|||
157135805|NCT01827384|567243148|FG002|Overall Study|No actionable mutation|0|||
157135806|NCT01827384|567243149|FG003|Overall Study|No actionable mutation|0|||
157135807|NCT01827384|567243150|FG004|Overall Study|No actionable mutation|0|||
157135808|NCT01827384|567243151|FG005|Overall Study|No actionable mutation|0|||
157135809|NCT01827384|567243152|FG006|Overall Study|No actionable mutation|0|||
157135810|NCT01827384|567243153|FG007|Overall Study|No actionable mutation|0|||
157135811|NCT01827384|567243154|FG008|Overall Study|No actionable mutation|0|||
157135812|NCT01827384|567243155|FG009|Overall Study|No actionable mutation|0|||
157135813|NCT01827384|567243156|FG010|Overall Study|No actionable mutation|0|||
157135814|NCT01827384|567243157|FG011|Overall Study|No actionable mutation|0|||
157135815|NCT01827384|567243158|FG012|Overall Study|No actionable mutation|0|||
157135816|NCT01827384|567243159|FG013|Overall Study|No actionable mutation|73|||
157135817|NCT01827384|567243146|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
157135818|NCT01827384|567243147|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
157135819|NCT01827384|567243148|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
157135820|NCT01827384|567243149|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
157135821|NCT01827384|567243150|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
157135822|NCT01827384|567243151|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
157135823|NCT01827384|567243152|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
157135824|NCT01827384|567243153|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
157135825|NCT01827384|567243154|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
157135826|NCT01827384|567243155|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
157135827|NCT01827384|567243156|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
157135828|NCT01827384|567243157|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
157135829|NCT01827384|567243158|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
157135830|NCT01827384|567243159|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
157135831|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
157135832|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
157135833|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
157135834|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
156721806|NCT01288079|565727513|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
156721807|NCT01288079|565727510|FG000|Overall Study|Condition under Investigation Worsened|0|||
156721808|NCT01288079|565727511|FG001|Overall Study|Condition under Investigation Worsened|0|||
156721809|NCT01288079|565727512|FG002|Overall Study|Condition under Investigation Worsened|0|||
156721810|NCT01288079|565727513|FG003|Overall Study|Condition under Investigation Worsened|1|||
156721811|NCT01288079|565727510|FG000|Overall Study|Lack of Efficacy|2|||
156721812|NCT01288079|565727511|FG001|Overall Study|Lack of Efficacy|2|||
156721813|NCT01288079|565727512|FG002|Overall Study|Lack of Efficacy|0|||
156721814|NCT01288079|565727513|FG003|Overall Study|Lack of Efficacy|2|||
156721815|NCT01288079|565727510|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
156721816|NCT01288079|565727511|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
156721817|NCT01288079|565727512|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
156721818|NCT01288079|565727513|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
156721819|NCT01288079|565727510|FG000|Overall Study|Lost to Follow-up|1|||
156721820|NCT01288079|565727511|FG001|Overall Study|Lost to Follow-up|1|||
156721821|NCT01288079|565727512|FG002|Overall Study|Lost to Follow-up|1|||
156721822|NCT01288079|565727513|FG003|Overall Study|Lost to Follow-up|0|||
156721823|NCT01288079|565727510|FG000|Overall Study|Other or Study Termination|11|||
156721824|NCT01288079|565727511|FG001|Overall Study|Other or Study Termination|15|||
156721825|NCT01288079|565727512|FG002|Overall Study|Other or Study Termination|14|||
156721826|NCT01288079|565727513|FG003|Overall Study|Other or Study Termination|8|||
156721827|NCT01530464|565727514|FG000|Washout (24h)|Withdrawal by Subject|1|||
156721828|NCT01530464|565727515|FG001|Washout (24h)|Withdrawal by Subject|0|||
156721829|NCT01530464|565727514|FG000|Washout (24h)|Withdrawal by Subject|0|||
156721830|NCT01530464|565727515|FG001|Washout (24h)|Withdrawal by Subject|1|||
156721831|NCT01709500|565727516|FG000|Overall Study|Randomized but not treated|0|||
157135835|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
157135836|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
157135837|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
157135838|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
156721832|NCT01709500|565727517|FG001|Overall Study|Randomized but not treated|1|||
156721833|NCT01709500|565727516|FG000|Overall Study|Adverse Event|5|||
156875437|NCT00947193|566302068|FG000|Overall Study|Factor VIII >1%|1|||
156875438|NCT00947193|566302069|FG001|Overall Study|Factor VIII >1%|0|||
157019151|NCT04927065|566824707|FG006|First Booster|Protocol Violation|0|||
157019152|NCT04927065|566824708|FG007|First Booster|Protocol Violation|2|||
157135839|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
157135840|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
157135841|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
157217324|NCT00738920|567541080|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
156721834|NCT01709500|565727517|FG001|Overall Study|Adverse Event|1|||
156721835|NCT01709500|565727516|FG000|Overall Study|Poor compliance to protocol|2|||
156721836|NCT01709500|565727517|FG001|Overall Study|Poor compliance to protocol|1|||
156721837|NCT01709500|565727516|FG000|Overall Study|Other|3|||
156721838|NCT01709500|565727517|FG001|Overall Study|Other|1|||
156721839|NCT01709500|565727516|FG000|Overall Study|Related to IMP administration|1|||
156875439|NCT04364984|566302070|FG000|Overall Study|Death|2|||
156721840|NCT01709500|565727517|FG001|Overall Study|Related to IMP administration|0|||
156721841|NCT01709500|565727516|FG000|Overall Study|Treatment ongoing|156|||
156721842|NCT01709500|565727517|FG001|Overall Study|Treatment ongoing|78|||
156721843|NCT03539302|565727524|FG000|Overall Study|Spontaneous cardio version|0|||
156721844|NCT03539302|565727525|FG001|Overall Study|Spontaneous cardio version|0|||
156721845|NCT03539302|565727526|FG002|Overall Study|Spontaneous cardio version|0|||
156721846|NCT03539302|565727527|FG003|Overall Study|Spontaneous cardio version|0|||
156721847|NCT03539302|565727528|FG004|Overall Study|Spontaneous cardio version|0|||
156721848|NCT03539302|565727529|FG005|Overall Study|Spontaneous cardio version|1|||
156721849|NCT03539302|565727530|FG006|Overall Study|Spontaneous cardio version|1|||
156721850|NCT02107131|565727532|FG000|Overall Study|Lost to Follow-up|4|||
156721851|NCT02107131|565727533|FG001|Overall Study|Lost to Follow-up|4|||
156721852|NCT02107131|565727532|FG000|Overall Study|Physician Decision|1|||
156721853|NCT02107131|565727533|FG001|Overall Study|Physician Decision|0|||
156721854|NCT02107131|565727532|FG000|Overall Study|Withdrawal by Subject|2|||
156721855|NCT02107131|565727533|FG001|Overall Study|Withdrawal by Subject|0|||
156721856|NCT02107131|565727532|FG000|Overall Study|mental instability|1|||
156721857|NCT02107131|565727533|FG001|Overall Study|mental instability|0|||
156721858|NCT02107131|565727532|FG000|Overall Study|Death|0|||
156721859|NCT02107131|565727533|FG001|Overall Study|Death|1|||
156721860|NCT02107131|565727532|FG000|Overall Study|Protocol Violation|0|||
157135842|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
157135843|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
157135844|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
157135845|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
156721861|NCT02107131|565727533|FG001|Overall Study|Protocol Violation|4|||
156721862|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Adverse Event|7|||
156721863|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
156721864|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Non-compliance|3|||
156721865|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Other|17|||
156721866|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Physician Decision|2|||
156721867|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Pregnancy|1|||
156721868|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
156721869|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
156721870|NCT05207865|565728879|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
156721871|NCT05207865|565728879|FG000|Follow-up Phase|Lost to Follow-up|1|||
156721872|NCT05207865|565728879|FG000|Follow-up Phase|Non-compliance|1|||
156721873|NCT05207865|565728879|FG000|Follow-up Phase|Not reported|2|||
156721874|NCT05207865|565728879|FG000|Follow-up Phase|Not collected|11|||
156721875|NCT05423093|565728880|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
156721876|NCT05423093|565728880|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
156721877|NCT05423093|565728880|FG000|Attended Intervention Session|Lost to Follow-up|3|||
156721878|NCT05423093|565728880|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
156721879|NCT05423093|565728880|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
156721880|NCT05364931|565728881|FG000|Overall Study|Adverse Event|0|||
156721881|NCT05364931|565728882|FG001|Overall Study|Adverse Event|2|||
156721882|NCT05364931|565728883|FG002|Overall Study|Adverse Event|1|||
157135846|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
156721883|NCT05364931|565728884|FG003|Overall Study|Adverse Event|0|||
156721884|NCT05364931|565728881|FG000|Overall Study|Lost to Follow-up|1|||
156794240|NCT01681849|565999529|FG002|Overall Study|Withdrawal by Subject|33|||
157135847|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
157135848|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
157135849|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
157135850|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
157135851|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
157135852|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
157135853|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
157135854|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
156721885|NCT05364931|565728882|FG001|Overall Study|Lost to Follow-up|0|||
156721886|NCT05364931|565728883|FG002|Overall Study|Lost to Follow-up|0|||
156721887|NCT05364931|565728884|FG003|Overall Study|Lost to Follow-up|0|||
156721888|NCT05364931|565728881|FG000|Overall Study|Withdrawal by Subject|1|||
156721889|NCT05364931|565728882|FG001|Overall Study|Withdrawal by Subject|1|||
156721890|NCT05364931|565728883|FG002|Overall Study|Withdrawal by Subject|3|||
156721891|NCT05364931|565728884|FG003|Overall Study|Withdrawal by Subject|2|||
156721892|NCT05364931|565728881|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156794241|NCT01681849|565999527|FG000|Overall Study|Lost to Follow-up|3|||
156794242|NCT01681849|565999528|FG001|Overall Study|Lost to Follow-up|2|||
156794243|NCT01681849|565999529|FG002|Overall Study|Lost to Follow-up|6|||
156794244|NCT02852005|565999535|FG000|Overall Study|Lost to Follow-up|0|||
156794245|NCT02852005|565999536|FG001|Overall Study|Lost to Follow-up|0|||
157135855|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
156721893|NCT05364931|565728882|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
156721894|NCT05364931|565728883|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156721895|NCT05364931|565728884|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
156721896|NCT05364931|565728881|FG000|Overall Study|Discontinued|1|||
156721897|NCT05364931|565728882|FG001|Overall Study|Discontinued|0|||
156721898|NCT05364931|565728883|FG002|Overall Study|Discontinued|0|||
156721899|NCT05364931|565728884|FG003|Overall Study|Discontinued|0|||
156875440|NCT04364984|566302071|FG001|Overall Study|Death|2|||
156875441|NCT04364984|566302072|FG002|Overall Study|Death|0|||
156875442|NCT02867384|566302073|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
156875443|NCT02867384|566302074|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
156875444|NCT02867384|566302075|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
156875445|NCT02867384|566302073|FG000|Overall Study|Progression/ Relapse|15|||
156875446|NCT02867384|566302074|FG001|Overall Study|Progression/ Relapse|19|||
156875447|NCT02867384|566302075|FG002|Overall Study|Progression/ Relapse|0|||
156875448|NCT02867384|566302073|FG000|Overall Study|Adverse Event|13|||
156875449|NCT02867384|566302074|FG001|Overall Study|Adverse Event|1|||
156875450|NCT02867384|566302075|FG002|Overall Study|Adverse Event|0|||
156875451|NCT02867384|566302073|FG000|Overall Study|Withdrawal by Subject|6|||
156875452|NCT02867384|566302074|FG001|Overall Study|Withdrawal by Subject|5|||
157019153|NCT04927065|566824709|FG008|First Booster|Protocol Violation|0|||
157019154|NCT04927065|566824710|FG009|First Booster|Protocol Violation|0|||
157019155|NCT04927065|566824711|FG010|First Booster|Protocol Violation|0|||
157135856|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
157135857|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
157135858|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
157135859|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
157135860|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
157135861|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
157135862|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
157135863|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
157135864|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
157135865|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
157135866|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
157135867|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
157135868|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
157135869|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
157135870|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
157135871|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
157135872|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
157135873|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
157135874|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
157135875|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
157135876|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
157135877|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
157135878|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
157135879|NCT01707992|567243160|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
157135880|NCT01707992|567243161|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
157135881|NCT01707992|567243162|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
157135882|NCT01707992|567243163|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
157135883|NCT01707992|567243164|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
157135884|NCT01707992|567243165|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
157135885|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
157135886|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
157135887|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
157135888|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
157135889|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
157135890|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
157135891|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
156721900|NCT03593525|565728885|FG000|Overall Study|Withdrawal by Subject|1|||
156721901|NCT03593525|565728886|FG001|Overall Study|Withdrawal by Subject|0|||
157019156|NCT04927065|566824712|FG011|First Booster|Protocol Violation|0|||
157019157|NCT04927065|566824713|FG012|First Booster|Protocol Violation|0|||
156721902|NCT03593525|565728885|FG000|Overall Study|Lost to Follow-up|7|||
156875453|NCT02867384|566302075|FG002|Overall Study|Withdrawal by Subject|0|||
156875454|NCT02867384|566302073|FG000|Overall Study|Physician Decision|1|||
157019158|NCT04927065|566824714|FG013|First Booster|Protocol Violation|0|||
157019159|NCT04927065|566824715|FG014|First Booster|Protocol Violation|0|||
156721903|NCT03593525|565728886|FG001|Overall Study|Lost to Follow-up|5|||
156721904|NCT04570670|565728894|FG000|Overall Study|Withdrawal by Subject|1|||
156721905|NCT04570670|565728895|FG001|Overall Study|Withdrawal by Subject|0|||
156721906|NCT00460603|565728896|FG000|Phase 1|Death|1|||
156721907|NCT00460603|565728897|FG001|Phase 1|Death|0|||
156721908|NCT00460603|565728898|FG002|Phase 1|Death|0|||
156721909|NCT00460603|565728899|FG003|Phase 1|Death|2|||
156721910|NCT00460603|565728900|FG004|Phase 1|Death|0|||
156721911|NCT00460603|565728901|FG005|Phase 1|Death|0|||
156721912|NCT00460603|565728902|FG006|Phase 1|Death|0|||
156721913|NCT00460603|565728903|FG007|Phase 1|Death|0|||
156721914|NCT00460603|565728904|FG008|Phase 1|Death|1|||
156721915|NCT00460603|565728905|FG009|Phase 1|Death|0|||
156721916|NCT00460603|565728906|FG010|Phase 1|Death|0|||
156721917|NCT00460603|565728907|FG011|Phase 1|Death|0|||
157135892|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
157135893|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
157135894|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
157135895|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
157135896|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
157135897|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
157135898|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
157135899|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
157135900|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
156721918|NCT00460603|565728896|FG000|Phase 1|Adverse Event|3|||
156721919|NCT00460603|565728897|FG001|Phase 1|Adverse Event|1|||
156721920|NCT00460603|565728898|FG002|Phase 1|Adverse Event|1|||
156721921|NCT00460603|565728899|FG003|Phase 1|Adverse Event|2|||
156721922|NCT00460603|565728900|FG004|Phase 1|Adverse Event|0|||
156721923|NCT00460603|565728901|FG005|Phase 1|Adverse Event|0|||
156721924|NCT00460603|565728902|FG006|Phase 1|Adverse Event|3|||
156721925|NCT00460603|565728903|FG007|Phase 1|Adverse Event|0|||
156721926|NCT00460603|565728904|FG008|Phase 1|Adverse Event|4|||
156721927|NCT00460603|565728905|FG009|Phase 1|Adverse Event|0|||
156721928|NCT00460603|565728906|FG010|Phase 1|Adverse Event|0|||
156721929|NCT00460603|565728907|FG011|Phase 1|Adverse Event|0|||
156721930|NCT00460603|565728896|FG000|Phase 1|Lack of Efficacy|1|||
156721931|NCT00460603|565728897|FG001|Phase 1|Lack of Efficacy|0|||
156721932|NCT00460603|565728898|FG002|Phase 1|Lack of Efficacy|1|||
156721933|NCT00460603|565728899|FG003|Phase 1|Lack of Efficacy|2|||
156721934|NCT00460603|565728900|FG004|Phase 1|Lack of Efficacy|2|||
156721935|NCT00460603|565728901|FG005|Phase 1|Lack of Efficacy|2|||
156721936|NCT00460603|565728902|FG006|Phase 1|Lack of Efficacy|2|||
156721937|NCT00460603|565728903|FG007|Phase 1|Lack of Efficacy|2|||
156721938|NCT00460603|565728904|FG008|Phase 1|Lack of Efficacy|11|||
157135901|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
157135902|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
157135903|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
157135904|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
157135905|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
157135906|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
157135907|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
157135908|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
157135909|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
157135910|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
157135911|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
157135912|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
157135913|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
157135914|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
157135915|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Death|0|||
157135916|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Death|0|||
157135917|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Death|0|||
157135918|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Death|2|||
156721939|NCT00460603|565728905|FG009|Phase 1|Lack of Efficacy|0|||
156721940|NCT00460603|565728906|FG010|Phase 1|Lack of Efficacy|0|||
156721941|NCT00460603|565728907|FG011|Phase 1|Lack of Efficacy|0|||
156721942|NCT00460603|565728896|FG000|Phase 1|Withdrawal by Subject|1|||
156721943|NCT00460603|565728897|FG001|Phase 1|Withdrawal by Subject|2|||
156721944|NCT00460603|565728898|FG002|Phase 1|Withdrawal by Subject|1|||
156721945|NCT00460603|565728899|FG003|Phase 1|Withdrawal by Subject|1|||
156721946|NCT00460603|565728900|FG004|Phase 1|Withdrawal by Subject|3|||
156721947|NCT00460603|565728901|FG005|Phase 1|Withdrawal by Subject|0|||
156721948|NCT00460603|565728902|FG006|Phase 1|Withdrawal by Subject|1|||
156721949|NCT00460603|565728903|FG007|Phase 1|Withdrawal by Subject|0|||
156721950|NCT00460603|565728904|FG008|Phase 1|Withdrawal by Subject|2|||
156721951|NCT00460603|565728905|FG009|Phase 1|Withdrawal by Subject|0|||
156721952|NCT00460603|565728906|FG010|Phase 1|Withdrawal by Subject|0|||
156721953|NCT00460603|565728907|FG011|Phase 1|Withdrawal by Subject|0|||
156721954|NCT00460603|565728896|FG000|Phase 1|Other|0|||
156721955|NCT00460603|565728897|FG001|Phase 1|Other|3|||
156721956|NCT00460603|565728898|FG002|Phase 1|Other|1|||
156721957|NCT00460603|565728899|FG003|Phase 1|Other|1|||
156721958|NCT00460603|565728900|FG004|Phase 1|Other|1|||
156721959|NCT00460603|565728901|FG005|Phase 1|Other|2|||
156721960|NCT00460603|565728902|FG006|Phase 1|Other|0|||
156721961|NCT00460603|565728903|FG007|Phase 1|Other|1|||
156721962|NCT00460603|565728904|FG008|Phase 1|Other|0|||
156721963|NCT00460603|565728905|FG009|Phase 1|Other|0|||
156721964|NCT00460603|565728906|FG010|Phase 1|Other|0|||
156721965|NCT00460603|565728907|FG011|Phase 1|Other|0|||
156721966|NCT00460603|565728896|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721967|NCT00460603|565728897|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721968|NCT00460603|565728898|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
157135919|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Death|0|||
157135920|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Death|0|||
157135921|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
157135922|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
157135923|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
157135924|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
156721969|NCT00460603|565728899|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721970|NCT00460603|565728900|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721971|NCT00460603|565728901|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721972|NCT00460603|565728902|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721973|NCT00460603|565728903|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
157135925|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
157135926|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
157135927|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
157135928|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
157135929|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
157135930|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
157135931|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
157135932|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
157135933|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
157135934|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
157135935|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
157135936|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
157135937|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
157135938|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
157135939|NCT01707992|567243160|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
157135940|NCT01707992|567243161|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
157135941|NCT01707992|567243162|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
157135942|NCT01707992|567243163|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
157135943|NCT01707992|567243164|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
157135944|NCT01707992|567243165|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
157135945|NCT03498521|567243166|FG000|Overall Study|Death|227|||
157135946|NCT03498521|567243167|FG001|Overall Study|Death|79|||
157135947|NCT03498521|567243168|FG002|Overall Study|Death|84|||
157135948|NCT03498521|567243166|FG000|Overall Study|Exclusion criteria|1|||
157135949|NCT03498521|567243167|FG001|Overall Study|Exclusion criteria|0|||
157135950|NCT03498521|567243168|FG002|Overall Study|Exclusion criteria|0|||
157135951|NCT03498521|567243166|FG000|Overall Study|Lost to Follow-up|4|||
157135952|NCT03498521|567243167|FG001|Overall Study|Lost to Follow-up|3|||
157135953|NCT03498521|567243168|FG002|Overall Study|Lost to Follow-up|3|||
157135954|NCT03498521|567243166|FG000|Overall Study|No profile due to technical failure|1|||
157135955|NCT03498521|567243167|FG001|Overall Study|No profile due to technical failure|0|||
157135956|NCT03498521|567243168|FG002|Overall Study|No profile due to technical failure|0|||
157135957|NCT03498521|567243166|FG000|Overall Study|Physician Decision|3|||
157135958|NCT03498521|567243167|FG001|Overall Study|Physician Decision|1|||
157135959|NCT03498521|567243168|FG002|Overall Study|Physician Decision|0|||
157135960|NCT03498521|567243166|FG000|Overall Study|Withdrawal by Subject|11|||
157135961|NCT03498521|567243167|FG001|Overall Study|Withdrawal by Subject|6|||
157135962|NCT03498521|567243168|FG002|Overall Study|Withdrawal by Subject|2|||
157135963|NCT03498521|567243166|FG000|Overall Study|Study terminated by sponsor|79|||
157135964|NCT03498521|567243167|FG001|Overall Study|Study terminated by sponsor|21|||
157135965|NCT03498521|567243168|FG002|Overall Study|Study terminated by sponsor|4|||
157135966|NCT04167345|567243169|FG000|Overall Study|Other|1|||
156721974|NCT00460603|565728904|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721975|NCT00460603|565728905|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
156721976|NCT00460603|565728906|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721977|NCT00460603|565728907|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
156721978|NCT00460603|565728896|FG000|Phase 2|Adverse Event|0|||
156721979|NCT00460603|565728897|FG001|Phase 2|Adverse Event|0|||
156721980|NCT00460603|565728898|FG002|Phase 2|Adverse Event|0|||
156721981|NCT00460603|565728899|FG003|Phase 2|Adverse Event|0|||
156721982|NCT00460603|565728900|FG004|Phase 2|Adverse Event|0|||
156721983|NCT00460603|565728901|FG005|Phase 2|Adverse Event|0|||
156721984|NCT00460603|565728902|FG006|Phase 2|Adverse Event|0|||
156721985|NCT00460603|565728903|FG007|Phase 2|Adverse Event|0|||
156721986|NCT00460603|565728904|FG008|Phase 2|Adverse Event|0|||
156721987|NCT00460603|565728905|FG009|Phase 2|Adverse Event|12|||
156721988|NCT00460603|565728906|FG010|Phase 2|Adverse Event|9|||
156721989|NCT00460603|565728907|FG011|Phase 2|Adverse Event|10|||
156721990|NCT00460603|565728896|FG000|Phase 2|Death|0|||
156721991|NCT00460603|565728897|FG001|Phase 2|Death|0|||
156721992|NCT00460603|565728898|FG002|Phase 2|Death|0|||
156721993|NCT00460603|565728899|FG003|Phase 2|Death|0|||
156721994|NCT00460603|565728900|FG004|Phase 2|Death|0|||
156721995|NCT00460603|565728901|FG005|Phase 2|Death|0|||
156721996|NCT00460603|565728902|FG006|Phase 2|Death|0|||
156721997|NCT00460603|565728903|FG007|Phase 2|Death|0|||
156721998|NCT00460603|565728904|FG008|Phase 2|Death|0|||
156721999|NCT00460603|565728905|FG009|Phase 2|Death|4|||
156722000|NCT00460603|565728906|FG010|Phase 2|Death|2|||
156722001|NCT00460603|565728907|FG011|Phase 2|Death|2|||
156722002|NCT00460603|565728896|FG000|Phase 2|Protocol Violation|0|||
156722003|NCT00460603|565728897|FG001|Phase 2|Protocol Violation|0|||
156722004|NCT00460603|565728898|FG002|Phase 2|Protocol Violation|0|||
156722005|NCT00460603|565728899|FG003|Phase 2|Protocol Violation|0|||
156722006|NCT00460603|565728900|FG004|Phase 2|Protocol Violation|0|||
156722007|NCT00460603|565728901|FG005|Phase 2|Protocol Violation|0|||
156722008|NCT00460603|565728902|FG006|Phase 2|Protocol Violation|0|||
156722009|NCT00460603|565728903|FG007|Phase 2|Protocol Violation|0|||
156722010|NCT00460603|565728904|FG008|Phase 2|Protocol Violation|0|||
156722011|NCT00460603|565728905|FG009|Phase 2|Protocol Violation|1|||
156722012|NCT00460603|565728906|FG010|Phase 2|Protocol Violation|1|||
156722013|NCT00460603|565728907|FG011|Phase 2|Protocol Violation|0|||
156722014|NCT00460603|565728896|FG000|Phase 2|Lost to Follow-up|0|||
156722015|NCT00460603|565728897|FG001|Phase 2|Lost to Follow-up|0|||
156722016|NCT00460603|565728898|FG002|Phase 2|Lost to Follow-up|0|||
156722017|NCT00460603|565728899|FG003|Phase 2|Lost to Follow-up|0|||
156722018|NCT00460603|565728900|FG004|Phase 2|Lost to Follow-up|0|||
156722019|NCT00460603|565728901|FG005|Phase 2|Lost to Follow-up|0|||
156722020|NCT00460603|565728902|FG006|Phase 2|Lost to Follow-up|0|||
156722021|NCT00460603|565728903|FG007|Phase 2|Lost to Follow-up|0|||
156722022|NCT00460603|565728904|FG008|Phase 2|Lost to Follow-up|0|||
156722023|NCT00460603|565728905|FG009|Phase 2|Lost to Follow-up|1|||
156722024|NCT00460603|565728906|FG010|Phase 2|Lost to Follow-up|0|||
156722025|NCT00460603|565728907|FG011|Phase 2|Lost to Follow-up|0|||
156722026|NCT00460603|565728896|FG000|Phase 2|Other|0|||
156722027|NCT00460603|565728897|FG001|Phase 2|Other|0|||
156722028|NCT00460603|565728898|FG002|Phase 2|Other|0|||
156722029|NCT00460603|565728899|FG003|Phase 2|Other|0|||
156722030|NCT00460603|565728900|FG004|Phase 2|Other|0|||
156722031|NCT00460603|565728901|FG005|Phase 2|Other|0|||
156722032|NCT00460603|565728902|FG006|Phase 2|Other|0|||
156722033|NCT00460603|565728903|FG007|Phase 2|Other|0|||
157135967|NCT04167345|567243170|FG001|Overall Study|Other|1|||
157135968|NCT04167345|567243171|FG002|Overall Study|Other|0|||
157135969|NCT04167345|567243172|FG003|Overall Study|Other|0|||
157135970|NCT04167345|567243173|FG004|Overall Study|Other|0|||
157135971|NCT01552057|567245276|FG000|Overall Study|Adverse Event|14|||
157135972|NCT01552057|567245277|FG001|Overall Study|Adverse Event|15|||
157135973|NCT01552057|567245276|FG000|Overall Study|Lack of Efficacy|8|||
156722034|NCT00460603|565728904|FG008|Phase 2|Other|0|||
157135974|NCT01552057|567245277|FG001|Overall Study|Lack of Efficacy|23|||
157135975|NCT01552057|567245276|FG000|Overall Study|Withdrawal by Subject|5|||
156722035|NCT00460603|565728905|FG009|Phase 2|Other|6|||
157135976|NCT01552057|567245277|FG001|Overall Study|Withdrawal by Subject|8|||
157135977|NCT01552057|567245276|FG000|Overall Study|Entry Criteria Not Met|2|||
157135978|NCT01552057|567245277|FG001|Overall Study|Entry Criteria Not Met|2|||
156722036|NCT00460603|565728906|FG010|Phase 2|Other|16|||
156722037|NCT00460603|565728907|FG011|Phase 2|Other|7|||
156722038|NCT00460603|565728896|FG000|Phase 2|Objective Progression or Relapse|0|||
156722039|NCT00460603|565728897|FG001|Phase 2|Objective Progression or Relapse|0|||
156722040|NCT00460603|565728898|FG002|Phase 2|Objective Progression or Relapse|0|||
156722041|NCT00460603|565728899|FG003|Phase 2|Objective Progression or Relapse|0|||
156722042|NCT00460603|565728900|FG004|Phase 2|Objective Progression or Relapse|0|||
156722043|NCT00460603|565728901|FG005|Phase 2|Objective Progression or Relapse|0|||
156722044|NCT00460603|565728902|FG006|Phase 2|Objective Progression or Relapse|0|||
157135979|NCT01552057|567245276|FG000|Overall Study|Physician Decision|1|||
156722045|NCT00460603|565728903|FG007|Phase 2|Objective Progression or Relapse|0|||
156722046|NCT00460603|565728904|FG008|Phase 2|Objective Progression or Relapse|0|||
156722047|NCT00460603|565728905|FG009|Phase 2|Objective Progression or Relapse|9|||
156722048|NCT00460603|565728906|FG010|Phase 2|Objective Progression or Relapse|10|||
156722049|NCT00460603|565728907|FG011|Phase 2|Objective Progression or Relapse|17|||
156722050|NCT00460603|565728896|FG000|Phase 2|Global Deterioration of Health Status|0|||
156794246|NCT02852005|565999537|FG002|Overall Study|Lost to Follow-up|0|||
156722051|NCT00460603|565728897|FG001|Phase 2|Global Deterioration of Health Status|0|||
156722052|NCT00460603|565728898|FG002|Phase 2|Global Deterioration of Health Status|0|||
156722053|NCT00460603|565728899|FG003|Phase 2|Global Deterioration of Health Status|0|||
156722054|NCT00460603|565728900|FG004|Phase 2|Global Deterioration of Health Status|0|||
156722055|NCT00460603|565728901|FG005|Phase 2|Global Deterioration of Health Status|0|||
156722056|NCT00460603|565728902|FG006|Phase 2|Global Deterioration of Health Status|0|||
156722057|NCT00460603|565728903|FG007|Phase 2|Global Deterioration of Health Status|0|||
156722058|NCT00460603|565728904|FG008|Phase 2|Global Deterioration of Health Status|0|||
156722059|NCT00460603|565728905|FG009|Phase 2|Global Deterioration of Health Status|0|||
156722060|NCT00460603|565728906|FG010|Phase 2|Global Deterioration of Health Status|1|||
156722061|NCT00460603|565728907|FG011|Phase 2|Global Deterioration of Health Status|0|||
156722062|NCT00460603|565728896|FG000|Phase 2|Withdrawal by Subject|0|||
156722063|NCT00460603|565728897|FG001|Phase 2|Withdrawal by Subject|0|||
156722064|NCT00460603|565728898|FG002|Phase 2|Withdrawal by Subject|0|||
156722065|NCT00460603|565728899|FG003|Phase 2|Withdrawal by Subject|0|||
156722066|NCT00460603|565728900|FG004|Phase 2|Withdrawal by Subject|0|||
156722067|NCT00460603|565728901|FG005|Phase 2|Withdrawal by Subject|0|||
156722068|NCT00460603|565728902|FG006|Phase 2|Withdrawal by Subject|0|||
156722069|NCT00460603|565728903|FG007|Phase 2|Withdrawal by Subject|0|||
156722070|NCT00460603|565728904|FG008|Phase 2|Withdrawal by Subject|0|||
156722071|NCT00460603|565728905|FG009|Phase 2|Withdrawal by Subject|5|||
156722072|NCT00460603|565728906|FG010|Phase 2|Withdrawal by Subject|4|||
156722073|NCT00460603|565728907|FG011|Phase 2|Withdrawal by Subject|5|||
156722074|NCT00460603|565728896|FG000|Phase 2|Randomized, but not treated|0|||
156722075|NCT00460603|565728897|FG001|Phase 2|Randomized, but not treated|0|||
156722076|NCT00460603|565728898|FG002|Phase 2|Randomized, but not treated|0|||
156722077|NCT00460603|565728899|FG003|Phase 2|Randomized, but not treated|0|||
156722078|NCT00460603|565728900|FG004|Phase 2|Randomized, but not treated|0|||
156722079|NCT00460603|565728901|FG005|Phase 2|Randomized, but not treated|0|||
156722080|NCT00460603|565728902|FG006|Phase 2|Randomized, but not treated|0|||
156722081|NCT00460603|565728903|FG007|Phase 2|Randomized, but not treated|0|||
156722082|NCT00460603|565728904|FG008|Phase 2|Randomized, but not treated|0|||
156722083|NCT00460603|565728905|FG009|Phase 2|Randomized, but not treated|3|||
156722084|NCT00460603|565728906|FG010|Phase 2|Randomized, but not treated|0|||
156722085|NCT00460603|565728907|FG011|Phase 2|Randomized, but not treated|0|||
156722086|NCT01082328|565728912|FG000|Overall Study|Adverse Event|1|||
156722087|NCT00031590|565728913|FG000|Overall Study|Adverse Event|1|||
156722088|NCT00031590|565728913|FG000|Overall Study|Withdrawal by parents|2|||
156722089|NCT00957801|565728914|FG000|Overall Study|Withdrawal by Subject|0|||
156722090|NCT00957801|565728915|FG001|Overall Study|Withdrawal by Subject|0|||
156722091|NCT00957801|565728916|FG002|Overall Study|Withdrawal by Subject|0|||
156722092|NCT00957801|565728917|FG003|Overall Study|Withdrawal by Subject|1|||
156722093|NCT05506046|565728920|FG000|Overall Study|Lost to Follow-up|89|||
156722094|NCT05506046|565728921|FG001|Overall Study|Lost to Follow-up|101|||
156722095|NCT05506046|565728922|FG002|Overall Study|Lost to Follow-up|102|||
156722096|NCT05506046|565728923|FG003|Overall Study|Lost to Follow-up|99|||
156722097|NCT01286467|565728929|FG000|Overall Study|Death|1|||
156722098|NCT01286467|565728930|FG001|Overall Study|Death|1|||
156722099|NCT01286467|565728931|FG002|Overall Study|Death|1|||
156722100|NCT01286467|565728932|FG003|Overall Study|Death|0|||
156722101|NCT01286467|565728929|FG000|Overall Study|Lost to Follow-up|0|||
156722102|NCT01286467|565728930|FG001|Overall Study|Lost to Follow-up|0|||
156722103|NCT01286467|565728931|FG002|Overall Study|Lost to Follow-up|0|||
156722104|NCT01286467|565728932|FG003|Overall Study|Lost to Follow-up|1|||
156722105|NCT01286467|565728929|FG000|Overall Study|Withdrawal by Subject|0|||
156722106|NCT01286467|565728930|FG001|Overall Study|Withdrawal by Subject|0|||
156722107|NCT01286467|565728931|FG002|Overall Study|Withdrawal by Subject|1|||
156722108|NCT01286467|565728932|FG003|Overall Study|Withdrawal by Subject|0|||
156722109|NCT01286467|565728929|FG000|Overall Study|Physician Decision|0|||
156722110|NCT01286467|565728930|FG001|Overall Study|Physician Decision|0|||
156722111|NCT01286467|565728931|FG002|Overall Study|Physician Decision|0|||
156722112|NCT01286467|565728932|FG003|Overall Study|Physician Decision|1|||
156722113|NCT01286467|565728929|FG000|Overall Study|Disease progression|3|||
156722114|NCT01286467|565728930|FG001|Overall Study|Disease progression|2|||
156722115|NCT01286467|565728931|FG002|Overall Study|Disease progression|2|||
156722116|NCT01286467|565728932|FG003|Overall Study|Disease progression|3|||
156794247|NCT02852005|565999538|FG003|Overall Study|Lost to Follow-up|0|||
156794248|NCT02852005|565999539|FG004|Overall Study|Lost to Follow-up|1|||
156722117|NCT01286467|565728929|FG000|Overall Study|Adverse Event|0|||
156722118|NCT01286467|565728930|FG001|Overall Study|Adverse Event|1|||
156722119|NCT01286467|565728931|FG002|Overall Study|Adverse Event|2|||
156722120|NCT01286467|565728932|FG003|Overall Study|Adverse Event|3|||
156722121|NCT01286467|565728929|FG000|Overall Study|Study drug stop longer than 14 days|0|||
156722122|NCT01286467|565728930|FG001|Overall Study|Study drug stop longer than 14 days|0|||
156722123|NCT01286467|565728931|FG002|Overall Study|Study drug stop longer than 14 days|1|||
156722124|NCT01286467|565728932|FG003|Overall Study|Study drug stop longer than 14 days|0|||
156722125|NCT00806403|565728933|FG000|Overall Study|Death|4|||
156875455|NCT02867384|566302074|FG001|Overall Study|Physician Decision|2|||
157135980|NCT01552057|567245277|FG001|Overall Study|Physician Decision|0|||
157135981|NCT00476086|567245278|FG000|Overall Study|Alternative therapy|1|||
156722126|NCT00806403|565728934|FG001|Overall Study|Death|3|||
156722127|NCT00765102|565728935|FG000|Overall Study|Progressive disease|18|||
156722128|NCT00765102|565728935|FG000|Overall Study|Adverse Event|6|||
156722129|NCT00765102|565728935|FG000|Overall Study|Physician Decision|4|||
156722130|NCT00765102|565728935|FG000|Overall Study|Withdrawal by Subject|2|||
156722131|NCT00765102|565728935|FG000|Overall Study|Protocol Violation|1|||
156722132|NCT01827111|565728936|FG000|Overall Study|Disease Progression|1|||
156722133|NCT03181633|565728937|FG000|Overall Study|Withdrawal by Subject|1|||
156722134|NCT03181633|565728937|FG000|Overall Study|Missing follow-up visit|1|||
156722135|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722136|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
156722137|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722138|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
156722139|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
156722140|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
156722141|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
156722142|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
157135982|NCT00476086|567245278|FG000|Overall Study|Progressive Disease|4|||
156722143|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
157019160|NCT04927065|566824716|FG015|First Booster|Protocol Violation|0|||
157019161|NCT04927065|566824701|FG000|First Booster|Withdrawal by Subject|8|||
157135983|NCT02900092|567245279|FG000|Overall Study|Adverse Event|1|||
157135984|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
157135985|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
157135986|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
157135987|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
157135988|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
157135989|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
157135990|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
157135991|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
157135992|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
157135993|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
157135994|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
156722144|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
156722145|NCT04837196|565728942|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722146|NCT04837196|565728943|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
156722147|NCT04837196|565728944|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722148|NCT04837196|565728945|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722149|NCT04837196|565728946|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
156722150|NCT04837196|565728942|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722151|NCT04837196|565728943|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722152|NCT04837196|565728944|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
156722153|NCT04837196|565728945|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722154|NCT04837196|565728946|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
156722155|NCT04837196|565728942|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722156|NCT04837196|565728943|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722157|NCT04837196|565728944|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
156722158|NCT04837196|565728945|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722159|NCT04837196|565728946|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
156722160|NCT02387840|565728948|FG000|Overall Study|Death|0|||
156722161|NCT02387840|565728949|FG001|Overall Study|Death|0|||
156722162|NCT02387840|565728950|FG002|Overall Study|Death|0|||
156722163|NCT02387840|565728951|FG003|Overall Study|Death|0|||
156722164|NCT02387840|565728952|FG004|Overall Study|Death|0|||
156722165|NCT02387840|565728953|FG005|Overall Study|Death|1|||
156722166|NCT01213966|565728954|FG000|Overall Study|Protocol Violation|1|||
156722167|NCT01213966|565728955|FG001|Overall Study|Protocol Violation|0|||
156722168|NCT01213966|565728956|FG002|Overall Study|Protocol Violation|3|||
156722169|NCT01213966|565728957|FG003|Overall Study|Protocol Violation|1|||
156722170|NCT00273182|565728967|FG000|Overall Study|Death|450|||
156722171|NCT00273182|565728967|FG000|Overall Study|Lost to Follow-up|88|||
156722172|NCT00273182|565728967|FG000|Overall Study|Withdrawal by Subject|257|||
156722173|NCT00273182|565728967|FG000|Overall Study|Device/System Explant|154|||
156722174|NCT00273182|565728967|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
156722175|NCT02208362|565728968|FG000|Overall Study|Participant did not complete treatment|0|||
156722176|NCT02208362|565728969|FG001|Overall Study|Participant did not complete treatment|1|||
156722177|NCT02208362|565728970|FG002|Overall Study|Participant did not complete treatment|0|||
156875456|NCT02867384|566302075|FG002|Overall Study|Physician Decision|0|||
156722178|NCT02208362|565728971|FG003|Overall Study|Participant did not complete treatment|0|||
156722179|NCT02208362|565728972|FG004|Overall Study|Participant did not complete treatment|0|||
156722180|NCT02208362|565728973|FG005|Overall Study|Participant did not complete treatment|0|||
156722181|NCT02208362|565728974|FG006|Overall Study|Participant did not complete treatment|1|||
156722182|NCT02208362|565728975|FG007|Overall Study|Participant did not complete treatment|1|||
157135995|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
157135996|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
157135997|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
157135998|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
156722183|NCT02208362|565728976|FG008|Overall Study|Participant did not complete treatment|2|||
156722184|NCT02208362|565728977|FG009|Overall Study|Participant did not complete treatment|0|||
156722185|NCT02208362|565728978|FG010|Overall Study|Participant did not complete treatment|1|||
156722186|NCT02208362|565728979|FG011|Overall Study|Participant did not complete treatment|0|||
156722187|NCT02208362|565728968|FG000|Overall Study|Participant received disallowed treatment|0|||
156722188|NCT02208362|565728969|FG001|Overall Study|Participant received disallowed treatment|0|||
156722189|NCT02208362|565728970|FG002|Overall Study|Participant received disallowed treatment|0|||
156722190|NCT02208362|565728971|FG003|Overall Study|Participant received disallowed treatment|0|||
156722191|NCT02208362|565728972|FG004|Overall Study|Participant received disallowed treatment|0|||
156722192|NCT02208362|565728973|FG005|Overall Study|Participant received disallowed treatment|0|||
156722193|NCT02208362|565728974|FG006|Overall Study|Participant received disallowed treatment|0|||
156722194|NCT02208362|565728975|FG007|Overall Study|Participant received disallowed treatment|0|||
156722195|NCT02208362|565728976|FG008|Overall Study|Participant received disallowed treatment|1|||
156722196|NCT02208362|565728977|FG009|Overall Study|Participant received disallowed treatment|0|||
156722197|NCT02208362|565728978|FG010|Overall Study|Participant received disallowed treatment|0|||
156722198|NCT02208362|565728979|FG011|Overall Study|Participant received disallowed treatment|0|||
156722199|NCT01609790|565728982|FG000|Overall Study|Protocol Violation|1|||
156722200|NCT01609790|565728983|FG001|Overall Study|Protocol Violation|7|||
156722201|NCT01609790|565728984|FG002|Overall Study|Protocol Violation|8|||
156722202|NCT00858273|565728985|FG000|Overall Study|Protocol Violation|3|||
156722203|NCT00858273|565728986|FG001|Overall Study|Protocol Violation|5|||
156794249|NCT02852005|565999535|FG000|Overall Study|Withdrawal by Subject|1|||
156794250|NCT02852005|565999536|FG001|Overall Study|Withdrawal by Subject|0|||
156794251|NCT02852005|565999537|FG002|Overall Study|Withdrawal by Subject|0|||
156794252|NCT02852005|565999538|FG003|Overall Study|Withdrawal by Subject|0|||
156794253|NCT02852005|565999539|FG004|Overall Study|Withdrawal by Subject|0|||
156794254|NCT04525183|565999540|FG000|Overall Study|Withdrawal by Subject|0|||
156794255|NCT04525183|565999541|FG001|Overall Study|Withdrawal by Subject|0|||
156794256|NCT04525183|565999542|FG002|Overall Study|Withdrawal by Subject|3|||
156794257|NCT04525183|565999540|FG000|Overall Study|Study non-compliance|0|||
156794258|NCT04525183|565999541|FG001|Overall Study|Study non-compliance|0|||
156794259|NCT04525183|565999542|FG002|Overall Study|Study non-compliance|1|||
156794260|NCT04525183|565999540|FG000|Overall Study|Recurrent disease before starting on study|0|||
156794261|NCT04525183|565999541|FG001|Overall Study|Recurrent disease before starting on study|0|||
156794262|NCT04525183|565999542|FG002|Overall Study|Recurrent disease before starting on study|1|||
156794263|NCT01922895|565999543|FG000|Overall Study|Death|0|||
156794264|NCT01922895|565999544|FG001|Overall Study|Death|1|||
156794265|NCT01922895|565999543|FG000|Overall Study|Withdrawal by Subject|1|||
156794266|NCT01922895|565999544|FG001|Overall Study|Withdrawal by Subject|2|||
156794267|NCT01922895|565999543|FG000|Overall Study|Lost to Follow-up|5|||
156794268|NCT01922895|565999544|FG001|Overall Study|Lost to Follow-up|11|||
156794269|NCT01916226|565999545|FG000|Overall Study|Adverse Event|1|||
156794270|NCT01916226|565999546|FG001|Overall Study|Adverse Event|0|||
156794271|NCT01916226|565999547|FG002|Overall Study|Adverse Event|1|||
156794272|NCT01916226|565999548|FG003|Overall Study|Adverse Event|1|||
156794273|NCT01916226|565999545|FG000|Overall Study|Lack of Efficacy|0|||
156794274|NCT01916226|565999546|FG001|Overall Study|Lack of Efficacy|0|||
156794275|NCT01916226|565999547|FG002|Overall Study|Lack of Efficacy|2|||
156794276|NCT01916226|565999548|FG003|Overall Study|Lack of Efficacy|1|||
156794277|NCT01916226|565999545|FG000|Overall Study|Protocol Violation|0|||
156794278|NCT01916226|565999546|FG001|Overall Study|Protocol Violation|1|||
156794279|NCT01916226|565999547|FG002|Overall Study|Protocol Violation|0|||
157135999|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
157136000|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
157136001|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
157136002|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
157136003|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
157136004|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
157136005|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
157136006|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
157217325|NCT00738920|567541081|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
156794280|NCT01916226|565999548|FG003|Overall Study|Protocol Violation|1|||
156722204|NCT01880554|565731326|FG000|Overall Study|Protocol Violation|14|||
156722205|NCT01880554|565731326|FG000|Overall Study|Simon's design requirements|2|||
156722206|NCT03976362|565731330|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
156722207|NCT03976362|565731331|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156722208|NCT03976362|565731332|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156722209|NCT03976362|565731330|FG000|Induction Phase|Death|62|||
156722210|NCT03976362|565731331|FG001|Induction Phase|Death|0|||
156722211|NCT03976362|565731332|FG002|Induction Phase|Death|0|||
156722212|NCT03976362|565731330|FG000|Maintenance Phase|Participants Ongoing|0|||
156722213|NCT03976362|565731331|FG001|Maintenance Phase|Participants Ongoing|106|||
156722214|NCT03976362|565731332|FG002|Maintenance Phase|Participants Ongoing|103|||
156722215|NCT03976362|565731330|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156722216|NCT03976362|565731331|FG001|Maintenance Phase|Withdrawal by Subject|4|||
156722217|NCT03976362|565731332|FG002|Maintenance Phase|Withdrawal by Subject|4|||
156722218|NCT03976362|565731330|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
156722219|NCT03976362|565731331|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
156722220|NCT03976362|565731332|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
156722221|NCT03976362|565731330|FG000|Maintenance Phase|Death|0|||
156722222|NCT03976362|565731331|FG001|Maintenance Phase|Death|186|||
156722223|NCT03976362|565731332|FG002|Maintenance Phase|Death|187|||
156722224|NCT04846569|565731333|FG000|Overall Study|Withdrawal by Subject|3|||
156722225|NCT04846569|565731334|FG001|Overall Study|Withdrawal by Subject|1|||
156722226|NCT02512302|565731335|FG000|Period 1|Adverse Event|0|||
156722227|NCT02512302|565731336|FG001|Period 1|Adverse Event|1|||
156722228|NCT02512302|565731337|FG002|Period 1|Adverse Event|0|||
156722229|NCT02512302|565731338|FG003|Period 1|Adverse Event|0|||
156722230|NCT02512302|565731339|FG004|Period 1|Adverse Event|0|||
156722231|NCT02512302|565731340|FG005|Period 1|Adverse Event|0|||
156722232|NCT02512302|565731341|FG006|Period 1|Adverse Event|0|||
156722233|NCT02512302|565731342|FG007|Period 1|Adverse Event|0|||
156722234|NCT02512302|565731343|FG008|Period 1|Adverse Event|0|||
156722235|NCT02512302|565731344|FG009|Period 1|Adverse Event|0|||
156722236|NCT02512302|565731335|FG000|Period 2|Adverse Event|0|||
156722237|NCT02512302|565731336|FG001|Period 2|Adverse Event|0|||
156722238|NCT02512302|565731337|FG002|Period 2|Adverse Event|0|||
156722239|NCT02512302|565731338|FG003|Period 2|Adverse Event|0|||
156722240|NCT02512302|565731339|FG004|Period 2|Adverse Event|0|||
156722241|NCT02512302|565731340|FG005|Period 2|Adverse Event|0|||
156722242|NCT02512302|565731341|FG006|Period 2|Adverse Event|0|||
156722243|NCT02512302|565731342|FG007|Period 2|Adverse Event|0|||
156722244|NCT02512302|565731343|FG008|Period 2|Adverse Event|0|||
156722245|NCT02512302|565731344|FG009|Period 2|Adverse Event|1|||
156722246|NCT02512302|565731335|FG000|Period 3|Lost to Follow-up|0|||
156722247|NCT02512302|565731336|FG001|Period 3|Lost to Follow-up|0|||
156722248|NCT02512302|565731337|FG002|Period 3|Lost to Follow-up|1|||
156722249|NCT02512302|565731338|FG003|Period 3|Lost to Follow-up|0|||
156722250|NCT02512302|565731339|FG004|Period 3|Lost to Follow-up|0|||
156722251|NCT02512302|565731340|FG005|Period 3|Lost to Follow-up|0|||
156722252|NCT02512302|565731341|FG006|Period 3|Lost to Follow-up|0|||
156722253|NCT02512302|565731342|FG007|Period 3|Lost to Follow-up|0|||
156722254|NCT02512302|565731343|FG008|Period 3|Lost to Follow-up|0|||
156722255|NCT02512302|565731344|FG009|Period 3|Lost to Follow-up|0|||
156722256|NCT02512302|565731335|FG000|Period 4|Adverse Event|0|||
156722257|NCT02512302|565731336|FG001|Period 4|Adverse Event|0|||
156722258|NCT02512302|565731337|FG002|Period 4|Adverse Event|0|||
156722259|NCT02512302|565731338|FG003|Period 4|Adverse Event|0|||
156722260|NCT02512302|565731339|FG004|Period 4|Adverse Event|0|||
156722261|NCT02512302|565731340|FG005|Period 4|Adverse Event|0|||
156722262|NCT02512302|565731341|FG006|Period 4|Adverse Event|1|||
156722263|NCT02512302|565731342|FG007|Period 4|Adverse Event|0|||
157136007|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
157136008|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156722264|NCT02512302|565731343|FG008|Period 4|Adverse Event|0|||
157136009|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
157136010|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
157136011|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156722265|NCT02512302|565731344|FG009|Period 4|Adverse Event|0|||
156722266|NCT00683618|565731347|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
156722267|NCT00683618|565731348|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
156722268|NCT00683618|565731349|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
156722269|NCT00683618|565731347|FG000|Randomised Treatment Period|Protocol Violation|0|||
156722270|NCT00683618|565731348|FG001|Randomised Treatment Period|Protocol Violation|1|||
156722271|NCT00683618|565731349|FG002|Randomised Treatment Period|Protocol Violation|0|||
157136012|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
156722272|NCT00683618|565731347|FG000|Randomised Treatment Period|Adverse Event|2|||
156722273|NCT00683618|565731348|FG001|Randomised Treatment Period|Adverse Event|0|||
156722274|NCT00683618|565731349|FG002|Randomised Treatment Period|Adverse Event|2|||
156722275|NCT00683618|565731347|FG000|Randomised Treatment Period|Reason not provided|0|||
157019162|NCT04927065|566824702|FG001|First Booster|Withdrawal by Subject|23|||
157019163|NCT04927065|566824703|FG002|First Booster|Withdrawal by Subject|0|||
157136013|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
157136014|NCT03895203|567245280|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
157136015|NCT03895203|567245281|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
157136016|NCT03895203|567245282|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
157136017|NCT03895203|567245283|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
157136018|NCT03895203|567245284|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
156722276|NCT00683618|565731348|FG001|Randomised Treatment Period|Reason not provided|0|||
156722277|NCT00683618|565731349|FG002|Randomised Treatment Period|Reason not provided|2|||
156722278|NCT00683618|565731347|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
156722279|NCT00683618|565731348|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156722280|NCT00683618|565731349|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156722281|NCT00683618|565731347|FG000|Extension Treatment Period|Adverse Event|1|||
156722282|NCT00683618|565731348|FG001|Extension Treatment Period|Adverse Event|0|||
156722283|NCT00683618|565731349|FG002|Extension Treatment Period|Adverse Event|0|||
156722284|NCT00683618|565731347|FG000|Extension Treatment Period|Protocol Violation|1|||
156722285|NCT00683618|565731348|FG001|Extension Treatment Period|Protocol Violation|0|||
156722286|NCT00683618|565731349|FG002|Extension Treatment Period|Protocol Violation|0|||
156722287|NCT02954601|565731350|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722288|NCT02954601|565731351|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722289|NCT02954601|565731352|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
156722290|NCT02954601|565731353|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
156722291|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
156722292|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
156722293|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
156722294|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
156722295|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
156722296|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722297|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722298|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722299|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722300|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722301|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722302|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722303|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722304|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722305|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
156722306|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
156722307|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
156722308|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
156722309|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
156722310|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
156722311|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722312|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722313|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722314|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722315|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722316|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722317|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722318|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722319|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
156722320|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
157019164|NCT04927065|566824704|FG003|First Booster|Withdrawal by Subject|19|||
157019165|NCT04927065|566824705|FG004|First Booster|Withdrawal by Subject|20|||
157136019|NCT03895203|567245285|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
157136020|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156722321|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
156722322|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
156722323|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
156722324|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
156722325|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
156722326|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722327|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722328|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722329|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
157136021|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156722330|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722331|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722332|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722333|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722334|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722335|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
156722336|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
156722337|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
156722338|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
156722339|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
156722340|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
156722341|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722342|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722343|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722344|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722345|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722346|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722347|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722348|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722349|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722350|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
156722351|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
156722352|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722353|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
156722354|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
156722355|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
156722356|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722357|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722358|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722359|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722360|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722361|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156875457|NCT02867384|566302073|FG000|Overall Study|Patient compliance|1|||
156875458|NCT02867384|566302074|FG001|Overall Study|Patient compliance|0|||
156875459|NCT02867384|566302075|FG002|Overall Study|Patient compliance|0|||
156875460|NCT02867384|566302073|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
156875461|NCT02867384|566302074|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
156875462|NCT02867384|566302075|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
156875463|NCT02867384|566302073|FG000|Overall Study|Never start treatment|3|||
157019166|NCT04927065|566824706|FG005|First Booster|Withdrawal by Subject|15|||
157019167|NCT04927065|566824707|FG006|First Booster|Withdrawal by Subject|6|||
156722362|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722363|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722364|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722365|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
156722366|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722367|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722368|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722369|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
156722370|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722371|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
156875464|NCT02867384|566302074|FG001|Overall Study|Never start treatment|0|||
156875465|NCT02867384|566302075|FG002|Overall Study|Never start treatment|0|||
157019168|NCT04927065|566824708|FG007|First Booster|Withdrawal by Subject|24|||
157019169|NCT04927065|566824709|FG008|First Booster|Withdrawal by Subject|0|||
157019170|NCT04927065|566824710|FG009|First Booster|Withdrawal by Subject|4|||
156722372|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722373|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722374|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722375|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722376|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722377|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722378|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722379|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722380|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
156722381|NCT03334435|565731367|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722382|NCT03334435|565731368|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
156722383|NCT03334435|565731369|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
156722384|NCT03334435|565731370|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
156722385|NCT03334435|565731371|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
156722386|NCT03334435|565731372|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722387|NCT03334435|565731373|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722388|NCT03334435|565731374|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722389|NCT03334435|565731375|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722390|NCT03334435|565731376|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722391|NCT03334435|565731377|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722392|NCT03334435|565731378|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722393|NCT03334435|565731379|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722394|NCT03334435|565731380|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722395|NCT03334435|565731381|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
156722396|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722397|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722398|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722399|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722400|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
156722401|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722402|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
156722403|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722404|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
156722405|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
156722406|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
156722407|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
156722408|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
156722409|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
156722410|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
156722411|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722412|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722413|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722414|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722415|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
156722416|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
156722417|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
156722418|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
156722419|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
156722420|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
156722421|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
156722422|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
156722423|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
156722424|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
156722425|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
156722426|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722427|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722428|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722429|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722430|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722431|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
156722432|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
157019171|NCT04927065|566824711|FG010|First Booster|Withdrawal by Subject|0|||
157019172|NCT04927065|566824712|FG011|First Booster|Withdrawal by Subject|0|||
157019173|NCT04927065|566824713|FG012|First Booster|Withdrawal by Subject|0|||
157019174|NCT04927065|566824714|FG013|First Booster|Withdrawal by Subject|0|||
156722433|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
156722434|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
156722435|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
156722436|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
156722437|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
156722438|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
156722439|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
156722440|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
156722441|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722442|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722443|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722444|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722445|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
156722446|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
156722447|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
156722448|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722449|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722450|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
156722451|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
156722452|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
156722453|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
156722454|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
156722455|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
156722456|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722457|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722458|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722459|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722460|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722461|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156794281|NCT01916226|565999545|FG000|Overall Study|Physician Decision|0|||
156794282|NCT01916226|565999546|FG001|Overall Study|Physician Decision|0|||
156794283|NCT01916226|565999547|FG002|Overall Study|Physician Decision|0|||
156794284|NCT01916226|565999548|FG003|Overall Study|Physician Decision|1|||
156794285|NCT00979407|565999549|FG000|Overall Study|Withdrawal by Subject|3|||
156794286|NCT00979407|565999550|FG001|Overall Study|Withdrawal by Subject|4|||
156794287|NCT00979407|565999549|FG000|Overall Study|Lost to Follow-up|3|||
156794288|NCT00979407|565999550|FG001|Overall Study|Lost to Follow-up|3|||
156794289|NCT01166646|565999551|FG000|Overall Study|Protocol Violation|0|||
156794290|NCT01166646|565999552|FG001|Overall Study|Protocol Violation|1|||
156794291|NCT01166646|565999551|FG000|Overall Study|Adverse Event|1|||
156794292|NCT01166646|565999552|FG001|Overall Study|Adverse Event|0|||
156794293|NCT02420314|565999553|FG000|Overall Study|Withdrawal by Subject|1|||
156794294|NCT02420314|565999553|FG000|Overall Study|Protocol Violation|1|||
156794295|NCT05142306|565999554|FG000|Overall Study|Withdrawal by Subject|0|||
156794296|NCT05142306|565999555|FG001|Overall Study|Withdrawal by Subject|0|||
156794297|NCT05142306|565999556|FG002|Overall Study|Withdrawal by Subject|1|||
156794298|NCT05430919|565999557|FG000|Overall Study|Protocol Violation|0|||
156794299|NCT05430919|565999558|FG001|Overall Study|Protocol Violation|0|||
156794300|NCT05430919|565999559|FG002|Overall Study|Protocol Violation|1|||
156794301|NCT05430919|565999560|FG003|Overall Study|Protocol Violation|0|||
156794302|NCT05430919|565999557|FG000|Overall Study|Lost to Follow-up|0|||
156794303|NCT05430919|565999558|FG001|Overall Study|Lost to Follow-up|1|||
156794304|NCT05430919|565999559|FG002|Overall Study|Lost to Follow-up|0|||
156794305|NCT05430919|565999560|FG003|Overall Study|Lost to Follow-up|0|||
156794306|NCT05430919|565999557|FG000|Overall Study|Withdrawal by Subject|3|||
156794307|NCT05430919|565999558|FG001|Overall Study|Withdrawal by Subject|0|||
156794308|NCT05430919|565999559|FG002|Overall Study|Withdrawal by Subject|0|||
156794309|NCT05430919|565999560|FG003|Overall Study|Withdrawal by Subject|1|||
157136022|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
157136023|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
157136024|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156794310|NCT02181413|565999569|FG000|Overall Study|Withdrawal by Subject|45|||
156794311|NCT02181413|565999570|FG001|Overall Study|Withdrawal by Subject|61|||
156794312|NCT02181413|565999569|FG000|Overall Study|Reason Not Specified|2|||
156794313|NCT02181413|565999570|FG001|Overall Study|Reason Not Specified|5|||
157136025|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
156794314|NCT02181413|565999569|FG000|Overall Study|Lost to Follow-up|8|||
156794315|NCT02181413|565999570|FG001|Overall Study|Lost to Follow-up|7|||
156794316|NCT02412436|565999573|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
156794317|NCT02412436|565999573|FG000|Overall Study|Lost to Follow-up|6|||
156794318|NCT02412436|565999573|FG000|Overall Study|Unable to get to clinic|3|||
156794319|NCT02412436|565999573|FG000|Overall Study|Death|1|||
156722462|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
156722463|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
156722464|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
156722465|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722466|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722467|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
156722468|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
156722469|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
156722470|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
156722471|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156875466|NCT01349959|566302076|FG000|Overall Study|Adverse Event|7|||
156875467|NCT01652534|566302077|FG000|Overall Study|Lack of Efficacy|1|||
156875468|NCT01652534|566302078|FG001|Overall Study|Lack of Efficacy|0|||
156875469|NCT01941186|566302079|FG000|Follow-up|Lost to Follow-up|1|||
156875470|NCT01941186|566302080|FG001|Follow-up|Lost to Follow-up|0|||
156875471|NCT02105961|566302081|FG000|Overall Study|Adverse Event|18|||
156875472|NCT02105961|566302082|FG001|Overall Study|Adverse Event|7|||
156875473|NCT02105961|566302083|FG002|Overall Study|Adverse Event|13|||
156875474|NCT02105961|566302081|FG000|Overall Study|Lack of Efficacy|3|||
156875475|NCT02105961|566302082|FG001|Overall Study|Lack of Efficacy|0|||
156875476|NCT02105961|566302083|FG002|Overall Study|Lack of Efficacy|3|||
156875477|NCT02105961|566302081|FG000|Overall Study|Lost to Follow-up|2|||
156875478|NCT02105961|566302082|FG001|Overall Study|Lost to Follow-up|0|||
156875479|NCT02105961|566302083|FG002|Overall Study|Lost to Follow-up|1|||
156875480|NCT02105961|566302081|FG000|Overall Study|Physician Decision|3|||
156875481|NCT02105961|566302082|FG001|Overall Study|Physician Decision|3|||
156875482|NCT02105961|566302083|FG002|Overall Study|Physician Decision|2|||
156875483|NCT02105961|566302081|FG000|Overall Study|Withdrawal by Subject|15|||
156875484|NCT02105961|566302082|FG001|Overall Study|Withdrawal by Subject|7|||
156875485|NCT02105961|566302083|FG002|Overall Study|Withdrawal by Subject|11|||
156875486|NCT00811018|566302084|FG000|Overall Study|Additional Chronic Treatment|31|||
156875487|NCT00811018|566302084|FG000|Overall Study|Adverse Event|79|||
156875488|NCT00811018|566302084|FG000|Overall Study|Death|147|||
156875489|NCT00811018|566302084|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
156875490|NCT00811018|566302084|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
156875491|NCT00811018|566302084|FG000|Overall Study|Investigator Decision|57|||
156875492|NCT00811018|566302084|FG000|Overall Study|Lost to Follow-up|19|||
156875493|NCT00811018|566302084|FG000|Overall Study|Pregnancy|6|||
157136026|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
157136027|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
157136028|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
157136029|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
157136030|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
157136031|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
157136032|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
157136033|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
157136034|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
157136035|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
157136036|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
157136037|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
157136038|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
157136039|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
157136040|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
157217326|NCT00738920|567541079|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
156722472|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722473|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722474|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722475|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722476|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156875494|NCT00811018|566302084|FG000|Overall Study|Sponsor Decision|450|||
156875495|NCT00811018|566302084|FG000|Overall Study|Withdrawal by Subject|70|||
156875496|NCT00811018|566302084|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
156875497|NCT00811018|566302084|FG000|Overall Study|Other|26|||
156875498|NCT02722304|566302088|FG000|Overall Study|Study Terminated by Sponsor|1|||
156875499|NCT02722304|566302089|FG001|Overall Study|Study Terminated by Sponsor|0|||
157136041|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
157217327|NCT00738920|567541080|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
156875500|NCT02722304|566302090|FG002|Overall Study|Study Terminated by Sponsor|2|||
156875501|NCT02722304|566302091|FG003|Overall Study|Study Terminated by Sponsor|1|||
156875502|NCT02722304|566302092|FG004|Overall Study|Study Terminated by Sponsor|1|||
156722477|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722478|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722479|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722480|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722481|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722482|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
156722483|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722484|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
156722485|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
156722486|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722487|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722488|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722489|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722490|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722491|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
156722492|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722493|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722494|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722495|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722496|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722497|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722498|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722499|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
156722500|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
156722501|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722502|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722503|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722504|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722505|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722506|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722507|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722508|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722509|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722510|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
156722511|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722512|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
156722513|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722514|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156722515|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
156794320|NCT02412436|565999573|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
156794321|NCT02544763|565999574|FG000|Overall Study|Adverse Event|8|||
156794322|NCT02544763|565999575|FG001|Overall Study|Adverse Event|8|||
156794323|NCT02544763|565999576|FG002|Overall Study|Adverse Event|0|||
156794324|NCT02544763|565999574|FG000|Overall Study|Withdrawn by parent/guardian|1|||
156722516|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722517|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156794325|NCT02544763|565999575|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156794326|NCT02544763|565999576|FG002|Overall Study|Withdrawn by parent/guardian|1|||
156794327|NCT02544763|565999574|FG000|Overall Study|Met withdrawal criteria|0|||
156794328|NCT02544763|565999575|FG001|Overall Study|Met withdrawal criteria|2|||
156794329|NCT02544763|565999576|FG002|Overall Study|Met withdrawal criteria|0|||
156794330|NCT02544763|565999574|FG000|Overall Study|Physician Decision|0|||
156794331|NCT02544763|565999575|FG001|Overall Study|Physician Decision|1|||
156794332|NCT02544763|565999576|FG002|Overall Study|Physician Decision|0|||
156794333|NCT02544763|565999574|FG000|Overall Study|Difficulties taking IMP|1|||
156794334|NCT02544763|565999575|FG001|Overall Study|Difficulties taking IMP|0|||
156794335|NCT02544763|565999576|FG002|Overall Study|Difficulties taking IMP|0|||
156794336|NCT02528305|565999577|FG000|Overall Study|Withdrawal by Subject|1|||
156794337|NCT02528305|565999577|FG000|Overall Study|Adverse Event|1|||
156794338|NCT02528305|565999577|FG000|Overall Study|Physician Decision|1|||
156794339|NCT01852214|565999578|FG000|Period 1|Adverse Event|1|||
156794340|NCT01852214|565999579|FG001|Period 1|Adverse Event|2|||
156794341|NCT01852214|565999578|FG000|Period 1|Withdrawal by Subject|0|||
156794342|NCT01852214|565999579|FG001|Period 1|Withdrawal by Subject|1|||
156794343|NCT01852214|565999578|FG000|Washout Period|Withdrawal by Subject|0|||
156794344|NCT01852214|565999579|FG001|Washout Period|Withdrawal by Subject|1|||
156875503|NCT02722304|566302088|FG000|Overall Study|Other|0|||
156875504|NCT02722304|566302089|FG001|Overall Study|Other|0|||
156875505|NCT02722304|566302090|FG002|Overall Study|Other|0|||
156875506|NCT02722304|566302091|FG003|Overall Study|Other|1|||
156875507|NCT02722304|566302092|FG004|Overall Study|Other|1|||
156875508|NCT00934362|566302093|FG000|Overall Study|Adverse Event|1|||
156875509|NCT00934362|566302094|FG001|Overall Study|Adverse Event|0|||
156875510|NCT04154189|566302097|FG000|Overall Study|Withdrawal by Subject|4|||
156875511|NCT04154189|566302098|FG001|Overall Study|Withdrawal by Subject|6|||
157136042|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
157136043|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
157136044|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
157136045|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
157136046|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
157136047|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
157136048|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
157136049|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
157136050|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
157136051|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
157136052|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
157136053|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
157136054|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
157136055|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
157136056|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
157136057|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
157136058|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
157136059|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
157136060|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
157136061|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
157136062|NCT03895203|567245280|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
157136063|NCT03895203|567245281|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
157136064|NCT03895203|567245282|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
157136065|NCT03895203|567245283|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
157136066|NCT03895203|567245284|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
157136067|NCT03895203|567245285|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
157136068|NCT01389245|567245286|FG000|Overall Study|Protocol Violation|10|||
157136069|NCT01389245|567245286|FG000|Overall Study|Lost to Follow-up|3|||
157136070|NCT01389245|567245286|FG000|Overall Study|Withdrawal by Subject|2|||
157136071|NCT05540652|567245287|FG000|Overall Study|Withdrawal by Subject|1|||
157136072|NCT05113940|567245290|FG000|Part A (18 Days)|Adverse Event|0|||
157136073|NCT05113940|567245291|FG001|Part A (18 Days)|Adverse Event|0|||
157136074|NCT05113940|567245292|FG002|Part A (18 Days)|Adverse Event|1|||
157136075|NCT05113940|567245293|FG003|Part A (18 Days)|Adverse Event|1|||
156722518|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722519|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722520|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722521|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722522|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156875512|NCT04154189|566302097|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
156875513|NCT04154189|566302098|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
156875514|NCT04154189|566302097|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
156875515|NCT04154189|566302098|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
156875516|NCT04154189|566302097|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
156875517|NCT04154189|566302098|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
156875518|NCT04154189|566302097|FG000|Overall Study|Death|25|||
156875519|NCT04154189|566302098|FG001|Overall Study|Death|25|||
156875520|NCT01092117|566302099|FG000|Index Procedure to 1 Month|Death|1|||
156875521|NCT01092117|566302099|FG000|1 Month|Death|1|||
156875522|NCT01092117|566302099|FG000|1 Month|Withdrawal by Subject|1|||
156875523|NCT01092117|566302099|FG000|1 Month|Lost to Follow-up|1|||
157019175|NCT04927065|566824715|FG014|First Booster|Withdrawal by Subject|0|||
157019176|NCT04927065|566824716|FG015|First Booster|Withdrawal by Subject|0|||
157019177|NCT04927065|566824701|FG000|First Booster|Other Than Specified|1|||
157019178|NCT04927065|566824702|FG001|First Booster|Other Than Specified|1|||
156875524|NCT01092117|566302099|FG000|6 Months|Death|2|||
156875525|NCT01092117|566302099|FG000|6 Months|Withdrawal by Subject|3|||
156875526|NCT01092117|566302099|FG000|12 Month|Death|11|||
156875527|NCT01092117|566302099|FG000|12 Month|Withdrawal by Subject|2|||
156875528|NCT01092117|566302099|FG000|12 Month|Lost to Follow-up|1|||
156722523|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722524|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722525|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722526|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
156722527|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722528|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
156722529|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
156722530|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
156722531|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722532|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722533|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722534|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722535|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722536|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722537|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722538|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722539|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722540|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722541|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722542|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722543|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722544|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
156722545|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
156722546|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722547|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722548|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722549|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722550|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722551|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722552|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722553|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722554|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722555|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722556|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722557|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
156722558|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
156722559|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722560|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
156722561|NCT03334435|565731367|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722562|NCT03334435|565731368|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722563|NCT03334435|565731369|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722564|NCT03334435|565731370|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722565|NCT03334435|565731371|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722566|NCT03334435|565731372|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722567|NCT03334435|565731373|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722568|NCT03334435|565731374|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722569|NCT03334435|565731375|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722570|NCT03334435|565731376|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722571|NCT03334435|565731377|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722572|NCT03334435|565731378|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722573|NCT03334435|565731379|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
156722574|NCT03334435|565731380|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722575|NCT03334435|565731381|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
156722576|NCT03922321|565731382|FG000|Overall Study|Participant Moved|1|||
156722577|NCT03922321|565731382|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
156722578|NCT02342678|565731386|FG000|Overall Study|Lost to Follow-up|0|||
156722579|NCT02342678|565731387|FG001|Overall Study|Lost to Follow-up|1|||
156722580|NCT02342678|565731386|FG000|Overall Study|Too busy to complete study|0|||
156722581|NCT02342678|565731387|FG001|Overall Study|Too busy to complete study|2|||
156722582|NCT02342678|565731386|FG000|Overall Study|Family illness/emergency|0|||
156722583|NCT02342678|565731387|FG001|Overall Study|Family illness/emergency|1|||
156722584|NCT02342678|565731386|FG000|Overall Study|Illness/medical reason|1|||
156722585|NCT02342678|565731387|FG001|Overall Study|Illness/medical reason|1|||
156722586|NCT00350207|565731392|FG000|Overall Study|Adverse Event|5|||
156722587|NCT00350207|565731393|FG001|Overall Study|Adverse Event|2|||
156722588|NCT00350207|565731394|FG002|Overall Study|Adverse Event|2|||
156722589|NCT00350207|565731392|FG000|Overall Study|Lack of Efficacy|1|||
157136076|NCT05113940|567245294|FG004|Part A (18 Days)|Adverse Event|1|||
157136077|NCT05113940|567245295|FG005|Part A (18 Days)|Adverse Event|0|||
157136078|NCT05113940|567245296|FG006|Part A (18 Days)|Adverse Event|0|||
157136079|NCT05113940|567245297|FG007|Part A (18 Days)|Adverse Event|0|||
157136080|NCT05113940|567245298|FG008|Part A (18 Days)|Adverse Event|0|||
157136081|NCT05113940|567245299|FG009|Part A (18 Days)|Adverse Event|0|||
157136082|NCT05113940|567245300|FG010|Part A (18 Days)|Adverse Event|0|||
157136083|NCT05113940|567245301|FG011|Part A (18 Days)|Adverse Event|2|||
157136084|NCT05113940|567245302|FG012|Part A (18 Days)|Adverse Event|0|||
157136085|NCT05113940|567245303|FG013|Part A (18 Days)|Adverse Event|0|||
157136086|NCT05113940|567245304|FG014|Part A (18 Days)|Adverse Event|0|||
157136087|NCT05113940|567245290|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136088|NCT05113940|567245291|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136089|NCT05113940|567245292|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136090|NCT05113940|567245293|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136091|NCT05113940|567245294|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136092|NCT05113940|567245295|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136093|NCT05113940|567245296|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136094|NCT05113940|567245297|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136095|NCT05113940|567245298|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136096|NCT05113940|567245299|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136097|NCT05113940|567245300|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136098|NCT05113940|567245301|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136099|NCT05113940|567245302|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136100|NCT05113940|567245303|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
157136101|NCT05113940|567245304|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
157019179|NCT04927065|566824703|FG002|First Booster|Other Than Specified|0|||
157019180|NCT04927065|566824704|FG003|First Booster|Other Than Specified|1|||
157019181|NCT04927065|566824705|FG004|First Booster|Other Than Specified|2|||
157019182|NCT04927065|566824706|FG005|First Booster|Other Than Specified|3|||
156722590|NCT00350207|565731393|FG001|Overall Study|Lack of Efficacy|0|||
156722591|NCT00350207|565731394|FG002|Overall Study|Lack of Efficacy|2|||
156722592|NCT00350207|565731392|FG000|Overall Study|Lost to Follow-up|1|||
156722593|NCT00350207|565731393|FG001|Overall Study|Lost to Follow-up|0|||
156722594|NCT00350207|565731394|FG002|Overall Study|Lost to Follow-up|1|||
157019183|NCT04927065|566824707|FG006|First Booster|Other Than Specified|2|||
157019184|NCT04927065|566824708|FG007|First Booster|Other Than Specified|6|||
157136102|NCT01756274|567245307|FG000|Overall Study|Protocol Violation|2|||
157136103|NCT01756274|567245307|FG000|Overall Study|Laboratory error|1|||
157136104|NCT00473876|567245312|FG000|Overall Study|Lost to Follow-up|3|||
157136105|NCT00473876|567245313|FG001|Overall Study|Lost to Follow-up|1|||
157136106|NCT01276288|567245314|FG000|Overall Study|Adverse Event|1|||
157136107|NCT01276288|567245315|FG001|Overall Study|Adverse Event|1|||
157136108|NCT01276288|567245316|FG002|Overall Study|Adverse Event|0|||
157136109|NCT01276288|567245317|FG003|Overall Study|Adverse Event|0|||
157136110|NCT01276288|567245314|FG000|Overall Study|not treated|1|||
157136111|NCT01276288|567245315|FG001|Overall Study|not treated|0|||
157136112|NCT01276288|567245316|FG002|Overall Study|not treated|0|||
157136113|NCT01276288|567245317|FG003|Overall Study|not treated|0|||
156722595|NCT00350207|565731392|FG000|Overall Study|Withdrawal by Subject|0|||
156722596|NCT00350207|565731393|FG001|Overall Study|Withdrawal by Subject|1|||
156722597|NCT00350207|565731394|FG002|Overall Study|Withdrawal by Subject|1|||
156722598|NCT00350207|565731392|FG000|Overall Study|Other|1|||
156722599|NCT00350207|565731393|FG001|Overall Study|Other|3|||
156722600|NCT00350207|565731394|FG002|Overall Study|Other|1|||
156722601|NCT03214224|565731395|FG000|Overall Study|Protocol Violation|1|||
156722602|NCT03214224|565731395|FG000|Overall Study|Withdrawal by Subject|2|||
156722603|NCT03214224|565731395|FG000|Overall Study|Practice controls or therapists|6|||
156722604|NCT03802825|565731404|FG000|Overall Study|Lost to follow-up for intervention|12|||
156794345|NCT00421408|565999580|FG000|Overall Study|Lost to Follow-up|30|||
157136114|NCT01193686|567245322|FG000|Overall Study|Withdrawal by Subject|4|||
157136115|NCT01193686|567245323|FG001|Overall Study|Withdrawal by Subject|1|||
157136116|NCT01193686|567245322|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
157136117|NCT01193686|567245323|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
157136118|NCT03401749|567245324|FG000|Overall Study|Lost to Follow-up|20|||
157136119|NCT03401749|567245325|FG001|Overall Study|Lost to Follow-up|16|||
157136120|NCT03401749|567245326|FG002|Overall Study|Lost to Follow-up|26|||
157136121|NCT03406962|567245331|FG000|Overall Study|Death|2|||
157136122|NCT03406962|567245331|FG000|Overall Study|Adverse Event|1|||
156794346|NCT00421408|565999581|FG001|Overall Study|Lost to Follow-up|20|||
157019185|NCT04927065|566824709|FG008|First Booster|Other Than Specified|0|||
157136123|NCT03853694|567245332|FG000|Overall Study|Protocol Violation|3|||
157136124|NCT03853694|567245333|FG001|Overall Study|Protocol Violation|5|||
157136125|NCT03853694|567245334|FG002|Overall Study|Protocol Violation|3|||
157019186|NCT04927065|566824710|FG009|First Booster|Other Than Specified|4|||
156722605|NCT03802825|565731405|FG001|Overall Study|Lost to follow-up for intervention|3|||
156722606|NCT03802825|565731404|FG000|Overall Study|Received only 1 component of intervention|0|||
156794347|NCT00421408|565999580|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
157019187|NCT04927065|566824711|FG010|First Booster|Other Than Specified|0|||
157019188|NCT04927065|566824712|FG011|First Booster|Other Than Specified|0|||
157019189|NCT04927065|566824713|FG012|First Booster|Other Than Specified|0|||
157136126|NCT03853694|567245332|FG000|Overall Study|Delivered early|0|||
157136127|NCT03853694|567245333|FG001|Overall Study|Delivered early|1|||
157136128|NCT03853694|567245334|FG002|Overall Study|Delivered early|0|||
157136129|NCT03853694|567245332|FG000|Overall Study|not suitable to proceed|0|||
156722607|NCT03802825|565731405|FG001|Overall Study|Received only 1 component of intervention|13|||
156722608|NCT05266053|565731406|FG000|Overall Study|Withdrawal by Subject|8|||
156722609|NCT05266053|565731407|FG001|Overall Study|Withdrawal by Subject|4|||
156722610|NCT01051960|565731411|FG000|Overall Study|Adverse Event|1|||
156722611|NCT00360282|565731412|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722612|NCT00360282|565731413|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722613|NCT00360282|565731414|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
156722614|NCT00360282|565731415|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
156722615|NCT00360282|565731412|FG000|Second Intervention|Adverse Event|0|||
156722616|NCT00360282|565731413|FG001|Second Intervention|Adverse Event|1|||
156722617|NCT00360282|565731414|FG002|Second Intervention|Adverse Event|0|||
156722618|NCT00360282|565731415|FG003|Second Intervention|Adverse Event|0|||
156722619|NCT02996968|565731416|FG000|Overall Study|Withdrawal by Subject|1|||
156722620|NCT02996968|565731417|FG001|Overall Study|Withdrawal by Subject|0|||
156722621|NCT04537078|565731420|FG000|Overall Study|Protocol Violation|3|||
156722622|NCT04537078|565731421|FG001|Overall Study|Protocol Violation|2|||
156722623|NCT04537078|565731420|FG000|Overall Study|Lost to Follow-up|1|||
156722624|NCT04537078|565731421|FG001|Overall Study|Lost to Follow-up|0|||
156722625|NCT04537078|565731420|FG000|Overall Study|Withdrawal by Subject|0|||
156722626|NCT04537078|565731421|FG001|Overall Study|Withdrawal by Subject|1|||
156722627|NCT02626026|565731425|FG000|Overall Study|Randomized but Never Treated|0|||
156722628|NCT02626026|565731426|FG001|Overall Study|Randomized but Never Treated|0|||
156722629|NCT02626026|565731427|FG002|Overall Study|Randomized but Never Treated|0|||
156722630|NCT02626026|565731428|FG003|Overall Study|Randomized but Never Treated|0|||
156722631|NCT02626026|565731429|FG004|Overall Study|Randomized but Never Treated|1|||
156722632|NCT02626026|565731430|FG005|Overall Study|Randomized but Never Treated|0|||
156722633|NCT01592786|565731435|FG000|Overall Study|Adverse Event|60|||
156722634|NCT01592786|565731435|FG000|Overall Study|Lack of Efficacy|19|||
156722635|NCT01592786|565731435|FG000|Overall Study|Protocol Violation|14|||
156722636|NCT01592786|565731435|FG000|Overall Study|Withdrawal by Subject|23|||
156722637|NCT01592786|565731435|FG000|Overall Study|Lost to Follow-up|19|||
156722638|NCT01592786|565731435|FG000|Overall Study|Other|3|||
156722639|NCT01909934|565731436|FG000|Overall Study|Withdrawal by Subject|3|||
156722640|NCT01909934|565731436|FG000|Overall Study|Lost to Follow-up|1|||
156722641|NCT01909934|565731436|FG000|Overall Study|Death|25|||
156722642|NCT01909934|565731436|FG000|Overall Study|Withdrawal of Informed Consent|1|||
156722643|NCT01909934|565731436|FG000|Overall Study|Reason Not Specified|1|||
156722644|NCT03810092|565731437|FG000|Overall Study|no ground support|17|||
156722645|NCT03810092|565731437|FG000|Overall Study|ADL not done at J0|16|||
156722646|NCT03810092|565731437|FG000|Overall Study|No hemoglobin measure at J5|27|||
156722647|NCT04578535|565731439|FG000|Overall Study|Lost to Follow-up|1|||
156722648|NCT04578535|565731440|FG001|Overall Study|Lost to Follow-up|0|||
156722649|NCT04578535|565731441|FG002|Overall Study|Lost to Follow-up|0|||
156722650|NCT04578535|565731442|FG003|Overall Study|Lost to Follow-up|1|||
156722651|NCT04578535|565731443|FG004|Overall Study|Lost to Follow-up|0|||
156722652|NCT04578535|565731444|FG005|Overall Study|Lost to Follow-up|2|||
156722653|NCT04578535|565731439|FG000|Overall Study|Pregnancy|1|||
156722654|NCT04578535|565731440|FG001|Overall Study|Pregnancy|0|||
156722655|NCT04578535|565731441|FG002|Overall Study|Pregnancy|0|||
156722656|NCT04578535|565731442|FG003|Overall Study|Pregnancy|0|||
156722657|NCT04578535|565731443|FG004|Overall Study|Pregnancy|0|||
156722658|NCT04578535|565731444|FG005|Overall Study|Pregnancy|0|||
156722659|NCT04578535|565731439|FG000|Overall Study|Withdrawal by Subject|0|||
156722660|NCT04578535|565731440|FG001|Overall Study|Withdrawal by Subject|0|||
156722661|NCT04578535|565731441|FG002|Overall Study|Withdrawal by Subject|0|||
156722662|NCT04578535|565731442|FG003|Overall Study|Withdrawal by Subject|1|||
156722663|NCT04578535|565731443|FG004|Overall Study|Withdrawal by Subject|1|||
156722664|NCT04578535|565731444|FG005|Overall Study|Withdrawal by Subject|5|||
156722665|NCT04578535|565731439|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
156722666|NCT04578535|565731440|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
156722667|NCT04578535|565731441|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
156722668|NCT04578535|565731442|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
157019190|NCT04927065|566824714|FG013|First Booster|Other Than Specified|0|||
157136130|NCT03853694|567245333|FG001|Overall Study|not suitable to proceed|1|||
157136131|NCT03853694|567245334|FG002|Overall Study|not suitable to proceed|0|||
156722669|NCT04578535|565731443|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
156722670|NCT04578535|565731444|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
156722671|NCT00235755|565731445|FG000|4-Week Titration Phase|Adverse Event|6|||
156722672|NCT00235755|565731446|FG001|4-Week Titration Phase|Adverse Event|14|||
156722673|NCT00235755|565731447|FG002|4-Week Titration Phase|Adverse Event|20|||
157019191|NCT04927065|566824715|FG014|First Booster|Other Than Specified|0|||
157019192|NCT04927065|566824716|FG015|First Booster|Other Than Specified|0|||
157019193|NCT04927065|566824701|FG000|Second Booster|Death|0|||
157019194|NCT04927065|566824702|FG001|Second Booster|Death|0|||
157019195|NCT04927065|566824703|FG002|Second Booster|Death|0|||
157019196|NCT04927065|566824704|FG003|Second Booster|Death|0|||
157019197|NCT04927065|566824705|FG004|Second Booster|Death|0|||
157019198|NCT04927065|566824706|FG005|Second Booster|Death|0|||
157019199|NCT04927065|566824707|FG006|Second Booster|Death|0|||
157019200|NCT04927065|566824708|FG007|Second Booster|Death|0|||
157019201|NCT04927065|566824709|FG008|Second Booster|Death|0|||
157019202|NCT04927065|566824710|FG009|Second Booster|Death|0|||
157019203|NCT04927065|566824711|FG010|Second Booster|Death|2|||
157019204|NCT04927065|566824712|FG011|Second Booster|Death|0|||
157019205|NCT04927065|566824713|FG012|Second Booster|Death|2|||
157019206|NCT04927065|566824714|FG013|Second Booster|Death|2|||
157019207|NCT04927065|566824715|FG014|Second Booster|Death|0|||
157019208|NCT04927065|566824716|FG015|Second Booster|Death|0|||
157019209|NCT04927065|566824701|FG000|Second Booster|Lost to Follow-up|0|||
157019210|NCT04927065|566824702|FG001|Second Booster|Lost to Follow-up|0|||
157019211|NCT04927065|566824703|FG002|Second Booster|Lost to Follow-up|3|||
157019212|NCT04927065|566824704|FG003|Second Booster|Lost to Follow-up|0|||
157019213|NCT04927065|566824705|FG004|Second Booster|Lost to Follow-up|0|||
157019214|NCT04927065|566824706|FG005|Second Booster|Lost to Follow-up|0|||
157019215|NCT04927065|566824707|FG006|Second Booster|Lost to Follow-up|0|||
157136132|NCT03853694|567245332|FG000|Overall Study|difficult surgery|0|||
156722674|NCT00235755|565731445|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
156722675|NCT00235755|565731446|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
156722676|NCT00235755|565731447|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
156722677|NCT00235755|565731445|FG000|4-Week Titration Phase|Protocol Violation|2|||
156722678|NCT00235755|565731446|FG001|4-Week Titration Phase|Protocol Violation|2|||
156722679|NCT00235755|565731447|FG002|4-Week Titration Phase|Protocol Violation|1|||
156722680|NCT00235755|565731445|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
156722681|NCT00235755|565731446|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
156722682|NCT00235755|565731447|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
156722683|NCT00235755|565731445|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156722684|NCT00235755|565731446|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156722685|NCT00235755|565731447|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
156722686|NCT00235755|565731445|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
156722687|NCT00235755|565731446|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
156722688|NCT00235755|565731447|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
156722689|NCT00235755|565731445|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
156722690|NCT00235755|565731446|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
156722691|NCT00235755|565731447|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
156722692|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Adverse Event|8|||
156722693|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Adverse Event|12|||
156722694|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Adverse Event|26|||
156722695|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
156722696|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
156722697|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
156722698|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
156722699|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
156722700|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
156722701|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
156722702|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
156722703|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
156722704|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
156722705|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
156722706|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
156722707|NCT00235755|565731445|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
156722708|NCT00235755|565731446|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
156722709|NCT00235755|565731447|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
156722710|NCT01707290|565731450|FG000|Overall Study|Adverse event (AE)|1|||
156722711|NCT01707290|565731451|FG001|Overall Study|Adverse event (AE)|0|||
157019216|NCT04927065|566824708|FG007|Second Booster|Lost to Follow-up|0|||
157019217|NCT04927065|566824709|FG008|Second Booster|Lost to Follow-up|0|||
157019218|NCT04927065|566824710|FG009|Second Booster|Lost to Follow-up|0|||
157019219|NCT04927065|566824711|FG010|Second Booster|Lost to Follow-up|14|||
157019220|NCT04927065|566824712|FG011|Second Booster|Lost to Follow-up|10|||
157019221|NCT04927065|566824713|FG012|Second Booster|Lost to Follow-up|13|||
157019222|NCT04927065|566824714|FG013|Second Booster|Lost to Follow-up|16|||
157136133|NCT03853694|567245333|FG001|Overall Study|difficult surgery|0|||
157136134|NCT03853694|567245334|FG002|Overall Study|difficult surgery|1|||
157136135|NCT03853694|567245332|FG000|Overall Study|Lost to Follow-up|0|||
157019223|NCT04927065|566824715|FG014|Second Booster|Lost to Follow-up|0|||
157136136|NCT03853694|567245333|FG001|Overall Study|Lost to Follow-up|1|||
157136137|NCT03853694|567245334|FG002|Overall Study|Lost to Follow-up|0|||
157136138|NCT03853694|567245332|FG000|Overall Study|Withdrawal by Subject|0|||
157136139|NCT03853694|567245333|FG001|Overall Study|Withdrawal by Subject|1|||
157136140|NCT03853694|567245334|FG002|Overall Study|Withdrawal by Subject|0|||
157136141|NCT01818297|567245335|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
157136142|NCT01818297|567245336|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
156722712|NCT01707290|565731450|FG000|Overall Study|Physician Decision|1|||
156722713|NCT01707290|565731451|FG001|Overall Study|Physician Decision|0|||
156722714|NCT01707290|565731450|FG000|Overall Study|Lost to Follow-up|3|||
156722715|NCT01707290|565731451|FG001|Overall Study|Lost to Follow-up|0|||
156722716|NCT01707290|565731450|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
156722717|NCT01707290|565731451|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
156722718|NCT01707290|565731450|FG000|Overall Study|Commercial drug available|60|||
156722719|NCT01707290|565731451|FG001|Overall Study|Commercial drug available|1|||
156722720|NCT01707290|565731450|FG000|Overall Study|Other unspecified|17|||
156722721|NCT01707290|565731451|FG001|Overall Study|Other unspecified|0|||
156722722|NCT01882985|565731454|FG000|Overall Study|Lost to Follow-up|1|||
156722723|NCT01882985|565731454|FG000|Overall Study|Withdrawal by Subject|1|||
156722724|NCT03193853|565731461|FG000|Overall Study|Death|6|||
156722725|NCT04129125|565731462|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
156722726|NCT04129125|565731462|FG000|Overall Study|Study device was not used|3|||
156722727|NCT01320293|565731470|FG000|Overall Study|Lack of Efficacy|1|||
156722728|NCT01320293|565731470|FG000|Overall Study|Adverse Event|1|||
156722729|NCT01787292|565731473|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
156722730|NCT01787292|565731474|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
156722731|NCT01787292|565731473|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
156722732|NCT01787292|565731474|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
156722733|NCT01532934|565731475|FG000|Overall Study|Lost to Follow-up|11|||
156722734|NCT01532934|565731476|FG001|Overall Study|Lost to Follow-up|11|||
156722735|NCT01532934|565731475|FG000|Overall Study|In controlled environment|3|||
156722736|NCT01532934|565731476|FG001|Overall Study|In controlled environment|2|||
156722737|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
156722738|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722739|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722740|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
157136143|NCT01818297|567245335|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
157136144|NCT01818297|567245336|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
156722741|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722742|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
156722743|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
156722744|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
156722745|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
156722746|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
156722747|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
156722748|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
156722749|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
156722750|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
156722751|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722752|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
156722753|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722754|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722755|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722756|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
156722757|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
156722758|NCT01147068|565731477|FG000|Subjects That Received 2nd Dose|Other|0|||
156722759|NCT01147068|565731478|FG001|Subjects That Received 2nd Dose|Other|3|||
156722760|NCT01147068|565731479|FG002|Subjects That Received 2nd Dose|Other|3|||
156722761|NCT01147068|565731480|FG003|Subjects That Received 2nd Dose|Other|0|||
156722762|NCT01147068|565731481|FG004|Subjects That Received 2nd Dose|Other|1|||
156722763|NCT01147068|565731482|FG005|Subjects That Received 2nd Dose|Other|0|||
156722764|NCT01147068|565731483|FG006|Subjects That Received 2nd Dose|Other|0|||
156722765|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722766|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722767|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722768|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722769|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
156722770|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722771|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
156722772|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722773|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722774|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722775|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
156722776|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722777|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722778|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
156722779|NCT01147068|565731477|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
157136145|NCT01818297|567245335|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
157136146|NCT01818297|567245336|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
157136147|NCT00481065|567245337|FG000|Overall Study|Adverse event or death|1|||
157136148|NCT00481065|567245338|FG001|Overall Study|Adverse event or death|1|||
157136149|NCT00481065|567245339|FG002|Overall Study|Adverse event or death|3|||
157136150|NCT00481065|567245340|FG003|Overall Study|Adverse event or death|0|||
157136151|NCT00481065|567245341|FG004|Overall Study|Adverse event or death|2|||
157136152|NCT00481065|567245342|FG005|Overall Study|Adverse event or death|0|||
157136153|NCT00481065|567245343|FG006|Overall Study|Adverse event or death|1|||
157136154|NCT00481065|567245344|FG007|Overall Study|Adverse event or death|1|||
157136155|NCT00481065|567245337|FG000|Overall Study|Withdrawal by Subject|11|||
157136156|NCT00481065|567245338|FG001|Overall Study|Withdrawal by Subject|12|||
157136157|NCT00481065|567245339|FG002|Overall Study|Withdrawal by Subject|7|||
157136158|NCT00481065|567245340|FG003|Overall Study|Withdrawal by Subject|11|||
157136159|NCT00481065|567245341|FG004|Overall Study|Withdrawal by Subject|13|||
157136160|NCT00481065|567245342|FG005|Overall Study|Withdrawal by Subject|12|||
157136161|NCT00481065|567245343|FG006|Overall Study|Withdrawal by Subject|9|||
157136162|NCT00481065|567245344|FG007|Overall Study|Withdrawal by Subject|10|||
157136163|NCT00481065|567245337|FG000|Overall Study|Lost to Follow-up|4|||
157136164|NCT00481065|567245338|FG001|Overall Study|Lost to Follow-up|2|||
157136165|NCT00481065|567245339|FG002|Overall Study|Lost to Follow-up|4|||
157136166|NCT00481065|567245340|FG003|Overall Study|Lost to Follow-up|3|||
156722780|NCT01147068|565731478|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
156722781|NCT01147068|565731479|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722782|NCT01147068|565731480|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722783|NCT01147068|565731481|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722784|NCT01147068|565731482|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722785|NCT01147068|565731483|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
156722786|NCT02962648|565731485|FG000|Overall Study|Withdrawal by Subject|3|||
156722787|NCT02962648|565731485|FG000|Overall Study|Lost to Follow-up|3|||
156722788|NCT02962648|565731485|FG000|Overall Study|Physician Decision|1|||
156722789|NCT02962648|565731485|FG000|Overall Study|Subject had problems with transportation|2|||
156722790|NCT01597778|565731486|FG000|Overall Study|Death|7|||
156722791|NCT01597778|565731487|FG001|Overall Study|Death|10|||
156722792|NCT01597778|565731486|FG000|Overall Study|Withdrawal by Subject|3|||
156722793|NCT01597778|565731487|FG001|Overall Study|Withdrawal by Subject|4|||
156722794|NCT01597778|565731486|FG000|Overall Study|Adverse Event|1|||
156722795|NCT01597778|565731487|FG001|Overall Study|Adverse Event|1|||
156722796|NCT01597778|565731486|FG000|Overall Study|Protocol Violation|1|||
156722797|NCT01597778|565731487|FG001|Overall Study|Protocol Violation|11|||
156722798|NCT01597778|565731486|FG000|Overall Study|Transplanted off protocol|2|||
156722799|NCT01597778|565731487|FG001|Overall Study|Transplanted off protocol|3|||
156722800|NCT03267212|565731489|FG000|First Intervention|Lost to Follow-up|0|||
156722801|NCT03267212|565731490|FG001|First Intervention|Lost to Follow-up|2|||
156722802|NCT03267212|565731489|FG000|First Intervention|Withdrawal by Subject|1|||
156722803|NCT03267212|565731490|FG001|First Intervention|Withdrawal by Subject|1|||
156722804|NCT03267212|565731489|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
156722805|NCT03267212|565731490|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
156722806|NCT04383327|565731492|FG000|Overall Study|Lost to Follow-up|112|||
156722807|NCT04383327|565731493|FG001|Overall Study|Lost to Follow-up|14|||
156722808|NCT04383327|565731494|FG002|Overall Study|Lost to Follow-up|78|||
156722809|NCT04383327|565731495|FG003|Overall Study|Lost to Follow-up|13|||
156722810|NCT04383327|565731496|FG004|Overall Study|Lost to Follow-up|110|||
156722811|NCT04383327|565731497|FG005|Overall Study|Lost to Follow-up|13|||
156722812|NCT04383327|565731498|FG006|Overall Study|Lost to Follow-up|74|||
156722813|NCT04383327|565731499|FG007|Overall Study|Lost to Follow-up|13|||
156722814|NCT04383327|565731500|FG008|Overall Study|Lost to Follow-up|78|||
156722815|NCT04383327|565731501|FG009|Overall Study|Lost to Follow-up|10|||
156722816|NCT04383327|565731502|FG010|Overall Study|Lost to Follow-up|160|||
157136167|NCT00481065|567245341|FG004|Overall Study|Lost to Follow-up|3|||
157136168|NCT00481065|567245342|FG005|Overall Study|Lost to Follow-up|3|||
157136169|NCT00481065|567245343|FG006|Overall Study|Lost to Follow-up|2|||
157136170|NCT00481065|567245344|FG007|Overall Study|Lost to Follow-up|5|||
157217328|NCT00738920|567541081|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
156722817|NCT04383327|565731503|FG011|Overall Study|Lost to Follow-up|13|||
156794348|NCT00421408|565999581|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
157136171|NCT00481065|567245337|FG000|Overall Study|Inappropriate enrollment|4|||
157217329|NCT00738920|567541079|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
157019224|NCT04927065|566824716|FG015|Second Booster|Lost to Follow-up|0|||
157019225|NCT04927065|566824701|FG000|Second Booster|Physician Decision|0|||
157019226|NCT04927065|566824702|FG001|Second Booster|Physician Decision|0|||
157019227|NCT04927065|566824703|FG002|Second Booster|Physician Decision|0|||
157019228|NCT04927065|566824704|FG003|Second Booster|Physician Decision|0|||
157019229|NCT04927065|566824705|FG004|Second Booster|Physician Decision|0|||
157019230|NCT04927065|566824706|FG005|Second Booster|Physician Decision|0|||
157019231|NCT04927065|566824707|FG006|Second Booster|Physician Decision|0|||
157019232|NCT04927065|566824708|FG007|Second Booster|Physician Decision|0|||
157019233|NCT04927065|566824709|FG008|Second Booster|Physician Decision|0|||
157019234|NCT04927065|566824710|FG009|Second Booster|Physician Decision|0|||
157019235|NCT04927065|566824711|FG010|Second Booster|Physician Decision|0|||
157019236|NCT04927065|566824712|FG011|Second Booster|Physician Decision|3|||
157019237|NCT04927065|566824713|FG012|Second Booster|Physician Decision|0|||
157019238|NCT04927065|566824714|FG013|Second Booster|Physician Decision|1|||
157019239|NCT04927065|566824715|FG014|Second Booster|Physician Decision|0|||
157019240|NCT04927065|566824716|FG015|Second Booster|Physician Decision|0|||
157019241|NCT04927065|566824701|FG000|Second Booster|Withdrawal by Subject|0|||
157019242|NCT04927065|566824702|FG001|Second Booster|Withdrawal by Subject|0|||
157019243|NCT04927065|566824703|FG002|Second Booster|Withdrawal by Subject|4|||
157019244|NCT04927065|566824704|FG003|Second Booster|Withdrawal by Subject|0|||
157019245|NCT04927065|566824705|FG004|Second Booster|Withdrawal by Subject|0|||
157019246|NCT04927065|566824706|FG005|Second Booster|Withdrawal by Subject|0|||
157019247|NCT04927065|566824707|FG006|Second Booster|Withdrawal by Subject|0|||
157019248|NCT04927065|566824708|FG007|Second Booster|Withdrawal by Subject|0|||
157019249|NCT04927065|566824709|FG008|Second Booster|Withdrawal by Subject|0|||
157019250|NCT04927065|566824710|FG009|Second Booster|Withdrawal by Subject|0|||
156722818|NCT05691712|565731504|FG000|Overall Study|Adverse Event|0|||
156722819|NCT05691712|565731505|FG001|Overall Study|Adverse Event|1|||
156722820|NCT05691712|565731506|FG002|Overall Study|Adverse Event|2|||
156722821|NCT05691712|565731507|FG003|Overall Study|Adverse Event|1|||
156722822|NCT05691712|565731504|FG000|Overall Study|Withdrawal by Subject|2|||
156722823|NCT05691712|565731505|FG001|Overall Study|Withdrawal by Subject|3|||
156722824|NCT05691712|565731506|FG002|Overall Study|Withdrawal by Subject|3|||
156722825|NCT05691712|565731507|FG003|Overall Study|Withdrawal by Subject|1|||
156722826|NCT05691712|565731504|FG000|Overall Study|Death|1|||
156722827|NCT05691712|565731505|FG001|Overall Study|Death|0|||
156722828|NCT05691712|565731506|FG002|Overall Study|Death|0|||
156722829|NCT05691712|565731507|FG003|Overall Study|Death|0|||
156722830|NCT05691712|565731504|FG000|Overall Study|Pregnancy|0|||
156722831|NCT05691712|565731505|FG001|Overall Study|Pregnancy|1|||
156722832|NCT05691712|565731506|FG002|Overall Study|Pregnancy|0|||
156722833|NCT05691712|565731507|FG003|Overall Study|Pregnancy|0|||
156722834|NCT05691712|565731504|FG000|Overall Study|Assigned Treatment by Mistake|1|||
156722835|NCT05691712|565731505|FG001|Overall Study|Assigned Treatment by Mistake|0|||
156722836|NCT05691712|565731506|FG002|Overall Study|Assigned Treatment by Mistake|0|||
156722837|NCT05691712|565731507|FG003|Overall Study|Assigned Treatment by Mistake|1|||
156722838|NCT05303194|565731508|FG000|Overall Study|Lost to Follow-up|1|||
156722839|NCT05303194|565731509|FG001|Overall Study|Lost to Follow-up|1|||
156722840|NCT05303194|565731508|FG000|Overall Study|Withdrawal by Subject|0|||
156722841|NCT05303194|565731509|FG001|Overall Study|Withdrawal by Subject|1|||
156722842|NCT01289678|565731519|FG000|Overall Study|Physician Decision|6|||
156722843|NCT00991887|565731520|FG000|Overall Study|Lost to Follow-up|2|||
156722844|NCT00991887|565731521|FG001|Overall Study|Lost to Follow-up|1|||
156722845|NCT00226499|565731522|FG000|Overall Study|Adverse Event|10|||
156722846|NCT00226499|565731523|FG001|Overall Study|Adverse Event|6|||
157019251|NCT04927065|566824711|FG010|Second Booster|Withdrawal by Subject|3|||
157019252|NCT04927065|566824712|FG011|Second Booster|Withdrawal by Subject|16|||
157019253|NCT04927065|566824713|FG012|Second Booster|Withdrawal by Subject|13|||
157019254|NCT04927065|566824714|FG013|Second Booster|Withdrawal by Subject|9|||
157019255|NCT04927065|566824715|FG014|Second Booster|Withdrawal by Subject|0|||
157019256|NCT04927065|566824716|FG015|Second Booster|Withdrawal by Subject|0|||
157019257|NCT04927065|566824701|FG000|Second Booster|Other Than Specified|0|||
157136172|NCT00481065|567245338|FG001|Overall Study|Inappropriate enrollment|0|||
157019258|NCT04927065|566824702|FG001|Second Booster|Other Than Specified|0|||
157019259|NCT04927065|566824703|FG002|Second Booster|Other Than Specified|0|||
156722847|NCT00226499|565731524|FG002|Overall Study|Adverse Event|3|||
156722848|NCT00226499|565731522|FG000|Overall Study|Others|1064|||
157019260|NCT04927065|566824704|FG003|Second Booster|Other Than Specified|0|||
157019261|NCT04927065|566824705|FG004|Second Booster|Other Than Specified|0|||
157019262|NCT04927065|566824706|FG005|Second Booster|Other Than Specified|0|||
157019263|NCT04927065|566824707|FG006|Second Booster|Other Than Specified|0|||
157019264|NCT04927065|566824708|FG007|Second Booster|Other Than Specified|0|||
157019265|NCT04927065|566824709|FG008|Second Booster|Other Than Specified|0|||
156722849|NCT00226499|565731523|FG001|Overall Study|Others|1066|||
156722850|NCT00226499|565731524|FG002|Overall Study|Others|356|||
156722851|NCT02723344|565731527|FG000|Overall Study|Lost to Follow-up|0|||
156722852|NCT02723344|565731528|FG001|Overall Study|Lost to Follow-up|4|||
157019266|NCT04927065|566824710|FG009|Second Booster|Other Than Specified|0|||
157136173|NCT00481065|567245339|FG002|Overall Study|Inappropriate enrollment|2|||
157136174|NCT00481065|567245340|FG003|Overall Study|Inappropriate enrollment|0|||
157136175|NCT00481065|567245341|FG004|Overall Study|Inappropriate enrollment|2|||
157136176|NCT00481065|567245342|FG005|Overall Study|Inappropriate enrollment|1|||
157136177|NCT00481065|567245343|FG006|Overall Study|Inappropriate enrollment|0|||
157136178|NCT00481065|567245344|FG007|Overall Study|Inappropriate enrollment|1|||
157136179|NCT00481065|567245337|FG000|Overall Study|Administrative reason|0|||
157136180|NCT00481065|567245338|FG001|Overall Study|Administrative reason|0|||
156722853|NCT02524847|565731530|FG000|Overall Study|Adverse Event|4|||
156722854|NCT02524847|565731530|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156722855|NCT02524847|565731530|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
156722856|NCT02524847|565731530|FG000|Overall Study|Death|1|||
156722857|NCT02524847|565731530|FG000|Overall Study|Reason not Specified|1|||
156722858|NCT04352101|565731531|FG000|Overall Study|Physician Decision|2|||
156722859|NCT04352101|565731532|FG001|Overall Study|Physician Decision|1|||
156722860|NCT03170544|565731538|FG000|Part 1|Lost to Follow-up|1|||
156722861|NCT03170544|565731539|FG001|Part 1|Lost to Follow-up|0|||
156722862|NCT03170544|565731540|FG002|Part 1|Lost to Follow-up|0|||
157136181|NCT00481065|567245339|FG002|Overall Study|Administrative reason|0|||
157136182|NCT00481065|567245340|FG003|Overall Study|Administrative reason|0|||
156722863|NCT03170544|565731541|FG003|Part 1|Lost to Follow-up|0|||
156722864|NCT03170544|565731542|FG004|Part 1|Lost to Follow-up|0|||
156722865|NCT03170544|565731543|FG005|Part 1|Lost to Follow-up|0|||
156722866|NCT03170544|565731544|FG006|Part 1|Lost to Follow-up|0|||
156722867|NCT03170544|565731545|FG007|Part 1|Lost to Follow-up|0|||
156722868|NCT03170544|565731546|FG008|Part 1|Lost to Follow-up|0|||
156722869|NCT03170544|565731547|FG009|Part 1|Lost to Follow-up|0|||
156722870|NCT03170544|565731548|FG010|Part 1|Lost to Follow-up|0|||
156722871|NCT03170544|565731549|FG011|Part 1|Lost to Follow-up|0|||
156722872|NCT03170544|565731538|FG000|Part 1|Not treated|0|||
156722873|NCT03170544|565731539|FG001|Part 1|Not treated|0|||
156722874|NCT03170544|565731540|FG002|Part 1|Not treated|0|||
156722875|NCT03170544|565731541|FG003|Part 1|Not treated|1|||
156722876|NCT03170544|565731542|FG004|Part 1|Not treated|0|||
156722877|NCT03170544|565731543|FG005|Part 1|Not treated|0|||
156722878|NCT03170544|565731544|FG006|Part 1|Not treated|0|||
156722879|NCT03170544|565731545|FG007|Part 1|Not treated|0|||
156722880|NCT03170544|565731546|FG008|Part 1|Not treated|0|||
156722881|NCT03170544|565731547|FG009|Part 1|Not treated|0|||
156722882|NCT03170544|565731548|FG010|Part 1|Not treated|0|||
156722883|NCT03170544|565731549|FG011|Part 1|Not treated|0|||
156722884|NCT00359424|565731550|FG000|Overall Study|Death|99|||
156722885|NCT00359424|565731551|FG001|Overall Study|Death|58|||
156722886|NCT00359424|565731550|FG000|Overall Study|Lost to Follow-up|19|||
156722887|NCT00359424|565731551|FG001|Overall Study|Lost to Follow-up|7|||
156722888|NCT00359424|565731550|FG000|Overall Study|Withdrawal by Subject|10|||
157136183|NCT00481065|567245341|FG004|Overall Study|Administrative reason|0|||
157136184|NCT00481065|567245342|FG005|Overall Study|Administrative reason|2|||
157136185|NCT00481065|567245343|FG006|Overall Study|Administrative reason|1|||
157136186|NCT00481065|567245344|FG007|Overall Study|Administrative reason|0|||
156722889|NCT00359424|565731551|FG001|Overall Study|Withdrawal by Subject|2|||
156722890|NCT00359424|565731550|FG000|Overall Study|follow up not conducted|2|||
156722891|NCT00359424|565731551|FG001|Overall Study|follow up not conducted|0|||
156722892|NCT01120184|565733249|FG000|Overall Study|Adverse Event|0|||
156722893|NCT01120184|565733250|FG001|Overall Study|Adverse Event|1|||
156722894|NCT01120184|565733251|FG002|Overall Study|Adverse Event|0|||
156722895|NCT01120184|565733249|FG000|Overall Study|Lost to Follow-up|13|||
156722896|NCT01120184|565733250|FG001|Overall Study|Lost to Follow-up|13|||
156722897|NCT01120184|565733251|FG002|Overall Study|Lost to Follow-up|11|||
156722898|NCT01120184|565733249|FG000|Overall Study|Physician Decision|9|||
156722899|NCT01120184|565733250|FG001|Overall Study|Physician Decision|1|||
156722900|NCT01120184|565733251|FG002|Overall Study|Physician Decision|3|||
157136187|NCT00481065|567245337|FG000|Overall Study|Protocol Violation|2|||
156722901|NCT01120184|565733249|FG000|Overall Study|Reason not Specified|8|||
156722902|NCT01120184|565733250|FG001|Overall Study|Reason not Specified|3|||
156722903|NCT01120184|565733251|FG002|Overall Study|Reason not Specified|12|||
156722904|NCT01120184|565733249|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
156722905|NCT01120184|565733250|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
156722906|NCT01120184|565733251|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
156722907|NCT01120184|565733249|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
157136188|NCT00481065|567245338|FG001|Overall Study|Protocol Violation|1|||
156722908|NCT01120184|565733250|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
156722909|NCT01120184|565733251|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
156722910|NCT01120184|565733249|FG000|Overall Study|Death|170|||
156722911|NCT01120184|565733250|FG001|Overall Study|Death|176|||
156722912|NCT01120184|565733251|FG002|Overall Study|Death|169|||
156722913|NCT02525783|565733253|FG000|Overall Study|Lost to Follow-up|10|||
156722914|NCT00824772|565733254|FG000|Overall Study|Withdrawal by Subject|8|||
156722915|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
156722916|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
156722917|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
156722918|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
156722919|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
156722920|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
156722921|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
156722922|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
156722923|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
156722924|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
156722925|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
156722926|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
156722927|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722928|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722929|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
156722930|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
156722931|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
156722932|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
156722933|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
156722934|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
156722935|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
156722936|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
156722937|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
156722938|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
156722939|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
156722940|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
156722941|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
156722942|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
156722943|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
156722944|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
156722945|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
156722946|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
156722947|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
157217330|NCT00738920|567541080|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
156722948|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
156722949|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
156722950|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
156722951|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722952|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722953|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
156722954|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
156722955|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
156722956|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722957|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722958|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
156722959|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
156722960|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
156722961|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
156722962|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
156722963|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722964|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722965|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
156722966|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
156722967|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Site closed|0|||
156722968|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Site closed|0|||
156722969|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Site closed|1|||
156722970|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Site closed|0|||
156722971|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
156722972|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722973|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722974|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
156722975|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
156722976|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
156722977|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
156722978|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
156722979|NCT00838903|565733255|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
156722980|NCT00838903|565733256|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156722981|NCT00838903|565733257|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156722982|NCT00838903|565733258|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
156722983|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
156722984|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
156722985|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
156722986|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
156722987|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
156722988|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
156722989|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
156722990|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
156722991|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
156722992|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
156722993|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
156722994|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
156722995|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
156722996|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
156722997|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
156722998|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
156722999|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
156723000|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
156723001|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
156723002|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
156723003|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723004|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723005|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
156875529|NCT01092117|566302099|FG000|Year 2|Death|5|||
156875530|NCT01092117|566302099|FG000|Year 2|Withdrawal by Subject|4|||
156875531|NCT01092117|566302099|FG000|Year 2|Lost to Follow-up|1|||
156875532|NCT01092117|566302099|FG000|Year 3|Death|7|||
156875533|NCT01092117|566302099|FG000|Year 3|Withdrawal by Subject|9|||
156875534|NCT01092117|566302099|FG000|Year 3|Lost to Follow-up|3|||
156875535|NCT01092117|566302099|FG000|Year 4|Death|8|||
156875536|NCT01092117|566302099|FG000|Year 4|Withdrawal by Subject|4|||
156875537|NCT01092117|566302099|FG000|Year 4|Lost to Follow-up|4|||
156875538|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
156875539|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
156875540|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
156875541|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
156875542|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
156875543|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
156875544|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
156875545|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
156875546|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
156875547|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
156875548|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
156875549|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
156875550|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
156875551|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
156875552|NCT04173494|566302100|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
156875553|NCT04173494|566302101|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
156875554|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
156875555|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
156875556|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
156875557|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
156875558|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
157019267|NCT04927065|566824711|FG010|Second Booster|Other Than Specified|1|||
156723006|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
156723007|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
156723008|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
156723009|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
156723010|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
156723011|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156723012|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
156723013|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156875559|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
156875560|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
156875561|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
156875562|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
156875563|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
157019268|NCT04927065|566824712|FG011|Second Booster|Other Than Specified|1|||
157019269|NCT04927065|566824713|FG012|Second Booster|Other Than Specified|4|||
157019270|NCT04927065|566824714|FG013|Second Booster|Other Than Specified|0|||
157019271|NCT04927065|566824715|FG014|Second Booster|Other Than Specified|0|||
157019272|NCT04927065|566824716|FG015|Second Booster|Other Than Specified|0|||
157019273|NCT04927065|566824701|FG000|Third Booster|Lost to Follow-up|0|||
157136189|NCT00481065|567245339|FG002|Overall Study|Protocol Violation|1|||
157136190|NCT00481065|567245340|FG003|Overall Study|Protocol Violation|1|||
157136191|NCT00481065|567245341|FG004|Overall Study|Protocol Violation|2|||
157136192|NCT00481065|567245342|FG005|Overall Study|Protocol Violation|6|||
157136193|NCT00481065|567245343|FG006|Overall Study|Protocol Violation|3|||
157136194|NCT00481065|567245344|FG007|Overall Study|Protocol Violation|2|||
157136195|NCT00481065|567245337|FG000|Overall Study|Unable to classify|0|||
156723014|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
156723015|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723016|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
156723017|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723018|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
156723019|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723020|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723021|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
156723022|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
156723023|NCT00838903|565733255|FG000|Follow-up Period (8 Weeks)|Missing|1|||
156723024|NCT00838903|565733256|FG001|Follow-up Period (8 Weeks)|Missing|2|||
156723025|NCT00838903|565733257|FG002|Follow-up Period (8 Weeks)|Missing|1|||
156723026|NCT00838903|565733258|FG003|Follow-up Period (8 Weeks)|Missing|1|||
156723027|NCT01002989|565733264|FG000|Overall Study|exclusion criteria, no consent|5|||
156723028|NCT00318474|565733265|FG000|Overall Study|Adverse Event|1|||
156723029|NCT00318474|565733266|FG001|Overall Study|Adverse Event|1|||
156723030|NCT00318474|565733265|FG000|Overall Study|Lost to Follow-up|0|||
156723031|NCT00318474|565733266|FG001|Overall Study|Lost to Follow-up|1|||
156723032|NCT00318474|565733265|FG000|Overall Study|Pregnancy|0|||
156723033|NCT00318474|565733266|FG001|Overall Study|Pregnancy|2|||
156723034|NCT00318474|565733265|FG000|Overall Study|Protocol Violation|1|||
156723035|NCT00318474|565733266|FG001|Overall Study|Protocol Violation|0|||
156723036|NCT00318474|565733265|FG000|Overall Study|Withdrawal by Subject|3|||
156723037|NCT00318474|565733266|FG001|Overall Study|Withdrawal by Subject|2|||
156723038|NCT00318474|565733265|FG000|Overall Study|Fall in GFR|3|||
156723039|NCT00318474|565733266|FG001|Overall Study|Fall in GFR|3|||
156723040|NCT00318474|565733265|FG000|Overall Study|Post-therapy hyperflycemia|0|||
156723041|NCT00318474|565733266|FG001|Overall Study|Post-therapy hyperflycemia|1|||
156723042|NCT00318474|565733265|FG000|Overall Study|Trial terminated|10|||
156723043|NCT00318474|565733266|FG001|Overall Study|Trial terminated|7|||
156723044|NCT05177484|565733267|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
156723045|NCT05177484|565733268|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
156723046|NCT05177484|565733267|FG000|Overall Study|Inadvertently withdrawn|3|||
156723047|NCT05177484|565733268|FG001|Overall Study|Inadvertently withdrawn|1|||
156723048|NCT05177484|565733267|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
156723049|NCT05177484|565733268|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
156723050|NCT02075203|565733269|FG000|Overall Study|Withdrawal by Subject|1|||
156723051|NCT02075203|565733270|FG001|Overall Study|Withdrawal by Subject|0|||
156723052|NCT02075203|565733271|FG002|Overall Study|Withdrawal by Subject|1|||
156723053|NCT02075203|565733269|FG000|Overall Study|Adverse Event|1|||
156723054|NCT02075203|565733270|FG001|Overall Study|Adverse Event|0|||
156723055|NCT02075203|565733271|FG002|Overall Study|Adverse Event|0|||
156723056|NCT02075203|565733269|FG000|Overall Study|participant refused to use contraception|1|||
156723057|NCT02075203|565733270|FG001|Overall Study|participant refused to use contraception|0|||
156723058|NCT02075203|565733271|FG002|Overall Study|participant refused to use contraception|0|||
156723059|NCT00495391|565733272|FG000|Overall Study|Lack of Efficacy|34|||
156794349|NCT00773461|565999585|FG000|Overall Study|Adverse Event|1|||
156723060|NCT00495391|565733273|FG001|Overall Study|Lack of Efficacy|18|||
156723061|NCT00495391|565733272|FG000|Overall Study|Withdrawal by Subject|2|||
156723062|NCT00495391|565733273|FG001|Overall Study|Withdrawal by Subject|3|||
156794350|NCT00773461|565999586|FG001|Overall Study|Adverse Event|3|||
156723063|NCT02712320|565733274|FG000|Overall Study|Lost to Follow-up|1|||
156723064|NCT02712320|565733274|FG000|Overall Study|Withdrawal by Subject|1|||
156723065|NCT02712320|565733274|FG000|Overall Study|Transferred to another facility|1|||
156723066|NCT02712320|565733274|FG000|Overall Study|Treating with the prohibited medications|2|||
156794351|NCT00773461|565999585|FG000|Overall Study|Withdrawal by Subject|4|||
156723067|NCT00568451|565733275|FG000|Overall Study|Disease Progression|0|||
157019274|NCT04927065|566824702|FG001|Third Booster|Lost to Follow-up|0|||
156723068|NCT00568451|565733276|FG001|Overall Study|Disease Progression|0|||
157136196|NCT00481065|567245338|FG001|Overall Study|Unable to classify|1|||
156723069|NCT00568451|565733277|FG002|Overall Study|Disease Progression|2|||
156723070|NCT00568451|565733278|FG003|Overall Study|Disease Progression|7|||
156794352|NCT00773461|565999586|FG001|Overall Study|Withdrawal by Subject|1|||
156794353|NCT02657356|566001151|FG000|Overall Study|Death|1|||
156794354|NCT02657356|566001152|FG001|Overall Study|Death|0|||
156794355|NCT02657356|566001151|FG000|Overall Study|Withdrawal by Subject|5|||
156794356|NCT02657356|566001152|FG001|Overall Study|Withdrawal by Subject|6|||
156794357|NCT02657356|566001151|FG000|Overall Study|Terminated by Sponsor|8|||
156794358|NCT02657356|566001152|FG001|Overall Study|Terminated by Sponsor|5|||
156794359|NCT02657356|566001151|FG000|Overall Study|Rolled over to EAP study|6|||
156794360|NCT02657356|566001152|FG001|Overall Study|Rolled over to EAP study|4|||
156794361|NCT03379870|566001153|FG000|Overall Study|Lost to Follow-up|1|||
156794362|NCT03379870|566001154|FG001|Overall Study|Lost to Follow-up|0|||
156794363|NCT03379870|566001153|FG000|Overall Study|Protocol Violation|1|||
156794364|NCT03379870|566001154|FG001|Overall Study|Protocol Violation|1|||
156794365|NCT03058952|566001155|FG000|Overall Study|Adverse Event|1|||
156794366|NCT03058952|566001156|FG001|Overall Study|Adverse Event|0|||
156794367|NCT03058952|566001155|FG000|Overall Study|Lost to Follow-up|15|||
156794368|NCT03058952|566001156|FG001|Overall Study|Lost to Follow-up|15|||
156794369|NCT03058952|566001155|FG000|Overall Study|Withdrawal by Subject|7|||
156794370|NCT03058952|566001156|FG001|Overall Study|Withdrawal by Subject|11|||
156794371|NCT03768336|566001159|FG000|Overall Study|Lost to Follow-up|3|||
156794372|NCT03768336|566001160|FG001|Overall Study|Lost to Follow-up|2|||
156794373|NCT03768336|566001159|FG000|Overall Study|Became Ineligible|2|||
156794374|NCT03768336|566001160|FG001|Overall Study|Became Ineligible|0|||
156794375|NCT03768336|566001159|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
156794376|NCT03768336|566001160|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
156794377|NCT03768336|566001159|FG000|Overall Study|Missed final survey (post-treatment|0|||
156794378|NCT03768336|566001160|FG001|Overall Study|Missed final survey (post-treatment|1|||
156794379|NCT05654181|566001161|FG000|Overall Study|Adverse Event|1|||
156794380|NCT05654181|566001162|FG001|Overall Study|Adverse Event|0|||
156794381|NCT05654181|566001163|FG002|Overall Study|Adverse Event|0|||
156794382|NCT05654181|566001164|FG003|Overall Study|Adverse Event|0|||
156794383|NCT05654181|566001165|FG004|Overall Study|Adverse Event|0|||
156794384|NCT05654181|566001166|FG005|Overall Study|Adverse Event|0|||
156794385|NCT05654181|566001167|FG006|Overall Study|Adverse Event|0|||
156794386|NCT05654181|566001168|FG007|Overall Study|Adverse Event|1|||
156794387|NCT05654181|566001169|FG008|Overall Study|Adverse Event|0|||
156794388|NCT05654181|566001170|FG009|Overall Study|Adverse Event|0|||
156794389|NCT05654181|566001161|FG000|Overall Study|Withdrawal by Subject|0|||
156794390|NCT05654181|566001162|FG001|Overall Study|Withdrawal by Subject|0|||
156794391|NCT05654181|566001163|FG002|Overall Study|Withdrawal by Subject|0|||
156794392|NCT05654181|566001164|FG003|Overall Study|Withdrawal by Subject|0|||
156794393|NCT05654181|566001165|FG004|Overall Study|Withdrawal by Subject|0|||
156794394|NCT05654181|566001166|FG005|Overall Study|Withdrawal by Subject|0|||
156794395|NCT05654181|566001167|FG006|Overall Study|Withdrawal by Subject|0|||
156794396|NCT05654181|566001168|FG007|Overall Study|Withdrawal by Subject|1|||
156794397|NCT05654181|566001169|FG008|Overall Study|Withdrawal by Subject|0|||
156794398|NCT05654181|566001170|FG009|Overall Study|Withdrawal by Subject|0|||
156794399|NCT05654181|566001161|FG000|Overall Study|Other|0|||
156794400|NCT05654181|566001162|FG001|Overall Study|Other|0|||
156794401|NCT05654181|566001163|FG002|Overall Study|Other|0|||
156794402|NCT05654181|566001164|FG003|Overall Study|Other|0|||
156794403|NCT05654181|566001165|FG004|Overall Study|Other|1|||
156794404|NCT05654181|566001166|FG005|Overall Study|Other|1|||
156794405|NCT05654181|566001167|FG006|Overall Study|Other|0|||
156794406|NCT05654181|566001168|FG007|Overall Study|Other|0|||
156794407|NCT05654181|566001169|FG008|Overall Study|Other|0|||
156794408|NCT05654181|566001170|FG009|Overall Study|Other|0|||
156794409|NCT01444781|566001171|FG000|Overall Study|Lost to Follow-up|0|||
156875564|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
156875565|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
156875566|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
157019275|NCT04927065|566824703|FG002|Third Booster|Lost to Follow-up|0|||
157136197|NCT00481065|567245339|FG002|Overall Study|Unable to classify|2|||
157136198|NCT00481065|567245340|FG003|Overall Study|Unable to classify|0|||
157136199|NCT00481065|567245341|FG004|Overall Study|Unable to classify|1|||
157136200|NCT00481065|567245342|FG005|Overall Study|Unable to classify|0|||
157136201|NCT00481065|567245343|FG006|Overall Study|Unable to classify|0|||
157136202|NCT00481065|567245344|FG007|Overall Study|Unable to classify|0|||
157136203|NCT03896295|567245350|FG000|Overall Study|Adverse Event|0|||
157136204|NCT03896295|567245351|FG001|Overall Study|Adverse Event|1|||
157136205|NCT03896295|567245350|FG000|Overall Study|COVID-19|7|||
156794410|NCT01444781|566001172|FG001|Overall Study|Lost to Follow-up|3|||
156794411|NCT01444781|566001173|FG002|Overall Study|Lost to Follow-up|1|||
156794412|NCT01444781|566001171|FG000|Overall Study|Withdrawal by Subject|3|||
156794413|NCT01444781|566001172|FG001|Overall Study|Withdrawal by Subject|1|||
156794414|NCT01444781|566001173|FG002|Overall Study|Withdrawal by Subject|2|||
156875567|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
157136206|NCT03896295|567245351|FG001|Overall Study|COVID-19|29|||
157136207|NCT01957137|567245352|FG000|Randomized Portion|Adverse Event|1|||
156723071|NCT05344560|565733279|FG000|Period 1|Subject out of visit window|1|||
156723072|NCT05344560|565733280|FG001|Period 1|Subject out of visit window|1|||
156723073|NCT05344560|565733279|FG000|Period 2|Covid-19 Related|1|||
156723074|NCT05344560|565733280|FG001|Period 2|Covid-19 Related|0|||
156723075|NCT05344560|565733279|FG000|Period 2|Adverse Event|1|||
156723076|NCT05344560|565733280|FG001|Period 2|Adverse Event|0|||
156723077|NCT05344560|565733279|FG000|Period 2|Subject out of visit window|1|||
156723078|NCT05344560|565733280|FG001|Period 2|Subject out of visit window|1|||
156723079|NCT05344560|565733279|FG000|Period 3|Subject out of visit window|1|||
156723080|NCT05344560|565733280|FG001|Period 3|Subject out of visit window|0|||
156723081|NCT01620138|565733281|FG000|Overall Study|Withdrawal by Subject|3|||
156723082|NCT01620138|565733282|FG001|Overall Study|Withdrawal by Subject|0|||
156723083|NCT01620138|565733281|FG000|Overall Study|Lack of Efficacy|1|||
156723084|NCT01620138|565733282|FG001|Overall Study|Lack of Efficacy|0|||
156723085|NCT01620138|565733281|FG000|Overall Study|Adverse Event|2|||
156723086|NCT01620138|565733282|FG001|Overall Study|Adverse Event|0|||
156723087|NCT00444535|565733283|FG000|Overall Study|Withdrawal by Subject|5|||
156723088|NCT00444535|565733283|FG000|Overall Study|Physician Decision|5|||
156794415|NCT02254291|566001174|FG000|Overall Study|Withdrawal by Subject|0|||
156794416|NCT02254291|566001175|FG001|Overall Study|Withdrawal by Subject|3|||
156794417|NCT02254291|566001176|FG002|Overall Study|Withdrawal by Subject|1|||
156794418|NCT02254291|566001174|FG000|Overall Study|Missing follow-up information|0|||
156794419|NCT02254291|566001175|FG001|Overall Study|Missing follow-up information|0|||
156794420|NCT02254291|566001176|FG002|Overall Study|Missing follow-up information|1|||
156794421|NCT03033784|566001177|FG000|Overall Study|Anxiety related to MRI scanner|0|||
156794422|NCT03033784|566001178|FG001|Overall Study|Anxiety related to MRI scanner|1|||
156794423|NCT03033784|566001179|FG002|Overall Study|Anxiety related to MRI scanner|0|||
156794424|NCT03033784|566001180|FG003|Overall Study|Anxiety related to MRI scanner|0|||
156794425|NCT03033784|566001181|FG004|Overall Study|Anxiety related to MRI scanner|0|||
156794426|NCT03033784|566001182|FG005|Overall Study|Anxiety related to MRI scanner|0|||
156794427|NCT03033784|566001183|FG006|Overall Study|Anxiety related to MRI scanner|0|||
156794428|NCT03033784|566001184|FG007|Overall Study|Anxiety related to MRI scanner|0|||
156794429|NCT03033784|566001185|FG008|Overall Study|Anxiety related to MRI scanner|0|||
156794430|NCT03033784|566001186|FG009|Overall Study|Anxiety related to MRI scanner|0|||
156794431|NCT03033784|566001187|FG010|Overall Study|Anxiety related to MRI scanner|0|||
156794432|NCT03033784|566001188|FG011|Overall Study|Anxiety related to MRI scanner|0|||
156794433|NCT03033784|566001189|FG012|Overall Study|Anxiety related to MRI scanner|0|||
156794434|NCT03033784|566001177|FG000|Overall Study|Withdrawal by Subject|0|||
156794435|NCT03033784|566001178|FG001|Overall Study|Withdrawal by Subject|0|||
156794436|NCT03033784|566001179|FG002|Overall Study|Withdrawal by Subject|0|||
156794437|NCT03033784|566001180|FG003|Overall Study|Withdrawal by Subject|0|||
156794438|NCT03033784|566001181|FG004|Overall Study|Withdrawal by Subject|0|||
156794439|NCT03033784|566001182|FG005|Overall Study|Withdrawal by Subject|0|||
156794440|NCT03033784|566001183|FG006|Overall Study|Withdrawal by Subject|0|||
156794441|NCT03033784|566001184|FG007|Overall Study|Withdrawal by Subject|0|||
156794442|NCT03033784|566001185|FG008|Overall Study|Withdrawal by Subject|0|||
156794443|NCT03033784|566001186|FG009|Overall Study|Withdrawal by Subject|0|||
156794444|NCT03033784|566001187|FG010|Overall Study|Withdrawal by Subject|0|||
156794445|NCT03033784|566001188|FG011|Overall Study|Withdrawal by Subject|0|||
156794446|NCT03033784|566001189|FG012|Overall Study|Withdrawal by Subject|2|||
156794447|NCT03257657|566001192|FG000|Overall Study|Lost to Follow-up|0|||
156794448|NCT03257657|566001193|FG001|Overall Study|Lost to Follow-up|3|||
156794449|NCT03257657|566001192|FG000|Overall Study|Withdrawn|0|||
156794450|NCT03257657|566001193|FG001|Overall Study|Withdrawn|1|||
156794451|NCT03257657|566001192|FG000|Overall Study|Noted not eligible right after enrolled|0|||
156794452|NCT03257657|566001193|FG001|Overall Study|Noted not eligible right after enrolled|1|||
156794453|NCT02801578|566001194|FG000|Overall Study|Adverse Event|2|||
156794454|NCT00137449|566001195|FG000|Overall Study|Disease Progression|8|||
156794455|NCT00137449|566001196|FG001|Overall Study|Disease Progression|13|||
156794456|NCT00137449|566001195|FG000|Overall Study|Death|4|||
156723089|NCT00444535|565733283|FG000|Overall Study|progressive disease|1|||
156794457|NCT00137449|566001196|FG001|Overall Study|Death|3|||
156794458|NCT00137449|566001195|FG000|Overall Study|Adverse Event|3|||
156723090|NCT00444535|565733283|FG000|Overall Study|Adverse Event|2|||
156723091|NCT01568892|565733284|FG000|Open-label Phase|Adverse Event|2|||
156794459|NCT00137449|566001196|FG001|Overall Study|Adverse Event|1|||
156794460|NCT00137449|566001195|FG000|Overall Study|Withdrawal by Subject|1|||
156794461|NCT00137449|566001196|FG001|Overall Study|Withdrawal by Subject|1|||
157217331|NCT00738920|567541081|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
156723092|NCT01568892|565733285|FG001|Open-label Phase|Adverse Event|0|||
156723093|NCT01568892|565733284|FG000|Open-label Phase|Lack of Efficacy|4|||
156794462|NCT00668642|566001199|FG000|First Off-cycle|Cancer progression|1|||
156794463|NCT00668642|566001200|FG001|First Off-cycle|Cancer progression|0|||
156794464|NCT00668642|566001199|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
156794465|NCT00668642|566001200|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
156794466|NCT03707821|566001205|FG000|Overall Study|Protocol Violation|0|||
156723094|NCT01568892|565733285|FG001|Open-label Phase|Lack of Efficacy|2|||
156723095|NCT01568892|565733284|FG000|Open-label Phase|Lost to Follow-up|0|||
156723096|NCT01568892|565733285|FG001|Open-label Phase|Lost to Follow-up|1|||
156723097|NCT03922308|565733290|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
156723098|NCT03922308|565733291|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
156723099|NCT03922308|565733292|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
156723100|NCT03922308|565733290|FG000|Overall Study|Lost to Follow-up|1|||
156723101|NCT03922308|565733291|FG001|Overall Study|Lost to Follow-up|0|||
156723102|NCT03922308|565733292|FG002|Overall Study|Lost to Follow-up|0|||
156723103|NCT03922308|565733290|FG000|Overall Study|Reason not Specified|0|||
156723104|NCT03922308|565733291|FG001|Overall Study|Reason not Specified|2|||
156723105|NCT03922308|565733292|FG002|Overall Study|Reason not Specified|1|||
156723106|NCT05005507|565733293|FG000|Overall Study|Premature termination of study|1|||
156723107|NCT03313180|565733297|FG000|Overall Study|Adverse Event|120|||
156723108|NCT03313180|565733297|FG000|Overall Study|Lost to Follow-up|3|||
156723109|NCT03313180|565733297|FG000|Overall Study|Withdrawal by Subject|39|||
156723110|NCT03313180|565733297|FG000|Overall Study|Other than listed above|15|||
156723111|NCT03313180|565733297|FG000|Overall Study|Covid-19 related|2|||
156723112|NCT01697748|565733301|FG000|Overall Study|ineligible skin incision|1|||
156723113|NCT01697748|565733302|FG001|Overall Study|ineligible skin incision|2|||
156723114|NCT01697748|565733301|FG000|Overall Study|ineligible uterine incision|4|||
156723115|NCT01697748|565733302|FG001|Overall Study|ineligible uterine incision|1|||
156723116|NCT01697748|565733301|FG000|Overall Study|Lost to Follow-up|53|||
156723117|NCT01697748|565733302|FG001|Overall Study|Lost to Follow-up|65|||
156723118|NCT01058642|565733304|FG000|Treatment Period 1|Adverse Event|0|||
156723119|NCT01058642|565733305|FG001|Treatment Period 1|Adverse Event|1|||
156723120|NCT01058642|565733306|FG002|Treatment Period 1|Adverse Event|1|||
156723121|NCT01058642|565733307|FG003|Treatment Period 1|Adverse Event|0|||
156723122|NCT01058642|565733304|FG000|Treatment Period 1|Physician Decision|0|||
156723123|NCT01058642|565733305|FG001|Treatment Period 1|Physician Decision|0|||
156723124|NCT01058642|565733306|FG002|Treatment Period 1|Physician Decision|1|||
156723125|NCT01058642|565733307|FG003|Treatment Period 1|Physician Decision|0|||
156723126|NCT01058642|565733304|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156723127|NCT01058642|565733305|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156723128|NCT01058642|565733306|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156723129|NCT01058642|565733307|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156723130|NCT01058642|565733304|FG000|Treatment Period 1|Lack of Efficacy|0|||
156723131|NCT01058642|565733305|FG001|Treatment Period 1|Lack of Efficacy|0|||
156723132|NCT01058642|565733306|FG002|Treatment Period 1|Lack of Efficacy|0|||
156723133|NCT01058642|565733307|FG003|Treatment Period 1|Lack of Efficacy|1|||
156723134|NCT01058642|565733304|FG000|Treatment Period 1|Protocol Violation|0|||
156723135|NCT01058642|565733305|FG001|Treatment Period 1|Protocol Violation|0|||
156723136|NCT01058642|565733306|FG002|Treatment Period 1|Protocol Violation|0|||
157019276|NCT04927065|566824704|FG003|Third Booster|Lost to Follow-up|0|||
157136208|NCT01957137|567245352|FG000|Randomized Portion|Withdrawal by Subject|1|||
157136209|NCT03029832|567245353|FG000|Overall Study|Safety Follow-Up Completed|2|||
157136210|NCT03029832|567245354|FG001|Overall Study|Safety Follow-Up Completed|0|||
156723137|NCT01058642|565733307|FG003|Treatment Period 1|Protocol Violation|1|||
156723138|NCT01058642|565733304|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
156723139|NCT01058642|565733305|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723140|NCT01058642|565733306|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723141|NCT01058642|565733307|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
156723142|NCT01704495|565733308|FG000|Subjects Randomized|Other Reason|3|||
156723143|NCT01704495|565733309|FG001|Subjects Randomized|Other Reason|2|||
156723144|NCT01704495|565733310|FG002|Subjects Randomized|Other Reason|3|||
156723145|NCT01704495|565733311|FG003|Subjects Randomized|Other Reason|2|||
156723146|NCT01704495|565733308|FG000|Subjects Randomized|Discontinuation criteria met|4|||
156723147|NCT01704495|565733309|FG001|Subjects Randomized|Discontinuation criteria met|2|||
156723148|NCT01704495|565733310|FG002|Subjects Randomized|Discontinuation criteria met|2|||
156723149|NCT01704495|565733311|FG003|Subjects Randomized|Discontinuation criteria met|0|||
157136211|NCT03029832|567245353|FG000|Overall Study|Death due to Disease Progression|1|||
157136212|NCT03029832|567245354|FG001|Overall Study|Death due to Disease Progression|0|||
156723150|NCT01704495|565733308|FG000|Subjects Randomized|Adverse Event|8|||
156723151|NCT01704495|565733309|FG001|Subjects Randomized|Adverse Event|2|||
156723152|NCT01704495|565733310|FG002|Subjects Randomized|Adverse Event|0|||
156723153|NCT01704495|565733311|FG003|Subjects Randomized|Adverse Event|7|||
156723154|NCT01704495|565733308|FG000|Subjects Randomized|Withdrawal by Subject|5|||
156723155|NCT01704495|565733309|FG001|Subjects Randomized|Withdrawal by Subject|5|||
156723156|NCT01704495|565733310|FG002|Subjects Randomized|Withdrawal by Subject|5|||
156723157|NCT01704495|565733311|FG003|Subjects Randomized|Withdrawal by Subject|5|||
156723158|NCT01704495|565733308|FG000|Subjects Randomized|Protocol Violation|1|||
156723159|NCT01704495|565733309|FG001|Subjects Randomized|Protocol Violation|1|||
157019277|NCT04927065|566824705|FG004|Third Booster|Lost to Follow-up|0|||
156723160|NCT01704495|565733310|FG002|Subjects Randomized|Protocol Violation|2|||
157019278|NCT04927065|566824706|FG005|Third Booster|Lost to Follow-up|0|||
156794467|NCT03707821|566001206|FG001|Overall Study|Protocol Violation|1|||
156794468|NCT03707821|566001205|FG000|Overall Study|Unsatisfactory Visual Response|1|||
156794469|NCT03707821|566001206|FG001|Overall Study|Unsatisfactory Visual Response|0|||
156794470|NCT03707821|566001205|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
156794471|NCT03707821|566001206|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
156794472|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
157136213|NCT03029832|567245353|FG000|Overall Study|Study Terminated By Sponsor|1|||
157136214|NCT03029832|567245354|FG001|Overall Study|Study Terminated By Sponsor|1|||
157136215|NCT01412229|567245355|FG000|Overall Study|Physician Decision|1|||
157136216|NCT04373460|567245356|FG000|Overall Study|Did not receive tranfusion|18|||
157136217|NCT04373460|567245357|FG001|Overall Study|Did not receive tranfusion|26|||
157136218|NCT00454207|567245358|FG000|Overall Study|Adverse Event|3|||
157136219|NCT00454207|567245359|FG001|Overall Study|Adverse Event|1|||
157136220|NCT00454207|567245358|FG000|Overall Study|Lack of Efficacy|1|||
157136221|NCT00454207|567245359|FG001|Overall Study|Lack of Efficacy|0|||
157136222|NCT00454207|567245358|FG000|Overall Study|Protocol Violation|0|||
157136223|NCT00454207|567245359|FG001|Overall Study|Protocol Violation|1|||
157136224|NCT01672957|567245360|FG000|Overall Study|Protocol Violation|48|||
156794473|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
156794474|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
156794475|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
156794476|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
156794477|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
156794478|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
156794479|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
156794480|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
156794481|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
156794482|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
157136225|NCT01672957|567245360|FG000|Overall Study|Death|2|||
156723161|NCT01704495|565733311|FG003|Subjects Randomized|Protocol Violation|0|||
156794483|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
156794484|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
156794485|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
156794486|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
156794487|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
156794488|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
156794489|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
156794490|NCT01432444|566001207|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
156794491|NCT01432444|566001208|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
156794492|NCT01432444|566001209|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
156794493|NCT01432444|566001207|FG000|Treatment Phase|Lost to Follow-up|0|||
156794494|NCT01432444|566001208|FG001|Treatment Phase|Lost to Follow-up|33|||
156794495|NCT01432444|566001209|FG002|Treatment Phase|Lost to Follow-up|0|||
156794496|NCT01432444|566001207|FG000|Treatment Phase|Adverse Event|0|||
156794497|NCT01432444|566001208|FG001|Treatment Phase|Adverse Event|37|||
156794498|NCT01432444|566001209|FG002|Treatment Phase|Adverse Event|0|||
156794499|NCT01432444|566001207|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
156794500|NCT01432444|566001208|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
156794501|NCT01432444|566001209|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
157136226|NCT01672957|567245360|FG000|Overall Study|ICF Signed After Transplantation|5|||
157136227|NCT00700804|567245363|FG000|Overall Study|Withdrawal by Subject|1|||
157136228|NCT00700804|567245364|FG001|Overall Study|Withdrawal by Subject|2|||
157136229|NCT00700804|567245363|FG000|Overall Study|Protocol Violation|1|||
157136230|NCT00700804|567245364|FG001|Overall Study|Protocol Violation|1|||
156723162|NCT01704495|565733308|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
157136231|NCT00700804|567245363|FG000|Overall Study|Loose Stools|1|||
156723163|NCT01704495|565733309|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
156723164|NCT01704495|565733310|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
156723165|NCT01704495|565733311|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
156723166|NCT01704495|565733308|FG000|Optional Safety Extension|Adverse Event|0|||
156723167|NCT01704495|565733309|FG001|Optional Safety Extension|Adverse Event|4|||
156723168|NCT01704495|565733310|FG002|Optional Safety Extension|Adverse Event|0|||
156723169|NCT01704495|565733311|FG003|Optional Safety Extension|Adverse Event|1|||
156723170|NCT01704495|565733308|FG000|Optional Safety Extension|Other reason|27|||
157136232|NCT00700804|567245364|FG001|Overall Study|Loose Stools|1|||
156723171|NCT01704495|565733309|FG001|Optional Safety Extension|Other reason|29|||
156794502|NCT01432444|566001207|FG000|Treatment Phase|Physician Decision|0|||
156794503|NCT01432444|566001208|FG001|Treatment Phase|Physician Decision|5|||
156794504|NCT01432444|566001209|FG002|Treatment Phase|Physician Decision|0|||
157136233|NCT00151892|567245365|FG000|Overall Study|Lack of Efficacy|50|||
157136234|NCT00151892|567245366|FG001|Overall Study|Lack of Efficacy|57|||
157136235|NCT00151892|567245365|FG000|Overall Study|Patient request|10|||
156723172|NCT01704495|565733310|FG002|Optional Safety Extension|Other reason|30|||
157136236|NCT00151892|567245366|FG001|Overall Study|Patient request|7|||
157136237|NCT00151892|567245365|FG000|Overall Study|Lost to Follow-up|5|||
157136238|NCT00151892|567245366|FG001|Overall Study|Lost to Follow-up|10|||
157136239|NCT00151892|567245365|FG000|Overall Study|Adverse Event|6|||
157136240|NCT00151892|567245366|FG001|Overall Study|Adverse Event|3|||
157136241|NCT00151892|567245365|FG000|Overall Study|Protocol Violation|3|||
157136242|NCT00151892|567245366|FG001|Overall Study|Protocol Violation|3|||
157136243|NCT00151892|567245365|FG000|Overall Study|Non-compliance|0|||
157136244|NCT00151892|567245366|FG001|Overall Study|Non-compliance|1|||
157136245|NCT00151892|567245365|FG000|Overall Study|Pregnancy|0|||
157136246|NCT00151892|567245366|FG001|Overall Study|Pregnancy|1|||
157136247|NCT00151892|567245365|FG000|Overall Study|Did not return for a visit|1|||
157136248|NCT00151892|567245366|FG001|Overall Study|Did not return for a visit|0|||
157136249|NCT00151892|567245365|FG000|Overall Study|Used prohibited corticosteroids|1|||
157136250|NCT00151892|567245366|FG001|Overall Study|Used prohibited corticosteroids|0|||
157136251|NCT00151892|567245365|FG000|Overall Study|Lack of study medication at center|0|||
157136252|NCT00151892|567245366|FG001|Overall Study|Lack of study medication at center|1|||
157136253|NCT04223609|567245367|FG000|Overall Study|Adverse Event|0|||
157136254|NCT04223609|567245368|FG001|Overall Study|Adverse Event|1|||
157136255|NCT04223609|567245367|FG000|Overall Study|Missed last visit|0|||
157136256|NCT04223609|567245368|FG001|Overall Study|Missed last visit|1|||
157136257|NCT03440944|567245369|FG000|Overall Study|Physician Decision|1|||
157136258|NCT03440944|567245370|FG001|Overall Study|Physician Decision|0|||
157136259|NCT03440944|567245369|FG000|Overall Study|No Acceptable Vasculature|0|||
157136260|NCT03440944|567245370|FG001|Overall Study|No Acceptable Vasculature|1|||
157136261|NCT04672083|567245371|FG000|Overall Study|Lost to Follow-up|1|||
157136262|NCT04672083|567245372|FG001|Overall Study|Lost to Follow-up|0|||
157136263|NCT04672083|567245373|FG002|Overall Study|Lost to Follow-up|0|||
157136264|NCT04672083|567245374|FG003|Overall Study|Lost to Follow-up|0|||
157136265|NCT04672083|567245375|FG004|Overall Study|Lost to Follow-up|0|||
157136266|NCT01551745|567245376|FG000|Overall Study|Withdrawal by Subject|1|||
157136267|NCT01551745|567245376|FG000|Overall Study|Disease Progression|2|||
157136268|NCT02764541|567245377|FG000|Overall Study|Withdrawal by Subject|0|||
157136269|NCT02764541|567245378|FG001|Overall Study|Withdrawal by Subject|0|||
157136270|NCT02764541|567245379|FG002|Overall Study|Withdrawal by Subject|0|||
157136271|NCT02764541|567245380|FG003|Overall Study|Withdrawal by Subject|0|||
157136272|NCT02764541|567245381|FG004|Overall Study|Withdrawal by Subject|1|||
157136273|NCT02764541|567245382|FG005|Overall Study|Withdrawal by Subject|1|||
157136274|NCT02764541|567245383|FG006|Overall Study|Withdrawal by Subject|0|||
157136275|NCT02764541|567245384|FG007|Overall Study|Withdrawal by Subject|1|||
157136276|NCT02764541|567245377|FG000|Overall Study|Adverse Event|1|||
157136277|NCT02764541|567245378|FG001|Overall Study|Adverse Event|0|||
157136278|NCT02764541|567245379|FG002|Overall Study|Adverse Event|0|||
157136279|NCT02764541|567245380|FG003|Overall Study|Adverse Event|0|||
157136280|NCT02764541|567245381|FG004|Overall Study|Adverse Event|0|||
157136281|NCT02764541|567245382|FG005|Overall Study|Adverse Event|0|||
157136282|NCT02764541|567245383|FG006|Overall Study|Adverse Event|1|||
157136283|NCT02764541|567245384|FG007|Overall Study|Adverse Event|0|||
157136284|NCT02764541|567245377|FG000|Overall Study|Metastasis|1|||
157136285|NCT02764541|567245378|FG001|Overall Study|Metastasis|0|||
157136286|NCT02764541|567245379|FG002|Overall Study|Metastasis|0|||
157136287|NCT02764541|567245380|FG003|Overall Study|Metastasis|0|||
157136288|NCT02764541|567245381|FG004|Overall Study|Metastasis|0|||
157136289|NCT02764541|567245382|FG005|Overall Study|Metastasis|0|||
157136290|NCT02764541|567245383|FG006|Overall Study|Metastasis|0|||
157136291|NCT02764541|567245384|FG007|Overall Study|Metastasis|0|||
157136292|NCT02764541|567245377|FG000|Overall Study|Disease progression|1|||
157136293|NCT02764541|567245378|FG001|Overall Study|Disease progression|1|||
157136294|NCT02764541|567245379|FG002|Overall Study|Disease progression|0|||
157136295|NCT02764541|567245380|FG003|Overall Study|Disease progression|0|||
157217332|NCT00738920|567541079|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
156794505|NCT01432444|566001207|FG000|Treatment Phase|Withdrawal by Subject|0|||
156794506|NCT01432444|566001208|FG001|Treatment Phase|Withdrawal by Subject|41|||
156794507|NCT01432444|566001209|FG002|Treatment Phase|Withdrawal by Subject|0|||
157136296|NCT02764541|567245381|FG004|Overall Study|Disease progression|0|||
157136297|NCT02764541|567245382|FG005|Overall Study|Disease progression|0|||
157136298|NCT02764541|567245383|FG006|Overall Study|Disease progression|0|||
157136299|NCT02764541|567245384|FG007|Overall Study|Disease progression|1|||
157136300|NCT02764541|567245377|FG000|Overall Study|Protocol Violation|0|||
157136301|NCT02764541|567245378|FG001|Overall Study|Protocol Violation|0|||
157136302|NCT02764541|567245379|FG002|Overall Study|Protocol Violation|0|||
156794508|NCT01432444|566001207|FG000|Treatment Phase|Protocol Deviation|0|||
157136303|NCT02764541|567245380|FG003|Overall Study|Protocol Violation|1|||
157136304|NCT02764541|567245381|FG004|Overall Study|Protocol Violation|0|||
157136305|NCT02764541|567245382|FG005|Overall Study|Protocol Violation|1|||
157136306|NCT02764541|567245383|FG006|Overall Study|Protocol Violation|0|||
157136307|NCT02764541|567245384|FG007|Overall Study|Protocol Violation|0|||
157136308|NCT02764541|567245377|FG000|Overall Study|Physician Decision|0|||
157136309|NCT02764541|567245378|FG001|Overall Study|Physician Decision|0|||
157136310|NCT02764541|567245379|FG002|Overall Study|Physician Decision|0|||
157136311|NCT02764541|567245380|FG003|Overall Study|Physician Decision|1|||
157136312|NCT02764541|567245381|FG004|Overall Study|Physician Decision|0|||
157136313|NCT02764541|567245382|FG005|Overall Study|Physician Decision|0|||
157136314|NCT02764541|567245383|FG006|Overall Study|Physician Decision|0|||
157136315|NCT02764541|567245384|FG007|Overall Study|Physician Decision|1|||
157136316|NCT02764541|567245377|FG000|Overall Study|Three Cycles completed before surgery|0|||
157136317|NCT02764541|567245378|FG001|Overall Study|Three Cycles completed before surgery|0|||
157136318|NCT02764541|567245379|FG002|Overall Study|Three Cycles completed before surgery|0|||
157136319|NCT02764541|567245380|FG003|Overall Study|Three Cycles completed before surgery|1|||
157136320|NCT02764541|567245381|FG004|Overall Study|Three Cycles completed before surgery|0|||
157136321|NCT02764541|567245382|FG005|Overall Study|Three Cycles completed before surgery|0|||
157136322|NCT02764541|567245383|FG006|Overall Study|Three Cycles completed before surgery|0|||
157136323|NCT02764541|567245384|FG007|Overall Study|Three Cycles completed before surgery|0|||
157136324|NCT02764541|567245377|FG000|Overall Study|Patient Compliance|0|||
157136325|NCT02764541|567245378|FG001|Overall Study|Patient Compliance|0|||
157136326|NCT02764541|567245379|FG002|Overall Study|Patient Compliance|1|||
157136327|NCT02764541|567245380|FG003|Overall Study|Patient Compliance|0|||
157136328|NCT02764541|567245381|FG004|Overall Study|Patient Compliance|0|||
157136329|NCT02764541|567245382|FG005|Overall Study|Patient Compliance|0|||
157136330|NCT02764541|567245383|FG006|Overall Study|Patient Compliance|0|||
157136331|NCT02764541|567245384|FG007|Overall Study|Patient Compliance|0|||
157136332|NCT02764541|567245377|FG000|Overall Study|Death|0|||
157136333|NCT02764541|567245378|FG001|Overall Study|Death|0|||
157136334|NCT02764541|567245379|FG002|Overall Study|Death|0|||
157136335|NCT02764541|567245380|FG003|Overall Study|Death|0|||
157136336|NCT02764541|567245381|FG004|Overall Study|Death|0|||
157136337|NCT02764541|567245382|FG005|Overall Study|Death|0|||
157136338|NCT02764541|567245383|FG006|Overall Study|Death|1|||
157136339|NCT02764541|567245384|FG007|Overall Study|Death|0|||
157136340|NCT02764541|567245377|FG000|Overall Study|Insurance reasons|0|||
157136341|NCT02764541|567245378|FG001|Overall Study|Insurance reasons|0|||
157136342|NCT02764541|567245379|FG002|Overall Study|Insurance reasons|0|||
157136343|NCT02764541|567245380|FG003|Overall Study|Insurance reasons|0|||
157136344|NCT02764541|567245381|FG004|Overall Study|Insurance reasons|0|||
157136345|NCT02764541|567245382|FG005|Overall Study|Insurance reasons|0|||
157136346|NCT02764541|567245383|FG006|Overall Study|Insurance reasons|1|||
157136347|NCT02764541|567245384|FG007|Overall Study|Insurance reasons|0|||
157136348|NCT02048904|567245385|FG000|Overall Study|Withdrawal by Subject|7|||
157136349|NCT02048904|567245385|FG000|Overall Study|Physician Decision|70|||
156723173|NCT01704495|565733311|FG003|Optional Safety Extension|Other reason|28|||
156723174|NCT01704495|565733308|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
156723175|NCT01704495|565733309|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
156723176|NCT01704495|565733310|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
156723177|NCT01704495|565733311|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
156723178|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
156723179|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
156723180|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
156723181|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723182|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723183|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
156723184|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
156723185|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
156723186|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
156723187|NCT02375971|565733312|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
156723188|NCT02375971|565733313|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
156723189|NCT02375971|565733314|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
156723190|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
156723191|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
156723192|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
156723193|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
156723194|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
156723195|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
156723196|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
156723197|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
156723198|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
156723199|NCT02375971|565733312|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
156723200|NCT02375971|565733313|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
156723201|NCT02375971|565733314|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
156723202|NCT00832455|565733319|FG000|Overall Study|Adverse Event|13|||
156723203|NCT00832455|565733319|FG000|Overall Study|Lost to Follow-up|26|||
157136350|NCT00749190|567245388|FG000|Overall Study|Adverse Event|0|||
157136351|NCT00749190|567245389|FG001|Overall Study|Adverse Event|2|||
157136352|NCT00749190|567245390|FG002|Overall Study|Adverse Event|0|||
157136353|NCT00749190|567245391|FG003|Overall Study|Adverse Event|4|||
157136354|NCT00749190|567245392|FG004|Overall Study|Adverse Event|0|||
157136355|NCT00749190|567245393|FG005|Overall Study|Adverse Event|3|||
157136356|NCT00749190|567245394|FG006|Overall Study|Adverse Event|0|||
157136357|NCT00749190|567245388|FG000|Overall Study|Lack of Efficacy|3|||
157136358|NCT00749190|567245389|FG001|Overall Study|Lack of Efficacy|1|||
157136359|NCT00749190|567245390|FG002|Overall Study|Lack of Efficacy|1|||
157136360|NCT00749190|567245391|FG003|Overall Study|Lack of Efficacy|0|||
157136361|NCT00749190|567245392|FG004|Overall Study|Lack of Efficacy|0|||
157136362|NCT00749190|567245393|FG005|Overall Study|Lack of Efficacy|1|||
157136363|NCT00749190|567245394|FG006|Overall Study|Lack of Efficacy|0|||
157136364|NCT00749190|567245388|FG000|Overall Study|Withdrawal by Subject|2|||
157136365|NCT00749190|567245389|FG001|Overall Study|Withdrawal by Subject|1|||
157136366|NCT00749190|567245390|FG002|Overall Study|Withdrawal by Subject|0|||
157136367|NCT00749190|567245391|FG003|Overall Study|Withdrawal by Subject|0|||
157136368|NCT00749190|567245392|FG004|Overall Study|Withdrawal by Subject|0|||
157136369|NCT00749190|567245393|FG005|Overall Study|Withdrawal by Subject|1|||
157136370|NCT00749190|567245394|FG006|Overall Study|Withdrawal by Subject|0|||
157136371|NCT00749190|567245388|FG000|Overall Study|Protocol Violation|0|||
157136372|NCT00749190|567245389|FG001|Overall Study|Protocol Violation|1|||
157136373|NCT00749190|567245390|FG002|Overall Study|Protocol Violation|0|||
157136374|NCT00749190|567245391|FG003|Overall Study|Protocol Violation|0|||
157136375|NCT00749190|567245392|FG004|Overall Study|Protocol Violation|0|||
157136376|NCT00749190|567245393|FG005|Overall Study|Protocol Violation|0|||
157136377|NCT00749190|567245394|FG006|Overall Study|Protocol Violation|1|||
157136378|NCT00749190|567245388|FG000|Overall Study|Other reason not defined above|0|||
157136379|NCT00749190|567245389|FG001|Overall Study|Other reason not defined above|0|||
156723204|NCT00832455|565733319|FG000|Overall Study|Protocol Violation|4|||
156723205|NCT00832455|565733319|FG000|Overall Study|Withdrawal by Subject|17|||
156723206|NCT00832455|565733319|FG000|Overall Study|Screening Failure|2|||
156723207|NCT00832455|565733319|FG000|Overall Study|Stopped Medication|4|||
156723208|NCT00832455|565733319|FG000|Overall Study|Parent misunderstood study|1|||
156723209|NCT00832455|565733319|FG000|Overall Study|Parent dissatisfied|1|||
156723210|NCT00832455|565733319|FG000|Overall Study|No improvement|3|||
156723211|NCT00832455|565733319|FG000|Overall Study|Patient moved|1|||
156723212|NCT02755103|565733321|FG000|Overall Study|Lost to Follow-up|17|||
156723213|NCT02755103|565733322|FG001|Overall Study|Lost to Follow-up|15|||
156723214|NCT02755103|565733321|FG000|Overall Study|Death|0|||
156723215|NCT02755103|565733322|FG001|Overall Study|Death|1|||
156723216|NCT02755103|565733321|FG000|Overall Study|Physician Decision|0|||
156875568|NCT04173494|566302100|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
156875569|NCT04173494|566302101|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
156875570|NCT01623050|566302102|FG000|Overall Study|Lost to Follow-up|9|||
156875571|NCT02147561|566302105|FG000|Overall Study|Lost to Follow-up|3|||
156875572|NCT02147561|566302105|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
156875573|NCT01191762|566302106|FG000|Overall Study|Adverse Event|1|||
156875574|NCT01191762|566302107|FG001|Overall Study|Adverse Event|0|||
156875575|NCT03023813|566302110|FG000|Overall Study|Lost to Follow-up|1|||
156875576|NCT03023813|566302111|FG001|Overall Study|Lost to Follow-up|2|||
156875577|NCT03023813|566302112|FG002|Overall Study|Lost to Follow-up|0|||
156875578|NCT00393861|566302113|FG000|Overall Study|Adverse Event|2|||
156875579|NCT00393861|566302113|FG000|Overall Study|Disease Progression|24|||
156875580|NCT03710083|566302114|FG000|Overall Study|Withdrawal by Subject|2|||
156875581|NCT03710083|566302114|FG000|Overall Study|Unsuccessful Procedure|1|||
156875582|NCT01727024|566302115|FG000|Period 1|Lost to Follow-up|1|||
156875583|NCT01727024|566302116|FG001|Period 1|Lost to Follow-up|1|||
156875584|NCT01727024|566302115|FG000|Period 1|Withdrawal by Subject|2|||
156875585|NCT01727024|566302116|FG001|Period 1|Withdrawal by Subject|3|||
156875586|NCT01587014|566302117|FG000|Overall Study|Death|2|||
156875587|NCT03962504|566302120|FG000|Overall Study|Other|11|||
156875588|NCT03962504|566302121|FG001|Overall Study|Other|32|||
156875589|NCT04695977|566302122|FG000|Overall Study|Sponsor Decision|9|||
157217333|NCT00738920|567541080|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
156723217|NCT02755103|565733322|FG001|Overall Study|Physician Decision|1|||
156723218|NCT02755103|565733321|FG000|Overall Study|Pregnancy|0|||
157136380|NCT00749190|567245390|FG002|Overall Study|Other reason not defined above|0|||
157136381|NCT00749190|567245391|FG003|Overall Study|Other reason not defined above|1|||
157136382|NCT00749190|567245392|FG004|Overall Study|Other reason not defined above|0|||
157136383|NCT00749190|567245393|FG005|Overall Study|Other reason not defined above|0|||
157136384|NCT00749190|567245394|FG006|Overall Study|Other reason not defined above|0|||
156723219|NCT02755103|565733322|FG001|Overall Study|Pregnancy|1|||
156723220|NCT02755103|565733321|FG000|Overall Study|Withdrawal by Subject|3|||
156723221|NCT02755103|565733322|FG001|Overall Study|Withdrawal by Subject|0|||
156723222|NCT04177095|565733331|FG000|Overall Study|Withdrawal by Subject|3|||
156875590|NCT04695977|566302123|FG001|Overall Study|Sponsor Decision|4|||
156875591|NCT04695977|566302122|FG000|Overall Study|Death|2|||
156875592|NCT04695977|566302123|FG001|Overall Study|Death|5|||
156875593|NCT01395524|566303595|FG000|Overall Study|Non-compliance with study schedule|1|||
156875594|NCT01395524|566303596|FG001|Overall Study|Non-compliance with study schedule|0|||
156875595|NCT01395524|566303597|FG002|Overall Study|Non-compliance with study schedule|1|||
157136385|NCT05775289|567245395|FG000|Overall Study|Study Ongoing|20|||
157136386|NCT05775289|567245396|FG001|Overall Study|Study Ongoing|53|||
157136387|NCT05775289|567245397|FG002|Overall Study|Study Ongoing|15|||
157136388|NCT05775289|567245398|FG003|Overall Study|Study Ongoing|55|||
157136389|NCT05775289|567245395|FG000|Overall Study|Death|4|||
157136390|NCT05775289|567245396|FG001|Overall Study|Death|11|||
157136391|NCT05775289|567245397|FG002|Overall Study|Death|8|||
157136392|NCT05775289|567245398|FG003|Overall Study|Death|12|||
157136393|NCT05775289|567245395|FG000|Overall Study|Lost to Follow-up|0|||
157136394|NCT05775289|567245396|FG001|Overall Study|Lost to Follow-up|1|||
157136395|NCT05775289|567245397|FG002|Overall Study|Lost to Follow-up|0|||
157136396|NCT05775289|567245398|FG003|Overall Study|Lost to Follow-up|0|||
157136397|NCT05775289|567245395|FG000|Overall Study|Progressive Disease|0|||
157136398|NCT05775289|567245396|FG001|Overall Study|Progressive Disease|0|||
157136399|NCT05775289|567245397|FG002|Overall Study|Progressive Disease|1|||
157136400|NCT05775289|567245398|FG003|Overall Study|Progressive Disease|0|||
157136401|NCT05775289|567245395|FG000|Overall Study|Withdrawal by Subject|1|||
157136402|NCT05775289|567245396|FG001|Overall Study|Withdrawal by Subject|1|||
157136403|NCT05775289|567245397|FG002|Overall Study|Withdrawal by Subject|0|||
157136404|NCT05775289|567245398|FG003|Overall Study|Withdrawal by Subject|0|||
157136405|NCT02330419|567245402|FG000|Overall Study|Lost to Follow-up|3|||
157136406|NCT02330419|567245403|FG001|Overall Study|Lost to Follow-up|7|||
157136407|NCT00490542|567245404|FG000|Overall Study|Lost to Follow-up|3|||
157136408|NCT00490542|567245405|FG001|Overall Study|Lost to Follow-up|0|||
157136409|NCT00490542|567245404|FG000|Overall Study|Adverse Event|3|||
157136410|NCT00490542|567245405|FG001|Overall Study|Adverse Event|3|||
157136411|NCT00490542|567245404|FG000|Overall Study|Lack of Efficacy|1|||
157136412|NCT00490542|567245405|FG001|Overall Study|Lack of Efficacy|1|||
157136413|NCT04370509|567245406|FG000|Overall Study|Adverse Event|1|||
157136414|NCT04370509|567245407|FG001|Overall Study|Adverse Event|0|||
156723223|NCT04177095|565733331|FG000|Overall Study|Screen Failure|3|||
156723224|NCT04177095|565733331|FG000|Overall Study|Problems with the Trugraf assay|1|||
156723225|NCT02275819|565733332|FG000|Overall Study|Adverse Event|0|||
156723226|NCT02275819|565733333|FG001|Overall Study|Adverse Event|1|||
156723227|NCT01346059|565733334|FG000|Overall Study|Withdrawal by Subject|1|||
156723228|NCT01346059|565733335|FG001|Overall Study|Withdrawal by Subject|0|||
156723229|NCT02556775|565733336|FG000|Overall Study|Withdrawal by Subject|1|||
156723230|NCT02556775|565733337|FG001|Overall Study|Withdrawal by Subject|0|||
156723231|NCT02556775|565733338|FG002|Overall Study|Withdrawal by Subject|1|||
156723232|NCT02556775|565733339|FG003|Overall Study|Withdrawal by Subject|0|||
156723233|NCT02556775|565733336|FG000|Overall Study|Lost to Follow-up|1|||
156723234|NCT02556775|565733337|FG001|Overall Study|Lost to Follow-up|0|||
156723235|NCT02556775|565733338|FG002|Overall Study|Lost to Follow-up|0|||
156723236|NCT02556775|565733339|FG003|Overall Study|Lost to Follow-up|0|||
156723237|NCT00777296|565733340|FG000|Overall Study|Adverse Event|0|||
156723238|NCT00777296|565733341|FG001|Overall Study|Adverse Event|1|||
156723239|NCT00777296|565733342|FG002|Overall Study|Adverse Event|0|||
156723240|NCT00777296|565733343|FG003|Overall Study|Adverse Event|1|||
156723241|NCT00777296|565733340|FG000|Overall Study|Withdrawal by Subject|1|||
156723242|NCT00777296|565733341|FG001|Overall Study|Withdrawal by Subject|0|||
156723243|NCT00777296|565733342|FG002|Overall Study|Withdrawal by Subject|0|||
156723244|NCT00777296|565733343|FG003|Overall Study|Withdrawal by Subject|0|||
156723245|NCT00777296|565733340|FG000|Overall Study|CRF form not completed|0|||
156723246|NCT00777296|565733341|FG001|Overall Study|CRF form not completed|0|||
156723247|NCT00777296|565733342|FG002|Overall Study|CRF form not completed|2|||
156723248|NCT00777296|565733343|FG003|Overall Study|CRF form not completed|0|||
157136415|NCT04370509|567245406|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
157136416|NCT04370509|567245407|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
157136417|NCT04743856|567245408|FG000|Overall Study|Lost to Follow-up|6|||
157136418|NCT04743856|567245409|FG001|Overall Study|Lost to Follow-up|7|||
157136419|NCT04743856|567245408|FG000|Overall Study|Withdrawal by Subject|1|||
157136420|NCT04743856|567245409|FG001|Overall Study|Withdrawal by Subject|0|||
157136421|NCT04696861|567245410|FG000|Overall Study|Death|1|||
157136422|NCT04696861|567245411|FG001|Overall Study|Death|0|||
157136423|NCT04696861|567245410|FG000|Overall Study|Lost to Follow-up|3|||
156723249|NCT02211209|565733344|FG000|Overall Study|Investigator judgment|0|||
156723250|NCT02211209|565733345|FG001|Overall Study|Investigator judgment|1|||
156723251|NCT02211209|565733344|FG000|Overall Study|Voluntary withdrawal|1|||
157136424|NCT04696861|567245411|FG001|Overall Study|Lost to Follow-up|0|||
157136425|NCT04439188|567245412|FG000|Overall Study|Ineligible|3|||
157136426|NCT04439188|567245412|FG000|Overall Study|Adverse Event|4|||
157136427|NCT04439188|567245412|FG000|Overall Study|Death|1|||
157136428|NCT04439188|567245412|FG000|Overall Study|Disease Progression|25|||
156875596|NCT01395524|566303595|FG000|Overall Study|Lost to Follow-up|3|||
157136429|NCT04439188|567245412|FG000|Overall Study|Withdrawal by Subject|2|||
157136430|NCT01813890|567245415|FG000|Overall Study|Adverse Event|0|||
157136431|NCT01813890|567245416|FG001|Overall Study|Adverse Event|3|||
157136432|NCT01813890|567245417|FG002|Overall Study|Adverse Event|4|||
157136433|NCT01813890|567245415|FG000|Overall Study|Lack of Efficacy|9|||
156794509|NCT01432444|566001208|FG001|Treatment Phase|Protocol Deviation|3|||
156794510|NCT01432444|566001209|FG002|Treatment Phase|Protocol Deviation|0|||
156794511|NCT01432444|566001207|FG000|Treatment Phase|Lack of Efficacy|0|||
156794512|NCT01432444|566001208|FG001|Treatment Phase|Lack of Efficacy|10|||
156794513|NCT01432444|566001209|FG002|Treatment Phase|Lack of Efficacy|0|||
156794514|NCT01432444|566001207|FG000|Extension Phase|Lost to Follow-up|0|||
156794515|NCT01432444|566001208|FG001|Extension Phase|Lost to Follow-up|0|||
156794516|NCT01432444|566001209|FG002|Extension Phase|Lost to Follow-up|17|||
156794517|NCT01432444|566001207|FG000|Extension Phase|Adverse Event|0|||
156794518|NCT01432444|566001208|FG001|Extension Phase|Adverse Event|0|||
156794519|NCT01432444|566001209|FG002|Extension Phase|Adverse Event|10|||
156794520|NCT01432444|566001207|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
156794521|NCT01432444|566001208|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
156794522|NCT01432444|566001209|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
156723252|NCT02211209|565733345|FG001|Overall Study|Voluntary withdrawal|4|||
156723253|NCT02211209|565733344|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156723254|NCT02211209|565733345|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
156723255|NCT02211209|565733344|FG000|Overall Study|Reason Not Specified|1|||
156723256|NCT02211209|565733345|FG001|Overall Study|Reason Not Specified|0|||
156723257|NCT00658723|565733349|FG000|Overall Study|Lost to Follow-up|0|||
156723258|NCT00658723|565733350|FG001|Overall Study|Lost to Follow-up|2|||
156723259|NCT00658723|565733351|FG002|Overall Study|Lost to Follow-up|2|||
156723260|NCT00658723|565733349|FG000|Overall Study|Death|2|||
156723261|NCT00658723|565733350|FG001|Overall Study|Death|1|||
156723262|NCT00658723|565733351|FG002|Overall Study|Death|4|||
156723263|NCT00658723|565733349|FG000|Overall Study|Scheduling Issue|1|||
156723264|NCT00658723|565733350|FG001|Overall Study|Scheduling Issue|1|||
156723265|NCT00658723|565733351|FG002|Overall Study|Scheduling Issue|0|||
156723266|NCT00658723|565733349|FG000|Overall Study|Withdrawal by Subject|1|||
156723267|NCT00658723|565733350|FG001|Overall Study|Withdrawal by Subject|0|||
156723268|NCT00658723|565733351|FG002|Overall Study|Withdrawal by Subject|1|||
156723269|NCT03876743|565733352|FG000|Overall Study|Lost to Follow-up|6|||
156723270|NCT03876743|565733353|FG001|Overall Study|Lost to Follow-up|4|||
156723271|NCT03876743|565733354|FG002|Overall Study|Lost to Follow-up|4|||
156723272|NCT03876743|565733355|FG003|Overall Study|Lost to Follow-up|7|||
156723273|NCT03889418|565733356|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
156723274|NCT03889418|565733357|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723275|NCT03889418|565733358|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723276|NCT03889418|565733359|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723277|NCT03889418|565733360|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723278|NCT03889418|565733361|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156794523|NCT01432444|566001207|FG000|Extension Phase|Met Withdrawal Criteria|0|||
156794524|NCT01432444|566001208|FG001|Extension Phase|Met Withdrawal Criteria|0|||
156794525|NCT01432444|566001209|FG002|Extension Phase|Met Withdrawal Criteria|144|||
156794526|NCT01432444|566001207|FG000|Extension Phase|Physician Decision|0|||
156794527|NCT01432444|566001208|FG001|Extension Phase|Physician Decision|0|||
156794528|NCT01432444|566001209|FG002|Extension Phase|Physician Decision|1|||
156794529|NCT01432444|566001207|FG000|Extension Phase|Withdrawal by Subject|0|||
156794530|NCT01432444|566001208|FG001|Extension Phase|Withdrawal by Subject|0|||
156794531|NCT01432444|566001209|FG002|Extension Phase|Withdrawal by Subject|13|||
156794532|NCT02014467|566001210|FG000|Overall Study|Adverse Event|4|||
156794533|NCT02014467|566001211|FG001|Overall Study|Adverse Event|0|||
156794534|NCT02014467|566001210|FG000|Overall Study|Protocol Violation|3|||
156794535|NCT02014467|566001211|FG001|Overall Study|Protocol Violation|0|||
156794536|NCT02014467|566001210|FG000|Overall Study|Physician Decision|2|||
156794537|NCT02014467|566001211|FG001|Overall Study|Physician Decision|3|||
156794538|NCT02014467|566001210|FG000|Overall Study|Withdrawal by Subject|16|||
156794539|NCT02014467|566001211|FG001|Overall Study|Withdrawal by Subject|4|||
156875597|NCT01395524|566303596|FG001|Overall Study|Lost to Follow-up|1|||
156723279|NCT03889418|565733362|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723280|NCT03889418|565733363|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156875598|NCT01395524|566303597|FG002|Overall Study|Lost to Follow-up|1|||
156723281|NCT03889418|565733364|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723282|NCT03889418|565733365|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
156723283|NCT03889418|565733356|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723284|NCT03889418|565733357|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
156723285|NCT03889418|565733358|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
156723286|NCT03889418|565733359|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723287|NCT03889418|565733360|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723288|NCT03889418|565733361|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156794540|NCT00443456|566001213|FG000|Overall Study|Adverse Event|16|||
156794541|NCT00443456|566001213|FG000|Overall Study|Move|1|||
156794542|NCT00443456|566001213|FG000|Overall Study|Withdrawal by Subject|1|||
156794543|NCT00557440|566001214|FG000|Treatment Period 1|Adverse Event|0|||
156794544|NCT00557440|566001215|FG001|Treatment Period 1|Adverse Event|0|||
156875599|NCT01395524|566303595|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
156875600|NCT01395524|566303596|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
156875601|NCT01395524|566303597|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
156875602|NCT01395524|566303595|FG000|Overall Study|Severe noncompliance with protocol|1|||
156875603|NCT01395524|566303596|FG001|Overall Study|Severe noncompliance with protocol|0|||
156875604|NCT01395524|566303597|FG002|Overall Study|Severe noncompliance with protocol|0|||
156875605|NCT01395524|566303595|FG000|Overall Study|Adverse Event|4|||
156875606|NCT01395524|566303596|FG001|Overall Study|Adverse Event|4|||
156875607|NCT01395524|566303597|FG002|Overall Study|Adverse Event|3|||
156875608|NCT01395524|566303595|FG000|Overall Study|Death|1|||
156875609|NCT01395524|566303596|FG001|Overall Study|Death|0|||
156723289|NCT03889418|565733362|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723290|NCT03889418|565733363|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723291|NCT03889418|565733364|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723292|NCT03889418|565733365|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
156723293|NCT03889418|565733356|FG000|October-December 2019 (Month 7-9)|Death|0|||
156723294|NCT03889418|565733357|FG001|October-December 2019 (Month 7-9)|Death|0|||
156723295|NCT03889418|565733358|FG002|October-December 2019 (Month 7-9)|Death|0|||
156723296|NCT03889418|565733359|FG003|October-December 2019 (Month 7-9)|Death|0|||
156723297|NCT03889418|565733360|FG004|October-December 2019 (Month 7-9)|Death|0|||
156723298|NCT03889418|565733361|FG005|October-December 2019 (Month 7-9)|Death|0|||
156723299|NCT03889418|565733362|FG006|October-December 2019 (Month 7-9)|Death|0|||
156723300|NCT03889418|565733363|FG007|October-December 2019 (Month 7-9)|Death|0|||
156723301|NCT03889418|565733364|FG008|October-December 2019 (Month 7-9)|Death|1|||
156723302|NCT03889418|565733365|FG009|October-December 2019 (Month 7-9)|Death|0|||
156723303|NCT03889418|565733356|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723304|NCT03889418|565733357|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723305|NCT03889418|565733358|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723306|NCT03889418|565733359|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
156723307|NCT03889418|565733360|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723308|NCT03889418|565733361|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723309|NCT03889418|565733362|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723310|NCT03889418|565733363|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
156723311|NCT03889418|565733364|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723312|NCT03889418|565733365|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
156723313|NCT03889418|565733356|FG000|April - June 2020 (Month 13-15)|Death|0|||
156723314|NCT03889418|565733357|FG001|April - June 2020 (Month 13-15)|Death|1|||
156723315|NCT03889418|565733358|FG002|April - June 2020 (Month 13-15)|Death|0|||
156723316|NCT03889418|565733359|FG003|April - June 2020 (Month 13-15)|Death|0|||
156723317|NCT03889418|565733360|FG004|April - June 2020 (Month 13-15)|Death|0|||
156723318|NCT03889418|565733361|FG005|April - June 2020 (Month 13-15)|Death|0|||
156723319|NCT03889418|565733362|FG006|April - June 2020 (Month 13-15)|Death|0|||
156723320|NCT03889418|565733363|FG007|April - June 2020 (Month 13-15)|Death|0|||
156723321|NCT03889418|565733364|FG008|April - June 2020 (Month 13-15)|Death|0|||
156723322|NCT03889418|565733365|FG009|April - June 2020 (Month 13-15)|Death|0|||
156723323|NCT03889418|565733356|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723324|NCT03889418|565733357|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723325|NCT03889418|565733358|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723326|NCT03889418|565733359|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
156723327|NCT03889418|565733360|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723328|NCT03889418|565733361|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723329|NCT03889418|565733362|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723330|NCT03889418|565733363|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723331|NCT03889418|565733364|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723332|NCT03889418|565733365|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
156723333|NCT03889418|565733356|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723334|NCT03889418|565733357|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723335|NCT03889418|565733358|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
156723336|NCT03889418|565733359|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723337|NCT03889418|565733360|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723338|NCT03889418|565733361|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
156875610|NCT01395524|566303597|FG002|Overall Study|Death|0|||
156875611|NCT01395524|566303595|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156875612|NCT01395524|566303596|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156875613|NCT01395524|566303597|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
156875614|NCT01395524|566303595|FG000|Overall Study|Withdrawal by Subject|4|||
156875615|NCT01395524|566303596|FG001|Overall Study|Withdrawal by Subject|8|||
156875616|NCT01395524|566303597|FG002|Overall Study|Withdrawal by Subject|8|||
156875617|NCT01395524|566303595|FG000|Overall Study|Did not receive treatment|1|||
156875618|NCT01395524|566303596|FG001|Overall Study|Did not receive treatment|1|||
156875619|NCT01395524|566303597|FG002|Overall Study|Did not receive treatment|3|||
156875620|NCT01395524|566303595|FG000|Overall Study|Subject had spinal surgery|0|||
156723339|NCT03889418|565733362|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723340|NCT03889418|565733363|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
156723341|NCT03889418|565733364|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723342|NCT03889418|565733365|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
156723343|NCT03889418|565733356|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723344|NCT03889418|565733357|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
156723345|NCT03889418|565733358|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
156723346|NCT03889418|565733359|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
156723347|NCT03889418|565733360|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723348|NCT03889418|565733361|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723349|NCT03889418|565733362|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723350|NCT03889418|565733363|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
156723351|NCT03889418|565733364|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
156723352|NCT03889418|565733365|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
156723353|NCT00092118|565733367|FG000|Overall Study|Adverse Event|35|||
156723354|NCT00092118|565733368|FG001|Overall Study|Adverse Event|32|||
156723355|NCT00092118|565733367|FG000|Overall Study|Lack of Efficacy|12|||
156723356|NCT00092118|565733368|FG001|Overall Study|Lack of Efficacy|14|||
156723357|NCT00092118|565733367|FG000|Overall Study|Lost to Follow-up|4|||
156723358|NCT00092118|565733368|FG001|Overall Study|Lost to Follow-up|3|||
156723359|NCT00092118|565733367|FG000|Overall Study|Protocol Violation|23|||
156723360|NCT00092118|565733368|FG001|Overall Study|Protocol Violation|25|||
156723361|NCT00092118|565733367|FG000|Overall Study|Withdrawal by Subject|4|||
156723362|NCT00092118|565733368|FG001|Overall Study|Withdrawal by Subject|10|||
156723363|NCT00092118|565733367|FG000|Overall Study|Other|6|||
156723364|NCT00092118|565733368|FG001|Overall Study|Other|5|||
156723365|NCT01139125|565733371|FG000|Overall Study|Withdrawal by Subject|1|||
156723366|NCT02025725|565733372|FG000|Overall Study|Adverse Event|5|||
156723367|NCT02025725|565733373|FG001|Overall Study|Adverse Event|0|||
156723368|NCT02025725|565733372|FG000|Overall Study|Lost to Follow-up|2|||
156723369|NCT02025725|565733373|FG001|Overall Study|Lost to Follow-up|0|||
156723370|NCT02025725|565733372|FG000|Overall Study|Protocol Violation|1|||
156723371|NCT02025725|565733373|FG001|Overall Study|Protocol Violation|1|||
156723372|NCT02025725|565733372|FG000|Overall Study|Withdrawal by Subject|3|||
156723373|NCT02025725|565733373|FG001|Overall Study|Withdrawal by Subject|2|||
156723374|NCT02025725|565733372|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
156723375|NCT02025725|565733373|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
156723376|NCT02172664|565733381|FG000|Overall Study|Lost to Follow-up|4|||
157136434|NCT01813890|567245416|FG001|Overall Study|Lack of Efficacy|1|||
157136435|NCT01813890|567245417|FG002|Overall Study|Lack of Efficacy|2|||
156723377|NCT02172664|565733382|FG001|Overall Study|Lost to Follow-up|4|||
156723378|NCT02172664|565733381|FG000|Overall Study|Death|1|||
156723379|NCT02172664|565733382|FG001|Overall Study|Death|1|||
156723380|NCT02172664|565733381|FG000|Overall Study|Moved out of area|1|||
156723381|NCT02172664|565733382|FG001|Overall Study|Moved out of area|1|||
156723382|NCT00739661|565733383|FG000|Overall Study|Adverse Event|2|||
156723383|NCT00739661|565733384|FG001|Overall Study|Adverse Event|0|||
156723384|NCT00739661|565733383|FG000|Overall Study|Physician decision to withdraw patient|1|||
156723385|NCT00739661|565733384|FG001|Overall Study|Physician decision to withdraw patient|0|||
156723386|NCT00739661|565733383|FG000|Overall Study|Patient decision to withdraw|9|||
156723387|NCT00739661|565733384|FG001|Overall Study|Patient decision to withdraw|4|||
156723388|NCT00739661|565733383|FG000|Overall Study|Disease progression, radiographic|33|||
156723389|NCT00739661|565733384|FG001|Overall Study|Disease progression, radiographic|37|||
156723390|NCT00739661|565733383|FG000|Overall Study|Reason for discontinuation not available|1|||
156723391|NCT00739661|565733384|FG001|Overall Study|Reason for discontinuation not available|1|||
156723392|NCT02946463|565733385|FG000|Primary Evaluation Period|Physician Decision|0|||
156723393|NCT02946463|565733386|FG001|Primary Evaluation Period|Physician Decision|1|||
156723394|NCT02946463|565733387|FG002|Primary Evaluation Period|Physician Decision|0|||
157136436|NCT04482647|567245418|FG000|Overall Study|Time constraints|2|||
157136437|NCT04482647|567245418|FG000|Overall Study|Health issues|1|||
157136438|NCT04482647|567245418|FG000|Overall Study|Death in the family|1|||
157136439|NCT04482647|567245418|FG000|Overall Study|Disliked the intervention|1|||
157136440|NCT04482647|567245418|FG000|Overall Study|No reasons specified|7|||
157136441|NCT03952559|567245419|FG000|Double Blind Treatment Period|Adverse Event|0|||
156723395|NCT02946463|565733388|FG003|Primary Evaluation Period|Physician Decision|0|||
156723396|NCT02946463|565733385|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
156723397|NCT02946463|565733386|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
156723398|NCT02946463|565733387|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
156723399|NCT02946463|565733388|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
157217334|NCT00738920|567541081|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
156723400|NCT02946463|565733385|FG000|Extension Period|Death|4|||
156723401|NCT02946463|565733386|FG001|Extension Period|Death|4|||
156723402|NCT02946463|565733387|FG002|Extension Period|Death|0|||
156723403|NCT02946463|565733388|FG003|Extension Period|Death|0|||
157136442|NCT03952559|567245420|FG001|Double Blind Treatment Period|Adverse Event|2|||
156723404|NCT02946463|565733385|FG000|Extension Period|Withdrawal by Subject|4|||
156723405|NCT02946463|565733386|FG001|Extension Period|Withdrawal by Subject|3|||
156723406|NCT02946463|565733387|FG002|Extension Period|Withdrawal by Subject|0|||
156723407|NCT02946463|565733388|FG003|Extension Period|Withdrawal by Subject|0|||
156723408|NCT02946463|565733385|FG000|Extension Period|Other than specified|2|||
156723409|NCT02946463|565733386|FG001|Extension Period|Other than specified|3|||
156723410|NCT02946463|565733387|FG002|Extension Period|Other than specified|2|||
156723411|NCT02946463|565733388|FG003|Extension Period|Other than specified|0|||
156723412|NCT02946463|565733385|FG000|Extension Period|Physician Decision|1|||
156723413|NCT02946463|565733386|FG001|Extension Period|Physician Decision|4|||
156723414|NCT02946463|565733387|FG002|Extension Period|Physician Decision|0|||
156723415|NCT02946463|565733388|FG003|Extension Period|Physician Decision|0|||
156723416|NCT02946463|565733385|FG000|Extension Period|Pregnancy|3|||
156723417|NCT02946463|565733386|FG001|Extension Period|Pregnancy|1|||
156723418|NCT02946463|565733387|FG002|Extension Period|Pregnancy|0|||
156723419|NCT02946463|565733388|FG003|Extension Period|Pregnancy|0|||
156723420|NCT02946463|565733385|FG000|Extension Period|Adverse Event|1|||
156723421|NCT02946463|565733386|FG001|Extension Period|Adverse Event|2|||
156723422|NCT02946463|565733387|FG002|Extension Period|Adverse Event|0|||
156723423|NCT02946463|565733388|FG003|Extension Period|Adverse Event|0|||
156723424|NCT02946463|565733385|FG000|Extension Period|Lost to Follow-up|1|||
156723425|NCT02946463|565733386|FG001|Extension Period|Lost to Follow-up|0|||
156723426|NCT02946463|565733387|FG002|Extension Period|Lost to Follow-up|0|||
156723427|NCT02946463|565733388|FG003|Extension Period|Lost to Follow-up|0|||
156723428|NCT04564092|565733392|FG000|Overall Study|Withdrawal by Subject|1|||
156723429|NCT00420420|565733393|FG000|Overall Study|Adverse Event|5|||
156723430|NCT00420420|565733394|FG001|Overall Study|Adverse Event|3|||
156723431|NCT00420420|565733393|FG000|Overall Study|Protocol Violation|1|||
156723432|NCT00420420|565733394|FG001|Overall Study|Protocol Violation|1|||
156723433|NCT00420420|565733393|FG000|Overall Study|Withdrawal by Subject|1|||
156723434|NCT00420420|565733394|FG001|Overall Study|Withdrawal by Subject|0|||
156723435|NCT00420420|565733393|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
156723436|NCT00420420|565733394|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
156723437|NCT04762160|565733395|FG000|Overall Study|Study terminated early due to business reasons|5|||
156723438|NCT02362360|565733402|FG000|Period 1|Lack of Efficacy|1|||
156723439|NCT02362360|565733403|FG001|Period 1|Lack of Efficacy|0|||
156723440|NCT02362360|565733402|FG000|Period 1|Withdrawal by Subject|2|||
156723441|NCT02362360|565733403|FG001|Period 1|Withdrawal by Subject|1|||
156723442|NCT00868530|565733406|FG000|Overall Study|Adverse Event|3|||
156723443|NCT00868530|565733406|FG000|Overall Study|Lost to Follow-up|1|||
156723444|NCT03760744|565735173|FG000|Overall Study|Lost to Follow-up|3|||
156723445|NCT03760744|565735174|FG001|Overall Study|Lost to Follow-up|0|||
156723446|NCT05142722|565735175|FG000|Overall Study|Lost to Follow-up|16|||
156723447|NCT05142722|565735176|FG001|Overall Study|Lost to Follow-up|38|||
156723448|NCT05142722|565735175|FG000|Overall Study|Withdrawal by Subject|20|||
156723449|NCT05142722|565735176|FG001|Overall Study|Withdrawal by Subject|27|||
156723450|NCT05142722|565735175|FG000|Overall Study|Death|11|||
156723451|NCT05142722|565735176|FG001|Overall Study|Death|17|||
156723452|NCT05142722|565735175|FG000|Overall Study|Physician Decision|0|||
156723453|NCT05142722|565735176|FG001|Overall Study|Physician Decision|1|||
156723454|NCT05142722|565735175|FG000|Overall Study|Participant Moved Away|0|||
156723455|NCT05142722|565735176|FG001|Overall Study|Participant Moved Away|2|||
156723456|NCT05142722|565735175|FG000|Overall Study|Adverse Event|2|||
156723457|NCT05142722|565735176|FG001|Overall Study|Adverse Event|1|||
157136443|NCT03952559|567245421|FG002|Double Blind Treatment Period|Adverse Event|1|||
157136444|NCT03952559|567245422|FG003|Double Blind Treatment Period|Adverse Event|0|||
157136445|NCT03952559|567245423|FG004|Double Blind Treatment Period|Adverse Event|1|||
157136446|NCT03952559|567245419|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
157136447|NCT03952559|567245420|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
157136448|NCT03952559|567245421|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
157136449|NCT03952559|567245422|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
157136450|NCT03952559|567245423|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
157136451|NCT03952559|567245419|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
157136452|NCT03952559|567245420|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156723458|NCT05086744|565735177|FG000|Part A|Adverse Event|0|||
156723459|NCT05086744|565735178|FG001|Part A|Adverse Event|1|||
156723460|NCT05086744|565735177|FG000|Part A|Lack of Efficacy|3|||
156723461|NCT05086744|565735178|FG001|Part A|Lack of Efficacy|0|||
156723462|NCT05086744|565735177|FG000|Part A|Protocol deviation|1|||
156723463|NCT05086744|565735178|FG001|Part A|Protocol deviation|0|||
156723464|NCT05086744|565735177|FG000|Part A|Subject decision|1|||
157136453|NCT03952559|567245421|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
157136454|NCT03952559|567245422|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
156723465|NCT05086744|565735178|FG001|Part A|Subject decision|0|||
156723466|NCT05086744|565735177|FG000|Part B|Adverse Event|0|||
156723467|NCT05086744|565735178|FG001|Part B|Adverse Event|1|||
156723468|NCT05086744|565735177|FG000|Part B|Lack of Efficacy|0|||
156723469|NCT05086744|565735178|FG001|Part B|Lack of Efficacy|1|||
156723470|NCT05086744|565735177|FG000|Part B|Study terminated by sponsor|1|||
156723471|NCT05086744|565735178|FG001|Part B|Study terminated by sponsor|6|||
156723472|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723473|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723474|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723475|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723476|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
156723477|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
157136455|NCT03952559|567245423|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156723478|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723479|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
156723480|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723481|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723482|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
156723483|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723484|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723485|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
156723486|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723487|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
156723488|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156794545|NCT00557440|566001216|FG002|Treatment Period 1|Adverse Event|1|||
156794546|NCT02157610|566001217|FG000|Overall Study|Death|4|||
156794547|NCT02157610|566001218|FG001|Overall Study|Death|4|||
156794548|NCT00124657|566001224|FG000|Overall Study|Toxicity|0|||
156794549|NCT00124657|566001225|FG001|Overall Study|Toxicity|0|||
156794550|NCT00124657|566001226|FG002|Overall Study|Toxicity|1|||
156794551|NCT00124657|566001224|FG000|Overall Study|Non-compliance|1|||
156794552|NCT00124657|566001225|FG001|Overall Study|Non-compliance|0|||
156794553|NCT00124657|566001226|FG002|Overall Study|Non-compliance|4|||
156794554|NCT00124657|566001224|FG000|Overall Study|Progressive disease|14|||
156794555|NCT00124657|566001225|FG001|Overall Study|Progressive disease|5|||
156794556|NCT00124657|566001226|FG002|Overall Study|Progressive disease|27|||
156794557|NCT00124657|566001224|FG000|Overall Study|Intercurrent illness|1|||
156794558|NCT00124657|566001225|FG001|Overall Study|Intercurrent illness|0|||
156794559|NCT00124657|566001226|FG002|Overall Study|Intercurrent illness|0|||
156794560|NCT00619918|566001231|FG000|Overall Study|Withdrawal by Subject|4|||
156794561|NCT00619918|566001232|FG001|Overall Study|Withdrawal by Subject|3|||
156794562|NCT00619918|566001231|FG000|Overall Study|Physician Decision|2|||
156794563|NCT00619918|566001232|FG001|Overall Study|Physician Decision|4|||
156794564|NCT00619918|566001231|FG000|Overall Study|Transfer to outside facility|3|||
156794565|NCT00619918|566001232|FG001|Overall Study|Transfer to outside facility|3|||
156794566|NCT00619918|566001231|FG000|Overall Study|Left before receiving first dose|7|||
156794567|NCT00619918|566001232|FG001|Overall Study|Left before receiving first dose|6|||
156794568|NCT00619918|566001231|FG000|Overall Study|ICU admission|4|||
156794569|NCT00619918|566001232|FG001|Overall Study|ICU admission|6|||
156794570|NCT03533491|566001233|FG000|Overall Study|Lost to Follow-up|2|||
156794571|NCT00721110|566001238|FG000|Overall Study|Ultram use|1|||
156794572|NCT00721110|566001239|FG001|Overall Study|Ultram use|0|||
156794573|NCT00721110|566001240|FG002|Overall Study|Ultram use|0|||
156794574|NCT00721110|566001241|FG003|Overall Study|Ultram use|0|||
156794575|NCT00721110|566001238|FG000|Overall Study|vertical incision|0|||
156794576|NCT00721110|566001239|FG001|Overall Study|vertical incision|0|||
156794577|NCT00721110|566001240|FG002|Overall Study|vertical incision|1|||
156794578|NCT00721110|566001241|FG003|Overall Study|vertical incision|0|||
156794579|NCT04079920|566001247|FG000|Overall Study|Adverse event, not related to study drug|2|||
156794580|NCT04079920|566001247|FG000|Overall Study|Adverse event related to study drug|10|||
156794581|NCT04079920|566001247|FG000|Overall Study|Death|2|||
156794582|NCT04079920|566001247|FG000|Overall Study|Lost to Follow-up|22|||
156794583|NCT04079920|566001247|FG000|Overall Study|Physician Decision|1|||
156794584|NCT04079920|566001247|FG000|Overall Study|Withdrawal by Subject|11|||
157136456|NCT03952559|567245419|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
157136457|NCT03952559|567245420|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
157136458|NCT03952559|567245421|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
157136459|NCT03952559|567245422|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
156794585|NCT01618708|566001248|FG000|Overall Study|Adverse Event|10|||
156794586|NCT01618708|566001249|FG001|Overall Study|Adverse Event|10|||
156794587|NCT01618708|566001248|FG000|Overall Study|Lost to Follow-up|3|||
156794588|NCT01618708|566001249|FG001|Overall Study|Lost to Follow-up|3|||
156794589|NCT01618708|566001248|FG000|Overall Study|Withdrawal by Subject|17|||
156794590|NCT01618708|566001249|FG001|Overall Study|Withdrawal by Subject|22|||
156794591|NCT01618708|566001248|FG000|Overall Study|Lack of Efficacy|8|||
156794592|NCT01618708|566001249|FG001|Overall Study|Lack of Efficacy|8|||
157136460|NCT03952559|567245423|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
157136461|NCT02875223|567245424|FG000|Overall Study|Other reasons|0|||
157136462|NCT02875223|567245425|FG001|Overall Study|Other reasons|0|||
157136463|NCT02875223|567245426|FG002|Overall Study|Other reasons|1|||
156723489|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723490|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723491|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723492|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723493|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723494|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
156723495|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
156723496|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723497|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723498|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723499|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723500|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723501|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
156723502|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723503|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
156723504|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723505|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723506|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
156723507|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723508|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723509|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723510|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
156723511|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723512|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723513|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723514|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
156723515|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723516|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723517|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
156723518|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
156723519|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
156723520|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
156723521|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
156723522|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723523|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723524|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723525|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723526|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
157136464|NCT02875223|567245427|FG003|Overall Study|Other reasons|0|||
157136465|NCT02875223|567245428|FG004|Overall Study|Other reasons|1|||
156723527|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
156723528|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723529|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
156723530|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723531|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723532|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723533|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723534|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156794593|NCT01618708|566001248|FG000|Overall Study|Technical problems|2|||
156794594|NCT01618708|566001249|FG001|Overall Study|Technical problems|0|||
156794595|NCT01618708|566001248|FG000|Overall Study|Other than specified above|1|||
156794596|NCT01618708|566001249|FG001|Overall Study|Other than specified above|1|||
156794597|NCT01618708|566001248|FG000|Overall Study|Randomized but not treated|3|||
156794598|NCT01618708|566001249|FG001|Overall Study|Randomized but not treated|2|||
156794599|NCT04042311|566001256|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
156794600|NCT04042311|566001256|FG000|Overall Study|Unable to tolerate|4|||
156794601|NCT04042311|566001256|FG000|Overall Study|Concurrent illness|2|||
157136466|NCT02875223|567245429|FG005|Overall Study|Other reasons|2|||
157136467|NCT02875223|567245430|FG006|Overall Study|Other reasons|0|||
157136468|NCT02875223|567245431|FG007|Overall Study|Other reasons|2|||
157136469|NCT02875223|567245432|FG008|Overall Study|Other reasons|0|||
156723535|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
156723536|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723537|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723538|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723539|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723540|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
156723541|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723542|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723543|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
156723544|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723545|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723546|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723547|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156794602|NCT04042311|566001256|FG000|Overall Study|Adverse Event|2|||
156794603|NCT04042311|566001256|FG000|Overall Study|No longer meeting inclusion criteria|2|||
156794604|NCT04042311|566001256|FG000|Overall Study|No reason given|1|||
156794605|NCT04042311|566001256|FG000|Overall Study|Withdrawal by Subject|4|||
156794606|NCT03518060|566001257|FG000|Overall Study|Death|1|||
156794607|NCT03518060|566001257|FG000|Overall Study|Poor adherence|1|||
156794608|NCT03518060|566001257|FG000|Overall Study|Withdrawal of informed consent|2|||
156794609|NCT03518060|566001257|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
156794610|NCT03518060|566001257|FG000|Overall Study|Physician Decision|7|||
156794611|NCT03518060|566001257|FG000|Overall Study|Adverse drug reactions|23|||
156794612|NCT03518060|566001257|FG000|Overall Study|Withdrawal by Subject|25|||
156794613|NCT03518060|566001257|FG000|Overall Study|Lost to Follow-up|13|||
156794614|NCT04903093|566001259|FG000|Overall Study|Withdrawal by Subject|0|||
156794615|NCT04903093|566001260|FG001|Overall Study|Withdrawal by Subject|0|||
156794616|NCT04903093|566001261|FG002|Overall Study|Withdrawal by Subject|0|||
156794617|NCT04903093|566001262|FG003|Overall Study|Withdrawal by Subject|1|||
156794618|NCT04903093|566001263|FG004|Overall Study|Withdrawal by Subject|0|||
156794619|NCT04903093|566001264|FG005|Overall Study|Withdrawal by Subject|0|||
156794620|NCT03204812|566001270|FG000|Overall Study|Adverse Event|3|||
156794621|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
156794622|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794623|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794624|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794625|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
156794626|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
156794627|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794628|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794629|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794630|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
156794631|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
156794632|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794633|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794634|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794635|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
156794636|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
156794637|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794638|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794639|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794640|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
156794641|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
156794642|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794643|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794644|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794645|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
156794646|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
157136470|NCT02875223|567245433|FG009|Overall Study|Other reasons|0|||
156794647|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794648|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794649|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794650|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
156794651|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
157136471|NCT02875223|567245434|FG010|Overall Study|Other reasons|0|||
157136472|NCT02875223|567245435|FG011|Overall Study|Other reasons|0|||
157136473|NCT02875223|567245436|FG012|Overall Study|Other reasons|0|||
157136474|NCT02875223|567245424|FG000|Overall Study|Withdrawal by Subject|0|||
157136475|NCT02875223|567245425|FG001|Overall Study|Withdrawal by Subject|0|||
157136476|NCT02875223|567245426|FG002|Overall Study|Withdrawal by Subject|0|||
157136477|NCT02875223|567245427|FG003|Overall Study|Withdrawal by Subject|0|||
157136478|NCT02875223|567245428|FG004|Overall Study|Withdrawal by Subject|1|||
157136479|NCT02875223|567245429|FG005|Overall Study|Withdrawal by Subject|1|||
157136480|NCT02875223|567245430|FG006|Overall Study|Withdrawal by Subject|0|||
157136481|NCT02875223|567245431|FG007|Overall Study|Withdrawal by Subject|0|||
157136482|NCT02875223|567245432|FG008|Overall Study|Withdrawal by Subject|1|||
157136483|NCT02875223|567245433|FG009|Overall Study|Withdrawal by Subject|0|||
157136484|NCT02875223|567245434|FG010|Overall Study|Withdrawal by Subject|0|||
157136485|NCT02875223|567245435|FG011|Overall Study|Withdrawal by Subject|0|||
157136486|NCT02875223|567245436|FG012|Overall Study|Withdrawal by Subject|0|||
157136487|NCT02875223|567245424|FG000|Overall Study|Progressive disease|0|||
157136488|NCT02875223|567245425|FG001|Overall Study|Progressive disease|0|||
157136489|NCT02875223|567245426|FG002|Overall Study|Progressive disease|1|||
157136490|NCT02875223|567245427|FG003|Overall Study|Progressive disease|0|||
157136491|NCT02875223|567245428|FG004|Overall Study|Progressive disease|0|||
157136492|NCT02875223|567245429|FG005|Overall Study|Progressive disease|0|||
157136493|NCT02875223|567245430|FG006|Overall Study|Progressive disease|0|||
156723548|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723549|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
156723550|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723551|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
156723552|NCT03896503|565735179|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723553|NCT03896503|565735180|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723554|NCT03896503|565735181|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723555|NCT03896503|565735182|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723556|NCT03896503|565735183|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723557|NCT03896503|565735184|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
156723558|NCT03896503|565735185|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
156794652|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794653|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794654|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156875621|NCT01395524|566303596|FG001|Overall Study|Subject had spinal surgery|0|||
156875622|NCT01395524|566303597|FG002|Overall Study|Subject had spinal surgery|1|||
156875623|NCT01296672|566303605|FG000|Overall Study|Lost to Follow-up|73|||
156875624|NCT01296672|566303606|FG001|Overall Study|Lost to Follow-up|18|||
156875625|NCT04248491|566303610|FG000|Overall Study|Lost to Follow-up|1|||
156875626|NCT04248491|566303611|FG001|Overall Study|Lost to Follow-up|0|||
156875627|NCT04605991|566303612|FG000|Overall Study|Adverse Event|5|||
156875628|NCT04605991|566303612|FG000|Overall Study|Lack of Efficacy|1|||
156875629|NCT04605991|566303612|FG000|Overall Study|Lost to Follow-up|8|||
156875630|NCT04605991|566303612|FG000|Overall Study|Physician Decision|4|||
156875631|NCT04605991|566303612|FG000|Overall Study|Withdrawal by Subject|14|||
156875632|NCT04605991|566303612|FG000|Overall Study|Non-compliance with study|1|||
156875633|NCT02123472|566303619|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
156875634|NCT02123472|566303620|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
156875635|NCT03801031|566303621|FG000|Overall Study|Lost to Follow-up|1|||
156875636|NCT03801031|566303622|FG001|Overall Study|Lost to Follow-up|0|||
157136494|NCT02875223|567245431|FG007|Overall Study|Progressive disease|0|||
157136495|NCT02875223|567245432|FG008|Overall Study|Progressive disease|0|||
157136496|NCT02875223|567245433|FG009|Overall Study|Progressive disease|12|||
157136497|NCT02875223|567245434|FG010|Overall Study|Progressive disease|2|||
157136498|NCT02875223|567245435|FG011|Overall Study|Progressive disease|3|||
157136499|NCT02875223|567245436|FG012|Overall Study|Progressive disease|6|||
157136500|NCT02875223|567245424|FG000|Overall Study|Death|4|||
157136501|NCT02875223|567245425|FG001|Overall Study|Death|4|||
156794655|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
156794656|NCT01111552|566001271|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
156794657|NCT01111552|566001272|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156794658|NCT01111552|566001273|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156794659|NCT01111552|566001274|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
156875637|NCT03801031|566303621|FG000|Overall Study|Unable to comply|1|||
156875638|NCT03801031|566303622|FG001|Overall Study|Unable to comply|0|||
156875639|NCT03801031|566303621|FG000|Overall Study|Withdrawal by Subject|0|||
156875640|NCT03801031|566303622|FG001|Overall Study|Withdrawal by Subject|1|||
157136502|NCT02875223|567245426|FG002|Overall Study|Death|3|||
157136503|NCT02875223|567245427|FG003|Overall Study|Death|4|||
157136504|NCT02875223|567245428|FG004|Overall Study|Death|2|||
157136505|NCT02875223|567245429|FG005|Overall Study|Death|3|||
157019279|NCT04927065|566824707|FG006|Third Booster|Lost to Follow-up|0|||
157019280|NCT04927065|566824708|FG007|Third Booster|Lost to Follow-up|0|||
157019281|NCT04927065|566824709|FG008|Third Booster|Lost to Follow-up|0|||
157019282|NCT04927065|566824710|FG009|Third Booster|Lost to Follow-up|0|||
157019283|NCT04927065|566824711|FG010|Third Booster|Lost to Follow-up|0|||
157019284|NCT04927065|566824712|FG011|Third Booster|Lost to Follow-up|0|||
157019285|NCT04927065|566824713|FG012|Third Booster|Lost to Follow-up|0|||
157019286|NCT04927065|566824714|FG013|Third Booster|Lost to Follow-up|0|||
157019287|NCT04927065|566824715|FG014|Third Booster|Lost to Follow-up|0|||
157019288|NCT04927065|566824716|FG015|Third Booster|Lost to Follow-up|1|||
157019289|NCT04927065|566824701|FG000|Third Booster|Withdrawal by Subject|0|||
157019290|NCT04927065|566824702|FG001|Third Booster|Withdrawal by Subject|0|||
157019291|NCT04927065|566824703|FG002|Third Booster|Withdrawal by Subject|0|||
157019292|NCT04927065|566824704|FG003|Third Booster|Withdrawal by Subject|0|||
157019293|NCT04927065|566824705|FG004|Third Booster|Withdrawal by Subject|0|||
157019294|NCT04927065|566824706|FG005|Third Booster|Withdrawal by Subject|0|||
157019295|NCT04927065|566824707|FG006|Third Booster|Withdrawal by Subject|0|||
157019296|NCT04927065|566824708|FG007|Third Booster|Withdrawal by Subject|0|||
157019297|NCT04927065|566824709|FG008|Third Booster|Withdrawal by Subject|0|||
157019298|NCT04927065|566824710|FG009|Third Booster|Withdrawal by Subject|0|||
157019299|NCT04927065|566824711|FG010|Third Booster|Withdrawal by Subject|0|||
157019300|NCT04927065|566824712|FG011|Third Booster|Withdrawal by Subject|0|||
157019301|NCT04927065|566824713|FG012|Third Booster|Withdrawal by Subject|0|||
157019302|NCT04927065|566824714|FG013|Third Booster|Withdrawal by Subject|0|||
157019303|NCT04927065|566824715|FG014|Third Booster|Withdrawal by Subject|0|||
157019304|NCT04927065|566824716|FG015|Third Booster|Withdrawal by Subject|1|||
157019305|NCT03338790|566824722|FG000|Overall Study|Disease Progression|65|||
157019306|NCT03338790|566824723|FG001|Overall Study|Disease Progression|43|||
157019307|NCT03338790|566824724|FG002|Overall Study|Disease Progression|50|||
157019308|NCT03338790|566824725|FG003|Overall Study|Disease Progression|37|||
157019309|NCT03338790|566824722|FG000|Overall Study|Study Drug Toxicity|9|||
157019310|NCT03338790|566824723|FG001|Overall Study|Study Drug Toxicity|8|||
157019311|NCT03338790|566824724|FG002|Overall Study|Study Drug Toxicity|15|||
157019312|NCT03338790|566824725|FG003|Overall Study|Study Drug Toxicity|0|||
157019313|NCT03338790|566824722|FG000|Overall Study|Death|1|||
157019314|NCT03338790|566824723|FG001|Overall Study|Death|1|||
157019315|NCT03338790|566824724|FG002|Overall Study|Death|1|||
157019316|NCT03338790|566824725|FG003|Overall Study|Death|0|||
157019317|NCT03338790|566824722|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
157019318|NCT03338790|566824723|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
157019319|NCT03338790|566824724|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
157019320|NCT03338790|566824725|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
157019321|NCT03338790|566824722|FG000|Overall Study|Participant request to discontinue study treatment|3|||
157019322|NCT03338790|566824723|FG001|Overall Study|Participant request to discontinue study treatment|3|||
157019323|NCT03338790|566824724|FG002|Overall Study|Participant request to discontinue study treatment|2|||
157019324|NCT03338790|566824725|FG003|Overall Study|Participant request to discontinue study treatment|1|||
157019325|NCT03338790|566824722|FG000|Overall Study|Poor/non-compliance|0|||
157019326|NCT03338790|566824723|FG001|Overall Study|Poor/non-compliance|1|||
157019327|NCT03338790|566824724|FG002|Overall Study|Poor/non-compliance|0|||
157019328|NCT03338790|566824725|FG003|Overall Study|Poor/non-compliance|0|||
157019329|NCT03338790|566824722|FG000|Overall Study|Participant withdrew consent|1|||
156794660|NCT01111552|566001275|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
157019330|NCT03338790|566824723|FG001|Overall Study|Participant withdrew consent|0|||
157019331|NCT03338790|566824724|FG002|Overall Study|Participant withdrew consent|1|||
157019332|NCT03338790|566824725|FG003|Overall Study|Participant withdrew consent|1|||
157136506|NCT02875223|567245430|FG006|Overall Study|Death|5|||
157136507|NCT02875223|567245431|FG007|Overall Study|Death|7|||
156794661|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794662|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794663|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794664|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
156794665|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
156794666|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
156794667|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156794668|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
156794669|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
157019333|NCT03338790|566824722|FG000|Overall Study|Other reasons|0|||
157019334|NCT03338790|566824723|FG001|Overall Study|Other reasons|5|||
157019335|NCT03338790|566824724|FG002|Overall Study|Other reasons|0|||
157019336|NCT03338790|566824725|FG003|Overall Study|Other reasons|2|||
157019337|NCT03338790|566824722|FG000|Overall Study|Not reported|0|||
157019338|NCT03338790|566824723|FG001|Overall Study|Not reported|0|||
157019339|NCT03338790|566824724|FG002|Overall Study|Not reported|1|||
157019340|NCT03338790|566824725|FG003|Overall Study|Not reported|0|||
157136508|NCT02875223|567245432|FG008|Overall Study|Death|3|||
156723559|NCT03896503|565735186|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
156723560|NCT05400655|565735187|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
156723561|NCT05400655|565735188|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
156723562|NCT05400655|565735189|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
156723563|NCT05400655|565735190|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
156723564|NCT05400655|565735191|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
156723565|NCT05400655|565735192|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
156723566|NCT05400655|565735193|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
156723567|NCT05400655|565735194|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
156723568|NCT05400655|565735195|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
156723569|NCT05400655|565735196|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
156723570|NCT05400655|565735197|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
156723571|NCT05400655|565735198|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
156723572|NCT05400655|565735199|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
156723573|NCT05400655|565735200|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
156723574|NCT05400655|565735201|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
156723575|NCT05400655|565735202|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
156723576|NCT05400655|565735203|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
156723577|NCT05400655|565735204|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
156723578|NCT05400655|565735205|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
156723579|NCT05400655|565735206|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
156723580|NCT05400655|565735207|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
156723581|NCT05400655|565735208|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
156723582|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723583|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156794670|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
156794671|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794672|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
156794673|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794674|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794675|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
156794676|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794677|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
156794678|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794679|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156875641|NCT01598506|566303624|FG000|Overall Study|Withdrawal by Subject|2|||
156875642|NCT02100696|566303625|FG000|Induction Phase|Adverse Event|0|||
156875643|NCT02100696|566303626|FG001|Induction Phase|Adverse Event|0|||
156875644|NCT02100696|566303627|FG002|Induction Phase|Adverse Event|1|||
156875645|NCT02100696|566303628|FG003|Induction Phase|Adverse Event|0|||
156875646|NCT02100696|566303629|FG004|Induction Phase|Adverse Event|0|||
156875647|NCT02100696|566303630|FG005|Induction Phase|Adverse Event|0|||
156875648|NCT02100696|566303625|FG000|Induction Phase|Lost to Follow-up|1|||
156875649|NCT02100696|566303626|FG001|Induction Phase|Lost to Follow-up|0|||
156875650|NCT02100696|566303627|FG002|Induction Phase|Lost to Follow-up|1|||
156875651|NCT02100696|566303628|FG003|Induction Phase|Lost to Follow-up|0|||
156875652|NCT02100696|566303629|FG004|Induction Phase|Lost to Follow-up|0|||
156875653|NCT02100696|566303630|FG005|Induction Phase|Lost to Follow-up|0|||
156875654|NCT02100696|566303625|FG000|Induction Phase|Protocol Violation|0|||
156875655|NCT02100696|566303626|FG001|Induction Phase|Protocol Violation|1|||
156875656|NCT02100696|566303627|FG002|Induction Phase|Protocol Violation|1|||
156875657|NCT02100696|566303628|FG003|Induction Phase|Protocol Violation|0|||
156875658|NCT02100696|566303629|FG004|Induction Phase|Protocol Violation|0|||
156875659|NCT02100696|566303630|FG005|Induction Phase|Protocol Violation|0|||
156875660|NCT02100696|566303625|FG000|Induction Phase|Withdrawal by Subject|8|||
156875661|NCT02100696|566303626|FG001|Induction Phase|Withdrawal by Subject|2|||
156875662|NCT02100696|566303627|FG002|Induction Phase|Withdrawal by Subject|13|||
156875663|NCT02100696|566303628|FG003|Induction Phase|Withdrawal by Subject|0|||
156875664|NCT02100696|566303629|FG004|Induction Phase|Withdrawal by Subject|0|||
156875665|NCT02100696|566303630|FG005|Induction Phase|Withdrawal by Subject|0|||
157136509|NCT02875223|567245433|FG009|Overall Study|Death|2|||
156723584|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723585|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723586|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723587|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156875666|NCT02100696|566303625|FG000|Induction Phase|Physician Decision|1|||
156875667|NCT02100696|566303626|FG001|Induction Phase|Physician Decision|0|||
156875668|NCT02100696|566303627|FG002|Induction Phase|Physician Decision|2|||
156875669|NCT02100696|566303628|FG003|Induction Phase|Physician Decision|0|||
156875670|NCT02100696|566303629|FG004|Induction Phase|Physician Decision|0|||
156875671|NCT02100696|566303630|FG005|Induction Phase|Physician Decision|0|||
156875672|NCT02100696|566303625|FG000|Induction Phase|Multiple Reasons|5|||
156875673|NCT02100696|566303626|FG001|Induction Phase|Multiple Reasons|2|||
157136510|NCT02875223|567245434|FG010|Overall Study|Death|0|||
157136511|NCT02875223|567245435|FG011|Overall Study|Death|0|||
157136512|NCT02875223|567245436|FG012|Overall Study|Death|0|||
157136513|NCT02875223|567245424|FG000|Overall Study|Lost to Follow-up|0|||
156723588|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723589|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723590|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723591|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723592|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
157136514|NCT02875223|567245425|FG001|Overall Study|Lost to Follow-up|1|||
157136515|NCT02875223|567245426|FG002|Overall Study|Lost to Follow-up|1|||
157136516|NCT02875223|567245427|FG003|Overall Study|Lost to Follow-up|0|||
157136517|NCT02875223|567245428|FG004|Overall Study|Lost to Follow-up|1|||
157136518|NCT02875223|567245429|FG005|Overall Study|Lost to Follow-up|0|||
157136519|NCT02875223|567245430|FG006|Overall Study|Lost to Follow-up|1|||
157136520|NCT02875223|567245431|FG007|Overall Study|Lost to Follow-up|1|||
157136521|NCT02875223|567245432|FG008|Overall Study|Lost to Follow-up|0|||
157136522|NCT02875223|567245433|FG009|Overall Study|Lost to Follow-up|0|||
157136523|NCT02875223|567245434|FG010|Overall Study|Lost to Follow-up|0|||
157136524|NCT02875223|567245435|FG011|Overall Study|Lost to Follow-up|0|||
157136525|NCT02875223|567245436|FG012|Overall Study|Lost to Follow-up|0|||
157136526|NCT02848833|567245442|FG000|Overall Study|subject who are duplicated|1|||
157136527|NCT02848833|567245442|FG000|Overall Study|have not taken the study drug|11|||
156723593|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723594|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723595|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723596|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723597|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723598|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723599|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723600|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
156723601|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
156723602|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723603|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
156723604|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723605|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723606|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723607|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723608|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723609|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723610|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723611|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723612|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723613|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723614|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723615|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723616|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723617|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
156723618|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723619|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723620|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
156723621|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723622|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
156723623|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723624|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723625|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
156723626|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723627|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
157217335|NCT00738920|567541079|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
157217336|NCT00738920|567541080|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
156723628|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723629|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723630|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723631|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156794680|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
156794681|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
157136528|NCT02848833|567245442|FG000|Overall Study|follow-up failure|6|||
157136529|NCT02848833|567245442|FG000|Overall Study|Protocol Violation|119|||
156723632|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723633|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723634|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156794682|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
157136530|NCT02847598|567245443|FG000|Overall Study|Adverse Event|0|||
157136531|NCT02847598|567245444|FG001|Overall Study|Adverse Event|0|||
157136532|NCT02847598|567245445|FG002|Overall Study|Adverse Event|0|||
157136533|NCT02847598|567245446|FG003|Overall Study|Adverse Event|0|||
157136534|NCT02847598|567245447|FG004|Overall Study|Adverse Event|0|||
157136535|NCT02847598|567245448|FG005|Overall Study|Adverse Event|0|||
157136536|NCT02847598|567245449|FG006|Overall Study|Adverse Event|0|||
157136537|NCT02847598|567245450|FG007|Overall Study|Adverse Event|1|||
157136538|NCT02847598|567245443|FG000|Overall Study|Consent withdrawn|2|||
157136539|NCT02847598|567245444|FG001|Overall Study|Consent withdrawn|0|||
157136540|NCT02847598|567245445|FG002|Overall Study|Consent withdrawn|0|||
157136541|NCT02847598|567245446|FG003|Overall Study|Consent withdrawn|4|||
157136542|NCT02847598|567245447|FG004|Overall Study|Consent withdrawn|3|||
157136543|NCT02847598|567245448|FG005|Overall Study|Consent withdrawn|2|||
157136544|NCT02847598|567245449|FG006|Overall Study|Consent withdrawn|1|||
157136545|NCT02847598|567245450|FG007|Overall Study|Consent withdrawn|3|||
157136546|NCT02847598|567245443|FG000|Overall Study|Death|3|||
157136547|NCT02847598|567245444|FG001|Overall Study|Death|0|||
157136548|NCT02847598|567245445|FG002|Overall Study|Death|0|||
157136549|NCT02847598|567245446|FG003|Overall Study|Death|0|||
157136550|NCT02847598|567245447|FG004|Overall Study|Death|0|||
157136551|NCT02847598|567245448|FG005|Overall Study|Death|0|||
157136552|NCT02847598|567245449|FG006|Overall Study|Death|0|||
157136553|NCT02847598|567245450|FG007|Overall Study|Death|0|||
157136554|NCT02847598|567245443|FG000|Overall Study|Lost to Follow-up|0|||
156723635|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723636|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723637|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
157136555|NCT02847598|567245444|FG001|Overall Study|Lost to Follow-up|0|||
157136556|NCT02847598|567245445|FG002|Overall Study|Lost to Follow-up|0|||
157136557|NCT02847598|567245446|FG003|Overall Study|Lost to Follow-up|0|||
157136558|NCT02847598|567245447|FG004|Overall Study|Lost to Follow-up|0|||
157136559|NCT02847598|567245448|FG005|Overall Study|Lost to Follow-up|1|||
157136560|NCT02847598|567245449|FG006|Overall Study|Lost to Follow-up|1|||
157136561|NCT02847598|567245450|FG007|Overall Study|Lost to Follow-up|0|||
157136562|NCT04375761|567246929|FG000|Overall Study|Death|1|||
157136563|NCT04375761|567246930|FG001|Overall Study|Death|2|||
157136564|NCT04375761|567246929|FG000|Overall Study|Lost to Follow-up|203|||
157136565|NCT04375761|567246930|FG001|Overall Study|Lost to Follow-up|380|||
157136566|NCT04375761|567246929|FG000|Overall Study|Withdrawal by Subject|47|||
157136567|NCT04375761|567246930|FG001|Overall Study|Withdrawal by Subject|98|||
157136568|NCT04375761|567246929|FG000|Overall Study|Noncompliance with study procedure|121|||
157136569|NCT04375761|567246930|FG001|Overall Study|Noncompliance with study procedure|251|||
156723638|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723639|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723640|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723641|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723642|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723643|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723644|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
156723645|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
156723646|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
156723647|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
156723648|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
157136570|NCT04375761|567246929|FG000|Overall Study|Reimbursement not enough|1|||
157136571|NCT04375761|567246930|FG001|Overall Study|Reimbursement not enough|2|||
157136572|NCT04375761|567246929|FG000|Overall Study|Unforeseen family circumstances|1|||
157136573|NCT04375761|567246930|FG001|Overall Study|Unforeseen family circumstances|3|||
157136574|NCT04375761|567246929|FG000|Overall Study|Test too painful|1|||
157136575|NCT04375761|567246930|FG001|Overall Study|Test too painful|1|||
157136576|NCT04375761|567246929|FG000|Overall Study|Moved|0|||
156723649|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723650|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723651|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723652|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723653|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723654|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723655|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156794683|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
157136577|NCT04375761|567246930|FG001|Overall Study|Moved|2|||
157136578|NCT04375761|567246929|FG000|Overall Study|Nonresponsive|0|||
157136579|NCT04375761|567246930|FG001|Overall Study|Nonresponsive|5|||
157136580|NCT03797001|567246931|FG000|Overall Study|Withdrawn due to COVID19|4|||
157136581|NCT03797001|567246932|FG001|Overall Study|Withdrawn due to COVID19|0|||
157136582|NCT03797001|567246931|FG000|Overall Study|Withdrawal by Subject|7|||
157136583|NCT03797001|567246932|FG001|Overall Study|Withdrawal by Subject|6|||
157136584|NCT03797001|567246931|FG000|Overall Study|Adverse Event|0|||
157136585|NCT03797001|567246932|FG001|Overall Study|Adverse Event|1|||
156723656|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
157136586|NCT00500266|567246944|FG000|Overall Study|Death|3|||
157136587|NCT00500266|567246944|FG000|Overall Study|Lost to Follow-up|3|||
157136588|NCT00500266|567246944|FG000|Overall Study|Withdrawal by Subject|3|||
157136589|NCT00500266|567246944|FG000|Overall Study|Assigned, not treated|4|||
157136590|NCT00278629|567246945|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
157136591|NCT05224258|567246946|FG000|Overall Study|Withdrawal by Subject|1|||
157136592|NCT05224258|567246947|FG001|Overall Study|Withdrawal by Subject|1|||
157136593|NCT05224258|567246946|FG000|Overall Study|Physician Decision|1|||
157136594|NCT05224258|567246947|FG001|Overall Study|Physician Decision|1|||
157136595|NCT05224258|567246946|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157136596|NCT05224258|567246947|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156723657|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723658|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723659|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723660|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723661|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723662|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723663|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723664|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723665|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
156723666|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
156723667|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723668|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723669|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
156723670|NCT05400655|565735187|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723671|NCT05400655|565735188|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723672|NCT05400655|565735189|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723673|NCT05400655|565735190|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723674|NCT05400655|565735191|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723675|NCT05400655|565735192|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723676|NCT05400655|565735193|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723677|NCT05400655|565735194|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723678|NCT05400655|565735195|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723679|NCT05400655|565735196|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723680|NCT05400655|565735197|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723681|NCT05400655|565735198|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156794684|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156794685|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
156794686|NCT01111552|566001271|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794687|NCT01111552|566001272|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794688|NCT01111552|566001273|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
156794689|NCT01111552|566001274|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794690|NCT01111552|566001275|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156794691|NCT02097225|566001276|FG000|Dose Level 4|Adverse Event|0|||
156794692|NCT02097225|566001277|FG001|Dose Level 4|Adverse Event|0|||
156794693|NCT02097225|566001278|FG002|Dose Level 4|Adverse Event|0|||
156794694|NCT02097225|566001279|FG003|Dose Level 4|Adverse Event|0|||
156794695|NCT02097225|566001280|FG004|Dose Level 4|Adverse Event|1|||
156794696|NCT01027351|566001282|FG000|Overall Study|Withdrawal by Subject|1|||
156794697|NCT01027351|566001283|FG001|Overall Study|Withdrawal by Subject|0|||
156794698|NCT01027351|566001284|FG002|Overall Study|Withdrawal by Subject|1|||
156794699|NCT01027351|566001285|FG003|Overall Study|Withdrawal by Subject|0|||
156794700|NCT01027351|566001286|FG004|Overall Study|Withdrawal by Subject|3|||
156794701|NCT01027351|566001287|FG005|Overall Study|Withdrawal by Subject|5|||
156794702|NCT01027351|566001282|FG000|Overall Study|Lost to Follow-up|1|||
156794703|NCT01027351|566001283|FG001|Overall Study|Lost to Follow-up|1|||
156794704|NCT01027351|566001284|FG002|Overall Study|Lost to Follow-up|0|||
156794705|NCT01027351|566001285|FG003|Overall Study|Lost to Follow-up|1|||
156794706|NCT01027351|566001286|FG004|Overall Study|Lost to Follow-up|6|||
157136597|NCT05224258|567246946|FG000|Overall Study|Study Product No Longer in Use|1|||
157136598|NCT05224258|567246947|FG001|Overall Study|Study Product No Longer in Use|0|||
157136599|NCT05224258|567246946|FG000|Overall Study|Adverse Event|0|||
156794707|NCT01027351|566001287|FG005|Overall Study|Lost to Follow-up|0|||
156794708|NCT01027351|566001282|FG000|Overall Study|Inappropriate enrollment|0|||
156794709|NCT01027351|566001283|FG001|Overall Study|Inappropriate enrollment|0|||
156794710|NCT01027351|566001284|FG002|Overall Study|Inappropriate enrollment|0|||
157136600|NCT05224258|567246947|FG001|Overall Study|Adverse Event|1|||
157136601|NCT05224258|567246946|FG000|Overall Study|Protocol Deviation|0|||
156723682|NCT05400655|565735199|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723683|NCT05400655|565735200|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156794711|NCT01027351|566001285|FG003|Overall Study|Inappropriate enrollment|0|||
156723684|NCT05400655|565735201|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723685|NCT05400655|565735202|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723686|NCT05400655|565735203|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723687|NCT05400655|565735204|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
156723688|NCT05400655|565735205|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723689|NCT05400655|565735206|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
156723690|NCT05400655|565735207|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
156723691|NCT05400655|565735208|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
156723692|NCT03055338|565735219|FG000|Overall Study|Lost to Follow-up|9|||
156723693|NCT03055338|565735220|FG001|Overall Study|Lost to Follow-up|2|||
156723694|NCT03055338|565735221|FG002|Overall Study|Lost to Follow-up|3|||
156723695|NCT03055338|565735219|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
156723696|NCT03055338|565735220|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
156723697|NCT03055338|565735221|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
156723698|NCT03055338|565735219|FG000|Overall Study|Physician Decision|0|||
156723699|NCT03055338|565735220|FG001|Overall Study|Physician Decision|0|||
156723700|NCT03055338|565735221|FG002|Overall Study|Physician Decision|2|||
156723701|NCT03055338|565735219|FG000|Overall Study|Withdrawal by Subject|9|||
156723702|NCT03055338|565735220|FG001|Overall Study|Withdrawal by Subject|8|||
156723703|NCT03055338|565735221|FG002|Overall Study|Withdrawal by Subject|7|||
156723704|NCT03058705|565735222|FG000|Overall Study|Withdrawal by Subject|2|||
156723705|NCT03058705|565735222|FG000|Overall Study|Physician Decision|2|||
156723706|NCT05161481|565735223|FG000|Overall Study|Withdrawal of consent|0|||
156723707|NCT05161481|565735224|FG001|Overall Study|Withdrawal of consent|1|||
156723708|NCT05161481|565735225|FG002|Overall Study|Withdrawal of consent|1|||
156723709|NCT05161481|565735223|FG000|Overall Study|Study terminated by sponsor|3|||
156723710|NCT05161481|565735224|FG001|Overall Study|Study terminated by sponsor|3|||
156723711|NCT05161481|565735225|FG002|Overall Study|Study terminated by sponsor|2|||
156723712|NCT05161481|565735223|FG000|Overall Study|Adverse Event|3|||
156723713|NCT05161481|565735224|FG001|Overall Study|Adverse Event|0|||
156723714|NCT05161481|565735225|FG002|Overall Study|Adverse Event|6|||
156723715|NCT05161481|565735223|FG000|Overall Study|Randomised in error and was not treated|1|||
156723716|NCT05161481|565735224|FG001|Overall Study|Randomised in error and was not treated|0|||
156723717|NCT05161481|565735225|FG002|Overall Study|Randomised in error and was not treated|0|||
156723718|NCT05161481|565735223|FG000|Overall Study|Subject decision|0|||
157019341|NCT03338790|566824722|FG000|Overall Study|Completed treatment period|1|||
157019342|NCT03338790|566824723|FG001|Overall Study|Completed treatment period|2|||
157136602|NCT05224258|567246947|FG001|Overall Study|Protocol Deviation|1|||
157136603|NCT04439266|567246949|FG000|Overall Study|Ineligible|1|||
156723719|NCT05161481|565735224|FG001|Overall Study|Subject decision|0|||
156723720|NCT05161481|565735225|FG002|Overall Study|Subject decision|1|||
156723721|NCT01102257|565735233|FG000|Overall Study|Adverse Event|1|||
156723722|NCT01102257|565735234|FG001|Overall Study|Adverse Event|0|||
156723723|NCT01102257|565735233|FG000|Overall Study|Adverse Event|1|||
156723724|NCT01102257|565735234|FG001|Overall Study|Adverse Event|0|||
156723725|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
156723726|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
156723727|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
156794712|NCT01027351|566001286|FG004|Overall Study|Inappropriate enrollment|1|||
156794713|NCT01027351|566001287|FG005|Overall Study|Inappropriate enrollment|0|||
157136604|NCT04439266|567246949|FG000|Overall Study|Adverse Event|1|||
157136605|NCT04439266|567246949|FG000|Overall Study|Death|1|||
156723728|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
156723729|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
156723730|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
156723731|NCT03752970|565735235|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
156723732|NCT03752970|565735236|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
156723733|NCT03752970|565735237|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
156723734|NCT03752970|565735235|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
156723735|NCT03752970|565735236|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
156723736|NCT03752970|565735237|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
156723737|NCT03752970|565735235|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
156723738|NCT03752970|565735236|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
156723739|NCT03752970|565735237|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
156723740|NCT04767282|565735238|FG000|Overall Study|Refused or did not begin surveys|6|||
157136606|NCT04439266|567246949|FG000|Overall Study|Disease progression|1|||
157136607|NCT04439266|567246949|FG000|Overall Study|Still on treatment|1|||
156723741|NCT04767282|565735239|FG001|Overall Study|Refused or did not begin surveys|2|||
156723742|NCT04767282|565735240|FG002|Overall Study|Refused or did not begin surveys|2|||
156723743|NCT04767282|565735238|FG000|Overall Study|Duplicate household previously enrolled|2|||
156723744|NCT04767282|565735239|FG001|Overall Study|Duplicate household previously enrolled|0|||
156723745|NCT04767282|565735240|FG002|Overall Study|Duplicate household previously enrolled|8|||
156723746|NCT04767282|565735238|FG000|Overall Study|Unable to confirm legal guardian|0|||
156723747|NCT04767282|565735239|FG001|Overall Study|Unable to confirm legal guardian|2|||
156723748|NCT04767282|565735240|FG002|Overall Study|Unable to confirm legal guardian|8|||
156723749|NCT04767282|565735238|FG000|Overall Study|Withdrawal by Subject|0|||
156723750|NCT04767282|565735239|FG001|Overall Study|Withdrawal by Subject|0|||
156723751|NCT04767282|565735240|FG002|Overall Study|Withdrawal by Subject|6|||
157136608|NCT06161012|567246951|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
157136609|NCT06161012|567246952|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
157136610|NCT00408005|567246953|FG000|Induction|Adverse Event|19|||
157136611|NCT00408005|567246954|FG001|Induction|Adverse Event|3|||
157136612|NCT00408005|567246955|FG002|Induction|Adverse Event|0|||
157136613|NCT00408005|567246956|FG003|Induction|Adverse Event|0|||
157136614|NCT00408005|567246957|FG004|Induction|Adverse Event|0|||
157136615|NCT00408005|567246958|FG005|Induction|Adverse Event|0|||
157136616|NCT00408005|567246959|FG006|Induction|Adverse Event|0|||
157136617|NCT00408005|567246960|FG007|Induction|Adverse Event|0|||
157136618|NCT00408005|567246953|FG000|Induction|Death|6|||
157136619|NCT00408005|567246954|FG001|Induction|Death|0|||
157136620|NCT00408005|567246955|FG002|Induction|Death|0|||
157136621|NCT00408005|567246956|FG003|Induction|Death|0|||
157136622|NCT00408005|567246957|FG004|Induction|Death|0|||
157136623|NCT00408005|567246958|FG005|Induction|Death|0|||
157136624|NCT00408005|567246959|FG006|Induction|Death|0|||
157136625|NCT00408005|567246960|FG007|Induction|Death|0|||
157136626|NCT00408005|567246953|FG000|Induction|Physician Decision|83|||
157136627|NCT00408005|567246954|FG001|Induction|Physician Decision|9|||
157136628|NCT00408005|567246955|FG002|Induction|Physician Decision|0|||
157136629|NCT00408005|567246956|FG003|Induction|Physician Decision|0|||
157136630|NCT00408005|567246957|FG004|Induction|Physician Decision|0|||
156723752|NCT04767282|565735238|FG000|Overall Study|Survey comprehension challenges|4|||
156794714|NCT01027351|566001282|FG000|Overall Study|Protocol Violation|1|||
156794715|NCT01027351|566001283|FG001|Overall Study|Protocol Violation|0|||
156794716|NCT01027351|566001284|FG002|Overall Study|Protocol Violation|0|||
156794717|NCT01027351|566001285|FG003|Overall Study|Protocol Violation|1|||
156794718|NCT01027351|566001286|FG004|Overall Study|Protocol Violation|1|||
156794719|NCT01027351|566001287|FG005|Overall Study|Protocol Violation|0|||
156794720|NCT04650893|566001288|FG000|Overall Study|Lost to Follow-up|11|||
156794721|NCT04650893|566001289|FG001|Overall Study|Lost to Follow-up|10|||
156794722|NCT04650893|566001290|FG002|Overall Study|Lost to Follow-up|11|||
156794723|NCT04091438|566001291|FG000|Treatment Period 1 (1 Day)|Other|1|||
156794724|NCT04091438|566001292|FG001|Treatment Period 1 (1 Day)|Other|0|||
156794725|NCT04091438|566001291|FG000|Washout Period (1 Day)|Protocol deviation|0|||
156794726|NCT04091438|566001292|FG001|Washout Period (1 Day)|Protocol deviation|1|||
156794727|NCT04091438|566001291|FG000|Washout Period (1 Day)|Other|0|||
156794728|NCT04091438|566001292|FG001|Washout Period (1 Day)|Other|1|||
156794729|NCT04309500|566001293|FG000|Overall Study|Lost to Follow-up|1|||
156794730|NCT04309500|566001294|FG001|Overall Study|Lost to Follow-up|0|||
156794731|NCT04309500|566001295|FG002|Overall Study|Lost to Follow-up|0|||
156794732|NCT04309500|566001296|FG003|Overall Study|Lost to Follow-up|0|||
156794733|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
156794734|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
156794735|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
156794736|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
156794737|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
156794738|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
156794739|NCT00913835|566001297|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
156794740|NCT00913835|566001298|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
156794741|NCT00913835|566001297|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
156794742|NCT00913835|566001298|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
156794743|NCT00461812|566001299|FG000|Overall Study|study terminated|10|||
156794744|NCT01308788|566001300|FG000|2-year Treatment|medication change by treating physician|4|||
156794745|NCT01308788|566001301|FG001|2-year Treatment|medication change by treating physician|11|||
156794746|NCT00322218|566001302|FG000|Overall Study|Death|3|||
156794747|NCT00322218|566001303|FG001|Overall Study|Death|6|||
156794748|NCT00908141|566001321|FG000|Overall Study|Withdrawal by Subject|0|||
157136631|NCT00408005|567246958|FG005|Induction|Physician Decision|0|||
156794749|NCT00908141|566001322|FG001|Overall Study|Withdrawal by Subject|1|||
156794750|NCT00003645|566002760|FG000|Overall Study|Death|4|||
156794751|NCT00003645|566002761|FG001|Overall Study|Death|1|||
156794752|NCT00003645|566002760|FG000|Overall Study|Lost to Follow-up|7|||
157136632|NCT00408005|567246959|FG006|Induction|Physician Decision|0|||
157136633|NCT00408005|567246960|FG007|Induction|Physician Decision|0|||
157136634|NCT00408005|567246953|FG000|Induction|Withdrawal by Subject|2|||
157136635|NCT00408005|567246954|FG001|Induction|Withdrawal by Subject|4|||
157136636|NCT00408005|567246955|FG002|Induction|Withdrawal by Subject|0|||
157136637|NCT00408005|567246956|FG003|Induction|Withdrawal by Subject|0|||
157136638|NCT00408005|567246957|FG004|Induction|Withdrawal by Subject|0|||
157136639|NCT00408005|567246958|FG005|Induction|Withdrawal by Subject|0|||
156875674|NCT02100696|566303627|FG002|Induction Phase|Multiple Reasons|8|||
156875675|NCT02100696|566303628|FG003|Induction Phase|Multiple Reasons|0|||
157019343|NCT03338790|566824724|FG002|Overall Study|Completed treatment period|0|||
157019344|NCT03338790|566824725|FG003|Overall Study|Completed treatment period|0|||
157019345|NCT03846505|566824726|FG000|Treatment Phase|Withdrawal by Subject|9|||
157136640|NCT00408005|567246959|FG006|Induction|Withdrawal by Subject|0|||
157136641|NCT00408005|567246960|FG007|Induction|Withdrawal by Subject|0|||
157136642|NCT00408005|567246953|FG000|Induction|Ineligible|33|||
157136643|NCT00408005|567246954|FG001|Induction|Ineligible|14|||
157136644|NCT00408005|567246955|FG002|Induction|Ineligible|0|||
157136645|NCT00408005|567246956|FG003|Induction|Ineligible|0|||
157136646|NCT00408005|567246957|FG004|Induction|Ineligible|0|||
157136647|NCT00408005|567246958|FG005|Induction|Ineligible|0|||
156875676|NCT02100696|566303629|FG004|Induction Phase|Multiple Reasons|0|||
156875677|NCT02100696|566303630|FG005|Induction Phase|Multiple Reasons|0|||
156875678|NCT02100696|566303625|FG000|Maintenance Phase|Adverse Event|0|||
156875679|NCT02100696|566303626|FG001|Maintenance Phase|Adverse Event|0|||
156875680|NCT02100696|566303627|FG002|Maintenance Phase|Adverse Event|0|||
156875681|NCT02100696|566303628|FG003|Maintenance Phase|Adverse Event|0|||
156875682|NCT02100696|566303629|FG004|Maintenance Phase|Adverse Event|0|||
156875683|NCT02100696|566303630|FG005|Maintenance Phase|Adverse Event|2|||
156875684|NCT02100696|566303625|FG000|Maintenance Phase|Lost to Follow-up|0|||
156875685|NCT02100696|566303626|FG001|Maintenance Phase|Lost to Follow-up|0|||
156875686|NCT02100696|566303627|FG002|Maintenance Phase|Lost to Follow-up|0|||
156875687|NCT02100696|566303628|FG003|Maintenance Phase|Lost to Follow-up|0|||
156875688|NCT02100696|566303629|FG004|Maintenance Phase|Lost to Follow-up|1|||
156875689|NCT02100696|566303630|FG005|Maintenance Phase|Lost to Follow-up|0|||
156875690|NCT02100696|566303625|FG000|Maintenance Phase|Protocol Violation|0|||
156875691|NCT02100696|566303626|FG001|Maintenance Phase|Protocol Violation|0|||
156875692|NCT02100696|566303627|FG002|Maintenance Phase|Protocol Violation|0|||
156875693|NCT02100696|566303628|FG003|Maintenance Phase|Protocol Violation|0|||
156875694|NCT02100696|566303629|FG004|Maintenance Phase|Protocol Violation|1|||
156875695|NCT02100696|566303630|FG005|Maintenance Phase|Protocol Violation|0|||
156875696|NCT02100696|566303625|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156875697|NCT02100696|566303626|FG001|Maintenance Phase|Withdrawal by Subject|0|||
156875698|NCT02100696|566303627|FG002|Maintenance Phase|Withdrawal by Subject|0|||
157136648|NCT00408005|567246959|FG006|Induction|Ineligible|0|||
157136649|NCT00408005|567246960|FG007|Induction|Ineligible|0|||
157136650|NCT00408005|567246953|FG000|Induction|Refusal of Further Protocol Therapy|225|||
157136651|NCT00408005|567246954|FG001|Induction|Refusal of Further Protocol Therapy|44|||
157136652|NCT00408005|567246955|FG002|Induction|Refusal of Further Protocol Therapy|0|||
157136653|NCT00408005|567246956|FG003|Induction|Refusal of Further Protocol Therapy|0|||
157136654|NCT00408005|567246957|FG004|Induction|Refusal of Further Protocol Therapy|0|||
157136655|NCT00408005|567246958|FG005|Induction|Refusal of Further Protocol Therapy|0|||
157136656|NCT00408005|567246959|FG006|Induction|Refusal of Further Protocol Therapy|0|||
157136657|NCT00408005|567246960|FG007|Induction|Refusal of Further Protocol Therapy|0|||
157136658|NCT00408005|567246953|FG000|Induction|Entered another COG therapeutic protocol|4|||
157136659|NCT00408005|567246954|FG001|Induction|Entered another COG therapeutic protocol|0|||
157136660|NCT00408005|567246955|FG002|Induction|Entered another COG therapeutic protocol|0|||
157136661|NCT00408005|567246956|FG003|Induction|Entered another COG therapeutic protocol|0|||
157136662|NCT00408005|567246957|FG004|Induction|Entered another COG therapeutic protocol|0|||
157136663|NCT00408005|567246958|FG005|Induction|Entered another COG therapeutic protocol|0|||
157136664|NCT00408005|567246959|FG006|Induction|Entered another COG therapeutic protocol|0|||
157136665|NCT00408005|567246960|FG007|Induction|Entered another COG therapeutic protocol|0|||
156723753|NCT04767282|565735239|FG001|Overall Study|Survey comprehension challenges|0|||
156875699|NCT02100696|566303628|FG003|Maintenance Phase|Withdrawal by Subject|1|||
156875700|NCT02100696|566303629|FG004|Maintenance Phase|Withdrawal by Subject|4|||
156875701|NCT02100696|566303630|FG005|Maintenance Phase|Withdrawal by Subject|2|||
156875702|NCT02100696|566303625|FG000|Maintenance Phase|Physician Decision|0|||
157019346|NCT03846505|566824727|FG001|Treatment Phase|Withdrawal by Subject|11|||
156875703|NCT02100696|566303626|FG001|Maintenance Phase|Physician Decision|0|||
156875704|NCT02100696|566303627|FG002|Maintenance Phase|Physician Decision|0|||
157019347|NCT03846505|566824726|FG000|Treatment Phase|Lost to Follow-up|6|||
157136666|NCT00408005|567246953|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
157136667|NCT00408005|567246954|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
157136668|NCT00408005|567246955|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
157136669|NCT00408005|567246956|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
156723754|NCT04767282|565735240|FG002|Overall Study|Survey comprehension challenges|0|||
156875705|NCT02100696|566303628|FG003|Maintenance Phase|Physician Decision|0|||
156875706|NCT02100696|566303629|FG004|Maintenance Phase|Physician Decision|1|||
156875707|NCT02100696|566303630|FG005|Maintenance Phase|Physician Decision|0|||
156875708|NCT02100696|566303625|FG000|Maintenance Phase|Multiple Reasons|0|||
156875709|NCT02100696|566303626|FG001|Maintenance Phase|Multiple Reasons|0|||
156875710|NCT02100696|566303627|FG002|Maintenance Phase|Multiple Reasons|0|||
156875711|NCT02100696|566303628|FG003|Maintenance Phase|Multiple Reasons|0|||
157136670|NCT00408005|567246957|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
157136671|NCT00408005|567246958|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
156723755|NCT01467713|565735242|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
156723756|NCT01467713|565735243|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
156723757|NCT01467713|565735244|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
156723758|NCT01467713|565735245|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
156723759|NCT01467713|565735242|FG000|Overall Study|Major Protocol Deviation|2|||
156723760|NCT01467713|565735243|FG001|Overall Study|Major Protocol Deviation|4|||
156723761|NCT01467713|565735244|FG002|Overall Study|Major Protocol Deviation|4|||
156723762|NCT01467713|565735245|FG003|Overall Study|Major Protocol Deviation|1|||
156723763|NCT01467713|565735242|FG000|Overall Study|Lost to Follow-up|9|||
156723764|NCT01467713|565735243|FG001|Overall Study|Lost to Follow-up|12|||
156723765|NCT01467713|565735244|FG002|Overall Study|Lost to Follow-up|6|||
156723766|NCT01467713|565735245|FG003|Overall Study|Lost to Follow-up|9|||
156723767|NCT01467713|565735242|FG000|Overall Study|Voluntary Withdrawal|18|||
156723768|NCT01467713|565735243|FG001|Overall Study|Voluntary Withdrawal|14|||
156723769|NCT01467713|565735244|FG002|Overall Study|Voluntary Withdrawal|21|||
156723770|NCT01467713|565735245|FG003|Overall Study|Voluntary Withdrawal|20|||
156723771|NCT01467713|565735242|FG000|Overall Study|Study Termination|23|||
156723772|NCT01467713|565735243|FG001|Overall Study|Study Termination|33|||
156723773|NCT01467713|565735244|FG002|Overall Study|Study Termination|28|||
156723774|NCT01467713|565735245|FG003|Overall Study|Study Termination|29|||
156723775|NCT01467713|565735242|FG000|Overall Study|Pregnancy|0|||
156723776|NCT01467713|565735243|FG001|Overall Study|Pregnancy|1|||
156723777|NCT01467713|565735244|FG002|Overall Study|Pregnancy|1|||
156723778|NCT01467713|565735245|FG003|Overall Study|Pregnancy|3|||
156723779|NCT01467713|565735242|FG000|Overall Study|Relapse|35|||
156723780|NCT01467713|565735243|FG001|Overall Study|Relapse|25|||
156723781|NCT01467713|565735244|FG002|Overall Study|Relapse|28|||
156723782|NCT01467713|565735245|FG003|Overall Study|Relapse|35|||
156723783|NCT01467713|565735242|FG000|Overall Study|Reason not Specified|6|||
156723784|NCT01467713|565735243|FG001|Overall Study|Reason not Specified|11|||
156723785|NCT01467713|565735244|FG002|Overall Study|Reason not Specified|8|||
156723786|NCT01467713|565735245|FG003|Overall Study|Reason not Specified|7|||
156723787|NCT01894841|565735248|FG000|Overall Study|Withdrawal by Subject|9|||
156723788|NCT01894841|565735249|FG001|Overall Study|Withdrawal by Subject|4|||
156723789|NCT01894841|565735248|FG000|Overall Study|Withdrawn by investigator|2|||
156723790|NCT01894841|565735249|FG001|Overall Study|Withdrawn by investigator|2|||
156723791|NCT01894841|565735248|FG000|Overall Study|Lost to Follow-up|7|||
156723792|NCT01894841|565735249|FG001|Overall Study|Lost to Follow-up|3|||
156723793|NCT01100086|565735250|FG000|Period 1|Withdrawal by Subject|1|||
157136672|NCT00408005|567246959|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
157136673|NCT00408005|567246960|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
157136674|NCT00408005|567246953|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
157136675|NCT00408005|567246954|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
156723794|NCT01100086|565735251|FG001|Period 1|Withdrawal by Subject|0|||
156723795|NCT01611935|565735252|FG000|Overall Study|Family Declined Participation|1|||
156723796|NCT01611935|565735253|FG001|Overall Study|Family Declined Participation|0|||
156723797|NCT01735916|565735254|FG000|Overall Study|Subject not eligible to be randomized|11|||
156723798|NCT01735916|565735255|FG001|Overall Study|Subject not eligible to be randomized|0|||
156723799|NCT01735916|565735256|FG002|Overall Study|Subject not eligible to be randomized|0|||
156723800|NCT01735916|565735254|FG000|Overall Study|Early termination of study by sponsor|4|||
156723801|NCT01735916|565735255|FG001|Overall Study|Early termination of study by sponsor|19|||
156723802|NCT01735916|565735256|FG002|Overall Study|Early termination of study by sponsor|7|||
156723803|NCT01735916|565735254|FG000|Overall Study|Withdrawal by Subject|3|||
156723804|NCT01735916|565735255|FG001|Overall Study|Withdrawal by Subject|0|||
156723805|NCT01735916|565735256|FG002|Overall Study|Withdrawal by Subject|0|||
156723806|NCT04227197|565735257|FG000|Randomization|Protocol Violation|1|||
156723807|NCT04227197|565735258|FG001|Randomization|Protocol Violation|0|||
156723808|NCT04227197|565735257|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
156723809|NCT04227197|565735258|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
156723810|NCT04227197|565735257|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
156794753|NCT00003645|566002761|FG001|Overall Study|Lost to Follow-up|8|||
156794754|NCT00003645|566002760|FG000|Overall Study|Withdrawal by Subject|1|||
156794755|NCT00003645|566002761|FG001|Overall Study|Withdrawal by Subject|3|||
156794756|NCT03345550|566002764|FG000|Overall Study|Withdrawal by Subject|1|||
156794757|NCT03345550|566002765|FG001|Overall Study|Withdrawal by Subject|0|||
156794758|NCT03345550|566002764|FG000|Overall Study|Lost to Follow-up|4|||
156794759|NCT03345550|566002765|FG001|Overall Study|Lost to Follow-up|5|||
156794760|NCT03014089|566002769|FG000|Overall Study|Withdrawal by Subject|0|||
156794761|NCT03014089|566002770|FG001|Overall Study|Withdrawal by Subject|1|||
156794762|NCT03014089|566002771|FG002|Overall Study|Withdrawal by Subject|1|||
156794763|NCT03014089|566002772|FG003|Overall Study|Withdrawal by Subject|1|||
157136676|NCT00408005|567246955|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
157136677|NCT00408005|567246956|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
157136678|NCT00408005|567246957|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
157136679|NCT00408005|567246958|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
157136680|NCT00408005|567246959|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
156723811|NCT04227197|565735258|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
156723812|NCT04227197|565735257|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
156723813|NCT04227197|565735258|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
156723814|NCT04227197|565735257|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
156723815|NCT04227197|565735258|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
156723816|NCT04227197|565735257|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
156723817|NCT04227197|565735258|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
156723818|NCT04227197|565735257|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
156723819|NCT04227197|565735258|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
156723820|NCT02549859|565735263|FG000|Long-term 60 Hz DBS|Study Closed|1|||
156723821|NCT01379768|565735264|FG000|Overall Study|Adverse Event|1|||
156723822|NCT01379768|565735265|FG001|Overall Study|Adverse Event|1|||
156723823|NCT01379768|565735266|FG002|Overall Study|Adverse Event|0|||
156723824|NCT01379768|565735264|FG000|Overall Study|Lost to Follow-up|2|||
156723825|NCT01379768|565735265|FG001|Overall Study|Lost to Follow-up|0|||
156723826|NCT01379768|565735266|FG002|Overall Study|Lost to Follow-up|0|||
156723827|NCT01209949|565735274|FG000|Overall Study|Lost to Follow-up|3|||
156723828|NCT00729612|565735279|FG000|Overall Study|Non evaluable for response|10|||
156723829|NCT00708552|565735280|FG000|Overall Study|Adverse Event|10|||
156723830|NCT00708552|565735281|FG001|Overall Study|Adverse Event|3|||
156723831|NCT00708552|565735282|FG002|Overall Study|Adverse Event|4|||
156723832|NCT00708552|565735283|FG003|Overall Study|Adverse Event|6|||
156723833|NCT00708552|565735280|FG000|Overall Study|Lack of Efficacy|0|||
156723834|NCT00708552|565735281|FG001|Overall Study|Lack of Efficacy|4|||
156723835|NCT00708552|565735282|FG002|Overall Study|Lack of Efficacy|1|||
156723836|NCT00708552|565735283|FG003|Overall Study|Lack of Efficacy|0|||
157019348|NCT03846505|566824727|FG001|Treatment Phase|Lost to Follow-up|2|||
157019349|NCT03846505|566824726|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
156723837|NCT00708552|565735280|FG000|Overall Study|Protocol Violation|0|||
156723838|NCT00708552|565735281|FG001|Overall Study|Protocol Violation|0|||
156723839|NCT00708552|565735282|FG002|Overall Study|Protocol Violation|2|||
156723840|NCT00708552|565735283|FG003|Overall Study|Protocol Violation|4|||
156794764|NCT03014089|566002769|FG000|Overall Study|Lost to Follow-up|1|||
156794765|NCT03014089|566002770|FG001|Overall Study|Lost to Follow-up|0|||
156794766|NCT03014089|566002771|FG002|Overall Study|Lost to Follow-up|0|||
156794767|NCT03014089|566002772|FG003|Overall Study|Lost to Follow-up|0|||
156794768|NCT03014089|566002769|FG000|Overall Study|Adverse Event|1|||
156794769|NCT03014089|566002770|FG001|Overall Study|Adverse Event|0|||
156794770|NCT03014089|566002771|FG002|Overall Study|Adverse Event|1|||
156794771|NCT03014089|566002772|FG003|Overall Study|Adverse Event|0|||
156794772|NCT01149460|566002773|FG000|Overall Study|Withdrawal by Subject|0|||
156794773|NCT01149460|566002774|FG001|Overall Study|Withdrawal by Subject|2|||
156794774|NCT00321932|566002775|FG000|Overall Study|Death|3|||
156794775|NCT00321932|566002776|FG001|Overall Study|Death|6|||
156794776|NCT00321932|566002775|FG000|Overall Study|Withdrawal by Subject|3|||
156794777|NCT00321932|566002776|FG001|Overall Study|Withdrawal by Subject|6|||
156794778|NCT00321932|566002775|FG000|Overall Study|Early relapse|2|||
156794779|NCT00321932|566002776|FG001|Overall Study|Early relapse|8|||
156794780|NCT00321932|566002775|FG000|Overall Study|Missing data|2|||
156794781|NCT00321932|566002776|FG001|Overall Study|Missing data|1|||
156794782|NCT02378480|566002777|FG000|Overall Study|Physician Decision|1|||
156794783|NCT02378480|566002778|FG001|Overall Study|Physician Decision|1|||
156794784|NCT02378480|566002777|FG000|Overall Study|Death|1|||
156794785|NCT02378480|566002778|FG001|Overall Study|Death|2|||
156794786|NCT02378480|566002777|FG000|Overall Study|Randomized, but Not Treated|6|||
156794787|NCT02378480|566002778|FG001|Overall Study|Randomized, but Not Treated|4|||
156794788|NCT02378480|566002777|FG000|Overall Study|Adverse Event|0|||
156794789|NCT02378480|566002778|FG001|Overall Study|Adverse Event|1|||
156794790|NCT02378480|566002777|FG000|Overall Study|Missed EOT/PTE Visit|1|||
156794791|NCT02378480|566002778|FG001|Overall Study|Missed EOT/PTE Visit|2|||
156794792|NCT02378480|566002777|FG000|Overall Study|Withdrawal by Subject|9|||
156794793|NCT02378480|566002778|FG001|Overall Study|Withdrawal by Subject|4|||
156794794|NCT02378480|566002777|FG000|Overall Study|Lost to Follow-up|10|||
156794795|NCT02378480|566002778|FG001|Overall Study|Lost to Follow-up|18|||
157019350|NCT03846505|566824727|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
157136681|NCT00408005|567246960|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
156794796|NCT01217892|566002779|FG000|Overall Study|Adverse Event|1|||
156794797|NCT01217892|566002780|FG001|Overall Study|Adverse Event|1|||
156794798|NCT01217892|566002781|FG002|Overall Study|Adverse Event|1|||
156794799|NCT01217892|566002782|FG003|Overall Study|Adverse Event|0|||
156723841|NCT00708552|565735280|FG000|Overall Study|Lost to Follow-up|4|||
156723842|NCT00708552|565735281|FG001|Overall Study|Lost to Follow-up|2|||
157136682|NCT00408005|567246953|FG000|Induction|Progressive Disease|0|||
156875712|NCT02100696|566303629|FG004|Maintenance Phase|Multiple Reasons|2|||
156875713|NCT02100696|566303630|FG005|Maintenance Phase|Multiple Reasons|1|||
156875714|NCT03865381|566303634|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
156875715|NCT03865381|566303634|FG000|Overall Study|Withdrawal by Subject|2|||
156875716|NCT01583296|566303639|FG000|Overall Study|Withdrawal by Subject|11|||
156875717|NCT01583296|566303640|FG001|Overall Study|Withdrawal by Subject|10|||
156875718|NCT01063283|566303641|FG000|Cycle 1|Adverse Event|2|||
156875719|NCT01063283|566303642|FG001|Cycle 1|Adverse Event|0|||
156875720|NCT01063283|566303643|FG002|Cycle 1|Adverse Event|0|||
156875721|NCT01063283|566303641|FG000|Cycle 1|Technical failure in data collection|1|||
156875722|NCT01063283|566303642|FG001|Cycle 1|Technical failure in data collection|0|||
156875723|NCT01063283|566303643|FG002|Cycle 1|Technical failure in data collection|0|||
156875724|NCT02504216|566303646|FG000|Overall Study|Lost to Follow-up|3|||
156875725|NCT02504216|566303647|FG001|Overall Study|Lost to Follow-up|3|||
156875726|NCT02504216|566303646|FG000|Overall Study|Withdrawal by Subject|8|||
156875727|NCT02504216|566303647|FG001|Overall Study|Withdrawal by Subject|12|||
156875728|NCT00223080|566303648|FG000|Overall Study|Withdrawal by Subject|253|||
156875729|NCT00223080|566303649|FG001|Overall Study|Withdrawal by Subject|232|||
156875730|NCT00223080|566303648|FG000|Overall Study|Required contraindicated med|0|||
156875731|NCT00223080|566303649|FG001|Overall Study|Required contraindicated med|1|||
156875732|NCT00223080|566303648|FG000|Overall Study|Non-compliant|7|||
156723843|NCT00708552|565735282|FG002|Overall Study|Lost to Follow-up|0|||
156723844|NCT00708552|565735283|FG003|Overall Study|Lost to Follow-up|1|||
156723845|NCT00708552|565735280|FG000|Overall Study|Physician Decision|1|||
156723846|NCT00708552|565735281|FG001|Overall Study|Physician Decision|2|||
156723847|NCT00708552|565735282|FG002|Overall Study|Physician Decision|0|||
156723848|NCT00708552|565735283|FG003|Overall Study|Physician Decision|0|||
156723849|NCT00708552|565735280|FG000|Overall Study|Withdrawal by Subject|12|||
156723850|NCT00708552|565735281|FG001|Overall Study|Withdrawal by Subject|7|||
156723851|NCT00708552|565735282|FG002|Overall Study|Withdrawal by Subject|8|||
156723852|NCT00708552|565735283|FG003|Overall Study|Withdrawal by Subject|10|||
156723853|NCT05600283|565735286|FG000|Overall Study|Withdrawal by Subject|3|||
156723854|NCT05600283|565735287|FG001|Overall Study|Withdrawal by Subject|8|||
156723855|NCT05600283|565735286|FG000|Overall Study|invalid individual swab|1|||
156723856|NCT05600283|565735287|FG001|Overall Study|invalid individual swab|0|||
156723857|NCT05600283|565735286|FG000|Overall Study|missing clinician collection|3|||
156723858|NCT05600283|565735287|FG001|Overall Study|missing clinician collection|0|||
156723859|NCT05600283|565735286|FG000|Overall Study|screening failure|0|||
156723860|NCT05600283|565735287|FG001|Overall Study|screening failure|2|||
156723861|NCT02883062|565735288|FG000|Overall Study|Withdrawal by Subject|6|||
156723862|NCT02883062|565735289|FG001|Overall Study|Withdrawal by Subject|0|||
156723863|NCT03839628|565735292|FG000|Overall Study|Withdrawal by Subject|1|||
156723864|NCT00380874|565735293|FG000|Overall Study|Adverse Event|7|||
156723865|NCT00380874|565735294|FG001|Overall Study|Adverse Event|7|||
156723866|NCT00380874|565735293|FG000|Overall Study|Death|1|||
156723867|NCT00380874|565735294|FG001|Overall Study|Death|0|||
156723868|NCT00380874|565735293|FG000|Overall Study|Withdrawal by Subject|2|||
156723869|NCT00380874|565735294|FG001|Overall Study|Withdrawal by Subject|1|||
156723870|NCT00380874|565735293|FG000|Overall Study|Not related to study drug|3|||
156723871|NCT00380874|565735294|FG001|Overall Study|Not related to study drug|2|||
156723872|NCT03380429|565735295|FG000|Overall Study|Physician Decision|0|||
156875733|NCT00223080|566303649|FG001|Overall Study|Non-compliant|7|||
156875734|NCT00223080|566303648|FG000|Overall Study|Moved from study area|37|||
156875735|NCT00223080|566303649|FG001|Overall Study|Moved from study area|47|||
157217337|NCT00738920|567541081|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
156723873|NCT03380429|565735296|FG001|Overall Study|Physician Decision|1|||
156723874|NCT03380429|565735297|FG002|Overall Study|Physician Decision|0|||
156723875|NCT03380429|565735298|FG003|Overall Study|Physician Decision|1|||
156723876|NCT03380429|565735299|FG004|Overall Study|Physician Decision|1|||
156723877|NCT03380429|565735295|FG000|Overall Study|Withdrawal by Subject|3|||
156723878|NCT03380429|565735296|FG001|Overall Study|Withdrawal by Subject|3|||
156723879|NCT03380429|565735297|FG002|Overall Study|Withdrawal by Subject|5|||
156723880|NCT03380429|565735298|FG003|Overall Study|Withdrawal by Subject|2|||
156723881|NCT03380429|565735299|FG004|Overall Study|Withdrawal by Subject|1|||
156723882|NCT03380429|565735295|FG000|Overall Study|Lost to Follow-up|0|||
156723883|NCT03380429|565735296|FG001|Overall Study|Lost to Follow-up|2|||
156723884|NCT03380429|565735297|FG002|Overall Study|Lost to Follow-up|4|||
156723885|NCT03380429|565735298|FG003|Overall Study|Lost to Follow-up|3|||
156723886|NCT03380429|565735299|FG004|Overall Study|Lost to Follow-up|1|||
156723887|NCT03380429|565735295|FG000|Overall Study|Protocol Violation|1|||
156875736|NCT00223080|566303648|FG000|Overall Study|Lost to Follow-up|259|||
156875737|NCT00223080|566303649|FG001|Overall Study|Lost to Follow-up|284|||
156875738|NCT00223080|566303648|FG000|Overall Study|Death|85|||
156875739|NCT00223080|566303649|FG001|Overall Study|Death|74|||
156875740|NCT00223080|566303648|FG000|Overall Study|Other|14|||
156875741|NCT00223080|566303649|FG001|Overall Study|Other|11|||
156875742|NCT00223080|566303648|FG000|Overall Study|Reason not provided|141|||
156875743|NCT00223080|566303649|FG001|Overall Study|Reason not provided|140|||
156723888|NCT03380429|565735296|FG001|Overall Study|Protocol Violation|0|||
156723889|NCT03380429|565735297|FG002|Overall Study|Protocol Violation|1|||
157136683|NCT00408005|567246954|FG001|Induction|Progressive Disease|1|||
157136684|NCT00408005|567246955|FG002|Induction|Progressive Disease|0|||
157136685|NCT00408005|567246956|FG003|Induction|Progressive Disease|0|||
157136686|NCT00408005|567246957|FG004|Induction|Progressive Disease|0|||
157136687|NCT00408005|567246958|FG005|Induction|Progressive Disease|0|||
157136688|NCT00408005|567246959|FG006|Induction|Progressive Disease|0|||
157136689|NCT00408005|567246960|FG007|Induction|Progressive Disease|0|||
157136690|NCT00408005|567246953|FG000|Induction|Inevaluable|18|||
156723890|NCT03380429|565735298|FG003|Overall Study|Protocol Violation|0|||
156723891|NCT03380429|565735299|FG004|Overall Study|Protocol Violation|1|||
156723892|NCT03380429|565735295|FG000|Overall Study|Lack of Efficacy|0|||
156723893|NCT03380429|565735296|FG001|Overall Study|Lack of Efficacy|0|||
156723894|NCT03380429|565735297|FG002|Overall Study|Lack of Efficacy|0|||
156723895|NCT03380429|565735298|FG003|Overall Study|Lack of Efficacy|2|||
156723896|NCT03380429|565735299|FG004|Overall Study|Lack of Efficacy|1|||
156723897|NCT03380429|565735295|FG000|Overall Study|Adverse Event|1|||
156723898|NCT03380429|565735296|FG001|Overall Study|Adverse Event|1|||
156723899|NCT03380429|565735297|FG002|Overall Study|Adverse Event|1|||
156723900|NCT03380429|565735298|FG003|Overall Study|Adverse Event|2|||
156723901|NCT03380429|565735299|FG004|Overall Study|Adverse Event|0|||
156723902|NCT01198470|565735304|FG000|Overall Study|Adverse Event|2|||
156723903|NCT02314026|565735305|FG000|Overall Study|Protocol Violation|28|||
156723904|NCT02949973|565735306|FG000|Overall Study|Physician Decision|1|||
156723905|NCT01139775|565735307|FG000|Overall Study|Adverse Event|0|||
156723906|NCT01139775|565735308|FG001|Overall Study|Adverse Event|6|||
156723907|NCT01139775|565735309|FG002|Overall Study|Adverse Event|2|||
156723908|NCT01139775|565735307|FG000|Overall Study|Protocol Violation|0|||
156723909|NCT01139775|565735308|FG001|Overall Study|Protocol Violation|5|||
156723910|NCT01139775|565735309|FG002|Overall Study|Protocol Violation|0|||
156723911|NCT01139775|565735307|FG000|Overall Study|Withdrawal by Subject|1|||
156723912|NCT01139775|565735308|FG001|Overall Study|Withdrawal by Subject|0|||
156723913|NCT01139775|565735309|FG002|Overall Study|Withdrawal by Subject|2|||
156723914|NCT01139775|565735307|FG000|Overall Study|Physician Decision|0|||
156723915|NCT01139775|565735308|FG001|Overall Study|Physician Decision|2|||
156723916|NCT01139775|565735309|FG002|Overall Study|Physician Decision|2|||
157136691|NCT00408005|567246954|FG001|Induction|Inevaluable|14|||
157136692|NCT00408005|567246955|FG002|Induction|Inevaluable|0|||
156723917|NCT00586703|565735310|FG000|Overall Study|Death|12|||
156723918|NCT01924689|565735311|FG000|Overall Study|Death|0|||
156723919|NCT01924689|565735312|FG001|Overall Study|Death|1|||
156723920|NCT01924689|565735313|FG002|Overall Study|Death|0|||
156723921|NCT01924689|565735314|FG003|Overall Study|Death|1|||
156723922|NCT01924689|565735315|FG004|Overall Study|Death|0|||
156723923|NCT01924689|565735316|FG005|Overall Study|Death|0|||
156723924|NCT01924689|565735311|FG000|Overall Study|Disease progression|0|||
156723925|NCT01924689|565735312|FG001|Overall Study|Disease progression|0|||
156723926|NCT01924689|565735313|FG002|Overall Study|Disease progression|2|||
156723927|NCT01924689|565735314|FG003|Overall Study|Disease progression|0|||
156723928|NCT01924689|565735315|FG004|Overall Study|Disease progression|3|||
156723929|NCT01924689|565735316|FG005|Overall Study|Disease progression|2|||
156723930|NCT01924689|565735311|FG000|Overall Study|New therapy or study|3|||
156723931|NCT01924689|565735312|FG001|Overall Study|New therapy or study|2|||
156723932|NCT01924689|565735313|FG002|Overall Study|New therapy or study|1|||
156723933|NCT01924689|565735314|FG003|Overall Study|New therapy or study|4|||
157136693|NCT00408005|567246956|FG003|Induction|Inevaluable|0|||
156723934|NCT01924689|565735315|FG004|Overall Study|New therapy or study|2|||
156723935|NCT01924689|565735316|FG005|Overall Study|New therapy or study|0|||
156723936|NCT01924689|565735311|FG000|Overall Study|Withdrawal of consent|0|||
156723937|NCT01924689|565735312|FG001|Overall Study|Withdrawal of consent|0|||
156723938|NCT01924689|565735313|FG002|Overall Study|Withdrawal of consent|1|||
156723939|NCT01924689|565735314|FG003|Overall Study|Withdrawal of consent|1|||
156723940|NCT01924689|565735315|FG004|Overall Study|Withdrawal of consent|0|||
156723941|NCT01924689|565735316|FG005|Overall Study|Withdrawal of consent|0|||
156723942|NCT01924689|565735311|FG000|Overall Study|Other|0|||
156723943|NCT01924689|565735312|FG001|Overall Study|Other|0|||
156723944|NCT01924689|565735313|FG002|Overall Study|Other|0|||
156723945|NCT01924689|565735314|FG003|Overall Study|Other|0|||
156723946|NCT01924689|565735315|FG004|Overall Study|Other|1|||
156723947|NCT01924689|565735316|FG005|Overall Study|Other|0|||
156723948|NCT05271175|565735318|FG000|One Week Follow up|Lost to Follow-up|10|||
156723949|NCT05271175|565735319|FG001|One Week Follow up|Lost to Follow-up|7|||
156723950|NCT05271175|565735320|FG002|One Week Follow up|Lost to Follow-up|5|||
156723951|NCT05271175|565735318|FG000|One Month Follow up|Lost to Follow-up|12|||
156723952|NCT05271175|565735319|FG001|One Month Follow up|Lost to Follow-up|7|||
156723953|NCT05271175|565735320|FG002|One Month Follow up|Lost to Follow-up|9|||
157136694|NCT00408005|567246957|FG004|Induction|Inevaluable|0|||
157136695|NCT00408005|567246958|FG005|Induction|Inevaluable|0|||
157136696|NCT00408005|567246959|FG006|Induction|Inevaluable|0|||
157136697|NCT00408005|567246960|FG007|Induction|Inevaluable|0|||
157136698|NCT00408005|567246953|FG000|Induction|Failed to Complete Randomization|3|||
157136699|NCT00408005|567246954|FG001|Induction|Failed to Complete Randomization|2|||
157136700|NCT00408005|567246955|FG002|Induction|Failed to Complete Randomization|0|||
157136701|NCT00408005|567246956|FG003|Induction|Failed to Complete Randomization|0|||
157136702|NCT00408005|567246957|FG004|Induction|Failed to Complete Randomization|0|||
156723954|NCT05271175|565735318|FG000|Six Months Follow up|Lost to Follow-up|8|||
156723955|NCT05271175|565735319|FG001|Six Months Follow up|Lost to Follow-up|2|||
156723956|NCT05271175|565735320|FG002|Six Months Follow up|Lost to Follow-up|2|||
156723957|NCT00468819|565735321|FG000|Overall Study|Withdrawal by Subject|4|||
156723958|NCT00468819|565735322|FG001|Overall Study|Withdrawal by Subject|0|||
156723959|NCT00468819|565735323|FG002|Overall Study|Withdrawal by Subject|1|||
156723960|NCT00468819|565735321|FG000|Overall Study|Lost to Follow-up|0|||
156723961|NCT00468819|565735322|FG001|Overall Study|Lost to Follow-up|0|||
156723962|NCT00468819|565735323|FG002|Overall Study|Lost to Follow-up|1|||
156723963|NCT00468819|565735321|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
156723964|NCT00468819|565735322|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
156723965|NCT00468819|565735323|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
156723966|NCT02492867|565735324|FG000|Overall Study|Alternate therapy|1|||
156723967|NCT02492867|565735324|FG000|Overall Study|Withdrawal by Subject|2|||
156723968|NCT02492867|565735324|FG000|Overall Study|Disease progression after treatment started|1|||
156723969|NCT02492867|565735324|FG000|Overall Study|Death|1|||
156723970|NCT03296527|565735325|FG000|Overall Study|Adverse Event|15|||
156723971|NCT03296527|565735326|FG001|Overall Study|Adverse Event|33|||
156723972|NCT03296527|565735325|FG000|Overall Study|Protocol Deviation|4|||
156723973|NCT03296527|565735326|FG001|Overall Study|Protocol Deviation|0|||
156723974|NCT03296527|565735325|FG000|Overall Study|Participant withdrew consent|3|||
156723975|NCT03296527|565735326|FG001|Overall Study|Participant withdrew consent|1|||
156723976|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
156723977|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
156723978|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
156723979|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
156723980|NCT03296527|565735325|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
156723981|NCT03296527|565735326|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
156723982|NCT03296527|565735325|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
156723983|NCT03296527|565735326|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
156723984|NCT03296527|565735325|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
156723985|NCT03296527|565735326|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
156723986|NCT01597973|565735327|FG000|Overall Study|Found ineligible before study medication started|4|||
157019351|NCT03846505|566824726|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
157019352|NCT03846505|566824727|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
157019353|NCT04021602|566824732|FG000|Overall Study|Lost to Follow-up|3|||
157019354|NCT04021602|566824733|FG001|Overall Study|Lost to Follow-up|3|||
157019355|NCT04021602|566824734|FG002|Overall Study|Lost to Follow-up|1|||
157136703|NCT00408005|567246958|FG005|Induction|Failed to Complete Randomization|0|||
157136704|NCT00408005|567246959|FG006|Induction|Failed to Complete Randomization|0|||
156723987|NCT01597973|565735328|FG001|Overall Study|Found ineligible before study medication started|2|||
156723988|NCT01597973|565735327|FG000|Overall Study|Eligible pathogen not confirmed|14|||
156723989|NCT01597973|565735328|FG001|Overall Study|Eligible pathogen not confirmed|15|||
156723990|NCT01597973|565735327|FG000|Overall Study|LAR not authorized to consent|0|||
156723991|NCT01597973|565735328|FG001|Overall Study|LAR not authorized to consent|1|||
156723992|NCT01597973|565735327|FG000|Overall Study|Ineligible due to early seizures|1|||
156723993|NCT01597973|565735328|FG001|Overall Study|Ineligible due to early seizures|0|||
156723994|NCT01597973|565735327|FG000|Overall Study|Ineligible due to non-target infection|1|||
156723995|NCT01597973|565735328|FG001|Overall Study|Ineligible due to non-target infection|1|||
156723996|NCT01326845|565735329|FG000|Overall Study|Administrative Problems|5|||
156723997|NCT01326845|565735330|FG001|Overall Study|Administrative Problems|2|||
156723998|NCT01326845|565735329|FG000|Overall Study|Adverse Event|1|||
156723999|NCT01326845|565735330|FG001|Overall Study|Adverse Event|0|||
156724000|NCT01326845|565735329|FG000|Overall Study|Misisng|1|||
156724001|NCT01326845|565735330|FG001|Overall Study|Misisng|3|||
156724002|NCT00682786|565735333|FG000|Overall Study|Withdrawal by Subject|2|||
156724003|NCT00682786|565735334|FG001|Overall Study|Withdrawal by Subject|2|||
156724004|NCT00682786|565735333|FG000|Overall Study|Did not receive irinotecan|0|||
156724005|NCT00682786|565735334|FG001|Overall Study|Did not receive irinotecan|1|||
156724006|NCT01831635|565735335|FG000|Overall Study|Withdrawal by Subject|0|||
156724007|NCT01831635|565735336|FG001|Overall Study|Withdrawal by Subject|2|||
156724008|NCT01831635|565735337|FG002|Overall Study|Withdrawal by Subject|0|||
156724009|NCT02859337|565735338|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
157019356|NCT04021602|566824732|FG000|Overall Study|Adverse Event|1|||
157136705|NCT00408005|567246960|FG007|Induction|Failed to Complete Randomization|0|||
157136706|NCT00408005|567246953|FG000|Induction|Protocol Deviation|3|||
156724010|NCT02859337|565735339|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
156724011|NCT02859337|565735340|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
156724012|NCT02859337|565735338|FG000|Overall Study|Withdrawal by Subject|3|||
156724013|NCT02859337|565735339|FG001|Overall Study|Withdrawal by Subject|1|||
156724014|NCT02859337|565735340|FG002|Overall Study|Withdrawal by Subject|0|||
156724015|NCT02859337|565735338|FG000|Overall Study|Lost to Follow-up|1|||
156724016|NCT02859337|565735339|FG001|Overall Study|Lost to Follow-up|0|||
156724017|NCT02859337|565735340|FG002|Overall Study|Lost to Follow-up|0|||
156724018|NCT03817190|565735341|FG000|Overall Study|Early Termination|13|||
156724019|NCT03817190|565735342|FG001|Overall Study|Early Termination|20|||
156724020|NCT03817190|565735341|FG000|Overall Study|Adverse Event|10|||
156724021|NCT03817190|565735342|FG001|Overall Study|Adverse Event|17|||
156724022|NCT03817190|565735341|FG000|Overall Study|Withdrawal by Subject|12|||
156724023|NCT03817190|565735342|FG001|Overall Study|Withdrawal by Subject|8|||
156724024|NCT03817190|565735341|FG000|Overall Study|Lost to Follow-up|11|||
156724025|NCT03817190|565735342|FG001|Overall Study|Lost to Follow-up|7|||
156724026|NCT03817190|565735341|FG000|Overall Study|Lack of Efficacy|7|||
156724027|NCT03817190|565735342|FG001|Overall Study|Lack of Efficacy|5|||
156724028|NCT03817190|565735341|FG000|Overall Study|Investigator Decision|5|||
156724029|NCT03817190|565735342|FG001|Overall Study|Investigator Decision|1|||
156724030|NCT03817190|565735341|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
156724031|NCT03817190|565735342|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
156724032|NCT03817190|565735341|FG000|Overall Study|Lack of Contact|1|||
156724033|NCT03817190|565735342|FG001|Overall Study|Lack of Contact|0|||
156724034|NCT03817190|565735341|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
156875744|NCT00223080|566303648|FG000|Overall Study|Adverse Event|0|||
156875745|NCT00223080|566303649|FG001|Overall Study|Adverse Event|1|||
156875746|NCT02598583|566303650|FG000|Extension Period|Withdrawal by Subject|1|||
156875747|NCT02598583|566303651|FG001|Extension Period|Withdrawal by Subject|0|||
156724035|NCT03817190|565735342|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
156724036|NCT04146012|565735343|FG000|Overall Study|Study Terminated|30|||
156724037|NCT04146012|565735344|FG001|Overall Study|Study Terminated|15|||
156724038|NCT01546025|565735345|FG000|Overall Study|Lost to Follow-up|0|||
156724039|NCT01546025|565735346|FG001|Overall Study|Lost to Follow-up|1|||
156724040|NCT02729025|565735347|FG000|Overall Study|Sponsor Decision|0|||
156724041|NCT02729025|565735348|FG001|Overall Study|Sponsor Decision|1|||
156724042|NCT03668119|565737001|FG000|Pre-treatment|Disease Progression|1|||
156724043|NCT03668119|565737002|FG001|Pre-treatment|Disease Progression|0|||
156724044|NCT03668119|565737001|FG000|Treatment|Disease Progression|76|||
156724045|NCT03668119|565737002|FG001|Treatment|Disease Progression|57|||
156724046|NCT03668119|565737001|FG000|Treatment|Study drug toxicity|19|||
156724047|NCT03668119|565737002|FG001|Treatment|Study drug toxicity|1|||
156724048|NCT03668119|565737001|FG000|Treatment|Death|3|||
156724049|NCT03668119|565737002|FG001|Treatment|Death|0|||
156724050|NCT03668119|565737001|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
156724051|NCT03668119|565737002|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
156724052|NCT03668119|565737001|FG000|Treatment|Withdrawal by Subject|1|||
156724053|NCT03668119|565737002|FG001|Treatment|Withdrawal by Subject|1|||
156724054|NCT03668119|565737001|FG000|Treatment|Participant request to discontinue study treatment|3|||
156724055|NCT03668119|565737002|FG001|Treatment|Participant request to discontinue study treatment|1|||
156724056|NCT03668119|565737001|FG000|Treatment|Maximum Clinical Benefit|0|||
156724057|NCT03668119|565737002|FG001|Treatment|Maximum Clinical Benefit|1|||
156724058|NCT03668119|565737001|FG000|Treatment|Participants completed treatment|27|||
156724059|NCT03668119|565737002|FG001|Treatment|Participants completed treatment|11|||
156724060|NCT03668119|565737001|FG000|Treatment|Other reasons|2|||
156724061|NCT03668119|565737002|FG001|Treatment|Other reasons|1|||
156724062|NCT03769168|565737003|FG000|Overall Study|Adverse Event|0|||
156724063|NCT03769168|565737004|FG001|Overall Study|Adverse Event|1|||
156724064|NCT03769168|565737003|FG000|Overall Study|Lack of Efficacy|2|||
156724065|NCT03769168|565737004|FG001|Overall Study|Lack of Efficacy|4|||
156724066|NCT03769168|565737003|FG000|Overall Study|Post study access to treatment|3|||
156724067|NCT03769168|565737004|FG001|Overall Study|Post study access to treatment|11|||
156724068|NCT03769168|565737003|FG000|Overall Study|Physician Decision|1|||
156724069|NCT03769168|565737004|FG001|Overall Study|Physician Decision|4|||
156724070|NCT03769168|565737003|FG000|Overall Study|Subject Decision|2|||
156724071|NCT03769168|565737004|FG001|Overall Study|Subject Decision|4|||
156724072|NCT03769168|565737003|FG000|Overall Study|Guardian decision|1|||
156724073|NCT03769168|565737004|FG001|Overall Study|Guardian decision|0|||
156724074|NCT04053868|565737005|FG000|Overall Study|Withdrawal by Subject|1|||
156724075|NCT04053868|565737006|FG001|Overall Study|Withdrawal by Subject|0|||
156724076|NCT05731700|565737007|FG000|Overall Study|Death|1|||
156724077|NCT00975611|565737008|FG000|Overall Study|Screen Fail|16|||
156724078|NCT00975611|565737008|FG000|Overall Study|Physician Decision|1|||
156724079|NCT05468164|565737011|FG000|Treatment Period 4|Adverse Event|0|||
156724080|NCT05468164|565737012|FG001|Treatment Period 4|Adverse Event|0|||
157136707|NCT00408005|567246954|FG001|Induction|Protocol Deviation|1|||
157136708|NCT00408005|567246955|FG002|Induction|Protocol Deviation|0|||
157136709|NCT00408005|567246956|FG003|Induction|Protocol Deviation|0|||
157136710|NCT00408005|567246957|FG004|Induction|Protocol Deviation|0|||
157136711|NCT00408005|567246958|FG005|Induction|Protocol Deviation|0|||
157136712|NCT00408005|567246959|FG006|Induction|Protocol Deviation|0|||
157136713|NCT00408005|567246960|FG007|Induction|Protocol Deviation|0|||
157136714|NCT00408005|567246953|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
157136715|NCT00408005|567246954|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136716|NCT00408005|567246955|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
156724081|NCT05468164|565737013|FG002|Treatment Period 4|Adverse Event|0|||
156724082|NCT05468164|565737014|FG003|Treatment Period 4|Adverse Event|1|||
156724083|NCT04632927|565737015|FG000|Overall Study|Adverse Event|0|||
156724084|NCT04632927|565737016|FG001|Overall Study|Adverse Event|1|||
156724085|NCT04632927|565737015|FG000|Overall Study|Lack of Efficacy|0|||
156724086|NCT04632927|565737016|FG001|Overall Study|Lack of Efficacy|4|||
156724087|NCT04632927|565737015|FG000|Overall Study|Loss of efficacy|0|||
156724088|NCT04632927|565737016|FG001|Overall Study|Loss of efficacy|1|||
156724089|NCT04632927|565737015|FG000|Overall Study|Non-compliance with study drug|0|||
156724090|NCT04632927|565737016|FG001|Overall Study|Non-compliance with study drug|1|||
156724091|NCT04632927|565737015|FG000|Overall Study|Physician Decision|0|||
156724092|NCT04632927|565737016|FG001|Overall Study|Physician Decision|1|||
156724093|NCT04632927|565737015|FG000|Overall Study|Subject decision|0|||
156724094|NCT04632927|565737016|FG001|Overall Study|Subject decision|1|||
156724095|NCT04632927|565737015|FG000|Overall Study|Withdrawal by Subject|0|||
156724096|NCT04632927|565737016|FG001|Overall Study|Withdrawal by Subject|1|||
156724097|NCT03827291|565737017|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
156724098|NCT03827291|565737018|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
156724099|NCT04795466|565737019|FG000|Overall Study|Adverse Event|3|||
156724100|NCT04795466|565737020|FG001|Overall Study|Adverse Event|1|||
156724101|NCT04795466|565737019|FG000|Overall Study|Physician Decision|1|||
156724102|NCT04795466|565737020|FG001|Overall Study|Physician Decision|0|||
156724103|NCT04795466|565737019|FG000|Overall Study|Withdrawal by Subject|2|||
156724104|NCT04795466|565737020|FG001|Overall Study|Withdrawal by Subject|1|||
156724105|NCT04652726|565737021|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
156724106|NCT04652726|565737022|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
156724107|NCT04652726|565737023|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
157136717|NCT00408005|567246956|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136718|NCT00408005|567246957|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136719|NCT00408005|567246958|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136720|NCT00408005|567246959|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136721|NCT00408005|567246960|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
157136722|NCT00408005|567246953|FG000|Induction|Recurrent leukemia|1|||
157136723|NCT00408005|567246954|FG001|Induction|Recurrent leukemia|0|||
157136724|NCT00408005|567246955|FG002|Induction|Recurrent leukemia|0|||
157136725|NCT00408005|567246956|FG003|Induction|Recurrent leukemia|0|||
157136726|NCT00408005|567246957|FG004|Induction|Recurrent leukemia|0|||
157136727|NCT00408005|567246958|FG005|Induction|Recurrent leukemia|0|||
157136728|NCT00408005|567246959|FG006|Induction|Recurrent leukemia|0|||
157136729|NCT00408005|567246960|FG007|Induction|Recurrent leukemia|0|||
157136730|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156724108|NCT04652726|565737021|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
156724109|NCT04652726|565737022|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
156724110|NCT04652726|565737023|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
156724111|NCT00536939|565737032|FG000|Overall Study|Withdrawal by Subject|1|||
156724112|NCT00536939|565737033|FG001|Overall Study|Withdrawal by Subject|0|||
156724113|NCT00536939|565737032|FG000|Overall Study|Other Complicating Disease|1|||
157136731|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
157136732|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
156724114|NCT00536939|565737033|FG001|Overall Study|Other Complicating Disease|0|||
156724115|NCT04225715|565737034|FG000|Overall Study|Reason not Specified|1|||
156724116|NCT04225715|565737035|FG001|Overall Study|Reason not Specified|0|||
156724117|NCT04225715|565737036|FG002|Overall Study|Reason not Specified|0|||
156724118|NCT04225715|565737037|FG003|Overall Study|Reason not Specified|0|||
156724119|NCT04225715|565737038|FG004|Overall Study|Reason not Specified|0|||
156875748|NCT03237286|566303652|FG000|Overall Study|Withdrawal by Subject|1|||
157136733|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
157136734|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
157136735|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
156724120|NCT04225715|565737039|FG005|Overall Study|Reason not Specified|0|||
156724121|NCT04225715|565737040|FG006|Overall Study|Reason not Specified|0|||
156724122|NCT04225715|565737041|FG007|Overall Study|Reason not Specified|0|||
156724123|NCT04225715|565737042|FG008|Overall Study|Reason not Specified|0|||
156875749|NCT03237286|566303653|FG001|Overall Study|Withdrawal by Subject|0|||
156724124|NCT04225715|565737034|FG000|Overall Study|Protocol Violation|1|||
156724125|NCT04225715|565737035|FG001|Overall Study|Protocol Violation|0|||
156724126|NCT04225715|565737036|FG002|Overall Study|Protocol Violation|0|||
156724127|NCT04225715|565737037|FG003|Overall Study|Protocol Violation|0|||
156724128|NCT04225715|565737038|FG004|Overall Study|Protocol Violation|0|||
156724129|NCT04225715|565737039|FG005|Overall Study|Protocol Violation|9|||
156724130|NCT04225715|565737040|FG006|Overall Study|Protocol Violation|0|||
156724131|NCT04225715|565737041|FG007|Overall Study|Protocol Violation|0|||
156724132|NCT04225715|565737042|FG008|Overall Study|Protocol Violation|0|||
156724133|NCT04225715|565737034|FG000|Overall Study|Withdrawal by Subject|4|||
156724134|NCT04225715|565737035|FG001|Overall Study|Withdrawal by Subject|1|||
156724135|NCT04225715|565737036|FG002|Overall Study|Withdrawal by Subject|1|||
156724136|NCT04225715|565737037|FG003|Overall Study|Withdrawal by Subject|0|||
156724137|NCT04225715|565737038|FG004|Overall Study|Withdrawal by Subject|3|||
156724138|NCT04225715|565737039|FG005|Overall Study|Withdrawal by Subject|1|||
156724139|NCT04225715|565737040|FG006|Overall Study|Withdrawal by Subject|1|||
156724140|NCT04225715|565737041|FG007|Overall Study|Withdrawal by Subject|1|||
156724141|NCT04225715|565737042|FG008|Overall Study|Withdrawal by Subject|0|||
156724142|NCT04225715|565737034|FG000|Overall Study|Adverse Event|0|||
156724143|NCT04225715|565737035|FG001|Overall Study|Adverse Event|0|||
156724144|NCT04225715|565737036|FG002|Overall Study|Adverse Event|0|||
156724145|NCT04225715|565737037|FG003|Overall Study|Adverse Event|0|||
156724146|NCT04225715|565737038|FG004|Overall Study|Adverse Event|0|||
156724147|NCT04225715|565737039|FG005|Overall Study|Adverse Event|0|||
156724148|NCT04225715|565737040|FG006|Overall Study|Adverse Event|0|||
156724149|NCT04225715|565737041|FG007|Overall Study|Adverse Event|0|||
156724150|NCT04225715|565737042|FG008|Overall Study|Adverse Event|1|||
156724151|NCT04225715|565737034|FG000|Overall Study|Arm Terminated By Sponsor|0|||
156724152|NCT04225715|565737035|FG001|Overall Study|Arm Terminated By Sponsor|0|||
156724153|NCT04225715|565737036|FG002|Overall Study|Arm Terminated By Sponsor|0|||
156724154|NCT04225715|565737037|FG003|Overall Study|Arm Terminated By Sponsor|0|||
156724155|NCT04225715|565737038|FG004|Overall Study|Arm Terminated By Sponsor|0|||
156724156|NCT04225715|565737039|FG005|Overall Study|Arm Terminated By Sponsor|0|||
156724157|NCT04225715|565737040|FG006|Overall Study|Arm Terminated By Sponsor|0|||
156724158|NCT04225715|565737041|FG007|Overall Study|Arm Terminated By Sponsor|17|||
156724159|NCT04225715|565737042|FG008|Overall Study|Arm Terminated By Sponsor|18|||
156724160|NCT02275546|565737045|FG000|Treatment Period 2|Withdrawal by Subject|2|||
156724161|NCT02275546|565737046|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156724162|NCT02275546|565737045|FG000|Treatment Period 2|Protocol Violation|0|||
156724163|NCT02275546|565737046|FG001|Treatment Period 2|Protocol Violation|1|||
156724164|NCT00570141|565737056|FG000|Overall Study|Adverse Event|1|||
156724165|NCT00570141|565737056|FG000|Overall Study|Missed visits|1|||
156724166|NCT00570141|565737056|FG000|Overall Study|Lost to Follow-up|1|||
156724167|NCT02309411|565737057|FG000|Overall Study|Physician Decision|1|||
156724168|NCT02309411|565737058|FG001|Overall Study|Physician Decision|0|||
156724169|NCT02309411|565737059|FG002|Overall Study|Physician Decision|0|||
156724170|NCT02309411|565737057|FG000|Overall Study|Withdrawal by Subject|1|||
156724171|NCT02309411|565737058|FG001|Overall Study|Withdrawal by Subject|1|||
156724172|NCT02309411|565737059|FG002|Overall Study|Withdrawal by Subject|0|||
156724173|NCT04878432|565737063|FG000|Overall Study|Adverse Event|1|||
156724174|NCT04878432|565737063|FG000|Overall Study|Death|2|||
156724175|NCT04878432|565737063|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156724176|NCT04878432|565737063|FG000|Overall Study|Withdrawal by Subject|6|||
156724177|NCT04878432|565737063|FG000|Overall Study|Progressive Disease|7|||
156724178|NCT04878432|565737063|FG000|Overall Study|New Therapy for Study Indication|7|||
156724179|NCT04878432|565737063|FG000|Overall Study|Physician Decision|11|||
156724180|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724181|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
156724182|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724183|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724184|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
156724185|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
156724186|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
156724187|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
156724188|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156724189|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
156724190|NCT03971071|565737064|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
156724191|NCT03971071|565737065|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
156724192|NCT03971071|565737066|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
156724193|NCT03971071|565737067|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
156724194|NCT03971071|565737068|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
156724195|NCT03971071|565737064|FG000|Open-label Treatment Period|Sponsor decision|0|||
156724196|NCT03971071|565737065|FG001|Open-label Treatment Period|Sponsor decision|0|||
156724197|NCT03971071|565737066|FG002|Open-label Treatment Period|Sponsor decision|0|||
156724198|NCT03971071|565737067|FG003|Open-label Treatment Period|Sponsor decision|0|||
157136736|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
156724199|NCT03971071|565737068|FG004|Open-label Treatment Period|Sponsor decision|1|||
156724200|NCT03971071|565737064|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
156724201|NCT03971071|565737065|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156724202|NCT03971071|565737066|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156724203|NCT03971071|565737067|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
156724204|NCT03971071|565737068|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
156724205|NCT03971071|565737064|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156724206|NCT03971071|565737065|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156724207|NCT03971071|565737066|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156724208|NCT03971071|565737067|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
156724209|NCT03971071|565737068|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
156724210|NCT00925704|565737069|FG000|First Intervention|Withdrew consent|0|||
156724211|NCT00925704|565737070|FG001|First Intervention|Withdrew consent|0|||
156724212|NCT00925704|565737071|FG002|First Intervention|Withdrew consent|0|||
156724213|NCT00925704|565737072|FG003|First Intervention|Withdrew consent|1|||
156724214|NCT00925704|565737073|FG004|First Intervention|Withdrew consent|1|||
156724215|NCT00925704|565737074|FG005|First Intervention|Withdrew consent|0|||
156724216|NCT00925704|565737069|FG000|Second Intervention|Withdrawal by Subject|1|||
156724217|NCT00925704|565737070|FG001|Second Intervention|Withdrawal by Subject|0|||
156724218|NCT00925704|565737071|FG002|Second Intervention|Withdrawal by Subject|0|||
156724219|NCT00925704|565737072|FG003|Second Intervention|Withdrawal by Subject|0|||
156724220|NCT00925704|565737073|FG004|Second Intervention|Withdrawal by Subject|1|||
156724221|NCT00925704|565737074|FG005|Second Intervention|Withdrawal by Subject|0|||
156724222|NCT00925704|565737069|FG000|Third Intervention|Withdrew consent|0|||
156724223|NCT00925704|565737070|FG001|Third Intervention|Withdrew consent|0|||
156724224|NCT00925704|565737071|FG002|Third Intervention|Withdrew consent|0|||
156724225|NCT00925704|565737072|FG003|Third Intervention|Withdrew consent|0|||
156724226|NCT00925704|565737073|FG004|Third Intervention|Withdrew consent|0|||
156724227|NCT00925704|565737074|FG005|Third Intervention|Withdrew consent|1|||
156724228|NCT03207815|565737075|FG000|Overall Study|Protocol Violation|3|||
156724229|NCT03207815|565737076|FG001|Overall Study|Protocol Violation|1|||
156724230|NCT03207815|565737075|FG000|Overall Study|Adverse Event|1|||
156724231|NCT03207815|565737076|FG001|Overall Study|Adverse Event|2|||
156724232|NCT03207815|565737075|FG000|Overall Study|Lost to Follow-up|1|||
156724233|NCT03207815|565737076|FG001|Overall Study|Lost to Follow-up|2|||
156724234|NCT03207815|565737075|FG000|Overall Study|Investigator's Discretion|1|||
156724235|NCT03207815|565737076|FG001|Overall Study|Investigator's Discretion|1|||
156724236|NCT03207815|565737075|FG000|Overall Study|Lack of Efficacy|0|||
156724237|NCT03207815|565737076|FG001|Overall Study|Lack of Efficacy|1|||
156875750|NCT03237286|566303654|FG002|Overall Study|Withdrawal by Subject|2|||
156875751|NCT03237286|566303652|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
156875752|NCT03237286|566303653|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
156875753|NCT03237286|566303654|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
156875754|NCT02792829|566303662|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
157019357|NCT04021602|566824733|FG001|Overall Study|Adverse Event|0|||
157019358|NCT04021602|566824734|FG002|Overall Study|Adverse Event|1|||
157136737|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
157136738|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
157136739|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
157136740|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
157136741|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
157136742|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
156724238|NCT03207815|565737075|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
156724239|NCT03207815|565737076|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
156724240|NCT03207815|565737075|FG000|Overall Study|Withdrew Consent|1|||
156724241|NCT03207815|565737076|FG001|Overall Study|Withdrew Consent|0|||
156724242|NCT03817853|565737077|FG000|Induction Phase|Adverse Event|5|||
156724243|NCT03817853|565737078|FG001|Induction Phase|Adverse Event|0|||
156724244|NCT03817853|565737079|FG002|Induction Phase|Adverse Event|0|||
156724245|NCT03817853|565737077|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
157136743|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
156724246|NCT03817853|565737078|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
156724247|NCT03817853|565737079|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
156724248|NCT03817853|565737077|FG000|Induction Phase|Physician Decision|2|||
156724249|NCT03817853|565737078|FG001|Induction Phase|Physician Decision|0|||
156724250|NCT03817853|565737079|FG002|Induction Phase|Physician Decision|0|||
156724251|NCT03817853|565737077|FG000|Induction Phase|Progressive Disease|6|||
156724252|NCT03817853|565737078|FG001|Induction Phase|Progressive Disease|0|||
156724253|NCT03817853|565737079|FG002|Induction Phase|Progressive Disease|0|||
156724254|NCT03817853|565737077|FG000|Induction Phase|Withdrawal by Subject|4|||
157136744|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
157136745|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
157136746|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
157136747|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
157136748|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
157136749|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
157136750|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
157136751|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
156724255|NCT03817853|565737078|FG001|Induction Phase|Withdrawal by Subject|0|||
156724256|NCT03817853|565737079|FG002|Induction Phase|Withdrawal by Subject|0|||
156724257|NCT03817853|565737077|FG000|Maintenance Phase|Adverse Event|0|||
156724258|NCT03817853|565737078|FG001|Maintenance Phase|Adverse Event|8|||
156724259|NCT03817853|565737079|FG002|Maintenance Phase|Adverse Event|0|||
156724260|NCT03817853|565737077|FG000|Maintenance Phase|Death|0|||
156724261|NCT03817853|565737078|FG001|Maintenance Phase|Death|5|||
156724262|NCT03817853|565737079|FG002|Maintenance Phase|Death|0|||
156724263|NCT03817853|565737077|FG000|Maintenance Phase|Progressive Disease|0|||
156724264|NCT03817853|565737078|FG001|Maintenance Phase|Progressive Disease|7|||
156724265|NCT03817853|565737079|FG002|Maintenance Phase|Progressive Disease|0|||
156724266|NCT03817853|565737077|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156724267|NCT03817853|565737078|FG001|Maintenance Phase|Withdrawal by Subject|2|||
156724268|NCT03817853|565737079|FG002|Maintenance Phase|Withdrawal by Subject|0|||
156724269|NCT03817853|565737077|FG000|Maintenance Phase|Physician Decision|0|||
156724270|NCT03817853|565737078|FG001|Maintenance Phase|Physician Decision|1|||
156724271|NCT03817853|565737079|FG002|Maintenance Phase|Physician Decision|0|||
156724272|NCT03817853|565737077|FG000|Maintenance Phase|Various reasons|0|||
156724273|NCT03817853|565737078|FG001|Maintenance Phase|Various reasons|4|||
156724274|NCT03817853|565737079|FG002|Maintenance Phase|Various reasons|0|||
156724275|NCT03817853|565737077|FG000|Maintenance Phase|Protocol Deviation|0|||
156724276|NCT03817853|565737078|FG001|Maintenance Phase|Protocol Deviation|1|||
156724277|NCT03817853|565737079|FG002|Maintenance Phase|Protocol Deviation|0|||
156724278|NCT03817853|565737077|FG000|Follow-up Phase|Adverse Event|0|||
156724279|NCT03817853|565737078|FG001|Follow-up Phase|Adverse Event|0|||
156724280|NCT03817853|565737079|FG002|Follow-up Phase|Adverse Event|2|||
156724281|NCT03817853|565737077|FG000|Follow-up Phase|Death|0|||
156724282|NCT03817853|565737078|FG001|Follow-up Phase|Death|0|||
156724283|NCT03817853|565737079|FG002|Follow-up Phase|Death|1|||
156724284|NCT03817853|565737077|FG000|Follow-up Phase|Progressive Disease|0|||
156875755|NCT02792829|566303663|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
156875756|NCT02792829|566303664|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875757|NCT02792829|566303665|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875758|NCT02792829|566303666|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875759|NCT02792829|566303667|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875760|NCT02792829|566303668|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875761|NCT02792829|566303669|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
156875762|NCT02792829|566303662|FG000|Treatment Period 2|Adverse Event|0|||
156875763|NCT02792829|566303663|FG001|Treatment Period 2|Adverse Event|0|||
156875764|NCT02792829|566303664|FG002|Treatment Period 2|Adverse Event|0|||
156875765|NCT02792829|566303665|FG003|Treatment Period 2|Adverse Event|0|||
156875766|NCT02792829|566303666|FG004|Treatment Period 2|Adverse Event|1|||
156875767|NCT02792829|566303667|FG005|Treatment Period 2|Adverse Event|0|||
156875768|NCT02792829|566303668|FG006|Treatment Period 2|Adverse Event|1|||
156875769|NCT02792829|566303669|FG007|Treatment Period 2|Adverse Event|1|||
156875770|NCT02792829|566303662|FG000|Treatment Period 2|Use of proscribed medications|0|||
156875771|NCT02792829|566303663|FG001|Treatment Period 2|Use of proscribed medications|0|||
156875772|NCT02792829|566303664|FG002|Treatment Period 2|Use of proscribed medications|0|||
157136752|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
157136753|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
157136754|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
157136755|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
156724285|NCT03817853|565737078|FG001|Follow-up Phase|Progressive Disease|0|||
156724286|NCT03817853|565737079|FG002|Follow-up Phase|Progressive Disease|3|||
156724287|NCT03817853|565737077|FG000|Follow-up Phase|Withdrawal by Subject|0|||
156724288|NCT03817853|565737078|FG001|Follow-up Phase|Withdrawal by Subject|0|||
157136756|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
156724289|NCT03817853|565737079|FG002|Follow-up Phase|Withdrawal by Subject|1|||
156724290|NCT00391768|565737080|FG000|Overall Study|Withdrawal by Subject|0|||
156724291|NCT00391768|565737081|FG001|Overall Study|Withdrawal by Subject|0|||
156724292|NCT00391768|565737082|FG002|Overall Study|Withdrawal by Subject|1|||
156724293|NCT00391768|565737083|FG003|Overall Study|Withdrawal by Subject|0|||
156724294|NCT00391768|565737084|FG004|Overall Study|Withdrawal by Subject|0|||
156875773|NCT02792829|566303665|FG003|Treatment Period 2|Use of proscribed medications|0|||
156875774|NCT02792829|566303666|FG004|Treatment Period 2|Use of proscribed medications|0|||
157136757|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
157136758|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
157136759|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
157136760|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
157136761|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
157136762|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
157136763|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
157136764|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
157136765|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
157136766|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
157136767|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
157136768|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
157136769|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
157136770|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
157136771|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
157136772|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
157136773|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
157136774|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
157136775|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
157136776|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
157136777|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
157136778|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136779|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136780|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136781|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136782|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
157136783|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136784|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136785|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
157136786|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
157136787|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
157136788|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
157136789|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
157136790|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
157136791|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
157136792|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
157136793|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
157136794|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
157136795|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
157136796|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
157136797|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
157136798|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
157136799|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
157136800|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
157136801|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
157136802|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156724295|NCT00391768|565737085|FG005|Overall Study|Withdrawal by Subject|1|||
156724296|NCT00391768|565737086|FG006|Overall Study|Withdrawal by Subject|1|||
156724297|NCT00391768|565737080|FG000|Overall Study|Lost to Follow-up|0|||
156724298|NCT00391768|565737081|FG001|Overall Study|Lost to Follow-up|0|||
156724299|NCT00391768|565737082|FG002|Overall Study|Lost to Follow-up|0|||
156724300|NCT00391768|565737083|FG003|Overall Study|Lost to Follow-up|1|||
156724301|NCT00391768|565737084|FG004|Overall Study|Lost to Follow-up|2|||
156724302|NCT00391768|565737085|FG005|Overall Study|Lost to Follow-up|2|||
156724303|NCT00391768|565737086|FG006|Overall Study|Lost to Follow-up|3|||
156724304|NCT01256450|565737089|FG000|Open-label Titration|Adverse Event|39|||
156794800|NCT01217892|566002779|FG000|Overall Study|Withdrawal by Subject|0|||
156724305|NCT01256450|565737090|FG001|Open-label Titration|Adverse Event|0|||
156724306|NCT01256450|565737091|FG002|Open-label Titration|Adverse Event|0|||
156724307|NCT01256450|565737089|FG000|Open-label Titration|Lost to Follow-up|7|||
156724308|NCT01256450|565737090|FG001|Open-label Titration|Lost to Follow-up|0|||
157136803|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
157136804|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
156724309|NCT01256450|565737091|FG002|Open-label Titration|Lost to Follow-up|0|||
157136805|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
157136806|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
157136807|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
157136808|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
157136809|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
157136810|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
157136811|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
157136812|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
157136813|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
157136814|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
157136815|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
157136816|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
157136817|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
157136818|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
157136819|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
157136820|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
157136821|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
157136822|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
157136823|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
157136824|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156724310|NCT01256450|565737089|FG000|Open-label Titration|Lack of analgesic effect|30|||
156724311|NCT01256450|565737090|FG001|Open-label Titration|Lack of analgesic effect|0|||
156724312|NCT01256450|565737091|FG002|Open-label Titration|Lack of analgesic effect|0|||
156724313|NCT01256450|565737089|FG000|Open-label Titration|Non-compliance|9|||
156724314|NCT01256450|565737090|FG001|Open-label Titration|Non-compliance|0|||
156724315|NCT01256450|565737091|FG002|Open-label Titration|Non-compliance|0|||
156724316|NCT01256450|565737089|FG000|Open-label Titration|Screen failure|1|||
156724317|NCT01256450|565737090|FG001|Open-label Titration|Screen failure|0|||
156724318|NCT01256450|565737091|FG002|Open-label Titration|Screen failure|0|||
156724319|NCT01256450|565737089|FG000|Open-label Titration|Other|13|||
156724320|NCT01256450|565737090|FG001|Open-label Titration|Other|0|||
156724321|NCT01256450|565737091|FG002|Open-label Titration|Other|0|||
156724322|NCT01256450|565737089|FG000|Double-blind Treatment|Adverse Event|0|||
156724323|NCT01256450|565737090|FG001|Double-blind Treatment|Adverse Event|8|||
156724324|NCT01256450|565737091|FG002|Double-blind Treatment|Adverse Event|6|||
156724325|NCT01256450|565737089|FG000|Double-blind Treatment|Lost to Follow-up|0|||
156724326|NCT01256450|565737090|FG001|Double-blind Treatment|Lost to Follow-up|1|||
156724327|NCT01256450|565737091|FG002|Double-blind Treatment|Lost to Follow-up|7|||
156724328|NCT01256450|565737089|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
156724329|NCT01256450|565737090|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
156724330|NCT01256450|565737091|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
156724331|NCT01256450|565737089|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
156724332|NCT01256450|565737090|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
156724333|NCT01256450|565737091|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
156724334|NCT01256450|565737089|FG000|Double-blind Treatment|Non-compliance|0|||
156724335|NCT01256450|565737090|FG001|Double-blind Treatment|Non-compliance|5|||
156724336|NCT01256450|565737091|FG002|Double-blind Treatment|Non-compliance|4|||
156724337|NCT01256450|565737089|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
156724338|NCT01256450|565737090|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
156724339|NCT01256450|565737091|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
156724340|NCT01256450|565737089|FG000|Double-blind Treatment|Other|0|||
156794801|NCT01217892|566002780|FG001|Overall Study|Withdrawal by Subject|2|||
156794802|NCT01217892|566002781|FG002|Overall Study|Withdrawal by Subject|1|||
156794803|NCT01217892|566002782|FG003|Overall Study|Withdrawal by Subject|0|||
157136825|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
156724341|NCT01256450|565737090|FG001|Double-blind Treatment|Other|9|||
156724342|NCT01256450|565737091|FG002|Double-blind Treatment|Other|12|||
156794804|NCT01217892|566002779|FG000|Overall Study|Lab value|1|||
156794805|NCT01217892|566002780|FG001|Overall Study|Lab value|0|||
156724343|NCT00891020|565737093|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
156724344|NCT00891020|565737094|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
156724345|NCT00891020|565737095|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
156724346|NCT00891020|565737093|FG000|24 Week Treatment Period|Death|0|||
156794806|NCT01217892|566002781|FG002|Overall Study|Lab value|1|||
156794807|NCT01217892|566002782|FG003|Overall Study|Lab value|0|||
156724347|NCT00891020|565737094|FG001|24 Week Treatment Period|Death|2|||
156724348|NCT00891020|565737095|FG002|24 Week Treatment Period|Death|0|||
156724349|NCT00891020|565737093|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
156724350|NCT00891020|565737094|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
156724351|NCT00891020|565737095|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
156724352|NCT00891020|565737093|FG000|24 Week Treatment Period|Failure to return|4|||
156724353|NCT00891020|565737094|FG001|24 Week Treatment Period|Failure to return|5|||
156724354|NCT00891020|565737095|FG002|24 Week Treatment Period|Failure to return|5|||
156724355|NCT00891020|565737093|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
156724356|NCT00891020|565737094|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
156724357|NCT00891020|565737095|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
156724358|NCT00891020|565737093|FG000|24 Week Treatment Period|Other protocol violation|1|||
156724359|NCT00891020|565737094|FG001|24 Week Treatment Period|Other protocol violation|1|||
156724360|NCT00891020|565737095|FG002|24 Week Treatment Period|Other protocol violation|2|||
156724361|NCT00891020|565737093|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
156724362|NCT00891020|565737094|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
156724363|NCT00891020|565737095|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
156724364|NCT00891020|565737093|FG000|24 Week Treatment Period|Withdrew consent|6|||
156724365|NCT00891020|565737094|FG001|24 Week Treatment Period|Withdrew consent|3|||
156724366|NCT00891020|565737095|FG002|24 Week Treatment Period|Withdrew consent|15|||
156724367|NCT00891020|565737093|FG000|24 Week Treatment Period|Administrative/Other|5|||
156724368|NCT00891020|565737094|FG001|24 Week Treatment Period|Administrative/Other|6|||
156724369|NCT00891020|565737095|FG002|24 Week Treatment Period|Administrative/Other|1|||
156724370|NCT00891020|565737093|FG000|Long-term Extension Period|Adverse Event|1|||
156724371|NCT00891020|565737094|FG001|Long-term Extension Period|Adverse Event|11|||
156724372|NCT00891020|565737095|FG002|Long-term Extension Period|Adverse Event|10|||
156724373|NCT00891020|565737093|FG000|Long-term Extension Period|Death|0|||
156724374|NCT00891020|565737094|FG001|Long-term Extension Period|Death|0|||
156724375|NCT00891020|565737095|FG002|Long-term Extension Period|Death|1|||
156724376|NCT00891020|565737093|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
156724377|NCT00891020|565737094|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
156724378|NCT00891020|565737095|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
156724379|NCT00891020|565737093|FG000|Long-term Extension Period|Protocol Violation|0|||
156724380|NCT00891020|565737094|FG001|Long-term Extension Period|Protocol Violation|1|||
156724381|NCT00891020|565737095|FG002|Long-term Extension Period|Protocol Violation|1|||
156724382|NCT00891020|565737093|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
157136826|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
157136827|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
157136828|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
157136829|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
157136830|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
157136831|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
157136832|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
157136833|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
157136834|NCT00408005|567246953|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
157136835|NCT00408005|567246954|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
157136836|NCT00408005|567246955|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
157136837|NCT00408005|567246956|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
157136838|NCT00408005|567246957|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
157136839|NCT00408005|567246958|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
156724383|NCT00891020|565737094|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
156724384|NCT00891020|565737095|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
156724385|NCT00891020|565737093|FG000|Long-term Extension Period|Failure to return|0|||
156724386|NCT00891020|565737094|FG001|Long-term Extension Period|Failure to return|2|||
156724387|NCT00891020|565737095|FG002|Long-term Extension Period|Failure to return|3|||
156724388|NCT00891020|565737093|FG000|Long-term Extension Period|Administrative|1|||
156724389|NCT00891020|565737094|FG001|Long-term Extension Period|Administrative|2|||
156724390|NCT00891020|565737095|FG002|Long-term Extension Period|Administrative|2|||
156724391|NCT03866512|565737097|FG000|Overall Study|Lost to Follow-up|1|||
156724392|NCT03866512|565737098|FG001|Overall Study|Lost to Follow-up|2|||
156724393|NCT03866512|565737099|FG002|Overall Study|Lost to Follow-up|1|||
156724394|NCT03866512|565737097|FG000|Overall Study|Cannulation issues|0|||
156724395|NCT03866512|565737098|FG001|Overall Study|Cannulation issues|1|||
156724396|NCT03866512|565737099|FG002|Overall Study|Cannulation issues|2|||
156724397|NCT00320710|565737100|FG000|Overall Study|Disease progression|24|||
156724398|NCT00320710|565737101|FG001|Overall Study|Disease progression|19|||
157136840|NCT00408005|567246959|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
156724399|NCT00320710|565737102|FG002|Overall Study|Disease progression|2|||
156724400|NCT00320710|565737100|FG000|Overall Study|Death|10|||
156724401|NCT00320710|565737101|FG001|Overall Study|Death|7|||
156724402|NCT00320710|565737102|FG002|Overall Study|Death|1|||
156724403|NCT00320710|565737100|FG000|Overall Study|Administrative problems|1|||
156724404|NCT00320710|565737101|FG001|Overall Study|Administrative problems|2|||
156724405|NCT00320710|565737102|FG002|Overall Study|Administrative problems|0|||
156724406|NCT00320710|565737100|FG000|Overall Study|Withdrawal by Subject|20|||
156724407|NCT00320710|565737101|FG001|Overall Study|Withdrawal by Subject|26|||
156724408|NCT00320710|565737102|FG002|Overall Study|Withdrawal by Subject|1|||
156724409|NCT00320710|565737100|FG000|Overall Study|Protocol Violation|6|||
156724410|NCT00320710|565737101|FG001|Overall Study|Protocol Violation|5|||
156724411|NCT00320710|565737102|FG002|Overall Study|Protocol Violation|0|||
156724412|NCT00320710|565737100|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156724413|NCT00320710|565737101|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156724414|NCT00320710|565737102|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156724415|NCT00320710|565737100|FG000|Overall Study|Abnormal laboratory value(s)|12|||
156724416|NCT00320710|565737101|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156724417|NCT00320710|565737102|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156724418|NCT00320710|565737100|FG000|Overall Study|Adverse Event|18|||
156724419|NCT00320710|565737101|FG001|Overall Study|Adverse Event|14|||
156724420|NCT00320710|565737102|FG002|Overall Study|Adverse Event|1|||
156724421|NCT00320710|565737100|FG000|Overall Study|Lost to Follow-up|1|||
156724422|NCT00320710|565737101|FG001|Overall Study|Lost to Follow-up|0|||
156724423|NCT00320710|565737102|FG002|Overall Study|Lost to Follow-up|0|||
156724424|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
156724425|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724426|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724427|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724428|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
156724429|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
156724430|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
157136841|NCT00408005|567246960|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
157136842|NCT05424276|567246965|FG000|Overall Study|Adverse Event|1|||
157136843|NCT05424276|567246966|FG001|Overall Study|Adverse Event|0|||
157136844|NCT05424276|567246967|FG002|Overall Study|Adverse Event|0|||
156724431|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
156724432|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
157136845|NCT05424276|567246968|FG003|Overall Study|Adverse Event|2|||
157136846|NCT05424276|567246965|FG000|Overall Study|Withdrawal by Subject|0|||
156724433|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724434|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724435|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
156724436|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
156724437|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724438|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724439|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724440|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
156724441|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724442|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724443|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724444|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
156724445|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724446|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724447|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724448|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
156724449|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156875775|NCT02792829|566303667|FG005|Treatment Period 2|Use of proscribed medications|0|||
157136847|NCT05424276|567246966|FG001|Overall Study|Withdrawal by Subject|0|||
156724450|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156724451|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
156724452|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
156724453|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724454|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724455|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
156724456|NCT00506415|565737104|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
156724457|NCT00506415|565737105|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
157136848|NCT05424276|567246967|FG002|Overall Study|Withdrawal by Subject|2|||
157136849|NCT05424276|567246968|FG003|Overall Study|Withdrawal by Subject|0|||
157136850|NCT05424276|567246965|FG000|Overall Study|Protocol Violation|0|||
157136851|NCT05424276|567246966|FG001|Overall Study|Protocol Violation|1|||
157136852|NCT05424276|567246967|FG002|Overall Study|Protocol Violation|0|||
157136853|NCT05424276|567246968|FG003|Overall Study|Protocol Violation|0|||
157136854|NCT05424276|567246965|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
157136855|NCT05424276|567246966|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
156875776|NCT02792829|566303668|FG006|Treatment Period 2|Use of proscribed medications|0|||
156875777|NCT02792829|566303669|FG007|Treatment Period 2|Use of proscribed medications|1|||
156875778|NCT00104520|566303672|FG000|Overall Study|Unrelated adverse event|34|||
156875779|NCT00104520|566303673|FG001|Overall Study|Unrelated adverse event|47|||
156875780|NCT00104520|566303672|FG000|Overall Study|Study drug intolerance|0|||
156875781|NCT00104520|566303673|FG001|Overall Study|Study drug intolerance|1|||
156875782|NCT00104520|566303672|FG000|Overall Study|Related adverse event|13|||
156875783|NCT00104520|566303673|FG001|Overall Study|Related adverse event|15|||
156875784|NCT00104520|566303672|FG000|Overall Study|Lost to Follow-up|1|||
157136856|NCT05424276|567246967|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
157136857|NCT05424276|567246968|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
157136858|NCT04454489|567246970|FG000|Overall Study|Disease progression|12|||
157136859|NCT04454489|567246970|FG000|Overall Study|Death|4|||
157136860|NCT04454489|567246970|FG000|Overall Study|Adverse Event|1|||
157136861|NCT04454489|567246970|FG000|Overall Study|Physician Decision|1|||
157136862|NCT00501228|567246972|FG000|Overall Study|Withdrawal by Subject|1|||
157136863|NCT01147926|567246975|FG000|Overall Study|Subject Withdrew Consent|9|||
156724458|NCT00506415|565737106|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724459|NCT00506415|565737107|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724460|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
156724461|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
156724462|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
156724463|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
156724464|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
156724465|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
156724466|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
156724467|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
156724468|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
156875785|NCT00104520|566303673|FG001|Overall Study|Lost to Follow-up|0|||
156875786|NCT00104520|566303672|FG000|Overall Study|Noncompliance|0|||
156875787|NCT00104520|566303673|FG001|Overall Study|Noncompliance|2|||
156875788|NCT00104520|566303672|FG000|Overall Study|Personal/administrative|1|||
156875789|NCT00104520|566303673|FG001|Overall Study|Personal/administrative|1|||
157136864|NCT01147926|567246976|FG001|Overall Study|Subject Withdrew Consent|10|||
157136865|NCT01147926|567246975|FG000|Overall Study|Adverse Event|7|||
157136866|NCT01147926|567246976|FG001|Overall Study|Adverse Event|6|||
157136867|NCT01147926|567246975|FG000|Overall Study|Subject Non-Compliant|5|||
157136868|NCT01147926|567246976|FG001|Overall Study|Subject Non-Compliant|4|||
157136869|NCT01147926|567246975|FG000|Overall Study|Principal investigator left hospital|1|||
157136870|NCT01147926|567246976|FG001|Overall Study|Principal investigator left hospital|3|||
157136871|NCT01147926|567246975|FG000|Overall Study|Selection criteria not met|3|||
156875790|NCT00104520|566303672|FG000|Overall Study|Other|1|||
156875791|NCT00104520|566303673|FG001|Overall Study|Other|5|||
157136872|NCT01147926|567246976|FG001|Overall Study|Selection criteria not met|1|||
157136873|NCT01147926|567246975|FG000|Overall Study|Lost to Follow-up|0|||
157136874|NCT01147926|567246976|FG001|Overall Study|Lost to Follow-up|2|||
157136875|NCT01147926|567246975|FG000|Overall Study|Sponsor's Decision|0|||
157136876|NCT01147926|567246976|FG001|Overall Study|Sponsor's Decision|1|||
157136877|NCT01147926|567246975|FG000|Overall Study|Lack of Efficacy|1|||
157136878|NCT01147926|567246976|FG001|Overall Study|Lack of Efficacy|0|||
157136879|NCT01147926|567246975|FG000|Overall Study|Too busy, no time for study|1|||
157136880|NCT01147926|567246976|FG001|Overall Study|Too busy, no time for study|0|||
157136881|NCT01147926|567246975|FG000|Overall Study|Went on holiday|0|||
156724469|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
156875792|NCT01010867|566303677|FG000|Overall Study|< 50% adherence to probiotic|1|||
156875793|NCT01668589|566303678|FG000|Overall Study|Lost to Follow-up|29|||
157136882|NCT01147926|567246976|FG001|Overall Study|Went on holiday|1|||
157136883|NCT01147926|567246975|FG000|Overall Study|Colonoscopy result|0|||
157136884|NCT01147926|567246976|FG001|Overall Study|Colonoscopy result|1|||
157136885|NCT03514914|567246977|FG000|Overall Study|Death|3|||
157136886|NCT03514914|567246978|FG001|Overall Study|Death|3|||
157136887|NCT03514914|567246977|FG000|Overall Study|Lost to Follow-up|117|||
157136888|NCT03514914|567246978|FG001|Overall Study|Lost to Follow-up|89|||
156724470|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
156724471|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
156875794|NCT01668589|566303679|FG001|Overall Study|Lost to Follow-up|37|||
156875795|NCT01668589|566303680|FG002|Overall Study|Lost to Follow-up|15|||
157136889|NCT03926143|567246980|FG000|Overall Study|Physician Decision|3|||
157136890|NCT03926143|567246980|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
157136891|NCT03926143|567246980|FG000|Overall Study|Adverse Event|2|||
157136892|NCT03926143|567246980|FG000|Overall Study|Progressive disease|3|||
156724472|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
156724473|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
156724474|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
156724475|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
156724476|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
156724477|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
156724478|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
156724479|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
156724480|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
156724481|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
156724482|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
156724483|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
156724484|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
156724485|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
156724486|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
156724487|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
156724488|NCT00506415|565737104|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724489|NCT00506415|565737105|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724490|NCT00506415|565737106|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
156724491|NCT00506415|565737107|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
156724492|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724493|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724494|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
156724495|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
156724496|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724497|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724498|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
156724499|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
156724500|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724501|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724502|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
156724503|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
156724504|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724505|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724506|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
156724507|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
156724508|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724509|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724510|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
156724511|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
157019359|NCT03892616|566824735|FG000|Washout Period 2|Met discontinuation criterion|0|||
157136893|NCT02561156|567246985|FG000|Part 2|Adverse Event|0|||
156724512|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724513|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724514|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
156724515|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
156724516|NCT00506415|565737104|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724517|NCT00506415|565737105|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724518|NCT00506415|565737106|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
156724519|NCT00506415|565737107|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
156724520|NCT00997373|565737108|FG000|Overall Study|Withdrawal by Subject|5|||
156724521|NCT00997373|565737109|FG001|Overall Study|Withdrawal by Subject|0|||
156724522|NCT00997373|565737108|FG000|Overall Study|wrong tumor type|4|||
156724523|NCT00997373|565737109|FG001|Overall Study|wrong tumor type|0|||
156724524|NCT00997373|565737108|FG000|Overall Study|could not have hysterectomy|6|||
156724525|NCT00997373|565737109|FG001|Overall Study|could not have hysterectomy|0|||
156724526|NCT04578457|565737110|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
156724527|NCT04578457|565737110|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
156724528|NCT04578457|565737110|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
156724529|NCT04578457|565737110|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
156724530|NCT02841995|565737117|FG000|Overall Study|Disease progression|5|||
156724531|NCT02841995|565737118|FG001|Overall Study|Disease progression|11|||
157019360|NCT03892616|566824736|FG001|Washout Period 2|Met discontinuation criterion|0|||
157136894|NCT02561156|567246986|FG001|Part 2|Adverse Event|0|||
157136895|NCT02561156|567246987|FG002|Part 2|Adverse Event|0|||
157136896|NCT02561156|567246988|FG003|Part 2|Adverse Event|0|||
157136897|NCT02561156|567246989|FG004|Part 2|Adverse Event|0|||
157136898|NCT02561156|567246990|FG005|Part 2|Adverse Event|0|||
157136899|NCT02561156|567246991|FG006|Part 2|Adverse Event|0|||
157136900|NCT02561156|567246992|FG007|Part 2|Adverse Event|0|||
156724532|NCT02841995|565737119|FG002|Overall Study|Disease progression|8|||
156724533|NCT02841995|565737117|FG000|Overall Study|Withdrawal by Subject|2|||
156724534|NCT02841995|565737118|FG001|Overall Study|Withdrawal by Subject|4|||
156724535|NCT02841995|565737119|FG002|Overall Study|Withdrawal by Subject|4|||
156724536|NCT02841995|565737117|FG000|Overall Study|Adverse Event|2|||
156724537|NCT02841995|565737118|FG001|Overall Study|Adverse Event|0|||
156724538|NCT02841995|565737119|FG002|Overall Study|Adverse Event|1|||
156724539|NCT02841995|565737117|FG000|Overall Study|Investigator decision|2|||
156724540|NCT02841995|565737118|FG001|Overall Study|Investigator decision|0|||
156724541|NCT02841995|565737119|FG002|Overall Study|Investigator decision|1|||
156724542|NCT02841995|565737117|FG000|Overall Study|Death|0|||
156724543|NCT02841995|565737118|FG001|Overall Study|Death|0|||
156724544|NCT02841995|565737119|FG002|Overall Study|Death|2|||
156724545|NCT02841995|565737117|FG000|Overall Study|Noncompliance to protocol|1|||
156724546|NCT02841995|565737118|FG001|Overall Study|Noncompliance to protocol|0|||
156724547|NCT02841995|565737119|FG002|Overall Study|Noncompliance to protocol|0|||
156724548|NCT02841995|565737117|FG000|Overall Study|Sponsor decision|1|||
156724549|NCT02841995|565737118|FG001|Overall Study|Sponsor decision|0|||
156724550|NCT02841995|565737119|FG002|Overall Study|Sponsor decision|0|||
156724551|NCT02841995|565737117|FG000|Overall Study|Other|4|||
156724552|NCT02841995|565737118|FG001|Overall Study|Other|1|||
156724553|NCT02841995|565737119|FG002|Overall Study|Other|5|||
156724554|NCT03376789|565737120|FG000|Overall Study|Withdrawal by Subject|3|||
156724555|NCT03376789|565737121|FG001|Overall Study|Withdrawal by Subject|5|||
156724556|NCT03376789|565737120|FG000|Overall Study|Protocol Violation|0|||
156724557|NCT03376789|565737121|FG001|Overall Study|Protocol Violation|1|||
156724558|NCT03376789|565737120|FG000|Overall Study|Adverse Event|0|||
156724559|NCT03376789|565737121|FG001|Overall Study|Adverse Event|1|||
156724560|NCT03376789|565737120|FG000|Overall Study|Lost to Follow-up|1|||
156724561|NCT03376789|565737121|FG001|Overall Study|Lost to Follow-up|1|||
156724562|NCT03376789|565737120|FG000|Overall Study|Per sponsor due to noncompliance|1|||
156724563|NCT03376789|565737121|FG001|Overall Study|Per sponsor due to noncompliance|0|||
156724564|NCT03376789|565737120|FG000|Overall Study|Subject off study medication|0|||
156724565|NCT03376789|565737121|FG001|Overall Study|Subject off study medication|1|||
156724566|NCT01703260|565737122|FG000|Overall Study|Adverse Event|1|||
156724567|NCT01703260|565737123|FG001|Overall Study|Adverse Event|2|||
156724568|NCT01703260|565737124|FG002|Overall Study|Adverse Event|2|||
156724569|NCT01703260|565737122|FG000|Overall Study|Lost to Follow-up|1|||
156724570|NCT01703260|565737123|FG001|Overall Study|Lost to Follow-up|0|||
156724571|NCT01703260|565737124|FG002|Overall Study|Lost to Follow-up|0|||
156724572|NCT01703260|565737122|FG000|Overall Study|Withdrawal by Subject|0|||
156724573|NCT01703260|565737123|FG001|Overall Study|Withdrawal by Subject|0|||
156724574|NCT01703260|565737124|FG002|Overall Study|Withdrawal by Subject|1|||
156724575|NCT01703260|565737122|FG000|Overall Study|Study Termination|1|||
156724576|NCT01703260|565737123|FG001|Overall Study|Study Termination|2|||
156724577|NCT01703260|565737124|FG002|Overall Study|Study Termination|0|||
156794808|NCT01217892|566002779|FG000|Overall Study|Subject no longer meets study criteria|5|||
157136901|NCT02561156|567246993|FG008|Part 2|Adverse Event|0|||
157136902|NCT02561156|567246994|FG009|Part 2|Adverse Event|0|||
157019361|NCT03892616|566824737|FG002|Washout Period 2|Met discontinuation criterion|0|||
157136903|NCT02561156|567246995|FG010|Part 2|Adverse Event|0|||
157136904|NCT02561156|567246996|FG011|Part 2|Adverse Event|1|||
157136905|NCT02561156|567246997|FG012|Part 2|Adverse Event|0|||
156724578|NCT01464424|565737128|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
156724579|NCT01464424|565737129|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
156724580|NCT02632409|565737132|FG000|Randomized|AE unrelated to study Drug|0|||
156724581|NCT02632409|565737133|FG001|Randomized|AE unrelated to study Drug|1|||
156724582|NCT02632409|565737132|FG000|Randomized|Participant withdrew consent|2|||
156724583|NCT02632409|565737133|FG001|Randomized|Participant withdrew consent|1|||
156724584|NCT02632409|565737132|FG000|Randomized|No Longer meets study criteria|5|||
156724585|NCT02632409|565737133|FG001|Randomized|No Longer meets study criteria|0|||
156875796|NCT01668589|566303681|FG003|Overall Study|Lost to Follow-up|5|||
157136906|NCT01071070|567247001|FG000|Overall Study|Adverse Event|0|||
157136907|NCT01071070|567247002|FG001|Overall Study|Adverse Event|3|||
156724586|NCT02632409|565737132|FG000|Randomized|other reasons|1|||
156724587|NCT02632409|565737133|FG001|Randomized|other reasons|0|||
156724588|NCT02632409|565737132|FG000|Treatment Period|Ongoing Treatment|20|||
156724589|NCT02632409|565737133|FG001|Treatment Period|Ongoing Treatment|21|||
156724590|NCT02632409|565737132|FG000|Treatment Period|Disease Recurrence|147|||
156724591|NCT02632409|565737133|FG001|Treatment Period|Disease Recurrence|90|||
156724592|NCT02632409|565737132|FG000|Treatment Period|Study Drug Toxicity|8|||
156724593|NCT02632409|565737133|FG001|Treatment Period|Study Drug Toxicity|49|||
157136908|NCT01071070|567247001|FG000|Overall Study|Withdrawal by Subject|1|||
157136909|NCT01071070|567247002|FG001|Overall Study|Withdrawal by Subject|0|||
157136910|NCT01071070|567247001|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
156724594|NCT02632409|565737132|FG000|Treatment Period|Death|1|||
156724595|NCT02632409|565737133|FG001|Treatment Period|Death|0|||
156724596|NCT02632409|565737132|FG000|Treatment Period|AE unrelated to study drug|15|||
156724597|NCT02632409|565737133|FG001|Treatment Period|AE unrelated to study drug|16|||
156724598|NCT02632409|565737132|FG000|Treatment Period|Request to discontinue treatment|4|||
156724599|NCT02632409|565737133|FG001|Treatment Period|Request to discontinue treatment|19|||
156724600|NCT02632409|565737132|FG000|Treatment Period|Participant withdrew consent|7|||
156724601|NCT02632409|565737133|FG001|Treatment Period|Participant withdrew consent|5|||
156724602|NCT02632409|565737132|FG000|Treatment Period|Lost to Follow-up|0|||
156724603|NCT02632409|565737133|FG001|Treatment Period|Lost to Follow-up|1|||
156724604|NCT02632409|565737132|FG000|Treatment Period|Maximum clinical benefit|1|||
156724605|NCT02632409|565737133|FG001|Treatment Period|Maximum clinical benefit|0|||
156724606|NCT02632409|565737132|FG000|Treatment Period|No longer meets study criteria|3|||
156724607|NCT02632409|565737133|FG001|Treatment Period|No longer meets study criteria|0|||
156724608|NCT02632409|565737132|FG000|Treatment Period|Administrative Reason by sponsor|0|||
156724609|NCT02632409|565737133|FG001|Treatment Period|Administrative Reason by sponsor|1|||
156724610|NCT02632409|565737132|FG000|Treatment Period|Other Reasons|10|||
156724611|NCT02632409|565737133|FG001|Treatment Period|Other Reasons|6|||
156724612|NCT03331796|565737134|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
156724613|NCT03331796|565737135|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
156724614|NCT03331796|565737136|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
156724615|NCT03331796|565737134|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
156724616|NCT03331796|565737135|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
156724617|NCT03331796|565737136|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
156724618|NCT03331796|565737134|FG000|Extended Follow-up|Adverse Event|1|||
156724619|NCT03331796|565737135|FG001|Extended Follow-up|Adverse Event|0|||
156724620|NCT03331796|565737136|FG002|Extended Follow-up|Adverse Event|1|||
156724621|NCT03331796|565737134|FG000|Extended Follow-up|Lost to Follow-up|0|||
156724622|NCT03331796|565737135|FG001|Extended Follow-up|Lost to Follow-up|0|||
156724623|NCT03331796|565737136|FG002|Extended Follow-up|Lost to Follow-up|1|||
156724624|NCT03331796|565737134|FG000|Extended Follow-up|Withdrawal by Subject|1|||
156724625|NCT03331796|565737135|FG001|Extended Follow-up|Withdrawal by Subject|0|||
156724626|NCT03331796|565737136|FG002|Extended Follow-up|Withdrawal by Subject|0|||
156724627|NCT03331796|565737134|FG000|Extended Follow-up|Termination of Funding|0|||
156724628|NCT03331796|565737135|FG001|Extended Follow-up|Termination of Funding|1|||
156724629|NCT03331796|565737136|FG002|Extended Follow-up|Termination of Funding|0|||
156724630|NCT04426006|565737137|FG000|Inclusion|Protocol Violation|1|||
156724631|NCT04426006|565737137|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
156724632|NCT04426006|565737137|FG000|Inclusion|Blood sample at inclusion not done|1|||
156724633|NCT04426006|565737137|FG000|3 Months|Lost to Follow-up|17|||
156724634|NCT04426006|565737137|FG000|12 Months|Lost to Follow-up|38|||
156724635|NCT01000155|565737138|FG000|Overall Study|Withdrawal by Subject|1|||
156724636|NCT01000155|565737138|FG000|Overall Study|Adverse Event|1|||
156724637|NCT04760626|565737139|FG000|Overall Study|Withdrawal by Subject|24|||
156724638|NCT04760626|565737140|FG001|Overall Study|Withdrawal by Subject|20|||
156724639|NCT04760626|565737139|FG000|Overall Study|Lost to Follow-up|14|||
156794809|NCT01217892|566002780|FG001|Overall Study|Subject no longer meets study criteria|2|||
156794810|NCT01217892|566002781|FG002|Overall Study|Subject no longer meets study criteria|4|||
156794811|NCT01217892|566002782|FG003|Overall Study|Subject no longer meets study criteria|8|||
156794812|NCT01217892|566002779|FG000|Overall Study|Incorrect enrollment|0|||
156794813|NCT01217892|566002780|FG001|Overall Study|Incorrect enrollment|1|||
156794814|NCT01217892|566002781|FG002|Overall Study|Incorrect enrollment|1|||
156794815|NCT01217892|566002782|FG003|Overall Study|Incorrect enrollment|0|||
156794816|NCT01217892|566002779|FG000|Overall Study|Poor/Non-Compliance|0|||
156794817|NCT01217892|566002780|FG001|Overall Study|Poor/Non-Compliance|0|||
156794818|NCT01217892|566002781|FG002|Overall Study|Poor/Non-Compliance|1|||
156794819|NCT01217892|566002782|FG003|Overall Study|Poor/Non-Compliance|0|||
156794820|NCT00480532|566002785|FG000|Overall Study|Withdrawal by Subject|2|||
156794821|NCT00480532|566002786|FG001|Overall Study|Withdrawal by Subject|4|||
156794822|NCT00480532|566002787|FG002|Overall Study|Withdrawal by Subject|3|||
156794823|NCT00480532|566002788|FG003|Overall Study|Withdrawal by Subject|1|||
157019362|NCT03892616|566824738|FG003|Washout Period 2|Met discontinuation criterion|0|||
157136911|NCT01071070|567247002|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
156724640|NCT04760626|565737140|FG001|Overall Study|Lost to Follow-up|19|||
156724641|NCT04760626|565737139|FG000|Overall Study|Physician Decision|3|||
156724642|NCT04760626|565737140|FG001|Overall Study|Physician Decision|5|||
156724643|NCT04760626|565737139|FG000|Overall Study|Death|3|||
156724644|NCT04760626|565737140|FG001|Overall Study|Death|6|||
156724645|NCT04760626|565737139|FG000|Overall Study|Site closure|1|||
156724646|NCT04760626|565737140|FG001|Overall Study|Site closure|0|||
156794824|NCT00480532|566002785|FG000|Overall Study|Protocol Violation|0|||
156794825|NCT00480532|566002786|FG001|Overall Study|Protocol Violation|0|||
156794826|NCT00480532|566002787|FG002|Overall Study|Protocol Violation|1|||
156794827|NCT00480532|566002788|FG003|Overall Study|Protocol Violation|0|||
156724647|NCT00908544|565737143|FG000|Overall Study|Withdrawal by Subject|2|||
156724648|NCT00908544|565737144|FG001|Overall Study|Withdrawal by Subject|4|||
156724649|NCT00908544|565737143|FG000|Overall Study|Lack of Efficacy|0|||
156724650|NCT00908544|565737144|FG001|Overall Study|Lack of Efficacy|1|||
156724651|NCT00908544|565737143|FG000|Overall Study|Pregnancy|1|||
156724652|NCT00908544|565737144|FG001|Overall Study|Pregnancy|0|||
156724653|NCT00908544|565737143|FG000|Overall Study|Relocation abroad|1|||
156724654|NCT00908544|565737144|FG001|Overall Study|Relocation abroad|1|||
156724655|NCT00908544|565737143|FG000|Overall Study|Unable to visit sutdy center|1|||
156724656|NCT00908544|565737144|FG001|Overall Study|Unable to visit sutdy center|0|||
156724657|NCT00740636|565737147|FG000|Overall Study|Adverse Event|0|||
156724658|NCT00740636|565737148|FG001|Overall Study|Adverse Event|2|||
156724659|NCT00740636|565737147|FG000|Overall Study|Patient Ineligible|0|||
156724660|NCT00740636|565737148|FG001|Overall Study|Patient Ineligible|1|||
156724661|NCT00740636|565737147|FG000|Overall Study|Patient Not Treated|0|||
156724662|NCT00740636|565737148|FG001|Overall Study|Patient Not Treated|1|||
156724663|NCT00740636|565737147|FG000|Overall Study|Progressive Disease|1|||
156724664|NCT00740636|565737148|FG001|Overall Study|Progressive Disease|0|||
156724665|NCT00740636|565737147|FG000|Overall Study|Death|1|||
156724666|NCT00740636|565737148|FG001|Overall Study|Death|0|||
156724667|NCT02462603|565737153|FG000|Overall Study|Investigator Decision|1|||
156724668|NCT02462603|565737153|FG000|Overall Study|Non-Compliance|1|||
156724669|NCT02462603|565737153|FG000|Overall Study|Withdrawal by Subject|2|||
156724670|NCT04955691|565738948|FG000|Period 2|Discontinued intervention|1|||
156724671|NCT04955691|565738949|FG001|Period 2|Discontinued intervention|2|||
156724672|NCT05795153|565738950|FG000|Overall Study|Adverse Event|2|||
156724673|NCT05795153|565738950|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156724674|NCT05795153|565738950|FG000|Overall Study|Lost to Follow-up|1|||
157136912|NCT01071070|567247001|FG000|Overall Study|Hypercalcemia|1|||
156724675|NCT05795153|565738950|FG000|Overall Study|Subject decision|2|||
156724676|NCT05336227|565738951|FG000|Overall Study|Adverse Event|1|||
156724677|NCT05336227|565738952|FG001|Overall Study|Adverse Event|0|||
156724678|NCT05336227|565738951|FG000|Overall Study|Lost to Follow-up|2|||
156724679|NCT05336227|565738952|FG001|Overall Study|Lost to Follow-up|0|||
156724680|NCT05336227|565738951|FG000|Overall Study|Withdrawal by Subject|1|||
156724681|NCT05336227|565738952|FG001|Overall Study|Withdrawal by Subject|0|||
156724682|NCT04050462|565738953|FG000|Overall Study|Withdrawal by Subject|1|||
156724683|NCT04050462|565738954|FG001|Overall Study|Withdrawal by Subject|0|||
156724684|NCT04050462|565738955|FG002|Overall Study|Withdrawal by Subject|0|||
156724685|NCT05151744|565738958|FG000|Overall Study|Adverse Event|6|||
156724686|NCT05151744|565738959|FG001|Overall Study|Adverse Event|2|||
156724687|NCT05151744|565738958|FG000|Overall Study|Death|1|||
156724688|NCT05151744|565738959|FG001|Overall Study|Death|2|||
156724689|NCT05151744|565738958|FG000|Overall Study|Lack of Efficacy|1|||
157136913|NCT01071070|567247002|FG001|Overall Study|Hypercalcemia|0|||
157136914|NCT01478958|567247012|FG000|Overall Study|Withdrawal by Subject|1|||
156724690|NCT05151744|565738959|FG001|Overall Study|Lack of Efficacy|1|||
156724691|NCT05151744|565738958|FG000|Overall Study|Lost to Follow-up|2|||
156724692|NCT05151744|565738959|FG001|Overall Study|Lost to Follow-up|2|||
156724693|NCT05151744|565738958|FG000|Overall Study|Need for Rescue Treatment|0|||
156724694|NCT05151744|565738959|FG001|Overall Study|Need for Rescue Treatment|1|||
156724695|NCT05151744|565738958|FG000|Overall Study|Non-compliance with Study Drug|0|||
156724696|NCT05151744|565738959|FG001|Overall Study|Non-compliance with Study Drug|1|||
156724697|NCT05151744|565738958|FG000|Overall Study|Reason not Specified|10|||
156724698|NCT05151744|565738959|FG001|Overall Study|Reason not Specified|0|||
156724699|NCT05151744|565738958|FG000|Overall Study|Physician Decision|2|||
156724700|NCT05151744|565738959|FG001|Overall Study|Physician Decision|1|||
156724701|NCT05151744|565738958|FG000|Overall Study|Protocol Violation|1|||
156724702|NCT05151744|565738959|FG001|Overall Study|Protocol Violation|0|||
156724703|NCT05151744|565738958|FG000|Overall Study|Withdrawal by Subject|6|||
156724704|NCT05151744|565738959|FG001|Overall Study|Withdrawal by Subject|3|||
156724705|NCT05228470|565738960|FG000|Overall Study|Death|6|||
156724706|NCT05228470|565738961|FG001|Overall Study|Death|11|||
156724707|NCT05228470|565738960|FG000|Overall Study|Withdrawal by Subject|1|||
156724708|NCT05228470|565738961|FG001|Overall Study|Withdrawal by Subject|8|||
156724709|NCT05228470|565738960|FG000|Overall Study|Ongoing|1|||
156724710|NCT05228470|565738961|FG001|Overall Study|Ongoing|11|||
156724711|NCT01068678|565738964|FG000|Overall Study|Lack of Efficacy|3|||
156724712|NCT01068678|565738965|FG001|Overall Study|Lack of Efficacy|2|||
156724713|NCT01068678|565738964|FG000|Overall Study|Protocol Violation|5|||
156724714|NCT01068678|565738965|FG001|Overall Study|Protocol Violation|1|||
156724715|NCT01068678|565738964|FG000|Overall Study|Withdrawal criteria|12|||
156724716|NCT01068678|565738965|FG001|Overall Study|Withdrawal criteria|6|||
156724717|NCT01068678|565738964|FG000|Overall Study|Unclassified|18|||
156724718|NCT01068678|565738965|FG001|Overall Study|Unclassified|15|||
156724719|NCT03123120|565738976|FG000|Overall Study|Lost to Follow-up|0|||
156724720|NCT03123120|565738977|FG001|Overall Study|Lost to Follow-up|1|||
156724721|NCT03123120|565738976|FG000|Overall Study|Withdrawal by Subject|0|||
156724722|NCT03123120|565738977|FG001|Overall Study|Withdrawal by Subject|1|||
156724723|NCT02632175|565738978|FG000|Overall Study|Withdrawal by Subject|6|||
156724724|NCT02632175|565738978|FG000|Overall Study|Lost to Follow-up|1|||
156724725|NCT02632175|565738978|FG000|Overall Study|Lack of Efficacy|18|||
156724726|NCT02632175|565738978|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
156724727|NCT02632175|565738978|FG000|Overall Study|Subject noncompliance|3|||
156724728|NCT02632175|565738978|FG000|Overall Study|other|2|||
156724729|NCT02088554|565738979|FG000|Overall Study|Exited before procedure|130|||
156724730|NCT02088554|565738979|FG000|Overall Study|Attempted but not implanted|31|||
156724731|NCT02088554|565738979|FG000|Overall Study|Implant not attempted|19|||
156724732|NCT02088554|565738979|FG000|Overall Study|Pending next visit|532|||
156724733|NCT02088554|565738979|FG000|Overall Study|Death|170|||
156724734|NCT02088554|565738979|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
156724735|NCT02088554|565738979|FG000|Overall Study|Lost to Follow-up|23|||
156724736|NCT02088554|565738979|FG000|Overall Study|Explanted|32|||
156724737|NCT02088554|565738979|FG000|Overall Study|Any other reason not covered by previous categories|11|||
156724738|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
156724739|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
156724740|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
156724741|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
156724742|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
156724743|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
156724744|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Death|0|||
156724745|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Death|0|||
156724746|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Death|0|||
156724747|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Death|0|||
156724748|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Death|0|||
156724749|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Death|2|||
156724750|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724751|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724752|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724753|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
157019363|NCT03892616|566824739|FG004|Washout Period 2|Met discontinuation criterion|0|||
156724754|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
156724755|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
156724756|NCT04066244|565738981|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724757|NCT04066244|565738982|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724758|NCT04066244|565738983|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724759|NCT04066244|565738984|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724760|NCT04066244|565738985|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
156724761|NCT04066244|565738986|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
156724762|NCT00866281|565738987|FG000|Overall Study|Adverse Event|1|||
156724763|NCT00866281|565738988|FG001|Overall Study|Adverse Event|0|||
156724764|NCT00866281|565738987|FG000|Overall Study|Withdrawal by participants|3|||
156724765|NCT00866281|565738988|FG001|Overall Study|Withdrawal by participants|0|||
156724766|NCT00866281|565738987|FG000|Overall Study|Disease progression|3|||
156724767|NCT00866281|565738988|FG001|Overall Study|Disease progression|11|||
156724768|NCT00866281|565738987|FG000|Overall Study|New cancer therapy|0|||
156724769|NCT00866281|565738988|FG001|Overall Study|New cancer therapy|4|||
156724770|NCT02955355|565738994|FG000|Overall Study|Adverse Event|4|||
156724771|NCT02955355|565738994|FG000|Overall Study|Death|1|||
156724772|NCT02955355|565738994|FG000|Overall Study|Physician Decision|21|||
156724773|NCT02955355|565738994|FG000|Overall Study|Site Terminated by Sponsor|35|||
156724774|NCT02955355|565738994|FG000|Overall Study|Withdrawal by Subject|19|||
156724775|NCT02955355|565738994|FG000|Overall Study|Reason Not Specified|5|||
156724776|NCT02612623|565738995|FG000|Overall Study|Withdrawal by Subject|0|||
156724777|NCT02612623|565738996|FG001|Overall Study|Withdrawal by Subject|1|||
156724778|NCT02612623|565738997|FG002|Overall Study|Withdrawal by Subject|0|||
156724779|NCT02612623|565738998|FG003|Overall Study|Withdrawal by Subject|0|||
156724780|NCT02612623|565738995|FG000|Overall Study|Adverse Event|1|||
156724781|NCT02612623|565738996|FG001|Overall Study|Adverse Event|0|||
156724782|NCT02612623|565738997|FG002|Overall Study|Adverse Event|1|||
156724783|NCT02612623|565738998|FG003|Overall Study|Adverse Event|0|||
156724784|NCT01671007|565739005|FG000|Overall Study|Other reasons than listed|166|||
156724785|NCT01671007|565739006|FG001|Overall Study|Other reasons than listed|373|||
156724786|NCT01671007|565739007|FG002|Overall Study|Other reasons than listed|197|||
156724787|NCT01671007|565739008|FG003|Overall Study|Other reasons than listed|228|||
156724788|NCT01671007|565739009|FG004|Overall Study|Other reasons than listed|14|||
156724789|NCT01671007|565739010|FG005|Overall Study|Other reasons than listed|71|||
156724790|NCT01671007|565739011|FG006|Overall Study|Other reasons than listed|17|||
156724791|NCT01671007|565739012|FG007|Overall Study|Other reasons than listed|66|||
156724792|NCT01671007|565739013|FG008|Overall Study|Other reasons than listed|0|||
156724793|NCT01671007|565739005|FG000|Overall Study|Withdrawal by Subject|36|||
156724794|NCT01671007|565739006|FG001|Overall Study|Withdrawal by Subject|59|||
156724795|NCT01671007|565739007|FG002|Overall Study|Withdrawal by Subject|53|||
156724796|NCT01671007|565739008|FG003|Overall Study|Withdrawal by Subject|58|||
156724797|NCT01671007|565739009|FG004|Overall Study|Withdrawal by Subject|4|||
156724798|NCT01671007|565739010|FG005|Overall Study|Withdrawal by Subject|15|||
156794828|NCT01592747|566002789|FG000|Overall Study|Loss of Therapeutic Response|107|||
156794829|NCT01592747|566002790|FG001|Overall Study|Loss of Therapeutic Response|108|||
156794830|NCT01592747|566002791|FG002|Overall Study|Loss of Therapeutic Response|100|||
156794831|NCT01592747|566002789|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156794832|NCT01592747|566002790|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156794833|NCT01592747|566002791|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
156794834|NCT01592747|566002789|FG000|Overall Study|Adverse Event|1|||
156794835|NCT01592747|566002790|FG001|Overall Study|Adverse Event|0|||
156794836|NCT01592747|566002791|FG002|Overall Study|Adverse Event|0|||
156794837|NCT01592747|566002789|FG000|Overall Study|Protocol Violation|4|||
156794838|NCT01592747|566002790|FG001|Overall Study|Protocol Violation|0|||
156794839|NCT01592747|566002791|FG002|Overall Study|Protocol Violation|4|||
156794840|NCT01592747|566002789|FG000|Overall Study|Lack of Efficacy|0|||
156875797|NCT01668589|566303678|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
156875798|NCT01668589|566303679|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
156875799|NCT01668589|566303680|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
156875800|NCT01668589|566303681|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
156875801|NCT01668589|566303678|FG000|Overall Study|Death|12|||
156875802|NCT01668589|566303679|FG001|Overall Study|Death|3|||
156875803|NCT01668589|566303680|FG002|Overall Study|Death|2|||
156875804|NCT01668589|566303681|FG003|Overall Study|Death|11|||
156875805|NCT01668589|566303678|FG000|Overall Study|Other|44|||
156875806|NCT01668589|566303679|FG001|Overall Study|Other|10|||
156875807|NCT01668589|566303680|FG002|Overall Study|Other|7|||
156875808|NCT01668589|566303681|FG003|Overall Study|Other|15|||
156875809|NCT00233064|566303682|FG000|Overall Study|Lost to Follow-up|7|||
156875810|NCT00233064|566303683|FG001|Overall Study|Lost to Follow-up|7|||
156875811|NCT00233064|566303682|FG000|Overall Study|Withdrawal by Subject|5|||
156875812|NCT00233064|566303683|FG001|Overall Study|Withdrawal by Subject|3|||
156875813|NCT00233064|566303682|FG000|Overall Study|Death|0|||
156875814|NCT00233064|566303683|FG001|Overall Study|Death|1|||
156875815|NCT00233064|566303682|FG000|Overall Study|Relocation|0|||
156875816|NCT00233064|566303683|FG001|Overall Study|Relocation|1|||
156875817|NCT00233064|566303682|FG000|Overall Study|Protocol Violation|1|||
156875818|NCT00233064|566303683|FG001|Overall Study|Protocol Violation|0|||
156875819|NCT00233064|566303682|FG000|Overall Study|Moved to Dom. Republic|1|||
156875820|NCT00233064|566303683|FG001|Overall Study|Moved to Dom. Republic|0|||
156875821|NCT02302339|566303684|FG000|Overall Study|Lost to Follow-up|1|||
156875822|NCT02302339|566303685|FG001|Overall Study|Lost to Follow-up|0|||
156875823|NCT02302339|566303686|FG002|Overall Study|Lost to Follow-up|0|||
156875824|NCT02302339|566303687|FG003|Overall Study|Lost to Follow-up|0|||
156875825|NCT02302339|566303684|FG000|Overall Study|Withdrawal by Subject|0|||
156875826|NCT02302339|566303685|FG001|Overall Study|Withdrawal by Subject|2|||
156875827|NCT02302339|566303686|FG002|Overall Study|Withdrawal by Subject|1|||
156875828|NCT02302339|566303687|FG003|Overall Study|Withdrawal by Subject|0|||
156875829|NCT04393454|566303690|FG000|Overall Study|Death|1|||
156875830|NCT04393454|566303690|FG000|Overall Study|Lost to Follow-up|1|||
156875831|NCT02752165|566303692|FG000|Overall Study|Withdrawal by Subject|6|||
156875832|NCT02752165|566303693|FG001|Overall Study|Withdrawal by Subject|6|||
156875833|NCT02752165|566303692|FG000|Overall Study|Protocol Violation|6|||
156875834|NCT02752165|566303693|FG001|Overall Study|Protocol Violation|5|||
156875835|NCT02752165|566303692|FG000|Overall Study|Lost to Follow-up|33|||
156875836|NCT02752165|566303693|FG001|Overall Study|Lost to Follow-up|38|||
156875837|NCT01120964|566303694|FG000|Overall Study|Did not receive full treatment|1|||
156875838|NCT01120964|566303695|FG001|Overall Study|Did not receive full treatment|0|||
156875839|NCT01704599|566303699|FG000|Overall Study|Adverse Event|1|||
156875840|NCT00912197|566303700|FG000|Overall Study|Withdrawal by Subject|3|||
157019364|NCT03892616|566824740|FG005|Washout Period 2|Met discontinuation criterion|0|||
157019365|NCT03892616|566824741|FG006|Washout Period 2|Met discontinuation criterion|0|||
157019366|NCT03892616|566824742|FG007|Washout Period 2|Met discontinuation criterion|0|||
156794841|NCT01592747|566002790|FG001|Overall Study|Lack of Efficacy|1|||
157136915|NCT01478958|567247013|FG001|Overall Study|Withdrawal by Subject|1|||
156794842|NCT01592747|566002791|FG002|Overall Study|Lack of Efficacy|0|||
156794843|NCT01592747|566002789|FG000|Overall Study|Withdrawal by Subject|2|||
156794844|NCT01592747|566002790|FG001|Overall Study|Withdrawal by Subject|0|||
156794845|NCT01592747|566002791|FG002|Overall Study|Withdrawal by Subject|2|||
156794846|NCT01592747|566002789|FG000|Overall Study|Lost to Follow-up|1|||
156794847|NCT01592747|566002790|FG001|Overall Study|Lost to Follow-up|0|||
156875841|NCT00912197|566303701|FG001|Overall Study|Withdrawal by Subject|3|||
156875842|NCT03304249|566303706|FG000|Overall Study|Lost to Follow-up|8|||
156875843|NCT03304249|566303707|FG001|Overall Study|Lost to Follow-up|10|||
156875844|NCT03304249|566303706|FG000|Overall Study|Withdrawal by Subject|12|||
156875845|NCT03304249|566303707|FG001|Overall Study|Withdrawal by Subject|2|||
156875846|NCT03304249|566303706|FG000|Overall Study|Moved Out of District|4|||
156875847|NCT03304249|566303707|FG001|Overall Study|Moved Out of District|2|||
156875848|NCT00494676|566303713|FG000|Allocation|Withdrawal by Subject|2|||
156875849|NCT00494676|566303714|FG001|Allocation|Withdrawal by Subject|4|||
156875850|NCT00494676|566303713|FG000|First Intervention|Withdrawal by Subject|1|||
156724799|NCT01671007|565739011|FG006|Overall Study|Withdrawal by Subject|1|||
156724800|NCT01671007|565739012|FG007|Overall Study|Withdrawal by Subject|19|||
156724801|NCT01671007|565739013|FG008|Overall Study|Withdrawal by Subject|0|||
156724802|NCT01671007|565739005|FG000|Overall Study|Lost to Follow-up|93|||
156724803|NCT01671007|565739006|FG001|Overall Study|Lost to Follow-up|142|||
156724804|NCT01671007|565739007|FG002|Overall Study|Lost to Follow-up|91|||
156724805|NCT01671007|565739008|FG003|Overall Study|Lost to Follow-up|63|||
156724806|NCT01671007|565739009|FG004|Overall Study|Lost to Follow-up|7|||
156724807|NCT01671007|565739010|FG005|Overall Study|Lost to Follow-up|20|||
156724808|NCT01671007|565739011|FG006|Overall Study|Lost to Follow-up|2|||
156724809|NCT01671007|565739012|FG007|Overall Study|Lost to Follow-up|28|||
156724810|NCT01671007|565739013|FG008|Overall Study|Lost to Follow-up|0|||
156724811|NCT01671007|565739005|FG000|Overall Study|No end of study case report form|3|||
156724812|NCT01671007|565739006|FG001|Overall Study|No end of study case report form|1|||
156724813|NCT01671007|565739007|FG002|Overall Study|No end of study case report form|0|||
156724814|NCT01671007|565739008|FG003|Overall Study|No end of study case report form|2|||
156724815|NCT01671007|565739009|FG004|Overall Study|No end of study case report form|0|||
156724816|NCT01671007|565739010|FG005|Overall Study|No end of study case report form|0|||
156724817|NCT01671007|565739011|FG006|Overall Study|No end of study case report form|0|||
156724818|NCT01671007|565739012|FG007|Overall Study|No end of study case report form|0|||
156724819|NCT01671007|565739013|FG008|Overall Study|No end of study case report form|0|||
156724820|NCT01671007|565739005|FG000|Overall Study|Not eligible|23|||
156724821|NCT01671007|565739006|FG001|Overall Study|Not eligible|76|||
156724822|NCT01671007|565739007|FG002|Overall Study|Not eligible|25|||
156724823|NCT01671007|565739008|FG003|Overall Study|Not eligible|17|||
156724824|NCT01671007|565739009|FG004|Overall Study|Not eligible|0|||
156724825|NCT01671007|565739010|FG005|Overall Study|Not eligible|6|||
156724826|NCT01671007|565739011|FG006|Overall Study|Not eligible|1|||
156724827|NCT01671007|565739012|FG007|Overall Study|Not eligible|19|||
156724828|NCT01671007|565739013|FG008|Overall Study|Not eligible|0|||
156724829|NCT03877068|565739014|FG000|Overall Study|Physician Decision|9|||
156724830|NCT03877068|565739015|FG001|Overall Study|Physician Decision|3|||
156724831|NCT03187301|565739018|FG000|Titration Period|Adverse Event|0|||
156724832|NCT03187301|565739019|FG001|Titration Period|Adverse Event|0|||
156724833|NCT03187301|565739020|FG002|Titration Period|Adverse Event|0|||
156724834|NCT03187301|565739021|FG003|Titration Period|Adverse Event|0|||
156724835|NCT03187301|565739022|FG004|Titration Period|Adverse Event|0|||
156724836|NCT03187301|565739023|FG005|Titration Period|Adverse Event|0|||
156724837|NCT03187301|565739024|FG006|Titration Period|Adverse Event|5|||
156724838|NCT03187301|565739018|FG000|Titration Period|Withdrawal by Subject|0|||
156724839|NCT03187301|565739019|FG001|Titration Period|Withdrawal by Subject|0|||
156724840|NCT03187301|565739020|FG002|Titration Period|Withdrawal by Subject|0|||
156724841|NCT03187301|565739021|FG003|Titration Period|Withdrawal by Subject|0|||
156724842|NCT03187301|565739022|FG004|Titration Period|Withdrawal by Subject|0|||
156724843|NCT03187301|565739023|FG005|Titration Period|Withdrawal by Subject|0|||
156724844|NCT03187301|565739024|FG006|Titration Period|Withdrawal by Subject|1|||
156724845|NCT03187301|565739018|FG000|Titration Period|Exclusion Criteria Met|0|||
156724846|NCT03187301|565739019|FG001|Titration Period|Exclusion Criteria Met|0|||
156724847|NCT03187301|565739020|FG002|Titration Period|Exclusion Criteria Met|0|||
156724848|NCT03187301|565739021|FG003|Titration Period|Exclusion Criteria Met|0|||
156724849|NCT03187301|565739022|FG004|Titration Period|Exclusion Criteria Met|0|||
156724850|NCT03187301|565739023|FG005|Titration Period|Exclusion Criteria Met|0|||
156794848|NCT01592747|566002791|FG002|Overall Study|Lost to Follow-up|1|||
156794849|NCT01592747|566002789|FG000|Overall Study|Other Reasons|1|||
156794850|NCT01592747|566002790|FG001|Overall Study|Other Reasons|1|||
156794851|NCT01592747|566002791|FG002|Overall Study|Other Reasons|0|||
156794852|NCT02367885|566002792|FG000|Overall Study|Lost to Follow-up|1|||
156794853|NCT02367885|566002793|FG001|Overall Study|Lost to Follow-up|0|||
156794854|NCT02367885|566002794|FG002|Overall Study|Lost to Follow-up|0|||
156794855|NCT02367885|566002792|FG000|Overall Study|Withdrawal by Subject|1|||
156794856|NCT02367885|566002793|FG001|Overall Study|Withdrawal by Subject|0|||
156724851|NCT03187301|565739024|FG006|Titration Period|Exclusion Criteria Met|1|||
156724852|NCT03187301|565739018|FG000|Pre-Intervention|Withdrawal by Subject|1|||
156724853|NCT03187301|565739019|FG001|Pre-Intervention|Withdrawal by Subject|0|||
156794857|NCT02367885|566002794|FG002|Overall Study|Withdrawal by Subject|0|||
156794858|NCT01602484|566002795|FG000|Overall Study|Airway issues unrelated to study|0|||
156794859|NCT01602484|566002796|FG001|Overall Study|Airway issues unrelated to study|1|||
156724854|NCT03187301|565739020|FG002|Pre-Intervention|Withdrawal by Subject|0|||
156724855|NCT03187301|565739021|FG003|Pre-Intervention|Withdrawal by Subject|0|||
156724856|NCT03187301|565739022|FG004|Pre-Intervention|Withdrawal by Subject|0|||
156724857|NCT03187301|565739023|FG005|Pre-Intervention|Withdrawal by Subject|0|||
156724858|NCT03187301|565739024|FG006|Pre-Intervention|Withdrawal by Subject|0|||
156724859|NCT03809663|565739027|FG000|Overall Study|Decision by sponsor|24|||
156724860|NCT03809663|565739028|FG001|Overall Study|Decision by sponsor|18|||
156724861|NCT03809663|565739029|FG002|Overall Study|Decision by sponsor|20|||
156724862|NCT03809663|565739030|FG003|Overall Study|Decision by sponsor|20|||
156724863|NCT03809663|565739031|FG004|Overall Study|Decision by sponsor|0|||
157136916|NCT01478958|567247014|FG002|Overall Study|Withdrawal by Subject|1|||
157136917|NCT01478958|567247012|FG000|Overall Study|Weight loss|1|||
157136918|NCT01478958|567247013|FG001|Overall Study|Weight loss|0|||
157136919|NCT01478958|567247014|FG002|Overall Study|Weight loss|0|||
157136920|NCT01478958|567247012|FG000|Overall Study|Re-located|0|||
157136921|NCT01478958|567247013|FG001|Overall Study|Re-located|1|||
157136922|NCT01478958|567247014|FG002|Overall Study|Re-located|0|||
157136923|NCT01478958|567247012|FG000|Overall Study|Unable to comply|0|||
157136924|NCT01478958|567247013|FG001|Overall Study|Unable to comply|0|||
157136925|NCT01478958|567247014|FG002|Overall Study|Unable to comply|2|||
157136926|NCT01147809|567247015|FG000|Phase I (168 Days)|Adverse Event|0|||
157136927|NCT01147809|567247016|FG001|Phase I (168 Days)|Adverse Event|0|||
157136928|NCT01147809|567247017|FG002|Phase I (168 Days)|Adverse Event|0|||
157136929|NCT01147809|567247018|FG003|Phase I (168 Days)|Adverse Event|1|||
157136930|NCT01147809|567247019|FG004|Phase I (168 Days)|Adverse Event|0|||
157136931|NCT01147809|567247020|FG005|Phase I (168 Days)|Adverse Event|0|||
157136932|NCT01147809|567247015|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
157136933|NCT01147809|567247016|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
157136934|NCT01147809|567247017|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
157136935|NCT01147809|567247018|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
157136936|NCT01147809|567247019|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
157136937|NCT01147809|567247020|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
157136938|NCT01147809|567247015|FG000|Phase I (168 Days)|Physician Decision|0|||
157136939|NCT01147809|567247016|FG001|Phase I (168 Days)|Physician Decision|1|||
157136940|NCT01147809|567247017|FG002|Phase I (168 Days)|Physician Decision|2|||
157136941|NCT01147809|567247018|FG003|Phase I (168 Days)|Physician Decision|0|||
157136942|NCT01147809|567247019|FG004|Phase I (168 Days)|Physician Decision|0|||
157136943|NCT01147809|567247020|FG005|Phase I (168 Days)|Physician Decision|0|||
157136944|NCT01147809|567247015|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
157136945|NCT01147809|567247016|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
157136946|NCT01147809|567247017|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
157136947|NCT01147809|567247018|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
157136948|NCT01147809|567247019|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
156724864|NCT03809663|565739032|FG005|Overall Study|Decision by sponsor|0|||
156724865|NCT03809663|565739027|FG000|Overall Study|Withdrawal by Subject|26|||
156724866|NCT03809663|565739028|FG001|Overall Study|Withdrawal by Subject|22|||
156724867|NCT03809663|565739029|FG002|Overall Study|Withdrawal by Subject|27|||
156724868|NCT03809663|565739030|FG003|Overall Study|Withdrawal by Subject|26|||
156724869|NCT03809663|565739031|FG004|Overall Study|Withdrawal by Subject|0|||
156724870|NCT03809663|565739032|FG005|Overall Study|Withdrawal by Subject|0|||
156724871|NCT03809663|565739027|FG000|Overall Study|Lost to Follow-up|1|||
156724872|NCT03809663|565739028|FG001|Overall Study|Lost to Follow-up|4|||
156724873|NCT03809663|565739029|FG002|Overall Study|Lost to Follow-up|1|||
156724874|NCT03809663|565739030|FG003|Overall Study|Lost to Follow-up|1|||
156724875|NCT03809663|565739031|FG004|Overall Study|Lost to Follow-up|0|||
156724876|NCT03809663|565739032|FG005|Overall Study|Lost to Follow-up|0|||
156724877|NCT02042014|565739036|FG000|Overall Study|Adverse Event|1|||
156724878|NCT02042014|565739036|FG000|Overall Study|Physician Decision|7|||
156724879|NCT02792062|565739037|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
156724880|NCT02792062|565739038|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724881|NCT02792062|565739039|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724882|NCT02792062|565739040|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724883|NCT02792062|565739041|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724884|NCT02792062|565739042|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
156724885|NCT00558701|565739046|FG000|Overall Study|Protocol Deviations|1|||
156724886|NCT00558701|565739047|FG001|Overall Study|Protocol Deviations|4|||
156724887|NCT02230904|565739048|FG000|Overall Study|Safety follow up could not take place|0|||
156724888|NCT02230904|565739049|FG001|Overall Study|Safety follow up could not take place|1|||
156724889|NCT01262872|565739051|FG000|Step 2|Death|0|||
156724890|NCT01262872|565739052|FG001|Step 2|Death|0|||
156724891|NCT01262872|565739053|FG002|Step 2|Death|0|||
156724892|NCT01262872|565739054|FG003|Step 2|Death|1|||
156724893|NCT01262872|565739055|FG004|Step 2|Death|0|||
156724894|NCT01262872|565739056|FG005|Step 2|Death|2|||
156724895|NCT01262872|565739057|FG006|Step 2|Death|2|||
156724896|NCT01262872|565739058|FG007|Step 2|Death|1|||
156724897|NCT01262872|565739051|FG000|Step 2|Protocol Violation|0|||
156724898|NCT01262872|565739052|FG001|Step 2|Protocol Violation|0|||
156724899|NCT01262872|565739053|FG002|Step 2|Protocol Violation|1|||
156724900|NCT01262872|565739054|FG003|Step 2|Protocol Violation|0|||
156724901|NCT01262872|565739055|FG004|Step 2|Protocol Violation|0|||
156724902|NCT01262872|565739056|FG005|Step 2|Protocol Violation|0|||
156724903|NCT01262872|565739057|FG006|Step 2|Protocol Violation|3|||
156724904|NCT01262872|565739058|FG007|Step 2|Protocol Violation|1|||
157136949|NCT01147809|567247020|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
157136950|NCT01147809|567247015|FG000|Phase II (168 Days)|Adverse Event|0|||
157136951|NCT01147809|567247016|FG001|Phase II (168 Days)|Adverse Event|0|||
157136952|NCT01147809|567247017|FG002|Phase II (168 Days)|Adverse Event|0|||
157136953|NCT01147809|567247018|FG003|Phase II (168 Days)|Adverse Event|0|||
157136954|NCT01147809|567247019|FG004|Phase II (168 Days)|Adverse Event|3|||
156724905|NCT01262872|565739051|FG000|Step 2|Withdrawal by Subject|0|||
156724906|NCT01262872|565739052|FG001|Step 2|Withdrawal by Subject|0|||
156724907|NCT01262872|565739053|FG002|Step 2|Withdrawal by Subject|4|||
156724908|NCT01262872|565739054|FG003|Step 2|Withdrawal by Subject|6|||
156724909|NCT01262872|565739055|FG004|Step 2|Withdrawal by Subject|3|||
156724910|NCT01262872|565739056|FG005|Step 2|Withdrawal by Subject|1|||
156724911|NCT01262872|565739057|FG006|Step 2|Withdrawal by Subject|2|||
156724912|NCT01262872|565739058|FG007|Step 2|Withdrawal by Subject|1|||
156724913|NCT01262872|565739051|FG000|Step 2|Migrated/moved from study area|0|||
156724914|NCT01262872|565739052|FG001|Step 2|Migrated/moved from study area|0|||
156724915|NCT01262872|565739053|FG002|Step 2|Migrated/moved from study area|4|||
156724916|NCT01262872|565739054|FG003|Step 2|Migrated/moved from study area|3|||
156724917|NCT01262872|565739055|FG004|Step 2|Migrated/moved from study area|2|||
156724918|NCT01262872|565739056|FG005|Step 2|Migrated/moved from study area|6|||
156724919|NCT01262872|565739057|FG006|Step 2|Migrated/moved from study area|2|||
156724920|NCT01262872|565739058|FG007|Step 2|Migrated/moved from study area|3|||
156724921|NCT01565889|565739063|FG000|Part A|Withdrawal by Subject|1|||
156724922|NCT01565889|565739064|FG001|Part A|Withdrawal by Subject|0|||
156724923|NCT01565889|565739065|FG002|Part A|Withdrawal by Subject|0|||
156724924|NCT01565889|565739066|FG003|Part A|Withdrawal by Subject|0|||
156724925|NCT01565889|565739067|FG004|Part A|Withdrawal by Subject|0|||
156724926|NCT01565889|565739068|FG005|Part A|Withdrawal by Subject|0|||
156724927|NCT01565889|565739063|FG000|Part B|Withdrawal by Subject|0|||
156724928|NCT01565889|565739064|FG001|Part B|Withdrawal by Subject|0|||
156724929|NCT01565889|565739065|FG002|Part B|Withdrawal by Subject|0|||
156724930|NCT01565889|565739066|FG003|Part B|Withdrawal by Subject|0|||
156724931|NCT01565889|565739067|FG004|Part B|Withdrawal by Subject|0|||
156724932|NCT01565889|565739068|FG005|Part B|Withdrawal by Subject|1|||
156724933|NCT01565889|565739063|FG000|Part B|Lack of Efficacy|0|||
156724934|NCT01565889|565739064|FG001|Part B|Lack of Efficacy|0|||
156724935|NCT01565889|565739065|FG002|Part B|Lack of Efficacy|0|||
156724936|NCT01565889|565739066|FG003|Part B|Lack of Efficacy|0|||
156724937|NCT01565889|565739067|FG004|Part B|Lack of Efficacy|0|||
156724938|NCT01565889|565739068|FG005|Part B|Lack of Efficacy|2|||
156724939|NCT01565889|565739063|FG000|Part B|Lost to Follow-up|0|||
156724940|NCT01565889|565739064|FG001|Part B|Lost to Follow-up|0|||
156724941|NCT01565889|565739065|FG002|Part B|Lost to Follow-up|0|||
156724942|NCT01565889|565739066|FG003|Part B|Lost to Follow-up|0|||
156724943|NCT01565889|565739067|FG004|Part B|Lost to Follow-up|0|||
156724944|NCT01565889|565739068|FG005|Part B|Lost to Follow-up|1|||
156724945|NCT00122382|565739069|FG000|Double-Blind Study|Adverse Event|9|||
156724946|NCT00122382|565739070|FG001|Double-Blind Study|Adverse Event|11|||
156724947|NCT00122382|565739071|FG002|Double-Blind Study|Adverse Event|0|||
156724948|NCT00122382|565739069|FG000|Double-Blind Study|Death|2|||
156724949|NCT00122382|565739070|FG001|Double-Blind Study|Death|2|||
156724950|NCT00122382|565739071|FG002|Double-Blind Study|Death|0|||
156724951|NCT00122382|565739069|FG000|Double-Blind Study|Lack of Efficacy|0|||
156724952|NCT00122382|565739070|FG001|Double-Blind Study|Lack of Efficacy|8|||
156724953|NCT00122382|565739071|FG002|Double-Blind Study|Lack of Efficacy|0|||
156724954|NCT00122382|565739069|FG000|Double-Blind Study|Lost to Follow-up|2|||
156724955|NCT00122382|565739070|FG001|Double-Blind Study|Lost to Follow-up|1|||
156724956|NCT00122382|565739071|FG002|Double-Blind Study|Lost to Follow-up|0|||
156724957|NCT00122382|565739069|FG000|Double-Blind Study|Pregnancy|2|||
156724958|NCT00122382|565739070|FG001|Double-Blind Study|Pregnancy|0|||
156724959|NCT00122382|565739071|FG002|Double-Blind Study|Pregnancy|0|||
156724960|NCT00122382|565739069|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
156724961|NCT00122382|565739070|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
156724962|NCT00122382|565739071|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
156724963|NCT00122382|565739069|FG000|Double-Blind Study|Withdrawal of Consent|7|||
156794860|NCT01378195|566002797|FG000|Overall Study|Lost to Follow-up|29|||
156794861|NCT01378195|566002798|FG001|Overall Study|Lost to Follow-up|18|||
156794862|NCT00425555|566002799|FG000|Overall Study|Withdrawal by Subject|11|||
156724964|NCT00122382|565739070|FG001|Double-Blind Study|Withdrawal of Consent|3|||
156724965|NCT00122382|565739071|FG002|Double-Blind Study|Withdrawal of Consent|0|||
156724966|NCT00122382|565739069|FG000|Double-Blind Study|Protocol Violation|1|||
156724967|NCT00122382|565739070|FG001|Double-Blind Study|Protocol Violation|0|||
156724968|NCT00122382|565739071|FG002|Double-Blind Study|Protocol Violation|0|||
156724969|NCT00122382|565739069|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
156794863|NCT00425555|566002800|FG001|Overall Study|Withdrawal by Subject|8|||
157136955|NCT01147809|567247020|FG005|Phase II (168 Days)|Adverse Event|6|||
156724970|NCT00122382|565739070|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
156724971|NCT00122382|565739071|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
156724972|NCT00122382|565739069|FG000|Double-Blind Study|Randomized but not treated|0|||
156794864|NCT00425555|566002799|FG000|Overall Study|Lost to Follow-up|0|||
156794865|NCT00425555|566002800|FG001|Overall Study|Lost to Follow-up|1|||
156724973|NCT00122382|565739070|FG001|Double-Blind Study|Randomized but not treated|2|||
156724974|NCT00122382|565739071|FG002|Double-Blind Study|Randomized but not treated|0|||
156724975|NCT00122382|565739069|FG000|Open-Label Study|Adverse Event|0|||
156724976|NCT00122382|565739070|FG001|Open-Label Study|Adverse Event|0|||
156724977|NCT00122382|565739071|FG002|Open-Label Study|Adverse Event|11|||
156724978|NCT00122382|565739069|FG000|Open-Label Study|Death|0|||
156724979|NCT00122382|565739070|FG001|Open-Label Study|Death|0|||
156724980|NCT00122382|565739071|FG002|Open-Label Study|Death|2|||
156724981|NCT00122382|565739069|FG000|Open-Label Study|Lack of Efficacy|0|||
156724982|NCT00122382|565739070|FG001|Open-Label Study|Lack of Efficacy|0|||
156724983|NCT00122382|565739071|FG002|Open-Label Study|Lack of Efficacy|3|||
156724984|NCT00122382|565739069|FG000|Open-Label Study|Lost to Follow-up|0|||
156724985|NCT00122382|565739070|FG001|Open-Label Study|Lost to Follow-up|0|||
156724986|NCT00122382|565739071|FG002|Open-Label Study|Lost to Follow-up|3|||
156724987|NCT00122382|565739069|FG000|Open-Label Study|Pregnancy|0|||
156724988|NCT00122382|565739070|FG001|Open-Label Study|Pregnancy|0|||
156724989|NCT00122382|565739071|FG002|Open-Label Study|Pregnancy|2|||
156724990|NCT00122382|565739069|FG000|Open-Label Study|Poor/Non-Compliance|0|||
156724991|NCT00122382|565739070|FG001|Open-Label Study|Poor/Non-Compliance|0|||
156724992|NCT00122382|565739071|FG002|Open-Label Study|Poor/Non-Compliance|1|||
156724993|NCT00122382|565739069|FG000|Open-Label Study|Withdrawal of Consent|0|||
156724994|NCT00122382|565739070|FG001|Open-Label Study|Withdrawal of Consent|0|||
156724995|NCT00122382|565739071|FG002|Open-Label Study|Withdrawal of Consent|4|||
156724996|NCT02040805|565739073|FG000|Overall Study|Lost to Follow-up|14|||
156724997|NCT02040805|565739074|FG001|Overall Study|Lost to Follow-up|9|||
156724998|NCT02040805|565739073|FG000|Overall Study|Withdrawal by Subject|28|||
156724999|NCT02040805|565739074|FG001|Overall Study|Withdrawal by Subject|41|||
156725000|NCT02174627|565739075|FG000|Overall Study|Missing|0|||
156725001|NCT02174627|565739076|FG001|Overall Study|Missing|1|||
156725002|NCT02174627|565739075|FG000|Overall Study|Incorrect enrolment before randomization|0|||
156725003|NCT02174627|565739076|FG001|Overall Study|Incorrect enrolment before randomization|1|||
156725004|NCT02174627|565739075|FG000|Overall Study|Participant decision|84|||
156725005|NCT02174627|565739076|FG001|Overall Study|Participant decision|128|||
156725006|NCT02166333|565739077|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
156725007|NCT02166333|565739078|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725008|NCT02166333|565739079|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725009|NCT02166333|565739080|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
156725010|NCT02166333|565739081|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
156725011|NCT02166333|565739082|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
156725012|NCT02166333|565739077|FG000|Stage 1|Death|4|||
156725013|NCT02166333|565739078|FG001|Stage 1|Death|0|||
156725014|NCT02166333|565739079|FG002|Stage 1|Death|2|||
156875851|NCT00494676|566303714|FG001|First Intervention|Withdrawal by Subject|3|||
156875852|NCT00494676|566303713|FG000|Second Intervention|Withdrawal by Subject|1|||
156875853|NCT00494676|566303714|FG001|Second Intervention|Withdrawal by Subject|1|||
156875854|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875855|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
156875856|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875857|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875858|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875859|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
157019367|NCT03892616|566824743|FG008|Washout Period 2|Met discontinuation criterion|1|||
157019368|NCT03892616|566824744|FG009|Washout Period 2|Met discontinuation criterion|0|||
157019369|NCT03892616|566824745|FG010|Washout Period 2|Met discontinuation criterion|0|||
157019370|NCT03892616|566824746|FG011|Washout Period 2|Met discontinuation criterion|0|||
157019371|NCT03683719|566824747|FG000|Overall Study|Lack of Efficacy|1|||
157019372|NCT03683719|566824748|FG001|Overall Study|Lack of Efficacy|3|||
157019373|NCT03683719|566824749|FG002|Overall Study|Lack of Efficacy|4|||
157136956|NCT01147809|567247015|FG000|Phase II (168 Days)|Protocol Violation|0|||
157136957|NCT01147809|567247016|FG001|Phase II (168 Days)|Protocol Violation|0|||
157136958|NCT01147809|567247017|FG002|Phase II (168 Days)|Protocol Violation|0|||
157136959|NCT01147809|567247018|FG003|Phase II (168 Days)|Protocol Violation|0|||
156725015|NCT02166333|565739080|FG003|Stage 1|Death|0|||
156725016|NCT02166333|565739081|FG004|Stage 1|Death|3|||
156725017|NCT02166333|565739082|FG005|Stage 1|Death|2|||
156725018|NCT02166333|565739077|FG000|Stage 1|Lost to Follow-up|12|||
156725019|NCT02166333|565739078|FG001|Stage 1|Lost to Follow-up|0|||
156725020|NCT02166333|565739079|FG002|Stage 1|Lost to Follow-up|6|||
156725021|NCT02166333|565739080|FG003|Stage 1|Lost to Follow-up|0|||
156725022|NCT02166333|565739081|FG004|Stage 1|Lost to Follow-up|3|||
156875860|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156725023|NCT02166333|565739082|FG005|Stage 1|Lost to Follow-up|3|||
157019374|NCT03683719|566824750|FG003|Overall Study|Lack of Efficacy|0|||
156725024|NCT02166333|565739077|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
156875861|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
157019375|NCT03683719|566824751|FG004|Overall Study|Lack of Efficacy|4|||
157019376|NCT03683719|566824747|FG000|Overall Study|Adverse Event|6|||
157136960|NCT01147809|567247019|FG004|Phase II (168 Days)|Protocol Violation|0|||
156725025|NCT02166333|565739078|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
156725026|NCT02166333|565739079|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
156725027|NCT02166333|565739080|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
156725028|NCT02166333|565739081|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
156725029|NCT02166333|565739082|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
156725030|NCT02166333|565739077|FG000|Stage 2|Death|4|||
156725031|NCT02166333|565739078|FG001|Stage 2|Death|2|||
156725032|NCT02166333|565739079|FG002|Stage 2|Death|1|||
156725033|NCT02166333|565739080|FG003|Stage 2|Death|0|||
156725034|NCT02166333|565739081|FG004|Stage 2|Death|0|||
156725035|NCT02166333|565739082|FG005|Stage 2|Death|1|||
156725036|NCT02166333|565739077|FG000|Stage 2|Lost to Follow-up|23|||
156725037|NCT02166333|565739078|FG001|Stage 2|Lost to Follow-up|4|||
156725038|NCT02166333|565739079|FG002|Stage 2|Lost to Follow-up|11|||
156725039|NCT02166333|565739080|FG003|Stage 2|Lost to Follow-up|9|||
156725040|NCT02166333|565739081|FG004|Stage 2|Lost to Follow-up|3|||
156725041|NCT02166333|565739082|FG005|Stage 2|Lost to Follow-up|6|||
156725042|NCT02269098|565739083|FG000|Overall Study|Lost to Follow-up|14|||
156725043|NCT02269098|565739084|FG001|Overall Study|Lost to Follow-up|9|||
156725044|NCT00503698|565739085|FG000|Overall Study|Protocol Violation|5|||
156725045|NCT00503698|565739086|FG001|Overall Study|Protocol Violation|6|||
156725046|NCT00503698|565739085|FG000|Overall Study|Adverse Event|52|||
156725047|NCT00503698|565739086|FG001|Overall Study|Adverse Event|41|||
156725048|NCT00503698|565739085|FG000|Overall Study|Death|1|||
156725049|NCT00503698|565739086|FG001|Overall Study|Death|0|||
156725050|NCT00503698|565739085|FG000|Overall Study|Lack of Efficacy|3|||
156725051|NCT00503698|565739086|FG001|Overall Study|Lack of Efficacy|4|||
156725052|NCT00503698|565739085|FG000|Overall Study|Trial terminated|216|||
156725053|NCT00503698|565739086|FG001|Overall Study|Trial terminated|253|||
156794866|NCT00425555|566002799|FG000|Overall Study|Administrative problems|3|||
156794867|NCT00425555|566002800|FG001|Overall Study|Administrative problems|0|||
156794868|NCT00425555|566002799|FG000|Overall Study|Death|1|||
156794869|NCT00425555|566002800|FG001|Overall Study|Death|2|||
156794870|NCT00425555|566002799|FG000|Overall Study|New cancer therapy|2|||
156794871|NCT00425555|566002800|FG001|Overall Study|New cancer therapy|1|||
156794872|NCT00425555|566002799|FG000|Overall Study|Disease progression|36|||
156794873|NCT00425555|566002800|FG001|Overall Study|Disease progression|33|||
156794874|NCT00425555|566002799|FG000|Overall Study|Adverse Event|25|||
156794875|NCT00425555|566002800|FG001|Overall Study|Adverse Event|15|||
156794876|NCT00425555|566002799|FG000|Overall Study|Protocol Violation|1|||
156794877|NCT00425555|566002800|FG001|Overall Study|Protocol Violation|0|||
156794878|NCT02327169|566002801|FG000|Overall Study|Progressive Disease|1|||
156794879|NCT02327169|566002802|FG001|Overall Study|Progressive Disease|3|||
156794880|NCT02327169|566002803|FG002|Overall Study|Progressive Disease|4|||
156794881|NCT02327169|566002804|FG003|Overall Study|Progressive Disease|3|||
156794882|NCT02327169|566002805|FG004|Overall Study|Progressive Disease|4|||
156794883|NCT02327169|566002806|FG005|Overall Study|Progressive Disease|3|||
156794884|NCT02327169|566002807|FG006|Overall Study|Progressive Disease|3|||
156794885|NCT02327169|566002808|FG007|Overall Study|Progressive Disease|3|||
156794886|NCT02327169|566002809|FG008|Overall Study|Progressive Disease|4|||
156794887|NCT02327169|566002810|FG009|Overall Study|Progressive Disease|4|||
156794888|NCT02327169|566002811|FG010|Overall Study|Progressive Disease|4|||
156794889|NCT02327169|566002812|FG011|Overall Study|Progressive Disease|3|||
156725054|NCT00503698|565739085|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
156725055|NCT00503698|565739086|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
156725056|NCT00503698|565739085|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
156725057|NCT00503698|565739086|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
156725058|NCT00503698|565739085|FG000|Overall Study|Any condition in exclusion criteria|4|||
156725059|NCT00503698|565739086|FG001|Overall Study|Any condition in exclusion criteria|6|||
156725060|NCT00503698|565739085|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
156725061|NCT00503698|565739086|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
156794890|NCT02327169|566002813|FG012|Overall Study|Progressive Disease|1|||
156794891|NCT02327169|566002814|FG013|Overall Study|Progressive Disease|3|||
156725062|NCT00503698|565739085|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
156725063|NCT00503698|565739086|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
156725064|NCT00503698|565739085|FG000|Overall Study|Critically ill|2|||
156725065|NCT00503698|565739086|FG001|Overall Study|Critically ill|0|||
156794892|NCT02327169|566002815|FG014|Overall Study|Progressive Disease|3|||
156794893|NCT02327169|566002801|FG000|Overall Study|Adverse Event|2|||
156794894|NCT02327169|566002802|FG001|Overall Study|Adverse Event|0|||
156794895|NCT02327169|566002803|FG002|Overall Study|Adverse Event|1|||
156794896|NCT02327169|566002804|FG003|Overall Study|Adverse Event|0|||
156794897|NCT02327169|566002805|FG004|Overall Study|Adverse Event|1|||
156794898|NCT02327169|566002806|FG005|Overall Study|Adverse Event|0|||
156725066|NCT00503698|565739085|FG000|Overall Study|Unclassified|48|||
156794899|NCT02327169|566002807|FG006|Overall Study|Adverse Event|0|||
156794900|NCT02327169|566002808|FG007|Overall Study|Adverse Event|0|||
156794901|NCT02327169|566002809|FG008|Overall Study|Adverse Event|0|||
157136961|NCT01147809|567247020|FG005|Phase II (168 Days)|Protocol Violation|1|||
157136962|NCT01147809|567247015|FG000|Phase II (168 Days)|Physician Decision|0|||
157136963|NCT01147809|567247016|FG001|Phase II (168 Days)|Physician Decision|0|||
157136964|NCT01147809|567247017|FG002|Phase II (168 Days)|Physician Decision|0|||
157136965|NCT01147809|567247018|FG003|Phase II (168 Days)|Physician Decision|0|||
157136966|NCT01147809|567247019|FG004|Phase II (168 Days)|Physician Decision|5|||
157136967|NCT01147809|567247020|FG005|Phase II (168 Days)|Physician Decision|11|||
157136968|NCT01147809|567247015|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
157136969|NCT01147809|567247016|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
157136970|NCT01147809|567247017|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
157136971|NCT01147809|567247018|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
157136972|NCT01147809|567247019|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
157136973|NCT01147809|567247020|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
157136974|NCT01147809|567247015|FG000|Phase II (168 Days)|Ongoing|0|||
157136975|NCT01147809|567247016|FG001|Phase II (168 Days)|Ongoing|0|||
157136976|NCT01147809|567247017|FG002|Phase II (168 Days)|Ongoing|0|||
157136977|NCT01147809|567247018|FG003|Phase II (168 Days)|Ongoing|0|||
157136978|NCT01147809|567247019|FG004|Phase II (168 Days)|Ongoing|1|||
157136979|NCT01147809|567247020|FG005|Phase II (168 Days)|Ongoing|0|||
157136980|NCT00805207|567247021|FG000|Overall Study|Protocol Violation|0|||
157136981|NCT00805207|567247022|FG001|Overall Study|Protocol Violation|0|||
157136982|NCT00805207|567247023|FG002|Overall Study|Protocol Violation|1|||
157136983|NCT00805207|567247024|FG003|Overall Study|Protocol Violation|0|||
157136984|NCT00805207|567247025|FG004|Overall Study|Protocol Violation|0|||
157136985|NCT00805207|567247026|FG005|Overall Study|Protocol Violation|0|||
157136986|NCT00805207|567247027|FG006|Overall Study|Protocol Violation|0|||
157136987|NCT00805207|567247028|FG007|Overall Study|Protocol Violation|0|||
157136988|NCT00805207|567247029|FG008|Overall Study|Protocol Violation|0|||
157136989|NCT00805207|567247021|FG000|Overall Study|Physician Decision|0|||
157136990|NCT00805207|567247022|FG001|Overall Study|Physician Decision|1|||
157136991|NCT00805207|567247023|FG002|Overall Study|Physician Decision|0|||
157136992|NCT00805207|567247024|FG003|Overall Study|Physician Decision|0|||
157136993|NCT00805207|567247025|FG004|Overall Study|Physician Decision|0|||
157136994|NCT00805207|567247026|FG005|Overall Study|Physician Decision|1|||
157136995|NCT00805207|567247027|FG006|Overall Study|Physician Decision|0|||
157136996|NCT00805207|567247028|FG007|Overall Study|Physician Decision|0|||
157136997|NCT00805207|567247029|FG008|Overall Study|Physician Decision|0|||
157136998|NCT00805207|567247021|FG000|Overall Study|Withdrawal by Subject|0|||
157136999|NCT00805207|567247022|FG001|Overall Study|Withdrawal by Subject|1|||
157137000|NCT00805207|567247023|FG002|Overall Study|Withdrawal by Subject|0|||
157137001|NCT00805207|567247024|FG003|Overall Study|Withdrawal by Subject|0|||
157137002|NCT00805207|567247025|FG004|Overall Study|Withdrawal by Subject|1|||
157137003|NCT00805207|567247026|FG005|Overall Study|Withdrawal by Subject|2|||
157137004|NCT00805207|567247027|FG006|Overall Study|Withdrawal by Subject|0|||
157137005|NCT00805207|567247028|FG007|Overall Study|Withdrawal by Subject|0|||
157137006|NCT00805207|567247029|FG008|Overall Study|Withdrawal by Subject|0|||
157137007|NCT04439344|567247030|FG000|Overall Study|Never started threapy|3|||
157137008|NCT04439344|567247030|FG000|Overall Study|Ineligible|3|||
157137009|NCT04439344|567247030|FG000|Overall Study|Adverse Event|13|||
156725067|NCT00503698|565739086|FG001|Overall Study|Unclassified|32|||
156725068|NCT00503698|565739085|FG000|Overall Study|Not exposed to trial drug|11|||
156725069|NCT00503698|565739086|FG001|Overall Study|Not exposed to trial drug|6|||
156725070|NCT03644342|565739092|FG000|Overall Study|Adverse Event|2|||
156725071|NCT03644342|565739093|FG001|Overall Study|Adverse Event|0|||
156725072|NCT03644342|565739092|FG000|Overall Study|Protocol Violation|0|||
156725073|NCT03644342|565739093|FG001|Overall Study|Protocol Violation|1|||
156725074|NCT02259010|565739094|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
156794902|NCT02327169|566002810|FG009|Overall Study|Adverse Event|2|||
156794903|NCT02327169|566002811|FG010|Overall Study|Adverse Event|0|||
157137010|NCT04439344|567247030|FG000|Overall Study|Death|2|||
156725075|NCT01662492|565739095|FG000|Overall Study|Other miscellaneous reasons.|1|||
156725076|NCT01662492|565739096|FG001|Overall Study|Other miscellaneous reasons.|0|||
156725077|NCT01662492|565739097|FG002|Overall Study|Other miscellaneous reasons.|1|||
157137011|NCT04439344|567247030|FG000|Overall Study|Disease progression|29|||
156725078|NCT01662492|565739095|FG000|Overall Study|Withdrawal by Subject|0|||
156725079|NCT01662492|565739096|FG001|Overall Study|Withdrawal by Subject|0|||
156725080|NCT01662492|565739097|FG002|Overall Study|Withdrawal by Subject|1|||
156794904|NCT02327169|566002812|FG011|Overall Study|Adverse Event|3|||
157137012|NCT04439344|567247030|FG000|Overall Study|Withdrawal by Subject|2|||
157137013|NCT04439344|567247030|FG000|Overall Study|Alternative therapy|1|||
157137014|NCT00772447|567247031|FG000|Overall Study|Withdrawal by Subject|9|||
157137015|NCT00772447|567247032|FG001|Overall Study|Withdrawal by Subject|5|||
157137016|NCT00772447|567247031|FG000|Overall Study|Physician Decision|4|||
157137017|NCT00772447|567247032|FG001|Overall Study|Physician Decision|8|||
156725081|NCT01662492|565739095|FG000|Overall Study|Protocol Violation|1|||
157137018|NCT00772447|567247031|FG000|Overall Study|Lost to Follow-up|2|||
157137019|NCT00772447|567247032|FG001|Overall Study|Lost to Follow-up|4|||
157137020|NCT00772447|567247031|FG000|Overall Study|incorrect enrolment|3|||
157137021|NCT00772447|567247032|FG001|Overall Study|incorrect enrolment|4|||
157137022|NCT00772447|567247031|FG000|Overall Study|Protocol Violation|0|||
157137023|NCT00772447|567247032|FG001|Overall Study|Protocol Violation|1|||
157137024|NCT00772447|567247031|FG000|Overall Study|all others|2|||
157137025|NCT00772447|567247032|FG001|Overall Study|all others|2|||
157137026|NCT03770403|567247033|FG000|Overall Study|Adverse Event|8|||
157137027|NCT03770403|567247033|FG000|Overall Study|Death|5|||
156725082|NCT01662492|565739096|FG001|Overall Study|Protocol Violation|0|||
156725083|NCT01662492|565739097|FG002|Overall Study|Protocol Violation|0|||
156725084|NCT01662492|565739095|FG000|Overall Study|Lost to Follow-up|0|||
156725085|NCT01662492|565739096|FG001|Overall Study|Lost to Follow-up|0|||
156725086|NCT01662492|565739097|FG002|Overall Study|Lost to Follow-up|2|||
156725087|NCT01662492|565739095|FG000|Overall Study|Lack of Efficacy|1|||
156725088|NCT01662492|565739096|FG001|Overall Study|Lack of Efficacy|1|||
156725089|NCT01662492|565739097|FG002|Overall Study|Lack of Efficacy|2|||
156725090|NCT01591096|565739098|FG000|Overall Study|Adverse Event|1|||
156725091|NCT03655405|565739101|FG000|Overall Study|Death after initial data collection|4|||
156725092|NCT03655405|565739102|FG001|Overall Study|Death after initial data collection|2|||
156725093|NCT03655405|565739101|FG000|Overall Study|Died before initial data collection|1|||
156725094|NCT03655405|565739102|FG001|Overall Study|Died before initial data collection|2|||
156725095|NCT03655405|565739101|FG000|Overall Study|Protocol Violation|0|||
156794905|NCT02327169|566002813|FG012|Overall Study|Adverse Event|0|||
156875862|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156794906|NCT02327169|566002814|FG013|Overall Study|Adverse Event|2|||
156794907|NCT02327169|566002815|FG014|Overall Study|Adverse Event|1|||
156794908|NCT02327169|566002801|FG000|Overall Study|Symptomatic Deterioration|0|||
156794909|NCT02327169|566002802|FG001|Overall Study|Symptomatic Deterioration|0|||
156794910|NCT02327169|566002803|FG002|Overall Study|Symptomatic Deterioration|1|||
156794911|NCT02327169|566002804|FG003|Overall Study|Symptomatic Deterioration|0|||
156794912|NCT02327169|566002805|FG004|Overall Study|Symptomatic Deterioration|1|||
156794913|NCT02327169|566002806|FG005|Overall Study|Symptomatic Deterioration|1|||
156794914|NCT02327169|566002807|FG006|Overall Study|Symptomatic Deterioration|0|||
156794915|NCT02327169|566002808|FG007|Overall Study|Symptomatic Deterioration|0|||
156794916|NCT02327169|566002809|FG008|Overall Study|Symptomatic Deterioration|2|||
156794917|NCT02327169|566002810|FG009|Overall Study|Symptomatic Deterioration|1|||
156794918|NCT02327169|566002811|FG010|Overall Study|Symptomatic Deterioration|0|||
156794919|NCT02327169|566002812|FG011|Overall Study|Symptomatic Deterioration|0|||
156794920|NCT02327169|566002813|FG012|Overall Study|Symptomatic Deterioration|0|||
156794921|NCT02327169|566002814|FG013|Overall Study|Symptomatic Deterioration|2|||
156794922|NCT02327169|566002815|FG014|Overall Study|Symptomatic Deterioration|1|||
156794923|NCT02327169|566002801|FG000|Overall Study|Reason Not Specified|0|||
156794924|NCT02327169|566002802|FG001|Overall Study|Reason Not Specified|0|||
156794925|NCT02327169|566002803|FG002|Overall Study|Reason Not Specified|1|||
156794926|NCT02327169|566002804|FG003|Overall Study|Reason Not Specified|0|||
156794927|NCT02327169|566002805|FG004|Overall Study|Reason Not Specified|0|||
156794928|NCT02327169|566002806|FG005|Overall Study|Reason Not Specified|0|||
156794929|NCT02327169|566002807|FG006|Overall Study|Reason Not Specified|0|||
156794930|NCT02327169|566002808|FG007|Overall Study|Reason Not Specified|0|||
156794931|NCT02327169|566002809|FG008|Overall Study|Reason Not Specified|0|||
156794932|NCT02327169|566002810|FG009|Overall Study|Reason Not Specified|1|||
156794933|NCT02327169|566002811|FG010|Overall Study|Reason Not Specified|2|||
156794934|NCT02327169|566002812|FG011|Overall Study|Reason Not Specified|1|||
156794935|NCT02327169|566002813|FG012|Overall Study|Reason Not Specified|0|||
156794936|NCT02327169|566002814|FG013|Overall Study|Reason Not Specified|0|||
156794937|NCT02327169|566002815|FG014|Overall Study|Reason Not Specified|2|||
156794938|NCT02327169|566002801|FG000|Overall Study|Withdrawal by Subject|1|||
156794939|NCT02327169|566002802|FG001|Overall Study|Withdrawal by Subject|0|||
156794940|NCT02327169|566002803|FG002|Overall Study|Withdrawal by Subject|0|||
156794941|NCT02327169|566002804|FG003|Overall Study|Withdrawal by Subject|0|||
156794942|NCT02327169|566002805|FG004|Overall Study|Withdrawal by Subject|1|||
157137028|NCT03770403|567247033|FG000|Overall Study|Physician Decision|1|||
157137029|NCT03770403|567247033|FG000|Overall Study|Sponsor decision|1|||
156725096|NCT03655405|565739102|FG001|Overall Study|Protocol Violation|1|||
156725097|NCT01991743|565739103|FG000|Overall Study|external cephalic version not performed|0|||
156725098|NCT01991743|565739104|FG001|Overall Study|external cephalic version not performed|0|||
156725099|NCT01991743|565739105|FG002|Overall Study|external cephalic version not performed|1|||
156794943|NCT02327169|566002806|FG005|Overall Study|Withdrawal by Subject|0|||
156794944|NCT02327169|566002807|FG006|Overall Study|Withdrawal by Subject|0|||
156794945|NCT02327169|566002808|FG007|Overall Study|Withdrawal by Subject|1|||
156794946|NCT02327169|566002809|FG008|Overall Study|Withdrawal by Subject|0|||
156794947|NCT02327169|566002810|FG009|Overall Study|Withdrawal by Subject|0|||
156794948|NCT02327169|566002811|FG010|Overall Study|Withdrawal by Subject|0|||
156794949|NCT02327169|566002812|FG011|Overall Study|Withdrawal by Subject|0|||
156794950|NCT02327169|566002813|FG012|Overall Study|Withdrawal by Subject|0|||
157019377|NCT03683719|566824748|FG001|Overall Study|Adverse Event|6|||
157137030|NCT03770403|567247033|FG000|Overall Study|Study terminated by Sponsor|1|||
156725100|NCT01991743|565739106|FG003|Overall Study|external cephalic version not performed|0|||
156725101|NCT00848718|565739108|FG000|Overall Study|Adverse Event|2|||
156725102|NCT00848718|565739109|FG001|Overall Study|Adverse Event|2|||
156725103|NCT00848718|565739110|FG002|Overall Study|Adverse Event|1|||
156725104|NCT00848718|565739111|FG003|Overall Study|Adverse Event|1|||
156725105|NCT00848718|565739112|FG004|Overall Study|Adverse Event|1|||
156875863|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
156875864|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
156875865|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156875866|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
156875867|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156875868|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875869|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875870|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875871|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875872|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875873|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875874|NCT04976192|566303715|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
156875875|NCT04976192|566303716|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875876|NCT04976192|566303717|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
156875877|NCT04976192|566303718|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875878|NCT04976192|566303719|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875879|NCT04976192|566303720|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875880|NCT04976192|566303721|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875881|NCT04976192|566303722|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875882|NCT04976192|566303723|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875883|NCT04976192|566303724|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
156875884|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875885|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875886|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875887|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156875888|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
156875889|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156875890|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156875891|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
156875892|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
156875893|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156875894|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875895|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875896|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875897|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875898|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
156725106|NCT00848718|565739113|FG005|Overall Study|Adverse Event|0|||
156725107|NCT00848718|565739114|FG006|Overall Study|Adverse Event|0|||
156725108|NCT00848718|565739115|FG007|Overall Study|Adverse Event|1|||
156875899|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875900|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875901|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875902|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875903|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
156875904|NCT04976192|566303715|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875905|NCT04976192|566303716|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875906|NCT04976192|566303717|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875907|NCT04976192|566303718|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875908|NCT04976192|566303719|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875909|NCT04976192|566303720|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156875910|NCT04976192|566303721|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875911|NCT04976192|566303722|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
157019378|NCT03683719|566824749|FG002|Overall Study|Adverse Event|0|||
157137031|NCT03770403|567247033|FG000|Overall Study|Withdrawal by Subject|13|||
157137032|NCT03770403|567247033|FG000|Overall Study|Other|88|||
157137033|NCT00642642|567247046|FG000|Treatment & Follow Up|Adverse Event|2|||
157137034|NCT00642642|567247046|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
157137035|NCT00642642|567247046|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
156725109|NCT00848718|565739116|FG008|Overall Study|Adverse Event|1|||
156725110|NCT00848718|565739117|FG009|Overall Study|Adverse Event|0|||
156725111|NCT00848718|565739118|FG010|Overall Study|Adverse Event|0|||
157019379|NCT03683719|566824750|FG003|Overall Study|Adverse Event|1|||
157019380|NCT03683719|566824751|FG004|Overall Study|Adverse Event|3|||
157019381|NCT03683719|566824747|FG000|Overall Study|Withdrawal by Subject|4|||
157019382|NCT03683719|566824748|FG001|Overall Study|Withdrawal by Subject|4|||
157019383|NCT03683719|566824749|FG002|Overall Study|Withdrawal by Subject|3|||
157019384|NCT03683719|566824750|FG003|Overall Study|Withdrawal by Subject|5|||
157019385|NCT03683719|566824751|FG004|Overall Study|Withdrawal by Subject|5|||
157019386|NCT03683719|566824747|FG000|Overall Study|Lost to Follow-up|1|||
157019387|NCT03683719|566824748|FG001|Overall Study|Lost to Follow-up|0|||
157019388|NCT03683719|566824749|FG002|Overall Study|Lost to Follow-up|0|||
157019389|NCT03683719|566824750|FG003|Overall Study|Lost to Follow-up|1|||
157019390|NCT03683719|566824751|FG004|Overall Study|Lost to Follow-up|1|||
157019391|NCT03683719|566824747|FG000|Overall Study|Other personal reasons|0|||
157019392|NCT03683719|566824748|FG001|Overall Study|Other personal reasons|0|||
157019393|NCT03683719|566824749|FG002|Overall Study|Other personal reasons|1|||
157019394|NCT03683719|566824750|FG003|Overall Study|Other personal reasons|0|||
157019395|NCT03683719|566824751|FG004|Overall Study|Other personal reasons|1|||
157019396|NCT00601900|566824752|FG000|Overall Study|Withdrawal by Subject|0|||
157019397|NCT00601900|566824753|FG001|Overall Study|Withdrawal by Subject|3|||
157019398|NCT03924986|566824754|FG000|Overall Study|Death|57|||
157019399|NCT03924986|566824755|FG001|Overall Study|Death|66|||
157019400|NCT03924986|566824754|FG000|Overall Study|Study Concluded by Sponsor|51|||
157019401|NCT03924986|566824755|FG001|Overall Study|Study Concluded by Sponsor|41|||
157019402|NCT03924986|566824754|FG000|Overall Study|Withdrawal by Subject|15|||
157019403|NCT03924986|566824755|FG001|Overall Study|Withdrawal by Subject|20|||
157019404|NCT03924986|566824754|FG000|Overall Study|Lost to Follow-up|7|||
157019405|NCT03924986|566824755|FG001|Overall Study|Lost to Follow-up|5|||
157019406|NCT03924986|566824754|FG000|Overall Study|Miscellaneous|1|||
157019407|NCT03924986|566824755|FG001|Overall Study|Miscellaneous|0|||
157019408|NCT02689284|566824761|FG000|Overall Study|Adverse Event|1|||
157019409|NCT02689284|566824762|FG001|Overall Study|Adverse Event|8|||
157019410|NCT02689284|566824761|FG000|Overall Study|Death|0|||
157019411|NCT02689284|566824762|FG001|Overall Study|Death|1|||
157019412|NCT02689284|566824761|FG000|Overall Study|Physician Decision|1|||
157019413|NCT02689284|566824762|FG001|Overall Study|Physician Decision|2|||
157019414|NCT02689284|566824761|FG000|Overall Study|Withdrawal by Subject|0|||
157019415|NCT02689284|566824762|FG001|Overall Study|Withdrawal by Subject|1|||
157019416|NCT02689284|566824761|FG000|Overall Study|progression of cancer|1|||
157019417|NCT02689284|566824762|FG001|Overall Study|progression of cancer|72|||
157019418|NCT02689284|566824761|FG000|Overall Study|decreased heart function|0|||
157019419|NCT02689284|566824762|FG001|Overall Study|decreased heart function|1|||
157019420|NCT02689284|566824761|FG000|Overall Study|concern for anemia|0|||
157019421|NCT02689284|566824762|FG001|Overall Study|concern for anemia|1|||
157019422|NCT02689284|566824761|FG000|Overall Study|no measurable cancer for evaluation|0|||
157019423|NCT02689284|566824762|FG001|Overall Study|no measurable cancer for evaluation|1|||
157019424|NCT05569252|566824763|FG000|Overall Study|Adverse event (central vision loss)|1|||
157019425|NCT05569252|566824764|FG001|Overall Study|Adverse event (central vision loss)|0|||
157019426|NCT05569252|566824765|FG002|Overall Study|Adverse event (central vision loss)|0|||
157019427|NCT05569252|566824766|FG003|Overall Study|Adverse event (central vision loss)|0|||
157019428|NCT03665597|566824767|FG000|Period 1|Adverse Event|1|||
157019429|NCT03665597|566824768|FG001|Period 1|Adverse Event|0|||
157019430|NCT03665597|566824769|FG002|Period 1|Adverse Event|0|||
157019431|NCT03665597|566824770|FG003|Period 1|Adverse Event|1|||
157019432|NCT03665597|566824771|FG004|Period 1|Adverse Event|0|||
157019433|NCT03665597|566824772|FG005|Period 1|Adverse Event|0|||
157019434|NCT03665597|566824773|FG006|Period 1|Adverse Event|0|||
157019435|NCT03665597|566824767|FG000|Period 1|Screen Failure|0|||
156725112|NCT00848718|565739119|FG011|Overall Study|Adverse Event|0|||
156725113|NCT00848718|565739120|FG012|Overall Study|Adverse Event|2|||
156725114|NCT00848718|565739108|FG000|Overall Study|Lack of Efficacy|0|||
156725115|NCT00848718|565739109|FG001|Overall Study|Lack of Efficacy|0|||
157019436|NCT03665597|566824768|FG001|Period 1|Screen Failure|0|||
157019437|NCT03665597|566824769|FG002|Period 1|Screen Failure|0|||
157019438|NCT03665597|566824770|FG003|Period 1|Screen Failure|1|||
157019439|NCT03665597|566824771|FG004|Period 1|Screen Failure|0|||
157019440|NCT03665597|566824772|FG005|Period 1|Screen Failure|0|||
157019441|NCT03665597|566824773|FG006|Period 1|Screen Failure|0|||
157019442|NCT03665597|566824767|FG000|Period 1|Death|0|||
157019443|NCT03665597|566824768|FG001|Period 1|Death|0|||
157019444|NCT03665597|566824769|FG002|Period 1|Death|0|||
157019445|NCT03665597|566824770|FG003|Period 1|Death|0|||
157019446|NCT03665597|566824771|FG004|Period 1|Death|0|||
157019447|NCT03665597|566824772|FG005|Period 1|Death|0|||
157019448|NCT03665597|566824773|FG006|Period 1|Death|45|||
157019449|NCT03665597|566824767|FG000|Period 1|Withdrawal by Subject|0|||
157019450|NCT03665597|566824768|FG001|Period 1|Withdrawal by Subject|0|||
157019451|NCT03665597|566824769|FG002|Period 1|Withdrawal by Subject|0|||
156725116|NCT00848718|565739110|FG002|Overall Study|Lack of Efficacy|1|||
157019452|NCT03665597|566824770|FG003|Period 1|Withdrawal by Subject|0|||
157019453|NCT03665597|566824771|FG004|Period 1|Withdrawal by Subject|0|||
157019454|NCT03665597|566824772|FG005|Period 1|Withdrawal by Subject|0|||
157137036|NCT03832387|567247049|FG000|Overall Study|Protocol Violation|2|||
157137037|NCT03832387|567247050|FG001|Overall Study|Protocol Violation|6|||
157137038|NCT03832387|567247049|FG000|Overall Study|EXCLUSION CRITERIA|3|||
157137039|NCT03832387|567247050|FG001|Overall Study|EXCLUSION CRITERIA|1|||
157137040|NCT00998738|567247052|FG000|Overall Study|Uknown|1|||
157137041|NCT01431287|567248999|FG000|Overall Study|not treated|0|||
157137042|NCT01431287|567249000|FG001|Overall Study|not treated|0|||
157137043|NCT01431287|567249001|FG002|Overall Study|not treated|1|||
157137044|NCT01431287|567249002|FG003|Overall Study|not treated|0|||
157137045|NCT01431287|567249003|FG004|Overall Study|not treated|0|||
157137046|NCT01431287|567248999|FG000|Overall Study|Adverse Event|59|||
157137047|NCT01431287|567249000|FG001|Overall Study|Adverse Event|57|||
157137048|NCT01431287|567249001|FG002|Overall Study|Adverse Event|53|||
157137049|NCT01431287|567249002|FG003|Overall Study|Adverse Event|33|||
157137050|NCT01431287|567249003|FG004|Overall Study|Adverse Event|41|||
157137051|NCT01431287|567248999|FG000|Overall Study|Non compliant with protocol|6|||
157137052|NCT01431287|567249000|FG001|Overall Study|Non compliant with protocol|6|||
157137053|NCT01431287|567249001|FG002|Overall Study|Non compliant with protocol|5|||
157137054|NCT01431287|567249002|FG003|Overall Study|Non compliant with protocol|6|||
157137055|NCT01431287|567249003|FG004|Overall Study|Non compliant with protocol|5|||
157137056|NCT01431287|567248999|FG000|Overall Study|Lost to Follow-up|0|||
157137057|NCT01431287|567249000|FG001|Overall Study|Lost to Follow-up|3|||
157137058|NCT01431287|567249001|FG002|Overall Study|Lost to Follow-up|2|||
157137059|NCT01431287|567249002|FG003|Overall Study|Lost to Follow-up|3|||
157137060|NCT01431287|567249003|FG004|Overall Study|Lost to Follow-up|1|||
157137061|NCT01431287|567248999|FG000|Overall Study|Consent withdrawn not due to AE|29|||
157137062|NCT01431287|567249000|FG001|Overall Study|Consent withdrawn not due to AE|30|||
157137063|NCT01431287|567249001|FG002|Overall Study|Consent withdrawn not due to AE|34|||
157137064|NCT01431287|567249002|FG003|Overall Study|Consent withdrawn not due to AE|19|||
157137065|NCT01431287|567249003|FG004|Overall Study|Consent withdrawn not due to AE|29|||
157137066|NCT01431287|567248999|FG000|Overall Study|not stated above|4|||
157137067|NCT01431287|567249000|FG001|Overall Study|not stated above|2|||
157137068|NCT01431287|567249001|FG002|Overall Study|not stated above|2|||
157137069|NCT01431287|567249002|FG003|Overall Study|not stated above|2|||
157137070|NCT01431287|567249003|FG004|Overall Study|not stated above|1|||
157137071|NCT00215150|567249006|FG000|Open Label Phase|Lost to Follow-up|7|||
157137072|NCT00215150|567249006|FG000|Open Label Phase|Withdrawal by Subject|1|||
157137073|NCT00215150|567249006|FG000|Open Label Phase|Did not complete a post base visit|13|||
157137074|NCT00215150|567249006|FG000|Open Label Phase|Did not meet randomization criteria|9|||
157137075|NCT00215150|567249006|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
157137076|NCT00215150|567249006|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
157137077|NCT00215150|567249006|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
157137078|NCT02251743|567249007|FG000|Overall Study|Withdrawal by Subject|1|||
156725117|NCT00848718|565739111|FG003|Overall Study|Lack of Efficacy|0|||
157137079|NCT02251743|567249008|FG001|Overall Study|Withdrawal by Subject|1|||
157137080|NCT02091440|567249014|FG000|Overall Study|Death|2|||
157137081|NCT00775021|567249017|FG000|First Intervention|Lost to Follow-up|1|||
157137082|NCT00775021|567249018|FG001|First Intervention|Lost to Follow-up|0|||
157137083|NCT00775021|567249017|FG000|Second Intervention|Adverse Event|0|||
157137084|NCT00775021|567249018|FG001|Second Intervention|Adverse Event|1|||
157137085|NCT02542267|567249019|FG000|Overall Study|Withdrawal by Subject|10|||
157137086|NCT02542267|567249019|FG000|Overall Study|Physician Decision|6|||
157137087|NCT02542267|567249019|FG000|Overall Study|Lost to Follow-up|4|||
157137088|NCT02542267|567249019|FG000|Overall Study|Death|13|||
157137089|NCT02542267|567249019|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
156725118|NCT00848718|565739112|FG004|Overall Study|Lack of Efficacy|0|||
156725119|NCT00848718|565739113|FG005|Overall Study|Lack of Efficacy|0|||
156725120|NCT00848718|565739114|FG006|Overall Study|Lack of Efficacy|1|||
156725121|NCT00848718|565739115|FG007|Overall Study|Lack of Efficacy|0|||
156725122|NCT00848718|565739116|FG008|Overall Study|Lack of Efficacy|0|||
156725123|NCT00848718|565739117|FG009|Overall Study|Lack of Efficacy|0|||
156725124|NCT00848718|565739118|FG010|Overall Study|Lack of Efficacy|0|||
156725125|NCT00848718|565739119|FG011|Overall Study|Lack of Efficacy|0|||
156725126|NCT00848718|565739120|FG012|Overall Study|Lack of Efficacy|0|||
156725127|NCT00848718|565739108|FG000|Overall Study|Physician Decision|0|||
156725128|NCT00848718|565739109|FG001|Overall Study|Physician Decision|1|||
156725129|NCT00848718|565739110|FG002|Overall Study|Physician Decision|0|||
156725130|NCT00848718|565739111|FG003|Overall Study|Physician Decision|0|||
156725131|NCT00848718|565739112|FG004|Overall Study|Physician Decision|1|||
156725132|NCT00848718|565739113|FG005|Overall Study|Physician Decision|1|||
156725133|NCT00848718|565739114|FG006|Overall Study|Physician Decision|0|||
156725134|NCT00848718|565739115|FG007|Overall Study|Physician Decision|0|||
156725135|NCT00848718|565739116|FG008|Overall Study|Physician Decision|1|||
156725136|NCT00848718|565739117|FG009|Overall Study|Physician Decision|2|||
156725137|NCT00848718|565739118|FG010|Overall Study|Physician Decision|0|||
156725138|NCT00848718|565739119|FG011|Overall Study|Physician Decision|0|||
156725139|NCT00848718|565739120|FG012|Overall Study|Physician Decision|1|||
156725140|NCT00848718|565739108|FG000|Overall Study|Progressive disease before treatment|1|||
156725141|NCT00848718|565739109|FG001|Overall Study|Progressive disease before treatment|5|||
156725142|NCT00848718|565739110|FG002|Overall Study|Progressive disease before treatment|1|||
156725143|NCT00848718|565739111|FG003|Overall Study|Progressive disease before treatment|3|||
156725144|NCT00848718|565739112|FG004|Overall Study|Progressive disease before treatment|4|||
156725145|NCT00848718|565739113|FG005|Overall Study|Progressive disease before treatment|4|||
156725146|NCT00848718|565739114|FG006|Overall Study|Progressive disease before treatment|2|||
156725147|NCT00848718|565739115|FG007|Overall Study|Progressive disease before treatment|1|||
156725148|NCT00848718|565739116|FG008|Overall Study|Progressive disease before treatment|2|||
156725149|NCT00848718|565739117|FG009|Overall Study|Progressive disease before treatment|7|||
156725150|NCT00848718|565739118|FG010|Overall Study|Progressive disease before treatment|3|||
156725151|NCT00848718|565739119|FG011|Overall Study|Progressive disease before treatment|6|||
156725152|NCT00848718|565739120|FG012|Overall Study|Progressive disease before treatment|2|||
156725153|NCT00848718|565739108|FG000|Overall Study|Protocol Violation|0|||
156725154|NCT00848718|565739109|FG001|Overall Study|Protocol Violation|1|||
156725155|NCT00848718|565739110|FG002|Overall Study|Protocol Violation|0|||
156725156|NCT00848718|565739111|FG003|Overall Study|Protocol Violation|0|||
156725157|NCT00848718|565739112|FG004|Overall Study|Protocol Violation|0|||
156725158|NCT00848718|565739113|FG005|Overall Study|Protocol Violation|0|||
156794951|NCT02327169|566002814|FG013|Overall Study|Withdrawal by Subject|0|||
156794952|NCT02327169|566002815|FG014|Overall Study|Withdrawal by Subject|3|||
156794953|NCT02327169|566002801|FG000|Overall Study|Lost to Follow-up|0|||
156794954|NCT02327169|566002802|FG001|Overall Study|Lost to Follow-up|0|||
156794955|NCT02327169|566002803|FG002|Overall Study|Lost to Follow-up|0|||
156794956|NCT02327169|566002804|FG003|Overall Study|Lost to Follow-up|0|||
156794957|NCT02327169|566002805|FG004|Overall Study|Lost to Follow-up|1|||
156794958|NCT02327169|566002806|FG005|Overall Study|Lost to Follow-up|0|||
156794959|NCT02327169|566002807|FG006|Overall Study|Lost to Follow-up|0|||
156794960|NCT02327169|566002808|FG007|Overall Study|Lost to Follow-up|0|||
156794961|NCT02327169|566002809|FG008|Overall Study|Lost to Follow-up|0|||
156794962|NCT02327169|566002810|FG009|Overall Study|Lost to Follow-up|0|||
156794963|NCT02327169|566002811|FG010|Overall Study|Lost to Follow-up|0|||
156794964|NCT02327169|566002812|FG011|Overall Study|Lost to Follow-up|0|||
156794965|NCT02327169|566002813|FG012|Overall Study|Lost to Follow-up|0|||
156794966|NCT02327169|566002814|FG013|Overall Study|Lost to Follow-up|0|||
156794967|NCT02327169|566002815|FG014|Overall Study|Lost to Follow-up|0|||
156794968|NCT03787615|566002816|FG000|Overall Study|Withdrawal by Subject|2|||
156794969|NCT03787615|566002816|FG000|Overall Study|Lost to Follow-up|2|||
156794970|NCT06582732|566002820|FG000|Initial Study Period|Adverse Event|0|||
156794971|NCT06582732|566002821|FG001|Initial Study Period|Adverse Event|0|||
156794972|NCT06582732|566002822|FG002|Initial Study Period|Adverse Event|0|||
156794973|NCT06582732|566002823|FG003|Initial Study Period|Adverse Event|2|||
156794974|NCT06582732|566002824|FG004|Initial Study Period|Adverse Event|0|||
156794975|NCT06582732|566002825|FG005|Initial Study Period|Adverse Event|0|||
156794976|NCT06582732|566002826|FG006|Initial Study Period|Adverse Event|0|||
156794977|NCT06582732|566002820|FG000|Initial Study Period|Death|1|||
156794978|NCT06582732|566002821|FG001|Initial Study Period|Death|0|||
156794979|NCT06582732|566002822|FG002|Initial Study Period|Death|0|||
156794980|NCT06582732|566002823|FG003|Initial Study Period|Death|0|||
156794981|NCT06582732|566002824|FG004|Initial Study Period|Death|1|||
156794982|NCT06582732|566002825|FG005|Initial Study Period|Death|0|||
156794983|NCT06582732|566002826|FG006|Initial Study Period|Death|0|||
156794984|NCT06582732|566002820|FG000|Initial Study Period|Lost to Follow-up|0|||
156794985|NCT06582732|566002821|FG001|Initial Study Period|Lost to Follow-up|0|||
156794986|NCT06582732|566002822|FG002|Initial Study Period|Lost to Follow-up|2|||
156794987|NCT06582732|566002823|FG003|Initial Study Period|Lost to Follow-up|0|||
157019455|NCT03665597|566824773|FG006|Period 1|Withdrawal by Subject|5|||
156725159|NCT00848718|565739114|FG006|Overall Study|Protocol Violation|0|||
156725160|NCT00848718|565739115|FG007|Overall Study|Protocol Violation|1|||
156725161|NCT00848718|565739116|FG008|Overall Study|Protocol Violation|0|||
156725162|NCT00848718|565739117|FG009|Overall Study|Protocol Violation|0|||
156725163|NCT00848718|565739118|FG010|Overall Study|Protocol Violation|0|||
156725164|NCT00848718|565739119|FG011|Overall Study|Protocol Violation|0|||
156725165|NCT00848718|565739120|FG012|Overall Study|Protocol Violation|1|||
156725166|NCT00848718|565739108|FG000|Overall Study|Withdrawal by Subject|1|||
156725167|NCT00848718|565739109|FG001|Overall Study|Withdrawal by Subject|0|||
156794988|NCT06582732|566002824|FG004|Initial Study Period|Lost to Follow-up|0|||
156794989|NCT06582732|566002825|FG005|Initial Study Period|Lost to Follow-up|0|||
156794990|NCT06582732|566002826|FG006|Initial Study Period|Lost to Follow-up|0|||
156794991|NCT06582732|566002820|FG000|Initial Study Period|Withdrawal by Subject|0|||
156794992|NCT06582732|566002821|FG001|Initial Study Period|Withdrawal by Subject|1|||
156794993|NCT06582732|566002822|FG002|Initial Study Period|Withdrawal by Subject|0|||
156794994|NCT06582732|566002823|FG003|Initial Study Period|Withdrawal by Subject|1|||
156725168|NCT00848718|565739110|FG002|Overall Study|Withdrawal by Subject|0|||
156794995|NCT06582732|566002824|FG004|Initial Study Period|Withdrawal by Subject|3|||
156794996|NCT06582732|566002825|FG005|Initial Study Period|Withdrawal by Subject|1|||
156725169|NCT00848718|565739111|FG003|Overall Study|Withdrawal by Subject|1|||
156725170|NCT00848718|565739112|FG004|Overall Study|Withdrawal by Subject|0|||
156725171|NCT00848718|565739113|FG005|Overall Study|Withdrawal by Subject|0|||
156725172|NCT00848718|565739114|FG006|Overall Study|Withdrawal by Subject|0|||
156725173|NCT00848718|565739115|FG007|Overall Study|Withdrawal by Subject|0|||
156725174|NCT00848718|565739116|FG008|Overall Study|Withdrawal by Subject|0|||
156725175|NCT00848718|565739117|FG009|Overall Study|Withdrawal by Subject|0|||
156725176|NCT00848718|565739118|FG010|Overall Study|Withdrawal by Subject|1|||
156725177|NCT00848718|565739119|FG011|Overall Study|Withdrawal by Subject|0|||
156725178|NCT00848718|565739120|FG012|Overall Study|Withdrawal by Subject|0|||
156725179|NCT00848718|565739108|FG000|Overall Study|Progressive disease during treatment|3|||
156725180|NCT00848718|565739109|FG001|Overall Study|Progressive disease during treatment|0|||
156725181|NCT00848718|565739110|FG002|Overall Study|Progressive disease during treatment|3|||
156725182|NCT00848718|565739111|FG003|Overall Study|Progressive disease during treatment|0|||
156725183|NCT00848718|565739112|FG004|Overall Study|Progressive disease during treatment|0|||
156725184|NCT00848718|565739113|FG005|Overall Study|Progressive disease during treatment|0|||
156725185|NCT00848718|565739114|FG006|Overall Study|Progressive disease during treatment|0|||
156725186|NCT00848718|565739115|FG007|Overall Study|Progressive disease during treatment|2|||
156725187|NCT00848718|565739116|FG008|Overall Study|Progressive disease during treatment|0|||
156725188|NCT00848718|565739117|FG009|Overall Study|Progressive disease during treatment|0|||
156725189|NCT00848718|565739118|FG010|Overall Study|Progressive disease during treatment|0|||
156725190|NCT00848718|565739119|FG011|Overall Study|Progressive disease during treatment|0|||
156725191|NCT00848718|565739120|FG012|Overall Study|Progressive disease during treatment|2|||
156725192|NCT02389829|565739126|FG000|Overall Study|Lost to Follow-up|0|||
156725193|NCT02389829|565739127|FG001|Overall Study|Lost to Follow-up|1|||
156725194|NCT05514873|565739130|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
156725195|NCT05514873|565739130|FG000|Main Treatment Period|Adverse Event|2|||
156725196|NCT05514873|565739130|FG000|Extension Treatment Period|Lost to Follow-up|3|||
156725197|NCT02588612|565740564|FG000|Overall Study|Physician Decision|1|||
156725198|NCT02588612|565740564|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
156725199|NCT02588612|565740564|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
156725200|NCT02588612|565740564|FG000|Overall Study|Death prior to T-cell infusion|1|||
156725201|NCT03123393|565740568|FG000|Overall Study|Study Terminated by Sponsor|6|||
156725202|NCT03123393|565740569|FG001|Overall Study|Study Terminated by Sponsor|9|||
156725203|NCT03123393|565740568|FG000|Overall Study|Withdrawal by Subject|2|||
156725204|NCT03123393|565740569|FG001|Overall Study|Withdrawal by Subject|1|||
156725205|NCT03123393|565740568|FG000|Overall Study|Reason not Specified|13|||
156725206|NCT03123393|565740569|FG001|Overall Study|Reason not Specified|13|||
156725207|NCT00427648|565740570|FG000|Overall Study|Protocol Violation|1|||
156725208|NCT00427648|565740571|FG001|Overall Study|Protocol Violation|2|||
156725209|NCT00427648|565740570|FG000|Overall Study|Adverse Event|0|||
156725210|NCT00427648|565740571|FG001|Overall Study|Adverse Event|1|||
156725211|NCT01681212|565740572|FG000|Overall Study|No longer met study criteria|5|||
156725212|NCT01681212|565740572|FG000|Overall Study|Administrative reason by sponsor|1|||
156725213|NCT01464333|565740573|FG000|Overall Study|Adverse Event|34|||
156725214|NCT01464333|565740573|FG000|Overall Study|Lack of Efficacy|72|||
156725215|NCT01464333|565740573|FG000|Overall Study|Withdrawal by Subject|11|||
156725216|NCT01464333|565740573|FG000|Overall Study|Other|4|||
156725217|NCT01464333|565740573|FG000|Overall Study|No Hospital Visit|42|||
156725218|NCT05047211|565740574|FG000|Overall Study|Lost to Follow-up|8|||
156725219|NCT05047211|565740575|FG001|Overall Study|Lost to Follow-up|5|||
156725220|NCT00561392|565740578|FG000|Overall Study|Adverse Event|38|||
156725221|NCT00561392|565740578|FG000|Overall Study|Lack of Efficacy|2|||
156725222|NCT00561392|565740578|FG000|Overall Study|Protocol Violation|1|||
156725223|NCT00561392|565740578|FG000|Overall Study|Withdrawal by Subject|8|||
156725224|NCT00561392|565740578|FG000|Overall Study|Administrative problems|4|||
156725225|NCT03321968|565740579|FG000|Overall Study|Withdrawal by Subject|1|||
156725226|NCT03321968|565740580|FG001|Overall Study|Withdrawal by Subject|2|||
156725227|NCT03321968|565740581|FG002|Overall Study|Withdrawal by Subject|1|||
156725228|NCT03321968|565740579|FG000|Overall Study|Lost to Follow-up|2|||
156725229|NCT03321968|565740580|FG001|Overall Study|Lost to Follow-up|0|||
156725230|NCT03321968|565740581|FG002|Overall Study|Lost to Follow-up|1|||
156725231|NCT03321968|565740579|FG000|Overall Study|Other than specified|0|||
156725232|NCT03321968|565740580|FG001|Overall Study|Other than specified|0|||
156725233|NCT03321968|565740581|FG002|Overall Study|Other than specified|1|||
156725234|NCT03822468|565740582|FG000|Treatment Period|Progressive disease|98|||
156725235|NCT03822468|565740583|FG001|Treatment Period|Progressive disease|94|||
156725236|NCT03822468|565740582|FG000|Treatment Period|Adverse Event|21|||
156725237|NCT03822468|565740583|FG001|Treatment Period|Adverse Event|24|||
156725238|NCT03822468|565740582|FG000|Treatment Period|Withdrawal by Subject|9|||
156725239|NCT03822468|565740583|FG001|Treatment Period|Withdrawal by Subject|5|||
156725240|NCT03822468|565740582|FG000|Treatment Period|Physician Decision|9|||
156725241|NCT03822468|565740583|FG001|Treatment Period|Physician Decision|7|||
156725242|NCT03822468|565740582|FG000|Treatment Period|Protocol Violation|2|||
157019456|NCT03665597|566824767|FG000|Period 2|Adverse Event|0|||
157019457|NCT03665597|566824768|FG001|Period 2|Adverse Event|0|||
157019458|NCT03665597|566824769|FG002|Period 2|Adverse Event|0|||
157019459|NCT03665597|566824770|FG003|Period 2|Adverse Event|0|||
157019460|NCT03665597|566824771|FG004|Period 2|Adverse Event|0|||
157019461|NCT03665597|566824772|FG005|Period 2|Adverse Event|1|||
157019462|NCT03665597|566824773|FG006|Period 2|Adverse Event|0|||
157019463|NCT03665597|566824767|FG000|Period 3|Adverse Event|0|||
157019464|NCT03665597|566824768|FG001|Period 3|Adverse Event|1|||
157019465|NCT03665597|566824769|FG002|Period 3|Adverse Event|0|||
157019466|NCT03665597|566824770|FG003|Period 3|Adverse Event|0|||
157019467|NCT03665597|566824771|FG004|Period 3|Adverse Event|0|||
157019468|NCT03665597|566824772|FG005|Period 3|Adverse Event|0|||
157019469|NCT03665597|566824773|FG006|Period 3|Adverse Event|0|||
157019470|NCT03665597|566824767|FG000|Period 3|Death|0|||
157019471|NCT03665597|566824768|FG001|Period 3|Death|0|||
157019472|NCT03665597|566824769|FG002|Period 3|Death|0|||
157019473|NCT03665597|566824770|FG003|Period 3|Death|0|||
157019474|NCT03665597|566824771|FG004|Period 3|Death|1|||
157019475|NCT03665597|566824772|FG005|Period 3|Death|0|||
157019476|NCT03665597|566824773|FG006|Period 3|Death|0|||
157019477|NCT03665597|566824767|FG000|Period 4|Adverse Event|2|||
157019478|NCT03665597|566824768|FG001|Period 4|Adverse Event|2|||
157019479|NCT03665597|566824769|FG002|Period 4|Adverse Event|2|||
157019480|NCT03665597|566824770|FG003|Period 4|Adverse Event|2|||
157019481|NCT03665597|566824771|FG004|Period 4|Adverse Event|1|||
157019482|NCT03665597|566824772|FG005|Period 4|Adverse Event|0|||
157019483|NCT03665597|566824773|FG006|Period 4|Adverse Event|0|||
157019484|NCT03665597|566824767|FG000|Period 4|Death|0|||
157019485|NCT03665597|566824768|FG001|Period 4|Death|0|||
157019486|NCT03665597|566824769|FG002|Period 4|Death|2|||
157019487|NCT03665597|566824770|FG003|Period 4|Death|0|||
157019488|NCT03665597|566824771|FG004|Period 4|Death|0|||
157019489|NCT03665597|566824772|FG005|Period 4|Death|0|||
157019490|NCT03665597|566824773|FG006|Period 4|Death|0|||
157019491|NCT03665597|566824767|FG000|Period 4|Physician Decision|1|||
157019492|NCT03665597|566824768|FG001|Period 4|Physician Decision|2|||
157019493|NCT03665597|566824769|FG002|Period 4|Physician Decision|0|||
157019494|NCT03665597|566824770|FG003|Period 4|Physician Decision|0|||
157019495|NCT03665597|566824771|FG004|Period 4|Physician Decision|0|||
157137090|NCT02542267|567249019|FG000|Overall Study|Other|9|||
157137091|NCT00442598|567249020|FG000|Overall Study|Adverse Event|1|||
157137092|NCT00442598|567249021|FG001|Overall Study|Adverse Event|0|||
157137093|NCT00442598|567249022|FG002|Overall Study|Adverse Event|0|||
157137094|NCT00442598|567249020|FG000|Overall Study|Tumor progression|3|||
157137095|NCT00442598|567249021|FG001|Overall Study|Tumor progression|4|||
157137096|NCT00442598|567249022|FG002|Overall Study|Tumor progression|0|||
157137097|NCT00442598|567249020|FG000|Overall Study|Clinical deterioration|1|||
157137098|NCT00442598|567249021|FG001|Overall Study|Clinical deterioration|2|||
157137099|NCT00442598|567249022|FG002|Overall Study|Clinical deterioration|0|||
157019496|NCT03665597|566824772|FG005|Period 4|Physician Decision|0|||
157019497|NCT03665597|566824773|FG006|Period 4|Physician Decision|0|||
157137100|NCT00442598|567249020|FG000|Overall Study|CA125 progression|0|||
156725243|NCT03822468|565740583|FG001|Treatment Period|Protocol Violation|1|||
156725244|NCT03822468|565740582|FG000|Treatment Period|Death|2|||
156725245|NCT03822468|565740583|FG001|Treatment Period|Death|3|||
156725246|NCT03822468|565740582|FG000|Treatment Period|Lost to Follow-up|1|||
156725247|NCT03822468|565740583|FG001|Treatment Period|Lost to Follow-up|1|||
156725248|NCT03822468|565740582|FG000|Treatment Period|Sponsor decision|46|||
156725249|NCT03822468|565740583|FG001|Treatment Period|Sponsor decision|53|||
156725250|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
156725251|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
156725252|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
156725253|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
156725254|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Death|1|||
156725255|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Death|0|||
156725256|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156725257|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156725258|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156725259|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
157019498|NCT05516147|566824774|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
157019499|NCT05371652|566824778|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
157137101|NCT00442598|567249021|FG001|Overall Study|CA125 progression|1|||
156725260|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
157019500|NCT05371652|566824778|FG000|Overall Study|Withdrawal by Subject|12|||
157019501|NCT05371652|566824778|FG000|Overall Study|Adverse Event|1|||
157019502|NCT05371652|566824778|FG000|Overall Study|Other|11|||
157019503|NCT05256706|566824780|FG000|Overall Study|Lost to Follow-up|9|||
157019504|NCT05256706|566824781|FG001|Overall Study|Lost to Follow-up|3|||
157019505|NCT05256706|566824780|FG000|Overall Study|Withdrawal by Subject|7|||
157019506|NCT05256706|566824781|FG001|Overall Study|Withdrawal by Subject|11|||
157137102|NCT00442598|567249022|FG002|Overall Study|CA125 progression|0|||
157137103|NCT00442598|567249020|FG000|Overall Study|Reduced creatinine clearance|1|||
157137104|NCT00442598|567249021|FG001|Overall Study|Reduced creatinine clearance|0|||
157137105|NCT00442598|567249022|FG002|Overall Study|Reduced creatinine clearance|0|||
157137106|NCT00442598|567249020|FG000|Overall Study|Death|0|||
157137107|NCT00442598|567249021|FG001|Overall Study|Death|1|||
157137108|NCT00442598|567249022|FG002|Overall Study|Death|0|||
157137109|NCT03093402|567249023|FG000|Overall Study|Lost to Follow-up|1|||
157137110|NCT03093402|567249024|FG001|Overall Study|Lost to Follow-up|0|||
157137111|NCT03093402|567249025|FG002|Overall Study|Lost to Follow-up|0|||
157137112|NCT03093402|567249026|FG003|Overall Study|Lost to Follow-up|0|||
157137113|NCT03093402|567249023|FG000|Overall Study|Withdrawal by Subject|3|||
157137114|NCT03093402|567249024|FG001|Overall Study|Withdrawal by Subject|3|||
157137115|NCT03093402|567249025|FG002|Overall Study|Withdrawal by Subject|0|||
157137116|NCT03093402|567249026|FG003|Overall Study|Withdrawal by Subject|1|||
157137117|NCT03093402|567249023|FG000|Overall Study|Withdrew prior to dosing|2|||
157137118|NCT03093402|567249024|FG001|Overall Study|Withdrew prior to dosing|1|||
157137119|NCT03093402|567249025|FG002|Overall Study|Withdrew prior to dosing|2|||
157137120|NCT03093402|567249026|FG003|Overall Study|Withdrew prior to dosing|3|||
157137121|NCT03093402|567249023|FG000|Overall Study|Ineligible for study|1|||
157137122|NCT03093402|567249024|FG001|Overall Study|Ineligible for study|0|||
157137123|NCT03093402|567249025|FG002|Overall Study|Ineligible for study|0|||
157137124|NCT03093402|567249026|FG003|Overall Study|Ineligible for study|0|||
157137125|NCT03093402|567249023|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
157137126|NCT03093402|567249024|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
157137127|NCT03093402|567249025|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
157137128|NCT03093402|567249026|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
157137129|NCT02886702|567249027|FG000|Overall Study|Other|4|||
157137130|NCT02886702|567249028|FG001|Overall Study|Other|3|||
157137131|NCT02886702|567249029|FG002|Overall Study|Other|9|||
157137132|NCT02886702|567249027|FG000|Overall Study|Withdrawal by Subject|24|||
157137133|NCT02886702|567249028|FG001|Overall Study|Withdrawal by Subject|18|||
157137134|NCT02886702|567249029|FG002|Overall Study|Withdrawal by Subject|22|||
157137135|NCT02886702|567249027|FG000|Overall Study|Significant Worsening of Condition|0|||
157137136|NCT02886702|567249028|FG001|Overall Study|Significant Worsening of Condition|1|||
157137137|NCT02886702|567249029|FG002|Overall Study|Significant Worsening of Condition|0|||
157137138|NCT02886702|567249027|FG000|Overall Study|Protocol Violation|2|||
157137139|NCT02886702|567249028|FG001|Overall Study|Protocol Violation|2|||
157137140|NCT02886702|567249029|FG002|Overall Study|Protocol Violation|1|||
157137141|NCT02886702|567249027|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157137142|NCT02886702|567249028|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157137143|NCT02886702|567249029|FG002|Overall Study|Non-Compliance With Study Drug|4|||
157137144|NCT02886702|567249027|FG000|Overall Study|Lost to Follow-up|11|||
157137145|NCT02886702|567249028|FG001|Overall Study|Lost to Follow-up|13|||
157137146|NCT02886702|567249029|FG002|Overall Study|Lost to Follow-up|8|||
157137147|NCT02886702|567249027|FG000|Overall Study|Lack of Efficacy|3|||
157137148|NCT02886702|567249028|FG001|Overall Study|Lack of Efficacy|4|||
157137149|NCT02886702|567249029|FG002|Overall Study|Lack of Efficacy|5|||
157137150|NCT02886702|567249027|FG000|Overall Study|Adverse Event|4|||
157137151|NCT02886702|567249028|FG001|Overall Study|Adverse Event|9|||
157137152|NCT02886702|567249029|FG002|Overall Study|Adverse Event|3|||
157137153|NCT02886702|567249027|FG000|Overall Study|Administrative Reasons|0|||
157137154|NCT02886702|567249028|FG001|Overall Study|Administrative Reasons|0|||
157137155|NCT02886702|567249029|FG002|Overall Study|Administrative Reasons|1|||
157137156|NCT01147497|567249037|FG000|Overall Study|failed insertion|2|||
157137157|NCT01147497|567249038|FG001|Overall Study|failed insertion|0|||
157137158|NCT02731742|567249039|FG000|Overall Study|Death|1|||
156725261|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156725262|NCT03822468|565740582|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
156725263|NCT03822468|565740583|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
156725264|NCT02198664|565740584|FG000|Overall Study|Adverse Event|2|||
156725265|NCT02198664|565740585|FG001|Overall Study|Adverse Event|0|||
156725266|NCT02198664|565740584|FG000|Overall Study|Withdrawal by Subject|11|||
157137159|NCT02731742|567249040|FG001|Overall Study|Death|2|||
156725267|NCT02198664|565740585|FG001|Overall Study|Withdrawal by Subject|8|||
156725268|NCT02198664|565740584|FG000|Overall Study|Failure to tolerate|2|||
157137160|NCT02731742|567249041|FG002|Overall Study|Death|5|||
157137161|NCT02731742|567249042|FG003|Overall Study|Death|0|||
157137162|NCT02731742|567249039|FG000|Overall Study|Physician Decision|0|||
157137163|NCT02731742|567249040|FG001|Overall Study|Physician Decision|0|||
157137164|NCT02731742|567249041|FG002|Overall Study|Physician Decision|0|||
157137165|NCT02731742|567249042|FG003|Overall Study|Physician Decision|1|||
157137166|NCT02731742|567249039|FG000|Overall Study|Study Terminated by Sponsor|2|||
157137167|NCT02731742|567249040|FG001|Overall Study|Study Terminated by Sponsor|1|||
156794997|NCT06582732|566002826|FG006|Initial Study Period|Withdrawal by Subject|2|||
156794998|NCT06582732|566002820|FG000|Initial Study Period|Moved Away|0|||
156794999|NCT06582732|566002821|FG001|Initial Study Period|Moved Away|0|||
157137168|NCT02731742|567249041|FG002|Overall Study|Study Terminated by Sponsor|1|||
156725269|NCT02198664|565740585|FG001|Overall Study|Failure to tolerate|0|||
156725270|NCT02198664|565740584|FG000|Overall Study|Not stated|1|||
156725271|NCT02198664|565740585|FG001|Overall Study|Not stated|0|||
156725272|NCT00529308|565740586|FG000|Overall Study|Withdrawal by Subject|1|||
156725273|NCT00529308|565740587|FG001|Overall Study|Withdrawal by Subject|1|||
156725274|NCT00720213|565740588|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
156725275|NCT00720213|565740589|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
156725276|NCT00720213|565740590|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
156725277|NCT01808066|565740596|FG000|Overall Study|Withdrawal by Subject|15|||
156725278|NCT01420068|565740601|FG000|Overall Study|Administrative problems|1|||
156725279|NCT01420068|565740602|FG001|Overall Study|Administrative problems|3|||
156725280|NCT01420068|565740601|FG000|Overall Study|Withdrawal by Subject|1|||
156725281|NCT01420068|565740602|FG001|Overall Study|Withdrawal by Subject|2|||
156725282|NCT01252095|565740603|FG000|Overall Study|Disease progression|1|||
157019507|NCT05256706|566824780|FG000|Overall Study|Screen Failures|3|||
156725283|NCT01252095|565740604|FG001|Overall Study|Disease progression|0|||
157019508|NCT05256706|566824781|FG001|Overall Study|Screen Failures|0|||
156725284|NCT00365794|565740605|FG000|Overall Study|Withdrawal by Subject|2|||
156725285|NCT00745901|565740606|FG000|Overall Study|Adverse Event|3|||
156725286|NCT00745901|565740607|FG001|Overall Study|Adverse Event|4|||
156725287|NCT00745901|565740606|FG000|Overall Study|Protocol Violation|0|||
156725288|NCT00745901|565740607|FG001|Overall Study|Protocol Violation|1|||
156725289|NCT00745901|565740606|FG000|Overall Study|Withdrawal by Subject|1|||
156725290|NCT00745901|565740607|FG001|Overall Study|Withdrawal by Subject|0|||
156725291|NCT00745901|565740606|FG000|Overall Study|Lost to Follow-up|7|||
156725292|NCT00745901|565740607|FG001|Overall Study|Lost to Follow-up|4|||
156725293|NCT00745901|565740606|FG000|Overall Study|Pregnancy|2|||
156725294|NCT00745901|565740607|FG001|Overall Study|Pregnancy|4|||
156725295|NCT00745901|565740606|FG000|Overall Study|Lack of compliance|2|||
156725296|NCT00745901|565740607|FG001|Overall Study|Lack of compliance|2|||
156725297|NCT00745901|565740606|FG000|Overall Study|Patient's next menses did not start with|1|||
156725298|NCT00745901|565740607|FG001|Overall Study|Patient's next menses did not start with|0|||
156725299|NCT00745901|565740606|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
156725300|NCT00745901|565740607|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
156725301|NCT00745901|565740606|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
156725302|NCT00745901|565740607|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
156725303|NCT00745901|565740606|FG000|Overall Study|Patient didn't take any study medication|7|||
156725304|NCT00745901|565740607|FG001|Overall Study|Patient didn't take any study medication|3|||
156725305|NCT02554682|565740608|FG000|Overall Study|Lost to Follow-up|11|||
156725306|NCT02554682|565740609|FG001|Overall Study|Lost to Follow-up|9|||
156725307|NCT02554682|565740610|FG002|Overall Study|Lost to Follow-up|4|||
156725308|NCT02554682|565740611|FG003|Overall Study|Lost to Follow-up|3|||
156725309|NCT02554682|565740612|FG004|Overall Study|Lost to Follow-up|2|||
156725310|NCT02554682|565740613|FG005|Overall Study|Lost to Follow-up|1|||
156725311|NCT02554682|565740614|FG006|Overall Study|Lost to Follow-up|6|||
156725312|NCT02554682|565740615|FG007|Overall Study|Lost to Follow-up|6|||
156725313|NCT02554682|565740616|FG008|Overall Study|Lost to Follow-up|2|||
156725314|NCT02554682|565740617|FG009|Overall Study|Lost to Follow-up|2|||
156725315|NCT02554682|565740608|FG000|Overall Study|Withdrawal by Subject|2|||
156725316|NCT02554682|565740609|FG001|Overall Study|Withdrawal by Subject|1|||
156725317|NCT02554682|565740610|FG002|Overall Study|Withdrawal by Subject|0|||
156725318|NCT02554682|565740611|FG003|Overall Study|Withdrawal by Subject|0|||
156725319|NCT02554682|565740612|FG004|Overall Study|Withdrawal by Subject|0|||
156725320|NCT02554682|565740613|FG005|Overall Study|Withdrawal by Subject|0|||
156725321|NCT02554682|565740614|FG006|Overall Study|Withdrawal by Subject|0|||
156725322|NCT02554682|565740615|FG007|Overall Study|Withdrawal by Subject|0|||
156725323|NCT02554682|565740616|FG008|Overall Study|Withdrawal by Subject|0|||
156725324|NCT02554682|565740617|FG009|Overall Study|Withdrawal by Subject|0|||
156725325|NCT02554682|565740608|FG000|Overall Study|Physician Decision|2|||
156725326|NCT02554682|565740609|FG001|Overall Study|Physician Decision|2|||
156725327|NCT02554682|565740610|FG002|Overall Study|Physician Decision|0|||
156725328|NCT02554682|565740611|FG003|Overall Study|Physician Decision|0|||
156725329|NCT02554682|565740612|FG004|Overall Study|Physician Decision|0|||
156725330|NCT02554682|565740613|FG005|Overall Study|Physician Decision|0|||
156725331|NCT02554682|565740614|FG006|Overall Study|Physician Decision|0|||
156725332|NCT02554682|565740615|FG007|Overall Study|Physician Decision|0|||
156725333|NCT02554682|565740616|FG008|Overall Study|Physician Decision|0|||
156725334|NCT02554682|565740617|FG009|Overall Study|Physician Decision|0|||
156725335|NCT00884117|565740620|FG000|Overall Study|Adverse Event|2|||
156725336|NCT00884117|565740620|FG000|Overall Study|Withdrawal by Subject|89|||
156725337|NCT00884117|565740620|FG000|Overall Study|Death|3|||
156725338|NCT00884117|565740620|FG000|Overall Study|Lost to Follow-up|143|||
156725339|NCT00884117|565740620|FG000|Overall Study|Other|12|||
156725340|NCT01753310|565740621|FG000|Overall Study|Entered into open label extension study|25|||
156725341|NCT01753310|565740622|FG001|Overall Study|Entered into open label extension study|22|||
156725342|NCT01753310|565740621|FG000|Overall Study|Adverse Event|1|||
157019509|NCT04410042|566824782|FG000|Overall Study|Not Eligible|1|||
156725343|NCT01753310|565740622|FG001|Overall Study|Adverse Event|0|||
156725344|NCT01753310|565740621|FG000|Overall Study|Lost to Follow-up|2|||
156725345|NCT01753310|565740622|FG001|Overall Study|Lost to Follow-up|0|||
156725346|NCT01753310|565740621|FG000|Overall Study|Subject decision|2|||
156725347|NCT01753310|565740622|FG001|Overall Study|Subject decision|2|||
156725348|NCT01753310|565740621|FG000|Overall Study|Sponsor decision|1|||
156725349|NCT01753310|565740622|FG001|Overall Study|Sponsor decision|0|||
156725350|NCT01753310|565740621|FG000|Overall Study|Withdrawal by Subject|1|||
156725351|NCT01753310|565740622|FG001|Overall Study|Withdrawal by Subject|0|||
156725352|NCT01580670|565740623|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
156725353|NCT01580670|565740623|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
156725354|NCT02022202|565740624|FG000|Overall Study|Withdrawal by Subject|2|||
156725355|NCT02022202|565740624|FG000|Overall Study|Disease Progression|3|||
156725356|NCT02022202|565740624|FG000|Overall Study|Desire go to immediately to surgery|3|||
156725357|NCT05581641|565740626|FG000|Overall Study|Withdrawal by Subject|0|||
156725358|NCT05581641|565740627|FG001|Overall Study|Withdrawal by Subject|1|||
156725359|NCT05581641|565740628|FG002|Overall Study|Withdrawal by Subject|3|||
156725360|NCT05581641|565740629|FG003|Overall Study|Withdrawal by Subject|1|||
156725361|NCT05581641|565740626|FG000|Overall Study|Lost to Follow-up|0|||
156725362|NCT05581641|565740627|FG001|Overall Study|Lost to Follow-up|1|||
156725363|NCT05581641|565740628|FG002|Overall Study|Lost to Follow-up|0|||
156725364|NCT05581641|565740629|FG003|Overall Study|Lost to Follow-up|1|||
156725365|NCT05581641|565740626|FG000|Overall Study|Protocol Violation|1|||
156725366|NCT05581641|565740627|FG001|Overall Study|Protocol Violation|0|||
156725367|NCT05581641|565740628|FG002|Overall Study|Protocol Violation|0|||
156725368|NCT05581641|565740629|FG003|Overall Study|Protocol Violation|0|||
156725369|NCT05581641|565740626|FG000|Overall Study|Other|1|||
156725370|NCT05581641|565740627|FG001|Overall Study|Other|0|||
156725371|NCT05581641|565740628|FG002|Overall Study|Other|2|||
156725372|NCT05581641|565740629|FG003|Overall Study|Other|1|||
156725373|NCT04390763|565740630|FG000|Safety run-in Part|Adverse Event|4|||
156725374|NCT04390763|565740631|FG001|Safety run-in Part|Adverse Event|0|||
156725375|NCT04390763|565740632|FG002|Safety run-in Part|Adverse Event|0|||
156725376|NCT04390763|565740633|FG003|Safety run-in Part|Adverse Event|0|||
156725377|NCT04390763|565740630|FG000|Safety run-in Part|Physician Decision|1|||
156725378|NCT04390763|565740631|FG001|Safety run-in Part|Physician Decision|0|||
156725379|NCT04390763|565740632|FG002|Safety run-in Part|Physician Decision|0|||
156725380|NCT04390763|565740633|FG003|Safety run-in Part|Physician Decision|0|||
156725381|NCT04390763|565740630|FG000|Safety run-in Part|Progressive Disease|6|||
156725382|NCT04390763|565740631|FG001|Safety run-in Part|Progressive Disease|0|||
156725383|NCT04390763|565740632|FG002|Safety run-in Part|Progressive Disease|0|||
156725384|NCT04390763|565740633|FG003|Safety run-in Part|Progressive Disease|0|||
156725385|NCT04390763|565740630|FG000|Randomized Part|Adverse Event|0|||
156725386|NCT04390763|565740631|FG001|Randomized Part|Adverse Event|11|||
156725387|NCT04390763|565740632|FG002|Randomized Part|Adverse Event|5|||
156725388|NCT04390763|565740633|FG003|Randomized Part|Adverse Event|5|||
156725389|NCT04390763|565740630|FG000|Randomized Part|Death|0|||
156725390|NCT04390763|565740631|FG001|Randomized Part|Death|3|||
156725391|NCT04390763|565740632|FG002|Randomized Part|Death|4|||
156725392|NCT04390763|565740633|FG003|Randomized Part|Death|2|||
156725393|NCT04390763|565740630|FG000|Randomized Part|Physician Decision|0|||
156725394|NCT04390763|565740631|FG001|Randomized Part|Physician Decision|2|||
156725395|NCT04390763|565740632|FG002|Randomized Part|Physician Decision|2|||
156725396|NCT04390763|565740633|FG003|Randomized Part|Physician Decision|9|||
156725397|NCT04390763|565740630|FG000|Randomized Part|Progressive Disease|0|||
156725398|NCT04390763|565740631|FG001|Randomized Part|Progressive Disease|24|||
156725399|NCT04390763|565740632|FG002|Randomized Part|Progressive Disease|31|||
156725400|NCT04390763|565740633|FG003|Randomized Part|Progressive Disease|23|||
156725401|NCT04390763|565740630|FG000|Randomized Part|Study terminated by sponsor|0|||
156725402|NCT04390763|565740631|FG001|Randomized Part|Study terminated by sponsor|1|||
156725403|NCT04390763|565740632|FG002|Randomized Part|Study terminated by sponsor|0|||
156725404|NCT04390763|565740633|FG003|Randomized Part|Study terminated by sponsor|0|||
156725405|NCT04390763|565740630|FG000|Randomized Part|Participant Decision|0|||
156725406|NCT04390763|565740631|FG001|Randomized Part|Participant Decision|5|||
156725407|NCT04390763|565740632|FG002|Randomized Part|Participant Decision|7|||
156725408|NCT04390763|565740633|FG003|Randomized Part|Participant Decision|6|||
156725409|NCT04390763|565740630|FG000|Randomized Part|Not treated|0|||
156725410|NCT04390763|565740631|FG001|Randomized Part|Not treated|4|||
156725411|NCT04390763|565740632|FG002|Randomized Part|Not treated|2|||
156725412|NCT04390763|565740633|FG003|Randomized Part|Not treated|7|||
156725413|NCT01956773|565740640|FG000|Overall Study|Lost to Follow-up|628|||
156725414|NCT01956773|565740641|FG001|Overall Study|Lost to Follow-up|1|||
156725415|NCT01383174|565740642|FG000|3 Month Assessment|Death|0|||
156725416|NCT01383174|565740643|FG001|3 Month Assessment|Death|1|||
156725417|NCT01383174|565740642|FG000|3 Month Assessment|Lost to Follow-up|2|||
156725418|NCT01383174|565740643|FG001|3 Month Assessment|Lost to Follow-up|0|||
156725419|NCT01383174|565740642|FG000|3 Month Assessment|Refused to complete|4|||
156725420|NCT01383174|565740643|FG001|3 Month Assessment|Refused to complete|0|||
157019510|NCT04410042|566824783|FG001|Overall Study|Not Eligible|1|||
156725421|NCT01383174|565740642|FG000|6 Month Assessment|Lost to Follow-up|1|||
156725422|NCT01383174|565740643|FG001|6 Month Assessment|Lost to Follow-up|1|||
156725423|NCT01383174|565740642|FG000|6 Month Assessment|Refused to complete|4|||
156725424|NCT01383174|565740643|FG001|6 Month Assessment|Refused to complete|0|||
156725425|NCT01153815|565740644|FG000|Overall Study|Adverse Event|3|||
156725426|NCT01153815|565740645|FG001|Overall Study|Adverse Event|1|||
156725427|NCT01153815|565740644|FG000|Overall Study|Withdrawal by Subject|6|||
156725428|NCT01153815|565740645|FG001|Overall Study|Withdrawal by Subject|4|||
156725429|NCT01786993|565740648|FG000|Overall Study|Death|6|||
156725430|NCT01786993|565740649|FG001|Overall Study|Death|7|||
156725431|NCT01786993|565740648|FG000|Overall Study|Withdrawal by Subject|3|||
156725432|NCT01786993|565740649|FG001|Overall Study|Withdrawal by Subject|2|||
156725433|NCT01786993|565740648|FG000|Overall Study|Lost to Follow-up|0|||
156725434|NCT01786993|565740649|FG001|Overall Study|Lost to Follow-up|1|||
156725435|NCT01786993|565740648|FG000|Overall Study|Subject Non-Compliance|1|||
156725436|NCT01786993|565740649|FG001|Overall Study|Subject Non-Compliance|0|||
156725437|NCT01786993|565740648|FG000|Overall Study|System Explant|1|||
156725438|NCT01786993|565740649|FG001|Overall Study|System Explant|0|||
156725439|NCT01786993|565740648|FG000|Overall Study|Hospice Admission|1|||
156725440|NCT01786993|565740649|FG001|Overall Study|Hospice Admission|0|||
156725441|NCT00450437|565740650|FG000|Overall Study|Withdrawal by Subject|10|||
156725442|NCT00450437|565740651|FG001|Overall Study|Withdrawal by Subject|2|||
156725443|NCT00450437|565740652|FG002|Overall Study|Withdrawal by Subject|0|||
156725444|NCT00450437|565740653|FG003|Overall Study|Withdrawal by Subject|1|||
156725445|NCT00450437|565740650|FG000|Overall Study|Lost to Follow-up|31|||
156725446|NCT00450437|565740651|FG001|Overall Study|Lost to Follow-up|12|||
156725447|NCT00450437|565740652|FG002|Overall Study|Lost to Follow-up|19|||
156725448|NCT00450437|565740653|FG003|Overall Study|Lost to Follow-up|9|||
156725449|NCT00450437|565740650|FG000|Overall Study|Protocol Violation|0|||
156725450|NCT00450437|565740651|FG001|Overall Study|Protocol Violation|1|||
156725451|NCT00450437|565740652|FG002|Overall Study|Protocol Violation|0|||
157019511|NCT03302494|566824784|FG000|Overall Study|Other|7|||
157019512|NCT03302494|566824785|FG001|Overall Study|Other|4|||
157019513|NCT03302494|566824786|FG002|Overall Study|Other|6|||
157019514|NCT03302494|566824784|FG000|Overall Study|Withdrawal by Subject|10|||
157019515|NCT03302494|566824785|FG001|Overall Study|Withdrawal by Subject|2|||
157019516|NCT03302494|566824786|FG002|Overall Study|Withdrawal by Subject|9|||
156725452|NCT00450437|565740653|FG003|Overall Study|Protocol Violation|1|||
156725453|NCT00450437|565740650|FG000|Overall Study|Inappropriate enrollment|4|||
156725454|NCT00450437|565740651|FG001|Overall Study|Inappropriate enrollment|1|||
156725455|NCT00450437|565740652|FG002|Overall Study|Inappropriate enrollment|3|||
156725456|NCT00450437|565740653|FG003|Overall Study|Inappropriate enrollment|0|||
157019517|NCT03302494|566824784|FG000|Overall Study|Study Terminated by Sponsor|32|||
157019518|NCT03302494|566824785|FG001|Overall Study|Study Terminated by Sponsor|29|||
157019519|NCT03302494|566824786|FG002|Overall Study|Study Terminated by Sponsor|30|||
157019520|NCT03302494|566824784|FG000|Overall Study|Physician Decision|1|||
157019521|NCT03302494|566824785|FG001|Overall Study|Physician Decision|0|||
157137169|NCT02731742|567249042|FG003|Overall Study|Study Terminated by Sponsor|1|||
157137170|NCT04026568|567249043|FG000|Overall Study|study terminated|0|||
157137171|NCT04026568|567249044|FG001|Overall Study|study terminated|1|||
156725457|NCT00450437|565740650|FG000|Overall Study|Administrative reason|0|||
156725458|NCT00450437|565740651|FG001|Overall Study|Administrative reason|0|||
156725459|NCT00450437|565740652|FG002|Overall Study|Administrative reason|1|||
156725460|NCT00450437|565740653|FG003|Overall Study|Administrative reason|0|||
156725461|NCT00450437|565740650|FG000|Overall Study|Unable to Classify|1|||
157137172|NCT00461175|567249045|FG000|Overall Study|Protocol Violation|522|||
157137173|NCT00461175|567249046|FG001|Overall Study|Protocol Violation|365|||
157137174|NCT00331760|567249047|FG000|Overall Study|Ineligible / no protocol treatment|15|||
156725462|NCT00450437|565740651|FG001|Overall Study|Unable to Classify|0|||
156725463|NCT00450437|565740652|FG002|Overall Study|Unable to Classify|1|||
156725464|NCT00450437|565740653|FG003|Overall Study|Unable to Classify|0|||
156725465|NCT01890122|565740654|FG000|Overall Study|Adverse Event|1|||
156725466|NCT01890122|565740655|FG001|Overall Study|Adverse Event|1|||
156725467|NCT01890122|565740656|FG002|Overall Study|Adverse Event|1|||
156725468|NCT01890122|565740657|FG003|Overall Study|Adverse Event|2|||
156725469|NCT01890122|565740654|FG000|Overall Study|Major Protocol Deviation|3|||
156725470|NCT01890122|565740655|FG001|Overall Study|Major Protocol Deviation|1|||
156725471|NCT01890122|565740656|FG002|Overall Study|Major Protocol Deviation|0|||
156725472|NCT01890122|565740657|FG003|Overall Study|Major Protocol Deviation|1|||
156725473|NCT01890122|565740654|FG000|Overall Study|Lost to Follow-up|0|||
157019522|NCT03302494|566824786|FG002|Overall Study|Physician Decision|1|||
157019523|NCT03302494|566824784|FG000|Overall Study|Lost to Follow-up|1|||
157019524|NCT03302494|566824785|FG001|Overall Study|Lost to Follow-up|3|||
157019525|NCT03302494|566824786|FG002|Overall Study|Lost to Follow-up|3|||
157019526|NCT03302494|566824784|FG000|Overall Study|Death|13|||
157019527|NCT03302494|566824785|FG001|Overall Study|Death|11|||
157019528|NCT03302494|566824786|FG002|Overall Study|Death|4|||
157137175|NCT00331760|567249048|FG001|Overall Study|Ineligible / no protocol treatment|8|||
157019529|NCT03302494|566824784|FG000|Overall Study|Adverse Event|1|||
157019530|NCT03302494|566824785|FG001|Overall Study|Adverse Event|2|||
157019531|NCT03302494|566824786|FG002|Overall Study|Adverse Event|0|||
157019532|NCT03302494|566824784|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
157019533|NCT03302494|566824785|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
157019534|NCT03302494|566824786|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
157019535|NCT03978871|566824787|FG000|Overall Study|Lost to Follow-up|11|||
157019536|NCT03978871|566824788|FG001|Overall Study|Lost to Follow-up|12|||
157019537|NCT05710107|566824789|FG000|Overall Study|Withdrawal by Subject|1|||
157019538|NCT05710107|566824790|FG001|Overall Study|Withdrawal by Subject|1|||
157019539|NCT05710107|566824789|FG000|Overall Study|Lost to Follow-up|8|||
157019540|NCT05710107|566824790|FG001|Overall Study|Lost to Follow-up|9|||
157019541|NCT05710107|566824789|FG000|Overall Study|Unable to place assigned block|2|||
157019542|NCT05710107|566824790|FG001|Overall Study|Unable to place assigned block|0|||
157019543|NCT05710107|566824789|FG000|Overall Study|Withdrawn by study team|0|||
157019544|NCT05710107|566824790|FG001|Overall Study|Withdrawn by study team|1|||
157019545|NCT04166773|566824791|FG000|Overall Study|Adverse Event|2|||
157019546|NCT04166773|566824792|FG001|Overall Study|Adverse Event|0|||
157019547|NCT04166773|566824793|FG002|Overall Study|Adverse Event|2|||
157019548|NCT04166773|566824794|FG003|Overall Study|Adverse Event|1|||
157019549|NCT04166773|566824791|FG000|Overall Study|Lost to Follow-up|4|||
157019550|NCT04166773|566824792|FG001|Overall Study|Lost to Follow-up|2|||
157019551|NCT04166773|566824793|FG002|Overall Study|Lost to Follow-up|1|||
157019552|NCT04166773|566824794|FG003|Overall Study|Lost to Follow-up|3|||
157019553|NCT04166773|566824791|FG000|Overall Study|Physician Decision|0|||
157019554|NCT04166773|566824792|FG001|Overall Study|Physician Decision|0|||
157019555|NCT04166773|566824793|FG002|Overall Study|Physician Decision|0|||
157019556|NCT04166773|566824794|FG003|Overall Study|Physician Decision|1|||
157019557|NCT04166773|566824791|FG000|Overall Study|Withdrawal by Subject|1|||
157019558|NCT04166773|566824792|FG001|Overall Study|Withdrawal by Subject|1|||
157019559|NCT04166773|566824793|FG002|Overall Study|Withdrawal by Subject|2|||
157019560|NCT04166773|566824794|FG003|Overall Study|Withdrawal by Subject|5|||
157019561|NCT05268302|566824795|FG000|Overall Study|Death|0|||
157019562|NCT05268302|566824796|FG001|Overall Study|Death|1|||
157019563|NCT02811679|566824797|FG000|Overall Study|Adverse Event|1|||
157019564|NCT02811679|566824797|FG000|Overall Study|Lack of Efficacy|6|||
157019565|NCT02811679|566824797|FG000|Overall Study|Early study closure due to slow accrual|3|||
157019566|NCT05319860|566824798|FG000|Overall Study|Death|1|||
157019567|NCT05319860|566824799|FG001|Overall Study|Death|1|||
157019568|NCT05319860|566824798|FG000|Overall Study|Lost to Follow-up|3|||
157019569|NCT05319860|566824799|FG001|Overall Study|Lost to Follow-up|1|||
157019570|NCT05319860|566824798|FG000|Overall Study|Withdrawal by Subject|1|||
157019571|NCT05319860|566824799|FG001|Overall Study|Withdrawal by Subject|7|||
157019572|NCT01361711|566824800|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
157019573|NCT01361711|566824800|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
157019574|NCT01361711|566824800|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
157019575|NCT01361711|566824800|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
157019576|NCT01361711|566824800|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
157019577|NCT01361711|566824800|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
157019578|NCT01361711|566824800|FG000|Completed Week 18 of Treatment|Other|9|||
157019579|NCT01361711|566824800|FG000|10 Year Follow-up|Still in follow-up|22|||
157019580|NCT01361711|566824800|FG000|10 Year Follow-up|Death|7|||
157019581|NCT01361711|566824800|FG000|10 Year Follow-up|Developed new cancer|1|||
157019582|NCT01361711|566824800|FG000|10 Year Follow-up|Lost to Follow-up|2|||
157019583|NCT01361711|566824800|FG000|10 Year Follow-up|New treatment started|6|||
157019584|NCT01361711|566824800|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
157019585|NCT01361711|566824800|FG000|10 Year Follow-up|Progressive Disease|1|||
157019586|NCT00753090|566826428|FG000|Overall Study|Withdrawal by Subject|10|||
157019587|NCT00753090|566826429|FG001|Overall Study|Withdrawal by Subject|10|||
157019588|NCT00753090|566826428|FG000|Overall Study|Death|17|||
157019589|NCT00753090|566826429|FG001|Overall Study|Death|6|||
157019590|NCT00753090|566826428|FG000|Overall Study|Study Prosthesis Removed|12|||
157019591|NCT00753090|566826429|FG001|Overall Study|Study Prosthesis Removed|3|||
157019592|NCT00753090|566826428|FG000|Overall Study|Lost to Follow-up|2|||
157019593|NCT00753090|566826429|FG001|Overall Study|Lost to Follow-up|2|||
157019594|NCT00753090|566826428|FG000|Overall Study|Other|127|||
157019595|NCT00753090|566826429|FG001|Overall Study|Other|75|||
157019596|NCT05113966|566826430|FG000|Overall Study|Death|21|||
157019597|NCT05113966|566826430|FG000|Overall Study|Study Terminated by Sponsor|9|||
157019598|NCT04521478|566826431|FG000|Overall Study|Protocol Violation|2|||
157019599|NCT04521478|566826432|FG001|Overall Study|Protocol Violation|0|||
157019600|NCT04521478|566826433|FG002|Overall Study|Protocol Violation|1|||
157019601|NCT04521478|566826434|FG003|Overall Study|Protocol Violation|0|||
157019602|NCT04521478|566826435|FG004|Overall Study|Protocol Violation|0|||
157019603|NCT04521478|566826436|FG005|Overall Study|Protocol Violation|0|||
157019604|NCT04521478|566826431|FG000|Overall Study|Technical Problems|0|||
156725474|NCT01890122|565740655|FG001|Overall Study|Lost to Follow-up|1|||
156725475|NCT01890122|565740656|FG002|Overall Study|Lost to Follow-up|2|||
156725476|NCT01890122|565740657|FG003|Overall Study|Lost to Follow-up|2|||
156725477|NCT01890122|565740654|FG000|Overall Study|Voluntary Withdrawal|8|||
156725478|NCT01890122|565740655|FG001|Overall Study|Voluntary Withdrawal|8|||
156725479|NCT01890122|565740656|FG002|Overall Study|Voluntary Withdrawal|2|||
156725480|NCT01890122|565740657|FG003|Overall Study|Voluntary Withdrawal|11|||
156725481|NCT01890122|565740654|FG000|Overall Study|Lack of Efficacy|14|||
156725482|NCT01890122|565740655|FG001|Overall Study|Lack of Efficacy|24|||
156725483|NCT01890122|565740656|FG002|Overall Study|Lack of Efficacy|7|||
156795000|NCT06582732|566002822|FG002|Initial Study Period|Moved Away|0|||
156795001|NCT06582732|566002823|FG003|Initial Study Period|Moved Away|0|||
156795002|NCT06582732|566002824|FG004|Initial Study Period|Moved Away|1|||
156795003|NCT06582732|566002825|FG005|Initial Study Period|Moved Away|0|||
156795004|NCT06582732|566002826|FG006|Initial Study Period|Moved Away|0|||
156795005|NCT03931330|566002827|FG000|Overall Study|Physician Decision|1|||
156795006|NCT03412929|566002828|FG000|Overall Study|Protocol Violation|3|||
156795007|NCT04661839|566002831|FG000|Overall Study|Not Treated|0|||
156795008|NCT04661839|566002832|FG001|Overall Study|Not Treated|0|||
156795009|NCT04661839|566002833|FG002|Overall Study|Not Treated|1|||
156795010|NCT04661839|566002834|FG003|Overall Study|Not Treated|0|||
156795011|NCT04661839|566002831|FG000|Overall Study|Lost to Follow-up|1|||
156795012|NCT04661839|566002832|FG001|Overall Study|Lost to Follow-up|0|||
156795013|NCT04661839|566002833|FG002|Overall Study|Lost to Follow-up|0|||
156795014|NCT04661839|566002834|FG003|Overall Study|Lost to Follow-up|1|||
156795015|NCT01946880|566002835|FG000|Overall Study|Lost to Follow-up|1|||
156795016|NCT01946880|566002836|FG001|Overall Study|Lost to Follow-up|0|||
156795017|NCT01946880|566002835|FG000|Overall Study|Physician Decision|1|||
156795018|NCT01946880|566002836|FG001|Overall Study|Physician Decision|1|||
156795019|NCT01946880|566002835|FG000|Overall Study|Withdrawal by Subject|3|||
156795020|NCT01946880|566002836|FG001|Overall Study|Withdrawal by Subject|2|||
156795021|NCT01946880|566002835|FG000|Overall Study|Met Primary Endpoint|1|||
156795022|NCT01946880|566002836|FG001|Overall Study|Met Primary Endpoint|0|||
156795023|NCT01946880|566002835|FG000|Overall Study|Personal and Family Issues|1|||
156795024|NCT01946880|566002836|FG001|Overall Study|Personal and Family Issues|0|||
156795025|NCT02609503|566002837|FG000|Overall Study|Adverse Event|1|||
156795026|NCT02609503|566002837|FG000|Overall Study|Death|1|||
156795027|NCT02609503|566002837|FG000|Overall Study|Withdrawal by Subject|1|||
156795028|NCT02609503|566002837|FG000|Overall Study|Disease progression|1|||
156795029|NCT00581919|566002841|FG000|Overall Study|Adverse Event|8|||
156795030|NCT00581919|566002841|FG000|Overall Study|Death|1|||
156795031|NCT00581919|566002841|FG000|Overall Study|Disease Progression|10|||
156795032|NCT00581919|566002841|FG000|Overall Study|Physician Decision|1|||
156795033|NCT00581919|566002841|FG000|Overall Study|Other Complicating Disease|1|||
156795034|NCT00581919|566002841|FG000|Overall Study|Started Non-Protocol Therapy|2|||
156795035|NCT00581919|566002841|FG000|Overall Study|Withdrawal by Subject|1|||
156795036|NCT02034565|566002842|FG000|Overall Study|Adverse Event|1|||
156795037|NCT02034565|566002843|FG001|Overall Study|Adverse Event|0|||
156795038|NCT03900650|566002844|FG000|Overall Study|Withdrawal by Subject|1|||
156795039|NCT03900650|566002845|FG001|Overall Study|Withdrawal by Subject|1|||
156795040|NCT03900650|566002846|FG002|Overall Study|Withdrawal by Subject|0|||
156795041|NCT03900650|566002847|FG003|Overall Study|Withdrawal by Subject|0|||
156795042|NCT03900650|566002844|FG000|Overall Study|Withdrawn by staff|1|||
156795043|NCT03900650|566002845|FG001|Overall Study|Withdrawn by staff|0|||
156795044|NCT03900650|566002846|FG002|Overall Study|Withdrawn by staff|0|||
156795045|NCT03900650|566002847|FG003|Overall Study|Withdrawn by staff|0|||
156795046|NCT03760068|566002854|FG000|Overall Study|Withdrawal by Subject|7|||
156795047|NCT03760068|566002855|FG001|Overall Study|Withdrawal by Subject|8|||
156795048|NCT03760068|566002854|FG000|Overall Study|Adverse Event|1|||
156795049|NCT03760068|566002855|FG001|Overall Study|Adverse Event|2|||
157019605|NCT04521478|566826432|FG001|Overall Study|Technical Problems|0|||
157019606|NCT04521478|566826433|FG002|Overall Study|Technical Problems|0|||
156725484|NCT01890122|565740657|FG003|Overall Study|Lack of Efficacy|41|||
156725485|NCT01890122|565740654|FG000|Overall Study|Reason not Specified|0|||
156725486|NCT01890122|565740655|FG001|Overall Study|Reason not Specified|1|||
156725487|NCT01890122|565740656|FG002|Overall Study|Reason not Specified|1|||
156725488|NCT01890122|565740657|FG003|Overall Study|Reason not Specified|2|||
157019607|NCT04521478|566826434|FG003|Overall Study|Technical Problems|1|||
156725489|NCT01890122|565740654|FG000|Overall Study|Randomized but not Treated|1|||
156795050|NCT03760068|566002854|FG000|Overall Study|Administrative Decision by Sponsor|0|||
156795051|NCT03760068|566002855|FG001|Overall Study|Administrative Decision by Sponsor|2|||
156795052|NCT03760068|566002854|FG000|Overall Study|Physician Decision|1|||
156795053|NCT03760068|566002855|FG001|Overall Study|Physician Decision|2|||
156795054|NCT03760068|566002854|FG000|Overall Study|Lost to Follow-up|4|||
156795055|NCT03760068|566002855|FG001|Overall Study|Lost to Follow-up|9|||
157019608|NCT04521478|566826435|FG004|Overall Study|Technical Problems|0|||
156795056|NCT03760068|566002854|FG000|Overall Study|Subject Moved Out of State|1|||
156795057|NCT03760068|566002855|FG001|Overall Study|Subject Moved Out of State|0|||
156795058|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
156725490|NCT01890122|565740655|FG001|Overall Study|Randomized but not Treated|1|||
156725491|NCT01890122|565740656|FG002|Overall Study|Randomized but not Treated|0|||
156725492|NCT01890122|565740657|FG003|Overall Study|Randomized but not Treated|0|||
156725493|NCT04025879|565740658|FG000|Randomization|Participant withdrew consent|0|||
156725494|NCT04025879|565740659|FG001|Randomization|Participant withdrew consent|1|||
156725495|NCT04025879|565740658|FG000|Randomization|Participant no longer met study criteria|1|||
156725496|NCT04025879|565740659|FG001|Randomization|Participant no longer met study criteria|1|||
156725497|NCT04025879|565740658|FG000|Treatment|Ongoing treatment|10|||
156725498|NCT04025879|565740659|FG001|Treatment|Ongoing treatment|8|||
156725499|NCT04025879|565740658|FG000|Treatment|Disease progression/recurrence|36|||
156725500|NCT04025879|565740659|FG001|Treatment|Disease progression/recurrence|72|||
156725501|NCT04025879|565740658|FG000|Treatment|Study drug toxicity|36|||
156725502|NCT04025879|565740659|FG001|Treatment|Study drug toxicity|13|||
156725503|NCT04025879|565740658|FG000|Treatment|Death|2|||
156795059|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
156795060|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
156795061|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
156795062|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
156795063|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
156795064|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
156795065|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
156795066|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
156795067|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
156795068|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795069|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795070|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
156795071|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
156795072|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
156795073|NCT05014919|566002858|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
156795074|NCT05014919|566002859|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
156795075|NCT05014919|566002860|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
156795076|NCT05014919|566002858|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
156795077|NCT05014919|566002859|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
156795078|NCT05014919|566002860|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
156795079|NCT05014919|566002858|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
156795080|NCT05014919|566002859|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
156795081|NCT05014919|566002860|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
156795082|NCT00680914|566002861|FG000|Overall Study|Consent withdrawal|6|||
156795083|NCT00680914|566002862|FG001|Overall Study|Consent withdrawal|3|||
156795084|NCT00680914|566002861|FG000|Overall Study|Lost to Follow-up|4|||
156795085|NCT00680914|566002862|FG001|Overall Study|Lost to Follow-up|0|||
156795086|NCT00680914|566002861|FG000|Overall Study|serious adverse event (SAE)|0|||
156795087|NCT00680914|566002862|FG001|Overall Study|serious adverse event (SAE)|1|||
156795088|NCT01848457|566002863|FG000|Overall Study|Death|1|||
156795089|NCT01848457|566002864|FG001|Overall Study|Death|0|||
156795090|NCT01848457|566002865|FG002|Overall Study|Death|0|||
156795091|NCT01848457|566002866|FG003|Overall Study|Death|0|||
156795092|NCT02940223|566002867|FG000|Overall Study|Failed Requirement|2|||
156795093|NCT02940223|566002868|FG001|Overall Study|Failed Requirement|0|||
156795094|NCT03773562|566002870|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
156875912|NCT04976192|566303723|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
157137176|NCT01085682|567249051|FG000|Overall Study|Withdrawal by Subject|25|||
157137177|NCT01085682|567249052|FG001|Overall Study|Withdrawal by Subject|25|||
157137178|NCT02207907|567249054|FG000|Overall Study|Lost to Follow-up|3|||
157137179|NCT02207907|567249055|FG001|Overall Study|Lost to Follow-up|1|||
157137180|NCT02207907|567249054|FG000|Overall Study|Withdrawal by Subject|5|||
157137181|NCT02207907|567249055|FG001|Overall Study|Withdrawal by Subject|6|||
157137182|NCT02207907|567249054|FG000|Overall Study|Did not meet study criteria|3|||
157137183|NCT02207907|567249055|FG001|Overall Study|Did not meet study criteria|0|||
156725504|NCT04025879|565740659|FG001|Treatment|Death|0|||
156725505|NCT04025879|565740658|FG000|Treatment|Adverse event unrelated to study drug|21|||
156725506|NCT04025879|565740659|FG001|Treatment|Adverse event unrelated to study drug|14|||
156725507|NCT04025879|565740658|FG000|Treatment|Participant request to discontinue study treatment|16|||
156725508|NCT04025879|565740659|FG001|Treatment|Participant request to discontinue study treatment|8|||
156725509|NCT04025879|565740658|FG000|Treatment|Participant withdrew consent|1|||
156725510|NCT04025879|565740659|FG001|Treatment|Participant withdrew consent|3|||
156725511|NCT04025879|565740658|FG000|Treatment|Participant no longer meets study criteria|3|||
156795095|NCT03773562|566002870|FG000|Overall Study|Lost to Follow-up|10|||
156795096|NCT03773562|566002870|FG000|Overall Study|Withdrawal by Subject|1|||
156795097|NCT02298946|566002871|FG000|Overall Study|Did not receive treatment|2|||
157019609|NCT04521478|566826436|FG005|Overall Study|Technical Problems|0|||
157137184|NCT02207907|567249054|FG000|Overall Study|Pregnancy|0|||
156725512|NCT04025879|565740659|FG001|Treatment|Participant no longer meets study criteria|2|||
156725513|NCT04025879|565740658|FG000|Treatment|Lost to Follow-up|1|||
156725514|NCT04025879|565740659|FG001|Treatment|Lost to Follow-up|0|||
156725515|NCT04025879|565740658|FG000|Treatment|Other reasons|15|||
156725516|NCT04025879|565740659|FG001|Treatment|Other reasons|17|||
156725517|NCT04025879|565740658|FG000|Treatment|Administrative reason by sponsor|0|||
156725518|NCT04025879|565740659|FG001|Treatment|Administrative reason by sponsor|1|||
156725519|NCT04025879|565740658|FG000|Treatment|Not reported|2|||
156725520|NCT04025879|565740659|FG001|Treatment|Not reported|0|||
156725521|NCT00071110|565740666|FG000|Overall Study|Protocol Violation|0|||
156725522|NCT00071110|565740667|FG001|Overall Study|Protocol Violation|4|||
156725523|NCT01167140|565740674|FG000|Overall Study|Withdrawal by Subject|1|||
156725524|NCT03805412|565740677|FG000|Overall Study|Lost to Follow-up|0|||
156725525|NCT03805412|565740678|FG001|Overall Study|Lost to Follow-up|1|||
156725526|NCT04390113|565740679|FG000|Overall Study|Not Treated|0|||
156725527|NCT04390113|565740680|FG001|Overall Study|Not Treated|1|||
156725528|NCT04390113|565740679|FG000|Overall Study|Adverse Event|1|||
156725529|NCT04390113|565740680|FG001|Overall Study|Adverse Event|0|||
156725530|NCT04390113|565740679|FG000|Overall Study|Death|2|||
156725531|NCT04390113|565740680|FG001|Overall Study|Death|1|||
156725532|NCT04390113|565740679|FG000|Overall Study|Physician Decision|1|||
156725533|NCT04390113|565740680|FG001|Overall Study|Physician Decision|3|||
156725534|NCT04390113|565740679|FG000|Overall Study|Study Terminated by Sponsor|5|||
156725535|NCT04390113|565740680|FG001|Overall Study|Study Terminated by Sponsor|3|||
156725536|NCT04390113|565740679|FG000|Overall Study|Withdrawal by Subject|10|||
156725537|NCT04390113|565740680|FG001|Overall Study|Withdrawal by Subject|5|||
156725538|NCT04390113|565740679|FG000|Overall Study|Other|1|||
156725539|NCT04390113|565740680|FG001|Overall Study|Other|0|||
156725540|NCT04390113|565740679|FG000|Overall Study|Missing|0|||
156725541|NCT04390113|565740680|FG001|Overall Study|Missing|1|||
156725542|NCT04031846|565740681|FG000|Overall Study|Lost to Follow-up|4|||
156725543|NCT04031846|565740682|FG001|Overall Study|Lost to Follow-up|4|||
156725544|NCT04031846|565740681|FG000|Overall Study|Physician Decision|0|||
156725545|NCT04031846|565740682|FG001|Overall Study|Physician Decision|1|||
156725546|NCT04031846|565740681|FG000|Overall Study|Protocol Violation|1|||
156725547|NCT04031846|565740682|FG001|Overall Study|Protocol Violation|1|||
156725548|NCT04031846|565740681|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
156725549|NCT04031846|565740682|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
156725550|NCT02431676|565740683|FG000|Overall Study|no lab obtained|0|||
156725551|NCT02431676|565740684|FG001|Overall Study|no lab obtained|1|||
156725552|NCT02431676|565740685|FG002|Overall Study|no lab obtained|2|||
156725553|NCT00571727|565740686|FG000|Overall Study|Did not enter in this study|1|||
156725554|NCT00571727|565740686|FG000|Overall Study|Non-compliance|4|||
156725555|NCT00571727|565740686|FG000|Overall Study|Lost to Follow-up|30|||
156725556|NCT00571727|565740686|FG000|Overall Study|Poor growth|1|||
156725557|NCT00571727|565740686|FG000|Overall Study|Parent/patient decision|2|||
156725558|NCT00571727|565740686|FG000|Overall Study|Participant transferred to commercial drug|14|||
156725559|NCT00571727|565740686|FG000|Overall Study|Unable to provide study drug|6|||
156725560|NCT00571727|565740686|FG000|Overall Study|On-treatment at end of study|8|||
156725561|NCT01622673|565740687|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156725562|NCT01622673|565740688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156725563|NCT01622673|565740689|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156725564|NCT01622673|565740690|FG003|Treatment Period 1|Withdrawal by Subject|1|||
156725565|NCT01622673|565740691|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156725566|NCT01622673|565740692|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156725567|NCT01622673|565740687|FG000|Treatment Period 1|Protocol Violation|0|||
156725568|NCT01622673|565740688|FG001|Treatment Period 1|Protocol Violation|1|||
156725569|NCT01622673|565740689|FG002|Treatment Period 1|Protocol Violation|0|||
156725570|NCT01622673|565740690|FG003|Treatment Period 1|Protocol Violation|0|||
156725571|NCT01622673|565740691|FG004|Treatment Period 1|Protocol Violation|0|||
156725572|NCT01622673|565740692|FG005|Treatment Period 1|Protocol Violation|0|||
156725573|NCT01622673|565740687|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156725574|NCT01622673|565740688|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156725575|NCT01622673|565740689|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156725576|NCT01622673|565740690|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156725577|NCT01622673|565740691|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156725578|NCT01622673|565740692|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156725579|NCT01622673|565740687|FG000|Treatment Period 3|Protocol Violation|0|||
156725580|NCT01622673|565740688|FG001|Treatment Period 3|Protocol Violation|1|||
156725581|NCT01622673|565740689|FG002|Treatment Period 3|Protocol Violation|0|||
156725582|NCT01622673|565740690|FG003|Treatment Period 3|Protocol Violation|0|||
157137185|NCT02207907|567249055|FG001|Overall Study|Pregnancy|1|||
156725583|NCT01622673|565740691|FG004|Treatment Period 3|Protocol Violation|0|||
156725584|NCT01622673|565740692|FG005|Treatment Period 3|Protocol Violation|0|||
156725585|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
156725586|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
156725587|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
157137186|NCT00158184|567249056|FG000|Overall Study|personal issues|3|||
157137187|NCT00158184|567249057|FG001|Overall Study|personal issues|1|||
157137188|NCT00158184|567249056|FG000|Overall Study|failed for follow unit/study rules|2|||
156725588|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
156725589|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
156725590|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
156725591|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
156725592|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725593|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725594|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
156725595|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
156725596|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
156725597|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
156725598|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
157137189|NCT00158184|567249057|FG001|Overall Study|failed for follow unit/study rules|0|||
157137190|NCT00158184|567249056|FG000|Overall Study|Adverse Event|1|||
156725599|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
156725600|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
156725601|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
156725602|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
157137191|NCT00158184|567249057|FG001|Overall Study|Adverse Event|1|||
157137192|NCT01025635|567249063|FG000|Overall Study|Withdrawal by Subject|6|||
157137193|NCT01025635|567249064|FG001|Overall Study|Withdrawal by Subject|7|||
157137194|NCT01025635|567249063|FG000|Overall Study|Protocol Violation|4|||
157137195|NCT01025635|567249064|FG001|Overall Study|Protocol Violation|2|||
157137196|NCT01025635|567249063|FG000|Overall Study|Lack of Efficacy|0|||
157137197|NCT01025635|567249064|FG001|Overall Study|Lack of Efficacy|1|||
157137198|NCT01025635|567249063|FG000|Overall Study|Lost to Follow-up|9|||
157137199|NCT01025635|567249064|FG001|Overall Study|Lost to Follow-up|13|||
157137200|NCT01025635|567249063|FG000|Overall Study|Reason not known|4|||
157137201|NCT01025635|567249064|FG001|Overall Study|Reason not known|2|||
157137202|NCT00727402|567249065|FG000|Overall Study|Physician Decision|116|||
157137203|NCT03751111|567249066|FG000|Overall Study|Lack of Efficacy|9|||
157137204|NCT03751111|567249067|FG001|Overall Study|Lack of Efficacy|30|||
157137205|NCT03751111|567249066|FG000|Overall Study|Adverse Event|3|||
157137206|NCT03751111|567249067|FG001|Overall Study|Adverse Event|2|||
157137207|NCT03545282|567249068|FG000|Overall Study|Lost to Follow-up|15|||
157137208|NCT03545282|567249069|FG001|Overall Study|Lost to Follow-up|10|||
157137209|NCT03545282|567249068|FG000|Overall Study|Withdrawal by Subject|2|||
156725603|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
156725604|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
156725605|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
156725606|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
156725607|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
156725608|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
156725609|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
156725610|NCT03525678|565740699|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
156725611|NCT03525678|565740700|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
156725612|NCT03525678|565740701|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725613|NCT03525678|565740702|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725614|NCT03525678|565740703|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
156725615|NCT01682226|565742237|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
156725616|NCT01682226|565742237|FG000|Overall Study|Participants did not receive treatment|2|||
156725617|NCT01682226|565742237|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
156725618|NCT03771898|565742238|FG000|Overall Study|Adverse Event|1|||
156725619|NCT03771898|565742239|FG001|Overall Study|Adverse Event|0|||
156725620|NCT03771898|565742240|FG002|Overall Study|Adverse Event|0|||
156725621|NCT03771898|565742241|FG003|Overall Study|Adverse Event|0|||
156725622|NCT03771898|565742242|FG004|Overall Study|Adverse Event|0|||
156725623|NCT03771898|565742238|FG000|Overall Study|Lost to Follow-up|1|||
156725624|NCT03771898|565742239|FG001|Overall Study|Lost to Follow-up|1|||
156725625|NCT03771898|565742240|FG002|Overall Study|Lost to Follow-up|1|||
156725626|NCT03771898|565742241|FG003|Overall Study|Lost to Follow-up|0|||
156725627|NCT03771898|565742242|FG004|Overall Study|Lost to Follow-up|0|||
156725628|NCT03771898|565742238|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156725629|NCT03771898|565742239|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156725630|NCT03771898|565742240|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156725631|NCT03771898|565742241|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156725632|NCT03771898|565742242|FG004|Overall Study|Withdrawal by parent/guardian|0|||
157137210|NCT03545282|567249069|FG001|Overall Study|Withdrawal by Subject|2|||
157137211|NCT00755079|567249070|FG000|Overall Study|Lost to Follow-up|1|||
157137212|NCT00755079|567249071|FG001|Overall Study|Lost to Follow-up|3|||
157137213|NCT00755079|567249070|FG000|Overall Study|Adverse Event|0|||
157137214|NCT00755079|567249071|FG001|Overall Study|Adverse Event|1|||
157137215|NCT00755079|567249070|FG000|Overall Study|Withdrawal by Subject|0|||
157137216|NCT00755079|567249071|FG001|Overall Study|Withdrawal by Subject|2|||
157137217|NCT02582671|567249072|FG000|Overall Study|Failure to return|1|||
157137218|NCT02582671|567249072|FG000|Overall Study|Other, not specified|1|||
157137219|NCT01287104|567249077|FG000|Overall Study|Patient developed progressive disease|1|||
157137220|NCT01287104|567249078|FG001|Overall Study|Patient developed progressive disease|1|||
157137221|NCT01287104|567249079|FG002|Overall Study|Patient developed progressive disease|3|||
157019610|NCT04521478|566826431|FG000|Overall Study|Burden of Study Procedures|1|||
157019611|NCT04521478|566826432|FG001|Overall Study|Burden of Study Procedures|0|||
157019612|NCT04521478|566826433|FG002|Overall Study|Burden of Study Procedures|0|||
157019613|NCT04521478|566826434|FG003|Overall Study|Burden of Study Procedures|1|||
157137222|NCT01287104|567249080|FG003|Overall Study|Patient developed progressive disease|2|||
157137223|NCT01287104|567249077|FG000|Overall Study|Donor anaphylaxis|0|||
157137224|NCT01287104|567249078|FG001|Overall Study|Donor anaphylaxis|1|||
157137225|NCT01287104|567249079|FG002|Overall Study|Donor anaphylaxis|0|||
157137226|NCT01287104|567249080|FG003|Overall Study|Donor anaphylaxis|1|||
157137227|NCT01287104|567249077|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
157137228|NCT01287104|567249078|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
157137229|NCT01287104|567249079|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
157137230|NCT01287104|567249080|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
157137231|NCT01287104|567249077|FG000|Overall Study|Low donor chimerism|0|||
157137232|NCT01287104|567249078|FG001|Overall Study|Low donor chimerism|1|||
156725633|NCT03771898|565742238|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725634|NCT03771898|565742239|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725635|NCT03771898|565742240|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725636|NCT03771898|565742241|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
156725637|NCT03771898|565742242|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
156725638|NCT03135548|565742243|FG000|Overall Study|Lost to Follow-up|3|||
156725639|NCT03135548|565742244|FG001|Overall Study|Lost to Follow-up|0|||
156725640|NCT03135548|565742245|FG002|Overall Study|Lost to Follow-up|0|||
156725641|NCT03135548|565742243|FG000|Overall Study|Withdrawal by Subject|2|||
156725642|NCT03135548|565742244|FG001|Overall Study|Withdrawal by Subject|2|||
156725643|NCT03135548|565742245|FG002|Overall Study|Withdrawal by Subject|1|||
156725644|NCT03135548|565742243|FG000|Overall Study|Other than listed|0|||
156725645|NCT03135548|565742244|FG001|Overall Study|Other than listed|2|||
156725646|NCT03135548|565742245|FG002|Overall Study|Other than listed|2|||
156725647|NCT04623216|565742246|FG000|Overall Study|Death|5|||
156725648|NCT04623216|565742247|FG001|Overall Study|Death|2|||
156725649|NCT04623216|565742248|FG002|Overall Study|Death|0|||
156725650|NCT04623216|565742249|FG003|Overall Study|Death|0|||
156725651|NCT04623216|565742246|FG000|Overall Study|Terminated by Sponsor|3|||
156725652|NCT04623216|565742247|FG001|Overall Study|Terminated by Sponsor|2|||
156725653|NCT04623216|565742248|FG002|Overall Study|Terminated by Sponsor|2|||
156725654|NCT04623216|565742249|FG003|Overall Study|Terminated by Sponsor|0|||
156725655|NCT04623216|565742246|FG000|Overall Study|Physician Decision|1|||
156725656|NCT04623216|565742247|FG001|Overall Study|Physician Decision|0|||
156725657|NCT04623216|565742248|FG002|Overall Study|Physician Decision|0|||
156725658|NCT04623216|565742249|FG003|Overall Study|Physician Decision|0|||
156725659|NCT03521154|565742250|FG000|Overall Study|Ongoing study at data cut-off|111|||
156725660|NCT03521154|565742251|FG001|Overall Study|Ongoing study at data cut-off|52|||
156725661|NCT05386680|565742252|FG000|Overall Study|Guardian decision|2|||
156725662|NCT00529087|565742257|FG000|Overall Study|Adverse Event|10|||
156725663|NCT00529087|565742258|FG001|Overall Study|Adverse Event|13|||
156725664|NCT00529087|565742259|FG002|Overall Study|Adverse Event|4|||
156725665|NCT00529087|565742257|FG000|Overall Study|Lost to Follow-up|6|||
156725666|NCT00529087|565742258|FG001|Overall Study|Lost to Follow-up|4|||
156725667|NCT00529087|565742259|FG002|Overall Study|Lost to Follow-up|1|||
156725668|NCT00529087|565742257|FG000|Overall Study|Protocol Violation|8|||
156725669|NCT00529087|565742258|FG001|Overall Study|Protocol Violation|7|||
156725670|NCT00529087|565742259|FG002|Overall Study|Protocol Violation|6|||
156725671|NCT00529087|565742257|FG000|Overall Study|Withdrawal by Subject|3|||
156725672|NCT00529087|565742258|FG001|Overall Study|Withdrawal by Subject|3|||
156725673|NCT00529087|565742259|FG002|Overall Study|Withdrawal by Subject|3|||
156725674|NCT00529087|565742257|FG000|Overall Study|Protocol deviation|1|||
156725675|NCT00529087|565742258|FG001|Overall Study|Protocol deviation|1|||
156725676|NCT00529087|565742259|FG002|Overall Study|Protocol deviation|2|||
156725677|NCT04168112|565742260|FG000|Overall Study|Lost to Follow-up|1|||
156795098|NCT02298946|566002872|FG001|Overall Study|Did not receive treatment|0|||
156795099|NCT02298946|566002871|FG000|Overall Study|Unevaluable|2|||
156795100|NCT02298946|566002872|FG001|Overall Study|Unevaluable|1|||
156795101|NCT04197583|566002873|FG000|Overall Study|Study Stent Replacement|34|||
156795102|NCT04197583|566002874|FG001|Overall Study|Study Stent Replacement|8|||
156795103|NCT04197583|566002873|FG000|Overall Study|Lost to Follow-up|14|||
156795104|NCT04197583|566002874|FG001|Overall Study|Lost to Follow-up|3|||
156795105|NCT04197583|566002873|FG000|Overall Study|Death|3|||
156795106|NCT04197583|566002874|FG001|Overall Study|Death|0|||
157137233|NCT01287104|567249079|FG002|Overall Study|Low donor chimerism|0|||
157137234|NCT01287104|567249080|FG003|Overall Study|Low donor chimerism|0|||
157137235|NCT01287104|567249077|FG000|Overall Study|NK cells did not meet release criteria|0|||
157137236|NCT01287104|567249078|FG001|Overall Study|NK cells did not meet release criteria|1|||
157137237|NCT01287104|567249079|FG002|Overall Study|NK cells did not meet release criteria|0|||
157137238|NCT01287104|567249080|FG003|Overall Study|NK cells did not meet release criteria|0|||
157137239|NCT00629083|567249083|FG000|Overall Study|Adverse Event|0|||
157137240|NCT00629083|567249084|FG001|Overall Study|Adverse Event|2|||
157137241|NCT00629083|567249083|FG000|Overall Study|Lack of Efficacy|3|||
157137242|NCT00629083|567249084|FG001|Overall Study|Lack of Efficacy|1|||
157137243|NCT00629083|567249083|FG000|Overall Study|Withdrawal by Subject|10|||
157137244|NCT00629083|567249084|FG001|Overall Study|Withdrawal by Subject|2|||
157137245|NCT00629083|567249083|FG000|Overall Study|Lost to Follow-up|12|||
157137246|NCT00629083|567249084|FG001|Overall Study|Lost to Follow-up|8|||
157137247|NCT00629083|567249083|FG000|Overall Study|Moved out of country/state|2|||
157137248|NCT00629083|567249084|FG001|Overall Study|Moved out of country/state|1|||
157137249|NCT00629083|567249083|FG000|Overall Study|Refused to return for 12 month visit|1|||
157137250|NCT00629083|567249084|FG001|Overall Study|Refused to return for 12 month visit|0|||
157137251|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
157137252|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
157137253|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
157137254|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137255|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137256|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137257|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137258|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137259|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
157137260|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
157019614|NCT04521478|566826435|FG004|Overall Study|Burden of Study Procedures|0|||
157019615|NCT04521478|566826436|FG005|Overall Study|Burden of Study Procedures|1|||
157019616|NCT04521478|566826431|FG000|Overall Study|Lack of Efficacy|0|||
157019617|NCT04521478|566826432|FG001|Overall Study|Lack of Efficacy|0|||
157137261|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
157137262|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
157019618|NCT04521478|566826433|FG002|Overall Study|Lack of Efficacy|0|||
157019619|NCT04521478|566826434|FG003|Overall Study|Lack of Efficacy|0|||
157019620|NCT04521478|566826435|FG004|Overall Study|Lack of Efficacy|1|||
157019621|NCT04521478|566826436|FG005|Overall Study|Lack of Efficacy|1|||
157019622|NCT04521478|566826431|FG000|Overall Study|Adverse Event|7|||
157019623|NCT04521478|566826432|FG001|Overall Study|Adverse Event|0|||
157019624|NCT04521478|566826433|FG002|Overall Study|Adverse Event|2|||
157019625|NCT04521478|566826434|FG003|Overall Study|Adverse Event|1|||
157019626|NCT04521478|566826435|FG004|Overall Study|Adverse Event|2|||
157019627|NCT04521478|566826436|FG005|Overall Study|Adverse Event|7|||
157019628|NCT04521478|566826431|FG000|Overall Study|No Reason Available|0|||
157019629|NCT04521478|566826432|FG001|Overall Study|No Reason Available|2|||
157019630|NCT04521478|566826433|FG002|Overall Study|No Reason Available|0|||
157019631|NCT04521478|566826434|FG003|Overall Study|No Reason Available|0|||
157019632|NCT04521478|566826435|FG004|Overall Study|No Reason Available|1|||
157019633|NCT04521478|566826436|FG005|Overall Study|No Reason Available|0|||
157019634|NCT04521478|566826431|FG000|Overall Study|Other than listed|3|||
157019635|NCT04521478|566826432|FG001|Overall Study|Other than listed|3|||
157019636|NCT04521478|566826433|FG002|Overall Study|Other than listed|3|||
157019637|NCT04521478|566826434|FG003|Overall Study|Other than listed|2|||
157019638|NCT04521478|566826435|FG004|Overall Study|Other than listed|3|||
157019639|NCT04521478|566826436|FG005|Overall Study|Other than listed|3|||
157019640|NCT04521478|566826431|FG000|Overall Study|Not treated|0|||
157019641|NCT04521478|566826432|FG001|Overall Study|Not treated|0|||
157019642|NCT04521478|566826433|FG002|Overall Study|Not treated|0|||
157019643|NCT04521478|566826434|FG003|Overall Study|Not treated|0|||
157019644|NCT04521478|566826435|FG004|Overall Study|Not treated|0|||
157137263|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157137264|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157137265|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157137266|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157137267|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157137268|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157019645|NCT04521478|566826436|FG005|Overall Study|Not treated|1|||
157019646|NCT03692676|566826440|FG000|Overall Study|exclude patients with prior use|4424|||
157019647|NCT03692676|566826441|FG001|Overall Study|exclude patients with prior use|24726|||
157137269|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
157019648|NCT03692676|566826442|FG002|Overall Study|exclude patients with prior use|0|||
157019649|NCT03692676|566826443|FG003|Overall Study|exclude patients with prior use|0|||
157019650|NCT03692676|566826440|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
157137270|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
157137271|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
157137272|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137273|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137274|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137275|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137276|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137277|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157137278|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137279|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137280|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
157137281|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137282|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137283|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137284|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137285|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137286|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
157137287|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
157137288|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
157137289|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
157137290|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157137291|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156875913|NCT04976192|566303724|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156875914|NCT04073225|566303725|FG000|Overall Study|Lost to Follow-up|4|||
156875915|NCT04073225|566303726|FG001|Overall Study|Lost to Follow-up|3|||
156875916|NCT00124306|566303728|FG000|Overall Study|Adverse Event|7|||
156875917|NCT00124306|566303729|FG001|Overall Study|Adverse Event|2|||
156875918|NCT00124306|566303728|FG000|Overall Study|Lost to Follow-up|10|||
156875919|NCT00124306|566303729|FG001|Overall Study|Lost to Follow-up|6|||
156875920|NCT00124306|566303728|FG000|Overall Study|Lack of Efficacy|3|||
156875921|NCT00124306|566303729|FG001|Overall Study|Lack of Efficacy|6|||
156875922|NCT00124306|566303728|FG000|Overall Study|Personal constraints|0|||
156875923|NCT00124306|566303729|FG001|Overall Study|Personal constraints|2|||
156875924|NCT00124306|566303728|FG000|Overall Study|Use of unacceptable medication|1|||
156875925|NCT00124306|566303729|FG001|Overall Study|Use of unacceptable medication|0|||
156875926|NCT00124306|566303728|FG000|Overall Study|Abnormal lab result|0|||
156875927|NCT00124306|566303729|FG001|Overall Study|Abnormal lab result|1|||
156875928|NCT00124306|566303728|FG000|Overall Study|Other|2|||
156875929|NCT00124306|566303729|FG001|Overall Study|Other|0|||
156875930|NCT04238819|566303730|FG000|Overall Study|Ongoing Treatment|0|||
156875931|NCT04238819|566303731|FG001|Overall Study|Ongoing Treatment|0|||
156875932|NCT04238819|566303732|FG002|Overall Study|Ongoing Treatment|0|||
156875933|NCT04238819|566303733|FG003|Overall Study|Ongoing Treatment|0|||
156875934|NCT04238819|566303734|FG004|Overall Study|Ongoing Treatment|1|||
156875935|NCT04238819|566303735|FG005|Overall Study|Ongoing Treatment|4|||
156875936|NCT04238819|566303736|FG006|Overall Study|Ongoing Treatment|0|||
156875937|NCT04238819|566303730|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
156875938|NCT04238819|566303731|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
156875939|NCT04238819|566303732|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
156875940|NCT04238819|566303733|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
156875941|NCT04238819|566303734|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
156875942|NCT04238819|566303735|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
156875943|NCT04238819|566303736|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
156875944|NCT05767749|566303737|FG000|Overall Study|Withdrawal by Subject|0|||
156875945|NCT05767749|566303738|FG001|Overall Study|Withdrawal by Subject|0|||
156875946|NCT05767749|566303739|FG002|Overall Study|Withdrawal by Subject|2|||
156875947|NCT05767749|566303740|FG003|Overall Study|Withdrawal by Subject|2|||
157137292|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157137293|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157137294|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157137295|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
157137296|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
157137297|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137298|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156875948|NCT05767749|566303741|FG004|Overall Study|Withdrawal by Subject|2|||
156875949|NCT05767749|566303742|FG005|Overall Study|Withdrawal by Subject|2|||
156875950|NCT00114517|566303743|FG000|Overall Study|Adverse Event|6|||
156875951|NCT00114517|566303744|FG001|Overall Study|Adverse Event|1|||
156875952|NCT00114517|566303745|FG002|Overall Study|Adverse Event|6|||
156875953|NCT00114517|566303746|FG003|Overall Study|Adverse Event|3|||
157137299|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137300|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156725678|NCT04168112|565742261|FG001|Overall Study|Lost to Follow-up|0|||
156725679|NCT04168112|565742260|FG000|Overall Study|Withdrawal by Subject|1|||
156725680|NCT04168112|565742261|FG001|Overall Study|Withdrawal by Subject|0|||
156725681|NCT01780038|565742264|FG000|Overall Study|Lost to Follow-up|4|||
156725682|NCT01780038|565742265|FG001|Overall Study|Lost to Follow-up|1|||
156725683|NCT03168711|565742266|FG000|Overall Study|Adverse Event|2|||
156725684|NCT03168711|565742267|FG001|Overall Study|Adverse Event|0|||
156725685|NCT03168711|565742266|FG000|Overall Study|Withdrawal by Subject|0|||
156725686|NCT03168711|565742267|FG001|Overall Study|Withdrawal by Subject|1|||
156725687|NCT03168711|565742266|FG000|Overall Study|Death|0|||
156725688|NCT03168711|565742267|FG001|Overall Study|Death|1|||
156875954|NCT00114517|566303743|FG000|Overall Study|Lost to Follow-up|2|||
157019651|NCT03692676|566826441|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
157019652|NCT03692676|566826442|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
157019653|NCT03692676|566826443|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
157137301|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137302|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137303|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137304|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157137305|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
157137306|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
157137307|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137308|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137309|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137310|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137311|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137312|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137313|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
157137314|NCT01307423|567249085|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
157137315|NCT01307423|567249086|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
157137316|NCT01307423|567249087|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
157137317|NCT01307423|567249088|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
157137318|NCT01307423|567249089|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
157137319|NCT01307423|567249090|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156725689|NCT03270657|565742270|FG000|Overall Study|Withdrawal by Subject|1|||
156725690|NCT00162981|565742271|FG000|Overall Study|Adverse Event|2|||
156725691|NCT00162981|565742272|FG001|Overall Study|Adverse Event|5|||
156725692|NCT00162981|565742271|FG000|Overall Study|Withdrawal by Subject|1|||
157137320|NCT01307423|567249091|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
157137321|NCT01307423|567249092|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
156725693|NCT00162981|565742272|FG001|Overall Study|Withdrawal by Subject|1|||
156725694|NCT00162981|565742271|FG000|Overall Study|Physician Decision|1|||
156725695|NCT00162981|565742272|FG001|Overall Study|Physician Decision|0|||
156725696|NCT00455403|565742273|FG000|Overall Study|Lost to Follow-up|2|||
156725697|NCT00455403|565742274|FG001|Overall Study|Lost to Follow-up|1|||
156725698|NCT00455403|565742273|FG000|Overall Study|Withdrawal by Subject|1|||
156725699|NCT00455403|565742274|FG001|Overall Study|Withdrawal by Subject|3|||
156725700|NCT00455403|565742273|FG000|Overall Study|Protocol Violation|0|||
156725701|NCT00455403|565742274|FG001|Overall Study|Protocol Violation|2|||
156725702|NCT00449865|565742279|FG000|Overall Study|Withdrawal by Subject|110|||
156725703|NCT00449865|565742280|FG001|Overall Study|Withdrawal by Subject|110|||
156725704|NCT00449865|565742279|FG000|Overall Study|Lost to Follow-up|36|||
156725705|NCT00449865|565742280|FG001|Overall Study|Lost to Follow-up|37|||
156725706|NCT00449865|565742279|FG000|Overall Study|Physician Decision|13|||
156725707|NCT00449865|565742280|FG001|Overall Study|Physician Decision|12|||
156725708|NCT00449865|565742279|FG000|Overall Study|Death|31|||
156725709|NCT00449865|565742280|FG001|Overall Study|Death|40|||
156725710|NCT00449865|565742279|FG000|Overall Study|Protocol Violation|8|||
156725711|NCT00449865|565742280|FG001|Overall Study|Protocol Violation|7|||
156725712|NCT00449865|565742279|FG000|Overall Study|Study was stopped|324|||
156725713|NCT00449865|565742280|FG001|Overall Study|Study was stopped|328|||
156725714|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
156725715|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
156725716|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
156725717|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
156725718|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
156725719|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
156725720|NCT00406367|565742281|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
156875955|NCT00114517|566303744|FG001|Overall Study|Lost to Follow-up|2|||
157137322|NCT01307423|567249093|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
157137323|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
157137324|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
157137325|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
157137326|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
157137327|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
157137328|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
157137329|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
157137330|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
157137331|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
157137332|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
157137333|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
157137334|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
157137335|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
157137336|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
157137337|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
157137338|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
157137339|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
157137340|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
157137341|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137342|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137343|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137344|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137345|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137346|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
157137347|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137348|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137349|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
157137350|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
157137351|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
156725721|NCT00406367|565742282|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
156725722|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
156725723|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
156725724|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
156725725|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
156725726|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
156725727|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
156725728|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
156725729|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
156725730|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
156725731|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
156725732|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
156725733|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
156725734|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
156725735|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
156725736|NCT00406367|565742281|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
156725737|NCT00406367|565742282|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
156725738|NCT00171210|565742283|FG000|Overall Study|Adverse Event|16|||
156725739|NCT00171210|565742284|FG001|Overall Study|Adverse Event|27|||
156725740|NCT00171210|565742283|FG000|Overall Study|Abnormal laboratory value(s)|6|||
156725741|NCT00171210|565742284|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156725742|NCT00171210|565742283|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156725743|NCT00171210|565742284|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156725744|NCT00171210|565742283|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
156725745|NCT00171210|565742284|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
156795107|NCT04197583|566002873|FG000|Overall Study|Physician Decision|1|||
157137352|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
157137353|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
156725746|NCT00171210|565742283|FG000|Overall Study|Protocol Violation|0|||
156725747|NCT00171210|565742284|FG001|Overall Study|Protocol Violation|2|||
156725748|NCT00171210|565742283|FG000|Overall Study|Withdrawal by Subject|32|||
156725749|NCT00171210|565742284|FG001|Overall Study|Withdrawal by Subject|30|||
156725750|NCT00171210|565742283|FG000|Overall Study|Lost to Follow-up|1|||
156725751|NCT00171210|565742284|FG001|Overall Study|Lost to Follow-up|0|||
156795108|NCT04197583|566002874|FG001|Overall Study|Physician Decision|0|||
157137354|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
157137355|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
157137356|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
156725752|NCT00171210|565742283|FG000|Overall Study|Administrative problems|1|||
156725753|NCT00171210|565742284|FG001|Overall Study|Administrative problems|1|||
156725754|NCT00171210|565742283|FG000|Overall Study|Death|2|||
156725755|NCT00171210|565742284|FG001|Overall Study|Death|3|||
156725756|NCT00171210|565742283|FG000|Overall Study|Stopped at end of core|0|||
156725757|NCT00171210|565742284|FG001|Overall Study|Stopped at end of core|32|||
156725758|NCT00171210|565742283|FG000|Overall Study|Stopped at end of extension 1|0|||
156725759|NCT00171210|565742284|FG001|Overall Study|Stopped at end of extension 1|1|||
156725760|NCT03252535|565742286|FG000|Overall Study|Withdrawal by Subject|1|||
156725761|NCT03252535|565742287|FG001|Overall Study|Withdrawal by Subject|0|||
156725762|NCT03252535|565742288|FG002|Overall Study|Withdrawal by Subject|0|||
156725763|NCT03252535|565742286|FG000|Overall Study|Physician Decision|0|||
156725764|NCT03252535|565742287|FG001|Overall Study|Physician Decision|1|||
156725765|NCT03252535|565742288|FG002|Overall Study|Physician Decision|0|||
156725766|NCT03252535|565742286|FG000|Overall Study|Met discontinuation criteria|0|||
156725767|NCT03252535|565742287|FG001|Overall Study|Met discontinuation criteria|1|||
156725768|NCT03252535|565742288|FG002|Overall Study|Met discontinuation criteria|0|||
156725769|NCT01966120|565742293|FG000|Overall Study|Withdrawal by Subject|0|||
156725770|NCT01966120|565742294|FG001|Overall Study|Withdrawal by Subject|5|||
156725771|NCT01966120|565742293|FG000|Overall Study|Lost to Follow-up|1|||
156725772|NCT01966120|565742294|FG001|Overall Study|Lost to Follow-up|1|||
156725773|NCT00461630|565742295|FG000|Overall Study|Death|798|||
156725774|NCT00461630|565742296|FG001|Overall Study|Death|732|||
156725775|NCT00461630|565742295|FG000|Overall Study|Lost to Follow-up|108|||
156725776|NCT00461630|565742296|FG001|Overall Study|Lost to Follow-up|95|||
156725777|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
156725778|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
156725779|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Death|0|||
156725780|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Death|1|||
156725781|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
156725782|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
156725783|NCT00442897|565742301|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
156725784|NCT00442897|565742302|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
156725785|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
156725786|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
156725787|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
156725788|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
156725789|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
156725790|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
156725791|NCT00442897|565742301|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
156725792|NCT00442897|565742302|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
156725793|NCT04498182|565742303|FG000|Overall Study|Adverse Event|2|||
156725794|NCT04498182|565742304|FG001|Overall Study|Adverse Event|3|||
156725795|NCT04498182|565742305|FG002|Overall Study|Adverse Event|2|||
156725796|NCT04498182|565742303|FG000|Overall Study|Withdrawal of Consent|3|||
156725797|NCT04498182|565742304|FG001|Overall Study|Withdrawal of Consent|4|||
156725798|NCT04498182|565742305|FG002|Overall Study|Withdrawal of Consent|3|||
156725799|NCT04498182|565742303|FG000|Overall Study|Non-Compliant|1|||
156725800|NCT04498182|565742304|FG001|Overall Study|Non-Compliant|0|||
156725801|NCT04498182|565742305|FG002|Overall Study|Non-Compliant|1|||
156725802|NCT04498182|565742303|FG000|Overall Study|Lost to Follow-up|0|||
156725803|NCT04498182|565742304|FG001|Overall Study|Lost to Follow-up|0|||
156725804|NCT04498182|565742305|FG002|Overall Study|Lost to Follow-up|1|||
156725805|NCT04498182|565742303|FG000|Overall Study|Investigator Decision|0|||
156725806|NCT04498182|565742304|FG001|Overall Study|Investigator Decision|0|||
156725807|NCT04498182|565742305|FG002|Overall Study|Investigator Decision|1|||
156725808|NCT04498182|565742303|FG000|Overall Study|Protocol Violation|1|||
156725809|NCT04498182|565742304|FG001|Overall Study|Protocol Violation|0|||
156725810|NCT04498182|565742305|FG002|Overall Study|Protocol Violation|2|||
156725811|NCT02182843|565742307|FG000|Overall Study|Withdrawal by Subject|7|||
156725812|NCT02182843|565742307|FG000|Overall Study|Lost to Follow-up|2|||
156725813|NCT02182843|565742307|FG000|Overall Study|Adverse Event|1|||
156725814|NCT02187198|565742318|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
156725815|NCT02187198|565742319|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
156725816|NCT02187198|565742318|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
156725817|NCT02187198|565742319|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
156725818|NCT01532518|565742320|FG000|Overall Study|Withdrawal by Subject|0|||
156725819|NCT01532518|565742321|FG001|Overall Study|Withdrawal by Subject|0|||
156725820|NCT01532518|565742322|FG002|Overall Study|Withdrawal by Subject|1|||
156725821|NCT06509438|565742325|FG000|Overall Study|Adverse Event|1|||
156725822|NCT06509438|565742325|FG000|Overall Study|Lost to Follow-up|3|||
156725823|NCT00952068|565742328|FG000|Overall Study|Adverse Event|3|||
156725824|NCT00952068|565742328|FG000|Overall Study|Withdrawal by Subject|4|||
157137357|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
157137358|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
157137359|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137360|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137361|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137362|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
157137363|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137364|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137365|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137366|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137367|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
157137368|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
157137369|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
157137370|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
157137371|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
157137372|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
157137373|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
157137374|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
157137375|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
157137376|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
157137377|NCT01307423|567249085|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137378|NCT01307423|567249086|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137379|NCT01307423|567249087|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137380|NCT01307423|567249088|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137381|NCT01307423|567249089|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137382|NCT01307423|567249090|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
157137383|NCT01307423|567249091|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137384|NCT01307423|567249092|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137385|NCT01307423|567249093|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
157137386|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
157137387|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
157137388|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
157137389|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
157137390|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
157137391|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
157137392|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
157137393|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
157137394|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
157137395|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
157137396|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
157137397|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
156725825|NCT00488644|565742329|FG000|Overall Study|Not Eligible|1|||
156725826|NCT00488644|565742329|FG000|Overall Study|Not Evaluable|1|||
156725827|NCT02169271|565742330|FG000|Overall Study|Protocol Violation|1|||
156725828|NCT02169271|565742331|FG001|Overall Study|Protocol Violation|2|||
156725829|NCT03591874|565742332|FG000|Overall Study|Adverse Event|4|||
156725830|NCT03591874|565742333|FG001|Overall Study|Adverse Event|0|||
156725831|NCT03591874|565742332|FG000|Overall Study|Withdrawal by Subject|2|||
156725832|NCT03591874|565742333|FG001|Overall Study|Withdrawal by Subject|1|||
157137398|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
157137399|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156725833|NCT03591874|565742332|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
156725834|NCT03591874|565742333|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
156725835|NCT03591874|565742332|FG000|Overall Study|On Study at Time of Study Termination|12|||
156725836|NCT03591874|565742333|FG001|Overall Study|On Study at Time of Study Termination|6|||
156725837|NCT03194542|565742336|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
156725838|NCT03194542|565742337|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725839|NCT03194542|565742338|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725840|NCT03194542|565742339|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
156725841|NCT03194542|565742336|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
156725842|NCT03194542|565742337|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
157137400|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156725843|NCT03194542|565742338|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
156725844|NCT03194542|565742339|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
156725845|NCT03194542|565742336|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
156725846|NCT03194542|565742337|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
156725847|NCT03194542|565742338|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
156725848|NCT03194542|565742339|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
157137401|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
157137402|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
157137403|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
157137404|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137405|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137406|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
157137407|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137408|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137409|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137410|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137411|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137412|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
157137413|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157137414|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
157137415|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
157137416|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157137417|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157137418|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157137419|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
157137420|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
157137421|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
157137422|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137423|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
157137424|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137425|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137426|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137427|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137428|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
157137429|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
157137430|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
157137431|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
157137432|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
157137433|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
157137434|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
157137435|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
157137436|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
157137437|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
157137438|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
157137439|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
157137440|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
157137441|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
157137442|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
157137443|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
157137444|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
157137445|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
157137446|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
157137447|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
157137448|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
157137449|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137450|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
157137451|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
157137452|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137453|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137454|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137455|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137456|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137457|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
157137458|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157137459|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
157137460|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
156725849|NCT03194542|565742336|FG000|Overall Study|Loss of Response|4|||
156725850|NCT03194542|565742337|FG001|Overall Study|Loss of Response|2|||
156725851|NCT03194542|565742338|FG002|Overall Study|Loss of Response|3|||
156725852|NCT03194542|565742339|FG003|Overall Study|Loss of Response|4|||
156725853|NCT03194542|565742336|FG000|Overall Study|Physician Decision|0|||
156725854|NCT03194542|565742337|FG001|Overall Study|Physician Decision|1|||
156725855|NCT03194542|565742338|FG002|Overall Study|Physician Decision|0|||
156725856|NCT03194542|565742339|FG003|Overall Study|Physician Decision|0|||
156725857|NCT03194542|565742336|FG000|Overall Study|Lack of Efficacy|2|||
157137461|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157137462|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157137463|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157137464|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
157137465|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
157137466|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
157137467|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
157137468|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
157137469|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
157137470|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
157137471|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
157137472|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
157137473|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
157137474|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
157137475|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
157137476|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137477|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
157137478|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137479|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137480|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137481|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137482|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137483|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
157137484|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157137485|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137486|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
157137487|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137488|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137489|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137490|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137491|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137492|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137493|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
157137494|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137495|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
157137496|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137497|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137498|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137499|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137500|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137501|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
157137502|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
157137503|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157137504|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
157137505|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
157137506|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157137507|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156725858|NCT03194542|565742337|FG001|Overall Study|Lack of Efficacy|2|||
156725859|NCT03194542|565742338|FG002|Overall Study|Lack of Efficacy|2|||
156725860|NCT03194542|565742339|FG003|Overall Study|Lack of Efficacy|6|||
156725861|NCT03194542|565742336|FG000|Overall Study|Withdrawal by Subject|2|||
156725862|NCT03194542|565742337|FG001|Overall Study|Withdrawal by Subject|1|||
157137508|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157137509|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
157137510|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
157137511|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
157137512|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137513|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137514|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
157137515|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137516|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156725863|NCT03194542|565742338|FG002|Overall Study|Withdrawal by Subject|5|||
156725864|NCT03194542|565742339|FG003|Overall Study|Withdrawal by Subject|4|||
156725865|NCT03194542|565742336|FG000|Overall Study|Progressive Disease|1|||
156725866|NCT03194542|565742337|FG001|Overall Study|Progressive Disease|0|||
156725867|NCT03194542|565742338|FG002|Overall Study|Progressive Disease|1|||
156725868|NCT03194542|565742339|FG003|Overall Study|Progressive Disease|1|||
156725869|NCT03194542|565742336|FG000|Overall Study|Adverse Event|1|||
156725870|NCT03194542|565742337|FG001|Overall Study|Adverse Event|2|||
156725871|NCT03194542|565742338|FG002|Overall Study|Adverse Event|0|||
157137517|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137518|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137519|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137520|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
157137521|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137522|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137523|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137524|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137525|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156725872|NCT03194542|565742339|FG003|Overall Study|Adverse Event|5|||
156725873|NCT03194542|565742336|FG000|Overall Study|Death|1|||
156725874|NCT03194542|565742337|FG001|Overall Study|Death|2|||
156725875|NCT03194542|565742338|FG002|Overall Study|Death|0|||
156725876|NCT03194542|565742339|FG003|Overall Study|Death|5|||
156725877|NCT03194542|565742336|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
156725878|NCT03194542|565742337|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
156725879|NCT03194542|565742338|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
156725880|NCT03194542|565742339|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
156725881|NCT02712554|565742342|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
156725882|NCT02712554|565742343|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
156725883|NCT02712554|565742342|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
156725884|NCT02712554|565742343|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
156725885|NCT02712554|565742342|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
156795109|NCT04197583|566002873|FG000|Overall Study|Withdrawal by Subject|1|||
156795110|NCT04197583|566002874|FG001|Overall Study|Withdrawal by Subject|1|||
156795111|NCT04197583|566002873|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
156795112|NCT04197583|566002874|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
156795113|NCT04197583|566002873|FG000|Overall Study|Screen Failure|0|||
156795114|NCT04197583|566002874|FG001|Overall Study|Screen Failure|20|||
156795115|NCT00637156|566002875|FG000|Overall Study|Withdrawal by Subject|0|||
156795116|NCT00637156|566002876|FG001|Overall Study|Withdrawal by Subject|7|||
156795117|NCT00637156|566002875|FG000|Overall Study|Death|0|||
156795118|NCT00637156|566002876|FG001|Overall Study|Death|1|||
156795119|NCT00637156|566002875|FG000|Overall Study|Lost to Follow-up|10|||
156795120|NCT00637156|566002876|FG001|Overall Study|Lost to Follow-up|16|||
156795121|NCT02679274|566002877|FG000|Overall Study|Withdrawal by Subject|1|||
156795122|NCT02679274|566002878|FG001|Overall Study|Withdrawal by Subject|0|||
156795123|NCT03193437|566002885|FG000|Overall Study|Adverse Event|4|||
156795124|NCT03193437|566002885|FG000|Overall Study|Withdrawal by Subject|2|||
156795125|NCT03193437|566002885|FG000|Overall Study|Disease Progression|2|||
156795126|NCT04976855|566002886|FG000|Part I|Withdrawal by Subject|0|||
156795127|NCT04976855|566002887|FG001|Part I|Withdrawal by Subject|1|||
156795128|NCT04976855|566002888|FG002|Part I|Withdrawal by Subject|0|||
156795129|NCT04976855|566002889|FG003|Part I|Withdrawal by Subject|0|||
156795130|NCT04976855|566002890|FG004|Part I|Withdrawal by Subject|0|||
156795131|NCT04976855|566002891|FG005|Part I|Withdrawal by Subject|0|||
156795132|NCT04976855|566002892|FG006|Part I|Withdrawal by Subject|0|||
156795133|NCT04976855|566002886|FG000|Part II|Adverse Event|0|||
156795134|NCT04976855|566002887|FG001|Part II|Adverse Event|0|||
156795135|NCT04976855|566002888|FG002|Part II|Adverse Event|0|||
156795136|NCT04976855|566002889|FG003|Part II|Adverse Event|1|||
156795137|NCT04976855|566002890|FG004|Part II|Adverse Event|0|||
156795138|NCT04976855|566002891|FG005|Part II|Adverse Event|0|||
156795139|NCT04976855|566002892|FG006|Part II|Adverse Event|0|||
156795140|NCT04976855|566002886|FG000|Part II|Withdrawal by Subject|0|||
156795141|NCT04976855|566002887|FG001|Part II|Withdrawal by Subject|0|||
156795142|NCT04976855|566002888|FG002|Part II|Withdrawal by Subject|0|||
156875956|NCT00114517|566303745|FG002|Overall Study|Lost to Follow-up|2|||
156725886|NCT02712554|565742343|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
156875957|NCT00114517|566303746|FG003|Overall Study|Lost to Follow-up|1|||
156875958|NCT00114517|566303743|FG000|Overall Study|Too busy|3|||
156725887|NCT02712554|565742342|FG000|Part B: Qualification Phase|Adverse Event|0|||
156725888|NCT02712554|565742343|FG001|Part B: Qualification Phase|Adverse Event|1|||
156725889|NCT02712554|565742342|FG000|Part B: Treatment Phase|Adverse Event|0|||
156795143|NCT04976855|566002889|FG003|Part II|Withdrawal by Subject|0|||
156795144|NCT04976855|566002890|FG004|Part II|Withdrawal by Subject|1|||
156875959|NCT00114517|566303744|FG001|Overall Study|Too busy|1|||
157137526|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137527|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156795145|NCT04976855|566002891|FG005|Part II|Withdrawal by Subject|0|||
156795146|NCT04976855|566002892|FG006|Part II|Withdrawal by Subject|0|||
156795147|NCT04976855|566002886|FG000|Part II|Lost to Follow-up|0|||
156795148|NCT04976855|566002887|FG001|Part II|Lost to Follow-up|0|||
156795149|NCT04976855|566002888|FG002|Part II|Lost to Follow-up|0|||
156795150|NCT04976855|566002889|FG003|Part II|Lost to Follow-up|0|||
156875960|NCT00114517|566303745|FG002|Overall Study|Too busy|1|||
157137528|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
157137529|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
157137530|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
157137531|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
157137532|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
157137533|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156725890|NCT02712554|565742343|FG001|Part B: Treatment Phase|Adverse Event|1|||
156725891|NCT02712554|565742342|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
156725892|NCT02712554|565742343|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
156725893|NCT02712554|565742342|FG000|Part B: Treatment Phase|Other|0|||
156725894|NCT02712554|565742343|FG001|Part B: Treatment Phase|Other|1|||
156725895|NCT03859427|565742345|FG000|Overall Study|Withdrawal by Subject|4|||
156725896|NCT03859427|565742346|FG001|Overall Study|Withdrawal by Subject|7|||
156725897|NCT03859427|565742345|FG000|Overall Study|Decision by sponsor|0|||
156725898|NCT03859427|565742346|FG001|Overall Study|Decision by sponsor|3|||
156725899|NCT03859427|565742345|FG000|Overall Study|Lost to Follow-up|3|||
156725900|NCT03859427|565742346|FG001|Overall Study|Lost to Follow-up|2|||
156725901|NCT03859427|565742345|FG000|Overall Study|Death|22|||
156795151|NCT04976855|566002890|FG004|Part II|Lost to Follow-up|0|||
156795152|NCT04976855|566002891|FG005|Part II|Lost to Follow-up|1|||
156795153|NCT04976855|566002892|FG006|Part II|Lost to Follow-up|0|||
156795154|NCT05487378|566002893|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
156795155|NCT05487378|566002894|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
156795156|NCT05487378|566002893|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
156795157|NCT05487378|566002894|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
156795158|NCT01385995|566002901|FG000|Period 1, 2 Months|Physician Decision|1|||
156795159|NCT01385995|566002902|FG001|Period 1, 2 Months|Physician Decision|0|||
156795160|NCT02414841|566002903|FG000|Overall Study|Withdrawal by Subject|7|||
156795161|NCT02414841|566002904|FG001|Overall Study|Withdrawal by Subject|5|||
156795162|NCT02414841|566002903|FG000|Overall Study|Lost to Follow-up|13|||
156795163|NCT02414841|566002904|FG001|Overall Study|Lost to Follow-up|6|||
156795164|NCT02414841|566002903|FG000|Overall Study|Death|17|||
156795165|NCT02414841|566002904|FG001|Overall Study|Death|14|||
156795166|NCT02414841|566002903|FG000|Overall Study|Received a Kidney Transplant|13|||
156795167|NCT02414841|566002904|FG001|Overall Study|Received a Kidney Transplant|4|||
156795168|NCT02414841|566002903|FG000|Overall Study|Randomized But Not Treated|6|||
156795169|NCT02414841|566002904|FG001|Overall Study|Randomized But Not Treated|4|||
156795170|NCT00112385|566002905|FG000|Overall Study|Lost to Follow-up|1|||
156795171|NCT00112385|566002906|FG001|Overall Study|Lost to Follow-up|0|||
156795172|NCT00112385|566002905|FG000|Overall Study|Withdrawal by Subject|0|||
156795173|NCT00112385|566002906|FG001|Overall Study|Withdrawal by Subject|1|||
156795174|NCT03514134|566004149|FG000|Overall Study|Lost to Follow-up|0|||
156795175|NCT03514134|566004150|FG001|Overall Study|Lost to Follow-up|1|||
156795176|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
156795177|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
156795178|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
156795179|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
156795180|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
156795181|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
156795182|NCT01373281|566004152|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
156795183|NCT01373281|566004153|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
156795184|NCT01373281|566004152|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
156795185|NCT01373281|566004153|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
156795186|NCT01373281|566004152|FG000|Surveillance Expansion Period|Protocol Violation|9|||
156795187|NCT01373281|566004153|FG001|Surveillance Expansion Period|Protocol Violation|1|||
156795188|NCT01373281|566004152|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
156795189|NCT01373281|566004153|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
156795190|NCT01373281|566004152|FG000|Surveillance Expansion Period|Serious adverse event|3|||
156875961|NCT00114517|566303746|FG003|Overall Study|Too busy|2|||
157137534|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
157137535|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
157137536|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156725902|NCT03859427|565742346|FG001|Overall Study|Death|25|||
156725903|NCT02503540|565742347|FG000|Overall Study|Death|2|||
156875962|NCT00114517|566303743|FG000|Overall Study|Moved from area|0|||
156725904|NCT02503540|565742347|FG000|Overall Study|Withdrawal by Subject|1|||
156795191|NCT01373281|566004153|FG001|Surveillance Expansion Period|Serious adverse event|4|||
156795192|NCT01397253|566004154|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
156795193|NCT01397253|566004155|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
156795194|NCT02296476|566004156|FG000|Overall Study|Disease Progression|6|||
156795195|NCT02296476|566004157|FG001|Overall Study|Disease Progression|4|||
156795196|NCT02296476|566004158|FG002|Overall Study|Disease Progression|2|||
157137537|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156725905|NCT00564850|565742348|FG000|Overall Study|Protocol Violation|2|||
157019654|NCT03692676|566826440|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
157019655|NCT03692676|566826441|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
157137538|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
157217338|NCT00738920|567541079|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
157217339|NCT00738920|567541080|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
156725906|NCT02640664|565742349|FG000|Epoch 1|Withdrawal of informed consent|1|||
156725907|NCT02640664|565742350|FG001|Epoch 1|Withdrawal of informed consent|0|||
156725908|NCT02640664|565742351|FG002|Epoch 1|Withdrawal of informed consent|0|||
156725909|NCT02640664|565742349|FG000|Epoch 1|Death|0|||
156725910|NCT02640664|565742350|FG001|Epoch 1|Death|0|||
156725911|NCT02640664|565742351|FG002|Epoch 1|Death|1|||
157137539|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137540|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
157137541|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
157137542|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137543|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137544|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137545|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137546|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
157137547|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156725912|NCT02640664|565742349|FG000|Epoch 2|Withdrawal of informed consent|3|||
156725913|NCT02640664|565742350|FG001|Epoch 2|Withdrawal of informed consent|4|||
156725914|NCT02640664|565742351|FG002|Epoch 2|Withdrawal of informed consent|2|||
156725915|NCT02640664|565742349|FG000|Epoch 2|Subject/guardian decision|0|||
156725916|NCT02640664|565742350|FG001|Epoch 2|Subject/guardian decision|2|||
156725917|NCT02640664|565742351|FG002|Epoch 2|Subject/guardian decision|2|||
156725918|NCT02640664|565742349|FG000|Epoch 2|Lost to Follow-up|3|||
156725919|NCT02640664|565742350|FG001|Epoch 2|Lost to Follow-up|4|||
156725920|NCT02640664|565742351|FG002|Epoch 2|Lost to Follow-up|1|||
156725921|NCT02640664|565742349|FG000|Epoch 2|Death|0|||
156725922|NCT02640664|565742350|FG001|Epoch 2|Death|0|||
156725923|NCT02640664|565742351|FG002|Epoch 2|Death|1|||
156725924|NCT00979654|565742354|FG000|Overall Study|Lost to Follow-up|1|||
156725925|NCT00979654|565742354|FG000|Overall Study|Withdrawal by Subject|22|||
156725926|NCT00979654|565742354|FG000|Overall Study|Death|1|||
156725927|NCT00979654|565742354|FG000|Overall Study|Lack of Efficacy|6|||
156725928|NCT00979654|565742354|FG000|Overall Study|Adverse Event|1|||
156725929|NCT00979654|565742354|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
156725930|NCT00979654|565742354|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
156725931|NCT00979654|565742354|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
156725932|NCT00979654|565742354|FG000|Overall Study|Serious Adverse Event|1|||
156725933|NCT00979654|565742354|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
156725934|NCT01129557|565742355|FG000|Overall Study|Adverse Event|1|||
156725935|NCT01129557|565742356|FG001|Overall Study|Adverse Event|2|||
156725936|NCT01129557|565742357|FG002|Overall Study|Adverse Event|2|||
156725937|NCT01129557|565742355|FG000|Overall Study|Novartis terminated study early|3|||
156725938|NCT01129557|565742356|FG001|Overall Study|Novartis terminated study early|3|||
156725939|NCT01129557|565742357|FG002|Overall Study|Novartis terminated study early|2|||
156725940|NCT01486446|565742358|FG000|Overall Study|Adverse Event|1|||
156725941|NCT01486446|565742359|FG001|Overall Study|Adverse Event|0|||
156725942|NCT01445730|565742360|FG000|Overall Study|Adverse Event|1|||
156725943|NCT01445730|565742360|FG000|Overall Study|For the advice of a dentist|1|||
156725944|NCT01445730|565742360|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
156725945|NCT01611883|565742361|FG000|Overall Study|Adverse Event|1|||
156725946|NCT01611883|565742362|FG001|Overall Study|Adverse Event|1|||
156725947|NCT00734994|565742364|FG000|Overall Study|Withdrawal by Subject|1|||
156725948|NCT05966584|565742368|FG000|Overall Study|Lost to Follow-up|1|||
156725949|NCT05343000|565744339|FG000|Overall Study|Physician Decision|2|||
156725950|NCT04432831|565744340|FG000|Overall Study|Withdrawal by Subject|24|||
156725951|NCT04432831|565744341|FG001|Overall Study|Withdrawal by Subject|28|||
156725952|NCT04432831|565744342|FG002|Overall Study|Withdrawal by Subject|21|||
156725953|NCT04432831|565744340|FG000|Overall Study|Death|23|||
156875963|NCT00114517|566303744|FG001|Overall Study|Moved from area|3|||
157137548|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156875964|NCT00114517|566303745|FG002|Overall Study|Moved from area|2|||
156875965|NCT00114517|566303746|FG003|Overall Study|Moved from area|1|||
157137549|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
157217340|NCT00738920|567541081|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
156725954|NCT04432831|565744341|FG001|Overall Study|Death|23|||
156725955|NCT04432831|565744342|FG002|Overall Study|Death|17|||
156875966|NCT00114517|566303743|FG000|Overall Study|Did not want estradiol|1|||
156725956|NCT04432831|565744340|FG000|Overall Study|Lost to Follow-up|15|||
156725957|NCT04432831|565744341|FG001|Overall Study|Lost to Follow-up|15|||
156725958|NCT04432831|565744342|FG002|Overall Study|Lost to Follow-up|12|||
156725959|NCT04432831|565744340|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
156875967|NCT00114517|566303744|FG001|Overall Study|Did not want estradiol|1|||
157137550|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
157137551|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157137552|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157137553|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157137554|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157137555|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
157137556|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
157137557|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137558|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
157137559|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137560|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137561|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137562|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137563|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137564|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137565|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
157137566|NCT01307423|567249085|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137567|NCT01307423|567249086|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137568|NCT01307423|567249087|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
157137569|NCT01307423|567249088|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137570|NCT01307423|567249089|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137571|NCT01307423|567249090|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137572|NCT01307423|567249091|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
157137573|NCT01307423|567249092|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
157137574|NCT01307423|567249093|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
157137575|NCT00064701|567249094|FG000|One Year Post-transplant|Did not receive study drug|7|||
157137576|NCT00064701|567249095|FG001|One Year Post-transplant|Did not receive study drug|12|||
157137577|NCT00064701|567249096|FG002|One Year Post-transplant|Did not receive study drug|11|||
157137578|NCT00064701|567249094|FG000|One Year Post-transplant|Adverse Event|23|||
157137579|NCT00064701|567249095|FG001|One Year Post-transplant|Adverse Event|19|||
157137580|NCT00064701|567249096|FG002|One Year Post-transplant|Adverse Event|37|||
157137581|NCT00064701|567249094|FG000|One Year Post-transplant|Rejection|0|||
157137582|NCT00064701|567249095|FG001|One Year Post-transplant|Rejection|1|||
157137583|NCT00064701|567249096|FG002|One Year Post-transplant|Rejection|16|||
157137584|NCT00064701|567249094|FG000|One Year Post-transplant|Non-compliance|4|||
157137585|NCT00064701|567249095|FG001|One Year Post-transplant|Non-compliance|2|||
157019656|NCT03692676|566826442|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
157137586|NCT00064701|567249096|FG002|One Year Post-transplant|Non-compliance|5|||
157137587|NCT00064701|567249094|FG000|One Year Post-transplant|Graft Failure|3|||
157137588|NCT00064701|567249095|FG001|One Year Post-transplant|Graft Failure|2|||
157137589|NCT00064701|567249096|FG002|One Year Post-transplant|Graft Failure|1|||
157137590|NCT00064701|567249094|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
157137591|NCT00064701|567249095|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
157137592|NCT00064701|567249096|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
157137593|NCT00064701|567249094|FG000|One Year Post-transplant|Lost to Follow-up|1|||
157137594|NCT00064701|567249095|FG001|One Year Post-transplant|Lost to Follow-up|0|||
157137595|NCT00064701|567249096|FG002|One Year Post-transplant|Lost to Follow-up|0|||
157137596|NCT00064701|567249094|FG000|One Year Post-transplant|Converted to rapamycin|1|||
157137597|NCT00064701|567249095|FG001|One Year Post-transplant|Converted to rapamycin|0|||
157137598|NCT00064701|567249096|FG002|One Year Post-transplant|Converted to rapamycin|0|||
157137599|NCT00064701|567249094|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
157137600|NCT00064701|567249095|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
157217341|NCT00738920|567541079|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
157217342|NCT00738920|567541080|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
156795197|NCT00980044|566004163|FG000|Overall Study|Withdrawal by Subject|5|||
156795198|NCT00980044|566004164|FG001|Overall Study|Withdrawal by Subject|7|||
156795199|NCT00980044|566004165|FG002|Overall Study|Withdrawal by Subject|3|||
156795200|NCT00980044|566004163|FG000|Overall Study|Protocol Violation|0|||
156795201|NCT00980044|566004164|FG001|Overall Study|Protocol Violation|0|||
156795202|NCT00980044|566004165|FG002|Overall Study|Protocol Violation|2|||
156795203|NCT03502681|566004168|FG000|Overall Study|Adverse Event|1|||
156795204|NCT03502681|566004169|FG001|Overall Study|Adverse Event|1|||
156795205|NCT03502681|566004168|FG000|Overall Study|Disease Progression|2|||
156795206|NCT03502681|566004169|FG001|Overall Study|Disease Progression|1|||
156795207|NCT00442702|566004170|FG000|Titration Period|Adverse Event|2|||
157019657|NCT03692676|566826443|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
157137601|NCT00064701|567249096|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
157137602|NCT00064701|567249094|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
157137603|NCT00064701|567249095|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
157137604|NCT00064701|567249096|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
157019658|NCT03692676|566826440|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
157019659|NCT03692676|566826441|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
157019660|NCT03692676|566826442|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
157019661|NCT03692676|566826443|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
157019662|NCT03692676|566826440|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
157019663|NCT03692676|566826441|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
157019664|NCT03692676|566826442|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
157019665|NCT03692676|566826443|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
157019666|NCT03692676|566826440|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
157019667|NCT03692676|566826441|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
157019668|NCT03692676|566826442|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
157019669|NCT03692676|566826443|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
157019670|NCT03692676|566826440|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
157019671|NCT03692676|566826441|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
157019672|NCT03692676|566826442|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
157019673|NCT03692676|566826443|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
157019674|NCT03692676|566826440|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
157019675|NCT03692676|566826441|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
157019676|NCT03692676|566826442|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
157019677|NCT03692676|566826443|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
157019678|NCT03692676|566826440|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
157019679|NCT03692676|566826441|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
157019680|NCT03692676|566826442|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
157019681|NCT03692676|566826443|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
157019682|NCT03692676|566826440|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
157019683|NCT03692676|566826441|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
157019684|NCT03692676|566826442|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
157019685|NCT03692676|566826443|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
157019686|NCT03692676|566826440|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
157019687|NCT03692676|566826441|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
157019688|NCT03692676|566826442|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
157019689|NCT03692676|566826443|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
157019690|NCT03692676|566826440|FG000|Overall Study|Other|0|||
157019691|NCT03692676|566826441|FG001|Overall Study|Other|805|||
157019692|NCT03692676|566826442|FG002|Overall Study|Other|758|||
157019693|NCT03692676|566826443|FG003|Overall Study|Other|277|||
157019694|NCT03692676|566826440|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
157019695|NCT03692676|566826441|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
157019696|NCT03692676|566826442|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
157019697|NCT03692676|566826443|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
157019698|NCT03692611|566826444|FG000|Overall Study|Found to be ineligible postrandomization|3|||
156795208|NCT00442702|566004171|FG001|Titration Period|Adverse Event|0|||
157019699|NCT03692611|566826445|FG001|Overall Study|Found to be ineligible postrandomization|0|||
156795209|NCT00442702|566004170|FG000|Titration Period|Death|3|||
156795210|NCT00442702|566004171|FG001|Titration Period|Death|2|||
156795211|NCT00442702|566004170|FG000|Titration Period|Insufficient Therapeutic Response|1|||
156795212|NCT00442702|566004171|FG001|Titration Period|Insufficient Therapeutic Response|0|||
156795213|NCT00442702|566004170|FG000|Titration Period|Refused Treatment|4|||
156795214|NCT00442702|566004171|FG001|Titration Period|Refused Treatment|1|||
156795215|NCT00442702|566004170|FG000|Titration Period|Failure to return|1|||
156795216|NCT00442702|566004171|FG001|Titration Period|Failure to return|0|||
156795217|NCT00442702|566004170|FG000|Titration Period|Hospitalized in another hospital|1|||
156795218|NCT00442702|566004171|FG001|Titration Period|Hospitalized in another hospital|0|||
156795219|NCT00442702|566004170|FG000|Evaluation Period|Adverse Event|1|||
156795220|NCT00442702|566004171|FG001|Evaluation Period|Adverse Event|0|||
156795221|NCT00442702|566004170|FG000|Evaluation Period|Death|1|||
156795222|NCT00442702|566004171|FG001|Evaluation Period|Death|1|||
156795223|NCT00442702|566004170|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
156795224|NCT00442702|566004171|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
156795225|NCT00442702|566004170|FG000|Evaluation Period|Refused treatment|1|||
157137605|NCT00064701|567249094|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
157137606|NCT00064701|567249095|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
157137607|NCT00064701|567249096|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
157137608|NCT00064701|567249094|FG000|One Year Post-transplant|Poor absorption|0|||
157137609|NCT00064701|567249095|FG001|One Year Post-transplant|Poor absorption|1|||
157137610|NCT00064701|567249096|FG002|One Year Post-transplant|Poor absorption|0|||
157137611|NCT00064701|567249094|FG000|One Year Post-transplant|Pancreas transplant|0|||
157137612|NCT00064701|567249095|FG001|One Year Post-transplant|Pancreas transplant|0|||
157137613|NCT00064701|567249096|FG002|One Year Post-transplant|Pancreas transplant|1|||
157137614|NCT00064701|567249094|FG000|Clinical Continuation Phase|Adverse Event|12|||
156725960|NCT04432831|565744341|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
156725961|NCT04432831|565744342|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
156725962|NCT04432831|565744340|FG000|Overall Study|Reason Not Specified|7|||
156725963|NCT04432831|565744341|FG001|Overall Study|Reason Not Specified|11|||
156725964|NCT04432831|565744342|FG002|Overall Study|Reason Not Specified|9|||
156725965|NCT04432831|565744340|FG000|Overall Study|Adverse Event|7|||
156725966|NCT04432831|565744341|FG001|Overall Study|Adverse Event|7|||
157137615|NCT00064701|567249095|FG001|Clinical Continuation Phase|Adverse Event|21|||
157137616|NCT00064701|567249096|FG002|Clinical Continuation Phase|Adverse Event|14|||
157137617|NCT00064701|567249094|FG000|Clinical Continuation Phase|Non-compliance|8|||
157137618|NCT00064701|567249095|FG001|Clinical Continuation Phase|Non-compliance|6|||
157137619|NCT00064701|567249096|FG002|Clinical Continuation Phase|Non-compliance|7|||
157137620|NCT00064701|567249094|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
157137621|NCT00064701|567249095|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
157137622|NCT00064701|567249096|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
157137623|NCT00064701|567249094|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
157137624|NCT00064701|567249095|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
156725967|NCT04432831|565744342|FG002|Overall Study|Adverse Event|7|||
156725968|NCT04432831|565744340|FG000|Overall Study|Physician Decision|1|||
157137625|NCT00064701|567249096|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
157137626|NCT00064701|567249094|FG000|Clinical Continuation Phase|Graft Failure|5|||
157137627|NCT00064701|567249095|FG001|Clinical Continuation Phase|Graft Failure|5|||
157137628|NCT00064701|567249096|FG002|Clinical Continuation Phase|Graft Failure|2|||
157137629|NCT00064701|567249094|FG000|Clinical Continuation Phase|Rejection|1|||
157137630|NCT00064701|567249095|FG001|Clinical Continuation Phase|Rejection|2|||
157137631|NCT00064701|567249096|FG002|Clinical Continuation Phase|Rejection|2|||
157137632|NCT00064701|567249094|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
157137633|NCT00064701|567249095|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
157137634|NCT00064701|567249096|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
157137635|NCT00064701|567249094|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
157137636|NCT00064701|567249095|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
157137637|NCT00064701|567249096|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
157137638|NCT00064701|567249094|FG000|Clinical Continuation Phase|Physician Decision|1|||
157137639|NCT00064701|567249095|FG001|Clinical Continuation Phase|Physician Decision|3|||
157137640|NCT00064701|567249096|FG002|Clinical Continuation Phase|Physician Decision|0|||
156725969|NCT04432831|565744341|FG001|Overall Study|Physician Decision|3|||
156725970|NCT04432831|565744342|FG002|Overall Study|Physician Decision|6|||
156725971|NCT04432831|565744340|FG000|Overall Study|Protocol Violation|1|||
156725972|NCT04432831|565744341|FG001|Overall Study|Protocol Violation|0|||
156725973|NCT04432831|565744342|FG002|Overall Study|Protocol Violation|2|||
156725974|NCT04432831|565744340|FG000|Overall Study|Pregnancy|0|||
156725975|NCT04432831|565744341|FG001|Overall Study|Pregnancy|1|||
156725976|NCT04432831|565744342|FG002|Overall Study|Pregnancy|0|||
156725977|NCT04432831|565744340|FG000|Overall Study|Lack of Efficacy|0|||
156725978|NCT04432831|565744341|FG001|Overall Study|Lack of Efficacy|0|||
156725979|NCT04432831|565744342|FG002|Overall Study|Lack of Efficacy|2|||
156725980|NCT03782792|565744343|FG000|Overall Study|Patient left the country|0|||
157019700|NCT04725240|566826446|FG000|Overall Study|Adverse Event|2|||
157019701|NCT03016169|566826453|FG000|Overall Study|Lost to Follow-up|4|||
156725981|NCT03782792|565744344|FG001|Overall Study|Patient left the country|1|||
156725982|NCT03782792|565744343|FG000|Overall Study|Withdrawal by Subject|1|||
156725983|NCT03782792|565744344|FG001|Overall Study|Withdrawal by Subject|2|||
156875968|NCT00114517|566303745|FG002|Overall Study|Did not want estradiol|0|||
157019702|NCT03016169|566826453|FG000|Overall Study|Death|54|||
157019703|NCT03016169|566826453|FG000|Overall Study|Device Explant|11|||
157019704|NCT03016169|566826453|FG000|Overall Study|Withdrawal by Subject|19|||
157019705|NCT03016169|566826453|FG000|Overall Study|Other Reasons|1|||
157137641|NCT00064701|567249094|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
156725984|NCT05271370|565744347|FG000|Overall Study|Study early termination|8|||
156725985|NCT05271370|565744348|FG001|Overall Study|Study early termination|16|||
157019706|NCT04060355|566826454|FG000|Overall Study|Lost to Follow-up|41|||
157137642|NCT00064701|567249095|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
157137643|NCT00064701|567249096|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
157137644|NCT00064701|567249094|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
157137645|NCT00064701|567249095|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
157137646|NCT00064701|567249096|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
157137647|NCT00064701|567249094|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
157137648|NCT00064701|567249095|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
157137649|NCT00064701|567249096|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
157137650|NCT00064701|567249094|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
157137651|NCT00064701|567249095|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
157137652|NCT00064701|567249096|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
157137653|NCT00064701|567249094|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
157137654|NCT00064701|567249095|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
157137655|NCT00064701|567249096|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
157137656|NCT00064701|567249094|FG000|Clinical Continuation Phase|Patient opted out|0|||
157137657|NCT00064701|567249095|FG001|Clinical Continuation Phase|Patient opted out|0|||
157137658|NCT00064701|567249096|FG002|Clinical Continuation Phase|Patient opted out|1|||
157137659|NCT03308188|567249097|FG000|Overall Study|Withdrawal by Subject|0|||
157137660|NCT03308188|567249098|FG001|Overall Study|Withdrawal by Subject|3|||
157137661|NCT03308188|567249097|FG000|Overall Study|Death|0|||
157137662|NCT03308188|567249098|FG001|Overall Study|Death|1|||
157137663|NCT01791855|567249099|FG000|Overall Study|Adverse Event|0|||
157137664|NCT01791855|567249100|FG001|Overall Study|Adverse Event|0|||
157137665|NCT01791855|567249101|FG002|Overall Study|Adverse Event|0|||
156725986|NCT05271370|565744349|FG002|Overall Study|Study early termination|29|||
156725987|NCT00617890|565744350|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
156725988|NCT00617890|565744351|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
157137666|NCT01791855|567249102|FG003|Overall Study|Adverse Event|1|||
157137667|NCT01791855|567249099|FG000|Overall Study|Randomized, not treated|0|||
157137668|NCT01791855|567249100|FG001|Overall Study|Randomized, not treated|1|||
157137669|NCT01791855|567249101|FG002|Overall Study|Randomized, not treated|0|||
157137670|NCT01791855|567249102|FG003|Overall Study|Randomized, not treated|0|||
157137671|NCT01709331|567249103|FG000|Overall Study|Adverse Event|1|||
157137672|NCT00552110|567249104|FG000|Overall Study|Serious or Life-Threatening AE|0|||
156725989|NCT00617890|565744352|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
156725990|NCT00617890|565744353|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
156725991|NCT00617890|565744350|FG000|Overall Study|Lack of Efficacy|23|||
156725992|NCT00617890|565744351|FG001|Overall Study|Lack of Efficacy|26|||
156725993|NCT00617890|565744352|FG002|Overall Study|Lack of Efficacy|30|||
156725994|NCT00617890|565744353|FG003|Overall Study|Lack of Efficacy|97|||
156725995|NCT00617890|565744350|FG000|Overall Study|Lost to Follow-up|0|||
156725996|NCT00617890|565744351|FG001|Overall Study|Lost to Follow-up|0|||
156725997|NCT00617890|565744352|FG002|Overall Study|Lost to Follow-up|1|||
156725998|NCT00617890|565744353|FG003|Overall Study|Lost to Follow-up|2|||
156725999|NCT00617890|565744350|FG000|Overall Study|Withdrawal by Subject|4|||
156726000|NCT00617890|565744351|FG001|Overall Study|Withdrawal by Subject|1|||
156726001|NCT00617890|565744352|FG002|Overall Study|Withdrawal by Subject|0|||
156726002|NCT00617890|565744353|FG003|Overall Study|Withdrawal by Subject|2|||
156726003|NCT00617890|565744350|FG000|Overall Study|Protocol Violation|2|||
156726004|NCT00617890|565744351|FG001|Overall Study|Protocol Violation|1|||
156726005|NCT00617890|565744352|FG002|Overall Study|Protocol Violation|0|||
156726006|NCT00617890|565744353|FG003|Overall Study|Protocol Violation|0|||
156726007|NCT00617890|565744350|FG000|Overall Study|Adverse Event|1|||
156726008|NCT00617890|565744351|FG001|Overall Study|Adverse Event|0|||
156726009|NCT00617890|565744352|FG002|Overall Study|Adverse Event|3|||
156726010|NCT00617890|565744353|FG003|Overall Study|Adverse Event|8|||
156726011|NCT00617890|565744350|FG000|Overall Study|Not treated|1|||
156726012|NCT00617890|565744351|FG001|Overall Study|Not treated|0|||
156726013|NCT00617890|565744352|FG002|Overall Study|Not treated|1|||
156726014|NCT00617890|565744353|FG003|Overall Study|Not treated|1|||
156726015|NCT02283268|565744363|FG000|Overall Study|Withdrawal by Subject|1|||
156726016|NCT00333983|565744364|FG000|Overall Study|Lost to Follow-up|2|||
156726017|NCT00333983|565744365|FG001|Overall Study|Lost to Follow-up|1|||
156726018|NCT00333983|565744366|FG002|Overall Study|Lost to Follow-up|0|||
156726019|NCT00333983|565744364|FG000|Overall Study|Adverse Event|1|||
156726020|NCT00333983|565744365|FG001|Overall Study|Adverse Event|1|||
156726021|NCT00333983|565744366|FG002|Overall Study|Adverse Event|1|||
156726022|NCT00333983|565744364|FG000|Overall Study|Withdrawal by Subject|0|||
156726023|NCT00333983|565744365|FG001|Overall Study|Withdrawal by Subject|3|||
156726024|NCT00333983|565744366|FG002|Overall Study|Withdrawal by Subject|1|||
156726025|NCT00833105|565744367|FG000|Overall Study|Withdrawal by Subject|1|||
156726026|NCT00833105|565744367|FG000|Overall Study|Adverse Event|2|||
157137673|NCT00552110|567249105|FG001|Overall Study|Serious or Life-Threatening AE|0|||
157137674|NCT00552110|567249106|FG002|Overall Study|Serious or Life-Threatening AE|1|||
157137675|NCT00552110|567249107|FG003|Overall Study|Serious or Life-Threatening AE|0|||
157137676|NCT00552110|567249108|FG004|Overall Study|Serious or Life-Threatening AE|0|||
157137677|NCT00552110|567249104|FG000|Overall Study|Lack of Efficacy|1|||
157137678|NCT00552110|567249105|FG001|Overall Study|Lack of Efficacy|0|||
157137679|NCT00552110|567249106|FG002|Overall Study|Lack of Efficacy|0|||
157137680|NCT00552110|567249107|FG003|Overall Study|Lack of Efficacy|1|||
157137681|NCT00552110|567249108|FG004|Overall Study|Lack of Efficacy|4|||
157137682|NCT00552110|567249104|FG000|Overall Study|Withdrawal by Subject|0|||
157137683|NCT00552110|567249105|FG001|Overall Study|Withdrawal by Subject|2|||
157137684|NCT00552110|567249106|FG002|Overall Study|Withdrawal by Subject|0|||
157137685|NCT00552110|567249107|FG003|Overall Study|Withdrawal by Subject|3|||
157137686|NCT00552110|567249108|FG004|Overall Study|Withdrawal by Subject|2|||
157137687|NCT00552110|567249104|FG000|Overall Study|Lost to Follow-up|0|||
157137688|NCT00552110|567249105|FG001|Overall Study|Lost to Follow-up|0|||
157137689|NCT00552110|567249106|FG002|Overall Study|Lost to Follow-up|0|||
157137690|NCT00552110|567249107|FG003|Overall Study|Lost to Follow-up|1|||
157137691|NCT00552110|567249108|FG004|Overall Study|Lost to Follow-up|1|||
157137692|NCT00552110|567249104|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
157137693|NCT00552110|567249105|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
157137694|NCT00552110|567249106|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
157137695|NCT00552110|567249107|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
157137696|NCT00552110|567249108|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
157137697|NCT00552110|567249104|FG000|Overall Study|Withdrawn per Sponsor|0|||
157137698|NCT00552110|567249105|FG001|Overall Study|Withdrawn per Sponsor|1|||
156795226|NCT00442702|566004171|FG001|Evaluation Period|Refused treatment|1|||
156795227|NCT00442702|566004170|FG000|Evaluation Period|Renal transplant|0|||
156795228|NCT00442702|566004171|FG001|Evaluation Period|Renal transplant|1|||
156795229|NCT00442702|566004170|FG000|Evaluation Period|Failure to return|1|||
156795230|NCT00442702|566004171|FG001|Evaluation Period|Failure to return|0|||
156795231|NCT00442702|566004170|FG000|Evaluation Period|Site closure|0|||
156795232|NCT00442702|566004171|FG001|Evaluation Period|Site closure|1|||
156795233|NCT00500331|566004180|FG000|Overall Study|Adverse Event|0|||
156795234|NCT00500331|566004181|FG001|Overall Study|Adverse Event|2|||
156795235|NCT00500331|566004182|FG002|Overall Study|Adverse Event|0|||
156795236|NCT00500331|566004183|FG003|Overall Study|Adverse Event|1|||
156795237|NCT00500331|566004184|FG004|Overall Study|Adverse Event|2|||
156795238|NCT00500331|566004185|FG005|Overall Study|Adverse Event|2|||
156795239|NCT00500331|566004186|FG006|Overall Study|Adverse Event|0|||
156795240|NCT00500331|566004180|FG000|Overall Study|Lost to Follow-up|1|||
156795241|NCT00500331|566004181|FG001|Overall Study|Lost to Follow-up|1|||
156795242|NCT00500331|566004182|FG002|Overall Study|Lost to Follow-up|1|||
156795243|NCT00500331|566004183|FG003|Overall Study|Lost to Follow-up|2|||
156795244|NCT00500331|566004184|FG004|Overall Study|Lost to Follow-up|1|||
156795245|NCT00500331|566004185|FG005|Overall Study|Lost to Follow-up|0|||
156795246|NCT00500331|566004186|FG006|Overall Study|Lost to Follow-up|0|||
156795247|NCT00500331|566004180|FG000|Overall Study|Protocol Violation|3|||
156795248|NCT00500331|566004181|FG001|Overall Study|Protocol Violation|1|||
156795249|NCT00500331|566004182|FG002|Overall Study|Protocol Violation|1|||
156795250|NCT00500331|566004183|FG003|Overall Study|Protocol Violation|0|||
156795251|NCT00500331|566004184|FG004|Overall Study|Protocol Violation|1|||
156795252|NCT00500331|566004185|FG005|Overall Study|Protocol Violation|1|||
156795253|NCT00500331|566004186|FG006|Overall Study|Protocol Violation|1|||
156795254|NCT00500331|566004180|FG000|Overall Study|Withdrawal by Subject|4|||
156795255|NCT00500331|566004181|FG001|Overall Study|Withdrawal by Subject|0|||
156795256|NCT00500331|566004182|FG002|Overall Study|Withdrawal by Subject|1|||
156795257|NCT00500331|566004183|FG003|Overall Study|Withdrawal by Subject|5|||
156795258|NCT00500331|566004184|FG004|Overall Study|Withdrawal by Subject|0|||
156795259|NCT00500331|566004185|FG005|Overall Study|Withdrawal by Subject|1|||
156795260|NCT00500331|566004186|FG006|Overall Study|Withdrawal by Subject|1|||
156795261|NCT00500331|566004180|FG000|Overall Study|Lack of Efficacy|3|||
156795262|NCT00500331|566004181|FG001|Overall Study|Lack of Efficacy|1|||
156795263|NCT00500331|566004182|FG002|Overall Study|Lack of Efficacy|0|||
156795264|NCT00500331|566004183|FG003|Overall Study|Lack of Efficacy|0|||
156795265|NCT00500331|566004184|FG004|Overall Study|Lack of Efficacy|0|||
156795266|NCT00500331|566004185|FG005|Overall Study|Lack of Efficacy|0|||
156795267|NCT00500331|566004186|FG006|Overall Study|Lack of Efficacy|0|||
156795268|NCT00500331|566004180|FG000|Overall Study|Liver function test abnormality|0|||
156795269|NCT00500331|566004181|FG001|Overall Study|Liver function test abnormality|0|||
156795270|NCT00500331|566004182|FG002|Overall Study|Liver function test abnormality|1|||
156795271|NCT00500331|566004183|FG003|Overall Study|Liver function test abnormality|0|||
156795272|NCT00500331|566004184|FG004|Overall Study|Liver function test abnormality|0|||
156795273|NCT00500331|566004185|FG005|Overall Study|Liver function test abnormality|0|||
156795274|NCT00500331|566004186|FG006|Overall Study|Liver function test abnormality|0|||
156795275|NCT00500331|566004180|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
156795276|NCT00500331|566004181|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
157137699|NCT00552110|567249106|FG002|Overall Study|Withdrawn per Sponsor|0|||
157137700|NCT00552110|567249107|FG003|Overall Study|Withdrawn per Sponsor|0|||
157137701|NCT00552110|567249108|FG004|Overall Study|Withdrawn per Sponsor|1|||
157137702|NCT00552110|567249104|FG000|Overall Study|Use of Prohibited Medication|1|||
157137703|NCT00552110|567249105|FG001|Overall Study|Use of Prohibited Medication|1|||
157137704|NCT00552110|567249106|FG002|Overall Study|Use of Prohibited Medication|0|||
157137705|NCT00552110|567249107|FG003|Overall Study|Use of Prohibited Medication|0|||
157137706|NCT00552110|567249108|FG004|Overall Study|Use of Prohibited Medication|0|||
157137707|NCT00552110|567249104|FG000|Overall Study|Delay of Study due to Relabeling|0|||
157137708|NCT00552110|567249105|FG001|Overall Study|Delay of Study due to Relabeling|0|||
157137709|NCT00552110|567249106|FG002|Overall Study|Delay of Study due to Relabeling|0|||
157137710|NCT00552110|567249107|FG003|Overall Study|Delay of Study due to Relabeling|1|||
157137711|NCT00552110|567249108|FG004|Overall Study|Delay of Study due to Relabeling|0|||
157137712|NCT00552110|567249104|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
157137713|NCT00552110|567249105|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
157137714|NCT00552110|567249106|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
157137715|NCT00552110|567249107|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
156726027|NCT02898597|565744368|FG000|Overall Study|Protocol Violation|4|||
156726028|NCT02898597|565744369|FG001|Overall Study|Protocol Violation|2|||
156726029|NCT02898597|565744368|FG000|Overall Study|Lost to Follow-up|0|||
156726030|NCT02898597|565744369|FG001|Overall Study|Lost to Follow-up|9|||
156726031|NCT02898597|565744368|FG000|Overall Study|Death|0|||
156726032|NCT02898597|565744369|FG001|Overall Study|Death|1|||
156726033|NCT03656068|565744370|FG000|Overall Study|Withdrawal by Subject|4|||
156726034|NCT03656068|565744370|FG000|Overall Study|Adverse Event|1|||
156726035|NCT01295671|565744379|FG000|Overall Study|Lost to Follow-up|4|||
156726036|NCT01295671|565744380|FG001|Overall Study|Lost to Follow-up|6|||
156726037|NCT01295671|565744381|FG002|Overall Study|Lost to Follow-up|3|||
156726038|NCT01295671|565744379|FG000|Overall Study|Withdrawal by Subject|3|||
156726039|NCT01295671|565744380|FG001|Overall Study|Withdrawal by Subject|1|||
156726040|NCT01295671|565744381|FG002|Overall Study|Withdrawal by Subject|0|||
156726041|NCT01436370|565744382|FG000|Overall Study|Lost to Follow-up|0|||
156726042|NCT01436370|565744383|FG001|Overall Study|Lost to Follow-up|0|||
156726043|NCT01436370|565744384|FG002|Overall Study|Lost to Follow-up|0|||
156726044|NCT01436370|565744385|FG003|Overall Study|Lost to Follow-up|0|||
156726045|NCT01436370|565744386|FG004|Overall Study|Lost to Follow-up|1|||
156726046|NCT01436370|565744387|FG005|Overall Study|Lost to Follow-up|0|||
156726047|NCT01436370|565744388|FG006|Overall Study|Lost to Follow-up|0|||
156726048|NCT01436370|565744389|FG007|Overall Study|Lost to Follow-up|0|||
156726049|NCT02395848|565744390|FG000|Overall Study|Lost to Follow-up|2|||
156726050|NCT02276560|565744391|FG000|Overall Study|Adverse Event|1|||
156726051|NCT02276560|565744392|FG001|Overall Study|Adverse Event|0|||
156726052|NCT02276560|565744393|FG002|Overall Study|Adverse Event|0|||
156726053|NCT01754129|565744394|FG000|Overall Study|Death|13|||
156726054|NCT01754129|565744394|FG000|Overall Study|Duodopa discontinuation|9|||
156726055|NCT01754129|565744394|FG000|Overall Study|Lost to Follow-up|7|||
156726056|NCT01754129|565744394|FG000|Overall Study|Withdrew consent|1|||
156726057|NCT01754129|565744394|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
156726058|NCT02126579|565744396|FG000|Overall Study|disease progression|0|||
156726059|NCT02126579|565744397|FG001|Overall Study|disease progression|0|||
156726060|NCT02126579|565744398|FG002|Overall Study|disease progression|0|||
156726061|NCT02126579|565744399|FG003|Overall Study|disease progression|1|||
156726062|NCT02126579|565744400|FG004|Overall Study|disease progression|0|||
156726063|NCT02126579|565744401|FG005|Overall Study|disease progression|0|||
156726064|NCT02126579|565744402|FG006|Overall Study|disease progression|1|||
156726065|NCT01343043|565744408|FG000|Overall Study|Disease progression before treatment|1|||
156726066|NCT01343043|565744409|FG001|Overall Study|Disease progression before treatment|0|||
156726067|NCT01343043|565744410|FG002|Overall Study|Disease progression before treatment|0|||
156726068|NCT01343043|565744411|FG003|Overall Study|Disease progression before treatment|0|||
156726069|NCT01343043|565744408|FG000|Overall Study|Withdrawal by Subject|1|||
156726070|NCT01343043|565744409|FG001|Overall Study|Withdrawal by Subject|0|||
156726071|NCT01343043|565744410|FG002|Overall Study|Withdrawal by Subject|0|||
156726072|NCT01343043|565744411|FG003|Overall Study|Withdrawal by Subject|0|||
156726073|NCT01343043|565744408|FG000|Overall Study|Death|1|||
156726074|NCT01343043|565744409|FG001|Overall Study|Death|1|||
156726075|NCT01343043|565744410|FG002|Overall Study|Death|0|||
156726076|NCT01343043|565744411|FG003|Overall Study|Death|1|||
156795277|NCT00500331|566004182|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
156795278|NCT00500331|566004183|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
156795279|NCT00500331|566004184|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
156795280|NCT00500331|566004185|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
157137716|NCT00552110|567249108|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
157217343|NCT00738920|567541081|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
156795281|NCT00500331|566004186|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
156726077|NCT00502242|565744414|FG000|Overall Study|Lack of Efficacy|1|||
156726078|NCT00502242|565744415|FG001|Overall Study|Lack of Efficacy|11|||
156726079|NCT00502242|565744414|FG000|Overall Study|Adverse Event|31|||
156726080|NCT00502242|565744415|FG001|Overall Study|Adverse Event|20|||
156726081|NCT00502242|565744414|FG000|Overall Study|Physician Decision|2|||
156726082|NCT00502242|565744415|FG001|Overall Study|Physician Decision|3|||
157137717|NCT00552110|567249104|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
157137718|NCT00552110|567249105|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
157137719|NCT00552110|567249106|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
157137720|NCT00552110|567249107|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
157137721|NCT00552110|567249108|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
157137722|NCT02500537|567249110|FG000|Overall Study|Death|2|||
157137723|NCT02500537|567249111|FG001|Overall Study|Death|0|||
157137724|NCT02500537|567249110|FG000|Overall Study|Lost to Follow-up|0|||
157137725|NCT02500537|567249111|FG001|Overall Study|Lost to Follow-up|1|||
157137726|NCT02500537|567249110|FG000|Overall Study|Withdrawal by Subject|1|||
157137727|NCT02500537|567249111|FG001|Overall Study|Withdrawal by Subject|0|||
157137728|NCT00355121|567249112|FG000|Overall Study|Did not receive study vaccine|1|||
157137729|NCT00355121|567249113|FG001|Overall Study|Did not receive study vaccine|0|||
157137730|NCT00355121|567249114|FG002|Overall Study|Did not receive study vaccine|1|||
157137731|NCT00355121|567249112|FG000|Overall Study|Adverse Event|0|||
157137732|NCT00355121|567249113|FG001|Overall Study|Adverse Event|1|||
157137733|NCT00355121|567249114|FG002|Overall Study|Adverse Event|0|||
157137734|NCT00355121|567249112|FG000|Overall Study|Protocol Violation|7|||
157137735|NCT00355121|567249113|FG001|Overall Study|Protocol Violation|9|||
157137736|NCT00355121|567249114|FG002|Overall Study|Protocol Violation|1|||
157137737|NCT00355121|567249112|FG000|Overall Study|Lost to Follow-up|4|||
157137738|NCT00355121|567249113|FG001|Overall Study|Lost to Follow-up|7|||
157137739|NCT00355121|567249114|FG002|Overall Study|Lost to Follow-up|1|||
157137740|NCT00355121|567249112|FG000|Overall Study|Withdrawal by Subject|9|||
157137741|NCT00355121|567249113|FG001|Overall Study|Withdrawal by Subject|10|||
157137742|NCT00355121|567249114|FG002|Overall Study|Withdrawal by Subject|2|||
157137743|NCT00355121|567249112|FG000|Overall Study|Serious adverse events|0|||
157137744|NCT00355121|567249113|FG001|Overall Study|Serious adverse events|2|||
157137745|NCT00355121|567249114|FG002|Overall Study|Serious adverse events|0|||
157137746|NCT00655928|567249118|FG000|Overall Study|Withdrawal by Subject|2|||
157137747|NCT00655928|567249119|FG001|Overall Study|Withdrawal by Subject|1|||
157137748|NCT00655928|567249118|FG000|Overall Study|Physician Decision|1|||
157137749|NCT00655928|567249119|FG001|Overall Study|Physician Decision|1|||
157137750|NCT01587989|567249120|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
157137751|NCT01587989|567249121|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
157137752|NCT01587989|567249122|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
157137753|NCT01587989|567249120|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
157137754|NCT01587989|567249121|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
157137755|NCT01587989|567249122|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
157137756|NCT01587989|567249120|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
157137757|NCT01587989|567249121|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
157137758|NCT01587989|567249122|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
157137759|NCT01587989|567249120|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
157137760|NCT01587989|567249121|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
157137761|NCT01587989|567249122|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
157137762|NCT01587989|567249120|FG000|Randomized Study Treatment|Screening failure|0|||
157137763|NCT01587989|567249121|FG001|Randomized Study Treatment|Screening failure|1|||
157137764|NCT01587989|567249122|FG002|Randomized Study Treatment|Screening failure|0|||
157137765|NCT01587989|567249120|FG000|Randomized Study Treatment|Physician Decision|0|||
157137766|NCT01587989|567249121|FG001|Randomized Study Treatment|Physician Decision|0|||
157137767|NCT01587989|567249122|FG002|Randomized Study Treatment|Physician Decision|1|||
157137768|NCT03313050|567249124|FG000|Stage 2: 12 Months|Adverse Event|0|||
157137769|NCT03313050|567249125|FG001|Stage 2: 12 Months|Adverse Event|0|||
157137770|NCT03313050|567249126|FG002|Stage 2: 12 Months|Adverse Event|0|||
157137771|NCT03313050|567249127|FG003|Stage 2: 12 Months|Adverse Event|1|||
157137772|NCT03313050|567249124|FG000|Stage 2: 12 Months|Death|0|||
156726083|NCT00502242|565744414|FG000|Overall Study|Other - Unspecified|8|||
156726084|NCT00502242|565744415|FG001|Overall Study|Other - Unspecified|14|||
156726085|NCT00502242|565744414|FG000|Overall Study|Protocol Violation|3|||
156726086|NCT00502242|565744415|FG001|Overall Study|Protocol Violation|1|||
156726087|NCT00502242|565744414|FG000|Overall Study|Withdrawal by Subject|6|||
156726088|NCT00502242|565744415|FG001|Overall Study|Withdrawal by Subject|7|||
157019707|NCT03779204|566826455|FG000|Overall Study|Lost to Follow-up|2|||
157019708|NCT03779204|566826456|FG001|Overall Study|Lost to Follow-up|0|||
157137773|NCT03313050|567249125|FG001|Stage 2: 12 Months|Death|0|||
157137774|NCT03313050|567249126|FG002|Stage 2: 12 Months|Death|3|||
157137775|NCT03313050|567249127|FG003|Stage 2: 12 Months|Death|0|||
157137776|NCT03313050|567249124|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
157217344|NCT00331630|567543211|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
156726089|NCT02356588|565744416|FG000|Overall Study|Lack of Efficacy|4|||
156726090|NCT02356588|565744417|FG001|Overall Study|Lack of Efficacy|10|||
156726091|NCT02356588|565744416|FG000|Overall Study|Adverse Event|0|||
157137777|NCT03313050|567249125|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
157137778|NCT03313050|567249126|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
157137779|NCT03313050|567249127|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
157019709|NCT05082909|566826457|FG000|Overall Study|Protocol Violation|0|||
157019710|NCT05082909|566826458|FG001|Overall Study|Protocol Violation|0|||
157019711|NCT05082909|566826459|FG002|Overall Study|Protocol Violation|1|||
157019712|NCT05082909|566826460|FG003|Overall Study|Protocol Violation|0|||
157019713|NCT05082909|566826461|FG004|Overall Study|Protocol Violation|0|||
157019714|NCT05082909|566826462|FG005|Overall Study|Protocol Violation|0|||
157137780|NCT03313050|567249124|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
157137781|NCT03313050|567249125|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
157137782|NCT03313050|567249126|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
157137783|NCT03313050|567249127|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
157137784|NCT03313050|567249124|FG000|Stage 2: 12 Months|Protocol deviation|0|||
157137785|NCT03313050|567249125|FG001|Stage 2: 12 Months|Protocol deviation|0|||
157137786|NCT03313050|567249126|FG002|Stage 2: 12 Months|Protocol deviation|7|||
157137787|NCT03313050|567249127|FG003|Stage 2: 12 Months|Protocol deviation|7|||
157137788|NCT03313050|567249124|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
157137789|NCT03313050|567249125|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
157137790|NCT03313050|567249126|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
157137791|NCT03313050|567249127|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
157137792|NCT03313050|567249124|FG000|Stage 2: 12 Months|Other|0|||
157137793|NCT03313050|567249125|FG001|Stage 2: 12 Months|Other|0|||
157137794|NCT03313050|567249126|FG002|Stage 2: 12 Months|Other|0|||
157137795|NCT03313050|567249127|FG003|Stage 2: 12 Months|Other|1|||
157137796|NCT04211337|567249128|FG000|Overall Study|On Treatment|175|||
157137797|NCT04211337|567249129|FG001|Overall Study|On Treatment|40|||
157137798|NCT04211337|567249128|FG000|Overall Study|Withdrawal by Subject|0|||
157137799|NCT04211337|567249129|FG001|Overall Study|Withdrawal by Subject|2|||
157137800|NCT01291017|567249136|FG000|Overall Study|Lost to Follow-up|2|||
157137801|NCT01291017|567249136|FG000|Overall Study|Withdrawal by Subject|3|||
157137802|NCT04980391|567249137|FG000|Overall Study|Death|0|||
157137803|NCT04980391|567249138|FG001|Overall Study|Death|0|||
157137804|NCT04980391|567249139|FG002|Overall Study|Death|1|||
157137805|NCT04980391|567249140|FG003|Overall Study|Death|1|||
157137806|NCT04980391|567249137|FG000|Overall Study|Lost to Follow-up|3|||
157137807|NCT04980391|567249138|FG001|Overall Study|Lost to Follow-up|3|||
157137808|NCT04980391|567249139|FG002|Overall Study|Lost to Follow-up|2|||
157137809|NCT04980391|567249140|FG003|Overall Study|Lost to Follow-up|3|||
157137810|NCT04980391|567249137|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
157137811|NCT04980391|567249138|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
157137812|NCT04980391|567249139|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
157137813|NCT04980391|567249140|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
157137814|NCT04980391|567249137|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157137815|NCT04980391|567249138|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157137816|NCT04980391|567249139|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
157137817|NCT04980391|567249140|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157137818|NCT04980391|567249137|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
157137819|NCT04980391|567249138|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
157137820|NCT04980391|567249139|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
157137821|NCT04980391|567249140|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
157137822|NCT03323749|567252046|FG000|Double-blind Period|Lost to Follow-up|4|||
157137823|NCT03323749|567252047|FG001|Double-blind Period|Lost to Follow-up|5|||
157137824|NCT03323749|567252046|FG000|Double-blind Period|Adverse Event|3|||
157137825|NCT03323749|567252047|FG001|Double-blind Period|Adverse Event|1|||
157137826|NCT03323749|567252046|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
157137827|NCT03323749|567252047|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
157137828|NCT03323749|567252046|FG000|Open-Label Period|Adverse Event|3|||
157137829|NCT03323749|567252047|FG001|Open-Label Period|Adverse Event|10|||
157137830|NCT03323749|567252046|FG000|Open-Label Period|Withdrawal by Subject|7|||
157137831|NCT03323749|567252047|FG001|Open-Label Period|Withdrawal by Subject|5|||
157137832|NCT01821963|567252048|FG000|Overall Study|Adverse Event|1|||
157137833|NCT00783289|567252049|FG000|Overall Study|Protocol Violation|0|||
157137834|NCT00783289|567252050|FG001|Overall Study|Protocol Violation|1|||
157137835|NCT00783289|567252051|FG002|Overall Study|Protocol Violation|0|||
157137836|NCT00783289|567252052|FG003|Overall Study|Protocol Violation|0|||
157137837|NCT00506389|567252053|FG000|In-treatment Period|Other|3|||
157137838|NCT00506389|567252054|FG001|In-treatment Period|Other|3|||
157137839|NCT00506389|567252055|FG002|In-treatment Period|Other|4|||
157137840|NCT00506389|567252053|FG000|In-treatment Period|Lost to Follow-up|0|||
156795282|NCT00500331|566004180|FG000|Overall Study|Didn't return for continuation of study|1|||
156795283|NCT00500331|566004181|FG001|Overall Study|Didn't return for continuation of study|0|||
156795284|NCT00500331|566004182|FG002|Overall Study|Didn't return for continuation of study|0|||
156795285|NCT00500331|566004183|FG003|Overall Study|Didn't return for continuation of study|0|||
156795286|NCT00500331|566004184|FG004|Overall Study|Didn't return for continuation of study|0|||
157137841|NCT00506389|567252054|FG001|In-treatment Period|Lost to Follow-up|0|||
157137842|NCT00506389|567252055|FG002|In-treatment Period|Lost to Follow-up|1|||
156795287|NCT00500331|566004185|FG005|Overall Study|Didn't return for continuation of study|0|||
156795288|NCT00500331|566004186|FG006|Overall Study|Didn't return for continuation of study|0|||
156795289|NCT00500331|566004180|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
156795290|NCT00500331|566004181|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795291|NCT00500331|566004182|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795292|NCT00500331|566004183|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795293|NCT00500331|566004184|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795294|NCT00500331|566004185|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795295|NCT00500331|566004186|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
156795296|NCT00500331|566004180|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
156795297|NCT00500331|566004181|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
156795298|NCT00500331|566004182|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
156795299|NCT00500331|566004183|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
156795300|NCT00500331|566004184|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
156795301|NCT00500331|566004185|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
156795302|NCT00500331|566004186|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
156795303|NCT00500331|566004180|FG000|Overall Study|Participant was randomized by mistake|1|||
156795304|NCT00500331|566004181|FG001|Overall Study|Participant was randomized by mistake|0|||
156795305|NCT00500331|566004182|FG002|Overall Study|Participant was randomized by mistake|0|||
156795306|NCT00500331|566004183|FG003|Overall Study|Participant was randomized by mistake|0|||
156795307|NCT00500331|566004184|FG004|Overall Study|Participant was randomized by mistake|0|||
156795308|NCT00500331|566004185|FG005|Overall Study|Participant was randomized by mistake|0|||
156795309|NCT00500331|566004186|FG006|Overall Study|Participant was randomized by mistake|0|||
156795310|NCT00500331|566004180|FG000|Overall Study|Diabetologist nurse in the study|0|||
156795311|NCT00500331|566004181|FG001|Overall Study|Diabetologist nurse in the study|0|||
156795312|NCT00500331|566004182|FG002|Overall Study|Diabetologist nurse in the study|1|||
156795313|NCT00500331|566004183|FG003|Overall Study|Diabetologist nurse in the study|0|||
156795314|NCT00500331|566004184|FG004|Overall Study|Diabetologist nurse in the study|0|||
156795315|NCT00500331|566004185|FG005|Overall Study|Diabetologist nurse in the study|0|||
156795316|NCT00500331|566004186|FG006|Overall Study|Diabetologist nurse in the study|0|||
156795317|NCT00500331|566004180|FG000|Overall Study|State ban of biological samples export|0|||
156795318|NCT00500331|566004181|FG001|Overall Study|State ban of biological samples export|0|||
156795319|NCT00500331|566004182|FG002|Overall Study|State ban of biological samples export|0|||
156795320|NCT00500331|566004183|FG003|Overall Study|State ban of biological samples export|1|||
156795321|NCT00500331|566004184|FG004|Overall Study|State ban of biological samples export|0|||
156795322|NCT00500331|566004185|FG005|Overall Study|State ban of biological samples export|0|||
156795323|NCT00500331|566004186|FG006|Overall Study|State ban of biological samples export|0|||
156795324|NCT00500331|566004180|FG000|Overall Study|Protocol violated|0|||
156795325|NCT00500331|566004181|FG001|Overall Study|Protocol violated|0|||
156795326|NCT00500331|566004182|FG002|Overall Study|Protocol violated|0|||
156795327|NCT00500331|566004183|FG003|Overall Study|Protocol violated|1|||
156795328|NCT00500331|566004184|FG004|Overall Study|Protocol violated|0|||
156795329|NCT00500331|566004185|FG005|Overall Study|Protocol violated|0|||
156795330|NCT00500331|566004186|FG006|Overall Study|Protocol violated|0|||
156795331|NCT03436732|566004187|FG000|Overall Study|Not treated-enrolled in different study|1|||
156795332|NCT03436732|566004188|FG001|Overall Study|Not treated-enrolled in different study|0|||
156795333|NCT03436732|566004187|FG000|Overall Study|Off study after cycle 1|1|||
156795334|NCT03436732|566004188|FG001|Overall Study|Off study after cycle 1|0|||
156795335|NCT03436732|566004187|FG000|Overall Study|Adverse Event|2|||
156795336|NCT03436732|566004188|FG001|Overall Study|Adverse Event|0|||
156795337|NCT03436732|566004187|FG000|Overall Study|Death|0|||
156795338|NCT03436732|566004188|FG001|Overall Study|Death|1|||
156795339|NCT00267488|566004189|FG000|Overall Study|Sponsor Terminated Study|9|||
156795340|NCT00267488|566004189|FG000|Overall Study|Protocol Violation|1|||
156795341|NCT00267488|566004189|FG000|Overall Study|Other (Disease Progression)|1|||
156795342|NCT02093520|566004190|FG000|Overall Study|Not treated|6|||
156795343|NCT02093520|566004191|FG001|Overall Study|Not treated|22|||
156795344|NCT00851084|566004192|FG000|Overall Study|Randomized but not treated|1|||
156795345|NCT00851084|566004193|FG001|Overall Study|Randomized but not treated|0|||
156795346|NCT00851084|566004192|FG000|Overall Study|Adverse Event|26|||
156795347|NCT00851084|566004193|FG001|Overall Study|Adverse Event|36|||
156795348|NCT00851084|566004192|FG000|Overall Study|Disease progression|52|||
156795349|NCT00851084|566004193|FG001|Overall Study|Disease progression|47|||
156795350|NCT00851084|566004192|FG000|Overall Study|Poor compliance to protocol|1|||
156795351|NCT00851084|566004193|FG001|Overall Study|Poor compliance to protocol|1|||
156795352|NCT00851084|566004192|FG000|Overall Study|Physician Decision|13|||
156795353|NCT00851084|566004193|FG001|Overall Study|Physician Decision|14|||
156795354|NCT00851084|566004192|FG000|Overall Study|Consent withdrawn|0|||
157019715|NCT04088630|566826463|FG000|Overall Study|Lost to Follow-up|3|||
157019716|NCT04088630|566826464|FG001|Overall Study|Lost to Follow-up|2|||
156795355|NCT00851084|566004193|FG001|Overall Study|Consent withdrawn|2|||
156795356|NCT00851084|566004192|FG000|Overall Study|Withdrawal by Subject|11|||
156875969|NCT00114517|566303746|FG003|Overall Study|Did not want estradiol|0|||
156875970|NCT00114517|566303743|FG000|Overall Study|Armed-services duty|0|||
156875971|NCT00114517|566303744|FG001|Overall Study|Armed-services duty|1|||
156875972|NCT00114517|566303745|FG002|Overall Study|Armed-services duty|0|||
156875973|NCT00114517|566303746|FG003|Overall Study|Armed-services duty|1|||
156875974|NCT00114517|566303743|FG000|Overall Study|Competing family issue|0|||
156875975|NCT00114517|566303744|FG001|Overall Study|Competing family issue|1|||
156875976|NCT00114517|566303745|FG002|Overall Study|Competing family issue|0|||
156875977|NCT00114517|566303746|FG003|Overall Study|Competing family issue|1|||
156875978|NCT00114517|566303743|FG000|Overall Study|Physician Decision|0|||
156875979|NCT00114517|566303744|FG001|Overall Study|Physician Decision|1|||
156875980|NCT00114517|566303745|FG002|Overall Study|Physician Decision|0|||
156875981|NCT00114517|566303746|FG003|Overall Study|Physician Decision|0|||
156875982|NCT00114517|566303743|FG000|Overall Study|Lost interest|0|||
156875983|NCT00114517|566303744|FG001|Overall Study|Lost interest|0|||
156875984|NCT00114517|566303745|FG002|Overall Study|Lost interest|1|||
156875985|NCT00114517|566303746|FG003|Overall Study|Lost interest|0|||
156875986|NCT00114517|566303743|FG000|Overall Study|Weight increase|0|||
156875987|NCT00114517|566303744|FG001|Overall Study|Weight increase|0|||
156875988|NCT00114517|566303745|FG002|Overall Study|Weight increase|1|||
156875989|NCT00114517|566303746|FG003|Overall Study|Weight increase|0|||
156875990|NCT00114517|566303743|FG000|Overall Study|Concern about blood clots|0|||
156875991|NCT00114517|566303744|FG001|Overall Study|Concern about blood clots|0|||
156875992|NCT00114517|566303745|FG002|Overall Study|Concern about blood clots|1|||
156875993|NCT00114517|566303746|FG003|Overall Study|Concern about blood clots|0|||
156875994|NCT00114517|566303743|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875995|NCT00114517|566303744|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875996|NCT00114517|566303745|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
156875997|NCT00114517|566303746|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
156875998|NCT04236141|566305703|FG000|Overall Study|Death|18|||
156875999|NCT04236141|566305704|FG001|Overall Study|Death|10|||
156876000|NCT04236141|566305703|FG000|Overall Study|Withdrawal by Participant|1|||
156876001|NCT04236141|566305704|FG001|Overall Study|Withdrawal by Participant|0|||
156876002|NCT04236141|566305703|FG000|Overall Study|Reason not Specified|1|||
157137843|NCT00506389|567252053|FG000|In-treatment Period|Lack of compliance|1|||
157137844|NCT00506389|567252054|FG001|In-treatment Period|Lack of compliance|0|||
157137845|NCT00506389|567252055|FG002|In-treatment Period|Lack of compliance|0|||
157137846|NCT00506389|567252053|FG000|In-treatment Period|Reasons not related to trial|4|||
156726092|NCT02356588|565744417|FG001|Overall Study|Adverse Event|2|||
156726093|NCT02356588|565744416|FG000|Overall Study|Withdrawal by Subject|1|||
156726094|NCT02356588|565744417|FG001|Overall Study|Withdrawal by Subject|0|||
156726095|NCT02356588|565744416|FG000|Overall Study|Protocol Violation|0|||
156726096|NCT02356588|565744417|FG001|Overall Study|Protocol Violation|1|||
156726097|NCT01812109|565744418|FG000|Overall Study|research personnel delay|16|||
156726098|NCT01812109|565744418|FG000|Overall Study|NIRS Unattainable|17|||
156726099|NCT01346696|565744419|FG000|Overall Study|Death|1|||
156726100|NCT04630002|565744420|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
156726101|NCT04630002|565744421|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726102|NCT04630002|565744422|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726103|NCT04630002|565744420|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
156726104|NCT04630002|565744421|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156876003|NCT04236141|566305704|FG001|Overall Study|Reason not Specified|0|||
156876004|NCT04236141|566305703|FG000|Overall Study|Study terminated by Sponsor|8|||
156876005|NCT04236141|566305704|FG001|Overall Study|Study terminated by Sponsor|4|||
156876006|NCT01925131|566305705|FG000|Overall Study|Death|0|||
156876007|NCT01925131|566305706|FG001|Overall Study|Death|0|||
156876008|NCT01925131|566305707|FG002|Overall Study|Death|1|||
156876009|NCT01925131|566305708|FG003|Overall Study|Death|0|||
156876010|NCT01925131|566305709|FG004|Overall Study|Death|0|||
156876011|NCT01925131|566305710|FG005|Overall Study|Death|0|||
156876012|NCT01925131|566305705|FG000|Overall Study|Progression/Relapse|1|||
156876013|NCT01925131|566305706|FG001|Overall Study|Progression/Relapse|1|||
156876014|NCT01925131|566305707|FG002|Overall Study|Progression/Relapse|4|||
156876015|NCT01925131|566305708|FG003|Overall Study|Progression/Relapse|0|||
156876016|NCT01925131|566305709|FG004|Overall Study|Progression/Relapse|0|||
156876017|NCT01925131|566305710|FG005|Overall Study|Progression/Relapse|1|||
157137847|NCT00506389|567252054|FG001|In-treatment Period|Reasons not related to trial|1|||
156726105|NCT04630002|565744422|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156726106|NCT04630002|565744420|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
156726107|NCT04630002|565744421|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156876018|NCT01925131|566305705|FG000|Overall Study|Patient Refusal|1|||
156876019|NCT01925131|566305706|FG001|Overall Study|Patient Refusal|0|||
156876020|NCT01925131|566305707|FG002|Overall Study|Patient Refusal|0|||
156876021|NCT01925131|566305708|FG003|Overall Study|Patient Refusal|0|||
156876022|NCT01925131|566305709|FG004|Overall Study|Patient Refusal|0|||
156876023|NCT01925131|566305710|FG005|Overall Study|Patient Refusal|0|||
156795357|NCT00851084|566004193|FG001|Overall Study|Withdrawal by Subject|12|||
156795358|NCT00851084|566004192|FG000|Overall Study|Metastatic surgery|6|||
156795359|NCT00851084|566004193|FG001|Overall Study|Metastatic surgery|6|||
156795360|NCT00851084|566004192|FG000|Overall Study|Other|7|||
156795361|NCT00851084|566004193|FG001|Overall Study|Other|1|||
156795362|NCT00734032|566004194|FG000|Overall Study|Adverse Event|0|||
156795363|NCT00734032|566004195|FG001|Overall Study|Adverse Event|1|||
156795364|NCT00734032|566004196|FG002|Overall Study|Adverse Event|0|||
156795365|NCT00734032|566004197|FG003|Overall Study|Adverse Event|0|||
156795366|NCT03468998|566004198|FG000|Overall Study|Withdrawal by Subject|1|||
156795367|NCT03468998|566004199|FG001|Overall Study|Withdrawal by Subject|1|||
156795368|NCT03468998|566004200|FG002|Overall Study|Withdrawal by Subject|0|||
156795369|NCT03468998|566004201|FG003|Overall Study|Withdrawal by Subject|4|||
156795370|NCT03468998|566004202|FG004|Overall Study|Withdrawal by Subject|1|||
156795371|NCT03468998|566004203|FG005|Overall Study|Withdrawal by Subject|0|||
156795372|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156795373|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
156795374|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156795375|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
156795376|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
156795377|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
156795378|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
156795379|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
156795380|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
156795381|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795382|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795383|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
156795384|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795385|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795386|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795387|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795388|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156795389|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156795390|NCT01892189|566004204|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795391|NCT01892189|566004205|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795392|NCT01892189|566004206|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795393|NCT01892189|566004207|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795394|NCT01892189|566004208|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795395|NCT01892189|566004209|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
156795396|NCT01892189|566004210|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795397|NCT01892189|566004211|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795398|NCT01892189|566004212|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
156795399|NCT02489279|566004217|FG000|Overall Study|Lost to Follow-up|12|||
156795400|NCT02489279|566004218|FG001|Overall Study|Lost to Follow-up|10|||
156795401|NCT02263547|566004219|FG000|Overall Study|Adverse Event|1|||
156795402|NCT02263547|566004219|FG000|Overall Study|Lost to Follow-up|2|||
156795403|NCT03440411|566004220|FG000|Overall Study|Adverse Event|0|||
156795404|NCT03440411|566004221|FG001|Overall Study|Adverse Event|0|||
156795405|NCT03440411|566004222|FG002|Overall Study|Adverse Event|1|||
156795406|NCT03440411|566004223|FG003|Overall Study|Adverse Event|0|||
156795407|NCT03440411|566004220|FG000|Overall Study|PD|2|||
156795408|NCT03440411|566004221|FG001|Overall Study|PD|1|||
156795409|NCT03440411|566004222|FG002|Overall Study|PD|1|||
156795410|NCT03440411|566004223|FG003|Overall Study|PD|1|||
156795411|NCT03440411|566004220|FG000|Overall Study|Withdrawal by Subject|1|||
156795412|NCT03440411|566004221|FG001|Overall Study|Withdrawal by Subject|0|||
156795413|NCT03440411|566004222|FG002|Overall Study|Withdrawal by Subject|0|||
156795414|NCT03440411|566004223|FG003|Overall Study|Withdrawal by Subject|0|||
156795415|NCT03440411|566004220|FG000|Overall Study|Closed study by sponsor|0|||
156795416|NCT03440411|566004221|FG001|Overall Study|Closed study by sponsor|0|||
156795417|NCT03440411|566004222|FG002|Overall Study|Closed study by sponsor|0|||
156795418|NCT03440411|566004223|FG003|Overall Study|Closed study by sponsor|1|||
156795419|NCT00856557|566004224|FG000|Overall Study|No patients with contextual flags|12|||
156795420|NCT00856557|566004225|FG001|Overall Study|No patients with contextual flags|16|||
156795421|NCT03673176|566004226|FG000|Overall Study|Death prior to intervention|1|||
156795422|NCT03673176|566004226|FG000|Overall Study|Death following intervention|3|||
156795423|NCT03673176|566004226|FG000|Overall Study|Withdrawal by Subject|1|||
156795424|NCT02301897|566004227|FG000|Treatment Course 1|Non-Compliance|0|||
156795425|NCT02301897|566004228|FG001|Treatment Course 1|Non-Compliance|0|||
156795426|NCT02301897|566004229|FG002|Treatment Course 1|Non-Compliance|1|||
156795427|NCT02301897|566004227|FG000|Treatment Course 1|Adverse Event|1|||
156795428|NCT02301897|566004228|FG001|Treatment Course 1|Adverse Event|1|||
156795429|NCT02301897|566004229|FG002|Treatment Course 1|Adverse Event|0|||
156795430|NCT02301897|566004227|FG000|Treatment Course 1|Lost to Follow-up|1|||
156795431|NCT02301897|566004228|FG001|Treatment Course 1|Lost to Follow-up|2|||
156795432|NCT02301897|566004229|FG002|Treatment Course 1|Lost to Follow-up|1|||
157137848|NCT00506389|567252055|FG002|In-treatment Period|Reasons not related to trial|0|||
157137849|NCT00506389|567252053|FG000|In-treatment Period|Withdrawal by Subject|3|||
157137850|NCT00506389|567252054|FG001|In-treatment Period|Withdrawal by Subject|3|||
156726108|NCT04630002|565744422|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156726109|NCT04630002|565744420|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726110|NCT04630002|565744421|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
156726111|NCT04630002|565744422|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
156726112|NCT04630002|565744420|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156726113|NCT04630002|565744421|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
156726114|NCT04630002|565744422|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
156795433|NCT02301897|566004227|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
156876024|NCT01925131|566305705|FG000|Overall Study|Adverse Event|0|||
156876025|NCT01925131|566305706|FG001|Overall Study|Adverse Event|0|||
156876026|NCT01925131|566305707|FG002|Overall Study|Adverse Event|2|||
156876027|NCT01925131|566305708|FG003|Overall Study|Adverse Event|0|||
156876028|NCT01925131|566305709|FG004|Overall Study|Adverse Event|1|||
156876029|NCT01925131|566305710|FG005|Overall Study|Adverse Event|3|||
156876030|NCT01925131|566305705|FG000|Overall Study|Other - Not Protocol Specified|3|||
156876031|NCT01925131|566305706|FG001|Overall Study|Other - Not Protocol Specified|1|||
156876032|NCT01925131|566305707|FG002|Overall Study|Other - Not Protocol Specified|2|||
156876033|NCT01925131|566305708|FG003|Overall Study|Other - Not Protocol Specified|5|||
156876034|NCT01925131|566305709|FG004|Overall Study|Other - Not Protocol Specified|10|||
156876035|NCT01925131|566305710|FG005|Overall Study|Other - Not Protocol Specified|6|||
156876036|NCT01657461|566305711|FG000|Overall Study|Death|9|||
156876037|NCT01657461|566305712|FG001|Overall Study|Death|12|||
156876038|NCT01657461|566305711|FG000|Overall Study|Lost to Follow-up|0|||
156876039|NCT01657461|566305712|FG001|Overall Study|Lost to Follow-up|3|||
156876040|NCT01657461|566305711|FG000|Overall Study|Physician Decision|0|||
156876041|NCT01657461|566305712|FG001|Overall Study|Physician Decision|2|||
156876042|NCT01657461|566305711|FG000|Overall Study|Withdrawal by Subject|1|||
156876043|NCT01657461|566305712|FG001|Overall Study|Withdrawal by Subject|3|||
156876044|NCT00122980|566305717|FG000|Overall Study|Death|0|||
156876045|NCT00122980|566305718|FG001|Overall Study|Death|1|||
156876046|NCT00122980|566305717|FG000|Overall Study|Physician Decision|2|||
156876047|NCT00122980|566305718|FG001|Overall Study|Physician Decision|0|||
156876048|NCT00122980|566305717|FG000|Overall Study|Protocol Violation|5|||
156876049|NCT00122980|566305718|FG001|Overall Study|Protocol Violation|1|||
156876050|NCT00122980|566305717|FG000|Overall Study|Withdrawal by Subject|2|||
156876051|NCT00122980|566305718|FG001|Overall Study|Withdrawal by Subject|3|||
156876052|NCT00122980|566305717|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
156876053|NCT00122980|566305718|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
156876054|NCT00122980|566305717|FG000|Overall Study|Study termination|27|||
156876055|NCT00122980|566305718|FG001|Overall Study|Study termination|35|||
156876056|NCT02175199|566305719|FG000|Overall Study|Withdrawal by Subject|1|||
156876057|NCT02175199|566305720|FG001|Overall Study|Withdrawal by Subject|5|||
156876058|NCT02175199|566305719|FG000|Overall Study|Randomized in Error|1|||
156876059|NCT02175199|566305720|FG001|Overall Study|Randomized in Error|0|||
156876060|NCT02175199|566305719|FG000|Overall Study|Sponsor Decision|1|||
156876061|NCT02175199|566305720|FG001|Overall Study|Sponsor Decision|0|||
156876062|NCT01124864|566305723|FG000|Overall Study|Follow up phase competed as per protocol|18|||
156876063|NCT01124864|566305724|FG001|Overall Study|Follow up phase competed as per protocol|22|||
156876064|NCT01124864|566305725|FG002|Overall Study|Follow up phase competed as per protocol|24|||
156876065|NCT01124864|566305726|FG003|Overall Study|Follow up phase competed as per protocol|18|||
156876066|NCT01124864|566305727|FG004|Overall Study|Follow up phase competed as per protocol|26|||
156876067|NCT01124864|566305728|FG005|Overall Study|Follow up phase competed as per protocol|2|||
156876068|NCT01124864|566305723|FG000|Overall Study|Death|6|||
156876069|NCT01124864|566305724|FG001|Overall Study|Death|9|||
156876070|NCT01124864|566305725|FG002|Overall Study|Death|6|||
156876071|NCT01124864|566305726|FG003|Overall Study|Death|2|||
157019717|NCT04088630|566826465|FG002|Overall Study|Lost to Follow-up|6|||
157019718|NCT04088630|566826463|FG000|Overall Study|Death|3|||
157019719|NCT04088630|566826464|FG001|Overall Study|Death|1|||
156726115|NCT04630002|565744420|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156795434|NCT02301897|566004228|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
156795435|NCT02301897|566004229|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
156795436|NCT02301897|566004227|FG000|Treatment Course 1|Withdrawal by Subject|0|||
156795437|NCT02301897|566004228|FG001|Treatment Course 1|Withdrawal by Subject|0|||
156795438|NCT02301897|566004229|FG002|Treatment Course 1|Withdrawal by Subject|2|||
156795439|NCT02301897|566004227|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
156795440|NCT02301897|566004228|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
156795441|NCT02301897|566004229|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
156876072|NCT01124864|566305727|FG004|Overall Study|Death|1|||
156876073|NCT01124864|566305728|FG005|Overall Study|Death|0|||
156876074|NCT01124864|566305723|FG000|Overall Study|Withdrawal by Subject|2|||
157019720|NCT04088630|566826465|FG002|Overall Study|Death|1|||
157137851|NCT00506389|567252055|FG002|In-treatment Period|Withdrawal by Subject|4|||
157137852|NCT00506389|567252053|FG000|In-treatment Period|Lack of Efficacy|0|||
157137853|NCT00506389|567252054|FG001|In-treatment Period|Lack of Efficacy|2|||
157137854|NCT00506389|567252055|FG002|In-treatment Period|Lack of Efficacy|0|||
157137855|NCT00506389|567252053|FG000|In-treatment Period|Adverse Event|11|||
157137856|NCT00506389|567252054|FG001|In-treatment Period|Adverse Event|5|||
157137857|NCT00506389|567252055|FG002|In-treatment Period|Adverse Event|2|||
157137858|NCT00506389|567252053|FG000|In-treatment Period|Randomized but not treated|4|||
157137859|NCT00506389|567252054|FG001|In-treatment Period|Randomized but not treated|1|||
157137860|NCT00506389|567252055|FG002|In-treatment Period|Randomized but not treated|1|||
157137861|NCT03095703|567252058|FG000|Overall Study|Withdrawal by Subject|1|||
157137862|NCT03539432|567252059|FG000|Overall Study|Lost to Follow-up|0|||
157137863|NCT03539432|567252060|FG001|Overall Study|Lost to Follow-up|1|||
157137864|NCT01381094|567252061|FG000|Overall Study|Adverse Event|1|||
157137865|NCT01381094|567252062|FG001|Overall Study|Adverse Event|2|||
157137866|NCT01381094|567252063|FG002|Overall Study|Adverse Event|0|||
157137867|NCT01381094|567252064|FG003|Overall Study|Adverse Event|1|||
157137868|NCT01381094|567252065|FG004|Overall Study|Adverse Event|0|||
157137869|NCT01381094|567252061|FG000|Overall Study|Lost to Follow-up|0|||
157137870|NCT01381094|567252062|FG001|Overall Study|Lost to Follow-up|0|||
157137871|NCT01381094|567252063|FG002|Overall Study|Lost to Follow-up|0|||
157137872|NCT01381094|567252064|FG003|Overall Study|Lost to Follow-up|0|||
157137873|NCT01381094|567252065|FG004|Overall Study|Lost to Follow-up|1|||
157137874|NCT01381094|567252061|FG000|Overall Study|Withdrawal of informed consent|0|||
157137875|NCT01381094|567252062|FG001|Overall Study|Withdrawal of informed consent|1|||
157137876|NCT01381094|567252063|FG002|Overall Study|Withdrawal of informed consent|0|||
157137877|NCT01381094|567252064|FG003|Overall Study|Withdrawal of informed consent|0|||
157137878|NCT01381094|567252065|FG004|Overall Study|Withdrawal of informed consent|0|||
157137879|NCT01381094|567252061|FG000|Overall Study|Participant given Aranesp injection|1|||
157137880|NCT01381094|567252062|FG001|Overall Study|Participant given Aranesp injection|0|||
157137881|NCT01381094|567252063|FG002|Overall Study|Participant given Aranesp injection|0|||
157137882|NCT01381094|567252064|FG003|Overall Study|Participant given Aranesp injection|0|||
157137883|NCT01381094|567252065|FG004|Overall Study|Participant given Aranesp injection|0|||
157137884|NCT02443402|567252070|FG000|Overall Study|Withdrawal by Subject|3|||
157137885|NCT02443402|567252071|FG001|Overall Study|Withdrawal by Subject|1|||
157137886|NCT02443402|567252070|FG000|Overall Study|Screen Failure|1|||
157137887|NCT02443402|567252071|FG001|Overall Study|Screen Failure|2|||
157137888|NCT01934504|567252073|FG000|Overall Study|Protocol Deviation|0|||
157137889|NCT01934504|567252074|FG001|Overall Study|Protocol Deviation|0|||
157137890|NCT01934504|567252075|FG002|Overall Study|Protocol Deviation|0|||
157137891|NCT01934504|567252076|FG003|Overall Study|Protocol Deviation|2|||
157137892|NCT01934504|567252073|FG000|Overall Study|Study Terminated by Sponsor|1|||
156726116|NCT04630002|565744421|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
156726117|NCT04630002|565744422|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
156726118|NCT04630002|565744420|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
156726119|NCT04630002|565744421|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
156726120|NCT04630002|565744422|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
156726121|NCT04630002|565744420|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
156726122|NCT04630002|565744421|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
157137893|NCT01934504|567252074|FG001|Overall Study|Study Terminated by Sponsor|0|||
157137894|NCT01934504|567252075|FG002|Overall Study|Study Terminated by Sponsor|5|||
157217345|NCT00331630|567543211|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
156726123|NCT04630002|565744422|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
156726124|NCT01372618|565744427|FG000|Overall Study|PI Died. Study Terminated|9|||
156726125|NCT03448419|565744437|FG000|Overall Study|Adverse Event|10|||
156726126|NCT03448419|565744438|FG001|Overall Study|Adverse Event|9|||
156726127|NCT03448419|565744437|FG000|Overall Study|Lost to Follow-up|0|||
156726128|NCT03448419|565744438|FG001|Overall Study|Lost to Follow-up|2|||
156726129|NCT03448419|565744437|FG000|Overall Study|Withdrawal by Subject|3|||
156726130|NCT03448419|565744438|FG001|Overall Study|Withdrawal by Subject|1|||
156726131|NCT03448419|565744437|FG000|Overall Study|Not treated|0|||
156726132|NCT03448419|565744438|FG001|Overall Study|Not treated|1|||
156726133|NCT03448419|565744437|FG000|Overall Study|Patient did not attend all visits|0|||
156726134|NCT03448419|565744438|FG001|Overall Study|Patient did not attend all visits|2|||
157217346|NCT00331630|567543211|FG000|Follow up for 5 Years|Death|5|||
157217347|NCT00331630|567543211|FG000|Follow up for 5 Years|Data collection was stopped|24|||
156726135|NCT03448419|565744437|FG000|Overall Study|Withdrawn by Sponsor|0|||
156726136|NCT03448419|565744438|FG001|Overall Study|Withdrawn by Sponsor|1|||
156726137|NCT04548193|565744440|FG000|Overall Study|Lost to Follow-up|0|||
156726138|NCT04548193|565744441|FG001|Overall Study|Lost to Follow-up|1|||
156726139|NCT04548193|565744440|FG000|Overall Study|Death|0|||
157137895|NCT01934504|567252076|FG003|Overall Study|Study Terminated by Sponsor|5|||
157137896|NCT02665689|567252077|FG000|Overall Study|Adverse Event|1|||
157137897|NCT02665689|567252078|FG001|Overall Study|Adverse Event|0|||
157137898|NCT02665689|567252077|FG000|Overall Study|Trial termination|1|||
157137899|NCT02665689|567252078|FG001|Overall Study|Trial termination|1|||
157137900|NCT02665689|567252077|FG000|Overall Study|Lost to Follow-up|0|||
157137901|NCT02665689|567252078|FG001|Overall Study|Lost to Follow-up|1|||
157137902|NCT00824564|567252079|FG000|Overall Study|Lost to Follow-up|5|||
156726140|NCT04548193|565744441|FG001|Overall Study|Death|1|||
156726141|NCT04548193|565744440|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
156726142|NCT04548193|565744441|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
156726143|NCT04548193|565744440|FG000|Overall Study|Withdrawal by Subject|2|||
156726144|NCT04548193|565744441|FG001|Overall Study|Withdrawal by Subject|2|||
156726145|NCT00630825|565744442|FG000|Overall Study|Adverse Event|4|||
156726146|NCT00630825|565744443|FG001|Overall Study|Adverse Event|4|||
156726147|NCT00630825|565744444|FG002|Overall Study|Adverse Event|3|||
156726148|NCT00630825|565744445|FG003|Overall Study|Adverse Event|1|||
156726149|NCT00630825|565744442|FG000|Overall Study|Entry Criteria Not Met|1|||
156726150|NCT00630825|565744443|FG001|Overall Study|Entry Criteria Not Met|0|||
156726151|NCT00630825|565744444|FG002|Overall Study|Entry Criteria Not Met|2|||
156726152|NCT00630825|565744445|FG003|Overall Study|Entry Criteria Not Met|1|||
157137903|NCT00824564|567252080|FG001|Overall Study|Lost to Follow-up|7|||
157137904|NCT00824564|567252079|FG000|Overall Study|Withdrawal by Subject|1|||
157137905|NCT00824564|567252080|FG001|Overall Study|Withdrawal by Subject|1|||
157137906|NCT00824564|567252079|FG000|Overall Study|Other|1|||
157137907|NCT00824564|567252080|FG001|Overall Study|Other|2|||
157137908|NCT00824564|567252079|FG000|Overall Study|Randomized, but not treated|1|||
157137909|NCT00824564|567252080|FG001|Overall Study|Randomized, but not treated|0|||
157137910|NCT00996840|567252089|FG000|Overall Study|Adverse Event|0|||
157137911|NCT00996840|567252090|FG001|Overall Study|Adverse Event|1|||
157217348|NCT01133821|567543212|FG000|Overall Study|Lost to Follow-up|8|||
156726153|NCT00630825|565744442|FG000|Overall Study|Lost to Follow-up|1|||
156726154|NCT00630825|565744443|FG001|Overall Study|Lost to Follow-up|1|||
156726155|NCT00630825|565744444|FG002|Overall Study|Lost to Follow-up|1|||
156726156|NCT00630825|565744445|FG003|Overall Study|Lost to Follow-up|1|||
156726157|NCT00630825|565744442|FG000|Overall Study|Physician Decision|1|||
156726158|NCT00630825|565744443|FG001|Overall Study|Physician Decision|0|||
156726159|NCT00630825|565744444|FG002|Overall Study|Physician Decision|0|||
156726160|NCT00630825|565744445|FG003|Overall Study|Physician Decision|0|||
156726161|NCT00630825|565744442|FG000|Overall Study|Withdrawal by Subject|2|||
156726162|NCT00630825|565744443|FG001|Overall Study|Withdrawal by Subject|2|||
156726163|NCT00630825|565744444|FG002|Overall Study|Withdrawal by Subject|2|||
156726164|NCT00630825|565744445|FG003|Overall Study|Withdrawal by Subject|3|||
156726165|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
156726166|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
156726167|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
156726168|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
156726169|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
156726170|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
156726171|NCT01081769|565744448|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
156726172|NCT01081769|565744449|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
156726173|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Adverse Event|14|||
156726174|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Adverse Event|11|||
156726175|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Death|1|||
156726176|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Death|1|||
156726177|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
156726178|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
156726179|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
156726180|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
156726181|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Pregnancy|1|||
156726182|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Pregnancy|0|||
156726183|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
156726184|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
156726185|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
156726186|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
156726187|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Other|0|||
156726188|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Other|1|||
156795442|NCT02301897|566004227|FG000|Treatment Course 2|Lost to Follow-up|0|||
156795443|NCT02301897|566004228|FG001|Treatment Course 2|Lost to Follow-up|2|||
156726189|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Ineligibility|3|||
156726190|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Ineligibility|4|||
156726191|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
156726192|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
156726193|NCT01081769|565744448|FG000|CORE Intent-To-Treat|Patient Moved|2|||
156726194|NCT01081769|565744449|FG001|CORE Intent-To-Treat|Patient Moved|2|||
156795444|NCT02301897|566004229|FG002|Treatment Course 2|Lost to Follow-up|0|||
157137912|NCT00996840|567252091|FG002|Overall Study|Adverse Event|0|||
157137913|NCT00996840|567252092|FG003|Overall Study|Adverse Event|0|||
157137914|NCT00996840|567252093|FG004|Overall Study|Adverse Event|0|||
157137915|NCT00996840|567252089|FG000|Overall Study|Physician Decision|0|||
157137916|NCT00996840|567252090|FG001|Overall Study|Physician Decision|0|||
157137917|NCT00996840|567252091|FG002|Overall Study|Physician Decision|1|||
157137918|NCT00996840|567252092|FG003|Overall Study|Physician Decision|1|||
157137919|NCT00996840|567252093|FG004|Overall Study|Physician Decision|2|||
156726195|NCT03309943|565744450|FG000|Overall Study|Withdrawal by Subject|0|||
156726196|NCT03309943|565744451|FG001|Overall Study|Withdrawal by Subject|1|||
156726197|NCT03309943|565744450|FG000|Overall Study|Inappropriate behavior towards staff|0|||
156726198|NCT03309943|565744451|FG001|Overall Study|Inappropriate behavior towards staff|1|||
156726199|NCT04926831|565744455|FG000|Overall Study|Withdrawal by Subject|2|||
156726200|NCT04926831|565744455|FG000|Overall Study|Adverse Event|2|||
156726201|NCT01804946|565744462|FG000|Overall Study|Protocol Violation|1|||
156726202|NCT01804946|565744463|FG001|Overall Study|Protocol Violation|0|||
156726203|NCT01804946|565744462|FG000|Overall Study|Adverse Event|0|||
156726204|NCT01804946|565744463|FG001|Overall Study|Adverse Event|1|||
156726205|NCT01804946|565744462|FG000|Overall Study|Insufficient data available|0|||
156726206|NCT01804946|565744463|FG001|Overall Study|Insufficient data available|1|||
156726207|NCT01804946|565744462|FG000|Overall Study|Do not meet inclusion criteria|1|||
156726208|NCT01804946|565744463|FG001|Overall Study|Do not meet inclusion criteria|2|||
156726209|NCT00722137|565744466|FG000|Overall Study|Overt Disease Progression|5|||
156726210|NCT00722137|565744467|FG001|Overall Study|Overt Disease Progression|4|||
156726211|NCT00722137|565744466|FG000|Overall Study|Adverse Event|17|||
156726212|NCT00722137|565744467|FG001|Overall Study|Adverse Event|21|||
156726213|NCT00722137|565744466|FG000|Overall Study|Death|12|||
156726214|NCT00722137|565744467|FG001|Overall Study|Death|7|||
156726215|NCT00722137|565744466|FG000|Overall Study|Withdrawal by Subject|6|||
156726216|NCT00722137|565744467|FG001|Overall Study|Withdrawal by Subject|9|||
156726217|NCT00722137|565744466|FG000|Overall Study|Other Reason Unknown|3|||
156726218|NCT00722137|565744467|FG001|Overall Study|Other Reason Unknown|4|||
156795445|NCT02301897|566004227|FG000|Treatment Course 2|Pregnancy|0|||
156795446|NCT02301897|566004228|FG001|Treatment Course 2|Pregnancy|1|||
156795447|NCT02301897|566004229|FG002|Treatment Course 2|Pregnancy|1|||
156795448|NCT02301897|566004227|FG000|Treatment Course 2|Withdrawal by Subject|0|||
156795449|NCT02301897|566004228|FG001|Treatment Course 2|Withdrawal by Subject|2|||
156795450|NCT02301897|566004229|FG002|Treatment Course 2|Withdrawal by Subject|0|||
156795451|NCT02301897|566004227|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
156795452|NCT02301897|566004228|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
156795453|NCT02301897|566004229|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
156795454|NCT00337168|566004230|FG000|Overall Study|Death|5|||
156795455|NCT00337168|566004230|FG000|Overall Study|Not protocol specified|2|||
156795456|NCT00337168|566004230|FG000|Overall Study|Did not start therapy|1|||
156795457|NCT01230060|566004234|FG000|Overall Study|Withdrawal by Subject|1|||
156795458|NCT01052779|566004236|FG000|Overall Study|Adverse Event|1|||
156795459|NCT01052779|566004237|FG001|Overall Study|Adverse Event|4|||
156795460|NCT01052779|566004236|FG000|Overall Study|Withdrawal by Subject|1|||
156795461|NCT01052779|566004237|FG001|Overall Study|Withdrawal by Subject|2|||
156795462|NCT01052779|566004236|FG000|Overall Study|Other-Protocol Violation|1|||
156795463|NCT01052779|566004237|FG001|Overall Study|Other-Protocol Violation|1|||
156795464|NCT01052779|566004236|FG000|Overall Study|Other-Surgery|0|||
156795465|NCT01052779|566004237|FG001|Overall Study|Other-Surgery|2|||
156795466|NCT01052779|566004236|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
156795467|NCT01052779|566004237|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
156795468|NCT03802916|566004238|FG000|Overall Study|Adverse Event|0|||
156795469|NCT03802916|566004239|FG001|Overall Study|Adverse Event|1|||
156795470|NCT03802916|566004238|FG000|Overall Study|Withdrawal by Subject|0|||
156795471|NCT03802916|566004239|FG001|Overall Study|Withdrawal by Subject|1|||
156795472|NCT03663582|566004240|FG000|Overall Study|Physician Decision|1|||
156795473|NCT01285102|566004241|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
156795474|NCT03524157|566004251|FG000|Overall Study|cytology not readable|0|||
156795475|NCT03524157|566004252|FG001|Overall Study|cytology not readable|0|||
156795476|NCT03524157|566004253|FG002|Overall Study|cytology not readable|1|||
156795477|NCT04507763|566004254|FG000|Overall Study|Participants did not meet entrance criteria|201|||
157137920|NCT00996840|567252089|FG000|Overall Study|Withdrawal by Subject|1|||
156795478|NCT03322566|566004255|FG000|Overall Study|Death|34|||
156795479|NCT03322566|566004256|FG001|Overall Study|Death|35|||
157137921|NCT00996840|567252090|FG001|Overall Study|Withdrawal by Subject|1|||
156726219|NCT00722137|565744466|FG000|Overall Study|Randomized But Not Treated|2|||
156726220|NCT00722137|565744467|FG001|Overall Study|Randomized But Not Treated|3|||
156726221|NCT03830333|565744468|FG000|Overall Study|Death|0|||
156726222|NCT03830333|565744469|FG001|Overall Study|Death|1|||
156795480|NCT03322566|566004257|FG002|Overall Study|Death|23|||
156795481|NCT03322566|566004255|FG000|Overall Study|Physician Decision|6|||
156795482|NCT03322566|566004256|FG001|Overall Study|Physician Decision|7|||
156795483|NCT03322566|566004257|FG002|Overall Study|Physician Decision|2|||
156795484|NCT03322566|566004255|FG000|Overall Study|Withdrawal by Subject|4|||
156795485|NCT03322566|566004256|FG001|Overall Study|Withdrawal by Subject|3|||
157137922|NCT00996840|567252091|FG002|Overall Study|Withdrawal by Subject|0|||
156795486|NCT03322566|566004257|FG002|Overall Study|Withdrawal by Subject|6|||
156795487|NCT03322566|566004255|FG000|Overall Study|Lost to Follow-up|0|||
156795488|NCT03322566|566004256|FG001|Overall Study|Lost to Follow-up|0|||
156795489|NCT03322566|566004257|FG002|Overall Study|Lost to Follow-up|1|||
156795490|NCT03322566|566004255|FG000|Overall Study|Study terminated by sponsor|1|||
156795491|NCT03322566|566004256|FG001|Overall Study|Study terminated by sponsor|0|||
156795492|NCT03322566|566004257|FG002|Overall Study|Study terminated by sponsor|1|||
156795493|NCT03427619|566004258|FG000|Overall Study|Physician Decision|3|||
156795494|NCT03427619|566004258|FG000|Overall Study|Withdrawal by Subject|4|||
156795495|NCT03427619|566004258|FG000|Overall Study|Lost to Follow-up|5|||
156795496|NCT03427619|566004258|FG000|Overall Study|Administrative|4|||
156795497|NCT03427619|566004258|FG000|Overall Study|Other|2|||
156795498|NCT03427619|566004258|FG000|Overall Study|Unknown or Missing Completion Status|48|||
156795499|NCT05763381|566004259|FG000|Overall Study|Lost to Follow-up|2|||
156795500|NCT05763381|566004260|FG001|Overall Study|Lost to Follow-up|3|||
156795501|NCT05763381|566004259|FG000|Overall Study|Withdrawal by Subject|1|||
156795502|NCT05763381|566004260|FG001|Overall Study|Withdrawal by Subject|2|||
156795503|NCT02853136|566004261|FG000|Wash-out|Adverse Event|0|||
156795504|NCT02853136|566004262|FG001|Wash-out|Adverse Event|0|||
156795505|NCT02853136|566004263|FG002|Wash-out|Adverse Event|0|||
156795506|NCT02853136|566004264|FG003|Wash-out|Adverse Event|1|||
156795507|NCT00841815|566004265|FG000|Washout|Withdrawal by Subject|0|||
156795508|NCT00841815|566004266|FG001|Washout|Withdrawal by Subject|1|||
156795509|NCT03729609|566004267|FG000|Overall Study|Protocol Violation|1|||
156795510|NCT00605189|566004273|FG000|Overall Study|Adverse Event|1|||
156795511|NCT00605189|566004274|FG001|Overall Study|Adverse Event|0|||
156795512|NCT00605189|566004275|FG002|Overall Study|Adverse Event|0|||
156795513|NCT00605189|566004273|FG000|Overall Study|Other|2|||
156795514|NCT00605189|566004274|FG001|Overall Study|Other|2|||
156795515|NCT00605189|566004275|FG002|Overall Study|Other|0|||
156795516|NCT02014376|566004278|FG000|Overall Study|Adverse Event|1|||
156795517|NCT02014376|566004279|FG001|Overall Study|Adverse Event|1|||
156795518|NCT02014376|566004280|FG002|Overall Study|Adverse Event|0|||
156795519|NCT02014376|566004278|FG000|Overall Study|Lost to Follow-up|2|||
156795520|NCT02014376|566004279|FG001|Overall Study|Lost to Follow-up|0|||
156795521|NCT02014376|566004280|FG002|Overall Study|Lost to Follow-up|0|||
156726223|NCT03830333|565744468|FG000|Overall Study|Withdrawal by Subject|5|||
156726224|NCT03830333|565744469|FG001|Overall Study|Withdrawal by Subject|1|||
156726225|NCT03830333|565744468|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
156726226|NCT03830333|565744469|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
156726227|NCT01367886|565744470|FG000|Overall Study|Lost to Follow-up|4|||
156726228|NCT01367886|565744470|FG000|Overall Study|Lack of Efficacy|2|||
157137923|NCT00996840|567252092|FG003|Overall Study|Withdrawal by Subject|0|||
157137924|NCT00996840|567252093|FG004|Overall Study|Withdrawal by Subject|0|||
157137925|NCT00603239|567252094|FG000|Overall Study|Adverse Event|4|||
157137926|NCT00603239|567252095|FG001|Overall Study|Adverse Event|1|||
157137927|NCT00603239|567252094|FG000|Overall Study|Entry criteria not met|0|||
157137928|NCT00603239|567252095|FG001|Overall Study|Entry criteria not met|1|||
156726229|NCT01367886|565744470|FG000|Overall Study|Death|1|||
156726230|NCT00985504|565744477|FG000|Acute Treatment Period|Adverse Event|3|||
156726231|NCT00985504|565744478|FG001|Acute Treatment Period|Adverse Event|4|||
156726232|NCT00985504|565744477|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
156726233|NCT00985504|565744478|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
156726234|NCT00985504|565744477|FG000|Acute Treatment Period|Protocol Violation|2|||
156726235|NCT00985504|565744478|FG001|Acute Treatment Period|Protocol Violation|0|||
156726236|NCT00985504|565744477|FG000|Acute Treatment Period|Sponsor Decision|0|||
156726237|NCT00985504|565744478|FG001|Acute Treatment Period|Sponsor Decision|1|||
156726238|NCT00985504|565744477|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
156726239|NCT00985504|565744478|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
156726240|NCT00985504|565744477|FG000|Optimization Period|Adverse Event|7|||
156726241|NCT00985504|565744478|FG001|Optimization Period|Adverse Event|9|||
156795522|NCT03034044|566004281|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
157137929|NCT00603239|567252094|FG000|Overall Study|Loss of glucose control|3|||
157137930|NCT00603239|567252095|FG001|Overall Study|Loss of glucose control|0|||
157137931|NCT00603239|567252094|FG000|Overall Study|Lost to Follow-up|2|||
156726242|NCT00985504|565744477|FG000|Optimization Period|Death|0|||
156726243|NCT00985504|565744478|FG001|Optimization Period|Death|1|||
156795523|NCT04134936|566004282|FG000|Overall Study|Adverse Event|3|||
156795524|NCT04134936|566004283|FG001|Overall Study|Adverse Event|2|||
156795525|NCT04134936|566004282|FG000|Overall Study|Withdrawal by Subject|2|||
156795526|NCT04134936|566004283|FG001|Overall Study|Withdrawal by Subject|3|||
156795527|NCT04134936|566004282|FG000|Overall Study|Physician Decision|0|||
156795528|NCT04134936|566004283|FG001|Overall Study|Physician Decision|1|||
156795529|NCT04134936|566004282|FG000|Overall Study|Progressive disease, joined another trial|1|||
156795530|NCT04134936|566004283|FG001|Overall Study|Progressive disease, joined another trial|0|||
157137932|NCT00603239|567252095|FG001|Overall Study|Lost to Follow-up|1|||
157137933|NCT00603239|567252094|FG000|Overall Study|Physician Decision|2|||
156726244|NCT00985504|565744477|FG000|Optimization Period|Lack of Efficacy|5|||
156726245|NCT00985504|565744478|FG001|Optimization Period|Lack of Efficacy|3|||
156726246|NCT00985504|565744477|FG000|Optimization Period|Lost to Follow-up|0|||
156726247|NCT00985504|565744478|FG001|Optimization Period|Lost to Follow-up|1|||
156726248|NCT00985504|565744477|FG000|Optimization Period|Physician Decision|1|||
156726249|NCT00985504|565744478|FG001|Optimization Period|Physician Decision|0|||
156726250|NCT00985504|565744477|FG000|Optimization Period|Protocol Violation|3|||
156726251|NCT00985504|565744478|FG001|Optimization Period|Protocol Violation|1|||
156726252|NCT00985504|565744477|FG000|Optimization Period|Withdrawal by Subject|10|||
156726253|NCT00985504|565744478|FG001|Optimization Period|Withdrawal by Subject|8|||
156726254|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
156726255|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
156726256|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
156726257|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
156726258|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
156726259|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
156726260|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
156726261|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
156726262|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
156726263|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
156726264|NCT03711786|565744479|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
156726265|NCT03711786|565744480|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
156726266|NCT03379727|565744481|FG000|Overall Study|Lack of Efficacy|73|||
156726267|NCT03379727|565744481|FG000|Overall Study|Adverse Event|32|||
156726268|NCT03379727|565744481|FG000|Overall Study|Death|18|||
156726269|NCT03379727|565744481|FG000|Overall Study|Patient/guardian decision|17|||
156726270|NCT03379727|565744481|FG000|Overall Study|Physician Decision|104|||
156726271|NCT03379727|565744481|FG000|Overall Study|Protocol Violation|4|||
156726272|NCT03379727|565744481|FG000|Overall Study|Lost to Follow-up|1|||
156726273|NCT00030901|565744485|FG000|Initial Registration|Ineligible|167|||
156726274|NCT00030901|565744486|FG001|Initial Registration|Ineligible|0|||
156726275|NCT00030901|565744487|FG002|Initial Registration|Ineligible|0|||
156726276|NCT00030901|565744485|FG000|Randomization|Adverse Event|0|||
156726277|NCT00030901|565744486|FG001|Randomization|Adverse Event|11|||
156726278|NCT00030901|565744487|FG002|Randomization|Adverse Event|7|||
156726279|NCT00030901|565744485|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
156726280|NCT00030901|565744486|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
156726281|NCT00030901|565744487|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
156795531|NCT04134936|566004282|FG000|Overall Study|Progressive disease|1|||
156795532|NCT04134936|566004283|FG001|Overall Study|Progressive disease|0|||
156795533|NCT04629196|566004284|FG000|Overall Study|Subject discontinued study drug|1|||
156795534|NCT04629196|566004285|FG001|Overall Study|Subject discontinued study drug|0|||
157137934|NCT00603239|567252095|FG001|Overall Study|Physician Decision|0|||
157137935|NCT00603239|567252094|FG000|Overall Study|Protocol Violation|2|||
157137936|NCT00603239|567252095|FG001|Overall Study|Protocol Violation|0|||
157137937|NCT00603239|567252094|FG000|Overall Study|Subject decision|2|||
157137938|NCT00603239|567252095|FG001|Overall Study|Subject decision|1|||
157137939|NCT02292849|567252096|FG000|Overall Study|Lost to Follow-up|0|||
157137940|NCT02292849|567252097|FG001|Overall Study|Lost to Follow-up|2|||
157137941|NCT02292849|567252098|FG002|Overall Study|Lost to Follow-up|2|||
157137942|NCT02292849|567252096|FG000|Overall Study|Physician Decision|4|||
157137943|NCT02292849|567252097|FG001|Overall Study|Physician Decision|0|||
157137944|NCT02292849|567252098|FG002|Overall Study|Physician Decision|0|||
157137945|NCT01562028|567252100|FG000|Overall Study|Withdrawal by Subject|1|||
157137946|NCT01562028|567252101|FG001|Overall Study|Withdrawal by Subject|1|||
157137947|NCT01562028|567252100|FG000|Overall Study|Lost to Follow-up|2|||
157137948|NCT01562028|567252101|FG001|Overall Study|Lost to Follow-up|1|||
157137949|NCT00097539|567252102|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
157137950|NCT00097539|567252103|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
157137951|NCT00097539|567252104|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
157137952|NCT00097539|567252105|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
157137953|NCT00097539|567252106|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
157137954|NCT00097539|567252107|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
157137955|NCT00097539|567252108|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
156795535|NCT04629196|566004284|FG000|Overall Study|Subject study drug dosing increased|1|||
156795536|NCT04629196|566004285|FG001|Overall Study|Subject study drug dosing increased|1|||
157137956|NCT00097539|567252102|FG000|Overall Study|Withdrawal by Subject|925|||
156726282|NCT00030901|565744485|FG000|Randomization|Progression/Relapse|0|||
156795537|NCT04629196|566004284|FG000|Overall Study|Withdrawal by Subject|1|||
156795538|NCT04629196|566004285|FG001|Overall Study|Withdrawal by Subject|2|||
157019721|NCT04088630|566826463|FG000|Overall Study|Physician Decision|0|||
157137957|NCT00097539|567252103|FG001|Overall Study|Withdrawal by Subject|323|||
157137958|NCT00097539|567252104|FG002|Overall Study|Withdrawal by Subject|346|||
157137959|NCT00097539|567252105|FG003|Overall Study|Withdrawal by Subject|217|||
157137960|NCT00097539|567252106|FG004|Overall Study|Withdrawal by Subject|68|||
157137961|NCT00097539|567252107|FG005|Overall Study|Withdrawal by Subject|229|||
157137962|NCT00097539|567252108|FG006|Overall Study|Withdrawal by Subject|3|||
157137963|NCT00097539|567252102|FG000|Overall Study|Participant Non-compliant|2140|||
157137964|NCT00097539|567252103|FG001|Overall Study|Participant Non-compliant|567|||
157137965|NCT00097539|567252104|FG002|Overall Study|Participant Non-compliant|1067|||
157137966|NCT00097539|567252105|FG003|Overall Study|Participant Non-compliant|353|||
156726283|NCT00030901|565744486|FG001|Randomization|Progression/Relapse|22|||
156726284|NCT00030901|565744487|FG002|Randomization|Progression/Relapse|21|||
156726285|NCT00030901|565744485|FG000|Randomization|Death|0|||
156726286|NCT00030901|565744486|FG001|Randomization|Death|1|||
156726287|NCT00030901|565744487|FG002|Randomization|Death|3|||
156726288|NCT00030901|565744485|FG000|Randomization|Other|0|||
156726289|NCT00030901|565744486|FG001|Randomization|Other|36|||
156795539|NCT00323622|566004289|FG000|Overall Study|Other|30|||
156795540|NCT00323622|566004290|FG001|Overall Study|Other|91|||
156795541|NCT00323622|566004291|FG002|Overall Study|Other|4|||
157137967|NCT00097539|567252106|FG004|Overall Study|Participant Non-compliant|136|||
157137968|NCT00097539|567252107|FG005|Overall Study|Participant Non-compliant|543|||
157137969|NCT00097539|567252108|FG006|Overall Study|Participant Non-compliant|18|||
157137970|NCT00097539|567252102|FG000|Overall Study|Lack of Efficacy|249|||
157137971|NCT00097539|567252103|FG001|Overall Study|Lack of Efficacy|122|||
157137972|NCT00097539|567252104|FG002|Overall Study|Lack of Efficacy|202|||
157137973|NCT00097539|567252105|FG003|Overall Study|Lack of Efficacy|105|||
157137974|NCT00097539|567252106|FG004|Overall Study|Lack of Efficacy|45|||
157137975|NCT00097539|567252107|FG005|Overall Study|Lack of Efficacy|228|||
157137976|NCT00097539|567252108|FG006|Overall Study|Lack of Efficacy|5|||
157137977|NCT00097539|567252102|FG000|Overall Study|Adverse Event|78|||
157137978|NCT00097539|567252103|FG001|Overall Study|Adverse Event|133|||
157137979|NCT00097539|567252104|FG002|Overall Study|Adverse Event|37|||
157137980|NCT00097539|567252105|FG003|Overall Study|Adverse Event|27|||
157137981|NCT00097539|567252106|FG004|Overall Study|Adverse Event|30|||
157137982|NCT00097539|567252107|FG005|Overall Study|Adverse Event|59|||
157137983|NCT00097539|567252108|FG006|Overall Study|Adverse Event|1|||
157137984|NCT00097539|567252102|FG000|Overall Study|Death|2|||
157137985|NCT00097539|567252103|FG001|Overall Study|Death|7|||
157137986|NCT00097539|567252104|FG002|Overall Study|Death|0|||
157137987|NCT00097539|567252105|FG003|Overall Study|Death|0|||
157137988|NCT00097539|567252106|FG004|Overall Study|Death|1|||
157137989|NCT00097539|567252107|FG005|Overall Study|Death|3|||
157137990|NCT00097539|567252108|FG006|Overall Study|Death|0|||
157137991|NCT00097539|567252102|FG000|Overall Study|Reasons Other Than Above|3602|||
157137992|NCT00097539|567252103|FG001|Overall Study|Reasons Other Than Above|1382|||
156726290|NCT00030901|565744487|FG002|Randomization|Other|33|||
156795542|NCT00323622|566004292|FG003|Overall Study|Other|12|||
156795543|NCT00323622|566004293|FG004|Overall Study|Other|32|||
156795544|NCT00323622|566004294|FG005|Overall Study|Other|74|||
156795545|NCT00323622|566004295|FG006|Overall Study|Other|5|||
156795546|NCT00323622|566004296|FG007|Overall Study|Other|13|||
156795547|NCT00323622|566004289|FG000|Overall Study|Death|1|||
156795548|NCT00323622|566004290|FG001|Overall Study|Death|1|||
156795549|NCT00323622|566004291|FG002|Overall Study|Death|0|||
156795550|NCT00323622|566004292|FG003|Overall Study|Death|0|||
156795551|NCT00323622|566004293|FG004|Overall Study|Death|7|||
157137993|NCT00097539|567252104|FG002|Overall Study|Reasons Other Than Above|1757|||
157137994|NCT00097539|567252105|FG003|Overall Study|Reasons Other Than Above|692|||
157137995|NCT00097539|567252106|FG004|Overall Study|Reasons Other Than Above|361|||
157137996|NCT00097539|567252107|FG005|Overall Study|Reasons Other Than Above|1244|||
157137997|NCT00097539|567252108|FG006|Overall Study|Reasons Other Than Above|34|||
157137998|NCT00097539|567252102|FG000|Overall Study|Reason not Specified|111|||
157137999|NCT00097539|567252103|FG001|Overall Study|Reason not Specified|49|||
156726291|NCT00030901|565744485|FG000|Randomization|Ineligible|0|||
156795552|NCT00323622|566004294|FG005|Overall Study|Death|0|||
156795553|NCT00323622|566004295|FG006|Overall Study|Death|0|||
157138000|NCT00097539|567252104|FG002|Overall Study|Reason not Specified|53|||
157138001|NCT00097539|567252105|FG003|Overall Study|Reason not Specified|21|||
156726292|NCT00030901|565744486|FG001|Randomization|Ineligible|15|||
156795554|NCT00323622|566004296|FG007|Overall Study|Death|2|||
156795555|NCT03709472|566004303|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
157138002|NCT00097539|567252106|FG004|Overall Study|Reason not Specified|11|||
157138003|NCT00097539|567252107|FG005|Overall Study|Reason not Specified|40|||
156726293|NCT00030901|565744487|FG002|Randomization|Ineligible|14|||
156726294|NCT01806051|565744492|FG000|Overall Study|Withdrawal by Subject|6|||
156795556|NCT03709472|566004304|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
156795557|NCT03709472|566004303|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
156795558|NCT03709472|566004304|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
157138004|NCT00097539|567252108|FG006|Overall Study|Reason not Specified|2|||
157138005|NCT04938648|567252109|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
157138006|NCT04938648|567252110|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
157138007|NCT04938648|567252109|FG000|Overall Study|Patient too ill|0|||
157138008|NCT04938648|567252110|FG001|Overall Study|Patient too ill|1|||
157138009|NCT04938648|567252109|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
157138010|NCT04938648|567252110|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
157138011|NCT04938648|567252109|FG000|Overall Study|Patient did not have memory problems|1|||
157138012|NCT04938648|567252110|FG001|Overall Study|Patient did not have memory problems|1|||
157138013|NCT04938648|567252109|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
156726295|NCT02576847|565744493|FG000|Overall Study|Adverse Event|27|||
156726296|NCT02576847|565744493|FG000|Overall Study|Lost to Follow-up|22|||
156726297|NCT02576847|565744493|FG000|Overall Study|Physician Decision|1|||
156726298|NCT02576847|565744493|FG000|Overall Study|Pregnancy|1|||
156726299|NCT02576847|565744493|FG000|Overall Study|Protocol Violation|3|||
156726300|NCT02576847|565744493|FG000|Overall Study|Withdrawal by Subject|78|||
156726301|NCT02576847|565744493|FG000|Overall Study|Other|5|||
156726302|NCT02418182|565744494|FG000|Overall Study|Unable to re-consent|18|||
156726303|NCT02418182|565744495|FG001|Overall Study|Unable to re-consent|15|||
156726304|NCT02418182|565744494|FG000|Overall Study|Lost to Follow-up|0|||
156726305|NCT02418182|565744495|FG001|Overall Study|Lost to Follow-up|2|||
156726306|NCT01205776|565744496|FG000|Overall Study|Lost to Follow-up|53|||
156726307|NCT01205776|565744497|FG001|Overall Study|Lost to Follow-up|61|||
156726308|NCT01205776|565744496|FG000|Overall Study|Withdrawal by Subject|11|||
156726309|NCT01205776|565744497|FG001|Overall Study|Withdrawal by Subject|34|||
156876075|NCT01124864|566305724|FG001|Overall Study|Withdrawal by Subject|3|||
156876076|NCT01124864|566305725|FG002|Overall Study|Withdrawal by Subject|4|||
156876077|NCT01124864|566305726|FG003|Overall Study|Withdrawal by Subject|0|||
156876078|NCT01124864|566305727|FG004|Overall Study|Withdrawal by Subject|2|||
156876079|NCT01124864|566305728|FG005|Overall Study|Withdrawal by Subject|1|||
156876080|NCT01124864|566305723|FG000|Overall Study|Lost to Follow-up|1|||
156876081|NCT01124864|566305724|FG001|Overall Study|Lost to Follow-up|1|||
156876082|NCT01124864|566305725|FG002|Overall Study|Lost to Follow-up|0|||
156876083|NCT01124864|566305726|FG003|Overall Study|Lost to Follow-up|1|||
156876084|NCT01124864|566305727|FG004|Overall Study|Lost to Follow-up|0|||
156726310|NCT06360588|565746188|FG000|Overall Study|Adverse Event|3|||
156726311|NCT06360588|565746188|FG000|Overall Study|Death|2|||
156726312|NCT06360588|565746188|FG000|Overall Study|Disease Progression|14|||
156726313|NCT06360588|565746188|FG000|Overall Study|Withdrawal by Subject|1|||
156726314|NCT06360588|565746188|FG000|Overall Study|Lack of Efficacy|1|||
156726315|NCT06360588|565746188|FG000|Overall Study|Ineligible|1|||
156726316|NCT04010240|565746189|FG000|Overall Study|IHC not performed|2299|||
156726317|NCT00570687|565746190|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726318|NCT00570687|565746191|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726319|NCT00570687|565746192|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726320|NCT00570687|565746193|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726321|NCT00570687|565746194|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726322|NCT00570687|565746195|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726323|NCT00570687|565746196|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
156726324|NCT00570687|565746197|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726325|NCT00570687|565746198|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
156726326|NCT00570687|565746199|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
156726327|NCT00570687|565746190|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726328|NCT00570687|565746191|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726329|NCT00570687|565746192|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726330|NCT00570687|565746193|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726331|NCT00570687|565746194|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726332|NCT00570687|565746195|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726333|NCT00570687|565746196|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726334|NCT00570687|565746197|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726335|NCT00570687|565746198|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
156726336|NCT00570687|565746199|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726337|NCT00570687|565746190|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156876085|NCT01124864|566305728|FG005|Overall Study|Lost to Follow-up|0|||
156876086|NCT01124864|566305723|FG000|Overall Study|Protocol Violation|1|||
157138014|NCT04938648|567252110|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
157217349|NCT01133821|567543213|FG001|Overall Study|Lost to Follow-up|11|||
156726338|NCT00570687|565746191|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726339|NCT00570687|565746192|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726340|NCT00570687|565746193|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726341|NCT00570687|565746194|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156876087|NCT01124864|566305724|FG001|Overall Study|Protocol Violation|0|||
156876088|NCT01124864|566305725|FG002|Overall Study|Protocol Violation|0|||
156876089|NCT01124864|566305726|FG003|Overall Study|Protocol Violation|0|||
157138015|NCT04938648|567252109|FG000|Overall Study|Care partner could not be reached|0|||
157138016|NCT04938648|567252110|FG001|Overall Study|Care partner could not be reached|1|||
156726342|NCT00570687|565746195|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726343|NCT00570687|565746196|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
156726344|NCT00570687|565746197|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726345|NCT00570687|565746198|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726346|NCT00570687|565746199|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
156726347|NCT01540487|565746200|FG000|Overall Study|Protocol Violation|1|||
157138017|NCT04938648|567252109|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
157138018|NCT04938648|567252110|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
157138019|NCT04938648|567252109|FG000|Overall Study|Withdrawal by Subject|2|||
157138020|NCT04938648|567252110|FG001|Overall Study|Withdrawal by Subject|1|||
157138021|NCT05127486|567252111|FG000|Overall Study|Adverse Event|2|||
157138022|NCT05127486|567252112|FG001|Overall Study|Adverse Event|4|||
157138023|NCT05127486|567252111|FG000|Overall Study|Lack of Efficacy|1|||
157138024|NCT05127486|567252112|FG001|Overall Study|Lack of Efficacy|0|||
157138025|NCT05127486|567252111|FG000|Overall Study|Pregnancy|0|||
157138026|NCT05127486|567252112|FG001|Overall Study|Pregnancy|1|||
157138027|NCT05127486|567252111|FG000|Overall Study|Physician Decision|4|||
157138028|NCT05127486|567252112|FG001|Overall Study|Physician Decision|1|||
157138029|NCT05127486|567252111|FG000|Overall Study|Withdrawal by Subject|14|||
157138030|NCT05127486|567252112|FG001|Overall Study|Withdrawal by Subject|13|||
157138031|NCT05127486|567252111|FG000|Overall Study|Lost to Follow-up|5|||
157138032|NCT05127486|567252112|FG001|Overall Study|Lost to Follow-up|8|||
157138033|NCT00363415|567252116|FG000|Overall Study|Progressive Disease|196|||
157138034|NCT00363415|567252117|FG001|Overall Study|Progressive Disease|107|||
157138035|NCT00363415|567252116|FG000|Overall Study|Sponsor Decision|67|||
157138036|NCT00363415|567252117|FG001|Overall Study|Sponsor Decision|31|||
157138037|NCT00363415|567252116|FG000|Overall Study|Death|32|||
157138038|NCT00363415|567252117|FG001|Overall Study|Death|29|||
157138039|NCT00363415|567252116|FG000|Overall Study|Adverse Event|24|||
157138040|NCT00363415|567252117|FG001|Overall Study|Adverse Event|15|||
157138041|NCT00363415|567252116|FG000|Overall Study|Physician Decision|18|||
157138042|NCT00363415|567252117|FG001|Overall Study|Physician Decision|35|||
157138043|NCT00363415|567252116|FG000|Overall Study|Entry Criteria Not Met|11|||
157138044|NCT00363415|567252117|FG001|Overall Study|Entry Criteria Not Met|10|||
157138045|NCT00363415|567252116|FG000|Overall Study|Withdrawal by Subject|9|||
157138046|NCT00363415|567252117|FG001|Overall Study|Withdrawal by Subject|15|||
157138047|NCT00363415|567252116|FG000|Overall Study|Lost to Follow-up|3|||
157138048|NCT00363415|567252117|FG001|Overall Study|Lost to Follow-up|3|||
157138049|NCT00363415|567252116|FG000|Overall Study|Protocol Violation|1|||
157138050|NCT00363415|567252117|FG001|Overall Study|Protocol Violation|4|||
157138051|NCT01287754|567252120|FG000|Overall Study|Death|2|||
157138052|NCT01287754|567252121|FG001|Overall Study|Death|12|||
157138053|NCT01287754|567252120|FG000|Overall Study|Lost to Follow-up|1|||
157138054|NCT01287754|567252121|FG001|Overall Study|Lost to Follow-up|6|||
157138055|NCT01287754|567252120|FG000|Overall Study|Protocol Violation|0|||
157138056|NCT01287754|567252121|FG001|Overall Study|Protocol Violation|3|||
157138057|NCT05027802|567252132|FG000|Overall Study|Adverse Event|2|||
157138058|NCT05027802|567252132|FG000|Overall Study|Withdrawal by Subject|18|||
157138059|NCT05027802|567252132|FG000|Overall Study|Death|2|||
157138060|NCT05027802|567252132|FG000|Overall Study|Other|1|||
157138061|NCT00001337|567252139|FG000|Overall Study|Switched to alternate treatment|2|||
157138062|NCT00001337|567252140|FG001|Overall Study|Switched to alternate treatment|2|||
157138063|NCT00001337|567252141|FG002|Overall Study|Switched to alternate treatment|0|||
157138064|NCT00001337|567252139|FG000|Overall Study|Refused further treatment|2|||
157138065|NCT00001337|567252140|FG001|Overall Study|Refused further treatment|1|||
157138066|NCT00001337|567252141|FG002|Overall Study|Refused further treatment|0|||
157138067|NCT00001337|567252139|FG000|Overall Study|Began other Tx|1|||
157138068|NCT00001337|567252140|FG001|Overall Study|Began other Tx|0|||
157138069|NCT00001337|567252141|FG002|Overall Study|Began other Tx|0|||
157138070|NCT00001337|567252139|FG000|Overall Study|Physician Decision|3|||
157138071|NCT00001337|567252140|FG001|Overall Study|Physician Decision|1|||
157138072|NCT00001337|567252141|FG002|Overall Study|Physician Decision|0|||
157138073|NCT00001337|567252139|FG000|Overall Study|Doesn't have NHL|0|||
157138074|NCT00001337|567252140|FG001|Overall Study|Doesn't have NHL|1|||
157138075|NCT00001337|567252141|FG002|Overall Study|Doesn't have NHL|0|||
157138076|NCT00001337|567252139|FG000|Overall Study|Non protocol tx needed|3|||
157138077|NCT00001337|567252140|FG001|Overall Study|Non protocol tx needed|1|||
157138078|NCT00001337|567252141|FG002|Overall Study|Non protocol tx needed|0|||
157138079|NCT00001337|567252139|FG000|Overall Study|Protocol change|1|||
156726348|NCT01540487|565746201|FG001|Overall Study|Protocol Violation|0|||
157138080|NCT00001337|567252140|FG001|Overall Study|Protocol change|0|||
157138081|NCT00001337|567252141|FG002|Overall Study|Protocol change|0|||
156726349|NCT04545489|565746203|FG000|Overall Study|Withdrawal by Subject|12|||
157138082|NCT00001337|567252139|FG000|Overall Study|2nd primary disease|0|||
157138083|NCT00001337|567252140|FG001|Overall Study|2nd primary disease|0|||
157138084|NCT00001337|567252141|FG002|Overall Study|2nd primary disease|1|||
157138085|NCT00001337|567252139|FG000|Overall Study|Death during follow up period|9|||
157138086|NCT00001337|567252140|FG001|Overall Study|Death during follow up period|4|||
157138087|NCT00001337|567252141|FG002|Overall Study|Death during follow up period|0|||
157138088|NCT00001337|567252139|FG000|Overall Study|Death on study|19|||
157138089|NCT00001337|567252140|FG001|Overall Study|Death on study|9|||
157138090|NCT00001337|567252141|FG002|Overall Study|Death on study|0|||
157138091|NCT00001337|567252139|FG000|Overall Study|Disease progression during follow-up period|3|||
157138092|NCT00001337|567252140|FG001|Overall Study|Disease progression during follow-up period|1|||
157138093|NCT00001337|567252141|FG002|Overall Study|Disease progression during follow-up period|0|||
157138094|NCT00001337|567252139|FG000|Overall Study|Disease progression on study|33|||
157138095|NCT00001337|567252140|FG001|Overall Study|Disease progression on study|41|||
157138096|NCT00001337|567252141|FG002|Overall Study|Disease progression on study|0|||
157138097|NCT00001337|567252139|FG000|Overall Study|Lost to further follow-up|10|||
157138098|NCT00001337|567252140|FG001|Overall Study|Lost to further follow-up|6|||
157138099|NCT00001337|567252141|FG002|Overall Study|Lost to further follow-up|0|||
157138100|NCT00001337|567252139|FG000|Overall Study|2nd malignancy|1|||
157138101|NCT00001337|567252140|FG001|Overall Study|2nd malignancy|0|||
157138102|NCT00001337|567252141|FG002|Overall Study|2nd malignancy|0|||
157138103|NCT00001337|567252139|FG000|Overall Study|Treatment for second lymphoma|0|||
157217350|NCT01133821|567543212|FG000|Overall Study|Withdrawal by Subject|8|||
157217351|NCT01133821|567543213|FG001|Overall Study|Withdrawal by Subject|3|||
157217352|NCT01133821|567543212|FG000|Overall Study|preferred other treatment|1|||
157217353|NCT01133821|567543213|FG001|Overall Study|preferred other treatment|1|||
157217354|NCT01133821|567543212|FG000|Overall Study|Protocol Violation|0|||
157217355|NCT01133821|567543213|FG001|Overall Study|Protocol Violation|1|||
157217356|NCT01133821|567543212|FG000|Overall Study|Refused participation|1|||
157138104|NCT00001337|567252140|FG001|Overall Study|Treatment for second lymphoma|1|||
157138105|NCT00001337|567252141|FG002|Overall Study|Treatment for second lymphoma|0|||
156726350|NCT04545489|565746204|FG001|Overall Study|Withdrawal by Subject|4|||
156726351|NCT04545489|565746203|FG000|Overall Study|Lost to Follow-up|17|||
157138106|NCT00001337|567252139|FG000|Overall Study|Transfer to transplant|0|||
157217357|NCT01133821|567543213|FG001|Overall Study|Refused participation|3|||
157217358|NCT03342898|567543214|FG000|Overall Study|Adverse Event|3|||
157217359|NCT03342898|567543215|FG001|Overall Study|Adverse Event|1|||
157217360|NCT03342898|567543216|FG002|Overall Study|Adverse Event|0|||
157217361|NCT03342898|567543214|FG000|Overall Study|Lost to Follow-up|44|||
157217362|NCT03342898|567543215|FG001|Overall Study|Lost to Follow-up|40|||
157217363|NCT03342898|567543216|FG002|Overall Study|Lost to Follow-up|42|||
157217364|NCT03342898|567543214|FG000|Overall Study|Withdrawal of Consent|5|||
157217365|NCT03342898|567543215|FG001|Overall Study|Withdrawal of Consent|9|||
157217366|NCT03342898|567543216|FG002|Overall Study|Withdrawal of Consent|11|||
157217367|NCT03342898|567543214|FG000|Overall Study|Death|0|||
157217368|NCT03342898|567543215|FG001|Overall Study|Death|1|||
157217369|NCT03342898|567543216|FG002|Overall Study|Death|1|||
157217370|NCT03342898|567543214|FG000|Overall Study|Reason not Specified|2|||
157217371|NCT03342898|567543215|FG001|Overall Study|Reason not Specified|2|||
157217372|NCT03342898|567543216|FG002|Overall Study|Reason not Specified|0|||
157217373|NCT01387282|567543217|FG000|Overall Study|Death|47|||
157217374|NCT01387282|567543218|FG001|Overall Study|Death|16|||
157217375|NCT01387282|567543217|FG000|Overall Study|Other|5|||
156726352|NCT04545489|565746204|FG001|Overall Study|Lost to Follow-up|18|||
156726353|NCT04545489|565746203|FG000|Overall Study|12month BP not collected|4|||
156726354|NCT04545489|565746204|FG001|Overall Study|12month BP not collected|4|||
156726355|NCT00154284|565746208|FG000|Overall Study|Adverse Event|6|||
157138107|NCT00001337|567252140|FG001|Overall Study|Transfer to transplant|1|||
157138108|NCT00001337|567252141|FG002|Overall Study|Transfer to transplant|0|||
157138109|NCT05817045|567252146|FG000|Overall Study|Protocol Violation|0|||
157217376|NCT01387282|567543218|FG001|Overall Study|Other|1|||
157217377|NCT01387282|567543217|FG000|Overall Study|Unrelated AE|6|||
157217378|NCT01387282|567543218|FG001|Overall Study|Unrelated AE|4|||
157217379|NCT01387282|567543217|FG000|Overall Study|Withdrawal by patient|33|||
157217380|NCT01387282|567543218|FG001|Overall Study|Withdrawal by patient|23|||
157217381|NCT01387282|567543217|FG000|Overall Study|Study drug-related AE|2|||
157217382|NCT01387282|567543218|FG001|Overall Study|Study drug-related AE|2|||
156726356|NCT00154284|565746209|FG001|Overall Study|Adverse Event|9|||
156726357|NCT00154284|565746208|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156726358|NCT00154284|565746209|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156795559|NCT03977155|566006118|FG000|Overall Study|Adverse Event|3|||
156795560|NCT03977155|566006119|FG001|Overall Study|Adverse Event|0|||
156795561|NCT03977155|566006120|FG002|Overall Study|Adverse Event|0|||
156795562|NCT03977155|566006118|FG000|Overall Study|Lost to Follow-up|0|||
157217383|NCT01387282|567543217|FG000|Overall Study|Lost to Follow-up|4|||
157217384|NCT01387282|567543218|FG001|Overall Study|Lost to Follow-up|1|||
157217385|NCT03997448|567543221|FG000|Study Treatment|Disease Progression|1|||
157217386|NCT03997448|567543221|FG000|Study Treatment|Symptomatic Deterioration|1|||
157217387|NCT03997448|567543221|FG000|Follow up|Death|2|||
156795563|NCT03977155|566006119|FG001|Overall Study|Lost to Follow-up|1|||
156795564|NCT03977155|566006120|FG002|Overall Study|Lost to Follow-up|0|||
156876090|NCT01124864|566305727|FG004|Overall Study|Protocol Violation|1|||
157217388|NCT03997448|567543221|FG000|Follow up|study terminated|1|||
156726359|NCT00154284|565746208|FG000|Overall Study|Lack of Efficacy|1|||
156726360|NCT00154284|565746209|FG001|Overall Study|Lack of Efficacy|2|||
156726361|NCT00154284|565746208|FG000|Overall Study|Protocol Violation|0|||
156726362|NCT00154284|565746209|FG001|Overall Study|Protocol Violation|1|||
156726363|NCT00326716|565746210|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
156726364|NCT00326716|565746211|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
156726365|NCT00326716|565746212|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
156726366|NCT00326716|565746213|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
156726367|NCT00684411|565746214|FG000|Overall Study|New Primary Cancer|1|||
156726368|NCT00684411|565746214|FG000|Overall Study|Disease Progression|10|||
156726369|NCT00684411|565746214|FG000|Overall Study|Adverse Event|1|||
156726370|NCT05253573|565746215|FG000|Overall Study|Death|1|||
156726371|NCT05253573|565746216|FG001|Overall Study|Death|0|||
156726372|NCT01344824|565746217|FG000|Overall Study|Adverse Event|15|||
156726373|NCT01344824|565746217|FG000|Overall Study|Withdrawal by Subject|6|||
156726374|NCT01344824|565746217|FG000|Overall Study|Other complicating disease|1|||
156726375|NCT01344824|565746217|FG000|Overall Study|Progression|15|||
156726376|NCT01085630|565746220|FG000|Overall Study|Insufficient data|1|||
156726377|NCT01085630|565746221|FG001|Overall Study|Insufficient data|0|||
156726378|NCT01085630|565746220|FG000|Overall Study|Ineligible|3|||
156726379|NCT01085630|565746221|FG001|Overall Study|Ineligible|0|||
156726380|NCT02366637|565746227|FG000|First Intervention Period|Adverse Event|0|||
156726381|NCT02366637|565746228|FG001|First Intervention Period|Adverse Event|1|||
156726382|NCT02366637|565746227|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
156726383|NCT02366637|565746228|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
156726384|NCT02366637|565746227|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
156726385|NCT02366637|565746228|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
156726386|NCT03691207|565746229|FG000|Overall Study|Death|41|||
156726387|NCT03691207|565746230|FG001|Overall Study|Death|26|||
156876091|NCT01124864|566305728|FG005|Overall Study|Protocol Violation|0|||
156876092|NCT01761162|566305735|FG000|Overall Study|Withdrawal by Subject|3|||
156876093|NCT00724711|566305742|FG000|Overall Study|Adverse Event|7|||
156876094|NCT00724711|566305743|FG001|Overall Study|Adverse Event|3|||
156876095|NCT00724711|566305742|FG000|Overall Study|Pregnancy|0|||
156876096|NCT00724711|566305743|FG001|Overall Study|Pregnancy|1|||
156726388|NCT03691207|565746229|FG000|Overall Study|Lost to Follow-up|1|||
156726389|NCT03691207|565746230|FG001|Overall Study|Lost to Follow-up|1|||
156726390|NCT03691207|565746229|FG000|Overall Study|Withdrawal by Subject|2|||
156726391|NCT03691207|565746230|FG001|Overall Study|Withdrawal by Subject|8|||
156795565|NCT03977155|566006118|FG000|Overall Study|Withdrawal by Subject|1|||
156795566|NCT03977155|566006119|FG001|Overall Study|Withdrawal by Subject|1|||
156795567|NCT03977155|566006120|FG002|Overall Study|Withdrawal by Subject|2|||
156795568|NCT03977155|566006118|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
156795569|NCT03977155|566006119|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
156795570|NCT03977155|566006120|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
156795571|NCT00936936|566006121|FG000|Overall Study|Adverse Event|7|||
156795572|NCT00936936|566006122|FG001|Overall Study|Adverse Event|1|||
156795573|NCT00936936|566006121|FG000|Overall Study|Disease Progression|2|||
156795574|NCT00936936|566006122|FG001|Overall Study|Disease Progression|2|||
156795575|NCT00936936|566006121|FG000|Overall Study|Unrelated|3|||
156795576|NCT00936936|566006122|FG001|Overall Study|Unrelated|1|||
156795577|NCT02278003|566006124|FG000|Overall Study|Withdrawal by Subject|11|||
156795578|NCT02278003|566006125|FG001|Overall Study|Withdrawal by Subject|0|||
156795579|NCT02278003|566006124|FG000|Overall Study|Not Treated|1|||
156795580|NCT02278003|566006125|FG001|Overall Study|Not Treated|0|||
156795581|NCT02278003|566006124|FG000|Overall Study|Recognition task improperly completed|7|||
156795582|NCT02278003|566006125|FG001|Overall Study|Recognition task improperly completed|0|||
156795583|NCT03440385|566006126|FG000|Overall Study|Other Reason|4|||
156795584|NCT03440385|566006127|FG001|Overall Study|Other Reason|1|||
156795585|NCT03440385|566006126|FG000|Overall Study|Site Closed|1|||
156795586|NCT03440385|566006127|FG001|Overall Study|Site Closed|0|||
156795587|NCT03440385|566006126|FG000|Overall Study|Lost to Follow-up|2|||
156795588|NCT03440385|566006127|FG001|Overall Study|Lost to Follow-up|0|||
156795589|NCT03440385|566006126|FG000|Overall Study|Withdrawal by Subject|12|||
156795590|NCT03440385|566006127|FG001|Overall Study|Withdrawal by Subject|6|||
156795591|NCT03440385|566006126|FG000|Overall Study|Lack of Efficacy|9|||
156795592|NCT03440385|566006127|FG001|Overall Study|Lack of Efficacy|2|||
156876097|NCT00724711|566305742|FG000|Overall Study|Lack of Efficacy|0|||
156726392|NCT03691207|565746229|FG000|Overall Study|Sponsor decision|1|||
156795593|NCT03440385|566006126|FG000|Overall Study|Adverse Event|15|||
156795594|NCT03440385|566006127|FG001|Overall Study|Adverse Event|11|||
156795595|NCT00488293|566006128|FG000|Overall Study|Lost to Follow-up|28|||
156876098|NCT00724711|566305743|FG001|Overall Study|Lack of Efficacy|1|||
156726393|NCT03691207|565746230|FG001|Overall Study|Sponsor decision|7|||
156795596|NCT00488293|566006129|FG001|Overall Study|Lost to Follow-up|25|||
156876099|NCT00724711|566305742|FG000|Overall Study|Physician Decision|0|||
156795597|NCT00488293|566006128|FG000|Overall Study|Withdrawal by Subject|5|||
156876100|NCT00724711|566305743|FG001|Overall Study|Physician Decision|3|||
156726394|NCT01609010|565746233|FG000|Overall Study|Stable disease (SD)|22|||
156726395|NCT01609010|565746234|FG001|Overall Study|Stable disease (SD)|16|||
156726396|NCT01609010|565746233|FG000|Overall Study|Progressive disease (PD)|8|||
156726397|NCT01609010|565746234|FG001|Overall Study|Progressive disease (PD)|10|||
156726398|NCT01609010|565746233|FG000|Overall Study|Adverse Event|3|||
156726399|NCT01609010|565746234|FG001|Overall Study|Adverse Event|6|||
156726400|NCT01609010|565746233|FG000|Overall Study|Withdrawal by Subject|2|||
156726401|NCT01609010|565746234|FG001|Overall Study|Withdrawal by Subject|2|||
157217389|NCT01621490|567543222|FG000|Overall Study|Subject no longer meets study criteria|0|||
157217390|NCT01621490|567543223|FG001|Overall Study|Subject no longer meets study criteria|0|||
157217391|NCT01621490|567543224|FG002|Overall Study|Subject no longer meets study criteria|0|||
157217392|NCT01621490|567543225|FG003|Overall Study|Subject no longer meets study criteria|0|||
157217393|NCT01621490|567543226|FG004|Overall Study|Subject no longer meets study criteria|1|||
157217394|NCT01621490|567543227|FG005|Overall Study|Subject no longer meets study criteria|0|||
157217395|NCT01621490|567543228|FG006|Overall Study|Subject no longer meets study criteria|0|||
157217396|NCT01621490|567543229|FG007|Overall Study|Subject no longer meets study criteria|0|||
157217397|NCT01621490|567543230|FG008|Overall Study|Subject no longer meets study criteria|0|||
157217398|NCT01621490|567543231|FG009|Overall Study|Subject no longer meets study criteria|0|||
157217399|NCT01621490|567543232|FG010|Overall Study|Subject no longer meets study criteria|0|||
157217400|NCT01621490|567543222|FG000|Overall Study|Maximum clinical benefit|3|||
157217401|NCT01621490|567543223|FG001|Overall Study|Maximum clinical benefit|2|||
157217402|NCT01621490|567543224|FG002|Overall Study|Maximum clinical benefit|0|||
157217403|NCT01621490|567543225|FG003|Overall Study|Maximum clinical benefit|0|||
157217404|NCT01621490|567543226|FG004|Overall Study|Maximum clinical benefit|0|||
157217405|NCT01621490|567543227|FG005|Overall Study|Maximum clinical benefit|0|||
157217406|NCT01621490|567543228|FG006|Overall Study|Maximum clinical benefit|1|||
157217407|NCT01621490|567543229|FG007|Overall Study|Maximum clinical benefit|2|||
157217408|NCT01621490|567543230|FG008|Overall Study|Maximum clinical benefit|2|||
157217409|NCT01621490|567543231|FG009|Overall Study|Maximum clinical benefit|0|||
157217410|NCT01621490|567543232|FG010|Overall Study|Maximum clinical benefit|0|||
156726402|NCT01609010|565746233|FG000|Overall Study|Other|2|||
157138110|NCT05817045|567252147|FG001|Overall Study|Protocol Violation|3|||
156726403|NCT01609010|565746234|FG001|Overall Study|Other|0|||
156726404|NCT01609010|565746233|FG000|Overall Study|Other malignancy|1|||
156726405|NCT01609010|565746234|FG001|Overall Study|Other malignancy|0|||
156726406|NCT01609010|565746233|FG000|Overall Study|Pathology review|2|||
156726407|NCT01609010|565746234|FG001|Overall Study|Pathology review|1|||
156726408|NCT01609010|565746233|FG000|Overall Study|Protocol Violation|1|||
156726409|NCT01609010|565746234|FG001|Overall Study|Protocol Violation|1|||
156726410|NCT01609010|565746233|FG000|Overall Study|New cancer|1|||
156726411|NCT01609010|565746234|FG001|Overall Study|New cancer|0|||
156726412|NCT01609010|565746233|FG000|Overall Study|Lost to Follow-up|1|||
156726413|NCT01609010|565746234|FG001|Overall Study|Lost to Follow-up|1|||
156726414|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
156726415|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
156726416|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
156726417|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
156726418|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
156726419|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
156795598|NCT00488293|566006129|FG001|Overall Study|Withdrawal by Subject|3|||
157138111|NCT05817045|567252146|FG000|Overall Study|Withdrawal by Subject|10|||
157138112|NCT05817045|567252147|FG001|Overall Study|Withdrawal by Subject|7|||
157138113|NCT05817045|567252146|FG000|Overall Study|Physician Decision|3|||
157138114|NCT05817045|567252147|FG001|Overall Study|Physician Decision|0|||
157138115|NCT05817045|567252146|FG000|Overall Study|Lost to Follow-up|0|||
157138116|NCT05817045|567252147|FG001|Overall Study|Lost to Follow-up|1|||
157138117|NCT05817045|567252146|FG000|Overall Study|Device Deficiency|1|||
157138118|NCT05817045|567252147|FG001|Overall Study|Device Deficiency|0|||
156795599|NCT00488293|566006128|FG000|Overall Study|Death|2|||
156795600|NCT00488293|566006129|FG001|Overall Study|Death|1|||
156795601|NCT00488293|566006128|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
157217411|NCT01621490|567543222|FG000|Overall Study|Withdrawal by Subject|1|||
156726420|NCT01134107|565746235|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
156726421|NCT01134107|565746236|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
157217412|NCT01621490|567543223|FG001|Overall Study|Withdrawal by Subject|0|||
156726422|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
156726423|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
156726424|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
157138119|NCT05817045|567252146|FG000|Overall Study|System Error|1|||
157138120|NCT05817045|567252147|FG001|Overall Study|System Error|0|||
156726425|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
156726426|NCT01134107|565746235|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
156726427|NCT01134107|565746236|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
156795602|NCT00488293|566006129|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
156795603|NCT02332928|566006132|FG000|Overall Study|Withdrawal by Subject|0|||
156795604|NCT02332928|566006133|FG001|Overall Study|Withdrawal by Subject|2|||
156795605|NCT02332928|566006132|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
156795606|NCT02332928|566006133|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
156726428|NCT02027545|565746238|FG000|Overall Study|Failed to sign HIPAA|0|||
156726429|NCT02027545|565746239|FG001|Overall Study|Failed to sign HIPAA|2|||
156726430|NCT02027545|565746238|FG000|Overall Study|Failed to attend study visit|2|||
156726431|NCT02027545|565746239|FG001|Overall Study|Failed to attend study visit|0|||
156726432|NCT02027545|565746238|FG000|Overall Study|Protocol Violation|1|||
156726433|NCT02027545|565746239|FG001|Overall Study|Protocol Violation|0|||
156726434|NCT04541589|565746243|FG000|Treatment Period|Adverse Event|8|||
156726435|NCT04541589|565746244|FG001|Treatment Period|Adverse Event|2|||
156726436|NCT04541589|565746243|FG000|Treatment Period|Physician Decision|3|||
156726437|NCT04541589|565746244|FG001|Treatment Period|Physician Decision|1|||
156726438|NCT04541589|565746243|FG000|Treatment Period|Subject decision|7|||
156726439|NCT04541589|565746244|FG001|Treatment Period|Subject decision|4|||
156726440|NCT04541589|565746243|FG000|Treatment Period|Withdrawal by Subject|1|||
156726441|NCT04541589|565746244|FG001|Treatment Period|Withdrawal by Subject|0|||
156726442|NCT04541589|565746243|FG000|Safety Follow-up Period|Adverse Event|2|||
156726443|NCT04541589|565746244|FG001|Safety Follow-up Period|Adverse Event|1|||
156726444|NCT04541589|565746243|FG000|Safety Follow-up Period|Physician Decision|1|||
156726445|NCT04541589|565746244|FG001|Safety Follow-up Period|Physician Decision|0|||
156726446|NCT04541589|565746243|FG000|Safety Follow-up Period|Subject decision|5|||
156726447|NCT04541589|565746244|FG001|Safety Follow-up Period|Subject decision|3|||
156726448|NCT04541589|565746243|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
156726449|NCT04541589|565746244|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
156726450|NCT02770170|565746245|FG000|Overall Study|Withdrawal by Subject|0|||
156726451|NCT02770170|565746246|FG001|Overall Study|Withdrawal by Subject|0|||
156726452|NCT02770170|565746247|FG002|Overall Study|Withdrawal by Subject|0|||
156726453|NCT02770170|565746248|FG003|Overall Study|Withdrawal by Subject|2|||
156726454|NCT02770170|565746245|FG000|Overall Study|due to pregnancy|1|||
156795607|NCT01497197|566006134|FG000|Overall Study|Lost to Follow-up|1|||
156795608|NCT01497197|566006135|FG001|Overall Study|Lost to Follow-up|0|||
156726455|NCT02770170|565746246|FG001|Overall Study|due to pregnancy|0|||
156726456|NCT02770170|565746247|FG002|Overall Study|due to pregnancy|0|||
156795609|NCT01497197|566006134|FG000|Overall Study|Protocol Violation|0|||
156795610|NCT01497197|566006135|FG001|Overall Study|Protocol Violation|2|||
156795611|NCT01497197|566006134|FG000|Overall Study|Withdrawal by Subject|2|||
156795612|NCT01497197|566006135|FG001|Overall Study|Withdrawal by Subject|1|||
156795613|NCT01497197|566006134|FG000|Overall Study|Excessive/lack of response to treatment|1|||
156795614|NCT01497197|566006135|FG001|Overall Study|Excessive/lack of response to treatment|0|||
156795615|NCT01497197|566006134|FG000|Overall Study|Risk of OHSS|1|||
156795616|NCT01497197|566006135|FG001|Overall Study|Risk of OHSS|0|||
156795617|NCT01497197|566006134|FG000|Overall Study|No oocytes retrieved|3|||
156795618|NCT01497197|566006135|FG001|Overall Study|No oocytes retrieved|2|||
156876101|NCT00724711|566305742|FG000|Overall Study|Withdrawal by Subject|5|||
156876102|NCT00724711|566305743|FG001|Overall Study|Withdrawal by Subject|4|||
156876103|NCT00724711|566305742|FG000|Overall Study|Lost to Follow-up|4|||
156876104|NCT00724711|566305743|FG001|Overall Study|Lost to Follow-up|5|||
156876105|NCT00724711|566305742|FG000|Overall Study|Protocol Violation|1|||
156876106|NCT00724711|566305743|FG001|Overall Study|Protocol Violation|0|||
156876107|NCT01368562|566305744|FG000|Overall Study|Adverse Event|1|||
156876108|NCT01368562|566305744|FG000|Overall Study|Disease progression|1|||
156876109|NCT01368562|566305744|FG000|Overall Study|Lost to Follow-up|1|||
156876110|NCT01368562|566305744|FG000|Overall Study|Death|6|||
156876111|NCT01368562|566305744|FG000|Overall Study|Unresponsive to treatment|5|||
156876112|NCT01368562|566305744|FG000|Overall Study|Other|3|||
156876113|NCT01368562|566305744|FG000|Overall Study|Other than specified|2|||
156876114|NCT00727441|566305745|FG000|Overall Study|Disease Progression|11|||
156876115|NCT00727441|566305746|FG001|Overall Study|Disease Progression|14|||
156876116|NCT00727441|566305747|FG002|Overall Study|Disease Progression|17|||
156876117|NCT00727441|566305745|FG000|Overall Study|Eligibility|7|||
156795619|NCT01497197|566006134|FG000|Overall Study|No fertilisation|6|||
156795620|NCT01497197|566006135|FG001|Overall Study|No fertilisation|5|||
156795621|NCT01497197|566006134|FG000|Overall Study|Intention to freeze all embryos|0|||
156876118|NCT00727441|566305746|FG001|Overall Study|Eligibility|5|||
156876119|NCT00727441|566305747|FG002|Overall Study|Eligibility|7|||
156876120|NCT00727441|566305745|FG000|Overall Study|Death|0|||
156876121|NCT00727441|566305746|FG001|Overall Study|Death|1|||
156876122|NCT00727441|566305747|FG002|Overall Study|Death|1|||
156876123|NCT00727441|566305745|FG000|Overall Study|Physician Decision|0|||
156726457|NCT02770170|565746248|FG003|Overall Study|due to pregnancy|0|||
156726458|NCT02770170|565746245|FG000|Overall Study|Lack of Efficacy|2|||
156726459|NCT02770170|565746246|FG001|Overall Study|Lack of Efficacy|0|||
156726460|NCT02770170|565746247|FG002|Overall Study|Lack of Efficacy|0|||
156726461|NCT02770170|565746248|FG003|Overall Study|Lack of Efficacy|1|||
156726462|NCT02770170|565746245|FG000|Overall Study|Adverse Event|4|||
157138121|NCT01506141|567252148|FG000|Overall Study|Adverse Event|0|||
157138122|NCT01506141|567252149|FG001|Overall Study|Adverse Event|2|||
157138123|NCT01506141|567252148|FG000|Overall Study|Participation Terminated by Investigator|1|||
157138124|NCT01506141|567252149|FG001|Overall Study|Participation Terminated by Investigator|1|||
157138125|NCT01506141|567252148|FG000|Overall Study|Site Terminated by Sponsor|2|||
157138126|NCT01506141|567252149|FG001|Overall Study|Site Terminated by Sponsor|0|||
157138127|NCT01506141|567252148|FG000|Overall Study|Reason Not Specified|4|||
157138128|NCT01506141|567252149|FG001|Overall Study|Reason Not Specified|2|||
157138129|NCT04889209|567252150|FG000|All Cohorts Except 15E|Adverse Event|0|||
157138130|NCT04889209|567252151|FG001|All Cohorts Except 15E|Adverse Event|0|||
157138131|NCT04889209|567252152|FG002|All Cohorts Except 15E|Adverse Event|0|||
157138132|NCT04889209|567252153|FG003|All Cohorts Except 15E|Adverse Event|0|||
157138133|NCT04889209|567252154|FG004|All Cohorts Except 15E|Adverse Event|0|||
157138134|NCT04889209|567252155|FG005|All Cohorts Except 15E|Adverse Event|0|||
157138135|NCT04889209|567252156|FG006|All Cohorts Except 15E|Adverse Event|1|||
157138136|NCT04889209|567252157|FG007|All Cohorts Except 15E|Adverse Event|0|||
157138137|NCT04889209|567252158|FG008|All Cohorts Except 15E|Adverse Event|0|||
157138138|NCT04889209|567252159|FG009|All Cohorts Except 15E|Adverse Event|0|||
157138139|NCT04889209|567252160|FG010|All Cohorts Except 15E|Adverse Event|0|||
157138140|NCT04889209|567252161|FG011|All Cohorts Except 15E|Adverse Event|0|||
157138141|NCT04889209|567252162|FG012|All Cohorts Except 15E|Adverse Event|0|||
157138142|NCT04889209|567252163|FG013|All Cohorts Except 15E|Adverse Event|0|||
157138143|NCT04889209|567252164|FG014|All Cohorts Except 15E|Adverse Event|0|||
157138144|NCT04889209|567252165|FG015|All Cohorts Except 15E|Adverse Event|0|||
157138145|NCT04889209|567252166|FG016|All Cohorts Except 15E|Adverse Event|0|||
157138146|NCT04889209|567252167|FG017|All Cohorts Except 15E|Adverse Event|0|||
156726463|NCT02770170|565746246|FG001|Overall Study|Adverse Event|3|||
156726464|NCT02770170|565746247|FG002|Overall Study|Adverse Event|5|||
156726465|NCT02770170|565746248|FG003|Overall Study|Adverse Event|3|||
156726466|NCT02770170|565746245|FG000|Overall Study|due to disease worsening|0|||
156726467|NCT02770170|565746246|FG001|Overall Study|due to disease worsening|0|||
156726468|NCT02770170|565746247|FG002|Overall Study|due to disease worsening|0|||
156726469|NCT02770170|565746248|FG003|Overall Study|due to disease worsening|1|||
156726470|NCT03581123|565746249|FG000|2-month Follow-up|Withdrawal by Subject|5|||
156726471|NCT03581123|565746250|FG001|2-month Follow-up|Withdrawal by Subject|4|||
156726472|NCT03581123|565746251|FG002|2-month Follow-up|Withdrawal by Subject|6|||
156726473|NCT03581123|565746252|FG003|2-month Follow-up|Withdrawal by Subject|4|||
156726474|NCT03581123|565746249|FG000|2-month Follow-up|Lost to Follow-up|8|||
156726475|NCT03581123|565746250|FG001|2-month Follow-up|Lost to Follow-up|1|||
156726476|NCT03581123|565746251|FG002|2-month Follow-up|Lost to Follow-up|2|||
156726477|NCT03581123|565746252|FG003|2-month Follow-up|Lost to Follow-up|2|||
156726478|NCT03581123|565746249|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
156726479|NCT03581123|565746250|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
156726480|NCT03581123|565746251|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
156726481|NCT03581123|565746252|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
156726482|NCT03581123|565746249|FG000|6-Month Follow-up|Lost to Follow-up|3|||
156726483|NCT03581123|565746250|FG001|6-Month Follow-up|Lost to Follow-up|3|||
156726484|NCT03581123|565746251|FG002|6-Month Follow-up|Lost to Follow-up|1|||
156726485|NCT03581123|565746252|FG003|6-Month Follow-up|Lost to Follow-up|1|||
156726486|NCT03581123|565746249|FG000|12-Month Follow-up|Lost to Follow-up|4|||
156726487|NCT03581123|565746250|FG001|12-Month Follow-up|Lost to Follow-up|3|||
156726488|NCT03581123|565746251|FG002|12-Month Follow-up|Lost to Follow-up|4|||
157138147|NCT04889209|567252150|FG000|All Cohorts Except 15E|Death|0|||
157138148|NCT04889209|567252151|FG001|All Cohorts Except 15E|Death|1|||
157138149|NCT04889209|567252152|FG002|All Cohorts Except 15E|Death|0|||
157138150|NCT04889209|567252153|FG003|All Cohorts Except 15E|Death|0|||
157138151|NCT04889209|567252154|FG004|All Cohorts Except 15E|Death|0|||
157138152|NCT04889209|567252155|FG005|All Cohorts Except 15E|Death|0|||
156726489|NCT03581123|565746252|FG003|12-Month Follow-up|Lost to Follow-up|5|||
156876124|NCT00727441|566305746|FG001|Overall Study|Physician Decision|1|||
156876125|NCT00727441|566305747|FG002|Overall Study|Physician Decision|0|||
156876126|NCT00727441|566305745|FG000|Overall Study|Withdrawal by Subject|0|||
157019722|NCT04088630|566826464|FG001|Overall Study|Physician Decision|1|||
157019723|NCT04088630|566826465|FG002|Overall Study|Physician Decision|1|||
157138153|NCT04889209|567252156|FG006|All Cohorts Except 15E|Death|0|||
156726490|NCT04195685|565746253|FG000|Overall Study|Withdrawal by Subject|6|||
156726491|NCT04195685|565746254|FG001|Overall Study|Withdrawal by Subject|2|||
157138154|NCT04889209|567252157|FG007|All Cohorts Except 15E|Death|0|||
157138155|NCT04889209|567252158|FG008|All Cohorts Except 15E|Death|0|||
157138156|NCT04889209|567252159|FG009|All Cohorts Except 15E|Death|0|||
157138157|NCT04889209|567252160|FG010|All Cohorts Except 15E|Death|0|||
157138158|NCT04889209|567252161|FG011|All Cohorts Except 15E|Death|0|||
157138159|NCT04889209|567252162|FG012|All Cohorts Except 15E|Death|0|||
157138160|NCT04889209|567252163|FG013|All Cohorts Except 15E|Death|0|||
157138161|NCT04889209|567252164|FG014|All Cohorts Except 15E|Death|0|||
156726492|NCT04195685|565746253|FG000|Overall Study|Lost to Follow-up|1|||
156726493|NCT04195685|565746254|FG001|Overall Study|Lost to Follow-up|4|||
156876127|NCT00727441|566305746|FG001|Overall Study|Withdrawal by Subject|1|||
156876128|NCT00727441|566305747|FG002|Overall Study|Withdrawal by Subject|0|||
156876129|NCT02810444|566305748|FG000|Overall Study|Screen Failures|14|||
156876130|NCT02810444|566305748|FG000|Overall Study|Withdrawal by Subject|4|||
156876131|NCT02810444|566305748|FG000|Overall Study|Adverse Event|3|||
156876132|NCT00745849|566305749|FG000|First Intervention|Withdrawal by Subject|0|||
156876133|NCT00745849|566305750|FG001|First Intervention|Withdrawal by Subject|1|||
156876134|NCT00745849|566305749|FG000|First Intervention|Lost to Follow-up|1|||
156876135|NCT00745849|566305750|FG001|First Intervention|Lost to Follow-up|1|||
156876136|NCT00745849|566305749|FG000|Second Intervention|Lost to Follow-up|2|||
156876137|NCT00745849|566305750|FG001|Second Intervention|Lost to Follow-up|1|||
156876138|NCT01139008|566305751|FG000|Overall Study|Withdrawal by Subject|5|||
156876139|NCT01139008|566305751|FG000|Overall Study|Non-compliant, lost product|1|||
156876140|NCT02785770|566305754|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876141|NCT02785770|566305755|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
156876142|NCT02785770|566305756|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876143|NCT02785770|566305757|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
156876144|NCT02785770|566305754|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876145|NCT02785770|566305755|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876146|NCT02785770|566305756|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
156876147|NCT02785770|566305757|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
156876148|NCT02785770|566305754|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876149|NCT02785770|566305755|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876150|NCT02785770|566305756|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
156876151|NCT02785770|566305757|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
156876152|NCT01904773|566305758|FG000|Screen|Screen failure|3|||
156876153|NCT01904773|566305759|FG001|Screen|Screen failure|0|||
156876154|NCT01904773|566305760|FG002|Screen|Screen failure|0|||
156876155|NCT01904773|566305761|FG003|Screen|Screen failure|0|||
156876156|NCT01904773|566305762|FG004|Screen|Screen failure|0|||
156876157|NCT01904773|566305763|FG005|Screen|Screen failure|0|||
156876158|NCT01904773|566305764|FG006|Screen|Screen failure|0|||
156876159|NCT01904773|566305765|FG007|Screen|Screen failure|0|||
156876160|NCT01904773|566305766|FG008|Screen|Screen failure|0|||
156876161|NCT01904773|566305758|FG000|Screen|Withdrawal by Subject|1|||
156876162|NCT01904773|566305759|FG001|Screen|Withdrawal by Subject|0|||
156876163|NCT01904773|566305760|FG002|Screen|Withdrawal by Subject|0|||
156876164|NCT01904773|566305761|FG003|Screen|Withdrawal by Subject|0|||
156876165|NCT01904773|566305762|FG004|Screen|Withdrawal by Subject|0|||
156876166|NCT01904773|566305763|FG005|Screen|Withdrawal by Subject|0|||
156876167|NCT01904773|566305764|FG006|Screen|Withdrawal by Subject|0|||
156876168|NCT01904773|566305765|FG007|Screen|Withdrawal by Subject|0|||
156876169|NCT01904773|566305766|FG008|Screen|Withdrawal by Subject|0|||
156876170|NCT01904773|566305758|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
156876171|NCT01904773|566305759|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876172|NCT01904773|566305760|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876173|NCT01904773|566305761|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876174|NCT01904773|566305762|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876175|NCT01904773|566305763|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876176|NCT01904773|566305764|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876177|NCT01904773|566305765|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876178|NCT01904773|566305766|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
156876179|NCT01904773|566305758|FG000|First Intervention|Adverse Event|0|||
156876180|NCT01904773|566305759|FG001|First Intervention|Adverse Event|0|||
156876181|NCT01904773|566305760|FG002|First Intervention|Adverse Event|0|||
156876182|NCT01904773|566305761|FG003|First Intervention|Adverse Event|0|||
156876183|NCT01904773|566305762|FG004|First Intervention|Adverse Event|0|||
156876184|NCT01904773|566305763|FG005|First Intervention|Adverse Event|0|||
156876185|NCT01904773|566305764|FG006|First Intervention|Adverse Event|1|||
156876186|NCT01904773|566305765|FG007|First Intervention|Adverse Event|0|||
156876187|NCT01904773|566305766|FG008|First Intervention|Adverse Event|0|||
156876188|NCT01904773|566305758|FG000|Placebo Washout First Intervention|Condition worsened|0|||
156876189|NCT01904773|566305759|FG001|Placebo Washout First Intervention|Condition worsened|1|||
156876190|NCT01904773|566305760|FG002|Placebo Washout First Intervention|Condition worsened|0|||
156876191|NCT01904773|566305761|FG003|Placebo Washout First Intervention|Condition worsened|0|||
156876192|NCT01904773|566305762|FG004|Placebo Washout First Intervention|Condition worsened|0|||
156876193|NCT01904773|566305763|FG005|Placebo Washout First Intervention|Condition worsened|0|||
156876194|NCT01904773|566305764|FG006|Placebo Washout First Intervention|Condition worsened|0|||
156876195|NCT01904773|566305765|FG007|Placebo Washout First Intervention|Condition worsened|0|||
156876196|NCT01904773|566305766|FG008|Placebo Washout First Intervention|Condition worsened|0|||
156876197|NCT01904773|566305758|FG000|Fifth Intervention|Adverse Event|0|||
157138162|NCT04889209|567252165|FG015|All Cohorts Except 15E|Death|0|||
156876198|NCT01904773|566305759|FG001|Fifth Intervention|Adverse Event|0|||
156876199|NCT01904773|566305760|FG002|Fifth Intervention|Adverse Event|0|||
156726494|NCT04509076|565746261|FG000|Overall Study|Withdrawal by Subject|1|||
156726495|NCT04509076|565746262|FG001|Overall Study|Withdrawal by Subject|2|||
156726496|NCT04509076|565746261|FG000|Overall Study|Lost to Follow-up|1|||
156726497|NCT04509076|565746262|FG001|Overall Study|Lost to Follow-up|2|||
156726498|NCT03351608|565746263|FG000|Overall Study|Lost to Follow-up|0|||
156726499|NCT03351608|565746264|FG001|Overall Study|Lost to Follow-up|1|||
156726500|NCT03351608|565746265|FG002|Overall Study|Lost to Follow-up|1|||
156726501|NCT03351608|565746266|FG003|Overall Study|Lost to Follow-up|1|||
156726502|NCT03351608|565746267|FG004|Overall Study|Lost to Follow-up|1|||
156726503|NCT03351608|565746263|FG000|Overall Study|Physician Decision|1|||
156726504|NCT03351608|565746264|FG001|Overall Study|Physician Decision|0|||
156726505|NCT03351608|565746265|FG002|Overall Study|Physician Decision|0|||
156726506|NCT03351608|565746266|FG003|Overall Study|Physician Decision|2|||
156726507|NCT03351608|565746267|FG004|Overall Study|Physician Decision|1|||
156726508|NCT03351608|565746263|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
156726509|NCT03351608|565746264|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
156726510|NCT03351608|565746265|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
156726511|NCT03351608|565746266|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
156726512|NCT03351608|565746267|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
156726513|NCT03351608|565746263|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156726514|NCT03351608|565746264|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156726515|NCT03351608|565746265|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156726516|NCT03351608|565746266|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156726517|NCT03351608|565746267|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156726518|NCT03351608|565746263|FG000|Overall Study|Other|0|||
156726519|NCT03351608|565746264|FG001|Overall Study|Other|1|||
156726520|NCT03351608|565746265|FG002|Overall Study|Other|1|||
156726521|NCT03351608|565746266|FG003|Overall Study|Other|3|||
156726522|NCT03351608|565746267|FG004|Overall Study|Other|0|||
156726523|NCT02877004|565746268|FG000|Overall Study|Pregnancy|0|||
156726524|NCT02877004|565746269|FG001|Overall Study|Pregnancy|0|||
156726525|NCT02877004|565746270|FG002|Overall Study|Pregnancy|1|||
156726526|NCT02727478|565746271|FG000|Overall Study|Withdrawal by Subject|8|||
156726527|NCT02727478|565746272|FG001|Overall Study|Withdrawal by Subject|10|||
156726528|NCT02633293|565746273|FG000|Overall Study|Death|56|||
156726529|NCT02633293|565746273|FG000|Overall Study|Progressive Disease|12|||
156726530|NCT02633293|565746273|FG000|Overall Study|Adverse Event|29|||
156726531|NCT02633293|565746273|FG000|Overall Study|Withdrawal by Subject|41|||
156726532|NCT02633293|565746273|FG000|Overall Study|Protocol Violation|1|||
156726533|NCT02633293|565746273|FG000|Overall Study|Lost to Follow-up|1|||
156726534|NCT02633293|565746273|FG000|Overall Study|Study Terminated by Sponsor|24|||
156726535|NCT02633293|565746273|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
156726536|NCT02633293|565746273|FG000|Overall Study|Lung Transplant|5|||
156726537|NCT02633293|565746273|FG000|Overall Study|Lack of Efficacy|2|||
156726538|NCT02633293|565746273|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
156726539|NCT01418378|565746274|FG000|Overall Study|Death|1|||
156726540|NCT01418378|565746275|FG001|Overall Study|Death|2|||
156726541|NCT01418378|565746274|FG000|Overall Study|Physician Decision|0|||
156726542|NCT01418378|565746275|FG001|Overall Study|Physician Decision|1|||
156726543|NCT01418378|565746274|FG000|Overall Study|ligament imbalance|0|||
156726544|NCT01418378|565746275|FG001|Overall Study|ligament imbalance|1|||
156726545|NCT01418378|565746274|FG000|Overall Study|developed chronic myopathy|0|||
156726546|NCT01418378|565746275|FG001|Overall Study|developed chronic myopathy|1|||
156726547|NCT01790984|565746278|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
156726548|NCT01790984|565746279|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
156876200|NCT01904773|566305761|FG003|Fifth Intervention|Adverse Event|0|||
157019724|NCT04024813|566826468|FG000|Overall Study|Study terminated by Sponsor|1|||
157138163|NCT04889209|567252166|FG016|All Cohorts Except 15E|Death|0|||
157138164|NCT04889209|567252167|FG017|All Cohorts Except 15E|Death|0|||
157138165|NCT04889209|567252150|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
157138166|NCT04889209|567252151|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
157138167|NCT04889209|567252152|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
157138168|NCT04889209|567252153|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
157138169|NCT04889209|567252154|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
157138170|NCT04889209|567252155|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
157138171|NCT04889209|567252156|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
157138172|NCT04889209|567252157|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
157138173|NCT04889209|567252158|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
157138174|NCT04889209|567252159|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
157138175|NCT04889209|567252160|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
157138176|NCT04889209|567252161|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
157138177|NCT04889209|567252162|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
157138178|NCT04889209|567252163|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
156726549|NCT01790984|565746280|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
156726550|NCT01790984|565746281|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
156726551|NCT01051791|565746282|FG000|Overall Study|Failed screening|3|||
156726552|NCT01051791|565746282|FG000|Overall Study|Withdrawal by Subject|1|||
156726553|NCT00288626|565746285|FG000|Overall Study|Death|3|||
156726554|NCT00288626|565746285|FG000|Overall Study|Withdrawal by Subject|4|||
156726555|NCT01609296|565746286|FG000|Overall Study|Death|253|||
156726556|NCT01609296|565746286|FG000|Overall Study|Withdrawal by Subject|151|||
156726557|NCT01609296|565746286|FG000|Overall Study|Lost to Follow-up|21|||
156726558|NCT01609296|565746286|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
156726559|NCT01609296|565746286|FG000|Overall Study|missed visit but known to be alive|28|||
156726560|NCT00546377|565746289|FG000|Overall Study|Deemed ineligible|1|||
156726561|NCT00546377|565746289|FG000|Overall Study|Adverse Event|6|||
156726562|NCT01575834|565746290|FG000|Overall Study|Withdrawal by Subject|352|||
156726563|NCT01575834|565746291|FG001|Overall Study|Withdrawal by Subject|390|||
156726564|NCT01575834|565746290|FG000|Overall Study|Death|81|||
156726565|NCT01575834|565746291|FG001|Overall Study|Death|74|||
156726566|NCT01575834|565746290|FG000|Overall Study|Other|70|||
156726567|NCT01575834|565746291|FG001|Overall Study|Other|70|||
156726568|NCT01575834|565746290|FG000|Overall Study|Adverse Event|63|||
156726569|NCT01575834|565746291|FG001|Overall Study|Adverse Event|61|||
156726570|NCT01575834|565746290|FG000|Overall Study|Lost to Follow-up|55|||
156726571|NCT01575834|565746291|FG001|Overall Study|Lost to Follow-up|68|||
156726572|NCT01575834|565746290|FG000|Overall Study|Noncompliance|52|||
156726573|NCT01575834|565746291|FG001|Overall Study|Noncompliance|27|||
156726574|NCT01575834|565746290|FG000|Overall Study|Administrative decision|15|||
156726575|NCT01575834|565746291|FG001|Overall Study|Administrative decision|33|||
156726576|NCT01575834|565746290|FG000|Overall Study|Ineligibility Determined|5|||
156726577|NCT01575834|565746291|FG001|Overall Study|Ineligibility Determined|8|||
156726578|NCT01575834|565746290|FG000|Overall Study|Protocol Deviation|4|||
156726579|NCT01575834|565746291|FG001|Overall Study|Protocol Deviation|3|||
156726580|NCT01575834|565746290|FG000|Overall Study|Requirement for Alternative Therapy|2|||
156726581|NCT01575834|565746291|FG001|Overall Study|Requirement for Alternative Therapy|4|||
156726582|NCT02155283|565746292|FG000|Overall Study|Lost to Follow-up|3|||
156726583|NCT02155283|565746292|FG000|Overall Study|Withdrawal by Subject|1|||
156726584|NCT02155283|565746292|FG000|Overall Study|Protocol Violation|3|||
156726585|NCT02282813|565746294|FG000|Overall Study|Withdrawal by Subject|4|||
156726586|NCT02282813|565746295|FG001|Overall Study|Withdrawal by Subject|5|||
156726587|NCT02282813|565746296|FG002|Overall Study|Withdrawal by Subject|0|||
156726588|NCT02282813|565746294|FG000|Overall Study|Adverse Event|3|||
156726589|NCT02282813|565746295|FG001|Overall Study|Adverse Event|10|||
156726590|NCT02282813|565746296|FG002|Overall Study|Adverse Event|1|||
156726591|NCT02282813|565746294|FG000|Overall Study|Subject non-compliance|1|||
156726592|NCT02282813|565746295|FG001|Overall Study|Subject non-compliance|4|||
156726593|NCT02282813|565746296|FG002|Overall Study|Subject non-compliance|0|||
156726594|NCT02282813|565746294|FG000|Overall Study|Physician Decision|0|||
156726595|NCT02282813|565746295|FG001|Overall Study|Physician Decision|3|||
156726596|NCT02282813|565746296|FG002|Overall Study|Physician Decision|1|||
156726597|NCT02282813|565746294|FG000|Overall Study|Lost to Follow-up|2|||
156726598|NCT02282813|565746295|FG001|Overall Study|Lost to Follow-up|0|||
156726599|NCT02282813|565746296|FG002|Overall Study|Lost to Follow-up|1|||
156726600|NCT02282813|565746294|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
156726601|NCT02282813|565746295|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
156726602|NCT02282813|565746296|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
156726603|NCT02282813|565746294|FG000|Overall Study|Lack of Efficacy|1|||
156726604|NCT02282813|565746295|FG001|Overall Study|Lack of Efficacy|0|||
156726605|NCT02282813|565746296|FG002|Overall Study|Lack of Efficacy|0|||
156726606|NCT02282813|565746294|FG000|Overall Study|Administrative reasons|0|||
156726607|NCT02282813|565746295|FG001|Overall Study|Administrative reasons|1|||
156726608|NCT02282813|565746296|FG002|Overall Study|Administrative reasons|0|||
156726609|NCT02268916|565746299|FG000|Overall Study|Lost to Follow-up|1|||
156726610|NCT02268916|565746300|FG001|Overall Study|Lost to Follow-up|1|||
156726611|NCT02268916|565746299|FG000|Overall Study|Withdrawal by Subject|6|||
156726612|NCT02268916|565746300|FG001|Overall Study|Withdrawal by Subject|5|||
156726613|NCT02268916|565746299|FG000|Overall Study|Participant did not have diabetes|1|||
157138179|NCT04889209|567252164|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
157138180|NCT04889209|567252165|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
157138181|NCT04889209|567252166|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
157138182|NCT04889209|567252167|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
156726614|NCT02268916|565746300|FG001|Overall Study|Participant did not have diabetes|0|||
156726615|NCT02268916|565746299|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
156726616|NCT02268916|565746300|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
156726617|NCT04526288|565746307|FG000|Overall Study|Disease Progression|1|||
157138183|NCT04889209|567252150|FG000|All Cohorts Except 15E|Physician Decision|0|||
156726618|NCT04526288|565746308|FG001|Overall Study|Disease Progression|0|||
156726619|NCT01796392|565746311|FG000|Overall Study|Withdrawal by Subject|2|||
156726620|NCT01796392|565746312|FG001|Overall Study|Withdrawal by Subject|0|||
156726621|NCT01796392|565746311|FG000|Overall Study|Death|5|||
157138184|NCT04889209|567252151|FG001|All Cohorts Except 15E|Physician Decision|0|||
156795622|NCT01497197|566006135|FG001|Overall Study|Intention to freeze all embryos|1|||
157138185|NCT04889209|567252152|FG002|All Cohorts Except 15E|Physician Decision|0|||
157138186|NCT04889209|567252153|FG003|All Cohorts Except 15E|Physician Decision|0|||
157138187|NCT04889209|567252154|FG004|All Cohorts Except 15E|Physician Decision|1|||
157138188|NCT04889209|567252155|FG005|All Cohorts Except 15E|Physician Decision|0|||
157138189|NCT04889209|567252156|FG006|All Cohorts Except 15E|Physician Decision|0|||
157138190|NCT04889209|567252157|FG007|All Cohorts Except 15E|Physician Decision|1|||
157138191|NCT04889209|567252158|FG008|All Cohorts Except 15E|Physician Decision|0|||
157138192|NCT04889209|567252159|FG009|All Cohorts Except 15E|Physician Decision|1|||
157138193|NCT04889209|567252160|FG010|All Cohorts Except 15E|Physician Decision|0|||
157138194|NCT04889209|567252161|FG011|All Cohorts Except 15E|Physician Decision|1|||
157138195|NCT04889209|567252162|FG012|All Cohorts Except 15E|Physician Decision|1|||
157138196|NCT04889209|567252163|FG013|All Cohorts Except 15E|Physician Decision|0|||
157138197|NCT04889209|567252164|FG014|All Cohorts Except 15E|Physician Decision|0|||
157138198|NCT04889209|567252165|FG015|All Cohorts Except 15E|Physician Decision|0|||
156726622|NCT01796392|565746312|FG001|Overall Study|Death|1|||
156726623|NCT01796392|565746311|FG000|Overall Study|Excluded for medical reasons|1|||
156726624|NCT01796392|565746312|FG001|Overall Study|Excluded for medical reasons|2|||
156726625|NCT01796392|565746311|FG000|Overall Study|Lost to Follow-up|1|||
156726626|NCT01796392|565746312|FG001|Overall Study|Lost to Follow-up|0|||
156726627|NCT04639219|565746313|FG000|Overall Study|Withdrawal by Subject|8|||
157019725|NCT02729311|566826469|FG000|Overall Study|Withdrawal by Subject|8|||
157019726|NCT02729311|566826470|FG001|Overall Study|Withdrawal by Subject|2|||
157019727|NCT05324124|566826471|FG000|Period 1|Withdrawal by Subject|1|||
157019728|NCT05324124|566826472|FG001|Period 1|Withdrawal by Subject|0|||
157138199|NCT04889209|567252166|FG016|All Cohorts Except 15E|Physician Decision|0|||
156726628|NCT04639219|565746313|FG000|Overall Study|Lost to Follow-up|6|||
156726629|NCT04639219|565746313|FG000|Overall Study|Death|55|||
156726630|NCT02747108|565746317|FG000|Overall Study|Death|2|||
156726631|NCT02747108|565746318|FG001|Overall Study|Death|2|||
156726632|NCT02747108|565746317|FG000|Overall Study|Withdrawal by Subject|1|||
156726633|NCT02747108|565746318|FG001|Overall Study|Withdrawal by Subject|0|||
156726634|NCT02747108|565746317|FG000|Overall Study|Protocol Violation|2|||
156726635|NCT02747108|565746318|FG001|Overall Study|Protocol Violation|0|||
156726636|NCT03474965|565746319|FG000|Overall Study|Pregnancy|1|||
156726637|NCT03474965|565746320|FG001|Overall Study|Pregnancy|0|||
156726638|NCT03474965|565746321|FG002|Overall Study|Pregnancy|0|||
156726639|NCT03474965|565746322|FG003|Overall Study|Pregnancy|0|||
156726640|NCT03474965|565746319|FG000|Overall Study|Lost to Follow-up|0|||
156726641|NCT03474965|565746320|FG001|Overall Study|Lost to Follow-up|0|||
156726642|NCT03474965|565746321|FG002|Overall Study|Lost to Follow-up|1|||
156726643|NCT03474965|565746322|FG003|Overall Study|Lost to Follow-up|0|||
156726644|NCT03474965|565746319|FG000|Overall Study|Death|1|||
156726645|NCT03474965|565746320|FG001|Overall Study|Death|0|||
156726646|NCT03474965|565746321|FG002|Overall Study|Death|0|||
156726647|NCT03474965|565746322|FG003|Overall Study|Death|0|||
156726648|NCT03474965|565746319|FG000|Overall Study|Adverse Event|1|||
156726649|NCT03474965|565746320|FG001|Overall Study|Adverse Event|0|||
156726650|NCT03474965|565746321|FG002|Overall Study|Adverse Event|0|||
156726651|NCT03474965|565746322|FG003|Overall Study|Adverse Event|1|||
156726652|NCT03474965|565746319|FG000|Overall Study|Physician Decision|3|||
156726653|NCT03474965|565746320|FG001|Overall Study|Physician Decision|1|||
156726654|NCT03474965|565746321|FG002|Overall Study|Physician Decision|2|||
156726655|NCT03474965|565746322|FG003|Overall Study|Physician Decision|0|||
156726656|NCT03474965|565746319|FG000|Overall Study|Participant Decision|7|||
156726657|NCT03474965|565746320|FG001|Overall Study|Participant Decision|0|||
156726658|NCT03474965|565746321|FG002|Overall Study|Participant Decision|1|||
156726659|NCT03474965|565746322|FG003|Overall Study|Participant Decision|0|||
156726660|NCT03474965|565746319|FG000|Overall Study|Guardian Decision|4|||
156726661|NCT03474965|565746320|FG001|Overall Study|Guardian Decision|2|||
156726662|NCT03474965|565746321|FG002|Overall Study|Guardian Decision|7|||
156726663|NCT03474965|565746322|FG003|Overall Study|Guardian Decision|2|||
156726664|NCT05678959|565748241|FG000|Overall Study|Study Terminated by Sponsor|76|||
156726665|NCT05678959|565748242|FG001|Overall Study|Study Terminated by Sponsor|76|||
156726666|NCT05678959|565748241|FG000|Overall Study|Physician Decision|2|||
156726667|NCT05678959|565748242|FG001|Overall Study|Physician Decision|3|||
156726668|NCT05678959|565748241|FG000|Overall Study|Adverse Event|1|||
156726669|NCT05678959|565748242|FG001|Overall Study|Adverse Event|1|||
156876201|NCT01904773|566305762|FG004|Fifth Intervention|Adverse Event|0|||
157138200|NCT04889209|567252167|FG017|All Cohorts Except 15E|Physician Decision|0|||
157138201|NCT04889209|567252150|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
157138202|NCT04889209|567252151|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
157138203|NCT04889209|567252152|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
157138204|NCT04889209|567252153|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
156726670|NCT05678959|565748241|FG000|Overall Study|Guardian Decision|1|||
156726671|NCT05678959|565748242|FG001|Overall Study|Guardian Decision|0|||
156726672|NCT05678959|565748241|FG000|Overall Study|Protocol Deviation|0|||
156726673|NCT05678959|565748242|FG001|Overall Study|Protocol Deviation|1|||
156726674|NCT05678959|565748241|FG000|Overall Study|Subject Decision|1|||
156726675|NCT05678959|565748242|FG001|Overall Study|Subject Decision|0|||
157138205|NCT04889209|567252154|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
157138206|NCT04889209|567252155|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138207|NCT04889209|567252156|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138208|NCT04889209|567252157|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
157138209|NCT04889209|567252158|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138210|NCT04889209|567252159|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138211|NCT04889209|567252160|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138212|NCT04889209|567252161|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138213|NCT04889209|567252162|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138214|NCT04889209|567252163|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
157138215|NCT04889209|567252164|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
157138216|NCT04889209|567252165|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
157138217|NCT04889209|567252166|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
157138218|NCT04889209|567252167|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
156726676|NCT05678959|565748241|FG000|Overall Study|Technical Problem|0|||
156726677|NCT05678959|565748242|FG001|Overall Study|Technical Problem|1|||
156726678|NCT03503370|565748243|FG000|Overall Study|Death|3|||
156726679|NCT03503370|565748244|FG001|Overall Study|Death|1|||
156726680|NCT03483961|565748245|FG000|Overall Study|Lost to Follow-up|7|||
156726681|NCT03483961|565748246|FG001|Overall Study|Lost to Follow-up|6|||
156726682|NCT03483961|565748247|FG002|Overall Study|Lost to Follow-up|6|||
156726683|NCT03483961|565748248|FG003|Overall Study|Lost to Follow-up|6|||
156726684|NCT03483961|565748249|FG004|Overall Study|Lost to Follow-up|6|||
156726685|NCT03483961|565748250|FG005|Overall Study|Lost to Follow-up|4|||
156726686|NCT03483961|565748251|FG006|Overall Study|Lost to Follow-up|4|||
156726687|NCT03483961|565748252|FG007|Overall Study|Lost to Follow-up|11|||
156726688|NCT03483961|565748253|FG008|Overall Study|Lost to Follow-up|1|||
156726689|NCT03483961|565748254|FG009|Overall Study|Lost to Follow-up|0|||
156726690|NCT03483961|565748245|FG000|Overall Study|Withdrawal by Subject|3|||
156726691|NCT03483961|565748246|FG001|Overall Study|Withdrawal by Subject|4|||
156726692|NCT03483961|565748247|FG002|Overall Study|Withdrawal by Subject|5|||
156726693|NCT03483961|565748248|FG003|Overall Study|Withdrawal by Subject|3|||
156726694|NCT03483961|565748249|FG004|Overall Study|Withdrawal by Subject|4|||
156726695|NCT03483961|565748250|FG005|Overall Study|Withdrawal by Subject|2|||
156726696|NCT03483961|565748251|FG006|Overall Study|Withdrawal by Subject|1|||
156726697|NCT03483961|565748252|FG007|Overall Study|Withdrawal by Subject|2|||
156726698|NCT03483961|565748253|FG008|Overall Study|Withdrawal by Subject|1|||
156726699|NCT03483961|565748254|FG009|Overall Study|Withdrawal by Subject|0|||
157019729|NCT05324124|566826471|FG000|Period 1|Physician Decision|0|||
157019730|NCT05324124|566826472|FG001|Period 1|Physician Decision|1|||
157019731|NCT00920621|566826476|FG000|Overall Study|Lost to Follow-up|16|||
157138219|NCT04889209|567252150|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
157138220|NCT04889209|567252151|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
157138221|NCT04889209|567252152|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138222|NCT04889209|567252153|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138223|NCT04889209|567252154|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138224|NCT04889209|567252155|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
157138225|NCT04889209|567252156|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138226|NCT04889209|567252157|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
157138227|NCT04889209|567252158|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138228|NCT04889209|567252159|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
157138229|NCT04889209|567252160|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138230|NCT04889209|567252161|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138231|NCT04889209|567252162|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138232|NCT04889209|567252163|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138233|NCT04889209|567252164|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138234|NCT04889209|567252165|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138235|NCT04889209|567252166|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
157138236|NCT04889209|567252167|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
157138237|NCT04889209|567252150|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138238|NCT04889209|567252151|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138239|NCT04889209|567252152|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157217413|NCT01621490|567543224|FG002|Overall Study|Withdrawal by Subject|0|||
157217414|NCT01621490|567543225|FG003|Overall Study|Withdrawal by Subject|0|||
156726700|NCT03483961|565748245|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
156795623|NCT01497197|566006134|FG000|Overall Study|All embryos discarded|0|||
157019732|NCT00920621|566826477|FG001|Overall Study|Lost to Follow-up|17|||
157019733|NCT00920621|566826478|FG002|Overall Study|Lost to Follow-up|19|||
156726701|NCT03483961|565748246|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726702|NCT03483961|565748247|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726703|NCT03483961|565748248|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726704|NCT03483961|565748249|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726705|NCT03483961|565748250|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726706|NCT03483961|565748251|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726707|NCT03483961|565748252|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726708|NCT03483961|565748253|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726709|NCT03483961|565748254|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
156726710|NCT03483961|565748245|FG000|Overall Study|Adverse Event|0|||
156726711|NCT03483961|565748246|FG001|Overall Study|Adverse Event|0|||
156726712|NCT03483961|565748247|FG002|Overall Study|Adverse Event|1|||
156726713|NCT03483961|565748248|FG003|Overall Study|Adverse Event|0|||
156726714|NCT03483961|565748249|FG004|Overall Study|Adverse Event|0|||
156726715|NCT03483961|565748250|FG005|Overall Study|Adverse Event|0|||
156726716|NCT03483961|565748251|FG006|Overall Study|Adverse Event|0|||
156726717|NCT03483961|565748252|FG007|Overall Study|Adverse Event|0|||
156726718|NCT03483961|565748253|FG008|Overall Study|Adverse Event|0|||
156726719|NCT03483961|565748254|FG009|Overall Study|Adverse Event|0|||
156726720|NCT00734162|565748255|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
156726721|NCT00734162|565748256|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
156726722|NCT00734162|565748257|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
156726723|NCT00734162|565748258|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
156726724|NCT00734162|565748255|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726725|NCT00734162|565748256|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726726|NCT00734162|565748257|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
156726727|NCT00734162|565748258|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
156726728|NCT00734162|565748255|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
156726729|NCT00734162|565748256|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726730|NCT00734162|565748257|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726731|NCT00734162|565748258|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
156726732|NCT00734162|565748255|FG000|Open-Label Phase|Withdrew Consent|1|||
156726733|NCT00734162|565748256|FG001|Open-Label Phase|Withdrew Consent|0|||
156726734|NCT00734162|565748257|FG002|Open-Label Phase|Withdrew Consent|1|||
156726735|NCT00734162|565748258|FG003|Open-Label Phase|Withdrew Consent|1|||
156726736|NCT00734162|565748255|FG000|Open-Label Phase|Lost to Follow-up|1|||
156726737|NCT00734162|565748256|FG001|Open-Label Phase|Lost to Follow-up|2|||
156726738|NCT00734162|565748257|FG002|Open-Label Phase|Lost to Follow-up|0|||
156726739|NCT00734162|565748258|FG003|Open-Label Phase|Lost to Follow-up|1|||
156726740|NCT00734162|565748255|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726741|NCT00734162|565748256|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726742|NCT00734162|565748257|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
156726743|NCT00734162|565748258|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
156726744|NCT00566020|565748259|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
156726745|NCT00566020|565748260|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
156726746|NCT00566020|565748259|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
156726747|NCT00566020|565748260|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
156726748|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
156726749|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
156726750|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
156726751|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
156726752|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
156726753|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
156726754|NCT00566020|565748259|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
156726755|NCT00566020|565748260|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
156726756|NCT02058537|565748261|FG000|Overall Study|Withdrawal by Subject|1|||
156795624|NCT01497197|566006135|FG001|Overall Study|All embryos discarded|3|||
156795625|NCT01497197|566006134|FG000|Overall Study|Other|3|||
156795626|NCT01497197|566006135|FG001|Overall Study|Other|1|||
156795627|NCT04484857|566006136|FG000|Overall Study|Adverse Event|2|||
156795628|NCT04484857|566006136|FG000|Overall Study|Death|10|||
156795629|NCT04484857|566006136|FG000|Overall Study|Withdrawal by Subject|3|||
156795630|NCT04484857|566006136|FG000|Overall Study|Transferred/Relocation|5|||
156726757|NCT02609607|565748267|FG000|Overall Study|Lost to Follow-up|0|||
156726758|NCT02609607|565748268|FG001|Overall Study|Lost to Follow-up|1|||
156795631|NCT04484857|566006136|FG000|Overall Study|Kidney Transplant|7|||
156876202|NCT01904773|566305763|FG005|Fifth Intervention|Adverse Event|0|||
156726759|NCT00651261|565748269|FG000|Overall Study|Adverse Event|32|||
157019734|NCT00920621|566826479|FG003|Overall Study|Lost to Follow-up|21|||
157019735|NCT00920621|566826476|FG000|Overall Study|Fetal/neonatal deaths|16|||
157019736|NCT00920621|566826477|FG001|Overall Study|Fetal/neonatal deaths|14|||
157019737|NCT00920621|566826478|FG002|Overall Study|Fetal/neonatal deaths|16|||
157019738|NCT00920621|566826479|FG003|Overall Study|Fetal/neonatal deaths|14|||
157019739|NCT00920621|566826476|FG000|Overall Study|Blood sample not collected|22|||
157019740|NCT00920621|566826477|FG001|Overall Study|Blood sample not collected|14|||
157019741|NCT00920621|566826478|FG002|Overall Study|Blood sample not collected|0|||
157019742|NCT00920621|566826479|FG003|Overall Study|Blood sample not collected|0|||
157019743|NCT06074523|566826480|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
157019744|NCT06074523|566826480|FG000|Overall Study|Withdrawal by Subject|1|||
157019745|NCT01426425|566826481|FG000|Overall Study|Exited prior to EP study|22|||
157019746|NCT01426425|566826481|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
157019747|NCT01426425|566826481|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
157019748|NCT00512070|566826487|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
157138240|NCT04889209|567252153|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
156726760|NCT00651261|565748270|FG001|Overall Study|Adverse Event|22|||
156726761|NCT00651261|565748269|FG000|Overall Study|Death|18|||
156726762|NCT00651261|565748270|FG001|Overall Study|Death|18|||
156726763|NCT00651261|565748269|FG000|Overall Study|Withdrawal by Subject|22|||
156726764|NCT00651261|565748270|FG001|Overall Study|Withdrawal by Subject|40|||
156726765|NCT00651261|565748269|FG000|Overall Study|Induction failure|24|||
156726766|NCT00651261|565748270|FG001|Overall Study|Induction failure|35|||
156726767|NCT00651261|565748269|FG000|Overall Study|Disease progression|58|||
156726768|NCT00651261|565748270|FG001|Overall Study|Disease progression|58|||
156726769|NCT00651261|565748269|FG000|Overall Study|Alternative therapy|109|||
156726770|NCT00651261|565748270|FG001|Overall Study|Alternative therapy|107|||
156726771|NCT00651261|565748269|FG000|Overall Study|Other disease or participant decisions|23|||
156726772|NCT00651261|565748270|FG001|Overall Study|Other disease or participant decisions|23|||
157138241|NCT04889209|567252154|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138242|NCT04889209|567252155|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138243|NCT04889209|567252156|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138244|NCT04889209|567252157|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138245|NCT04889209|567252158|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138246|NCT04889209|567252159|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138247|NCT04889209|567252160|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138248|NCT04889209|567252161|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138249|NCT04889209|567252162|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138250|NCT04889209|567252163|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138251|NCT04889209|567252164|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138252|NCT04889209|567252165|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138253|NCT04889209|567252166|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138254|NCT04889209|567252167|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
157138255|NCT04889209|567252150|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138256|NCT04889209|567252151|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138257|NCT04889209|567252152|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138258|NCT04889209|567252153|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138259|NCT04889209|567252154|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138260|NCT04889209|567252155|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138261|NCT04889209|567252156|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138262|NCT04889209|567252157|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138263|NCT04889209|567252158|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138264|NCT04889209|567252159|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138265|NCT04889209|567252160|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138266|NCT04889209|567252161|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157217415|NCT01621490|567543226|FG004|Overall Study|Withdrawal by Subject|0|||
157217416|NCT01621490|567543227|FG005|Overall Study|Withdrawal by Subject|1|||
156726773|NCT00651261|565748269|FG000|Overall Study|Never treated|5|||
156726774|NCT00651261|565748270|FG001|Overall Study|Never treated|3|||
156726775|NCT04610346|565748273|FG000|Overall Study|Withdrawal by Subject|1|||
156726776|NCT04610346|565748274|FG001|Overall Study|Withdrawal by Subject|1|||
156726777|NCT04610346|565748273|FG000|Overall Study|did not complete shelter onboarding|2|||
156726778|NCT04610346|565748274|FG001|Overall Study|did not complete shelter onboarding|1|||
156726779|NCT00558467|565748275|FG000|Overall Study|Adverse Event|1|||
157138267|NCT04889209|567252162|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138268|NCT04889209|567252163|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138269|NCT04889209|567252164|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138270|NCT04889209|567252165|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138271|NCT04889209|567252166|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
157138272|NCT04889209|567252167|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
157138273|NCT04889209|567252150|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138274|NCT04889209|567252151|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138275|NCT04889209|567252152|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138276|NCT04889209|567252153|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138277|NCT04889209|567252154|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138278|NCT04889209|567252155|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138279|NCT04889209|567252156|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138280|NCT04889209|567252157|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138281|NCT04889209|567252158|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138282|NCT04889209|567252159|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138283|NCT04889209|567252160|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138284|NCT04889209|567252161|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138285|NCT04889209|567252162|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138286|NCT04889209|567252163|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138287|NCT04889209|567252164|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138288|NCT04889209|567252165|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138289|NCT04889209|567252166|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
157138290|NCT04889209|567252167|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
157138291|NCT04889209|567252150|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138292|NCT04889209|567252151|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138293|NCT04889209|567252152|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138294|NCT04889209|567252153|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138295|NCT04889209|567252154|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138296|NCT04889209|567252155|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138297|NCT04889209|567252156|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138298|NCT04889209|567252157|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138299|NCT04889209|567252158|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138300|NCT04889209|567252159|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138301|NCT04889209|567252160|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138302|NCT04889209|567252161|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138303|NCT04889209|567252162|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138304|NCT04889209|567252163|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138305|NCT04889209|567252164|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138306|NCT04889209|567252165|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138307|NCT04889209|567252166|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
157138308|NCT04889209|567252167|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
157138309|NCT04889209|567252150|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138310|NCT04889209|567252151|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138311|NCT04889209|567252152|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138312|NCT04889209|567252153|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138313|NCT04889209|567252154|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138314|NCT04889209|567252155|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138315|NCT04889209|567252156|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138316|NCT04889209|567252157|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138317|NCT04889209|567252158|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138318|NCT04889209|567252159|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157217417|NCT01621490|567543228|FG006|Overall Study|Withdrawal by Subject|0|||
157217418|NCT01621490|567543229|FG007|Overall Study|Withdrawal by Subject|0|||
157217419|NCT01621490|567543230|FG008|Overall Study|Withdrawal by Subject|0|||
157217420|NCT01621490|567543231|FG009|Overall Study|Withdrawal by Subject|0|||
157217421|NCT01621490|567543232|FG010|Overall Study|Withdrawal by Subject|0|||
157217422|NCT01621490|567543222|FG000|Overall Study|Subject request to discontinue study|1|||
157217423|NCT01621490|567543223|FG001|Overall Study|Subject request to discontinue study|3|||
157138319|NCT04889209|567252160|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138320|NCT04889209|567252161|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157217424|NCT01621490|567543224|FG002|Overall Study|Subject request to discontinue study|1|||
157217425|NCT01621490|567543225|FG003|Overall Study|Subject request to discontinue study|1|||
156726780|NCT00558467|565748276|FG001|Overall Study|Adverse Event|2|||
156726781|NCT00558467|565748275|FG000|Overall Study|Lack of Efficacy|0|||
156726782|NCT00558467|565748276|FG001|Overall Study|Lack of Efficacy|1|||
156726783|NCT00558467|565748275|FG000|Overall Study|Patient moving out of state|0|||
156726784|NCT00558467|565748276|FG001|Overall Study|Patient moving out of state|1|||
156726785|NCT00931255|565748277|FG000|Overall Study|Follow up biopsy not done|2|||
156726786|NCT00931255|565748278|FG001|Overall Study|Follow up biopsy not done|3|||
156726787|NCT02019264|565748281|FG000|Overall Study|Not treated|6|||
156726788|NCT02019264|565748282|FG001|Overall Study|Not treated|4|||
156726789|NCT02019264|565748281|FG000|Overall Study|Lost to Follow-up|50|||
156726790|NCT02019264|565748282|FG001|Overall Study|Lost to Follow-up|47|||
156726791|NCT02019264|565748281|FG000|Overall Study|Withdrawal by Subject|142|||
156726792|NCT02019264|565748282|FG001|Overall Study|Withdrawal by Subject|117|||
156726793|NCT02019264|565748281|FG000|Overall Study|Administrative reason|36|||
156726794|NCT02019264|565748282|FG001|Overall Study|Administrative reason|28|||
156726795|NCT02019264|565748281|FG000|Overall Study|Missing|14|||
156726796|NCT02019264|565748282|FG001|Overall Study|Missing|11|||
156726797|NCT01684423|565748287|FG000|Overall Study|Withdrawal by Subject|0|||
156726798|NCT01684423|565748288|FG001|Overall Study|Withdrawal by Subject|0|||
156726799|NCT01684423|565748289|FG002|Overall Study|Withdrawal by Subject|1|||
156726800|NCT01684423|565748290|FG003|Overall Study|Withdrawal by Subject|0|||
156726801|NCT01684423|565748291|FG004|Overall Study|Withdrawal by Subject|0|||
156726802|NCT01741688|565748294|FG000|Overall Study|Lack of insurance coverage|2|||
156726803|NCT01741688|565748294|FG000|Overall Study|Withdrawal by Subject|1|||
156726804|NCT03850496|565748299|FG000|Overall Study|Withdrawal by Subject|1|||
156726805|NCT03850496|565748300|FG001|Overall Study|Withdrawal by Subject|0|||
156726806|NCT03850496|565748301|FG002|Overall Study|Withdrawal by Subject|0|||
156726807|NCT03850496|565748299|FG000|Overall Study|Lost to Follow-up|0|||
156726808|NCT03850496|565748300|FG001|Overall Study|Lost to Follow-up|1|||
156795632|NCT04484857|566006136|FG000|Overall Study|Other than specified|4|||
156795633|NCT04484857|566006136|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
156795634|NCT01425814|566006137|FG000|Period 1|Stability criteria not fulfilled|0|||
156795635|NCT01425814|566006138|FG001|Period 1|Stability criteria not fulfilled|1|||
156795636|NCT01425814|566006139|FG002|Period 1|Stability criteria not fulfilled|0|||
156795637|NCT01425814|566006140|FG003|Period 1|Stability criteria not fulfilled|0|||
156795638|NCT01425814|566006141|FG004|Period 1|Stability criteria not fulfilled|0|||
156726809|NCT03850496|565748301|FG002|Overall Study|Lost to Follow-up|4|||
156726810|NCT00869999|565748309|FG000|Overall Study|Withdrawal by Subject|1|||
156726811|NCT00869999|565748309|FG000|Overall Study|removed prior to starting therapy|1|||
156726812|NCT00463047|565748312|FG000|Titration Period 1|Adverse Event|10|||
156726813|NCT00463047|565748313|FG001|Titration Period 1|Adverse Event|8|||
156795639|NCT01425814|566006142|FG005|Period 1|Stability criteria not fulfilled|0|||
156795640|NCT01425814|566006137|FG000|Period 2|Stability criteria not fulfilled|0|||
156795641|NCT01425814|566006138|FG001|Period 2|Stability criteria not fulfilled|1|||
156795642|NCT01425814|566006139|FG002|Period 2|Stability criteria not fulfilled|0|||
156795643|NCT01425814|566006140|FG003|Period 2|Stability criteria not fulfilled|0|||
156795644|NCT01425814|566006141|FG004|Period 2|Stability criteria not fulfilled|0|||
156795645|NCT01425814|566006142|FG005|Period 2|Stability criteria not fulfilled|0|||
156795646|NCT01425814|566006137|FG000|Period 3|Adverse Event|0|||
156795647|NCT01425814|566006138|FG001|Period 3|Adverse Event|0|||
156795648|NCT01425814|566006139|FG002|Period 3|Adverse Event|0|||
156795649|NCT01425814|566006140|FG003|Period 3|Adverse Event|0|||
156795650|NCT01425814|566006141|FG004|Period 3|Adverse Event|0|||
156795651|NCT01425814|566006142|FG005|Period 3|Adverse Event|1|||
156795652|NCT01425814|566006137|FG000|Period 4|Adverse Event|1|||
156795653|NCT01425814|566006138|FG001|Period 4|Adverse Event|0|||
156795654|NCT01425814|566006139|FG002|Period 4|Adverse Event|1|||
156795655|NCT01425814|566006140|FG003|Period 4|Adverse Event|0|||
156795656|NCT01425814|566006141|FG004|Period 4|Adverse Event|0|||
156795657|NCT01425814|566006142|FG005|Period 4|Adverse Event|0|||
156795658|NCT01425814|566006137|FG000|Period 5|Stability criteria not fulfilled|0|||
156795659|NCT01425814|566006138|FG001|Period 5|Stability criteria not fulfilled|0|||
156795660|NCT01425814|566006139|FG002|Period 5|Stability criteria not fulfilled|1|||
156795661|NCT01425814|566006140|FG003|Period 5|Stability criteria not fulfilled|0|||
156795662|NCT01425814|566006141|FG004|Period 5|Stability criteria not fulfilled|0|||
156726814|NCT00463047|565748312|FG000|Titration Period 1|Lack of Efficacy|10|||
156726815|NCT00463047|565748313|FG001|Titration Period 1|Lack of Efficacy|4|||
156795663|NCT01425814|566006142|FG005|Period 5|Stability criteria not fulfilled|1|||
156795664|NCT00565747|566006143|FG000|Overall Study|No embryo transfer|67|||
156795665|NCT00565747|566006144|FG001|Overall Study|No embryo transfer|73|||
156795666|NCT02684461|566006145|FG000|Overall Study|Adverse Event|1|||
156795667|NCT02684461|566006146|FG001|Overall Study|Adverse Event|0|||
156795668|NCT02684461|566006147|FG002|Overall Study|Adverse Event|0|||
156795669|NCT02684461|566006145|FG000|Overall Study|Lack of Efficacy|1|||
156795670|NCT02684461|566006146|FG001|Overall Study|Lack of Efficacy|2|||
156795671|NCT02684461|566006147|FG002|Overall Study|Lack of Efficacy|0|||
156795672|NCT04507204|566006148|FG000|Overall Study|Adverse Event|8|||
156795673|NCT04507204|566006149|FG001|Overall Study|Adverse Event|13|||
156795674|NCT04507204|566006148|FG000|Overall Study|Death|0|||
156795675|NCT04507204|566006149|FG001|Overall Study|Death|1|||
156795676|NCT04507204|566006148|FG000|Overall Study|Lost to Follow-up|15|||
157138321|NCT04889209|567252162|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138322|NCT04889209|567252163|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138323|NCT04889209|567252164|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
156726816|NCT00463047|565748312|FG000|Titration Period 1|Lost to Follow-up|2|||
156726817|NCT00463047|565748313|FG001|Titration Period 1|Lost to Follow-up|0|||
156726818|NCT00463047|565748312|FG000|Titration Period 1|Non-compliance with study medication|3|||
156726819|NCT00463047|565748313|FG001|Titration Period 1|Non-compliance with study medication|5|||
156726820|NCT00463047|565748312|FG000|Titration Period 1|Protocol Violation|5|||
156726821|NCT00463047|565748313|FG001|Titration Period 1|Protocol Violation|5|||
156726822|NCT00463047|565748312|FG000|Titration Period 1|Withdrawal by Subject|3|||
156726823|NCT00463047|565748313|FG001|Titration Period 1|Withdrawal by Subject|5|||
156726824|NCT00463047|565748312|FG000|Titration Period 1|Non-compliance procedures|4|||
156726825|NCT00463047|565748313|FG001|Titration Period 1|Non-compliance procedures|10|||
156726826|NCT00463047|565748312|FG000|Titration Period 1|Other|0|||
156726827|NCT00463047|565748313|FG001|Titration Period 1|Other|2|||
156726828|NCT00463047|565748312|FG000|Titration Period 2|Adverse Event|9|||
156726829|NCT00463047|565748313|FG001|Titration Period 2|Adverse Event|9|||
156726830|NCT00463047|565748312|FG000|Titration Period 2|Lack of Efficacy|6|||
156726831|NCT00463047|565748313|FG001|Titration Period 2|Lack of Efficacy|4|||
156726832|NCT00463047|565748312|FG000|Titration Period 2|Withdrawal by Subject|1|||
156726833|NCT00463047|565748313|FG001|Titration Period 2|Withdrawal by Subject|0|||
156726834|NCT00463047|565748312|FG000|Titration Period 2|Protocol Violation|2|||
156726835|NCT00463047|565748313|FG001|Titration Period 2|Protocol Violation|3|||
156726836|NCT00463047|565748312|FG000|Titration Period 2|Lost to Follow-up|1|||
156726837|NCT00463047|565748313|FG001|Titration Period 2|Lost to Follow-up|2|||
156726838|NCT00463047|565748312|FG000|Titration Period 2|Non-compliance study medication|4|||
156726839|NCT00463047|565748313|FG001|Titration Period 2|Non-compliance study medication|2|||
156726840|NCT00463047|565748312|FG000|Titration Period 2|Non-compliance procedures|4|||
156726841|NCT00463047|565748313|FG001|Titration Period 2|Non-compliance procedures|1|||
156726842|NCT00463047|565748312|FG000|Titration Period 2|Other|3|||
156726843|NCT00463047|565748313|FG001|Titration Period 2|Other|2|||
156726844|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
156726845|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
156726846|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
156726847|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
156726848|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
156726849|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
156726850|NCT00463047|565748312|FG000|Double-Blind Treatment Period 1|Other|1|||
156726851|NCT00463047|565748313|FG001|Double-Blind Treatment Period 1|Other|0|||
156726852|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
156726853|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
156795677|NCT04507204|566006149|FG001|Overall Study|Lost to Follow-up|14|||
156795678|NCT04507204|566006148|FG000|Overall Study|Poor Compliance with Protocol|2|||
156795679|NCT04507204|566006149|FG001|Overall Study|Poor Compliance with Protocol|4|||
156795680|NCT04507204|566006148|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
156795681|NCT04507204|566006149|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
156795682|NCT04507204|566006148|FG000|Overall Study|Withdrawal of Patient Consent|21|||
156795683|NCT04507204|566006149|FG001|Overall Study|Withdrawal of Patient Consent|13|||
156795684|NCT03580044|566006150|FG000|Overall Study|Death|2|||
156795685|NCT03580044|566006151|FG001|Overall Study|Death|1|||
156795686|NCT03580044|566006150|FG000|Overall Study|Withdrawal by Subject|1|||
156795687|NCT03580044|566006151|FG001|Overall Study|Withdrawal by Subject|1|||
156795688|NCT02697448|566006156|FG000|Overall Study|Protocol Violation|2|||
156795689|NCT02697448|566006157|FG001|Overall Study|Protocol Violation|4|||
156795690|NCT02697448|566006156|FG000|Overall Study|Clinical concerns during ablation|1|||
156795691|NCT02697448|566006157|FG001|Overall Study|Clinical concerns during ablation|1|||
156795692|NCT02697448|566006156|FG000|Overall Study|No data collected|2|||
156795693|NCT02697448|566006157|FG001|Overall Study|No data collected|0|||
156795694|NCT02919618|566006162|FG000|Overall Study|Death|1|||
156795695|NCT02592863|566006163|FG000|Overall Study|Withdrawal by Subject|2|||
156795696|NCT02592863|566006164|FG001|Overall Study|Withdrawal by Subject|2|||
156795697|NCT02592863|566006163|FG000|Overall Study|Lost to Follow-up|1|||
156795698|NCT02592863|566006164|FG001|Overall Study|Lost to Follow-up|1|||
156795699|NCT02743221|566006165|FG000|Overall Study|Progressive disease|29|||
156795700|NCT02743221|566006166|FG001|Overall Study|Progressive disease|38|||
156795701|NCT02743221|566006165|FG000|Overall Study|Adverse Event|17|||
156795702|NCT02743221|566006166|FG001|Overall Study|Adverse Event|14|||
156795703|NCT02743221|566006165|FG000|Overall Study|non medical reason|8|||
156795704|NCT02743221|566006166|FG001|Overall Study|non medical reason|2|||
156795705|NCT02743221|566006165|FG000|Overall Study|Physician Decision|2|||
156795706|NCT02743221|566006166|FG001|Overall Study|Physician Decision|5|||
156795707|NCT02743221|566006165|FG000|Overall Study|Patient not eligible, not treated|0|||
156795708|NCT02743221|566006166|FG001|Overall Study|Patient not eligible, not treated|1|||
156795709|NCT03411044|566006169|FG000|Overall Study|Death|30|||
156726854|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
156726855|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
156726856|NCT00463047|565748312|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
156726857|NCT00463047|565748313|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
156726858|NCT03674112|565748314|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
156726859|NCT03674112|565748315|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
156726860|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
156726861|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
156726862|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
156726863|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
156726864|NCT03674112|565748314|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
156726865|NCT03674112|565748315|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
156726866|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
156726867|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
157019749|NCT00512070|566826488|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
157019750|NCT00512070|566826489|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
157019751|NCT00512070|566826487|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
157019752|NCT00512070|566826488|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
157019753|NCT00512070|566826489|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
157019754|NCT00961571|566826490|FG000|Overall Study|Physician Decision|39|||
157019755|NCT05862870|566826496|FG000|Overall Study|Lost to Follow-up|3|||
157019756|NCT04321031|566826497|FG000|Overall Study|Adverse Event|0|||
157019757|NCT04321031|566826498|FG001|Overall Study|Adverse Event|2|||
157019758|NCT04321031|566826499|FG002|Overall Study|Adverse Event|2|||
157019759|NCT04321031|566826500|FG003|Overall Study|Adverse Event|2|||
157019760|NCT04321031|566826501|FG004|Overall Study|Adverse Event|2|||
157019761|NCT04321031|566826502|FG005|Overall Study|Adverse Event|2|||
157019762|NCT04321031|566826503|FG006|Overall Study|Adverse Event|0|||
157019763|NCT04321031|566826497|FG000|Overall Study|Lost to Follow-up|0|||
157019764|NCT04321031|566826498|FG001|Overall Study|Lost to Follow-up|0|||
157019765|NCT04321031|566826499|FG002|Overall Study|Lost to Follow-up|0|||
157019766|NCT04321031|566826500|FG003|Overall Study|Lost to Follow-up|1|||
157019767|NCT04321031|566826501|FG004|Overall Study|Lost to Follow-up|0|||
157019768|NCT04321031|566826502|FG005|Overall Study|Lost to Follow-up|2|||
157019769|NCT04321031|566826503|FG006|Overall Study|Lost to Follow-up|1|||
157019770|NCT04321031|566826497|FG000|Overall Study|Withdrawal by Subject|2|||
157019771|NCT04321031|566826498|FG001|Overall Study|Withdrawal by Subject|2|||
157019772|NCT04321031|566826499|FG002|Overall Study|Withdrawal by Subject|1|||
157019773|NCT04321031|566826500|FG003|Overall Study|Withdrawal by Subject|3|||
157019774|NCT04321031|566826501|FG004|Overall Study|Withdrawal by Subject|1|||
157019775|NCT04321031|566826502|FG005|Overall Study|Withdrawal by Subject|0|||
157019776|NCT04321031|566826503|FG006|Overall Study|Withdrawal by Subject|1|||
157019777|NCT04321031|566826497|FG000|Overall Study|Non-compliance with study drug|0|||
157019778|NCT04321031|566826498|FG001|Overall Study|Non-compliance with study drug|0|||
157019779|NCT04321031|566826499|FG002|Overall Study|Non-compliance with study drug|0|||
157019780|NCT04321031|566826500|FG003|Overall Study|Non-compliance with study drug|0|||
157019781|NCT04321031|566826501|FG004|Overall Study|Non-compliance with study drug|0|||
157019782|NCT04321031|566826502|FG005|Overall Study|Non-compliance with study drug|1|||
157019783|NCT04321031|566826503|FG006|Overall Study|Non-compliance with study drug|0|||
157019784|NCT04321031|566826497|FG000|Overall Study|Other|0|||
157019785|NCT04321031|566826498|FG001|Overall Study|Other|0|||
157019786|NCT04321031|566826499|FG002|Overall Study|Other|0|||
157019787|NCT04321031|566826500|FG003|Overall Study|Other|1|||
157019788|NCT04321031|566826501|FG004|Overall Study|Other|0|||
157019789|NCT04321031|566826502|FG005|Overall Study|Other|0|||
157019790|NCT04321031|566826503|FG006|Overall Study|Other|0|||
157019791|NCT02900924|566826504|FG000|Overall Study|Death|52|||
157019792|NCT02900924|566826504|FG000|Overall Study|Lost to Follow-up|4|||
157019793|NCT02900924|566826504|FG000|Overall Study|Withdrawal by Subject|20|||
157019794|NCT02900924|566826504|FG000|Overall Study|Missed Visit|33|||
156726868|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
156726869|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
156726870|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Death|2|||
157019795|NCT05536440|566826507|FG000|Overall Study|Adverse Event|0|||
157019796|NCT05536440|566826508|FG001|Overall Study|Adverse Event|0|||
157019797|NCT05536440|566826509|FG002|Overall Study|Adverse Event|0|||
157019798|NCT05536440|566826510|FG003|Overall Study|Adverse Event|0|||
157019799|NCT05536440|566826511|FG004|Overall Study|Adverse Event|0|||
157019800|NCT05536440|566826512|FG005|Overall Study|Adverse Event|0|||
157019801|NCT05536440|566826513|FG006|Overall Study|Adverse Event|0|||
157019802|NCT05536440|566826514|FG007|Overall Study|Adverse Event|0|||
157019803|NCT05536440|566826515|FG008|Overall Study|Adverse Event|1|||
157019804|NCT04784559|566826517|FG000|Overall Study|Withdrawal by Subject|3|||
157019805|NCT04784559|566826518|FG001|Overall Study|Withdrawal by Subject|2|||
157138324|NCT04889209|567252165|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138325|NCT04889209|567252166|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
156726871|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Death|0|||
156726872|NCT03674112|565748314|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
156726873|NCT03674112|565748315|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
156726874|NCT02220764|565748321|FG000|Overall Study|Lost to Follow-up|3|||
156726875|NCT02220764|565748322|FG001|Overall Study|Lost to Follow-up|1|||
156726876|NCT02220764|565748321|FG000|Overall Study|Death|1|||
156726877|NCT02220764|565748322|FG001|Overall Study|Death|0|||
156726878|NCT05000164|565748323|FG000|Overall Study|Adverse Event|1|||
156726879|NCT05000164|565748323|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156726880|NCT05000164|565748323|FG000|Overall Study|Lens Discomfort|3|||
156726881|NCT05000164|565748323|FG000|Overall Study|Withdrew Consent during Study|2|||
156726882|NCT05000164|565748323|FG000|Overall Study|Subject Withdrawn by PI|2|||
156726883|NCT05000164|565748323|FG000|Overall Study|Other Fractured Test Article|1|||
156726884|NCT03020992|565748324|FG000|Overall Study|Adverse Event|5|||
156726885|NCT03020992|565748324|FG000|Overall Study|Withdrawal by Subject|1|||
156726886|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
156726887|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
156726888|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
156726889|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
156726890|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Pregnancy|0|||
156726891|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Pregnancy|1|||
156726892|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
156726893|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
156726894|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
156726895|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
156726896|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
156726897|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
156726898|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Other|3|||
156726899|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Other|0|||
156726900|NCT01006122|565748325|FG000|First Double-blind Intervention Period|Adverse Event|0|||
156726901|NCT01006122|565748326|FG001|First Double-blind Intervention Period|Adverse Event|4|||
156726902|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
156726903|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
156726904|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
156726905|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
156726906|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
156726907|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
156726908|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
156726909|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
156726910|NCT01006122|565748325|FG000|Second Double-blind Intervention Period|Death|0|||
156726911|NCT01006122|565748326|FG001|Second Double-blind Intervention Period|Death|1|||
156726912|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
156726913|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
156726914|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
156795710|NCT03411044|566006169|FG000|Overall Study|Withdrawal by Subject|48|||
156795711|NCT03411044|566006169|FG000|Overall Study|Lost to Follow-up|78|||
157138326|NCT04889209|567252167|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
157138327|NCT04607408|567252168|FG000|Overall Study|Lost to Follow-up|0|||
157138328|NCT04607408|567252169|FG001|Overall Study|Lost to Follow-up|0|||
157138329|NCT04607408|567252170|FG002|Overall Study|Lost to Follow-up|0|||
157138330|NCT04607408|567252171|FG003|Overall Study|Lost to Follow-up|1|||
157138331|NCT04607408|567252172|FG004|Overall Study|Lost to Follow-up|0|||
157138332|NCT04607408|567252168|FG000|Overall Study|Withdrawal by Subject|0|||
157138333|NCT04607408|567252169|FG001|Overall Study|Withdrawal by Subject|1|||
157138334|NCT04607408|567252170|FG002|Overall Study|Withdrawal by Subject|0|||
157138335|NCT04607408|567252171|FG003|Overall Study|Withdrawal by Subject|1|||
156795712|NCT03411044|566006169|FG000|Overall Study|Adverse Event|30|||
156795713|NCT03411044|566006169|FG000|Overall Study|Missing status|4|||
157138336|NCT04607408|567252172|FG004|Overall Study|Withdrawal by Subject|0|||
157138337|NCT01725165|567252175|FG000|Overall Study|Death|11|||
157138338|NCT01725165|567252176|FG001|Overall Study|Death|18|||
157138339|NCT02688647|567252179|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
157138340|NCT02688647|567252180|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
157138341|NCT02688647|567252179|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
157217426|NCT01621490|567543226|FG004|Overall Study|Subject request to discontinue study|0|||
157217427|NCT01621490|567543227|FG005|Overall Study|Subject request to discontinue study|2|||
156795714|NCT01674062|566006177|FG000|Overall Study|Insufficient Therapeutic Response|56|||
156795715|NCT01674062|566006178|FG001|Overall Study|Insufficient Therapeutic Response|26|||
156726915|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
156726916|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
156726917|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
156726918|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
156726919|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
156726920|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
156726921|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
156726922|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
156726923|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
156726924|NCT03493854|565748327|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
156726925|NCT03493854|565748328|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
156726926|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
156726927|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
156726928|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
156726929|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
156726930|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
156726931|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
156726932|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
156726933|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
156726934|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
156726935|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
156726936|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
156726937|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
156726938|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
156726939|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
156726940|NCT03493854|565748327|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
156726941|NCT03493854|565748328|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
156726942|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
156726943|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
156726944|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
156726945|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
156726946|NCT03493854|565748327|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
156726947|NCT03493854|565748328|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
156726948|NCT00410813|565748331|FG000|Overall Study|Adverse Event|6|||
156726949|NCT00410813|565748332|FG001|Overall Study|Adverse Event|11|||
156726950|NCT00410813|565748331|FG000|Overall Study|Progression|32|||
156726951|NCT00410813|565748332|FG001|Overall Study|Progression|21|||
156726952|NCT00410813|565748331|FG000|Overall Study|Not protocol specified|3|||
156726953|NCT00410813|565748332|FG001|Overall Study|Not protocol specified|4|||
156726954|NCT00410813|565748331|FG000|Overall Study|Ineligible|2|||
156726955|NCT00410813|565748332|FG001|Overall Study|Ineligible|4|||
156726956|NCT00410813|565748331|FG000|Overall Study|Death|0|||
156726957|NCT00410813|565748332|FG001|Overall Study|Death|2|||
156726958|NCT04278417|565748341|FG000|Overall Study|Withdrawal by Subject|20|||
156726959|NCT04278417|565748342|FG001|Overall Study|Withdrawal by Subject|20|||
156726960|NCT04278417|565748341|FG000|Overall Study|Progressive disease|0|||
156726961|NCT04278417|565748342|FG001|Overall Study|Progressive disease|2|||
156726962|NCT04278417|565748341|FG000|Overall Study|Physician Decision|4|||
156726963|NCT04278417|565748342|FG001|Overall Study|Physician Decision|6|||
156726964|NCT04278417|565748341|FG000|Overall Study|Lost to Follow-up|11|||
156726965|NCT04278417|565748342|FG001|Overall Study|Lost to Follow-up|13|||
156726966|NCT04278417|565748341|FG000|Overall Study|Death|8|||
156726967|NCT04278417|565748342|FG001|Overall Study|Death|9|||
156726968|NCT04278417|565748341|FG000|Overall Study|Adverse Event|3|||
156726969|NCT04278417|565748342|FG001|Overall Study|Adverse Event|5|||
156726970|NCT00594165|565748343|FG000|Overall Study|Major protocol violation|1|||
156726971|NCT00594165|565748343|FG000|Overall Study|Lack of Efficacy|12|||
156726972|NCT00594165|565748343|FG000|Overall Study|Adverse Event|52|||
156726973|NCT00594165|565748343|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
156726974|NCT00594165|565748343|FG000|Overall Study|Subject withdrew consent|27|||
156726975|NCT00594165|565748343|FG000|Overall Study|Study ended per sponsor|102|||
156726976|NCT00594165|565748343|FG000|Overall Study|Lost to Follow-up|4|||
157138342|NCT02688647|567252180|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
157138343|NCT02688647|567252179|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
156726977|NCT00594165|565748343|FG000|Overall Study|Other: PI discretion|5|||
156726978|NCT00594165|565748343|FG000|Overall Study|Other: Subject moving|3|||
156726979|NCT00594165|565748343|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
156795716|NCT01674062|566006177|FG000|Overall Study|Other|8|||
156795717|NCT01674062|566006178|FG001|Overall Study|Other|1|||
156795718|NCT01674062|566006177|FG000|Overall Study|Adverse Event|1|||
156795719|NCT01674062|566006178|FG001|Overall Study|Adverse Event|1|||
157019806|NCT04784559|566826519|FG002|Overall Study|Withdrawal by Subject|1|||
157019807|NCT04784559|566826517|FG000|Overall Study|Death|2|||
157019808|NCT04784559|566826518|FG001|Overall Study|Death|1|||
157019809|NCT04784559|566826519|FG002|Overall Study|Death|2|||
157019810|NCT04784559|566826517|FG000|Overall Study|Lost to Follow-up|0|||
157019811|NCT04784559|566826518|FG001|Overall Study|Lost to Follow-up|0|||
157019812|NCT04784559|566826519|FG002|Overall Study|Lost to Follow-up|2|||
157019813|NCT04784559|566826517|FG000|Overall Study|Participant worsened, PI decision|1|||
157019814|NCT04784559|566826518|FG001|Overall Study|Participant worsened, PI decision|0|||
157019815|NCT04784559|566826519|FG002|Overall Study|Participant worsened, PI decision|0|||
157019816|NCT04784559|566826517|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
157019817|NCT04784559|566826518|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
157019818|NCT04784559|566826519|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
157019819|NCT04784559|566826517|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
157019820|NCT04784559|566826518|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
157019821|NCT04784559|566826519|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
157019822|NCT04784559|566826517|FG000|Overall Study|Did not meet all inclusion criteria|0|||
157217428|NCT01621490|567543228|FG006|Overall Study|Subject request to discontinue study|1|||
157217429|NCT01621490|567543229|FG007|Overall Study|Subject request to discontinue study|0|||
156726980|NCT00594165|565748343|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
156726981|NCT00594165|565748343|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
156726982|NCT00594165|565748343|FG000|Overall Study|Other: Site terminated participation|2|||
156726983|NCT04830969|565748344|FG000|Overall Study|Withdrawal by Subject|6|||
156726984|NCT04830969|565748345|FG001|Overall Study|Withdrawal by Subject|2|||
156726985|NCT04830969|565748344|FG000|Overall Study|Protocol Violation|3|||
156726986|NCT04830969|565748345|FG001|Overall Study|Protocol Violation|9|||
156726987|NCT04830969|565748344|FG000|Overall Study|Lost to Follow-up|4|||
156726988|NCT04830969|565748345|FG001|Overall Study|Lost to Follow-up|4|||
156726989|NCT00996125|565748346|FG000|Overall Study|Adverse Event|0|||
156726990|NCT00996125|565748347|FG001|Overall Study|Adverse Event|2|||
156726991|NCT00996125|565748346|FG000|Overall Study|Lost to Follow-up|1|||
156726992|NCT00996125|565748347|FG001|Overall Study|Lost to Follow-up|6|||
156726993|NCT00996125|565748346|FG000|Overall Study|Withdrawal by Subject|4|||
156726994|NCT00996125|565748347|FG001|Overall Study|Withdrawal by Subject|3|||
156726995|NCT05236764|565748348|FG000|Overall Study|In follow up (ongoing)|1|||
156726996|NCT05236764|565748348|FG000|Overall Study|Taken off study - secondary graft failure|1|||
156726997|NCT05236764|565748348|FG000|Overall Study|Death|1|||
156726998|NCT02203721|565748352|FG000|Overall Study|Lost to Follow-up|1|||
156726999|NCT02203721|565748353|FG001|Overall Study|Lost to Follow-up|0|||
156727000|NCT02203721|565748352|FG000|Overall Study|Death|0|||
156727001|NCT02203721|565748353|FG001|Overall Study|Death|2|||
156727002|NCT02203721|565748352|FG000|Overall Study|Illness|0|||
156727003|NCT02203721|565748353|FG001|Overall Study|Illness|1|||
156727004|NCT00703157|565748354|FG000|Overall Study|Lost to Follow-up|0|||
156727005|NCT00703157|565748355|FG001|Overall Study|Lost to Follow-up|1|||
156727006|NCT00703157|565748354|FG000|Overall Study|source data permanently lost/ other|4|||
156727007|NCT00703157|565748355|FG001|Overall Study|source data permanently lost/ other|1|||
156727008|NCT00347009|565748356|FG000|Overall Study|Death|1|||
156727009|NCT00347009|565748356|FG000|Overall Study|Adverse Event|6|||
156727010|NCT00347009|565748356|FG000|Overall Study|Withdrawal by Subject|3|||
156727011|NCT00347009|565748356|FG000|Overall Study|Physician Decision|5|||
156727012|NCT00347009|565748356|FG000|Overall Study|Lost to Follow-up|4|||
156727013|NCT00347009|565748356|FG000|Overall Study|Protocol Violation|2|||
156727014|NCT00347009|565748356|FG000|Overall Study|Adverse Laboratory Experience|1|||
156727015|NCT00347009|565748356|FG000|Overall Study|Insufficient Viral Suppression|3|||
156727016|NCT00347009|565748356|FG000|Overall Study|Increased ALT/HBV DNA|1|||
156727017|NCT00347009|565748356|FG000|Overall Study|Serious Adverse Event|1|||
156727018|NCT02907177|565748359|FG000|Overall Study|Death|0|||
156727019|NCT02907177|565748360|FG001|Overall Study|Death|1|||
156727020|NCT02907177|565748359|FG000|Overall Study|Physician Decision|3|||
156727021|NCT02907177|565748360|FG001|Overall Study|Physician Decision|3|||
156727022|NCT02907177|565748359|FG000|Overall Study|Withdrawal by Subject|15|||
157019823|NCT04784559|566826518|FG001|Overall Study|Did not meet all inclusion criteria|1|||
157019824|NCT04784559|566826519|FG002|Overall Study|Did not meet all inclusion criteria|0|||
157138344|NCT02688647|567252180|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
156727023|NCT02907177|565748360|FG001|Overall Study|Withdrawal by Subject|7|||
157138345|NCT02688647|567252179|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
157138346|NCT02688647|567252180|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
157138347|NCT02688647|567252179|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
157138348|NCT02688647|567252180|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
157138349|NCT02688647|567252179|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
157138350|NCT02688647|567252180|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
157217430|NCT01621490|567543230|FG008|Overall Study|Subject request to discontinue study|1|||
157138351|NCT02688647|567252179|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
157138352|NCT02688647|567252180|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
157138353|NCT03619213|567252181|FG000|Overall Study|Lost to Follow-up|2|||
157138354|NCT03619213|567252182|FG001|Overall Study|Lost to Follow-up|1|||
157138355|NCT03619213|567252181|FG000|Overall Study|Withdrawal by Subject|8|||
157138356|NCT03619213|567252182|FG001|Overall Study|Withdrawal by Subject|10|||
157138357|NCT00382967|567252183|FG000|Overall Study|Protocol Violation|1|||
157138358|NCT00382967|567252184|FG001|Overall Study|Protocol Violation|1|||
157138359|NCT02786901|567252190|FG000|Overall Study|Adverse Event|1|||
157138360|NCT02786901|567252191|FG001|Overall Study|Adverse Event|1|||
157138361|NCT02786901|567252192|FG002|Overall Study|Adverse Event|2|||
157138362|NCT02786901|567252190|FG000|Overall Study|Physician Decision|1|||
157138363|NCT02786901|567252191|FG001|Overall Study|Physician Decision|0|||
157138364|NCT02786901|567252192|FG002|Overall Study|Physician Decision|0|||
157138365|NCT02786901|567252190|FG000|Overall Study|Rescue Therapy Use|71|||
157138366|NCT02786901|567252191|FG001|Overall Study|Rescue Therapy Use|49|||
157138367|NCT02786901|567252192|FG002|Overall Study|Rescue Therapy Use|33|||
157138368|NCT02786901|567252190|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
157138369|NCT02786901|567252191|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
157138370|NCT02786901|567252192|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
157138371|NCT02786901|567252190|FG000|Overall Study|Disallowed medication|1|||
157138372|NCT02786901|567252191|FG001|Overall Study|Disallowed medication|1|||
157138373|NCT02786901|567252192|FG002|Overall Study|Disallowed medication|0|||
157138374|NCT02786901|567252190|FG000|Overall Study|Randomized in error|2|||
157138375|NCT02786901|567252191|FG001|Overall Study|Randomized in error|0|||
157138376|NCT02786901|567252192|FG002|Overall Study|Randomized in error|1|||
157138377|NCT01075178|567252193|FG000|Subject Matching|eligible but not matched|130|||
157138378|NCT01075178|567252194|FG001|Subject Matching|eligible but not matched|403|||
157138379|NCT01075178|567252193|FG000|Subject Chart Review|died before chart review period|0|||
157138380|NCT01075178|567252194|FG001|Subject Chart Review|died before chart review period|2|||
157138381|NCT01075178|567252193|FG000|Subject Chart Review|no data collected due to site closure|3|||
157138382|NCT01075178|567252194|FG001|Subject Chart Review|no data collected due to site closure|4|||
157138383|NCT01075178|567252193|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
157138384|NCT01075178|567252194|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
156876203|NCT01904773|566305764|FG006|Fifth Intervention|Adverse Event|0|||
156876204|NCT01904773|566305765|FG007|Fifth Intervention|Adverse Event|1|||
156876205|NCT01904773|566305766|FG008|Fifth Intervention|Adverse Event|0|||
156876206|NCT01904773|566305758|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876207|NCT01904773|566305759|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
156876208|NCT01904773|566305760|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876209|NCT01904773|566305761|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876210|NCT01904773|566305762|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876211|NCT01904773|566305763|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876212|NCT01904773|566305764|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876213|NCT01904773|566305765|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876214|NCT01904773|566305766|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
156876215|NCT03390101|566305767|FG000|Weeks 0-12|Withdrawal by Subject|0|||
156876216|NCT03390101|566305768|FG001|Weeks 0-12|Withdrawal by Subject|1|||
156876217|NCT03390101|566305769|FG002|Weeks 0-12|Withdrawal by Subject|1|||
156876218|NCT03390101|566305767|FG000|Weeks 0-12|Lost to Follow-up|0|||
157138385|NCT00316264|567252196|FG000|Overall Study|Lost to Follow-up|0|||
157138386|NCT00316264|567252197|FG001|Overall Study|Lost to Follow-up|1|||
157138387|NCT00316264|567252198|FG002|Overall Study|Lost to Follow-up|0|||
157138388|NCT00316264|567252196|FG000|Overall Study|Withdrawal of Consent|3|||
157138389|NCT00316264|567252197|FG001|Overall Study|Withdrawal of Consent|5|||
157138390|NCT00316264|567252198|FG002|Overall Study|Withdrawal of Consent|6|||
157138391|NCT00316264|567252196|FG000|Overall Study|Death|2|||
157138392|NCT00316264|567252197|FG001|Overall Study|Death|0|||
157138393|NCT00316264|567252198|FG002|Overall Study|Death|0|||
157138394|NCT00316264|567252196|FG000|Overall Study|Other|1|||
156876219|NCT03390101|566305768|FG001|Weeks 0-12|Lost to Follow-up|1|||
157138395|NCT00316264|567252197|FG001|Overall Study|Other|1|||
157138396|NCT00316264|567252198|FG002|Overall Study|Other|0|||
157138397|NCT00607048|567252199|FG000|Overall Study|Adverse Event|0|||
156876220|NCT03390101|566305769|FG002|Weeks 0-12|Lost to Follow-up|0|||
156876221|NCT03390101|566305767|FG000|Weeks 12-54|Withdrawal by Subject|0|||
157138398|NCT00607048|567252200|FG001|Overall Study|Adverse Event|1|||
157138399|NCT00607048|567252201|FG002|Overall Study|Adverse Event|0|||
157138400|NCT00607048|567252202|FG003|Overall Study|Adverse Event|0|||
157138401|NCT00607048|567252203|FG004|Overall Study|Adverse Event|4|||
157138402|NCT00607048|567252204|FG005|Overall Study|Adverse Event|0|||
157138403|NCT00607048|567252199|FG000|Overall Study|Global deterioration of health|1|||
157138404|NCT00607048|567252200|FG001|Overall Study|Global deterioration of health|0|||
157138405|NCT00607048|567252201|FG002|Overall Study|Global deterioration of health|0|||
157138406|NCT00607048|567252202|FG003|Overall Study|Global deterioration of health|0|||
157138407|NCT00607048|567252203|FG004|Overall Study|Global deterioration of health|0|||
157138408|NCT00607048|567252204|FG005|Overall Study|Global deterioration of health|0|||
157138409|NCT00607048|567252199|FG000|Overall Study|Objective disease progression - relapse|1|||
157138410|NCT00607048|567252200|FG001|Overall Study|Objective disease progression - relapse|2|||
157138411|NCT00607048|567252201|FG002|Overall Study|Objective disease progression - relapse|4|||
157138412|NCT00607048|567252202|FG003|Overall Study|Objective disease progression - relapse|2|||
157138413|NCT00607048|567252203|FG004|Overall Study|Objective disease progression - relapse|2|||
157138414|NCT00607048|567252204|FG005|Overall Study|Objective disease progression - relapse|2|||
157138415|NCT00607048|567252199|FG000|Overall Study|Withdrawal by Subject|0|||
157138416|NCT00607048|567252200|FG001|Overall Study|Withdrawal by Subject|0|||
157138417|NCT00607048|567252201|FG002|Overall Study|Withdrawal by Subject|0|||
157138418|NCT00607048|567252202|FG003|Overall Study|Withdrawal by Subject|1|||
157138419|NCT00607048|567252203|FG004|Overall Study|Withdrawal by Subject|0|||
156727024|NCT02907177|565748359|FG000|Overall Study|Sponsor's Decision|50|||
156727025|NCT02907177|565748360|FG001|Overall Study|Sponsor's Decision|57|||
156727026|NCT03482635|565748361|FG000|Overall Study|Lack of Efficacy|0|||
157138420|NCT00607048|567252204|FG005|Overall Study|Withdrawal by Subject|2|||
157138421|NCT00607048|567252199|FG000|Overall Study|Other|1|||
157138422|NCT00607048|567252200|FG001|Overall Study|Other|1|||
157138423|NCT00607048|567252201|FG002|Overall Study|Other|0|||
156727027|NCT03482635|565748362|FG001|Overall Study|Lack of Efficacy|0|||
156727028|NCT03482635|565748363|FG002|Overall Study|Lack of Efficacy|1|||
156727029|NCT03482635|565748364|FG003|Overall Study|Lack of Efficacy|3|||
157138424|NCT00607048|567252202|FG003|Overall Study|Other|0|||
157138425|NCT00607048|567252203|FG004|Overall Study|Other|0|||
157138426|NCT00607048|567252204|FG005|Overall Study|Other|1|||
157138427|NCT00699192|567252205|FG000|Overall Study|Missing|1|||
157138428|NCT00699192|567252206|FG001|Overall Study|Missing|1|||
157138429|NCT00699192|567252207|FG002|Overall Study|Missing|1|||
157138430|NCT00699192|567252205|FG000|Overall Study|Adverse Event|9|||
157138431|NCT00699192|567252206|FG001|Overall Study|Adverse Event|4|||
157138432|NCT00699192|567252207|FG002|Overall Study|Adverse Event|3|||
157138433|NCT00699192|567252205|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157138434|NCT00699192|567252206|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157138435|NCT00699192|567252207|FG002|Overall Study|Abnormal test procedure result(s)|1|||
157138436|NCT00699192|567252205|FG000|Overall Study|Lack of Efficacy|0|||
157138437|NCT00699192|567252206|FG001|Overall Study|Lack of Efficacy|0|||
157138438|NCT00699192|567252207|FG002|Overall Study|Lack of Efficacy|1|||
157138439|NCT00699192|567252205|FG000|Overall Study|Withdrawal by Subject|3|||
157138440|NCT00699192|567252206|FG001|Overall Study|Withdrawal by Subject|2|||
157138441|NCT00699192|567252207|FG002|Overall Study|Withdrawal by Subject|4|||
156727030|NCT03482635|565748361|FG000|Overall Study|Adverse Event|2|||
156727031|NCT03482635|565748362|FG001|Overall Study|Adverse Event|2|||
156727032|NCT03482635|565748363|FG002|Overall Study|Adverse Event|0|||
156727033|NCT03482635|565748364|FG003|Overall Study|Adverse Event|3|||
156727034|NCT03482635|565748361|FG000|Overall Study|Withdrawal by Subject|2|||
156727035|NCT03482635|565748362|FG001|Overall Study|Withdrawal by Subject|1|||
156727036|NCT03482635|565748363|FG002|Overall Study|Withdrawal by Subject|0|||
156727037|NCT03482635|565748364|FG003|Overall Study|Withdrawal by Subject|1|||
156727038|NCT03482635|565748361|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
156727039|NCT03482635|565748362|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
156727040|NCT03482635|565748363|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
156727041|NCT03482635|565748364|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
156727042|NCT03482635|565748361|FG000|Overall Study|Not treated|0|||
156727043|NCT03482635|565748362|FG001|Overall Study|Not treated|0|||
156727044|NCT03482635|565748363|FG002|Overall Study|Not treated|0|||
156727045|NCT03482635|565748364|FG003|Overall Study|Not treated|1|||
156727046|NCT04681066|565748365|FG000|Overall Study|Lost to Follow-up|3|||
156727047|NCT04681066|565748366|FG001|Overall Study|Lost to Follow-up|1|||
156727048|NCT04681066|565748367|FG002|Overall Study|Lost to Follow-up|2|||
156727049|NCT04681066|565748368|FG003|Overall Study|Lost to Follow-up|1|||
156727050|NCT04681066|565748365|FG000|Overall Study|Withdrawal by Subject|2|||
156727051|NCT04681066|565748366|FG001|Overall Study|Withdrawal by Subject|1|||
156727052|NCT04681066|565748367|FG002|Overall Study|Withdrawal by Subject|0|||
156727053|NCT04681066|565748368|FG003|Overall Study|Withdrawal by Subject|3|||
156727054|NCT04681066|565748365|FG000|Overall Study|Death|0|||
156727055|NCT04681066|565748366|FG001|Overall Study|Death|1|||
156727056|NCT04681066|565748367|FG002|Overall Study|Death|0|||
156727057|NCT04681066|565748368|FG003|Overall Study|Death|0|||
157138442|NCT00699192|567252205|FG000|Overall Study|Administrative problems|1|||
157138443|NCT00699192|567252206|FG001|Overall Study|Administrative problems|3|||
157138444|NCT00699192|567252207|FG002|Overall Study|Administrative problems|1|||
157138445|NCT00699192|567252205|FG000|Overall Study|Protocol Violation|2|||
157138446|NCT00699192|567252206|FG001|Overall Study|Protocol Violation|2|||
157138447|NCT00699192|567252207|FG002|Overall Study|Protocol Violation|0|||
157138448|NCT04336163|567252208|FG000|Overall Study|Lost to Follow-up|55|||
156727058|NCT04495829|565748369|FG000|Overall Study|Lost to Follow-up|2|||
156727059|NCT04495829|565748369|FG000|Overall Study|Inclusion criterion not met|3|||
156727060|NCT01205269|565748372|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727061|NCT01205269|565748373|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
157138449|NCT04336163|567252209|FG001|Overall Study|Lost to Follow-up|0|||
157138450|NCT01773473|567252210|FG000|Overall Study|Adverse Event|3|||
157138451|NCT01773473|567252211|FG001|Overall Study|Adverse Event|2|||
156727062|NCT01205269|565748374|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727063|NCT01205269|565748375|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
156727064|NCT01205269|565748376|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727065|NCT01205269|565748377|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
156727066|NCT00987337|565748378|FG000|Overall Study|Adverse Event|10|||
156727067|NCT00987337|565748379|FG001|Overall Study|Adverse Event|9|||
156727068|NCT00987337|565748380|FG002|Overall Study|Adverse Event|8|||
156727069|NCT00987337|565748378|FG000|Overall Study|Insufficient Virologic Response|10|||
156727070|NCT00987337|565748379|FG001|Overall Study|Insufficient Virologic Response|7|||
156727071|NCT00987337|565748380|FG002|Overall Study|Insufficient Virologic Response|12|||
157019825|NCT04784559|566826517|FG000|Overall Study|The participant was transferred to IRCU|0|||
157138452|NCT01773473|567252210|FG000|Overall Study|Protocol Violation|0|||
157138453|NCT01773473|567252211|FG001|Overall Study|Protocol Violation|4|||
156727072|NCT00987337|565748378|FG000|Overall Study|Virologic Breakthrough|2|||
156727073|NCT00987337|565748379|FG001|Overall Study|Virologic Breakthrough|2|||
156795720|NCT01674062|566006177|FG000|Overall Study|Death|0|||
156795721|NCT01674062|566006178|FG001|Overall Study|Death|1|||
156795722|NCT01674062|566006177|FG000|Overall Study|Programming Error|1|||
156795723|NCT01674062|566006178|FG001|Overall Study|Programming Error|0|||
156795724|NCT03895372|566006179|FG000|Investigational Treatment Period|Adverse Event|1|||
156795725|NCT03895372|566006180|FG001|Investigational Treatment Period|Adverse Event|0|||
156795726|NCT03895372|566006181|FG002|Investigational Treatment Period|Adverse Event|0|||
156795727|NCT03895372|566006182|FG003|Investigational Treatment Period|Adverse Event|0|||
156795728|NCT03895372|566006183|FG004|Investigational Treatment Period|Adverse Event|0|||
156795729|NCT03895372|566006184|FG005|Investigational Treatment Period|Adverse Event|0|||
156795730|NCT03895372|566006185|FG006|Investigational Treatment Period|Adverse Event|4|||
156795731|NCT03895372|566006186|FG007|Investigational Treatment Period|Adverse Event|3|||
156795732|NCT03895372|566006179|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
156795733|NCT03895372|566006180|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
156795734|NCT03895372|566006181|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
156795735|NCT03895372|566006182|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
156795736|NCT03895372|566006183|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
156795737|NCT03895372|566006184|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
156795738|NCT03895372|566006185|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
156795739|NCT03895372|566006186|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
156795740|NCT03895372|566006179|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
156795741|NCT03895372|566006180|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
156795742|NCT03895372|566006181|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
156795743|NCT03895372|566006182|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
156795744|NCT03895372|566006183|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
156795745|NCT03895372|566006184|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
156795746|NCT03895372|566006185|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
156795747|NCT03895372|566006186|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
156795748|NCT03895372|566006179|FG000|Investigational Treatment Period|Other|0|||
156795749|NCT03895372|566006180|FG001|Investigational Treatment Period|Other|0|||
156795750|NCT03895372|566006181|FG002|Investigational Treatment Period|Other|0|||
156795751|NCT03895372|566006182|FG003|Investigational Treatment Period|Other|0|||
156795752|NCT03895372|566006183|FG004|Investigational Treatment Period|Other|0|||
156795753|NCT03895372|566006184|FG005|Investigational Treatment Period|Other|1|||
156795754|NCT03895372|566006185|FG006|Investigational Treatment Period|Other|0|||
156795755|NCT03895372|566006186|FG007|Investigational Treatment Period|Other|2|||
156795756|NCT03895372|566006179|FG000|Investigational Treatment Period|Protocol Violation|0|||
156795757|NCT03895372|566006180|FG001|Investigational Treatment Period|Protocol Violation|0|||
156795758|NCT03895372|566006181|FG002|Investigational Treatment Period|Protocol Violation|0|||
156795759|NCT03895372|566006182|FG003|Investigational Treatment Period|Protocol Violation|1|||
156795760|NCT03895372|566006183|FG004|Investigational Treatment Period|Protocol Violation|0|||
156795761|NCT03895372|566006184|FG005|Investigational Treatment Period|Protocol Violation|0|||
156795762|NCT03895372|566006185|FG006|Investigational Treatment Period|Protocol Violation|0|||
156795763|NCT03895372|566006186|FG007|Investigational Treatment Period|Protocol Violation|0|||
156795764|NCT03895372|566006179|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
156795765|NCT03895372|566006180|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
156795766|NCT03895372|566006181|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
156795767|NCT03895372|566006182|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
156727074|NCT00987337|565748380|FG002|Overall Study|Virologic Breakthrough|8|||
157138454|NCT01773473|567252210|FG000|Overall Study|Physician Decision|3|||
157138455|NCT01773473|567252211|FG001|Overall Study|Physician Decision|5|||
156727075|NCT00987337|565748378|FG000|Overall Study|Lost to Follow-up|10|||
156727076|NCT00987337|565748379|FG001|Overall Study|Lost to Follow-up|6|||
156727077|NCT00987337|565748380|FG002|Overall Study|Lost to Follow-up|2|||
156727078|NCT00987337|565748378|FG000|Overall Study|Withdrawal by Subject|6|||
156727079|NCT00987337|565748379|FG001|Overall Study|Withdrawal by Subject|9|||
156727080|NCT00987337|565748380|FG002|Overall Study|Withdrawal by Subject|9|||
156727081|NCT00987337|565748378|FG000|Overall Study|Other|0|||
156727082|NCT00987337|565748379|FG001|Overall Study|Other|2|||
156727083|NCT00987337|565748380|FG002|Overall Study|Other|5|||
156727084|NCT00987337|565748378|FG000|Overall Study|Protocol Violation|1|||
157138456|NCT01773473|567252210|FG000|Overall Study|Sponsor Decision|2|||
157138457|NCT01773473|567252211|FG001|Overall Study|Sponsor Decision|0|||
157138458|NCT01773473|567252210|FG000|Overall Study|Lack of Efficacy|0|||
157138459|NCT01773473|567252211|FG001|Overall Study|Lack of Efficacy|1|||
157138460|NCT01773473|567252210|FG000|Overall Study|Non-Compliance with study drug|1|||
156727085|NCT00987337|565748379|FG001|Overall Study|Protocol Violation|0|||
156727086|NCT00987337|565748380|FG002|Overall Study|Protocol Violation|2|||
156727087|NCT00987337|565748378|FG000|Overall Study|Participant Relapsed|18|||
156727088|NCT00987337|565748379|FG001|Overall Study|Participant Relapsed|20|||
156727089|NCT00987337|565748380|FG002|Overall Study|Participant Relapsed|5|||
156727090|NCT00669669|565748386|FG000|Overall Study|To late to start treatment|1|||
156727091|NCT03103152|565748387|FG000|Overall Study|Physician Decision|5|||
156727092|NCT03103152|565748388|FG001|Overall Study|Physician Decision|2|||
156727093|NCT03103152|565748389|FG002|Overall Study|Physician Decision|6|||
156727094|NCT03103152|565748390|FG003|Overall Study|Physician Decision|3|||
156727095|NCT03103152|565748391|FG004|Overall Study|Physician Decision|3|||
156727096|NCT03103152|565748392|FG005|Overall Study|Physician Decision|1|||
156727097|NCT03103152|565748387|FG000|Overall Study|Protocol Violation|2|||
156727098|NCT03103152|565748388|FG001|Overall Study|Protocol Violation|2|||
156727099|NCT03103152|565748389|FG002|Overall Study|Protocol Violation|1|||
156727100|NCT03103152|565748390|FG003|Overall Study|Protocol Violation|2|||
156727101|NCT03103152|565748391|FG004|Overall Study|Protocol Violation|1|||
156727102|NCT03103152|565748392|FG005|Overall Study|Protocol Violation|1|||
156727103|NCT03103152|565748387|FG000|Overall Study|Inter-current illness|0|||
156727104|NCT03103152|565748388|FG001|Overall Study|Inter-current illness|0|||
156727105|NCT03103152|565748389|FG002|Overall Study|Inter-current illness|1|||
156727106|NCT03103152|565748390|FG003|Overall Study|Inter-current illness|0|||
156727107|NCT03103152|565748391|FG004|Overall Study|Inter-current illness|0|||
156727108|NCT03103152|565748392|FG005|Overall Study|Inter-current illness|0|||
156727109|NCT03103152|565748387|FG000|Overall Study|Death|0|||
156727110|NCT03103152|565748388|FG001|Overall Study|Death|1|||
156727111|NCT03103152|565748389|FG002|Overall Study|Death|0|||
156727112|NCT03103152|565748390|FG003|Overall Study|Death|0|||
156727113|NCT03103152|565748391|FG004|Overall Study|Death|0|||
156727114|NCT03103152|565748392|FG005|Overall Study|Death|0|||
156727115|NCT03103152|565748387|FG000|Overall Study|Adverse Event|0|||
156727116|NCT03103152|565748388|FG001|Overall Study|Adverse Event|0|||
156727117|NCT03103152|565748389|FG002|Overall Study|Adverse Event|1|||
156727118|NCT03103152|565748390|FG003|Overall Study|Adverse Event|0|||
156727119|NCT03103152|565748391|FG004|Overall Study|Adverse Event|0|||
156727120|NCT03103152|565748392|FG005|Overall Study|Adverse Event|1|||
156727121|NCT03103152|565748387|FG000|Overall Study|Withdrawal by Subject|1|||
156727122|NCT03103152|565748388|FG001|Overall Study|Withdrawal by Subject|0|||
156727123|NCT03103152|565748389|FG002|Overall Study|Withdrawal by Subject|1|||
156727124|NCT03103152|565748390|FG003|Overall Study|Withdrawal by Subject|1|||
156727125|NCT03103152|565748391|FG004|Overall Study|Withdrawal by Subject|1|||
156727126|NCT03103152|565748392|FG005|Overall Study|Withdrawal by Subject|1|||
156727127|NCT03103152|565748387|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
156727128|NCT03103152|565748388|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
156727129|NCT03103152|565748389|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
156727130|NCT03103152|565748390|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
156727131|NCT03103152|565748391|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
156727132|NCT03103152|565748392|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
156727133|NCT03103152|565748387|FG000|Overall Study|Unacceptable side effects|0|||
157138461|NCT01773473|567252211|FG001|Overall Study|Non-Compliance with study drug|4|||
157138462|NCT01773473|567252210|FG000|Overall Study|Withdrawal by Subject|5|||
156727134|NCT03103152|565748388|FG001|Overall Study|Unacceptable side effects|0|||
156727135|NCT03103152|565748389|FG002|Overall Study|Unacceptable side effects|0|||
156727136|NCT03103152|565748390|FG003|Overall Study|Unacceptable side effects|0|||
156727137|NCT03103152|565748391|FG004|Overall Study|Unacceptable side effects|0|||
156876222|NCT03390101|566305768|FG001|Weeks 12-54|Withdrawal by Subject|3|||
156727138|NCT03103152|565748392|FG005|Overall Study|Unacceptable side effects|1|||
156727139|NCT03103152|565748387|FG000|Overall Study|Lost to Follow-up|0|||
156727140|NCT03103152|565748388|FG001|Overall Study|Lost to Follow-up|1|||
156727141|NCT03103152|565748389|FG002|Overall Study|Lost to Follow-up|0|||
157138463|NCT01773473|567252211|FG001|Overall Study|Withdrawal by Subject|3|||
157138464|NCT01773473|567252210|FG000|Overall Study|Lost to Follow-up|2|||
157138465|NCT01773473|567252211|FG001|Overall Study|Lost to Follow-up|0|||
157138466|NCT00826514|567252212|FG000|Overall Study|Adverse Event|1|||
157138467|NCT00826514|567252213|FG001|Overall Study|Adverse Event|1|||
157138468|NCT00826514|567252212|FG000|Overall Study|Lack of Efficacy|0|||
157138469|NCT00826514|567252213|FG001|Overall Study|Lack of Efficacy|1|||
157138470|NCT00826514|567252212|FG000|Overall Study|Withdrawal by Subject|2|||
157138471|NCT00826514|567252213|FG001|Overall Study|Withdrawal by Subject|3|||
157138472|NCT03663166|567252216|FG000|Overall Study|Withdrawal by Subject|1|||
157138473|NCT04927312|567252218|FG000|Overall Study|Adverse Event|1|||
157138474|NCT04927312|567252218|FG000|Overall Study|Death|1|||
157138475|NCT04927312|567252218|FG000|Overall Study|Withdrawal by Subject|1|||
157138476|NCT04927312|567252218|FG000|Overall Study|Other|1|||
157138477|NCT02620020|567252222|FG000|Overall Study|Adverse Event|8|||
157138478|NCT02620020|567252223|FG001|Overall Study|Adverse Event|4|||
157138479|NCT02620020|567252224|FG002|Overall Study|Adverse Event|3|||
157138480|NCT02620020|567252225|FG003|Overall Study|Adverse Event|5|||
157138481|NCT02620020|567252222|FG000|Overall Study|Lost to Follow-up|4|||
157138482|NCT02620020|567252223|FG001|Overall Study|Lost to Follow-up|8|||
157138483|NCT02620020|567252224|FG002|Overall Study|Lost to Follow-up|1|||
157138484|NCT02620020|567252225|FG003|Overall Study|Lost to Follow-up|4|||
157138485|NCT02620020|567252222|FG000|Overall Study|Physician Decision|7|||
157138486|NCT02620020|567252223|FG001|Overall Study|Physician Decision|4|||
157138487|NCT02620020|567252224|FG002|Overall Study|Physician Decision|3|||
157138488|NCT02620020|567252225|FG003|Overall Study|Physician Decision|4|||
157138489|NCT02620020|567252222|FG000|Overall Study|Protocol Violation|5|||
157138490|NCT02620020|567252223|FG001|Overall Study|Protocol Violation|2|||
157138491|NCT02620020|567252224|FG002|Overall Study|Protocol Violation|1|||
157138492|NCT02620020|567252225|FG003|Overall Study|Protocol Violation|1|||
157138493|NCT02620020|567252222|FG000|Overall Study|Withdrawal by Subject|20|||
157138494|NCT02620020|567252223|FG001|Overall Study|Withdrawal by Subject|16|||
157138495|NCT02620020|567252224|FG002|Overall Study|Withdrawal by Subject|17|||
157138496|NCT02620020|567252225|FG003|Overall Study|Withdrawal by Subject|12|||
157138497|NCT02620020|567252222|FG000|Overall Study|Death|0|||
157138498|NCT02620020|567252223|FG001|Overall Study|Death|1|||
157138499|NCT02620020|567252224|FG002|Overall Study|Death|0|||
157138500|NCT02620020|567252225|FG003|Overall Study|Death|0|||
157138501|NCT02393209|567252227|FG000|Overall Study|Study Terminated by Sponsor|1|||
157138502|NCT02393209|567252228|FG001|Overall Study|Study Terminated by Sponsor|1|||
157138503|NCT02393209|567252229|FG002|Overall Study|Study Terminated by Sponsor|0|||
157138504|NCT02393209|567252230|FG003|Overall Study|Study Terminated by Sponsor|0|||
157138505|NCT02393209|567252227|FG000|Overall Study|Withdrawal by Patient|1|||
157138506|NCT02393209|567252228|FG001|Overall Study|Withdrawal by Patient|0|||
157138507|NCT02393209|567252229|FG002|Overall Study|Withdrawal by Patient|0|||
157138508|NCT02393209|567252230|FG003|Overall Study|Withdrawal by Patient|0|||
157138509|NCT02393209|567252227|FG000|Overall Study|Death|2|||
157138510|NCT02393209|567252228|FG001|Overall Study|Death|2|||
157138511|NCT02393209|567252229|FG002|Overall Study|Death|0|||
157138512|NCT02393209|567252230|FG003|Overall Study|Death|0|||
157138513|NCT02393209|567252227|FG000|Overall Study|Death due to Disease Progression|2|||
157138514|NCT02393209|567252228|FG001|Overall Study|Death due to Disease Progression|2|||
157138515|NCT02393209|567252229|FG002|Overall Study|Death due to Disease Progression|0|||
157138516|NCT02393209|567252230|FG003|Overall Study|Death due to Disease Progression|0|||
157138517|NCT02393209|567252227|FG000|Overall Study|Death from Legionella Infection|0|||
157138518|NCT02393209|567252228|FG001|Overall Study|Death from Legionella Infection|1|||
157138519|NCT02393209|567252229|FG002|Overall Study|Death from Legionella Infection|0|||
157138520|NCT02393209|567252230|FG003|Overall Study|Death from Legionella Infection|0|||
157138521|NCT02393209|567252227|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
157138522|NCT02393209|567252228|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
157138523|NCT02393209|567252229|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
157138524|NCT02393209|567252230|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
157138525|NCT02393209|567252227|FG000|Overall Study|Lost to Follow-up|0|||
157217431|NCT01621490|567543231|FG009|Overall Study|Subject request to discontinue study|0|||
157217432|NCT01621490|567543232|FG010|Overall Study|Subject request to discontinue study|0|||
157138526|NCT02393209|567252228|FG001|Overall Study|Lost to Follow-up|1|||
157138527|NCT02393209|567252229|FG002|Overall Study|Lost to Follow-up|0|||
157138528|NCT02393209|567252230|FG003|Overall Study|Lost to Follow-up|0|||
157138529|NCT00929240|567252231|FG000|Initial Treatment Phase|Adverse Event|31|||
157138530|NCT00929240|567252232|FG001|Initial Treatment Phase|Adverse Event|0|||
157138531|NCT00929240|567252233|FG002|Initial Treatment Phase|Adverse Event|0|||
157138532|NCT00929240|567252231|FG000|Initial Treatment Phase|Disease progression|41|||
157138533|NCT00929240|567252232|FG001|Initial Treatment Phase|Disease progression|0|||
157138534|NCT00929240|567252233|FG002|Initial Treatment Phase|Disease progression|0|||
157138535|NCT00929240|567252231|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
157138536|NCT00929240|567252232|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
157138537|NCT00929240|567252233|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
157138538|NCT00929240|567252231|FG000|Initial Treatment Phase|Protocol Violation|5|||
157138539|NCT00929240|567252232|FG001|Initial Treatment Phase|Protocol Violation|0|||
156727142|NCT03103152|565748390|FG003|Overall Study|Lost to Follow-up|1|||
156727143|NCT03103152|565748391|FG004|Overall Study|Lost to Follow-up|0|||
156727144|NCT03103152|565748392|FG005|Overall Study|Lost to Follow-up|1|||
156727145|NCT03103152|565748387|FG000|Overall Study|Testicular pain|0|||
156727146|NCT03103152|565748388|FG001|Overall Study|Testicular pain|0|||
156727147|NCT03103152|565748389|FG002|Overall Study|Testicular pain|0|||
156727148|NCT03103152|565748390|FG003|Overall Study|Testicular pain|1|||
156727149|NCT03103152|565748391|FG004|Overall Study|Testicular pain|0|||
156727150|NCT03103152|565748392|FG005|Overall Study|Testicular pain|0|||
156727151|NCT03100903|565750342|FG000|Overall Study|Withdrawal by Subject|0|||
156727152|NCT03100903|565750343|FG001|Overall Study|Withdrawal by Subject|0|||
156727153|NCT03100903|565750344|FG002|Overall Study|Withdrawal by Subject|1|||
156727154|NCT04659993|565750345|FG000|Overall Study|Withdrawal by Subject|2|||
156727155|NCT04659993|565750345|FG000|Overall Study|Lost to Follow-up|2|||
156727156|NCT00754234|565750349|FG000|Overall Study|Withdrawal by Subject|3|||
156727157|NCT03263936|565750350|FG000|Overall Study|Adverse Event|0|||
156727158|NCT03263936|565750351|FG001|Overall Study|Adverse Event|1|||
156727159|NCT03263936|565750352|FG002|Overall Study|Adverse Event|0|||
156727160|NCT03263936|565750350|FG000|Overall Study|Death|0|||
156727161|NCT03263936|565750351|FG001|Overall Study|Death|1|||
156727162|NCT03263936|565750352|FG002|Overall Study|Death|0|||
156727163|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
156727164|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
156727165|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
156727166|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
156727167|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
156727168|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
156727169|NCT03868930|565750353|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
156727170|NCT03868930|565750354|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
156727171|NCT03868930|565750353|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
156727172|NCT03868930|565750354|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
156727173|NCT02151851|565750357|FG000|Overall Study|Lack of Efficacy|67|||
156727174|NCT02151851|565750358|FG001|Overall Study|Lack of Efficacy|94|||
156795768|NCT03895372|566006183|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
156795769|NCT03895372|566006184|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
157138540|NCT00929240|567252233|FG002|Initial Treatment Phase|Protocol Violation|0|||
156727175|NCT02151851|565750357|FG000|Overall Study|Protocol Violation|0|||
156795770|NCT03895372|566006185|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
156795771|NCT03895372|566006186|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
156795772|NCT03895372|566006179|FG000|Extension Treatment Period|Adverse Event|0|||
156795773|NCT03895372|566006180|FG001|Extension Treatment Period|Adverse Event|1|||
156795774|NCT03895372|566006181|FG002|Extension Treatment Period|Adverse Event|0|||
156795775|NCT03895372|566006182|FG003|Extension Treatment Period|Adverse Event|1|||
156795776|NCT03895372|566006183|FG004|Extension Treatment Period|Adverse Event|0|||
156795777|NCT03895372|566006184|FG005|Extension Treatment Period|Adverse Event|0|||
156795778|NCT03895372|566006185|FG006|Extension Treatment Period|Adverse Event|3|||
156795779|NCT03895372|566006186|FG007|Extension Treatment Period|Adverse Event|3|||
156795780|NCT03895372|566006179|FG000|Extension Treatment Period|Other|1|||
156795781|NCT03895372|566006180|FG001|Extension Treatment Period|Other|3|||
156795782|NCT03895372|566006181|FG002|Extension Treatment Period|Other|0|||
156795783|NCT03895372|566006182|FG003|Extension Treatment Period|Other|0|||
156795784|NCT03895372|566006183|FG004|Extension Treatment Period|Other|1|||
156795785|NCT03895372|566006184|FG005|Extension Treatment Period|Other|0|||
156795786|NCT03895372|566006185|FG006|Extension Treatment Period|Other|0|||
156795787|NCT03895372|566006186|FG007|Extension Treatment Period|Other|2|||
156795788|NCT03895372|566006179|FG000|Extension Treatment Period|Pregnancy|0|||
156795789|NCT03895372|566006180|FG001|Extension Treatment Period|Pregnancy|0|||
156795790|NCT03895372|566006181|FG002|Extension Treatment Period|Pregnancy|0|||
156795791|NCT03895372|566006182|FG003|Extension Treatment Period|Pregnancy|0|||
156795792|NCT03895372|566006183|FG004|Extension Treatment Period|Pregnancy|1|||
156795793|NCT03895372|566006184|FG005|Extension Treatment Period|Pregnancy|0|||
156795794|NCT03895372|566006185|FG006|Extension Treatment Period|Pregnancy|0|||
156795795|NCT03895372|566006186|FG007|Extension Treatment Period|Pregnancy|0|||
156795796|NCT03895372|566006179|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
157138541|NCT00929240|567252231|FG000|Initial Treatment Phase|Death|2|||
156727176|NCT02151851|565750358|FG001|Overall Study|Protocol Violation|1|||
156795797|NCT03895372|566006180|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
156795798|NCT03895372|566006181|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
156727177|NCT02151851|565750357|FG000|Overall Study|Withdrawal by Subject|2|||
156727178|NCT02151851|565750358|FG001|Overall Study|Withdrawal by Subject|5|||
156795799|NCT03895372|566006182|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
156795800|NCT03895372|566006183|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
156795801|NCT03895372|566006184|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
156876223|NCT03390101|566305769|FG002|Weeks 12-54|Withdrawal by Subject|1|||
156727179|NCT02151851|565750357|FG000|Overall Study|Medical impairment|1|||
157138542|NCT00929240|567252232|FG001|Initial Treatment Phase|Death|0|||
156727180|NCT02151851|565750358|FG001|Overall Study|Medical impairment|0|||
156727181|NCT02151851|565750357|FG000|Overall Study|Low compliance to study visits|0|||
156727182|NCT02151851|565750358|FG001|Overall Study|Low compliance to study visits|1|||
156727183|NCT02151851|565750357|FG000|Overall Study|Subject entered into study in error|0|||
156727184|NCT02151851|565750358|FG001|Overall Study|Subject entered into study in error|1|||
156727185|NCT02151851|565750357|FG000|Overall Study|Adverse Event|6|||
156727186|NCT02151851|565750358|FG001|Overall Study|Adverse Event|28|||
156727187|NCT02640950|565750359|FG000|Overall Study|Adverse Event|1|||
156727188|NCT02640950|565750359|FG000|Overall Study|Withdrawal by Subject|1|||
156727189|NCT00652626|565750360|FG000|Initial Treatment Phase|Adverse Event|0|||
156727190|NCT00652626|565750361|FG001|Initial Treatment Phase|Adverse Event|0|||
156727191|NCT00652626|565750362|FG002|Initial Treatment Phase|Adverse Event|0|||
156727192|NCT00652626|565750363|FG003|Initial Treatment Phase|Adverse Event|0|||
156727193|NCT00652626|565750364|FG004|Initial Treatment Phase|Adverse Event|1|||
156727194|NCT00652626|565750365|FG005|Initial Treatment Phase|Adverse Event|0|||
156727195|NCT00652626|565750366|FG006|Initial Treatment Phase|Adverse Event|0|||
156727196|NCT00652626|565750360|FG000|Initial Treatment Phase|Protocol Violation|0|||
156727197|NCT00652626|565750361|FG001|Initial Treatment Phase|Protocol Violation|0|||
156727198|NCT00652626|565750362|FG002|Initial Treatment Phase|Protocol Violation|0|||
156727199|NCT00652626|565750363|FG003|Initial Treatment Phase|Protocol Violation|1|||
156727200|NCT00652626|565750364|FG004|Initial Treatment Phase|Protocol Violation|0|||
156727201|NCT00652626|565750365|FG005|Initial Treatment Phase|Protocol Violation|0|||
156727202|NCT00652626|565750366|FG006|Initial Treatment Phase|Protocol Violation|0|||
156727203|NCT00652626|565750360|FG000|Initial Treatment Phase|Physician Decision|0|||
156727204|NCT00652626|565750361|FG001|Initial Treatment Phase|Physician Decision|0|||
156727205|NCT00652626|565750362|FG002|Initial Treatment Phase|Physician Decision|0|||
156727206|NCT00652626|565750363|FG003|Initial Treatment Phase|Physician Decision|0|||
156727207|NCT00652626|565750364|FG004|Initial Treatment Phase|Physician Decision|1|||
156727208|NCT00652626|565750365|FG005|Initial Treatment Phase|Physician Decision|0|||
156727209|NCT00652626|565750366|FG006|Initial Treatment Phase|Physician Decision|0|||
156727210|NCT00652626|565750360|FG000|Initial Treatment Phase|Sponsor Request|0|||
156727211|NCT00652626|565750361|FG001|Initial Treatment Phase|Sponsor Request|0|||
156727212|NCT00652626|565750362|FG002|Initial Treatment Phase|Sponsor Request|1|||
156727213|NCT00652626|565750363|FG003|Initial Treatment Phase|Sponsor Request|0|||
156727214|NCT00652626|565750364|FG004|Initial Treatment Phase|Sponsor Request|0|||
156727215|NCT00652626|565750365|FG005|Initial Treatment Phase|Sponsor Request|0|||
156727216|NCT00652626|565750366|FG006|Initial Treatment Phase|Sponsor Request|0|||
156727217|NCT00652626|565750360|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
156727218|NCT00652626|565750361|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
156727219|NCT00652626|565750362|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
156727220|NCT00652626|565750363|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
156727221|NCT00652626|565750364|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
156727222|NCT00652626|565750365|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
156727223|NCT00652626|565750366|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
156727224|NCT00652626|565750360|FG000|Extension Phase|Withdrawal by Subject|0|||
156727225|NCT00652626|565750361|FG001|Extension Phase|Withdrawal by Subject|0|||
156727226|NCT00652626|565750362|FG002|Extension Phase|Withdrawal by Subject|0|||
156727227|NCT00652626|565750363|FG003|Extension Phase|Withdrawal by Subject|0|||
156727228|NCT00652626|565750364|FG004|Extension Phase|Withdrawal by Subject|0|||
156727229|NCT00652626|565750365|FG005|Extension Phase|Withdrawal by Subject|2|||
156727230|NCT00652626|565750366|FG006|Extension Phase|Withdrawal by Subject|0|||
156727231|NCT00652626|565750360|FG000|Extension Phase|Adverse Event|0|||
156727232|NCT00652626|565750361|FG001|Extension Phase|Adverse Event|0|||
156727233|NCT00652626|565750362|FG002|Extension Phase|Adverse Event|0|||
156727234|NCT00652626|565750363|FG003|Extension Phase|Adverse Event|0|||
156727235|NCT00652626|565750364|FG004|Extension Phase|Adverse Event|0|||
156727236|NCT00652626|565750365|FG005|Extension Phase|Adverse Event|2|||
156727237|NCT00652626|565750366|FG006|Extension Phase|Adverse Event|1|||
156727238|NCT00652626|565750360|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727239|NCT00652626|565750361|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727240|NCT00652626|565750362|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727241|NCT00652626|565750363|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156727242|NCT00652626|565750364|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
156795802|NCT03895372|566006185|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
156795803|NCT03895372|566006186|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
156795804|NCT03685149|566006187|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
156795805|NCT03685149|566006188|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
157138543|NCT00929240|567252233|FG002|Initial Treatment Phase|Death|0|||
156795806|NCT03685149|566006187|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156727243|NCT00652626|565750365|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
157138544|NCT00929240|567252231|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
156727244|NCT00652626|565750366|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
157138545|NCT00929240|567252232|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
157138546|NCT00929240|567252233|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
157138547|NCT00929240|567252231|FG000|Initial Treatment Phase|Physician Decision|4|||
157138548|NCT00929240|567252232|FG001|Initial Treatment Phase|Physician Decision|0|||
157138549|NCT00929240|567252233|FG002|Initial Treatment Phase|Physician Decision|0|||
157138550|NCT00929240|567252231|FG000|Maintenance Phase|Disease progression|0|||
157138551|NCT00929240|567252232|FG001|Maintenance Phase|Disease progression|73|||
157138552|NCT00929240|567252233|FG002|Maintenance Phase|Disease progression|60|||
157138553|NCT00929240|567252231|FG000|Maintenance Phase|Adverse Event|0|||
157138554|NCT00929240|567252232|FG001|Maintenance Phase|Adverse Event|9|||
157138555|NCT00929240|567252233|FG002|Maintenance Phase|Adverse Event|12|||
157138556|NCT00929240|567252231|FG000|Maintenance Phase|Withdrawal by Subject|0|||
157138557|NCT00929240|567252232|FG001|Maintenance Phase|Withdrawal by Subject|2|||
157138558|NCT00929240|567252233|FG002|Maintenance Phase|Withdrawal by Subject|6|||
157138559|NCT00929240|567252231|FG000|Maintenance Phase|Protocol Violation|0|||
157138560|NCT00929240|567252232|FG001|Maintenance Phase|Protocol Violation|1|||
157138561|NCT00929240|567252233|FG002|Maintenance Phase|Protocol Violation|0|||
157138562|NCT00929240|567252231|FG000|Maintenance Phase|Health authority/Study termination|0|||
157138563|NCT00929240|567252232|FG001|Maintenance Phase|Health authority/Study termination|1|||
157138564|NCT00929240|567252233|FG002|Maintenance Phase|Health authority/Study termination|2|||
157138565|NCT00929240|567252231|FG000|Maintenance Phase|Physician Decision|0|||
157138566|NCT00929240|567252232|FG001|Maintenance Phase|Physician Decision|2|||
157138567|NCT00929240|567252233|FG002|Maintenance Phase|Physician Decision|1|||
157138568|NCT00929240|567252231|FG000|Maintenance Phase|Change of treatment|0|||
157138569|NCT00929240|567252232|FG001|Maintenance Phase|Change of treatment|4|||
157138570|NCT00929240|567252233|FG002|Maintenance Phase|Change of treatment|0|||
157138571|NCT00929240|567252231|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
157138572|NCT00929240|567252232|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
157138573|NCT00929240|567252233|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
157138574|NCT00929240|567252231|FG000|Maintenance Phase|Participant not treated|0|||
157138575|NCT00929240|567252232|FG001|Maintenance Phase|Participant not treated|2|||
157138576|NCT00929240|567252233|FG002|Maintenance Phase|Participant not treated|0|||
157138577|NCT02209506|567252234|FG000|Overall Study|Withdrawal by Subject|0|||
157138578|NCT02209506|567252235|FG001|Overall Study|Withdrawal by Subject|0|||
157138579|NCT02209506|567252236|FG002|Overall Study|Withdrawal by Subject|0|||
157138580|NCT02209506|567252237|FG003|Overall Study|Withdrawal by Subject|0|||
156727245|NCT00652626|565750360|FG000|Extension Phase|Physician Decision|0|||
156727246|NCT00652626|565750361|FG001|Extension Phase|Physician Decision|0|||
156727247|NCT00652626|565750362|FG002|Extension Phase|Physician Decision|0|||
156727248|NCT00652626|565750363|FG003|Extension Phase|Physician Decision|0|||
156727249|NCT00652626|565750364|FG004|Extension Phase|Physician Decision|0|||
156727250|NCT00652626|565750365|FG005|Extension Phase|Physician Decision|1|||
156727251|NCT00652626|565750366|FG006|Extension Phase|Physician Decision|1|||
156727252|NCT00652626|565750360|FG000|Extension Phase|Death|0|||
156727253|NCT00652626|565750361|FG001|Extension Phase|Death|0|||
156727254|NCT00652626|565750362|FG002|Extension Phase|Death|0|||
156727255|NCT00652626|565750363|FG003|Extension Phase|Death|0|||
156727256|NCT00652626|565750364|FG004|Extension Phase|Death|0|||
156727257|NCT00652626|565750365|FG005|Extension Phase|Death|1|||
156727258|NCT00652626|565750366|FG006|Extension Phase|Death|1|||
156727259|NCT04003636|565750367|FG000|Overall Study|Death|409|||
156727260|NCT04003636|565750368|FG001|Overall Study|Death|443|||
156727261|NCT04003636|565750367|FG000|Overall Study|Lost to Follow-up|0|||
156727262|NCT04003636|565750368|FG001|Overall Study|Lost to Follow-up|1|||
156727263|NCT04003636|565750367|FG000|Overall Study|Withdrawal by Subject|5|||
156727264|NCT04003636|565750368|FG001|Overall Study|Withdrawal by Subject|2|||
156727265|NCT04003636|565750367|FG000|Overall Study|Participant On-going|119|||
156795807|NCT03685149|566006188|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156795808|NCT03685149|566006187|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
156795809|NCT03685149|566006188|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
156795810|NCT02655601|566006192|FG000|Overall Study|Adverse Event|0|||
156795811|NCT02655601|566006193|FG001|Overall Study|Adverse Event|0|||
156795812|NCT02655601|566006194|FG002|Overall Study|Adverse Event|0|||
156727266|NCT04003636|565750368|FG001|Overall Study|Participant On-going|90|||
156727267|NCT03048747|565750369|FG000|Overall Study|Adverse Event|2|||
156727268|NCT03048747|565750369|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
156727269|NCT03048747|565750369|FG000|Overall Study|Physician Decision|1|||
156727270|NCT00298272|565750370|FG000|Double-blind Phase|Adverse Event|2|||
156727271|NCT00298272|565750371|FG001|Double-blind Phase|Adverse Event|0|||
156727272|NCT00298272|565750370|FG000|Double-blind Phase|Failure to Return|2|||
156795813|NCT02655601|566006195|FG003|Overall Study|Adverse Event|1|||
157138581|NCT02209506|567252238|FG004|Overall Study|Withdrawal by Subject|1|||
157138582|NCT00098787|567252239|FG000|Overall Study|Never started treatment|3|||
157138583|NCT00098787|567252240|FG001|Overall Study|Never started treatment|2|||
157138584|NCT00098787|567252241|FG002|Overall Study|Never started treatment|1|||
157138585|NCT00098787|567252239|FG000|Overall Study|Ineligible|9|||
156727273|NCT00298272|565750371|FG001|Double-blind Phase|Failure to Return|0|||
156727274|NCT00298272|565750370|FG000|Double-blind Phase|Protocol Violation|2|||
156727275|NCT00298272|565750371|FG001|Double-blind Phase|Protocol Violation|0|||
156727276|NCT00298272|565750370|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156727277|NCT00298272|565750371|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156727278|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Adverse Event|1|||
156727279|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Adverse Event|2|||
156727280|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
156727281|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
156727282|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Failure to Return|1|||
156727283|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Failure to Return|0|||
156727284|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
156727285|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
156727286|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
156727287|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
156727288|NCT00298272|565750370|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
156727289|NCT00298272|565750371|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
156727290|NCT00298272|565750370|FG000|Safety Follow-up Phase|Failure to Return|1|||
156727291|NCT00298272|565750371|FG001|Safety Follow-up Phase|Failure to Return|1|||
156727292|NCT00298272|565750370|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
156727293|NCT00298272|565750371|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
156727294|NCT00298272|565750370|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
156727295|NCT00298272|565750371|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
156727296|NCT00915018|565750372|FG000|Overall Study|Death|75|||
156727297|NCT00915018|565750373|FG001|Overall Study|Death|70|||
156727298|NCT00915018|565750372|FG000|Overall Study|Lost to Follow-up|10|||
156727299|NCT00915018|565750373|FG001|Overall Study|Lost to Follow-up|5|||
156727300|NCT00915018|565750372|FG000|Overall Study|Withdrawal by Subject|38|||
156727301|NCT00915018|565750373|FG001|Overall Study|Withdrawal by Subject|27|||
156727302|NCT00915018|565750372|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
156727303|NCT00915018|565750373|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
156727304|NCT00457002|565750374|FG000|Overall Study|Death|40|||
156727305|NCT00457002|565750375|FG001|Overall Study|Death|47|||
156727306|NCT00457002|565750374|FG000|Overall Study|Adverse Event|284|||
156727307|NCT00457002|565750375|FG001|Overall Study|Adverse Event|260|||
156727308|NCT00457002|565750374|FG000|Overall Study|Withdrawal by Subject|299|||
156727309|NCT00457002|565750375|FG001|Overall Study|Withdrawal by Subject|271|||
156727310|NCT00457002|565750374|FG000|Overall Study|Lost to Follow-up|72|||
156727311|NCT00457002|565750375|FG001|Overall Study|Lost to Follow-up|71|||
156727312|NCT00457002|565750374|FG000|Overall Study|Poor/Non-compliance|46|||
156727313|NCT00457002|565750375|FG001|Overall Study|Poor/Non-compliance|33|||
156727314|NCT00457002|565750374|FG000|Overall Study|No longer met criteria|41|||
156727315|NCT00457002|565750375|FG001|Overall Study|No longer met criteria|37|||
156727316|NCT00457002|565750374|FG000|Overall Study|Administrative reason by Sponsor|1|||
156727317|NCT00457002|565750375|FG001|Overall Study|Administrative reason by Sponsor|0|||
156727318|NCT00457002|565750374|FG000|Overall Study|non-specified|29|||
156727319|NCT00457002|565750375|FG001|Overall Study|non-specified|38|||
156727320|NCT00457002|565750374|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
156727321|NCT00457002|565750375|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
156727322|NCT01623310|565750376|FG000|Overall Study|Adverse Event|21|||
156727323|NCT01623310|565750376|FG000|Overall Study|Lost to Follow-up|18|||
156727324|NCT01623310|565750376|FG000|Overall Study|Lack of Efficacy|6|||
156727325|NCT01623310|565750376|FG000|Overall Study|Protocol Violation|6|||
156727326|NCT01623310|565750376|FG000|Overall Study|Withdrawal by Subject|25|||
156727327|NCT01623310|565750376|FG000|Overall Study|Became potentially child-bearing|1|||
156727328|NCT01623310|565750376|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
156727329|NCT01623310|565750376|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
156727330|NCT00454246|565750377|FG000|Overall Study|Adverse Event|2|||
156727331|NCT00454246|565750378|FG001|Overall Study|Adverse Event|2|||
156727332|NCT00454246|565750379|FG002|Overall Study|Adverse Event|0|||
156727333|NCT00454246|565750377|FG000|Overall Study|Violation of selection criteria at entry|6|||
156727334|NCT00454246|565750378|FG001|Overall Study|Violation of selection criteria at entry|0|||
156727335|NCT00454246|565750379|FG002|Overall Study|Violation of selection criteria at entry|0|||
156727336|NCT00454246|565750377|FG000|Overall Study|Protocol Violation|1|||
156727337|NCT00454246|565750378|FG001|Overall Study|Protocol Violation|0|||
156727338|NCT00454246|565750379|FG002|Overall Study|Protocol Violation|0|||
156727339|NCT00454246|565750377|FG000|Overall Study|Refused Treatment|1|||
156727340|NCT00454246|565750378|FG001|Overall Study|Refused Treatment|1|||
156727341|NCT00454246|565750379|FG002|Overall Study|Refused Treatment|0|||
156727342|NCT00454246|565750377|FG000|Overall Study|Failure to return|1|||
156727343|NCT00454246|565750378|FG001|Overall Study|Failure to return|0|||
156727344|NCT00454246|565750379|FG002|Overall Study|Failure to return|0|||
156727345|NCT00454246|565750377|FG000|Overall Study|Early termination of study|62|||
156727346|NCT00454246|565750378|FG001|Overall Study|Early termination of study|26|||
156727347|NCT00454246|565750379|FG002|Overall Study|Early termination of study|9|||
156727348|NCT05326529|565750380|FG000|Overall Study|Lack of Efficacy|0|||
156727349|NCT05326529|565750381|FG001|Overall Study|Lack of Efficacy|1|||
156727350|NCT05326529|565750382|FG002|Overall Study|Lack of Efficacy|0|||
156727351|NCT05326529|565750380|FG000|Overall Study|Physician Decision|0|||
156727352|NCT05326529|565750381|FG001|Overall Study|Physician Decision|0|||
156727353|NCT05326529|565750382|FG002|Overall Study|Physician Decision|2|||
156727354|NCT00932373|565750384|FG000|Overall Study|Progressive disease|3|||
156727355|NCT00932373|565750385|FG001|Overall Study|Progressive disease|1|||
156727356|NCT00932373|565750386|FG002|Overall Study|Progressive disease|0|||
156727357|NCT00932373|565750387|FG003|Overall Study|Progressive disease|0|||
156727358|NCT00932373|565750388|FG004|Overall Study|Progressive disease|10|||
156727359|NCT00932373|565750389|FG005|Overall Study|Progressive disease|1|||
156727360|NCT00932373|565750390|FG006|Overall Study|Progressive disease|0|||
156727361|NCT00932373|565750391|FG007|Overall Study|Progressive disease|2|||
156727362|NCT00932373|565750392|FG008|Overall Study|Progressive disease|1|||
156727363|NCT00932373|565750393|FG009|Overall Study|Progressive disease|9|||
156727364|NCT00932373|565750394|FG010|Overall Study|Progressive disease|2|||
156727365|NCT00932373|565750384|FG000|Overall Study|Adverse Event|0|||
156727366|NCT00932373|565750385|FG001|Overall Study|Adverse Event|0|||
156727367|NCT00932373|565750386|FG002|Overall Study|Adverse Event|0|||
156727368|NCT00932373|565750387|FG003|Overall Study|Adverse Event|0|||
156727369|NCT00932373|565750388|FG004|Overall Study|Adverse Event|2|||
156727370|NCT00932373|565750389|FG005|Overall Study|Adverse Event|1|||
156727371|NCT00932373|565750390|FG006|Overall Study|Adverse Event|0|||
156727372|NCT00932373|565750391|FG007|Overall Study|Adverse Event|1|||
156727373|NCT00932373|565750392|FG008|Overall Study|Adverse Event|0|||
156727374|NCT00932373|565750393|FG009|Overall Study|Adverse Event|2|||
156727375|NCT00932373|565750394|FG010|Overall Study|Adverse Event|1|||
156727376|NCT00932373|565750384|FG000|Overall Study|Physician Decision|0|||
156727377|NCT00932373|565750385|FG001|Overall Study|Physician Decision|0|||
156727378|NCT00932373|565750386|FG002|Overall Study|Physician Decision|1|||
156727379|NCT00932373|565750387|FG003|Overall Study|Physician Decision|0|||
156727380|NCT00932373|565750388|FG004|Overall Study|Physician Decision|2|||
156727381|NCT00932373|565750389|FG005|Overall Study|Physician Decision|0|||
156727382|NCT00932373|565750390|FG006|Overall Study|Physician Decision|0|||
156727383|NCT00932373|565750391|FG007|Overall Study|Physician Decision|0|||
156727384|NCT00932373|565750392|FG008|Overall Study|Physician Decision|0|||
156727385|NCT00932373|565750393|FG009|Overall Study|Physician Decision|1|||
156727386|NCT00932373|565750394|FG010|Overall Study|Physician Decision|0|||
156727387|NCT00932373|565750384|FG000|Overall Study|Dose limiting toxicity|0|||
156727388|NCT00932373|565750385|FG001|Overall Study|Dose limiting toxicity|0|||
156727389|NCT00932373|565750386|FG002|Overall Study|Dose limiting toxicity|0|||
156727390|NCT00932373|565750387|FG003|Overall Study|Dose limiting toxicity|0|||
156727391|NCT00932373|565750388|FG004|Overall Study|Dose limiting toxicity|0|||
156727392|NCT00932373|565750389|FG005|Overall Study|Dose limiting toxicity|1|||
156727393|NCT00932373|565750390|FG006|Overall Study|Dose limiting toxicity|0|||
156727394|NCT00932373|565750391|FG007|Overall Study|Dose limiting toxicity|0|||
156727395|NCT00932373|565750392|FG008|Overall Study|Dose limiting toxicity|0|||
156727396|NCT00932373|565750393|FG009|Overall Study|Dose limiting toxicity|0|||
156727397|NCT00932373|565750394|FG010|Overall Study|Dose limiting toxicity|0|||
156727398|NCT00932373|565750384|FG000|Overall Study|Withdrawal by Subject|0|||
156727399|NCT00932373|565750385|FG001|Overall Study|Withdrawal by Subject|0|||
156727400|NCT00932373|565750386|FG002|Overall Study|Withdrawal by Subject|0|||
156727401|NCT00932373|565750387|FG003|Overall Study|Withdrawal by Subject|0|||
156727402|NCT00932373|565750388|FG004|Overall Study|Withdrawal by Subject|0|||
156727403|NCT00932373|565750389|FG005|Overall Study|Withdrawal by Subject|0|||
156727404|NCT00932373|565750390|FG006|Overall Study|Withdrawal by Subject|0|||
156727405|NCT00932373|565750391|FG007|Overall Study|Withdrawal by Subject|0|||
156727406|NCT00932373|565750392|FG008|Overall Study|Withdrawal by Subject|1|||
156727407|NCT00932373|565750393|FG009|Overall Study|Withdrawal by Subject|0|||
156727408|NCT00932373|565750394|FG010|Overall Study|Withdrawal by Subject|0|||
156727409|NCT00932373|565750384|FG000|Overall Study|Clinical progression|0|||
157138586|NCT00098787|567252240|FG001|Overall Study|Ineligible|7|||
157138587|NCT00098787|567252241|FG002|Overall Study|Ineligible|3|||
156727410|NCT00932373|565750385|FG001|Overall Study|Clinical progression|0|||
156727411|NCT00932373|565750386|FG002|Overall Study|Clinical progression|0|||
156727412|NCT00932373|565750387|FG003|Overall Study|Clinical progression|0|||
156727413|NCT00932373|565750388|FG004|Overall Study|Clinical progression|0|||
156727414|NCT00932373|565750389|FG005|Overall Study|Clinical progression|0|||
156727415|NCT00932373|565750390|FG006|Overall Study|Clinical progression|1|||
156727416|NCT00932373|565750391|FG007|Overall Study|Clinical progression|0|||
156727417|NCT00932373|565750392|FG008|Overall Study|Clinical progression|0|||
156727418|NCT00932373|565750393|FG009|Overall Study|Clinical progression|0|||
156727419|NCT00932373|565750394|FG010|Overall Study|Clinical progression|0|||
156727420|NCT00932373|565750384|FG000|Overall Study|Lack of Efficacy|0|||
157138588|NCT00098787|567252239|FG000|Overall Study|Disease progression|28|||
156727421|NCT00932373|565750385|FG001|Overall Study|Lack of Efficacy|0|||
157138589|NCT00098787|567252240|FG001|Overall Study|Disease progression|17|||
157138590|NCT00098787|567252241|FG002|Overall Study|Disease progression|23|||
157138591|NCT00098787|567252239|FG000|Overall Study|Adverse Event|8|||
157138592|NCT00098787|567252240|FG001|Overall Study|Adverse Event|17|||
157138593|NCT00098787|567252241|FG002|Overall Study|Adverse Event|8|||
156727422|NCT00932373|565750386|FG002|Overall Study|Lack of Efficacy|0|||
156727423|NCT00932373|565750387|FG003|Overall Study|Lack of Efficacy|0|||
156727424|NCT00932373|565750388|FG004|Overall Study|Lack of Efficacy|0|||
156727425|NCT00932373|565750389|FG005|Overall Study|Lack of Efficacy|0|||
156727426|NCT00932373|565750390|FG006|Overall Study|Lack of Efficacy|0|||
156727427|NCT00932373|565750391|FG007|Overall Study|Lack of Efficacy|0|||
156727428|NCT00932373|565750392|FG008|Overall Study|Lack of Efficacy|0|||
156727429|NCT00932373|565750393|FG009|Overall Study|Lack of Efficacy|1|||
156727430|NCT00932373|565750394|FG010|Overall Study|Lack of Efficacy|0|||
156727431|NCT04134767|565750396|FG000|Overall Study|Death|0|||
156727432|NCT04134767|565750397|FG001|Overall Study|Death|1|||
156727433|NCT04134767|565750396|FG000|Overall Study|Removed for harassing staff|0|||
156727434|NCT04134767|565750397|FG001|Overall Study|Removed for harassing staff|1|||
156727435|NCT04134767|565750396|FG000|Overall Study|Lost to Follow-up|44|||
156727436|NCT04134767|565750397|FG001|Overall Study|Lost to Follow-up|40|||
156727437|NCT02582242|565750398|FG000|Overall Study|Adverse Event|4|||
156727438|NCT02582242|565750399|FG001|Overall Study|Adverse Event|3|||
156727439|NCT02582242|565750398|FG000|Overall Study|Protocol Violation|3|||
156727440|NCT02582242|565750399|FG001|Overall Study|Protocol Violation|1|||
156727441|NCT02582242|565750398|FG000|Overall Study|Lost to Follow-up|0|||
156727442|NCT02582242|565750399|FG001|Overall Study|Lost to Follow-up|1|||
156727443|NCT02582242|565750398|FG000|Overall Study|Withdrawal by Subject|11|||
156727444|NCT02582242|565750399|FG001|Overall Study|Withdrawal by Subject|11|||
156727445|NCT02582242|565750398|FG000|Overall Study|Unclassified|2|||
156727446|NCT02582242|565750399|FG001|Overall Study|Unclassified|1|||
156727447|NCT00638404|565750400|FG000|Overall Study|Physician Decision|8|||
156727448|NCT00638404|565750401|FG001|Overall Study|Physician Decision|0|||
156727449|NCT02101736|565750405|FG000|Overall Study|Protocol Violation|3|||
156727450|NCT02101736|565750406|FG001|Overall Study|Protocol Violation|0|||
156727451|NCT02101736|565750405|FG000|Overall Study|Withdrawal by Subject|1|||
156727452|NCT02101736|565750406|FG001|Overall Study|Withdrawal by Subject|1|||
156727453|NCT02282631|565750407|FG000|Overall Study|Lost to Follow-up|2|||
156727454|NCT02282631|565750408|FG001|Overall Study|Lost to Follow-up|0|||
156727455|NCT00687271|565750409|FG000|Overall Study|Adverse Event|1|||
156727456|NCT00687271|565750410|FG001|Overall Study|Adverse Event|3|||
156727457|NCT00687271|565750411|FG002|Overall Study|Adverse Event|1|||
156727458|NCT00687271|565750412|FG003|Overall Study|Adverse Event|0|||
156727459|NCT00687271|565750409|FG000|Overall Study|Lost to Follow-up|0|||
156727460|NCT00687271|565750410|FG001|Overall Study|Lost to Follow-up|1|||
156727461|NCT00687271|565750411|FG002|Overall Study|Lost to Follow-up|0|||
156727462|NCT00687271|565750412|FG003|Overall Study|Lost to Follow-up|0|||
156727463|NCT00687271|565750409|FG000|Overall Study|Protocol Violation|2|||
156727464|NCT00687271|565750410|FG001|Overall Study|Protocol Violation|1|||
156727465|NCT00687271|565750411|FG002|Overall Study|Protocol Violation|1|||
156727466|NCT00687271|565750412|FG003|Overall Study|Protocol Violation|0|||
156727467|NCT00687271|565750409|FG000|Overall Study|Withdrawal by Subject|0|||
156727468|NCT00687271|565750410|FG001|Overall Study|Withdrawal by Subject|1|||
156727469|NCT00687271|565750411|FG002|Overall Study|Withdrawal by Subject|3|||
156727470|NCT00687271|565750412|FG003|Overall Study|Withdrawal by Subject|0|||
156727471|NCT01017874|565750416|FG000|Overall Study|Withdrawal by Subject|23|||
156727472|NCT01017874|565750417|FG001|Overall Study|Withdrawal by Subject|20|||
156727473|NCT01017874|565750416|FG000|Overall Study|Sponsor decision|3|||
156727474|NCT01017874|565750417|FG001|Overall Study|Sponsor decision|1|||
156727475|NCT01017874|565750416|FG000|Overall Study|Lost to Follow-up|3|||
156727476|NCT01017874|565750417|FG001|Overall Study|Lost to Follow-up|2|||
156727477|NCT01017874|565750416|FG000|Overall Study|Physician Decision|1|||
156727478|NCT01017874|565750417|FG001|Overall Study|Physician Decision|3|||
156727479|NCT00808210|565750421|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
156727480|NCT00808210|565750422|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
156795814|NCT02655601|566006196|FG004|Overall Study|Adverse Event|1|||
156795815|NCT02655601|566006197|FG005|Overall Study|Adverse Event|0|||
156795816|NCT02655601|566006192|FG000|Overall Study|Physician Decision|0|||
156727481|NCT00808210|565750421|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
156727482|NCT00808210|565750422|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
156727483|NCT00808210|565750421|FG000|Double-Blind TX Period|Adverse Event|0|||
156795817|NCT02655601|566006193|FG001|Overall Study|Physician Decision|0|||
157138594|NCT00098787|567252239|FG000|Overall Study|Death|6|||
156727484|NCT00808210|565750422|FG001|Double-Blind TX Period|Adverse Event|1|||
156727485|NCT00808210|565750421|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
156727486|NCT00808210|565750422|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
156727487|NCT00808210|565750421|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
156727488|NCT00808210|565750422|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
156727489|NCT00808210|565750421|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
157138595|NCT00098787|567252240|FG001|Overall Study|Death|1|||
157138596|NCT00098787|567252241|FG002|Overall Study|Death|0|||
157138597|NCT00098787|567252239|FG000|Overall Study|Withdrawal by Subject|4|||
156727490|NCT00808210|565750422|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
156727491|NCT02044302|565750423|FG000|Overall Study|study terminated|2|||
156727492|NCT02044302|565750424|FG001|Overall Study|study terminated|0|||
156727493|NCT00778817|565750426|FG000|Overall Study|Adverse Event|2|||
156727494|NCT00778817|565750426|FG000|Overall Study|Withdrawal by Subject|2|||
156727495|NCT02509507|565750427|FG000|Overall Study|Death|21|||
157138598|NCT00098787|567252240|FG001|Overall Study|Withdrawal by Subject|12|||
157138599|NCT00098787|567252241|FG002|Overall Study|Withdrawal by Subject|6|||
157138600|NCT00098787|567252239|FG000|Overall Study|Alternative therapy|8|||
157138601|NCT00098787|567252240|FG001|Overall Study|Alternative therapy|13|||
157138602|NCT00098787|567252241|FG002|Overall Study|Alternative therapy|13|||
157138603|NCT00098787|567252239|FG000|Overall Study|Other|7|||
157138604|NCT00098787|567252240|FG001|Overall Study|Other|6|||
157138605|NCT00098787|567252241|FG002|Overall Study|Other|9|||
157138606|NCT00684814|567252242|FG000|Washout Period of 7 Days|Adverse Event|1|||
157138607|NCT00684814|567252243|FG001|Washout Period of 7 Days|Adverse Event|2|||
157138608|NCT00684814|567252242|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
157138609|NCT00684814|567252243|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
157138610|NCT00684814|567252242|FG000|Second Intervention|Adverse Event|1|||
157138611|NCT00684814|567252243|FG001|Second Intervention|Adverse Event|0|||
157138612|NCT04348851|567252245|FG000|Post-Test 1|Withdrawal by Subject|0|||
157138613|NCT04348851|567252246|FG001|Post-Test 1|Withdrawal by Subject|1|||
157138614|NCT04348851|567252247|FG002|Post-Test 1|Withdrawal by Subject|0|||
157138615|NCT04348851|567252248|FG003|Post-Test 1|Withdrawal by Subject|0|||
157138616|NCT04348851|567252245|FG000|Post-Test 1|Lost to Follow-up|0|||
157138617|NCT04348851|567252246|FG001|Post-Test 1|Lost to Follow-up|1|||
157138618|NCT04348851|567252247|FG002|Post-Test 1|Lost to Follow-up|0|||
157138619|NCT04348851|567252248|FG003|Post-Test 1|Lost to Follow-up|0|||
157138620|NCT04348851|567252245|FG000|Post-Test 2|Stroke survivor death|0|||
157138621|NCT04348851|567252246|FG001|Post-Test 2|Stroke survivor death|1|||
157138622|NCT04348851|567252247|FG002|Post-Test 2|Stroke survivor death|0|||
157138623|NCT04348851|567252248|FG003|Post-Test 2|Stroke survivor death|1|||
157138624|NCT00195650|567252249|FG000|Overall Study|Adverse Event|194|||
157138625|NCT00195650|567252249|FG000|Overall Study|Lack of Efficacy|99|||
157138626|NCT00195650|567252249|FG000|Overall Study|Withdrawal by Subject|67|||
157138627|NCT00195650|567252249|FG000|Overall Study|Lost to Follow-up|44|||
157138628|NCT00195650|567252249|FG000|Overall Study|Death|23|||
157138629|NCT00195650|567252249|FG000|Overall Study|Protocol Violation|15|||
157138630|NCT00195650|567252249|FG000|Overall Study|Administrative reasons|83|||
157138631|NCT01499290|567252250|FG000|Overall Study|Withdrawal by Subject|22|||
157138632|NCT01499290|567252251|FG001|Overall Study|Withdrawal by Subject|15|||
157138633|NCT01499290|567252250|FG000|Overall Study|Not specified in study report|11|||
157138634|NCT01499290|567252251|FG001|Overall Study|Not specified in study report|5|||
157138635|NCT01499290|567252250|FG000|Overall Study|Condition improved/subject recovered|1|||
157138636|NCT01499290|567252251|FG001|Overall Study|Condition improved/subject recovered|0|||
157138637|NCT01499290|567252250|FG000|Overall Study|Lack of Efficacy|7|||
157138638|NCT01499290|567252251|FG001|Overall Study|Lack of Efficacy|8|||
157138639|NCT01499290|567252250|FG000|Overall Study|Adverse Event|14|||
157138640|NCT01499290|567252251|FG001|Overall Study|Adverse Event|7|||
157138641|NCT04052139|567252252|FG000|Overall Study|Lost to Follow-up|2|||
157138642|NCT04052139|567252253|FG001|Overall Study|Lost to Follow-up|0|||
157138643|NCT04052139|567252254|FG002|Overall Study|Lost to Follow-up|0|||
157138644|NCT04052139|567252252|FG000|Overall Study|Withdrawal by Subject|1|||
157138645|NCT04052139|567252253|FG001|Overall Study|Withdrawal by Subject|0|||
157138646|NCT04052139|567252254|FG002|Overall Study|Withdrawal by Subject|0|||
156727496|NCT02509507|565750428|FG001|Overall Study|Death|3|||
156727497|NCT02509507|565750429|FG002|Overall Study|Death|22|||
156727498|NCT02509507|565750430|FG003|Overall Study|Death|14|||
157138647|NCT00707577|567252255|FG000|Overall Study|Withdrawal by Subject|3|||
157138648|NCT00707577|567252256|FG001|Overall Study|Withdrawal by Subject|2|||
157138649|NCT00707577|567252255|FG000|Overall Study|Lost to Follow-up|34|||
157138650|NCT00707577|567252256|FG001|Overall Study|Lost to Follow-up|25|||
157138651|NCT00707577|567252255|FG000|Overall Study|Left employment|13|||
157138652|NCT00707577|567252256|FG001|Overall Study|Left employment|10|||
156727499|NCT02509507|565750431|FG004|Overall Study|Death|8|||
156727500|NCT02509507|565750432|FG005|Overall Study|Death|12|||
157138653|NCT00707577|567252255|FG000|Overall Study|Pregnancy|4|||
157138654|NCT00707577|567252256|FG001|Overall Study|Pregnancy|1|||
157138655|NCT00190775|567252257|FG000|Overall Study|Adverse Event|57|||
157138656|NCT00190775|567252258|FG001|Overall Study|Adverse Event|22|||
157138657|NCT00190775|567252257|FG000|Overall Study|Satisfactory Response|1|||
157138658|NCT00190775|567252258|FG001|Overall Study|Satisfactory Response|0|||
157138659|NCT00190775|567252257|FG000|Overall Study|Lack of Efficacy|28|||
157138660|NCT00190775|567252258|FG001|Overall Study|Lack of Efficacy|32|||
157138661|NCT00190775|567252257|FG000|Overall Study|Lost to Follow-up|31|||
156727501|NCT02509507|565750433|FG006|Overall Study|Death|5|||
156727502|NCT02509507|565750434|FG007|Overall Study|Death|4|||
156727503|NCT02509507|565750435|FG008|Overall Study|Death|8|||
156727504|NCT02509507|565750427|FG000|Overall Study|Lost to Follow-up|0|||
156727505|NCT02509507|565750428|FG001|Overall Study|Lost to Follow-up|1|||
157138662|NCT00190775|567252258|FG001|Overall Study|Lost to Follow-up|23|||
157138663|NCT00190775|567252257|FG000|Overall Study|Participant Moved|0|||
157138664|NCT00190775|567252258|FG001|Overall Study|Participant Moved|1|||
157138665|NCT00190775|567252257|FG000|Overall Study|Withdrawal by Subject|24|||
157138666|NCT00190775|567252258|FG001|Overall Study|Withdrawal by Subject|13|||
157138667|NCT00190775|567252257|FG000|Overall Study|Sponsor Decision|1|||
157138668|NCT00190775|567252258|FG001|Overall Study|Sponsor Decision|0|||
157138669|NCT00190775|567252257|FG000|Overall Study|Physician Decision|3|||
157138670|NCT00190775|567252258|FG001|Overall Study|Physician Decision|0|||
157138671|NCT00190775|567252257|FG000|Overall Study|Noncompliance|3|||
157138672|NCT00190775|567252258|FG001|Overall Study|Noncompliance|5|||
157138673|NCT00190775|567252257|FG000|Overall Study|Protocol Violation|0|||
157138674|NCT00190775|567252258|FG001|Overall Study|Protocol Violation|1|||
157138675|NCT00190775|567252257|FG000|Overall Study|Exclusion Criteria Met|1|||
157138676|NCT00190775|567252258|FG001|Overall Study|Exclusion Criteria Met|3|||
157138677|NCT01794780|567252259|FG000|Overall Study|Adverse Event|0|||
157138678|NCT01794780|567252260|FG001|Overall Study|Adverse Event|1|||
157138679|NCT01794780|567252261|FG002|Overall Study|Adverse Event|2|||
157138680|NCT01794780|567252262|FG003|Overall Study|Adverse Event|0|||
157138681|NCT01794780|567252263|FG004|Overall Study|Adverse Event|0|||
157138682|NCT01794780|567252264|FG005|Overall Study|Adverse Event|0|||
157138683|NCT01794780|567252265|FG006|Overall Study|Adverse Event|0|||
157138684|NCT01794780|567252266|FG007|Overall Study|Adverse Event|0|||
157138685|NCT01794780|567252259|FG000|Overall Study|Death|0|||
157138686|NCT01794780|567252260|FG001|Overall Study|Death|2|||
157138687|NCT01794780|567252261|FG002|Overall Study|Death|14|||
157138688|NCT01794780|567252262|FG003|Overall Study|Death|1|||
157138689|NCT01794780|567252263|FG004|Overall Study|Death|0|||
157138690|NCT01794780|567252264|FG005|Overall Study|Death|9|||
157138691|NCT01794780|567252265|FG006|Overall Study|Death|4|||
157138692|NCT01794780|567252266|FG007|Overall Study|Death|0|||
157138693|NCT01794780|567252259|FG000|Overall Study|Lost to Follow-up|10|||
157138694|NCT01794780|567252260|FG001|Overall Study|Lost to Follow-up|64|||
157138695|NCT01794780|567252261|FG002|Overall Study|Lost to Follow-up|165|||
157138696|NCT01794780|567252262|FG003|Overall Study|Lost to Follow-up|53|||
157138697|NCT01794780|567252263|FG004|Overall Study|Lost to Follow-up|2|||
157138698|NCT01794780|567252264|FG005|Overall Study|Lost to Follow-up|99|||
157138699|NCT01794780|567252265|FG006|Overall Study|Lost to Follow-up|30|||
157138700|NCT01794780|567252266|FG007|Overall Study|Lost to Follow-up|5|||
157138701|NCT01794780|567252259|FG000|Overall Study|Withdrew informed consent|7|||
157138702|NCT01794780|567252260|FG001|Overall Study|Withdrew informed consent|17|||
157138703|NCT01794780|567252261|FG002|Overall Study|Withdrew informed consent|36|||
157138704|NCT01794780|567252262|FG003|Overall Study|Withdrew informed consent|9|||
157138705|NCT01794780|567252263|FG004|Overall Study|Withdrew informed consent|0|||
157138706|NCT01794780|567252264|FG005|Overall Study|Withdrew informed consent|48|||
157138707|NCT01794780|567252265|FG006|Overall Study|Withdrew informed consent|4|||
157138708|NCT01794780|567252266|FG007|Overall Study|Withdrew informed consent|3|||
157138709|NCT01794780|567252259|FG000|Overall Study|Other|0|||
157138710|NCT01794780|567252260|FG001|Overall Study|Other|12|||
157138711|NCT01794780|567252261|FG002|Overall Study|Other|25|||
157138712|NCT01794780|567252262|FG003|Overall Study|Other|20|||
156727506|NCT02509507|565750429|FG002|Overall Study|Lost to Follow-up|0|||
156727507|NCT02509507|565750430|FG003|Overall Study|Lost to Follow-up|0|||
156727508|NCT02509507|565750431|FG004|Overall Study|Lost to Follow-up|0|||
156727509|NCT02509507|565750432|FG005|Overall Study|Lost to Follow-up|2|||
156727510|NCT02509507|565750433|FG006|Overall Study|Lost to Follow-up|0|||
156727511|NCT02509507|565750434|FG007|Overall Study|Lost to Follow-up|0|||
157138713|NCT01794780|567252263|FG004|Overall Study|Other|1|||
157138714|NCT01794780|567252264|FG005|Overall Study|Other|24|||
157138715|NCT01794780|567252265|FG006|Overall Study|Other|4|||
157138716|NCT01794780|567252266|FG007|Overall Study|Other|1|||
157138717|NCT02209766|567252268|FG000|Overall Study|Withdrawal by Subject|0|||
157217433|NCT01621490|567543222|FG000|Overall Study|Adverse event unrelated to study drug|1|||
156727512|NCT02509507|565750435|FG008|Overall Study|Lost to Follow-up|0|||
156727513|NCT02509507|565750427|FG000|Overall Study|Withdrawal by Subject|2|||
156727514|NCT02509507|565750428|FG001|Overall Study|Withdrawal by Subject|0|||
157138718|NCT02209766|567252269|FG001|Overall Study|Withdrawal by Subject|0|||
157138719|NCT02209766|567252270|FG002|Overall Study|Withdrawal by Subject|0|||
157138720|NCT02209766|567252271|FG003|Overall Study|Withdrawal by Subject|1|||
157138721|NCT02209766|567252272|FG004|Overall Study|Withdrawal by Subject|0|||
157138722|NCT00327444|567252273|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
157138723|NCT00327444|567252274|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
157138724|NCT00327444|567252273|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
157138725|NCT00327444|567252274|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
156727515|NCT02509507|565750429|FG002|Overall Study|Withdrawal by Subject|1|||
157138726|NCT00327444|567252273|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
156727516|NCT02509507|565750430|FG003|Overall Study|Withdrawal by Subject|4|||
156727517|NCT02509507|565750431|FG004|Overall Study|Withdrawal by Subject|1|||
156727518|NCT02509507|565750432|FG005|Overall Study|Withdrawal by Subject|3|||
156727519|NCT02509507|565750433|FG006|Overall Study|Withdrawal by Subject|4|||
156727520|NCT02509507|565750434|FG007|Overall Study|Withdrawal by Subject|0|||
156727521|NCT02509507|565750435|FG008|Overall Study|Withdrawal by Subject|1|||
156727522|NCT03150719|565750436|FG000|Overall Study|Adverse Event|0|||
156727523|NCT03150719|565750437|FG001|Overall Study|Adverse Event|1|||
156727524|NCT03150719|565750436|FG000|Overall Study|Death|0|||
156727525|NCT03150719|565750437|FG001|Overall Study|Death|1|||
156727526|NCT03150719|565750436|FG000|Overall Study|Other|1|||
156727527|NCT03150719|565750437|FG001|Overall Study|Other|0|||
156727528|NCT03337113|565750443|FG000|Overall Study|Adverse Event|1|||
156727529|NCT03337113|565750444|FG001|Overall Study|Adverse Event|1|||
156727530|NCT03337113|565750445|FG002|Overall Study|Adverse Event|0|||
156727531|NCT03337113|565750446|FG003|Overall Study|Adverse Event|1|||
156727532|NCT03337113|565750443|FG000|Overall Study|Physician Decision|0|||
156727533|NCT03337113|565750444|FG001|Overall Study|Physician Decision|2|||
156727534|NCT03337113|565750445|FG002|Overall Study|Physician Decision|0|||
156727535|NCT03337113|565750446|FG003|Overall Study|Physician Decision|1|||
156727536|NCT03337113|565750443|FG000|Overall Study|Withdrawal by Subject|0|||
157138727|NCT00327444|567252274|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
157138728|NCT00327444|567252273|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
157138729|NCT00327444|567252274|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
157138730|NCT00327444|567252273|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
157138731|NCT00327444|567252274|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
157138732|NCT00327444|567252273|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
157138733|NCT00327444|567252274|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
157138734|NCT00327444|567252273|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
157138735|NCT00327444|567252274|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
157138736|NCT00327444|567252273|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
157138737|NCT00327444|567252274|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
157138738|NCT03019549|567254393|FG000|Washout|DId not meet genotype criteria|11|||
157138739|NCT03019549|567254393|FG000|Period 2|Adverse Event|2|||
157138740|NCT03019549|567254393|FG000|Period 2|Physician Decision|2|||
157138741|NCT03019549|567254393|FG000|Period 2|Withdrawal by Subject|1|||
157138742|NCT04030195|567254394|FG000|Overall Study|Withdrawal by Subject|2|||
157138743|NCT04030195|567254395|FG001|Overall Study|Withdrawal by Subject|0|||
157138744|NCT04030195|567254396|FG002|Overall Study|Withdrawal by Subject|0|||
157138745|NCT01412879|567254397|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
157138746|NCT01412879|567254398|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
157138747|NCT01412879|567254399|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
157138748|NCT01412879|567254397|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
157138749|NCT01412879|567254398|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
157138750|NCT01412879|567254399|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
157138751|NCT01412879|567254397|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
157138752|NCT01412879|567254398|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
157138753|NCT01412879|567254399|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
157138754|NCT01412879|567254397|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
157138755|NCT01412879|567254398|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
157138756|NCT01412879|567254399|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
156727537|NCT03337113|565750444|FG001|Overall Study|Withdrawal by Subject|0|||
156727538|NCT03337113|565750445|FG002|Overall Study|Withdrawal by Subject|1|||
156727539|NCT03337113|565750446|FG003|Overall Study|Withdrawal by Subject|0|||
156727540|NCT00507455|565750453|FG000|Overall Study|Adverse Event|3|||
156727541|NCT00507455|565750454|FG001|Overall Study|Adverse Event|3|||
156727542|NCT00507455|565750455|FG002|Overall Study|Adverse Event|6|||
156727543|NCT00507455|565750453|FG000|Overall Study|Withdrawal by Subject|2|||
156795818|NCT02655601|566006194|FG002|Overall Study|Physician Decision|0|||
156795819|NCT02655601|566006195|FG003|Overall Study|Physician Decision|0|||
156795820|NCT02655601|566006196|FG004|Overall Study|Physician Decision|1|||
156795821|NCT02655601|566006197|FG005|Overall Study|Physician Decision|1|||
157138757|NCT01412879|567254397|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
156727544|NCT00507455|565750454|FG001|Overall Study|Withdrawal by Subject|1|||
156795822|NCT02655601|566006192|FG000|Overall Study|Withdrawal by Subject|0|||
156795823|NCT02655601|566006193|FG001|Overall Study|Withdrawal by Subject|0|||
156795824|NCT02655601|566006194|FG002|Overall Study|Withdrawal by Subject|0|||
156727545|NCT00507455|565750455|FG002|Overall Study|Withdrawal by Subject|2|||
156727546|NCT00507455|565750453|FG000|Overall Study|Protocol Violation|4|||
156727547|NCT00507455|565750454|FG001|Overall Study|Protocol Violation|1|||
156727548|NCT00507455|565750455|FG002|Overall Study|Protocol Violation|1|||
156727549|NCT00507455|565750453|FG000|Overall Study|Lost to Follow-up|2|||
156727550|NCT00507455|565750454|FG001|Overall Study|Lost to Follow-up|0|||
156727551|NCT00507455|565750455|FG002|Overall Study|Lost to Follow-up|2|||
156727552|NCT00507455|565750453|FG000|Overall Study|Lack of Efficacy|0|||
156727553|NCT00507455|565750454|FG001|Overall Study|Lack of Efficacy|1|||
157138758|NCT01412879|567254398|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
157138759|NCT01412879|567254399|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
157138760|NCT01056107|567254401|FG000|Overall Study|Withdrawal by Subject|0|||
157138761|NCT01056107|567254402|FG001|Overall Study|Withdrawal by Subject|1|||
157138762|NCT01056107|567254403|FG002|Overall Study|Withdrawal by Subject|3|||
157138763|NCT01056107|567254404|FG003|Overall Study|Withdrawal by Subject|0|||
157138764|NCT00377962|567254405|FG000|Core Study: 0-12 Months|Adverse Event|18|||
157138765|NCT00377962|567254406|FG001|Core Study: 0-12 Months|Adverse Event|2|||
157138766|NCT00377962|567254405|FG000|Core Study: 0-12 Months|Death|3|||
157138767|NCT00377962|567254406|FG001|Core Study: 0-12 Months|Death|0|||
157138768|NCT00377962|567254405|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
157138769|NCT00377962|567254406|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
157138770|NCT00377962|567254405|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
157138771|NCT00377962|567254406|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
157138772|NCT00377962|567254405|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
157138773|NCT00377962|567254406|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
157138774|NCT00377962|567254405|FG000|Extension Study: 12-24 Months|Death|1|||
157138775|NCT00377962|567254406|FG001|Extension Study: 12-24 Months|Death|1|||
157138776|NCT00377962|567254405|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
157138777|NCT00377962|567254406|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
157138778|NCT00377962|567254405|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
157138779|NCT00377962|567254406|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
157138780|NCT00377962|567254405|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
157138781|NCT00377962|567254406|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
157138782|NCT00496366|567254412|FG000|Overall Study|Death|1|||
157138783|NCT00260208|567254414|FG000|Overall Study|Subject withdrew consent|11|||
157138784|NCT00260208|567254415|FG001|Overall Study|Subject withdrew consent|7|||
157138785|NCT00260208|567254414|FG000|Overall Study|Lost to Follow-up|6|||
157138786|NCT00260208|567254415|FG001|Overall Study|Lost to Follow-up|1|||
157138787|NCT00260208|567254414|FG000|Overall Study|Death|12|||
157138788|NCT00260208|567254415|FG001|Overall Study|Death|10|||
157138789|NCT00260208|567254414|FG000|Overall Study|Missing|18|||
157138790|NCT00260208|567254415|FG001|Overall Study|Missing|16|||
157138791|NCT00768222|567254416|FG000|Overall Study|Lost to Follow-up|1|||
157138792|NCT00768222|567254417|FG001|Overall Study|Lost to Follow-up|1|||
157138793|NCT00768222|567254416|FG000|Overall Study|Withdrawal by Subject|3|||
157138794|NCT00768222|567254417|FG001|Overall Study|Withdrawal by Subject|1|||
157138795|NCT00768222|567254416|FG000|Overall Study|Protocol Violation|0|||
157138796|NCT00768222|567254417|FG001|Overall Study|Protocol Violation|2|||
157138797|NCT03263091|567254419|FG000|OL Component|Withdrawal by Subject|1|||
157138798|NCT03263091|567254420|FG001|OL Component|Withdrawal by Subject|1|||
157138799|NCT03263091|567254421|FG002|OL Component|Withdrawal by Subject|0|||
157138800|NCT03263091|567254422|FG003|OL Component|Withdrawal by Subject|0|||
157138801|NCT03263091|567254423|FG004|OL Component|Withdrawal by Subject|0|||
157138802|NCT03263091|567254424|FG005|OL Component|Withdrawal by Subject|0|||
157138803|NCT03263091|567254419|FG000|OL Component|Physician Decision|0|||
157138804|NCT03263091|567254420|FG001|OL Component|Physician Decision|1|||
157138805|NCT03263091|567254421|FG002|OL Component|Physician Decision|2|||
157138806|NCT03263091|567254422|FG003|OL Component|Physician Decision|0|||
157138807|NCT03263091|567254423|FG004|OL Component|Physician Decision|0|||
157138808|NCT03263091|567254424|FG005|OL Component|Physician Decision|0|||
157138809|NCT03263091|567254419|FG000|OL Component|Death|1|||
157138810|NCT03263091|567254420|FG001|OL Component|Death|0|||
157138811|NCT03263091|567254421|FG002|OL Component|Death|0|||
157138812|NCT03263091|567254422|FG003|OL Component|Death|0|||
157138813|NCT03263091|567254423|FG004|OL Component|Death|0|||
157138814|NCT03263091|567254424|FG005|OL Component|Death|0|||
157138815|NCT03263091|567254419|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
157138816|NCT03263091|567254420|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
157138817|NCT03263091|567254421|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
157138818|NCT03263091|567254422|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
156727554|NCT00507455|565750455|FG002|Overall Study|Lack of Efficacy|0|||
156727555|NCT00507455|565750453|FG000|Overall Study|Other - miscellaneous reason|1|||
156876224|NCT03390101|566305767|FG000|Weeks 12-54|Pregnancy|1|||
157138819|NCT03263091|567254423|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
157138820|NCT03263091|567254424|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
157138821|NCT03263091|567254419|FG000|OL High-EPO Component|Physician Decision|0|||
157138822|NCT03263091|567254420|FG001|OL High-EPO Component|Physician Decision|0|||
157138823|NCT03263091|567254421|FG002|OL High-EPO Component|Physician Decision|0|||
157138824|NCT03263091|567254422|FG003|OL High-EPO Component|Physician Decision|1|||
157138825|NCT03263091|567254423|FG004|OL High-EPO Component|Physician Decision|0|||
157138826|NCT03263091|567254424|FG005|OL High-EPO Component|Physician Decision|0|||
157138827|NCT03263091|567254419|FG000|OL High-EPO Component|Death|0|||
157138828|NCT03263091|567254420|FG001|OL High-EPO Component|Death|0|||
157138829|NCT03263091|567254421|FG002|OL High-EPO Component|Death|0|||
157138830|NCT03263091|567254422|FG003|OL High-EPO Component|Death|3|||
157138831|NCT03263091|567254423|FG004|OL High-EPO Component|Death|0|||
157138832|NCT03263091|567254424|FG005|OL High-EPO Component|Death|0|||
157138833|NCT03263091|567254419|FG000|DB Component|Withdrawal by Subject|0|||
157138834|NCT03263091|567254420|FG001|DB Component|Withdrawal by Subject|0|||
157138835|NCT03263091|567254421|FG002|DB Component|Withdrawal by Subject|0|||
157138836|NCT03263091|567254422|FG003|DB Component|Withdrawal by Subject|0|||
157138837|NCT03263091|567254423|FG004|DB Component|Withdrawal by Subject|22|||
157138838|NCT03263091|567254424|FG005|DB Component|Withdrawal by Subject|8|||
157138839|NCT03263091|567254419|FG000|DB Component|Physician Decision|0|||
157138840|NCT03263091|567254420|FG001|DB Component|Physician Decision|0|||
157138841|NCT03263091|567254421|FG002|DB Component|Physician Decision|0|||
157138842|NCT03263091|567254422|FG003|DB Component|Physician Decision|0|||
157138843|NCT03263091|567254423|FG004|DB Component|Physician Decision|3|||
157138844|NCT03263091|567254424|FG005|DB Component|Physician Decision|1|||
157138845|NCT03263091|567254419|FG000|DB Component|Adverse Event|0|||
157138846|NCT03263091|567254420|FG001|DB Component|Adverse Event|0|||
157138847|NCT03263091|567254421|FG002|DB Component|Adverse Event|0|||
157138848|NCT03263091|567254422|FG003|DB Component|Adverse Event|0|||
157138849|NCT03263091|567254423|FG004|DB Component|Adverse Event|2|||
157138850|NCT03263091|567254424|FG005|DB Component|Adverse Event|1|||
157138851|NCT03263091|567254419|FG000|DB Component|Lost to Follow-up|0|||
157138852|NCT03263091|567254420|FG001|DB Component|Lost to Follow-up|0|||
157138853|NCT03263091|567254421|FG002|DB Component|Lost to Follow-up|0|||
157138854|NCT03263091|567254422|FG003|DB Component|Lost to Follow-up|0|||
157138855|NCT03263091|567254423|FG004|DB Component|Lost to Follow-up|2|||
157138856|NCT03263091|567254424|FG005|DB Component|Lost to Follow-up|1|||
157138857|NCT03263091|567254419|FG000|DB Component|Death|0|||
157138858|NCT03263091|567254420|FG001|DB Component|Death|0|||
156727556|NCT00507455|565750454|FG001|Overall Study|Other - miscellaneous reason|0|||
156727557|NCT00507455|565750455|FG002|Overall Study|Other - miscellaneous reason|1|||
156727558|NCT01372995|565750456|FG000|Overall Study|Spouse withdrew participant from study|0|||
156727559|NCT01372995|565750457|FG001|Overall Study|Spouse withdrew participant from study|1|||
156727560|NCT01372995|565750458|FG002|Overall Study|Spouse withdrew participant from study|0|||
156727561|NCT01372995|565750456|FG000|Overall Study|Physician Decision|0|||
156727562|NCT01372995|565750457|FG001|Overall Study|Physician Decision|0|||
156727563|NCT01372995|565750458|FG002|Overall Study|Physician Decision|1|||
156727564|NCT01297517|565750466|FG000|Overall Study|Adverse Event|21|||
156727565|NCT01297517|565750467|FG001|Overall Study|Adverse Event|7|||
156727566|NCT01297517|565750468|FG002|Overall Study|Adverse Event|16|||
156727567|NCT01297517|565750466|FG000|Overall Study|Lost to Follow-up|1|||
156727568|NCT01297517|565750467|FG001|Overall Study|Lost to Follow-up|0|||
156727569|NCT01297517|565750468|FG002|Overall Study|Lost to Follow-up|1|||
156727570|NCT01297517|565750466|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
156727571|NCT01297517|565750467|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
156727572|NCT01297517|565750468|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
156727573|NCT01297517|565750466|FG000|Overall Study|Noncompliance|1|||
156727574|NCT01297517|565750467|FG001|Overall Study|Noncompliance|0|||
156727575|NCT01297517|565750468|FG002|Overall Study|Noncompliance|0|||
156727576|NCT01297517|565750466|FG000|Overall Study|Protocol Violation|1|||
156727577|NCT01297517|565750467|FG001|Overall Study|Protocol Violation|1|||
156727578|NCT01297517|565750468|FG002|Overall Study|Protocol Violation|1|||
156727579|NCT01297517|565750466|FG000|Overall Study|Inadequate Control of IOP|1|||
156876225|NCT03390101|566305768|FG001|Weeks 12-54|Pregnancy|0|||
157138859|NCT03263091|567254421|FG002|DB Component|Death|0|||
157138860|NCT03263091|567254422|FG003|DB Component|Death|0|||
157138861|NCT03263091|567254423|FG004|DB Component|Death|7|||
157138862|NCT03263091|567254424|FG005|DB Component|Death|4|||
157138863|NCT03263091|567254419|FG000|DB Component|Other than specified|0|||
157138864|NCT03263091|567254420|FG001|DB Component|Other than specified|0|||
156727580|NCT01297517|565750467|FG001|Overall Study|Inadequate Control of IOP|1|||
156727581|NCT01297517|565750468|FG002|Overall Study|Inadequate Control of IOP|2|||
157138865|NCT03263091|567254421|FG002|DB Component|Other than specified|0|||
157138866|NCT03263091|567254422|FG003|DB Component|Other than specified|0|||
157138867|NCT03263091|567254423|FG004|DB Component|Other than specified|8|||
157138868|NCT03263091|567254424|FG005|DB Component|Other than specified|6|||
157138869|NCT04125680|567254432|FG000|Overall Study|Lost to Follow-up|15|||
157138870|NCT00364793|567254433|FG000|Overall Study|Adverse Event|2|||
157138871|NCT00364793|567254434|FG001|Overall Study|Adverse Event|0|||
157138872|NCT00364793|567254435|FG002|Overall Study|Adverse Event|0|||
157138873|NCT00364793|567254436|FG003|Overall Study|Adverse Event|0|||
156727582|NCT02914613|565750469|FG000|Overall Study|Withdrawal by Subject|1|||
156727583|NCT02914613|565750470|FG001|Overall Study|Withdrawal by Subject|2|||
156727584|NCT02914613|565750469|FG000|Overall Study|Adverse Event|1|||
156727585|NCT02914613|565750470|FG001|Overall Study|Adverse Event|0|||
157138874|NCT00364793|567254433|FG000|Overall Study|Death|1|||
157138875|NCT00364793|567254434|FG001|Overall Study|Death|0|||
156727586|NCT01163851|565750473|FG000|Overall Study|Site Closure|0|||
156727587|NCT01163851|565750474|FG001|Overall Study|Site Closure|1|||
156727588|NCT01163851|565750473|FG000|Overall Study|Enrolled but not treated|1|||
156727589|NCT01163851|565750474|FG001|Overall Study|Enrolled but not treated|0|||
156727590|NCT00789373|565750475|FG000|Induction|Adverse Event|64|||
156727591|NCT00789373|565750476|FG001|Induction|Adverse Event|0|||
156727592|NCT00789373|565750477|FG002|Induction|Adverse Event|0|||
156727593|NCT00789373|565750475|FG000|Induction|Death Due to study disease|24|||
156727594|NCT00789373|565750476|FG001|Induction|Death Due to study disease|0|||
156727595|NCT00789373|565750477|FG002|Induction|Death Due to study disease|0|||
156727596|NCT00789373|565750475|FG000|Induction|Death due to adverse event|19|||
156727597|NCT00789373|565750476|FG001|Induction|Death due to adverse event|0|||
156727598|NCT00789373|565750477|FG002|Induction|Death due to adverse event|0|||
156727599|NCT00789373|565750475|FG000|Induction|Death due to toxicity|11|||
156727600|NCT00789373|565750476|FG001|Induction|Death due to toxicity|0|||
156727601|NCT00789373|565750477|FG002|Induction|Death due to toxicity|0|||
156727602|NCT00789373|565750475|FG000|Induction|Death due to procedure|1|||
156727603|NCT00789373|565750476|FG001|Induction|Death due to procedure|0|||
156727604|NCT00789373|565750477|FG002|Induction|Death due to procedure|0|||
156727605|NCT00789373|565750475|FG000|Induction|Investigator decision|7|||
156727606|NCT00789373|565750476|FG001|Induction|Investigator decision|0|||
156727607|NCT00789373|565750477|FG002|Induction|Investigator decision|0|||
156727608|NCT00789373|565750475|FG000|Induction|Protocol entry criteria not met|9|||
156727609|NCT00789373|565750476|FG001|Induction|Protocol entry criteria not met|0|||
156727610|NCT00789373|565750477|FG002|Induction|Protocol entry criteria not met|0|||
156727611|NCT00789373|565750475|FG000|Induction|Lost to Follow-up|6|||
156727612|NCT00789373|565750476|FG001|Induction|Lost to Follow-up|0|||
156727613|NCT00789373|565750477|FG002|Induction|Lost to Follow-up|0|||
156727614|NCT00789373|565750475|FG000|Induction|Protocol Violation|1|||
156727615|NCT00789373|565750476|FG001|Induction|Protocol Violation|0|||
156727616|NCT00789373|565750477|FG002|Induction|Protocol Violation|0|||
156727617|NCT00789373|565750475|FG000|Induction|Progressive Disease|220|||
156727618|NCT00789373|565750476|FG001|Induction|Progressive Disease|0|||
156727619|NCT00789373|565750477|FG002|Induction|Progressive Disease|0|||
156727620|NCT00789373|565750475|FG000|Induction|Withdrawal by Subject|37|||
156727621|NCT00789373|565750476|FG001|Induction|Withdrawal by Subject|0|||
156727622|NCT00789373|565750477|FG002|Induction|Withdrawal by Subject|0|||
156727623|NCT00789373|565750475|FG000|Maintenance|Adverse Event|0|||
156727624|NCT00789373|565750476|FG001|Maintenance|Adverse Event|65|||
156727625|NCT00789373|565750477|FG002|Maintenance|Adverse Event|12|||
156727626|NCT00789373|565750475|FG000|Maintenance|Death due to study disease|0|||
156727627|NCT00789373|565750476|FG001|Maintenance|Death due to study disease|3|||
156727628|NCT00789373|565750477|FG002|Maintenance|Death due to study disease|1|||
156727629|NCT00789373|565750475|FG000|Maintenance|Death due to adverse event|0|||
156876226|NCT03390101|566305769|FG002|Weeks 12-54|Pregnancy|0|||
156876227|NCT03390101|566305767|FG000|Weeks 12-54|Adverse Event|2|||
156727630|NCT00789373|565750476|FG001|Maintenance|Death due to adverse event|4|||
156727631|NCT00789373|565750477|FG002|Maintenance|Death due to adverse event|1|||
156727632|NCT00789373|565750475|FG000|Maintenance|Death due to toxicity|0|||
156727633|NCT00789373|565750476|FG001|Maintenance|Death due to toxicity|1|||
156727634|NCT00789373|565750477|FG002|Maintenance|Death due to toxicity|2|||
156727635|NCT00789373|565750475|FG000|Maintenance|Investigator Decision|0|||
156727636|NCT00789373|565750476|FG001|Maintenance|Investigator Decision|4|||
156727637|NCT00789373|565750477|FG002|Maintenance|Investigator Decision|2|||
156727638|NCT00789373|565750475|FG000|Maintenance|Protocol entry criteria not met|0|||
156727639|NCT00789373|565750476|FG001|Maintenance|Protocol entry criteria not met|2|||
156727640|NCT00789373|565750477|FG002|Maintenance|Protocol entry criteria not met|0|||
156727641|NCT00789373|565750475|FG000|Maintenance|Lost to Follow-up|0|||
156727642|NCT00789373|565750476|FG001|Maintenance|Lost to Follow-up|2|||
156727643|NCT00789373|565750477|FG002|Maintenance|Lost to Follow-up|0|||
156727644|NCT00789373|565750475|FG000|Maintenance|Progressive Disease|0|||
156727645|NCT00789373|565750476|FG001|Maintenance|Progressive Disease|253|||
156727646|NCT00789373|565750477|FG002|Maintenance|Progressive Disease|152|||
156727647|NCT00789373|565750475|FG000|Maintenance|Withdrawal by Subject|0|||
156727648|NCT00789373|565750476|FG001|Maintenance|Withdrawal by Subject|21|||
156727649|NCT00789373|565750477|FG002|Maintenance|Withdrawal by Subject|8|||
156727650|NCT00789373|565750475|FG000|Maintenance|Sponsor Decision|0|||
156727651|NCT00789373|565750476|FG001|Maintenance|Sponsor Decision|0|||
156727652|NCT00789373|565750477|FG002|Maintenance|Sponsor Decision|2|||
156727653|NCT00789373|565750475|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
156727654|NCT00789373|565750476|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
156727655|NCT00789373|565750477|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
156727656|NCT04938180|565750483|FG000|Overall Study|Adverse Event|1|||
156727657|NCT01964222|565750484|FG000|Overall Study|Lost to Follow-up|7|||
156727658|NCT01964222|565750485|FG001|Overall Study|Lost to Follow-up|5|||
156727659|NCT01964222|565750484|FG000|Overall Study|Withdrawal by Subject|6|||
156876228|NCT03390101|566305768|FG001|Weeks 12-54|Adverse Event|1|||
156727660|NCT01964222|565750485|FG001|Overall Study|Withdrawal by Subject|6|||
156727661|NCT01964222|565750484|FG000|Overall Study|Screening Failure|2|||
156876229|NCT03390101|566305769|FG002|Weeks 12-54|Adverse Event|1|||
157138876|NCT00364793|567254435|FG002|Overall Study|Death|1|||
157138877|NCT00364793|567254436|FG003|Overall Study|Death|0|||
156727662|NCT01964222|565750485|FG001|Overall Study|Screening Failure|0|||
156727663|NCT03363776|565750493|FG000|Overall Study|Progressive disease|2|||
156727664|NCT03363776|565750494|FG001|Overall Study|Progressive disease|3|||
156727665|NCT03363776|565750495|FG002|Overall Study|Progressive disease|1|||
156727666|NCT03363776|565750493|FG000|Overall Study|Study drug toxicity|0|||
156727667|NCT03363776|565750494|FG001|Overall Study|Study drug toxicity|0|||
156727668|NCT03363776|565750495|FG002|Overall Study|Study drug toxicity|1|||
156727669|NCT03363776|565750493|FG000|Overall Study|Death|1|||
156727670|NCT03363776|565750494|FG001|Overall Study|Death|0|||
156727671|NCT03363776|565750495|FG002|Overall Study|Death|0|||
156727672|NCT04157348|565750496|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
156727673|NCT04157348|565750497|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
156727674|NCT04157348|565750496|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156727675|NCT04157348|565750497|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156727676|NCT04157348|565750496|FG000|Double-blind Treatment Period|Adverse Event|0|||
156727677|NCT04157348|565750497|FG001|Double-blind Treatment Period|Adverse Event|1|||
156727678|NCT04157348|565750496|FG000|Open-label Extension Period|Adverse Event|1|||
156727679|NCT04157348|565750497|FG001|Open-label Extension Period|Adverse Event|1|||
156727680|NCT04157348|565750496|FG000|Open-label Extension Period|Death|0|||
156727681|NCT04157348|565750497|FG001|Open-label Extension Period|Death|1|||
156727682|NCT04157348|565750496|FG000|Open-label Extension Period|Lack of Efficacy|2|||
156727683|NCT04157348|565750497|FG001|Open-label Extension Period|Lack of Efficacy|2|||
157138878|NCT00364793|567254433|FG000|Overall Study|Lack of Efficacy|3|||
157138879|NCT00364793|567254434|FG001|Overall Study|Lack of Efficacy|3|||
156727684|NCT04157348|565750496|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
156727685|NCT04157348|565750497|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156727686|NCT04157348|565750496|FG000|Open-label Extension Period|Ongoing|60|||
156727687|NCT04157348|565750497|FG001|Open-label Extension Period|Ongoing|57|||
156727688|NCT04157348|565750496|FG000|Open-label Extension Period|other reasons|1|||
156727689|NCT04157348|565750497|FG001|Open-label Extension Period|other reasons|1|||
156727690|NCT02062450|565750512|FG000|Overall Study|No follow-up visit|124|||
156727691|NCT02589639|565750514|FG000|Overall Study|Lost to Follow-up|1|||
156727692|NCT02589639|565750515|FG001|Overall Study|Lost to Follow-up|0|||
156727693|NCT02589639|565750516|FG002|Overall Study|Lost to Follow-up|0|||
156727694|NCT02589639|565750514|FG000|Overall Study|Protocol Violation|1|||
156727695|NCT02589639|565750515|FG001|Overall Study|Protocol Violation|0|||
156727696|NCT02589639|565750516|FG002|Overall Study|Protocol Violation|0|||
156727697|NCT02589639|565750514|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
156727698|NCT02589639|565750515|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
156727699|NCT02589639|565750516|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
156727700|NCT02589639|565750514|FG000|Overall Study|Adverse Event|4|||
156727701|NCT02589639|565750515|FG001|Overall Study|Adverse Event|5|||
156727702|NCT02589639|565750516|FG002|Overall Study|Adverse Event|3|||
156727703|NCT02589639|565750514|FG000|Overall Study|Other reason than specified above|1|||
156727704|NCT02589639|565750515|FG001|Overall Study|Other reason than specified above|2|||
156727705|NCT02589639|565750516|FG002|Overall Study|Other reason than specified above|1|||
156727706|NCT02589639|565750514|FG000|Overall Study|Not Treated|0|||
156727707|NCT02589639|565750515|FG001|Overall Study|Not Treated|3|||
156727708|NCT02589639|565750516|FG002|Overall Study|Not Treated|0|||
156727709|NCT01481766|565752137|FG000|4 months|Lost to Follow-up|3|||
156727710|NCT01481766|565752138|FG001|4 months|Lost to Follow-up|2|||
156727711|NCT01481766|565752139|FG002|4 months|Lost to Follow-up|1|||
156727712|NCT01481766|565752140|FG003|4 months|Lost to Follow-up|5|||
156727713|NCT01481766|565752137|FG000|12 months|Lost to Follow-up|7|||
156727714|NCT01481766|565752138|FG001|12 months|Lost to Follow-up|8|||
156727715|NCT01481766|565752139|FG002|12 months|Lost to Follow-up|5|||
156727716|NCT01481766|565752140|FG003|12 months|Lost to Follow-up|3|||
156727717|NCT00347958|565752141|FG000|Overall Study|Adverse Event|1|||
156727718|NCT00347958|565752141|FG000|Overall Study|Protocol Violation|2|||
156727719|NCT00347958|565752141|FG000|Overall Study|Withdrawal by Subject|1|||
156727720|NCT02159053|565752142|FG000|Overall Study|Death|2|||
156727721|NCT02159053|565752143|FG001|Overall Study|Death|0|||
156727722|NCT02159053|565752144|FG002|Overall Study|Death|1|||
156727723|NCT02159053|565752142|FG000|Overall Study|Physician Decision|0|||
157019826|NCT04784559|566826518|FG001|Overall Study|The participant was transferred to IRCU|1|||
157138880|NCT00364793|567254435|FG002|Overall Study|Lack of Efficacy|1|||
157138881|NCT00364793|567254436|FG003|Overall Study|Lack of Efficacy|1|||
157138882|NCT00364793|567254433|FG000|Overall Study|Lost to Follow-up|1|||
157019827|NCT04784559|566826519|FG002|Overall Study|The participant was transferred to IRCU|0|||
157138883|NCT00364793|567254434|FG001|Overall Study|Lost to Follow-up|0|||
156727724|NCT02159053|565752143|FG001|Overall Study|Physician Decision|1|||
156727725|NCT02159053|565752144|FG002|Overall Study|Physician Decision|1|||
156727726|NCT02159053|565752142|FG000|Overall Study|Lack of Efficacy|3|||
156727727|NCT02159053|565752143|FG001|Overall Study|Lack of Efficacy|4|||
156727728|NCT02159053|565752144|FG002|Overall Study|Lack of Efficacy|7|||
157138884|NCT00364793|567254435|FG002|Overall Study|Lost to Follow-up|2|||
156795825|NCT02655601|566006195|FG003|Overall Study|Withdrawal by Subject|0|||
156795826|NCT02655601|566006196|FG004|Overall Study|Withdrawal by Subject|4|||
156795827|NCT02655601|566006197|FG005|Overall Study|Withdrawal by Subject|8|||
156795828|NCT02655601|566006192|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
156795829|NCT02655601|566006193|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795830|NCT02655601|566006194|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795831|NCT02655601|566006195|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795832|NCT02655601|566006196|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795833|NCT02655601|566006197|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
156795834|NCT04642079|566006200|FG000|Overall Study|Lost to Follow-up|2|||
156795835|NCT04642079|566006201|FG001|Overall Study|Lost to Follow-up|5|||
156795836|NCT04642079|566006202|FG002|Overall Study|Lost to Follow-up|2|||
156795837|NCT04642079|566006203|FG003|Overall Study|Lost to Follow-up|0|||
156795838|NCT04642079|566006200|FG000|Overall Study|Withdrawal by Subject|0|||
156795839|NCT04642079|566006201|FG001|Overall Study|Withdrawal by Subject|4|||
156795840|NCT04642079|566006202|FG002|Overall Study|Withdrawal by Subject|1|||
156795841|NCT04642079|566006203|FG003|Overall Study|Withdrawal by Subject|2|||
156795842|NCT04642079|566006200|FG000|Overall Study|Other|0|||
156795843|NCT04642079|566006201|FG001|Overall Study|Other|0|||
156795844|NCT04642079|566006202|FG002|Overall Study|Other|0|||
156795845|NCT04642079|566006203|FG003|Overall Study|Other|1|||
156795846|NCT04642079|566006200|FG000|Overall Study|No longer met eligibility criteria|1|||
156795847|NCT04642079|566006201|FG001|Overall Study|No longer met eligibility criteria|0|||
156795848|NCT04642079|566006202|FG002|Overall Study|No longer met eligibility criteria|1|||
156795849|NCT04642079|566006203|FG003|Overall Study|No longer met eligibility criteria|1|||
156795850|NCT02226653|566006204|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
156795851|NCT02226653|566006205|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
156795852|NCT02226653|566006204|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
156795853|NCT02226653|566006205|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
156795854|NCT00759395|566006207|FG000|Overall Study|Adverse Event|1|||
156795855|NCT00759395|566006208|FG001|Overall Study|Adverse Event|0|||
156795856|NCT00759395|566006207|FG000|Overall Study|Withdrawal by Subject|1|||
156795857|NCT00759395|566006208|FG001|Overall Study|Withdrawal by Subject|0|||
156795858|NCT00759395|566006207|FG000|Overall Study|Lack of Efficacy|0|||
156795859|NCT00759395|566006208|FG001|Overall Study|Lack of Efficacy|2|||
156795860|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
156795861|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
156795862|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
156795863|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
156795864|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
156795865|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
156795866|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
156795867|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
156795868|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
156795869|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
156795870|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
156795871|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
156795872|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
156795873|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
156795874|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
156795875|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
156795876|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
156795877|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
156795878|NCT00086515|566006209|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
156795879|NCT00086515|566006210|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
156795880|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
156795881|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
156795882|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
156795883|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
156795884|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
156795885|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
156795886|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
156795887|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
156795888|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
156795889|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
156808802|NCT03688919|566054465|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
156808803|NCT03688919|566054466|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
156808804|NCT01484496|566054473|FG000|Period 1|Protocol Violation|3|||
156808805|NCT01484496|566054474|FG001|Period 1|Protocol Violation|4|||
156808806|NCT01484496|566054475|FG002|Period 1|Protocol Violation|0|||
156727729|NCT02159053|565752142|FG000|Overall Study|Adverse Event|7|||
157138885|NCT00364793|567254436|FG003|Overall Study|Lost to Follow-up|0|||
157138886|NCT00364793|567254433|FG000|Overall Study|Poor or non-compliance|1|||
157138887|NCT00364793|567254434|FG001|Overall Study|Poor or non-compliance|1|||
157138888|NCT00364793|567254435|FG002|Overall Study|Poor or non-compliance|0|||
156727730|NCT02159053|565752143|FG001|Overall Study|Adverse Event|6|||
156727731|NCT02159053|565752144|FG002|Overall Study|Adverse Event|5|||
156727732|NCT02159053|565752142|FG000|Overall Study|Participants/guardian decision|8|||
156727733|NCT02159053|565752143|FG001|Overall Study|Participants/guardian decision|10|||
157138889|NCT00364793|567254436|FG003|Overall Study|Poor or non-compliance|1|||
157138890|NCT00364793|567254433|FG000|Overall Study|No longer meets criteria|0|||
157138891|NCT00364793|567254434|FG001|Overall Study|No longer meets criteria|0|||
157138892|NCT00364793|567254435|FG002|Overall Study|No longer meets criteria|0|||
157138893|NCT00364793|567254436|FG003|Overall Study|No longer meets criteria|1|||
157138894|NCT00364793|567254433|FG000|Overall Study|Withdrawal by Subject|0|||
157138895|NCT00364793|567254434|FG001|Overall Study|Withdrawal by Subject|1|||
157138896|NCT00364793|567254435|FG002|Overall Study|Withdrawal by Subject|0|||
157138897|NCT00364793|567254436|FG003|Overall Study|Withdrawal by Subject|0|||
157138898|NCT00391976|567254437|FG000|Overall Study|Adverse Event|0|||
157138899|NCT00391976|567254438|FG001|Overall Study|Adverse Event|0|||
157138900|NCT00391976|567254439|FG002|Overall Study|Adverse Event|1|||
157138901|NCT00391976|567254437|FG000|Overall Study|Withdrawal of consent|0|||
157138902|NCT00391976|567254438|FG001|Overall Study|Withdrawal of consent|1|||
157138903|NCT00391976|567254439|FG002|Overall Study|Withdrawal of consent|1|||
157138904|NCT00391976|567254437|FG000|Overall Study|Lost to Follow-up|1|||
157138905|NCT00391976|567254438|FG001|Overall Study|Lost to Follow-up|2|||
157138906|NCT00391976|567254439|FG002|Overall Study|Lost to Follow-up|0|||
157138907|NCT00391976|567254437|FG000|Overall Study|Inappropriate enrollment|1|||
157138908|NCT00391976|567254438|FG001|Overall Study|Inappropriate enrollment|1|||
157138909|NCT00391976|567254439|FG002|Overall Study|Inappropriate enrollment|0|||
157138910|NCT00391976|567254437|FG000|Overall Study|Protocol deviation/violation|4|||
157138911|NCT00391976|567254438|FG001|Overall Study|Protocol deviation/violation|2|||
157138912|NCT00391976|567254439|FG002|Overall Study|Protocol deviation/violation|1|||
157138913|NCT00391976|567254437|FG000|Overall Study|Recurrence/no eradication of infection|21|||
157138914|NCT00391976|567254438|FG001|Overall Study|Recurrence/no eradication of infection|19|||
157138915|NCT00391976|567254439|FG002|Overall Study|Recurrence/no eradication of infection|0|||
157138916|NCT00391976|567254437|FG000|Overall Study|Unable to classify|0|||
157138917|NCT00391976|567254438|FG001|Overall Study|Unable to classify|0|||
157138918|NCT00391976|567254439|FG002|Overall Study|Unable to classify|1|||
157138919|NCT00391976|567254437|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
157138920|NCT00391976|567254438|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
157138921|NCT00391976|567254439|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
156727734|NCT02159053|565752144|FG002|Overall Study|Participants/guardian decision|6|||
156727735|NCT00356603|565752147|FG000|Overall Study|Other|6|||
156727736|NCT00356603|565752148|FG001|Overall Study|Other|3|||
156727737|NCT01262287|565752149|FG000|Overall Study|Lost to Follow-up|2|||
156727738|NCT01262287|565752150|FG001|Overall Study|Lost to Follow-up|1|||
156727739|NCT02492984|565752152|FG000|Overall Study|Adverse Event|1|||
156727740|NCT02492984|565752153|FG001|Overall Study|Adverse Event|0|||
156795890|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
156727741|NCT02492984|565752152|FG000|Overall Study|Protocol Violation|1|||
156727742|NCT02492984|565752153|FG001|Overall Study|Protocol Violation|0|||
156727743|NCT02492984|565752152|FG000|Overall Study|Withdrawal by Subject|1|||
156727744|NCT02492984|565752153|FG001|Overall Study|Withdrawal by Subject|0|||
156727745|NCT00459290|565752154|FG000|Overall Study|Adverse Event|3|||
156727746|NCT00459290|565752154|FG000|Overall Study|Ineligible|2|||
156727747|NCT05483686|565752155|FG000|Overall Study|Lost to Follow-up|5|||
156727748|NCT05483686|565752156|FG001|Overall Study|Lost to Follow-up|7|||
156727749|NCT06152224|565752158|FG000|Overall Study|Withdrawal by Subject|1|||
156795891|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
156795892|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
156727750|NCT06152224|565752159|FG001|Overall Study|Withdrawal by Subject|0|||
156727751|NCT06152224|565752158|FG000|Overall Study|Lost to Follow-up|0|||
156795893|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
156795894|NCT00086515|566006209|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
156795895|NCT00086515|566006210|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
156795896|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
157138922|NCT00049127|567254440|FG000|Overall Study|Withdrawal by Subject|0|||
157138923|NCT00049127|567254441|FG001|Overall Study|Withdrawal by Subject|0|||
157138924|NCT00049127|567254442|FG002|Overall Study|Withdrawal by Subject|1|||
157138925|NCT00049127|567254443|FG003|Overall Study|Withdrawal by Subject|0|||
157138926|NCT00049127|567254444|FG004|Overall Study|Withdrawal by Subject|0|||
157138927|NCT02582515|567254445|FG000|Overall Study|Withdrawal by Subject|0|||
156727752|NCT06152224|565752159|FG001|Overall Study|Lost to Follow-up|1|||
157138928|NCT02582515|567254446|FG001|Overall Study|Withdrawal by Subject|1|||
157138929|NCT02197377|567254455|FG000|Overall Study|Insertion Failure|0|||
157138930|NCT02197377|567254456|FG001|Overall Study|Insertion Failure|3|||
157138931|NCT00502840|567254457|FG000|Overall Study|Adverse Event|5|||
157138932|NCT00502840|567254457|FG000|Overall Study|Additional or changed therapy|48|||
157138933|NCT00502840|567254457|FG000|Overall Study|Lack of Efficacy|11|||
157138934|NCT00502840|567254457|FG000|Overall Study|Protocol Violation|4|||
157138935|NCT00502840|567254457|FG000|Overall Study|Withdrawal by Subject|5|||
157138936|NCT00502840|567254457|FG000|Overall Study|Lost to Follow-up|6|||
157138937|NCT00502840|567254457|FG000|Overall Study|Administrative problems|1|||
157138938|NCT00502840|567254457|FG000|Overall Study|Other|20|||
157138939|NCT01974323|567254458|FG000|Overall Study|Other Reasons|25|||
157138940|NCT01974323|567254459|FG001|Overall Study|Other Reasons|28|||
157138941|NCT01974323|567254458|FG000|Overall Study|Protocol Violation|2|||
157138942|NCT01974323|567254459|FG001|Overall Study|Protocol Violation|2|||
157138943|NCT01974323|567254458|FG000|Overall Study|Personal Reasons|15|||
157138944|NCT01974323|567254459|FG001|Overall Study|Personal Reasons|19|||
157138945|NCT01974323|567254458|FG000|Overall Study|Lost to Follow-up|45|||
157138946|NCT01974323|567254459|FG001|Overall Study|Lost to Follow-up|40|||
157138947|NCT01974323|567254458|FG000|Overall Study|Pregnancy|2|||
157138948|NCT01974323|567254459|FG001|Overall Study|Pregnancy|1|||
157138949|NCT01974323|567254458|FG000|Overall Study|Lack of Efficacy|1|||
157138950|NCT01974323|567254459|FG001|Overall Study|Lack of Efficacy|1|||
157138951|NCT01974323|567254458|FG000|Overall Study|Adverse Event|2|||
157138952|NCT01974323|567254459|FG001|Overall Study|Adverse Event|2|||
157138953|NCT00809133|567254460|FG000|Overall Study|Progressive disease|2|||
157138954|NCT00809133|567254461|FG001|Overall Study|Progressive disease|5|||
157138955|NCT00809133|567254462|FG002|Overall Study|Progressive disease|5|||
157138956|NCT00809133|567254463|FG003|Overall Study|Progressive disease|3|||
157138957|NCT00809133|567254464|FG004|Overall Study|Progressive disease|4|||
157138958|NCT00809133|567254465|FG005|Overall Study|Progressive disease|1|||
157138959|NCT00809133|567254466|FG006|Overall Study|Progressive disease|3|||
157138960|NCT00809133|567254467|FG007|Overall Study|Progressive disease|3|||
157138961|NCT00809133|567254468|FG008|Overall Study|Progressive disease|3|||
157138962|NCT00809133|567254469|FG009|Overall Study|Progressive disease|9|||
157138963|NCT00809133|567254470|FG010|Overall Study|Progressive disease|5|||
157138964|NCT00809133|567254471|FG011|Overall Study|Progressive disease|7|||
157138965|NCT00809133|567254472|FG012|Overall Study|Progressive disease|5|||
157138966|NCT00809133|567254473|FG013|Overall Study|Progressive disease|4|||
157138967|NCT00809133|567254460|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138968|NCT00809133|567254461|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138969|NCT00809133|567254462|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138970|NCT00809133|567254463|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156727753|NCT06152224|565752158|FG000|Overall Study|On Follow Up|18|||
156727754|NCT06152224|565752159|FG001|Overall Study|On Follow Up|18|||
156727755|NCT05780983|565752160|FG000|Overall Study|Withdrawal by Subject|1|||
156727756|NCT06028438|565752161|FG000|Overall Study|Adverse Event|3|||
156727757|NCT06028438|565752162|FG001|Overall Study|Adverse Event|9|||
156727758|NCT06028438|565752161|FG000|Overall Study|Lack of Efficacy|1|||
156727759|NCT06028438|565752162|FG001|Overall Study|Lack of Efficacy|1|||
156727760|NCT06028438|565752161|FG000|Overall Study|Lost to Follow-up|1|||
156727761|NCT06028438|565752162|FG001|Overall Study|Lost to Follow-up|0|||
156727762|NCT06028438|565752161|FG000|Overall Study|Withdrawal by Subject|1|||
156727763|NCT06028438|565752162|FG001|Overall Study|Withdrawal by Subject|0|||
156727764|NCT06028438|565752161|FG000|Overall Study|Other|3|||
156727765|NCT06028438|565752162|FG001|Overall Study|Other|3|||
156727766|NCT05625802|565752163|FG000|Overall Study|Lost to Follow-up|1|||
156727767|NCT05625802|565752164|FG001|Overall Study|Lost to Follow-up|0|||
156727768|NCT01019694|565752171|FG000|Overall Study|Adverse Event|12|||
156727769|NCT01019694|565752172|FG001|Overall Study|Adverse Event|16|||
156876230|NCT04838977|566305770|FG000|Overall Study|Lost to Follow-up|2|||
156876231|NCT04838977|566305771|FG001|Overall Study|Lost to Follow-up|3|||
157138971|NCT00809133|567254464|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138972|NCT00809133|567254465|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
157138973|NCT00809133|567254466|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
157138974|NCT00809133|567254467|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
157138975|NCT00809133|567254468|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138976|NCT00809133|567254469|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138977|NCT00809133|567254470|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138978|NCT00809133|567254471|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138979|NCT00809133|567254472|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157138980|NCT00809133|567254473|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156727770|NCT01019694|565752173|FG002|Overall Study|Adverse Event|19|||
156727771|NCT01019694|565752171|FG000|Overall Study|Protocol Violation|2|||
156727772|NCT01019694|565752172|FG001|Overall Study|Protocol Violation|6|||
156727773|NCT01019694|565752173|FG002|Overall Study|Protocol Violation|4|||
157138981|NCT00809133|567254460|FG000|Overall Study|Other adverse event|1|||
157138982|NCT00809133|567254461|FG001|Overall Study|Other adverse event|1|||
157138983|NCT00809133|567254462|FG002|Overall Study|Other adverse event|1|||
156727774|NCT01019694|565752171|FG000|Overall Study|Lost to Follow-up|5|||
156727775|NCT01019694|565752172|FG001|Overall Study|Lost to Follow-up|3|||
156727776|NCT01019694|565752173|FG002|Overall Study|Lost to Follow-up|3|||
156727777|NCT01019694|565752171|FG000|Overall Study|Withdrawal by Subject|4|||
156727778|NCT01019694|565752172|FG001|Overall Study|Withdrawal by Subject|6|||
156727779|NCT01019694|565752173|FG002|Overall Study|Withdrawal by Subject|12|||
156727780|NCT01019694|565752171|FG000|Overall Study|Not treated|0|||
156727781|NCT01019694|565752172|FG001|Overall Study|Not treated|2|||
156727782|NCT01019694|565752173|FG002|Overall Study|Not treated|3|||
156727783|NCT01019694|565752171|FG000|Overall Study|Other reason (not specified)|1|||
156727784|NCT01019694|565752172|FG001|Overall Study|Other reason (not specified)|5|||
156727785|NCT01019694|565752173|FG002|Overall Study|Other reason (not specified)|6|||
156727786|NCT00026494|565752176|FG000|Overall Study|Withdrawal by Subject|1|||
156727787|NCT00026494|565752177|FG001|Overall Study|Withdrawal by Subject|0|||
156727788|NCT00026494|565752178|FG002|Overall Study|Withdrawal by Subject|1|||
156727789|NCT00026494|565752179|FG003|Overall Study|Withdrawal by Subject|0|||
156727790|NCT00026494|565752176|FG000|Overall Study|Patient non-compliance|1|||
156727791|NCT00026494|565752177|FG001|Overall Study|Patient non-compliance|0|||
156727792|NCT00026494|565752178|FG002|Overall Study|Patient non-compliance|0|||
156727793|NCT00026494|565752179|FG003|Overall Study|Patient non-compliance|0|||
156727794|NCT00026494|565752176|FG000|Overall Study|Patient not treated|0|||
156727795|NCT00026494|565752177|FG001|Overall Study|Patient not treated|0|||
156727796|NCT00026494|565752178|FG002|Overall Study|Patient not treated|2|||
156727797|NCT00026494|565752179|FG003|Overall Study|Patient not treated|0|||
156727798|NCT00026494|565752176|FG000|Overall Study|Clinical progression|0|||
156727799|NCT00026494|565752177|FG001|Overall Study|Clinical progression|0|||
156727800|NCT00026494|565752178|FG002|Overall Study|Clinical progression|3|||
156727801|NCT00026494|565752179|FG003|Overall Study|Clinical progression|0|||
156727802|NCT00441129|565752180|FG000|Overall Study|Withdrawal by Subject|6|||
156727803|NCT00441129|565752181|FG001|Overall Study|Withdrawal by Subject|14|||
156727804|NCT03777436|565752182|FG000|Placebo-controlled Phase|Adverse Event|8|||
156727805|NCT03777436|565752183|FG001|Placebo-controlled Phase|Adverse Event|10|||
156727806|NCT03777436|565752184|FG002|Placebo-controlled Phase|Adverse Event|0|||
156727807|NCT03777436|565752182|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
156727808|NCT03777436|565752183|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
156727809|NCT03777436|565752184|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
156727810|NCT03777436|565752182|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
156727811|NCT03777436|565752183|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
156727812|NCT03777436|565752184|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
156727813|NCT03777436|565752182|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
156727814|NCT03777436|565752183|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
156727815|NCT03777436|565752184|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
156727816|NCT03777436|565752182|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
156727817|NCT03777436|565752183|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
156727818|NCT03777436|565752184|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
156727819|NCT03777436|565752182|FG000|Placebo-controlled Phase|Physician Decision|0|||
156727820|NCT03777436|565752183|FG001|Placebo-controlled Phase|Physician Decision|1|||
156727821|NCT03777436|565752184|FG002|Placebo-controlled Phase|Physician Decision|0|||
156727822|NCT03777436|565752182|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
156727823|NCT03777436|565752183|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
156727824|NCT03777436|565752184|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
156727825|NCT03777436|565752182|FG000|Apremilast Extension Phase|Adverse Event|0|||
156727826|NCT03777436|565752183|FG001|Apremilast Extension Phase|Adverse Event|0|||
156727827|NCT03777436|565752184|FG002|Apremilast Extension Phase|Adverse Event|6|||
156727828|NCT03777436|565752182|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
156727829|NCT03777436|565752183|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
156727830|NCT03777436|565752184|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
156727831|NCT03777436|565752182|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
156727832|NCT03777436|565752183|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
157138984|NCT00809133|567254463|FG003|Overall Study|Other adverse event|0|||
156727833|NCT03777436|565752184|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
156727834|NCT03777436|565752182|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
156727835|NCT03777436|565752183|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
156727836|NCT03777436|565752184|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
156727837|NCT03777436|565752182|FG000|Apremilast Extension Phase|Miscellaneous|0|||
156727838|NCT03777436|565752183|FG001|Apremilast Extension Phase|Miscellaneous|0|||
156727839|NCT03777436|565752184|FG002|Apremilast Extension Phase|Miscellaneous|1|||
156727840|NCT02035202|565752185|FG000|Overall Study|Lost to Follow-up|8|||
156727841|NCT02035202|565752186|FG001|Overall Study|Lost to Follow-up|16|||
156727842|NCT02035202|565752187|FG002|Overall Study|Lost to Follow-up|2|||
157138985|NCT00809133|567254464|FG004|Overall Study|Other adverse event|0|||
156727843|NCT00758485|565752190|FG000|Overall Study|Lost to Follow-up|0|||
156727844|NCT00758485|565752191|FG001|Overall Study|Lost to Follow-up|1|||
156727845|NCT00758485|565752190|FG000|Overall Study|Not Treated|1|||
156727846|NCT00758485|565752191|FG001|Overall Study|Not Treated|2|||
156727847|NCT00656292|565752192|FG000|Overall Study|Withdrawal by Subject|2|||
156727848|NCT00656292|565752193|FG001|Overall Study|Withdrawal by Subject|3|||
156727849|NCT00656292|565752192|FG000|Overall Study|Screen failure|1|||
156727850|NCT00656292|565752193|FG001|Overall Study|Screen failure|2|||
156727851|NCT00921557|565752194|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
156727852|NCT00921557|565752195|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
156727853|NCT00921557|565752196|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
156727854|NCT00921557|565752194|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
156727855|NCT00921557|565752195|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
156727856|NCT00921557|565752196|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
156727857|NCT00921557|565752194|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
156727858|NCT00921557|565752195|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
156727859|NCT00921557|565752196|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
156727860|NCT00921557|565752194|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
156727861|NCT00921557|565752195|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
156727862|NCT00921557|565752196|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
156727863|NCT00921557|565752194|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
156727864|NCT00921557|565752195|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
156727865|NCT00921557|565752196|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
156727866|NCT03259425|565752197|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
156727867|NCT02527434|565752203|FG000|Overall Study|Lost to Follow-up|2|||
156727868|NCT02527434|565752204|FG001|Overall Study|Lost to Follow-up|2|||
156727869|NCT02527434|565752205|FG002|Overall Study|Lost to Follow-up|0|||
156727870|NCT02527434|565752203|FG000|Overall Study|Death|19|||
156727871|NCT02527434|565752204|FG001|Overall Study|Death|6|||
156727872|NCT02527434|565752205|FG002|Overall Study|Death|17|||
156727873|NCT02527434|565752203|FG000|Overall Study|Withdrawal by Subject|5|||
156727874|NCT02527434|565752204|FG001|Overall Study|Withdrawal by Subject|3|||
156727875|NCT02527434|565752205|FG002|Overall Study|Withdrawal by Subject|3|||
156727876|NCT02527434|565752203|FG000|Overall Study|Reason Not Specified|1|||
156727877|NCT02527434|565752204|FG001|Overall Study|Reason Not Specified|0|||
156727878|NCT02527434|565752205|FG002|Overall Study|Reason Not Specified|0|||
156727879|NCT02527434|565752203|FG000|Overall Study|Site closure|1|||
156727880|NCT02527434|565752204|FG001|Overall Study|Site closure|0|||
156727881|NCT02527434|565752205|FG002|Overall Study|Site closure|0|||
156727882|NCT02861807|565752206|FG000|Overall Study|Lost to Follow-up|7|||
156727883|NCT02861807|565752207|FG001|Overall Study|Lost to Follow-up|6|||
156795897|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
156795898|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
157138986|NCT00809133|567254465|FG005|Overall Study|Other adverse event|3|||
157138987|NCT00809133|567254466|FG006|Overall Study|Other adverse event|2|||
157138988|NCT00809133|567254467|FG007|Overall Study|Other adverse event|4|||
157138989|NCT00809133|567254468|FG008|Overall Study|Other adverse event|0|||
157138990|NCT00809133|567254469|FG009|Overall Study|Other adverse event|0|||
157138991|NCT00809133|567254470|FG010|Overall Study|Other adverse event|1|||
157138992|NCT00809133|567254471|FG011|Overall Study|Other adverse event|1|||
156795899|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
156795900|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
156795901|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
156795902|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
157138993|NCT00809133|567254472|FG012|Overall Study|Other adverse event|0|||
157138994|NCT00809133|567254473|FG013|Overall Study|Other adverse event|1|||
157138995|NCT00809133|567254460|FG000|Overall Study|Lost to Follow-up|0|||
157138996|NCT00809133|567254461|FG001|Overall Study|Lost to Follow-up|0|||
157138997|NCT00809133|567254462|FG002|Overall Study|Lost to Follow-up|0|||
157138998|NCT00809133|567254463|FG003|Overall Study|Lost to Follow-up|0|||
156795903|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
156795904|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
156795905|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
156795906|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
156727884|NCT02861807|565752206|FG000|Overall Study|Withdrawal by Subject|5|||
156727885|NCT02861807|565752207|FG001|Overall Study|Withdrawal by Subject|8|||
156727886|NCT00568061|565752210|FG000|Overall Study|Inclusion / exclusion criteria|5|||
156795907|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
156795908|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
156795909|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
156808807|NCT01484496|566054476|FG003|Period 1|Protocol Violation|0|||
156727887|NCT00568061|565752211|FG001|Overall Study|Inclusion / exclusion criteria|1|||
156727888|NCT00568061|565752210|FG000|Overall Study|Adverse Event|0|||
156727889|NCT00568061|565752211|FG001|Overall Study|Adverse Event|1|||
156727890|NCT05027451|565752212|FG000|Overall Study|Lost to Follow-up|1|||
157138999|NCT00809133|567254464|FG004|Overall Study|Lost to Follow-up|0|||
157139000|NCT00809133|567254465|FG005|Overall Study|Lost to Follow-up|1|||
157139001|NCT00809133|567254466|FG006|Overall Study|Lost to Follow-up|0|||
157139002|NCT00809133|567254467|FG007|Overall Study|Lost to Follow-up|0|||
157139003|NCT00809133|567254468|FG008|Overall Study|Lost to Follow-up|0|||
157139004|NCT00809133|567254469|FG009|Overall Study|Lost to Follow-up|0|||
157139005|NCT00809133|567254470|FG010|Overall Study|Lost to Follow-up|0|||
157139006|NCT00809133|567254471|FG011|Overall Study|Lost to Follow-up|0|||
157139007|NCT00809133|567254472|FG012|Overall Study|Lost to Follow-up|0|||
157139008|NCT00809133|567254473|FG013|Overall Study|Lost to Follow-up|0|||
157139009|NCT00809133|567254460|FG000|Overall Study|Consent withdrawn|0|||
157139010|NCT00809133|567254461|FG001|Overall Study|Consent withdrawn|0|||
157139011|NCT00809133|567254462|FG002|Overall Study|Consent withdrawn|0|||
157139012|NCT00809133|567254463|FG003|Overall Study|Consent withdrawn|0|||
157139013|NCT00809133|567254464|FG004|Overall Study|Consent withdrawn|1|||
157139014|NCT00809133|567254465|FG005|Overall Study|Consent withdrawn|0|||
156727891|NCT05027451|565752213|FG001|Overall Study|Lost to Follow-up|1|||
156727892|NCT02693002|565752215|FG000|Overall Study|Withdrawal by Subject|1|||
157139015|NCT00809133|567254466|FG006|Overall Study|Consent withdrawn|0|||
157139016|NCT00809133|567254467|FG007|Overall Study|Consent withdrawn|0|||
157139017|NCT00809133|567254468|FG008|Overall Study|Consent withdrawn|0|||
157139018|NCT00809133|567254469|FG009|Overall Study|Consent withdrawn|0|||
157139019|NCT00809133|567254470|FG010|Overall Study|Consent withdrawn|0|||
157139020|NCT00809133|567254471|FG011|Overall Study|Consent withdrawn|0|||
157139021|NCT00809133|567254472|FG012|Overall Study|Consent withdrawn|0|||
157139022|NCT00809133|567254473|FG013|Overall Study|Consent withdrawn|0|||
157139023|NCT00809133|567254460|FG000|Overall Study|Other not mentioned above|0|||
157139024|NCT00809133|567254461|FG001|Overall Study|Other not mentioned above|1|||
157139025|NCT00809133|567254462|FG002|Overall Study|Other not mentioned above|0|||
157139026|NCT00809133|567254463|FG003|Overall Study|Other not mentioned above|0|||
157139027|NCT00809133|567254464|FG004|Overall Study|Other not mentioned above|0|||
157139028|NCT00809133|567254465|FG005|Overall Study|Other not mentioned above|1|||
157139029|NCT00809133|567254466|FG006|Overall Study|Other not mentioned above|0|||
157139030|NCT00809133|567254467|FG007|Overall Study|Other not mentioned above|0|||
157139031|NCT00809133|567254468|FG008|Overall Study|Other not mentioned above|0|||
157139032|NCT00809133|567254469|FG009|Overall Study|Other not mentioned above|0|||
157217434|NCT01621490|567543223|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156727893|NCT02693002|565752216|FG001|Overall Study|Withdrawal by Subject|0|||
156727894|NCT00812981|565752219|FG000|Overall Study|Other|0|||
156727895|NCT00812981|565752220|FG001|Overall Study|Other|1|||
156727896|NCT04666259|565752224|FG000|Treatment Phase|Physician Decision|9|||
156727897|NCT04666259|565752225|FG001|Treatment Phase|Physician Decision|3|||
156727898|NCT04666259|565752226|FG002|Treatment Phase|Physician Decision|3|||
156727899|NCT04666259|565752224|FG000|Treatment Phase|Adverse Event|3|||
156727900|NCT04666259|565752225|FG001|Treatment Phase|Adverse Event|1|||
156876232|NCT04838977|566305770|FG000|Overall Study|Withdrawal by Subject|1|||
156876233|NCT04838977|566305771|FG001|Overall Study|Withdrawal by Subject|1|||
156876234|NCT01088048|566305775|FG000|Overall Study|Adverse Event|7|||
156876235|NCT01088048|566305776|FG001|Overall Study|Adverse Event|9|||
156876236|NCT01088048|566305777|FG002|Overall Study|Adverse Event|7|||
156876237|NCT01088048|566305778|FG003|Overall Study|Adverse Event|5|||
156876238|NCT01088048|566305779|FG004|Overall Study|Adverse Event|6|||
156727901|NCT04666259|565752226|FG002|Treatment Phase|Adverse Event|0|||
156727902|NCT04666259|565752224|FG000|Treatment Phase|Subject decision|1|||
156727903|NCT04666259|565752225|FG001|Treatment Phase|Subject decision|2|||
156727904|NCT04666259|565752226|FG002|Treatment Phase|Subject decision|0|||
156727905|NCT04666259|565752224|FG000|Treatment Phase|Progressive disease|0|||
156727906|NCT04666259|565752225|FG001|Treatment Phase|Progressive disease|1|||
156727907|NCT04666259|565752226|FG002|Treatment Phase|Progressive disease|0|||
156727908|NCT04666259|565752224|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
156727909|NCT04666259|565752225|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
156727910|NCT04666259|565752226|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
156876239|NCT01088048|566305780|FG005|Overall Study|Adverse Event|3|||
156876240|NCT01088048|566305781|FG006|Overall Study|Adverse Event|3|||
156876241|NCT01088048|566305782|FG007|Overall Study|Adverse Event|0|||
156876242|NCT01088048|566305783|FG008|Overall Study|Adverse Event|2|||
157217435|NCT01621490|567543224|FG002|Overall Study|Adverse event unrelated to study drug|0|||
157139033|NCT00809133|567254470|FG010|Overall Study|Other not mentioned above|0|||
156727911|NCT04666259|565752224|FG000|Safety Follow-up Phase|Physician Decision|2|||
156727912|NCT04666259|565752225|FG001|Safety Follow-up Phase|Physician Decision|0|||
156727913|NCT04666259|565752226|FG002|Safety Follow-up Phase|Physician Decision|0|||
156727914|NCT04666259|565752224|FG000|Safety Follow-up Phase|Subject decision|1|||
157217436|NCT01621490|567543225|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156727915|NCT04666259|565752225|FG001|Safety Follow-up Phase|Subject decision|0|||
156876243|NCT01088048|566305784|FG009|Overall Study|Adverse Event|2|||
156876244|NCT01088048|566305775|FG000|Overall Study|Withdrew Consent|1|||
156876245|NCT01088048|566305776|FG001|Overall Study|Withdrew Consent|1|||
156876246|NCT01088048|566305777|FG002|Overall Study|Withdrew Consent|1|||
156876247|NCT01088048|566305778|FG003|Overall Study|Withdrew Consent|1|||
157139034|NCT00809133|567254471|FG011|Overall Study|Other not mentioned above|0|||
157139035|NCT00809133|567254472|FG012|Overall Study|Other not mentioned above|0|||
156727916|NCT04666259|565752226|FG002|Safety Follow-up Phase|Subject decision|0|||
156727917|NCT04666259|565752224|FG000|Safety Follow-up Phase|Death|0|||
156727918|NCT04666259|565752225|FG001|Safety Follow-up Phase|Death|1|||
156727919|NCT04666259|565752226|FG002|Safety Follow-up Phase|Death|0|||
156727920|NCT04178122|565752227|FG000|Overall Study|Withdrawal by Subject|1|||
156727921|NCT04178122|565752228|FG001|Overall Study|Withdrawal by Subject|1|||
156727922|NCT04178122|565752227|FG000|Overall Study|Death|2|||
156727923|NCT04178122|565752228|FG001|Overall Study|Death|0|||
156795910|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
156795911|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
156795912|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
156795913|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
156795914|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
157139036|NCT00809133|567254473|FG013|Overall Study|Other not mentioned above|0|||
156727924|NCT04178122|565752227|FG000|Overall Study|Did not complete testing|3|||
156727925|NCT04178122|565752228|FG001|Overall Study|Did not complete testing|13|||
156727926|NCT05343364|565752229|FG000|Overall Study|Miscellaneous|0|||
156727927|NCT05343364|565752230|FG001|Overall Study|Miscellaneous|1|||
156727928|NCT01753570|565752231|FG000|Overall Study|Adverse Event|1|||
156727929|NCT01753570|565752232|FG001|Overall Study|Adverse Event|0|||
156727930|NCT01753570|565752233|FG002|Overall Study|Adverse Event|1|||
156727931|NCT01753570|565752231|FG000|Overall Study|Physician Decision|0|||
156727932|NCT01753570|565752232|FG001|Overall Study|Physician Decision|1|||
156727933|NCT01753570|565752233|FG002|Overall Study|Physician Decision|0|||
156727934|NCT01753570|565752231|FG000|Overall Study|Withdrawal by Subject|1|||
156727935|NCT01753570|565752232|FG001|Overall Study|Withdrawal by Subject|4|||
156727936|NCT01753570|565752233|FG002|Overall Study|Withdrawal by Subject|0|||
156727937|NCT01791894|565752234|FG000|Overall Study|Adverse Event|1|||
156727938|NCT01422889|565752235|FG000|Overall Study|No Data Entered for Study Stent|9|||
156727939|NCT02684097|565752240|FG000|Overall Study|Lack of Efficacy|13|||
156727940|NCT02684097|565752241|FG001|Overall Study|Lack of Efficacy|6|||
156727941|NCT00462709|565752242|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
156727942|NCT00462709|565752242|FG000|Overall Study|Lost to Follow-up|10|||
156727943|NCT00462709|565752242|FG000|Overall Study|Withdrawal by Subject|8|||
156727944|NCT00462709|565752242|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
156727945|NCT00462709|565752242|FG000|Overall Study|Death|2|||
156727946|NCT00462709|565752242|FG000|Overall Study|Logistical reasons|2|||
156727947|NCT00462709|565752242|FG000|Overall Study|Physician Decision|1|||
156727948|NCT00462709|565752242|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
156727949|NCT02748356|565752243|FG000|Overall Study|Withdrawal by Subject|1|||
156727950|NCT00425750|565752244|FG000|Overall Study|Death|1|||
156727951|NCT00425750|565752244|FG000|Overall Study|Withdrawal by Subject|3|||
156727952|NCT00425750|565752244|FG000|Overall Study|Adverse Event|3|||
156727953|NCT00425750|565752244|FG000|Overall Study|Progression of disease|18|||
156727954|NCT01732458|565752245|FG000|Overall Study|Lost to Follow-up|0|||
156727955|NCT01732458|565752246|FG001|Overall Study|Lost to Follow-up|2|||
156727956|NCT01732458|565752247|FG002|Overall Study|Lost to Follow-up|0|||
156727957|NCT01732458|565752248|FG003|Overall Study|Lost to Follow-up|0|||
156727958|NCT01732458|565752245|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156727959|NCT01732458|565752246|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156727960|NCT01732458|565752247|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156727961|NCT01732458|565752248|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156727962|NCT01732458|565752245|FG000|Overall Study|Physician Decision|1|||
156727963|NCT01732458|565752246|FG001|Overall Study|Physician Decision|2|||
156727964|NCT01732458|565752247|FG002|Overall Study|Physician Decision|2|||
156727965|NCT01732458|565752248|FG003|Overall Study|Physician Decision|0|||
156727966|NCT01732458|565752245|FG000|Overall Study|Protocol Violation|2|||
156727967|NCT01732458|565752246|FG001|Overall Study|Protocol Violation|0|||
156727968|NCT01732458|565752247|FG002|Overall Study|Protocol Violation|0|||
156727969|NCT01732458|565752248|FG003|Overall Study|Protocol Violation|2|||
156727970|NCT01732458|565752245|FG000|Overall Study|Screen Failure|0|||
156727971|NCT01732458|565752246|FG001|Overall Study|Screen Failure|1|||
156727972|NCT01732458|565752247|FG002|Overall Study|Screen Failure|0|||
156795915|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
156795916|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
156795917|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
156795918|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
156795919|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
156795920|NCT00086515|566006209|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
156795921|NCT00086515|566006210|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
156795922|NCT01435356|566006211|FG000|Overall Study|Adverse Event|2|||
156795923|NCT01435356|566006212|FG001|Overall Study|Adverse Event|0|||
156795924|NCT01435356|566006211|FG000|Overall Study|Disease progression/recurrence|17|||
156795925|NCT01435356|566006212|FG001|Overall Study|Disease progression/recurrence|10|||
156727973|NCT01732458|565752248|FG003|Overall Study|Screen Failure|0|||
156727974|NCT05107492|565752250|FG000|Overall Study|Lost to Follow-up|1|||
156727975|NCT05107492|565752251|FG001|Overall Study|Lost to Follow-up|0|||
156727976|NCT04331067|565752252|FG000|Overall Study|Adverse Event|1|||
156727977|NCT04331067|565752253|FG001|Overall Study|Adverse Event|3|||
156727978|NCT04331067|565752254|FG002|Overall Study|Adverse Event|1|||
156727979|NCT04331067|565752252|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
156727980|NCT04331067|565752253|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
156727981|NCT04331067|565752254|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
156727982|NCT05870371|565752255|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
156727983|NCT05870371|565752256|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
156727984|NCT02522884|565752259|FG000|Overall Study|Withdrawal by Subject|6|||
156876248|NCT01088048|566305779|FG004|Overall Study|Withdrew Consent|2|||
156727985|NCT02522884|565752259|FG000|Overall Study|Death|3|||
156727986|NCT02522884|565752259|FG000|Overall Study|Missed 12-month Follow-up|9|||
156727987|NCT04495751|565752260|FG000|Overall Study|Withdrawal by Subject|1|||
156727988|NCT04495751|565752261|FG001|Overall Study|Withdrawal by Subject|0|||
156727989|NCT04495751|565752260|FG000|Overall Study|Lost to Follow-up|1|||
156727990|NCT04495751|565752261|FG001|Overall Study|Lost to Follow-up|0|||
156727991|NCT03289754|565752262|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
156727992|NCT04873934|565752263|FG000|Overall Study|Adverse Event|0|||
156727993|NCT04873934|565752264|FG001|Overall Study|Adverse Event|1|||
156727994|NCT04873934|565752263|FG000|Overall Study|Death|0|||
156727995|NCT04873934|565752264|FG001|Overall Study|Death|2|||
156727996|NCT04873934|565752263|FG000|Overall Study|Lost to Follow-up|13|||
156727997|NCT04873934|565752264|FG001|Overall Study|Lost to Follow-up|9|||
156727998|NCT04873934|565752263|FG000|Overall Study|Physician Decision|1|||
156727999|NCT04873934|565752264|FG001|Overall Study|Physician Decision|1|||
156728000|NCT04873934|565752263|FG000|Overall Study|Protocol deviation|2|||
156728001|NCT04873934|565752264|FG001|Overall Study|Protocol deviation|1|||
156728002|NCT04873934|565752263|FG000|Overall Study|Subject decision|1|||
156728003|NCT04873934|565752264|FG001|Overall Study|Subject decision|8|||
156728004|NCT04873934|565752263|FG000|Overall Study|Withdrew consent|0|||
156728005|NCT04873934|565752264|FG001|Overall Study|Withdrew consent|4|||
156728006|NCT04873934|565752263|FG000|Overall Study|Missing|1|||
156728007|NCT04873934|565752264|FG001|Overall Study|Missing|0|||
156728008|NCT00708461|565752265|FG000|Overall Study|Lost to Follow-up|18|||
156728009|NCT00708461|565752266|FG001|Overall Study|Lost to Follow-up|11|||
156728010|NCT00708461|565752265|FG000|Overall Study|Withdrawal by Subject|8|||
156728011|NCT00708461|565752266|FG001|Overall Study|Withdrawal by Subject|9|||
156728012|NCT00708461|565752265|FG000|Overall Study|left workforce|115|||
156728013|NCT00708461|565752266|FG001|Overall Study|left workforce|180|||
156728014|NCT03584854|565752268|FG000|Overall Study|Primary outcome not measured|1|||
156728015|NCT03584854|565752269|FG001|Overall Study|Primary outcome not measured|2|||
156728016|NCT02968173|565752270|FG000|Overall Study|Withdrawal by Subject|1|||
156728017|NCT00153179|565752277|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
156728018|NCT00153179|565752278|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
156728019|NCT00153179|565752279|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
156728020|NCT00153179|565752280|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
156728021|NCT00314327|565752285|FG000|Overall Study|Withdrawal by Subject|1|||
156728022|NCT02134015|565752286|FG000|Overall Study|Protocol Violation|0|||
156728023|NCT02134015|565752287|FG001|Overall Study|Protocol Violation|1|||
156728024|NCT02134015|565752286|FG000|Overall Study|Death|2|||
156728025|NCT02134015|565752287|FG001|Overall Study|Death|1|||
156728026|NCT02134015|565752286|FG000|Overall Study|Reason not provided|1|||
156728027|NCT02134015|565752287|FG001|Overall Study|Reason not provided|2|||
156728028|NCT02134015|565752286|FG000|Overall Study|Clinical progression|14|||
156728029|NCT02134015|565752287|FG001|Overall Study|Clinical progression|7|||
156728030|NCT02134015|565752286|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
156728031|NCT02134015|565752287|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
157139037|NCT03093155|567254475|FG000|Overall Study|Not Eligible|1|||
157139038|NCT03093155|567254476|FG001|Overall Study|Not Eligible|0|||
156728032|NCT02134015|565752286|FG000|Overall Study|Study terminated by sponsor|2|||
156876249|NCT01088048|566305780|FG005|Overall Study|Withdrew Consent|1|||
156876250|NCT01088048|566305781|FG006|Overall Study|Withdrew Consent|0|||
157139039|NCT03093155|567254475|FG000|Overall Study|Withdrawal by Subject|0|||
157139040|NCT03093155|567254476|FG001|Overall Study|Withdrawal by Subject|1|||
156728033|NCT02134015|565752287|FG001|Overall Study|Study terminated by sponsor|3|||
156728034|NCT02134015|565752286|FG000|Overall Study|Adverse Event|9|||
156728035|NCT02134015|565752287|FG001|Overall Study|Adverse Event|10|||
156728036|NCT02134015|565752286|FG000|Overall Study|Withdrawal by Subject|3|||
156728037|NCT02134015|565752287|FG001|Overall Study|Withdrawal by Subject|7|||
156728038|NCT02453334|565753951|FG000|Overall Study|Death|15|||
156728039|NCT02453334|565753952|FG001|Overall Study|Death|13|||
156728040|NCT02453334|565753951|FG000|Overall Study|Adverse Event|2|||
156728041|NCT02453334|565753952|FG001|Overall Study|Adverse Event|1|||
156728042|NCT02453334|565753951|FG000|Overall Study|Lost to Follow-up|5|||
156728043|NCT02453334|565753952|FG001|Overall Study|Lost to Follow-up|9|||
156728044|NCT02453334|565753951|FG000|Overall Study|Physician Decision|1|||
157139041|NCT00833092|567254477|FG000|Overall Study|Withdrawal by Subject|2|||
156728045|NCT02453334|565753952|FG001|Overall Study|Physician Decision|0|||
156728046|NCT02453334|565753951|FG000|Overall Study|Withdrawal by Subject|17|||
156728047|NCT02453334|565753952|FG001|Overall Study|Withdrawal by Subject|13|||
156728048|NCT02453334|565753951|FG000|Overall Study|Other reason|1|||
156728049|NCT02453334|565753952|FG001|Overall Study|Other reason|4|||
156728050|NCT01841762|565753953|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
156728051|NCT01841762|565753953|FG000|Treatment Period|Adverse Event|16|||
156728052|NCT01841762|565753953|FG000|Treatment Period|Death|1|||
156728053|NCT01841762|565753953|FG000|Treatment Period|Withdrawal by Subject|7|||
156728054|NCT01841762|565753953|FG000|Treatment Period|Lost to Follow-up|1|||
156728055|NCT01841762|565753953|FG000|Treatment Period|Physician Decision|2|||
156728056|NCT01841762|565753953|FG000|Treatment Period|Other, including non-compliance|5|||
156728057|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
156728058|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
156728059|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
156728060|NCT01841762|565753953|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
156728061|NCT01954056|565753961|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
156728062|NCT01954056|565753962|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
156728063|NCT06110494|565753976|FG000|Overall Study|Protocol Violation|2|||
156728064|NCT06110494|565753977|FG001|Overall Study|Protocol Violation|0|||
156728065|NCT06110494|565753978|FG002|Overall Study|Protocol Violation|1|||
156728066|NCT06110494|565753976|FG000|Overall Study|Dixon's test for outlier analysis|1|||
156728067|NCT06110494|565753977|FG001|Overall Study|Dixon's test for outlier analysis|1|||
156728068|NCT06110494|565753978|FG002|Overall Study|Dixon's test for outlier analysis|0|||
156728069|NCT00105079|565753979|FG000|Overall Study|Adverse Event|5|||
156728070|NCT00105079|565753980|FG001|Overall Study|Adverse Event|12|||
156728071|NCT00105079|565753979|FG000|Overall Study|Death|3|||
156876251|NCT01088048|566305782|FG007|Overall Study|Withdrew Consent|2|||
157139042|NCT00833092|567254478|FG001|Overall Study|Withdrawal by Subject|3|||
156728072|NCT00105079|565753980|FG001|Overall Study|Death|1|||
156728073|NCT00105079|565753979|FG000|Overall Study|Lost to Follow-up|12|||
156728074|NCT00105079|565753980|FG001|Overall Study|Lost to Follow-up|12|||
156728075|NCT00105079|565753979|FG000|Overall Study|Lack of Efficacy|9|||
156728076|NCT00105079|565753980|FG001|Overall Study|Lack of Efficacy|3|||
156876252|NCT01088048|566305783|FG008|Overall Study|Withdrew Consent|2|||
156876253|NCT01088048|566305784|FG009|Overall Study|Withdrew Consent|1|||
156876254|NCT01088048|566305775|FG000|Overall Study|Concomitant Medication Prohibited|1|||
156876255|NCT01088048|566305776|FG001|Overall Study|Concomitant Medication Prohibited|0|||
156876256|NCT01088048|566305777|FG002|Overall Study|Concomitant Medication Prohibited|0|||
156876257|NCT01088048|566305778|FG003|Overall Study|Concomitant Medication Prohibited|0|||
156876258|NCT01088048|566305779|FG004|Overall Study|Concomitant Medication Prohibited|0|||
156876259|NCT01088048|566305780|FG005|Overall Study|Concomitant Medication Prohibited|0|||
156876260|NCT01088048|566305781|FG006|Overall Study|Concomitant Medication Prohibited|0|||
156876261|NCT01088048|566305782|FG007|Overall Study|Concomitant Medication Prohibited|0|||
156876262|NCT01088048|566305783|FG008|Overall Study|Concomitant Medication Prohibited|0|||
156876263|NCT01088048|566305784|FG009|Overall Study|Concomitant Medication Prohibited|0|||
156876264|NCT01088048|566305775|FG000|Overall Study|Investigator Request|2|||
156876265|NCT01088048|566305776|FG001|Overall Study|Investigator Request|2|||
156876266|NCT01088048|566305777|FG002|Overall Study|Investigator Request|0|||
156876267|NCT01088048|566305778|FG003|Overall Study|Investigator Request|0|||
156876268|NCT01088048|566305779|FG004|Overall Study|Investigator Request|3|||
156876269|NCT01088048|566305780|FG005|Overall Study|Investigator Request|1|||
156876270|NCT01088048|566305781|FG006|Overall Study|Investigator Request|1|||
156876271|NCT01088048|566305782|FG007|Overall Study|Investigator Request|0|||
156876272|NCT01088048|566305783|FG008|Overall Study|Investigator Request|0|||
156876273|NCT01088048|566305784|FG009|Overall Study|Investigator Request|0|||
156876274|NCT01088048|566305775|FG000|Overall Study|Patient Non-compliance|0|||
156876275|NCT01088048|566305776|FG001|Overall Study|Patient Non-compliance|1|||
156876276|NCT01088048|566305777|FG002|Overall Study|Patient Non-compliance|0|||
156876277|NCT01088048|566305778|FG003|Overall Study|Patient Non-compliance|0|||
156876278|NCT01088048|566305779|FG004|Overall Study|Patient Non-compliance|0|||
156876279|NCT01088048|566305780|FG005|Overall Study|Patient Non-compliance|0|||
156876280|NCT01088048|566305781|FG006|Overall Study|Patient Non-compliance|0|||
156876281|NCT01088048|566305782|FG007|Overall Study|Patient Non-compliance|0|||
156876282|NCT01088048|566305783|FG008|Overall Study|Patient Non-compliance|0|||
157139043|NCT00833092|567254477|FG000|Overall Study|Protocol Violation|2|||
156728077|NCT00105079|565753979|FG000|Overall Study|Refused treatment|6|||
156728078|NCT00105079|565753980|FG001|Overall Study|Refused treatment|4|||
156728079|NCT00105079|565753979|FG000|Overall Study|Violation of selection criteria at entry|0|||
156728080|NCT00105079|565753980|FG001|Overall Study|Violation of selection criteria at entry|2|||
156728081|NCT00105079|565753979|FG000|Overall Study|Protocol Violation|1|||
156876283|NCT01088048|566305784|FG009|Overall Study|Patient Non-compliance|0|||
156876284|NCT01088048|566305775|FG000|Overall Study|Disease Progression|7|||
156876285|NCT01088048|566305776|FG001|Overall Study|Disease Progression|4|||
157139044|NCT00833092|567254478|FG001|Overall Study|Protocol Violation|1|||
157139045|NCT00833092|567254477|FG000|Overall Study|Diarrhea|0|||
156876286|NCT01088048|566305777|FG002|Overall Study|Disease Progression|3|||
156876287|NCT01088048|566305778|FG003|Overall Study|Disease Progression|5|||
156876288|NCT01088048|566305779|FG004|Overall Study|Disease Progression|3|||
156876289|NCT01088048|566305780|FG005|Overall Study|Disease Progression|3|||
156876290|NCT01088048|566305781|FG006|Overall Study|Disease Progression|2|||
156876291|NCT01088048|566305782|FG007|Overall Study|Disease Progression|1|||
156876292|NCT01088048|566305783|FG008|Overall Study|Disease Progression|0|||
156876293|NCT01088048|566305784|FG009|Overall Study|Disease Progression|0|||
156876294|NCT01088048|566305775|FG000|Overall Study|Death|1|||
156876295|NCT01088048|566305776|FG001|Overall Study|Death|5|||
156876296|NCT01088048|566305777|FG002|Overall Study|Death|3|||
156876297|NCT01088048|566305778|FG003|Overall Study|Death|3|||
156876298|NCT01088048|566305779|FG004|Overall Study|Death|1|||
156876299|NCT01088048|566305780|FG005|Overall Study|Death|3|||
156876300|NCT01088048|566305781|FG006|Overall Study|Death|0|||
156876301|NCT01088048|566305782|FG007|Overall Study|Death|0|||
156876302|NCT01088048|566305783|FG008|Overall Study|Death|3|||
156876303|NCT01088048|566305784|FG009|Overall Study|Death|1|||
156876304|NCT01088048|566305775|FG000|Overall Study|Other|3|||
156876305|NCT01088048|566305776|FG001|Overall Study|Other|5|||
156876306|NCT01088048|566305777|FG002|Overall Study|Other|0|||
156876307|NCT01088048|566305778|FG003|Overall Study|Other|0|||
156876308|NCT01088048|566305779|FG004|Overall Study|Other|2|||
156876309|NCT01088048|566305780|FG005|Overall Study|Other|0|||
156876310|NCT01088048|566305781|FG006|Overall Study|Other|0|||
156876311|NCT01088048|566305782|FG007|Overall Study|Other|2|||
156876312|NCT01088048|566305783|FG008|Overall Study|Other|0|||
156876313|NCT01088048|566305784|FG009|Overall Study|Other|0|||
156876314|NCT00950859|566305785|FG000|Overall Study|Adverse Event|3|||
156876315|NCT00950859|566305786|FG001|Overall Study|Adverse Event|3|||
156876316|NCT00950859|566305785|FG000|Overall Study|Insufficient Viral Load Response|12|||
156876317|NCT00950859|566305786|FG001|Overall Study|Insufficient Viral Load Response|3|||
156876318|NCT00950859|566305785|FG000|Overall Study|Protocol Violation|1|||
156876319|NCT00950859|566305786|FG001|Overall Study|Protocol Violation|1|||
156876320|NCT00950859|566305785|FG000|Overall Study|Lost to Follow-up|0|||
156876321|NCT00950859|566305786|FG001|Overall Study|Lost to Follow-up|3|||
156876322|NCT01343693|566305788|FG000|Overall Study|Lost to Follow-up|9|||
156876323|NCT00265148|566305789|FG000|Overall Study|Adverse Event|2|||
156876324|NCT00265148|566305790|FG001|Overall Study|Adverse Event|2|||
156876325|NCT00265148|566305789|FG000|Overall Study|Lack of Efficacy|0|||
156876326|NCT00265148|566305790|FG001|Overall Study|Lack of Efficacy|2|||
156876327|NCT00265148|566305789|FG000|Overall Study|Protocol Violation|3|||
156876328|NCT00265148|566305790|FG001|Overall Study|Protocol Violation|2|||
156876329|NCT00265148|566305789|FG000|Overall Study|Lost to Follow-up|0|||
156876330|NCT00265148|566305790|FG001|Overall Study|Lost to Follow-up|1|||
156876331|NCT00265148|566305789|FG000|Overall Study|Withdrawal by Subject|2|||
156876332|NCT00265148|566305790|FG001|Overall Study|Withdrawal by Subject|1|||
156876333|NCT00265148|566305789|FG000|Overall Study|Physician Decision|1|||
156876334|NCT00265148|566305790|FG001|Overall Study|Physician Decision|0|||
156876335|NCT00265148|566305789|FG000|Overall Study|Increasing frailty|0|||
156876336|NCT00265148|566305790|FG001|Overall Study|Increasing frailty|1|||
156876337|NCT00265148|566305789|FG000|Overall Study|Subject chose to change of the dose|1|||
156876338|NCT00265148|566305790|FG001|Overall Study|Subject chose to change of the dose|0|||
156876339|NCT01463007|566305791|FG000|Overall Study|Physician Decision|1|||
156876340|NCT03583385|566305792|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156876341|NCT03583385|566305793|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156876342|NCT03583385|566305792|FG000|Treatment Period 2|Adverse Event|1|||
156876343|NCT03583385|566305793|FG001|Treatment Period 2|Adverse Event|0|||
156876344|NCT00545272|566305799|FG000|Overall Study|Protocol deviation|0|||
156876345|NCT00545272|566305800|FG001|Overall Study|Protocol deviation|1|||
156876346|NCT00545272|566305801|FG002|Overall Study|Protocol deviation|0|||
156876347|NCT00545272|566305802|FG003|Overall Study|Protocol deviation|1|||
156876348|NCT00545272|566305803|FG004|Overall Study|Protocol deviation|0|||
156876349|NCT00545272|566305804|FG005|Overall Study|Protocol deviation|1|||
157139046|NCT00833092|567254478|FG001|Overall Study|Diarrhea|2|||
157139047|NCT00833092|567254477|FG000|Overall Study|constipation|0|||
156876350|NCT00545272|566305799|FG000|Overall Study|Adverse Event|0|||
156876351|NCT00545272|566305800|FG001|Overall Study|Adverse Event|0|||
156876352|NCT00545272|566305801|FG002|Overall Study|Adverse Event|1|||
156876353|NCT00545272|566305802|FG003|Overall Study|Adverse Event|0|||
156876354|NCT00545272|566305803|FG004|Overall Study|Adverse Event|0|||
156876355|NCT00545272|566305804|FG005|Overall Study|Adverse Event|1|||
156876356|NCT00545272|566305799|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156876357|NCT00545272|566305800|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156876358|NCT00545272|566305801|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156876359|NCT00545272|566305802|FG003|Overall Study|Abnormal laboratory value(s)|0|||
156876360|NCT00545272|566305803|FG004|Overall Study|Abnormal laboratory value(s)|0|||
156876361|NCT00545272|566305804|FG005|Overall Study|Abnormal laboratory value(s)|1|||
156876362|NCT00545272|566305799|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157139048|NCT00833092|567254478|FG001|Overall Study|constipation|1|||
156728082|NCT00105079|565753980|FG001|Overall Study|Protocol Violation|0|||
156728083|NCT00105079|565753979|FG000|Overall Study|Other|3|||
156728084|NCT00105079|565753980|FG001|Overall Study|Other|1|||
156728085|NCT01464593|565753983|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
156728086|NCT00386360|565753984|FG000|Overall Study|Adverse Event|4|||
156728087|NCT00386360|565753985|FG001|Overall Study|Adverse Event|2|||
156728088|NCT00386360|565753984|FG000|Overall Study|Physician Decision|2|||
156728089|NCT00386360|565753985|FG001|Overall Study|Physician Decision|2|||
157139049|NCT00619229|567254479|FG000|Overall Study|Withdrawal by Subject|1|||
156728090|NCT00386360|565753984|FG000|Overall Study|Lost to Follow-up|0|||
156728091|NCT00386360|565753985|FG001|Overall Study|Lost to Follow-up|2|||
156728092|NCT00386360|565753984|FG000|Overall Study|Protocol Violation|0|||
156728093|NCT00386360|565753985|FG001|Overall Study|Protocol Violation|3|||
156728094|NCT00386360|565753984|FG000|Overall Study|Withdrawal by Subject|3|||
156728095|NCT00386360|565753985|FG001|Overall Study|Withdrawal by Subject|6|||
156728096|NCT00386360|565753984|FG000|Overall Study|Did not take any study medication|0|||
156728097|NCT00386360|565753985|FG001|Overall Study|Did not take any study medication|2|||
157019828|NCT04784559|566826517|FG000|Overall Study|SAE|0|||
157019829|NCT04784559|566826518|FG001|Overall Study|SAE|1|||
157019830|NCT04784559|566826519|FG002|Overall Study|SAE|0|||
157019831|NCT04784559|566826517|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
157019832|NCT04784559|566826518|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
157019833|NCT04784559|566826519|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
157019834|NCT04382404|566826520|FG000|Overall Study|Adverse Event|1|||
157019835|NCT04382404|566826520|FG000|Overall Study|Lost to Follow-up|2|||
156728106|NCT02490371|565753992|FG000|Overall Study|Lost to Follow-up|1|||
156728107|NCT02490371|565753993|FG001|Overall Study|Lost to Follow-up|1|||
156728108|NCT01073605|565753996|FG000|Overall Study|Ongoing at Cutoff Date|1|||
156728109|NCT01073605|565753997|FG001|Overall Study|Ongoing at Cutoff Date|1|||
156728110|NCT01073605|565753998|FG002|Overall Study|Ongoing at Cutoff Date|0|||
156728111|NCT01073605|565753996|FG000|Overall Study|Adverse Event|2|||
156728112|NCT01073605|565753997|FG001|Overall Study|Adverse Event|1|||
156728113|NCT01073605|565753998|FG002|Overall Study|Adverse Event|0|||
156728114|NCT01073605|565753996|FG000|Overall Study|Lost to Follow-up|3|||
156728115|NCT01073605|565753997|FG001|Overall Study|Lost to Follow-up|4|||
156728116|NCT01073605|565753998|FG002|Overall Study|Lost to Follow-up|9|||
156728117|NCT01073605|565753996|FG000|Overall Study|Other|25|||
156728118|NCT01073605|565753997|FG001|Overall Study|Other|21|||
156728119|NCT01073605|565753998|FG002|Overall Study|Other|29|||
156728120|NCT01073605|565753996|FG000|Overall Study|Withdrawal by Subject|31|||
156728121|NCT01073605|565753997|FG001|Overall Study|Withdrawal by Subject|39|||
156728122|NCT01073605|565753998|FG002|Overall Study|Withdrawal by Subject|22|||
156728123|NCT01073605|565753996|FG000|Overall Study|Randomized But Not Treated|0|||
156728124|NCT01073605|565753997|FG001|Overall Study|Randomized But Not Treated|1|||
156728125|NCT01073605|565753998|FG002|Overall Study|Randomized But Not Treated|1|||
156728126|NCT03018080|565753999|FG000|Overall Study|Death|12|||
156728127|NCT03018080|565754000|FG001|Overall Study|Death|19|||
156728128|NCT03491462|565754001|FG000|Overall Study|Lost to Follow-up|2|||
156728129|NCT03491462|565754002|FG001|Overall Study|Lost to Follow-up|0|||
156728130|NCT03491462|565754001|FG000|Overall Study|Adverse Event|11|||
156728131|NCT03491462|565754002|FG001|Overall Study|Adverse Event|1|||
156728132|NCT03491462|565754001|FG000|Overall Study|Physician Decision|3|||
156728133|NCT03491462|565754002|FG001|Overall Study|Physician Decision|0|||
156728134|NCT03491462|565754001|FG000|Overall Study|Withdrawal by Subject|22|||
156728135|NCT03491462|565754002|FG001|Overall Study|Withdrawal by Subject|15|||
156728136|NCT00740792|565754003|FG000|Overall Study|Adverse Event|3|||
156728137|NCT00740792|565754004|FG001|Overall Study|Adverse Event|1|||
156728138|NCT00740792|565754005|FG002|Overall Study|Adverse Event|1|||
156728139|NCT00740792|565754006|FG003|Overall Study|Adverse Event|3|||
156728140|NCT00740792|565754003|FG000|Overall Study|Lack of Efficacy|1|||
157139050|NCT00619229|567254480|FG001|Overall Study|Withdrawal by Subject|1|||
156728141|NCT00740792|565754004|FG001|Overall Study|Lack of Efficacy|1|||
156728142|NCT00740792|565754005|FG002|Overall Study|Lack of Efficacy|0|||
156728143|NCT00740792|565754006|FG003|Overall Study|Lack of Efficacy|3|||
156728144|NCT00740792|565754003|FG000|Overall Study|Lost to Follow-up|2|||
156728145|NCT00740792|565754004|FG001|Overall Study|Lost to Follow-up|1|||
156728146|NCT00740792|565754005|FG002|Overall Study|Lost to Follow-up|0|||
156728147|NCT00740792|565754006|FG003|Overall Study|Lost to Follow-up|0|||
156728148|NCT00740792|565754003|FG000|Overall Study|Protocol Violation|0|||
156728149|NCT00740792|565754004|FG001|Overall Study|Protocol Violation|1|||
156728150|NCT00740792|565754005|FG002|Overall Study|Protocol Violation|0|||
156728151|NCT00740792|565754006|FG003|Overall Study|Protocol Violation|2|||
156728152|NCT00740792|565754003|FG000|Overall Study|Withdrawal by Subject|1|||
156728153|NCT00740792|565754004|FG001|Overall Study|Withdrawal by Subject|1|||
156728154|NCT00740792|565754005|FG002|Overall Study|Withdrawal by Subject|0|||
156728155|NCT00740792|565754006|FG003|Overall Study|Withdrawal by Subject|0|||
156728156|NCT00740792|565754003|FG000|Overall Study|administrative|3|||
156728157|NCT00740792|565754004|FG001|Overall Study|administrative|3|||
157139051|NCT00619229|567254479|FG000|Overall Study|Lost to Follow-up|1|||
157139052|NCT00619229|567254480|FG001|Overall Study|Lost to Follow-up|0|||
157139053|NCT00619229|567254479|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
157139054|NCT00619229|567254480|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
157139055|NCT00619229|567254479|FG000|Overall Study|Investigator planned Cataract Operation|1|||
157139056|NCT00619229|567254480|FG001|Overall Study|Investigator planned Cataract Operation|0|||
157139057|NCT01700829|567254481|FG000|Overall Study|Withdrawal by Subject|1|||
157139058|NCT01700829|567254482|FG001|Overall Study|Withdrawal by Subject|1|||
157139059|NCT03417440|567254483|FG000|Overall Study|Lost to Follow-up|0|||
157139060|NCT03417440|567254484|FG001|Overall Study|Lost to Follow-up|1|||
156728158|NCT00740792|565754005|FG002|Overall Study|administrative|8|||
156728159|NCT00740792|565754006|FG003|Overall Study|administrative|2|||
156728160|NCT01455597|565754007|FG000|Overall Study|Adverse Event|7|||
156728161|NCT01455597|565754008|FG001|Overall Study|Adverse Event|0|||
157139061|NCT03417440|567254485|FG002|Overall Study|Lost to Follow-up|0|||
157139062|NCT03417440|567254486|FG003|Overall Study|Lost to Follow-up|0|||
157139063|NCT03417440|567254487|FG004|Overall Study|Lost to Follow-up|1|||
157139064|NCT03417440|567254488|FG005|Overall Study|Lost to Follow-up|0|||
157139065|NCT03417440|567254489|FG006|Overall Study|Lost to Follow-up|0|||
157139066|NCT03417440|567254490|FG007|Overall Study|Lost to Follow-up|0|||
157139067|NCT03417440|567254483|FG000|Overall Study|Withdrawal by Subject|2|||
157139068|NCT03417440|567254484|FG001|Overall Study|Withdrawal by Subject|0|||
157139069|NCT03417440|567254485|FG002|Overall Study|Withdrawal by Subject|2|||
157139070|NCT03417440|567254486|FG003|Overall Study|Withdrawal by Subject|1|||
157139071|NCT03417440|567254487|FG004|Overall Study|Withdrawal by Subject|1|||
157139072|NCT03417440|567254488|FG005|Overall Study|Withdrawal by Subject|0|||
157139073|NCT03417440|567254489|FG006|Overall Study|Withdrawal by Subject|0|||
157139074|NCT03417440|567254490|FG007|Overall Study|Withdrawal by Subject|1|||
157139075|NCT02983604|567254491|FG000|Overall Study|Enrolled but not Treated|0|||
157139076|NCT02983604|567254492|FG001|Overall Study|Enrolled but not Treated|0|||
157139077|NCT02983604|567254493|FG002|Overall Study|Enrolled but not Treated|1|||
157139078|NCT02983604|567254494|FG003|Overall Study|Enrolled but not Treated|0|||
157139079|NCT00466505|567254495|FG000|Overall Study|disease progression|13|||
156728162|NCT01455597|565754009|FG002|Overall Study|Adverse Event|5|||
156728163|NCT01455597|565754010|FG003|Overall Study|Adverse Event|1|||
156728164|NCT01455597|565754007|FG000|Overall Study|Lack of Efficacy|0|||
156728165|NCT01455597|565754008|FG001|Overall Study|Lack of Efficacy|1|||
156728166|NCT01455597|565754009|FG002|Overall Study|Lack of Efficacy|2|||
156728167|NCT01455597|565754010|FG003|Overall Study|Lack of Efficacy|0|||
156728168|NCT01455597|565754007|FG000|Overall Study|Lost to Follow-up|3|||
156728169|NCT01455597|565754008|FG001|Overall Study|Lost to Follow-up|0|||
156728170|NCT01455597|565754009|FG002|Overall Study|Lost to Follow-up|2|||
156728171|NCT01455597|565754010|FG003|Overall Study|Lost to Follow-up|1|||
156728172|NCT01455597|565754007|FG000|Overall Study|Withdrew Consent|6|||
156728173|NCT01455597|565754008|FG001|Overall Study|Withdrew Consent|5|||
156728174|NCT01455597|565754009|FG002|Overall Study|Withdrew Consent|8|||
156728175|NCT01455597|565754010|FG003|Overall Study|Withdrew Consent|5|||
156728176|NCT01455597|565754007|FG000|Overall Study|Reason not Specified|1|||
156728177|NCT01455597|565754008|FG001|Overall Study|Reason not Specified|2|||
156728178|NCT01455597|565754009|FG002|Overall Study|Reason not Specified|3|||
156728179|NCT01455597|565754010|FG003|Overall Study|Reason not Specified|3|||
156728180|NCT01737710|565754012|FG000|Overall Study|Lost to Follow-up|0|||
156728181|NCT01737710|565754013|FG001|Overall Study|Lost to Follow-up|2|||
156728182|NCT01737710|565754014|FG002|Overall Study|Lost to Follow-up|2|||
156728183|NCT01737710|565754015|FG003|Overall Study|Lost to Follow-up|0|||
156728184|NCT01737710|565754016|FG004|Overall Study|Lost to Follow-up|0|||
156728185|NCT01737710|565754012|FG000|Overall Study|Withdrawal by Subject|1|||
156728186|NCT01737710|565754013|FG001|Overall Study|Withdrawal by Subject|1|||
156728187|NCT01737710|565754014|FG002|Overall Study|Withdrawal by Subject|1|||
156728188|NCT01737710|565754015|FG003|Overall Study|Withdrawal by Subject|0|||
156728189|NCT01737710|565754016|FG004|Overall Study|Withdrawal by Subject|0|||
156728190|NCT01737710|565754012|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
156728191|NCT01737710|565754013|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
156795926|NCT01435356|566006211|FG000|Overall Study|Protocol Violation|0|||
157139080|NCT00466505|567254495|FG000|Overall Study|Adverse Event|4|||
157139081|NCT00355264|567254496|FG000|Extension (Variable Duration)|Adverse Event|1|||
157139082|NCT00355264|567254496|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
157139083|NCT01451645|567254497|FG000|Overall Study|Protocol Violation|1|||
157139084|NCT01451645|567254498|FG001|Overall Study|Protocol Violation|0|||
157139085|NCT01451645|567254497|FG000|Overall Study|Adverse Event|0|||
156728192|NCT01737710|565754014|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
156728193|NCT01737710|565754015|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
156728194|NCT01737710|565754016|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
156728195|NCT03412734|565754020|FG000|Overall Study|Incorrect labeling of samples|2|||
156728196|NCT03412734|565754021|FG001|Overall Study|Incorrect labeling of samples|0|||
156728197|NCT03412734|565754020|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
156728198|NCT03412734|565754021|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
156728199|NCT00423332|565754022|FG000|Overall Study|Adverse Event|6|||
156728200|NCT00423332|565754023|FG001|Overall Study|Adverse Event|2|||
156728201|NCT00423332|565754022|FG000|Overall Study|Withdrawal by Subject|1|||
156728202|NCT00423332|565754023|FG001|Overall Study|Withdrawal by Subject|0|||
156728203|NCT00423332|565754022|FG000|Overall Study|Condition under investigation worsened|1|||
156728204|NCT00423332|565754023|FG001|Overall Study|Condition under investigation worsened|1|||
156728205|NCT00423332|565754022|FG000|Overall Study|Progressive at Week 6|0|||
156728206|NCT00423332|565754023|FG001|Overall Study|Progressive at Week 6|1|||
156728207|NCT00423332|565754022|FG000|Overall Study|Unblinded before 12 weeks|1|||
156728208|NCT00423332|565754023|FG001|Overall Study|Unblinded before 12 weeks|3|||
156728209|NCT00685399|565754026|FG000|Treatment Period 1|Withdrawal by Subject|2|||
156728210|NCT00685399|565754027|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156728211|NCT00685399|565754028|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156728212|NCT00685399|565754029|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156728213|NCT00685399|565754030|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156728214|NCT00685399|565754031|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156728215|NCT00685399|565754032|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156728216|NCT00685399|565754033|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156728217|NCT00685399|565754026|FG000|Treatment Period 1|Protocol Violation|1|||
156728218|NCT00685399|565754027|FG001|Treatment Period 1|Protocol Violation|0|||
156728219|NCT00685399|565754028|FG002|Treatment Period 1|Protocol Violation|0|||
156728220|NCT00685399|565754029|FG003|Treatment Period 1|Protocol Violation|0|||
156728221|NCT00685399|565754030|FG004|Treatment Period 1|Protocol Violation|0|||
156728222|NCT00685399|565754031|FG005|Treatment Period 1|Protocol Violation|0|||
156728223|NCT00685399|565754032|FG006|Treatment Period 1|Protocol Violation|0|||
156728224|NCT00685399|565754033|FG007|Treatment Period 1|Protocol Violation|0|||
156728225|NCT00685399|565754026|FG000|Treatment Period 1|Administrative|2|||
156728226|NCT00685399|565754027|FG001|Treatment Period 1|Administrative|0|||
156728227|NCT00685399|565754028|FG002|Treatment Period 1|Administrative|0|||
156728228|NCT00685399|565754029|FG003|Treatment Period 1|Administrative|0|||
156728229|NCT00685399|565754030|FG004|Treatment Period 1|Administrative|0|||
156728230|NCT00685399|565754031|FG005|Treatment Period 1|Administrative|0|||
156728231|NCT00685399|565754032|FG006|Treatment Period 1|Administrative|0|||
156728232|NCT00685399|565754033|FG007|Treatment Period 1|Administrative|0|||
156728233|NCT00685399|565754026|FG000|Treatment Period 1|Lack of Efficacy|1|||
156728234|NCT00685399|565754027|FG001|Treatment Period 1|Lack of Efficacy|0|||
156728235|NCT00685399|565754028|FG002|Treatment Period 1|Lack of Efficacy|0|||
156728236|NCT00685399|565754029|FG003|Treatment Period 1|Lack of Efficacy|0|||
156728237|NCT00685399|565754030|FG004|Treatment Period 1|Lack of Efficacy|0|||
156728238|NCT00685399|565754031|FG005|Treatment Period 1|Lack of Efficacy|0|||
156728239|NCT00685399|565754032|FG006|Treatment Period 1|Lack of Efficacy|0|||
156728240|NCT00685399|565754033|FG007|Treatment Period 1|Lack of Efficacy|0|||
156728241|NCT00685399|565754026|FG000|Treatment Period 2|Administrative Problems|0|||
156728242|NCT00685399|565754027|FG001|Treatment Period 2|Administrative Problems|2|||
156728243|NCT00685399|565754028|FG002|Treatment Period 2|Administrative Problems|1|||
156728244|NCT00685399|565754029|FG003|Treatment Period 2|Administrative Problems|0|||
156728245|NCT00685399|565754030|FG004|Treatment Period 2|Administrative Problems|0|||
156728246|NCT00685399|565754031|FG005|Treatment Period 2|Administrative Problems|0|||
156728247|NCT00685399|565754032|FG006|Treatment Period 2|Administrative Problems|0|||
156728248|NCT00685399|565754033|FG007|Treatment Period 2|Administrative Problems|0|||
156728249|NCT00685399|565754026|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156728250|NCT00685399|565754027|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156728251|NCT00685399|565754028|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156728252|NCT00685399|565754029|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156728253|NCT00685399|565754030|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156728254|NCT00685399|565754031|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156728255|NCT00685399|565754032|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156728256|NCT00685399|565754033|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156728257|NCT00685399|565754026|FG000|Treatment Period 2|Adverse Event|0|||
156728258|NCT00685399|565754027|FG001|Treatment Period 2|Adverse Event|0|||
156728259|NCT00685399|565754028|FG002|Treatment Period 2|Adverse Event|0|||
156728260|NCT00685399|565754029|FG003|Treatment Period 2|Adverse Event|0|||
156728261|NCT00685399|565754030|FG004|Treatment Period 2|Adverse Event|0|||
156728262|NCT00685399|565754031|FG005|Treatment Period 2|Adverse Event|1|||
156728263|NCT00685399|565754032|FG006|Treatment Period 2|Adverse Event|0|||
156728264|NCT00685399|565754033|FG007|Treatment Period 2|Adverse Event|0|||
156728265|NCT00685399|565754026|FG000|Treatment Period 2|Lack of Efficacy|0|||
156795927|NCT01435356|566006212|FG001|Overall Study|Protocol Violation|1|||
156795928|NCT01435356|566006211|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
156808808|NCT01484496|566054473|FG000|Period 1|Physician Decision|5|||
156728266|NCT00685399|565754027|FG001|Treatment Period 2|Lack of Efficacy|10|||
156728267|NCT00685399|565754028|FG002|Treatment Period 2|Lack of Efficacy|2|||
156728268|NCT00685399|565754029|FG003|Treatment Period 2|Lack of Efficacy|0|||
156728269|NCT00685399|565754030|FG004|Treatment Period 2|Lack of Efficacy|0|||
156728270|NCT00685399|565754031|FG005|Treatment Period 2|Lack of Efficacy|1|||
156728271|NCT00685399|565754032|FG006|Treatment Period 2|Lack of Efficacy|0|||
157139086|NCT01451645|567254498|FG001|Overall Study|Adverse Event|3|||
157139087|NCT01451645|567254497|FG000|Overall Study|Withdrawal by Subject|4|||
157139088|NCT01451645|567254498|FG001|Overall Study|Withdrawal by Subject|2|||
157139089|NCT01451645|567254497|FG000|Overall Study|Lost to Follow-up|4|||
157139090|NCT01451645|567254498|FG001|Overall Study|Lost to Follow-up|3|||
157139091|NCT04919564|567254502|FG000|Overall Study|Lost to Follow-up|1|||
157139092|NCT04919564|567254503|FG001|Overall Study|Lost to Follow-up|0|||
157139093|NCT04919564|567254502|FG000|Overall Study|Physician Decision|1|||
157139094|NCT04919564|567254503|FG001|Overall Study|Physician Decision|1|||
157139095|NCT01241786|567254509|FG000|Overall Study|Lack of Efficacy|5|||
157139096|NCT02203149|567254510|FG000|Part 1|Adverse Event|0|||
157139097|NCT02203149|567254511|FG001|Part 1|Adverse Event|1|||
157139098|NCT02203149|567254512|FG002|Part 1|Adverse Event|0|||
157139099|NCT02203149|567254513|FG003|Part 1|Adverse Event|0|||
157139100|NCT02203149|567254514|FG004|Part 1|Adverse Event|0|||
157139101|NCT02203149|567254510|FG000|Part 2|Death|0|||
157139102|NCT02203149|567254511|FG001|Part 2|Death|0|||
157139103|NCT02203149|567254512|FG002|Part 2|Death|1|||
157139104|NCT02203149|567254513|FG003|Part 2|Death|1|||
157139105|NCT02203149|567254514|FG004|Part 2|Death|0|||
157139106|NCT02203149|567254510|FG000|Part 2|Withdrawal by Subject|0|||
157139107|NCT02203149|567254511|FG001|Part 2|Withdrawal by Subject|0|||
157139108|NCT02203149|567254512|FG002|Part 2|Withdrawal by Subject|0|||
157139109|NCT02203149|567254513|FG003|Part 2|Withdrawal by Subject|1|||
157139110|NCT02203149|567254514|FG004|Part 2|Withdrawal by Subject|0|||
157139111|NCT02203149|567254510|FG000|Part 2|Adverse Event|0|||
157139112|NCT02203149|567254511|FG001|Part 2|Adverse Event|0|||
157139113|NCT02203149|567254512|FG002|Part 2|Adverse Event|0|||
157139114|NCT02203149|567254513|FG003|Part 2|Adverse Event|1|||
157139115|NCT02203149|567254514|FG004|Part 2|Adverse Event|1|||
157139116|NCT02537678|567254515|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
157139117|NCT02537678|567254516|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
157139118|NCT02537678|567254515|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
157139119|NCT02537678|567254516|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
157139120|NCT02537678|567254515|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
157139121|NCT02537678|567254516|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
157139122|NCT02537678|567254515|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
157139123|NCT02537678|567254516|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
157139124|NCT02537678|567254515|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
157139125|NCT02537678|567254516|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
157139126|NCT02537678|567254515|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
157139127|NCT02537678|567254516|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
157139128|NCT02537678|567254515|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
157139129|NCT02537678|567254516|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
157139130|NCT00432809|567254517|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
157139131|NCT00432809|567254518|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
157139132|NCT00432809|567254519|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
156728272|NCT00685399|565754033|FG007|Treatment Period 2|Lack of Efficacy|0|||
156728273|NCT00685399|565754026|FG000|Extension|Administrative Issues|0|||
156728274|NCT00685399|565754027|FG001|Extension|Administrative Issues|0|||
156728275|NCT00685399|565754028|FG002|Extension|Administrative Issues|0|||
156728276|NCT00685399|565754029|FG003|Extension|Administrative Issues|1|||
156728277|NCT00685399|565754030|FG004|Extension|Administrative Issues|0|||
156728278|NCT00685399|565754031|FG005|Extension|Administrative Issues|0|||
157139133|NCT00432809|567254517|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
157139134|NCT00432809|567254518|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
157217437|NCT01621490|567543226|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156728279|NCT00685399|565754032|FG006|Extension|Administrative Issues|0|||
156728280|NCT00685399|565754033|FG007|Extension|Administrative Issues|0|||
156728281|NCT00685399|565754026|FG000|Extension|Withdrawal by Subject|0|||
156728282|NCT00685399|565754027|FG001|Extension|Withdrawal by Subject|0|||
156728283|NCT00685399|565754028|FG002|Extension|Withdrawal by Subject|0|||
156728284|NCT00685399|565754029|FG003|Extension|Withdrawal by Subject|1|||
156728285|NCT00685399|565754030|FG004|Extension|Withdrawal by Subject|0|||
156728286|NCT00685399|565754031|FG005|Extension|Withdrawal by Subject|0|||
156728287|NCT00685399|565754032|FG006|Extension|Withdrawal by Subject|0|||
156728288|NCT00685399|565754033|FG007|Extension|Withdrawal by Subject|0|||
156728289|NCT00685399|565754026|FG000|Extension|Protocol Violation|0|||
156728290|NCT00685399|565754027|FG001|Extension|Protocol Violation|0|||
156728291|NCT00685399|565754028|FG002|Extension|Protocol Violation|0|||
157139135|NCT00432809|567254519|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
157139136|NCT01658514|567254520|FG000|Overall Study|Protocol Violation|1|||
156728292|NCT00685399|565754029|FG003|Extension|Protocol Violation|1|||
156728293|NCT00685399|565754030|FG004|Extension|Protocol Violation|0|||
156728294|NCT00685399|565754031|FG005|Extension|Protocol Violation|0|||
156728295|NCT00685399|565754032|FG006|Extension|Protocol Violation|0|||
157139137|NCT01658514|567254521|FG001|Overall Study|Protocol Violation|0|||
157139138|NCT01658514|567254522|FG002|Overall Study|Protocol Violation|2|||
157139139|NCT00144170|567254523|FG000|Overall Study|Adverse Event|84|||
157139140|NCT00144170|567254524|FG001|Overall Study|Adverse Event|41|||
157139141|NCT00144170|567254523|FG000|Overall Study|Protocol Violation|23|||
157139142|NCT00144170|567254524|FG001|Overall Study|Protocol Violation|16|||
157139143|NCT00144170|567254523|FG000|Overall Study|Lost to Follow-up|5|||
157217438|NCT01621490|567543227|FG005|Overall Study|Adverse event unrelated to study drug|0|||
156728296|NCT00685399|565754033|FG007|Extension|Protocol Violation|0|||
156728297|NCT00685399|565754026|FG000|Extension|Lack of Efficacy|0|||
156728298|NCT00685399|565754027|FG001|Extension|Lack of Efficacy|0|||
156728299|NCT00685399|565754028|FG002|Extension|Lack of Efficacy|0|||
156728300|NCT00685399|565754029|FG003|Extension|Lack of Efficacy|2|||
156728301|NCT00685399|565754030|FG004|Extension|Lack of Efficacy|0|||
156728302|NCT00685399|565754031|FG005|Extension|Lack of Efficacy|0|||
156728303|NCT00685399|565754032|FG006|Extension|Lack of Efficacy|0|||
156728304|NCT00685399|565754033|FG007|Extension|Lack of Efficacy|0|||
156728305|NCT00685399|565754026|FG000|Extension|Adverse Event|0|||
156728306|NCT00685399|565754027|FG001|Extension|Adverse Event|0|||
156728307|NCT00685399|565754028|FG002|Extension|Adverse Event|0|||
156728308|NCT00685399|565754029|FG003|Extension|Adverse Event|2|||
156728309|NCT00685399|565754030|FG004|Extension|Adverse Event|0|||
156728310|NCT00685399|565754031|FG005|Extension|Adverse Event|0|||
156728311|NCT00685399|565754032|FG006|Extension|Adverse Event|0|||
156728312|NCT00685399|565754033|FG007|Extension|Adverse Event|0|||
156728313|NCT02993250|565754034|FG000|Overall Study|Lost to Follow-up|0|||
156728314|NCT02993250|565754035|FG001|Overall Study|Lost to Follow-up|1|||
156795929|NCT01435356|566006212|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
156795930|NCT01435356|566006211|FG000|Overall Study|Withdrawal by Subject|1|||
156795931|NCT01435356|566006212|FG001|Overall Study|Withdrawal by Subject|1|||
156795932|NCT01435356|566006211|FG000|Overall Study|Facial palsy|1|||
156795933|NCT01435356|566006212|FG001|Overall Study|Facial palsy|0|||
156876363|NCT00545272|566305800|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156876364|NCT00545272|566305801|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156876365|NCT00545272|566305802|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156876366|NCT00545272|566305803|FG004|Overall Study|Abnormal test procedure result(s)|1|||
156876367|NCT00545272|566305804|FG005|Overall Study|Abnormal test procedure result(s)|0|||
156876368|NCT00545272|566305799|FG000|Overall Study|Lost to Follow-up|0|||
156876369|NCT00545272|566305800|FG001|Overall Study|Lost to Follow-up|0|||
156876370|NCT00545272|566305801|FG002|Overall Study|Lost to Follow-up|0|||
156876371|NCT00545272|566305802|FG003|Overall Study|Lost to Follow-up|0|||
156876372|NCT00545272|566305803|FG004|Overall Study|Lost to Follow-up|1|||
156876373|NCT00545272|566305804|FG005|Overall Study|Lost to Follow-up|0|||
156876374|NCT02314637|566305805|FG000|Overall Study|Adverse Event|4|||
156876375|NCT02314637|566305806|FG001|Overall Study|Adverse Event|8|||
156876376|NCT02314637|566305805|FG000|Overall Study|Lack of Efficacy|1|||
156876377|NCT02314637|566305806|FG001|Overall Study|Lack of Efficacy|0|||
156876378|NCT02314637|566305805|FG000|Overall Study|Physician Decision|5|||
156876379|NCT02314637|566305806|FG001|Overall Study|Physician Decision|2|||
156876380|NCT02314637|566305805|FG000|Overall Study|Withdrawal by Subject|5|||
156876381|NCT02314637|566305806|FG001|Overall Study|Withdrawal by Subject|4|||
156876382|NCT02314637|566305805|FG000|Overall Study|Other Reason|1|||
157139144|NCT00144170|567254524|FG001|Overall Study|Lost to Follow-up|10|||
156795934|NCT01435356|566006211|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
156795935|NCT01435356|566006212|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
156795936|NCT01435356|566006211|FG000|Overall Study|Physician Decision|1|||
156795937|NCT01435356|566006212|FG001|Overall Study|Physician Decision|0|||
156795938|NCT01435356|566006211|FG000|Overall Study|Patient decision|3|||
156795939|NCT01435356|566006212|FG001|Overall Study|Patient decision|0|||
156795940|NCT01435356|566006211|FG000|Overall Study|Patient moved to another city|1|||
156795941|NCT01435356|566006212|FG001|Overall Study|Patient moved to another city|1|||
156795942|NCT02796651|566006213|FG000|Overall Study|Adverse Event|6|||
156795943|NCT02796651|566006213|FG000|Overall Study|Lost to Follow-up|1|||
156795944|NCT02796651|566006213|FG000|Overall Study|Withdrawal by Subject|4|||
156795945|NCT02796651|566006213|FG000|Overall Study|Protocol Violation|4|||
156876383|NCT02314637|566305806|FG001|Overall Study|Other Reason|0|||
156876384|NCT02934503|566305807|FG000|Overall Study|progression of disease|3|||
156876385|NCT02934503|566305807|FG000|Overall Study|Withdrawal by Subject|1|||
156876386|NCT00724867|566305808|FG000|Overall Study|Adverse Event|25|||
157139145|NCT00144170|567254523|FG000|Overall Study|Withdrawal by Subject|29|||
156728315|NCT00356148|565754036|FG000|Overall Study|Reoperation within 30 days|2|||
156728316|NCT00356148|565754037|FG001|Overall Study|Reoperation within 30 days|1|||
156795946|NCT02796651|566006213|FG000|Overall Study|Lack of Efficacy|1|||
156795947|NCT02796651|566006213|FG000|Overall Study|Other|10|||
156795948|NCT02251041|566006217|FG000|Overall Study|Did not receive intervention|15|||
157139146|NCT00144170|567254524|FG001|Overall Study|Withdrawal by Subject|13|||
156728317|NCT02737930|565754039|FG000|Overall Study|Withdrawal by Subject|0|||
156728318|NCT02737930|565754040|FG001|Overall Study|Withdrawal by Subject|1|||
156728319|NCT04481789|565754041|FG000|Period 1|Withdrawal by Subject|1|||
156728320|NCT04481789|565754042|FG001|Period 1|Withdrawal by Subject|0|||
156728321|NCT04481789|565754043|FG002|Period 1|Withdrawal by Subject|0|||
156728322|NCT04481789|565754044|FG003|Period 1|Withdrawal by Subject|0|||
156728323|NCT04481789|565754045|FG004|Period 1|Withdrawal by Subject|0|||
156728324|NCT04481789|565754046|FG005|Period 1|Withdrawal by Subject|0|||
156728325|NCT03124407|565754051|FG000|Overall Study|Lost to Follow-up|1|||
156728326|NCT03124407|565754052|FG001|Overall Study|Lost to Follow-up|0|||
156728327|NCT03124407|565754053|FG002|Overall Study|Lost to Follow-up|0|||
156795949|NCT02251041|566006218|FG001|Overall Study|Did not receive intervention|4|||
156795950|NCT02971163|566006221|FG000|Overall Study|Lost to Follow-up|4|||
156795951|NCT02971163|566006222|FG001|Overall Study|Lost to Follow-up|2|||
156795952|NCT00526799|566006223|FG000|Overall Study|Withdrawal by Subject|1|||
156795953|NCT00526799|566006224|FG001|Overall Study|Withdrawal by Subject|0|||
156795954|NCT00526799|566006223|FG000|Overall Study|Intercurrent Complicating Disease|0|||
156795955|NCT00526799|566006224|FG001|Overall Study|Intercurrent Complicating Disease|1|||
156795956|NCT02871219|566006226|FG000|Overall Study|Adverse Event|15|||
156795957|NCT02871219|566006226|FG000|Overall Study|Death|3|||
156795958|NCT02871219|566006226|FG000|Overall Study|Progression|3|||
156795959|NCT02871219|566006226|FG000|Overall Study|Infections|7|||
156795960|NCT02871219|566006226|FG000|Overall Study|Infusion Related|4|||
156795961|NCT00050011|566006228|FG000|Overall Study|Adverse Event|41|||
156795962|NCT00050011|566006229|FG001|Overall Study|Adverse Event|46|||
156795963|NCT00050011|566006228|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156795964|NCT00050011|566006229|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156795965|NCT00050011|566006228|FG000|Overall Study|Abnormal test procedure results|0|||
156795966|NCT00050011|566006229|FG001|Overall Study|Abnormal test procedure results|1|||
156795967|NCT00050011|566006228|FG000|Overall Study|Lack of Efficacy|16|||
156795968|NCT00050011|566006229|FG001|Overall Study|Lack of Efficacy|21|||
156795969|NCT00050011|566006228|FG000|Overall Study|Participant condition no longer required|1|||
156795970|NCT00050011|566006229|FG001|Overall Study|Participant condition no longer required|0|||
156795971|NCT00050011|566006228|FG000|Overall Study|Protocol Violation|4|||
156795972|NCT00050011|566006229|FG001|Overall Study|Protocol Violation|10|||
156795973|NCT00050011|566006228|FG000|Overall Study|Withdrawal by Subject|34|||
156795974|NCT00050011|566006229|FG001|Overall Study|Withdrawal by Subject|26|||
156795975|NCT00050011|566006228|FG000|Overall Study|Lost to Follow-up|7|||
156795976|NCT00050011|566006229|FG001|Overall Study|Lost to Follow-up|9|||
156795977|NCT00050011|566006228|FG000|Overall Study|Administrative problems|10|||
156795978|NCT00050011|566006229|FG001|Overall Study|Administrative problems|6|||
156795979|NCT00050011|566006228|FG000|Overall Study|Death|7|||
156795980|NCT00050011|566006229|FG001|Overall Study|Death|4|||
156795981|NCT00050011|566006228|FG000|Overall Study|Unknown - Reason is missing|0|||
156795982|NCT00050011|566006229|FG001|Overall Study|Unknown - Reason is missing|2|||
156795983|NCT00835354|566006230|FG000|First Intervention|Adverse Event|0|||
156795984|NCT00835354|566006231|FG001|First Intervention|Adverse Event|1|||
156795985|NCT02061085|566006232|FG000|Overall Study|Adverse Event|8|||
156795986|NCT02038036|566006234|FG000|Core Study|Adverse Event|7|||
156795987|NCT02038036|566006235|FG001|Core Study|Adverse Event|7|||
156795988|NCT02038036|566006234|FG000|Core Study|Death|1|||
156795989|NCT02038036|566006235|FG001|Core Study|Death|1|||
156795990|NCT02038036|566006234|FG000|Core Study|Disease progression|2|||
156795991|NCT02038036|566006235|FG001|Core Study|Disease progression|2|||
156795992|NCT02038036|566006234|FG000|Core Study|Lost to Follow-up|0|||
156795993|NCT02038036|566006235|FG001|Core Study|Lost to Follow-up|1|||
156795994|NCT02038036|566006234|FG000|Core Study|Physician Decision|2|||
156795995|NCT02038036|566006235|FG001|Core Study|Physician Decision|1|||
156795996|NCT02038036|566006234|FG000|Core Study|Subject/guardian decision|0|||
156795997|NCT02038036|566006235|FG001|Core Study|Subject/guardian decision|1|||
156795998|NCT02038036|566006234|FG000|Core Study|Withdrawal by Subject|3|||
156876387|NCT00724867|566305808|FG000|Overall Study|Lack of Efficacy|14|||
156876388|NCT00724867|566305808|FG000|Overall Study|Lost to Follow-up|12|||
156795999|NCT02038036|566006235|FG001|Core Study|Withdrawal by Subject|1|||
156796000|NCT02038036|566006234|FG000|Crossover Period|Withdrawal by Subject|0|||
156796001|NCT02038036|566006235|FG001|Crossover Period|Withdrawal by Subject|3|||
156796002|NCT02038036|566006234|FG000|Crossover Period|Adverse Event|0|||
156796003|NCT02038036|566006235|FG001|Crossover Period|Adverse Event|9|||
156876389|NCT00724867|566305808|FG000|Overall Study|Non-compliance with study drug|6|||
156728328|NCT03124407|565754054|FG003|Overall Study|Lost to Follow-up|0|||
156796004|NCT02038036|566006234|FG000|Crossover Period|Death|0|||
156796005|NCT02038036|566006235|FG001|Crossover Period|Death|2|||
156796006|NCT02038036|566006234|FG000|Crossover Period|Disease progression|0|||
156796007|NCT02038036|566006235|FG001|Crossover Period|Disease progression|3|||
156796008|NCT02038036|566006234|FG000|Crossover Period|Lost to Follow-up|0|||
156796009|NCT02038036|566006235|FG001|Crossover Period|Lost to Follow-up|1|||
156796010|NCT02038036|566006234|FG000|Crossover Period|Physician Decision|0|||
156796011|NCT02038036|566006235|FG001|Crossover Period|Physician Decision|2|||
156796012|NCT02613507|566006240|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
156796013|NCT02613507|566006241|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
157139147|NCT00144170|567254523|FG000|Overall Study|Other reason not defined above|211|||
157139148|NCT00144170|567254524|FG001|Overall Study|Other reason not defined above|316|||
157139149|NCT00981526|567254525|FG000|Overall Study|Withdrawal by Subject|0|||
157139150|NCT00981526|567254526|FG001|Overall Study|Withdrawal by Subject|2|||
156728329|NCT03124407|565754051|FG000|Overall Study|Adverse Event|0|||
156728330|NCT03124407|565754052|FG001|Overall Study|Adverse Event|0|||
156728331|NCT03124407|565754053|FG002|Overall Study|Adverse Event|1|||
156728332|NCT03124407|565754054|FG003|Overall Study|Adverse Event|0|||
157139151|NCT00981526|567254525|FG000|Overall Study|Physician Decision|4|||
157139152|NCT00981526|567254526|FG001|Overall Study|Physician Decision|4|||
157139153|NCT00332202|567254527|FG000|Overall Study|Adverse Event|72|||
157139154|NCT00332202|567254528|FG001|Overall Study|Adverse Event|28|||
157139155|NCT00332202|567254527|FG000|Overall Study|Lost to Follow-up|2|||
157139156|NCT00332202|567254528|FG001|Overall Study|Lost to Follow-up|1|||
157139157|NCT00332202|567254527|FG000|Overall Study|Physician Decision|6|||
157139158|NCT00332202|567254528|FG001|Overall Study|Physician Decision|8|||
157139159|NCT00332202|567254527|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
157139160|NCT00332202|567254528|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
157139161|NCT00332202|567254527|FG000|Overall Study|Protocol Violation|7|||
157139162|NCT00332202|567254528|FG001|Overall Study|Protocol Violation|2|||
157139163|NCT00332202|567254527|FG000|Overall Study|Sponsor Decision|1|||
157139164|NCT00332202|567254528|FG001|Overall Study|Sponsor Decision|2|||
157139165|NCT00332202|567254527|FG000|Overall Study|Withdrawal by Subject|36|||
157139166|NCT00332202|567254528|FG001|Overall Study|Withdrawal by Subject|17|||
157139167|NCT00332202|567254527|FG000|Overall Study|Progressive Disease|106|||
157139168|NCT00332202|567254528|FG001|Overall Study|Progressive Disease|60|||
157139169|NCT00332202|567254527|FG000|Overall Study|Death|5|||
157139170|NCT00332202|567254528|FG001|Overall Study|Death|2|||
157139171|NCT00957853|567254529|FG000|Overall Study|Withdrawal by Subject|1|||
157139172|NCT00957853|567254530|FG001|Overall Study|Withdrawal by Subject|0|||
157139173|NCT00957853|567254531|FG002|Overall Study|Withdrawal by Subject|0|||
157139174|NCT02495948|567254534|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
157139175|NCT02495948|567254535|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
157139176|NCT02495948|567254534|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
157139177|NCT02495948|567254535|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
157139178|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
157139179|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
157139180|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
157139181|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
157139182|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
157139183|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
157139184|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
157139185|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
157139186|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
157139187|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
157139188|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
157139189|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
157139190|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
157139191|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
157139192|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
157139193|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
157139194|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
157139195|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
157139196|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
157139197|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
157139198|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
156728333|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
156728334|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
157139199|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
157139200|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
157139201|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
157139202|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
157139203|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
157139204|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
157139205|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
157139206|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
157139207|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
156728335|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728336|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
157139208|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
157139209|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
156876390|NCT00724867|566305808|FG000|Overall Study|Physician Decision|17|||
156876391|NCT00724867|566305808|FG000|Overall Study|Protocol Violation|1|||
156876392|NCT00724867|566305808|FG000|Overall Study|Withdrawal by Subject|31|||
156876393|NCT00724867|566305808|FG000|Overall Study|Sponsor decision to end study|14|||
156876394|NCT00724867|566305808|FG000|Overall Study|Subject incarcerated|1|||
157139210|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
157139211|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
157139212|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
157139213|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
157139214|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
157139215|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
157139216|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
157139217|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
157139218|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
157139219|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
157139220|NCT00100048|567254537|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
157139221|NCT00100048|567254538|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
157139222|NCT00100048|567254539|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
157139223|NCT00100048|567254540|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
157139224|NCT00100048|567254541|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
157139225|NCT00100048|567254542|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
157139226|NCT02970929|567254544|FG000|Overall Study|Adverse Event|18|||
157139227|NCT02970929|567254544|FG000|Overall Study|Lack of Efficacy|8|||
157139228|NCT02970929|567254544|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
157139229|NCT02970929|567254544|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
157145171|NCT05755438|567278013|FG001|40-week OLE Period|Withdrawal by Subject|6|||
156728337|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728338|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
156728339|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
156728340|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
156728341|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728342|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728343|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728344|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
156728345|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
156728346|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
156728347|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728348|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728349|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728350|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728351|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728352|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728353|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728354|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728355|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728356|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728357|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
156728358|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
156728359|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728360|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728361|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728362|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
156728363|NCT02105987|565754058|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728364|NCT02105987|565754059|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
156728365|NCT02105987|565754060|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728366|NCT02105987|565754061|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728367|NCT02105987|565754062|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728368|NCT02105987|565754063|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
156728369|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728370|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728371|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
156876395|NCT00724867|566305808|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
156876396|NCT00724867|566305808|FG000|Overall Study|Subject moved out of state|1|||
156876397|NCT00724867|566305808|FG000|Overall Study|Elected to exit due to site closure|2|||
156876398|NCT00436345|566305809|FG000|Overall Study|ICU resident beyond follow-up period|3|||
156876399|NCT00436345|566305810|FG001|Overall Study|ICU resident beyond follow-up period|0|||
156728372|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
156728373|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728374|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
156728375|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728376|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728377|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
156728378|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
156728379|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728380|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
156728381|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728382|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728383|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
156728384|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
156728385|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728386|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
156728387|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728388|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728389|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
156728390|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
156728391|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728392|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
156728393|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728394|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728395|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
156728396|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728397|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728398|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
156728399|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728400|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728401|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728402|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
156728403|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728404|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
156728405|NCT02105987|565754058|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728406|NCT02105987|565754059|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728407|NCT02105987|565754060|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
156728408|NCT02105987|565754061|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728409|NCT02105987|565754062|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728410|NCT02105987|565754063|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
156728411|NCT02105987|565754058|FG000|Continuation Phase|Protocol Violation|0|||
156728412|NCT02105987|565754059|FG001|Continuation Phase|Protocol Violation|0|||
156796014|NCT02613507|566006240|FG000|Pre-Treamtent|Participant withdrew consent|0|||
156796015|NCT02613507|566006241|FG001|Pre-Treamtent|Participant withdrew consent|4|||
156796016|NCT02613507|566006240|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
156796017|NCT02613507|566006241|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
156796018|NCT02613507|566006240|FG000|Treatment|Not reported|3|||
156796019|NCT02613507|566006241|FG001|Treatment|Not reported|0|||
156796020|NCT02613507|566006240|FG000|Treatment|Other reasons|8|||
156796021|NCT02613507|566006241|FG001|Treatment|Other reasons|0|||
156796022|NCT02613507|566006240|FG000|Treatment|Participant no longer meets criteria|3|||
156796023|NCT02613507|566006241|FG001|Treatment|Participant no longer meets criteria|0|||
156796024|NCT02613507|566006240|FG000|Treatment|Maximum clinical benefit|5|||
156796025|NCT02613507|566006241|FG001|Treatment|Maximum clinical benefit|10|||
156796026|NCT02613507|566006240|FG000|Treatment|Lost to Follow-up|1|||
156796027|NCT02613507|566006241|FG001|Treatment|Lost to Follow-up|0|||
156796028|NCT02613507|566006240|FG000|Treatment|Participant withdrew consent|0|||
156796029|NCT02613507|566006241|FG001|Treatment|Participant withdrew consent|2|||
156796030|NCT02613507|566006240|FG000|Treatment|Participant request to discontinue study treatment|13|||
156796031|NCT02613507|566006241|FG001|Treatment|Participant request to discontinue study treatment|17|||
156796032|NCT02613507|566006240|FG000|Treatment|Adverse event unrelated to study drug|20|||
156796033|NCT02613507|566006241|FG001|Treatment|Adverse event unrelated to study drug|3|||
156796034|NCT02613507|566006240|FG000|Treatment|Death|2|||
156728413|NCT02105987|565754060|FG002|Continuation Phase|Protocol Violation|0|||
156796035|NCT02613507|566006241|FG001|Treatment|Death|0|||
156796036|NCT02613507|566006240|FG000|Treatment|Study drug toxicity|19|||
156796037|NCT02613507|566006241|FG001|Treatment|Study drug toxicity|14|||
156796038|NCT02613507|566006240|FG000|Treatment|Disease progression|263|||
156796039|NCT02613507|566006241|FG001|Treatment|Disease progression|110|||
156796040|NCT03648372|566006257|FG000|Overall Study|Withdrawal by Subject|2|||
156796041|NCT03648372|566006258|FG001|Overall Study|Withdrawal by Subject|0|||
156796042|NCT03648372|566006259|FG002|Overall Study|Withdrawal by Subject|0|||
156728414|NCT02105987|565754061|FG003|Continuation Phase|Protocol Violation|0|||
156728415|NCT02105987|565754062|FG004|Continuation Phase|Protocol Violation|1|||
156728416|NCT02105987|565754063|FG005|Continuation Phase|Protocol Violation|0|||
156728417|NCT00984542|565754076|FG000|Overall Study|disease progression|19|||
156728418|NCT00984542|565754076|FG000|Overall Study|toxicity|7|||
156728419|NCT00984542|565754076|FG000|Overall Study|Death|7|||
156728420|NCT00984542|565754076|FG000|Overall Study|complicating disease|3|||
156728421|NCT00984542|565754076|FG000|Overall Study|Withdrawal by Subject|3|||
156728422|NCT00984542|565754076|FG000|Overall Study|clinical deterioration|2|||
156728423|NCT02097745|565754081|FG000|Overall Study|Adverse Event|25|||
156728424|NCT02097745|565754081|FG000|Overall Study|Death|16|||
156728425|NCT02097745|565754081|FG000|Overall Study|Failure to Return|14|||
156728426|NCT02097745|565754081|FG000|Overall Study|Administrative/Other|27|||
156728427|NCT02097745|565754081|FG000|Overall Study|Reason Not Specified|96|||
156728428|NCT04468347|565754084|FG000|Overall Study|Withdrawal by Subject|0|||
156728429|NCT04468347|565754085|FG001|Overall Study|Withdrawal by Subject|1|||
156728430|NCT04468347|565754086|FG002|Overall Study|Withdrawal by Subject|3|||
156728431|NCT04468347|565754087|FG003|Overall Study|Withdrawal by Subject|3|||
156728432|NCT04468347|565754084|FG000|Overall Study|Lost to Follow-up|0|||
156728433|NCT04468347|565754085|FG001|Overall Study|Lost to Follow-up|0|||
156728434|NCT04468347|565754086|FG002|Overall Study|Lost to Follow-up|1|||
156728435|NCT04468347|565754087|FG003|Overall Study|Lost to Follow-up|1|||
156728436|NCT04468347|565754084|FG000|Overall Study|Physician Decision|1|||
156728437|NCT04468347|565754085|FG001|Overall Study|Physician Decision|0|||
156728438|NCT04468347|565754086|FG002|Overall Study|Physician Decision|2|||
156728439|NCT04468347|565754087|FG003|Overall Study|Physician Decision|0|||
156728440|NCT04468347|565754084|FG000|Overall Study|Protocol Violation|1|||
156728441|NCT04468347|565754085|FG001|Overall Study|Protocol Violation|0|||
156728442|NCT04468347|565754086|FG002|Overall Study|Protocol Violation|0|||
157139230|NCT02970929|567254544|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
157139231|NCT02970929|567254544|FG000|Overall Study|LOST TO FOLLOWUP|6|||
157139232|NCT02970929|567254544|FG000|Overall Study|MOVED OUT OF STATE|1|||
157139233|NCT02970929|567254544|FG000|Overall Study|Withdrawal by Subject|16|||
157139234|NCT02370121|567254553|FG000|Overall Study|Lost to Follow-up|1|||
157139235|NCT02370121|567254554|FG001|Overall Study|Lost to Follow-up|1|||
157139236|NCT02654002|567254557|FG000|Overall Study|Adverse Event|0|||
157139237|NCT02654002|567254558|FG001|Overall Study|Adverse Event|0|||
157139238|NCT02654002|567254559|FG002|Overall Study|Adverse Event|0|||
156728443|NCT04468347|565754087|FG003|Overall Study|Protocol Violation|0|||
156728444|NCT02505217|565754088|FG000|Overall Study|Withdrawal by Subject|1|||
156728445|NCT02505217|565754089|FG001|Overall Study|Withdrawal by Subject|2|||
156728446|NCT01408303|565754090|FG000|Overall Study|Adverse Event|3|||
156728447|NCT01408303|565754091|FG001|Overall Study|Adverse Event|7|||
156728448|NCT01408303|565754092|FG002|Overall Study|Adverse Event|2|||
156728449|NCT01408303|565754090|FG000|Overall Study|Lost to Follow-up|0|||
156728450|NCT01408303|565754091|FG001|Overall Study|Lost to Follow-up|1|||
156728451|NCT01408303|565754092|FG002|Overall Study|Lost to Follow-up|2|||
156728452|NCT01408303|565754090|FG000|Overall Study|Withdrawal by Subject|2|||
156728453|NCT01408303|565754091|FG001|Overall Study|Withdrawal by Subject|3|||
156728454|NCT01408303|565754092|FG002|Overall Study|Withdrawal by Subject|1|||
156728455|NCT01408303|565754090|FG000|Overall Study|Protocol Violation|0|||
156728456|NCT01408303|565754091|FG001|Overall Study|Protocol Violation|1|||
156728457|NCT01408303|565754092|FG002|Overall Study|Protocol Violation|0|||
156728458|NCT01408303|565754090|FG000|Overall Study|Noncompliance|1|||
156728459|NCT01408303|565754091|FG001|Overall Study|Noncompliance|0|||
156728460|NCT01408303|565754092|FG002|Overall Study|Noncompliance|1|||
156728461|NCT01207687|565754093|FG000|Overall Study|Adverse Event|1|||
156728462|NCT01207687|565754093|FG000|Overall Study|Withdrawal by Subject|1|||
156728463|NCT01801865|565754094|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
156728464|NCT01801865|565754094|FG000|Overall Study|Physician Decision|7|||
156728465|NCT01500382|565754097|FG000|Washout Period|Study site went out of business|0|||
156728466|NCT01500382|565754098|FG001|Washout Period|Study site went out of business|0|||
156796043|NCT03648372|566006260|FG003|Overall Study|Withdrawal by Subject|0|||
157139239|NCT02654002|567254560|FG003|Overall Study|Adverse Event|0|||
157139240|NCT02654002|567254561|FG004|Overall Study|Adverse Event|0|||
157139241|NCT02654002|567254562|FG005|Overall Study|Adverse Event|0|||
157139242|NCT02654002|567254563|FG006|Overall Study|Adverse Event|1|||
156728467|NCT01500382|565754099|FG002|Washout Period|Study site went out of business|1|||
156728468|NCT01500382|565754100|FG003|Washout Period|Study site went out of business|0|||
156728469|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
156728470|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
156728471|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
156728472|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
156728473|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
156728474|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
156728475|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
157139243|NCT02654002|567254564|FG007|Overall Study|Adverse Event|0|||
156728476|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
156728477|NCT03867201|565754103|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
156728478|NCT03867201|565754104|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
156728479|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Adverse Event|5|||
156728480|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Adverse Event|11|||
156728481|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
156728482|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
156728483|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Physician Decision|6|||
156728484|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Physician Decision|3|||
156728485|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Pregnancy|2|||
156728486|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Pregnancy|2|||
156728487|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
156728488|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
156728489|NCT03867201|565754103|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
156728490|NCT03867201|565754104|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
156728491|NCT03867201|565754103|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
156728492|NCT03867201|565754104|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
156728493|NCT03867201|565754103|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
156728494|NCT03867201|565754104|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
156728495|NCT05763875|565754109|FG000|Overall Study|Subject decision|5|||
156728496|NCT05763875|565754110|FG001|Overall Study|Subject decision|2|||
156728497|NCT05763875|565754111|FG002|Overall Study|Subject decision|1|||
156728498|NCT05763875|565754109|FG000|Overall Study|Lost to Follow-up|4|||
156728499|NCT05763875|565754110|FG001|Overall Study|Lost to Follow-up|1|||
156728500|NCT05763875|565754111|FG002|Overall Study|Lost to Follow-up|2|||
156728501|NCT05763875|565754109|FG000|Overall Study|Adverse Event|1|||
156728502|NCT05763875|565754110|FG001|Overall Study|Adverse Event|0|||
156728503|NCT05763875|565754111|FG002|Overall Study|Adverse Event|0|||
156728504|NCT01777282|565754112|FG000|Overall Study|Persistent Hyperglycemia|0|||
156728505|NCT01777282|565754113|FG001|Overall Study|Persistent Hyperglycemia|0|||
156728506|NCT01777282|565754114|FG002|Overall Study|Persistent Hyperglycemia|1|||
156728507|NCT01777282|565754115|FG003|Overall Study|Persistent Hyperglycemia|0|||
156728508|NCT01777282|565754116|FG004|Overall Study|Persistent Hyperglycemia|0|||
156728509|NCT01777282|565754112|FG000|Overall Study|New Antidiabetic Medication|0|||
156728510|NCT01777282|565754113|FG001|Overall Study|New Antidiabetic Medication|0|||
156728511|NCT01777282|565754114|FG002|Overall Study|New Antidiabetic Medication|1|||
156728512|NCT01777282|565754115|FG003|Overall Study|New Antidiabetic Medication|0|||
156728513|NCT01777282|565754116|FG004|Overall Study|New Antidiabetic Medication|0|||
156728514|NCT01777282|565754112|FG000|Overall Study|Adverse Event|4|||
156728515|NCT01777282|565754113|FG001|Overall Study|Adverse Event|4|||
156728516|NCT01777282|565754114|FG002|Overall Study|Adverse Event|2|||
156728517|NCT01777282|565754115|FG003|Overall Study|Adverse Event|1|||
156728518|NCT01777282|565754116|FG004|Overall Study|Adverse Event|3|||
156728519|NCT01777282|565754112|FG000|Overall Study|Withdrawal by Subject|4|||
156728520|NCT01777282|565754113|FG001|Overall Study|Withdrawal by Subject|0|||
156728521|NCT01777282|565754114|FG002|Overall Study|Withdrawal by Subject|0|||
156728522|NCT01777282|565754115|FG003|Overall Study|Withdrawal by Subject|1|||
156728523|NCT01777282|565754116|FG004|Overall Study|Withdrawal by Subject|2|||
156728524|NCT01777282|565754112|FG000|Overall Study|Protocol Violation|2|||
156728525|NCT01777282|565754113|FG001|Overall Study|Protocol Violation|0|||
156728526|NCT01777282|565754114|FG002|Overall Study|Protocol Violation|1|||
156728527|NCT01777282|565754115|FG003|Overall Study|Protocol Violation|0|||
156728528|NCT01777282|565754116|FG004|Overall Study|Protocol Violation|2|||
156728529|NCT01777282|565754112|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
156728530|NCT01777282|565754113|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156728531|NCT01777282|565754114|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
156728532|NCT01777282|565754115|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156728533|NCT01777282|565754116|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
156876400|NCT01311024|566305811|FG000|Overall Study|Protocol Violation|35|||
156876401|NCT01311024|566305812|FG001|Overall Study|Protocol Violation|22|||
156876402|NCT01092546|566305813|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
156876403|NCT02280408|566305814|FG000|Overall Study|Lost to Follow-up|0|||
156876404|NCT02280408|566305815|FG001|Overall Study|Lost to Follow-up|2|||
156876405|NCT02280408|566305816|FG002|Overall Study|Lost to Follow-up|0|||
156876406|NCT02280408|566305817|FG003|Overall Study|Lost to Follow-up|0|||
156876407|NCT01519869|566305818|FG000|Overall Study|Lost to Follow-up|1|||
156876408|NCT00126490|566305826|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
156728534|NCT00550745|565754117|FG000|Overall Study|Death|20|||
156728535|NCT00550745|565754118|FG001|Overall Study|Death|16|||
156728536|NCT00550745|565754117|FG000|Overall Study|Lost to Follow-up|45|||
156728537|NCT00550745|565754118|FG001|Overall Study|Lost to Follow-up|30|||
156728538|NCT00550745|565754117|FG000|Overall Study|Physician Decision|0|||
156728539|NCT00550745|565754118|FG001|Overall Study|Physician Decision|2|||
156728540|NCT00550745|565754117|FG000|Overall Study|Protocol Violation|4|||
156876409|NCT00200356|566305827|FG000|Overall Study|Lack of Efficacy|3|||
156728541|NCT00550745|565754118|FG001|Overall Study|Protocol Violation|2|||
156728542|NCT00550745|565754117|FG000|Overall Study|Withdrawal by Subject|17|||
156728543|NCT00550745|565754118|FG001|Overall Study|Withdrawal by Subject|10|||
156728544|NCT00550745|565754117|FG000|Overall Study|Screen failure|1|||
156728545|NCT00550745|565754118|FG001|Overall Study|Screen failure|0|||
156728546|NCT01131455|565754119|FG000|Overall Study|Death of PI|6|||
156728547|NCT01131455|565754120|FG001|Overall Study|Death of PI|4|||
156728548|NCT01131455|565754121|FG002|Overall Study|Death of PI|0|||
156728549|NCT00764660|565754122|FG000|Overall Study|Adverse Event|6|||
156728550|NCT00764660|565754123|FG001|Overall Study|Adverse Event|3|||
156728551|NCT00764660|565754122|FG000|Overall Study|Lost to Follow-up|3|||
156728552|NCT00764660|565754123|FG001|Overall Study|Lost to Follow-up|4|||
156728553|NCT00764660|565754122|FG000|Overall Study|Withdrawal by Subject|7|||
156728554|NCT00764660|565754123|FG001|Overall Study|Withdrawal by Subject|3|||
156728555|NCT00764660|565754122|FG000|Overall Study|Noncompliance With Protocol|5|||
156728556|NCT00764660|565754123|FG001|Overall Study|Noncompliance With Protocol|1|||
156728557|NCT00764660|565754122|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156728558|NCT00764660|565754123|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
156728559|NCT00300885|565755830|FG000|Treatment|Adverse Event|134|||
156728560|NCT00300885|565755831|FG001|Treatment|Adverse Event|82|||
156728561|NCT00300885|565755830|FG000|Treatment|Death|20|||
156728562|NCT00300885|565755831|FG001|Treatment|Death|7|||
156728563|NCT00300885|565755830|FG000|Treatment|Lack of Efficacy|1|||
156728564|NCT00300885|565755831|FG001|Treatment|Lack of Efficacy|1|||
156728565|NCT00300885|565755830|FG000|Treatment|Lost to Follow-up|3|||
156728566|NCT00300885|565755831|FG001|Treatment|Lost to Follow-up|2|||
156728567|NCT00300885|565755830|FG000|Treatment|Physician Decision|4|||
156728568|NCT00300885|565755831|FG001|Treatment|Physician Decision|5|||
156728569|NCT00300885|565755830|FG000|Treatment|Protocol Violation|11|||
156728570|NCT00300885|565755831|FG001|Treatment|Protocol Violation|11|||
156728571|NCT00300885|565755830|FG000|Treatment|Withdrawal by Subject|26|||
156728572|NCT00300885|565755831|FG001|Treatment|Withdrawal by Subject|23|||
156728573|NCT00300885|565755830|FG000|Treatment|Disease progression|171|||
156728574|NCT00300885|565755831|FG001|Treatment|Disease progression|238|||
156728575|NCT00300885|565755830|FG000|Treatment|Random code broken (subject died)|0|||
156728576|NCT00300885|565755831|FG001|Treatment|Random code broken (subject died)|1|||
156728577|NCT00300885|565755830|FG000|Treatment|Non-compliant with study medication|3|||
156728578|NCT00300885|565755831|FG001|Treatment|Non-compliant with study medication|4|||
156728579|NCT00300885|565755830|FG000|Follow-up|Death|141|||
156728580|NCT00300885|565755831|FG001|Follow-up|Death|163|||
156728581|NCT00300885|565755830|FG000|Follow-up|Lost to Follow-up|11|||
156728582|NCT00300885|565755831|FG001|Follow-up|Lost to Follow-up|7|||
156728583|NCT00300885|565755830|FG000|Follow-up|Withdrawal by Subject|26|||
156728584|NCT00300885|565755831|FG001|Follow-up|Withdrawal by Subject|25|||
156728585|NCT01637922|565755832|FG000|Overall Study|Adverse Event|0|||
156728586|NCT01637922|565755833|FG001|Overall Study|Adverse Event|1|||
156728587|NCT01637922|565755832|FG000|Overall Study|Protocol Violation|0|||
156728588|NCT01637922|565755833|FG001|Overall Study|Protocol Violation|1|||
156728589|NCT01637922|565755832|FG000|Overall Study|Withdrawal by Subject|0|||
156728590|NCT01637922|565755833|FG001|Overall Study|Withdrawal by Subject|3|||
156728591|NCT01637922|565755832|FG000|Overall Study|Lost to Follow-up|2|||
156796044|NCT03648372|566006261|FG004|Overall Study|Withdrawal by Subject|0|||
156796045|NCT03648372|566006262|FG005|Overall Study|Withdrawal by Subject|1|||
156796046|NCT03648372|566006263|FG006|Overall Study|Withdrawal by Subject|2|||
156796047|NCT03648372|566006264|FG007|Overall Study|Withdrawal by Subject|0|||
156796048|NCT03648372|566006265|FG008|Overall Study|Withdrawal by Subject|0|||
156796049|NCT03648372|566006266|FG009|Overall Study|Withdrawal by Subject|0|||
156796050|NCT03648372|566006267|FG010|Overall Study|Withdrawal by Subject|2|||
156796051|NCT03648372|566006268|FG011|Overall Study|Withdrawal by Subject|0|||
156796052|NCT03648372|566006269|FG012|Overall Study|Withdrawal by Subject|2|||
156796053|NCT03648372|566006270|FG013|Overall Study|Withdrawal by Subject|0|||
156796054|NCT03648372|566006271|FG014|Overall Study|Withdrawal by Subject|0|||
156796055|NCT03648372|566006272|FG015|Overall Study|Withdrawal by Subject|0|||
156796056|NCT03648372|566006273|FG016|Overall Study|Withdrawal by Subject|1|||
156796057|NCT03648372|566006274|FG017|Overall Study|Withdrawal by Subject|0|||
156796058|NCT03648372|566006275|FG018|Overall Study|Withdrawal by Subject|0|||
156728592|NCT01637922|565755833|FG001|Overall Study|Lost to Follow-up|0|||
156728593|NCT01515865|565755834|FG000|Part A (Open-label)|Other|3|||
156728594|NCT01515865|565755835|FG001|Part A (Open-label)|Other|0|||
156728595|NCT01515865|565755836|FG002|Part A (Open-label)|Other|0|||
156728596|NCT01515865|565755834|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
156728597|NCT01515865|565755835|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
156728598|NCT01515865|565755836|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
156728599|NCT01515865|565755834|FG000|Part B (Open-label)|Other|1|||
156728600|NCT01515865|565755835|FG001|Part B (Open-label)|Other|0|||
156728601|NCT01515865|565755836|FG002|Part B (Open-label)|Other|0|||
156728602|NCT02693106|565755837|FG000|Overall Study|No time|3|||
156728603|NCT03981900|565755838|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
156728604|NCT03981900|565755838|FG000|Overall Study|Adverse Event|5|||
156728605|NCT03981900|565755838|FG000|Overall Study|Protocol Violation|1|||
156728606|NCT03981900|565755838|FG000|Overall Study|Withdrawal by Subject|7|||
156728607|NCT03981900|565755838|FG000|Overall Study|Lost to Follow-up|46|||
156728608|NCT03981900|565755838|FG000|Overall Study|Decision of the researcher|3|||
156728609|NCT03981900|565755838|FG000|Overall Study|Death|3|||
156728610|NCT03981900|565755838|FG000|Overall Study|Other|5|||
156728611|NCT04090060|565755848|FG000|Overall Study|Lost to Follow-up|76|||
156728612|NCT04090060|565755849|FG001|Overall Study|Lost to Follow-up|77|||
156728613|NCT01164579|565755850|FG000|Overall Study|Lack of Efficacy|0|||
156728614|NCT01164579|565755851|FG001|Overall Study|Lack of Efficacy|0|||
156728615|NCT01164579|565755852|FG002|Overall Study|Lack of Efficacy|6|||
156728616|NCT01164579|565755850|FG000|Overall Study|Lost to Follow-up|1|||
156728617|NCT01164579|565755851|FG001|Overall Study|Lost to Follow-up|1|||
156728618|NCT01164579|565755852|FG002|Overall Study|Lost to Follow-up|0|||
156728619|NCT01164579|565755850|FG000|Overall Study|Withdrawal by Subject|2|||
156728620|NCT01164579|565755851|FG001|Overall Study|Withdrawal by Subject|5|||
156728621|NCT01164579|565755852|FG002|Overall Study|Withdrawal by Subject|3|||
156728622|NCT01164579|565755850|FG000|Overall Study|Protocol Violation|0|||
156728623|NCT01164579|565755851|FG001|Overall Study|Protocol Violation|1|||
156728624|NCT01164579|565755852|FG002|Overall Study|Protocol Violation|2|||
156728625|NCT01164579|565755850|FG000|Overall Study|Adverse Event|4|||
156728626|NCT01164579|565755851|FG001|Overall Study|Adverse Event|2|||
156728627|NCT01164579|565755852|FG002|Overall Study|Adverse Event|5|||
156728628|NCT01164579|565755850|FG000|Overall Study|Reason not specified|1|||
156728629|NCT01164579|565755851|FG001|Overall Study|Reason not specified|0|||
156728630|NCT01164579|565755852|FG002|Overall Study|Reason not specified|0|||
156728631|NCT02176655|565755853|FG000|Overall Study|Subjects did not treat|6|||
156728632|NCT00179660|565755862|FG000|Overall Study|Adverse Event|7|||
156728633|NCT00179660|565755862|FG000|Overall Study|Lack of therapeutic effect|28|||
156728634|NCT00179660|565755862|FG000|Overall Study|Withdrawal by Subject|2|||
156728635|NCT00179660|565755862|FG000|Overall Study|Lost to Follow-up|1|||
156728636|NCT00179660|565755862|FG000|Overall Study|Death|3|||
156728637|NCT00179660|565755862|FG000|Overall Study|Other - Unspecified|9|||
156728638|NCT04478695|565755863|FG000|Overall Study|Death|1|||
156728639|NCT04478695|565755864|FG001|Overall Study|Death|0|||
156728640|NCT00644917|565755865|FG000|Overall Study|Withdrawal by Subject|2|||
156728641|NCT00402688|565755866|FG000|Overall Study|Adverse Event|12|||
156728642|NCT00402688|565755867|FG001|Overall Study|Adverse Event|9|||
156728643|NCT00402688|565755868|FG002|Overall Study|Adverse Event|3|||
156728644|NCT00402688|565755866|FG000|Overall Study|Withdrawal by Subject|3|||
156728645|NCT00402688|565755867|FG001|Overall Study|Withdrawal by Subject|1|||
156728646|NCT00402688|565755868|FG002|Overall Study|Withdrawal by Subject|1|||
156728647|NCT00402688|565755866|FG000|Overall Study|Physician Decision|0|||
156728648|NCT00402688|565755867|FG001|Overall Study|Physician Decision|0|||
156728649|NCT00402688|565755868|FG002|Overall Study|Physician Decision|1|||
156728650|NCT00402688|565755866|FG000|Overall Study|Lack of Efficacy|4|||
156728651|NCT00402688|565755867|FG001|Overall Study|Lack of Efficacy|4|||
156728652|NCT00402688|565755868|FG002|Overall Study|Lack of Efficacy|5|||
156728653|NCT00402688|565755866|FG000|Overall Study|Protocol Violation|1|||
156728654|NCT00402688|565755867|FG001|Overall Study|Protocol Violation|1|||
156728655|NCT00402688|565755868|FG002|Overall Study|Protocol Violation|1|||
156728656|NCT00402688|565755866|FG000|Overall Study|Lost to Follow-up|1|||
156728657|NCT00402688|565755867|FG001|Overall Study|Lost to Follow-up|0|||
156728658|NCT00402688|565755868|FG002|Overall Study|Lost to Follow-up|2|||
156728659|NCT00402688|565755866|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
156728660|NCT00402688|565755867|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
156728661|NCT00402688|565755868|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
156728662|NCT00402688|565755866|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
156728663|NCT00402688|565755867|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
156728664|NCT00402688|565755868|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
156728665|NCT00402688|565755866|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
156728666|NCT00402688|565755867|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
156728667|NCT00402688|565755868|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
156728668|NCT00927862|565755869|FG000|Overall Study|Missing data needed for endpt analyses|27|||
156728669|NCT00927862|565755870|FG001|Overall Study|Missing data needed for endpt analyses|45|||
156728670|NCT04157296|565755880|FG000|Overall Study|Withdrawal by Subject|0|||
156728671|NCT04157296|565755881|FG001|Overall Study|Withdrawal by Subject|1|||
156728672|NCT04157296|565755880|FG000|Overall Study|Did not obtain second fMRI.|0|||
156728673|NCT04157296|565755881|FG001|Overall Study|Did not obtain second fMRI.|1|||
156728674|NCT04157296|565755880|FG000|Overall Study|MRI failed/no second fMRI|0|||
156728675|NCT04157296|565755881|FG001|Overall Study|MRI failed/no second fMRI|1|||
156728676|NCT02088905|565755888|FG000|Overall Study|Withdrawal by Subject|5|||
156728677|NCT02088905|565755889|FG001|Overall Study|Withdrawal by Subject|1|||
156728678|NCT01562782|565755895|FG000|Overall Study|Withdrawal by Subject|3|||
156728679|NCT01562782|565755896|FG001|Overall Study|Withdrawal by Subject|3|||
156728680|NCT01562782|565755895|FG000|Overall Study|screen failure|1|||
156728681|NCT01562782|565755896|FG001|Overall Study|screen failure|2|||
157139244|NCT02654002|567254565|FG008|Overall Study|Adverse Event|0|||
157139245|NCT02654002|567254557|FG000|Overall Study|Withdrew Consent|0|||
157139246|NCT02654002|567254558|FG001|Overall Study|Withdrew Consent|0|||
157139247|NCT02654002|567254559|FG002|Overall Study|Withdrew Consent|0|||
156728682|NCT02308540|565755897|FG000|Overall Study|Lost to Follow-up|0|||
156728683|NCT02308540|565755898|FG001|Overall Study|Lost to Follow-up|0|||
156728684|NCT02308540|565755899|FG002|Overall Study|Lost to Follow-up|0|||
156728685|NCT02308540|565755900|FG003|Overall Study|Lost to Follow-up|0|||
156728686|NCT02308540|565755901|FG004|Overall Study|Lost to Follow-up|0|||
156728687|NCT02308540|565755902|FG005|Overall Study|Lost to Follow-up|1|||
156728688|NCT04109391|565755903|FG000|Overall Study|Adverse Event|2|||
156728689|NCT04109391|565755904|FG001|Overall Study|Adverse Event|2|||
156728690|NCT04109391|565755905|FG002|Overall Study|Adverse Event|0|||
156728691|NCT04109391|565755903|FG000|Overall Study|Withdrawal by Subject|2|||
156796059|NCT03648372|566006276|FG019|Overall Study|Withdrawal by Subject|0|||
157139248|NCT02654002|567254560|FG003|Overall Study|Withdrew Consent|0|||
157139249|NCT02654002|567254561|FG004|Overall Study|Withdrew Consent|0|||
157139250|NCT02654002|567254562|FG005|Overall Study|Withdrew Consent|1|||
157139251|NCT02654002|567254563|FG006|Overall Study|Withdrew Consent|0|||
157139252|NCT02654002|567254564|FG007|Overall Study|Withdrew Consent|1|||
157139253|NCT02654002|567254565|FG008|Overall Study|Withdrew Consent|0|||
157139254|NCT01523873|567254566|FG000|Overall Study|Protocol Violation|422|||
157139255|NCT00275561|567254569|FG000|Overall Study|Withdrawal by Subject|0|||
157139256|NCT00275561|567254570|FG001|Overall Study|Withdrawal by Subject|1|||
157139257|NCT00275561|567254569|FG000|Overall Study|Travel|1|||
157139258|NCT00275561|567254570|FG001|Overall Study|Travel|1|||
157139259|NCT00275561|567254569|FG000|Overall Study|Scheduling|1|||
157139260|NCT00275561|567254570|FG001|Overall Study|Scheduling|2|||
157139261|NCT00275561|567254569|FG000|Overall Study|Family Issues|0|||
157139262|NCT00275561|567254570|FG001|Overall Study|Family Issues|2|||
157139263|NCT01769105|567254575|FG000|First Intervention|Protocol Violation|2|||
157139264|NCT01769105|567254576|FG001|First Intervention|Protocol Violation|2|||
157139265|NCT01769105|567254575|FG000|Cross-over|Lost to Follow-up|5|||
157139266|NCT01769105|567254576|FG001|Cross-over|Lost to Follow-up|0|||
157139267|NCT05630846|567255887|FG000|Overall Study|Death|1|||
157139268|NCT05630846|567255888|FG001|Overall Study|Death|0|||
157139269|NCT05630846|567255889|FG002|Overall Study|Death|0|||
157139270|NCT05630846|567255890|FG003|Overall Study|Death|0|||
157139271|NCT05630846|567255887|FG000|Overall Study|Withdrawal by Subject|3|||
157139272|NCT05630846|567255888|FG001|Overall Study|Withdrawal by Subject|3|||
157139273|NCT05630846|567255889|FG002|Overall Study|Withdrawal by Subject|4|||
157139274|NCT05630846|567255890|FG003|Overall Study|Withdrawal by Subject|1|||
157139275|NCT05630846|567255887|FG000|Overall Study|Lost to Follow-up|6|||
157139276|NCT05630846|567255888|FG001|Overall Study|Lost to Follow-up|5|||
157139277|NCT05630846|567255889|FG002|Overall Study|Lost to Follow-up|2|||
157139278|NCT05630846|567255890|FG003|Overall Study|Lost to Follow-up|5|||
157139279|NCT05630846|567255887|FG000|Overall Study|Other|1|||
157139280|NCT05630846|567255888|FG001|Overall Study|Other|0|||
157139281|NCT05630846|567255889|FG002|Overall Study|Other|0|||
157139282|NCT05630846|567255890|FG003|Overall Study|Other|0|||
157139283|NCT00265941|567255891|FG000|Overall Study|Protocol Violation|22|||
157139284|NCT00265941|567255892|FG001|Overall Study|Protocol Violation|25|||
157139285|NCT00265941|567255891|FG000|Overall Study|Lost to Follow-up|1|||
157139286|NCT00265941|567255892|FG001|Overall Study|Lost to Follow-up|1|||
157139287|NCT03976401|567255896|FG000|Overall Study|Adverse Event|2|||
157139288|NCT03976401|567255897|FG001|Overall Study|Adverse Event|0|||
157139289|NCT03976401|567255898|FG002|Overall Study|Adverse Event|4|||
157139290|NCT03976401|567255899|FG003|Overall Study|Adverse Event|1|||
157139291|NCT03976401|567255900|FG004|Overall Study|Adverse Event|1|||
157139292|NCT03976401|567255901|FG005|Overall Study|Adverse Event|0|||
157139293|NCT03976401|567255896|FG000|Overall Study|Withdrawal by Subject|0|||
157139294|NCT03976401|567255897|FG001|Overall Study|Withdrawal by Subject|1|||
157139295|NCT03976401|567255898|FG002|Overall Study|Withdrawal by Subject|0|||
157139296|NCT03976401|567255899|FG003|Overall Study|Withdrawal by Subject|0|||
156728692|NCT04109391|565755904|FG001|Overall Study|Withdrawal by Subject|0|||
156728693|NCT04109391|565755905|FG002|Overall Study|Withdrawal by Subject|0|||
156796060|NCT03648372|566006277|FG020|Overall Study|Withdrawal by Subject|0|||
157139297|NCT03976401|567255900|FG004|Overall Study|Withdrawal by Subject|0|||
157139298|NCT03976401|567255901|FG005|Overall Study|Withdrawal by Subject|1|||
157139299|NCT03976401|567255896|FG000|Overall Study|Physician Decision|0|||
157139300|NCT03976401|567255897|FG001|Overall Study|Physician Decision|0|||
157139301|NCT03976401|567255898|FG002|Overall Study|Physician Decision|1|||
157139302|NCT03976401|567255899|FG003|Overall Study|Physician Decision|0|||
157139303|NCT03976401|567255900|FG004|Overall Study|Physician Decision|0|||
157139304|NCT03976401|567255901|FG005|Overall Study|Physician Decision|0|||
157139305|NCT03976401|567255896|FG000|Overall Study|Lost to Follow-up|1|||
157139306|NCT03976401|567255897|FG001|Overall Study|Lost to Follow-up|2|||
157139307|NCT03976401|567255898|FG002|Overall Study|Lost to Follow-up|0|||
157139308|NCT03976401|567255899|FG003|Overall Study|Lost to Follow-up|0|||
157139309|NCT03976401|567255900|FG004|Overall Study|Lost to Follow-up|0|||
157139310|NCT03976401|567255901|FG005|Overall Study|Lost to Follow-up|0|||
157139311|NCT03976401|567255896|FG000|Overall Study|Protocol Violation|0|||
157139312|NCT03976401|567255897|FG001|Overall Study|Protocol Violation|1|||
157139313|NCT03976401|567255898|FG002|Overall Study|Protocol Violation|0|||
157139314|NCT03976401|567255899|FG003|Overall Study|Protocol Violation|0|||
156728694|NCT04109391|565755903|FG000|Overall Study|Pregnancy|1|||
156728695|NCT04109391|565755904|FG001|Overall Study|Pregnancy|0|||
156728696|NCT04109391|565755905|FG002|Overall Study|Pregnancy|0|||
156728697|NCT04109391|565755903|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
156728698|NCT04109391|565755904|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
156728699|NCT04109391|565755905|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
156728700|NCT04109391|565755903|FG000|Overall Study|Lost to Follow-up|0|||
156728701|NCT04109391|565755904|FG001|Overall Study|Lost to Follow-up|0|||
156728702|NCT04109391|565755905|FG002|Overall Study|Lost to Follow-up|1|||
156728703|NCT04109391|565755903|FG000|Overall Study|Lack of Efficacy|2|||
156728704|NCT04109391|565755904|FG001|Overall Study|Lack of Efficacy|2|||
156728705|NCT04109391|565755905|FG002|Overall Study|Lack of Efficacy|3|||
156728706|NCT02097238|565755911|FG000|Overall Study|Death|1|||
156728707|NCT02097238|565755911|FG000|Overall Study|Physician Decision|1|||
156728708|NCT02097238|565755911|FG000|Overall Study|Progressive Disease|17|||
156728709|NCT01106911|565755912|FG000|Overall Study|Physician Decision|2|||
156728710|NCT01106911|565755912|FG000|Overall Study|deemed ineligible after screening|3|||
156728711|NCT01282372|565755921|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
156728712|NCT01282372|565755921|FG000|Overall Study|Lost to Follow-up|23|||
156728713|NCT01282372|565755921|FG000|Overall Study|Withdrawal by Subject|11|||
156728714|NCT01282372|565755921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
156728715|NCT01282372|565755921|FG000|Overall Study|Death|1|||
156728716|NCT01282372|565755921|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
156728717|NCT01282372|565755921|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
156728718|NCT01282372|565755921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
156728719|NCT01282372|565755921|FG000|Overall Study|Adverse Event|12|||
156728720|NCT01814696|565755922|FG000|Overall Study|Withdrawal by Subject|1|||
156728721|NCT01814696|565755923|FG001|Overall Study|Withdrawal by Subject|0|||
156728722|NCT01814696|565755922|FG000|Overall Study|Randomized to wrong group|1|||
156728723|NCT01814696|565755923|FG001|Overall Study|Randomized to wrong group|0|||
156728724|NCT02064816|565755930|FG000|Overall Study|Adverse Event|3|||
156728725|NCT02064816|565755931|FG001|Overall Study|Adverse Event|2|||
156728726|NCT02064816|565755930|FG000|Overall Study|Withdrawal by Subject|2|||
156796061|NCT03648372|566006257|FG000|Overall Study|Progressive Disease|2|||
156796062|NCT03648372|566006258|FG001|Overall Study|Progressive Disease|3|||
156796063|NCT03648372|566006259|FG002|Overall Study|Progressive Disease|4|||
156796064|NCT03648372|566006260|FG003|Overall Study|Progressive Disease|3|||
156796065|NCT03648372|566006261|FG004|Overall Study|Progressive Disease|2|||
156796066|NCT03648372|566006262|FG005|Overall Study|Progressive Disease|2|||
156796067|NCT03648372|566006263|FG006|Overall Study|Progressive Disease|3|||
156796068|NCT03648372|566006264|FG007|Overall Study|Progressive Disease|3|||
156796069|NCT03648372|566006265|FG008|Overall Study|Progressive Disease|5|||
156796070|NCT03648372|566006266|FG009|Overall Study|Progressive Disease|5|||
156796071|NCT03648372|566006267|FG010|Overall Study|Progressive Disease|2|||
156796072|NCT03648372|566006268|FG011|Overall Study|Progressive Disease|3|||
156796073|NCT03648372|566006269|FG012|Overall Study|Progressive Disease|3|||
156796074|NCT03648372|566006270|FG013|Overall Study|Progressive Disease|3|||
156796075|NCT03648372|566006271|FG014|Overall Study|Progressive Disease|6|||
156796076|NCT03648372|566006272|FG015|Overall Study|Progressive Disease|0|||
156796077|NCT03648372|566006273|FG016|Overall Study|Progressive Disease|0|||
156796078|NCT03648372|566006274|FG017|Overall Study|Progressive Disease|0|||
156796079|NCT03648372|566006275|FG018|Overall Study|Progressive Disease|0|||
156796080|NCT03648372|566006276|FG019|Overall Study|Progressive Disease|0|||
156796081|NCT03648372|566006277|FG020|Overall Study|Progressive Disease|0|||
156796082|NCT03648372|566006257|FG000|Overall Study|Other|0|||
156796083|NCT03648372|566006258|FG001|Overall Study|Other|0|||
156796084|NCT03648372|566006259|FG002|Overall Study|Other|0|||
157139315|NCT03976401|567255900|FG004|Overall Study|Protocol Violation|0|||
156796085|NCT03648372|566006260|FG003|Overall Study|Other|0|||
156728727|NCT02064816|565755931|FG001|Overall Study|Withdrawal by Subject|1|||
156728728|NCT02064816|565755930|FG000|Overall Study|Lost to Follow-up|2|||
156728729|NCT02064816|565755931|FG001|Overall Study|Lost to Follow-up|1|||
156728730|NCT02064816|565755930|FG000|Overall Study|Therapeutic failure|0|||
156728731|NCT02064816|565755931|FG001|Overall Study|Therapeutic failure|1|||
156796086|NCT03648372|566006261|FG004|Overall Study|Other|1|||
156796087|NCT03648372|566006262|FG005|Overall Study|Other|0|||
156796088|NCT03648372|566006263|FG006|Overall Study|Other|0|||
156796089|NCT03648372|566006264|FG007|Overall Study|Other|0|||
156796090|NCT03648372|566006265|FG008|Overall Study|Other|0|||
156728732|NCT02064816|565755930|FG000|Overall Study|Other|1|||
156796091|NCT03648372|566006266|FG009|Overall Study|Other|0|||
156796092|NCT03648372|566006267|FG010|Overall Study|Other|1|||
156796093|NCT03648372|566006268|FG011|Overall Study|Other|2|||
156796094|NCT03648372|566006269|FG012|Overall Study|Other|1|||
157139316|NCT03976401|567255901|FG005|Overall Study|Protocol Violation|0|||
157139317|NCT03976401|567255896|FG000|Overall Study|Withdrew Consent|0|||
157139318|NCT03976401|567255897|FG001|Overall Study|Withdrew Consent|0|||
157139319|NCT03976401|567255898|FG002|Overall Study|Withdrew Consent|0|||
157139320|NCT03976401|567255899|FG003|Overall Study|Withdrew Consent|1|||
157139321|NCT03976401|567255900|FG004|Overall Study|Withdrew Consent|0|||
157139322|NCT03976401|567255901|FG005|Overall Study|Withdrew Consent|0|||
157139323|NCT03182738|567255912|FG000|Overall Study|Lost to Follow-up|9|||
157139324|NCT03182738|567255913|FG001|Overall Study|Lost to Follow-up|3|||
157139325|NCT03182738|567255912|FG000|Overall Study|Pregnancy|0|||
157139326|NCT03182738|567255913|FG001|Overall Study|Pregnancy|1|||
157139327|NCT03182738|567255912|FG000|Overall Study|Withdrawal by Subject|0|||
157139328|NCT03182738|567255913|FG001|Overall Study|Withdrawal by Subject|1|||
157139329|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
157139330|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
156728733|NCT02064816|565755931|FG001|Overall Study|Other|3|||
156728734|NCT01757184|565755934|FG000|Double-blind Period|Adverse Event|1|||
156728735|NCT01757184|565755935|FG001|Double-blind Period|Adverse Event|0|||
156728736|NCT01757184|565755936|FG002|Double-blind Period|Adverse Event|0|||
156728737|NCT01757184|565755937|FG003|Double-blind Period|Adverse Event|0|||
156728738|NCT01757184|565755934|FG000|Open-label Period|Lost to Follow-up|0|||
156728739|NCT01757184|565755935|FG001|Open-label Period|Lost to Follow-up|0|||
156728740|NCT01757184|565755936|FG002|Open-label Period|Lost to Follow-up|2|||
156728741|NCT01757184|565755937|FG003|Open-label Period|Lost to Follow-up|0|||
156728742|NCT01757184|565755934|FG000|Open-label Period|Withdrawal by Subject|0|||
156728743|NCT01757184|565755935|FG001|Open-label Period|Withdrawal by Subject|0|||
156728744|NCT01757184|565755936|FG002|Open-label Period|Withdrawal by Subject|1|||
156728745|NCT01757184|565755937|FG003|Open-label Period|Withdrawal by Subject|1|||
156728746|NCT01757184|565755934|FG000|Open-label Period|Discontinued by Sponsor|0|||
156728747|NCT01757184|565755935|FG001|Open-label Period|Discontinued by Sponsor|0|||
156728748|NCT01757184|565755936|FG002|Open-label Period|Discontinued by Sponsor|1|||
156728749|NCT01757184|565755937|FG003|Open-label Period|Discontinued by Sponsor|2|||
156728750|NCT03515811|565755938|FG000|Overall Study|Lost to Follow-up|2|||
156728751|NCT03515811|565755939|FG001|Overall Study|Lost to Follow-up|1|||
156728752|NCT03515811|565755938|FG000|Overall Study|Protocol Violation|1|||
156728753|NCT03515811|565755939|FG001|Overall Study|Protocol Violation|1|||
156728754|NCT03515811|565755938|FG000|Overall Study|Death|1|||
156728755|NCT03515811|565755939|FG001|Overall Study|Death|1|||
156728756|NCT03515811|565755938|FG000|Overall Study|Withdrawal by Subject|0|||
156728757|NCT03515811|565755939|FG001|Overall Study|Withdrawal by Subject|2|||
156728758|NCT03515811|565755938|FG000|Overall Study|Technical Problems|1|||
156728759|NCT03515811|565755939|FG001|Overall Study|Technical Problems|0|||
156728760|NCT03515811|565755938|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
156728761|NCT03515811|565755939|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
156728762|NCT03515811|565755938|FG000|Overall Study|COVID-19|0|||
156728763|NCT03515811|565755939|FG001|Overall Study|COVID-19|1|||
156728764|NCT00237458|565755940|FG000|Overall Study|Lack of Efficacy|1|||
156728765|NCT00237458|565755940|FG000|Overall Study|Adverse Event|1|||
156728766|NCT00237458|565755940|FG000|Overall Study|Withdrawal by Subject|1|||
156728767|NCT04339062|565755941|FG000|Overall Study|Death|0|||
156796095|NCT03648372|566006270|FG013|Overall Study|Other|3|||
156796096|NCT03648372|566006271|FG014|Overall Study|Other|0|||
156796097|NCT03648372|566006272|FG015|Overall Study|Other|5|||
156796098|NCT03648372|566006273|FG016|Overall Study|Other|1|||
156796099|NCT03648372|566006274|FG017|Overall Study|Other|5|||
156796100|NCT03648372|566006275|FG018|Overall Study|Other|0|||
157019836|NCT05687916|566826521|FG000|Overall Study|Adverse Event|1|||
157019837|NCT05687916|566826522|FG001|Overall Study|Adverse Event|2|||
157019838|NCT05687916|566826523|FG002|Overall Study|Adverse Event|0|||
157019839|NCT05687916|566826521|FG000|Overall Study|Withdrawal by Subject|1|||
157019840|NCT05687916|566826522|FG001|Overall Study|Withdrawal by Subject|0|||
157139331|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
157139332|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
157139333|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
157139334|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
156728768|NCT04339062|565755942|FG001|Overall Study|Death|1|||
156728769|NCT03218826|565755943|FG000|Overall Study|Non-compliance with protocol|1|||
156728770|NCT03218826|565755944|FG001|Overall Study|Non-compliance with protocol|0|||
156728771|NCT03218826|565755945|FG002|Overall Study|Non-compliance with protocol|2|||
156728772|NCT03218826|565755946|FG003|Overall Study|Non-compliance with protocol|1|||
156728773|NCT03218826|565755947|FG004|Overall Study|Non-compliance with protocol|1|||
156796101|NCT03648372|566006276|FG019|Overall Study|Other|1|||
157139335|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
156796102|NCT03648372|566006277|FG020|Overall Study|Other|0|||
156728774|NCT01197534|565755948|FG000|Overall Study|Not reported|16|||
156728775|NCT01197534|565755949|FG001|Overall Study|Not reported|10|||
156728776|NCT01197534|565755950|FG002|Overall Study|Not reported|16|||
156796103|NCT03648372|566006257|FG000|Overall Study|Lost to Follow-up|0|||
156796104|NCT03648372|566006258|FG001|Overall Study|Lost to Follow-up|0|||
157019841|NCT05687916|566826523|FG002|Overall Study|Withdrawal by Subject|1|||
156728777|NCT01197534|565755948|FG000|Overall Study|Enrolment in long term extension|57|||
156728778|NCT01197534|565755949|FG001|Overall Study|Enrolment in long term extension|66|||
156728779|NCT01197534|565755950|FG002|Overall Study|Enrolment in long term extension|119|||
156728780|NCT01197534|565755948|FG000|Overall Study|Severe non-compliance to protocol|3|||
156728781|NCT01197534|565755949|FG001|Overall Study|Severe non-compliance to protocol|4|||
156728782|NCT01197534|565755950|FG002|Overall Study|Severe non-compliance to protocol|1|||
156728783|NCT01197534|565755948|FG000|Overall Study|Lack of therapeutic response|9|||
156728784|NCT01197534|565755949|FG001|Overall Study|Lack of therapeutic response|4|||
156728785|NCT01197534|565755950|FG002|Overall Study|Lack of therapeutic response|9|||
156728786|NCT01197534|565755948|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
156728787|NCT01197534|565755949|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
156728788|NCT01197534|565755950|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
156728789|NCT01197534|565755948|FG000|Overall Study|Lost to Follow-up|1|||
156728790|NCT01197534|565755949|FG001|Overall Study|Lost to Follow-up|4|||
157019842|NCT05687916|566826521|FG000|Overall Study|Protocol Violation|0|||
157019843|NCT05687916|566826522|FG001|Overall Study|Protocol Violation|2|||
157019844|NCT05687916|566826523|FG002|Overall Study|Protocol Violation|1|||
157019845|NCT05687916|566826521|FG000|Overall Study|Reason not Specified|1|||
157019846|NCT05687916|566826522|FG001|Overall Study|Reason not Specified|0|||
157019847|NCT05687916|566826523|FG002|Overall Study|Reason not Specified|0|||
157019848|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
157019849|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
157019850|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
157019851|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157019852|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157019853|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156728791|NCT01197534|565755950|FG002|Overall Study|Lost to Follow-up|2|||
156728792|NCT01197534|565755948|FG000|Overall Study|Adverse Event|35|||
156728793|NCT01197534|565755949|FG001|Overall Study|Adverse Event|36|||
156728794|NCT01197534|565755950|FG002|Overall Study|Adverse Event|24|||
156728795|NCT01276756|565755953|FG000|Overall Study|Lost to Follow-up|2|||
156728796|NCT01276756|565755954|FG001|Overall Study|Lost to Follow-up|0|||
156728797|NCT01276756|565755953|FG000|Overall Study|Adverse Event|3|||
156728798|NCT01276756|565755954|FG001|Overall Study|Adverse Event|2|||
156728799|NCT05868577|565755955|FG000|Overall Study|Lost to Follow-up|5|||
156728800|NCT05868577|565755956|FG001|Overall Study|Lost to Follow-up|5|||
156728801|NCT02630251|565755961|FG000|Overall Study|Physician Decision|0|||
156728802|NCT02630251|565755962|FG001|Overall Study|Physician Decision|0|||
156728803|NCT02630251|565755963|FG002|Overall Study|Physician Decision|1|||
156728804|NCT02630251|565755964|FG003|Overall Study|Physician Decision|0|||
156728805|NCT04586244|565755967|FG000|Overall Study|Lost to Follow-up|1|||
156728806|NCT04586244|565755968|FG001|Overall Study|Lost to Follow-up|0|||
156728807|NCT04586244|565755969|FG002|Overall Study|Lost to Follow-up|0|||
156728808|NCT04586244|565755970|FG003|Overall Study|Lost to Follow-up|1|||
156728809|NCT04586244|565755971|FG004|Overall Study|Lost to Follow-up|0|||
156728810|NCT04586244|565755967|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728811|NCT04586244|565755968|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
156728812|NCT04586244|565755969|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728813|NCT04586244|565755970|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728814|NCT04586244|565755971|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
156728815|NCT02670525|565755972|FG000|Overall Study|Death|94|||
156728816|NCT02670525|565755973|FG001|Overall Study|Death|14|||
156728817|NCT02670525|565755972|FG000|Overall Study|Lost to Follow-up|4|||
156728818|NCT02670525|565755973|FG001|Overall Study|Lost to Follow-up|1|||
156728819|NCT02670525|565755972|FG000|Overall Study|Subject withdrew consent|1|||
156728820|NCT02670525|565755973|FG001|Overall Study|Subject withdrew consent|0|||
157019854|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156728821|NCT02670525|565755972|FG000|Overall Study|Unknown, data entry delayed|123|||
156728822|NCT02670525|565755973|FG001|Overall Study|Unknown, data entry delayed|78|||
156728823|NCT03564119|565755976|FG000|Overall Study|Adverse Event|4|||
156728824|NCT03564119|565755977|FG001|Overall Study|Adverse Event|0|||
156728825|NCT03564119|565755976|FG000|Overall Study|Lost to Follow-up|1|||
156728826|NCT03564119|565755977|FG001|Overall Study|Lost to Follow-up|4|||
156728827|NCT03564119|565755976|FG000|Overall Study|Protocol Violation|1|||
156728828|NCT03564119|565755977|FG001|Overall Study|Protocol Violation|0|||
156728829|NCT03564119|565755976|FG000|Overall Study|Withdrawal by Subject|9|||
156728830|NCT03564119|565755977|FG001|Overall Study|Withdrawal by Subject|4|||
156728831|NCT03564119|565755976|FG000|Overall Study|Other Than Specified|0|||
156728832|NCT03564119|565755977|FG001|Overall Study|Other Than Specified|1|||
156728833|NCT00634036|565755978|FG000|Overall Study|Lost to Follow-up|1|||
156728834|NCT00634036|565755979|FG001|Overall Study|Lost to Follow-up|1|||
156728835|NCT00634036|565755978|FG000|Overall Study|Withdrawal by Subject|1|||
156728836|NCT00634036|565755979|FG001|Overall Study|Withdrawal by Subject|1|||
157019855|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
156728837|NCT03517540|565755980|FG000|Overall Study|Protocol Violation|2|||
156728838|NCT03517540|565755981|FG001|Overall Study|Protocol Violation|0|||
156728839|NCT03517540|565755982|FG002|Overall Study|Protocol Violation|0|||
156728840|NCT03517540|565755983|FG003|Overall Study|Protocol Violation|1|||
156728841|NCT03517540|565755980|FG000|Overall Study|Adverse Event|9|||
156728842|NCT03517540|565755981|FG001|Overall Study|Adverse Event|3|||
156728843|NCT03517540|565755982|FG002|Overall Study|Adverse Event|8|||
156728844|NCT03517540|565755983|FG003|Overall Study|Adverse Event|1|||
156728845|NCT03517540|565755980|FG000|Overall Study|Withdrawal by Subject|3|||
156728846|NCT03517540|565755981|FG001|Overall Study|Withdrawal by Subject|4|||
156728847|NCT03517540|565755982|FG002|Overall Study|Withdrawal by Subject|1|||
156728848|NCT03517540|565755983|FG003|Overall Study|Withdrawal by Subject|3|||
156728849|NCT03896022|565755988|FG000|Overall Study|Withdrawal by Subject|1|||
156728850|NCT03896022|565755989|FG001|Overall Study|Withdrawal by Subject|0|||
156728851|NCT03896022|565755990|FG002|Overall Study|Withdrawal by Subject|0|||
156728852|NCT03896022|565755988|FG000|Overall Study|Did not have procedure|3|||
156728853|NCT03896022|565755989|FG001|Overall Study|Did not have procedure|0|||
156728854|NCT03896022|565755990|FG002|Overall Study|Did not have procedure|0|||
156728855|NCT00615550|565755991|FG000|Overall Study|Lost to Follow-up|6|||
156728856|NCT00615550|565755992|FG001|Overall Study|Lost to Follow-up|1|||
156728857|NCT02741076|565755993|FG000|Overall Study|Adverse Event|0|||
156728858|NCT02741076|565755994|FG001|Overall Study|Adverse Event|1|||
156728859|NCT02741076|565755995|FG002|Overall Study|Adverse Event|1|||
156728860|NCT02741076|565755996|FG003|Overall Study|Adverse Event|0|||
156728861|NCT02741076|565755993|FG000|Overall Study|Lack of Efficacy|1|||
156728862|NCT02741076|565755994|FG001|Overall Study|Lack of Efficacy|0|||
156728863|NCT02741076|565755995|FG002|Overall Study|Lack of Efficacy|0|||
156728864|NCT02741076|565755996|FG003|Overall Study|Lack of Efficacy|0|||
156728865|NCT02741076|565755993|FG000|Overall Study|Withdrawal by Subject|0|||
156728866|NCT02741076|565755994|FG001|Overall Study|Withdrawal by Subject|1|||
156728867|NCT02741076|565755995|FG002|Overall Study|Withdrawal by Subject|0|||
156728868|NCT02741076|565755996|FG003|Overall Study|Withdrawal by Subject|0|||
156796105|NCT03648372|566006259|FG002|Overall Study|Lost to Follow-up|0|||
156796106|NCT03648372|566006260|FG003|Overall Study|Lost to Follow-up|0|||
156796107|NCT03648372|566006261|FG004|Overall Study|Lost to Follow-up|0|||
156796108|NCT03648372|566006262|FG005|Overall Study|Lost to Follow-up|0|||
156796109|NCT03648372|566006263|FG006|Overall Study|Lost to Follow-up|0|||
156796110|NCT03648372|566006264|FG007|Overall Study|Lost to Follow-up|0|||
156796111|NCT03648372|566006265|FG008|Overall Study|Lost to Follow-up|0|||
156796112|NCT03648372|566006266|FG009|Overall Study|Lost to Follow-up|0|||
156796113|NCT03648372|566006267|FG010|Overall Study|Lost to Follow-up|0|||
156796114|NCT03648372|566006268|FG011|Overall Study|Lost to Follow-up|0|||
156796115|NCT03648372|566006269|FG012|Overall Study|Lost to Follow-up|0|||
156796116|NCT03648372|566006270|FG013|Overall Study|Lost to Follow-up|1|||
156796117|NCT03648372|566006271|FG014|Overall Study|Lost to Follow-up|0|||
156796118|NCT03648372|566006272|FG015|Overall Study|Lost to Follow-up|1|||
156796119|NCT03648372|566006273|FG016|Overall Study|Lost to Follow-up|0|||
156796120|NCT03648372|566006274|FG017|Overall Study|Lost to Follow-up|1|||
156796121|NCT03648372|566006275|FG018|Overall Study|Lost to Follow-up|0|||
156796122|NCT03648372|566006276|FG019|Overall Study|Lost to Follow-up|0|||
156796123|NCT03648372|566006277|FG020|Overall Study|Lost to Follow-up|0|||
156796124|NCT03648372|566006257|FG000|Overall Study|Start of a New Systemic Treatment|0|||
156796125|NCT03648372|566006258|FG001|Overall Study|Start of a New Systemic Treatment|0|||
156796126|NCT03648372|566006259|FG002|Overall Study|Start of a New Systemic Treatment|0|||
156796127|NCT03648372|566006260|FG003|Overall Study|Start of a New Systemic Treatment|0|||
157019856|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157139336|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
157139337|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
156728869|NCT02741076|565755993|FG000|Overall Study|Sponsor Request|2|||
156728870|NCT02741076|565755994|FG001|Overall Study|Sponsor Request|3|||
156728871|NCT02741076|565755995|FG002|Overall Study|Sponsor Request|0|||
156796128|NCT03648372|566006261|FG004|Overall Study|Start of a New Systemic Treatment|0|||
156796129|NCT03648372|566006262|FG005|Overall Study|Start of a New Systemic Treatment|0|||
156796130|NCT03648372|566006263|FG006|Overall Study|Start of a New Systemic Treatment|0|||
156796131|NCT03648372|566006264|FG007|Overall Study|Start of a New Systemic Treatment|2|||
156796132|NCT03648372|566006265|FG008|Overall Study|Start of a New Systemic Treatment|0|||
156728872|NCT02741076|565755996|FG003|Overall Study|Sponsor Request|1|||
156728873|NCT02741076|565755993|FG000|Overall Study|No additional information available|0|||
156728874|NCT02741076|565755994|FG001|Overall Study|No additional information available|0|||
156728875|NCT02741076|565755995|FG002|Overall Study|No additional information available|1|||
156728876|NCT02741076|565755996|FG003|Overall Study|No additional information available|1|||
156728877|NCT01779440|565755997|FG000|Overall Study|Withdrawal by Subject|3|||
156728878|NCT01779440|565755998|FG001|Overall Study|Withdrawal by Subject|5|||
156796133|NCT03648372|566006266|FG009|Overall Study|Start of a New Systemic Treatment|0|||
156728879|NCT00086619|565756001|FG000|Overall Study|Withdrawal by Subject|6|||
156796134|NCT03648372|566006267|FG010|Overall Study|Start of a New Systemic Treatment|1|||
156796135|NCT03648372|566006268|FG011|Overall Study|Start of a New Systemic Treatment|0|||
156796136|NCT03648372|566006269|FG012|Overall Study|Start of a New Systemic Treatment|0|||
156796137|NCT03648372|566006270|FG013|Overall Study|Start of a New Systemic Treatment|0|||
156796138|NCT03648372|566006271|FG014|Overall Study|Start of a New Systemic Treatment|0|||
156796139|NCT03648372|566006272|FG015|Overall Study|Start of a New Systemic Treatment|0|||
156796140|NCT03648372|566006273|FG016|Overall Study|Start of a New Systemic Treatment|0|||
156796141|NCT03648372|566006274|FG017|Overall Study|Start of a New Systemic Treatment|0|||
156796142|NCT03648372|566006275|FG018|Overall Study|Start of a New Systemic Treatment|0|||
156796143|NCT03648372|566006276|FG019|Overall Study|Start of a New Systemic Treatment|0|||
156796144|NCT03648372|566006277|FG020|Overall Study|Start of a New Systemic Treatment|0|||
156796145|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
156796146|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
156796147|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
156796148|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
156796149|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
156796150|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
156796151|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
156796152|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
156796153|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
156796154|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
156796155|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
156796156|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796157|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796158|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796159|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
156796160|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796161|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796162|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796163|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796164|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796165|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
157139338|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
157139339|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
157139340|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
156796166|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
156796167|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796168|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796169|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
156796170|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796171|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796172|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796173|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796174|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796175|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796176|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796177|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
156796178|NCT02471144|566007979|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
156796179|NCT02471144|566007980|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
156796180|NCT02471144|566007981|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796181|NCT02471144|566007982|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796182|NCT02471144|566007983|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796183|NCT02471144|566007984|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796184|NCT02471144|566007985|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796185|NCT02471144|566007986|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796186|NCT02471144|566007987|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796187|NCT02471144|566007988|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
157139341|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
157139342|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
156796188|NCT02471144|566007989|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
156796189|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796190|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796191|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796192|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796193|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156796194|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796195|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156728880|NCT00086619|565756002|FG001|Overall Study|Withdrawal by Subject|6|||
156728881|NCT00086619|565756001|FG000|Overall Study|Adverse Event|8|||
156728882|NCT00086619|565756002|FG001|Overall Study|Adverse Event|10|||
156728883|NCT00086619|565756001|FG000|Overall Study|Protocol Violation|1|||
156728884|NCT00086619|565756002|FG001|Overall Study|Protocol Violation|1|||
156728885|NCT02644668|565756003|FG000|Overall Study|Adverse Event|2|||
156728886|NCT02644668|565756004|FG001|Overall Study|Adverse Event|0|||
156728887|NCT02644668|565756005|FG002|Overall Study|Adverse Event|1|||
156728888|NCT02644668|565756003|FG000|Overall Study|Protocol Violation|0|||
156728889|NCT02644668|565756004|FG001|Overall Study|Protocol Violation|0|||
156728890|NCT02644668|565756005|FG002|Overall Study|Protocol Violation|1|||
156728891|NCT02644668|565756003|FG000|Overall Study|Withdrawal by Subject|0|||
156728892|NCT02644668|565756004|FG001|Overall Study|Withdrawal by Subject|0|||
156728893|NCT02644668|565756005|FG002|Overall Study|Withdrawal by Subject|1|||
156728894|NCT01209520|565756006|FG000|Overall Study|Withdrawal by Subject|3|||
156728895|NCT00961350|565756007|FG000|Overall Study|Adverse Event|18|||
156728896|NCT00961350|565756008|FG001|Overall Study|Adverse Event|33|||
156728897|NCT00961350|565756007|FG000|Overall Study|Withdrawal by Subject|10|||
156728898|NCT00961350|565756008|FG001|Overall Study|Withdrawal by Subject|10|||
156728899|NCT00961350|565756007|FG000|Overall Study|Lost to Follow-up|3|||
156728900|NCT00961350|565756008|FG001|Overall Study|Lost to Follow-up|3|||
156728901|NCT00961350|565756007|FG000|Overall Study|Misc|16|||
156728902|NCT00961350|565756008|FG001|Overall Study|Misc|21|||
156728903|NCT06868654|565756009|FG000|Overall Study|Death|4|||
156728904|NCT06868654|565756010|FG001|Overall Study|Death|14|||
156728905|NCT06868654|565756009|FG000|Overall Study|Lost to Follow-up|0|||
156728906|NCT06868654|565756010|FG001|Overall Study|Lost to Follow-up|1|||
156728907|NCT06868654|565756009|FG000|Overall Study|Withdrawal by Subject|5|||
156728908|NCT06868654|565756010|FG001|Overall Study|Withdrawal by Subject|3|||
156728909|NCT06868654|565756009|FG000|Overall Study|Physician Decision|0|||
156728910|NCT06868654|565756010|FG001|Overall Study|Physician Decision|1|||
156728911|NCT06868654|565756009|FG000|Overall Study|Ongoing|23|||
156728912|NCT06868654|565756010|FG001|Overall Study|Ongoing|21|||
156728913|NCT04015518|565756011|FG000|Overall Study|Adverse Event|6|||
156728914|NCT04015518|565756012|FG001|Overall Study|Adverse Event|1|||
156728915|NCT04015518|565756013|FG002|Overall Study|Adverse Event|1|||
156728916|NCT04015518|565756014|FG003|Overall Study|Adverse Event|3|||
156728917|NCT04015518|565756015|FG004|Overall Study|Adverse Event|3|||
156728918|NCT04015518|565756011|FG000|Overall Study|Lack of Efficacy|1|||
156728919|NCT04015518|565756012|FG001|Overall Study|Lack of Efficacy|0|||
156728920|NCT04015518|565756013|FG002|Overall Study|Lack of Efficacy|1|||
156728921|NCT04015518|565756014|FG003|Overall Study|Lack of Efficacy|0|||
156728922|NCT04015518|565756015|FG004|Overall Study|Lack of Efficacy|4|||
156728923|NCT04015518|565756011|FG000|Overall Study|Lost to Follow-up|0|||
156728924|NCT04015518|565756012|FG001|Overall Study|Lost to Follow-up|0|||
157139343|NCT00446030|567255914|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
157139344|NCT00446030|567255915|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
156728925|NCT04015518|565756013|FG002|Overall Study|Lost to Follow-up|0|||
156728926|NCT04015518|565756014|FG003|Overall Study|Lost to Follow-up|0|||
156728927|NCT04015518|565756015|FG004|Overall Study|Lost to Follow-up|1|||
156728928|NCT04015518|565756011|FG000|Overall Study|Withdrawal by Subject|0|||
156728929|NCT04015518|565756012|FG001|Overall Study|Withdrawal by Subject|1|||
156728930|NCT04015518|565756013|FG002|Overall Study|Withdrawal by Subject|0|||
156728931|NCT04015518|565756014|FG003|Overall Study|Withdrawal by Subject|1|||
156728932|NCT04015518|565756015|FG004|Overall Study|Withdrawal by Subject|1|||
156728933|NCT04015518|565756011|FG000|Overall Study|Patient did not come for consecutive visits|0|||
156728934|NCT04015518|565756012|FG001|Overall Study|Patient did not come for consecutive visits|1|||
156728935|NCT04015518|565756013|FG002|Overall Study|Patient did not come for consecutive visits|0|||
156728936|NCT04015518|565756014|FG003|Overall Study|Patient did not come for consecutive visits|0|||
156728937|NCT04015518|565756015|FG004|Overall Study|Patient did not come for consecutive visits|0|||
156728938|NCT04015518|565756011|FG000|Overall Study|not willing to travel due to Covid-19|0|||
156728939|NCT04015518|565756012|FG001|Overall Study|not willing to travel due to Covid-19|0|||
156728940|NCT04015518|565756013|FG002|Overall Study|not willing to travel due to Covid-19|1|||
157139345|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
157139346|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
156728941|NCT04015518|565756014|FG003|Overall Study|not willing to travel due to Covid-19|0|||
156728942|NCT04015518|565756015|FG004|Overall Study|not willing to travel due to Covid-19|0|||
156728943|NCT04015518|565756011|FG000|Overall Study|Patient wants to discontinue treatment|0|||
156728944|NCT04015518|565756012|FG001|Overall Study|Patient wants to discontinue treatment|0|||
156728945|NCT04015518|565756013|FG002|Overall Study|Patient wants to discontinue treatment|0|||
156728946|NCT04015518|565756014|FG003|Overall Study|Patient wants to discontinue treatment|1|||
156728947|NCT04015518|565756015|FG004|Overall Study|Patient wants to discontinue treatment|0|||
156728948|NCT04015518|565756011|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
156728949|NCT04015518|565756012|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
156728950|NCT04015518|565756013|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
156876410|NCT00200356|566305828|FG001|Overall Study|Lack of Efficacy|3|||
156876411|NCT00200356|566305827|FG000|Overall Study|Protocol Violation|4|||
156728951|NCT04015518|565756014|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
156728952|NCT04015518|565756015|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
156728953|NCT04015518|565756011|FG000|Overall Study|Pregnancy|0|||
156728954|NCT04015518|565756012|FG001|Overall Study|Pregnancy|0|||
156876412|NCT00200356|566305828|FG001|Overall Study|Protocol Violation|4|||
156728955|NCT04015518|565756013|FG002|Overall Study|Pregnancy|0|||
156728956|NCT04015518|565756014|FG003|Overall Study|Pregnancy|0|||
156728957|NCT04015518|565756015|FG004|Overall Study|Pregnancy|1|||
156728958|NCT04015518|565756011|FG000|Overall Study|Personal reasons|1|||
156728959|NCT04015518|565756012|FG001|Overall Study|Personal reasons|0|||
156728960|NCT04015518|565756013|FG002|Overall Study|Personal reasons|0|||
156728961|NCT04015518|565756014|FG003|Overall Study|Personal reasons|0|||
156728962|NCT04015518|565756015|FG004|Overall Study|Personal reasons|1|||
156728963|NCT04015518|565756011|FG000|Overall Study|Withdrew consent|1|||
156728964|NCT04015518|565756012|FG001|Overall Study|Withdrew consent|0|||
156728965|NCT04015518|565756013|FG002|Overall Study|Withdrew consent|0|||
156728966|NCT04015518|565756014|FG003|Overall Study|Withdrew consent|0|||
156728967|NCT04015518|565756015|FG004|Overall Study|Withdrew consent|0|||
156728968|NCT04015518|565756011|FG000|Overall Study|Prostate carcinoma|1|||
156728969|NCT04015518|565756012|FG001|Overall Study|Prostate carcinoma|0|||
156728970|NCT04015518|565756013|FG002|Overall Study|Prostate carcinoma|0|||
156728971|NCT04015518|565756014|FG003|Overall Study|Prostate carcinoma|0|||
156728972|NCT04015518|565756015|FG004|Overall Study|Prostate carcinoma|0|||
156728973|NCT04015518|565756011|FG000|Overall Study|Could not keep appointments due to work|1|||
156728974|NCT04015518|565756012|FG001|Overall Study|Could not keep appointments due to work|0|||
156728975|NCT04015518|565756013|FG002|Overall Study|Could not keep appointments due to work|0|||
156728976|NCT04015518|565756014|FG003|Overall Study|Could not keep appointments due to work|0|||
156728977|NCT04015518|565756015|FG004|Overall Study|Could not keep appointments due to work|0|||
156728978|NCT02186873|565757223|FG000|Overall Study|Adverse Event|1|||
156728979|NCT02186873|565757224|FG001|Overall Study|Adverse Event|3|||
156728980|NCT02186873|565757223|FG000|Overall Study|Lack of Efficacy|0|||
156728981|NCT02186873|565757224|FG001|Overall Study|Lack of Efficacy|1|||
156728982|NCT02186873|565757223|FG000|Overall Study|Lost to Follow-up|1|||
156728983|NCT02186873|565757224|FG001|Overall Study|Lost to Follow-up|2|||
156728984|NCT02186873|565757223|FG000|Overall Study|Withdrawal by Subject|7|||
156728985|NCT02186873|565757224|FG001|Overall Study|Withdrawal by Subject|2|||
156728986|NCT03694002|565757225|FG000|Overall Study|Progression|4|||
156728987|NCT03694002|565757226|FG001|Overall Study|Progression|2|||
156728988|NCT03694002|565757225|FG000|Overall Study|Adverse Event|2|||
156728989|NCT03694002|565757226|FG001|Overall Study|Adverse Event|0|||
156728990|NCT03694002|565757225|FG000|Overall Study|Other not protocol specified|1|||
156728991|NCT03694002|565757226|FG001|Overall Study|Other not protocol specified|0|||
156728992|NCT03694002|565757225|FG000|Overall Study|Ineligible|0|||
156728993|NCT03694002|565757226|FG001|Overall Study|Ineligible|1|||
156728994|NCT03694002|565757225|FG000|Overall Study|Withdrew consent before starting treatment|0|||
156728995|NCT03694002|565757226|FG001|Overall Study|Withdrew consent before starting treatment|3|||
156728996|NCT01760655|565757227|FG000|Overall Study|Death|18|||
156728997|NCT01760655|565757227|FG000|Overall Study|Physician Decision|1|||
156728998|NCT03056638|565757232|FG000|Overall Study|Death|1|||
156728999|NCT03056638|565757233|FG001|Overall Study|Death|0|||
156729000|NCT02530125|565757234|FG000|Completed Treatment|Early termination of study|1|||
156729001|NCT02530125|565757234|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
156729002|NCT00468481|565757235|FG000|Overall Study|Adverse Event|13|||
156729003|NCT00468481|565757236|FG001|Overall Study|Adverse Event|3|||
156729004|NCT00468481|565757235|FG000|Overall Study|Lost to Follow-up|25|||
156729005|NCT00468481|565757236|FG001|Overall Study|Lost to Follow-up|8|||
156729006|NCT00468481|565757235|FG000|Overall Study|Pregnancy|2|||
156729007|NCT00468481|565757236|FG001|Overall Study|Pregnancy|0|||
156729008|NCT00468481|565757235|FG000|Overall Study|Protocol Violation|18|||
156876413|NCT00200356|566305827|FG000|Overall Study|Nontreatment|1|||
156876414|NCT00200356|566305828|FG001|Overall Study|Nontreatment|0|||
156876415|NCT00035932|566305833|FG000|Overall Study|Adverse Event|10|||
156876416|NCT00035932|566305834|FG001|Overall Study|Adverse Event|9|||
156729009|NCT00468481|565757236|FG001|Overall Study|Protocol Violation|8|||
156729010|NCT00468481|565757235|FG000|Overall Study|Withdrawal by Subject|12|||
156729011|NCT00468481|565757236|FG001|Overall Study|Withdrawal by Subject|3|||
156729012|NCT00468481|565757235|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
156729013|NCT00468481|565757236|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
156729014|NCT00468481|565757235|FG000|Overall Study|Prohibited Medication|1|||
156729015|NCT00468481|565757236|FG001|Overall Study|Prohibited Medication|1|||
156729016|NCT00468481|565757235|FG000|Overall Study|Egg Donor|1|||
156729017|NCT00468481|565757236|FG001|Overall Study|Egg Donor|0|||
156729018|NCT00468481|565757235|FG000|Overall Study|Moved out of area|4|||
156729019|NCT00468481|565757236|FG001|Overall Study|Moved out of area|1|||
156729020|NCT00468481|565757235|FG000|Overall Study|Non-Compliance|5|||
156876417|NCT00035932|566305835|FG002|Overall Study|Adverse Event|9|||
156729021|NCT00468481|565757236|FG001|Overall Study|Non-Compliance|0|||
156729022|NCT00468481|565757235|FG000|Overall Study|Other|6|||
156729023|NCT00468481|565757236|FG001|Overall Study|Other|0|||
156729024|NCT00728468|565757238|FG000|Overall Study|Enrolled but not treated|1|||
156729025|NCT00728468|565757238|FG000|Overall Study|Death|1|||
156729026|NCT00728468|565757238|FG000|Overall Study|Protocol Violation|4|||
156729027|NCT00728468|565757238|FG000|Overall Study|Objective progression or relapse|9|||
156729028|NCT00728468|565757238|FG000|Overall Study|Study terminated by sponsor|1|||
156729029|NCT01568034|565757239|FG000|Overall Study|Withdrawal by Subject|1|||
156729030|NCT01568034|565757240|FG001|Overall Study|Withdrawal by Subject|0|||
156729031|NCT01568034|565757241|FG002|Overall Study|Withdrawal by Subject|0|||
156729032|NCT01568034|565757242|FG003|Overall Study|Withdrawal by Subject|0|||
156729033|NCT00596687|565757243|FG000|Overall Study|< 24 hours of insulin treatment|8|||
156729034|NCT00596687|565757244|FG001|Overall Study|< 24 hours of insulin treatment|6|||
156729035|NCT00596687|565757243|FG000|Overall Study|continuous insulin infusion during TPN|2|||
156729036|NCT00596687|565757244|FG001|Overall Study|continuous insulin infusion during TPN|1|||
156729037|NCT00596687|565757243|FG000|Overall Study|Withdrawal by Subject|3|||
156729038|NCT00596687|565757244|FG001|Overall Study|Withdrawal by Subject|1|||
156729039|NCT00596687|565757243|FG000|Overall Study|cancelled surgery|1|||
156729040|NCT00596687|565757244|FG001|Overall Study|cancelled surgery|1|||
156729041|NCT06098339|565757245|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
156729042|NCT06098339|565757246|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
156729043|NCT06098339|565757245|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
156729044|NCT06098339|565757246|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
156729045|NCT03831113|565757247|FG000|Overall Study|Withdrawal by Subject|0|||
156729046|NCT03831113|565757248|FG001|Overall Study|Withdrawal by Subject|2|||
156729047|NCT03831113|565757247|FG000|Overall Study|Protocol Violation|0|||
156729048|NCT03831113|565757248|FG001|Overall Study|Protocol Violation|9|||
156729049|NCT02510664|565757259|FG000|Overall Study|Transferred Care|9|||
156729050|NCT02510664|565757260|FG001|Overall Study|Transferred Care|9|||
156729051|NCT02510664|565757261|FG002|Overall Study|Transferred Care|0|||
156729052|NCT02510664|565757259|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
156729053|NCT02510664|565757260|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
156729054|NCT02510664|565757261|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
156729055|NCT02510664|565757259|FG000|Overall Study|Time Constraints|1|||
156729056|NCT02510664|565757260|FG001|Overall Study|Time Constraints|1|||
156729057|NCT02510664|565757261|FG002|Overall Study|Time Constraints|0|||
156729058|NCT01718535|565757277|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
156729059|NCT01718535|565757278|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
156729060|NCT01718535|565757279|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
156729061|NCT01718535|565757280|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
156729062|NCT01718535|565757281|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
156729063|NCT01718535|565757282|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
156729064|NCT01718535|565757283|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
156729065|NCT01718535|565757284|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
156729066|NCT01718535|565757285|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
156729067|NCT01718535|565757286|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
156729068|NCT02476578|565757287|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
156729069|NCT02476578|565757288|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
156729070|NCT02476578|565757287|FG000|Overall Study|Lost to Follow-up|6|||
156729071|NCT02476578|565757288|FG001|Overall Study|Lost to Follow-up|13|||
156729072|NCT04747886|565757289|FG000|Overall Study|Withdrawal by Subject|1|||
156729073|NCT04747886|565757290|FG001|Overall Study|Withdrawal by Subject|4|||
156729074|NCT00820248|565757291|FG000|Overall Study|No treated|4|||
156729075|NCT00820248|565757292|FG001|Overall Study|No treated|1|||
156729076|NCT01057810|565757293|FG000|Overall Study|Disease progression|156|||
156729077|NCT01057810|565757294|FG001|Overall Study|Disease progression|197|||
156729078|NCT01057810|565757293|FG000|Overall Study|Study drug toxicity|5|||
156796196|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156796197|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
156796198|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156729079|NCT01057810|565757294|FG001|Overall Study|Study drug toxicity|114|||
156729080|NCT01057810|565757293|FG000|Overall Study|Adverse event unrelated to study drug|13|||
156729081|NCT01057810|565757294|FG001|Overall Study|Adverse event unrelated to study drug|29|||
156729082|NCT01057810|565757293|FG000|Overall Study|Withdrawal by Subject|10|||
156729083|NCT01057810|565757294|FG001|Overall Study|Withdrawal by Subject|25|||
156729084|NCT01057810|565757293|FG000|Overall Study|Death|2|||
156729085|NCT01057810|565757294|FG001|Overall Study|Death|12|||
156729086|NCT01057810|565757293|FG000|Overall Study|Maximum clinical benefit|5|||
156729087|NCT01057810|565757294|FG001|Overall Study|Maximum clinical benefit|5|||
156729088|NCT01057810|565757293|FG000|Overall Study|Poor/non-compliance|0|||
156729089|NCT01057810|565757294|FG001|Overall Study|Poor/non-compliance|1|||
157139347|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
157139348|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
157139349|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
157139350|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
156729090|NCT01057810|565757293|FG000|Overall Study|No longer met study criteria|0|||
156729091|NCT01057810|565757294|FG001|Overall Study|No longer met study criteria|1|||
156729092|NCT01057810|565757293|FG000|Overall Study|Other|7|||
156729093|NCT01057810|565757294|FG001|Overall Study|Other|14|||
156729094|NCT00267969|565757295|FG000|Controlled Period|Adverse Event|6|||
156729095|NCT00267969|565757296|FG001|Controlled Period|Adverse Event|0|||
156729096|NCT00267969|565757297|FG002|Controlled Period|Adverse Event|2|||
156729097|NCT00267969|565757298|FG003|Controlled Period|Adverse Event|0|||
156729098|NCT00267969|565757299|FG004|Controlled Period|Adverse Event|0|||
156729099|NCT00267969|565757300|FG005|Controlled Period|Adverse Event|0|||
156729100|NCT00267969|565757301|FG006|Controlled Period|Adverse Event|0|||
156729101|NCT00267969|565757295|FG000|Controlled Period|Lack of Efficacy|3|||
156729102|NCT00267969|565757296|FG001|Controlled Period|Lack of Efficacy|0|||
156729103|NCT00267969|565757297|FG002|Controlled Period|Lack of Efficacy|1|||
156729104|NCT00267969|565757298|FG003|Controlled Period|Lack of Efficacy|0|||
156729105|NCT00267969|565757299|FG004|Controlled Period|Lack of Efficacy|0|||
156729106|NCT00267969|565757300|FG005|Controlled Period|Lack of Efficacy|0|||
156729107|NCT00267969|565757301|FG006|Controlled Period|Lack of Efficacy|0|||
156729108|NCT00267969|565757295|FG000|Controlled Period|Lost to Follow-up|1|||
156729109|NCT00267969|565757296|FG001|Controlled Period|Lost to Follow-up|0|||
156729110|NCT00267969|565757297|FG002|Controlled Period|Lost to Follow-up|1|||
156729111|NCT00267969|565757298|FG003|Controlled Period|Lost to Follow-up|0|||
156729112|NCT00267969|565757299|FG004|Controlled Period|Lost to Follow-up|0|||
156729113|NCT00267969|565757300|FG005|Controlled Period|Lost to Follow-up|0|||
156729114|NCT00267969|565757301|FG006|Controlled Period|Lost to Follow-up|0|||
156729115|NCT00267969|565757295|FG000|Controlled Period|Randomized but not treated|0|||
156729116|NCT00267969|565757296|FG001|Controlled Period|Randomized but not treated|0|||
156729117|NCT00267969|565757297|FG002|Controlled Period|Randomized but not treated|1|||
156729118|NCT00267969|565757298|FG003|Controlled Period|Randomized but not treated|0|||
156729119|NCT00267969|565757299|FG004|Controlled Period|Randomized but not treated|0|||
156729120|NCT00267969|565757300|FG005|Controlled Period|Randomized but not treated|0|||
156729121|NCT00267969|565757301|FG006|Controlled Period|Randomized but not treated|0|||
156729122|NCT00267969|565757295|FG000|Controlled Period|Other|2|||
156729123|NCT00267969|565757296|FG001|Controlled Period|Other|1|||
156729124|NCT00267969|565757297|FG002|Controlled Period|Other|6|||
156729125|NCT00267969|565757298|FG003|Controlled Period|Other|0|||
156729126|NCT00267969|565757299|FG004|Controlled Period|Other|0|||
156729127|NCT00267969|565757300|FG005|Controlled Period|Other|0|||
156729128|NCT00267969|565757301|FG006|Controlled Period|Other|0|||
156729129|NCT00267969|565757295|FG000|After Controlled Period|Adverse Event|0|||
156729130|NCT00267969|565757296|FG001|After Controlled Period|Adverse Event|0|||
156729131|NCT00267969|565757297|FG002|After Controlled Period|Adverse Event|0|||
156729132|NCT00267969|565757298|FG003|After Controlled Period|Adverse Event|7|||
156729133|NCT00267969|565757299|FG004|After Controlled Period|Adverse Event|8|||
156729134|NCT00267969|565757300|FG005|After Controlled Period|Adverse Event|23|||
156729135|NCT00267969|565757301|FG006|After Controlled Period|Adverse Event|21|||
156729136|NCT00267969|565757295|FG000|After Controlled Period|Death|0|||
156729137|NCT00267969|565757296|FG001|After Controlled Period|Death|0|||
156729138|NCT00267969|565757297|FG002|After Controlled Period|Death|0|||
156729139|NCT00267969|565757298|FG003|After Controlled Period|Death|1|||
156729140|NCT00267969|565757299|FG004|After Controlled Period|Death|2|||
156729141|NCT00267969|565757300|FG005|After Controlled Period|Death|0|||
156729142|NCT00267969|565757301|FG006|After Controlled Period|Death|1|||
156729143|NCT00267969|565757295|FG000|After Controlled Period|Lack of Efficacy|0|||
156729144|NCT00267969|565757296|FG001|After Controlled Period|Lack of Efficacy|0|||
156729145|NCT00267969|565757297|FG002|After Controlled Period|Lack of Efficacy|0|||
156729146|NCT00267969|565757298|FG003|After Controlled Period|Lack of Efficacy|10|||
156729147|NCT00267969|565757299|FG004|After Controlled Period|Lack of Efficacy|6|||
156729148|NCT00267969|565757300|FG005|After Controlled Period|Lack of Efficacy|28|||
156729149|NCT00267969|565757301|FG006|After Controlled Period|Lack of Efficacy|15|||
156729150|NCT00267969|565757295|FG000|After Controlled Period|Lost to Follow-up|0|||
156729151|NCT00267969|565757296|FG001|After Controlled Period|Lost to Follow-up|0|||
156729152|NCT00267969|565757297|FG002|After Controlled Period|Lost to Follow-up|0|||
157139351|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
156729153|NCT00267969|565757298|FG003|After Controlled Period|Lost to Follow-up|5|||
156729154|NCT00267969|565757299|FG004|After Controlled Period|Lost to Follow-up|8|||
156729155|NCT00267969|565757300|FG005|After Controlled Period|Lost to Follow-up|9|||
156729156|NCT00267969|565757301|FG006|After Controlled Period|Lost to Follow-up|10|||
156729157|NCT00267969|565757295|FG000|After Controlled Period|Other|0|||
156729158|NCT00267969|565757296|FG001|After Controlled Period|Other|0|||
156729159|NCT00267969|565757297|FG002|After Controlled Period|Other|0|||
156729160|NCT00267969|565757298|FG003|After Controlled Period|Other|13|||
157139352|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
156729161|NCT00267969|565757299|FG004|After Controlled Period|Other|11|||
156729162|NCT00267969|565757300|FG005|After Controlled Period|Other|22|||
156729163|NCT00267969|565757301|FG006|After Controlled Period|Other|25|||
156729164|NCT00887315|565757302|FG000|Overall Study|Study termination|7|||
156729165|NCT00887315|565757303|FG001|Overall Study|Study termination|4|||
156729166|NCT00619892|565757304|FG000|Overall Study|Adverse Event|3|||
156729167|NCT00619892|565757305|FG001|Overall Study|Adverse Event|0|||
156729168|NCT00619892|565757304|FG000|Overall Study|Lost to Follow-up|0|||
156729169|NCT00619892|565757305|FG001|Overall Study|Lost to Follow-up|1|||
156729170|NCT00619892|565757304|FG000|Overall Study|Intercurrent illness|0|||
156729171|NCT00619892|565757305|FG001|Overall Study|Intercurrent illness|1|||
156729172|NCT01091662|565757309|FG000|Overall Study|Adverse Event|1|||
156729173|NCT01091662|565757310|FG001|Overall Study|Adverse Event|9|||
156729174|NCT01091662|565757309|FG000|Overall Study|Physician Decision|1|||
156729175|NCT01091662|565757310|FG001|Overall Study|Physician Decision|1|||
156729176|NCT01091662|565757309|FG000|Overall Study|Withdrawal by Subject|7|||
156729177|NCT01091662|565757310|FG001|Overall Study|Withdrawal by Subject|6|||
156729178|NCT01091662|565757309|FG000|Overall Study|met exit criteria|7|||
156729179|NCT01091662|565757310|FG001|Overall Study|met exit criteria|13|||
156729180|NCT01091662|565757309|FG000|Overall Study|met exclusion criteria|1|||
156729181|NCT01091662|565757310|FG001|Overall Study|met exclusion criteria|0|||
156729182|NCT01091662|565757309|FG000|Overall Study|Lost to Follow-up|0|||
156729183|NCT01091662|565757310|FG001|Overall Study|Lost to Follow-up|1|||
156729184|NCT01091662|565757309|FG000|Overall Study|Pregnancy|0|||
156729185|NCT01091662|565757310|FG001|Overall Study|Pregnancy|1|||
156729186|NCT01091662|565757309|FG000|Overall Study|Protocol Violation|0|||
156729187|NCT01091662|565757310|FG001|Overall Study|Protocol Violation|2|||
156729188|NCT01091662|565757309|FG000|Overall Study|unable to swallow capsule|0|||
156729189|NCT01091662|565757310|FG001|Overall Study|unable to swallow capsule|1|||
156729190|NCT00443079|565757313|FG000|Overall Study|Lost to Follow-up|0|||
156729191|NCT00443079|565757314|FG001|Overall Study|Lost to Follow-up|1|||
156729192|NCT02649439|565757315|FG000|Overall Study|Switched to alternative treatment|6|||
156729193|NCT02649439|565757316|FG001|Overall Study|Switched to alternative treatment|4|||
156729194|NCT02649439|565757315|FG000|Overall Study|Patient decision|1|||
156729195|NCT02649439|565757316|FG001|Overall Study|Patient decision|0|||
156729196|NCT02649439|565757315|FG000|Overall Study|Patient going out of country|1|||
156729197|NCT02649439|565757316|FG001|Overall Study|Patient going out of country|0|||
156729198|NCT02649439|565757315|FG000|Overall Study|To start finasteride|1|||
156729199|NCT02649439|565757316|FG001|Overall Study|To start finasteride|0|||
156729200|NCT02649439|565757315|FG000|Overall Study|Physician Decision|1|||
156729201|NCT02649439|565757316|FG001|Overall Study|Physician Decision|0|||
156729202|NCT02649439|565757315|FG000|Overall Study|Disease progression on study|12|||
156729203|NCT02649439|565757316|FG001|Overall Study|Disease progression on study|13|||
156729204|NCT02649439|565757315|FG000|Overall Study|Refused further treatment|1|||
156729205|NCT02649439|565757316|FG001|Overall Study|Refused further treatment|0|||
156729206|NCT02649439|565757315|FG000|Overall Study|Refused further follow up|2|||
156729207|NCT02649439|565757316|FG001|Overall Study|Refused further follow up|7|||
156729208|NCT02649439|565757315|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
156729209|NCT02649439|565757316|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
156729210|NCT02649439|565757315|FG000|Overall Study|No treatment, per protocol|1|||
156729211|NCT02649439|565757316|FG001|Overall Study|No treatment, per protocol|0|||
156729212|NCT02649439|565757315|FG000|Overall Study|PSA DT makes ineligible|0|||
156729213|NCT02649439|565757316|FG001|Overall Study|PSA DT makes ineligible|1|||
156729214|NCT02649439|565757315|FG000|Overall Study|Rising PSA No Mets|0|||
156729215|NCT02649439|565757316|FG001|Overall Study|Rising PSA No Mets|1|||
156729216|NCT02649439|565757315|FG000|Overall Study|Rising PSA|0|||
156729217|NCT02649439|565757316|FG001|Overall Study|Rising PSA|1|||
157217439|NCT01621490|567543228|FG006|Overall Study|Adverse event unrelated to study drug|0|||
157217440|NCT01621490|567543229|FG007|Overall Study|Adverse event unrelated to study drug|2|||
157217441|NCT01621490|567543230|FG008|Overall Study|Adverse event unrelated to study drug|0|||
157217442|NCT01621490|567543231|FG009|Overall Study|Adverse event unrelated to study drug|0|||
157217443|NCT01621490|567543232|FG010|Overall Study|Adverse event unrelated to study drug|0|||
156729218|NCT02649439|565757315|FG000|Overall Study|Signed follow up protocol|0|||
156729219|NCT02649439|565757316|FG001|Overall Study|Signed follow up protocol|1|||
156729220|NCT02677922|565757319|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
156729221|NCT02677922|565757320|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
156729222|NCT02677922|565757321|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
156729223|NCT02677922|565757322|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
156729224|NCT02677922|565757323|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
156729225|NCT02677922|565757324|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
156729226|NCT02677922|565757319|FG000|Treatment Period|Adverse Event|0|||
156729227|NCT02677922|565757320|FG001|Treatment Period|Adverse Event|0|||
156729228|NCT02677922|565757321|FG002|Treatment Period|Adverse Event|1|||
156729229|NCT02677922|565757322|FG003|Treatment Period|Adverse Event|3|||
156729230|NCT02677922|565757323|FG004|Treatment Period|Adverse Event|5|||
156729231|NCT02677922|565757324|FG005|Treatment Period|Adverse Event|2|||
156729232|NCT02677922|565757319|FG000|Treatment Period|Progressive Disease|1|||
156729233|NCT02677922|565757320|FG001|Treatment Period|Progressive Disease|1|||
156729234|NCT02677922|565757321|FG002|Treatment Period|Progressive Disease|0|||
156729235|NCT02677922|565757322|FG003|Treatment Period|Progressive Disease|0|||
156729236|NCT02677922|565757323|FG004|Treatment Period|Progressive Disease|8|||
156729237|NCT02677922|565757324|FG005|Treatment Period|Progressive Disease|7|||
156729238|NCT02677922|565757319|FG000|Treatment Period|Lack of Efficacy|0|||
156729239|NCT02677922|565757320|FG001|Treatment Period|Lack of Efficacy|0|||
156729240|NCT02677922|565757321|FG002|Treatment Period|Lack of Efficacy|0|||
156729241|NCT02677922|565757322|FG003|Treatment Period|Lack of Efficacy|1|||
156729242|NCT02677922|565757323|FG004|Treatment Period|Lack of Efficacy|1|||
156729243|NCT02677922|565757324|FG005|Treatment Period|Lack of Efficacy|6|||
156729244|NCT02677922|565757319|FG000|Treatment Period|Withdrawal by Subject|0|||
156729245|NCT02677922|565757320|FG001|Treatment Period|Withdrawal by Subject|0|||
156729246|NCT02677922|565757321|FG002|Treatment Period|Withdrawal by Subject|1|||
156729247|NCT02677922|565757322|FG003|Treatment Period|Withdrawal by Subject|3|||
156729248|NCT02677922|565757323|FG004|Treatment Period|Withdrawal by Subject|5|||
156729249|NCT02677922|565757324|FG005|Treatment Period|Withdrawal by Subject|5|||
156729250|NCT02677922|565757319|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
156729251|NCT02677922|565757320|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
156729252|NCT02677922|565757321|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
156729253|NCT02677922|565757322|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
156729254|NCT02677922|565757323|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
156729255|NCT02677922|565757324|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
156729256|NCT02677922|565757319|FG000|Treatment Period|Disease Relapse|0|||
156729257|NCT02677922|565757320|FG001|Treatment Period|Disease Relapse|0|||
156729258|NCT02677922|565757321|FG002|Treatment Period|Disease Relapse|0|||
156729259|NCT02677922|565757322|FG003|Treatment Period|Disease Relapse|3|||
156729260|NCT02677922|565757323|FG004|Treatment Period|Disease Relapse|6|||
156729261|NCT02677922|565757324|FG005|Treatment Period|Disease Relapse|1|||
156729262|NCT02677922|565757319|FG000|Treatment Period|Allogeneic HSCT|1|||
156729263|NCT02677922|565757320|FG001|Treatment Period|Allogeneic HSCT|0|||
156729264|NCT02677922|565757321|FG002|Treatment Period|Allogeneic HSCT|0|||
156729265|NCT02677922|565757322|FG003|Treatment Period|Allogeneic HSCT|1|||
156729266|NCT02677922|565757323|FG004|Treatment Period|Allogeneic HSCT|4|||
156729267|NCT02677922|565757324|FG005|Treatment Period|Allogeneic HSCT|1|||
156729268|NCT02677922|565757319|FG000|Treatment Period|Other Reasons|0|||
156729269|NCT02677922|565757320|FG001|Treatment Period|Other Reasons|0|||
156729270|NCT02677922|565757321|FG002|Treatment Period|Other Reasons|0|||
156729271|NCT02677922|565757322|FG003|Treatment Period|Other Reasons|1|||
156729272|NCT02677922|565757323|FG004|Treatment Period|Other Reasons|3|||
156729273|NCT02677922|565757324|FG005|Treatment Period|Other Reasons|5|||
156729274|NCT02677922|565757319|FG000|Treatment Period|Death|0|||
156729275|NCT02677922|565757320|FG001|Treatment Period|Death|0|||
156729276|NCT02677922|565757321|FG002|Treatment Period|Death|0|||
156796199|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
156729277|NCT02677922|565757322|FG003|Treatment Period|Death|0|||
156729278|NCT02677922|565757323|FG004|Treatment Period|Death|12|||
156729279|NCT02677922|565757324|FG005|Treatment Period|Death|1|||
156729280|NCT02677922|565757319|FG000|Treatment Period|Non-compliance with Study Drug|0|||
156729281|NCT02677922|565757320|FG001|Treatment Period|Non-compliance with Study Drug|0|||
156729282|NCT02677922|565757321|FG002|Treatment Period|Non-compliance with Study Drug|0|||
156729283|NCT02677922|565757322|FG003|Treatment Period|Non-compliance with Study Drug|0|||
156729284|NCT02677922|565757323|FG004|Treatment Period|Non-compliance with Study Drug|1|||
156729285|NCT02677922|565757324|FG005|Treatment Period|Non-compliance with Study Drug|0|||
156796200|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796201|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796202|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796203|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796204|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796205|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
156729286|NCT02677922|565757319|FG000|Treatment Period|Physician Decision|0|||
156729287|NCT02677922|565757320|FG001|Treatment Period|Physician Decision|0|||
156729288|NCT02677922|565757321|FG002|Treatment Period|Physician Decision|0|||
156729289|NCT02677922|565757322|FG003|Treatment Period|Physician Decision|0|||
156729290|NCT02677922|565757323|FG004|Treatment Period|Physician Decision|0|||
156796206|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796207|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156729291|NCT02677922|565757324|FG005|Treatment Period|Physician Decision|1|||
156729292|NCT02677922|565757319|FG000|Treatment Period|Symptomatic Deterioration|0|||
156729293|NCT02677922|565757320|FG001|Treatment Period|Symptomatic Deterioration|0|||
156729294|NCT02677922|565757321|FG002|Treatment Period|Symptomatic Deterioration|0|||
156729295|NCT02677922|565757322|FG003|Treatment Period|Symptomatic Deterioration|0|||
156729296|NCT02677922|565757323|FG004|Treatment Period|Symptomatic Deterioration|1|||
156796208|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
156796209|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796210|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
156796211|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796212|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796213|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796214|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796215|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796216|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
157019857|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157019858|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157019859|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157019860|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
157139353|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
157139354|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
157139355|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
157139356|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
157139357|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
157139358|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
157139359|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
157139360|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
157139361|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
157139362|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
157139363|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
157139364|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
157139365|NCT00446030|567255914|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
157139366|NCT00446030|567255915|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
157139367|NCT02886715|567255916|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157139368|NCT02886715|567255917|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156729297|NCT02677922|565757324|FG005|Treatment Period|Symptomatic Deterioration|0|||
156729298|NCT05708976|565757327|FG000|Overall Study|Withdrawal by Subject|0|||
156729299|NCT05708976|565757328|FG001|Overall Study|Withdrawal by Subject|1|||
156729300|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
156729301|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
156729302|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
156729303|NCT00403481|565757329|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
156729304|NCT00403481|565757329|FG000|Olm 40 mg|Adverse Event|2|||
156729305|NCT00403481|565757329|FG000|Olm 40 mg|Protocol Violation|1|||
156729306|NCT00403481|565757329|FG000|Olm 40 mg|Withdrawal by Subject|1|||
156729307|NCT00403481|565757329|FG000|Olm 40 mg|Other|1|||
156729308|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
156729309|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
156729310|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
156729311|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
156729312|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
156729313|NCT00403481|565757329|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
156729314|NCT02929589|565757331|FG000|Overall Study|Withdrawal by Subject|1|||
156729315|NCT02929589|565757332|FG001|Overall Study|Withdrawal by Subject|0|||
156729316|NCT02929589|565757333|FG002|Overall Study|Withdrawal by Subject|0|||
156729317|NCT02929589|565757334|FG003|Overall Study|Withdrawal by Subject|0|||
156729318|NCT02929589|565757331|FG000|Overall Study|Physician Decision|2|||
156729319|NCT02929589|565757332|FG001|Overall Study|Physician Decision|0|||
156729320|NCT02929589|565757333|FG002|Overall Study|Physician Decision|0|||
156729321|NCT02929589|565757334|FG003|Overall Study|Physician Decision|0|||
156729322|NCT00396656|565757335|FG000|First Treatment Period|Withdrawal by Subject|0|||
156729323|NCT00396656|565757336|FG001|First Treatment Period|Withdrawal by Subject|2|||
156796217|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796218|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796219|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
156796220|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
156796221|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
157019861|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
157139369|NCT02886715|567255918|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157139370|NCT02886715|567255916|FG000|Overall Study|Adverse Event|4|||
157217444|NCT01621490|567543222|FG000|Overall Study|Disease progression|27|||
156729324|NCT00396656|565757335|FG000|Second Treatment Period|Adverse Event|0|||
156729325|NCT00396656|565757336|FG001|Second Treatment Period|Adverse Event|1|||
156729326|NCT02343939|565757338|FG000|Overall Study|Death|0|||
156729327|NCT02343939|565757339|FG001|Overall Study|Death|15|||
156729328|NCT02343939|565757340|FG002|Overall Study|Death|4|||
156729329|NCT02343939|565757341|FG003|Overall Study|Death|2|||
156729330|NCT02343939|565757342|FG004|Overall Study|Death|5|||
156729331|NCT02343939|565757343|FG005|Overall Study|Death|11|||
156729332|NCT02343939|565757344|FG006|Overall Study|Death|8|||
156729333|NCT02343939|565757345|FG007|Overall Study|Death|22|||
156729334|NCT02343939|565757346|FG008|Overall Study|Death|1|||
156729335|NCT02343939|565757338|FG000|Overall Study|Study terminated by sponsor|0|||
156729336|NCT02343939|565757339|FG001|Overall Study|Study terminated by sponsor|27|||
156796222|NCT02471144|566007979|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796223|NCT02471144|566007980|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796224|NCT02471144|566007981|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796225|NCT02471144|566007982|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796226|NCT02471144|566007983|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796227|NCT02471144|566007984|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156729337|NCT02343939|565757340|FG002|Overall Study|Study terminated by sponsor|0|||
156729338|NCT02343939|565757341|FG003|Overall Study|Study terminated by sponsor|1|||
156729339|NCT02343939|565757342|FG004|Overall Study|Study terminated by sponsor|1|||
156729340|NCT02343939|565757343|FG005|Overall Study|Study terminated by sponsor|5|||
156729341|NCT02343939|565757344|FG006|Overall Study|Study terminated by sponsor|3|||
156729342|NCT02343939|565757345|FG007|Overall Study|Study terminated by sponsor|4|||
156729343|NCT02343939|565757346|FG008|Overall Study|Study terminated by sponsor|0|||
156796228|NCT02471144|566007985|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796229|NCT02471144|566007986|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
156796230|NCT02471144|566007987|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
156796231|NCT02471144|566007988|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796232|NCT02471144|566007989|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
156796233|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796234|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796235|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796236|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796237|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796238|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156876418|NCT00035932|566305833|FG000|Overall Study|Death|0|||
156876419|NCT00035932|566305834|FG001|Overall Study|Death|0|||
156876420|NCT00035932|566305835|FG002|Overall Study|Death|1|||
156876421|NCT00035932|566305833|FG000|Overall Study|Disease Progression / Relapse|1|||
156876422|NCT00035932|566305834|FG001|Overall Study|Disease Progression / Relapse|1|||
156876423|NCT00035932|566305835|FG002|Overall Study|Disease Progression / Relapse|0|||
156876424|NCT00035932|566305833|FG000|Overall Study|Lost to Follow-up|4|||
156876425|NCT00035932|566305834|FG001|Overall Study|Lost to Follow-up|4|||
156876426|NCT00035932|566305835|FG002|Overall Study|Lost to Follow-up|3|||
156876427|NCT00035932|566305833|FG000|Overall Study|Noncompliance|6|||
156876428|NCT00035932|566305834|FG001|Overall Study|Noncompliance|7|||
156876429|NCT00035932|566305835|FG002|Overall Study|Noncompliance|6|||
156876430|NCT00035932|566305833|FG000|Overall Study|Protocol Violation While on Study|0|||
156876431|NCT00035932|566305834|FG001|Overall Study|Protocol Violation While on Study|1|||
156876432|NCT00035932|566305835|FG002|Overall Study|Protocol Violation While on Study|2|||
156876433|NCT00035932|566305833|FG000|Overall Study|Withdrawal by Subject|1|||
156876434|NCT00035932|566305834|FG001|Overall Study|Withdrawal by Subject|5|||
156876435|NCT00035932|566305835|FG002|Overall Study|Withdrawal by Subject|0|||
156876436|NCT00035932|566305833|FG000|Overall Study|Study Termination by Sponsor|1|||
156876437|NCT00035932|566305834|FG001|Overall Study|Study Termination by Sponsor|0|||
156876438|NCT00035932|566305835|FG002|Overall Study|Study Termination by Sponsor|0|||
156876439|NCT00035932|566305833|FG000|Overall Study|Lack of Efficacy|33|||
156876440|NCT00035932|566305834|FG001|Overall Study|Lack of Efficacy|33|||
156876441|NCT00035932|566305835|FG002|Overall Study|Lack of Efficacy|28|||
157217445|NCT01621490|567543223|FG001|Overall Study|Disease progression|28|||
157217446|NCT01621490|567543224|FG002|Overall Study|Disease progression|1|||
156729344|NCT02343939|565757338|FG000|Overall Study|Withdrew consent|3|||
156729345|NCT02343939|565757339|FG001|Overall Study|Withdrew consent|6|||
156729346|NCT02343939|565757340|FG002|Overall Study|Withdrew consent|1|||
156729347|NCT02343939|565757341|FG003|Overall Study|Withdrew consent|2|||
156796239|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796240|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156796241|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
156729348|NCT02343939|565757342|FG004|Overall Study|Withdrew consent|2|||
156729349|NCT02343939|565757343|FG005|Overall Study|Withdrew consent|0|||
156796242|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
156796243|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
156876442|NCT00889720|566305838|FG000|Overall Study|Withdrawal by Subject|4|||
156876443|NCT00889720|566305838|FG000|Overall Study|Other|4|||
156876444|NCT04080167|566305839|FG000|Overall Study|Lost to Follow-up-Patients|7|||
156876445|NCT04080167|566305840|FG001|Overall Study|Lost to Follow-up-Patients|14|||
157139371|NCT02886715|567255917|FG001|Overall Study|Adverse Event|2|||
157139372|NCT02886715|567255918|FG002|Overall Study|Adverse Event|0|||
157139373|NCT02886715|567255916|FG000|Overall Study|Lack of Efficacy|0|||
157139374|NCT02886715|567255917|FG001|Overall Study|Lack of Efficacy|2|||
156729350|NCT02343939|565757344|FG006|Overall Study|Withdrew consent|0|||
156729351|NCT02343939|565757345|FG007|Overall Study|Withdrew consent|8|||
156729352|NCT02343939|565757346|FG008|Overall Study|Withdrew consent|6|||
156729353|NCT02343939|565757338|FG000|Overall Study|Treatment failure|0|||
156729354|NCT02343939|565757339|FG001|Overall Study|Treatment failure|0|||
156729355|NCT02343939|565757340|FG002|Overall Study|Treatment failure|0|||
156729356|NCT02343939|565757341|FG003|Overall Study|Treatment failure|0|||
156729357|NCT02343939|565757342|FG004|Overall Study|Treatment failure|0|||
156729358|NCT02343939|565757343|FG005|Overall Study|Treatment failure|0|||
156729359|NCT02343939|565757344|FG006|Overall Study|Treatment failure|2|||
156729360|NCT02343939|565757345|FG007|Overall Study|Treatment failure|1|||
156729361|NCT02343939|565757346|FG008|Overall Study|Treatment failure|0|||
156729362|NCT02343939|565757338|FG000|Overall Study|Investigator's discretion|0|||
156729363|NCT02343939|565757339|FG001|Overall Study|Investigator's discretion|0|||
156729364|NCT02343939|565757340|FG002|Overall Study|Investigator's discretion|0|||
156729365|NCT02343939|565757341|FG003|Overall Study|Investigator's discretion|1|||
156729366|NCT02343939|565757342|FG004|Overall Study|Investigator's discretion|0|||
156729367|NCT02343939|565757343|FG005|Overall Study|Investigator's discretion|0|||
156729368|NCT02343939|565757344|FG006|Overall Study|Investigator's discretion|1|||
156729369|NCT02343939|565757345|FG007|Overall Study|Investigator's discretion|0|||
156729370|NCT02343939|565757346|FG008|Overall Study|Investigator's discretion|0|||
156729371|NCT02343939|565757338|FG000|Overall Study|Adverse Event|0|||
156729372|NCT02343939|565757339|FG001|Overall Study|Adverse Event|0|||
156729373|NCT02343939|565757340|FG002|Overall Study|Adverse Event|0|||
156729374|NCT02343939|565757341|FG003|Overall Study|Adverse Event|0|||
156729375|NCT02343939|565757342|FG004|Overall Study|Adverse Event|0|||
156729376|NCT02343939|565757343|FG005|Overall Study|Adverse Event|1|||
156729377|NCT02343939|565757344|FG006|Overall Study|Adverse Event|0|||
156729378|NCT02343939|565757345|FG007|Overall Study|Adverse Event|0|||
156729379|NCT02343939|565757346|FG008|Overall Study|Adverse Event|0|||
156729380|NCT02343939|565757338|FG000|Overall Study|Never Treated With ENTO|0|||
156729381|NCT02343939|565757339|FG001|Overall Study|Never Treated With ENTO|0|||
156729382|NCT02343939|565757340|FG002|Overall Study|Never Treated With ENTO|0|||
156729383|NCT02343939|565757341|FG003|Overall Study|Never Treated With ENTO|0|||
156729384|NCT02343939|565757342|FG004|Overall Study|Never Treated With ENTO|0|||
156729385|NCT02343939|565757343|FG005|Overall Study|Never Treated With ENTO|0|||
156729386|NCT02343939|565757344|FG006|Overall Study|Never Treated With ENTO|1|||
156729387|NCT02343939|565757345|FG007|Overall Study|Never Treated With ENTO|2|||
156729388|NCT02343939|565757346|FG008|Overall Study|Never Treated With ENTO|0|||
156729389|NCT01303172|565757347|FG000|Overall Study|Physician Decision|9|||
156729390|NCT01303172|565757348|FG001|Overall Study|Physician Decision|6|||
156729391|NCT01303172|565757347|FG000|Overall Study|Adverse Event|5|||
156729392|NCT01303172|565757348|FG001|Overall Study|Adverse Event|2|||
156729393|NCT01303172|565757347|FG000|Overall Study|Withdrawal by Subject|4|||
156729394|NCT01303172|565757348|FG001|Overall Study|Withdrawal by Subject|2|||
156729395|NCT01303172|565757347|FG000|Overall Study|Death|20|||
156729396|NCT01303172|565757348|FG001|Overall Study|Death|7|||
156729397|NCT01303172|565757347|FG000|Overall Study|Lack of Efficacy|25|||
156729398|NCT01303172|565757348|FG001|Overall Study|Lack of Efficacy|17|||
156729399|NCT02099110|565757353|FG000|Overall Study|Protocol Violation|2|||
156729400|NCT02099110|565757354|FG001|Overall Study|Protocol Violation|1|||
156729401|NCT02099110|565757355|FG002|Overall Study|Protocol Violation|0|||
156729402|NCT02099110|565757356|FG003|Overall Study|Protocol Violation|3|||
156729403|NCT02099110|565757357|FG004|Overall Study|Protocol Violation|1|||
157019862|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
157139375|NCT02886715|567255918|FG002|Overall Study|Lack of Efficacy|1|||
157139376|NCT02886715|567255916|FG000|Overall Study|Lost to Follow-up|29|||
157139377|NCT02886715|567255917|FG001|Overall Study|Lost to Follow-up|26|||
157139378|NCT02886715|567255918|FG002|Overall Study|Lost to Follow-up|10|||
157139379|NCT02886715|567255916|FG000|Overall Study|Pregnancy|1|||
156729404|NCT02099110|565757353|FG000|Overall Study|Participant moved|1|||
156729405|NCT02099110|565757354|FG001|Overall Study|Participant moved|1|||
156729406|NCT02099110|565757355|FG002|Overall Study|Participant moved|1|||
156729407|NCT02099110|565757356|FG003|Overall Study|Participant moved|0|||
156729408|NCT02099110|565757357|FG004|Overall Study|Participant moved|2|||
156729409|NCT02099110|565757353|FG000|Overall Study|Withdrawal by Subject|7|||
156729410|NCT02099110|565757354|FG001|Overall Study|Withdrawal by Subject|11|||
156729411|NCT02099110|565757355|FG002|Overall Study|Withdrawal by Subject|13|||
157139380|NCT02886715|567255917|FG001|Overall Study|Pregnancy|1|||
156729412|NCT02099110|565757356|FG003|Overall Study|Withdrawal by Subject|9|||
157139381|NCT02886715|567255918|FG002|Overall Study|Pregnancy|1|||
156729413|NCT02099110|565757357|FG004|Overall Study|Withdrawal by Subject|13|||
156729414|NCT02099110|565757353|FG000|Overall Study|Adverse Event|3|||
157139382|NCT02886715|567255916|FG000|Overall Study|Protocol Violation|3|||
156729415|NCT02099110|565757354|FG001|Overall Study|Adverse Event|5|||
157217447|NCT01621490|567543225|FG003|Overall Study|Disease progression|5|||
157217448|NCT01621490|567543226|FG004|Overall Study|Disease progression|3|||
156729416|NCT02099110|565757355|FG002|Overall Study|Adverse Event|2|||
156729417|NCT02099110|565757356|FG003|Overall Study|Adverse Event|3|||
156729418|NCT02099110|565757357|FG004|Overall Study|Adverse Event|2|||
156729419|NCT02099110|565757353|FG000|Overall Study|Lost to Follow-up|6|||
156729420|NCT02099110|565757354|FG001|Overall Study|Lost to Follow-up|12|||
156729421|NCT02099110|565757355|FG002|Overall Study|Lost to Follow-up|11|||
156729422|NCT02099110|565757356|FG003|Overall Study|Lost to Follow-up|5|||
156729423|NCT02099110|565757357|FG004|Overall Study|Lost to Follow-up|6|||
156729424|NCT02099110|565757353|FG000|Overall Study|Death|0|||
156729425|NCT02099110|565757354|FG001|Overall Study|Death|1|||
156729426|NCT02099110|565757355|FG002|Overall Study|Death|0|||
156729427|NCT02099110|565757356|FG003|Overall Study|Death|0|||
156729428|NCT02099110|565757357|FG004|Overall Study|Death|0|||
156729429|NCT02099110|565757353|FG000|Overall Study|Screen failure|0|||
156729430|NCT02099110|565757354|FG001|Overall Study|Screen failure|0|||
156729431|NCT02099110|565757355|FG002|Overall Study|Screen failure|0|||
156729432|NCT02099110|565757356|FG003|Overall Study|Screen failure|0|||
156729433|NCT02099110|565757357|FG004|Overall Study|Screen failure|1|||
156729434|NCT02099110|565757353|FG000|Overall Study|Non-compliance with study drug|2|||
156729435|NCT02099110|565757354|FG001|Overall Study|Non-compliance with study drug|0|||
156729436|NCT02099110|565757355|FG002|Overall Study|Non-compliance with study drug|0|||
156729437|NCT02099110|565757356|FG003|Overall Study|Non-compliance with study drug|0|||
156729438|NCT02099110|565757357|FG004|Overall Study|Non-compliance with study drug|1|||
156729439|NCT02099110|565757353|FG000|Overall Study|Physician Decision|3|||
156729440|NCT02099110|565757354|FG001|Overall Study|Physician Decision|0|||
156729441|NCT02099110|565757355|FG002|Overall Study|Physician Decision|1|||
156729442|NCT02099110|565757356|FG003|Overall Study|Physician Decision|2|||
156729443|NCT02099110|565757357|FG004|Overall Study|Physician Decision|1|||
156729444|NCT00994461|565757363|FG000|Overall Study|Adverse Event|2|||
156729445|NCT00994461|565757364|FG001|Overall Study|Adverse Event|1|||
156729446|NCT00994461|565757365|FG002|Overall Study|Adverse Event|0|||
156729447|NCT03291431|565757367|FG000|Overall Study|Protocol Violation|2|||
156729448|NCT03291431|565757368|FG001|Overall Study|Protocol Violation|1|||
156729449|NCT03291431|565757367|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
156729450|NCT03291431|565757368|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
156729451|NCT03291431|565757367|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
156729452|NCT03291431|565757368|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
156729453|NCT00068393|565758987|FG000|Overall Study|Adverse Event|2|||
156729454|NCT00068393|565758987|FG000|Overall Study|Death|3|||
156729455|NCT00068393|565758987|FG000|Overall Study|Withdrawal by Subject|3|||
156729456|NCT00068393|565758987|FG000|Overall Study|Alternative treatment|1|||
156729457|NCT00068393|565758987|FG000|Overall Study|Quality of life worsening|1|||
156729458|NCT01399047|565758988|FG000|Overall Study|Withdrawal by Subject|0|||
156729459|NCT01399047|565758989|FG001|Overall Study|Withdrawal by Subject|1|||
156729460|NCT03300505|565759009|FG000|Overall Study|Death|0|||
156729461|NCT03300505|565759010|FG001|Overall Study|Death|1|||
156729462|NCT03300505|565759011|FG002|Overall Study|Death|0|||
156729463|NCT03300505|565759009|FG000|Overall Study|Withdrawal by Subject|0|||
156729464|NCT03300505|565759010|FG001|Overall Study|Withdrawal by Subject|1|||
156729465|NCT03300505|565759011|FG002|Overall Study|Withdrawal by Subject|1|||
156729466|NCT03300505|565759009|FG000|Overall Study|Sponsor Termination|0|||
156729467|NCT03300505|565759010|FG001|Overall Study|Sponsor Termination|1|||
156729468|NCT03300505|565759011|FG002|Overall Study|Sponsor Termination|0|||
156729469|NCT03300505|565759009|FG000|Overall Study|Adverse Event|0|||
156729470|NCT03300505|565759010|FG001|Overall Study|Adverse Event|0|||
156729471|NCT03300505|565759011|FG002|Overall Study|Adverse Event|2|||
156729472|NCT05119595|565759012|FG000|Overall Study|Death|1|||
156729473|NCT05119595|565759012|FG000|Overall Study|Lost to Follow-up|7|||
156729474|NCT01806961|565759013|FG000|Overall Study|sponsor decision|16|||
156729475|NCT01108341|565759017|FG000|Overall Study|Death|2|||
156729476|NCT01108341|565759017|FG000|Overall Study|Withdrawal by Subject|1|||
156729477|NCT01108341|565759017|FG000|Overall Study|Lost to Follow-up|1|||
156729478|NCT01108341|565759017|FG000|Overall Study|Other|1|||
156729479|NCT02498444|565759023|FG000|Overall Study|Withdrawal by Subject|3|||
156729480|NCT02498444|565759024|FG001|Overall Study|Withdrawal by Subject|0|||
156729481|NCT02498444|565759023|FG000|Overall Study|Physician Decision|1|||
156729482|NCT02498444|565759024|FG001|Overall Study|Physician Decision|0|||
156729483|NCT03656692|565759025|FG000|Overall Study|Worsening of disease activity|2|||
156729484|NCT03656692|565759025|FG000|Overall Study|Physician Decision|1|||
156729485|NCT00912743|565759032|FG000|Overall Study|Adverse Event|3|||
156729486|NCT00912743|565759033|FG001|Overall Study|Adverse Event|1|||
156729487|NCT00912743|565759032|FG000|Overall Study|Lack of Efficacy|9|||
156729488|NCT00912743|565759033|FG001|Overall Study|Lack of Efficacy|18|||
156796244|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156729489|NCT00912743|565759032|FG000|Overall Study|Toxicity|0|||
156729490|NCT00912743|565759033|FG001|Overall Study|Toxicity|1|||
157139383|NCT02886715|567255917|FG001|Overall Study|Protocol Violation|2|||
157139384|NCT02886715|567255918|FG002|Overall Study|Protocol Violation|1|||
157139385|NCT02886715|567255916|FG000|Overall Study|Withdrawal by Subject|20|||
157139386|NCT02886715|567255917|FG001|Overall Study|Withdrawal by Subject|18|||
157139387|NCT02886715|567255918|FG002|Overall Study|Withdrawal by Subject|5|||
157139388|NCT02886715|567255916|FG000|Overall Study|missing|7|||
157139389|NCT02886715|567255917|FG001|Overall Study|missing|2|||
157139390|NCT02886715|567255918|FG002|Overall Study|missing|2|||
157139391|NCT00503399|567255919|FG000|Overall Study|Death|2|||
157139392|NCT00503399|567255920|FG001|Overall Study|Death|1|||
157139393|NCT00503399|567255919|FG000|Overall Study|Protocol Violation|1|||
157139394|NCT00503399|567255920|FG001|Overall Study|Protocol Violation|0|||
157139395|NCT00503399|567255919|FG000|Overall Study|Withdrawal by Subject|4|||
157139396|NCT00503399|567255920|FG001|Overall Study|Withdrawal by Subject|2|||
157139397|NCT00503399|567255919|FG000|Overall Study|Adverse Event|0|||
157139398|NCT00503399|567255920|FG001|Overall Study|Adverse Event|3|||
157139399|NCT00503399|567255919|FG000|Overall Study|Lost to Follow-up|0|||
157139400|NCT00503399|567255920|FG001|Overall Study|Lost to Follow-up|2|||
157139401|NCT01676961|567255921|FG000|Overall Study|Death|3|||
157139402|NCT01676961|567255921|FG000|Overall Study|Lost to Follow-up|1|||
157139403|NCT01676961|567255921|FG000|Overall Study|Withdrawal by Subject|1|||
157139404|NCT03168867|567255922|FG000|Overall Study|Withdrawal by Subject|1|||
157139405|NCT03168867|567255923|FG001|Overall Study|Withdrawal by Subject|5|||
157139406|NCT05292755|567255926|FG000|Overall Study|Lost to Follow-up|5|||
157139407|NCT05292755|567255927|FG001|Overall Study|Lost to Follow-up|9|||
157139408|NCT00519077|567255928|FG000|Overall Study|Death|6|||
157139409|NCT00519077|567255928|FG000|Overall Study|Other|2|||
157139410|NCT02286102|567255929|FG000|Overall Study|Screen Failure|1|||
157139411|NCT02286102|567255930|FG001|Overall Study|Screen Failure|1|||
157139412|NCT01967225|567255931|FG000|Overall Study|Adverse Event|3|||
157139413|NCT01967225|567255932|FG001|Overall Study|Adverse Event|1|||
157217449|NCT01621490|567543227|FG005|Overall Study|Disease progression|8|||
156729491|NCT00912743|565759032|FG000|Overall Study|End of treatment form was not collected|1|||
156729492|NCT00912743|565759033|FG001|Overall Study|End of treatment form was not collected|0|||
156729493|NCT01136356|565759034|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
156729494|NCT01136356|565759035|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
156729495|NCT01136356|565759034|FG000|First 18-day Withdrawal|Physician Decision|1|||
156729496|NCT01136356|565759035|FG001|First 18-day Withdrawal|Physician Decision|0|||
156729497|NCT01136356|565759034|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
156729498|NCT01136356|565759035|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
156729499|NCT00178685|565759036|FG000|Overall Study|Death|3|||
156729500|NCT00178685|565759037|FG001|Overall Study|Death|3|||
156729501|NCT00178685|565759038|FG002|Overall Study|Death|6|||
156729502|NCT00178685|565759036|FG000|Overall Study|Lost to Follow-up|100|||
156729503|NCT00178685|565759037|FG001|Overall Study|Lost to Follow-up|187|||
156729504|NCT00178685|565759038|FG002|Overall Study|Lost to Follow-up|183|||
156729505|NCT00178685|565759036|FG000|Overall Study|Withdrawal by Subject|8|||
156729506|NCT00178685|565759037|FG001|Overall Study|Withdrawal by Subject|14|||
156729507|NCT00178685|565759038|FG002|Overall Study|Withdrawal by Subject|7|||
156729508|NCT02237196|565759039|FG000|Overall Study|Adverse Event|0|||
156729509|NCT02237196|565759040|FG001|Overall Study|Adverse Event|1|||
156729510|NCT02237196|565759041|FG002|Overall Study|Adverse Event|1|||
156729511|NCT02237196|565759042|FG003|Overall Study|Adverse Event|0|||
156729512|NCT02237196|565759039|FG000|Overall Study|Lost to Follow-up|4|||
156729513|NCT02237196|565759040|FG001|Overall Study|Lost to Follow-up|2|||
156729514|NCT02237196|565759041|FG002|Overall Study|Lost to Follow-up|4|||
156729515|NCT02237196|565759042|FG003|Overall Study|Lost to Follow-up|6|||
156729516|NCT02237196|565759039|FG000|Overall Study|Physician Decision|2|||
156729517|NCT02237196|565759040|FG001|Overall Study|Physician Decision|0|||
156729518|NCT02237196|565759041|FG002|Overall Study|Physician Decision|0|||
156729519|NCT02237196|565759042|FG003|Overall Study|Physician Decision|1|||
156729520|NCT02237196|565759039|FG000|Overall Study|Pregnancy|0|||
157139414|NCT01967225|567255931|FG000|Overall Study|Withdrawal by Subject|2|||
156729521|NCT02237196|565759040|FG001|Overall Study|Pregnancy|0|||
156729522|NCT02237196|565759041|FG002|Overall Study|Pregnancy|1|||
156729523|NCT02237196|565759042|FG003|Overall Study|Pregnancy|1|||
156729524|NCT02237196|565759039|FG000|Overall Study|Withdrawal by Subject|1|||
156729525|NCT02237196|565759040|FG001|Overall Study|Withdrawal by Subject|1|||
157139415|NCT01967225|567255932|FG001|Overall Study|Withdrawal by Subject|1|||
157139416|NCT01967225|567255931|FG000|Overall Study|Lack of Efficacy|1|||
156729526|NCT02237196|565759041|FG002|Overall Study|Withdrawal by Subject|4|||
156729527|NCT02237196|565759042|FG003|Overall Study|Withdrawal by Subject|1|||
156729528|NCT02237196|565759039|FG000|Overall Study|Site Error|1|||
156729529|NCT02237196|565759040|FG001|Overall Study|Site Error|2|||
156729530|NCT02237196|565759041|FG002|Overall Study|Site Error|0|||
157139417|NCT01967225|567255932|FG001|Overall Study|Lack of Efficacy|1|||
157139418|NCT01967225|567255931|FG000|Overall Study|Switching to other therapy|2|||
157139419|NCT01967225|567255932|FG001|Overall Study|Switching to other therapy|0|||
157139420|NCT01967225|567255931|FG000|Overall Study|Protocol driven decision point|1|||
156729531|NCT02237196|565759042|FG003|Overall Study|Site Error|2|||
156729532|NCT00862823|565759043|FG000|First Intervention|Withdrawal by Subject|1|||
156729533|NCT00862823|565759044|FG001|First Intervention|Withdrawal by Subject|1|||
156729534|NCT02049814|565759051|FG000|Overall Study|Reason not Specified|4|||
156729535|NCT02049814|565759052|FG001|Overall Study|Reason not Specified|3|||
156729536|NCT02049814|565759051|FG000|Overall Study|Pregnancy|1|||
156729537|NCT02049814|565759052|FG001|Overall Study|Pregnancy|0|||
156729538|NCT02049814|565759051|FG000|Overall Study|Lost to Follow-up|2|||
156729539|NCT02049814|565759052|FG001|Overall Study|Lost to Follow-up|3|||
156729540|NCT02049814|565759051|FG000|Overall Study|Serious Protocol Violation|5|||
156729541|NCT02049814|565759052|FG001|Overall Study|Serious Protocol Violation|7|||
156729542|NCT02049814|565759051|FG000|Overall Study|Study Termination|0|||
156729543|NCT02049814|565759052|FG001|Overall Study|Study Termination|1|||
156729544|NCT02049814|565759051|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
156729545|NCT02049814|565759052|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
156729546|NCT02049814|565759051|FG000|Overall Study|Voluntary withdrawal|9|||
156729547|NCT02049814|565759052|FG001|Overall Study|Voluntary withdrawal|8|||
156729548|NCT00713258|565759053|FG000|Overall Study|Adverse Event|2|||
156729549|NCT00713258|565759054|FG001|Overall Study|Adverse Event|4|||
156729550|NCT00713258|565759053|FG000|Overall Study|Non-Compliance|2|||
156729551|NCT00713258|565759054|FG001|Overall Study|Non-Compliance|1|||
156729552|NCT00713258|565759053|FG000|Overall Study|Other|1|||
156729553|NCT00713258|565759054|FG001|Overall Study|Other|1|||
156729554|NCT02484456|565759057|FG000|Washout Period|Withdrawal by Subject|0|||
156729555|NCT02484456|565759058|FG001|Washout Period|Withdrawal by Subject|1|||
156729556|NCT02484456|565759057|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
156729557|NCT02484456|565759058|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
156729558|NCT02484456|565759057|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
156729559|NCT02484456|565759058|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
156729560|NCT02484456|565759057|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
156729561|NCT02484456|565759058|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
156729562|NCT00708214|565759059|FG000|Overall Study|Other Adverse Event|3|||
156729563|NCT00708214|565759060|FG001|Overall Study|Other Adverse Event|6|||
156729564|NCT00708214|565759061|FG002|Overall Study|Other Adverse Event|2|||
156729565|NCT00708214|565759059|FG000|Overall Study|Other|0|||
156729566|NCT00708214|565759060|FG001|Overall Study|Other|1|||
156729567|NCT00708214|565759061|FG002|Overall Study|Other|1|||
156729568|NCT00708214|565759059|FG000|Overall Study|Progressive Disease|4|||
156729569|NCT00708214|565759060|FG001|Overall Study|Progressive Disease|6|||
156729570|NCT00708214|565759061|FG002|Overall Study|Progressive Disease|5|||
156729571|NCT02199795|565759062|FG000|Overall Study|no longer met inclusion criteria|1|||
156729572|NCT02199795|565759063|FG001|Overall Study|no longer met inclusion criteria|0|||
156729573|NCT02199795|565759062|FG000|Overall Study|withdrew due to shoulder pain|1|||
156729574|NCT02199795|565759063|FG001|Overall Study|withdrew due to shoulder pain|0|||
156729575|NCT05310071|565759067|FG000|Overall Study|Death|0|||
156729576|NCT05310071|565759068|FG001|Overall Study|Death|3|||
156729577|NCT05310071|565759067|FG000|Overall Study|Adverse Event|4|||
156729578|NCT05310071|565759068|FG001|Overall Study|Adverse Event|31|||
156729579|NCT05310071|565759067|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
156729580|NCT05310071|565759068|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
156729581|NCT05310071|565759067|FG000|Overall Study|Protocol Deviation|2|||
156729582|NCT05310071|565759068|FG001|Overall Study|Protocol Deviation|0|||
156729583|NCT05310071|565759067|FG000|Overall Study|Randomized by Mistake|0|||
156729584|NCT05310071|565759068|FG001|Overall Study|Randomized by Mistake|1|||
156729585|NCT05310071|565759067|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
156729586|NCT05310071|565759068|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156729587|NCT05310071|565759067|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
156729588|NCT05310071|565759068|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
156729589|NCT05310071|565759067|FG000|Overall Study|Site Terminated by Sponsor|0|||
156729590|NCT05310071|565759068|FG001|Overall Study|Site Terminated by Sponsor|2|||
156729591|NCT05310071|565759067|FG000|Overall Study|Study Terminated by Sponsor|282|||
156729592|NCT05310071|565759068|FG001|Overall Study|Study Terminated by Sponsor|559|||
156729593|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
157139421|NCT01967225|567255932|FG001|Overall Study|Protocol driven decision point|0|||
156729594|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
156729595|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
156729596|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
156729597|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
156729598|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
156729599|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
156729600|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
156729601|NCT05310071|565759067|FG000|Overall Study|Withdrawal by Participant - Other|25|||
156729602|NCT05310071|565759068|FG001|Overall Study|Withdrawal by Participant - Other|30|||
156729603|NCT05310071|565759067|FG000|Overall Study|Lost to Follow-up|2|||
156729604|NCT05310071|565759068|FG001|Overall Study|Lost to Follow-up|4|||
156729605|NCT05310071|565759067|FG000|Overall Study|Reason Not Specified|1|||
156729606|NCT05310071|565759068|FG001|Overall Study|Reason Not Specified|3|||
156729607|NCT02418949|565759069|FG000|Overall Study|Withdrawal by Subject|1|||
156729608|NCT02418949|565759070|FG001|Overall Study|Withdrawal by Subject|0|||
156729609|NCT02418949|565759071|FG002|Overall Study|Withdrawal by Subject|1|||
156729610|NCT02418949|565759072|FG003|Overall Study|Withdrawal by Subject|1|||
156729611|NCT02418949|565759069|FG000|Overall Study|Lost to Follow-up|1|||
156729612|NCT02418949|565759070|FG001|Overall Study|Lost to Follow-up|0|||
156729613|NCT02418949|565759071|FG002|Overall Study|Lost to Follow-up|1|||
156729614|NCT02418949|565759072|FG003|Overall Study|Lost to Follow-up|0|||
156729615|NCT02418949|565759069|FG000|Overall Study|Physician Decision|1|||
156729616|NCT02418949|565759070|FG001|Overall Study|Physician Decision|1|||
156729617|NCT02418949|565759071|FG002|Overall Study|Physician Decision|1|||
156729618|NCT02418949|565759072|FG003|Overall Study|Physician Decision|0|||
156729619|NCT00014495|565759073|FG000|Overall Study|Death|0|||
156729620|NCT00014495|565759074|FG001|Overall Study|Death|0|||
156729621|NCT00014495|565759075|FG002|Overall Study|Death|1|||
156729622|NCT00014495|565759076|FG003|Overall Study|Death|0|||
156729623|NCT00014495|565759073|FG000|Overall Study|Clinical deterioration|0|||
156729624|NCT00014495|565759074|FG001|Overall Study|Clinical deterioration|0|||
156729625|NCT00014495|565759075|FG002|Overall Study|Clinical deterioration|0|||
156729626|NCT00014495|565759076|FG003|Overall Study|Clinical deterioration|1|||
156729627|NCT00828568|565759077|FG000|Randomized|Withdrawal by Subject|1|||
156729628|NCT00828568|565759078|FG001|Randomized|Withdrawal by Subject|0|||
156729629|NCT00828568|565759079|FG002|Randomized|Withdrawal by Subject|2|||
156729630|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
156729631|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
156729632|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
156729633|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
156729634|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
156729635|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
156729636|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
156729637|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
156729638|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
156729639|NCT00828568|565759077|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
156729640|NCT00828568|565759078|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
156729641|NCT00828568|565759079|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
156729642|NCT02091089|565759114|FG000|Overall Study|Lost to Follow-up|2|||
156729643|NCT00460811|565759119|FG000|Overall Study|Adverse Event|4|||
156729644|NCT00460811|565759120|FG001|Overall Study|Adverse Event|6|||
156729645|NCT00460811|565759121|FG002|Overall Study|Adverse Event|3|||
156729646|NCT00460811|565759122|FG003|Overall Study|Adverse Event|10|||
156729647|NCT00460811|565759123|FG004|Overall Study|Adverse Event|2|||
156729648|NCT00460811|565759119|FG000|Overall Study|Noncompliance|1|||
156729649|NCT00460811|565759120|FG001|Overall Study|Noncompliance|0|||
156729650|NCT00460811|565759121|FG002|Overall Study|Noncompliance|0|||
156729651|NCT00460811|565759122|FG003|Overall Study|Noncompliance|2|||
156729652|NCT00460811|565759123|FG004|Overall Study|Noncompliance|1|||
156729653|NCT00460811|565759119|FG000|Overall Study|Withdrawal by Subject|7|||
157139422|NCT01967225|567255931|FG000|Overall Study|Logistical difficulties|1|||
157139423|NCT01967225|567255932|FG001|Overall Study|Logistical difficulties|0|||
156729654|NCT00460811|565759120|FG001|Overall Study|Withdrawal by Subject|7|||
156729655|NCT00460811|565759121|FG002|Overall Study|Withdrawal by Subject|6|||
156729656|NCT00460811|565759122|FG003|Overall Study|Withdrawal by Subject|3|||
156729657|NCT00460811|565759123|FG004|Overall Study|Withdrawal by Subject|11|||
156729658|NCT00460811|565759119|FG000|Overall Study|Physician Decision|1|||
156729659|NCT00460811|565759120|FG001|Overall Study|Physician Decision|0|||
156729660|NCT00460811|565759121|FG002|Overall Study|Physician Decision|0|||
156729661|NCT00460811|565759122|FG003|Overall Study|Physician Decision|0|||
156729662|NCT00460811|565759123|FG004|Overall Study|Physician Decision|0|||
156729663|NCT00460811|565759119|FG000|Overall Study|Lost to Follow-up|3|||
157139424|NCT01967225|567255931|FG000|Overall Study|Protocol Violation|2|||
156729664|NCT00460811|565759120|FG001|Overall Study|Lost to Follow-up|2|||
156729665|NCT00460811|565759121|FG002|Overall Study|Lost to Follow-up|5|||
156729666|NCT00460811|565759122|FG003|Overall Study|Lost to Follow-up|3|||
157139425|NCT01967225|567255932|FG001|Overall Study|Protocol Violation|0|||
156729667|NCT00460811|565759123|FG004|Overall Study|Lost to Follow-up|6|||
156729668|NCT02821754|565759124|FG000|Overall Study|Procedure not required prior to amendment change|13|||
156729669|NCT02821754|565759125|FG001|Overall Study|Procedure not required prior to amendment change|11|||
156729670|NCT02821754|565759126|FG002|Overall Study|Procedure not required prior to amendment change|0|||
156729671|NCT02821754|565759124|FG000|Overall Study|Participant's Clinical status|2|||
156729672|NCT02821754|565759125|FG001|Overall Study|Participant's Clinical status|0|||
157139426|NCT01440101|567255933|FG000|Overall Study|Adverse Event|2|||
156796245|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796246|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156729673|NCT02821754|565759126|FG002|Overall Study|Participant's Clinical status|0|||
156729674|NCT02821754|565759124|FG000|Overall Study|Participant removed for noncompliance|1|||
156729675|NCT02821754|565759125|FG001|Overall Study|Participant removed for noncompliance|0|||
156729676|NCT02821754|565759126|FG002|Overall Study|Participant removed for noncompliance|0|||
156796247|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796248|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796249|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796250|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796251|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796252|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796253|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
156796254|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
156796255|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796256|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796257|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796258|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796259|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796260|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796261|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796262|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796263|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796264|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
156796265|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
156796266|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156729677|NCT02821754|565759124|FG000|Overall Study|Drug not available.|0|||
156729678|NCT02821754|565759125|FG001|Overall Study|Drug not available.|0|||
156729679|NCT02821754|565759126|FG002|Overall Study|Drug not available.|1|||
156729680|NCT02821754|565759124|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
156729681|NCT02821754|565759125|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
156729682|NCT02821754|565759126|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
156729683|NCT02977572|565759131|FG000|Overall Study|Exclusion criterion|2|||
156729684|NCT02977572|565759132|FG001|Overall Study|Exclusion criterion|2|||
156729685|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
156729686|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
156729687|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
156729688|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
156729689|NCT01166438|565759135|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
156729690|NCT01166438|565759136|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
156729691|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
156729692|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
156729693|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
156729694|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
156729695|NCT01166438|565759135|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
156796267|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796268|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796269|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796270|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796271|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796272|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796273|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796274|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
156796275|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
156796276|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
156796277|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796278|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796279|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796280|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796281|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
157139427|NCT01440101|567255934|FG001|Overall Study|Adverse Event|0|||
157139428|NCT01440101|567255935|FG002|Overall Study|Adverse Event|0|||
157139429|NCT01440101|567255933|FG000|Overall Study|Withdrawal by Subject|0|||
157139430|NCT01440101|567255934|FG001|Overall Study|Withdrawal by Subject|3|||
157139431|NCT01440101|567255935|FG002|Overall Study|Withdrawal by Subject|1|||
157139432|NCT01440101|567255933|FG000|Overall Study|Other|0|||
157139433|NCT01440101|567255934|FG001|Overall Study|Other|1|||
157139434|NCT01440101|567255935|FG002|Overall Study|Other|0|||
157217450|NCT01621490|567543228|FG006|Overall Study|Disease progression|7|||
156729696|NCT01166438|565759136|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
156729697|NCT03502070|565759137|FG000|Overall Study|Withdrawal by Subject|1|||
156729698|NCT03502070|565759137|FG000|Overall Study|Screen Failure|1|||
156729699|NCT00454363|565759145|FG000|Overall Study|Adverse Event|1|||
156729700|NCT00454363|565759146|FG001|Overall Study|Adverse Event|2|||
156729701|NCT00454363|565759145|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
156729702|NCT00454363|565759146|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
156729703|NCT01863667|565759148|FG000|Overall Study|Adverse Event|1|||
156729704|NCT01863667|565759149|FG001|Overall Study|Adverse Event|0|||
156729705|NCT01863667|565759148|FG000|Overall Study|Study terminated by Sponsor|30|||
156729706|NCT01863667|565759149|FG001|Overall Study|Study terminated by Sponsor|30|||
156729707|NCT01863667|565759148|FG000|Overall Study|Withdrawal by Subject|2|||
156729708|NCT01863667|565759149|FG001|Overall Study|Withdrawal by Subject|2|||
156729709|NCT03627546|565759152|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
156729710|NCT03627546|565759153|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
156729711|NCT03627546|565759154|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
156729712|NCT03627546|565759152|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
156729713|NCT03627546|565759153|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
156729714|NCT03627546|565759154|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
156729715|NCT01537042|565759156|FG000|Overall Study|Adverse Event|0|||
156729716|NCT01537042|565759157|FG001|Overall Study|Adverse Event|2|||
156729717|NCT01537042|565759156|FG000|Overall Study|Lack of Efficacy|0|||
156729718|NCT01537042|565759157|FG001|Overall Study|Lack of Efficacy|1|||
156729719|NCT01537042|565759156|FG000|Overall Study|Protocol Violation|0|||
156729720|NCT01537042|565759157|FG001|Overall Study|Protocol Violation|1|||
156729721|NCT01537042|565759156|FG000|Overall Study|Other|0|||
156729722|NCT01537042|565759157|FG001|Overall Study|Other|1|||
156729723|NCT02837731|565759158|FG000|Allocation|Admitted to General Floor|3|||
156729724|NCT02837731|565759159|FG001|Allocation|Admitted to General Floor|4|||
156729725|NCT02837731|565759158|FG000|Allocation|Immediate surgery/withdrew|2|||
156729726|NCT02837731|565759159|FG001|Allocation|Immediate surgery/withdrew|0|||
156729727|NCT02837731|565759158|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
156729728|NCT02837731|565759159|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
156729729|NCT02837731|565759158|FG000|Allocation|Withdrawal by Subject|2|||
156729730|NCT02837731|565759159|FG001|Allocation|Withdrawal by Subject|0|||
156729731|NCT02837731|565759158|FG000|Allocation|Device not available|1|||
156729732|NCT02837731|565759159|FG001|Allocation|Device not available|0|||
156729733|NCT02837731|565759158|FG000|Allocation|Protocol not implemented|7|||
156729734|NCT02837731|565759159|FG001|Allocation|Protocol not implemented|0|||
156729735|NCT02837731|565759158|FG000|Allocation|Moribund/Do not resuscitate|2|||
156729736|NCT02837731|565759159|FG001|Allocation|Moribund/Do not resuscitate|0|||
156729737|NCT02837731|565759158|FG000|Allocation|Did not meet sepsis criteria|1|||
156729738|NCT02837731|565759159|FG001|Allocation|Did not meet sepsis criteria|2|||
156729739|NCT02837731|565759158|FG000|Allocation|Known aortic abnormalities|0|||
156729740|NCT02837731|565759159|FG001|Allocation|Known aortic abnormalities|1|||
156729741|NCT02965573|565759161|FG000|Overall Study|Lack of Efficacy|1|||
156729742|NCT02965573|565759162|FG001|Overall Study|Lack of Efficacy|0|||
156729743|NCT00315458|565759163|FG000|Overall Study|Administrative|0|||
156729744|NCT00315458|565759164|FG001|Overall Study|Administrative|3|||
156729745|NCT00315458|565759165|FG002|Overall Study|Administrative|8|||
156729746|NCT00315458|565759166|FG003|Overall Study|Administrative|21|||
156729747|NCT00315458|565759163|FG000|Overall Study|Adverse Event|2|||
156729748|NCT00315458|565759164|FG001|Overall Study|Adverse Event|4|||
156729749|NCT00315458|565759165|FG002|Overall Study|Adverse Event|23|||
156729750|NCT00315458|565759166|FG003|Overall Study|Adverse Event|3|||
156729751|NCT00315458|565759163|FG000|Overall Study|Lost to Follow-up|1|||
156729752|NCT00315458|565759164|FG001|Overall Study|Lost to Follow-up|2|||
156729753|NCT00315458|565759165|FG002|Overall Study|Lost to Follow-up|0|||
156729754|NCT00315458|565759166|FG003|Overall Study|Lost to Follow-up|2|||
156729755|NCT00315458|565759163|FG000|Overall Study|Withdrawal by Subject|0|||
156729756|NCT00315458|565759164|FG001|Overall Study|Withdrawal by Subject|3|||
156729757|NCT00315458|565759165|FG002|Overall Study|Withdrawal by Subject|0|||
156729758|NCT00315458|565759166|FG003|Overall Study|Withdrawal by Subject|2|||
156729759|NCT00315458|565759163|FG000|Overall Study|Lack of Efficacy|0|||
156729760|NCT00315458|565759164|FG001|Overall Study|Lack of Efficacy|0|||
157139435|NCT02305563|567255938|FG000|Treatment Period|Disease progression|0|||
156729761|NCT00315458|565759165|FG002|Overall Study|Lack of Efficacy|20|||
157139436|NCT02305563|567255939|FG001|Treatment Period|Disease progression|0|||
157139437|NCT02305563|567255940|FG002|Treatment Period|Disease progression|15|||
157139438|NCT02305563|567255941|FG003|Treatment Period|Disease progression|6|||
156729762|NCT00315458|565759166|FG003|Overall Study|Lack of Efficacy|1|||
156729763|NCT00315458|565759163|FG000|Overall Study|Did not qualify|0|||
156729764|NCT00315458|565759164|FG001|Overall Study|Did not qualify|0|||
156729765|NCT00315458|565759165|FG002|Overall Study|Did not qualify|1|||
156729766|NCT00315458|565759166|FG003|Overall Study|Did not qualify|0|||
156729767|NCT00523848|565759168|FG000|Overall Study|Adverse Event|11|||
156729768|NCT00523848|565759168|FG000|Overall Study|Withdrawal by Subject|2|||
156729769|NCT00523848|565759168|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
156729770|NCT00523848|565759168|FG000|Overall Study|Disease Progression|5|||
156729771|NCT00523848|565759168|FG000|Overall Study|Other, unspecified|4|||
156729772|NCT00489918|565759170|FG000|Overall Study|Withdrawal by Subject|2|||
156729773|NCT00489918|565759171|FG001|Overall Study|Withdrawal by Subject|1|||
156729774|NCT00489918|565759172|FG002|Overall Study|Withdrawal by Subject|1|||
156729775|NCT00489918|565759173|FG003|Overall Study|Withdrawal by Subject|0|||
156729776|NCT00489918|565759174|FG004|Overall Study|Withdrawal by Subject|1|||
156729777|NCT00489918|565759170|FG000|Overall Study|Adverse Event|0|||
156729778|NCT00489918|565759171|FG001|Overall Study|Adverse Event|1|||
156729779|NCT00489918|565759172|FG002|Overall Study|Adverse Event|1|||
156729780|NCT00489918|565759173|FG003|Overall Study|Adverse Event|0|||
156729781|NCT00489918|565759174|FG004|Overall Study|Adverse Event|0|||
156729782|NCT00489918|565759170|FG000|Overall Study|Lost to Follow-up|0|||
156729783|NCT00489918|565759171|FG001|Overall Study|Lost to Follow-up|0|||
156729784|NCT00489918|565759172|FG002|Overall Study|Lost to Follow-up|1|||
156729785|NCT00489918|565759173|FG003|Overall Study|Lost to Follow-up|1|||
156729786|NCT00489918|565759174|FG004|Overall Study|Lost to Follow-up|0|||
156729787|NCT00489918|565759170|FG000|Overall Study|Physician Decision|0|||
156729788|NCT00489918|565759171|FG001|Overall Study|Physician Decision|0|||
156729789|NCT00489918|565759172|FG002|Overall Study|Physician Decision|1|||
156729790|NCT00489918|565759173|FG003|Overall Study|Physician Decision|0|||
156729791|NCT00489918|565759174|FG004|Overall Study|Physician Decision|0|||
156729792|NCT02748213|565759175|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
156729793|NCT02748213|565759176|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
156729794|NCT02748213|565759175|FG000|Overall Study|Abnormal Laboratory Test|1|||
156729795|NCT02748213|565759176|FG001|Overall Study|Abnormal Laboratory Test|0|||
156729796|NCT02748213|565759175|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
156729797|NCT02748213|565759176|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
156729798|NCT02748213|565759175|FG000|Overall Study|Death|5|||
156729799|NCT02748213|565759176|FG001|Overall Study|Death|3|||
156729800|NCT02748213|565759175|FG000|Overall Study|Insufficient Therapeutic Response|56|||
156729801|NCT02748213|565759176|FG001|Overall Study|Insufficient Therapeutic Response|57|||
156729802|NCT02748213|565759175|FG000|Overall Study|Violation of Selection Criteria|2|||
156729803|NCT02748213|565759176|FG001|Overall Study|Violation of Selection Criteria|0|||
156729804|NCT02748213|565759175|FG000|Overall Study|Protocol Violation|6|||
156729805|NCT02748213|565759176|FG001|Overall Study|Protocol Violation|4|||
156729806|NCT02748213|565759175|FG000|Overall Study|Refused Treatment*|6|||
156729807|NCT02748213|565759176|FG001|Overall Study|Refused Treatment*|6|||
156729808|NCT02748213|565759175|FG000|Overall Study|Failure to Return|1|||
156729809|NCT02748213|565759176|FG001|Overall Study|Failure to Return|0|||
156729810|NCT02748213|565759175|FG000|Overall Study|Other|30|||
156729811|NCT02748213|565759176|FG001|Overall Study|Other|29|||
156729812|NCT03850483|565759180|FG000|Treatment for Stage 1|Adverse Event|1|||
156729813|NCT03850483|565759181|FG001|Treatment for Stage 1|Adverse Event|1|||
156729814|NCT03850483|565759182|FG002|Treatment for Stage 1|Adverse Event|3|||
156729815|NCT03850483|565759183|FG003|Treatment for Stage 1|Adverse Event|0|||
156729816|NCT03850483|565759184|FG004|Treatment for Stage 1|Adverse Event|2|||
156729817|NCT03850483|565759185|FG005|Treatment for Stage 1|Adverse Event|0|||
156729818|NCT03850483|565759186|FG006|Treatment for Stage 1|Adverse Event|2|||
156729819|NCT03850483|565759187|FG007|Treatment for Stage 1|Adverse Event|2|||
156729820|NCT03850483|565759188|FG008|Treatment for Stage 1|Adverse Event|0|||
156729821|NCT03850483|565759189|FG009|Treatment for Stage 1|Adverse Event|0|||
156729822|NCT03850483|565759180|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
156729823|NCT03850483|565759181|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
156729824|NCT03850483|565759182|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
156729825|NCT03850483|565759183|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
156729826|NCT03850483|565759184|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
156729827|NCT03850483|565759185|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
156729828|NCT03850483|565759186|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
157139439|NCT02305563|567255942|FG004|Treatment Period|Disease progression|6|||
156729829|NCT03850483|565759187|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
156729830|NCT03850483|565759188|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
156729831|NCT03850483|565759189|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
157139440|NCT02305563|567255938|FG000|Treatment Period|Study drug toxicity|0|||
156729832|NCT03850483|565759180|FG000|Treatment for Stage 1|Protocol Violation|1|||
156729833|NCT03850483|565759181|FG001|Treatment for Stage 1|Protocol Violation|0|||
156729834|NCT03850483|565759182|FG002|Treatment for Stage 1|Protocol Violation|0|||
156729835|NCT03850483|565759183|FG003|Treatment for Stage 1|Protocol Violation|0|||
156729836|NCT03850483|565759184|FG004|Treatment for Stage 1|Protocol Violation|0|||
156729837|NCT03850483|565759185|FG005|Treatment for Stage 1|Protocol Violation|0|||
157139441|NCT02305563|567255939|FG001|Treatment Period|Study drug toxicity|0|||
157139442|NCT02305563|567255940|FG002|Treatment Period|Study drug toxicity|0|||
156729838|NCT03850483|565759186|FG006|Treatment for Stage 1|Protocol Violation|1|||
156729839|NCT03850483|565759187|FG007|Treatment for Stage 1|Protocol Violation|0|||
157139443|NCT02305563|567255941|FG003|Treatment Period|Study drug toxicity|1|||
157139444|NCT02305563|567255942|FG004|Treatment Period|Study drug toxicity|2|||
157139445|NCT02305563|567255938|FG000|Treatment Period|Death|0|||
157139446|NCT02305563|567255939|FG001|Treatment Period|Death|0|||
157139447|NCT02305563|567255940|FG002|Treatment Period|Death|1|||
157139448|NCT02305563|567255941|FG003|Treatment Period|Death|2|||
157139449|NCT02305563|567255942|FG004|Treatment Period|Death|1|||
156729840|NCT03850483|565759188|FG008|Treatment for Stage 1|Protocol Violation|0|||
156729841|NCT03850483|565759189|FG009|Treatment for Stage 1|Protocol Violation|0|||
156729842|NCT03850483|565759180|FG000|Treatment for Stage 1|Physician Decision|0|||
156729843|NCT03850483|565759181|FG001|Treatment for Stage 1|Physician Decision|0|||
156729844|NCT03850483|565759182|FG002|Treatment for Stage 1|Physician Decision|0|||
156729845|NCT03850483|565759183|FG003|Treatment for Stage 1|Physician Decision|0|||
156729846|NCT03850483|565759184|FG004|Treatment for Stage 1|Physician Decision|0|||
156729847|NCT03850483|565759185|FG005|Treatment for Stage 1|Physician Decision|1|||
156729848|NCT03850483|565759186|FG006|Treatment for Stage 1|Physician Decision|0|||
156729849|NCT03850483|565759187|FG007|Treatment for Stage 1|Physician Decision|0|||
156729850|NCT03850483|565759188|FG008|Treatment for Stage 1|Physician Decision|0|||
156729851|NCT03850483|565759189|FG009|Treatment for Stage 1|Physician Decision|0|||
156729852|NCT03850483|565759180|FG000|Treatment for Stage 1|Other|0|||
156729853|NCT03850483|565759181|FG001|Treatment for Stage 1|Other|0|||
156729854|NCT03850483|565759182|FG002|Treatment for Stage 1|Other|0|||
156729855|NCT03850483|565759183|FG003|Treatment for Stage 1|Other|0|||
156729856|NCT03850483|565759184|FG004|Treatment for Stage 1|Other|2|||
156729857|NCT03850483|565759185|FG005|Treatment for Stage 1|Other|1|||
156729858|NCT03850483|565759186|FG006|Treatment for Stage 1|Other|0|||
156729859|NCT03850483|565759187|FG007|Treatment for Stage 1|Other|0|||
156729860|NCT03850483|565759188|FG008|Treatment for Stage 1|Other|0|||
156729861|NCT03850483|565759189|FG009|Treatment for Stage 1|Other|0|||
156729862|NCT03850483|565759180|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729863|NCT03850483|565759181|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729864|NCT03850483|565759182|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
156729865|NCT03850483|565759183|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729866|NCT03850483|565759184|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729867|NCT03850483|565759185|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729868|NCT03850483|565759186|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729869|NCT03850483|565759187|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729870|NCT03850483|565759188|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729871|NCT03850483|565759189|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
156729872|NCT03850483|565759180|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729873|NCT03850483|565759181|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729874|NCT03850483|565759182|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729875|NCT03850483|565759183|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729876|NCT03850483|565759184|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729877|NCT03850483|565759185|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
156729878|NCT03850483|565759186|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729879|NCT03850483|565759187|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729880|NCT03850483|565759188|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729881|NCT03850483|565759189|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
156729882|NCT03850483|565759180|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
156729883|NCT03850483|565759181|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
156729884|NCT03850483|565759182|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
156729885|NCT03850483|565759183|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
156729886|NCT03850483|565759184|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
156796282|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796283|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796284|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796285|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796286|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
156796287|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
156796288|NCT02471144|566007979|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796289|NCT02471144|566007980|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796290|NCT02471144|566007981|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796291|NCT02471144|566007982|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796292|NCT02471144|566007983|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156808809|NCT01484496|566054474|FG001|Period 1|Physician Decision|1|||
157019863|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
157019864|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156729887|NCT03850483|565759185|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
157139450|NCT02305563|567255938|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
157139451|NCT02305563|567255939|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
157139452|NCT02305563|567255940|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
156729888|NCT03850483|565759186|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
156729889|NCT03850483|565759187|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
156729890|NCT03850483|565759188|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
156729891|NCT03850483|565759189|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
156729892|NCT03850483|565759180|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
156729893|NCT03850483|565759181|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
156729894|NCT03850483|565759182|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
156729895|NCT03850483|565759183|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
156729896|NCT03850483|565759184|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
156729897|NCT03850483|565759185|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
156729898|NCT03850483|565759186|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
156729899|NCT03850483|565759187|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
156729900|NCT03850483|565759188|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
156729901|NCT03850483|565759189|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
156729902|NCT03850483|565759180|FG000|Treatment for Stage 1|Death|0|||
156729903|NCT03850483|565759181|FG001|Treatment for Stage 1|Death|0|||
156729904|NCT03850483|565759182|FG002|Treatment for Stage 1|Death|0|||
156729905|NCT03850483|565759183|FG003|Treatment for Stage 1|Death|0|||
156729906|NCT03850483|565759184|FG004|Treatment for Stage 1|Death|0|||
156729907|NCT03850483|565759185|FG005|Treatment for Stage 1|Death|1|||
156729908|NCT03850483|565759186|FG006|Treatment for Stage 1|Death|0|||
156729909|NCT03850483|565759187|FG007|Treatment for Stage 1|Death|0|||
156729910|NCT03850483|565759188|FG008|Treatment for Stage 1|Death|0|||
156729911|NCT03850483|565759189|FG009|Treatment for Stage 1|Death|0|||
156729912|NCT03850483|565759180|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
156729913|NCT03850483|565759181|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
156729914|NCT03850483|565759182|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
156729915|NCT03850483|565759183|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
156729916|NCT03850483|565759184|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
156729917|NCT03850483|565759185|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
156729918|NCT03850483|565759186|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
156729919|NCT03850483|565759187|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
156729920|NCT03850483|565759188|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
156729921|NCT03850483|565759189|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
156729922|NCT03850483|565759180|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
156729923|NCT03850483|565759181|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
156729924|NCT03850483|565759182|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
156729925|NCT03850483|565759183|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
156796293|NCT02471144|566007984|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796294|NCT02471144|566007985|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796295|NCT02471144|566007986|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796296|NCT02471144|566007987|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
156796297|NCT02471144|566007988|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
156796298|NCT02471144|566007989|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
156796299|NCT00791648|566007993|FG000|Overall Study|Physician Decision|0|||
156796300|NCT00791648|566007994|FG001|Overall Study|Physician Decision|1|||
156796301|NCT00791648|566007993|FG000|Overall Study|Withdrawal by Subject|0|||
156796302|NCT00791648|566007994|FG001|Overall Study|Withdrawal by Subject|1|||
156796303|NCT00462826|566007995|FG000|Overall Study|Ineligible - second primary|1|||
156796304|NCT00462826|566007995|FG000|Overall Study|Ineligible - wrong cell type|1|||
156796305|NCT00462826|566007995|FG000|Overall Study|Ineligible - wrong primary|2|||
156796306|NCT00462826|566007995|FG000|Overall Study|Never treated|1|||
156796307|NCT04123704|566008008|FG000|Overall Study|Disease progression|2|||
156796308|NCT00939185|566008009|FG000|Overall Study|Adverse Event|3|||
156796309|NCT00939185|566008009|FG000|Overall Study|Lack of Efficacy|1|||
156796310|NCT00939185|566008009|FG000|Overall Study|Lost to Follow-up|6|||
156796311|NCT00939185|566008009|FG000|Overall Study|Other|3|||
156796312|NCT00939185|566008009|FG000|Overall Study|Withdrawal by Subject|2|||
156796313|NCT00939185|566008009|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
156796314|NCT02374255|566008010|FG000|Overall Study|Withdrawal by Subject|2|||
156876446|NCT04080167|566305841|FG002|Overall Study|Lost to Follow-up-Patients|0|||
156876447|NCT04080167|566305839|FG000|Overall Study|Lost to Follow-up-Providers|2|||
157019865|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156729926|NCT03850483|565759184|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
156729927|NCT03850483|565759185|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
156729928|NCT03850483|565759186|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
156729929|NCT03850483|565759187|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
156729930|NCT03850483|565759188|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
156729931|NCT03850483|565759189|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
156729932|NCT03850483|565759180|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729933|NCT03850483|565759181|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729934|NCT03850483|565759182|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729935|NCT03850483|565759183|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
157139453|NCT02305563|567255941|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
157139454|NCT02305563|567255942|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
157139455|NCT02305563|567255938|FG000|Treatment Period|Participant request to stop therapy|0|||
157139456|NCT02305563|567255939|FG001|Treatment Period|Participant request to stop therapy|2|||
157139457|NCT02305563|567255940|FG002|Treatment Period|Participant request to stop therapy|0|||
157139458|NCT02305563|567255941|FG003|Treatment Period|Participant request to stop therapy|1|||
157139459|NCT02305563|567255942|FG004|Treatment Period|Participant request to stop therapy|0|||
156729936|NCT03850483|565759184|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
157139460|NCT02305563|567255938|FG000|Treatment Period|Participant withdrew consent|0|||
157139461|NCT02305563|567255939|FG001|Treatment Period|Participant withdrew consent|0|||
156729937|NCT03850483|565759185|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729938|NCT03850483|565759186|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
156729939|NCT03850483|565759187|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
156729940|NCT03850483|565759188|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729941|NCT03850483|565759189|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
156729942|NCT03850483|565759180|FG000|Follow-up for Stage 1|Physician Decision|0|||
156729943|NCT03850483|565759181|FG001|Follow-up for Stage 1|Physician Decision|0|||
156729944|NCT03850483|565759182|FG002|Follow-up for Stage 1|Physician Decision|0|||
156729945|NCT03850483|565759183|FG003|Follow-up for Stage 1|Physician Decision|0|||
156729946|NCT03850483|565759184|FG004|Follow-up for Stage 1|Physician Decision|1|||
156729947|NCT03850483|565759185|FG005|Follow-up for Stage 1|Physician Decision|0|||
156729948|NCT03850483|565759186|FG006|Follow-up for Stage 1|Physician Decision|1|||
156729949|NCT03850483|565759187|FG007|Follow-up for Stage 1|Physician Decision|0|||
156729950|NCT03850483|565759188|FG008|Follow-up for Stage 1|Physician Decision|0|||
156729951|NCT03850483|565759189|FG009|Follow-up for Stage 1|Physician Decision|0|||
156729952|NCT03850483|565759180|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
156729953|NCT03850483|565759181|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
156729954|NCT03850483|565759182|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
156729955|NCT03850483|565759183|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
156729956|NCT03850483|565759184|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
156729957|NCT03850483|565759185|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
156729958|NCT03850483|565759186|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
156729959|NCT03850483|565759187|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
156729960|NCT03850483|565759188|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
156729961|NCT03850483|565759189|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
156729962|NCT03850483|565759180|FG000|Follow-up for Stage 1|Adverse Event|0|||
156729963|NCT03850483|565759181|FG001|Follow-up for Stage 1|Adverse Event|0|||
156729964|NCT03850483|565759182|FG002|Follow-up for Stage 1|Adverse Event|1|||
156729965|NCT03850483|565759183|FG003|Follow-up for Stage 1|Adverse Event|0|||
156729966|NCT03850483|565759184|FG004|Follow-up for Stage 1|Adverse Event|0|||
156729967|NCT03850483|565759185|FG005|Follow-up for Stage 1|Adverse Event|1|||
156729968|NCT03850483|565759186|FG006|Follow-up for Stage 1|Adverse Event|0|||
156729969|NCT03850483|565759187|FG007|Follow-up for Stage 1|Adverse Event|0|||
156729970|NCT03850483|565759188|FG008|Follow-up for Stage 1|Adverse Event|0|||
156729971|NCT03850483|565759189|FG009|Follow-up for Stage 1|Adverse Event|0|||
156729972|NCT03850483|565759180|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729973|NCT03850483|565759181|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
156729974|NCT03850483|565759182|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729975|NCT03850483|565759183|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729976|NCT03850483|565759184|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
156729977|NCT03850483|565759185|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
156729978|NCT03850483|565759186|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729979|NCT03850483|565759187|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729980|NCT03850483|565759188|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729981|NCT03850483|565759189|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
156729982|NCT03850483|565759180|FG000|Follow-up for Stage 1|Other|0|||
157139462|NCT02305563|567255940|FG002|Treatment Period|Participant withdrew consent|1|||
157217451|NCT01621490|567543229|FG007|Overall Study|Disease progression|1|||
157217452|NCT01621490|567543230|FG008|Overall Study|Disease progression|4|||
157217453|NCT01621490|567543231|FG009|Overall Study|Disease progression|1|||
156729983|NCT03850483|565759181|FG001|Follow-up for Stage 1|Other|2|||
156729984|NCT03850483|565759182|FG002|Follow-up for Stage 1|Other|0|||
156729985|NCT03850483|565759183|FG003|Follow-up for Stage 1|Other|2|||
156729986|NCT03850483|565759184|FG004|Follow-up for Stage 1|Other|0|||
156729987|NCT03850483|565759185|FG005|Follow-up for Stage 1|Other|1|||
156729988|NCT03850483|565759186|FG006|Follow-up for Stage 1|Other|0|||
156729989|NCT03850483|565759187|FG007|Follow-up for Stage 1|Other|0|||
156729990|NCT03850483|565759188|FG008|Follow-up for Stage 1|Other|0|||
156729991|NCT03850483|565759189|FG009|Follow-up for Stage 1|Other|0|||
156729992|NCT03850483|565759180|FG000|Treatment for Stage 2|Adverse Event|0|||
156729993|NCT03850483|565759181|FG001|Treatment for Stage 2|Adverse Event|0|||
156729994|NCT03850483|565759182|FG002|Treatment for Stage 2|Adverse Event|0|||
156729995|NCT03850483|565759183|FG003|Treatment for Stage 2|Adverse Event|0|||
156729996|NCT03850483|565759184|FG004|Treatment for Stage 2|Adverse Event|0|||
156729997|NCT03850483|565759185|FG005|Treatment for Stage 2|Adverse Event|0|||
156729998|NCT03850483|565759186|FG006|Treatment for Stage 2|Adverse Event|0|||
156729999|NCT03850483|565759187|FG007|Treatment for Stage 2|Adverse Event|0|||
156730000|NCT03850483|565759188|FG008|Treatment for Stage 2|Adverse Event|0|||
156730001|NCT03850483|565759189|FG009|Treatment for Stage 2|Adverse Event|1|||
157139463|NCT02305563|567255941|FG003|Treatment Period|Participant withdrew consent|1|||
157139464|NCT02305563|567255942|FG004|Treatment Period|Participant withdrew consent|1|||
157139465|NCT02305563|567255938|FG000|Treatment Period|Maximum clinical benefit|0|||
157139466|NCT02305563|567255939|FG001|Treatment Period|Maximum clinical benefit|0|||
157139467|NCT02305563|567255940|FG002|Treatment Period|Maximum clinical benefit|0|||
157139468|NCT02305563|567255941|FG003|Treatment Period|Maximum clinical benefit|0|||
157139469|NCT02305563|567255942|FG004|Treatment Period|Maximum clinical benefit|1|||
157139470|NCT02305563|567255938|FG000|Treatment Period|Poor/non-compliance|0|||
157139471|NCT02305563|567255939|FG001|Treatment Period|Poor/non-compliance|0|||
157139472|NCT02305563|567255940|FG002|Treatment Period|Poor/non-compliance|0|||
157139473|NCT02305563|567255941|FG003|Treatment Period|Poor/non-compliance|0|||
157139474|NCT02305563|567255942|FG004|Treatment Period|Poor/non-compliance|1|||
157139475|NCT02305563|567255938|FG000|Treatment Period|Administrative reason by Sponsor|0|||
157217454|NCT01621490|567543232|FG010|Overall Study|Disease progression|1|||
156730002|NCT03850483|565759180|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
156730003|NCT03850483|565759181|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
156730004|NCT03850483|565759182|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
156730005|NCT03850483|565759183|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
156730006|NCT03850483|565759184|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
156730007|NCT03850483|565759185|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
156730008|NCT03850483|565759186|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
156730009|NCT03850483|565759187|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
156730010|NCT03850483|565759188|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
156730011|NCT03850483|565759189|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
156730012|NCT03850483|565759180|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
156730013|NCT03850483|565759181|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
156796315|NCT02374255|566008011|FG001|Overall Study|Withdrawal by Subject|0|||
156796316|NCT02374255|566008012|FG002|Overall Study|Withdrawal by Subject|0|||
156796317|NCT02374255|566008013|FG003|Overall Study|Withdrawal by Subject|0|||
156796318|NCT03360344|566008016|FG000|Overall Study|Withdrawal by Subject|0|||
156796319|NCT03360344|566008017|FG001|Overall Study|Withdrawal by Subject|1|||
156796320|NCT03360344|566008018|FG002|Overall Study|Withdrawal by Subject|1|||
156796321|NCT00133705|566008019|FG000|Overall Study|Withdrawal by Subject|2|||
156796322|NCT00133705|566008020|FG001|Overall Study|Withdrawal by Subject|3|||
156796323|NCT00959049|566008021|FG000|Overall Study|Adverse Event|1|||
156796324|NCT00959049|566008022|FG001|Overall Study|Adverse Event|0|||
156796325|NCT00959049|566008023|FG002|Overall Study|Adverse Event|0|||
156796326|NCT00959049|566008024|FG003|Overall Study|Adverse Event|0|||
156796327|NCT00959049|566008025|FG004|Overall Study|Adverse Event|0|||
156796328|NCT00959049|566008026|FG005|Overall Study|Adverse Event|0|||
156796329|NCT00959049|566008021|FG000|Overall Study|Lost to Follow-up|17|||
156796330|NCT00959049|566008022|FG001|Overall Study|Lost to Follow-up|5|||
156796331|NCT00959049|566008023|FG002|Overall Study|Lost to Follow-up|1|||
156796332|NCT00959049|566008024|FG003|Overall Study|Lost to Follow-up|10|||
156796333|NCT00959049|566008025|FG004|Overall Study|Lost to Follow-up|9|||
156796334|NCT00959049|566008026|FG005|Overall Study|Lost to Follow-up|1|||
156796335|NCT00959049|566008021|FG000|Overall Study|Contraindicated medication|0|||
156796336|NCT00959049|566008022|FG001|Overall Study|Contraindicated medication|0|||
156796337|NCT00959049|566008023|FG002|Overall Study|Contraindicated medication|0|||
156796338|NCT00959049|566008024|FG003|Overall Study|Contraindicated medication|1|||
156796339|NCT00959049|566008025|FG004|Overall Study|Contraindicated medication|0|||
156796340|NCT00959049|566008026|FG005|Overall Study|Contraindicated medication|0|||
156796341|NCT00959049|566008021|FG000|Overall Study|Withdrawal by Subject|0|||
156796342|NCT00959049|566008022|FG001|Overall Study|Withdrawal by Subject|2|||
156796343|NCT00959049|566008023|FG002|Overall Study|Withdrawal by Subject|0|||
156796344|NCT00959049|566008024|FG003|Overall Study|Withdrawal by Subject|0|||
156796345|NCT00959049|566008025|FG004|Overall Study|Withdrawal by Subject|0|||
156796346|NCT00959049|566008026|FG005|Overall Study|Withdrawal by Subject|0|||
156796347|NCT00836706|566008035|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
156796348|NCT00836706|566008036|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
157139476|NCT02305563|567255939|FG001|Treatment Period|Administrative reason by Sponsor|0|||
157139477|NCT02305563|567255940|FG002|Treatment Period|Administrative reason by Sponsor|0|||
157139478|NCT02305563|567255941|FG003|Treatment Period|Administrative reason by Sponsor|0|||
157217455|NCT01621490|567543222|FG000|Overall Study|Study drug toxicity|1|||
157217456|NCT01621490|567543223|FG001|Overall Study|Study drug toxicity|4|||
156730014|NCT03850483|565759182|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
156730015|NCT03850483|565759183|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
156796349|NCT01992757|566008037|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
156796350|NCT00863304|566008039|FG000|Overall Study|Adverse Event|10|||
156796351|NCT00863304|566008040|FG001|Overall Study|Adverse Event|4|||
156730016|NCT03850483|565759184|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
156730017|NCT03850483|565759185|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
156730018|NCT03850483|565759186|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
156730019|NCT03850483|565759187|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
156730020|NCT03850483|565759188|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
156730021|NCT03850483|565759189|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
156730022|NCT03850483|565759180|FG000|Treatment for Stage 2|Physician Decision|0|||
156730023|NCT03850483|565759181|FG001|Treatment for Stage 2|Physician Decision|0|||
156730024|NCT03850483|565759182|FG002|Treatment for Stage 2|Physician Decision|0|||
156730025|NCT03850483|565759183|FG003|Treatment for Stage 2|Physician Decision|0|||
156730026|NCT03850483|565759184|FG004|Treatment for Stage 2|Physician Decision|0|||
156730027|NCT03850483|565759185|FG005|Treatment for Stage 2|Physician Decision|0|||
156730028|NCT03850483|565759186|FG006|Treatment for Stage 2|Physician Decision|0|||
156730029|NCT03850483|565759187|FG007|Treatment for Stage 2|Physician Decision|0|||
156730030|NCT03850483|565759188|FG008|Treatment for Stage 2|Physician Decision|0|||
156730031|NCT03850483|565759189|FG009|Treatment for Stage 2|Physician Decision|1|||
156730032|NCT03850483|565759180|FG000|Treatment for Stage 2|Protocol Violation|0|||
156730033|NCT03850483|565759181|FG001|Treatment for Stage 2|Protocol Violation|0|||
156730034|NCT03850483|565759182|FG002|Treatment for Stage 2|Protocol Violation|0|||
156730035|NCT03850483|565759183|FG003|Treatment for Stage 2|Protocol Violation|0|||
156730036|NCT03850483|565759184|FG004|Treatment for Stage 2|Protocol Violation|0|||
156730037|NCT03850483|565759185|FG005|Treatment for Stage 2|Protocol Violation|0|||
156730038|NCT03850483|565759186|FG006|Treatment for Stage 2|Protocol Violation|0|||
156730039|NCT03850483|565759187|FG007|Treatment for Stage 2|Protocol Violation|0|||
156730040|NCT03850483|565759188|FG008|Treatment for Stage 2|Protocol Violation|1|||
156730041|NCT03850483|565759189|FG009|Treatment for Stage 2|Protocol Violation|0|||
156730042|NCT03850483|565759180|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
156730043|NCT03850483|565759181|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
156730044|NCT03850483|565759182|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
156730045|NCT03850483|565759183|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
156796352|NCT00863304|566008041|FG002|Overall Study|Adverse Event|14|||
156796353|NCT00863304|566008042|FG003|Overall Study|Adverse Event|16|||
156796354|NCT00863304|566008039|FG000|Overall Study|Lost to Follow-up|1|||
156796355|NCT00863304|566008040|FG001|Overall Study|Lost to Follow-up|5|||
156796356|NCT00863304|566008041|FG002|Overall Study|Lost to Follow-up|4|||
156796357|NCT00863304|566008042|FG003|Overall Study|Lost to Follow-up|2|||
156796358|NCT00863304|566008039|FG000|Overall Study|Lack of Efficacy|57|||
157139479|NCT02305563|567255942|FG004|Treatment Period|Administrative reason by Sponsor|1|||
156796359|NCT00863304|566008040|FG001|Overall Study|Lack of Efficacy|26|||
156796360|NCT00863304|566008041|FG002|Overall Study|Lack of Efficacy|30|||
156796361|NCT00863304|566008042|FG003|Overall Study|Lack of Efficacy|28|||
156796362|NCT00863304|566008039|FG000|Overall Study|Withdrawal by Subject|19|||
156796363|NCT00863304|566008040|FG001|Overall Study|Withdrawal by Subject|14|||
156796364|NCT00863304|566008041|FG002|Overall Study|Withdrawal by Subject|20|||
156796365|NCT00863304|566008042|FG003|Overall Study|Withdrawal by Subject|18|||
156796366|NCT00863304|566008039|FG000|Overall Study|Other|1|||
156796367|NCT00863304|566008040|FG001|Overall Study|Other|0|||
156796368|NCT00863304|566008041|FG002|Overall Study|Other|0|||
156796369|NCT00863304|566008042|FG003|Overall Study|Other|1|||
156796370|NCT00863304|566008039|FG000|Overall Study|Protocol Violation|2|||
156796371|NCT00863304|566008040|FG001|Overall Study|Protocol Violation|6|||
156796372|NCT00863304|566008041|FG002|Overall Study|Protocol Violation|2|||
156796373|NCT00863304|566008042|FG003|Overall Study|Protocol Violation|0|||
156796374|NCT00863304|566008039|FG000|Overall Study|Randomized, but not Treated|3|||
156796375|NCT00863304|566008040|FG001|Overall Study|Randomized, but not Treated|1|||
156796376|NCT00863304|566008041|FG002|Overall Study|Randomized, but not Treated|4|||
156796377|NCT00863304|566008042|FG003|Overall Study|Randomized, but not Treated|1|||
156796378|NCT00863304|566008039|FG000|Overall Study|Entered extension study|101|||
157139480|NCT02305563|567255938|FG000|Treatment Period|other reason|2|||
157139481|NCT02305563|567255939|FG001|Treatment Period|other reason|0|||
156730046|NCT03850483|565759184|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
156730047|NCT03850483|565759185|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
156730048|NCT03850483|565759186|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
156730049|NCT03850483|565759187|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
156730050|NCT03850483|565759188|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
156730051|NCT03850483|565759189|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
156730052|NCT03850483|565759180|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730053|NCT03850483|565759181|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730054|NCT03850483|565759182|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730055|NCT03850483|565759183|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156796379|NCT00863304|566008040|FG001|Overall Study|Entered extension study|129|||
156796380|NCT00863304|566008041|FG002|Overall Study|Entered extension study|113|||
156796381|NCT00863304|566008042|FG003|Overall Study|Entered extension study|125|||
156796382|NCT00478257|566008043|FG000|Overall Study|Withdrawal by Subject|8|||
156796383|NCT00478257|566008044|FG001|Overall Study|Withdrawal by Subject|3|||
156730056|NCT03850483|565759184|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730057|NCT03850483|565759185|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730058|NCT03850483|565759186|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730059|NCT03850483|565759187|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730060|NCT03850483|565759188|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
156730061|NCT03850483|565759189|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
156730062|NCT03850483|565759180|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
156730063|NCT03850483|565759181|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
156730064|NCT03850483|565759182|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
156730065|NCT03850483|565759183|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
156730066|NCT03850483|565759184|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
156730067|NCT03850483|565759185|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
156730068|NCT03850483|565759186|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
156730069|NCT03850483|565759187|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
156730070|NCT03850483|565759188|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
156730071|NCT03850483|565759189|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
156730072|NCT03850483|565759180|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
156730073|NCT03850483|565759181|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
156730074|NCT03850483|565759182|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
156730075|NCT03850483|565759183|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
156730076|NCT03850483|565759184|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
156730077|NCT03850483|565759185|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
156730078|NCT03850483|565759186|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
156730079|NCT03850483|565759187|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
156730080|NCT03850483|565759188|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
156730081|NCT03850483|565759189|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
156730082|NCT03850483|565759180|FG000|Follow-up For Stage 2|Other|0|||
156730083|NCT03850483|565759181|FG001|Follow-up For Stage 2|Other|0|||
156730084|NCT03850483|565759182|FG002|Follow-up For Stage 2|Other|0|||
156730085|NCT03850483|565759183|FG003|Follow-up For Stage 2|Other|0|||
156730086|NCT03850483|565759184|FG004|Follow-up For Stage 2|Other|0|||
156730087|NCT03850483|565759185|FG005|Follow-up For Stage 2|Other|0|||
156730088|NCT03850483|565759186|FG006|Follow-up For Stage 2|Other|0|||
156730089|NCT03850483|565759187|FG007|Follow-up For Stage 2|Other|0|||
156730090|NCT03850483|565759188|FG008|Follow-up For Stage 2|Other|0|||
156730091|NCT03850483|565759189|FG009|Follow-up For Stage 2|Other|1|||
156730092|NCT01283334|565760728|FG000|Overall Study|Withdrawal by Subject|1|||
156730093|NCT01283334|565760728|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
156730094|NCT01283334|565760728|FG000|Overall Study|Adverse Event|4|||
156730095|NCT01283334|565760728|FG000|Overall Study|Physician Decision|1|||
156730096|NCT03467217|565760729|FG000|Overall Study|Trial stopped early|5|||
156730097|NCT03467217|565760730|FG001|Overall Study|Trial stopped early|2|||
156730098|NCT03467217|565760729|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
156730099|NCT03467217|565760730|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
156730100|NCT03467217|565760729|FG000|Overall Study|Lost to Follow-up|0|||
156730101|NCT03467217|565760730|FG001|Overall Study|Lost to Follow-up|2|||
156730102|NCT00769067|565760731|FG000|Overall Study|Death|89|||
156730103|NCT00769067|565760732|FG001|Overall Study|Death|86|||
156730104|NCT00769067|565760731|FG000|Overall Study|Lost to Follow-up|3|||
156730105|NCT00769067|565760732|FG001|Overall Study|Lost to Follow-up|1|||
156730106|NCT00769067|565760731|FG000|Overall Study|Study terminated by sponsor|1|||
156730107|NCT00769067|565760732|FG001|Overall Study|Study terminated by sponsor|3|||
156730108|NCT00769067|565760731|FG000|Overall Study|Other|1|||
156730109|NCT00769067|565760732|FG001|Overall Study|Other|3|||
156730110|NCT00769067|565760731|FG000|Overall Study|Withdrawal by Subject|0|||
156730111|NCT00769067|565760732|FG001|Overall Study|Withdrawal by Subject|1|||
157139482|NCT02305563|567255940|FG002|Treatment Period|other reason|2|||
157139483|NCT02305563|567255941|FG003|Treatment Period|other reason|2|||
157139484|NCT02305563|567255942|FG004|Treatment Period|other reason|1|||
157139485|NCT02305563|567255938|FG000|Treatment Period|Randomized but not treated|0|||
157139486|NCT02305563|567255939|FG001|Treatment Period|Randomized but not treated|0|||
157139487|NCT02305563|567255940|FG002|Treatment Period|Randomized but not treated|0|||
157139488|NCT02305563|567255941|FG003|Treatment Period|Randomized but not treated|0|||
156730112|NCT04981470|565760735|FG000|Overall Study|Device failure in all 4 patients|4|||
156730113|NCT04402138|565760736|FG000|Overall Study|Progressive Disease|2|||
156730114|NCT04402138|565760736|FG000|Overall Study|Adverse Event|1|||
156730115|NCT00784238|565760737|FG000|Overall Study|Adverse Event|14|||
156730116|NCT00784238|565760737|FG000|Overall Study|Death|2|||
156730117|NCT00784238|565760737|FG000|Overall Study|Lack of Efficacy|33|||
156730118|NCT00784238|565760737|FG000|Overall Study|Lost to Follow-up|29|||
156730119|NCT00784238|565760737|FG000|Overall Study|Pregnancy|1|||
156730120|NCT00784238|565760737|FG000|Overall Study|Withdrawal by Subject|26|||
156730121|NCT00784238|565760737|FG000|Overall Study|Other|14|||
156730122|NCT04390503|565760739|FG000|Overall Study|Physician Decision|2|||
156730123|NCT04390503|565760740|FG001|Overall Study|Physician Decision|1|||
156730124|NCT04390503|565760739|FG000|Overall Study|Adverse Event|1|||
156730125|NCT04390503|565760740|FG001|Overall Study|Adverse Event|0|||
156730126|NCT00078767|565760741|FG000|Overall Study|Withdrawal by Subject|1|||
156730127|NCT00078767|565760742|FG001|Overall Study|Withdrawal by Subject|1|||
156730128|NCT01068730|565760743|FG000|Period 3|Personal reason|1|||
156730129|NCT01068730|565760744|FG001|Period 3|Personal reason|0|||
156730130|NCT01068730|565760745|FG002|Period 3|Personal reason|0|||
156730131|NCT01068730|565760746|FG003|Period 3|Personal reason|0|||
156730132|NCT01068730|565760743|FG000|Period 4|Family emergency|0|||
156730133|NCT01068730|565760744|FG001|Period 4|Family emergency|1|||
156730134|NCT01068730|565760745|FG002|Period 4|Family emergency|0|||
156730135|NCT01068730|565760746|FG003|Period 4|Family emergency|0|||
156730136|NCT03508726|565760747|FG000|Overall Study|Withdrawal by Subject|0|||
156730137|NCT03508726|565760748|FG001|Overall Study|Withdrawal by Subject|1|||
156730138|NCT03233529|565760752|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
156730139|NCT03233529|565760752|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
156730140|NCT01177293|565760753|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
156730141|NCT01177293|565760754|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
156730142|NCT00594100|565760755|FG000|Procedure|Technical Failure|9|||
156730143|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
156730144|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
156730145|NCT00594100|565760755|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
156730146|NCT02448537|565760756|FG000|Overall Study|Withdrawal by Subject|1|||
156730147|NCT02448537|565760757|FG001|Overall Study|Withdrawal by Subject|1|||
156730148|NCT02448537|565760758|FG002|Overall Study|Withdrawal by Subject|1|||
156730149|NCT03528369|565760761|FG000|Overall Study|Withdrawal by Subject|2|||
156730150|NCT03528369|565760762|FG001|Overall Study|Withdrawal by Subject|0|||
156730151|NCT03528369|565760763|FG002|Overall Study|Withdrawal by Subject|0|||
156730152|NCT03528369|565760761|FG000|Overall Study|Lost to Follow-up|1|||
156730153|NCT03528369|565760762|FG001|Overall Study|Lost to Follow-up|0|||
156730154|NCT03528369|565760763|FG002|Overall Study|Lost to Follow-up|0|||
156730155|NCT03528369|565760761|FG000|Overall Study|Adverse Event|0|||
156730156|NCT03528369|565760762|FG001|Overall Study|Adverse Event|1|||
156730157|NCT03528369|565760763|FG002|Overall Study|Adverse Event|0|||
156730158|NCT04725812|565760764|FG000|Overall Study|Withdrawal by Subject|1|||
156730159|NCT05656534|565760766|FG000|Overall Study|Withdrawal by Subject|1|||
156730160|NCT05656534|565760767|FG001|Overall Study|Withdrawal by Subject|1|||
156730161|NCT05656534|565760768|FG002|Overall Study|Withdrawal by Subject|0|||
156730162|NCT05656534|565760769|FG003|Overall Study|Withdrawal by Subject|0|||
156730163|NCT05656534|565760766|FG000|Overall Study|Physician Decision|1|||
156730164|NCT05656534|565760767|FG001|Overall Study|Physician Decision|1|||
156730165|NCT05656534|565760768|FG002|Overall Study|Physician Decision|0|||
156730166|NCT05656534|565760769|FG003|Overall Study|Physician Decision|0|||
156730167|NCT00839800|565760770|FG000|Overall Study|Adverse Event|8|||
156730168|NCT00839800|565760771|FG001|Overall Study|Adverse Event|12|||
156730169|NCT00839800|565760770|FG000|Overall Study|Lost to Follow-up|31|||
156730170|NCT00839800|565760771|FG001|Overall Study|Lost to Follow-up|26|||
156730171|NCT00839800|565760770|FG000|Overall Study|Withdrawal by Subject|28|||
156730172|NCT00839800|565760771|FG001|Overall Study|Withdrawal by Subject|34|||
156730173|NCT00839800|565760770|FG000|Overall Study|Incorrect Enrolment|3|||
156730174|NCT00839800|565760771|FG001|Overall Study|Incorrect Enrolment|3|||
156730175|NCT00839800|565760770|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
156730176|NCT00839800|565760771|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
156730177|NCT00839800|565760770|FG000|Overall Study|Safety Reasons|2|||
156730178|NCT00839800|565760771|FG001|Overall Study|Safety Reasons|1|||
156730179|NCT00839800|565760770|FG000|Overall Study|Other|8|||
156730180|NCT00839800|565760771|FG001|Overall Study|Other|14|||
156730181|NCT00839800|565760770|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
156730182|NCT00839800|565760771|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
156730183|NCT02801617|565760772|FG000|Overall Study|Protocol Violation|2|||
156796384|NCT01182350|566008045|FG000|Overall Study|Adverse Event|5|||
156796385|NCT01182350|566008046|FG001|Overall Study|Adverse Event|0|||
156796386|NCT01182350|566008047|FG002|Overall Study|Adverse Event|0|||
156796387|NCT01182350|566008048|FG003|Overall Study|Adverse Event|0|||
156796388|NCT01182350|566008049|FG004|Overall Study|Adverse Event|0|||
156730184|NCT02801617|565760773|FG001|Overall Study|Protocol Violation|6|||
156730185|NCT00302328|565760774|FG000|Overall Study|Physician Decision|0|||
156730186|NCT00302328|565760775|FG001|Overall Study|Physician Decision|1|||
156730187|NCT00302328|565760776|FG002|Overall Study|Physician Decision|0|||
156730188|NCT01288937|565760777|FG000|Overall Study|Adverse Event|1|||
156730189|NCT01288937|565760778|FG001|Overall Study|Adverse Event|0|||
156730190|NCT00857896|565760781|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
156730191|NCT01431716|565760785|FG000|Overall Study|Withdrawal of consent|1|||
156730192|NCT01996254|565760786|FG000|Overall Study|Change in Eligibility|0|||
156730193|NCT01996254|565760787|FG001|Overall Study|Change in Eligibility|2|||
156730194|NCT01996254|565760788|FG002|Overall Study|Change in Eligibility|0|||
156730195|NCT01996254|565760786|FG000|Overall Study|Withdrawal by Subject|0|||
156796389|NCT01182350|566008045|FG000|Overall Study|Disease Progression|15|||
156796390|NCT01182350|566008046|FG001|Overall Study|Disease Progression|12|||
156796391|NCT01182350|566008047|FG002|Overall Study|Disease Progression|0|||
156796392|NCT01182350|566008048|FG003|Overall Study|Disease Progression|1|||
156796393|NCT01182350|566008049|FG004|Overall Study|Disease Progression|0|||
156796394|NCT01182350|566008045|FG000|Overall Study|Death|0|||
156796395|NCT01182350|566008046|FG001|Overall Study|Death|1|||
156796396|NCT01182350|566008047|FG002|Overall Study|Death|1|||
156796397|NCT01182350|566008048|FG003|Overall Study|Death|0|||
156796398|NCT01182350|566008049|FG004|Overall Study|Death|0|||
156730196|NCT01996254|565760787|FG001|Overall Study|Withdrawal by Subject|3|||
156796399|NCT01182350|566008045|FG000|Overall Study|Withdrawal by Subject|3|||
156796400|NCT01182350|566008046|FG001|Overall Study|Withdrawal by Subject|1|||
156796401|NCT01182350|566008047|FG002|Overall Study|Withdrawal by Subject|0|||
156796402|NCT01182350|566008048|FG003|Overall Study|Withdrawal by Subject|1|||
156796403|NCT01182350|566008049|FG004|Overall Study|Withdrawal by Subject|0|||
156796404|NCT01182350|566008045|FG000|Overall Study|Alternative Therapy|2|||
156796405|NCT01182350|566008046|FG001|Overall Study|Alternative Therapy|0|||
156796406|NCT01182350|566008047|FG002|Overall Study|Alternative Therapy|1|||
156796407|NCT01182350|566008048|FG003|Overall Study|Alternative Therapy|0|||
156796408|NCT01182350|566008049|FG004|Overall Study|Alternative Therapy|0|||
156796409|NCT01182350|566008045|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
156796410|NCT01182350|566008046|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
156796411|NCT01182350|566008047|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
156796412|NCT01182350|566008048|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
156796413|NCT01182350|566008049|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
156730197|NCT01996254|565760788|FG002|Overall Study|Withdrawal by Subject|4|||
156730198|NCT01996254|565760786|FG000|Overall Study|Lost to Follow-up|1|||
156730199|NCT01996254|565760787|FG001|Overall Study|Lost to Follow-up|0|||
156730200|NCT01996254|565760788|FG002|Overall Study|Lost to Follow-up|4|||
156730201|NCT03852264|565760791|FG000|Third Research Visit|Lost to Follow-up|1|||
156730202|NCT03852264|565760792|FG001|Third Research Visit|Lost to Follow-up|0|||
156730203|NCT02411396|565760796|FG000|Overall Study|Lost to Follow-up|31|||
156730204|NCT02411396|565760796|FG000|Overall Study|Death|10|||
156730205|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
156796414|NCT01182350|566008045|FG000|Overall Study|Unevaluable for Biopsy|0|||
156796415|NCT01182350|566008046|FG001|Overall Study|Unevaluable for Biopsy|0|||
156796416|NCT01182350|566008047|FG002|Overall Study|Unevaluable for Biopsy|0|||
156796417|NCT01182350|566008048|FG003|Overall Study|Unevaluable for Biopsy|0|||
156796418|NCT01182350|566008049|FG004|Overall Study|Unevaluable for Biopsy|3|||
156796419|NCT01381679|566008052|FG000|Overall Study|Adverse Event|3|||
156796420|NCT01381679|566008052|FG000|Overall Study|Lost to Follow-up|885|||
156796421|NCT05473715|566008053|FG000|Overall Study|Trial terminate|2|||
156796422|NCT05473715|566008054|FG001|Overall Study|Trial terminate|1|||
156796423|NCT03528902|566008055|FG000|Overall Study|Adverse Event|1|||
156796424|NCT03528902|566008056|FG001|Overall Study|Adverse Event|0|||
156796425|NCT04770285|566008057|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
156796426|NCT04770285|566008058|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
156796427|NCT04770285|566008057|FG000|Overall Study|Lack of Efficacy|0|||
156796428|NCT04770285|566008058|FG001|Overall Study|Lack of Efficacy|1|||
156796429|NCT04770285|566008057|FG000|Overall Study|Lost to Follow-up|11|||
156796430|NCT04770285|566008058|FG001|Overall Study|Lost to Follow-up|8|||
156796431|NCT04770285|566008057|FG000|Overall Study|Protocol Deviation|6|||
156796432|NCT04770285|566008058|FG001|Overall Study|Protocol Deviation|6|||
156796433|NCT04770285|566008057|FG000|Overall Study|Technical Problem|0|||
156796434|NCT04770285|566008058|FG001|Overall Study|Technical Problem|1|||
156796435|NCT04770285|566008057|FG000|Overall Study|Withdrawal by Subject|9|||
156796436|NCT04770285|566008058|FG001|Overall Study|Withdrawal by Subject|8|||
156796437|NCT04770285|566008057|FG000|Overall Study|Reason Not Specified|0|||
156796438|NCT04770285|566008058|FG001|Overall Study|Reason Not Specified|1|||
156796439|NCT03232567|566008059|FG000|Overall Study|Withdrawal by Subject|0|||
156796440|NCT03232567|566008060|FG001|Overall Study|Withdrawal by Subject|1|||
156796441|NCT03232567|566008061|FG002|Overall Study|Withdrawal by Subject|0|||
156796442|NCT03232567|566008062|FG003|Overall Study|Withdrawal by Subject|0|||
156796443|NCT05837481|566008063|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
156730206|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
156730207|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
156730208|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
156796444|NCT05837481|566008064|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
156796445|NCT00427700|566008065|FG000|Overall Study|Lost to Follow-up|2|||
156796446|NCT00427700|566008066|FG001|Overall Study|Lost to Follow-up|5|||
156730209|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
156796447|NCT00427700|566008065|FG000|Overall Study|no induction of menses|1|||
156796448|NCT00427700|566008066|FG001|Overall Study|no induction of menses|4|||
156796449|NCT00427700|566008065|FG000|Overall Study|Pregnancy|0|||
156730210|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
156730211|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
156730212|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
156730213|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
156730214|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
156730215|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
156730216|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
156730217|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
156730218|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
156730219|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730220|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730221|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730222|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
156730223|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
156730224|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
156730225|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
156730226|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
156730227|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
156730228|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
156730229|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
156730230|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
156730231|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
156730232|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
156730233|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
156730234|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
156730235|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
156730236|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
156730237|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730238|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730239|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730240|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
156730241|NCT02016105|565760801|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
156730242|NCT02016105|565760802|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
156730243|NCT02016105|565760803|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730244|NCT02016105|565760804|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730245|NCT02016105|565760805|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730246|NCT02016105|565760806|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
156730247|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730248|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730249|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730250|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730251|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
156730252|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
156730253|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
156730254|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
156730255|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
156730256|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
156730257|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
156730258|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
156730259|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
156730260|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
156730261|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
156730262|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
156730263|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
156730264|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
156730265|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Death|0|||
156730266|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Death|0|||
156730267|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Death|0|||
156730268|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Death|0|||
156730269|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Death|0|||
156730270|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Death|1|||
156730271|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
156730272|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
156730273|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
156730274|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
156730275|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
156730276|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
156730277|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
156730278|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
156730279|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
156730280|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
156730281|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
156730282|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
156730283|NCT02016105|565760801|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730284|NCT02016105|565760802|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730285|NCT02016105|565760803|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
156730286|NCT02016105|565760804|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156796450|NCT00427700|566008066|FG001|Overall Study|Pregnancy|2|||
156730287|NCT02016105|565760805|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
156730288|NCT02016105|565760806|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
156730289|NCT02016105|565760801|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
156730290|NCT02016105|565760802|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
156730291|NCT02016105|565760803|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
156730292|NCT02016105|565760804|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
156730293|NCT02016105|565760805|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
156730294|NCT02016105|565760806|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
156730295|NCT02016105|565760801|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
156730296|NCT02016105|565760802|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
156730297|NCT02016105|565760803|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
156730298|NCT02016105|565760804|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
156730299|NCT02016105|565760805|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
156730300|NCT02016105|565760806|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
156730301|NCT02016105|565760801|FG000|EXTENSION PERIOD|Adverse Event|0|||
156730302|NCT02016105|565760802|FG001|EXTENSION PERIOD|Adverse Event|0|||
156730303|NCT02016105|565760803|FG002|EXTENSION PERIOD|Adverse Event|2|||
156730304|NCT02016105|565760804|FG003|EXTENSION PERIOD|Adverse Event|0|||
156730305|NCT02016105|565760805|FG004|EXTENSION PERIOD|Adverse Event|1|||
156730306|NCT02016105|565760806|FG005|EXTENSION PERIOD|Adverse Event|0|||
156730307|NCT02016105|565760801|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
156730308|NCT02016105|565760802|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
156730309|NCT02016105|565760803|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730310|NCT02016105|565760804|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730311|NCT02016105|565760805|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730312|NCT02016105|565760806|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
156730313|NCT02016105|565760801|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730314|NCT02016105|565760802|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730315|NCT02016105|565760803|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730316|NCT02016105|565760804|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730317|NCT02016105|565760805|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
156730318|NCT02016105|565760806|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
156730319|NCT02016105|565760801|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
156730320|NCT02016105|565760802|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
156730321|NCT02016105|565760803|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
156730322|NCT02016105|565760804|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
156730323|NCT02016105|565760805|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
156730324|NCT02016105|565760806|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
156730325|NCT01908829|565760810|FG000|Overall Study|Adverse Event|13|||
156730326|NCT01908829|565760811|FG001|Overall Study|Adverse Event|11|||
156730327|NCT01908829|565760812|FG002|Overall Study|Adverse Event|13|||
156730328|NCT01908829|565760810|FG000|Overall Study|Lost to Follow-up|4|||
156730329|NCT01908829|565760811|FG001|Overall Study|Lost to Follow-up|2|||
156730330|NCT01908829|565760812|FG002|Overall Study|Lost to Follow-up|1|||
156730331|NCT01908829|565760810|FG000|Overall Study|Randomized no double-blind drug received|1|||
156730332|NCT01908829|565760811|FG001|Overall Study|Randomized no double-blind drug received|0|||
156730333|NCT01908829|565760812|FG002|Overall Study|Randomized no double-blind drug received|1|||
156730334|NCT01908829|565760810|FG000|Overall Study|Discontinued (no EoT page)|2|||
156730335|NCT01908829|565760811|FG001|Overall Study|Discontinued (no EoT page)|0|||
156730336|NCT01908829|565760812|FG002|Overall Study|Discontinued (no EoT page)|0|||
156730337|NCT01908829|565760810|FG000|Overall Study|Miscellaneous|0|||
156730338|NCT01908829|565760811|FG001|Overall Study|Miscellaneous|2|||
156730339|NCT01908829|565760812|FG002|Overall Study|Miscellaneous|0|||
156730340|NCT01908829|565760810|FG000|Overall Study|Protocol Violation|2|||
156730341|NCT01908829|565760811|FG001|Overall Study|Protocol Violation|2|||
156730342|NCT01908829|565760812|FG002|Overall Study|Protocol Violation|0|||
156730343|NCT01908829|565760810|FG000|Overall Study|Lack of Efficacy|1|||
156730344|NCT01908829|565760811|FG001|Overall Study|Lack of Efficacy|3|||
156730345|NCT01908829|565760812|FG002|Overall Study|Lack of Efficacy|2|||
156730346|NCT01908829|565760810|FG000|Overall Study|Withdrawal by Subject|26|||
156730347|NCT01908829|565760811|FG001|Overall Study|Withdrawal by Subject|29|||
156730348|NCT01908829|565760812|FG002|Overall Study|Withdrawal by Subject|22|||
156730349|NCT02865499|565760813|FG000|Baseline|Adverse Event|1|||
156730350|NCT02865499|565760813|FG000|Baseline|Withdrawal by Subject|1|||
156730351|NCT02792192|565760814|FG000|Overall Study|Death|1|||
156730352|NCT02792192|565760815|FG001|Overall Study|Death|0|||
156730353|NCT02792192|565760816|FG002|Overall Study|Death|0|||
156730354|NCT02792192|565760817|FG003|Overall Study|Death|0|||
156730355|NCT02792192|565760814|FG000|Overall Study|Informed Consent Withdrawn|4|||
156730356|NCT02792192|565760815|FG001|Overall Study|Informed Consent Withdrawn|0|||
156730357|NCT02792192|565760816|FG002|Overall Study|Informed Consent Withdrawn|0|||
156730358|NCT02792192|565760817|FG003|Overall Study|Informed Consent Withdrawn|0|||
156730359|NCT02792192|565760814|FG000|Overall Study|Physician Decision|1|||
156730360|NCT02792192|565760815|FG001|Overall Study|Physician Decision|0|||
156730361|NCT02792192|565760816|FG002|Overall Study|Physician Decision|0|||
156730362|NCT02792192|565760817|FG003|Overall Study|Physician Decision|0|||
156730363|NCT02792192|565760814|FG000|Overall Study|Progressive Disease|0|||
157139489|NCT02305563|567255942|FG004|Treatment Period|Randomized but not treated|2|||
156730364|NCT02792192|565760815|FG001|Overall Study|Progressive Disease|1|||
156730365|NCT02792192|565760816|FG002|Overall Study|Progressive Disease|0|||
156730366|NCT02792192|565760817|FG003|Overall Study|Progressive Disease|0|||
156730367|NCT02792192|565760814|FG000|Overall Study|Study Terminated By Sponsor|6|||
156730368|NCT02792192|565760815|FG001|Overall Study|Study Terminated By Sponsor|10|||
156730369|NCT02792192|565760816|FG002|Overall Study|Study Terminated By Sponsor|0|||
156730370|NCT02792192|565760817|FG003|Overall Study|Study Terminated By Sponsor|0|||
156730371|NCT02320058|565760818|FG000|Overall Study|Death|25|||
156730372|NCT02320058|565760819|FG001|Overall Study|Death|10|||
156730373|NCT02320058|565760818|FG000|Overall Study|Lost to Follow-up|4|||
156730374|NCT02320058|565760819|FG001|Overall Study|Lost to Follow-up|0|||
156730375|NCT02320058|565760818|FG000|Overall Study|Other reasons|4|||
156730376|NCT02320058|565760819|FG001|Overall Study|Other reasons|1|||
156730377|NCT02320058|565760818|FG000|Overall Study|Withdrawal by Subject|8|||
156730378|NCT02320058|565760819|FG001|Overall Study|Withdrawal by Subject|2|||
156730379|NCT02320058|565760818|FG000|Overall Study|Not reported|1|||
156730380|NCT02320058|565760819|FG001|Overall Study|Not reported|0|||
156730381|NCT01339923|565760820|FG000|Overall Study|Adverse Event|1|||
156730382|NCT01339923|565760821|FG001|Overall Study|Adverse Event|1|||
156730383|NCT01339923|565760822|FG002|Overall Study|Adverse Event|1|||
156730384|NCT01339923|565760823|FG003|Overall Study|Adverse Event|0|||
156730385|NCT01339923|565760824|FG004|Overall Study|Adverse Event|0|||
156730386|NCT01339923|565760825|FG005|Overall Study|Adverse Event|0|||
156730387|NCT01339923|565760826|FG006|Overall Study|Adverse Event|1|||
156730388|NCT01339923|565760820|FG000|Overall Study|Inappropriate Enrollment|1|||
156730389|NCT01339923|565760821|FG001|Overall Study|Inappropriate Enrollment|0|||
156730390|NCT01339923|565760822|FG002|Overall Study|Inappropriate Enrollment|0|||
156730391|NCT01339923|565760823|FG003|Overall Study|Inappropriate Enrollment|0|||
156730392|NCT01339923|565760824|FG004|Overall Study|Inappropriate Enrollment|0|||
156730393|NCT01339923|565760825|FG005|Overall Study|Inappropriate Enrollment|1|||
156730394|NCT01339923|565760826|FG006|Overall Study|Inappropriate Enrollment|0|||
156730395|NCT01339923|565760820|FG000|Overall Study|Lost to Follow-up|4|||
156730396|NCT01339923|565760821|FG001|Overall Study|Lost to Follow-up|4|||
156730397|NCT01339923|565760822|FG002|Overall Study|Lost to Follow-up|0|||
156730398|NCT01339923|565760823|FG003|Overall Study|Lost to Follow-up|3|||
156730399|NCT01339923|565760824|FG004|Overall Study|Lost to Follow-up|1|||
156730400|NCT01339923|565760825|FG005|Overall Study|Lost to Follow-up|1|||
156730401|NCT01339923|565760826|FG006|Overall Study|Lost to Follow-up|5|||
156730402|NCT01339923|565760820|FG000|Overall Study|Protocol Violation|0|||
156730403|NCT01339923|565760821|FG001|Overall Study|Protocol Violation|0|||
156730404|NCT01339923|565760822|FG002|Overall Study|Protocol Violation|0|||
156730405|NCT01339923|565760823|FG003|Overall Study|Protocol Violation|0|||
156730406|NCT01339923|565760824|FG004|Overall Study|Protocol Violation|0|||
156730407|NCT01339923|565760825|FG005|Overall Study|Protocol Violation|3|||
156730408|NCT01339923|565760826|FG006|Overall Study|Protocol Violation|1|||
156730409|NCT01339923|565760820|FG000|Overall Study|Unable to Classify|1|||
156730410|NCT01339923|565760821|FG001|Overall Study|Unable to Classify|0|||
156730411|NCT01339923|565760822|FG002|Overall Study|Unable to Classify|1|||
156730412|NCT01339923|565760823|FG003|Overall Study|Unable to Classify|0|||
156730413|NCT01339923|565760824|FG004|Overall Study|Unable to Classify|0|||
156730414|NCT01339923|565760825|FG005|Overall Study|Unable to Classify|1|||
156730415|NCT01339923|565760826|FG006|Overall Study|Unable to Classify|5|||
156730416|NCT01339923|565760820|FG000|Overall Study|Withdrawal by Subject|7|||
156730417|NCT01339923|565760821|FG001|Overall Study|Withdrawal by Subject|11|||
156730418|NCT01339923|565760822|FG002|Overall Study|Withdrawal by Subject|6|||
156730419|NCT01339923|565760823|FG003|Overall Study|Withdrawal by Subject|1|||
156730420|NCT01339923|565760824|FG004|Overall Study|Withdrawal by Subject|4|||
157139490|NCT02305563|567255938|FG000|Treatment Period|added ULO, then disease progression|0|||
156730421|NCT01339923|565760825|FG005|Overall Study|Withdrawal by Subject|3|||
156730422|NCT01339923|565760826|FG006|Overall Study|Withdrawal by Subject|2|||
156730423|NCT01430403|565760827|FG000|Overall Study|Lost to Follow-up|5|||
156730424|NCT01430403|565760828|FG001|Overall Study|Lost to Follow-up|5|||
156796451|NCT04581395|566008067|FG000|Overall Study|Protocol Violation|4|||
156796452|NCT04581395|566008068|FG001|Overall Study|Protocol Violation|3|||
156796453|NCT04581395|566008069|FG002|Overall Study|Protocol Violation|2|||
156796454|NCT04581395|566008067|FG000|Overall Study|Physician Decision|0|||
157139491|NCT02305563|567255939|FG001|Treatment Period|added ULO, then disease progression|0|||
157139492|NCT02305563|567255940|FG002|Treatment Period|added ULO, then disease progression|0|||
156730425|NCT01430403|565760829|FG002|Overall Study|Lost to Follow-up|3|||
156730426|NCT01430403|565760827|FG000|Overall Study|Physician Decision|1|||
156730427|NCT01430403|565760828|FG001|Overall Study|Physician Decision|0|||
156730428|NCT01430403|565760829|FG002|Overall Study|Physician Decision|0|||
156796455|NCT04581395|566008068|FG001|Overall Study|Physician Decision|1|||
156730429|NCT01430403|565760827|FG000|Overall Study|Protocol Violation|2|||
156730430|NCT01430403|565760828|FG001|Overall Study|Protocol Violation|3|||
156730431|NCT01430403|565760829|FG002|Overall Study|Protocol Violation|2|||
156796456|NCT04581395|566008069|FG002|Overall Study|Physician Decision|0|||
156730432|NCT01430403|565760827|FG000|Overall Study|Withdrawal by Subject|9|||
156730433|NCT01430403|565760828|FG001|Overall Study|Withdrawal by Subject|1|||
156730434|NCT01430403|565760829|FG002|Overall Study|Withdrawal by Subject|3|||
156730435|NCT02477826|565760850|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730436|NCT02477826|565760851|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730437|NCT02477826|565760852|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
156730438|NCT02477826|565760853|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730439|NCT02477826|565760854|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730440|NCT02477826|565760855|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
157139493|NCT02305563|567255941|FG003|Treatment Period|added ULO, then disease progression|0|||
157139494|NCT02305563|567255942|FG004|Treatment Period|added ULO, then disease progression|4|||
157139495|NCT02305563|567255938|FG000|Treatment Period|added ULO; then other reason|0|||
157139496|NCT02305563|567255939|FG001|Treatment Period|added ULO; then other reason|0|||
156730441|NCT02477826|565760856|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
156730442|NCT02477826|565760857|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
156730443|NCT02477826|565760858|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730444|NCT02477826|565760859|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
156730445|NCT02477826|565760850|FG000|Pre-Treatment|Other reasons|4|||
156730446|NCT02477826|565760851|FG001|Pre-Treatment|Other reasons|1|||
156730447|NCT02477826|565760852|FG002|Pre-Treatment|Other reasons|4|||
156730448|NCT02477826|565760853|FG003|Pre-Treatment|Other reasons|1|||
156730449|NCT02477826|565760854|FG004|Pre-Treatment|Other reasons|4|||
156730450|NCT02477826|565760855|FG005|Pre-Treatment|Other reasons|2|||
156730451|NCT02477826|565760856|FG006|Pre-Treatment|Other reasons|0|||
156730452|NCT02477826|565760857|FG007|Pre-Treatment|Other reasons|0|||
156730453|NCT02477826|565760858|FG008|Pre-Treatment|Other reasons|0|||
156730454|NCT02477826|565760859|FG009|Pre-Treatment|Other reasons|0|||
156730455|NCT02477826|565760850|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
156730456|NCT02477826|565760851|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
156730457|NCT02477826|565760852|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
156730458|NCT02477826|565760853|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
156730459|NCT02477826|565760854|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
156730460|NCT02477826|565760855|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
156730461|NCT02477826|565760856|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
156730462|NCT02477826|565760857|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
156730463|NCT02477826|565760858|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
156730464|NCT02477826|565760859|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
156730465|NCT02477826|565760850|FG000|Pre-Treatment|Subject withdrew consent|0|||
156730466|NCT02477826|565760851|FG001|Pre-Treatment|Subject withdrew consent|0|||
156730467|NCT02477826|565760852|FG002|Pre-Treatment|Subject withdrew consent|3|||
156730468|NCT02477826|565760853|FG003|Pre-Treatment|Subject withdrew consent|0|||
156730469|NCT02477826|565760854|FG004|Pre-Treatment|Subject withdrew consent|0|||
156730470|NCT02477826|565760855|FG005|Pre-Treatment|Subject withdrew consent|1|||
156730471|NCT02477826|565760856|FG006|Pre-Treatment|Subject withdrew consent|0|||
156730472|NCT02477826|565760857|FG007|Pre-Treatment|Subject withdrew consent|1|||
156730473|NCT02477826|565760858|FG008|Pre-Treatment|Subject withdrew consent|0|||
156730474|NCT02477826|565760859|FG009|Pre-Treatment|Subject withdrew consent|3|||
156730475|NCT02477826|565760850|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730476|NCT02477826|565760851|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
156730477|NCT02477826|565760852|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730478|NCT02477826|565760853|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730479|NCT02477826|565760854|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730480|NCT02477826|565760855|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730481|NCT02477826|565760856|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730482|NCT02477826|565760857|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
156796457|NCT00815633|566008074|FG000|Overall Study|study terminated|1|||
156796458|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
156796459|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796460|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796461|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796462|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796463|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796464|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
156796465|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
156796466|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
156796467|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
156796468|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
156796469|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
156796470|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
156796471|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
156730483|NCT02477826|565760858|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
156730484|NCT02477826|565760859|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
156730485|NCT02477826|565760850|FG000|Pre-Treatment|Death|0|||
156730486|NCT02477826|565760851|FG001|Pre-Treatment|Death|0|||
156730487|NCT02477826|565760852|FG002|Pre-Treatment|Death|0|||
156730488|NCT02477826|565760853|FG003|Pre-Treatment|Death|0|||
156730489|NCT02477826|565760854|FG004|Pre-Treatment|Death|0|||
156730490|NCT02477826|565760855|FG005|Pre-Treatment|Death|0|||
156730491|NCT02477826|565760856|FG006|Pre-Treatment|Death|1|||
156730492|NCT02477826|565760857|FG007|Pre-Treatment|Death|0|||
156730493|NCT02477826|565760858|FG008|Pre-Treatment|Death|0|||
156730494|NCT02477826|565760859|FG009|Pre-Treatment|Death|0|||
156730495|NCT02477826|565760850|FG000|Treatment Period|Not reported|8|||
156730496|NCT02477826|565760851|FG001|Treatment Period|Not reported|6|||
156730497|NCT02477826|565760852|FG002|Treatment Period|Not reported|4|||
156730498|NCT02477826|565760853|FG003|Treatment Period|Not reported|4|||
156730499|NCT02477826|565760854|FG004|Treatment Period|Not reported|2|||
156730500|NCT02477826|565760855|FG005|Treatment Period|Not reported|1|||
156730501|NCT02477826|565760856|FG006|Treatment Period|Not reported|14|||
156730502|NCT02477826|565760857|FG007|Treatment Period|Not reported|8|||
156730503|NCT02477826|565760858|FG008|Treatment Period|Not reported|5|||
156730504|NCT02477826|565760859|FG009|Treatment Period|Not reported|2|||
156730505|NCT02477826|565760850|FG000|Treatment Period|Other reasons|5|||
156730506|NCT02477826|565760851|FG001|Treatment Period|Other reasons|6|||
156730507|NCT02477826|565760852|FG002|Treatment Period|Other reasons|12|||
156730508|NCT02477826|565760853|FG003|Treatment Period|Other reasons|7|||
156730509|NCT02477826|565760854|FG004|Treatment Period|Other reasons|5|||
156730510|NCT02477826|565760855|FG005|Treatment Period|Other reasons|1|||
156730511|NCT02477826|565760856|FG006|Treatment Period|Other reasons|8|||
156730512|NCT02477826|565760857|FG007|Treatment Period|Other reasons|8|||
156730513|NCT02477826|565760858|FG008|Treatment Period|Other reasons|21|||
156730514|NCT02477826|565760859|FG009|Treatment Period|Other reasons|1|||
156730515|NCT02477826|565760850|FG000|Treatment Period|Administrative reason by sponsor|0|||
156730516|NCT02477826|565760851|FG001|Treatment Period|Administrative reason by sponsor|3|||
156730517|NCT02477826|565760852|FG002|Treatment Period|Administrative reason by sponsor|0|||
156730518|NCT02477826|565760853|FG003|Treatment Period|Administrative reason by sponsor|0|||
156730519|NCT02477826|565760854|FG004|Treatment Period|Administrative reason by sponsor|0|||
156730520|NCT02477826|565760855|FG005|Treatment Period|Administrative reason by sponsor|0|||
156730521|NCT02477826|565760856|FG006|Treatment Period|Administrative reason by sponsor|0|||
156730522|NCT02477826|565760857|FG007|Treatment Period|Administrative reason by sponsor|0|||
156730523|NCT02477826|565760858|FG008|Treatment Period|Administrative reason by sponsor|0|||
156730524|NCT02477826|565760859|FG009|Treatment Period|Administrative reason by sponsor|0|||
156730525|NCT02477826|565760850|FG000|Treatment Period|Participant meet no longer study criteria|1|||
156730526|NCT02477826|565760851|FG001|Treatment Period|Participant meet no longer study criteria|1|||
156730527|NCT02477826|565760852|FG002|Treatment Period|Participant meet no longer study criteria|0|||
156730528|NCT02477826|565760853|FG003|Treatment Period|Participant meet no longer study criteria|0|||
156730529|NCT02477826|565760854|FG004|Treatment Period|Participant meet no longer study criteria|1|||
156730530|NCT02477826|565760855|FG005|Treatment Period|Participant meet no longer study criteria|1|||
156730531|NCT02477826|565760856|FG006|Treatment Period|Participant meet no longer study criteria|0|||
156730532|NCT02477826|565760857|FG007|Treatment Period|Participant meet no longer study criteria|1|||
156730533|NCT02477826|565760858|FG008|Treatment Period|Participant meet no longer study criteria|0|||
156730534|NCT02477826|565760859|FG009|Treatment Period|Participant meet no longer study criteria|0|||
156730535|NCT02477826|565760850|FG000|Treatment Period|Poor/Non Compliance|1|||
156730536|NCT02477826|565760851|FG001|Treatment Period|Poor/Non Compliance|0|||
156730537|NCT02477826|565760852|FG002|Treatment Period|Poor/Non Compliance|2|||
156730538|NCT02477826|565760853|FG003|Treatment Period|Poor/Non Compliance|0|||
156730539|NCT02477826|565760854|FG004|Treatment Period|Poor/Non Compliance|0|||
156730540|NCT02477826|565760855|FG005|Treatment Period|Poor/Non Compliance|1|||
156730541|NCT02477826|565760856|FG006|Treatment Period|Poor/Non Compliance|1|||
156730542|NCT02477826|565760857|FG007|Treatment Period|Poor/Non Compliance|0|||
156796472|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
156730543|NCT02477826|565760858|FG008|Treatment Period|Poor/Non Compliance|0|||
156730544|NCT02477826|565760859|FG009|Treatment Period|Poor/Non Compliance|1|||
156730545|NCT02477826|565760850|FG000|Treatment Period|Maximum Clinical Benefit|3|||
156730546|NCT02477826|565760851|FG001|Treatment Period|Maximum Clinical Benefit|3|||
156730547|NCT02477826|565760852|FG002|Treatment Period|Maximum Clinical Benefit|1|||
156796473|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
156730548|NCT02477826|565760853|FG003|Treatment Period|Maximum Clinical Benefit|1|||
156730549|NCT02477826|565760854|FG004|Treatment Period|Maximum Clinical Benefit|3|||
156730550|NCT02477826|565760855|FG005|Treatment Period|Maximum Clinical Benefit|0|||
156730551|NCT02477826|565760856|FG006|Treatment Period|Maximum Clinical Benefit|3|||
156730552|NCT02477826|565760857|FG007|Treatment Period|Maximum Clinical Benefit|2|||
156730553|NCT02477826|565760858|FG008|Treatment Period|Maximum Clinical Benefit|2|||
156730554|NCT02477826|565760859|FG009|Treatment Period|Maximum Clinical Benefit|2|||
156730555|NCT02477826|565760850|FG000|Treatment Period|Lost to Follow-up|0|||
156730556|NCT02477826|565760851|FG001|Treatment Period|Lost to Follow-up|0|||
156730557|NCT02477826|565760852|FG002|Treatment Period|Lost to Follow-up|1|||
156730558|NCT02477826|565760853|FG003|Treatment Period|Lost to Follow-up|1|||
156730559|NCT02477826|565760854|FG004|Treatment Period|Lost to Follow-up|0|||
156730560|NCT02477826|565760855|FG005|Treatment Period|Lost to Follow-up|0|||
156730561|NCT02477826|565760856|FG006|Treatment Period|Lost to Follow-up|2|||
156730562|NCT02477826|565760857|FG007|Treatment Period|Lost to Follow-up|2|||
156730563|NCT02477826|565760858|FG008|Treatment Period|Lost to Follow-up|0|||
156730564|NCT02477826|565760859|FG009|Treatment Period|Lost to Follow-up|0|||
156730565|NCT02477826|565760850|FG000|Treatment Period|Participant withdrew Consent|5|||
156730566|NCT02477826|565760851|FG001|Treatment Period|Participant withdrew Consent|5|||
156730567|NCT02477826|565760852|FG002|Treatment Period|Participant withdrew Consent|3|||
156730568|NCT02477826|565760853|FG003|Treatment Period|Participant withdrew Consent|3|||
156730569|NCT02477826|565760854|FG004|Treatment Period|Participant withdrew Consent|1|||
156876448|NCT04080167|566305840|FG001|Overall Study|Lost to Follow-up-Providers|2|||
156730570|NCT02477826|565760855|FG005|Treatment Period|Participant withdrew Consent|3|||
156730571|NCT02477826|565760856|FG006|Treatment Period|Participant withdrew Consent|3|||
156730572|NCT02477826|565760857|FG007|Treatment Period|Participant withdrew Consent|3|||
156730573|NCT02477826|565760858|FG008|Treatment Period|Participant withdrew Consent|2|||
156730574|NCT02477826|565760859|FG009|Treatment Period|Participant withdrew Consent|3|||
156730575|NCT02477826|565760850|FG000|Treatment Period|Participant request to discontinue treatment|5|||
156730576|NCT02477826|565760851|FG001|Treatment Period|Participant request to discontinue treatment|3|||
156730577|NCT02477826|565760852|FG002|Treatment Period|Participant request to discontinue treatment|15|||
156730578|NCT02477826|565760853|FG003|Treatment Period|Participant request to discontinue treatment|5|||
156730579|NCT02477826|565760854|FG004|Treatment Period|Participant request to discontinue treatment|3|||
156730580|NCT02477826|565760855|FG005|Treatment Period|Participant request to discontinue treatment|6|||
156730581|NCT02477826|565760856|FG006|Treatment Period|Participant request to discontinue treatment|13|||
156730582|NCT02477826|565760857|FG007|Treatment Period|Participant request to discontinue treatment|15|||
156730583|NCT02477826|565760858|FG008|Treatment Period|Participant request to discontinue treatment|4|||
156730584|NCT02477826|565760859|FG009|Treatment Period|Participant request to discontinue treatment|18|||
156730585|NCT02477826|565760850|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
156730586|NCT02477826|565760851|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
156730587|NCT02477826|565760852|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
156730588|NCT02477826|565760853|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
156730589|NCT02477826|565760854|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
156730590|NCT02477826|565760855|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
156730591|NCT02477826|565760856|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
156730592|NCT02477826|565760857|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
156730593|NCT02477826|565760858|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
156730594|NCT02477826|565760859|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
156730595|NCT02477826|565760850|FG000|Treatment Period|Death|4|||
156730596|NCT02477826|565760851|FG001|Treatment Period|Death|7|||
156876449|NCT04080167|566305841|FG002|Overall Study|Lost to Follow-up-Providers|0|||
156876450|NCT04080167|566305839|FG000|Overall Study|Withdrawal by Subject|1|||
156876451|NCT04080167|566305840|FG001|Overall Study|Withdrawal by Subject|2|||
156876452|NCT04080167|566305841|FG002|Overall Study|Withdrawal by Subject|0|||
156876453|NCT04080167|566305839|FG000|Overall Study|Withdrawal by Provider|0|||
156876454|NCT04080167|566305840|FG001|Overall Study|Withdrawal by Provider|0|||
156876455|NCT04080167|566305841|FG002|Overall Study|Withdrawal by Provider|4|||
156876456|NCT04080167|566305839|FG000|Overall Study|Death-Patient|2|||
156876457|NCT04080167|566305840|FG001|Overall Study|Death-Patient|1|||
156876458|NCT04080167|566305841|FG002|Overall Study|Death-Patient|0|||
156876459|NCT04080167|566305839|FG000|Overall Study|Hydroxyurea New Starts|0|||
156876460|NCT04080167|566305840|FG001|Overall Study|Hydroxyurea New Starts|0|||
156876461|NCT04080167|566305841|FG002|Overall Study|Hydroxyurea New Starts|1|||
156876462|NCT04080167|566305839|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
156876463|NCT04080167|566305840|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
156730597|NCT02477826|565760852|FG002|Treatment Period|Death|0|||
156730598|NCT02477826|565760853|FG003|Treatment Period|Death|0|||
156730599|NCT02477826|565760854|FG004|Treatment Period|Death|1|||
156730600|NCT02477826|565760855|FG005|Treatment Period|Death|2|||
156876464|NCT04080167|566305841|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
156876465|NCT02067676|566305842|FG000|Overall Study|Withdrawal by Subject|1|||
156876466|NCT02067676|566305843|FG001|Overall Study|Withdrawal by Subject|0|||
157019866|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
157217457|NCT01621490|567543224|FG002|Overall Study|Study drug toxicity|5|||
156730601|NCT02477826|565760856|FG006|Treatment Period|Death|6|||
156730602|NCT02477826|565760857|FG007|Treatment Period|Death|5|||
156730603|NCT02477826|565760858|FG008|Treatment Period|Death|9|||
156730604|NCT02477826|565760859|FG009|Treatment Period|Death|0|||
156876467|NCT02067676|566305844|FG002|Overall Study|Withdrawal by Subject|0|||
156876468|NCT02067676|566305845|FG003|Overall Study|Withdrawal by Subject|0|||
157139497|NCT02305563|567255940|FG002|Treatment Period|added ULO; then other reason|0|||
157139498|NCT02305563|567255941|FG003|Treatment Period|added ULO; then other reason|0|||
157139499|NCT02305563|567255942|FG004|Treatment Period|added ULO; then other reason|1|||
157139500|NCT02305563|567255938|FG000|Treatment Period|added ULO, then request to stop|0|||
156730605|NCT02477826|565760850|FG000|Treatment Period|Study Drug Toxicity|79|||
156730606|NCT02477826|565760851|FG001|Treatment Period|Study Drug Toxicity|51|||
156730607|NCT02477826|565760852|FG002|Treatment Period|Study Drug Toxicity|31|||
156730608|NCT02477826|565760853|FG003|Treatment Period|Study Drug Toxicity|39|||
156730609|NCT02477826|565760854|FG004|Treatment Period|Study Drug Toxicity|12|||
156730610|NCT02477826|565760855|FG005|Treatment Period|Study Drug Toxicity|25|||
156730611|NCT02477826|565760856|FG006|Treatment Period|Study Drug Toxicity|52|||
156730612|NCT02477826|565760857|FG007|Treatment Period|Study Drug Toxicity|30|||
156730613|NCT02477826|565760858|FG008|Treatment Period|Study Drug Toxicity|20|||
156730614|NCT02477826|565760859|FG009|Treatment Period|Study Drug Toxicity|9|||
156730615|NCT02477826|565760850|FG000|Treatment Period|Disease progression|212|||
156730616|NCT02477826|565760851|FG001|Treatment Period|Disease progression|240|||
156730617|NCT02477826|565760852|FG002|Treatment Period|Disease progression|202|||
156730618|NCT02477826|565760853|FG003|Treatment Period|Disease progression|93|||
156730619|NCT02477826|565760854|FG004|Treatment Period|Disease progression|113|||
156730620|NCT02477826|565760855|FG005|Treatment Period|Disease progression|96|||
156730621|NCT02477826|565760856|FG006|Treatment Period|Disease progression|208|||
156730622|NCT02477826|565760857|FG007|Treatment Period|Disease progression|195|||
156730623|NCT02477826|565760858|FG008|Treatment Period|Disease progression|59|||
156730624|NCT02477826|565760859|FG009|Treatment Period|Disease progression|46|||
156730625|NCT02477826|565760850|FG000|Treatment Period|Pregnancy|0|||
156730626|NCT02477826|565760851|FG001|Treatment Period|Pregnancy|0|||
156730627|NCT02477826|565760852|FG002|Treatment Period|Pregnancy|0|||
156730628|NCT02477826|565760853|FG003|Treatment Period|Pregnancy|0|||
156730629|NCT02477826|565760854|FG004|Treatment Period|Pregnancy|0|||
156730630|NCT02477826|565760855|FG005|Treatment Period|Pregnancy|0|||
156730631|NCT02477826|565760856|FG006|Treatment Period|Pregnancy|0|||
156730632|NCT02477826|565760857|FG007|Treatment Period|Pregnancy|0|||
156730633|NCT02477826|565760858|FG008|Treatment Period|Pregnancy|0|||
156730634|NCT02477826|565760859|FG009|Treatment Period|Pregnancy|1|||
156730635|NCT02477826|565760850|FG000|Treatment Period|Other|0|||
156730636|NCT02477826|565760851|FG001|Treatment Period|Other|0|||
156730637|NCT02477826|565760852|FG002|Treatment Period|Other|0|||
156730638|NCT02477826|565760853|FG003|Treatment Period|Other|0|||
156730639|NCT02477826|565760854|FG004|Treatment Period|Other|0|||
156730640|NCT02477826|565760855|FG005|Treatment Period|Other|0|||
156730641|NCT02477826|565760856|FG006|Treatment Period|Other|0|||
156730642|NCT02477826|565760857|FG007|Treatment Period|Other|0|||
156730643|NCT02477826|565760858|FG008|Treatment Period|Other|0|||
156730644|NCT02477826|565760859|FG009|Treatment Period|Other|1|||
156730645|NCT00183885|565760862|FG000|Overall Study|Adverse Event|11|||
156730646|NCT00183885|565760862|FG000|Overall Study|Death|1|||
156730647|NCT00183885|565760862|FG000|Overall Study|Lost to Follow-up|3|||
156730648|NCT00183885|565760862|FG000|Overall Study|Physician Decision|6|||
156730649|NCT00183885|565760862|FG000|Overall Study|Withdrawal by Subject|5|||
156730650|NCT00183885|565760862|FG000|Overall Study|Switched to alternative treatment|8|||
156730651|NCT00183885|565760862|FG000|Overall Study|Treatment delayed too long|4|||
156730652|NCT00183885|565760862|FG000|Overall Study|Developed second malignancy|1|||
156730653|NCT01075256|565760878|FG000|Overall Study|Withdrawal by Subject|1|||
156730654|NCT01075256|565760879|FG001|Overall Study|Withdrawal by Subject|0|||
156730655|NCT01075256|565760880|FG002|Overall Study|Withdrawal by Subject|0|||
156730656|NCT00591565|565760888|FG000|Overall Study|lost follow up, withdrawn|5|||
156730657|NCT01052480|565760889|FG000|Overall Study|Lost to Follow-up|3|||
156730658|NCT01052480|565760890|FG001|Overall Study|Lost to Follow-up|3|||
156730659|NCT01052480|565760889|FG000|Overall Study|Protocol Violation|1|||
157139501|NCT02305563|567255939|FG001|Treatment Period|added ULO, then request to stop|0|||
156730660|NCT01052480|565760890|FG001|Overall Study|Protocol Violation|0|||
156730661|NCT01052480|565760889|FG000|Overall Study|Withdrawal by Subject|3|||
156730662|NCT01052480|565760890|FG001|Overall Study|Withdrawal by Subject|7|||
156730663|NCT01052480|565760889|FG000|Overall Study|Physician Decision|0|||
156730664|NCT01052480|565760890|FG001|Overall Study|Physician Decision|2|||
157019867|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156730665|NCT01052480|565760889|FG000|Overall Study|Death|1|||
156730666|NCT01052480|565760890|FG001|Overall Study|Death|5|||
156730667|NCT03232931|565762067|FG000|Overall Study|Physician Decision|1|||
156730668|NCT03232931|565762068|FG001|Overall Study|Physician Decision|1|||
156730669|NCT03232931|565762067|FG000|Overall Study|Withdrawal by Subject|6|||
156730670|NCT03232931|565762068|FG001|Overall Study|Withdrawal by Subject|0|||
156730671|NCT03232931|565762067|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
156730672|NCT03232931|565762068|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
156730673|NCT03232931|565762067|FG000|Overall Study|Parent did not record voice|1|||
156730674|NCT03232931|565762068|FG001|Overall Study|Parent did not record voice|2|||
156730675|NCT03232931|565762067|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
157139502|NCT02305563|567255940|FG002|Treatment Period|added ULO, then request to stop|0|||
157139503|NCT02305563|567255941|FG003|Treatment Period|added ULO, then request to stop|0|||
157139504|NCT02305563|567255942|FG004|Treatment Period|added ULO, then request to stop|1|||
157139505|NCT02305563|567255938|FG000|Follow-up Period|Death|0|||
157139506|NCT02305563|567255939|FG001|Follow-up Period|Death|0|||
157139507|NCT02305563|567255940|FG002|Follow-up Period|Death|5|||
157139508|NCT02305563|567255941|FG003|Follow-up Period|Death|4|||
157139509|NCT02305563|567255942|FG004|Follow-up Period|Death|7|||
157139510|NCT02305563|567255938|FG000|Follow-up Period|Participant withdrew consent|0|||
157139511|NCT02305563|567255939|FG001|Follow-up Period|Participant withdrew consent|0|||
157139512|NCT02305563|567255940|FG002|Follow-up Period|Participant withdrew consent|2|||
157139513|NCT02305563|567255941|FG003|Follow-up Period|Participant withdrew consent|1|||
157139514|NCT02305563|567255942|FG004|Follow-up Period|Participant withdrew consent|0|||
157139515|NCT02305563|567255938|FG000|Follow-up Period|other reason|0|||
157139516|NCT02305563|567255939|FG001|Follow-up Period|other reason|0|||
157139517|NCT02305563|567255940|FG002|Follow-up Period|other reason|0|||
157139518|NCT02305563|567255941|FG003|Follow-up Period|other reason|0|||
157139519|NCT02305563|567255942|FG004|Follow-up Period|other reason|1|||
157139520|NCT02305563|567255938|FG000|Follow-up Period|Followup no longer required per protocol|3|||
157139521|NCT02305563|567255939|FG001|Follow-up Period|Followup no longer required per protocol|3|||
157139522|NCT02305563|567255940|FG002|Follow-up Period|Followup no longer required per protocol|4|||
157139523|NCT02305563|567255941|FG003|Follow-up Period|Followup no longer required per protocol|1|||
157139524|NCT02305563|567255942|FG004|Follow-up Period|Followup no longer required per protocol|4|||
157139525|NCT01275222|567255946|FG000|Phase l by Treatment|Adverse Event|1|||
157139526|NCT01275222|567255947|FG001|Phase l by Treatment|Adverse Event|4|||
157139527|NCT01275222|567255948|FG002|Phase l by Treatment|Adverse Event|2|||
157139528|NCT01275222|567255949|FG003|Phase l by Treatment|Adverse Event|3|||
157139529|NCT01275222|567255950|FG004|Phase l by Treatment|Adverse Event|0|||
157139530|NCT01275222|567255951|FG005|Phase l by Treatment|Adverse Event|0|||
157139531|NCT01275222|567255946|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
157139532|NCT01275222|567255947|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
157139533|NCT01275222|567255948|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
157139534|NCT01275222|567255949|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
157139535|NCT01275222|567255950|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
157139536|NCT01275222|567255951|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
157139537|NCT01275222|567255946|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
157139538|NCT01275222|567255947|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
157139539|NCT01275222|567255948|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
157139540|NCT01275222|567255949|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
157139541|NCT01275222|567255950|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
157139542|NCT01275222|567255951|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
157139543|NCT01275222|567255946|FG000|Phase l by Treatment|Disease progression|12|||
157139544|NCT01275222|567255947|FG001|Phase l by Treatment|Disease progression|8|||
157139545|NCT01275222|567255948|FG002|Phase l by Treatment|Disease progression|2|||
157139546|NCT01275222|567255949|FG003|Phase l by Treatment|Disease progression|5|||
157139547|NCT01275222|567255950|FG004|Phase l by Treatment|Disease progression|0|||
157139548|NCT01275222|567255951|FG005|Phase l by Treatment|Disease progression|0|||
157139549|NCT01275222|567255946|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
157139550|NCT01275222|567255947|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
157139551|NCT01275222|567255948|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
157139552|NCT01275222|567255949|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
156730676|NCT03232931|565762068|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
156730677|NCT04925557|565762069|FG000|Overall Study|Study closed|5|||
156730678|NCT04925557|565762070|FG001|Overall Study|Study closed|3|||
156730679|NCT05488470|565762071|FG000|Overall Study|Physician Decision|2|||
156730680|NCT05488470|565762071|FG000|Overall Study|Withdrawal by Subject|1|||
156730681|NCT05488470|565762071|FG000|Overall Study|Death|1|||
156730682|NCT01190410|565762072|FG000|Overall Study|Adverse Event|0|||
156730683|NCT01190410|565762073|FG001|Overall Study|Adverse Event|3|||
156730684|NCT01190410|565762072|FG000|Overall Study|Lack of Efficacy|0|||
156730685|NCT01190410|565762073|FG001|Overall Study|Lack of Efficacy|2|||
157019868|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
157139553|NCT01275222|567255950|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
157139554|NCT01275222|567255951|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
157139555|NCT01275222|567255946|FG000|Phase l by Treatment|Death|0|||
156730686|NCT01190410|565762072|FG000|Overall Study|Withdrawal by Subject|0|||
157139556|NCT01275222|567255947|FG001|Phase l by Treatment|Death|1|||
157139557|NCT01275222|567255948|FG002|Phase l by Treatment|Death|0|||
157139558|NCT01275222|567255949|FG003|Phase l by Treatment|Death|1|||
157139559|NCT01275222|567255950|FG004|Phase l by Treatment|Death|0|||
157139560|NCT01275222|567255951|FG005|Phase l by Treatment|Death|0|||
156730687|NCT01190410|565762073|FG001|Overall Study|Withdrawal by Subject|2|||
156730688|NCT01190410|565762072|FG000|Overall Study|Administrative decision|1|||
157139561|NCT01275222|567255946|FG000|Phase ll by Stratum|Adverse Event|0|||
157139562|NCT01275222|567255947|FG001|Phase ll by Stratum|Adverse Event|0|||
157139563|NCT01275222|567255948|FG002|Phase ll by Stratum|Adverse Event|0|||
157139564|NCT01275222|567255949|FG003|Phase ll by Stratum|Adverse Event|0|||
157139565|NCT01275222|567255950|FG004|Phase ll by Stratum|Adverse Event|2|||
157139566|NCT01275222|567255951|FG005|Phase ll by Stratum|Adverse Event|10|||
157139567|NCT01275222|567255946|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
157139568|NCT01275222|567255947|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
157139569|NCT01275222|567255948|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
157139570|NCT01275222|567255949|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
157139571|NCT01275222|567255950|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
157139572|NCT01275222|567255951|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
157139573|NCT01275222|567255946|FG000|Phase ll by Stratum|Disease progression|0|||
157139574|NCT01275222|567255947|FG001|Phase ll by Stratum|Disease progression|0|||
157139575|NCT01275222|567255948|FG002|Phase ll by Stratum|Disease progression|0|||
157139576|NCT01275222|567255949|FG003|Phase ll by Stratum|Disease progression|0|||
157139577|NCT01275222|567255950|FG004|Phase ll by Stratum|Disease progression|23|||
157139578|NCT01275222|567255951|FG005|Phase ll by Stratum|Disease progression|31|||
157139579|NCT01275222|567255946|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
156730689|NCT01190410|565762073|FG001|Overall Study|Administrative decision|0|||
156730690|NCT01190410|565762072|FG000|Overall Study|PI discretion|0|||
156730691|NCT01190410|565762073|FG001|Overall Study|PI discretion|2|||
156730692|NCT01270464|565762080|FG000|Overall Study|Protocol Violation|4|||
156730693|NCT01270464|565762081|FG001|Overall Study|Protocol Violation|3|||
156730694|NCT01270464|565762082|FG002|Overall Study|Protocol Violation|2|||
156730695|NCT01270464|565762080|FG000|Overall Study|Lack of Efficacy|2|||
156730696|NCT01270464|565762081|FG001|Overall Study|Lack of Efficacy|3|||
156730697|NCT01270464|565762082|FG002|Overall Study|Lack of Efficacy|1|||
156730698|NCT01270464|565762080|FG000|Overall Study|Adverse Event|9|||
156730699|NCT01270464|565762081|FG001|Overall Study|Adverse Event|1|||
156730700|NCT01270464|565762082|FG002|Overall Study|Adverse Event|7|||
156730701|NCT01270464|565762080|FG000|Overall Study|Withdrawal by Subject|2|||
156730702|NCT01270464|565762081|FG001|Overall Study|Withdrawal by Subject|1|||
156730703|NCT01270464|565762082|FG002|Overall Study|Withdrawal by Subject|4|||
156730704|NCT01270464|565762080|FG000|Overall Study|Lost to Follow-up|2|||
156730705|NCT01270464|565762081|FG001|Overall Study|Lost to Follow-up|3|||
156730706|NCT01270464|565762082|FG002|Overall Study|Lost to Follow-up|1|||
156730707|NCT01270464|565762080|FG000|Overall Study|Other|1|||
156730708|NCT01270464|565762081|FG001|Overall Study|Other|1|||
156730709|NCT01270464|565762082|FG002|Overall Study|Other|3|||
156730710|NCT02875613|565762088|FG000|Overall Study|Withdrawal by Subject|1|||
156730711|NCT02875613|565762088|FG000|Overall Study|Screen Failure|1|||
156730712|NCT02347774|565762089|FG000|Study Participation|Lost to Follow-up|3|||
156730713|NCT02347774|565762090|FG001|Study Participation|Lost to Follow-up|6|||
156730714|NCT02347774|565762091|FG002|Study Participation|Lost to Follow-up|2|||
156730715|NCT02347774|565762089|FG000|Study Participation|Withdrawal by Subject|8|||
156730716|NCT02347774|565762090|FG001|Study Participation|Withdrawal by Subject|9|||
156730717|NCT02347774|565762091|FG002|Study Participation|Withdrawal by Subject|15|||
156730718|NCT02347774|565762089|FG000|Study Participation|Adverse Event|1|||
156730719|NCT02347774|565762090|FG001|Study Participation|Adverse Event|4|||
156730720|NCT02347774|565762091|FG002|Study Participation|Adverse Event|6|||
156730721|NCT02347774|565762089|FG000|Study Participation|withdrew consent|1|||
156730722|NCT02347774|565762090|FG001|Study Participation|withdrew consent|1|||
156730723|NCT02347774|565762091|FG002|Study Participation|withdrew consent|1|||
156730724|NCT02347774|565762089|FG000|Study Participation|Met Prolonged QT criteria|1|||
156730725|NCT02347774|565762090|FG001|Study Participation|Met Prolonged QT criteria|0|||
156730726|NCT02347774|565762091|FG002|Study Participation|Met Prolonged QT criteria|0|||
156796474|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
157139580|NCT01275222|567255947|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
157139581|NCT01275222|567255948|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
156796475|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
156808810|NCT01484496|566054475|FG002|Period 1|Physician Decision|0|||
157139582|NCT01275222|567255949|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
156730727|NCT02347774|565762089|FG000|Study Participation|non-compliance with study drug|0|||
156730728|NCT02347774|565762090|FG001|Study Participation|non-compliance with study drug|1|||
157139583|NCT01275222|567255950|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
157139584|NCT01275222|567255951|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
157139585|NCT01275222|567255946|FG000|Phase ll by Stratum|Death|0|||
157139586|NCT01275222|567255947|FG001|Phase ll by Stratum|Death|0|||
157139587|NCT01275222|567255948|FG002|Phase ll by Stratum|Death|0|||
156730729|NCT02347774|565762091|FG002|Study Participation|non-compliance with study drug|0|||
156730730|NCT02347774|565762089|FG000|Study Participation|incarceration|1|||
156730731|NCT02347774|565762090|FG001|Study Participation|incarceration|0|||
156730732|NCT02347774|565762091|FG002|Study Participation|incarceration|0|||
156730733|NCT02347774|565762089|FG000|Study Participation|randomized in error|0|||
156730734|NCT02347774|565762090|FG001|Study Participation|randomized in error|0|||
156730735|NCT02347774|565762091|FG002|Study Participation|randomized in error|1|||
156730736|NCT02347774|565762089|FG000|On Study Treatment|Adverse Event|9|||
156730737|NCT02347774|565762090|FG001|On Study Treatment|Adverse Event|15|||
156730738|NCT02347774|565762091|FG002|On Study Treatment|Adverse Event|19|||
156730739|NCT02347774|565762089|FG000|On Study Treatment|Lack of Efficacy|3|||
156730740|NCT02347774|565762090|FG001|On Study Treatment|Lack of Efficacy|0|||
156730741|NCT02347774|565762091|FG002|On Study Treatment|Lack of Efficacy|2|||
156730742|NCT02347774|565762089|FG000|On Study Treatment|non-complicance with study medication|0|||
156730743|NCT02347774|565762090|FG001|On Study Treatment|non-complicance with study medication|2|||
156730744|NCT02347774|565762091|FG002|On Study Treatment|non-complicance with study medication|0|||
156730745|NCT02347774|565762089|FG000|On Study Treatment|Protocol Violation|0|||
156730746|NCT02347774|565762090|FG001|On Study Treatment|Protocol Violation|0|||
156730747|NCT02347774|565762091|FG002|On Study Treatment|Protocol Violation|1|||
156730748|NCT02347774|565762089|FG000|On Study Treatment|withdrew consent|9|||
156730749|NCT02347774|565762090|FG001|On Study Treatment|withdrew consent|8|||
156730750|NCT02347774|565762091|FG002|On Study Treatment|withdrew consent|12|||
156730751|NCT02347774|565762089|FG000|On Study Treatment|Lost to Follow-up|2|||
156730752|NCT02347774|565762090|FG001|On Study Treatment|Lost to Follow-up|6|||
156730753|NCT02347774|565762091|FG002|On Study Treatment|Lost to Follow-up|1|||
156730754|NCT02347774|565762089|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
156730755|NCT02347774|565762090|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
156730756|NCT02347774|565762091|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
156730757|NCT02347774|565762089|FG000|On Study Treatment|ranomized in error|0|||
156730758|NCT02347774|565762090|FG001|On Study Treatment|ranomized in error|0|||
156730759|NCT02347774|565762091|FG002|On Study Treatment|ranomized in error|1|||
156730760|NCT04112043|565762093|FG000|Overall Study|Withdrawal by Subject|1|||
156730761|NCT04112043|565762094|FG001|Overall Study|Withdrawal by Subject|1|||
156730762|NCT04112043|565762095|FG002|Overall Study|Withdrawal by Subject|1|||
156730763|NCT04112043|565762093|FG000|Overall Study|Taking NR supplement|1|||
156730764|NCT04112043|565762094|FG001|Overall Study|Taking NR supplement|0|||
156730765|NCT04112043|565762095|FG002|Overall Study|Taking NR supplement|0|||
156730766|NCT04112043|565762093|FG000|Overall Study|Adverse Event|0|||
156730767|NCT04112043|565762094|FG001|Overall Study|Adverse Event|1|||
156730768|NCT04112043|565762095|FG002|Overall Study|Adverse Event|0|||
156730769|NCT01750697|565762098|FG000|Overall Study|Transferred Back to Local Hospital|1|||
156730770|NCT01750697|565762098|FG000|Overall Study|Physician and Family Decision|1|||
156730771|NCT01750697|565762098|FG000|Overall Study|Transferred to Adult Services|5|||
156730772|NCT01750697|565762098|FG000|Overall Study|Physician Decision|1|||
156730773|NCT01750697|565762098|FG000|Overall Study|Withdrawal by Subject|1|||
156730774|NCT02285166|565762099|FG000|Overall Study|Case Report Forms Uncollected|564|||
156730775|NCT02285166|565762099|FG000|Overall Study|Protocol Deviation|402|||
156730776|NCT00384839|565762104|FG000|Overall Study|Adverse Event|4|||
156730777|NCT00384839|565762104|FG000|Overall Study|Investigator Request|1|||
156730778|NCT00384839|565762104|FG000|Overall Study|Patient Request|1|||
156730779|NCT00384839|565762104|FG000|Overall Study|Ineligible|2|||
157139588|NCT01275222|567255949|FG003|Phase ll by Stratum|Death|0|||
156730780|NCT01421225|565762107|FG000|Overall Study|Withdrawal by Subject|0|||
156730781|NCT01421225|565762108|FG001|Overall Study|Withdrawal by Subject|1|||
156730782|NCT02714595|565762109|FG000|Overall Study|Lost to Follow-up|1|||
156730783|NCT02714595|565762110|FG001|Overall Study|Lost to Follow-up|0|||
156730784|NCT02714595|565762109|FG000|Overall Study|Withdrawal by Subject|1|||
156730785|NCT02714595|565762110|FG001|Overall Study|Withdrawal by Subject|2|||
156730786|NCT02714595|565762109|FG000|Overall Study|Lack of Efficacy|0|||
156730787|NCT02714595|565762110|FG001|Overall Study|Lack of Efficacy|1|||
156730788|NCT02714595|565762109|FG000|Overall Study|Death|30|||
156730789|NCT02714595|565762110|FG001|Overall Study|Death|9|||
156730790|NCT02714595|565762109|FG000|Overall Study|Other-Miscellaneous|0|||
157139589|NCT01275222|567255950|FG004|Phase ll by Stratum|Death|1|||
156730791|NCT02714595|565762110|FG001|Overall Study|Other-Miscellaneous|1|||
156730792|NCT01322490|565762111|FG000|Treatment Period|Adverse Event|12|||
156730793|NCT01322490|565762112|FG001|Treatment Period|Adverse Event|18|||
157139590|NCT01275222|567255951|FG005|Phase ll by Stratum|Death|1|||
157139591|NCT04325503|567255954|FG000|Overall Study|Withdrawal by Subject|1|||
157139592|NCT04325503|567255954|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
157139593|NCT02337387|567255955|FG000|Overall Study|Adverse Event|0|||
156730794|NCT01322490|565762113|FG002|Treatment Period|Adverse Event|15|||
156730795|NCT01322490|565762111|FG000|Treatment Period|Death|5|||
156730796|NCT01322490|565762112|FG001|Treatment Period|Death|7|||
156730797|NCT01322490|565762113|FG002|Treatment Period|Death|3|||
156730798|NCT01322490|565762111|FG000|Treatment Period|Lack of Efficacy|89|||
156730799|NCT01322490|565762112|FG001|Treatment Period|Lack of Efficacy|100|||
156730800|NCT01322490|565762113|FG002|Treatment Period|Lack of Efficacy|112|||
156730801|NCT01322490|565762111|FG000|Treatment Period|Physician Decision|0|||
156730802|NCT01322490|565762112|FG001|Treatment Period|Physician Decision|2|||
156730803|NCT01322490|565762113|FG002|Treatment Period|Physician Decision|1|||
156730804|NCT01322490|565762111|FG000|Treatment Period|Protocol Violation|7|||
156730805|NCT01322490|565762112|FG001|Treatment Period|Protocol Violation|5|||
156730806|NCT01322490|565762113|FG002|Treatment Period|Protocol Violation|4|||
156796476|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
156796477|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
156796478|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
156796479|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
156796480|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
156796481|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
156796482|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
156796483|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
156796484|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
156796485|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
156796486|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
156796487|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
156796488|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
156796489|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
156796490|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
156796491|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
156796492|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
156796493|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
156796494|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
156796495|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
156796496|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
156796497|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
156796498|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
156796499|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
156796500|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
156796501|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796502|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796503|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796504|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796505|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796506|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
156796507|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796508|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
156796509|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796510|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796511|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796512|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796513|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
156796514|NCT01362790|566008075|FG000|Pilot Phase & Phase 2|Death on study|0|||
156796515|NCT01362790|566008076|FG001|Pilot Phase & Phase 2|Death on study|0|||
156796516|NCT01362790|566008077|FG002|Pilot Phase & Phase 2|Death on study|0|||
156796517|NCT01362790|566008078|FG003|Pilot Phase & Phase 2|Death on study|1|||
156796518|NCT01362790|566008079|FG004|Pilot Phase & Phase 2|Death on study|0|||
156796519|NCT01362790|566008080|FG005|Pilot Phase & Phase 2|Death on study|0|||
156796520|NCT01362790|566008081|FG006|Pilot Phase & Phase 2|Death on study|0|||
156796521|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
156796522|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
156796523|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
156796524|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
156796525|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
156796526|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
156796527|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
156796528|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796529|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796530|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796531|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796532|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
156796533|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796534|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
156796535|NCT01362790|566008075|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
156796536|NCT01362790|566008076|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
156796537|NCT01362790|566008077|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
156796538|NCT01362790|566008078|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
156796539|NCT01362790|566008079|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
156796540|NCT01362790|566008080|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
156796541|NCT01362790|566008081|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
156796542|NCT02457065|566008082|FG000|Overall Study|Lost to Follow-up|9|||
156796543|NCT02457065|566008083|FG001|Overall Study|Lost to Follow-up|11|||
156796544|NCT03038087|566008084|FG000|Overall Study|lost data|1|||
156796545|NCT00654355|566008085|FG000|Overall Study|Lost to Follow-up|2|||
156730807|NCT01322490|565762111|FG000|Treatment Period|Withdrawal by Subject|14|||
156730808|NCT01322490|565762112|FG001|Treatment Period|Withdrawal by Subject|16|||
156730809|NCT01322490|565762113|FG002|Treatment Period|Withdrawal by Subject|11|||
157139594|NCT02337387|567255956|FG001|Overall Study|Adverse Event|1|||
157139595|NCT02337387|567255957|FG002|Overall Study|Adverse Event|0|||
157139596|NCT02337387|567255958|FG003|Overall Study|Adverse Event|0|||
157139597|NCT02337387|567255955|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
157139598|NCT02337387|567255956|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
157139599|NCT02337387|567255957|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
157139600|NCT02337387|567255958|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
157139601|NCT01243268|567255959|FG000|Overall Study|Lost to Follow-up|4|||
157139602|NCT01243268|567255959|FG000|Overall Study|Protocol Violation|51|||
156730810|NCT01322490|565762111|FG000|Treatment Period|Non-compliance with study drug|0|||
156730811|NCT01322490|565762112|FG001|Treatment Period|Non-compliance with study drug|0|||
156730812|NCT01322490|565762113|FG002|Treatment Period|Non-compliance with study drug|1|||
156730813|NCT01322490|565762111|FG000|Treatment Period|Other per report|2|||
156730814|NCT01322490|565762112|FG001|Treatment Period|Other per report|2|||
156730815|NCT01322490|565762113|FG002|Treatment Period|Other per report|1|||
156730816|NCT01322490|565762111|FG000|Treatment Period|Randomized but Not Treated|3|||
156730817|NCT01322490|565762112|FG001|Treatment Period|Randomized but Not Treated|3|||
156730818|NCT01322490|565762113|FG002|Treatment Period|Randomized but Not Treated|5|||
156730819|NCT01322490|565762111|FG000|Long Term Follow-up Period|Death|235|||
156730820|NCT01322490|565762112|FG001|Long Term Follow-up Period|Death|239|||
156730821|NCT01322490|565762113|FG002|Long Term Follow-up Period|Death|236|||
156730822|NCT01322490|565762111|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
156730823|NCT01322490|565762112|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
156730824|NCT01322490|565762113|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
156730825|NCT01322490|565762111|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
156730826|NCT01322490|565762112|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
156730827|NCT01322490|565762113|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
156730828|NCT01322490|565762111|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
156730829|NCT01322490|565762112|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
156730830|NCT01322490|565762113|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
156730831|NCT01322490|565762111|FG000|Long Term Follow-up Period|Other per report|3|||
156730832|NCT01322490|565762112|FG001|Long Term Follow-up Period|Other per report|2|||
156730833|NCT01322490|565762113|FG002|Long Term Follow-up Period|Other per report|2|||
156730834|NCT01322490|565762111|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
156730835|NCT01322490|565762112|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
156730836|NCT01322490|565762113|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
156730837|NCT02257489|565762114|FG000|Overall Study|Withdrawal by Subject|0|||
156730838|NCT02257489|565762115|FG001|Overall Study|Withdrawal by Subject|0|||
156730839|NCT02257489|565762116|FG002|Overall Study|Withdrawal by Subject|0|||
156730840|NCT02257489|565762117|FG003|Overall Study|Withdrawal by Subject|1|||
156730841|NCT02257489|565762118|FG004|Overall Study|Withdrawal by Subject|0|||
156730842|NCT02257489|565762119|FG005|Overall Study|Withdrawal by Subject|0|||
156730843|NCT02257489|565762120|FG006|Overall Study|Withdrawal by Subject|0|||
156730844|NCT02257489|565762121|FG007|Overall Study|Withdrawal by Subject|0|||
156730845|NCT02257489|565762122|FG008|Overall Study|Withdrawal by Subject|0|||
156730846|NCT01896128|565762123|FG000|Overall Study|Withdrawal by Subject|3|||
156730847|NCT01896128|565762124|FG001|Overall Study|Withdrawal by Subject|3|||
156730848|NCT02920008|565762128|FG000|Overall Study|Death|117|||
156730849|NCT02920008|565762129|FG001|Overall Study|Death|127|||
156730850|NCT02920008|565762128|FG000|Overall Study|Withdrawal by Subject|3|||
156730851|NCT02920008|565762129|FG001|Overall Study|Withdrawal by Subject|6|||
156730852|NCT02920008|565762128|FG000|Overall Study|Lost to Follow-up|0|||
156730853|NCT02920008|565762129|FG001|Overall Study|Lost to Follow-up|1|||
156796546|NCT00654355|566008086|FG001|Overall Study|Lost to Follow-up|2|||
157139603|NCT01243268|567255959|FG000|Overall Study|Deviation with contract date|7|||
157139604|NCT01243268|567255959|FG000|Overall Study|Duplicate subject|2|||
156730854|NCT01862250|565762130|FG000|Overall Study|Adverse Event|4|||
156730855|NCT00090493|565762133|FG000|Overall Study|Physician Decision|2|||
156730856|NCT02071706|565762134|FG000|Overall Study|Adverse Event|1|||
156730857|NCT02071706|565762134|FG000|Overall Study|Withdrawal by Subject|2|||
156730858|NCT02247440|565762137|FG000|Overall Study|Withdrawal by Subject|1|||
156730859|NCT02247440|565762137|FG000|Overall Study|Lack of Efficacy|3|||
156730860|NCT00661609|565762138|FG000|Overall Study|Adverse Event|4|||
156730861|NCT00661609|565762138|FG000|Overall Study|Death|20|||
156730862|NCT00661609|565762138|FG000|Overall Study|Withdrawal by Subject|2|||
156730863|NCT00661609|565762138|FG000|Overall Study|PI Decision|1|||
156730864|NCT00661609|565762138|FG000|Overall Study|Survival follow up stage discontinued|11|||
156730865|NCT00661609|565762138|FG000|Overall Study|Disease progression|3|||
156730866|NCT01769508|565762141|FG000|Overall Study|Death|3|||
156730867|NCT01769508|565762141|FG000|Overall Study|Withdrawal by Subject|1|||
156730868|NCT01769508|565762141|FG000|Overall Study|Adverse Event|1|||
156730869|NCT01769508|565762141|FG000|Overall Study|Lost to Follow-up|1|||
156730870|NCT02593097|565762149|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
156730871|NCT02593097|565762150|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
156730872|NCT02593097|565762149|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156730873|NCT02593097|565762150|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156730874|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
156730875|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
156730876|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
156730877|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
156730878|NCT02593097|565762149|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
156730879|NCT02593097|565762150|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
156730880|NCT02858583|565762151|FG000|Overall Study|Declined consent|1|||
156730881|NCT02858583|565762152|FG001|Overall Study|Declined consent|1|||
156730882|NCT03759587|565762154|FG000|Overall Study|Adverse Event|5|||
156730883|NCT03759587|565762154|FG000|Overall Study|Progressive Disease|10|||
156730884|NCT03759587|565762154|FG000|Overall Study|Site Terminated by Sponsor|3|||
156730885|NCT03759587|565762154|FG000|Overall Study|Withdrawal by Subject|1|||
156730886|NCT01218087|565762156|FG000|Overall Study|Death|2|||
156730887|NCT01218087|565762157|FG001|Overall Study|Death|1|||
156730888|NCT01218087|565762156|FG000|Overall Study|Withdrawal by Subject|5|||
156730889|NCT01218087|565762157|FG001|Overall Study|Withdrawal by Subject|0|||
156730890|NCT01218087|565762156|FG000|Overall Study|Transferred|8|||
156730891|NCT01218087|565762157|FG001|Overall Study|Transferred|5|||
156730892|NCT00552396|565762158|FG000|Overall Study|protocol withdrawal criteria|3|||
156730893|NCT00552396|565762159|FG001|Overall Study|protocol withdrawal criteria|3|||
156730894|NCT00552396|565762160|FG002|Overall Study|protocol withdrawal criteria|3|||
156730895|NCT00552396|565762161|FG003|Overall Study|protocol withdrawal criteria|6|||
156730896|NCT00552396|565762162|FG004|Overall Study|protocol withdrawal criteria|3|||
156730897|NCT00552396|565762163|FG005|Overall Study|protocol withdrawal criteria|3|||
156730898|NCT00552396|565762164|FG006|Overall Study|protocol withdrawal criteria|9|||
156730899|NCT03170362|565762165|FG000|Overall Study|Death|2|||
156730900|NCT03170362|565762166|FG001|Overall Study|Death|2|||
156730901|NCT03170362|565762165|FG000|Overall Study|Withdrawal by Subject|23|||
156730902|NCT03170362|565762166|FG001|Overall Study|Withdrawal by Subject|22|||
156730903|NCT03170362|565762165|FG000|Overall Study|Lost to Follow-up|187|||
156730904|NCT03170362|565762166|FG001|Overall Study|Lost to Follow-up|167|||
156730905|NCT04615403|565762167|FG000|Overall Study|Death|1|||
156730906|NCT00665431|565762168|FG000|Overall Study|Adverse Event|16|||
156730907|NCT00665431|565762169|FG001|Overall Study|Adverse Event|22|||
156730908|NCT00665431|565762170|FG002|Overall Study|Adverse Event|6|||
156730909|NCT00665431|565762168|FG000|Overall Study|Withdrawal by Subject|17|||
156730910|NCT00665431|565762169|FG001|Overall Study|Withdrawal by Subject|25|||
156730911|NCT00665431|565762170|FG002|Overall Study|Withdrawal by Subject|15|||
156730912|NCT00665431|565762168|FG000|Overall Study|Lost to Follow-up|3|||
156730913|NCT00665431|565762169|FG001|Overall Study|Lost to Follow-up|3|||
156730914|NCT00665431|565762170|FG002|Overall Study|Lost to Follow-up|1|||
156730915|NCT00665431|565762168|FG000|Overall Study|Other|4|||
156730916|NCT00665431|565762169|FG001|Overall Study|Other|7|||
156730917|NCT00665431|565762170|FG002|Overall Study|Other|2|||
156730918|NCT04185220|565762181|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
156730919|NCT04185220|565762182|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
156876469|NCT02067676|566305846|FG004|Overall Study|Withdrawal by Subject|0|||
156876470|NCT02067676|566305847|FG005|Overall Study|Withdrawal by Subject|0|||
156876471|NCT00476229|566305848|FG000|Overall Study|Progressive shortness of breath|1|||
156876472|NCT01262820|566305850|FG000|Overall Study|Adverse Event|5|||
156876473|NCT01262820|566305850|FG000|Overall Study|Lack of Efficacy|9|||
156876474|NCT01262820|566305850|FG000|Overall Study|Drug held for 21+ days|1|||
156876475|NCT00452361|566305851|FG000|Overall Study|Adverse Event|8|||
156876476|NCT00452361|566305852|FG001|Overall Study|Adverse Event|0|||
157019869|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156730920|NCT04185220|565762181|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
156730921|NCT04185220|565762182|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
156730922|NCT03260244|565763822|FG000|Overall Study|Death|19|||
156730923|NCT03260244|565763822|FG000|Overall Study|Lost to Follow-up|60|||
156730924|NCT03260244|565763822|FG000|Overall Study|Withdrawal by Subject|48|||
157019870|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
157019871|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
157019872|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156730925|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed|21|||
156730926|NCT03260244|565763822|FG000|Overall Study|Enrollment Criteria Not Met|31|||
156730927|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
156730928|NCT03260244|565763822|FG000|Overall Study|Subject Noncompliance|6|||
156730929|NCT03260244|565763822|FG000|Overall Study|No inducible Arrhythmia|2|||
156876477|NCT00452361|566305851|FG000|Overall Study|Withdrawal by Subject|0|||
156730930|NCT03260244|565763822|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
156730931|NCT03260244|565763822|FG000|Overall Study|Screen Failure|2|||
156730932|NCT03260244|565763822|FG000|Overall Study|Treated Off Label|69|||
156730933|NCT03260244|565763822|FG000|Overall Study|No Radiofrequency Ablation|14|||
156730934|NCT00892151|565763823|FG000|Overall Study|Protocol Violation|1|||
156730935|NCT01222520|565763826|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
156730936|NCT01222520|565763827|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
156730937|NCT01222520|565763826|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
156730938|NCT01222520|565763827|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
156730939|NCT01222520|565763826|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
156730940|NCT01222520|565763827|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
156730941|NCT01222520|565763826|FG000|Double-blind Period|Adverse Event|0|||
156730942|NCT01222520|565763827|FG001|Double-blind Period|Adverse Event|1|||
156730943|NCT01222520|565763826|FG000|Double-blind Period|Lack of Efficacy|0|||
156730944|NCT01222520|565763827|FG001|Double-blind Period|Lack of Efficacy|1|||
156730945|NCT01222520|565763826|FG000|Double-blind Period|Study medication stolen|1|||
156730946|NCT01222520|565763827|FG001|Double-blind Period|Study medication stolen|0|||
156730947|NCT04606394|565763832|FG000|Overall Study|Withdrawal by Subject|3|||
156730948|NCT04606394|565763832|FG000|Overall Study|Exclusion criteria screen failure|12|||
156730949|NCT00954941|565763833|FG000|Overall Study|Received treatment at home|1|||
156730950|NCT00954941|565763834|FG001|Overall Study|Received treatment at home|0|||
156730951|NCT00954941|565763833|FG000|Overall Study|Withdrawal by Subject|1|||
156730952|NCT00954941|565763834|FG001|Overall Study|Withdrawal by Subject|0|||
156730953|NCT00954941|565763833|FG000|Overall Study|Insurance Denial|2|||
156730954|NCT00954941|565763834|FG001|Overall Study|Insurance Denial|2|||
156730955|NCT00954941|565763833|FG000|Overall Study|Physician Decision|2|||
156730956|NCT00954941|565763834|FG001|Overall Study|Physician Decision|2|||
156730957|NCT00954941|565763833|FG000|Overall Study|Ineligible|2|||
156730958|NCT00954941|565763834|FG001|Overall Study|Ineligible|2|||
156730959|NCT00954941|565763833|FG000|Overall Study|Adverse Event|0|||
156730960|NCT00954941|565763834|FG001|Overall Study|Adverse Event|1|||
156730961|NCT00637000|565763835|FG000|Overall Study|Withdrawal by Subject|4|||
156730962|NCT00637000|565763836|FG001|Overall Study|Withdrawal by Subject|3|||
156730963|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
156730964|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
156730965|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
156730966|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
156730967|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
156730968|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
156730969|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
156730970|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
156730971|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
156730972|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
156730973|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
156730974|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
156730975|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
156730976|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
156730977|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
157217458|NCT01621490|567543225|FG003|Overall Study|Study drug toxicity|3|||
157217459|NCT01621490|567543226|FG004|Overall Study|Study drug toxicity|1|||
157217460|NCT01621490|567543227|FG005|Overall Study|Study drug toxicity|10|||
156730978|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
156730979|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
156730980|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
156730981|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
156730982|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
156730983|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
156730984|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
156730985|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
156730986|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
156730987|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
156730988|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
156730989|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
156730990|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
156730991|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156730992|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
156730993|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
156730994|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
156730995|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
156730996|NCT00839527|565763837|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
156808811|NCT01484496|566054476|FG003|Period 1|Physician Decision|0|||
156730997|NCT00839527|565763838|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
156730998|NCT00839527|565763839|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
156730999|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156731000|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
156731001|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
156731002|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
156731003|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
156731004|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
156731005|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
156731006|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
156731007|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
156731008|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
156731009|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
156731010|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
156731011|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
156731012|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
156731013|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
156731014|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
156731015|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
156731016|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
156731017|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
156731018|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
156731019|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
156731020|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
156731021|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
156731022|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
156731023|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
156731024|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
156731025|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
156731026|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
156731027|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
156731028|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
156731029|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
156731030|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
156731031|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
156731032|NCT00839527|565763837|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
156731033|NCT00839527|565763838|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
156731034|NCT00839527|565763839|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
156731035|NCT02751450|565763840|FG000|Overall Study|Adverse Event|1|||
156731036|NCT02751450|565763841|FG001|Overall Study|Adverse Event|0|||
156731037|NCT00562302|565763842|FG000|Overall Study|Lost to Follow-up|3|||
156731038|NCT00562302|565763843|FG001|Overall Study|Lost to Follow-up|3|||
156731039|NCT00562302|565763842|FG000|Overall Study|Adverse Event|0|||
156731040|NCT00562302|565763843|FG001|Overall Study|Adverse Event|6|||
156731041|NCT00562302|565763842|FG000|Overall Study|Non-compliance|1|||
156731042|NCT00562302|565763843|FG001|Overall Study|Non-compliance|2|||
156731043|NCT00562302|565763842|FG000|Overall Study|Withdrawal by Subject|7|||
156731044|NCT00562302|565763843|FG001|Overall Study|Withdrawal by Subject|8|||
156731045|NCT00562302|565763842|FG000|Overall Study|Death|1|||
156731046|NCT00562302|565763843|FG001|Overall Study|Death|2|||
156731047|NCT00562302|565763842|FG000|Overall Study|Lung resection prior to study completion|7|||
156731048|NCT00562302|565763843|FG001|Overall Study|Lung resection prior to study completion|7|||
156731049|NCT00562302|565763842|FG000|Overall Study|Not stated|1|||
156731050|NCT00562302|565763843|FG001|Overall Study|Not stated|4|||
156731051|NCT01855243|565763844|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
156731052|NCT01855243|565763845|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
156731053|NCT01855243|565763846|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
156731054|NCT03615144|565763847|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
156731055|NCT03615144|565763848|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
156731056|NCT02587598|565763851|FG000|Overall Study|Death|4|||
156731057|NCT02587598|565763852|FG001|Overall Study|Death|8|||
156796547|NCT03485157|566008088|FG000|Double Blind Phase|Lost to Follow-up|4|||
156731058|NCT02587598|565763853|FG002|Overall Study|Death|4|||
156731059|NCT02587598|565763854|FG003|Overall Study|Death|16|||
156731060|NCT02587598|565763855|FG004|Overall Study|Death|9|||
156731061|NCT02587598|565763856|FG005|Overall Study|Death|4|||
156731062|NCT02587598|565763857|FG006|Overall Study|Death|6|||
156731063|NCT02587598|565763858|FG007|Overall Study|Death|7|||
156731064|NCT02587598|565763859|FG008|Overall Study|Death|9|||
156796548|NCT03485157|566008089|FG001|Double Blind Phase|Lost to Follow-up|4|||
156731065|NCT02587598|565763860|FG009|Overall Study|Death|1|||
156731066|NCT02587598|565763861|FG010|Overall Study|Death|3|||
156731067|NCT02587598|565763851|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156731068|NCT02587598|565763852|FG001|Overall Study|Study Terminated by the Sponsor|1|||
156731069|NCT02587598|565763853|FG002|Overall Study|Study Terminated by the Sponsor|0|||
156731070|NCT02587598|565763854|FG003|Overall Study|Study Terminated by the Sponsor|3|||
156731071|NCT02587598|565763855|FG004|Overall Study|Study Terminated by the Sponsor|0|||
156731072|NCT02587598|565763856|FG005|Overall Study|Study Terminated by the Sponsor|1|||
156731073|NCT02587598|565763857|FG006|Overall Study|Study Terminated by the Sponsor|0|||
156731074|NCT02587598|565763858|FG007|Overall Study|Study Terminated by the Sponsor|0|||
156731075|NCT02587598|565763859|FG008|Overall Study|Study Terminated by the Sponsor|0|||
156731076|NCT02587598|565763860|FG009|Overall Study|Study Terminated by the Sponsor|1|||
156731077|NCT02587598|565763861|FG010|Overall Study|Study Terminated by the Sponsor|6|||
156731078|NCT02587598|565763851|FG000|Overall Study|Reason for study withdrawal not specified|0|||
156731079|NCT02587598|565763852|FG001|Overall Study|Reason for study withdrawal not specified|1|||
156731080|NCT02587598|565763853|FG002|Overall Study|Reason for study withdrawal not specified|0|||
156731081|NCT02587598|565763854|FG003|Overall Study|Reason for study withdrawal not specified|0|||
156731082|NCT02587598|565763855|FG004|Overall Study|Reason for study withdrawal not specified|0|||
156731083|NCT02587598|565763856|FG005|Overall Study|Reason for study withdrawal not specified|0|||
156731084|NCT02587598|565763857|FG006|Overall Study|Reason for study withdrawal not specified|0|||
156731085|NCT02587598|565763858|FG007|Overall Study|Reason for study withdrawal not specified|0|||
156731086|NCT02587598|565763859|FG008|Overall Study|Reason for study withdrawal not specified|0|||
156731087|NCT02587598|565763860|FG009|Overall Study|Reason for study withdrawal not specified|0|||
156731088|NCT02587598|565763861|FG010|Overall Study|Reason for study withdrawal not specified|0|||
156731089|NCT02587598|565763851|FG000|Overall Study|Withdrawal by Subject|0|||
156731090|NCT02587598|565763852|FG001|Overall Study|Withdrawal by Subject|1|||
156731091|NCT02587598|565763853|FG002|Overall Study|Withdrawal by Subject|0|||
156731092|NCT02587598|565763854|FG003|Overall Study|Withdrawal by Subject|2|||
156731093|NCT02587598|565763855|FG004|Overall Study|Withdrawal by Subject|3|||
156731094|NCT02587598|565763856|FG005|Overall Study|Withdrawal by Subject|1|||
156731095|NCT02587598|565763857|FG006|Overall Study|Withdrawal by Subject|0|||
156731096|NCT02587598|565763858|FG007|Overall Study|Withdrawal by Subject|0|||
156731097|NCT02587598|565763859|FG008|Overall Study|Withdrawal by Subject|0|||
156731098|NCT02587598|565763860|FG009|Overall Study|Withdrawal by Subject|1|||
156731099|NCT02587598|565763861|FG010|Overall Study|Withdrawal by Subject|2|||
156731100|NCT02587598|565763851|FG000|Overall Study|Physician Decision|0|||
156731101|NCT02587598|565763852|FG001|Overall Study|Physician Decision|0|||
156731102|NCT02587598|565763853|FG002|Overall Study|Physician Decision|0|||
156731103|NCT02587598|565763854|FG003|Overall Study|Physician Decision|0|||
156731104|NCT02587598|565763855|FG004|Overall Study|Physician Decision|0|||
156731105|NCT02587598|565763856|FG005|Overall Study|Physician Decision|0|||
156731106|NCT02587598|565763857|FG006|Overall Study|Physician Decision|0|||
156731107|NCT02587598|565763858|FG007|Overall Study|Physician Decision|0|||
156731108|NCT02587598|565763859|FG008|Overall Study|Physician Decision|0|||
156731109|NCT02587598|565763860|FG009|Overall Study|Physician Decision|0|||
156731110|NCT02587598|565763861|FG010|Overall Study|Physician Decision|3|||
156731111|NCT01704651|565763862|FG000|Overall Study|Pre-op withdrawal by subject|1|||
156731112|NCT01704651|565763863|FG001|Overall Study|Pre-op withdrawal by subject|1|||
156731113|NCT01704651|565763862|FG000|Overall Study|Pre-op change in treatment plan|1|||
156731114|NCT01704651|565763863|FG001|Overall Study|Pre-op change in treatment plan|4|||
156731115|NCT01704651|565763862|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
156731116|NCT01704651|565763863|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
156731117|NCT01704651|565763862|FG000|Overall Study|Post-op did not have laparotomy|2|||
156731118|NCT01704651|565763863|FG001|Overall Study|Post-op did not have laparotomy|1|||
156731119|NCT01860040|565763864|FG000|Overall Study|Withdrawal by Subject|1|||
156731120|NCT01860040|565763865|FG001|Overall Study|Withdrawal by Subject|0|||
156731121|NCT01931995|565763866|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
156731122|NCT01931995|565763867|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
156731123|NCT01931995|565763866|FG000|First Intervention (1 Day)|Physician Decision|1|||
156731124|NCT01931995|565763867|FG001|First Intervention (1 Day)|Physician Decision|1|||
156731125|NCT01931995|565763866|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
156731126|NCT01931995|565763867|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
157217461|NCT01621490|567543228|FG006|Overall Study|Study drug toxicity|1|||
156731127|NCT00791661|565763868|FG000|7 Day Wash-out|Adverse Event|0|||
156731128|NCT00791661|565763869|FG001|7 Day Wash-out|Adverse Event|0|||
156731129|NCT00791661|565763870|FG002|7 Day Wash-out|Adverse Event|1|||
156731130|NCT00791661|565763868|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
156731131|NCT00791661|565763869|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
156731132|NCT00791661|565763870|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
156731133|NCT00679289|565763871|FG000|Overall Study|Progressive disease|4|||
156731134|NCT00679289|565763872|FG001|Overall Study|Progressive disease|5|||
156731135|NCT00679289|565763873|FG002|Overall Study|Progressive disease|18|||
156796549|NCT03485157|566008088|FG000|Double Blind Phase|Adverse Event|2|||
156731136|NCT00679289|565763871|FG000|Overall Study|Withdrawal by Subject|0|||
156731137|NCT00679289|565763872|FG001|Overall Study|Withdrawal by Subject|1|||
156731138|NCT00679289|565763873|FG002|Overall Study|Withdrawal by Subject|1|||
156731139|NCT00679289|565763871|FG000|Overall Study|Adverse Event|0|||
156731140|NCT00679289|565763872|FG001|Overall Study|Adverse Event|0|||
156731141|NCT00679289|565763873|FG002|Overall Study|Adverse Event|3|||
156731142|NCT00679289|565763871|FG000|Overall Study|Physician Decision|1|||
156731143|NCT00679289|565763872|FG001|Overall Study|Physician Decision|0|||
156731144|NCT00679289|565763873|FG002|Overall Study|Physician Decision|1|||
156731145|NCT00937040|565763874|FG000|Overall Study|Adverse Event|5|||
156731146|NCT00937040|565763875|FG001|Overall Study|Adverse Event|8|||
156731147|NCT00937040|565763874|FG000|Overall Study|Lost to Follow-up|12|||
156731148|NCT00937040|565763875|FG001|Overall Study|Lost to Follow-up|12|||
156731149|NCT00937040|565763874|FG000|Overall Study|Protocol Violation|3|||
156731150|NCT00937040|565763875|FG001|Overall Study|Protocol Violation|0|||
156731151|NCT00937040|565763874|FG000|Overall Study|Withdrawal by Subject|13|||
156731152|NCT00937040|565763875|FG001|Overall Study|Withdrawal by Subject|7|||
156731153|NCT00937040|565763874|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
156731154|NCT00937040|565763875|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
156731155|NCT00937040|565763874|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
156731156|NCT00937040|565763875|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
156731157|NCT00554515|565763880|FG000|Overall Study|Withdrawal by Subject|3|||
156731158|NCT00554515|565763880|FG000|Overall Study|Disease progression|52|||
156731159|NCT00554515|565763880|FG000|Overall Study|Physician Decision|18|||
156731160|NCT00554515|565763880|FG000|Overall Study|Withdrawal by Subject|11|||
156731161|NCT00554515|565763880|FG000|Overall Study|Adverse Event|9|||
156731162|NCT00554515|565763880|FG000|Overall Study|Death|2|||
156731163|NCT00554515|565763880|FG000|Overall Study|Achieved Stable Disease|7|||
156731164|NCT00554515|565763880|FG000|Overall Study|Other|1|||
156731165|NCT00554515|565763880|FG000|Overall Study|Misc|15|||
156731166|NCT02477332|565763883|FG000|Overall Study|Adverse Event|0|||
156731167|NCT02477332|565763884|FG001|Overall Study|Adverse Event|1|||
156731168|NCT02477332|565763885|FG002|Overall Study|Adverse Event|1|||
156731169|NCT02477332|565763886|FG003|Overall Study|Adverse Event|2|||
156731170|NCT02477332|565763887|FG004|Overall Study|Adverse Event|1|||
156731171|NCT02477332|565763888|FG005|Overall Study|Adverse Event|2|||
156731172|NCT02477332|565763883|FG000|Overall Study|Lack of Efficacy|1|||
156731173|NCT02477332|565763884|FG001|Overall Study|Lack of Efficacy|2|||
156731174|NCT02477332|565763885|FG002|Overall Study|Lack of Efficacy|1|||
156731175|NCT02477332|565763886|FG003|Overall Study|Lack of Efficacy|2|||
156731176|NCT02477332|565763887|FG004|Overall Study|Lack of Efficacy|1|||
156731177|NCT02477332|565763888|FG005|Overall Study|Lack of Efficacy|1|||
156731178|NCT02477332|565763883|FG000|Overall Study|Non-compliance with study treatment|0|||
156731179|NCT02477332|565763884|FG001|Overall Study|Non-compliance with study treatment|1|||
156731180|NCT02477332|565763885|FG002|Overall Study|Non-compliance with study treatment|2|||
156731181|NCT02477332|565763886|FG003|Overall Study|Non-compliance with study treatment|0|||
156731182|NCT02477332|565763887|FG004|Overall Study|Non-compliance with study treatment|0|||
156731183|NCT02477332|565763888|FG005|Overall Study|Non-compliance with study treatment|0|||
156731184|NCT02477332|565763883|FG000|Overall Study|Pregnancy|0|||
156731185|NCT02477332|565763884|FG001|Overall Study|Pregnancy|0|||
156731186|NCT02477332|565763885|FG002|Overall Study|Pregnancy|0|||
156731187|NCT02477332|565763886|FG003|Overall Study|Pregnancy|1|||
156731188|NCT02477332|565763887|FG004|Overall Study|Pregnancy|0|||
156731189|NCT02477332|565763888|FG005|Overall Study|Pregnancy|0|||
156731190|NCT02477332|565763883|FG000|Overall Study|Protocol Violation|2|||
156731191|NCT02477332|565763884|FG001|Overall Study|Protocol Violation|0|||
156731192|NCT02477332|565763885|FG002|Overall Study|Protocol Violation|3|||
156731193|NCT02477332|565763886|FG003|Overall Study|Protocol Violation|3|||
156876478|NCT00452361|566305852|FG001|Overall Study|Withdrawal by Subject|1|||
156876479|NCT00452361|566305851|FG000|Overall Study|Premature termination|13|||
157019873|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
156731194|NCT02477332|565763887|FG004|Overall Study|Protocol Violation|1|||
156731195|NCT02477332|565763888|FG005|Overall Study|Protocol Violation|1|||
156731196|NCT02477332|565763883|FG000|Overall Study|Technical problems|0|||
156731197|NCT02477332|565763884|FG001|Overall Study|Technical problems|0|||
156731198|NCT02477332|565763885|FG002|Overall Study|Technical problems|1|||
157019874|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
156731199|NCT02477332|565763886|FG003|Overall Study|Technical problems|0|||
156731200|NCT02477332|565763887|FG004|Overall Study|Technical problems|0|||
156731201|NCT02477332|565763888|FG005|Overall Study|Technical problems|0|||
156731202|NCT02477332|565763883|FG000|Overall Study|Lost to Follow-up|0|||
156731203|NCT02477332|565763884|FG001|Overall Study|Lost to Follow-up|0|||
156731204|NCT02477332|565763885|FG002|Overall Study|Lost to Follow-up|2|||
156731205|NCT02477332|565763886|FG003|Overall Study|Lost to Follow-up|0|||
156731206|NCT02477332|565763887|FG004|Overall Study|Lost to Follow-up|0|||
156731207|NCT02477332|565763888|FG005|Overall Study|Lost to Follow-up|0|||
156731208|NCT02477332|565763883|FG000|Overall Study|Physician Decision|0|||
156731209|NCT02477332|565763884|FG001|Overall Study|Physician Decision|0|||
156731210|NCT02477332|565763885|FG002|Overall Study|Physician Decision|1|||
156796550|NCT03485157|566008089|FG001|Double Blind Phase|Adverse Event|1|||
156796551|NCT03485157|566008088|FG000|Double Blind Phase|Withdrawal by Subject|6|||
156796552|NCT03485157|566008089|FG001|Double Blind Phase|Withdrawal by Subject|9|||
156796553|NCT03485157|566008088|FG000|Double Blind Phase|Removal by PI|3|||
156796554|NCT03485157|566008089|FG001|Double Blind Phase|Removal by PI|7|||
156796555|NCT03485157|566008088|FG000|Open Label Phase|Lost to Follow-up|1|||
156796556|NCT03485157|566008089|FG001|Open Label Phase|Lost to Follow-up|2|||
156796557|NCT03485157|566008088|FG000|Open Label Phase|Adverse Event|0|||
156796558|NCT03485157|566008089|FG001|Open Label Phase|Adverse Event|1|||
156796559|NCT03485157|566008088|FG000|Open Label Phase|Withdrawal by Subject|1|||
156796560|NCT03485157|566008089|FG001|Open Label Phase|Withdrawal by Subject|2|||
156796561|NCT03485157|566008088|FG000|Open Label Phase|Removal by PI|2|||
156796562|NCT03485157|566008089|FG001|Open Label Phase|Removal by PI|0|||
156796563|NCT01849276|566008090|FG000|Followed for Survival for 5 Years|Death|1|||
156796564|NCT01849276|566008090|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
156796565|NCT02011542|566008095|FG000|Overall Study|Physician Decision|1|||
156796566|NCT01813357|566008096|FG000|Overall Study|Lost to Follow-up|5|||
156796567|NCT01813357|566008097|FG001|Overall Study|Lost to Follow-up|6|||
156796568|NCT02607722|566008108|FG000|Overall Study|No data reliability|1|||
156796569|NCT02607722|566008108|FG000|Overall Study|no patient visit|18|||
156796570|NCT02607722|566008108|FG000|Overall Study|missing info in CRF|13|||
156796571|NCT02607722|566008108|FG000|Overall Study|Withdrawal by Subject|616|||
156796572|NCT02607722|566008108|FG000|Overall Study|Lost to Follow-up|312|||
156796573|NCT02607722|566008108|FG000|Overall Study|Improved|22|||
156796574|NCT02607722|566008108|FG000|Overall Study|Lack of Efficacy|316|||
156796575|NCT02607722|566008108|FG000|Overall Study|Adverse Event|2553|||
156796576|NCT02607722|566008108|FG000|Overall Study|Not treated|1|||
156796577|NCT02607722|566008108|FG000|Overall Study|No CRF collected|138|||
156796578|NCT02607722|566008108|FG000|Overall Study|without CRF|4225|||
156796579|NCT02607722|566008108|FG000|Overall Study|Physician Decision|367|||
156796580|NCT04347538|566008109|FG000|Overall Study|Lost to Follow-up|4|||
156796581|NCT04347538|566008110|FG001|Overall Study|Lost to Follow-up|5|||
156796582|NCT04347538|566008111|FG002|Overall Study|Lost to Follow-up|7|||
157139605|NCT05202808|567255962|FG000|Overall Study|Lost to Follow-up|3|||
157139606|NCT05202808|567255963|FG001|Overall Study|Lost to Follow-up|1|||
157139607|NCT02793544|567255964|FG000|Overall Study|Death|10|||
157139608|NCT02793544|567255965|FG001|Overall Study|Death|8|||
157139609|NCT02793544|567255964|FG000|Overall Study|Lost to Follow-up|2|||
157139610|NCT02793544|567255965|FG001|Overall Study|Lost to Follow-up|0|||
157139611|NCT02793544|567255964|FG000|Overall Study|Withdrawal by Subject|1|||
157139612|NCT02793544|567255965|FG001|Overall Study|Withdrawal by Subject|0|||
157139613|NCT01822561|567255968|FG000|Overall Study|Withdrawal by Subject|2|||
157139614|NCT01444300|567255969|FG000|Overall Study|Adverse Event|4|||
157139615|NCT01444300|567255970|FG001|Overall Study|Adverse Event|0|||
157139616|NCT02722044|567255971|FG000|Overall Study|Adverse Event|2|||
157139617|NCT02722044|567255971|FG000|Overall Study|Physician Decision|1|||
157139618|NCT02722044|567255971|FG000|Overall Study|Withdrawal by Subject|1|||
157139619|NCT02722044|567255971|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
157139620|NCT04885257|567255975|FG000|Overall Study|Withdrawal by Subject|1|||
157139621|NCT04885257|567255976|FG001|Overall Study|Withdrawal by Subject|0|||
157139622|NCT00818259|567255977|FG000|Part I|Withdrawal by Subject|1|||
157139623|NCT00818259|567255978|FG001|Part I|Withdrawal by Subject|0|||
157139624|NCT00818259|567255979|FG002|Part I|Withdrawal by Subject|0|||
157139625|NCT00818259|567255980|FG003|Part I|Withdrawal by Subject|0|||
157139626|NCT00818259|567255981|FG004|Part I|Withdrawal by Subject|0|||
157139627|NCT00818259|567255982|FG005|Part I|Withdrawal by Subject|0|||
157139628|NCT00818259|567255983|FG006|Part I|Withdrawal by Subject|0|||
157139629|NCT00818259|567255984|FG007|Part I|Withdrawal by Subject|0|||
157139630|NCT00818259|567255985|FG008|Part I|Withdrawal by Subject|0|||
157139631|NCT00818259|567255977|FG000|Part II|Physician Decision|0|||
157139632|NCT00818259|567255978|FG001|Part II|Physician Decision|0|||
157139633|NCT00818259|567255979|FG002|Part II|Physician Decision|1|||
157139634|NCT00818259|567255980|FG003|Part II|Physician Decision|0|||
157139635|NCT00818259|567255981|FG004|Part II|Physician Decision|0|||
157139636|NCT00818259|567255982|FG005|Part II|Physician Decision|0|||
157139637|NCT00818259|567255983|FG006|Part II|Physician Decision|0|||
157139638|NCT00818259|567255984|FG007|Part II|Physician Decision|0|||
157139639|NCT00818259|567255985|FG008|Part II|Physician Decision|0|||
157139640|NCT00818259|567255977|FG000|Part II|Lack of Efficacy|0|||
156796583|NCT02135133|566008112|FG000|Overall Study|Adverse Event|10|||
156796584|NCT02135133|566008112|FG000|Overall Study|regulatory mandate|5|||
156796585|NCT02259231|566008113|FG000|Overall Study|Adverse Event|1|||
156796586|NCT02259231|566008114|FG001|Overall Study|Adverse Event|1|||
156796587|NCT02259231|566008115|FG002|Overall Study|Adverse Event|2|||
157139641|NCT00818259|567255978|FG001|Part II|Lack of Efficacy|0|||
156796588|NCT02259231|566008116|FG003|Overall Study|Adverse Event|0|||
156796589|NCT02259231|566008117|FG004|Overall Study|Adverse Event|0|||
156796590|NCT02259231|566008118|FG005|Overall Study|Adverse Event|0|||
156796591|NCT02259231|566008119|FG006|Overall Study|Adverse Event|0|||
156796592|NCT02259231|566008113|FG000|Overall Study|Progressive Disease|4|||
157019875|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
157019876|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019877|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019878|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019879|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019880|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019881|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019882|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019883|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019884|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019885|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019886|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
157019887|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
157019888|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
157019889|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019890|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019891|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019892|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019893|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019894|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019895|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157139642|NCT00818259|567255979|FG002|Part II|Lack of Efficacy|0|||
157139643|NCT00818259|567255980|FG003|Part II|Lack of Efficacy|1|||
157139644|NCT00818259|567255981|FG004|Part II|Lack of Efficacy|0|||
157139645|NCT00818259|567255982|FG005|Part II|Lack of Efficacy|0|||
156731211|NCT02477332|565763886|FG003|Overall Study|Physician Decision|3|||
156731212|NCT02477332|565763887|FG004|Overall Study|Physician Decision|0|||
156731213|NCT02477332|565763888|FG005|Overall Study|Physician Decision|1|||
156731214|NCT02477332|565763883|FG000|Overall Study|Withdrawal by Subject|0|||
156731215|NCT02477332|565763884|FG001|Overall Study|Withdrawal by Subject|3|||
156731216|NCT02477332|565763885|FG002|Overall Study|Withdrawal by Subject|1|||
156731217|NCT02477332|565763886|FG003|Overall Study|Withdrawal by Subject|2|||
156731218|NCT02477332|565763887|FG004|Overall Study|Withdrawal by Subject|1|||
156731219|NCT02477332|565763888|FG005|Overall Study|Withdrawal by Subject|0|||
156731220|NCT03793842|565763889|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
156731221|NCT03793842|565763890|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
156731222|NCT03793842|565763889|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
156731223|NCT03793842|565763890|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
156731224|NCT04657198|565763891|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
156731225|NCT04657198|565763892|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156731226|NCT04657198|565763893|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
156731227|NCT02549287|565763894|FG000|Overall Study|Lost to Follow-up|65|||
156731228|NCT02549287|565763895|FG001|Overall Study|Lost to Follow-up|26|||
156731229|NCT02549287|565763894|FG000|Overall Study|Withdrawal by Subject|15|||
156731230|NCT02549287|565763895|FG001|Overall Study|Withdrawal by Subject|6|||
156731231|NCT00427921|565763899|FG000|Overall Study|Adverse Event|26|||
156731232|NCT00427921|565763899|FG000|Overall Study|Withdrawal by Subject|4|||
156731233|NCT00427921|565763899|FG000|Overall Study|Lost to Follow-up|2|||
156731234|NCT00427921|565763899|FG000|Overall Study|Other reason not specified|10|||
156731235|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Hospitalization|1|||
156731236|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
156731237|NCT00427921|565763899|FG000|Overall Study|Adverse Event + No Response|1|||
156731238|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
156731239|NCT00427921|565763899|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
156731240|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Lost Response|1|||
156731241|NCT00427921|565763899|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
156731242|NCT00427921|565763899|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
156731243|NCT00900159|565763900|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
156731244|NCT00900159|565763901|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
156731245|NCT00520533|565763902|FG000|Overall Study|Death|1|||
156731246|NCT00520533|565763902|FG000|Overall Study|Suspension of the study for safety reasons|1|||
157019896|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019897|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019898|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
156731247|NCT00520533|565763902|FG000|Overall Study|Withdrawal by Subject|1|||
156731248|NCT00520533|565763902|FG000|Overall Study|Physician Decision|1|||
157139646|NCT00818259|567255983|FG006|Part II|Lack of Efficacy|0|||
157139647|NCT00818259|567255984|FG007|Part II|Lack of Efficacy|0|||
157139648|NCT00818259|567255985|FG008|Part II|Lack of Efficacy|0|||
157139649|NCT00818259|567255977|FG000|Part II|Not Treated|0|||
157139650|NCT00818259|567255978|FG001|Part II|Not Treated|0|||
157139651|NCT00818259|567255979|FG002|Part II|Not Treated|0|||
157139652|NCT00818259|567255980|FG003|Part II|Not Treated|1|||
157139653|NCT00818259|567255981|FG004|Part II|Not Treated|0|||
157139654|NCT00818259|567255982|FG005|Part II|Not Treated|0|||
157139655|NCT00818259|567255983|FG006|Part II|Not Treated|0|||
157139656|NCT00818259|567255984|FG007|Part II|Not Treated|0|||
157139657|NCT00818259|567255985|FG008|Part II|Not Treated|0|||
157139658|NCT00818259|567255977|FG000|Part IV|Physician Decision|0|||
157139659|NCT00818259|567255978|FG001|Part IV|Physician Decision|0|||
157139660|NCT00818259|567255979|FG002|Part IV|Physician Decision|0|||
157139661|NCT00818259|567255980|FG003|Part IV|Physician Decision|0|||
157139662|NCT00818259|567255981|FG004|Part IV|Physician Decision|0|||
157139663|NCT00818259|567255982|FG005|Part IV|Physician Decision|1|||
157139664|NCT00818259|567255983|FG006|Part IV|Physician Decision|0|||
157139665|NCT00818259|567255984|FG007|Part IV|Physician Decision|0|||
157139666|NCT00818259|567255985|FG008|Part IV|Physician Decision|0|||
157139667|NCT00818259|567255977|FG000|Part V|Adverse Event|0|||
157139668|NCT00818259|567255978|FG001|Part V|Adverse Event|0|||
157139669|NCT00818259|567255979|FG002|Part V|Adverse Event|0|||
157139670|NCT00818259|567255980|FG003|Part V|Adverse Event|0|||
157139671|NCT00818259|567255981|FG004|Part V|Adverse Event|0|||
157139672|NCT00818259|567255982|FG005|Part V|Adverse Event|0|||
157139673|NCT00818259|567255983|FG006|Part V|Adverse Event|0|||
157139674|NCT00818259|567255984|FG007|Part V|Adverse Event|1|||
157139675|NCT00818259|567255985|FG008|Part V|Adverse Event|0|||
157139676|NCT04640766|567255986|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
157139677|NCT00609622|567255987|FG000|Overall Study|Adverse Event|14|||
157139678|NCT00609622|567255988|FG001|Overall Study|Adverse Event|10|||
157139679|NCT00609622|567255987|FG000|Overall Study|Withdrawal by Subject|4|||
157139680|NCT00609622|567255988|FG001|Overall Study|Withdrawal by Subject|20|||
157139681|NCT00609622|567255987|FG000|Overall Study|Death|1|||
157139682|NCT00609622|567255988|FG001|Overall Study|Death|4|||
157139683|NCT00609622|567255987|FG000|Overall Study|Protocol Violation|1|||
157139684|NCT00609622|567255988|FG001|Overall Study|Protocol Violation|1|||
157139685|NCT00609622|567255987|FG000|Overall Study|Objective progression or relapse|47|||
157139686|NCT00609622|567255988|FG001|Overall Study|Objective progression or relapse|41|||
157139687|NCT00609622|567255987|FG000|Overall Study|Study terminated by sponsor|16|||
157139688|NCT00609622|567255988|FG001|Overall Study|Study terminated by sponsor|3|||
157139689|NCT00609622|567255987|FG000|Overall Study|Other|7|||
157139690|NCT00609622|567255988|FG001|Overall Study|Other|14|||
157139691|NCT00609622|567255987|FG000|Overall Study|Global deterioration of health status|6|||
157139692|NCT00609622|567255988|FG001|Overall Study|Global deterioration of health status|2|||
157217462|NCT01621490|567543229|FG007|Overall Study|Study drug toxicity|4|||
157217463|NCT01621490|567543230|FG008|Overall Study|Study drug toxicity|1|||
157217464|NCT01621490|567543231|FG009|Overall Study|Study drug toxicity|0|||
157217465|NCT01621490|567543232|FG010|Overall Study|Study drug toxicity|0|||
156731249|NCT03340454|565763903|FG000|Overall Study|Lost to Follow-up|0|||
156731250|NCT03340454|565763904|FG001|Overall Study|Lost to Follow-up|4|||
156731251|NCT02568189|565763910|FG000|Overall Study|Protocol Violation|0|||
156731252|NCT02568189|565763911|FG001|Overall Study|Protocol Violation|0|||
156731253|NCT02568189|565763912|FG002|Overall Study|Protocol Violation|19|||
156731254|NCT02568189|565763913|FG003|Overall Study|Protocol Violation|18|||
156731255|NCT00529373|565763914|FG000|Base Study|Adverse Event|525|||
156731256|NCT00529373|565763915|FG001|Base Study|Adverse Event|470|||
156731257|NCT00529373|565763914|FG000|Base Study|Lack of Efficacy|16|||
156731258|NCT00529373|565763915|FG001|Base Study|Lack of Efficacy|75|||
156731259|NCT00529373|565763914|FG000|Base Study|Lost to Follow-up|221|||
156731260|NCT00529373|565763915|FG001|Base Study|Lost to Follow-up|208|||
156731261|NCT00529373|565763914|FG000|Base Study|Other Protocol Specified Criteria|19|||
156731262|NCT00529373|565763915|FG001|Base Study|Other Protocol Specified Criteria|20|||
156876480|NCT00452361|566305852|FG001|Overall Study|Premature termination|9|||
156876481|NCT02954172|566305853|FG000|Overall Study|Protocol Violation|3|||
157139693|NCT01237951|567255989|FG000|Overall Study|Death|1|||
156731263|NCT00529373|565763914|FG000|Base Study|Physician Decision|60|||
156731264|NCT00529373|565763915|FG001|Base Study|Physician Decision|52|||
156731265|NCT00529373|565763914|FG000|Base Study|Protocol Violation|48|||
157139694|NCT00666562|567255999|FG000|Overall Study|Withdrawal by Subject|0|||
157139695|NCT00666562|567256000|FG001|Overall Study|Withdrawal by Subject|1|||
157139696|NCT00666562|567256001|FG002|Overall Study|Withdrawal by Subject|0|||
157139697|NCT00666562|567255999|FG000|Overall Study|Concomitant Medication|0|||
157139698|NCT00666562|567256000|FG001|Overall Study|Concomitant Medication|1|||
157139699|NCT00666562|567256001|FG002|Overall Study|Concomitant Medication|0|||
157139700|NCT05262764|567256003|FG000|Overall Study|Case report form not collected|9|||
157139701|NCT05262764|567256003|FG000|Overall Study|No patient visits after entry|23|||
156731266|NCT00529373|565763915|FG001|Base Study|Protocol Violation|38|||
156731267|NCT00529373|565763914|FG000|Base Study|Withdrawal by Subject|1062|||
156731268|NCT00529373|565763915|FG001|Base Study|Withdrawal by Subject|967|||
157139702|NCT05262764|567256003|FG000|Overall Study|Registration rule not followed|2|||
157139703|NCT05262764|567256003|FG000|Overall Study|Patient of non-chronic heart failure|1|||
157217466|NCT01621490|567543222|FG000|Overall Study|Death|0|||
156731269|NCT00529373|565763914|FG000|Base Study|Did not continue into Extension|1795|||
156731270|NCT00529373|565763915|FG001|Base Study|Did not continue into Extension|2238|||
156731271|NCT00529373|565763914|FG000|First Extension Study|Adverse Event|162|||
156731272|NCT00529373|565763915|FG001|First Extension Study|Adverse Event|142|||
156731273|NCT00529373|565763914|FG000|First Extension Study|Lack of Efficacy|65|||
156731274|NCT00529373|565763915|FG001|First Extension Study|Lack of Efficacy|427|||
156731275|NCT00529373|565763914|FG000|First Extension Study|Lost to Follow-up|41|||
156731276|NCT00529373|565763915|FG001|First Extension Study|Lost to Follow-up|37|||
156731277|NCT00529373|565763914|FG000|First Extension Study|Other|27|||
156731278|NCT00529373|565763915|FG001|First Extension Study|Other|47|||
156731279|NCT00529373|565763914|FG000|First Extension Study|Physician Decision|50|||
156731280|NCT00529373|565763915|FG001|First Extension Study|Physician Decision|45|||
156731281|NCT00529373|565763914|FG000|First Extension Study|Protocol Violation|16|||
156731282|NCT00529373|565763915|FG001|First Extension Study|Protocol Violation|13|||
156876482|NCT02954172|566305854|FG001|Overall Study|Protocol Violation|0|||
156876483|NCT02954172|566305853|FG000|Overall Study|allergic reaction|2|||
156876484|NCT02954172|566305854|FG001|Overall Study|allergic reaction|1|||
156876485|NCT02954172|566305853|FG000|Overall Study|non-measurable lesions at baseline|1|||
156876486|NCT02954172|566305854|FG001|Overall Study|non-measurable lesions at baseline|2|||
156876487|NCT02621151|566305855|FG000|Overall Study|Not eligible for trial|6|||
156876488|NCT04198714|566305856|FG000|Overall Study|Physician Decision|0|||
156876489|NCT04198714|566305857|FG001|Overall Study|Physician Decision|1|||
156876490|NCT02529553|566305858|FG000|Overall Study|Progressive Disease|1|||
156876491|NCT02529553|566305859|FG001|Overall Study|Progressive Disease|0|||
156876492|NCT02529553|566305860|FG002|Overall Study|Progressive Disease|1|||
156876493|NCT02529553|566305861|FG003|Overall Study|Progressive Disease|3|||
156876494|NCT02529553|566305862|FG004|Overall Study|Progressive Disease|2|||
156876495|NCT02529553|566305863|FG005|Overall Study|Progressive Disease|3|||
156876496|NCT02529553|566305864|FG006|Overall Study|Progressive Disease|3|||
156731283|NCT00529373|565763914|FG000|First Extension Study|Withdrawal by Subject|296|||
156731284|NCT00529373|565763915|FG001|First Extension Study|Withdrawal by Subject|287|||
156731285|NCT00529373|565763914|FG000|First Extension Study|Disposition record non-existing|0|||
156731286|NCT00529373|565763915|FG001|First Extension Study|Disposition record non-existing|1|||
156731287|NCT00529373|565763914|FG000|First Extension Study|Discontinued after 5 years completion|208|||
156731288|NCT00529373|565763915|FG001|First Extension Study|Discontinued after 5 years completion|346|||
156731289|NCT00529373|565763914|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
156731290|NCT00529373|565763915|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
156731291|NCT00529373|565763914|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
156731292|NCT00529373|565763915|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
156731293|NCT00529373|565763914|FG000|Second Extension Study|Adverse Event|101|||
156731294|NCT00529373|565763915|FG001|Second Extension Study|Adverse Event|51|||
156731295|NCT00529373|565763914|FG000|Second Extension Study|Lack of Efficacy|7|||
156731296|NCT00529373|565763915|FG001|Second Extension Study|Lack of Efficacy|15|||
156731297|NCT00529373|565763914|FG000|Second Extension Study|Lost to Follow-up|18|||
156731298|NCT00529373|565763915|FG001|Second Extension Study|Lost to Follow-up|12|||
156731299|NCT00529373|565763914|FG000|Second Extension Study|Other|7|||
156731300|NCT00529373|565763915|FG001|Second Extension Study|Other|12|||
156731301|NCT00529373|565763914|FG000|Second Extension Study|Physician Decision|63|||
156876497|NCT02529553|566305865|FG007|Overall Study|Progressive Disease|5|||
156876498|NCT02529553|566305866|FG008|Overall Study|Progressive Disease|3|||
156876499|NCT02529553|566305858|FG000|Overall Study|Physician Decision|0|||
156876500|NCT02529553|566305859|FG001|Overall Study|Physician Decision|1|||
156876501|NCT02529553|566305860|FG002|Overall Study|Physician Decision|0|||
156876502|NCT02529553|566305861|FG003|Overall Study|Physician Decision|0|||
156731302|NCT00529373|565763915|FG001|Second Extension Study|Physician Decision|26|||
156731303|NCT00529373|565763914|FG000|Second Extension Study|Protocol Violation|2|||
156731304|NCT00529373|565763915|FG001|Second Extension Study|Protocol Violation|1|||
156731305|NCT00529373|565763914|FG000|Second Extension Study|Withdrawal by Subject|97|||
156731306|NCT00529373|565763915|FG001|Second Extension Study|Withdrawal by Subject|75|||
156731307|NCT00529373|565763914|FG000|Second Extension Study|Status Missing|5|||
156731308|NCT00529373|565763915|FG001|Second Extension Study|Status Missing|5|||
156731309|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
156731310|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
156876503|NCT02529553|566305862|FG004|Overall Study|Physician Decision|1|||
157019899|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
157019900|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
157019901|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
157139704|NCT01392183|567256004|FG000|First Drug Administration|Adverse Event|3|||
156731311|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
156731312|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
156731313|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
156876504|NCT02529553|566305863|FG005|Overall Study|Physician Decision|0|||
156876505|NCT02529553|566305864|FG006|Overall Study|Physician Decision|0|||
156876506|NCT02529553|566305865|FG007|Overall Study|Physician Decision|0|||
156731314|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
156731315|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
156731316|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
156731317|NCT01074268|565763916|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
156731318|NCT01074268|565763917|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
156731319|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
156731320|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
156731321|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
156731322|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
156731323|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
156731324|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
156731325|NCT01074268|565763916|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
156731326|NCT01074268|565763917|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
156731327|NCT01578239|565763918|FG000|Treatment Period|Progressive Disease|19|||
156731328|NCT01578239|565763919|FG001|Treatment Period|Progressive Disease|64|||
156731329|NCT01578239|565763918|FG000|Treatment Period|Physician Decision|17|||
156731330|NCT01578239|565763919|FG001|Treatment Period|Physician Decision|17|||
156731331|NCT01578239|565763918|FG000|Treatment Period|Adverse Event|13|||
156731332|NCT01578239|565763919|FG001|Treatment Period|Adverse Event|10|||
156731333|NCT01578239|565763918|FG000|Treatment Period|Non-compliance|2|||
156731334|NCT01578239|565763919|FG001|Treatment Period|Non-compliance|0|||
156731335|NCT01578239|565763918|FG000|Treatment Period|Withdrawal by Subject|10|||
156731336|NCT01578239|565763919|FG001|Treatment Period|Withdrawal by Subject|9|||
156731337|NCT01578239|565763918|FG000|Treatment Period|Other|6|||
156731338|NCT01578239|565763919|FG001|Treatment Period|Other|1|||
156731339|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Death|69|||
156876507|NCT02529553|566305866|FG008|Overall Study|Physician Decision|0|||
156876508|NCT02529553|566305858|FG000|Overall Study|Withdrawal by Subject|0|||
156876509|NCT02529553|566305859|FG001|Overall Study|Withdrawal by Subject|0|||
156876510|NCT02529553|566305860|FG002|Overall Study|Withdrawal by Subject|0|||
156876511|NCT02529553|566305861|FG003|Overall Study|Withdrawal by Subject|0|||
156876512|NCT02529553|566305862|FG004|Overall Study|Withdrawal by Subject|0|||
156876513|NCT02529553|566305863|FG005|Overall Study|Withdrawal by Subject|1|||
156876514|NCT02529553|566305864|FG006|Overall Study|Withdrawal by Subject|0|||
156876515|NCT02529553|566305865|FG007|Overall Study|Withdrawal by Subject|1|||
156876516|NCT02529553|566305866|FG008|Overall Study|Withdrawal by Subject|0|||
156876517|NCT00924027|566305871|FG000|Overall Study|Lost to Further Follow-Up|4|||
156876518|NCT00924027|566305872|FG001|Overall Study|Lost to Further Follow-Up|0|||
156876519|NCT00924027|566305873|FG002|Overall Study|Lost to Further Follow-Up|0|||
156876520|NCT00924027|566305874|FG003|Overall Study|Lost to Further Follow-Up|0|||
156876521|NCT00924027|566305871|FG000|Overall Study|Physician Decision|1|||
156876522|NCT00924027|566305872|FG001|Overall Study|Physician Decision|0|||
156731340|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Death|64|||
156731341|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
156731342|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
156731343|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
156731344|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
156731345|NCT01578239|565763918|FG000|Long-term Follow-Up Period|Other|2|||
156876523|NCT00924027|566305873|FG002|Overall Study|Physician Decision|0|||
156876524|NCT00924027|566305874|FG003|Overall Study|Physician Decision|1|||
156876525|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
156876526|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
156876527|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
156876528|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
157139705|NCT01392183|567256005|FG001|First Drug Administration|Adverse Event|2|||
157139706|NCT01392183|567256004|FG000|First Drug Administration|Death|1|||
157139707|NCT01392183|567256005|FG001|First Drug Administration|Death|0|||
157139708|NCT01392183|567256004|FG000|First Drug Administration|Withdrawal by Subject|10|||
157139709|NCT01392183|567256005|FG001|First Drug Administration|Withdrawal by Subject|17|||
157139710|NCT00963807|567256008|FG000|Overall Study|Physician Decision|2|||
157139711|NCT00963807|567256008|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
157139712|NCT00963807|567256008|FG000|Overall Study|Disease progression|15|||
157139713|NCT00684177|567256011|FG000|Overall Study|Adverse Event|4|||
157139714|NCT00684177|567256012|FG001|Overall Study|Adverse Event|3|||
156731346|NCT01578239|565763919|FG001|Long-term Follow-Up Period|Other|2|||
156876529|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
156876530|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
156876531|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
156876532|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
157139715|NCT00684177|567256011|FG000|Overall Study|Lack of Efficacy|10|||
157139716|NCT00684177|567256012|FG001|Overall Study|Lack of Efficacy|15|||
157139717|NCT00684177|567256011|FG000|Overall Study|Protocol Violation|1|||
157139718|NCT00684177|567256012|FG001|Overall Study|Protocol Violation|0|||
157139719|NCT00684177|567256011|FG000|Overall Study|Lost to Follow-up|2|||
156876533|NCT00924027|566305871|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
156876534|NCT00924027|566305872|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
156876535|NCT00924027|566305873|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
156731347|NCT02347813|565763922|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
156731348|NCT02347813|565763923|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
156731349|NCT02347813|565763922|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
156731350|NCT02347813|565763923|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
156731351|NCT01119859|565763926|FG000|Overall Study|Adverse Event|9|||
156731352|NCT01119859|565763927|FG001|Overall Study|Adverse Event|10|||
156876536|NCT00924027|566305874|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
156876537|NCT01217307|566307621|FG000|Overall Study|Withdrawal by Subject|0|||
156876538|NCT01217307|566307622|FG001|Overall Study|Withdrawal by Subject|1|||
156731353|NCT01119859|565763926|FG000|Overall Study|Death|2|||
156731354|NCT01119859|565763927|FG001|Overall Study|Death|0|||
156731355|NCT01119859|565763926|FG000|Overall Study|Insufficient therapeutic response|7|||
156731356|NCT01119859|565763927|FG001|Overall Study|Insufficient therapeutic response|14|||
156731357|NCT01119859|565763926|FG000|Overall Study|Refused treatment|3|||
156731358|NCT01119859|565763927|FG001|Overall Study|Refused treatment|6|||
156731359|NCT01119859|565763926|FG000|Overall Study|Failure to return|3|||
156731360|NCT01119859|565763927|FG001|Overall Study|Failure to return|0|||
156731361|NCT00603473|565763928|FG000|Overall Study|Adverse Event|4|||
156731362|NCT00603473|565763928|FG000|Overall Study|Lack of Efficacy|4|||
156731363|NCT00603473|565763928|FG000|Overall Study|Protocol Violation|1|||
156731364|NCT01134939|565763932|FG000|Overall Study|Adverse Event|9|||
156731365|NCT01134939|565763933|FG001|Overall Study|Adverse Event|3|||
156731366|NCT01134939|565763934|FG002|Overall Study|Adverse Event|4|||
156731367|NCT01134939|565763935|FG003|Overall Study|Adverse Event|5|||
156731368|NCT01134939|565763936|FG004|Overall Study|Adverse Event|5|||
156731369|NCT01134939|565763937|FG005|Overall Study|Adverse Event|5|||
156731370|NCT01134939|565763938|FG006|Overall Study|Adverse Event|1|||
156731371|NCT01134939|565763939|FG007|Overall Study|Adverse Event|0|||
156731372|NCT01134939|565763932|FG000|Overall Study|Lack of Efficacy|2|||
156731373|NCT01134939|565763933|FG001|Overall Study|Lack of Efficacy|5|||
156731374|NCT01134939|565763934|FG002|Overall Study|Lack of Efficacy|1|||
156731375|NCT01134939|565763935|FG003|Overall Study|Lack of Efficacy|0|||
156731376|NCT01134939|565763936|FG004|Overall Study|Lack of Efficacy|3|||
156731377|NCT01134939|565763937|FG005|Overall Study|Lack of Efficacy|0|||
156731378|NCT01134939|565763938|FG006|Overall Study|Lack of Efficacy|1|||
156731379|NCT01134939|565763939|FG007|Overall Study|Lack of Efficacy|0|||
156731380|NCT01134939|565763932|FG000|Overall Study|Lost to Follow-up|2|||
156731381|NCT01134939|565763933|FG001|Overall Study|Lost to Follow-up|3|||
156731382|NCT01134939|565763934|FG002|Overall Study|Lost to Follow-up|0|||
156731383|NCT01134939|565763935|FG003|Overall Study|Lost to Follow-up|1|||
156731384|NCT01134939|565763936|FG004|Overall Study|Lost to Follow-up|2|||
156731385|NCT01134939|565763937|FG005|Overall Study|Lost to Follow-up|1|||
156731386|NCT01134939|565763938|FG006|Overall Study|Lost to Follow-up|0|||
156731387|NCT01134939|565763939|FG007|Overall Study|Lost to Follow-up|0|||
156731388|NCT01134939|565763932|FG000|Overall Study|Death|0|||
156731389|NCT01134939|565763933|FG001|Overall Study|Death|1|||
156731390|NCT01134939|565763934|FG002|Overall Study|Death|0|||
156731391|NCT01134939|565763935|FG003|Overall Study|Death|0|||
156731392|NCT01134939|565763936|FG004|Overall Study|Death|0|||
156731393|NCT01134939|565763937|FG005|Overall Study|Death|0|||
156731394|NCT01134939|565763938|FG006|Overall Study|Death|0|||
156731395|NCT01134939|565763939|FG007|Overall Study|Death|0|||
156731396|NCT01134939|565763932|FG000|Overall Study|Termination page not available|4|||
156731397|NCT01134939|565763933|FG001|Overall Study|Termination page not available|6|||
156731398|NCT01134939|565763934|FG002|Overall Study|Termination page not available|5|||
156731399|NCT01134939|565763935|FG003|Overall Study|Termination page not available|8|||
156731400|NCT01134939|565763936|FG004|Overall Study|Termination page not available|0|||
156731401|NCT01134939|565763937|FG005|Overall Study|Termination page not available|3|||
156731402|NCT01134939|565763938|FG006|Overall Study|Termination page not available|7|||
156731403|NCT01134939|565763939|FG007|Overall Study|Termination page not available|0|||
156731404|NCT00733421|565763940|FG000|Overall Study|Withdrawal by Subject|1|||
156731405|NCT00733421|565763941|FG001|Overall Study|Withdrawal by Subject|1|||
156731406|NCT01029782|565763944|FG000|Overall Study|Lost to Follow-up|2|||
156731407|NCT01029782|565763945|FG001|Overall Study|Lost to Follow-up|2|||
156731408|NCT01029782|565763944|FG000|Overall Study|Diagnosis changed|1|||
156731409|NCT01029782|565763945|FG001|Overall Study|Diagnosis changed|1|||
156876539|NCT01868542|566307623|FG000|Overall Study|Protocol Violation|0|||
156876540|NCT01868542|566307624|FG001|Overall Study|Protocol Violation|1|||
156876541|NCT01868542|566307623|FG000|Overall Study|Unclassified|0|||
156731410|NCT01029782|565763944|FG000|Overall Study|Adverse Event|0|||
156731411|NCT01029782|565763945|FG001|Overall Study|Adverse Event|1|||
156731412|NCT01029782|565763944|FG000|Overall Study|Physician Decision|0|||
156731413|NCT01029782|565763945|FG001|Overall Study|Physician Decision|1|||
156731414|NCT01029782|565763944|FG000|Overall Study|Protocol Violation|0|||
156731415|NCT01029782|565763945|FG001|Overall Study|Protocol Violation|2|||
156731416|NCT01029782|565763944|FG000|Overall Study|Withdrawal by Subject|0|||
156731417|NCT01029782|565763945|FG001|Overall Study|Withdrawal by Subject|1|||
156731418|NCT02195869|565763949|FG000|Overall Study|cGVHD Progression|5|||
156731419|NCT02195869|565763949|FG000|Overall Study|Malignancy Progression/relapse|2|||
156731420|NCT02195869|565763949|FG000|Overall Study|Adverse Event|15|||
156731421|NCT02195869|565763949|FG000|Overall Study|Withdrawal by Subject|7|||
156731422|NCT02195869|565763949|FG000|Overall Study|Physician Decision|4|||
156731423|NCT02195869|565763949|FG000|Overall Study|Study Terminated by Sponsor|7|||
156731424|NCT02195869|565763949|FG000|Overall Study|Noncompliance with study drug|2|||
156731425|NCT00757042|565763950|FG000|Overall Study|Lost to Follow-up|0|||
157019902|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
157019903|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019904|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019905|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019906|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019907|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019908|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019909|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019910|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019911|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019912|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
157019913|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
157019914|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
157019915|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
157019916|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019917|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019918|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019919|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019920|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019921|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157139720|NCT00684177|567256012|FG001|Overall Study|Lost to Follow-up|1|||
157139721|NCT00684177|567256011|FG000|Overall Study|Physician Decision|2|||
157139722|NCT00684177|567256012|FG001|Overall Study|Physician Decision|0|||
156731426|NCT00757042|565763951|FG001|Overall Study|Lost to Follow-up|0|||
156731427|NCT00757042|565763952|FG002|Overall Study|Lost to Follow-up|0|||
156731428|NCT00757042|565763953|FG003|Overall Study|Lost to Follow-up|0|||
156731429|NCT00757042|565763954|FG004|Overall Study|Lost to Follow-up|0|||
156731430|NCT00757042|565763955|FG005|Overall Study|Lost to Follow-up|0|||
156731431|NCT00757042|565763956|FG006|Overall Study|Lost to Follow-up|0|||
156731432|NCT00757042|565763957|FG007|Overall Study|Lost to Follow-up|0|||
156731433|NCT00757042|565763958|FG008|Overall Study|Lost to Follow-up|1|||
156731434|NCT00757042|565763959|FG009|Overall Study|Lost to Follow-up|0|||
156731435|NCT00757042|565763960|FG010|Overall Study|Lost to Follow-up|0|||
156731436|NCT00757042|565763950|FG000|Overall Study|Ineligibility Determined|0|||
156731437|NCT00757042|565763951|FG001|Overall Study|Ineligibility Determined|0|||
156731438|NCT00757042|565763952|FG002|Overall Study|Ineligibility Determined|0|||
156731439|NCT00757042|565763953|FG003|Overall Study|Ineligibility Determined|0|||
156731440|NCT00757042|565763954|FG004|Overall Study|Ineligibility Determined|0|||
156731441|NCT00757042|565763955|FG005|Overall Study|Ineligibility Determined|0|||
156731442|NCT00757042|565763956|FG006|Overall Study|Ineligibility Determined|0|||
156731443|NCT00757042|565763957|FG007|Overall Study|Ineligibility Determined|0|||
156731444|NCT00757042|565763958|FG008|Overall Study|Ineligibility Determined|0|||
156731445|NCT00757042|565763959|FG009|Overall Study|Ineligibility Determined|0|||
156731446|NCT00757042|565763960|FG010|Overall Study|Ineligibility Determined|1|||
157139723|NCT00684177|567256011|FG000|Overall Study|Withdrawal by Subject|1|||
157139724|NCT00684177|567256012|FG001|Overall Study|Withdrawal by Subject|2|||
157139725|NCT00684177|567256011|FG000|Overall Study|Other|1|||
157139726|NCT00684177|567256012|FG001|Overall Study|Other|2|||
157139727|NCT00075881|567257469|FG000|Overall Study|Lack of Efficacy|18|||
156731447|NCT00757042|565763950|FG000|Overall Study|Withdrawal by Subject|0|||
156731448|NCT00757042|565763951|FG001|Overall Study|Withdrawal by Subject|0|||
156731449|NCT00757042|565763952|FG002|Overall Study|Withdrawal by Subject|0|||
157139728|NCT00075881|567257469|FG000|Overall Study|Adverse Event|7|||
157139729|NCT00075881|567257469|FG000|Overall Study|Death|1|||
157139730|NCT00075881|567257469|FG000|Overall Study|Withdrawal by Subject|2|||
157139731|NCT00075881|567257469|FG000|Overall Study|Protocol Violation|4|||
157139732|NCT00075881|567257469|FG000|Overall Study|other complicating disease|3|||
157139733|NCT00075881|567257469|FG000|Overall Study|other|4|||
157139734|NCT00075881|567257469|FG000|Overall Study|missing data|2|||
157139735|NCT00075881|567257469|FG000|Overall Study|Ineligible|1|||
157139736|NCT00075881|567257469|FG000|Overall Study|never start protocol therapy|1|||
156731450|NCT00757042|565763953|FG003|Overall Study|Withdrawal by Subject|0|||
156731451|NCT00757042|565763954|FG004|Overall Study|Withdrawal by Subject|0|||
156731452|NCT00757042|565763955|FG005|Overall Study|Withdrawal by Subject|0|||
156731453|NCT00757042|565763956|FG006|Overall Study|Withdrawal by Subject|0|||
156731454|NCT00757042|565763957|FG007|Overall Study|Withdrawal by Subject|0|||
156731455|NCT00757042|565763958|FG008|Overall Study|Withdrawal by Subject|0|||
156731456|NCT00757042|565763959|FG009|Overall Study|Withdrawal by Subject|1|||
156731457|NCT00757042|565763960|FG010|Overall Study|Withdrawal by Subject|0|||
156731458|NCT02654977|565763962|FG000|Overall Study|Death|1|||
156731459|NCT02654977|565763962|FG000|Overall Study|Lost to Follow-up|1|||
156731460|NCT02654977|565763962|FG000|Overall Study|Adverse Event|1|||
156731461|NCT02654977|565763962|FG000|Overall Study|Withdrawal by Subject|1|||
156731462|NCT02654977|565763962|FG000|Overall Study|Lack of Efficacy|3|||
156731463|NCT01921101|565763963|FG000|Overall Study|Death|16|||
156731464|NCT01921101|565763964|FG001|Overall Study|Death|6|||
156731465|NCT02729051|565763970|FG000|Overall Study|Adverse Event|21|||
156731466|NCT02729051|565763971|FG001|Overall Study|Adverse Event|11|||
156731467|NCT02729051|565763970|FG000|Overall Study|Lack of Efficacy|1|||
156731468|NCT02729051|565763971|FG001|Overall Study|Lack of Efficacy|1|||
156731469|NCT02729051|565763970|FG000|Overall Study|Lost to Follow-up|1|||
156731470|NCT02729051|565763971|FG001|Overall Study|Lost to Follow-up|2|||
156731471|NCT02729051|565763970|FG000|Overall Study|Physician Decision|1|||
156731472|NCT02729051|565763971|FG001|Overall Study|Physician Decision|1|||
156731473|NCT02729051|565763970|FG000|Overall Study|Withdrawal by Subject|6|||
156731474|NCT02729051|565763971|FG001|Overall Study|Withdrawal by Subject|17|||
156731475|NCT03225105|565763975|FG000|Overall Study|Withdrawal by Subject|1|||
156731476|NCT03225105|565763976|FG001|Overall Study|Withdrawal by Subject|0|||
156731477|NCT03225105|565763977|FG002|Overall Study|Withdrawal by Subject|0|||
156731478|NCT03225105|565763978|FG003|Overall Study|Withdrawal by Subject|0|||
156731479|NCT03225105|565763975|FG000|Overall Study|Death|0|||
156731480|NCT03225105|565763976|FG001|Overall Study|Death|4|||
156731481|NCT03225105|565763977|FG002|Overall Study|Death|2|||
156731482|NCT03225105|565763978|FG003|Overall Study|Death|0|||
156731483|NCT03225105|565763975|FG000|Overall Study|Study termination per Sponsor Decision|2|||
156731484|NCT03225105|565763976|FG001|Overall Study|Study termination per Sponsor Decision|0|||
156731485|NCT03225105|565763977|FG002|Overall Study|Study termination per Sponsor Decision|3|||
156731486|NCT03225105|565763978|FG003|Overall Study|Study termination per Sponsor Decision|3|||
156731487|NCT03652636|565765827|FG000|Overall Study|Withdrawal by Subject|7|||
156731488|NCT03806933|565765831|FG000|Main Period|Physician Decision|0|||
156731489|NCT03806933|565765832|FG001|Main Period|Physician Decision|0|||
156731490|NCT03806933|565765833|FG002|Main Period|Physician Decision|0|||
156731491|NCT03806933|565765834|FG003|Main Period|Physician Decision|1|||
156731492|NCT03806933|565765831|FG000|Main Period|Pregnancy|0|||
156731493|NCT03806933|565765832|FG001|Main Period|Pregnancy|0|||
156731494|NCT03806933|565765833|FG002|Main Period|Pregnancy|1|||
156731495|NCT03806933|565765834|FG003|Main Period|Pregnancy|0|||
156731496|NCT03806933|565765831|FG000|Main Period|Withdrawal by Subject|2|||
156731497|NCT03806933|565765832|FG001|Main Period|Withdrawal by Subject|1|||
156731498|NCT03806933|565765833|FG002|Main Period|Withdrawal by Subject|1|||
156731499|NCT03806933|565765834|FG003|Main Period|Withdrawal by Subject|2|||
156731500|NCT03806933|565765831|FG000|Main Period|Lost to Follow-up|2|||
156731501|NCT03806933|565765832|FG001|Main Period|Lost to Follow-up|2|||
156731502|NCT03806933|565765833|FG002|Main Period|Lost to Follow-up|0|||
156731503|NCT03806933|565765834|FG003|Main Period|Lost to Follow-up|0|||
156731504|NCT03806933|565765831|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731505|NCT03806933|565765832|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731506|NCT03806933|565765833|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
156731507|NCT03806933|565765834|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
156731508|NCT01736397|565765835|FG000|Overall Study|Lack of Efficacy|1|||
156731509|NCT01736397|565765836|FG001|Overall Study|Lack of Efficacy|11|||
156731510|NCT01736397|565765835|FG000|Overall Study|Withdrawal by Subject|6|||
156731511|NCT01736397|565765836|FG001|Overall Study|Withdrawal by Subject|5|||
156731512|NCT01736397|565765835|FG000|Overall Study|Lost to Follow-up|0|||
156731513|NCT01736397|565765836|FG001|Overall Study|Lost to Follow-up|1|||
156796593|NCT02259231|566008114|FG001|Overall Study|Progressive Disease|5|||
156796594|NCT02259231|566008115|FG002|Overall Study|Progressive Disease|4|||
156731514|NCT01736397|565765835|FG000|Overall Study|Adverse Event|6|||
156731515|NCT01736397|565765836|FG001|Overall Study|Adverse Event|3|||
156731516|NCT01736397|565765835|FG000|Overall Study|Not stated|1|||
156731517|NCT01736397|565765836|FG001|Overall Study|Not stated|4|||
156731518|NCT05088603|565765837|FG000|Overall Study|Protocol Violation|6|||
156731519|NCT05088603|565765838|FG001|Overall Study|Protocol Violation|1|||
156731520|NCT01868438|565765839|FG000|First Intervention|Withdrawal by Subject|5|||
156731521|NCT01868438|565765840|FG001|First Intervention|Withdrawal by Subject|1|||
156731522|NCT01868438|565765839|FG000|First Intervention|Lost to Follow-up|2|||
156731523|NCT01868438|565765840|FG001|First Intervention|Lost to Follow-up|3|||
156731524|NCT01868438|565765839|FG000|First Intervention|Meeting the non-redosing criteria|0|||
156731525|NCT01868438|565765840|FG001|First Intervention|Meeting the non-redosing criteria|1|||
157139737|NCT02109029|567257472|FG000|Part B|Adverse Event|0|||
157139738|NCT02109029|567257473|FG001|Part B|Adverse Event|0|||
157139739|NCT02109029|567257474|FG002|Part B|Adverse Event|0|||
157139740|NCT02109029|567257475|FG003|Part B|Adverse Event|0|||
157139741|NCT02109029|567257476|FG004|Part B|Adverse Event|1|||
157139742|NCT02109029|567257477|FG005|Part B|Adverse Event|1|||
157139743|NCT03195894|567257478|FG000|Overall Study|"An example is Started other treatment."|4|||
157139744|NCT03195894|567257479|FG001|Overall Study|"An example is Started other treatment."|5|||
157139745|NCT03195894|567257478|FG000|Overall Study|Withdrawal by Subject|15|||
157139746|NCT03195894|567257479|FG001|Overall Study|Withdrawal by Subject|4|||
157139747|NCT03195894|567257478|FG000|Overall Study|Lost to Follow-up|14|||
157139748|NCT03195894|567257479|FG001|Overall Study|Lost to Follow-up|19|||
157139749|NCT01024244|567257490|FG000|Overall Study|Adverse Event|1|||
157139750|NCT01024244|567257491|FG001|Overall Study|Adverse Event|2|||
157139751|NCT01024244|567257492|FG002|Overall Study|Adverse Event|0|||
157139752|NCT01024244|567257493|FG003|Overall Study|Adverse Event|1|||
157139753|NCT01024244|567257494|FG004|Overall Study|Adverse Event|2|||
157139754|NCT01024244|567257490|FG000|Overall Study|Entry Criteria Not Met|0|||
157139755|NCT01024244|567257491|FG001|Overall Study|Entry Criteria Not Met|1|||
157139756|NCT01024244|567257492|FG002|Overall Study|Entry Criteria Not Met|0|||
157139757|NCT01024244|567257493|FG003|Overall Study|Entry Criteria Not Met|0|||
157139758|NCT01024244|567257494|FG004|Overall Study|Entry Criteria Not Met|0|||
157139759|NCT01024244|567257490|FG000|Overall Study|Lack of Efficacy|1|||
157139760|NCT01024244|567257491|FG001|Overall Study|Lack of Efficacy|0|||
157139761|NCT01024244|567257492|FG002|Overall Study|Lack of Efficacy|0|||
157139762|NCT01024244|567257493|FG003|Overall Study|Lack of Efficacy|0|||
157139763|NCT01024244|567257494|FG004|Overall Study|Lack of Efficacy|0|||
157139764|NCT01024244|567257490|FG000|Overall Study|Protocol Violation|1|||
157139765|NCT01024244|567257491|FG001|Overall Study|Protocol Violation|0|||
157139766|NCT01024244|567257492|FG002|Overall Study|Protocol Violation|0|||
157139767|NCT01024244|567257493|FG003|Overall Study|Protocol Violation|0|||
157139768|NCT01024244|567257494|FG004|Overall Study|Protocol Violation|2|||
157139769|NCT01024244|567257490|FG000|Overall Study|Sponsor Decision|14|||
157139770|NCT01024244|567257491|FG001|Overall Study|Sponsor Decision|7|||
157139771|NCT01024244|567257492|FG002|Overall Study|Sponsor Decision|14|||
157139772|NCT01024244|567257493|FG003|Overall Study|Sponsor Decision|12|||
157139773|NCT01024244|567257494|FG004|Overall Study|Sponsor Decision|10|||
157139774|NCT01024244|567257490|FG000|Overall Study|Withdrawal by Subject|0|||
156731526|NCT01868438|565765839|FG000|Second Intervention|Adverse Event|3|||
156731527|NCT01868438|565765840|FG001|Second Intervention|Adverse Event|3|||
156731528|NCT03555565|565765843|FG000|Overall Study|Case Report Forms Uncollected|2|||
156796595|NCT02259231|566008116|FG003|Overall Study|Progressive Disease|5|||
156731529|NCT03555565|565765843|FG000|Overall Study|Protocol Deviation|13|||
156731530|NCT00076752|565765844|FG000|Overall Study|Death|2|||
156731531|NCT00076752|565765844|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
156731532|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
156731533|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
156731534|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
156731535|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
156731536|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
156731537|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
156731538|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
156731539|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
156796596|NCT02259231|566008117|FG004|Overall Study|Progressive Disease|4|||
156796597|NCT02259231|566008118|FG005|Overall Study|Progressive Disease|5|||
156796598|NCT02259231|566008119|FG006|Overall Study|Progressive Disease|4|||
156796599|NCT02259231|566008113|FG000|Overall Study|Sponsor termination of study|1|||
156796600|NCT02259231|566008114|FG001|Overall Study|Sponsor termination of study|0|||
156796601|NCT02259231|566008115|FG002|Overall Study|Sponsor termination of study|0|||
156796602|NCT02259231|566008116|FG003|Overall Study|Sponsor termination of study|1|||
156796603|NCT02259231|566008117|FG004|Overall Study|Sponsor termination of study|2|||
156796604|NCT02259231|566008118|FG005|Overall Study|Sponsor termination of study|1|||
156796605|NCT02259231|566008119|FG006|Overall Study|Sponsor termination of study|1|||
156796606|NCT05081843|566008120|FG000|Overall Study|Lost to Follow-up|135|||
157139775|NCT01024244|567257491|FG001|Overall Study|Withdrawal by Subject|1|||
157139776|NCT01024244|567257492|FG002|Overall Study|Withdrawal by Subject|0|||
156731540|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Death|0|||
156731541|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Death|1|||
156731542|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
156731543|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
156796607|NCT05081843|566008121|FG001|Overall Study|Lost to Follow-up|145|||
157139777|NCT01024244|567257493|FG003|Overall Study|Withdrawal by Subject|0|||
157139778|NCT01024244|567257494|FG004|Overall Study|Withdrawal by Subject|0|||
157139779|NCT03874234|567257499|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139780|NCT03874234|567257500|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139781|NCT03874234|567257501|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157217467|NCT01621490|567543223|FG001|Overall Study|Death|0|||
157217468|NCT01621490|567543224|FG002|Overall Study|Death|0|||
157217469|NCT01621490|567543225|FG003|Overall Study|Death|0|||
157217470|NCT01621490|567543226|FG004|Overall Study|Death|0|||
157217471|NCT01621490|567543227|FG005|Overall Study|Death|0|||
157217472|NCT01621490|567543228|FG006|Overall Study|Death|0|||
157217473|NCT01621490|567543229|FG007|Overall Study|Death|0|||
157217474|NCT01621490|567543230|FG008|Overall Study|Death|1|||
157217475|NCT01621490|567543231|FG009|Overall Study|Death|0|||
157217476|NCT01621490|567543232|FG010|Overall Study|Death|0|||
157217477|NCT01621490|567543222|FG000|Overall Study|Other reasons|7|||
157019922|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019923|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019924|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157217478|NCT01621490|567543223|FG001|Overall Study|Other reasons|6|||
156796608|NCT03312543|566008123|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
156796609|NCT03312543|566008124|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
156796610|NCT03312543|566008123|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
156796611|NCT03312543|566008124|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
156796612|NCT03312543|566008123|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
157217479|NCT01621490|567543224|FG002|Overall Study|Other reasons|4|||
157217480|NCT01621490|567543225|FG003|Overall Study|Other reasons|1|||
157217481|NCT01621490|567543226|FG004|Overall Study|Other reasons|1|||
157217482|NCT01621490|567543227|FG005|Overall Study|Other reasons|3|||
157217483|NCT01621490|567543228|FG006|Overall Study|Other reasons|1|||
157217484|NCT01621490|567543229|FG007|Overall Study|Other reasons|1|||
157217485|NCT01621490|567543230|FG008|Overall Study|Other reasons|1|||
157217486|NCT01621490|567543231|FG009|Overall Study|Other reasons|0|||
157217487|NCT01621490|567543232|FG010|Overall Study|Other reasons|0|||
157217488|NCT00461500|567543233|FG000|Overall Study|Adverse Event|1|||
157217489|NCT00461500|567543234|FG001|Overall Study|Adverse Event|0|||
157217490|NCT00461500|567543233|FG000|Overall Study|Lack of Efficacy|0|||
157217491|NCT00461500|567543234|FG001|Overall Study|Lack of Efficacy|1|||
157217492|NCT00461500|567543233|FG000|Overall Study|Expired Drug Treatment|1|||
157217493|NCT00461500|567543234|FG001|Overall Study|Expired Drug Treatment|1|||
157217494|NCT00461500|567543233|FG000|Overall Study|Study Stopped|1|||
157217495|NCT00461500|567543234|FG001|Overall Study|Study Stopped|2|||
157217496|NCT00461500|567543233|FG000|Overall Study|Drug Treatment Misuse|1|||
157217497|NCT00461500|567543234|FG001|Overall Study|Drug Treatment Misuse|0|||
157217498|NCT00461500|567543233|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
157217499|NCT00461500|567543234|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
157217500|NCT00461500|567543233|FG000|Overall Study|Lost to Follow-up|2|||
157217501|NCT00461500|567543234|FG001|Overall Study|Lost to Follow-up|2|||
157217502|NCT01513551|567543235|FG000|Overall Study|Death|0|||
157217503|NCT01513551|567543236|FG001|Overall Study|Death|1|||
157217504|NCT01513551|567543237|FG002|Overall Study|Death|0|||
157217505|NCT01513551|567543235|FG000|Overall Study|Lost to Follow-up|3|||
157217506|NCT01513551|567543236|FG001|Overall Study|Lost to Follow-up|5|||
157217507|NCT01513551|567543237|FG002|Overall Study|Lost to Follow-up|2|||
157217508|NCT01513551|567543235|FG000|Overall Study|Withdrawal by Subject|1|||
157217509|NCT01513551|567543236|FG001|Overall Study|Withdrawal by Subject|0|||
157217510|NCT01513551|567543237|FG002|Overall Study|Withdrawal by Subject|2|||
156796613|NCT03312543|566008124|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
156796614|NCT03312543|566008123|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
156796615|NCT03312543|566008124|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
156796616|NCT03312543|566008123|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
156796617|NCT03312543|566008124|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
156796618|NCT03312543|566008123|FG000|Regression (Week 12 to Week 24)|Death|0|||
156796619|NCT03312543|566008124|FG001|Regression (Week 12 to Week 24)|Death|1|||
156796620|NCT04507269|566008125|FG000|Overall Study|Withdrawal by Subject|1|||
156796621|NCT04507269|566008126|FG001|Overall Study|Withdrawal by Subject|1|||
156796622|NCT04507269|566008127|FG002|Overall Study|Withdrawal by Subject|0|||
156796623|NCT04507269|566008128|FG003|Overall Study|Withdrawal by Subject|0|||
156796624|NCT04507269|566008129|FG004|Overall Study|Withdrawal by Subject|0|||
156796625|NCT04507269|566008130|FG005|Overall Study|Withdrawal by Subject|0|||
156796626|NCT04507269|566008125|FG000|Overall Study|Lost to Follow-up|0|||
156796627|NCT04507269|566008126|FG001|Overall Study|Lost to Follow-up|0|||
156796628|NCT04507269|566008127|FG002|Overall Study|Lost to Follow-up|0|||
156796629|NCT04507269|566008128|FG003|Overall Study|Lost to Follow-up|0|||
156796630|NCT04507269|566008129|FG004|Overall Study|Lost to Follow-up|1|||
156796631|NCT04507269|566008130|FG005|Overall Study|Lost to Follow-up|0|||
156796632|NCT05852340|566008131|FG000|Period 5|Not completing the meal|0|||
156796633|NCT05852340|566008132|FG001|Period 5|Not completing the meal|1|||
156796634|NCT05852340|566008133|FG002|Period 5|Not completing the meal|0|||
156796635|NCT05852340|566008134|FG003|Period 5|Not completing the meal|0|||
156796636|NCT05852340|566008131|FG000|Period 5|Adverse Event|0|||
156731544|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
156731545|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
156731546|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
156731547|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
157139782|NCT03874234|567257502|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
156731548|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
156731549|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
156731550|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
157139783|NCT03874234|567257503|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
156731551|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
156731552|NCT00394836|565765847|FG000|Teatment or Follow-up Phase|Non compliance|0|||
156731553|NCT00394836|565765848|FG001|Teatment or Follow-up Phase|Non compliance|1|||
156731554|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
156731555|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
156731556|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
156731557|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
156731558|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
156731559|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
156731560|NCT00394836|565765847|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
156731561|NCT00394836|565765848|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
156731562|NCT01560234|565765849|FG000|Overall Study|Lost to Follow-up|3|||
156731563|NCT01560234|565765850|FG001|Overall Study|Lost to Follow-up|0|||
156731564|NCT01560234|565765851|FG002|Overall Study|Lost to Follow-up|1|||
156731565|NCT01560234|565765852|FG003|Overall Study|Lost to Follow-up|0|||
156731566|NCT01560234|565765853|FG004|Overall Study|Lost to Follow-up|0|||
156731567|NCT01560234|565765854|FG005|Overall Study|Lost to Follow-up|2|||
156731568|NCT01560234|565765855|FG006|Overall Study|Lost to Follow-up|0|||
156731569|NCT01560234|565765856|FG007|Overall Study|Lost to Follow-up|2|||
156731570|NCT02028767|565765857|FG000|Treatment Period 2|Non compliant with protocol|1|||
156731571|NCT02028767|565765858|FG001|Treatment Period 2|Non compliant with protocol|0|||
156731572|NCT02028767|565765857|FG000|Treatment Period 2|Reason other than those specified above|1|||
156731573|NCT02028767|565765858|FG001|Treatment Period 2|Reason other than those specified above|0|||
156731574|NCT01284348|565765859|FG000|Overall Study|Death|1|||
156731575|NCT01284348|565765860|FG001|Overall Study|Death|1|||
156731576|NCT01284348|565765859|FG000|Overall Study|Withdrew consent|0|||
156731577|NCT01284348|565765860|FG001|Overall Study|Withdrew consent|1|||
156731578|NCT01284348|565765859|FG000|Overall Study|Status not recorded|9|||
156731579|NCT01284348|565765860|FG001|Overall Study|Status not recorded|10|||
156731580|NCT04075682|565765865|FG000|Overall Study|Lost to Follow-up|5|||
156731581|NCT04075682|565765866|FG001|Overall Study|Lost to Follow-up|5|||
156731582|NCT04075682|565765867|FG002|Overall Study|Lost to Follow-up|2|||
156731583|NCT04075682|565765868|FG003|Overall Study|Lost to Follow-up|2|||
156731584|NCT04075682|565765865|FG000|Overall Study|Withdrawal by Subject|1|||
156731585|NCT04075682|565765866|FG001|Overall Study|Withdrawal by Subject|0|||
156731586|NCT04075682|565765867|FG002|Overall Study|Withdrawal by Subject|1|||
156731587|NCT04075682|565765868|FG003|Overall Study|Withdrawal by Subject|0|||
156731588|NCT04075682|565765865|FG000|Overall Study|Protocol Violation|0|||
156731589|NCT04075682|565765866|FG001|Overall Study|Protocol Violation|1|||
156731590|NCT04075682|565765867|FG002|Overall Study|Protocol Violation|1|||
156731591|NCT04075682|565765868|FG003|Overall Study|Protocol Violation|0|||
156731592|NCT04075682|565765865|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
156731593|NCT04075682|565765866|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
156731594|NCT04075682|565765867|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
156731595|NCT04075682|565765868|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
156731596|NCT04075682|565765865|FG000|Overall Study|Lost study phone the first day of study participation|0|||
156731597|NCT04075682|565765866|FG001|Overall Study|Lost study phone the first day of study participation|1|||
156731598|NCT04075682|565765867|FG002|Overall Study|Lost study phone the first day of study participation|0|||
156731599|NCT04075682|565765868|FG003|Overall Study|Lost study phone the first day of study participation|0|||
156731600|NCT04292912|565765869|FG000|Overall Study|Physician Decision|1|||
156731601|NCT04292912|565765869|FG000|Overall Study|Protocol Violation|6|||
156731602|NCT00955955|565765870|FG000|Overall Study|Lost to Follow-up|2|||
156731603|NCT00955955|565765871|FG001|Overall Study|Lost to Follow-up|0|||
156731604|NCT00955955|565765872|FG002|Overall Study|Lost to Follow-up|0|||
156731605|NCT03423173|565765873|FG000|Overall Study|Randomized but not vaccinated|1|||
156731606|NCT03423173|565765874|FG001|Overall Study|Randomized but not vaccinated|0|||
156731607|NCT03423173|565765875|FG002|Overall Study|Randomized but not vaccinated|2|||
156796637|NCT05852340|566008132|FG001|Period 5|Adverse Event|0|||
156796638|NCT05852340|566008133|FG002|Period 5|Adverse Event|0|||
156796639|NCT05852340|566008134|FG003|Period 5|Adverse Event|1|||
156731608|NCT03423173|565765876|FG003|Overall Study|Randomized but not vaccinated|1|||
156796640|NCT04976777|566009619|FG000|Overall Study|COVID-19 Infection|1|||
156731609|NCT03423173|565765873|FG000|Overall Study|Adverse Event|1|||
156731610|NCT03423173|565765874|FG001|Overall Study|Adverse Event|1|||
156731611|NCT03423173|565765875|FG002|Overall Study|Adverse Event|1|||
156731612|NCT03423173|565765876|FG003|Overall Study|Adverse Event|1|||
156731613|NCT03423173|565765873|FG000|Overall Study|Lost to Follow-up|10|||
156731614|NCT03423173|565765874|FG001|Overall Study|Lost to Follow-up|19|||
156731615|NCT03423173|565765875|FG002|Overall Study|Lost to Follow-up|17|||
156731616|NCT03423173|565765876|FG003|Overall Study|Lost to Follow-up|22|||
156731617|NCT03423173|565765873|FG000|Overall Study|Withdrawal of consent|4|||
156731618|NCT03423173|565765874|FG001|Overall Study|Withdrawal of consent|10|||
156731619|NCT03423173|565765875|FG002|Overall Study|Withdrawal of consent|4|||
156731620|NCT03423173|565765876|FG003|Overall Study|Withdrawal of consent|5|||
156731621|NCT03423173|565765873|FG000|Overall Study|Death|1|||
156731622|NCT03423173|565765874|FG001|Overall Study|Death|0|||
156731623|NCT03423173|565765875|FG002|Overall Study|Death|0|||
156731624|NCT03423173|565765876|FG003|Overall Study|Death|0|||
156731625|NCT03423173|565765873|FG000|Overall Study|Reason not Specified|2|||
156731626|NCT03423173|565765874|FG001|Overall Study|Reason not Specified|5|||
156731627|NCT03423173|565765875|FG002|Overall Study|Reason not Specified|3|||
156731628|NCT03423173|565765876|FG003|Overall Study|Reason not Specified|1|||
156731629|NCT03348930|565765877|FG000|Washout (1 Week)|Lost to Follow-up|1|||
156731630|NCT03348930|565765878|FG001|Washout (1 Week)|Lost to Follow-up|1|||
156731631|NCT01053663|565765879|FG000|Overall Study|Death|2|||
156731632|NCT01053663|565765879|FG000|Overall Study|Lost to Follow-up|1|||
156731633|NCT01053663|565765879|FG000|Overall Study|Poor IV Access|1|||
156731634|NCT01053663|565765879|FG000|Overall Study|Transferred to Another Hospital|1|||
156731635|NCT01053663|565765879|FG000|Overall Study|Negative Influenza Diagnosis|1|||
156731636|NCT03533114|565765880|FG000|Overall|Adverse Event|16|||
156731637|NCT03533114|565765881|FG001|Overall|Adverse Event|11|||
156731638|NCT03533114|565765880|FG000|Overall|Consent Withdrawal by Participant|7|||
156731639|NCT03533114|565765881|FG001|Overall|Consent Withdrawal by Participant|6|||
156731640|NCT03533114|565765880|FG000|Overall|Lack of Efficacy|5|||
156731641|NCT03533114|565765881|FG001|Overall|Lack of Efficacy|3|||
156731642|NCT03533114|565765880|FG000|Overall|Lost to Follow-up|1|||
156731643|NCT03533114|565765881|FG001|Overall|Lost to Follow-up|1|||
156731644|NCT03533114|565765880|FG000|Overall|Physician Decision|0|||
156731645|NCT03533114|565765881|FG001|Overall|Physician Decision|2|||
156731646|NCT03533114|565765880|FG000|Overall|Protocol deviation|1|||
156731647|NCT03533114|565765881|FG001|Overall|Protocol deviation|1|||
156731648|NCT03533114|565765880|FG000|Overall|Failure to meet randomization criteria|1|||
156731649|NCT03533114|565765881|FG001|Overall|Failure to meet randomization criteria|2|||
156731650|NCT03533114|565765880|FG000|Overall|Non-Compliance with study drug|0|||
156731651|NCT03533114|565765881|FG001|Overall|Non-Compliance with study drug|1|||
156731652|NCT03533114|565765880|FG000|Overall|Other|0|||
156731653|NCT03533114|565765881|FG001|Overall|Other|1|||
156731654|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Adverse Event|11|||
156731655|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Adverse Event|8|||
156731656|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
156731657|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
156731658|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
156731659|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
156731660|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
156731661|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
156731662|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
156731663|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
156731664|NCT03533114|565765880|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
156731665|NCT03533114|565765881|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
156731666|NCT03533114|565765880|FG000|Stable Dose|Adverse Event|0|||
156731667|NCT03533114|565765881|FG001|Stable Dose|Adverse Event|2|||
156731668|NCT03533114|565765880|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
156731669|NCT03533114|565765881|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
156731670|NCT03533114|565765880|FG000|Stable Dose|Lack of Efficacy|1|||
156731671|NCT03533114|565765881|FG001|Stable Dose|Lack of Efficacy|0|||
156731672|NCT03533114|565765880|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
156731673|NCT03533114|565765881|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
156731674|NCT03533114|565765880|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
156731675|NCT03533114|565765881|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
156731676|NCT03533114|565765880|FG000|Open-Label Safety Extension|Adverse Event|3|||
156731677|NCT03533114|565765881|FG001|Open-Label Safety Extension|Adverse Event|0|||
156731678|NCT03533114|565765880|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
156731679|NCT03533114|565765881|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
156731680|NCT03533114|565765880|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
156731681|NCT03533114|565765881|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
156796641|NCT04976777|566009620|FG001|Overall Study|COVID-19 Infection|0|||
157139784|NCT03874234|567257504|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139785|NCT03874234|567257505|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139786|NCT03874234|567257506|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139787|NCT03874234|567257507|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139788|NCT03874234|567257508|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139789|NCT03874234|567257509|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139790|NCT03874234|567257510|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139791|NCT03874234|567257511|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
157139792|NCT03874234|567257499|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
157139793|NCT03874234|567257500|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139794|NCT03874234|567257501|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139795|NCT03874234|567257502|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139796|NCT03874234|567257503|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139797|NCT03874234|567257504|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
156731682|NCT03533114|565765880|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
157139798|NCT03874234|567257505|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139799|NCT03874234|567257506|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139800|NCT03874234|567257507|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139801|NCT03874234|567257508|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139802|NCT03874234|567257509|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139803|NCT03874234|567257510|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139804|NCT03874234|567257511|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
157139805|NCT03874234|567257499|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139806|NCT03874234|567257500|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139807|NCT03874234|567257501|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139808|NCT03874234|567257502|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
157139809|NCT03874234|567257503|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139810|NCT03874234|567257504|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139811|NCT03874234|567257505|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139812|NCT03874234|567257506|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
156731683|NCT03533114|565765881|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
156731684|NCT03533114|565765880|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
156731685|NCT03533114|565765881|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
156731686|NCT03575793|565765882|FG000|Overall Study|Withdrawal by Subject|0|||
157019925|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
157019926|NCT01261312|566826524|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
157019927|NCT01261312|566826525|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019928|NCT01261312|566826526|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
157019929|NCT01261312|566826527|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019930|NCT01261312|566826528|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019931|NCT01261312|566826529|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019932|NCT01261312|566826530|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019933|NCT01261312|566826531|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019934|NCT01261312|566826532|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019935|NCT01261312|566826533|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019936|NCT01261312|566826534|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019937|NCT01261312|566826535|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157019938|NCT01261312|566826536|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
157139813|NCT03874234|567257507|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139814|NCT03874234|567257508|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139815|NCT03874234|567257509|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139816|NCT03874234|567257510|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139817|NCT03874234|567257511|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
157139818|NCT03874234|567257499|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139819|NCT03874234|567257500|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139820|NCT03874234|567257501|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157217511|NCT01513551|567543235|FG000|Overall Study|Randomized but not vaccinated|0|||
156731687|NCT03575793|565765883|FG001|Overall Study|Withdrawal by Subject|1|||
156731688|NCT03575793|565765882|FG000|Overall Study|Never Treated|0|||
157019939|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019940|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019941|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157139821|NCT03874234|567257502|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139822|NCT03874234|567257503|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
156731689|NCT03575793|565765883|FG001|Overall Study|Never Treated|2|||
156731690|NCT01062113|565765884|FG000|Overall Study|Adverse Event|1|||
156731691|NCT01062113|565765885|FG001|Overall Study|Adverse Event|0|||
156731692|NCT01062113|565765886|FG002|Overall Study|Adverse Event|0|||
156731693|NCT01062113|565765884|FG000|Overall Study|Lack of Efficacy|38|||
156731694|NCT01062113|565765885|FG001|Overall Study|Lack of Efficacy|22|||
156731695|NCT01062113|565765886|FG002|Overall Study|Lack of Efficacy|31|||
156731696|NCT01062113|565765884|FG000|Overall Study|Withdrawal by Subject|1|||
156731697|NCT01062113|565765885|FG001|Overall Study|Withdrawal by Subject|0|||
156731698|NCT01062113|565765886|FG002|Overall Study|Withdrawal by Subject|0|||
156731699|NCT00634803|565765890|FG000|Overall Study|Lost to Follow-up|6|||
156731700|NCT00634803|565765891|FG001|Overall Study|Lost to Follow-up|7|||
156731701|NCT00634803|565765892|FG002|Overall Study|Lost to Follow-up|7|||
156731702|NCT00364923|565765893|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
156731703|NCT00364923|565765893|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
156731704|NCT00766636|565765903|FG000|Overall Study|Withdrawal by Subject|1|||
156731705|NCT00766636|565765904|FG001|Overall Study|Withdrawal by Subject|1|||
156731706|NCT00766636|565765903|FG000|Overall Study|Incomplete Treatment|0|||
156731707|NCT00766636|565765904|FG001|Overall Study|Incomplete Treatment|1|||
156731708|NCT00766636|565765903|FG000|Overall Study|Adverse Event|1|||
156731709|NCT00766636|565765904|FG001|Overall Study|Adverse Event|0|||
156731710|NCT00766636|565765903|FG000|Overall Study|Disease Progression|1|||
156731711|NCT00766636|565765904|FG001|Overall Study|Disease Progression|0|||
156731712|NCT01355575|565765909|FG000|Overall Study|Withdrawal by Subject|2|||
156731713|NCT04087720|565765910|FG000|Overall Study|Withdrawal by Subject|2|||
156731714|NCT04087720|565765910|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
156731715|NCT00765336|565765915|FG000|Overall Study|Protocol Violation|4|||
156731716|NCT00765336|565765916|FG001|Overall Study|Protocol Violation|2|||
156731717|NCT00765336|565765915|FG000|Overall Study|Withdrawal by Subject|6|||
156731718|NCT00765336|565765916|FG001|Overall Study|Withdrawal by Subject|4|||
156731719|NCT00765336|565765915|FG000|Overall Study|Lost to Follow-up|7|||
156731720|NCT00765336|565765916|FG001|Overall Study|Lost to Follow-up|9|||
156731721|NCT00765336|565765915|FG000|Overall Study|Adverse Event|2|||
156731722|NCT00765336|565765916|FG001|Overall Study|Adverse Event|1|||
156731723|NCT00478777|565765917|FG000|Overall Study|Adverse Event|29|||
156731724|NCT00478777|565765917|FG000|Overall Study|Lack of Efficacy|23|||
156731725|NCT00478777|565765917|FG000|Overall Study|Withdrawal by Subject|4|||
156731726|NCT00478777|565765917|FG000|Overall Study|Death|3|||
156731727|NCT00478777|565765917|FG000|Overall Study|Protocol Violation|3|||
156731728|NCT00478777|565765917|FG000|Overall Study|Lost to Follow-up|3|||
156731729|NCT00478777|565765917|FG000|Overall Study|Physician Decision|1|||
156731730|NCT00478777|565765917|FG000|Overall Study|Intolerance of therapy|1|||
156731731|NCT00478777|565765917|FG000|Overall Study|Lack of compliance|1|||
156731732|NCT00478777|565765917|FG000|Overall Study|Lymphocytes infusion|1|||
156731733|NCT00478777|565765917|FG000|Overall Study|End of therapy|2|||
156731734|NCT00478777|565765917|FG000|Overall Study|Not treated with lenalidomide|6|||
156731735|NCT01377922|565765918|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
156731736|NCT01377922|565765919|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
156731737|NCT02553499|565765927|FG000|Overall Study|Adverse Event|0|||
156731738|NCT02553499|565765928|FG001|Overall Study|Adverse Event|0|||
156731739|NCT02553499|565765929|FG002|Overall Study|Adverse Event|0|||
156731740|NCT02553499|565765930|FG003|Overall Study|Adverse Event|0|||
156731741|NCT02553499|565765931|FG004|Overall Study|Adverse Event|0|||
156731742|NCT02553499|565765932|FG005|Overall Study|Adverse Event|0|||
156731743|NCT02553499|565765933|FG006|Overall Study|Adverse Event|1|||
156731744|NCT02553499|565765934|FG007|Overall Study|Adverse Event|1|||
156731745|NCT02553499|565765935|FG008|Overall Study|Adverse Event|0|||
156731746|NCT02553499|565765936|FG009|Overall Study|Adverse Event|0|||
156731747|NCT02553499|565765937|FG010|Overall Study|Adverse Event|0|||
156731748|NCT02553499|565765938|FG011|Overall Study|Adverse Event|0|||
156731749|NCT02553499|565765939|FG012|Overall Study|Adverse Event|0|||
157217512|NCT01513551|567543236|FG001|Overall Study|Randomized but not vaccinated|0|||
157217513|NCT01513551|567543237|FG002|Overall Study|Randomized but not vaccinated|1|||
157217514|NCT02482805|567543241|FG000|Overall Study|Lost to Follow-up|4|||
157217515|NCT02482805|567543242|FG001|Overall Study|Lost to Follow-up|4|||
157217516|NCT02482805|567543243|FG002|Overall Study|Lost to Follow-up|0|||
157217517|NCT01806597|567543244|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
156731750|NCT02553499|565765940|FG013|Overall Study|Adverse Event|1|||
156731751|NCT02553499|565765927|FG000|Overall Study|Death|0|||
156731752|NCT02553499|565765928|FG001|Overall Study|Death|1|||
156731753|NCT02553499|565765929|FG002|Overall Study|Death|1|||
156731754|NCT02553499|565765930|FG003|Overall Study|Death|0|||
156731755|NCT02553499|565765931|FG004|Overall Study|Death|1|||
156731756|NCT02553499|565765932|FG005|Overall Study|Death|2|||
156731757|NCT02553499|565765933|FG006|Overall Study|Death|0|||
156731758|NCT02553499|565765934|FG007|Overall Study|Death|0|||
156731759|NCT02553499|565765935|FG008|Overall Study|Death|0|||
156731760|NCT02553499|565765936|FG009|Overall Study|Death|0|||
156731761|NCT02553499|565765937|FG010|Overall Study|Death|1|||
156731762|NCT02553499|565765938|FG011|Overall Study|Death|0|||
157217518|NCT01806597|567543245|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
157139823|NCT03874234|567257504|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139824|NCT03874234|567257505|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139825|NCT03874234|567257506|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
156731763|NCT02553499|565765939|FG012|Overall Study|Death|0|||
156731764|NCT02553499|565765940|FG013|Overall Study|Death|0|||
156731765|NCT02553499|565765927|FG000|Overall Study|Lost to Follow-up|0|||
156731766|NCT02553499|565765928|FG001|Overall Study|Lost to Follow-up|0|||
156731767|NCT02553499|565765929|FG002|Overall Study|Lost to Follow-up|0|||
156731768|NCT02553499|565765930|FG003|Overall Study|Lost to Follow-up|0|||
156731769|NCT02553499|565765931|FG004|Overall Study|Lost to Follow-up|0|||
156731770|NCT02553499|565765932|FG005|Overall Study|Lost to Follow-up|0|||
156731771|NCT02553499|565765933|FG006|Overall Study|Lost to Follow-up|1|||
156731772|NCT02553499|565765934|FG007|Overall Study|Lost to Follow-up|0|||
156731773|NCT02553499|565765935|FG008|Overall Study|Lost to Follow-up|0|||
156731774|NCT02553499|565765936|FG009|Overall Study|Lost to Follow-up|0|||
156731775|NCT02553499|565765937|FG010|Overall Study|Lost to Follow-up|0|||
156731776|NCT02553499|565765938|FG011|Overall Study|Lost to Follow-up|0|||
156731777|NCT02553499|565765939|FG012|Overall Study|Lost to Follow-up|0|||
156731778|NCT02553499|565765940|FG013|Overall Study|Lost to Follow-up|0|||
156731779|NCT02553499|565765927|FG000|Overall Study|Physician Decision|0|||
156731780|NCT02553499|565765928|FG001|Overall Study|Physician Decision|1|||
156731781|NCT02553499|565765929|FG002|Overall Study|Physician Decision|1|||
156731782|NCT02553499|565765930|FG003|Overall Study|Physician Decision|0|||
156731783|NCT02553499|565765931|FG004|Overall Study|Physician Decision|1|||
156731784|NCT02553499|565765932|FG005|Overall Study|Physician Decision|0|||
156731785|NCT02553499|565765933|FG006|Overall Study|Physician Decision|0|||
156731786|NCT02553499|565765934|FG007|Overall Study|Physician Decision|1|||
156731787|NCT02553499|565765935|FG008|Overall Study|Physician Decision|1|||
156731788|NCT02553499|565765936|FG009|Overall Study|Physician Decision|2|||
156731789|NCT02553499|565765937|FG010|Overall Study|Physician Decision|1|||
156731790|NCT02553499|565765938|FG011|Overall Study|Physician Decision|3|||
156731791|NCT02553499|565765939|FG012|Overall Study|Physician Decision|1|||
156731792|NCT02553499|565765940|FG013|Overall Study|Physician Decision|0|||
156731793|NCT02553499|565765927|FG000|Overall Study|Progressive Disease|0|||
156731794|NCT02553499|565765928|FG001|Overall Study|Progressive Disease|0|||
156731795|NCT02553499|565765929|FG002|Overall Study|Progressive Disease|0|||
156731796|NCT02553499|565765930|FG003|Overall Study|Progressive Disease|2|||
156731797|NCT02553499|565765931|FG004|Overall Study|Progressive Disease|1|||
156731798|NCT02553499|565765932|FG005|Overall Study|Progressive Disease|1|||
156731799|NCT02553499|565765933|FG006|Overall Study|Progressive Disease|1|||
156731800|NCT02553499|565765934|FG007|Overall Study|Progressive Disease|0|||
156731801|NCT02553499|565765935|FG008|Overall Study|Progressive Disease|0|||
156731802|NCT02553499|565765936|FG009|Overall Study|Progressive Disease|1|||
156731803|NCT02553499|565765937|FG010|Overall Study|Progressive Disease|0|||
156731804|NCT02553499|565765938|FG011|Overall Study|Progressive Disease|0|||
156731805|NCT02553499|565765939|FG012|Overall Study|Progressive Disease|2|||
156731806|NCT02553499|565765940|FG013|Overall Study|Progressive Disease|1|||
156731807|NCT02553499|565765927|FG000|Overall Study|Study Terminated by Sponsor|0|||
156731808|NCT02553499|565765928|FG001|Overall Study|Study Terminated by Sponsor|0|||
156731809|NCT02553499|565765929|FG002|Overall Study|Study Terminated by Sponsor|0|||
156731810|NCT02553499|565765930|FG003|Overall Study|Study Terminated by Sponsor|0|||
156731811|NCT02553499|565765931|FG004|Overall Study|Study Terminated by Sponsor|0|||
156731812|NCT02553499|565765932|FG005|Overall Study|Study Terminated by Sponsor|0|||
156731813|NCT02553499|565765933|FG006|Overall Study|Study Terminated by Sponsor|0|||
157139826|NCT03874234|567257507|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139827|NCT03874234|567257508|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139828|NCT03874234|567257509|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139829|NCT03874234|567257510|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139830|NCT03874234|567257511|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
157139831|NCT03874234|567257499|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139832|NCT03874234|567257500|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139833|NCT03874234|567257501|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139834|NCT03874234|567257502|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156731814|NCT02553499|565765934|FG007|Overall Study|Study Terminated by Sponsor|0|||
156731815|NCT02553499|565765935|FG008|Overall Study|Study Terminated by Sponsor|1|||
157139835|NCT03874234|567257503|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156731816|NCT02553499|565765936|FG009|Overall Study|Study Terminated by Sponsor|0|||
156731817|NCT02553499|565765937|FG010|Overall Study|Study Terminated by Sponsor|0|||
156731818|NCT02553499|565765938|FG011|Overall Study|Study Terminated by Sponsor|0|||
156731819|NCT02553499|565765939|FG012|Overall Study|Study Terminated by Sponsor|0|||
156731820|NCT02553499|565765940|FG013|Overall Study|Study Terminated by Sponsor|0|||
156731821|NCT02553499|565765927|FG000|Overall Study|Withdrawal by Subject|2|||
156731822|NCT02553499|565765928|FG001|Overall Study|Withdrawal by Subject|0|||
156731823|NCT02553499|565765929|FG002|Overall Study|Withdrawal by Subject|0|||
156731824|NCT02553499|565765930|FG003|Overall Study|Withdrawal by Subject|0|||
156731825|NCT02553499|565765931|FG004|Overall Study|Withdrawal by Subject|0|||
156731826|NCT02553499|565765932|FG005|Overall Study|Withdrawal by Subject|0|||
156731827|NCT02553499|565765933|FG006|Overall Study|Withdrawal by Subject|0|||
156731828|NCT02553499|565765934|FG007|Overall Study|Withdrawal by Subject|1|||
156731829|NCT02553499|565765935|FG008|Overall Study|Withdrawal by Subject|1|||
156731830|NCT02553499|565765936|FG009|Overall Study|Withdrawal by Subject|0|||
156731831|NCT02553499|565765937|FG010|Overall Study|Withdrawal by Subject|1|||
156731832|NCT02553499|565765938|FG011|Overall Study|Withdrawal by Subject|0|||
156731833|NCT02553499|565765939|FG012|Overall Study|Withdrawal by Subject|0|||
156731834|NCT02553499|565765940|FG013|Overall Study|Withdrawal by Subject|0|||
156731835|NCT01582178|565765941|FG000|Overall Study|Physician Decision|6|||
156731836|NCT01582178|565765942|FG001|Overall Study|Physician Decision|5|||
156731837|NCT01726270|565765945|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
156731838|NCT01726270|565765945|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
156731839|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
156731840|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
156731841|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
156731842|NCT01726270|565765945|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
156731843|NCT01323387|565765946|FG000|Overall Study|Withdrawal by Subject|41|||
156731844|NCT01323387|565765946|FG000|Overall Study|Radiographic Data Unavailable|1|||
156731845|NCT01323387|565765946|FG000|Overall Study|Revision|14|||
156731846|NCT01323387|565765946|FG000|Overall Study|Protocol Violation|12|||
156731847|NCT01323387|565765946|FG000|Overall Study|Randomized but Never Treated|16|||
156731848|NCT01464164|565765948|FG000|Overall Study|Screen failure|0|||
156731849|NCT01464164|565765949|FG001|Overall Study|Screen failure|1|||
156731850|NCT01464164|565765950|FG002|Overall Study|Screen failure|2|||
156731851|NCT01464164|565765951|FG003|Overall Study|Screen failure|0|||
156731852|NCT01464164|565765952|FG004|Overall Study|Screen failure|0|||
156731853|NCT01464164|565765953|FG005|Overall Study|Screen failure|0|||
156731854|NCT01464164|565765954|FG006|Overall Study|Screen failure|0|||
156731855|NCT01464164|565765948|FG000|Overall Study|Physician Decision|0|||
156731856|NCT01464164|565765949|FG001|Overall Study|Physician Decision|1|||
156731857|NCT01464164|565765950|FG002|Overall Study|Physician Decision|0|||
156731858|NCT01464164|565765951|FG003|Overall Study|Physician Decision|0|||
156731859|NCT01464164|565765952|FG004|Overall Study|Physician Decision|0|||
157139836|NCT03874234|567257504|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
156731860|NCT01464164|565765953|FG005|Overall Study|Physician Decision|0|||
156731861|NCT01464164|565765954|FG006|Overall Study|Physician Decision|2|||
156731862|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Death|1|||
156731863|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Death|0|||
156731864|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
156731865|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
156731866|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
156731867|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
156731868|NCT01972438|565765955|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
156731869|NCT01972438|565765956|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
156731870|NCT01972438|565765955|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
156731871|NCT01972438|565765956|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
157139837|NCT03874234|567257505|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139838|NCT03874234|567257506|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
157139839|NCT03874234|567257507|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139840|NCT03874234|567257508|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139841|NCT03874234|567257509|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139842|NCT03874234|567257510|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139843|NCT03874234|567257511|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
157139844|NCT03874234|567257499|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139845|NCT03874234|567257500|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139846|NCT03874234|567257501|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157217519|NCT01806597|567543246|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
156731872|NCT01972438|565765955|FG000|Months 6-12 Study Period|Death|1|||
156731873|NCT01972438|565765956|FG001|Months 6-12 Study Period|Death|0|||
156731874|NCT01972438|565765955|FG000|Months 6-12 Study Period|Early Study Closure|2|||
156731875|NCT01972438|565765956|FG001|Months 6-12 Study Period|Early Study Closure|2|||
156731876|NCT01972438|565765955|FG000|Post Month 12 Study Period|Early Study Closure|3|||
157217520|NCT01806597|567543247|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
156731877|NCT01972438|565765956|FG001|Post Month 12 Study Period|Early Study Closure|4|||
156731878|NCT00570063|565765959|FG000|Overall Study|Adverse Event|4|||
156731879|NCT00570063|565765960|FG001|Overall Study|Adverse Event|1|||
156731880|NCT00570063|565765959|FG000|Overall Study|Lack of Efficacy|0|||
156731881|NCT00570063|565765960|FG001|Overall Study|Lack of Efficacy|1|||
156731882|NCT00570063|565765959|FG000|Overall Study|Withdrawal by Subject|4|||
156731883|NCT00570063|565765960|FG001|Overall Study|Withdrawal by Subject|3|||
156731884|NCT00570063|565765959|FG000|Overall Study|Sponsor's Decision|7|||
157217521|NCT01806597|567543248|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
157217522|NCT01806597|567543249|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
157217523|NCT01806597|567543244|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
157217524|NCT01806597|567543245|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
157217525|NCT01806597|567543246|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
157217526|NCT01806597|567543247|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
157217527|NCT01806597|567543248|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
157217528|NCT01806597|567543249|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
157217529|NCT01806597|567543244|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
157217530|NCT01806597|567543245|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
157217531|NCT01806597|567543246|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
157217532|NCT01806597|567543247|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
157217533|NCT01806597|567543248|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
157217534|NCT01806597|567543249|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
157217535|NCT01806597|567543244|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
157217536|NCT01806597|567543245|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
157217537|NCT01806597|567543246|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
157217538|NCT01806597|567543247|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
157217539|NCT01806597|567543248|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
157217540|NCT01806597|567543249|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
157217541|NCT01806597|567543244|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
157217542|NCT01806597|567543245|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
157217543|NCT01806597|567543246|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
157217544|NCT01806597|567543247|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
157217545|NCT01806597|567543248|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
156876542|NCT01868542|566307624|FG001|Overall Study|Unclassified|1|||
156876543|NCT00130247|566307625|FG000|Overall Study|Pregnancy|1|||
156876544|NCT00130247|566307626|FG001|Overall Study|Pregnancy|0|||
156876545|NCT00130247|566307625|FG000|Overall Study|Post-randomization exclusion|1|||
156876546|NCT00130247|566307626|FG001|Overall Study|Post-randomization exclusion|2|||
156876547|NCT00130247|566307625|FG000|Overall Study|Not compliant with DOT|0|||
156876548|NCT00130247|566307626|FG001|Overall Study|Not compliant with DOT|2|||
156876549|NCT00843284|566307629|FG000|Overall Study|Adverse Event|39|||
156876550|NCT00843284|566307629|FG000|Overall Study|Lack of Efficacy|5|||
156876551|NCT00843284|566307629|FG000|Overall Study|Lost to Follow-up|11|||
156876552|NCT00843284|566307629|FG000|Overall Study|Other|10|||
156876553|NCT00843284|566307629|FG000|Overall Study|Withdrawal by Subject|4|||
157139847|NCT03874234|567257502|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139848|NCT03874234|567257503|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
157139849|NCT03874234|567257504|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
157139850|NCT03874234|567257505|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139851|NCT03874234|567257506|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139852|NCT03874234|567257507|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
156876554|NCT00843284|566307629|FG000|Overall Study|Death|3|||
156876555|NCT02160899|566307632|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876556|NCT02160899|566307633|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156876557|NCT02160899|566307634|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876558|NCT02160899|566307635|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
156876559|NCT02160899|566307636|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
156876560|NCT02160899|566307637|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
156876561|NCT04129151|566307638|FG000|Overall Study|Adverse Event|1|||
156876562|NCT04129151|566307638|FG000|Overall Study|Disease Progression|7|||
156876563|NCT04129151|566307638|FG000|Overall Study|Study closure|1|||
156876564|NCT04473235|566307639|FG000|Overall Study|Lost to Follow-up|6|||
156876565|NCT04473235|566307640|FG001|Overall Study|Lost to Follow-up|5|||
156876566|NCT04473235|566307639|FG000|Overall Study|Declined continuation|2|||
156876567|NCT04473235|566307640|FG001|Overall Study|Declined continuation|0|||
157019942|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
157139853|NCT03874234|567257508|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139854|NCT03874234|567257509|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139855|NCT03874234|567257510|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157139856|NCT03874234|567257511|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
157217546|NCT01806597|567543249|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
157217547|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
157139857|NCT03874234|567257499|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157217548|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
156876568|NCT04473235|566307639|FG000|Overall Study|Physician Decision|1|||
156876569|NCT04473235|566307640|FG001|Overall Study|Physician Decision|1|||
156876570|NCT04473235|566307639|FG000|Overall Study|Protocol Violation|10|||
156876571|NCT04473235|566307640|FG001|Overall Study|Protocol Violation|6|||
156876572|NCT00798759|566307641|FG000|Overall Study|Adverse Event|3|||
156731885|NCT00570063|565765960|FG001|Overall Study|Sponsor's Decision|3|||
156731886|NCT00697463|565765961|FG000|Overall Study|Withdrawal by Subject|1|||
156731887|NCT03307252|565765962|FG000|Part 2, Period 1|Treatment not received|0|||
156731888|NCT03307252|565765963|FG001|Part 2, Period 1|Treatment not received|0|||
156731889|NCT03307252|565765964|FG002|Part 2, Period 1|Treatment not received|0|||
156731890|NCT03307252|565765965|FG003|Part 2, Period 1|Treatment not received|0|||
156731891|NCT03307252|565765966|FG004|Part 2, Period 1|Treatment not received|0|||
156731892|NCT03307252|565765967|FG005|Part 2, Period 1|Treatment not received|1|||
156731893|NCT03307252|565765968|FG006|Part 2, Period 1|Treatment not received|0|||
156731894|NCT03307252|565765969|FG007|Part 2, Period 1|Treatment not received|0|||
156731895|NCT03307252|565765970|FG008|Part 2, Period 1|Treatment not received|0|||
156731896|NCT03307252|565765971|FG009|Part 2, Period 1|Treatment not received|0|||
156731897|NCT03307252|565765972|FG010|Part 2, Period 1|Treatment not received|0|||
156731898|NCT03307252|565765962|FG000|Part 2, Period 3|Other than listed|0|||
156731899|NCT03307252|565765963|FG001|Part 2, Period 3|Other than listed|0|||
156731900|NCT03307252|565765964|FG002|Part 2, Period 3|Other than listed|0|||
156731901|NCT03307252|565765965|FG003|Part 2, Period 3|Other than listed|0|||
156731902|NCT03307252|565765966|FG004|Part 2, Period 3|Other than listed|1|||
156731903|NCT03307252|565765967|FG005|Part 2, Period 3|Other than listed|0|||
156731904|NCT03307252|565765968|FG006|Part 2, Period 3|Other than listed|0|||
156731905|NCT03307252|565765969|FG007|Part 2, Period 3|Other than listed|0|||
156731906|NCT03307252|565765970|FG008|Part 2, Period 3|Other than listed|0|||
156731907|NCT03307252|565765971|FG009|Part 2, Period 3|Other than listed|0|||
156731908|NCT03307252|565765972|FG010|Part 2, Period 3|Other than listed|0|||
156731909|NCT03307252|565765962|FG000|Part 2, Period 4|Other than listed|0|||
156731910|NCT03307252|565765963|FG001|Part 2, Period 4|Other than listed|0|||
156731911|NCT03307252|565765964|FG002|Part 2, Period 4|Other than listed|0|||
156731912|NCT03307252|565765965|FG003|Part 2, Period 4|Other than listed|0|||
156731913|NCT03307252|565765966|FG004|Part 2, Period 4|Other than listed|0|||
156731914|NCT03307252|565765967|FG005|Part 2, Period 4|Other than listed|0|||
156731915|NCT03307252|565765968|FG006|Part 2, Period 4|Other than listed|1|||
156731916|NCT03307252|565765969|FG007|Part 2, Period 4|Other than listed|0|||
156731917|NCT03307252|565765970|FG008|Part 2, Period 4|Other than listed|0|||
156731918|NCT03307252|565765971|FG009|Part 2, Period 4|Other than listed|0|||
156731919|NCT03307252|565765972|FG010|Part 2, Period 4|Other than listed|0|||
156731920|NCT03307252|565765962|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731921|NCT03307252|565765963|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731922|NCT03307252|565765964|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731923|NCT03307252|565765965|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731924|NCT03307252|565765966|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731925|NCT03307252|565765967|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731926|NCT03307252|565765968|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731927|NCT03307252|565765969|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731928|NCT03307252|565765970|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731929|NCT03307252|565765971|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
156731930|NCT03307252|565765972|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
156731931|NCT01554527|565765973|FG000|Overall Study|Withdrawal by Subject|1|||
156731932|NCT01554527|565765974|FG001|Overall Study|Withdrawal by Subject|0|||
156731933|NCT01554527|565765975|FG002|Overall Study|Withdrawal by Subject|3|||
156731934|NCT01554527|565765973|FG000|Overall Study|Lost to Follow-up|0|||
156731935|NCT01554527|565765974|FG001|Overall Study|Lost to Follow-up|0|||
156731936|NCT01554527|565765975|FG002|Overall Study|Lost to Follow-up|4|||
156731937|NCT01554527|565765973|FG000|Overall Study|Physician Decision|0|||
156731938|NCT01554527|565765974|FG001|Overall Study|Physician Decision|0|||
156731939|NCT01554527|565765975|FG002|Overall Study|Physician Decision|1|||
156731940|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
157217549|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
156731941|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
156731942|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
156731943|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
156731944|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731945|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
156731946|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731947|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
156731948|NCT03817229|565765978|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
157217550|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
156731949|NCT03817229|565765979|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
156731950|NCT03817229|565765980|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
156731951|NCT03817229|565765981|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
156731952|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
156731953|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
156731954|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
156731955|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
156731956|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731957|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731958|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
156731959|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
156731960|NCT03817229|565765978|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
156731961|NCT03817229|565765979|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
156731962|NCT03817229|565765980|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
156731963|NCT03817229|565765981|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
156731964|NCT03817229|565765978|FG000|Post-Intervention|Withdrawal by Subject|6|||
157019943|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
157019944|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
157019945|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019946|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019947|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019948|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019949|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019950|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019951|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
157019952|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019953|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019954|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019955|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019956|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
157019957|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
157019958|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019959|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019960|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019961|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019962|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019963|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019964|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
157019965|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019966|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019967|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019968|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157139858|NCT03874234|567257500|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139859|NCT03874234|567257501|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139860|NCT03874234|567257502|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139861|NCT03874234|567257503|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156731965|NCT03817229|565765979|FG001|Post-Intervention|Withdrawal by Subject|0|||
156731966|NCT03817229|565765980|FG002|Post-Intervention|Withdrawal by Subject|2|||
156731967|NCT03817229|565765981|FG003|Post-Intervention|Withdrawal by Subject|2|||
156731968|NCT03817229|565765978|FG000|Post-Intervention|Withdrawal by Study Team|3|||
156731969|NCT03817229|565765979|FG001|Post-Intervention|Withdrawal by Study Team|1|||
156731970|NCT03817229|565765980|FG002|Post-Intervention|Withdrawal by Study Team|1|||
156731971|NCT03817229|565765981|FG003|Post-Intervention|Withdrawal by Study Team|4|||
156731972|NCT03817229|565765978|FG000|Post-Intervention|Weaned from medication|3|||
156731973|NCT03817229|565765979|FG001|Post-Intervention|Weaned from medication|0|||
156731974|NCT03817229|565765980|FG002|Post-Intervention|Weaned from medication|2|||
156731975|NCT03817229|565765981|FG003|Post-Intervention|Weaned from medication|1|||
156731976|NCT03817229|565765978|FG000|Post-Intervention|Transferred care to another institution|1|||
157019969|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
157019970|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
157019971|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019972|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019973|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019974|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019975|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019976|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019977|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
157019978|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019979|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019980|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019981|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
157139862|NCT03874234|567257504|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139863|NCT03874234|567257505|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
156731977|NCT03817229|565765979|FG001|Post-Intervention|Transferred care to another institution|0|||
156731978|NCT03817229|565765980|FG002|Post-Intervention|Transferred care to another institution|0|||
156731979|NCT03817229|565765981|FG003|Post-Intervention|Transferred care to another institution|0|||
156731980|NCT03817229|565765978|FG000|Post-Intervention|Change in parental guardianship|0|||
156731981|NCT03817229|565765979|FG001|Post-Intervention|Change in parental guardianship|0|||
156731982|NCT03817229|565765980|FG002|Post-Intervention|Change in parental guardianship|1|||
156731983|NCT03817229|565765981|FG003|Post-Intervention|Change in parental guardianship|0|||
156731984|NCT03817229|565765978|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
156731985|NCT03817229|565765979|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
156731986|NCT03817229|565765980|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
156731987|NCT03817229|565765981|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
156731988|NCT03817229|565765978|FG000|Follow-up 1|Withdrawal by Subject|1|||
156731989|NCT03817229|565765979|FG001|Follow-up 1|Withdrawal by Subject|2|||
156731990|NCT03817229|565765980|FG002|Follow-up 1|Withdrawal by Subject|0|||
156731991|NCT03817229|565765981|FG003|Follow-up 1|Withdrawal by Subject|0|||
156731992|NCT03817229|565765978|FG000|Follow-up 1|Withdrawal by Study Team|3|||
156731993|NCT03817229|565765979|FG001|Follow-up 1|Withdrawal by Study Team|1|||
156731994|NCT03817229|565765980|FG002|Follow-up 1|Withdrawal by Study Team|0|||
156731995|NCT03817229|565765981|FG003|Follow-up 1|Withdrawal by Study Team|0|||
156731996|NCT03817229|565765978|FG000|Follow-up 1|Wean from medication|3|||
156731997|NCT03817229|565765979|FG001|Follow-up 1|Wean from medication|4|||
156731998|NCT03817229|565765980|FG002|Follow-up 1|Wean from medication|0|||
156731999|NCT03817229|565765981|FG003|Follow-up 1|Wean from medication|1|||
156732000|NCT03817229|565765978|FG000|Follow-up 1|Transferred care to another hospital|1|||
156732001|NCT03817229|565765979|FG001|Follow-up 1|Transferred care to another hospital|0|||
156732002|NCT03817229|565765980|FG002|Follow-up 1|Transferred care to another hospital|0|||
156732003|NCT03817229|565765981|FG003|Follow-up 1|Transferred care to another hospital|0|||
156732004|NCT03817229|565765978|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
156732005|NCT03817229|565765979|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
156732006|NCT03817229|565765980|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
156732007|NCT03817229|565765981|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
156732008|NCT03817229|565765978|FG000|Follow-up 2|Withdrawal by Subject|2|||
156732009|NCT03817229|565765979|FG001|Follow-up 2|Withdrawal by Subject|0|||
156732010|NCT03817229|565765980|FG002|Follow-up 2|Withdrawal by Subject|1|||
156732011|NCT03817229|565765981|FG003|Follow-up 2|Withdrawal by Subject|1|||
156732012|NCT03817229|565765978|FG000|Follow-up 2|Withdrawal by Study Team|2|||
156732013|NCT03817229|565765979|FG001|Follow-up 2|Withdrawal by Study Team|0|||
156732014|NCT03817229|565765980|FG002|Follow-up 2|Withdrawal by Study Team|1|||
156732015|NCT03817229|565765981|FG003|Follow-up 2|Withdrawal by Study Team|0|||
156732016|NCT03817229|565765978|FG000|Follow-up 2|Wean from medication|1|||
156732017|NCT03817229|565765979|FG001|Follow-up 2|Wean from medication|0|||
156732018|NCT03817229|565765980|FG002|Follow-up 2|Wean from medication|0|||
156732019|NCT03817229|565765981|FG003|Follow-up 2|Wean from medication|0|||
156732020|NCT03817229|565765978|FG000|Follow-up 2|Transferred care|0|||
156732021|NCT03817229|565765979|FG001|Follow-up 2|Transferred care|0|||
156732022|NCT03817229|565765980|FG002|Follow-up 2|Transferred care|1|||
156732023|NCT03817229|565765981|FG003|Follow-up 2|Transferred care|0|||
156732024|NCT02887183|565765982|FG000|Overall Study|Adverse Event|44|||
156732025|NCT02887183|565765982|FG000|Overall Study|Death|30|||
156732026|NCT02887183|565765982|FG000|Overall Study|Pregnancy|1|||
156732027|NCT02887183|565765982|FG000|Overall Study|Protocol Violation|6|||
156732028|NCT02887183|565765982|FG000|Overall Study|Technical Problems|2|||
156732029|NCT02887183|565765982|FG000|Overall Study|Lost to Follow-up|13|||
156732030|NCT02887183|565765982|FG000|Overall Study|Physician Decision|10|||
156732031|NCT02887183|565765982|FG000|Overall Study|Withdrawal by Subject|35|||
157217551|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
156732032|NCT01031680|565765983|FG000|Overall Study|Adverse Event|8|||
156732033|NCT01031680|565765984|FG001|Overall Study|Adverse Event|3|||
156732034|NCT01031680|565765983|FG000|Overall Study|Lost to Follow-up|2|||
156732035|NCT01031680|565765984|FG001|Overall Study|Lost to Follow-up|10|||
156732036|NCT01031680|565765983|FG000|Overall Study|Withdrawal by Subject|12|||
156732037|NCT01031680|565765984|FG001|Overall Study|Withdrawal by Subject|16|||
156732038|NCT01031680|565765983|FG000|Overall Study|Death|2|||
156732039|NCT01031680|565765984|FG001|Overall Study|Death|1|||
156732040|NCT01031680|565765983|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
156732041|NCT01031680|565765984|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
156732042|NCT01031680|565765983|FG000|Overall Study|Poor/Non-compliance|5|||
156732043|NCT01031680|565765984|FG001|Overall Study|Poor/Non-compliance|6|||
156732044|NCT01031680|565765983|FG000|Overall Study|Safety|1|||
156732045|NCT01031680|565765984|FG001|Overall Study|Safety|0|||
156732046|NCT01031680|565765983|FG000|Overall Study|Incorrect Enrolment|1|||
156732047|NCT01031680|565765984|FG001|Overall Study|Incorrect Enrolment|2|||
156732048|NCT01031680|565765983|FG000|Overall Study|Administrative Reason by Sponsor|0|||
156732049|NCT01031680|565765984|FG001|Overall Study|Administrative Reason by Sponsor|1|||
156732050|NCT01031680|565765983|FG000|Overall Study|Various|0|||
156732051|NCT01031680|565765984|FG001|Overall Study|Various|2|||
156732052|NCT01186692|565765987|FG000|Overall Study|Not Catheterized|11|||
156732053|NCT01186692|565765987|FG000|Overall Study|Futher testing contraindicated implant|19|||
156732054|NCT01186692|565765987|FG000|Overall Study|Adverse Event|2|||
156732055|NCT03319732|565765988|FG000|Overall Study|Adverse Event|40|||
156732056|NCT03319732|565765988|FG000|Overall Study|Withdrawal by Subject|50|||
156732057|NCT03319732|565765988|FG000|Overall Study|MS relapse|10|||
156732058|NCT03319732|565765988|FG000|Overall Study|reason not specified|5|||
157139864|NCT03874234|567257506|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156732059|NCT01266291|565765990|FG000|Overall Study|Adverse Event|1|||
156732060|NCT02702388|565765991|FG000|Overall Study|Disease Progression|18|||
156732061|NCT02702388|565765992|FG001|Overall Study|Disease Progression|25|||
156732062|NCT02702388|565765991|FG000|Overall Study|Withdrawal by Subject|9|||
156732063|NCT02702388|565765992|FG001|Overall Study|Withdrawal by Subject|7|||
156732064|NCT02702388|565765991|FG000|Overall Study|Adverse Event|11|||
156732065|NCT02702388|565765992|FG001|Overall Study|Adverse Event|15|||
156732066|NCT02702388|565765991|FG000|Overall Study|Other|2|||
156732067|NCT02702388|565765992|FG001|Overall Study|Other|4|||
156732068|NCT04250350|565767525|FG000|Overall Study|Withdrawal by Subject|13|||
156732069|NCT04250350|565767525|FG000|Overall Study|Lost to Follow-up|8|||
156732070|NCT04250350|565767525|FG000|Overall Study|Adverse Event|5|||
156732071|NCT04250350|565767525|FG000|Overall Study|Lack of Efficacy|4|||
156732072|NCT04250350|565767525|FG000|Overall Study|Physician Decision|1|||
156732073|NCT04250350|565767525|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
156732074|NCT00679029|565767529|FG000|Overall Study|Adverse Event|3|||
156732075|NCT00679029|565767529|FG000|Overall Study|Withdrawal by Subject|1|||
156732076|NCT00679029|565767529|FG000|Overall Study|Lost to Follow-up|1|||
156732077|NCT00956592|565767533|FG000|Overall Study|Protocol Violation|1|||
156732078|NCT00956592|565767534|FG001|Overall Study|Protocol Violation|3|||
156732079|NCT00160706|565767535|FG000|Overall Study|Adverse Event|53|||
156732080|NCT00160706|565767535|FG000|Overall Study|Adverse Event and Other Reason|105|||
156732081|NCT00160706|565767535|FG000|Overall Study|Protocol Violation|3|||
156732082|NCT00160706|565767535|FG000|Overall Study|Withdrawal by Subject|41|||
156732083|NCT00160706|565767535|FG000|Overall Study|Withdrawal by Subject and Other|12|||
156732084|NCT00160706|565767535|FG000|Overall Study|Physician Decision|10|||
156732085|NCT00160706|565767535|FG000|Overall Study|Physician Decision and Other|3|||
156732086|NCT00160706|565767535|FG000|Overall Study|Lost to Follow-up|4|||
156732087|NCT00160706|565767535|FG000|Overall Study|Lost to Follow-up and Other|1|||
156732088|NCT00160706|565767535|FG000|Overall Study|Lack of Efficacy|42|||
156732089|NCT00160706|565767535|FG000|Overall Study|Lack of Efficacy and Other|1|||
156732090|NCT00160706|565767535|FG000|Overall Study|Other Reason|11|||
156732091|NCT02162719|565767536|FG000|Overall Study|Death|41|||
157139865|NCT03874234|567257507|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
156732092|NCT02162719|565767537|FG001|Overall Study|Death|46|||
156732093|NCT02162719|565767536|FG000|Overall Study|Lost to Follow-up|1|||
156732094|NCT02162719|565767537|FG001|Overall Study|Lost to Follow-up|3|||
156732095|NCT02162719|565767536|FG000|Overall Study|Disease Progression|2|||
156732096|NCT02162719|565767537|FG001|Overall Study|Disease Progression|1|||
156732097|NCT02162719|565767536|FG000|Overall Study|Withdrawal by Subject|8|||
156732098|NCT02162719|565767537|FG001|Overall Study|Withdrawal by Subject|2|||
156732099|NCT02162719|565767536|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
156732100|NCT02162719|565767537|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
156732101|NCT03214380|565767538|FG000|Lead-in|Adverse Event|3|||
156732102|NCT03214380|565767539|FG001|Lead-in|Adverse Event|0|||
156732103|NCT03214380|565767540|FG002|Lead-in|Adverse Event|0|||
156732104|NCT03214380|565767541|FG003|Lead-in|Adverse Event|1|||
156732105|NCT03214380|565767542|FG004|Lead-in|Adverse Event|0|||
156732106|NCT03214380|565767543|FG005|Lead-in|Adverse Event|0|||
156732107|NCT03214380|565767538|FG000|Lead-in|Lost to Follow-up|4|||
156732108|NCT03214380|565767539|FG001|Lead-in|Lost to Follow-up|0|||
156732109|NCT03214380|565767540|FG002|Lead-in|Lost to Follow-up|0|||
156732110|NCT03214380|565767541|FG003|Lead-in|Lost to Follow-up|1|||
156732111|NCT03214380|565767542|FG004|Lead-in|Lost to Follow-up|0|||
156732112|NCT03214380|565767543|FG005|Lead-in|Lost to Follow-up|0|||
156732113|NCT03214380|565767538|FG000|Lead-in|Eligibility Criteria|3|||
156732114|NCT03214380|565767539|FG001|Lead-in|Eligibility Criteria|0|||
156732115|NCT03214380|565767540|FG002|Lead-in|Eligibility Criteria|0|||
156732116|NCT03214380|565767541|FG003|Lead-in|Eligibility Criteria|0|||
156732117|NCT03214380|565767542|FG004|Lead-in|Eligibility Criteria|0|||
156732118|NCT03214380|565767543|FG005|Lead-in|Eligibility Criteria|0|||
156732119|NCT03214380|565767538|FG000|Lead-in|Physician Decision|6|||
156732120|NCT03214380|565767539|FG001|Lead-in|Physician Decision|0|||
156732121|NCT03214380|565767540|FG002|Lead-in|Physician Decision|0|||
156732122|NCT03214380|565767541|FG003|Lead-in|Physician Decision|0|||
156732123|NCT03214380|565767542|FG004|Lead-in|Physician Decision|0|||
156732124|NCT03214380|565767543|FG005|Lead-in|Physician Decision|0|||
156732125|NCT03214380|565767538|FG000|Lead-in|Protocol Deviation|7|||
156732126|NCT03214380|565767539|FG001|Lead-in|Protocol Deviation|0|||
156732127|NCT03214380|565767540|FG002|Lead-in|Protocol Deviation|0|||
156732128|NCT03214380|565767541|FG003|Lead-in|Protocol Deviation|3|||
156732129|NCT03214380|565767542|FG004|Lead-in|Protocol Deviation|0|||
156732130|NCT03214380|565767543|FG005|Lead-in|Protocol Deviation|0|||
156732131|NCT03214380|565767538|FG000|Lead-in|Withdrawal by Subject|41|||
157019982|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
157019983|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
157019984|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019985|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019986|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019987|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019988|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019989|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019990|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
157019991|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019992|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019993|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019994|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019995|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019996|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
157019997|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019998|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157019999|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157020000|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
156732132|NCT03214380|565767539|FG001|Lead-in|Withdrawal by Subject|0|||
156732133|NCT03214380|565767540|FG002|Lead-in|Withdrawal by Subject|0|||
157020001|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157020002|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157020003|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
157020004|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020005|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020006|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020007|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
157020008|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
157020009|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
157020010|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020011|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020012|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020013|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020014|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020015|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020016|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
157020017|NCT01261312|566826524|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020018|NCT01261312|566826525|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020019|NCT01261312|566826526|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157217552|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
157217553|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
156732134|NCT03214380|565767541|FG003|Lead-in|Withdrawal by Subject|14|||
156732135|NCT03214380|565767542|FG004|Lead-in|Withdrawal by Subject|0|||
156732136|NCT03214380|565767543|FG005|Lead-in|Withdrawal by Subject|0|||
156732137|NCT03214380|565767538|FG000|Lead-in|Family Emergency|1|||
156732138|NCT03214380|565767539|FG001|Lead-in|Family Emergency|0|||
157020020|NCT01261312|566826527|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
157020021|NCT01261312|566826528|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
157020022|NCT01261312|566826529|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
157020023|NCT01261312|566826530|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020024|NCT01261312|566826531|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020025|NCT01261312|566826532|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020026|NCT01261312|566826533|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020027|NCT01261312|566826534|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020028|NCT01261312|566826535|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020029|NCT01261312|566826536|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
157020030|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020031|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020032|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020033|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157217554|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
156732139|NCT03214380|565767540|FG002|Lead-in|Family Emergency|0|||
156732140|NCT03214380|565767541|FG003|Lead-in|Family Emergency|0|||
156732141|NCT03214380|565767542|FG004|Lead-in|Family Emergency|0|||
156876573|NCT00798759|566307642|FG001|Overall Study|Adverse Event|3|||
156732142|NCT03214380|565767543|FG005|Lead-in|Family Emergency|0|||
156732143|NCT03214380|565767538|FG000|Lead-in|Natural Disaster|9|||
156732144|NCT03214380|565767539|FG001|Lead-in|Natural Disaster|0|||
156732145|NCT03214380|565767540|FG002|Lead-in|Natural Disaster|0|||
156732146|NCT03214380|565767541|FG003|Lead-in|Natural Disaster|0|||
156732147|NCT03214380|565767542|FG004|Lead-in|Natural Disaster|0|||
156732148|NCT03214380|565767543|FG005|Lead-in|Natural Disaster|0|||
156732149|NCT03214380|565767538|FG000|Lead-in|Non Compliance|1|||
156732150|NCT03214380|565767539|FG001|Lead-in|Non Compliance|0|||
156732151|NCT03214380|565767540|FG002|Lead-in|Non Compliance|0|||
156732152|NCT03214380|565767541|FG003|Lead-in|Non Compliance|0|||
156732153|NCT03214380|565767542|FG004|Lead-in|Non Compliance|0|||
156732154|NCT03214380|565767543|FG005|Lead-in|Non Compliance|0|||
156732155|NCT03214380|565767538|FG000|Lead-in|Participant Schedule|2|||
156732156|NCT03214380|565767539|FG001|Lead-in|Participant Schedule|0|||
156732157|NCT03214380|565767540|FG002|Lead-in|Participant Schedule|0|||
156732158|NCT03214380|565767541|FG003|Lead-in|Participant Schedule|0|||
156732159|NCT03214380|565767542|FG004|Lead-in|Participant Schedule|0|||
156732160|NCT03214380|565767543|FG005|Lead-in|Participant Schedule|0|||
156732161|NCT03214380|565767538|FG000|Treatment Period|Adverse Event|0|||
156732162|NCT03214380|565767539|FG001|Treatment Period|Adverse Event|1|||
156732163|NCT03214380|565767540|FG002|Treatment Period|Adverse Event|1|||
156732164|NCT03214380|565767541|FG003|Treatment Period|Adverse Event|0|||
156732165|NCT03214380|565767542|FG004|Treatment Period|Adverse Event|1|||
156732166|NCT03214380|565767543|FG005|Treatment Period|Adverse Event|0|||
156732167|NCT03214380|565767538|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
156732168|NCT03214380|565767539|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
156732169|NCT03214380|565767540|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
156732170|NCT03214380|565767541|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
156732171|NCT03214380|565767542|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
156732172|NCT03214380|565767543|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
156732173|NCT03214380|565767538|FG000|Treatment Period|Withdrawal by Subject|0|||
156732174|NCT03214380|565767539|FG001|Treatment Period|Withdrawal by Subject|10|||
156732175|NCT03214380|565767540|FG002|Treatment Period|Withdrawal by Subject|8|||
156732176|NCT03214380|565767541|FG003|Treatment Period|Withdrawal by Subject|0|||
156732177|NCT03214380|565767542|FG004|Treatment Period|Withdrawal by Subject|7|||
156732178|NCT03214380|565767543|FG005|Treatment Period|Withdrawal by Subject|11|||
156732179|NCT03214380|565767538|FG000|Treatment Period|Death|0|||
156732180|NCT03214380|565767539|FG001|Treatment Period|Death|1|||
156732181|NCT03214380|565767540|FG002|Treatment Period|Death|2|||
156732182|NCT03214380|565767541|FG003|Treatment Period|Death|0|||
156732183|NCT03214380|565767542|FG004|Treatment Period|Death|0|||
156732184|NCT03214380|565767543|FG005|Treatment Period|Death|0|||
156732185|NCT03214380|565767538|FG000|Treatment Period|Lost to Follow-up|0|||
156876574|NCT00798759|566307641|FG000|Overall Study|Lost to Follow-up|1|||
157020034|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157139866|NCT03874234|567257508|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139867|NCT03874234|567257509|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139868|NCT03874234|567257510|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139869|NCT03874234|567257511|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
157139870|NCT03874234|567257499|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139871|NCT03874234|567257500|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139872|NCT03874234|567257501|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139873|NCT03874234|567257502|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139874|NCT03874234|567257503|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
157139875|NCT03874234|567257504|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139876|NCT03874234|567257505|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139877|NCT03874234|567257506|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139878|NCT03874234|567257507|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139879|NCT03874234|567257508|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139880|NCT03874234|567257509|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139881|NCT03874234|567257510|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139882|NCT03874234|567257511|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
157139883|NCT01896232|567257517|FG000|Overall Study|Death|6|||
157139884|NCT01896232|567257518|FG001|Overall Study|Death|10|||
157139885|NCT01896232|567257517|FG000|Overall Study|Withdrawal by Subject|32|||
157139886|NCT01896232|567257518|FG001|Overall Study|Withdrawal by Subject|31|||
157217555|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
156732186|NCT03214380|565767539|FG001|Treatment Period|Lost to Follow-up|6|||
156732187|NCT03214380|565767540|FG002|Treatment Period|Lost to Follow-up|3|||
156732188|NCT03214380|565767541|FG003|Treatment Period|Lost to Follow-up|0|||
156732189|NCT03214380|565767542|FG004|Treatment Period|Lost to Follow-up|0|||
156732190|NCT03214380|565767543|FG005|Treatment Period|Lost to Follow-up|0|||
156732191|NCT03214380|565767538|FG000|Treatment Period|Participant schedule|0|||
156732192|NCT03214380|565767539|FG001|Treatment Period|Participant schedule|0|||
156732193|NCT03214380|565767540|FG002|Treatment Period|Participant schedule|1|||
156732194|NCT03214380|565767541|FG003|Treatment Period|Participant schedule|0|||
157139887|NCT01896232|567257517|FG000|Overall Study|Sponsor Decision|2|||
157139888|NCT01896232|567257518|FG001|Overall Study|Sponsor Decision|0|||
157139889|NCT01896232|567257517|FG000|Overall Study|Lost to Follow-up|9|||
157139890|NCT01896232|567257518|FG001|Overall Study|Lost to Follow-up|12|||
157139891|NCT00686205|567257527|FG000|Overall Study|Protocol Violation|127|||
157139892|NCT00686205|567257528|FG001|Overall Study|Protocol Violation|0|||
157139893|NCT00686205|567257527|FG000|Overall Study|Withdrawal by Subject|2|||
157139894|NCT00686205|567257528|FG001|Overall Study|Withdrawal by Subject|0|||
157139895|NCT00686205|567257527|FG000|Overall Study|Specimen handling procedure altered|5878|||
157139896|NCT00686205|567257528|FG001|Overall Study|Specimen handling procedure altered|0|||
157139897|NCT00686205|567257527|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
157139898|NCT00686205|567257528|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
157139899|NCT01217606|567257530|FG000|Initial Treatment Phase|Other Reasons|0|||
157139900|NCT01217606|567257531|FG001|Initial Treatment Phase|Other Reasons|2|||
157139901|NCT01217606|567257530|FG000|Initial Treatment Phase|Protocol Violation|3|||
157139902|NCT01217606|567257531|FG001|Initial Treatment Phase|Protocol Violation|2|||
157139903|NCT01217606|567257530|FG000|Initial Treatment Phase|Personal Reasons|0|||
157139904|NCT01217606|567257531|FG001|Initial Treatment Phase|Personal Reasons|2|||
157139905|NCT01217606|567257530|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
157139906|NCT01217606|567257531|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
157139907|NCT01217606|567257530|FG000|Initial Treatment Phase|Adverse Event|10|||
157139908|NCT01217606|567257531|FG001|Initial Treatment Phase|Adverse Event|6|||
156796642|NCT00363298|566009621|FG000|First Study Week|Lack of Efficacy|6|||
156796643|NCT00363298|566009622|FG001|First Study Week|Lack of Efficacy|5|||
156796644|NCT00363298|566009621|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
156796645|NCT00363298|566009622|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
156796646|NCT03332056|566009629|FG000|Overall Study|Incomplete questionnaires|8|||
156796647|NCT03332056|566009630|FG001|Overall Study|Incomplete questionnaires|9|||
156796648|NCT03332056|566009629|FG000|Overall Study|Passed stone prior to surgery date|1|||
156796649|NCT03332056|566009630|FG001|Overall Study|Passed stone prior to surgery date|0|||
156796650|NCT03332056|566009629|FG000|Overall Study|Did not require a ureteral stent|0|||
156796651|NCT03332056|566009630|FG001|Overall Study|Did not require a ureteral stent|1|||
156796652|NCT00730327|566009631|FG000|Overall Study|Lost to Follow-up|14|||
156796653|NCT00730327|566009632|FG001|Overall Study|Lost to Follow-up|16|||
156796654|NCT00730327|566009631|FG000|Overall Study|Adverse Event|8|||
156796655|NCT00730327|566009632|FG001|Overall Study|Adverse Event|1|||
156796656|NCT00730327|566009631|FG000|Overall Study|Withdrawal by Subject|3|||
156796657|NCT00730327|566009632|FG001|Overall Study|Withdrawal by Subject|13|||
156796658|NCT00730327|566009631|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
156796659|NCT00730327|566009632|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
156796660|NCT02989857|566009638|FG000|Randomization Phase|Not Treated|3|||
156796661|NCT02989857|566009639|FG001|Randomization Phase|Not Treated|2|||
156796662|NCT02989857|566009640|FG002|Randomization Phase|Not Treated|0|||
156796663|NCT00688740|566009641|FG000|Overall Study|Adverse Event|45|||
156796664|NCT00688740|566009642|FG001|Overall Study|Adverse Event|8|||
156796665|NCT00688740|566009641|FG000|Overall Study|Death|2|||
156796666|NCT00688740|566009642|FG001|Overall Study|Death|2|||
156796667|NCT00688740|566009641|FG000|Overall Study|Lost to Follow-up|0|||
156796668|NCT00688740|566009642|FG001|Overall Study|Lost to Follow-up|1|||
157139909|NCT01217606|567257530|FG000|9-Month Masked Extension|Adverse Event|3|||
157139910|NCT01217606|567257531|FG001|9-Month Masked Extension|Adverse Event|6|||
157139911|NCT01217606|567257530|FG000|9-Month Masked Extension|Other Reasons|4|||
157139912|NCT01217606|567257531|FG001|9-Month Masked Extension|Other Reasons|4|||
157139913|NCT01217606|567257530|FG000|9-Month Masked Extension|Personal Reasons|2|||
157139914|NCT01217606|567257531|FG001|9-Month Masked Extension|Personal Reasons|1|||
157139915|NCT01217606|567257530|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
157139916|NCT01217606|567257531|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
157139917|NCT01217606|567257530|FG000|9-Month Masked Extension|Pregnancy|1|||
157139918|NCT01217606|567257531|FG001|9-Month Masked Extension|Pregnancy|0|||
157139919|NCT01217606|567257530|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
157139920|NCT01217606|567257531|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
157139921|NCT02432807|567257535|FG000|Overall Study|Adverse Event|0|||
157139922|NCT02432807|567257536|FG001|Overall Study|Adverse Event|2|||
156796669|NCT00688740|566009641|FG000|Overall Study|Consent Withdrawn|17|||
156796670|NCT00688740|566009642|FG001|Overall Study|Consent Withdrawn|17|||
156796671|NCT00688740|566009641|FG000|Overall Study|Breast Cancer Relapse|1|||
156796672|NCT00688740|566009642|FG001|Overall Study|Breast Cancer Relapse|4|||
156796673|NCT00688740|566009641|FG000|Overall Study|Violation of Inclusion Criteria|1|||
156796674|NCT00688740|566009642|FG001|Overall Study|Violation of Inclusion Criteria|3|||
156796675|NCT00095576|566009643|FG000|Overall Study|Adverse Event|5|||
156796676|NCT00095576|566009644|FG001|Overall Study|Adverse Event|3|||
156796677|NCT00095576|566009643|FG000|Overall Study|Lost to Follow-up|233|||
157139923|NCT02432807|567257535|FG000|Overall Study|Lost to Follow-up|1|||
157139924|NCT02432807|567257536|FG001|Overall Study|Lost to Follow-up|0|||
157139925|NCT02432807|567257535|FG000|Overall Study|Withdrawal by Subject|1|||
157139926|NCT02432807|567257536|FG001|Overall Study|Withdrawal by Subject|1|||
156732195|NCT03214380|565767542|FG004|Treatment Period|Participant schedule|0|||
156732196|NCT03214380|565767543|FG005|Treatment Period|Participant schedule|0|||
156732197|NCT03214380|565767538|FG000|Treatment Period|Treatment Interruption|0|||
156732198|NCT03214380|565767539|FG001|Treatment Period|Treatment Interruption|0|||
156732199|NCT03214380|565767540|FG002|Treatment Period|Treatment Interruption|1|||
156732200|NCT03214380|565767541|FG003|Treatment Period|Treatment Interruption|0|||
156732201|NCT03214380|565767542|FG004|Treatment Period|Treatment Interruption|0|||
156732202|NCT03214380|565767543|FG005|Treatment Period|Treatment Interruption|0|||
156732203|NCT03692325|565767546|FG000|Overall Study|Adverse Event|2|||
157139927|NCT02432807|567257535|FG000|Overall Study|Other|1|||
157139928|NCT02432807|567257536|FG001|Overall Study|Other|1|||
157139929|NCT02210780|567257539|FG000|Overall Study|Adverse Event|0|||
157139930|NCT02210780|567257540|FG001|Overall Study|Adverse Event|5|||
157139931|NCT02210780|567257539|FG000|Overall Study|Lost to Follow-up|2|||
156732204|NCT03692325|565767546|FG000|Overall Study|Progression/Recurrence|2|||
156732205|NCT02817516|565767547|FG000|Overall Study|Other|0|||
156732206|NCT02817516|565767548|FG001|Overall Study|Other|0|||
156732207|NCT02817516|565767549|FG002|Overall Study|Other|1|||
156732208|NCT02817516|565767550|FG003|Overall Study|Other|0|||
156732209|NCT01920958|565767552|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
156732210|NCT00083759|565767556|FG000|Overall Study|Adverse Event|5|||
156732211|NCT00083759|565767557|FG001|Overall Study|Adverse Event|3|||
156732212|NCT00083759|565767556|FG000|Overall Study|Lost to Follow-up|1|||
156732213|NCT00083759|565767557|FG001|Overall Study|Lost to Follow-up|0|||
156732214|NCT00083759|565767556|FG000|Overall Study|Death|1|||
156732215|NCT00083759|565767557|FG001|Overall Study|Death|1|||
156732216|NCT00083759|565767556|FG000|Overall Study|Inadequate Therapeutic Response|32|||
156732217|NCT00083759|565767557|FG001|Overall Study|Inadequate Therapeutic Response|35|||
156732218|NCT00083759|565767556|FG000|Overall Study|Subject Withdrew Consent|2|||
156732219|NCT00083759|565767557|FG001|Overall Study|Subject Withdrew Consent|2|||
156732220|NCT00083759|565767556|FG000|Overall Study|Non-Compliance|1|||
156796678|NCT00095576|566009644|FG001|Overall Study|Lost to Follow-up|229|||
156796679|NCT00095576|566009643|FG000|Overall Study|Protocol Violation|1|||
156796680|NCT00095576|566009644|FG001|Overall Study|Protocol Violation|0|||
156796681|NCT00095576|566009643|FG000|Overall Study|Withdrawal by Subject|34|||
156796682|NCT00095576|566009644|FG001|Overall Study|Withdrawal by Subject|47|||
156796683|NCT00095576|566009643|FG000|Overall Study|Option to switch to a rollover study|1097|||
157139932|NCT02210780|567257540|FG001|Overall Study|Lost to Follow-up|1|||
157139933|NCT02210780|567257539|FG000|Overall Study|Withdrawal by Subject|1|||
157139934|NCT02210780|567257540|FG001|Overall Study|Withdrawal by Subject|1|||
157139935|NCT02210780|567257539|FG000|Overall Study|Physician Decision|1|||
157139936|NCT02210780|567257540|FG001|Overall Study|Physician Decision|0|||
157139937|NCT02210780|567257539|FG000|Overall Study|Protocol Violation|1|||
157139938|NCT02210780|567257540|FG001|Overall Study|Protocol Violation|0|||
157139939|NCT02210780|567257539|FG000|Overall Study|Other than specified above|0|||
157139940|NCT02210780|567257540|FG001|Overall Study|Other than specified above|1|||
157139941|NCT02966314|567257543|FG000|Overall Study|Lost to Follow-up|1|||
157139942|NCT02966314|567257544|FG001|Overall Study|Lost to Follow-up|0|||
157139943|NCT02725788|567257547|FG000|Overall Study|Lost to Follow-up|1|||
157139944|NCT02725788|567257548|FG001|Overall Study|Lost to Follow-up|1|||
157139945|NCT02725788|567257547|FG000|Overall Study|Protocol Violation|0|||
157139946|NCT02725788|567257548|FG001|Overall Study|Protocol Violation|1|||
157139947|NCT00828464|567257549|FG000|Overall Study|Withdrawal by Subject|1|||
157139948|NCT00474240|567257550|FG000|Overall Study|Withdrawal by Subject|1|||
157139949|NCT00474240|567257551|FG001|Overall Study|Withdrawal by Subject|1|||
157139950|NCT00474240|567257552|FG002|Overall Study|Withdrawal by Subject|0|||
157139951|NCT00474240|567257553|FG003|Overall Study|Withdrawal by Subject|2|||
157139952|NCT00474240|567257554|FG004|Overall Study|Withdrawal by Subject|3|||
157139953|NCT00474240|567257555|FG005|Overall Study|Withdrawal by Subject|1|||
157139954|NCT00474240|567257550|FG000|Overall Study|Adverse Event|0|||
156732221|NCT00083759|565767557|FG001|Overall Study|Non-Compliance|0|||
156732222|NCT00083759|565767556|FG000|Overall Study|Sponsor's Discretion|28|||
156732223|NCT00083759|565767557|FG001|Overall Study|Sponsor's Discretion|29|||
156732224|NCT00083759|565767556|FG000|Overall Study|Other|14|||
156732225|NCT00083759|565767557|FG001|Overall Study|Other|13|||
156796684|NCT00095576|566009644|FG001|Overall Study|Option to switch to a rollover study|1099|||
156732226|NCT01089608|565767560|FG000|Overall Study|Adverse Event|0|||
156796685|NCT00095576|566009643|FG000|Overall Study|Site terminated|75|||
156732227|NCT01089608|565767561|FG001|Overall Study|Adverse Event|4|||
156732228|NCT01089608|565767560|FG000|Overall Study|Lost to Follow-up|0|||
156796686|NCT00095576|566009644|FG001|Overall Study|Site terminated|67|||
156796687|NCT00095576|566009643|FG000|Overall Study|Subject moved|30|||
156796688|NCT00095576|566009644|FG001|Overall Study|Subject moved|36|||
157139955|NCT00474240|567257551|FG001|Overall Study|Adverse Event|0|||
157139956|NCT00474240|567257552|FG002|Overall Study|Adverse Event|9|||
157139957|NCT00474240|567257553|FG003|Overall Study|Adverse Event|14|||
157139958|NCT00474240|567257554|FG004|Overall Study|Adverse Event|5|||
157139959|NCT00474240|567257555|FG005|Overall Study|Adverse Event|16|||
157139960|NCT00474240|567257550|FG000|Overall Study|Removed due to lab value|0|||
157139961|NCT00474240|567257551|FG001|Overall Study|Removed due to lab value|0|||
157139962|NCT00474240|567257552|FG002|Overall Study|Removed due to lab value|0|||
157139963|NCT00474240|567257553|FG003|Overall Study|Removed due to lab value|0|||
157139964|NCT00474240|567257554|FG004|Overall Study|Removed due to lab value|0|||
157139965|NCT00474240|567257555|FG005|Overall Study|Removed due to lab value|1|||
157139966|NCT03812510|567257558|FG000|Overall Study|Lost to Follow-up|39|||
157139967|NCT03812510|567257558|FG000|Overall Study|Withdrawal by Subject|42|||
156732229|NCT01089608|565767561|FG001|Overall Study|Lost to Follow-up|2|||
156732230|NCT00729157|565767562|FG000|Overall Study|Withdrawal by Subject|1|||
156732231|NCT03521115|565767570|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
156732232|NCT03521115|565767571|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
156732233|NCT03521115|565767570|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
156732234|NCT03521115|565767571|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
157139968|NCT03812510|567257558|FG000|Overall Study|Physician Decision|2|||
157139969|NCT03812510|567257558|FG000|Overall Study|Study Terminated by Sponsor|9|||
157139970|NCT03812510|567257558|FG000|Overall Study|Did Not Start Study Medication|55|||
157139971|NCT03812510|567257558|FG000|Overall Study|Adverse Event|5|||
157139972|NCT01128387|567257559|FG000|Overall Study|Physician Decision|0|||
157139973|NCT01128387|567257560|FG001|Overall Study|Physician Decision|1|||
157139974|NCT00858832|567257561|FG000|Overall Study|became ineligible: delivered vaginally|1|||
157139975|NCT00858832|567257562|FG001|Overall Study|became ineligible: delivered vaginally|0|||
157139976|NCT00858832|567257561|FG000|Overall Study|Adverse Event|0|||
157139977|NCT00858832|567257562|FG001|Overall Study|Adverse Event|1|||
157139978|NCT03075839|567257569|FG000|Overall Study|Lost to Follow-up|4|||
157139979|NCT04433117|567257571|FG000|Overall Study|Withdrawal by Subject|1|||
156732235|NCT03655470|565767572|FG000|Overall Study|Lost to Follow-up|6|||
156732236|NCT03655470|565767573|FG001|Overall Study|Lost to Follow-up|7|||
156732237|NCT05481125|565767574|FG000|Overall Study|Adverse Event|1|||
156732238|NCT05481125|565767575|FG001|Overall Study|Adverse Event|0|||
156732239|NCT05481125|565767574|FG000|Overall Study|Lost to Follow-up|0|||
156732240|NCT05481125|565767575|FG001|Overall Study|Lost to Follow-up|1|||
156732241|NCT05481125|565767574|FG000|Overall Study|Withdrawal by Subject|0|||
156732242|NCT05481125|565767575|FG001|Overall Study|Withdrawal by Subject|1|||
156732243|NCT02244463|565767578|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
157139980|NCT04433117|567257572|FG001|Overall Study|Withdrawal by Subject|0|||
157139981|NCT00824421|567257574|FG000|Overall Study|Adverse Event|6|||
157139982|NCT00824421|567257575|FG001|Overall Study|Adverse Event|6|||
157139983|NCT00824421|567257576|FG002|Overall Study|Adverse Event|6|||
156732244|NCT02244463|565767579|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732245|NCT02244463|565767580|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732246|NCT02244463|565767581|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732247|NCT02244463|565767582|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732248|NCT02244463|565767583|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
156732249|NCT02244463|565767578|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
156732250|NCT02244463|565767579|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
156732251|NCT02244463|565767580|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
156732252|NCT02244463|565767581|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
156732253|NCT02244463|565767582|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
156732254|NCT02244463|565767583|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
156732255|NCT02244463|565767578|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732256|NCT02244463|565767579|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
156732257|NCT02244463|565767580|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732258|NCT02244463|565767581|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156796689|NCT01822925|566009649|FG000|Overall Study|Adverse Event|1|||
156796690|NCT01822925|566009650|FG001|Overall Study|Adverse Event|1|||
156796691|NCT01822925|566009651|FG002|Overall Study|Adverse Event|1|||
156796692|NCT01822925|566009652|FG003|Overall Study|Adverse Event|1|||
156796693|NCT01822925|566009649|FG000|Overall Study|Lost to Follow-up|0|||
156796694|NCT01822925|566009650|FG001|Overall Study|Lost to Follow-up|1|||
156796695|NCT01822925|566009651|FG002|Overall Study|Lost to Follow-up|0|||
156796696|NCT01822925|566009652|FG003|Overall Study|Lost to Follow-up|0|||
156796697|NCT01822925|566009649|FG000|Overall Study|Protocol Violation|1|||
156796698|NCT01822925|566009650|FG001|Overall Study|Protocol Violation|0|||
156796699|NCT01822925|566009651|FG002|Overall Study|Protocol Violation|0|||
157139984|NCT00824421|567257574|FG000|Overall Study|Death|0|||
156732259|NCT02244463|565767582|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156732260|NCT02244463|565767583|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
156796700|NCT01822925|566009652|FG003|Overall Study|Protocol Violation|1|||
156796701|NCT01822925|566009649|FG000|Overall Study|Withdrawal by Subject|2|||
156796702|NCT01822925|566009650|FG001|Overall Study|Withdrawal by Subject|0|||
157139985|NCT00824421|567257575|FG001|Overall Study|Death|1|||
157139986|NCT00824421|567257576|FG002|Overall Study|Death|0|||
157139987|NCT00824421|567257574|FG000|Overall Study|Lack of Efficacy|5|||
157139988|NCT00824421|567257575|FG001|Overall Study|Lack of Efficacy|7|||
157139989|NCT00824421|567257576|FG002|Overall Study|Lack of Efficacy|4|||
156732261|NCT02244463|565767578|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732262|NCT02244463|565767579|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732263|NCT02244463|565767580|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
156732264|NCT02244463|565767581|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732265|NCT02244463|565767582|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732266|NCT02244463|565767583|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
156732267|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732268|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732269|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732270|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
156732271|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732272|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
156732273|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732274|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732275|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732276|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
156732277|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732278|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
156732279|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732280|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732281|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732282|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
156732283|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732284|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
156732285|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732286|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732287|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732288|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
156732289|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732290|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
156732291|NCT02244463|565767578|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732292|NCT02244463|565767579|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732293|NCT02244463|565767580|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732294|NCT02244463|565767581|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
156732295|NCT02244463|565767582|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732296|NCT02244463|565767583|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
156732297|NCT02244463|565767578|FG000|Period 5: Phase II|Disease Progression|0|||
156732298|NCT02244463|565767579|FG001|Period 5: Phase II|Disease Progression|0|||
156732299|NCT02244463|565767580|FG002|Period 5: Phase II|Disease Progression|0|||
156732300|NCT02244463|565767581|FG003|Period 5: Phase II|Disease Progression|0|||
156732301|NCT02244463|565767582|FG004|Period 5: Phase II|Disease Progression|10|||
156732302|NCT02244463|565767583|FG005|Period 5: Phase II|Disease Progression|11|||
156732303|NCT02244463|565767578|FG000|Period 5: Phase II|Physician Decision|0|||
156732304|NCT02244463|565767579|FG001|Period 5: Phase II|Physician Decision|0|||
156732305|NCT02244463|565767580|FG002|Period 5: Phase II|Physician Decision|0|||
156732306|NCT02244463|565767581|FG003|Period 5: Phase II|Physician Decision|0|||
156732307|NCT02244463|565767582|FG004|Period 5: Phase II|Physician Decision|3|||
156732308|NCT02244463|565767583|FG005|Period 5: Phase II|Physician Decision|2|||
156732309|NCT02244463|565767578|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
156732310|NCT02244463|565767579|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
156732311|NCT02244463|565767580|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
156732312|NCT02244463|565767581|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
156732313|NCT02244463|565767582|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
156732314|NCT02244463|565767583|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
156732315|NCT02244463|565767578|FG000|Period 5: Phase II|Intercurrent Illness|0|||
156732316|NCT02244463|565767579|FG001|Period 5: Phase II|Intercurrent Illness|0|||
156732317|NCT02244463|565767580|FG002|Period 5: Phase II|Intercurrent Illness|0|||
156732318|NCT02244463|565767581|FG003|Period 5: Phase II|Intercurrent Illness|0|||
156732319|NCT02244463|565767582|FG004|Period 5: Phase II|Intercurrent Illness|2|||
156732320|NCT02244463|565767583|FG005|Period 5: Phase II|Intercurrent Illness|0|||
156732321|NCT02244463|565767578|FG000|Period 5: Phase II|Adverse Event|0|||
156732322|NCT02244463|565767579|FG001|Period 5: Phase II|Adverse Event|0|||
156732323|NCT02244463|565767580|FG002|Period 5: Phase II|Adverse Event|0|||
156732324|NCT02244463|565767581|FG003|Period 5: Phase II|Adverse Event|0|||
156732325|NCT02244463|565767582|FG004|Period 5: Phase II|Adverse Event|0|||
156732326|NCT02244463|565767583|FG005|Period 5: Phase II|Adverse Event|2|||
156732327|NCT02244463|565767578|FG000|Period 5: Phase II|Still On treatment|0|||
156732328|NCT02244463|565767579|FG001|Period 5: Phase II|Still On treatment|0|||
156732329|NCT02244463|565767580|FG002|Period 5: Phase II|Still On treatment|0|||
156732330|NCT02244463|565767581|FG003|Period 5: Phase II|Still On treatment|0|||
156732331|NCT02244463|565767582|FG004|Period 5: Phase II|Still On treatment|0|||
156732332|NCT02244463|565767583|FG005|Period 5: Phase II|Still On treatment|3|||
156732333|NCT03702010|565767586|FG000|Follow-up (30days)|Lack of Efficacy|2|||
156732334|NCT03702010|565767587|FG001|Follow-up (30days)|Lack of Efficacy|2|||
156732335|NCT02295020|565767599|FG000|Overall Study|Adverse Event|0|||
156732336|NCT02295020|565767600|FG001|Overall Study|Adverse Event|1|||
156732337|NCT02295020|565767599|FG000|Overall Study|Withdrawal by Subject|3|||
156732338|NCT02295020|565767600|FG001|Overall Study|Withdrawal by Subject|2|||
156732339|NCT01290679|565767601|FG000|Overall Study|Adverse Event|2|||
156732340|NCT01290679|565767602|FG001|Overall Study|Adverse Event|0|||
156732341|NCT01290679|565767601|FG000|Overall Study|Lost to Follow-up|8|||
156732342|NCT01290679|565767602|FG001|Overall Study|Lost to Follow-up|10|||
156732343|NCT01290679|565767601|FG000|Overall Study|Protocol Violation|0|||
156732344|NCT01290679|565767602|FG001|Overall Study|Protocol Violation|1|||
156732345|NCT01290679|565767601|FG000|Overall Study|Withdrawal by Subject|6|||
156732346|NCT01290679|565767602|FG001|Overall Study|Withdrawal by Subject|5|||
156732347|NCT01290679|565767601|FG000|Overall Study|Subject Entered Another Trial|0|||
156732348|NCT01290679|565767602|FG001|Overall Study|Subject Entered Another Trial|5|||
156732349|NCT01598090|565767603|FG000|Treatment Period|Poor/non-compliance|0|||
156732350|NCT01598090|565767604|FG001|Treatment Period|Poor/non-compliance|2|||
156732351|NCT01598090|565767605|FG002|Treatment Period|Poor/non-compliance|0|||
156732352|NCT01598090|565767603|FG000|Treatment Period|No longer meet study criteria|0|||
156732353|NCT01598090|565767604|FG001|Treatment Period|No longer meet study criteria|1|||
156732354|NCT01598090|565767605|FG002|Treatment Period|No longer meet study criteria|0|||
156732355|NCT01598090|565767603|FG000|Treatment Period|Lack of Efficacy|5|||
156732356|NCT01598090|565767604|FG001|Treatment Period|Lack of Efficacy|14|||
156732357|NCT01598090|565767605|FG002|Treatment Period|Lack of Efficacy|6|||
156732358|NCT01598090|565767603|FG000|Treatment Period|Adverse Event|2|||
156732359|NCT01598090|565767604|FG001|Treatment Period|Adverse Event|33|||
156732360|NCT01598090|565767605|FG002|Treatment Period|Adverse Event|17|||
156732361|NCT01598090|565767603|FG000|Treatment Period|Other reasons|0|||
156732362|NCT01598090|565767604|FG001|Treatment Period|Other reasons|4|||
156732363|NCT01598090|565767605|FG002|Treatment Period|Other reasons|1|||
156732364|NCT01598090|565767603|FG000|Treatment Period|Withdrawal by Subject|3|||
156732365|NCT01598090|565767604|FG001|Treatment Period|Withdrawal by Subject|13|||
156732366|NCT01598090|565767605|FG002|Treatment Period|Withdrawal by Subject|10|||
156732367|NCT01598090|565767603|FG000|Treatment Period|Lost to Follow-up|1|||
156732368|NCT01598090|565767604|FG001|Treatment Period|Lost to Follow-up|5|||
156732369|NCT01598090|565767605|FG002|Treatment Period|Lost to Follow-up|1|||
156732370|NCT01598090|565767603|FG000|Follow-up Period|Death|0|||
156732371|NCT01598090|565767604|FG001|Follow-up Period|Death|1|||
156732372|NCT01598090|565767605|FG002|Follow-up Period|Death|0|||
156732373|NCT01598090|565767603|FG000|Follow-up Period|No longer required per protocol|1|||
157139990|NCT00824421|567257574|FG000|Overall Study|Lost to Follow-up|2|||
157139991|NCT00824421|567257575|FG001|Overall Study|Lost to Follow-up|3|||
157139992|NCT00824421|567257576|FG002|Overall Study|Lost to Follow-up|0|||
157139993|NCT00824421|567257574|FG000|Overall Study|Pregnancy|1|||
157139994|NCT00824421|567257575|FG001|Overall Study|Pregnancy|0|||
157139995|NCT00824421|567257576|FG002|Overall Study|Pregnancy|1|||
157139996|NCT00824421|567257574|FG000|Overall Study|Withdrawal by Subject|2|||
157139997|NCT00824421|567257575|FG001|Overall Study|Withdrawal by Subject|3|||
157139998|NCT00824421|567257576|FG002|Overall Study|Withdrawal by Subject|3|||
157139999|NCT00824421|567257574|FG000|Overall Study|Randomized but not Treated|1|||
157140000|NCT00824421|567257575|FG001|Overall Study|Randomized but not Treated|1|||
157140001|NCT00824421|567257576|FG002|Overall Study|Randomized but not Treated|0|||
157140002|NCT00824421|567257574|FG000|Overall Study|Other|0|||
157140003|NCT00824421|567257575|FG001|Overall Study|Other|1|||
157140004|NCT00824421|567257576|FG002|Overall Study|Other|0|||
157140005|NCT02499952|567257577|FG000|Overall Study|Lost to Follow-up|1|||
157140006|NCT02499952|567257577|FG000|Overall Study|Death|9|||
157140007|NCT05089708|567257578|FG000|Overall Study|Lost to Follow-up|9|||
157140008|NCT05089708|567257579|FG001|Overall Study|Lost to Follow-up|7|||
156732374|NCT01598090|565767604|FG001|Follow-up Period|No longer required per protocol|3|||
156732375|NCT01598090|565767605|FG002|Follow-up Period|No longer required per protocol|2|||
156732376|NCT01598090|565767603|FG000|Follow-up Period|Not reported|0|||
156732377|NCT01598090|565767604|FG001|Follow-up Period|Not reported|10|||
156732378|NCT01598090|565767605|FG002|Follow-up Period|Not reported|4|||
156796703|NCT01822925|566009651|FG002|Overall Study|Withdrawal by Subject|2|||
156796704|NCT01822925|566009652|FG003|Overall Study|Withdrawal by Subject|2|||
156732379|NCT01598090|565767603|FG000|Follow-up Period|Withdrawal by Subject|0|||
156732380|NCT01598090|565767604|FG001|Follow-up Period|Withdrawal by Subject|3|||
156732381|NCT01598090|565767605|FG002|Follow-up Period|Withdrawal by Subject|2|||
156796705|NCT01822925|566009649|FG000|Overall Study|Taking prohibited medication|2|||
156796706|NCT01822925|566009650|FG001|Overall Study|Taking prohibited medication|0|||
157140009|NCT05089708|567257578|FG000|Overall Study|Withdrawal by Subject|3|||
157140010|NCT05089708|567257579|FG001|Overall Study|Withdrawal by Subject|1|||
157140011|NCT05089708|567257578|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
157140012|NCT05089708|567257579|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
157140013|NCT05089708|567257578|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
156732382|NCT01598090|565767603|FG000|Follow-up Period|Other reasons|2|||
156732383|NCT01598090|565767604|FG001|Follow-up Period|Other reasons|8|||
156732384|NCT01598090|565767605|FG002|Follow-up Period|Other reasons|8|||
156732385|NCT01598090|565767603|FG000|Follow-up Period|Lost to Follow-up|2|||
156732386|NCT01598090|565767604|FG001|Follow-up Period|Lost to Follow-up|10|||
156732387|NCT01598090|565767605|FG002|Follow-up Period|Lost to Follow-up|12|||
156732388|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
156732389|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
156732390|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
156732391|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
156732392|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732393|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732394|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732395|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732396|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732397|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732398|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
156732399|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
156732400|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732401|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
156732402|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
156732403|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732404|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732405|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732406|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732407|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732408|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732409|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
156732410|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
156732411|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
156732412|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
156732413|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
156732414|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732415|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732416|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732417|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732418|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732419|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732420|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
156732421|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
156732422|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
156732423|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
156732424|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
156732425|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732426|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732427|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732428|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732429|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732430|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732431|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
156732432|NCT04791319|565767606|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732433|NCT04791319|565767607|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732434|NCT04791319|565767608|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732435|NCT04791319|565767609|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
156732436|NCT04791319|565767610|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732437|NCT04791319|565767611|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732438|NCT04791319|565767612|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732439|NCT04791319|565767613|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732440|NCT04791319|565767614|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732441|NCT04791319|565767615|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
157140014|NCT05089708|567257579|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
157140015|NCT02120417|567257580|FG000|Overall Study|Death|5|||
157140016|NCT02120417|567257581|FG001|Overall Study|Death|1|||
157020035|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020036|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
157020037|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
157020038|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
157020039|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020040|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020041|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157020042|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
157140017|NCT02120417|567257580|FG000|Overall Study|Adverse Event|3|||
157140018|NCT02120417|567257581|FG001|Overall Study|Adverse Event|9|||
157020043|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157020044|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157140019|NCT02120417|567257580|FG000|Overall Study|Participant decision|4|||
157140020|NCT02120417|567257581|FG001|Overall Study|Participant decision|4|||
157140021|NCT02120417|567257580|FG000|Overall Study|Disease progression|41|||
157140022|NCT02120417|567257581|FG001|Overall Study|Disease progression|45|||
157140023|NCT02120417|567257580|FG000|Overall Study|Noncompliance with study treatment|0|||
157140024|NCT02120417|567257581|FG001|Overall Study|Noncompliance with study treatment|2|||
157140025|NCT02120417|567257580|FG000|Overall Study|Physician Decision|2|||
157140026|NCT02120417|567257581|FG001|Overall Study|Physician Decision|3|||
157140027|NCT02120417|567257580|FG000|Overall Study|Other unspecified|5|||
157140028|NCT02120417|567257581|FG001|Overall Study|Other unspecified|4|||
157140029|NCT00927485|567257582|FG000|Overall Study|Adverse Event|4|||
157140030|NCT00927485|567257583|FG001|Overall Study|Adverse Event|2|||
157140031|NCT00927485|567257582|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
157140032|NCT00927485|567257583|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
157140033|NCT00702143|567257589|FG000|Overall Study|Lost to Follow-up|0|||
156732442|NCT04791319|565767616|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
156732443|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732444|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732445|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732446|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732447|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
156732448|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
156732449|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
156732450|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732451|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732452|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
156732453|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
156732454|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732455|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732456|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732457|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732458|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732459|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732460|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732461|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732462|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732463|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
156732464|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
156732465|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732466|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732467|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732468|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732469|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
156732470|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
157020045|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157020046|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157140034|NCT00702143|567257590|FG001|Overall Study|Lost to Follow-up|0|||
157140035|NCT00702143|567257591|FG002|Overall Study|Lost to Follow-up|1|||
157140036|NCT03871491|567257592|FG000|Overall Study|Withdrawal by Subject|14|||
157140037|NCT03871491|567257593|FG001|Overall Study|Withdrawal by Subject|14|||
157140038|NCT03871491|567257594|FG002|Overall Study|Withdrawal by Subject|14|||
157140039|NCT03871491|567257595|FG003|Overall Study|Withdrawal by Subject|14|||
157140040|NCT03871491|567257592|FG000|Overall Study|Physician Decision|0|||
157140041|NCT03871491|567257593|FG001|Overall Study|Physician Decision|0|||
157140042|NCT03871491|567257594|FG002|Overall Study|Physician Decision|1|||
157140043|NCT03871491|567257595|FG003|Overall Study|Physician Decision|1|||
157140044|NCT03871491|567257592|FG000|Overall Study|Lost to Follow-up|50|||
157140045|NCT03871491|567257593|FG001|Overall Study|Lost to Follow-up|15|||
157140046|NCT03871491|567257594|FG002|Overall Study|Lost to Follow-up|36|||
157140047|NCT03871491|567257595|FG003|Overall Study|Lost to Follow-up|11|||
157140048|NCT04996797|567257596|FG000|Overall Study|Adverse Event|0|||
156732471|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
156732472|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
156732473|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
156732474|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
156732475|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
156732476|NCT04791319|565767606|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732477|NCT04791319|565767607|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732478|NCT04791319|565767608|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732479|NCT04791319|565767609|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
156732480|NCT04791319|565767610|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
156732481|NCT04791319|565767611|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
156732482|NCT04791319|565767612|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
156732483|NCT04791319|565767613|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
156732484|NCT04791319|565767614|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
156732485|NCT04791319|565767615|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
156732486|NCT04791319|565767616|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
156732487|NCT00355147|565767625|FG000|Overall Study|Lost to Follow-up|10|||
156732488|NCT00355147|565767626|FG001|Overall Study|Lost to Follow-up|8|||
156732489|NCT00355147|565767625|FG000|Overall Study|Withdrawal by Subject|8|||
156732490|NCT00355147|565767626|FG001|Overall Study|Withdrawal by Subject|12|||
156732491|NCT03557931|565767633|FG000|Overall Study|Adverse Event|4|||
156732492|NCT03557931|565767634|FG001|Overall Study|Adverse Event|6|||
156732493|NCT03557931|565767635|FG002|Overall Study|Adverse Event|1|||
156732494|NCT03557931|565767633|FG000|Overall Study|Lost to Follow-up|4|||
156732495|NCT03557931|565767634|FG001|Overall Study|Lost to Follow-up|4|||
156732496|NCT03557931|565767635|FG002|Overall Study|Lost to Follow-up|1|||
156732497|NCT03557931|565767633|FG000|Overall Study|Protocol Violation|1|||
156732498|NCT03557931|565767634|FG001|Overall Study|Protocol Violation|4|||
156732499|NCT03557931|565767635|FG002|Overall Study|Protocol Violation|1|||
156732500|NCT03557931|565767633|FG000|Overall Study|Withdrawal by Subject|14|||
156732501|NCT03557931|565767634|FG001|Overall Study|Withdrawal by Subject|0|||
156732502|NCT03557931|565767635|FG002|Overall Study|Withdrawal by Subject|7|||
156732503|NCT03557931|565767633|FG000|Overall Study|Miscellaneous|8|||
156732504|NCT03557931|565767634|FG001|Overall Study|Miscellaneous|5|||
156732505|NCT03557931|565767635|FG002|Overall Study|Miscellaneous|3|||
156732506|NCT02394340|565767636|FG000|Overall Study|Failed drug screen test|1|||
156732507|NCT02394340|565767636|FG000|Overall Study|Adverse Event|1|||
156732508|NCT03605862|565767639|FG000|Overall Study|Withdrawal by Subject|12|||
156732509|NCT03605862|565767640|FG001|Overall Study|Withdrawal by Subject|9|||
156732510|NCT03605862|565767639|FG000|Overall Study|Adverse Event|2|||
156732511|NCT03605862|565767640|FG001|Overall Study|Adverse Event|1|||
156732512|NCT03605862|565767639|FG000|Overall Study|Physician Decision|3|||
156732513|NCT03605862|565767640|FG001|Overall Study|Physician Decision|1|||
156732514|NCT03605862|565767639|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
156732515|NCT03605862|565767640|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
156732516|NCT02157376|565767647|FG000|Overall Study|Death|10|||
156732517|NCT02157376|565767648|FG001|Overall Study|Death|4|||
156732518|NCT02157376|565767647|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156732519|NCT02157376|565767648|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156732520|NCT02157376|565767647|FG000|Overall Study|Withdrawal by Subject|3|||
156732521|NCT02157376|565767648|FG001|Overall Study|Withdrawal by Subject|8|||
156732522|NCT02157376|565767647|FG000|Overall Study|Not treated|8|||
156732523|NCT02157376|565767648|FG001|Overall Study|Not treated|3|||
156732524|NCT02157376|565767647|FG000|Overall Study|Investigator's misjudgement|1|||
156732525|NCT02157376|565767648|FG001|Overall Study|Investigator's misjudgement|2|||
156732526|NCT04200651|565767649|FG000|Overall Study|Moved to another country during follow-up|2|||
156732527|NCT04200651|565767650|FG001|Overall Study|Moved to another country during follow-up|2|||
156732528|NCT04200651|565767649|FG000|Overall Study|Lost to Follow-up|1|||
157140049|NCT04996797|567257597|FG001|Overall Study|Adverse Event|2|||
157140050|NCT04996797|567257598|FG002|Overall Study|Adverse Event|0|||
157140051|NCT04996797|567257599|FG003|Overall Study|Adverse Event|1|||
157140052|NCT04996797|567257596|FG000|Overall Study|Lack of Efficacy|0|||
157140053|NCT04996797|567257597|FG001|Overall Study|Lack of Efficacy|2|||
157140054|NCT04996797|567257598|FG002|Overall Study|Lack of Efficacy|0|||
157140055|NCT04996797|567257599|FG003|Overall Study|Lack of Efficacy|0|||
156732529|NCT04200651|565767650|FG001|Overall Study|Lost to Follow-up|3|||
156732530|NCT02547220|565767657|FG000|Overall Study|Withdrawal by Subject|1|||
156732531|NCT02547220|565767658|FG001|Overall Study|Withdrawal by Subject|0|||
156732532|NCT02547220|565767657|FG000|Overall Study|Study terminated by sponsor|18|||
156732533|NCT02547220|565767658|FG001|Overall Study|Study terminated by sponsor|20|||
157140056|NCT04996797|567257596|FG000|Overall Study|Prohibited Medication|0|||
157140057|NCT04996797|567257597|FG001|Overall Study|Prohibited Medication|1|||
156732534|NCT00789698|565767663|FG000|Overall Study|Lack of Efficacy|10|||
156732535|NCT00789698|565767664|FG001|Overall Study|Lack of Efficacy|4|||
156732536|NCT00789698|565767665|FG002|Overall Study|Lack of Efficacy|5|||
156732537|NCT00789698|565767666|FG003|Overall Study|Lack of Efficacy|18|||
156732538|NCT00789698|565767663|FG000|Overall Study|Adverse Event|5|||
156732539|NCT00789698|565767664|FG001|Overall Study|Adverse Event|5|||
156732540|NCT00789698|565767665|FG002|Overall Study|Adverse Event|3|||
156732541|NCT00789698|565767666|FG003|Overall Study|Adverse Event|4|||
156732542|NCT00789698|565767663|FG000|Overall Study|Lost to Follow-up|5|||
156732543|NCT00789698|565767664|FG001|Overall Study|Lost to Follow-up|5|||
156732544|NCT00789698|565767665|FG002|Overall Study|Lost to Follow-up|2|||
156732545|NCT00789698|565767666|FG003|Overall Study|Lost to Follow-up|9|||
156732546|NCT00789698|565767663|FG000|Overall Study|Protocol Violation|6|||
156732547|NCT00789698|565767664|FG001|Overall Study|Protocol Violation|1|||
156732548|NCT00789698|565767665|FG002|Overall Study|Protocol Violation|2|||
156732549|NCT00789698|565767666|FG003|Overall Study|Protocol Violation|1|||
156732550|NCT00789698|565767663|FG000|Overall Study|Withdrawal by Subject|14|||
156732551|NCT00789698|565767664|FG001|Overall Study|Withdrawal by Subject|15|||
156732552|NCT00789698|565767665|FG002|Overall Study|Withdrawal by Subject|12|||
156732553|NCT00789698|565767666|FG003|Overall Study|Withdrawal by Subject|19|||
156732554|NCT00789698|565767663|FG000|Overall Study|Administrative|0|||
156732555|NCT00789698|565767664|FG001|Overall Study|Administrative|3|||
156732556|NCT00789698|565767665|FG002|Overall Study|Administrative|3|||
156732557|NCT00789698|565767666|FG003|Overall Study|Administrative|1|||
156732558|NCT02981082|565767668|FG000|Overall Study|Withdrawal by Subject|2|||
156732559|NCT02981082|565767669|FG001|Overall Study|Withdrawal by Subject|0|||
156732560|NCT02981082|565767668|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
156732561|NCT02981082|565767669|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
156732562|NCT02981082|565767668|FG000|Overall Study|Adverse Event|0|||
156732563|NCT02981082|565767669|FG001|Overall Study|Adverse Event|1|||
156732564|NCT00596817|565767670|FG000|Open-label Period|Adverse Event|0|||
156732565|NCT00596817|565767671|FG001|Open-label Period|Adverse Event|49|||
156732566|NCT00596817|565767670|FG000|Open-label Period|Lack of Efficacy|0|||
156732567|NCT00596817|565767671|FG001|Open-label Period|Lack of Efficacy|33|||
156876575|NCT00798759|566307642|FG001|Overall Study|Lost to Follow-up|1|||
156876576|NCT00798759|566307641|FG000|Overall Study|Protocol Violation|4|||
156876577|NCT00798759|566307642|FG001|Overall Study|Protocol Violation|8|||
156876578|NCT00798759|566307641|FG000|Overall Study|Other|0|||
156876579|NCT00798759|566307642|FG001|Overall Study|Other|1|||
156876580|NCT03387111|566307643|FG000|Overall Study|Progressive Disease|3|||
156876581|NCT03387111|566307643|FG000|Overall Study|Other|1|||
156876582|NCT01945710|566307644|FG000|Overall Study|Progressive Disease|5|||
156876583|NCT01945710|566307645|FG001|Overall Study|Progressive Disease|4|||
156876584|NCT01945710|566307646|FG002|Overall Study|Progressive Disease|3|||
156876585|NCT01945710|566307647|FG003|Overall Study|Progressive Disease|2|||
156876586|NCT01945710|566307648|FG004|Overall Study|Progressive Disease|7|||
156876587|NCT01945710|566307649|FG005|Overall Study|Progressive Disease|3|||
156876588|NCT01945710|566307650|FG006|Overall Study|Progressive Disease|19|||
156876589|NCT01945710|566307644|FG000|Overall Study|Adverse Event|0|||
157140058|NCT04996797|567257598|FG002|Overall Study|Prohibited Medication|0|||
157140059|NCT04996797|567257599|FG003|Overall Study|Prohibited Medication|0|||
157140060|NCT04996797|567257596|FG000|Overall Study|Ongoing|68|||
157140061|NCT04996797|567257597|FG001|Overall Study|Ongoing|60|||
156732568|NCT00596817|565767670|FG000|Open-label Period|Other Reasons|0|||
156732569|NCT00596817|565767671|FG001|Open-label Period|Other Reasons|65|||
156732570|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
156732571|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
156732572|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
156876590|NCT01945710|566307645|FG001|Overall Study|Adverse Event|1|||
157140062|NCT04996797|567257598|FG002|Overall Study|Ongoing|22|||
157140063|NCT04996797|567257599|FG003|Overall Study|Ongoing|20|||
156732573|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
156732574|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
156732575|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
156732576|NCT00596817|565767670|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
156876591|NCT01945710|566307646|FG002|Overall Study|Adverse Event|0|||
156876592|NCT01945710|566307647|FG003|Overall Study|Adverse Event|0|||
156876593|NCT01945710|566307648|FG004|Overall Study|Adverse Event|0|||
156876594|NCT01945710|566307649|FG005|Overall Study|Adverse Event|0|||
156876595|NCT01945710|566307650|FG006|Overall Study|Adverse Event|0|||
157140064|NCT04996797|567257596|FG000|Overall Study|Withdrawal by Subject|0|||
156732577|NCT00596817|565767671|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
156732578|NCT00596817|565767670|FG000|Double-blind Period|Adverse Event|5|||
156732579|NCT00596817|565767671|FG001|Double-blind Period|Adverse Event|16|||
156732580|NCT00596817|565767670|FG000|Double-blind Period|Lack of Efficacy|52|||
156732581|NCT00596817|565767671|FG001|Double-blind Period|Lack of Efficacy|28|||
156732582|NCT00596817|565767670|FG000|Double-blind Period|Non-compliance With Study Product|3|||
156732583|NCT00596817|565767671|FG001|Double-blind Period|Non-compliance With Study Product|4|||
156732584|NCT00596817|565767670|FG000|Double-blind Period|Protocol Violation|11|||
156732585|NCT00596817|565767671|FG001|Double-blind Period|Protocol Violation|8|||
156732586|NCT00596817|565767670|FG000|Double-blind Period|Withdrawal of Consent|7|||
156732587|NCT00596817|565767671|FG001|Double-blind Period|Withdrawal of Consent|3|||
156732588|NCT00596817|565767670|FG000|Double-blind Period|Lost to Follow-up|0|||
156732589|NCT00596817|565767671|FG001|Double-blind Period|Lost to Follow-up|2|||
156732590|NCT00596817|565767670|FG000|Double-blind Period|Other Reasons|10|||
156732591|NCT00596817|565767671|FG001|Double-blind Period|Other Reasons|18|||
156732592|NCT01314872|565767680|FG000|Treatment Period 1|Protocol Violation|2|||
156732593|NCT01314872|565767681|FG001|Treatment Period 1|Protocol Violation|1|||
156732594|NCT01314872|565767682|FG002|Treatment Period 1|Protocol Violation|1|||
156732595|NCT01314872|565767683|FG003|Treatment Period 1|Protocol Violation|0|||
156732596|NCT01314872|565767684|FG004|Treatment Period 1|Protocol Violation|1|||
156732597|NCT01314872|565767685|FG005|Treatment Period 1|Protocol Violation|0|||
156732598|NCT01314872|565767686|FG006|Treatment Period 1|Protocol Violation|0|||
156732599|NCT01314872|565767687|FG007|Treatment Period 1|Protocol Violation|0|||
156732600|NCT01314872|565767688|FG008|Treatment Period 1|Protocol Violation|0|||
156732601|NCT01314872|565767689|FG009|Treatment Period 1|Protocol Violation|1|||
156732602|NCT01314872|565767690|FG010|Treatment Period 1|Protocol Violation|1|||
156732603|NCT01314872|565767691|FG011|Treatment Period 1|Protocol Violation|0|||
156732604|NCT01314872|565767692|FG012|Treatment Period 1|Protocol Violation|0|||
156732605|NCT01314872|565767693|FG013|Treatment Period 1|Protocol Violation|0|||
156732606|NCT01314872|565767694|FG014|Treatment Period 1|Protocol Violation|0|||
156732607|NCT01314872|565767680|FG000|Treatment Period 1|Physician Decision|0|||
156732608|NCT01314872|565767681|FG001|Treatment Period 1|Physician Decision|1|||
156732609|NCT01314872|565767682|FG002|Treatment Period 1|Physician Decision|0|||
156732610|NCT01314872|565767683|FG003|Treatment Period 1|Physician Decision|1|||
156732611|NCT01314872|565767684|FG004|Treatment Period 1|Physician Decision|0|||
156732612|NCT01314872|565767685|FG005|Treatment Period 1|Physician Decision|0|||
156732613|NCT01314872|565767686|FG006|Treatment Period 1|Physician Decision|0|||
156732614|NCT01314872|565767687|FG007|Treatment Period 1|Physician Decision|0|||
156732615|NCT01314872|565767688|FG008|Treatment Period 1|Physician Decision|0|||
156732616|NCT01314872|565767689|FG009|Treatment Period 1|Physician Decision|1|||
156732617|NCT01314872|565767690|FG010|Treatment Period 1|Physician Decision|0|||
156732618|NCT01314872|565767691|FG011|Treatment Period 1|Physician Decision|0|||
156732619|NCT01314872|565767692|FG012|Treatment Period 1|Physician Decision|0|||
156732620|NCT01314872|565767693|FG013|Treatment Period 1|Physician Decision|0|||
156732621|NCT01314872|565767694|FG014|Treatment Period 1|Physician Decision|0|||
156732622|NCT01314872|565767680|FG000|Treatment Period 1|Lack of Efficacy|1|||
156732623|NCT01314872|565767681|FG001|Treatment Period 1|Lack of Efficacy|0|||
156732624|NCT01314872|565767682|FG002|Treatment Period 1|Lack of Efficacy|0|||
156732625|NCT01314872|565767683|FG003|Treatment Period 1|Lack of Efficacy|0|||
156732626|NCT01314872|565767684|FG004|Treatment Period 1|Lack of Efficacy|0|||
156732627|NCT01314872|565767685|FG005|Treatment Period 1|Lack of Efficacy|1|||
156732628|NCT01314872|565767686|FG006|Treatment Period 1|Lack of Efficacy|0|||
156732629|NCT01314872|565767687|FG007|Treatment Period 1|Lack of Efficacy|2|||
156732630|NCT01314872|565767688|FG008|Treatment Period 1|Lack of Efficacy|0|||
156732631|NCT01314872|565767689|FG009|Treatment Period 1|Lack of Efficacy|0|||
156732632|NCT01314872|565767690|FG010|Treatment Period 1|Lack of Efficacy|0|||
156732633|NCT01314872|565767691|FG011|Treatment Period 1|Lack of Efficacy|0|||
156732634|NCT01314872|565767692|FG012|Treatment Period 1|Lack of Efficacy|0|||
156732635|NCT01314872|565767693|FG013|Treatment Period 1|Lack of Efficacy|0|||
156732636|NCT01314872|565767694|FG014|Treatment Period 1|Lack of Efficacy|0|||
156732637|NCT01314872|565767680|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
156732638|NCT01314872|565767681|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
156732639|NCT01314872|565767682|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
156732640|NCT01314872|565767683|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
156732641|NCT01314872|565767684|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
156732642|NCT01314872|565767685|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
156732643|NCT01314872|565767686|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
156732644|NCT01314872|565767687|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
156732645|NCT01314872|565767688|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
156732646|NCT01314872|565767689|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
156732647|NCT01314872|565767690|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
156796707|NCT01822925|566009651|FG002|Overall Study|Taking prohibited medication|0|||
156732648|NCT01314872|565767691|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
156732649|NCT01314872|565767692|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
156732650|NCT01314872|565767693|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
156732651|NCT01314872|565767694|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
156732652|NCT01314872|565767680|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156732653|NCT01314872|565767681|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156732654|NCT01314872|565767682|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156732655|NCT01314872|565767683|FG003|Treatment Period 1|Withdrawal by Subject|2|||
156732656|NCT01314872|565767684|FG004|Treatment Period 1|Withdrawal by Subject|3|||
156732657|NCT01314872|565767685|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156732658|NCT01314872|565767686|FG006|Treatment Period 1|Withdrawal by Subject|3|||
156732659|NCT01314872|565767687|FG007|Treatment Period 1|Withdrawal by Subject|2|||
156732660|NCT01314872|565767688|FG008|Treatment Period 1|Withdrawal by Subject|2|||
156732661|NCT01314872|565767689|FG009|Treatment Period 1|Withdrawal by Subject|2|||
156732662|NCT01314872|565767690|FG010|Treatment Period 1|Withdrawal by Subject|1|||
156732663|NCT01314872|565767691|FG011|Treatment Period 1|Withdrawal by Subject|0|||
156732664|NCT01314872|565767692|FG012|Treatment Period 1|Withdrawal by Subject|0|||
156732665|NCT01314872|565767693|FG013|Treatment Period 1|Withdrawal by Subject|0|||
156732666|NCT01314872|565767694|FG014|Treatment Period 1|Withdrawal by Subject|0|||
156732667|NCT01314872|565767680|FG000|Treatment Period 1|Lost to Follow-up|0|||
156732668|NCT01314872|565767681|FG001|Treatment Period 1|Lost to Follow-up|1|||
156732669|NCT01314872|565767682|FG002|Treatment Period 1|Lost to Follow-up|2|||
156732670|NCT01314872|565767683|FG003|Treatment Period 1|Lost to Follow-up|2|||
156732671|NCT01314872|565767684|FG004|Treatment Period 1|Lost to Follow-up|1|||
156732672|NCT01314872|565767685|FG005|Treatment Period 1|Lost to Follow-up|1|||
156732673|NCT01314872|565767686|FG006|Treatment Period 1|Lost to Follow-up|1|||
156732674|NCT01314872|565767687|FG007|Treatment Period 1|Lost to Follow-up|1|||
156732675|NCT01314872|565767688|FG008|Treatment Period 1|Lost to Follow-up|1|||
156732676|NCT01314872|565767689|FG009|Treatment Period 1|Lost to Follow-up|0|||
156732677|NCT01314872|565767690|FG010|Treatment Period 1|Lost to Follow-up|0|||
156732678|NCT01314872|565767691|FG011|Treatment Period 1|Lost to Follow-up|0|||
156732679|NCT01314872|565767692|FG012|Treatment Period 1|Lost to Follow-up|0|||
156732680|NCT01314872|565767693|FG013|Treatment Period 1|Lost to Follow-up|0|||
156732681|NCT01314872|565767694|FG014|Treatment Period 1|Lost to Follow-up|0|||
156732682|NCT01314872|565767680|FG000|Period 2|Protocol Violation|0|||
156732683|NCT01314872|565767681|FG001|Period 2|Protocol Violation|0|||
156732684|NCT01314872|565767682|FG002|Period 2|Protocol Violation|0|||
156732685|NCT01314872|565767683|FG003|Period 2|Protocol Violation|0|||
156732686|NCT01314872|565767684|FG004|Period 2|Protocol Violation|0|||
156732687|NCT01314872|565767685|FG005|Period 2|Protocol Violation|0|||
156732688|NCT01314872|565767686|FG006|Period 2|Protocol Violation|0|||
156732689|NCT01314872|565767687|FG007|Period 2|Protocol Violation|0|||
156732690|NCT01314872|565767688|FG008|Period 2|Protocol Violation|0|||
156732691|NCT01314872|565767689|FG009|Period 2|Protocol Violation|0|||
156732692|NCT01314872|565767690|FG010|Period 2|Protocol Violation|0|||
156732693|NCT01314872|565767691|FG011|Period 2|Protocol Violation|3|||
156732694|NCT01314872|565767692|FG012|Period 2|Protocol Violation|3|||
156732695|NCT01314872|565767693|FG013|Period 2|Protocol Violation|2|||
156732696|NCT01314872|565767694|FG014|Period 2|Protocol Violation|0|||
156732697|NCT01314872|565767680|FG000|Period 2|Non-compliance with study drug|0|||
156732698|NCT01314872|565767681|FG001|Period 2|Non-compliance with study drug|0|||
156732699|NCT01314872|565767682|FG002|Period 2|Non-compliance with study drug|0|||
156732700|NCT01314872|565767683|FG003|Period 2|Non-compliance with study drug|0|||
156732701|NCT01314872|565767684|FG004|Period 2|Non-compliance with study drug|0|||
156732702|NCT01314872|565767685|FG005|Period 2|Non-compliance with study drug|0|||
156732703|NCT01314872|565767686|FG006|Period 2|Non-compliance with study drug|0|||
156732704|NCT01314872|565767687|FG007|Period 2|Non-compliance with study drug|0|||
156732705|NCT01314872|565767688|FG008|Period 2|Non-compliance with study drug|0|||
156732706|NCT01314872|565767689|FG009|Period 2|Non-compliance with study drug|0|||
156732707|NCT01314872|565767690|FG010|Period 2|Non-compliance with study drug|0|||
156732708|NCT01314872|565767691|FG011|Period 2|Non-compliance with study drug|3|||
156732709|NCT01314872|565767692|FG012|Period 2|Non-compliance with study drug|3|||
156732710|NCT01314872|565767693|FG013|Period 2|Non-compliance with study drug|1|||
156732711|NCT01314872|565767694|FG014|Period 2|Non-compliance with study drug|2|||
156732712|NCT01314872|565767680|FG000|Period 2|Lack of Efficacy|0|||
156732713|NCT01314872|565767681|FG001|Period 2|Lack of Efficacy|0|||
156732714|NCT01314872|565767682|FG002|Period 2|Lack of Efficacy|0|||
156732715|NCT01314872|565767683|FG003|Period 2|Lack of Efficacy|0|||
156732716|NCT01314872|565767684|FG004|Period 2|Lack of Efficacy|0|||
156732717|NCT01314872|565767685|FG005|Period 2|Lack of Efficacy|0|||
156732718|NCT01314872|565767686|FG006|Period 2|Lack of Efficacy|0|||
156732719|NCT01314872|565767687|FG007|Period 2|Lack of Efficacy|0|||
156732720|NCT01314872|565767688|FG008|Period 2|Lack of Efficacy|0|||
156732721|NCT01314872|565767689|FG009|Period 2|Lack of Efficacy|0|||
156732722|NCT01314872|565767690|FG010|Period 2|Lack of Efficacy|0|||
156732723|NCT01314872|565767691|FG011|Period 2|Lack of Efficacy|7|||
156732724|NCT01314872|565767692|FG012|Period 2|Lack of Efficacy|12|||
156732725|NCT01314872|565767693|FG013|Period 2|Lack of Efficacy|9|||
156732726|NCT01314872|565767694|FG014|Period 2|Lack of Efficacy|2|||
156732727|NCT01314872|565767680|FG000|Period 2|Pregnancy|0|||
156732728|NCT01314872|565767681|FG001|Period 2|Pregnancy|0|||
156732729|NCT01314872|565767682|FG002|Period 2|Pregnancy|0|||
156732730|NCT01314872|565767683|FG003|Period 2|Pregnancy|0|||
156732731|NCT01314872|565767684|FG004|Period 2|Pregnancy|0|||
156732732|NCT01314872|565767685|FG005|Period 2|Pregnancy|0|||
156732733|NCT01314872|565767686|FG006|Period 2|Pregnancy|0|||
156732734|NCT01314872|565767687|FG007|Period 2|Pregnancy|0|||
156732735|NCT01314872|565767688|FG008|Period 2|Pregnancy|0|||
156732736|NCT01314872|565767689|FG009|Period 2|Pregnancy|0|||
156732737|NCT01314872|565767690|FG010|Period 2|Pregnancy|0|||
156732738|NCT01314872|565767691|FG011|Period 2|Pregnancy|0|||
156732739|NCT01314872|565767692|FG012|Period 2|Pregnancy|0|||
156732740|NCT01314872|565767693|FG013|Period 2|Pregnancy|0|||
156732741|NCT01314872|565767694|FG014|Period 2|Pregnancy|1|||
156732742|NCT01314872|565767680|FG000|Period 2|Study terminated by Sponsor|0|||
156732743|NCT01314872|565767681|FG001|Period 2|Study terminated by Sponsor|0|||
156732744|NCT01314872|565767682|FG002|Period 2|Study terminated by Sponsor|0|||
156732745|NCT01314872|565767683|FG003|Period 2|Study terminated by Sponsor|0|||
156732746|NCT01314872|565767684|FG004|Period 2|Study terminated by Sponsor|0|||
156732747|NCT01314872|565767685|FG005|Period 2|Study terminated by Sponsor|0|||
156732748|NCT01314872|565767686|FG006|Period 2|Study terminated by Sponsor|0|||
156732749|NCT01314872|565767687|FG007|Period 2|Study terminated by Sponsor|0|||
156732750|NCT01314872|565767688|FG008|Period 2|Study terminated by Sponsor|0|||
156732751|NCT01314872|565767689|FG009|Period 2|Study terminated by Sponsor|0|||
156732752|NCT01314872|565767690|FG010|Period 2|Study terminated by Sponsor|0|||
156732753|NCT01314872|565767691|FG011|Period 2|Study terminated by Sponsor|2|||
156732754|NCT01314872|565767692|FG012|Period 2|Study terminated by Sponsor|2|||
156732755|NCT01314872|565767693|FG013|Period 2|Study terminated by Sponsor|3|||
156732756|NCT01314872|565767694|FG014|Period 2|Study terminated by Sponsor|0|||
156732757|NCT01314872|565767680|FG000|Period 2|Adverse event, non-fatal|0|||
156732758|NCT01314872|565767681|FG001|Period 2|Adverse event, non-fatal|0|||
156732759|NCT01314872|565767682|FG002|Period 2|Adverse event, non-fatal|0|||
156732760|NCT01314872|565767683|FG003|Period 2|Adverse event, non-fatal|0|||
156732761|NCT01314872|565767684|FG004|Period 2|Adverse event, non-fatal|0|||
156732762|NCT01314872|565767685|FG005|Period 2|Adverse event, non-fatal|0|||
156732763|NCT01314872|565767686|FG006|Period 2|Adverse event, non-fatal|0|||
156732764|NCT01314872|565767687|FG007|Period 2|Adverse event, non-fatal|0|||
156732765|NCT01314872|565767688|FG008|Period 2|Adverse event, non-fatal|0|||
156732766|NCT01314872|565767689|FG009|Period 2|Adverse event, non-fatal|0|||
156732767|NCT01314872|565767690|FG010|Period 2|Adverse event, non-fatal|0|||
156732768|NCT01314872|565767691|FG011|Period 2|Adverse event, non-fatal|13|||
156732769|NCT01314872|565767692|FG012|Period 2|Adverse event, non-fatal|16|||
156732770|NCT01314872|565767693|FG013|Period 2|Adverse event, non-fatal|24|||
156732771|NCT01314872|565767694|FG014|Period 2|Adverse event, non-fatal|9|||
156732772|NCT01314872|565767680|FG000|Period 2|Withdrawal by Subject|0|||
156732773|NCT01314872|565767681|FG001|Period 2|Withdrawal by Subject|0|||
156732774|NCT01314872|565767682|FG002|Period 2|Withdrawal by Subject|0|||
156732775|NCT01314872|565767683|FG003|Period 2|Withdrawal by Subject|0|||
156732776|NCT01314872|565767684|FG004|Period 2|Withdrawal by Subject|0|||
156732777|NCT01314872|565767685|FG005|Period 2|Withdrawal by Subject|0|||
156732778|NCT01314872|565767686|FG006|Period 2|Withdrawal by Subject|0|||
156732779|NCT01314872|565767687|FG007|Period 2|Withdrawal by Subject|0|||
156732780|NCT01314872|565767688|FG008|Period 2|Withdrawal by Subject|0|||
156732781|NCT01314872|565767689|FG009|Period 2|Withdrawal by Subject|0|||
156732782|NCT01314872|565767690|FG010|Period 2|Withdrawal by Subject|0|||
156732783|NCT01314872|565767691|FG011|Period 2|Withdrawal by Subject|14|||
156732784|NCT01314872|565767692|FG012|Period 2|Withdrawal by Subject|17|||
156732785|NCT01314872|565767693|FG013|Period 2|Withdrawal by Subject|12|||
156732786|NCT01314872|565767694|FG014|Period 2|Withdrawal by Subject|4|||
156732787|NCT01314872|565767680|FG000|Period 2|Lost to Follow-up|0|||
156732788|NCT01314872|565767681|FG001|Period 2|Lost to Follow-up|0|||
156732789|NCT01314872|565767682|FG002|Period 2|Lost to Follow-up|0|||
156732790|NCT01314872|565767683|FG003|Period 2|Lost to Follow-up|0|||
156732791|NCT01314872|565767684|FG004|Period 2|Lost to Follow-up|0|||
156732792|NCT01314872|565767685|FG005|Period 2|Lost to Follow-up|0|||
156732793|NCT01314872|565767686|FG006|Period 2|Lost to Follow-up|0|||
156732794|NCT01314872|565767687|FG007|Period 2|Lost to Follow-up|0|||
156732795|NCT01314872|565767688|FG008|Period 2|Lost to Follow-up|0|||
156732796|NCT01314872|565767689|FG009|Period 2|Lost to Follow-up|0|||
156732797|NCT01314872|565767690|FG010|Period 2|Lost to Follow-up|0|||
156732798|NCT01314872|565767691|FG011|Period 2|Lost to Follow-up|6|||
156732799|NCT01314872|565767692|FG012|Period 2|Lost to Follow-up|7|||
156732800|NCT01314872|565767693|FG013|Period 2|Lost to Follow-up|2|||
156732801|NCT01314872|565767694|FG014|Period 2|Lost to Follow-up|6|||
156732802|NCT00199797|565769032|FG000|Overall Study|Progressive Disease|1|||
156732803|NCT00199797|565769032|FG000|Overall Study|Adverse Event|1|||
156732804|NCT00199797|565769032|FG000|Overall Study|Physician Decision|1|||
156732805|NCT00504725|565769035|FG000|Overall Study|Protocol Violation|1|||
156732806|NCT00504725|565769036|FG001|Overall Study|Protocol Violation|0|||
156732807|NCT01435018|565769037|FG000|Overall Study|Death|37|||
156732808|NCT01435018|565769038|FG001|Overall Study|Death|18|||
156732809|NCT01435018|565769039|FG002|Overall Study|Death|25|||
156732810|NCT01435018|565769037|FG000|Overall Study|Site is closing|4|||
156732811|NCT01435018|565769038|FG001|Overall Study|Site is closing|9|||
156732812|NCT01435018|565769039|FG002|Overall Study|Site is closing|7|||
156732813|NCT01435018|565769037|FG000|Overall Study|Withdrew consent|0|||
156732814|NCT01435018|565769038|FG001|Overall Study|Withdrew consent|3|||
156732815|NCT01435018|565769039|FG002|Overall Study|Withdrew consent|1|||
156732816|NCT01435018|565769037|FG000|Overall Study|Not willing to adhere to requirements|0|||
156732817|NCT01435018|565769038|FG001|Overall Study|Not willing to adhere to requirements|2|||
156732818|NCT01435018|565769039|FG002|Overall Study|Not willing to adhere to requirements|3|||
156732819|NCT01435018|565769037|FG000|Overall Study|Not able to get to clinic|2|||
156732820|NCT01435018|565769038|FG001|Overall Study|Not able to get to clinic|0|||
156732821|NCT01435018|565769039|FG002|Overall Study|Not able to get to clinic|2|||
156732822|NCT01435018|565769037|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156732823|NCT01435018|565769038|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156732824|NCT01435018|565769039|FG002|Overall Study|Severe debilitation, unable to continue|1|||
156732825|NCT01435018|565769037|FG000|Overall Study|Unable to contact participant/parent|1|||
156732826|NCT01435018|565769038|FG001|Overall Study|Unable to contact participant/parent|1|||
156732827|NCT01435018|565769039|FG002|Overall Study|Unable to contact participant/parent|1|||
156732828|NCT01435018|565769037|FG000|Overall Study|Enrollment Violation|0|||
156732829|NCT01435018|565769038|FG001|Overall Study|Enrollment Violation|1|||
156732830|NCT01435018|565769039|FG002|Overall Study|Enrollment Violation|0|||
156732831|NCT01435018|565769037|FG000|Overall Study|Never started chemotherapy|3|||
156732832|NCT01435018|565769038|FG001|Overall Study|Never started chemotherapy|0|||
156732833|NCT01435018|565769039|FG002|Overall Study|Never started chemotherapy|1|||
156732834|NCT00378508|565769040|FG000|Overall Study|Withdrawal by Subject|1|||
156732835|NCT00378508|565769041|FG001|Overall Study|Withdrawal by Subject|3|||
156732836|NCT00378508|565769040|FG000|Overall Study|Lost to Follow-up|1|||
156732837|NCT00378508|565769041|FG001|Overall Study|Lost to Follow-up|0|||
156732838|NCT03205761|565769042|FG000|Overall Study|Withdrawal by Subject|1|||
156732839|NCT03205761|565769042|FG000|Overall Study|Progressive Disease|10|||
156732840|NCT00636194|565769043|FG000|Overall Study|Study related symptoms and complaints|1|||
156732841|NCT00636194|565769044|FG001|Overall Study|Study related symptoms and complaints|0|||
156732842|NCT00636194|565769043|FG000|Overall Study|Protocol Violation|2|||
156732843|NCT00636194|565769044|FG001|Overall Study|Protocol Violation|0|||
156732844|NCT00972816|565769046|FG000|Overall Study|Adverse Event|0|||
156732845|NCT00972816|565769047|FG001|Overall Study|Adverse Event|0|||
156732846|NCT00972816|565769048|FG002|Overall Study|Adverse Event|1|||
156732847|NCT00972816|565769049|FG003|Overall Study|Adverse Event|0|||
156732848|NCT00972816|565769050|FG004|Overall Study|Adverse Event|0|||
156732849|NCT00972816|565769051|FG005|Overall Study|Adverse Event|0|||
156732850|NCT00972816|565769052|FG006|Overall Study|Adverse Event|0|||
156732851|NCT00972816|565769053|FG007|Overall Study|Adverse Event|0|||
156732852|NCT00972816|565769046|FG000|Overall Study|Withdrawal by Subject|4|||
156732853|NCT00972816|565769047|FG001|Overall Study|Withdrawal by Subject|2|||
156732854|NCT00972816|565769048|FG002|Overall Study|Withdrawal by Subject|1|||
156732855|NCT00972816|565769049|FG003|Overall Study|Withdrawal by Subject|3|||
156732856|NCT00972816|565769050|FG004|Overall Study|Withdrawal by Subject|0|||
156732857|NCT00972816|565769051|FG005|Overall Study|Withdrawal by Subject|1|||
156732858|NCT00972816|565769052|FG006|Overall Study|Withdrawal by Subject|1|||
156732859|NCT00972816|565769053|FG007|Overall Study|Withdrawal by Subject|2|||
156732860|NCT00972816|565769046|FG000|Overall Study|Lost to Follow-up|11|||
156732861|NCT00972816|565769047|FG001|Overall Study|Lost to Follow-up|9|||
156732862|NCT00972816|565769048|FG002|Overall Study|Lost to Follow-up|7|||
156732863|NCT00972816|565769049|FG003|Overall Study|Lost to Follow-up|5|||
156732864|NCT00972816|565769050|FG004|Overall Study|Lost to Follow-up|11|||
156732865|NCT00972816|565769051|FG005|Overall Study|Lost to Follow-up|10|||
156732866|NCT00972816|565769052|FG006|Overall Study|Lost to Follow-up|7|||
156732867|NCT00972816|565769053|FG007|Overall Study|Lost to Follow-up|7|||
156732868|NCT00972816|565769046|FG000|Overall Study|Inappropriate enrolment|0|||
156732869|NCT00972816|565769047|FG001|Overall Study|Inappropriate enrolment|0|||
156732870|NCT00972816|565769048|FG002|Overall Study|Inappropriate enrolment|0|||
156732871|NCT00972816|565769049|FG003|Overall Study|Inappropriate enrolment|0|||
156732872|NCT00972816|565769050|FG004|Overall Study|Inappropriate enrolment|0|||
156732873|NCT00972816|565769051|FG005|Overall Study|Inappropriate enrolment|0|||
156732874|NCT00972816|565769052|FG006|Overall Study|Inappropriate enrolment|2|||
156732875|NCT00972816|565769053|FG007|Overall Study|Inappropriate enrolment|0|||
156732876|NCT00972816|565769046|FG000|Overall Study|Unable to classify|2|||
156732877|NCT00972816|565769047|FG001|Overall Study|Unable to classify|0|||
156732878|NCT00972816|565769048|FG002|Overall Study|Unable to classify|0|||
156732879|NCT00972816|565769049|FG003|Overall Study|Unable to classify|0|||
156732880|NCT00972816|565769050|FG004|Overall Study|Unable to classify|1|||
156732881|NCT00972816|565769051|FG005|Overall Study|Unable to classify|0|||
156732882|NCT00972816|565769052|FG006|Overall Study|Unable to classify|0|||
157020047|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156732883|NCT00972816|565769053|FG007|Overall Study|Unable to classify|0|||
156732884|NCT02163226|565769054|FG000|Overall Study|Death|2|||
156732885|NCT02163226|565769055|FG001|Overall Study|Death|1|||
156732886|NCT02163226|565769054|FG000|Overall Study|Withdrawal by Subject|5|||
156732887|NCT02163226|565769055|FG001|Overall Study|Withdrawal by Subject|2|||
156732888|NCT02163226|565769054|FG000|Overall Study|Returned home, local radiotherapy|3|||
156732889|NCT02163226|565769055|FG001|Overall Study|Returned home, local radiotherapy|0|||
156732890|NCT02163226|565769054|FG000|Overall Study|Repeat imaging showed no disease|2|||
156732891|NCT02163226|565769055|FG001|Overall Study|Repeat imaging showed no disease|0|||
156732892|NCT02163226|565769054|FG000|Overall Study|Incomplete radiotherapy|3|||
156732893|NCT02163226|565769055|FG001|Overall Study|Incomplete radiotherapy|0|||
156732894|NCT02163226|565769054|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
156732895|NCT02163226|565769055|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
156732896|NCT02163226|565769054|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
156732897|NCT02163226|565769055|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
156732898|NCT02163226|565769054|FG000|Overall Study|ineligible|0|||
156732899|NCT02163226|565769055|FG001|Overall Study|ineligible|3|||
156732900|NCT00593684|565769058|FG000|Overall Study|Death|2|||
156732901|NCT00593684|565769059|FG001|Overall Study|Death|1|||
156732902|NCT03625466|565769060|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
156732903|NCT03625466|565769061|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
156732904|NCT03625466|565769062|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
156732905|NCT03625466|565769060|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732906|NCT03625466|565769061|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156732907|NCT03625466|565769062|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732908|NCT03625466|565769060|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732909|NCT03625466|565769061|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
156732910|NCT03625466|565769062|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
156732911|NCT05318092|565769064|FG000|Overall Study|Lost to Follow-up|3|||
156732912|NCT05318092|565769064|FG000|Overall Study|Withdrawal by Subject|1|||
156732913|NCT01905553|565769069|FG000|Period 2|Adverse Event|1|||
156732914|NCT01905553|565769070|FG001|Period 2|Adverse Event|0|||
156732915|NCT04696055|565769072|FG000|Overall Study|Adverse Event|10|||
156732916|NCT04696055|565769073|FG001|Overall Study|Adverse Event|2|||
156732917|NCT04696055|565769072|FG000|Overall Study|Death|4|||
156732918|NCT04696055|565769073|FG001|Overall Study|Death|0|||
156732919|NCT04696055|565769072|FG000|Overall Study|Other|7|||
156732920|NCT04696055|565769073|FG001|Overall Study|Other|2|||
156732921|NCT04696055|565769072|FG000|Overall Study|Physician Decision|3|||
156732922|NCT04696055|565769073|FG001|Overall Study|Physician Decision|0|||
156732923|NCT04696055|565769072|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
156732924|NCT04696055|565769073|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
156732925|NCT04696055|565769072|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
156732926|NCT04696055|565769073|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
156732927|NCT04696055|565769072|FG000|Overall Study|Subject Decision|1|||
156732928|NCT04696055|565769073|FG001|Overall Study|Subject Decision|2|||
156732929|NCT03969901|565769074|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156732930|NCT03969901|565769075|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156732931|NCT03969901|565769076|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156732932|NCT03969901|565769077|FG003|Overall Study|Withdrawal by parent/guardian|0|||
156732933|NCT03969901|565769078|FG004|Overall Study|Withdrawal by parent/guardian|1|||
156732934|NCT03969901|565769079|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156732935|NCT03969901|565769080|FG006|Overall Study|Withdrawal by parent/guardian|0|||
156732936|NCT03969901|565769081|FG007|Overall Study|Withdrawal by parent/guardian|1|||
156732937|NCT03969901|565769082|FG008|Overall Study|Withdrawal by parent/guardian|1|||
156876596|NCT01945710|566307644|FG000|Overall Study|Other|2|||
156876597|NCT01945710|566307645|FG001|Overall Study|Other|0|||
156732938|NCT03969901|565769083|FG009|Overall Study|Withdrawal by parent/guardian|0|||
156732939|NCT00348595|565769084|FG000|Overall Study|Adverse Event|5|||
156732940|NCT00348595|565769085|FG001|Overall Study|Adverse Event|8|||
156732941|NCT00610155|565769090|FG000|Period 1|Withdrawal by Subject|0|||
156732942|NCT00610155|565769091|FG001|Period 1|Withdrawal by Subject|0|||
156876598|NCT01945710|566307646|FG002|Overall Study|Other|3|||
156876599|NCT01945710|566307647|FG003|Overall Study|Other|1|||
156732943|NCT00610155|565769092|FG002|Period 1|Withdrawal by Subject|1|||
156732944|NCT00610155|565769093|FG003|Period 1|Withdrawal by Subject|0|||
156732945|NCT00610155|565769094|FG004|Period 1|Withdrawal by Subject|0|||
156732946|NCT00610155|565769095|FG005|Period 1|Withdrawal by Subject|0|||
156732947|NCT00610155|565769090|FG000|Period 3|Adverse Event|1|||
156732948|NCT00610155|565769091|FG001|Period 3|Adverse Event|0|||
156732949|NCT00610155|565769092|FG002|Period 3|Adverse Event|0|||
156732950|NCT00610155|565769093|FG003|Period 3|Adverse Event|0|||
156732951|NCT00610155|565769094|FG004|Period 3|Adverse Event|0|||
156732952|NCT00610155|565769095|FG005|Period 3|Adverse Event|0|||
156876600|NCT01945710|566307648|FG004|Overall Study|Other|1|||
156876601|NCT01945710|566307649|FG005|Overall Study|Other|0|||
156732953|NCT03192306|565769100|FG000|Overall Study|Did not treat cold sore during study|149|||
156732954|NCT03192306|565769101|FG001|Overall Study|Did not treat cold sore during study|143|||
156732955|NCT03192306|565769100|FG000|Overall Study|Withdrawal by Subject|1|||
156732956|NCT03192306|565769101|FG001|Overall Study|Withdrawal by Subject|1|||
156732957|NCT03192306|565769100|FG000|Overall Study|Lost to Follow-up|1|||
156732958|NCT03192306|565769101|FG001|Overall Study|Lost to Follow-up|0|||
156732959|NCT03192306|565769100|FG000|Overall Study|Protocol Violation|1|||
156732960|NCT03192306|565769101|FG001|Overall Study|Protocol Violation|1|||
156732961|NCT02589626|565769106|FG000|Overall Study|Other than the reason specified|1|||
156732962|NCT02589626|565769107|FG001|Overall Study|Other than the reason specified|0|||
156732963|NCT02589626|565769106|FG000|Overall Study|Withdrawal by Subject|1|||
156732964|NCT02589626|565769107|FG001|Overall Study|Withdrawal by Subject|1|||
156732965|NCT02589626|565769106|FG000|Overall Study|Adverse Event|1|||
156732966|NCT02589626|565769107|FG001|Overall Study|Adverse Event|1|||
156732967|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
156732968|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732969|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732970|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
156732971|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732972|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
156732973|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732974|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
156732975|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732976|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732977|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
156732978|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
156732979|NCT03645395|565769108|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
156732980|NCT03645395|565769109|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
156732981|NCT03645395|565769110|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
156732982|NCT03645395|565769111|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
156732983|NCT00379080|565769112|FG000|Overall Study|Withdrawal by Subject|0|||
156732984|NCT00379080|565769113|FG001|Overall Study|Withdrawal by Subject|4|||
156732985|NCT00379080|565769114|FG002|Overall Study|Withdrawal by Subject|0|||
156732986|NCT01250873|565769126|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
156732987|NCT01250873|565769126|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
156732988|NCT01127451|565769130|FG000|Overall Study|Other|2|||
156732989|NCT01127451|565769131|FG001|Overall Study|Other|1|||
156732990|NCT01127451|565769130|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
156732991|NCT01127451|565769131|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
156732992|NCT01127451|565769130|FG000|Overall Study|Death|22|||
156732993|NCT01127451|565769131|FG001|Overall Study|Death|17|||
156732994|NCT01127451|565769130|FG000|Overall Study|Lost to Follow-up|3|||
156732995|NCT01127451|565769131|FG001|Overall Study|Lost to Follow-up|0|||
156732996|NCT01127451|565769130|FG000|Overall Study|Administrative Reason by Sponsor|2|||
156732997|NCT01127451|565769131|FG001|Overall Study|Administrative Reason by Sponsor|2|||
156732998|NCT02429778|565769133|FG000|Overall Study|Lost to Follow-up|2|||
156732999|NCT02429778|565769134|FG001|Overall Study|Lost to Follow-up|0|||
156733000|NCT02429778|565769133|FG000|Overall Study|Withdrawal by Subject|5|||
156733001|NCT02429778|565769134|FG001|Overall Study|Withdrawal by Subject|0|||
156733002|NCT02475265|565769135|FG000|Overall Study|Physician Decision|1|||
156733003|NCT02475265|565769135|FG000|Overall Study|Withdrawal by Subject|2|||
156733004|NCT03499899|565769136|FG000|Overall Study|Adverse Event|2|||
156733005|NCT03499899|565769137|FG001|Overall Study|Adverse Event|3|||
156733006|NCT03499899|565769138|FG002|Overall Study|Adverse Event|3|||
156733007|NCT03499899|565769136|FG000|Overall Study|Death|0|||
156733008|NCT03499899|565769137|FG001|Overall Study|Death|0|||
156733009|NCT03499899|565769138|FG002|Overall Study|Death|1|||
157217556|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
157217557|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
157217558|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
156733010|NCT03499899|565769136|FG000|Overall Study|Physician Decision|3|||
156733011|NCT03499899|565769137|FG001|Overall Study|Physician Decision|6|||
156733012|NCT03499899|565769138|FG002|Overall Study|Physician Decision|6|||
156733013|NCT03499899|565769136|FG000|Overall Study|Progressive disease|15|||
156733014|NCT03499899|565769137|FG001|Overall Study|Progressive disease|23|||
156733015|NCT03499899|565769138|FG002|Overall Study|Progressive disease|23|||
156733016|NCT03499899|565769136|FG000|Overall Study|Patient decision|0|||
156733017|NCT03499899|565769137|FG001|Overall Study|Patient decision|1|||
156733018|NCT03499899|565769138|FG002|Overall Study|Patient decision|1|||
156733019|NCT03499899|565769136|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
156733020|NCT03499899|565769137|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
156733021|NCT03499899|565769138|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
156733022|NCT04590586|565769143|FG000|Overall Study|Death|7|||
157217559|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
157140065|NCT04996797|567257597|FG001|Overall Study|Withdrawal by Subject|2|||
157140066|NCT04996797|567257598|FG002|Overall Study|Withdrawal by Subject|0|||
156733023|NCT04590586|565769144|FG001|Overall Study|Death|1|||
156733024|NCT04590586|565769145|FG002|Overall Study|Death|37|||
156733025|NCT04590586|565769146|FG003|Overall Study|Death|34|||
156733026|NCT04590586|565769147|FG004|Overall Study|Death|19|||
156733027|NCT04590586|565769148|FG005|Overall Study|Death|3|||
156733028|NCT04590586|565769143|FG000|Overall Study|Lost to Follow-up|3|||
156733029|NCT04590586|565769144|FG001|Overall Study|Lost to Follow-up|0|||
156733030|NCT04590586|565769145|FG002|Overall Study|Lost to Follow-up|11|||
156733031|NCT04590586|565769146|FG003|Overall Study|Lost to Follow-up|11|||
156733032|NCT04590586|565769147|FG004|Overall Study|Lost to Follow-up|6|||
156733033|NCT04590586|565769148|FG005|Overall Study|Lost to Follow-up|0|||
156733034|NCT04590586|565769143|FG000|Overall Study|Withdrawal by Subject|0|||
156733035|NCT04590586|565769144|FG001|Overall Study|Withdrawal by Subject|0|||
156733036|NCT04590586|565769145|FG002|Overall Study|Withdrawal by Subject|6|||
156733037|NCT04590586|565769146|FG003|Overall Study|Withdrawal by Subject|0|||
156733038|NCT04590586|565769147|FG004|Overall Study|Withdrawal by Subject|3|||
156733039|NCT04590586|565769148|FG005|Overall Study|Withdrawal by Subject|0|||
156733040|NCT04590586|565769143|FG000|Overall Study|Other|3|||
156733041|NCT04590586|565769144|FG001|Overall Study|Other|0|||
156733042|NCT04590586|565769145|FG002|Overall Study|Other|1|||
156733043|NCT04590586|565769146|FG003|Overall Study|Other|1|||
156733044|NCT04590586|565769147|FG004|Overall Study|Other|2|||
156733045|NCT04590586|565769148|FG005|Overall Study|Other|1|||
156733046|NCT03063086|565769149|FG000|Overall Study|technical problems|1|||
156733047|NCT03063086|565769150|FG001|Overall Study|technical problems|0|||
156733048|NCT03063086|565769151|FG002|Overall Study|technical problems|0|||
156733049|NCT03063086|565769152|FG003|Overall Study|technical problems|0|||
156733050|NCT03063086|565769153|FG004|Overall Study|technical problems|0|||
156733051|NCT03063086|565769154|FG005|Overall Study|technical problems|0|||
156733052|NCT03063086|565769149|FG000|Overall Study|Adverse Event|1|||
156733053|NCT03063086|565769150|FG001|Overall Study|Adverse Event|1|||
156733054|NCT03063086|565769151|FG002|Overall Study|Adverse Event|1|||
156733055|NCT03063086|565769152|FG003|Overall Study|Adverse Event|1|||
156733056|NCT03063086|565769153|FG004|Overall Study|Adverse Event|0|||
156733057|NCT03063086|565769154|FG005|Overall Study|Adverse Event|0|||
156733058|NCT03063086|565769149|FG000|Overall Study|subject/guardian decision|1|||
156733059|NCT03063086|565769150|FG001|Overall Study|subject/guardian decision|0|||
156733060|NCT03063086|565769151|FG002|Overall Study|subject/guardian decision|0|||
156733061|NCT03063086|565769152|FG003|Overall Study|subject/guardian decision|0|||
156733062|NCT03063086|565769153|FG004|Overall Study|subject/guardian decision|0|||
156733063|NCT03063086|565769154|FG005|Overall Study|subject/guardian decision|0|||
156733064|NCT03063086|565769149|FG000|Overall Study|Non-compliance with study treatment|0|||
156733065|NCT03063086|565769150|FG001|Overall Study|Non-compliance with study treatment|0|||
156733066|NCT03063086|565769151|FG002|Overall Study|Non-compliance with study treatment|0|||
156733067|NCT03063086|565769152|FG003|Overall Study|Non-compliance with study treatment|1|||
156733068|NCT03063086|565769153|FG004|Overall Study|Non-compliance with study treatment|0|||
156733069|NCT03063086|565769154|FG005|Overall Study|Non-compliance with study treatment|1|||
156733070|NCT03063086|565769149|FG000|Overall Study|Physician Decision|0|||
156733071|NCT03063086|565769150|FG001|Overall Study|Physician Decision|0|||
156733072|NCT03063086|565769151|FG002|Overall Study|Physician Decision|0|||
156733073|NCT03063086|565769152|FG003|Overall Study|Physician Decision|1|||
156733074|NCT03063086|565769153|FG004|Overall Study|Physician Decision|0|||
156733075|NCT03063086|565769154|FG005|Overall Study|Physician Decision|0|||
156733076|NCT01893281|565769155|FG000|Overall Study|Adverse Event|1|||
156733077|NCT01893281|565769155|FG000|Overall Study|Protocol Violation|1|||
156733078|NCT01893281|565769155|FG000|Overall Study|Withdrawal by Subject|1|||
156733079|NCT03474731|565769159|FG000|Overall Study|Withdrawal by Subject|36|||
156733080|NCT03474731|565769160|FG001|Overall Study|Withdrawal by Subject|29|||
156733081|NCT03474731|565769161|FG002|Overall Study|Withdrawal by Subject|11|||
156733082|NCT03474731|565769162|FG003|Overall Study|Withdrawal by Subject|27|||
157140067|NCT04996797|567257599|FG003|Overall Study|Withdrawal by Subject|0|||
157140068|NCT04091217|567257600|FG000|Overall Study|Lost to Follow-up|2|||
157140069|NCT02747004|567257601|FG000|Overall Study|Withdrawal by Subject|8|||
157140070|NCT02747004|567257602|FG001|Overall Study|Withdrawal by Subject|5|||
157140071|NCT02747004|567257603|FG002|Overall Study|Withdrawal by Subject|4|||
156733083|NCT03474731|565769159|FG000|Overall Study|COVID|0|||
156733084|NCT03474731|565769160|FG001|Overall Study|COVID|23|||
156733085|NCT03474731|565769161|FG002|Overall Study|COVID|0|||
156733086|NCT03474731|565769162|FG003|Overall Study|COVID|0|||
156733087|NCT03474731|565769159|FG000|Overall Study|Participant moved from area|1|||
156733088|NCT03474731|565769160|FG001|Overall Study|Participant moved from area|0|||
156733089|NCT03474731|565769161|FG002|Overall Study|Participant moved from area|0|||
156733090|NCT03474731|565769162|FG003|Overall Study|Participant moved from area|0|||
156733091|NCT03474731|565769159|FG000|Overall Study|Lost to Follow-up|11|||
156733092|NCT03474731|565769160|FG001|Overall Study|Lost to Follow-up|3|||
156733093|NCT03474731|565769161|FG002|Overall Study|Lost to Follow-up|18|||
156733094|NCT03474731|565769162|FG003|Overall Study|Lost to Follow-up|17|||
156733095|NCT03474731|565769159|FG000|Overall Study|Death|0|||
156733096|NCT03474731|565769160|FG001|Overall Study|Death|1|||
156733097|NCT03474731|565769161|FG002|Overall Study|Death|0|||
156733098|NCT03474731|565769162|FG003|Overall Study|Death|0|||
156733099|NCT03474731|565769159|FG000|Overall Study|Participant Removed|0|||
156733100|NCT03474731|565769160|FG001|Overall Study|Participant Removed|0|||
156733101|NCT03474731|565769161|FG002|Overall Study|Participant Removed|0|||
156733102|NCT03474731|565769162|FG003|Overall Study|Participant Removed|1|||
156733103|NCT00675428|565769164|FG000|Overall Study|Disease Progression|2|||
156733104|NCT00675428|565769165|FG001|Overall Study|Disease Progression|2|||
156733105|NCT00675428|565769164|FG000|Overall Study|No Disease Response After Cycle 6|0|||
156733106|NCT00675428|565769165|FG001|Overall Study|No Disease Response After Cycle 6|1|||
156733107|NCT00675428|565769164|FG000|Overall Study|Physician Decision|1|||
156733108|NCT00675428|565769165|FG001|Overall Study|Physician Decision|0|||
156733109|NCT00886743|565769167|FG000|Overall Study|Adverse Event|3|||
156733110|NCT00886743|565769167|FG000|Overall Study|Other|1|||
156733111|NCT04105218|565769168|FG000|Overall Study|Withdrawal by Subject|3|||
156733112|NCT04105218|565769169|FG001|Overall Study|Withdrawal by Subject|2|||
156733113|NCT04105218|565769168|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
156733114|NCT04105218|565769169|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
156733115|NCT04105218|565769168|FG000|Overall Study|Failed screening tests|2|||
156733116|NCT04105218|565769169|FG001|Overall Study|Failed screening tests|1|||
156733117|NCT00550043|565769170|FG000|Overall Study|Adverse Event|0|||
156733118|NCT00550043|565769171|FG001|Overall Study|Adverse Event|0|||
156733119|NCT00550043|565769172|FG002|Overall Study|Adverse Event|0|||
156733120|NCT00550043|565769173|FG003|Overall Study|Adverse Event|1|||
156733121|NCT00550043|565769174|FG004|Overall Study|Adverse Event|1|||
156733122|NCT00550043|565769170|FG000|Overall Study|Subject Withdrew Consent|0|||
156733123|NCT00550043|565769171|FG001|Overall Study|Subject Withdrew Consent|2|||
156733124|NCT00550043|565769172|FG002|Overall Study|Subject Withdrew Consent|1|||
156733125|NCT00550043|565769173|FG003|Overall Study|Subject Withdrew Consent|0|||
156733126|NCT00550043|565769174|FG004|Overall Study|Subject Withdrew Consent|0|||
156733127|NCT00550043|565769170|FG000|Overall Study|Other Reasons- Unspecified|0|||
156733128|NCT00550043|565769171|FG001|Overall Study|Other Reasons- Unspecified|1|||
156733129|NCT00550043|565769172|FG002|Overall Study|Other Reasons- Unspecified|0|||
156733130|NCT00550043|565769173|FG003|Overall Study|Other Reasons- Unspecified|1|||
156733131|NCT00550043|565769174|FG004|Overall Study|Other Reasons- Unspecified|0|||
156733132|NCT01870973|565769175|FG000|Overall Study|Lost to Follow-up|10|||
156733133|NCT01870973|565769176|FG001|Overall Study|Lost to Follow-up|3|||
156733134|NCT04310397|565771010|FG000|Overall Study|Lack of Efficacy|3|||
156733135|NCT04310397|565771010|FG000|Overall Study|Withdrawal by Subject|1|||
156733136|NCT00723255|565771013|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
156733137|NCT00723255|565771013|FG000|Overall Study|Ineligible: Second primary|1|||
156733138|NCT00723255|565771013|FG000|Overall Study|Ineligible: Wrong Primary|2|||
156733139|NCT00614523|565771016|FG000|Overall Study|Adverse Event|4|||
156733140|NCT00614523|565771017|FG001|Overall Study|Adverse Event|20|||
156733141|NCT00614523|565771016|FG000|Overall Study|Death|5|||
156733142|NCT00614523|565771017|FG001|Overall Study|Death|8|||
156733143|NCT00614523|565771016|FG000|Overall Study|Lack of Efficacy|9|||
156733144|NCT00614523|565771017|FG001|Overall Study|Lack of Efficacy|11|||
156733145|NCT00614523|565771016|FG000|Overall Study|Lost to Follow-up|0|||
156733146|NCT00614523|565771017|FG001|Overall Study|Lost to Follow-up|1|||
156733147|NCT00614523|565771016|FG000|Overall Study|Protocol Violation|3|||
156733148|NCT00614523|565771017|FG001|Overall Study|Protocol Violation|2|||
156733149|NCT00614523|565771016|FG000|Overall Study|Withdrawal by Subject|12|||
156796708|NCT01822925|566009652|FG003|Overall Study|Taking prohibited medication|1|||
156796709|NCT01905540|566009655|FG000|Period 3|Other|1|||
157020048|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157217560|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
157217561|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
157217562|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
157217563|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
156733150|NCT00614523|565771017|FG001|Overall Study|Withdrawal by Subject|22|||
156733151|NCT00614523|565771016|FG000|Overall Study|Other|6|||
156733152|NCT00614523|565771017|FG001|Overall Study|Other|11|||
156733153|NCT00614523|565771016|FG000|Overall Study|Ineligibility Determined|1|||
156733154|NCT00614523|565771017|FG001|Overall Study|Ineligibility Determined|2|||
156733155|NCT00614523|565771016|FG000|Overall Study|Disease Progression|0|||
156733156|NCT00614523|565771017|FG001|Overall Study|Disease Progression|8|||
156733157|NCT00614523|565771016|FG000|Overall Study|Administrative Decision|23|||
156733158|NCT00614523|565771017|FG001|Overall Study|Administrative Decision|46|||
156733159|NCT03962790|565771018|FG000|Period 1|Adverse Event|0|||
156733160|NCT03962790|565771019|FG001|Period 1|Adverse Event|1|||
156733161|NCT03962790|565771018|FG000|Period 1|Failed to meet all eligibility criteria|1|||
156733162|NCT03962790|565771019|FG001|Period 1|Failed to meet all eligibility criteria|1|||
156733163|NCT03962790|565771018|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
156733164|NCT03962790|565771019|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
156733165|NCT03962790|565771018|FG000|Period 1|Withdrawal by Subject|1|||
156733166|NCT03962790|565771019|FG001|Period 1|Withdrawal by Subject|0|||
156733167|NCT03854370|565771029|FG000|Overall Study|samples not collected|1|||
156733168|NCT03854370|565771030|FG001|Overall Study|samples not collected|1|||
156733169|NCT03854370|565771031|FG002|Overall Study|samples not collected|1|||
156733170|NCT03854370|565771032|FG003|Overall Study|samples not collected|1|||
156733171|NCT00452673|565771036|FG000|Dose Escalation Period|Disease Progression|6|||
156733172|NCT00452673|565771037|FG001|Dose Escalation Period|Disease Progression|6|||
156733173|NCT00452673|565771038|FG002|Dose Escalation Period|Disease Progression|2|||
156733174|NCT00452673|565771039|FG003|Dose Escalation Period|Disease Progression|6|||
156733175|NCT00452673|565771040|FG004|Dose Escalation Period|Disease Progression|0|||
156733176|NCT00452673|565771036|FG000|Dose Escalation Period|study drug toxicity|1|||
156733177|NCT00452673|565771037|FG001|Dose Escalation Period|study drug toxicity|3|||
156733178|NCT00452673|565771038|FG002|Dose Escalation Period|study drug toxicity|3|||
156733179|NCT00452673|565771039|FG003|Dose Escalation Period|study drug toxicity|1|||
156733180|NCT00452673|565771040|FG004|Dose Escalation Period|study drug toxicity|0|||
156733181|NCT00452673|565771036|FG000|Dose Escalation Period|Other|0|||
156733182|NCT00452673|565771037|FG001|Dose Escalation Period|Other|0|||
156733183|NCT00452673|565771038|FG002|Dose Escalation Period|Other|1|||
156733184|NCT00452673|565771039|FG003|Dose Escalation Period|Other|0|||
156733185|NCT00452673|565771040|FG004|Dose Escalation Period|Other|0|||
156733186|NCT00452673|565771036|FG000|Dose Escalation Period|Adverse Event|0|||
156733187|NCT00452673|565771037|FG001|Dose Escalation Period|Adverse Event|0|||
156733188|NCT00452673|565771038|FG002|Dose Escalation Period|Adverse Event|0|||
156733189|NCT00452673|565771039|FG003|Dose Escalation Period|Adverse Event|1|||
156733190|NCT00452673|565771040|FG004|Dose Escalation Period|Adverse Event|0|||
156733191|NCT00452673|565771036|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
156733192|NCT00452673|565771037|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
156733193|NCT00452673|565771038|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
156733194|NCT00452673|565771039|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
156733195|NCT00452673|565771040|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
156733196|NCT00452673|565771036|FG000|Dose Expansion Period|Disease Progression|0|||
156733197|NCT00452673|565771037|FG001|Dose Expansion Period|Disease Progression|0|||
156733198|NCT00452673|565771038|FG002|Dose Expansion Period|Disease Progression|0|||
156733199|NCT00452673|565771039|FG003|Dose Expansion Period|Disease Progression|0|||
156733200|NCT00452673|565771040|FG004|Dose Expansion Period|Disease Progression|19|||
156733201|NCT00452673|565771036|FG000|Dose Expansion Period|Other|0|||
156733202|NCT00452673|565771037|FG001|Dose Expansion Period|Other|0|||
156733203|NCT00452673|565771038|FG002|Dose Expansion Period|Other|0|||
156733204|NCT00452673|565771039|FG003|Dose Expansion Period|Other|0|||
156733205|NCT00452673|565771040|FG004|Dose Expansion Period|Other|2|||
156733206|NCT02656290|565771041|FG000|Overall Study|Lost to Follow-up|1|||
156733207|NCT02656290|565771041|FG000|Overall Study|Reintervention|3|||
156733208|NCT00664859|565771044|FG000|Overall Study|Adverse Event|2|||
156733209|NCT00664859|565771045|FG001|Overall Study|Adverse Event|1|||
156733210|NCT00664859|565771046|FG002|Overall Study|Adverse Event|3|||
156733211|NCT00664859|565771044|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
156733212|NCT00664859|565771045|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
156733213|NCT00664859|565771046|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
156733214|NCT00664859|565771044|FG000|Overall Study|Noncompliance with protocol|1|||
156733215|NCT00664859|565771045|FG001|Overall Study|Noncompliance with protocol|0|||
156876602|NCT01945710|566307650|FG006|Overall Study|Other|4|||
156876603|NCT01945710|566307644|FG000|Overall Study|Withdrawal by Subject|0|||
156876604|NCT01945710|566307645|FG001|Overall Study|Withdrawal by Subject|1|||
156876605|NCT01945710|566307646|FG002|Overall Study|Withdrawal by Subject|1|||
156876606|NCT01945710|566307647|FG003|Overall Study|Withdrawal by Subject|0|||
156876607|NCT01945710|566307648|FG004|Overall Study|Withdrawal by Subject|1|||
156876608|NCT01945710|566307649|FG005|Overall Study|Withdrawal by Subject|0|||
156876609|NCT01945710|566307650|FG006|Overall Study|Withdrawal by Subject|0|||
156876610|NCT02730195|566307653|FG000|Overall Study|Withdrawal by Subject|1|||
156876611|NCT01239992|566307655|FG000|Overall Study|Withdrawal by Subject|2|||
156876612|NCT00535288|566307656|FG000|Overall Study|Adverse Event|20|||
156733216|NCT00664859|565771046|FG002|Overall Study|Noncompliance with protocol|4|||
156733217|NCT00664859|565771044|FG000|Overall Study|Laboratory abnormality|2|||
156733218|NCT00664859|565771045|FG001|Overall Study|Laboratory abnormality|1|||
156733219|NCT00664859|565771046|FG002|Overall Study|Laboratory abnormality|4|||
156733220|NCT00664859|565771044|FG000|Overall Study|Withdrawal by Subject|4|||
156733221|NCT00664859|565771045|FG001|Overall Study|Withdrawal by Subject|1|||
156733222|NCT00664859|565771046|FG002|Overall Study|Withdrawal by Subject|3|||
156876613|NCT00535288|566307657|FG001|Overall Study|Adverse Event|19|||
156876614|NCT00535288|566307658|FG002|Overall Study|Adverse Event|25|||
156876615|NCT00535288|566307659|FG003|Overall Study|Adverse Event|20|||
156733223|NCT00664859|565771044|FG000|Overall Study|Lost to Follow-up|2|||
156733224|NCT00664859|565771045|FG001|Overall Study|Lost to Follow-up|2|||
156733225|NCT00664859|565771046|FG002|Overall Study|Lost to Follow-up|1|||
156876616|NCT00535288|566307660|FG004|Overall Study|Adverse Event|30|||
156733226|NCT00664859|565771044|FG000|Overall Study|Other|0|||
156733227|NCT00664859|565771045|FG001|Overall Study|Other|1|||
156733228|NCT00664859|565771046|FG002|Overall Study|Other|2|||
156733229|NCT00748189|565771047|FG000|Overall Study|Death|99|||
156733230|NCT00748189|565771048|FG001|Overall Study|Death|84|||
156733231|NCT00748189|565771047|FG000|Overall Study|Withdrawal by Subject|23|||
156733232|NCT00748189|565771048|FG001|Overall Study|Withdrawal by Subject|29|||
156733233|NCT00748189|565771047|FG000|Overall Study|Physician Decision|16|||
156733234|NCT00748189|565771048|FG001|Overall Study|Physician Decision|5|||
156733235|NCT00748189|565771047|FG000|Overall Study|Lost to Follow-up|8|||
156733236|NCT00748189|565771048|FG001|Overall Study|Lost to Follow-up|15|||
156733237|NCT00748189|565771047|FG000|Overall Study|Study terminated by Sponsor|70|||
156733238|NCT00748189|565771048|FG001|Overall Study|Study terminated by Sponsor|79|||
156733239|NCT04481191|565771055|FG000|Overall Study|Withdrawn by parent/guardian|15|||
156733240|NCT04481191|565771056|FG001|Overall Study|Withdrawn by parent/guardian|10|||
156733241|NCT00546117|565771061|FG000|Overall Study|Withdrawal by Subject|3|||
156733242|NCT00546117|565771062|FG001|Overall Study|Withdrawal by Subject|0|||
156733243|NCT00546117|565771061|FG000|Overall Study|Inability to schedule follow-up visit|1|||
156733244|NCT00546117|565771062|FG001|Overall Study|Inability to schedule follow-up visit|0|||
156733245|NCT04984278|565771068|FG000|Period 1|Withdrawal by Subject|1|||
156733246|NCT04984278|565771069|FG001|Period 1|Withdrawal by Subject|0|||
156733247|NCT04984278|565771068|FG000|Period 1|Other|0|||
156733248|NCT04984278|565771069|FG001|Period 1|Other|1|||
156733249|NCT04984278|565771068|FG000|Period 2|Adverse Event|1|||
156733250|NCT04984278|565771069|FG001|Period 2|Adverse Event|0|||
156733251|NCT04984278|565771068|FG000|Period 2|Other|0|||
156733252|NCT04984278|565771069|FG001|Period 2|Other|1|||
156733253|NCT02564900|565771070|FG000|Dose Escalation|Progressive disease per RECIST|2|||
156733254|NCT02564900|565771071|FG001|Dose Escalation|Progressive disease per RECIST|3|||
156733255|NCT02564900|565771072|FG002|Dose Escalation|Progressive disease per RECIST|3|||
156733256|NCT02564900|565771073|FG003|Dose Escalation|Progressive disease per RECIST|3|||
156733257|NCT02564900|565771074|FG004|Dose Escalation|Progressive disease per RECIST|3|||
156733258|NCT02564900|565771075|FG005|Dose Escalation|Progressive disease per RECIST|1|||
156733259|NCT02564900|565771076|FG006|Dose Escalation|Progressive disease per RECIST|0|||
156733260|NCT02564900|565771077|FG007|Dose Escalation|Progressive disease per RECIST|0|||
156733261|NCT02564900|565771078|FG008|Dose Escalation|Progressive disease per RECIST|0|||
156733262|NCT02564900|565771079|FG009|Dose Escalation|Progressive disease per RECIST|0|||
156733263|NCT02564900|565771080|FG010|Dose Escalation|Progressive disease per RECIST|0|||
156733264|NCT02564900|565771081|FG011|Dose Escalation|Progressive disease per RECIST|0|||
156733265|NCT02564900|565771082|FG012|Dose Escalation|Progressive disease per RECIST|0|||
156733266|NCT02564900|565771083|FG013|Dose Escalation|Progressive disease per RECIST|0|||
156733267|NCT02564900|565771084|FG014|Dose Escalation|Progressive disease per RECIST|0|||
156733268|NCT02564900|565771070|FG000|Dose Escalation|Ongoing|1|||
156733269|NCT02564900|565771071|FG001|Dose Escalation|Ongoing|0|||
156733270|NCT02564900|565771072|FG002|Dose Escalation|Ongoing|0|||
156733271|NCT02564900|565771073|FG003|Dose Escalation|Ongoing|2|||
156733272|NCT02564900|565771074|FG004|Dose Escalation|Ongoing|2|||
156733273|NCT02564900|565771075|FG005|Dose Escalation|Ongoing|2|||
156733274|NCT02564900|565771076|FG006|Dose Escalation|Ongoing|0|||
156733275|NCT02564900|565771077|FG007|Dose Escalation|Ongoing|0|||
156733276|NCT02564900|565771078|FG008|Dose Escalation|Ongoing|0|||
156733277|NCT02564900|565771079|FG009|Dose Escalation|Ongoing|0|||
156733278|NCT02564900|565771080|FG010|Dose Escalation|Ongoing|0|||
156733279|NCT02564900|565771081|FG011|Dose Escalation|Ongoing|0|||
156733280|NCT02564900|565771082|FG012|Dose Escalation|Ongoing|0|||
156733281|NCT02564900|565771083|FG013|Dose Escalation|Ongoing|0|||
156733282|NCT02564900|565771084|FG014|Dose Escalation|Ongoing|0|||
156733283|NCT02564900|565771070|FG000|Dose Escalation|Adverse Event|0|||
156733284|NCT02564900|565771071|FG001|Dose Escalation|Adverse Event|0|||
156733285|NCT02564900|565771072|FG002|Dose Escalation|Adverse Event|0|||
156733286|NCT02564900|565771073|FG003|Dose Escalation|Adverse Event|1|||
156733287|NCT02564900|565771074|FG004|Dose Escalation|Adverse Event|1|||
156733288|NCT02564900|565771075|FG005|Dose Escalation|Adverse Event|3|||
156733289|NCT02564900|565771076|FG006|Dose Escalation|Adverse Event|0|||
156733290|NCT02564900|565771077|FG007|Dose Escalation|Adverse Event|0|||
156733291|NCT02564900|565771078|FG008|Dose Escalation|Adverse Event|0|||
156733292|NCT02564900|565771079|FG009|Dose Escalation|Adverse Event|0|||
156733293|NCT02564900|565771080|FG010|Dose Escalation|Adverse Event|0|||
156733294|NCT02564900|565771081|FG011|Dose Escalation|Adverse Event|0|||
156733295|NCT02564900|565771082|FG012|Dose Escalation|Adverse Event|0|||
156733296|NCT02564900|565771083|FG013|Dose Escalation|Adverse Event|0|||
156733297|NCT02564900|565771084|FG014|Dose Escalation|Adverse Event|0|||
156733298|NCT02564900|565771070|FG000|Dose Expansion|Progressive disease per RECIST|0|||
156733299|NCT02564900|565771071|FG001|Dose Expansion|Progressive disease per RECIST|0|||
156733300|NCT02564900|565771072|FG002|Dose Expansion|Progressive disease per RECIST|0|||
156733301|NCT02564900|565771073|FG003|Dose Expansion|Progressive disease per RECIST|0|||
156733302|NCT02564900|565771074|FG004|Dose Expansion|Progressive disease per RECIST|0|||
156733303|NCT02564900|565771075|FG005|Dose Expansion|Progressive disease per RECIST|0|||
156733304|NCT02564900|565771076|FG006|Dose Expansion|Progressive disease per RECIST|19|||
157020049|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157020050|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
157020051|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
157020052|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
156733305|NCT02564900|565771077|FG007|Dose Expansion|Progressive disease per RECIST|17|||
156733306|NCT02564900|565771078|FG008|Dose Expansion|Progressive disease per RECIST|8|||
156733307|NCT02564900|565771079|FG009|Dose Expansion|Progressive disease per RECIST|16|||
156733308|NCT02564900|565771080|FG010|Dose Expansion|Progressive disease per RECIST|13|||
156733309|NCT02564900|565771081|FG011|Dose Expansion|Progressive disease per RECIST|19|||
156733310|NCT02564900|565771082|FG012|Dose Expansion|Progressive disease per RECIST|10|||
156733311|NCT02564900|565771083|FG013|Dose Expansion|Progressive disease per RECIST|13|||
156733312|NCT02564900|565771084|FG014|Dose Expansion|Progressive disease per RECIST|11|||
156733313|NCT02564900|565771070|FG000|Dose Expansion|Clinical progression|0|||
156733314|NCT02564900|565771071|FG001|Dose Expansion|Clinical progression|0|||
156733315|NCT02564900|565771072|FG002|Dose Expansion|Clinical progression|0|||
156733316|NCT02564900|565771073|FG003|Dose Expansion|Clinical progression|0|||
156733317|NCT02564900|565771074|FG004|Dose Expansion|Clinical progression|0|||
156733318|NCT02564900|565771075|FG005|Dose Expansion|Clinical progression|0|||
156733319|NCT02564900|565771076|FG006|Dose Expansion|Clinical progression|5|||
156733320|NCT02564900|565771077|FG007|Dose Expansion|Clinical progression|12|||
156733321|NCT02564900|565771078|FG008|Dose Expansion|Clinical progression|0|||
156733322|NCT02564900|565771079|FG009|Dose Expansion|Clinical progression|3|||
156796710|NCT01905540|566009656|FG001|Period 3|Other|0|||
156796711|NCT01905540|566009657|FG002|Period 3|Other|1|||
157217564|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
157217565|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
157217566|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
157217567|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
157217568|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
157217569|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
157217570|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
157217571|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
157217572|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
157217573|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
157217574|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
157217575|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
157217576|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
157217577|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
157217578|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
157217579|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
157217580|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
157217581|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
157217582|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
157217583|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
157217584|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
157217585|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
157217586|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
156733323|NCT02564900|565771080|FG010|Dose Expansion|Clinical progression|2|||
156733324|NCT02564900|565771081|FG011|Dose Expansion|Clinical progression|0|||
156733325|NCT02564900|565771082|FG012|Dose Expansion|Clinical progression|1|||
156733326|NCT02564900|565771083|FG013|Dose Expansion|Clinical progression|3|||
156733327|NCT02564900|565771084|FG014|Dose Expansion|Clinical progression|1|||
156733328|NCT02564900|565771070|FG000|Dose Expansion|Adverse Event|0|||
156733329|NCT02564900|565771071|FG001|Dose Expansion|Adverse Event|0|||
156733330|NCT02564900|565771072|FG002|Dose Expansion|Adverse Event|0|||
156733331|NCT02564900|565771073|FG003|Dose Expansion|Adverse Event|0|||
156796712|NCT01905540|566009658|FG003|Period 3|Other|1|||
157020053|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157217587|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
157217588|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
157217589|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
157217590|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
157217591|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
157217592|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
157217593|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
157217594|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
157217595|NCT01806597|567543244|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
157140072|NCT02747004|567257601|FG000|Overall Study|Lost to Follow-up|1|||
157140073|NCT02747004|567257602|FG001|Overall Study|Lost to Follow-up|2|||
157140074|NCT02747004|567257603|FG002|Overall Study|Lost to Follow-up|2|||
157140075|NCT02747004|567257601|FG000|Overall Study|on study treatment/follow-up|48|||
157140076|NCT02747004|567257602|FG001|Overall Study|on study treatment/follow-up|42|||
157140077|NCT02747004|567257603|FG002|Overall Study|on study treatment/follow-up|41|||
157140078|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
157140079|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
157140080|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
157140081|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
157140082|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
157140083|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
157140084|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
157140085|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
157140086|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
157140087|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
157140088|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
157140089|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
157140090|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
157140091|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156733332|NCT02564900|565771074|FG004|Dose Expansion|Adverse Event|0|||
156733333|NCT02564900|565771075|FG005|Dose Expansion|Adverse Event|0|||
157140092|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156733334|NCT02564900|565771076|FG006|Dose Expansion|Adverse Event|9|||
156733335|NCT02564900|565771077|FG007|Dose Expansion|Adverse Event|22|||
156733336|NCT02564900|565771078|FG008|Dose Expansion|Adverse Event|0|||
156733337|NCT02564900|565771079|FG009|Dose Expansion|Adverse Event|11|||
156733338|NCT02564900|565771080|FG010|Dose Expansion|Adverse Event|0|||
156733339|NCT02564900|565771081|FG011|Dose Expansion|Adverse Event|5|||
156733340|NCT02564900|565771082|FG012|Dose Expansion|Adverse Event|2|||
156733341|NCT02564900|565771083|FG013|Dose Expansion|Adverse Event|2|||
156733342|NCT02564900|565771084|FG014|Dose Expansion|Adverse Event|1|||
156733343|NCT02564900|565771070|FG000|Dose Expansion|Ongoing|0|||
156733344|NCT02564900|565771071|FG001|Dose Expansion|Ongoing|0|||
156733345|NCT02564900|565771072|FG002|Dose Expansion|Ongoing|0|||
157140093|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
156733346|NCT02564900|565771073|FG003|Dose Expansion|Ongoing|0|||
156733347|NCT02564900|565771074|FG004|Dose Expansion|Ongoing|0|||
156733348|NCT02564900|565771075|FG005|Dose Expansion|Ongoing|0|||
156733349|NCT02564900|565771076|FG006|Dose Expansion|Ongoing|9|||
156733350|NCT02564900|565771077|FG007|Dose Expansion|Ongoing|10|||
156733351|NCT02564900|565771078|FG008|Dose Expansion|Ongoing|11|||
156733352|NCT02564900|565771079|FG009|Dose Expansion|Ongoing|3|||
156733353|NCT02564900|565771080|FG010|Dose Expansion|Ongoing|0|||
157140094|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
157140095|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
157140096|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
157140097|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
157140098|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Death|0|||
157140099|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Death|1|||
157140100|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Death|0|||
157140101|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Death|0|||
157140102|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Death|0|||
157140103|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
157140104|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
157140105|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
157140106|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
156733354|NCT02564900|565771081|FG011|Dose Expansion|Ongoing|0|||
156733355|NCT02564900|565771082|FG012|Dose Expansion|Ongoing|4|||
156733356|NCT02564900|565771083|FG013|Dose Expansion|Ongoing|0|||
156733357|NCT02564900|565771084|FG014|Dose Expansion|Ongoing|6|||
156733358|NCT02564900|565771070|FG000|Dose Expansion|Death|0|||
157020054|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157140107|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
157140108|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
157140109|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156733359|NCT02564900|565771071|FG001|Dose Expansion|Death|0|||
156733360|NCT02564900|565771072|FG002|Dose Expansion|Death|0|||
157140110|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
157140111|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
156733361|NCT02564900|565771073|FG003|Dose Expansion|Death|0|||
156733362|NCT02564900|565771074|FG004|Dose Expansion|Death|0|||
156733363|NCT02564900|565771075|FG005|Dose Expansion|Death|0|||
156733364|NCT02564900|565771076|FG006|Dose Expansion|Death|1|||
156733365|NCT02564900|565771077|FG007|Dose Expansion|Death|0|||
156733366|NCT02564900|565771078|FG008|Dose Expansion|Death|0|||
156733367|NCT02564900|565771079|FG009|Dose Expansion|Death|0|||
156733368|NCT02564900|565771080|FG010|Dose Expansion|Death|1|||
156733369|NCT02564900|565771081|FG011|Dose Expansion|Death|0|||
156733370|NCT02564900|565771082|FG012|Dose Expansion|Death|1|||
156733371|NCT02564900|565771083|FG013|Dose Expansion|Death|1|||
156733372|NCT02564900|565771084|FG014|Dose Expansion|Death|0|||
156733373|NCT02564900|565771070|FG000|Dose Expansion|Withdrawal by Subject|0|||
156733374|NCT02564900|565771071|FG001|Dose Expansion|Withdrawal by Subject|0|||
156733375|NCT02564900|565771072|FG002|Dose Expansion|Withdrawal by Subject|0|||
156733376|NCT02564900|565771073|FG003|Dose Expansion|Withdrawal by Subject|0|||
156733377|NCT02564900|565771074|FG004|Dose Expansion|Withdrawal by Subject|0|||
156733378|NCT02564900|565771075|FG005|Dose Expansion|Withdrawal by Subject|0|||
156733379|NCT02564900|565771076|FG006|Dose Expansion|Withdrawal by Subject|4|||
156733380|NCT02564900|565771077|FG007|Dose Expansion|Withdrawal by Subject|0|||
156733381|NCT02564900|565771078|FG008|Dose Expansion|Withdrawal by Subject|0|||
156733382|NCT02564900|565771079|FG009|Dose Expansion|Withdrawal by Subject|0|||
156733383|NCT02564900|565771080|FG010|Dose Expansion|Withdrawal by Subject|1|||
156733384|NCT02564900|565771081|FG011|Dose Expansion|Withdrawal by Subject|0|||
156733385|NCT02564900|565771082|FG012|Dose Expansion|Withdrawal by Subject|0|||
156733386|NCT02564900|565771083|FG013|Dose Expansion|Withdrawal by Subject|1|||
156733387|NCT02564900|565771084|FG014|Dose Expansion|Withdrawal by Subject|1|||
156733388|NCT02564900|565771070|FG000|Dose Expansion|Other|0|||
156733389|NCT02564900|565771071|FG001|Dose Expansion|Other|0|||
156733390|NCT02564900|565771072|FG002|Dose Expansion|Other|0|||
156733391|NCT02564900|565771073|FG003|Dose Expansion|Other|0|||
156733392|NCT02564900|565771074|FG004|Dose Expansion|Other|0|||
156733393|NCT02564900|565771075|FG005|Dose Expansion|Other|0|||
156733394|NCT02564900|565771076|FG006|Dose Expansion|Other|1|||
156733395|NCT02564900|565771077|FG007|Dose Expansion|Other|0|||
156733396|NCT02564900|565771078|FG008|Dose Expansion|Other|1|||
156733397|NCT02564900|565771079|FG009|Dose Expansion|Other|0|||
156733398|NCT02564900|565771080|FG010|Dose Expansion|Other|0|||
156733399|NCT02564900|565771081|FG011|Dose Expansion|Other|0|||
156733400|NCT02564900|565771082|FG012|Dose Expansion|Other|0|||
156733401|NCT02564900|565771083|FG013|Dose Expansion|Other|0|||
156733402|NCT02564900|565771084|FG014|Dose Expansion|Other|1|||
156733403|NCT02564900|565771070|FG000|Dose Expansion|Did not receive treatment|0|||
156733404|NCT02564900|565771071|FG001|Dose Expansion|Did not receive treatment|0|||
156733405|NCT02564900|565771072|FG002|Dose Expansion|Did not receive treatment|0|||
156733406|NCT02564900|565771073|FG003|Dose Expansion|Did not receive treatment|0|||
156733407|NCT02564900|565771074|FG004|Dose Expansion|Did not receive treatment|0|||
156733408|NCT02564900|565771075|FG005|Dose Expansion|Did not receive treatment|0|||
156733409|NCT02564900|565771076|FG006|Dose Expansion|Did not receive treatment|1|||
156733410|NCT02564900|565771077|FG007|Dose Expansion|Did not receive treatment|1|||
156733411|NCT02564900|565771078|FG008|Dose Expansion|Did not receive treatment|0|||
156733412|NCT02564900|565771079|FG009|Dose Expansion|Did not receive treatment|0|||
156733413|NCT02564900|565771080|FG010|Dose Expansion|Did not receive treatment|0|||
156733414|NCT02564900|565771081|FG011|Dose Expansion|Did not receive treatment|0|||
156733415|NCT02564900|565771082|FG012|Dose Expansion|Did not receive treatment|0|||
156733416|NCT02564900|565771083|FG013|Dose Expansion|Did not receive treatment|0|||
156796713|NCT02743962|566009659|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
156796714|NCT02743962|566009660|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
156796715|NCT02314923|566009661|FG000|Overall Study|Death|0|||
156796716|NCT02314923|566009662|FG001|Overall Study|Death|0|||
157217596|NCT01806597|567543245|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
157217597|NCT01806597|567543246|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
157217598|NCT01806597|567543247|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
157217599|NCT01806597|567543248|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
157217600|NCT01806597|567543249|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
156733417|NCT02564900|565771084|FG014|Dose Expansion|Did not receive treatment|1|||
156733418|NCT01289639|565771086|FG000|Overall Study|Lost to Follow-up|1|||
157020055|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
157020056|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
156733419|NCT01289639|565771087|FG001|Overall Study|Lost to Follow-up|0|||
156733420|NCT01289639|565771088|FG002|Overall Study|Lost to Follow-up|0|||
156733421|NCT02780713|565771089|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733422|NCT02780713|565771090|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156796717|NCT02314923|566009663|FG002|Overall Study|Death|0|||
157217601|NCT01806597|567543244|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
157217602|NCT01806597|567543245|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156733423|NCT02780713|565771091|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
156733424|NCT02780713|565771092|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733425|NCT02780713|565771093|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
156733426|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
156733427|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
156733428|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
156796718|NCT02314923|566009664|FG003|Overall Study|Death|1|||
157020057|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020058|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020059|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020060|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020061|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020062|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
157020063|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
157020064|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
157020065|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020066|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020067|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020068|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
157020069|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
157020070|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
157020071|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
157020072|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
157020073|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
157020074|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
157020075|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
157020076|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
157020077|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
157020078|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
157020079|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
157020080|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
156733429|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
156733430|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
156733431|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
157020081|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
157020082|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020083|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020084|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
156733432|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
156733433|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
156733434|NCT01931475|565771094|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
156733435|NCT01931475|565771095|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
156733436|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
156733437|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
156733438|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
156733439|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
156733440|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
156733441|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
156733442|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
156733443|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
156733444|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
156733445|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
156733446|NCT01931475|565771094|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
156733447|NCT01931475|565771095|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
156733448|NCT00280397|565771096|FG000|Overall Study|Adverse Event|1|||
156733449|NCT01028014|565771097|FG000|Overall Study|Lost to Follow-up|1|||
156733450|NCT01028014|565771098|FG001|Overall Study|Lost to Follow-up|2|||
156733451|NCT01028014|565771099|FG002|Overall Study|Lost to Follow-up|0|||
156733452|NCT01028014|565771100|FG003|Overall Study|Lost to Follow-up|1|||
156733453|NCT01028014|565771101|FG004|Overall Study|Lost to Follow-up|1|||
156733454|NCT01028014|565771102|FG005|Overall Study|Lost to Follow-up|2|||
156733455|NCT05338502|565771103|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
156733456|NCT05338502|565771104|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
156876617|NCT00535288|566307656|FG000|Overall Study|Lost to Follow-up|0|||
157020085|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020086|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020087|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020088|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
156733457|NCT05338502|565771105|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
156733458|NCT05338502|565771103|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
157020089|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
157020090|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
156733459|NCT05338502|565771104|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
156733460|NCT05338502|565771105|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
156733461|NCT02423343|565771108|FG000|Overall Study|Withdrawal by Subject|0|||
156876618|NCT00535288|566307657|FG001|Overall Study|Lost to Follow-up|3|||
156876619|NCT00535288|566307658|FG002|Overall Study|Lost to Follow-up|0|||
157020091|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157140112|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
157140113|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
157140114|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
157140115|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
157140116|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
157140117|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
157140118|NCT05087030|567257604|FG000|Main Period (Week 0 to Week 52)|Other|1|||
157140119|NCT05087030|567257605|FG001|Main Period (Week 0 to Week 52)|Other|2|||
157140120|NCT05087030|567257606|FG002|Main Period (Week 0 to Week 52)|Other|0|||
157140121|NCT05087030|567257607|FG003|Main Period (Week 0 to Week 52)|Other|0|||
157140122|NCT05087030|567257608|FG004|Main Period (Week 0 to Week 52)|Other|0|||
156733462|NCT02423343|565771109|FG001|Overall Study|Withdrawal by Subject|1|||
156733463|NCT02423343|565771110|FG002|Overall Study|Withdrawal by Subject|0|||
156733464|NCT02423343|565771111|FG003|Overall Study|Withdrawal by Subject|0|||
156733465|NCT02423343|565771112|FG004|Overall Study|Withdrawal by Subject|0|||
156733466|NCT02423343|565771113|FG005|Overall Study|Withdrawal by Subject|0|||
156733467|NCT02423343|565771108|FG000|Overall Study|Progressive Disease|0|||
156733468|NCT02423343|565771109|FG001|Overall Study|Progressive Disease|0|||
156733469|NCT02423343|565771110|FG002|Overall Study|Progressive Disease|0|||
156733470|NCT02423343|565771111|FG003|Overall Study|Progressive Disease|0|||
156733471|NCT02423343|565771112|FG004|Overall Study|Progressive Disease|2|||
156733472|NCT02423343|565771113|FG005|Overall Study|Progressive Disease|0|||
156733473|NCT02423343|565771108|FG000|Overall Study|Adverse Event|0|||
156733474|NCT02423343|565771109|FG001|Overall Study|Adverse Event|0|||
156733475|NCT02423343|565771110|FG002|Overall Study|Adverse Event|0|||
156733476|NCT02423343|565771111|FG003|Overall Study|Adverse Event|0|||
156733477|NCT02423343|565771112|FG004|Overall Study|Adverse Event|2|||
156733478|NCT02423343|565771113|FG005|Overall Study|Adverse Event|0|||
156733479|NCT02423343|565771108|FG000|Overall Study|Death|0|||
156733480|NCT02423343|565771109|FG001|Overall Study|Death|0|||
156733481|NCT02423343|565771110|FG002|Overall Study|Death|0|||
156733482|NCT02423343|565771111|FG003|Overall Study|Death|0|||
156733483|NCT02423343|565771112|FG004|Overall Study|Death|1|||
156733484|NCT02423343|565771113|FG005|Overall Study|Death|0|||
156733485|NCT02111577|565771116|FG000|Overall Study|Protocol Violation|2|||
156733486|NCT02111577|565771117|FG001|Overall Study|Protocol Violation|0|||
156733487|NCT02111577|565771116|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
156733488|NCT02111577|565771117|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
156733489|NCT02111577|565771116|FG000|Overall Study|Failure to produce study treatment|6|||
156733490|NCT02111577|565771117|FG001|Overall Study|Failure to produce study treatment|0|||
156733491|NCT02111577|565771116|FG000|Overall Study|Death|518|||
156733492|NCT02111577|565771117|FG001|Overall Study|Death|254|||
156733493|NCT02111577|565771116|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
156733494|NCT02111577|565771117|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
156733495|NCT02111577|565771116|FG000|Overall Study|Adverse Event|1|||
156733496|NCT02111577|565771117|FG001|Overall Study|Adverse Event|1|||
156733497|NCT02111577|565771116|FG000|Overall Study|Withdrawal by Subject|51|||
156733498|NCT02111577|565771117|FG001|Overall Study|Withdrawal by Subject|23|||
156733499|NCT02111577|565771116|FG000|Overall Study|Disease progression|0|||
156733500|NCT02111577|565771117|FG001|Overall Study|Disease progression|1|||
156733501|NCT02111577|565771116|FG000|Overall Study|Lost to Follow-up|19|||
156733502|NCT02111577|565771117|FG001|Overall Study|Lost to Follow-up|10|||
156733503|NCT04967885|565771118|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
156733504|NCT04967885|565771119|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
156733505|NCT04967885|565771118|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
156733506|NCT04967885|565771119|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
156733507|NCT04967885|565771118|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
156733508|NCT04967885|565771119|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
156733509|NCT04967885|565771118|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
156733510|NCT04967885|565771119|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
156733511|NCT04967885|565771118|FG000|EMI-II Intervention|Lost to Follow-up|14|||
156733512|NCT04967885|565771119|FG001|EMI-II Intervention|Lost to Follow-up|10|||
156733513|NCT00654875|565771120|FG000|Overall Study|Adverse Event|5|||
156733514|NCT00654875|565771121|FG001|Overall Study|Adverse Event|5|||
156733515|NCT00654875|565771120|FG000|Overall Study|Withdrawal by Subject|4|||
156733516|NCT00654875|565771121|FG001|Overall Study|Withdrawal by Subject|4|||
156733517|NCT00654875|565771120|FG000|Overall Study|Protocol Violation|3|||
156796719|NCT02314923|566009665|FG004|Overall Study|Death|0|||
156733518|NCT00654875|565771121|FG001|Overall Study|Protocol Violation|3|||
156733519|NCT00654875|565771120|FG000|Overall Study|Lack of Efficacy|2|||
156733520|NCT00654875|565771121|FG001|Overall Study|Lack of Efficacy|2|||
156733521|NCT00654875|565771120|FG000|Overall Study|Lost to Follow-up|1|||
156733522|NCT00654875|565771121|FG001|Overall Study|Lost to Follow-up|3|||
156733523|NCT00654875|565771120|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156733524|NCT00654875|565771121|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156733525|NCT00654875|565771120|FG000|Overall Study|Administrative Problems|1|||
156733526|NCT00654875|565771121|FG001|Overall Study|Administrative Problems|0|||
156733527|NCT01011465|565771122|FG000|Overall Study|Withdrawal by Subject|2|||
156733528|NCT01011465|565771123|FG001|Overall Study|Withdrawal by Subject|1|||
156733529|NCT01011465|565771124|FG002|Overall Study|Withdrawal by Subject|0|||
156733530|NCT01011465|565771125|FG003|Overall Study|Withdrawal by Subject|0|||
156733531|NCT01011465|565771126|FG004|Overall Study|Withdrawal by Subject|1|||
156733532|NCT01011465|565771127|FG005|Overall Study|Withdrawal by Subject|0|||
156733533|NCT01011465|565771128|FG006|Overall Study|Withdrawal by Subject|1|||
156733534|NCT01011465|565771129|FG007|Overall Study|Withdrawal by Subject|0|||
156733535|NCT02042950|565771132|FG000|Overall Study|Progressive Disease|4|||
156733536|NCT01014988|565771135|FG000|Overall Study|Adverse Event|20|||
156733537|NCT01014988|565771136|FG001|Overall Study|Adverse Event|0|||
156733538|NCT01014988|565771137|FG002|Overall Study|Adverse Event|1|||
156733539|NCT01014988|565771138|FG003|Overall Study|Adverse Event|0|||
156733540|NCT01014988|565771139|FG004|Overall Study|Adverse Event|1|||
156733541|NCT01014988|565771140|FG005|Overall Study|Adverse Event|3|||
156733542|NCT01014988|565771135|FG000|Overall Study|Lost to Follow-up|1|||
156733543|NCT01014988|565771136|FG001|Overall Study|Lost to Follow-up|0|||
156733544|NCT01014988|565771137|FG002|Overall Study|Lost to Follow-up|1|||
156733545|NCT01014988|565771138|FG003|Overall Study|Lost to Follow-up|0|||
156733546|NCT01014988|565771139|FG004|Overall Study|Lost to Follow-up|0|||
156733547|NCT01014988|565771140|FG005|Overall Study|Lost to Follow-up|0|||
156733548|NCT01014988|565771135|FG000|Overall Study|Physician Decision|1|||
156733549|NCT01014988|565771136|FG001|Overall Study|Physician Decision|0|||
156733550|NCT01014988|565771137|FG002|Overall Study|Physician Decision|0|||
156733551|NCT01014988|565771138|FG003|Overall Study|Physician Decision|0|||
156733552|NCT01014988|565771139|FG004|Overall Study|Physician Decision|0|||
156733553|NCT01014988|565771140|FG005|Overall Study|Physician Decision|0|||
156733554|NCT01014988|565771135|FG000|Overall Study|Withdrawal by Subject|1|||
156733555|NCT01014988|565771136|FG001|Overall Study|Withdrawal by Subject|0|||
156733556|NCT01014988|565771137|FG002|Overall Study|Withdrawal by Subject|0|||
156733557|NCT01014988|565771138|FG003|Overall Study|Withdrawal by Subject|0|||
156733558|NCT01014988|565771139|FG004|Overall Study|Withdrawal by Subject|0|||
156733559|NCT01014988|565771140|FG005|Overall Study|Withdrawal by Subject|0|||
156733560|NCT01683266|565771143|FG000|Overall Study|Adverse Event|5|||
156733561|NCT01683266|565771144|FG001|Overall Study|Adverse Event|4|||
156733562|NCT01683266|565771143|FG000|Overall Study|Lack of Efficacy|5|||
156733563|NCT01683266|565771144|FG001|Overall Study|Lack of Efficacy|2|||
156733564|NCT01683266|565771143|FG000|Overall Study|Protocol Violation|13|||
156733565|NCT01683266|565771144|FG001|Overall Study|Protocol Violation|6|||
156733566|NCT01683266|565771143|FG000|Overall Study|Personal Reason|17|||
156733567|NCT01683266|565771144|FG001|Overall Study|Personal Reason|25|||
156733568|NCT01683266|565771143|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
156733569|NCT01683266|565771144|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
156733570|NCT01683266|565771143|FG000|Overall Study|Lost to Follow-up|5|||
156733571|NCT01683266|565771144|FG001|Overall Study|Lost to Follow-up|0|||
156733572|NCT01683266|565771143|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
156733573|NCT01683266|565771144|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
156733574|NCT01683266|565771143|FG000|Overall Study|Nonserious Hypoglycemia|0|||
156733575|NCT01683266|565771144|FG001|Overall Study|Nonserious Hypoglycemia|3|||
156733576|NCT01683266|565771143|FG000|Overall Study|Perceived Lack of Efficacy|1|||
156733577|NCT01683266|565771144|FG001|Overall Study|Perceived Lack of Efficacy|1|||
156733578|NCT01683266|565771143|FG000|Overall Study|Possibly Hypoglycemia|1|||
156733579|NCT01683266|565771144|FG001|Overall Study|Possibly Hypoglycemia|0|||
156733580|NCT01683266|565771143|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
156733581|NCT01683266|565771144|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
156733582|NCT02217410|565771147|FG000|Overall Study|Graft Loss|0|||
156733583|NCT02217410|565771148|FG001|Overall Study|Graft Loss|0|||
156733584|NCT02217410|565771149|FG002|Overall Study|Graft Loss|2|||
156733585|NCT02217410|565771147|FG000|Overall Study|Withdrawal by Subject|0|||
156733586|NCT02217410|565771148|FG001|Overall Study|Withdrawal by Subject|0|||
156733587|NCT02217410|565771149|FG002|Overall Study|Withdrawal by Subject|2|||
156733588|NCT02217410|565771147|FG000|Overall Study|Lost to Follow-up|0|||
156733589|NCT02217410|565771148|FG001|Overall Study|Lost to Follow-up|0|||
156733590|NCT02217410|565771149|FG002|Overall Study|Lost to Follow-up|1|||
156733591|NCT02217410|565771147|FG000|Overall Study|Lack of Efficacy|0|||
156733592|NCT02217410|565771148|FG001|Overall Study|Lack of Efficacy|1|||
156733593|NCT02217410|565771149|FG002|Overall Study|Lack of Efficacy|0|||
156733594|NCT02217410|565771147|FG000|Overall Study|Physician Decision|1|||
156733595|NCT02217410|565771148|FG001|Overall Study|Physician Decision|3|||
156733596|NCT02217410|565771149|FG002|Overall Study|Physician Decision|0|||
156733597|NCT01940887|565771150|FG000|Year 1|Protocol Violation|0|||
156733598|NCT01940887|565771151|FG001|Year 1|Protocol Violation|1|||
156733599|NCT01940887|565771150|FG000|Year 1|Physician Decision|7|||
156733600|NCT01940887|565771151|FG001|Year 1|Physician Decision|3|||
156733601|NCT01940887|565771150|FG000|Year 1|Death|5|||
156733602|NCT01940887|565771151|FG001|Year 1|Death|3|||
156733603|NCT01940887|565771150|FG000|Year 1|Adverse Event|7|||
156733604|NCT01940887|565771151|FG001|Year 1|Adverse Event|6|||
156733605|NCT01940887|565771150|FG000|Year 1|Withdrawal by Subject|18|||
156733606|NCT01940887|565771151|FG001|Year 1|Withdrawal by Subject|9|||
156733607|NCT01940887|565771150|FG000|Year 1|Lost to Follow-up|2|||
156733608|NCT01940887|565771151|FG001|Year 1|Lost to Follow-up|1|||
156733609|NCT01940887|565771150|FG000|Year 2|Physician Decision|8|||
156733610|NCT01940887|565771151|FG001|Year 2|Physician Decision|1|||
156733611|NCT01940887|565771150|FG000|Year 2|Death|0|||
156733612|NCT01940887|565771151|FG001|Year 2|Death|2|||
156733613|NCT01940887|565771150|FG000|Year 2|Sponsor Decision, early termination|192|||
156733614|NCT01940887|565771151|FG001|Year 2|Sponsor Decision, early termination|203|||
156733615|NCT01940887|565771150|FG000|Year 2|Adverse Event|8|||
156733616|NCT01940887|565771151|FG001|Year 2|Adverse Event|2|||
156733617|NCT01940887|565771150|FG000|Year 2|Withdrawal by Subject|8|||
156733618|NCT01940887|565771151|FG001|Year 2|Withdrawal by Subject|8|||
156733619|NCT01940887|565771150|FG000|Year 2|Lost to Follow-up|1|||
156733620|NCT01940887|565771151|FG001|Year 2|Lost to Follow-up|6|||
156733621|NCT00090220|565771152|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
156733622|NCT00090220|565771153|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
156733623|NCT00090220|565771154|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733624|NCT00090220|565771155|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733625|NCT00090220|565771156|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733626|NCT00090220|565771157|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
156733627|NCT00090220|565771152|FG000|Base Study Vaccination Period|Adverse Event|6|||
156733628|NCT00090220|565771153|FG001|Base Study Vaccination Period|Adverse Event|1|||
156733629|NCT00090220|565771154|FG002|Base Study Vaccination Period|Adverse Event|0|||
156733630|NCT00090220|565771155|FG003|Base Study Vaccination Period|Adverse Event|0|||
156733631|NCT00090220|565771156|FG004|Base Study Vaccination Period|Adverse Event|0|||
156733632|NCT00090220|565771157|FG005|Base Study Vaccination Period|Adverse Event|0|||
156733633|NCT00090220|565771152|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
156733634|NCT00090220|565771153|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
156733635|NCT00090220|565771154|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
156733636|NCT00090220|565771155|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
156733637|NCT00090220|565771156|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
156733638|NCT00090220|565771157|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
156733639|NCT00090220|565771152|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
156733640|NCT00090220|565771153|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
156733641|NCT00090220|565771154|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733642|NCT00090220|565771155|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733643|NCT00090220|565771156|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733644|NCT00090220|565771157|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
156733645|NCT00090220|565771152|FG000|Base Study Vaccination Period|Patient Moved|6|||
156733646|NCT00090220|565771153|FG001|Base Study Vaccination Period|Patient Moved|2|||
156733647|NCT00090220|565771154|FG002|Base Study Vaccination Period|Patient Moved|0|||
156733648|NCT00090220|565771155|FG003|Base Study Vaccination Period|Patient Moved|0|||
156733649|NCT00090220|565771156|FG004|Base Study Vaccination Period|Patient Moved|0|||
156733650|NCT00090220|565771157|FG005|Base Study Vaccination Period|Patient Moved|0|||
156733651|NCT00090220|565771152|FG000|Base Study Vaccination Period|Other|4|||
156733652|NCT00090220|565771153|FG001|Base Study Vaccination Period|Other|4|||
156733653|NCT00090220|565771154|FG002|Base Study Vaccination Period|Other|0|||
156733654|NCT00090220|565771155|FG003|Base Study Vaccination Period|Other|0|||
156733655|NCT00090220|565771156|FG004|Base Study Vaccination Period|Other|0|||
156733656|NCT00090220|565771157|FG005|Base Study Vaccination Period|Other|0|||
156733657|NCT00090220|565771152|FG000|Base Study Follow-up Period|Adverse Event|6|||
156733658|NCT00090220|565771153|FG001|Base Study Follow-up Period|Adverse Event|1|||
156733659|NCT00090220|565771154|FG002|Base Study Follow-up Period|Adverse Event|0|||
156733660|NCT00090220|565771155|FG003|Base Study Follow-up Period|Adverse Event|0|||
156733661|NCT00090220|565771156|FG004|Base Study Follow-up Period|Adverse Event|0|||
156733662|NCT00090220|565771157|FG005|Base Study Follow-up Period|Adverse Event|0|||
156733663|NCT00090220|565771152|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
156733664|NCT00090220|565771153|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
156733665|NCT00090220|565771154|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
156733666|NCT00090220|565771155|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
156733667|NCT00090220|565771156|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
156733668|NCT00090220|565771157|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
156733669|NCT00090220|565771152|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
156733670|NCT00090220|565771153|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
156733671|NCT00090220|565771154|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733672|NCT00090220|565771155|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733673|NCT00090220|565771156|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733674|NCT00090220|565771157|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
156733675|NCT00090220|565771152|FG000|Base Study Follow-up Period|Patient Moved|20|||
157020092|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020093|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020094|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
157020095|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020096|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020097|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020098|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020099|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020100|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020101|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
157020102|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
157020103|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
157020104|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020105|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157140123|NCT05087030|567257604|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
157140124|NCT05087030|567257605|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156733676|NCT00090220|565771153|FG001|Base Study Follow-up Period|Patient Moved|28|||
156733677|NCT00090220|565771154|FG002|Base Study Follow-up Period|Patient Moved|0|||
156733678|NCT00090220|565771155|FG003|Base Study Follow-up Period|Patient Moved|0|||
156733679|NCT00090220|565771156|FG004|Base Study Follow-up Period|Patient Moved|0|||
156733680|NCT00090220|565771157|FG005|Base Study Follow-up Period|Patient Moved|0|||
156733681|NCT00090220|565771152|FG000|Base Study Follow-up Period|Other|19|||
156733682|NCT00090220|565771153|FG001|Base Study Follow-up Period|Other|21|||
156733683|NCT00090220|565771154|FG002|Base Study Follow-up Period|Other|0|||
156733684|NCT00090220|565771155|FG003|Base Study Follow-up Period|Other|0|||
156733685|NCT00090220|565771156|FG004|Base Study Follow-up Period|Other|0|||
156733686|NCT00090220|565771157|FG005|Base Study Follow-up Period|Other|0|||
156733687|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Adverse Event|0|||
156733688|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Adverse Event|0|||
156733689|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Adverse Event|4|||
156733690|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Adverse Event|0|||
156733691|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Adverse Event|0|||
156733692|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Adverse Event|0|||
156733693|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733694|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733695|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
156733696|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733697|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733698|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
156733699|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Moved|0|||
156733700|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Moved|0|||
156733701|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Moved|2|||
156733702|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Moved|1|||
156733703|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Moved|0|||
156733704|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Moved|0|||
156733705|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733706|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733707|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
156733708|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733709|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733710|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
156733711|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
156733712|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
156733713|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
156733714|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
156733715|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
156733716|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
156733717|NCT00090220|565771152|FG000|Extension 1 (EXT1)|Other reason|0|||
156733718|NCT00090220|565771153|FG001|Extension 1 (EXT1)|Other reason|0|||
156733719|NCT00090220|565771154|FG002|Extension 1 (EXT1)|Other reason|2|||
156733720|NCT00090220|565771155|FG003|Extension 1 (EXT1)|Other reason|0|||
156733721|NCT00090220|565771156|FG004|Extension 1 (EXT1)|Other reason|0|||
156733722|NCT00090220|565771157|FG005|Extension 1 (EXT1)|Other reason|0|||
156733723|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
157140125|NCT05087030|567257606|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156733724|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733725|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733726|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156733727|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
156733728|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
156733729|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Death|0|||
156733730|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Death|0|||
156733731|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Death|0|||
156733732|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Death|0|||
156733733|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Death|1|||
156733734|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Death|1|||
156733735|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733736|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733737|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733738|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156733739|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
156733740|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
156733741|NCT00090220|565771152|FG000|Long-term Follow-up (EXT2)|Other|0|||
156733742|NCT00090220|565771153|FG001|Long-term Follow-up (EXT2)|Other|0|||
156733743|NCT00090220|565771154|FG002|Long-term Follow-up (EXT2)|Other|0|||
156733744|NCT00090220|565771155|FG003|Long-term Follow-up (EXT2)|Other|0|||
156733745|NCT00090220|565771156|FG004|Long-term Follow-up (EXT2)|Other|1|||
156733746|NCT00090220|565771157|FG005|Long-term Follow-up (EXT2)|Other|0|||
156733747|NCT01609543|565771160|FG000|Overall Study|Disease Progression|28|||
156733748|NCT01609543|565771160|FG000|Overall Study|Adverse Event|5|||
156733749|NCT01609543|565771160|FG000|Overall Study|Withdrawal by Subject|1|||
156733750|NCT01609543|565771160|FG000|Overall Study|Protocol Violation|1|||
156733751|NCT01609543|565771160|FG000|Overall Study|Death|7|||
156733752|NCT01254318|565771162|FG000|Overall Study|Lost to Follow-up|5|||
157140126|NCT05087030|567257607|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
157140127|NCT05087030|567257608|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
157140128|NCT02597062|567257609|FG000|Overall Study|Ineligible|1|||
157140129|NCT00741819|567257610|FG000|Overall Study|Adverse Event|3|||
157140130|NCT00741819|567257610|FG000|Overall Study|Withdrawal by Subject|3|||
157140131|NCT00741819|567257610|FG000|Overall Study|Death|1|||
157140132|NCT00741819|567257610|FG000|Overall Study|Disease progression|1|||
157140133|NCT00686543|567257613|FG000|Overall Study|Adverse Event|9|||
157140134|NCT00686543|567257614|FG001|Overall Study|Adverse Event|1|||
157140135|NCT00686543|567257615|FG002|Overall Study|Adverse Event|3|||
157140136|NCT00686543|567257616|FG003|Overall Study|Adverse Event|2|||
157140137|NCT00686543|567257613|FG000|Overall Study|Withdrawal by Subject|2|||
157140138|NCT00686543|567257614|FG001|Overall Study|Withdrawal by Subject|0|||
157140139|NCT00686543|567257615|FG002|Overall Study|Withdrawal by Subject|0|||
157140140|NCT00686543|567257616|FG003|Overall Study|Withdrawal by Subject|0|||
157140141|NCT00686543|567257613|FG000|Overall Study|Protocol Violation|3|||
157140142|NCT00686543|567257614|FG001|Overall Study|Protocol Violation|0|||
157140143|NCT00686543|567257615|FG002|Overall Study|Protocol Violation|2|||
157140144|NCT00686543|567257616|FG003|Overall Study|Protocol Violation|1|||
157140145|NCT01708057|567257617|FG000|Overall Study|Withdrawal due to study termination.|1|||
157217603|NCT01806597|567543246|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
156733753|NCT01254318|565771162|FG000|Overall Study|Death|47|||
156733754|NCT01137110|565771169|FG000|Overall Study|Protocol Violation|1|||
156733755|NCT01137110|565771170|FG001|Overall Study|Protocol Violation|0|||
156796720|NCT02314923|566009666|FG005|Overall Study|Death|0|||
156796721|NCT02314923|566009667|FG006|Overall Study|Death|0|||
156796722|NCT02314923|566009668|FG007|Overall Study|Death|0|||
156796723|NCT02314923|566009669|FG008|Overall Study|Death|0|||
156796724|NCT02314923|566009670|FG009|Overall Study|Death|0|||
156796725|NCT02314923|566009661|FG000|Overall Study|Lost to Follow-up|2|||
156796726|NCT02314923|566009662|FG001|Overall Study|Lost to Follow-up|3|||
156796727|NCT02314923|566009663|FG002|Overall Study|Lost to Follow-up|1|||
156796728|NCT02314923|566009664|FG003|Overall Study|Lost to Follow-up|0|||
156796729|NCT02314923|566009665|FG004|Overall Study|Lost to Follow-up|0|||
156796730|NCT02314923|566009666|FG005|Overall Study|Lost to Follow-up|0|||
156796731|NCT02314923|566009667|FG006|Overall Study|Lost to Follow-up|3|||
156796732|NCT02314923|566009668|FG007|Overall Study|Lost to Follow-up|4|||
156796733|NCT02314923|566009669|FG008|Overall Study|Lost to Follow-up|2|||
156796734|NCT02314923|566009670|FG009|Overall Study|Lost to Follow-up|0|||
156796735|NCT02314923|566009661|FG000|Overall Study|Withdrawal by Subject|0|||
156796736|NCT02314923|566009662|FG001|Overall Study|Withdrawal by Subject|0|||
156796737|NCT02314923|566009663|FG002|Overall Study|Withdrawal by Subject|1|||
156796738|NCT02314923|566009664|FG003|Overall Study|Withdrawal by Subject|0|||
156796739|NCT02314923|566009665|FG004|Overall Study|Withdrawal by Subject|1|||
156796740|NCT02314923|566009666|FG005|Overall Study|Withdrawal by Subject|0|||
156796741|NCT02314923|566009667|FG006|Overall Study|Withdrawal by Subject|1|||
156796742|NCT02314923|566009668|FG007|Overall Study|Withdrawal by Subject|0|||
156796743|NCT02314923|566009669|FG008|Overall Study|Withdrawal by Subject|0|||
156796744|NCT02314923|566009670|FG009|Overall Study|Withdrawal by Subject|0|||
156796745|NCT02314923|566009661|FG000|Overall Study|Physician Decision|0|||
156796746|NCT02314923|566009662|FG001|Overall Study|Physician Decision|1|||
156796747|NCT02314923|566009663|FG002|Overall Study|Physician Decision|0|||
156796748|NCT02314923|566009664|FG003|Overall Study|Physician Decision|0|||
156796749|NCT02314923|566009665|FG004|Overall Study|Physician Decision|0|||
156733756|NCT00582608|565771173|FG000|Overall Study|Not Treated|7|||
156796750|NCT02314923|566009666|FG005|Overall Study|Physician Decision|0|||
157140146|NCT01708057|567257618|FG001|Overall Study|Withdrawal due to study termination.|1|||
157140147|NCT01708057|567257619|FG002|Overall Study|Withdrawal due to study termination.|1|||
157140148|NCT00924703|567257620|FG000|Overall Study|Withdrawal by Subject|11|||
157140149|NCT00924703|567257620|FG000|Overall Study|Physician Decision|5|||
157140150|NCT00924703|567257620|FG000|Overall Study|Lost to Follow-up|3|||
157140151|NCT00924703|567257620|FG000|Overall Study|Adverse Event|2|||
157140152|NCT00924703|567257620|FG000|Overall Study|Withdrawal by Sponsor|1|||
157140153|NCT04906707|567257621|FG000|Overall Study|Withdrawal by Subject|2|||
157140154|NCT04906707|567257622|FG001|Overall Study|Withdrawal by Subject|0|||
157140155|NCT04906707|567257621|FG000|Overall Study|Withdrawal due to PI decision|1|||
157140156|NCT04906707|567257622|FG001|Overall Study|Withdrawal due to PI decision|0|||
157140157|NCT04906707|567257621|FG000|Overall Study|Lost to Follow-up|0|||
157140158|NCT04906707|567257622|FG001|Overall Study|Lost to Follow-up|1|||
157140159|NCT04909463|567258878|FG000|Overall Study|Withdrawal by Subject|0|||
157140160|NCT04909463|567258879|FG001|Overall Study|Withdrawal by Subject|1|||
157140161|NCT04909463|567258880|FG002|Overall Study|Withdrawal by Subject|0|||
157140162|NCT04909463|567258881|FG003|Overall Study|Withdrawal by Subject|0|||
157140163|NCT04909463|567258878|FG000|Overall Study|Lost to Follow-up|2|||
157140164|NCT04909463|567258879|FG001|Overall Study|Lost to Follow-up|1|||
157140165|NCT04909463|567258880|FG002|Overall Study|Lost to Follow-up|1|||
157140166|NCT04909463|567258881|FG003|Overall Study|Lost to Follow-up|0|||
157140167|NCT02224664|567258882|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
157140168|NCT02224664|567258883|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
157140169|NCT02224664|567258884|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
157140170|NCT02224664|567258885|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
157140171|NCT02224664|567258886|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
157140172|NCT02224664|567258882|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
157140173|NCT02224664|567258883|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
156733757|NCT00582608|565771173|FG000|Overall Study|Patient Ineligible|1|||
156733758|NCT00582608|565771173|FG000|Overall Study|Lack of accrual|4|||
156733759|NCT03634033|565773564|FG000|Overall Study|Did not have a post-assessment|384|||
156733760|NCT03634033|565773565|FG001|Overall Study|Did not have a post-assessment|291|||
156733761|NCT03634033|565773566|FG002|Overall Study|Did not have a post-assessment|114|||
156733762|NCT03634033|565773567|FG003|Overall Study|Did not have a post-assessment|161|||
156733763|NCT03634033|565773568|FG004|Overall Study|Did not have a post-assessment|5|||
156733764|NCT03634033|565773569|FG005|Overall Study|Did not have a post-assessment|0|||
156733765|NCT03634033|565773570|FG006|Overall Study|Did not have a post-assessment|0|||
156733766|NCT03634033|565773564|FG000|Overall Study|Death|0|||
156733767|NCT03634033|565773565|FG001|Overall Study|Death|0|||
156733768|NCT03634033|565773566|FG002|Overall Study|Death|0|||
156733769|NCT03634033|565773567|FG003|Overall Study|Death|0|||
156733770|NCT03634033|565773568|FG004|Overall Study|Death|0|||
156733771|NCT03634033|565773569|FG005|Overall Study|Death|7|||
156733772|NCT03634033|565773570|FG006|Overall Study|Death|7|||
156733773|NCT03634033|565773564|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733774|NCT03634033|565773565|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733775|NCT03634033|565773566|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733776|NCT03634033|565773567|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733777|NCT03634033|565773568|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
156733778|NCT03634033|565773569|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
156733779|NCT03634033|565773570|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
156733780|NCT03634033|565773564|FG000|Overall Study|Lost to Follow-up|0|||
156733781|NCT03634033|565773565|FG001|Overall Study|Lost to Follow-up|0|||
156733782|NCT03634033|565773566|FG002|Overall Study|Lost to Follow-up|0|||
156796751|NCT02314923|566009667|FG006|Overall Study|Physician Decision|0|||
156796752|NCT02314923|566009668|FG007|Overall Study|Physician Decision|0|||
156796753|NCT02314923|566009669|FG008|Overall Study|Physician Decision|0|||
156796754|NCT02314923|566009670|FG009|Overall Study|Physician Decision|0|||
156796755|NCT02314923|566009661|FG000|Overall Study|Participant unavailable|0|||
156796756|NCT02314923|566009662|FG001|Overall Study|Participant unavailable|0|||
156796757|NCT02314923|566009663|FG002|Overall Study|Participant unavailable|0|||
156796758|NCT02314923|566009664|FG003|Overall Study|Participant unavailable|0|||
156796759|NCT02314923|566009665|FG004|Overall Study|Participant unavailable|0|||
157140174|NCT02224664|567258884|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
157140175|NCT02224664|567258885|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
156733783|NCT03634033|565773567|FG003|Overall Study|Lost to Follow-up|0|||
156733784|NCT03634033|565773568|FG004|Overall Study|Lost to Follow-up|0|||
156733785|NCT03634033|565773569|FG005|Overall Study|Lost to Follow-up|1|||
156796760|NCT02314923|566009666|FG005|Overall Study|Participant unavailable|1|||
157021789|NCT00378105|566832970|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
156733786|NCT03634033|565773570|FG006|Overall Study|Lost to Follow-up|2|||
156733787|NCT03634033|565773564|FG000|Overall Study|Withdrawal by Subject|0|||
156733788|NCT03634033|565773565|FG001|Overall Study|Withdrawal by Subject|0|||
156796761|NCT02314923|566009667|FG006|Overall Study|Participant unavailable|0|||
156733789|NCT03634033|565773566|FG002|Overall Study|Withdrawal by Subject|0|||
156733790|NCT03634033|565773567|FG003|Overall Study|Withdrawal by Subject|0|||
156733791|NCT03634033|565773568|FG004|Overall Study|Withdrawal by Subject|0|||
156733792|NCT03634033|565773569|FG005|Overall Study|Withdrawal by Subject|0|||
156733793|NCT03634033|565773570|FG006|Overall Study|Withdrawal by Subject|1|||
156733794|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
156733795|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
156733796|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156733797|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156733798|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
156733799|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
156733800|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156733801|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
156733802|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156733803|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
156733804|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156733805|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156733806|NCT02836236|565773572|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
156733807|NCT02836236|565773573|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733808|NCT02836236|565773574|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733809|NCT02836236|565773575|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156733810|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156733811|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156733812|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
156733813|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
156733814|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156733815|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156733816|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
156733817|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
156733818|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Death|0|||
156733819|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Death|0|||
156733820|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Death|1|||
156733821|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Death|1|||
156733822|NCT02836236|565773572|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733823|NCT02836236|565773573|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733824|NCT02836236|565773574|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
156733825|NCT02836236|565773575|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
156733826|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
156733827|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
156733828|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
156733829|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
156733830|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Death|0|||
156733831|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Death|0|||
156733832|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Death|1|||
156733833|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Death|0|||
156733834|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
156733835|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733836|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733837|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
156733838|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
156733839|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
156733840|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
156733841|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
156733842|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
156733843|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
156733844|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
156733845|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
156733846|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
156733847|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
156733848|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
156733849|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
156733850|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
156733851|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
156733852|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
156733853|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
156733854|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
156733855|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
156808812|NCT01484496|566054473|FG000|Period 1|Lack of Efficacy|10|||
156808813|NCT01484496|566054474|FG001|Period 1|Lack of Efficacy|15|||
156733856|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
156733857|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
156733858|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
156733859|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
156733860|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156733861|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
156733862|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
156733863|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
156733864|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
156733865|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
156733866|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
156733867|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
156733868|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
156733869|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
156733870|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Other|8|||
156733871|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Other|14|||
156733872|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Other|8|||
156733873|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Other|23|||
156733874|NCT01106677|565773579|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
156733875|NCT01106677|565773580|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
156733876|NCT01106677|565773581|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
156733877|NCT01106677|565773582|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
156733878|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156733879|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
156733880|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
156733881|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
156733882|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Death|0|||
156733883|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Death|0|||
156733884|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Death|0|||
156733885|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Death|1|||
156733886|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
156733887|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
156733888|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
156733889|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
156733890|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
156733891|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733892|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733893|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
156733894|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156733895|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
156733896|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
156733897|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
156733898|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
156733899|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733900|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733901|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
156733902|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156733903|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
156733904|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
156733905|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156733906|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
156733907|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
156733908|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
156733909|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
156733910|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733911|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733912|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
156733913|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
156733914|NCT01106677|565773579|FG000|Extension Period: Week 26 to Week 52|Other|6|||
156733915|NCT01106677|565773580|FG001|Extension Period: Week 26 to Week 52|Other|5|||
156733916|NCT01106677|565773581|FG002|Extension Period: Week 26 to Week 52|Other|8|||
156733917|NCT01106677|565773582|FG003|Extension Period: Week 26 to Week 52|Other|5|||
156733918|NCT03937908|565773583|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
156733919|NCT03937908|565773584|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
156733920|NCT03875092|565773585|FG000|Overall Study|Adverse Event|2|||
156733921|NCT03875092|565773586|FG001|Overall Study|Adverse Event|5|||
156733922|NCT03875092|565773585|FG000|Overall Study|Death|44|||
156733923|NCT03875092|565773586|FG001|Overall Study|Death|51|||
156733924|NCT03875092|565773585|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
156733925|NCT03875092|565773586|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
156733926|NCT04114357|565773587|FG000|Baseline-Randomization|Adverse Event|2|||
156733927|NCT04114357|565773588|FG001|Baseline-Randomization|Adverse Event|1|||
156733928|NCT04114357|565773587|FG000|Baseline-Randomization|Lost to Follow-up|1|||
156733929|NCT04114357|565773588|FG001|Baseline-Randomization|Lost to Follow-up|1|||
156733930|NCT04114357|565773587|FG000|Cross-over|Adverse Event|0|||
156733931|NCT04114357|565773588|FG001|Cross-over|Adverse Event|1|||
156733932|NCT03693612|565773592|FG000|Overall Study|Lost to Follow-up|0|||
156733933|NCT03693612|565773593|FG001|Overall Study|Lost to Follow-up|0|||
156733934|NCT03693612|565773594|FG002|Overall Study|Lost to Follow-up|0|||
156733935|NCT03693612|565773595|FG003|Overall Study|Lost to Follow-up|0|||
156733936|NCT03693612|565773596|FG004|Overall Study|Lost to Follow-up|1|||
156733937|NCT03693612|565773597|FG005|Overall Study|Lost to Follow-up|0|||
156733938|NCT03693612|565773598|FG006|Overall Study|Lost to Follow-up|0|||
156733939|NCT03693612|565773592|FG000|Overall Study|Withdrawal by Subject|0|||
156733940|NCT03693612|565773593|FG001|Overall Study|Withdrawal by Subject|0|||
156733941|NCT03693612|565773594|FG002|Overall Study|Withdrawal by Subject|1|||
156733942|NCT03693612|565773595|FG003|Overall Study|Withdrawal by Subject|0|||
156733943|NCT03693612|565773596|FG004|Overall Study|Withdrawal by Subject|2|||
156733944|NCT03693612|565773597|FG005|Overall Study|Withdrawal by Subject|0|||
156733945|NCT03693612|565773598|FG006|Overall Study|Withdrawal by Subject|0|||
156733946|NCT03693612|565773592|FG000|Overall Study|Study Terminated by Sponsor|0|||
156733947|NCT03693612|565773593|FG001|Overall Study|Study Terminated by Sponsor|1|||
156733948|NCT03693612|565773594|FG002|Overall Study|Study Terminated by Sponsor|0|||
156733949|NCT03693612|565773595|FG003|Overall Study|Study Terminated by Sponsor|0|||
156733950|NCT03693612|565773596|FG004|Overall Study|Study Terminated by Sponsor|3|||
156733951|NCT03693612|565773597|FG005|Overall Study|Study Terminated by Sponsor|0|||
156733952|NCT03693612|565773598|FG006|Overall Study|Study Terminated by Sponsor|0|||
156733953|NCT00809471|565773599|FG000|Overall Study|Protocol non-compliance|15|||
156733954|NCT00809471|565773600|FG001|Overall Study|Protocol non-compliance|15|||
156733955|NCT00809471|565773601|FG002|Overall Study|Protocol non-compliance|6|||
156733956|NCT00809471|565773599|FG000|Overall Study|Lost to Follow-up|4|||
156733957|NCT00809471|565773600|FG001|Overall Study|Lost to Follow-up|2|||
156733958|NCT00809471|565773601|FG002|Overall Study|Lost to Follow-up|9|||
156733959|NCT00809471|565773599|FG000|Overall Study|Adverse Event|0|||
156733960|NCT00809471|565773600|FG001|Overall Study|Adverse Event|2|||
156733961|NCT00809471|565773601|FG002|Overall Study|Adverse Event|2|||
156733962|NCT00809471|565773599|FG000|Overall Study|Requirement for restricted medication|1|||
156733963|NCT00809471|565773600|FG001|Overall Study|Requirement for restricted medication|1|||
156733964|NCT00809471|565773601|FG002|Overall Study|Requirement for restricted medication|0|||
156733965|NCT00831311|565773603|FG000|Overall Study|Definitive Contraindication|3|||
156733966|NCT00831311|565773604|FG001|Overall Study|Definitive Contraindication|3|||
156733967|NCT00831311|565773603|FG000|Overall Study|Lost to Follow-up|3|||
156733968|NCT00831311|565773604|FG001|Overall Study|Lost to Follow-up|0|||
156733969|NCT00831311|565773603|FG000|Overall Study|Physician Decision|0|||
156733970|NCT00831311|565773604|FG001|Overall Study|Physician Decision|1|||
156733971|NCT00831311|565773603|FG000|Overall Study|Withdrawal by Subject|6|||
156733972|NCT00831311|565773604|FG001|Overall Study|Withdrawal by Subject|4|||
156733973|NCT01669174|565773614|FG000|Overall Study|Subject withdrew consent|2|||
156733974|NCT01669174|565773615|FG001|Overall Study|Subject withdrew consent|2|||
156733975|NCT01669174|565773614|FG000|Overall Study|Lost to Follow-up|1|||
156733976|NCT01669174|565773615|FG001|Overall Study|Lost to Follow-up|0|||
156733977|NCT01669174|565773614|FG000|Overall Study|Adverse Event|2|||
156733978|NCT01669174|565773615|FG001|Overall Study|Adverse Event|2|||
156733979|NCT01669174|565773614|FG000|Overall Study|Administrative problems|1|||
156733980|NCT01669174|565773615|FG001|Overall Study|Administrative problems|2|||
156733981|NCT01953601|565773619|FG000|Part 1 (Base Study)|Adverse Event|24|||
156733982|NCT01953601|565773620|FG001|Part 1 (Base Study)|Adverse Event|37|||
156733983|NCT01953601|565773621|FG002|Part 1 (Base Study)|Adverse Event|15|||
156733984|NCT01953601|565773619|FG000|Part 1 (Base Study)|Death|2|||
156733985|NCT01953601|565773620|FG001|Part 1 (Base Study)|Death|0|||
156733986|NCT01953601|565773621|FG002|Part 1 (Base Study)|Death|3|||
156733987|NCT01953601|565773619|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
156733988|NCT01953601|565773620|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
156733989|NCT01953601|565773621|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
156733990|NCT01953601|565773619|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
156796762|NCT02314923|566009668|FG007|Overall Study|Participant unavailable|0|||
156733991|NCT01953601|565773620|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
156733992|NCT01953601|565773621|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
156733993|NCT01953601|565773619|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
156733994|NCT01953601|565773620|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
156733995|NCT01953601|565773621|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
156733996|NCT01953601|565773619|FG000|Part 1 (Base Study)|Physician Decision|3|||
156733997|NCT01953601|565773620|FG001|Part 1 (Base Study)|Physician Decision|7|||
156733998|NCT01953601|565773621|FG002|Part 1 (Base Study)|Physician Decision|4|||
156733999|NCT01953601|565773619|FG000|Part 1 (Base Study)|Screen failure|1|||
156734000|NCT01953601|565773620|FG001|Part 1 (Base Study)|Screen failure|0|||
156734001|NCT01953601|565773621|FG002|Part 1 (Base Study)|Screen failure|1|||
156734002|NCT01953601|565773619|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
156734003|NCT01953601|565773620|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
156734004|NCT01953601|565773621|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
156734005|NCT01953601|565773619|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
156734006|NCT01953601|565773620|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
156734007|NCT01953601|565773621|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
156734008|NCT01953601|565773619|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
156734009|NCT01953601|565773620|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
156734010|NCT01953601|565773621|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
156734011|NCT01953601|565773619|FG000|Part 1 (Base Study)|Subject moved|2|||
156734012|NCT01953601|565773620|FG001|Part 1 (Base Study)|Subject moved|2|||
156734013|NCT01953601|565773621|FG002|Part 1 (Base Study)|Subject moved|1|||
156734014|NCT01953601|565773619|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
156734015|NCT01953601|565773620|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
156734016|NCT01953601|565773621|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
156734017|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Adverse Event|1|||
156734018|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Adverse Event|1|||
156734019|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Adverse Event|10|||
156734020|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Death|0|||
156734021|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Death|3|||
156734022|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Death|0|||
156734023|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
156734024|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
156734025|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
156734026|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
156734027|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
156734028|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
156734029|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Physician Decision|2|||
156734030|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Physician Decision|0|||
156734031|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Physician Decision|2|||
156734032|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
156734033|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
156734034|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
156734035|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
156734036|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
156734037|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
156734038|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
156734039|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
156734040|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
156734041|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Subject moved|0|||
156734042|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Subject moved|0|||
156734043|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Subject moved|1|||
156796763|NCT02314923|566009669|FG008|Overall Study|Participant unavailable|0|||
156796764|NCT02314923|566009670|FG009|Overall Study|Participant unavailable|0|||
156796765|NCT02314923|566009661|FG000|Overall Study|Screen failure|0|||
156796766|NCT02314923|566009662|FG001|Overall Study|Screen failure|0|||
156796767|NCT02314923|566009663|FG002|Overall Study|Screen failure|0|||
156796768|NCT02314923|566009664|FG003|Overall Study|Screen failure|0|||
156796769|NCT02314923|566009665|FG004|Overall Study|Screen failure|0|||
157217604|NCT01806597|567543247|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
157217605|NCT01806597|567543248|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
157217606|NCT01806597|567543249|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
157217607|NCT01806597|567543244|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
157217608|NCT01806597|567543245|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
157217609|NCT01806597|567543246|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
157217610|NCT01806597|567543247|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
157217611|NCT01806597|567543248|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
156734044|NCT01953601|565773619|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
156734045|NCT01953601|565773620|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
156734046|NCT01953601|565773621|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
156796770|NCT02314923|566009666|FG005|Overall Study|Screen failure|0|||
156796771|NCT02314923|566009667|FG006|Overall Study|Screen failure|1|||
156796772|NCT02314923|566009668|FG007|Overall Study|Screen failure|0|||
156796773|NCT02314923|566009669|FG008|Overall Study|Screen failure|0|||
156796774|NCT02314923|566009670|FG009|Overall Study|Screen failure|0|||
157217612|NCT01806597|567543249|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
156734047|NCT01608087|565773622|FG000|Overall Study|Lost to Follow-up|0|||
156734048|NCT01608087|565773623|FG001|Overall Study|Lost to Follow-up|1|||
156734049|NCT01608087|565773624|FG002|Overall Study|Lost to Follow-up|0|||
156734050|NCT01608087|565773622|FG000|Overall Study|Other Reason|0|||
156734051|NCT01608087|565773623|FG001|Overall Study|Other Reason|1|||
156734052|NCT01608087|565773624|FG002|Overall Study|Other Reason|0|||
156734053|NCT01300338|565773631|FG000|Overall Study|Lost to Follow-up|5|||
156734054|NCT01300338|565773632|FG001|Overall Study|Lost to Follow-up|0|||
156734055|NCT02461524|565773636|FG000|Overall Study|Death|16|||
156734056|NCT02461524|565773636|FG000|Overall Study|Withdrawal by Subject|4|||
156734057|NCT02461524|565773636|FG000|Overall Study|Device Explanted|5|||
156734058|NCT02461524|565773636|FG000|Overall Study|Missed Visit|6|||
156734059|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734060|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734061|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734062|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734063|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734064|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734065|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734066|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156734067|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
156796775|NCT02314923|566009661|FG000|Overall Study|Participant relocation|1|||
156796776|NCT02314923|566009662|FG001|Overall Study|Participant relocation|0|||
156796777|NCT02314923|566009663|FG002|Overall Study|Participant relocation|0|||
157217613|NCT01806597|567543244|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
156796778|NCT02314923|566009664|FG003|Overall Study|Participant relocation|0|||
156796779|NCT02314923|566009665|FG004|Overall Study|Participant relocation|0|||
156796780|NCT02314923|566009666|FG005|Overall Study|Participant relocation|0|||
156796781|NCT02314923|566009667|FG006|Overall Study|Participant relocation|0|||
156796782|NCT02314923|566009668|FG007|Overall Study|Participant relocation|1|||
156796783|NCT02314923|566009669|FG008|Overall Study|Participant relocation|0|||
156796784|NCT02314923|566009670|FG009|Overall Study|Participant relocation|0|||
156796785|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Adverse Event|20|||
157217614|NCT01806597|567543245|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
157217615|NCT01806597|567543246|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
157217616|NCT01806597|567543247|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
157217617|NCT01806597|567543248|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
157217618|NCT01806597|567543249|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
157217619|NCT01806597|567543244|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
157217620|NCT01806597|567543245|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
157217621|NCT01806597|567543246|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
157217622|NCT01806597|567543247|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
157217623|NCT01806597|567543248|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
157217624|NCT01806597|567543249|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
157217625|NCT01806597|567543244|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
157217626|NCT01806597|567543245|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
157217627|NCT01806597|567543246|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
157217628|NCT01806597|567543247|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
157217629|NCT01806597|567543248|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
157217630|NCT01806597|567543249|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
157217631|NCT01144663|567543252|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
157217632|NCT01144663|567543253|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
157217633|NCT01144663|567543254|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
157217634|NCT01144663|567543255|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
157217635|NCT01144663|567543252|FG000|Primary Vaccination Phase|Adverse Event|1|||
157217636|NCT01144663|567543253|FG001|Primary Vaccination Phase|Adverse Event|0|||
157217637|NCT01144663|567543254|FG002|Primary Vaccination Phase|Adverse Event|0|||
157217638|NCT01144663|567543255|FG003|Primary Vaccination Phase|Adverse Event|1|||
157217639|NCT01144663|567543252|FG000|Primary Vaccination Phase|Protocol Violation|2|||
157217640|NCT01144663|567543253|FG001|Primary Vaccination Phase|Protocol Violation|0|||
157217641|NCT01144663|567543254|FG002|Primary Vaccination Phase|Protocol Violation|1|||
156796786|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Adverse Event|10|||
156796787|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Adverse Event|5|||
157217642|NCT01144663|567543255|FG003|Primary Vaccination Phase|Protocol Violation|0|||
156734068|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734069|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734070|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156796788|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Adverse Event|0|||
156796789|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Adverse Event|0|||
156796790|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Adverse Event|0|||
157140176|NCT02224664|567258886|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
156734071|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734072|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734073|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734074|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734075|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734076|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
156734077|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734078|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734079|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734080|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734081|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
156734082|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734083|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734084|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
156734085|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734086|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734087|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734088|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734089|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734090|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734091|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734092|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734093|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734094|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
156734095|NCT01943851|565773638|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734096|NCT01943851|565773639|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734097|NCT01943851|565773640|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734098|NCT01943851|565773641|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734099|NCT01943851|565773642|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734100|NCT01943851|565773643|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734101|NCT01943851|565773644|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734102|NCT01943851|565773645|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734103|NCT01943851|565773646|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734104|NCT01943851|565773647|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734105|NCT01943851|565773648|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734106|NCT01943851|565773649|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734107|NCT01943851|565773650|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734108|NCT01943851|565773651|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
156734109|NCT01943851|565773652|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734110|NCT01943851|565773653|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734111|NCT01943851|565773654|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734112|NCT01943851|565773655|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
156734113|NCT01943851|565773638|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734114|NCT01943851|565773639|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734115|NCT01943851|565773640|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734116|NCT01943851|565773641|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734117|NCT01943851|565773642|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734118|NCT01943851|565773643|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734119|NCT01943851|565773644|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734120|NCT01943851|565773645|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734121|NCT01943851|565773646|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734122|NCT01943851|565773647|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734123|NCT01943851|565773648|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734124|NCT01943851|565773649|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734125|NCT01943851|565773650|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734126|NCT01943851|565773651|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734127|NCT01943851|565773652|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734128|NCT01943851|565773653|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
156734129|NCT01943851|565773654|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734130|NCT01943851|565773655|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
156734131|NCT01943851|565773638|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734132|NCT01943851|565773639|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734133|NCT01943851|565773640|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734134|NCT01943851|565773641|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
157140177|NCT02224664|567258882|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
157140178|NCT02224664|567258883|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
157140179|NCT02224664|567258884|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
157140180|NCT02224664|567258885|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
157140181|NCT02224664|567258886|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
156734135|NCT01943851|565773642|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
157140182|NCT01614457|567258897|FG000|Overall Study|Non-Compliance|1|||
157140183|NCT01614457|567258898|FG001|Overall Study|Non-Compliance|0|||
157140184|NCT01614457|567258897|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
157140185|NCT01614457|567258898|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
157140186|NCT03518840|567258899|FG000|Overall Study|Lost to Follow-up|6|||
157140187|NCT02945657|567258902|FG000|Overall Study|Adverse Event|1|||
157140188|NCT02945657|567258902|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
157140189|NCT00283387|567258909|FG000|First Intervention|Subject non-compliant|1|||
157140190|NCT00283387|567258910|FG001|First Intervention|Subject non-compliant|1|||
157140191|NCT00283387|567258909|FG000|First Intervention|Withdrawal by Subject|0|||
157140192|NCT00283387|567258910|FG001|First Intervention|Withdrawal by Subject|1|||
157140193|NCT03830281|567258915|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
157140194|NCT03830281|567258916|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
157140195|NCT03830281|567258915|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
156734136|NCT01943851|565773643|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734137|NCT01943851|565773644|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734138|NCT01943851|565773645|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734139|NCT01943851|565773646|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734140|NCT01943851|565773647|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734141|NCT01943851|565773648|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734142|NCT01943851|565773649|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734143|NCT01943851|565773650|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734144|NCT01943851|565773651|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156734145|NCT01943851|565773652|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
156796791|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Adverse Event|0|||
156796792|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Adverse Event|0|||
156796793|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Adverse Event|0|||
156796794|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Adverse Event|0|||
157140196|NCT03830281|567258916|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
157140197|NCT03830281|567258915|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
157140198|NCT03830281|567258916|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
157140199|NCT03830281|567258915|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
157140200|NCT03830281|567258916|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
157140201|NCT03830281|567258915|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
157140202|NCT03830281|567258916|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
157140203|NCT03830281|567258915|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
157140204|NCT03830281|567258916|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
157140205|NCT03830281|567258915|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
157140206|NCT03830281|567258916|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
157140207|NCT03830281|567258915|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
156796795|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Adverse Event|0|||
156796796|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Adverse Event|0|||
156796797|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796798|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796799|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
156796800|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796801|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796802|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796803|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796804|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796805|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796806|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796807|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796808|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
156796809|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
156796810|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
156796811|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
156796812|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
157140208|NCT03830281|567258916|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
157140209|NCT03830281|567258915|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
157140210|NCT03830281|567258916|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
157140211|NCT00659438|567258917|FG000|Overall Study|Withdrawal by Subject|2|||
157140212|NCT00659438|567258918|FG001|Overall Study|Withdrawal by Subject|2|||
157140213|NCT00659438|567258917|FG000|Overall Study|Death|11|||
156734146|NCT01943851|565773653|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
156734147|NCT01943851|565773654|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
156734148|NCT01943851|565773655|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
156734149|NCT00401544|565773660|FG000|Overall Study|Adverse Event|5|||
156734150|NCT00401544|565773661|FG001|Overall Study|Adverse Event|1|||
156796813|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
157140214|NCT00659438|567258918|FG001|Overall Study|Death|6|||
157020106|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020107|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
157020108|NCT01261312|566826524|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020109|NCT01261312|566826525|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020110|NCT01261312|566826526|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020111|NCT01261312|566826527|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157140215|NCT00659438|567258917|FG000|Overall Study|Lost to Follow-up|1|||
157140216|NCT00659438|567258918|FG001|Overall Study|Lost to Follow-up|0|||
156734151|NCT00401544|565773662|FG002|Overall Study|Adverse Event|1|||
156734152|NCT00401544|565773663|FG003|Overall Study|Adverse Event|1|||
156734153|NCT00401544|565773660|FG000|Overall Study|Death|3|||
156734154|NCT00401544|565773661|FG001|Overall Study|Death|6|||
156734155|NCT00401544|565773662|FG002|Overall Study|Death|2|||
156734156|NCT00401544|565773663|FG003|Overall Study|Death|5|||
156734157|NCT00401544|565773660|FG000|Overall Study|Lost to Follow-up|2|||
156734158|NCT00401544|565773661|FG001|Overall Study|Lost to Follow-up|0|||
156734159|NCT00401544|565773662|FG002|Overall Study|Lost to Follow-up|1|||
156734160|NCT00401544|565773663|FG003|Overall Study|Lost to Follow-up|1|||
156734161|NCT00401544|565773660|FG000|Overall Study|Withdrawal by Subject|7|||
156734162|NCT00401544|565773661|FG001|Overall Study|Withdrawal by Subject|6|||
156734163|NCT00401544|565773662|FG002|Overall Study|Withdrawal by Subject|6|||
156734164|NCT00401544|565773663|FG003|Overall Study|Withdrawal by Subject|5|||
156734165|NCT00401544|565773660|FG000|Overall Study|Physician Decision|1|||
156734166|NCT00401544|565773661|FG001|Overall Study|Physician Decision|3|||
156734167|NCT00401544|565773662|FG002|Overall Study|Physician Decision|0|||
156734168|NCT00401544|565773663|FG003|Overall Study|Physician Decision|0|||
156734169|NCT00401544|565773660|FG000|Overall Study|Ineligibility determined|0|||
156734170|NCT00401544|565773661|FG001|Overall Study|Ineligibility determined|1|||
156734171|NCT00401544|565773662|FG002|Overall Study|Ineligibility determined|0|||
156734172|NCT00401544|565773663|FG003|Overall Study|Ineligibility determined|2|||
156734173|NCT00401544|565773660|FG000|Overall Study|Disease progression|0|||
156734174|NCT00401544|565773661|FG001|Overall Study|Disease progression|1|||
156734175|NCT00401544|565773662|FG002|Overall Study|Disease progression|0|||
156734176|NCT00401544|565773663|FG003|Overall Study|Disease progression|0|||
156734177|NCT00401544|565773660|FG000|Overall Study|Other|0|||
156734178|NCT00401544|565773661|FG001|Overall Study|Other|0|||
156734179|NCT00401544|565773662|FG002|Overall Study|Other|2|||
156734180|NCT00401544|565773663|FG003|Overall Study|Other|2|||
156734181|NCT03991299|565773666|FG000|Overall Study|Study closed, sponsor decision|3|||
157020112|NCT01261312|566826528|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157140217|NCT00201851|567258920|FG000|Overall Study|Lost to Follow-up|2|||
157140218|NCT00201851|567258921|FG001|Overall Study|Lost to Follow-up|1|||
157140219|NCT00201851|567258922|FG002|Overall Study|Lost to Follow-up|0|||
157140220|NCT00201851|567258920|FG000|Overall Study|Ineligible post enrollment|6|||
157140221|NCT00201851|567258921|FG001|Overall Study|Ineligible post enrollment|1|||
157140222|NCT00201851|567258922|FG002|Overall Study|Ineligible post enrollment|1|||
157140223|NCT02469246|567258923|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
157140224|NCT02469246|567258924|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
157140225|NCT02469246|567258923|FG000|Double-Blind Phase|Adverse Event|12|||
157217643|NCT01144663|567543252|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
156734182|NCT03991299|565773666|FG000|Overall Study|Withdrawal by Subject|1|||
156734183|NCT00723008|565773667|FG000|Enrollment|Lost to Follow-up|1|||
156734184|NCT00723008|565773668|FG001|Enrollment|Lost to Follow-up|0|||
156734185|NCT00723008|565773667|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
156734186|NCT00723008|565773668|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
156734187|NCT00723008|565773667|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
156734188|NCT00723008|565773668|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
157140226|NCT02469246|567258924|FG001|Double-Blind Phase|Adverse Event|9|||
156734189|NCT00723008|565773667|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
156734190|NCT00723008|565773668|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
156734191|NCT00723008|565773667|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
156734192|NCT00723008|565773668|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
157140227|NCT02469246|567258923|FG000|Double-Blind Phase|Death|2|||
157140228|NCT02469246|567258924|FG001|Double-Blind Phase|Death|0|||
157217644|NCT01144663|567543253|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
157217645|NCT01144663|567543254|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
156734193|NCT00723008|565773667|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
156734194|NCT00723008|565773668|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
156734195|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
156734196|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
156734197|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
156734198|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
156734199|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
156734200|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734201|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
156808814|NCT01484496|566054475|FG002|Period 1|Lack of Efficacy|0|||
157140229|NCT02469246|567258923|FG000|Double-Blind Phase|Lack of Efficacy|2|||
156734202|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734203|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
156734204|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
156734205|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
157140230|NCT02469246|567258924|FG001|Double-Blind Phase|Lack of Efficacy|1|||
157140231|NCT02469246|567258923|FG000|Double-Blind Phase|Investigator's Discretion|8|||
157140232|NCT02469246|567258924|FG001|Double-Blind Phase|Investigator's Discretion|8|||
157140233|NCT02469246|567258923|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
157140234|NCT02469246|567258924|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
157140235|NCT02469246|567258923|FG000|Double-Blind Phase|Protocol Violation|1|||
157140236|NCT02469246|567258924|FG001|Double-Blind Phase|Protocol Violation|1|||
157140237|NCT02469246|567258923|FG000|Double-Blind Phase|Withdrew Consent|25|||
157140238|NCT02469246|567258924|FG001|Double-Blind Phase|Withdrew Consent|25|||
157140239|NCT02469246|567258923|FG000|Double-Blind Phase|Lost to Follow-up|9|||
157140240|NCT02469246|567258924|FG001|Double-Blind Phase|Lost to Follow-up|5|||
157140241|NCT00922935|567258928|FG000|Overall Study|Protocol Violation|0|||
157140242|NCT00922935|567258929|FG001|Overall Study|Protocol Violation|3|||
157140243|NCT00922935|567258930|FG002|Overall Study|Protocol Violation|0|||
157140244|NCT00922935|567258928|FG000|Overall Study|Physician Decision|1|||
157140245|NCT00922935|567258929|FG001|Overall Study|Physician Decision|1|||
157140246|NCT00922935|567258930|FG002|Overall Study|Physician Decision|0|||
157140247|NCT00922935|567258928|FG000|Overall Study|Lost to Follow-up|0|||
157140248|NCT00922935|567258929|FG001|Overall Study|Lost to Follow-up|1|||
157140249|NCT00922935|567258930|FG002|Overall Study|Lost to Follow-up|0|||
157140250|NCT01491945|567258931|FG000|Overall Study|Death|30|||
157140251|NCT01491945|567258931|FG000|Overall Study|Withdrwan/LTF|16|||
157140252|NCT01491945|567258931|FG000|Overall Study|Conversion|4|||
157140253|NCT01491945|567258931|FG000|Overall Study|Missed Visit|1|||
157140254|NCT02201940|567258932|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
157140255|NCT02201940|567258933|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
157140256|NCT02201940|567258932|FG000|Overall Study|Lack of Efficacy|2|||
157140257|NCT02201940|567258933|FG001|Overall Study|Lack of Efficacy|113|||
157140258|NCT02201940|567258932|FG000|Overall Study|Lost to Follow-up|5|||
157140259|NCT02201940|567258933|FG001|Overall Study|Lost to Follow-up|0|||
157140260|NCT02201940|567258932|FG000|Overall Study|Withdrew Consent|2|||
157140261|NCT02201940|567258933|FG001|Overall Study|Withdrew Consent|1|||
157140262|NCT02201940|567258932|FG000|Overall Study|Investigator's Discretion|1|||
157140263|NCT02201940|567258933|FG001|Overall Study|Investigator's Discretion|1|||
157140264|NCT02201940|567258932|FG000|Overall Study|Death|1|||
157140265|NCT02201940|567258933|FG001|Overall Study|Death|0|||
157140266|NCT02201940|567258932|FG000|Overall Study|Adverse Event|0|||
157140267|NCT02201940|567258933|FG001|Overall Study|Adverse Event|1|||
157140268|NCT00074958|567258934|FG000|Overall Study|Adverse Event|1|||
157140269|NCT02690701|567258938|FG000|Treatment Period 1|Adverse Event|2|||
157140270|NCT02690701|567258939|FG001|Treatment Period 1|Adverse Event|2|||
157140271|NCT02690701|567258938|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157140272|NCT02690701|567258939|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157140273|NCT02690701|567258938|FG000|Treatment Period 2|Adverse Event|2|||
157140274|NCT02690701|567258939|FG001|Treatment Period 2|Adverse Event|0|||
157140275|NCT02690701|567258938|FG000|Treatment Period 2|Lack of Efficacy|1|||
157140276|NCT02690701|567258939|FG001|Treatment Period 2|Lack of Efficacy|0|||
157140277|NCT02690701|567258938|FG000|Treatment Period 2|Lost to Follow-up|0|||
157140278|NCT02690701|567258939|FG001|Treatment Period 2|Lost to Follow-up|2|||
157140279|NCT02690701|567258938|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157140280|NCT02690701|567258939|FG001|Treatment Period 2|Withdrawal by Subject|2|||
157140281|NCT02690701|567258938|FG000|Treatment Period 2|Protocol Violation|0|||
157140282|NCT02690701|567258939|FG001|Treatment Period 2|Protocol Violation|1|||
157140283|NCT02700451|567258940|FG000|Overall Study|Protocol Violation|2|||
157140284|NCT02700451|567258941|FG001|Overall Study|Protocol Violation|2|||
157140285|NCT02700451|567258942|FG002|Overall Study|Protocol Violation|3|||
157140286|NCT02700451|567258940|FG000|Overall Study|Discontinued intervention|14|||
157140287|NCT02700451|567258941|FG001|Overall Study|Discontinued intervention|15|||
157140288|NCT02700451|567258942|FG002|Overall Study|Discontinued intervention|14|||
157140289|NCT00404092|567258944|FG000|Overall Study|Death|1|||
157140290|NCT00404092|567258945|FG001|Overall Study|Death|0|||
156808815|NCT01484496|566054476|FG003|Period 1|Lack of Efficacy|0|||
156808816|NCT01484496|566054473|FG000|Period 1|Adverse Event|25|||
156808817|NCT01484496|566054474|FG001|Period 1|Adverse Event|40|||
156808818|NCT01484496|566054475|FG002|Period 1|Adverse Event|0|||
156808819|NCT01484496|566054476|FG003|Period 1|Adverse Event|0|||
157140291|NCT00404092|567258946|FG002|Overall Study|Death|0|||
156808820|NCT01484496|566054473|FG000|Period 1|Withdrawal by Subject|15|||
157140292|NCT00404092|567258947|FG003|Overall Study|Death|0|||
157140293|NCT00404092|567258944|FG000|Overall Study|Adverse Event|0|||
157140294|NCT00404092|567258945|FG001|Overall Study|Adverse Event|0|||
157140295|NCT00404092|567258946|FG002|Overall Study|Adverse Event|1|||
157140296|NCT00404092|567258947|FG003|Overall Study|Adverse Event|0|||
156734206|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
156734207|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
156734208|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
156734209|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
156734210|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Death|0|||
156734211|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Death|0|||
156734212|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Death|1|||
156734213|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Death|2|||
156734214|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Death|7|||
157020113|NCT01261312|566826529|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020114|NCT01261312|566826530|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
157020115|NCT01261312|566826531|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
157020116|NCT01261312|566826532|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
157020117|NCT01261312|566826533|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020118|NCT01261312|566826534|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020119|NCT01261312|566826535|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020120|NCT01261312|566826536|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
157020121|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020122|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020123|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020124|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020125|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020126|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020127|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020128|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020129|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
157020130|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
157020131|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
157020132|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
157020133|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
157020134|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020135|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020136|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020137|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020138|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020139|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157140297|NCT01511445|567258948|FG000|Overall Study|Lost to Follow-up|3|||
157140298|NCT01511445|567258949|FG001|Overall Study|Lost to Follow-up|1|||
157140299|NCT01511445|567258948|FG000|Overall Study|Protocol Violation|1|||
157140300|NCT01511445|567258949|FG001|Overall Study|Protocol Violation|3|||
157140301|NCT01511445|567258948|FG000|Overall Study|Protocol Violation|1|||
157140302|NCT01511445|567258949|FG001|Overall Study|Protocol Violation|0|||
157140303|NCT02344576|567258953|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
157140304|NCT02344576|567258954|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
157140305|NCT02344576|567258955|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
157140306|NCT02344576|567258956|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
157140307|NCT02344576|567258953|FG000|1-Month Follow-Up|Death|13|||
157140308|NCT02344576|567258954|FG001|1-Month Follow-Up|Death|8|||
157140309|NCT02344576|567258955|FG002|1-Month Follow-Up|Death|0|||
157140310|NCT02344576|567258956|FG003|1-Month Follow-Up|Death|0|||
157140311|NCT02344576|567258953|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
157140312|NCT02344576|567258954|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
157140313|NCT02344576|567258955|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
157140314|NCT02344576|567258956|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
157140315|NCT02344576|567258953|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
157140316|NCT02344576|567258954|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
157140317|NCT02344576|567258955|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
156734215|NCT00941863|565773669|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
156734216|NCT00941863|565773670|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
156734217|NCT00941863|565773671|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
156734218|NCT00941863|565773672|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
156734219|NCT00941863|565773673|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
157140318|NCT02344576|567258956|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
157140319|NCT02344576|567258953|FG000|6-Month Follow-Up|Death|14|||
157140320|NCT02344576|567258954|FG001|6-Month Follow-Up|Death|14|||
157217646|NCT01144663|567543255|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
157140321|NCT02344576|567258955|FG002|6-Month Follow-Up|Death|0|||
157140322|NCT02344576|567258956|FG003|6-Month Follow-Up|Death|0|||
156734220|NCT00941863|565773669|FG000|Continued After PCD|Withdrawal by Subject|0|||
156734221|NCT00941863|565773670|FG001|Continued After PCD|Withdrawal by Subject|0|||
156734222|NCT00941863|565773671|FG002|Continued After PCD|Withdrawal by Subject|0|||
156734223|NCT00941863|565773672|FG003|Continued After PCD|Withdrawal by Subject|0|||
156734224|NCT00941863|565773673|FG004|Continued After PCD|Withdrawal by Subject|1|||
156734225|NCT00941863|565773669|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734226|NCT00941863|565773670|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734227|NCT00941863|565773671|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734228|NCT00941863|565773672|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
156734229|NCT00941863|565773673|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
156734230|NCT01471340|565773674|FG000|Overall Study|Death|5|||
156734231|NCT01471340|565773675|FG001|Overall Study|Death|4|||
156734232|NCT01471340|565773674|FG000|Overall Study|Lost to Follow-up|0|||
156734233|NCT01471340|565773675|FG001|Overall Study|Lost to Follow-up|1|||
156734234|NCT01471340|565773674|FG000|Overall Study|Investigational site closure|0|||
156734235|NCT01471340|565773675|FG001|Overall Study|Investigational site closure|1|||
156734236|NCT01471340|565773674|FG000|Overall Study|Invalid informed consent|1|||
156734237|NCT01471340|565773675|FG001|Overall Study|Invalid informed consent|0|||
156734238|NCT00179673|565773682|FG000|Overall Study|Adverse Event|7|||
156734239|NCT00179673|565773682|FG000|Overall Study|Lack of Efficacy|15|||
156734240|NCT00179673|565773682|FG000|Overall Study|Withdrawal by Subject|3|||
156734241|NCT00179673|565773682|FG000|Overall Study|Death|4|||
156734242|NCT00179673|565773682|FG000|Overall Study|Other Observations and options|14|||
156734243|NCT00492648|565773683|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
156734244|NCT00492648|565773684|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
156734245|NCT00282113|565773685|FG000|Overall Study|Removed at parents request|1|||
156734246|NCT00282113|565773686|FG001|Overall Study|Removed at parents request|0|||
156734247|NCT00282113|565773687|FG002|Overall Study|Removed at parents request|0|||
156734248|NCT02120833|565773688|FG000|Overall Study|Adverse Event|1|||
156734249|NCT02120833|565773689|FG001|Overall Study|Adverse Event|0|||
156734250|NCT02120833|565773688|FG000|Overall Study|Withdrawal by Subject|2|||
156734251|NCT02120833|565773689|FG001|Overall Study|Withdrawal by Subject|0|||
156734252|NCT02120833|565773688|FG000|Overall Study|Lost to Follow-up|1|||
156734253|NCT02120833|565773689|FG001|Overall Study|Lost to Follow-up|1|||
156734254|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
156734255|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
156734256|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
156734257|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
156734258|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
156734259|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734260|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734261|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156734262|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
156734263|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
156734264|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156734265|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156734266|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
156734267|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
156734268|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
156734269|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
156734270|NCT02438826|565773690|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
156734271|NCT02438826|565773691|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
156734272|NCT02438826|565773692|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
156734273|NCT02438826|565773693|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
156876620|NCT00535288|566307659|FG003|Overall Study|Lost to Follow-up|0|||
156876621|NCT00535288|566307660|FG004|Overall Study|Lost to Follow-up|0|||
156876622|NCT00535288|566307656|FG000|Overall Study|Lack of Efficacy|26|||
156876623|NCT00535288|566307657|FG001|Overall Study|Lack of Efficacy|3|||
156876624|NCT00535288|566307658|FG002|Overall Study|Lack of Efficacy|4|||
156876625|NCT00535288|566307659|FG003|Overall Study|Lack of Efficacy|4|||
156876626|NCT00535288|566307660|FG004|Overall Study|Lack of Efficacy|7|||
156876627|NCT00535288|566307656|FG000|Overall Study|Unwilling to cooperate|6|||
156876628|NCT00535288|566307657|FG001|Overall Study|Unwilling to cooperate|6|||
156734274|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Adverse Event|11|||
156734275|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Adverse Event|6|||
157020140|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
156734276|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Adverse Event|0|||
156734277|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Adverse Event|0|||
156734278|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
156734279|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
156734280|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
156876629|NCT00535288|566307658|FG002|Overall Study|Unwilling to cooperate|3|||
157140323|NCT02344576|567258953|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
157140324|NCT02344576|567258954|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
157140325|NCT02344576|567258955|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
156734281|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
156734282|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734283|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
156734284|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734285|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
156734286|NCT02438826|565773690|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
156734287|NCT02438826|565773691|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
156734288|NCT02438826|565773692|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
156734289|NCT02438826|565773693|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
156734290|NCT02438826|565773690|FG000|Post-Treatment Phase|Adverse Event|3|||
156734291|NCT02438826|565773691|FG001|Post-Treatment Phase|Adverse Event|0|||
156734292|NCT02438826|565773692|FG002|Post-Treatment Phase|Adverse Event|0|||
156734293|NCT02438826|565773693|FG003|Post-Treatment Phase|Adverse Event|0|||
156734294|NCT02438826|565773690|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
156734295|NCT02438826|565773691|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
156734296|NCT02438826|565773692|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
156734297|NCT02438826|565773693|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
156734298|NCT02438826|565773690|FG000|Post-Treatment Phase|Physician Decision|1|||
156734299|NCT02438826|565773691|FG001|Post-Treatment Phase|Physician Decision|0|||
156734300|NCT02438826|565773692|FG002|Post-Treatment Phase|Physician Decision|0|||
156734301|NCT02438826|565773693|FG003|Post-Treatment Phase|Physician Decision|0|||
156734302|NCT02438826|565773690|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
156734303|NCT02438826|565773691|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
156734304|NCT02438826|565773692|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
156734305|NCT02438826|565773693|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
156734306|NCT03482453|565773712|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734307|NCT03482453|565773713|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
157140326|NCT02344576|567258956|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
156734308|NCT03482453|565773714|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734309|NCT03482453|565773715|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734310|NCT03482453|565773716|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734311|NCT03482453|565773717|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734312|NCT03482453|565773718|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734313|NCT03482453|565773719|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734314|NCT03482453|565773720|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734315|NCT03482453|565773721|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734316|NCT03482453|565773722|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
156734317|NCT03482453|565773723|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
156734318|NCT03478644|565773726|FG000|Phase 2|Withdrawal by Subject|2|||
156734319|NCT03478644|565773727|FG001|Phase 2|Withdrawal by Subject|1|||
156734320|NCT03478644|565773726|FG000|Phase 2|Lost to Follow-up|1|||
156734321|NCT03478644|565773727|FG001|Phase 2|Lost to Follow-up|0|||
156734322|NCT04152837|565773728|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
156734323|NCT04152837|565773728|FG000|Maintenance Period|Adverse Event|1|||
156734324|NCT04152837|565773728|FG000|Maintenance Period|Withdrawal by Subject|1|||
156734325|NCT04152837|565773728|FG000|Maintenance Period|Sponsor Termination of Study|2|||
156734326|NCT00586820|565773729|FG000|Overall Study|Unsuccessful PCI|1|||
156734327|NCT00586820|565773730|FG001|Overall Study|Unsuccessful PCI|0|||
156734328|NCT02073929|565773731|FG000|Overall Study|Lost to Follow-up|2|||
156734329|NCT02073929|565773732|FG001|Overall Study|Lost to Follow-up|1|||
156734330|NCT02073929|565773731|FG000|Overall Study|Adverse Event|2|||
156734331|NCT02073929|565773732|FG001|Overall Study|Adverse Event|1|||
156734332|NCT02073929|565773731|FG000|Overall Study|Withdrawal by Subject|0|||
156734333|NCT02073929|565773732|FG001|Overall Study|Withdrawal by Subject|1|||
156734334|NCT00767455|565773733|FG000|Overall Study|Investigator error|19|||
156734335|NCT01483027|565773734|FG000|Overall Study|Administrative Reasons|2|||
156734336|NCT01483027|565773735|FG001|Overall Study|Administrative Reasons|1|||
156734337|NCT01483027|565773734|FG000|Overall Study|Withdrawal by Subject|21|||
156734338|NCT01483027|565773735|FG001|Overall Study|Withdrawal by Subject|32|||
156734339|NCT01483027|565773734|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
156734340|NCT01483027|565773735|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
156796814|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
156796815|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
156796816|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
156796817|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
156796818|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
156796819|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
156796820|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
156796821|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
157140327|NCT02344576|567258953|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
156734341|NCT01483027|565773734|FG000|Overall Study|Lost to Follow-up|1|||
156734342|NCT01483027|565773735|FG001|Overall Study|Lost to Follow-up|1|||
156734343|NCT01483027|565773734|FG000|Overall Study|Adverse Event|0|||
156734344|NCT01483027|565773735|FG001|Overall Study|Adverse Event|1|||
156734345|NCT01483027|565773734|FG000|Overall Study|Withdrawal by Subject|0|||
156734346|NCT01483027|565773735|FG001|Overall Study|Withdrawal by Subject|1|||
156734347|NCT02504827|565773738|FG000|Overall Study|Could not produce sputum|1|||
156734348|NCT00686829|565773739|FG000|Overall Study|Adverse Event|5|||
157140328|NCT02344576|567258954|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
157140329|NCT02344576|567258955|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
157140330|NCT02344576|567258956|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
157140331|NCT01856114|567258957|FG000|Overall Study|Withdrawal by Subject|1|||
157140332|NCT01856114|567258958|FG001|Overall Study|Withdrawal by Subject|0|||
156734349|NCT00686829|565773739|FG000|Overall Study|Lack of Efficacy|6|||
156734350|NCT00686829|565773739|FG000|Overall Study|Lost to Follow-up|4|||
156734351|NCT00686829|565773739|FG000|Overall Study|Withdrawal by Subject|14|||
156734352|NCT00686829|565773739|FG000|Overall Study|Protocol Violation|3|||
156734353|NCT00686829|565773739|FG000|Overall Study|Sponsor discontinued VCV|47|||
156734354|NCT01732640|565773740|FG000|Overall Study|Adverse Event|0|||
156734355|NCT01732640|565773741|FG001|Overall Study|Adverse Event|1|||
156734356|NCT01732640|565773740|FG000|Overall Study|Death|0|||
156734357|NCT01732640|565773741|FG001|Overall Study|Death|1|||
156734358|NCT06366087|565776359|FG000|Overall Study|Withdrawal by Subject|0|||
156734359|NCT06366087|565776360|FG001|Overall Study|Withdrawal by Subject|1|||
156734360|NCT01397786|565776363|FG000|Phase A|Lost to Follow-up|0|||
156734361|NCT01397786|565776364|FG001|Phase A|Lost to Follow-up|0|||
156734362|NCT01397786|565776365|FG002|Phase A|Lost to Follow-up|6|||
156734363|NCT01397786|565776363|FG000|Phase A|Adverse Event|0|||
156734364|NCT01397786|565776364|FG001|Phase A|Adverse Event|0|||
156734365|NCT01397786|565776365|FG002|Phase A|Adverse Event|8|||
156734366|NCT01397786|565776363|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
156734367|NCT01397786|565776364|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
156734368|NCT01397786|565776365|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
156734369|NCT01397786|565776363|FG000|Phase A|Physician Decision|0|||
156734370|NCT01397786|565776364|FG001|Phase A|Physician Decision|0|||
156734371|NCT01397786|565776365|FG002|Phase A|Physician Decision|1|||
156734372|NCT01397786|565776363|FG000|Phase A|Withdrawal by Subject|0|||
156734373|NCT01397786|565776364|FG001|Phase A|Withdrawal by Subject|0|||
156734374|NCT01397786|565776365|FG002|Phase A|Withdrawal by Subject|5|||
156734375|NCT01397786|565776363|FG000|Phase A|Lack of Efficacy|0|||
156734376|NCT01397786|565776364|FG001|Phase A|Lack of Efficacy|0|||
156734377|NCT01397786|565776365|FG002|Phase A|Lack of Efficacy|1|||
156734378|NCT01397786|565776363|FG000|Phase B|Lost to Follow-up|22|||
156734379|NCT01397786|565776364|FG001|Phase B|Lost to Follow-up|12|||
156734380|NCT01397786|565776365|FG002|Phase B|Lost to Follow-up|22|||
156734381|NCT01397786|565776363|FG000|Phase B|Adverse Event|109|||
156734382|NCT01397786|565776364|FG001|Phase B|Adverse Event|23|||
156734383|NCT01397786|565776365|FG002|Phase B|Adverse Event|27|||
156734384|NCT01397786|565776363|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
156734385|NCT01397786|565776364|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
156734386|NCT01397786|565776365|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
156734387|NCT01397786|565776363|FG000|Phase B|Physician Decision|9|||
156734388|NCT01397786|565776364|FG001|Phase B|Physician Decision|1|||
156734389|NCT01397786|565776365|FG002|Phase B|Physician Decision|3|||
156734390|NCT01397786|565776363|FG000|Phase B|Withdrawal by Subject|102|||
156734391|NCT01397786|565776364|FG001|Phase B|Withdrawal by Subject|45|||
156734392|NCT01397786|565776365|FG002|Phase B|Withdrawal by Subject|30|||
156734393|NCT01397786|565776363|FG000|Phase B|Protocol Deviation|1|||
156734394|NCT01397786|565776364|FG001|Phase B|Protocol Deviation|2|||
156734395|NCT01397786|565776365|FG002|Phase B|Protocol Deviation|4|||
157140333|NCT01856114|567258957|FG000|Overall Study|Adverse Event|1|||
157140334|NCT01856114|567258958|FG001|Overall Study|Adverse Event|0|||
157140335|NCT02853760|567258959|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
157140336|NCT02853760|567258960|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
157140337|NCT02853760|567258961|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
157140338|NCT02853760|567258962|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
157140339|NCT02853760|567258963|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
157140340|NCT02853760|567258964|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
156734396|NCT01397786|565776363|FG000|Phase B|Lack of Efficacy|22|||
156734397|NCT01397786|565776364|FG001|Phase B|Lack of Efficacy|7|||
156734398|NCT01397786|565776365|FG002|Phase B|Lack of Efficacy|14|||
156734399|NCT00860249|565776369|FG000|Overall Study|trial was terminated prior to completion|21|||
156734400|NCT00860249|565776370|FG001|Overall Study|trial was terminated prior to completion|18|||
156734401|NCT00860249|565776371|FG002|Overall Study|trial was terminated prior to completion|21|||
156734402|NCT00743288|565776372|FG000|Overall Study|Adverse Event|1|||
156734403|NCT00743288|565776373|FG001|Overall Study|Adverse Event|1|||
156876630|NCT00535288|566307659|FG003|Overall Study|Unwilling to cooperate|3|||
156734404|NCT00743288|565776374|FG002|Overall Study|Adverse Event|2|||
156734405|NCT00743288|565776375|FG003|Overall Study|Adverse Event|2|||
156734406|NCT00743288|565776376|FG004|Overall Study|Adverse Event|1|||
156734407|NCT00743288|565776377|FG005|Overall Study|Adverse Event|1|||
156796822|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
156796823|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
156796824|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
156796825|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
156796826|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
156796827|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
156796828|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
156796829|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
156796830|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
156796831|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
156796832|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
156796833|NCT00725985|566009671|FG000|ITP- Treatment Disposition|Other|50|||
156796834|NCT00725985|566009672|FG001|ITP- Treatment Disposition|Other|38|||
156876631|NCT00535288|566307660|FG004|Overall Study|Unwilling to cooperate|4|||
156876632|NCT00535288|566307656|FG000|Overall Study|Other|2|||
156876633|NCT00535288|566307657|FG001|Overall Study|Other|1|||
156876634|NCT00535288|566307658|FG002|Overall Study|Other|1|||
156876635|NCT00535288|566307659|FG003|Overall Study|Other|2|||
156876636|NCT00535288|566307660|FG004|Overall Study|Other|1|||
156876637|NCT01754727|566307661|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
156876638|NCT02848729|566307667|FG000|Overall Study|Withdrawal by Subject|1|||
156876639|NCT02848729|566307668|FG001|Overall Study|Withdrawal by Subject|0|||
156876640|NCT02848729|566307667|FG000|Overall Study|Emesis|15|||
156876641|NCT02848729|566307668|FG001|Overall Study|Emesis|11|||
156876642|NCT04518995|566307669|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
156876643|NCT04518995|566307670|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
156876644|NCT04518995|566307671|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
156876645|NCT04518995|566307669|FG000|Overall Study|Lack of Efficacy|2|||
156876646|NCT04518995|566307670|FG001|Overall Study|Lack of Efficacy|1|||
156876647|NCT04518995|566307671|FG002|Overall Study|Lack of Efficacy|0|||
156876648|NCT04518995|566307669|FG000|Overall Study|Non-compliance With Study Drug|0|||
156876649|NCT04518995|566307670|FG001|Overall Study|Non-compliance With Study Drug|3|||
156876650|NCT04518995|566307671|FG002|Overall Study|Non-compliance With Study Drug|2|||
156876651|NCT04518995|566307669|FG000|Overall Study|Pregnancy|0|||
157140341|NCT01624142|567258965|FG000|Overall Study|Withdrawal by Subject|14|||
157140342|NCT01624142|567258966|FG001|Overall Study|Withdrawal by Subject|4|||
157140343|NCT01624142|567258965|FG000|Overall Study|Death|3|||
157140344|NCT01624142|567258966|FG001|Overall Study|Death|6|||
157140345|NCT01624142|567258965|FG000|Overall Study|Study Closure|12|||
157217647|NCT01144663|567543252|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
157217648|NCT01144663|567543253|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
156734408|NCT00743288|565776378|FG006|Overall Study|Adverse Event|2|||
156734409|NCT00743288|565776372|FG000|Overall Study|Withdrawal by Subject|0|||
156734410|NCT00743288|565776373|FG001|Overall Study|Withdrawal by Subject|0|||
156734411|NCT00743288|565776374|FG002|Overall Study|Withdrawal by Subject|1|||
156796835|NCT00725985|566009673|FG002|ITP- Treatment Disposition|Other|24|||
156796836|NCT00725985|566009674|FG003|ITP- Treatment Disposition|Other|0|||
156796837|NCT00725985|566009675|FG004|ITP- Treatment Disposition|Other|0|||
156876652|NCT04518995|566307670|FG001|Overall Study|Pregnancy|0|||
156734412|NCT00743288|565776375|FG003|Overall Study|Withdrawal by Subject|0|||
156734413|NCT00743288|565776376|FG004|Overall Study|Withdrawal by Subject|0|||
156734414|NCT00743288|565776377|FG005|Overall Study|Withdrawal by Subject|1|||
156734415|NCT00743288|565776378|FG006|Overall Study|Withdrawal by Subject|1|||
156734416|NCT00743288|565776372|FG000|Overall Study|Progressive disease (PD)|2|||
156734417|NCT00743288|565776373|FG001|Overall Study|Progressive disease (PD)|0|||
156734418|NCT00743288|565776374|FG002|Overall Study|Progressive disease (PD)|1|||
156734419|NCT00743288|565776375|FG003|Overall Study|Progressive disease (PD)|4|||
156734420|NCT00743288|565776376|FG004|Overall Study|Progressive disease (PD)|5|||
156734421|NCT00743288|565776377|FG005|Overall Study|Progressive disease (PD)|3|||
156734422|NCT00743288|565776378|FG006|Overall Study|Progressive disease (PD)|6|||
156734423|NCT00743288|565776372|FG000|Overall Study|Worsening of condition (Not PD)|0|||
156796838|NCT00725985|566009676|FG005|ITP- Treatment Disposition|Other|0|||
156796839|NCT00725985|566009677|FG006|ITP- Treatment Disposition|Other|0|||
156876653|NCT04518995|566307671|FG002|Overall Study|Pregnancy|1|||
156876654|NCT04518995|566307669|FG000|Overall Study|Protocol Violation|2|||
156876655|NCT04518995|566307670|FG001|Overall Study|Protocol Violation|0|||
156876656|NCT04518995|566307671|FG002|Overall Study|Protocol Violation|1|||
157140346|NCT01624142|567258966|FG001|Overall Study|Study Closure|6|||
157140347|NCT01624142|567258965|FG000|Overall Study|Lost to Follow-up|2|||
157140348|NCT01624142|567258966|FG001|Overall Study|Lost to Follow-up|0|||
157217649|NCT01144663|567543254|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
156734424|NCT00743288|565776373|FG001|Overall Study|Worsening of condition (Not PD)|2|||
156734425|NCT00743288|565776374|FG002|Overall Study|Worsening of condition (Not PD)|1|||
156796840|NCT00725985|566009678|FG007|ITP- Treatment Disposition|Other|0|||
156876657|NCT04518995|566307669|FG000|Overall Study|Reason not Specified|4|||
157140349|NCT01624142|567258965|FG000|Overall Study|Other|1|||
157140350|NCT01624142|567258966|FG001|Overall Study|Other|0|||
157140351|NCT04826900|567258967|FG000|Overall Study|Family factor|1|||
157140352|NCT04826900|567258968|FG001|Overall Study|Family factor|1|||
157140353|NCT03372941|567258969|FG000|Overall Study|Lost to Follow-up|2|||
157140354|NCT03372941|567258970|FG001|Overall Study|Lost to Follow-up|4|||
157140355|NCT01053429|567258971|FG000|Overall Study|Adverse Event|64|||
157140356|NCT01053429|567258971|FG000|Overall Study|Other|309|||
156734426|NCT00743288|565776375|FG003|Overall Study|Worsening of condition (Not PD)|1|||
156734427|NCT00743288|565776376|FG004|Overall Study|Worsening of condition (Not PD)|0|||
156734428|NCT00743288|565776377|FG005|Overall Study|Worsening of condition (Not PD)|0|||
156734429|NCT00743288|565776378|FG006|Overall Study|Worsening of condition (Not PD)|0|||
156734430|NCT00519428|565776379|FG000|Overall Study|Adverse Event|5|||
156734431|NCT00519428|565776380|FG001|Overall Study|Adverse Event|2|||
156734432|NCT00519428|565776381|FG002|Overall Study|Adverse Event|10|||
156734433|NCT00519428|565776379|FG000|Overall Study|Lost to Follow-up|7|||
156734434|NCT00519428|565776380|FG001|Overall Study|Lost to Follow-up|7|||
156734435|NCT00519428|565776381|FG002|Overall Study|Lost to Follow-up|6|||
156734436|NCT00519428|565776379|FG000|Overall Study|Withdrawal by Subject|8|||
156734437|NCT00519428|565776380|FG001|Overall Study|Withdrawal by Subject|3|||
156734438|NCT00519428|565776381|FG002|Overall Study|Withdrawal by Subject|7|||
156734439|NCT00519428|565776379|FG000|Overall Study|unstated|1|||
156734440|NCT00519428|565776380|FG001|Overall Study|unstated|3|||
156734441|NCT00519428|565776381|FG002|Overall Study|unstated|2|||
156734442|NCT00688701|565776382|FG000|Overall Study|Adverse Event|1|||
156734443|NCT00688701|565776383|FG001|Overall Study|Adverse Event|0|||
156734444|NCT00688701|565776384|FG002|Overall Study|Adverse Event|5|||
156734445|NCT00688701|565776385|FG003|Overall Study|Adverse Event|3|||
156734446|NCT00688701|565776382|FG000|Overall Study|Lack of Efficacy|0|||
156734447|NCT00688701|565776383|FG001|Overall Study|Lack of Efficacy|1|||
156734448|NCT00688701|565776384|FG002|Overall Study|Lack of Efficacy|0|||
157140357|NCT00752986|567258972|FG000|Overall Study|Withdrawal by Subject|2|||
157140358|NCT00752986|567258973|FG001|Overall Study|Withdrawal by Subject|1|||
157140359|NCT00752986|567258974|FG002|Overall Study|Withdrawal by Subject|2|||
157140360|NCT00752986|567258972|FG000|Overall Study|Protocol Violation|3|||
157140361|NCT00752986|567258973|FG001|Overall Study|Protocol Violation|0|||
157140362|NCT00752986|567258974|FG002|Overall Study|Protocol Violation|0|||
157140363|NCT01976806|567258975|FG000|Overall Study|Lost to Follow-up|1|||
157140364|NCT01976806|567258976|FG001|Overall Study|Lost to Follow-up|4|||
157140365|NCT01976806|567258975|FG000|Overall Study|Adverse Event|1|||
157140366|NCT01976806|567258976|FG001|Overall Study|Adverse Event|1|||
157140367|NCT01976806|567258975|FG000|Overall Study|Withdrawal by Subject|1|||
157140368|NCT01976806|567258976|FG001|Overall Study|Withdrawal by Subject|1|||
157140369|NCT03929250|567258979|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
157140370|NCT03929250|567258980|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
157140371|NCT04429022|567258983|FG000|Overall Study|Protocol Violation|18|||
157140372|NCT04429022|567258984|FG001|Overall Study|Protocol Violation|1|||
157140373|NCT03972488|567258985|FG000|Overall Study|Progressive disease|42|||
157140374|NCT03972488|567258986|FG001|Overall Study|Progressive disease|44|||
157140375|NCT03972488|567258985|FG000|Overall Study|Physician Decision|13|||
157140376|NCT03972488|567258986|FG001|Overall Study|Physician Decision|7|||
157140377|NCT03972488|567258985|FG000|Overall Study|Adverse Event|8|||
157140378|NCT03972488|567258986|FG001|Overall Study|Adverse Event|1|||
156734449|NCT00688701|565776385|FG003|Overall Study|Lack of Efficacy|0|||
156734450|NCT00688701|565776382|FG000|Overall Study|Withdrawal by Subject|3|||
156734451|NCT00688701|565776383|FG001|Overall Study|Withdrawal by Subject|3|||
156734452|NCT00688701|565776384|FG002|Overall Study|Withdrawal by Subject|4|||
156734453|NCT00688701|565776385|FG003|Overall Study|Withdrawal by Subject|8|||
156734454|NCT00688701|565776382|FG000|Overall Study|Poor compliance to protocol|0|||
156734455|NCT00688701|565776383|FG001|Overall Study|Poor compliance to protocol|1|||
156734456|NCT00688701|565776384|FG002|Overall Study|Poor compliance to protocol|1|||
156734457|NCT00688701|565776385|FG003|Overall Study|Poor compliance to protocol|0|||
156734458|NCT01275755|565776395|FG000|Double-blind Treatment Period|Adverse Event|0|||
157140379|NCT03972488|567258985|FG000|Overall Study|Death|4|||
157140380|NCT03972488|567258986|FG001|Overall Study|Death|4|||
157140381|NCT03972488|567258985|FG000|Overall Study|Withdrawal by Subject|3|||
157140382|NCT03972488|567258986|FG001|Overall Study|Withdrawal by Subject|4|||
156734459|NCT01275755|565776396|FG001|Double-blind Treatment Period|Adverse Event|2|||
156734460|NCT01275755|565776395|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156734461|NCT01275755|565776396|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
157140383|NCT03972488|567258985|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
156734462|NCT01275755|565776395|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156734463|NCT01275755|565776396|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156734464|NCT01275755|565776395|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
157140384|NCT03972488|567258986|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
157140385|NCT00045032|567258995|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
157140386|NCT00045032|567258996|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
156734465|NCT01275755|565776396|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
156734466|NCT00381238|565776401|FG000|Overall Study|Adverse Event|3|||
157140387|NCT00045032|567258997|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
157140388|NCT00045032|567258995|FG000|Overall Study|Death|22|||
157140389|NCT00045032|567258996|FG001|Overall Study|Death|24|||
157140390|NCT00045032|567258997|FG002|Overall Study|Death|17|||
157140391|NCT00045032|567258995|FG000|Overall Study|Insufficient Therapeutic Response|542|||
157140392|NCT00045032|567258996|FG001|Overall Study|Insufficient Therapeutic Response|437|||
157140393|NCT00045032|567258997|FG002|Overall Study|Insufficient Therapeutic Response|445|||
157140394|NCT00045032|567258995|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
157140395|NCT00045032|567258996|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
157140396|NCT00045032|567258997|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
157140397|NCT00045032|567258995|FG000|Overall Study|Other Protocol Violation|2|||
157140398|NCT00045032|567258996|FG001|Overall Study|Other Protocol Violation|0|||
157140399|NCT00045032|567258997|FG002|Overall Study|Other Protocol Violation|1|||
157140400|NCT00045032|567258995|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
157140401|NCT00045032|567258996|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
157140402|NCT00045032|567258997|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
157140403|NCT00045032|567258995|FG000|Overall Study|Failure to Return|57|||
157140404|NCT00045032|567258996|FG001|Overall Study|Failure to Return|62|||
157140405|NCT00045032|567258997|FG002|Overall Study|Failure to Return|61|||
157140406|NCT00045032|567258995|FG000|Overall Study|Other|93|||
157140407|NCT00045032|567258996|FG001|Overall Study|Other|84|||
157140408|NCT00045032|567258997|FG002|Overall Study|Other|105|||
157140409|NCT02582658|567258998|FG000|Overall Study|Failure to Return|10|||
157140410|NCT02582658|567258998|FG000|Overall Study|Insufficient Virological Response|2|||
157140411|NCT02582658|567258998|FG000|Overall Study|Withdrawn Consent|1|||
157140412|NCT02582658|567258998|FG000|Overall Study|Death|1|||
157140413|NCT02582658|567258998|FG000|Overall Study|Not further specified|11|||
157140414|NCT02581995|567258999|FG000|Overall Study|Unspecified other|3|||
157140415|NCT02581995|567258999|FG000|Overall Study|Adverse Event|6|||
157140416|NCT02581995|567258999|FG000|Overall Study|Lost to Follow-up|5|||
157140417|NCT02581995|567258999|FG000|Overall Study|Withdrawal by participant|12|||
157140418|NCT02581995|567258999|FG000|Overall Study|Physician Decision|1|||
157140419|NCT02581995|567258999|FG000|Overall Study|Death|4|||
157140420|NCT03277196|567259001|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
157140421|NCT03277196|567259001|FG000|Overall Study|Lost to Follow-up|3|||
157140422|NCT03277196|567259001|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
157140423|NCT03277196|567259001|FG000|Overall Study|Other|2|||
157140424|NCT06119191|567259002|FG000|Overall Study|Adverse Event|0|||
157140425|NCT06119191|567259003|FG001|Overall Study|Adverse Event|1|||
157140426|NCT06119191|567259002|FG000|Overall Study|Protocol Violation|1|||
157140427|NCT06119191|567259003|FG001|Overall Study|Protocol Violation|0|||
157140428|NCT00374556|567260951|FG000|Overall Study|Lost to Follow-up|1|||
157140429|NCT00374556|567260952|FG001|Overall Study|Lost to Follow-up|0|||
157140430|NCT00374556|567260951|FG000|Overall Study|Removed at baseline due to medical cond|0|||
157140431|NCT00374556|567260952|FG001|Overall Study|Removed at baseline due to medical cond|1|||
157140432|NCT00473694|567260953|FG000|Overall Study|Adverse Event|0|||
157140433|NCT00473694|567260954|FG001|Overall Study|Adverse Event|1|||
157140434|NCT00473694|567260955|FG002|Overall Study|Adverse Event|0|||
157140435|NCT00473694|567260956|FG003|Overall Study|Adverse Event|0|||
157140436|NCT00473694|567260953|FG000|Overall Study|Participants did not receive treatment|11|||
157140437|NCT00473694|567260954|FG001|Overall Study|Participants did not receive treatment|3|||
157140438|NCT00473694|567260955|FG002|Overall Study|Participants did not receive treatment|5|||
157140439|NCT00473694|567260956|FG003|Overall Study|Participants did not receive treatment|6|||
157140440|NCT00473694|567260953|FG000|Overall Study|Lost to Follow-up|0|||
157140441|NCT00473694|567260954|FG001|Overall Study|Lost to Follow-up|0|||
157140442|NCT00473694|567260955|FG002|Overall Study|Lost to Follow-up|0|||
157140443|NCT00473694|567260956|FG003|Overall Study|Lost to Follow-up|1|||
157140444|NCT02468193|567260957|FG000|Overall Study|Adverse Event|4|||
156734467|NCT00381238|565776401|FG000|Overall Study|Protocol Violation|1|||
156734468|NCT00381238|565776401|FG000|Overall Study|Withdrawal by Subject|4|||
156734469|NCT00381238|565776401|FG000|Overall Study|Lack of Efficacy|2|||
156734470|NCT00381238|565776401|FG000|Overall Study|Withdrew by physician|1|||
156734471|NCT00381238|565776401|FG000|Overall Study|Disease progression|1|||
157140445|NCT02468193|567260957|FG000|Overall Study|Subject/ Guardian decision|2|||
157140446|NCT00742781|567260958|FG000|Overall Study|Withdrawal by Subject|3|||
157140447|NCT01416181|567260959|FG000|Part 1|Other|10|||
157140448|NCT01416181|567260960|FG001|Part 1|Other|24|||
157140449|NCT01416181|567260959|FG000|Part 1|Death|0|||
157140450|NCT01416181|567260960|FG001|Part 1|Death|1|||
157140451|NCT01416181|567260959|FG000|Part 1|Investigator Decision|7|||
157140452|NCT01416181|567260960|FG001|Part 1|Investigator Decision|6|||
157140453|NCT01416181|567260959|FG000|Part 1|Withdrawal by Subject|74|||
156734472|NCT00843037|565776405|FG000|Overall Study|Lost to Follow-up|1|||
156734473|NCT03535194|565776406|FG000|Induction Period|Adverse Event|2|||
156734474|NCT03535194|565776407|FG001|Induction Period|Adverse Event|2|||
156734475|NCT03535194|565776408|FG002|Induction Period|Adverse Event|1|||
157140454|NCT01416181|567260960|FG001|Part 1|Withdrawal by Subject|48|||
156734476|NCT03535194|565776409|FG003|Induction Period|Adverse Event|3|||
156734477|NCT03535194|565776410|FG004|Induction Period|Adverse Event|0|||
156734478|NCT03535194|565776406|FG000|Induction Period|Death|0|||
156734479|NCT03535194|565776407|FG001|Induction Period|Death|1|||
156734480|NCT03535194|565776408|FG002|Induction Period|Death|0|||
156734481|NCT03535194|565776409|FG003|Induction Period|Death|0|||
156734482|NCT03535194|565776410|FG004|Induction Period|Death|0|||
157140455|NCT01416181|567260959|FG000|Part 1|Lack of Efficacy|16|||
157140456|NCT01416181|567260960|FG001|Part 1|Lack of Efficacy|8|||
157140457|NCT01416181|567260959|FG000|Part 1|Lost to Follow-up|1|||
157140458|NCT01416181|567260960|FG001|Part 1|Lost to Follow-up|1|||
157140459|NCT01416181|567260959|FG000|Part 1|Adverse Event|15|||
157140460|NCT01416181|567260960|FG001|Part 1|Adverse Event|18|||
157140461|NCT01416181|567260959|FG000|Part 1|Ongoing in Follow-Up|14|||
157140462|NCT01416181|567260960|FG001|Part 1|Ongoing in Follow-Up|8|||
157140463|NCT01416181|567260959|FG000|Part 2|Adverse Event|11|||
157140464|NCT01416181|567260960|FG001|Part 2|Adverse Event|4|||
157140465|NCT01416181|567260959|FG000|Part 2|Other|234|||
157140466|NCT01416181|567260960|FG001|Part 2|Other|267|||
157140467|NCT01416181|567260959|FG000|Part 2|Investigator Decision|6|||
157140468|NCT01416181|567260960|FG001|Part 2|Investigator Decision|7|||
157140469|NCT01416181|567260959|FG000|Part 2|Withdrawal by Subject|14|||
157140470|NCT01416181|567260960|FG001|Part 2|Withdrawal by Subject|5|||
157140471|NCT01416181|567260959|FG000|Part 2|Lack of Efficacy|4|||
157140472|NCT01416181|567260960|FG001|Part 2|Lack of Efficacy|1|||
157140473|NCT01416181|567260959|FG000|Part 2|Lost to Follow-up|2|||
157140474|NCT01416181|567260960|FG001|Part 2|Lost to Follow-up|2|||
157140475|NCT00486902|567260963|FG000|Overall Study|Withdrawal by Subject|1|||
157140476|NCT00486902|567260964|FG001|Overall Study|Withdrawal by Subject|2|||
157140477|NCT00486902|567260963|FG000|Overall Study|decision for postpartum tubal ligation|3|||
157140478|NCT00486902|567260964|FG001|Overall Study|decision for postpartum tubal ligation|1|||
157140479|NCT00486902|567260963|FG000|Overall Study|spinal anesthetic protocal violation|1|||
157140480|NCT00486902|567260964|FG001|Overall Study|spinal anesthetic protocal violation|1|||
157140481|NCT00486902|567260963|FG000|Overall Study|Did not meet inclusion criteria|1|||
157140482|NCT00486902|567260964|FG001|Overall Study|Did not meet inclusion criteria|0|||
157140483|NCT00486902|567260963|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
157140484|NCT00486902|567260964|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
157140485|NCT00541307|567260965|FG000|Overall Study|Death|5|||
157140486|NCT00541307|567260965|FG000|Overall Study|Physician Decision|3|||
157140487|NCT00541307|567260965|FG000|Overall Study|Withdrawal by Subject|6|||
157140488|NCT00541307|567260965|FG000|Overall Study|Lost to Follow-up|4|||
157140489|NCT00541307|567260965|FG000|Overall Study|Subject returned early (outside window)|1|||
157140490|NCT00541307|567260965|FG000|Overall Study|Surgical Bypass|5|||
157140491|NCT04178590|567260966|FG000|Overall Study|Pregnancy|1|||
157140492|NCT04178590|567260966|FG000|Overall Study|Lost to Follow-up|1|||
157140493|NCT04723537|567260967|FG000|Overall Study|Withdrawal by Subject|3|||
157140494|NCT04723537|567260968|FG001|Overall Study|Withdrawal by Subject|0|||
157140495|NCT04723537|567260969|FG002|Overall Study|Withdrawal by Subject|0|||
157140496|NCT04723537|567260967|FG000|Overall Study|Physician Decision|0|||
157140497|NCT04723537|567260968|FG001|Overall Study|Physician Decision|0|||
157140498|NCT04723537|567260969|FG002|Overall Study|Physician Decision|1|||
157140499|NCT04723537|567260967|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
157140500|NCT04723537|567260968|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
157217650|NCT01144663|567543255|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
156734483|NCT03535194|565776406|FG000|Induction Period|Lack of Efficacy|1|||
156734484|NCT03535194|565776407|FG001|Induction Period|Lack of Efficacy|3|||
156734485|NCT03535194|565776408|FG002|Induction Period|Lack of Efficacy|2|||
156734486|NCT03535194|565776409|FG003|Induction Period|Lack of Efficacy|2|||
156734487|NCT03535194|565776410|FG004|Induction Period|Lack of Efficacy|0|||
156734488|NCT03535194|565776406|FG000|Induction Period|Lost to Follow-up|3|||
156734489|NCT03535194|565776407|FG001|Induction Period|Lost to Follow-up|5|||
156734490|NCT03535194|565776408|FG002|Induction Period|Lost to Follow-up|2|||
156734491|NCT03535194|565776409|FG003|Induction Period|Lost to Follow-up|3|||
157140501|NCT04723537|567260969|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
157140502|NCT01485614|567260976|FG000|Randomization|Not Treated|1|||
157140503|NCT01485614|567260977|FG001|Randomization|Not Treated|0|||
156734492|NCT03535194|565776410|FG004|Induction Period|Lost to Follow-up|0|||
156734493|NCT03535194|565776406|FG000|Induction Period|Physician Decision|1|||
157140504|NCT01485614|567260978|FG002|Randomization|Not Treated|0|||
157140505|NCT01485614|567260979|FG003|Randomization|Not Treated|0|||
157140506|NCT01485614|567260976|FG000|Weeks 0-20|Lost to Follow-up|2|||
157140507|NCT01485614|567260977|FG001|Weeks 0-20|Lost to Follow-up|0|||
157140508|NCT01485614|567260978|FG002|Weeks 0-20|Lost to Follow-up|0|||
156734494|NCT03535194|565776407|FG001|Induction Period|Physician Decision|1|||
156734495|NCT03535194|565776408|FG002|Induction Period|Physician Decision|0|||
156796841|NCT00725985|566009679|FG008|ITP- Treatment Disposition|Other|0|||
157140509|NCT01485614|567260979|FG003|Weeks 0-20|Lost to Follow-up|0|||
157140510|NCT01485614|567260976|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
157217651|NCT01144663|567543252|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
157217652|NCT01144663|567543253|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
157217653|NCT01144663|567543254|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
157217654|NCT01144663|567543255|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
157217655|NCT01144663|567543252|FG000|Primary Vaccination Phase|Other|0|||
157217656|NCT01144663|567543253|FG001|Primary Vaccination Phase|Other|1|||
157217657|NCT01144663|567543254|FG002|Primary Vaccination Phase|Other|0|||
157217658|NCT01144663|567543255|FG003|Primary Vaccination Phase|Other|2|||
157217659|NCT01144663|567543252|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
157217660|NCT01144663|567543253|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
157217661|NCT01144663|567543254|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
157217662|NCT01144663|567543255|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
157217663|NCT01144663|567543252|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
157217664|NCT01144663|567543253|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
157217665|NCT01144663|567543254|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
157217666|NCT01144663|567543255|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
157217667|NCT01144663|567543252|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
157020141|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020142|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157020143|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
157020144|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
157140511|NCT01485614|567260977|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
157140512|NCT01485614|567260978|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
157140513|NCT01485614|567260979|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
157140514|NCT01485614|567260976|FG000|Weeks 0-20|Withdrawal by Subject|3|||
157140515|NCT01485614|567260977|FG001|Weeks 0-20|Withdrawal by Subject|2|||
157140516|NCT01485614|567260978|FG002|Weeks 0-20|Withdrawal by Subject|1|||
157140517|NCT01485614|567260979|FG003|Weeks 0-20|Withdrawal by Subject|0|||
157140518|NCT01485614|567260976|FG000|Weeks 20-54|Lost to Follow-up|4|||
157140519|NCT01485614|567260977|FG001|Weeks 20-54|Lost to Follow-up|3|||
157140520|NCT01485614|567260978|FG002|Weeks 20-54|Lost to Follow-up|1|||
157140521|NCT01485614|567260979|FG003|Weeks 20-54|Lost to Follow-up|0|||
157140522|NCT01485614|567260976|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
157140523|NCT01485614|567260977|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
157140524|NCT01485614|567260978|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
157140525|NCT01485614|567260979|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
157140526|NCT01485614|567260976|FG000|Weeks 20-54|Withdrawal by Subject|5|||
157140527|NCT01485614|567260977|FG001|Weeks 20-54|Withdrawal by Subject|3|||
157140528|NCT01485614|567260978|FG002|Weeks 20-54|Withdrawal by Subject|0|||
157140529|NCT01485614|567260979|FG003|Weeks 20-54|Withdrawal by Subject|0|||
157140530|NCT00733902|567260980|FG000|Overall Study|Death|0|||
157140531|NCT00733902|567260981|FG001|Overall Study|Death|0|||
157140532|NCT00733902|567260982|FG002|Overall Study|Death|0|||
157140533|NCT00733902|567260983|FG003|Overall Study|Death|1|||
157140534|NCT00733902|567260980|FG000|Overall Study|Adverse Event|3|||
157140535|NCT00733902|567260981|FG001|Overall Study|Adverse Event|4|||
157140536|NCT00733902|567260982|FG002|Overall Study|Adverse Event|7|||
157140537|NCT00733902|567260983|FG003|Overall Study|Adverse Event|11|||
157140538|NCT00733902|567260980|FG000|Overall Study|Lack of Efficacy|56|||
157140539|NCT00733902|567260981|FG001|Overall Study|Lack of Efficacy|21|||
157140540|NCT00733902|567260982|FG002|Overall Study|Lack of Efficacy|34|||
157140541|NCT00733902|567260983|FG003|Overall Study|Lack of Efficacy|23|||
157140542|NCT00733902|567260980|FG000|Overall Study|Protocol Violation|4|||
157140543|NCT00733902|567260981|FG001|Overall Study|Protocol Violation|6|||
157140544|NCT00733902|567260982|FG002|Overall Study|Protocol Violation|3|||
157140545|NCT00733902|567260983|FG003|Overall Study|Protocol Violation|3|||
157140546|NCT00733902|567260980|FG000|Overall Study|Withdrawal by Subject|10|||
157140547|NCT00733902|567260981|FG001|Overall Study|Withdrawal by Subject|5|||
157140548|NCT00733902|567260982|FG002|Overall Study|Withdrawal by Subject|4|||
157140549|NCT00733902|567260983|FG003|Overall Study|Withdrawal by Subject|16|||
157140550|NCT00733902|567260980|FG000|Overall Study|Entered extension study|89|||
157140551|NCT00733902|567260981|FG001|Overall Study|Entered extension study|124|||
157140552|NCT00733902|567260982|FG002|Overall Study|Entered extension study|111|||
157140553|NCT00733902|567260983|FG003|Overall Study|Entered extension study|109|||
157140554|NCT00733902|567260980|FG000|Overall Study|Randomized but not treated|2|||
157140555|NCT00733902|567260981|FG001|Overall Study|Randomized but not treated|2|||
157140556|NCT00733902|567260982|FG002|Overall Study|Randomized but not treated|2|||
157140557|NCT00733902|567260983|FG003|Overall Study|Randomized but not treated|1|||
157140558|NCT00942409|567260984|FG000|Overall Study|Lack of Efficacy|1|||
157140559|NCT00942409|567260984|FG000|Overall Study|study drug unavailable|2|||
157140560|NCT01503021|567260989|FG000|Overall Study|Adverse Event|7|||
157140561|NCT01503021|567260990|FG001|Overall Study|Adverse Event|6|||
157217668|NCT01144663|567543253|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
156734496|NCT03535194|565776409|FG003|Induction Period|Physician Decision|0|||
157140562|NCT01503021|567260989|FG000|Overall Study|Death|0|||
157140563|NCT01503021|567260990|FG001|Overall Study|Death|2|||
157217669|NCT01144663|567543254|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
157217670|NCT01144663|567543255|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
157217671|NCT01144663|567543252|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
157217672|NCT01144663|567543253|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
157217673|NCT01144663|567543254|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
157217674|NCT01144663|567543255|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
157217675|NCT01144663|567543252|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
157217676|NCT01144663|567543253|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
157217677|NCT01144663|567543254|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
157217678|NCT01144663|567543255|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
157217679|NCT01144663|567543252|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
157217680|NCT01144663|567543253|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
157217681|NCT01144663|567543254|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
157217682|NCT01144663|567543255|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
157140564|NCT01503021|567260989|FG000|Overall Study|Lost to Follow-up|2|||
157140565|NCT01503021|567260990|FG001|Overall Study|Lost to Follow-up|0|||
157140566|NCT01503021|567260989|FG000|Overall Study|Physician Decision|3|||
157140567|NCT01503021|567260990|FG001|Overall Study|Physician Decision|0|||
157140568|NCT01503021|567260989|FG000|Overall Study|Protocol Violation|1|||
157140569|NCT01503021|567260990|FG001|Overall Study|Protocol Violation|3|||
157140570|NCT01503021|567260989|FG000|Overall Study|Withdrawal by Subject|9|||
157140571|NCT01503021|567260990|FG001|Overall Study|Withdrawal by Subject|8|||
157140572|NCT01503021|567260989|FG000|Overall Study|Moved, received transplant, etc.|5|||
157140573|NCT01503021|567260990|FG001|Overall Study|Moved, received transplant, etc.|7|||
157140574|NCT03941548|567260991|FG000|Overall Study|Adverse Event|0|||
157140575|NCT03941548|567260992|FG001|Overall Study|Adverse Event|1|||
157140576|NCT03941548|567260991|FG000|Overall Study|Lost to Follow-up|0|||
157217683|NCT01267266|567543258|FG000|Enrollment Phase|Withdrawal by Subject|2|||
157217684|NCT01267266|567543259|FG001|Enrollment Phase|Withdrawal by Subject|0|||
157217685|NCT01267266|567543258|FG000|Lead-in Phase|Lack of Efficacy|20|||
157217686|NCT01267266|567543259|FG001|Lead-in Phase|Lack of Efficacy|0|||
157217687|NCT01267266|567543258|FG000|Lead-in Phase|Adverse Event|2|||
157217688|NCT01267266|567543259|FG001|Lead-in Phase|Adverse Event|0|||
157217689|NCT01267266|567543258|FG000|Lead-in Phase|Withdrawal by Subject|1|||
157217690|NCT01267266|567543259|FG001|Lead-in Phase|Withdrawal by Subject|0|||
157217691|NCT01335477|567543261|FG000|Overall Study|Adverse Event|30|||
157217692|NCT01335477|567543262|FG001|Overall Study|Adverse Event|42|||
157217693|NCT01335477|567543261|FG000|Overall Study|Non compliant with protocol|0|||
157217694|NCT01335477|567543262|FG001|Overall Study|Non compliant with protocol|2|||
157217695|NCT01335477|567543261|FG000|Overall Study|Lost to Follow-up|1|||
157217696|NCT01335477|567543262|FG001|Overall Study|Lost to Follow-up|2|||
157217697|NCT01335477|567543261|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
157217698|NCT01335477|567543262|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
157217699|NCT01335477|567543261|FG000|Overall Study|Not treated|1|||
157217700|NCT01335477|567543262|FG001|Overall Study|Not treated|2|||
157217701|NCT01335477|567543261|FG000|Overall Study|Reason other than those stated above|2|||
157217702|NCT01335477|567543262|FG001|Overall Study|Reason other than those stated above|2|||
157217703|NCT02038634|567543264|FG000|Overall Study|Lost to Follow-up|0|||
157217704|NCT02038634|567543265|FG001|Overall Study|Lost to Follow-up|1|||
157217705|NCT00549198|567543267|FG000|Overall Study|Adverse Event|28|||
157217706|NCT00549198|567543268|FG001|Overall Study|Adverse Event|26|||
157217707|NCT00549198|567543267|FG000|Overall Study|Insufficient Viral Load Response|4|||
157217708|NCT00549198|567543268|FG001|Overall Study|Insufficient Viral Load Response|2|||
157217709|NCT00549198|567543267|FG000|Overall Study|Protocol-defined Virological Failure|7|||
157217710|NCT00549198|567543268|FG001|Overall Study|Protocol-defined Virological Failure|0|||
157217711|NCT00549198|567543267|FG000|Overall Study|Non-compliance|2|||
157217712|NCT00549198|567543268|FG001|Overall Study|Non-compliance|4|||
157217713|NCT00549198|567543267|FG000|Overall Study|Lost to Follow-up|7|||
157217714|NCT00549198|567543268|FG001|Overall Study|Lost to Follow-up|8|||
157217715|NCT00549198|567543267|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
157217716|NCT00549198|567543268|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
157217717|NCT00549198|567543267|FG000|Overall Study|Protocol Violation|7|||
157217718|NCT00549198|567543268|FG001|Overall Study|Protocol Violation|2|||
157217719|NCT00549198|567543267|FG000|Overall Study|Investigator Decision|4|||
157140577|NCT03941548|567260992|FG001|Overall Study|Lost to Follow-up|1|||
157140578|NCT03941548|567260991|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
157140579|NCT03941548|567260992|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
157217720|NCT00549198|567543268|FG001|Overall Study|Investigator Decision|3|||
157217721|NCT00549198|567543267|FG000|Overall Study|Withdrawal by Subject|7|||
157217722|NCT00549198|567543268|FG001|Overall Study|Withdrawal by Subject|7|||
157217723|NCT00549198|567543267|FG000|Overall Study|Disease Progression|1|||
157217724|NCT00549198|567543268|FG001|Overall Study|Disease Progression|0|||
157217725|NCT00549198|567543267|FG000|Overall Study|Participant Moved|2|||
157217726|NCT00549198|567543268|FG001|Overall Study|Participant Moved|0|||
156734497|NCT03535194|565776410|FG004|Induction Period|Physician Decision|0|||
156734498|NCT03535194|565776406|FG000|Induction Period|Protocol Violation|1|||
156734499|NCT03535194|565776407|FG001|Induction Period|Protocol Violation|0|||
156734500|NCT03535194|565776408|FG002|Induction Period|Protocol Violation|0|||
156734501|NCT03535194|565776409|FG003|Induction Period|Protocol Violation|1|||
156734502|NCT03535194|565776410|FG004|Induction Period|Protocol Violation|0|||
156734503|NCT03535194|565776406|FG000|Induction Period|Screen Failure|0|||
156734504|NCT03535194|565776407|FG001|Induction Period|Screen Failure|1|||
156734505|NCT03535194|565776408|FG002|Induction Period|Screen Failure|0|||
156734506|NCT03535194|565776409|FG003|Induction Period|Screen Failure|0|||
157020145|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
157020146|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
157140580|NCT01242111|567260994|FG000|Overall Study|Adverse Event|1|||
157140581|NCT01242111|567260994|FG000|Overall Study|Withdrawal by Subject|1|||
157140582|NCT01242111|567260994|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
157140583|NCT00870688|567260995|FG000|Overall Study|Lost to Follow-up|2|||
157140584|NCT00870688|567260995|FG000|Overall Study|Death, Unrelated|1|||
157140585|NCT00870688|567260995|FG000|Overall Study|Granules in the Stools|1|||
157140586|NCT02015819|567260996|FG000|Overall Study|Rickham catheter was misaligned|0|||
157140587|NCT02015819|567260997|FG001|Overall Study|Rickham catheter was misaligned|0|||
157140588|NCT02015819|567260998|FG002|Overall Study|Rickham catheter was misaligned|0|||
157140589|NCT02015819|567260999|FG003|Overall Study|Rickham catheter was misaligned|1|||
157140590|NCT01697215|567261002|FG000|Overall Study|Physician Decision|5|||
157140591|NCT01697215|567261002|FG000|Overall Study|Malfunction|9|||
157140592|NCT01697215|567261002|FG000|Overall Study|CXR not available|9|||
157140593|NCT01929083|567261003|FG000|Intervention 1|Lost to Follow-up|2|||
157140594|NCT01929083|567261004|FG001|Intervention 1|Lost to Follow-up|0|||
157140595|NCT01929083|567261003|FG000|Intervention 1|Nonadherent to study medications|1|||
157140596|NCT01929083|567261004|FG001|Intervention 1|Nonadherent to study medications|0|||
157140597|NCT01929083|567261003|FG000|Intervention 2|Adverse Event|0|||
157140598|NCT01929083|567261004|FG001|Intervention 2|Adverse Event|1|||
157140599|NCT02599402|567261005|FG000|Overall Study|Disease progression|153|||
157140600|NCT02599402|567261005|FG000|Overall Study|Study drug toxicity|201|||
157140601|NCT02599402|567261005|FG000|Overall Study|Death|26|||
157140602|NCT02599402|567261005|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
157140603|NCT02599402|567261005|FG000|Overall Study|Participant request to discontinue study treatment|13|||
157140604|NCT02599402|567261005|FG000|Overall Study|Participant withdrew consent|5|||
157140605|NCT02599402|567261005|FG000|Overall Study|Lost to Follow-up|1|||
157140606|NCT02599402|567261005|FG000|Overall Study|Maximum Clinical Benefit|7|||
157140607|NCT02599402|567261005|FG000|Overall Study|Poor/non-compliance|1|||
157140608|NCT02599402|567261005|FG000|Overall Study|Pregnancy|1|||
157140609|NCT02599402|567261005|FG000|Overall Study|Participant no longer met study criteria|7|||
157140610|NCT02599402|567261005|FG000|Overall Study|Other Reasons|95|||
157140611|NCT00087438|567261006|FG000|Overall Study|Ineligible / No protocol treatment|4|||
157140612|NCT01486264|567261007|FG000|Overall Study|Death|1|||
157140613|NCT01486264|567261008|FG001|Overall Study|Death|1|||
157140614|NCT01486264|567261007|FG000|Overall Study|Adverse Event|3|||
157140615|NCT01486264|567261008|FG001|Overall Study|Adverse Event|3|||
157140616|NCT01486264|567261007|FG000|Overall Study|Lack of Efficacy|6|||
157140617|NCT01486264|567261008|FG001|Overall Study|Lack of Efficacy|10|||
157140618|NCT01486264|567261007|FG000|Overall Study|Withdrawal by Subject|7|||
157140619|NCT01486264|567261008|FG001|Overall Study|Withdrawal by Subject|18|||
157140620|NCT01486264|567261007|FG000|Overall Study|Physician Decision|1|||
157140621|NCT01486264|567261008|FG001|Overall Study|Physician Decision|1|||
157140622|NCT01486264|567261007|FG000|Overall Study|Protocol Violation|3|||
157140623|NCT01486264|567261008|FG001|Overall Study|Protocol Violation|0|||
157140624|NCT01486264|567261007|FG000|Overall Study|Lost to Follow-up|3|||
157140625|NCT01486264|567261008|FG001|Overall Study|Lost to Follow-up|2|||
157140626|NCT01486264|567261007|FG000|Overall Study|Other|5|||
157140627|NCT01486264|567261008|FG001|Overall Study|Other|11|||
157140628|NCT01486264|567261007|FG000|Overall Study|Not treated|0|||
157140629|NCT01486264|567261008|FG001|Overall Study|Not treated|1|||
157140630|NCT05340504|567261009|FG000|Overall Study|Withdrawal by Subject|1|||
157140631|NCT05340504|567261010|FG001|Overall Study|Withdrawal by Subject|0|||
157140632|NCT03068715|567261021|FG000|Overall Study|No longer met inclusion criteria|1|||
157140633|NCT03068715|567261022|FG001|Overall Study|No longer met inclusion criteria|0|||
157140634|NCT00728416|567261023|FG000|Overall Study|Adverse Event|1|||
157140635|NCT00728416|567261024|FG001|Overall Study|Adverse Event|1|||
157140636|NCT00728416|567261023|FG000|Overall Study|Treatment Failure|0|||
157140637|NCT00728416|567261024|FG001|Overall Study|Treatment Failure|1|||
157140638|NCT00728416|567261023|FG000|Overall Study|Withdrawal by Subject|1|||
157140639|NCT00728416|567261024|FG001|Overall Study|Withdrawal by Subject|0|||
157140640|NCT03584009|567261025|FG000|Overall Study|Death|25|||
157140641|NCT03584009|567261026|FG001|Overall Study|Death|18|||
157140642|NCT03584009|567261025|FG000|Overall Study|Lost to Follow-up|0|||
157140643|NCT03584009|567261026|FG001|Overall Study|Lost to Follow-up|1|||
156734507|NCT03535194|565776410|FG004|Induction Period|Screen Failure|0|||
157140644|NCT03584009|567261025|FG000|Overall Study|Physician Decision|1|||
157140645|NCT03584009|567261026|FG001|Overall Study|Physician Decision|1|||
157140646|NCT03584009|567261025|FG000|Overall Study|Study Terminated by Sponsor|22|||
157140647|NCT03584009|567261026|FG001|Overall Study|Study Terminated by Sponsor|30|||
157140648|NCT03584009|567261025|FG000|Overall Study|Withdrawal by Subject|3|||
157140649|NCT03584009|567261026|FG001|Overall Study|Withdrawal by Subject|2|||
157140650|NCT04112914|567261027|FG000|Overall Study|Lost to Follow-up|13|||
157140651|NCT04112914|567261028|FG001|Overall Study|Lost to Follow-up|9|||
157140652|NCT04112914|567261027|FG000|Overall Study|Withdrawal by Subject|1|||
157140653|NCT04112914|567261028|FG001|Overall Study|Withdrawal by Subject|0|||
157140654|NCT00768560|567261029|FG000|Intervention Set 1|Adverse Event|0|||
157140655|NCT00768560|567261030|FG001|Intervention Set 1|Adverse Event|1|||
157140656|NCT00768560|567261031|FG002|Intervention Set 1|Adverse Event|0|||
157140657|NCT00768560|567261032|FG003|Intervention Set 1|Adverse Event|0|||
157217727|NCT00549198|567543267|FG000|Overall Study|Participant not able to perform Week 96|1|||
156734508|NCT03535194|565776406|FG000|Induction Period|Withdrawal by Subject|3|||
156734509|NCT03535194|565776407|FG001|Induction Period|Withdrawal by Subject|4|||
156734510|NCT03535194|565776408|FG002|Induction Period|Withdrawal by Subject|3|||
156734511|NCT03535194|565776409|FG003|Induction Period|Withdrawal by Subject|2|||
156734512|NCT03535194|565776410|FG004|Induction Period|Withdrawal by Subject|0|||
156734513|NCT03535194|565776406|FG000|Maintenance Period|Adverse Event|6|||
156734514|NCT03535194|565776407|FG001|Maintenance Period|Adverse Event|5|||
156734515|NCT03535194|565776408|FG002|Maintenance Period|Adverse Event|1|||
156734516|NCT03535194|565776409|FG003|Maintenance Period|Adverse Event|11|||
156734517|NCT03535194|565776410|FG004|Maintenance Period|Adverse Event|4|||
156734518|NCT03535194|565776406|FG000|Maintenance Period|Lack of Efficacy|3|||
156734519|NCT03535194|565776407|FG001|Maintenance Period|Lack of Efficacy|2|||
156734520|NCT03535194|565776408|FG002|Maintenance Period|Lack of Efficacy|5|||
156734521|NCT03535194|565776409|FG003|Maintenance Period|Lack of Efficacy|9|||
156734522|NCT03535194|565776410|FG004|Maintenance Period|Lack of Efficacy|0|||
156734523|NCT03535194|565776406|FG000|Maintenance Period|Lost to Follow-up|4|||
156734524|NCT03535194|565776407|FG001|Maintenance Period|Lost to Follow-up|2|||
156734525|NCT03535194|565776408|FG002|Maintenance Period|Lost to Follow-up|1|||
156734526|NCT03535194|565776409|FG003|Maintenance Period|Lost to Follow-up|5|||
156734527|NCT03535194|565776410|FG004|Maintenance Period|Lost to Follow-up|2|||
156734528|NCT03535194|565776406|FG000|Maintenance Period|Other|1|||
156734529|NCT03535194|565776407|FG001|Maintenance Period|Other|2|||
156734530|NCT03535194|565776408|FG002|Maintenance Period|Other|0|||
156734531|NCT03535194|565776409|FG003|Maintenance Period|Other|0|||
156734532|NCT03535194|565776410|FG004|Maintenance Period|Other|0|||
156734533|NCT03535194|565776406|FG000|Maintenance Period|Physician Decision|1|||
156734534|NCT03535194|565776407|FG001|Maintenance Period|Physician Decision|2|||
156734535|NCT03535194|565776408|FG002|Maintenance Period|Physician Decision|0|||
156734536|NCT03535194|565776409|FG003|Maintenance Period|Physician Decision|2|||
156734537|NCT03535194|565776410|FG004|Maintenance Period|Physician Decision|0|||
156734538|NCT03535194|565776406|FG000|Maintenance Period|Pregnancy|0|||
156734539|NCT03535194|565776407|FG001|Maintenance Period|Pregnancy|0|||
156734540|NCT03535194|565776408|FG002|Maintenance Period|Pregnancy|0|||
156734541|NCT03535194|565776409|FG003|Maintenance Period|Pregnancy|2|||
156734542|NCT03535194|565776410|FG004|Maintenance Period|Pregnancy|0|||
156734543|NCT03535194|565776406|FG000|Maintenance Period|Protocol Violation|0|||
156734544|NCT03535194|565776407|FG001|Maintenance Period|Protocol Violation|1|||
156734545|NCT03535194|565776408|FG002|Maintenance Period|Protocol Violation|0|||
156734546|NCT03535194|565776409|FG003|Maintenance Period|Protocol Violation|0|||
156734547|NCT03535194|565776410|FG004|Maintenance Period|Protocol Violation|0|||
156734548|NCT03535194|565776406|FG000|Maintenance Period|Withdrawal by Subject|7|||
156734549|NCT03535194|565776407|FG001|Maintenance Period|Withdrawal by Subject|2|||
156734550|NCT03535194|565776408|FG002|Maintenance Period|Withdrawal by Subject|1|||
156734551|NCT03535194|565776409|FG003|Maintenance Period|Withdrawal by Subject|8|||
156734552|NCT03535194|565776410|FG004|Maintenance Period|Withdrawal by Subject|0|||
156734553|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Adverse Event|4|||
156734554|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Adverse Event|5|||
156734555|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Adverse Event|1|||
156734556|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Adverse Event|8|||
156734557|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Adverse Event|0|||
156734558|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
156876658|NCT04518995|566307670|FG001|Overall Study|Reason not Specified|11|||
156734559|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
156734560|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
156734561|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
157140658|NCT00768560|567261033|FG004|Intervention Set 1|Adverse Event|0|||
157140659|NCT00768560|567261034|FG005|Intervention Set 1|Adverse Event|0|||
156734562|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
157020147|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157140660|NCT00117312|567261035|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
157217728|NCT00549198|567543268|FG001|Overall Study|Participant not able to perform Week 96|0|||
157140661|NCT00117312|567261036|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
157140662|NCT00117312|567261037|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
157140663|NCT00117312|567261038|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
157140664|NCT00117312|567261035|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
157140665|NCT00117312|567261036|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
157140666|NCT00117312|567261037|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
157140667|NCT00117312|567261038|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
157140668|NCT00117312|567261035|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
157140669|NCT00117312|567261036|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
157140670|NCT00117312|567261037|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
157140671|NCT00117312|567261038|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
157140672|NCT00117312|567261035|FG000|Overall Study|Other|0|||
157140673|NCT00117312|567261036|FG001|Overall Study|Other|1|||
157140674|NCT00117312|567261037|FG002|Overall Study|Other|3|||
157140675|NCT00117312|567261038|FG003|Overall Study|Other|1|||
157140676|NCT00117312|567261035|FG000|Overall Study|Patient choice|0|||
157140677|NCT00117312|567261036|FG001|Overall Study|Patient choice|0|||
157140678|NCT00117312|567261037|FG002|Overall Study|Patient choice|2|||
157140679|NCT00117312|567261038|FG003|Overall Study|Patient choice|1|||
157140680|NCT00117312|567261035|FG000|Overall Study|Adverse Event|0|||
157140681|NCT00117312|567261036|FG001|Overall Study|Adverse Event|2|||
157140682|NCT00117312|567261037|FG002|Overall Study|Adverse Event|0|||
157140683|NCT00117312|567261038|FG003|Overall Study|Adverse Event|0|||
157140684|NCT00117312|567261035|FG000|Overall Study|Protocol Violation|0|||
157140685|NCT00117312|567261036|FG001|Overall Study|Protocol Violation|1|||
157140686|NCT00117312|567261037|FG002|Overall Study|Protocol Violation|3|||
157140687|NCT00117312|567261038|FG003|Overall Study|Protocol Violation|0|||
157140688|NCT00117312|567261035|FG000|Overall Study|PSA decrease <=50%|0|||
157140689|NCT00117312|567261036|FG001|Overall Study|PSA decrease <=50%|2|||
157140690|NCT00117312|567261037|FG002|Overall Study|PSA decrease <=50%|2|||
157140691|NCT00117312|567261038|FG003|Overall Study|PSA decrease <=50%|4|||
157140692|NCT00117312|567261035|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
157140693|NCT00117312|567261036|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
157140694|NCT00117312|567261037|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
157140695|NCT00117312|567261038|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
156876659|NCT04518995|566307671|FG002|Overall Study|Reason not Specified|2|||
156876660|NCT04518995|566307669|FG000|Overall Study|Lost to Follow-up|1|||
156876661|NCT04518995|566307670|FG001|Overall Study|Lost to Follow-up|10|||
157140696|NCT00117312|567261035|FG000|Overall Study|Hepatic abnormality|0|||
157140697|NCT00117312|567261036|FG001|Overall Study|Hepatic abnormality|1|||
157140698|NCT00117312|567261037|FG002|Overall Study|Hepatic abnormality|0|||
157140699|NCT00117312|567261038|FG003|Overall Study|Hepatic abnormality|1|||
157140700|NCT00117312|567261035|FG000|Overall Study|Withdrawal by Subject|0|||
157140701|NCT00117312|567261036|FG001|Overall Study|Withdrawal by Subject|2|||
157140702|NCT00117312|567261037|FG002|Overall Study|Withdrawal by Subject|0|||
157140703|NCT00117312|567261038|FG003|Overall Study|Withdrawal by Subject|0|||
157140704|NCT01120626|567261039|FG000|Overall Study|Withdrawal by Subject|1|||
157140705|NCT01120626|567261040|FG001|Overall Study|Withdrawal by Subject|0|||
157140706|NCT02635204|567261041|FG000|Overall Study|Adverse Event|1|||
157140707|NCT02635204|567261042|FG001|Overall Study|Adverse Event|0|||
157140708|NCT02635204|567261041|FG000|Overall Study|Lost to Follow-up|1|||
157140709|NCT02635204|567261042|FG001|Overall Study|Lost to Follow-up|1|||
157140710|NCT01535235|567261044|FG000|Overall Study|Adverse Event|1|||
157140711|NCT01535235|567261045|FG001|Overall Study|Adverse Event|0|||
157140712|NCT00509106|567261047|FG000|Overall Study|Adverse Event|3|||
157140713|NCT00509106|567261048|FG001|Overall Study|Adverse Event|2|||
157140714|NCT00509106|567261047|FG000|Overall Study|Noncompliance|0|||
157140715|NCT00509106|567261048|FG001|Overall Study|Noncompliance|1|||
157140716|NCT00509106|567261047|FG000|Overall Study|At the request of sponsor/investigator|1|||
157140717|NCT00509106|567261048|FG001|Overall Study|At the request of sponsor/investigator|2|||
157140718|NCT00509106|567261047|FG000|Overall Study|Withdrew consent|4|||
157140719|NCT00509106|567261048|FG001|Overall Study|Withdrew consent|8|||
157140720|NCT00509106|567261047|FG000|Overall Study|Lost to Follow-up|16|||
157140721|NCT00509106|567261048|FG001|Overall Study|Lost to Follow-up|10|||
157140722|NCT00509106|567261047|FG000|Overall Study|Other|1|||
157140723|NCT00509106|567261048|FG001|Overall Study|Other|0|||
157140724|NCT00509106|567261047|FG000|Overall Study|Death|6|||
157140725|NCT00509106|567261048|FG001|Overall Study|Death|6|||
156876662|NCT04518995|566307671|FG002|Overall Study|Lost to Follow-up|6|||
157140726|NCT05421754|567261054|FG000|Overall Study|Technical issue with sensor|1|||
157140727|NCT01051739|567261055|FG000|Overall Study|Death|3|||
157140728|NCT01051739|567261056|FG001|Overall Study|Death|3|||
157140729|NCT01051739|567261055|FG000|Overall Study|Withdrawal by Subject|25|||
156876663|NCT04590248|566307674|FG000|Overall Study|Lost to Follow-up|1|||
157140730|NCT01051739|567261056|FG001|Overall Study|Withdrawal by Subject|10|||
157140731|NCT03527043|567261057|FG000|Overall Study|Withdrawal by Subject|1|||
157140732|NCT03527043|567261058|FG001|Overall Study|Withdrawal by Subject|0|||
157140733|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
157140734|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
157140735|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
157140736|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
157140737|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
157140738|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
157140739|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Personal issues|2|||
157140740|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Personal issues|0|||
157140741|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Personal issues|0|||
157140742|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Too busy|7|||
157140743|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Too busy|1|||
157140744|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Too busy|0|||
157140745|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Pain|2|||
157140746|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Pain|0|||
157140747|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Pain|0|||
157140748|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Moved|1|||
157140749|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Moved|0|||
157140750|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Moved|0|||
157140751|NCT00594399|567261059|FG000|Initial 3 Month Counseling|Family illness|1|||
157140752|NCT00594399|567261060|FG001|Initial 3 Month Counseling|Family illness|0|||
157140753|NCT00594399|567261061|FG002|Initial 3 Month Counseling|Family illness|0|||
157140754|NCT00594399|567261059|FG000|Rerandomization Arm 1 Only|Death|2|||
157140755|NCT00594399|567261060|FG001|Rerandomization Arm 1 Only|Death|1|||
157140756|NCT00594399|567261061|FG002|Rerandomization Arm 1 Only|Death|0|||
157140757|NCT00594399|567261059|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
157140758|NCT00594399|567261060|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
157140759|NCT00594399|567261061|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
157140760|NCT00709202|567261063|FG000|Overall Study|Withdrawal by Subject|6|||
157140761|NCT00709202|567261064|FG001|Overall Study|Withdrawal by Subject|6|||
157140762|NCT03133767|567261065|FG000|Overall Study|Lost to Follow-up|38|||
157140763|NCT03133767|567261066|FG001|Overall Study|Lost to Follow-up|24|||
157140764|NCT03133767|567261065|FG000|Overall Study|Protocol Violation|0|||
157140765|NCT03133767|567261066|FG001|Overall Study|Protocol Violation|1|||
157140766|NCT03301857|567261067|FG000|Overall Study|Death|0|||
157140767|NCT03301857|567261068|FG001|Overall Study|Death|2|||
157140768|NCT03301857|567261067|FG000|Overall Study|Lost to Follow-up|4|||
157140769|NCT03301857|567261068|FG001|Overall Study|Lost to Follow-up|2|||
157140770|NCT03301857|567261067|FG000|Overall Study|Decision by Sponsor|6|||
156734563|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734564|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734565|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
156734566|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
156734567|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
156734568|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Other|1|||
156734569|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Other|0|||
156734570|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Other|0|||
156734571|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Other|5|||
156734572|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Other|0|||
156734573|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Physician Decision|0|||
156734574|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Physician Decision|2|||
156734575|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Physician Decision|1|||
156734576|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Physician Decision|1|||
156734577|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Physician Decision|0|||
156734578|NCT03535194|565776406|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
156734579|NCT03535194|565776407|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
156734580|NCT03535194|565776408|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
156734581|NCT03535194|565776409|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
156734582|NCT03535194|565776410|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156734583|NCT04411810|565776411|FG000|Overall Study|Screen failure|1|||
156734584|NCT04411810|565776411|FG000|Overall Study|Withdrawal by Subject|1|||
156734585|NCT04304235|565776415|FG000|Overall Study|incomplete triage data|0|||
156734586|NCT04304235|565776416|FG001|Overall Study|incomplete triage data|69|||
156734587|NCT04304235|565776417|FG002|Overall Study|incomplete triage data|0|||
156734588|NCT04304235|565776418|FG003|Overall Study|incomplete triage data|0|||
156734589|NCT04304235|565776419|FG004|Overall Study|incomplete triage data|289|||
156734590|NCT04304235|565776420|FG005|Overall Study|incomplete triage data|123|||
157140771|NCT03301857|567261068|FG001|Overall Study|Decision by Sponsor|0|||
157140772|NCT03301857|567261067|FG000|Overall Study|Withdrawal by Subject|12|||
157140773|NCT03301857|567261068|FG001|Overall Study|Withdrawal by Subject|4|||
157140774|NCT01642212|567261082|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
157140775|NCT01642212|567261083|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
157140776|NCT01642212|567261084|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
157140777|NCT01642212|567261085|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
157217729|NCT00549198|567543267|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
156734591|NCT04304235|565776421|FG006|Overall Study|incomplete triage data|65|||
157217730|NCT00549198|567543268|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
157217731|NCT00549198|567543267|FG000|Overall Study|Prohibited Medication|1|||
157217732|NCT00549198|567543268|FG001|Overall Study|Prohibited Medication|2|||
157217733|NCT00549198|567543267|FG000|Overall Study|Participant planning pregnancy|1|||
157217734|NCT00549198|567543268|FG001|Overall Study|Participant planning pregnancy|0|||
157217735|NCT00549198|567543267|FG000|Overall Study|Participant overweight, no scan possible|1|||
157217736|NCT00549198|567543268|FG001|Overall Study|Participant overweight, no scan possible|0|||
157217737|NCT00549198|567543267|FG000|Overall Study|No scan facilities|0|||
157217738|NCT00549198|567543268|FG001|Overall Study|No scan facilities|2|||
157217739|NCT00549198|567543267|FG000|Overall Study|Pregnancy|0|||
157217740|NCT00549198|567543268|FG001|Overall Study|Pregnancy|3|||
157217741|NCT00549198|567543267|FG000|Overall Study|Not Exposed to Study Drug|3|||
156734592|NCT02278939|565776426|FG000|Overall Study|lack of time|1|||
156734593|NCT02278939|565776427|FG001|Overall Study|lack of time|0|||
156734594|NCT02278939|565776426|FG000|Overall Study|Lost to Follow-up|1|||
156734595|NCT02278939|565776427|FG001|Overall Study|Lost to Follow-up|1|||
156734596|NCT02278939|565776426|FG000|Overall Study|death in family|1|||
156734597|NCT02278939|565776427|FG001|Overall Study|death in family|0|||
156734598|NCT02278939|565776426|FG000|Overall Study|family emergency unable to commit|2|||
156734599|NCT02278939|565776427|FG001|Overall Study|family emergency unable to commit|0|||
156734600|NCT04429555|565776430|FG000|Overall Study|Death|0|||
156734601|NCT04429555|565776431|FG001|Overall Study|Death|2|||
156734602|NCT04429555|565776430|FG000|Overall Study|Other|2|||
156734603|NCT04429555|565776431|FG001|Overall Study|Other|0|||
156734604|NCT00930774|565776432|FG000|Overall Study|Withdrawal by Subject|1|||
156734605|NCT00930774|565776433|FG001|Overall Study|Withdrawal by Subject|9|||
156734606|NCT00930774|565776434|FG002|Overall Study|Withdrawal by Subject|2|||
156734607|NCT00930774|565776435|FG003|Overall Study|Withdrawal by Subject|0|||
156734608|NCT03200704|565776436|FG000|Overall Study|Withdrawal by Subject|1|||
156734609|NCT00425061|565776437|FG000|Overall Study|Adverse Event|1|||
156734610|NCT00425061|565776438|FG001|Overall Study|Adverse Event|0|||
156734611|NCT00425061|565776439|FG002|Overall Study|Adverse Event|0|||
156734612|NCT00425061|565776440|FG003|Overall Study|Adverse Event|2|||
156734613|NCT00425061|565776441|FG004|Overall Study|Adverse Event|2|||
156734614|NCT00425061|565776442|FG005|Overall Study|Adverse Event|0|||
156734615|NCT00425061|565776443|FG006|Overall Study|Adverse Event|0|||
156734616|NCT00425061|565776437|FG000|Overall Study|Lost to Follow-up|0|||
156734617|NCT00425061|565776438|FG001|Overall Study|Lost to Follow-up|1|||
156734618|NCT00425061|565776439|FG002|Overall Study|Lost to Follow-up|0|||
156734619|NCT00425061|565776440|FG003|Overall Study|Lost to Follow-up|0|||
156734620|NCT00425061|565776441|FG004|Overall Study|Lost to Follow-up|0|||
156734621|NCT00425061|565776442|FG005|Overall Study|Lost to Follow-up|0|||
156734622|NCT00425061|565776443|FG006|Overall Study|Lost to Follow-up|0|||
156734623|NCT00425061|565776437|FG000|Overall Study|Protocol Violation|1|||
156734624|NCT00425061|565776438|FG001|Overall Study|Protocol Violation|0|||
156734625|NCT00425061|565776439|FG002|Overall Study|Protocol Violation|0|||
156734626|NCT00425061|565776440|FG003|Overall Study|Protocol Violation|0|||
156734627|NCT00425061|565776441|FG004|Overall Study|Protocol Violation|0|||
156734628|NCT00425061|565776442|FG005|Overall Study|Protocol Violation|0|||
156734629|NCT00425061|565776443|FG006|Overall Study|Protocol Violation|0|||
156734630|NCT00425061|565776437|FG000|Overall Study|Withdrawal by Subject|0|||
156734631|NCT00425061|565776438|FG001|Overall Study|Withdrawal by Subject|1|||
156734632|NCT00425061|565776439|FG002|Overall Study|Withdrawal by Subject|0|||
156734633|NCT00425061|565776440|FG003|Overall Study|Withdrawal by Subject|0|||
156734634|NCT00425061|565776441|FG004|Overall Study|Withdrawal by Subject|1|||
156734635|NCT00425061|565776442|FG005|Overall Study|Withdrawal by Subject|0|||
156734636|NCT00425061|565776443|FG006|Overall Study|Withdrawal by Subject|3|||
156734637|NCT00425061|565776437|FG000|Overall Study|Sponsor's request|0|||
156734638|NCT00425061|565776438|FG001|Overall Study|Sponsor's request|0|||
156734639|NCT00425061|565776439|FG002|Overall Study|Sponsor's request|0|||
156734640|NCT00425061|565776440|FG003|Overall Study|Sponsor's request|0|||
156734641|NCT00425061|565776441|FG004|Overall Study|Sponsor's request|19|||
156876664|NCT04590248|566307674|FG000|Overall Study|Withdrawal by Subject|16|||
156876665|NCT04590248|566307674|FG000|Overall Study|Other|2|||
157217742|NCT00549198|567543268|FG001|Overall Study|Not Exposed to Study Drug|4|||
157217743|NCT01473758|567543270|FG000|Cycle 1|Adverse Event|10|||
157217744|NCT01473758|567543271|FG001|Cycle 1|Adverse Event|2|||
156734642|NCT00425061|565776442|FG005|Overall Study|Sponsor's request|4|||
156734643|NCT00425061|565776443|FG006|Overall Study|Sponsor's request|15|||
156734644|NCT00425061|565776437|FG000|Overall Study|Physician Decision|0|||
156734645|NCT00425061|565776438|FG001|Overall Study|Physician Decision|0|||
156734646|NCT00425061|565776439|FG002|Overall Study|Physician Decision|0|||
156734647|NCT00425061|565776440|FG003|Overall Study|Physician Decision|0|||
156734648|NCT00425061|565776441|FG004|Overall Study|Physician Decision|1|||
156734649|NCT00425061|565776442|FG005|Overall Study|Physician Decision|0|||
156734650|NCT00425061|565776443|FG006|Overall Study|Physician Decision|0|||
156734651|NCT00425061|565776437|FG000|Overall Study|Other|0|||
156876666|NCT02052414|566307675|FG000|Overall Study|Adverse Event|12|||
157217745|NCT01473758|567543272|FG002|Cycle 1|Adverse Event|0|||
157140778|NCT01642212|567261086|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
157140779|NCT01642212|567261082|FG000|Double-blind Treatment|Other|0|||
157140780|NCT01642212|567261083|FG001|Double-blind Treatment|Other|2|||
157140781|NCT01642212|567261084|FG002|Double-blind Treatment|Other|1|||
157140782|NCT01642212|567261085|FG003|Double-blind Treatment|Other|0|||
157140783|NCT01642212|567261086|FG004|Double-blind Treatment|Other|0|||
157140784|NCT01642212|567261082|FG000|Double-blind Treatment|Non-compliance|0|||
157140785|NCT01642212|567261083|FG001|Double-blind Treatment|Non-compliance|1|||
157140786|NCT01642212|567261084|FG002|Double-blind Treatment|Non-compliance|0|||
157140787|NCT01642212|567261085|FG003|Double-blind Treatment|Non-compliance|0|||
157140788|NCT01642212|567261086|FG004|Double-blind Treatment|Non-compliance|0|||
157140789|NCT01642212|567261082|FG000|Double-blind Treatment|Adverse Event|0|||
157140790|NCT01642212|567261083|FG001|Double-blind Treatment|Adverse Event|0|||
157140791|NCT01642212|567261084|FG002|Double-blind Treatment|Adverse Event|1|||
157140792|NCT01642212|567261085|FG003|Double-blind Treatment|Adverse Event|0|||
157140793|NCT01642212|567261086|FG004|Double-blind Treatment|Adverse Event|0|||
157140794|NCT01642212|567261082|FG000|Open-label Extension|Adverse Event|0|||
157140795|NCT01642212|567261083|FG001|Open-label Extension|Adverse Event|0|||
157140796|NCT01642212|567261084|FG002|Open-label Extension|Adverse Event|0|||
157140797|NCT01642212|567261085|FG003|Open-label Extension|Adverse Event|3|||
157140798|NCT01642212|567261086|FG004|Open-label Extension|Adverse Event|0|||
157140799|NCT01642212|567261082|FG000|Open-label Extension|Sponsor Decision|0|||
157140800|NCT01642212|567261083|FG001|Open-label Extension|Sponsor Decision|0|||
157140801|NCT01642212|567261084|FG002|Open-label Extension|Sponsor Decision|0|||
157140802|NCT01642212|567261085|FG003|Open-label Extension|Sponsor Decision|7|||
157140803|NCT01642212|567261086|FG004|Open-label Extension|Sponsor Decision|4|||
157140804|NCT01642212|567261082|FG000|Open-label Extension|Consent Withdrawn|0|||
157140805|NCT01642212|567261083|FG001|Open-label Extension|Consent Withdrawn|0|||
157140806|NCT01642212|567261084|FG002|Open-label Extension|Consent Withdrawn|0|||
157140807|NCT01642212|567261085|FG003|Open-label Extension|Consent Withdrawn|0|||
157140808|NCT01642212|567261086|FG004|Open-label Extension|Consent Withdrawn|2|||
157140809|NCT01642212|567261082|FG000|Open-label Extension|Lost to Follow-up|0|||
157140810|NCT01642212|567261083|FG001|Open-label Extension|Lost to Follow-up|0|||
157140811|NCT01642212|567261084|FG002|Open-label Extension|Lost to Follow-up|0|||
157140812|NCT01642212|567261085|FG003|Open-label Extension|Lost to Follow-up|0|||
157140813|NCT01642212|567261086|FG004|Open-label Extension|Lost to Follow-up|1|||
157140814|NCT01642212|567261082|FG000|Open-label Extension|Other|0|||
157140815|NCT01642212|567261083|FG001|Open-label Extension|Other|0|||
157140816|NCT01642212|567261084|FG002|Open-label Extension|Other|0|||
157140817|NCT01642212|567261085|FG003|Open-label Extension|Other|0|||
157140818|NCT01642212|567261086|FG004|Open-label Extension|Other|1|||
157140819|NCT01697345|567261087|FG000|Overall Study|Withdrawal by Subject|1|||
157140820|NCT02382133|567261088|FG000|Overall Study|Death|22|||
157140821|NCT02382133|567261088|FG000|Overall Study|transfer out of ICU|4|||
157140822|NCT02382133|567261088|FG000|Overall Study|Physician Decision|2|||
157140823|NCT02382133|567261088|FG000|Overall Study|arterial catheter loss|4|||
157140824|NCT02382133|567261088|FG000|Overall Study|pressure injury both sites|1|||
157140825|NCT03430310|567261089|FG000|Overall Study|Protocol Violation|2|||
157140826|NCT03430310|567261090|FG001|Overall Study|Protocol Violation|0|||
157140827|NCT03430310|567261089|FG000|Overall Study|Withdrawal by Subject|3|||
157140828|NCT03430310|567261090|FG001|Overall Study|Withdrawal by Subject|2|||
157140829|NCT03430310|567261089|FG000|Overall Study|COVID shutdown March 2020|0|||
157140830|NCT03430310|567261090|FG001|Overall Study|COVID shutdown March 2020|1|||
157140831|NCT01446809|567261091|FG000|Overall Study|Adverse Event|0|||
157140832|NCT01446809|567261092|FG001|Overall Study|Adverse Event|0|||
157140833|NCT01446809|567261093|FG002|Overall Study|Adverse Event|1|||
157140834|NCT01446809|567261091|FG000|Overall Study|Failure to complete study procedures|0|||
157140835|NCT01446809|567261092|FG001|Overall Study|Failure to complete study procedures|0|||
157140836|NCT01446809|567261093|FG002|Overall Study|Failure to complete study procedures|1|||
157140837|NCT01331161|567261094|FG000|Overall Study|Physician Decision|1|||
157140838|NCT01331161|567261095|FG001|Overall Study|Physician Decision|0|||
157140839|NCT01331161|567261094|FG000|Overall Study|Lost to Follow-up|0|||
157140840|NCT01331161|567261095|FG001|Overall Study|Lost to Follow-up|1|||
157140841|NCT01331161|567261094|FG000|Overall Study|Pregnancy|0|||
157140842|NCT01331161|567261095|FG001|Overall Study|Pregnancy|1|||
157140843|NCT03528681|567263350|FG000|Open-Label Phase|Physician Decision|2|||
157140844|NCT03528681|567263351|FG001|Open-Label Phase|Physician Decision|0|||
157140845|NCT03528681|567263352|FG002|Open-Label Phase|Physician Decision|0|||
157140846|NCT03528681|567263353|FG003|Open-Label Phase|Physician Decision|0|||
156734652|NCT00425061|565776438|FG001|Overall Study|Other|0|||
156734653|NCT00425061|565776439|FG002|Overall Study|Other|0|||
157140847|NCT03528681|567263350|FG000|Open-Label Phase|Withdrawal by Subject|8|||
157140848|NCT03528681|567263351|FG001|Open-Label Phase|Withdrawal by Subject|0|||
157140849|NCT03528681|567263352|FG002|Open-Label Phase|Withdrawal by Subject|0|||
157140850|NCT03528681|567263353|FG003|Open-Label Phase|Withdrawal by Subject|0|||
157140851|NCT03528681|567263350|FG000|Open-Label Phase|(Not collected)|4|||
156734654|NCT00425061|565776440|FG003|Overall Study|Other|0|||
157217746|NCT01473758|567543273|FG003|Cycle 1|Adverse Event|0|||
157217747|NCT01473758|567543270|FG000|Cycle 1|Withdrawal by Subject|1|||
157217748|NCT01473758|567543271|FG001|Cycle 1|Withdrawal by Subject|1|||
157217749|NCT01473758|567543272|FG002|Cycle 1|Withdrawal by Subject|0|||
157217750|NCT01473758|567543273|FG003|Cycle 1|Withdrawal by Subject|0|||
157217751|NCT01473758|567543270|FG000|Cycle 2|Adverse Event|0|||
157217752|NCT01473758|567543271|FG001|Cycle 2|Adverse Event|0|||
157217753|NCT01473758|567543272|FG002|Cycle 2|Adverse Event|5|||
157217754|NCT01473758|567543273|FG003|Cycle 2|Adverse Event|0|||
157217755|NCT02763579|567543283|FG000|Global Period|Death|167|||
157217756|NCT02763579|567543284|FG001|Global Period|Death|151|||
157217757|NCT02763579|567543285|FG002|Global Period|Death|0|||
157217758|NCT02763579|567543286|FG003|Global Period|Death|0|||
157217759|NCT02763579|567543283|FG000|Global Period|Lost to Follow-up|2|||
157217760|NCT02763579|567543284|FG001|Global Period|Lost to Follow-up|4|||
157217761|NCT02763579|567543285|FG002|Global Period|Lost to Follow-up|0|||
157217762|NCT02763579|567543286|FG003|Global Period|Lost to Follow-up|0|||
157217763|NCT02763579|567543283|FG000|Global Period|Physician Decision|0|||
157217764|NCT02763579|567543284|FG001|Global Period|Physician Decision|2|||
157217765|NCT02763579|567543285|FG002|Global Period|Physician Decision|0|||
157217766|NCT02763579|567543286|FG003|Global Period|Physician Decision|0|||
157140852|NCT03528681|567263351|FG001|Open-Label Phase|(Not collected)|0|||
157140853|NCT03528681|567263352|FG002|Open-Label Phase|(Not collected)|0|||
157140854|NCT03528681|567263353|FG003|Open-Label Phase|(Not collected)|0|||
157140855|NCT03528681|567263350|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
157140856|NCT03528681|567263351|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
157140857|NCT03528681|567263352|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
157140858|NCT03528681|567263353|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
157140859|NCT03528681|567263350|FG000|Randomized Treatment Phase|Physician Decision|0|||
157140860|NCT03528681|567263351|FG001|Randomized Treatment Phase|Physician Decision|5|||
157140861|NCT03528681|567263352|FG002|Randomized Treatment Phase|Physician Decision|1|||
157140862|NCT03528681|567263353|FG003|Randomized Treatment Phase|Physician Decision|2|||
157140863|NCT03528681|567263350|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
157140864|NCT03528681|567263351|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
157140865|NCT03528681|567263352|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
157140866|NCT03528681|567263353|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
157140867|NCT03528681|567263350|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
157140868|NCT03528681|567263351|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
157140869|NCT03528681|567263352|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
157140870|NCT03528681|567263353|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
157140871|NCT03528681|567263350|FG000|Randomized Treatment Phase|(Not collected)|0|||
157140872|NCT03528681|567263351|FG001|Randomized Treatment Phase|(Not collected)|4|||
157140873|NCT03528681|567263352|FG002|Randomized Treatment Phase|(Not collected)|6|||
157140874|NCT03528681|567263353|FG003|Randomized Treatment Phase|(Not collected)|5|||
157140875|NCT02017444|567263358|FG000|Overall Study|Physician Decision|1|||
157140876|NCT02017444|567263359|FG001|Overall Study|Physician Decision|0|||
157140877|NCT02017444|567263358|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
157140878|NCT02017444|567263359|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
157140879|NCT03816995|567263364|FG000|Overall Study|Withdrawal by Subject|3|||
157140880|NCT03816995|567263365|FG001|Overall Study|Withdrawal by Subject|1|||
157140881|NCT03816995|567263364|FG000|Overall Study|Cancelled Surgery|8|||
157140882|NCT03816995|567263365|FG001|Overall Study|Cancelled Surgery|12|||
157140883|NCT03816995|567263364|FG000|Overall Study|No wound protector used|11|||
157140884|NCT03816995|567263365|FG001|Overall Study|No wound protector used|17|||
157140885|NCT03816995|567263364|FG000|Overall Study|Protocol Violation|2|||
157140886|NCT03816995|567263365|FG001|Overall Study|Protocol Violation|3|||
157140887|NCT03596164|567263368|FG000|Overall Study|Adverse Event|0|||
157140888|NCT03596164|567263369|FG001|Overall Study|Adverse Event|1|||
157140889|NCT03596164|567263368|FG000|Overall Study|Death|1|||
157140890|NCT03596164|567263369|FG001|Overall Study|Death|0|||
157140891|NCT00389207|567263370|FG000|Overall Study|Adverse Event|26|||
157140892|NCT00389207|567263371|FG001|Overall Study|Adverse Event|32|||
157140893|NCT00389207|567263372|FG002|Overall Study|Adverse Event|10|||
157217767|NCT02763579|567543283|FG000|Global Period|Study Terminated By Sponsor|21|||
157217768|NCT02763579|567543284|FG001|Global Period|Study Terminated By Sponsor|26|||
157140894|NCT00389207|567263370|FG000|Overall Study|Protocol Violation|3|||
157140895|NCT00389207|567263371|FG001|Overall Study|Protocol Violation|1|||
157140896|NCT00389207|567263372|FG002|Overall Study|Protocol Violation|4|||
157217769|NCT02763579|567543285|FG002|Global Period|Study Terminated By Sponsor|0|||
157217770|NCT02763579|567543286|FG003|Global Period|Study Terminated By Sponsor|0|||
157217771|NCT02763579|567543283|FG000|Global Period|Withdrawal by Subject|12|||
157217772|NCT02763579|567543284|FG001|Global Period|Withdrawal by Subject|18|||
157217773|NCT02763579|567543285|FG002|Global Period|Withdrawal by Subject|0|||
157217774|NCT02763579|567543286|FG003|Global Period|Withdrawal by Subject|0|||
157217775|NCT02763579|567543283|FG000|China Period|Death|0|||
157217776|NCT02763579|567543284|FG001|China Period|Death|0|||
157020148|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157140897|NCT00389207|567263370|FG000|Overall Study|Lost to Follow-up|12|||
157140898|NCT00389207|567263371|FG001|Overall Study|Lost to Follow-up|9|||
157140899|NCT00389207|567263372|FG002|Overall Study|Lost to Follow-up|7|||
157140900|NCT00389207|567263370|FG000|Overall Study|Withdrawal by Subject|5|||
157140901|NCT00389207|567263371|FG001|Overall Study|Withdrawal by Subject|7|||
157140902|NCT00389207|567263372|FG002|Overall Study|Withdrawal by Subject|11|||
157140903|NCT00389207|567263370|FG000|Overall Study|Other|17|||
157140904|NCT00389207|567263371|FG001|Overall Study|Other|23|||
157140905|NCT00389207|567263372|FG002|Overall Study|Other|9|||
157140906|NCT01772134|567263380|FG000|Overall Study|Adverse Event|6|||
157140907|NCT01772134|567263381|FG001|Overall Study|Adverse Event|5|||
157140908|NCT01772134|567263382|FG002|Overall Study|Adverse Event|10|||
157140909|NCT01772134|567263380|FG000|Overall Study|Withdrew Consent|3|||
157140910|NCT01772134|567263381|FG001|Overall Study|Withdrew Consent|1|||
157140911|NCT01772134|567263382|FG002|Overall Study|Withdrew Consent|5|||
157140912|NCT01772134|567263380|FG000|Overall Study|Lost to Follow-up|2|||
157140913|NCT01772134|567263381|FG001|Overall Study|Lost to Follow-up|0|||
157140914|NCT01772134|567263382|FG002|Overall Study|Lost to Follow-up|0|||
157140915|NCT01772134|567263380|FG000|Overall Study|Protocol Deviation|4|||
157140916|NCT01772134|567263381|FG001|Overall Study|Protocol Deviation|3|||
157140917|NCT01772134|567263382|FG002|Overall Study|Protocol Deviation|3|||
157140918|NCT01772134|567263380|FG000|Overall Study|Lack of Efficacy|11|||
157140919|NCT01772134|567263381|FG001|Overall Study|Lack of Efficacy|5|||
157140920|NCT01772134|567263382|FG002|Overall Study|Lack of Efficacy|3|||
157140921|NCT01772134|567263380|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
157140922|NCT01772134|567263381|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
157140923|NCT01772134|567263382|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
157140924|NCT01772134|567263380|FG000|Overall Study|Randomized Study Medication Not Received|2|||
157140925|NCT01772134|567263381|FG001|Overall Study|Randomized Study Medication Not Received|0|||
157140926|NCT01772134|567263382|FG002|Overall Study|Randomized Study Medication Not Received|1|||
157140927|NCT02500550|567263383|FG000|Overall Study|Death|7|||
157140928|NCT03293680|567263388|FG000|Overall Study|Death|1|||
157140929|NCT03293680|567263388|FG000|Overall Study|Did not meet inclusion criteria|8|||
157140930|NCT00636818|567263389|FG000|Overall Study|Adverse Event|1|||
157140931|NCT00636818|567263389|FG000|Overall Study|Lost to Follow-up|2|||
157140932|NCT00636818|567263389|FG000|Overall Study|Entry Criteria Exclusion|3|||
157140933|NCT00636818|567263389|FG000|Overall Study|Protocol Violation|1|||
157140934|NCT00636818|567263389|FG000|Overall Study|Withdrawal by Subject|4|||
157140935|NCT02604264|567263392|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
157140936|NCT02604264|567263393|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
157140937|NCT03192904|567263395|FG000|Overall Study|Physician Decision|3|||
157140938|NCT03192904|567263396|FG001|Overall Study|Physician Decision|1|||
157140939|NCT03192904|567263395|FG000|Overall Study|Lost to Follow-up|0|||
157140940|NCT03192904|567263396|FG001|Overall Study|Lost to Follow-up|1|||
157140941|NCT00424398|567263397|FG000|Overall Study|Withdrawal by Subject|2|||
157140942|NCT00424398|567263398|FG001|Overall Study|Withdrawal by Subject|1|||
157140943|NCT00424398|567263399|FG002|Overall Study|Withdrawal by Subject|0|||
157140944|NCT00424398|567263397|FG000|Overall Study|Subject met exclusion criteria|1|||
156734655|NCT00425061|565776441|FG004|Overall Study|Other|3|||
156734656|NCT00425061|565776442|FG005|Overall Study|Other|0|||
156734657|NCT00425061|565776443|FG006|Overall Study|Other|1|||
157140945|NCT00424398|567263398|FG001|Overall Study|Subject met exclusion criteria|0|||
157140946|NCT00424398|567263399|FG002|Overall Study|Subject met exclusion criteria|0|||
157140947|NCT01023789|567263400|FG000|3 - Year Visit|Death|29|||
157140948|NCT01023789|567263400|FG000|3 - Year Visit|Withdrawal of consent|1|||
156734658|NCT03436693|565776444|FG000|Overall Study|Adverse Event|22|||
156734659|NCT03436693|565776445|FG001|Overall Study|Adverse Event|10|||
156734660|NCT03436693|565776444|FG000|Overall Study|Physician Decision|3|||
156734661|NCT03436693|565776445|FG001|Overall Study|Physician Decision|3|||
156734662|NCT03436693|565776444|FG000|Overall Study|Withdrawal by Subject|4|||
156734663|NCT03436693|565776445|FG001|Overall Study|Withdrawal by Subject|13|||
156734664|NCT03436693|565776444|FG000|Overall Study|Progressive Disease|1|||
156734665|NCT03436693|565776445|FG001|Overall Study|Progressive Disease|1|||
156734666|NCT05835011|565776446|FG000|Overall Study|Study Terminated by the Sponsor|1|||
156734667|NCT05835011|565776446|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
156734668|NCT00626821|565776449|FG000|Overall Study|Adverse Event|44|||
156734669|NCT00626821|565776449|FG000|Overall Study|Protocol Violation|33|||
156734670|NCT00626821|565776449|FG000|Overall Study|Withdrawal by Subject|10|||
157217777|NCT02763579|567543285|FG002|China Period|Death|46|||
156734671|NCT00626821|565776449|FG000|Overall Study|Physician Decision|9|||
157140949|NCT01023789|567263400|FG000|3 - Year Visit|Lost to Follow-up|13|||
157140950|NCT02115308|567263409|FG000|Overall Study|Safety Screening|2|||
157140951|NCT02115308|567263410|FG001|Overall Study|Safety Screening|2|||
157140952|NCT01309737|567263411|FG000|Week 0 to 16|Death|1|||
157140953|NCT01309737|567263412|FG001|Week 0 to 16|Death|0|||
157140954|NCT01309737|567263413|FG002|Week 0 to 16|Death|1|||
156734672|NCT00626821|565776449|FG000|Overall Study|Product dysfunction|21|||
157140955|NCT01309737|567263414|FG003|Week 0 to 16|Death|0|||
157140956|NCT01309737|567263415|FG004|Week 0 to 16|Death|0|||
157140957|NCT01309737|567263411|FG000|Week 0 to 16|Adverse Event|11|||
157140958|NCT01309737|567263412|FG001|Week 0 to 16|Adverse Event|10|||
157140959|NCT01309737|567263413|FG002|Week 0 to 16|Adverse Event|5|||
157140960|NCT01309737|567263414|FG003|Week 0 to 16|Adverse Event|0|||
157140961|NCT01309737|567263415|FG004|Week 0 to 16|Adverse Event|0|||
157140962|NCT01309737|567263411|FG000|Week 0 to 16|Lack of Efficacy|15|||
157140963|NCT01309737|567263412|FG001|Week 0 to 16|Lack of Efficacy|2|||
157140964|NCT01309737|567263413|FG002|Week 0 to 16|Lack of Efficacy|24|||
157140965|NCT01309737|567263414|FG003|Week 0 to 16|Lack of Efficacy|0|||
157140966|NCT01309737|567263415|FG004|Week 0 to 16|Lack of Efficacy|0|||
157140967|NCT01309737|567263411|FG000|Week 0 to 16|Lost to Follow-up|7|||
157140968|NCT01309737|567263412|FG001|Week 0 to 16|Lost to Follow-up|8|||
157140969|NCT01309737|567263413|FG002|Week 0 to 16|Lost to Follow-up|3|||
157140970|NCT01309737|567263414|FG003|Week 0 to 16|Lost to Follow-up|0|||
157140971|NCT01309737|567263415|FG004|Week 0 to 16|Lost to Follow-up|0|||
157140972|NCT01309737|567263411|FG000|Week 0 to 16|Withdrawal by Subject|7|||
157140973|NCT01309737|567263412|FG001|Week 0 to 16|Withdrawal by Subject|6|||
157140974|NCT01309737|567263413|FG002|Week 0 to 16|Withdrawal by Subject|7|||
157140975|NCT01309737|567263414|FG003|Week 0 to 16|Withdrawal by Subject|0|||
157140976|NCT01309737|567263415|FG004|Week 0 to 16|Withdrawal by Subject|0|||
157140977|NCT01309737|567263411|FG000|Week 0 to 16|Other|10|||
157140978|NCT01309737|567263412|FG001|Week 0 to 16|Other|14|||
157140979|NCT01309737|567263413|FG002|Week 0 to 16|Other|4|||
157140980|NCT01309737|567263414|FG003|Week 0 to 16|Other|0|||
157140981|NCT01309737|567263415|FG004|Week 0 to 16|Other|0|||
157140982|NCT01309737|567263411|FG000|Week 0 to 16|Randomized, but not treated|1|||
157140983|NCT01309737|567263412|FG001|Week 0 to 16|Randomized, but not treated|0|||
157140984|NCT01309737|567263413|FG002|Week 0 to 16|Randomized, but not treated|0|||
157140985|NCT01309737|567263414|FG003|Week 0 to 16|Randomized, but not treated|0|||
157140986|NCT01309737|567263415|FG004|Week 0 to 16|Randomized, but not treated|0|||
157140987|NCT01309737|567263411|FG000|Week 16 to 52|Death|0|||
157140988|NCT01309737|567263412|FG001|Week 16 to 52|Death|0|||
157140989|NCT01309737|567263413|FG002|Week 16 to 52|Death|0|||
157140990|NCT01309737|567263414|FG003|Week 16 to 52|Death|0|||
157140991|NCT01309737|567263415|FG004|Week 16 to 52|Death|1|||
157140992|NCT01309737|567263411|FG000|Week 16 to 52|Adverse Event|7|||
157140993|NCT01309737|567263412|FG001|Week 16 to 52|Adverse Event|7|||
157140994|NCT01309737|567263413|FG002|Week 16 to 52|Adverse Event|0|||
157140995|NCT01309737|567263414|FG003|Week 16 to 52|Adverse Event|6|||
157140996|NCT01309737|567263415|FG004|Week 16 to 52|Adverse Event|5|||
157140997|NCT01309737|567263411|FG000|Week 16 to 52|Lack of Efficacy|107|||
157140998|NCT01309737|567263412|FG001|Week 16 to 52|Lack of Efficacy|76|||
157140999|NCT01309737|567263413|FG002|Week 16 to 52|Lack of Efficacy|0|||
157141000|NCT01309737|567263414|FG003|Week 16 to 52|Lack of Efficacy|25|||
157141001|NCT01309737|567263415|FG004|Week 16 to 52|Lack of Efficacy|21|||
157141002|NCT01309737|567263411|FG000|Week 16 to 52|Lost to Follow-up|4|||
157141003|NCT01309737|567263412|FG001|Week 16 to 52|Lost to Follow-up|2|||
157141004|NCT01309737|567263413|FG002|Week 16 to 52|Lost to Follow-up|0|||
157141005|NCT01309737|567263414|FG003|Week 16 to 52|Lost to Follow-up|1|||
157141006|NCT01309737|567263415|FG004|Week 16 to 52|Lost to Follow-up|4|||
157141007|NCT01309737|567263411|FG000|Week 16 to 52|Withdrawal by Subject|5|||
157141008|NCT01309737|567263412|FG001|Week 16 to 52|Withdrawal by Subject|6|||
157141009|NCT01309737|567263413|FG002|Week 16 to 52|Withdrawal by Subject|0|||
157141010|NCT01309737|567263414|FG003|Week 16 to 52|Withdrawal by Subject|0|||
157141011|NCT01309737|567263415|FG004|Week 16 to 52|Withdrawal by Subject|2|||
157141012|NCT01309737|567263411|FG000|Week 16 to 52|Other|10|||
157141013|NCT01309737|567263412|FG001|Week 16 to 52|Other|12|||
157141014|NCT01309737|567263413|FG002|Week 16 to 52|Other|0|||
157141015|NCT01309737|567263414|FG003|Week 16 to 52|Other|2|||
156734673|NCT00626821|565776449|FG000|Overall Study|other/unknown reason|104|||
157141016|NCT01309737|567263415|FG004|Week 16 to 52|Other|0|||
157141017|NCT01442181|567263423|FG000|Overall Study|patient refused surgery|1|||
157141018|NCT01442181|567263424|FG001|Overall Study|patient refused surgery|0|||
157141019|NCT01442181|567263423|FG000|Overall Study|no insurance for surgery|1|||
157141020|NCT01442181|567263424|FG001|Overall Study|no insurance for surgery|0|||
157141021|NCT01442181|567263423|FG000|Overall Study|low ejection factor|0|||
157141022|NCT01442181|567263424|FG001|Overall Study|low ejection factor|1|||
157141023|NCT01442181|567263423|FG000|Overall Study|Lost to Follow-up|1|||
157141024|NCT01442181|567263424|FG001|Overall Study|Lost to Follow-up|1|||
157141025|NCT01442181|567263423|FG000|Overall Study|patient in an additional study|1|||
157141026|NCT01442181|567263424|FG001|Overall Study|patient in an additional study|0|||
157141027|NCT01442181|567263423|FG000|Overall Study|atrial fibrillation not noted|0|||
157141028|NCT01442181|567263424|FG001|Overall Study|atrial fibrillation not noted|1|||
157141029|NCT00749203|567263425|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
157141030|NCT00749203|567263426|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
157141031|NCT00749203|567263425|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
157141032|NCT00749203|567263426|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
157141033|NCT00749203|567263425|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
157141034|NCT00749203|567263426|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
157141035|NCT00749203|567263425|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
157141036|NCT00749203|567263426|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
157141037|NCT00749203|567263425|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
157141038|NCT00749203|567263426|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
157141039|NCT00749203|567263425|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
157141040|NCT00749203|567263426|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
157141041|NCT02034123|567263427|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141042|NCT02034123|567263428|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141043|NCT02034123|567263429|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141044|NCT02034123|567263430|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141045|NCT02034123|567263431|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
157141046|NCT02034123|567263432|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141047|NCT02034123|567263433|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141048|NCT02034123|567263434|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
157141049|NCT02034123|567263435|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
157141050|NCT02034123|567263436|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141051|NCT02034123|567263437|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141052|NCT02034123|567263438|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141053|NCT02034123|567263439|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141054|NCT02034123|567263440|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141055|NCT02034123|567263441|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141056|NCT02034123|567263442|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141057|NCT02034123|567263443|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
156734674|NCT01981954|565776453|FG000|Titration Period|Protocol Deviation|1|||
156734675|NCT01981954|565776453|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
156734676|NCT04016779|565776455|FG000|Overall Study|Adverse Event|9|||
156734677|NCT04016779|565776456|FG001|Overall Study|Adverse Event|17|||
157141058|NCT02034123|567263444|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
157141059|NCT02034123|567263427|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141060|NCT02034123|567263428|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141061|NCT02034123|567263429|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141062|NCT02034123|567263430|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
157141063|NCT02034123|567263431|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
156734678|NCT04016779|565776455|FG000|Overall Study|Lack of Efficacy|4|||
156734679|NCT04016779|565776456|FG001|Overall Study|Lack of Efficacy|1|||
156734680|NCT04016779|565776455|FG000|Overall Study|Lost to Follow-up|5|||
156734681|NCT04016779|565776456|FG001|Overall Study|Lost to Follow-up|14|||
156734682|NCT04016779|565776455|FG000|Overall Study|Physician Decision|1|||
156734683|NCT04016779|565776456|FG001|Overall Study|Physician Decision|3|||
156734684|NCT04016779|565776455|FG000|Overall Study|Withdrawal by Subject|6|||
156734685|NCT04016779|565776456|FG001|Overall Study|Withdrawal by Subject|8|||
156734686|NCT04016779|565776455|FG000|Overall Study|Non-compliance with Study Drug|2|||
156734687|NCT04016779|565776456|FG001|Overall Study|Non-compliance with Study Drug|3|||
156734688|NCT04016779|565776455|FG000|Overall Study|Other, Multiple categories|17|||
156734689|NCT04016779|565776456|FG001|Overall Study|Other, Multiple categories|17|||
156734690|NCT00623935|565776457|FG000|Overall Study|Death|1|||
156734691|NCT00623935|565776457|FG000|Overall Study|Patient Declined Transplant|1|||
156734692|NCT03315286|565776458|FG000|Overall Study|Lost to Follow-up|0|||
156734693|NCT03315286|565776459|FG001|Overall Study|Lost to Follow-up|3|||
156734694|NCT03315286|565776458|FG000|Overall Study|Withdrawal by Subject|1|||
156734695|NCT03315286|565776459|FG001|Overall Study|Withdrawal by Subject|0|||
156734696|NCT03315286|565776458|FG000|Overall Study|Protocol Violation|0|||
156734697|NCT03315286|565776459|FG001|Overall Study|Protocol Violation|1|||
156734698|NCT02828124|565776460|FG000|Overall Study|Disease Progression|1|||
156734699|NCT02828124|565776461|FG001|Overall Study|Disease Progression|2|||
156734700|NCT02828124|565776462|FG002|Overall Study|Disease Progression|1|||
156734701|NCT02828124|565776463|FG003|Overall Study|Disease Progression|4|||
156734702|NCT02828124|565776460|FG000|Overall Study|AE Unrelated to Study Drug|0|||
156734703|NCT02828124|565776461|FG001|Overall Study|AE Unrelated to Study Drug|0|||
156734704|NCT02828124|565776462|FG002|Overall Study|AE Unrelated to Study Drug|0|||
156734705|NCT02828124|565776463|FG003|Overall Study|AE Unrelated to Study Drug|1|||
156734706|NCT02828124|565776460|FG000|Overall Study|Subject Withdrew Consent|0|||
156734707|NCT02828124|565776461|FG001|Overall Study|Subject Withdrew Consent|0|||
156734708|NCT02828124|565776462|FG002|Overall Study|Subject Withdrew Consent|0|||
156734709|NCT02828124|565776463|FG003|Overall Study|Subject Withdrew Consent|1|||
156734710|NCT00747474|565776464|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734711|NCT00747474|565776465|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734712|NCT00747474|565776466|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734713|NCT00747474|565776467|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734714|NCT00747474|565776468|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
157217778|NCT02763579|567543286|FG003|China Period|Death|48|||
157217779|NCT02763579|567543283|FG000|China Period|Lost to Follow-up|0|||
157217780|NCT02763579|567543284|FG001|China Period|Lost to Follow-up|0|||
157217781|NCT02763579|567543285|FG002|China Period|Lost to Follow-up|1|||
157217782|NCT02763579|567543286|FG003|China Period|Lost to Follow-up|1|||
157217783|NCT02763579|567543283|FG000|China Period|Physician Decision|0|||
157217784|NCT02763579|567543284|FG001|China Period|Physician Decision|0|||
157217785|NCT02763579|567543285|FG002|China Period|Physician Decision|0|||
156734715|NCT00747474|565776469|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734716|NCT00747474|565776470|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734717|NCT00747474|565776471|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
156734718|NCT00747474|565776472|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734719|NCT00747474|565776473|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734720|NCT00747474|565776474|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734721|NCT00747474|565776475|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
156734722|NCT02829723|565776477|FG000|Overall Study|Adverse Event|0|||
156734723|NCT02829723|565776478|FG001|Overall Study|Adverse Event|0|||
156734724|NCT02829723|565776479|FG002|Overall Study|Adverse Event|1|||
156734725|NCT02829723|565776480|FG003|Overall Study|Adverse Event|1|||
156734726|NCT02829723|565776481|FG004|Overall Study|Adverse Event|0|||
156734727|NCT02829723|565776482|FG005|Overall Study|Adverse Event|0|||
156734728|NCT02829723|565776483|FG006|Overall Study|Adverse Event|0|||
156734729|NCT02829723|565776484|FG007|Overall Study|Adverse Event|1|||
156734730|NCT02829723|565776485|FG008|Overall Study|Adverse Event|0|||
156734731|NCT02829723|565776486|FG009|Overall Study|Adverse Event|0|||
156734732|NCT02829723|565776487|FG010|Overall Study|Adverse Event|0|||
156734733|NCT02829723|565776488|FG011|Overall Study|Adverse Event|0|||
156734734|NCT02829723|565776489|FG012|Overall Study|Adverse Event|0|||
156734735|NCT02829723|565776490|FG013|Overall Study|Adverse Event|0|||
157141064|NCT02034123|567263432|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141065|NCT02034123|567263433|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141066|NCT02034123|567263434|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141067|NCT02034123|567263435|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141068|NCT02034123|567263436|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141069|NCT02034123|567263437|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141070|NCT02034123|567263438|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141071|NCT02034123|567263439|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141072|NCT02034123|567263440|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141073|NCT02034123|567263441|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141074|NCT02034123|567263442|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141075|NCT02034123|567263443|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141076|NCT02034123|567263444|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
157141077|NCT02034123|567263427|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141078|NCT02034123|567263428|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141079|NCT02034123|567263429|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141080|NCT02034123|567263430|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141081|NCT02034123|567263431|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141082|NCT02034123|567263432|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141083|NCT02034123|567263433|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141084|NCT02034123|567263434|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141085|NCT02034123|567263435|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
157141086|NCT02034123|567263436|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141087|NCT02034123|567263437|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141088|NCT02034123|567263438|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141089|NCT02034123|567263439|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141090|NCT02034123|567263440|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141091|NCT02034123|567263441|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141092|NCT02034123|567263442|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141093|NCT02034123|567263443|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141094|NCT02034123|567263444|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
157141095|NCT02034123|567263427|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157217786|NCT02763579|567543286|FG003|China Period|Physician Decision|1|||
157217787|NCT02763579|567543283|FG000|China Period|Study Terminated By Sponsor|0|||
156734736|NCT02829723|565776491|FG014|Overall Study|Adverse Event|1|||
156734737|NCT02829723|565776492|FG015|Overall Study|Adverse Event|1|||
156734738|NCT02829723|565776493|FG016|Overall Study|Adverse Event|1|||
156734739|NCT02829723|565776494|FG017|Overall Study|Adverse Event|2|||
156734740|NCT02829723|565776495|FG018|Overall Study|Adverse Event|1|||
157217788|NCT02763579|567543284|FG001|China Period|Study Terminated By Sponsor|0|||
157217789|NCT02763579|567543285|FG002|China Period|Study Terminated By Sponsor|3|||
157217790|NCT02763579|567543286|FG003|China Period|Study Terminated By Sponsor|4|||
157217791|NCT02763579|567543283|FG000|China Period|Withdrawal by Subject|0|||
157217792|NCT02763579|567543284|FG001|China Period|Withdrawal by Subject|0|||
157217793|NCT02763579|567543285|FG002|China Period|Withdrawal by Subject|3|||
157217794|NCT02763579|567543286|FG003|China Period|Withdrawal by Subject|3|||
157217795|NCT01034137|567543291|FG000|Overall Study|Adverse Event|9|||
157217796|NCT01034137|567543292|FG001|Overall Study|Adverse Event|10|||
157217797|NCT01034137|567543293|FG002|Overall Study|Adverse Event|8|||
157217798|NCT01034137|567543291|FG000|Overall Study|Withdrawal by Subject|4|||
156734741|NCT02829723|565776496|FG019|Overall Study|Adverse Event|1|||
156734742|NCT02829723|565776497|FG020|Overall Study|Adverse Event|3|||
156734743|NCT02829723|565776498|FG021|Overall Study|Adverse Event|0|||
156734744|NCT02829723|565776499|FG022|Overall Study|Adverse Event|0|||
156734745|NCT02829723|565776500|FG023|Overall Study|Adverse Event|1|||
156734746|NCT02829723|565776501|FG024|Overall Study|Adverse Event|1|||
156734747|NCT02829723|565776502|FG025|Overall Study|Adverse Event|3|||
156734748|NCT02829723|565776503|FG026|Overall Study|Adverse Event|5|||
156734749|NCT02829723|565776477|FG000|Overall Study|Death|1|||
156734750|NCT02829723|565776478|FG001|Overall Study|Death|0|||
156734751|NCT02829723|565776479|FG002|Overall Study|Death|1|||
156734752|NCT02829723|565776480|FG003|Overall Study|Death|1|||
156734753|NCT02829723|565776481|FG004|Overall Study|Death|0|||
156734754|NCT02829723|565776482|FG005|Overall Study|Death|0|||
156734755|NCT02829723|565776483|FG006|Overall Study|Death|2|||
156734756|NCT02829723|565776484|FG007|Overall Study|Death|0|||
156734757|NCT02829723|565776485|FG008|Overall Study|Death|1|||
156734758|NCT02829723|565776486|FG009|Overall Study|Death|0|||
156734759|NCT02829723|565776487|FG010|Overall Study|Death|0|||
156734760|NCT02829723|565776488|FG011|Overall Study|Death|0|||
156734761|NCT02829723|565776489|FG012|Overall Study|Death|2|||
156734762|NCT02829723|565776490|FG013|Overall Study|Death|1|||
156734763|NCT02829723|565776491|FG014|Overall Study|Death|0|||
156734764|NCT02829723|565776492|FG015|Overall Study|Death|0|||
156734765|NCT02829723|565776493|FG016|Overall Study|Death|0|||
156734766|NCT02829723|565776494|FG017|Overall Study|Death|0|||
156734767|NCT02829723|565776495|FG018|Overall Study|Death|0|||
156734768|NCT02829723|565776496|FG019|Overall Study|Death|0|||
156734769|NCT02829723|565776497|FG020|Overall Study|Death|0|||
156734770|NCT02829723|565776498|FG021|Overall Study|Death|2|||
156734771|NCT02829723|565776499|FG022|Overall Study|Death|0|||
156734772|NCT02829723|565776500|FG023|Overall Study|Death|0|||
156734773|NCT02829723|565776501|FG024|Overall Study|Death|0|||
157217799|NCT01034137|567543292|FG001|Overall Study|Withdrawal by Subject|3|||
157217800|NCT01034137|567543293|FG002|Overall Study|Withdrawal by Subject|3|||
157217801|NCT01034137|567543291|FG000|Overall Study|Lack of Efficacy|9|||
157217802|NCT01034137|567543292|FG001|Overall Study|Lack of Efficacy|4|||
157217803|NCT01034137|567543293|FG002|Overall Study|Lack of Efficacy|13|||
157217804|NCT01034137|567543291|FG000|Overall Study|Protocol Violation|2|||
157217805|NCT01034137|567543292|FG001|Overall Study|Protocol Violation|2|||
157217806|NCT01034137|567543293|FG002|Overall Study|Protocol Violation|1|||
157217807|NCT01034137|567543291|FG000|Overall Study|Refused treatment or did not cooperate|2|||
157217808|NCT01034137|567543292|FG001|Overall Study|Refused treatment or did not cooperate|0|||
157217809|NCT01034137|567543293|FG002|Overall Study|Refused treatment or did not cooperate|1|||
157217810|NCT01034137|567543291|FG000|Overall Study|Administrative or other|2|||
157217811|NCT01034137|567543292|FG001|Overall Study|Administrative or other|3|||
157217812|NCT01034137|567543293|FG002|Overall Study|Administrative or other|4|||
156734774|NCT02829723|565776502|FG025|Overall Study|Death|1|||
156734775|NCT02829723|565776503|FG026|Overall Study|Death|2|||
156734776|NCT02829723|565776477|FG000|Overall Study|Physician Decision|0|||
157020149|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156734777|NCT02829723|565776478|FG001|Overall Study|Physician Decision|0|||
156734778|NCT02829723|565776479|FG002|Overall Study|Physician Decision|0|||
156734779|NCT02829723|565776480|FG003|Overall Study|Physician Decision|0|||
156796842|NCT00725985|566009680|FG009|ITP- Treatment Disposition|Other|0|||
157020150|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
156734780|NCT02829723|565776481|FG004|Overall Study|Physician Decision|0|||
156734781|NCT02829723|565776482|FG005|Overall Study|Physician Decision|0|||
156734782|NCT02829723|565776483|FG006|Overall Study|Physician Decision|0|||
156734783|NCT02829723|565776484|FG007|Overall Study|Physician Decision|0|||
156734784|NCT02829723|565776485|FG008|Overall Study|Physician Decision|0|||
156734785|NCT02829723|565776486|FG009|Overall Study|Physician Decision|1|||
156734786|NCT02829723|565776487|FG010|Overall Study|Physician Decision|1|||
156734787|NCT02829723|565776488|FG011|Overall Study|Physician Decision|0|||
156734788|NCT02829723|565776489|FG012|Overall Study|Physician Decision|0|||
157217813|NCT03572933|567543294|FG000|Overall Study|Adverse Event|4|||
157217814|NCT03572933|567543295|FG001|Overall Study|Adverse Event|1|||
157217815|NCT03572933|567543294|FG000|Overall Study|Withdrawal by Subject|0|||
157217816|NCT03572933|567543295|FG001|Overall Study|Withdrawal by Subject|1|||
157217817|NCT01764854|567543299|FG000|Overall Study|Adverse Event|0|||
156734789|NCT02829723|565776490|FG013|Overall Study|Physician Decision|1|||
156734790|NCT02829723|565776491|FG014|Overall Study|Physician Decision|0|||
156734791|NCT02829723|565776492|FG015|Overall Study|Physician Decision|0|||
156734792|NCT02829723|565776493|FG016|Overall Study|Physician Decision|2|||
156734793|NCT02829723|565776494|FG017|Overall Study|Physician Decision|0|||
156734794|NCT02829723|565776495|FG018|Overall Study|Physician Decision|0|||
156876667|NCT02052414|566307675|FG000|Overall Study|Lack of Efficacy|2|||
156876668|NCT02052414|566307675|FG000|Overall Study|Withdrawal by Subject|3|||
156876669|NCT05367492|566307681|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
156876670|NCT05367492|566307682|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
156876671|NCT05367492|566307683|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
156876672|NCT05367492|566307681|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
156876673|NCT05367492|566307682|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
156876674|NCT05367492|566307683|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
156876675|NCT05367492|566307681|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
156876676|NCT05367492|566307682|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
156876677|NCT05367492|566307683|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
156876678|NCT05367492|566307681|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
157141096|NCT02034123|567263428|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141097|NCT02034123|567263429|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141098|NCT02034123|567263430|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
157141099|NCT02034123|567263431|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
157141100|NCT02034123|567263432|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141101|NCT02034123|567263433|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141102|NCT02034123|567263434|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141103|NCT02034123|567263435|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141104|NCT02034123|567263436|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141105|NCT02034123|567263437|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141106|NCT02034123|567263438|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141107|NCT02034123|567263439|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141108|NCT02034123|567263440|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141109|NCT02034123|567263441|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141110|NCT02034123|567263442|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141111|NCT02034123|567263443|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141112|NCT02034123|567263444|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
157141113|NCT00246259|567263445|FG000|Overall Study|Other|3|||
157141114|NCT00246259|567263446|FG001|Overall Study|Other|3|||
157141115|NCT00246259|567263445|FG000|Overall Study|Not stable by Week 18|2|||
157141116|NCT00246259|567263446|FG001|Overall Study|Not stable by Week 18|1|||
157141117|NCT00246259|567263445|FG000|Overall Study|Participant non-compliant|4|||
157141118|NCT00246259|567263446|FG001|Overall Study|Participant non-compliant|9|||
157141119|NCT00246259|567263445|FG000|Overall Study|Lack of Efficacy|2|||
157141120|NCT00246259|567263446|FG001|Overall Study|Lack of Efficacy|2|||
157141121|NCT00246259|567263445|FG000|Overall Study|Investigator withdrew participant|2|||
157141122|NCT00246259|567263446|FG001|Overall Study|Investigator withdrew participant|0|||
157141123|NCT00246259|567263445|FG000|Overall Study|Adverse Event|5|||
157141124|NCT00246259|567263446|FG001|Overall Study|Adverse Event|0|||
157141125|NCT00246259|567263445|FG000|Overall Study|Lost to Follow-up|3|||
157141126|NCT00246259|567263446|FG001|Overall Study|Lost to Follow-up|4|||
157141127|NCT00246259|567263445|FG000|Overall Study|Withdrawal by Subject|5|||
157141128|NCT00246259|567263446|FG001|Overall Study|Withdrawal by Subject|1|||
157141129|NCT00246259|567263445|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
157141130|NCT00246259|567263446|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
157141131|NCT04233424|567263447|FG000|Overall Study|Death|15|||
157141132|NCT04233424|567263448|FG001|Overall Study|Death|16|||
157141133|NCT04233424|567263447|FG000|Overall Study|Withdrawal by Subject|2|||
157141134|NCT04233424|567263448|FG001|Overall Study|Withdrawal by Subject|8|||
157141135|NCT04233424|567263447|FG000|Overall Study|Physician Decision|1|||
157141136|NCT04233424|567263448|FG001|Overall Study|Physician Decision|3|||
157141137|NCT04233424|567263447|FG000|Overall Study|Protocol Violation|3|||
157141138|NCT04233424|567263448|FG001|Overall Study|Protocol Violation|1|||
156876679|NCT05367492|566307682|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
157141139|NCT04233424|567263447|FG000|Overall Study|Lost to Follow-up|1|||
156876680|NCT05367492|566307683|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
157020151|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157141140|NCT04233424|567263448|FG001|Overall Study|Lost to Follow-up|3|||
157141141|NCT04233424|567263447|FG000|Overall Study|subject refuse to visit site|2|||
157141142|NCT04233424|567263448|FG001|Overall Study|subject refuse to visit site|0|||
157141143|NCT02698189|567263449|FG000|Overall Study|Physician Decision|3|||
157141144|NCT02698189|567263450|FG001|Overall Study|Physician Decision|0|||
156734795|NCT02829723|565776496|FG019|Overall Study|Physician Decision|0|||
156734796|NCT02829723|565776497|FG020|Overall Study|Physician Decision|0|||
157141145|NCT02698189|567263449|FG000|Overall Study|Progressive disease|0|||
157141146|NCT02698189|567263450|FG001|Overall Study|Progressive disease|5|||
156734797|NCT02829723|565776498|FG021|Overall Study|Physician Decision|0|||
156734798|NCT02829723|565776499|FG022|Overall Study|Physician Decision|1|||
156734799|NCT02829723|565776500|FG023|Overall Study|Physician Decision|1|||
156734800|NCT02829723|565776501|FG024|Overall Study|Physician Decision|1|||
156734801|NCT02829723|565776502|FG025|Overall Study|Physician Decision|1|||
156734802|NCT02829723|565776503|FG026|Overall Study|Physician Decision|3|||
156734803|NCT02829723|565776477|FG000|Overall Study|Progressive disease|4|||
156734804|NCT02829723|565776478|FG001|Overall Study|Progressive disease|6|||
156734805|NCT02829723|565776479|FG002|Overall Study|Progressive disease|3|||
156734806|NCT02829723|565776480|FG003|Overall Study|Progressive disease|3|||
156734807|NCT02829723|565776481|FG004|Overall Study|Progressive disease|3|||
157141147|NCT02698189|567263449|FG000|Overall Study|Study terminated by sponsor|0|||
157141148|NCT02698189|567263450|FG001|Overall Study|Study terminated by sponsor|1|||
157141149|NCT02240706|567263451|FG000|Overall Study|Lack of Efficacy|2|||
157141150|NCT02240706|567263452|FG001|Overall Study|Lack of Efficacy|2|||
157141151|NCT02240706|567263453|FG002|Overall Study|Lack of Efficacy|2|||
157141152|NCT02240706|567263454|FG003|Overall Study|Lack of Efficacy|2|||
157141153|NCT02240706|567263455|FG004|Overall Study|Lack of Efficacy|5|||
157141154|NCT02240706|567263456|FG005|Overall Study|Lack of Efficacy|0|||
157141155|NCT02240706|567263457|FG006|Overall Study|Lack of Efficacy|0|||
157141156|NCT02240706|567263451|FG000|Overall Study|Adverse Event|1|||
157141157|NCT02240706|567263452|FG001|Overall Study|Adverse Event|0|||
157141158|NCT02240706|567263453|FG002|Overall Study|Adverse Event|1|||
157141159|NCT02240706|567263454|FG003|Overall Study|Adverse Event|0|||
157141160|NCT02240706|567263455|FG004|Overall Study|Adverse Event|2|||
157141161|NCT02240706|567263456|FG005|Overall Study|Adverse Event|0|||
157141162|NCT02240706|567263457|FG006|Overall Study|Adverse Event|0|||
157141163|NCT02240706|567263451|FG000|Overall Study|Progressive disease|0|||
157141164|NCT02240706|567263452|FG001|Overall Study|Progressive disease|0|||
157141165|NCT02240706|567263453|FG002|Overall Study|Progressive disease|0|||
157141166|NCT02240706|567263454|FG003|Overall Study|Progressive disease|0|||
157141167|NCT02240706|567263455|FG004|Overall Study|Progressive disease|1|||
157141168|NCT02240706|567263456|FG005|Overall Study|Progressive disease|0|||
157141169|NCT02240706|567263457|FG006|Overall Study|Progressive disease|0|||
156734808|NCT02829723|565776482|FG005|Overall Study|Progressive disease|5|||
156734809|NCT02829723|565776483|FG006|Overall Study|Progressive disease|4|||
156734810|NCT02829723|565776484|FG007|Overall Study|Progressive disease|6|||
156734811|NCT02829723|565776485|FG008|Overall Study|Progressive disease|8|||
156734812|NCT02829723|565776486|FG009|Overall Study|Progressive disease|4|||
156734813|NCT02829723|565776487|FG010|Overall Study|Progressive disease|9|||
156734814|NCT02829723|565776488|FG011|Overall Study|Progressive disease|0|||
156734815|NCT02829723|565776489|FG012|Overall Study|Progressive disease|3|||
156734816|NCT02829723|565776490|FG013|Overall Study|Progressive disease|4|||
156734817|NCT02829723|565776491|FG014|Overall Study|Progressive disease|2|||
156734818|NCT02829723|565776492|FG015|Overall Study|Progressive disease|4|||
156734819|NCT02829723|565776493|FG016|Overall Study|Progressive disease|5|||
156734820|NCT02829723|565776494|FG017|Overall Study|Progressive disease|3|||
156734821|NCT02829723|565776495|FG018|Overall Study|Progressive disease|4|||
156734822|NCT02829723|565776496|FG019|Overall Study|Progressive disease|4|||
156734823|NCT02829723|565776497|FG020|Overall Study|Progressive disease|7|||
156734824|NCT02829723|565776498|FG021|Overall Study|Progressive disease|6|||
156734825|NCT02829723|565776499|FG022|Overall Study|Progressive disease|3|||
156734826|NCT02829723|565776500|FG023|Overall Study|Progressive disease|3|||
156734827|NCT02829723|565776501|FG024|Overall Study|Progressive disease|3|||
156734828|NCT02829723|565776502|FG025|Overall Study|Progressive disease|16|||
156734829|NCT02829723|565776503|FG026|Overall Study|Progressive disease|10|||
156734830|NCT02829723|565776477|FG000|Overall Study|Subject/guardian decision|0|||
156734831|NCT02829723|565776478|FG001|Overall Study|Subject/guardian decision|1|||
156734832|NCT02829723|565776479|FG002|Overall Study|Subject/guardian decision|0|||
156734833|NCT02829723|565776480|FG003|Overall Study|Subject/guardian decision|1|||
156796843|NCT00725985|566009681|FG010|ITP- Treatment Disposition|Other|0|||
157141170|NCT02240706|567263451|FG000|Overall Study|Dose limiting toxicity|0|||
157141171|NCT02240706|567263452|FG001|Overall Study|Dose limiting toxicity|0|||
157141172|NCT02240706|567263453|FG002|Overall Study|Dose limiting toxicity|0|||
157141173|NCT02240706|567263454|FG003|Overall Study|Dose limiting toxicity|0|||
156734834|NCT02829723|565776481|FG004|Overall Study|Subject/guardian decision|0|||
156734835|NCT02829723|565776482|FG005|Overall Study|Subject/guardian decision|0|||
156734836|NCT02829723|565776483|FG006|Overall Study|Subject/guardian decision|0|||
156734837|NCT02829723|565776484|FG007|Overall Study|Subject/guardian decision|1|||
156734838|NCT02829723|565776485|FG008|Overall Study|Subject/guardian decision|0|||
156734839|NCT02829723|565776486|FG009|Overall Study|Subject/guardian decision|0|||
156734840|NCT02829723|565776487|FG010|Overall Study|Subject/guardian decision|0|||
156734841|NCT02829723|565776488|FG011|Overall Study|Subject/guardian decision|0|||
156734842|NCT02829723|565776489|FG012|Overall Study|Subject/guardian decision|0|||
157141174|NCT02240706|567263455|FG004|Overall Study|Dose limiting toxicity|1|||
157141175|NCT02240706|567263456|FG005|Overall Study|Dose limiting toxicity|0|||
156734843|NCT02829723|565776490|FG013|Overall Study|Subject/guardian decision|0|||
156734844|NCT02829723|565776491|FG014|Overall Study|Subject/guardian decision|1|||
156734845|NCT02829723|565776492|FG015|Overall Study|Subject/guardian decision|0|||
156734846|NCT02829723|565776493|FG016|Overall Study|Subject/guardian decision|1|||
156734847|NCT02829723|565776494|FG017|Overall Study|Subject/guardian decision|0|||
156734848|NCT02829723|565776495|FG018|Overall Study|Subject/guardian decision|1|||
156734849|NCT02829723|565776496|FG019|Overall Study|Subject/guardian decision|0|||
156734850|NCT02829723|565776497|FG020|Overall Study|Subject/guardian decision|1|||
156734851|NCT02829723|565776498|FG021|Overall Study|Subject/guardian decision|0|||
156734852|NCT02829723|565776499|FG022|Overall Study|Subject/guardian decision|0|||
156734853|NCT02829723|565776500|FG023|Overall Study|Subject/guardian decision|1|||
156734854|NCT02829723|565776501|FG024|Overall Study|Subject/guardian decision|0|||
156734855|NCT02829723|565776502|FG025|Overall Study|Subject/guardian decision|1|||
156734856|NCT02829723|565776503|FG026|Overall Study|Subject/guardian decision|1|||
156734857|NCT02829723|565776477|FG000|Overall Study|Study terminated by sponsor|0|||
156734858|NCT02829723|565776478|FG001|Overall Study|Study terminated by sponsor|0|||
156734859|NCT02829723|565776479|FG002|Overall Study|Study terminated by sponsor|0|||
156734860|NCT02829723|565776480|FG003|Overall Study|Study terminated by sponsor|0|||
156734861|NCT02829723|565776481|FG004|Overall Study|Study terminated by sponsor|0|||
156734862|NCT02829723|565776482|FG005|Overall Study|Study terminated by sponsor|0|||
156734863|NCT02829723|565776483|FG006|Overall Study|Study terminated by sponsor|0|||
157141176|NCT02240706|567263457|FG006|Overall Study|Dose limiting toxicity|0|||
157141177|NCT02240706|567263451|FG000|Overall Study|Refused to continue taking medication|0|||
157141178|NCT02240706|567263452|FG001|Overall Study|Refused to continue taking medication|1|||
157141179|NCT02240706|567263453|FG002|Overall Study|Refused to continue taking medication|3|||
157141180|NCT02240706|567263454|FG003|Overall Study|Refused to continue taking medication|1|||
157141181|NCT02240706|567263455|FG004|Overall Study|Refused to continue taking medication|2|||
157141182|NCT02240706|567263456|FG005|Overall Study|Refused to continue taking medication|0|||
156734864|NCT02829723|565776484|FG007|Overall Study|Study terminated by sponsor|0|||
156734865|NCT02829723|565776485|FG008|Overall Study|Study terminated by sponsor|0|||
156734866|NCT02829723|565776486|FG009|Overall Study|Study terminated by sponsor|0|||
156734867|NCT02829723|565776487|FG010|Overall Study|Study terminated by sponsor|0|||
156734868|NCT02829723|565776488|FG011|Overall Study|Study terminated by sponsor|0|||
156734869|NCT02829723|565776489|FG012|Overall Study|Study terminated by sponsor|0|||
156734870|NCT02829723|565776490|FG013|Overall Study|Study terminated by sponsor|0|||
156734871|NCT02829723|565776491|FG014|Overall Study|Study terminated by sponsor|0|||
156734872|NCT02829723|565776492|FG015|Overall Study|Study terminated by sponsor|0|||
156734873|NCT02829723|565776493|FG016|Overall Study|Study terminated by sponsor|0|||
156734874|NCT02829723|565776494|FG017|Overall Study|Study terminated by sponsor|0|||
156734875|NCT02829723|565776495|FG018|Overall Study|Study terminated by sponsor|0|||
156734876|NCT02829723|565776496|FG019|Overall Study|Study terminated by sponsor|0|||
156734877|NCT02829723|565776497|FG020|Overall Study|Study terminated by sponsor|0|||
156734878|NCT02829723|565776498|FG021|Overall Study|Study terminated by sponsor|1|||
156734879|NCT02829723|565776499|FG022|Overall Study|Study terminated by sponsor|0|||
156734880|NCT02829723|565776500|FG023|Overall Study|Study terminated by sponsor|0|||
156734881|NCT02829723|565776501|FG024|Overall Study|Study terminated by sponsor|0|||
156734882|NCT02829723|565776502|FG025|Overall Study|Study terminated by sponsor|0|||
156734883|NCT02829723|565776503|FG026|Overall Study|Study terminated by sponsor|0|||
156734884|NCT02989649|565776504|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
156734885|NCT02989649|565776504|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
156734886|NCT02989649|565776504|FG000|Overall Study|Lost For Observation During Study|3|||
156734887|NCT02989649|565776504|FG000|Overall Study|Reason Not Specified|13|||
156734888|NCT00330343|565776505|FG000|Overall Study|Lost to Follow-up|5|||
156734889|NCT00256854|565776506|FG000|Overall Study|Withdrawal by Subject|2|||
156734890|NCT00256854|565776507|FG001|Overall Study|Withdrawal by Subject|3|||
156734891|NCT00256854|565776508|FG002|Overall Study|Withdrawal by Subject|0|||
156734892|NCT00256854|565776509|FG003|Overall Study|Withdrawal by Subject|0|||
157141183|NCT02240706|567263457|FG006|Overall Study|Refused to continue taking medication|0|||
157141184|NCT02240706|567263451|FG000|Overall Study|Insurance billing concerns|0|||
157141185|NCT02240706|567263452|FG001|Overall Study|Insurance billing concerns|0|||
157141186|NCT02240706|567263453|FG002|Overall Study|Insurance billing concerns|0|||
157141187|NCT02240706|567263454|FG003|Overall Study|Insurance billing concerns|1|||
157141188|NCT02240706|567263455|FG004|Overall Study|Insurance billing concerns|0|||
156734893|NCT00256854|565776510|FG004|Overall Study|Withdrawal by Subject|0|||
156734894|NCT00256854|565776511|FG005|Overall Study|Withdrawal by Subject|0|||
156734895|NCT00256854|565776506|FG000|Overall Study|Lack of Efficacy|1|||
156734896|NCT00256854|565776507|FG001|Overall Study|Lack of Efficacy|0|||
156734897|NCT00256854|565776508|FG002|Overall Study|Lack of Efficacy|0|||
156734898|NCT00256854|565776509|FG003|Overall Study|Lack of Efficacy|0|||
156734899|NCT00256854|565776510|FG004|Overall Study|Lack of Efficacy|0|||
156734900|NCT00256854|565776511|FG005|Overall Study|Lack of Efficacy|0|||
156734901|NCT00256854|565776506|FG000|Overall Study|Protocol Violation|0|||
156734902|NCT00256854|565776507|FG001|Overall Study|Protocol Violation|1|||
156734903|NCT00256854|565776508|FG002|Overall Study|Protocol Violation|1|||
156734904|NCT00256854|565776509|FG003|Overall Study|Protocol Violation|1|||
156734905|NCT00256854|565776510|FG004|Overall Study|Protocol Violation|0|||
157217818|NCT01764854|567543300|FG001|Overall Study|Adverse Event|0|||
157217819|NCT01764854|567543301|FG002|Overall Study|Adverse Event|2|||
157217820|NCT01764854|567543302|FG003|Overall Study|Adverse Event|0|||
157217821|NCT01764854|567543299|FG000|Overall Study|Withdrawal by Subject|0|||
157217822|NCT01764854|567543300|FG001|Overall Study|Withdrawal by Subject|0|||
157217823|NCT01764854|567543301|FG002|Overall Study|Withdrawal by Subject|1|||
157217824|NCT01764854|567543302|FG003|Overall Study|Withdrawal by Subject|0|||
157217825|NCT01764854|567543299|FG000|Overall Study|relocation|0|||
157217826|NCT01764854|567543300|FG001|Overall Study|relocation|0|||
157217827|NCT01764854|567543301|FG002|Overall Study|relocation|2|||
157217828|NCT01764854|567543302|FG003|Overall Study|relocation|0|||
157217829|NCT01764854|567543299|FG000|Overall Study|Protocol Violation|0|||
157217830|NCT01764854|567543300|FG001|Overall Study|Protocol Violation|0|||
157217831|NCT01764854|567543301|FG002|Overall Study|Protocol Violation|1|||
156734906|NCT00256854|565776511|FG005|Overall Study|Protocol Violation|0|||
156734907|NCT00256854|565776506|FG000|Overall Study|Adverse Event|0|||
156734908|NCT00256854|565776507|FG001|Overall Study|Adverse Event|0|||
156734909|NCT00256854|565776508|FG002|Overall Study|Adverse Event|2|||
156734910|NCT00256854|565776509|FG003|Overall Study|Adverse Event|2|||
156734911|NCT00256854|565776510|FG004|Overall Study|Adverse Event|0|||
156734912|NCT00256854|565776511|FG005|Overall Study|Adverse Event|1|||
156734913|NCT00256854|565776506|FG000|Overall Study|Not compliant with the study drug|0|||
156734914|NCT00256854|565776507|FG001|Overall Study|Not compliant with the study drug|0|||
156734915|NCT00256854|565776508|FG002|Overall Study|Not compliant with the study drug|0|||
156734916|NCT00256854|565776509|FG003|Overall Study|Not compliant with the study drug|0|||
156734917|NCT00256854|565776510|FG004|Overall Study|Not compliant with the study drug|1|||
156734918|NCT00256854|565776511|FG005|Overall Study|Not compliant with the study drug|0|||
156734919|NCT06586788|565776512|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
156734920|NCT03990571|565776513|FG000|Overall Study|Withdrawal by Subject|1|||
156734921|NCT03990571|565776513|FG000|Overall Study|Insurance Issues|3|||
156734922|NCT03990571|565776513|FG000|Overall Study|Covid Restrictions|2|||
156734923|NCT03514485|565776514|FG000|Overall Study|Lost to Follow-up|5|||
156734924|NCT03514485|565776515|FG001|Overall Study|Lost to Follow-up|3|||
156734925|NCT03514485|565776516|FG002|Overall Study|Lost to Follow-up|2|||
156734926|NCT03514485|565776517|FG003|Overall Study|Lost to Follow-up|0|||
156734927|NCT03514485|565776518|FG004|Overall Study|Lost to Follow-up|1|||
157020152|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157020153|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157020154|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157141189|NCT02240706|567263456|FG005|Overall Study|Insurance billing concerns|0|||
157141190|NCT02240706|567263457|FG006|Overall Study|Insurance billing concerns|0|||
157141191|NCT00855439|567263462|FG000|Overall Study|Withdrawal by Subject|2|||
157141192|NCT00855439|567263463|FG001|Overall Study|Withdrawal by Subject|0|||
157141193|NCT00855439|567263462|FG000|Overall Study|Pregnancy|1|||
157141194|NCT00855439|567263463|FG001|Overall Study|Pregnancy|0|||
157141195|NCT05502289|567263464|FG000|Period 1|Out Of Window|1|||
157141196|NCT05502289|567263465|FG001|Period 1|Out Of Window|0|||
157141197|NCT01564784|567263476|FG000|Overall Study|Other|1|||
157141198|NCT01564784|567263477|FG001|Overall Study|Other|0|||
157141199|NCT01564784|567263476|FG000|Overall Study|Subject refused further follow-up|1|||
157141200|NCT01564784|567263477|FG001|Overall Study|Subject refused further follow-up|6|||
157141201|NCT01564784|567263476|FG000|Overall Study|Lost to Follow-up|1|||
157141202|NCT01564784|567263477|FG001|Overall Study|Lost to Follow-up|1|||
157141203|NCT01564784|567263476|FG000|Overall Study|Death|131|||
157141204|NCT01564784|567263477|FG001|Overall Study|Death|126|||
157141205|NCT05300087|567263478|FG000|Overall Study|Withdrawal by Subject|0|||
157141206|NCT05300087|567263479|FG001|Overall Study|Withdrawal by Subject|1|||
157141207|NCT03248128|567263480|FG000|Overall Study|Lost to Follow-up|1|||
157141208|NCT03248128|567263481|FG001|Overall Study|Lost to Follow-up|0|||
157141209|NCT03248128|567263480|FG000|Overall Study|Withdrawal by Subject|16|||
157141210|NCT03248128|567263481|FG001|Overall Study|Withdrawal by Subject|14|||
157141211|NCT03248128|567263480|FG000|Overall Study|Site Closed|4|||
157141212|NCT03248128|567263481|FG001|Overall Study|Site Closed|3|||
157141213|NCT03248128|567263480|FG000|Overall Study|Randomized, but did not receive treatment|1|||
157141214|NCT03248128|567263481|FG001|Overall Study|Randomized, but did not receive treatment|3|||
157217832|NCT01764854|567543302|FG003|Overall Study|Protocol Violation|2|||
156734928|NCT03514485|565776519|FG005|Overall Study|Lost to Follow-up|4|||
157141215|NCT01914679|567263482|FG000|Overall Study|Lack of Efficacy|1|||
157141216|NCT01914679|567263482|FG000|Overall Study|Sponsor terminated study|4|||
157141217|NCT00256295|567263486|FG000|Overall Study|Withdrawal by Subject|3|||
157141218|NCT00256295|567263486|FG000|Overall Study|Death|1|||
156734929|NCT03514485|565776514|FG000|Overall Study|Withdrawal by Subject|0|||
156734930|NCT03514485|565776515|FG001|Overall Study|Withdrawal by Subject|1|||
156734931|NCT03514485|565776516|FG002|Overall Study|Withdrawal by Subject|3|||
156876681|NCT03539549|566307690|FG000|Overall Study|Adverse Event|12|||
157141219|NCT01126580|567263487|FG000|Overall Study|Adverse Event|14|||
157217833|NCT00901628|567543335|FG000|Overall Study|disconnection of catheter|4|||
157217834|NCT00901628|567543336|FG001|Overall Study|disconnection of catheter|8|||
157020155|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
157020156|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
157020157|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
157020158|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
157020159|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
157020160|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020161|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020162|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020163|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020164|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020165|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020166|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020167|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020168|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
157020169|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
157020170|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
157020171|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
157020172|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
157020173|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020174|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020175|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020176|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020177|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020178|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020179|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020180|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020181|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
157020182|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
157020183|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
157020184|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
157020185|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
157020186|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020187|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020188|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020189|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020190|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020191|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157141220|NCT01126580|567263488|FG001|Overall Study|Adverse Event|8|||
157141221|NCT01126580|567263489|FG002|Overall Study|Adverse Event|12|||
157141222|NCT01126580|567263487|FG000|Overall Study|Withdrawal by Subject|11|||
157141223|NCT01126580|567263488|FG001|Overall Study|Withdrawal by Subject|19|||
157141224|NCT01126580|567263489|FG002|Overall Study|Withdrawal by Subject|14|||
157141225|NCT01126580|567263487|FG000|Overall Study|Sponsor Decision|5|||
157141226|NCT01126580|567263488|FG001|Overall Study|Sponsor Decision|4|||
157141227|NCT01126580|567263489|FG002|Overall Study|Sponsor Decision|7|||
157141228|NCT01126580|567263487|FG000|Overall Study|Physician Decision|1|||
157141229|NCT01126580|567263488|FG001|Overall Study|Physician Decision|1|||
157141230|NCT01126580|567263489|FG002|Overall Study|Physician Decision|2|||
157141231|NCT01126580|567263487|FG000|Overall Study|Entry Criteria Not Met|1|||
157141232|NCT01126580|567263488|FG001|Overall Study|Entry Criteria Not Met|1|||
157141233|NCT01126580|567263489|FG002|Overall Study|Entry Criteria Not Met|2|||
157141234|NCT01126580|567263487|FG000|Overall Study|Lack of Efficacy|2|||
157141235|NCT01126580|567263488|FG001|Overall Study|Lack of Efficacy|3|||
157141236|NCT01126580|567263489|FG002|Overall Study|Lack of Efficacy|4|||
157141237|NCT01126580|567263487|FG000|Overall Study|Protocol Violation|0|||
157141238|NCT01126580|567263488|FG001|Overall Study|Protocol Violation|1|||
157141239|NCT01126580|567263489|FG002|Overall Study|Protocol Violation|2|||
157141240|NCT01126580|567263487|FG000|Overall Study|Lost to Follow-up|15|||
157141241|NCT01126580|567263488|FG001|Overall Study|Lost to Follow-up|13|||
157141242|NCT01126580|567263489|FG002|Overall Study|Lost to Follow-up|9|||
157141243|NCT01126580|567263487|FG000|Overall Study|Treatment Non-compliance|0|||
157141244|NCT01126580|567263488|FG001|Overall Study|Treatment Non-compliance|2|||
157141245|NCT01126580|567263489|FG002|Overall Study|Treatment Non-compliance|3|||
156734932|NCT03514485|565776517|FG003|Overall Study|Withdrawal by Subject|1|||
156734933|NCT03514485|565776518|FG004|Overall Study|Withdrawal by Subject|2|||
157020192|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157141246|NCT01731002|567263499|FG000|Overall Study|Adverse Event|0|||
157141247|NCT01731002|567263500|FG001|Overall Study|Adverse Event|2|||
157141248|NCT01731002|567263501|FG002|Overall Study|Adverse Event|2|||
157141249|NCT01731002|567263499|FG000|Overall Study|Non-Compliant|0|||
157141250|NCT01731002|567263500|FG001|Overall Study|Non-Compliant|1|||
157141251|NCT01731002|567263501|FG002|Overall Study|Non-Compliant|0|||
157217835|NCT00901628|567543335|FG000|Overall Study|disconnection of drain|0|||
157217836|NCT00901628|567543336|FG001|Overall Study|disconnection of drain|1|||
157217837|NCT00901628|567543335|FG000|Overall Study|peroneal nerve palsy|0|||
157217838|NCT00901628|567543336|FG001|Overall Study|peroneal nerve palsy|1|||
157217839|NCT01003886|567543339|FG000|Overall Study|Lack of Efficacy|5|||
157217840|NCT01003886|567543339|FG000|Overall Study|Lost to Follow-up|169|||
157217841|NCT01003886|567543339|FG000|Overall Study|Withdrawal by Subject|39|||
157217842|NCT01003886|567543339|FG000|Overall Study|Other|14|||
157217843|NCT01003886|567543339|FG000|Overall Study|Adverse Event|3|||
157217844|NCT00909727|567543357|FG000|Overall Study|Adverse Event|1|||
157217845|NCT00909727|567543358|FG001|Overall Study|Adverse Event|0|||
157217846|NCT00909727|567543357|FG000|Overall Study|Wrong Genotype|1|||
156734934|NCT03514485|565776519|FG005|Overall Study|Withdrawal by Subject|1|||
156734935|NCT03075891|565776520|FG000|Overall Study|Withdrawal by Subject|3|||
156734936|NCT03075891|565776521|FG001|Overall Study|Withdrawal by Subject|6|||
156734937|NCT03075891|565776520|FG000|Overall Study|Lost to Follow-up|1|||
156734938|NCT03075891|565776521|FG001|Overall Study|Lost to Follow-up|0|||
156734939|NCT03075891|565776520|FG000|Overall Study|Pregnancy|3|||
156876682|NCT03539549|566307690|FG000|Overall Study|Lost to Follow-up|1|||
157141252|NCT01731002|567263499|FG000|Overall Study|Lost to Follow-up|1|||
157141253|NCT01731002|567263500|FG001|Overall Study|Lost to Follow-up|0|||
157141254|NCT01731002|567263501|FG002|Overall Study|Lost to Follow-up|0|||
157141255|NCT01731002|567263499|FG000|Overall Study|Test Agent Discontinuation|0|||
157141256|NCT01731002|567263500|FG001|Overall Study|Test Agent Discontinuation|1|||
157141257|NCT01731002|567263501|FG002|Overall Study|Test Agent Discontinuation|0|||
157141258|NCT01731002|567263499|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
157141259|NCT01731002|567263500|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
157141260|NCT01731002|567263501|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
157141261|NCT01731002|567263499|FG000|Overall Study|Elevated IOP|1|||
157141262|NCT01731002|567263500|FG001|Overall Study|Elevated IOP|0|||
157141263|NCT01731002|567263501|FG002|Overall Study|Elevated IOP|0|||
157141264|NCT01731002|567263499|FG000|Overall Study|Inappropriate use of study medications|0|||
157141265|NCT01731002|567263500|FG001|Overall Study|Inappropriate use of study medications|0|||
157141266|NCT01731002|567263501|FG002|Overall Study|Inappropriate use of study medications|1|||
157141267|NCT00947349|567263504|FG000|Triple Treatment Combination Period|Adverse Event|0|||
157141268|NCT00947349|567263505|FG001|Triple Treatment Combination Period|Adverse Event|1|||
157141269|NCT00947349|567263506|FG002|Triple Treatment Combination Period|Adverse Event|0|||
157141270|NCT00947349|567263507|FG003|Triple Treatment Combination Period|Adverse Event|0|||
157141271|NCT00947349|567263504|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
157141272|NCT00947349|567263505|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
157141273|NCT00947349|567263506|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
157141274|NCT00947349|567263507|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
157141275|NCT00947349|567263504|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
157141276|NCT00947349|567263505|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
157141277|NCT00947349|567263506|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
157141278|NCT00947349|567263507|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
157141279|NCT00947349|567263504|FG000|Overall Study Standard of Care|Other|0|||
157141280|NCT00947349|567263505|FG001|Overall Study Standard of Care|Other|0|||
157141281|NCT00947349|567263506|FG002|Overall Study Standard of Care|Other|0|||
157141282|NCT00947349|567263507|FG003|Overall Study Standard of Care|Other|1|||
157141283|NCT00538681|567263508|FG000|Overall Study|Progressive Disease|7|||
157141284|NCT00538681|567263509|FG001|Overall Study|Progressive Disease|0|||
157141285|NCT00538681|567263510|FG002|Overall Study|Progressive Disease|1|||
157141286|NCT00538681|567263511|FG003|Overall Study|Progressive Disease|0|||
157141287|NCT00538681|567263508|FG000|Overall Study|Sponsor Decision|1|||
157141288|NCT00538681|567263509|FG001|Overall Study|Sponsor Decision|3|||
157141289|NCT00538681|567263510|FG002|Overall Study|Sponsor Decision|8|||
157141290|NCT00538681|567263511|FG003|Overall Study|Sponsor Decision|9|||
157141291|NCT00538681|567263508|FG000|Overall Study|Adverse Event|1|||
157141292|NCT00538681|567263509|FG001|Overall Study|Adverse Event|1|||
157141293|NCT00538681|567263510|FG002|Overall Study|Adverse Event|1|||
157141294|NCT00538681|567263511|FG003|Overall Study|Adverse Event|0|||
157141295|NCT00538681|567263508|FG000|Overall Study|Death|0|||
157217847|NCT00909727|567543358|FG001|Overall Study|Wrong Genotype|0|||
156734940|NCT03075891|565776521|FG001|Overall Study|Pregnancy|1|||
157141296|NCT00538681|567263509|FG001|Overall Study|Death|0|||
157141297|NCT00538681|567263510|FG002|Overall Study|Death|1|||
157217848|NCT00909727|567543357|FG000|Overall Study|Withdrawal of Consent|1|||
157217849|NCT00909727|567543358|FG001|Overall Study|Withdrawal of Consent|0|||
156734941|NCT03075891|565776520|FG000|Overall Study|visits not performed (no time)|1|||
157141298|NCT00538681|567263511|FG003|Overall Study|Death|1|||
157141299|NCT00538681|567263508|FG000|Overall Study|Investigator Decision|0|||
157141300|NCT00538681|567263509|FG001|Overall Study|Investigator Decision|0|||
157217850|NCT00909727|567543357|FG000|Overall Study|Prohibited Medication|1|||
157217851|NCT00909727|567543358|FG001|Overall Study|Prohibited Medication|0|||
157217852|NCT05751629|567543359|FG000|Overall Study|Withdrawal by Subject|6|||
157217853|NCT05751629|567543359|FG000|Overall Study|Death|25|||
157217854|NCT05751629|567543359|FG000|Overall Study|Study Site Closed|9|||
156734942|NCT03075891|565776521|FG001|Overall Study|visits not performed (no time)|0|||
156734943|NCT03075891|565776520|FG000|Overall Study|Drug abuse relapse issue|0|||
157217855|NCT05751629|567543359|FG000|Overall Study|Physician Decision|1|||
157217856|NCT01909466|567543361|FG000|Overall Study|Lost to Follow-up|5|||
156734944|NCT03075891|565776521|FG001|Overall Study|Drug abuse relapse issue|1|||
156734945|NCT03075891|565776520|FG000|Overall Study|Participant requiring study withdrawal|0|||
156734946|NCT03075891|565776521|FG001|Overall Study|Participant requiring study withdrawal|1|||
156734947|NCT03075891|565776520|FG000|Overall Study|Adverse event, non-fatal|1|||
156734948|NCT03075891|565776521|FG001|Overall Study|Adverse event, non-fatal|4|||
156734949|NCT02387957|565776525|FG000|Overall Study|The study was discontinued|21|||
157217857|NCT01909466|567543362|FG001|Overall Study|Lost to Follow-up|7|||
157217858|NCT01909466|567543361|FG000|Overall Study|Adverse Event|3|||
157217859|NCT01909466|567543362|FG001|Overall Study|Adverse Event|4|||
157217860|NCT01909466|567543361|FG000|Overall Study|Met Withdrawal Criteria|0|||
157217861|NCT01909466|567543362|FG001|Overall Study|Met Withdrawal Criteria|3|||
157217862|NCT01909466|567543361|FG000|Overall Study|Physician Decision|2|||
157217863|NCT01909466|567543362|FG001|Overall Study|Physician Decision|0|||
157217864|NCT01909466|567543361|FG000|Overall Study|Withdrawal by Subject|11|||
157217865|NCT01909466|567543362|FG001|Overall Study|Withdrawal by Subject|9|||
157217866|NCT01909466|567543361|FG000|Overall Study|Lack of Efficacy|1|||
157217867|NCT01909466|567543362|FG001|Overall Study|Lack of Efficacy|0|||
156734950|NCT02387957|565776526|FG001|Overall Study|The study was discontinued|21|||
156734951|NCT02387957|565776527|FG002|Overall Study|The study was discontinued|20|||
157217868|NCT00772577|567543368|FG000|Overall Study|Adverse Event|6|||
157217869|NCT00772577|567543369|FG001|Overall Study|Adverse Event|3|||
157217870|NCT00772577|567543368|FG000|Overall Study|Abnormal laboratory values|0|||
157217871|NCT00772577|567543369|FG001|Overall Study|Abnormal laboratory values|1|||
157217872|NCT00772577|567543368|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157217873|NCT00772577|567543369|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
157217874|NCT00772577|567543368|FG000|Overall Study|Patient withdrew consent|8|||
157217875|NCT00772577|567543369|FG001|Overall Study|Patient withdrew consent|5|||
157217876|NCT00772577|567543368|FG000|Overall Study|Lost to Follow-up|4|||
157217877|NCT00772577|567543369|FG001|Overall Study|Lost to Follow-up|3|||
157217878|NCT00772577|567543368|FG000|Overall Study|Administrative problems|2|||
157217879|NCT00772577|567543369|FG001|Overall Study|Administrative problems|1|||
156734952|NCT02887248|565776528|FG000|Overall Study|Withdrawal by Subject|1|||
156734953|NCT02887248|565776528|FG000|Overall Study|Adverse Event|1|||
156734954|NCT02887248|565776528|FG000|Overall Study|Progressive Disease|1|||
156734955|NCT02294396|565776529|FG000|Overall Study|Adverse Event|26|||
156734956|NCT02294396|565776530|FG001|Overall Study|Adverse Event|25|||
156734957|NCT02294396|565776531|FG002|Overall Study|Adverse Event|21|||
156734958|NCT02294396|565776532|FG003|Overall Study|Adverse Event|24|||
156734959|NCT02294396|565776529|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
156734960|NCT02294396|565776530|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
156734961|NCT02294396|565776531|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
156734962|NCT02294396|565776532|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
156734963|NCT02294396|565776529|FG000|Overall Study|Withdrawal by Subject|8|||
156734964|NCT02294396|565776530|FG001|Overall Study|Withdrawal by Subject|6|||
156734965|NCT02294396|565776531|FG002|Overall Study|Withdrawal by Subject|6|||
156734966|NCT02294396|565776532|FG003|Overall Study|Withdrawal by Subject|8|||
156734967|NCT02294396|565776529|FG000|Overall Study|Lost to Follow-up|0|||
156734968|NCT02294396|565776530|FG001|Overall Study|Lost to Follow-up|0|||
156734969|NCT02294396|565776531|FG002|Overall Study|Lost to Follow-up|1|||
156734970|NCT02294396|565776532|FG003|Overall Study|Lost to Follow-up|1|||
156734971|NCT02294396|565776529|FG000|Overall Study|Protocol Deviation|3|||
156734972|NCT02294396|565776530|FG001|Overall Study|Protocol Deviation|2|||
156734973|NCT02294396|565776531|FG002|Overall Study|Protocol Deviation|2|||
156876683|NCT03539549|566307690|FG000|Overall Study|Death|2|||
157217880|NCT00772577|567543368|FG000|Overall Study|Protocol Deviation|3|||
157217881|NCT00772577|567543369|FG001|Overall Study|Protocol Deviation|2|||
157217882|NCT02965820|567543370|FG000|Period 2, Second 30 Days|Adverse Event|1|||
157217883|NCT02965820|567543371|FG001|Period 2, Second 30 Days|Adverse Event|1|||
156734974|NCT02294396|565776532|FG003|Overall Study|Protocol Deviation|1|||
156876684|NCT03539549|566307690|FG000|Overall Study|Progressive Disease|1|||
157217884|NCT01567306|567543372|FG000|Overall Study|Protocol Violation|2|||
157217885|NCT01567306|567543373|FG001|Overall Study|Protocol Violation|2|||
156734975|NCT02294396|565776529|FG000|Overall Study|Miscellaneous|2|||
156734976|NCT02294396|565776530|FG001|Overall Study|Miscellaneous|0|||
156734977|NCT02294396|565776531|FG002|Overall Study|Miscellaneous|5|||
156734978|NCT02294396|565776532|FG003|Overall Study|Miscellaneous|2|||
156734979|NCT01500187|565776535|FG000|Overall Study|Lost to Follow-up|6|||
156734980|NCT01500187|565776536|FG001|Overall Study|Lost to Follow-up|0|||
157217886|NCT01567306|567543374|FG002|Overall Study|Protocol Violation|0|||
157217887|NCT01567306|567543375|FG003|Overall Study|Protocol Violation|3|||
157141301|NCT00538681|567263510|FG002|Overall Study|Investigator Decision|0|||
157141302|NCT00538681|567263511|FG003|Overall Study|Investigator Decision|1|||
157141303|NCT05369806|567263514|FG000|Overall Study|Lost to Follow-up|1|||
156734981|NCT03070002|565776548|FG000|Follow up for 2 Years|Death|1|||
156734982|NCT00712543|565776551|FG000|Day 8-14|Lost to Follow-up|0|||
156734983|NCT00712543|565776552|FG001|Day 8-14|Lost to Follow-up|2|||
156734984|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
156734985|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
156734986|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
156734987|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
156734988|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
156734989|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
156734990|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
156734991|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
156734992|NCT04740827|565776553|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
156734993|NCT04740827|565776554|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
156734994|NCT04740827|565776553|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
156734995|NCT04740827|565776554|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
156734996|NCT02147158|565776555|FG000|Treatment Course 1|Adverse Event|1|||
156734997|NCT02147158|565776556|FG001|Treatment Course 1|Adverse Event|4|||
156734998|NCT02147158|565776557|FG002|Treatment Course 1|Adverse Event|3|||
156734999|NCT02147158|565776558|FG003|Treatment Course 1|Adverse Event|4|||
156735000|NCT02147158|565776559|FG004|Treatment Course 1|Adverse Event|1|||
156735001|NCT02147158|565776560|FG005|Treatment Course 1|Adverse Event|2|||
156735002|NCT02147158|565776555|FG000|Treatment Course 1|Lost to Follow-up|2|||
156735003|NCT02147158|565776556|FG001|Treatment Course 1|Lost to Follow-up|4|||
156735004|NCT02147158|565776557|FG002|Treatment Course 1|Lost to Follow-up|3|||
156735005|NCT02147158|565776558|FG003|Treatment Course 1|Lost to Follow-up|3|||
156735006|NCT02147158|565776559|FG004|Treatment Course 1|Lost to Follow-up|2|||
156735007|NCT02147158|565776560|FG005|Treatment Course 1|Lost to Follow-up|4|||
156735008|NCT02147158|565776555|FG000|Treatment Course 1|Protocol Violation|0|||
156735009|NCT02147158|565776556|FG001|Treatment Course 1|Protocol Violation|0|||
156735010|NCT02147158|565776557|FG002|Treatment Course 1|Protocol Violation|1|||
156735011|NCT02147158|565776558|FG003|Treatment Course 1|Protocol Violation|1|||
156735012|NCT02147158|565776559|FG004|Treatment Course 1|Protocol Violation|0|||
156735013|NCT02147158|565776560|FG005|Treatment Course 1|Protocol Violation|0|||
156735014|NCT02147158|565776555|FG000|Treatment Course 1|Withdrawal of Consent|1|||
157141304|NCT00628355|567263515|FG000|Overall Study|Withdrawal by Subject|1|||
157141305|NCT00628355|567263516|FG001|Overall Study|Withdrawal by Subject|1|||
156735015|NCT02147158|565776556|FG001|Treatment Course 1|Withdrawal of Consent|1|||
157141306|NCT04321343|567263521|FG000|Overall Study|Adverse Event|0|||
157141307|NCT04321343|567263522|FG001|Overall Study|Adverse Event|0|||
156735016|NCT02147158|565776557|FG002|Treatment Course 1|Withdrawal of Consent|1|||
156735017|NCT02147158|565776558|FG003|Treatment Course 1|Withdrawal of Consent|5|||
156735018|NCT02147158|565776559|FG004|Treatment Course 1|Withdrawal of Consent|3|||
156735019|NCT02147158|565776560|FG005|Treatment Course 1|Withdrawal of Consent|2|||
156735020|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Adverse Event|1|||
156735021|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Adverse Event|0|||
156735022|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Adverse Event|0|||
156735023|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Adverse Event|1|||
156735024|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Adverse Event|0|||
156735025|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Adverse Event|0|||
156735026|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735027|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
156735028|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
156735029|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735030|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
156735031|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
156735032|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
156735033|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
156735034|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
156735035|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
156735036|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
156735037|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
156735038|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
156735039|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
156735040|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
156735041|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
156735042|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
156796844|NCT00725985|566009682|FG011|ITP- Treatment Disposition|Other|0|||
156796845|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796846|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796847|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156735043|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
156735044|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735045|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735046|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
156735047|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735048|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
156735049|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
156735050|NCT02147158|565776555|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
156735051|NCT02147158|565776556|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735052|NCT02147158|565776557|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
156735053|NCT02147158|565776558|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
156735054|NCT02147158|565776559|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735055|NCT02147158|565776560|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
156735056|NCT02147158|565776555|FG000|Treatment Course 2|Adverse Event|0|||
156735057|NCT02147158|565776556|FG001|Treatment Course 2|Adverse Event|4|||
156735058|NCT02147158|565776557|FG002|Treatment Course 2|Adverse Event|2|||
156735059|NCT02147158|565776558|FG003|Treatment Course 2|Adverse Event|1|||
156735060|NCT02147158|565776559|FG004|Treatment Course 2|Adverse Event|0|||
156735061|NCT02147158|565776560|FG005|Treatment Course 2|Adverse Event|1|||
156735062|NCT02147158|565776555|FG000|Treatment Course 2|Withdrawal of Consent|0|||
156735063|NCT02147158|565776556|FG001|Treatment Course 2|Withdrawal of Consent|1|||
156735064|NCT02147158|565776557|FG002|Treatment Course 2|Withdrawal of Consent|2|||
156735065|NCT02147158|565776558|FG003|Treatment Course 2|Withdrawal of Consent|3|||
156735066|NCT02147158|565776559|FG004|Treatment Course 2|Withdrawal of Consent|0|||
156735067|NCT02147158|565776560|FG005|Treatment Course 2|Withdrawal of Consent|0|||
156735068|NCT02147158|565776555|FG000|Treatment Course 2|Lost to Follow-up|1|||
156735069|NCT02147158|565776556|FG001|Treatment Course 2|Lost to Follow-up|0|||
156735070|NCT02147158|565776557|FG002|Treatment Course 2|Lost to Follow-up|1|||
156735071|NCT02147158|565776558|FG003|Treatment Course 2|Lost to Follow-up|1|||
156735072|NCT02147158|565776559|FG004|Treatment Course 2|Lost to Follow-up|0|||
156735073|NCT02147158|565776560|FG005|Treatment Course 2|Lost to Follow-up|1|||
156735074|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735075|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
156735076|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
156735077|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735078|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735079|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
156735080|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
156735081|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
156735082|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
156735083|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
156735084|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
156735085|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
156735086|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
156735087|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
156735088|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
156735089|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735090|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735091|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
156735092|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
156735093|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
156735094|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
156735095|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
156735096|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
156735097|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
156735098|NCT02147158|565776555|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
156735099|NCT02147158|565776556|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
156735100|NCT02147158|565776557|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
156735101|NCT02147158|565776558|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
156735102|NCT02147158|565776559|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
156735103|NCT02147158|565776560|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
156735104|NCT00940823|565776561|FG000|Overall Study|Death|8|||
156735105|NCT00940823|565776562|FG001|Overall Study|Death|12|||
156735106|NCT00940823|565776561|FG000|Overall Study|Lost to Follow-up|27|||
156735107|NCT00940823|565776562|FG001|Overall Study|Lost to Follow-up|20|||
157217888|NCT01567306|567543376|FG004|Overall Study|Protocol Violation|1|||
156735108|NCT04520997|565776565|FG000|Overall Study|Lost to Follow-up|1|||
156735109|NCT04520997|565776566|FG001|Overall Study|Lost to Follow-up|1|||
156735110|NCT04520997|565776565|FG000|Overall Study|Withdrawal by Subject|1|||
156735111|NCT04520997|565776566|FG001|Overall Study|Withdrawal by Subject|0|||
156735112|NCT04520997|565776565|FG000|Overall Study|Not Treated|0|||
156735113|NCT04520997|565776566|FG001|Overall Study|Not Treated|1|||
156735114|NCT03689374|565776567|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
156735115|NCT03689374|565776568|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
156735116|NCT03689374|565776569|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
156735117|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
156735118|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
157217889|NCT01567306|567543377|FG005|Overall Study|Protocol Violation|1|||
157217890|NCT01567306|567543372|FG000|Overall Study|Change site living|1|||
157217891|NCT01567306|567543373|FG001|Overall Study|Change site living|0|||
157217892|NCT01567306|567543374|FG002|Overall Study|Change site living|0|||
157217893|NCT01567306|567543375|FG003|Overall Study|Change site living|0|||
157217894|NCT01567306|567543376|FG004|Overall Study|Change site living|0|||
157217895|NCT01567306|567543377|FG005|Overall Study|Change site living|0|||
157217896|NCT01567306|567543372|FG000|Overall Study|Adverse Event|0|||
157217897|NCT01567306|567543373|FG001|Overall Study|Adverse Event|0|||
157217898|NCT01567306|567543374|FG002|Overall Study|Adverse Event|0|||
157217899|NCT01567306|567543375|FG003|Overall Study|Adverse Event|2|||
157217900|NCT01567306|567543376|FG004|Overall Study|Adverse Event|4|||
157217901|NCT01567306|567543377|FG005|Overall Study|Adverse Event|1|||
157217902|NCT01567306|567543372|FG000|Overall Study|Lost to Follow-up|0|||
157217903|NCT01567306|567543373|FG001|Overall Study|Lost to Follow-up|0|||
157217904|NCT01567306|567543374|FG002|Overall Study|Lost to Follow-up|0|||
157217905|NCT01567306|567543375|FG003|Overall Study|Lost to Follow-up|0|||
157217906|NCT01567306|567543376|FG004|Overall Study|Lost to Follow-up|2|||
157217907|NCT01567306|567543377|FG005|Overall Study|Lost to Follow-up|0|||
157217908|NCT01567306|567543372|FG000|Overall Study|Withdrawal by Subject|0|||
157217909|NCT01567306|567543373|FG001|Overall Study|Withdrawal by Subject|0|||
157217910|NCT01567306|567543374|FG002|Overall Study|Withdrawal by Subject|0|||
157217911|NCT01567306|567543375|FG003|Overall Study|Withdrawal by Subject|0|||
157217912|NCT01567306|567543376|FG004|Overall Study|Withdrawal by Subject|0|||
157217913|NCT01567306|567543377|FG005|Overall Study|Withdrawal by Subject|1|||
157217914|NCT04272775|567543385|FG000|Overall Study|Study Terminated by Sponsor|1|||
157217915|NCT04272775|567543386|FG001|Overall Study|Study Terminated by Sponsor|0|||
157217916|NCT04272775|567543385|FG000|Overall Study|Protocol Violation|0|||
157217917|NCT04272775|567543386|FG001|Overall Study|Protocol Violation|1|||
157217918|NCT04272775|567543385|FG000|Overall Study|Symptomatic Deterioration|1|||
157217919|NCT04272775|567543386|FG001|Overall Study|Symptomatic Deterioration|1|||
157217920|NCT04272775|567543385|FG000|Overall Study|Withdrawal by Subject|1|||
157217921|NCT04272775|567543386|FG001|Overall Study|Withdrawal by Subject|2|||
157217922|NCT04272775|567543385|FG000|Overall Study|Adverse Event|1|||
157217923|NCT04272775|567543386|FG001|Overall Study|Adverse Event|2|||
157217924|NCT04272775|567543385|FG000|Overall Study|Progressive Disease|3|||
157217925|NCT04272775|567543386|FG001|Overall Study|Progressive Disease|1|||
157217926|NCT00475852|567543396|FG000|Overall Study|Death|444|||
157217927|NCT00475852|567543397|FG001|Overall Study|Death|456|||
157217928|NCT00475852|567543396|FG000|Overall Study|Withdrawal by Subject|19|||
157217929|NCT00475852|567543397|FG001|Overall Study|Withdrawal by Subject|24|||
157217930|NCT00475852|567543396|FG000|Overall Study|Lost to Follow-up|54|||
157217931|NCT00475852|567543397|FG001|Overall Study|Lost to Follow-up|68|||
157217932|NCT02063698|567543398|FG000|Overall Study|did not complete booklet for days 2-8|1|||
157217933|NCT02063698|567543399|FG001|Overall Study|did not complete booklet for days 2-8|2|||
157217934|NCT02974114|567543400|FG000|Overall Study|Other (Not specified)|0|||
157217935|NCT02974114|567543401|FG001|Overall Study|Other (Not specified)|1|||
156735119|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
156735120|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
156735121|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
156735122|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
156735123|NCT03689374|565776567|FG000|Treatment Period (Week 0 to 52)|Death|0|||
156735124|NCT03689374|565776568|FG001|Treatment Period (Week 0 to 52)|Death|11|||
156735125|NCT03689374|565776569|FG002|Treatment Period (Week 0 to 52)|Death|1|||
156735126|NCT04420585|565778357|FG000|Overall Study|Adverse Event|1|||
156735127|NCT04420585|565778357|FG000|Overall Study|Never initiated medication|2|||
156735128|NCT00477750|565778359|FG000|Overall Study|Currently Receiving Treatment|11|||
156735129|NCT00601172|565778360|FG000|Overall Study|Adverse Event|43|||
156735130|NCT00601172|565778361|FG001|Overall Study|Adverse Event|32|||
156735131|NCT00601172|565778360|FG000|Overall Study|Lack of Efficacy|11|||
157217936|NCT02974114|567543402|FG002|Overall Study|Other (Not specified)|2|||
157217937|NCT02133352|567543406|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
156735132|NCT00601172|565778361|FG001|Overall Study|Lack of Efficacy|12|||
157020193|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157217938|NCT00185211|567543407|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
157217939|NCT00185211|567543408|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
157217940|NCT00185211|567543407|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
156735133|NCT00601172|565778360|FG000|Overall Study|Protocol Violation|2|||
157217941|NCT00185211|567543408|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
157217942|NCT00185211|567543407|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
157217943|NCT00185211|567543408|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
156876685|NCT03539549|566307690|FG000|Overall Study|Reason not Specified|1|||
156876686|NCT04027608|566307691|FG000|Overall Study|Withdrawal by Subject|13|||
156876687|NCT04027608|566307692|FG001|Overall Study|Withdrawal by Subject|2|||
156876688|NCT04027608|566307691|FG000|Overall Study|Protocol Violation|2|||
156876689|NCT04027608|566307692|FG001|Overall Study|Protocol Violation|1|||
156876690|NCT04027608|566307691|FG000|Overall Study|Physician Decision|1|||
156876691|NCT04027608|566307692|FG001|Overall Study|Physician Decision|0|||
156876692|NCT04027608|566307691|FG000|Overall Study|Lost to Follow-up|20|||
156876693|NCT04027608|566307692|FG001|Overall Study|Lost to Follow-up|4|||
156876694|NCT01652469|566307696|FG000|Overall Study|Withdrawal by Subject|1|||
156876695|NCT01652469|566307697|FG001|Overall Study|Withdrawal by Subject|4|||
156876696|NCT01652469|566307696|FG000|Overall Study|Lost to Follow-up|0|||
156876697|NCT01652469|566307697|FG001|Overall Study|Lost to Follow-up|2|||
156876698|NCT01049009|566307698|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156876699|NCT01049009|566307699|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
156876700|NCT01049009|566307698|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156876701|NCT01049009|566307699|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156876702|NCT01049009|566307698|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
156876703|NCT01049009|566307699|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
156876704|NCT01049009|566307698|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
156876705|NCT01049009|566307699|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
156876706|NCT01667419|566307704|FG000|Overall Study|Reason Not Specified|1|||
157141308|NCT04321343|567263523|FG002|Overall Study|Adverse Event|1|||
157141309|NCT04321343|567263524|FG003|Overall Study|Adverse Event|0|||
157141310|NCT04321343|567263521|FG000|Overall Study|Death|0|||
157141311|NCT04321343|567263522|FG001|Overall Study|Death|0|||
157141312|NCT04321343|567263523|FG002|Overall Study|Death|0|||
157141313|NCT04321343|567263524|FG003|Overall Study|Death|1|||
157141314|NCT04321343|567263521|FG000|Overall Study|Pregnancy|1|||
157141315|NCT04321343|567263522|FG001|Overall Study|Pregnancy|0|||
157141316|NCT04321343|567263523|FG002|Overall Study|Pregnancy|0|||
157141317|NCT04321343|567263524|FG003|Overall Study|Pregnancy|0|||
157141318|NCT04321343|567263521|FG000|Overall Study|Protocol Violation|1|||
157141319|NCT04321343|567263522|FG001|Overall Study|Protocol Violation|1|||
157141320|NCT04321343|567263523|FG002|Overall Study|Protocol Violation|1|||
157141321|NCT04321343|567263524|FG003|Overall Study|Protocol Violation|1|||
157141322|NCT04321343|567263521|FG000|Overall Study|Withdrawal by Subject|0|||
157141323|NCT04321343|567263522|FG001|Overall Study|Withdrawal by Subject|6|||
157141324|NCT04321343|567263523|FG002|Overall Study|Withdrawal by Subject|0|||
157141325|NCT04321343|567263524|FG003|Overall Study|Withdrawal by Subject|2|||
157141326|NCT04321343|567263521|FG000|Overall Study|Lost to Follow-up|2|||
157141327|NCT04321343|567263522|FG001|Overall Study|Lost to Follow-up|2|||
157141328|NCT04321343|567263523|FG002|Overall Study|Lost to Follow-up|1|||
157141329|NCT04321343|567263524|FG003|Overall Study|Lost to Follow-up|3|||
157141330|NCT02770807|567263528|FG000|Overall Study|Adverse Event|3|||
157141331|NCT02770807|567263529|FG001|Overall Study|Adverse Event|3|||
157141332|NCT02770807|567263530|FG002|Overall Study|Adverse Event|1|||
157141333|NCT02770807|567263528|FG000|Overall Study|Withdrawal by Subject|7|||
157141334|NCT02770807|567263529|FG001|Overall Study|Withdrawal by Subject|3|||
157141335|NCT02770807|567263530|FG002|Overall Study|Withdrawal by Subject|4|||
157141336|NCT02770807|567263528|FG000|Overall Study|Other|0|||
157141337|NCT02770807|567263529|FG001|Overall Study|Other|1|||
157141338|NCT02770807|567263530|FG002|Overall Study|Other|0|||
157141339|NCT02770807|567263528|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
157141340|NCT02770807|567263529|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
157141341|NCT02770807|567263530|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
157141342|NCT02770807|567263528|FG000|Overall Study|Physician Decision|0|||
157141343|NCT02770807|567263529|FG001|Overall Study|Physician Decision|0|||
157141344|NCT02770807|567263530|FG002|Overall Study|Physician Decision|1|||
157141345|NCT00222105|567263533|FG000|Overall Study|Removed due to wrong diagnosis|1|||
157141346|NCT00222105|567263533|FG000|Overall Study|Withdrawal by Subject|1|||
157141347|NCT00222105|567263533|FG000|Overall Study|Adverse Event|8|||
157141348|NCT00222105|567263533|FG000|Overall Study|Treatment delays|2|||
157141349|NCT00222105|567263533|FG000|Overall Study|Death|2|||
157141350|NCT01084252|567265281|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141351|NCT01084252|567265282|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141352|NCT01084252|567265283|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141353|NCT01084252|567265284|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141354|NCT01084252|567265285|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141355|NCT01084252|567265286|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141356|NCT01084252|567265287|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156876707|NCT01667419|566307705|FG001|Overall Study|Reason Not Specified|0|||
156876708|NCT01667419|566307706|FG002|Overall Study|Reason Not Specified|0|||
156876709|NCT01667419|566307707|FG003|Overall Study|Reason Not Specified|0|||
157141357|NCT01084252|567265288|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
156876710|NCT01667419|566307704|FG000|Overall Study|Withdrawal by Subject|16|||
157141358|NCT01084252|567265289|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141359|NCT01084252|567265290|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141360|NCT01084252|567265291|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141361|NCT01084252|567265292|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141362|NCT01084252|567265293|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
157141363|NCT01084252|567265294|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
157141364|NCT00853632|567265295|FG000|Overall Study|Death|88|||
156735134|NCT00601172|565778361|FG001|Overall Study|Protocol Violation|5|||
156735135|NCT00601172|565778360|FG000|Overall Study|Lost to Follow-up|4|||
156735136|NCT00601172|565778361|FG001|Overall Study|Lost to Follow-up|3|||
156735137|NCT00601172|565778360|FG000|Overall Study|Physician Decision|27|||
156735138|NCT00601172|565778361|FG001|Overall Study|Physician Decision|28|||
156735139|NCT00601172|565778360|FG000|Overall Study|Withdrawal by Subject|35|||
157141365|NCT00853632|567265295|FG000|Overall Study|Withdrawal by Subject|45|||
157141366|NCT00853632|567265295|FG000|Overall Study|Lost to Follow-up|30|||
157141367|NCT00853632|567265295|FG000|Overall Study|Reoperation/Explant|17|||
157141368|NCT00853632|567265295|FG000|Overall Study|Exit with other reason|22|||
157141369|NCT04364854|567265296|FG000|Overall Study|Withdrawal by Subject|1|||
157141370|NCT04364854|567265297|FG001|Overall Study|Withdrawal by Subject|0|||
157141371|NCT04364854|567265298|FG002|Overall Study|Withdrawal by Subject|1|||
157141372|NCT04364854|567265299|FG003|Overall Study|Withdrawal by Subject|3|||
157141373|NCT04364854|567265296|FG000|Overall Study|Death|1|||
157141374|NCT04364854|567265297|FG001|Overall Study|Death|0|||
157141375|NCT04364854|567265298|FG002|Overall Study|Death|0|||
157141376|NCT04364854|567265299|FG003|Overall Study|Death|0|||
157141377|NCT04364854|567265296|FG000|Overall Study|Lost to Follow-up|0|||
157141378|NCT04364854|567265297|FG001|Overall Study|Lost to Follow-up|0|||
157141379|NCT04364854|567265298|FG002|Overall Study|Lost to Follow-up|0|||
157141380|NCT04364854|567265299|FG003|Overall Study|Lost to Follow-up|1|||
157141381|NCT04493619|567265301|FG000|Overall Study|Death|4|||
157141382|NCT04493619|567265302|FG001|Overall Study|Death|3|||
157141383|NCT04493619|567265303|FG002|Overall Study|Death|3|||
157141384|NCT04493619|567265304|FG003|Overall Study|Death|4|||
157141385|NCT04493619|567265301|FG000|Overall Study|Study discontinued early|10|||
157141386|NCT04493619|567265302|FG001|Overall Study|Study discontinued early|0|||
157141387|NCT04493619|567265303|FG002|Overall Study|Study discontinued early|4|||
157141388|NCT04493619|567265304|FG003|Overall Study|Study discontinued early|8|||
157141389|NCT04493619|567265301|FG000|Overall Study|Lost to Follow-up|0|||
157141390|NCT04493619|567265302|FG001|Overall Study|Lost to Follow-up|0|||
157141391|NCT04493619|567265303|FG002|Overall Study|Lost to Follow-up|0|||
157141392|NCT04493619|567265304|FG003|Overall Study|Lost to Follow-up|1|||
157141393|NCT02342171|567265308|FG000|Overall Study|Death|4|||
157141394|NCT02342171|567265309|FG001|Overall Study|Death|87|||
157141395|NCT02342171|567265308|FG000|Overall Study|Received favipiravir|10|||
157141396|NCT02342171|567265309|FG001|Overall Study|Received favipiravir|0|||
157141397|NCT02342171|567265308|FG000|Overall Study|Missing cycle treshold value|1|||
157141398|NCT02342171|567265309|FG001|Overall Study|Missing cycle treshold value|0|||
157141399|NCT02342171|567265308|FG000|Overall Study|Unknown outcome|0|||
157141400|NCT02342171|567265309|FG001|Overall Study|Unknown outcome|1|||
157141401|NCT02342171|567265308|FG000|Overall Study|Missing age data|0|||
157141402|NCT02342171|567265309|FG001|Overall Study|Missing age data|1|||
157141403|NCT00886821|567265310|FG000|Stage 2|Adverse Event|0|||
157141404|NCT00886821|567265311|FG001|Stage 2|Adverse Event|0|||
157141405|NCT00886821|567265312|FG002|Stage 2|Adverse Event|0|||
157141406|NCT00886821|567265313|FG003|Stage 2|Adverse Event|0|||
157141407|NCT00886821|567265314|FG004|Stage 2|Adverse Event|0|||
157141408|NCT00886821|567265315|FG005|Stage 2|Adverse Event|0|||
157141409|NCT00886821|567265316|FG006|Stage 2|Adverse Event|0|||
157141410|NCT00886821|567265317|FG007|Stage 2|Adverse Event|0|||
157141411|NCT00886821|567265318|FG008|Stage 2|Adverse Event|0|||
157141412|NCT00886821|567265319|FG009|Stage 2|Adverse Event|0|||
157141413|NCT00886821|567265320|FG010|Stage 2|Adverse Event|0|||
157141414|NCT00886821|567265321|FG011|Stage 2|Adverse Event|1|||
156735140|NCT00601172|565778361|FG001|Overall Study|Withdrawal by Subject|27|||
156735141|NCT00601172|565778360|FG000|Overall Study|Did not meet continuation criteria|19|||
156735142|NCT00601172|565778361|FG001|Overall Study|Did not meet continuation criteria|20|||
156735143|NCT04434469|565778362|FG000|Overall Study|Death|2|||
157141415|NCT00886821|567265322|FG012|Stage 2|Adverse Event|3|||
157141416|NCT00886821|567265323|FG013|Stage 2|Adverse Event|0|||
157141417|NCT00886821|567265310|FG000|Stage 2|Lost to Follow-up|0|||
157141418|NCT00886821|567265311|FG001|Stage 2|Lost to Follow-up|0|||
157141419|NCT00886821|567265312|FG002|Stage 2|Lost to Follow-up|0|||
157141420|NCT00886821|567265313|FG003|Stage 2|Lost to Follow-up|0|||
157141421|NCT00886821|567265314|FG004|Stage 2|Lost to Follow-up|0|||
156735144|NCT04434469|565778363|FG001|Overall Study|Death|3|||
157141422|NCT00886821|567265315|FG005|Stage 2|Lost to Follow-up|0|||
156808821|NCT01484496|566054474|FG001|Period 1|Withdrawal by Subject|12|||
157141423|NCT00886821|567265316|FG006|Stage 2|Lost to Follow-up|0|||
157141424|NCT00886821|567265317|FG007|Stage 2|Lost to Follow-up|0|||
156735145|NCT04434469|565778364|FG002|Overall Study|Death|2|||
157141425|NCT00886821|567265318|FG008|Stage 2|Lost to Follow-up|0|||
157141426|NCT00886821|567265319|FG009|Stage 2|Lost to Follow-up|0|||
156735146|NCT04434469|565778365|FG003|Overall Study|Death|2|||
156735147|NCT04434469|565778366|FG004|Overall Study|Death|2|||
156735148|NCT04434469|565778367|FG005|Overall Study|Death|0|||
156735149|NCT04434469|565778362|FG000|Overall Study|Lost to Follow-up|0|||
156735150|NCT04434469|565778363|FG001|Overall Study|Lost to Follow-up|0|||
156735151|NCT04434469|565778364|FG002|Overall Study|Lost to Follow-up|0|||
156735152|NCT04434469|565778365|FG003|Overall Study|Lost to Follow-up|1|||
156735153|NCT04434469|565778366|FG004|Overall Study|Lost to Follow-up|1|||
156735154|NCT04434469|565778367|FG005|Overall Study|Lost to Follow-up|0|||
156735155|NCT04434469|565778362|FG000|Overall Study|Study terminated by sponsor|1|||
156735156|NCT04434469|565778363|FG001|Overall Study|Study terminated by sponsor|1|||
156735157|NCT04434469|565778364|FG002|Overall Study|Study terminated by sponsor|1|||
156735158|NCT04434469|565778365|FG003|Overall Study|Study terminated by sponsor|2|||
156735159|NCT04434469|565778366|FG004|Overall Study|Study terminated by sponsor|3|||
156735160|NCT04434469|565778367|FG005|Overall Study|Study terminated by sponsor|3|||
156735161|NCT04434469|565778362|FG000|Overall Study|Withdrawal by Subject|0|||
156735162|NCT04434469|565778363|FG001|Overall Study|Withdrawal by Subject|0|||
156735163|NCT04434469|565778364|FG002|Overall Study|Withdrawal by Subject|1|||
156735164|NCT04434469|565778365|FG003|Overall Study|Withdrawal by Subject|0|||
156735165|NCT04434469|565778366|FG004|Overall Study|Withdrawal by Subject|0|||
156735166|NCT04434469|565778367|FG005|Overall Study|Withdrawal by Subject|0|||
156735167|NCT02703272|565778371|FG000|Overall Study|Death|4|||
156735168|NCT02703272|565778372|FG001|Overall Study|Death|9|||
156735169|NCT02703272|565778373|FG002|Overall Study|Death|19|||
156735170|NCT02703272|565778374|FG003|Overall Study|Death|10|||
156735171|NCT02703272|565778371|FG000|Overall Study|Withdrawal by Subject|0|||
156735172|NCT02703272|565778372|FG001|Overall Study|Withdrawal by Subject|0|||
156735173|NCT02703272|565778373|FG002|Overall Study|Withdrawal by Subject|4|||
157141427|NCT00886821|567265320|FG010|Stage 2|Lost to Follow-up|0|||
157141428|NCT00886821|567265321|FG011|Stage 2|Lost to Follow-up|0|||
157141429|NCT00886821|567265322|FG012|Stage 2|Lost to Follow-up|2|||
157141430|NCT00886821|567265323|FG013|Stage 2|Lost to Follow-up|1|||
157141431|NCT03368859|567265324|FG000|Overall Study|Withdrew Consent|5|||
157141432|NCT03368859|567265325|FG001|Overall Study|Withdrew Consent|4|||
157141433|NCT03368859|567265324|FG000|Overall Study|Death|12|||
157141434|NCT03368859|567265325|FG001|Overall Study|Death|6|||
157141435|NCT03368859|567265324|FG000|Overall Study|Study terminated by Sponsor|18|||
157141436|NCT03368859|567265325|FG001|Overall Study|Study terminated by Sponsor|23|||
157141437|NCT03368859|567265324|FG000|Overall Study|Other|1|||
157141438|NCT03368859|567265325|FG001|Overall Study|Other|1|||
157141439|NCT03090191|567265326|FG000|Overall Study|Adverse Event|90|||
157141440|NCT03090191|567265327|FG001|Overall Study|Adverse Event|72|||
157141441|NCT03090191|567265326|FG000|Overall Study|Death|365|||
157141442|NCT03090191|567265327|FG001|Overall Study|Death|358|||
157141443|NCT03090191|567265326|FG000|Overall Study|Lost to Follow-up|382|||
157141444|NCT03090191|567265327|FG001|Overall Study|Lost to Follow-up|394|||
157141445|NCT03090191|567265326|FG000|Overall Study|Physician Decision|77|||
157141446|NCT03090191|567265327|FG001|Overall Study|Physician Decision|66|||
157141447|NCT03090191|567265326|FG000|Overall Study|Protocol Violation|43|||
157141448|NCT03090191|567265327|FG001|Overall Study|Protocol Violation|52|||
157141449|NCT03090191|567265326|FG000|Overall Study|Withdrawal by Subject|2160|||
157141450|NCT03090191|567265327|FG001|Overall Study|Withdrawal by Subject|2133|||
157141451|NCT03090191|567265326|FG000|Overall Study|Site terminated|7|||
156735174|NCT02703272|565778374|FG003|Overall Study|Withdrawal by Subject|2|||
156735175|NCT02703272|565778371|FG000|Overall Study|Study Terminated by Sponsor|6|||
156735176|NCT02703272|565778372|FG001|Overall Study|Study Terminated by Sponsor|1|||
156735177|NCT02703272|565778373|FG002|Overall Study|Study Terminated by Sponsor|12|||
156735178|NCT02703272|565778374|FG003|Overall Study|Study Terminated by Sponsor|4|||
156735179|NCT02703272|565778371|FG000|Overall Study|Other|1|||
156735180|NCT02703272|565778372|FG001|Overall Study|Other|0|||
156735181|NCT02703272|565778373|FG002|Overall Study|Other|0|||
157141452|NCT03090191|567265327|FG001|Overall Study|Site terminated|8|||
157141453|NCT03090191|567265326|FG000|Overall Study|Other|66|||
157141454|NCT03090191|567265327|FG001|Overall Study|Other|60|||
157141455|NCT03090191|567265326|FG000|Overall Study|Withdrawn before any study vaccination|43|||
157141456|NCT03090191|567265327|FG001|Overall Study|Withdrawn before any study vaccination|52|||
156735182|NCT02703272|565778374|FG003|Overall Study|Other|0|||
156735183|NCT04470544|565778377|FG000|Overall Study|Withdrawal by Subject|4|||
156735184|NCT04470544|565778378|FG001|Overall Study|Withdrawal by Subject|6|||
156735185|NCT00712881|565778379|FG000|Overall Study|Adverse Event|3|||
156735186|NCT00712881|565778380|FG001|Overall Study|Adverse Event|3|||
156735187|NCT00712881|565778379|FG000|Overall Study|Withdrawal by Subject|1|||
156735188|NCT00712881|565778380|FG001|Overall Study|Withdrawal by Subject|1|||
156735189|NCT00712881|565778379|FG000|Overall Study|Disease Progression|2|||
156735190|NCT00712881|565778380|FG001|Overall Study|Disease Progression|1|||
156735191|NCT00712881|565778379|FG000|Overall Study|Lost to Follow-up|1|||
157141457|NCT01845025|567265330|FG000|Overall Study|Adverse Event|6|||
157141458|NCT01845025|567265331|FG001|Overall Study|Adverse Event|3|||
157141459|NCT01845025|567265330|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157217944|NCT00185211|567543407|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
157217945|NCT00185211|567543408|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
157217946|NCT00185211|567543407|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
157217947|NCT00185211|567543408|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
157217948|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
157217949|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
157217950|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
157217951|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
157217952|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
157217953|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
157217954|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
157217955|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
157217956|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
157217957|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
157217958|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
157217959|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
157217960|NCT00185211|567543407|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
157217961|NCT00185211|567543408|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
157217962|NCT00433381|567545528|FG000|Overall Study|Ineligible / no protocol treatment|3|||
157217963|NCT00433381|567545529|FG001|Overall Study|Ineligible / no protocol treatment|3|||
157217964|NCT00458302|567545530|FG000|Overall Study|Adverse Event|4|||
157217965|NCT00458302|567545531|FG001|Overall Study|Adverse Event|14|||
157217966|NCT00458302|567545530|FG000|Overall Study|Pregnancy|2|||
157217967|NCT00458302|567545531|FG001|Overall Study|Pregnancy|1|||
156735192|NCT00712881|565778380|FG001|Overall Study|Lost to Follow-up|1|||
156735193|NCT00712881|565778379|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
156735194|NCT00712881|565778380|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
156735195|NCT00712881|565778379|FG000|Overall Study|Protocol Violation|1|||
156735196|NCT00712881|565778380|FG001|Overall Study|Protocol Violation|1|||
156735197|NCT00712881|565778379|FG000|Overall Study|Randomized but not treated|1|||
156735198|NCT00712881|565778380|FG001|Overall Study|Randomized but not treated|0|||
156735199|NCT01680861|565778381|FG000|Early Post-transplant Period|Protocol Violation|1|||
156735200|NCT01680861|565778382|FG001|Early Post-transplant Period|Protocol Violation|1|||
156735201|NCT04720911|565778385|FG000|Overall Study|Withdrawal by Subject|0|||
156735202|NCT04720911|565778386|FG001|Overall Study|Withdrawal by Subject|1|||
156735203|NCT04720911|565778387|FG002|Overall Study|Withdrawal by Subject|0|||
156735204|NCT00537316|565778389|FG000|Part 1|Adverse Event|7|||
156735205|NCT00537316|565778390|FG001|Part 1|Adverse Event|11|||
157217968|NCT00458302|567545530|FG000|Overall Study|Protocol Violation|0|||
157217969|NCT00458302|567545531|FG001|Overall Study|Protocol Violation|2|||
157217970|NCT00458302|567545530|FG000|Overall Study|Withdrawal by Subject|6|||
157217971|NCT00458302|567545531|FG001|Overall Study|Withdrawal by Subject|4|||
157217972|NCT00458302|567545530|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
157217973|NCT00458302|567545531|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
157217974|NCT00458302|567545530|FG000|Overall Study|Study Termination By Sponsor|1|||
157217975|NCT00458302|567545531|FG001|Overall Study|Study Termination By Sponsor|0|||
157217976|NCT00458302|567545530|FG000|Overall Study|Lost to Follow-up|2|||
157217977|NCT00458302|567545531|FG001|Overall Study|Lost to Follow-up|0|||
157217978|NCT00458302|567545530|FG000|Overall Study|Other|4|||
157217979|NCT00458302|567545531|FG001|Overall Study|Other|2|||
157217980|NCT01381900|567545538|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
157217981|NCT01381900|567545539|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
156735206|NCT00537316|565778391|FG002|Part 1|Adverse Event|8|||
156735207|NCT00537316|565778392|FG003|Part 1|Adverse Event|0|||
156735208|NCT00537316|565778393|FG004|Part 1|Adverse Event|0|||
156735209|NCT00537316|565778394|FG005|Part 1|Adverse Event|0|||
156735210|NCT00537316|565778395|FG006|Part 1|Adverse Event|0|||
156735211|NCT00537316|565778389|FG000|Part 1|Protocol defined clinical event|1|||
157217982|NCT01381900|567545540|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
156735212|NCT00537316|565778390|FG001|Part 1|Protocol defined clinical event|0|||
156735213|NCT00537316|565778391|FG002|Part 1|Protocol defined clinical event|0|||
156808822|NCT01484496|566054475|FG002|Period 1|Withdrawal by Subject|0|||
156808823|NCT01484496|566054476|FG003|Period 1|Withdrawal by Subject|0|||
156808824|NCT01484496|566054473|FG000|Period 1|Lost to Follow-up|2|||
156808825|NCT01484496|566054474|FG001|Period 1|Lost to Follow-up|6|||
156808826|NCT01484496|566054475|FG002|Period 1|Lost to Follow-up|0|||
156808827|NCT01484496|566054476|FG003|Period 1|Lost to Follow-up|0|||
156808828|NCT01484496|566054473|FG000|Period 1|Positive Pregnancy|1|||
156808829|NCT01484496|566054474|FG001|Period 1|Positive Pregnancy|6|||
156808830|NCT01484496|566054475|FG002|Period 1|Positive Pregnancy|0|||
156808831|NCT01484496|566054476|FG003|Period 1|Positive Pregnancy|0|||
156808832|NCT01484496|566054473|FG000|Period 1|Treatment Failure|3|||
156808833|NCT01484496|566054474|FG001|Period 1|Treatment Failure|6|||
157217983|NCT01381900|567545538|FG000|Overall Study|Adverse Event|4|||
156735214|NCT00537316|565778392|FG003|Part 1|Protocol defined clinical event|0|||
156735215|NCT00537316|565778393|FG004|Part 1|Protocol defined clinical event|0|||
156735216|NCT00537316|565778394|FG005|Part 1|Protocol defined clinical event|0|||
156735217|NCT00537316|565778395|FG006|Part 1|Protocol defined clinical event|0|||
157141460|NCT01845025|567265331|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157141461|NCT01845025|567265330|FG000|Overall Study|Withdrawal by Subject|48|||
157141462|NCT01845025|567265331|FG001|Overall Study|Withdrawal by Subject|44|||
157141463|NCT01845025|567265330|FG000|Overall Study|Lost to Follow-up|13|||
157141464|NCT01845025|567265331|FG001|Overall Study|Lost to Follow-up|13|||
157141465|NCT01845025|567265330|FG000|Overall Study|Administrative problems|8|||
157141466|NCT01845025|567265331|FG001|Overall Study|Administrative problems|8|||
156735218|NCT00537316|565778389|FG000|Part 1|Lost to Follow-up|1|||
156735219|NCT00537316|565778390|FG001|Part 1|Lost to Follow-up|0|||
156735220|NCT00537316|565778391|FG002|Part 1|Lost to Follow-up|0|||
156735221|NCT00537316|565778392|FG003|Part 1|Lost to Follow-up|0|||
156735222|NCT00537316|565778393|FG004|Part 1|Lost to Follow-up|0|||
156735223|NCT00537316|565778394|FG005|Part 1|Lost to Follow-up|0|||
156735224|NCT00537316|565778395|FG006|Part 1|Lost to Follow-up|0|||
156735225|NCT00537316|565778389|FG000|Part 1|Withdrawal by Subject|3|||
156735226|NCT00537316|565778390|FG001|Part 1|Withdrawal by Subject|8|||
156735227|NCT00537316|565778391|FG002|Part 1|Withdrawal by Subject|4|||
156735228|NCT00537316|565778392|FG003|Part 1|Withdrawal by Subject|0|||
156735229|NCT00537316|565778393|FG004|Part 1|Withdrawal by Subject|0|||
156735230|NCT00537316|565778394|FG005|Part 1|Withdrawal by Subject|0|||
156735231|NCT00537316|565778395|FG006|Part 1|Withdrawal by Subject|0|||
156735232|NCT00537316|565778389|FG000|Part 1|Protocol Violation|1|||
156735233|NCT00537316|565778390|FG001|Part 1|Protocol Violation|5|||
156735234|NCT00537316|565778391|FG002|Part 1|Protocol Violation|1|||
156735235|NCT00537316|565778392|FG003|Part 1|Protocol Violation|0|||
156735236|NCT00537316|565778393|FG004|Part 1|Protocol Violation|0|||
156735237|NCT00537316|565778394|FG005|Part 1|Protocol Violation|0|||
156735238|NCT00537316|565778395|FG006|Part 1|Protocol Violation|0|||
156735239|NCT00537316|565778389|FG000|Part 1|Did not meet protocol eligibility|1|||
156735240|NCT00537316|565778390|FG001|Part 1|Did not meet protocol eligibility|3|||
156735241|NCT00537316|565778391|FG002|Part 1|Did not meet protocol eligibility|2|||
156735242|NCT00537316|565778392|FG003|Part 1|Did not meet protocol eligibility|0|||
156735243|NCT00537316|565778393|FG004|Part 1|Did not meet protocol eligibility|0|||
156735244|NCT00537316|565778394|FG005|Part 1|Did not meet protocol eligibility|0|||
157141467|NCT01845025|567265330|FG000|Overall Study|Death|2|||
157141468|NCT01845025|567265331|FG001|Overall Study|Death|0|||
157141469|NCT01845025|567265330|FG000|Overall Study|Protocol deviation|3|||
157141470|NCT01845025|567265331|FG001|Overall Study|Protocol deviation|6|||
157141471|NCT01845025|567265330|FG000|Overall Study|Missing|1|||
157141472|NCT01845025|567265331|FG001|Overall Study|Missing|1|||
157141473|NCT04645797|567265332|FG000|Overall Study|Disease Progression|3|||
157141474|NCT04645797|567265333|FG001|Overall Study|Disease Progression|3|||
157141475|NCT04645797|567265334|FG002|Overall Study|Disease Progression|1|||
157141476|NCT04645797|567265335|FG003|Overall Study|Disease Progression|0|||
157141477|NCT04645797|567265336|FG004|Overall Study|Disease Progression|0|||
157141478|NCT04645797|567265337|FG005|Overall Study|Disease Progression|0|||
157141479|NCT04645797|567265338|FG006|Overall Study|Disease Progression|0|||
157141480|NCT04645797|567265332|FG000|Overall Study|Death|3|||
157141481|NCT04645797|567265333|FG001|Overall Study|Death|1|||
157141482|NCT04645797|567265334|FG002|Overall Study|Death|0|||
157141483|NCT04645797|567265335|FG003|Overall Study|Death|0|||
157141484|NCT04645797|567265336|FG004|Overall Study|Death|0|||
157141485|NCT04645797|567265337|FG005|Overall Study|Death|0|||
156735245|NCT00537316|565778395|FG006|Part 1|Did not meet protocol eligibility|0|||
156735246|NCT00537316|565778389|FG000|Part 1|Administrative|0|||
156735247|NCT00537316|565778390|FG001|Part 1|Administrative|0|||
156735248|NCT00537316|565778391|FG002|Part 1|Administrative|2|||
156735249|NCT00537316|565778392|FG003|Part 1|Administrative|0|||
156735250|NCT00537316|565778393|FG004|Part 1|Administrative|0|||
156735251|NCT00537316|565778394|FG005|Part 1|Administrative|0|||
156735252|NCT00537316|565778395|FG006|Part 1|Administrative|0|||
156735253|NCT00537316|565778389|FG000|Part 2|Never entered follow-up|0|||
156735254|NCT00537316|565778390|FG001|Part 2|Never entered follow-up|0|||
156735255|NCT00537316|565778391|FG002|Part 2|Never entered follow-up|0|||
156735256|NCT00537316|565778392|FG003|Part 2|Never entered follow-up|0|||
156735257|NCT00537316|565778393|FG004|Part 2|Never entered follow-up|0|||
156735258|NCT00537316|565778394|FG005|Part 2|Never entered follow-up|0|||
157141486|NCT04645797|567265338|FG006|Overall Study|Death|0|||
157141487|NCT00813748|567265341|FG000|Skin Test Substudy|Physician Decision|0|||
157141488|NCT00813748|567265342|FG001|Skin Test Substudy|Physician Decision|1|||
157141489|NCT01931865|567265345|FG000|Overall Study|Lost to Follow-up|2|||
157141490|NCT01931865|567265345|FG000|Overall Study|Withdrawal by Subject|2|||
157141491|NCT01829048|567265346|FG000|Overall Study|Withdrawal by Subject|0|||
156735259|NCT00537316|565778395|FG006|Part 2|Never entered follow-up|1|||
156735260|NCT00537316|565778389|FG000|Part 2|Adverse Event|4|||
156735261|NCT00537316|565778390|FG001|Part 2|Adverse Event|0|||
157141492|NCT01829048|567265347|FG001|Overall Study|Withdrawal by Subject|0|||
156876711|NCT01667419|566307705|FG001|Overall Study|Withdrawal by Subject|8|||
156876712|NCT01667419|566307706|FG002|Overall Study|Withdrawal by Subject|9|||
156876713|NCT01667419|566307707|FG003|Overall Study|Withdrawal by Subject|8|||
157020194|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
157020195|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
157020196|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
156735262|NCT00537316|565778391|FG002|Part 2|Adverse Event|2|||
156735263|NCT00537316|565778392|FG003|Part 2|Adverse Event|0|||
157020197|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
157020198|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
157141493|NCT01829048|567265348|FG002|Overall Study|Withdrawal by Subject|0|||
157141494|NCT01829048|567265349|FG003|Overall Study|Withdrawal by Subject|2|||
157141495|NCT01829048|567265350|FG004|Overall Study|Withdrawal by Subject|0|||
157141496|NCT01121406|567265351|FG000|Overall Study|Progressive disease RECIST|44|||
156735264|NCT00537316|565778393|FG004|Part 2|Adverse Event|0|||
156735265|NCT00537316|565778394|FG005|Part 2|Adverse Event|0|||
156735266|NCT00537316|565778395|FG006|Part 2|Adverse Event|0|||
156735267|NCT00537316|565778389|FG000|Part 2|Lost to Follow-up|1|||
156735268|NCT00537316|565778390|FG001|Part 2|Lost to Follow-up|0|||
156735269|NCT00537316|565778391|FG002|Part 2|Lost to Follow-up|2|||
156735270|NCT00537316|565778392|FG003|Part 2|Lost to Follow-up|0|||
156735271|NCT00537316|565778393|FG004|Part 2|Lost to Follow-up|0|||
156735272|NCT00537316|565778394|FG005|Part 2|Lost to Follow-up|0|||
156735273|NCT00537316|565778395|FG006|Part 2|Lost to Follow-up|0|||
157141497|NCT01121406|567265352|FG001|Overall Study|Progressive disease RECIST|28|||
157141498|NCT01121406|567265351|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
157141499|NCT01121406|567265352|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
156735274|NCT00537316|565778389|FG000|Part 2|Withdrawal by Subject|5|||
156735275|NCT00537316|565778390|FG001|Part 2|Withdrawal by Subject|1|||
156735276|NCT00537316|565778391|FG002|Part 2|Withdrawal by Subject|4|||
156735277|NCT00537316|565778392|FG003|Part 2|Withdrawal by Subject|0|||
156735278|NCT00537316|565778393|FG004|Part 2|Withdrawal by Subject|0|||
156735279|NCT00537316|565778394|FG005|Part 2|Withdrawal by Subject|0|||
156735280|NCT00537316|565778395|FG006|Part 2|Withdrawal by Subject|0|||
156735281|NCT00537316|565778389|FG000|Part 2|Administrative|16|||
156735282|NCT00537316|565778390|FG001|Part 2|Administrative|8|||
156735283|NCT00537316|565778391|FG002|Part 2|Administrative|24|||
156735284|NCT00537316|565778392|FG003|Part 2|Administrative|3|||
156735285|NCT00537316|565778393|FG004|Part 2|Administrative|1|||
156735286|NCT00537316|565778394|FG005|Part 2|Administrative|4|||
156735287|NCT00537316|565778395|FG006|Part 2|Administrative|1|||
156735288|NCT02651155|565778398|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156735289|NCT02651155|565778399|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156735290|NCT02651155|565778398|FG000|Overall Study|Voluntary Withdrawal|5|||
156735291|NCT02651155|565778399|FG001|Overall Study|Voluntary Withdrawal|0|||
156735292|NCT01867710|565778400|FG000|Overall Study|Death|25|||
156735293|NCT01867710|565778401|FG001|Overall Study|Death|15|||
156735294|NCT01867710|565778402|FG002|Overall Study|Death|27|||
156796848|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
156796849|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
156796850|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
156796851|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796852|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796853|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796854|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796855|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796856|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
156796857|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Death|0|||
156796858|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Death|0|||
156796859|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Death|0|||
156796860|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Death|0|||
156796861|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Death|1|||
156796862|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Death|0|||
156796863|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Death|0|||
156796864|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Death|0|||
157020199|NCT01261312|566826524|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157141500|NCT01121406|567265351|FG000|Overall Study|Other AE|3|||
157141501|NCT01121406|567265352|FG001|Overall Study|Other AE|10|||
157141502|NCT01121406|567265351|FG000|Overall Study|Non-compliant with protocol|0|||
157141503|NCT01121406|567265352|FG001|Overall Study|Non-compliant with protocol|2|||
157141504|NCT01121406|567265351|FG000|Overall Study|Lost to Follow-up|0|||
157141505|NCT01121406|567265352|FG001|Overall Study|Lost to Follow-up|1|||
157141506|NCT01121406|567265351|FG000|Overall Study|Refused continuation of study med.|1|||
157141507|NCT01121406|567265352|FG001|Overall Study|Refused continuation of study med.|2|||
157141508|NCT01121406|567265351|FG000|Overall Study|Reason other than specified above|2|||
156735295|NCT01867710|565778403|FG003|Overall Study|Death|20|||
156735296|NCT01867710|565778400|FG000|Overall Study|Lost to Follow-up|3|||
156735297|NCT01867710|565778401|FG001|Overall Study|Lost to Follow-up|4|||
157141509|NCT01121406|567265352|FG001|Overall Study|Reason other than specified above|6|||
157141510|NCT01121406|567265351|FG000|Overall Study|Not treated|1|||
157141511|NCT01121406|567265352|FG001|Overall Study|Not treated|0|||
157141512|NCT03185130|567265353|FG000|Overall Study|Withdrawal by Subject|0|||
157141513|NCT03185130|567265354|FG001|Overall Study|Withdrawal by Subject|2|||
157141514|NCT00500071|567265372|FG000|Screening and Washout Phase|Protocol Violation|1|||
157141515|NCT00500071|567265372|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
157217984|NCT01381900|567545539|FG001|Overall Study|Adverse Event|6|||
157217985|NCT01381900|567545540|FG002|Overall Study|Adverse Event|7|||
157217986|NCT01381900|567545538|FG000|Overall Study|Noncompliance with study drug|0|||
157217987|NCT01381900|567545539|FG001|Overall Study|Noncompliance with study drug|0|||
157217988|NCT01381900|567545540|FG002|Overall Study|Noncompliance with study drug|1|||
157217989|NCT01381900|567545538|FG000|Overall Study|Physician Decision|0|||
157217990|NCT01381900|567545539|FG001|Overall Study|Physician Decision|1|||
157217991|NCT01381900|567545540|FG002|Overall Study|Physician Decision|1|||
157217992|NCT01381900|567545538|FG000|Overall Study|Protocol Violation|0|||
157217993|NCT01381900|567545539|FG001|Overall Study|Protocol Violation|1|||
156735298|NCT01867710|565778402|FG002|Overall Study|Lost to Follow-up|3|||
156735299|NCT01867710|565778403|FG003|Overall Study|Lost to Follow-up|2|||
156735300|NCT01867710|565778400|FG000|Overall Study|Withdrawal of consent|2|||
156735301|NCT01867710|565778401|FG001|Overall Study|Withdrawal of consent|5|||
156735302|NCT01867710|565778402|FG002|Overall Study|Withdrawal of consent|1|||
156735303|NCT01867710|565778403|FG003|Overall Study|Withdrawal of consent|2|||
156735304|NCT01867710|565778400|FG000|Overall Study|Study Terminated by Sponsor|9|||
156735305|NCT01867710|565778401|FG001|Overall Study|Study Terminated by Sponsor|13|||
156735306|NCT01867710|565778402|FG002|Overall Study|Study Terminated by Sponsor|8|||
156735307|NCT01867710|565778403|FG003|Overall Study|Study Terminated by Sponsor|16|||
156735308|NCT01867710|565778400|FG000|Overall Study|Biochemical progression|0|||
156876714|NCT01667419|566307704|FG000|Overall Study|Non-compliance|0|||
156876715|NCT01667419|566307705|FG001|Overall Study|Non-compliance|0|||
156876716|NCT01667419|566307706|FG002|Overall Study|Non-compliance|0|||
156876717|NCT01667419|566307707|FG003|Overall Study|Non-compliance|1|||
156876718|NCT01667419|566307704|FG000|Overall Study|Protocol Violation|1|||
156876719|NCT01667419|566307705|FG001|Overall Study|Protocol Violation|0|||
156876720|NCT01667419|566307706|FG002|Overall Study|Protocol Violation|0|||
156876721|NCT01667419|566307707|FG003|Overall Study|Protocol Violation|0|||
156876722|NCT01667419|566307704|FG000|Overall Study|Lost to Follow-up|7|||
156876723|NCT01667419|566307705|FG001|Overall Study|Lost to Follow-up|6|||
156876724|NCT01667419|566307706|FG002|Overall Study|Lost to Follow-up|2|||
156876725|NCT01667419|566307707|FG003|Overall Study|Lost to Follow-up|4|||
156876726|NCT01667419|566307704|FG000|Overall Study|Death|18|||
156876727|NCT01667419|566307705|FG001|Overall Study|Death|33|||
156876728|NCT01667419|566307706|FG002|Overall Study|Death|25|||
157141516|NCT00500071|567265372|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
157141517|NCT00500071|567265372|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
157141518|NCT00500071|567265372|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
157141519|NCT00500071|567265372|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
157141520|NCT00500071|567265372|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
157141521|NCT02333227|567265375|FG000|Overall Study|Lost to Follow-up|137|||
157217994|NCT01381900|567545540|FG002|Overall Study|Protocol Violation|1|||
157217995|NCT01381900|567545538|FG000|Overall Study|Withdrawal by Subject|0|||
156735309|NCT01867710|565778401|FG001|Overall Study|Biochemical progression|1|||
156735310|NCT01867710|565778402|FG002|Overall Study|Biochemical progression|0|||
156735311|NCT01867710|565778403|FG003|Overall Study|Biochemical progression|0|||
156735312|NCT01867710|565778400|FG000|Overall Study|Clinical progression|0|||
156735313|NCT01867710|565778401|FG001|Overall Study|Clinical progression|0|||
156735314|NCT01867710|565778402|FG002|Overall Study|Clinical progression|1|||
156735315|NCT01867710|565778403|FG003|Overall Study|Clinical progression|0|||
156735316|NCT01867710|565778400|FG000|Overall Study|Disease progression|1|||
156735317|NCT01867710|565778401|FG001|Overall Study|Disease progression|0|||
156735318|NCT01867710|565778402|FG002|Overall Study|Disease progression|0|||
156735319|NCT01867710|565778403|FG003|Overall Study|Disease progression|0|||
156735320|NCT01867710|565778400|FG000|Overall Study|Patient decision|0|||
156735321|NCT01867710|565778401|FG001|Overall Study|Patient decision|0|||
156735322|NCT01867710|565778402|FG002|Overall Study|Patient decision|0|||
156735323|NCT01867710|565778403|FG003|Overall Study|Patient decision|1|||
156735324|NCT01867710|565778400|FG000|Overall Study|Patient to follow subsequent treatment|0|||
156735325|NCT01867710|565778401|FG001|Overall Study|Patient to follow subsequent treatment|1|||
156735326|NCT01867710|565778402|FG002|Overall Study|Patient to follow subsequent treatment|0|||
156735327|NCT01867710|565778403|FG003|Overall Study|Patient to follow subsequent treatment|0|||
156735328|NCT01867710|565778400|FG000|Overall Study|Progressive disease|1|||
156735329|NCT01867710|565778401|FG001|Overall Study|Progressive disease|0|||
156876729|NCT01667419|566307707|FG003|Overall Study|Death|26|||
157141522|NCT02333227|567265376|FG001|Overall Study|Lost to Follow-up|106|||
156735330|NCT01867710|565778402|FG002|Overall Study|Progressive disease|0|||
156876730|NCT00856518|566307708|FG000|Overall Study|Lost to Follow-up|4|||
156876731|NCT00856518|566307709|FG001|Overall Study|Lost to Follow-up|2|||
156796865|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Death|0|||
156796866|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Death|0|||
156796867|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Death|0|||
156796868|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Death|0|||
156796869|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796870|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796871|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796872|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
156796873|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796874|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796875|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796876|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796877|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796878|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796879|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796880|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
156796881|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796882|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796883|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796884|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
157141523|NCT02333227|567265375|FG000|Overall Study|Pregnancy Interrupted|42|||
157141524|NCT02333227|567265376|FG001|Overall Study|Pregnancy Interrupted|89|||
157141525|NCT02333227|567265375|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
157141526|NCT02333227|567265376|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
157141527|NCT01076179|567265379|FG000|Overall Study|Withdrawal by Subject|1|||
157141528|NCT03459040|567265380|FG000|Overall Study|Death|8|||
157141529|NCT03459040|567265380|FG000|Overall Study|Withdrawal by Subject|1|||
157141530|NCT00986349|567265381|FG000|Overall Study|Unsuccessful implant procedure|3|||
157141531|NCT00986349|567265381|FG000|Overall Study|Adverse Event|2|||
157141532|NCT00986349|567265381|FG000|Overall Study|Physician Decision|1|||
157141533|NCT00986349|567265381|FG000|Overall Study|device migration|1|||
157141534|NCT02299934|567265382|FG000|Overall Study|Termination of study|13|||
157141535|NCT00561353|567265383|FG000|Overall Study|Subject reached a virologic endpoint|2|||
157141536|NCT00561353|567265384|FG001|Overall Study|Subject reached a virologic endpoint|1|||
157141537|NCT00561353|567265385|FG002|Overall Study|Subject reached a virologic endpoint|1|||
157141538|NCT00561353|567265386|FG003|Overall Study|Subject reached a virologic endpoint|4|||
157141539|NCT00561353|567265387|FG004|Overall Study|Subject reached a virologic endpoint|1|||
157141540|NCT00561353|567265388|FG005|Overall Study|Subject reached a virologic endpoint|3|||
157141541|NCT00561353|567265389|FG006|Overall Study|Subject reached a virologic endpoint|4|||
157141542|NCT00561353|567265390|FG007|Overall Study|Subject reached a virologic endpoint|4|||
157141543|NCT00561353|567265391|FG008|Overall Study|Subject reached a virologic endpoint|5|||
157141544|NCT00561353|567265392|FG009|Overall Study|Subject reached a virologic endpoint|0|||
157141545|NCT00561353|567265383|FG000|Overall Study|Subject ineligible to continue the trial|0|||
157141546|NCT00561353|567265384|FG001|Overall Study|Subject ineligible to continue the trial|0|||
157141547|NCT00561353|567265385|FG002|Overall Study|Subject ineligible to continue the trial|0|||
157141548|NCT00561353|567265386|FG003|Overall Study|Subject ineligible to continue the trial|0|||
157141549|NCT00561353|567265387|FG004|Overall Study|Subject ineligible to continue the trial|0|||
157141550|NCT00561353|567265388|FG005|Overall Study|Subject ineligible to continue the trial|1|||
157141551|NCT00561353|567265389|FG006|Overall Study|Subject ineligible to continue the trial|1|||
157141552|NCT00561353|567265390|FG007|Overall Study|Subject ineligible to continue the trial|0|||
157141553|NCT00561353|567265391|FG008|Overall Study|Subject ineligible to continue the trial|2|||
157141554|NCT00561353|567265392|FG009|Overall Study|Subject ineligible to continue the trial|1|||
157141555|NCT00561353|567265383|FG000|Overall Study|Other|1|||
157141556|NCT00561353|567265384|FG001|Overall Study|Other|0|||
157141557|NCT00561353|567265385|FG002|Overall Study|Other|1|||
157141558|NCT00561353|567265386|FG003|Overall Study|Other|0|||
157141559|NCT00561353|567265387|FG004|Overall Study|Other|0|||
157141560|NCT00561353|567265388|FG005|Overall Study|Other|2|||
157141561|NCT00561353|567265389|FG006|Overall Study|Other|0|||
157141562|NCT00561353|567265390|FG007|Overall Study|Other|0|||
157141563|NCT00561353|567265391|FG008|Overall Study|Other|0|||
157141564|NCT00561353|567265392|FG009|Overall Study|Other|0|||
157141565|NCT00561353|567265383|FG000|Overall Study|Adverse Event|0|||
157141566|NCT00561353|567265384|FG001|Overall Study|Adverse Event|0|||
157141567|NCT00561353|567265385|FG002|Overall Study|Adverse Event|0|||
157217996|NCT01381900|567545539|FG001|Overall Study|Withdrawal by Subject|0|||
156796885|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796886|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
156796887|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
157141568|NCT00561353|567265386|FG003|Overall Study|Adverse Event|2|||
157141569|NCT00561353|567265387|FG004|Overall Study|Adverse Event|0|||
156796888|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
157141570|NCT00561353|567265388|FG005|Overall Study|Adverse Event|0|||
157141571|NCT00561353|567265389|FG006|Overall Study|Adverse Event|1|||
157141572|NCT00561353|567265390|FG007|Overall Study|Adverse Event|0|||
157141573|NCT00561353|567265391|FG008|Overall Study|Adverse Event|0|||
157141574|NCT00561353|567265392|FG009|Overall Study|Adverse Event|1|||
157141575|NCT00561353|567265383|FG000|Overall Study|Lost to Follow-up|2|||
157141576|NCT00561353|567265384|FG001|Overall Study|Lost to Follow-up|0|||
157141577|NCT00561353|567265385|FG002|Overall Study|Lost to Follow-up|1|||
157141578|NCT00561353|567265386|FG003|Overall Study|Lost to Follow-up|0|||
157141579|NCT00561353|567265387|FG004|Overall Study|Lost to Follow-up|0|||
157141580|NCT00561353|567265388|FG005|Overall Study|Lost to Follow-up|0|||
157141581|NCT00561353|567265389|FG006|Overall Study|Lost to Follow-up|0|||
157141582|NCT00561353|567265390|FG007|Overall Study|Lost to Follow-up|0|||
157141583|NCT00561353|567265391|FG008|Overall Study|Lost to Follow-up|0|||
157141584|NCT00561353|567265392|FG009|Overall Study|Lost to Follow-up|0|||
157141585|NCT00561353|567265383|FG000|Overall Study|Withdrawal by Subject|0|||
157141586|NCT00561353|567265384|FG001|Overall Study|Withdrawal by Subject|2|||
156876732|NCT03860259|566307719|FG000|Overall Study|Lost to Follow-up|5|||
156876733|NCT03860259|566307720|FG001|Overall Study|Lost to Follow-up|5|||
156876734|NCT03860259|566307719|FG000|Overall Study|Protocol Violation|1|||
156876735|NCT03860259|566307720|FG001|Overall Study|Protocol Violation|0|||
156876736|NCT01068600|566307721|FG000|Overall Study|Withdrawal by Subject|5|||
156876737|NCT01068600|566307722|FG001|Overall Study|Withdrawal by Subject|6|||
156876738|NCT01068600|566307721|FG000|Overall Study|Adverse Event|3|||
156876739|NCT01068600|566307722|FG001|Overall Study|Adverse Event|3|||
156876740|NCT01068600|566307721|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156876741|NCT01068600|566307722|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156876742|NCT01068600|566307721|FG000|Overall Study|Lost to Follow-up|1|||
156876743|NCT01068600|566307722|FG001|Overall Study|Lost to Follow-up|2|||
156876744|NCT01068600|566307721|FG000|Overall Study|Protocol deviation|1|||
156876745|NCT01068600|566307722|FG001|Overall Study|Protocol deviation|1|||
156876746|NCT01068600|566307721|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156876747|NCT01068600|566307722|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156876748|NCT01068600|566307721|FG000|Overall Study|Administrative problems|0|||
156876749|NCT01068600|566307722|FG001|Overall Study|Administrative problems|1|||
156876750|NCT02644109|566307723|FG000|Overall Study|Adverse Event|0|||
156876751|NCT02644109|566307724|FG001|Overall Study|Adverse Event|4|||
156876752|NCT02474069|566307725|FG000|Selection Phase (SP)|Adverse Event|8|||
157141587|NCT00561353|567265385|FG002|Overall Study|Withdrawal by Subject|0|||
157141588|NCT00561353|567265386|FG003|Overall Study|Withdrawal by Subject|0|||
157141589|NCT00561353|567265387|FG004|Overall Study|Withdrawal by Subject|0|||
157141590|NCT00561353|567265388|FG005|Overall Study|Withdrawal by Subject|0|||
157141591|NCT00561353|567265389|FG006|Overall Study|Withdrawal by Subject|0|||
157141592|NCT00561353|567265390|FG007|Overall Study|Withdrawal by Subject|0|||
157141593|NCT00561353|567265391|FG008|Overall Study|Withdrawal by Subject|0|||
157141594|NCT00561353|567265392|FG009|Overall Study|Withdrawal by Subject|0|||
157141595|NCT01273818|567265393|FG000|Overall Study|Physician Decision|13|||
157141596|NCT01273818|567265394|FG001|Overall Study|Physician Decision|2|||
157141597|NCT01273818|567265395|FG002|Overall Study|Physician Decision|9|||
157141598|NCT03815175|567265396|FG000|Overall Study|Subject Lost to Follow-up|6|||
157141599|NCT03815175|567265396|FG000|Overall Study|Subject Withdrew Consent|48|||
157141600|NCT03815175|567265396|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
157141601|NCT03815175|567265396|FG000|Overall Study|Death|86|||
157141602|NCT03815175|567265396|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
157141603|NCT03815175|567265396|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
157141604|NCT03815175|567265396|FG000|Overall Study|Other Status Change Reason|1|||
157141605|NCT03815175|567265396|FG000|Overall Study|Missed Visit|12|||
157141606|NCT03577990|567265397|FG000|Overall Study|Lost to Follow-up|4|||
157141607|NCT03577990|567265398|FG001|Overall Study|Lost to Follow-up|6|||
157141608|NCT03577990|567265397|FG000|Overall Study|Withdrawal by Subject|4|||
157141609|NCT03577990|567265398|FG001|Overall Study|Withdrawal by Subject|7|||
156735331|NCT01867710|565778403|FG003|Overall Study|Progressive disease|0|||
156735332|NCT01867710|565778400|FG000|Overall Study|Protocol Violation|0|||
156735333|NCT01867710|565778401|FG001|Overall Study|Protocol Violation|0|||
156735334|NCT01867710|565778402|FG002|Overall Study|Protocol Violation|0|||
156735335|NCT01867710|565778403|FG003|Overall Study|Protocol Violation|1|||
156876753|NCT02474069|566307726|FG001|Selection Phase (SP)|Adverse Event|0|||
157141610|NCT03934684|567265403|FG000|Overall Study|Participants continuing in study|11|||
156876754|NCT02474069|566307727|FG002|Selection Phase (SP)|Adverse Event|0|||
156876755|NCT02474069|566307725|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
156876756|NCT02474069|566307726|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
157141611|NCT03934684|567265404|FG001|Overall Study|Participants continuing in study|4|||
157141612|NCT03934684|567265403|FG000|Overall Study|Discontinuation of carfilzomib|20|||
157141613|NCT03934684|567265404|FG001|Overall Study|Discontinuation of carfilzomib|30|||
156735336|NCT01867710|565778400|FG000|Overall Study|PSA-progression|0|||
157141614|NCT03934684|567265403|FG000|Overall Study|Death|2|||
157141615|NCT03934684|567265404|FG001|Overall Study|Death|2|||
157141616|NCT03934684|567265403|FG000|Overall Study|Lost to Follow-up|2|||
157141617|NCT03934684|567265404|FG001|Overall Study|Lost to Follow-up|5|||
157141618|NCT03934684|567265403|FG000|Overall Study|Withdrawal by Subject|7|||
157141619|NCT03934684|567265404|FG001|Overall Study|Withdrawal by Subject|8|||
157141620|NCT00488631|567265410|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
157141621|NCT00488631|567265411|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
157141622|NCT00488631|567265412|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
157141623|NCT00488631|567265413|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
157141624|NCT00488631|567265414|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
157141625|NCT00488631|567265415|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
157141626|NCT00488631|567265416|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
157141627|NCT00488631|567265417|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
157141628|NCT00488631|567265418|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
157141629|NCT00488631|567265419|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
157141630|NCT00488631|567265410|FG000|Double Blind Period (Week 0-54)|Death|0|||
157141631|NCT00488631|567265411|FG001|Double Blind Period (Week 0-54)|Death|0|||
157141632|NCT00488631|567265412|FG002|Double Blind Period (Week 0-54)|Death|0|||
156735337|NCT01867710|565778401|FG001|Overall Study|PSA-progression|1|||
156735338|NCT01867710|565778402|FG002|Overall Study|PSA-progression|0|||
156735339|NCT01867710|565778403|FG003|Overall Study|PSA-progression|0|||
156735340|NCT01867710|565778400|FG000|Overall Study|Study medication no longer effective|0|||
156735341|NCT01867710|565778401|FG001|Overall Study|Study medication no longer effective|1|||
156735342|NCT01867710|565778402|FG002|Overall Study|Study medication no longer effective|0|||
156735343|NCT01867710|565778403|FG003|Overall Study|Study medication no longer effective|0|||
156735344|NCT02048826|565778404|FG000|Overall Study|Withdrawal by Subject|1|||
156735345|NCT02048826|565778405|FG001|Overall Study|Withdrawal by Subject|0|||
156735346|NCT00526669|565778406|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
156735347|NCT00526669|565778407|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
156735348|NCT00526669|565778406|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
156735349|NCT00526669|565778407|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
156735350|NCT00526669|565778406|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
157020200|NCT01261312|566826525|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157141633|NCT00488631|567265413|FG003|Double Blind Period (Week 0-54)|Death|0|||
157141634|NCT00488631|567265414|FG004|Double Blind Period (Week 0-54)|Death|0|||
157141635|NCT00488631|567265415|FG005|Double Blind Period (Week 0-54)|Death|1|||
157141636|NCT00488631|567265416|FG006|Double Blind Period (Week 0-54)|Death|0|||
157141637|NCT00488631|567265417|FG007|Double Blind Period (Week 0-54)|Death|0|||
157141638|NCT00488631|567265418|FG008|Double Blind Period (Week 0-54)|Death|0|||
157141639|NCT00488631|567265419|FG009|Double Blind Period (Week 0-54)|Death|0|||
157141640|NCT00488631|567265410|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
157141641|NCT00488631|567265411|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
157141642|NCT00488631|567265412|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
157141643|NCT00488631|567265413|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
157141644|NCT00488631|567265414|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
157141645|NCT00488631|567265415|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
157141646|NCT00488631|567265416|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
157141647|NCT00488631|567265417|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
157141648|NCT00488631|567265418|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
157141649|NCT00488631|567265419|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
157141650|NCT00488631|567265410|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
157141651|NCT00488631|567265411|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
157141652|NCT00488631|567265412|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
157141653|NCT00488631|567265413|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
157141654|NCT00488631|567265414|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
157141655|NCT00488631|567265415|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
157141656|NCT00488631|567265416|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
157141657|NCT00488631|567265417|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
157141658|NCT00488631|567265418|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
157141659|NCT00488631|567265419|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
157141660|NCT00488631|567265410|FG000|Double Blind Period (Week 0-54)|Other|6|||
157141661|NCT00488631|567265411|FG001|Double Blind Period (Week 0-54)|Other|12|||
157141662|NCT00488631|567265412|FG002|Double Blind Period (Week 0-54)|Other|10|||
157141663|NCT00488631|567265413|FG003|Double Blind Period (Week 0-54)|Other|11|||
157141664|NCT00488631|567265414|FG004|Double Blind Period (Week 0-54)|Other|14|||
157141665|NCT00488631|567265415|FG005|Double Blind Period (Week 0-54)|Other|34|||
157217997|NCT01381900|567545540|FG002|Overall Study|Withdrawal by Subject|1|||
157217998|NCT01381900|567545538|FG000|Overall Study|Early withdraw|3|||
157217999|NCT01381900|567545539|FG001|Overall Study|Early withdraw|1|||
156735351|NCT00526669|565778407|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
156735352|NCT00526669|565778406|FG000|Combined Treatment Phase|Death|0|||
156796889|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
157020201|NCT01261312|566826526|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157020202|NCT01261312|566826527|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157020203|NCT01261312|566826528|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157020204|NCT01261312|566826529|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157141666|NCT00488631|567265416|FG006|Double Blind Period (Week 0-54)|Other|0|||
157141667|NCT00488631|567265417|FG007|Double Blind Period (Week 0-54)|Other|0|||
157141668|NCT00488631|567265418|FG008|Double Blind Period (Week 0-54)|Other|0|||
157141669|NCT00488631|567265419|FG009|Double Blind Period (Week 0-54)|Other|0|||
157141670|NCT00488631|567265410|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141671|NCT00488631|567265411|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141672|NCT00488631|567265412|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141673|NCT00488631|567265413|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141674|NCT00488631|567265414|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141675|NCT00488631|567265415|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
156735353|NCT00526669|565778407|FG001|Combined Treatment Phase|Death|2|||
156735354|NCT02218736|565778419|FG000|Overall Study|Withdrawal by Subject|10|||
156735355|NCT02218736|565778420|FG001|Overall Study|Withdrawal by Subject|9|||
156735356|NCT02218736|565778419|FG000|Overall Study|Protocol Violation|2|||
156735357|NCT02218736|565778420|FG001|Overall Study|Protocol Violation|0|||
157141676|NCT00488631|567265416|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
157141677|NCT00488631|567265417|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
157141678|NCT00488631|567265418|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
157141679|NCT00488631|567265419|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
157141680|NCT00488631|567265410|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
157141681|NCT00488631|567265411|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
157141682|NCT00488631|567265412|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
157141683|NCT00488631|567265413|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
157141684|NCT00488631|567265414|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
157141685|NCT00488631|567265415|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
157141686|NCT00488631|567265416|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
157141687|NCT00488631|567265417|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
157141688|NCT00488631|567265418|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
157141689|NCT00488631|567265419|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
157141690|NCT00488631|567265410|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141691|NCT00488631|567265411|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141692|NCT00488631|567265412|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141693|NCT00488631|567265413|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141694|NCT00488631|567265414|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141695|NCT00488631|567265415|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
157141696|NCT00488631|567265416|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
157141697|NCT00488631|567265417|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
156735358|NCT03452488|565778421|FG000|Overall Study|Adverse Event|4|||
156735359|NCT03452488|565778422|FG001|Overall Study|Adverse Event|6|||
156735360|NCT03452488|565778423|FG002|Overall Study|Adverse Event|1|||
156735361|NCT03452488|565778421|FG000|Overall Study|Death|0|||
156735362|NCT03452488|565778422|FG001|Overall Study|Death|0|||
156735363|NCT03452488|565778423|FG002|Overall Study|Death|1|||
156735364|NCT03452488|565778421|FG000|Overall Study|Lost to Follow-up|1|||
156735365|NCT03452488|565778422|FG001|Overall Study|Lost to Follow-up|2|||
156735366|NCT03452488|565778423|FG002|Overall Study|Lost to Follow-up|0|||
156735367|NCT03452488|565778421|FG000|Overall Study|PI Decision|1|||
156735368|NCT03452488|565778422|FG001|Overall Study|PI Decision|0|||
156796890|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796891|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796892|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
156796893|NCT00725985|566009671|FG000|OLMP (Up to 96 Weeks)|Other|0|||
156796894|NCT00725985|566009672|FG001|OLMP (Up to 96 Weeks)|Other|0|||
156796895|NCT00725985|566009673|FG002|OLMP (Up to 96 Weeks)|Other|0|||
156796896|NCT00725985|566009674|FG003|OLMP (Up to 96 Weeks)|Other|15|||
156796897|NCT00725985|566009675|FG004|OLMP (Up to 96 Weeks)|Other|20|||
156796898|NCT00725985|566009676|FG005|OLMP (Up to 96 Weeks)|Other|44|||
156796899|NCT00725985|566009677|FG006|OLMP (Up to 96 Weeks)|Other|0|||
156796900|NCT00725985|566009678|FG007|OLMP (Up to 96 Weeks)|Other|0|||
156796901|NCT00725985|566009679|FG008|OLMP (Up to 96 Weeks)|Other|0|||
156796902|NCT00725985|566009680|FG009|OLMP (Up to 96 Weeks)|Other|0|||
156796903|NCT00725985|566009681|FG010|OLMP (Up to 96 Weeks)|Other|0|||
156796904|NCT00725985|566009682|FG011|OLMP (Up to 96 Weeks)|Other|0|||
156796905|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
157218000|NCT01381900|567545540|FG002|Overall Study|Early withdraw|1|||
156735369|NCT03452488|565778423|FG002|Overall Study|PI Decision|0|||
156735370|NCT03452488|565778421|FG000|Overall Study|Withdrew consent|4|||
156735371|NCT03452488|565778422|FG001|Overall Study|Withdrew consent|2|||
156796906|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156808834|NCT01484496|566054475|FG002|Period 1|Treatment Failure|0|||
157141698|NCT00488631|567265418|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
157141699|NCT00488631|567265419|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
157141700|NCT00488631|567265410|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141701|NCT00488631|567265411|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141702|NCT00488631|567265412|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141703|NCT00488631|567265413|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141704|NCT00488631|567265414|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141705|NCT00488631|567265415|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141706|NCT00488631|567265416|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
157141707|NCT00488631|567265417|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141708|NCT00488631|567265418|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
157141709|NCT00488631|567265419|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
157141710|NCT00488631|567265410|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141711|NCT00488631|567265411|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141712|NCT00488631|567265412|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141713|NCT00488631|567265413|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141714|NCT00488631|567265414|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141715|NCT00488631|567265415|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141716|NCT00488631|567265416|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
157141717|NCT00488631|567265417|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
157141718|NCT00488631|567265418|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
157141719|NCT00488631|567265419|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
157141720|NCT00761215|567265420|FG000|Overall Study|Randomized but didn't receive drug|1|||
157141721|NCT00761215|567265421|FG001|Overall Study|Randomized but didn't receive drug|1|||
157141722|NCT00761215|567265422|FG002|Overall Study|Randomized but didn't receive drug|2|||
157141723|NCT00761215|567265420|FG000|Overall Study|Lost to Follow-up|6|||
157141724|NCT00761215|567265421|FG001|Overall Study|Lost to Follow-up|3|||
157141725|NCT00761215|567265422|FG002|Overall Study|Lost to Follow-up|6|||
157141726|NCT00761215|567265420|FG000|Overall Study|Withdrawal by Subject|1|||
157141727|NCT00761215|567265421|FG001|Overall Study|Withdrawal by Subject|0|||
157141728|NCT00761215|567265422|FG002|Overall Study|Withdrawal by Subject|0|||
157141729|NCT00761215|567265420|FG000|Overall Study|Bacteremia|1|||
157141730|NCT00761215|567265421|FG001|Overall Study|Bacteremia|0|||
157141731|NCT00761215|567265422|FG002|Overall Study|Bacteremia|0|||
157141732|NCT05662332|567265423|FG000|Overall Study|Death|3|||
157141733|NCT05662332|567265424|FG001|Overall Study|Death|3|||
157141734|NCT05662332|567265423|FG000|Overall Study|Lost to Follow-up|3|||
157141735|NCT05662332|567265424|FG001|Overall Study|Lost to Follow-up|8|||
157141736|NCT05662332|567265423|FG000|Overall Study|Physician Decision|1|||
157141737|NCT05662332|567265424|FG001|Overall Study|Physician Decision|2|||
157141738|NCT05662332|567265423|FG000|Overall Study|Protocol Deviation|2|||
157141739|NCT05662332|567265424|FG001|Overall Study|Protocol Deviation|1|||
157141740|NCT05662332|567265423|FG000|Overall Study|Withdrawal by Subject|14|||
157141741|NCT05662332|567265424|FG001|Overall Study|Withdrawal by Subject|14|||
157141742|NCT05662332|567265423|FG000|Overall Study|Assigned Treatment by Mistake|5|||
157141743|NCT05662332|567265424|FG001|Overall Study|Assigned Treatment by Mistake|7|||
157141744|NCT05662332|567265423|FG000|Overall Study|Non-compliance with study drug|4|||
157141745|NCT05662332|567265424|FG001|Overall Study|Non-compliance with study drug|1|||
157141746|NCT05662332|567265423|FG000|Overall Study|Due to Bariatric surgery|1|||
157141747|NCT05662332|567265424|FG001|Overall Study|Due to Bariatric surgery|0|||
157141748|NCT05662332|567265423|FG000|Overall Study|Subject Moving out of State|0|||
157141749|NCT05662332|567265424|FG001|Overall Study|Subject Moving out of State|1|||
157141750|NCT05662332|567265423|FG000|Overall Study|Subject Missed the Schedule|1|||
157141751|NCT05662332|567265424|FG001|Overall Study|Subject Missed the Schedule|0|||
157141752|NCT05662332|567265423|FG000|Overall Study|The Patient Moved to Another City|1|||
157141753|NCT05662332|567265424|FG001|Overall Study|The Patient Moved to Another City|0|||
157141754|NCT00667277|567265425|FG000|Overall Study|Withdrawal by Subject|2|||
157141755|NCT00140855|567265426|FG000|Overall Study|Progressive disease|2|||
157141756|NCT03542682|567265428|FG000|Overall Study|COVID-19 Protocol|0|||
156735372|NCT03452488|565778423|FG002|Overall Study|Withdrew consent|2|||
156735373|NCT03452488|565778421|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
156735374|NCT03452488|565778422|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
156735375|NCT03452488|565778423|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
156735376|NCT03452488|565778421|FG000|Overall Study|Other|0|||
156735377|NCT03452488|565778422|FG001|Overall Study|Other|2|||
156735378|NCT03452488|565778423|FG002|Overall Study|Other|2|||
157020205|NCT01261312|566826530|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157141757|NCT03542682|567265429|FG001|Overall Study|COVID-19 Protocol|1|||
157141758|NCT01097044|567265433|FG000|Overall Study|Withdrawal by Subject|4|||
157141759|NCT01097044|567265434|FG001|Overall Study|Withdrawal by Subject|4|||
156735379|NCT00281632|565778426|FG000|Overall Study|Adverse Event|7|||
156735380|NCT00281632|565778426|FG000|Overall Study|Withdrawal by Subject|2|||
156735381|NCT00281632|565778426|FG000|Overall Study|Disease Progression|22|||
156735382|NCT00281632|565778426|FG000|Overall Study|Death|1|||
156735383|NCT00281632|565778426|FG000|Overall Study|Physician Decision|1|||
156735384|NCT00281632|565778426|FG000|Overall Study|Ongoing|3|||
156735385|NCT01878084|565778431|FG000|Overall Study|Physician Decision|2|||
156735386|NCT03696108|565778432|FG000|Overall Study|Physician Decision|1|||
156735387|NCT03696108|565778433|FG001|Overall Study|Physician Decision|0|||
156735388|NCT03696108|565778432|FG000|Overall Study|Withdrawal by Subject|3|||
156735389|NCT03696108|565778433|FG001|Overall Study|Withdrawal by Subject|6|||
156735390|NCT04143594|565778434|FG000|Overall Study|Withdrew consent|3|||
156735391|NCT04143594|565778435|FG001|Overall Study|Withdrew consent|10|||
156735392|NCT04143594|565778436|FG002|Overall Study|Withdrew consent|3|||
156735393|NCT04143594|565778437|FG003|Overall Study|Withdrew consent|1|||
156735394|NCT04143594|565778434|FG000|Overall Study|Lost to Follow-up|3|||
156735395|NCT04143594|565778435|FG001|Overall Study|Lost to Follow-up|5|||
156735396|NCT04143594|565778436|FG002|Overall Study|Lost to Follow-up|11|||
156735397|NCT04143594|565778437|FG003|Overall Study|Lost to Follow-up|0|||
156735398|NCT04143594|565778434|FG000|Overall Study|Investigator's discretion|2|||
156735399|NCT04143594|565778435|FG001|Overall Study|Investigator's discretion|2|||
157218001|NCT02668783|567545542|FG000|Overall Study|Pregnancy|0|||
157218002|NCT02668783|567545543|FG001|Overall Study|Pregnancy|1|||
157218003|NCT02668783|567545542|FG000|Overall Study|Protocol Violation|2|||
157218004|NCT02668783|567545543|FG001|Overall Study|Protocol Violation|1|||
157218005|NCT02668783|567545542|FG000|Overall Study|Study terminated by sponsor|9|||
157218006|NCT02668783|567545543|FG001|Overall Study|Study terminated by sponsor|10|||
157218007|NCT02668783|567545542|FG000|Overall Study|Subject moved|1|||
157218008|NCT02668783|567545543|FG001|Overall Study|Subject moved|0|||
157218009|NCT02668783|567545542|FG000|Overall Study|Withdrawal by Subject|1|||
157218010|NCT02668783|567545543|FG001|Overall Study|Withdrawal by Subject|0|||
157218011|NCT02891200|567545544|FG000|Overall Study|Lost to Follow-up|31|||
157218012|NCT02891200|567545545|FG001|Overall Study|Lost to Follow-up|36|||
157218013|NCT02891200|567545544|FG000|Overall Study|Death|10|||
157218014|NCT02891200|567545545|FG001|Overall Study|Death|9|||
157218015|NCT02891200|567545544|FG000|Overall Study|Withdrawal by Subject|1|||
157141760|NCT01097044|567265433|FG000|Overall Study|Lost to Follow-up|1|||
157141761|NCT01097044|567265434|FG001|Overall Study|Lost to Follow-up|0|||
157141762|NCT01097044|567265433|FG000|Overall Study|Withdrawal by Sponsor|0|||
157141763|NCT01097044|567265434|FG001|Overall Study|Withdrawal by Sponsor|1|||
157141764|NCT04865731|567265441|FG000|Overall Study|Physician Decision|2|||
157141765|NCT04865731|567265442|FG001|Overall Study|Physician Decision|1|||
157141766|NCT04865731|567265441|FG000|Overall Study|Adverse Event|1|||
157141767|NCT04865731|567265442|FG001|Overall Study|Adverse Event|0|||
157141768|NCT04865731|567265441|FG000|Overall Study|Withdrawal by Subject|0|||
157141769|NCT04865731|567265442|FG001|Overall Study|Withdrawal by Subject|1|||
157141770|NCT00875420|567267723|FG000|Overall Study|Adverse Event|0|||
157141771|NCT00875420|567267724|FG001|Overall Study|Adverse Event|1|||
157141772|NCT00875420|567267725|FG002|Overall Study|Adverse Event|1|||
157141773|NCT00875420|567267726|FG003|Overall Study|Adverse Event|0|||
157141774|NCT00875420|567267727|FG004|Overall Study|Adverse Event|0|||
157141775|NCT00875420|567267723|FG000|Overall Study|Inability to complete study procedures|1|||
157218016|NCT02891200|567545545|FG001|Overall Study|Withdrawal by Subject|4|||
157218017|NCT03907280|567545546|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
157218018|NCT03907280|567545547|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
157218019|NCT03907280|567545548|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
157218020|NCT02231710|567545549|FG000|Overall Study|Physician Decision|1|||
157218021|NCT01339910|567545550|FG000|Overall Study|Withdrawal by Subject|1|||
156735400|NCT04143594|565778436|FG002|Overall Study|Investigator's discretion|0|||
156735401|NCT04143594|565778437|FG003|Overall Study|Investigator's discretion|0|||
156735402|NCT04143594|565778434|FG000|Overall Study|Randomized but never treated|0|||
156735403|NCT04143594|565778435|FG001|Overall Study|Randomized but never treated|0|||
156735404|NCT04143594|565778436|FG002|Overall Study|Randomized but never treated|0|||
156735405|NCT04143594|565778437|FG003|Overall Study|Randomized but never treated|1|||
156735406|NCT04143594|565778434|FG000|Overall Study|Death|1|||
156735407|NCT04143594|565778435|FG001|Overall Study|Death|0|||
156735408|NCT04143594|565778436|FG002|Overall Study|Death|1|||
156796907|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796908|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796909|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796910|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156735409|NCT04143594|565778437|FG003|Overall Study|Death|0|||
156735410|NCT04143594|565778434|FG000|Overall Study|Adverse Event|1|||
156735411|NCT04143594|565778435|FG001|Overall Study|Adverse Event|0|||
157141776|NCT00875420|567267724|FG001|Overall Study|Inability to complete study procedures|0|||
157141777|NCT00875420|567267725|FG002|Overall Study|Inability to complete study procedures|1|||
156735412|NCT04143594|565778436|FG002|Overall Study|Adverse Event|0|||
156735413|NCT04143594|565778437|FG003|Overall Study|Adverse Event|0|||
156735414|NCT04143594|565778434|FG000|Overall Study|Pregnancy|0|||
156735415|NCT04143594|565778435|FG001|Overall Study|Pregnancy|0|||
156735416|NCT04143594|565778436|FG002|Overall Study|Pregnancy|1|||
156735417|NCT04143594|565778437|FG003|Overall Study|Pregnancy|0|||
156735418|NCT04143594|565778434|FG000|Overall Study|Lack of Efficacy|1|||
156735419|NCT04143594|565778435|FG001|Overall Study|Lack of Efficacy|1|||
156735420|NCT04143594|565778436|FG002|Overall Study|Lack of Efficacy|0|||
156735421|NCT04143594|565778437|FG003|Overall Study|Lack of Efficacy|0|||
156735422|NCT03047720|565778440|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
156735423|NCT03047720|565778441|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
156735424|NCT01475851|565778442|FG000|Overall Study|Protocol defined stopping criteria|1|||
156735425|NCT01475851|565778443|FG001|Overall Study|Protocol defined stopping criteria|0|||
156735426|NCT04603482|565778444|FG000|Overall Study|Lost to Follow-up|15|||
156735427|NCT04603482|565778445|FG001|Overall Study|Lost to Follow-up|15|||
156735428|NCT04603482|565778446|FG002|Overall Study|Lost to Follow-up|15|||
156735429|NCT00732758|565778447|FG000|Overall Study|Lost to Follow-up|8|||
156735430|NCT00732758|565778448|FG001|Overall Study|Lost to Follow-up|16|||
156735431|NCT00373958|565778449|FG000|Infant Series|Withdrawal by Subject|13|||
156735432|NCT00373958|565778450|FG001|Infant Series|Withdrawal by Subject|15|||
156735433|NCT00373958|565778449|FG000|Infant Series|Failed to return|8|||
156735434|NCT00373958|565778450|FG001|Infant Series|Failed to return|13|||
156735435|NCT00373958|565778449|FG000|Infant Series|Lost to Follow-up|6|||
156735436|NCT00373958|565778450|FG001|Infant Series|Lost to Follow-up|5|||
156735437|NCT00373958|565778449|FG000|Infant Series|Protocol Violation|3|||
156735438|NCT00373958|565778450|FG001|Infant Series|Protocol Violation|7|||
156735439|NCT00373958|565778449|FG000|Infant Series|Lost Kaiser coverage|4|||
156735440|NCT00373958|565778450|FG001|Infant Series|Lost Kaiser coverage|0|||
156735441|NCT00373958|565778449|FG000|Infant Series|Child relocated|1|||
156735442|NCT00373958|565778450|FG001|Infant Series|Child relocated|0|||
157141778|NCT00875420|567267726|FG003|Overall Study|Inability to complete study procedures|1|||
157141779|NCT00875420|567267727|FG004|Overall Study|Inability to complete study procedures|1|||
157141780|NCT00875420|567267723|FG000|Overall Study|Lost to Follow-up|1|||
157141781|NCT00875420|567267724|FG001|Overall Study|Lost to Follow-up|0|||
157141782|NCT00875420|567267725|FG002|Overall Study|Lost to Follow-up|0|||
157141783|NCT00875420|567267726|FG003|Overall Study|Lost to Follow-up|0|||
157141784|NCT00875420|567267727|FG004|Overall Study|Lost to Follow-up|0|||
157141785|NCT00875420|567267723|FG000|Overall Study|Personal reason|0|||
157141786|NCT00875420|567267724|FG001|Overall Study|Personal reason|0|||
157141787|NCT00875420|567267725|FG002|Overall Study|Personal reason|0|||
157141788|NCT00875420|567267726|FG003|Overall Study|Personal reason|0|||
157141789|NCT00875420|567267727|FG004|Overall Study|Personal reason|1|||
157141790|NCT00875420|567267723|FG000|Overall Study|Prohibited medication|0|||
157141791|NCT00875420|567267724|FG001|Overall Study|Prohibited medication|0|||
157141792|NCT00875420|567267725|FG002|Overall Study|Prohibited medication|0|||
157141793|NCT00875420|567267726|FG003|Overall Study|Prohibited medication|1|||
157141794|NCT00875420|567267727|FG004|Overall Study|Prohibited medication|0|||
157141795|NCT00875420|567267723|FG000|Overall Study|Sponsor decision|0|||
157141796|NCT00875420|567267724|FG001|Overall Study|Sponsor decision|1|||
157141797|NCT00875420|567267725|FG002|Overall Study|Sponsor decision|0|||
157141798|NCT00875420|567267726|FG003|Overall Study|Sponsor decision|0|||
157218022|NCT01339910|567545551|FG001|Overall Study|Withdrawal by Subject|0|||
157218023|NCT01339910|567545550|FG000|Overall Study|Physician Decision|1|||
157141799|NCT00875420|567267727|FG004|Overall Study|Sponsor decision|0|||
157141800|NCT00875420|567267723|FG000|Overall Study|Withdrawal by Subject|0|||
157141801|NCT00875420|567267724|FG001|Overall Study|Withdrawal by Subject|0|||
157141802|NCT00875420|567267725|FG002|Overall Study|Withdrawal by Subject|1|||
157141803|NCT00875420|567267726|FG003|Overall Study|Withdrawal by Subject|0|||
156735443|NCT00373958|565778449|FG000|Infant Series|Consent was not received|1|||
156735444|NCT00373958|565778450|FG001|Infant Series|Consent was not received|0|||
157141804|NCT00875420|567267727|FG004|Overall Study|Withdrawal by Subject|0|||
156735445|NCT00373958|565778449|FG000|Infant Series|Adverse Event|3|||
156735446|NCT00373958|565778450|FG001|Infant Series|Adverse Event|1|||
156735447|NCT00373958|565778449|FG000|Infant Series|Physician Decision|1|||
156735448|NCT00373958|565778450|FG001|Infant Series|Physician Decision|1|||
156735449|NCT00373958|565778449|FG000|Toddler Dose|Lost to Follow-up|5|||
156735450|NCT00373958|565778450|FG001|Toddler Dose|Lost to Follow-up|8|||
157141805|NCT00914628|567267728|FG000|Overall Study|Death|35|||
157141806|NCT00914628|567267729|FG001|Overall Study|Death|17|||
157141807|NCT00914628|567267728|FG000|Overall Study|Medical decision|4|||
157141808|NCT00914628|567267729|FG001|Overall Study|Medical decision|0|||
157141809|NCT00914628|567267728|FG000|Overall Study|Protocol Violation|1|||
156735451|NCT00373958|565778449|FG000|Toddler Dose|Withdrawal by Subject|2|||
156735452|NCT00373958|565778450|FG001|Toddler Dose|Withdrawal by Subject|2|||
156735453|NCT00373958|565778449|FG000|Toddler Dose|Failed to return|1|||
156735454|NCT00373958|565778450|FG001|Toddler Dose|Failed to return|2|||
156735455|NCT00373958|565778449|FG000|Toddler Dose|Protocol Violation|0|||
157141810|NCT00914628|567267729|FG001|Overall Study|Protocol Violation|0|||
156735456|NCT00373958|565778450|FG001|Toddler Dose|Protocol Violation|1|||
156735457|NCT00373958|565778449|FG000|Toddler Dose|Withdrawn after infant series|22|||
156735458|NCT00373958|565778450|FG001|Toddler Dose|Withdrawn after infant series|25|||
156735459|NCT03382834|565778453|FG000|Step 1|Lost to Follow-up|0|||
156735460|NCT03382834|565778454|FG001|Step 1|Lost to Follow-up|1|||
156735461|NCT03382834|565778453|FG000|Step 2|Death|1|||
156735462|NCT03382834|565778454|FG001|Step 2|Death|0|||
156735463|NCT03382834|565778453|FG000|Step 2|Lost to Follow-up|2|||
156735464|NCT03382834|565778454|FG001|Step 2|Lost to Follow-up|2|||
156735465|NCT03382834|565778453|FG000|Step 2|Site Terminated by Sponsor|1|||
156735466|NCT03382834|565778454|FG001|Step 2|Site Terminated by Sponsor|0|||
156735467|NCT02949843|565778455|FG000|Overall Study|Withdrawal by Subject|0|||
156735468|NCT02949843|565778456|FG001|Overall Study|Withdrawal by Subject|1|||
156735469|NCT02949843|565778457|FG002|Overall Study|Withdrawal by Subject|1|||
156735470|NCT03613649|565778458|FG000|Second Treatment|Lost to Follow-up|0|||
156735471|NCT03613649|565778459|FG001|Second Treatment|Lost to Follow-up|0|||
156735472|NCT03613649|565778460|FG002|Second Treatment|Lost to Follow-up|1|||
156735473|NCT03613649|565778461|FG003|Second Treatment|Lost to Follow-up|0|||
156735474|NCT03613649|565778462|FG004|Second Treatment|Lost to Follow-up|0|||
156735475|NCT03613649|565778463|FG005|Second Treatment|Lost to Follow-up|0|||
157141811|NCT00914628|567267728|FG000|Overall Study|Lack of Efficacy|1|||
157141812|NCT00914628|567267729|FG001|Overall Study|Lack of Efficacy|0|||
157141813|NCT00914628|567267728|FG000|Overall Study|non-randomized|1|||
157141814|NCT00914628|567267729|FG001|Overall Study|non-randomized|0|||
157141815|NCT00914628|567267728|FG000|Overall Study|Relapse|1|||
157141816|NCT00914628|567267729|FG001|Overall Study|Relapse|2|||
157141817|NCT00914628|567267728|FG000|Overall Study|Study terminated by Sponsor|14|||
157141818|NCT00914628|567267729|FG001|Overall Study|Study terminated by Sponsor|8|||
157141819|NCT00914628|567267728|FG000|Overall Study|Patients who did not receive a single dose|7|||
156735476|NCT03613649|565778464|FG006|Second Treatment|Lost to Follow-up|0|||
157141820|NCT00914628|567267729|FG001|Overall Study|Patients who did not receive a single dose|1|||
157141821|NCT03716726|567267730|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
157141822|NCT03716726|567267731|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
157141823|NCT03716726|567267730|FG000|12 Months Followup|Lost to Follow-up|10|||
157141824|NCT03716726|567267731|FG001|12 Months Followup|Lost to Follow-up|17|||
157141825|NCT02579603|567267732|FG000|Overall Study|Not treated|1|||
157141826|NCT02579603|567267733|FG001|Overall Study|Not treated|0|||
157141827|NCT02579603|567267732|FG000|Overall Study|Adverse Event|2|||
157141828|NCT02579603|567267733|FG001|Overall Study|Adverse Event|2|||
157141829|NCT02579603|567267732|FG000|Overall Study|Other than stated|1|||
157141830|NCT02579603|567267733|FG001|Overall Study|Other than stated|0|||
157141831|NCT00469079|567267734|FG000|Overall Study|Lack of Efficacy|3|||
157141832|NCT00469079|567267735|FG001|Overall Study|Lack of Efficacy|8|||
157141833|NCT00469079|567267736|FG002|Overall Study|Lack of Efficacy|5|||
157141834|NCT00469079|567267734|FG000|Overall Study|Adverse Event|1|||
157141835|NCT00469079|567267735|FG001|Overall Study|Adverse Event|3|||
157141836|NCT00469079|567267736|FG002|Overall Study|Adverse Event|2|||
157141837|NCT00469079|567267734|FG000|Overall Study|Lost to Follow-up|4|||
157141838|NCT00469079|567267735|FG001|Overall Study|Lost to Follow-up|8|||
157141839|NCT00469079|567267736|FG002|Overall Study|Lost to Follow-up|10|||
157141840|NCT00469079|567267734|FG000|Overall Study|Withdrawal by Subject|1|||
157218024|NCT01339910|567545551|FG001|Overall Study|Physician Decision|0|||
157218025|NCT01339910|567545550|FG000|Overall Study|Disease relapse|1|||
157218026|NCT01339910|567545551|FG001|Overall Study|Disease relapse|4|||
157218027|NCT01399723|567545552|FG000|Overall Study|Lost to Follow-up|0|||
157218028|NCT01399723|567545553|FG001|Overall Study|Lost to Follow-up|1|||
157141841|NCT00469079|567267735|FG001|Overall Study|Withdrawal by Subject|2|||
157141842|NCT00469079|567267736|FG002|Overall Study|Withdrawal by Subject|2|||
157141843|NCT00469079|567267734|FG000|Overall Study|Ineligible|0|||
157141844|NCT00469079|567267735|FG001|Overall Study|Ineligible|1|||
157141845|NCT00469079|567267736|FG002|Overall Study|Ineligible|0|||
157218029|NCT00673361|567545554|FG000|Overall Study|Screen Failure|2|||
157218030|NCT00829413|567545555|FG000|Overall Study|No study drug admimnistered|13|||
156735477|NCT03613649|565778465|FG007|Second Treatment|Lost to Follow-up|0|||
156735478|NCT03613649|565778466|FG008|Second Treatment|Lost to Follow-up|0|||
157141846|NCT00942162|567267737|FG000|Overall Study|Death|45|||
156735479|NCT03613649|565778467|FG009|Second Treatment|Lost to Follow-up|0|||
156735480|NCT03613649|565778468|FG010|Second Treatment|Lost to Follow-up|0|||
157141847|NCT00942162|567267738|FG001|Overall Study|Death|35|||
156735481|NCT03613649|565778469|FG011|Second Treatment|Lost to Follow-up|0|||
156735482|NCT03613649|565778458|FG000|Second Treatment|Withdrawal by Subject|0|||
156808835|NCT01484496|566054476|FG003|Period 1|Treatment Failure|0|||
156808836|NCT01484496|566054473|FG000|Period 1|Lack of Compliance|2|||
156808837|NCT01484496|566054474|FG001|Period 1|Lack of Compliance|1|||
156808838|NCT01484496|566054475|FG002|Period 1|Lack of Compliance|0|||
156808839|NCT01484496|566054476|FG003|Period 1|Lack of Compliance|0|||
156808840|NCT01484496|566054473|FG000|Period 1|Unable to Visit Site|0|||
156808841|NCT01484496|566054474|FG001|Period 1|Unable to Visit Site|2|||
156808842|NCT01484496|566054475|FG002|Period 1|Unable to Visit Site|0|||
157141848|NCT00942162|567267739|FG002|Overall Study|Death|0|||
157141849|NCT00942162|567267737|FG000|Overall Study|Withdrawal by Subject|7|||
156735483|NCT03613649|565778459|FG001|Second Treatment|Withdrawal by Subject|0|||
156735484|NCT03613649|565778460|FG002|Second Treatment|Withdrawal by Subject|0|||
156735485|NCT03613649|565778461|FG003|Second Treatment|Withdrawal by Subject|0|||
156735486|NCT03613649|565778462|FG004|Second Treatment|Withdrawal by Subject|1|||
156735487|NCT03613649|565778463|FG005|Second Treatment|Withdrawal by Subject|0|||
156735488|NCT03613649|565778464|FG006|Second Treatment|Withdrawal by Subject|0|||
156735489|NCT03613649|565778465|FG007|Second Treatment|Withdrawal by Subject|0|||
157141850|NCT00942162|567267738|FG001|Overall Study|Withdrawal by Subject|2|||
157141851|NCT00942162|567267739|FG002|Overall Study|Withdrawal by Subject|0|||
157141852|NCT00942162|567267737|FG000|Overall Study|Lost to Follow-up|4|||
157141853|NCT00942162|567267738|FG001|Overall Study|Lost to Follow-up|0|||
157141854|NCT00942162|567267739|FG002|Overall Study|Lost to Follow-up|0|||
157141855|NCT00942162|567267737|FG000|Overall Study|Other|14|||
157141856|NCT00942162|567267738|FG001|Overall Study|Other|13|||
157141857|NCT00942162|567267739|FG002|Overall Study|Other|2|||
157141858|NCT01006356|567267740|FG000|Overall Study|Adverse Event|6|||
157141859|NCT01006356|567267740|FG000|Overall Study|Physician Decision|1|||
157141860|NCT01006356|567267740|FG000|Overall Study|Paticipants did not cooperate|6|||
157141861|NCT01006356|567267740|FG000|Overall Study|Withdrawal by Subject|1|||
157141862|NCT01006356|567267740|FG000|Overall Study|Choice by participants|2|||
157141863|NCT01006356|567267740|FG000|Overall Study|Protocol Violation|3|||
157141864|NCT01006356|567267740|FG000|Overall Study|Other|23|||
157141865|NCT02981472|567267745|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
157141866|NCT02981472|567267746|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
157141867|NCT02981472|567267745|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
157141868|NCT02981472|567267746|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157141869|NCT02981472|567267745|FG000|Treatment Period|Adverse Event|6|||
157141870|NCT02981472|567267746|FG001|Treatment Period|Adverse Event|1|||
157141871|NCT02981472|567267745|FG000|Treatment Period|Participant withdrew consent|1|||
157141872|NCT02981472|567267746|FG001|Treatment Period|Participant withdrew consent|0|||
157141873|NCT02981472|567267745|FG000|Treatment Period|Lost to Follow-up|0|||
157141874|NCT02981472|567267746|FG001|Treatment Period|Lost to Follow-up|1|||
157141875|NCT01756157|567267749|FG000|First Intervention Period|Withdrawal by Subject|1|||
157141876|NCT01756157|567267750|FG001|First Intervention Period|Withdrawal by Subject|0|||
157141877|NCT01756157|567267749|FG000|First Intervention Period|Lost to Follow-up|0|||
157141878|NCT01756157|567267750|FG001|First Intervention Period|Lost to Follow-up|2|||
157141879|NCT02799381|567267753|FG000|Overall Study|Withdrew consent|3|||
157141880|NCT02799381|567267754|FG001|Overall Study|Withdrew consent|2|||
157141881|NCT02799381|567267753|FG000|Overall Study|Adverse Event|0|||
157141882|NCT02799381|567267754|FG001|Overall Study|Adverse Event|1|||
157141883|NCT02799381|567267753|FG000|Overall Study|Participant did not take any study drug|1|||
157141884|NCT02799381|567267754|FG001|Overall Study|Participant did not take any study drug|0|||
157141885|NCT02698410|567267757|FG000|Overall Study|Adverse Event|2|||
157141886|NCT02698410|567267757|FG000|Overall Study|Withdrawal by Subject|1|||
156735490|NCT03613649|565778466|FG008|Second Treatment|Withdrawal by Subject|0|||
156735491|NCT03613649|565778467|FG009|Second Treatment|Withdrawal by Subject|0|||
156735492|NCT03613649|565778468|FG010|Second Treatment|Withdrawal by Subject|0|||
156735493|NCT03613649|565778469|FG011|Second Treatment|Withdrawal by Subject|0|||
156735494|NCT03613649|565778458|FG000|Third Treatment|Lost to Follow-up|0|||
156735495|NCT03613649|565778459|FG001|Third Treatment|Lost to Follow-up|0|||
156735496|NCT03613649|565778460|FG002|Third Treatment|Lost to Follow-up|0|||
156735497|NCT03613649|565778461|FG003|Third Treatment|Lost to Follow-up|0|||
156735498|NCT03613649|565778462|FG004|Third Treatment|Lost to Follow-up|1|||
156735499|NCT03613649|565778463|FG005|Third Treatment|Lost to Follow-up|0|||
156735500|NCT03613649|565778464|FG006|Third Treatment|Lost to Follow-up|0|||
156735501|NCT03613649|565778465|FG007|Third Treatment|Lost to Follow-up|0|||
156735502|NCT03613649|565778466|FG008|Third Treatment|Lost to Follow-up|0|||
156735503|NCT03613649|565778467|FG009|Third Treatment|Lost to Follow-up|0|||
156735504|NCT03613649|565778468|FG010|Third Treatment|Lost to Follow-up|0|||
156735505|NCT03613649|565778469|FG011|Third Treatment|Lost to Follow-up|1|||
156735506|NCT03613649|565778458|FG000|Third Treatment|Protocol Violation|0|||
156735507|NCT03613649|565778459|FG001|Third Treatment|Protocol Violation|0|||
157141887|NCT02698410|567267757|FG000|Overall Study|Other|1|||
157141888|NCT03952130|567267758|FG000|Overall Study|Adverse Event|0|||
157141889|NCT03952130|567267759|FG001|Overall Study|Adverse Event|1|||
157141890|NCT03952130|567267758|FG000|Overall Study|Lost to Follow-up|1|||
157141891|NCT03952130|567267759|FG001|Overall Study|Lost to Follow-up|0|||
157141892|NCT03952130|567267758|FG000|Overall Study|Withdrawal by Subject|1|||
157141893|NCT03952130|567267759|FG001|Overall Study|Withdrawal by Subject|5|||
157141894|NCT01713348|567267760|FG000|Overall Study|Withdrawal by Subject|3|||
157141895|NCT01713348|567267761|FG001|Overall Study|Withdrawal by Subject|2|||
157141896|NCT01713348|567267762|FG002|Overall Study|Withdrawal by Subject|2|||
157218031|NCT00829413|567545555|FG000|Overall Study|Training Patients|67|||
156735508|NCT03613649|565778460|FG002|Third Treatment|Protocol Violation|0|||
156735509|NCT03613649|565778461|FG003|Third Treatment|Protocol Violation|0|||
156735510|NCT03613649|565778462|FG004|Third Treatment|Protocol Violation|0|||
156735511|NCT03613649|565778463|FG005|Third Treatment|Protocol Violation|0|||
156735512|NCT03613649|565778464|FG006|Third Treatment|Protocol Violation|1|||
156735513|NCT03613649|565778465|FG007|Third Treatment|Protocol Violation|0|||
156735514|NCT03613649|565778466|FG008|Third Treatment|Protocol Violation|0|||
156735515|NCT03613649|565778467|FG009|Third Treatment|Protocol Violation|0|||
156735516|NCT03613649|565778468|FG010|Third Treatment|Protocol Violation|0|||
156735517|NCT03613649|565778469|FG011|Third Treatment|Protocol Violation|1|||
157141897|NCT01713348|567267763|FG003|Overall Study|Withdrawal by Subject|0|||
157141898|NCT01713348|567267760|FG000|Overall Study|Lost to Follow-up|1|||
157141899|NCT01713348|567267761|FG001|Overall Study|Lost to Follow-up|0|||
157141900|NCT01713348|567267762|FG002|Overall Study|Lost to Follow-up|0|||
157141901|NCT01713348|567267763|FG003|Overall Study|Lost to Follow-up|0|||
157141902|NCT02638012|567267766|FG000|Overall Study|Lost to Follow-up|1|||
157141903|NCT00621023|567267768|FG000|Overall Study|Death|5|||
157141904|NCT00621023|567267768|FG000|Overall Study|Follow up discontinued|1|||
157141905|NCT03199911|567267775|FG000|Overall Study|Lost to Follow-up|5|||
157141906|NCT03199911|567267776|FG001|Overall Study|Lost to Follow-up|5|||
157141907|NCT03199911|567267775|FG000|Overall Study|Did not proceed with surgery|2|||
157141908|NCT03199911|567267776|FG001|Overall Study|Did not proceed with surgery|1|||
157141909|NCT02559505|567267777|FG000|Overall Study|Lost to Follow-up|23|||
157141910|NCT02559505|567267778|FG001|Overall Study|Lost to Follow-up|20|||
157141911|NCT02559505|567267777|FG000|Overall Study|Withdrawal by Subject|4|||
157141912|NCT02559505|567267778|FG001|Overall Study|Withdrawal by Subject|2|||
157141913|NCT03523585|567267779|FG000|Overall Study|Progressive Disease|174|||
157141914|NCT03523585|567267780|FG001|Overall Study|Progressive Disease|64|||
157141915|NCT03523585|567267781|FG002|Overall Study|Progressive Disease|77|||
157141916|NCT03523585|567267779|FG000|Overall Study|Adverse Event|74|||
157141917|NCT03523585|567267780|FG001|Overall Study|Adverse Event|5|||
157141918|NCT03523585|567267781|FG002|Overall Study|Adverse Event|9|||
157141919|NCT03523585|567267779|FG000|Overall Study|Withdrawal by Subject|30|||
157141920|NCT03523585|567267780|FG001|Overall Study|Withdrawal by Subject|11|||
157141921|NCT03523585|567267781|FG002|Overall Study|Withdrawal by Subject|6|||
157141922|NCT03523585|567267779|FG000|Overall Study|Clinical Progression|23|||
157141923|NCT03523585|567267780|FG001|Overall Study|Clinical Progression|5|||
157141924|NCT03523585|567267781|FG002|Overall Study|Clinical Progression|10|||
157141925|NCT03523585|567267779|FG000|Overall Study|Death|4|||
157141926|NCT03523585|567267780|FG001|Overall Study|Death|0|||
157141927|NCT03523585|567267781|FG002|Overall Study|Death|1|||
157141928|NCT03523585|567267779|FG000|Overall Study|Physician Decision|2|||
157141929|NCT03523585|567267780|FG001|Overall Study|Physician Decision|1|||
157141930|NCT03523585|567267781|FG002|Overall Study|Physician Decision|0|||
157141931|NCT03523585|567267779|FG000|Overall Study|Lost to Follow-up|1|||
157218032|NCT00829413|567545555|FG000|Overall Study|No truth standard procedure available|9|||
157218033|NCT00829413|567545555|FG000|Overall Study|Technically inadequate truth standard|2|||
157218034|NCT00829413|567545555|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
156735518|NCT03613649|565778458|FG000|Fourth Treatment|Protocol Violation|1|||
156735519|NCT03613649|565778459|FG001|Fourth Treatment|Protocol Violation|0|||
156735520|NCT03613649|565778460|FG002|Fourth Treatment|Protocol Violation|0|||
156735521|NCT03613649|565778461|FG003|Fourth Treatment|Protocol Violation|0|||
156735522|NCT03613649|565778462|FG004|Fourth Treatment|Protocol Violation|1|||
156735523|NCT03613649|565778463|FG005|Fourth Treatment|Protocol Violation|0|||
156735524|NCT03613649|565778464|FG006|Fourth Treatment|Protocol Violation|0|||
156735525|NCT03613649|565778465|FG007|Fourth Treatment|Protocol Violation|0|||
156735526|NCT03613649|565778466|FG008|Fourth Treatment|Protocol Violation|0|||
156735527|NCT03613649|565778467|FG009|Fourth Treatment|Protocol Violation|0|||
156735528|NCT03613649|565778468|FG010|Fourth Treatment|Protocol Violation|0|||
156735529|NCT03613649|565778469|FG011|Fourth Treatment|Protocol Violation|0|||
156735530|NCT03613649|565778458|FG000|Fourth Treatment|Physician Decision|0|||
156735531|NCT03613649|565778459|FG001|Fourth Treatment|Physician Decision|0|||
156735532|NCT03613649|565778460|FG002|Fourth Treatment|Physician Decision|0|||
156735533|NCT03613649|565778461|FG003|Fourth Treatment|Physician Decision|0|||
156735534|NCT03613649|565778462|FG004|Fourth Treatment|Physician Decision|0|||
156735535|NCT03613649|565778463|FG005|Fourth Treatment|Physician Decision|0|||
156735536|NCT03613649|565778464|FG006|Fourth Treatment|Physician Decision|1|||
156735537|NCT03613649|565778465|FG007|Fourth Treatment|Physician Decision|0|||
157141932|NCT03523585|567267780|FG001|Overall Study|Lost to Follow-up|0|||
156735538|NCT03613649|565778466|FG008|Fourth Treatment|Physician Decision|0|||
156735539|NCT03613649|565778467|FG009|Fourth Treatment|Physician Decision|0|||
156735540|NCT03613649|565778468|FG010|Fourth Treatment|Physician Decision|0|||
157141933|NCT03523585|567267781|FG002|Overall Study|Lost to Follow-up|0|||
157141934|NCT03523585|567267779|FG000|Overall Study|Miscellaneous|1|||
157141935|NCT03523585|567267780|FG001|Overall Study|Miscellaneous|0|||
157141936|NCT03523585|567267781|FG002|Overall Study|Miscellaneous|0|||
157141937|NCT03523585|567267779|FG000|Overall Study|Protocol Deviation|1|||
157141938|NCT03523585|567267780|FG001|Overall Study|Protocol Deviation|0|||
157141939|NCT03523585|567267781|FG002|Overall Study|Protocol Deviation|1|||
156735541|NCT03613649|565778469|FG011|Fourth Treatment|Physician Decision|0|||
156735542|NCT02693171|565778470|FG000|Overall Study|Adverse Event|1|||
156735543|NCT02693171|565778470|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
156735544|NCT00319592|565778472|FG000|Overall Study|Protocol Violation|1|||
156735545|NCT00319592|565778473|FG001|Overall Study|Protocol Violation|0|||
156735546|NCT00319592|565778472|FG000|Overall Study|Physician Decision|0|||
156735547|NCT00319592|565778473|FG001|Overall Study|Physician Decision|1|||
156735548|NCT03429244|565778474|FG000|Overall Study|Withdrawal by Subject|2|||
156735549|NCT03429244|565778475|FG001|Overall Study|Withdrawal by Subject|1|||
156735550|NCT03429244|565778476|FG002|Overall Study|Withdrawal by Subject|1|||
156735551|NCT00430573|565778481|FG000|Overall Study|Withdrawal by Subject|5|||
156735552|NCT04463251|565778488|FG000|Overall Study|Death|1|||
156735553|NCT04463251|565778489|FG001|Overall Study|Death|0|||
156735554|NCT04463251|565778490|FG002|Overall Study|Death|1|||
156735555|NCT04463251|565778488|FG000|Overall Study|Adverse Event|0|||
156735556|NCT04463251|565778489|FG001|Overall Study|Adverse Event|1|||
156735557|NCT04463251|565778490|FG002|Overall Study|Adverse Event|0|||
156735558|NCT04463251|565778488|FG000|Overall Study|Lost to Follow-up|0|||
156735559|NCT04463251|565778489|FG001|Overall Study|Lost to Follow-up|1|||
156735560|NCT04463251|565778490|FG002|Overall Study|Lost to Follow-up|0|||
156735561|NCT04463251|565778488|FG000|Overall Study|Withdrawal by Subject|0|||
156735562|NCT04463251|565778489|FG001|Overall Study|Withdrawal by Subject|2|||
156735563|NCT04463251|565778490|FG002|Overall Study|Withdrawal by Subject|2|||
156735564|NCT05020665|565778491|FG000|Overall Study|Study terminated by Sponsor|5|||
156735565|NCT05020665|565778492|FG001|Overall Study|Study terminated by Sponsor|4|||
156735566|NCT05020665|565778491|FG000|Overall Study|Death|2|||
156735567|NCT05020665|565778492|FG001|Overall Study|Death|1|||
156735568|NCT05020665|565778491|FG000|Overall Study|Physician Decision|0|||
156735569|NCT05020665|565778492|FG001|Overall Study|Physician Decision|1|||
156735570|NCT05020665|565778491|FG000|Overall Study|Withdrawal by Subject|0|||
156735571|NCT05020665|565778492|FG001|Overall Study|Withdrawal by Subject|1|||
156735572|NCT05020665|565778491|FG000|Overall Study|Reason not specified|1|||
156735573|NCT05020665|565778492|FG001|Overall Study|Reason not specified|0|||
156735574|NCT01628198|565778493|FG000|Overall Study|Lost to Follow-up|7|||
156735575|NCT01628198|565778493|FG000|Overall Study|Withdrawal by Subject|10|||
156735576|NCT01628198|565778493|FG000|Overall Study|Screen failure|1|||
156735577|NCT03386994|565778498|FG000|Overall Study|Lung transplant|1|||
156735578|NCT03386994|565778498|FG000|Overall Study|Adverse Event|14|||
156735579|NCT03386994|565778498|FG000|Overall Study|Lost to Follow-up|4|||
156735580|NCT03386994|565778498|FG000|Overall Study|Withdrawal by Subject|3|||
156735581|NCT03386994|565778498|FG000|Overall Study|Death|16|||
156735582|NCT01743560|565778499|FG000|Overall Study|Disease progression|26|||
156735583|NCT01743560|565778499|FG000|Overall Study|Adverse Event|8|||
156735584|NCT01743560|565778499|FG000|Overall Study|Death|3|||
156735585|NCT01743560|565778499|FG000|Overall Study|Withdrawal by Subject|2|||
156735586|NCT01743560|565778499|FG000|Overall Study|Protocol Violation|1|||
156735587|NCT01743560|565778499|FG000|Overall Study|>1 dose of study drug|3|||
156735588|NCT01827267|565778505|FG000|Overall Study|Did not receive study drug|1|||
156735589|NCT01827267|565778506|FG001|Overall Study|Did not receive study drug|1|||
156735590|NCT01827267|565778505|FG000|Overall Study|Physician Decision|1|||
156735591|NCT01827267|565778506|FG001|Overall Study|Physician Decision|0|||
156735592|NCT01827267|565778505|FG000|Overall Study|Disease Progression|1|||
156735593|NCT01827267|565778506|FG001|Overall Study|Disease Progression|1|||
156735594|NCT01827267|565778505|FG000|Overall Study|Sponsor Discontinued Study|2|||
156735595|NCT01827267|565778506|FG001|Overall Study|Sponsor Discontinued Study|8|||
156735596|NCT01827267|565778505|FG000|Overall Study|Still on study|0|||
156735597|NCT01827267|565778506|FG001|Overall Study|Still on study|2|||
157020206|NCT01261312|566826531|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
157020207|NCT01261312|566826532|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
156735598|NCT00877487|565778507|FG000|Open-label Treatment Phase|Adverse Event|1|||
156735599|NCT00877487|565778508|FG001|Open-label Treatment Phase|Adverse Event|0|||
156735600|NCT00877487|565778507|FG000|Open-label Treatment Phase|Protocol Violation|3|||
156735601|NCT00877487|565778508|FG001|Open-label Treatment Phase|Protocol Violation|0|||
156735602|NCT00877487|565778507|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
156735603|NCT00877487|565778508|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
157218035|NCT00124020|567545563|FG000|Overall Study|Death|67|||
156735604|NCT00877487|565778507|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
156735605|NCT00877487|565778508|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
156735606|NCT00877487|565778507|FG000|Open-label Treatment Phase|Out of country for business|1|||
156735607|NCT00877487|565778508|FG001|Open-label Treatment Phase|Out of country for business|0|||
156735608|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
156735609|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
156735610|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
156735611|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
156735612|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
156735613|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
156735614|NCT00877487|565778507|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
156735615|NCT00877487|565778508|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
156735616|NCT03425396|565778511|FG000|Overall Study|Lost to Follow-up|2|||
156735617|NCT03425396|565778512|FG001|Overall Study|Lost to Follow-up|5|||
156735618|NCT03425396|565778513|FG002|Overall Study|Lost to Follow-up|2|||
156735619|NCT03425396|565778514|FG003|Overall Study|Lost to Follow-up|0|||
156735620|NCT03425396|565778515|FG004|Overall Study|Lost to Follow-up|0|||
156735621|NCT03425396|565778511|FG000|Overall Study|Withdrawal by Subject|0|||
156735622|NCT03425396|565778512|FG001|Overall Study|Withdrawal by Subject|1|||
156735623|NCT03425396|565778513|FG002|Overall Study|Withdrawal by Subject|0|||
156735624|NCT03425396|565778514|FG003|Overall Study|Withdrawal by Subject|1|||
156735625|NCT03425396|565778515|FG004|Overall Study|Withdrawal by Subject|0|||
156735626|NCT03425396|565778511|FG000|Overall Study|Other|0|||
156735627|NCT03425396|565778512|FG001|Overall Study|Other|1|||
156735628|NCT03425396|565778513|FG002|Overall Study|Other|1|||
156735629|NCT03425396|565778514|FG003|Overall Study|Other|0|||
156735630|NCT03425396|565778515|FG004|Overall Study|Other|1|||
156735631|NCT02122887|565778519|FG000|Overall Study|Withdrawal by Subject|20|||
156735632|NCT02122887|565778520|FG001|Overall Study|Withdrawal by Subject|2|||
156735633|NCT04999163|565778521|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
156735634|NCT04999163|565778522|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
156735635|NCT04999163|565778521|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
156735636|NCT04999163|565778522|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
156735637|NCT04999163|565778521|FG000|Overall Study|Withdrawal by Subject|1|||
156735638|NCT04999163|565778522|FG001|Overall Study|Withdrawal by Subject|0|||
156735639|NCT00784550|565780376|FG000|Overall Study|Adverse Event|12|||
156735640|NCT00784550|565780377|FG001|Overall Study|Adverse Event|10|||
156735641|NCT00784550|565780376|FG000|Overall Study|Lack of Efficacy|0|||
156735642|NCT00784550|565780377|FG001|Overall Study|Lack of Efficacy|1|||
156735643|NCT00784550|565780376|FG000|Overall Study|Protocol Violation|10|||
156735644|NCT00784550|565780377|FG001|Overall Study|Protocol Violation|10|||
156735645|NCT00784550|565780376|FG000|Overall Study|Lost to Follow-up|8|||
156735646|NCT00784550|565780377|FG001|Overall Study|Lost to Follow-up|5|||
156735647|NCT00784550|565780376|FG000|Overall Study|Physician Decision|2|||
156735648|NCT00784550|565780377|FG001|Overall Study|Physician Decision|3|||
156735649|NCT00784550|565780376|FG000|Overall Study|Withdrawal by Subject|4|||
156735650|NCT00784550|565780377|FG001|Overall Study|Withdrawal by Subject|13|||
156735651|NCT03558152|565780378|FG000|Overall Study|Adverse Event|0|||
156735652|NCT03558152|565780379|FG001|Overall Study|Adverse Event|0|||
156735653|NCT03558152|565780380|FG002|Overall Study|Adverse Event|1|||
156735654|NCT03558152|565780381|FG003|Overall Study|Adverse Event|1|||
156735655|NCT03558152|565780382|FG004|Overall Study|Adverse Event|2|||
156735656|NCT03558152|565780383|FG005|Overall Study|Adverse Event|1|||
156735657|NCT03558152|565780384|FG006|Overall Study|Adverse Event|1|||
156735658|NCT03558152|565780385|FG007|Overall Study|Adverse Event|0|||
156735659|NCT03558152|565780378|FG000|Overall Study|Death|0|||
156735660|NCT03558152|565780379|FG001|Overall Study|Death|0|||
156735661|NCT03558152|565780380|FG002|Overall Study|Death|0|||
156735662|NCT03558152|565780381|FG003|Overall Study|Death|0|||
156735663|NCT03558152|565780382|FG004|Overall Study|Death|1|||
156735664|NCT03558152|565780383|FG005|Overall Study|Death|0|||
156735665|NCT03558152|565780384|FG006|Overall Study|Death|0|||
156735666|NCT03558152|565780385|FG007|Overall Study|Death|0|||
156735667|NCT03558152|565780378|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
156735668|NCT03558152|565780379|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735669|NCT03558152|565780380|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735670|NCT03558152|565780381|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735671|NCT03558152|565780382|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735672|NCT03558152|565780383|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735673|NCT03558152|565780384|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735674|NCT03558152|565780385|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
156735675|NCT03558152|565780378|FG000|Overall Study|Miscalculation in mmcs|0|||
156735676|NCT03558152|565780379|FG001|Overall Study|Miscalculation in mmcs|0|||
156735677|NCT03558152|565780380|FG002|Overall Study|Miscalculation in mmcs|0|||
156735678|NCT03558152|565780381|FG003|Overall Study|Miscalculation in mmcs|0|||
156735679|NCT03558152|565780382|FG004|Overall Study|Miscalculation in mmcs|0|||
156735680|NCT03558152|565780383|FG005|Overall Study|Miscalculation in mmcs|0|||
156735681|NCT03558152|565780384|FG006|Overall Study|Miscalculation in mmcs|1|||
156735682|NCT03558152|565780385|FG007|Overall Study|Miscalculation in mmcs|0|||
156735683|NCT03558152|565780378|FG000|Overall Study|Mistake in calculation|0|||
156735684|NCT03558152|565780379|FG001|Overall Study|Mistake in calculation|0|||
157218036|NCT00124020|567545564|FG001|Overall Study|Death|71|||
156735685|NCT03558152|565780380|FG002|Overall Study|Mistake in calculation|0|||
156735686|NCT03558152|565780381|FG003|Overall Study|Mistake in calculation|1|||
156735687|NCT03558152|565780382|FG004|Overall Study|Mistake in calculation|0|||
156808843|NCT01484496|566054476|FG003|Period 1|Unable to Visit Site|0|||
156735688|NCT03558152|565780383|FG005|Overall Study|Mistake in calculation|0|||
156735689|NCT03558152|565780384|FG006|Overall Study|Mistake in calculation|0|||
156735690|NCT03558152|565780385|FG007|Overall Study|Mistake in calculation|0|||
156735691|NCT03558152|565780378|FG000|Overall Study|Mistake in evaluation of disease status|0|||
156735692|NCT03558152|565780379|FG001|Overall Study|Mistake in evaluation of disease status|0|||
156735693|NCT03558152|565780380|FG002|Overall Study|Mistake in evaluation of disease status|0|||
156735694|NCT03558152|565780381|FG003|Overall Study|Mistake in evaluation of disease status|0|||
156735695|NCT03558152|565780382|FG004|Overall Study|Mistake in evaluation of disease status|0|||
156735696|NCT03558152|565780383|FG005|Overall Study|Mistake in evaluation of disease status|0|||
156735697|NCT03558152|565780384|FG006|Overall Study|Mistake in evaluation of disease status|0|||
156735698|NCT03558152|565780385|FG007|Overall Study|Mistake in evaluation of disease status|1|||
156735699|NCT03558152|565780378|FG000|Overall Study|Physician Decision|0|||
156735700|NCT03558152|565780379|FG001|Overall Study|Physician Decision|0|||
156735701|NCT03558152|565780380|FG002|Overall Study|Physician Decision|0|||
156735702|NCT03558152|565780381|FG003|Overall Study|Physician Decision|0|||
156735703|NCT03558152|565780382|FG004|Overall Study|Physician Decision|0|||
156735704|NCT03558152|565780383|FG005|Overall Study|Physician Decision|0|||
156735705|NCT03558152|565780384|FG006|Overall Study|Physician Decision|1|||
156735706|NCT03558152|565780385|FG007|Overall Study|Physician Decision|0|||
156735707|NCT03558152|565780378|FG000|Overall Study|Withdrawal by Subject|2|||
156735708|NCT03558152|565780379|FG001|Overall Study|Withdrawal by Subject|3|||
156735709|NCT03558152|565780380|FG002|Overall Study|Withdrawal by Subject|2|||
156735710|NCT03558152|565780381|FG003|Overall Study|Withdrawal by Subject|1|||
156735711|NCT03558152|565780382|FG004|Overall Study|Withdrawal by Subject|1|||
156735712|NCT03558152|565780383|FG005|Overall Study|Withdrawal by Subject|1|||
156735713|NCT03558152|565780384|FG006|Overall Study|Withdrawal by Subject|3|||
156735714|NCT03558152|565780385|FG007|Overall Study|Withdrawal by Subject|2|||
156735715|NCT03558152|565780378|FG000|Overall Study|Lack of Efficacy|11|||
156735716|NCT03558152|565780379|FG001|Overall Study|Lack of Efficacy|11|||
156735717|NCT03558152|565780380|FG002|Overall Study|Lack of Efficacy|10|||
156735718|NCT03558152|565780381|FG003|Overall Study|Lack of Efficacy|11|||
156735719|NCT03558152|565780382|FG004|Overall Study|Lack of Efficacy|14|||
156735720|NCT03558152|565780383|FG005|Overall Study|Lack of Efficacy|12|||
156735721|NCT03558152|565780384|FG006|Overall Study|Lack of Efficacy|14|||
156735722|NCT03558152|565780385|FG007|Overall Study|Lack of Efficacy|13|||
156735723|NCT03558152|565780378|FG000|Overall Study|Protocol Violation|1|||
156735724|NCT03558152|565780379|FG001|Overall Study|Protocol Violation|1|||
156735725|NCT03558152|565780380|FG002|Overall Study|Protocol Violation|0|||
156735726|NCT03558152|565780381|FG003|Overall Study|Protocol Violation|1|||
156735727|NCT03558152|565780382|FG004|Overall Study|Protocol Violation|1|||
156735728|NCT03558152|565780383|FG005|Overall Study|Protocol Violation|0|||
156735729|NCT03558152|565780384|FG006|Overall Study|Protocol Violation|2|||
156735730|NCT03558152|565780385|FG007|Overall Study|Protocol Violation|0|||
156735731|NCT04166591|565780386|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156735732|NCT04166591|565780387|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
157218037|NCT00124020|567545563|FG000|Overall Study|Withdrawal by Subject|13|||
157218038|NCT00124020|567545564|FG001|Overall Study|Withdrawal by Subject|11|||
157218039|NCT00124020|567545563|FG000|Overall Study|Lost to Follow-up|5|||
156735733|NCT04166591|565780388|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735734|NCT04166591|565780389|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735735|NCT04166591|565780386|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
156735736|NCT04166591|565780387|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
156735737|NCT04166591|565780388|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735738|NCT04166591|565780389|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156735739|NCT03960021|565780390|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
156735740|NCT01936181|565780395|FG000|Randomised, Double-blind|Adverse Event|27|||
156735741|NCT01936181|565780396|FG001|Randomised, Double-blind|Adverse Event|21|||
156735742|NCT01936181|565780397|FG002|Randomised, Double-blind|Adverse Event|0|||
156735743|NCT01936181|565780398|FG003|Randomised, Double-blind|Adverse Event|0|||
156735744|NCT01936181|565780395|FG000|Randomised, Double-blind|Protocol Violation|1|||
156735745|NCT01936181|565780396|FG001|Randomised, Double-blind|Protocol Violation|5|||
156735746|NCT01936181|565780397|FG002|Randomised, Double-blind|Protocol Violation|0|||
156735747|NCT01936181|565780398|FG003|Randomised, Double-blind|Protocol Violation|0|||
156735748|NCT01936181|565780395|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
157218040|NCT00124020|567545564|FG001|Overall Study|Lost to Follow-up|8|||
156735749|NCT01936181|565780396|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
156735750|NCT01936181|565780397|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
156735751|NCT01936181|565780398|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
156735752|NCT01936181|565780395|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
156735753|NCT01936181|565780396|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
156735754|NCT01936181|565780397|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
156735755|NCT01936181|565780398|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
156735756|NCT01936181|565780395|FG000|Randomised, Double-blind|Pregnancy|0|||
157218041|NCT00124020|567545563|FG000|Overall Study|Other|1|||
156735757|NCT01936181|565780396|FG001|Randomised, Double-blind|Pregnancy|1|||
156735758|NCT01936181|565780397|FG002|Randomised, Double-blind|Pregnancy|0|||
156735759|NCT01936181|565780398|FG003|Randomised, Double-blind|Pregnancy|0|||
156735760|NCT01936181|565780395|FG000|Randomised, Double-blind|Physician Decision|4|||
157020208|NCT01261312|566826533|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
157020209|NCT01261312|566826534|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
157020210|NCT01261312|566826535|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
156735761|NCT01936181|565780396|FG001|Randomised, Double-blind|Physician Decision|4|||
156735762|NCT01936181|565780397|FG002|Randomised, Double-blind|Physician Decision|0|||
156735763|NCT01936181|565780398|FG003|Randomised, Double-blind|Physician Decision|0|||
156735764|NCT01936181|565780395|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
156735765|NCT01936181|565780396|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
156735766|NCT01936181|565780397|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
156735767|NCT01936181|565780398|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
156735768|NCT01936181|565780395|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
156735769|NCT01936181|565780396|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
156735770|NCT01936181|565780397|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
156735771|NCT01936181|565780398|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
156735772|NCT01936181|565780395|FG000|Transition-extension|Adverse Event|3|||
156735773|NCT01936181|565780396|FG001|Transition-extension|Adverse Event|0|||
156735774|NCT01936181|565780397|FG002|Transition-extension|Adverse Event|3|||
156735775|NCT01936181|565780398|FG003|Transition-extension|Adverse Event|1|||
156735776|NCT01936181|565780395|FG000|Transition-extension|Lost to Follow-up|3|||
156735777|NCT01936181|565780396|FG001|Transition-extension|Lost to Follow-up|0|||
156735778|NCT01936181|565780397|FG002|Transition-extension|Lost to Follow-up|1|||
156735779|NCT01936181|565780398|FG003|Transition-extension|Lost to Follow-up|2|||
156735780|NCT01936181|565780395|FG000|Transition-extension|Physician Decision|2|||
156735781|NCT01936181|565780396|FG001|Transition-extension|Physician Decision|0|||
156735782|NCT01936181|565780397|FG002|Transition-extension|Physician Decision|0|||
156735783|NCT01936181|565780398|FG003|Transition-extension|Physician Decision|1|||
156735784|NCT01936181|565780395|FG000|Transition-extension|Withdrawal by Subject|7|||
156735785|NCT01936181|565780396|FG001|Transition-extension|Withdrawal by Subject|0|||
156735786|NCT01936181|565780397|FG002|Transition-extension|Withdrawal by Subject|2|||
156735787|NCT01936181|565780398|FG003|Transition-extension|Withdrawal by Subject|1|||
156735788|NCT01346189|565780399|FG000|Overall Study|Withdrawal by Subject|7|||
156735789|NCT01346189|565780400|FG001|Overall Study|Withdrawal by Subject|5|||
156735790|NCT01346189|565780401|FG002|Overall Study|Withdrawal by Subject|3|||
156735791|NCT01346189|565780402|FG003|Overall Study|Withdrawal by Subject|5|||
156735792|NCT01346189|565780399|FG000|Overall Study|Physician Decision|4|||
156735793|NCT01346189|565780400|FG001|Overall Study|Physician Decision|0|||
156735794|NCT01346189|565780401|FG002|Overall Study|Physician Decision|0|||
156735795|NCT01346189|565780402|FG003|Overall Study|Physician Decision|0|||
156735796|NCT01346189|565780399|FG000|Overall Study|Moved|3|||
156735797|NCT01346189|565780400|FG001|Overall Study|Moved|0|||
156735798|NCT01346189|565780401|FG002|Overall Study|Moved|4|||
156735799|NCT01346189|565780402|FG003|Overall Study|Moved|0|||
156735800|NCT01346189|565780399|FG000|Overall Study|Other|2|||
156735801|NCT01346189|565780400|FG001|Overall Study|Other|4|||
156735802|NCT01346189|565780401|FG002|Overall Study|Other|7|||
157020211|NCT01261312|566826536|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
157020212|NCT03336333|566826541|FG000|Overall Study|Remained on study at time of data cut-off|202|||
157020213|NCT03336333|566826542|FG001|Overall Study|Remained on study at time of data cut-off|219|||
157020214|NCT03336333|566826543|FG002|Overall Study|Remained on study at time of data cut-off|102|||
157020215|NCT03336333|566826541|FG000|Overall Study|Death|14|||
157020216|NCT03336333|566826542|FG001|Overall Study|Death|16|||
157020217|NCT03336333|566826543|FG002|Overall Study|Death|8|||
157020218|NCT03336333|566826541|FG000|Overall Study|Withdrawal by Subject|16|||
157020219|NCT03336333|566826542|FG001|Overall Study|Withdrawal by Subject|5|||
157020220|NCT03336333|566826543|FG002|Overall Study|Withdrawal by Subject|1|||
156735803|NCT01346189|565780402|FG003|Overall Study|Other|3|||
157020221|NCT03336333|566826541|FG000|Overall Study|Physician Decision|5|||
157020222|NCT03336333|566826542|FG001|Overall Study|Physician Decision|1|||
156735804|NCT01346189|565780399|FG000|Overall Study|Death|0|||
156735805|NCT01346189|565780400|FG001|Overall Study|Death|3|||
156735806|NCT01346189|565780401|FG002|Overall Study|Death|0|||
156735807|NCT01346189|565780402|FG003|Overall Study|Death|0|||
156735808|NCT01346189|565780399|FG000|Overall Study|Non-health system primary care physician|0|||
156735809|NCT01346189|565780400|FG001|Overall Study|Non-health system primary care physician|5|||
156735810|NCT01346189|565780401|FG002|Overall Study|Non-health system primary care physician|0|||
156735811|NCT01346189|565780402|FG003|Overall Study|Non-health system primary care physician|0|||
157020223|NCT03336333|566826543|FG002|Overall Study|Physician Decision|0|||
156735812|NCT01346189|565780399|FG000|Overall Study|Travel|0|||
157020224|NCT03336333|566826541|FG000|Overall Study|Lost to Follow-up|1|||
156735813|NCT01346189|565780400|FG001|Overall Study|Travel|0|||
156735814|NCT01346189|565780401|FG002|Overall Study|Travel|0|||
156735815|NCT01346189|565780402|FG003|Overall Study|Travel|3|||
156735816|NCT00900757|565780403|FG000|Overall Study|screen failure|19|||
156735817|NCT05113979|565780408|FG000|Overall Study|Death|2|||
156735818|NCT05113979|565780408|FG000|Overall Study|Lost to Follow-up|1|||
156735819|NCT00976820|565780409|FG000|Overall Study|Lost to Follow-up|5|||
156735820|NCT00976820|565780410|FG001|Overall Study|Lost to Follow-up|16|||
156735821|NCT00976820|565780411|FG002|Overall Study|Lost to Follow-up|2|||
156735822|NCT00976820|565780412|FG003|Overall Study|Lost to Follow-up|3|||
156735823|NCT00976820|565780409|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
156735824|NCT00976820|565780410|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
156735825|NCT00976820|565780411|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
156735826|NCT00976820|565780412|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
156735827|NCT00976820|565780409|FG000|Overall Study|Withdrawal by Subject|2|||
156735828|NCT00976820|565780410|FG001|Overall Study|Withdrawal by Subject|4|||
156735829|NCT00976820|565780411|FG002|Overall Study|Withdrawal by Subject|1|||
156735830|NCT00976820|565780412|FG003|Overall Study|Withdrawal by Subject|4|||
156735831|NCT00968981|565780413|FG000|Overall Study|Adverse Event|2|||
156735832|NCT00968981|565780414|FG001|Overall Study|Adverse Event|0|||
156735833|NCT00968981|565780415|FG002|Overall Study|Adverse Event|0|||
156735834|NCT00968981|565780413|FG000|Overall Study|Disease Progression|14|||
156735835|NCT00968981|565780414|FG001|Overall Study|Disease Progression|16|||
156735836|NCT00968981|565780415|FG002|Overall Study|Disease Progression|13|||
156735837|NCT00968981|565780413|FG000|Overall Study|Lost to Follow-up|0|||
156735838|NCT00968981|565780414|FG001|Overall Study|Lost to Follow-up|0|||
156735839|NCT00968981|565780415|FG002|Overall Study|Lost to Follow-up|1|||
156735840|NCT00968981|565780413|FG000|Overall Study|Physician Decision|5|||
156735841|NCT00968981|565780414|FG001|Overall Study|Physician Decision|3|||
156735842|NCT00968981|565780415|FG002|Overall Study|Physician Decision|5|||
156735843|NCT00968981|565780413|FG000|Overall Study|Withdrawal by Subject|1|||
156735844|NCT00968981|565780414|FG001|Overall Study|Withdrawal by Subject|3|||
156735845|NCT00968981|565780415|FG002|Overall Study|Withdrawal by Subject|3|||
156735846|NCT01489254|565780416|FG000|Double-blind Part|Adverse Event|7|||
156735847|NCT01489254|565780417|FG001|Double-blind Part|Adverse Event|2|||
156735848|NCT01489254|565780418|FG002|Double-blind Part|Adverse Event|2|||
156735849|NCT01489254|565780419|FG003|Double-blind Part|Adverse Event|0|||
156735850|NCT01489254|565780416|FG000|Double-blind Part|Pregnancy|1|||
156735851|NCT01489254|565780417|FG001|Double-blind Part|Pregnancy|3|||
156735852|NCT01489254|565780418|FG002|Double-blind Part|Pregnancy|0|||
156735853|NCT01489254|565780419|FG003|Double-blind Part|Pregnancy|0|||
156735854|NCT01489254|565780416|FG000|Double-blind Part|Withdrawal by Subject|12|||
156735855|NCT01489254|565780417|FG001|Double-blind Part|Withdrawal by Subject|20|||
156735856|NCT01489254|565780418|FG002|Double-blind Part|Withdrawal by Subject|1|||
156735857|NCT01489254|565780419|FG003|Double-blind Part|Withdrawal by Subject|0|||
156735858|NCT01489254|565780416|FG000|Double-blind Part|Lost to Follow-up|1|||
156735859|NCT01489254|565780417|FG001|Double-blind Part|Lost to Follow-up|2|||
156735860|NCT01489254|565780418|FG002|Double-blind Part|Lost to Follow-up|0|||
156735861|NCT01489254|565780419|FG003|Double-blind Part|Lost to Follow-up|0|||
156735862|NCT01489254|565780416|FG000|Double-blind Part|Other reasons for not completing study|4|||
156735863|NCT01489254|565780417|FG001|Double-blind Part|Other reasons for not completing study|6|||
156735864|NCT01489254|565780418|FG002|Double-blind Part|Other reasons for not completing study|0|||
156735865|NCT01489254|565780419|FG003|Double-blind Part|Other reasons for not completing study|0|||
156735866|NCT01489254|565780416|FG000|Open-label Extension Part|Adverse Event|0|||
156735867|NCT01489254|565780417|FG001|Open-label Extension Part|Adverse Event|0|||
156735868|NCT01489254|565780418|FG002|Open-label Extension Part|Adverse Event|0|||
156735869|NCT01489254|565780419|FG003|Open-label Extension Part|Adverse Event|10|||
156735870|NCT01489254|565780416|FG000|Open-label Extension Part|Pregnancy|0|||
156735871|NCT01489254|565780417|FG001|Open-label Extension Part|Pregnancy|0|||
156735872|NCT01489254|565780418|FG002|Open-label Extension Part|Pregnancy|0|||
156735873|NCT01489254|565780419|FG003|Open-label Extension Part|Pregnancy|3|||
156735874|NCT01489254|565780416|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
156735875|NCT01489254|565780417|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
156735876|NCT01489254|565780418|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
156735877|NCT01489254|565780419|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
156735878|NCT01489254|565780416|FG000|Open-label Extension Part|Protocol Violation|0|||
156735879|NCT01489254|565780417|FG001|Open-label Extension Part|Protocol Violation|0|||
156735880|NCT01489254|565780418|FG002|Open-label Extension Part|Protocol Violation|0|||
156735881|NCT01489254|565780419|FG003|Open-label Extension Part|Protocol Violation|1|||
156735882|NCT01489254|565780416|FG000|Open-label Extension Part|Lost to Follow-up|0|||
156735883|NCT01489254|565780417|FG001|Open-label Extension Part|Lost to Follow-up|0|||
156735884|NCT01489254|565780418|FG002|Open-label Extension Part|Lost to Follow-up|0|||
157218042|NCT00124020|567545564|FG001|Overall Study|Other|1|||
156735885|NCT01489254|565780419|FG003|Open-label Extension Part|Lost to Follow-up|9|||
156735886|NCT01489254|565780416|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
156735887|NCT01489254|565780417|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
156808844|NCT01484496|566054473|FG000|Period 2|Lack of Efficacy|0|||
156735888|NCT01489254|565780418|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
156735889|NCT01489254|565780419|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
156735890|NCT02980341|565780424|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735891|NCT02980341|565780425|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735892|NCT02980341|565780426|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
156735893|NCT02980341|565780427|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
156735894|NCT02980341|565780428|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
156735895|NCT02980341|565780429|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735896|NCT02980341|565780430|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735897|NCT02980341|565780431|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735898|NCT02980341|565780432|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735899|NCT02980341|565780433|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735900|NCT02980341|565780434|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
156735901|NCT02980341|565780424|FG000|Dose Escalation|Clinical progression|0|||
156735902|NCT02980341|565780425|FG001|Dose Escalation|Clinical progression|0|||
156735903|NCT02980341|565780426|FG002|Dose Escalation|Clinical progression|2|||
156735904|NCT02980341|565780427|FG003|Dose Escalation|Clinical progression|1|||
156735905|NCT02980341|565780428|FG004|Dose Escalation|Clinical progression|0|||
156735906|NCT02980341|565780429|FG005|Dose Escalation|Clinical progression|0|||
156735907|NCT02980341|565780430|FG006|Dose Escalation|Clinical progression|0|||
157218043|NCT00124020|567545563|FG000|Overall Study|Transfer to another hospital|2|||
157218044|NCT00124020|567545564|FG001|Overall Study|Transfer to another hospital|0|||
157218045|NCT00268346|567545565|FG000|Overall Study|Adverse Event|0|||
157218046|NCT00268346|567545566|FG001|Overall Study|Adverse Event|1|||
157218047|NCT00268346|567545565|FG000|Overall Study|Death|0|||
157218048|NCT00268346|567545566|FG001|Overall Study|Death|1|||
156735908|NCT02980341|565780431|FG007|Dose Escalation|Clinical progression|0|||
156735909|NCT02980341|565780432|FG008|Dose Escalation|Clinical progression|0|||
156735910|NCT02980341|565780433|FG009|Dose Escalation|Clinical progression|0|||
156735911|NCT02980341|565780434|FG010|Dose Escalation|Clinical progression|0|||
156735912|NCT02980341|565780424|FG000|Dose Escalation|Adverse Event|0|||
156735913|NCT02980341|565780425|FG001|Dose Escalation|Adverse Event|0|||
156735914|NCT02980341|565780426|FG002|Dose Escalation|Adverse Event|1|||
156735915|NCT02980341|565780427|FG003|Dose Escalation|Adverse Event|2|||
156735916|NCT02980341|565780428|FG004|Dose Escalation|Adverse Event|2|||
156735917|NCT02980341|565780429|FG005|Dose Escalation|Adverse Event|0|||
156735918|NCT02980341|565780430|FG006|Dose Escalation|Adverse Event|0|||
156735919|NCT02980341|565780431|FG007|Dose Escalation|Adverse Event|0|||
156735920|NCT02980341|565780432|FG008|Dose Escalation|Adverse Event|0|||
156735921|NCT02980341|565780433|FG009|Dose Escalation|Adverse Event|0|||
156735922|NCT02980341|565780434|FG010|Dose Escalation|Adverse Event|0|||
156735923|NCT02980341|565780424|FG000|Dose Escalation|Withdrawal by Subject|0|||
156735924|NCT02980341|565780425|FG001|Dose Escalation|Withdrawal by Subject|0|||
156735925|NCT02980341|565780426|FG002|Dose Escalation|Withdrawal by Subject|1|||
156735926|NCT02980341|565780427|FG003|Dose Escalation|Withdrawal by Subject|0|||
156735927|NCT02980341|565780428|FG004|Dose Escalation|Withdrawal by Subject|0|||
156735928|NCT02980341|565780429|FG005|Dose Escalation|Withdrawal by Subject|0|||
156735929|NCT02980341|565780430|FG006|Dose Escalation|Withdrawal by Subject|0|||
156735930|NCT02980341|565780431|FG007|Dose Escalation|Withdrawal by Subject|0|||
156735931|NCT02980341|565780432|FG008|Dose Escalation|Withdrawal by Subject|0|||
156735932|NCT02980341|565780433|FG009|Dose Escalation|Withdrawal by Subject|0|||
156735933|NCT02980341|565780434|FG010|Dose Escalation|Withdrawal by Subject|0|||
156735934|NCT02980341|565780424|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735935|NCT02980341|565780425|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735936|NCT02980341|565780426|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735937|NCT02980341|565780427|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
156735938|NCT02980341|565780428|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735939|NCT02980341|565780429|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735940|NCT02980341|565780430|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735941|NCT02980341|565780431|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
157020225|NCT03336333|566826542|FG001|Overall Study|Lost to Follow-up|0|||
157020226|NCT03336333|566826543|FG002|Overall Study|Lost to Follow-up|0|||
157218049|NCT00268346|567545565|FG000|Overall Study|Withdrawal by Subject|0|||
157218050|NCT00268346|567545566|FG001|Overall Study|Withdrawal by Subject|1|||
157218051|NCT01799590|567545570|FG000|Overall Study|Adverse Event|13|||
156735942|NCT02980341|565780432|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735943|NCT02980341|565780433|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735944|NCT02980341|565780434|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
156735945|NCT02980341|565780424|FG000|Dose Escalation|Due to investigator's decision|0|||
156735946|NCT02980341|565780425|FG001|Dose Escalation|Due to investigator's decision|0|||
157218052|NCT01799590|567545571|FG001|Overall Study|Adverse Event|7|||
157218053|NCT01799590|567545572|FG002|Overall Study|Adverse Event|5|||
156735947|NCT02980341|565780426|FG002|Dose Escalation|Due to investigator's decision|0|||
156735948|NCT02980341|565780427|FG003|Dose Escalation|Due to investigator's decision|0|||
156735949|NCT02980341|565780428|FG004|Dose Escalation|Due to investigator's decision|1|||
156735950|NCT02980341|565780429|FG005|Dose Escalation|Due to investigator's decision|0|||
156735951|NCT02980341|565780430|FG006|Dose Escalation|Due to investigator's decision|0|||
156735952|NCT02980341|565780431|FG007|Dose Escalation|Due to investigator's decision|0|||
156735953|NCT02980341|565780432|FG008|Dose Escalation|Due to investigator's decision|0|||
156735954|NCT02980341|565780433|FG009|Dose Escalation|Due to investigator's decision|0|||
156735955|NCT02980341|565780434|FG010|Dose Escalation|Due to investigator's decision|0|||
156735956|NCT02980341|565780424|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735957|NCT02980341|565780425|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735958|NCT02980341|565780426|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735959|NCT02980341|565780427|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735960|NCT02980341|565780428|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735961|NCT02980341|565780429|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
156735962|NCT02980341|565780430|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
156735963|NCT02980341|565780431|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735964|NCT02980341|565780432|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735965|NCT02980341|565780433|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735966|NCT02980341|565780434|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
156735967|NCT02980341|565780424|FG000|Dose Finding|Adverse Event|0|||
156735968|NCT02980341|565780425|FG001|Dose Finding|Adverse Event|0|||
156735969|NCT02980341|565780426|FG002|Dose Finding|Adverse Event|0|||
156735970|NCT02980341|565780427|FG003|Dose Finding|Adverse Event|0|||
156735971|NCT02980341|565780428|FG004|Dose Finding|Adverse Event|0|||
156735972|NCT02980341|565780429|FG005|Dose Finding|Adverse Event|3|||
156735973|NCT02980341|565780430|FG006|Dose Finding|Adverse Event|0|||
156735974|NCT02980341|565780431|FG007|Dose Finding|Adverse Event|0|||
156735975|NCT02980341|565780432|FG008|Dose Finding|Adverse Event|0|||
156735976|NCT02980341|565780433|FG009|Dose Finding|Adverse Event|0|||
156735977|NCT02980341|565780434|FG010|Dose Finding|Adverse Event|0|||
156735978|NCT02980341|565780424|FG000|Dose Finding|Withdrawal by Subject|0|||
156735979|NCT02980341|565780425|FG001|Dose Finding|Withdrawal by Subject|0|||
156735980|NCT02980341|565780426|FG002|Dose Finding|Withdrawal by Subject|0|||
156735981|NCT02980341|565780427|FG003|Dose Finding|Withdrawal by Subject|0|||
156735982|NCT02980341|565780428|FG004|Dose Finding|Withdrawal by Subject|0|||
156735983|NCT02980341|565780429|FG005|Dose Finding|Withdrawal by Subject|1|||
156735984|NCT02980341|565780430|FG006|Dose Finding|Withdrawal by Subject|1|||
156735985|NCT02980341|565780431|FG007|Dose Finding|Withdrawal by Subject|0|||
156735986|NCT02980341|565780432|FG008|Dose Finding|Withdrawal by Subject|0|||
156735987|NCT02980341|565780433|FG009|Dose Finding|Withdrawal by Subject|0|||
156735988|NCT02980341|565780434|FG010|Dose Finding|Withdrawal by Subject|0|||
156735989|NCT02980341|565780424|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735990|NCT02980341|565780425|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735991|NCT02980341|565780426|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735992|NCT02980341|565780427|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735993|NCT02980341|565780428|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735994|NCT02980341|565780429|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735995|NCT02980341|565780430|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
156735996|NCT02980341|565780431|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
156735997|NCT02980341|565780432|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
156735998|NCT02980341|565780433|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
156735999|NCT02980341|565780434|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
156736000|NCT02980341|565780424|FG000|Dose Expansion|Clinical progression|0|||
156736001|NCT02980341|565780425|FG001|Dose Expansion|Clinical progression|0|||
156736002|NCT02980341|565780426|FG002|Dose Expansion|Clinical progression|0|||
156736003|NCT02980341|565780427|FG003|Dose Expansion|Clinical progression|0|||
156736004|NCT02980341|565780428|FG004|Dose Expansion|Clinical progression|0|||
156736005|NCT02980341|565780429|FG005|Dose Expansion|Clinical progression|0|||
156736006|NCT02980341|565780430|FG006|Dose Expansion|Clinical progression|0|||
156736007|NCT02980341|565780431|FG007|Dose Expansion|Clinical progression|4|||
156736008|NCT02980341|565780432|FG008|Dose Expansion|Clinical progression|3|||
156736009|NCT02980341|565780433|FG009|Dose Expansion|Clinical progression|1|||
156736010|NCT02980341|565780434|FG010|Dose Expansion|Clinical progression|4|||
156736011|NCT02980341|565780424|FG000|Dose Expansion|Adverse Event|0|||
156736012|NCT02980341|565780425|FG001|Dose Expansion|Adverse Event|0|||
156736013|NCT02980341|565780426|FG002|Dose Expansion|Adverse Event|0|||
156736014|NCT02980341|565780427|FG003|Dose Expansion|Adverse Event|0|||
156736015|NCT02980341|565780428|FG004|Dose Expansion|Adverse Event|0|||
156736016|NCT02980341|565780429|FG005|Dose Expansion|Adverse Event|0|||
156736017|NCT02980341|565780430|FG006|Dose Expansion|Adverse Event|0|||
156736018|NCT02980341|565780431|FG007|Dose Expansion|Adverse Event|3|||
156736019|NCT02980341|565780432|FG008|Dose Expansion|Adverse Event|0|||
156736020|NCT02980341|565780433|FG009|Dose Expansion|Adverse Event|1|||
156736021|NCT02980341|565780434|FG010|Dose Expansion|Adverse Event|3|||
156736022|NCT02980341|565780424|FG000|Dose Expansion|Death|0|||
156736023|NCT02980341|565780425|FG001|Dose Expansion|Death|0|||
156736024|NCT02980341|565780426|FG002|Dose Expansion|Death|0|||
156736025|NCT02980341|565780427|FG003|Dose Expansion|Death|0|||
156736026|NCT02980341|565780428|FG004|Dose Expansion|Death|0|||
156736027|NCT02980341|565780429|FG005|Dose Expansion|Death|0|||
156736028|NCT02980341|565780430|FG006|Dose Expansion|Death|0|||
156736029|NCT02980341|565780431|FG007|Dose Expansion|Death|0|||
156736030|NCT02980341|565780432|FG008|Dose Expansion|Death|2|||
156736031|NCT02980341|565780433|FG009|Dose Expansion|Death|1|||
156736032|NCT02980341|565780434|FG010|Dose Expansion|Death|0|||
156736033|NCT02980341|565780424|FG000|Dose Expansion|Withdrawal by Subject|0|||
156736034|NCT02980341|565780425|FG001|Dose Expansion|Withdrawal by Subject|0|||
156736035|NCT02980341|565780426|FG002|Dose Expansion|Withdrawal by Subject|0|||
156736036|NCT02980341|565780427|FG003|Dose Expansion|Withdrawal by Subject|0|||
156736037|NCT02980341|565780428|FG004|Dose Expansion|Withdrawal by Subject|0|||
156736038|NCT02980341|565780429|FG005|Dose Expansion|Withdrawal by Subject|0|||
156736039|NCT02980341|565780430|FG006|Dose Expansion|Withdrawal by Subject|0|||
156736040|NCT02980341|565780431|FG007|Dose Expansion|Withdrawal by Subject|2|||
156736041|NCT02980341|565780432|FG008|Dose Expansion|Withdrawal by Subject|0|||
156736042|NCT02980341|565780433|FG009|Dose Expansion|Withdrawal by Subject|1|||
156736043|NCT02980341|565780434|FG010|Dose Expansion|Withdrawal by Subject|0|||
156736044|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736045|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736046|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736047|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736048|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736049|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736050|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736051|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
156736052|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736053|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736054|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
156736055|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736056|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736057|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736058|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736059|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736060|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736061|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736062|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736063|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
156876757|NCT02474069|566307727|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
156876758|NCT02474069|566307725|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
156876759|NCT02474069|566307726|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
156876760|NCT02474069|566307727|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
156736064|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736065|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
156736066|NCT02980341|565780424|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736067|NCT02980341|565780425|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736068|NCT02980341|565780426|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736069|NCT02980341|565780427|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736070|NCT02980341|565780428|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736071|NCT02980341|565780429|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736072|NCT02980341|565780430|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736073|NCT02980341|565780431|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736074|NCT02980341|565780432|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
156736075|NCT02980341|565780433|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
156736076|NCT02980341|565780434|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
157141940|NCT03523585|567267779|FG000|Overall Study|Randomized But Not Treated|2|||
157141941|NCT03523585|567267780|FG001|Overall Study|Randomized But Not Treated|4|||
157141942|NCT03523585|567267781|FG002|Overall Study|Randomized But Not Treated|3|||
156736077|NCT02980341|565780424|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736078|NCT02980341|565780425|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736079|NCT02980341|565780426|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736080|NCT02980341|565780427|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736081|NCT02980341|565780428|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736082|NCT02980341|565780429|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736083|NCT02980341|565780430|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736084|NCT02980341|565780431|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736085|NCT02980341|565780432|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736086|NCT02980341|565780433|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
156736087|NCT02980341|565780434|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
156736088|NCT01895608|565780436|FG000|Overall Study|change in health status|0|||
156736089|NCT01895608|565780437|FG001|Overall Study|change in health status|1|||
156736090|NCT01895608|565780438|FG002|Overall Study|change in health status|1|||
156736091|NCT01895608|565780439|FG003|Overall Study|change in health status|0|||
156736092|NCT01895608|565780436|FG000|Overall Study|Withdrawal by Subject|0|||
156736093|NCT01895608|565780437|FG001|Overall Study|Withdrawal by Subject|0|||
156736094|NCT01895608|565780438|FG002|Overall Study|Withdrawal by Subject|2|||
156736095|NCT01895608|565780439|FG003|Overall Study|Withdrawal by Subject|0|||
156736096|NCT02691936|565780440|FG000|Overall Study|Withdrawal by Subject|2|||
156736097|NCT02691936|565780441|FG001|Overall Study|Withdrawal by Subject|5|||
156736098|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
156736099|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
156736100|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
156736101|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
156736102|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
156736103|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
156736104|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
156736105|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
156736106|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
156736107|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
156736108|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Death|1|||
156736109|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Death|0|||
156736110|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
156736111|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
156736112|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
156736113|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
156736114|NCT01876784|565780442|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
156796911|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796912|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
156796913|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796914|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
157141943|NCT00698516|567267782|FG000|Overall Study|Study Termination|2|||
157141944|NCT00698516|567267782|FG000|Overall Study|Withdrawal by Subject|3|||
156796915|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796916|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
156796917|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796918|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796919|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796920|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796921|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796922|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796923|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796924|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796925|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
156796926|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796927|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796928|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
156796929|NCT00725985|566009671|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796930|NCT00725985|566009672|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796931|NCT00725985|566009673|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796932|NCT00725985|566009674|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796933|NCT00725985|566009675|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796934|NCT00725985|566009676|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796935|NCT00725985|566009677|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
156736115|NCT01876784|565780443|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
156736116|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
156736117|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
156736118|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Adverse Event|2|||
156736119|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Adverse Event|6|||
156736120|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
156736121|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
156736122|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Progressive disease|4|||
156736123|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Progressive disease|35|||
156736124|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
156736125|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
156736126|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
156736127|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
156736128|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Death|0|||
156736129|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Death|1|||
156736130|NCT01876784|565780442|FG000|Open-label Period (31 Months)|Other than specified above|9|||
156736131|NCT01876784|565780443|FG001|Open-label Period (31 Months)|Other than specified above|18|||
156736132|NCT00749684|565780444|FG000|Overall Study|Death|1|||
156736133|NCT00749684|565780444|FG000|Overall Study|Adverse Event|27|||
156736134|NCT00749684|565780444|FG000|Overall Study|Participant's Wish|10|||
156736135|NCT00749684|565780444|FG000|Overall Study|Not Documented|1|||
156736136|NCT00749684|565780444|FG000|Overall Study|Progressive Desease|31|||
156736137|NCT00749684|565780444|FG000|Overall Study|Therapy according to protocol + AE|2|||
156736138|NCT00749684|565780444|FG000|Overall Study|AE+discontinuation on participants wish|1|||
156736139|NCT00749684|565780444|FG000|Overall Study|Missing|9|||
156736140|NCT01194531|565780446|FG000|Overall Study|Withdrawal by Subject|1|||
156736141|NCT01194531|565780447|FG001|Overall Study|Withdrawal by Subject|0|||
156736142|NCT01194531|565780446|FG000|Overall Study|Protocol Violation|4|||
156736143|NCT01194531|565780447|FG001|Overall Study|Protocol Violation|1|||
156736144|NCT01194531|565780446|FG000|Overall Study|Physician Decision|0|||
156736145|NCT01194531|565780447|FG001|Overall Study|Physician Decision|2|||
156736146|NCT03891862|565780448|FG000|Open-label Period|Adverse Event|2|||
156736147|NCT03891862|565780449|FG001|Open-label Period|Adverse Event|0|||
156736148|NCT03891862|565780450|FG002|Open-label Period|Adverse Event|0|||
156736149|NCT03891862|565780448|FG000|Open-label Period|Protocol Violation|5|||
156736150|NCT03891862|565780449|FG001|Open-label Period|Protocol Violation|0|||
156736151|NCT03891862|565780450|FG002|Open-label Period|Protocol Violation|0|||
156736152|NCT03891862|565780448|FG000|Open-label Period|Withdrawal by Subject|6|||
156736153|NCT03891862|565780449|FG001|Open-label Period|Withdrawal by Subject|0|||
156736154|NCT03891862|565780450|FG002|Open-label Period|Withdrawal by Subject|0|||
156736155|NCT03891862|565780448|FG000|Open-label Period|Death|1|||
156736156|NCT03891862|565780449|FG001|Open-label Period|Death|0|||
156736157|NCT03891862|565780450|FG002|Open-label Period|Death|0|||
156736158|NCT03891862|565780448|FG000|Open-label Period|Lost to Follow-up|2|||
156736159|NCT03891862|565780449|FG001|Open-label Period|Lost to Follow-up|0|||
156736160|NCT03891862|565780450|FG002|Open-label Period|Lost to Follow-up|0|||
156736161|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
156736162|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
156736163|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
156736164|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
156736165|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
156736166|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
156736167|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
156736168|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
156736169|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
156736170|NCT03891862|565780448|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
156736171|NCT03891862|565780449|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
156736172|NCT03891862|565780450|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
156736173|NCT01053962|565780451|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736174|NCT01053962|565780452|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736175|NCT01053962|565780453|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
156736176|NCT01053962|565780454|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
156736177|NCT01053962|565780455|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
156736178|NCT01053962|565780451|FG000|Pretreatment Period|Venipuncture Failure|0|||
156736179|NCT01053962|565780452|FG001|Pretreatment Period|Venipuncture Failure|0|||
156736180|NCT01053962|565780453|FG002|Pretreatment Period|Venipuncture Failure|1|||
156736181|NCT01053962|565780454|FG003|Pretreatment Period|Venipuncture Failure|0|||
156736182|NCT01053962|565780455|FG004|Pretreatment Period|Venipuncture Failure|0|||
156736183|NCT01053962|565780451|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736184|NCT01053962|565780452|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
156736185|NCT01053962|565780453|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
157141945|NCT05882890|567267783|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
157141946|NCT04331899|567267794|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
157141947|NCT04331899|567267795|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
157141948|NCT01062399|567267798|FG000|Overall Study|Protocol Violation|0|||
157141949|NCT01062399|567267799|FG001|Overall Study|Protocol Violation|1|||
156736186|NCT01053962|565780454|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736187|NCT01053962|565780455|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
156736188|NCT01053962|565780451|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736189|NCT01053962|565780452|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736190|NCT01053962|565780453|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736191|NCT01053962|565780454|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
156736192|NCT01053962|565780455|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
156736193|NCT01053962|565780451|FG000|Treatment Period|Lack of Efficacy|0|||
156736194|NCT01053962|565780452|FG001|Treatment Period|Lack of Efficacy|0|||
156736195|NCT01053962|565780453|FG002|Treatment Period|Lack of Efficacy|0|||
156736196|NCT01053962|565780454|FG003|Treatment Period|Lack of Efficacy|0|||
156736197|NCT01053962|565780455|FG004|Treatment Period|Lack of Efficacy|1|||
156736198|NCT01053962|565780451|FG000|Treatment Period|Adverse Event|0|||
156736199|NCT01053962|565780452|FG001|Treatment Period|Adverse Event|0|||
156736200|NCT01053962|565780453|FG002|Treatment Period|Adverse Event|0|||
156736201|NCT01053962|565780454|FG003|Treatment Period|Adverse Event|0|||
156736202|NCT01053962|565780455|FG004|Treatment Period|Adverse Event|1|||
156736203|NCT01053962|565780451|FG000|Treatment Period|Withdrawal by Subject|0|||
156736204|NCT01053962|565780452|FG001|Treatment Period|Withdrawal by Subject|0|||
156736205|NCT01053962|565780453|FG002|Treatment Period|Withdrawal by Subject|0|||
156736206|NCT01053962|565780454|FG003|Treatment Period|Withdrawal by Subject|0|||
156876761|NCT02474069|566307725|FG000|Selection Phase (SP)|Physician Decision|1|||
156876762|NCT02474069|566307726|FG001|Selection Phase (SP)|Physician Decision|0|||
156876763|NCT02474069|566307727|FG002|Selection Phase (SP)|Physician Decision|0|||
156876764|NCT02474069|566307725|FG000|Selection Phase (SP)|Protocol Violation|1|||
156876765|NCT02474069|566307726|FG001|Selection Phase (SP)|Protocol Violation|0|||
156876766|NCT02474069|566307727|FG002|Selection Phase (SP)|Protocol Violation|0|||
156876767|NCT02474069|566307725|FG000|Selection Phase (SP)|No longer requires treatment|1|||
156876768|NCT02474069|566307726|FG001|Selection Phase (SP)|No longer requires treatment|0|||
156876769|NCT02474069|566307727|FG002|Selection Phase (SP)|No longer requires treatment|0|||
156876770|NCT02474069|566307725|FG000|Selection Phase (SP)|Technical Problem|1|||
156876771|NCT02474069|566307726|FG001|Selection Phase (SP)|Technical Problem|0|||
156876772|NCT02474069|566307727|FG002|Selection Phase (SP)|Technical Problem|0|||
156876773|NCT02474069|566307725|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
156876774|NCT02474069|566307726|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
156876775|NCT02474069|566307727|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
156876776|NCT02474069|566307725|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
156876777|NCT02474069|566307726|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
156876778|NCT02474069|566307727|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
156876779|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
156876780|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
156876781|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
156876782|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
156876783|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
156876784|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
156876785|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
156876786|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
156876787|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
156876788|NCT02474069|566307725|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
156876789|NCT02474069|566307726|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
156876790|NCT02474069|566307727|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
156876791|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
157141950|NCT01062399|567267800|FG002|Overall Study|Protocol Violation|0|||
157141951|NCT01062399|567267801|FG003|Overall Study|Protocol Violation|6|||
156736207|NCT01053962|565780455|FG004|Treatment Period|Withdrawal by Subject|1|||
156736208|NCT01053962|565780451|FG000|Treatment Period|Noncompliance with protocol|1|||
156736209|NCT01053962|565780452|FG001|Treatment Period|Noncompliance with protocol|0|||
156736210|NCT01053962|565780453|FG002|Treatment Period|Noncompliance with protocol|0|||
156876792|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
156876793|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
156876794|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
156876795|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
156736211|NCT01053962|565780454|FG003|Treatment Period|Noncompliance with protocol|0|||
156876796|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
157141952|NCT01062399|567267802|FG004|Overall Study|Protocol Violation|4|||
156736212|NCT01053962|565780455|FG004|Treatment Period|Noncompliance with protocol|0|||
156736213|NCT03089697|565780458|FG000|Overall Study|Adverse Event|1|||
156736214|NCT03089697|565780459|FG001|Overall Study|Adverse Event|2|||
156736215|NCT03089697|565780458|FG000|Overall Study|Withdrawal by Subject|1|||
156736216|NCT03089697|565780459|FG001|Overall Study|Withdrawal by Subject|0|||
156736217|NCT00638443|565780460|FG000|First Intervention|Adverse Event|2|||
156736218|NCT00638443|565780461|FG001|First Intervention|Adverse Event|1|||
156736219|NCT01044290|565780462|FG000|Follow-up 1|Death|3|||
156736220|NCT01044290|565780463|FG001|Follow-up 1|Death|3|||
156736221|NCT01044290|565780464|FG002|Follow-up 1|Death|1|||
156736222|NCT01044290|565780462|FG000|Follow-up 1|Withdrawal by Subject|2|||
156736223|NCT01044290|565780463|FG001|Follow-up 1|Withdrawal by Subject|2|||
156736224|NCT01044290|565780464|FG002|Follow-up 1|Withdrawal by Subject|0|||
156736225|NCT01044290|565780462|FG000|Follow-Up 2|Death|0|||
156736226|NCT01044290|565780463|FG001|Follow-Up 2|Death|1|||
156736227|NCT01044290|565780464|FG002|Follow-Up 2|Death|1|||
156736228|NCT01044290|565780462|FG000|Follow-Up 2|Withdrawal by Subject|0|||
156736229|NCT01044290|565780463|FG001|Follow-Up 2|Withdrawal by Subject|1|||
156736230|NCT01044290|565780464|FG002|Follow-Up 2|Withdrawal by Subject|1|||
156736231|NCT01646021|565780465|FG000|Overall Study|Death|77|||
156736232|NCT01646021|565780466|FG001|Overall Study|Death|83|||
156736233|NCT01646021|565780465|FG000|Overall Study|Study Terminated by Sponsor|50|||
156736234|NCT01646021|565780466|FG001|Overall Study|Study Terminated by Sponsor|41|||
156736235|NCT01646021|565780465|FG000|Overall Study|Lost to Follow-up|2|||
156736236|NCT01646021|565780466|FG001|Overall Study|Lost to Follow-up|2|||
156736237|NCT01646021|565780465|FG000|Overall Study|Withdrawal by Subject|10|||
156736238|NCT01646021|565780466|FG001|Overall Study|Withdrawal by Subject|15|||
156736239|NCT01967706|565780469|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
156736240|NCT01967706|565780470|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736241|NCT01967706|565780471|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736242|NCT01967706|565780472|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
156736243|NCT01552915|565780483|FG000|Overall Study|Adverse Event|3|||
156736244|NCT01552915|565780484|FG001|Overall Study|Adverse Event|14|||
156736245|NCT01552915|565780485|FG002|Overall Study|Adverse Event|3|||
156736246|NCT01552915|565780483|FG000|Overall Study|Lost to Follow-up|4|||
156736247|NCT01552915|565780484|FG001|Overall Study|Lost to Follow-up|6|||
156736248|NCT01552915|565780485|FG002|Overall Study|Lost to Follow-up|5|||
156736249|NCT01552915|565780483|FG000|Overall Study|Withdrawal by Subject|6|||
156736250|NCT01552915|565780484|FG001|Overall Study|Withdrawal by Subject|4|||
156736251|NCT01552915|565780485|FG002|Overall Study|Withdrawal by Subject|5|||
156736252|NCT01552915|565780483|FG000|Overall Study|Protocol Violation|0|||
156736253|NCT01552915|565780484|FG001|Overall Study|Protocol Violation|4|||
156736254|NCT01552915|565780485|FG002|Overall Study|Protocol Violation|4|||
156736255|NCT01552915|565780483|FG000|Overall Study|Lack of Efficacy|8|||
156736256|NCT01552915|565780484|FG001|Overall Study|Lack of Efficacy|1|||
156736257|NCT01552915|565780485|FG002|Overall Study|Lack of Efficacy|4|||
156736258|NCT01552915|565780483|FG000|Overall Study|Other|2|||
156736259|NCT01552915|565780484|FG001|Overall Study|Other|0|||
156736260|NCT01552915|565780485|FG002|Overall Study|Other|6|||
156736261|NCT00750139|565780494|FG000|Overall Study|Adverse Event|1|||
156736262|NCT00750139|565780495|FG001|Overall Study|Adverse Event|2|||
156736263|NCT00750139|565780496|FG002|Overall Study|Adverse Event|0|||
156736264|NCT00750139|565780497|FG003|Overall Study|Adverse Event|1|||
156736265|NCT00750139|565780494|FG000|Overall Study|Lost to Follow-up|17|||
156736266|NCT00750139|565780495|FG001|Overall Study|Lost to Follow-up|12|||
156736267|NCT00750139|565780496|FG002|Overall Study|Lost to Follow-up|15|||
156736268|NCT00750139|565780497|FG003|Overall Study|Lost to Follow-up|6|||
156736269|NCT00750139|565780494|FG000|Overall Study|Withdrawal by Subject|3|||
156736270|NCT00750139|565780495|FG001|Overall Study|Withdrawal by Subject|2|||
156736271|NCT00750139|565780496|FG002|Overall Study|Withdrawal by Subject|6|||
156736272|NCT00750139|565780497|FG003|Overall Study|Withdrawal by Subject|2|||
156736273|NCT00750139|565780494|FG000|Overall Study|Physician Decision|1|||
156736274|NCT00750139|565780495|FG001|Overall Study|Physician Decision|1|||
156736275|NCT00750139|565780496|FG002|Overall Study|Physician Decision|0|||
157141953|NCT02424539|567267803|FG000|Overall Study|Adverse Event|0|||
156736276|NCT00750139|565780497|FG003|Overall Study|Physician Decision|0|||
156736277|NCT00750139|565780494|FG000|Overall Study|Non-compliance|1|||
156736278|NCT00750139|565780495|FG001|Overall Study|Non-compliance|0|||
156736279|NCT00750139|565780496|FG002|Overall Study|Non-compliance|1|||
156736280|NCT00750139|565780497|FG003|Overall Study|Non-compliance|3|||
156736281|NCT00750139|565780494|FG000|Overall Study|Termination by sponsor|4|||
156736282|NCT00750139|565780495|FG001|Overall Study|Termination by sponsor|0|||
156736283|NCT00750139|565780496|FG002|Overall Study|Termination by sponsor|0|||
156736284|NCT00750139|565780497|FG003|Overall Study|Termination by sponsor|1|||
156736285|NCT00750139|565780494|FG000|Overall Study|Non-specific|62|||
156736286|NCT00750139|565780495|FG001|Overall Study|Non-specific|42|||
156736287|NCT00750139|565780496|FG002|Overall Study|Non-specific|79|||
156736288|NCT00750139|565780497|FG003|Overall Study|Non-specific|33|||
156736289|NCT00658775|565780498|FG000|Overall Study|Adverse Event|4|||
156736290|NCT00658775|565780499|FG001|Overall Study|Adverse Event|6|||
156736291|NCT00658775|565780498|FG000|Overall Study|Lost to Follow-up|17|||
156736292|NCT00658775|565780499|FG001|Overall Study|Lost to Follow-up|18|||
157141954|NCT02424539|567267804|FG001|Overall Study|Adverse Event|0|||
156876797|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
156876798|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
156876799|NCT02283762|566307732|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
156876800|NCT02283762|566307733|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
157141955|NCT02424539|567267805|FG002|Overall Study|Adverse Event|1|||
156736293|NCT00658775|565780498|FG000|Overall Study|Withdrawal by Subject|6|||
157141956|NCT02424539|567267803|FG000|Overall Study|Physician Decision|0|||
157141957|NCT02424539|567267804|FG001|Overall Study|Physician Decision|0|||
157141958|NCT02424539|567267805|FG002|Overall Study|Physician Decision|1|||
157141959|NCT02424539|567267803|FG000|Overall Study|Withdrawal by Subject|3|||
157141960|NCT02424539|567267804|FG001|Overall Study|Withdrawal by Subject|1|||
157141961|NCT02424539|567267805|FG002|Overall Study|Withdrawal by Subject|0|||
157141962|NCT02424539|567267803|FG000|Overall Study|Other: Reached stopping criteria|11|||
156736294|NCT00658775|565780499|FG001|Overall Study|Withdrawal by Subject|4|||
156736295|NCT00658775|565780498|FG000|Overall Study|Withdrawal of consent|8|||
156736296|NCT00658775|565780499|FG001|Overall Study|Withdrawal of consent|7|||
156736297|NCT00658775|565780498|FG000|Overall Study|Other|7|||
156736298|NCT00658775|565780499|FG001|Overall Study|Other|8|||
156736299|NCT01992653|565780502|FG000|Overall Study|Death|0|||
156736300|NCT01992653|565780503|FG001|Overall Study|Death|0|||
156736301|NCT01992653|565780504|FG002|Overall Study|Death|1|||
156736302|NCT01992653|565780505|FG003|Overall Study|Death|0|||
156736303|NCT01992653|565780506|FG004|Overall Study|Death|1|||
156736304|NCT01992653|565780507|FG005|Overall Study|Death|0|||
157141963|NCT02424539|567267804|FG001|Overall Study|Other: Reached stopping criteria|7|||
157141964|NCT02424539|567267805|FG002|Overall Study|Other: Reached stopping criteria|6|||
157141965|NCT00719810|567267806|FG000|Overall Study|Adverse Event|0|||
157141966|NCT00719810|567267807|FG001|Overall Study|Adverse Event|2|||
157141967|NCT00719810|567267808|FG002|Overall Study|Adverse Event|3|||
157141968|NCT00719810|567267806|FG000|Overall Study|Lost to Follow-up|2|||
157141969|NCT00719810|567267807|FG001|Overall Study|Lost to Follow-up|0|||
157141970|NCT00719810|567267808|FG002|Overall Study|Lost to Follow-up|3|||
157141971|NCT00719810|567267806|FG000|Overall Study|Physician Decision|0|||
157141972|NCT00719810|567267807|FG001|Overall Study|Physician Decision|1|||
157141973|NCT00719810|567267808|FG002|Overall Study|Physician Decision|0|||
157141974|NCT00719810|567267806|FG000|Overall Study|Withdrawal by Subject|1|||
157141975|NCT00719810|567267807|FG001|Overall Study|Withdrawal by Subject|1|||
157141976|NCT00719810|567267808|FG002|Overall Study|Withdrawal by Subject|2|||
157141977|NCT04893265|567267831|FG000|Overall Study|Withdrawal by Subject|2|||
157141978|NCT04893265|567267832|FG001|Overall Study|Withdrawal by Subject|5|||
157141979|NCT04893265|567267831|FG000|Overall Study|Lost to Follow-up|0|||
157141980|NCT04893265|567267832|FG001|Overall Study|Lost to Follow-up|4|||
157141981|NCT02465034|567267833|FG000|Overall Study|Withdrawal by Subject|1|||
157141982|NCT02465034|567267834|FG001|Overall Study|Withdrawal by Subject|1|||
157141983|NCT02465034|567267833|FG000|Overall Study|Screen fail|2|||
157141984|NCT02465034|567267834|FG001|Overall Study|Screen fail|0|||
157141985|NCT02465034|567267833|FG000|Overall Study|Could not be scheduled for study visit|0|||
157141986|NCT02465034|567267834|FG001|Overall Study|Could not be scheduled for study visit|5|||
157141987|NCT00573131|567267835|FG000|Overall Study|Withdrawal by Subject|10|||
157141988|NCT00573131|567267836|FG001|Overall Study|Withdrawal by Subject|8|||
157141989|NCT02401256|567267841|FG000|Overall Study|Adverse Event|5|||
157141990|NCT02401256|567267841|FG000|Overall Study|Withdrawal by Subject|12|||
157141991|NCT00893789|567267842|FG000|Overall Study|Withdrawal by Subject|3|||
157141992|NCT00893789|567267843|FG001|Overall Study|Withdrawal by Subject|1|||
157141993|NCT00893789|567267844|FG002|Overall Study|Withdrawal by Subject|3|||
157141994|NCT00893789|567267845|FG003|Overall Study|Withdrawal by Subject|1|||
157141995|NCT00893789|567267842|FG000|Overall Study|Noncompliance With Study Drug|1|||
157141996|NCT00893789|567267843|FG001|Overall Study|Noncompliance With Study Drug|0|||
156736305|NCT01992653|565780508|FG006|Overall Study|Death|4|||
156736306|NCT01992653|565780509|FG007|Overall Study|Death|2|||
156736307|NCT01992653|565780502|FG000|Overall Study|Lost to Follow-up|0|||
156736308|NCT01992653|565780503|FG001|Overall Study|Lost to Follow-up|0|||
156736309|NCT01992653|565780504|FG002|Overall Study|Lost to Follow-up|0|||
156736310|NCT01992653|565780505|FG003|Overall Study|Lost to Follow-up|0|||
156736311|NCT01992653|565780506|FG004|Overall Study|Lost to Follow-up|0|||
156736312|NCT01992653|565780507|FG005|Overall Study|Lost to Follow-up|0|||
156876801|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
157141997|NCT00893789|567267844|FG002|Overall Study|Noncompliance With Study Drug|1|||
157141998|NCT00893789|567267845|FG003|Overall Study|Noncompliance With Study Drug|2|||
156736313|NCT01992653|565780508|FG006|Overall Study|Lost to Follow-up|0|||
156736314|NCT01992653|565780509|FG007|Overall Study|Lost to Follow-up|1|||
156736315|NCT01992653|565780502|FG000|Overall Study|Study Completed|0|||
156736316|NCT01992653|565780503|FG001|Overall Study|Study Completed|0|||
156736317|NCT01992653|565780504|FG002|Overall Study|Study Completed|0|||
156736318|NCT01992653|565780505|FG003|Overall Study|Study Completed|0|||
156736319|NCT01992653|565780506|FG004|Overall Study|Study Completed|0|||
157141999|NCT00893789|567267842|FG000|Overall Study|Noncompliance With Study Procedures|1|||
157142000|NCT00893789|567267843|FG001|Overall Study|Noncompliance With Study Procedures|0|||
157020227|NCT03406871|566826547|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
157020228|NCT03406871|566826548|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
157020229|NCT03406871|566826549|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
157020230|NCT03406871|566826547|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
157020231|NCT03406871|566826548|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
157020232|NCT03406871|566826549|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
157020233|NCT03406871|566826547|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
157020234|NCT03406871|566826548|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
157020235|NCT03406871|566826549|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
157020236|NCT03406871|566826547|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
157020237|NCT03406871|566826548|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
157020238|NCT03406871|566826549|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
157020239|NCT03406871|566826547|FG000|Expansion Cohort(Final Analysis)|Death|0|||
157020240|NCT03406871|566826548|FG001|Expansion Cohort(Final Analysis)|Death|1|||
157020241|NCT03406871|566826549|FG002|Expansion Cohort(Final Analysis)|Death|0|||
157020242|NCT03406871|566826547|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
157020243|NCT03406871|566826548|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
157020244|NCT03406871|566826549|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
157020245|NCT04588298|566826554|FG000|Overall Study|Adverse Event|0|||
157020246|NCT04588298|566826555|FG001|Overall Study|Adverse Event|0|||
157020247|NCT04588298|566826556|FG002|Overall Study|Adverse Event|1|||
157020248|NCT04588298|566826557|FG003|Overall Study|Adverse Event|0|||
157020249|NCT04588298|566826558|FG004|Overall Study|Adverse Event|2|||
157020250|NCT04588298|566826554|FG000|Overall Study|Withdrawal by Subject|1|||
157020251|NCT04588298|566826555|FG001|Overall Study|Withdrawal by Subject|0|||
157142001|NCT00893789|567267844|FG002|Overall Study|Noncompliance With Study Procedures|0|||
157142002|NCT00893789|567267845|FG003|Overall Study|Noncompliance With Study Procedures|0|||
157142003|NCT00893789|567267842|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
157142004|NCT00893789|567267843|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
156736320|NCT01992653|565780507|FG005|Overall Study|Study Completed|0|||
156736321|NCT01992653|565780508|FG006|Overall Study|Study Completed|0|||
156736322|NCT01992653|565780509|FG007|Overall Study|Study Completed|1|||
156736323|NCT01992653|565780502|FG000|Overall Study|Disease Progression|0|||
156736324|NCT01992653|565780503|FG001|Overall Study|Disease Progression|0|||
156736325|NCT01992653|565780504|FG002|Overall Study|Disease Progression|0|||
156736326|NCT01992653|565780505|FG003|Overall Study|Disease Progression|0|||
156736327|NCT01992653|565780506|FG004|Overall Study|Disease Progression|0|||
156736328|NCT01992653|565780507|FG005|Overall Study|Disease Progression|0|||
156736329|NCT01992653|565780508|FG006|Overall Study|Disease Progression|4|||
156736330|NCT01992653|565780509|FG007|Overall Study|Disease Progression|0|||
156736331|NCT01435460|565780510|FG000|Overall Study|Adverse Event|2|||
156736332|NCT01435460|565780511|FG001|Overall Study|Adverse Event|1|||
156736333|NCT01435460|565780510|FG000|Overall Study|Lost to Follow-up|6|||
156736334|NCT01435460|565780511|FG001|Overall Study|Lost to Follow-up|1|||
156736335|NCT01435460|565780510|FG000|Overall Study|Withdrawal by Subject|1|||
156736336|NCT01435460|565780511|FG001|Overall Study|Withdrawal by Subject|3|||
156736337|NCT01435460|565780510|FG000|Overall Study|Protocol Violation|0|||
156736338|NCT01435460|565780511|FG001|Overall Study|Protocol Violation|1|||
156736339|NCT01435460|565780510|FG000|Overall Study|Did not meet eligibility criteria|2|||
156736340|NCT01435460|565780511|FG001|Overall Study|Did not meet eligibility criteria|0|||
156736341|NCT01706939|565780512|FG000|Pre Randomization|Screen Failure|1|||
156736342|NCT01706939|565780513|FG001|Pre Randomization|Screen Failure|0|||
156736343|NCT01706939|565780514|FG002|Pre Randomization|Screen Failure|0|||
156736344|NCT01706939|565780512|FG000|Pre Randomization|Ineligible for Randomization|1|||
156736345|NCT01706939|565780513|FG001|Pre Randomization|Ineligible for Randomization|0|||
156736346|NCT01706939|565780514|FG002|Pre Randomization|Ineligible for Randomization|0|||
157142005|NCT00893789|567267844|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
156736347|NCT01706939|565780512|FG000|Pre Randomization|Withdrawal by Subject|1|||
157142006|NCT00893789|567267845|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
157142007|NCT00893789|567267842|FG000|Overall Study|Adverse Event|0|||
157142008|NCT00893789|567267843|FG001|Overall Study|Adverse Event|2|||
157142009|NCT00893789|567267844|FG002|Overall Study|Adverse Event|1|||
157142010|NCT00893789|567267845|FG003|Overall Study|Adverse Event|5|||
157142011|NCT00893789|567267842|FG000|Overall Study|Protocol Violation|0|||
157142012|NCT00893789|567267843|FG001|Overall Study|Protocol Violation|1|||
156736348|NCT01706939|565780513|FG001|Pre Randomization|Withdrawal by Subject|0|||
156736349|NCT01706939|565780514|FG002|Pre Randomization|Withdrawal by Subject|0|||
156736350|NCT01706939|565780512|FG000|Randomization|Insufficient QoL survey compliance|0|||
156736351|NCT01706939|565780513|FG001|Randomization|Insufficient QoL survey compliance|1|||
156736352|NCT01706939|565780514|FG002|Randomization|Insufficient QoL survey compliance|1|||
156736353|NCT01706939|565780512|FG000|Randomization|Progression of disease|0|||
157020252|NCT04588298|566826556|FG002|Overall Study|Withdrawal by Subject|0|||
157020253|NCT04588298|566826557|FG003|Overall Study|Withdrawal by Subject|1|||
157142013|NCT00893789|567267844|FG002|Overall Study|Protocol Violation|1|||
157142014|NCT00893789|567267845|FG003|Overall Study|Protocol Violation|4|||
157142015|NCT00893789|567267842|FG000|Overall Study|Lost to Follow-up|0|||
157142016|NCT00893789|567267843|FG001|Overall Study|Lost to Follow-up|0|||
157142017|NCT00893789|567267844|FG002|Overall Study|Lost to Follow-up|0|||
157142018|NCT00893789|567267845|FG003|Overall Study|Lost to Follow-up|1|||
157142019|NCT02024464|567267846|FG000|Overall Study|Discontinued|5|||
157142020|NCT02024464|567267847|FG001|Overall Study|Discontinued|4|||
157142021|NCT02024464|567267846|FG000|Overall Study|Missed Visits|1|||
156736354|NCT01706939|565780513|FG001|Randomization|Progression of disease|2|||
156736355|NCT01706939|565780514|FG002|Randomization|Progression of disease|1|||
156736356|NCT01046903|565780515|FG000|Overall Study|Lost to Follow-up|16|||
156736357|NCT01046903|565780515|FG000|Overall Study|Adverse Event|4|||
156736358|NCT01046903|565780515|FG000|Overall Study|Withdrawal by Subject|3|||
156736359|NCT01046903|565780515|FG000|Overall Study|Other|5|||
156736360|NCT04013672|565780517|FG000|Overall Study|Withdrawal by Subject|3|||
156736361|NCT04013672|565780518|FG001|Overall Study|Withdrawal by Subject|0|||
156736362|NCT04013672|565780517|FG000|Overall Study|Death|1|||
156736363|NCT04013672|565780518|FG001|Overall Study|Death|0|||
156736364|NCT04013672|565780517|FG000|Overall Study|Physician Decision|5|||
156736365|NCT04013672|565780518|FG001|Overall Study|Physician Decision|0|||
156736366|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
156736367|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
156736368|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
156736369|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
156736370|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736371|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736372|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
156736373|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
156736374|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
156736375|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736376|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736377|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
156736378|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
156736379|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
156736380|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
156736381|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
156736382|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
156736383|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
156736384|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
157142022|NCT02024464|567267847|FG001|Overall Study|Missed Visits|0|||
157142023|NCT02024464|567267846|FG000|Overall Study|Lost to Follow-up|4|||
157142024|NCT02024464|567267847|FG001|Overall Study|Lost to Follow-up|7|||
157142025|NCT02586805|567267860|FG000|Overall Study|Withdrawal by Subject|3|||
156736385|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
156736386|NCT00556933|565780519|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736387|NCT00556933|565780520|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
156736388|NCT00556933|565780521|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736389|NCT00556933|565780522|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
156736390|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
156736391|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
156736392|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
156736393|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
156736394|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
156876802|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
156876803|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
156876804|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
156876805|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
156876806|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
156876807|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
156876808|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
156876809|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
157142026|NCT02586805|567267861|FG001|Overall Study|Withdrawal by Subject|1|||
157142027|NCT02586805|567267862|FG002|Overall Study|Withdrawal by Subject|1|||
157142028|NCT02586805|567267863|FG003|Overall Study|Withdrawal by Subject|2|||
157142029|NCT02586805|567267860|FG000|Overall Study|Adverse Event|2|||
156736395|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
157020254|NCT04588298|566826558|FG004|Overall Study|Withdrawal by Subject|0|||
157020255|NCT02281955|566826559|FG000|Overall Study|Death|1|||
157020256|NCT02243709|566826563|FG000|Phase 1|Lost to Follow-up|0|||
157142030|NCT02586805|567267861|FG001|Overall Study|Adverse Event|0|||
157142031|NCT02586805|567267862|FG002|Overall Study|Adverse Event|1|||
156736396|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
156736397|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
156736398|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
156736399|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
156736400|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
156736401|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
156736402|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
156736403|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
156736404|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
157218054|NCT01799590|567545570|FG000|Overall Study|Pregnancy|2|||
157218055|NCT01799590|567545571|FG001|Overall Study|Pregnancy|0|||
157218056|NCT01799590|567545572|FG002|Overall Study|Pregnancy|0|||
157218057|NCT01799590|567545570|FG000|Overall Study|Lack of Efficacy|3|||
157218058|NCT01799590|567545571|FG001|Overall Study|Lack of Efficacy|1|||
157218059|NCT01799590|567545572|FG002|Overall Study|Lack of Efficacy|3|||
157218060|NCT01799590|567545570|FG000|Overall Study|Participants convenience|4|||
157218061|NCT01799590|567545571|FG001|Overall Study|Participants convenience|4|||
157218062|NCT01799590|567545572|FG002|Overall Study|Participants convenience|2|||
157218063|NCT01799590|567545570|FG000|Overall Study|Aggravation of complications|0|||
157218064|NCT01799590|567545571|FG001|Overall Study|Aggravation of complications|1|||
157218065|NCT01799590|567545572|FG002|Overall Study|Aggravation of complications|1|||
157218066|NCT01799590|567545570|FG000|Overall Study|Using drugs with restricted days of use|0|||
157218067|NCT01799590|567545571|FG001|Overall Study|Using drugs with restricted days of use|3|||
157218068|NCT01799590|567545572|FG002|Overall Study|Using drugs with restricted days of use|2|||
157218069|NCT01799590|567545570|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
157218070|NCT01799590|567545571|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
157218071|NCT01799590|567545572|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
156736405|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
156736406|NCT00556933|565780519|FG000|CNI Withdrawal vs. Minimization|Death|0|||
156736407|NCT00556933|565780520|FG001|CNI Withdrawal vs. Minimization|Death|0|||
156736408|NCT00556933|565780521|FG002|CNI Withdrawal vs. Minimization|Death|0|||
156736409|NCT00556933|565780522|FG003|CNI Withdrawal vs. Minimization|Death|1|||
156736410|NCT03887442|565780523|FG000|Overall Study|Adverse Event|1|||
156736411|NCT03887442|565780524|FG001|Overall Study|Adverse Event|0|||
156736412|NCT05367973|565780527|FG000|Overall Study|Adverse Event|0|||
156736413|NCT05367973|565780528|FG001|Overall Study|Adverse Event|2|||
156736414|NCT00986921|565780529|FG000|Overall Study|Physician Decision|1|||
156736415|NCT00986921|565780530|FG001|Overall Study|Physician Decision|0|||
156736416|NCT01758731|565780531|FG000|Overall Study|Physician Decision|1|||
156736417|NCT04445714|565780532|FG000|Overall Study|Discontinuation of the study|14|||
156736418|NCT04445714|565780532|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
156736419|NCT04445714|565780532|FG000|Overall Study|Withdrawal of Informed Consent|8|||
156736420|NCT02396420|565780537|FG000|Overall Study|Death|1|||
156736421|NCT01273623|565780539|FG000|Overall Study|did not meet IVUS criteria|29|||
156736422|NCT02086448|565782818|FG000|Overall Study|Withdrawal by Subject|1|||
156736423|NCT02086448|565782819|FG001|Overall Study|Withdrawal by Subject|0|||
156736424|NCT02086448|565782820|FG002|Overall Study|Withdrawal by Subject|0|||
156736425|NCT02086448|565782821|FG003|Overall Study|Withdrawal by Subject|2|||
156736426|NCT01871402|565782830|FG000|Overall Study|Lost to Follow-up|1|||
156736427|NCT01871402|565782831|FG001|Overall Study|Lost to Follow-up|0|||
156736428|NCT01871402|565782830|FG000|Overall Study|Withdrawal by Subject|0|||
156736429|NCT01871402|565782831|FG001|Overall Study|Withdrawal by Subject|2|||
156736430|NCT01871402|565782830|FG000|Overall Study|Non-compliance|0|||
156736431|NCT01871402|565782831|FG001|Overall Study|Non-compliance|1|||
156736432|NCT04594941|565782832|FG000|Overall Study|Other|0|||
156736433|NCT04594941|565782833|FG001|Overall Study|Other|3|||
156736434|NCT04594941|565782834|FG002|Overall Study|Other|1|||
156736435|NCT04594941|565782835|FG003|Overall Study|Other|0|||
156736436|NCT00231114|565782836|FG000|Randomized|Withdrawal by Subject|6|||
156736437|NCT00231114|565782837|FG001|Randomized|Withdrawal by Subject|3|||
156736438|NCT00231114|565782836|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
156736439|NCT00231114|565782837|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
156736440|NCT00231114|565782836|FG000|Post-Treatment Period|Lost to Follow-up|6|||
156736441|NCT00231114|565782837|FG001|Post-Treatment Period|Lost to Follow-up|1|||
156736442|NCT00231114|565782836|FG000|Post-Treatment Period|Physician Decision|1|||
156736443|NCT00231114|565782837|FG001|Post-Treatment Period|Physician Decision|0|||
156736444|NCT00231114|565782836|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
156736445|NCT00231114|565782837|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
156736446|NCT02031640|565782841|FG000|Screening Period|Adverse Event|1|||
156736447|NCT02031640|565782842|FG001|Screening Period|Adverse Event|0|||
157218072|NCT01799590|567545570|FG000|Overall Study|Other|3|||
156736448|NCT02031640|565782843|FG002|Screening Period|Adverse Event|0|||
156736449|NCT02031640|565782844|FG003|Screening Period|Adverse Event|0|||
157218073|NCT01799590|567545571|FG001|Overall Study|Other|0|||
157218074|NCT01799590|567545572|FG002|Overall Study|Other|1|||
156736450|NCT02031640|565782845|FG004|Screening Period|Adverse Event|0|||
156736451|NCT02031640|565782846|FG005|Screening Period|Adverse Event|0|||
156736452|NCT02031640|565782841|FG000|Screening Period|Withdrawal by Subject|29|||
156736453|NCT02031640|565782842|FG001|Screening Period|Withdrawal by Subject|0|||
156736454|NCT02031640|565782843|FG002|Screening Period|Withdrawal by Subject|0|||
156736455|NCT02031640|565782844|FG003|Screening Period|Withdrawal by Subject|0|||
156736456|NCT02031640|565782845|FG004|Screening Period|Withdrawal by Subject|0|||
156736457|NCT02031640|565782846|FG005|Screening Period|Withdrawal by Subject|0|||
156736458|NCT02031640|565782841|FG000|Screening Period|Inclusion criteria not met|312|||
156736459|NCT02031640|565782842|FG001|Screening Period|Inclusion criteria not met|0|||
156736460|NCT02031640|565782843|FG002|Screening Period|Inclusion criteria not met|0|||
156736461|NCT02031640|565782844|FG003|Screening Period|Inclusion criteria not met|0|||
156736462|NCT02031640|565782845|FG004|Screening Period|Inclusion criteria not met|0|||
156736463|NCT02031640|565782846|FG005|Screening Period|Inclusion criteria not met|0|||
156736464|NCT02031640|565782841|FG000|Screening Period|Exclusion criteria met|30|||
156736465|NCT02031640|565782842|FG001|Screening Period|Exclusion criteria met|0|||
156736466|NCT02031640|565782843|FG002|Screening Period|Exclusion criteria met|0|||
156736467|NCT02031640|565782844|FG003|Screening Period|Exclusion criteria met|0|||
156736468|NCT02031640|565782845|FG004|Screening Period|Exclusion criteria met|0|||
156736469|NCT02031640|565782846|FG005|Screening Period|Exclusion criteria met|0|||
156736470|NCT02031640|565782841|FG000|Screening Period|Lost to Follow-up|14|||
156736471|NCT02031640|565782842|FG001|Screening Period|Lost to Follow-up|0|||
156736472|NCT02031640|565782843|FG002|Screening Period|Lost to Follow-up|0|||
156736473|NCT02031640|565782844|FG003|Screening Period|Lost to Follow-up|0|||
156736474|NCT02031640|565782845|FG004|Screening Period|Lost to Follow-up|0|||
156736475|NCT02031640|565782846|FG005|Screening Period|Lost to Follow-up|0|||
156736476|NCT02031640|565782841|FG000|Screening Period|Enrollment closed|26|||
156736477|NCT02031640|565782842|FG001|Screening Period|Enrollment closed|0|||
156736478|NCT02031640|565782843|FG002|Screening Period|Enrollment closed|0|||
156736479|NCT02031640|565782844|FG003|Screening Period|Enrollment closed|0|||
156736480|NCT02031640|565782845|FG004|Screening Period|Enrollment closed|0|||
156736481|NCT02031640|565782846|FG005|Screening Period|Enrollment closed|0|||
156736482|NCT02031640|565782841|FG000|Run-In Period|Adverse Event|4|||
156736483|NCT02031640|565782842|FG001|Run-In Period|Adverse Event|0|||
156736484|NCT02031640|565782843|FG002|Run-In Period|Adverse Event|0|||
156736485|NCT02031640|565782844|FG003|Run-In Period|Adverse Event|0|||
156736486|NCT02031640|565782845|FG004|Run-In Period|Adverse Event|0|||
156736487|NCT02031640|565782846|FG005|Run-In Period|Adverse Event|0|||
156736488|NCT02031640|565782841|FG000|Run-In Period|Withdrawal by Subject|17|||
156736489|NCT02031640|565782842|FG001|Run-In Period|Withdrawal by Subject|0|||
156736490|NCT02031640|565782843|FG002|Run-In Period|Withdrawal by Subject|0|||
156736491|NCT02031640|565782844|FG003|Run-In Period|Withdrawal by Subject|0|||
156736492|NCT02031640|565782845|FG004|Run-In Period|Withdrawal by Subject|0|||
156736493|NCT02031640|565782846|FG005|Run-In Period|Withdrawal by Subject|0|||
156736494|NCT02031640|565782841|FG000|Run-In Period|Inclusion criteria not met|38|||
156736495|NCT02031640|565782842|FG001|Run-In Period|Inclusion criteria not met|0|||
156736496|NCT02031640|565782843|FG002|Run-In Period|Inclusion criteria not met|0|||
156736497|NCT02031640|565782844|FG003|Run-In Period|Inclusion criteria not met|0|||
156736498|NCT02031640|565782845|FG004|Run-In Period|Inclusion criteria not met|0|||
156736499|NCT02031640|565782846|FG005|Run-In Period|Inclusion criteria not met|0|||
157142032|NCT02586805|567267863|FG003|Overall Study|Adverse Event|0|||
157142033|NCT02586805|567267860|FG000|Overall Study|Lost to Follow-up|0|||
157142034|NCT02586805|567267861|FG001|Overall Study|Lost to Follow-up|0|||
157142035|NCT02586805|567267862|FG002|Overall Study|Lost to Follow-up|1|||
156736500|NCT02031640|565782841|FG000|Run-In Period|Exclusion criteria met|8|||
156736501|NCT02031640|565782842|FG001|Run-In Period|Exclusion criteria met|0|||
156736502|NCT02031640|565782843|FG002|Run-In Period|Exclusion criteria met|0|||
156796936|NCT00725985|566009678|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
156796937|NCT00725985|566009679|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
156796938|NCT00725985|566009680|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796939|NCT00725985|566009681|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
156796940|NCT00725985|566009682|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
157142036|NCT02586805|567267863|FG003|Overall Study|Lost to Follow-up|0|||
157142037|NCT02586805|567267860|FG000|Overall Study|Physician Decision|1|||
157142038|NCT02586805|567267861|FG001|Overall Study|Physician Decision|0|||
156736503|NCT02031640|565782844|FG003|Run-In Period|Exclusion criteria met|0|||
156736504|NCT02031640|565782845|FG004|Run-In Period|Exclusion criteria met|0|||
156736505|NCT02031640|565782846|FG005|Run-In Period|Exclusion criteria met|0|||
156736506|NCT02031640|565782841|FG000|Run-In Period|Randomization criteria not met|85|||
156736507|NCT02031640|565782842|FG001|Run-In Period|Randomization criteria not met|0|||
156736508|NCT02031640|565782843|FG002|Run-In Period|Randomization criteria not met|0|||
156796941|NCT00725985|566009671|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
157142039|NCT02586805|567267862|FG002|Overall Study|Physician Decision|0|||
156796942|NCT00725985|566009672|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796943|NCT00725985|566009673|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156736509|NCT02031640|565782844|FG003|Run-In Period|Randomization criteria not met|0|||
156736510|NCT02031640|565782845|FG004|Run-In Period|Randomization criteria not met|0|||
156736511|NCT02031640|565782846|FG005|Run-In Period|Randomization criteria not met|0|||
156736512|NCT02031640|565782841|FG000|Run-In Period|Various administrative reasons|17|||
156736513|NCT02031640|565782842|FG001|Run-In Period|Various administrative reasons|0|||
156736514|NCT02031640|565782843|FG002|Run-In Period|Various administrative reasons|0|||
156736515|NCT02031640|565782844|FG003|Run-In Period|Various administrative reasons|0|||
156736516|NCT02031640|565782845|FG004|Run-In Period|Various administrative reasons|0|||
156736517|NCT02031640|565782846|FG005|Run-In Period|Various administrative reasons|0|||
156736518|NCT02031640|565782841|FG000|Double-blind Treatment Period|Protocol deviation|0|||
156736519|NCT02031640|565782842|FG001|Double-blind Treatment Period|Protocol deviation|2|||
157142040|NCT02586805|567267863|FG003|Overall Study|Physician Decision|0|||
157142041|NCT01859403|567267864|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
156736520|NCT02031640|565782843|FG002|Double-blind Treatment Period|Protocol deviation|0|||
156736521|NCT02031640|565782844|FG003|Double-blind Treatment Period|Protocol deviation|1|||
156736522|NCT02031640|565782845|FG004|Double-blind Treatment Period|Protocol deviation|3|||
156736523|NCT02031640|565782846|FG005|Double-blind Treatment Period|Protocol deviation|1|||
156736524|NCT02031640|565782841|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156736525|NCT02031640|565782842|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
156736526|NCT02031640|565782843|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
156736527|NCT02031640|565782844|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
156736528|NCT02031640|565782845|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
156736529|NCT02031640|565782846|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
156736530|NCT02031640|565782841|FG000|Double-blind Treatment Period|Non-compliance|0|||
156736531|NCT02031640|565782842|FG001|Double-blind Treatment Period|Non-compliance|1|||
156736532|NCT02031640|565782843|FG002|Double-blind Treatment Period|Non-compliance|0|||
156736533|NCT02031640|565782844|FG003|Double-blind Treatment Period|Non-compliance|1|||
156736534|NCT02031640|565782845|FG004|Double-blind Treatment Period|Non-compliance|1|||
156736535|NCT02031640|565782846|FG005|Double-blind Treatment Period|Non-compliance|0|||
156736536|NCT02031640|565782841|FG000|Double-blind Treatment Period|Adverse Event|0|||
156736537|NCT02031640|565782842|FG001|Double-blind Treatment Period|Adverse Event|0|||
156736538|NCT02031640|565782843|FG002|Double-blind Treatment Period|Adverse Event|0|||
156736539|NCT02031640|565782844|FG003|Double-blind Treatment Period|Adverse Event|2|||
156736540|NCT02031640|565782845|FG004|Double-blind Treatment Period|Adverse Event|0|||
156736541|NCT02031640|565782846|FG005|Double-blind Treatment Period|Adverse Event|0|||
156736542|NCT02031640|565782841|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
156736543|NCT02031640|565782842|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
156736544|NCT02031640|565782843|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
156736545|NCT02031640|565782844|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736546|NCT02031640|565782845|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736547|NCT02031640|565782846|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
156736548|NCT02031640|565782841|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156736549|NCT02031640|565782842|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
156736550|NCT02031640|565782843|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
157142042|NCT01859403|567267865|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
157142043|NCT01859403|567267864|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
157142044|NCT01859403|567267865|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
157142045|NCT01859403|567267864|FG000|Primary Endpoint Measure|Physician Decision|0|||
157142046|NCT01859403|567267865|FG001|Primary Endpoint Measure|Physician Decision|1|||
157142047|NCT01859403|567267864|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
157142048|NCT01859403|567267865|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
157142049|NCT00811252|567267866|FG000|Overall Study|Adverse Event|6|||
157142050|NCT00811252|567267867|FG001|Overall Study|Adverse Event|10|||
157142051|NCT00811252|567267868|FG002|Overall Study|Adverse Event|15|||
156736551|NCT02031640|565782844|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156736552|NCT02031640|565782845|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
156736553|NCT02031640|565782846|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
156736554|NCT02005692|565782847|FG000|Overall Study|Protocol Violation|1|||
156736555|NCT02005692|565782847|FG000|Overall Study|Withdrawal by Subject|1|||
156808845|NCT01484496|566054474|FG001|Period 2|Lack of Efficacy|0|||
156808846|NCT01484496|566054475|FG002|Period 2|Lack of Efficacy|1|||
156808847|NCT01484496|566054476|FG003|Period 2|Lack of Efficacy|3|||
156808848|NCT01484496|566054473|FG000|Period 2|Adverse Event|0|||
156808849|NCT01484496|566054474|FG001|Period 2|Adverse Event|0|||
156808850|NCT01484496|566054475|FG002|Period 2|Adverse Event|5|||
156808851|NCT01484496|566054476|FG003|Period 2|Adverse Event|13|||
156808852|NCT01484496|566054473|FG000|Period 2|Other|0|||
156808853|NCT01484496|566054474|FG001|Period 2|Other|0|||
156808854|NCT01484496|566054475|FG002|Period 2|Other|9|||
156808855|NCT01484496|566054476|FG003|Period 2|Other|6|||
156808856|NCT01645735|566054477|FG000|Overall Study|Physician Decision|2|||
156808857|NCT01645735|566054478|FG001|Overall Study|Physician Decision|0|||
156808858|NCT01645735|566054477|FG000|Overall Study|Withdrawal by Subject|1|||
157142052|NCT00811252|567267866|FG000|Overall Study|Lack of Efficacy|7|||
156736556|NCT02005692|565782847|FG000|Overall Study|Discharged earlier than anticipated|5|||
156736557|NCT01194999|565782848|FG000|Overall Study|Lost to Follow-up|17|||
156736558|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
156736559|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
156736560|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
156736561|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
156736562|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
156736563|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
156736564|NCT01895270|565782849|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
156736565|NCT01895270|565782850|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
156736566|NCT01895270|565782849|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
156736567|NCT01895270|565782850|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
156736568|NCT01895270|565782849|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
156736569|NCT01895270|565782850|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
156736570|NCT01895270|565782849|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
156736571|NCT01895270|565782850|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
156736572|NCT02091375|565782853|FG000|Overall Study|Adverse Event|8|||
156736573|NCT02091375|565782854|FG001|Overall Study|Adverse Event|1|||
156736574|NCT02091375|565782853|FG000|Overall Study|Lost to Follow-up|0|||
156736575|NCT02091375|565782854|FG001|Overall Study|Lost to Follow-up|1|||
156736576|NCT02091375|565782853|FG000|Overall Study|Withdrawal by Subject|0|||
156736577|NCT02091375|565782854|FG001|Overall Study|Withdrawal by Subject|1|||
156736578|NCT02091375|565782853|FG000|Overall Study|Withdrawn by the investigator|1|||
156736579|NCT02091375|565782854|FG001|Overall Study|Withdrawn by the investigator|0|||
156736580|NCT02682823|565782856|FG000|Overall Study|Withdrawal by Subject|0|||
156736581|NCT02682823|565782857|FG001|Overall Study|Withdrawal by Subject|0|||
156736582|NCT02682823|565782858|FG002|Overall Study|Withdrawal by Subject|1|||
156736583|NCT02682823|565782859|FG003|Overall Study|Withdrawal by Subject|0|||
156736584|NCT02682823|565782860|FG004|Overall Study|Withdrawal by Subject|1|||
156736585|NCT02682823|565782856|FG000|Overall Study|Protocol Deviation|0|||
156736586|NCT02682823|565782857|FG001|Overall Study|Protocol Deviation|1|||
156736587|NCT02682823|565782858|FG002|Overall Study|Protocol Deviation|0|||
156736588|NCT02682823|565782859|FG003|Overall Study|Protocol Deviation|0|||
156736589|NCT02682823|565782860|FG004|Overall Study|Protocol Deviation|0|||
156736590|NCT02682823|565782856|FG000|Overall Study|Adverse Event|0|||
156736591|NCT02682823|565782857|FG001|Overall Study|Adverse Event|0|||
156736592|NCT02682823|565782858|FG002|Overall Study|Adverse Event|0|||
156736593|NCT02682823|565782859|FG003|Overall Study|Adverse Event|1|||
156736594|NCT02682823|565782860|FG004|Overall Study|Adverse Event|0|||
156736595|NCT05896527|565782861|FG000|Overall Study|Withdrawal by Subject|11|||
156736596|NCT05896527|565782862|FG001|Overall Study|Withdrawal by Subject|10|||
156736597|NCT05896527|565782863|FG002|Overall Study|Withdrawal by Subject|4|||
156736598|NCT05896527|565782864|FG003|Overall Study|Withdrawal by Subject|3|||
156736599|NCT05896527|565782865|FG004|Overall Study|Withdrawal by Subject|2|||
156736600|NCT05896527|565782861|FG000|Overall Study|Lost to Follow-up|0|||
156736601|NCT05896527|565782862|FG001|Overall Study|Lost to Follow-up|2|||
156736602|NCT05896527|565782863|FG002|Overall Study|Lost to Follow-up|2|||
156736603|NCT05896527|565782864|FG003|Overall Study|Lost to Follow-up|2|||
156736604|NCT05896527|565782865|FG004|Overall Study|Lost to Follow-up|1|||
156736605|NCT05896527|565782861|FG000|Overall Study|Significant protocol noncompliance|0|||
156796944|NCT00725985|566009674|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796945|NCT00725985|566009675|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796946|NCT00725985|566009676|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796947|NCT00725985|566009677|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796948|NCT00725985|566009678|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
157142053|NCT00811252|567267867|FG001|Overall Study|Lack of Efficacy|2|||
156736606|NCT05896527|565782862|FG001|Overall Study|Significant protocol noncompliance|1|||
156736607|NCT05896527|565782863|FG002|Overall Study|Significant protocol noncompliance|0|||
156736608|NCT05896527|565782864|FG003|Overall Study|Significant protocol noncompliance|0|||
156736609|NCT05896527|565782865|FG004|Overall Study|Significant protocol noncompliance|0|||
156736610|NCT05896527|565782861|FG000|Overall Study|Eligibility criteria not met|1|||
156796949|NCT00725985|566009679|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
156796950|NCT00725985|566009680|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
156796951|NCT00725985|566009681|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
156796952|NCT00725985|566009682|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
156796953|NCT04476784|566009683|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
156796954|NCT04476784|566009684|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
156796955|NCT01055028|566009689|FG000|Screening|Screen Failure|1|||
156736611|NCT05896527|565782862|FG001|Overall Study|Eligibility criteria not met|0|||
156736612|NCT05896527|565782863|FG002|Overall Study|Eligibility criteria not met|0|||
156796956|NCT01055028|566009690|FG001|Screening|Screen Failure|1|||
156796957|NCT01055028|566009689|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
157142054|NCT00811252|567267868|FG002|Overall Study|Lack of Efficacy|0|||
157142055|NCT00811252|567267866|FG000|Overall Study|Protocol Violation|3|||
157142056|NCT00811252|567267867|FG001|Overall Study|Protocol Violation|3|||
157142057|NCT00811252|567267868|FG002|Overall Study|Protocol Violation|2|||
156736613|NCT05896527|565782864|FG003|Overall Study|Eligibility criteria not met|0|||
156736614|NCT05896527|565782865|FG004|Overall Study|Eligibility criteria not met|0|||
156736615|NCT05896527|565782861|FG000|Overall Study|Sponsor's decision|0|||
156736616|NCT05896527|565782862|FG001|Overall Study|Sponsor's decision|0|||
156736617|NCT05896527|565782863|FG002|Overall Study|Sponsor's decision|0|||
156736618|NCT05896527|565782864|FG003|Overall Study|Sponsor's decision|1|||
156736619|NCT05896527|565782865|FG004|Overall Study|Sponsor's decision|0|||
156736620|NCT05896527|565782861|FG000|Overall Study|Investigator's decision|0|||
156736621|NCT05896527|565782862|FG001|Overall Study|Investigator's decision|1|||
156736622|NCT05896527|565782863|FG002|Overall Study|Investigator's decision|0|||
157218075|NCT00294723|567545575|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
157142058|NCT00811252|567267866|FG000|Overall Study|Withdrawal of Consent|1|||
157142059|NCT00811252|567267867|FG001|Overall Study|Withdrawal of Consent|2|||
157218076|NCT00294723|567545576|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
156736623|NCT05896527|565782864|FG003|Overall Study|Investigator's decision|0|||
157142060|NCT00811252|567267868|FG002|Overall Study|Withdrawal of Consent|2|||
157218077|NCT00294723|567545577|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
157218078|NCT00294723|567545575|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
157218079|NCT00294723|567545576|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
157218080|NCT00294723|567545577|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
157218081|NCT00294723|567545575|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
157218082|NCT00294723|567545576|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
157218083|NCT00294723|567545577|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
157218084|NCT00294723|567545575|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
157218085|NCT00294723|567545576|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
157218086|NCT00294723|567545577|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
157218087|NCT00294723|567545575|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
157218088|NCT00294723|567545576|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
157218089|NCT00294723|567545577|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
157218090|NCT00294723|567545575|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
157218091|NCT00294723|567545576|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
157218092|NCT00294723|567545577|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
157218093|NCT00294723|567545575|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
157218094|NCT00294723|567545576|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
157218095|NCT00294723|567545577|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
157218096|NCT00294723|567545575|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
157218097|NCT00294723|567545576|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
157218098|NCT00294723|567545577|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
157218099|NCT00294723|567545575|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
157218100|NCT00294723|567545576|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
157218101|NCT00294723|567545577|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
157218102|NCT00294723|567545575|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
157218103|NCT00294723|567545576|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
157218104|NCT00294723|567545577|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
157218105|NCT00294723|567545575|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
157218106|NCT00294723|567545576|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
157218107|NCT00294723|567545577|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
157218108|NCT00294723|567545575|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
157218109|NCT00294723|567545576|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
157218110|NCT00294723|567545577|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
157218111|NCT00752791|567545578|FG000|Overall Study|Adverse Event|7|||
157218112|NCT00752791|567545578|FG000|Overall Study|Withdrawal by Subject|1|||
157218113|NCT00752791|567545578|FG000|Overall Study|Physician Decision|1|||
157218114|NCT00752791|567545578|FG000|Overall Study|Death|1|||
156736624|NCT05896527|565782865|FG004|Overall Study|Investigator's decision|0|||
157142061|NCT00811252|567267866|FG000|Overall Study|Lost to Follow-up|0|||
157142062|NCT00811252|567267867|FG001|Overall Study|Lost to Follow-up|0|||
157142063|NCT00811252|567267868|FG002|Overall Study|Lost to Follow-up|2|||
157142064|NCT00811252|567267866|FG000|Overall Study|Administrative or Other Reasons|0|||
157142065|NCT00811252|567267867|FG001|Overall Study|Administrative or Other Reasons|3|||
157142066|NCT00811252|567267868|FG002|Overall Study|Administrative or Other Reasons|2|||
157142067|NCT00892437|567267870|FG000|Randomized Phase|Randomized but not treated|6|||
157142068|NCT00892437|567267871|FG001|Randomized Phase|Randomized but not treated|0|||
157142069|NCT00892437|567267870|FG000|Randomized Phase|Adverse Event|2|||
157218115|NCT00752791|567545578|FG000|Overall Study|Renal transplant|3|||
156736625|NCT05896527|565782861|FG000|Overall Study|Pregnancy of his partner|0|||
157142070|NCT00892437|567267871|FG001|Randomized Phase|Adverse Event|2|||
156736626|NCT05896527|565782862|FG001|Overall Study|Pregnancy of his partner|0|||
156736627|NCT05896527|565782863|FG002|Overall Study|Pregnancy of his partner|0|||
156736628|NCT05896527|565782864|FG003|Overall Study|Pregnancy of his partner|1|||
156736629|NCT05896527|565782865|FG004|Overall Study|Pregnancy of his partner|0|||
156736630|NCT01279070|565782867|FG000|Overall Study|Withdrawal by Subject|2|||
156736631|NCT01279070|565782868|FG001|Overall Study|Withdrawal by Subject|3|||
156736632|NCT01279070|565782867|FG000|Overall Study|Acute exacerbation|3|||
156736633|NCT01279070|565782868|FG001|Overall Study|Acute exacerbation|1|||
156736634|NCT03781583|565782869|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
156736635|NCT03781583|565782870|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
156736636|NCT03781583|565782871|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
156736637|NCT03781583|565782872|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
156736638|NCT03781583|565782869|FG000|Overall Study|Technology did not work for that person in that environment|1|||
156736639|NCT03781583|565782870|FG001|Overall Study|Technology did not work for that person in that environment|0|||
156736640|NCT03781583|565782871|FG002|Overall Study|Technology did not work for that person in that environment|0|||
156736641|NCT03781583|565782872|FG003|Overall Study|Technology did not work for that person in that environment|0|||
156736642|NCT03781583|565782869|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
156736643|NCT03781583|565782870|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
156736644|NCT03781583|565782871|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
156736645|NCT03781583|565782872|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
156736646|NCT03781583|565782869|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736647|NCT03781583|565782870|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
156736648|NCT03781583|565782871|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736649|NCT03781583|565782872|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
156736650|NCT02222545|565782873|FG000|Overall Study|Adverse Event|1|||
156876810|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
156876811|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
156876812|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
156876813|NCT02283762|566307732|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
156876814|NCT02283762|566307733|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
156876815|NCT00202878|566307735|FG000|Overall Study|Death|964|||
156876816|NCT00202878|566307736|FG001|Overall Study|Death|968|||
156876817|NCT00202878|566307735|FG000|Overall Study|Only Vital Status Known|357|||
156876818|NCT00202878|566307736|FG001|Overall Study|Only Vital Status Known|356|||
156876819|NCT00202878|566307735|FG000|Overall Study|Lost to Follow-up|44|||
156876820|NCT00202878|566307736|FG001|Overall Study|Lost to Follow-up|49|||
156876821|NCT00202878|566307735|FG000|Overall Study|Site Closure|39|||
156876822|NCT00202878|566307736|FG001|Overall Study|Site Closure|36|||
156876823|NCT00202878|566307735|FG000|Overall Study|Withdrawal by Subject|795|||
156876824|NCT00202878|566307736|FG001|Overall Study|Withdrawal by Subject|808|||
156876825|NCT00918736|566307737|FG000|Overall Study|Withdrawal by Subject|4|||
156876826|NCT01474018|566307738|FG000|Overall Study|Lost to Follow-up|0|||
156876827|NCT01474018|566307739|FG001|Overall Study|Lost to Follow-up|1|||
156876828|NCT01474018|566307738|FG000|Overall Study|Withdrawal by Subject|0|||
157218116|NCT00752791|567545578|FG000|Overall Study|Switched to hemodialysis|2|||
157218117|NCT00752791|567545578|FG000|Overall Study|Protocol deviation|1|||
156876829|NCT01474018|566307739|FG001|Overall Study|Withdrawal by Subject|2|||
156876830|NCT02433080|566307741|FG000|Overall Study|Lost to Follow-up|1|||
157218118|NCT01967888|567545581|FG000|Overall Study|Lost to Follow-up|6|||
157218119|NCT01967888|567545582|FG001|Overall Study|Lost to Follow-up|4|||
157218120|NCT01967888|567545581|FG000|Overall Study|Withdrawal by Subject|1|||
157218121|NCT01967888|567545582|FG001|Overall Study|Withdrawal by Subject|1|||
157218122|NCT01967888|567545581|FG000|Overall Study|Did Not Have Transplant|1|||
157218123|NCT01967888|567545582|FG001|Overall Study|Did Not Have Transplant|0|||
157218124|NCT01967888|567545581|FG000|Overall Study|Research visit not done, data recorded|1|||
157218125|NCT01967888|567545582|FG001|Overall Study|Research visit not done, data recorded|0|||
157218126|NCT01967888|567545581|FG000|Overall Study|Subject excluded after randomization|1|||
157218127|NCT01967888|567545582|FG001|Overall Study|Subject excluded after randomization|0|||
157218128|NCT01967888|567545581|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
157218129|NCT01967888|567545582|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
156876831|NCT02433080|566307742|FG001|Overall Study|Lost to Follow-up|2|||
156876832|NCT02433080|566307741|FG000|Overall Study|Withdrawal by Subject|0|||
157218130|NCT01967888|567545581|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
157218131|NCT01967888|567545582|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
157218132|NCT00891774|567545583|FG000|Overall Study|Lost to Follow-up|5|||
157218133|NCT00891774|567545583|FG000|Overall Study|Illness (Self/Mother)|3|||
157218134|NCT00891774|567545583|FG000|Overall Study|Withdrawal by Subject|2|||
156876833|NCT02433080|566307742|FG001|Overall Study|Withdrawal by Subject|2|||
157218135|NCT00891774|567545583|FG000|Overall Study|Protocol Violation|4|||
156736651|NCT02222545|565782874|FG001|Overall Study|Adverse Event|0|||
156736652|NCT02222545|565782875|FG002|Overall Study|Adverse Event|2|||
156736653|NCT02222545|565782873|FG000|Overall Study|Death|0|||
156736654|NCT02222545|565782874|FG001|Overall Study|Death|0|||
156736655|NCT02222545|565782875|FG002|Overall Study|Death|9|||
156736656|NCT02222545|565782873|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
156736657|NCT02222545|565782874|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
156736658|NCT02222545|565782875|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
156736659|NCT02222545|565782873|FG000|Overall Study|Withdrawal by Subject|0|||
156736660|NCT02222545|565782874|FG001|Overall Study|Withdrawal by Subject|0|||
156736661|NCT02222545|565782875|FG002|Overall Study|Withdrawal by Subject|3|||
156736662|NCT02222545|565782873|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
157218136|NCT03175120|567545589|FG000|Overall Study|Adverse Event|2|||
157218137|NCT03175120|567545590|FG001|Overall Study|Adverse Event|2|||
157218138|NCT03175120|567545589|FG000|Overall Study|Protocol Violation|5|||
157218139|NCT03175120|567545590|FG001|Overall Study|Protocol Violation|2|||
157218140|NCT03175120|567545589|FG000|Overall Study|Lost to Follow-up|1|||
157218141|NCT03175120|567545590|FG001|Overall Study|Lost to Follow-up|0|||
157218142|NCT03175120|567545589|FG000|Overall Study|Withdrawal by Subject|2|||
157218143|NCT03175120|567545590|FG001|Overall Study|Withdrawal by Subject|5|||
157218144|NCT03175120|567545589|FG000|Overall Study|Other|2|||
157218145|NCT03175120|567545590|FG001|Overall Study|Other|3|||
157218146|NCT01958281|567545591|FG000|Overall Study|Lack of Efficacy|5|||
157218147|NCT01958281|567545592|FG001|Overall Study|Lack of Efficacy|2|||
157218148|NCT01958281|567545593|FG002|Overall Study|Lack of Efficacy|0|||
157218149|NCT01958281|567545591|FG000|Overall Study|Adverse Event|0|||
157218150|NCT01958281|567545592|FG001|Overall Study|Adverse Event|2|||
157218151|NCT01958281|567545593|FG002|Overall Study|Adverse Event|0|||
157218152|NCT01958281|567545591|FG000|Overall Study|Withdrew Consent|1|||
157218153|NCT01958281|567545592|FG001|Overall Study|Withdrew Consent|0|||
157218154|NCT01958281|567545593|FG002|Overall Study|Withdrew Consent|0|||
157218155|NCT02784106|567545594|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
157218156|NCT02784106|567545595|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
157218157|NCT02784106|567545596|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
157218158|NCT02784106|567545597|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
157218159|NCT02784106|567545594|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
157218160|NCT02784106|567545595|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
157218161|NCT02784106|567545596|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
157218162|NCT02784106|567545597|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
157218163|NCT02784106|567545594|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
157218164|NCT02784106|567545595|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
157218165|NCT02784106|567545596|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
157218166|NCT02784106|567545597|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
157218167|NCT02784106|567545594|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
157218168|NCT02784106|567545595|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
157218169|NCT02784106|567545596|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
157218170|NCT02784106|567545597|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
157218171|NCT02784106|567545594|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
157218172|NCT02784106|567545595|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
157218173|NCT02784106|567545596|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
157218174|NCT02784106|567545597|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
157218175|NCT02784106|567545594|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
157218176|NCT02784106|567545595|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
157218177|NCT02784106|567545596|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
157218178|NCT02784106|567545597|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
157218179|NCT00553540|567545598|FG000|Overall Study|discharged after first visit|2|||
157218180|NCT00553540|567545599|FG001|Overall Study|discharged after first visit|5|||
157218181|NCT01755858|567545600|FG000|Overall Study|Adverse Event|1|||
157218182|NCT01755858|567545601|FG001|Overall Study|Adverse Event|1|||
157218183|NCT03882047|567545602|FG000|Overall Study|Adverse Event|0|||
157218184|NCT03882047|567545603|FG001|Overall Study|Adverse Event|2|||
157218185|NCT03882047|567545604|FG002|Overall Study|Adverse Event|2|||
157218186|NCT03882047|567545602|FG000|Overall Study|Treatment Failure|3|||
157218187|NCT03882047|567545603|FG001|Overall Study|Treatment Failure|3|||
157218188|NCT03882047|567545604|FG002|Overall Study|Treatment Failure|12|||
156736663|NCT02222545|565782874|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
157218189|NCT03882047|567545602|FG000|Overall Study|Lost to Follow-up|0|||
157218190|NCT03882047|567545603|FG001|Overall Study|Lost to Follow-up|1|||
157218191|NCT03882047|567545604|FG002|Overall Study|Lost to Follow-up|0|||
157218192|NCT03882047|567545602|FG000|Overall Study|Did Not Wish to Continue|1|||
157218193|NCT03882047|567545603|FG001|Overall Study|Did Not Wish to Continue|4|||
157218194|NCT03882047|567545604|FG002|Overall Study|Did Not Wish to Continue|1|||
157218195|NCT03882047|567545602|FG000|Overall Study|Noncompliance With Protocol|2|||
156736664|NCT02222545|565782875|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
156736665|NCT01938430|565782876|FG000|Overall Study|Randomized but Not Treated|0|||
156736666|NCT01938430|565782877|FG001|Overall Study|Randomized but Not Treated|0|||
156736667|NCT01938430|565782878|FG002|Overall Study|Randomized but Not Treated|0|||
156736668|NCT01938430|565782879|FG003|Overall Study|Randomized but Not Treated|0|||
156736669|NCT01938430|565782880|FG004|Overall Study|Randomized but Not Treated|0|||
156736670|NCT01938430|565782881|FG005|Overall Study|Randomized but Not Treated|0|||
156736671|NCT01938430|565782882|FG006|Overall Study|Randomized but Not Treated|0|||
156736672|NCT01938430|565782883|FG007|Overall Study|Randomized but Not Treated|0|||
156736673|NCT01938430|565782884|FG008|Overall Study|Randomized but Not Treated|0|||
156736674|NCT01938430|565782885|FG009|Overall Study|Randomized but Not Treated|0|||
156736675|NCT01938430|565782886|FG010|Overall Study|Randomized but Not Treated|1|||
156736676|NCT01938430|565782887|FG011|Overall Study|Randomized but Not Treated|0|||
156736677|NCT01938430|565782888|FG012|Overall Study|Randomized but Not Treated|0|||
156736678|NCT01938430|565782889|FG013|Overall Study|Randomized but Not Treated|1|||
156736679|NCT01938430|565782876|FG000|Overall Study|Adverse Event|0|||
156736680|NCT01938430|565782877|FG001|Overall Study|Adverse Event|0|||
156736681|NCT01938430|565782878|FG002|Overall Study|Adverse Event|0|||
156736682|NCT01938430|565782879|FG003|Overall Study|Adverse Event|0|||
156736683|NCT01938430|565782880|FG004|Overall Study|Adverse Event|0|||
156736684|NCT01938430|565782881|FG005|Overall Study|Adverse Event|0|||
156736685|NCT01938430|565782882|FG006|Overall Study|Adverse Event|1|||
156736686|NCT01938430|565782883|FG007|Overall Study|Adverse Event|0|||
156736687|NCT01938430|565782884|FG008|Overall Study|Adverse Event|0|||
156736688|NCT01938430|565782885|FG009|Overall Study|Adverse Event|0|||
156736689|NCT01938430|565782886|FG010|Overall Study|Adverse Event|0|||
156736690|NCT01938430|565782887|FG011|Overall Study|Adverse Event|0|||
156736691|NCT01938430|565782888|FG012|Overall Study|Adverse Event|0|||
156736692|NCT01938430|565782889|FG013|Overall Study|Adverse Event|0|||
156736693|NCT01938430|565782876|FG000|Overall Study|Death|1|||
156736694|NCT01938430|565782877|FG001|Overall Study|Death|2|||
156876834|NCT01942733|566307744|FG000|Overall Study|Lost to Follow-up|1|||
156876835|NCT01942733|566307744|FG000|Overall Study|Non-compliance with IMP|1|||
157142071|NCT00892437|567267870|FG000|Randomized Phase|Lost to Follow-up|1|||
157142072|NCT00892437|567267871|FG001|Randomized Phase|Lost to Follow-up|3|||
157142073|NCT00892437|567267870|FG000|Randomized Phase|Investigator's Discretion|1|||
157142074|NCT00892437|567267871|FG001|Randomized Phase|Investigator's Discretion|0|||
157142075|NCT00892437|567267870|FG000|Randomized Phase|Withdrew Consent|1|||
157142076|NCT00892437|567267871|FG001|Randomized Phase|Withdrew Consent|0|||
157142077|NCT00892437|567267870|FG000|Open-Label Extension Phase|Adverse Event|4|||
157142078|NCT00892437|567267871|FG001|Open-Label Extension Phase|Adverse Event|2|||
157142079|NCT00892437|567267870|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
157142080|NCT00892437|567267871|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
157142081|NCT00892437|567267870|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
157142082|NCT00892437|567267871|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
157142083|NCT00892437|567267870|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
157142084|NCT00892437|567267871|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
157142085|NCT00892437|567267870|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
157142086|NCT00892437|567267871|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
157142087|NCT02286960|567267873|FG000|Overall Study|Lost to Follow-up|3|||
157142088|NCT02286960|567267874|FG001|Overall Study|Lost to Follow-up|3|||
157142089|NCT02750410|567267876|FG000|Double-Blind Treatment Period|Adverse Event|2|||
157142090|NCT02750410|567267877|FG001|Double-Blind Treatment Period|Adverse Event|2|||
157142091|NCT02750410|567267876|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157142092|NCT02750410|567267877|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157142093|NCT02750410|567267876|FG000|Open-Label Extension Period|Adverse Event|5|||
156876836|NCT01942733|566307744|FG000|Overall Study|Administrative|1|||
156876837|NCT00486291|566307748|FG000|Overall Study|Adverse Event|3|||
156876838|NCT00486291|566307749|FG001|Overall Study|Adverse Event|4|||
156876839|NCT00486291|566307748|FG000|Overall Study|Lost to Follow-up|3|||
156876840|NCT00486291|566307749|FG001|Overall Study|Lost to Follow-up|7|||
156876841|NCT00486291|566307748|FG000|Overall Study|protocol non-compliance|10|||
157142094|NCT02750410|567267877|FG001|Open-Label Extension Period|Adverse Event|3|||
156736695|NCT01938430|565782878|FG002|Overall Study|Death|2|||
157142095|NCT02750410|567267876|FG000|Open-Label Extension Period|Protocol Violation|0|||
157142096|NCT02750410|567267877|FG001|Open-Label Extension Period|Protocol Violation|1|||
156736696|NCT01938430|565782879|FG003|Overall Study|Death|1|||
156736697|NCT01938430|565782880|FG004|Overall Study|Death|0|||
156876842|NCT00486291|566307749|FG001|Overall Study|protocol non-compliance|15|||
156736698|NCT01938430|565782881|FG005|Overall Study|Death|0|||
156876843|NCT00486291|566307748|FG000|Overall Study|requirement for restricted medication|0|||
156736699|NCT01938430|565782882|FG006|Overall Study|Death|1|||
156876844|NCT00486291|566307749|FG001|Overall Study|requirement for restricted medication|3|||
156736700|NCT01938430|565782883|FG007|Overall Study|Death|1|||
156736701|NCT01938430|565782884|FG008|Overall Study|Death|2|||
156736702|NCT01938430|565782885|FG009|Overall Study|Death|3|||
156736703|NCT01938430|565782886|FG010|Overall Study|Death|0|||
156736704|NCT01938430|565782887|FG011|Overall Study|Death|0|||
156736705|NCT01938430|565782888|FG012|Overall Study|Death|0|||
156736706|NCT01938430|565782889|FG013|Overall Study|Death|0|||
156736707|NCT01938430|565782876|FG000|Overall Study|Investigator's Discretion|0|||
156736708|NCT01938430|565782877|FG001|Overall Study|Investigator's Discretion|0|||
156736709|NCT01938430|565782878|FG002|Overall Study|Investigator's Discretion|1|||
156736710|NCT01938430|565782879|FG003|Overall Study|Investigator's Discretion|0|||
156736711|NCT01938430|565782880|FG004|Overall Study|Investigator's Discretion|0|||
157142097|NCT02750410|567267876|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
157142098|NCT02750410|567267877|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
156736712|NCT01938430|565782881|FG005|Overall Study|Investigator's Discretion|0|||
156736713|NCT01938430|565782882|FG006|Overall Study|Investigator's Discretion|0|||
157142099|NCT02504541|567267878|FG000|Overall Study|Adverse Event|4|||
157142100|NCT02504541|567267878|FG000|Overall Study|Withdrawal by Subject|4|||
157142101|NCT02504541|567267878|FG000|Overall Study|Lost to Follow-up|1|||
157142102|NCT02504541|567267878|FG000|Overall Study|Met Stopping Criteria|1|||
157142103|NCT02504541|567267878|FG000|Overall Study|Protocol Violation|2|||
157142104|NCT02504541|567267878|FG000|Overall Study|Termination by Sponsor|1|||
157142105|NCT02504541|567267878|FG000|Overall Study|Other|2|||
157142106|NCT02504541|567267878|FG000|Overall Study|Multiple|5|||
157142107|NCT01531725|567267879|FG000|Overall Study|Protocol Violation|5|||
157142108|NCT03215277|567267880|FG000|Overall Study|Adverse Event|2|||
157142109|NCT03215277|567267881|FG001|Overall Study|Adverse Event|3|||
157142110|NCT03215277|567267880|FG000|Overall Study|Death|1|||
157142111|NCT03215277|567267881|FG001|Overall Study|Death|0|||
157142112|NCT03215277|567267880|FG000|Overall Study|Lost to Follow-up|0|||
157142113|NCT03215277|567267881|FG001|Overall Study|Lost to Follow-up|1|||
157142114|NCT03215277|567267880|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
157142115|NCT03215277|567267881|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
157142116|NCT02317510|567267882|FG000|Overall Study|Adverse Event|0|||
157142117|NCT02317510|567267883|FG001|Overall Study|Adverse Event|1|||
157142118|NCT00472303|567267884|FG000|Titration Phase|Adverse Event|22|||
157142119|NCT00472303|567267885|FG001|Titration Phase|Adverse Event|12|||
157142120|NCT00472303|567267886|FG002|Titration Phase|Adverse Event|0|||
157142121|NCT00472303|567267884|FG000|Titration Phase|Death|4|||
157142122|NCT00472303|567267885|FG001|Titration Phase|Death|2|||
157142123|NCT00472303|567267886|FG002|Titration Phase|Death|0|||
157142124|NCT00472303|567267884|FG000|Titration Phase|Lack of Efficacy|10|||
157142125|NCT00472303|567267885|FG001|Titration Phase|Lack of Efficacy|0|||
157142126|NCT00472303|567267886|FG002|Titration Phase|Lack of Efficacy|0|||
157142127|NCT00472303|567267884|FG000|Titration Phase|Withdrawal by Subject|16|||
157142128|NCT00472303|567267885|FG001|Titration Phase|Withdrawal by Subject|13|||
157142129|NCT00472303|567267886|FG002|Titration Phase|Withdrawal by Subject|0|||
157142130|NCT00472303|567267884|FG000|Titration Phase|Trial Medication non-compliant|4|||
157142131|NCT00472303|567267885|FG001|Titration Phase|Trial Medication non-compliant|1|||
157142132|NCT00472303|567267886|FG002|Titration Phase|Trial Medication non-compliant|0|||
157142133|NCT00472303|567267884|FG000|Titration Phase|Other|3|||
157142134|NCT00472303|567267885|FG001|Titration Phase|Other|1|||
157142135|NCT00472303|567267886|FG002|Titration Phase|Other|0|||
157142136|NCT00472303|567267884|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
157142137|NCT00472303|567267885|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
157142138|NCT00472303|567267886|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
157142139|NCT00472303|567267884|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
157142140|NCT00472303|567267885|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
157142141|NCT00472303|567267886|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
157142142|NCT00472303|567267884|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
157142143|NCT00472303|567267885|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
157142144|NCT00472303|567267886|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
157142145|NCT00472303|567267884|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
157142146|NCT00472303|567267885|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
157142147|NCT00472303|567267886|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
157142148|NCT00472303|567267884|FG000|Discontinuations After Titration Phase|Other|5|||
157142149|NCT00472303|567267885|FG001|Discontinuations After Titration Phase|Other|0|||
157142150|NCT00472303|567267886|FG002|Discontinuations After Titration Phase|Other|0|||
157142151|NCT00472303|567267884|FG000|Maintenance Phase|Adverse Event|5|||
157142152|NCT00472303|567267885|FG001|Maintenance Phase|Adverse Event|6|||
157142153|NCT00472303|567267886|FG002|Maintenance Phase|Adverse Event|6|||
157142154|NCT00472303|567267884|FG000|Maintenance Phase|Death|3|||
157142155|NCT00472303|567267885|FG001|Maintenance Phase|Death|0|||
157142156|NCT00472303|567267886|FG002|Maintenance Phase|Death|2|||
156736714|NCT01938430|565782883|FG007|Overall Study|Investigator's Discretion|0|||
157142157|NCT00472303|567267884|FG000|Maintenance Phase|Lack of Efficacy|2|||
157142158|NCT00472303|567267885|FG001|Maintenance Phase|Lack of Efficacy|2|||
157142159|NCT00472303|567267886|FG002|Maintenance Phase|Lack of Efficacy|4|||
157142160|NCT00472303|567267884|FG000|Maintenance Phase|Withdrawal by Subject|6|||
156736715|NCT01938430|565782884|FG008|Overall Study|Investigator's Discretion|0|||
156736716|NCT01938430|565782885|FG009|Overall Study|Investigator's Discretion|0|||
156736717|NCT01938430|565782886|FG010|Overall Study|Investigator's Discretion|0|||
156736718|NCT01938430|565782887|FG011|Overall Study|Investigator's Discretion|0|||
156736719|NCT01938430|565782888|FG012|Overall Study|Investigator's Discretion|0|||
156736720|NCT01938430|565782889|FG013|Overall Study|Investigator's Discretion|0|||
156736721|NCT01938430|565782876|FG000|Overall Study|Lack of Efficacy|3|||
156736722|NCT01938430|565782877|FG001|Overall Study|Lack of Efficacy|1|||
156736723|NCT01938430|565782878|FG002|Overall Study|Lack of Efficacy|1|||
156736724|NCT01938430|565782879|FG003|Overall Study|Lack of Efficacy|1|||
156736725|NCT01938430|565782880|FG004|Overall Study|Lack of Efficacy|0|||
156736726|NCT01938430|565782881|FG005|Overall Study|Lack of Efficacy|0|||
156736727|NCT01938430|565782882|FG006|Overall Study|Lack of Efficacy|0|||
156736728|NCT01938430|565782883|FG007|Overall Study|Lack of Efficacy|0|||
156736729|NCT01938430|565782884|FG008|Overall Study|Lack of Efficacy|1|||
156736730|NCT01938430|565782885|FG009|Overall Study|Lack of Efficacy|0|||
156736731|NCT01938430|565782886|FG010|Overall Study|Lack of Efficacy|2|||
156736732|NCT01938430|565782887|FG011|Overall Study|Lack of Efficacy|1|||
156736733|NCT01938430|565782888|FG012|Overall Study|Lack of Efficacy|0|||
156736734|NCT01938430|565782889|FG013|Overall Study|Lack of Efficacy|0|||
156736735|NCT01938430|565782876|FG000|Overall Study|Lost to Follow-up|0|||
156736736|NCT01938430|565782877|FG001|Overall Study|Lost to Follow-up|0|||
156736737|NCT01938430|565782878|FG002|Overall Study|Lost to Follow-up|1|||
156736738|NCT01938430|565782879|FG003|Overall Study|Lost to Follow-up|0|||
156736739|NCT01938430|565782880|FG004|Overall Study|Lost to Follow-up|0|||
156736740|NCT01938430|565782881|FG005|Overall Study|Lost to Follow-up|1|||
156736741|NCT01938430|565782882|FG006|Overall Study|Lost to Follow-up|0|||
156736742|NCT01938430|565782883|FG007|Overall Study|Lost to Follow-up|0|||
156736743|NCT01938430|565782884|FG008|Overall Study|Lost to Follow-up|0|||
156736744|NCT01938430|565782885|FG009|Overall Study|Lost to Follow-up|0|||
156736745|NCT01938430|565782886|FG010|Overall Study|Lost to Follow-up|0|||
156736746|NCT01938430|565782887|FG011|Overall Study|Lost to Follow-up|0|||
156736747|NCT01938430|565782888|FG012|Overall Study|Lost to Follow-up|0|||
156736748|NCT01938430|565782889|FG013|Overall Study|Lost to Follow-up|0|||
156736749|NCT01938430|565782876|FG000|Overall Study|Withdrew Consent|0|||
156736750|NCT01938430|565782877|FG001|Overall Study|Withdrew Consent|0|||
156736751|NCT01938430|565782878|FG002|Overall Study|Withdrew Consent|0|||
156736752|NCT01938430|565782879|FG003|Overall Study|Withdrew Consent|0|||
156736753|NCT01938430|565782880|FG004|Overall Study|Withdrew Consent|0|||
156736754|NCT01938430|565782881|FG005|Overall Study|Withdrew Consent|0|||
156736755|NCT01938430|565782882|FG006|Overall Study|Withdrew Consent|0|||
156736756|NCT01938430|565782883|FG007|Overall Study|Withdrew Consent|0|||
156736757|NCT01938430|565782884|FG008|Overall Study|Withdrew Consent|1|||
156736758|NCT01938430|565782885|FG009|Overall Study|Withdrew Consent|0|||
156736759|NCT01938430|565782886|FG010|Overall Study|Withdrew Consent|0|||
156736760|NCT01938430|565782887|FG011|Overall Study|Withdrew Consent|0|||
156736761|NCT01938430|565782888|FG012|Overall Study|Withdrew Consent|0|||
156736762|NCT01938430|565782889|FG013|Overall Study|Withdrew Consent|0|||
156736763|NCT04533412|565782890|FG000|Overall Study|Withdrawal by Subject|1|||
156736764|NCT04533412|565782891|FG001|Overall Study|Withdrawal by Subject|1|||
156736765|NCT04533412|565782890|FG000|Overall Study|Lost to Follow-up|1|||
156736766|NCT04533412|565782891|FG001|Overall Study|Lost to Follow-up|4|||
156736767|NCT02738879|565782896|FG000|Overall Study|Adverse Event|1|||
157142161|NCT00472303|567267885|FG001|Maintenance Phase|Withdrawal by Subject|7|||
156736768|NCT02738879|565782897|FG001|Overall Study|Adverse Event|1|||
156736769|NCT02738879|565782896|FG000|Overall Study|Death|0|||
156736770|NCT02738879|565782897|FG001|Overall Study|Death|2|||
156736771|NCT02738879|565782896|FG000|Overall Study|Lost to Follow-up|1|||
156736772|NCT02738879|565782897|FG001|Overall Study|Lost to Follow-up|5|||
156736773|NCT02738879|565782896|FG000|Overall Study|Protocol Violation|1|||
156736774|NCT02738879|565782897|FG001|Overall Study|Protocol Violation|3|||
157020257|NCT02243709|566826564|FG001|Phase 1|Lost to Follow-up|1|||
156736775|NCT02738879|565782896|FG000|Overall Study|Physician Decision|3|||
156736776|NCT02738879|565782897|FG001|Overall Study|Physician Decision|4|||
156736777|NCT02738879|565782896|FG000|Overall Study|Pregnancy|0|||
156736778|NCT02738879|565782897|FG001|Overall Study|Pregnancy|1|||
157142162|NCT00472303|567267886|FG002|Maintenance Phase|Withdrawal by Subject|3|||
157142163|NCT00472303|567267884|FG000|Maintenance Phase|Trial medication non-compliant|0|||
157142164|NCT00472303|567267885|FG001|Maintenance Phase|Trial medication non-compliant|0|||
157142165|NCT00472303|567267886|FG002|Maintenance Phase|Trial medication non-compliant|1|||
157142166|NCT00472303|567267884|FG000|Maintenance Phase|Resolution of pain|0|||
156736779|NCT02738879|565782896|FG000|Overall Study|Screen Failure|1|||
156736780|NCT02738879|565782897|FG001|Overall Study|Screen Failure|2|||
156736781|NCT02738879|565782896|FG000|Overall Study|Site Discontinued Study Participation|1|||
156736782|NCT02738879|565782897|FG001|Overall Study|Site Discontinued Study Participation|0|||
156736783|NCT02738879|565782896|FG000|Overall Study|Withdrawal by Subject|5|||
156736784|NCT02738879|565782897|FG001|Overall Study|Withdrawal by Subject|7|||
156736785|NCT00890084|565782898|FG000|Overall Study|Adverse Event|16|||
156736786|NCT00890084|565782898|FG000|Overall Study|Lost to Follow-up|126|||
156736787|NCT01730534|565782900|FG000|Overall Study|Withdrawal by Subject|97|||
156736788|NCT01730534|565782901|FG001|Overall Study|Withdrawal by Subject|127|||
156736789|NCT01730534|565782900|FG000|Overall Study|Lost to Follow-up|12|||
156736790|NCT01730534|565782901|FG001|Overall Study|Lost to Follow-up|18|||
156736791|NCT02892422|565782905|FG000|Overall Study|Enrolled not treated|4|||
156736792|NCT02892422|565782905|FG000|Overall Study|Adverse Event|38|||
156736793|NCT02892422|565782905|FG000|Overall Study|Lack of Efficacy|32|||
156736794|NCT02892422|565782905|FG000|Overall Study|Non-compliance with study drug|11|||
157142167|NCT00472303|567267885|FG001|Maintenance Phase|Resolution of pain|0|||
157142168|NCT00472303|567267886|FG002|Maintenance Phase|Resolution of pain|1|||
157142169|NCT00472303|567267884|FG000|Maintenance Phase|Other|1|||
157142170|NCT00472303|567267885|FG001|Maintenance Phase|Other|1|||
157142171|NCT00472303|567267886|FG002|Maintenance Phase|Other|0|||
157142172|NCT02835495|567267896|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
157142173|NCT02835495|567267897|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
157142174|NCT02835495|567267896|FG000|Overall Study|Declined in-person follow-up visit|4|||
157142175|NCT02835495|567267897|FG001|Overall Study|Declined in-person follow-up visit|2|||
157142176|NCT00356915|567267898|FG000|Overall Study|Non compliance|1|||
157142177|NCT00356915|567267899|FG001|Overall Study|Non compliance|2|||
157142178|NCT00356915|567267900|FG002|Overall Study|Non compliance|1|||
157142179|NCT00356915|567267898|FG000|Overall Study|Protocol Violation|2|||
157142180|NCT00356915|567267899|FG001|Overall Study|Protocol Violation|3|||
157142181|NCT00356915|567267900|FG002|Overall Study|Protocol Violation|2|||
157142182|NCT00356915|567267898|FG000|Overall Study|Withdrawal by Subject|14|||
157142183|NCT00356915|567267899|FG001|Overall Study|Withdrawal by Subject|14|||
157142184|NCT00356915|567267900|FG002|Overall Study|Withdrawal by Subject|10|||
157142185|NCT00356915|567267898|FG000|Overall Study|Lack of Efficacy|0|||
157142186|NCT00356915|567267899|FG001|Overall Study|Lack of Efficacy|0|||
157142187|NCT00356915|567267900|FG002|Overall Study|Lack of Efficacy|3|||
157142188|NCT00356915|567267898|FG000|Overall Study|Lost to Follow-up|27|||
157142189|NCT00356915|567267899|FG001|Overall Study|Lost to Follow-up|34|||
157142190|NCT00356915|567267900|FG002|Overall Study|Lost to Follow-up|14|||
157142191|NCT00356915|567267898|FG000|Overall Study|Administrative Decision|0|||
156736795|NCT02892422|565782905|FG000|Overall Study|Protocol Violation|4|||
156736796|NCT02892422|565782905|FG000|Overall Study|Withdrawal by Subject|56|||
156736797|NCT02892422|565782905|FG000|Overall Study|Lost to Follow-up|5|||
156736798|NCT02892422|565782905|FG000|Overall Study|sponsor information 16159A results|21|||
156736799|NCT02892422|565782905|FG000|Overall Study|withdrawal of consent|13|||
156736800|NCT02892422|565782905|FG000|Overall Study|exclusion criteria met|3|||
156736801|NCT02892422|565782905|FG000|Overall Study|moving elsewhere|4|||
156736802|NCT02892422|565782905|FG000|Overall Study|non-compliance|10|||
156736803|NCT02892422|565782905|FG000|Overall Study|patient legally incapable|1|||
156736804|NCT02892422|565782905|FG000|Overall Study|patient decision|7|||
156736805|NCT02892422|565782905|FG000|Overall Study|Investigator decision|1|||
156736806|NCT00725608|565782910|FG000|Overall Study|Lost to Follow-up|60|||
156736807|NCT00725608|565782910|FG000|Overall Study|Adverse Event|14|||
156736808|NCT00725608|565782910|FG000|Overall Study|Individual reasons|86|||
156736809|NCT00725608|565782910|FG000|Overall Study|Other|7|||
156736810|NCT00614120|565782914|FG000|Overall Study|Adverse Event|9|||
156736811|NCT00614120|565782915|FG001|Overall Study|Adverse Event|22|||
156736812|NCT00614120|565782916|FG002|Overall Study|Adverse Event|30|||
156736813|NCT00614120|565782917|FG003|Overall Study|Adverse Event|3|||
156736814|NCT00614120|565782914|FG000|Overall Study|Lack of Efficacy|3|||
156736815|NCT00614120|565782915|FG001|Overall Study|Lack of Efficacy|3|||
156736816|NCT00614120|565782916|FG002|Overall Study|Lack of Efficacy|2|||
156736817|NCT00614120|565782917|FG003|Overall Study|Lack of Efficacy|2|||
156736818|NCT00614120|565782914|FG000|Overall Study|Protocol Violation|2|||
156736819|NCT00614120|565782915|FG001|Overall Study|Protocol Violation|5|||
156736820|NCT00614120|565782916|FG002|Overall Study|Protocol Violation|3|||
156736821|NCT00614120|565782917|FG003|Overall Study|Protocol Violation|1|||
156736822|NCT00614120|565782914|FG000|Overall Study|Withdrawal criteria|1|||
156736823|NCT00614120|565782915|FG001|Overall Study|Withdrawal criteria|0|||
156736824|NCT00614120|565782916|FG002|Overall Study|Withdrawal criteria|0|||
156736825|NCT00614120|565782917|FG003|Overall Study|Withdrawal criteria|0|||
156736826|NCT00614120|565782914|FG000|Overall Study|Withdrawal by Subject|9|||
156736827|NCT00614120|565782915|FG001|Overall Study|Withdrawal by Subject|10|||
156736828|NCT00614120|565782916|FG002|Overall Study|Withdrawal by Subject|16|||
156736829|NCT00614120|565782917|FG003|Overall Study|Withdrawal by Subject|3|||
156736830|NCT00614120|565782914|FG000|Overall Study|Did not meet trial criteria|0|||
157142192|NCT00356915|567267899|FG001|Overall Study|Administrative Decision|0|||
157142193|NCT00356915|567267900|FG002|Overall Study|Administrative Decision|1|||
157142194|NCT00356915|567267898|FG000|Overall Study|Physician Decision|0|||
157142195|NCT00356915|567267899|FG001|Overall Study|Physician Decision|2|||
157142196|NCT00356915|567267900|FG002|Overall Study|Physician Decision|0|||
157142197|NCT00356915|567267898|FG000|Overall Study|Adverse Event|21|||
156736831|NCT00614120|565782915|FG001|Overall Study|Did not meet trial criteria|1|||
156736832|NCT00614120|565782916|FG002|Overall Study|Did not meet trial criteria|1|||
157142198|NCT00356915|567267899|FG001|Overall Study|Adverse Event|31|||
157142199|NCT00356915|567267900|FG002|Overall Study|Adverse Event|8|||
156736833|NCT00614120|565782917|FG003|Overall Study|Did not meet trial criteria|1|||
156736834|NCT00614120|565782914|FG000|Overall Study|hCG positive (not pregnant)|0|||
156736835|NCT00614120|565782915|FG001|Overall Study|hCG positive (not pregnant)|0|||
156736836|NCT00614120|565782916|FG002|Overall Study|hCG positive (not pregnant)|1|||
156736837|NCT00614120|565782917|FG003|Overall Study|hCG positive (not pregnant)|0|||
156736838|NCT00614120|565782914|FG000|Overall Study|Hypoglycaemia|0|||
156736839|NCT00614120|565782915|FG001|Overall Study|Hypoglycaemia|0|||
156736840|NCT00614120|565782916|FG002|Overall Study|Hypoglycaemia|0|||
156736841|NCT00614120|565782917|FG003|Overall Study|Hypoglycaemia|1|||
156736842|NCT00614120|565782914|FG000|Overall Study|Lack of trial product|3|||
156736843|NCT00614120|565782915|FG001|Overall Study|Lack of trial product|3|||
156736844|NCT00614120|565782916|FG002|Overall Study|Lack of trial product|2|||
156736845|NCT00614120|565782917|FG003|Overall Study|Lack of trial product|0|||
156736846|NCT00614120|565782914|FG000|Overall Study|Late syphilis, latent|1|||
156736847|NCT00614120|565782915|FG001|Overall Study|Late syphilis, latent|0|||
156736848|NCT00614120|565782916|FG002|Overall Study|Late syphilis, latent|0|||
156736849|NCT00614120|565782917|FG003|Overall Study|Late syphilis, latent|0|||
156736850|NCT00614120|565782914|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
156736851|NCT00614120|565782915|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
156736852|NCT00614120|565782916|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
156736853|NCT00614120|565782917|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
156736854|NCT00614120|565782914|FG000|Overall Study|Lost to Follow-up|1|||
156736855|NCT00614120|565782915|FG001|Overall Study|Lost to Follow-up|2|||
156736856|NCT00614120|565782916|FG002|Overall Study|Lost to Follow-up|3|||
156736857|NCT00614120|565782917|FG003|Overall Study|Lost to Follow-up|4|||
156736858|NCT01154088|565782918|FG000|Overall Study|Lost to Follow-up|4|||
156736859|NCT01154088|565782919|FG001|Overall Study|Lost to Follow-up|6|||
156736860|NCT01154088|565782920|FG002|Overall Study|Lost to Follow-up|7|||
156736861|NCT05129137|565782922|FG000|Second Period|Adverse Event|1|||
156736862|NCT05129137|565782923|FG001|Second Period|Adverse Event|0|||
156736863|NCT05129137|565782924|FG002|Second Period|Adverse Event|0|||
156736864|NCT05129137|565782925|FG003|Second Period|Adverse Event|0|||
156736865|NCT05129137|565782922|FG000|Second Period|Protocol Violation|0|||
156736866|NCT05129137|565782923|FG001|Second Period|Protocol Violation|0|||
156736867|NCT05129137|565782924|FG002|Second Period|Protocol Violation|0|||
156736868|NCT05129137|565782925|FG003|Second Period|Protocol Violation|1|||
156736869|NCT05129137|565782922|FG000|Third Period|Protocol Violation|0|||
156736870|NCT05129137|565782923|FG001|Third Period|Protocol Violation|0|||
156736871|NCT05129137|565782924|FG002|Third Period|Protocol Violation|0|||
156736872|NCT05129137|565782925|FG003|Third Period|Protocol Violation|1|||
156736873|NCT05129137|565782922|FG000|Forth Period|Protocol Violation|0|||
156736874|NCT05129137|565782923|FG001|Forth Period|Protocol Violation|1|||
156736875|NCT05129137|565782924|FG002|Forth Period|Protocol Violation|0|||
156736876|NCT05129137|565782925|FG003|Forth Period|Protocol Violation|0|||
156736877|NCT05129137|565782922|FG000|Forth Period|Withdrawal by Subject|0|||
156736878|NCT05129137|565782923|FG001|Forth Period|Withdrawal by Subject|0|||
156736879|NCT05129137|565782924|FG002|Forth Period|Withdrawal by Subject|1|||
156736880|NCT05129137|565782925|FG003|Forth Period|Withdrawal by Subject|0|||
156736881|NCT01084668|565782926|FG000|Overall Study|Lack of Efficacy|5|||
156736882|NCT01084668|565782926|FG000|Overall Study|Withdrawal by Subject|2|||
156736883|NCT01084668|565782926|FG000|Overall Study|Pregnancy|1|||
156736884|NCT01084668|565782926|FG000|Overall Study|Non-compliance|1|||
156736885|NCT00979420|565782927|FG000|Overall Study|Adverse Event|1|||
156736886|NCT00979420|565782928|FG001|Overall Study|Adverse Event|0|||
156736887|NCT00979420|565782929|FG002|Overall Study|Adverse Event|0|||
156736888|NCT00979420|565782930|FG003|Overall Study|Adverse Event|0|||
156736889|NCT00979420|565782927|FG000|Overall Study|Lack of Efficacy|3|||
156736890|NCT00979420|565782928|FG001|Overall Study|Lack of Efficacy|0|||
157142200|NCT00356915|567267898|FG000|Overall Study|Miscellaneous reasons|11|||
157142201|NCT00356915|567267899|FG001|Overall Study|Miscellaneous reasons|8|||
157142202|NCT00356915|567267900|FG002|Overall Study|Miscellaneous reasons|3|||
157142203|NCT02580058|567267902|FG000|Overall Study|Adverse Event|16|||
157142204|NCT02580058|567267903|FG001|Overall Study|Adverse Event|30|||
156736891|NCT00979420|565782929|FG002|Overall Study|Lack of Efficacy|1|||
156736892|NCT00979420|565782930|FG003|Overall Study|Lack of Efficacy|1|||
156736893|NCT00979420|565782927|FG000|Overall Study|Other reasons not related to Viramune|3|||
156736894|NCT00979420|565782928|FG001|Overall Study|Other reasons not related to Viramune|0|||
156736895|NCT00979420|565782929|FG002|Overall Study|Other reasons not related to Viramune|0|||
156736896|NCT00979420|565782930|FG003|Overall Study|Other reasons not related to Viramune|1|||
156736897|NCT01054196|565782931|FG000|Overall Study|Physician Decision|0|||
157020258|NCT02243709|566826563|FG000|Phase 1|Withdrawal by Subject|1|||
156736898|NCT01054196|565782932|FG001|Overall Study|Physician Decision|0|||
156736899|NCT01054196|565782933|FG002|Overall Study|Physician Decision|0|||
156736900|NCT01054196|565782934|FG003|Overall Study|Physician Decision|1|||
156736901|NCT01054196|565782935|FG004|Overall Study|Physician Decision|0|||
156736902|NCT01054196|565782936|FG005|Overall Study|Physician Decision|0|||
156736903|NCT01054196|565782937|FG006|Overall Study|Physician Decision|1|||
157142205|NCT02580058|567267904|FG002|Overall Study|Adverse Event|20|||
156736904|NCT01820572|565782942|FG000|Randomization|Not Treated|2|||
156736905|NCT01820572|565782943|FG001|Randomization|Not Treated|1|||
156736906|NCT01820572|565782942|FG000|Treatment Period|Adverse Event|12|||
156736907|NCT01820572|565782943|FG001|Treatment Period|Adverse Event|7|||
156736908|NCT01820572|565782942|FG000|Treatment Period|Death|3|||
156736909|NCT01820572|565782943|FG001|Treatment Period|Death|3|||
156736910|NCT01820572|565782942|FG000|Treatment Period|Lack of Efficacy|1|||
156736911|NCT01820572|565782943|FG001|Treatment Period|Lack of Efficacy|0|||
156736912|NCT01820572|565782942|FG000|Treatment Period|poor/non compliance|0|||
156736913|NCT01820572|565782943|FG001|Treatment Period|poor/non compliance|3|||
156736914|NCT01820572|565782942|FG000|Treatment Period|request to discontinue|6|||
156736915|NCT01820572|565782943|FG001|Treatment Period|request to discontinue|11|||
156736916|NCT01820572|565782942|FG000|Treatment Period|No longer meets study criteria|3|||
156736917|NCT01820572|565782943|FG001|Treatment Period|No longer meets study criteria|10|||
156736918|NCT01820572|565782942|FG000|Treatment Period|withdrew consent|1|||
156736919|NCT01820572|565782943|FG001|Treatment Period|withdrew consent|2|||
156736920|NCT00595517|565782944|FG000|Overall Study|Adverse Event|6|||
156736921|NCT00595517|565782944|FG000|Overall Study|Withdrawal by Subject|4|||
156736922|NCT00595517|565782944|FG000|Overall Study|Protocol Violation|2|||
156736923|NCT00595517|565782944|FG000|Overall Study|Recurrence of ulcer|5|||
156736924|NCT00595517|565782944|FG000|Overall Study|usage of prohibited treatment|1|||
156736925|NCT00595517|565782944|FG000|Overall Study|No intention to attend regularly|1|||
156736926|NCT01167881|565782945|FG000|Overall Study|Adverse Event|47|||
156736927|NCT01167881|565782946|FG001|Overall Study|Adverse Event|51|||
156736928|NCT01167881|565782945|FG000|Overall Study|Lack of Efficacy|4|||
156736929|NCT01167881|565782946|FG001|Overall Study|Lack of Efficacy|7|||
156736930|NCT01167881|565782945|FG000|Overall Study|Non compliant with protocol|9|||
156736931|NCT01167881|565782946|FG001|Overall Study|Non compliant with protocol|18|||
156736932|NCT01167881|565782945|FG000|Overall Study|Lost to Follow-up|19|||
156736933|NCT01167881|565782946|FG001|Overall Study|Lost to Follow-up|20|||
156736934|NCT01167881|565782945|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
156736935|NCT01167881|565782946|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
156736936|NCT01167881|565782945|FG000|Overall Study|Not treated|4|||
156736937|NCT01167881|565782946|FG001|Overall Study|Not treated|0|||
156736938|NCT01167881|565782945|FG000|Overall Study|Other not defined above|31|||
156736939|NCT01167881|565782946|FG001|Overall Study|Other not defined above|55|||
156736940|NCT00977314|565782947|FG000|Overall Study|Withdrawal by Subject|1|||
156736941|NCT00977314|565782948|FG001|Overall Study|Withdrawal by Subject|0|||
156736942|NCT00977314|565782947|FG000|Overall Study|Physician Decision|1|||
156736943|NCT00977314|565782948|FG001|Overall Study|Physician Decision|0|||
156736944|NCT02107859|565782949|FG000|Overall Study|Withdrawal by Subject|14|||
156736945|NCT02107859|565782949|FG000|Overall Study|Adverse Event|3|||
156736946|NCT02107859|565782949|FG000|Overall Study|Study closure|41|||
156736947|NCT02107859|565782949|FG000|Overall Study|Other than specified|3|||
156736948|NCT01343277|565782950|FG000|Overall Study|Other|3|||
156736949|NCT01343277|565782951|FG001|Overall Study|Other|3|||
156736950|NCT01343277|565782950|FG000|Overall Study|Withdrawal by Subject|18|||
156736951|NCT01343277|565782951|FG001|Overall Study|Withdrawal by Subject|13|||
156736952|NCT01343277|565782950|FG000|Overall Study|Physician Decision|1|||
156736953|NCT01343277|565782951|FG001|Overall Study|Physician Decision|2|||
156736954|NCT01343277|565782950|FG000|Overall Study|Death|10|||
156736955|NCT01343277|565782951|FG001|Overall Study|Death|1|||
156736956|NCT01343277|565782950|FG000|Overall Study|Adverse Event|67|||
156736957|NCT01343277|565782951|FG001|Overall Study|Adverse Event|13|||
156736958|NCT01343277|565782950|FG000|Overall Study|Disease progression|270|||
156736959|NCT01343277|565782951|FG001|Overall Study|Disease progression|138|||
156736960|NCT01343277|565782950|FG000|Overall Study|Randomized not treated|6|||
156736961|NCT01343277|565782951|FG001|Overall Study|Randomized not treated|21|||
156736962|NCT01343277|565782950|FG000|Overall Study|Treatment ongoing|8|||
156736963|NCT01343277|565782951|FG001|Overall Study|Treatment ongoing|2|||
156736964|NCT01343277|565782950|FG000|Overall Study|Subsequent anticancer therapy|1|||
156736965|NCT01343277|565782951|FG001|Overall Study|Subsequent anticancer therapy|0|||
156736966|NCT01894100|565782954|FG000|Overall Study|Lost to Follow-up|0|||
156736967|NCT01894100|565782955|FG001|Overall Study|Lost to Follow-up|1|||
156736968|NCT01894100|565782954|FG000|Overall Study|Withdrawal by Subject|3|||
156736969|NCT01894100|565782955|FG001|Overall Study|Withdrawal by Subject|0|||
156736970|NCT01094301|565782958|FG000|Trial Stage|Withdrawal by Subject|1|||
156796958|NCT01055028|566009690|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
156796959|NCT01055028|566009689|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
156796960|NCT01055028|566009690|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
156796961|NCT01055028|566009689|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
156796962|NCT01055028|566009690|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
156796963|NCT04620668|566009691|FG000|Overall Study|Withdrawal by Subject|2|||
156796964|NCT04620668|566009692|FG001|Overall Study|Withdrawal by Subject|0|||
156796965|NCT04620668|566009691|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
156796966|NCT04620668|566009692|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
157020259|NCT02243709|566826564|FG001|Phase 1|Withdrawal by Subject|0|||
156736971|NCT01094301|565782958|FG000|Implant Stage|Adverse Event|1|||
156736972|NCT01094301|565782958|FG000|Implant Stage|Protocol Violation|1|||
156736973|NCT01094301|565782958|FG000|Implant Stage|Withdrawal by Subject|2|||
156736974|NCT01094301|565782958|FG000|Implant Stage|No return of pain|4|||
156736975|NCT00135512|565782959|FG000|Overall Study|Adverse Event|56|||
156736976|NCT00135512|565782959|FG000|Overall Study|Lack of Efficacy|25|||
156736977|NCT00135512|565782959|FG000|Overall Study|Other|42|||
156736978|NCT04439214|565782963|FG000|Overall Study|Adverse Event|13|||
156736979|NCT04439214|565782963|FG000|Overall Study|Disease progression|16|||
156736980|NCT04439214|565782963|FG000|Overall Study|Death|1|||
156736981|NCT04439214|565782963|FG000|Overall Study|Withdrawal by Subject|2|||
156736982|NCT04439214|565782963|FG000|Overall Study|Declining health|1|||
156736983|NCT04439214|565782963|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
156736984|NCT04439214|565782963|FG000|Overall Study|Ineligible|5|||
156736985|NCT02235077|565782964|FG000|Overall Study|Death|5|||
156736986|NCT02235077|565782965|FG001|Overall Study|Death|7|||
156736987|NCT02235077|565782964|FG000|Overall Study|Lost to Follow-up|5|||
156736988|NCT02235077|565782965|FG001|Overall Study|Lost to Follow-up|6|||
156736989|NCT02235077|565782964|FG000|Overall Study|Withdrawal by Subject|8|||
156736990|NCT02235077|565782965|FG001|Overall Study|Withdrawal by Subject|5|||
156736991|NCT02235077|565782964|FG000|Overall Study|Physician Decision|0|||
156736992|NCT02235077|565782965|FG001|Overall Study|Physician Decision|1|||
156736993|NCT03852628|565782966|FG000|Overall Study|Lost to Follow-up|7|||
156736994|NCT03852628|565782967|FG001|Overall Study|Lost to Follow-up|6|||
156736995|NCT03852628|565782966|FG000|Overall Study|Lack of Efficacy|6|||
156736996|NCT03852628|565782967|FG001|Overall Study|Lack of Efficacy|6|||
156736997|NCT02964208|565782968|FG000|Overall Study|Death|103|||
156736998|NCT02964208|565782968|FG000|Overall Study|Withdrawal by Subject|6|||
156736999|NCT02964208|565782968|FG000|Overall Study|Lost to Follow-up|6|||
156737000|NCT02964208|565782968|FG000|Overall Study|Unsuccessful Procedure|5|||
156737001|NCT02964208|565782968|FG000|Overall Study|Device Explant|1|||
156737002|NCT02964208|565782968|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
156737003|NCT01668173|565782975|FG000|Overall Study|Adverse Event|3|||
156737004|NCT01668173|565782975|FG000|Overall Study|Trial suspension|4|||
156737005|NCT01295827|565782976|FG000|Overall Study|Adverse Event|1|||
156737006|NCT01295827|565782977|FG001|Overall Study|Adverse Event|2|||
156737007|NCT01295827|565782978|FG002|Overall Study|Adverse Event|2|||
156737008|NCT01295827|565782979|FG003|Overall Study|Adverse Event|1|||
156737009|NCT01295827|565782980|FG004|Overall Study|Adverse Event|1|||
156737010|NCT01295827|565782981|FG005|Overall Study|Adverse Event|4|||
156737011|NCT01295827|565782982|FG006|Overall Study|Adverse Event|15|||
156737012|NCT01295827|565782983|FG007|Overall Study|Adverse Event|49|||
156737013|NCT01295827|565782984|FG008|Overall Study|Adverse Event|22|||
156737014|NCT01295827|565782985|FG009|Overall Study|Adverse Event|7|||
156737015|NCT01295827|565782986|FG010|Overall Study|Adverse Event|50|||
156737016|NCT01295827|565782987|FG011|Overall Study|Adverse Event|21|||
156737017|NCT01295827|565782988|FG012|Overall Study|Adverse Event|0|||
156737018|NCT01295827|565782989|FG013|Overall Study|Adverse Event|0|||
156737019|NCT01295827|565782990|FG014|Overall Study|Adverse Event|0|||
156737020|NCT01295827|565782976|FG000|Overall Study|Lost to Follow-up|0|||
156737021|NCT01295827|565782977|FG001|Overall Study|Lost to Follow-up|0|||
156737022|NCT01295827|565782978|FG002|Overall Study|Lost to Follow-up|3|||
156737023|NCT01295827|565782979|FG003|Overall Study|Lost to Follow-up|0|||
156737024|NCT01295827|565782980|FG004|Overall Study|Lost to Follow-up|1|||
156737025|NCT01295827|565782981|FG005|Overall Study|Lost to Follow-up|0|||
156737026|NCT01295827|565782982|FG006|Overall Study|Lost to Follow-up|4|||
156737027|NCT01295827|565782983|FG007|Overall Study|Lost to Follow-up|8|||
156737028|NCT01295827|565782984|FG008|Overall Study|Lost to Follow-up|7|||
156737029|NCT01295827|565782985|FG009|Overall Study|Lost to Follow-up|4|||
157218196|NCT03882047|567545603|FG001|Overall Study|Noncompliance With Protocol|0|||
157218197|NCT03882047|567545604|FG002|Overall Study|Noncompliance With Protocol|0|||
157218198|NCT03882047|567545602|FG000|Overall Study|Did Not Meet Eligibility|0|||
157218199|NCT03882047|567545603|FG001|Overall Study|Did Not Meet Eligibility|0|||
156876845|NCT03462511|566307754|FG000|Overall Study|Withdrawal by Subject|2|||
157020260|NCT02243709|566826563|FG000|Phase 1|Protocol Violation|0|||
157218200|NCT03882047|567545604|FG002|Overall Study|Did Not Meet Eligibility|1|||
157218201|NCT00723554|567545605|FG000|Overall Study|Adverse Event|12|||
157218202|NCT00723554|567545605|FG000|Overall Study|Investigator's judgement|5|||
156737030|NCT01295827|565782986|FG010|Overall Study|Lost to Follow-up|7|||
156737031|NCT01295827|565782987|FG011|Overall Study|Lost to Follow-up|3|||
156737032|NCT01295827|565782988|FG012|Overall Study|Lost to Follow-up|0|||
156737033|NCT01295827|565782989|FG013|Overall Study|Lost to Follow-up|0|||
156737034|NCT01295827|565782990|FG014|Overall Study|Lost to Follow-up|0|||
156737035|NCT01295827|565782976|FG000|Overall Study|Not Reported|0|||
156737036|NCT01295827|565782977|FG001|Overall Study|Not Reported|0|||
156737037|NCT01295827|565782978|FG002|Overall Study|Not Reported|0|||
156737038|NCT01295827|565782979|FG003|Overall Study|Not Reported|1|||
156737039|NCT01295827|565782980|FG004|Overall Study|Not Reported|0|||
156737040|NCT01295827|565782981|FG005|Overall Study|Not Reported|0|||
157218203|NCT00723554|567545605|FG000|Overall Study|Inhaled medication other than iloprost|4|||
157218204|NCT00723554|567545605|FG000|Overall Study|Withdrawal of consent|3|||
157218205|NCT00723554|567545605|FG000|Overall Study|Other|3|||
157218206|NCT00723554|567545605|FG000|Overall Study|Lost to Follow-up|1|||
157218207|NCT00723554|567545605|FG000|Overall Study|Non-compliance|1|||
157218208|NCT01894984|567545611|FG000|Overall Study|Other|314|||
157218209|NCT01894984|567545612|FG001|Overall Study|Other|175|||
157218210|NCT00602030|567545615|FG000|Lead-in Phase|Disease Progression|2|||
157218211|NCT00602030|567545616|FG001|Lead-in Phase|Disease Progression|3|||
157218212|NCT00602030|567545617|FG002|Lead-in Phase|Disease Progression|0|||
157218213|NCT00602030|567545618|FG003|Lead-in Phase|Disease Progression|0|||
157218214|NCT00602030|567545619|FG004|Lead-in Phase|Disease Progression|0|||
157218215|NCT00602030|567545615|FG000|Lead-in Phase|Adverse Event|0|||
157218216|NCT00602030|567545616|FG001|Lead-in Phase|Adverse Event|2|||
157218217|NCT00602030|567545617|FG002|Lead-in Phase|Adverse Event|0|||
157218218|NCT00602030|567545618|FG003|Lead-in Phase|Adverse Event|0|||
157218219|NCT00602030|567545619|FG004|Lead-in Phase|Adverse Event|0|||
157218220|NCT00602030|567545615|FG000|Double-blind Phase|Disease progression|0|||
156737041|NCT01295827|565782982|FG006|Overall Study|Not Reported|24|||
156737042|NCT01295827|565782983|FG007|Overall Study|Not Reported|58|||
156737043|NCT01295827|565782984|FG008|Overall Study|Not Reported|41|||
156737044|NCT01295827|565782985|FG009|Overall Study|Not Reported|2|||
156737045|NCT01295827|565782986|FG010|Overall Study|Not Reported|23|||
156737046|NCT01295827|565782987|FG011|Overall Study|Not Reported|13|||
156737047|NCT01295827|565782988|FG012|Overall Study|Not Reported|0|||
156737048|NCT01295827|565782989|FG013|Overall Study|Not Reported|0|||
156737049|NCT01295827|565782990|FG014|Overall Study|Not Reported|0|||
156737050|NCT01295827|565782976|FG000|Overall Study|Progressive Disease|2|||
156737051|NCT01295827|565782977|FG001|Overall Study|Progressive Disease|1|||
156737052|NCT01295827|565782978|FG002|Overall Study|Progressive Disease|5|||
156737053|NCT01295827|565782979|FG003|Overall Study|Progressive Disease|2|||
156737054|NCT01295827|565782980|FG004|Overall Study|Progressive Disease|0|||
156737055|NCT01295827|565782981|FG005|Overall Study|Progressive Disease|1|||
156737056|NCT01295827|565782982|FG006|Overall Study|Progressive Disease|87|||
156737057|NCT01295827|565782983|FG007|Overall Study|Progressive Disease|144|||
156737058|NCT01295827|565782984|FG008|Overall Study|Progressive Disease|85|||
156737059|NCT01295827|565782985|FG009|Overall Study|Progressive Disease|40|||
156737060|NCT01295827|565782986|FG010|Overall Study|Progressive Disease|175|||
156737061|NCT01295827|565782987|FG011|Overall Study|Progressive Disease|136|||
156737062|NCT01295827|565782988|FG012|Overall Study|Progressive Disease|0|||
156737063|NCT01295827|565782989|FG013|Overall Study|Progressive Disease|0|||
156737064|NCT01295827|565782990|FG014|Overall Study|Progressive Disease|0|||
156737065|NCT01295827|565782976|FG000|Overall Study|Screen Failure|0|||
156737066|NCT01295827|565782977|FG001|Overall Study|Screen Failure|0|||
156737067|NCT01295827|565782978|FG002|Overall Study|Screen Failure|0|||
156737068|NCT01295827|565782979|FG003|Overall Study|Screen Failure|0|||
156737069|NCT01295827|565782980|FG004|Overall Study|Screen Failure|0|||
156737070|NCT01295827|565782981|FG005|Overall Study|Screen Failure|0|||
156737071|NCT01295827|565782982|FG006|Overall Study|Screen Failure|2|||
156737072|NCT01295827|565782983|FG007|Overall Study|Screen Failure|2|||
156737073|NCT01295827|565782984|FG008|Overall Study|Screen Failure|2|||
156737074|NCT01295827|565782985|FG009|Overall Study|Screen Failure|0|||
156737075|NCT01295827|565782986|FG010|Overall Study|Screen Failure|1|||
156737076|NCT01295827|565782987|FG011|Overall Study|Screen Failure|0|||
156737077|NCT01295827|565782988|FG012|Overall Study|Screen Failure|0|||
156737078|NCT01295827|565782989|FG013|Overall Study|Screen Failure|0|||
156737079|NCT01295827|565782990|FG014|Overall Study|Screen Failure|0|||
156796967|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: missing data|2|||
156796968|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: missing data|0|||
156796969|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
156796970|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
157218221|NCT00602030|567545616|FG001|Double-blind Phase|Disease progression|0|||
156737080|NCT01295827|565782976|FG000|Overall Study|Withdrawal by Subject|1|||
156796971|NCT04620668|566009691|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
156796972|NCT04620668|566009692|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
156737081|NCT01295827|565782977|FG001|Overall Study|Withdrawal by Subject|0|||
156737082|NCT01295827|565782978|FG002|Overall Study|Withdrawal by Subject|2|||
157020261|NCT02243709|566826564|FG001|Phase 1|Protocol Violation|1|||
156737083|NCT01295827|565782979|FG003|Overall Study|Withdrawal by Subject|0|||
156737084|NCT01295827|565782980|FG004|Overall Study|Withdrawal by Subject|0|||
156796973|NCT03559530|566009693|FG000|Overall Study|non-location of medical records|44|||
157218222|NCT00602030|567545617|FG002|Double-blind Phase|Disease progression|33|||
157218223|NCT00602030|567545618|FG003|Double-blind Phase|Disease progression|30|||
157218224|NCT00602030|567545619|FG004|Double-blind Phase|Disease progression|0|||
157218225|NCT00602030|567545615|FG000|Double-blind Phase|Adverse Event|0|||
156737085|NCT01295827|565782981|FG005|Overall Study|Withdrawal by Subject|1|||
156737086|NCT01295827|565782982|FG006|Overall Study|Withdrawal by Subject|13|||
157218226|NCT00602030|567545616|FG001|Double-blind Phase|Adverse Event|0|||
156737087|NCT01295827|565782983|FG007|Overall Study|Withdrawal by Subject|35|||
156737088|NCT01295827|565782984|FG008|Overall Study|Withdrawal by Subject|11|||
156737089|NCT01295827|565782985|FG009|Overall Study|Withdrawal by Subject|2|||
156737090|NCT01295827|565782986|FG010|Overall Study|Withdrawal by Subject|18|||
156737091|NCT01295827|565782987|FG011|Overall Study|Withdrawal by Subject|13|||
156737092|NCT01295827|565782988|FG012|Overall Study|Withdrawal by Subject|0|||
156737093|NCT01295827|565782989|FG013|Overall Study|Withdrawal by Subject|0|||
156737094|NCT01295827|565782990|FG014|Overall Study|Withdrawal by Subject|0|||
156737095|NCT01295827|565782976|FG000|Overall Study|Other|0|||
156737096|NCT01295827|565782977|FG001|Overall Study|Other|0|||
156737097|NCT01295827|565782978|FG002|Overall Study|Other|0|||
156737098|NCT01295827|565782979|FG003|Overall Study|Other|0|||
156737099|NCT01295827|565782980|FG004|Overall Study|Other|0|||
156737100|NCT01295827|565782981|FG005|Overall Study|Other|0|||
156737101|NCT01295827|565782982|FG006|Overall Study|Other|1|||
156737102|NCT01295827|565782983|FG007|Overall Study|Other|1|||
156737103|NCT01295827|565782984|FG008|Overall Study|Other|1|||
156737104|NCT01295827|565782985|FG009|Overall Study|Other|0|||
156737105|NCT01295827|565782986|FG010|Overall Study|Other|2|||
156737106|NCT01295827|565782987|FG011|Overall Study|Other|0|||
156737107|NCT01295827|565782988|FG012|Overall Study|Other|0|||
156737108|NCT01295827|565782989|FG013|Overall Study|Other|0|||
156737109|NCT01295827|565782990|FG014|Overall Study|Other|0|||
156737110|NCT00101166|565782991|FG000|Overall Study|progressive disease|10|||
156737111|NCT01868022|565782992|FG000|Overall Study|Withdrawal by Subject|0|||
156737112|NCT01868022|565782993|FG001|Overall Study|Withdrawal by Subject|0|||
156737113|NCT01868022|565782994|FG002|Overall Study|Withdrawal by Subject|1|||
156737114|NCT01868022|565782995|FG003|Overall Study|Withdrawal by Subject|1|||
156737115|NCT01868022|565782996|FG004|Overall Study|Withdrawal by Subject|0|||
156737116|NCT01868022|565782997|FG005|Overall Study|Withdrawal by Subject|0|||
156737117|NCT01868022|565782998|FG006|Overall Study|Withdrawal by Subject|0|||
156737118|NCT01868022|565782999|FG007|Overall Study|Withdrawal by Subject|1|||
156737119|NCT01868022|565783000|FG008|Overall Study|Withdrawal by Subject|0|||
156737120|NCT01868022|565782992|FG000|Overall Study|Adverse Event|0|||
156737121|NCT01868022|565782993|FG001|Overall Study|Adverse Event|0|||
156737122|NCT01868022|565782994|FG002|Overall Study|Adverse Event|0|||
156737123|NCT01868022|565782995|FG003|Overall Study|Adverse Event|0|||
156737124|NCT01868022|565782996|FG004|Overall Study|Adverse Event|2|||
156737125|NCT01868022|565782997|FG005|Overall Study|Adverse Event|0|||
156737126|NCT01868022|565782998|FG006|Overall Study|Adverse Event|0|||
156737127|NCT01868022|565782999|FG007|Overall Study|Adverse Event|2|||
156737128|NCT01868022|565783000|FG008|Overall Study|Adverse Event|2|||
156737129|NCT01868022|565782992|FG000|Overall Study|Physician Decision|0|||
156737130|NCT01868022|565782993|FG001|Overall Study|Physician Decision|0|||
156737131|NCT01868022|565782994|FG002|Overall Study|Physician Decision|0|||
156737132|NCT01868022|565782995|FG003|Overall Study|Physician Decision|0|||
156737133|NCT01868022|565782996|FG004|Overall Study|Physician Decision|0|||
156737134|NCT01868022|565782997|FG005|Overall Study|Physician Decision|1|||
156737135|NCT01868022|565782998|FG006|Overall Study|Physician Decision|0|||
156737136|NCT01868022|565782999|FG007|Overall Study|Physician Decision|2|||
156737137|NCT01868022|565783000|FG008|Overall Study|Physician Decision|0|||
156737138|NCT01868022|565782992|FG000|Overall Study|Study closed/terminated|0|||
156737139|NCT01868022|565782993|FG001|Overall Study|Study closed/terminated|0|||
156737140|NCT01868022|565782994|FG002|Overall Study|Study closed/terminated|0|||
156737141|NCT01868022|565782995|FG003|Overall Study|Study closed/terminated|0|||
156737142|NCT01868022|565782996|FG004|Overall Study|Study closed/terminated|0|||
156737143|NCT01868022|565782997|FG005|Overall Study|Study closed/terminated|0|||
156737144|NCT01868022|565782998|FG006|Overall Study|Study closed/terminated|0|||
156737145|NCT01868022|565782999|FG007|Overall Study|Study closed/terminated|1|||
156737146|NCT01868022|565783000|FG008|Overall Study|Study closed/terminated|0|||
156737147|NCT01868022|565782992|FG000|Overall Study|Ongoing|0|||
156737148|NCT01868022|565782993|FG001|Overall Study|Ongoing|0|||
156737149|NCT01868022|565782994|FG002|Overall Study|Ongoing|0|||
156737150|NCT01868022|565782995|FG003|Overall Study|Ongoing|0|||
156737151|NCT01868022|565782996|FG004|Overall Study|Ongoing|0|||
156737152|NCT01868022|565782997|FG005|Overall Study|Ongoing|0|||
156737153|NCT01868022|565782998|FG006|Overall Study|Ongoing|0|||
156737154|NCT01868022|565782999|FG007|Overall Study|Ongoing|3|||
156737155|NCT01868022|565783000|FG008|Overall Study|Ongoing|0|||
156737156|NCT00746564|565783001|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
157020262|NCT02243709|566826563|FG000|Phase 1|Adverse Event|0|||
157020263|NCT02243709|566826564|FG001|Phase 1|Adverse Event|1|||
156737157|NCT00022698|565783002|FG000|Overall Study|Adverse Event|5|||
156737158|NCT00022698|565783003|FG001|Overall Study|Adverse Event|9|||
156737159|NCT00022698|565783002|FG000|Overall Study|Death|0|||
156737160|NCT00022698|565783003|FG001|Overall Study|Death|2|||
157020264|NCT01748448|566826565|FG000|Treatment Period|Consent withdrawn by subject|1|||
157020265|NCT01748448|566826566|FG001|Treatment Period|Consent withdrawn by subject|0|||
156737161|NCT00022698|565783002|FG000|Overall Study|Failure to return|0|||
156737162|NCT00022698|565783003|FG001|Overall Study|Failure to return|1|||
156737163|NCT00022698|565783002|FG000|Overall Study|Refused treatment|0|||
156737164|NCT00022698|565783003|FG001|Overall Study|Refused treatment|2|||
156737165|NCT00022698|565783002|FG000|Overall Study|Insufficient therapeutic response|2|||
156737166|NCT00022698|565783003|FG001|Overall Study|Insufficient therapeutic response|14|||
156737167|NCT00022698|565783002|FG000|Overall Study|Administrative /other|1|||
156737168|NCT00022698|565783003|FG001|Overall Study|Administrative /other|7|||
157020266|NCT01748448|566826565|FG000|Treatment Period|Adverse Event|1|||
157020267|NCT01748448|566826566|FG001|Treatment Period|Adverse Event|0|||
157020268|NCT01748448|566826565|FG000|Treatment Period|Personal|0|||
157020269|NCT01748448|566826566|FG001|Treatment Period|Personal|1|||
157020270|NCT02907099|566826567|FG000|Overall Study|Adverse Event|1|||
157020271|NCT02907099|566826567|FG000|Overall Study|Withdrawal by Subject|2|||
157020272|NCT02907099|566826567|FG000|Overall Study|Screen Fail|2|||
157142206|NCT02580058|567267902|FG000|Overall Study|Death|4|||
157142207|NCT02580058|567267903|FG001|Overall Study|Death|4|||
157142208|NCT02580058|567267904|FG002|Overall Study|Death|5|||
157142209|NCT02580058|567267902|FG000|Overall Study|Physician Decision|1|||
156737169|NCT01217476|565783008|FG000|Overall Study|Adverse Event|6|||
156737170|NCT01217476|565783009|FG001|Overall Study|Adverse Event|1|||
156737171|NCT01217476|565783008|FG000|Overall Study|Physician Decision|0|||
156737172|NCT01217476|565783009|FG001|Overall Study|Physician Decision|1|||
156737173|NCT01217476|565783008|FG000|Overall Study|Withdrawal by Subject|3|||
156737174|NCT01217476|565783009|FG001|Overall Study|Withdrawal by Subject|3|||
156737175|NCT01217476|565783008|FG000|Overall Study|Surgery on the Target Limb|0|||
156737176|NCT01217476|565783009|FG001|Overall Study|Surgery on the Target Limb|2|||
156737177|NCT01217476|565783008|FG000|Overall Study|Protocol Deviation|1|||
156737178|NCT01217476|565783009|FG001|Overall Study|Protocol Deviation|0|||
156737179|NCT01217476|565783008|FG000|Overall Study|Other|2|||
156737180|NCT01217476|565783009|FG001|Overall Study|Other|0|||
156737181|NCT03033602|565783010|FG000|Overall Study|Withdrawal by Subject|11|||
156737182|NCT03033602|565783011|FG001|Overall Study|Withdrawal by Subject|21|||
156737183|NCT03033602|565783010|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
156737184|NCT03033602|565783011|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
156737185|NCT01441765|565783012|FG000|Overall Study|Death|1|||
156737186|NCT01441765|565783013|FG001|Overall Study|Death|0|||
156737187|NCT01493284|565783018|FG000|Overall Study|Death|29|||
156737188|NCT01493284|565783018|FG000|Overall Study|Withdrawal by Subject|32|||
156737189|NCT03489707|565783019|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
156737190|NCT03489707|565783020|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
156737191|NCT03489707|565783019|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
156737192|NCT03489707|565783020|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
156737193|NCT00325156|565783021|FG000|Overall Study|Protocol Violation|8|||
156737194|NCT00325156|565783021|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
156876846|NCT03462511|566307755|FG001|Overall Study|Withdrawal by Subject|3|||
157142210|NCT02580058|567267903|FG001|Overall Study|Physician Decision|3|||
157142211|NCT02580058|567267904|FG002|Overall Study|Physician Decision|11|||
157142212|NCT02580058|567267902|FG000|Overall Study|Other|5|||
157142213|NCT02580058|567267903|FG001|Overall Study|Other|1|||
156737195|NCT00325156|565783021|FG000|Overall Study|Migrated/moved from study area|12|||
156737196|NCT00325156|565783021|FG000|Overall Study|Adverse event, non-fatal|3|||
156737197|NCT00325156|565783021|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
156737198|NCT00325156|565783021|FG000|Overall Study|Other|1|||
156737199|NCT00325156|565783021|FG000|Overall Study|Withdrawal by Subject|31|||
156876847|NCT02925416|566307756|FG000|Overall Study|Adverse Event|2|||
156876848|NCT02925416|566307757|FG001|Overall Study|Adverse Event|0|||
156876849|NCT02625909|566307758|FG000|Overall Study|Death|2|||
156876850|NCT02625909|566307759|FG001|Overall Study|Death|0|||
156876851|NCT02625909|566307758|FG000|Overall Study|Lost to Follow-up|3|||
156876852|NCT02625909|566307759|FG001|Overall Study|Lost to Follow-up|5|||
156876853|NCT02625909|566307758|FG000|Overall Study|Lack of Efficacy|9|||
156876854|NCT02625909|566307759|FG001|Overall Study|Lack of Efficacy|2|||
157142214|NCT02580058|567267904|FG002|Overall Study|Other|3|||
157142215|NCT02580058|567267902|FG000|Overall Study|Withdrawal by Subject|4|||
157142216|NCT02580058|567267903|FG001|Overall Study|Withdrawal by Subject|7|||
156876855|NCT02625909|566307758|FG000|Overall Study|Reinfection|3|||
157142217|NCT02580058|567267904|FG002|Overall Study|Withdrawal by Subject|31|||
157142218|NCT02580058|567267902|FG000|Overall Study|Global Deterioration of Health Status|19|||
156737200|NCT01082211|565783025|FG000|Overall Study|Protocol Violation|4|||
156737201|NCT01082211|565783025|FG000|Overall Study|No protocol treatment received|3|||
156737202|NCT03725761|565783026|FG000|Overall Study|still on study|1|||
156876856|NCT02625909|566307759|FG001|Overall Study|Reinfection|2|||
157020273|NCT03110315|566826568|FG000|Overall Study|Withdrawal by Subject|1|||
157020274|NCT03110315|566826569|FG001|Overall Study|Withdrawal by Subject|0|||
157020275|NCT02187003|566828375|FG000|Overall Study|Adverse Event|2|||
157020276|NCT02187003|566828376|FG001|Overall Study|Adverse Event|0|||
157142219|NCT02580058|567267903|FG001|Overall Study|Global Deterioration of Health Status|18|||
157142220|NCT02580058|567267904|FG002|Overall Study|Global Deterioration of Health Status|24|||
156737203|NCT05903924|565784777|FG000|Overall Study|Lost to Follow-up|1|||
156737204|NCT05903924|565784778|FG001|Overall Study|Lost to Follow-up|0|||
156737205|NCT05903924|565784779|FG002|Overall Study|Lost to Follow-up|0|||
156737206|NCT00174967|565784780|FG000|Overall Study|Adverse Event|1|||
156737207|NCT00174967|565784781|FG001|Overall Study|Adverse Event|2|||
156737208|NCT00174967|565784782|FG002|Overall Study|Adverse Event|2|||
156737209|NCT00174967|565784783|FG003|Overall Study|Adverse Event|1|||
156737210|NCT00174967|565784780|FG000|Overall Study|Gout Flare|0|||
156737211|NCT00174967|565784781|FG001|Overall Study|Gout Flare|0|||
156737212|NCT00174967|565784782|FG002|Overall Study|Gout Flare|0|||
156737213|NCT00174967|565784783|FG003|Overall Study|Gout Flare|1|||
156737214|NCT00174967|565784780|FG000|Overall Study|Other|0|||
156737215|NCT00174967|565784781|FG001|Overall Study|Other|1|||
156737216|NCT00174967|565784782|FG002|Overall Study|Other|0|||
156737217|NCT00174967|565784783|FG003|Overall Study|Other|0|||
156737218|NCT03030989|565784784|FG000|Overall Study|Fever|2|||
156737219|NCT03030989|565784785|FG001|Overall Study|Fever|2|||
156737220|NCT03030989|565784784|FG000|Overall Study|Rash|2|||
156737221|NCT03030989|565784785|FG001|Overall Study|Rash|1|||
156737222|NCT03030989|565784784|FG000|Overall Study|Fatigue/Overwhelmed|1|||
156876857|NCT02367833|566307760|FG000|Overall Study|Withdrawal by Subject|1|||
156737223|NCT03030989|565784785|FG001|Overall Study|Fatigue/Overwhelmed|5|||
156737224|NCT03030989|565784784|FG000|Overall Study|Positive Blood Cultures|2|||
156876858|NCT02367833|566307761|FG001|Overall Study|Withdrawal by Subject|1|||
156876859|NCT02367833|566307762|FG002|Overall Study|Withdrawal by Subject|0|||
156876860|NCT02167139|566307763|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
156876861|NCT02167139|566307764|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
156876862|NCT02167139|566307765|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
156876863|NCT02167139|566307766|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
156876864|NCT02167139|566307763|FG000|Randomised, Double-blind|Adverse Event|2|||
156876865|NCT02167139|566307764|FG001|Randomised, Double-blind|Adverse Event|9|||
156876866|NCT02167139|566307765|FG002|Randomised, Double-blind|Adverse Event|0|||
156876867|NCT02167139|566307766|FG003|Randomised, Double-blind|Adverse Event|0|||
156876868|NCT02167139|566307763|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
156876869|NCT02167139|566307764|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
156876870|NCT02167139|566307765|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
156876871|NCT02167139|566307766|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
156876872|NCT02167139|566307763|FG000|Randomised, Double-blind|Other|3|||
156876873|NCT02167139|566307764|FG001|Randomised, Double-blind|Other|0|||
156876874|NCT02167139|566307765|FG002|Randomised, Double-blind|Other|0|||
156876875|NCT02167139|566307766|FG003|Randomised, Double-blind|Other|0|||
156876876|NCT02167139|566307763|FG000|Transition-extension|Adverse Event|2|||
156876877|NCT02167139|566307764|FG001|Transition-extension|Adverse Event|0|||
156876878|NCT02167139|566307765|FG002|Transition-extension|Adverse Event|2|||
156876879|NCT02167139|566307766|FG003|Transition-extension|Adverse Event|3|||
156876880|NCT02167139|566307763|FG000|Transition-extension|Withdrawal by Subject|2|||
156876881|NCT02167139|566307764|FG001|Transition-extension|Withdrawal by Subject|0|||
156876882|NCT02167139|566307765|FG002|Transition-extension|Withdrawal by Subject|4|||
156876883|NCT02167139|566307766|FG003|Transition-extension|Withdrawal by Subject|1|||
156876884|NCT02167139|566307763|FG000|Transition-extension|Lack of Efficacy|0|||
156876885|NCT02167139|566307764|FG001|Transition-extension|Lack of Efficacy|0|||
156876886|NCT02167139|566307765|FG002|Transition-extension|Lack of Efficacy|1|||
156876887|NCT02167139|566307766|FG003|Transition-extension|Lack of Efficacy|1|||
156876888|NCT02167139|566307763|FG000|Transition-extension|Other|1|||
156876889|NCT02167139|566307764|FG001|Transition-extension|Other|0|||
156876890|NCT02167139|566307765|FG002|Transition-extension|Other|1|||
156737225|NCT03030989|565784785|FG001|Overall Study|Positive Blood Cultures|1|||
156737226|NCT03030989|565784784|FG000|Overall Study|Line Removed|0|||
156737227|NCT03030989|565784785|FG001|Overall Study|Line Removed|2|||
156737228|NCT03030989|565784784|FG000|Overall Study|No longer interested|5|||
156737229|NCT03030989|565784785|FG001|Overall Study|No longer interested|3|||
156876891|NCT02167139|566307766|FG003|Transition-extension|Other|0|||
157218227|NCT00602030|567545617|FG002|Double-blind Phase|Adverse Event|9|||
156737230|NCT02730377|565784786|FG000|Overall Study|Other|5|||
156737231|NCT02730377|565784787|FG001|Overall Study|Other|4|||
156737232|NCT02730377|565784786|FG000|Overall Study|Death|1|||
156737233|NCT02730377|565784787|FG001|Overall Study|Death|8|||
156876892|NCT02167139|566307763|FG000|Transition-extension|Lost to Follow-up|1|||
156876893|NCT02167139|566307764|FG001|Transition-extension|Lost to Follow-up|0|||
156876894|NCT02167139|566307765|FG002|Transition-extension|Lost to Follow-up|0|||
156876895|NCT02167139|566307766|FG003|Transition-extension|Lost to Follow-up|0|||
156876896|NCT00996333|566307767|FG000|Overall Study|Screen failure|1|||
156876897|NCT00996333|566307767|FG000|Overall Study|Withdrawal by Subject|1|||
156876898|NCT00996333|566307767|FG000|Overall Study|Death|4|||
156876899|NCT00996333|566307767|FG000|Overall Study|Adverse Event|1|||
156737234|NCT02730377|565784786|FG000|Overall Study|Inadequate glycaemic control|368|||
156876900|NCT00996333|566307767|FG000|Overall Study|Physician Decision|1|||
156737235|NCT02730377|565784787|FG001|Overall Study|Inadequate glycaemic control|473|||
156737236|NCT02730377|565784786|FG000|Overall Study|Adverse Event|79|||
157020277|NCT02187003|566828375|FG000|Overall Study|Lost to Follow-up|14|||
157020278|NCT02187003|566828376|FG001|Overall Study|Lost to Follow-up|10|||
157020279|NCT02187003|566828375|FG000|Overall Study|Withdrawal by Subject|3|||
157020280|NCT02187003|566828376|FG001|Overall Study|Withdrawal by Subject|7|||
157020281|NCT02187003|566828375|FG000|Overall Study|Protocol Violation|2|||
157020282|NCT02187003|566828376|FG001|Overall Study|Protocol Violation|4|||
157020283|NCT02187003|566828375|FG000|Overall Study|Other|5|||
157020284|NCT02187003|566828376|FG001|Overall Study|Other|5|||
157020285|NCT02187003|566828375|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157020286|NCT02187003|566828376|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
157218228|NCT00602030|567545618|FG003|Double-blind Phase|Adverse Event|18|||
156737237|NCT02730377|565784787|FG001|Overall Study|Adverse Event|41|||
157020287|NCT05816551|566828377|FG000|Overall Study|Withdrawal by Subject|0|||
157020288|NCT05816551|566828378|FG001|Overall Study|Withdrawal by Subject|1|||
157020289|NCT05816551|566828377|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
157020290|NCT05816551|566828378|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
157020291|NCT04593472|566828381|FG000|Overall Study|Death|31|||
157218229|NCT00602030|567545619|FG004|Double-blind Phase|Adverse Event|0|||
157218230|NCT00602030|567545615|FG000|Double-blind Phase|Consent withdrawal|0|||
157218231|NCT00602030|567545616|FG001|Double-blind Phase|Consent withdrawal|0|||
157218232|NCT00602030|567545617|FG002|Double-blind Phase|Consent withdrawal|4|||
156737238|NCT02730377|565784786|FG000|Overall Study|Protocol Violation|23|||
156737239|NCT02730377|565784787|FG001|Overall Study|Protocol Violation|30|||
156737240|NCT02730377|565784786|FG000|Overall Study|Lack of Efficacy|4|||
156737241|NCT02730377|565784787|FG001|Overall Study|Lack of Efficacy|13|||
156737242|NCT02730377|565784786|FG000|Overall Study|Pregnancy|0|||
156737243|NCT02730377|565784787|FG001|Overall Study|Pregnancy|1|||
156737244|NCT02730377|565784786|FG000|Overall Study|Withdrawal by Subject|45|||
156737245|NCT02730377|565784787|FG001|Overall Study|Withdrawal by Subject|42|||
156737246|NCT02730377|565784786|FG000|Overall Study|Lost to Follow-up|25|||
156737247|NCT02730377|565784787|FG001|Overall Study|Lost to Follow-up|21|||
156737248|NCT02706886|565784788|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
156737249|NCT02706886|565784789|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
156737250|NCT02706886|565784790|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
156737251|NCT02706886|565784791|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
156737252|NCT02706886|565784792|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
156737253|NCT02706886|565784793|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
156737254|NCT02706886|565784794|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
156737255|NCT02706886|565784795|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
156737256|NCT02706886|565784796|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
156737257|NCT03917472|565784797|FG000|Overall Study|Physician Decision|4|||
156737258|NCT03917472|565784798|FG001|Overall Study|Physician Decision|0|||
156737259|NCT03917472|565784797|FG000|Overall Study|Adverse Event|3|||
156737260|NCT03917472|565784798|FG001|Overall Study|Adverse Event|1|||
156737261|NCT03917472|565784797|FG000|Overall Study|Death|7|||
156737262|NCT03917472|565784798|FG001|Overall Study|Death|5|||
156737263|NCT03917472|565784797|FG000|Overall Study|Withdrawal by Subject|11|||
156737264|NCT03917472|565784798|FG001|Overall Study|Withdrawal by Subject|4|||
156737265|NCT03917472|565784797|FG000|Overall Study|Lost to Follow-up|10|||
156737266|NCT03917472|565784798|FG001|Overall Study|Lost to Follow-up|5|||
156737267|NCT01154296|565784799|FG000|Randomization and Intervention|Decided to decline|1|||
156737268|NCT01154296|565784800|FG001|Randomization and Intervention|Decided to decline|1|||
156737269|NCT01154296|565784799|FG000|Randomization and Intervention|Declined by staff|1|||
156737270|NCT01154296|565784800|FG001|Randomization and Intervention|Declined by staff|0|||
156737271|NCT01154296|565784799|FG000|Randomization and Intervention|Did not return|1|||
156737272|NCT01154296|565784800|FG001|Randomization and Intervention|Did not return|0|||
156737273|NCT01154296|565784799|FG000|Randomization and Intervention|Left before test|0|||
156737274|NCT01154296|565784800|FG001|Randomization and Intervention|Left before test|1|||
156737275|NCT01154296|565784799|FG000|Randomization and Intervention|Left clinic early|2|||
156737276|NCT01154296|565784800|FG001|Randomization and Intervention|Left clinic early|0|||
156737277|NCT01154296|565784799|FG000|6-month Follow-up|Lost contact|269|||
157218233|NCT00602030|567545618|FG003|Double-blind Phase|Consent withdrawal|3|||
157218234|NCT00602030|567545619|FG004|Double-blind Phase|Consent withdrawal|0|||
157218235|NCT00602030|567545615|FG000|Double-blind Phase|Death|0|||
156737278|NCT01154296|565784800|FG001|6-month Follow-up|Lost contact|275|||
156737279|NCT01154296|565784799|FG000|6-month Follow-up|Incarcerated|37|||
156737280|NCT01154296|565784800|FG001|6-month Follow-up|Incarcerated|32|||
156737281|NCT01154296|565784799|FG000|6-month Follow-up|Withdrew consent|14|||
156737282|NCT01154296|565784800|FG001|6-month Follow-up|Withdrew consent|15|||
156737283|NCT01154296|565784799|FG000|6-month Follow-up|Death|3|||
156737284|NCT01154296|565784800|FG001|6-month Follow-up|Death|2|||
157218236|NCT00602030|567545616|FG001|Double-blind Phase|Death|0|||
157020292|NCT04593472|566828382|FG001|Overall Study|Death|27|||
157020293|NCT04593472|566828381|FG000|Overall Study|Withdrawal by Subject|12|||
157020294|NCT04593472|566828382|FG001|Overall Study|Withdrawal by Subject|12|||
157020295|NCT04593472|566828381|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
157020296|NCT04593472|566828382|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
157020297|NCT04593472|566828381|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
157020298|NCT04593472|566828382|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
157020299|NCT04593472|566828381|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
157020300|NCT04593472|566828382|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
157020301|NCT04593472|566828381|FG000|Overall Study|Lost to Follow-up|0|||
157020302|NCT04593472|566828382|FG001|Overall Study|Lost to Follow-up|2|||
157020303|NCT04593472|566828381|FG000|Overall Study|Still collecting 24-month assessment|17|||
157020304|NCT04593472|566828382|FG001|Overall Study|Still collecting 24-month assessment|10|||
157020305|NCT03648840|566828384|FG000|First IV Infusion Session|Adverse Event|0|||
157020306|NCT03648840|566828385|FG001|First IV Infusion Session|Adverse Event|2|||
157020307|NCT03648840|566828384|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
157020308|NCT03648840|566828385|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
157020309|NCT03648840|566828384|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
157020310|NCT03648840|566828385|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
157020311|NCT03648840|566828384|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
157020312|NCT03648840|566828385|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
157020313|NCT05382936|566828387|FG000|Overall Study|Progressive Disease|3|||
157020314|NCT05382936|566828388|FG001|Overall Study|Progressive Disease|5|||
157020315|NCT05382936|566828389|FG002|Overall Study|Progressive Disease|2|||
157020316|NCT05382936|566828390|FG003|Overall Study|Progressive Disease|5|||
157020317|NCT05382936|566828387|FG000|Overall Study|Adverse Event|0|||
157020318|NCT05382936|566828388|FG001|Overall Study|Adverse Event|1|||
157020319|NCT05382936|566828389|FG002|Overall Study|Adverse Event|1|||
157020320|NCT05382936|566828390|FG003|Overall Study|Adverse Event|0|||
157020321|NCT05382936|566828387|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
157020322|NCT05382936|566828388|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
157020323|NCT05382936|566828389|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
156737285|NCT01154296|565784799|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
156737286|NCT01154296|565784800|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
156737287|NCT02203851|565784801|FG000|Overall Study|Lost to Follow-up|4|||
156737288|NCT02203851|565784801|FG000|Overall Study|Withdrawal by Subject|6|||
156737289|NCT02203851|565784801|FG000|Overall Study|Other|1|||
156737290|NCT04934189|565784802|FG000|Overall Study|Lost to Follow-up|4|||
156737291|NCT04934189|565784802|FG000|Overall Study|Withdrawal by Subject|17|||
156737292|NCT03320850|565784805|FG000|Overall Study|Lost to Follow-up|0|||
156737293|NCT03320850|565784806|FG001|Overall Study|Lost to Follow-up|0|||
156737294|NCT03320850|565784807|FG002|Overall Study|Lost to Follow-up|0|||
156737295|NCT03320850|565784808|FG003|Overall Study|Lost to Follow-up|0|||
156737296|NCT03320850|565784809|FG004|Overall Study|Lost to Follow-up|1|||
156737297|NCT03320850|565784810|FG005|Overall Study|Lost to Follow-up|2|||
156737298|NCT03320850|565784811|FG006|Overall Study|Lost to Follow-up|2|||
156737299|NCT03320850|565784812|FG007|Overall Study|Lost to Follow-up|0|||
156737300|NCT03320850|565784813|FG008|Overall Study|Lost to Follow-up|6|||
156737301|NCT03320850|565784814|FG009|Overall Study|Lost to Follow-up|4|||
156737302|NCT03320850|565784805|FG000|Overall Study|Withdrawal by Subject|0|||
156737303|NCT03320850|565784806|FG001|Overall Study|Withdrawal by Subject|0|||
156737304|NCT03320850|565784807|FG002|Overall Study|Withdrawal by Subject|0|||
156737305|NCT03320850|565784808|FG003|Overall Study|Withdrawal by Subject|0|||
156737306|NCT03320850|565784809|FG004|Overall Study|Withdrawal by Subject|1|||
156737307|NCT03320850|565784810|FG005|Overall Study|Withdrawal by Subject|2|||
156737308|NCT03320850|565784811|FG006|Overall Study|Withdrawal by Subject|4|||
156737309|NCT03320850|565784812|FG007|Overall Study|Withdrawal by Subject|5|||
156737310|NCT03320850|565784813|FG008|Overall Study|Withdrawal by Subject|2|||
156737311|NCT03320850|565784814|FG009|Overall Study|Withdrawal by Subject|1|||
156737312|NCT03320850|565784805|FG000|Overall Study|Lack of Efficacy|0|||
156737313|NCT03320850|565784806|FG001|Overall Study|Lack of Efficacy|0|||
156737314|NCT03320850|565784807|FG002|Overall Study|Lack of Efficacy|0|||
156737315|NCT03320850|565784808|FG003|Overall Study|Lack of Efficacy|1|||
156737316|NCT03320850|565784809|FG004|Overall Study|Lack of Efficacy|0|||
156737317|NCT03320850|565784810|FG005|Overall Study|Lack of Efficacy|1|||
156737318|NCT03320850|565784811|FG006|Overall Study|Lack of Efficacy|0|||
156737319|NCT03320850|565784812|FG007|Overall Study|Lack of Efficacy|2|||
157020324|NCT05382936|566828390|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
156737320|NCT03320850|565784813|FG008|Overall Study|Lack of Efficacy|0|||
156737321|NCT03320850|565784814|FG009|Overall Study|Lack of Efficacy|3|||
156737322|NCT03320850|565784805|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
157020325|NCT05382936|566828387|FG000|Overall Study|Withdrawal by Subject|0|||
157020326|NCT05382936|566828388|FG001|Overall Study|Withdrawal by Subject|0|||
156737323|NCT03320850|565784806|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
156737324|NCT03320850|565784807|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
156737325|NCT03320850|565784808|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
156737326|NCT03320850|565784809|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
156737327|NCT03320850|565784810|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
156737328|NCT03320850|565784811|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
156737329|NCT03320850|565784812|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
156737330|NCT03320850|565784813|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
156737331|NCT03320850|565784814|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
156737332|NCT03320850|565784805|FG000|Overall Study|Adverse Event|0|||
156737333|NCT03320850|565784806|FG001|Overall Study|Adverse Event|0|||
156737334|NCT03320850|565784807|FG002|Overall Study|Adverse Event|0|||
156737335|NCT03320850|565784808|FG003|Overall Study|Adverse Event|0|||
156737336|NCT03320850|565784809|FG004|Overall Study|Adverse Event|0|||
156737337|NCT03320850|565784810|FG005|Overall Study|Adverse Event|2|||
156737338|NCT03320850|565784811|FG006|Overall Study|Adverse Event|1|||
156737339|NCT03320850|565784812|FG007|Overall Study|Adverse Event|0|||
156737340|NCT03320850|565784813|FG008|Overall Study|Adverse Event|2|||
156737341|NCT03320850|565784814|FG009|Overall Study|Adverse Event|0|||
156737342|NCT03320850|565784805|FG000|Overall Study|Reason Not Specified|0|||
156737343|NCT03320850|565784806|FG001|Overall Study|Reason Not Specified|0|||
156737344|NCT03320850|565784807|FG002|Overall Study|Reason Not Specified|0|||
157218237|NCT00602030|567545617|FG002|Double-blind Phase|Death|3|||
157218238|NCT00602030|567545618|FG003|Double-blind Phase|Death|3|||
157218239|NCT00602030|567545619|FG004|Double-blind Phase|Death|0|||
157218240|NCT00602030|567545615|FG000|Double-blind Phase|Administrative decision|0|||
157218241|NCT00602030|567545616|FG001|Double-blind Phase|Administrative decision|0|||
157218242|NCT00602030|567545617|FG002|Double-blind Phase|Administrative decision|0|||
157218243|NCT00602030|567545618|FG003|Double-blind Phase|Administrative decision|2|||
157218244|NCT00602030|567545619|FG004|Double-blind Phase|Administrative decision|0|||
157218245|NCT00602030|567545615|FG000|Double-blind Phase|Ineligibility|0|||
157218246|NCT00602030|567545616|FG001|Double-blind Phase|Ineligibility|0|||
157218247|NCT00602030|567545617|FG002|Double-blind Phase|Ineligibility|0|||
157218248|NCT00602030|567545618|FG003|Double-blind Phase|Ineligibility|1|||
156876901|NCT00996333|566307767|FG000|Overall Study|Other|5|||
156876902|NCT02164461|566307768|FG000|Overall Study|Adverse Event|0|||
157218249|NCT00602030|567545619|FG004|Double-blind Phase|Ineligibility|0|||
156737345|NCT03320850|565784808|FG003|Overall Study|Reason Not Specified|0|||
156737346|NCT03320850|565784809|FG004|Overall Study|Reason Not Specified|0|||
156737347|NCT03320850|565784810|FG005|Overall Study|Reason Not Specified|1|||
156737348|NCT03320850|565784811|FG006|Overall Study|Reason Not Specified|0|||
156737349|NCT03320850|565784812|FG007|Overall Study|Reason Not Specified|0|||
156737350|NCT03320850|565784813|FG008|Overall Study|Reason Not Specified|0|||
156737351|NCT03320850|565784814|FG009|Overall Study|Reason Not Specified|1|||
156737352|NCT03261674|565784816|FG000|Overall Study|Lost to Follow-up|6|||
156737353|NCT03261674|565784817|FG001|Overall Study|Lost to Follow-up|7|||
156737354|NCT03261674|565784816|FG000|Overall Study|Protocol Violation|1|||
156737355|NCT03261674|565784817|FG001|Overall Study|Protocol Violation|4|||
156737356|NCT03261674|565784816|FG000|Overall Study|Withdrawal by Subject|1|||
156737357|NCT03261674|565784817|FG001|Overall Study|Withdrawal by Subject|4|||
156737358|NCT03261674|565784816|FG000|Overall Study|Physician Decision|1|||
156737359|NCT03261674|565784817|FG001|Overall Study|Physician Decision|0|||
156737360|NCT02353442|565784818|FG000|Overall Study|Withdrawal by Subject|3|||
156737361|NCT02353442|565784819|FG001|Overall Study|Withdrawal by Subject|4|||
156737362|NCT00782184|565784832|FG000|Overall Study|Adverse Event|1|||
156737363|NCT00782184|565784833|FG001|Overall Study|Adverse Event|2|||
156737364|NCT00782184|565784832|FG000|Overall Study|Protocol Violation|0|||
156737365|NCT00782184|565784833|FG001|Overall Study|Protocol Violation|1|||
156737366|NCT00782184|565784832|FG000|Overall Study|Withdrawal by Subject|3|||
156737367|NCT00782184|565784833|FG001|Overall Study|Withdrawal by Subject|2|||
156737368|NCT01438294|565784834|FG000|Overall Study|Lost to Follow-up|3|||
156737369|NCT01438294|565784835|FG001|Overall Study|Lost to Follow-up|7|||
156737370|NCT01075646|565784838|FG000|Overall Study|Lost to Follow-up|4|||
156737371|NCT01075646|565784839|FG001|Overall Study|Lost to Follow-up|3|||
156737372|NCT01075646|565784840|FG002|Overall Study|Lost to Follow-up|1|||
156737373|NCT01075646|565784841|FG003|Overall Study|Lost to Follow-up|2|||
156737374|NCT01676896|565784845|FG000|Overall Study|Withdrawal by Subject|12|||
156876903|NCT02164461|566307769|FG001|Overall Study|Adverse Event|0|||
156876904|NCT02164461|566307770|FG002|Overall Study|Adverse Event|1|||
157218250|NCT00602030|567545615|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
156737375|NCT01676896|565784846|FG001|Overall Study|Withdrawal by Subject|7|||
156737376|NCT01676896|565784847|FG002|Overall Study|Withdrawal by Subject|19|||
156737377|NCT01647516|565784848|FG000|Induction Period (IP)|Physician Decision|2|||
156737378|NCT01647516|565784849|FG001|Induction Period (IP)|Physician Decision|0|||
156737379|NCT01647516|565784850|FG002|Induction Period (IP)|Physician Decision|0|||
156737380|NCT01647516|565784851|FG003|Induction Period (IP)|Physician Decision|0|||
156737381|NCT01647516|565784852|FG004|Induction Period (IP)|Physician Decision|0|||
156876905|NCT02164461|566307768|FG000|Overall Study|Disease Progression|1|||
157218251|NCT00602030|567545616|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
157218252|NCT00602030|567545617|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
157218253|NCT00602030|567545618|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
157218254|NCT00602030|567545619|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
156737382|NCT01647516|565784853|FG005|Induction Period (IP)|Physician Decision|0|||
156737383|NCT01647516|565784848|FG000|Induction Period (IP)|Adverse Event|1|||
156737384|NCT01647516|565784849|FG001|Induction Period (IP)|Adverse Event|2|||
156737385|NCT01647516|565784850|FG002|Induction Period (IP)|Adverse Event|0|||
156737386|NCT01647516|565784851|FG003|Induction Period (IP)|Adverse Event|0|||
156737387|NCT01647516|565784852|FG004|Induction Period (IP)|Adverse Event|0|||
156737388|NCT01647516|565784853|FG005|Induction Period (IP)|Adverse Event|0|||
156737389|NCT01647516|565784848|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
156737390|NCT01647516|565784849|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
156737391|NCT01647516|565784850|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
156737392|NCT01647516|565784851|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
156737393|NCT01647516|565784852|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
156737394|NCT01647516|565784853|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
156737395|NCT01647516|565784848|FG000|Induction Period (IP)|Participant Choice|0|||
156737396|NCT01647516|565784849|FG001|Induction Period (IP)|Participant Choice|0|||
156737397|NCT01647516|565784850|FG002|Induction Period (IP)|Participant Choice|1|||
156737398|NCT01647516|565784851|FG003|Induction Period (IP)|Participant Choice|0|||
156737399|NCT01647516|565784852|FG004|Induction Period (IP)|Participant Choice|0|||
156737400|NCT01647516|565784853|FG005|Induction Period (IP)|Participant Choice|0|||
156737401|NCT01647516|565784848|FG000|Induction Period (IP)|Lack of Efficacy|1|||
156737402|NCT01647516|565784849|FG001|Induction Period (IP)|Lack of Efficacy|0|||
156737403|NCT01647516|565784850|FG002|Induction Period (IP)|Lack of Efficacy|0|||
156737404|NCT01647516|565784851|FG003|Induction Period (IP)|Lack of Efficacy|0|||
156737405|NCT01647516|565784852|FG004|Induction Period (IP)|Lack of Efficacy|0|||
156737406|NCT01647516|565784853|FG005|Induction Period (IP)|Lack of Efficacy|0|||
156737407|NCT01647516|565784848|FG000|Induction Period (IP)|No study drug received|1|||
156737408|NCT01647516|565784849|FG001|Induction Period (IP)|No study drug received|1|||
156737409|NCT01647516|565784850|FG002|Induction Period (IP)|No study drug received|0|||
156737410|NCT01647516|565784851|FG003|Induction Period (IP)|No study drug received|0|||
156737411|NCT01647516|565784852|FG004|Induction Period (IP)|No study drug received|0|||
156737412|NCT01647516|565784853|FG005|Induction Period (IP)|No study drug received|0|||
156737413|NCT01647516|565784848|FG000|Maintenance Period (MP)|Adverse Event|2|||
156876906|NCT02164461|566307769|FG001|Overall Study|Disease Progression|3|||
156876907|NCT02164461|566307770|FG002|Overall Study|Disease Progression|4|||
156876908|NCT02164461|566307768|FG000|Overall Study|Withdrawal by Subject|0|||
156876909|NCT02164461|566307769|FG001|Overall Study|Withdrawal by Subject|3|||
156876910|NCT02164461|566307770|FG002|Overall Study|Withdrawal by Subject|0|||
156876911|NCT02355184|566307771|FG000|Overall Study|Lost to Follow-up|2|||
156876912|NCT02355184|566307771|FG000|Overall Study|Study Terminated|10|||
156876913|NCT05091567|566309693|FG000|Enrollment Phase|Death|37|||
156876914|NCT05091567|566309694|FG001|Enrollment Phase|Death|0|||
156876915|NCT05091567|566309695|FG002|Enrollment Phase|Death|0|||
156876916|NCT05091567|566309693|FG000|Enrollment Phase|Adverse Event|21|||
156876917|NCT05091567|566309694|FG001|Enrollment Phase|Adverse Event|0|||
156876918|NCT05091567|566309695|FG002|Enrollment Phase|Adverse Event|0|||
156876919|NCT05091567|566309693|FG000|Enrollment Phase|Progressive Disease|10|||
156876920|NCT05091567|566309694|FG001|Enrollment Phase|Progressive Disease|0|||
156876921|NCT05091567|566309695|FG002|Enrollment Phase|Progressive Disease|0|||
156876922|NCT05091567|566309693|FG000|Enrollment Phase|Withdrawal by Subject|8|||
156876923|NCT05091567|566309694|FG001|Enrollment Phase|Withdrawal by Subject|0|||
156876924|NCT05091567|566309695|FG002|Enrollment Phase|Withdrawal by Subject|0|||
156876925|NCT05091567|566309693|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
156876926|NCT05091567|566309694|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
156876927|NCT05091567|566309695|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
156876928|NCT05091567|566309693|FG000|Enrollment Phase|Physician Decision|3|||
156876929|NCT05091567|566309694|FG001|Enrollment Phase|Physician Decision|0|||
156876930|NCT05091567|566309695|FG002|Enrollment Phase|Physician Decision|0|||
156876931|NCT05091567|566309693|FG000|Enrollment Phase|Protocol Violation|2|||
156876932|NCT05091567|566309694|FG001|Enrollment Phase|Protocol Violation|0|||
156876933|NCT05091567|566309695|FG002|Enrollment Phase|Protocol Violation|0|||
156876934|NCT05091567|566309693|FG000|Enrollment Phase|Reason not Specified|1|||
156876935|NCT05091567|566309694|FG001|Enrollment Phase|Reason not Specified|0|||
156876936|NCT05091567|566309695|FG002|Enrollment Phase|Reason not Specified|0|||
156737414|NCT01647516|565784849|FG001|Maintenance Period (MP)|Adverse Event|1|||
156737415|NCT01647516|565784850|FG002|Maintenance Period (MP)|Adverse Event|0|||
156737416|NCT01647516|565784851|FG003|Maintenance Period (MP)|Adverse Event|0|||
156737417|NCT01647516|565784852|FG004|Maintenance Period (MP)|Adverse Event|0|||
156876937|NCT05091567|566309693|FG000|Randomized Phase|Death|0|||
156876938|NCT05091567|566309694|FG001|Randomized Phase|Death|135|||
156876939|NCT05091567|566309695|FG002|Randomized Phase|Death|112|||
156876940|NCT05091567|566309693|FG000|Randomized Phase|Progressive Disease|0|||
156876941|NCT05091567|566309694|FG001|Randomized Phase|Progressive Disease|2|||
156876942|NCT05091567|566309695|FG002|Randomized Phase|Progressive Disease|0|||
156876943|NCT05091567|566309693|FG000|Randomized Phase|Withdrawal by Subject|0|||
156876944|NCT05091567|566309694|FG001|Randomized Phase|Withdrawal by Subject|1|||
157142221|NCT02580058|567267902|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
157142222|NCT02580058|567267903|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
157142223|NCT02580058|567267904|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
157142224|NCT02580058|567267902|FG000|Overall Study|Progressive Disease|137|||
157142225|NCT02580058|567267903|FG001|Overall Study|Progressive Disease|125|||
157142226|NCT02580058|567267904|FG002|Overall Study|Progressive Disease|94|||
157142227|NCT02580058|567267902|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157218255|NCT00602030|567545615|FG000|Double-blind Phase|Reason not specified|0|||
157218256|NCT00602030|567545616|FG001|Double-blind Phase|Reason not specified|0|||
157218257|NCT00602030|567545617|FG002|Double-blind Phase|Reason not specified|4|||
157218258|NCT00602030|567545618|FG003|Double-blind Phase|Reason not specified|2|||
157218259|NCT00602030|567545619|FG004|Double-blind Phase|Reason not specified|0|||
157218260|NCT00602030|567545615|FG000|Crossover Phase|Disease Progression|0|||
157218261|NCT00602030|567545616|FG001|Crossover Phase|Disease Progression|0|||
157218262|NCT00602030|567545617|FG002|Crossover Phase|Disease Progression|0|||
157218263|NCT00602030|567545618|FG003|Crossover Phase|Disease Progression|0|||
157218264|NCT00602030|567545619|FG004|Crossover Phase|Disease Progression|11|||
157218265|NCT00602030|567545615|FG000|Crossover Phase|Adverse Event|0|||
157218266|NCT00602030|567545616|FG001|Crossover Phase|Adverse Event|0|||
157218267|NCT00602030|567545617|FG002|Crossover Phase|Adverse Event|0|||
157218268|NCT00602030|567545618|FG003|Crossover Phase|Adverse Event|0|||
157218269|NCT00602030|567545619|FG004|Crossover Phase|Adverse Event|3|||
157218270|NCT00602030|567545615|FG000|Crossover Phase|Consent withdrawal|0|||
157218271|NCT00602030|567545616|FG001|Crossover Phase|Consent withdrawal|0|||
157218272|NCT00602030|567545617|FG002|Crossover Phase|Consent withdrawal|0|||
157218273|NCT00602030|567545618|FG003|Crossover Phase|Consent withdrawal|0|||
157218274|NCT00602030|567545619|FG004|Crossover Phase|Consent withdrawal|2|||
157218275|NCT01580020|567545620|FG000|Overall Study|Lack of Efficacy|0|||
157218276|NCT01580020|567545621|FG001|Overall Study|Lack of Efficacy|5|||
157218277|NCT01580020|567545622|FG002|Overall Study|Lack of Efficacy|0|||
157218278|NCT01580020|567545623|FG003|Overall Study|Lack of Efficacy|1|||
157218279|NCT01580020|567545620|FG000|Overall Study|Withdrawal by Subject|0|||
157218280|NCT01580020|567545621|FG001|Overall Study|Withdrawal by Subject|1|||
157218281|NCT01580020|567545622|FG002|Overall Study|Withdrawal by Subject|1|||
157218282|NCT01580020|567545623|FG003|Overall Study|Withdrawal by Subject|0|||
157218283|NCT01580020|567545620|FG000|Overall Study|Adverse Event|1|||
157218284|NCT01580020|567545621|FG001|Overall Study|Adverse Event|1|||
157218285|NCT01580020|567545622|FG002|Overall Study|Adverse Event|1|||
157218286|NCT01580020|567545623|FG003|Overall Study|Adverse Event|1|||
157218287|NCT01580020|567545620|FG000|Overall Study|Administrative Problems|0|||
157218288|NCT01580020|567545621|FG001|Overall Study|Administrative Problems|0|||
157218289|NCT01580020|567545622|FG002|Overall Study|Administrative Problems|1|||
157218290|NCT01580020|567545623|FG003|Overall Study|Administrative Problems|0|||
157218291|NCT01580020|567545620|FG000|Overall Study|Lost to Follow-up|0|||
157218292|NCT01580020|567545621|FG001|Overall Study|Lost to Follow-up|0|||
157218293|NCT01580020|567545622|FG002|Overall Study|Lost to Follow-up|1|||
157218294|NCT01580020|567545623|FG003|Overall Study|Lost to Follow-up|0|||
157218295|NCT00575328|567545627|FG000|Overall Study|Adverse Event|1|||
157218296|NCT00575328|567545628|FG001|Overall Study|Adverse Event|1|||
157218297|NCT00575328|567545627|FG000|Overall Study|Lost to Follow-up|2|||
157218298|NCT00575328|567545628|FG001|Overall Study|Lost to Follow-up|1|||
157218299|NCT02868281|567545629|FG000|Overall Study|Adverse Event|2|||
157218300|NCT02868281|567545630|FG001|Overall Study|Adverse Event|2|||
157218301|NCT02868281|567545629|FG000|Overall Study|Protocol Violation|13|||
157218302|NCT02868281|567545630|FG001|Overall Study|Protocol Violation|10|||
157218303|NCT02868281|567545629|FG000|Overall Study|Lost to Follow-up|3|||
157218304|NCT02868281|567545630|FG001|Overall Study|Lost to Follow-up|6|||
157218305|NCT02868281|567545629|FG000|Overall Study|Withdrawal by Subject|11|||
157218306|NCT02868281|567545630|FG001|Overall Study|Withdrawal by Subject|15|||
157218307|NCT02868281|567545629|FG000|Overall Study|Physician Decision|2|||
157218308|NCT02868281|567545630|FG001|Overall Study|Physician Decision|0|||
157218309|NCT02868281|567545629|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
157218310|NCT02868281|567545630|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
157218311|NCT02868281|567545629|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
156876945|NCT05091567|566309695|FG002|Randomized Phase|Withdrawal by Subject|3|||
157218312|NCT02868281|567545630|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
157218313|NCT02868281|567545629|FG000|Overall Study|Long journey/moving away|1|||
157218314|NCT02868281|567545630|FG001|Overall Study|Long journey/moving away|1|||
157218315|NCT01722266|567545635|FG000|Overall Study|Withdrawal by Subject|1|||
157218316|NCT01722266|567545636|FG001|Overall Study|Withdrawal by Subject|2|||
157218317|NCT01722266|567545637|FG002|Overall Study|Withdrawal by Subject|0|||
157218318|NCT01722266|567545638|FG003|Overall Study|Withdrawal by Subject|0|||
157142228|NCT02580058|567267903|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157218319|NCT01722266|567545635|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
157218320|NCT01722266|567545636|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
157218321|NCT01722266|567545637|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
156876946|NCT05091567|566309693|FG000|Randomized Phase|Lost to Follow-up|0|||
156876947|NCT05091567|566309694|FG001|Randomized Phase|Lost to Follow-up|1|||
156876948|NCT05091567|566309695|FG002|Randomized Phase|Lost to Follow-up|1|||
156876949|NCT05091567|566309693|FG000|Randomized Phase|Ongoing in Study|0|||
156876950|NCT05091567|566309694|FG001|Randomized Phase|Ongoing in Study|102|||
156876951|NCT05091567|566309695|FG002|Randomized Phase|Ongoing in Study|126|||
157020327|NCT05382936|566828389|FG002|Overall Study|Withdrawal by Subject|1|||
157020328|NCT05382936|566828390|FG003|Overall Study|Withdrawal by Subject|1|||
156737418|NCT01647516|565784853|FG005|Maintenance Period (MP)|Adverse Event|0|||
156737419|NCT01647516|565784848|FG000|Maintenance Period (MP)|Non-compliance|1|||
156737420|NCT01647516|565784849|FG001|Maintenance Period (MP)|Non-compliance|0|||
156737421|NCT01647516|565784850|FG002|Maintenance Period (MP)|Non-compliance|0|||
156737422|NCT01647516|565784851|FG003|Maintenance Period (MP)|Non-compliance|0|||
156737423|NCT01647516|565784852|FG004|Maintenance Period (MP)|Non-compliance|0|||
156737424|NCT01647516|565784853|FG005|Maintenance Period (MP)|Non-compliance|0|||
156737425|NCT01647516|565784848|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737426|NCT01647516|565784849|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
156737427|NCT01647516|565784850|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
156737428|NCT01647516|565784851|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737429|NCT01647516|565784852|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737430|NCT01647516|565784853|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
156737431|NCT01647516|565784848|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
156737432|NCT01647516|565784849|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
156737433|NCT01647516|565784850|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
156737434|NCT01647516|565784851|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
156737435|NCT01647516|565784852|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
156737436|NCT01647516|565784853|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
156737437|NCT01647516|565784848|FG000|Open-Label Period|Adverse Event|0|||
156737438|NCT01647516|565784849|FG001|Open-Label Period|Adverse Event|0|||
157020329|NCT05063994|566828391|FG000|Cortef Run-In|Withdrawal of Consent|1|||
157142229|NCT02580058|567267904|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157142230|NCT02272790|567267905|FG000|Overall Study|Physician Decision|0|||
157142231|NCT02272790|567267906|FG001|Overall Study|Physician Decision|1|||
157142232|NCT02272790|567267907|FG002|Overall Study|Physician Decision|0|||
157142233|NCT02272790|567267908|FG003|Overall Study|Physician Decision|0|||
157142234|NCT02272790|567267909|FG004|Overall Study|Physician Decision|0|||
157142235|NCT02272790|567267910|FG005|Overall Study|Physician Decision|0|||
157142236|NCT04375878|567267911|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
157142237|NCT04375878|567267912|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
157142238|NCT04375878|567267913|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
157142239|NCT04375878|567267914|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
157142240|NCT04375878|567267915|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
157142241|NCT04375878|567267916|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
157142242|NCT04375878|567267911|FG000|Crossover First and Second Interventions|Adverse Event|0|||
157142243|NCT04375878|567267912|FG001|Crossover First and Second Interventions|Adverse Event|0|||
157142244|NCT04375878|567267913|FG002|Crossover First and Second Interventions|Adverse Event|1|||
157142245|NCT04375878|567267914|FG003|Crossover First and Second Interventions|Adverse Event|0|||
157142246|NCT04375878|567267915|FG004|Crossover First and Second Interventions|Adverse Event|0|||
157142247|NCT04375878|567267916|FG005|Crossover First and Second Interventions|Adverse Event|0|||
157142248|NCT04375878|567267911|FG000|Extension Phase|Withdrawal by Subject|0|||
157142249|NCT04375878|567267912|FG001|Extension Phase|Withdrawal by Subject|0|||
157142250|NCT04375878|567267913|FG002|Extension Phase|Withdrawal by Subject|0|||
157142251|NCT04375878|567267914|FG003|Extension Phase|Withdrawal by Subject|0|||
157142252|NCT04375878|567267915|FG004|Extension Phase|Withdrawal by Subject|1|||
157142253|NCT04375878|567267916|FG005|Extension Phase|Withdrawal by Subject|0|||
157142254|NCT03022461|567267917|FG000|Overall Study|Death|3|||
157142255|NCT01982630|567267918|FG000|Overall Study|Adverse Event|2|||
157142256|NCT01982630|567267919|FG001|Overall Study|Adverse Event|0|||
157142257|NCT01982630|567267920|FG002|Overall Study|Adverse Event|1|||
156737439|NCT01647516|565784850|FG002|Open-Label Period|Adverse Event|0|||
156737440|NCT01647516|565784851|FG003|Open-Label Period|Adverse Event|5|||
156737441|NCT01647516|565784852|FG004|Open-Label Period|Adverse Event|6|||
156737442|NCT01647516|565784853|FG005|Open-Label Period|Adverse Event|3|||
157020330|NCT05063994|566828392|FG001|Cortef Run-In|Withdrawal of Consent|0|||
157142258|NCT01982630|567267921|FG003|Overall Study|Adverse Event|0|||
157142259|NCT01982630|567267922|FG004|Overall Study|Adverse Event|1|||
157142260|NCT01982630|567267923|FG005|Overall Study|Adverse Event|2|||
157142261|NCT01982630|567267924|FG006|Overall Study|Adverse Event|1|||
157142262|NCT01982630|567267925|FG007|Overall Study|Adverse Event|0|||
157142263|NCT01982630|567267918|FG000|Overall Study|Physician Decision|1|||
157142264|NCT01982630|567267919|FG001|Overall Study|Physician Decision|0|||
156737443|NCT01647516|565784848|FG000|Open-Label Period|Pregnancy|0|||
156737444|NCT01647516|565784849|FG001|Open-Label Period|Pregnancy|0|||
156737445|NCT01647516|565784850|FG002|Open-Label Period|Pregnancy|0|||
156737446|NCT01647516|565784851|FG003|Open-Label Period|Pregnancy|0|||
156737447|NCT01647516|565784852|FG004|Open-Label Period|Pregnancy|0|||
156737448|NCT01647516|565784853|FG005|Open-Label Period|Pregnancy|1|||
156737449|NCT01647516|565784848|FG000|Open-Label Period|Non-compliance|0|||
156737450|NCT01647516|565784849|FG001|Open-Label Period|Non-compliance|0|||
156737451|NCT01647516|565784850|FG002|Open-Label Period|Non-compliance|0|||
156737452|NCT01647516|565784851|FG003|Open-Label Period|Non-compliance|1|||
156737453|NCT01647516|565784852|FG004|Open-Label Period|Non-compliance|0|||
156737454|NCT01647516|565784853|FG005|Open-Label Period|Non-compliance|1|||
156737455|NCT01647516|565784848|FG000|Open-Label Period|Physician Decision|0|||
156737456|NCT01647516|565784849|FG001|Open-Label Period|Physician Decision|0|||
156737457|NCT01647516|565784850|FG002|Open-Label Period|Physician Decision|0|||
156737458|NCT01647516|565784851|FG003|Open-Label Period|Physician Decision|1|||
156737459|NCT01647516|565784852|FG004|Open-Label Period|Physician Decision|1|||
156737460|NCT01647516|565784853|FG005|Open-Label Period|Physician Decision|0|||
156737461|NCT01647516|565784848|FG000|Open-Label Period|Withdrawal by Subject|0|||
156737462|NCT01647516|565784849|FG001|Open-Label Period|Withdrawal by Subject|0|||
156737463|NCT01647516|565784850|FG002|Open-Label Period|Withdrawal by Subject|0|||
156737464|NCT01647516|565784851|FG003|Open-Label Period|Withdrawal by Subject|9|||
156737465|NCT01647516|565784852|FG004|Open-Label Period|Withdrawal by Subject|11|||
156737466|NCT01647516|565784853|FG005|Open-Label Period|Withdrawal by Subject|6|||
156737467|NCT01647516|565784848|FG000|Open-Label Period|Lost to Follow-up|0|||
156737468|NCT01647516|565784849|FG001|Open-Label Period|Lost to Follow-up|0|||
156737469|NCT01647516|565784850|FG002|Open-Label Period|Lost to Follow-up|0|||
156737470|NCT01647516|565784851|FG003|Open-Label Period|Lost to Follow-up|1|||
156737471|NCT01647516|565784852|FG004|Open-Label Period|Lost to Follow-up|0|||
156737472|NCT01647516|565784853|FG005|Open-Label Period|Lost to Follow-up|1|||
156737473|NCT01647516|565784848|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737474|NCT01647516|565784849|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737475|NCT01647516|565784850|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
156737476|NCT01647516|565784851|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
156737477|NCT01647516|565784852|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
156737478|NCT01647516|565784853|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
156737479|NCT01647516|565784848|FG000|Open-Label Period|Lack of Efficacy|0|||
156737480|NCT01647516|565784849|FG001|Open-Label Period|Lack of Efficacy|0|||
156737481|NCT01647516|565784850|FG002|Open-Label Period|Lack of Efficacy|0|||
156737482|NCT01647516|565784851|FG003|Open-Label Period|Lack of Efficacy|7|||
156737483|NCT01647516|565784852|FG004|Open-Label Period|Lack of Efficacy|9|||
156737484|NCT01647516|565784853|FG005|Open-Label Period|Lack of Efficacy|10|||
156737485|NCT01647516|565784848|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737486|NCT01647516|565784849|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737487|NCT01647516|565784850|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
156737488|NCT01647516|565784851|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
156737489|NCT01647516|565784852|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
156737490|NCT01647516|565784853|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
156737491|NCT01647516|565784848|FG000|Open-Label Period|No completion / discontinuation visit|0|||
156737492|NCT01647516|565784849|FG001|Open-Label Period|No completion / discontinuation visit|0|||
156737493|NCT01647516|565784850|FG002|Open-Label Period|No completion / discontinuation visit|0|||
156737494|NCT01647516|565784851|FG003|Open-Label Period|No completion / discontinuation visit|0|||
156737495|NCT01647516|565784852|FG004|Open-Label Period|No completion / discontinuation visit|2|||
156737496|NCT01647516|565784853|FG005|Open-Label Period|No completion / discontinuation visit|1|||
157020331|NCT05063994|566828393|FG002|Cortef Run-In|Withdrawal of Consent|0|||
157020332|NCT05063994|566828391|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
157020333|NCT05063994|566828392|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
157020334|NCT05063994|566828393|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
157020335|NCT05063994|566828391|FG000|Treatment|Physician Decision|0|||
157020336|NCT05063994|566828392|FG001|Treatment|Physician Decision|0|||
157020337|NCT05063994|566828393|FG002|Treatment|Physician Decision|1|||
157020338|NCT05063994|566828391|FG000|Treatment|Withdrawal by Subject|0|||
157020339|NCT05063994|566828392|FG001|Treatment|Withdrawal by Subject|0|||
157020340|NCT05063994|566828393|FG002|Treatment|Withdrawal by Subject|1|||
157020341|NCT05063994|566828391|FG000|Treatment|Withdrawal of Consent|0|||
156737497|NCT03614078|565784856|FG000|Overall Study|Withdrawal by Subject|2|||
156737498|NCT03614078|565784857|FG001|Overall Study|Withdrawal by Subject|2|||
156737499|NCT03614078|565784858|FG002|Overall Study|Withdrawal by Subject|3|||
156737500|NCT03614078|565784856|FG000|Overall Study|Participant Did Not Return for Visit|0|||
156737501|NCT03614078|565784857|FG001|Overall Study|Participant Did Not Return for Visit|1|||
156737502|NCT03614078|565784858|FG002|Overall Study|Participant Did Not Return for Visit|0|||
156737503|NCT03614078|565784856|FG000|Overall Study|High Neutrophils|0|||
156737504|NCT03614078|565784857|FG001|Overall Study|High Neutrophils|0|||
156737505|NCT03614078|565784858|FG002|Overall Study|High Neutrophils|2|||
156737506|NCT03614078|565784856|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
156737507|NCT03614078|565784857|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
156737508|NCT03614078|565784858|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
156737509|NCT03614078|565784856|FG000|Overall Study|Exacerbation of Psoriasis|0|||
157020342|NCT05063994|566828392|FG001|Treatment|Withdrawal of Consent|0|||
157020343|NCT05063994|566828393|FG002|Treatment|Withdrawal of Consent|1|||
157020344|NCT01195831|566828397|FG000|Overall Study|Lost to Follow-up|2|||
157020345|NCT01195831|566828398|FG001|Overall Study|Lost to Follow-up|4|||
157020346|NCT01195831|566828397|FG000|Overall Study|Withdrawal by Subject|2|||
157020347|NCT01195831|566828398|FG001|Overall Study|Withdrawal by Subject|2|||
157020348|NCT01195831|566828397|FG000|Overall Study|Adverse Event|4|||
157020349|NCT01195831|566828398|FG001|Overall Study|Adverse Event|2|||
157020350|NCT01195831|566828397|FG000|Overall Study|Protocol Violation|0|||
157020351|NCT01195831|566828398|FG001|Overall Study|Protocol Violation|2|||
157020352|NCT01180634|566828400|FG000|Overall Study|Adverse Event|4|||
157020353|NCT01180634|566828401|FG001|Overall Study|Adverse Event|1|||
157142265|NCT01982630|567267920|FG002|Overall Study|Physician Decision|2|||
157142266|NCT01982630|567267921|FG003|Overall Study|Physician Decision|1|||
157142267|NCT01982630|567267922|FG004|Overall Study|Physician Decision|2|||
157142268|NCT01982630|567267923|FG005|Overall Study|Physician Decision|0|||
157142269|NCT01982630|567267924|FG006|Overall Study|Physician Decision|0|||
157142270|NCT01982630|567267925|FG007|Overall Study|Physician Decision|0|||
157142271|NCT01982630|567267918|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156737510|NCT03614078|565784857|FG001|Overall Study|Exacerbation of Psoriasis|1|||
157020354|NCT01180634|566828400|FG000|Overall Study|Miscellaneous|2|||
156737511|NCT03614078|565784858|FG002|Overall Study|Exacerbation of Psoriasis|0|||
156737512|NCT03614078|565784856|FG000|Overall Study|Adverse Event|0|||
156737513|NCT03614078|565784857|FG001|Overall Study|Adverse Event|2|||
156737514|NCT03614078|565784858|FG002|Overall Study|Adverse Event|0|||
156737515|NCT03614078|565784856|FG000|Overall Study|Dizziness and Rash|0|||
157020355|NCT01180634|566828401|FG001|Overall Study|Miscellaneous|0|||
157020356|NCT01180634|566828400|FG000|Overall Study|Withdrawal by Subject|4|||
157020357|NCT01180634|566828401|FG001|Overall Study|Withdrawal by Subject|0|||
157020358|NCT04490915|566828403|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
157020359|NCT04490915|566828404|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157142272|NCT01982630|567267919|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
157142273|NCT01982630|567267920|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
157142274|NCT01982630|567267921|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
157142275|NCT01982630|567267922|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
157142276|NCT01982630|567267923|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
156737516|NCT03614078|565784857|FG001|Overall Study|Dizziness and Rash|1|||
157142277|NCT01982630|567267924|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
157142278|NCT01982630|567267925|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
157142279|NCT01982630|567267918|FG000|Overall Study|Withdrawal by Subject|0|||
156737517|NCT03614078|565784858|FG002|Overall Study|Dizziness and Rash|0|||
156737518|NCT02004886|565784859|FG000|Overall Study|Adverse Event|0|||
156737519|NCT02004886|565784860|FG001|Overall Study|Adverse Event|1|||
156737520|NCT02004886|565784861|FG002|Overall Study|Adverse Event|0|||
156737521|NCT02004886|565784862|FG003|Overall Study|Adverse Event|0|||
156737522|NCT02004886|565784859|FG000|Overall Study|Unable to attend future visits|1|||
156737523|NCT02004886|565784860|FG001|Overall Study|Unable to attend future visits|0|||
156737524|NCT02004886|565784861|FG002|Overall Study|Unable to attend future visits|0|||
156737525|NCT02004886|565784862|FG003|Overall Study|Unable to attend future visits|0|||
156737526|NCT04964544|565784865|FG000|Overall Study|Screen failure or other uncategorised|10|||
156737527|NCT04964544|565784865|FG000|Overall Study|Physician Decision|4|||
156737528|NCT04964544|565784865|FG000|Overall Study|Lost to Follow-up|9|||
156737529|NCT04964544|565784865|FG000|Overall Study|Withdrawal by Subject|18|||
156737530|NCT04964544|565784865|FG000|Overall Study|Death|1|||
156737531|NCT01613222|565784868|FG000|Overall Study|Physician Decision|1|||
156737532|NCT01613222|565784868|FG000|Overall Study|Unable to place arterial line|1|||
156737533|NCT01613222|565784868|FG000|Overall Study|Reused disposable sensors|10|||
156737534|NCT03505593|565784869|FG000|Overall Study|Withdrawal by Subject|1|||
156737535|NCT03505593|565784869|FG000|Overall Study|Died before procedure|1|||
156737536|NCT03505593|565784869|FG000|Overall Study|Anatomical abnormality|1|||
156737537|NCT03505593|565784869|FG000|Overall Study|Unable to pass through esophagus|1|||
156737538|NCT03505593|565784869|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
156737539|NCT05239494|565784870|FG000|Overall Study|Lost to Follow-up|1|||
156737540|NCT02822573|565784872|FG000|Overall Study|Lost to Follow-up|5|||
156737541|NCT02822573|565784873|FG001|Overall Study|Lost to Follow-up|3|||
156737542|NCT02822573|565784872|FG000|Overall Study|Physician Decision|1|||
156737543|NCT02822573|565784873|FG001|Overall Study|Physician Decision|1|||
156737544|NCT02822573|565784872|FG000|Overall Study|Withdrawal by Subject|9|||
156737545|NCT02822573|565784873|FG001|Overall Study|Withdrawal by Subject|5|||
156737546|NCT02822573|565784872|FG000|Overall Study|Protocol Violation|6|||
156737547|NCT02822573|565784873|FG001|Overall Study|Protocol Violation|4|||
156737548|NCT02822573|565784872|FG000|Overall Study|Too sick or ill|2|||
156737549|NCT02822573|565784873|FG001|Overall Study|Too sick or ill|1|||
156737550|NCT02822573|565784872|FG000|Overall Study|Disease Progression|1|||
156737551|NCT02822573|565784873|FG001|Overall Study|Disease Progression|1|||
156737552|NCT02822573|565784872|FG000|Overall Study|No reason given|6|||
156737553|NCT02822573|565784873|FG001|Overall Study|No reason given|4|||
156737554|NCT02855359|565784874|FG000|Overall Study|Death|2|||
156737555|NCT02855359|565784875|FG001|Overall Study|Death|2|||
156737556|NCT02855359|565784876|FG002|Overall Study|Death|0|||
156737557|NCT02855359|565784877|FG003|Overall Study|Death|0|||
157020360|NCT04490915|566828403|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157020361|NCT04490915|566828404|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157020362|NCT04490915|566828403|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
157142280|NCT01982630|567267919|FG001|Overall Study|Withdrawal by Subject|0|||
157142281|NCT01982630|567267920|FG002|Overall Study|Withdrawal by Subject|0|||
157142282|NCT01982630|567267921|FG003|Overall Study|Withdrawal by Subject|0|||
156737558|NCT02855359|565784874|FG000|Overall Study|Study Termination by Sponsor|9|||
156737559|NCT02855359|565784875|FG001|Overall Study|Study Termination by Sponsor|11|||
156737560|NCT02855359|565784876|FG002|Overall Study|Study Termination by Sponsor|0|||
156737561|NCT02855359|565784877|FG003|Overall Study|Study Termination by Sponsor|0|||
156737562|NCT03155178|565784878|FG000|Overall Study|Did not meet treatment day baseline|7|||
156737563|NCT03155178|565784879|FG001|Overall Study|Did not meet treatment day baseline|7|||
156737564|NCT03155178|565784880|FG002|Overall Study|Did not meet treatment day baseline|7|||
156737565|NCT03155178|565784881|FG003|Overall Study|Did not meet treatment day baseline|7|||
156737566|NCT01023256|565784882|FG000|Overall Study|Protocol Violation|2|||
157020363|NCT04490915|566828404|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
157020364|NCT04490915|566828403|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
157020365|NCT04490915|566828404|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
157020366|NCT04490915|566828403|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
157020367|NCT04490915|566828404|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
157020368|NCT04490915|566828403|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
157020369|NCT04490915|566828404|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
157020370|NCT04490915|566828403|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
157142283|NCT01982630|567267922|FG004|Overall Study|Withdrawal by Subject|0|||
157142284|NCT01982630|567267923|FG005|Overall Study|Withdrawal by Subject|1|||
157142285|NCT01982630|567267924|FG006|Overall Study|Withdrawal by Subject|0|||
157142286|NCT01982630|567267925|FG007|Overall Study|Withdrawal by Subject|0|||
157142287|NCT01073943|567267926|FG000|Overall Study|Withdrawal by Subject|8|||
157142288|NCT01073943|567267927|FG001|Overall Study|Withdrawal by Subject|2|||
156737567|NCT01023256|565784883|FG001|Overall Study|Protocol Violation|3|||
156737568|NCT01023256|565784884|FG002|Overall Study|Protocol Violation|0|||
156737569|NCT01023256|565784885|FG003|Overall Study|Protocol Violation|0|||
156737570|NCT01023256|565784882|FG000|Overall Study|Randomized but not treated|1|||
157142289|NCT01073943|567267926|FG000|Overall Study|Protocol Violation|2|||
157142290|NCT01073943|567267927|FG001|Overall Study|Protocol Violation|1|||
157142291|NCT01073943|567267926|FG000|Overall Study|Adverse Event|1|||
156737571|NCT01023256|565784883|FG001|Overall Study|Randomized but not treated|0|||
156737572|NCT01023256|565784884|FG002|Overall Study|Randomized but not treated|1|||
156737573|NCT01023256|565784885|FG003|Overall Study|Randomized but not treated|0|||
156737574|NCT01023256|565784882|FG000|Overall Study|Other|1|||
156737575|NCT01023256|565784883|FG001|Overall Study|Other|0|||
156737576|NCT01023256|565784884|FG002|Overall Study|Other|0|||
156737577|NCT01023256|565784885|FG003|Overall Study|Other|2|||
156737578|NCT01023256|565784882|FG000|Overall Study|Adverse Event|0|||
156737579|NCT01023256|565784883|FG001|Overall Study|Adverse Event|0|||
156737580|NCT01023256|565784884|FG002|Overall Study|Adverse Event|0|||
156737581|NCT01023256|565784885|FG003|Overall Study|Adverse Event|1|||
156737582|NCT01023256|565784882|FG000|Overall Study|Withdrawal by Subject|0|||
156737583|NCT01023256|565784883|FG001|Overall Study|Withdrawal by Subject|0|||
156737584|NCT01023256|565784884|FG002|Overall Study|Withdrawal by Subject|0|||
156737585|NCT01023256|565784885|FG003|Overall Study|Withdrawal by Subject|2|||
156737586|NCT02833844|565784886|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156737587|NCT02833844|565784887|FG001|Double-Blind Period|Withdrawal by Subject|3|||
156737588|NCT02833844|565784886|FG000|Double-Blind Period|Protocol Violation|0|||
156737589|NCT02833844|565784887|FG001|Double-Blind Period|Protocol Violation|4|||
156737590|NCT02833844|565784886|FG000|Open-Label Period|Death|0|||
156737591|NCT02833844|565784887|FG001|Open-Label Period|Death|2|||
156737592|NCT02833844|565784886|FG000|Open-Label Period|Lost to Follow-up|1|||
156737593|NCT02833844|565784887|FG001|Open-Label Period|Lost to Follow-up|0|||
156737594|NCT02833844|565784886|FG000|Open-Label Period|Withdrawal by Subject|1|||
156737595|NCT02833844|565784887|FG001|Open-Label Period|Withdrawal by Subject|0|||
156737596|NCT00308087|565784888|FG000|Overall Study|Progressive Disease|19|||
156737597|NCT00308087|565784889|FG001|Overall Study|Progressive Disease|21|||
156737598|NCT00308087|565784888|FG000|Overall Study|Study Closure|11|||
156737599|NCT00308087|565784889|FG001|Overall Study|Study Closure|12|||
156737600|NCT00308087|565784888|FG000|Overall Study|Withdrawal by Subject|2|||
156737601|NCT00308087|565784889|FG001|Overall Study|Withdrawal by Subject|1|||
156737602|NCT00308087|565784888|FG000|Overall Study|Other|4|||
156796974|NCT03559530|566009694|FG001|Overall Study|non-location of medical records|0|||
156796975|NCT03559530|566009693|FG000|Overall Study|culture results not considered for treat|29|||
156796976|NCT03559530|566009694|FG001|Overall Study|culture results not considered for treat|0|||
156796977|NCT03559530|566009693|FG000|Overall Study|duplicate cases|8|||
156796978|NCT03559530|566009694|FG001|Overall Study|duplicate cases|0|||
156796979|NCT03559530|566009693|FG000|Overall Study|other species of Acinetobacte|7|||
156796980|NCT03559530|566009694|FG001|Overall Study|other species of Acinetobacte|0|||
156796981|NCT03559530|566009693|FG000|Overall Study|contamination / colonization|3|||
156796982|NCT03559530|566009694|FG001|Overall Study|contamination / colonization|0|||
156796983|NCT01472185|566009699|FG000|Overall Study|Randomized but Not Treated|0|||
156796984|NCT01472185|566009700|FG001|Overall Study|Randomized but Not Treated|1|||
156796985|NCT01472185|566009699|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
156796986|NCT01472185|566009700|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
156796987|NCT01472185|566009699|FG000|Overall Study|Hyperglycemia|5|||
156796988|NCT01472185|566009700|FG001|Overall Study|Hyperglycemia|2|||
156796989|NCT01472185|566009699|FG000|Overall Study|Investigator's Discretion|3|||
156796990|NCT01472185|566009700|FG001|Overall Study|Investigator's Discretion|1|||
156796991|NCT01472185|566009699|FG000|Overall Study|Lost to Follow-up|4|||
156796992|NCT01472185|566009700|FG001|Overall Study|Lost to Follow-up|1|||
156796993|NCT01472185|566009699|FG000|Overall Study|Protocol Violation|5|||
156796994|NCT01472185|566009700|FG001|Overall Study|Protocol Violation|1|||
156796995|NCT01472185|566009699|FG000|Overall Study|Subject Noncompliance|8|||
156796996|NCT01472185|566009700|FG001|Overall Study|Subject Noncompliance|15|||
156796997|NCT01472185|566009699|FG000|Overall Study|Subject Withdrew Consent|6|||
156796998|NCT01472185|566009700|FG001|Overall Study|Subject Withdrew Consent|3|||
156796999|NCT01767987|566009703|FG000|Overall Study|Physician Decision|4|||
156797000|NCT01767987|566009704|FG001|Overall Study|Physician Decision|1|||
156797001|NCT01153516|566009705|FG000|Overall Study|Both subjects refused surgery|2|||
157218322|NCT01722266|567545638|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
156737603|NCT00308087|565784889|FG001|Overall Study|Other|3|||
156797002|NCT01153516|566009706|FG001|Overall Study|Both subjects refused surgery|0|||
156797003|NCT00635050|566009709|FG000|Overall Study|Withdrawal by Subject|1|||
156797004|NCT04875533|566009713|FG000|Overall Study|Adverse Event|6|||
156797005|NCT04875533|566009714|FG001|Overall Study|Adverse Event|4|||
156797006|NCT04875533|566009713|FG000|Overall Study|Protocol Violation|4|||
156737604|NCT04323306|565784890|FG000|Overall Study|Physician Decision|1|||
156737605|NCT04323306|565784891|FG001|Overall Study|Physician Decision|0|||
156737606|NCT04323306|565784892|FG002|Overall Study|Physician Decision|0|||
156737607|NCT04323306|565784893|FG003|Overall Study|Physician Decision|0|||
156797007|NCT04875533|566009714|FG001|Overall Study|Protocol Violation|0|||
156797008|NCT04875533|566009713|FG000|Overall Study|Withdrawal by Subject|8|||
156737608|NCT04323306|565784894|FG004|Overall Study|Physician Decision|0|||
156737609|NCT04323306|565784895|FG005|Overall Study|Physician Decision|0|||
156737610|NCT04323306|565784896|FG006|Overall Study|Physician Decision|0|||
156737611|NCT04323306|565784897|FG007|Overall Study|Physician Decision|0|||
156737612|NCT04323306|565784898|FG008|Overall Study|Physician Decision|0|||
156737613|NCT04323306|565784890|FG000|Overall Study|Withdrawal by Subject|0|||
156737614|NCT04323306|565784891|FG001|Overall Study|Withdrawal by Subject|0|||
156737615|NCT04323306|565784892|FG002|Overall Study|Withdrawal by Subject|0|||
156737616|NCT04323306|565784893|FG003|Overall Study|Withdrawal by Subject|0|||
156737617|NCT04323306|565784894|FG004|Overall Study|Withdrawal by Subject|0|||
156737618|NCT04323306|565784895|FG005|Overall Study|Withdrawal by Subject|1|||
156737619|NCT04323306|565784896|FG006|Overall Study|Withdrawal by Subject|3|||
156737620|NCT04323306|565784897|FG007|Overall Study|Withdrawal by Subject|0|||
156737621|NCT04323306|565784898|FG008|Overall Study|Withdrawal by Subject|1|||
156737622|NCT00089778|565784900|FG000|Overall Study|Protocol Violation|0|||
156737623|NCT00089778|565784901|FG001|Overall Study|Protocol Violation|0|||
156737624|NCT00089778|565784902|FG002|Overall Study|Protocol Violation|1|||
156737625|NCT04712019|565784903|FG000|Overall Study|Withdrawal by Subject|2|||
156737626|NCT04712019|565784904|FG001|Overall Study|Withdrawal by Subject|2|||
156737627|NCT04712019|565784903|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
156737628|NCT04712019|565784904|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
156737629|NCT03729570|565784912|FG000|Overall Study|Lost to Follow-up|16|||
156737630|NCT03729570|565784913|FG001|Overall Study|Lost to Follow-up|20|||
156737631|NCT03729570|565784912|FG000|Overall Study|Seroconversion|5|||
156737632|NCT03729570|565784913|FG001|Overall Study|Seroconversion|0|||
156737633|NCT03729570|565784912|FG000|Overall Study|Moved out of the city|1|||
156737634|NCT03729570|565784913|FG001|Overall Study|Moved out of the city|0|||
156737635|NCT03729570|565784912|FG000|Overall Study|Time Conflict|1|||
156737636|NCT03729570|565784913|FG001|Overall Study|Time Conflict|0|||
156737637|NCT03729570|565784912|FG000|Overall Study|Time Commitment|2|||
156737638|NCT03729570|565784913|FG001|Overall Study|Time Commitment|0|||
156737639|NCT03729570|565784912|FG000|Overall Study|Bad Experience|0|||
156737640|NCT03729570|565784913|FG001|Overall Study|Bad Experience|1|||
156737641|NCT03729570|565784912|FG000|Overall Study|No reason provided|2|||
156737642|NCT03729570|565784913|FG001|Overall Study|No reason provided|1|||
156737643|NCT03729570|565784912|FG000|Overall Study|Family Conflict|0|||
156737644|NCT03729570|565784913|FG001|Overall Study|Family Conflict|1|||
156737645|NCT03729570|565784912|FG000|Overall Study|Did not want to continue taking medications|0|||
156737646|NCT03729570|565784913|FG001|Overall Study|Did not want to continue taking medications|1|||
156737647|NCT03729570|565784912|FG000|Overall Study|Found another PrEP provider|1|||
156737648|NCT03729570|565784913|FG001|Overall Study|Found another PrEP provider|0|||
156737649|NCT03729570|565784912|FG000|Overall Study|Did not enjoy being in the control group|0|||
156737650|NCT03729570|565784913|FG001|Overall Study|Did not enjoy being in the control group|1|||
156737651|NCT00631410|565784918|FG000|Overall Study|Adverse Event|1|||
156737652|NCT00631410|565784919|FG001|Overall Study|Adverse Event|3|||
156737653|NCT00631410|565784918|FG000|Overall Study|Objective Progression or Relapse|4|||
156737654|NCT00631410|565784919|FG001|Overall Study|Objective Progression or Relapse|3|||
156737655|NCT00631410|565784918|FG000|Overall Study|Surgery|1|||
156737656|NCT00631410|565784919|FG001|Overall Study|Surgery|0|||
156737657|NCT02447497|565784921|FG000|Overall Study|Did not meet treatment day baseline.|6|||
156737658|NCT02447497|565784922|FG001|Overall Study|Did not meet treatment day baseline.|5|||
156737659|NCT02447497|565784923|FG002|Overall Study|Did not meet treatment day baseline.|2|||
156737660|NCT02447497|565784924|FG003|Overall Study|Did not meet treatment day baseline.|2|||
156737661|NCT02447497|565784921|FG000|Overall Study|Dressing was compromised|0|||
156737662|NCT02447497|565784922|FG001|Overall Study|Dressing was compromised|1|||
156737663|NCT02447497|565784923|FG002|Overall Study|Dressing was compromised|0|||
156737664|NCT02447497|565784924|FG003|Overall Study|Dressing was compromised|0|||
156737665|NCT00727844|565784925|FG000|Initial Randomization|Physician Decision|2|||
156737666|NCT00727844|565784926|FG001|Initial Randomization|Physician Decision|0|||
156737667|NCT00727844|565784927|FG002|Initial Randomization|Physician Decision|0|||
156797009|NCT04875533|566009714|FG001|Overall Study|Withdrawal by Subject|5|||
156797010|NCT04875533|566009713|FG000|Overall Study|No longer meets eligibility criteria|1|||
156737668|NCT00727844|565784928|FG003|Initial Randomization|Physician Decision|0|||
156797011|NCT04875533|566009714|FG001|Overall Study|No longer meets eligibility criteria|0|||
156797012|NCT04875533|566009713|FG000|Overall Study|Other|0|||
156797013|NCT04875533|566009714|FG001|Overall Study|Other|2|||
156797014|NCT01299961|566009716|FG000|Overall Study|Adverse Event|3|||
156797015|NCT01299961|566009716|FG000|Overall Study|Lack of Efficacy|2|||
156737669|NCT04240457|565784939|FG000|Overall Study|Lost to Follow-up|5|||
156737670|NCT04240457|565784940|FG001|Overall Study|Lost to Follow-up|1|||
156797016|NCT01299961|566009716|FG000|Overall Study|Lost to Follow-up|1|||
156797017|NCT02904096|566009717|FG000|Overall Study|Adverse Event|1|||
156737671|NCT00985959|565784941|FG000|Overall Study|Adverse Event|0|||
156737672|NCT00985959|565784942|FG001|Overall Study|Adverse Event|0|||
156737673|NCT00985959|565784943|FG002|Overall Study|Adverse Event|19|||
156737674|NCT00985959|565784941|FG000|Overall Study|Withdrawal by Subject|0|||
156737675|NCT00985959|565784942|FG001|Overall Study|Withdrawal by Subject|0|||
156737676|NCT00985959|565784943|FG002|Overall Study|Withdrawal by Subject|8|||
156737677|NCT00985959|565784941|FG000|Overall Study|Progressive disease|1|||
156737678|NCT00985959|565784942|FG001|Overall Study|Progressive disease|2|||
156737679|NCT00985959|565784943|FG002|Overall Study|Progressive disease|8|||
156737680|NCT00985959|565784941|FG000|Overall Study|Unrecovered toxicity|0|||
156737681|NCT00985959|565784942|FG001|Overall Study|Unrecovered toxicity|0|||
156737682|NCT00985959|565784943|FG002|Overall Study|Unrecovered toxicity|7|||
156737683|NCT00985959|565784941|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
156737684|NCT00985959|565784942|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
156737685|NCT00985959|565784943|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
156737686|NCT00985959|565784941|FG000|Overall Study|Complete response observed over 2 cycles|0|||
156737687|NCT00985959|565784942|FG001|Overall Study|Complete response observed over 2 cycles|1|||
156737688|NCT00985959|565784943|FG002|Overall Study|Complete response observed over 2 cycles|4|||
156737689|NCT00985959|565784941|FG000|Overall Study|Other|0|||
156737690|NCT00985959|565784942|FG001|Overall Study|Other|0|||
156737691|NCT00985959|565784943|FG002|Overall Study|Other|11|||
156737692|NCT00844480|565784944|FG000|Overall Study|Withdrawal by Subject|2|||
156737693|NCT00844480|565784945|FG001|Overall Study|Withdrawal by Subject|3|||
156737694|NCT02858180|565784946|FG000|Overall Study|Lost to Follow-up|0|||
156737695|NCT02858180|565784947|FG001|Overall Study|Lost to Follow-up|2|||
156737696|NCT03843632|565784956|FG000|Overall Study|Withdrawal by Subject|1|||
156737697|NCT03843632|565784957|FG001|Overall Study|Withdrawal by Subject|0|||
156737698|NCT03843632|565784958|FG002|Overall Study|Withdrawal by Subject|0|||
156737699|NCT03843632|565784959|FG003|Overall Study|Withdrawal by Subject|0|||
156737700|NCT00813813|565784969|FG000|Overall Study|Withdrawal by Subject|1|||
156737701|NCT00813813|565784970|FG001|Overall Study|Withdrawal by Subject|1|||
156737702|NCT00813813|565784969|FG000|Overall Study|Lost to Follow-up|2|||
156737703|NCT00813813|565784970|FG001|Overall Study|Lost to Follow-up|7|||
156737704|NCT00813813|565784969|FG000|Overall Study|Other|0|||
156737705|NCT00813813|565784970|FG001|Overall Study|Other|1|||
156737706|NCT03197467|565786748|FG000|Overall Study|Withdrawal by Subject|1|||
156737707|NCT03666533|565786749|FG000|Overall Study|Lost to Follow-up|2|||
156737708|NCT03666533|565786750|FG001|Overall Study|Lost to Follow-up|2|||
156737709|NCT04743804|565786751|FG000|Overall Study|Other|1|||
156737710|NCT04743804|565786752|FG001|Overall Study|Other|0|||
156737711|NCT04743804|565786751|FG000|Overall Study|Withdrawal by Subject|0|||
156797018|NCT02904096|566009718|FG001|Overall Study|Adverse Event|0|||
156797019|NCT02904096|566009717|FG000|Overall Study|Withdrawal by Subject|4|||
156797020|NCT02904096|566009718|FG001|Overall Study|Withdrawal by Subject|3|||
156797021|NCT02904096|566009717|FG000|Overall Study|Lost to Follow-up|10|||
156797022|NCT02904096|566009718|FG001|Overall Study|Lost to Follow-up|17|||
156797023|NCT02904096|566009717|FG000|Overall Study|Non-compliant|3|||
156797024|NCT02904096|566009718|FG001|Overall Study|Non-compliant|1|||
156797025|NCT02904096|566009717|FG000|Overall Study|Sponsor instructed|1|||
156797026|NCT02904096|566009718|FG001|Overall Study|Sponsor instructed|0|||
156797027|NCT00663260|566009720|FG000|Overall Study|Lack of Efficacy|2|||
156797028|NCT00663260|566009721|FG001|Overall Study|Lack of Efficacy|0|||
156797029|NCT00663260|566009722|FG002|Overall Study|Lack of Efficacy|0|||
156797030|NCT00663260|566009720|FG000|Overall Study|Adverse Event|12|||
156797031|NCT00663260|566009721|FG001|Overall Study|Adverse Event|7|||
156797032|NCT00663260|566009722|FG002|Overall Study|Adverse Event|6|||
156797033|NCT00663260|566009720|FG000|Overall Study|Withdrawal by Subject|3|||
156797034|NCT00663260|566009721|FG001|Overall Study|Withdrawal by Subject|1|||
156797035|NCT00663260|566009722|FG002|Overall Study|Withdrawal by Subject|6|||
156797036|NCT00663260|566009720|FG000|Overall Study|Death|1|||
156797037|NCT00663260|566009721|FG001|Overall Study|Death|0|||
156797038|NCT00663260|566009722|FG002|Overall Study|Death|1|||
156797039|NCT00663260|566009720|FG000|Overall Study|Lost to Follow-up|0|||
156797040|NCT00663260|566009721|FG001|Overall Study|Lost to Follow-up|1|||
156797041|NCT00663260|566009722|FG002|Overall Study|Lost to Follow-up|0|||
156797042|NCT00663260|566009720|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
156797043|NCT00663260|566009721|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
156797044|NCT00663260|566009722|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
156737712|NCT04743804|565786752|FG001|Overall Study|Withdrawal by Subject|1|||
156797045|NCT01979185|566009723|FG000|Period 2|Other|0|||
156797046|NCT01979185|566009724|FG001|Period 2|Other|1|||
156797047|NCT00980798|566009725|FG000|Overall Study|Adverse Event|7|||
156797048|NCT00980798|566009726|FG001|Overall Study|Adverse Event|36|||
156797049|NCT00980798|566009725|FG000|Overall Study|Lack of Efficacy|16|||
156797050|NCT00980798|566009726|FG001|Overall Study|Lack of Efficacy|5|||
156737713|NCT04743804|565786751|FG000|Overall Study|Study Terminated by Sponsor|1|||
156737714|NCT04743804|565786752|FG001|Overall Study|Study Terminated by Sponsor|4|||
156737715|NCT04743804|565786751|FG000|Overall Study|Physician Decision|0|||
156737716|NCT04743804|565786752|FG001|Overall Study|Physician Decision|1|||
156737717|NCT04743804|565786751|FG000|Overall Study|Death|3|||
156797051|NCT00980798|566009725|FG000|Overall Study|Lost to Follow-up|0|||
157142292|NCT01073943|567267927|FG001|Overall Study|Adverse Event|1|||
156737718|NCT04743804|565786752|FG001|Overall Study|Death|0|||
156737719|NCT04338269|565786753|FG000|Overall Study|Death|86|||
156737720|NCT04338269|565786754|FG001|Overall Study|Death|89|||
156737721|NCT04338269|565786753|FG000|Overall Study|Lost to Follow-up|1|||
156737722|NCT04338269|565786754|FG001|Overall Study|Lost to Follow-up|2|||
156737723|NCT04338269|565786753|FG000|Overall Study|Physician Decision|1|||
156737724|NCT04338269|565786754|FG001|Overall Study|Physician Decision|0|||
156737725|NCT04338269|565786753|FG000|Overall Study|Withdrawal by Subject|14|||
156737726|NCT04338269|565786754|FG001|Overall Study|Withdrawal by Subject|11|||
156737727|NCT01424514|565786760|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
156737728|NCT01424514|565786761|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
156737729|NCT01424514|565786760|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
156737730|NCT01424514|565786761|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
156737731|NCT02002533|565786764|FG000|Overall Study|Withdrawal by Subject|6|||
156737732|NCT02002533|565786765|FG001|Overall Study|Withdrawal by Subject|13|||
156737733|NCT02002533|565786764|FG000|Overall Study|Protocol Violation|0|||
156737734|NCT02002533|565786765|FG001|Overall Study|Protocol Violation|1|||
156737735|NCT02002533|565786764|FG000|Overall Study|Adverse Event|0|||
156737736|NCT02002533|565786765|FG001|Overall Study|Adverse Event|3|||
156737737|NCT02002533|565786764|FG000|Overall Study|Lost to Follow-up|0|||
156737738|NCT02002533|565786765|FG001|Overall Study|Lost to Follow-up|1|||
156737739|NCT03408444|565786774|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
156737740|NCT03408444|565786775|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737741|NCT03408444|565786776|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737742|NCT03408444|565786777|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
156737743|NCT03408444|565786774|FG000|Overall Study|Lens Discomfort|0|||
156737744|NCT03408444|565786775|FG001|Overall Study|Lens Discomfort|1|||
156737745|NCT03408444|565786776|FG002|Overall Study|Lens Discomfort|0|||
156737746|NCT03408444|565786777|FG003|Overall Study|Lens Discomfort|0|||
156737747|NCT03408444|565786774|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
156737748|NCT03408444|565786775|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
157218323|NCT01722266|567545635|FG000|Overall Study|Dropped out due to Nausea|0|||
157218324|NCT01722266|567545636|FG001|Overall Study|Dropped out due to Nausea|0|||
157218325|NCT01722266|567545637|FG002|Overall Study|Dropped out due to Nausea|2|||
157218326|NCT01722266|567545638|FG003|Overall Study|Dropped out due to Nausea|0|||
157218327|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
157218328|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
157218329|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
157218330|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
157218331|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
157218332|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
157218333|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
157218334|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
157218335|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
157218336|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
157218337|NCT00124449|567545641|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
157218338|NCT00124449|567545642|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
157218339|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
157218340|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
157218341|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
157218342|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
157218343|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
156737749|NCT03408444|565786776|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
156737750|NCT03408444|565786777|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
156797052|NCT00980798|566009726|FG001|Overall Study|Lost to Follow-up|1|||
156797053|NCT00980798|566009725|FG000|Overall Study|Physician Decision|2|||
156797054|NCT00980798|566009726|FG001|Overall Study|Physician Decision|1|||
156797055|NCT00980798|566009725|FG000|Overall Study|Withdrawal by Subject|8|||
156797056|NCT00980798|566009726|FG001|Overall Study|Withdrawal by Subject|11|||
156797057|NCT00980798|566009725|FG000|Overall Study|Other|0|||
156797058|NCT00980798|566009726|FG001|Overall Study|Other|1|||
156797059|NCT00522379|566009727|FG000|Overall Study|Adverse Event|12|||
156797060|NCT00522379|566009728|FG001|Overall Study|Adverse Event|15|||
156797061|NCT00522379|566009729|FG002|Overall Study|Adverse Event|12|||
156797062|NCT00522379|566009730|FG003|Overall Study|Adverse Event|5|||
156797063|NCT00522379|566009731|FG004|Overall Study|Adverse Event|17|||
156797064|NCT00522379|566009727|FG000|Overall Study|Lack of Efficacy|3|||
156797065|NCT00522379|566009728|FG001|Overall Study|Lack of Efficacy|0|||
156797066|NCT00522379|566009729|FG002|Overall Study|Lack of Efficacy|2|||
157218344|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
157218345|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
157218346|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
156737751|NCT03408444|565786774|FG000|Overall Study|Withdrawal by Subject|0|||
156737752|NCT03408444|565786775|FG001|Overall Study|Withdrawal by Subject|2|||
156737753|NCT03408444|565786776|FG002|Overall Study|Withdrawal by Subject|3|||
156737754|NCT03408444|565786777|FG003|Overall Study|Withdrawal by Subject|0|||
156737755|NCT03408444|565786774|FG000|Overall Study|Lost to Follow-up|0|||
156737756|NCT03408444|565786775|FG001|Overall Study|Lost to Follow-up|0|||
156737757|NCT03408444|565786776|FG002|Overall Study|Lost to Follow-up|1|||
156737758|NCT03408444|565786777|FG003|Overall Study|Lost to Follow-up|0|||
156737759|NCT03408444|565786774|FG000|Overall Study|Adverse Event|0|||
156737760|NCT03408444|565786775|FG001|Overall Study|Adverse Event|0|||
156737761|NCT03408444|565786776|FG002|Overall Study|Adverse Event|0|||
156737762|NCT03408444|565786777|FG003|Overall Study|Adverse Event|1|||
156737763|NCT03408444|565786774|FG000|Overall Study|Lens Handling Difficulties|0|||
156737764|NCT03408444|565786775|FG001|Overall Study|Lens Handling Difficulties|0|||
156737765|NCT03408444|565786776|FG002|Overall Study|Lens Handling Difficulties|1|||
156737766|NCT03408444|565786777|FG003|Overall Study|Lens Handling Difficulties|0|||
156737767|NCT03408444|565786774|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737768|NCT03408444|565786775|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737769|NCT03408444|565786776|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
156737770|NCT03408444|565786777|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
156737771|NCT01741792|565786778|FG000|Overall Study|Death|6|||
156737772|NCT01741792|565786779|FG001|Overall Study|Death|1|||
156737773|NCT01741792|565786780|FG002|Overall Study|Death|12|||
156737774|NCT05139303|565786781|FG000|Overall Study|Lost to Follow-up|3|||
156737775|NCT05139303|565786782|FG001|Overall Study|Lost to Follow-up|0|||
156737776|NCT05139303|565786781|FG000|Overall Study|Adverse Event|1|||
156737777|NCT05139303|565786782|FG001|Overall Study|Adverse Event|0|||
156737778|NCT03875482|565786783|FG000|Overall Study|Adverse Event|0|||
156737779|NCT03875482|565786784|FG001|Overall Study|Adverse Event|1|||
156737780|NCT03875482|565786783|FG000|Overall Study|Withdrew consent|5|||
156737781|NCT03875482|565786784|FG001|Overall Study|Withdrew consent|6|||
156737782|NCT03875482|565786783|FG000|Overall Study|Lost to Follow-up|8|||
156797067|NCT00522379|566009730|FG003|Overall Study|Lack of Efficacy|2|||
156797068|NCT00522379|566009731|FG004|Overall Study|Lack of Efficacy|7|||
156797069|NCT00522379|566009727|FG000|Overall Study|Withdrawal by Subject|2|||
156797070|NCT00522379|566009728|FG001|Overall Study|Withdrawal by Subject|3|||
157218347|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
156797071|NCT00522379|566009729|FG002|Overall Study|Withdrawal by Subject|1|||
156797072|NCT00522379|566009730|FG003|Overall Study|Withdrawal by Subject|2|||
156797073|NCT00522379|566009731|FG004|Overall Study|Withdrawal by Subject|0|||
156797074|NCT00522379|566009727|FG000|Overall Study|Protocol Violation|1|||
156797075|NCT00522379|566009728|FG001|Overall Study|Protocol Violation|1|||
156797076|NCT00522379|566009729|FG002|Overall Study|Protocol Violation|2|||
156797077|NCT00522379|566009730|FG003|Overall Study|Protocol Violation|0|||
156797078|NCT00522379|566009731|FG004|Overall Study|Protocol Violation|0|||
156797079|NCT00522379|566009727|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
156797080|NCT00522379|566009728|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
156797081|NCT00522379|566009729|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
156797082|NCT00522379|566009730|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
156797083|NCT00522379|566009731|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
156797084|NCT00522379|566009727|FG000|Overall Study|Lost to Follow-up|1|||
156797085|NCT00522379|566009728|FG001|Overall Study|Lost to Follow-up|0|||
157218348|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
156737783|NCT03875482|565786784|FG001|Overall Study|Lost to Follow-up|2|||
156737784|NCT03875482|565786783|FG000|Overall Study|Lack of Efficacy|0|||
156737785|NCT03875482|565786784|FG001|Overall Study|Lack of Efficacy|11|||
156737786|NCT03197870|565786788|FG000|Overall Study|Adverse Event|9|||
156737787|NCT03197870|565786789|FG001|Overall Study|Adverse Event|4|||
156737788|NCT03197870|565786790|FG002|Overall Study|Adverse Event|6|||
156797086|NCT00522379|566009729|FG002|Overall Study|Lost to Follow-up|4|||
156797087|NCT00522379|566009730|FG003|Overall Study|Lost to Follow-up|2|||
156737789|NCT03197870|565786788|FG000|Overall Study|Withdrawal by Subject|2|||
156737790|NCT03197870|565786789|FG001|Overall Study|Withdrawal by Subject|3|||
156737791|NCT03197870|565786790|FG002|Overall Study|Withdrawal by Subject|0|||
156737792|NCT03197870|565786788|FG000|Overall Study|Lost to Follow-up|2|||
156737793|NCT03197870|565786789|FG001|Overall Study|Lost to Follow-up|2|||
156737794|NCT03197870|565786790|FG002|Overall Study|Lost to Follow-up|0|||
156797088|NCT00522379|566009731|FG004|Overall Study|Lost to Follow-up|2|||
156737795|NCT03197870|565786788|FG000|Overall Study|data not available|1|||
156797089|NCT00522379|566009727|FG000|Overall Study|Randomization error|0|||
156797090|NCT00522379|566009728|FG001|Overall Study|Randomization error|0|||
156737796|NCT03197870|565786789|FG001|Overall Study|data not available|1|||
156737797|NCT03197870|565786790|FG002|Overall Study|data not available|0|||
156737798|NCT01618019|565786791|FG000|Overall Study|Withdrawal by Subject|14|||
156737799|NCT01618019|565786792|FG001|Overall Study|Withdrawal by Subject|14|||
156737800|NCT01508130|565786793|FG000|Overall Study|Adverse Event|81|||
156737801|NCT01508130|565786794|FG001|Overall Study|Adverse Event|28|||
156737802|NCT01508130|565786793|FG000|Overall Study|Death|3|||
156737803|NCT01508130|565786794|FG001|Overall Study|Death|1|||
156737804|NCT01508130|565786793|FG000|Overall Study|Protocol Violation|2|||
156737805|NCT01508130|565786794|FG001|Overall Study|Protocol Violation|0|||
156737806|NCT01508130|565786793|FG000|Overall Study|Lost to Follow-up|25|||
156737807|NCT01508130|565786794|FG001|Overall Study|Lost to Follow-up|2|||
156737808|NCT01508130|565786793|FG000|Overall Study|Withdrawal by Subject|3|||
156737809|NCT01508130|565786794|FG001|Overall Study|Withdrawal by Subject|3|||
156737810|NCT01508130|565786793|FG000|Overall Study|Subject's substantial non-compliance|25|||
156737811|NCT01508130|565786794|FG001|Overall Study|Subject's substantial non-compliance|9|||
156737812|NCT01508130|565786793|FG000|Overall Study|Insufficient therapeutic response|74|||
156737813|NCT01508130|565786794|FG001|Overall Study|Insufficient therapeutic response|23|||
156737814|NCT01508130|565786793|FG000|Overall Study|Administrative|14|||
156737815|NCT01508130|565786794|FG001|Overall Study|Administrative|3|||
156737816|NCT01680159|565786795|FG000|Screening Period|Not meet criteria for dose-up period|7|||
156737817|NCT01680159|565786795|FG000|Increased Dose Period|Adverse Event|6|||
156737818|NCT01680159|565786795|FG000|Increased Dose Period|Withdrawal by Subject|2|||
156737819|NCT02783729|565786799|FG000|Overall Study|Lack of Efficacy|1|||
156737820|NCT02783729|565786800|FG001|Overall Study|Lack of Efficacy|0|||
156737821|NCT02783729|565786801|FG002|Overall Study|Lack of Efficacy|0|||
156737822|NCT02783729|565786802|FG003|Overall Study|Lack of Efficacy|0|||
156737823|NCT02783729|565786799|FG000|Overall Study|Adverse Event|2|||
156737824|NCT02783729|565786800|FG001|Overall Study|Adverse Event|6|||
156737825|NCT02783729|565786801|FG002|Overall Study|Adverse Event|2|||
156737826|NCT02783729|565786802|FG003|Overall Study|Adverse Event|3|||
156737827|NCT02783729|565786799|FG000|Overall Study|Other|1|||
156737828|NCT02783729|565786800|FG001|Overall Study|Other|6|||
156737829|NCT02783729|565786801|FG002|Overall Study|Other|2|||
156737830|NCT02783729|565786802|FG003|Overall Study|Other|3|||
156737831|NCT02783729|565786799|FG000|Overall Study|Withdrawal by Subject|2|||
156737832|NCT02783729|565786800|FG001|Overall Study|Withdrawal by Subject|3|||
156737833|NCT02783729|565786801|FG002|Overall Study|Withdrawal by Subject|1|||
156737834|NCT02783729|565786802|FG003|Overall Study|Withdrawal by Subject|2|||
156737835|NCT02783729|565786799|FG000|Overall Study|Participant's choice|2|||
156737836|NCT02783729|565786800|FG001|Overall Study|Participant's choice|1|||
156737837|NCT02783729|565786801|FG002|Overall Study|Participant's choice|2|||
156737838|NCT02783729|565786802|FG003|Overall Study|Participant's choice|1|||
156737839|NCT02783729|565786799|FG000|Overall Study|Lost to Follow-up|2|||
156737840|NCT02783729|565786800|FG001|Overall Study|Lost to Follow-up|1|||
156737841|NCT02783729|565786801|FG002|Overall Study|Lost to Follow-up|1|||
156737842|NCT02783729|565786802|FG003|Overall Study|Lost to Follow-up|0|||
156737843|NCT02288091|565786804|FG000|Overall Study|Lost to Follow-up|1|||
156737844|NCT02288091|565786804|FG000|Overall Study|Screen fail|7|||
156737845|NCT03403751|565786805|FG000|Overall Study|Death|5|||
156737846|NCT03403751|565786806|FG001|Overall Study|Death|6|||
156737847|NCT03403751|565786805|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
156737848|NCT03403751|565786806|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
156737849|NCT00387010|565786810|FG000|Dose Titration Period|Adverse Event|12|||
156737850|NCT00387010|565786810|FG000|Dose Titration Period|Lack of Efficacy|5|||
156737851|NCT00387010|565786810|FG000|Dose Titration Period|Withdrawal by Subject|3|||
156737852|NCT00387010|565786810|FG000|Dose Titration Period|Protocol Violation|1|||
156737853|NCT00387010|565786810|FG000|Dose Titration Period|Lost to Follow-up|2|||
156737854|NCT00387010|565786810|FG000|Dose Titration Period|Noncompliance with study medication|8|||
156737855|NCT00387010|565786810|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
156737856|NCT00387010|565786810|FG000|Treatment Period|Adverse Event|4|||
156737857|NCT00387010|565786810|FG000|Treatment Period|Withdrawal by Subject|1|||
156737858|NCT00387010|565786810|FG000|Treatment Period|Noncompliance with study medication|2|||
156737859|NCT00387010|565786810|FG000|Treatment Period|Noncompliance with study procedures|3|||
157218349|NCT00124449|567545641|FG000|18-Month Untreated Observation Period|Relocated|1|||
156737860|NCT00387010|565786810|FG000|Treatment Period|Participant reported study drug stolen|1|||
156737861|NCT03085238|565786817|FG000|Overall Study|Adverse Event|2|||
156737862|NCT03085238|565786817|FG000|Overall Study|Death|2|||
156737863|NCT01931956|565786818|FG000|Overall Study|Death|42|||
156737864|NCT01931956|565786819|FG001|Overall Study|Death|7|||
156737865|NCT01931956|565786820|FG002|Overall Study|Death|379|||
156797091|NCT00522379|566009729|FG002|Overall Study|Randomization error|0|||
156797092|NCT00522379|566009730|FG003|Overall Study|Randomization error|0|||
156737866|NCT01931956|565786821|FG003|Overall Study|Death|96|||
156737867|NCT01931956|565786818|FG000|Overall Study|Withdrawal by Subject|5|||
156737868|NCT01931956|565786819|FG001|Overall Study|Withdrawal by Subject|0|||
156797093|NCT00522379|566009731|FG004|Overall Study|Randomization error|1|||
156737869|NCT01931956|565786820|FG002|Overall Study|Withdrawal by Subject|70|||
156737870|NCT01931956|565786821|FG003|Overall Study|Withdrawal by Subject|30|||
156737871|NCT01931956|565786818|FG000|Overall Study|Lost to Follow-up|2|||
156737872|NCT01931956|565786819|FG001|Overall Study|Lost to Follow-up|0|||
156737873|NCT01931956|565786820|FG002|Overall Study|Lost to Follow-up|11|||
156737874|NCT01931956|565786821|FG003|Overall Study|Lost to Follow-up|7|||
156737875|NCT01931956|565786818|FG000|Overall Study|Expected|2|||
156737876|NCT01931956|565786819|FG001|Overall Study|Expected|0|||
156737877|NCT01931956|565786820|FG002|Overall Study|Expected|6|||
156737878|NCT01931956|565786821|FG003|Overall Study|Expected|0|||
156737879|NCT01931956|565786818|FG000|Overall Study|Not due|0|||
156737880|NCT01931956|565786819|FG001|Overall Study|Not due|0|||
156737881|NCT01931956|565786820|FG002|Overall Study|Not due|21|||
156737882|NCT01931956|565786821|FG003|Overall Study|Not due|0|||
156737883|NCT02847494|565786822|FG000|Overall Study|Lost to Follow-up|8|||
156737884|NCT02847494|565786823|FG001|Overall Study|Lost to Follow-up|5|||
156737885|NCT02294175|565786824|FG000|Overall Study|Withdrawal by Subject|1|||
156737886|NCT02294175|565786825|FG001|Overall Study|Withdrawal by Subject|2|||
156737887|NCT02294175|565786824|FG000|Overall Study|pt taking excluded medication|3|||
156737888|NCT02294175|565786825|FG001|Overall Study|pt taking excluded medication|1|||
156737889|NCT02294175|565786824|FG000|Overall Study|Protocol Violation|1|||
156737890|NCT02294175|565786825|FG001|Overall Study|Protocol Violation|0|||
156737891|NCT02294175|565786824|FG000|Overall Study|Lost to Follow-up|0|||
156737892|NCT02294175|565786825|FG001|Overall Study|Lost to Follow-up|1|||
156737893|NCT02294175|565786824|FG000|Overall Study|wound healed|0|||
156737894|NCT02294175|565786825|FG001|Overall Study|wound healed|2|||
156737895|NCT02548351|565786826|FG000|Overall Study|Withdrawal by Subject|149|||
156737896|NCT02548351|565786827|FG001|Overall Study|Withdrawal by Subject|154|||
156737897|NCT02548351|565786828|FG002|Overall Study|Withdrawal by Subject|152|||
156737898|NCT02548351|565786826|FG000|Overall Study|Death|11|||
156737899|NCT02548351|565786827|FG001|Overall Study|Death|15|||
156737900|NCT02548351|565786828|FG002|Overall Study|Death|12|||
156737901|NCT02548351|565786826|FG000|Overall Study|Adverse Event|22|||
156737902|NCT02548351|565786827|FG001|Overall Study|Adverse Event|56|||
156737903|NCT02548351|565786828|FG002|Overall Study|Adverse Event|36|||
156737904|NCT02548351|565786826|FG000|Overall Study|Study Terminated by Sponsor|549|||
156737905|NCT02548351|565786827|FG001|Overall Study|Study Terminated by Sponsor|509|||
156737906|NCT02548351|565786828|FG002|Overall Study|Study Terminated by Sponsor|528|||
156737907|NCT02548351|565786826|FG000|Overall Study|Site Closure|14|||
156737908|NCT02548351|565786827|FG001|Overall Study|Site Closure|5|||
156737909|NCT02548351|565786828|FG002|Overall Study|Site Closure|7|||
156737910|NCT02548351|565786826|FG000|Overall Study|Non-compliance with Study Drug|4|||
156737911|NCT02548351|565786827|FG001|Overall Study|Non-compliance with Study Drug|2|||
156737912|NCT02548351|565786828|FG002|Overall Study|Non-compliance with Study Drug|0|||
156737913|NCT02548351|565786826|FG000|Overall Study|Protocol Violation|2|||
156737914|NCT02548351|565786827|FG001|Overall Study|Protocol Violation|1|||
156737915|NCT02548351|565786828|FG002|Overall Study|Protocol Violation|2|||
156737916|NCT02548351|565786826|FG000|Overall Study|Physician Decision|11|||
156737917|NCT02548351|565786827|FG001|Overall Study|Physician Decision|18|||
156737918|NCT02548351|565786828|FG002|Overall Study|Physician Decision|11|||
156737919|NCT02548351|565786826|FG000|Overall Study|Lost to Follow-up|43|||
156737920|NCT02548351|565786827|FG001|Overall Study|Lost to Follow-up|50|||
156737921|NCT02548351|565786828|FG002|Overall Study|Lost to Follow-up|57|||
156737922|NCT02548351|565786826|FG000|Overall Study|Other|19|||
156737923|NCT02548351|565786827|FG001|Overall Study|Other|16|||
156737924|NCT02548351|565786828|FG002|Overall Study|Other|20|||
156737925|NCT02548351|565786826|FG000|Overall Study|Missing|1|||
156737926|NCT02548351|565786827|FG001|Overall Study|Missing|1|||
156737927|NCT02548351|565786828|FG002|Overall Study|Missing|0|||
156737928|NCT01901653|565786829|FG000|Overall Study|Death|2|||
156737929|NCT01901653|565786830|FG001|Overall Study|Death|1|||
156737930|NCT01901653|565786831|FG002|Overall Study|Death|8|||
156737931|NCT01901653|565786832|FG003|Overall Study|Death|3|||
156737932|NCT01901653|565786833|FG004|Overall Study|Death|2|||
156737933|NCT01901653|565786834|FG005|Overall Study|Death|2|||
156737934|NCT01901653|565786835|FG006|Overall Study|Death|6|||
156737935|NCT01901653|565786836|FG007|Overall Study|Death|9|||
156737936|NCT01901653|565786837|FG008|Overall Study|Death|1|||
157020371|NCT04490915|566828404|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
157020372|NCT04083235|566828405|FG000|Overall Study|Death|252|||
156737937|NCT01901653|565786838|FG009|Overall Study|Death|16|||
156737938|NCT01901653|565786839|FG010|Overall Study|Death|2|||
156737939|NCT01901653|565786840|FG011|Overall Study|Death|15|||
156737940|NCT01901653|565786841|FG012|Overall Study|Death|4|||
156737941|NCT01901653|565786829|FG000|Overall Study|Lost to Follow-up|1|||
156737942|NCT01901653|565786830|FG001|Overall Study|Lost to Follow-up|0|||
156737943|NCT01901653|565786831|FG002|Overall Study|Lost to Follow-up|2|||
156737944|NCT01901653|565786832|FG003|Overall Study|Lost to Follow-up|0|||
156737945|NCT01901653|565786833|FG004|Overall Study|Lost to Follow-up|0|||
156737946|NCT01901653|565786834|FG005|Overall Study|Lost to Follow-up|1|||
156737947|NCT01901653|565786835|FG006|Overall Study|Lost to Follow-up|0|||
157020373|NCT04083235|566828406|FG001|Overall Study|Death|277|||
156737948|NCT01901653|565786836|FG007|Overall Study|Lost to Follow-up|1|||
156737949|NCT01901653|565786837|FG008|Overall Study|Lost to Follow-up|0|||
156737950|NCT01901653|565786838|FG009|Overall Study|Lost to Follow-up|0|||
156737951|NCT01901653|565786839|FG010|Overall Study|Lost to Follow-up|0|||
156737952|NCT01901653|565786840|FG011|Overall Study|Lost to Follow-up|0|||
156737953|NCT01901653|565786841|FG012|Overall Study|Lost to Follow-up|0|||
156737954|NCT01901653|565786829|FG000|Overall Study|Withdrawal by Subject|0|||
156737955|NCT01901653|565786830|FG001|Overall Study|Withdrawal by Subject|0|||
156737956|NCT01901653|565786831|FG002|Overall Study|Withdrawal by Subject|0|||
156737957|NCT01901653|565786832|FG003|Overall Study|Withdrawal by Subject|0|||
156737958|NCT01901653|565786833|FG004|Overall Study|Withdrawal by Subject|0|||
156737959|NCT01901653|565786834|FG005|Overall Study|Withdrawal by Subject|0|||
156737960|NCT01901653|565786835|FG006|Overall Study|Withdrawal by Subject|1|||
156737961|NCT01901653|565786836|FG007|Overall Study|Withdrawal by Subject|0|||
156737962|NCT01901653|565786837|FG008|Overall Study|Withdrawal by Subject|0|||
156737963|NCT01901653|565786838|FG009|Overall Study|Withdrawal by Subject|0|||
156737964|NCT01901653|565786839|FG010|Overall Study|Withdrawal by Subject|0|||
156737965|NCT01901653|565786840|FG011|Overall Study|Withdrawal by Subject|0|||
156737966|NCT01901653|565786841|FG012|Overall Study|Withdrawal by Subject|0|||
156737967|NCT01901653|565786829|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
156737968|NCT01901653|565786830|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
156737969|NCT01901653|565786831|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
156737970|NCT01901653|565786832|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
156737971|NCT01901653|565786833|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
156737972|NCT01901653|565786834|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
156737973|NCT01901653|565786835|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
156737974|NCT01901653|565786836|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
156737975|NCT01901653|565786837|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
156737976|NCT01901653|565786838|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
156737977|NCT01901653|565786839|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
156737978|NCT01901653|565786840|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
156737979|NCT01901653|565786841|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
156737980|NCT03226769|565786847|FG000|Overall Study|Withdrawal by Subject|0|||
156737981|NCT03226769|565786848|FG001|Overall Study|Withdrawal by Subject|1|||
156737982|NCT02640677|565786849|FG000|Overall Study|Lost to Follow-up|1|||
156737983|NCT02640677|565786849|FG000|Overall Study|Withdrawal by Subject|1|||
156737984|NCT01516008|565786856|FG000|Overall Study|Adverse Event|0|||
156737985|NCT01516008|565786857|FG001|Overall Study|Adverse Event|2|||
156737986|NCT01516008|565786858|FG002|Overall Study|Adverse Event|7|||
156737987|NCT01516008|565786856|FG000|Overall Study|Lack of Efficacy|44|||
156737988|NCT01516008|565786857|FG001|Overall Study|Lack of Efficacy|14|||
156737989|NCT01516008|565786858|FG002|Overall Study|Lack of Efficacy|10|||
156737990|NCT01516008|565786856|FG000|Overall Study|Protocol Violation|1|||
157218350|NCT00124449|567545642|FG001|18-Month Untreated Observation Period|Relocated|0|||
157218351|NCT03811249|567545643|FG000|Overall Study|Withdrawal by Subject|44|||
157218352|NCT03811249|567545643|FG000|Overall Study|Missed Visit|24|||
157218353|NCT01783730|567545645|FG000|Overall Study|Failed to meet inclusion criteria|6|||
157218354|NCT02151461|567545646|FG000|Overall Study|Adverse Event|5|||
157218355|NCT02151461|567545647|FG001|Overall Study|Adverse Event|1|||
157218356|NCT02151461|567545648|FG002|Overall Study|Adverse Event|0|||
157218357|NCT02151461|567545649|FG003|Overall Study|Adverse Event|2|||
157218358|NCT02151461|567545646|FG000|Overall Study|Lost to Follow-up|0|||
157218359|NCT02151461|567545647|FG001|Overall Study|Lost to Follow-up|0|||
157218360|NCT02151461|567545648|FG002|Overall Study|Lost to Follow-up|1|||
157218361|NCT02151461|567545649|FG003|Overall Study|Lost to Follow-up|1|||
157218362|NCT02151461|567545646|FG000|Overall Study|Withdrawal by Subject|1|||
157218363|NCT02151461|567545647|FG001|Overall Study|Withdrawal by Subject|0|||
157218364|NCT02151461|567545648|FG002|Overall Study|Withdrawal by Subject|1|||
157218365|NCT02151461|567545649|FG003|Overall Study|Withdrawal by Subject|1|||
157218366|NCT02151461|567545646|FG000|Overall Study|Treatment discontinuation|0|||
157218367|NCT02151461|567545647|FG001|Overall Study|Treatment discontinuation|0|||
157218368|NCT02151461|567545648|FG002|Overall Study|Treatment discontinuation|1|||
157218369|NCT02151461|567545649|FG003|Overall Study|Treatment discontinuation|0|||
157218370|NCT04304950|567545650|FG000|Overall Study|Lost to Follow-up|1|||
157218371|NCT04304950|567545651|FG001|Overall Study|Lost to Follow-up|1|||
156737991|NCT01516008|565786857|FG001|Overall Study|Protocol Violation|0|||
156737992|NCT01516008|565786858|FG002|Overall Study|Protocol Violation|0|||
156737993|NCT01516008|565786856|FG000|Overall Study|Reason not specified|0|||
156737994|NCT01516008|565786857|FG001|Overall Study|Reason not specified|0|||
156797094|NCT00522379|566009727|FG000|Overall Study|Dispensing error|1|||
157218372|NCT00408876|567545656|FG000|Overall Study|Adverse Event|9|||
157218373|NCT00408876|567545657|FG001|Overall Study|Adverse Event|17|||
157218374|NCT00408876|567545658|FG002|Overall Study|Adverse Event|27|||
157218375|NCT00408876|567545659|FG003|Overall Study|Adverse Event|10|||
157218376|NCT00408876|567545656|FG000|Overall Study|Withdrawal by Subject|3|||
157020374|NCT04083235|566828405|FG000|Overall Study|Withdrawal by Subject|13|||
157020375|NCT04083235|566828406|FG001|Overall Study|Withdrawal by Subject|17|||
157020376|NCT04083235|566828405|FG000|Overall Study|Lost to Follow-up|1|||
157020377|NCT04083235|566828406|FG001|Overall Study|Lost to Follow-up|1|||
157020378|NCT04083235|566828405|FG000|Overall Study|Does not meet entry criteria|1|||
157020379|NCT04083235|566828406|FG001|Overall Study|Does not meet entry criteria|0|||
157020380|NCT04083235|566828405|FG000|Overall Study|Did not receive treatment|13|||
157020381|NCT04083235|566828406|FG001|Overall Study|Did not receive treatment|8|||
157020382|NCT04083235|566828405|FG000|Overall Study|Ongoing at the time of DCO|44|||
157020383|NCT04083235|566828406|FG001|Overall Study|Ongoing at the time of DCO|7|||
157020384|NCT02992925|566828407|FG000|Cohort 2|Physician Decision|0|||
157020385|NCT02992925|566828408|FG001|Cohort 2|Physician Decision|0|||
157020386|NCT02992925|566828409|FG002|Cohort 2|Physician Decision|1|||
157020387|NCT02992925|566828410|FG003|Cohort 2|Physician Decision|0|||
157020388|NCT02992925|566828407|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
157020389|NCT02992925|566828408|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
156737995|NCT01516008|565786858|FG002|Overall Study|Reason not specified|1|||
156737996|NCT04553471|565786859|FG000|Overall Study|Did not start treatment on protocol|3|||
156737997|NCT04553471|565786859|FG000|Overall Study|Death|1|||
156737998|NCT02805660|565786861|FG000|Overall Study|Death|5|||
156737999|NCT02805660|565786862|FG001|Overall Study|Death|2|||
156738000|NCT02805660|565786863|FG002|Overall Study|Death|9|||
156738001|NCT02805660|565786864|FG003|Overall Study|Death|5|||
156738002|NCT02805660|565786865|FG004|Overall Study|Death|0|||
156738003|NCT02805660|565786866|FG005|Overall Study|Death|14|||
156738004|NCT02805660|565786867|FG006|Overall Study|Death|12|||
156738005|NCT02805660|565786861|FG000|Overall Study|Lost to Follow-up|0|||
156738006|NCT02805660|565786862|FG001|Overall Study|Lost to Follow-up|1|||
156738007|NCT02805660|565786863|FG002|Overall Study|Lost to Follow-up|1|||
156738008|NCT02805660|565786864|FG003|Overall Study|Lost to Follow-up|2|||
156738009|NCT02805660|565786865|FG004|Overall Study|Lost to Follow-up|0|||
156738010|NCT02805660|565786866|FG005|Overall Study|Lost to Follow-up|0|||
156738011|NCT02805660|565786867|FG006|Overall Study|Lost to Follow-up|0|||
156738012|NCT02805660|565786861|FG000|Overall Study|Withdrawal by Subject|0|||
156738013|NCT02805660|565786862|FG001|Overall Study|Withdrawal by Subject|0|||
156738014|NCT02805660|565786863|FG002|Overall Study|Withdrawal by Subject|0|||
156738015|NCT02805660|565786864|FG003|Overall Study|Withdrawal by Subject|3|||
156738016|NCT02805660|565786865|FG004|Overall Study|Withdrawal by Subject|1|||
156738017|NCT02805660|565786866|FG005|Overall Study|Withdrawal by Subject|0|||
156738018|NCT02805660|565786867|FG006|Overall Study|Withdrawal by Subject|2|||
156738019|NCT02805660|565786861|FG000|Overall Study|Study terminated by Sponsor|0|||
156797095|NCT00522379|566009728|FG001|Overall Study|Dispensing error|0|||
156797096|NCT00522379|566009729|FG002|Overall Study|Dispensing error|0|||
156797097|NCT00522379|566009730|FG003|Overall Study|Dispensing error|1|||
156797098|NCT00522379|566009731|FG004|Overall Study|Dispensing error|0|||
156797099|NCT00522379|566009727|FG000|Overall Study|Subject Moved|1|||
156797100|NCT00522379|566009728|FG001|Overall Study|Subject Moved|1|||
156797101|NCT00522379|566009729|FG002|Overall Study|Subject Moved|0|||
156797102|NCT00522379|566009730|FG003|Overall Study|Subject Moved|0|||
156797103|NCT00522379|566009731|FG004|Overall Study|Subject Moved|0|||
156797104|NCT00522379|566009727|FG000|Overall Study|Sponsor Request|0|||
156797105|NCT00522379|566009728|FG001|Overall Study|Sponsor Request|1|||
156797106|NCT00522379|566009729|FG002|Overall Study|Sponsor Request|0|||
156797107|NCT00522379|566009730|FG003|Overall Study|Sponsor Request|0|||
156797108|NCT00522379|566009731|FG004|Overall Study|Sponsor Request|0|||
156797109|NCT00522379|566009727|FG000|Overall Study|Family Problem|0|||
156797110|NCT00522379|566009728|FG001|Overall Study|Family Problem|0|||
156797111|NCT00522379|566009729|FG002|Overall Study|Family Problem|1|||
156797112|NCT00522379|566009730|FG003|Overall Study|Family Problem|0|||
156797113|NCT00522379|566009731|FG004|Overall Study|Family Problem|0|||
156797114|NCT00522379|566009727|FG000|Overall Study|Site Closed|0|||
156797115|NCT00522379|566009728|FG001|Overall Study|Site Closed|0|||
156797116|NCT00522379|566009729|FG002|Overall Study|Site Closed|0|||
156797117|NCT00522379|566009730|FG003|Overall Study|Site Closed|1|||
156797118|NCT00522379|566009731|FG004|Overall Study|Site Closed|0|||
156797119|NCT00522379|566009727|FG000|Overall Study|Subject Withdrawal|0|||
156797120|NCT00522379|566009728|FG001|Overall Study|Subject Withdrawal|0|||
156797121|NCT00522379|566009729|FG002|Overall Study|Subject Withdrawal|0|||
156797122|NCT00522379|566009730|FG003|Overall Study|Subject Withdrawal|1|||
156797123|NCT00522379|566009731|FG004|Overall Study|Subject Withdrawal|0|||
156797124|NCT03238196|566009734|FG000|Overall Study|Adverse Event|3|||
156797125|NCT03238196|566009735|FG001|Overall Study|Adverse Event|0|||
157020390|NCT02992925|566828409|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
156738020|NCT02805660|565786862|FG001|Overall Study|Study terminated by Sponsor|0|||
156738021|NCT02805660|565786863|FG002|Overall Study|Study terminated by Sponsor|1|||
156738022|NCT02805660|565786864|FG003|Overall Study|Study terminated by Sponsor|4|||
156738023|NCT02805660|565786865|FG004|Overall Study|Study terminated by Sponsor|2|||
156797126|NCT03238196|566009736|FG002|Overall Study|Adverse Event|2|||
156797127|NCT03238196|566009737|FG003|Overall Study|Adverse Event|2|||
156797128|NCT03238196|566009734|FG000|Overall Study|Withdrawal by Subject|4|||
156738024|NCT02805660|565786866|FG005|Overall Study|Study terminated by Sponsor|3|||
156738025|NCT02805660|565786867|FG006|Overall Study|Study terminated by Sponsor|1|||
156738026|NCT02805660|565786861|FG000|Overall Study|Miscellaneous|0|||
156738027|NCT02805660|565786862|FG001|Overall Study|Miscellaneous|1|||
156738028|NCT02805660|565786863|FG002|Overall Study|Miscellaneous|0|||
156738029|NCT02805660|565786864|FG003|Overall Study|Miscellaneous|4|||
156738030|NCT02805660|565786865|FG004|Overall Study|Miscellaneous|0|||
156738031|NCT02805660|565786866|FG005|Overall Study|Miscellaneous|6|||
156738032|NCT02805660|565786867|FG006|Overall Study|Miscellaneous|4|||
156738033|NCT02572076|565786869|FG000|Overall Study|Protocol Violation|1|||
156738034|NCT02778074|565786870|FG000|Overall Study|Lost to Follow-up|7|||
156738035|NCT02778074|565786871|FG001|Overall Study|Lost to Follow-up|10|||
156738036|NCT01684943|565786874|FG000|Overall Study|Inadequate Venous Access|3|||
156738037|NCT01684943|565786875|FG001|Overall Study|Inadequate Venous Access|0|||
156738038|NCT01684943|565786876|FG002|Overall Study|Inadequate Venous Access|0|||
156738039|NCT01684943|565786874|FG000|Overall Study|Principal Investigator Determination|1|||
156738040|NCT01684943|565786875|FG001|Overall Study|Principal Investigator Determination|0|||
156738041|NCT01684943|565786876|FG002|Overall Study|Principal Investigator Determination|0|||
156738042|NCT01684943|565786874|FG000|Overall Study|Excluded from Analysis|1|||
156738043|NCT01684943|565786875|FG001|Overall Study|Excluded from Analysis|1|||
156738044|NCT01684943|565786876|FG002|Overall Study|Excluded from Analysis|1|||
156738045|NCT01684943|565786874|FG000|Overall Study|Lost to Follow-up|3|||
156738046|NCT01684943|565786875|FG001|Overall Study|Lost to Follow-up|0|||
156738047|NCT01684943|565786876|FG002|Overall Study|Lost to Follow-up|0|||
156738048|NCT01684943|565786874|FG000|Overall Study|Planning Pregnancy|1|||
156738049|NCT01684943|565786875|FG001|Overall Study|Planning Pregnancy|0|||
156738050|NCT01684943|565786876|FG002|Overall Study|Planning Pregnancy|0|||
156738051|NCT04064411|565786877|FG000|Overall Study|Adverse Event|29|||
156738052|NCT04064411|565786878|FG001|Overall Study|Adverse Event|19|||
156738053|NCT04064411|565786877|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
156738054|NCT04064411|565786878|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
156738055|NCT04064411|565786877|FG000|Overall Study|Protocol Deviation|0|||
156738056|NCT04064411|565786878|FG001|Overall Study|Protocol Deviation|2|||
156738057|NCT04064411|565786877|FG000|Overall Study|Withdrawal by Subject|25|||
156738058|NCT04064411|565786878|FG001|Overall Study|Withdrawal by Subject|29|||
156738059|NCT04064411|565786877|FG000|Overall Study|Lost to Follow-up|5|||
156738060|NCT04064411|565786878|FG001|Overall Study|Lost to Follow-up|2|||
156738061|NCT04064411|565786877|FG000|Overall Study|Other than Specified|4|||
156738062|NCT04064411|565786878|FG001|Overall Study|Other than Specified|1|||
156738063|NCT04064411|565786877|FG000|Overall Study|Death|1|||
156738064|NCT04064411|565786878|FG001|Overall Study|Death|0|||
156738065|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
156738066|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
156738067|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
156738068|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738069|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738070|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738071|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
156738072|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738073|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
156738074|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
156738075|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738076|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738077|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738078|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
156738079|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
156738080|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
156738081|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738082|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738083|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738084|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738085|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
156738086|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738087|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
156738088|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738089|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738090|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738091|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738092|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
156738093|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
157142293|NCT01073943|567267926|FG000|Overall Study|Lost to Follow-up|0|||
156738094|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738095|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
156738096|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738097|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738098|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738099|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
156738100|NCT03395184|565786879|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
156738101|NCT03395184|565786880|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
156738102|NCT03395184|565786881|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
156738103|NCT03395184|565786882|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
156738104|NCT03395184|565786883|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
156738105|NCT03395184|565786884|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
157218377|NCT00408876|567545657|FG001|Overall Study|Withdrawal by Subject|6|||
157218378|NCT00408876|567545658|FG002|Overall Study|Withdrawal by Subject|6|||
157218379|NCT00408876|567545659|FG003|Overall Study|Withdrawal by Subject|14|||
157218380|NCT00408876|567545656|FG000|Overall Study|Lack of Efficacy|2|||
157218381|NCT00408876|567545657|FG001|Overall Study|Lack of Efficacy|4|||
157218382|NCT00408876|567545658|FG002|Overall Study|Lack of Efficacy|5|||
157218383|NCT00408876|567545659|FG003|Overall Study|Lack of Efficacy|6|||
157218384|NCT00408876|567545656|FG000|Overall Study|Lost to Follow-up|1|||
157218385|NCT00408876|567545657|FG001|Overall Study|Lost to Follow-up|6|||
157218386|NCT00408876|567545658|FG002|Overall Study|Lost to Follow-up|5|||
157218387|NCT00408876|567545659|FG003|Overall Study|Lost to Follow-up|2|||
157218388|NCT00408876|567545656|FG000|Overall Study|Protocol Violation|0|||
157218389|NCT00408876|567545657|FG001|Overall Study|Protocol Violation|3|||
157218390|NCT00408876|567545658|FG002|Overall Study|Protocol Violation|4|||
157218391|NCT00408876|567545659|FG003|Overall Study|Protocol Violation|3|||
157218392|NCT00408876|567545656|FG000|Overall Study|Physician Decision|1|||
157218393|NCT00408876|567545657|FG001|Overall Study|Physician Decision|0|||
157218394|NCT00408876|567545658|FG002|Overall Study|Physician Decision|3|||
157218395|NCT00408876|567545659|FG003|Overall Study|Physician Decision|0|||
157218396|NCT01337050|567545665|FG000|Overall Study|Death|0|||
157218397|NCT01337050|567545666|FG001|Overall Study|Death|0|||
157218398|NCT01337050|567545667|FG002|Overall Study|Death|4|||
157218399|NCT01337050|567545665|FG000|Overall Study|Other|4|||
157218400|NCT01337050|567545666|FG001|Overall Study|Other|6|||
157218401|NCT01337050|567545667|FG002|Overall Study|Other|8|||
157218402|NCT01337050|567545665|FG000|Overall Study|Participants refused further follow-up|0|||
157218403|NCT01337050|567545666|FG001|Overall Study|Participants refused further follow-up|7|||
157218404|NCT01337050|567545667|FG002|Overall Study|Participants refused further follow-up|7|||
157218405|NCT00003102|567545668|FG000|Overall Study|Physician Decision|1|||
157218406|NCT00003102|567545669|FG001|Overall Study|Physician Decision|1|||
157218407|NCT00003102|567545670|FG002|Overall Study|Physician Decision|0|||
157218408|NCT00003102|567545668|FG000|Overall Study|Progressive Disease|0|||
157218409|NCT00003102|567545669|FG001|Overall Study|Progressive Disease|1|||
157218410|NCT00003102|567545670|FG002|Overall Study|Progressive Disease|0|||
157218411|NCT00003102|567545668|FG000|Overall Study|Adverse Event|0|||
157218412|NCT00003102|567545669|FG001|Overall Study|Adverse Event|1|||
157218413|NCT00003102|567545670|FG002|Overall Study|Adverse Event|1|||
157218414|NCT00003102|567545668|FG000|Overall Study|Death|0|||
157218415|NCT00003102|567545669|FG001|Overall Study|Death|0|||
157218416|NCT00003102|567545670|FG002|Overall Study|Death|1|||
157218417|NCT00096486|567545673|FG000|Overall Study|Withdrawal by Subject|0|||
157218418|NCT00096486|567545674|FG001|Overall Study|Withdrawal by Subject|0|||
157218419|NCT00096486|567545675|FG002|Overall Study|Withdrawal by Subject|1|||
157218420|NCT00096486|567545676|FG003|Overall Study|Withdrawal by Subject|1|||
157218421|NCT00096486|567545673|FG000|Overall Study|Not Treated|0|||
157218422|NCT00096486|567545674|FG001|Overall Study|Not Treated|0|||
157218423|NCT00096486|567545675|FG002|Overall Study|Not Treated|1|||
156738106|NCT03395184|565786885|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
156738107|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
156738108|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
157218424|NCT00096486|567545676|FG003|Overall Study|Not Treated|1|||
157218425|NCT01559818|567545677|FG000|Overall Study|Physician Decision|1|||
157218426|NCT01559818|567545677|FG000|Overall Study|Pregnancy|1|||
157218427|NCT01559818|567545677|FG000|Overall Study|Study terminated by Sponsor|4|||
156738109|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
156738110|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
156738111|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
156738112|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
157218428|NCT01559818|567545677|FG000|Overall Study|Withdrawal by Subject|1|||
157218429|NCT01512979|567545678|FG000|Overall Study|Adverse Event|2|||
157218430|NCT01512979|567545679|FG001|Overall Study|Adverse Event|2|||
157218431|NCT01512979|567545678|FG000|Overall Study|Protocol Violation|1|||
157218432|NCT01512979|567545679|FG001|Overall Study|Protocol Violation|4|||
157218433|NCT01512979|567545678|FG000|Overall Study|Lost to Follow-up|2|||
157218434|NCT01512979|567545679|FG001|Overall Study|Lost to Follow-up|5|||
157218435|NCT01512979|567545678|FG000|Overall Study|Withdrawal by Subject|1|||
157218436|NCT01512979|567545679|FG001|Overall Study|Withdrawal by Subject|2|||
156738113|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
156738114|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738115|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738116|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
156738117|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
156738118|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
156738119|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
156738120|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
156738121|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738122|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738123|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738124|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738125|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
156738126|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738127|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
156738128|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738129|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738130|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
156738131|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
156738132|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
156738133|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
156738134|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
156797129|NCT03238196|566009735|FG001|Overall Study|Withdrawal by Subject|1|||
156797130|NCT03238196|566009736|FG002|Overall Study|Withdrawal by Subject|1|||
156797131|NCT03238196|566009737|FG003|Overall Study|Withdrawal by Subject|0|||
156797132|NCT03238196|566009734|FG000|Overall Study|Disease progression|14|||
156797133|NCT03238196|566009735|FG001|Overall Study|Disease progression|2|||
156797134|NCT03238196|566009736|FG002|Overall Study|Disease progression|3|||
156797135|NCT03238196|566009737|FG003|Overall Study|Disease progression|2|||
156797136|NCT03238196|566009734|FG000|Overall Study|Still on treatment|1|||
156797137|NCT03238196|566009735|FG001|Overall Study|Still on treatment|0|||
156797138|NCT03238196|566009736|FG002|Overall Study|Still on treatment|0|||
156797139|NCT03238196|566009737|FG003|Overall Study|Still on treatment|0|||
156797140|NCT04562090|566009738|FG000|Overall Study|Withdrawal by Subject|3|||
156797141|NCT04562090|566009739|FG001|Overall Study|Withdrawal by Subject|4|||
156797142|NCT04562090|566009738|FG000|Overall Study|Protocol Violation|2|||
156797143|NCT04562090|566009739|FG001|Overall Study|Protocol Violation|0|||
156797144|NCT04562090|566009738|FG000|Overall Study|Lack of Efficacy|0|||
156797145|NCT04562090|566009739|FG001|Overall Study|Lack of Efficacy|1|||
156797146|NCT04562090|566009738|FG000|Overall Study|Adverse Event|1|||
156797147|NCT04562090|566009739|FG001|Overall Study|Adverse Event|4|||
156797148|NCT04562090|566009738|FG000|Overall Study|Miscellaneous|0|||
156797149|NCT04562090|566009739|FG001|Overall Study|Miscellaneous|3|||
156797150|NCT00847730|566009740|FG000|Overall Study|Multiple interruptions in therapy|8|||
156797151|NCT04938427|566009743|FG000|Overall Study|Adverse Event|5|||
156797152|NCT04938427|566009744|FG001|Overall Study|Adverse Event|19|||
156797153|NCT04938427|566009743|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156797154|NCT04938427|566009744|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156797155|NCT04938427|566009743|FG000|Overall Study|Withdrawal by Subject|1|||
156797156|NCT04938427|566009744|FG001|Overall Study|Withdrawal by Subject|0|||
156797157|NCT04938427|566009743|FG000|Overall Study|Reason Not Specified|2|||
156797158|NCT04938427|566009744|FG001|Overall Study|Reason Not Specified|1|||
156797159|NCT02402647|566009755|FG000|Overall Study|Lost to Follow-up|13|||
156797160|NCT02402647|566009756|FG001|Overall Study|Lost to Follow-up|7|||
156797161|NCT02402647|566009755|FG000|Overall Study|Protocol Violation|1|||
156797162|NCT02402647|566009756|FG001|Overall Study|Protocol Violation|1|||
156797163|NCT02402647|566009755|FG000|Overall Study|scheduled and timed out|2|||
156797164|NCT02402647|566009756|FG001|Overall Study|scheduled and timed out|1|||
156797165|NCT02402647|566009755|FG000|Overall Study|medical illness|2|||
156797166|NCT02402647|566009756|FG001|Overall Study|medical illness|4|||
156797167|NCT02402647|566009755|FG000|Overall Study|Moved|2|||
156797168|NCT02402647|566009756|FG001|Overall Study|Moved|0|||
157020391|NCT02992925|566828410|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
157218437|NCT01512979|567545678|FG000|Overall Study|Reason other than stated above|13|||
156797169|NCT02402647|566009755|FG000|Overall Study|loved one illness|1|||
156797170|NCT02402647|566009756|FG001|Overall Study|loved one illness|0|||
156797171|NCT02402647|566009755|FG000|Overall Study|deceased preexisting condition|2|||
156797172|NCT02402647|566009756|FG001|Overall Study|deceased preexisting condition|0|||
156797173|NCT02402647|566009755|FG000|Overall Study|Other|2|||
156797174|NCT02402647|566009756|FG001|Overall Study|Other|1|||
156738135|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
157020392|NCT04150718|566828414|FG000|Overall Study|Withdrawal by Subject|2|||
157020393|NCT04150718|566828415|FG001|Overall Study|Withdrawal by Subject|7|||
156738136|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738137|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738138|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
156738139|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738140|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
156738141|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
156738142|NCT03395184|565786879|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738143|NCT03395184|565786880|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738144|NCT03395184|565786881|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
156738145|NCT03395184|565786882|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
156738146|NCT03395184|565786883|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
156738147|NCT03395184|565786884|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
156738148|NCT03395184|565786885|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
156738149|NCT00356135|565786889|FG000|Overall Study|Protocol Violation|1|||
156738150|NCT00356135|565786890|FG001|Overall Study|Protocol Violation|0|||
156738151|NCT00356135|565786891|FG002|Overall Study|Protocol Violation|0|||
156738152|NCT00356135|565786889|FG000|Overall Study|Adverse Event|1|||
156738153|NCT00356135|565786890|FG001|Overall Study|Adverse Event|0|||
156738154|NCT00356135|565786891|FG002|Overall Study|Adverse Event|0|||
156738155|NCT00356135|565786889|FG000|Overall Study|Lost to Follow-up|0|||
156738156|NCT00356135|565786890|FG001|Overall Study|Lost to Follow-up|0|||
156738157|NCT00356135|565786891|FG002|Overall Study|Lost to Follow-up|1|||
156738158|NCT00356135|565786889|FG000|Overall Study|Physician Decision|1|||
156738159|NCT00356135|565786890|FG001|Overall Study|Physician Decision|1|||
156738160|NCT00356135|565786891|FG002|Overall Study|Physician Decision|1|||
156738161|NCT00356135|565786889|FG000|Overall Study|Subject non-compliance|1|||
156738162|NCT00356135|565786890|FG001|Overall Study|Subject non-compliance|1|||
156738163|NCT00356135|565786891|FG002|Overall Study|Subject non-compliance|3|||
156738164|NCT03617770|565786892|FG000|Overall Study|Lost to Follow-up|1|||
156738165|NCT03617770|565786893|FG001|Overall Study|Lost to Follow-up|0|||
156738166|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156738167|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
156738168|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
156738169|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
156738170|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
156738171|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
156738172|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
156738173|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
156738174|NCT03963232|565786894|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
156738175|NCT03963232|565786895|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
156738176|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Adverse Event|1|||
156738177|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Adverse Event|2|||
157020394|NCT04150718|566828416|FG002|Overall Study|Withdrawal by Subject|1|||
156738178|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
156738179|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
157020395|NCT04150718|566828414|FG000|Overall Study|Lost to Follow-up|1|||
157020396|NCT04150718|566828415|FG001|Overall Study|Lost to Follow-up|2|||
157020397|NCT04150718|566828416|FG002|Overall Study|Lost to Follow-up|0|||
156738180|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
156738181|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
157020398|NCT04150718|566828414|FG000|Overall Study|Ineligible|1|||
156738182|NCT03963232|565786894|FG000|Open-Label Treatment Phase|Pregnancy|1|||
156738183|NCT03963232|565786895|FG001|Open-Label Treatment Phase|Pregnancy|0|||
156738184|NCT03963232|565786894|FG000|Follow-up Phase|Withdrawal by Subject|7|||
156738185|NCT03963232|565786895|FG001|Follow-up Phase|Withdrawal by Subject|5|||
156738186|NCT03963232|565786894|FG000|Follow-up Phase|Protocol Violation|0|||
156738187|NCT03963232|565786895|FG001|Follow-up Phase|Protocol Violation|2|||
156738188|NCT03963232|565786894|FG000|Follow-up Phase|Adverse Event|0|||
156738189|NCT03963232|565786895|FG001|Follow-up Phase|Adverse Event|1|||
156738190|NCT03963232|565786894|FG000|Follow-up Phase|Lost to Follow-up|0|||
156738191|NCT03963232|565786895|FG001|Follow-up Phase|Lost to Follow-up|1|||
156738192|NCT03512210|565786896|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
156738193|NCT03512210|565786896|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
156738194|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Death|2|||
156738195|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
156738196|NCT03512210|565786896|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
156738197|NCT01672710|565786897|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
156738198|NCT01672710|565786898|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
156738199|NCT01672710|565786897|FG000|3 Month Follow up|Lost to Follow-up|2|||
156738200|NCT01672710|565786898|FG001|3 Month Follow up|Lost to Follow-up|3|||
156738201|NCT01672710|565786897|FG000|3 Month Follow up|follow up due after termination date|4|||
156738202|NCT01672710|565786898|FG001|3 Month Follow up|follow up due after termination date|1|||
156738203|NCT05033262|565786904|FG000|Overall Study|Lost to Follow-up|1|||
156738204|NCT05033262|565786905|FG001|Overall Study|Lost to Follow-up|0|||
156738205|NCT05033262|565786906|FG002|Overall Study|Lost to Follow-up|0|||
156738206|NCT05033262|565786907|FG003|Overall Study|Lost to Follow-up|1|||
156738207|NCT05270395|565786908|FG000|Overall Study|Lost to Follow-up|2|||
156738208|NCT05270395|565786909|FG001|Overall Study|Lost to Follow-up|2|||
156738209|NCT05270395|565786908|FG000|Overall Study|Death|1|||
156738210|NCT05270395|565786909|FG001|Overall Study|Death|2|||
156738211|NCT05270395|565786908|FG000|Overall Study|Study Team Withdrew|1|||
156738212|NCT05270395|565786909|FG001|Overall Study|Study Team Withdrew|0|||
156738213|NCT00970632|565788914|FG000|Overall Study|Adverse Event|2|||
156738214|NCT00970632|565788915|FG001|Overall Study|Adverse Event|2|||
156738215|NCT00970632|565788916|FG002|Overall Study|Adverse Event|1|||
156738216|NCT00970632|565788914|FG000|Overall Study|Lack of Efficacy|3|||
156738217|NCT00970632|565788915|FG001|Overall Study|Lack of Efficacy|0|||
156738218|NCT00970632|565788916|FG002|Overall Study|Lack of Efficacy|0|||
156738219|NCT00970632|565788914|FG000|Overall Study|Lost to Follow-up|3|||
156738220|NCT00970632|565788915|FG001|Overall Study|Lost to Follow-up|0|||
156738221|NCT00970632|565788916|FG002|Overall Study|Lost to Follow-up|2|||
156738222|NCT00970632|565788914|FG000|Overall Study|Protocol Violation|8|||
156738223|NCT00970632|565788915|FG001|Overall Study|Protocol Violation|5|||
156738224|NCT00970632|565788916|FG002|Overall Study|Protocol Violation|8|||
156738225|NCT00970632|565788914|FG000|Overall Study|Withdrawal by Subject|7|||
157020399|NCT04150718|566828415|FG001|Overall Study|Ineligible|0|||
157020400|NCT04150718|566828416|FG002|Overall Study|Ineligible|10|||
157020401|NCT04673929|566828417|FG000|Overall Study|Death|73|||
157020402|NCT04673929|566828417|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
157020403|NCT03175029|566828420|FG000|Overall Study|Withdrawal by Subject|2|||
157020404|NCT03175029|566828421|FG001|Overall Study|Withdrawal by Subject|1|||
157020405|NCT03175029|566828420|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
157020406|NCT03175029|566828421|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
157020407|NCT03047928|566828425|FG000|Overall Study|Adverse Event|0|||
157020408|NCT03047928|566828426|FG001|Overall Study|Adverse Event|2|||
157020409|NCT03047928|566828427|FG002|Overall Study|Adverse Event|0|||
157020410|NCT03047928|566828425|FG000|Overall Study|Protocol Violation|0|||
157020411|NCT03047928|566828426|FG001|Overall Study|Protocol Violation|1|||
157020412|NCT03047928|566828427|FG002|Overall Study|Protocol Violation|0|||
157020413|NCT03047928|566828425|FG000|Overall Study|included in another protocol|0|||
157020414|NCT03047928|566828426|FG001|Overall Study|included in another protocol|1|||
157142294|NCT01073943|567267927|FG001|Overall Study|Lost to Follow-up|2|||
157020415|NCT03047928|566828427|FG002|Overall Study|included in another protocol|0|||
156797178|NCT03559556|566009761|FG000|Overall Study|Withdrawal by Subject|1|||
156797179|NCT02457793|566009762|FG000|Overall Study|Reason not specified|0|||
156797180|NCT02457793|566009763|FG001|Overall Study|Reason not specified|0|||
156797181|NCT02457793|566009764|FG002|Overall Study|Reason not specified|0|||
156797182|NCT02457793|566009765|FG003|Overall Study|Reason not specified|1|||
156797183|NCT02457793|566009766|FG004|Overall Study|Reason not specified|1|||
156797184|NCT02457793|566009767|FG005|Overall Study|Reason not specified|1|||
156797185|NCT02457793|566009762|FG000|Overall Study|Withdrawal by Subject|0|||
156797186|NCT02457793|566009763|FG001|Overall Study|Withdrawal by Subject|4|||
156797187|NCT02457793|566009764|FG002|Overall Study|Withdrawal by Subject|2|||
156797188|NCT02457793|566009765|FG003|Overall Study|Withdrawal by Subject|2|||
156797189|NCT02457793|566009766|FG004|Overall Study|Withdrawal by Subject|2|||
156797190|NCT02457793|566009767|FG005|Overall Study|Withdrawal by Subject|2|||
156797191|NCT02457793|566009762|FG000|Overall Study|Adverse Event|0|||
156797192|NCT02457793|566009763|FG001|Overall Study|Adverse Event|0|||
156797193|NCT02457793|566009764|FG002|Overall Study|Adverse Event|0|||
156797194|NCT02457793|566009765|FG003|Overall Study|Adverse Event|1|||
156797195|NCT02457793|566009766|FG004|Overall Study|Adverse Event|0|||
156797196|NCT02457793|566009767|FG005|Overall Study|Adverse Event|0|||
156797197|NCT02457793|566009762|FG000|Overall Study|Physician Decision|1|||
156797198|NCT02457793|566009763|FG001|Overall Study|Physician Decision|0|||
156797199|NCT02457793|566009764|FG002|Overall Study|Physician Decision|1|||
156797200|NCT02457793|566009765|FG003|Overall Study|Physician Decision|1|||
156797201|NCT02457793|566009766|FG004|Overall Study|Physician Decision|1|||
156797202|NCT02457793|566009767|FG005|Overall Study|Physician Decision|3|||
156797203|NCT00835172|566009772|FG000|Washout|Protocol Violation|0|||
156797204|NCT00835172|566009773|FG001|Washout|Protocol Violation|1|||
156797205|NCT03941093|566009774|FG000|Overall Study|Protocol Violation|0|||
156797206|NCT03941093|566009775|FG001|Overall Study|Protocol Violation|1|||
156797207|NCT03941093|566009774|FG000|Overall Study|Withdrawal by Subject|9|||
156797208|NCT03941093|566009775|FG001|Overall Study|Withdrawal by Subject|6|||
156797209|NCT01344356|566011236|FG000|Overall Study|Physician Decision|0|||
156797210|NCT01344356|566011237|FG001|Overall Study|Physician Decision|3|||
156797211|NCT01344356|566011236|FG000|Overall Study|Lost to Follow-up|0|||
156797212|NCT01344356|566011237|FG001|Overall Study|Lost to Follow-up|6|||
156797213|NCT02390076|566011239|FG000|Overall Study|Lost to Follow-up|2|||
156797214|NCT02390076|566011240|FG001|Overall Study|Lost to Follow-up|1|||
156797215|NCT02390076|566011241|FG002|Overall Study|Lost to Follow-up|4|||
156797216|NCT01206517|566011242|FG000|Overall Study|Withdrawal by Subject|0|||
156797217|NCT01206517|566011243|FG001|Overall Study|Withdrawal by Subject|0|||
156797218|NCT01206517|566011244|FG002|Overall Study|Withdrawal by Subject|2|||
156797219|NCT01206517|566011245|FG003|Overall Study|Withdrawal by Subject|0|||
156797220|NCT01206517|566011246|FG004|Overall Study|Withdrawal by Subject|1|||
156797221|NCT01206517|566011247|FG005|Overall Study|Withdrawal by Subject|0|||
156797222|NCT00553254|566011250|FG000|Overall Study|Death|3|||
156797223|NCT00553254|566011251|FG001|Overall Study|Death|6|||
156797224|NCT00553254|566011252|FG002|Overall Study|Death|25|||
156797225|NCT00553254|566011250|FG000|Overall Study|Lost to Follow-up|0|||
156797226|NCT00553254|566011251|FG001|Overall Study|Lost to Follow-up|0|||
156797227|NCT00553254|566011252|FG002|Overall Study|Lost to Follow-up|2|||
156797228|NCT00553254|566011250|FG000|Overall Study|Withdrawal by Subject|2|||
156797229|NCT00553254|566011251|FG001|Overall Study|Withdrawal by Subject|0|||
156797230|NCT00553254|566011252|FG002|Overall Study|Withdrawal by Subject|2|||
157021790|NCT00378105|566832971|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
156797231|NCT00553254|566011250|FG000|Overall Study|Study terminated by Sponsor|0|||
156797232|NCT00553254|566011251|FG001|Overall Study|Study terminated by Sponsor|0|||
156797233|NCT00553254|566011252|FG002|Overall Study|Study terminated by Sponsor|1|||
156797234|NCT00553254|566011250|FG000|Overall Study|Other|1|||
156797235|NCT00553254|566011251|FG001|Overall Study|Other|0|||
156738226|NCT00970632|565788915|FG001|Overall Study|Withdrawal by Subject|6|||
156738227|NCT00970632|565788916|FG002|Overall Study|Withdrawal by Subject|4|||
156738228|NCT00970632|565788914|FG000|Overall Study|Entry criteria not met|0|||
156738229|NCT00970632|565788915|FG001|Overall Study|Entry criteria not met|2|||
156738230|NCT00970632|565788916|FG002|Overall Study|Entry criteria not met|2|||
156738231|NCT00970632|565788914|FG000|Overall Study|Sponsor decision|1|||
156738232|NCT00970632|565788915|FG001|Overall Study|Sponsor decision|0|||
156738233|NCT00970632|565788916|FG002|Overall Study|Sponsor decision|1|||
156797236|NCT00553254|566011252|FG002|Overall Study|Other|13|||
156877159|NCT03760731|566309767|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
156877160|NCT03760731|566309768|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
156877161|NCT03760731|566309767|FG000|Treatment|Attended less than 70% of sessions|10|||
156877162|NCT03760731|566309768|FG001|Treatment|Attended less than 70% of sessions|15|||
156877163|NCT01970358|566309769|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
156877164|NCT01970358|566309769|FG000|Overall Study|Ineligible at time of second consent|4|||
156797237|NCT02546323|566011253|FG000|Overall Study|Withdrawal by Subject|36|||
156797238|NCT02546323|566011254|FG001|Overall Study|Withdrawal by Subject|33|||
156797239|NCT02546323|566011253|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
156797240|NCT02546323|566011254|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
156797241|NCT02546323|566011253|FG000|Overall Study|Adverse Event|17|||
156797242|NCT02546323|566011254|FG001|Overall Study|Adverse Event|11|||
156797243|NCT02546323|566011253|FG000|Overall Study|Patient Specific Reasons|1|||
156797244|NCT02546323|566011254|FG001|Overall Study|Patient Specific Reasons|2|||
156797245|NCT02546323|566011253|FG000|Overall Study|Lost to Follow-up|2|||
156797246|NCT02546323|566011254|FG001|Overall Study|Lost to Follow-up|3|||
156797247|NCT02546323|566011253|FG000|Overall Study|Non-compliance with Study Drug|2|||
156738234|NCT01286168|565788919|FG000|Overall Study|Withdrawal by Subject|1|||
156738235|NCT01286168|565788919|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
156797248|NCT02546323|566011254|FG001|Overall Study|Non-compliance with Study Drug|2|||
156738236|NCT02487771|565788920|FG000|Overall Study|Lost to Follow-up|2|||
157218438|NCT01512979|567545679|FG001|Overall Study|Reason other than stated above|9|||
156738237|NCT02487771|565788921|FG001|Overall Study|Lost to Follow-up|3|||
156738238|NCT02487771|565788920|FG000|Overall Study|Moved out of area|5|||
156738239|NCT02487771|565788921|FG001|Overall Study|Moved out of area|6|||
156738240|NCT02487771|565788920|FG000|Overall Study|Withdrawal by Subject|3|||
156738241|NCT02487771|565788921|FG001|Overall Study|Withdrawal by Subject|5|||
156738242|NCT02653170|565788922|FG000|Overall Study|Withdrawal by Subject|3|||
156738243|NCT02653170|565788923|FG001|Overall Study|Withdrawal by Subject|8|||
156738244|NCT02653170|565788924|FG002|Overall Study|Withdrawal by Subject|3|||
156738245|NCT02653170|565788922|FG000|Overall Study|withdrawn by study team|2|||
156738246|NCT02653170|565788923|FG001|Overall Study|withdrawn by study team|4|||
156738247|NCT02653170|565788924|FG002|Overall Study|withdrawn by study team|5|||
156738248|NCT02653170|565788922|FG000|Overall Study|Lost to Follow-up|12|||
156738249|NCT02653170|565788923|FG001|Overall Study|Lost to Follow-up|4|||
156738250|NCT02653170|565788924|FG002|Overall Study|Lost to Follow-up|10|||
156738251|NCT01482065|565788925|FG000|Overall Study|Withdrawal by Subject|0|||
156738252|NCT01482065|565788926|FG001|Overall Study|Withdrawal by Subject|1|||
156738253|NCT01942486|565788927|FG000|Overall Study|Lost to Follow-up|27|||
156738254|NCT03728426|565788928|FG000|Overall Study|Death|3|||
156738255|NCT02424630|565788931|FG000|Overall Study|No rotator cuff tear|1|||
156738256|NCT02424630|565788932|FG001|Overall Study|No rotator cuff tear|2|||
156738257|NCT02424630|565788931|FG000|Overall Study|Open procedure|0|||
156738258|NCT02424630|565788932|FG001|Overall Study|Open procedure|1|||
156738259|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
156738260|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
156738261|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
156738262|NCT01995175|565788933|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
156738263|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
156738264|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
156738265|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
156738266|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
156738267|NCT01995175|565788933|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
156738268|NCT00984061|565788934|FG000|Clarithromycin Alone|Protocol Violation|1|||
156738269|NCT00761280|565788935|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
156738270|NCT00761280|565788936|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
156738271|NCT00761280|565788935|FG000|Randomization to First Dose|Sponsor decision|1|||
156738272|NCT00761280|565788936|FG001|Randomization to First Dose|Sponsor decision|0|||
156738273|NCT00761280|565788935|FG000|Randomization to First Dose|Other|1|||
156738274|NCT00761280|565788936|FG001|Randomization to First Dose|Other|0|||
156738275|NCT00761280|565788935|FG000|First Dose to End of Study|End of trial|5|||
156738276|NCT00761280|565788936|FG001|First Dose to End of Study|End of trial|5|||
156738277|NCT00761280|565788935|FG000|First Dose to End of Study|Progressive disease|5|||
156738278|NCT00761280|565788936|FG001|First Dose to End of Study|Progressive disease|3|||
156738279|NCT00761280|565788935|FG000|First Dose to End of Study|Sponsor decision|1|||
156738280|NCT00761280|565788936|FG001|First Dose to End of Study|Sponsor decision|2|||
156738281|NCT00761280|565788935|FG000|First Dose to End of Study|Death|1|||
156738282|NCT00761280|565788936|FG001|First Dose to End of Study|Death|0|||
156738283|NCT00761280|565788935|FG000|First Dose to End of Study|Lost to Follow-up|0|||
156738284|NCT00761280|565788936|FG001|First Dose to End of Study|Lost to Follow-up|1|||
156738285|NCT04777201|565788940|FG000|Main Study|Withdrawal by Subject|19|||
156738286|NCT04777201|565788941|FG001|Main Study|Withdrawal by Subject|27|||
156738287|NCT04777201|565788942|FG002|Main Study|Withdrawal by Subject|0|||
156738288|NCT04777201|565788940|FG000|Main Study|Death|13|||
156738289|NCT04777201|565788941|FG001|Main Study|Death|27|||
156738290|NCT04777201|565788942|FG002|Main Study|Death|0|||
156738291|NCT04777201|565788940|FG000|Main Study|Subject missed the safety follow-up visit|9|||
156738292|NCT04777201|565788941|FG001|Main Study|Subject missed the safety follow-up visit|10|||
156738293|NCT04777201|565788942|FG002|Main Study|Subject missed the safety follow-up visit|0|||
156738294|NCT04777201|565788940|FG000|Main Study|Physician Decision|8|||
156738295|NCT04777201|565788941|FG001|Main Study|Physician Decision|10|||
156738296|NCT04777201|565788942|FG002|Main Study|Physician Decision|0|||
156738297|NCT04777201|565788940|FG000|Main Study|Adverse Event|8|||
156797249|NCT02546323|566011253|FG000|Overall Study|Met Withdrawal Criteria|2|||
156797250|NCT02546323|566011254|FG001|Overall Study|Met Withdrawal Criteria|14|||
156797251|NCT04023487|566011256|FG000|Overall Study|Lost to Follow-up|5|||
156797252|NCT04023487|566011257|FG001|Overall Study|Lost to Follow-up|4|||
156797253|NCT04023487|566011256|FG000|Overall Study|Pregnancy|1|||
156797254|NCT04023487|566011257|FG001|Overall Study|Pregnancy|2|||
156797255|NCT04023487|566011256|FG000|Overall Study|Withdrawal by Subject|4|||
156797256|NCT04023487|566011257|FG001|Overall Study|Withdrawal by Subject|5|||
156797257|NCT04023487|566011256|FG000|Overall Study|Partially completed testing|8|||
156738298|NCT04777201|565788941|FG001|Main Study|Adverse Event|8|||
156738299|NCT04777201|565788942|FG002|Main Study|Adverse Event|0|||
156738300|NCT04777201|565788940|FG000|Main Study|Lost to Follow-up|9|||
156738301|NCT04777201|565788941|FG001|Main Study|Lost to Follow-up|4|||
156738302|NCT04777201|565788942|FG002|Main Study|Lost to Follow-up|0|||
156797258|NCT04023487|566011257|FG001|Overall Study|Partially completed testing|4|||
156797259|NCT03898180|566011258|FG000|Overall Study|Death|178|||
156797260|NCT03898180|566011259|FG001|Overall Study|Death|173|||
156738303|NCT04777201|565788940|FG000|Main Study|Reason not specified|3|||
156738304|NCT04777201|565788941|FG001|Main Study|Reason not specified|3|||
156738305|NCT04777201|565788942|FG002|Main Study|Reason not specified|0|||
156738306|NCT04777201|565788940|FG000|Main Study|Lack of Efficacy|1|||
156738307|NCT04777201|565788941|FG001|Main Study|Lack of Efficacy|1|||
156738308|NCT04777201|565788942|FG002|Main Study|Lack of Efficacy|0|||
156738309|NCT04777201|565788940|FG000|Main Study|Protocol Violation|1|||
156738310|NCT04777201|565788941|FG001|Main Study|Protocol Violation|0|||
156738311|NCT04777201|565788942|FG002|Main Study|Protocol Violation|0|||
156738312|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
156738313|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
156738314|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
156738315|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
156738316|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
156738317|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
156738318|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
156738319|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
156738320|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
156738321|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
156738322|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
156738323|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
156738324|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
156738325|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
156738326|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
156738327|NCT04777201|565788940|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
156738328|NCT04777201|565788941|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
156738329|NCT04777201|565788942|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
156738330|NCT00507819|565788945|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
156738331|NCT00507819|565788946|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
156738332|NCT02045862|565788949|FG000|Overall Study|Death|0|||
156738333|NCT02045862|565788950|FG001|Overall Study|Death|0|||
156738334|NCT02045862|565788951|FG002|Overall Study|Death|1|||
156738335|NCT02045862|565788949|FG000|Overall Study|Miscellaneous|5|||
156738336|NCT02045862|565788950|FG001|Overall Study|Miscellaneous|0|||
156738337|NCT02045862|565788951|FG002|Overall Study|Miscellaneous|8|||
156738338|NCT02045862|565788949|FG000|Overall Study|Withdrawal by Patient|18|||
156738339|NCT02045862|565788950|FG001|Overall Study|Withdrawal by Patient|27|||
156797261|NCT03898180|566011258|FG000|Overall Study|Physician Decision|1|||
156797262|NCT03898180|566011259|FG001|Overall Study|Physician Decision|0|||
156797263|NCT03898180|566011258|FG000|Overall Study|Sponsor Decision|3|||
156797264|NCT03898180|566011259|FG001|Overall Study|Sponsor Decision|0|||
156797265|NCT03898180|566011258|FG000|Overall Study|Lost to Follow-up|1|||
156797266|NCT03898180|566011259|FG001|Overall Study|Lost to Follow-up|0|||
156797267|NCT03898180|566011258|FG000|Overall Study|Withdrawal by Subject|5|||
156797268|NCT03898180|566011259|FG001|Overall Study|Withdrawal by Subject|4|||
156738340|NCT02045862|565788951|FG002|Overall Study|Withdrawal by Patient|57|||
156738341|NCT02045862|565788949|FG000|Overall Study|Protocol Violation|0|||
156797269|NCT00645658|566011260|FG000|Overall Study|Withdrawal by Subject|1|||
156738342|NCT02045862|565788950|FG001|Overall Study|Protocol Violation|0|||
156738343|NCT02045862|565788951|FG002|Overall Study|Protocol Violation|6|||
156738344|NCT02045862|565788949|FG000|Overall Study|Lack of Efficacy|8|||
156738345|NCT02045862|565788950|FG001|Overall Study|Lack of Efficacy|4|||
156797270|NCT00645658|566011261|FG001|Overall Study|Withdrawal by Subject|0|||
156797271|NCT00645658|566011260|FG000|Overall Study|Did not complete all assesments|0|||
156738346|NCT02045862|565788951|FG002|Overall Study|Lack of Efficacy|13|||
156738347|NCT02045862|565788949|FG000|Overall Study|Randomized but not Received Study Drug|0|||
156738348|NCT02045862|565788950|FG001|Overall Study|Randomized but not Received Study Drug|2|||
156877285|NCT03869216|566309776|FG000|Overall Study|prostate removed during the study|1|||
156877286|NCT03869216|566309777|FG001|Overall Study|prostate removed during the study|1|||
156877287|NCT03869216|566309776|FG000|Overall Study|Withdrawal by Subject|0|||
156877288|NCT03869216|566309777|FG001|Overall Study|Withdrawal by Subject|1|||
156877289|NCT03869216|566309776|FG000|Overall Study|Lost to Follow-up|3|||
156877290|NCT03869216|566309777|FG001|Overall Study|Lost to Follow-up|12|||
156877291|NCT03869216|566309776|FG000|Overall Study|Changed clinical site or moved out of city|5|||
156738349|NCT02045862|565788951|FG002|Overall Study|Randomized but not Received Study Drug|8|||
156738350|NCT02045862|565788949|FG000|Overall Study|Adverse Event|7|||
156738351|NCT02045862|565788950|FG001|Overall Study|Adverse Event|5|||
156738352|NCT02045862|565788951|FG002|Overall Study|Adverse Event|27|||
156738353|NCT02045862|565788949|FG000|Overall Study|Lost to Follow-up|1|||
156738354|NCT02045862|565788950|FG001|Overall Study|Lost to Follow-up|2|||
156738355|NCT02045862|565788951|FG002|Overall Study|Lost to Follow-up|6|||
156738356|NCT02691013|565788956|FG000|Overall Study|Withdrawal by Subject|3|||
156738357|NCT02691013|565788957|FG001|Overall Study|Withdrawal by Subject|0|||
156738358|NCT04507256|565788958|FG000|Overall Study|Withdrawal by Subject|1|||
156738359|NCT04507256|565788959|FG001|Overall Study|Withdrawal by Subject|0|||
156738360|NCT04507256|565788960|FG002|Overall Study|Withdrawal by Subject|0|||
156738361|NCT04507256|565788961|FG003|Overall Study|Withdrawal by Subject|1|||
156877292|NCT03869216|566309777|FG001|Overall Study|Changed clinical site or moved out of city|9|||
156877293|NCT03869216|566309776|FG000|Overall Study|No primary care appointment scheduled|10|||
156877294|NCT03869216|566309777|FG001|Overall Study|No primary care appointment scheduled|4|||
156877295|NCT03869216|566309776|FG000|Overall Study|Death|1|||
156738362|NCT04507256|565788962|FG004|Overall Study|Withdrawal by Subject|0|||
156738363|NCT04507256|565788963|FG005|Overall Study|Withdrawal by Subject|0|||
156797272|NCT00645658|566011261|FG001|Overall Study|Did not complete all assesments|2|||
156797273|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
156797274|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
156797275|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
156797276|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
156797277|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
156797278|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
156797279|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
156797280|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
156797281|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
156797282|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
156797283|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
156797284|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
156797285|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
156797286|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
156797287|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
156797288|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
156797289|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
156797290|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
156797291|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
156797292|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
156797293|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
156797294|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
156797295|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
156797296|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
156797297|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
156797298|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
156797299|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
156797300|NCT03093415|566011264|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
156797301|NCT03093415|566011265|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
156797302|NCT03093415|566011266|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
156797303|NCT03093415|566011264|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
156797304|NCT03093415|566011265|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
156797305|NCT03093415|566011266|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
156797306|NCT01605097|566011272|FG000|Overall Study|Protocol Violation|1|||
156797307|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Adverse Event|3|||
156797308|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Adverse Event|0|||
156797309|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Adverse Event|0|||
156797310|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
156797311|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
156797312|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
156797313|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
156797314|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
156797315|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
156797316|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
156797317|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
156797318|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
156797319|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
156797320|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
156797321|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
156797322|NCT04380142|566011284|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
156797323|NCT04380142|566011285|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
156797324|NCT04380142|566011286|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
156797325|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156797326|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156797327|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Adverse Event|14|||
156797328|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
156797329|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
156797330|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
156797331|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156797332|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156797333|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
156797334|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
156877296|NCT03869216|566309777|FG001|Overall Study|Death|1|||
156738364|NCT02111785|565788964|FG000|Overall Study|Death|0|||
156738365|NCT02111785|565788965|FG001|Overall Study|Death|1|||
156738366|NCT02111785|565788966|FG002|Overall Study|Death|0|||
156738367|NCT02111785|565788967|FG003|Overall Study|Death|0|||
156738368|NCT02256982|565788970|FG000|Overall Study|Disease Progression|0|||
156738369|NCT02256982|565788971|FG001|Overall Study|Disease Progression|1|||
156738370|NCT01899742|565788972|FG000|Overall Study|Adverse Event|5|||
156738371|NCT01899742|565788973|FG001|Overall Study|Adverse Event|4|||
157142295|NCT01073943|567267926|FG000|Overall Study|Power outage; colonoscopy not done|1|||
157142296|NCT01073943|567267927|FG001|Overall Study|Power outage; colonoscopy not done|0|||
156738372|NCT01899742|565788972|FG000|Overall Study|Lack of Efficacy|1|||
156738373|NCT01899742|565788973|FG001|Overall Study|Lack of Efficacy|5|||
156738374|NCT01899742|565788972|FG000|Overall Study|Protocol Violation|2|||
156738375|NCT01899742|565788973|FG001|Overall Study|Protocol Violation|2|||
156738376|NCT01899742|565788972|FG000|Overall Study|Withdrawal by Subject|9|||
156738377|NCT01899742|565788973|FG001|Overall Study|Withdrawal by Subject|5|||
156738378|NCT02662764|565788974|FG000|Overall Study|Adverse Event|6|||
156738379|NCT02662764|565788974|FG000|Overall Study|Lack of Efficacy|8|||
156738380|NCT02662764|565788974|FG000|Overall Study|Protocol Violation|1|||
157142297|NCT01073943|567267926|FG000|Overall Study|Subject forgot|0|||
157142298|NCT01073943|567267927|FG001|Overall Study|Subject forgot|1|||
157142299|NCT01073943|567267926|FG000|Overall Study|Unable to return for follow-up|0|||
157142300|NCT01073943|567267927|FG001|Overall Study|Unable to return for follow-up|1|||
156738381|NCT02662764|565788974|FG000|Overall Study|Withdrawal by Subject|5|||
156738382|NCT02662764|565788974|FG000|Overall Study|Device failure|4|||
156738383|NCT02662764|565788974|FG000|Overall Study|Patient changed treatment|1|||
156738384|NCT02662764|565788974|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
156738385|NCT00759785|565788979|FG000|Overall Study|Participant sample not evaluable|11|||
156738386|NCT00759785|565788980|FG001|Overall Study|Participant sample not evaluable|2|||
156738387|NCT00759785|565788979|FG000|Overall Study|Participant sample lost|0|||
156738388|NCT00759785|565788980|FG001|Overall Study|Participant sample lost|1|||
156738389|NCT00759785|565788979|FG000|Overall Study|Protocol Violation|1|||
156738390|NCT00759785|565788980|FG001|Overall Study|Protocol Violation|0|||
156738391|NCT00759785|565788979|FG000|Overall Study|Physician Decision|0|||
156738392|NCT00759785|565788980|FG001|Overall Study|Physician Decision|1|||
156738393|NCT00759785|565788979|FG000|Overall Study|Withdrawal by Subject|0|||
156738394|NCT00759785|565788980|FG001|Overall Study|Withdrawal by Subject|1|||
156738395|NCT02677038|565788981|FG000|Overall Study|Physician Decision|1|||
156738396|NCT02677038|565788981|FG000|Overall Study|Withdrawal by Subject|1|||
156738397|NCT02777970|565788988|FG000|Overall Study|Lost to Follow-up|0|||
156738398|NCT02777970|565788989|FG001|Overall Study|Lost to Follow-up|1|||
156738399|NCT02777970|565788990|FG002|Overall Study|Lost to Follow-up|0|||
157142301|NCT01073943|567267926|FG000|Overall Study|Could not tolerate prep|1|||
157142302|NCT01073943|567267927|FG001|Overall Study|Could not tolerate prep|0|||
157142303|NCT01682044|567267931|FG000|Overall Study|Death|1|||
157142304|NCT01682044|567267931|FG000|Overall Study|Progression|3|||
157142305|NCT05738486|567269615|FG000|Overall Study|Continuing Study|194|||
157142306|NCT05738486|567269616|FG001|Overall Study|Continuing Study|196|||
157142307|NCT05738486|567269617|FG002|Overall Study|Continuing Study|193|||
157142308|NCT05738486|567269618|FG003|Overall Study|Continuing Study|191|||
157142309|NCT05738486|567269615|FG000|Overall Study|Withdrawal by Subject|8|||
157142310|NCT05738486|567269616|FG001|Overall Study|Withdrawal by Subject|5|||
157142311|NCT05738486|567269617|FG002|Overall Study|Withdrawal by Subject|7|||
157142312|NCT05738486|567269618|FG003|Overall Study|Withdrawal by Subject|13|||
157142313|NCT05738486|567269615|FG000|Overall Study|Adverse Event|4|||
157142314|NCT05738486|567269616|FG001|Overall Study|Adverse Event|6|||
157142315|NCT05738486|567269617|FG002|Overall Study|Adverse Event|4|||
157142316|NCT05738486|567269618|FG003|Overall Study|Adverse Event|5|||
156738400|NCT02777970|565788988|FG000|Overall Study|Protocol Violation|1|||
156738401|NCT02777970|565788989|FG001|Overall Study|Protocol Violation|0|||
156738402|NCT02777970|565788990|FG002|Overall Study|Protocol Violation|0|||
157142317|NCT05738486|567269615|FG000|Overall Study|Physician Decision|0|||
157142318|NCT05738486|567269616|FG001|Overall Study|Physician Decision|2|||
156738403|NCT02347891|565788991|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
156738404|NCT02347891|565788992|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
156738405|NCT02347891|565788991|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
156738406|NCT02347891|565788992|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
156738407|NCT02541669|565788998|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
156738408|NCT02541669|565788999|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
157142319|NCT05738486|567269617|FG002|Overall Study|Physician Decision|4|||
157142320|NCT05738486|567269618|FG003|Overall Study|Physician Decision|1|||
157142321|NCT05738486|567269615|FG000|Overall Study|Lost to Follow-up|1|||
157142322|NCT05738486|567269616|FG001|Overall Study|Lost to Follow-up|1|||
157142323|NCT05738486|567269617|FG002|Overall Study|Lost to Follow-up|2|||
157142324|NCT05738486|567269618|FG003|Overall Study|Lost to Follow-up|1|||
157142325|NCT05738486|567269615|FG000|Overall Study|Participant was Non-ambulatory|0|||
157142326|NCT05738486|567269616|FG001|Overall Study|Participant was Non-ambulatory|0|||
157142327|NCT05738486|567269617|FG002|Overall Study|Participant was Non-ambulatory|1|||
157142328|NCT05738486|567269618|FG003|Overall Study|Participant was Non-ambulatory|0|||
157142329|NCT05738486|567269615|FG000|Overall Study|Participant had Poor Venous Access|0|||
157142330|NCT05738486|567269616|FG001|Overall Study|Participant had Poor Venous Access|0|||
157142331|NCT05738486|567269617|FG002|Overall Study|Participant had Poor Venous Access|0|||
157142332|NCT05738486|567269618|FG003|Overall Study|Participant had Poor Venous Access|1|||
157142333|NCT05738486|567269615|FG000|Overall Study|Assigned Treatment by Mistake|0|||
157142334|NCT05738486|567269616|FG001|Overall Study|Assigned Treatment by Mistake|0|||
157142335|NCT05738486|567269617|FG002|Overall Study|Assigned Treatment by Mistake|0|||
157142336|NCT05738486|567269618|FG003|Overall Study|Assigned Treatment by Mistake|1|||
157142337|NCT05738486|567269615|FG000|Overall Study|Death|0|||
157142338|NCT05738486|567269616|FG001|Overall Study|Death|0|||
157142339|NCT05738486|567269617|FG002|Overall Study|Death|1|||
157142340|NCT05738486|567269618|FG003|Overall Study|Death|0|||
157142341|NCT05738486|567269615|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
157142342|NCT05738486|567269616|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
157142343|NCT05738486|567269617|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
157142344|NCT05738486|567269618|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
157142345|NCT03395210|567269619|FG000|Overall Study|Other|0|||
157142346|NCT03395210|567269620|FG001|Overall Study|Other|0|||
157142347|NCT03395210|567269621|FG002|Overall Study|Other|0|||
157142348|NCT03395210|567269622|FG003|Overall Study|Other|0|||
157142349|NCT03395210|567269623|FG004|Overall Study|Other|1|||
157142350|NCT03395210|567269619|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
157142351|NCT03395210|567269620|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
157142352|NCT03395210|567269621|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
157142353|NCT03395210|567269622|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
157142354|NCT03395210|567269623|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
157142355|NCT03395210|567269619|FG000|Overall Study|Adverse Event|1|||
157142356|NCT03395210|567269620|FG001|Overall Study|Adverse Event|0|||
156738409|NCT02541669|565789000|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156738410|NCT02541669|565789001|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
156738411|NCT02541669|565789002|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156738412|NCT00834639|565789003|FG000|Second Intervention|Physician Decision|0|||
156738413|NCT00834639|565789004|FG001|Second Intervention|Physician Decision|2|||
156738414|NCT04739722|565789005|FG000|Overall Study|Lost to Follow-up|5301|||
156738415|NCT04739722|565789005|FG000|Overall Study|Withdrawal by Subject|42|||
156738416|NCT04739722|565789005|FG000|Overall Study|Non Average-risk|1157|||
156738417|NCT05178641|565789009|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
156738418|NCT05178641|565789010|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
156738419|NCT05178641|565789009|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
156738420|NCT05178641|565789010|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
156738421|NCT01869699|565789011|FG000|Overall Study|Withdrawal by Subject|1|||
156738422|NCT01869699|565789012|FG001|Overall Study|Withdrawal by Subject|0|||
156738423|NCT01083186|565789014|FG000|Overall Study|Lost to Follow-up|48|||
156738424|NCT01083186|565789014|FG000|Overall Study|Consent Withdrawal|7|||
156738425|NCT01083186|565789014|FG000|Overall Study|Death|3|||
156738426|NCT01083186|565789014|FG000|Overall Study|Adverse Event|3|||
156738427|NCT01083186|565789014|FG000|Overall Study|Lack of Efficacy|2|||
156738428|NCT01083186|565789014|FG000|Overall Study|Hemodialysis Initiation|28|||
156797335|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
156797336|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
156797337|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
156797338|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
156797339|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
156738429|NCT01083186|565789014|FG000|Overall Study|Administrative Reasons|2|||
156797340|NCT04380142|566011284|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
156797341|NCT04380142|566011285|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
156797342|NCT04380142|566011286|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
157142357|NCT03395210|567269621|FG002|Overall Study|Adverse Event|2|||
157142358|NCT03395210|567269622|FG003|Overall Study|Adverse Event|4|||
157142359|NCT03395210|567269623|FG004|Overall Study|Adverse Event|3|||
157142360|NCT03395210|567269619|FG000|Overall Study|Need of Rescue Medication|1|||
157142361|NCT03395210|567269620|FG001|Overall Study|Need of Rescue Medication|0|||
157218439|NCT04071626|567545680|FG000|Overall Study|Withdrawal by Subject|1|||
157218440|NCT04071626|567545681|FG001|Overall Study|Withdrawal by Subject|1|||
156738430|NCT01083186|565789014|FG000|Overall Study|Non-compliance to Study Treatment|1|||
156738431|NCT01867294|565789024|FG000|Overall Study|Withdrawal by Subject|1|||
156738432|NCT01867294|565789025|FG001|Overall Study|Withdrawal by Subject|1|||
156738433|NCT01867294|565789026|FG002|Overall Study|Withdrawal by Subject|0|||
156738434|NCT01867294|565789027|FG003|Overall Study|Withdrawal by Subject|0|||
156738435|NCT00278148|565789028|FG000|Phase II - Expansion Phase|Disease progression|0|||
156738436|NCT00278148|565789029|FG001|Phase II - Expansion Phase|Disease progression|0|||
156738437|NCT00278148|565789030|FG002|Phase II - Expansion Phase|Disease progression|4|||
156738438|NCT00278148|565789028|FG000|Phase II - Expansion Phase|Adverse Event|0|||
156738439|NCT00278148|565789029|FG001|Phase II - Expansion Phase|Adverse Event|0|||
156738440|NCT00278148|565789030|FG002|Phase II - Expansion Phase|Adverse Event|2|||
157142362|NCT03395210|567269621|FG002|Overall Study|Need of Rescue Medication|1|||
157142363|NCT03395210|567269622|FG003|Overall Study|Need of Rescue Medication|4|||
157142364|NCT03395210|567269623|FG004|Overall Study|Need of Rescue Medication|0|||
157142365|NCT03395210|567269619|FG000|Overall Study|Lack of Response|0|||
157142366|NCT03395210|567269620|FG001|Overall Study|Lack of Response|0|||
157142367|NCT03395210|567269621|FG002|Overall Study|Lack of Response|0|||
157142368|NCT03395210|567269622|FG003|Overall Study|Lack of Response|5|||
157142369|NCT03395210|567269623|FG004|Overall Study|Lack of Response|5|||
157142370|NCT03395210|567269619|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
157142371|NCT03395210|567269620|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
156738441|NCT03419598|565789031|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
156738442|NCT00380081|565789034|FG000|Overall Study|Withdrawal by Subject|0|||
156738443|NCT00380081|565789035|FG001|Overall Study|Withdrawal by Subject|0|||
156738444|NCT00380081|565789036|FG002|Overall Study|Withdrawal by Subject|0|||
156738445|NCT00380081|565789037|FG003|Overall Study|Withdrawal by Subject|0|||
156738446|NCT00380081|565789038|FG004|Overall Study|Withdrawal by Subject|1|||
156738447|NCT00380081|565789039|FG005|Overall Study|Withdrawal by Subject|0|||
156738448|NCT00380081|565789034|FG000|Overall Study|Family Emergency|0|||
156738449|NCT00380081|565789035|FG001|Overall Study|Family Emergency|0|||
157142372|NCT03395210|567269621|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
157142373|NCT03395210|567269622|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
157142374|NCT03395210|567269623|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
157142375|NCT03395210|567269619|FG000|Overall Study|Participant Decision|1|||
157142376|NCT03395210|567269620|FG001|Overall Study|Participant Decision|1|||
156738450|NCT00380081|565789036|FG002|Overall Study|Family Emergency|0|||
156738451|NCT00380081|565789037|FG003|Overall Study|Family Emergency|0|||
157142377|NCT03395210|567269621|FG002|Overall Study|Participant Decision|0|||
157142378|NCT03395210|567269622|FG003|Overall Study|Participant Decision|4|||
157142379|NCT03395210|567269623|FG004|Overall Study|Participant Decision|0|||
157142380|NCT03395210|567269619|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
157142381|NCT03395210|567269620|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
157142382|NCT03395210|567269621|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
157142383|NCT03395210|567269622|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
157142384|NCT03395210|567269623|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
157142385|NCT01672892|567269624|FG000|Overall Study|Protocol Violation|7|||
157142386|NCT01672892|567269625|FG001|Overall Study|Protocol Violation|3|||
157142387|NCT02874794|567269638|FG000|Overall Study|Physician Decision|3|||
157142388|NCT02874794|567269639|FG001|Overall Study|Physician Decision|2|||
157142389|NCT02874794|567269638|FG000|Overall Study|Withdrawal by Subject|2|||
157142390|NCT02874794|567269639|FG001|Overall Study|Withdrawal by Subject|8|||
157142391|NCT02874794|567269638|FG000|Overall Study|Death|2|||
156738452|NCT00380081|565789038|FG004|Overall Study|Family Emergency|0|||
156738453|NCT00380081|565789039|FG005|Overall Study|Family Emergency|1|||
156738454|NCT00459706|565789040|FG000|Overall Study|Adverse Event|19|||
156738455|NCT00459706|565789041|FG001|Overall Study|Adverse Event|13|||
156738456|NCT00459706|565789040|FG000|Overall Study|Withdrawal by Subject|1|||
156738457|NCT00459706|565789041|FG001|Overall Study|Withdrawal by Subject|6|||
156738458|NCT00459706|565789040|FG000|Overall Study|Physician Decision|2|||
156738459|NCT00459706|565789041|FG001|Overall Study|Physician Decision|0|||
156738460|NCT00459706|565789040|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
157142392|NCT02874794|567269639|FG001|Overall Study|Death|1|||
157142393|NCT01473004|567269640|FG000|Overall Study|Incomplete Lobar Treatment|1|||
157142394|NCT01473004|567269641|FG001|Overall Study|Incomplete Lobar Treatment|0|||
157142395|NCT00613314|567269645|FG000|Overall Study|Adverse Event|5|||
157142396|NCT00613314|567269645|FG000|Overall Study|Protocol Violation|14|||
156738461|NCT00459706|565789041|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156738462|NCT00459706|565789040|FG000|Overall Study|Protocol Violation|2|||
156738463|NCT00459706|565789041|FG001|Overall Study|Protocol Violation|1|||
156738464|NCT00459706|565789040|FG000|Overall Study|Failed to Return|1|||
156738465|NCT00459706|565789041|FG001|Overall Study|Failed to Return|0|||
157142397|NCT00613314|567269645|FG000|Overall Study|Lost to Follow-up|46|||
157142398|NCT00613314|567269645|FG000|Overall Study|Other reason not defined above|90|||
157142399|NCT01584024|567269646|FG000|Overall Study|Lost to Follow-up|10|||
156738466|NCT00459706|565789040|FG000|Overall Study|Other|0|||
156738467|NCT00459706|565789041|FG001|Overall Study|Other|1|||
156738468|NCT00189306|565789042|FG000|Treatment Period|Withdrawal by Subject|2|||
156738469|NCT00189306|565789042|FG000|Treatment Period|Adverse Event|2|||
156738470|NCT00189306|565789042|FG000|Treatment Period|Protocol Violation|1|||
156738471|NCT00189306|565789042|FG000|Posttreatment Period|Death|1|||
156738472|NCT00189306|565789042|FG000|Posttreatment Period|Withdrawal by Subject|2|||
156738473|NCT00189306|565789042|FG000|Posttreatment Period|Noncompliance|1|||
156738474|NCT00189306|565789042|FG000|Posttreatment Period|Target lesion excised|1|||
156738475|NCT00189306|565789042|FG000|Posttreatment Period|Protocol Violation|1|||
156738476|NCT00189306|565789042|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
157142400|NCT01584024|567269646|FG000|Overall Study|Withdrawal by Subject|3|||
157142401|NCT00345605|567269650|FG000|Arm 1|Adverse Event|0|||
157142402|NCT00345605|567269651|FG001|Arm 1|Adverse Event|1|||
157142403|NCT00345605|567269650|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
156738477|NCT00189306|565789042|FG000|Posttreatment Period|Local skin reaction/sign|1|||
156738478|NCT00189306|565789042|FG000|Long-Term Follow-up|Adverse Event|2|||
157142404|NCT00345605|567269651|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
157142405|NCT01324830|567269652|FG000|Overall Study|Progressive Disease|3|||
157142406|NCT01324830|567269653|FG001|Overall Study|Progressive Disease|2|||
157142407|NCT01324830|567269654|FG002|Overall Study|Progressive Disease|3|||
156797343|NCT00209131|566011287|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
156797344|NCT00209131|566011288|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
156797345|NCT05360784|566011289|FG000|Overall Study|Discontinued|25|||
156797346|NCT05360784|566011290|FG001|Overall Study|Discontinued|11|||
156797347|NCT00437073|566011291|FG000|Overall Study|Sponsor Terminated Study|1|||
156797348|NCT00437073|566011292|FG001|Overall Study|Sponsor Terminated Study|0|||
156797349|NCT00437073|566011291|FG000|Overall Study|Physician Decision|0|||
156797350|NCT00437073|566011292|FG001|Overall Study|Physician Decision|1|||
156797351|NCT04918771|566011293|FG000|Overall Study|Withdrawal by Subject|4|||
156797352|NCT04918771|566011294|FG001|Overall Study|Withdrawal by Subject|5|||
156797353|NCT04918771|566011293|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
156797354|NCT04918771|566011294|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
156797355|NCT00539500|566011295|FG000|Overall Study|Disease Progression|1|||
156797356|NCT00539500|566011295|FG000|Overall Study|Lost to Follow-up|2|||
156797357|NCT02657343|566011298|FG000|Overall Study|Death|0|||
156797358|NCT02657343|566011299|FG001|Overall Study|Death|2|||
156797359|NCT02657343|566011300|FG002|Overall Study|Death|0|||
156797360|NCT02657343|566011301|FG003|Overall Study|Death|0|||
156797361|NCT02657343|566011302|FG004|Overall Study|Death|0|||
156797362|NCT02657343|566011303|FG005|Overall Study|Death|0|||
156797363|NCT02657343|566011298|FG000|Overall Study|Patient went to hospice|1|||
156797364|NCT02657343|566011299|FG001|Overall Study|Patient went to hospice|0|||
156797365|NCT02657343|566011300|FG002|Overall Study|Patient went to hospice|0|||
156797366|NCT02657343|566011301|FG003|Overall Study|Patient went to hospice|0|||
156797367|NCT02657343|566011302|FG004|Overall Study|Patient went to hospice|0|||
156797368|NCT02657343|566011303|FG005|Overall Study|Patient went to hospice|0|||
156797369|NCT02657343|566011298|FG000|Overall Study|Withdrawal by Subject|0|||
156797370|NCT02657343|566011299|FG001|Overall Study|Withdrawal by Subject|0|||
156797371|NCT02657343|566011300|FG002|Overall Study|Withdrawal by Subject|0|||
156797372|NCT02657343|566011301|FG003|Overall Study|Withdrawal by Subject|0|||
156797373|NCT02657343|566011302|FG004|Overall Study|Withdrawal by Subject|1|||
156797374|NCT02657343|566011303|FG005|Overall Study|Withdrawal by Subject|0|||
156797375|NCT01506726|566011306|FG000|Overall Study|Adverse Event|1|||
156797376|NCT01506726|566011307|FG001|Overall Study|Adverse Event|2|||
156797377|NCT00210132|566011308|FG000|Overall Study|Protocol Violation|1|||
156797378|NCT00210132|566011309|FG001|Overall Study|Protocol Violation|4|||
156797379|NCT03633058|566011310|FG000|Overall Study|Adverse Event|0|||
156797380|NCT03633058|566011311|FG001|Overall Study|Adverse Event|0|||
156797381|NCT03633058|566011312|FG002|Overall Study|Adverse Event|1|||
156797382|NCT03633058|566011313|FG003|Overall Study|Adverse Event|0|||
156797383|NCT00432965|566011314|FG000|Overall Study|Lost to Follow-up|22|||
156797384|NCT00432965|566011315|FG001|Overall Study|Lost to Follow-up|19|||
156797385|NCT00432965|566011314|FG000|Overall Study|Withdrawal by Subject|13|||
156797386|NCT00432965|566011315|FG001|Overall Study|Withdrawal by Subject|13|||
156797387|NCT00432965|566011314|FG000|Overall Study|Physician Decision|14|||
156797388|NCT00432965|566011315|FG001|Overall Study|Physician Decision|13|||
156797389|NCT00432965|566011314|FG000|Overall Study|Lack of Efficacy|8|||
157142408|NCT01324830|567269655|FG003|Overall Study|Progressive Disease|3|||
156738479|NCT00189306|565789042|FG000|Long-Term Follow-up|Death|4|||
156797390|NCT00432965|566011315|FG001|Overall Study|Lack of Efficacy|13|||
156797391|NCT00432965|566011314|FG000|Overall Study|Non-compliance|7|||
156797392|NCT00432965|566011315|FG001|Overall Study|Non-compliance|0|||
156797393|NCT00432965|566011314|FG000|Overall Study|Adverse Event|22|||
156797394|NCT00432965|566011315|FG001|Overall Study|Adverse Event|19|||
156797395|NCT00432965|566011314|FG000|Overall Study|Death|3|||
156797396|NCT00432965|566011315|FG001|Overall Study|Death|4|||
157142409|NCT01324830|567269656|FG004|Overall Study|Progressive Disease|6|||
157142410|NCT01324830|567269657|FG005|Overall Study|Progressive Disease|6|||
157142411|NCT01324830|567269658|FG006|Overall Study|Progressive Disease|3|||
157142412|NCT01324830|567269659|FG007|Overall Study|Progressive Disease|3|||
157142413|NCT01324830|567269660|FG008|Overall Study|Progressive Disease|3|||
157142414|NCT01324830|567269661|FG009|Overall Study|Progressive Disease|6|||
157142415|NCT01324830|567269662|FG010|Overall Study|Progressive Disease|2|||
157142416|NCT01324830|567269663|FG011|Overall Study|Progressive Disease|1|||
157142417|NCT01324830|567269664|FG012|Overall Study|Progressive Disease|1|||
157142418|NCT01324830|567269665|FG013|Overall Study|Progressive Disease|1|||
157142419|NCT01324830|567269666|FG014|Overall Study|Progressive Disease|1|||
157142420|NCT01324830|567269667|FG015|Overall Study|Progressive Disease|3|||
157142421|NCT01324830|567269668|FG016|Overall Study|Progressive Disease|2|||
157142422|NCT01324830|567269669|FG017|Overall Study|Progressive Disease|3|||
157142423|NCT01324830|567269670|FG018|Overall Study|Progressive Disease|4|||
157142424|NCT01324830|567269652|FG000|Overall Study|Dose limiting toxicity|0|||
157142425|NCT01324830|567269653|FG001|Overall Study|Dose limiting toxicity|0|||
157142426|NCT01324830|567269654|FG002|Overall Study|Dose limiting toxicity|0|||
157142427|NCT01324830|567269655|FG003|Overall Study|Dose limiting toxicity|0|||
157142428|NCT01324830|567269656|FG004|Overall Study|Dose limiting toxicity|1|||
157142429|NCT01324830|567269657|FG005|Overall Study|Dose limiting toxicity|0|||
157142430|NCT01324830|567269658|FG006|Overall Study|Dose limiting toxicity|0|||
157142431|NCT01324830|567269659|FG007|Overall Study|Dose limiting toxicity|0|||
157142432|NCT01324830|567269660|FG008|Overall Study|Dose limiting toxicity|0|||
157142433|NCT01324830|567269661|FG009|Overall Study|Dose limiting toxicity|0|||
157142434|NCT01324830|567269662|FG010|Overall Study|Dose limiting toxicity|0|||
157142435|NCT01324830|567269663|FG011|Overall Study|Dose limiting toxicity|0|||
157142436|NCT01324830|567269664|FG012|Overall Study|Dose limiting toxicity|0|||
157142437|NCT01324830|567269665|FG013|Overall Study|Dose limiting toxicity|0|||
157142438|NCT01324830|567269666|FG014|Overall Study|Dose limiting toxicity|0|||
157142439|NCT01324830|567269667|FG015|Overall Study|Dose limiting toxicity|0|||
157142440|NCT01324830|567269668|FG016|Overall Study|Dose limiting toxicity|1|||
157142441|NCT01324830|567269669|FG017|Overall Study|Dose limiting toxicity|1|||
157142442|NCT01324830|567269670|FG018|Overall Study|Dose limiting toxicity|1|||
157142443|NCT01324830|567269652|FG000|Overall Study|Reason not mentioned above|0|||
157142444|NCT01324830|567269653|FG001|Overall Study|Reason not mentioned above|0|||
157142445|NCT01324830|567269654|FG002|Overall Study|Reason not mentioned above|0|||
157142446|NCT01324830|567269655|FG003|Overall Study|Reason not mentioned above|0|||
157142447|NCT01324830|567269656|FG004|Overall Study|Reason not mentioned above|0|||
157142448|NCT01324830|567269657|FG005|Overall Study|Reason not mentioned above|0|||
157142449|NCT01324830|567269658|FG006|Overall Study|Reason not mentioned above|0|||
157142450|NCT01324830|567269659|FG007|Overall Study|Reason not mentioned above|0|||
157142451|NCT01324830|567269660|FG008|Overall Study|Reason not mentioned above|0|||
157142452|NCT01324830|567269661|FG009|Overall Study|Reason not mentioned above|0|||
157142453|NCT01324830|567269662|FG010|Overall Study|Reason not mentioned above|0|||
157142454|NCT01324830|567269663|FG011|Overall Study|Reason not mentioned above|0|||
157142455|NCT01324830|567269664|FG012|Overall Study|Reason not mentioned above|0|||
157142456|NCT01324830|567269665|FG013|Overall Study|Reason not mentioned above|0|||
157142457|NCT01324830|567269666|FG014|Overall Study|Reason not mentioned above|0|||
157142458|NCT01324830|567269667|FG015|Overall Study|Reason not mentioned above|0|||
157142459|NCT01324830|567269668|FG016|Overall Study|Reason not mentioned above|0|||
157142460|NCT01324830|567269669|FG017|Overall Study|Reason not mentioned above|1|||
157142461|NCT01324830|567269670|FG018|Overall Study|Reason not mentioned above|0|||
157142462|NCT01324830|567269652|FG000|Overall Study|Adverse Event, serious fatal|0|||
157142463|NCT01324830|567269653|FG001|Overall Study|Adverse Event, serious fatal|1|||
157142464|NCT01324830|567269654|FG002|Overall Study|Adverse Event, serious fatal|0|||
157142465|NCT01324830|567269655|FG003|Overall Study|Adverse Event, serious fatal|0|||
157142466|NCT01324830|567269656|FG004|Overall Study|Adverse Event, serious fatal|0|||
157142467|NCT01324830|567269657|FG005|Overall Study|Adverse Event, serious fatal|0|||
157142468|NCT01324830|567269658|FG006|Overall Study|Adverse Event, serious fatal|0|||
157142469|NCT01324830|567269659|FG007|Overall Study|Adverse Event, serious fatal|0|||
157142470|NCT01324830|567269660|FG008|Overall Study|Adverse Event, serious fatal|0|||
157142471|NCT01324830|567269661|FG009|Overall Study|Adverse Event, serious fatal|0|||
157218441|NCT04071626|567545680|FG000|Overall Study|Protocol Violation|0|||
156797397|NCT00432965|566011314|FG000|Overall Study|Exclusionary Methods|1|||
156797398|NCT00432965|566011315|FG001|Overall Study|Exclusionary Methods|2|||
156797399|NCT00432965|566011314|FG000|Overall Study|Incomplete Data|4|||
156797400|NCT00432965|566011315|FG001|Overall Study|Incomplete Data|3|||
156797401|NCT01889251|566011316|FG000|Overall Study|Adverse Event|1|||
156797402|NCT01889251|566011317|FG001|Overall Study|Adverse Event|0|||
156797403|NCT00071032|566011318|FG000|Overall Study|Lost to Follow-up|1|||
157142472|NCT01324830|567269662|FG010|Overall Study|Adverse Event, serious fatal|0|||
157142473|NCT01324830|567269663|FG011|Overall Study|Adverse Event, serious fatal|0|||
157142474|NCT01324830|567269664|FG012|Overall Study|Adverse Event, serious fatal|0|||
157142475|NCT01324830|567269665|FG013|Overall Study|Adverse Event, serious fatal|0|||
157142476|NCT01324830|567269666|FG014|Overall Study|Adverse Event, serious fatal|0|||
157142477|NCT01324830|567269667|FG015|Overall Study|Adverse Event, serious fatal|0|||
157142478|NCT01324830|567269668|FG016|Overall Study|Adverse Event, serious fatal|0|||
157142479|NCT01324830|567269669|FG017|Overall Study|Adverse Event, serious fatal|0|||
157142480|NCT01324830|567269670|FG018|Overall Study|Adverse Event, serious fatal|0|||
157142481|NCT01324830|567269652|FG000|Overall Study|Adverse Event, non-fatal|0|||
157142482|NCT01324830|567269653|FG001|Overall Study|Adverse Event, non-fatal|0|||
157142483|NCT01324830|567269654|FG002|Overall Study|Adverse Event, non-fatal|0|||
157142484|NCT01324830|567269655|FG003|Overall Study|Adverse Event, non-fatal|0|||
157142485|NCT01324830|567269656|FG004|Overall Study|Adverse Event, non-fatal|0|||
157142486|NCT01324830|567269657|FG005|Overall Study|Adverse Event, non-fatal|0|||
157142487|NCT01324830|567269658|FG006|Overall Study|Adverse Event, non-fatal|0|||
157142488|NCT01324830|567269659|FG007|Overall Study|Adverse Event, non-fatal|0|||
157142489|NCT01324830|567269660|FG008|Overall Study|Adverse Event, non-fatal|2|||
157142490|NCT01324830|567269661|FG009|Overall Study|Adverse Event, non-fatal|0|||
157142491|NCT01324830|567269662|FG010|Overall Study|Adverse Event, non-fatal|1|||
156738480|NCT00189306|565789042|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
156738481|NCT00189306|565789042|FG000|Long-Term Follow-up|Intercurrent disease|2|||
156738482|NCT00189306|565789042|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
156738483|NCT00189306|565789042|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
156738484|NCT02017912|565789043|FG000|Overall Study|Withdrawal by Subject|2|||
156738485|NCT02017912|565789044|FG001|Overall Study|Withdrawal by Subject|1|||
156738486|NCT02017912|565789043|FG000|Overall Study|miscellaneous|1|||
156738487|NCT02017912|565789044|FG001|Overall Study|miscellaneous|1|||
156738488|NCT01322035|565789045|FG000|Overall Study|Lost to Follow-up|8|||
156738489|NCT01322035|565789046|FG001|Overall Study|Lost to Follow-up|3|||
156738490|NCT00535847|565789047|FG000|Overall Study|Adverse Event|5|||
156738491|NCT00535847|565789048|FG001|Overall Study|Adverse Event|3|||
156738492|NCT00535847|565789049|FG002|Overall Study|Adverse Event|2|||
156738493|NCT00535847|565789047|FG000|Overall Study|Non compliance|1|||
156738494|NCT00535847|565789048|FG001|Overall Study|Non compliance|1|||
156738495|NCT00535847|565789049|FG002|Overall Study|Non compliance|0|||
156738496|NCT00535847|565789047|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
156738497|NCT00535847|565789048|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
156738498|NCT00535847|565789049|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
156738499|NCT04569968|565789050|FG000|Overall Study|Lost to Follow-up|2|||
156738500|NCT04569968|565789051|FG001|Overall Study|Lost to Follow-up|5|||
156738501|NCT04569968|565789050|FG000|Overall Study|Story of head and/or neck surgery|2|||
156738502|NCT04569968|565789051|FG001|Overall Study|Story of head and/or neck surgery|2|||
156738503|NCT04569968|565789050|FG000|Overall Study|Time of stroke onset|8|||
156738504|NCT04569968|565789051|FG001|Overall Study|Time of stroke onset|7|||
156738505|NCT04569968|565789050|FG000|Overall Study|Type of strokr|12|||
157142492|NCT01324830|567269663|FG011|Overall Study|Adverse Event, non-fatal|0|||
157142493|NCT01324830|567269664|FG012|Overall Study|Adverse Event, non-fatal|0|||
157142494|NCT01324830|567269665|FG013|Overall Study|Adverse Event, non-fatal|0|||
157142495|NCT01324830|567269666|FG014|Overall Study|Adverse Event, non-fatal|0|||
157142496|NCT01324830|567269667|FG015|Overall Study|Adverse Event, non-fatal|0|||
157142497|NCT01324830|567269668|FG016|Overall Study|Adverse Event, non-fatal|0|||
157142498|NCT01324830|567269669|FG017|Overall Study|Adverse Event, non-fatal|1|||
157142499|NCT01324830|567269670|FG018|Overall Study|Adverse Event, non-fatal|0|||
157142500|NCT01324830|567269652|FG000|Overall Study|Withdrawal by Subject|0|||
157142501|NCT01324830|567269653|FG001|Overall Study|Withdrawal by Subject|0|||
157142502|NCT01324830|567269654|FG002|Overall Study|Withdrawal by Subject|0|||
157142503|NCT01324830|567269655|FG003|Overall Study|Withdrawal by Subject|0|||
157142504|NCT01324830|567269656|FG004|Overall Study|Withdrawal by Subject|0|||
157142505|NCT01324830|567269657|FG005|Overall Study|Withdrawal by Subject|1|||
157142506|NCT01324830|567269658|FG006|Overall Study|Withdrawal by Subject|0|||
157142507|NCT01324830|567269659|FG007|Overall Study|Withdrawal by Subject|0|||
157142508|NCT01324830|567269660|FG008|Overall Study|Withdrawal by Subject|0|||
157142509|NCT01324830|567269661|FG009|Overall Study|Withdrawal by Subject|0|||
157142510|NCT01324830|567269662|FG010|Overall Study|Withdrawal by Subject|1|||
157142511|NCT01324830|567269663|FG011|Overall Study|Withdrawal by Subject|0|||
157142512|NCT01324830|567269664|FG012|Overall Study|Withdrawal by Subject|0|||
157142513|NCT01324830|567269665|FG013|Overall Study|Withdrawal by Subject|0|||
157142514|NCT01324830|567269666|FG014|Overall Study|Withdrawal by Subject|0|||
157142515|NCT01324830|567269667|FG015|Overall Study|Withdrawal by Subject|0|||
157142516|NCT01324830|567269668|FG016|Overall Study|Withdrawal by Subject|0|||
157142517|NCT01324830|567269669|FG017|Overall Study|Withdrawal by Subject|0|||
157142518|NCT01324830|567269670|FG018|Overall Study|Withdrawal by Subject|1|||
157142519|NCT01973283|567269671|FG000|Overall Study|Lost to Follow-up|4|||
157142520|NCT00817414|567269672|FG000|Overall Study|Adverse Event|1|||
157142521|NCT00817414|567269673|FG001|Overall Study|Adverse Event|1|||
156738506|NCT04569968|565789051|FG001|Overall Study|Type of strokr|8|||
156738507|NCT04569968|565789050|FG000|Overall Study|Cooperation|8|||
156738508|NCT04569968|565789051|FG001|Overall Study|Cooperation|8|||
156738509|NCT04569968|565789050|FG000|Overall Study|Age interval|17|||
156738510|NCT04569968|565789051|FG001|Overall Study|Age interval|6|||
157142522|NCT00817414|567269674|FG002|Overall Study|Adverse Event|1|||
157142523|NCT00817414|567269675|FG003|Overall Study|Adverse Event|0|||
157142524|NCT00817414|567269676|FG004|Overall Study|Adverse Event|0|||
157142525|NCT00817414|567269672|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
157142526|NCT00817414|567269673|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
157142527|NCT00817414|567269674|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
157142528|NCT00817414|567269675|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
157142529|NCT00817414|567269676|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
157142530|NCT00817414|567269672|FG000|Overall Study|Withdrawal by Subject|1|||
157142531|NCT00817414|567269673|FG001|Overall Study|Withdrawal by Subject|1|||
157142532|NCT00817414|567269674|FG002|Overall Study|Withdrawal by Subject|0|||
157142533|NCT00817414|567269675|FG003|Overall Study|Withdrawal by Subject|0|||
157142534|NCT00817414|567269676|FG004|Overall Study|Withdrawal by Subject|0|||
156738511|NCT04569968|565789050|FG000|Overall Study|Denial of participation to the study|0|||
156738512|NCT04569968|565789051|FG001|Overall Study|Denial of participation to the study|3|||
156738513|NCT04569968|565789050|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
156738514|NCT04569968|565789051|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
156738515|NCT04569968|565789050|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
156738516|NCT04569968|565789051|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
156738517|NCT04569968|565789050|FG000|Overall Study|Quarantine|1|||
156738518|NCT04569968|565789051|FG001|Overall Study|Quarantine|0|||
156738519|NCT04569968|565789050|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
156738520|NCT04569968|565789051|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
156738521|NCT04569968|565789050|FG000|Overall Study|Repetitive stroke|8|||
156738522|NCT04569968|565789051|FG001|Overall Study|Repetitive stroke|0|||
156738523|NCT04569968|565789050|FG000|Overall Study|Insufficient mastication|1|||
156738524|NCT04569968|565789051|FG001|Overall Study|Insufficient mastication|0|||
156738525|NCT04569968|565789050|FG000|Overall Study|Infection|1|||
156738526|NCT04569968|565789051|FG001|Overall Study|Infection|0|||
156738527|NCT00520481|565789063|FG000|Overall Study|Adverse Event|4|||
156738528|NCT00520481|565789064|FG001|Overall Study|Adverse Event|1|||
156738529|NCT00520481|565789063|FG000|Overall Study|Withdrawal by Subject|3|||
156738530|NCT00520481|565789064|FG001|Overall Study|Withdrawal by Subject|0|||
156738531|NCT00471718|565789067|FG000|Overall Study|Adverse Event|3|||
156738532|NCT00471718|565789067|FG000|Overall Study|other complicating disease|1|||
156738533|NCT00471718|565789067|FG000|Overall Study|disease progression|22|||
156738534|NCT00471718|565789067|FG000|Overall Study|Withdrawal by Subject|1|||
156738535|NCT01817582|565789073|FG000|Overall Study|Withdrawal by Subject|0|||
156738536|NCT01817582|565789074|FG001|Overall Study|Withdrawal by Subject|1|||
156738537|NCT01817582|565789075|FG002|Overall Study|Withdrawal by Subject|0|||
156738538|NCT01817582|565789073|FG000|Overall Study|Participant revealed masked treatment|1|||
156738539|NCT01817582|565789074|FG001|Overall Study|Participant revealed masked treatment|0|||
156738540|NCT01817582|565789075|FG002|Overall Study|Participant revealed masked treatment|0|||
156738541|NCT01817582|565789073|FG000|Overall Study|Randomized but exclusion criteria met|1|||
156738542|NCT01817582|565789074|FG001|Overall Study|Randomized but exclusion criteria met|0|||
156738543|NCT01817582|565789075|FG002|Overall Study|Randomized but exclusion criteria met|0|||
156738544|NCT03053063|565789081|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
156738545|NCT03053063|565789082|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
156738546|NCT03053063|565789083|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
156738547|NCT03053063|565789084|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
156738548|NCT03053063|565789081|FG000|Randomized Phase|Withdrew consent|8|||
156738549|NCT03053063|565789082|FG001|Randomized Phase|Withdrew consent|11|||
156738550|NCT03053063|565789083|FG002|Randomized Phase|Withdrew consent|5|||
156738551|NCT03053063|565789084|FG003|Randomized Phase|Withdrew consent|0|||
156738552|NCT03053063|565789081|FG000|Randomized Phase|Investigator's Discretion|8|||
156738553|NCT03053063|565789082|FG001|Randomized Phase|Investigator's Discretion|6|||
156738554|NCT03053063|565789083|FG002|Randomized Phase|Investigator's Discretion|2|||
156738555|NCT03053063|565789084|FG003|Randomized Phase|Investigator's Discretion|0|||
156738556|NCT03053063|565789081|FG000|Randomized Phase|Lost to Follow-up|3|||
156738557|NCT03053063|565789082|FG001|Randomized Phase|Lost to Follow-up|5|||
156738558|NCT03053063|565789083|FG002|Randomized Phase|Lost to Follow-up|1|||
156797404|NCT00071032|566011319|FG001|Overall Study|Lost to Follow-up|1|||
157142535|NCT00817414|567269672|FG000|Overall Study|Lost to Follow-up|0|||
157142536|NCT00817414|567269673|FG001|Overall Study|Lost to Follow-up|0|||
157142537|NCT00817414|567269674|FG002|Overall Study|Lost to Follow-up|1|||
157142538|NCT00817414|567269675|FG003|Overall Study|Lost to Follow-up|1|||
157142539|NCT00817414|567269676|FG004|Overall Study|Lost to Follow-up|1|||
157142540|NCT00817414|567269672|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156738559|NCT03053063|565789084|FG003|Randomized Phase|Lost to Follow-up|0|||
156738560|NCT03053063|565789081|FG000|Randomized Phase|Adverse Event|0|||
156738561|NCT03053063|565789082|FG001|Randomized Phase|Adverse Event|1|||
156738562|NCT03053063|565789083|FG002|Randomized Phase|Adverse Event|0|||
156738563|NCT03053063|565789084|FG003|Randomized Phase|Adverse Event|0|||
156738564|NCT03053063|565789081|FG000|Randomized Phase|Randomized but Never Treated|1|||
157142541|NCT00817414|567269673|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
157142542|NCT00817414|567269674|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
156738565|NCT03053063|565789082|FG001|Randomized Phase|Randomized but Never Treated|3|||
156738566|NCT03053063|565789083|FG002|Randomized Phase|Randomized but Never Treated|2|||
157142543|NCT00817414|567269675|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
157142544|NCT00817414|567269676|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
157142545|NCT00817414|567269672|FG000|Overall Study|Protocol Violation|0|||
157142546|NCT00817414|567269673|FG001|Overall Study|Protocol Violation|0|||
157142547|NCT00817414|567269674|FG002|Overall Study|Protocol Violation|0|||
157142548|NCT00817414|567269675|FG003|Overall Study|Protocol Violation|0|||
157142549|NCT00817414|567269676|FG004|Overall Study|Protocol Violation|1|||
157142550|NCT00886938|567269677|FG000|Overall Study|Adverse Event|1|||
157142551|NCT00886938|567269677|FG000|Overall Study|Withdrawal by Subject|1|||
157142552|NCT03872180|567269682|FG000|Overall Study|Adverse Event|4|||
157142553|NCT03872180|567269682|FG000|Overall Study|Lack of Efficacy|2|||
157142554|NCT01126619|567269683|FG000|Overall Study|Not eligible for the study|2|||
157142555|NCT01126619|567269683|FG000|Overall Study|Investigator decision|4|||
157142556|NCT01126619|567269683|FG000|Overall Study|Serious adverse event|1|||
157142557|NCT01126619|567269683|FG000|Overall Study|Withdrawal by Subject|9|||
157142558|NCT01126619|567269683|FG000|Overall Study|Non-compliance|1|||
157142559|NCT00947154|567269684|FG000|Overall Study|Lost to Follow-up|1|||
157142560|NCT04876391|567269685|FG000|Overall Study|Withdrawal by Subject|1|||
157142561|NCT04876391|567269686|FG001|Overall Study|Withdrawal by Subject|10|||
156738567|NCT03053063|565789084|FG003|Randomized Phase|Randomized but Never Treated|0|||
156738568|NCT03053063|565789081|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
156738569|NCT03053063|565789082|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
157142562|NCT04876391|567269685|FG000|Overall Study|Lost to Follow-up|2|||
157142563|NCT04876391|567269686|FG001|Overall Study|Lost to Follow-up|4|||
157142564|NCT04876391|567269685|FG000|Overall Study|Lack of Efficacy|0|||
156738570|NCT03053063|565789083|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
157020416|NCT04034251|566828428|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
156738571|NCT03053063|565789084|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
156738572|NCT03053063|565789081|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
156738573|NCT03053063|565789082|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
156738574|NCT03053063|565789083|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
156738575|NCT03053063|565789084|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
156738576|NCT03053063|565789081|FG000|Open-Label Phase|Death|0|||
156738577|NCT03053063|565789082|FG001|Open-Label Phase|Death|0|||
156738578|NCT03053063|565789083|FG002|Open-Label Phase|Death|0|||
156738579|NCT03053063|565789084|FG003|Open-Label Phase|Death|2|||
156738580|NCT03053063|565789081|FG000|Open-Label Phase|Investigator's discretion|0|||
156738581|NCT03053063|565789082|FG001|Open-Label Phase|Investigator's discretion|0|||
156738582|NCT03053063|565789083|FG002|Open-Label Phase|Investigator's discretion|0|||
156738583|NCT03053063|565789084|FG003|Open-Label Phase|Investigator's discretion|2|||
156738584|NCT02600845|565789085|FG000|Overall Study|Reason Not Specified|3|||
156738585|NCT02600845|565789085|FG000|Overall Study|Non-compliance with Study Procedures|10|||
156738586|NCT02600845|565789085|FG000|Overall Study|Consent Withdrawal|5|||
156738587|NCT03055494|565791129|FG000|Overall Study|Lost to Follow-up|6|||
156738588|NCT03055494|565791130|FG001|Overall Study|Lost to Follow-up|0|||
156738589|NCT03055494|565791129|FG000|Overall Study|Physician Decision|2|||
156738590|NCT03055494|565791130|FG001|Overall Study|Physician Decision|0|||
156738591|NCT03055494|565791129|FG000|Overall Study|Withdrawal by Subject|1|||
156738592|NCT03055494|565791130|FG001|Overall Study|Withdrawal by Subject|0|||
156738593|NCT03055494|565791129|FG000|Overall Study|Adverse Event|0|||
156738594|NCT03055494|565791130|FG001|Overall Study|Adverse Event|1|||
156738595|NCT03055494|565791129|FG000|Overall Study|Non-compliance with study treatment|1|||
156738596|NCT03055494|565791130|FG001|Overall Study|Non-compliance with study treatment|0|||
156797405|NCT00071032|566011318|FG000|Overall Study|Withdrawal by Subject|8|||
156797406|NCT00071032|566011319|FG001|Overall Study|Withdrawal by Subject|6|||
157142565|NCT04876391|567269686|FG001|Overall Study|Lack of Efficacy|2|||
157142566|NCT04876391|567269685|FG000|Overall Study|Adverse Event|3|||
157142567|NCT04876391|567269686|FG001|Overall Study|Adverse Event|1|||
157142568|NCT04876391|567269685|FG000|Overall Study|Patient non-compliance|0|||
157142569|NCT04876391|567269686|FG001|Overall Study|Patient non-compliance|1|||
157142570|NCT04876391|567269685|FG000|Overall Study|Personal reasons|0|||
157142571|NCT04876391|567269686|FG001|Overall Study|Personal reasons|1|||
157142572|NCT04876391|567269685|FG000|Overall Study|Withdrawn as per protocol|2|||
156738597|NCT02017717|565791131|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738598|NCT02017717|565791132|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738599|NCT02017717|565791133|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738600|NCT02017717|565791134|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738601|NCT02017717|565791135|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
157142573|NCT04876391|567269686|FG001|Overall Study|Withdrawn as per protocol|2|||
157142574|NCT00900796|567269687|FG000|Phase 1|Lacked sufficient information|4|||
157020417|NCT04034251|566828429|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
157020418|NCT04034251|566828430|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
157142575|NCT00900796|567269687|FG000|Phase 1|Missing information at Week 16|7|||
157142576|NCT00900796|567269687|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
157142577|NCT00900796|567269687|FG000|Phase 2|Lost to Follow-up|5|||
157142578|NCT01157117|567269690|FG000|Overall Study|Dosing Symptoms|0|||
157142579|NCT01157117|567269691|FG001|Overall Study|Dosing Symptoms|4|||
157142580|NCT01157117|567269692|FG002|Overall Study|Dosing Symptoms|0|||
157142581|NCT01157117|567269690|FG000|Overall Study|Withdrawal by Subject|4|||
157142582|NCT01157117|567269691|FG001|Overall Study|Withdrawal by Subject|1|||
157142583|NCT01157117|567269692|FG002|Overall Study|Withdrawal by Subject|1|||
157142584|NCT01157117|567269690|FG000|Overall Study|Lack of Efficacy|1|||
157142585|NCT01157117|567269691|FG001|Overall Study|Lack of Efficacy|1|||
157142586|NCT01157117|567269692|FG002|Overall Study|Lack of Efficacy|0|||
157142587|NCT01157117|567269690|FG000|Overall Study|Lost to Follow-up|0|||
157142588|NCT01157117|567269691|FG001|Overall Study|Lost to Follow-up|0|||
157142589|NCT01157117|567269692|FG002|Overall Study|Lost to Follow-up|1|||
157142590|NCT01157117|567269690|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
157142591|NCT01157117|567269691|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
157142592|NCT01157117|567269692|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
157142593|NCT00504257|567269693|FG000|Overall Study|Withdrawal by Subject|2|||
157142594|NCT00504257|567269693|FG000|Overall Study|ineligible histology|2|||
157142595|NCT01122927|567269694|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
157142596|NCT01122927|567269695|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
157142597|NCT01122927|567269694|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
157142598|NCT01122927|567269695|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
157142599|NCT01122927|567269694|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
157142600|NCT01122927|567269695|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
157142601|NCT01122927|567269694|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
157142602|NCT01122927|567269695|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
157142603|NCT01122927|567269694|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
157142604|NCT01122927|567269695|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
157142605|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
157142606|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
157142607|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
157142608|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
157142609|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
157142610|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
157142611|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
157142612|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
157142613|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
157142614|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
157142615|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
157218442|NCT04071626|567545681|FG001|Overall Study|Protocol Violation|1|||
156738602|NCT02017717|565791136|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738603|NCT02017717|565791137|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738604|NCT02017717|565791138|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
156738605|NCT02017717|565791139|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
156738606|NCT02017717|565791131|FG000|Before Treatment Period|Participant request to stop therapy|0|||
156738607|NCT02017717|565791132|FG001|Before Treatment Period|Participant request to stop therapy|0|||
156738608|NCT02017717|565791133|FG002|Before Treatment Period|Participant request to stop therapy|0|||
156738609|NCT02017717|565791134|FG003|Before Treatment Period|Participant request to stop therapy|0|||
156738610|NCT02017717|565791135|FG004|Before Treatment Period|Participant request to stop therapy|0|||
156738611|NCT02017717|565791136|FG005|Before Treatment Period|Participant request to stop therapy|0|||
156738612|NCT02017717|565791137|FG006|Before Treatment Period|Participant request to stop therapy|0|||
156738613|NCT02017717|565791138|FG007|Before Treatment Period|Participant request to stop therapy|0|||
156738614|NCT02017717|565791139|FG008|Before Treatment Period|Participant request to stop therapy|5|||
156738615|NCT02017717|565791131|FG000|Before Treatment Period|Participant withdrew consent|0|||
156738616|NCT02017717|565791132|FG001|Before Treatment Period|Participant withdrew consent|0|||
156738617|NCT02017717|565791133|FG002|Before Treatment Period|Participant withdrew consent|0|||
156738618|NCT02017717|565791134|FG003|Before Treatment Period|Participant withdrew consent|0|||
156738619|NCT02017717|565791135|FG004|Before Treatment Period|Participant withdrew consent|0|||
156738620|NCT02017717|565791136|FG005|Before Treatment Period|Participant withdrew consent|0|||
156738621|NCT02017717|565791137|FG006|Before Treatment Period|Participant withdrew consent|2|||
156738622|NCT02017717|565791138|FG007|Before Treatment Period|Participant withdrew consent|0|||
156738623|NCT02017717|565791139|FG008|Before Treatment Period|Participant withdrew consent|11|||
156738624|NCT02017717|565791131|FG000|Before Treatment Period|Lost to Follow-up|0|||
156738625|NCT02017717|565791132|FG001|Before Treatment Period|Lost to Follow-up|0|||
156738626|NCT02017717|565791133|FG002|Before Treatment Period|Lost to Follow-up|0|||
156738627|NCT02017717|565791134|FG003|Before Treatment Period|Lost to Follow-up|0|||
156738628|NCT02017717|565791135|FG004|Before Treatment Period|Lost to Follow-up|0|||
156738629|NCT02017717|565791136|FG005|Before Treatment Period|Lost to Follow-up|0|||
156738630|NCT02017717|565791137|FG006|Before Treatment Period|Lost to Follow-up|0|||
156738631|NCT02017717|565791138|FG007|Before Treatment Period|Lost to Follow-up|0|||
156738632|NCT02017717|565791139|FG008|Before Treatment Period|Lost to Follow-up|1|||
156738633|NCT02017717|565791131|FG000|Before Treatment Period|Participant no longer met criteria|0|||
156738634|NCT02017717|565791132|FG001|Before Treatment Period|Participant no longer met criteria|0|||
156738635|NCT02017717|565791133|FG002|Before Treatment Period|Participant no longer met criteria|0|||
156738636|NCT02017717|565791134|FG003|Before Treatment Period|Participant no longer met criteria|0|||
156738637|NCT02017717|565791135|FG004|Before Treatment Period|Participant no longer met criteria|0|||
157142616|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
157142617|NCT01122927|567269694|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
157142618|NCT01122927|567269695|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
157142619|NCT03427073|567269696|FG000|Overall Study|Disease Progression|1|||
157142620|NCT03427073|567269697|FG001|Overall Study|Disease Progression|1|||
157142621|NCT03427073|567269698|FG002|Overall Study|Disease Progression|1|||
157142622|NCT03427073|567269699|FG003|Overall Study|Disease Progression|3|||
157142623|NCT03427073|567269700|FG004|Overall Study|Disease Progression|3|||
157142624|NCT03427073|567269701|FG005|Overall Study|Disease Progression|4|||
157142625|NCT03427073|567269702|FG006|Overall Study|Disease Progression|2|||
157142626|NCT03427073|567269703|FG007|Overall Study|Disease Progression|3|||
157142627|NCT03427073|567269696|FG000|Overall Study|Physician Decision|0|||
157142628|NCT03427073|567269697|FG001|Overall Study|Physician Decision|0|||
157142629|NCT03427073|567269698|FG002|Overall Study|Physician Decision|0|||
157142630|NCT03427073|567269699|FG003|Overall Study|Physician Decision|0|||
157142631|NCT03427073|567269700|FG004|Overall Study|Physician Decision|0|||
156738638|NCT02017717|565791136|FG005|Before Treatment Period|Participant no longer met criteria|1|||
156738639|NCT02017717|565791137|FG006|Before Treatment Period|Participant no longer met criteria|0|||
156738640|NCT02017717|565791138|FG007|Before Treatment Period|Participant no longer met criteria|1|||
156738641|NCT02017717|565791139|FG008|Before Treatment Period|Participant no longer met criteria|2|||
156738642|NCT02017717|565791131|FG000|Before Treatment Period|other reason|0|||
156738643|NCT02017717|565791132|FG001|Before Treatment Period|other reason|0|||
156738644|NCT02017717|565791133|FG002|Before Treatment Period|other reason|0|||
156738645|NCT02017717|565791134|FG003|Before Treatment Period|other reason|0|||
156738646|NCT02017717|565791135|FG004|Before Treatment Period|other reason|0|||
156738647|NCT02017717|565791136|FG005|Before Treatment Period|other reason|0|||
156738648|NCT02017717|565791137|FG006|Before Treatment Period|other reason|0|||
156738649|NCT02017717|565791138|FG007|Before Treatment Period|other reason|0|||
156738650|NCT02017717|565791139|FG008|Before Treatment Period|other reason|1|||
156738651|NCT02017717|565791131|FG000|Treatment Period|Disease progression|7|||
156738652|NCT02017717|565791132|FG001|Treatment Period|Disease progression|9|||
157142632|NCT03427073|567269701|FG005|Overall Study|Physician Decision|0|||
157142633|NCT03427073|567269702|FG006|Overall Study|Physician Decision|1|||
157142634|NCT03427073|567269703|FG007|Overall Study|Physician Decision|1|||
157142635|NCT01244737|567269704|FG000|Overall Study|Physician Decision|2|||
156738653|NCT02017717|565791133|FG002|Treatment Period|Disease progression|12|||
156738654|NCT02017717|565791134|FG003|Treatment Period|Disease progression|20|||
156738655|NCT02017717|565791135|FG004|Treatment Period|Disease progression|26|||
156738656|NCT02017717|565791136|FG005|Treatment Period|Disease progression|16|||
156738657|NCT02017717|565791137|FG006|Treatment Period|Disease progression|22|||
156738658|NCT02017717|565791138|FG007|Treatment Period|Disease progression|165|||
156738659|NCT02017717|565791139|FG008|Treatment Period|Disease progression|135|||
156738660|NCT02017717|565791131|FG000|Treatment Period|Study drug toxicity|3|||
156738661|NCT02017717|565791132|FG001|Treatment Period|Study drug toxicity|0|||
156738662|NCT02017717|565791133|FG002|Treatment Period|Study drug toxicity|1|||
156738663|NCT02017717|565791134|FG003|Treatment Period|Study drug toxicity|4|||
156738664|NCT02017717|565791135|FG004|Treatment Period|Study drug toxicity|4|||
156738665|NCT02017717|565791136|FG005|Treatment Period|Study drug toxicity|5|||
157142636|NCT01244737|567269705|FG001|Overall Study|Physician Decision|18|||
157142637|NCT01244737|567269706|FG002|Overall Study|Physician Decision|5|||
157142638|NCT01244737|567269704|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
157142639|NCT01244737|567269705|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
157142640|NCT01244737|567269706|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
157142641|NCT01244737|567269704|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
157142642|NCT01244737|567269705|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
157142643|NCT01244737|567269706|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
157142644|NCT01244737|567269704|FG000|Overall Study|MIB immunopathology results not available|3|||
157142645|NCT01244737|567269705|FG001|Overall Study|MIB immunopathology results not available|2|||
157142646|NCT01244737|567269706|FG002|Overall Study|MIB immunopathology results not available|0|||
157142647|NCT01244737|567269704|FG000|Overall Study|PET data failure|0|||
157142648|NCT01244737|567269705|FG001|Overall Study|PET data failure|1|||
157142649|NCT01244737|567269706|FG002|Overall Study|PET data failure|0|||
157142650|NCT01244737|567269704|FG000|Overall Study|Withdrawal by Subject|0|||
157142651|NCT01244737|567269705|FG001|Overall Study|Withdrawal by Subject|0|||
157142652|NCT01244737|567269706|FG002|Overall Study|Withdrawal by Subject|1|||
157142653|NCT02371629|567269717|FG000|Overall Study|Patient decision|14|||
157142654|NCT02371629|567269718|FG001|Overall Study|Patient decision|10|||
157142655|NCT02371629|567269717|FG000|Overall Study|Adverse Event|8|||
157142656|NCT02371629|567269718|FG001|Overall Study|Adverse Event|8|||
157142657|NCT02371629|567269717|FG000|Overall Study|Physician Decision|2|||
157142658|NCT02371629|567269718|FG001|Overall Study|Physician Decision|3|||
157142659|NCT02371629|567269717|FG000|Overall Study|Death|1|||
157142660|NCT02371629|567269718|FG001|Overall Study|Death|1|||
157142661|NCT02371629|567269717|FG000|Overall Study|Noncompliance with study treatment|1|||
157142662|NCT02371629|567269718|FG001|Overall Study|Noncompliance with study treatment|0|||
157142663|NCT02371629|567269717|FG000|Overall Study|Lack of Efficacy|0|||
157142664|NCT02371629|567269718|FG001|Overall Study|Lack of Efficacy|2|||
157142665|NCT02371629|567269717|FG000|Overall Study|Protocol deviation|0|||
157142666|NCT02371629|567269718|FG001|Overall Study|Protocol deviation|1|||
157142667|NCT03486314|567269719|FG000|Part A|Adverse Event|1|||
157142668|NCT03486314|567269720|FG001|Part A|Adverse Event|0|||
157142669|NCT03486314|567269721|FG002|Part A|Adverse Event|0|||
157142670|NCT03486314|567269719|FG000|Part A|Symptomatic Deterioration|2|||
157142671|NCT03486314|567269720|FG001|Part A|Symptomatic Deterioration|0|||
157142672|NCT03486314|567269721|FG002|Part A|Symptomatic Deterioration|0|||
157142673|NCT03228186|567269726|FG000|Overall Study|Patient never started treatment|1|||
157142674|NCT01634243|567269727|FG000|Overall Study|Adverse Event|5|||
157142675|NCT01634243|567269728|FG001|Overall Study|Adverse Event|5|||
157142676|NCT01634243|567269727|FG000|Overall Study|Lack of Efficacy|1|||
157142677|NCT01634243|567269728|FG001|Overall Study|Lack of Efficacy|0|||
157142678|NCT04283461|567269729|FG000|Overall Study|Enrolled in separate trial|0|||
157142679|NCT04283461|567269730|FG001|Overall Study|Enrolled in separate trial|0|||
157142680|NCT04283461|567269731|FG002|Overall Study|Enrolled in separate trial|8|||
157142681|NCT04283461|567269732|FG003|Overall Study|Enrolled in separate trial|13|||
157142682|NCT04283461|567269733|FG004|Overall Study|Enrolled in separate trial|12|||
157142683|NCT04283461|567269734|FG005|Overall Study|Enrolled in separate trial|0|||
157142684|NCT04283461|567269735|FG006|Overall Study|Enrolled in separate trial|0|||
157142685|NCT04283461|567269736|FG007|Overall Study|Enrolled in separate trial|8|||
157142686|NCT04283461|567269737|FG008|Overall Study|Enrolled in separate trial|0|||
156738666|NCT02017717|565791137|FG006|Treatment Period|Study drug toxicity|3|||
156738667|NCT02017717|565791138|FG007|Treatment Period|Study drug toxicity|7|||
157142687|NCT04283461|567269738|FG009|Overall Study|Enrolled in separate trial|0|||
157142688|NCT04283461|567269739|FG010|Overall Study|Enrolled in separate trial|0|||
157142689|NCT04283461|567269740|FG011|Overall Study|Enrolled in separate trial|7|||
157142690|NCT04283461|567269741|FG012|Overall Study|Enrolled in separate trial|0|||
157142691|NCT00258154|567269742|FG000|Overall Study|Adverse Event|1|||
157142692|NCT00258154|567269743|FG001|Overall Study|Adverse Event|0|||
157142693|NCT00258154|567269742|FG000|Overall Study|Lost to Follow-up|0|||
157142694|NCT00258154|567269743|FG001|Overall Study|Lost to Follow-up|1|||
157142695|NCT00258154|567269742|FG000|Overall Study|Protocol Violation|2|||
157142696|NCT00258154|567269743|FG001|Overall Study|Protocol Violation|1|||
156738668|NCT02017717|565791139|FG008|Treatment Period|Study drug toxicity|11|||
156738669|NCT02017717|565791131|FG000|Treatment Period|Death|0|||
156738670|NCT02017717|565791132|FG001|Treatment Period|Death|0|||
156738671|NCT02017717|565791133|FG002|Treatment Period|Death|1|||
156738672|NCT02017717|565791134|FG003|Treatment Period|Death|0|||
156738673|NCT02017717|565791135|FG004|Treatment Period|Death|0|||
156738674|NCT02017717|565791136|FG005|Treatment Period|Death|2|||
156738675|NCT02017717|565791137|FG006|Treatment Period|Death|0|||
156738676|NCT02017717|565791138|FG007|Treatment Period|Death|0|||
156738677|NCT02017717|565791139|FG008|Treatment Period|Death|0|||
156738678|NCT02017717|565791131|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
156738679|NCT02017717|565791132|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
156738680|NCT02017717|565791133|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
156738681|NCT02017717|565791134|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
156738682|NCT02017717|565791135|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
156738683|NCT02017717|565791136|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
156738684|NCT02017717|565791137|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
156738685|NCT02017717|565791138|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
156738686|NCT02017717|565791139|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
156738687|NCT02017717|565791131|FG000|Treatment Period|Participant request to stop therapy|0|||
156738688|NCT02017717|565791132|FG001|Treatment Period|Participant request to stop therapy|0|||
156738689|NCT02017717|565791133|FG002|Treatment Period|Participant request to stop therapy|3|||
156738690|NCT02017717|565791134|FG003|Treatment Period|Participant request to stop therapy|6|||
156738691|NCT02017717|565791135|FG004|Treatment Period|Participant request to stop therapy|0|||
156738692|NCT02017717|565791136|FG005|Treatment Period|Participant request to stop therapy|2|||
156738693|NCT02017717|565791137|FG006|Treatment Period|Participant request to stop therapy|1|||
156738694|NCT02017717|565791138|FG007|Treatment Period|Participant request to stop therapy|4|||
156738695|NCT02017717|565791139|FG008|Treatment Period|Participant request to stop therapy|7|||
156738696|NCT02017717|565791131|FG000|Treatment Period|Participant withdrew consent|0|||
156738697|NCT02017717|565791132|FG001|Treatment Period|Participant withdrew consent|0|||
156738698|NCT02017717|565791133|FG002|Treatment Period|Participant withdrew consent|1|||
157142697|NCT00258154|567269742|FG000|Overall Study|Withdrawal by Subject|3|||
156738699|NCT02017717|565791134|FG003|Treatment Period|Participant withdrew consent|0|||
156738700|NCT02017717|565791135|FG004|Treatment Period|Participant withdrew consent|0|||
156738701|NCT02017717|565791136|FG005|Treatment Period|Participant withdrew consent|2|||
156738702|NCT02017717|565791137|FG006|Treatment Period|Participant withdrew consent|0|||
156738703|NCT02017717|565791138|FG007|Treatment Period|Participant withdrew consent|1|||
156738704|NCT02017717|565791139|FG008|Treatment Period|Participant withdrew consent|4|||
156738705|NCT02017717|565791131|FG000|Treatment Period|Participant no longer met criteria|0|||
156738706|NCT02017717|565791132|FG001|Treatment Period|Participant no longer met criteria|0|||
156738707|NCT02017717|565791133|FG002|Treatment Period|Participant no longer met criteria|0|||
156738708|NCT02017717|565791134|FG003|Treatment Period|Participant no longer met criteria|0|||
156738709|NCT02017717|565791135|FG004|Treatment Period|Participant no longer met criteria|0|||
156738710|NCT02017717|565791136|FG005|Treatment Period|Participant no longer met criteria|0|||
156738711|NCT02017717|565791137|FG006|Treatment Period|Participant no longer met criteria|0|||
156738712|NCT02017717|565791138|FG007|Treatment Period|Participant no longer met criteria|0|||
156738713|NCT02017717|565791139|FG008|Treatment Period|Participant no longer met criteria|1|||
156738714|NCT02017717|565791131|FG000|Treatment Period|Other reasons|0|||
156738715|NCT02017717|565791132|FG001|Treatment Period|Other reasons|0|||
156738716|NCT02017717|565791133|FG002|Treatment Period|Other reasons|0|||
156738717|NCT02017717|565791134|FG003|Treatment Period|Other reasons|1|||
156738718|NCT02017717|565791135|FG004|Treatment Period|Other reasons|0|||
156738719|NCT02017717|565791136|FG005|Treatment Period|Other reasons|1|||
156738720|NCT02017717|565791137|FG006|Treatment Period|Other reasons|1|||
156738721|NCT02017717|565791138|FG007|Treatment Period|Other reasons|1|||
156738722|NCT02017717|565791139|FG008|Treatment Period|Other reasons|1|||
156738723|NCT02017717|565791131|FG000|Treatment Period|Maximum clinical benefit|0|||
156738724|NCT02017717|565791132|FG001|Treatment Period|Maximum clinical benefit|0|||
156738725|NCT02017717|565791133|FG002|Treatment Period|Maximum clinical benefit|0|||
156738726|NCT02017717|565791134|FG003|Treatment Period|Maximum clinical benefit|0|||
156738727|NCT02017717|565791135|FG004|Treatment Period|Maximum clinical benefit|0|||
156738728|NCT02017717|565791136|FG005|Treatment Period|Maximum clinical benefit|0|||
156738729|NCT02017717|565791137|FG006|Treatment Period|Maximum clinical benefit|0|||
156738730|NCT02017717|565791138|FG007|Treatment Period|Maximum clinical benefit|0|||
156738731|NCT02017717|565791139|FG008|Treatment Period|Maximum clinical benefit|1|||
156738732|NCT02017717|565791131|FG000|Treatment Period|Not reported|0|||
156738733|NCT02017717|565791132|FG001|Treatment Period|Not reported|1|||
156738734|NCT02017717|565791133|FG002|Treatment Period|Not reported|0|||
156738735|NCT02017717|565791134|FG003|Treatment Period|Not reported|0|||
156738736|NCT02017717|565791135|FG004|Treatment Period|Not reported|0|||
157142698|NCT00258154|567269743|FG001|Overall Study|Withdrawal by Subject|4|||
157142699|NCT00258154|567269742|FG000|Overall Study|Patient Moved|3|||
157142700|NCT00258154|567269743|FG001|Overall Study|Patient Moved|1|||
156738737|NCT02017717|565791136|FG005|Treatment Period|Not reported|0|||
156738738|NCT02017717|565791137|FG006|Treatment Period|Not reported|0|||
156738739|NCT02017717|565791138|FG007|Treatment Period|Not reported|0|||
156738740|NCT02017717|565791139|FG008|Treatment Period|Not reported|0|||
156738741|NCT05072106|565791142|FG000|Overall Study|Progressive disease|3|||
156738742|NCT05072106|565791143|FG001|Overall Study|Progressive disease|3|||
156738743|NCT05072106|565791142|FG000|Overall Study|Compassionate use|3|||
156738744|NCT05072106|565791143|FG001|Overall Study|Compassionate use|1|||
156738745|NCT05072106|565791142|FG000|Overall Study|Withdrawal by Subject|1|||
156738746|NCT05072106|565791143|FG001|Overall Study|Withdrawal by Subject|0|||
157142701|NCT05490771|567269744|FG000|Overall Study|Disease progression|18|||
156738747|NCT03839459|565791144|FG000|Overall Study|Withdrawal by Subject|2|||
156738748|NCT03839459|565791144|FG000|Overall Study|progression of disease|3|||
156738749|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
156738750|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
157142702|NCT05490771|567269744|FG000|Overall Study|Adverse Event|3|||
157142703|NCT05490771|567269744|FG000|Overall Study|Other complicating disease|1|||
157142704|NCT05490771|567269744|FG000|Overall Study|Withdrawal by Subject|3|||
157142705|NCT05490771|567269744|FG000|Overall Study|Physician Decision|1|||
157142706|NCT05490771|567269744|FG000|Overall Study|Still on treatment|2|||
156738751|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
156738752|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
157142707|NCT05490771|567269744|FG000|Overall Study|Never start protocol therapy|5|||
157142708|NCT05490771|567269744|FG000|Overall Study|Ineligible|2|||
157142709|NCT02502864|567269752|FG000|Overall Study|Withdrawal by Subject|1|||
157142710|NCT00613626|567269754|FG000|Overall Study|Ineligible|0|||
157142711|NCT00613626|567269755|FG001|Overall Study|Ineligible|1|||
157142712|NCT00613626|567269756|FG002|Overall Study|Ineligible|0|||
157142713|NCT01299025|567269757|FG000|Overall Study|Withdrawal by Subject|2|||
157142714|NCT01299025|567269758|FG001|Overall Study|Withdrawal by Subject|1|||
157142715|NCT01299025|567269757|FG000|Overall Study|Lost to Follow-up|1|||
157142716|NCT01299025|567269758|FG001|Overall Study|Lost to Follow-up|0|||
157142717|NCT01624194|567269759|FG000|Overall Study|Lost to Follow-up|1|||
156738753|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
156738754|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
156738755|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
156738756|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
156738757|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
156738758|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
156738759|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
156738760|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
156738761|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
156738762|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
156738763|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
156738764|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
156738765|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
156738766|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
156738767|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
156738768|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
156738769|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
156738770|NCT04488419|565791146|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
156738771|NCT04488419|565791147|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
156738772|NCT04488419|565791148|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
156738773|NCT04488419|565791146|FG000|Primary Analysis Population|Adverse Event|6|||
156738774|NCT04488419|565791147|FG001|Primary Analysis Population|Adverse Event|9|||
156738775|NCT04488419|565791148|FG002|Primary Analysis Population|Adverse Event|0|||
156738776|NCT04488419|565791146|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
156738777|NCT04488419|565791147|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
156738778|NCT04488419|565791148|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
156738779|NCT04488419|565791146|FG000|Primary Analysis Population|Protocol Violation|1|||
156738780|NCT04488419|565791147|FG001|Primary Analysis Population|Protocol Violation|1|||
156738781|NCT04488419|565791148|FG002|Primary Analysis Population|Protocol Violation|0|||
156738782|NCT04488419|565791146|FG000|Primary Analysis Population|Undetermined|7|||
156738783|NCT04488419|565791147|FG001|Primary Analysis Population|Undetermined|3|||
156738784|NCT04488419|565791148|FG002|Primary Analysis Population|Undetermined|0|||
156738785|NCT04488419|565791146|FG000|Primary Analysis Population|>1 Reason|2|||
156738786|NCT04488419|565791147|FG001|Primary Analysis Population|>1 Reason|4|||
156738787|NCT04488419|565791148|FG002|Primary Analysis Population|>1 Reason|0|||
156738788|NCT04598451|565791151|FG000|Overall Study|Adverse Event|3|||
156738789|NCT04598451|565791152|FG001|Overall Study|Adverse Event|2|||
156738790|NCT04598451|565791151|FG000|Overall Study|Withdrawal by Subject|3|||
156738791|NCT04598451|565791152|FG001|Overall Study|Withdrawal by Subject|7|||
156738792|NCT04598451|565791151|FG000|Overall Study|Lost to Follow-up|2|||
156738793|NCT04598451|565791152|FG001|Overall Study|Lost to Follow-up|0|||
157142718|NCT01624194|567269760|FG001|Overall Study|Lost to Follow-up|0|||
157142719|NCT01624194|567269759|FG000|Overall Study|Withdrawal by Subject|1|||
157142720|NCT01624194|567269760|FG001|Overall Study|Withdrawal by Subject|0|||
157142721|NCT03212261|567269761|FG000|Overall Study|Became ineligible d/t tech|2|||
156738794|NCT04598451|565791151|FG000|Overall Study|Physician Decision|4|||
156738795|NCT04598451|565791152|FG001|Overall Study|Physician Decision|1|||
156738796|NCT04598451|565791151|FG000|Overall Study|Requires Prohibited Medication|1|||
156797407|NCT00071032|566011318|FG000|Overall Study|Missing Primary Outcome|0|||
156797408|NCT00071032|566011319|FG001|Overall Study|Missing Primary Outcome|1|||
156797409|NCT02255656|566011327|FG000|Overall Study|Adverse Event|11|||
156797410|NCT02255656|566011327|FG000|Overall Study|Poor compliance to protocol|3|||
156797411|NCT02255656|566011327|FG000|Overall Study|Lost to Follow-up|30|||
157142722|NCT03212261|567269761|FG000|Overall Study|Tech Trouble- No first study visit|1|||
156738797|NCT04598451|565791152|FG001|Overall Study|Requires Prohibited Medication|0|||
156738798|NCT04598451|565791151|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
156797412|NCT02255656|566011327|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
156797413|NCT02255656|566011327|FG000|Overall Study|Other|126|||
157142723|NCT03212261|567269761|FG000|Overall Study|Lost to Follow-up|7|||
157142724|NCT03212261|567269761|FG000|Overall Study|Family Emergency|1|||
157142725|NCT03212261|567269761|FG000|Overall Study|Too busy/ No time|5|||
157142726|NCT05480514|567269762|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
156738799|NCT04598451|565791152|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
157142727|NCT05480514|567269763|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
157142728|NCT05480514|567269762|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
156738800|NCT01632150|565791155|FG000|Overall Study|Disease progression|27|||
156738801|NCT01632150|565791155|FG000|Overall Study|Study drug toxicity|1|||
156738802|NCT01632150|565791155|FG000|Overall Study|Unrelated adverse event|7|||
156738803|NCT01632150|565791155|FG000|Overall Study|Withdrawal by Subject|2|||
156738804|NCT01632150|565791155|FG000|Overall Study|Patient underwent autologous transplant|1|||
156738805|NCT01632150|565791155|FG000|Overall Study|Moved to compassionate program|2|||
156738806|NCT04327661|565791160|FG000|Overall Study|Withdrawal by Subject|1|||
156738807|NCT04327661|565791161|FG001|Overall Study|Withdrawal by Subject|0|||
156738808|NCT04327661|565791162|FG002|Overall Study|Withdrawal by Subject|0|||
156738809|NCT01473394|565791163|FG000|Overall Study|Adverse Event|13|||
156738810|NCT01473394|565791164|FG001|Overall Study|Adverse Event|16|||
156738811|NCT01473394|565791163|FG000|Overall Study|Insufficient Therapeutic Response|4|||
156738812|NCT01473394|565791164|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156797414|NCT03909971|566011328|FG000|Overall Study|Participant transition to rollover study|26|||
156797415|NCT03909971|566011329|FG001|Overall Study|Participant transition to rollover study|9|||
156797416|NCT03909971|566011328|FG000|Overall Study|Global Deterioration of Health Status|2|||
157142729|NCT05480514|567269763|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
157142730|NCT05480514|567269762|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
157142731|NCT05480514|567269763|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
157142732|NCT05480514|567269762|FG000|Period 1|Covid-19 Related|1|||
157142733|NCT05480514|567269763|FG001|Period 1|Covid-19 Related|0|||
157142734|NCT05480514|567269762|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
157142735|NCT05480514|567269763|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
157142736|NCT02296840|567269767|FG000|Overall Study|Adverse Event|1|||
157142737|NCT02296840|567269768|FG001|Overall Study|Adverse Event|1|||
157142738|NCT02296840|567269767|FG000|Overall Study|Protocol Violation|2|||
157142739|NCT02296840|567269768|FG001|Overall Study|Protocol Violation|1|||
157142740|NCT02296840|567269767|FG000|Overall Study|Lost to Follow-up|6|||
157142741|NCT02296840|567269768|FG001|Overall Study|Lost to Follow-up|17|||
157142742|NCT02485717|567269769|FG000|Overall Study|Lost to Follow-up|6|||
157142743|NCT02485717|567269770|FG001|Overall Study|Lost to Follow-up|0|||
157142744|NCT02485717|567269771|FG002|Overall Study|Lost to Follow-up|0|||
157142745|NCT02485717|567269769|FG000|Overall Study|Withdrawal by Subject|0|||
157142746|NCT02485717|567269770|FG001|Overall Study|Withdrawal by Subject|0|||
157142747|NCT02485717|567269771|FG002|Overall Study|Withdrawal by Subject|1|||
157142748|NCT02485717|567269769|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
157142749|NCT02485717|567269770|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
156797417|NCT03909971|566011329|FG001|Overall Study|Global Deterioration of Health Status|2|||
156797418|NCT03909971|566011328|FG000|Overall Study|Progressive Disease|28|||
156797419|NCT03909971|566011329|FG001|Overall Study|Progressive Disease|21|||
156797420|NCT03909971|566011328|FG000|Overall Study|Death|6|||
156797421|NCT03909971|566011329|FG001|Overall Study|Death|6|||
156797422|NCT03909971|566011328|FG000|Overall Study|Adverse Event|1|||
156797423|NCT03909971|566011329|FG001|Overall Study|Adverse Event|2|||
156797424|NCT03909971|566011328|FG000|Overall Study|Withdrawal by Subject|2|||
156797425|NCT03909971|566011329|FG001|Overall Study|Withdrawal by Subject|1|||
156797426|NCT03909971|566011328|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
156797427|NCT03909971|566011329|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
156797428|NCT03909971|566011328|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
156797429|NCT03909971|566011329|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
156797430|NCT01877278|566011330|FG000|Overall Study|Lost to Follow-up|3|||
156797431|NCT01877278|566011331|FG001|Overall Study|Lost to Follow-up|3|||
156797432|NCT01969058|566011332|FG000|Overall Study|Withdrawal by Subject|2|||
156797433|NCT01969058|566011333|FG001|Overall Study|Withdrawal by Subject|0|||
156797434|NCT01969058|566011332|FG000|Overall Study|Adverse Event|1|||
156797435|NCT01969058|566011333|FG001|Overall Study|Adverse Event|0|||
156797436|NCT04090749|566011336|FG000|Open Label Pilot|Lost to Follow-up|1|||
156797437|NCT04090749|566011337|FG001|Open Label Pilot|Lost to Follow-up|0|||
157142750|NCT02485717|567269771|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
157142751|NCT02485717|567269769|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
157142752|NCT02485717|567269770|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
157142753|NCT02485717|567269771|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
157142754|NCT02827877|567269772|FG000|Overall Study|Withdrawal by Subject|1|||
157142755|NCT00814710|567269775|FG000|Overall Study|Adverse Event|1|||
157142756|NCT00814710|567269776|FG001|Overall Study|Adverse Event|0|||
157142757|NCT00814710|567269775|FG000|Overall Study|Lost to Follow-up|7|||
157142758|NCT00814710|567269776|FG001|Overall Study|Lost to Follow-up|3|||
157142759|NCT04090164|567269777|FG000|Overall Study|incomplete data on file|245|||
157142760|NCT04090164|567269778|FG001|Overall Study|incomplete data on file|0|||
157142761|NCT02452359|567269781|FG000|Overall Study|Adverse Event|1|||
157142762|NCT02452359|567269781|FG000|Overall Study|Lost to Follow-up|15|||
157142763|NCT02452359|567269781|FG000|Overall Study|Pregnancy|1|||
157142764|NCT02452359|567269781|FG000|Overall Study|Withdrawal by Subject|4|||
157142765|NCT03414359|567269782|FG000|Overall Study|Lack of Efficacy|1|||
157142766|NCT03414359|567269783|FG001|Overall Study|Lack of Efficacy|1|||
157142767|NCT03414359|567269782|FG000|Overall Study|Protocol Violation|0|||
157142768|NCT03414359|567269783|FG001|Overall Study|Protocol Violation|1|||
157142769|NCT01386385|567271108|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
157142770|NCT01386385|567271109|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142771|NCT01386385|567271110|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142772|NCT01386385|567271111|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142773|NCT01386385|567271112|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142774|NCT01386385|567271113|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142775|NCT01386385|567271114|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142776|NCT01386385|567271115|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
157142777|NCT01386385|567271108|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
157142778|NCT01386385|567271109|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142779|NCT01386385|567271110|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142780|NCT01386385|567271111|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142781|NCT01386385|567271112|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142782|NCT01386385|567271113|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142783|NCT01386385|567271114|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142784|NCT01386385|567271115|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
157142785|NCT01386385|567271108|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142786|NCT01386385|567271109|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142787|NCT01386385|567271110|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
157142788|NCT01386385|567271111|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142789|NCT01386385|567271112|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
156738813|NCT01473394|565791163|FG000|Overall Study|Protocol Violation|7|||
156738814|NCT01473394|565791164|FG001|Overall Study|Protocol Violation|5|||
156738815|NCT01473394|565791163|FG000|Overall Study|Withdrew Consent|12|||
156738816|NCT01473394|565791164|FG001|Overall Study|Withdrew Consent|10|||
156738817|NCT01473394|565791163|FG000|Overall Study|Lost to Follow-up|9|||
157142790|NCT01386385|567271113|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142791|NCT01386385|567271114|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142792|NCT01386385|567271115|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
157142793|NCT01386385|567271108|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142794|NCT01386385|567271109|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142795|NCT01386385|567271110|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142796|NCT01386385|567271111|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142797|NCT01386385|567271112|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
157142798|NCT01386385|567271113|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142799|NCT01386385|567271114|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142800|NCT01386385|567271115|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
157142801|NCT01386385|567271108|FG000|Phase II Concurrent CRT|Adverse Event|0|||
157142802|NCT01386385|567271109|FG001|Phase II Concurrent CRT|Adverse Event|0|||
157142803|NCT01386385|567271110|FG002|Phase II Concurrent CRT|Adverse Event|0|||
157142804|NCT01386385|567271111|FG003|Phase II Concurrent CRT|Adverse Event|0|||
157142805|NCT01386385|567271112|FG004|Phase II Concurrent CRT|Adverse Event|0|||
157142806|NCT01386385|567271113|FG005|Phase II Concurrent CRT|Adverse Event|0|||
157142807|NCT01386385|567271114|FG006|Phase II Concurrent CRT|Adverse Event|3|||
157142808|NCT01386385|567271115|FG007|Phase II Concurrent CRT|Adverse Event|3|||
157142809|NCT01386385|567271108|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142810|NCT01386385|567271109|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142811|NCT01386385|567271110|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142812|NCT01386385|567271111|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142813|NCT01386385|567271112|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142814|NCT01386385|567271113|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142815|NCT01386385|567271114|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
157142816|NCT01386385|567271115|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
157142817|NCT01386385|567271108|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
157218443|NCT00125359|567545682|FG000|Overall Study|Death|4|||
156738818|NCT01473394|565791164|FG001|Overall Study|Lost to Follow-up|11|||
156738819|NCT03391232|565791165|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
157142818|NCT01386385|567271109|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
157142819|NCT01386385|567271110|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
157142820|NCT01386385|567271111|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
157142821|NCT01386385|567271112|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
157142822|NCT01386385|567271113|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
157142823|NCT01386385|567271114|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
157142824|NCT01386385|567271115|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
157142825|NCT01386385|567271108|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142826|NCT01386385|567271109|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142827|NCT01386385|567271110|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142828|NCT01386385|567271111|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142829|NCT01386385|567271112|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142830|NCT01386385|567271113|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
157142831|NCT01386385|567271114|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
156738820|NCT03391232|565791166|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
156738821|NCT03391232|565791165|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
156738822|NCT03391232|565791166|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
156738823|NCT02091960|565791167|FG000|Overall Study|Death|7|||
156738824|NCT02091960|565791167|FG000|Overall Study|Withdrawal by Subject|1|||
156738825|NCT02091960|565791167|FG000|Overall Study|Miscellaneous Reasons|37|||
156738826|NCT02637895|565791181|FG000|Overall Study|Lost to Follow-up|4|||
156738827|NCT02637895|565791182|FG001|Overall Study|Lost to Follow-up|0|||
156738828|NCT02637895|565791181|FG000|Overall Study|Protocol Violation|0|||
156738829|NCT02637895|565791182|FG001|Overall Study|Protocol Violation|1|||
156738830|NCT02637895|565791181|FG000|Overall Study|Lack of Efficacy|1|||
157142832|NCT01386385|567271115|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
156738831|NCT02637895|565791182|FG001|Overall Study|Lack of Efficacy|0|||
156738832|NCT02637895|565791181|FG000|Overall Study|Withdrawal by Subject|1|||
156738833|NCT02637895|565791182|FG001|Overall Study|Withdrawal by Subject|1|||
156738834|NCT02637895|565791181|FG000|Overall Study|Abnormal baseline lab|0|||
156738835|NCT02637895|565791182|FG001|Overall Study|Abnormal baseline lab|1|||
156738836|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Adverse Event|6|||
156738837|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Adverse Event|14|||
156738838|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Death|3|||
156738839|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Death|1|||
156738840|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
156738841|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
156738842|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
156738843|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
156738844|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
156738845|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
156738846|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
156738847|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
156738848|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
156738849|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
156738850|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Physician Decision|2|||
156738851|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Physician Decision|4|||
156738852|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Pregnancy|2|||
156738853|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Pregnancy|1|||
156738854|NCT02275780|565791188|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
156738855|NCT02275780|565791189|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
156738856|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
156738857|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
156738858|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
156738859|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
156738860|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
156738861|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
156738862|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
156738863|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
156738864|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
156738865|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
156738866|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
156738867|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
156738868|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
156738869|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
156738870|NCT02275780|565791188|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
156738871|NCT02275780|565791189|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
156738872|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
156738873|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
156738874|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
156738875|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
156738876|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
156738877|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
156738878|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
156738879|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
156738880|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
156738881|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
156738882|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
156738883|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
156738884|NCT02275780|565791188|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
156738885|NCT02275780|565791189|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
156738886|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
156738887|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
156738888|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
156738889|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
156738890|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
156738891|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
156738892|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
156738893|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
156738894|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
156738895|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
156738896|NCT02275780|565791188|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
156738897|NCT02275780|565791189|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
156738898|NCT01054300|565791194|FG000|Period 1|Adverse Event|1|||
156738899|NCT01054300|565791195|FG001|Period 1|Adverse Event|0|||
156738900|NCT01054300|565791196|FG002|Period 1|Adverse Event|0|||
156738901|NCT01054300|565791197|FG003|Period 1|Adverse Event|0|||
156738902|NCT01054300|565791194|FG000|Period 2|Withdrawal by Subject|0|||
156738903|NCT01054300|565791195|FG001|Period 2|Withdrawal by Subject|0|||
156738904|NCT01054300|565791196|FG002|Period 2|Withdrawal by Subject|1|||
156738905|NCT01054300|565791197|FG003|Period 2|Withdrawal by Subject|0|||
156738906|NCT00738881|565791205|FG000|Overall Study|Withdrawal by Subject|0|||
156738907|NCT00738881|565791206|FG001|Overall Study|Withdrawal by Subject|2|||
156738908|NCT00177307|565791210|FG000|Overall Study|Withdrawal by Subject|1|||
156738909|NCT01282164|565791211|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
156738910|NCT01282164|565791212|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
156738911|NCT04521621|565791213|FG000|Overall Study|Death|17|||
156738912|NCT04521621|565791214|FG001|Overall Study|Death|8|||
156738913|NCT04521621|565791215|FG002|Overall Study|Death|8|||
156738914|NCT04521621|565791216|FG003|Overall Study|Death|5|||
156738915|NCT04521621|565791217|FG004|Overall Study|Death|2|||
156738916|NCT04521621|565791218|FG005|Overall Study|Death|7|||
156738917|NCT04521621|565791219|FG006|Overall Study|Death|0|||
156738918|NCT04521621|565791220|FG007|Overall Study|Death|0|||
156738919|NCT04521621|565791213|FG000|Overall Study|Study Terminated by Sponsor|4|||
156738920|NCT04521621|565791214|FG001|Overall Study|Study Terminated by Sponsor|6|||
156738921|NCT04521621|565791215|FG002|Overall Study|Study Terminated by Sponsor|8|||
156738922|NCT04521621|565791216|FG003|Overall Study|Study Terminated by Sponsor|0|||
156738923|NCT04521621|565791217|FG004|Overall Study|Study Terminated by Sponsor|1|||
156738924|NCT04521621|565791218|FG005|Overall Study|Study Terminated by Sponsor|7|||
156738925|NCT04521621|565791219|FG006|Overall Study|Study Terminated by Sponsor|0|||
156738926|NCT04521621|565791220|FG007|Overall Study|Study Terminated by Sponsor|0|||
156738927|NCT04521621|565791213|FG000|Overall Study|Withdrawal by Subject|0|||
156738928|NCT04521621|565791214|FG001|Overall Study|Withdrawal by Subject|0|||
156738929|NCT04521621|565791215|FG002|Overall Study|Withdrawal by Subject|1|||
156738930|NCT04521621|565791216|FG003|Overall Study|Withdrawal by Subject|1|||
156738931|NCT04521621|565791217|FG004|Overall Study|Withdrawal by Subject|0|||
156738932|NCT04521621|565791218|FG005|Overall Study|Withdrawal by Subject|0|||
156877532|NCT04927364|566309850|FG000|Overall Study|Withdrawal by Subject|3|||
156877533|NCT04927364|566309850|FG000|Overall Study|Unable to complete preassessment MRI|1|||
156738933|NCT04521621|565791219|FG006|Overall Study|Withdrawal by Subject|0|||
156738934|NCT04521621|565791220|FG007|Overall Study|Withdrawal by Subject|0|||
156738935|NCT04521621|565791213|FG000|Overall Study|Allocated in error without study intervention|1|||
156797438|NCT04090749|566011338|FG002|Open Label Pilot|Lost to Follow-up|0|||
156797439|NCT04090749|566011336|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
156797440|NCT04090749|566011337|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
156797441|NCT04090749|566011338|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
156797442|NCT04090749|566011336|FG000|Pilot Trial|Lost to Follow-up|0|||
156797443|NCT04090749|566011337|FG001|Pilot Trial|Lost to Follow-up|1|||
156797444|NCT04090749|566011338|FG002|Pilot Trial|Lost to Follow-up|1|||
156797445|NCT03510715|566011339|FG000|Overall Study|Adverse Event|1|||
156797446|NCT03510715|566011340|FG001|Overall Study|Adverse Event|0|||
156797447|NCT05185453|566011352|FG000|Overall Study|Lost to Follow-up|13|||
156797448|NCT05185453|566011353|FG001|Overall Study|Lost to Follow-up|3|||
156797449|NCT04144517|566011357|FG000|Overall Study|Physician Decision|0|||
156738936|NCT04521621|565791214|FG001|Overall Study|Allocated in error without study intervention|0|||
156738937|NCT04521621|565791215|FG002|Overall Study|Allocated in error without study intervention|0|||
156738938|NCT04521621|565791216|FG003|Overall Study|Allocated in error without study intervention|0|||
156738939|NCT04521621|565791217|FG004|Overall Study|Allocated in error without study intervention|0|||
156738940|NCT04521621|565791218|FG005|Overall Study|Allocated in error without study intervention|0|||
156738941|NCT04521621|565791219|FG006|Overall Study|Allocated in error without study intervention|0|||
156797450|NCT04144517|566011358|FG001|Overall Study|Physician Decision|1|||
156797451|NCT04144517|566011357|FG000|Overall Study|Other|2|||
156797452|NCT04144517|566011358|FG001|Overall Study|Other|2|||
156738942|NCT04521621|565791220|FG007|Overall Study|Allocated in error without study intervention|0|||
156738943|NCT03671564|565791221|FG000|Overall Study|Progressive Disease|3|||
156738944|NCT03671564|565791222|FG001|Overall Study|Progressive Disease|5|||
156738945|NCT03671564|565791223|FG002|Overall Study|Progressive Disease|3|||
156738946|NCT03671564|565791221|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
156738947|NCT03671564|565791222|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
156738948|NCT03671564|565791223|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
156738949|NCT03671564|565791221|FG000|Overall Study|Withdrawal by Subject|1|||
156738950|NCT03671564|565791222|FG001|Overall Study|Withdrawal by Subject|1|||
156738951|NCT03671564|565791223|FG002|Overall Study|Withdrawal by Subject|0|||
156738952|NCT01968707|565791228|FG000|Overall Study|Did not meet treatment day baseline|49|||
156738953|NCT01968707|565791229|FG001|Overall Study|Did not meet treatment day baseline|12|||
156738954|NCT01968707|565791230|FG002|Overall Study|Did not meet treatment day baseline|41|||
156738955|NCT01968707|565791231|FG003|Overall Study|Did not meet treatment day baseline|44|||
156738956|NCT01968707|565791232|FG004|Overall Study|Did not meet treatment day baseline|36|||
156738957|NCT01968707|565791233|FG005|Overall Study|Did not meet treatment day baseline|11|||
156738958|NCT01968707|565791234|FG006|Overall Study|Did not meet treatment day baseline|34|||
156738959|NCT01968707|565791235|FG007|Overall Study|Did not meet treatment day baseline|35|||
156738960|NCT01104246|565791240|FG000|Overall Study|Withdrawal by Subject|1|||
156738961|NCT01104246|565791240|FG000|Overall Study|did not meet inclusion criteria|4|||
156738962|NCT03640481|565791243|FG000|Overall Study|Death|14|||
156738963|NCT03640481|565791244|FG001|Overall Study|Death|14|||
156738964|NCT03640481|565791245|FG002|Overall Study|Death|0|||
156738965|NCT03640481|565791246|FG003|Overall Study|Death|0|||
156738966|NCT03640481|565791243|FG000|Overall Study|Lost to Follow-up|2|||
156738967|NCT03640481|565791244|FG001|Overall Study|Lost to Follow-up|0|||
156738968|NCT03640481|565791245|FG002|Overall Study|Lost to Follow-up|0|||
156738969|NCT03640481|565791246|FG003|Overall Study|Lost to Follow-up|0|||
156738970|NCT03640481|565791243|FG000|Overall Study|Site terminated by sponsor|1|||
156738971|NCT03640481|565791244|FG001|Overall Study|Site terminated by sponsor|3|||
156738972|NCT03640481|565791245|FG002|Overall Study|Site terminated by sponsor|0|||
156738973|NCT03640481|565791246|FG003|Overall Study|Site terminated by sponsor|0|||
156738974|NCT03640481|565791243|FG000|Overall Study|Study terminated by sponsor|29|||
156738975|NCT03640481|565791244|FG001|Overall Study|Study terminated by sponsor|42|||
156738976|NCT03640481|565791245|FG002|Overall Study|Study terminated by sponsor|1|||
156738977|NCT03640481|565791246|FG003|Overall Study|Study terminated by sponsor|0|||
156738978|NCT03640481|565791243|FG000|Overall Study|Withdrawal by Subject|5|||
156738979|NCT03640481|565791244|FG001|Overall Study|Withdrawal by Subject|4|||
156738980|NCT03640481|565791245|FG002|Overall Study|Withdrawal by Subject|0|||
156738981|NCT03640481|565791246|FG003|Overall Study|Withdrawal by Subject|1|||
156738982|NCT03640481|565791243|FG000|Overall Study|Other|26|||
156738983|NCT03640481|565791244|FG001|Overall Study|Other|12|||
156738984|NCT03640481|565791245|FG002|Overall Study|Other|1|||
156738985|NCT03640481|565791246|FG003|Overall Study|Other|0|||
156738986|NCT03640481|565791243|FG000|Overall Study|Randomized, but not treated|1|||
156738987|NCT03640481|565791244|FG001|Overall Study|Randomized, but not treated|3|||
156738988|NCT03640481|565791245|FG002|Overall Study|Randomized, but not treated|0|||
156738989|NCT03640481|565791246|FG003|Overall Study|Randomized, but not treated|0|||
156738990|NCT01546168|565791247|FG000|Overall Study|Lost to Follow-up|1|||
156797453|NCT04144517|566011357|FG000|Overall Study|Death|6|||
156797454|NCT04144517|566011358|FG001|Overall Study|Death|3|||
156797455|NCT05929326|566011376|FG000|Overall Study|unqualified sample|2|||
156797456|NCT05929326|566011377|FG001|Overall Study|unqualified sample|3|||
156797457|NCT05929326|566011378|FG002|Overall Study|unqualified sample|7|||
156738991|NCT01546168|565791248|FG001|Overall Study|Lost to Follow-up|0|||
156738992|NCT01546168|565791247|FG000|Overall Study|Withdrawal by Subject|1|||
156738993|NCT01546168|565791248|FG001|Overall Study|Withdrawal by Subject|0|||
156797458|NCT02495883|566011385|FG000|Overall Study|Excessive head motion|1|||
156797459|NCT02495883|566011386|FG001|Overall Study|Excessive head motion|0|||
157020419|NCT05034952|566828431|FG000|Overall Study|Adverse Event|1|||
156738994|NCT01546168|565791247|FG000|Overall Study|ineligible after signing consent|2|||
156738995|NCT01546168|565791248|FG001|Overall Study|ineligible after signing consent|0|||
156738996|NCT02850016|565791251|FG000|Overall Study|Withdrawal by Subject|1|||
156738997|NCT02850016|565791252|FG001|Overall Study|Withdrawal by Subject|2|||
156738998|NCT00070018|565791255|FG000|Overall Study|Adverse Event|2|||
156738999|NCT00070018|565791255|FG000|Overall Study|Lack of Efficacy|1|||
156739000|NCT00070018|565791255|FG000|Overall Study|Withdrawal by Subject|1|||
156797460|NCT00964678|566011387|FG000|Overall Study|Physician Decision|4|||
156797461|NCT03359395|566011388|FG000|First Intervention A / B|Withdrawal by Subject|1|||
156797462|NCT03359395|566011389|FG001|First Intervention A / B|Withdrawal by Subject|0|||
156797463|NCT03359395|566011388|FG000|First Intervention A / B|Lost to Follow-up|2|||
156797464|NCT03359395|566011389|FG001|First Intervention A / B|Lost to Follow-up|3|||
156797465|NCT03359395|566011388|FG000|Second Intervention B/A|Exclusion criteria|0|||
156797466|NCT03359395|566011389|FG001|Second Intervention B/A|Exclusion criteria|1|||
156797467|NCT03359395|566011388|FG000|Second Intervention B/A|Lost to Follow-up|3|||
156797468|NCT03359395|566011389|FG001|Second Intervention B/A|Lost to Follow-up|2|||
156797469|NCT03164356|566011390|FG000|Overall Study|Lost to Follow-up|1|||
156797470|NCT03164356|566011391|FG001|Overall Study|Lost to Follow-up|1|||
156797471|NCT03164356|566011392|FG002|Overall Study|Lost to Follow-up|2|||
156797472|NCT03164356|566011393|FG003|Overall Study|Lost to Follow-up|1|||
156797473|NCT03164356|566011390|FG000|Overall Study|Physician Decision|0|||
156797474|NCT03164356|566011391|FG001|Overall Study|Physician Decision|0|||
156797475|NCT03164356|566011392|FG002|Overall Study|Physician Decision|3|||
156797476|NCT03164356|566011393|FG003|Overall Study|Physician Decision|0|||
156797477|NCT03164356|566011390|FG000|Overall Study|Protocol Violation|2|||
156797478|NCT03164356|566011391|FG001|Overall Study|Protocol Violation|1|||
156797479|NCT03164356|566011392|FG002|Overall Study|Protocol Violation|0|||
156797480|NCT03164356|566011393|FG003|Overall Study|Protocol Violation|0|||
156739001|NCT02939716|565791256|FG000|Overall Study|scanner failure|0|||
156739002|NCT02939716|565791257|FG001|Overall Study|scanner failure|0|||
156739003|NCT02939716|565791258|FG002|Overall Study|scanner failure|0|||
156739004|NCT02939716|565791259|FG003|Overall Study|scanner failure|1|||
156739005|NCT02939716|565791260|FG004|Overall Study|scanner failure|1|||
156739006|NCT02939716|565791261|FG005|Overall Study|scanner failure|1|||
156739007|NCT04442269|565791264|FG000|Overall Study|Adverse Event|1|||
156739008|NCT04442269|565791265|FG001|Overall Study|Adverse Event|0|||
156739009|NCT04442269|565791264|FG000|Overall Study|Death|0|||
156739010|NCT04442269|565791265|FG001|Overall Study|Death|1|||
156739011|NCT04442269|565791264|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
156739012|NCT04442269|565791265|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
156739013|NCT04442269|565791264|FG000|Overall Study|Lost to Follow-up|1|||
156739014|NCT04442269|565791265|FG001|Overall Study|Lost to Follow-up|0|||
156739015|NCT04442269|565791264|FG000|Overall Study|Withdrawal by Subject|3|||
156739016|NCT04442269|565791265|FG001|Overall Study|Withdrawal by Subject|2|||
156739017|NCT04442269|565791264|FG000|Overall Study|Protocol Deviation|0|||
156739018|NCT04442269|565791265|FG001|Overall Study|Protocol Deviation|1|||
156739019|NCT04442269|565791264|FG000|Overall Study|Travel Limitations|1|||
156739020|NCT04442269|565791265|FG001|Overall Study|Travel Limitations|1|||
156739021|NCT03802565|565791269|FG000|Overall Study|Adverse Event|0|||
156739022|NCT03802565|565791270|FG001|Overall Study|Adverse Event|1|||
156739023|NCT03802565|565791271|FG002|Overall Study|Adverse Event|2|||
156739024|NCT03802565|565791272|FG003|Overall Study|Adverse Event|1|||
156739025|NCT03802565|565791273|FG004|Overall Study|Adverse Event|1|||
156739026|NCT03802565|565791269|FG000|Overall Study|Withdrawal by Subject|2|||
156797481|NCT03164356|566011390|FG000|Overall Study|Withdrawal by Subject|1|||
156739027|NCT03802565|565791270|FG001|Overall Study|Withdrawal by Subject|2|||
156739028|NCT03802565|565791271|FG002|Overall Study|Withdrawal by Subject|2|||
156797482|NCT03164356|566011391|FG001|Overall Study|Withdrawal by Subject|0|||
156797483|NCT03164356|566011392|FG002|Overall Study|Withdrawal by Subject|0|||
156797484|NCT03164356|566011393|FG003|Overall Study|Withdrawal by Subject|0|||
156739029|NCT03802565|565791272|FG003|Overall Study|Withdrawal by Subject|0|||
156797485|NCT03164356|566011390|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
156797486|NCT03164356|566011391|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
156797487|NCT03164356|566011392|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
156739030|NCT03802565|565791273|FG004|Overall Study|Withdrawal by Subject|1|||
156739031|NCT03802565|565791269|FG000|Overall Study|Protocol Violation|2|||
156739032|NCT03802565|565791270|FG001|Overall Study|Protocol Violation|1|||
156739033|NCT03802565|565791271|FG002|Overall Study|Protocol Violation|4|||
156739034|NCT03802565|565791272|FG003|Overall Study|Protocol Violation|5|||
156739035|NCT03802565|565791273|FG004|Overall Study|Protocol Violation|1|||
156739036|NCT03802565|565791269|FG000|Overall Study|Lost to Follow-up|0|||
156739037|NCT03802565|565791270|FG001|Overall Study|Lost to Follow-up|0|||
156739038|NCT03802565|565791271|FG002|Overall Study|Lost to Follow-up|1|||
156739039|NCT03802565|565791272|FG003|Overall Study|Lost to Follow-up|0|||
156739040|NCT03802565|565791273|FG004|Overall Study|Lost to Follow-up|0|||
156739041|NCT03802565|565791269|FG000|Overall Study|Subjects Related to Each Other|1|||
156739042|NCT03802565|565791270|FG001|Overall Study|Subjects Related to Each Other|0|||
156739043|NCT03802565|565791271|FG002|Overall Study|Subjects Related to Each Other|0|||
156739044|NCT03802565|565791272|FG003|Overall Study|Subjects Related to Each Other|2|||
156739045|NCT03802565|565791273|FG004|Overall Study|Subjects Related to Each Other|1|||
156739046|NCT03802565|565791269|FG000|Overall Study|Elevated Enzymes|0|||
156739047|NCT03802565|565791270|FG001|Overall Study|Elevated Enzymes|0|||
156739048|NCT03802565|565791271|FG002|Overall Study|Elevated Enzymes|0|||
156739049|NCT03802565|565791272|FG003|Overall Study|Elevated Enzymes|0|||
156739050|NCT03802565|565791273|FG004|Overall Study|Elevated Enzymes|2|||
156739051|NCT00430352|565791274|FG000|Overall Study|Disease progression|58|||
156739052|NCT00430352|565791274|FG000|Overall Study|Withdrawal by Subject|11|||
156739053|NCT00430352|565791274|FG000|Overall Study|Adverse Event|16|||
156739054|NCT00430352|565791274|FG000|Overall Study|Death|5|||
156739055|NCT00430352|565791274|FG000|Overall Study|Other|48|||
156739056|NCT03099694|565791275|FG000|Overall Study|Withdrawal by Subject|11|||
156739057|NCT03099694|565791276|FG001|Overall Study|Withdrawal by Subject|13|||
156739058|NCT03099694|565791275|FG000|Overall Study|Lost to Follow-up|9|||
156739059|NCT03099694|565791276|FG001|Overall Study|Lost to Follow-up|5|||
156739060|NCT04326439|565791277|FG000|Overall Study|Withdrawal by Subject|1|||
156739061|NCT04326439|565791278|FG001|Overall Study|Withdrawal by Subject|0|||
156739062|NCT04326439|565791277|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
156739063|NCT04326439|565791278|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
156739064|NCT04326439|565791277|FG000|Overall Study|Relapse after Induction 2|0|||
156739065|NCT04326439|565791278|FG001|Overall Study|Relapse after Induction 2|1|||
156739066|NCT04326439|565791277|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
156739067|NCT04326439|565791278|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
156739068|NCT01446237|565791281|FG000|Overall Study|Adverse Event|1|||
156739069|NCT01446237|565791281|FG000|Overall Study|Lost to Follow-up|2|||
156739070|NCT01446237|565791281|FG000|Overall Study|Withdrawal by Subject|7|||
156739071|NCT01744184|565791296|FG000|Overall Study|Adverse Event|1|||
156739072|NCT01744184|565791297|FG001|Overall Study|Adverse Event|0|||
156739073|NCT01744184|565791296|FG000|Overall Study|Withdrawal by Subject|0|||
156739074|NCT01744184|565791297|FG001|Overall Study|Withdrawal by Subject|1|||
156739075|NCT00072280|565791298|FG000|Treatment|Found ineligible|1|||
156739076|NCT00072280|565791299|FG001|Treatment|Found ineligible|2|||
156739077|NCT00072280|565791298|FG000|Follow-up|Early termination of study|2|||
156739078|NCT00072280|565791299|FG001|Follow-up|Early termination of study|2|||
156739079|NCT02841280|565791300|FG000|Overall Study|Adverse Event|2|||
156739080|NCT02841280|565791301|FG001|Overall Study|Adverse Event|1|||
156739081|NCT02841280|565791300|FG000|Overall Study|Death|1|||
156739082|NCT02841280|565791301|FG001|Overall Study|Death|0|||
156739083|NCT02841280|565791300|FG000|Overall Study|Lost to Follow-up|2|||
156739084|NCT02841280|565791301|FG001|Overall Study|Lost to Follow-up|2|||
156739085|NCT02841280|565791300|FG000|Overall Study|Withdrawal by Subject|7|||
156739086|NCT02841280|565791301|FG001|Overall Study|Withdrawal by Subject|3|||
156739087|NCT02841280|565791300|FG000|Overall Study|Stop Point: BP above threshold|2|||
156739088|NCT02841280|565791301|FG001|Overall Study|Stop Point: BP above threshold|0|||
156739089|NCT00957268|565791302|FG000|Overall Study|Voluntary Withdrawal|0|||
156739090|NCT00957268|565791303|FG001|Overall Study|Voluntary Withdrawal|0|||
156739091|NCT00957268|565791304|FG002|Overall Study|Voluntary Withdrawal|1|||
156739092|NCT00957268|565791305|FG003|Overall Study|Voluntary Withdrawal|0|||
156739093|NCT00957268|565791306|FG004|Overall Study|Voluntary Withdrawal|0|||
156739094|NCT01340027|565791308|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
156739095|NCT01340027|565791309|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
156739096|NCT01340027|565791310|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
156739097|NCT01340027|565791311|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
156739098|NCT01340027|565791312|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
156739099|NCT01340027|565791313|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
156739100|NCT01340027|565791314|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
156739101|NCT01340027|565791315|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
156739102|NCT01340027|565791316|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
156739103|NCT01340027|565791317|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
156739104|NCT01340027|565791318|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
156739105|NCT01340027|565791319|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
156739106|NCT01340027|565791308|FG000|Overall Study|Adverse Event|0|||
156739107|NCT01340027|565791309|FG001|Overall Study|Adverse Event|1|||
156739108|NCT01340027|565791310|FG002|Overall Study|Adverse Event|2|||
156739109|NCT01340027|565791311|FG003|Overall Study|Adverse Event|0|||
156739110|NCT01340027|565791312|FG004|Overall Study|Adverse Event|1|||
156739111|NCT01340027|565791313|FG005|Overall Study|Adverse Event|2|||
156739112|NCT01340027|565791314|FG006|Overall Study|Adverse Event|2|||
156739113|NCT01340027|565791315|FG007|Overall Study|Adverse Event|1|||
156739114|NCT01340027|565791316|FG008|Overall Study|Adverse Event|4|||
156739115|NCT01340027|565791317|FG009|Overall Study|Adverse Event|1|||
156739116|NCT01340027|565791318|FG010|Overall Study|Adverse Event|1|||
156739117|NCT01340027|565791319|FG011|Overall Study|Adverse Event|3|||
156739118|NCT01340027|565791308|FG000|Overall Study|Lack of Efficacy|0|||
156739119|NCT01340027|565791309|FG001|Overall Study|Lack of Efficacy|0|||
156739120|NCT01340027|565791310|FG002|Overall Study|Lack of Efficacy|0|||
156739121|NCT01340027|565791311|FG003|Overall Study|Lack of Efficacy|0|||
156739122|NCT01340027|565791312|FG004|Overall Study|Lack of Efficacy|0|||
156739123|NCT01340027|565791313|FG005|Overall Study|Lack of Efficacy|0|||
156739124|NCT01340027|565791314|FG006|Overall Study|Lack of Efficacy|1|||
156739125|NCT01340027|565791315|FG007|Overall Study|Lack of Efficacy|1|||
156739126|NCT01340027|565791316|FG008|Overall Study|Lack of Efficacy|1|||
156739127|NCT01340027|565791317|FG009|Overall Study|Lack of Efficacy|0|||
156739128|NCT01340027|565791318|FG010|Overall Study|Lack of Efficacy|0|||
156739129|NCT01340027|565791319|FG011|Overall Study|Lack of Efficacy|0|||
156739130|NCT01340027|565791308|FG000|Overall Study|Lost to Follow-up|0|||
156739131|NCT01340027|565791309|FG001|Overall Study|Lost to Follow-up|1|||
156739132|NCT01340027|565791310|FG002|Overall Study|Lost to Follow-up|0|||
156739133|NCT01340027|565791311|FG003|Overall Study|Lost to Follow-up|0|||
156739134|NCT01340027|565791312|FG004|Overall Study|Lost to Follow-up|0|||
156739135|NCT01340027|565791313|FG005|Overall Study|Lost to Follow-up|0|||
156739136|NCT01340027|565791314|FG006|Overall Study|Lost to Follow-up|1|||
156739137|NCT01340027|565791315|FG007|Overall Study|Lost to Follow-up|0|||
156739138|NCT01340027|565791316|FG008|Overall Study|Lost to Follow-up|0|||
156739139|NCT01340027|565791317|FG009|Overall Study|Lost to Follow-up|1|||
156739140|NCT01340027|565791318|FG010|Overall Study|Lost to Follow-up|0|||
156739141|NCT01340027|565791319|FG011|Overall Study|Lost to Follow-up|0|||
156739142|NCT01340027|565791308|FG000|Overall Study|Protocol Violation|1|||
156739143|NCT01340027|565791309|FG001|Overall Study|Protocol Violation|2|||
156739144|NCT01340027|565791310|FG002|Overall Study|Protocol Violation|0|||
156739145|NCT01340027|565791311|FG003|Overall Study|Protocol Violation|0|||
156739146|NCT01340027|565791312|FG004|Overall Study|Protocol Violation|6|||
156739147|NCT01340027|565791313|FG005|Overall Study|Protocol Violation|0|||
156739148|NCT01340027|565791314|FG006|Overall Study|Protocol Violation|0|||
156739149|NCT01340027|565791315|FG007|Overall Study|Protocol Violation|1|||
156739150|NCT01340027|565791316|FG008|Overall Study|Protocol Violation|2|||
156739151|NCT01340027|565791317|FG009|Overall Study|Protocol Violation|2|||
156739152|NCT01340027|565791318|FG010|Overall Study|Protocol Violation|0|||
156739153|NCT01340027|565791319|FG011|Overall Study|Protocol Violation|0|||
156739154|NCT01340027|565791308|FG000|Overall Study|Withdrawal by Subject|4|||
156739155|NCT01340027|565791309|FG001|Overall Study|Withdrawal by Subject|3|||
156739156|NCT01340027|565791310|FG002|Overall Study|Withdrawal by Subject|1|||
156739157|NCT01340027|565791311|FG003|Overall Study|Withdrawal by Subject|3|||
156739158|NCT01340027|565791312|FG004|Overall Study|Withdrawal by Subject|3|||
156739159|NCT01340027|565791313|FG005|Overall Study|Withdrawal by Subject|2|||
156739160|NCT01340027|565791314|FG006|Overall Study|Withdrawal by Subject|3|||
156739161|NCT01340027|565791315|FG007|Overall Study|Withdrawal by Subject|4|||
156739162|NCT01340027|565791316|FG008|Overall Study|Withdrawal by Subject|1|||
156739163|NCT01340027|565791317|FG009|Overall Study|Withdrawal by Subject|2|||
156739164|NCT01340027|565791318|FG010|Overall Study|Withdrawal by Subject|0|||
156739165|NCT01340027|565791319|FG011|Overall Study|Withdrawal by Subject|1|||
156739166|NCT01340027|565791308|FG000|Overall Study|Miscellaneous|0|||
156739167|NCT01340027|565791309|FG001|Overall Study|Miscellaneous|0|||
156739168|NCT01340027|565791310|FG002|Overall Study|Miscellaneous|0|||
156739169|NCT01340027|565791311|FG003|Overall Study|Miscellaneous|1|||
156739170|NCT01340027|565791312|FG004|Overall Study|Miscellaneous|0|||
156739171|NCT01340027|565791313|FG005|Overall Study|Miscellaneous|0|||
156739172|NCT01340027|565791314|FG006|Overall Study|Miscellaneous|0|||
156739173|NCT01340027|565791315|FG007|Overall Study|Miscellaneous|0|||
156739174|NCT01340027|565791316|FG008|Overall Study|Miscellaneous|0|||
156739175|NCT01340027|565791317|FG009|Overall Study|Miscellaneous|0|||
156739176|NCT01340027|565791318|FG010|Overall Study|Miscellaneous|1|||
156739177|NCT01340027|565791319|FG011|Overall Study|Miscellaneous|0|||
156739178|NCT00833482|565791320|FG000|Days 11-20|Adverse Event|0|||
156739179|NCT00833482|565791321|FG001|Days 11-20|Adverse Event|2|||
156739180|NCT00833482|565791322|FG002|Days 11-20|Adverse Event|0|||
156739181|NCT00833482|565791323|FG003|Days 11-20|Adverse Event|0|||
156739182|NCT00833482|565791324|FG004|Days 11-20|Adverse Event|0|||
156739183|NCT00833482|565791325|FG005|Days 11-20|Adverse Event|0|||
156739184|NCT00833482|565791320|FG000|Days 11-20|Withdrawal by Subject|0|||
156739185|NCT00833482|565791321|FG001|Days 11-20|Withdrawal by Subject|1|||
156739186|NCT00833482|565791322|FG002|Days 11-20|Withdrawal by Subject|0|||
156739187|NCT00833482|565791323|FG003|Days 11-20|Withdrawal by Subject|0|||
156739188|NCT00833482|565791324|FG004|Days 11-20|Withdrawal by Subject|0|||
156797488|NCT03164356|566011393|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
156797489|NCT03164356|566011390|FG000|Overall Study|Subject Incarcerated|0|||
156797490|NCT03164356|566011391|FG001|Overall Study|Subject Incarcerated|1|||
156797491|NCT03164356|566011392|FG002|Overall Study|Subject Incarcerated|0|||
157020420|NCT05034952|566828432|FG001|Overall Study|Adverse Event|0|||
157020421|NCT05034952|566828433|FG002|Overall Study|Adverse Event|0|||
157020422|NCT05034952|566828434|FG003|Overall Study|Adverse Event|0|||
156739189|NCT00833482|565791325|FG005|Days 11-20|Withdrawal by Subject|0|||
156739190|NCT00833482|565791320|FG000|Days 21-30|Adverse Event|0|||
156739191|NCT00833482|565791321|FG001|Days 21-30|Adverse Event|0|||
156739192|NCT00833482|565791322|FG002|Days 21-30|Adverse Event|1|||
156739193|NCT00833482|565791323|FG003|Days 21-30|Adverse Event|0|||
156739194|NCT00833482|565791324|FG004|Days 21-30|Adverse Event|0|||
156739195|NCT00833482|565791325|FG005|Days 21-30|Adverse Event|0|||
156739196|NCT00833482|565791320|FG000|Days 21-30|Withdrawal by Subject|0|||
156739197|NCT00833482|565791321|FG001|Days 21-30|Withdrawal by Subject|0|||
156739198|NCT00833482|565791322|FG002|Days 21-30|Withdrawal by Subject|0|||
156739199|NCT00833482|565791323|FG003|Days 21-30|Withdrawal by Subject|0|||
156739200|NCT00833482|565791324|FG004|Days 21-30|Withdrawal by Subject|1|||
156739201|NCT00833482|565791325|FG005|Days 21-30|Withdrawal by Subject|0|||
156739202|NCT02496091|565791326|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156739203|NCT02234596|565791330|FG000|Overall Study|Participant not treated|2|||
156739204|NCT00197002|565793102|FG000|Overall Study|Adverse Event|0|||
156739205|NCT00197002|565793103|FG001|Overall Study|Adverse Event|1|||
156739206|NCT00197002|565793104|FG002|Overall Study|Adverse Event|0|||
156739207|NCT00197002|565793102|FG000|Overall Study|Protocol Violation|1|||
156739208|NCT00197002|565793103|FG001|Overall Study|Protocol Violation|0|||
156739209|NCT00197002|565793104|FG002|Overall Study|Protocol Violation|2|||
156739210|NCT00197002|565793102|FG000|Overall Study|Withdrawal by Subject|9|||
156739211|NCT00197002|565793103|FG001|Overall Study|Withdrawal by Subject|5|||
156739212|NCT00197002|565793104|FG002|Overall Study|Withdrawal by Subject|7|||
156739213|NCT00197002|565793102|FG000|Overall Study|Migrated/moved from study area|3|||
156739214|NCT00197002|565793103|FG001|Overall Study|Migrated/moved from study area|5|||
156739215|NCT00197002|565793104|FG002|Overall Study|Migrated/moved from study area|1|||
156739216|NCT00197002|565793102|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
156739217|NCT00197002|565793103|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
156739218|NCT00197002|565793104|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
156739219|NCT00197002|565793102|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
156739220|NCT00197002|565793103|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
156739221|NCT00197002|565793104|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
156739222|NCT00197002|565793102|FG000|Overall Study|Others|3|||
156739223|NCT00197002|565793103|FG001|Overall Study|Others|1|||
156739224|NCT00197002|565793104|FG002|Overall Study|Others|1|||
156739225|NCT05376241|565793105|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
156739226|NCT05376241|565793105|FG000|Overall Study|103 did not complete the survey|103|||
156739227|NCT05376241|565793105|FG000|Overall Study|17 failed 2 attention check questions|17|||
156739228|NCT03036098|565793106|FG000|Pre-Treatment|Other Reasons|1|||
156739229|NCT03036098|565793107|FG001|Pre-Treatment|Other Reasons|2|||
156739230|NCT03036098|565793108|FG002|Pre-Treatment|Other Reasons|0|||
156739231|NCT03036098|565793109|FG003|Pre-Treatment|Other Reasons|5|||
156739232|NCT03036098|565793106|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
156739233|NCT03036098|565793107|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
156739234|NCT03036098|565793108|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
156739235|NCT03036098|565793109|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
156739236|NCT03036098|565793106|FG000|Pre-Treatment|Withdrawal by Subject|1|||
156739237|NCT03036098|565793107|FG001|Pre-Treatment|Withdrawal by Subject|14|||
156739238|NCT03036098|565793108|FG002|Pre-Treatment|Withdrawal by Subject|0|||
156739239|NCT03036098|565793109|FG003|Pre-Treatment|Withdrawal by Subject|5|||
156739240|NCT03036098|565793106|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
156739241|NCT03036098|565793107|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
156739242|NCT03036098|565793108|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
156739243|NCT03036098|565793109|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
156739244|NCT03036098|565793106|FG000|Treatment|Disease Progression|130|||
156739245|NCT03036098|565793107|FG001|Treatment|Disease Progression|77|||
156739246|NCT03036098|565793108|FG002|Treatment|Disease Progression|168|||
156739247|NCT03036098|565793109|FG003|Treatment|Disease Progression|50|||
156739248|NCT03036098|565793106|FG000|Treatment|Study Drug Toxicity|95|||
156739249|NCT03036098|565793107|FG001|Treatment|Study Drug Toxicity|45|||
156739250|NCT03036098|565793108|FG002|Treatment|Study Drug Toxicity|26|||
156739251|NCT03036098|565793109|FG003|Treatment|Study Drug Toxicity|22|||
156739252|NCT03036098|565793106|FG000|Treatment|Death|9|||
156739253|NCT03036098|565793107|FG001|Treatment|Death|3|||
156739254|NCT03036098|565793108|FG002|Treatment|Death|1|||
156797492|NCT03164356|566011393|FG003|Overall Study|Subject Incarcerated|0|||
156739255|NCT03036098|565793109|FG003|Treatment|Death|2|||
156739256|NCT03036098|565793106|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
156739257|NCT03036098|565793107|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
156739258|NCT03036098|565793108|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
156739259|NCT03036098|565793109|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
156739260|NCT03036098|565793106|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
156739261|NCT03036098|565793107|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
156739262|NCT03036098|565793108|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
156739263|NCT03036098|565793109|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
156739264|NCT03036098|565793106|FG000|Treatment|Withdrawal by Subject|2|||
156739265|NCT03036098|565793107|FG001|Treatment|Withdrawal by Subject|9|||
156739266|NCT03036098|565793108|FG002|Treatment|Withdrawal by Subject|2|||
156739267|NCT03036098|565793109|FG003|Treatment|Withdrawal by Subject|4|||
156739268|NCT03036098|565793106|FG000|Treatment|Maximum Clinical Benefit|6|||
156739269|NCT03036098|565793107|FG001|Treatment|Maximum Clinical Benefit|1|||
156739270|NCT03036098|565793108|FG002|Treatment|Maximum Clinical Benefit|6|||
156739271|NCT03036098|565793109|FG003|Treatment|Maximum Clinical Benefit|10|||
156739272|NCT03036098|565793106|FG000|Treatment|Poor/Non Compliance|1|||
156739273|NCT03036098|565793107|FG001|Treatment|Poor/Non Compliance|2|||
156739274|NCT03036098|565793108|FG002|Treatment|Poor/Non Compliance|0|||
156739275|NCT03036098|565793109|FG003|Treatment|Poor/Non Compliance|1|||
156739276|NCT03036098|565793106|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
156739277|NCT03036098|565793107|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
156739278|NCT03036098|565793108|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
156739279|NCT03036098|565793109|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
156739280|NCT03036098|565793106|FG000|Treatment|Administrative Reason by Sponsor|1|||
156739281|NCT03036098|565793107|FG001|Treatment|Administrative Reason by Sponsor|0|||
156739282|NCT03036098|565793108|FG002|Treatment|Administrative Reason by Sponsor|2|||
156739283|NCT03036098|565793109|FG003|Treatment|Administrative Reason by Sponsor|1|||
156739284|NCT03036098|565793106|FG000|Treatment|Other Reasons|31|||
156739285|NCT03036098|565793107|FG001|Treatment|Other Reasons|5|||
156739286|NCT03036098|565793108|FG002|Treatment|Other Reasons|21|||
156739287|NCT03036098|565793109|FG003|Treatment|Other Reasons|8|||
156739288|NCT03036098|565793106|FG000|Treatment|Ongoing Treatment|0|||
156739289|NCT03036098|565793107|FG001|Treatment|Ongoing Treatment|0|||
156739290|NCT03036098|565793108|FG002|Treatment|Ongoing Treatment|23|||
156739291|NCT03036098|565793109|FG003|Treatment|Ongoing Treatment|0|||
156739292|NCT04240886|565793112|FG000|Treatment Phase|Death|4|||
156739293|NCT04240886|565793112|FG000|Treatment Phase|Discontinuation by Subject|1|||
156739294|NCT04240886|565793112|FG000|Treatment Phase|Adverse Event|5|||
156739295|NCT04240886|565793112|FG000|Follow-up Phase|Withdrawal by Subject|1|||
156739296|NCT04240886|565793112|FG000|Follow-up Phase|Discontinuation by Subject|1|||
156739297|NCT04240886|565793112|FG000|Follow-up Phase|Death|2|||
156739298|NCT01632904|565793113|FG000|Overall Study|Adverse Event|4|||
156739299|NCT01632904|565793114|FG001|Overall Study|Adverse Event|1|||
156739300|NCT01632904|565793113|FG000|Overall Study|Physician Decision|0|||
156739301|NCT01632904|565793114|FG001|Overall Study|Physician Decision|1|||
156739302|NCT01632904|565793113|FG000|Overall Study|Subject decision|3|||
156739303|NCT01632904|565793114|FG001|Overall Study|Subject decision|2|||
156739304|NCT01632904|565793113|FG000|Overall Study|Disease Progression|0|||
156739305|NCT01632904|565793114|FG001|Overall Study|Disease Progression|1|||
156739306|NCT01632904|565793113|FG000|Overall Study|Reason for discontinuation not available|0|||
156739307|NCT01632904|565793114|FG001|Overall Study|Reason for discontinuation not available|1|||
156739308|NCT01944670|565793117|FG000|Overall Study|Lost to Follow-up|2|||
156739309|NCT03339726|565793121|FG000|Overall Study|Withdrawal by Subject|1|||
156739310|NCT03339726|565793122|FG001|Overall Study|Withdrawal by Subject|0|||
156739311|NCT03339726|565793123|FG002|Overall Study|Withdrawal by Subject|0|||
156739312|NCT03339726|565793121|FG000|Overall Study|Lost to Follow-up|0|||
156739313|NCT03339726|565793122|FG001|Overall Study|Lost to Follow-up|1|||
156739314|NCT03339726|565793123|FG002|Overall Study|Lost to Follow-up|0|||
156739315|NCT04542499|565793130|FG000|Overall Study|Adverse Event|23|||
156739316|NCT04542499|565793131|FG001|Overall Study|Adverse Event|43|||
156739317|NCT04542499|565793130|FG000|Overall Study|Lack of Efficacy|5|||
156739318|NCT04542499|565793131|FG001|Overall Study|Lack of Efficacy|2|||
156739319|NCT04542499|565793130|FG000|Overall Study|Lost to Follow-up|3|||
156739320|NCT04542499|565793131|FG001|Overall Study|Lost to Follow-up|4|||
156739321|NCT04542499|565793130|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
156739322|NCT04542499|565793131|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
156739323|NCT04542499|565793130|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
156797493|NCT03164356|566011390|FG000|Overall Study|Prosthetist unable to participate|0|||
157020423|NCT05034952|566828431|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156739324|NCT04542499|565793131|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156739325|NCT04542499|565793130|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156739326|NCT04542499|565793131|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156739327|NCT04542499|565793130|FG000|Overall Study|Physician Decision|0|||
156739328|NCT04542499|565793131|FG001|Overall Study|Physician Decision|1|||
156739329|NCT04542499|565793130|FG000|Overall Study|Site Terminated by Sponsor|3|||
156739330|NCT04542499|565793131|FG001|Overall Study|Site Terminated by Sponsor|5|||
156739331|NCT04542499|565793130|FG000|Overall Study|Withdrawal by Subject|12|||
156739332|NCT04542499|565793131|FG001|Overall Study|Withdrawal by Subject|33|||
156739333|NCT04542499|565793130|FG000|Overall Study|Other|2|||
156739334|NCT04542499|565793131|FG001|Overall Study|Other|2|||
156739335|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739336|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739337|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739338|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
156739339|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739340|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739341|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739342|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739343|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739344|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739345|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739346|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739347|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739348|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739349|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739350|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
156739351|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739352|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
156739353|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739354|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
156739355|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739356|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739357|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
156739358|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
156739359|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
156739360|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
156739361|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739362|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739363|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739364|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739365|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739366|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739367|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739368|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739369|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739370|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
156739371|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739372|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
156739373|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
156739374|NCT04035434|565793137|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739375|NCT04035434|565793138|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739376|NCT04035434|565793139|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739377|NCT04035434|565793140|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
156739378|NCT04035434|565793141|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156797494|NCT03164356|566011391|FG001|Overall Study|Prosthetist unable to participate|2|||
156797495|NCT03164356|566011392|FG002|Overall Study|Prosthetist unable to participate|1|||
156797496|NCT03164356|566011393|FG003|Overall Study|Prosthetist unable to participate|0|||
156797497|NCT04490278|566013339|FG000|Overall Study|Lost to Follow-up|6|||
156797498|NCT03243084|566013341|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
156797499|NCT03243084|566013342|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
156797500|NCT02507934|566013348|FG000|Overall Study|Lost to Follow-up|2|||
156797501|NCT02507934|566013349|FG001|Overall Study|Lost to Follow-up|0|||
156797502|NCT02507934|566013348|FG000|Overall Study|Withdrawal by Subject|2|||
156797503|NCT02507934|566013349|FG001|Overall Study|Withdrawal by Subject|0|||
156797504|NCT03766399|566013351|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
157020424|NCT05034952|566828432|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
157020425|NCT05034952|566828433|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
156797505|NCT03766399|566013352|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797506|NCT03766399|566013353|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
157020426|NCT05034952|566828434|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
157020427|NCT05034952|566828431|FG000|Overall Study|Lost to Follow-up|1|||
156739379|NCT04035434|565793142|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739380|NCT04035434|565793143|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739381|NCT04035434|565793144|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739382|NCT04035434|565793145|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739383|NCT04035434|565793146|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739384|NCT04035434|565793147|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739385|NCT04035434|565793148|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739386|NCT04035434|565793149|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
156739387|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739388|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739389|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739390|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739391|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739392|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
156739393|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
156739394|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739395|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739396|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739397|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739398|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739399|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
156739400|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739401|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739402|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739403|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739404|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739405|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739406|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
156739407|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739408|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739409|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739410|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739411|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739412|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
156739413|NCT04035434|565793137|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739414|NCT04035434|565793138|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739415|NCT04035434|565793139|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739416|NCT04035434|565793140|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739417|NCT04035434|565793141|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739418|NCT04035434|565793142|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
156739419|NCT04035434|565793143|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
156739420|NCT04035434|565793144|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739421|NCT04035434|565793145|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739422|NCT04035434|565793146|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739423|NCT04035434|565793147|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739424|NCT04035434|565793148|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739425|NCT04035434|565793149|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
156739426|NCT02759055|565793150|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
156739427|NCT02759055|565793151|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
156739428|NCT04161079|565793152|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
156739429|NCT02515994|565793153|FG000|Overall Study|Protocol Violation|3|||
156739430|NCT02515994|565793154|FG001|Overall Study|Protocol Violation|5|||
156739431|NCT02515994|565793153|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
156739432|NCT02515994|565793154|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156739433|NCT02515994|565793153|FG000|Overall Study|Adverse Event|3|||
156739434|NCT02515994|565793154|FG001|Overall Study|Adverse Event|1|||
156739435|NCT02515994|565793153|FG000|Overall Study|Withdrawal by Subject|2|||
156739436|NCT02515994|565793154|FG001|Overall Study|Withdrawal by Subject|0|||
156739437|NCT04045132|565793158|FG000|Overall Study|Lost to Follow-up|3|||
156739438|NCT04045132|565793159|FG001|Overall Study|Lost to Follow-up|6|||
156739439|NCT02879994|565793160|FG000|Overall Study|off treatment early|7|||
156739440|NCT02879994|565793160|FG000|Overall Study|Adverse Event|2|||
156739441|NCT02879994|565793160|FG000|Overall Study|Death|2|||
156739442|NCT02143791|565793161|FG000|Enrolled|Withdrawal by Subject|4|||
156739443|NCT02143791|565793161|FG000|Trial Stimulation|Lack of Efficacy|21|||
156739444|NCT02143791|565793161|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
156739445|NCT02143791|565793161|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
156739446|NCT02143791|565793161|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
156739447|NCT02143791|565793161|FG000|Any Programming (3-6 Months)|Missing Data|1|||
156739448|NCT02143791|565793161|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
156739449|NCT04984681|565793167|FG000|Overall Study|Lost to Follow-up|3|||
156739450|NCT04984681|565793168|FG001|Overall Study|Lost to Follow-up|1|||
156739451|NCT01214252|565793169|FG000|Overall Study|Not eligible per protocol|82|||
156739452|NCT00552032|565793171|FG000|Overall Study|Withdrawal by Subject|2|||
156739453|NCT00552032|565793172|FG001|Overall Study|Withdrawal by Subject|2|||
156739454|NCT00552032|565793171|FG000|Overall Study|Protocol Violation|7|||
156739455|NCT00552032|565793172|FG001|Overall Study|Protocol Violation|12|||
156739456|NCT00552032|565793171|FG000|Overall Study|Lost to Follow-up|8|||
156739457|NCT00552032|565793172|FG001|Overall Study|Lost to Follow-up|5|||
156739458|NCT05845567|565793175|FG000|Overall Study|Withdrawal by Subject|1|||
156739459|NCT02062944|565793180|FG000|Overall Study|Lost to Follow-up|1|||
156739460|NCT02062944|565793180|FG000|Overall Study|New hemotological disorder identified|1|||
156739461|NCT02062944|565793180|FG000|Overall Study|Uncontrolled Hypertension|1|||
156739462|NCT02062944|565793180|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
156739463|NCT02035748|565793181|FG000|Overall Study|Adverse Event|5|||
156739464|NCT02035748|565793181|FG000|Overall Study|Death|3|||
156739465|NCT02035748|565793181|FG000|Overall Study|Lost to Follow-up|2|||
156739466|NCT02035748|565793181|FG000|Overall Study|Physician Decision|3|||
156739467|NCT02035748|565793181|FG000|Overall Study|Withdrawal by Subject|6|||
156739468|NCT02035748|565793181|FG000|Overall Study|Progressive Disease|1|||
156739469|NCT02083185|565793182|FG000|Overall Study|Lost to Follow-up|0|||
156739470|NCT02083185|565793183|FG001|Overall Study|Lost to Follow-up|3|||
156739471|NCT02083185|565793184|FG002|Overall Study|Lost to Follow-up|0|||
156739472|NCT02083185|565793182|FG000|Overall Study|Withdrawal by Subject|9|||
156739473|NCT02083185|565793183|FG001|Overall Study|Withdrawal by Subject|15|||
156739474|NCT02083185|565793184|FG002|Overall Study|Withdrawal by Subject|1|||
156739475|NCT02083185|565793182|FG000|Overall Study|Death|2|||
156739476|NCT02083185|565793183|FG001|Overall Study|Death|2|||
156739477|NCT02083185|565793184|FG002|Overall Study|Death|1|||
156739478|NCT02083185|565793182|FG000|Overall Study|Reason not Specified|9|||
156739479|NCT02083185|565793183|FG001|Overall Study|Reason not Specified|6|||
156739480|NCT02083185|565793184|FG002|Overall Study|Reason not Specified|5|||
156739481|NCT02083185|565793182|FG000|Overall Study|Study Terminated by Sponsor|0|||
156739482|NCT02083185|565793183|FG001|Overall Study|Study Terminated by Sponsor|1|||
156739483|NCT02083185|565793184|FG002|Overall Study|Study Terminated by Sponsor|0|||
156739484|NCT02083185|565793182|FG000|Overall Study|Did not Receive Study Drug|0|||
156739485|NCT02083185|565793183|FG001|Overall Study|Did not Receive Study Drug|2|||
156739486|NCT02083185|565793184|FG002|Overall Study|Did not Receive Study Drug|0|||
156739487|NCT01740128|565793185|FG000|Overall Study|Pregnancy|0|||
156739488|NCT01740128|565793186|FG001|Overall Study|Pregnancy|1|||
156739489|NCT01740128|565793185|FG000|Overall Study|Protocol Violation|1|||
156739490|NCT01740128|565793186|FG001|Overall Study|Protocol Violation|2|||
156739491|NCT01740128|565793185|FG000|Overall Study|Lost to Follow-up|2|||
156739492|NCT01740128|565793186|FG001|Overall Study|Lost to Follow-up|2|||
156739493|NCT01740128|565793185|FG000|Overall Study|Withdrawal by Subject|1|||
156739494|NCT01740128|565793186|FG001|Overall Study|Withdrawal by Subject|0|||
156739495|NCT01740128|565793185|FG000|Overall Study|Insufficient protocol compliance|2|||
156739496|NCT01740128|565793186|FG001|Overall Study|Insufficient protocol compliance|2|||
156797507|NCT03766399|566013354|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797508|NCT03766399|566013355|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797509|NCT03766399|566013356|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797510|NCT03766399|566013357|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156739497|NCT02474589|565793187|FG000|Overall Study|Adverse Event|6|||
156739498|NCT02474589|565793188|FG001|Overall Study|Adverse Event|2|||
156739499|NCT02474589|565793187|FG000|Overall Study|Lost to Follow-up|6|||
156739500|NCT02474589|565793188|FG001|Overall Study|Lost to Follow-up|1|||
156739501|NCT02474589|565793187|FG000|Overall Study|Protocol Violation|4|||
156739502|NCT02474589|565793188|FG001|Overall Study|Protocol Violation|1|||
156739503|NCT02474589|565793187|FG000|Overall Study|Withdrawal by Subject|4|||
156739504|NCT02474589|565793188|FG001|Overall Study|Withdrawal by Subject|0|||
156739505|NCT02474589|565793187|FG000|Overall Study|Inability to complete study procedures|5|||
156739506|NCT02474589|565793188|FG001|Overall Study|Inability to complete study procedures|1|||
156739507|NCT02231879|565793189|FG000|Overall Study|Adverse Event|2|||
156739508|NCT02231879|565793190|FG001|Overall Study|Adverse Event|1|||
156739509|NCT02231879|565793189|FG000|Overall Study|Lack of Efficacy|0|||
156739510|NCT02231879|565793190|FG001|Overall Study|Lack of Efficacy|1|||
156739511|NCT05007041|565793191|FG000|Overall Study|Missing Diary Entries|0|||
156739512|NCT05007041|565793192|FG001|Overall Study|Missing Diary Entries|1|||
156739513|NCT00705718|565793193|FG000|Overall Study|Death|6|||
156739514|NCT00705718|565793194|FG001|Overall Study|Death|6|||
156739515|NCT00705718|565793193|FG000|Overall Study|Not due for Visit|0|||
156739516|NCT00705718|565793194|FG001|Overall Study|Not due for Visit|12|||
156739517|NCT00705718|565793193|FG000|Overall Study|Follow up not done|1|||
156739518|NCT00705718|565793194|FG001|Overall Study|Follow up not done|4|||
156739519|NCT00423189|565793196|FG000|Overall Study|Death|0|||
156739520|NCT00423189|565793197|FG001|Overall Study|Death|1|||
156739521|NCT00423189|565793198|FG002|Overall Study|Death|0|||
156739522|NCT01459718|565793205|FG000|Overall Study|Physician Decision|1|||
156739523|NCT01459718|565793205|FG000|Overall Study|Lost to Follow-up|1|||
156739524|NCT01459718|565793205|FG000|Overall Study|Adverse Event|1|||
156739525|NCT01258075|565793206|FG000|Overall Study|Adverse Event|8|||
156739526|NCT01258075|565793207|FG001|Overall Study|Adverse Event|3|||
156739527|NCT01258075|565793206|FG000|Overall Study|Lost to Follow-up|11|||
156739528|NCT01258075|565793207|FG001|Overall Study|Lost to Follow-up|6|||
156739529|NCT01258075|565793206|FG000|Overall Study|Withdrawal by Subject|10|||
156739530|NCT01258075|565793207|FG001|Overall Study|Withdrawal by Subject|7|||
156739531|NCT01258075|565793206|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
156739532|NCT01258075|565793207|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
156739533|NCT01258075|565793206|FG000|Overall Study|Other|12|||
156739534|NCT01258075|565793207|FG001|Overall Study|Other|5|||
156739535|NCT00976209|565793208|FG000|Treatment Period 1|Protocol Violation|1|||
156739536|NCT00976209|565793209|FG001|Treatment Period 1|Protocol Violation|0|||
156739537|NCT00976209|565793208|FG000|Treatment Period 1|Lost to Follow-up|2|||
156739538|NCT00976209|565793209|FG001|Treatment Period 1|Lost to Follow-up|0|||
156739539|NCT00976209|565793208|FG000|Treatment Period 1|Other|0|||
156739540|NCT00976209|565793209|FG001|Treatment Period 1|Other|1|||
156739541|NCT00976209|565793208|FG000|Wash-out Period|Adverse Event|1|||
156739542|NCT00976209|565793209|FG001|Wash-out Period|Adverse Event|2|||
156739543|NCT00976209|565793208|FG000|Wash-out Period|Lost to Follow-up|1|||
156797511|NCT03766399|566013358|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797512|NCT03766399|566013359|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797513|NCT03766399|566013360|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797514|NCT03766399|566013361|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797515|NCT03766399|566013362|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797516|NCT03766399|566013363|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797517|NCT03766399|566013364|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
156797518|NCT03766399|566013365|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797519|NCT03766399|566013366|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797520|NCT03766399|566013367|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797521|NCT03766399|566013368|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
156797522|NCT05030766|566013369|FG000|Phase 1 Participants|Lost to Follow-up|12|||
156797523|NCT05030766|566013370|FG001|Phase 1 Participants|Lost to Follow-up|22|||
156797524|NCT05030766|566013371|FG002|Phase 1 Participants|Lost to Follow-up|0|||
156797525|NCT05030766|566013372|FG003|Phase 1 Participants|Lost to Follow-up|0|||
156797526|NCT05030766|566013369|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
156797527|NCT05030766|566013370|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
156797528|NCT05030766|566013371|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
156797529|NCT05030766|566013372|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
156797530|NCT05030766|566013369|FG000|Phase 2 Participants|Lost to Follow-up|0|||
156797531|NCT05030766|566013370|FG001|Phase 2 Participants|Lost to Follow-up|0|||
156797532|NCT05030766|566013371|FG002|Phase 2 Participants|Lost to Follow-up|6|||
156739544|NCT00976209|565793209|FG001|Wash-out Period|Lost to Follow-up|0|||
156739545|NCT00976209|565793208|FG000|Wash-out Period|Protocol Violation|1|||
156739546|NCT00976209|565793209|FG001|Wash-out Period|Protocol Violation|0|||
156739547|NCT00976209|565793208|FG000|Wash-out Period|Other|1|||
156739548|NCT00976209|565793209|FG001|Wash-out Period|Other|0|||
156739549|NCT00976209|565793208|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156739550|NCT00976209|565793209|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156739551|NCT00976209|565793208|FG000|Treatment Period 2|Lost to Follow-up|0|||
156739552|NCT00976209|565793209|FG001|Treatment Period 2|Lost to Follow-up|1|||
156739553|NCT00574249|565793210|FG000|Overall Study|Adverse Event|6|||
156739554|NCT00574249|565793211|FG001|Overall Study|Adverse Event|18|||
156739555|NCT00574249|565793210|FG000|Overall Study|Lack of Efficacy|5|||
156739556|NCT00574249|565793211|FG001|Overall Study|Lack of Efficacy|3|||
156739557|NCT00574249|565793210|FG000|Overall Study|Lost to Follow-up|4|||
156739558|NCT00574249|565793211|FG001|Overall Study|Lost to Follow-up|3|||
156739559|NCT00574249|565793210|FG000|Overall Study|Protocol Violation|5|||
156739560|NCT00574249|565793211|FG001|Overall Study|Protocol Violation|2|||
156739561|NCT00574249|565793210|FG000|Overall Study|History of carcinoma|1|||
156739562|NCT00574249|565793211|FG001|Overall Study|History of carcinoma|0|||
156739563|NCT00574249|565793210|FG000|Overall Study|Withdrawal by Subject|3|||
156739564|NCT00574249|565793211|FG001|Overall Study|Withdrawal by Subject|0|||
156739565|NCT00574249|565793210|FG000|Overall Study|Physician Decision|1|||
156739566|NCT00574249|565793211|FG001|Overall Study|Physician Decision|0|||
156739567|NCT00574249|565793210|FG000|Overall Study|Pregnancy|1|||
156739568|NCT00574249|565793211|FG001|Overall Study|Pregnancy|0|||
156739569|NCT00574249|565793210|FG000|Overall Study|Excluded by company|0|||
156739570|NCT00574249|565793211|FG001|Overall Study|Excluded by company|1|||
156739571|NCT00574249|565793210|FG000|Overall Study|PPD test taken twice|0|||
156739572|NCT00574249|565793211|FG001|Overall Study|PPD test taken twice|1|||
156739573|NCT01542034|565793215|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
156739574|NCT01542034|565793216|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
156739575|NCT01542034|565793215|FG000|Overall Study|Administrative decision|0|||
156739576|NCT01542034|565793216|FG001|Overall Study|Administrative decision|3|||
156739577|NCT01542034|565793215|FG000|Overall Study|Subject Noncompliance|1|||
156739578|NCT01542034|565793216|FG001|Overall Study|Subject Noncompliance|0|||
156739579|NCT01542034|565793215|FG000|Overall Study|Adverse Event|2|||
156739580|NCT01542034|565793216|FG001|Overall Study|Adverse Event|2|||
156739581|NCT01542034|565793215|FG000|Overall Study|Lost to Follow-up|7|||
156739582|NCT01542034|565793216|FG001|Overall Study|Lost to Follow-up|6|||
156739583|NCT02612610|565793217|FG000|Overall Study|Withdrawal by Subject|1|||
156739584|NCT02612610|565793218|FG001|Overall Study|Withdrawal by Subject|1|||
156739585|NCT02612610|565793219|FG002|Overall Study|Withdrawal by Subject|0|||
156739586|NCT02612610|565793220|FG003|Overall Study|Withdrawal by Subject|2|||
156739587|NCT02612610|565793217|FG000|Overall Study|Adverse Event|2|||
156739588|NCT02612610|565793218|FG001|Overall Study|Adverse Event|2|||
156739589|NCT02612610|565793219|FG002|Overall Study|Adverse Event|3|||
156739590|NCT02612610|565793220|FG003|Overall Study|Adverse Event|10|||
156739591|NCT02612610|565793217|FG000|Overall Study|Lost to Follow-up|0|||
156739592|NCT02612610|565793218|FG001|Overall Study|Lost to Follow-up|1|||
156739593|NCT02612610|565793219|FG002|Overall Study|Lost to Follow-up|0|||
156739594|NCT02612610|565793220|FG003|Overall Study|Lost to Follow-up|0|||
156739595|NCT02612610|565793217|FG000|Overall Study|Protocol Violation|0|||
156739596|NCT02612610|565793218|FG001|Overall Study|Protocol Violation|1|||
156739597|NCT02612610|565793219|FG002|Overall Study|Protocol Violation|1|||
156739598|NCT02612610|565793220|FG003|Overall Study|Protocol Violation|0|||
156739599|NCT02612610|565793217|FG000|Overall Study|Lack of Efficacy|1|||
156739600|NCT02612610|565793218|FG001|Overall Study|Lack of Efficacy|2|||
156739601|NCT02612610|565793219|FG002|Overall Study|Lack of Efficacy|0|||
156739602|NCT02612610|565793220|FG003|Overall Study|Lack of Efficacy|1|||
156739603|NCT02612610|565793217|FG000|Overall Study|Physician Decision|0|||
156739604|NCT02612610|565793218|FG001|Overall Study|Physician Decision|1|||
156739605|NCT02612610|565793219|FG002|Overall Study|Physician Decision|0|||
156739606|NCT02612610|565793220|FG003|Overall Study|Physician Decision|0|||
156739607|NCT02612610|565793217|FG000|Overall Study|Noncompliance|1|||
156739608|NCT02612610|565793218|FG001|Overall Study|Noncompliance|0|||
156739609|NCT02612610|565793219|FG002|Overall Study|Noncompliance|0|||
156797533|NCT05030766|566013372|FG003|Phase 2 Participants|Lost to Follow-up|2|||
156797534|NCT01559935|566013375|FG000|Car Phase|Toxicity|4|||
156797535|NCT01559935|566013375|FG000|Car Phase|Death|1|||
156739610|NCT02612610|565793220|FG003|Overall Study|Noncompliance|0|||
156739611|NCT02612610|565793217|FG000|Overall Study|Cough Improvement|0|||
156739612|NCT02612610|565793218|FG001|Overall Study|Cough Improvement|0|||
156739613|NCT02612610|565793219|FG002|Overall Study|Cough Improvement|1|||
156797536|NCT01559935|566013375|FG000|Car Phase|Lack of Efficacy|2|||
156797537|NCT01559935|566013375|FG000|Car Phase|Lost to Follow-up|1|||
156797538|NCT01559935|566013375|FG000|Car Phase|Physician Decision|1|||
156797539|NCT01559935|566013375|FG000|Car Phase|Withdrawal by Subject|2|||
156739614|NCT02612610|565793220|FG003|Overall Study|Cough Improvement|0|||
156739615|NCT01546571|565793223|FG000|Overall Study|Adverse Event|1|||
156739616|NCT01546571|565793224|FG001|Overall Study|Adverse Event|0|||
156739617|NCT01546571|565793225|FG002|Overall Study|Adverse Event|0|||
156739618|NCT01546571|565793226|FG003|Overall Study|Adverse Event|1|||
156739619|NCT01546571|565793227|FG004|Overall Study|Adverse Event|0|||
156739620|NCT01546571|565793223|FG000|Overall Study|assigned placebo in Part A|0|||
156739621|NCT01546571|565793224|FG001|Overall Study|assigned placebo in Part A|0|||
156739622|NCT01546571|565793225|FG002|Overall Study|assigned placebo in Part A|22|||
156739623|NCT01546571|565793226|FG003|Overall Study|assigned placebo in Part A|0|||
156797540|NCT01559935|566013375|FG000|Car Phase|Per protocol|1|||
156797541|NCT01559935|566013375|FG000|Car Phase|Insurance|1|||
156739624|NCT01546571|565793227|FG004|Overall Study|assigned placebo in Part A|0|||
156739625|NCT01546571|565793223|FG000|Overall Study|Death|0|||
156739626|NCT01546571|565793224|FG001|Overall Study|Death|1|||
156739627|NCT01546571|565793225|FG002|Overall Study|Death|0|||
156739628|NCT01546571|565793226|FG003|Overall Study|Death|0|||
156739629|NCT01546571|565793227|FG004|Overall Study|Death|0|||
156739630|NCT01546571|565793223|FG000|Overall Study|Lost to Follow-up|0|||
156739631|NCT01546571|565793224|FG001|Overall Study|Lost to Follow-up|0|||
156739632|NCT01546571|565793225|FG002|Overall Study|Lost to Follow-up|2|||
156739633|NCT01546571|565793226|FG003|Overall Study|Lost to Follow-up|2|||
156739634|NCT01546571|565793227|FG004|Overall Study|Lost to Follow-up|3|||
156739635|NCT01546571|565793223|FG000|Overall Study|Pregnancy|0|||
156739636|NCT01546571|565793224|FG001|Overall Study|Pregnancy|0|||
156739637|NCT01546571|565793225|FG002|Overall Study|Pregnancy|0|||
156739638|NCT01546571|565793226|FG003|Overall Study|Pregnancy|1|||
156739639|NCT01546571|565793227|FG004|Overall Study|Pregnancy|0|||
156797542|NCT01559935|566013375|FG000|Car Phase|non-compliance|1|||
156797543|NCT01559935|566013375|FG000|BiRD Phase|Toxicity|1|||
156797544|NCT01559935|566013375|FG000|BiRD Phase|Lack of Efficacy|1|||
156797545|NCT01559935|566013375|FG000|BiRD Phase|Withdrawal by Subject|2|||
156797546|NCT01559935|566013375|FG000|Maintenance Phase|Remains on study|28|||
156797547|NCT01559935|566013375|FG000|Maintenance Phase|Toxicity|1|||
156797548|NCT01559935|566013375|FG000|Maintenance Phase|Lack of Efficacy|18|||
156797549|NCT01559935|566013375|FG000|Maintenance Phase|Withdrawal by Subject|5|||
156797550|NCT01559935|566013375|FG000|Maintenance Phase|Non-compliance|2|||
156797551|NCT05889468|566013377|FG000|Overall Study|Lost to Follow-up|9|||
156797552|NCT05889468|566013378|FG001|Overall Study|Lost to Follow-up|2|||
156797553|NCT05889468|566013377|FG000|Overall Study|Withdrawal by Subject|2|||
156797554|NCT05889468|566013378|FG001|Overall Study|Withdrawal by Subject|2|||
156797555|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797556|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
156797557|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797558|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
156797559|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
156797560|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
156797561|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
156797562|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797563|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797564|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797565|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
157142833|NCT01386385|567271108|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
157142834|NCT01386385|567271109|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
157142835|NCT01386385|567271110|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
157142836|NCT01386385|567271111|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
156739640|NCT01546571|565793223|FG000|Overall Study|Disease Progression|20|||
156739641|NCT01546571|565793224|FG001|Overall Study|Disease Progression|18|||
156739642|NCT01546571|565793225|FG002|Overall Study|Disease Progression|15|||
156797566|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797567|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797568|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156739643|NCT01546571|565793226|FG003|Overall Study|Disease Progression|73|||
156739644|NCT01546571|565793227|FG004|Overall Study|Disease Progression|37|||
156739645|NCT01546571|565793223|FG000|Overall Study|Withdrawal by Subject|1|||
157142837|NCT01386385|567271112|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
157142838|NCT01386385|567271113|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
157142839|NCT01386385|567271114|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
157142840|NCT01386385|567271115|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
157142841|NCT03746080|567271117|FG000|Overall Study|In follow up|2|||
156739646|NCT01546571|565793224|FG001|Overall Study|Withdrawal by Subject|2|||
156739647|NCT01546571|565793225|FG002|Overall Study|Withdrawal by Subject|4|||
156739648|NCT01546571|565793226|FG003|Overall Study|Withdrawal by Subject|9|||
156739649|NCT01546571|565793227|FG004|Overall Study|Withdrawal by Subject|2|||
156739650|NCT01546571|565793223|FG000|Overall Study|Intercurrent Illness|1|||
156739651|NCT01546571|565793224|FG001|Overall Study|Intercurrent Illness|2|||
156739652|NCT01546571|565793225|FG002|Overall Study|Intercurrent Illness|0|||
156739653|NCT01546571|565793226|FG003|Overall Study|Intercurrent Illness|0|||
156739654|NCT01546571|565793227|FG004|Overall Study|Intercurrent Illness|0|||
156739655|NCT01546571|565793223|FG000|Overall Study|Other Cancers|0|||
156739656|NCT01546571|565793224|FG001|Overall Study|Other Cancers|0|||
156739657|NCT01546571|565793225|FG002|Overall Study|Other Cancers|0|||
156739658|NCT01546571|565793226|FG003|Overall Study|Other Cancers|3|||
156739659|NCT01546571|565793227|FG004|Overall Study|Other Cancers|1|||
156739660|NCT01546571|565793223|FG000|Overall Study|Other|0|||
156739661|NCT01546571|565793224|FG001|Overall Study|Other|0|||
156739662|NCT01546571|565793225|FG002|Overall Study|Other|3|||
156739663|NCT01546571|565793226|FG003|Overall Study|Other|0|||
156739664|NCT01546571|565793227|FG004|Overall Study|Other|0|||
156739665|NCT00478699|565793228|FG000|Overall Study|Inclusion Error|1|||
156739666|NCT00478699|565793229|FG001|Overall Study|Inclusion Error|7|||
156739667|NCT00478699|565793228|FG000|Overall Study|Not receive study treatment|6|||
156739668|NCT00478699|565793229|FG001|Overall Study|Not receive study treatment|30|||
156739669|NCT01252563|565793233|FG000|Overall Study|Contract Deviation|41|||
156739670|NCT01252563|565793233|FG000|Overall Study|Centralized Registration Deviation|30|||
156739671|NCT01252563|565793233|FG000|Overall Study|Lost to Follow-up|161|||
156739672|NCT01252563|565793233|FG000|Overall Study|No visit after first day of treatment|194|||
156739673|NCT01252563|565793233|FG000|Overall Study|No drug administration|6|||
156739674|NCT01866657|565793234|FG000|Overall Study|Surgery canceled|2|||
156739675|NCT01866657|565793235|FG001|Overall Study|Surgery canceled|0|||
156739676|NCT01880086|565793241|FG000|Overall Study|Lost to Follow-up|1|||
156739677|NCT01880086|565793242|FG001|Overall Study|Lost to Follow-up|1|||
156739678|NCT04063657|565795019|FG000|Overall Study|Lost to Follow-up|1|||
156739679|NCT04063657|565795020|FG001|Overall Study|Lost to Follow-up|0|||
156739680|NCT01041976|565795021|FG000|Overall Study|Withdrawal by Subject|3|||
156739681|NCT01041976|565795022|FG001|Overall Study|Withdrawal by Subject|0|||
156739682|NCT01041976|565795021|FG000|Overall Study|Incarceration|2|||
156739683|NCT01041976|565795022|FG001|Overall Study|Incarceration|0|||
156739684|NCT01041976|565795021|FG000|Overall Study|Death|0|||
156739685|NCT01041976|565795022|FG001|Overall Study|Death|4|||
156739686|NCT02658734|565795023|FG000|Overall Study|Adverse Event|2|||
156739687|NCT02658734|565795023|FG000|Overall Study|Death|4|||
156739688|NCT02658734|565795023|FG000|Overall Study|Lost to Follow-up|7|||
156739689|NCT02658734|565795023|FG000|Overall Study|Withdrawal of Consent|16|||
156739690|NCT02658734|565795023|FG000|Overall Study|Disease Progression|28|||
156739691|NCT04021121|565795038|FG000|Overall Study|Death|3|||
156739692|NCT04021121|565795039|FG001|Overall Study|Death|3|||
156739693|NCT04021121|565795040|FG002|Overall Study|Death|5|||
156739694|NCT04021121|565795041|FG003|Overall Study|Death|4|||
156739695|NCT00978250|565795043|FG000|Overall Study|Late determination of ineligibility|0|||
156739696|NCT00978250|565795044|FG001|Overall Study|Late determination of ineligibility|1|||
156739697|NCT00978250|565795045|FG002|Overall Study|Late determination of ineligibility|0|||
156739698|NCT00978250|565795046|FG003|Overall Study|Late determination of ineligibility|1|||
156739699|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
156739700|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
156739701|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
156739702|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
156739703|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
156739704|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
156739705|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
156739706|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
156739707|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
156739708|NCT02951533|565795052|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
156739709|NCT02951533|565795053|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
156739710|NCT02951533|565795054|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
156739711|NCT02951533|565795052|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
156739712|NCT02951533|565795053|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
156739713|NCT02951533|565795054|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
156739714|NCT02951533|565795052|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
156739715|NCT02951533|565795053|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
156739716|NCT02951533|565795054|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
156739717|NCT02951533|565795052|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
156739718|NCT02951533|565795053|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
156739719|NCT02951533|565795054|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
156739720|NCT02951533|565795052|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
156739721|NCT02951533|565795053|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
156739722|NCT02951533|565795054|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
156739723|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
156739724|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
156739725|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
156739726|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
156739727|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
156739728|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
156739729|NCT02951533|565795052|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
156739730|NCT02951533|565795053|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
156739731|NCT02951533|565795054|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
156739732|NCT05174949|565795055|FG000|Overall Study|Physician Decision|1|||
156739733|NCT05174949|565795056|FG001|Overall Study|Physician Decision|2|||
156739734|NCT05174949|565795057|FG002|Overall Study|Physician Decision|0|||
156739735|NCT05174949|565795058|FG003|Overall Study|Physician Decision|1|||
156739736|NCT05174949|565795059|FG004|Overall Study|Physician Decision|0|||
156739737|NCT05174949|565795060|FG005|Overall Study|Physician Decision|0|||
156739738|NCT05174949|565795055|FG000|Overall Study|Withdrawal by Subject|0|||
156739739|NCT05174949|565795056|FG001|Overall Study|Withdrawal by Subject|1|||
156739740|NCT05174949|565795057|FG002|Overall Study|Withdrawal by Subject|0|||
156739741|NCT05174949|565795058|FG003|Overall Study|Withdrawal by Subject|0|||
156797569|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156739742|NCT05174949|565795059|FG004|Overall Study|Withdrawal by Subject|0|||
156797570|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
156797571|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
156797572|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
156797573|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
156797574|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
156739743|NCT05174949|565795060|FG005|Overall Study|Withdrawal by Subject|0|||
156739744|NCT05174949|565795055|FG000|Overall Study|Lost to Follow-up|0|||
156739745|NCT05174949|565795056|FG001|Overall Study|Lost to Follow-up|0|||
156739746|NCT05174949|565795057|FG002|Overall Study|Lost to Follow-up|0|||
156739747|NCT05174949|565795058|FG003|Overall Study|Lost to Follow-up|1|||
156739748|NCT05174949|565795059|FG004|Overall Study|Lost to Follow-up|0|||
156739749|NCT05174949|565795060|FG005|Overall Study|Lost to Follow-up|0|||
156739750|NCT02029989|565795061|FG000|Overall Study|Withdrawal by Subject|1|||
156739751|NCT02029989|565795062|FG001|Overall Study|Withdrawal by Subject|0|||
156739752|NCT02029989|565795061|FG000|Overall Study|Withdrawal: Fear of needles|1|||
156739753|NCT02029989|565795062|FG001|Overall Study|Withdrawal: Fear of needles|0|||
156739754|NCT02029989|565795061|FG000|Overall Study|Change of location|2|||
156739755|NCT02029989|565795062|FG001|Overall Study|Change of location|3|||
156739756|NCT02029989|565795061|FG000|Overall Study|Physician Decision|2|||
156739757|NCT02029989|565795062|FG001|Overall Study|Physician Decision|0|||
156739758|NCT02029989|565795061|FG000|Overall Study|Lost to Follow-up|9|||
156739759|NCT02029989|565795062|FG001|Overall Study|Lost to Follow-up|7|||
156739760|NCT02029989|565795061|FG000|Overall Study|Death|0|||
156739761|NCT02029989|565795062|FG001|Overall Study|Death|1|||
156739762|NCT02029989|565795061|FG000|Overall Study|Protocol Violation|1|||
156739763|NCT02029989|565795062|FG001|Overall Study|Protocol Violation|0|||
156739764|NCT04351373|565795063|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
156739765|NCT01123941|565795069|FG000|Overall Study|Lost to Follow-up|2|||
156739766|NCT01123941|565795070|FG001|Overall Study|Lost to Follow-up|1|||
156739767|NCT05036668|565795071|FG000|Overall Study|lost to follow Up|0|||
156739768|NCT05036668|565795072|FG001|Overall Study|lost to follow Up|0|||
156739769|NCT05036668|565795073|FG002|Overall Study|lost to follow Up|1|||
156739770|NCT04601103|565795075|FG000|Overall Study|Needed crown & cleaning|0|||
156739771|NCT04601103|565795076|FG001|Overall Study|Needed crown & cleaning|0|||
156739772|NCT04601103|565795077|FG002|Overall Study|Needed crown & cleaning|1|||
156739773|NCT04601103|565795075|FG000|Overall Study|study was terminated|18|||
156739774|NCT04601103|565795076|FG001|Overall Study|study was terminated|18|||
156739775|NCT04601103|565795077|FG002|Overall Study|study was terminated|16|||
156739776|NCT05083923|565795082|FG000|Overall Study|Adverse Event|2|||
156739777|NCT05083923|565795083|FG001|Overall Study|Adverse Event|0|||
156739778|NCT05083923|565795082|FG000|Overall Study|Lack of Efficacy|1|||
156739779|NCT05083923|565795083|FG001|Overall Study|Lack of Efficacy|3|||
156739780|NCT05083923|565795082|FG000|Overall Study|Withdrawal by Subject|2|||
156739781|NCT05083923|565795083|FG001|Overall Study|Withdrawal by Subject|6|||
156739782|NCT05083923|565795082|FG000|Overall Study|Reason Not Specified|0|||
156739783|NCT05083923|565795083|FG001|Overall Study|Reason Not Specified|1|||
156739784|NCT01537068|565795088|FG000|Overall Study|Lost to Follow-up|2|||
156739785|NCT01537068|565795089|FG001|Overall Study|Lost to Follow-up|1|||
156739786|NCT01537068|565795088|FG000|Overall Study|Adverse Event|0|||
156739787|NCT01537068|565795089|FG001|Overall Study|Adverse Event|1|||
156739788|NCT01537068|565795088|FG000|Overall Study|Withdrawal by Subject|1|||
156739789|NCT01537068|565795089|FG001|Overall Study|Withdrawal by Subject|1|||
156739790|NCT01537068|565795088|FG000|Overall Study|Lack of Efficacy|1|||
156739791|NCT01537068|565795089|FG001|Overall Study|Lack of Efficacy|0|||
156739792|NCT06011161|565795090|FG000|Overall Study|Withdrawal by Subject|2|||
156739793|NCT06011161|565795090|FG000|Overall Study|Lost to Follow-up|5|||
156739794|NCT02291601|565795093|FG000|Abdomen|Did not qualify|333|||
156739795|NCT02291601|565795094|FG001|Abdomen|Did not qualify|54|||
156739796|NCT02291601|565795095|FG002|Abdomen|Did not qualify|339|||
156739797|NCT02291601|565795093|FG000|Groin|Did not qualify|183|||
156739798|NCT02291601|565795094|FG001|Groin|Did not qualify|30|||
156739799|NCT02291601|565795095|FG002|Groin|Did not qualify|177|||
156739800|NCT00381043|565795096|FG000|Overall Study|Lost to Follow-up|8|||
156739801|NCT00381043|565795097|FG001|Overall Study|Lost to Follow-up|6|||
157020428|NCT05034952|566828432|FG001|Overall Study|Lost to Follow-up|4|||
157020429|NCT05034952|566828433|FG002|Overall Study|Lost to Follow-up|3|||
157020430|NCT05034952|566828434|FG003|Overall Study|Lost to Follow-up|3|||
156739802|NCT00381043|565795096|FG000|Overall Study|Withdrawal by Subject|3|||
156739803|NCT00381043|565795097|FG001|Overall Study|Withdrawal by Subject|1|||
156739804|NCT00381043|565795096|FG000|Overall Study|wanted more care|0|||
156739805|NCT00381043|565795097|FG001|Overall Study|wanted more care|1|||
156739806|NCT00381043|565795096|FG000|Overall Study|incarcerated|1|||
157020431|NCT05034952|566828431|FG000|Overall Study|Other|0|||
157142842|NCT03746080|567271117|FG000|Overall Study|Death|15|||
156739807|NCT00381043|565795097|FG001|Overall Study|incarcerated|0|||
156739808|NCT02880865|565795105|FG000|Overall Study|Adverse Event|1|||
156739809|NCT02880865|565795106|FG001|Overall Study|Adverse Event|0|||
156739810|NCT02880865|565795105|FG000|Overall Study|Withdrawal by Subject|0|||
156739811|NCT02880865|565795106|FG001|Overall Study|Withdrawal by Subject|2|||
156739812|NCT02880865|565795105|FG000|Overall Study|Physician Decision|0|||
156739813|NCT02880865|565795106|FG001|Overall Study|Physician Decision|1|||
156739814|NCT03045276|565795109|FG000|Intervention Phase|Withdrawal by Subject|7|||
156739815|NCT03045276|565795110|FG001|Intervention Phase|Withdrawal by Subject|2|||
156739816|NCT03045276|565795111|FG002|Intervention Phase|Withdrawal by Subject|3|||
156739817|NCT03045276|565795112|FG003|Intervention Phase|Withdrawal by Subject|7|||
156739818|NCT03045276|565795109|FG000|Intervention Phase|Developed exclusionary criteria|3|||
156739819|NCT03045276|565795110|FG001|Intervention Phase|Developed exclusionary criteria|3|||
156739820|NCT03045276|565795111|FG002|Intervention Phase|Developed exclusionary criteria|0|||
156739821|NCT03045276|565795112|FG003|Intervention Phase|Developed exclusionary criteria|0|||
156739822|NCT03045276|565795109|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
156739823|NCT03045276|565795110|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
156739824|NCT03045276|565795111|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
156739825|NCT03045276|565795112|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
156739826|NCT03045276|565795109|FG000|Follow-Up Phase|Lost to Follow-up|0|||
156739827|NCT03045276|565795110|FG001|Follow-Up Phase|Lost to Follow-up|1|||
156739828|NCT03045276|565795111|FG002|Follow-Up Phase|Lost to Follow-up|0|||
156739829|NCT03045276|565795112|FG003|Follow-Up Phase|Lost to Follow-up|1|||
156739830|NCT03045276|565795109|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
156739831|NCT03045276|565795110|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
156739832|NCT03045276|565795111|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
156739833|NCT03045276|565795112|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
156739834|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
156739835|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
156739836|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
156739837|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
156739838|NCT01597375|565795113|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
156739839|NCT01597375|565795114|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
156739840|NCT01597375|565795113|FG000|Washout (2 Weeks)|Adverse Event|1|||
156739841|NCT01597375|565795114|FG001|Washout (2 Weeks)|Adverse Event|0|||
156739842|NCT01597375|565795113|FG000|Second Intervention|Failed to react at both Aspirin|1|||
156739843|NCT01597375|565795114|FG001|Second Intervention|Failed to react at both Aspirin|1|||
156739844|NCT01190267|565795119|FG000|Overall Study|Adverse Event|10|||
156739845|NCT01190267|565795120|FG001|Overall Study|Adverse Event|0|||
156739846|NCT01190267|565795119|FG000|Overall Study|Treatment Failure|8|||
156739847|NCT01190267|565795120|FG001|Overall Study|Treatment Failure|2|||
156739848|NCT01190267|565795119|FG000|Overall Study|Lost to Follow-up|2|||
156739849|NCT01190267|565795120|FG001|Overall Study|Lost to Follow-up|0|||
156739850|NCT01190267|565795119|FG000|Overall Study|Withdrawal by Subject|13|||
156739851|NCT01190267|565795120|FG001|Overall Study|Withdrawal by Subject|1|||
156739852|NCT01190267|565795119|FG000|Overall Study|Protocol Violation|8|||
156739853|NCT01190267|565795120|FG001|Overall Study|Protocol Violation|1|||
156739854|NCT04017832|565795121|FG000|Overall Study|Withdrawal by Subject|13|||
156739855|NCT04017832|565795122|FG001|Overall Study|Withdrawal by Subject|12|||
156739856|NCT04017832|565795123|FG002|Overall Study|Withdrawal by Subject|21|||
156739857|NCT04017832|565795124|FG003|Overall Study|Withdrawal by Subject|7|||
156739858|NCT04017832|565795121|FG000|Overall Study|Lost to Follow-up|0|||
156739859|NCT04017832|565795122|FG001|Overall Study|Lost to Follow-up|3|||
156739860|NCT04017832|565795123|FG002|Overall Study|Lost to Follow-up|3|||
156739861|NCT04017832|565795124|FG003|Overall Study|Lost to Follow-up|1|||
156739862|NCT04017832|565795121|FG000|Overall Study|Physician Decision|1|||
156739863|NCT04017832|565795122|FG001|Overall Study|Physician Decision|1|||
156739864|NCT04017832|565795123|FG002|Overall Study|Physician Decision|1|||
156739865|NCT04017832|565795124|FG003|Overall Study|Physician Decision|1|||
156739866|NCT04017832|565795121|FG000|Overall Study|Death|2|||
156739867|NCT04017832|565795122|FG001|Overall Study|Death|2|||
156739868|NCT04017832|565795123|FG002|Overall Study|Death|1|||
156739869|NCT04017832|565795124|FG003|Overall Study|Death|0|||
156739870|NCT02375555|565795134|FG000|Induction Period|Adverse Event|7|||
156739871|NCT02375555|565795134|FG000|Induction Period|Withdrawal by Subject|2|||
156739872|NCT02375555|565795134|FG000|Induction Period|Other|1|||
156739873|NCT02375555|565795134|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
156739874|NCT02375555|565795134|FG000|Maintenance Period|Adverse Event|2|||
156739875|NCT02375555|565795134|FG000|Maintenance Period|Withdrawal by Subject|4|||
156739876|NCT02375555|565795134|FG000|Maintenance Period|Death|1|||
156797575|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
156797576|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
156797577|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
156797578|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
156797579|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
156797580|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
156797581|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
156797582|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
156797583|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
156797584|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
156739877|NCT02375555|565795134|FG000|Maintenance Period|Disease Progression|5|||
156739878|NCT02375555|565795134|FG000|Maintenance Period|Patient Non-compliance|1|||
156739879|NCT02375555|565795134|FG000|Maintenance Period|Still on maintenance|16|||
156739880|NCT02091986|565795138|FG000|Overall Study|7 rand in error 1 patient decision|2|||
156739881|NCT02091986|565795139|FG001|Overall Study|7 rand in error 1 patient decision|3|||
156739882|NCT02091986|565795140|FG002|Overall Study|7 rand in error 1 patient decision|3|||
156739883|NCT02091986|565795138|FG000|Overall Study|Lost to Follow-up|1|||
156739884|NCT02091986|565795139|FG001|Overall Study|Lost to Follow-up|0|||
156739885|NCT02091986|565795140|FG002|Overall Study|Lost to Follow-up|0|||
156739886|NCT02091986|565795138|FG000|Overall Study|Withdrawal by Subject|4|||
156739887|NCT02091986|565795139|FG001|Overall Study|Withdrawal by Subject|8|||
156739888|NCT02091986|565795140|FG002|Overall Study|Withdrawal by Subject|3|||
156739889|NCT02091986|565795138|FG000|Overall Study|Adverse Event|0|||
156739890|NCT02091986|565795139|FG001|Overall Study|Adverse Event|0|||
156739891|NCT02091986|565795140|FG002|Overall Study|Adverse Event|2|||
156739892|NCT00125242|565795141|FG000|Overall Study|did not qualify|7|||
156739893|NCT00125242|565795142|FG001|Overall Study|did not qualify|2|||
156739894|NCT01664949|565795145|FG000|Overall Study|Adverse Event|11|||
156739895|NCT01664949|565795146|FG001|Overall Study|Adverse Event|12|||
156739896|NCT01664949|565795145|FG000|Overall Study|Lack of Efficacy|1|||
156739897|NCT01664949|565795146|FG001|Overall Study|Lack of Efficacy|1|||
156739898|NCT01664949|565795145|FG000|Overall Study|Lost to Follow-up|1|||
156739899|NCT01664949|565795146|FG001|Overall Study|Lost to Follow-up|2|||
156739900|NCT01664949|565795145|FG000|Overall Study|Personal Reasons|3|||
156739901|NCT01664949|565795146|FG001|Overall Study|Personal Reasons|4|||
156739902|NCT01664949|565795145|FG000|Overall Study|Protocol Violation|5|||
156739903|NCT01664949|565795146|FG001|Overall Study|Protocol Violation|5|||
156739904|NCT01664949|565795145|FG000|Overall Study|Other Miscellaneous Reasons|3|||
156739905|NCT01664949|565795146|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156739906|NCT02727777|565795153|FG000|Overall Study|Screen Failure|2|||
156739907|NCT02727777|565795154|FG001|Overall Study|Screen Failure|0|||
156739908|NCT02727777|565795155|FG002|Overall Study|Screen Failure|0|||
156739909|NCT02727777|565795153|FG000|Overall Study|Progressive disease|2|||
156739910|NCT02727777|565795154|FG001|Overall Study|Progressive disease|0|||
156739911|NCT02727777|565795155|FG002|Overall Study|Progressive disease|0|||
156739912|NCT03003494|565795156|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
156739913|NCT01738503|565795157|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
156739914|NCT01738503|565795158|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739915|NCT01738503|565795159|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739916|NCT01738503|565795160|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739917|NCT01738503|565795161|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739918|NCT01738503|565795162|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739919|NCT01738503|565795163|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
156739920|NCT01738503|565795157|FG000|Treatment Period|Adverse Event|0|||
156739921|NCT01738503|565795158|FG001|Treatment Period|Adverse Event|1|||
156739922|NCT01738503|565795159|FG002|Treatment Period|Adverse Event|0|||
156739923|NCT01738503|565795160|FG003|Treatment Period|Adverse Event|1|||
156739924|NCT01738503|565795161|FG004|Treatment Period|Adverse Event|2|||
156739925|NCT01738503|565795162|FG005|Treatment Period|Adverse Event|2|||
156739926|NCT01738503|565795163|FG006|Treatment Period|Adverse Event|2|||
156739927|NCT01738503|565795157|FG000|Treatment Period|Lost to Follow-up|0|||
156739928|NCT01738503|565795158|FG001|Treatment Period|Lost to Follow-up|0|||
156739929|NCT01738503|565795159|FG002|Treatment Period|Lost to Follow-up|3|||
156739930|NCT01738503|565795160|FG003|Treatment Period|Lost to Follow-up|4|||
156739931|NCT01738503|565795161|FG004|Treatment Period|Lost to Follow-up|1|||
156739932|NCT01738503|565795162|FG005|Treatment Period|Lost to Follow-up|1|||
156739933|NCT01738503|565795163|FG006|Treatment Period|Lost to Follow-up|5|||
156739934|NCT01738503|565795157|FG000|Treatment Period|Withdrawal by Subject|0|||
156739935|NCT01738503|565795158|FG001|Treatment Period|Withdrawal by Subject|1|||
156739936|NCT01738503|565795159|FG002|Treatment Period|Withdrawal by Subject|0|||
156739937|NCT01738503|565795160|FG003|Treatment Period|Withdrawal by Subject|1|||
156739938|NCT01738503|565795161|FG004|Treatment Period|Withdrawal by Subject|1|||
156739939|NCT01738503|565795162|FG005|Treatment Period|Withdrawal by Subject|1|||
156739940|NCT01738503|565795163|FG006|Treatment Period|Withdrawal by Subject|1|||
156739941|NCT01738503|565795157|FG000|Treatment Period|Protocol Violation|0|||
156739942|NCT01738503|565795158|FG001|Treatment Period|Protocol Violation|3|||
156739943|NCT01738503|565795159|FG002|Treatment Period|Protocol Violation|1|||
156739944|NCT01738503|565795160|FG003|Treatment Period|Protocol Violation|0|||
156739945|NCT01738503|565795161|FG004|Treatment Period|Protocol Violation|4|||
156739946|NCT01738503|565795162|FG005|Treatment Period|Protocol Violation|2|||
156739947|NCT01738503|565795163|FG006|Treatment Period|Protocol Violation|0|||
156739948|NCT01738503|565795157|FG000|Treatment Period|Other|0|||
156739949|NCT01738503|565795158|FG001|Treatment Period|Other|0|||
156739950|NCT01738503|565795159|FG002|Treatment Period|Other|1|||
156739951|NCT01738503|565795160|FG003|Treatment Period|Other|0|||
156739952|NCT01738503|565795161|FG004|Treatment Period|Other|0|||
156739953|NCT01738503|565795162|FG005|Treatment Period|Other|0|||
156739954|NCT01738503|565795163|FG006|Treatment Period|Other|0|||
156739955|NCT01738503|565795157|FG000|PET Imaging Sub-study|Adverse Event|0|||
156739956|NCT01738503|565795158|FG001|PET Imaging Sub-study|Adverse Event|0|||
156739957|NCT01738503|565795159|FG002|PET Imaging Sub-study|Adverse Event|0|||
156739958|NCT01738503|565795160|FG003|PET Imaging Sub-study|Adverse Event|0|||
156739959|NCT01738503|565795161|FG004|PET Imaging Sub-study|Adverse Event|0|||
156739960|NCT01738503|565795162|FG005|PET Imaging Sub-study|Adverse Event|1|||
156739961|NCT01738503|565795163|FG006|PET Imaging Sub-study|Adverse Event|0|||
156739962|NCT01738503|565795157|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739963|NCT01738503|565795158|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739964|NCT01738503|565795159|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739965|NCT01738503|565795160|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739966|NCT01738503|565795161|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
156739967|NCT01738503|565795162|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
156739968|NCT01738503|565795163|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
156739969|NCT03005327|565795164|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739970|NCT03005327|565795165|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739971|NCT03005327|565795166|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
156739972|NCT03005327|565795167|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
156739973|NCT03005327|565795164|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739974|NCT03005327|565795165|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
156739975|NCT03005327|565795166|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739976|NCT03005327|565795167|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
156739977|NCT04687072|565795169|FG000|Overall Study|Adverse Event|2|||
156739978|NCT04687072|565795170|FG001|Overall Study|Adverse Event|0|||
156739979|NCT04687072|565795169|FG000|Overall Study|Death|1|||
156739980|NCT04687072|565795170|FG001|Overall Study|Death|0|||
156739981|NCT04687072|565795169|FG000|Overall Study|Lack of Efficacy|2|||
156739982|NCT04687072|565795170|FG001|Overall Study|Lack of Efficacy|1|||
156739983|NCT04687072|565795169|FG000|Overall Study|Physician Decision|1|||
156739984|NCT04687072|565795170|FG001|Overall Study|Physician Decision|0|||
156739985|NCT04687072|565795169|FG000|Overall Study|Pregnancy|1|||
156739986|NCT04687072|565795170|FG001|Overall Study|Pregnancy|0|||
156739987|NCT04687072|565795169|FG000|Overall Study|Requires Prohibited Medication|2|||
156739988|NCT04687072|565795170|FG001|Overall Study|Requires Prohibited Medication|0|||
156739989|NCT04687072|565795169|FG000|Overall Study|Withdrawal of Consent|11|||
156739990|NCT04687072|565795170|FG001|Overall Study|Withdrawal of Consent|6|||
156739991|NCT04687072|565795169|FG000|Overall Study|Miscellaneous|4|||
156739992|NCT04687072|565795170|FG001|Overall Study|Miscellaneous|1|||
156739993|NCT01263782|565795171|FG000|Overall Study|Death|0|||
156739994|NCT01263782|565795172|FG001|Overall Study|Death|0|||
156739995|NCT01263782|565795173|FG002|Overall Study|Death|1|||
156739996|NCT01263782|565795174|FG003|Overall Study|Death|0|||
156739997|NCT01263782|565795171|FG000|Overall Study|Progressive disease|0|||
156739998|NCT01263782|565795172|FG001|Overall Study|Progressive disease|0|||
156739999|NCT01263782|565795173|FG002|Overall Study|Progressive disease|0|||
156740000|NCT01263782|565795174|FG003|Overall Study|Progressive disease|1|||
156740001|NCT01263782|565795171|FG000|Overall Study|Too early|0|||
156740002|NCT01263782|565795172|FG001|Overall Study|Too early|0|||
156740003|NCT01263782|565795173|FG002|Overall Study|Too early|1|||
156740004|NCT01263782|565795174|FG003|Overall Study|Too early|0|||
156740005|NCT01263782|565795171|FG000|Overall Study|Inevaluable|0|||
156740006|NCT01263782|565795172|FG001|Overall Study|Inevaluable|0|||
156740007|NCT01263782|565795173|FG002|Overall Study|Inevaluable|1|||
156740008|NCT01263782|565795174|FG003|Overall Study|Inevaluable|0|||
156740009|NCT00915876|565795175|FG000|Overall Study|Adverse Event|0|||
156740010|NCT00915876|565795176|FG001|Overall Study|Adverse Event|1|||
156740011|NCT04545567|565795182|FG000|Overall Study|tested positive for SARS-co-V2|1|||
156740012|NCT04545567|565795183|FG001|Overall Study|tested positive for SARS-co-V2|1|||
156740013|NCT04545567|565795182|FG000|Overall Study|Withdrawal by Subject|0|||
156740014|NCT04545567|565795183|FG001|Overall Study|Withdrawal by Subject|1|||
156740015|NCT02272842|565795184|FG000|Overall Study|Lost to Follow-up|8|||
156740016|NCT02272842|565795185|FG001|Overall Study|Lost to Follow-up|8|||
156740017|NCT02272842|565795184|FG000|Overall Study|Withdrawal by Subject|8|||
156740018|NCT02272842|565795185|FG001|Overall Study|Withdrawal by Subject|2|||
156740019|NCT01294696|565795194|FG000|Overall Study|Screening failures|7|||
156740020|NCT01294696|565795194|FG000|Overall Study|Protocol Violation|8|||
156740021|NCT01294696|565795194|FG000|Overall Study|Missing BPI Response|7|||
157020432|NCT05034952|566828432|FG001|Overall Study|Other|0|||
156740022|NCT01294696|565795194|FG000|Overall Study|Site closure|52|||
156740023|NCT05897827|565796747|FG000|Overall Study|Lost to Follow-up|33|||
156740024|NCT05897827|565796748|FG001|Overall Study|Lost to Follow-up|14|||
156740025|NCT05897827|565796747|FG000|Overall Study|Withdrawal by Subject|1|||
156740026|NCT05897827|565796748|FG001|Overall Study|Withdrawal by Subject|1|||
156740027|NCT03569293|565796749|FG000|Overall Study|Adverse Event|4|||
156740028|NCT03569293|565796750|FG001|Overall Study|Adverse Event|1|||
156740029|NCT03569293|565796751|FG002|Overall Study|Adverse Event|5|||
156740030|NCT03569293|565796752|FG003|Overall Study|Adverse Event|1|||
156740031|NCT03569293|565796753|FG004|Overall Study|Adverse Event|0|||
156740032|NCT03569293|565796754|FG005|Overall Study|Adverse Event|0|||
156740033|NCT03569293|565796749|FG000|Overall Study|Withdrawal by Subject|16|||
156740034|NCT03569293|565796750|FG001|Overall Study|Withdrawal by Subject|2|||
156740035|NCT03569293|565796751|FG002|Overall Study|Withdrawal by Subject|4|||
156740036|NCT03569293|565796752|FG003|Overall Study|Withdrawal by Subject|1|||
156740037|NCT03569293|565796753|FG004|Overall Study|Withdrawal by Subject|0|||
156740038|NCT03569293|565796754|FG005|Overall Study|Withdrawal by Subject|0|||
156740039|NCT03569293|565796749|FG000|Overall Study|Lost to Follow-up|1|||
156740040|NCT03569293|565796750|FG001|Overall Study|Lost to Follow-up|3|||
156740041|NCT03569293|565796751|FG002|Overall Study|Lost to Follow-up|1|||
156740042|NCT03569293|565796752|FG003|Overall Study|Lost to Follow-up|1|||
156740043|NCT03569293|565796753|FG004|Overall Study|Lost to Follow-up|0|||
156740044|NCT03569293|565796754|FG005|Overall Study|Lost to Follow-up|0|||
156740045|NCT03569293|565796749|FG000|Overall Study|Other|8|||
156740046|NCT03569293|565796750|FG001|Overall Study|Other|2|||
156740047|NCT03569293|565796751|FG002|Overall Study|Other|1|||
156740048|NCT03569293|565796752|FG003|Overall Study|Other|1|||
156740049|NCT03569293|565796753|FG004|Overall Study|Other|0|||
156740050|NCT03569293|565796754|FG005|Overall Study|Other|0|||
156740051|NCT03569293|565796749|FG000|Overall Study|Ongoing at Time of Analysis|8|||
156740052|NCT03569293|565796750|FG001|Overall Study|Ongoing at Time of Analysis|1|||
156740053|NCT03569293|565796751|FG002|Overall Study|Ongoing at Time of Analysis|3|||
156740054|NCT03569293|565796752|FG003|Overall Study|Ongoing at Time of Analysis|0|||
156740055|NCT03569293|565796753|FG004|Overall Study|Ongoing at Time of Analysis|0|||
156740056|NCT03569293|565796754|FG005|Overall Study|Ongoing at Time of Analysis|0|||
156740057|NCT02276053|565796765|FG000|Overall Study|Death|2|||
156740058|NCT02276053|565796765|FG000|Overall Study|Adverse Event|5|||
156740059|NCT02276053|565796765|FG000|Overall Study|Lack of Efficacy|2|||
156740060|NCT02276053|565796765|FG000|Overall Study|Withdrawal by Subject|1|||
156740061|NCT02276053|565796765|FG000|Overall Study|Patient does not meet selection criteria|3|||
156740062|NCT02276053|565796765|FG000|Overall Study|Patient needs to increase baseline AED|1|||
156740063|NCT02059434|565796766|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
156740064|NCT02059434|565796767|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
156740065|NCT02059434|565796768|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
156740066|NCT02059434|565796769|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
156740067|NCT02059434|565796770|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
156740068|NCT02059434|565796771|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
156740069|NCT02059434|565796772|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
156740070|NCT02059434|565796773|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
156740071|NCT02059434|565796774|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
156740072|NCT02059434|565796766|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
156740073|NCT02059434|565796767|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
156740074|NCT02059434|565796768|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
156740075|NCT02059434|565796769|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
156740076|NCT02059434|565796770|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
156740077|NCT02059434|565796771|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
156740078|NCT02059434|565796772|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
156740079|NCT02059434|565796773|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
156740080|NCT02059434|565796774|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
156740081|NCT02059434|565796766|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
156740082|NCT02059434|565796767|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
156740083|NCT02059434|565796768|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
156740084|NCT02059434|565796769|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
156740085|NCT02059434|565796770|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
156740086|NCT02059434|565796771|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
156740087|NCT02059434|565796772|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
156740088|NCT02059434|565796773|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
156740089|NCT02059434|565796774|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
156740090|NCT02059434|565796766|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
156740091|NCT02059434|565796767|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
156740092|NCT02059434|565796768|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
156740093|NCT02059434|565796769|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
156740094|NCT02059434|565796770|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
156740095|NCT02059434|565796771|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
156740096|NCT02059434|565796772|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
156740097|NCT02059434|565796773|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
156740098|NCT02059434|565796774|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
156740099|NCT02059434|565796766|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740100|NCT02059434|565796767|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740101|NCT02059434|565796768|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740102|NCT02059434|565796769|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740103|NCT02059434|565796770|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740104|NCT02059434|565796771|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740105|NCT02059434|565796772|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740106|NCT02059434|565796773|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
156740107|NCT02059434|565796774|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
156740108|NCT01004406|565796777|FG000|Overall Study|Withdrawal by Subject|2|||
156740109|NCT01004406|565796778|FG001|Overall Study|Withdrawal by Subject|0|||
156740110|NCT01004406|565796777|FG000|Overall Study|Lost to Follow-up|1|||
156740111|NCT01004406|565796778|FG001|Overall Study|Lost to Follow-up|0|||
156740112|NCT02928770|565796779|FG000|Overall Study|Withdrawal by Subject|2|||
156740113|NCT03201874|565796782|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
156740114|NCT03201874|565796783|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
156740115|NCT03201874|565796782|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
156740116|NCT03201874|565796783|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
156740117|NCT02907593|565796784|FG000|Overall Study|Withdrawal by Subject|0|||
156740118|NCT02907593|565796785|FG001|Overall Study|Withdrawal by Subject|0|||
156740119|NCT02907593|565796786|FG002|Overall Study|Withdrawal by Subject|1|||
156740120|NCT02907593|565796787|FG003|Overall Study|Withdrawal by Subject|0|||
156740121|NCT04488497|565796795|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
156740122|NCT04488497|565796796|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
156740123|NCT04488497|565796795|FG000|Intervention|Physician Decision|2|||
156740124|NCT04488497|565796796|FG001|Intervention|Physician Decision|1|||
156740125|NCT04488497|565796795|FG000|Intervention|Withdrawal by Subject|5|||
156740126|NCT04488497|565796796|FG001|Intervention|Withdrawal by Subject|6|||
156740127|NCT04488497|565796795|FG000|Intervention|Lost to Follow-up|2|||
156740128|NCT04488497|565796796|FG001|Intervention|Lost to Follow-up|0|||
156740129|NCT04488497|565796795|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
156740130|NCT04488497|565796796|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
156740131|NCT04488497|565796795|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
156740132|NCT04488497|565796796|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
156740133|NCT04322539|565796797|FG000|Overall Study|Adverse Event|2|||
156740134|NCT04322539|565796798|FG001|Overall Study|Adverse Event|0|||
156740135|NCT04322539|565796797|FG000|Overall Study|Death|411|||
156740136|NCT04322539|565796798|FG001|Overall Study|Death|203|||
156740137|NCT04322539|565796797|FG000|Overall Study|Lost to Follow-up|3|||
156740138|NCT04322539|565796798|FG001|Overall Study|Lost to Follow-up|1|||
156740139|NCT04322539|565796797|FG000|Overall Study|Withdrawal of consent|14|||
156740140|NCT04322539|565796798|FG001|Overall Study|Withdrawal of consent|8|||
156740141|NCT04322539|565796797|FG000|Overall Study|Radiological Disease Progression|6|||
156740142|NCT04322539|565796798|FG001|Overall Study|Radiological Disease Progression|0|||
156740143|NCT04322539|565796797|FG000|Overall Study|Sponsor Decision|19|||
156740144|NCT04322539|565796798|FG001|Overall Study|Sponsor Decision|14|||
156740145|NCT04322539|565796797|FG000|Overall Study|Other|6|||
156740146|NCT04322539|565796798|FG001|Overall Study|Other|4|||
156740147|NCT01877551|565796799|FG000|Overall Study|Physician Decision|0|||
156740148|NCT01877551|565796800|FG001|Overall Study|Physician Decision|1|||
156740149|NCT02659514|565796801|FG000|Overall Study|Adverse Event|3|||
156740150|NCT02659514|565796802|FG001|Overall Study|Adverse Event|12|||
156740151|NCT02659514|565796801|FG000|Overall Study|Disease Progression|23|||
156740152|NCT02659514|565796802|FG001|Overall Study|Disease Progression|13|||
156740153|NCT02659514|565796801|FG000|Overall Study|Withdrawal by Subject|0|||
156740154|NCT02659514|565796802|FG001|Overall Study|Withdrawal by Subject|4|||
156740155|NCT02659514|565796801|FG000|Overall Study|Lost to Follow-up|0|||
156740156|NCT02659514|565796802|FG001|Overall Study|Lost to Follow-up|1|||
156740157|NCT02659514|565796801|FG000|Overall Study|Death|6|||
156740158|NCT02659514|565796802|FG001|Overall Study|Death|1|||
156740159|NCT02659514|565796801|FG000|Overall Study|Reason Unspecified|0|||
156740160|NCT02659514|565796802|FG001|Overall Study|Reason Unspecified|3|||
156740161|NCT00348790|565796803|FG000|Completed Treatment|Withdrawal by Subject|4|||
156740162|NCT00348790|565796803|FG000|Completed Treatment|Disease progression|14|||
156740163|NCT00348790|565796803|FG000|Completed Treatment|Adverse Event|4|||
156740164|NCT00348790|565796803|FG000|Completed Treatment|Required surgery|2|||
156740165|NCT00348790|565796803|FG000|Completed Treatment|Unable to travel to study site|1|||
156740166|NCT03409107|565796807|FG000|Overall Study|Withdrawal by Subject|4|||
156740167|NCT03409107|565796808|FG001|Overall Study|Withdrawal by Subject|2|||
156740168|NCT03409107|565796807|FG000|Overall Study|Physician Decision|1|||
156740169|NCT03409107|565796808|FG001|Overall Study|Physician Decision|0|||
156740170|NCT03409107|565796807|FG000|Overall Study|Lost to Follow-up|7|||
156740171|NCT03409107|565796808|FG001|Overall Study|Lost to Follow-up|2|||
156740172|NCT03409107|565796807|FG000|Overall Study|Adverse Event|5|||
156740173|NCT03409107|565796808|FG001|Overall Study|Adverse Event|3|||
156740174|NCT01185509|565796809|FG000|Overall Study|Progression/Relapse|9|||
157218444|NCT00125359|567545682|FG000|Overall Study|Adverse Event|5|||
157218445|NCT00125359|567545682|FG000|Overall Study|Physician Decision|14|||
157218446|NCT01201356|567545683|FG000|Overall Study|Adverse Event|170|||
157218447|NCT01201356|567545683|FG000|Overall Study|Abnormal laboratory value(s)|51|||
157218448|NCT01201356|567545683|FG000|Overall Study|Abnormal test procedure result(s)|3|||
157218449|NCT01201356|567545683|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
157218450|NCT01201356|567545683|FG000|Overall Study|Condition no longer requires study drug|12|||
157218451|NCT01201356|567545683|FG000|Overall Study|Withdrawal by Subject|144|||
157218452|NCT01201356|567545683|FG000|Overall Study|Lost to Follow-up|50|||
157218453|NCT01201356|567545683|FG000|Overall Study|administrative problems|74|||
157218454|NCT01201356|567545683|FG000|Overall Study|Death|16|||
157218455|NCT01201356|567545683|FG000|Overall Study|Protocol Violation|12|||
157218456|NCT00811070|567545684|FG000|Overall Study|Death|0|||
157218457|NCT00811070|567545685|FG001|Overall Study|Death|0|||
157218458|NCT00811070|567545686|FG002|Overall Study|Death|0|||
157218459|NCT00811070|567545687|FG003|Overall Study|Death|2|||
157218460|NCT00811070|567545688|FG004|Overall Study|Death|5|||
157218461|NCT00811070|567545689|FG005|Overall Study|Death|0|||
157218462|NCT00811070|567545684|FG000|Overall Study|Other|1|||
157218463|NCT00811070|567545685|FG001|Overall Study|Other|0|||
157218464|NCT00811070|567545686|FG002|Overall Study|Other|0|||
157218465|NCT00811070|567545687|FG003|Overall Study|Other|0|||
157218466|NCT00811070|567545688|FG004|Overall Study|Other|0|||
157218467|NCT00811070|567545689|FG005|Overall Study|Other|0|||
157218468|NCT00811070|567545684|FG000|Overall Study|Withdrawal by Subject|0|||
157218469|NCT00811070|567545685|FG001|Overall Study|Withdrawal by Subject|1|||
157218470|NCT00811070|567545686|FG002|Overall Study|Withdrawal by Subject|0|||
157218471|NCT00811070|567545687|FG003|Overall Study|Withdrawal by Subject|0|||
157218472|NCT00811070|567545688|FG004|Overall Study|Withdrawal by Subject|0|||
157218473|NCT00811070|567545689|FG005|Overall Study|Withdrawal by Subject|0|||
157218474|NCT00811070|567545684|FG000|Overall Study|Physician Decision|0|||
157218475|NCT00811070|567545685|FG001|Overall Study|Physician Decision|0|||
157218476|NCT00811070|567545686|FG002|Overall Study|Physician Decision|0|||
157218477|NCT00811070|567545687|FG003|Overall Study|Physician Decision|0|||
157218478|NCT00811070|567545688|FG004|Overall Study|Physician Decision|0|||
157218479|NCT00811070|567545689|FG005|Overall Study|Physician Decision|1|||
157218480|NCT00665626|567545694|FG000|Overall Study|Lack of Efficacy|8|||
157218481|NCT00665626|567545695|FG001|Overall Study|Lack of Efficacy|5|||
157218482|NCT00665626|567545694|FG000|Overall Study|Lost to Follow-up|0|||
157218483|NCT00665626|567545695|FG001|Overall Study|Lost to Follow-up|2|||
157218484|NCT00665626|567545694|FG000|Overall Study|Withdrawal by Subject|0|||
157218485|NCT00665626|567545695|FG001|Overall Study|Withdrawal by Subject|1|||
157218486|NCT00665626|567545694|FG000|Overall Study|Protocol Violation|0|||
157218487|NCT00665626|567545695|FG001|Overall Study|Protocol Violation|2|||
157218488|NCT00665626|567545694|FG000|Overall Study|Adverse Event|1|||
157218489|NCT00665626|567545695|FG001|Overall Study|Adverse Event|9|||
157218490|NCT00665626|567545694|FG000|Overall Study|Due to exclusion criteria|0|||
157218491|NCT00665626|567545695|FG001|Overall Study|Due to exclusion criteria|1|||
157218492|NCT00665626|567545694|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
157218493|NCT00665626|567545695|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
157218494|NCT00665626|567545694|FG000|Overall Study|Unably to comply with dosing regimen|0|||
157218495|NCT00665626|567545695|FG001|Overall Study|Unably to comply with dosing regimen|1|||
157218496|NCT00665626|567545694|FG000|Overall Study|Death|1|||
157218497|NCT00665626|567545695|FG001|Overall Study|Death|0|||
157218498|NCT00585039|567545696|FG000|Overall Study|medication spilled|2|||
157218499|NCT00585039|567545697|FG001|Overall Study|medication spilled|0|||
156740175|NCT01185509|565796810|FG001|Overall Study|Progression/Relapse|15|||
157218500|NCT01629693|567545700|FG000|Overall Study|Lost to Follow-up|2|||
157218501|NCT01629693|567545701|FG001|Overall Study|Lost to Follow-up|4|||
157218502|NCT01629693|567545700|FG000|Overall Study|Withdrawal by Subject|2|||
157218503|NCT01629693|567545701|FG001|Overall Study|Withdrawal by Subject|2|||
157218504|NCT01629693|567545700|FG000|Overall Study|Adverse Event|1|||
157218505|NCT01629693|567545701|FG001|Overall Study|Adverse Event|0|||
157218506|NCT01629693|567545700|FG000|Overall Study|Investigator decision|0|||
157218507|NCT01629693|567545701|FG001|Overall Study|Investigator decision|1|||
156740176|NCT01185509|565796809|FG000|Overall Study|Physician Decision|2|||
157218508|NCT01629693|567545700|FG000|Overall Study|Poor comfort of study lenses|0|||
157218509|NCT01629693|567545701|FG001|Overall Study|Poor comfort of study lenses|2|||
157218510|NCT01629693|567545700|FG000|Overall Study|Subject decision unrelated to AE|0|||
157218511|NCT01629693|567545701|FG001|Overall Study|Subject decision unrelated to AE|1|||
157218512|NCT01025193|567545703|FG000|Overall Study|Protocol Violation|1|||
156740177|NCT01185509|565796810|FG001|Overall Study|Physician Decision|2|||
156740178|NCT01185509|565796809|FG000|Overall Study|Withdrawal by Subject|0|||
156740179|NCT01185509|565796810|FG001|Overall Study|Withdrawal by Subject|1|||
156740180|NCT01185509|565796809|FG000|Overall Study|Death|0|||
156740181|NCT01185509|565796810|FG001|Overall Study|Death|1|||
156740182|NCT01185509|565796809|FG000|Overall Study|Intercurrent Illness|0|||
156740183|NCT01185509|565796810|FG001|Overall Study|Intercurrent Illness|1|||
156740184|NCT03687372|565796811|FG000|Overall Study|Lost to Follow-up|12|||
156740185|NCT03687372|565796812|FG001|Overall Study|Lost to Follow-up|21|||
156740186|NCT03687372|565796811|FG000|Overall Study|Withdrawal by Subject|4|||
156740187|NCT03687372|565796812|FG001|Overall Study|Withdrawal by Subject|17|||
156740188|NCT03687372|565796811|FG000|Overall Study|Investigator Decision|1|||
156740189|NCT03687372|565796812|FG001|Overall Study|Investigator Decision|1|||
156740190|NCT02370667|565796820|FG000|Overall Study|Lost to Follow-up|0|||
156740191|NCT02370667|565796821|FG001|Overall Study|Lost to Follow-up|1|||
156740192|NCT02370667|565796822|FG002|Overall Study|Lost to Follow-up|0|||
156740193|NCT03536949|565796823|FG000|Overall Study|Adverse Event|4|||
156740194|NCT03536949|565796824|FG001|Overall Study|Adverse Event|0|||
156740195|NCT03536949|565796823|FG000|Overall Study|Lost to Follow-up|2|||
156740196|NCT03536949|565796824|FG001|Overall Study|Lost to Follow-up|1|||
156740197|NCT03536949|565796823|FG000|Overall Study|Withdrawal by Subject|6|||
156740198|NCT03536949|565796824|FG001|Overall Study|Withdrawal by Subject|0|||
156740199|NCT03536949|565796823|FG000|Overall Study|Non-compliance|2|||
156740200|NCT03536949|565796824|FG001|Overall Study|Non-compliance|1|||
156740201|NCT02954653|565796826|FG000|Overall Study|Death|3|||
156740202|NCT02954653|565796827|FG001|Overall Study|Death|1|||
156740203|NCT02954653|565796828|FG002|Overall Study|Death|0|||
156740204|NCT02954653|565796829|FG003|Overall Study|Death|0|||
156740205|NCT02954653|565796830|FG004|Overall Study|Death|0|||
156740206|NCT02954653|565796831|FG005|Overall Study|Death|0|||
156740207|NCT02954653|565796832|FG006|Overall Study|Death|0|||
156740208|NCT02954653|565796833|FG007|Overall Study|Death|0|||
156740209|NCT02954653|565796834|FG008|Overall Study|Death|0|||
157218513|NCT01025193|567545703|FG000|Overall Study|Adverse Event|3|||
157218514|NCT04079842|567545704|FG000|Overall Study|Request of subject|2|||
157218515|NCT04079842|567545704|FG000|Overall Study|Unable to draw Arterial samples|1|||
157218516|NCT02904200|567545705|FG000|Overall Study|Withdrawal by Subject|1|||
157218517|NCT02904200|567545706|FG001|Overall Study|Withdrawal by Subject|0|||
157218518|NCT01759537|567545709|FG000|Overall Study|Death|1|||
157218519|NCT01759537|567545710|FG001|Overall Study|Death|1|||
157218520|NCT01759537|567545709|FG000|Overall Study|Pregnancy|1|||
157218521|NCT01759537|567545710|FG001|Overall Study|Pregnancy|1|||
157218522|NCT01759537|567545709|FG000|Overall Study|Lost to Follow-up|9|||
157218523|NCT01759537|567545710|FG001|Overall Study|Lost to Follow-up|9|||
157218524|NCT01759537|567545709|FG000|Overall Study|Accident involving jaw fracture|1|||
157218525|NCT01759537|567545710|FG001|Overall Study|Accident involving jaw fracture|1|||
157218526|NCT01759537|567545709|FG000|Overall Study|Subcrestal implant too coronal|1|||
157218527|NCT01759537|567545710|FG001|Overall Study|Subcrestal implant too coronal|1|||
156740210|NCT02954653|565796826|FG000|Overall Study|Randomized but did not receive treatment|1|||
156740211|NCT02954653|565796827|FG001|Overall Study|Randomized but did not receive treatment|0|||
156797585|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
156797586|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
156797587|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
156797588|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
156797589|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797590|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156740212|NCT02954653|565796828|FG002|Overall Study|Randomized but did not receive treatment|0|||
156740213|NCT02954653|565796829|FG003|Overall Study|Randomized but did not receive treatment|0|||
156740214|NCT02954653|565796830|FG004|Overall Study|Randomized but did not receive treatment|0|||
156740215|NCT02954653|565796831|FG005|Overall Study|Randomized but did not receive treatment|0|||
156740216|NCT02954653|565796832|FG006|Overall Study|Randomized but did not receive treatment|0|||
156797591|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797592|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797593|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797594|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797595|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
157218528|NCT00420290|567545711|FG000|Overall Study|Adverse Event|3|||
157218529|NCT00420290|567545712|FG001|Overall Study|Adverse Event|1|||
157218530|NCT00420290|567545711|FG000|Overall Study|Withdrawal by Subject|0|||
156740217|NCT02954653|565796833|FG007|Overall Study|Randomized but did not receive treatment|0|||
156740218|NCT02954653|565796834|FG008|Overall Study|Randomized but did not receive treatment|0|||
156740219|NCT02954653|565796826|FG000|Overall Study|Started another anti-cancer therapy|0|||
156740220|NCT02954653|565796827|FG001|Overall Study|Started another anti-cancer therapy|1|||
157218531|NCT00420290|567545712|FG001|Overall Study|Withdrawal by Subject|2|||
157218532|NCT00420290|567545711|FG000|Overall Study|did not meet inclusion/exclusion|1|||
156740221|NCT02954653|565796828|FG002|Overall Study|Started another anti-cancer therapy|0|||
156740222|NCT02954653|565796829|FG003|Overall Study|Started another anti-cancer therapy|0|||
156740223|NCT02954653|565796830|FG004|Overall Study|Started another anti-cancer therapy|0|||
156740224|NCT02954653|565796831|FG005|Overall Study|Started another anti-cancer therapy|0|||
156740225|NCT02954653|565796832|FG006|Overall Study|Started another anti-cancer therapy|0|||
156740226|NCT02954653|565796833|FG007|Overall Study|Started another anti-cancer therapy|0|||
156740227|NCT02954653|565796834|FG008|Overall Study|Started another anti-cancer therapy|0|||
156740228|NCT02954653|565796826|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
156740229|NCT02954653|565796827|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
156740230|NCT02954653|565796828|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
156740231|NCT02954653|565796829|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
156740232|NCT02954653|565796830|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
156740233|NCT02954653|565796831|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
156740234|NCT02954653|565796832|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
156740235|NCT02954653|565796833|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
156740236|NCT02954653|565796834|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
156740237|NCT03054064|565796835|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
156740238|NCT03054064|565796835|FG000|Overall Study|Investigator Decision|2|||
156740239|NCT03054064|565796835|FG000|Overall Study|Bladder Issue|1|||
156740240|NCT03054064|565796835|FG000|Overall Study|High Blood Pressure|1|||
156740241|NCT03054064|565796835|FG000|Overall Study|Change in Status|1|||
156740242|NCT04329091|565796836|FG000|Overall Study|Physician Decision|5|||
156740243|NCT03787303|565796839|FG000|Overall Study|Death|1|||
156740244|NCT03787303|565796839|FG000|Overall Study|Premature Termination of Study|1|||
156740245|NCT05020366|565796844|FG000|Overall Study|Lost to Follow-up|2|||
156740246|NCT05020366|565796845|FG001|Overall Study|Lost to Follow-up|0|||
156740247|NCT05020366|565796844|FG000|Overall Study|Withdrawal by Subject|2|||
156740248|NCT05020366|565796845|FG001|Overall Study|Withdrawal by Subject|0|||
156740249|NCT00794040|565796849|FG000|Overall Study|Withdrawal by Subject|3|||
156740250|NCT00794040|565796850|FG001|Overall Study|Withdrawal by Subject|4|||
156740251|NCT00794040|565796849|FG000|Overall Study|Physician Decision|0|||
156740252|NCT00794040|565796850|FG001|Overall Study|Physician Decision|1|||
156740253|NCT04696354|565796851|FG000|Overall Study|Study termination|6|||
156740254|NCT04696354|565796852|FG001|Overall Study|Study termination|6|||
156740255|NCT03626363|565796855|FG000|Overall Study|Protocol Violation|4|||
156740256|NCT03626363|565796856|FG001|Overall Study|Protocol Violation|0|||
156740257|NCT03626363|565796855|FG000|Overall Study|Lost to Follow-up|5|||
156740258|NCT03626363|565796856|FG001|Overall Study|Lost to Follow-up|7|||
156740259|NCT00965341|565796862|FG000|Overall Study|Withdrew consent|1|||
156740260|NCT00965341|565796863|FG001|Overall Study|Withdrew consent|5|||
156740261|NCT00965341|565796862|FG000|Overall Study|Lost to Follow-up|1|||
156740262|NCT00965341|565796863|FG001|Overall Study|Lost to Follow-up|0|||
156740263|NCT00965341|565796862|FG000|Overall Study|Transportation issues|4|||
156740264|NCT00965341|565796863|FG001|Overall Study|Transportation issues|3|||
156740265|NCT01970475|565796864|FG000|Overall Study|Withdrawal by Subject|11|||
156740266|NCT01970475|565796865|FG001|Overall Study|Withdrawal by Subject|6|||
156740267|NCT01970475|565796864|FG000|Overall Study|Adverse Event|7|||
156740268|NCT01970475|565796865|FG001|Overall Study|Adverse Event|3|||
156740269|NCT01970475|565796864|FG000|Overall Study|Lost to Follow-up|2|||
156740270|NCT01970475|565796865|FG001|Overall Study|Lost to Follow-up|2|||
156740271|NCT01970475|565796864|FG000|Overall Study|Protocol Violation|1|||
156740272|NCT01970475|565796865|FG001|Overall Study|Protocol Violation|0|||
156740273|NCT01077739|565796866|FG000|Overall Study|Premature withdrawal|1|||
156740274|NCT01077739|565796867|FG001|Overall Study|Premature withdrawal|3|||
156740275|NCT01077739|565796866|FG000|Overall Study|Withdrawal by Subject|1|||
156740276|NCT01077739|565796867|FG001|Overall Study|Withdrawal by Subject|0|||
156740277|NCT01077739|565796866|FG000|Overall Study|Death|0|||
156740278|NCT01077739|565796867|FG001|Overall Study|Death|3|||
156740279|NCT01077739|565796866|FG000|Overall Study|Unacceptable toxicity|1|||
156740280|NCT01077739|565796867|FG001|Overall Study|Unacceptable toxicity|2|||
156740281|NCT01077739|565796866|FG000|Overall Study|Other|2|||
156740282|NCT01077739|565796867|FG001|Overall Study|Other|2|||
156740283|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
156740284|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
156740285|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
156740286|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
156740287|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
156740288|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
156740289|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
156740290|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
156740291|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
156740292|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740293|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740294|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
156740295|NCT00960986|565796868|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
156740296|NCT00960986|565796869|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
156740297|NCT00960986|565796870|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
156740298|NCT00960986|565796871|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
157218533|NCT00420290|567545712|FG001|Overall Study|did not meet inclusion/exclusion|1|||
157218534|NCT01466686|567547422|FG000|Overall Study|Withdrawal by Subject|1|||
157218535|NCT02049359|567547423|FG000|Overall Study|Lost to Follow-up|26|||
157218536|NCT02049359|567547424|FG001|Overall Study|Lost to Follow-up|19|||
157218537|NCT03273387|567547425|FG000|Overall Study|Death|2|||
157218538|NCT03273387|567547426|FG001|Overall Study|Death|2|||
157218539|NCT03273387|567547425|FG000|Overall Study|Withdrawal by Subject|1|||
157218540|NCT03273387|567547426|FG001|Overall Study|Withdrawal by Subject|1|||
157218541|NCT01405950|567547427|FG000|Overall Study|Withdrawal by Subject|1|||
156740299|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
156740300|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
156740301|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
156740302|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
156740303|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Death|0|||
156740304|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Death|0|||
156740305|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Death|1|||
156740306|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Death|0|||
156740307|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
156740308|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
156740309|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
156740310|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
157218542|NCT01405950|567547428|FG001|Overall Study|Withdrawal by Subject|0|||
157218543|NCT01405950|567547429|FG002|Overall Study|Withdrawal by Subject|0|||
157218544|NCT01405950|567547430|FG003|Overall Study|Withdrawal by Subject|0|||
157218545|NCT00387712|567547433|FG000|Overall Study|Physician Decision|6|||
157218546|NCT00387712|567547434|FG001|Overall Study|Physician Decision|4|||
157218547|NCT00387712|567547433|FG000|Overall Study|Lost to Follow-up|17|||
157218548|NCT00387712|567547434|FG001|Overall Study|Lost to Follow-up|20|||
157218549|NCT00387712|567547433|FG000|Overall Study|Withdrawal by Subject|6|||
157218550|NCT00387712|567547434|FG001|Overall Study|Withdrawal by Subject|12|||
157218551|NCT01772368|567547435|FG000|Overall Study|Adverse Event|1|||
157218552|NCT01772368|567547435|FG000|Overall Study|Withdrawal by Subject|3|||
157218553|NCT01772368|567547435|FG000|Overall Study|Protocol Violation|2|||
157218554|NCT01772368|567547435|FG000|Overall Study|Other|1|||
157218555|NCT03347695|567547452|FG000|Overall Study|Death|0|||
157218556|NCT03347695|567547453|FG001|Overall Study|Death|4|||
157218557|NCT03347695|567547452|FG000|Overall Study|Lost to Follow-up|0|||
157218558|NCT03347695|567547453|FG001|Overall Study|Lost to Follow-up|1|||
157218559|NCT04633837|567547454|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
157218560|NCT04633837|567547455|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
157218561|NCT00112489|567547456|FG000|Overall Study|Refused further treatment|8|||
157218562|NCT00112489|567547456|FG000|Overall Study|Adverse Event|12|||
156740311|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
156740312|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
156740313|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
157218563|NCT00112489|567547456|FG000|Overall Study|Death|2|||
157218564|NCT00112489|567547456|FG000|Overall Study|Other, Not Specified|9|||
156740314|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
156740315|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740316|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740317|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
156740318|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
156740319|NCT00960986|565796868|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
156740320|NCT00960986|565796869|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
156740321|NCT00960986|565796870|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
156740322|NCT00960986|565796871|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
156740323|NCT00877071|565796872|FG000|Overall Study|disease progression|2|||
156740324|NCT01984892|565796873|FG000|Overall Study|Progressive disease|7|||
156797596|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
157218565|NCT00112489|567547456|FG000|Overall Study|Patient never treated|2|||
157218566|NCT00112489|567547456|FG000|Overall Study|Ineligible|7|||
156797597|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
157218567|NCT04467697|567547462|FG000|Overall Study|Adverse Event|2|||
157218568|NCT04467697|567547462|FG000|Overall Study|Lost to Follow-up|6|||
157218569|NCT04467697|567547462|FG000|Overall Study|Withdrawal by Subject|9|||
157218570|NCT04467697|567547462|FG000|Overall Study|Protocol Violation|3|||
157218571|NCT04480463|567547465|FG000|Overall Study|Death|0|||
157218572|NCT04480463|567547466|FG001|Overall Study|Death|1|||
157218573|NCT04480463|567547465|FG000|Overall Study|Adverse Event|6|||
156740325|NCT04464720|565796874|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
156740326|NCT04413552|565796880|FG000|Overall Study|Adverse Event|0|||
156740327|NCT04413552|565796881|FG001|Overall Study|Adverse Event|0|||
156740328|NCT04413552|565796882|FG002|Overall Study|Adverse Event|0|||
156740329|NCT04413552|565796883|FG003|Overall Study|Adverse Event|0|||
156740330|NCT04413552|565796884|FG004|Overall Study|Adverse Event|0|||
156740331|NCT04413552|565796885|FG005|Overall Study|Adverse Event|0|||
156740332|NCT04413552|565796886|FG006|Overall Study|Adverse Event|1|||
156740333|NCT04413552|565796887|FG007|Overall Study|Adverse Event|0|||
156740334|NCT04413552|565796888|FG008|Overall Study|Adverse Event|0|||
156740335|NCT04413552|565796889|FG009|Overall Study|Adverse Event|0|||
156740336|NCT05723328|565796890|FG000|Overall Study|Investigator's Decision|5|||
156740337|NCT05723328|565796891|FG001|Overall Study|Investigator's Decision|2|||
156740338|NCT01794793|565796894|FG000|Treatment Period|Withdrawal by Subject|24|||
156740339|NCT01794793|565796894|FG000|Treatment Period|Lack of Efficacy|22|||
156740340|NCT01794793|565796894|FG000|Treatment Period|Adverse Event|17|||
156740341|NCT01794793|565796894|FG000|Treatment Period|Physician Decision|14|||
156740342|NCT01794793|565796894|FG000|Treatment Period|Lost to Follow-up|7|||
156740343|NCT01794793|565796894|FG000|Treatment Period|Death|6|||
156740344|NCT01794793|565796894|FG000|Treatment Period|Protocol Violation|5|||
156740345|NCT01794793|565796894|FG000|Treatment Period|administrative problem|3|||
156740346|NCT01794793|565796894|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
156740347|NCT01794793|565796894|FG000|Post-treatment Follow-up|Adverse Event|8|||
156740348|NCT01794793|565796894|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
156740349|NCT01794793|565796894|FG000|Post-treatment Follow-up|administrative problem|5|||
156740350|NCT01794793|565796894|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
156740351|NCT01794793|565796894|FG000|Post-treatment Follow-up|Protocol Violation|3|||
156740352|NCT03495154|565796895|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
156740353|NCT03495154|565796895|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
156740354|NCT03495154|565796895|FG000|Overall Study|Screen Failures During Surgery|6|||
156740355|NCT03495154|565796895|FG000|Overall Study|Death|2|||
156740356|NCT03495154|565796895|FG000|Overall Study|Lost to Follow-up|16|||
156740357|NCT03495154|565796895|FG000|Overall Study|Withdrawal by Subject|2|||
156740358|NCT03495154|565796895|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
156740359|NCT04852679|565796898|FG000|Main Intervention Period|Withdrawal by Subject|3|||
156740360|NCT04852679|565796898|FG000|Main Intervention Period|Adverse Event|1|||
156740361|NCT04852679|565796898|FG000|Main Intervention Period|Progressive Disease|16|||
156740362|NCT04852679|565796898|FG000|Main Intervention Period|Refused study visit|1|||
156740363|NCT04852679|565796898|FG000|Independent Injection Period|Missed study visit|1|||
156740364|NCT02000882|565798664|FG000|Overall Study|Adverse Event|3|||
156740365|NCT02000882|565798664|FG000|Overall Study|Physician Decision|2|||
156740366|NCT02000882|565798664|FG000|Overall Study|Withdrawal by Subject|1|||
156740367|NCT02417961|565798668|FG000|Overall Study|Adverse Event|1|||
156740368|NCT02417961|565798668|FG000|Overall Study|Lost to Follow-up|1|||
156740369|NCT02417961|565798668|FG000|Overall Study|Withdrawal by Subject|2|||
156740370|NCT01390428|565798669|FG000|Overall Study|Elective Surgery|0|||
156740371|NCT01390428|565798670|FG001|Overall Study|Elective Surgery|0|||
156740372|NCT01390428|565798671|FG002|Overall Study|Elective Surgery|0|||
156740373|NCT01390428|565798672|FG003|Overall Study|Elective Surgery|0|||
156740374|NCT01390428|565798673|FG004|Overall Study|Elective Surgery|1|||
156740375|NCT01390428|565798674|FG005|Overall Study|Elective Surgery|0|||
156740376|NCT01390428|565798669|FG000|Overall Study|Withdrawal by Subject|0|||
156740377|NCT01390428|565798670|FG001|Overall Study|Withdrawal by Subject|0|||
156740378|NCT01390428|565798671|FG002|Overall Study|Withdrawal by Subject|1|||
156740379|NCT01390428|565798672|FG003|Overall Study|Withdrawal by Subject|0|||
156740380|NCT01390428|565798673|FG004|Overall Study|Withdrawal by Subject|0|||
156740381|NCT01390428|565798674|FG005|Overall Study|Withdrawal by Subject|0|||
156797598|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797599|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
157218574|NCT04480463|567547466|FG001|Overall Study|Adverse Event|8|||
157218575|NCT04480463|567547465|FG000|Overall Study|Lost to Follow-up|3|||
157218576|NCT04480463|567547466|FG001|Overall Study|Lost to Follow-up|2|||
156740382|NCT05079750|565798675|FG000|Overall Study|Lost to Follow-up|0|||
156740383|NCT05079750|565798676|FG001|Overall Study|Lost to Follow-up|0|||
156740384|NCT05079750|565798677|FG002|Overall Study|Lost to Follow-up|1|||
156740385|NCT05091346|565798680|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
156740386|NCT05091346|565798681|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
156740387|NCT05091346|565798682|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
156740388|NCT05091346|565798683|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
156740389|NCT05091346|565798684|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
156740390|NCT05091346|565798680|FG000|Overall Study|Death|6|||
156740391|NCT05091346|565798681|FG001|Overall Study|Death|5|||
157218577|NCT04480463|567547465|FG000|Overall Study|Physician Decision|2|||
156740392|NCT05091346|565798682|FG002|Overall Study|Death|8|||
156740393|NCT05091346|565798683|FG003|Overall Study|Death|16|||
156740394|NCT05091346|565798684|FG004|Overall Study|Death|26|||
156740395|NCT05091346|565798680|FG000|Overall Study|Lost to Follow-up|0|||
156740396|NCT05091346|565798681|FG001|Overall Study|Lost to Follow-up|0|||
156740397|NCT05091346|565798682|FG002|Overall Study|Lost to Follow-up|0|||
156740398|NCT05091346|565798683|FG003|Overall Study|Lost to Follow-up|1|||
156740399|NCT05091346|565798684|FG004|Overall Study|Lost to Follow-up|0|||
156740400|NCT05091346|565798680|FG000|Overall Study|Withdrawal by Subject|0|||
156740401|NCT05091346|565798681|FG001|Overall Study|Withdrawal by Subject|1|||
156740402|NCT05091346|565798682|FG002|Overall Study|Withdrawal by Subject|2|||
156740403|NCT05091346|565798683|FG003|Overall Study|Withdrawal by Subject|2|||
156740404|NCT05091346|565798684|FG004|Overall Study|Withdrawal by Subject|1|||
156740405|NCT05128773|565798696|FG000|Overall Study|Sponsor decision to terminate study|3|||
156740406|NCT04250714|565798697|FG000|Overall Study|Treatment - withdrawal by subject|14|||
156740407|NCT04250714|565798697|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
156740408|NCT04250714|565798697|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
156740409|NCT04250714|565798697|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
156740410|NCT04250714|565798697|FG000|Overall Study|Treatment - Death|1|||
156740411|NCT04250714|565798697|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
156740412|NCT04250714|565798697|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
156740413|NCT04250714|565798697|FG000|Overall Study|Attempt|2|||
156740414|NCT04250714|565798697|FG000|Overall Study|Intent|7|||
156740415|NCT04697056|565798698|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
156740416|NCT04697056|565798699|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
156740417|NCT03617861|565798700|FG000|Second Intervention (1 Day)|Adverse Event|0|||
156740418|NCT03617861|565798701|FG001|Second Intervention (1 Day)|Adverse Event|0|||
156740419|NCT03617861|565798702|FG002|Second Intervention (1 Day)|Adverse Event|1|||
156740420|NCT03617861|565798703|FG003|Second Intervention (1 Day)|Adverse Event|0|||
156740421|NCT01702532|565798704|FG000|Overall Study|Adverse Event|0|||
156740422|NCT01702532|565798705|FG001|Overall Study|Adverse Event|1|||
156740423|NCT00623597|565798706|FG000|Overall Study|Failed to return|1|||
156740424|NCT00623597|565798707|FG001|Overall Study|Failed to return|0|||
156740425|NCT01451164|565798708|FG000|Overall Study|Adverse Event|19|||
156740426|NCT01451164|565798709|FG001|Overall Study|Adverse Event|12|||
156740427|NCT01451164|565798710|FG002|Overall Study|Adverse Event|18|||
156740428|NCT01451164|565798711|FG003|Overall Study|Adverse Event|21|||
156740429|NCT01451164|565798708|FG000|Overall Study|Withdrawal Criteria|1|||
156740430|NCT01451164|565798709|FG001|Overall Study|Withdrawal Criteria|1|||
156740431|NCT01451164|565798710|FG002|Overall Study|Withdrawal Criteria|1|||
156740432|NCT01451164|565798711|FG003|Overall Study|Withdrawal Criteria|1|||
156740433|NCT01451164|565798708|FG000|Overall Study|Physician Decision|2|||
156740434|NCT01451164|565798709|FG001|Overall Study|Physician Decision|0|||
156740435|NCT01451164|565798710|FG002|Overall Study|Physician Decision|1|||
156740436|NCT01451164|565798711|FG003|Overall Study|Physician Decision|0|||
156740437|NCT01451164|565798708|FG000|Overall Study|Withdrawal by Subject|14|||
156740438|NCT01451164|565798709|FG001|Overall Study|Withdrawal by Subject|11|||
156740439|NCT01451164|565798710|FG002|Overall Study|Withdrawal by Subject|16|||
156740440|NCT01451164|565798711|FG003|Overall Study|Withdrawal by Subject|17|||
156740441|NCT01451164|565798708|FG000|Overall Study|Protocol Violation|0|||
156740442|NCT01451164|565798709|FG001|Overall Study|Protocol Violation|1|||
156740443|NCT01451164|565798710|FG002|Overall Study|Protocol Violation|0|||
156740444|NCT01451164|565798711|FG003|Overall Study|Protocol Violation|0|||
156740445|NCT01451164|565798708|FG000|Overall Study|Lack of Efficacy|7|||
156740446|NCT01451164|565798709|FG001|Overall Study|Lack of Efficacy|9|||
156740447|NCT01451164|565798710|FG002|Overall Study|Lack of Efficacy|9|||
156740448|NCT01451164|565798711|FG003|Overall Study|Lack of Efficacy|7|||
156797600|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797601|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797602|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
156797603|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
156797604|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797605|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
156797606|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797607|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156740449|NCT00345878|565798714|FG000|Overall Study|Adverse Event|1|||
156740450|NCT00345878|565798715|FG001|Overall Study|Adverse Event|0|||
156740451|NCT00345878|565798714|FG000|Overall Study|Lost to Follow-up|2|||
156740452|NCT00345878|565798715|FG001|Overall Study|Lost to Follow-up|1|||
156740453|NCT00345878|565798714|FG000|Overall Study|Other|1|||
156740454|NCT00345878|565798715|FG001|Overall Study|Other|0|||
156740455|NCT00308750|565798716|FG000|Overall Study|Adverse Event|9|||
156740456|NCT00308750|565798717|FG001|Overall Study|Adverse Event|9|||
156740457|NCT00308750|565798718|FG002|Overall Study|Adverse Event|13|||
156740458|NCT00308750|565798716|FG000|Overall Study|Withdrawal by Subject|6|||
156740459|NCT00308750|565798717|FG001|Overall Study|Withdrawal by Subject|2|||
156740460|NCT00308750|565798718|FG002|Overall Study|Withdrawal by Subject|3|||
156740461|NCT00308750|565798716|FG000|Overall Study|Physician Decision|3|||
156740462|NCT00308750|565798717|FG001|Overall Study|Physician Decision|4|||
156740463|NCT00308750|565798718|FG002|Overall Study|Physician Decision|3|||
156740464|NCT00308750|565798716|FG000|Overall Study|Sponsor Decision|1|||
156740465|NCT00308750|565798717|FG001|Overall Study|Sponsor Decision|0|||
156740466|NCT00308750|565798718|FG002|Overall Study|Sponsor Decision|0|||
156740467|NCT00308750|565798716|FG000|Overall Study|Disease Progression|47|||
156740468|NCT00308750|565798717|FG001|Overall Study|Disease Progression|24|||
156740469|NCT00308750|565798718|FG002|Overall Study|Disease Progression|28|||
156740470|NCT00308750|565798716|FG000|Overall Study|Unrelated Complication|3|||
156740471|NCT00308750|565798717|FG001|Overall Study|Unrelated Complication|0|||
156740472|NCT00308750|565798718|FG002|Overall Study|Unrelated Complication|1|||
156740473|NCT00308750|565798716|FG000|Overall Study|Death|1|||
156740474|NCT00308750|565798717|FG001|Overall Study|Death|0|||
156740475|NCT00308750|565798718|FG002|Overall Study|Death|1|||
156740476|NCT00308750|565798716|FG000|Overall Study|Protocol Violation|1|||
156740477|NCT00308750|565798717|FG001|Overall Study|Protocol Violation|0|||
156740478|NCT00308750|565798718|FG002|Overall Study|Protocol Violation|0|||
156740479|NCT00308750|565798716|FG000|Overall Study|New Primary Disease Identified|1|||
156740480|NCT00308750|565798717|FG001|Overall Study|New Primary Disease Identified|1|||
156740481|NCT00308750|565798718|FG002|Overall Study|New Primary Disease Identified|0|||
156740482|NCT01358578|565798719|FG000|Induction Period|Adverse Event|2|||
156740483|NCT01358578|565798720|FG001|Induction Period|Adverse Event|4|||
156740484|NCT01358578|565798721|FG002|Induction Period|Adverse Event|2|||
156740485|NCT01358578|565798722|FG003|Induction Period|Adverse Event|6|||
156740486|NCT01358578|565798723|FG004|Induction Period|Adverse Event|0|||
156740487|NCT01358578|565798724|FG005|Induction Period|Adverse Event|0|||
156740488|NCT01358578|565798719|FG000|Induction Period|Lack of Efficacy|0|||
156740489|NCT01358578|565798720|FG001|Induction Period|Lack of Efficacy|0|||
156740490|NCT01358578|565798721|FG002|Induction Period|Lack of Efficacy|9|||
156740491|NCT01358578|565798722|FG003|Induction Period|Lack of Efficacy|1|||
156740492|NCT01358578|565798723|FG004|Induction Period|Lack of Efficacy|0|||
156740493|NCT01358578|565798724|FG005|Induction Period|Lack of Efficacy|0|||
156740494|NCT01358578|565798719|FG000|Induction Period|Lost to Follow-up|0|||
156740495|NCT01358578|565798720|FG001|Induction Period|Lost to Follow-up|0|||
156740496|NCT01358578|565798721|FG002|Induction Period|Lost to Follow-up|1|||
156740497|NCT01358578|565798722|FG003|Induction Period|Lost to Follow-up|4|||
156740498|NCT01358578|565798723|FG004|Induction Period|Lost to Follow-up|0|||
156740499|NCT01358578|565798724|FG005|Induction Period|Lost to Follow-up|0|||
156740500|NCT01358578|565798719|FG000|Induction Period|Physician Decision|2|||
156740501|NCT01358578|565798720|FG001|Induction Period|Physician Decision|1|||
156740502|NCT01358578|565798721|FG002|Induction Period|Physician Decision|2|||
156740503|NCT01358578|565798722|FG003|Induction Period|Physician Decision|0|||
156740504|NCT01358578|565798723|FG004|Induction Period|Physician Decision|0|||
156740505|NCT01358578|565798724|FG005|Induction Period|Physician Decision|0|||
156740506|NCT01358578|565798719|FG000|Induction Period|Protocol Deviation|3|||
156877675|NCT05422638|566309887|FG000|Overall Study|Withdrawal by Subject|8|||
156877676|NCT05422638|566309888|FG001|Overall Study|Withdrawal by Subject|2|||
156740507|NCT01358578|565798720|FG001|Induction Period|Protocol Deviation|5|||
156740508|NCT01358578|565798721|FG002|Induction Period|Protocol Deviation|0|||
157142843|NCT02128490|567271121|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156740509|NCT01358578|565798722|FG003|Induction Period|Protocol Deviation|3|||
156740510|NCT01358578|565798723|FG004|Induction Period|Protocol Deviation|0|||
156740511|NCT01358578|565798724|FG005|Induction Period|Protocol Deviation|0|||
156740512|NCT01358578|565798719|FG000|Induction Period|technical problems|0|||
156740513|NCT01358578|565798720|FG001|Induction Period|technical problems|0|||
156740514|NCT01358578|565798721|FG002|Induction Period|technical problems|1|||
156740515|NCT01358578|565798722|FG003|Induction Period|technical problems|1|||
156740516|NCT01358578|565798723|FG004|Induction Period|technical problems|0|||
156740517|NCT01358578|565798724|FG005|Induction Period|technical problems|0|||
156740518|NCT01358578|565798719|FG000|Induction Period|Withdrawal by Subject|5|||
156740519|NCT01358578|565798720|FG001|Induction Period|Withdrawal by Subject|5|||
156740520|NCT01358578|565798721|FG002|Induction Period|Withdrawal by Subject|10|||
156740521|NCT01358578|565798722|FG003|Induction Period|Withdrawal by Subject|6|||
156740522|NCT01358578|565798723|FG004|Induction Period|Withdrawal by Subject|0|||
156740523|NCT01358578|565798724|FG005|Induction Period|Withdrawal by Subject|0|||
156740524|NCT01358578|565798719|FG000|Maintenance Period|Adverse Event|2|||
156740525|NCT01358578|565798720|FG001|Maintenance Period|Adverse Event|7|||
156740526|NCT01358578|565798721|FG002|Maintenance Period|Adverse Event|0|||
156740527|NCT01358578|565798722|FG003|Maintenance Period|Adverse Event|6|||
156740528|NCT01358578|565798723|FG004|Maintenance Period|Adverse Event|4|||
156740529|NCT01358578|565798724|FG005|Maintenance Period|Adverse Event|3|||
156740530|NCT01358578|565798719|FG000|Maintenance Period|Lack of Efficacy|10|||
156740531|NCT01358578|565798720|FG001|Maintenance Period|Lack of Efficacy|2|||
156740532|NCT01358578|565798721|FG002|Maintenance Period|Lack of Efficacy|0|||
156740533|NCT01358578|565798722|FG003|Maintenance Period|Lack of Efficacy|11|||
156740534|NCT01358578|565798723|FG004|Maintenance Period|Lack of Efficacy|3|||
156740535|NCT01358578|565798724|FG005|Maintenance Period|Lack of Efficacy|0|||
156740536|NCT01358578|565798719|FG000|Maintenance Period|Lost to Follow-up|4|||
156740537|NCT01358578|565798720|FG001|Maintenance Period|Lost to Follow-up|0|||
156740538|NCT01358578|565798721|FG002|Maintenance Period|Lost to Follow-up|0|||
156740539|NCT01358578|565798722|FG003|Maintenance Period|Lost to Follow-up|5|||
156740540|NCT01358578|565798723|FG004|Maintenance Period|Lost to Follow-up|1|||
156740541|NCT01358578|565798724|FG005|Maintenance Period|Lost to Follow-up|1|||
156740542|NCT01358578|565798719|FG000|Maintenance Period|Non-compliance with study treatment|3|||
156740543|NCT01358578|565798720|FG001|Maintenance Period|Non-compliance with study treatment|1|||
156740544|NCT01358578|565798721|FG002|Maintenance Period|Non-compliance with study treatment|0|||
156740545|NCT01358578|565798722|FG003|Maintenance Period|Non-compliance with study treatment|2|||
156740546|NCT01358578|565798723|FG004|Maintenance Period|Non-compliance with study treatment|1|||
156740547|NCT01358578|565798724|FG005|Maintenance Period|Non-compliance with study treatment|2|||
156740548|NCT01358578|565798719|FG000|Maintenance Period|Physician Decision|0|||
156740549|NCT01358578|565798720|FG001|Maintenance Period|Physician Decision|1|||
156740550|NCT01358578|565798721|FG002|Maintenance Period|Physician Decision|0|||
156740551|NCT01358578|565798722|FG003|Maintenance Period|Physician Decision|1|||
156740552|NCT01358578|565798723|FG004|Maintenance Period|Physician Decision|0|||
156740553|NCT01358578|565798724|FG005|Maintenance Period|Physician Decision|0|||
156740554|NCT01358578|565798719|FG000|Maintenance Period|Pregnancy|1|||
156740555|NCT01358578|565798720|FG001|Maintenance Period|Pregnancy|0|||
156740556|NCT01358578|565798721|FG002|Maintenance Period|Pregnancy|0|||
156740557|NCT01358578|565798722|FG003|Maintenance Period|Pregnancy|0|||
156740558|NCT01358578|565798723|FG004|Maintenance Period|Pregnancy|0|||
156740559|NCT01358578|565798724|FG005|Maintenance Period|Pregnancy|0|||
156740560|NCT01358578|565798719|FG000|Maintenance Period|Protocol deviation|7|||
156740561|NCT01358578|565798720|FG001|Maintenance Period|Protocol deviation|4|||
156740562|NCT01358578|565798721|FG002|Maintenance Period|Protocol deviation|0|||
156740563|NCT01358578|565798722|FG003|Maintenance Period|Protocol deviation|2|||
156740564|NCT01358578|565798723|FG004|Maintenance Period|Protocol deviation|2|||
156740565|NCT01358578|565798724|FG005|Maintenance Period|Protocol deviation|2|||
156740566|NCT01358578|565798719|FG000|Maintenance Period|Withdrawal by Subject|12|||
156740567|NCT01358578|565798720|FG001|Maintenance Period|Withdrawal by Subject|7|||
156740568|NCT01358578|565798721|FG002|Maintenance Period|Withdrawal by Subject|2|||
156740569|NCT01358578|565798722|FG003|Maintenance Period|Withdrawal by Subject|15|||
156740570|NCT01358578|565798723|FG004|Maintenance Period|Withdrawal by Subject|6|||
156740571|NCT01358578|565798724|FG005|Maintenance Period|Withdrawal by Subject|3|||
156740572|NCT01358578|565798719|FG000|Follow-up Period|Adverse Event|1|||
156740573|NCT01358578|565798720|FG001|Follow-up Period|Adverse Event|1|||
156740574|NCT01358578|565798721|FG002|Follow-up Period|Adverse Event|0|||
156740575|NCT01358578|565798722|FG003|Follow-up Period|Adverse Event|0|||
156740576|NCT01358578|565798723|FG004|Follow-up Period|Adverse Event|0|||
156740577|NCT01358578|565798724|FG005|Follow-up Period|Adverse Event|0|||
156740578|NCT01358578|565798719|FG000|Follow-up Period|Lack of Efficacy|3|||
156740579|NCT01358578|565798720|FG001|Follow-up Period|Lack of Efficacy|0|||
156740580|NCT01358578|565798721|FG002|Follow-up Period|Lack of Efficacy|4|||
156740581|NCT01358578|565798722|FG003|Follow-up Period|Lack of Efficacy|1|||
156740582|NCT01358578|565798723|FG004|Follow-up Period|Lack of Efficacy|0|||
156740583|NCT01358578|565798724|FG005|Follow-up Period|Lack of Efficacy|0|||
156740584|NCT01358578|565798719|FG000|Follow-up Period|Lost to Follow-up|0|||
156740585|NCT01358578|565798720|FG001|Follow-up Period|Lost to Follow-up|1|||
156740586|NCT01358578|565798721|FG002|Follow-up Period|Lost to Follow-up|0|||
156740587|NCT01358578|565798722|FG003|Follow-up Period|Lost to Follow-up|4|||
156740588|NCT01358578|565798723|FG004|Follow-up Period|Lost to Follow-up|0|||
156740589|NCT01358578|565798724|FG005|Follow-up Period|Lost to Follow-up|0|||
156740590|NCT01358578|565798719|FG000|Follow-up Period|non- compliance with study treatment|1|||
156740591|NCT01358578|565798720|FG001|Follow-up Period|non- compliance with study treatment|0|||
156740592|NCT01358578|565798721|FG002|Follow-up Period|non- compliance with study treatment|0|||
156740593|NCT01358578|565798722|FG003|Follow-up Period|non- compliance with study treatment|0|||
156740594|NCT01358578|565798723|FG004|Follow-up Period|non- compliance with study treatment|0|||
156740595|NCT01358578|565798724|FG005|Follow-up Period|non- compliance with study treatment|0|||
156740596|NCT01358578|565798719|FG000|Follow-up Period|Pregnancy|1|||
156740597|NCT01358578|565798720|FG001|Follow-up Period|Pregnancy|0|||
156740598|NCT01358578|565798721|FG002|Follow-up Period|Pregnancy|0|||
156740599|NCT01358578|565798722|FG003|Follow-up Period|Pregnancy|0|||
156740600|NCT01358578|565798723|FG004|Follow-up Period|Pregnancy|0|||
156740601|NCT01358578|565798724|FG005|Follow-up Period|Pregnancy|0|||
156740602|NCT01358578|565798719|FG000|Follow-up Period|Withdrawal by Subject|3|||
156740603|NCT01358578|565798720|FG001|Follow-up Period|Withdrawal by Subject|3|||
156740604|NCT01358578|565798721|FG002|Follow-up Period|Withdrawal by Subject|1|||
156740605|NCT01358578|565798722|FG003|Follow-up Period|Withdrawal by Subject|12|||
156740606|NCT01358578|565798723|FG004|Follow-up Period|Withdrawal by Subject|0|||
156740607|NCT01358578|565798724|FG005|Follow-up Period|Withdrawal by Subject|0|||
156740608|NCT01358578|565798719|FG000|Follow-up Period|Physician Decision|1|||
156740609|NCT01358578|565798720|FG001|Follow-up Period|Physician Decision|1|||
156740610|NCT01358578|565798721|FG002|Follow-up Period|Physician Decision|0|||
156740611|NCT01358578|565798722|FG003|Follow-up Period|Physician Decision|2|||
156740612|NCT01358578|565798723|FG004|Follow-up Period|Physician Decision|0|||
156740613|NCT01358578|565798724|FG005|Follow-up Period|Physician Decision|0|||
156740614|NCT01643798|565798725|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
156740615|NCT01643798|565798726|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
156740616|NCT03605849|565798727|FG000|Overall Study|Adverse Event|20|||
156740617|NCT03605849|565798728|FG001|Overall Study|Adverse Event|21|||
156740618|NCT03605849|565798729|FG002|Overall Study|Adverse Event|29|||
156740619|NCT03605849|565798730|FG003|Overall Study|Adverse Event|11|||
156740620|NCT03605849|565798727|FG000|Overall Study|Lack of Efficacy|4|||
156740621|NCT03605849|565798728|FG001|Overall Study|Lack of Efficacy|7|||
156740622|NCT03605849|565798729|FG002|Overall Study|Lack of Efficacy|9|||
156740623|NCT03605849|565798730|FG003|Overall Study|Lack of Efficacy|2|||
156740624|NCT03605849|565798727|FG000|Overall Study|Lost to Follow-up|8|||
156740625|NCT03605849|565798728|FG001|Overall Study|Lost to Follow-up|8|||
156740626|NCT03605849|565798729|FG002|Overall Study|Lost to Follow-up|14|||
156740627|NCT03605849|565798730|FG003|Overall Study|Lost to Follow-up|11|||
157020433|NCT05034952|566828433|FG002|Overall Study|Other|0|||
157218578|NCT04480463|567547466|FG001|Overall Study|Physician Decision|5|||
157218579|NCT04480463|567547465|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
157218580|NCT04480463|567547466|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
157218581|NCT04480463|567547465|FG000|Overall Study|Protocol Violation|2|||
157218582|NCT04480463|567547466|FG001|Overall Study|Protocol Violation|1|||
157218583|NCT04480463|567547465|FG000|Overall Study|Withdrawal by Subject|6|||
157218584|NCT04480463|567547466|FG001|Overall Study|Withdrawal by Subject|7|||
157218585|NCT04480463|567547465|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
157218586|NCT04480463|567547466|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
157218587|NCT04480463|567547465|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
157218588|NCT04480463|567547466|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
157218589|NCT04480463|567547465|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
157218590|NCT04480463|567547466|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
157218591|NCT04480463|567547465|FG000|Overall Study|Other|6|||
157218592|NCT04480463|567547466|FG001|Overall Study|Other|4|||
157218593|NCT01769378|567547467|FG000|Overall Study|Adverse Event|10|||
156740628|NCT03605849|565798727|FG000|Overall Study|Non-compliance With IMP|6|||
156740629|NCT03605849|565798728|FG001|Overall Study|Non-compliance With IMP|5|||
156740630|NCT03605849|565798729|FG002|Overall Study|Non-compliance With IMP|2|||
156740631|NCT03605849|565798730|FG003|Overall Study|Non-compliance With IMP|1|||
156740632|NCT03605849|565798727|FG000|Overall Study|Protocol Deviation|1|||
156740633|NCT03605849|565798728|FG001|Overall Study|Protocol Deviation|2|||
156740634|NCT03605849|565798729|FG002|Overall Study|Protocol Deviation|1|||
156740635|NCT03605849|565798730|FG003|Overall Study|Protocol Deviation|3|||
156740636|NCT03605849|565798727|FG000|Overall Study|Withdrawal by Subject|33|||
156740637|NCT03605849|565798728|FG001|Overall Study|Withdrawal by Subject|28|||
156740638|NCT03605849|565798729|FG002|Overall Study|Withdrawal by Subject|30|||
156740639|NCT03605849|565798730|FG003|Overall Study|Withdrawal by Subject|28|||
156740640|NCT03605849|565798727|FG000|Overall Study|Site Terminated by Sponsor|0|||
156740641|NCT03605849|565798728|FG001|Overall Study|Site Terminated by Sponsor|0|||
156740642|NCT03605849|565798729|FG002|Overall Study|Site Terminated by Sponsor|0|||
156740643|NCT03605849|565798730|FG003|Overall Study|Site Terminated by Sponsor|1|||
156740644|NCT03605849|565798727|FG000|Overall Study|Physician Decision|2|||
156740645|NCT03605849|565798728|FG001|Overall Study|Physician Decision|1|||
156740646|NCT03605849|565798729|FG002|Overall Study|Physician Decision|2|||
156740647|NCT03605849|565798730|FG003|Overall Study|Physician Decision|1|||
156740648|NCT03605849|565798727|FG000|Overall Study|Enrolled, but not Treated|2|||
156740649|NCT03605849|565798728|FG001|Overall Study|Enrolled, but not Treated|2|||
156740650|NCT03605849|565798729|FG002|Overall Study|Enrolled, but not Treated|3|||
156740651|NCT03605849|565798730|FG003|Overall Study|Enrolled, but not Treated|2|||
156740652|NCT03605849|565798727|FG000|Overall Study|Other (COVID-19 Related)|0|||
156740653|NCT03605849|565798728|FG001|Overall Study|Other (COVID-19 Related)|1|||
156740654|NCT03605849|565798729|FG002|Overall Study|Other (COVID-19 Related)|1|||
156740655|NCT03605849|565798730|FG003|Overall Study|Other (COVID-19 Related)|0|||
156740656|NCT03605849|565798727|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
156740657|NCT03605849|565798728|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
156740658|NCT03605849|565798729|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
156740659|NCT03605849|565798730|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
156740660|NCT02045732|565798735|FG000|Overall Study|At the discretion of the investigator|1|||
156740661|NCT02045732|565798736|FG001|Overall Study|At the discretion of the investigator|1|||
156740662|NCT05014815|565798737|FG000|Overall Study|Death|63|||
156740663|NCT05014815|565798738|FG001|Overall Study|Death|70|||
156740664|NCT05014815|565798737|FG000|Overall Study|Withdrawal by Subject|10|||
156740665|NCT05014815|565798738|FG001|Overall Study|Withdrawal by Subject|10|||
156740666|NCT05014815|565798737|FG000|Overall Study|Lost to Follow-up|4|||
156740667|NCT05014815|565798738|FG001|Overall Study|Lost to Follow-up|2|||
156740668|NCT05014815|565798737|FG000|Overall Study|Physician Decision|2|||
156740669|NCT05014815|565798738|FG001|Overall Study|Physician Decision|4|||
156740670|NCT06303167|565798749|FG000|Overall Study|Ineligible|1|||
156740671|NCT06303167|565798749|FG000|Overall Study|Never start protocol therapy|2|||
156740672|NCT06303167|565798749|FG000|Overall Study|Disease progression|16|||
156740673|NCT00916344|565798750|FG000|Overall Study|Death|2|||
156740674|NCT00916344|565798750|FG000|Overall Study|ICD upgrade|1|||
156740675|NCT00916344|565798750|FG000|Overall Study|Drop-out|5|||
156740676|NCT03602391|565798751|FG000|Overall Study|COVID-19|7|||
156740677|NCT03602391|565798752|FG001|Overall Study|COVID-19|6|||
156740678|NCT01088243|565798760|FG000|Overall Study|Adverse Event|1|||
156740679|NCT01088243|565798761|FG001|Overall Study|Adverse Event|0|||
156740680|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
156740681|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740682|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
156740683|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
156740684|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740685|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
156740686|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Other|0|||
156740687|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Other|0|||
156740688|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Other|1|||
156740689|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Other|0|||
156740690|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Other|0|||
156740691|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Other|0|||
156740692|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740693|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
156740694|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740695|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740696|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740697|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
156740698|NCT02122770|565798764|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
156740699|NCT02122770|565798765|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
156740700|NCT02122770|565798766|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740701|NCT02122770|565798767|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
156740702|NCT02122770|565798768|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740703|NCT02122770|565798769|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
156740704|NCT02122770|565798764|FG000|Part B: Standard of Care|Adverse Event|0|||
156740705|NCT02122770|565798765|FG001|Part B: Standard of Care|Adverse Event|0|||
157020434|NCT05034952|566828434|FG003|Overall Study|Other|1|||
156740706|NCT02122770|565798766|FG002|Part B: Standard of Care|Adverse Event|0|||
156740707|NCT02122770|565798767|FG003|Part B: Standard of Care|Adverse Event|0|||
156740708|NCT02122770|565798768|FG004|Part B: Standard of Care|Adverse Event|4|||
156740709|NCT02122770|565798769|FG005|Part B: Standard of Care|Adverse Event|1|||
156740710|NCT02122770|565798764|FG000|Part B: Standard of Care|Other|0|||
156740711|NCT02122770|565798765|FG001|Part B: Standard of Care|Other|0|||
156740712|NCT02122770|565798766|FG002|Part B: Standard of Care|Other|0|||
156740713|NCT02122770|565798767|FG003|Part B: Standard of Care|Other|0|||
156740714|NCT02122770|565798768|FG004|Part B: Standard of Care|Other|0|||
156740715|NCT02122770|565798769|FG005|Part B: Standard of Care|Other|2|||
156740716|NCT02122770|565798764|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
156740717|NCT02122770|565798765|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
156740718|NCT02122770|565798766|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
156740719|NCT02122770|565798767|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
156740720|NCT02122770|565798768|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
156740721|NCT02122770|565798769|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
156740722|NCT02122770|565798764|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740723|NCT02122770|565798765|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740724|NCT02122770|565798766|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740725|NCT02122770|565798767|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740726|NCT02122770|565798768|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
156740727|NCT02122770|565798769|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
156740728|NCT02122770|565798764|FG000|Part B: Standard of Care|Progressive Disease|0|||
156740729|NCT02122770|565798765|FG001|Part B: Standard of Care|Progressive Disease|0|||
156740730|NCT02122770|565798766|FG002|Part B: Standard of Care|Progressive Disease|0|||
156740731|NCT02122770|565798767|FG003|Part B: Standard of Care|Progressive Disease|0|||
156740732|NCT02122770|565798768|FG004|Part B: Standard of Care|Progressive Disease|10|||
156740733|NCT02122770|565798769|FG005|Part B: Standard of Care|Progressive Disease|8|||
156740734|NCT04495816|565798772|FG000|Overall Study|Lost to Follow-up|10|||
156740735|NCT04495816|565798773|FG001|Overall Study|Lost to Follow-up|4|||
156740736|NCT04495816|565798772|FG000|Overall Study|Withdrawal by Subject|3|||
156740737|NCT04495816|565798773|FG001|Overall Study|Withdrawal by Subject|5|||
156740738|NCT01210495|565798776|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
156740739|NCT01210495|565798777|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
156740740|NCT01210495|565798778|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
156740741|NCT01210495|565798779|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
156740742|NCT01210495|565798776|FG000|Overall Study|Death|14|||
156740743|NCT01210495|565798777|FG001|Overall Study|Death|7|||
156740744|NCT01210495|565798778|FG002|Overall Study|Death|112|||
156740745|NCT01210495|565798779|FG003|Overall Study|Death|54|||
156740746|NCT01210495|565798776|FG000|Overall Study|Study Terminated by Sponsor|0|||
156740747|NCT01210495|565798777|FG001|Overall Study|Study Terminated by Sponsor|0|||
156740748|NCT01210495|565798778|FG002|Overall Study|Study Terminated by Sponsor|4|||
156740749|NCT01210495|565798779|FG003|Overall Study|Study Terminated by Sponsor|11|||
156740750|NCT01210495|565798776|FG000|Overall Study|Lost to Follow-up|0|||
156740751|NCT01210495|565798777|FG001|Overall Study|Lost to Follow-up|0|||
156740752|NCT01210495|565798778|FG002|Overall Study|Lost to Follow-up|1|||
156740753|NCT01210495|565798779|FG003|Overall Study|Lost to Follow-up|1|||
156740754|NCT01210495|565798776|FG000|Overall Study|Other unspecified|0|||
156740755|NCT01210495|565798777|FG001|Overall Study|Other unspecified|0|||
156740756|NCT01210495|565798778|FG002|Overall Study|Other unspecified|6|||
156740757|NCT01210495|565798779|FG003|Overall Study|Other unspecified|0|||
156740758|NCT01384019|565798780|FG000|Overall Study|Withdrawal by Subject|3|||
156740759|NCT01384019|565798781|FG001|Overall Study|Withdrawal by Subject|0|||
156740760|NCT01384019|565798780|FG000|Overall Study|Death|1|||
156740761|NCT01384019|565798781|FG001|Overall Study|Death|0|||
156740762|NCT01384019|565798780|FG000|Overall Study|MRI refusal|6|||
156740763|NCT01384019|565798781|FG001|Overall Study|MRI refusal|6|||
156740764|NCT01826370|565798786|FG000|Overall Study|Protocol Violation|6|||
156740765|NCT01826370|565798786|FG000|Overall Study|Lost to Follow-up|12|||
156740766|NCT01826370|565798786|FG000|Overall Study|Other reason not defined above|2|||
156740767|NCT04416737|565798787|FG000|Week 1 (First Injection)|Physician Decision|0|||
156740768|NCT04416737|565798788|FG001|Week 1 (First Injection)|Physician Decision|1|||
156740769|NCT03332628|565798789|FG000|Overall Study|Physician Decision|2|||
156740770|NCT04489381|565798801|FG000|Overall Study|Lost to Follow-up|2|||
156740771|NCT04489381|565798802|FG001|Overall Study|Lost to Follow-up|3|||
156740772|NCT04489381|565798801|FG000|Overall Study|Withdrawal by Subject|1|||
156740773|NCT04489381|565798802|FG001|Overall Study|Withdrawal by Subject|0|||
156740774|NCT01500213|565798803|FG000|Overall Study|Adverse Event|35|||
156740775|NCT01500213|565798804|FG001|Overall Study|Adverse Event|35|||
156740776|NCT01500213|565798803|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
156740777|NCT01500213|565798804|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
156740778|NCT01500213|565798803|FG000|Overall Study|Withdrawal by Subject|28|||
156740779|NCT01500213|565798804|FG001|Overall Study|Withdrawal by Subject|37|||
156740780|NCT01500213|565798803|FG000|Overall Study|Death|7|||
156740781|NCT01500213|565798804|FG001|Overall Study|Death|3|||
156740782|NCT01500213|565798803|FG000|Overall Study|Disease Progression|13|||
156740783|NCT01500213|565798804|FG001|Overall Study|Disease Progression|21|||
156740784|NCT01500213|565798803|FG000|Overall Study|Protocol Violation|19|||
156740785|NCT01500213|565798804|FG001|Overall Study|Protocol Violation|19|||
156740786|NCT01500213|565798803|FG000|Overall Study|Physician Decision|12|||
156740787|NCT01500213|565798804|FG001|Overall Study|Physician Decision|10|||
156740788|NCT01500213|565798803|FG000|Overall Study|Lack of Efficacy|9|||
156740789|NCT01500213|565798804|FG001|Overall Study|Lack of Efficacy|7|||
156740790|NCT01500213|565798803|FG000|Overall Study|Lost to Follow-up|3|||
156740791|NCT01500213|565798804|FG001|Overall Study|Lost to Follow-up|6|||
156740792|NCT01500213|565798803|FG000|Overall Study|Other Reasons|7|||
156740793|NCT01500213|565798804|FG001|Overall Study|Other Reasons|5|||
156740794|NCT00785213|565798805|FG000|Quinine Sulfate Alone|Adverse Event|4|||
156740795|NCT00785213|565798805|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
156740796|NCT02386345|565798806|FG000|Overall Study|Not treated|14|||
156740797|NCT02386345|565798806|FG000|Overall Study|Lost to Follow-up|1|||
156740798|NCT02386345|565798806|FG000|Overall Study|Adverse Event|5|||
156740799|NCT02386345|565798806|FG000|Overall Study|Repeat Procedure|10|||
156740800|NCT02386345|565798806|FG000|Overall Study|Did not complete 12-month follow-up|72|||
156740801|NCT01043705|565798809|FG000|Overall Study|Death|28|||
156740802|NCT01043705|565798810|FG001|Overall Study|Death|60|||
156740803|NCT01043705|565798811|FG002|Overall Study|Death|26|||
156740804|NCT01043705|565798809|FG000|Overall Study|Lost to Follow-up|27|||
156740805|NCT01043705|565798810|FG001|Overall Study|Lost to Follow-up|12|||
156740806|NCT01043705|565798811|FG002|Overall Study|Lost to Follow-up|0|||
156740807|NCT01043705|565798809|FG000|Overall Study|Multiple Reasons|4|||
156740808|NCT01043705|565798810|FG001|Overall Study|Multiple Reasons|7|||
156740809|NCT01043705|565798811|FG002|Overall Study|Multiple Reasons|0|||
156740810|NCT01043705|565798809|FG000|Overall Study|Protocol Violation|2|||
156740811|NCT01043705|565798810|FG001|Overall Study|Protocol Violation|1|||
156740812|NCT01043705|565798811|FG002|Overall Study|Protocol Violation|0|||
156740813|NCT01043705|565798809|FG000|Overall Study|Withdrawal by Subject|8|||
156740814|NCT01043705|565798810|FG001|Overall Study|Withdrawal by Subject|6|||
157218594|NCT01769378|567547468|FG001|Overall Study|Adverse Event|0|||
157218595|NCT01769378|567547467|FG000|Overall Study|Entry criteria not met|1|||
157218596|NCT01769378|567547468|FG001|Overall Study|Entry criteria not met|0|||
157218597|NCT01769378|567547467|FG000|Overall Study|Protocol Violation|1|||
157218598|NCT01769378|567547468|FG001|Overall Study|Protocol Violation|1|||
157218599|NCT01769378|567547467|FG000|Overall Study|Withdrawal by Subject|10|||
157218600|NCT01769378|567547468|FG001|Overall Study|Withdrawal by Subject|3|||
157218601|NCT01769378|567547467|FG000|Overall Study|Sponsor Decision|1|||
157218602|NCT01769378|567547468|FG001|Overall Study|Sponsor Decision|0|||
157218603|NCT01769378|567547467|FG000|Overall Study|Lost to Follow-up|2|||
157218604|NCT01769378|567547468|FG001|Overall Study|Lost to Follow-up|0|||
156740815|NCT01043705|565798811|FG002|Overall Study|Withdrawal by Subject|0|||
156740816|NCT01043705|565798809|FG000|Overall Study|Site Closure|8|||
156740817|NCT01043705|565798810|FG001|Overall Study|Site Closure|0|||
156740818|NCT01043705|565798811|FG002|Overall Study|Site Closure|0|||
156740819|NCT01043705|565798809|FG000|Overall Study|Subsequent Procedure|9|||
156740820|NCT01043705|565798810|FG001|Overall Study|Subsequent Procedure|24|||
156740821|NCT01043705|565798811|FG002|Overall Study|Subsequent Procedure|29|||
156740822|NCT01043705|565798809|FG000|Overall Study|Adverse Event|0|||
156740823|NCT01043705|565798810|FG001|Overall Study|Adverse Event|2|||
156740824|NCT01043705|565798811|FG002|Overall Study|Adverse Event|0|||
156740825|NCT01043705|565798809|FG000|Overall Study|Screen Fail|21|||
156740826|NCT01043705|565798810|FG001|Overall Study|Screen Fail|0|||
156797608|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797609|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
156797610|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797611|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797612|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797613|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797614|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797615|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797616|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797617|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797618|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156797619|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797620|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
157218605|NCT01977092|567547469|FG000|Overall Study|Death|3|||
157218606|NCT01977092|567547470|FG001|Overall Study|Death|4|||
156740827|NCT01043705|565798811|FG002|Overall Study|Screen Fail|0|||
156740828|NCT01043705|565798809|FG000|Overall Study|Other|0|||
156740829|NCT01043705|565798810|FG001|Overall Study|Other|19|||
156740830|NCT01043705|565798811|FG002|Overall Study|Other|25|||
156740831|NCT02003963|565798813|FG000|Overall Study|Lost to Follow-up|2|||
156740832|NCT02003963|565798814|FG001|Overall Study|Lost to Follow-up|1|||
157218607|NCT01977092|567547469|FG000|Overall Study|Lost to Follow-up|23|||
156740833|NCT00581542|565798815|FG000|Overall Study|they met an exclusion criteria|2|||
156740834|NCT00581542|565798816|FG001|Overall Study|they met an exclusion criteria|2|||
156740835|NCT00581542|565798815|FG000|Overall Study|Lost to Follow-up|9|||
156740836|NCT00581542|565798816|FG001|Overall Study|Lost to Follow-up|21|||
156740837|NCT00176644|565798817|FG000|Overall Study|Withdrawal by Subject|1|||
156740838|NCT01801280|565798818|FG000|Period 1|Withdrawal by Subject|0|||
156740839|NCT01801280|565798819|FG001|Period 1|Withdrawal by Subject|1|||
156740840|NCT01801280|565798820|FG002|Period 1|Withdrawal by Subject|0|||
156740841|NCT01801280|565798821|FG003|Period 1|Withdrawal by Subject|0|||
156740842|NCT01801280|565798818|FG000|Period 2|Withdrawal by Subject|1|||
156740843|NCT01801280|565798819|FG001|Period 2|Withdrawal by Subject|0|||
156740844|NCT01801280|565798820|FG002|Period 2|Withdrawal by Subject|0|||
156740845|NCT01801280|565798821|FG003|Period 2|Withdrawal by Subject|0|||
156740846|NCT01801280|565798818|FG000|Period 4|Protocol Violation|0|||
156740847|NCT01801280|565798819|FG001|Period 4|Protocol Violation|0|||
156740848|NCT01801280|565798820|FG002|Period 4|Protocol Violation|1|||
156740849|NCT01801280|565798821|FG003|Period 4|Protocol Violation|0|||
156740850|NCT03973918|565798822|FG000|Overall Study|Adverse Event|0|||
156740851|NCT03973918|565798823|FG001|Overall Study|Adverse Event|0|||
156740852|NCT03973918|565798824|FG002|Overall Study|Adverse Event|0|||
156740853|NCT03973918|565798825|FG003|Overall Study|Adverse Event|1|||
156740854|NCT03973918|565798822|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740855|NCT03973918|565798823|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
156740856|NCT03973918|565798824|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740857|NCT03973918|565798825|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
156740858|NCT04050124|565798830|FG000|Overall Study|Death|1|||
156740859|NCT04050124|565798831|FG001|Overall Study|Death|0|||
156740860|NCT00347919|565798838|FG000|Overall Study|Lost to Follow-up|11|||
156740861|NCT00347919|565798839|FG001|Overall Study|Lost to Follow-up|13|||
156740862|NCT00347919|565798840|FG002|Overall Study|Lost to Follow-up|0|||
156740863|NCT00347919|565798838|FG000|Overall Study|Withdrawal by Subject|6|||
156740864|NCT00347919|565798839|FG001|Overall Study|Withdrawal by Subject|8|||
156740865|NCT00347919|565798840|FG002|Overall Study|Withdrawal by Subject|0|||
156740866|NCT00347919|565798838|FG000|Overall Study|Physician Decision|1|||
156740867|NCT00347919|565798839|FG001|Overall Study|Physician Decision|1|||
156740868|NCT00347919|565798840|FG002|Overall Study|Physician Decision|0|||
156740869|NCT00347919|565798838|FG000|Overall Study|Sponsor terminated study|15|||
156740870|NCT00347919|565798839|FG001|Overall Study|Sponsor terminated study|10|||
156740871|NCT00347919|565798840|FG002|Overall Study|Sponsor terminated study|16|||
156740872|NCT00347919|565798838|FG000|Overall Study|Death|35|||
156740873|NCT00347919|565798839|FG001|Overall Study|Death|42|||
156740874|NCT00347919|565798840|FG002|Overall Study|Death|19|||
156740875|NCT00347919|565798838|FG000|Overall Study|Par. Started Other Treatment|1|||
156740876|NCT00347919|565798839|FG001|Overall Study|Par. Started Other Treatment|1|||
156740877|NCT00347919|565798840|FG002|Overall Study|Par. Started Other Treatment|1|||
156740878|NCT00347919|565798838|FG000|Overall Study|Missing|2|||
156740879|NCT00347919|565798839|FG001|Overall Study|Missing|1|||
156740880|NCT00347919|565798840|FG002|Overall Study|Missing|2|||
156740881|NCT04450407|565798841|FG000|Overall Study|Withdrawal by Subject|10|||
156740882|NCT04450407|565798842|FG001|Overall Study|Withdrawal by Subject|1|||
156740883|NCT04450407|565798843|FG002|Overall Study|Withdrawal by Subject|4|||
156740884|NCT04450407|565798841|FG000|Overall Study|Adverse Event|0|||
156740885|NCT04450407|565798842|FG001|Overall Study|Adverse Event|0|||
156740886|NCT04450407|565798843|FG002|Overall Study|Adverse Event|1|||
156740887|NCT04450407|565798841|FG000|Overall Study|Lost to Follow-up|1|||
156740888|NCT04450407|565798842|FG001|Overall Study|Lost to Follow-up|0|||
156740889|NCT04450407|565798843|FG002|Overall Study|Lost to Follow-up|0|||
156740890|NCT04450407|565798841|FG000|Overall Study|Physician Decision|0|||
156740891|NCT04450407|565798842|FG001|Overall Study|Physician Decision|0|||
156740892|NCT04450407|565798843|FG002|Overall Study|Physician Decision|1|||
157218608|NCT01977092|567547470|FG001|Overall Study|Lost to Follow-up|14|||
157218609|NCT01977092|567547469|FG000|Overall Study|Withdrawal by Subject|2|||
156740893|NCT04450407|565798841|FG000|Overall Study|Pregnancy|1|||
156740894|NCT04450407|565798842|FG001|Overall Study|Pregnancy|0|||
156740895|NCT04450407|565798843|FG002|Overall Study|Pregnancy|0|||
156740896|NCT04450407|565798841|FG000|Overall Study|Protocol Violation|2|||
156740897|NCT04450407|565798842|FG001|Overall Study|Protocol Violation|0|||
156740898|NCT04450407|565798843|FG002|Overall Study|Protocol Violation|0|||
156740899|NCT04450407|565798841|FG000|Overall Study|Investigational site terminated by sponsor|3|||
156740900|NCT04450407|565798842|FG001|Overall Study|Investigational site terminated by sponsor|0|||
156740901|NCT04450407|565798843|FG002|Overall Study|Investigational site terminated by sponsor|2|||
156740902|NCT02419612|565798851|FG000|Short-term Treatment Period|Adverse Event|1|||
156740903|NCT02419612|565798852|FG001|Short-term Treatment Period|Adverse Event|1|||
157020435|NCT02287610|566828435|FG000|Overall Study|Lost to Follow-up|3|||
156740904|NCT02419612|565798851|FG000|Short-term Treatment Period|Death|0|||
157218610|NCT01977092|567547470|FG001|Overall Study|Withdrawal by Subject|1|||
156740905|NCT02419612|565798852|FG001|Short-term Treatment Period|Death|2|||
156740906|NCT02419612|565798851|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
156740907|NCT02419612|565798852|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
156740908|NCT02419612|565798851|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
156740909|NCT02419612|565798852|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
156740910|NCT02419612|565798851|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
156740911|NCT02419612|565798852|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
156740912|NCT02419612|565798851|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
156740913|NCT02419612|565798852|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
156740914|NCT02419612|565798851|FG000|Short-term Treatment Period|Worsening of liver function|0|||
156740915|NCT02419612|565798852|FG001|Short-term Treatment Period|Worsening of liver function|1|||
156740916|NCT02419612|565798851|FG000|Short-term Treatment Period|Subject moved out of state|0|||
156740917|NCT02419612|565798852|FG001|Short-term Treatment Period|Subject moved out of state|1|||
156740918|NCT02419612|565798851|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
156740919|NCT02419612|565798852|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
156740920|NCT02419612|565798851|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
156740921|NCT02419612|565798852|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
156740922|NCT02419612|565798851|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
156740923|NCT02419612|565798852|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
156740924|NCT02419612|565798851|FG000|Long-term Treatment Period|Death|0|||
156740925|NCT02419612|565798852|FG001|Long-term Treatment Period|Death|1|||
156740926|NCT02419612|565798851|FG000|Long-term Treatment Period|Adverse Event|0|||
156740927|NCT02419612|565798852|FG001|Long-term Treatment Period|Adverse Event|5|||
156740928|NCT02419612|565798851|FG000|Long-term Treatment Period|Other|4|||
156740929|NCT02419612|565798852|FG001|Long-term Treatment Period|Other|4|||
156740930|NCT02419612|565798851|FG000|Long-term Treatment Period|Subject Decision|2|||
156740931|NCT02419612|565798852|FG001|Long-term Treatment Period|Subject Decision|4|||
156740932|NCT02419612|565798851|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
156740933|NCT02419612|565798852|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
156740934|NCT00533702|565798853|FG000|Overall Study|Withdrawal by Subject|3|||
156740935|NCT00533702|565798854|FG001|Overall Study|Withdrawal by Subject|1|||
156740936|NCT00533702|565798853|FG000|Overall Study|Found ineligible after randomization|2|||
156740937|NCT00533702|565798854|FG001|Overall Study|Found ineligible after randomization|1|||
156740938|NCT01095978|565798855|FG000|Overall Study|Did not take Klacid SR|2|||
156740939|NCT01095978|565798855|FG000|Overall Study|Adverse Event|1|||
156740940|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740941|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740942|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
156740943|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
156740944|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
156740945|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
156740946|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740947|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
156740948|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740949|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740950|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740951|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
156740952|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
156740953|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
156740954|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740955|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740956|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
156740957|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
156740958|NCT01752634|565800480|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
156740959|NCT01752634|565800481|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740960|NCT01752634|565800482|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
156740961|NCT01752634|565800483|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740962|NCT01752634|565800484|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
156740963|NCT01752634|565800485|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
156740964|NCT01752634|565800480|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
156740965|NCT01752634|565800481|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
156740966|NCT01752634|565800482|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
156740967|NCT01752634|565800483|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
156740968|NCT01752634|565800484|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
156740969|NCT01752634|565800485|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
156740970|NCT01752634|565800480|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
156740971|NCT01752634|565800481|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
156740972|NCT01752634|565800482|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
156740973|NCT01752634|565800483|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
156740974|NCT01752634|565800484|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
156740975|NCT01752634|565800485|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
156740976|NCT01752634|565800480|FG000|Week 24 to Week 260|Physician Decision|1|||
156740977|NCT01752634|565800481|FG001|Week 24 to Week 260|Physician Decision|2|||
156740978|NCT01752634|565800482|FG002|Week 24 to Week 260|Physician Decision|4|||
156740979|NCT01752634|565800483|FG003|Week 24 to Week 260|Physician Decision|2|||
156740980|NCT01752634|565800484|FG004|Week 24 to Week 260|Physician Decision|1|||
156740981|NCT01752634|565800485|FG005|Week 24 to Week 260|Physician Decision|0|||
156740982|NCT01752634|565800480|FG000|Week 24 to Week 260|Death|0|||
156740983|NCT01752634|565800481|FG001|Week 24 to Week 260|Death|1|||
156740984|NCT01752634|565800482|FG002|Week 24 to Week 260|Death|0|||
156740985|NCT01752634|565800483|FG003|Week 24 to Week 260|Death|0|||
156740986|NCT01752634|565800484|FG004|Week 24 to Week 260|Death|0|||
156740987|NCT01752634|565800485|FG005|Week 24 to Week 260|Death|0|||
156740988|NCT01752634|565800480|FG000|Week 24 to Week 260|Pregnancy|0|||
156740989|NCT01752634|565800481|FG001|Week 24 to Week 260|Pregnancy|0|||
156740990|NCT01752634|565800482|FG002|Week 24 to Week 260|Pregnancy|1|||
156740991|NCT01752634|565800483|FG003|Week 24 to Week 260|Pregnancy|0|||
156740992|NCT01752634|565800484|FG004|Week 24 to Week 260|Pregnancy|0|||
156740993|NCT01752634|565800485|FG005|Week 24 to Week 260|Pregnancy|0|||
156740994|NCT01752634|565800480|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740995|NCT01752634|565800481|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740996|NCT01752634|565800482|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
156740997|NCT01752634|565800483|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740998|NCT01752634|565800484|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
156740999|NCT01752634|565800485|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
156741000|NCT01752634|565800480|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
156741001|NCT01752634|565800481|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
156741002|NCT01752634|565800482|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
156741003|NCT01752634|565800483|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
156741004|NCT01752634|565800484|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
156741005|NCT01752634|565800485|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
156741006|NCT01752634|565800480|FG000|Week 24 to Week 260|Adverse Event|4|||
156741007|NCT01752634|565800481|FG001|Week 24 to Week 260|Adverse Event|8|||
156741008|NCT01752634|565800482|FG002|Week 24 to Week 260|Adverse Event|8|||
156741009|NCT01752634|565800483|FG003|Week 24 to Week 260|Adverse Event|4|||
156741010|NCT01752634|565800484|FG004|Week 24 to Week 260|Adverse Event|2|||
156741011|NCT01752634|565800485|FG005|Week 24 to Week 260|Adverse Event|0|||
156741012|NCT05562934|565800486|FG000|Overall Study|Adverse Event|0|||
156741013|NCT05562934|565800487|FG001|Overall Study|Adverse Event|2|||
156741014|NCT05562934|565800488|FG002|Overall Study|Adverse Event|0|||
156741015|NCT05562934|565800489|FG003|Overall Study|Adverse Event|0|||
156741016|NCT05562934|565800490|FG004|Overall Study|Adverse Event|2|||
156741017|NCT05562934|565800486|FG000|Overall Study|Lost to Follow-up|0|||
156741018|NCT05562934|565800487|FG001|Overall Study|Lost to Follow-up|0|||
156741019|NCT05562934|565800488|FG002|Overall Study|Lost to Follow-up|0|||
156741020|NCT05562934|565800489|FG003|Overall Study|Lost to Follow-up|0|||
156741021|NCT05562934|565800490|FG004|Overall Study|Lost to Follow-up|1|||
156741022|NCT05562934|565800486|FG000|Overall Study|Protocol Violation|0|||
156741023|NCT05562934|565800487|FG001|Overall Study|Protocol Violation|0|||
156741024|NCT05562934|565800488|FG002|Overall Study|Protocol Violation|0|||
156741025|NCT05562934|565800489|FG003|Overall Study|Protocol Violation|1|||
156741026|NCT05562934|565800490|FG004|Overall Study|Protocol Violation|1|||
156741027|NCT05562934|565800486|FG000|Overall Study|Withdrawal by Subject|0|||
156741028|NCT05562934|565800487|FG001|Overall Study|Withdrawal by Subject|0|||
156741029|NCT05562934|565800488|FG002|Overall Study|Withdrawal by Subject|1|||
156741030|NCT05562934|565800489|FG003|Overall Study|Withdrawal by Subject|1|||
156741031|NCT05562934|565800490|FG004|Overall Study|Withdrawal by Subject|0|||
156741032|NCT05906836|565800493|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
156741033|NCT05906836|565800493|FG000|Overall Study|Lost to Follow-up|1|||
156741034|NCT01846221|565800494|FG000|Overall Study|Catheter Failure|2|||
156741035|NCT01846221|565800495|FG001|Overall Study|Catheter Failure|0|||
156741036|NCT01846221|565800494|FG000|Overall Study|Age Exclusion|1|||
156741037|NCT01846221|565800495|FG001|Overall Study|Age Exclusion|0|||
156741038|NCT04599933|565800496|FG000|Overall Study|Adverse Event|4|||
156741039|NCT04599933|565800497|FG001|Overall Study|Adverse Event|1|||
156741040|NCT04599933|565800496|FG000|Overall Study|Withdrawal by Subject|4|||
156741041|NCT04599933|565800497|FG001|Overall Study|Withdrawal by Subject|2|||
156741042|NCT04599933|565800496|FG000|Overall Study|Lost to Follow-up|0|||
156741043|NCT04599933|565800497|FG001|Overall Study|Lost to Follow-up|1|||
156741044|NCT04599933|565800496|FG000|Overall Study|Physician Decision|0|||
156741045|NCT04599933|565800497|FG001|Overall Study|Physician Decision|1|||
156741046|NCT04599933|565800496|FG000|Overall Study|Screen Failure|1|||
156741047|NCT04599933|565800497|FG001|Overall Study|Screen Failure|2|||
157020436|NCT02287610|566828435|FG000|Overall Study|Withdrawal by Subject|8|||
157020437|NCT02287610|566828435|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
156741048|NCT02963558|565800505|FG000|Overall Study|Withdrawn by investigator|1|||
156741049|NCT02963558|565800506|FG001|Overall Study|Withdrawn by investigator|0|||
156741050|NCT02963558|565800505|FG000|Overall Study|Withdrawal by Subject|0|||
156741051|NCT02963558|565800506|FG001|Overall Study|Withdrawal by Subject|1|||
156741052|NCT02339155|565800507|FG000|Overall Study|Adverse Event|0|||
156741053|NCT02339155|565800508|FG001|Overall Study|Adverse Event|6|||
156741054|NCT02339155|565800507|FG000|Overall Study|Death|1|||
156741055|NCT02339155|565800508|FG001|Overall Study|Death|1|||
156741056|NCT02339155|565800507|FG000|Overall Study|Lost to Follow-up|8|||
156741057|NCT02339155|565800508|FG001|Overall Study|Lost to Follow-up|9|||
156741058|NCT02339155|565800507|FG000|Overall Study|Physician Decision|2|||
156741059|NCT02339155|565800508|FG001|Overall Study|Physician Decision|1|||
156741060|NCT02339155|565800507|FG000|Overall Study|Withdrawal by Subject|4|||
156741061|NCT02339155|565800508|FG001|Overall Study|Withdrawal by Subject|4|||
156741062|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Adverse Event|0|||
156741063|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Adverse Event|1|||
156741064|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Adverse Event|0|||
156741065|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Adverse Event|0|||
156741066|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Adverse Event|0|||
156741067|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Adverse Event|0|||
156741068|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Death|0|||
156741069|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Death|0|||
156741070|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Death|1|||
156741071|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Death|0|||
156741072|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Death|0|||
156741073|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Death|0|||
156741074|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741075|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
156741076|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741077|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741078|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741079|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
156741080|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741081|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741082|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
156741083|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741084|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741085|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
156741086|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741087|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741088|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741089|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
156741090|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741091|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
156741092|NCT03226678|565800513|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
156741093|NCT03226678|565800514|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
156741094|NCT03226678|565800515|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741095|NCT03226678|565800516|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741096|NCT03226678|565800517|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741097|NCT03226678|565800518|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
156741098|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741099|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741100|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741101|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
156741102|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
156741103|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
156741104|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Death|0|||
156741105|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Death|0|||
156741106|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Death|0|||
157020438|NCT04950660|566828436|FG000|Overall Study|Protocol Violation|4|||
156741107|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Death|0|||
156741108|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Death|0|||
156741109|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Death|1|||
156741110|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741111|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741112|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741113|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741114|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
156741115|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
156741116|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741117|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741118|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741119|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
156741120|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
156741121|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
156741122|NCT03226678|565800513|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741123|NCT03226678|565800514|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741124|NCT03226678|565800515|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741125|NCT03226678|565800516|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741126|NCT03226678|565800517|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
156741127|NCT03226678|565800518|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
156741128|NCT01371877|565800521|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
156741129|NCT01371877|565800522|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
156741130|NCT05932225|565800525|FG000|Overall Study|Lost to Follow-up|0|||
156741131|NCT05932225|565800526|FG001|Overall Study|Lost to Follow-up|1|||
156741132|NCT05932225|565800527|FG002|Overall Study|Lost to Follow-up|0|||
156741133|NCT05932225|565800525|FG000|Overall Study|Withdrawal by Subject|1|||
156741134|NCT05932225|565800526|FG001|Overall Study|Withdrawal by Subject|0|||
156741135|NCT05932225|565800527|FG002|Overall Study|Withdrawal by Subject|0|||
156741136|NCT05932225|565800525|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
156741137|NCT05932225|565800526|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
156741138|NCT05932225|565800527|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
156741139|NCT03427268|565800528|FG000|Overall Study|Progressive disease|25|||
156741140|NCT03427268|565800528|FG000|Overall Study|Never treated|2|||
156741141|NCT03427268|565800528|FG000|Overall Study|Compassionate use|1|||
156741142|NCT03427268|565800528|FG000|Overall Study|Withdrawal by Subject|1|||
156741143|NCT03427268|565800528|FG000|Overall Study|Adverse Event|3|||
156741144|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
156741145|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
156741146|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
156741147|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
156741148|NCT01911780|565800534|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
156797621|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797622|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
156797623|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156741149|NCT01911780|565800535|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
156741150|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
156797624|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156741151|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
156741152|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
156741153|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
156797625|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
156797626|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797627|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797628|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797629|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797630|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797631|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797632|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797633|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797634|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
156797635|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797636|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797637|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
156797638|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156741154|NCT01911780|565800534|FG000|Extension Period (52 Weeks)|Personal reason|1|||
156741155|NCT01911780|565800535|FG001|Extension Period (52 Weeks)|Personal reason|1|||
156741156|NCT04247880|565800536|FG000|Overall Study|Lost to Follow-up|24|||
156741157|NCT04247880|565800537|FG001|Overall Study|Lost to Follow-up|17|||
156741158|NCT04247880|565800536|FG000|Overall Study|Withdrawal by Subject|3|||
156741159|NCT04247880|565800537|FG001|Overall Study|Withdrawal by Subject|0|||
156741160|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Death|117|||
156741161|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Death|197|||
156741162|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
156741163|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
156741164|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
156741165|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
156741166|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
156741167|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
156741168|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
156741169|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
156741170|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
156741171|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
156741172|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
156741173|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
156741174|NCT02677896|565800538|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
156741175|NCT02677896|565800539|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
156741176|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
156741177|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
156741178|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
156741179|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
156741180|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
156741181|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
156741182|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
156741183|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
156741184|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
156741185|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
156741186|NCT02677896|565800538|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
156741187|NCT02677896|565800539|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
156741188|NCT00108485|565800548|FG000|Overall Study|Withdrawal by Subject|3|||
156741189|NCT00108485|565800549|FG001|Overall Study|Withdrawal by Subject|0|||
156741190|NCT00108485|565800548|FG000|Overall Study|Lost to Follow-up|0|||
156741191|NCT00108485|565800549|FG001|Overall Study|Lost to Follow-up|2|||
156741192|NCT00878969|565800551|FG000|Overall Study|Physician Decision|5|||
156741193|NCT00878969|565800552|FG001|Overall Study|Physician Decision|3|||
156741194|NCT00878969|565800553|FG002|Overall Study|Physician Decision|2|||
156741195|NCT00878969|565800551|FG000|Overall Study|Withdrawal by Subject|1|||
156741196|NCT00878969|565800552|FG001|Overall Study|Withdrawal by Subject|6|||
156741197|NCT00878969|565800553|FG002|Overall Study|Withdrawal by Subject|3|||
156741198|NCT00878969|565800551|FG000|Overall Study|kidney transplant|2|||
156741199|NCT00878969|565800552|FG001|Overall Study|kidney transplant|3|||
156741200|NCT00878969|565800553|FG002|Overall Study|kidney transplant|2|||
156741201|NCT00878969|565800551|FG000|Overall Study|Adverse Event|3|||
156741202|NCT00878969|565800552|FG001|Overall Study|Adverse Event|1|||
156741203|NCT00878969|565800553|FG002|Overall Study|Adverse Event|2|||
156741204|NCT00878969|565800551|FG000|Overall Study|Lost to Follow-up|2|||
156741205|NCT00878969|565800552|FG001|Overall Study|Lost to Follow-up|1|||
156741206|NCT00878969|565800553|FG002|Overall Study|Lost to Follow-up|0|||
156741207|NCT00878969|565800551|FG000|Overall Study|Protocol Violation|2|||
156741208|NCT00878969|565800552|FG001|Overall Study|Protocol Violation|0|||
156741209|NCT00878969|565800553|FG002|Overall Study|Protocol Violation|0|||
156741210|NCT00878969|565800551|FG000|Overall Study|Death|0|||
156741211|NCT00878969|565800552|FG001|Overall Study|Death|0|||
156741212|NCT00878969|565800553|FG002|Overall Study|Death|2|||
156741213|NCT00878969|565800551|FG000|Overall Study|Pregnancy|0|||
156741214|NCT00878969|565800552|FG001|Overall Study|Pregnancy|1|||
156741215|NCT00878969|565800553|FG002|Overall Study|Pregnancy|0|||
156741216|NCT00655733|565800554|FG000|Overall Study|Lost to Follow-up|2|||
156741217|NCT00655733|565800555|FG001|Overall Study|Lost to Follow-up|2|||
156741218|NCT00655733|565800554|FG000|Overall Study|Adverse Event|2|||
156741219|NCT00655733|565800555|FG001|Overall Study|Adverse Event|2|||
156741220|NCT00655733|565800554|FG000|Overall Study|Withdrawal by Subject|3|||
156741221|NCT00655733|565800555|FG001|Overall Study|Withdrawal by Subject|3|||
156741222|NCT00655733|565800554|FG000|Overall Study|Physician Decision|0|||
156741223|NCT00655733|565800555|FG001|Overall Study|Physician Decision|1|||
156741224|NCT01701193|565800559|FG000|Overall Study|Withdrawal by Subject|2|||
156741225|NCT01701193|565800560|FG001|Overall Study|Withdrawal by Subject|2|||
156741226|NCT01701193|565800561|FG002|Overall Study|Withdrawal by Subject|1|||
156741227|NCT01701193|565800562|FG003|Overall Study|Withdrawal by Subject|2|||
156741228|NCT01701193|565800559|FG000|Overall Study|Adverse Event|1|||
156741229|NCT01701193|565800560|FG001|Overall Study|Adverse Event|0|||
156741230|NCT01701193|565800561|FG002|Overall Study|Adverse Event|0|||
156741231|NCT01701193|565800562|FG003|Overall Study|Adverse Event|0|||
156741232|NCT01482962|565800563|FG000|Overall Study|Progressive Disease|65|||
156741233|NCT01482962|565800564|FG001|Overall Study|Progressive Disease|53|||
156741234|NCT01482962|565800563|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
156741235|NCT01482962|565800564|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
156741236|NCT01482962|565800563|FG000|Overall Study|Adverse Event|18|||
156741237|NCT01482962|565800564|FG001|Overall Study|Adverse Event|22|||
156741238|NCT01482962|565800563|FG000|Overall Study|Withdrawal by Participant|8|||
156741239|NCT01482962|565800564|FG001|Overall Study|Withdrawal by Participant|13|||
156741240|NCT01482962|565800563|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
156741241|NCT01482962|565800564|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
156741242|NCT01482962|565800563|FG000|Overall Study|Other Reason|1|||
156741243|NCT01482962|565800564|FG001|Overall Study|Other Reason|5|||
156741244|NCT01482962|565800563|FG000|Overall Study|Study Terminated by Sponsor|5|||
156741245|NCT01482962|565800564|FG001|Overall Study|Study Terminated by Sponsor|2|||
156741246|NCT01482962|565800563|FG000|Overall Study|Did not Receive Study Drug|1|||
156741247|NCT01482962|565800564|FG001|Overall Study|Did not Receive Study Drug|6|||
156741248|NCT02407457|565800565|FG000|1 Month|Death|3|||
156741249|NCT02407457|565800566|FG001|1 Month|Death|0|||
156741250|NCT02407457|565800565|FG000|1 Month|Lost to Follow-up|1|||
156741251|NCT02407457|565800566|FG001|1 Month|Lost to Follow-up|1|||
156741252|NCT02407457|565800565|FG000|1 Month|missed visit|2|||
156741253|NCT02407457|565800566|FG001|1 Month|missed visit|5|||
156741254|NCT02407457|565800565|FG000|6-Month|Death|2|||
156741255|NCT02407457|565800566|FG001|6-Month|Death|8|||
156741256|NCT02407457|565800565|FG000|6-Month|Lost to Follow-up|2|||
156741257|NCT02407457|565800566|FG001|6-Month|Lost to Follow-up|2|||
156741258|NCT02407457|565800565|FG000|6-Month|missed visit|16|||
156741259|NCT02407457|565800566|FG001|6-Month|missed visit|14|||
156741260|NCT02407457|565800565|FG000|6-Month|Open Repair|0|||
156741261|NCT02407457|565800566|FG001|6-Month|Open Repair|1|||
156741262|NCT02407457|565800565|FG000|1 Year|Death|6|||
156741263|NCT02407457|565800566|FG001|1 Year|Death|11|||
156741264|NCT02407457|565800565|FG000|1 Year|Lost to Follow-up|3|||
156741265|NCT02407457|565800566|FG001|1 Year|Lost to Follow-up|2|||
156741266|NCT02407457|565800565|FG000|1 Year|Missed Visit|24|||
156741267|NCT02407457|565800566|FG001|1 Year|Missed Visit|14|||
156741268|NCT02407457|565800565|FG000|1 Year|Open Repair|0|||
156741269|NCT02407457|565800566|FG001|1 Year|Open Repair|1|||
156741270|NCT02407457|565800565|FG000|2-year|Death|14|||
156741271|NCT02407457|565800566|FG001|2-year|Death|8|||
156741272|NCT02407457|565800565|FG000|2-year|Lost to Follow-up|7|||
156741273|NCT02407457|565800566|FG001|2-year|Lost to Follow-up|10|||
156741274|NCT02407457|565800565|FG000|2-year|Missed Visit|13|||
156741275|NCT02407457|565800566|FG001|2-year|Missed Visit|15|||
156741276|NCT02407457|565800565|FG000|2-year|Open Repair|0|||
156741277|NCT02407457|565800566|FG001|2-year|Open Repair|2|||
156741278|NCT02407457|565800565|FG000|3-year|Death|11|||
156741279|NCT02407457|565800566|FG001|3-year|Death|10|||
156741280|NCT02407457|565800565|FG000|3-year|Lost to Follow-up|9|||
156741281|NCT02407457|565800566|FG001|3-year|Lost to Follow-up|10|||
156741282|NCT02407457|565800565|FG000|3-year|Missed Visit|19|||
156741283|NCT02407457|565800566|FG001|3-year|Missed Visit|16|||
156741284|NCT02407457|565800565|FG000|4-year|Death|18|||
156741285|NCT02407457|565800566|FG001|4-year|Death|10|||
156741286|NCT02407457|565800565|FG000|4-year|Lost to Follow-up|10|||
156741287|NCT02407457|565800566|FG001|4-year|Lost to Follow-up|12|||
156741288|NCT02407457|565800565|FG000|4-year|Missed Visit|18|||
156741289|NCT02407457|565800566|FG001|4-year|Missed Visit|16|||
156741290|NCT02407457|565800565|FG000|5-year|Death|10|||
156741291|NCT02407457|565800566|FG001|5-year|Death|3|||
156741292|NCT02407457|565800565|FG000|5-year|Lost to Follow-up|22|||
156741293|NCT02407457|565800566|FG001|5-year|Lost to Follow-up|13|||
156741294|NCT02407457|565800565|FG000|5-year|Missed Visit|9|||
156741295|NCT02407457|565800566|FG001|5-year|Missed Visit|1|||
156741296|NCT01549041|565800569|FG000|Overall Study|Lack of Efficacy|2|||
156741297|NCT01549041|565800570|FG001|Overall Study|Lack of Efficacy|4|||
156741298|NCT01549041|565800569|FG000|Overall Study|Adverse Event|0|||
156741299|NCT01549041|565800570|FG001|Overall Study|Adverse Event|4|||
156741300|NCT03199612|565800571|FG000|Overall Study|Adverse Event|1|||
156741301|NCT03199612|565800572|FG001|Overall Study|Adverse Event|0|||
156741302|NCT02543892|565800573|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
156741303|NCT02543892|565800574|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156741304|NCT02543892|565800575|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
156741305|NCT02543892|565800576|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156741306|NCT02543892|565800577|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
156741307|NCT02543892|565800578|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
156741308|NCT02543892|565800579|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
156741309|NCT02543892|565800580|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
156741310|NCT02543892|565800573|FG000|Received Vaccination 2|Physician Decision|0|||
156741311|NCT02543892|565800574|FG001|Received Vaccination 2|Physician Decision|0|||
156741312|NCT02543892|565800575|FG002|Received Vaccination 2|Physician Decision|0|||
156741313|NCT02543892|565800576|FG003|Received Vaccination 2|Physician Decision|0|||
156741314|NCT02543892|565800577|FG004|Received Vaccination 2|Physician Decision|0|||
156741315|NCT02543892|565800578|FG005|Received Vaccination 2|Physician Decision|1|||
156741316|NCT02543892|565800579|FG006|Received Vaccination 2|Physician Decision|0|||
156741317|NCT02543892|565800580|FG007|Received Vaccination 2|Physician Decision|0|||
156741318|NCT02543892|565800573|FG000|Received Vaccination 2|Adverse Event|0|||
156741319|NCT02543892|565800574|FG001|Received Vaccination 2|Adverse Event|1|||
156741320|NCT02543892|565800575|FG002|Received Vaccination 2|Adverse Event|0|||
156741321|NCT02543892|565800576|FG003|Received Vaccination 2|Adverse Event|0|||
156741322|NCT02543892|565800577|FG004|Received Vaccination 2|Adverse Event|0|||
156741323|NCT02543892|565800578|FG005|Received Vaccination 2|Adverse Event|0|||
156741324|NCT02543892|565800579|FG006|Received Vaccination 2|Adverse Event|0|||
156741325|NCT02543892|565800580|FG007|Received Vaccination 2|Adverse Event|0|||
156741326|NCT02543892|565800573|FG000|Had Immunology Data|Withdrawal by Subject|0|||
156741327|NCT02543892|565800574|FG001|Had Immunology Data|Withdrawal by Subject|0|||
156741328|NCT02543892|565800575|FG002|Had Immunology Data|Withdrawal by Subject|0|||
156741329|NCT02543892|565800576|FG003|Had Immunology Data|Withdrawal by Subject|0|||
156741330|NCT02543892|565800577|FG004|Had Immunology Data|Withdrawal by Subject|0|||
156741331|NCT02543892|565800578|FG005|Had Immunology Data|Withdrawal by Subject|0|||
156741332|NCT02543892|565800579|FG006|Had Immunology Data|Withdrawal by Subject|1|||
156741333|NCT02543892|565800580|FG007|Had Immunology Data|Withdrawal by Subject|0|||
156741334|NCT01199822|565800581|FG000|Overall Study|Investigator discontinued therapy|0|||
156741335|NCT01199822|565800582|FG001|Overall Study|Investigator discontinued therapy|1|||
156741336|NCT01199822|565800583|FG002|Overall Study|Investigator discontinued therapy|0|||
156741337|NCT04027075|565800584|FG000|Overall Study|Lost to Follow-up|41|||
156741338|NCT04027075|565800585|FG001|Overall Study|Lost to Follow-up|22|||
156741339|NCT00526331|565800586|FG000|Overall Study|Sponsor Termination|55|||
156741340|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
156741341|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
156741342|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
156741343|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
156741344|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Death|1|||
156741345|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Death|1|||
156741346|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
156741347|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
156741348|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
156741349|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
156741350|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
156741351|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
157218611|NCT01977092|567547469|FG000|Overall Study|In prison|3|||
157218612|NCT01977092|567547470|FG001|Overall Study|In prison|11|||
157218613|NCT03038113|567547471|FG000|Overall Study|Withdrawal by Subject|0|||
157218614|NCT03038113|567547472|FG001|Overall Study|Withdrawal by Subject|0|||
157218615|NCT03038113|567547473|FG002|Overall Study|Withdrawal by Subject|1|||
157218616|NCT03038113|567547474|FG003|Overall Study|Withdrawal by Subject|0|||
157218617|NCT03038113|567547475|FG004|Overall Study|Withdrawal by Subject|0|||
157218618|NCT03038113|567547476|FG005|Overall Study|Withdrawal by Subject|0|||
157218619|NCT03038113|567547477|FG006|Overall Study|Withdrawal by Subject|0|||
157218620|NCT03038113|567547478|FG007|Overall Study|Withdrawal by Subject|0|||
157218621|NCT03038113|567547479|FG008|Overall Study|Withdrawal by Subject|0|||
157218622|NCT03038113|567547480|FG009|Overall Study|Withdrawal by Subject|0|||
157218623|NCT03038113|567547481|FG010|Overall Study|Withdrawal by Subject|0|||
157218624|NCT03038113|567547482|FG011|Overall Study|Withdrawal by Subject|0|||
157218625|NCT03038113|567547483|FG012|Overall Study|Withdrawal by Subject|0|||
157218626|NCT03038113|567547484|FG013|Overall Study|Withdrawal by Subject|1|||
157218627|NCT03038113|567547471|FG000|Overall Study|Lost to Follow-up|0|||
157218628|NCT03038113|567547472|FG001|Overall Study|Lost to Follow-up|0|||
156741352|NCT00033657|565800588|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
157218629|NCT03038113|567547473|FG002|Overall Study|Lost to Follow-up|0|||
157218630|NCT03038113|567547474|FG003|Overall Study|Lost to Follow-up|0|||
157218631|NCT03038113|567547475|FG004|Overall Study|Lost to Follow-up|0|||
157218632|NCT03038113|567547476|FG005|Overall Study|Lost to Follow-up|0|||
157218633|NCT03038113|567547477|FG006|Overall Study|Lost to Follow-up|1|||
157218634|NCT03038113|567547478|FG007|Overall Study|Lost to Follow-up|0|||
156741353|NCT00033657|565800589|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
156741354|NCT00033657|565800588|FG000|Surgical Resection|not complete resection|0|||
156741355|NCT00033657|565800589|FG001|Surgical Resection|not complete resection|3|||
156741356|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
156741357|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
156741358|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
156741359|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
156741360|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Death|2|||
156741361|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Death|1|||
157218635|NCT03038113|567547479|FG008|Overall Study|Lost to Follow-up|0|||
156877720|NCT01827956|566309902|FG000|Overall Study|Protocol Violation|3|||
156741362|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
156741363|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
156741364|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
156741365|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
156741366|NCT00033657|565800588|FG000|Adjuvant Chemotherapy|Other|0|||
156741367|NCT00033657|565800589|FG001|Adjuvant Chemotherapy|Other|2|||
156741368|NCT03448939|565800590|FG000|Overall Study|Adverse Event|5|||
156741369|NCT03448939|565800591|FG001|Overall Study|Adverse Event|1|||
156741370|NCT03448939|565800590|FG000|Overall Study|Lost to Follow-up|6|||
156741371|NCT03448939|565800591|FG001|Overall Study|Lost to Follow-up|6|||
156741372|NCT03448939|565800590|FG000|Overall Study|Pregnancy|1|||
156741373|NCT03448939|565800591|FG001|Overall Study|Pregnancy|1|||
156741374|NCT03448939|565800590|FG000|Overall Study|Withdrawal by Subject|9|||
156741375|NCT03448939|565800591|FG001|Overall Study|Withdrawal by Subject|3|||
156741376|NCT01259375|565800592|FG000|Overall Study|Adverse Event|1|||
156741377|NCT00986986|565800593|FG000|Overall Study|Lost to Follow-up|0|||
156741378|NCT00986986|565800594|FG001|Overall Study|Lost to Follow-up|1|||
156741379|NCT00628095|565800595|FG000|Overall Study|Adverse Event|5|||
156741380|NCT00628095|565800596|FG001|Overall Study|Adverse Event|3|||
156741381|NCT00628095|565800595|FG000|Overall Study|Lack of Efficacy|0|||
156741382|NCT00628095|565800596|FG001|Overall Study|Lack of Efficacy|3|||
156741383|NCT00628095|565800595|FG000|Overall Study|Withdrawal by Subject|2|||
156741384|NCT00628095|565800596|FG001|Overall Study|Withdrawal by Subject|0|||
156741385|NCT00628095|565800595|FG000|Overall Study|Other|0|||
156741386|NCT00628095|565800596|FG001|Overall Study|Other|1|||
156741387|NCT00656851|565800603|FG000|Overall Study|Withdrawal by Subject|0|||
156741388|NCT00656851|565800604|FG001|Overall Study|Withdrawal by Subject|4|||
156741389|NCT03932331|565800607|FG000|Overall Study|Death|0|||
156741390|NCT03932331|565800608|FG001|Overall Study|Death|7|||
156741391|NCT03932331|565800609|FG002|Overall Study|Death|2|||
156741392|NCT03932331|565800607|FG000|Overall Study|Withdrawal by Subject|0|||
156741393|NCT03932331|565800608|FG001|Overall Study|Withdrawal by Subject|3|||
156741394|NCT03932331|565800609|FG002|Overall Study|Withdrawal by Subject|0|||
156741395|NCT03932331|565800607|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
156741396|NCT03932331|565800608|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
156741397|NCT03932331|565800609|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
156741398|NCT03932331|565800607|FG000|Overall Study|Progressive disease|3|||
156741399|NCT03932331|565800608|FG001|Overall Study|Progressive disease|0|||
156741400|NCT03932331|565800609|FG002|Overall Study|Progressive disease|0|||
156741401|NCT03932331|565800607|FG000|Overall Study|Lung infection|1|||
156741402|NCT03932331|565800608|FG001|Overall Study|Lung infection|0|||
156741403|NCT03932331|565800609|FG002|Overall Study|Lung infection|0|||
156741404|NCT03932331|565800607|FG000|Overall Study|Other|0|||
157020439|NCT04950660|566828437|FG001|Overall Study|Protocol Violation|2|||
156741405|NCT03932331|565800608|FG001|Overall Study|Other|0|||
156741406|NCT03932331|565800609|FG002|Overall Study|Other|58|||
156741407|NCT03379753|565800610|FG000|Overall Study|Withdrawal by Subject|2|||
156741408|NCT03379753|565800611|FG001|Overall Study|Withdrawal by Subject|1|||
156741409|NCT03379753|565800610|FG000|Overall Study|not having correct procedure|1|||
156741410|NCT03379753|565800611|FG001|Overall Study|not having correct procedure|2|||
156741411|NCT03379753|565800610|FG000|Overall Study|No primary outcome|12|||
156741412|NCT03379753|565800611|FG001|Overall Study|No primary outcome|22|||
156741413|NCT02225366|565800618|FG000|Overall Study|Lack of Efficacy|1|||
156741414|NCT02225366|565800619|FG001|Overall Study|Lack of Efficacy|0|||
156741415|NCT02431806|565800620|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741416|NCT02431806|565800621|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
156741417|NCT02431806|565800622|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741418|NCT02431806|565800623|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
156741419|NCT02431806|565800620|FG000|Double-blind Treatment Period|Adverse Event|4|||
156741420|NCT02431806|565800621|FG001|Double-blind Treatment Period|Adverse Event|7|||
156741421|NCT02431806|565800622|FG002|Double-blind Treatment Period|Adverse Event|11|||
156741422|NCT02431806|565800623|FG003|Double-blind Treatment Period|Adverse Event|7|||
156741423|NCT02431806|565800620|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
156741424|NCT02431806|565800621|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156741425|NCT02431806|565800622|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
156741426|NCT02431806|565800623|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
156741427|NCT02431806|565800620|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
156741428|NCT02431806|565800621|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
156741429|NCT02431806|565800622|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
156741430|NCT02431806|565800623|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
156741431|NCT02431806|565800620|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
156741432|NCT02431806|565800621|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
156741433|NCT02431806|565800622|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156741434|NCT02431806|565800623|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
156741435|NCT02431806|565800620|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
156741436|NCT02431806|565800621|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
156741437|NCT02431806|565800622|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
156741438|NCT02431806|565800623|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
156797639|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797640|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797641|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797642|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797643|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797644|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797645|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797646|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
157142844|NCT02128490|567271122|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
157142845|NCT02128490|567271123|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
157142846|NCT02128490|567271124|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
156797647|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797648|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797649|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797650|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
156797651|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797652|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797653|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156797654|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797655|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797656|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797657|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797658|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797659|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797660|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797661|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797662|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797663|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797664|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797665|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797666|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156797667|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
156797668|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
156797669|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
156797670|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
156797671|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
156797672|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
156797673|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
156797674|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
156797675|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
156797676|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
156797677|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
157142847|NCT02128490|567271125|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
157218636|NCT03038113|567547480|FG009|Overall Study|Lost to Follow-up|0|||
156741439|NCT02431806|565800620|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
156741440|NCT02431806|565800621|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
156741441|NCT02431806|565800622|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
156741442|NCT02431806|565800623|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
156741443|NCT01419080|565800626|FG000|Overall Study|Withdrawal by Subject|75|||
156741444|NCT01419080|565800626|FG000|Overall Study|Death|30|||
156741445|NCT01419080|565800626|FG000|Overall Study|Lost to Follow-up|23|||
156741446|NCT01419080|565800626|FG000|Overall Study|Too Ill|3|||
156741447|NCT00710684|565800627|FG000|Overall Study|Adverse Event|11|||
156741448|NCT00710684|565800628|FG001|Overall Study|Adverse Event|19|||
156741449|NCT00710684|565800629|FG002|Overall Study|Adverse Event|16|||
156741450|NCT00710684|565800627|FG000|Overall Study|Lack of Efficacy|4|||
156741451|NCT00710684|565800628|FG001|Overall Study|Lack of Efficacy|3|||
156741452|NCT00710684|565800629|FG002|Overall Study|Lack of Efficacy|5|||
156741453|NCT00710684|565800627|FG000|Overall Study|Protocol Violation|5|||
156741454|NCT00710684|565800628|FG001|Overall Study|Protocol Violation|5|||
156741455|NCT00710684|565800629|FG002|Overall Study|Protocol Violation|5|||
156741456|NCT00710684|565800627|FG000|Overall Study|Lost to Follow-up|4|||
156741457|NCT00710684|565800628|FG001|Overall Study|Lost to Follow-up|6|||
156741458|NCT00710684|565800629|FG002|Overall Study|Lost to Follow-up|7|||
156741459|NCT00710684|565800627|FG000|Overall Study|Physician Decision|0|||
157020440|NCT04950660|566828436|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
157020441|NCT04950660|566828437|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
157020442|NCT04950660|566828436|FG000|Overall Study|Withdrawal by Subject|0|||
157020443|NCT04950660|566828437|FG001|Overall Study|Withdrawal by Subject|1|||
157020444|NCT04950660|566828436|FG000|Overall Study|Hypotension|1|||
157020445|NCT04950660|566828437|FG001|Overall Study|Hypotension|0|||
157020446|NCT04783935|566828442|FG000|Overall Study|Withdrawal by Subject|6|||
157020447|NCT04783935|566828442|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
157020448|NCT04783935|566828442|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
156741460|NCT00710684|565800628|FG001|Overall Study|Physician Decision|2|||
156741461|NCT00710684|565800629|FG002|Overall Study|Physician Decision|4|||
156741462|NCT00710684|565800627|FG000|Overall Study|Withdrawal by Subject|24|||
156741463|NCT00710684|565800628|FG001|Overall Study|Withdrawal by Subject|18|||
156741464|NCT00710684|565800629|FG002|Overall Study|Withdrawal by Subject|11|||
156741465|NCT00710684|565800627|FG000|Overall Study|Missing|1|||
156741466|NCT00710684|565800628|FG001|Overall Study|Missing|0|||
156741467|NCT00710684|565800629|FG002|Overall Study|Missing|0|||
156741468|NCT00710684|565800627|FG000|Overall Study|Did not continue after week 24|25|||
156741469|NCT00710684|565800628|FG001|Overall Study|Did not continue after week 24|21|||
156741470|NCT00710684|565800629|FG002|Overall Study|Did not continue after week 24|16|||
156741471|NCT04778059|565800630|FG000|Overall Study|Death|2|||
156741472|NCT04778059|565800631|FG001|Overall Study|Death|2|||
156741473|NCT04778059|565800632|FG002|Overall Study|Death|1|||
156741474|NCT04778059|565800633|FG003|Overall Study|Death|1|||
156741475|NCT04778059|565800634|FG004|Overall Study|Death|1|||
156741476|NCT04778059|565800630|FG000|Overall Study|Lost to Follow-up|0|||
156741477|NCT04778059|565800631|FG001|Overall Study|Lost to Follow-up|0|||
156741478|NCT04778059|565800632|FG002|Overall Study|Lost to Follow-up|0|||
156741479|NCT04778059|565800633|FG003|Overall Study|Lost to Follow-up|0|||
156741480|NCT04778059|565800634|FG004|Overall Study|Lost to Follow-up|1|||
156741481|NCT04778059|565800630|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741482|NCT04778059|565800631|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741483|NCT04778059|565800632|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
157218637|NCT03038113|567547481|FG010|Overall Study|Lost to Follow-up|0|||
157218638|NCT03038113|567547482|FG011|Overall Study|Lost to Follow-up|0|||
156741484|NCT04778059|565800633|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
156741485|NCT04778059|565800634|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
156741486|NCT02832375|565800635|FG000|Overall Study|Lost to Follow-up|1|||
156797678|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
156797679|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
156797680|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
156797681|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
157020449|NCT04783935|566828442|FG000|Overall Study|Lost to Follow-up|3|||
157020450|NCT04783935|566828442|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
156741487|NCT02832375|565800636|FG001|Overall Study|Lost to Follow-up|0|||
156741488|NCT02832375|565800635|FG000|Overall Study|Withdrawal of Consent|1|||
156741489|NCT02832375|565800636|FG001|Overall Study|Withdrawal of Consent|0|||
157020451|NCT02437318|566828443|FG000|Overall Study|Progressive disease|207|||
156741490|NCT00514904|565800637|FG000|Overall Study|Withdrawal by Subject|3|||
157020452|NCT02437318|566828444|FG001|Overall Study|Progressive disease|240|||
157020453|NCT02437318|566828443|FG000|Overall Study|Subject/guardian decision|24|||
157218639|NCT03038113|567547483|FG012|Overall Study|Lost to Follow-up|0|||
156741491|NCT00514904|565800638|FG001|Overall Study|Withdrawal by Subject|2|||
156741492|NCT00514904|565800637|FG000|Overall Study|Lost to Follow-up|21|||
156741493|NCT00514904|565800638|FG001|Overall Study|Lost to Follow-up|3|||
156741494|NCT00084318|565800639|FG000|Overall Study|Withdrawal by Subject|5|||
156741495|NCT00084318|565800640|FG001|Overall Study|Withdrawal by Subject|2|||
156741496|NCT00084318|565800639|FG000|Overall Study|Protocol Violation|15|||
156741497|NCT00084318|565800640|FG001|Overall Study|Protocol Violation|11|||
156741498|NCT00084318|565800639|FG000|Overall Study|No protocol treatment|2|||
156741499|NCT00084318|565800640|FG001|Overall Study|No protocol treatment|0|||
156741500|NCT01317797|565800641|FG000|Overall Study|Other|0|||
156741501|NCT01317797|565800642|FG001|Overall Study|Other|1|||
156741502|NCT01317797|565800643|FG002|Overall Study|Other|0|||
156741503|NCT01317797|565800641|FG000|Overall Study|Withdrawal of Patient|0|||
156741504|NCT01317797|565800642|FG001|Overall Study|Withdrawal of Patient|0|||
156741505|NCT01317797|565800643|FG002|Overall Study|Withdrawal of Patient|1|||
156741506|NCT03026530|565800647|FG000|Overall Study|Lost to Follow-up|19|||
157218640|NCT03038113|567547484|FG013|Overall Study|Lost to Follow-up|0|||
157218641|NCT02927847|567547488|FG000|Overall Study|Lost to Follow-up|1|||
157218642|NCT02927847|567547489|FG001|Overall Study|Lost to Follow-up|0|||
156741507|NCT03026530|565800648|FG001|Overall Study|Lost to Follow-up|24|||
156741508|NCT03026530|565800647|FG000|Overall Study|Protocol Violation|2|||
156741509|NCT03026530|565800648|FG001|Overall Study|Protocol Violation|5|||
156741510|NCT03721835|565800649|FG000|Overall Study|Participant not able to return|1|||
156741511|NCT03721835|565800649|FG000|Overall Study|Lost to Follow-up|1|||
156741512|NCT03721835|565800649|FG000|Overall Study|Revision of the components of the study device|2|||
156741513|NCT03721835|565800649|FG000|Overall Study|Sponsor terminated study|6|||
156741514|NCT03721835|565800649|FG000|Overall Study|Death|1|||
156741515|NCT03721835|565800649|FG000|Overall Study|Sponsor decision|1|||
156741516|NCT02100670|565800650|FG000|Overall Study|Adverse Event|10|||
156741517|NCT02100670|565800651|FG001|Overall Study|Adverse Event|3|||
156741518|NCT02100670|565800652|FG002|Overall Study|Adverse Event|3|||
156741519|NCT02100670|565800653|FG003|Overall Study|Adverse Event|0|||
156741520|NCT02100670|565800650|FG000|Overall Study|Lost to Follow-up|1|||
156741521|NCT02100670|565800651|FG001|Overall Study|Lost to Follow-up|0|||
156741522|NCT02100670|565800652|FG002|Overall Study|Lost to Follow-up|0|||
156741523|NCT02100670|565800653|FG003|Overall Study|Lost to Follow-up|0|||
156741524|NCT02100670|565800650|FG000|Overall Study|Protocol Violation|0|||
156741525|NCT02100670|565800651|FG001|Overall Study|Protocol Violation|1|||
156741526|NCT02100670|565800652|FG002|Overall Study|Protocol Violation|0|||
156741527|NCT02100670|565800653|FG003|Overall Study|Protocol Violation|1|||
156741528|NCT02100670|565800650|FG000|Overall Study|Withdrawal of Consent|0|||
156741529|NCT02100670|565800651|FG001|Overall Study|Withdrawal of Consent|1|||
156741530|NCT02100670|565800652|FG002|Overall Study|Withdrawal of Consent|1|||
156741531|NCT02100670|565800653|FG003|Overall Study|Withdrawal of Consent|0|||
156741532|NCT02100670|565800650|FG000|Overall Study|No swelling no pain|1|||
156741533|NCT02100670|565800651|FG001|Overall Study|No swelling no pain|0|||
156741534|NCT02100670|565800652|FG002|Overall Study|No swelling no pain|0|||
157218643|NCT02927847|567547488|FG000|Overall Study|Withdrawal by Subject|4|||
157218644|NCT02927847|567547489|FG001|Overall Study|Withdrawal by Subject|2|||
157218645|NCT02927847|567547488|FG000|Overall Study|PI withdrawn due to missed visits|1|||
156741535|NCT02100670|565800653|FG003|Overall Study|No swelling no pain|0|||
156797682|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
156797683|NCT02958865|566013379|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797684|NCT02958865|566013380|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797685|NCT02958865|566013381|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797686|NCT02958865|566013382|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797687|NCT02958865|566013383|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
156797688|NCT02958865|566013384|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797689|NCT02958865|566013385|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797690|NCT02958865|566013386|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797691|NCT02958865|566013387|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797692|NCT02958865|566013388|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797693|NCT02958865|566013389|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797694|NCT02958865|566013390|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797695|NCT02958865|566013391|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797696|NCT02958865|566013392|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797697|NCT02958865|566013393|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156797698|NCT02958865|566013394|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156741536|NCT02100670|565800650|FG000|Overall Study|Poor Efficacy|0|||
156741537|NCT02100670|565800651|FG001|Overall Study|Poor Efficacy|1|||
156741538|NCT02100670|565800652|FG002|Overall Study|Poor Efficacy|0|||
156741539|NCT02100670|565800653|FG003|Overall Study|Poor Efficacy|0|||
156741540|NCT02100670|565800650|FG000|Overall Study|Physician Decision|0|||
156741541|NCT02100670|565800651|FG001|Overall Study|Physician Decision|1|||
156797699|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
157021791|NCT03623321|566832972|FG000|Overall Study|Adverse Event|32|||
156741542|NCT02100670|565800652|FG002|Overall Study|Physician Decision|0|||
156741543|NCT02100670|565800653|FG003|Overall Study|Physician Decision|0|||
156741544|NCT02100670|565800650|FG000|Overall Study|Withdrawal by Subject|1|||
156741545|NCT02100670|565800651|FG001|Overall Study|Withdrawal by Subject|0|||
156741546|NCT02100670|565800652|FG002|Overall Study|Withdrawal by Subject|0|||
156741547|NCT02100670|565800653|FG003|Overall Study|Withdrawal by Subject|0|||
156741548|NCT05741346|565802421|FG000|Overall Study|Withdrawn due to termination of study|28|||
156741549|NCT04439357|565802425|FG000|Overall Study|Disease Progression|4|||
156741550|NCT01458951|565802440|FG000|Overall Study|Other|1|||
156741551|NCT01458951|565802441|FG001|Overall Study|Other|0|||
156741552|NCT01458951|565802442|FG002|Overall Study|Other|0|||
156741553|NCT01458951|565802440|FG000|Overall Study|Protocol Violation|5|||
156741554|NCT01458951|565802441|FG001|Overall Study|Protocol Violation|1|||
156741555|NCT01458951|565802442|FG002|Overall Study|Protocol Violation|0|||
156741556|NCT01458951|565802440|FG000|Overall Study|Withdrawal by Subject|2|||
156741557|NCT01458951|565802441|FG001|Overall Study|Withdrawal by Subject|0|||
156741558|NCT01458951|565802442|FG002|Overall Study|Withdrawal by Subject|2|||
156741559|NCT01458951|565802440|FG000|Overall Study|Adverse Event|7|||
156741560|NCT01458951|565802441|FG001|Overall Study|Adverse Event|0|||
156741561|NCT01458951|565802442|FG002|Overall Study|Adverse Event|2|||
156741562|NCT01458951|565802440|FG000|Overall Study|Insufficient Clinical Response|17|||
156741563|NCT01458951|565802441|FG001|Overall Study|Insufficient Clinical Response|0|||
156741564|NCT01458951|565802442|FG002|Overall Study|Insufficient Clinical Response|11|||
156741565|NCT01668966|565802447|FG000|Overall Study|Withdrawal by Subject|1|||
156741566|NCT01668966|565802447|FG000|Overall Study|Death|1|||
156741567|NCT01668966|565802447|FG000|Overall Study|Not treated|2|||
156741568|NCT04392167|565802449|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
156741569|NCT01573767|565802450|FG000|Overall Study|Adverse Event|0|||
156741570|NCT01573767|565802451|FG001|Overall Study|Adverse Event|1|||
156741571|NCT01573767|565802452|FG002|Overall Study|Adverse Event|0|||
156741572|NCT01573767|565802453|FG003|Overall Study|Adverse Event|1|||
156741573|NCT01573767|565802450|FG000|Overall Study|Lack of Efficacy|18|||
156741574|NCT01573767|565802451|FG001|Overall Study|Lack of Efficacy|15|||
156741575|NCT01573767|565802452|FG002|Overall Study|Lack of Efficacy|12|||
156741576|NCT01573767|565802453|FG003|Overall Study|Lack of Efficacy|17|||
156741577|NCT01573767|565802450|FG000|Overall Study|Protocol Violation|3|||
156741578|NCT01573767|565802451|FG001|Overall Study|Protocol Violation|1|||
156741579|NCT01573767|565802452|FG002|Overall Study|Protocol Violation|1|||
156741580|NCT01573767|565802453|FG003|Overall Study|Protocol Violation|3|||
156741581|NCT01573767|565802450|FG000|Overall Study|Lost to Follow-up|0|||
156741582|NCT01573767|565802451|FG001|Overall Study|Lost to Follow-up|1|||
156741583|NCT01573767|565802452|FG002|Overall Study|Lost to Follow-up|1|||
156741584|NCT01573767|565802453|FG003|Overall Study|Lost to Follow-up|1|||
156741585|NCT01573767|565802450|FG000|Overall Study|Physician Decision|1|||
156741586|NCT01573767|565802451|FG001|Overall Study|Physician Decision|2|||
156741587|NCT01573767|565802452|FG002|Overall Study|Physician Decision|0|||
156741588|NCT01573767|565802453|FG003|Overall Study|Physician Decision|2|||
156741589|NCT01573767|565802450|FG000|Overall Study|Withdrawal by Subject|0|||
156741590|NCT01573767|565802451|FG001|Overall Study|Withdrawal by Subject|1|||
156741591|NCT01573767|565802452|FG002|Overall Study|Withdrawal by Subject|0|||
156741592|NCT01573767|565802453|FG003|Overall Study|Withdrawal by Subject|0|||
156741593|NCT04076059|565802456|FG000|Double Blind Phase|Progressive disease|22|||
156741594|NCT04076059|565802457|FG001|Double Blind Phase|Progressive disease|26|||
156741595|NCT04076059|565802458|FG002|Double Blind Phase|Progressive disease|0|||
156741596|NCT04076059|565802456|FG000|Double Blind Phase|Withdrawal by Subject|4|||
156741597|NCT04076059|565802457|FG001|Double Blind Phase|Withdrawal by Subject|11|||
156741598|NCT04076059|565802458|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156741599|NCT04076059|565802456|FG000|Double Blind Phase|Death|1|||
156741600|NCT04076059|565802457|FG001|Double Blind Phase|Death|1|||
156741601|NCT04076059|565802458|FG002|Double Blind Phase|Death|0|||
156741602|NCT04076059|565802456|FG000|Double Blind Phase|Lost to Follow-up|1|||
156741603|NCT04076059|565802457|FG001|Double Blind Phase|Lost to Follow-up|0|||
156741604|NCT04076059|565802458|FG002|Double Blind Phase|Lost to Follow-up|0|||
157020454|NCT02437318|566828444|FG001|Overall Study|Subject/guardian decision|11|||
156741605|NCT04076059|565802456|FG000|Double Blind Phase|Adverse Event|5|||
156741606|NCT04076059|565802457|FG001|Double Blind Phase|Adverse Event|1|||
156741607|NCT04076059|565802458|FG002|Double Blind Phase|Adverse Event|0|||
156741608|NCT04076059|565802456|FG000|Double Blind Phase|Ongoing Participants|82|||
156741609|NCT04076059|565802457|FG001|Double Blind Phase|Ongoing Participants|18|||
157218646|NCT02927847|567547489|FG001|Overall Study|PI withdrawn due to missed visits|1|||
157218647|NCT00175019|567547493|FG000|Overall Study|Adverse Event|54|||
157218648|NCT00175019|567547494|FG001|Overall Study|Adverse Event|22|||
157218649|NCT00175019|567547495|FG002|Overall Study|Adverse Event|2|||
157218650|NCT00175019|567547493|FG000|Overall Study|Protocol Violation|6|||
157218651|NCT00175019|567547494|FG001|Overall Study|Protocol Violation|3|||
157218652|NCT00175019|567547495|FG002|Overall Study|Protocol Violation|3|||
157218653|NCT00175019|567547493|FG000|Overall Study|Lost to Follow-up|42|||
157218654|NCT00175019|567547494|FG001|Overall Study|Lost to Follow-up|39|||
157218655|NCT00175019|567547495|FG002|Overall Study|Lost to Follow-up|9|||
157218656|NCT00175019|567547493|FG000|Overall Study|Did not continue under Amendment 4|1|||
157218657|NCT00175019|567547494|FG001|Overall Study|Did not continue under Amendment 4|1|||
157218658|NCT00175019|567547495|FG002|Overall Study|Did not continue under Amendment 4|2|||
157218659|NCT00175019|567547493|FG000|Overall Study|Personal Reason(s)|39|||
157218660|NCT00175019|567547494|FG001|Overall Study|Personal Reason(s)|31|||
157218661|NCT00175019|567547495|FG002|Overall Study|Personal Reason(s)|8|||
157218662|NCT00175019|567547493|FG000|Overall Study|Therapeutic Failure|10|||
157218663|NCT00175019|567547494|FG001|Overall Study|Therapeutic Failure|38|||
157218664|NCT00175019|567547495|FG002|Overall Study|Therapeutic Failure|22|||
157218665|NCT00175019|567547493|FG000|Overall Study|Gout Flare|2|||
157218666|NCT00175019|567547494|FG001|Overall Study|Gout Flare|3|||
157218667|NCT00175019|567547495|FG002|Overall Study|Gout Flare|0|||
157218668|NCT00175019|567547493|FG000|Overall Study|Reason Not Specified|40|||
157218669|NCT00175019|567547494|FG001|Overall Study|Reason Not Specified|34|||
157218670|NCT00175019|567547495|FG002|Overall Study|Reason Not Specified|11|||
157218671|NCT01405820|567547496|FG000|Randomized Treatment Period|Adverse Event|3|||
157218672|NCT01405820|567547497|FG001|Randomized Treatment Period|Adverse Event|3|||
157218673|NCT01405820|567547498|FG002|Randomized Treatment Period|Adverse Event|3|||
157218674|NCT01405820|567547499|FG003|Randomized Treatment Period|Adverse Event|0|||
157218675|NCT01405820|567547500|FG004|Randomized Treatment Period|Adverse Event|2|||
157218676|NCT01405820|567547501|FG005|Randomized Treatment Period|Adverse Event|1|||
157218677|NCT01405820|567547496|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
157218678|NCT01405820|567547497|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
157218679|NCT01405820|567547498|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
157218680|NCT01405820|567547499|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
157218681|NCT01405820|567547500|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
157218682|NCT01405820|567547501|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
157218683|NCT01405820|567547496|FG000|Randomized Treatment Period|Other|2|||
157218684|NCT01405820|567547497|FG001|Randomized Treatment Period|Other|2|||
157218685|NCT01405820|567547498|FG002|Randomized Treatment Period|Other|1|||
157218686|NCT01405820|567547499|FG003|Randomized Treatment Period|Other|1|||
157218687|NCT01405820|567547500|FG004|Randomized Treatment Period|Other|0|||
157218688|NCT01405820|567547501|FG005|Randomized Treatment Period|Other|0|||
157218689|NCT01405820|567547496|FG000|Randomized Treatment Period|Physician Decision|0|||
157218690|NCT01405820|567547497|FG001|Randomized Treatment Period|Physician Decision|2|||
157218691|NCT01405820|567547498|FG002|Randomized Treatment Period|Physician Decision|1|||
157218692|NCT01405820|567547499|FG003|Randomized Treatment Period|Physician Decision|0|||
157218693|NCT01405820|567547500|FG004|Randomized Treatment Period|Physician Decision|0|||
157218694|NCT01405820|567547501|FG005|Randomized Treatment Period|Physician Decision|0|||
157218695|NCT01405820|567547496|FG000|Randomized Treatment Period|Rescue|0|||
157218696|NCT01405820|567547497|FG001|Randomized Treatment Period|Rescue|1|||
157218697|NCT01405820|567547498|FG002|Randomized Treatment Period|Rescue|13|||
157218698|NCT01405820|567547499|FG003|Randomized Treatment Period|Rescue|10|||
157218699|NCT01405820|567547500|FG004|Randomized Treatment Period|Rescue|8|||
157218700|NCT01405820|567547501|FG005|Randomized Treatment Period|Rescue|8|||
156741610|NCT04076059|565802458|FG002|Double Blind Phase|Ongoing Participants|0|||
156741611|NCT04076059|565802456|FG000|Double Blind Phase|Miscellaneous|3|||
156741612|NCT04076059|565802457|FG001|Double Blind Phase|Miscellaneous|1|||
156741613|NCT04076059|565802458|FG002|Double Blind Phase|Miscellaneous|0|||
156741614|NCT04076059|565802456|FG000|Double Blind Phase|Protocol Deviation|1|||
156741615|NCT04076059|565802457|FG001|Double Blind Phase|Protocol Deviation|1|||
156741616|NCT04076059|565802458|FG002|Double Blind Phase|Protocol Deviation|0|||
156741617|NCT04076059|565802456|FG000|Double Blind Phase|Did not take study drug|1|||
156741618|NCT04076059|565802457|FG001|Double Blind Phase|Did not take study drug|1|||
156741619|NCT04076059|565802458|FG002|Double Blind Phase|Did not take study drug|0|||
156741620|NCT04076059|565802456|FG000|Open Label Phase|Progressive disease|0|||
156741621|NCT04076059|565802457|FG001|Open Label Phase|Progressive disease|0|||
157218701|NCT01405820|567547496|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
157218702|NCT01405820|567547497|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
157218703|NCT01405820|567547498|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
157218704|NCT01405820|567547499|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
157218705|NCT01405820|567547500|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
157218706|NCT01405820|567547501|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
157218707|NCT01405820|567547496|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
157020455|NCT02437318|566828443|FG000|Overall Study|Physician Decision|29|||
156797700|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797701|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797702|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797703|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797704|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797705|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797706|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797707|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797708|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
156797709|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
156797710|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797711|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
156797712|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797713|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
156797714|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
156797715|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797716|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797717|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797718|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797719|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797720|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797721|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797722|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797723|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
156797724|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
156797725|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797726|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
156797727|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797728|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
156797729|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
156797730|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
156797731|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797732|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797733|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797734|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797735|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797736|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797737|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797738|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
157020456|NCT02437318|566828444|FG001|Overall Study|Physician Decision|22|||
157020457|NCT02437318|566828443|FG000|Overall Study|Adverse Event|14|||
157020458|NCT02437318|566828444|FG001|Overall Study|Adverse Event|4|||
157020459|NCT02437318|566828443|FG000|Overall Study|Death|4|||
157020460|NCT02437318|566828444|FG001|Overall Study|Death|4|||
157142848|NCT02128490|567271121|FG000|Overall Study|Major Protocol Deviation|1|||
156741622|NCT04076059|565802458|FG002|Open Label Phase|Progressive disease|7|||
156741623|NCT04076059|565802456|FG000|Open Label Phase|Withdrawal by Subject|0|||
156741624|NCT04076059|565802457|FG001|Open Label Phase|Withdrawal by Subject|0|||
156741625|NCT04076059|565802458|FG002|Open Label Phase|Withdrawal by Subject|3|||
156741626|NCT04076059|565802456|FG000|Open Label Phase|Death|0|||
156741627|NCT04076059|565802457|FG001|Open Label Phase|Death|0|||
156741628|NCT04076059|565802458|FG002|Open Label Phase|Death|2|||
156741629|NCT04076059|565802456|FG000|Open Label Phase|Ongoing Participants|0|||
156741630|NCT04076059|565802457|FG001|Open Label Phase|Ongoing Participants|0|||
156741631|NCT04076059|565802458|FG002|Open Label Phase|Ongoing Participants|11|||
156741632|NCT04186806|565802459|FG000|Period 1: 7 Days|Adverse Event|1|||
156741633|NCT04186806|565802460|FG001|Period 1: 7 Days|Adverse Event|0|||
156741634|NCT02720744|565802464|FG000|Overall Study|Protocol Violation|0|||
156741635|NCT02720744|565802465|FG001|Overall Study|Protocol Violation|2|||
156741636|NCT02720744|565802464|FG000|Overall Study|Pregnancy|2|||
156741637|NCT02720744|565802465|FG001|Overall Study|Pregnancy|0|||
156741638|NCT02720744|565802464|FG000|Overall Study|Lack of Efficacy|2|||
156741639|NCT02720744|565802465|FG001|Overall Study|Lack of Efficacy|8|||
156741640|NCT02720744|565802464|FG000|Overall Study|Adverse Event|21|||
156741641|NCT02720744|565802465|FG001|Overall Study|Adverse Event|3|||
156741642|NCT02720744|565802464|FG000|Overall Study|Withdrawal by Subject|11|||
156741643|NCT02720744|565802465|FG001|Overall Study|Withdrawal by Subject|11|||
156741644|NCT02720744|565802464|FG000|Overall Study|Lost to follow up|2|||
156741645|NCT02720744|565802465|FG001|Overall Study|Lost to follow up|0|||
156741646|NCT02720744|565802464|FG000|Overall Study|Non Compliance with Investigational Product|0|||
156741647|NCT02720744|565802465|FG001|Overall Study|Non Compliance with Investigational Product|1|||
156741648|NCT02720744|565802464|FG000|Overall Study|Excluded Concomitant Medication|0|||
156741649|NCT02720744|565802465|FG001|Overall Study|Excluded Concomitant Medication|1|||
156741650|NCT06137703|565802466|FG000|Overall Study|Other|0|||
156797739|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797740|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
156797741|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797742|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797743|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797744|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797745|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
156797746|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
156797747|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797748|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797749|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797750|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797751|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797752|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797753|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797754|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797755|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797756|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
157142849|NCT02128490|567271122|FG001|Overall Study|Major Protocol Deviation|2|||
157142850|NCT02128490|567271123|FG002|Overall Study|Major Protocol Deviation|0|||
157142851|NCT02128490|567271124|FG003|Overall Study|Major Protocol Deviation|2|||
157142852|NCT02128490|567271125|FG004|Overall Study|Major Protocol Deviation|2|||
157142853|NCT02128490|567271121|FG000|Overall Study|Lost to Follow-up|0|||
157142854|NCT02128490|567271122|FG001|Overall Study|Lost to Follow-up|0|||
157142855|NCT02128490|567271123|FG002|Overall Study|Lost to Follow-up|1|||
157142856|NCT02128490|567271124|FG003|Overall Study|Lost to Follow-up|1|||
157142857|NCT02128490|567271125|FG004|Overall Study|Lost to Follow-up|1|||
157142858|NCT02128490|567271121|FG000|Overall Study|Voluntary Withdrawal|3|||
157142859|NCT02128490|567271122|FG001|Overall Study|Voluntary Withdrawal|3|||
157142860|NCT02128490|567271123|FG002|Overall Study|Voluntary Withdrawal|1|||
157142861|NCT02128490|567271124|FG003|Overall Study|Voluntary Withdrawal|1|||
157142862|NCT02128490|567271125|FG004|Overall Study|Voluntary Withdrawal|2|||
157142863|NCT02128490|567271121|FG000|Overall Study|Lack of Efficacy|0|||
157142864|NCT02128490|567271122|FG001|Overall Study|Lack of Efficacy|1|||
157142865|NCT02128490|567271123|FG002|Overall Study|Lack of Efficacy|0|||
157142866|NCT02128490|567271124|FG003|Overall Study|Lack of Efficacy|0|||
156741651|NCT06137703|565802467|FG001|Overall Study|Other|1|||
156741652|NCT06137703|565802468|FG002|Overall Study|Other|0|||
156741653|NCT06137703|565802469|FG003|Overall Study|Other|0|||
157142867|NCT02128490|567271125|FG004|Overall Study|Lack of Efficacy|0|||
157142868|NCT02128490|567271121|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156741654|NCT06137703|565802466|FG000|Overall Study|Adverse Event|0|||
156741655|NCT06137703|565802467|FG001|Overall Study|Adverse Event|0|||
156741656|NCT06137703|565802468|FG002|Overall Study|Adverse Event|1|||
156741657|NCT06137703|565802469|FG003|Overall Study|Adverse Event|0|||
156741658|NCT00741091|565802470|FG000|Overall Study|Death|13|||
156741659|NCT00741091|565802470|FG000|Overall Study|Lost to Follow-up|16|||
156741660|NCT00741091|565802470|FG000|Overall Study|Withdrawal by Subject|6|||
156741661|NCT00741091|565802470|FG000|Overall Study|Missed Visit|22|||
156741662|NCT01801358|565802471|FG000|Overall Study|Adverse Event|0|||
156741663|NCT01801358|565802472|FG001|Overall Study|Adverse Event|2|||
156741664|NCT01801358|565802473|FG002|Overall Study|Adverse Event|1|||
156741665|NCT01801358|565802474|FG003|Overall Study|Adverse Event|0|||
156741666|NCT01801358|565802475|FG004|Overall Study|Adverse Event|0|||
156741667|NCT01801358|565802476|FG005|Overall Study|Adverse Event|1|||
156741668|NCT01801358|565802471|FG000|Overall Study|Physician Decision|0|||
156741669|NCT01801358|565802472|FG001|Overall Study|Physician Decision|0|||
156741670|NCT01801358|565802473|FG002|Overall Study|Physician Decision|1|||
156741671|NCT01801358|565802474|FG003|Overall Study|Physician Decision|0|||
156741672|NCT01801358|565802475|FG004|Overall Study|Physician Decision|0|||
156741673|NCT01801358|565802476|FG005|Overall Study|Physician Decision|0|||
156741674|NCT01801358|565802471|FG000|Overall Study|Progressive Disease|6|||
156741675|NCT01801358|565802472|FG001|Overall Study|Progressive Disease|4|||
156741676|NCT01801358|565802473|FG002|Overall Study|Progressive Disease|4|||
156741677|NCT01801358|565802474|FG003|Overall Study|Progressive Disease|5|||
156741678|NCT01801358|565802475|FG004|Overall Study|Progressive Disease|6|||
156741679|NCT01801358|565802476|FG005|Overall Study|Progressive Disease|5|||
156741680|NCT01801358|565802471|FG000|Overall Study|Withdrawal by Subject|0|||
156741681|NCT01801358|565802472|FG001|Overall Study|Withdrawal by Subject|0|||
156741682|NCT01801358|565802473|FG002|Overall Study|Withdrawal by Subject|0|||
156741683|NCT01801358|565802474|FG003|Overall Study|Withdrawal by Subject|1|||
156741684|NCT01801358|565802475|FG004|Overall Study|Withdrawal by Subject|0|||
156741685|NCT01801358|565802476|FG005|Overall Study|Withdrawal by Subject|2|||
156741686|NCT01527487|565802477|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
156741687|NCT01527487|565802478|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
156741688|NCT01527487|565802477|FG000|Overall Study|Disease Progression|4|||
156741689|NCT01527487|565802478|FG001|Overall Study|Disease Progression|1|||
156741690|NCT01527487|565802477|FG000|Overall Study|Adverse Event|1|||
156741691|NCT01527487|565802478|FG001|Overall Study|Adverse Event|1|||
156741692|NCT01527487|565802477|FG000|Overall Study|Death|0|||
156741693|NCT01527487|565802478|FG001|Overall Study|Death|1|||
156741694|NCT01472757|565802481|FG000|Overall Study|Withdrawal by Subject|1|||
156741695|NCT01472757|565802482|FG001|Overall Study|Withdrawal by Subject|2|||
156741696|NCT01472757|565802483|FG002|Overall Study|Withdrawal by Subject|2|||
156741697|NCT01472757|565802484|FG003|Overall Study|Withdrawal by Subject|0|||
156741698|NCT01472757|565802481|FG000|Overall Study|Asthma exacerbation|4|||
156741699|NCT01472757|565802482|FG001|Overall Study|Asthma exacerbation|1|||
156741700|NCT01472757|565802483|FG002|Overall Study|Asthma exacerbation|2|||
156741701|NCT01472757|565802484|FG003|Overall Study|Asthma exacerbation|1|||
156741702|NCT01472757|565802481|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
156741703|NCT01472757|565802482|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
156741704|NCT01472757|565802483|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
156741705|NCT01472757|565802484|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
156741706|NCT01472757|565802481|FG000|Overall Study|Protocol Violation|3|||
156741707|NCT01472757|565802482|FG001|Overall Study|Protocol Violation|2|||
156741708|NCT01472757|565802483|FG002|Overall Study|Protocol Violation|4|||
156741709|NCT01472757|565802484|FG003|Overall Study|Protocol Violation|4|||
156741710|NCT01472757|565802481|FG000|Overall Study|Other reasons|1|||
156741711|NCT01472757|565802482|FG001|Overall Study|Other reasons|0|||
156741712|NCT01472757|565802483|FG002|Overall Study|Other reasons|2|||
156741713|NCT01472757|565802484|FG003|Overall Study|Other reasons|2|||
156741714|NCT02505334|565802485|FG000|Main Treatment Period|Adverse Event|3|||
156741715|NCT02505334|565802486|FG001|Main Treatment Period|Adverse Event|3|||
156741716|NCT02505334|565802485|FG000|Main Treatment Period|Lack of Efficacy|7|||
156741717|NCT02505334|565802486|FG001|Main Treatment Period|Lack of Efficacy|17|||
156741718|NCT02505334|565802485|FG000|Main Treatment Period|Protocol Violation|0|||
156741719|NCT02505334|565802486|FG001|Main Treatment Period|Protocol Violation|1|||
156741720|NCT02505334|565802485|FG000|Main Treatment Period|Withdrawal by Subject|1|||
156741721|NCT02505334|565802486|FG001|Main Treatment Period|Withdrawal by Subject|8|||
156741722|NCT02505334|565802485|FG000|Main Treatment Period|Unclassified|4|||
156741723|NCT02505334|565802486|FG001|Main Treatment Period|Unclassified|10|||
156797757|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
156797758|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
156797759|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
156797760|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
156797761|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
156797762|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
156797763|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
156797764|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
156797765|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
156797766|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
156797767|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
156797768|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
156797769|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
156797770|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
156797771|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
156797772|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
156797773|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
156797774|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
156797775|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
156797776|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
156797777|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
156797778|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
156797779|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797780|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797781|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797782|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156741724|NCT02505334|565802485|FG000|Extension Treatment Period|Adverse Event|5|||
156741725|NCT02505334|565802486|FG001|Extension Treatment Period|Adverse Event|0|||
156741726|NCT02505334|565802485|FG000|Extension Treatment Period|Lack of Efficacy|4|||
156741727|NCT02505334|565802486|FG001|Extension Treatment Period|Lack of Efficacy|0|||
156741728|NCT02505334|565802485|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
156741729|NCT02505334|565802486|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
156741730|NCT02505334|565802485|FG000|Extension Treatment Period|Unclassified|3|||
156797783|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156741731|NCT02505334|565802486|FG001|Extension Treatment Period|Unclassified|0|||
156741732|NCT00597506|565802489|FG000|Overall Study|Subject is being followed for survival|1|||
156741733|NCT00081731|565802492|FG000|Overall Study|scientific integrity issue|8|||
156741734|NCT00081731|565802493|FG001|Overall Study|scientific integrity issue|8|||
156741735|NCT01629823|565802494|FG000|Trial Period|Missed visit|11|||
156741736|NCT01629823|565802495|FG001|Trial Period|Missed visit|9|||
156741737|NCT01629823|565802496|FG002|Trial Period|Missed visit|8|||
156741738|NCT01629823|565802494|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741739|NCT01629823|565802495|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741740|NCT01629823|565802496|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
156741741|NCT01629823|565802494|FG000|Trial Period|Pregnancy|1|||
156741742|NCT01629823|565802495|FG001|Trial Period|Pregnancy|0|||
156741743|NCT01629823|565802496|FG002|Trial Period|Pregnancy|0|||
156741744|NCT01629823|565802494|FG000|Trial Period|Adverse Event|0|||
156741745|NCT01629823|565802495|FG001|Trial Period|Adverse Event|1|||
156741746|NCT01629823|565802496|FG002|Trial Period|Adverse Event|0|||
156741747|NCT01629823|565802494|FG000|Trial Period|Out-of-window visit|0|||
156741748|NCT01629823|565802495|FG001|Trial Period|Out-of-window visit|2|||
156741749|NCT01629823|565802496|FG002|Trial Period|Out-of-window visit|0|||
156741750|NCT01629823|565802494|FG000|Trial Period|Failed to hold medication|0|||
156741751|NCT01629823|565802495|FG001|Trial Period|Failed to hold medication|0|||
156741752|NCT01629823|565802496|FG002|Trial Period|Failed to hold medication|1|||
156741753|NCT01629823|565802494|FG000|Washout Period|Safety|2|||
156741754|NCT01629823|565802495|FG001|Washout Period|Safety|5|||
156741755|NCT01629823|565802496|FG002|Washout Period|Safety|0|||
156741756|NCT01629823|565802494|FG000|Washout Period|Pregnancy|1|||
156741757|NCT01629823|565802495|FG001|Washout Period|Pregnancy|0|||
156741758|NCT01629823|565802496|FG002|Washout Period|Pregnancy|0|||
156741759|NCT01629823|565802494|FG000|Washout Period|Protocol Violation|0|||
156741760|NCT01629823|565802495|FG001|Washout Period|Protocol Violation|1|||
156741761|NCT01629823|565802496|FG002|Washout Period|Protocol Violation|0|||
156741762|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
156741763|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
156741764|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
156741765|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
156741766|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
156741767|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
156741768|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
156741769|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
156741770|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
156741771|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
156741772|NCT00455520|565802498|FG000|Open Label Tapentadol Extended Release|All other|33|||
156741773|NCT00455520|565802499|FG001|Open Label Tapentadol Extended Release|All other|0|||
156741774|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
156741775|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
156741776|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
156741777|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
156741778|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
156741779|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
156741780|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
156741781|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
156741782|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
156741783|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
156741784|NCT00455520|565802498|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
156741785|NCT00455520|565802499|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
156741786|NCT03235115|565802502|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741787|NCT03235115|565802503|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741788|NCT03235115|565802504|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741789|NCT03235115|565802505|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741790|NCT03235115|565802506|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
156741791|NCT03235115|565802507|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
156741792|NCT00503997|565802509|FG000|Overall Study|disease progression|1|||
156741793|NCT00503997|565802509|FG000|Overall Study|Adverse Event|5|||
156741794|NCT00503997|565802509|FG000|Overall Study|Death|1|||
156741795|NCT00503997|565802509|FG000|Overall Study|Withdrawal by Subject|1|||
156741796|NCT01195844|565802510|FG000|Overall Study|Fecal sample not collected|40|||
156741797|NCT05020899|565802511|FG000|8 Week Follow-up|Lost to Follow-up|3|||
157142869|NCT02128490|567271122|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156741798|NCT05020899|565802512|FG001|8 Week Follow-up|Lost to Follow-up|6|||
156741799|NCT05020899|565802511|FG000|12 Week Follow-up|Lost to Follow-up|1|||
156741800|NCT05020899|565802512|FG001|12 Week Follow-up|Lost to Follow-up|0|||
156741801|NCT05020899|565802511|FG000|12 Week Follow-up|Death|0|||
156741802|NCT05020899|565802512|FG001|12 Week Follow-up|Death|1|||
157020461|NCT02437318|566828443|FG000|Overall Study|Protocol deviation|5|||
156741803|NCT01068626|565802515|FG000|Overall Study|Adverse Event|3|||
156741804|NCT01068626|565802516|FG001|Overall Study|Adverse Event|0|||
156741805|NCT01068626|565802515|FG000|Overall Study|Withdrawal by Subject|0|||
156741806|NCT01068626|565802516|FG001|Overall Study|Withdrawal by Subject|2|||
156741807|NCT01785849|565802517|FG000|Overall Study|Death|7|||
156741808|NCT01785849|565802518|FG001|Overall Study|Death|9|||
156741809|NCT01785849|565802517|FG000|Overall Study|Protocol Specified Criteria|29|||
156741810|NCT01785849|565802518|FG001|Overall Study|Protocol Specified Criteria|1|||
156741811|NCT01785849|565802517|FG000|Overall Study|Withdrawal by Subject|15|||
156741812|NCT01785849|565802518|FG001|Overall Study|Withdrawal by Subject|12|||
156741813|NCT01785849|565802517|FG000|Overall Study|Sponsor Decision|0|||
157142870|NCT02128490|567271123|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
157142871|NCT02128490|567271124|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
156741814|NCT01785849|565802518|FG001|Overall Study|Sponsor Decision|1|||
156741815|NCT01785849|565802517|FG000|Overall Study|Lost to Follow-up|10|||
156741816|NCT01785849|565802518|FG001|Overall Study|Lost to Follow-up|11|||
156741817|NCT01032239|565802519|FG000|Overall Study|Lost to Follow-up|3|||
156877891|NCT06173063|566311225|FG000|Overall Study|Withdrawal by Subject|2|||
157020462|NCT02437318|566828444|FG001|Overall Study|Protocol deviation|7|||
157020463|NCT02437318|566828443|FG000|Overall Study|Sponsor decision|1|||
157020464|NCT02437318|566828444|FG001|Overall Study|Sponsor decision|0|||
157020465|NCT03281291|566828448|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
157020466|NCT03281291|566828449|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
157020467|NCT03281291|566828450|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
157020468|NCT03281291|566828451|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
157020469|NCT03281291|566828452|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
157020470|NCT03281291|566828448|FG000|Overall Study|Protocol Deviation|2|||
157020471|NCT03281291|566828449|FG001|Overall Study|Protocol Deviation|0|||
156741818|NCT01032239|565802520|FG001|Overall Study|Lost to Follow-up|2|||
156741819|NCT01032239|565802519|FG000|Overall Study|Withdrawal by Subject|2|||
156741820|NCT01032239|565802520|FG001|Overall Study|Withdrawal by Subject|3|||
156741821|NCT01032239|565802519|FG000|Overall Study|Death|1|||
156741822|NCT01032239|565802520|FG001|Overall Study|Death|0|||
156741823|NCT01032239|565802519|FG000|Overall Study|Protocol Violation|1|||
156741824|NCT01032239|565802520|FG001|Overall Study|Protocol Violation|0|||
156741825|NCT01940900|565802521|FG000|Overall Study|Physician Decision|4|||
156741826|NCT01940900|565802522|FG001|Overall Study|Physician Decision|0|||
156741827|NCT01940900|565802521|FG000|Overall Study|Adverse Event|10|||
156741828|NCT01940900|565802522|FG001|Overall Study|Adverse Event|15|||
156741829|NCT01940900|565802521|FG000|Overall Study|Withdrawal by Subject|11|||
156741830|NCT01940900|565802522|FG001|Overall Study|Withdrawal by Subject|15|||
156741831|NCT01940900|565802521|FG000|Overall Study|Lost to Follow-up|1|||
156741832|NCT01940900|565802522|FG001|Overall Study|Lost to Follow-up|0|||
156741833|NCT01940900|565802521|FG000|Overall Study|Sponsor Decision|1|||
156741834|NCT01940900|565802522|FG001|Overall Study|Sponsor Decision|0|||
156797784|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797785|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797786|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797787|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797788|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797789|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797790|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797791|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797792|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
156797793|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797794|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
156797795|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797796|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797797|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797798|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797799|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797800|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797801|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797802|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797803|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797804|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797805|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797806|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797807|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797808|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
156797809|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797810|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
156797811|NCT02958865|566013379|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797812|NCT02958865|566013380|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797813|NCT02958865|566013381|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797814|NCT02958865|566013382|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797815|NCT02958865|566013383|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797816|NCT02958865|566013384|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797817|NCT02958865|566013385|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797818|NCT02958865|566013386|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
157020472|NCT03281291|566828450|FG002|Overall Study|Protocol Deviation|1|||
157020473|NCT03281291|566828451|FG003|Overall Study|Protocol Deviation|2|||
157020474|NCT03281291|566828452|FG004|Overall Study|Protocol Deviation|1|||
157020475|NCT03281291|566828448|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
156741835|NCT01940900|565802521|FG000|Overall Study|subject non-compliance|1|||
156741836|NCT01940900|565802522|FG001|Overall Study|subject non-compliance|1|||
156741837|NCT01940900|565802521|FG000|Overall Study|other|1|||
157218708|NCT01405820|567547497|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
157218709|NCT01405820|567547498|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
157218710|NCT01405820|567547499|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
157218711|NCT01405820|567547500|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
157218712|NCT01405820|567547501|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
157218713|NCT01405820|567547496|FG000|Randomized Treatment Period|Death|0|||
157218714|NCT01405820|567547497|FG001|Randomized Treatment Period|Death|0|||
157218715|NCT01405820|567547498|FG002|Randomized Treatment Period|Death|0|||
157218716|NCT01405820|567547499|FG003|Randomized Treatment Period|Death|1|||
157218717|NCT01405820|567547500|FG004|Randomized Treatment Period|Death|0|||
157218718|NCT01405820|567547501|FG005|Randomized Treatment Period|Death|0|||
157218719|NCT01405820|567547496|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
157218720|NCT01405820|567547497|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
157218721|NCT01405820|567547498|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156741838|NCT01940900|565802522|FG001|Overall Study|other|0|||
156741839|NCT00204477|565802523|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
156741840|NCT00204477|565802524|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
156741841|NCT00204477|565802523|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
156741842|NCT00204477|565802524|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
156741843|NCT04713592|565802527|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741844|NCT04713592|565802528|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
156741845|NCT04713592|565802529|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741846|NCT04713592|565802530|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
156741847|NCT04713592|565802527|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
156741848|NCT04713592|565802528|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
156741849|NCT04713592|565802529|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
156741850|NCT04713592|565802530|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
156741851|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
156741852|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
156741853|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
156741854|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
156741855|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156741856|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
156741857|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
156741858|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
156741859|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
156741860|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
156741861|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
156741862|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
156741863|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156741864|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
156741865|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156741866|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
156741867|NCT04713592|565802527|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
156741868|NCT04713592|565802528|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
156741869|NCT04713592|565802529|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
156741870|NCT04713592|565802530|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
156741871|NCT03782298|565802535|FG000|Overall Study|Protocol Deviation|4|||
156741872|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
156741873|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
156741874|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
156741875|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
156741876|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
156741877|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
156741878|NCT00742508|565802536|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
156741879|NCT00742508|565802537|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
156741880|NCT00742508|565802536|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
156741881|NCT00742508|565802537|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
156741882|NCT01382225|565802538|FG000|Overall Study|Adverse Event|3|||
156741883|NCT01382225|565802539|FG001|Overall Study|Adverse Event|2|||
156741884|NCT01382225|565802538|FG000|Overall Study|Protocol Violation|2|||
156741885|NCT01382225|565802539|FG001|Overall Study|Protocol Violation|1|||
156741886|NCT01382225|565802538|FG000|Overall Study|Subject Withdrew Consent|5|||
156741887|NCT01382225|565802539|FG001|Overall Study|Subject Withdrew Consent|2|||
156741888|NCT01382225|565802538|FG000|Overall Study|Other|4|||
156741889|NCT01382225|565802539|FG001|Overall Study|Other|2|||
156741890|NCT01797081|565802540|FG000|Overall Study|Adverse Event|1|||
156741891|NCT01797081|565802541|FG001|Overall Study|Adverse Event|0|||
156741892|NCT01797081|565802542|FG002|Overall Study|Adverse Event|1|||
156741893|NCT01797081|565802543|FG003|Overall Study|Adverse Event|0|||
156741894|NCT01797081|565802540|FG000|Overall Study|Pregnancy|1|||
156741895|NCT01797081|565802541|FG001|Overall Study|Pregnancy|0|||
156741896|NCT01797081|565802542|FG002|Overall Study|Pregnancy|0|||
156741897|NCT01797081|565802543|FG003|Overall Study|Pregnancy|0|||
156741898|NCT01797081|565802540|FG000|Overall Study|Personal Reasons|12|||
156797819|NCT02958865|566013387|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797820|NCT02958865|566013388|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
156797821|NCT02958865|566013389|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797822|NCT02958865|566013390|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797823|NCT02958865|566013391|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
157020476|NCT03281291|566828449|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
157020477|NCT03281291|566828450|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
156741899|NCT01797081|565802541|FG001|Overall Study|Personal Reasons|4|||
156741900|NCT01797081|565802542|FG002|Overall Study|Personal Reasons|4|||
156741901|NCT01797081|565802543|FG003|Overall Study|Personal Reasons|8|||
156741902|NCT01797081|565802540|FG000|Overall Study|Protocol Violation|0|||
156741903|NCT01797081|565802541|FG001|Overall Study|Protocol Violation|0|||
156741904|NCT01797081|565802542|FG002|Overall Study|Protocol Violation|0|||
156741905|NCT01797081|565802543|FG003|Overall Study|Protocol Violation|1|||
156741906|NCT05513703|565802552|FG000|Overall Study|Death|4|||
156797824|NCT02958865|566013392|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797825|NCT02958865|566013393|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797826|NCT02958865|566013394|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
156797827|NCT01309230|566013395|FG000|Overall Study|Withdrawal by Subject|0|||
156797828|NCT01309230|566013396|FG001|Overall Study|Withdrawal by Subject|2|||
156797829|NCT01309230|566013395|FG000|Overall Study|Observation arm closed|0|||
156797830|NCT01309230|566013396|FG001|Overall Study|Observation arm closed|2|||
156797831|NCT02661815|566013397|FG000|Overall Study|Withdrawal by Subject|1|||
156797832|NCT02661815|566013398|FG001|Overall Study|Withdrawal by Subject|0|||
156797833|NCT02661815|566013399|FG002|Overall Study|Withdrawal by Subject|0|||
156797834|NCT02661815|566013400|FG003|Overall Study|Withdrawal by Subject|0|||
156797835|NCT03078868|566013406|FG000|Overall Study|Physician Decision|3|||
156797836|NCT03038620|566013407|FG000|Overall Study|Lost to Follow-up|18|||
156797837|NCT03038620|566013408|FG001|Overall Study|Lost to Follow-up|23|||
156797838|NCT03038620|566013407|FG000|Overall Study|Withdrawal by Subject|0|||
156797839|NCT03038620|566013408|FG001|Overall Study|Withdrawal by Subject|15|||
156797840|NCT03038620|566013407|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
156797841|NCT03038620|566013408|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
156797842|NCT00105066|566013409|FG000|Overall Study|Adverse Event|2|||
156797843|NCT00105066|566013410|FG001|Overall Study|Adverse Event|5|||
156797844|NCT03261505|566013419|FG000|Overall Study|Withdrawal by Subject|2|||
156741907|NCT05513703|565802552|FG000|Overall Study|Study terminated by sponsor|5|||
156741908|NCT02484651|565802554|FG000|Overall Study|Patients' data files were corrupted.|1|||
156741909|NCT02484651|565802555|FG001|Overall Study|Patients' data files were corrupted.|1|||
156741910|NCT02484651|565802554|FG000|Overall Study|BIS monitoring failed.|1|||
156741911|NCT02484651|565802555|FG001|Overall Study|BIS monitoring failed.|1|||
156741912|NCT02484651|565802554|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
156797845|NCT03261505|566013420|FG001|Overall Study|Withdrawal by Subject|3|||
156797846|NCT03261505|566013421|FG002|Overall Study|Withdrawal by Subject|4|||
156797847|NCT03261505|566013422|FG003|Overall Study|Withdrawal by Subject|3|||
156797848|NCT03261505|566013419|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797849|NCT03261505|566013420|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797850|NCT03261505|566013421|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
156741913|NCT02484651|565802555|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
156741914|NCT03619902|565802557|FG000|Overall Study|Termination of Study by Investigator|1|||
156741915|NCT03619902|565802557|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
156741916|NCT02537431|565802560|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
156741917|NCT02278120|565802562|FG000|Treatment Period|Progressive disease|234|||
156741918|NCT02278120|565802563|FG001|Treatment Period|Progressive disease|260|||
156741919|NCT02278120|565802562|FG000|Treatment Period|Subject/guardian decision|23|||
156741920|NCT02278120|565802563|FG001|Treatment Period|Subject/guardian decision|20|||
156741921|NCT02278120|565802562|FG000|Treatment Period|Adverse Event|16|||
156741922|NCT02278120|565802563|FG001|Treatment Period|Adverse Event|14|||
156741923|NCT02278120|565802562|FG000|Treatment Period|Physician Decision|14|||
156741924|NCT02278120|565802563|FG001|Treatment Period|Physician Decision|27|||
156741925|NCT02278120|565802562|FG000|Treatment Period|Death|3|||
156741926|NCT02278120|565802563|FG001|Treatment Period|Death|3|||
156741927|NCT02278120|565802562|FG000|Treatment Period|Lost to Follow-up|2|||
156741928|NCT02278120|565802563|FG001|Treatment Period|Lost to Follow-up|0|||
156741929|NCT02278120|565802562|FG000|Treatment Period|Protocol deviation|0|||
156741930|NCT02278120|565802563|FG001|Treatment Period|Protocol deviation|2|||
156741931|NCT02278120|565802562|FG000|Treatment Period|Study terminated as per protocol|43|||
156741932|NCT02278120|565802563|FG001|Treatment Period|Study terminated as per protocol|11|||
156741933|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156741934|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Death|1|||
156741935|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156741936|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156741937|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
156741938|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
156741939|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
156741940|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
156741941|NCT02278120|565802562|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156741942|NCT02278120|565802563|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156741943|NCT03197324|565802567|FG000|Overall Study|Adverse Event|0|||
156741944|NCT03197324|565802568|FG001|Overall Study|Adverse Event|1|||
156741945|NCT00102531|565802569|FG000|Overall Study|Adverse Event|0|||
156741946|NCT00102531|565802570|FG001|Overall Study|Adverse Event|1|||
156741947|NCT00102531|565802569|FG000|Overall Study|Disease Progression|5|||
156741948|NCT00102531|565802570|FG001|Overall Study|Disease Progression|9|||
156741949|NCT00102531|565802569|FG000|Overall Study|Physician Decision|0|||
156741950|NCT00102531|565802570|FG001|Overall Study|Physician Decision|1|||
156741951|NCT04216589|565802575|FG000|Overall Study|Withdrawal by Subject|2|||
156741952|NCT04216589|565802575|FG000|Overall Study|Protocol Violation|1|||
156741953|NCT04216589|565802575|FG000|Overall Study|Incarceration|1|||
156741954|NCT04676412|565803839|FG000|Overall Study|Death|28|||
156741955|NCT04676412|565803840|FG001|Overall Study|Death|31|||
156741956|NCT04676412|565803839|FG000|Overall Study|Lost to Follow-up|1|||
156741957|NCT04676412|565803840|FG001|Overall Study|Lost to Follow-up|2|||
156741958|NCT04676412|565803839|FG000|Overall Study|Sponsor Decision|20|||
156741959|NCT04676412|565803840|FG001|Overall Study|Sponsor Decision|23|||
156741960|NCT04676412|565803839|FG000|Overall Study|Withdrawal by Subject|0|||
156741961|NCT04676412|565803840|FG001|Overall Study|Withdrawal by Subject|2|||
156741962|NCT00250458|565803842|FG000|Overall Study|Lost to Follow-up|4|||
156741963|NCT00250458|565803843|FG001|Overall Study|Lost to Follow-up|2|||
156741964|NCT00250458|565803842|FG000|Overall Study|Protocol Violation|0|||
156741965|NCT00250458|565803843|FG001|Overall Study|Protocol Violation|1|||
156741966|NCT00250458|565803842|FG000|Overall Study|Withdrawal by Subject|4|||
156741967|NCT00250458|565803843|FG001|Overall Study|Withdrawal by Subject|2|||
156741968|NCT00250458|565803842|FG000|Overall Study|Lack of Migraine Attack|20|||
156741969|NCT00250458|565803843|FG001|Overall Study|Lack of Migraine Attack|9|||
156741970|NCT00250458|565803842|FG000|Overall Study|Qualifying migraine but did not treat|3|||
156741971|NCT00250458|565803843|FG001|Overall Study|Qualifying migraine but did not treat|3|||
156741972|NCT00250458|565803842|FG000|Overall Study|Other|1|||
156741973|NCT00250458|565803843|FG001|Overall Study|Other|0|||
156741974|NCT01892085|565803846|FG000|Overall Study|Death|4|||
156741975|NCT01892085|565803847|FG001|Overall Study|Death|1|||
156741976|NCT01892085|565803848|FG002|Overall Study|Death|3|||
156741977|NCT01892085|565803846|FG000|Overall Study|Withdrawal by Subject|2|||
156741978|NCT01892085|565803847|FG001|Overall Study|Withdrawal by Subject|0|||
156741979|NCT01892085|565803848|FG002|Overall Study|Withdrawal by Subject|2|||
156741980|NCT00767039|565803849|FG000|Overall Study|Death|5|||
156741981|NCT00767039|565803850|FG001|Overall Study|Death|2|||
156741982|NCT00525902|565803854|FG000|Overall Study|Lack of Efficacy|1|||
156741983|NCT03747302|565803855|FG000|Overall Study|Withdrawal by Subject|1|||
156741984|NCT03747302|565803856|FG001|Overall Study|Withdrawal by Subject|2|||
156741985|NCT00738062|565803859|FG000|Open Label Treatment|Lack of Efficacy|5|||
156741986|NCT00738062|565803860|FG001|Open Label Treatment|Lack of Efficacy|0|||
157020478|NCT03281291|566828451|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
157020479|NCT03281291|566828452|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
157020480|NCT03281291|566828448|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
157020481|NCT03281291|566828449|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
157020482|NCT03281291|566828450|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
157020483|NCT03281291|566828451|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
157020484|NCT03281291|566828452|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
157020485|NCT03281291|566828448|FG000|Overall Study|Lost to Follow-up|10|||
157020486|NCT03281291|566828449|FG001|Overall Study|Lost to Follow-up|10|||
157020487|NCT03281291|566828450|FG002|Overall Study|Lost to Follow-up|4|||
157020488|NCT03281291|566828451|FG003|Overall Study|Lost to Follow-up|6|||
157020489|NCT03281291|566828452|FG004|Overall Study|Lost to Follow-up|10|||
157020490|NCT03281291|566828448|FG000|Overall Study|Other|0|||
157020491|NCT03281291|566828449|FG001|Overall Study|Other|2|||
157020492|NCT03281291|566828450|FG002|Overall Study|Other|0|||
157020493|NCT03281291|566828451|FG003|Overall Study|Other|2|||
157020494|NCT03281291|566828452|FG004|Overall Study|Other|1|||
157020495|NCT04956861|566828453|FG000|Overall Study|Withdrawal by Subject|4|||
157020496|NCT04956861|566828454|FG001|Overall Study|Withdrawal by Subject|4|||
157020497|NCT04956861|566828455|FG002|Overall Study|Withdrawal by Subject|2|||
157218722|NCT01405820|567547499|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
157218723|NCT01405820|567547500|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
156741987|NCT00738062|565803861|FG002|Open Label Treatment|Lack of Efficacy|0|||
156741988|NCT00738062|565803859|FG000|Open Label Treatment|Adverse Event|11|||
156741989|NCT00738062|565803860|FG001|Open Label Treatment|Adverse Event|0|||
156741990|NCT00738062|565803861|FG002|Open Label Treatment|Adverse Event|0|||
156741991|NCT00738062|565803859|FG000|Open Label Treatment|Protocol Violation|2|||
156741992|NCT00738062|565803860|FG001|Open Label Treatment|Protocol Violation|0|||
156741993|NCT00738062|565803861|FG002|Open Label Treatment|Protocol Violation|0|||
156741994|NCT00738062|565803859|FG000|Open Label Treatment|Withdrawal by Subject|9|||
156741995|NCT00738062|565803860|FG001|Open Label Treatment|Withdrawal by Subject|0|||
156741996|NCT00738062|565803861|FG002|Open Label Treatment|Withdrawal by Subject|0|||
156741997|NCT00738062|565803859|FG000|Open Label Treatment|Investigator Decision|1|||
156741998|NCT00738062|565803860|FG001|Open Label Treatment|Investigator Decision|0|||
156741999|NCT00738062|565803861|FG002|Open Label Treatment|Investigator Decision|0|||
156742000|NCT00738062|565803859|FG000|Open-Label Extension|Adverse Event|5|||
156742001|NCT00738062|565803860|FG001|Open-Label Extension|Adverse Event|0|||
156742002|NCT00738062|565803861|FG002|Open-Label Extension|Adverse Event|0|||
156797851|NCT03261505|566013422|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
156797852|NCT03261505|566013419|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797853|NCT03261505|566013420|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797854|NCT03261505|566013421|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
156797855|NCT03261505|566013422|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
156797856|NCT03261505|566013419|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
156797857|NCT03261505|566013420|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797858|NCT03261505|566013421|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797859|NCT03261505|566013422|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
156797860|NCT02231580|566013423|FG000|Overall Study|Adverse Event|5|||
156797861|NCT02231580|566013424|FG001|Overall Study|Adverse Event|0|||
156797862|NCT04079738|566013425|FG000|Study Treatment|Death|1|||
156797863|NCT04079738|566013426|FG001|Study Treatment|Death|0|||
156797864|NCT04079738|566013427|FG002|Study Treatment|Death|0|||
156797865|NCT04079738|566013428|FG003|Study Treatment|Death|0|||
156797866|NCT04079738|566013425|FG000|Study Treatment|Adverse Event|2|||
156797867|NCT04079738|566013426|FG001|Study Treatment|Adverse Event|0|||
156797868|NCT04079738|566013427|FG002|Study Treatment|Adverse Event|0|||
156797869|NCT04079738|566013428|FG003|Study Treatment|Adverse Event|0|||
156797870|NCT04079738|566013425|FG000|Study Treatment|withdrawal before treatment|1|||
156797871|NCT04079738|566013426|FG001|Study Treatment|withdrawal before treatment|0|||
156797872|NCT04079738|566013427|FG002|Study Treatment|withdrawal before treatment|0|||
156797873|NCT04079738|566013428|FG003|Study Treatment|withdrawal before treatment|0|||
156742003|NCT00738062|565803859|FG000|Open-Label Extension|Physician Decision|1|||
156742004|NCT00738062|565803860|FG001|Open-Label Extension|Physician Decision|0|||
156742005|NCT00738062|565803861|FG002|Open-Label Extension|Physician Decision|0|||
156742006|NCT00738062|565803859|FG000|Open-Label Extension|Lack of Efficacy|2|||
156742007|NCT00738062|565803860|FG001|Open-Label Extension|Lack of Efficacy|0|||
156742008|NCT00738062|565803861|FG002|Open-Label Extension|Lack of Efficacy|0|||
156742009|NCT00738062|565803859|FG000|Open-Label Extension|Withdrawal by Subject|6|||
156742010|NCT00738062|565803860|FG001|Open-Label Extension|Withdrawal by Subject|0|||
156742011|NCT00738062|565803861|FG002|Open-Label Extension|Withdrawal by Subject|0|||
157020498|NCT04956861|566828453|FG000|Overall Study|Physician Decision|4|||
157218724|NCT01405820|567547501|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
157218725|NCT01405820|567547496|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
157218726|NCT01405820|567547497|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
157218727|NCT01405820|567547498|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
157218728|NCT01405820|567547499|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
157218729|NCT01405820|567547500|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
157218730|NCT01405820|567547501|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
157218731|NCT01405820|567547496|FG000|Open-Label Treatment Period|Other|1|||
157218732|NCT01405820|567547497|FG001|Open-Label Treatment Period|Other|1|||
157218733|NCT01405820|567547498|FG002|Open-Label Treatment Period|Other|1|||
157218734|NCT01405820|567547499|FG003|Open-Label Treatment Period|Other|1|||
157218735|NCT01405820|567547500|FG004|Open-Label Treatment Period|Other|1|||
157218736|NCT01405820|567547501|FG005|Open-Label Treatment Period|Other|1|||
157218737|NCT01405820|567547496|FG000|Open-Label Treatment Period|Physician Decision|0|||
157218738|NCT01405820|567547497|FG001|Open-Label Treatment Period|Physician Decision|0|||
157218739|NCT01405820|567547498|FG002|Open-Label Treatment Period|Physician Decision|1|||
157218740|NCT01405820|567547499|FG003|Open-Label Treatment Period|Physician Decision|2|||
157218741|NCT01405820|567547500|FG004|Open-Label Treatment Period|Physician Decision|1|||
157218742|NCT01405820|567547501|FG005|Open-Label Treatment Period|Physician Decision|0|||
157218743|NCT01405820|567547496|FG000|Open-Label Treatment Period|Adverse Event|0|||
156742012|NCT00738062|565803859|FG000|Open-Label Extension|Protocol Violation|1|||
156742013|NCT00738062|565803860|FG001|Open-Label Extension|Protocol Violation|0|||
156742014|NCT00738062|565803861|FG002|Open-Label Extension|Protocol Violation|0|||
156742015|NCT00738062|565803859|FG000|Open-Label Extension|Study Terminated|2|||
156742016|NCT00738062|565803860|FG001|Open-Label Extension|Study Terminated|0|||
156742017|NCT00738062|565803861|FG002|Open-Label Extension|Study Terminated|0|||
156742018|NCT03488225|565803862|FG000|Overall Study|Off Protocol Therapy|2|||
156742019|NCT03488225|565803862|FG000|Overall Study|Stem Cell Transplant|2|||
156742020|NCT01711619|565803863|FG000|Overall Study|Early study termination|10|||
156742021|NCT01711619|565803864|FG001|Overall Study|Early study termination|14|||
156742022|NCT01711619|565803863|FG000|Overall Study|Withdrawal by Subject|3|||
156742023|NCT01711619|565803864|FG001|Overall Study|Withdrawal by Subject|7|||
156742024|NCT01711619|565803863|FG000|Overall Study|Protocol Violation|2|||
156742025|NCT01711619|565803864|FG001|Overall Study|Protocol Violation|3|||
156742026|NCT01711619|565803863|FG000|Overall Study|Adverse Event|2|||
156742027|NCT01711619|565803864|FG001|Overall Study|Adverse Event|0|||
156742028|NCT01711619|565803863|FG000|Overall Study|Lost to Follow-up|1|||
156742029|NCT01711619|565803864|FG001|Overall Study|Lost to Follow-up|0|||
156742030|NCT00087126|565803868|FG000|Overall Study|Ineligible - second primary|1|||
156742031|NCT00087126|565803868|FG000|Overall Study|Never treated|1|||
156742032|NCT00096993|565803871|FG000|Overall Study|Death|1|||
156742033|NCT00096993|565803872|FG001|Overall Study|Death|0|||
156742034|NCT00096993|565803871|FG000|Overall Study|Disease progression|56|||
156742035|NCT00096993|565803872|FG001|Overall Study|Disease progression|53|||
156742036|NCT00096993|565803871|FG000|Overall Study|Adverse Event|2|||
156742037|NCT00096993|565803872|FG001|Overall Study|Adverse Event|8|||
156742038|NCT00096993|565803871|FG000|Overall Study|Subject's decision|3|||
156742039|NCT00096993|565803872|FG001|Overall Study|Subject's decision|1|||
156742040|NCT00096993|565803871|FG000|Overall Study|Physician Decision|2|||
156742041|NCT00096993|565803872|FG001|Overall Study|Physician Decision|1|||
156742042|NCT00096993|565803871|FG000|Overall Study|Non-compliance|0|||
156742043|NCT00096993|565803872|FG001|Overall Study|Non-compliance|1|||
156742044|NCT00096993|565803871|FG000|Overall Study|Other unspecified|1|||
156742045|NCT00096993|565803872|FG001|Overall Study|Other unspecified|1|||
156742046|NCT01438814|565803875|FG000|Overall Study|Adverse Event|3|||
156742047|NCT01438814|565803876|FG001|Overall Study|Adverse Event|3|||
156742048|NCT01438814|565803875|FG000|Overall Study|Protocol Violation|1|||
156742049|NCT01438814|565803876|FG001|Overall Study|Protocol Violation|2|||
156742050|NCT01438814|565803875|FG000|Overall Study|Lost to Follow-up|4|||
156742051|NCT01438814|565803876|FG001|Overall Study|Lost to Follow-up|3|||
156742052|NCT01438814|565803875|FG000|Overall Study|Withdrawal by Subject|4|||
156742053|NCT01438814|565803876|FG001|Overall Study|Withdrawal by Subject|2|||
156742054|NCT01438814|565803875|FG000|Overall Study|Other|2|||
156742055|NCT01438814|565803876|FG001|Overall Study|Other|4|||
156742056|NCT00195494|565803879|FG000|Year 1|Adverse Event|0|||
156742057|NCT00195494|565803880|FG001|Year 1|Adverse Event|0|||
156742058|NCT00195494|565803881|FG002|Year 1|Adverse Event|0|||
157218744|NCT01405820|567547497|FG001|Open-Label Treatment Period|Adverse Event|0|||
157218745|NCT01405820|567547498|FG002|Open-Label Treatment Period|Adverse Event|0|||
156742059|NCT00195494|565803882|FG003|Year 1|Adverse Event|0|||
156742060|NCT00195494|565803883|FG004|Year 1|Adverse Event|34|||
156742061|NCT00195494|565803884|FG005|Year 1|Adverse Event|27|||
156742062|NCT00195494|565803879|FG000|Year 1|System Toxicity|0|||
156742063|NCT00195494|565803880|FG001|Year 1|System Toxicity|0|||
156742064|NCT00195494|565803881|FG002|Year 1|System Toxicity|0|||
156742065|NCT00195494|565803882|FG003|Year 1|System Toxicity|0|||
156742066|NCT00195494|565803883|FG004|Year 1|System Toxicity|0|||
156742067|NCT00195494|565803884|FG005|Year 1|System Toxicity|1|||
156742068|NCT00195494|565803879|FG000|Year 1|Lack of Efficacy|0|||
156742069|NCT00195494|565803880|FG001|Year 1|Lack of Efficacy|0|||
156742070|NCT00195494|565803881|FG002|Year 1|Lack of Efficacy|0|||
156742071|NCT00195494|565803882|FG003|Year 1|Lack of Efficacy|0|||
156742072|NCT00195494|565803883|FG004|Year 1|Lack of Efficacy|24|||
156742073|NCT00195494|565803884|FG005|Year 1|Lack of Efficacy|9|||
156742074|NCT00195494|565803879|FG000|Year 1|Compliance|0|||
156742075|NCT00195494|565803880|FG001|Year 1|Compliance|0|||
156742076|NCT00195494|565803881|FG002|Year 1|Compliance|0|||
156742077|NCT00195494|565803882|FG003|Year 1|Compliance|0|||
156742078|NCT00195494|565803883|FG004|Year 1|Compliance|5|||
156742079|NCT00195494|565803884|FG005|Year 1|Compliance|1|||
156742080|NCT00195494|565803879|FG000|Year 1|Lost to Follow-up|0|||
156742081|NCT00195494|565803880|FG001|Year 1|Lost to Follow-up|0|||
156742082|NCT00195494|565803881|FG002|Year 1|Lost to Follow-up|0|||
156742083|NCT00195494|565803882|FG003|Year 1|Lost to Follow-up|0|||
156742084|NCT00195494|565803883|FG004|Year 1|Lost to Follow-up|1|||
156742085|NCT00195494|565803884|FG005|Year 1|Lost to Follow-up|0|||
156742086|NCT00195494|565803879|FG000|Year 1|Missed >4 consecutive doses|0|||
156742087|NCT00195494|565803880|FG001|Year 1|Missed >4 consecutive doses|0|||
156742088|NCT00195494|565803881|FG002|Year 1|Missed >4 consecutive doses|0|||
156742089|NCT00195494|565803882|FG003|Year 1|Missed >4 consecutive doses|0|||
156742090|NCT00195494|565803883|FG004|Year 1|Missed >4 consecutive doses|3|||
156742091|NCT00195494|565803884|FG005|Year 1|Missed >4 consecutive doses|2|||
156742092|NCT00195494|565803879|FG000|Year 1|Protocol deviation|0|||
156742093|NCT00195494|565803880|FG001|Year 1|Protocol deviation|0|||
156742094|NCT00195494|565803881|FG002|Year 1|Protocol deviation|0|||
156742095|NCT00195494|565803882|FG003|Year 1|Protocol deviation|0|||
156742096|NCT00195494|565803883|FG004|Year 1|Protocol deviation|2|||
156742097|NCT00195494|565803884|FG005|Year 1|Protocol deviation|3|||
156742098|NCT00195494|565803879|FG000|Year 1|Physician Decision|0|||
156742099|NCT00195494|565803880|FG001|Year 1|Physician Decision|0|||
156742100|NCT00195494|565803881|FG002|Year 1|Physician Decision|0|||
156797874|NCT04079738|566013425|FG000|Study Treatment|symptomatic deterioration|2|||
156797875|NCT04079738|566013426|FG001|Study Treatment|symptomatic deterioration|0|||
156797876|NCT04079738|566013427|FG002|Study Treatment|symptomatic deterioration|0|||
156797877|NCT04079738|566013428|FG003|Study Treatment|symptomatic deterioration|0|||
156797878|NCT04079738|566013425|FG000|Study Treatment|Disease Progression|1|||
156797879|NCT04079738|566013426|FG001|Study Treatment|Disease Progression|0|||
156797880|NCT04079738|566013427|FG002|Study Treatment|Disease Progression|0|||
156797881|NCT04079738|566013428|FG003|Study Treatment|Disease Progression|0|||
156797882|NCT04079738|566013425|FG000|Study Treatment|withdrawal after treatment|1|||
156797883|NCT04079738|566013426|FG001|Study Treatment|withdrawal after treatment|0|||
156797884|NCT04079738|566013427|FG002|Study Treatment|withdrawal after treatment|0|||
156797885|NCT04079738|566013428|FG003|Study Treatment|withdrawal after treatment|0|||
156797886|NCT04079738|566013425|FG000|Follow up|Withdrawal by Subject|3|||
156797887|NCT04079738|566013426|FG001|Follow up|Withdrawal by Subject|0|||
156797888|NCT04079738|566013427|FG002|Follow up|Withdrawal by Subject|0|||
156797889|NCT04079738|566013428|FG003|Follow up|Withdrawal by Subject|0|||
156797890|NCT04079738|566013425|FG000|Follow up|Death|5|||
156742101|NCT00195494|565803882|FG003|Year 1|Physician Decision|0|||
156742102|NCT00195494|565803883|FG004|Year 1|Physician Decision|1|||
156797891|NCT04079738|566013426|FG001|Follow up|Death|0|||
156797892|NCT04079738|566013427|FG002|Follow up|Death|0|||
156797893|NCT04079738|566013428|FG003|Follow up|Death|0|||
156808859|NCT01645735|566054478|FG001|Overall Study|Withdrawal by Subject|0|||
156742103|NCT00195494|565803884|FG005|Year 1|Physician Decision|0|||
156742104|NCT00195494|565803879|FG000|Year 1|Withdrawal by Subject|0|||
156742105|NCT00195494|565803880|FG001|Year 1|Withdrawal by Subject|0|||
156742106|NCT00195494|565803881|FG002|Year 1|Withdrawal by Subject|0|||
156742107|NCT00195494|565803882|FG003|Year 1|Withdrawal by Subject|0|||
156742108|NCT00195494|565803883|FG004|Year 1|Withdrawal by Subject|8|||
156742109|NCT00195494|565803884|FG005|Year 1|Withdrawal by Subject|9|||
156742110|NCT00195494|565803879|FG000|Year 1|Protocol Violation|0|||
156742111|NCT00195494|565803880|FG001|Year 1|Protocol Violation|0|||
156808860|NCT01645735|566054477|FG000|Overall Study|Protocol Violation|1|||
156808861|NCT01645735|566054478|FG001|Overall Study|Protocol Violation|0|||
156808862|NCT01645735|566054477|FG000|Overall Study|Adverse Event|0|||
156808863|NCT01645735|566054478|FG001|Overall Study|Adverse Event|1|||
156808864|NCT03369665|566054489|FG000|Overall Study|Adverse Event|3|||
156808865|NCT03369665|566054489|FG000|Overall Study|Lost to Follow-up|7|||
156808866|NCT03369665|566054489|FG000|Overall Study|Withdrawal by Subject|15|||
156808867|NCT03369665|566054489|FG000|Overall Study|Progression Disease|2|||
156808868|NCT03369665|566054489|FG000|Overall Study|Not classified|3|||
156808869|NCT02168101|566054490|FG000|Overall Study|Death|2|||
156808870|NCT02168101|566054491|FG001|Overall Study|Death|2|||
156808871|NCT02168101|566054492|FG002|Overall Study|Death|1|||
156808872|NCT00589797|566054493|FG000|Overall Study|Death|1|||
156808873|NCT00589797|566054494|FG001|Overall Study|Death|0|||
156808874|NCT00589797|566054493|FG000|Overall Study|Lost to Follow-up|12|||
156808875|NCT00589797|566054494|FG001|Overall Study|Lost to Follow-up|9|||
156808876|NCT00589797|566054493|FG000|Overall Study|Physician Decision|8|||
156808877|NCT00589797|566054494|FG001|Overall Study|Physician Decision|3|||
156808878|NCT00589797|566054493|FG000|Overall Study|Withdrawal by Subject|6|||
156883107|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883108|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883109|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883110|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883111|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
156883112|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883113|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883114|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883115|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883116|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
156883117|NCT01185353|566330925|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
156883118|NCT01185353|566330926|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883119|NCT01185353|566330927|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883120|NCT01185353|566330928|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883121|NCT01185353|566330929|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
156883122|NCT01185353|566330930|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883123|NCT01185353|566330931|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883124|NCT01185353|566330932|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883125|NCT01185353|566330933|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883126|NCT01185353|566330934|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
156883127|NCT01185353|566330925|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883128|NCT01185353|566330926|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883129|NCT01185353|566330927|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
156883130|NCT01185353|566330928|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883131|NCT01185353|566330929|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883132|NCT01185353|566330930|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
156883133|NCT01185353|566330931|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883134|NCT01185353|566330932|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883135|NCT01185353|566330933|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883136|NCT01185353|566330934|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
156883137|NCT01185353|566330925|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883138|NCT01185353|566330926|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
156883139|NCT01185353|566330927|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883140|NCT01185353|566330928|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
156883141|NCT01185353|566330929|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883142|NCT01185353|566330930|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883143|NCT01185353|566330931|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883144|NCT01185353|566330932|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883145|NCT01185353|566330933|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883146|NCT01185353|566330934|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
156883147|NCT01185353|566330925|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156878075|NCT00813943|566313927|FG000|Overall Study|Ongoing at cut-off date|5|||
156878076|NCT00813943|566313928|FG001|Overall Study|Ongoing at cut-off date|5|||
156878077|NCT00813943|566313929|FG002|Overall Study|Ongoing at cut-off date|3|||
156878078|NCT02891070|566313934|FG000|Overall Study|Adverse Event|1|||
156878079|NCT02891070|566313935|FG001|Overall Study|Adverse Event|0|||
156878080|NCT02891070|566313934|FG000|Overall Study|Physician Decision|0|||
156878081|NCT02891070|566313935|FG001|Overall Study|Physician Decision|1|||
156878082|NCT02891070|566313934|FG000|Overall Study|Lost to Follow-up|4|||
156878083|NCT02891070|566313935|FG001|Overall Study|Lost to Follow-up|4|||
156878084|NCT02891070|566313934|FG000|Overall Study|Other|1|||
156878085|NCT02891070|566313935|FG001|Overall Study|Other|0|||
156878086|NCT02891070|566313934|FG000|Overall Study|Protocol Violation|0|||
156878087|NCT02891070|566313935|FG001|Overall Study|Protocol Violation|1|||
156742112|NCT00195494|565803881|FG002|Year 1|Protocol Violation|0|||
156742113|NCT00195494|565803882|FG003|Year 1|Protocol Violation|0|||
156742114|NCT00195494|565803883|FG004|Year 1|Protocol Violation|1|||
156878088|NCT02891070|566313934|FG000|Overall Study|Withdrawal by Subject|1|||
156878089|NCT02891070|566313935|FG001|Overall Study|Withdrawal by Subject|2|||
156878090|NCT02891070|566313934|FG000|Overall Study|Death|3|||
156878091|NCT02891070|566313935|FG001|Overall Study|Death|0|||
156878092|NCT02704143|566313936|FG000|Overall Study|disease progression|10|||
156878093|NCT01235598|566313937|FG000|Overall Study|Adverse Event|0|||
156878094|NCT01235598|566313938|FG001|Overall Study|Adverse Event|3|||
156878095|NCT01235598|566313937|FG000|Overall Study|Lack of Efficacy|0|||
156878096|NCT01235598|566313938|FG001|Overall Study|Lack of Efficacy|1|||
156878097|NCT01235598|566313937|FG000|Overall Study|Withdrawal by Subject|1|||
156878098|NCT01235598|566313938|FG001|Overall Study|Withdrawal by Subject|0|||
156878099|NCT02551991|566313939|FG000|Overall Study|Death|5|||
156878100|NCT02551991|566313940|FG001|Overall Study|Death|7|||
156878101|NCT02551991|566313941|FG002|Overall Study|Death|8|||
156878102|NCT02551991|566313942|FG003|Overall Study|Death|7|||
156878103|NCT02551991|566313943|FG004|Overall Study|Death|17|||
156878104|NCT02551991|566313939|FG000|Overall Study|Withdrawal by Subject|1|||
156878105|NCT02551991|566313940|FG001|Overall Study|Withdrawal by Subject|0|||
156878106|NCT02551991|566313941|FG002|Overall Study|Withdrawal by Subject|0|||
156878107|NCT02551991|566313942|FG003|Overall Study|Withdrawal by Subject|0|||
156878108|NCT02551991|566313943|FG004|Overall Study|Withdrawal by Subject|2|||
156878109|NCT02551991|566313939|FG000|Overall Study|Lost to Follow-up|0|||
156878110|NCT02551991|566313940|FG001|Overall Study|Lost to Follow-up|0|||
156878111|NCT02551991|566313941|FG002|Overall Study|Lost to Follow-up|1|||
156878112|NCT02551991|566313942|FG003|Overall Study|Lost to Follow-up|0|||
156878113|NCT02551991|566313943|FG004|Overall Study|Lost to Follow-up|0|||
156878114|NCT02551991|566313939|FG000|Overall Study|Sponsor Decision|1|||
156878115|NCT02551991|566313940|FG001|Overall Study|Sponsor Decision|0|||
156878116|NCT02551991|566313941|FG002|Overall Study|Sponsor Decision|1|||
156878117|NCT02551991|566313942|FG003|Overall Study|Sponsor Decision|0|||
156878118|NCT02551991|566313943|FG004|Overall Study|Sponsor Decision|5|||
156878119|NCT02551991|566313939|FG000|Overall Study|Other|0|||
156878120|NCT02551991|566313940|FG001|Overall Study|Other|0|||
156878121|NCT02551991|566313941|FG002|Overall Study|Other|0|||
156878122|NCT02551991|566313942|FG003|Overall Study|Other|0|||
156878123|NCT02551991|566313943|FG004|Overall Study|Other|1|||
156878124|NCT00395343|566313944|FG000|Overall Study|Adverse Event|13|||
156878125|NCT00395343|566313945|FG001|Overall Study|Adverse Event|5|||
156878126|NCT00395343|566313944|FG000|Overall Study|Lack of Efficacy|0|||
156878127|NCT00395343|566313945|FG001|Overall Study|Lack of Efficacy|1|||
156878128|NCT00395343|566313944|FG000|Overall Study|Lost to Follow-up|4|||
156878129|NCT00395343|566313945|FG001|Overall Study|Lost to Follow-up|4|||
156878130|NCT00395343|566313944|FG000|Overall Study|Physician Decision|2|||
156878131|NCT00395343|566313945|FG001|Overall Study|Physician Decision|4|||
156878132|NCT00395343|566313944|FG000|Overall Study|Protocol Violation|6|||
156878133|NCT00395343|566313945|FG001|Overall Study|Protocol Violation|8|||
156878134|NCT00395343|566313944|FG000|Overall Study|Withdrawal by Subject|11|||
156878135|NCT00395343|566313945|FG001|Overall Study|Withdrawal by Subject|12|||
156878136|NCT00395343|566313944|FG000|Overall Study|Other|5|||
156878137|NCT00395343|566313945|FG001|Overall Study|Other|2|||
156878138|NCT00942994|566313949|FG000|Overall Study|Adverse Event|7|||
156878139|NCT00942994|566313950|FG001|Overall Study|Adverse Event|4|||
156878140|NCT00942994|566313949|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156878141|NCT00942994|566313950|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156878142|NCT00942994|566313949|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156878143|NCT00942994|566313950|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156878144|NCT00942994|566313949|FG000|Overall Study|Patient withdrew consent|5|||
156878145|NCT00942994|566313950|FG001|Overall Study|Patient withdrew consent|8|||
156878146|NCT00942994|566313949|FG000|Overall Study|Lost to Follow-up|1|||
156878147|NCT00942994|566313950|FG001|Overall Study|Lost to Follow-up|4|||
156878148|NCT00942994|566313949|FG000|Overall Study|Protocol deviation|1|||
156878149|NCT00942994|566313950|FG001|Overall Study|Protocol deviation|2|||
156742115|NCT00195494|565803884|FG005|Year 1|Protocol Violation|1|||
156878150|NCT00387790|566313951|FG000|Overall Study|Adverse Event|5|||
156878151|NCT00387790|566313951|FG000|Overall Study|Lack of Efficacy|2|||
156878152|NCT00387790|566313951|FG000|Overall Study|Physician Decision|2|||
156878153|NCT00387790|566313951|FG000|Overall Study|Withdrawal by Subject|3|||
156878154|NCT00387790|566313951|FG000|Overall Study|Ineligible for study|2|||
156878155|NCT01716052|566313955|FG000|Overall Study|Withdrawal of funding|1|||
156878156|NCT01716052|566313956|FG001|Overall Study|Withdrawal of funding|1|||
156878157|NCT03598114|566313965|FG000|Overall Study|Staff turnover/left the program|3|||
156878158|NCT03598114|566313966|FG001|Overall Study|Staff turnover/left the program|39|||
156878159|NCT02527200|566313967|FG000|Overall Study|Withdrawal by Subject|3|||
156878160|NCT02527200|566313968|FG001|Overall Study|Withdrawal by Subject|2|||
156878161|NCT02527200|566313969|FG002|Overall Study|Withdrawal by Subject|1|||
156878162|NCT02527200|566313970|FG003|Overall Study|Withdrawal by Subject|0|||
156878163|NCT02527200|566313967|FG000|Overall Study|Unclassified|0|||
156878164|NCT02527200|566313968|FG001|Overall Study|Unclassified|1|||
156878165|NCT02527200|566313969|FG002|Overall Study|Unclassified|0|||
156878166|NCT02527200|566313970|FG003|Overall Study|Unclassified|0|||
156878167|NCT02527200|566313967|FG000|Overall Study|Lost to Follow-up|0|||
156878168|NCT02527200|566313968|FG001|Overall Study|Lost to Follow-up|0|||
156878169|NCT02527200|566313969|FG002|Overall Study|Lost to Follow-up|1|||
156878170|NCT02527200|566313970|FG003|Overall Study|Lost to Follow-up|0|||
156878171|NCT02597478|566313972|FG000|Overall Study|Withdrawal by Subject|2|||
156878172|NCT02597478|566313973|FG001|Overall Study|Withdrawal by Subject|0|||
156878173|NCT02597478|566313972|FG000|Overall Study|Change of opioid dose|1|||
156878174|NCT02597478|566313973|FG001|Overall Study|Change of opioid dose|0|||
156878175|NCT02597478|566313972|FG000|Overall Study|Insufficient exertional dyspnea|0|||
156878176|NCT02597478|566313973|FG001|Overall Study|Insufficient exertional dyspnea|1|||
156878177|NCT01305577|566313975|FG000|Overall Study|Adverse Event|2|||
156878178|NCT01305577|566313976|FG001|Overall Study|Adverse Event|2|||
156878179|NCT01305577|566313977|FG002|Overall Study|Adverse Event|1|||
156878180|NCT01305577|566313975|FG000|Overall Study|Withdrawal by Subject|7|||
156878181|NCT01305577|566313976|FG001|Overall Study|Withdrawal by Subject|5|||
156878182|NCT01305577|566313977|FG002|Overall Study|Withdrawal by Subject|6|||
156878183|NCT01305577|566313975|FG000|Overall Study|Lost to Follow-up|4|||
156878184|NCT01305577|566313976|FG001|Overall Study|Lost to Follow-up|3|||
156878185|NCT01305577|566313977|FG002|Overall Study|Lost to Follow-up|2|||
156878186|NCT01305577|566313975|FG000|Overall Study|Protocol Deviation|0|||
156878187|NCT01305577|566313976|FG001|Overall Study|Protocol Deviation|1|||
156878188|NCT01305577|566313977|FG002|Overall Study|Protocol Deviation|1|||
156878189|NCT00796978|566313978|FG000|Overall Study|Cardiac adverse event|5|||
156878190|NCT00796978|566313978|FG000|Overall Study|Adverse Event|4|||
156878191|NCT00796978|566313978|FG000|Overall Study|Withdrawal by Subject|3|||
156878192|NCT01256190|566313979|FG000|Overall Study|Lost to Follow-up|2|||
156878193|NCT01256190|566313980|FG001|Overall Study|Lost to Follow-up|0|||
156878194|NCT02834793|566313981|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
156878195|NCT02834793|566313982|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
156878196|NCT02834793|566313983|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
156878197|NCT02834793|566313984|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
156878198|NCT02834793|566313981|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
156878199|NCT02834793|566313982|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156878200|NCT02834793|566313983|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156878201|NCT02834793|566313984|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
156878202|NCT02834793|566313981|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
156878203|NCT02834793|566313982|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156878204|NCT02834793|566313983|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156878205|NCT02834793|566313984|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
156878206|NCT02834793|566313981|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156878207|NCT02834793|566313982|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
156742116|NCT00195494|565803879|FG000|Year 2|Adverse Event|3|||
156742117|NCT00195494|565803880|FG001|Year 2|Adverse Event|7|||
156742118|NCT00195494|565803881|FG002|Year 2|Adverse Event|5|||
156742119|NCT00195494|565803882|FG003|Year 2|Adverse Event|9|||
156742120|NCT00195494|565803883|FG004|Year 2|Adverse Event|0|||
156742121|NCT00195494|565803884|FG005|Year 2|Adverse Event|0|||
156742122|NCT00195494|565803879|FG000|Year 2|Lack of Efficacy|0|||
156878208|NCT02834793|566313983|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156878209|NCT02834793|566313984|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
156878210|NCT02834793|566313981|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156878211|NCT02834793|566313982|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
156878212|NCT02834793|566313983|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156878213|NCT02834793|566313984|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
156878214|NCT02834793|566313981|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156878215|NCT02834793|566313982|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156878216|NCT02834793|566313983|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
156878217|NCT02834793|566313984|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
156742123|NCT00195494|565803880|FG001|Year 2|Lack of Efficacy|1|||
156742124|NCT00195494|565803881|FG002|Year 2|Lack of Efficacy|7|||
156742125|NCT00195494|565803882|FG003|Year 2|Lack of Efficacy|7|||
156742126|NCT00195494|565803883|FG004|Year 2|Lack of Efficacy|0|||
156742127|NCT00195494|565803884|FG005|Year 2|Lack of Efficacy|0|||
156742128|NCT00195494|565803879|FG000|Year 2|Compliance|1|||
156742129|NCT00195494|565803880|FG001|Year 2|Compliance|0|||
156742130|NCT00195494|565803881|FG002|Year 2|Compliance|0|||
156742131|NCT00195494|565803882|FG003|Year 2|Compliance|2|||
156742132|NCT00195494|565803883|FG004|Year 2|Compliance|0|||
156742133|NCT00195494|565803884|FG005|Year 2|Compliance|0|||
156742134|NCT00195494|565803879|FG000|Year 2|Lost to Follow-up|0|||
156742135|NCT00195494|565803880|FG001|Year 2|Lost to Follow-up|0|||
156742136|NCT00195494|565803881|FG002|Year 2|Lost to Follow-up|1|||
156742137|NCT00195494|565803882|FG003|Year 2|Lost to Follow-up|1|||
156797894|NCT05552859|566013429|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
156797895|NCT05552859|566013430|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
156797896|NCT01380080|566013431|FG000|Overall Study|Death|36|||
156797897|NCT01380080|566013432|FG001|Overall Study|Death|44|||
156797898|NCT01380080|566013431|FG000|Overall Study|Site is closing|28|||
156797899|NCT01380080|566013432|FG001|Overall Study|Site is closing|31|||
156797900|NCT01380080|566013431|FG000|Overall Study|Not able to get to clinic|7|||
156797901|NCT01380080|566013432|FG001|Overall Study|Not able to get to clinic|1|||
156797902|NCT01380080|566013431|FG000|Overall Study|Not willing to adhere to requirements|6|||
156797903|NCT01380080|566013432|FG001|Overall Study|Not willing to adhere to requirements|2|||
156797904|NCT01380080|566013431|FG000|Overall Study|Withdrawal by Subject|5|||
156797905|NCT01380080|566013432|FG001|Overall Study|Withdrawal by Subject|2|||
156797906|NCT01380080|566013431|FG000|Overall Study|Lost to Follow-up|3|||
156797907|NCT01380080|566013432|FG001|Overall Study|Lost to Follow-up|3|||
156797908|NCT02711202|566013433|FG000|Overall Study|Adverse Event|3|||
156797909|NCT02711202|566013434|FG001|Overall Study|Adverse Event|0|||
156797910|NCT02711202|566013433|FG000|Overall Study|graft loss|1|||
156797911|NCT02711202|566013434|FG001|Overall Study|graft loss|0|||
156797912|NCT05852470|566013436|FG000|Overall Study|Withdrawal by Subject|0|||
156797913|NCT05852470|566013437|FG001|Overall Study|Withdrawal by Subject|1|||
156797914|NCT01903863|566013438|FG000|Overall Study|Physician Decision|2|||
156797915|NCT01903863|566013439|FG001|Overall Study|Physician Decision|0|||
156797916|NCT01722669|566013442|FG000|Overall Study|Withdrawal by Subject|0|||
156797917|NCT01722669|566013443|FG001|Overall Study|Withdrawal by Subject|0|||
156797918|NCT01722669|566013444|FG002|Overall Study|Withdrawal by Subject|0|||
156797919|NCT01722669|566013445|FG003|Overall Study|Withdrawal by Subject|0|||
156797920|NCT01722669|566013446|FG004|Overall Study|Withdrawal by Subject|0|||
156797921|NCT01722669|566013447|FG005|Overall Study|Withdrawal by Subject|2|||
156797922|NCT01107496|566013448|FG000|Overall Study|Adverse Event|1|||
156797923|NCT01107496|566013449|FG001|Overall Study|Adverse Event|0|||
156797924|NCT01107496|566013448|FG000|Overall Study|Lack of Efficacy|1|||
156797925|NCT01107496|566013449|FG001|Overall Study|Lack of Efficacy|0|||
156797926|NCT01107496|566013448|FG000|Overall Study|Protocol Violation|0|||
156797927|NCT01107496|566013449|FG001|Overall Study|Protocol Violation|1|||
156797928|NCT01107496|566013448|FG000|Overall Study|Lost to Follow-up|0|||
156797929|NCT01107496|566013449|FG001|Overall Study|Lost to Follow-up|1|||
156797930|NCT02496000|566013454|FG000|Overall Study|Withdrawal by Subject|1|||
156797931|NCT02496000|566013455|FG001|Overall Study|Withdrawal by Subject|2|||
156797932|NCT02496000|566013456|FG002|Overall Study|Withdrawal by Subject|0|||
156797933|NCT02496000|566013454|FG000|Overall Study|Lost to Follow-up|1|||
156797934|NCT02496000|566013455|FG001|Overall Study|Lost to Follow-up|0|||
156797935|NCT02496000|566013456|FG002|Overall Study|Lost to Follow-up|1|||
156797936|NCT02496000|566013454|FG000|Overall Study|Protocol Violation|0|||
156797937|NCT02496000|566013455|FG001|Overall Study|Protocol Violation|0|||
156797938|NCT02496000|566013456|FG002|Overall Study|Protocol Violation|1|||
156797939|NCT02496000|566013454|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
156797940|NCT02496000|566013455|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
156797941|NCT02496000|566013456|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
156797942|NCT02496000|566013454|FG000|Overall Study|undetermined|0|||
156797943|NCT02496000|566013455|FG001|Overall Study|undetermined|1|||
156797944|NCT02496000|566013456|FG002|Overall Study|undetermined|0|||
156797945|NCT03734536|566013457|FG000|Overall Study|Withdrew Consent|1|||
156797946|NCT03734536|566013458|FG001|Overall Study|Withdrew Consent|5|||
156797947|NCT03734536|566013457|FG000|Overall Study|Lost to Follow-up|10|||
156742138|NCT00195494|565803883|FG004|Year 2|Lost to Follow-up|0|||
156742139|NCT00195494|565803884|FG005|Year 2|Lost to Follow-up|0|||
156797948|NCT03734536|566013458|FG001|Overall Study|Lost to Follow-up|7|||
156742140|NCT00195494|565803879|FG000|Year 2|Missed >4 consecutive doses|1|||
156742141|NCT00195494|565803880|FG001|Year 2|Missed >4 consecutive doses|1|||
156742142|NCT00195494|565803881|FG002|Year 2|Missed >4 consecutive doses|1|||
156742143|NCT00195494|565803882|FG003|Year 2|Missed >4 consecutive doses|0|||
156797949|NCT04727151|566013462|FG000|Overall Study|Death|0|||
156797950|NCT04727151|566013463|FG001|Overall Study|Death|0|||
156797951|NCT04727151|566013464|FG002|Overall Study|Death|0|||
156797952|NCT04727151|566013465|FG003|Overall Study|Death|0|||
156797953|NCT04727151|566013466|FG004|Overall Study|Death|3|||
156742144|NCT00195494|565803883|FG004|Year 2|Missed >4 consecutive doses|0|||
156878218|NCT02834793|566313981|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156878219|NCT02834793|566313982|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156878220|NCT02834793|566313983|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
156878221|NCT02834793|566313984|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
156878222|NCT02834793|566313981|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156878223|NCT02834793|566313982|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156878224|NCT02834793|566313983|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
156878225|NCT02834793|566313984|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
156878226|NCT02834793|566313981|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156878227|NCT02834793|566313982|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156878228|NCT02834793|566313983|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
156878229|NCT02834793|566313984|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
156878230|NCT02834793|566313981|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
156878231|NCT02834793|566313982|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
156878232|NCT02834793|566313983|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
156878233|NCT02834793|566313984|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
156878234|NCT02834793|566313981|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156878235|NCT02834793|566313982|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156878236|NCT02834793|566313983|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
156878237|NCT02834793|566313984|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
156878238|NCT02834793|566313981|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156878239|NCT02834793|566313982|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156878240|NCT02834793|566313983|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
156878241|NCT02834793|566313984|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
156878242|NCT02834793|566313981|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156878243|NCT02834793|566313982|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156878244|NCT02834793|566313983|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
156878245|NCT02834793|566313984|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
156878246|NCT02834793|566313981|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
156878247|NCT02834793|566313982|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
156878248|NCT02834793|566313983|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
156878249|NCT02834793|566313984|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
156878250|NCT02834793|566313981|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156878251|NCT02834793|566313982|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156878252|NCT02834793|566313983|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
156878253|NCT02834793|566313984|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
156878254|NCT02364336|566313985|FG000|Overall Study|Adverse Event|0|||
156878255|NCT02364336|566313986|FG001|Overall Study|Adverse Event|1|||
156878256|NCT01731938|566313987|FG000|Preliminary Part I|Withdrawal by Subject|2|||
156878257|NCT01731938|566313988|FG001|Preliminary Part I|Withdrawal by Subject|2|||
156878258|NCT01731938|566313987|FG000|Preliminary Part I|Physician Decision|1|||
156878259|NCT01731938|566313988|FG001|Preliminary Part I|Physician Decision|0|||
156878260|NCT01731938|566313987|FG000|Preliminary Part I|Lost to Follow-up|0|||
156878261|NCT01731938|566313988|FG001|Preliminary Part I|Lost to Follow-up|3|||
156878262|NCT01731938|566313987|FG000|Preliminary Part I|Missed Week 6 visit|0|||
156878263|NCT01731938|566313988|FG001|Preliminary Part I|Missed Week 6 visit|3|||
156878264|NCT01731938|566313987|FG000|Primary Part II|Withdrawal by Subject|5|||
156878265|NCT01731938|566313988|FG001|Primary Part II|Withdrawal by Subject|4|||
156878266|NCT01731938|566313987|FG000|Primary Part II|Lost to Follow-up|4|||
156878267|NCT01731938|566313988|FG001|Primary Part II|Lost to Follow-up|5|||
156878268|NCT01731938|566313987|FG000|Primary Part II|Death|2|||
156878269|NCT01731938|566313988|FG001|Primary Part II|Death|1|||
156878270|NCT01731938|566313987|FG000|Primary Part II|Missed Week 6 visit|2|||
156878271|NCT01731938|566313988|FG001|Primary Part II|Missed Week 6 visit|3|||
156878272|NCT04931888|566313989|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
156878273|NCT04931888|566313990|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
156878274|NCT04931888|566313991|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
156878275|NCT04931888|566313992|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
156878276|NCT03179202|566313993|FG000|Overall Study|Screen Failure|67|||
156878277|NCT03179202|566313993|FG000|Overall Study|Subject Lost to Follow Up|12|||
156878278|NCT03179202|566313993|FG000|Overall Study|Withdrawal by Subject|7|||
156878279|NCT03179202|566313993|FG000|Overall Study|Adverse Event|3|||
156878280|NCT03179202|566313993|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
156878281|NCT03179202|566313993|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
156878282|NCT02969408|566313994|FG000|Overall Study|Adverse Event|2|||
156878283|NCT02969408|566313994|FG000|Overall Study|Withdrawal by Subject|8|||
156878284|NCT02969408|566313994|FG000|Overall Study|Lost to Follow-up|4|||
157020499|NCT04956861|566828454|FG001|Overall Study|Physician Decision|5|||
156878285|NCT02969408|566313994|FG000|Overall Study|Protocol Violation|1|||
157020500|NCT04956861|566828455|FG002|Overall Study|Physician Decision|1|||
157021792|NCT03623321|566832972|FG000|Overall Study|Death|9|||
156797954|NCT04727151|566013462|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797955|NCT04727151|566013463|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797956|NCT04727151|566013464|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797957|NCT04727151|566013465|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
156797958|NCT04727151|566013466|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
156797959|NCT03448393|566013467|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156742145|NCT00195494|565803884|FG005|Year 2|Missed >4 consecutive doses|0|||
156742146|NCT00195494|565803879|FG000|Year 2|Protocol deviation|0|||
156742147|NCT00195494|565803880|FG001|Year 2|Protocol deviation|1|||
156742148|NCT00195494|565803881|FG002|Year 2|Protocol deviation|0|||
156742149|NCT00195494|565803882|FG003|Year 2|Protocol deviation|0|||
156742150|NCT00195494|565803883|FG004|Year 2|Protocol deviation|0|||
156742151|NCT00195494|565803884|FG005|Year 2|Protocol deviation|0|||
156742152|NCT00195494|565803879|FG000|Year 2|Physician Decision|1|||
156742153|NCT00195494|565803880|FG001|Year 2|Physician Decision|1|||
156742154|NCT00195494|565803881|FG002|Year 2|Physician Decision|0|||
156742155|NCT00195494|565803882|FG003|Year 2|Physician Decision|0|||
156742156|NCT00195494|565803883|FG004|Year 2|Physician Decision|0|||
156742157|NCT00195494|565803884|FG005|Year 2|Physician Decision|0|||
156742158|NCT00195494|565803879|FG000|Year 2|Withdrawal by Subject|1|||
156742159|NCT00195494|565803880|FG001|Year 2|Withdrawal by Subject|5|||
156742160|NCT00195494|565803881|FG002|Year 2|Withdrawal by Subject|4|||
156742161|NCT00195494|565803882|FG003|Year 2|Withdrawal by Subject|3|||
156742162|NCT00195494|565803883|FG004|Year 2|Withdrawal by Subject|0|||
156742163|NCT00195494|565803884|FG005|Year 2|Withdrawal by Subject|0|||
156742164|NCT00195494|565803879|FG000|Year 2|System toxicity|0|||
156742165|NCT00195494|565803880|FG001|Year 2|System toxicity|0|||
156742166|NCT00195494|565803881|FG002|Year 2|System toxicity|0|||
156742167|NCT00195494|565803882|FG003|Year 2|System toxicity|1|||
156742168|NCT00195494|565803883|FG004|Year 2|System toxicity|0|||
156742169|NCT00195494|565803884|FG005|Year 2|System toxicity|0|||
156742170|NCT00513357|565803885|FG000|Overall Study|did not receive allocated placebo|2|||
156742171|NCT00513357|565803886|FG001|Overall Study|did not receive allocated placebo|3|||
156742172|NCT00513357|565803885|FG000|Overall Study|Adverse Event|4|||
156742173|NCT00513357|565803886|FG001|Overall Study|Adverse Event|2|||
156742174|NCT00513357|565803885|FG000|Overall Study|Death|2|||
156742175|NCT00513357|565803886|FG001|Overall Study|Death|0|||
156742176|NCT00513357|565803885|FG000|Overall Study|Withdrawal by Subject|5|||
156742177|NCT00513357|565803886|FG001|Overall Study|Withdrawal by Subject|4|||
156742178|NCT00513357|565803885|FG000|Overall Study|Disease Progression|2|||
156742179|NCT00513357|565803886|FG001|Overall Study|Disease Progression|1|||
156742180|NCT01162122|565803887|FG000|Overall Study|Withdrawal by Subject|52|||
156742181|NCT01162122|565803888|FG001|Overall Study|Withdrawal by Subject|43|||
156742182|NCT01162122|565803887|FG000|Overall Study|Lost to Follow-up|73|||
156742183|NCT01162122|565803888|FG001|Overall Study|Lost to Follow-up|91|||
156742184|NCT01162122|565803887|FG000|Overall Study|Adverse Event|3|||
156742185|NCT01162122|565803888|FG001|Overall Study|Adverse Event|2|||
156742186|NCT01162122|565803887|FG000|Overall Study|Death|51|||
156742187|NCT01162122|565803888|FG001|Overall Study|Death|46|||
156742188|NCT01162122|565803887|FG000|Overall Study|Protocol Violation|2|||
156742189|NCT01162122|565803888|FG001|Overall Study|Protocol Violation|2|||
156742190|NCT01162122|565803887|FG000|Overall Study|Inappropriate enrollment|5|||
156742191|NCT01162122|565803888|FG001|Overall Study|Inappropriate enrollment|4|||
156742192|NCT01162122|565803887|FG000|Overall Study|Administrative reason|1|||
156742193|NCT01162122|565803888|FG001|Overall Study|Administrative reason|1|||
156742194|NCT01162122|565803887|FG000|Overall Study|Unable to classify|3|||
156742195|NCT01162122|565803888|FG001|Overall Study|Unable to classify|7|||
156742196|NCT01162122|565803887|FG000|Overall Study|Missing primary reason|1|||
156742197|NCT01162122|565803888|FG001|Overall Study|Missing primary reason|0|||
156742198|NCT02020512|565803889|FG000|Overall Study|Adverse Event|1|||
156742199|NCT02020512|565803889|FG000|Overall Study|Lost to Follow-up|3|||
156742200|NCT02020512|565803889|FG000|Overall Study|Protocol Violation|4|||
156797960|NCT03448393|566013468|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156742201|NCT00435487|565803892|FG000|Overall Study|Death|3|||
156742202|NCT00435487|565803893|FG001|Overall Study|Death|4|||
156742203|NCT00435487|565803892|FG000|Overall Study|Adverse Event|0|||
156742204|NCT00435487|565803893|FG001|Overall Study|Adverse Event|3|||
156742205|NCT00435487|565803892|FG000|Overall Study|Lost to Follow-up|2|||
156742206|NCT00435487|565803893|FG001|Overall Study|Lost to Follow-up|2|||
156742207|NCT00435487|565803892|FG000|Overall Study|Other|5|||
156742208|NCT00435487|565803893|FG001|Overall Study|Other|2|||
156742209|NCT00435487|565803892|FG000|Overall Study|Withdrawal by Subject|2|||
156742210|NCT00435487|565803893|FG001|Overall Study|Withdrawal by Subject|1|||
156742211|NCT00435487|565803892|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
156742212|NCT00435487|565803893|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
156742213|NCT00435487|565803892|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
156742214|NCT00435487|565803893|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
156742215|NCT00835679|565803895|FG000|Overall Study|Withdrawal by Subject|1|||
156742216|NCT00835679|565803896|FG001|Overall Study|Withdrawal by Subject|0|||
156742217|NCT00835679|565803897|FG002|Overall Study|Withdrawal by Subject|0|||
156742218|NCT00835679|565803898|FG003|Overall Study|Withdrawal by Subject|0|||
156742219|NCT00955968|565803902|FG000|Overall Study|Death|2|||
156742220|NCT00955968|565803903|FG001|Overall Study|Death|4|||
156742221|NCT00955968|565803902|FG000|Overall Study|Withdrawal by Subject|35|||
156742222|NCT00955968|565803903|FG001|Overall Study|Withdrawal by Subject|31|||
156742223|NCT00955968|565803902|FG000|Overall Study|Lost to Follow-up|45|||
156742224|NCT00955968|565803903|FG001|Overall Study|Lost to Follow-up|39|||
156742225|NCT00955968|565803902|FG000|Overall Study|Site closed|55|||
156742226|NCT00955968|565803903|FG001|Overall Study|Site closed|52|||
156742227|NCT04972968|565803907|FG000|Overall Study|Adverse Event|3|||
156742228|NCT04972968|565803908|FG001|Overall Study|Adverse Event|1|||
156742229|NCT04972968|565803909|FG002|Overall Study|Adverse Event|1|||
156742230|NCT04972968|565803910|FG003|Overall Study|Adverse Event|7|||
156742231|NCT04972968|565803907|FG000|Overall Study|Lack of Efficacy|2|||
156742232|NCT04972968|565803908|FG001|Overall Study|Lack of Efficacy|1|||
156742233|NCT04972968|565803909|FG002|Overall Study|Lack of Efficacy|0|||
156742234|NCT04972968|565803910|FG003|Overall Study|Lack of Efficacy|0|||
156742235|NCT04972968|565803907|FG000|Overall Study|Withdrawal by Subject|7|||
156742236|NCT04972968|565803908|FG001|Overall Study|Withdrawal by Subject|4|||
156742237|NCT04972968|565803909|FG002|Overall Study|Withdrawal by Subject|3|||
156742238|NCT04972968|565803910|FG003|Overall Study|Withdrawal by Subject|2|||
156742239|NCT04972968|565803907|FG000|Overall Study|Study Terminated by Sponsor|25|||
156742240|NCT04972968|565803908|FG001|Overall Study|Study Terminated by Sponsor|28|||
156742241|NCT04972968|565803909|FG002|Overall Study|Study Terminated by Sponsor|32|||
156742242|NCT04972968|565803910|FG003|Overall Study|Study Terminated by Sponsor|27|||
156797961|NCT03448393|566013469|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
156797962|NCT03448393|566013470|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797963|NCT03448393|566013471|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797964|NCT03448393|566013472|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797965|NCT03448393|566013473|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797966|NCT03448393|566013474|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
156797967|NCT03448393|566013475|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
156797968|NCT03448393|566013467|FG000|Dose Expansion|Not treated - screen failure|0|||
156797969|NCT03448393|566013468|FG001|Dose Expansion|Not treated - screen failure|0|||
156797970|NCT03448393|566013469|FG002|Dose Expansion|Not treated - screen failure|0|||
156797971|NCT03448393|566013470|FG003|Dose Expansion|Not treated - screen failure|0|||
156797972|NCT03448393|566013471|FG004|Dose Expansion|Not treated - screen failure|0|||
156797973|NCT03448393|566013472|FG005|Dose Expansion|Not treated - screen failure|0|||
156797974|NCT03448393|566013473|FG006|Dose Expansion|Not treated - screen failure|0|||
156797975|NCT03448393|566013474|FG007|Dose Expansion|Not treated - screen failure|0|||
156797976|NCT03448393|566013475|FG008|Dose Expansion|Not treated - screen failure|7|||
156797977|NCT01587196|566013476|FG000|Overall Study|Lost to Follow-up|50|||
156797978|NCT01587196|566013476|FG000|Overall Study|Withdrawal by Subject|4|||
156797979|NCT00642759|566013477|FG000|Overall Study|Protocol Violation|1|||
156797980|NCT03612570|566013482|FG000|Overall Study|Lost to Follow-up|1|||
156797981|NCT05318287|566013483|FG000|Overall Study|Lost to Follow-up|8|||
156797982|NCT03537508|566013486|FG000|Overall Study|Adverse Event|2|||
156797983|NCT03537508|566013487|FG001|Overall Study|Adverse Event|1|||
156797984|NCT03537508|566013486|FG000|Overall Study|Protocol Violation|65|||
156797985|NCT03537508|566013487|FG001|Overall Study|Protocol Violation|48|||
156797986|NCT03537508|566013486|FG000|Overall Study|Lost to Follow-up|86|||
156797987|NCT03537508|566013487|FG001|Overall Study|Lost to Follow-up|60|||
156797988|NCT03537508|566013486|FG000|Overall Study|Withdrawal by parent/guardian|263|||
156797989|NCT03537508|566013487|FG001|Overall Study|Withdrawal by parent/guardian|149|||
156797990|NCT01972659|566013500|FG000|Overall Study|Protocol Violation|2|||
156797991|NCT01972659|566013501|FG001|Overall Study|Protocol Violation|2|||
156797992|NCT01972659|566013500|FG000|Overall Study|problems realted to acceleromyograph|2|||
156797993|NCT01972659|566013501|FG001|Overall Study|problems realted to acceleromyograph|1|||
156797994|NCT03814044|566013509|FG000|Overall Study|Protocol deviation|1|||
156797995|NCT02757768|566013510|FG000|Overall Study|Randomized Never Received Study Drug|3|||
156797996|NCT02757768|566013511|FG001|Overall Study|Randomized Never Received Study Drug|4|||
156797997|NCT02757768|566013510|FG000|Overall Study|Adverse Event|5|||
156797998|NCT02757768|566013511|FG001|Overall Study|Adverse Event|3|||
156797999|NCT02757768|566013510|FG000|Overall Study|Lack of Efficacy|2|||
157021793|NCT03623321|566832972|FG000|Overall Study|Lack of Efficacy|9|||
156798000|NCT02757768|566013511|FG001|Overall Study|Lack of Efficacy|1|||
157218746|NCT01405820|567547499|FG003|Open-Label Treatment Period|Adverse Event|1|||
156742243|NCT04972968|565803907|FG000|Overall Study|Other|1|||
156742244|NCT04972968|565803908|FG001|Overall Study|Other|0|||
156742245|NCT04972968|565803909|FG002|Overall Study|Other|1|||
156742246|NCT04972968|565803910|FG003|Overall Study|Other|1|||
156742247|NCT01698879|565803911|FG000|Overall Study|Withdrawal by Subject|1|||
156742248|NCT01698879|565803912|FG001|Overall Study|Withdrawal by Subject|0|||
156878286|NCT02969408|566313994|FG000|Overall Study|Other than specified|1|||
156878287|NCT04540198|566313995|FG000|Overall Study|Lost to Follow-up|25|||
156878288|NCT04540198|566313996|FG001|Overall Study|Lost to Follow-up|23|||
156878289|NCT04540198|566313995|FG000|Overall Study|Withdrawal by Subject|15|||
156878290|NCT04540198|566313996|FG001|Overall Study|Withdrawal by Subject|9|||
156878291|NCT04540198|566313995|FG000|Overall Study|Discontinued|1|||
156878292|NCT04540198|566313996|FG001|Overall Study|Discontinued|0|||
156878293|NCT02350478|566313997|FG000|Overall Study|Lost to Follow-up|5|||
156878294|NCT02350478|566313998|FG001|Overall Study|Lost to Follow-up|1|||
156878295|NCT02779556|566313999|FG000|Baseline|Partial baseline interview completed|1|||
156878296|NCT02779556|566314000|FG001|Baseline|Partial baseline interview completed|0|||
156878297|NCT02779556|566313999|FG000|3 Months|Lost to Follow-up|40|||
156878298|NCT02779556|566314000|FG001|3 Months|Lost to Follow-up|29|||
156878299|NCT02779556|566313999|FG000|3 Months|Missed 3 month clinic visit|27|||
156878300|NCT02779556|566314000|FG001|3 Months|Missed 3 month clinic visit|19|||
156878301|NCT02779556|566313999|FG000|6 Month|Lost to Follow-up|33|||
156878302|NCT02779556|566314000|FG001|6 Month|Lost to Follow-up|39|||
156878303|NCT02779556|566313999|FG000|6 Month HbA1c|No value collected during window|69|||
156878304|NCT02779556|566314000|FG001|6 Month HbA1c|No value collected during window|50|||
156878305|NCT02779556|566313999|FG000|12 Month HbA1c|No value collected during window|138|||
156742249|NCT01698879|565803913|FG002|Overall Study|Withdrawal by Subject|0|||
156742250|NCT03649178|565803914|FG000|Overall Study|Adverse Event|1|||
156742251|NCT03649178|565803915|FG001|Overall Study|Adverse Event|2|||
156742252|NCT03649178|565803914|FG000|Overall Study|Withdrawal by Subject|0|||
156742253|NCT03649178|565803915|FG001|Overall Study|Withdrawal by Subject|2|||
156742254|NCT03649178|565803914|FG000|Overall Study|COVID regulation required halt in protocol|1|||
156742255|NCT03649178|565803915|FG001|Overall Study|COVID regulation required halt in protocol|0|||
156742256|NCT05238025|565803916|FG000|Overall Study|Adverse Event|2|||
156742257|NCT05238025|565803917|FG001|Overall Study|Adverse Event|2|||
156742258|NCT05238025|565803916|FG000|Overall Study|Lost to Follow-up|334|||
156742259|NCT05238025|565803917|FG001|Overall Study|Lost to Follow-up|339|||
156742260|NCT05238025|565803916|FG000|Overall Study|Withdrawal by Subject|203|||
156742261|NCT05238025|565803917|FG001|Overall Study|Withdrawal by Subject|222|||
156742262|NCT05238025|565803916|FG000|Overall Study|Physician Decision|20|||
156742263|NCT05238025|565803917|FG001|Overall Study|Physician Decision|8|||
156742264|NCT05238025|565803916|FG000|Overall Study|Protocol Violation|6|||
156742265|NCT05238025|565803917|FG001|Overall Study|Protocol Violation|2|||
156742266|NCT05238025|565803916|FG000|Overall Study|Death|38|||
156742267|NCT05238025|565803917|FG001|Overall Study|Death|32|||
156742268|NCT05238025|565803916|FG000|Overall Study|Study terminated by Sponsor|6358|||
156742269|NCT05238025|565803917|FG001|Overall Study|Study terminated by Sponsor|6358|||
156798001|NCT02757768|566013510|FG000|Overall Study|Lost to Follow-up|1|||
156798002|NCT02757768|566013511|FG001|Overall Study|Lost to Follow-up|0|||
156798003|NCT02757768|566013510|FG000|Overall Study|Protocol Deviation|2|||
156798004|NCT02757768|566013511|FG001|Overall Study|Protocol Deviation|9|||
156798005|NCT02757768|566013510|FG000|Overall Study|Withdrawal by Subject|16|||
156798006|NCT02757768|566013511|FG001|Overall Study|Withdrawal by Subject|9|||
156798007|NCT02757768|566013510|FG000|Overall Study|Miscellaneous|4|||
156798008|NCT02757768|566013511|FG001|Overall Study|Miscellaneous|2|||
156798009|NCT00835367|566013512|FG000|Washout|Adverse Event|2|||
156798010|NCT00835367|566013513|FG001|Washout|Adverse Event|0|||
156798011|NCT00835367|566013512|FG000|Washout|Withdrawal by Subject|1|||
156798012|NCT00835367|566013513|FG001|Washout|Withdrawal by Subject|0|||
156798013|NCT00835367|566013512|FG000|Second Intervention|Adverse Event|1|||
156798014|NCT00835367|566013513|FG001|Second Intervention|Adverse Event|1|||
156798015|NCT03557502|566013515|FG000|Protocol 2|Withdrawal by Subject|1|||
156798016|NCT03557502|566013516|FG001|Protocol 2|Withdrawal by Subject|1|||
156798017|NCT03557502|566013515|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
156798018|NCT03557502|566013516|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
156798019|NCT02333799|566015633|FG000|Treatment Period|Withdrawal by Subject|1|||
156798020|NCT02333799|566015633|FG000|Treatment Period|Death|6|||
156798021|NCT02333799|566015633|FG000|6 Month Follow Up Period|Physician Decision|1|||
156798022|NCT02333799|566015633|FG000|6 Month Follow Up Period|Death|1|||
156798023|NCT02333799|566015633|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
156798024|NCT02333799|566015633|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
156798025|NCT03716830|566015634|FG000|Overall Study|Withdrawal by Subject|2|||
156798026|NCT03716830|566015635|FG001|Overall Study|Withdrawal by Subject|2|||
156798027|NCT03716830|566015636|FG002|Overall Study|Withdrawal by Subject|6|||
156798028|NCT03716830|566015637|FG003|Overall Study|Withdrawal by Subject|5|||
156798029|NCT03716830|566015634|FG000|Overall Study|Adverse Event|1|||
156798030|NCT03716830|566015635|FG001|Overall Study|Adverse Event|2|||
156742270|NCT05238025|565803916|FG000|Overall Study|Other Reason|669|||
156742271|NCT05238025|565803917|FG001|Overall Study|Other Reason|690|||
156742272|NCT03814720|565803920|FG000|Overall Study|Lost to Follow-up|0|||
156742273|NCT03814720|565803921|FG001|Overall Study|Lost to Follow-up|1|||
156798031|NCT03716830|566015636|FG002|Overall Study|Adverse Event|0|||
156878306|NCT02779556|566314000|FG001|12 Month HbA1c|No value collected during window|102|||
156878307|NCT03110770|566314001|FG000|Overall Study|Death|1|||
157218747|NCT01405820|567547500|FG004|Open-Label Treatment Period|Adverse Event|0|||
157218748|NCT01405820|567547501|FG005|Open-Label Treatment Period|Adverse Event|0|||
157218749|NCT00827359|567547506|FG000|Overall Study|Progressive Diseas|19|||
156798032|NCT03716830|566015637|FG003|Overall Study|Adverse Event|1|||
156798033|NCT03716830|566015634|FG000|Overall Study|Lost to Follow-up|1|||
156798034|NCT03716830|566015635|FG001|Overall Study|Lost to Follow-up|1|||
156798035|NCT03716830|566015636|FG002|Overall Study|Lost to Follow-up|0|||
156798036|NCT03716830|566015637|FG003|Overall Study|Lost to Follow-up|0|||
156798037|NCT05484895|566015638|FG000|Overall Study|Lost to Follow-up|63|||
156798038|NCT05484895|566015639|FG001|Overall Study|Lost to Follow-up|64|||
156798039|NCT04795531|566015640|FG000|Overall Study|Withdrawal by Subject|4|||
156798040|NCT04795531|566015641|FG001|Overall Study|Withdrawal by Subject|4|||
156798041|NCT04795531|566015640|FG000|Overall Study|Lost to Follow-up|0|||
156798042|NCT04795531|566015641|FG001|Overall Study|Lost to Follow-up|1|||
156798043|NCT04795531|566015640|FG000|Overall Study|Physician Decision|0|||
156798044|NCT04795531|566015641|FG001|Overall Study|Physician Decision|2|||
156798045|NCT04795531|566015640|FG000|Overall Study|Death|2|||
156798046|NCT04795531|566015641|FG001|Overall Study|Death|1|||
156798047|NCT04887831|566015642|FG000|Overall Study|Death|26|||
156798048|NCT04887831|566015643|FG001|Overall Study|Death|26|||
156798049|NCT04887831|566015642|FG000|Overall Study|Lost to Follow-up|0|||
156798050|NCT04887831|566015643|FG001|Overall Study|Lost to Follow-up|1|||
156798051|NCT04887831|566015642|FG000|Overall Study|Withdrawal by Subject|2|||
156798052|NCT04887831|566015643|FG001|Overall Study|Withdrawal by Subject|1|||
156798053|NCT04887831|566015642|FG000|Overall Study|Study Terminated by Sponsor|18|||
156798054|NCT04887831|566015643|FG001|Overall Study|Study Terminated by Sponsor|17|||
156798055|NCT04887831|566015642|FG000|Overall Study|Other|1|||
156798056|NCT04887831|566015643|FG001|Overall Study|Other|0|||
156798057|NCT03396445|566015644|FG000|Treatment Period|Death|2|||
156798058|NCT03396445|566015645|FG001|Treatment Period|Death|2|||
156798059|NCT03396445|566015646|FG002|Treatment Period|Death|1|||
156798060|NCT03396445|566015647|FG003|Treatment Period|Death|1|||
156798061|NCT03396445|566015648|FG004|Treatment Period|Death|3|||
156798062|NCT03396445|566015649|FG005|Treatment Period|Death|2|||
156798063|NCT03396445|566015650|FG006|Treatment Period|Death|5|||
156798064|NCT03396445|566015651|FG007|Treatment Period|Death|3|||
156798065|NCT03396445|566015652|FG008|Treatment Period|Death|3|||
156798066|NCT03396445|566015653|FG009|Treatment Period|Death|3|||
156798067|NCT03396445|566015654|FG010|Treatment Period|Death|7|||
156798068|NCT03396445|566015655|FG011|Treatment Period|Death|12|||
156798069|NCT03396445|566015656|FG012|Treatment Period|Death|28|||
156798070|NCT03396445|566015657|FG013|Treatment Period|Death|14|||
156798071|NCT03396445|566015658|FG014|Treatment Period|Death|10|||
156798072|NCT03396445|566015659|FG015|Treatment Period|Death|8|||
156798073|NCT03396445|566015660|FG016|Treatment Period|Death|18|||
156798074|NCT03396445|566015661|FG017|Treatment Period|Death|0|||
156798075|NCT03396445|566015662|FG018|Treatment Period|Death|0|||
156798076|NCT03396445|566015663|FG019|Treatment Period|Death|0|||
156798077|NCT03396445|566015664|FG020|Treatment Period|Death|0|||
156798078|NCT03396445|566015665|FG021|Treatment Period|Death|0|||
156798079|NCT03396445|566015666|FG022|Treatment Period|Death|0|||
156798080|NCT03396445|566015667|FG023|Treatment Period|Death|0|||
156798081|NCT03396445|566015668|FG024|Treatment Period|Death|0|||
156798082|NCT03396445|566015669|FG025|Treatment Period|Death|0|||
156798083|NCT03396445|566015644|FG000|Treatment Period|Lost to Follow-up|0|||
156798084|NCT03396445|566015645|FG001|Treatment Period|Lost to Follow-up|0|||
156798085|NCT03396445|566015646|FG002|Treatment Period|Lost to Follow-up|0|||
156798086|NCT03396445|566015647|FG003|Treatment Period|Lost to Follow-up|0|||
156798087|NCT03396445|566015648|FG004|Treatment Period|Lost to Follow-up|0|||
156798088|NCT03396445|566015649|FG005|Treatment Period|Lost to Follow-up|0|||
156798089|NCT03396445|566015650|FG006|Treatment Period|Lost to Follow-up|0|||
156798090|NCT03396445|566015651|FG007|Treatment Period|Lost to Follow-up|0|||
156798091|NCT03396445|566015652|FG008|Treatment Period|Lost to Follow-up|0|||
156798092|NCT03396445|566015653|FG009|Treatment Period|Lost to Follow-up|0|||
156798093|NCT03396445|566015654|FG010|Treatment Period|Lost to Follow-up|0|||
156798094|NCT03396445|566015655|FG011|Treatment Period|Lost to Follow-up|0|||
156798095|NCT03396445|566015656|FG012|Treatment Period|Lost to Follow-up|1|||
156798096|NCT03396445|566015657|FG013|Treatment Period|Lost to Follow-up|0|||
156798097|NCT03396445|566015658|FG014|Treatment Period|Lost to Follow-up|1|||
156798098|NCT03396445|566015659|FG015|Treatment Period|Lost to Follow-up|0|||
156798099|NCT03396445|566015660|FG016|Treatment Period|Lost to Follow-up|0|||
156798100|NCT03396445|566015661|FG017|Treatment Period|Lost to Follow-up|0|||
156798101|NCT03396445|566015662|FG018|Treatment Period|Lost to Follow-up|0|||
156798102|NCT03396445|566015663|FG019|Treatment Period|Lost to Follow-up|0|||
156798103|NCT03396445|566015664|FG020|Treatment Period|Lost to Follow-up|0|||
156798104|NCT03396445|566015665|FG021|Treatment Period|Lost to Follow-up|0|||
156798105|NCT03396445|566015666|FG022|Treatment Period|Lost to Follow-up|0|||
156798106|NCT03396445|566015667|FG023|Treatment Period|Lost to Follow-up|0|||
156798107|NCT03396445|566015668|FG024|Treatment Period|Lost to Follow-up|0|||
156798108|NCT03396445|566015669|FG025|Treatment Period|Lost to Follow-up|0|||
156798109|NCT03396445|566015644|FG000|Treatment Period|Physician Decision|0|||
156878308|NCT03110770|566314002|FG001|Overall Study|Death|0|||
156878309|NCT03110770|566314003|FG002|Overall Study|Death|0|||
156878310|NCT03110770|566314004|FG003|Overall Study|Death|1|||
156878311|NCT03110770|566314005|FG004|Overall Study|Death|0|||
156878312|NCT03110770|566314001|FG000|Overall Study|Enrolled but did not receive product|0|||
156878313|NCT03110770|566314002|FG001|Overall Study|Enrolled but did not receive product|0|||
156742274|NCT03814720|565803922|FG002|Overall Study|Lost to Follow-up|0|||
156742275|NCT03814720|565803923|FG003|Overall Study|Lost to Follow-up|0|||
156742276|NCT03814720|565803924|FG004|Overall Study|Lost to Follow-up|0|||
156742277|NCT00474045|565803925|FG000|Overall Study|Adverse Event|18|||
156742278|NCT00474045|565803926|FG001|Overall Study|Adverse Event|8|||
156742279|NCT00474045|565803925|FG000|Overall Study|Unclassified|1|||
156742280|NCT00474045|565803926|FG001|Overall Study|Unclassified|3|||
156742281|NCT00474045|565803925|FG000|Overall Study|Lack of Efficacy|0|||
156742282|NCT00474045|565803926|FG001|Overall Study|Lack of Efficacy|9|||
156742283|NCT00474045|565803925|FG000|Overall Study|Lost to Follow-up|1|||
156742284|NCT00474045|565803926|FG001|Overall Study|Lost to Follow-up|1|||
156742285|NCT00474045|565803925|FG000|Overall Study|Protocol Violation|10|||
156742286|NCT00474045|565803926|FG001|Overall Study|Protocol Violation|12|||
156742287|NCT00474045|565803925|FG000|Overall Study|Withdrawal by Subject|16|||
156742288|NCT00474045|565803926|FG001|Overall Study|Withdrawal by Subject|18|||
156742289|NCT00474045|565803925|FG000|Overall Study|Withdrawal criteria|60|||
156742290|NCT00474045|565803926|FG001|Overall Study|Withdrawal criteria|50|||
156742291|NCT02135107|565803933|FG000|Treatment Period|Withdrawal by Subject|11|||
156742292|NCT02135107|565803934|FG001|Treatment Period|Withdrawal by Subject|0|||
156742293|NCT02135107|565803935|FG002|Treatment Period|Withdrawal by Subject|0|||
156742294|NCT02135107|565803936|FG003|Treatment Period|Withdrawal by Subject|0|||
156742295|NCT02135107|565803933|FG000|Treatment Period|Adverse Event|5|||
156742296|NCT02135107|565803934|FG001|Treatment Period|Adverse Event|2|||
156742297|NCT02135107|565803935|FG002|Treatment Period|Adverse Event|0|||
156742298|NCT02135107|565803936|FG003|Treatment Period|Adverse Event|0|||
156742299|NCT02135107|565803933|FG000|Treatment Period|Pregnancy|1|||
156742300|NCT02135107|565803934|FG001|Treatment Period|Pregnancy|0|||
156742301|NCT02135107|565803935|FG002|Treatment Period|Pregnancy|0|||
156742302|NCT02135107|565803936|FG003|Treatment Period|Pregnancy|0|||
156742303|NCT02135107|565803933|FG000|Treatment Period|Other|115|||
156742304|NCT02135107|565803934|FG001|Treatment Period|Other|24|||
156742305|NCT02135107|565803935|FG002|Treatment Period|Other|0|||
156742306|NCT02135107|565803936|FG003|Treatment Period|Other|0|||
156742307|NCT02135107|565803933|FG000|Maintenance Therapy Period|Adverse Event|0|||
156742308|NCT02135107|565803934|FG001|Maintenance Therapy Period|Adverse Event|0|||
156742309|NCT02135107|565803935|FG002|Maintenance Therapy Period|Adverse Event|3|||
156742310|NCT02135107|565803936|FG003|Maintenance Therapy Period|Adverse Event|7|||
156742311|NCT02135107|565803933|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
156742312|NCT02135107|565803934|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
156742313|NCT02135107|565803935|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
156742314|NCT02135107|565803936|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
156742315|NCT02135107|565803933|FG000|Maintenance Therapy Period|Pregnancy|0|||
156742316|NCT02135107|565803934|FG001|Maintenance Therapy Period|Pregnancy|0|||
156742317|NCT02135107|565803935|FG002|Maintenance Therapy Period|Pregnancy|0|||
156742318|NCT02135107|565803936|FG003|Maintenance Therapy Period|Pregnancy|1|||
156742319|NCT02135107|565803933|FG000|Maintenance Therapy Period|Other|0|||
156742320|NCT02135107|565803934|FG001|Maintenance Therapy Period|Other|0|||
156742321|NCT02135107|565803935|FG002|Maintenance Therapy Period|Other|7|||
156742322|NCT02135107|565803936|FG003|Maintenance Therapy Period|Other|8|||
156742323|NCT02009397|565803939|FG000|Overall Study|Protocol Violation|6|||
156742324|NCT02009397|565803939|FG000|Overall Study|Death|8|||
156742325|NCT02009397|565803939|FG000|Overall Study|Lost to Follow-up|6|||
156742326|NCT01966068|565803941|FG000|Overall Study|Withdrawal by Subject|57|||
156742327|NCT01966068|565803941|FG000|Overall Study|Lost to Follow-up|81|||
156742328|NCT00808639|565803942|FG000|Overall Study|Disease progression before surgery.|1|||
156878314|NCT03110770|566314003|FG002|Overall Study|Enrolled but did not receive product|0|||
156742329|NCT00191282|565803943|FG000|Overall Study|Adverse Event|5|||
156742330|NCT00191282|565803944|FG001|Overall Study|Adverse Event|6|||
156742331|NCT00191282|565803943|FG000|Overall Study|Death|51|||
156742332|NCT00191282|565803944|FG001|Overall Study|Death|51|||
156742333|NCT00191282|565803943|FG000|Overall Study|Lack of Efficacy|11|||
156742334|NCT00191282|565803944|FG001|Overall Study|Lack of Efficacy|6|||
156742335|NCT00191282|565803943|FG000|Overall Study|Noncompliance|14|||
156742336|NCT00191282|565803944|FG001|Overall Study|Noncompliance|17|||
156742337|NCT00191282|565803943|FG000|Overall Study|Patient moved|11|||
156742338|NCT00191282|565803944|FG001|Overall Study|Patient moved|14|||
156742339|NCT00191282|565803943|FG000|Overall Study|Withdrawal by Subject|59|||
156742340|NCT00191282|565803944|FG001|Overall Study|Withdrawal by Subject|44|||
156878315|NCT03110770|566314004|FG003|Overall Study|Enrolled but did not receive product|8|||
156878316|NCT03110770|566314005|FG004|Overall Study|Enrolled but did not receive product|7|||
156742341|NCT00191282|565803943|FG000|Overall Study|Physician Decision|18|||
156742342|NCT00191282|565803944|FG001|Overall Study|Physician Decision|15|||
156742343|NCT00191282|565803943|FG000|Overall Study|Protocol entry criteria not met|14|||
156878317|NCT03110770|566314001|FG000|Overall Study|Lost to Follow-up|0|||
156878318|NCT03110770|566314002|FG001|Overall Study|Lost to Follow-up|0|||
156878319|NCT03110770|566314003|FG002|Overall Study|Lost to Follow-up|0|||
156878320|NCT03110770|566314004|FG003|Overall Study|Lost to Follow-up|53|||
156878321|NCT03110770|566314005|FG004|Overall Study|Lost to Follow-up|45|||
156878322|NCT03110770|566314001|FG000|Overall Study|Investigator Decision|0|||
156878323|NCT03110770|566314002|FG001|Overall Study|Investigator Decision|0|||
156878324|NCT03110770|566314003|FG002|Overall Study|Investigator Decision|0|||
156878325|NCT03110770|566314004|FG003|Overall Study|Investigator Decision|5|||
156878326|NCT03110770|566314005|FG004|Overall Study|Investigator Decision|3|||
156878327|NCT03110770|566314001|FG000|Overall Study|Withdrawal by Subject|0|||
156878328|NCT03110770|566314002|FG001|Overall Study|Withdrawal by Subject|0|||
156878329|NCT03110770|566314003|FG002|Overall Study|Withdrawal by Subject|0|||
156878330|NCT03110770|566314004|FG003|Overall Study|Withdrawal by Subject|24|||
156878331|NCT03110770|566314005|FG004|Overall Study|Withdrawal by Subject|24|||
156878332|NCT03110770|566314001|FG000|Overall Study|Moved from area|5|||
156878333|NCT03110770|566314002|FG001|Overall Study|Moved from area|0|||
156878334|NCT03110770|566314003|FG002|Overall Study|Moved from area|2|||
156878335|NCT03110770|566314004|FG003|Overall Study|Moved from area|42|||
156878336|NCT03110770|566314005|FG004|Overall Study|Moved from area|43|||
156878337|NCT03110770|566314001|FG000|Overall Study|Illness/Injury unrelated to product|0|||
156878338|NCT03110770|566314002|FG001|Overall Study|Illness/Injury unrelated to product|0|||
156878339|NCT03110770|566314003|FG002|Overall Study|Illness/Injury unrelated to product|0|||
156878340|NCT03110770|566314004|FG003|Overall Study|Illness/Injury unrelated to product|0|||
156878341|NCT03110770|566314005|FG004|Overall Study|Illness/Injury unrelated to product|1|||
156878342|NCT02082340|566314013|FG000|Overall Study|Lost to Follow-up|1|||
156878343|NCT02082340|566314014|FG001|Overall Study|Lost to Follow-up|1|||
156878344|NCT01625260|566314015|FG000|Overall Study|Adverse Event|3|||
156878345|NCT01625260|566314016|FG001|Overall Study|Adverse Event|0|||
156878346|NCT01625260|566314015|FG000|Overall Study|Study Terminated by Investigator|2|||
156878347|NCT01625260|566314016|FG001|Overall Study|Study Terminated by Investigator|0|||
156878348|NCT01625260|566314015|FG000|Overall Study|Disease Progression|2|||
156878349|NCT01625260|566314016|FG001|Overall Study|Disease Progression|0|||
156878350|NCT01625260|566314015|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
156878351|NCT01625260|566314016|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
156878352|NCT03899805|566314017|FG000|Overall Study|Physician Decision|3|||
156878353|NCT03899805|566314018|FG001|Overall Study|Physician Decision|0|||
156878354|NCT03899805|566314019|FG002|Overall Study|Physician Decision|2|||
156878355|NCT03899805|566314017|FG000|Overall Study|Withdrawal by Subject|1|||
156878356|NCT03899805|566314018|FG001|Overall Study|Withdrawal by Subject|0|||
156878357|NCT03899805|566314019|FG002|Overall Study|Withdrawal by Subject|2|||
156878358|NCT03899805|566314017|FG000|Overall Study|Progressive Disease|10|||
156878359|NCT03899805|566314018|FG001|Overall Study|Progressive Disease|18|||
156878360|NCT03899805|566314019|FG002|Overall Study|Progressive Disease|12|||
156878361|NCT03899805|566314017|FG000|Overall Study|Adverse Event|3|||
156878362|NCT03899805|566314018|FG001|Overall Study|Adverse Event|1|||
156878363|NCT03899805|566314019|FG002|Overall Study|Adverse Event|0|||
156878364|NCT03899805|566314017|FG000|Overall Study|Death|2|||
156878365|NCT03899805|566314018|FG001|Overall Study|Death|0|||
156878366|NCT03899805|566314019|FG002|Overall Study|Death|0|||
156878367|NCT03899805|566314017|FG000|Overall Study|Came off for surgery|0|||
156878368|NCT03899805|566314018|FG001|Overall Study|Came off for surgery|0|||
156878369|NCT03899805|566314019|FG002|Overall Study|Came off for surgery|1|||
156878370|NCT03646123|566314020|FG000|Overall Study|Withdrawal by Subject|2|||
156878371|NCT03646123|566314021|FG001|Overall Study|Withdrawal by Subject|2|||
156878372|NCT03646123|566314022|FG002|Overall Study|Withdrawal by Subject|3|||
156878373|NCT03646123|566314020|FG000|Overall Study|Study termination by sponsor|0|||
156878374|NCT03646123|566314021|FG001|Overall Study|Study termination by sponsor|45|||
156878375|NCT03646123|566314022|FG002|Overall Study|Study termination by sponsor|139|||
156878376|NCT03646123|566314020|FG000|Overall Study|Lost to Follow-up|4|||
156878377|NCT03646123|566314021|FG001|Overall Study|Lost to Follow-up|10|||
156878378|NCT03646123|566314022|FG002|Overall Study|Lost to Follow-up|10|||
156878379|NCT03646123|566314020|FG000|Overall Study|Death|2|||
156878380|NCT03646123|566314021|FG001|Overall Study|Death|1|||
156878381|NCT03646123|566314022|FG002|Overall Study|Death|1|||
156742344|NCT00191282|565803944|FG001|Overall Study|Protocol entry criteria not met|9|||
156742345|NCT00191282|565803943|FG000|Overall Study|Protocol Violation|9|||
156878382|NCT03646123|566314020|FG000|Overall Study|Other|2|||
156878383|NCT03646123|566314021|FG001|Overall Study|Other|0|||
156878384|NCT03646123|566314022|FG002|Overall Study|Other|2|||
156878385|NCT04195893|566314023|FG000|Second Intervention|Withdrawal by Subject|1|||
156878386|NCT04195893|566314024|FG001|Second Intervention|Withdrawal by Subject|0|||
156878387|NCT04075734|566314027|FG000|Overall Study|Lost to Follow-up|1|||
156878388|NCT04075734|566314028|FG001|Overall Study|Lost to Follow-up|1|||
156878389|NCT04075734|566314029|FG002|Overall Study|Lost to Follow-up|0|||
156878390|NCT04075734|566314027|FG000|Overall Study|Withdrawal by Subject|3|||
156878391|NCT04075734|566314028|FG001|Overall Study|Withdrawal by Subject|0|||
156878392|NCT04075734|566314029|FG002|Overall Study|Withdrawal by Subject|0|||
156878393|NCT01802073|566314030|FG000|Overall Study|Lost to Follow-up|0|||
156878394|NCT01802073|566314031|FG001|Overall Study|Lost to Follow-up|1|||
156878395|NCT01802073|566314030|FG000|Overall Study|Non-compliant|4|||
156878396|NCT01802073|566314031|FG001|Overall Study|Non-compliant|2|||
156878397|NCT01802073|566314030|FG000|Overall Study|Withdrawal by Subject|1|||
157021794|NCT03623321|566832972|FG000|Overall Study|Lost to Follow-up|6|||
156742346|NCT00191282|565803944|FG001|Overall Study|Protocol Violation|12|||
156742347|NCT00191282|565803943|FG000|Overall Study|Severity of outcome|2|||
156742348|NCT00191282|565803944|FG001|Overall Study|Severity of outcome|5|||
156742349|NCT00191282|565803943|FG000|Overall Study|Sponsor's decision|2|||
156742350|NCT00191282|565803944|FG001|Overall Study|Sponsor's decision|2|||
156742351|NCT00191282|565803943|FG000|Overall Study|Lost to Follow-up|24|||
156742352|NCT00191282|565803944|FG001|Overall Study|Lost to Follow-up|31|||
156742353|NCT01790828|565803945|FG000|Overall Study|Other|34|||
156742354|NCT03589976|565803947|FG000|Overall Study|Death|5|||
156742355|NCT03589976|565803948|FG001|Overall Study|Death|1|||
156742356|NCT03589976|565803947|FG000|Overall Study|Adverse Event|5|||
156742357|NCT03589976|565803948|FG001|Overall Study|Adverse Event|1|||
156742358|NCT03589976|565803947|FG000|Overall Study|Withdrawal by Subject|4|||
156742359|NCT03589976|565803948|FG001|Overall Study|Withdrawal by Subject|1|||
156742360|NCT03589976|565803947|FG000|Overall Study|Lost to Follow-up|1|||
156742361|NCT03589976|565803948|FG001|Overall Study|Lost to Follow-up|0|||
156742362|NCT03589976|565803947|FG000|Overall Study|Other|4|||
156742363|NCT03589976|565803948|FG001|Overall Study|Other|3|||
156742364|NCT02089334|565803949|FG000|Overall Study|Withdrawal by Subject|0|||
156742365|NCT02089334|565803950|FG001|Overall Study|Withdrawal by Subject|0|||
156742366|NCT02089334|565803951|FG002|Overall Study|Withdrawal by Subject|0|||
156742367|NCT02089334|565803952|FG003|Overall Study|Withdrawal by Subject|2|||
156742368|NCT02089334|565803949|FG000|Overall Study|Adverse Event|0|||
156742369|NCT02089334|565803950|FG001|Overall Study|Adverse Event|0|||
156742370|NCT02089334|565803951|FG002|Overall Study|Adverse Event|0|||
156742371|NCT02089334|565803952|FG003|Overall Study|Adverse Event|2|||
156742372|NCT02089334|565803949|FG000|Overall Study|Progressive disease|0|||
156742373|NCT02089334|565803950|FG001|Overall Study|Progressive disease|0|||
156742374|NCT02089334|565803951|FG002|Overall Study|Progressive disease|0|||
156742375|NCT02089334|565803952|FG003|Overall Study|Progressive disease|2|||
156742376|NCT02089334|565803949|FG000|Overall Study|Physician Decision|0|||
156742377|NCT02089334|565803950|FG001|Overall Study|Physician Decision|0|||
156742378|NCT02089334|565803951|FG002|Overall Study|Physician Decision|1|||
156742379|NCT02089334|565803952|FG003|Overall Study|Physician Decision|1|||
156742380|NCT00954512|565803955|FG000|Overall Study|Withdrawal by Subject|0|||
156742381|NCT00954512|565803956|FG001|Overall Study|Withdrawal by Subject|0|||
156742382|NCT00954512|565803957|FG002|Overall Study|Withdrawal by Subject|0|||
156742383|NCT00954512|565803958|FG003|Overall Study|Withdrawal by Subject|0|||
156742384|NCT00954512|565803959|FG004|Overall Study|Withdrawal by Subject|0|||
156742385|NCT00954512|565803960|FG005|Overall Study|Withdrawal by Subject|1|||
156742386|NCT00954512|565803955|FG000|Overall Study|Adverse Event|0|||
156742387|NCT00954512|565803956|FG001|Overall Study|Adverse Event|0|||
156742388|NCT00954512|565803957|FG002|Overall Study|Adverse Event|0|||
156742389|NCT00954512|565803958|FG003|Overall Study|Adverse Event|0|||
156742390|NCT00954512|565803959|FG004|Overall Study|Adverse Event|1|||
156742391|NCT00954512|565803960|FG005|Overall Study|Adverse Event|2|||
156742392|NCT00954512|565803955|FG000|Overall Study|Physician Decision|0|||
156742393|NCT00954512|565803956|FG001|Overall Study|Physician Decision|1|||
156742394|NCT00954512|565803957|FG002|Overall Study|Physician Decision|0|||
156742395|NCT00954512|565803958|FG003|Overall Study|Physician Decision|1|||
156742396|NCT00954512|565803959|FG004|Overall Study|Physician Decision|0|||
156742397|NCT00954512|565803960|FG005|Overall Study|Physician Decision|0|||
156742398|NCT00954512|565803955|FG000|Overall Study|Symptomatic Deterioration|0|||
156742399|NCT00954512|565803956|FG001|Overall Study|Symptomatic Deterioration|1|||
156742400|NCT00954512|565803957|FG002|Overall Study|Symptomatic Deterioration|0|||
156742401|NCT00954512|565803958|FG003|Overall Study|Symptomatic Deterioration|0|||
156742402|NCT00954512|565803959|FG004|Overall Study|Symptomatic Deterioration|2|||
156742403|NCT00954512|565803960|FG005|Overall Study|Symptomatic Deterioration|0|||
156742404|NCT00954512|565803955|FG000|Overall Study|Progression of Disease|2|||
156742405|NCT00954512|565803956|FG001|Overall Study|Progression of Disease|1|||
156742406|NCT00954512|565803957|FG002|Overall Study|Progression of Disease|0|||
156742407|NCT00954512|565803958|FG003|Overall Study|Progression of Disease|1|||
156742408|NCT00954512|565803959|FG004|Overall Study|Progression of Disease|1|||
156742409|NCT00954512|565803960|FG005|Overall Study|Progression of Disease|1|||
156742410|NCT04814368|565803961|FG000|Overall Study|Study Terminated by Sponsor|0|||
156742411|NCT04814368|565803962|FG001|Overall Study|Study Terminated by Sponsor|3|||
156742412|NCT04814368|565803963|FG002|Overall Study|Study Terminated by Sponsor|0|||
156742413|NCT04814368|565803964|FG003|Overall Study|Study Terminated by Sponsor|2|||
156742414|NCT04814368|565803961|FG000|Overall Study|Subject Decision|1|||
156742415|NCT04814368|565803962|FG001|Overall Study|Subject Decision|2|||
156742416|NCT04814368|565803963|FG002|Overall Study|Subject Decision|0|||
157020501|NCT02736409|566828456|FG000|Overall Study|Withdrawal by Subject|4|||
156742417|NCT04814368|565803964|FG003|Overall Study|Subject Decision|0|||
156742418|NCT00224406|565806318|FG000|Overall Study|Re-transplant|0|||
156742419|NCT00224406|565806319|FG001|Overall Study|Re-transplant|2|||
156742420|NCT00224406|565806318|FG000|Overall Study|Death|0|||
156742421|NCT00224406|565806319|FG001|Overall Study|Death|1|||
156742422|NCT00224406|565806318|FG000|Overall Study|Transplant cancelled|0|||
156742423|NCT00224406|565806319|FG001|Overall Study|Transplant cancelled|4|||
156742424|NCT00224406|565806318|FG000|Overall Study|Drug not delivered|2|||
156742425|NCT00224406|565806319|FG001|Overall Study|Drug not delivered|0|||
156798110|NCT03396445|566015645|FG001|Treatment Period|Physician Decision|0|||
156798111|NCT03396445|566015646|FG002|Treatment Period|Physician Decision|0|||
156798112|NCT03396445|566015647|FG003|Treatment Period|Physician Decision|0|||
156798113|NCT03396445|566015648|FG004|Treatment Period|Physician Decision|1|||
156798114|NCT03396445|566015649|FG005|Treatment Period|Physician Decision|0|||
156798115|NCT03396445|566015650|FG006|Treatment Period|Physician Decision|0|||
156798116|NCT03396445|566015651|FG007|Treatment Period|Physician Decision|0|||
156798117|NCT03396445|566015652|FG008|Treatment Period|Physician Decision|0|||
156798118|NCT03396445|566015653|FG009|Treatment Period|Physician Decision|1|||
156798119|NCT03396445|566015654|FG010|Treatment Period|Physician Decision|0|||
156798120|NCT03396445|566015655|FG011|Treatment Period|Physician Decision|0|||
156798121|NCT03396445|566015656|FG012|Treatment Period|Physician Decision|0|||
156798122|NCT03396445|566015657|FG013|Treatment Period|Physician Decision|0|||
156798123|NCT03396445|566015658|FG014|Treatment Period|Physician Decision|0|||
156798124|NCT03396445|566015659|FG015|Treatment Period|Physician Decision|0|||
156798125|NCT03396445|566015660|FG016|Treatment Period|Physician Decision|0|||
156798126|NCT03396445|566015661|FG017|Treatment Period|Physician Decision|0|||
156798127|NCT03396445|566015662|FG018|Treatment Period|Physician Decision|0|||
156798128|NCT03396445|566015663|FG019|Treatment Period|Physician Decision|0|||
156798129|NCT03396445|566015664|FG020|Treatment Period|Physician Decision|0|||
156798130|NCT03396445|566015665|FG021|Treatment Period|Physician Decision|0|||
156798131|NCT03396445|566015666|FG022|Treatment Period|Physician Decision|0|||
156798132|NCT03396445|566015667|FG023|Treatment Period|Physician Decision|0|||
156798133|NCT03396445|566015668|FG024|Treatment Period|Physician Decision|0|||
156798134|NCT03396445|566015669|FG025|Treatment Period|Physician Decision|0|||
156798135|NCT03396445|566015644|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798136|NCT03396445|566015645|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798137|NCT03396445|566015646|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798138|NCT03396445|566015647|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798139|NCT03396445|566015648|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798140|NCT03396445|566015649|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798141|NCT03396445|566015650|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798142|NCT03396445|566015651|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798143|NCT03396445|566015652|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798144|NCT03396445|566015653|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798145|NCT03396445|566015654|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798146|NCT03396445|566015655|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798147|NCT03396445|566015656|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
156798148|NCT03396445|566015657|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798149|NCT03396445|566015658|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
156798150|NCT03396445|566015659|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798151|NCT03396445|566015660|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798152|NCT03396445|566015661|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798153|NCT03396445|566015662|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798154|NCT03396445|566015663|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798155|NCT03396445|566015664|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798156|NCT03396445|566015665|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798157|NCT03396445|566015666|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798158|NCT03396445|566015667|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798159|NCT03396445|566015668|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798160|NCT03396445|566015669|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
156798161|NCT03396445|566015644|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
157020502|NCT02736409|566828457|FG001|Overall Study|Withdrawal by Subject|2|||
157020503|NCT02736409|566828458|FG002|Overall Study|Withdrawal by Subject|17|||
157020504|NCT02736409|566828459|FG003|Overall Study|Withdrawal by Subject|3|||
156742426|NCT00224406|565806318|FG000|Overall Study|Other|4|||
156798162|NCT03396445|566015645|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
157020505|NCT02736409|566828456|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156742427|NCT00224406|565806319|FG001|Overall Study|Other|0|||
157020506|NCT02736409|566828457|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157020507|NCT02736409|566828458|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157020508|NCT02736409|566828459|FG003|Overall Study|Non-Compliance with Study Drug|1|||
157020509|NCT02736409|566828456|FG000|Overall Study|Adverse Event|0|||
157020510|NCT02736409|566828457|FG001|Overall Study|Adverse Event|1|||
157020511|NCT02736409|566828458|FG002|Overall Study|Adverse Event|5|||
157020512|NCT02736409|566828459|FG003|Overall Study|Adverse Event|4|||
157020513|NCT02736409|566828456|FG000|Overall Study|Other|0|||
157020514|NCT02736409|566828457|FG001|Overall Study|Other|0|||
156798163|NCT03396445|566015646|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
156798164|NCT03396445|566015647|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
156798165|NCT03396445|566015648|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
156798166|NCT03396445|566015649|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
157020515|NCT02736409|566828458|FG002|Overall Study|Other|1|||
157020516|NCT02736409|566828459|FG003|Overall Study|Other|1|||
157020517|NCT02736409|566828456|FG000|Overall Study|Pregnancy|0|||
157020518|NCT02736409|566828457|FG001|Overall Study|Pregnancy|0|||
157020519|NCT02736409|566828458|FG002|Overall Study|Pregnancy|1|||
156878398|NCT01802073|566314031|FG001|Overall Study|Withdrawal by Subject|1|||
156878399|NCT01802073|566314030|FG000|Overall Study|Physician Decision|0|||
156878400|NCT01802073|566314031|FG001|Overall Study|Physician Decision|7|||
156878401|NCT01776307|566314036|FG000|Overall Study|Not dosed|0|||
156878402|NCT01776307|566314037|FG001|Overall Study|Not dosed|0|||
156878403|NCT01776307|566314038|FG002|Overall Study|Not dosed|1|||
156878404|NCT02745145|566314044|FG000|Overall Study|Adverse Event|1|||
156798167|NCT03396445|566015650|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
156798168|NCT03396445|566015651|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798169|NCT03396445|566015652|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798170|NCT03396445|566015653|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798171|NCT03396445|566015654|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798172|NCT03396445|566015655|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798173|NCT03396445|566015656|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156878405|NCT02745145|566314045|FG001|Overall Study|Adverse Event|0|||
156878406|NCT02745145|566314046|FG002|Overall Study|Adverse Event|0|||
156878407|NCT02745145|566314044|FG000|Overall Study|Death|0|||
156878408|NCT02745145|566314045|FG001|Overall Study|Death|1|||
156878409|NCT02745145|566314046|FG002|Overall Study|Death|0|||
156878410|NCT02745145|566314044|FG000|Overall Study|Progressive disease|0|||
156878411|NCT02745145|566314045|FG001|Overall Study|Progressive disease|0|||
156878412|NCT02745145|566314046|FG002|Overall Study|Progressive disease|1|||
156878413|NCT02745145|566314044|FG000|Overall Study|Withdrew consent|1|||
156878414|NCT02745145|566314045|FG001|Overall Study|Withdrew consent|1|||
156878415|NCT02745145|566314046|FG002|Overall Study|Withdrew consent|1|||
156878416|NCT02745145|566314044|FG000|Overall Study|Study Termination|8|||
156878417|NCT02745145|566314045|FG001|Overall Study|Study Termination|3|||
156878418|NCT02745145|566314046|FG002|Overall Study|Study Termination|7|||
156878419|NCT01297491|566314052|FG000|Overall Study|Adverse Event|11|||
156878420|NCT01297491|566314053|FG001|Overall Study|Adverse Event|6|||
156878421|NCT01297491|566314052|FG000|Overall Study|Physician Decision|3|||
156878422|NCT01297491|566314053|FG001|Overall Study|Physician Decision|2|||
156878423|NCT01297491|566314052|FG000|Overall Study|Progressive disease|11|||
156878424|NCT01297491|566314053|FG001|Overall Study|Progressive disease|20|||
156878425|NCT01297491|566314052|FG000|Overall Study|Patient/Guardian decision|3|||
156878426|NCT01297491|566314053|FG001|Overall Study|Patient/Guardian decision|4|||
156878427|NCT01297491|566314052|FG000|Overall Study|Death|2|||
156878428|NCT01297491|566314053|FG001|Overall Study|Death|1|||
156878429|NCT04413617|566314059|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156878430|NCT04413617|566314060|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156878431|NCT04413617|566314061|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156878432|NCT04413617|566314062|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
156878433|NCT04413617|566314063|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
156878434|NCT04413617|566314059|FG000|Overall Study|Protocol Violation|0|||
156878435|NCT04413617|566314060|FG001|Overall Study|Protocol Violation|1|||
156878436|NCT04413617|566314061|FG002|Overall Study|Protocol Violation|0|||
157218750|NCT00827359|567547506|FG000|Overall Study|Unacceptable Toxicity|5|||
156878437|NCT04413617|566314062|FG003|Overall Study|Protocol Violation|0|||
156878438|NCT04413617|566314063|FG004|Overall Study|Protocol Violation|1|||
156878439|NCT04413617|566314059|FG000|Overall Study|Lack of Efficacy|2|||
157020520|NCT02736409|566828459|FG003|Overall Study|Pregnancy|0|||
157020521|NCT02736409|566828456|FG000|Overall Study|Lost to Follow-up|0|||
157218751|NCT00827359|567547506|FG000|Overall Study|Ineligible|1|||
157218752|NCT02436135|567547507|FG000|Overall Study|Progressive Disease|3|||
156878440|NCT04413617|566314060|FG001|Overall Study|Lack of Efficacy|0|||
156878441|NCT04413617|566314061|FG002|Overall Study|Lack of Efficacy|2|||
156878442|NCT04413617|566314062|FG003|Overall Study|Lack of Efficacy|1|||
156878443|NCT04413617|566314063|FG004|Overall Study|Lack of Efficacy|0|||
156878444|NCT04413617|566314059|FG000|Overall Study|Withdrawal by Subject|3|||
156878445|NCT04413617|566314060|FG001|Overall Study|Withdrawal by Subject|4|||
156878446|NCT04413617|566314061|FG002|Overall Study|Withdrawal by Subject|2|||
156878447|NCT04413617|566314062|FG003|Overall Study|Withdrawal by Subject|5|||
156878448|NCT04413617|566314063|FG004|Overall Study|Withdrawal by Subject|3|||
156878449|NCT04413617|566314059|FG000|Overall Study|Death|1|||
156878450|NCT04413617|566314060|FG001|Overall Study|Death|0|||
156878451|NCT04413617|566314061|FG002|Overall Study|Death|0|||
156878452|NCT04413617|566314062|FG003|Overall Study|Death|0|||
156878453|NCT04413617|566314063|FG004|Overall Study|Death|0|||
156878454|NCT04413617|566314059|FG000|Overall Study|Adverse Event|1|||
156878455|NCT04413617|566314060|FG001|Overall Study|Adverse Event|0|||
156878456|NCT04413617|566314061|FG002|Overall Study|Adverse Event|0|||
156878457|NCT04413617|566314062|FG003|Overall Study|Adverse Event|1|||
156878458|NCT04413617|566314063|FG004|Overall Study|Adverse Event|1|||
156878459|NCT04413617|566314059|FG000|Overall Study|COVID-19|0|||
156878460|NCT04413617|566314060|FG001|Overall Study|COVID-19|1|||
156878461|NCT04413617|566314061|FG002|Overall Study|COVID-19|0|||
156878462|NCT04413617|566314062|FG003|Overall Study|COVID-19|0|||
156878463|NCT04413617|566314063|FG004|Overall Study|COVID-19|0|||
156878464|NCT00775593|566314064|FG000|Overall Study|Unmet eligibility criteria|6|||
156878465|NCT00775593|566314064|FG000|Overall Study|Death|1|||
156878466|NCT02511106|566314067|FG000|Overall Study|Lost to Follow-up|6|||
156878467|NCT02511106|566314068|FG001|Overall Study|Lost to Follow-up|4|||
156878468|NCT02511106|566314067|FG000|Overall Study|Withdrawal by Subject|24|||
156878469|NCT02511106|566314068|FG001|Overall Study|Withdrawal by Subject|21|||
156878470|NCT02511106|566314067|FG000|Overall Study|Death|42|||
156878471|NCT02511106|566314068|FG001|Overall Study|Death|82|||
156878472|NCT02511106|566314067|FG000|Overall Study|Ongoing study at data cut-off|3|||
156878473|NCT02511106|566314068|FG001|Overall Study|Ongoing study at data cut-off|2|||
156878474|NCT02511106|566314067|FG000|Overall Study|Without specified reason|3|||
156878475|NCT02511106|566314068|FG001|Overall Study|Without specified reason|0|||
156878476|NCT01015638|566314069|FG000|Overall Study|Withdrawal by Subject|1|||
156878477|NCT01015638|566314070|FG001|Overall Study|Withdrawal by Subject|0|||
156878478|NCT00984620|566314071|FG000|Overall Study|Adverse Event|5|||
156878479|NCT00984620|566314072|FG001|Overall Study|Adverse Event|5|||
156878480|NCT00984620|566314071|FG000|Overall Study|Lost to Follow-up|1|||
156878481|NCT00984620|566314072|FG001|Overall Study|Lost to Follow-up|1|||
156878482|NCT00984620|566314071|FG000|Overall Study|Withdrawal by Subject|0|||
156878483|NCT00984620|566314072|FG001|Overall Study|Withdrawal by Subject|2|||
156878484|NCT00984620|566314071|FG000|Overall Study|reason other than listed above|0|||
156878485|NCT00984620|566314072|FG001|Overall Study|reason other than listed above|4|||
156878486|NCT00324961|566314076|FG000|Overall Study|Adverse Event|5|||
156878487|NCT00324961|566314076|FG000|Overall Study|Consent Withdrawn|11|||
156878488|NCT00324961|566314076|FG000|Overall Study|Lost to Follow-up|22|||
156878489|NCT00324961|566314076|FG000|Overall Study|Protocol Violation|3|||
156878490|NCT00324961|566314076|FG000|Overall Study|Other|2|||
156878491|NCT00344487|566314077|FG000|Overall Study|immunologic failure|1|||
156878492|NCT01703754|566314078|FG000|Overall Study|Clinically significant disease progression|2|||
156878493|NCT01703754|566314079|FG001|Overall Study|Clinically significant disease progression|2|||
157218753|NCT02436135|567547508|FG001|Overall Study|Progressive Disease|1|||
157218754|NCT02436135|567547507|FG000|Overall Study|Investigator Discretion|1|||
156878494|NCT01703754|566314080|FG002|Overall Study|Clinically significant disease progression|1|||
156878495|NCT01703754|566314078|FG000|Overall Study|Adverse Event|1|||
156878496|NCT01703754|566314079|FG001|Overall Study|Adverse Event|1|||
156878497|NCT01703754|566314080|FG002|Overall Study|Adverse Event|0|||
156878498|NCT01703754|566314078|FG000|Overall Study|Withdrawal by Subject|2|||
156878499|NCT01703754|566314079|FG001|Overall Study|Withdrawal by Subject|0|||
156878500|NCT01703754|566314080|FG002|Overall Study|Withdrawal by Subject|0|||
156878501|NCT01459497|566314084|FG000|Overall Study|Inability to meet trial constraints.|1|||
156878502|NCT01459497|566314085|FG001|Overall Study|Inability to meet trial constraints.|0|||
156878503|NCT01459497|566314084|FG000|Overall Study|Physician Decision|1|||
156878504|NCT01459497|566314085|FG001|Overall Study|Physician Decision|1|||
156878505|NCT01459497|566314084|FG000|Overall Study|Hospitalization.|0|||
157218755|NCT02436135|567547508|FG001|Overall Study|Investigator Discretion|2|||
156878506|NCT01459497|566314085|FG001|Overall Study|Hospitalization.|3|||
156878507|NCT01459497|566314084|FG000|Overall Study|Disease progression.|0|||
156878508|NCT01459497|566314085|FG001|Overall Study|Disease progression.|1|||
156878509|NCT03530124|566314086|FG000|Overall Study|Withdrawal by Subject|0|||
156878510|NCT03530124|566314087|FG001|Overall Study|Withdrawal by Subject|1|||
156878511|NCT03530124|566314086|FG000|Overall Study|Protocol Violation|1|||
156878512|NCT03530124|566314087|FG001|Overall Study|Protocol Violation|0|||
156878513|NCT03530124|566314086|FG000|Overall Study|Discharged prior to study completion|1|||
157020522|NCT02736409|566828457|FG001|Overall Study|Lost to Follow-up|0|||
156878514|NCT03530124|566314087|FG001|Overall Study|Discharged prior to study completion|0|||
156878515|NCT05188053|566314088|FG000|Overall Study|Lost to Follow-up|23|||
156878516|NCT05188053|566314089|FG001|Overall Study|Lost to Follow-up|30|||
156878517|NCT05188053|566314088|FG000|Overall Study|Protocol Violation|16|||
156878518|NCT05188053|566314089|FG001|Overall Study|Protocol Violation|16|||
156878519|NCT05188053|566314088|FG000|Overall Study|Physician Decision|3|||
156878520|NCT05188053|566314089|FG001|Overall Study|Physician Decision|0|||
156878521|NCT05188053|566314088|FG000|Overall Study|Withdrawal by Subject|0|||
156878522|NCT05188053|566314089|FG001|Overall Study|Withdrawal by Subject|1|||
156878523|NCT01561313|566314101|FG000|Overall Study|Withdrawal by Subject|1|||
156878524|NCT01561313|566314102|FG001|Overall Study|Withdrawal by Subject|0|||
156878525|NCT01561313|566314101|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
156878526|NCT01561313|566314102|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
156878527|NCT04535453|566314103|FG000|Overall Study|Death|0|||
156878528|NCT04535453|566314104|FG001|Overall Study|Death|1|||
156878529|NCT04535453|566314105|FG002|Overall Study|Death|0|||
156878530|NCT04535453|566314106|FG003|Overall Study|Death|0|||
156878531|NCT04535453|566314107|FG004|Overall Study|Death|0|||
156878532|NCT04535453|566314108|FG005|Overall Study|Death|0|||
156878533|NCT04535453|566314109|FG006|Overall Study|Death|0|||
156878534|NCT04535453|566314110|FG007|Overall Study|Death|0|||
156878535|NCT04535453|566314111|FG008|Overall Study|Death|0|||
156878536|NCT04535453|566314112|FG009|Overall Study|Death|0|||
156878537|NCT04535453|566314113|FG010|Overall Study|Death|0|||
156878538|NCT04535453|566314114|FG011|Overall Study|Death|0|||
156878539|NCT04535453|566314103|FG000|Overall Study|Lost to Follow-up|1|||
156878540|NCT04535453|566314104|FG001|Overall Study|Lost to Follow-up|1|||
156878541|NCT04535453|566314105|FG002|Overall Study|Lost to Follow-up|1|||
156878542|NCT04535453|566314106|FG003|Overall Study|Lost to Follow-up|0|||
156878543|NCT04535453|566314107|FG004|Overall Study|Lost to Follow-up|3|||
156878544|NCT04535453|566314108|FG005|Overall Study|Lost to Follow-up|1|||
156878545|NCT04535453|566314109|FG006|Overall Study|Lost to Follow-up|0|||
156878546|NCT04535453|566314110|FG007|Overall Study|Lost to Follow-up|0|||
156878547|NCT04535453|566314111|FG008|Overall Study|Lost to Follow-up|1|||
156878548|NCT04535453|566314112|FG009|Overall Study|Lost to Follow-up|1|||
156878549|NCT04535453|566314113|FG010|Overall Study|Lost to Follow-up|0|||
156878550|NCT04535453|566314114|FG011|Overall Study|Lost to Follow-up|0|||
156878551|NCT04535453|566314103|FG000|Overall Study|Physician Decision|0|||
156878552|NCT04535453|566314104|FG001|Overall Study|Physician Decision|0|||
156878553|NCT04535453|566314105|FG002|Overall Study|Physician Decision|0|||
156878554|NCT04535453|566314106|FG003|Overall Study|Physician Decision|1|||
156878555|NCT04535453|566314107|FG004|Overall Study|Physician Decision|0|||
156878556|NCT04535453|566314108|FG005|Overall Study|Physician Decision|0|||
156878557|NCT04535453|566314109|FG006|Overall Study|Physician Decision|0|||
156878558|NCT04535453|566314110|FG007|Overall Study|Physician Decision|0|||
156878559|NCT04535453|566314111|FG008|Overall Study|Physician Decision|0|||
156878560|NCT04535453|566314112|FG009|Overall Study|Physician Decision|0|||
156878561|NCT04535453|566314113|FG010|Overall Study|Physician Decision|0|||
156878562|NCT04535453|566314114|FG011|Overall Study|Physician Decision|0|||
156878563|NCT04535453|566314103|FG000|Overall Study|Withdrawal by Subject|3|||
156878564|NCT04535453|566314104|FG001|Overall Study|Withdrawal by Subject|6|||
156878565|NCT04535453|566314105|FG002|Overall Study|Withdrawal by Subject|3|||
156878566|NCT04535453|566314106|FG003|Overall Study|Withdrawal by Subject|3|||
156878567|NCT04535453|566314107|FG004|Overall Study|Withdrawal by Subject|2|||
156878568|NCT04535453|566314108|FG005|Overall Study|Withdrawal by Subject|1|||
156878569|NCT04535453|566314109|FG006|Overall Study|Withdrawal by Subject|1|||
156878570|NCT04535453|566314110|FG007|Overall Study|Withdrawal by Subject|1|||
156878571|NCT04535453|566314111|FG008|Overall Study|Withdrawal by Subject|1|||
157020523|NCT02736409|566828458|FG002|Overall Study|Lost to Follow-up|2|||
157020524|NCT02736409|566828459|FG003|Overall Study|Lost to Follow-up|1|||
157020525|NCT02736409|566828456|FG000|Overall Study|Physician Decision|0|||
156878572|NCT04535453|566314112|FG009|Overall Study|Withdrawal by Subject|1|||
156878573|NCT04535453|566314113|FG010|Overall Study|Withdrawal by Subject|0|||
156878574|NCT04535453|566314114|FG011|Overall Study|Withdrawal by Subject|1|||
156878575|NCT04535453|566314103|FG000|Overall Study|Other|0|||
156878576|NCT04535453|566314104|FG001|Overall Study|Other|0|||
156878577|NCT04535453|566314105|FG002|Overall Study|Other|1|||
156878578|NCT04535453|566314106|FG003|Overall Study|Other|0|||
156878579|NCT04535453|566314107|FG004|Overall Study|Other|1|||
156878580|NCT04535453|566314108|FG005|Overall Study|Other|0|||
156878581|NCT04535453|566314109|FG006|Overall Study|Other|1|||
157020526|NCT02736409|566828457|FG001|Overall Study|Physician Decision|0|||
157020527|NCT02736409|566828458|FG002|Overall Study|Physician Decision|0|||
156878582|NCT04535453|566314110|FG007|Overall Study|Other|1|||
156878583|NCT04535453|566314111|FG008|Overall Study|Other|1|||
156878584|NCT04535453|566314112|FG009|Overall Study|Other|0|||
156878585|NCT04535453|566314113|FG010|Overall Study|Other|0|||
156878586|NCT04535453|566314114|FG011|Overall Study|Other|0|||
156878587|NCT02878798|566314115|FG000|Overall Study|Withdrawal by Subject|5|||
156878588|NCT02878798|566314116|FG001|Overall Study|Withdrawal by Subject|4|||
156878589|NCT02878798|566314115|FG000|Overall Study|Lost to Follow-up|2|||
156742428|NCT00224406|565806318|FG000|Overall Study|Transplant cancelled|3|||
156742429|NCT00224406|565806319|FG001|Overall Study|Transplant cancelled|0|||
156742430|NCT04823130|565806320|FG000|Overall Study|Withdrawal by Subject|2|||
156742431|NCT04823130|565806321|FG001|Overall Study|Withdrawal by Subject|3|||
156742432|NCT04823130|565806320|FG000|Overall Study|Failure to meet inclusion criteria|6|||
156742433|NCT04823130|565806321|FG001|Overall Study|Failure to meet inclusion criteria|4|||
156742434|NCT04823130|565806320|FG000|Overall Study|Other-unspecified|1|||
156742435|NCT04823130|565806321|FG001|Overall Study|Other-unspecified|0|||
156742436|NCT03315455|565806322|FG000|Overall Study|Ongoing in the Study|13|||
156742437|NCT03315455|565806323|FG001|Overall Study|Ongoing in the Study|24|||
156742438|NCT03315455|565806324|FG002|Overall Study|Ongoing in the Study|17|||
156742439|NCT03315455|565806325|FG003|Overall Study|Ongoing in the Study|15|||
156742440|NCT03315455|565806322|FG000|Overall Study|Withdrawal by Subject|0|||
156742441|NCT03315455|565806323|FG001|Overall Study|Withdrawal by Subject|1|||
156742442|NCT03315455|565806324|FG002|Overall Study|Withdrawal by Subject|0|||
156742443|NCT03315455|565806325|FG003|Overall Study|Withdrawal by Subject|0|||
156742444|NCT03117881|565806328|FG000|Baseline|Withdrawal by Subject|21|||
156742445|NCT03117881|565806329|FG001|Baseline|Withdrawal by Subject|10|||
156742446|NCT03117881|565806330|FG002|Baseline|Withdrawal by Subject|0|||
156742447|NCT03117881|565806328|FG000|Baseline|Lost to Follow-up|22|||
156742448|NCT03117881|565806329|FG001|Baseline|Lost to Follow-up|25|||
156742449|NCT03117881|565806330|FG002|Baseline|Lost to Follow-up|0|||
156742450|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
156742451|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
156742452|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
156742453|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
156742454|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
156742455|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
156742456|NCT03117881|565806328|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
156742457|NCT03117881|565806329|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
156742458|NCT03117881|565806330|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
156742459|NCT03117881|565806328|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
156742460|NCT03117881|565806329|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
156742461|NCT03117881|565806330|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
156742462|NCT03117881|565806328|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
156742463|NCT03117881|565806329|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
156742464|NCT03117881|565806330|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
156742465|NCT03117881|565806328|FG000|6-Month Follow-Up|Did not complete test|53|||
156742466|NCT03117881|565806329|FG001|6-Month Follow-Up|Did not complete test|25|||
156742467|NCT03117881|565806330|FG002|6-Month Follow-Up|Did not complete test|7|||
156742468|NCT03117881|565806328|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
156742469|NCT03117881|565806329|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
156742470|NCT03117881|565806330|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
156742471|NCT03117881|565806328|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
156742472|NCT03117881|565806329|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
156742473|NCT03117881|565806330|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
156742474|NCT03117881|565806328|FG000|12-Month Follow-Up|Did not complete test|40|||
156742475|NCT03117881|565806329|FG001|12-Month Follow-Up|Did not complete test|0|||
156742476|NCT03117881|565806330|FG002|12-Month Follow-Up|Did not complete test|0|||
156742477|NCT02304380|565806332|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742478|NCT02304380|565806333|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742479|NCT02304380|565806334|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742480|NCT02304380|565806335|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
156742481|NCT02304380|565806336|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742482|NCT02304380|565806337|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
156742483|NCT01027897|565806338|FG000|Overall Study|Protocol Violation|1|||
156742484|NCT01027897|565806338|FG000|Overall Study|Withdrawal by Subject|1|||
156742485|NCT00473824|565806339|FG000|Overall Study|Virologic Breakthrough|1|||
156742486|NCT00473824|565806340|FG001|Overall Study|Virologic Breakthrough|0|||
156742487|NCT00473824|565806339|FG000|Overall Study|Adverse Event|1|||
156742488|NCT00473824|565806340|FG001|Overall Study|Adverse Event|0|||
156798174|NCT03396445|566015657|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798175|NCT03396445|566015658|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156808879|NCT00589797|566054494|FG001|Overall Study|Withdrawal by Subject|5|||
156742489|NCT00473824|565806339|FG000|Overall Study|Death|1|||
156742490|NCT00473824|565806340|FG001|Overall Study|Death|0|||
156742491|NCT00473824|565806339|FG000|Overall Study|Lost to Follow-up|1|||
156742492|NCT00473824|565806340|FG001|Overall Study|Lost to Follow-up|0|||
156742493|NCT00473824|565806339|FG000|Overall Study|Withdrawal by physician|1|||
156742494|NCT00473824|565806340|FG001|Overall Study|Withdrawal by physician|0|||
156742495|NCT01349322|565806341|FG000|Overall Study|Protocol Violation|45|||
156742496|NCT01349322|565806342|FG001|Overall Study|Protocol Violation|47|||
156878590|NCT02878798|566314116|FG001|Overall Study|Lost to Follow-up|2|||
156878591|NCT02878798|566314115|FG000|Overall Study|Protocol Violation|0|||
156878592|NCT02878798|566314116|FG001|Overall Study|Protocol Violation|1|||
156878593|NCT01309282|566314117|FG000|Overall Study|Lost to Follow-up|1|||
156878594|NCT02087423|566314118|FG000|Overall Study|Withdrawal by Subject|20|||
156878595|NCT02087423|566314119|FG001|Overall Study|Withdrawal by Subject|20|||
156878596|NCT02087423|566314120|FG002|Overall Study|Withdrawal by Subject|3|||
156878597|NCT02087423|566314118|FG000|Overall Study|Death|68|||
156878598|NCT02087423|566314119|FG001|Overall Study|Death|207|||
156878599|NCT02087423|566314120|FG002|Overall Study|Death|40|||
156878600|NCT02087423|566314118|FG000|Overall Study|Lost to Follow-up|0|||
156878601|NCT02087423|566314119|FG001|Overall Study|Lost to Follow-up|2|||
156878602|NCT02087423|566314120|FG002|Overall Study|Lost to Follow-up|0|||
156878603|NCT02087423|566314118|FG000|Overall Study|Terminated from study at final DCO|23|||
156878604|NCT02087423|566314119|FG001|Overall Study|Terminated from study at final DCO|36|||
156878605|NCT02087423|566314120|FG002|Overall Study|Terminated from study at final DCO|25|||
156878606|NCT01387542|566314121|FG000|Overall Study|Adverse Event|3|||
156878607|NCT01387542|566314121|FG000|Overall Study|Withdrawal by Subject|1|||
156878608|NCT01387542|566314121|FG000|Overall Study|Changed diagnosis|1|||
156878609|NCT01387542|566314121|FG000|Overall Study|Insufficient response|1|||
156878610|NCT01387542|566314121|FG000|Overall Study|Non-compliant|1|||
156878611|NCT01387542|566314121|FG000|Overall Study|Lost to Follow-up|1|||
156878612|NCT01761240|566314124|FG000|Overall Study|Progressive disease:radiology assessment|3|||
156878613|NCT01761240|566314125|FG001|Overall Study|Progressive disease:radiology assessment|3|||
156878614|NCT01761240|566314126|FG002|Overall Study|Progressive disease:radiology assessment|0|||
156878615|NCT01761240|566314127|FG003|Overall Study|Progressive disease:radiology assessment|0|||
156742497|NCT00985426|565806346|FG000|Overall Study|Adverse Event|0|||
156742498|NCT00985426|565806347|FG001|Overall Study|Adverse Event|1|||
156742499|NCT00985426|565806346|FG000|Overall Study|Subject Non-Compliance|3|||
156742500|NCT00985426|565806347|FG001|Overall Study|Subject Non-Compliance|3|||
156742501|NCT00985426|565806346|FG000|Overall Study|Withdrawal by Subject|12|||
156742502|NCT00985426|565806347|FG001|Overall Study|Withdrawal by Subject|16|||
156742503|NCT00985426|565806346|FG000|Overall Study|Lost to Follow-up|8|||
156742504|NCT00985426|565806347|FG001|Overall Study|Lost to Follow-up|10|||
156742505|NCT00985426|565806346|FG000|Overall Study|Death|7|||
156742506|NCT00985426|565806347|FG001|Overall Study|Death|3|||
156742507|NCT00985426|565806346|FG000|Overall Study|Protocol Violation|2|||
156742508|NCT00985426|565806347|FG001|Overall Study|Protocol Violation|0|||
156742509|NCT00985426|565806346|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
156742510|NCT00985426|565806347|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
156742511|NCT01661933|565806348|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
156742512|NCT01661933|565806348|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
156742513|NCT03385304|565806349|FG000|Overall Study|Death|19|||
156742514|NCT03385304|565806350|FG001|Overall Study|Death|7|||
156742515|NCT03385304|565806349|FG000|Overall Study|Lost to Follow-up|17|||
156878616|NCT01761240|566314128|FG004|Overall Study|Progressive disease:radiology assessment|0|||
156878617|NCT01761240|566314124|FG000|Overall Study|Progressive disease:clinical assessment|0|||
156878618|NCT01761240|566314125|FG001|Overall Study|Progressive disease:clinical assessment|0|||
156878619|NCT01761240|566314126|FG002|Overall Study|Progressive disease:clinical assessment|3|||
156878620|NCT01761240|566314127|FG003|Overall Study|Progressive disease:clinical assessment|1|||
156878621|NCT01761240|566314128|FG004|Overall Study|Progressive disease:clinical assessment|0|||
156878622|NCT01761240|566314124|FG000|Overall Study|Withdrawal by Subject|0|||
156742516|NCT03385304|565806350|FG001|Overall Study|Lost to Follow-up|14|||
156742517|NCT03385304|565806349|FG000|Overall Study|Withdrawal by Subject|3|||
156878623|NCT01761240|566314125|FG001|Overall Study|Withdrawal by Subject|0|||
156878624|NCT01761240|566314126|FG002|Overall Study|Withdrawal by Subject|0|||
156878625|NCT01761240|566314127|FG003|Overall Study|Withdrawal by Subject|3|||
156878626|NCT01761240|566314128|FG004|Overall Study|Withdrawal by Subject|1|||
156878627|NCT01761240|566314124|FG000|Overall Study|Adverse Event|0|||
156878628|NCT01761240|566314125|FG001|Overall Study|Adverse Event|0|||
156742518|NCT03385304|565806350|FG001|Overall Study|Withdrawal by Subject|2|||
156742519|NCT03385304|565806349|FG000|Overall Study|Incarceration|2|||
156878629|NCT01761240|566314126|FG002|Overall Study|Adverse Event|0|||
156878630|NCT01761240|566314127|FG003|Overall Study|Adverse Event|1|||
156878631|NCT01761240|566314128|FG004|Overall Study|Adverse Event|6|||
156878632|NCT01761240|566314124|FG000|Overall Study|Death|0|||
156878633|NCT01761240|566314125|FG001|Overall Study|Death|1|||
156878634|NCT01761240|566314126|FG002|Overall Study|Death|1|||
156878635|NCT01761240|566314127|FG003|Overall Study|Death|2|||
157218756|NCT02436135|567547507|FG000|Overall Study|Adverse Event|1|||
156878636|NCT01761240|566314128|FG004|Overall Study|Death|1|||
156742520|NCT03385304|565806350|FG001|Overall Study|Incarceration|3|||
156742521|NCT00723190|565806351|FG000|Overall Study|Withdrawal by Subject|45|||
156742522|NCT00723190|565806351|FG000|Overall Study|Lost to Follow-up|37|||
157218757|NCT02436135|567547508|FG001|Overall Study|Adverse Event|0|||
156742523|NCT00723190|565806351|FG000|Overall Study|Adverse Event|18|||
156742524|NCT00723190|565806351|FG000|Overall Study|Lack of Efficacy|16|||
156742525|NCT00723190|565806351|FG000|Overall Study|Protocol Violation|15|||
156878637|NCT01761240|566314124|FG000|Overall Study|Non-compliance|0|||
156878638|NCT01761240|566314125|FG001|Overall Study|Non-compliance|0|||
156878639|NCT01761240|566314126|FG002|Overall Study|Non-compliance|1|||
156878640|NCT01761240|566314127|FG003|Overall Study|Non-compliance|0|||
156878641|NCT01761240|566314128|FG004|Overall Study|Non-compliance|0|||
156878642|NCT01233232|566314129|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
156878643|NCT01233232|566314130|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
156878644|NCT01233232|566314131|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
156878645|NCT01031836|566316365|FG000|Stage I|Adverse Event|1|||
156878646|NCT01031836|566316366|FG001|Stage I|Adverse Event|1|||
156878647|NCT01031836|566316367|FG002|Stage I|Adverse Event|0|||
156878648|NCT01031836|566316368|FG003|Stage I|Adverse Event|0|||
156878649|NCT01031836|566316369|FG004|Stage I|Adverse Event|0|||
156878650|NCT01031836|566316370|FG005|Stage I|Adverse Event|0|||
156878651|NCT01031836|566316365|FG000|Stage I|Other|0|||
156878652|NCT01031836|566316366|FG001|Stage I|Other|1|||
156878653|NCT01031836|566316367|FG002|Stage I|Other|0|||
156878654|NCT01031836|566316368|FG003|Stage I|Other|0|||
156878655|NCT01031836|566316369|FG004|Stage I|Other|0|||
156878656|NCT01031836|566316370|FG005|Stage I|Other|1|||
156878657|NCT01031836|566316365|FG000|Stage II|Adverse Event|0|||
156878658|NCT01031836|566316366|FG001|Stage II|Adverse Event|0|||
156878659|NCT01031836|566316367|FG002|Stage II|Adverse Event|2|||
156878660|NCT01031836|566316368|FG003|Stage II|Adverse Event|2|||
156878661|NCT01031836|566316369|FG004|Stage II|Adverse Event|1|||
156878662|NCT01031836|566316370|FG005|Stage II|Adverse Event|1|||
156742526|NCT00723190|565806351|FG000|Overall Study|Other-Premature Discontinuation|9|||
156878663|NCT01031836|566316365|FG000|Stage II|Other|2|||
156878664|NCT01031836|566316366|FG001|Stage II|Other|0|||
156878665|NCT01031836|566316367|FG002|Stage II|Other|0|||
156878666|NCT01031836|566316368|FG003|Stage II|Other|1|||
156878667|NCT01031836|566316369|FG004|Stage II|Other|1|||
156878668|NCT01031836|566316370|FG005|Stage II|Other|0|||
156878669|NCT01888432|566316375|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
156878670|NCT01888432|566316376|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
156878671|NCT01888432|566316375|FG000|12-month Analysis (FAS)|Physician Decision|1|||
156878672|NCT01888432|566316376|FG001|12-month Analysis (FAS)|Physician Decision|1|||
156878673|NCT01888432|566316375|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
156878674|NCT01888432|566316376|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
156878675|NCT01888432|566316375|FG000|12-month Analysis (FAS)|Death|4|||
156878676|NCT01888432|566316376|FG001|12-month Analysis (FAS)|Death|3|||
156878677|NCT01888432|566316375|FG000|24-month Analysis (FAS)|Graft loss|0|||
156878678|NCT01888432|566316376|FG001|24-month Analysis (FAS)|Graft loss|1|||
156878679|NCT01888432|566316375|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
156878680|NCT01888432|566316376|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
156878681|NCT01888432|566316375|FG000|24-month Analysis (FAS)|Physician Decision|2|||
156878682|NCT01888432|566316376|FG001|24-month Analysis (FAS)|Physician Decision|4|||
156878683|NCT01888432|566316375|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
156878684|NCT01888432|566316376|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
156878685|NCT01888432|566316375|FG000|24-month Analysis (FAS)|Death|8|||
156878686|NCT01888432|566316376|FG001|24-month Analysis (FAS)|Death|4|||
156878687|NCT01888432|566316375|FG000|36-month Analysis (Extension)|Death|1|||
156878688|NCT01888432|566316376|FG001|36-month Analysis (Extension)|Death|0|||
156878689|NCT03254459|566316380|FG000|Overall Study|Adverse Event|7|||
156878690|NCT03254459|566316381|FG001|Overall Study|Adverse Event|20|||
156878691|NCT03254459|566316380|FG000|Overall Study|Withdrawal by Subject Consent|3|||
156878692|NCT03254459|566316381|FG001|Overall Study|Withdrawal by Subject Consent|1|||
156878693|NCT03254459|566316380|FG000|Overall Study|Lost to Follow-up|0|||
156878694|NCT03254459|566316381|FG001|Overall Study|Lost to Follow-up|1|||
156878695|NCT03254459|566316380|FG000|Overall Study|Miscellaneous|0|||
156878696|NCT03254459|566316381|FG001|Overall Study|Miscellaneous|1|||
156878697|NCT01129583|566316382|FG000|Overall Study|Death|1|||
156878698|NCT01129583|566316383|FG001|Overall Study|Death|0|||
156878699|NCT01129583|566316382|FG000|Overall Study|Lost to Follow-up|1|||
156878700|NCT01129583|566316383|FG001|Overall Study|Lost to Follow-up|1|||
156742527|NCT00723190|565806351|FG000|Overall Study|Other-Not included in safety population|2|||
156878701|NCT01129583|566316382|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
156878702|NCT01129583|566316383|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
156878703|NCT02338882|566316384|FG000|Overall Study|Death|1|||
156878704|NCT02338882|566316385|FG001|Overall Study|Death|0|||
156878705|NCT02338882|566316384|FG000|Overall Study|Lost to Follow-up|6|||
156878706|NCT02338882|566316385|FG001|Overall Study|Lost to Follow-up|3|||
156878707|NCT02617485|566316395|FG000|Treatment and Observation Period|Adverse Event|9|||
156878708|NCT02617485|566316396|FG001|Treatment and Observation Period|Adverse Event|1|||
156878709|NCT02617485|566316395|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
156878710|NCT02617485|566316396|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
156878711|NCT02617485|566316395|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
156878712|NCT02617485|566316396|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
156742528|NCT00480493|565806356|FG000|Overall Study|moved|2|||
156742529|NCT00480493|565806357|FG001|Overall Study|moved|7|||
156742530|NCT03769675|565806358|FG000|Overall Study|Lost to Follow-up|1|||
156742531|NCT02844907|565806359|FG000|With Dexamethasone|No IV access|1|||
156742532|NCT02772276|565806360|FG000|Overall Study|Lost to Follow-up|0|||
156742533|NCT02772276|565806361|FG001|Overall Study|Lost to Follow-up|0|||
156742534|NCT02772276|565806362|FG002|Overall Study|Lost to Follow-up|0|||
156742535|NCT02772276|565806363|FG003|Overall Study|Lost to Follow-up|0|||
156742536|NCT02772276|565806364|FG004|Overall Study|Lost to Follow-up|0|||
156742537|NCT02772276|565806365|FG005|Overall Study|Lost to Follow-up|0|||
156742538|NCT02772276|565806366|FG006|Overall Study|Lost to Follow-up|1|||
156742539|NCT02772276|565806367|FG007|Overall Study|Lost to Follow-up|0|||
156742540|NCT02772276|565806368|FG008|Overall Study|Lost to Follow-up|0|||
156742541|NCT02772276|565806369|FG009|Overall Study|Lost to Follow-up|0|||
156742542|NCT02772276|565806370|FG010|Overall Study|Lost to Follow-up|0|||
156742543|NCT02772276|565806371|FG011|Overall Study|Lost to Follow-up|0|||
156742544|NCT02772276|565806372|FG012|Overall Study|Lost to Follow-up|0|||
156742545|NCT02772276|565806360|FG000|Overall Study|Withdrew consent|0|||
156742546|NCT02772276|565806361|FG001|Overall Study|Withdrew consent|0|||
156742547|NCT02772276|565806362|FG002|Overall Study|Withdrew consent|0|||
156742548|NCT02772276|565806363|FG003|Overall Study|Withdrew consent|0|||
156742549|NCT02772276|565806364|FG004|Overall Study|Withdrew consent|0|||
156742550|NCT02772276|565806365|FG005|Overall Study|Withdrew consent|0|||
156742551|NCT02772276|565806366|FG006|Overall Study|Withdrew consent|0|||
156742552|NCT02772276|565806367|FG007|Overall Study|Withdrew consent|1|||
156742553|NCT02772276|565806368|FG008|Overall Study|Withdrew consent|0|||
156742554|NCT02772276|565806369|FG009|Overall Study|Withdrew consent|0|||
156742555|NCT02772276|565806370|FG010|Overall Study|Withdrew consent|0|||
156742556|NCT02772276|565806371|FG011|Overall Study|Withdrew consent|0|||
156742557|NCT02772276|565806372|FG012|Overall Study|Withdrew consent|0|||
156742558|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
156742559|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
156742560|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
156742561|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
156742562|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
156742563|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
156742564|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742565|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
156742566|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742567|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
156742568|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742569|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742570|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
156742571|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742572|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
156742573|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742574|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742575|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
156742576|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742577|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
156742578|NCT00550862|565806373|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742579|NCT00550862|565806374|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
156742580|NCT00550862|565806375|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742581|NCT00550862|565806376|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742582|NCT00550862|565806377|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
156742583|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156742584|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156798176|NCT03396445|566015659|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798177|NCT03396445|566015660|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798178|NCT03396445|566015661|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798179|NCT03396445|566015662|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798180|NCT03396445|566015663|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798181|NCT03396445|566015664|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156808880|NCT00589797|566054493|FG000|Overall Study|Non-Randomized Training Subjects|46|||
156742585|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156742586|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
156878713|NCT02617485|566316395|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
156878714|NCT02617485|566316396|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
156878715|NCT02617485|566316395|FG000|Treatment and Observation Period|Physician Decision|0|||
156878716|NCT02617485|566316396|FG001|Treatment and Observation Period|Physician Decision|1|||
156878717|NCT02617485|566316395|FG000|Follow-up Period|Adverse Event|1|||
156878718|NCT02617485|566316396|FG001|Follow-up Period|Adverse Event|0|||
156878719|NCT02617485|566316395|FG000|Follow-up Period|Withdrawal by Subject|1|||
156878720|NCT02617485|566316396|FG001|Follow-up Period|Withdrawal by Subject|0|||
156878721|NCT02617485|566316395|FG000|Follow-up Period|Disease progression|2|||
156878722|NCT02617485|566316396|FG001|Follow-up Period|Disease progression|1|||
156742587|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
156742588|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742589|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742590|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156742591|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
156878723|NCT02617485|566316395|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
156878724|NCT02617485|566316396|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
156878725|NCT02617485|566316395|FG000|Follow-up Period|Patient needed radiotherapy|9|||
156742592|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
156742593|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742594|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742595|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742596|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
156742597|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
156742598|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
156742599|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
156742600|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
156742601|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
156742602|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
156742603|NCT00550862|565806373|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742604|NCT00550862|565806374|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742605|NCT00550862|565806375|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156742606|NCT00550862|565806376|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
156798182|NCT03396445|566015665|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798183|NCT03396445|566015666|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798184|NCT03396445|566015667|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798185|NCT03396445|566015668|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156798186|NCT03396445|566015669|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
156878726|NCT02617485|566316396|FG001|Follow-up Period|Patient needed radiotherapy|5|||
156878727|NCT02617485|566316395|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
156878728|NCT02617485|566316396|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
156878729|NCT00220779|566316400|FG000|Overall Study|Adverse Event|1|||
156878730|NCT00220779|566316401|FG001|Overall Study|Adverse Event|0|||
156878731|NCT00220779|566316402|FG002|Overall Study|Adverse Event|0|||
156878732|NCT00220779|566316400|FG000|Overall Study|Withdrawal by Subject|1|||
156878733|NCT00220779|566316401|FG001|Overall Study|Withdrawal by Subject|4|||
156878734|NCT00220779|566316402|FG002|Overall Study|Withdrawal by Subject|1|||
156878735|NCT00220779|566316400|FG000|Overall Study|Non-compliance|1|||
156878736|NCT00220779|566316401|FG001|Overall Study|Non-compliance|0|||
156878737|NCT00220779|566316402|FG002|Overall Study|Non-compliance|0|||
156878738|NCT00220779|566316400|FG000|Overall Study|Too time consuming|1|||
156878739|NCT00220779|566316401|FG001|Overall Study|Too time consuming|0|||
156878740|NCT00220779|566316402|FG002|Overall Study|Too time consuming|0|||
156878741|NCT00220779|566316400|FG000|Overall Study|Pregnancy|0|||
156878742|NCT00220779|566316401|FG001|Overall Study|Pregnancy|0|||
156798187|NCT03396445|566015644|FG000|Treatment Period|Withdrawal by Subject|0|||
156798188|NCT03396445|566015645|FG001|Treatment Period|Withdrawal by Subject|0|||
156798189|NCT03396445|566015646|FG002|Treatment Period|Withdrawal by Subject|0|||
156798190|NCT03396445|566015647|FG003|Treatment Period|Withdrawal by Subject|0|||
156798191|NCT03396445|566015648|FG004|Treatment Period|Withdrawal by Subject|0|||
156878743|NCT00220779|566316402|FG002|Overall Study|Pregnancy|2|||
156878744|NCT00220779|566316400|FG000|Overall Study|Lack of Efficacy|3|||
156878745|NCT00220779|566316401|FG001|Overall Study|Lack of Efficacy|0|||
156878746|NCT00220779|566316402|FG002|Overall Study|Lack of Efficacy|1|||
156878747|NCT00791076|566316403|FG000|Overall Study|Study was terminated,PI left institution|8|||
156878748|NCT01511055|566316404|FG000|Overall Study|Withdrawal by Subject|6|||
156878749|NCT00669409|566316410|FG000|Part 2|Withdrawal by Subject|0|||
156878750|NCT00669409|566316411|FG001|Part 2|Withdrawal by Subject|0|||
156878751|NCT00669409|566316412|FG002|Part 2|Withdrawal by Subject|0|||
156878752|NCT00669409|566316413|FG003|Part 2|Withdrawal by Subject|0|||
156742607|NCT00550862|565806377|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
156742608|NCT02248974|565806381|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
156742609|NCT02248974|565806382|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
156742610|NCT02248974|565806381|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
156742611|NCT02248974|565806382|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
156742612|NCT02248974|565806381|FG000|1-Day Follow-Up|Enrolled in another study|1|||
156742613|NCT02248974|565806382|FG001|1-Day Follow-Up|Enrolled in another study|0|||
156742614|NCT02248974|565806381|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
156742615|NCT02248974|565806382|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
156742616|NCT02248974|565806381|FG000|1-Week Follow-Up|Enrolled in another study|1|||
156742617|NCT02248974|565806382|FG001|1-Week Follow-Up|Enrolled in another study|1|||
156742618|NCT02248974|565806381|FG000|1-Week Follow-Up|Transferred to another facility|1|||
156742619|NCT02248974|565806382|FG001|1-Week Follow-Up|Transferred to another facility|0|||
156742620|NCT02248974|565806381|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
156742621|NCT02248974|565806382|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
156742622|NCT02248974|565806381|FG000|1-Week Follow-Up|Death|1|||
156742623|NCT02248974|565806382|FG001|1-Week Follow-Up|Death|1|||
156742624|NCT02248974|565806381|FG000|1-Week Follow-Up|Excluded because of age|0|||
156742625|NCT02248974|565806382|FG001|1-Week Follow-Up|Excluded because of age|1|||
156742626|NCT02248974|565806381|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
156742627|NCT02248974|565806382|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
156742628|NCT02248974|565806381|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
156742629|NCT02248974|565806382|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
156742630|NCT02248974|565806381|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
156742631|NCT02248974|565806382|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
156742632|NCT02248974|565806381|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
156742633|NCT02248974|565806382|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
156742634|NCT02248974|565806381|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
156742635|NCT02248974|565806382|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
156742636|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
156742637|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
156742638|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
156742639|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
156742640|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|No response|5|||
156742641|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|No response|5|||
156742642|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|No response|5|||
156742643|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|No response|2|||
156742644|NCT04093492|565806383|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742645|NCT04093492|565806384|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742646|NCT04093492|565806385|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
156742647|NCT04093492|565806386|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
156742648|NCT04093492|565806383|FG000|30 Weeks GA|Delivered before assessment|1|||
156742649|NCT04093492|565806384|FG001|30 Weeks GA|Delivered before assessment|2|||
156742650|NCT04093492|565806385|FG002|30 Weeks GA|Delivered before assessment|0|||
156742651|NCT04093492|565806386|FG003|30 Weeks GA|Delivered before assessment|0|||
156742652|NCT04093492|565806383|FG000|30 Weeks GA|No response|7|||
156742653|NCT04093492|565806384|FG001|30 Weeks GA|No response|5|||
156742654|NCT04093492|565806385|FG002|30 Weeks GA|No response|5|||
156742655|NCT04093492|565806386|FG003|30 Weeks GA|No response|2|||
156742656|NCT04093492|565806383|FG000|30 Weeks GA|Lost to Follow-up|0|||
156742657|NCT04093492|565806384|FG001|30 Weeks GA|Lost to Follow-up|1|||
156742658|NCT04093492|565806385|FG002|30 Weeks GA|Lost to Follow-up|0|||
156742659|NCT04093492|565806386|FG003|30 Weeks GA|Lost to Follow-up|0|||
156742660|NCT04093492|565806383|FG000|34 Weeks GA|Delivered before assessment|6|||
156742661|NCT04093492|565806384|FG001|34 Weeks GA|Delivered before assessment|3|||
156742662|NCT04093492|565806385|FG002|34 Weeks GA|Delivered before assessment|0|||
156742663|NCT04093492|565806386|FG003|34 Weeks GA|Delivered before assessment|0|||
156742664|NCT04093492|565806383|FG000|34 Weeks GA|No response|0|||
156742665|NCT04093492|565806384|FG001|34 Weeks GA|No response|7|||
156742666|NCT04093492|565806385|FG002|34 Weeks GA|No response|5|||
156742667|NCT04093492|565806386|FG003|34 Weeks GA|No response|3|||
156742668|NCT04093492|565806383|FG000|34 Weeks GA|Lost to Follow-up|0|||
156742669|NCT04093492|565806384|FG001|34 Weeks GA|Lost to Follow-up|1|||
156742670|NCT04093492|565806385|FG002|34 Weeks GA|Lost to Follow-up|0|||
156742671|NCT04093492|565806386|FG003|34 Weeks GA|Lost to Follow-up|0|||
156798192|NCT03396445|566015649|FG005|Treatment Period|Withdrawal by Subject|0|||
156742672|NCT02945254|565806393|FG000|Overall Study|Lost to Follow-up|1|||
156798193|NCT03396445|566015650|FG006|Treatment Period|Withdrawal by Subject|0|||
157020528|NCT02736409|566828459|FG003|Overall Study|Physician Decision|2|||
156742673|NCT02945254|565806394|FG001|Overall Study|Lost to Follow-up|0|||
156742674|NCT02945254|565806393|FG000|Overall Study|Withdrawal by Subject|1|||
156742675|NCT02945254|565806394|FG001|Overall Study|Withdrawal by Subject|0|||
156742676|NCT00783224|565806395|FG000|Overall Study|Adverse Event|0|||
156742677|NCT00783224|565806396|FG001|Overall Study|Adverse Event|0|||
156798194|NCT03396445|566015651|FG007|Treatment Period|Withdrawal by Subject|0|||
156742678|NCT00783224|565806397|FG002|Overall Study|Adverse Event|1|||
156742679|NCT00783224|565806398|FG003|Overall Study|Adverse Event|0|||
156742680|NCT00783224|565806395|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
156742681|NCT00783224|565806396|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
156742682|NCT00783224|565806397|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
156742683|NCT00783224|565806398|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
156742684|NCT00783224|565806395|FG000|Overall Study|Inappropriate as a study subject|0|||
156742685|NCT00783224|565806396|FG001|Overall Study|Inappropriate as a study subject|0|||
156742686|NCT00783224|565806397|FG002|Overall Study|Inappropriate as a study subject|0|||
156742687|NCT00783224|565806398|FG003|Overall Study|Inappropriate as a study subject|1|||
156742688|NCT04631107|565806399|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
156742689|NCT04631107|565806399|FG000|Second Intervention (1 Night)|Adverse Event|1|||
156742690|NCT04631107|565806399|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
156742691|NCT04631107|565806399|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
156742692|NCT00772005|565806401|FG000|Overall Study|Adverse Event|9|||
156742693|NCT00772005|565806402|FG001|Overall Study|Adverse Event|14|||
156742694|NCT00772005|565806403|FG002|Overall Study|Adverse Event|10|||
156742695|NCT00772005|565806404|FG003|Overall Study|Adverse Event|13|||
156798195|NCT03396445|566015652|FG008|Treatment Period|Withdrawal by Subject|0|||
156798196|NCT03396445|566015653|FG009|Treatment Period|Withdrawal by Subject|0|||
156798197|NCT03396445|566015654|FG010|Treatment Period|Withdrawal by Subject|0|||
156798198|NCT03396445|566015655|FG011|Treatment Period|Withdrawal by Subject|0|||
156798199|NCT03396445|566015656|FG012|Treatment Period|Withdrawal by Subject|0|||
156798200|NCT03396445|566015657|FG013|Treatment Period|Withdrawal by Subject|0|||
156798201|NCT03396445|566015658|FG014|Treatment Period|Withdrawal by Subject|1|||
156798202|NCT03396445|566015659|FG015|Treatment Period|Withdrawal by Subject|0|||
156798203|NCT03396445|566015660|FG016|Treatment Period|Withdrawal by Subject|1|||
156798204|NCT03396445|566015661|FG017|Treatment Period|Withdrawal by Subject|0|||
156798205|NCT03396445|566015662|FG018|Treatment Period|Withdrawal by Subject|0|||
156798206|NCT03396445|566015663|FG019|Treatment Period|Withdrawal by Subject|0|||
156798207|NCT03396445|566015664|FG020|Treatment Period|Withdrawal by Subject|0|||
156798208|NCT03396445|566015665|FG021|Treatment Period|Withdrawal by Subject|0|||
156798209|NCT03396445|566015666|FG022|Treatment Period|Withdrawal by Subject|0|||
156798210|NCT03396445|566015667|FG023|Treatment Period|Withdrawal by Subject|0|||
156798211|NCT03396445|566015668|FG024|Treatment Period|Withdrawal by Subject|0|||
156798212|NCT03396445|566015669|FG025|Treatment Period|Withdrawal by Subject|0|||
156798213|NCT03396445|566015644|FG000|Switch-over Period|Death|0|||
156798214|NCT03396445|566015645|FG001|Switch-over Period|Death|0|||
156798215|NCT03396445|566015646|FG002|Switch-over Period|Death|0|||
156798216|NCT03396445|566015647|FG003|Switch-over Period|Death|0|||
156798217|NCT03396445|566015648|FG004|Switch-over Period|Death|0|||
156798218|NCT03396445|566015649|FG005|Switch-over Period|Death|0|||
156798219|NCT03396445|566015650|FG006|Switch-over Period|Death|0|||
156798220|NCT03396445|566015651|FG007|Switch-over Period|Death|0|||
156798221|NCT03396445|566015652|FG008|Switch-over Period|Death|0|||
156798222|NCT03396445|566015653|FG009|Switch-over Period|Death|0|||
156798223|NCT03396445|566015654|FG010|Switch-over Period|Death|0|||
156798224|NCT03396445|566015655|FG011|Switch-over Period|Death|0|||
156798225|NCT03396445|566015656|FG012|Switch-over Period|Death|0|||
156798226|NCT03396445|566015657|FG013|Switch-over Period|Death|0|||
156798227|NCT03396445|566015658|FG014|Switch-over Period|Death|0|||
156798228|NCT03396445|566015659|FG015|Switch-over Period|Death|0|||
156798229|NCT03396445|566015660|FG016|Switch-over Period|Death|0|||
156798230|NCT03396445|566015661|FG017|Switch-over Period|Death|0|||
156798231|NCT03396445|566015662|FG018|Switch-over Period|Death|1|||
156798232|NCT03396445|566015663|FG019|Switch-over Period|Death|2|||
156798233|NCT03396445|566015664|FG020|Switch-over Period|Death|2|||
156798234|NCT03396445|566015665|FG021|Switch-over Period|Death|1|||
156798235|NCT03396445|566015666|FG022|Switch-over Period|Death|2|||
156742696|NCT00772005|565806401|FG000|Overall Study|Lack of Efficacy|0|||
156742697|NCT00772005|565806402|FG001|Overall Study|Lack of Efficacy|1|||
156742698|NCT00772005|565806403|FG002|Overall Study|Lack of Efficacy|0|||
156798236|NCT03396445|566015667|FG023|Switch-over Period|Death|0|||
156798237|NCT03396445|566015668|FG024|Switch-over Period|Death|1|||
156798238|NCT03396445|566015669|FG025|Switch-over Period|Death|6|||
156742699|NCT00772005|565806404|FG003|Overall Study|Lack of Efficacy|0|||
156742700|NCT00772005|565806401|FG000|Overall Study|Withdrawal by Subject|3|||
156742701|NCT00772005|565806402|FG001|Overall Study|Withdrawal by Subject|7|||
156742702|NCT00772005|565806403|FG002|Overall Study|Withdrawal by Subject|10|||
156798239|NCT03396445|566015644|FG000|Switch-over Period|Lost to Follow-up|0|||
156798240|NCT03396445|566015645|FG001|Switch-over Period|Lost to Follow-up|0|||
156798241|NCT03396445|566015646|FG002|Switch-over Period|Lost to Follow-up|0|||
156798242|NCT03396445|566015647|FG003|Switch-over Period|Lost to Follow-up|0|||
156798243|NCT03396445|566015648|FG004|Switch-over Period|Lost to Follow-up|0|||
156742703|NCT00772005|565806404|FG003|Overall Study|Withdrawal by Subject|2|||
156798244|NCT03396445|566015649|FG005|Switch-over Period|Lost to Follow-up|0|||
156798245|NCT03396445|566015650|FG006|Switch-over Period|Lost to Follow-up|0|||
156798246|NCT03396445|566015651|FG007|Switch-over Period|Lost to Follow-up|0|||
156742704|NCT00772005|565806401|FG000|Overall Study|Protocol Violation|2|||
156742705|NCT00772005|565806402|FG001|Overall Study|Protocol Violation|4|||
156742706|NCT00772005|565806403|FG002|Overall Study|Protocol Violation|1|||
156742707|NCT00772005|565806404|FG003|Overall Study|Protocol Violation|6|||
156742708|NCT00772005|565806401|FG000|Overall Study|Lost to Follow-up|7|||
156742709|NCT00772005|565806402|FG001|Overall Study|Lost to Follow-up|3|||
156742710|NCT00772005|565806403|FG002|Overall Study|Lost to Follow-up|6|||
156742711|NCT00772005|565806404|FG003|Overall Study|Lost to Follow-up|3|||
156742712|NCT00772005|565806401|FG000|Overall Study|Non-compliance with study procedures|1|||
156742713|NCT00772005|565806402|FG001|Overall Study|Non-compliance with study procedures|1|||
156742714|NCT00772005|565806403|FG002|Overall Study|Non-compliance with study procedures|0|||
156742715|NCT00772005|565806404|FG003|Overall Study|Non-compliance with study procedures|1|||
156742716|NCT00772005|565806401|FG000|Overall Study|Non-compliance with drug administration|3|||
156742717|NCT00772005|565806402|FG001|Overall Study|Non-compliance with drug administration|0|||
156742718|NCT00772005|565806403|FG002|Overall Study|Non-compliance with drug administration|1|||
156742719|NCT00772005|565806404|FG003|Overall Study|Non-compliance with drug administration|1|||
156742720|NCT01440569|565806409|FG000|Main Study|Enrolled but not treated|1|||
156742721|NCT01440569|565806410|FG001|Main Study|Enrolled but not treated|0|||
156742722|NCT01440569|565806409|FG000|Main Study|Adverse Event|9|||
156798247|NCT03396445|566015652|FG008|Switch-over Period|Lost to Follow-up|0|||
156798248|NCT03396445|566015653|FG009|Switch-over Period|Lost to Follow-up|0|||
156798249|NCT03396445|566015654|FG010|Switch-over Period|Lost to Follow-up|0|||
156798250|NCT03396445|566015655|FG011|Switch-over Period|Lost to Follow-up|0|||
156798251|NCT03396445|566015656|FG012|Switch-over Period|Lost to Follow-up|0|||
156798252|NCT03396445|566015657|FG013|Switch-over Period|Lost to Follow-up|0|||
156798253|NCT03396445|566015658|FG014|Switch-over Period|Lost to Follow-up|0|||
156798254|NCT03396445|566015659|FG015|Switch-over Period|Lost to Follow-up|0|||
156798255|NCT03396445|566015660|FG016|Switch-over Period|Lost to Follow-up|0|||
156798256|NCT03396445|566015661|FG017|Switch-over Period|Lost to Follow-up|0|||
156798257|NCT03396445|566015662|FG018|Switch-over Period|Lost to Follow-up|0|||
156798258|NCT03396445|566015663|FG019|Switch-over Period|Lost to Follow-up|0|||
156798259|NCT03396445|566015664|FG020|Switch-over Period|Lost to Follow-up|0|||
156798260|NCT03396445|566015665|FG021|Switch-over Period|Lost to Follow-up|0|||
156798261|NCT03396445|566015666|FG022|Switch-over Period|Lost to Follow-up|0|||
156798262|NCT03396445|566015667|FG023|Switch-over Period|Lost to Follow-up|1|||
156798263|NCT03396445|566015668|FG024|Switch-over Period|Lost to Follow-up|0|||
156798264|NCT03396445|566015669|FG025|Switch-over Period|Lost to Follow-up|0|||
156798265|NCT03552029|566015673|FG000|Overall Study|Death|3|||
156798266|NCT03552029|566015674|FG001|Overall Study|Death|0|||
156798267|NCT03552029|566015673|FG000|Overall Study|Adverse Event|1|||
156798268|NCT03552029|566015674|FG001|Overall Study|Adverse Event|0|||
156798269|NCT03552029|566015673|FG000|Overall Study|Lack of Efficacy|0|||
156798270|NCT03552029|566015674|FG001|Overall Study|Lack of Efficacy|2|||
156798271|NCT03552029|566015673|FG000|Overall Study|Physician Decision|0|||
156798272|NCT03552029|566015674|FG001|Overall Study|Physician Decision|1|||
156798273|NCT03552029|566015673|FG000|Overall Study|Study terminated by Sponsor|0|||
156798274|NCT03552029|566015674|FG001|Overall Study|Study terminated by Sponsor|1|||
156798275|NCT03552029|566015673|FG000|Overall Study|Other|0|||
156798276|NCT03552029|566015674|FG001|Overall Study|Other|2|||
156798277|NCT02552225|566015675|FG000|Overall Study|Withdrawal by Subject|1|||
156798278|NCT02552225|566015676|FG001|Overall Study|Withdrawal by Subject|0|||
156798279|NCT03122184|566015677|FG000|Overall Study|Lost to Follow-up|4|||
156798280|NCT03122184|566015678|FG001|Overall Study|Lost to Follow-up|6|||
156798281|NCT03122184|566015677|FG000|Overall Study|Withdrawal by Subject|3|||
156798282|NCT03122184|566015678|FG001|Overall Study|Withdrawal by Subject|0|||
156798283|NCT03122184|566015677|FG000|Overall Study|Terminated due to cognitive problem|1|||
156798284|NCT03122184|566015678|FG001|Overall Study|Terminated due to cognitive problem|0|||
156798285|NCT00633126|566015679|FG000|Overall Study|Did not receive full dose|1|||
156798286|NCT01168596|566015687|FG000|Overall Study|Withdrawal by Subject|3|||
156798287|NCT01168596|566015688|FG001|Overall Study|Withdrawal by Subject|1|||
156798288|NCT00876447|566015689|FG000|Overall Study|Other miscellaneous reasons|3|||
156798289|NCT00876447|566015690|FG001|Overall Study|Other miscellaneous reasons|8|||
156798290|NCT00876447|566015689|FG000|Overall Study|Site closure|19|||
156798291|NCT00876447|566015690|FG001|Overall Study|Site closure|14|||
156798292|NCT00876447|566015689|FG000|Overall Study|Protocol Violation|9|||
156798293|NCT00876447|566015690|FG001|Overall Study|Protocol Violation|3|||
156798294|NCT00876447|566015689|FG000|Overall Study|Personal reasons|30|||
156798295|NCT00876447|566015690|FG001|Overall Study|Personal reasons|28|||
156742723|NCT01440569|565806410|FG001|Main Study|Adverse Event|0|||
156798296|NCT00876447|566015689|FG000|Overall Study|Lost to Follow-up|6|||
156798297|NCT00876447|566015690|FG001|Overall Study|Lost to Follow-up|15|||
156798298|NCT00876447|566015689|FG000|Overall Study|Pregnancy|4|||
156798299|NCT00876447|566015690|FG001|Overall Study|Pregnancy|2|||
156798300|NCT00876447|566015689|FG000|Overall Study|Lack of Efficacy|5|||
156798301|NCT00876447|566015690|FG001|Overall Study|Lack of Efficacy|3|||
156798302|NCT00876447|566015689|FG000|Overall Study|Adverse Event|4|||
156798303|NCT00876447|566015690|FG001|Overall Study|Adverse Event|8|||
156878753|NCT00669409|566316414|FG004|Part 2|Withdrawal by Subject|0|||
156878754|NCT00669409|566316415|FG005|Part 2|Withdrawal by Subject|0|||
156878755|NCT00669409|566316416|FG006|Part 2|Withdrawal by Subject|0|||
156878756|NCT00669409|566316417|FG007|Part 2|Withdrawal by Subject|0|||
156878757|NCT00669409|566316418|FG008|Part 2|Withdrawal by Subject|0|||
156878758|NCT00669409|566316419|FG009|Part 2|Withdrawal by Subject|1|||
156878759|NCT00669409|566316420|FG010|Part 2|Withdrawal by Subject|0|||
156878760|NCT04491604|566316421|FG000|Overall Study|Withdrawal by Subject|3|||
156878761|NCT01874340|566316422|FG000|Overall Study|Study terminated by Sponsor|6|||
156878762|NCT01874340|566316423|FG001|Overall Study|Study terminated by Sponsor|8|||
156878763|NCT01874340|566316424|FG002|Overall Study|Study terminated by Sponsor|8|||
156878764|NCT01874340|566316425|FG003|Overall Study|Study terminated by Sponsor|4|||
156878765|NCT01874340|566316422|FG000|Overall Study|Withdrawal by Subject|0|||
156878766|NCT01874340|566316423|FG001|Overall Study|Withdrawal by Subject|0|||
156878767|NCT01874340|566316424|FG002|Overall Study|Withdrawal by Subject|0|||
156878768|NCT01874340|566316425|FG003|Overall Study|Withdrawal by Subject|1|||
156878769|NCT03263702|566316426|FG000|Overall Study|Lost to Follow-up|2|||
156878770|NCT03263702|566316427|FG001|Overall Study|Lost to Follow-up|2|||
157020529|NCT01415154|566828460|FG000|Overall Study|Lack of Efficacy|4|||
156742724|NCT01440569|565806409|FG000|Main Study|Pregnancy|1|||
156742725|NCT01440569|565806410|FG001|Main Study|Pregnancy|0|||
156742726|NCT01440569|565806409|FG000|Main Study|Investigator's Discretion|1|||
156742727|NCT01440569|565806410|FG001|Main Study|Investigator's Discretion|1|||
156742728|NCT01440569|565806409|FG000|Main Study|Withdrew Consent|7|||
156742729|NCT01440569|565806410|FG001|Main Study|Withdrew Consent|1|||
156742730|NCT01440569|565806409|FG000|Main Study|Lost to Follow-up|13|||
156742731|NCT01440569|565806410|FG001|Main Study|Lost to Follow-up|2|||
156742732|NCT01440569|565806409|FG000|Main Study|Subject Non-Compliance|3|||
156742733|NCT01440569|565806410|FG001|Main Study|Subject Non-Compliance|0|||
156742734|NCT01440569|565806409|FG000|Main Study|Protocol Violation|1|||
156742735|NCT01440569|565806410|FG001|Main Study|Protocol Violation|0|||
156742736|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Adverse Event|3|||
156742737|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Adverse Event|0|||
156742738|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Pregnancy|1|||
156742739|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Pregnancy|0|||
156742740|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
156742741|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
156742742|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
156742743|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
156742744|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
156742745|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
156742746|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
156742747|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
156742748|NCT01440569|565806409|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
156742749|NCT01440569|565806410|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
156742750|NCT02584959|565806419|FG000|Period 1|Withdrawn from study|3|||
156742751|NCT02584959|565806420|FG001|Period 1|Withdrawn from study|4|||
156742752|NCT02584959|565806421|FG002|Period 1|Withdrawn from study|0|||
156742753|NCT02584959|565806419|FG000|Period 2|Withdrawn from study|6|||
156742754|NCT02584959|565806420|FG001|Period 2|Withdrawn from study|1|||
156742755|NCT02584959|565806421|FG002|Period 2|Withdrawn from study|2|||
156742756|NCT01793688|565806430|FG000|Overall Study|Protocol Violation|2|||
156742757|NCT00150800|565806431|FG000|Overall Study|Adverse Event|89|||
156742758|NCT00150800|565806431|FG000|Overall Study|Death|18|||
156742759|NCT00150800|565806431|FG000|Overall Study|Lack of Efficacy|166|||
156742760|NCT00150800|565806431|FG000|Overall Study|Lost to Follow-up|58|||
156742761|NCT00150800|565806431|FG000|Overall Study|Subject's choice|90|||
156742762|NCT00150800|565806431|FG000|Overall Study|No compliance|18|||
156742763|NCT00150800|565806431|FG000|Overall Study|IP misshandling|1|||
156742764|NCT00150800|565806431|FG000|Overall Study|Site closure|24|||
156742765|NCT00150800|565806431|FG000|Overall Study|Protocol non-adherence|2|||
156742766|NCT00150800|565806431|FG000|Overall Study|Nobody to accompany patient|1|||
156742767|NCT00150800|565806431|FG000|Overall Study|Distance too long for patient|1|||
156742768|NCT00150800|565806431|FG000|Overall Study|Neurosurgery|2|||
156878771|NCT03263702|566316426|FG000|Overall Study|Withdrawal by Subject|1|||
156878772|NCT03263702|566316427|FG001|Overall Study|Withdrawal by Subject|2|||
157020530|NCT01415154|566828461|FG001|Overall Study|Lack of Efficacy|5|||
156742769|NCT00150800|565806431|FG000|Overall Study|BRV monotherapy|1|||
156878773|NCT02888119|566316429|FG000|Overall Study|Lost to Follow-up|5|||
156742770|NCT00150800|565806431|FG000|Overall Study|Visit refusal|3|||
156742771|NCT00150800|565806431|FG000|Overall Study|Sponsor's request|2|||
156742772|NCT00150800|565806431|FG000|Overall Study|Generalized Epilepsy|1|||
156878774|NCT02888119|566316430|FG001|Overall Study|Lost to Follow-up|4|||
156742773|NCT00150800|565806431|FG000|Overall Study|Moved from area/country|8|||
156878775|NCT02888119|566316431|FG002|Overall Study|Lost to Follow-up|0|||
156878776|NCT03330002|566316432|FG000|Overall Study|Lost to Follow-up|15|||
156878777|NCT03330002|566316432|FG000|Overall Study|Death|7|||
157020531|NCT01415154|566828460|FG000|Overall Study|Withdrawal by Subject|7|||
156742774|NCT00150800|565806431|FG000|Overall Study|PI retiring|2|||
156742775|NCT00150800|565806431|FG000|Overall Study|PI leaving site|2|||
156742776|NCT00150800|565806431|FG000|Overall Study|Patient insurance|1|||
156742777|NCT00150800|565806431|FG000|Overall Study|Surgical intervention|4|||
157020532|NCT01415154|566828461|FG001|Overall Study|Withdrawal by Subject|8|||
156742778|NCT00150800|565806431|FG000|Overall Study|Pregnancy planned|1|||
156742779|NCT00150800|565806431|FG000|Overall Study|PI discontinuation request|1|||
156742780|NCT04756154|565806442|FG000|Overall Study|Did not meet treatment day baseline|30|||
156742781|NCT04756154|565806443|FG001|Overall Study|Did not meet treatment day baseline|28|||
156742782|NCT04756154|565806444|FG002|Overall Study|Did not meet treatment day baseline|7|||
156742783|NCT04756154|565806442|FG000|Overall Study|Did not return for final sample collection|1|||
156742784|NCT04756154|565806443|FG001|Overall Study|Did not return for final sample collection|1|||
156742785|NCT04756154|565806444|FG002|Overall Study|Did not return for final sample collection|0|||
156742786|NCT03430895|565806451|FG000|Overall Study|Not Treated|2|||
156742787|NCT01645891|565806457|FG000|Overall Study|Adverse Event|6|||
156742788|NCT01645891|565806458|FG001|Overall Study|Adverse Event|10|||
156878778|NCT05573386|566316433|FG000|Overall Study|Withdrawal by Subject|3|||
156878779|NCT05573386|566316434|FG001|Overall Study|Withdrawal by Subject|2|||
156742789|NCT01645891|565806457|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
156742790|NCT01645891|565806458|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
156742791|NCT01645891|565806457|FG000|Overall Study|Withdrawal by Subject|3|||
156742792|NCT01645891|565806458|FG001|Overall Study|Withdrawal by Subject|3|||
156742793|NCT01645891|565806457|FG000|Overall Study|Protocol Violation|4|||
156742794|NCT01645891|565806458|FG001|Overall Study|Protocol Violation|0|||
156742795|NCT01645891|565806457|FG000|Overall Study|Lost to Follow-up|4|||
156742796|NCT01645891|565806458|FG001|Overall Study|Lost to Follow-up|1|||
156742797|NCT01645891|565806457|FG000|Overall Study|Death|0|||
156742798|NCT01645891|565806458|FG001|Overall Study|Death|2|||
156742799|NCT00138073|565806459|FG000|Overall Study|lack of resources|55|||
156742800|NCT03301740|565806460|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
156742801|NCT03301740|565806461|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
156742802|NCT03301740|565806460|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
156742803|NCT03301740|565806461|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
156742804|NCT01173055|565806466|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
156742805|NCT01173055|565806467|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
156742806|NCT01173055|565806466|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
156742807|NCT01173055|565806467|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
156742808|NCT04253782|565806468|FG000|Overall Study|Death|2|||
156742809|NCT04253782|565806469|FG001|Overall Study|Death|0|||
156742810|NCT01306045|565806474|FG000|Met General Eligibility Criteria|Screen failures|193|||
156742811|NCT01306045|565806475|FG001|Met General Eligibility Criteria|Screen failures|11|||
156742812|NCT01306045|565806476|FG002|Met General Eligibility Criteria|Screen failures|8|||
156742813|NCT05685732|565806477|FG000|Overall Study|Withdrawal by Subject|2|||
156742814|NCT05685732|565806478|FG001|Overall Study|Withdrawal by Subject|0|||
156742815|NCT05685732|565806479|FG002|Overall Study|Withdrawal by Subject|2|||
156742816|NCT05685732|565806480|FG003|Overall Study|Withdrawal by Subject|3|||
156742817|NCT05685732|565806477|FG000|Overall Study|Protocol Violation|1|||
156742818|NCT05685732|565806478|FG001|Overall Study|Protocol Violation|2|||
156742819|NCT05685732|565806479|FG002|Overall Study|Protocol Violation|4|||
156742820|NCT05685732|565806480|FG003|Overall Study|Protocol Violation|1|||
156742821|NCT05685732|565806477|FG000|Overall Study|Lost to Follow-up|5|||
156742822|NCT05685732|565806478|FG001|Overall Study|Lost to Follow-up|1|||
156742823|NCT05685732|565806479|FG002|Overall Study|Lost to Follow-up|3|||
156742824|NCT05685732|565806480|FG003|Overall Study|Lost to Follow-up|1|||
156742825|NCT05685732|565806477|FG000|Overall Study|Adverse Event|2|||
156742826|NCT05685732|565806478|FG001|Overall Study|Adverse Event|1|||
156742827|NCT05685732|565806479|FG002|Overall Study|Adverse Event|0|||
156742828|NCT05685732|565806480|FG003|Overall Study|Adverse Event|0|||
156742829|NCT05685732|565806477|FG000|Overall Study|Physician Decision|1|||
156742830|NCT05685732|565806478|FG001|Overall Study|Physician Decision|0|||
156742831|NCT05685732|565806479|FG002|Overall Study|Physician Decision|0|||
156742832|NCT05685732|565806480|FG003|Overall Study|Physician Decision|0|||
156742833|NCT02640404|565806481|FG000|Overall Study|Protocol Violation|1|||
156742834|NCT02640404|565806482|FG001|Overall Study|Protocol Violation|0|||
156742835|NCT02640404|565806481|FG000|Overall Study|Withdrawal by Subject|1|||
156742836|NCT02640404|565806482|FG001|Overall Study|Withdrawal by Subject|0|||
156742837|NCT04908202|565806483|FG000|Pre-Treatment Period|OTHER REASONS|3|||
156742838|NCT04908202|565806484|FG001|Pre-Treatment Period|OTHER REASONS|1|||
156742839|NCT04908202|565806485|FG002|Pre-Treatment Period|OTHER REASONS|0|||
156742840|NCT04908202|565806486|FG003|Pre-Treatment Period|OTHER REASONS|0|||
156742841|NCT04908202|565806483|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
156742842|NCT04908202|565806484|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156878780|NCT05246514|566316435|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
156742843|NCT04908202|565806485|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742844|NCT04908202|565806486|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
157020533|NCT01415154|566828460|FG000|Overall Study|Lost to Follow-up|1|||
156878781|NCT05246514|566316435|FG000|Overall Study|Withdrawal by Subject|1|||
156742845|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
156742846|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
156742847|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156742848|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
156742849|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
156742850|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
156742851|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
156742852|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
156742853|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742854|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
156742855|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742856|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742857|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
156742858|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
156742859|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742860|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742861|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742862|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
156742863|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742864|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
156742865|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742866|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742867|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742868|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742869|NCT04908202|565806483|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
156742870|NCT04908202|565806484|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
156742871|NCT04908202|565806485|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
156742872|NCT04908202|565806486|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
156742873|NCT04908202|565806483|FG000|Active Treatment Period|OTHER REASONS|0|||
156742874|NCT04908202|565806484|FG001|Active Treatment Period|OTHER REASONS|0|||
156742875|NCT04908202|565806485|FG002|Active Treatment Period|OTHER REASONS|1|||
156742876|NCT04908202|565806486|FG003|Active Treatment Period|OTHER REASONS|3|||
156742877|NCT04908202|565806483|FG000|Active Treatment Period|Lack of Efficacy|0|||
156742878|NCT04908202|565806484|FG001|Active Treatment Period|Lack of Efficacy|0|||
156742879|NCT04908202|565806485|FG002|Active Treatment Period|Lack of Efficacy|4|||
156742880|NCT04908202|565806486|FG003|Active Treatment Period|Lack of Efficacy|5|||
156742881|NCT04908202|565806483|FG000|Active Treatment Period|Adverse Event|0|||
156742882|NCT04908202|565806484|FG001|Active Treatment Period|Adverse Event|0|||
156742883|NCT04908202|565806485|FG002|Active Treatment Period|Adverse Event|5|||
156742884|NCT04908202|565806486|FG003|Active Treatment Period|Adverse Event|8|||
156742885|NCT04908202|565806483|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742886|NCT04908202|565806484|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
156742887|NCT04908202|565806485|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742888|NCT04908202|565806486|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
156742889|NCT04908202|565806483|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742890|NCT04908202|565806484|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
156742891|NCT04908202|565806485|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
156742892|NCT04908202|565806486|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
156742893|NCT04908202|565806483|FG000|Active Treatment Period|Lost to Follow-up|0|||
156742894|NCT04908202|565806484|FG001|Active Treatment Period|Lost to Follow-up|0|||
156742895|NCT04908202|565806485|FG002|Active Treatment Period|Lost to Follow-up|2|||
156742896|NCT04908202|565806486|FG003|Active Treatment Period|Lost to Follow-up|2|||
156742897|NCT04908202|565806483|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742898|NCT04908202|565806484|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742899|NCT04908202|565806485|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
156742900|NCT04908202|565806486|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
156742901|NCT04908202|565806483|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742902|NCT04908202|565806484|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
156742903|NCT04908202|565806485|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742904|NCT04908202|565806486|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
156742905|NCT04908202|565806483|FG000|Active Treatment Period|ONGOING Treatment|0|||
156742906|NCT04908202|565806484|FG001|Active Treatment Period|ONGOING Treatment|0|||
156742907|NCT04908202|565806485|FG002|Active Treatment Period|ONGOING Treatment|117|||
156742908|NCT04908202|565806486|FG003|Active Treatment Period|ONGOING Treatment|114|||
156742909|NCT05397171|565806487|FG000|Overall Study|Death|2|||
156742910|NCT05397171|565806488|FG001|Overall Study|Death|3|||
156742911|NCT05397171|565806489|FG002|Overall Study|Death|3|||
156742912|NCT05397171|565806487|FG000|Overall Study|Study Terminated By Sponsor|1|||
156742913|NCT05397171|565806488|FG001|Overall Study|Study Terminated By Sponsor|2|||
156742914|NCT05397171|565806489|FG002|Overall Study|Study Terminated By Sponsor|3|||
156742915|NCT05397171|565806487|FG000|Overall Study|Withdrawal by Subject|0|||
156742916|NCT05397171|565806488|FG001|Overall Study|Withdrawal by Subject|1|||
156742917|NCT05397171|565806489|FG002|Overall Study|Withdrawal by Subject|1|||
156742918|NCT00549601|565808164|FG000|Randomized|Protocol Violation|0|||
156742919|NCT00549601|565808165|FG001|Randomized|Protocol Violation|0|||
156742920|NCT00549601|565808166|FG002|Randomized|Protocol Violation|1|||
156742921|NCT00549601|565808164|FG000|Randomized|Withdrawal by Subject|0|||
156742922|NCT00549601|565808165|FG001|Randomized|Withdrawal by Subject|1|||
156742923|NCT00549601|565808166|FG002|Randomized|Withdrawal by Subject|1|||
156742924|NCT00549601|565808164|FG000|Received Study Drug|Adverse Event|2|||
156742925|NCT00549601|565808165|FG001|Received Study Drug|Adverse Event|5|||
156742926|NCT00549601|565808166|FG002|Received Study Drug|Adverse Event|1|||
156742927|NCT00549601|565808164|FG000|Received Study Drug|Death|0|||
156742928|NCT00549601|565808165|FG001|Received Study Drug|Death|1|||
156742929|NCT00549601|565808166|FG002|Received Study Drug|Death|0|||
156742930|NCT00549601|565808164|FG000|Received Study Drug|Lost to Follow-up|0|||
156742931|NCT00549601|565808165|FG001|Received Study Drug|Lost to Follow-up|1|||
156742932|NCT00549601|565808166|FG002|Received Study Drug|Lost to Follow-up|1|||
156742933|NCT00549601|565808164|FG000|Received Study Drug|Protocol Violation|3|||
156742934|NCT00549601|565808165|FG001|Received Study Drug|Protocol Violation|4|||
156742935|NCT00549601|565808166|FG002|Received Study Drug|Protocol Violation|1|||
156742936|NCT00549601|565808164|FG000|Received Study Drug|Withdrawal by Subject|2|||
156742937|NCT00549601|565808165|FG001|Received Study Drug|Withdrawal by Subject|0|||
156742938|NCT00549601|565808166|FG002|Received Study Drug|Withdrawal by Subject|1|||
156742939|NCT01250171|565808170|FG000|Overall Study|Administrative reasons|1|||
156742940|NCT01250171|565808171|FG001|Overall Study|Administrative reasons|0|||
156742941|NCT01250171|565808172|FG002|Overall Study|Administrative reasons|0|||
156742942|NCT04550832|565808173|FG000|Overall Study|Adverse Event|0|||
156742943|NCT04550832|565808174|FG001|Overall Study|Adverse Event|0|||
156742944|NCT04550832|565808175|FG002|Overall Study|Adverse Event|2|||
156742945|NCT04550832|565808176|FG003|Overall Study|Adverse Event|0|||
156742946|NCT04550832|565808177|FG004|Overall Study|Adverse Event|1|||
156742947|NCT00328094|565808183|FG000|Overall Study|Physician Decision|3|||
156742948|NCT00328094|565808184|FG001|Overall Study|Physician Decision|3|||
156742949|NCT01143064|565808185|FG000|Overall Study|Death|109|||
156742950|NCT01143064|565808186|FG001|Overall Study|Death|91|||
156742951|NCT01143064|565808185|FG000|Overall Study|Adverse Event|0|||
156742952|NCT01143064|565808186|FG001|Overall Study|Adverse Event|1|||
156742953|NCT01143064|565808185|FG000|Overall Study|Withdrawal by Subject|7|||
156742954|NCT01143064|565808186|FG001|Overall Study|Withdrawal by Subject|5|||
156742955|NCT01143064|565808185|FG000|Overall Study|Lost to Follow-up|17|||
156742956|NCT01143064|565808186|FG001|Overall Study|Lost to Follow-up|14|||
156742957|NCT01143064|565808185|FG000|Overall Study|Physician Decision|0|||
156742958|NCT01143064|565808186|FG001|Overall Study|Physician Decision|4|||
156742959|NCT02453282|565808187|FG000|Overall Study|Death|275|||
156742960|NCT02453282|565808188|FG001|Overall Study|Death|277|||
156742961|NCT02453282|565808189|FG002|Overall Study|Death|296|||
156742962|NCT02453282|565808187|FG000|Overall Study|Lost to Follow-up|1|||
156742963|NCT02453282|565808188|FG001|Overall Study|Lost to Follow-up|0|||
156742964|NCT02453282|565808189|FG002|Overall Study|Lost to Follow-up|2|||
156742965|NCT02453282|565808187|FG000|Overall Study|Withdrawal by Subject|12|||
156742966|NCT02453282|565808188|FG001|Overall Study|Withdrawal by Subject|10|||
156742967|NCT02453282|565808189|FG002|Overall Study|Withdrawal by Subject|11|||
156742968|NCT02453282|565808187|FG000|Overall Study|Participants ongoing at data cut-off|85|||
156798304|NCT00567502|566015693|FG000|Overall Study|Lost to Follow-up|91|||
156798305|NCT00567502|566015694|FG001|Overall Study|Lost to Follow-up|14|||
156798306|NCT00567502|566015695|FG002|Overall Study|Lost to Follow-up|351|||
156798307|NCT00567502|566015696|FG003|Overall Study|Lost to Follow-up|2|||
156798308|NCT00567502|566015693|FG000|Overall Study|Death|65|||
156798309|NCT00567502|566015694|FG001|Overall Study|Death|16|||
156742969|NCT02453282|565808188|FG001|Overall Study|Participants ongoing at data cut-off|84|||
156742970|NCT02453282|565808189|FG002|Overall Study|Participants ongoing at data cut-off|62|||
156742971|NCT02453282|565808187|FG000|Overall Study|Other|1|||
156742972|NCT02453282|565808188|FG001|Overall Study|Other|1|||
156742973|NCT02453282|565808189|FG002|Overall Study|Other|1|||
156742974|NCT02327013|565808192|FG000|Overall Study|Adverse Event|4|||
156742975|NCT02327013|565808193|FG001|Overall Study|Adverse Event|4|||
156742976|NCT02327013|565808194|FG002|Overall Study|Adverse Event|3|||
156798310|NCT00567502|566015695|FG002|Overall Study|Death|360|||
156742977|NCT02327013|565808195|FG003|Overall Study|Adverse Event|0|||
156742978|NCT02327013|565808196|FG004|Overall Study|Adverse Event|1|||
156742979|NCT02327013|565808192|FG000|Overall Study|Lack of Efficacy|2|||
156742980|NCT02327013|565808193|FG001|Overall Study|Lack of Efficacy|0|||
156742981|NCT02327013|565808194|FG002|Overall Study|Lack of Efficacy|5|||
156798311|NCT00567502|566015696|FG003|Overall Study|Death|5|||
156798312|NCT00567502|566015693|FG000|Overall Study|Other|64|||
156878782|NCT05246514|566316435|FG000|Overall Study|Death|13|||
156878783|NCT00947882|566316438|FG000|Overall Study|Adverse Event|0|||
156878784|NCT00947882|566316439|FG001|Overall Study|Adverse Event|1|||
156878785|NCT00947882|566316440|FG002|Overall Study|Adverse Event|4|||
156878786|NCT00947882|566316441|FG003|Overall Study|Adverse Event|4|||
156878787|NCT00947882|566316438|FG000|Overall Study|Withdrawal by Subject|2|||
156878788|NCT00947882|566316439|FG001|Overall Study|Withdrawal by Subject|0|||
156878789|NCT00947882|566316440|FG002|Overall Study|Withdrawal by Subject|8|||
156878790|NCT00947882|566316441|FG003|Overall Study|Withdrawal by Subject|2|||
156878791|NCT00947882|566316438|FG000|Overall Study|Protocol Violation|0|||
156878792|NCT00947882|566316439|FG001|Overall Study|Protocol Violation|0|||
156878793|NCT00947882|566316440|FG002|Overall Study|Protocol Violation|1|||
156878794|NCT00947882|566316441|FG003|Overall Study|Protocol Violation|0|||
156878795|NCT00947882|566316438|FG000|Overall Study|Lost to Follow-up|0|||
156878796|NCT00947882|566316439|FG001|Overall Study|Lost to Follow-up|2|||
156878797|NCT00947882|566316440|FG002|Overall Study|Lost to Follow-up|1|||
156878798|NCT00947882|566316441|FG003|Overall Study|Lost to Follow-up|0|||
156878799|NCT00947882|566316438|FG000|Overall Study|Other/Unknown|10|||
156878800|NCT00947882|566316439|FG001|Overall Study|Other/Unknown|13|||
156878801|NCT00947882|566316440|FG002|Overall Study|Other/Unknown|3|||
156878802|NCT00947882|566316441|FG003|Overall Study|Other/Unknown|6|||
156878803|NCT00947882|566316438|FG000|Overall Study|Trial Terminated by Sponsor|62|||
156878804|NCT00947882|566316439|FG001|Overall Study|Trial Terminated by Sponsor|61|||
156878805|NCT00947882|566316440|FG002|Overall Study|Trial Terminated by Sponsor|62|||
156878806|NCT00947882|566316441|FG003|Overall Study|Trial Terminated by Sponsor|70|||
157020534|NCT01415154|566828461|FG001|Overall Study|Lost to Follow-up|4|||
157020535|NCT01415154|566828460|FG000|Overall Study|Protocol Violation|0|||
157020536|NCT01415154|566828461|FG001|Overall Study|Protocol Violation|1|||
157020537|NCT01415154|566828460|FG000|Overall Study|Satisfactory Response|0|||
157020538|NCT01415154|566828461|FG001|Overall Study|Satisfactory Response|1|||
157020539|NCT01415154|566828460|FG000|Overall Study|Adverse Event|1|||
157020540|NCT01415154|566828461|FG001|Overall Study|Adverse Event|1|||
157020541|NCT03763708|566828465|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
157020542|NCT03763708|566828466|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020543|NCT03763708|566828467|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020544|NCT03763708|566828468|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020545|NCT03763708|566828469|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020546|NCT03763708|566828470|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020547|NCT03763708|566828471|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020548|NCT03763708|566828472|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020549|NCT03763708|566828473|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
157020550|NCT03763708|566828465|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020551|NCT03763708|566828466|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020552|NCT03763708|566828467|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
157020553|NCT03763708|566828468|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020554|NCT03763708|566828469|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020555|NCT03763708|566828470|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020556|NCT03763708|566828471|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020557|NCT03763708|566828472|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020558|NCT03763708|566828473|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
157020559|NCT03763708|566828465|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020560|NCT03763708|566828466|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020561|NCT03763708|566828467|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020562|NCT03763708|566828468|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
157020563|NCT03763708|566828469|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020564|NCT03763708|566828470|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020565|NCT03763708|566828471|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156878807|NCT02379637|566316442|FG000|Overall Study|Protocol Violation|0|||
156878808|NCT02379637|566316443|FG001|Overall Study|Protocol Violation|1|||
156878809|NCT02379637|566316442|FG000|Overall Study|Adverse Event|1|||
156878810|NCT02379637|566316443|FG001|Overall Study|Adverse Event|0|||
156878811|NCT02379637|566316442|FG000|Overall Study|Withdrawal by Subject|1|||
156878812|NCT02379637|566316443|FG001|Overall Study|Withdrawal by Subject|0|||
157020566|NCT03763708|566828472|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
157020567|NCT03763708|566828473|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
156878813|NCT02447302|566316444|FG000|Overall Study|Physician Decision|1|||
156878814|NCT02447302|566316445|FG001|Overall Study|Physician Decision|0|||
156878815|NCT02447302|566316446|FG002|Overall Study|Physician Decision|0|||
156878816|NCT02447302|566316444|FG000|Overall Study|Adverse Event|4|||
157020568|NCT03763708|566828465|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157020569|NCT03763708|566828466|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157020570|NCT03763708|566828467|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156878817|NCT02447302|566316445|FG001|Overall Study|Adverse Event|3|||
156798313|NCT00567502|566015694|FG001|Overall Study|Other|2|||
156798314|NCT00567502|566015695|FG002|Overall Study|Other|134|||
156798315|NCT00567502|566015696|FG003|Overall Study|Other|6|||
156798316|NCT00567502|566015693|FG000|Overall Study|Participant request|12|||
156798317|NCT00567502|566015694|FG001|Overall Study|Participant request|1|||
156798318|NCT00567502|566015695|FG002|Overall Study|Participant request|33|||
156798319|NCT00567502|566015696|FG003|Overall Study|Participant request|1|||
156798320|NCT00567502|566015693|FG000|Overall Study|Sponsor request|9|||
156798321|NCT00567502|566015694|FG001|Overall Study|Sponsor request|0|||
156798322|NCT00567502|566015695|FG002|Overall Study|Sponsor request|30|||
156798323|NCT00567502|566015696|FG003|Overall Study|Sponsor request|1|||
156798324|NCT00567502|566015693|FG000|Overall Study|Never Initiated Treatment|0|||
156798325|NCT00567502|566015694|FG001|Overall Study|Never Initiated Treatment|0|||
156798326|NCT00567502|566015695|FG002|Overall Study|Never Initiated Treatment|0|||
156798327|NCT00567502|566015696|FG003|Overall Study|Never Initiated Treatment|72|||
156798328|NCT02297516|566015697|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
156798329|NCT02297516|566015698|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
156798330|NCT02297516|566015697|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
156798331|NCT02297516|566015698|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
156798332|NCT02297516|566015697|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
156798333|NCT02297516|566015698|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
156798334|NCT00710593|566015699|FG000|Overall Study|Incarceration|1|||
156798335|NCT00710593|566015700|FG001|Overall Study|Incarceration|0|||
156798336|NCT00710593|566015699|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
156798337|NCT00710593|566015700|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
156798338|NCT00710593|566015699|FG000|Overall Study|Lost to Follow-up|3|||
156798339|NCT00710593|566015700|FG001|Overall Study|Lost to Follow-up|1|||
156798340|NCT00710593|566015699|FG000|Overall Study|Moved out of area|1|||
156798341|NCT00710593|566015700|FG001|Overall Study|Moved out of area|0|||
156798342|NCT00710593|566015699|FG000|Overall Study|Failure to adhere or complete study eval|1|||
156798343|NCT00710593|566015700|FG001|Overall Study|Failure to adhere or complete study eval|1|||
156798344|NCT00710593|566015699|FG000|Overall Study|Protocol Violation|1|||
156798345|NCT00710593|566015700|FG001|Overall Study|Protocol Violation|1|||
156798346|NCT00710593|566015699|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
156798347|NCT00710593|566015700|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
156798348|NCT00366457|566015704|FG000|Overall Study|never began study therapy|2|||
156798349|NCT02538614|566015705|FG000|Overall Study|Progressive Disease|2|||
156798350|NCT02829996|566015706|FG000|Overall Study|Withdrawal by Subject|1|||
156798351|NCT02829996|566015707|FG001|Overall Study|Withdrawal by Subject|0|||
156798352|NCT02829996|566015708|FG002|Overall Study|Withdrawal by Subject|0|||
156798353|NCT02829996|566015709|FG003|Overall Study|Withdrawal by Subject|0|||
156798354|NCT02829996|566015710|FG004|Overall Study|Withdrawal by Subject|0|||
156798355|NCT00189423|566015721|FG000|Overall Study|Death|746|||
156798356|NCT00189423|566015722|FG001|Overall Study|Death|747|||
156798357|NCT00189423|566015721|FG000|Overall Study|Withdrawal by Subject|9|||
156798358|NCT00189423|566015722|FG001|Overall Study|Withdrawal by Subject|9|||
156798359|NCT00189423|566015721|FG000|Overall Study|Lost to Follow-up|10|||
156798360|NCT00189423|566015722|FG001|Overall Study|Lost to Follow-up|10|||
156798361|NCT00183248|566015732|FG000|Overall Study|Lost to Follow-up|0|||
156798362|NCT00183248|566015733|FG001|Overall Study|Lost to Follow-up|1|||
156798363|NCT00183248|566015732|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
156798364|NCT00183248|566015733|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
156798365|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
156798366|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
156798367|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
156798368|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
156798369|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
156798370|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
156798371|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
156798372|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
156798373|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
156798374|NCT04734210|566015734|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
156808881|NCT00589797|566054494|FG001|Overall Study|Non-Randomized Training Subjects|6|||
156808882|NCT04011735|566054499|FG000|Overall Study|Withdrawal by Subject|1|||
156808883|NCT04011735|566054500|FG001|Overall Study|Withdrawal by Subject|0|||
156808884|NCT04011735|566054501|FG002|Overall Study|Withdrawal by Subject|1|||
156808885|NCT04011735|566054499|FG000|Overall Study|Met exclusion criteria after study entry|0|||
156808886|NCT04011735|566054500|FG001|Overall Study|Met exclusion criteria after study entry|1|||
156808887|NCT04011735|566054501|FG002|Overall Study|Met exclusion criteria after study entry|0|||
156808888|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
156878818|NCT02447302|566316446|FG002|Overall Study|Adverse Event|0|||
156878819|NCT02447302|566316444|FG000|Overall Study|Withdrawal by Subject|0|||
156878820|NCT02447302|566316445|FG001|Overall Study|Withdrawal by Subject|1|||
156878821|NCT02447302|566316446|FG002|Overall Study|Withdrawal by Subject|5|||
156878822|NCT02447302|566316444|FG000|Overall Study|Sponsor Decision|0|||
156878823|NCT02447302|566316445|FG001|Overall Study|Sponsor Decision|0|||
156878824|NCT02447302|566316446|FG002|Overall Study|Sponsor Decision|1|||
156878825|NCT02791763|566316447|FG000|Overall Study|Protocol Violation|0|||
156878826|NCT02791763|566316448|FG001|Overall Study|Protocol Violation|0|||
156878827|NCT02791763|566316449|FG002|Overall Study|Protocol Violation|1|||
156878828|NCT02791763|566316447|FG000|Overall Study|Withdrawal by Subject|5|||
156878829|NCT02791763|566316448|FG001|Overall Study|Withdrawal by Subject|1|||
156878830|NCT02791763|566316449|FG002|Overall Study|Withdrawal by Subject|0|||
156878831|NCT02791763|566316447|FG000|Overall Study|Physician Decision|0|||
156878832|NCT02791763|566316448|FG001|Overall Study|Physician Decision|1|||
156878833|NCT02791763|566316449|FG002|Overall Study|Physician Decision|0|||
156878834|NCT02791763|566316447|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
156878835|NCT02791763|566316448|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
156878836|NCT02791763|566316449|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
156878837|NCT02791763|566316447|FG000|Overall Study|Cancer event|1|||
156878838|NCT02791763|566316448|FG001|Overall Study|Cancer event|3|||
156878839|NCT02791763|566316449|FG002|Overall Study|Cancer event|0|||
156878840|NCT02791763|566316447|FG000|Overall Study|Participant had renal transplant|3|||
156878841|NCT02791763|566316448|FG001|Overall Study|Participant had renal transplant|0|||
156878842|NCT02791763|566316449|FG002|Overall Study|Participant had renal transplant|0|||
156878843|NCT02791763|566316447|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
156878844|NCT02791763|566316448|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
156878845|NCT02791763|566316449|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
156878846|NCT02791763|566316447|FG000|Overall Study|Adverse Event|12|||
156878847|NCT02791763|566316448|FG001|Overall Study|Adverse Event|13|||
156878848|NCT02791763|566316449|FG002|Overall Study|Adverse Event|7|||
156878849|NCT05334212|566316450|FG000|Overall Study|Study terminated prematurely|7|||
156878850|NCT01456897|566316451|FG000|Overall Study|Adverse Event|19|||
156878851|NCT01456897|566316452|FG001|Overall Study|Adverse Event|22|||
156878852|NCT01456897|566316451|FG000|Overall Study|Protocol Violation|3|||
156878853|NCT01456897|566316452|FG001|Overall Study|Protocol Violation|4|||
156878854|NCT01456897|566316451|FG000|Overall Study|Physician Decision|5|||
156878855|NCT01456897|566316452|FG001|Overall Study|Physician Decision|3|||
156878856|NCT01456897|566316451|FG000|Overall Study|Withdrawal by Subject|44|||
156878857|NCT01456897|566316452|FG001|Overall Study|Withdrawal by Subject|17|||
156878858|NCT01456897|566316451|FG000|Overall Study|Lack of Efficacy|4|||
156878859|NCT01456897|566316452|FG001|Overall Study|Lack of Efficacy|11|||
156878860|NCT02695420|566316453|FG000|Overall Study|Death|0|||
156878861|NCT02695420|566316454|FG001|Overall Study|Death|1|||
156878862|NCT02695420|566316455|FG002|Overall Study|Death|0|||
156878863|NCT02695420|566316456|FG003|Overall Study|Death|0|||
156742982|NCT02327013|565808195|FG003|Overall Study|Lack of Efficacy|0|||
156742983|NCT02327013|565808196|FG004|Overall Study|Lack of Efficacy|1|||
156742984|NCT02327013|565808192|FG000|Overall Study|Non-compliance with IMP|1|||
156742985|NCT02327013|565808193|FG001|Overall Study|Non-compliance with IMP|2|||
156742986|NCT02327013|565808194|FG002|Overall Study|Non-compliance with IMP|7|||
156742987|NCT02327013|565808195|FG003|Overall Study|Non-compliance with IMP|0|||
156742988|NCT02327013|565808196|FG004|Overall Study|Non-compliance with IMP|0|||
156742989|NCT02327013|565808192|FG000|Overall Study|Withdrawal of Consent|1|||
156742990|NCT02327013|565808193|FG001|Overall Study|Withdrawal of Consent|0|||
156742991|NCT02327013|565808194|FG002|Overall Study|Withdrawal of Consent|3|||
156742992|NCT02327013|565808195|FG003|Overall Study|Withdrawal of Consent|0|||
156742993|NCT02327013|565808196|FG004|Overall Study|Withdrawal of Consent|0|||
156742994|NCT02327013|565808192|FG000|Overall Study|Lost to Follow-up|2|||
156742995|NCT02327013|565808193|FG001|Overall Study|Lost to Follow-up|4|||
156742996|NCT02327013|565808194|FG002|Overall Study|Lost to Follow-up|5|||
156742997|NCT02327013|565808195|FG003|Overall Study|Lost to Follow-up|0|||
156742998|NCT02327013|565808196|FG004|Overall Study|Lost to Follow-up|0|||
156742999|NCT02327013|565808192|FG000|Overall Study|Administrative or other reason(s)|1|||
156743000|NCT02327013|565808193|FG001|Overall Study|Administrative or other reason(s)|5|||
156743001|NCT02327013|565808194|FG002|Overall Study|Administrative or other reason(s)|11|||
156878864|NCT02929407|566316459|FG000|Overall Study|Adverse Event|1|||
156878865|NCT00916929|566316460|FG000|Overall Study|Lost to Follow-up|1|||
156878866|NCT00916929|566316461|FG001|Overall Study|Lost to Follow-up|3|||
156878867|NCT00916929|566316460|FG000|Overall Study|Death|5|||
156878868|NCT00916929|566316461|FG001|Overall Study|Death|10|||
156878869|NCT00916929|566316460|FG000|Overall Study|Withdrawal by Subject|1|||
156878870|NCT00916929|566316461|FG001|Overall Study|Withdrawal by Subject|5|||
157020571|NCT03763708|566828468|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
156743002|NCT02327013|565808195|FG003|Overall Study|Administrative or other reason(s)|1|||
156878871|NCT00916929|566316460|FG000|Overall Study|Left ventricular epicardial lead|1|||
156878872|NCT00916929|566316461|FG001|Overall Study|Left ventricular epicardial lead|2|||
156743003|NCT02327013|565808196|FG004|Overall Study|Administrative or other reason(s)|1|||
156743004|NCT02327013|565808192|FG000|Overall Study|Protocol Violation|0|||
156743005|NCT02327013|565808193|FG001|Overall Study|Protocol Violation|0|||
156878873|NCT00916929|566316460|FG000|Overall Study|Transferred to hospice care|1|||
156743006|NCT02327013|565808194|FG002|Overall Study|Protocol Violation|3|||
156743007|NCT02327013|565808195|FG003|Overall Study|Protocol Violation|0|||
156743008|NCT02327013|565808196|FG004|Overall Study|Protocol Violation|1|||
156743009|NCT02327013|565808192|FG000|Overall Study|Withdrawal before treatment|2|||
156743010|NCT02327013|565808193|FG001|Overall Study|Withdrawal before treatment|1|||
156743011|NCT02327013|565808194|FG002|Overall Study|Withdrawal before treatment|5|||
156743012|NCT02327013|565808195|FG003|Overall Study|Withdrawal before treatment|0|||
156743013|NCT02327013|565808196|FG004|Overall Study|Withdrawal before treatment|0|||
156743014|NCT02380859|565808197|FG000|Overall Study|Withdrawal by Subject|2|||
156743015|NCT02380859|565808198|FG001|Overall Study|Withdrawal by Subject|0|||
156743016|NCT01565668|565808199|FG000|Overall Study|Death|2|||
156743017|NCT01565668|565808200|FG001|Overall Study|Death|1|||
156743018|NCT01565668|565808199|FG000|Overall Study|Lack of Efficacy|4|||
156878874|NCT00916929|566316461|FG001|Overall Study|Transferred to hospice care|1|||
156878875|NCT00916929|566316460|FG000|Overall Study|System explant|1|||
156878876|NCT00916929|566316461|FG001|Overall Study|System explant|0|||
156878877|NCT00916929|566316460|FG000|Overall Study|Moved to another state|0|||
156878878|NCT00916929|566316461|FG001|Overall Study|Moved to another state|1|||
156878879|NCT00916929|566316460|FG000|Overall Study|Device unable to process impedance data|0|||
156878880|NCT00916929|566316461|FG001|Overall Study|Device unable to process impedance data|7|||
156878881|NCT01742286|566316462|FG000|Escalation Phase|Administrative problems|1|||
156878882|NCT01742286|566316463|FG001|Escalation Phase|Administrative problems|1|||
156878883|NCT01742286|566316464|FG002|Escalation Phase|Administrative problems|0|||
156878884|NCT01742286|566316465|FG003|Escalation Phase|Administrative problems|0|||
156878885|NCT01742286|566316466|FG004|Escalation Phase|Administrative problems|0|||
156878886|NCT01742286|566316467|FG005|Escalation Phase|Administrative problems|0|||
156878887|NCT01742286|566316468|FG006|Escalation Phase|Administrative problems|2|||
156878888|NCT01742286|566316462|FG000|Escalation Phase|Adverse Event|0|||
156878889|NCT01742286|566316463|FG001|Escalation Phase|Adverse Event|1|||
156878890|NCT01742286|566316464|FG002|Escalation Phase|Adverse Event|2|||
156878891|NCT01742286|566316465|FG003|Escalation Phase|Adverse Event|0|||
156878892|NCT01742286|566316466|FG004|Escalation Phase|Adverse Event|0|||
156878893|NCT01742286|566316467|FG005|Escalation Phase|Adverse Event|1|||
156878894|NCT01742286|566316468|FG006|Escalation Phase|Adverse Event|0|||
156878895|NCT01742286|566316462|FG000|Escalation Phase|Disease progression|3|||
156878896|NCT01742286|566316463|FG001|Escalation Phase|Disease progression|7|||
156878897|NCT01742286|566316464|FG002|Escalation Phase|Disease progression|4|||
156878898|NCT01742286|566316465|FG003|Escalation Phase|Disease progression|1|||
156878899|NCT01742286|566316466|FG004|Escalation Phase|Disease progression|4|||
156878900|NCT01742286|566316467|FG005|Escalation Phase|Disease progression|3|||
156878901|NCT01742286|566316468|FG006|Escalation Phase|Disease progression|2|||
156878902|NCT01742286|566316462|FG000|Escalation Phase|Death|0|||
156878903|NCT01742286|566316463|FG001|Escalation Phase|Death|0|||
156878904|NCT01742286|566316464|FG002|Escalation Phase|Death|0|||
156878905|NCT01742286|566316465|FG003|Escalation Phase|Death|0|||
156878906|NCT01742286|566316466|FG004|Escalation Phase|Death|0|||
156878907|NCT01742286|566316467|FG005|Escalation Phase|Death|1|||
156878908|NCT01742286|566316468|FG006|Escalation Phase|Death|0|||
156878909|NCT01742286|566316462|FG000|Escalation Phase|Physician Decision|0|||
156878910|NCT01742286|566316463|FG001|Escalation Phase|Physician Decision|3|||
156878911|NCT01742286|566316464|FG002|Escalation Phase|Physician Decision|0|||
156878912|NCT01742286|566316465|FG003|Escalation Phase|Physician Decision|1|||
156878913|NCT01742286|566316466|FG004|Escalation Phase|Physician Decision|0|||
156878914|NCT01742286|566316467|FG005|Escalation Phase|Physician Decision|0|||
156743019|NCT01565668|565808200|FG001|Overall Study|Lack of Efficacy|2|||
156743020|NCT01565668|565808199|FG000|Overall Study|Participant went on Hospice Care|1|||
156878915|NCT01742286|566316468|FG006|Escalation Phase|Physician Decision|2|||
156878916|NCT01742286|566316462|FG000|Escalation Phase|Subject/guardian decision|1|||
156878917|NCT01742286|566316463|FG001|Escalation Phase|Subject/guardian decision|0|||
156878918|NCT01742286|566316464|FG002|Escalation Phase|Subject/guardian decision|0|||
156878919|NCT01742286|566316465|FG003|Escalation Phase|Subject/guardian decision|0|||
156878920|NCT01742286|566316466|FG004|Escalation Phase|Subject/guardian decision|0|||
156878921|NCT01742286|566316467|FG005|Escalation Phase|Subject/guardian decision|0|||
157218758|NCT02436135|567547507|FG000|Overall Study|Withdrawal by Participant|1|||
156743021|NCT01565668|565808200|FG001|Overall Study|Participant went on Hospice Care|0|||
157218759|NCT02436135|567547508|FG001|Overall Study|Withdrawal by Participant|0|||
157218760|NCT02436135|567547507|FG000|Overall Study|Study Terminated By Sponsor|0|||
156743022|NCT01565668|565808199|FG000|Overall Study|Adverse Event|6|||
156878922|NCT01742286|566316468|FG006|Escalation Phase|Subject/guardian decision|0|||
156878923|NCT01742286|566316462|FG000|Expansion Phase|Administrative problems|0|||
156878924|NCT01742286|566316463|FG001|Expansion Phase|Administrative problems|0|||
156878925|NCT01742286|566316464|FG002|Expansion Phase|Administrative problems|0|||
157218761|NCT02436135|567547508|FG001|Overall Study|Study Terminated By Sponsor|1|||
156743023|NCT01565668|565808200|FG001|Overall Study|Adverse Event|1|||
156743024|NCT01565668|565808199|FG000|Overall Study|Randomized, but never received drug|0|||
156878926|NCT01742286|566316465|FG003|Expansion Phase|Administrative problems|0|||
156878927|NCT01742286|566316466|FG004|Expansion Phase|Administrative problems|0|||
156878928|NCT01742286|566316467|FG005|Expansion Phase|Administrative problems|0|||
156878929|NCT01742286|566316468|FG006|Expansion Phase|Administrative problems|5|||
156878930|NCT01742286|566316462|FG000|Expansion Phase|Physician Decision|0|||
156878931|NCT01742286|566316463|FG001|Expansion Phase|Physician Decision|0|||
156878932|NCT01742286|566316464|FG002|Expansion Phase|Physician Decision|4|||
156878933|NCT01742286|566316465|FG003|Expansion Phase|Physician Decision|0|||
156878934|NCT01742286|566316466|FG004|Expansion Phase|Physician Decision|0|||
156878935|NCT01742286|566316467|FG005|Expansion Phase|Physician Decision|0|||
156878936|NCT01742286|566316468|FG006|Expansion Phase|Physician Decision|9|||
156878937|NCT01742286|566316462|FG000|Expansion Phase|Adverse Event|0|||
156878938|NCT01742286|566316463|FG001|Expansion Phase|Adverse Event|0|||
156878939|NCT01742286|566316464|FG002|Expansion Phase|Adverse Event|0|||
156878940|NCT01742286|566316465|FG003|Expansion Phase|Adverse Event|0|||
156878941|NCT01742286|566316466|FG004|Expansion Phase|Adverse Event|0|||
157142872|NCT02128490|567271125|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
157142873|NCT02128490|567271121|FG000|Overall Study|Other Miscellaneous Reasons|0|||
157142874|NCT02128490|567271122|FG001|Overall Study|Other Miscellaneous Reasons|0|||
157142875|NCT02128490|567271123|FG002|Overall Study|Other Miscellaneous Reasons|2|||
157142876|NCT02128490|567271124|FG003|Overall Study|Other Miscellaneous Reasons|1|||
157142877|NCT02128490|567271125|FG004|Overall Study|Other Miscellaneous Reasons|1|||
156743025|NCT01565668|565808200|FG001|Overall Study|Randomized, but never received drug|2|||
156743026|NCT01565668|565808199|FG000|Overall Study|Progressive disease|13|||
156743027|NCT01565668|565808200|FG001|Overall Study|Progressive disease|14|||
156743028|NCT01565668|565808199|FG000|Overall Study|Withdrawal by Subject|1|||
156743029|NCT01565668|565808200|FG001|Overall Study|Withdrawal by Subject|3|||
156743030|NCT01565668|565808199|FG000|Overall Study|HSCT Transplant|11|||
156743031|NCT01565668|565808200|FG001|Overall Study|HSCT Transplant|15|||
156743032|NCT01097421|565808201|FG000|Overall Study|Adverse Event|8|||
156743033|NCT01097421|565808201|FG000|Overall Study|Protocol Violation|2|||
156743034|NCT01097421|565808201|FG000|Overall Study|Lost to Follow-up|1|||
156743035|NCT01097421|565808201|FG000|Overall Study|Withdrawal by Subject|3|||
156743036|NCT04258254|565808202|FG000|Overall Study|Withdrawal by Subject|0|||
156743037|NCT04258254|565808203|FG001|Overall Study|Withdrawal by Subject|1|||
156743038|NCT04258254|565808204|FG002|Overall Study|Withdrawal by Subject|0|||
156743039|NCT01120249|565808205|FG000|Overall Study|No protocol treatment received|21|||
156743040|NCT01120249|565808206|FG001|Overall Study|No protocol treatment received|15|||
156743041|NCT01120249|565808205|FG000|Overall Study|Disease recurrence|107|||
156743042|NCT01120249|565808206|FG001|Overall Study|Disease recurrence|57|||
156743043|NCT01120249|565808205|FG000|Overall Study|Death|1|||
156743044|NCT01120249|565808206|FG001|Overall Study|Death|0|||
156743045|NCT01120249|565808205|FG000|Overall Study|Adverse Event|40|||
156743046|NCT01120249|565808206|FG001|Overall Study|Adverse Event|276|||
156743047|NCT01120249|565808205|FG000|Overall Study|Participant refusal|34|||
156743048|NCT01120249|565808206|FG001|Overall Study|Participant refusal|42|||
156743049|NCT01120249|565808205|FG000|Overall Study|Other reasons, not protocol specified|29|||
156743050|NCT01120249|565808206|FG001|Overall Study|Other reasons, not protocol specified|22|||
156743051|NCT02052596|565808207|FG000|Active Phase|Adverse Event|3|||
156743052|NCT02052596|565808208|FG001|Active Phase|Adverse Event|2|||
156743053|NCT02052596|565808207|FG000|Active Phase|Lost to Follow-up|8|||
156743054|NCT02052596|565808208|FG001|Active Phase|Lost to Follow-up|11|||
156743055|NCT02052596|565808207|FG000|Active Phase|Protocol Violation|1|||
156743056|NCT02052596|565808208|FG001|Active Phase|Protocol Violation|2|||
156743057|NCT02052596|565808207|FG000|Active Phase|Withdrawal by Subject|3|||
156743058|NCT02052596|565808208|FG001|Active Phase|Withdrawal by Subject|4|||
156743059|NCT02052596|565808207|FG000|Active Phase|Enrolled in error|1|||
156743060|NCT02052596|565808208|FG001|Active Phase|Enrolled in error|0|||
156743061|NCT02052596|565808207|FG000|Active Phase|Lost due to Crohn's disease|0|||
156743062|NCT02052596|565808208|FG001|Active Phase|Lost due to Crohn's disease|1|||
156743063|NCT02052596|565808207|FG000|Safety Phase|Adverse Event|6|||
156743064|NCT02052596|565808208|FG001|Safety Phase|Adverse Event|3|||
157142878|NCT02243176|567271126|FG000|Overall Study|Other reason|1|||
156743065|NCT02052596|565808207|FG000|Safety Phase|Lost to Follow-up|11|||
156743066|NCT02052596|565808208|FG001|Safety Phase|Lost to Follow-up|18|||
156743067|NCT02052596|565808207|FG000|Safety Phase|Protocol Violation|1|||
156743068|NCT02052596|565808208|FG001|Safety Phase|Protocol Violation|2|||
156743069|NCT02052596|565808207|FG000|Safety Phase|Withdrawal by Subject|8|||
156743070|NCT02052596|565808208|FG001|Safety Phase|Withdrawal by Subject|11|||
156743071|NCT02052596|565808207|FG000|Safety Phase|Enrolled in error|1|||
156743072|NCT02052596|565808208|FG001|Safety Phase|Enrolled in error|0|||
156743073|NCT02052596|565808207|FG000|Safety Phase|Lost due to Crohn's disease|0|||
156743074|NCT02052596|565808208|FG001|Safety Phase|Lost due to Crohn's disease|1|||
156743075|NCT00558896|565808209|FG000|Overall Study|Adverse Event|1|||
156743076|NCT00558896|565808210|FG001|Overall Study|Adverse Event|1|||
156878942|NCT01742286|566316467|FG005|Expansion Phase|Adverse Event|0|||
156878943|NCT01742286|566316468|FG006|Expansion Phase|Adverse Event|6|||
156878944|NCT01742286|566316462|FG000|Expansion Phase|Disease progression|0|||
156878945|NCT01742286|566316463|FG001|Expansion Phase|Disease progression|0|||
156878946|NCT01742286|566316464|FG002|Expansion Phase|Disease progression|3|||
156878947|NCT01742286|566316465|FG003|Expansion Phase|Disease progression|0|||
156878948|NCT01742286|566316466|FG004|Expansion Phase|Disease progression|0|||
156878949|NCT01742286|566316467|FG005|Expansion Phase|Disease progression|0|||
156878950|NCT01742286|566316468|FG006|Expansion Phase|Disease progression|15|||
156878951|NCT01742286|566316462|FG000|Expansion Phase|Withdrawal by Subject|0|||
156878952|NCT01742286|566316463|FG001|Expansion Phase|Withdrawal by Subject|0|||
156878953|NCT01742286|566316464|FG002|Expansion Phase|Withdrawal by Subject|0|||
156878954|NCT01742286|566316465|FG003|Expansion Phase|Withdrawal by Subject|0|||
156878955|NCT01742286|566316466|FG004|Expansion Phase|Withdrawal by Subject|0|||
156878956|NCT01742286|566316467|FG005|Expansion Phase|Withdrawal by Subject|0|||
156878957|NCT01742286|566316468|FG006|Expansion Phase|Withdrawal by Subject|1|||
156878958|NCT02762370|566316469|FG000|Overall Study|Protocol Violation|1|||
156878959|NCT02762370|566316470|FG001|Overall Study|Protocol Violation|0|||
156878960|NCT01708902|566316477|FG000|Overall Study|Adverse Event|3|||
156878961|NCT01708902|566316478|FG001|Overall Study|Adverse Event|4|||
156878962|NCT01708902|566316479|FG002|Overall Study|Adverse Event|9|||
156878963|NCT01708902|566316480|FG003|Overall Study|Adverse Event|2|||
156878964|NCT01708902|566316481|FG004|Overall Study|Adverse Event|7|||
156878965|NCT01708902|566316482|FG005|Overall Study|Adverse Event|3|||
156878966|NCT01708902|566316483|FG006|Overall Study|Adverse Event|5|||
156878967|NCT01708902|566316477|FG000|Overall Study|Lack of Efficacy|3|||
156878968|NCT01708902|566316478|FG001|Overall Study|Lack of Efficacy|1|||
156878969|NCT01708902|566316479|FG002|Overall Study|Lack of Efficacy|0|||
156878970|NCT01708902|566316480|FG003|Overall Study|Lack of Efficacy|0|||
156878971|NCT01708902|566316481|FG004|Overall Study|Lack of Efficacy|0|||
156878972|NCT01708902|566316482|FG005|Overall Study|Lack of Efficacy|1|||
156878973|NCT01708902|566316483|FG006|Overall Study|Lack of Efficacy|0|||
156878974|NCT01708902|566316477|FG000|Overall Study|Non compliance with protocol|0|||
156878975|NCT01708902|566316478|FG001|Overall Study|Non compliance with protocol|2|||
156878976|NCT01708902|566316479|FG002|Overall Study|Non compliance with protocol|1|||
156878977|NCT01708902|566316480|FG003|Overall Study|Non compliance with protocol|3|||
156878978|NCT01708902|566316481|FG004|Overall Study|Non compliance with protocol|0|||
156878979|NCT01708902|566316482|FG005|Overall Study|Non compliance with protocol|0|||
156878980|NCT01708902|566316483|FG006|Overall Study|Non compliance with protocol|0|||
156878981|NCT01708902|566316477|FG000|Overall Study|Lost to Follow-up|2|||
156878982|NCT01708902|566316478|FG001|Overall Study|Lost to Follow-up|1|||
156878983|NCT01708902|566316479|FG002|Overall Study|Lost to Follow-up|2|||
156878984|NCT01708902|566316480|FG003|Overall Study|Lost to Follow-up|2|||
156878985|NCT01708902|566316481|FG004|Overall Study|Lost to Follow-up|0|||
156878986|NCT01708902|566316482|FG005|Overall Study|Lost to Follow-up|0|||
156878987|NCT01708902|566316483|FG006|Overall Study|Lost to Follow-up|1|||
156878988|NCT01708902|566316477|FG000|Overall Study|Refused to continue trial medication|8|||
156878989|NCT01708902|566316478|FG001|Overall Study|Refused to continue trial medication|0|||
156878990|NCT01708902|566316479|FG002|Overall Study|Refused to continue trial medication|4|||
156878991|NCT01708902|566316480|FG003|Overall Study|Refused to continue trial medication|2|||
156878992|NCT01708902|566316481|FG004|Overall Study|Refused to continue trial medication|8|||
156878993|NCT01708902|566316482|FG005|Overall Study|Refused to continue trial medication|1|||
156878994|NCT01708902|566316483|FG006|Overall Study|Refused to continue trial medication|1|||
156878995|NCT01708902|566316477|FG000|Overall Study|Other Reason|1|||
156878996|NCT01708902|566316478|FG001|Overall Study|Other Reason|0|||
156878997|NCT01708902|566316479|FG002|Overall Study|Other Reason|1|||
156878998|NCT01708902|566316480|FG003|Overall Study|Other Reason|1|||
156743077|NCT00558896|565808211|FG002|Overall Study|Adverse Event|1|||
156743078|NCT00558896|565808212|FG003|Overall Study|Adverse Event|3|||
156743079|NCT00558896|565808213|FG004|Overall Study|Adverse Event|4|||
156743080|NCT00558896|565808214|FG005|Overall Study|Adverse Event|10|||
156878999|NCT01708902|566316481|FG004|Overall Study|Other Reason|1|||
156879000|NCT01708902|566316482|FG005|Overall Study|Other Reason|2|||
156879001|NCT01708902|566316483|FG006|Overall Study|Other Reason|0|||
156879002|NCT02633020|566316486|FG000|Overall Study|Adverse Event|1|||
156879003|NCT02633020|566316487|FG001|Overall Study|Adverse Event|0|||
156879004|NCT00934440|566316488|FG000|Overall Study|Lost to Follow-up|1|||
156879005|NCT05661851|566316489|FG000|Overall Study|Protocol Violation|1|||
156879006|NCT05661851|566316490|FG001|Overall Study|Protocol Violation|1|||
156879007|NCT05661851|566316489|FG000|Overall Study|Covid-19 Related|3|||
156879008|NCT05661851|566316490|FG001|Overall Study|Covid-19 Related|4|||
156879009|NCT05661851|566316489|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
156879010|NCT05661851|566316490|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
156879011|NCT05661851|566316489|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
156879012|NCT05661851|566316490|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
156743081|NCT00558896|565808215|FG006|Overall Study|Adverse Event|3|||
157142879|NCT02243176|567271127|FG001|Overall Study|Other reason|2|||
157142880|NCT02243176|567271126|FG000|Overall Study|protocol specified withdrawal critera|1|||
157142881|NCT02243176|567271127|FG001|Overall Study|protocol specified withdrawal critera|3|||
157142882|NCT02243176|567271126|FG000|Overall Study|Protocol Violation|2|||
157142883|NCT02243176|567271127|FG001|Overall Study|Protocol Violation|1|||
157142884|NCT02243176|567271126|FG000|Overall Study|Withdrawal by Subject|8|||
157142885|NCT02243176|567271127|FG001|Overall Study|Withdrawal by Subject|7|||
156743082|NCT00558896|565808209|FG000|Overall Study|Death|3|||
156743083|NCT00558896|565808210|FG001|Overall Study|Death|0|||
157020572|NCT03763708|566828469|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
157142886|NCT02243176|567271126|FG000|Overall Study|Adverse Event|2|||
156743084|NCT00558896|565808211|FG002|Overall Study|Death|2|||
156743085|NCT00558896|565808212|FG003|Overall Study|Death|3|||
156743086|NCT00558896|565808213|FG004|Overall Study|Death|2|||
156743087|NCT00558896|565808214|FG005|Overall Study|Death|2|||
156743088|NCT00558896|565808215|FG006|Overall Study|Death|6|||
156743089|NCT00558896|565808209|FG000|Overall Study|Withdrawal by Subject|2|||
156743090|NCT00558896|565808210|FG001|Overall Study|Withdrawal by Subject|1|||
156743091|NCT00558896|565808211|FG002|Overall Study|Withdrawal by Subject|1|||
156743092|NCT00558896|565808212|FG003|Overall Study|Withdrawal by Subject|1|||
156743093|NCT00558896|565808213|FG004|Overall Study|Withdrawal by Subject|1|||
156743094|NCT00558896|565808214|FG005|Overall Study|Withdrawal by Subject|5|||
156743095|NCT00558896|565808215|FG006|Overall Study|Withdrawal by Subject|5|||
156743096|NCT00558896|565808209|FG000|Overall Study|Alternative Treatment|2|||
156743097|NCT00558896|565808210|FG001|Overall Study|Alternative Treatment|2|||
156743098|NCT00558896|565808211|FG002|Overall Study|Alternative Treatment|0|||
156743099|NCT00558896|565808212|FG003|Overall Study|Alternative Treatment|2|||
156743100|NCT00558896|565808213|FG004|Overall Study|Alternative Treatment|6|||
156743101|NCT00558896|565808214|FG005|Overall Study|Alternative Treatment|7|||
156743102|NCT00558896|565808215|FG006|Overall Study|Alternative Treatment|1|||
156743103|NCT00558896|565808209|FG000|Overall Study|Physician discretion|3|||
156743104|NCT00558896|565808210|FG001|Overall Study|Physician discretion|2|||
156743105|NCT00558896|565808211|FG002|Overall Study|Physician discretion|1|||
156743106|NCT00558896|565808212|FG003|Overall Study|Physician discretion|2|||
156743107|NCT00558896|565808213|FG004|Overall Study|Physician discretion|1|||
156743108|NCT00558896|565808214|FG005|Overall Study|Physician discretion|3|||
156743109|NCT00558896|565808215|FG006|Overall Study|Physician discretion|3|||
156743110|NCT00558896|565808209|FG000|Overall Study|Continues on treatment|10|||
156743111|NCT00558896|565808210|FG001|Overall Study|Continues on treatment|1|||
156743112|NCT00558896|565808211|FG002|Overall Study|Continues on treatment|0|||
156743113|NCT00558896|565808212|FG003|Overall Study|Continues on treatment|1|||
156743114|NCT00558896|565808213|FG004|Overall Study|Continues on treatment|9|||
156743115|NCT00558896|565808214|FG005|Overall Study|Continues on treatment|25|||
156743116|NCT00558896|565808215|FG006|Overall Study|Continues on treatment|6|||
156743117|NCT04472026|565808222|FG000|Overall Study|Lost to Follow-up|5|||
156743118|NCT01404208|565808223|FG000|Overall Study|Discontinued|3|||
156798375|NCT04734210|566015735|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
156798376|NCT04734210|566015736|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
156798377|NCT01358734|566015737|FG000|Overall Study|Adverse Event|4|||
156798378|NCT01358734|566015738|FG001|Overall Study|Adverse Event|7|||
156798379|NCT01358734|566015739|FG002|Overall Study|Adverse Event|3|||
156798380|NCT01358734|566015737|FG000|Overall Study|Lack of Efficacy|0|||
156798381|NCT01358734|566015738|FG001|Overall Study|Lack of Efficacy|1|||
156798382|NCT01358734|566015739|FG002|Overall Study|Lack of Efficacy|3|||
156798383|NCT01358734|566015737|FG000|Overall Study|Withdrawal by Subject|1|||
156798384|NCT01358734|566015738|FG001|Overall Study|Withdrawal by Subject|6|||
156798385|NCT01358734|566015739|FG002|Overall Study|Withdrawal by Subject|3|||
156798386|NCT01358734|566015737|FG000|Overall Study|Death|3|||
156798387|NCT01358734|566015738|FG001|Overall Study|Death|7|||
156798388|NCT01358734|566015739|FG002|Overall Study|Death|2|||
156798389|NCT01358734|566015737|FG000|Overall Study|Progressive Disease|5|||
156798390|NCT01358734|566015738|FG001|Overall Study|Progressive Disease|13|||
156798391|NCT01358734|566015739|FG002|Overall Study|Progressive Disease|16|||
156798392|NCT01358734|566015737|FG000|Overall Study|Non-compliance with study drug|0|||
156798393|NCT01358734|566015738|FG001|Overall Study|Non-compliance with study drug|0|||
156798394|NCT01358734|566015739|FG002|Overall Study|Non-compliance with study drug|1|||
156798395|NCT01358734|566015737|FG000|Overall Study|Other|2|||
156798396|NCT01358734|566015738|FG001|Overall Study|Other|5|||
156798397|NCT01358734|566015739|FG002|Overall Study|Other|4|||
156798398|NCT01358734|566015737|FG000|Overall Study|Protocol Violation|0|||
156798399|NCT01358734|566015738|FG001|Overall Study|Protocol Violation|0|||
156743119|NCT01404208|565808224|FG001|Overall Study|Discontinued|0|||
156743120|NCT00334802|565808227|FG000|Overall Study|Progressive Disease|2|||
156743121|NCT00334802|565808228|FG001|Overall Study|Progressive Disease|24|||
156798400|NCT01358734|566015739|FG002|Overall Study|Protocol Violation|2|||
156798401|NCT03847519|566015744|FG000|Overall Study|Death|5|||
156879013|NCT02152956|566316491|FG000|Overall Study|Adverse Event|0|||
156879014|NCT02152956|566316492|FG001|Overall Study|Adverse Event|0|||
157142887|NCT02243176|567271127|FG001|Overall Study|Adverse Event|2|||
157142888|NCT02517515|567271130|FG000|Overall Study|Adverse Event|0|||
156743122|NCT00334802|565808227|FG000|Overall Study|Toxicity|1|||
156743123|NCT00334802|565808228|FG001|Overall Study|Toxicity|5|||
156743124|NCT00334802|565808227|FG000|Overall Study|Lack of Efficacy|1|||
156743125|NCT00334802|565808228|FG001|Overall Study|Lack of Efficacy|3|||
156743126|NCT00334802|565808227|FG000|Overall Study|Patient Condition Aggrevated|1|||
156743127|NCT00334802|565808228|FG001|Overall Study|Patient Condition Aggrevated|0|||
156743128|NCT00334802|565808227|FG000|Overall Study|Physician Decision|1|||
156743129|NCT00334802|565808228|FG001|Overall Study|Physician Decision|0|||
156743130|NCT00334802|565808227|FG000|Overall Study|Withdrawal by Subject|0|||
156743131|NCT00334802|565808228|FG001|Overall Study|Withdrawal by Subject|4|||
156743132|NCT00334802|565808227|FG000|Overall Study|Adverse Event|0|||
156743133|NCT00334802|565808228|FG001|Overall Study|Adverse Event|3|||
156743134|NCT00334802|565808227|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
156743135|NCT00334802|565808228|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
156743136|NCT03422159|565808229|FG000|Overall Study|Exclusion due to terminal disease|2|||
156743137|NCT03422159|565808230|FG001|Overall Study|Exclusion due to terminal disease|1|||
156743138|NCT03436199|565808231|FG000|Overall Study|Adverse Event|15|||
156743139|NCT03436199|565808232|FG001|Overall Study|Adverse Event|40|||
156743140|NCT03436199|565808233|FG002|Overall Study|Adverse Event|7|||
156743141|NCT03436199|565808231|FG000|Overall Study|Withdrawal by Subject|4|||
156743142|NCT03436199|565808232|FG001|Overall Study|Withdrawal by Subject|10|||
156743143|NCT03436199|565808233|FG002|Overall Study|Withdrawal by Subject|3|||
156743144|NCT03436199|565808231|FG000|Overall Study|Lost to Follow-up|1|||
156743145|NCT03436199|565808232|FG001|Overall Study|Lost to Follow-up|0|||
156743146|NCT03436199|565808233|FG002|Overall Study|Lost to Follow-up|2|||
156743147|NCT03436199|565808231|FG000|Overall Study|Protocol Violation|1|||
156743148|NCT03436199|565808232|FG001|Overall Study|Protocol Violation|1|||
156743149|NCT03436199|565808233|FG002|Overall Study|Protocol Violation|0|||
156743150|NCT03436199|565808231|FG000|Overall Study|Physician Decision|0|||
156743151|NCT03436199|565808232|FG001|Overall Study|Physician Decision|1|||
156743152|NCT03436199|565808233|FG002|Overall Study|Physician Decision|0|||
156743153|NCT03436199|565808231|FG000|Overall Study|Could not return to clinic|1|||
156743154|NCT03436199|565808232|FG001|Overall Study|Could not return to clinic|0|||
156743155|NCT03436199|565808233|FG002|Overall Study|Could not return to clinic|0|||
156743156|NCT03436199|565808231|FG000|Overall Study|Withdrawn per physician|0|||
156743157|NCT03436199|565808232|FG001|Overall Study|Withdrawn per physician|1|||
156743158|NCT03436199|565808233|FG002|Overall Study|Withdrawn per physician|0|||
156743159|NCT00085098|565808234|FG000|Overall Study|Withdrawal by Subject|0|||
156743160|NCT00085098|565808235|FG001|Overall Study|Withdrawal by Subject|1|||
156743161|NCT00085098|565808234|FG000|Overall Study|Ineligible|1|||
156743162|NCT00085098|565808235|FG001|Overall Study|Ineligible|1|||
156743163|NCT01886781|565808240|FG000|Overall Study|Protocol Violation|5|||
156743164|NCT01886781|565808241|FG001|Overall Study|Protocol Violation|0|||
156743165|NCT01886781|565808240|FG000|Overall Study|Adverse Event|1|||
156743166|NCT01886781|565808241|FG001|Overall Study|Adverse Event|0|||
156743167|NCT01886781|565808240|FG000|Overall Study|Lost to Follow-up|5|||
156743168|NCT01886781|565808241|FG001|Overall Study|Lost to Follow-up|0|||
156743169|NCT01886781|565808240|FG000|Overall Study|Withdrawal by Subject|2|||
156743170|NCT01886781|565808241|FG001|Overall Study|Withdrawal by Subject|1|||
156743171|NCT01886781|565808240|FG000|Overall Study|Worsening of symptoms|1|||
156743172|NCT01886781|565808241|FG001|Overall Study|Worsening of symptoms|1|||
156743173|NCT01432275|565808243|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
156743174|NCT01432275|565808244|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
156743175|NCT01432275|565808243|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
156743176|NCT01432275|565808244|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
156743177|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
156743178|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
156743179|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
156743180|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
156743181|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
156743182|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
156743183|NCT01432275|565808243|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
156743184|NCT01432275|565808244|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
156743185|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
156743186|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
156743187|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
156743188|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
156743189|NCT01432275|565808243|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
157142889|NCT02517515|567271131|FG001|Overall Study|Adverse Event|1|||
156743190|NCT01432275|565808244|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
156743191|NCT01935700|565808249|FG000|Overall Study|Withdrawal by Subject|1|||
156743192|NCT01935700|565808250|FG001|Overall Study|Withdrawal by Subject|0|||
157142890|NCT02517515|567271130|FG000|Overall Study|Withdrew Consent|0|||
157142891|NCT02517515|567271131|FG001|Overall Study|Withdrew Consent|1|||
157142892|NCT02517515|567271130|FG000|Overall Study|Lost to Follow-up|1|||
157142893|NCT02517515|567271131|FG001|Overall Study|Lost to Follow-up|0|||
157142894|NCT02517515|567271130|FG000|Overall Study|Other|1|||
157142895|NCT02517515|567271131|FG001|Overall Study|Other|0|||
157142896|NCT06400238|567271134|FG000|Overall Study|Started Protocol Therapy|2|||
157142897|NCT06400238|567271134|FG000|Overall Study|Adverse Event|1|||
157142898|NCT06400238|567271134|FG000|Overall Study|Death|1|||
157142899|NCT06400238|567271134|FG000|Overall Study|Disease Progression|27|||
156743193|NCT01935700|565808249|FG000|Overall Study|Physician Decision|4|||
156743194|NCT01935700|565808250|FG001|Overall Study|Physician Decision|0|||
156743195|NCT01935128|565808251|FG000|Overall Study|Death|1|||
156743196|NCT01935128|565808251|FG000|Overall Study|Adverse Event|6|||
156743197|NCT01273155|565808253|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
156743198|NCT01273155|565808254|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
156743199|NCT01273155|565808255|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
156743200|NCT01273155|565808256|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
156743201|NCT01273155|565808257|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
156743202|NCT01273155|565808258|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
156743203|NCT01273155|565808259|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
156743204|NCT01273155|565808253|FG000|Overall Study|Change in liver function/no longer eval.|0|||
156743205|NCT01273155|565808254|FG001|Overall Study|Change in liver function/no longer eval.|1|||
156743206|NCT01273155|565808255|FG002|Overall Study|Change in liver function/no longer eval.|0|||
156743207|NCT01273155|565808256|FG003|Overall Study|Change in liver function/no longer eval.|0|||
156743208|NCT01273155|565808257|FG004|Overall Study|Change in liver function/no longer eval.|1|||
156743209|NCT01273155|565808258|FG005|Overall Study|Change in liver function/no longer eval.|0|||
156743210|NCT01273155|565808259|FG006|Overall Study|Change in liver function/no longer eval.|0|||
156743211|NCT01273155|565808253|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
156743212|NCT01273155|565808254|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
156743213|NCT01273155|565808255|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
156743214|NCT01273155|565808256|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
156743215|NCT01273155|565808257|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
156743216|NCT01273155|565808258|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
156743217|NCT01273155|565808259|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
156743218|NCT01273155|565808253|FG000|Overall Study|Died during Cycle 1|0|||
156743219|NCT01273155|565808254|FG001|Overall Study|Died during Cycle 1|0|||
156743220|NCT01273155|565808255|FG002|Overall Study|Died during Cycle 1|1|||
156743221|NCT01273155|565808256|FG003|Overall Study|Died during Cycle 1|1|||
156743222|NCT01273155|565808257|FG004|Overall Study|Died during Cycle 1|0|||
156743223|NCT01273155|565808258|FG005|Overall Study|Died during Cycle 1|2|||
156743224|NCT01273155|565808259|FG006|Overall Study|Died during Cycle 1|2|||
156743225|NCT01273155|565808253|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
156743226|NCT01273155|565808254|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
156743227|NCT01273155|565808255|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
156743228|NCT01273155|565808256|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
156743229|NCT01273155|565808257|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
156743230|NCT01273155|565808258|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
156743231|NCT01273155|565808259|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
156743232|NCT03887117|565808260|FG000|Overall Study|Discontinued prematurely|0|||
156743233|NCT03887117|565808261|FG001|Overall Study|Discontinued prematurely|1|||
156743234|NCT03887117|565808262|FG002|Overall Study|Discontinued prematurely|1|||
156743235|NCT03887117|565808263|FG003|Overall Study|Discontinued prematurely|2|||
156743236|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
156743237|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743238|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743239|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743240|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743241|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156743242|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
156743243|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743244|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743245|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743246|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156798402|NCT03847519|566015745|FG001|Overall Study|Death|8|||
156798403|NCT03847519|566015746|FG002|Overall Study|Death|1|||
157142900|NCT06400238|567271134|FG000|Overall Study|Withdrawal by Subject|2|||
156798404|NCT03847519|566015744|FG000|Overall Study|Lost to Follow-up|1|||
156798405|NCT03847519|566015745|FG001|Overall Study|Lost to Follow-up|2|||
157142901|NCT06400238|567271134|FG000|Overall Study|Physician Decision|2|||
157142902|NCT03839524|567271138|FG000|Overall Study|Adverse Event|1|||
157020573|NCT03763708|566828470|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157020574|NCT03763708|566828471|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157020575|NCT03763708|566828472|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157142903|NCT04419506|567271146|FG000|Overall Study|Adverse Event|0|||
157142904|NCT04419506|567271147|FG001|Overall Study|Adverse Event|10|||
157142905|NCT04419506|567271148|FG002|Overall Study|Adverse Event|0|||
157142906|NCT04419506|567271149|FG003|Overall Study|Adverse Event|3|||
157142907|NCT04419506|567271146|FG000|Overall Study|Withdrawal by Subject|0|||
157142908|NCT04419506|567271147|FG001|Overall Study|Withdrawal by Subject|0|||
157142909|NCT04419506|567271148|FG002|Overall Study|Withdrawal by Subject|0|||
157142910|NCT04419506|567271149|FG003|Overall Study|Withdrawal by Subject|1|||
157142911|NCT04419506|567271146|FG000|Overall Study|poor-compliance|0|||
157142912|NCT04419506|567271147|FG001|Overall Study|poor-compliance|0|||
157142913|NCT04419506|567271148|FG002|Overall Study|poor-compliance|0|||
157142914|NCT04419506|567271149|FG003|Overall Study|poor-compliance|1|||
156743247|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
156743248|NCT04908475|565808264|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
156743249|NCT04908475|565808265|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743250|NCT04908475|565808266|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743251|NCT04908475|565808267|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743252|NCT04908475|565808268|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743253|NCT04908475|565808269|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
156743254|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743255|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
156743256|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
156743257|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
156743258|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743259|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
156743260|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
156743261|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
156743262|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
156743263|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
156743264|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
156743265|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
156743266|NCT04908475|565808264|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
156743267|NCT04908475|565808265|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
156743268|NCT04908475|565808266|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
156743269|NCT04908475|565808267|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
156743270|NCT04908475|565808268|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
156743271|NCT04908475|565808269|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
156743272|NCT01739764|565808270|FG000|Overall Study|Adverse Event|0|||
156743273|NCT01739764|565808271|FG001|Overall Study|Adverse Event|3|||
156743274|NCT01739764|565808272|FG002|Overall Study|Adverse Event|4|||
156743275|NCT01739764|565808270|FG000|Overall Study|Death|4|||
156743276|NCT01739764|565808271|FG001|Overall Study|Death|6|||
156743277|NCT01739764|565808272|FG002|Overall Study|Death|38|||
156743278|NCT01739764|565808270|FG000|Overall Study|Lost to Follow-up|0|||
156743279|NCT01739764|565808271|FG001|Overall Study|Lost to Follow-up|0|||
156743280|NCT01739764|565808272|FG002|Overall Study|Lost to Follow-up|5|||
156743281|NCT01739764|565808270|FG000|Overall Study|Non-Compliance|0|||
156743282|NCT01739764|565808271|FG001|Overall Study|Non-Compliance|0|||
156743283|NCT01739764|565808272|FG002|Overall Study|Non-Compliance|1|||
156743284|NCT01739764|565808270|FG000|Overall Study|Multiple Reasons|3|||
156743285|NCT01739764|565808271|FG001|Overall Study|Multiple Reasons|2|||
156743286|NCT01739764|565808272|FG002|Overall Study|Multiple Reasons|3|||
156743287|NCT01739764|565808270|FG000|Overall Study|Physician Decision|2|||
156743288|NCT01739764|565808271|FG001|Overall Study|Physician Decision|2|||
156743289|NCT01739764|565808272|FG002|Overall Study|Physician Decision|4|||
156743290|NCT01739764|565808270|FG000|Overall Study|Progressive Disease|3|||
156743291|NCT01739764|565808271|FG001|Overall Study|Progressive Disease|5|||
156743292|NCT01739764|565808272|FG002|Overall Study|Progressive Disease|16|||
156743293|NCT01739764|565808270|FG000|Overall Study|Protocol Violation|0|||
156743294|NCT01739764|565808271|FG001|Overall Study|Protocol Violation|0|||
156743295|NCT01739764|565808272|FG002|Overall Study|Protocol Violation|2|||
157020576|NCT03763708|566828473|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
157020577|NCT03763708|566828465|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
157142915|NCT04329949|567271150|FG000|Overall Study|Death|36|||
157142916|NCT04329949|567271150|FG000|Overall Study|Withdrawal by Subject|4|||
156743296|NCT01739764|565808270|FG000|Overall Study|Study Terminated by Sponsor|8|||
156743297|NCT01739764|565808271|FG001|Overall Study|Study Terminated by Sponsor|13|||
157142917|NCT04329949|567271150|FG000|Overall Study|Termination of study by sponsor|3|||
156743298|NCT01739764|565808272|FG002|Overall Study|Study Terminated by Sponsor|26|||
156743299|NCT01739764|565808270|FG000|Overall Study|Withdrawal by Subject|6|||
156743300|NCT01739764|565808271|FG001|Overall Study|Withdrawal by Subject|5|||
156743301|NCT01739764|565808272|FG002|Overall Study|Withdrawal by Subject|27|||
156743302|NCT00404924|565808273|FG000|Overall Study|Adverse Event|75|||
156743303|NCT00404924|565808274|FG001|Overall Study|Adverse Event|16|||
156743304|NCT00404924|565808273|FG000|Overall Study|Condition under investigation worsened|475|||
156743305|NCT00404924|565808274|FG001|Overall Study|Condition under investigation worsened|264|||
156743306|NCT00404924|565808273|FG000|Overall Study|Lost to Follow-up|1|||
156743307|NCT00404924|565808274|FG001|Overall Study|Lost to Follow-up|1|||
156743308|NCT00404924|565808273|FG000|Overall Study|Withdrawal by Subject|26|||
156743309|NCT00404924|565808274|FG001|Overall Study|Withdrawal by Subject|13|||
156743310|NCT00404924|565808273|FG000|Overall Study|Other|25|||
156743311|NCT00404924|565808274|FG001|Overall Study|Other|11|||
156743312|NCT00404924|565808273|FG000|Overall Study|Randomised but not received treatment|1|||
156743313|NCT00404924|565808274|FG001|Overall Study|Randomised but not received treatment|1|||
156743314|NCT05087966|565808279|FG000|Overall Study|Lost to Follow-up|1|||
156743315|NCT05087966|565808279|FG000|Overall Study|Withdrawal by Subject|5|||
156743316|NCT01037127|565808282|FG000|Overall Study|Lost to Follow-up|2|||
156743317|NCT01037127|565808283|FG001|Overall Study|Lost to Follow-up|4|||
156743318|NCT01037127|565808282|FG000|Overall Study|Physician Decision|1|||
156743319|NCT01037127|565808283|FG001|Overall Study|Physician Decision|0|||
156743320|NCT01037127|565808282|FG000|Overall Study|Study Closed Terminated|2|||
156743321|NCT01037127|565808283|FG001|Overall Study|Study Closed Terminated|17|||
156743322|NCT04325698|565808290|FG000|Overall Study|Study Terminated By Sponsor|1|||
156743323|NCT04325698|565808291|FG001|Overall Study|Study Terminated By Sponsor|1|||
156743324|NCT04325698|565808290|FG000|Overall Study|Withdrawal by Subject|0|||
156743325|NCT04325698|565808291|FG001|Overall Study|Withdrawal by Subject|2|||
156743326|NCT02044874|565808292|FG000|Overall Study|Adverse Event|5|||
156743327|NCT02044874|565808293|FG001|Overall Study|Adverse Event|6|||
156743328|NCT02044874|565808294|FG002|Overall Study|Adverse Event|6|||
156743329|NCT02044874|565808292|FG000|Overall Study|Withdrawal by Subject|8|||
156743330|NCT02044874|565808293|FG001|Overall Study|Withdrawal by Subject|16|||
156743331|NCT02044874|565808294|FG002|Overall Study|Withdrawal by Subject|23|||
156743332|NCT02044874|565808292|FG000|Overall Study|Physician Decision|0|||
156743333|NCT02044874|565808293|FG001|Overall Study|Physician Decision|2|||
156798406|NCT03847519|566015746|FG002|Overall Study|Lost to Follow-up|0|||
156798407|NCT03847519|566015744|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798408|NCT03847519|566015745|FG001|Overall Study|Study Terminated by Sponsor|3|||
157142918|NCT00917384|567271153|FG000|Overall Study|Lost to Follow-up|4|||
157142919|NCT00917384|567271154|FG001|Overall Study|Lost to Follow-up|2|||
157142920|NCT00917384|567271153|FG000|Overall Study|Withdrawal by Subject|10|||
157142921|NCT00917384|567271154|FG001|Overall Study|Withdrawal by Subject|2|||
157142922|NCT03717922|567271157|FG000|Overall Study|Lost to Follow-up|2|||
156798409|NCT03847519|566015746|FG002|Overall Study|Study Terminated by Sponsor|2|||
156798410|NCT02095106|566015747|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156798411|NCT02095106|566015748|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156798412|NCT00806585|566015761|FG000|Overall Study|Study terminated by Sponsor|0|||
156798413|NCT00806585|566015762|FG001|Overall Study|Study terminated by Sponsor|0|||
156798414|NCT00806585|566015763|FG002|Overall Study|Study terminated by Sponsor|1|||
156798415|NCT00806585|566015764|FG003|Overall Study|Study terminated by Sponsor|2|||
156798416|NCT00806585|566015765|FG004|Overall Study|Study terminated by Sponsor|0|||
156798417|NCT00806585|566015761|FG000|Overall Study|Protocol Violation|3|||
156798418|NCT00806585|566015762|FG001|Overall Study|Protocol Violation|1|||
156798419|NCT00806585|566015763|FG002|Overall Study|Protocol Violation|2|||
156798420|NCT00806585|566015764|FG003|Overall Study|Protocol Violation|0|||
156798421|NCT00806585|566015765|FG004|Overall Study|Protocol Violation|0|||
156798422|NCT00806585|566015761|FG000|Overall Study|Physician Decision|0|||
156798423|NCT00806585|566015762|FG001|Overall Study|Physician Decision|2|||
156798424|NCT00806585|566015763|FG002|Overall Study|Physician Decision|3|||
156798425|NCT00806585|566015764|FG003|Overall Study|Physician Decision|0|||
156798426|NCT00806585|566015765|FG004|Overall Study|Physician Decision|1|||
156798427|NCT00806585|566015761|FG000|Overall Study|Lost to Follow-up|2|||
156798428|NCT00806585|566015762|FG001|Overall Study|Lost to Follow-up|1|||
156798429|NCT00806585|566015763|FG002|Overall Study|Lost to Follow-up|2|||
157142923|NCT03717922|567271158|FG001|Overall Study|Lost to Follow-up|2|||
157142924|NCT01458340|567271161|FG000|Overall Study|Adverse Event|5|||
156743334|NCT02044874|565808294|FG002|Overall Study|Physician Decision|1|||
156743335|NCT02044874|565808292|FG000|Overall Study|Lost to Follow-up|10|||
156798430|NCT00806585|566015764|FG003|Overall Study|Lost to Follow-up|2|||
157142925|NCT01458340|567271162|FG001|Overall Study|Adverse Event|4|||
156743336|NCT02044874|565808293|FG001|Overall Study|Lost to Follow-up|27|||
156743337|NCT02044874|565808294|FG002|Overall Study|Lost to Follow-up|21|||
156743338|NCT02044874|565808292|FG000|Overall Study|Sponsor Decision|0|||
156743339|NCT02044874|565808293|FG001|Overall Study|Sponsor Decision|1|||
156743340|NCT02044874|565808294|FG002|Overall Study|Sponsor Decision|1|||
156798431|NCT00806585|566015765|FG004|Overall Study|Lost to Follow-up|5|||
156798432|NCT00806585|566015761|FG000|Overall Study|Lack of Efficacy|1|||
156798433|NCT00806585|566015762|FG001|Overall Study|Lack of Efficacy|0|||
156798434|NCT00806585|566015763|FG002|Overall Study|Lack of Efficacy|0|||
157142926|NCT01458340|567271163|FG002|Overall Study|Adverse Event|2|||
156743341|NCT02044874|565808292|FG000|Overall Study|Other|7|||
156743342|NCT02044874|565808293|FG001|Overall Study|Other|3|||
156743343|NCT02044874|565808294|FG002|Overall Study|Other|8|||
156743344|NCT02889835|565808295|FG000|Overall Study|Lost to Follow-up|13|||
156743345|NCT02889835|565808296|FG001|Overall Study|Lost to Follow-up|13|||
156743346|NCT02889835|565808297|FG002|Overall Study|Lost to Follow-up|13|||
156743347|NCT02889835|565808295|FG000|Overall Study|Withdrawal by Subject|2|||
156743348|NCT02889835|565808296|FG001|Overall Study|Withdrawal by Subject|2|||
156743349|NCT02889835|565808297|FG002|Overall Study|Withdrawal by Subject|2|||
156743350|NCT02889835|565808295|FG000|Overall Study|Protocol Violation|1|||
156743351|NCT02889835|565808296|FG001|Overall Study|Protocol Violation|1|||
156743352|NCT02889835|565808297|FG002|Overall Study|Protocol Violation|1|||
156743353|NCT02889835|565808295|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
156743354|NCT02889835|565808296|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
156743355|NCT02889835|565808297|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
156743356|NCT02889835|565808295|FG000|Overall Study|Death|1|||
156743357|NCT02889835|565808296|FG001|Overall Study|Death|1|||
156743358|NCT02889835|565808297|FG002|Overall Study|Death|1|||
156743359|NCT01047332|565808300|FG000|Overall Study|SEMS Obstruction|11|||
156743360|NCT01047332|565808301|FG001|Overall Study|SEMS Obstruction|20|||
156743361|NCT01047332|565808300|FG000|Overall Study|Died Unobstructed|38|||
156743362|NCT01047332|565808301|FG001|Overall Study|Died Unobstructed|41|||
156743363|NCT01047332|565808300|FG000|Overall Study|Lost to Follow-up|8|||
156743364|NCT01047332|565808301|FG001|Overall Study|Lost to Follow-up|3|||
156743365|NCT00787917|565808302|FG000|Blinded Treatment|Adverse Event|1|||
156743366|NCT00787917|565808303|FG001|Blinded Treatment|Adverse Event|0|||
156743367|NCT00787917|565808302|FG000|Blinded Treatment|Lack of Efficacy|1|||
156743368|NCT00787917|565808303|FG001|Blinded Treatment|Lack of Efficacy|0|||
156743369|NCT00787917|565808302|FG000|Blinded Treatment|Administrative problems|3|||
156743370|NCT00787917|565808303|FG001|Blinded Treatment|Administrative problems|2|||
156743371|NCT00787917|565808302|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
156743372|NCT00787917|565808303|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
156743373|NCT00787917|565808302|FG000|Open Label|Administrative problems|3|||
156743374|NCT00787917|565808303|FG001|Open Label|Administrative problems|0|||
156743375|NCT03521817|565808304|FG000|Overall Study|Protocol Violation|0|||
156743376|NCT03521817|565808305|FG001|Overall Study|Protocol Violation|1|||
156743377|NCT00778102|565808307|FG000|Overall Study|Adverse Event|8|||
156743378|NCT00778102|565808308|FG001|Overall Study|Adverse Event|5|||
156743379|NCT00778102|565808307|FG000|Overall Study|Death|1|||
156743380|NCT00778102|565808308|FG001|Overall Study|Death|1|||
156743381|NCT00778102|565808307|FG000|Overall Study|Lost to Follow-up|1|||
156743382|NCT00778102|565808308|FG001|Overall Study|Lost to Follow-up|0|||
156743383|NCT00778102|565808307|FG000|Overall Study|Violation of Selection Criteria|1|||
156743384|NCT00778102|565808308|FG001|Overall Study|Violation of Selection Criteria|1|||
156743385|NCT00778102|565808307|FG000|Overall Study|Protocol Violation|0|||
156743386|NCT00778102|565808308|FG001|Overall Study|Protocol Violation|1|||
156743387|NCT00778102|565808307|FG000|Overall Study|Refused Treatment|2|||
156743388|NCT00778102|565808308|FG001|Overall Study|Refused Treatment|3|||
156743389|NCT00778102|565808307|FG000|Overall Study|Withdrawal by Subject|1|||
156743390|NCT00778102|565808308|FG001|Overall Study|Withdrawal by Subject|1|||
156743391|NCT00778102|565808307|FG000|Overall Study|Administrative Reason|7|||
156743392|NCT00778102|565808308|FG001|Overall Study|Administrative Reason|10|||
156743393|NCT01328548|565808309|FG000|Overall Study|Death|3|||
156743394|NCT01328548|565808310|FG001|Overall Study|Death|0|||
156743395|NCT01328548|565808309|FG000|Overall Study|Protocol Violation|1|||
156743396|NCT01328548|565808310|FG001|Overall Study|Protocol Violation|0|||
156743397|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
156743398|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
156743399|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
156743400|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
156743401|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
156743402|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
156743403|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
156743404|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
156743405|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
156798435|NCT00806585|566015764|FG003|Overall Study|Lack of Efficacy|0|||
156798436|NCT00806585|566015765|FG004|Overall Study|Lack of Efficacy|0|||
156798437|NCT00806585|566015761|FG000|Overall Study|Adverse Event|1|||
156798438|NCT00806585|566015762|FG001|Overall Study|Adverse Event|5|||
157142927|NCT01458340|567271161|FG000|Overall Study|Lost to Follow-up|3|||
156743406|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
156743407|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
156743408|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
156743409|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
156743410|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
156798439|NCT00806585|566015763|FG002|Overall Study|Adverse Event|3|||
156879015|NCT02152956|566316493|FG002|Overall Study|Adverse Event|0|||
156879016|NCT02152956|566316494|FG003|Overall Study|Adverse Event|0|||
156879017|NCT02152956|566316495|FG004|Overall Study|Adverse Event|0|||
156879018|NCT02152956|566316496|FG005|Overall Study|Adverse Event|0|||
156743411|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
156743412|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
156743413|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
156743414|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
156743415|NCT02294461|565808312|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
156743416|NCT02294461|565808313|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
156743417|NCT02294461|565808314|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
156743418|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
156743419|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
156743420|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
156743421|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
156743422|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
156743423|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
156743424|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
156743425|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
156743426|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
156743427|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
156743428|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
156743429|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
156743430|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
156743431|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
156743432|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
156743433|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
156798440|NCT00806585|566015764|FG003|Overall Study|Adverse Event|4|||
156798441|NCT00806585|566015765|FG004|Overall Study|Adverse Event|2|||
156798442|NCT00806585|566015761|FG000|Overall Study|Withdrawal by Subject|10|||
156798443|NCT00806585|566015762|FG001|Overall Study|Withdrawal by Subject|8|||
156798444|NCT00806585|566015763|FG002|Overall Study|Withdrawal by Subject|9|||
156798445|NCT00806585|566015764|FG003|Overall Study|Withdrawal by Subject|3|||
156798446|NCT00806585|566015765|FG004|Overall Study|Withdrawal by Subject|11|||
156798447|NCT00806585|566015761|FG000|Overall Study|Completion status unknown|15|||
156798448|NCT00806585|566015762|FG001|Overall Study|Completion status unknown|14|||
156798449|NCT00806585|566015763|FG002|Overall Study|Completion status unknown|12|||
156798450|NCT00806585|566015764|FG003|Overall Study|Completion status unknown|4|||
156798451|NCT00806585|566015765|FG004|Overall Study|Completion status unknown|12|||
156798452|NCT00023595|566015766|FG000|5 Year Follow up|Lost to Follow-up|2|||
156798453|NCT00023595|566015767|FG001|5 Year Follow up|Lost to Follow-up|2|||
156798454|NCT00023595|566015768|FG002|5 Year Follow up|Lost to Follow-up|1|||
156798455|NCT00023595|566015769|FG003|5 Year Follow up|Lost to Follow-up|7|||
156798456|NCT00023595|566015770|FG004|5 Year Follow up|Lost to Follow-up|3|||
156798457|NCT00023595|566015766|FG000|10 Year Follow up|Lost to Follow-up|12|||
156798458|NCT00023595|566015767|FG001|10 Year Follow up|Lost to Follow-up|10|||
156798459|NCT00023595|566015768|FG002|10 Year Follow up|Lost to Follow-up|3|||
156798460|NCT00023595|566015769|FG003|10 Year Follow up|Lost to Follow-up|0|||
156798461|NCT00023595|566015770|FG004|10 Year Follow up|Lost to Follow-up|0|||
156798462|NCT02284893|566015771|FG000|26 Week (Short Term)|Adverse Event|1|||
156798463|NCT02284893|566015772|FG001|26 Week (Short Term)|Adverse Event|9|||
156798464|NCT02284893|566015771|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
156798465|NCT02284893|566015772|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
156798466|NCT02284893|566015771|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
156798467|NCT02284893|566015772|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
156798468|NCT02284893|566015771|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
156798469|NCT02284893|566015772|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
156798470|NCT02284893|566015771|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
156798471|NCT02284893|566015772|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
156798472|NCT02284893|566015771|FG000|26 Week (Short Term)|Other|1|||
156798473|NCT02284893|566015772|FG001|26 Week (Short Term)|Other|1|||
156879019|NCT02152956|566316497|FG006|Overall Study|Adverse Event|0|||
156798474|NCT02284893|566015771|FG000|52 Week (Long Term)|Adverse Event|3|||
156798475|NCT02284893|566015772|FG001|52 Week (Long Term)|Adverse Event|1|||
156798476|NCT02284893|566015771|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
156798477|NCT02284893|566015772|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
156798478|NCT02284893|566015771|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
156798479|NCT02284893|566015772|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
156798480|NCT02284893|566015771|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
156879020|NCT02152956|566316498|FG007|Overall Study|Adverse Event|0|||
156879021|NCT02152956|566316499|FG008|Overall Study|Adverse Event|0|||
156879022|NCT02152956|566316500|FG009|Overall Study|Adverse Event|0|||
156879023|NCT02152956|566316501|FG010|Overall Study|Adverse Event|0|||
156879024|NCT02152956|566316502|FG011|Overall Study|Adverse Event|4|||
156879025|NCT02152956|566316503|FG012|Overall Study|Adverse Event|0|||
156879026|NCT02152956|566316491|FG000|Overall Study|Death|0|||
156879027|NCT02152956|566316492|FG001|Overall Study|Death|3|||
156879028|NCT02152956|566316493|FG002|Overall Study|Death|3|||
156879029|NCT02152956|566316494|FG003|Overall Study|Death|4|||
156879030|NCT02152956|566316495|FG004|Overall Study|Death|1|||
156879031|NCT02152956|566316496|FG005|Overall Study|Death|2|||
156879032|NCT02152956|566316497|FG006|Overall Study|Death|6|||
156879033|NCT02152956|566316498|FG007|Overall Study|Death|6|||
156879034|NCT02152956|566316499|FG008|Overall Study|Death|4|||
156879035|NCT02152956|566316500|FG009|Overall Study|Death|5|||
156879036|NCT02152956|566316501|FG010|Overall Study|Death|3|||
156879037|NCT02152956|566316502|FG011|Overall Study|Death|143|||
156879038|NCT02152956|566316503|FG012|Overall Study|Death|12|||
156879039|NCT02152956|566316491|FG000|Overall Study|Lost to Follow-up|0|||
156879040|NCT02152956|566316492|FG001|Overall Study|Lost to Follow-up|1|||
156879041|NCT02152956|566316493|FG002|Overall Study|Lost to Follow-up|0|||
156879042|NCT02152956|566316494|FG003|Overall Study|Lost to Follow-up|0|||
156879043|NCT02152956|566316495|FG004|Overall Study|Lost to Follow-up|0|||
156879044|NCT02152956|566316496|FG005|Overall Study|Lost to Follow-up|0|||
156879045|NCT02152956|566316497|FG006|Overall Study|Lost to Follow-up|0|||
156879046|NCT02152956|566316498|FG007|Overall Study|Lost to Follow-up|0|||
156879047|NCT02152956|566316499|FG008|Overall Study|Lost to Follow-up|0|||
156879048|NCT02152956|566316500|FG009|Overall Study|Lost to Follow-up|0|||
156879049|NCT02152956|566316501|FG010|Overall Study|Lost to Follow-up|0|||
156879050|NCT02152956|566316502|FG011|Overall Study|Lost to Follow-up|3|||
156879051|NCT02152956|566316503|FG012|Overall Study|Lost to Follow-up|0|||
156879052|NCT02152956|566316491|FG000|Overall Study|Withdrawal by Subject|1|||
156879053|NCT02152956|566316492|FG001|Overall Study|Withdrawal by Subject|0|||
156879054|NCT02152956|566316493|FG002|Overall Study|Withdrawal by Subject|1|||
156879055|NCT02152956|566316494|FG003|Overall Study|Withdrawal by Subject|0|||
156879056|NCT02152956|566316495|FG004|Overall Study|Withdrawal by Subject|2|||
156879057|NCT02152956|566316496|FG005|Overall Study|Withdrawal by Subject|2|||
156879058|NCT02152956|566316497|FG006|Overall Study|Withdrawal by Subject|0|||
156879059|NCT02152956|566316498|FG007|Overall Study|Withdrawal by Subject|0|||
156879060|NCT02152956|566316499|FG008|Overall Study|Withdrawal by Subject|1|||
156879061|NCT02152956|566316500|FG009|Overall Study|Withdrawal by Subject|0|||
156879062|NCT02152956|566316501|FG010|Overall Study|Withdrawal by Subject|0|||
156743434|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
156743435|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
156743436|NCT02294461|565808312|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
156879063|NCT02152956|566316502|FG011|Overall Study|Withdrawal by Subject|4|||
156879064|NCT02152956|566316503|FG012|Overall Study|Withdrawal by Subject|0|||
156879065|NCT02152956|566316491|FG000|Overall Study|Physician Decision|0|||
156743437|NCT02294461|565808313|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
156743438|NCT02294461|565808314|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
156743439|NCT00908596|565809812|FG000|Overall Study|Other reasons|46|||
156743440|NCT00908596|565809813|FG001|Overall Study|Other reasons|6|||
156743441|NCT00908596|565809814|FG002|Overall Study|Other reasons|2|||
156743442|NCT00908596|565809815|FG003|Overall Study|Other reasons|0|||
156743443|NCT00908596|565809812|FG000|Overall Study|Lost to Follow-up|0|||
156743444|NCT00908596|565809813|FG001|Overall Study|Lost to Follow-up|1|||
156743445|NCT00908596|565809814|FG002|Overall Study|Lost to Follow-up|12|||
156743446|NCT00908596|565809815|FG003|Overall Study|Lost to Follow-up|4|||
156743447|NCT00908596|565809812|FG000|Overall Study|Death|0|||
156743448|NCT00908596|565809813|FG001|Overall Study|Death|5|||
156879066|NCT02152956|566316492|FG001|Overall Study|Physician Decision|0|||
156879067|NCT02152956|566316493|FG002|Overall Study|Physician Decision|0|||
156879068|NCT02152956|566316494|FG003|Overall Study|Physician Decision|0|||
156879069|NCT02152956|566316495|FG004|Overall Study|Physician Decision|0|||
157142928|NCT01458340|567271162|FG001|Overall Study|Lost to Follow-up|3|||
157142929|NCT01458340|567271163|FG002|Overall Study|Lost to Follow-up|10|||
157142930|NCT01458340|567271161|FG000|Overall Study|Miscellaneous|0|||
157142931|NCT01458340|567271162|FG001|Overall Study|Miscellaneous|1|||
157142932|NCT01458340|567271163|FG002|Overall Study|Miscellaneous|0|||
157142933|NCT01458340|567271161|FG000|Overall Study|Physician Decision|1|||
156743449|NCT00908596|565809814|FG002|Overall Study|Death|57|||
156879070|NCT02152956|566316496|FG005|Overall Study|Physician Decision|0|||
156879071|NCT02152956|566316497|FG006|Overall Study|Physician Decision|0|||
156879072|NCT02152956|566316498|FG007|Overall Study|Physician Decision|0|||
156879073|NCT02152956|566316499|FG008|Overall Study|Physician Decision|0|||
156879074|NCT02152956|566316500|FG009|Overall Study|Physician Decision|0|||
156879075|NCT02152956|566316501|FG010|Overall Study|Physician Decision|0|||
156879076|NCT02152956|566316502|FG011|Overall Study|Physician Decision|1|||
156879077|NCT02152956|566316503|FG012|Overall Study|Physician Decision|0|||
156879078|NCT02152956|566316491|FG000|Overall Study|Study terminated by sponsor|0|||
156743450|NCT00908596|565809815|FG003|Overall Study|Death|32|||
156743451|NCT00908596|565809812|FG000|Overall Study|Protocol Violation|1|||
156743452|NCT00908596|565809813|FG001|Overall Study|Protocol Violation|0|||
156743453|NCT00908596|565809814|FG002|Overall Study|Protocol Violation|0|||
156743454|NCT00908596|565809815|FG003|Overall Study|Protocol Violation|0|||
156743455|NCT00908596|565809812|FG000|Overall Study|Withdrawal by Subject|0|||
156743456|NCT00908596|565809813|FG001|Overall Study|Withdrawal by Subject|1|||
156743457|NCT00908596|565809814|FG002|Overall Study|Withdrawal by Subject|3|||
156743458|NCT00908596|565809815|FG003|Overall Study|Withdrawal by Subject|1|||
156743459|NCT01556997|565809816|FG000|Overall Study|Adverse Event|10|||
156743460|NCT01556997|565809817|FG001|Overall Study|Adverse Event|12|||
156743461|NCT01556997|565809818|FG002|Overall Study|Adverse Event|12|||
156743462|NCT01556997|565809816|FG000|Overall Study|Lost to Follow-up|6|||
156743463|NCT01556997|565809817|FG001|Overall Study|Lost to Follow-up|6|||
156743464|NCT01556997|565809818|FG002|Overall Study|Lost to Follow-up|4|||
156743465|NCT01556997|565809816|FG000|Overall Study|Physician Decision|1|||
156743466|NCT01556997|565809817|FG001|Overall Study|Physician Decision|1|||
156743467|NCT01556997|565809818|FG002|Overall Study|Physician Decision|1|||
156743468|NCT01556997|565809816|FG000|Overall Study|Withdrawal by Subject|7|||
156743469|NCT01556997|565809817|FG001|Overall Study|Withdrawal by Subject|6|||
156743470|NCT01556997|565809818|FG002|Overall Study|Withdrawal by Subject|8|||
156743471|NCT01556997|565809816|FG000|Overall Study|Other|2|||
156743472|NCT01556997|565809817|FG001|Overall Study|Other|3|||
156743473|NCT01556997|565809818|FG002|Overall Study|Other|7|||
156743474|NCT00078949|565809822|FG000|Overall Study|No treated|4|||
156743475|NCT00078949|565809823|FG001|Overall Study|No treated|5|||
156743476|NCT00078949|565809824|FG002|Overall Study|No treated|3|||
156743477|NCT00078949|565809825|FG003|Overall Study|No treated|3|||
156798481|NCT02284893|566015772|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
156798482|NCT02284893|566015771|FG000|52 Week (Long Term)|Non-Compliance|2|||
156798483|NCT02284893|566015772|FG001|52 Week (Long Term)|Non-Compliance|3|||
156798484|NCT01983111|566015777|FG000|Overall Study|Withdrawal by Subject|8|||
156798485|NCT01983111|566015778|FG001|Overall Study|Withdrawal by Subject|6|||
156798486|NCT01983111|566015777|FG000|Overall Study|Adverse Event|4|||
156798487|NCT01983111|566015778|FG001|Overall Study|Adverse Event|0|||
156798488|NCT01983111|566015777|FG000|Overall Study|Protocol Violation|0|||
156798489|NCT01983111|566015778|FG001|Overall Study|Protocol Violation|1|||
156798490|NCT00855335|566015779|FG000|Overall Study|Lost to Follow-up|0|||
156798491|NCT00855335|566015780|FG001|Overall Study|Lost to Follow-up|0|||
156798492|NCT00855335|566015781|FG002|Overall Study|Lost to Follow-up|3|||
156798493|NCT00855335|566015782|FG003|Overall Study|Lost to Follow-up|1|||
156798494|NCT00855335|566015783|FG004|Overall Study|Lost to Follow-up|0|||
156798495|NCT00855335|566015779|FG000|Overall Study|Withdrawal by Subject|0|||
156798496|NCT00855335|566015780|FG001|Overall Study|Withdrawal by Subject|0|||
156798497|NCT00855335|566015781|FG002|Overall Study|Withdrawal by Subject|0|||
156798498|NCT00855335|566015782|FG003|Overall Study|Withdrawal by Subject|1|||
156798499|NCT00855335|566015783|FG004|Overall Study|Withdrawal by Subject|0|||
156798500|NCT00855335|566015779|FG000|Overall Study|Adverse Event|2|||
156798501|NCT00855335|566015780|FG001|Overall Study|Adverse Event|0|||
156798502|NCT00855335|566015781|FG002|Overall Study|Adverse Event|0|||
156798503|NCT00855335|566015782|FG003|Overall Study|Adverse Event|0|||
156798504|NCT00855335|566015783|FG004|Overall Study|Adverse Event|0|||
156798505|NCT00855335|566015779|FG000|Overall Study|Physician Decision|1|||
156798506|NCT00855335|566015780|FG001|Overall Study|Physician Decision|1|||
156798507|NCT00855335|566015781|FG002|Overall Study|Physician Decision|0|||
156798508|NCT00855335|566015782|FG003|Overall Study|Physician Decision|0|||
156743478|NCT00577005|565809826|FG000|Overall Study|Lost to Follow-up|3|||
156798509|NCT00855335|566015783|FG004|Overall Study|Physician Decision|0|||
156798510|NCT00855335|566015779|FG000|Overall Study|Other|2|||
156798511|NCT00855335|566015780|FG001|Overall Study|Other|1|||
156798512|NCT00855335|566015781|FG002|Overall Study|Other|2|||
156798513|NCT00855335|566015782|FG003|Overall Study|Other|5|||
156798514|NCT00855335|566015783|FG004|Overall Study|Other|1|||
156798515|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
156798516|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
156798517|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
156743479|NCT00577005|565809827|FG001|Overall Study|Lost to Follow-up|2|||
156743480|NCT00577005|565809826|FG000|Overall Study|Withdrawal by Subject|2|||
156743481|NCT00577005|565809827|FG001|Overall Study|Withdrawal by Subject|1|||
156743482|NCT02667626|565809828|FG000|Overall Study|Withdrawal by Subject|0|||
156743483|NCT02667626|565809829|FG001|Overall Study|Withdrawal by Subject|1|||
156798518|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
156798519|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
156798520|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
156798521|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
156743484|NCT02309723|565809830|FG000|Overall Study|Withdrawal by Subject|24|||
156798522|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
156879079|NCT02152956|566316492|FG001|Overall Study|Study terminated by sponsor|0|||
156743485|NCT02309723|565809831|FG001|Overall Study|Withdrawal by Subject|23|||
156798523|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
156743486|NCT02309723|565809832|FG002|Overall Study|Withdrawal by Subject|24|||
156743487|NCT02560623|565809833|FG000|Overall Study|Unable to swallow sponge|0|||
156743488|NCT02560623|565809834|FG001|Overall Study|Unable to swallow sponge|1|||
156743489|NCT02560623|565809835|FG002|Overall Study|Unable to swallow sponge|0|||
156743490|NCT02560623|565809836|FG003|Overall Study|Unable to swallow sponge|0|||
156743491|NCT02560623|565809833|FG000|Overall Study|Intervention prior to sponge administration|0|||
156743492|NCT02560623|565809834|FG001|Overall Study|Intervention prior to sponge administration|1|||
156743493|NCT02560623|565809835|FG002|Overall Study|Intervention prior to sponge administration|0|||
156743494|NCT02560623|565809836|FG003|Overall Study|Intervention prior to sponge administration|0|||
156743495|NCT01125813|565809837|FG000|Overall Study|Death|1|||
156743496|NCT01125813|565809837|FG000|Overall Study|Withdrawal by Subject|1|||
156743497|NCT01125813|565809837|FG000|Overall Study|Screen Failures|4|||
156743498|NCT02255552|565809840|FG000|Overall Study|Participants enrolled into another study|0|||
156743499|NCT02255552|565809841|FG001|Overall Study|Participants enrolled into another study|11|||
156743500|NCT02255552|565809840|FG000|Overall Study|Withdrawal by Subject|1|||
156743501|NCT02255552|565809841|FG001|Overall Study|Withdrawal by Subject|4|||
156743502|NCT01447446|565809842|FG000|Overall Study|Death|6|||
156743503|NCT01447446|565809843|FG001|Overall Study|Death|3|||
156743504|NCT01447446|565809844|FG002|Overall Study|Death|2|||
156743505|NCT01447446|565809845|FG003|Overall Study|Death|1|||
156743506|NCT01447446|565809846|FG004|Overall Study|Death|7|||
156743507|NCT01447446|565809847|FG005|Overall Study|Death|0|||
156743508|NCT01447446|565809842|FG000|Overall Study|Adverse Event|3|||
156743509|NCT01447446|565809843|FG001|Overall Study|Adverse Event|0|||
156743510|NCT01447446|565809844|FG002|Overall Study|Adverse Event|1|||
156743511|NCT01447446|565809845|FG003|Overall Study|Adverse Event|0|||
156743512|NCT01447446|565809846|FG004|Overall Study|Adverse Event|2|||
156743513|NCT01447446|565809847|FG005|Overall Study|Adverse Event|0|||
156798524|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
156798525|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798526|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798527|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798528|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798529|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798530|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798531|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798532|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
156798533|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798534|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
156798535|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798536|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798537|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798538|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798539|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798540|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
156798541|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798542|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798543|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798544|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
156798545|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798546|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798547|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798548|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798549|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798550|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798551|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
156798552|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
156798553|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
156798554|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
156798555|NCT02082977|566015786|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798556|NCT02082977|566015787|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798557|NCT02082977|566015788|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798558|NCT02082977|566015789|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798559|NCT02082977|566015790|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798560|NCT02082977|566015791|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
157142934|NCT01458340|567271162|FG001|Overall Study|Physician Decision|1|||
156743514|NCT01447446|565809842|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
156798561|NCT02082977|566015792|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156743515|NCT01447446|565809843|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
156743516|NCT01447446|565809844|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
156798562|NCT02082977|566015793|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
156798563|NCT02082977|566015794|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
157142935|NCT01458340|567271163|FG002|Overall Study|Physician Decision|2|||
156743517|NCT01447446|565809845|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
157020578|NCT03763708|566828466|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156743518|NCT01447446|565809846|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
156743519|NCT01447446|565809847|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
156743520|NCT01447446|565809842|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
156743521|NCT01447446|565809843|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
156743522|NCT01447446|565809844|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
156743523|NCT01447446|565809845|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
156743524|NCT01447446|565809846|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
156743525|NCT01447446|565809847|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
156743526|NCT01447446|565809842|FG000|Overall Study|Administrative/Other|34|||
156743527|NCT01447446|565809843|FG001|Overall Study|Administrative/Other|9|||
156743528|NCT01447446|565809844|FG002|Overall Study|Administrative/Other|10|||
156743529|NCT01447446|565809845|FG003|Overall Study|Administrative/Other|2|||
156743530|NCT01447446|565809846|FG004|Overall Study|Administrative/Other|33|||
156743531|NCT01447446|565809847|FG005|Overall Study|Administrative/Other|4|||
156743532|NCT01447446|565809842|FG000|Overall Study|SVR12 Assessment|13|||
156743533|NCT01447446|565809843|FG001|Overall Study|SVR12 Assessment|1|||
156743534|NCT01447446|565809844|FG002|Overall Study|SVR12 Assessment|2|||
156743535|NCT01447446|565809845|FG003|Overall Study|SVR12 Assessment|1|||
156743536|NCT01447446|565809846|FG004|Overall Study|SVR12 Assessment|5|||
156743537|NCT01447446|565809847|FG005|Overall Study|SVR12 Assessment|5|||
156743538|NCT01447446|565809842|FG000|Overall Study|New Treatment Started|8|||
156743539|NCT01447446|565809843|FG001|Overall Study|New Treatment Started|2|||
156743540|NCT01447446|565809844|FG002|Overall Study|New Treatment Started|1|||
156743541|NCT01447446|565809845|FG003|Overall Study|New Treatment Started|0|||
156743542|NCT01447446|565809846|FG004|Overall Study|New Treatment Started|2|||
156743543|NCT01447446|565809847|FG005|Overall Study|New Treatment Started|0|||
156743544|NCT01447446|565809842|FG000|Overall Study|Reason not Specified|1|||
156743545|NCT01447446|565809843|FG001|Overall Study|Reason not Specified|1|||
156743546|NCT01447446|565809844|FG002|Overall Study|Reason not Specified|1|||
156743547|NCT01447446|565809845|FG003|Overall Study|Reason not Specified|1|||
156743548|NCT01447446|565809846|FG004|Overall Study|Reason not Specified|1|||
156743549|NCT01447446|565809847|FG005|Overall Study|Reason not Specified|0|||
156743550|NCT04829331|565809850|FG000|Overall Study|Lost to Follow-up|1|||
156743551|NCT04829331|565809851|FG001|Overall Study|Lost to Follow-up|0|||
156743552|NCT05323994|565809852|FG000|Overall Study|Protocol Violation|1|||
156743553|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
156743554|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743555|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743556|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743557|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
156743558|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Death|0|||
156743559|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Death|1|||
156743560|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Death|0|||
156743561|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Death|0|||
156743562|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Death|0|||
156743563|NCT00454818|565809856|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156743564|NCT00454818|565809857|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156798564|NCT02082977|566015795|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
156798565|NCT02106832|566015796|FG000|Overall Study|Adverse Event|1|||
156798566|NCT02106832|566015797|FG001|Overall Study|Adverse Event|2|||
156798567|NCT02106832|566015798|FG002|Overall Study|Adverse Event|3|||
156798568|NCT02106832|566015799|FG003|Overall Study|Adverse Event|0|||
156798569|NCT02106832|566015796|FG000|Overall Study|Death|4|||
156798570|NCT02106832|566015797|FG001|Overall Study|Death|4|||
156798571|NCT02106832|566015798|FG002|Overall Study|Death|1|||
156798572|NCT02106832|566015799|FG003|Overall Study|Death|4|||
156798573|NCT02106832|566015796|FG000|Overall Study|Deterioration of general conditions|0|||
156798574|NCT02106832|566015797|FG001|Overall Study|Deterioration of general conditions|0|||
156798575|NCT02106832|566015798|FG002|Overall Study|Deterioration of general conditions|1|||
156798576|NCT02106832|566015799|FG003|Overall Study|Deterioration of general conditions|0|||
156798577|NCT02106832|566015796|FG000|Overall Study|Lost to Follow-up|0|||
156798578|NCT02106832|566015797|FG001|Overall Study|Lost to Follow-up|1|||
156798579|NCT02106832|566015798|FG002|Overall Study|Lost to Follow-up|1|||
156798580|NCT02106832|566015799|FG003|Overall Study|Lost to Follow-up|3|||
156798581|NCT02106832|566015796|FG000|Overall Study|Physician Decision|1|||
157218762|NCT03255031|567547509|FG000|Overall Study|Adverse Event|5|||
156743565|NCT00454818|565809858|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
156743566|NCT00454818|565809859|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
156798582|NCT02106832|566015797|FG001|Overall Study|Physician Decision|0|||
156798583|NCT02106832|566015798|FG002|Overall Study|Physician Decision|0|||
156798584|NCT02106832|566015799|FG003|Overall Study|Physician Decision|0|||
157020579|NCT03763708|566828467|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
157020580|NCT03763708|566828468|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
157218763|NCT03255031|567547510|FG001|Overall Study|Adverse Event|3|||
157218764|NCT03255031|567547509|FG000|Overall Study|Physician Decision|2|||
157218765|NCT03255031|567547510|FG001|Overall Study|Physician Decision|1|||
157218766|NCT03255031|567547509|FG000|Overall Study|Withdrawal by Subject|9|||
157218767|NCT03255031|567547510|FG001|Overall Study|Withdrawal by Subject|3|||
156798585|NCT02106832|566015796|FG000|Overall Study|Protocol Violation|0|||
156798586|NCT02106832|566015797|FG001|Overall Study|Protocol Violation|0|||
156798587|NCT02106832|566015798|FG002|Overall Study|Protocol Violation|0|||
156798588|NCT02106832|566015799|FG003|Overall Study|Protocol Violation|1|||
156798589|NCT02106832|566015796|FG000|Overall Study|Withdrawal by Subject|17|||
156798590|NCT02106832|566015797|FG001|Overall Study|Withdrawal by Subject|17|||
156798591|NCT02106832|566015798|FG002|Overall Study|Withdrawal by Subject|10|||
156798592|NCT02106832|566015799|FG003|Overall Study|Withdrawal by Subject|7|||
156798593|NCT02106832|566015796|FG000|Overall Study|Technical problems|0|||
156798594|NCT02106832|566015797|FG001|Overall Study|Technical problems|1|||
156798595|NCT02106832|566015798|FG002|Overall Study|Technical problems|0|||
156798596|NCT02106832|566015799|FG003|Overall Study|Technical problems|0|||
156798597|NCT00619866|566015816|FG000|Weeks 1 - 12|Adverse Event|0|||
156798598|NCT00619866|566015817|FG001|Weeks 1 - 12|Adverse Event|1|||
156798599|NCT00619866|566015818|FG002|Weeks 1 - 12|Adverse Event|2|||
156798600|NCT00619866|566015819|FG003|Weeks 1 - 12|Adverse Event|0|||
156798601|NCT00619866|566015820|FG004|Weeks 1 - 12|Adverse Event|0|||
156798602|NCT00619866|566015816|FG000|Weeks 1 - 12|Non-compliance|0|||
156798603|NCT00619866|566015817|FG001|Weeks 1 - 12|Non-compliance|0|||
156798604|NCT00619866|566015818|FG002|Weeks 1 - 12|Non-compliance|1|||
156798605|NCT00619866|566015819|FG003|Weeks 1 - 12|Non-compliance|0|||
156798606|NCT00619866|566015820|FG004|Weeks 1 - 12|Non-compliance|0|||
156798607|NCT00619866|566015816|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
156798608|NCT00619866|566015817|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
156798609|NCT00619866|566015818|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
156798610|NCT00619866|566015819|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
156798611|NCT00619866|566015820|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
156798612|NCT00619866|566015816|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
156798613|NCT00619866|566015817|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
156798614|NCT00619866|566015818|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
156798615|NCT00619866|566015819|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
156798616|NCT00619866|566015820|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
156798617|NCT00619866|566015816|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
156798618|NCT00619866|566015817|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
156798619|NCT00619866|566015818|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
156798620|NCT00619866|566015819|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
156798621|NCT00619866|566015820|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
156798622|NCT00619866|566015816|FG000|Weeks 1 - 12|Sponsor Decision|0|||
156798623|NCT00619866|566015817|FG001|Weeks 1 - 12|Sponsor Decision|1|||
156798624|NCT00619866|566015818|FG002|Weeks 1 - 12|Sponsor Decision|0|||
156798625|NCT00619866|566015819|FG003|Weeks 1 - 12|Sponsor Decision|0|||
156798626|NCT00619866|566015820|FG004|Weeks 1 - 12|Sponsor Decision|0|||
156798627|NCT00619866|566015816|FG000|Weeks 13 - 24|Adverse Event|0|||
156798628|NCT00619866|566015817|FG001|Weeks 13 - 24|Adverse Event|0|||
156798629|NCT00619866|566015818|FG002|Weeks 13 - 24|Adverse Event|2|||
156798630|NCT00619866|566015819|FG003|Weeks 13 - 24|Adverse Event|1|||
156798631|NCT00619866|566015820|FG004|Weeks 13 - 24|Adverse Event|0|||
156798632|NCT00619866|566015816|FG000|Weeks 13 - 24|Protocol Deviation|0|||
156798633|NCT00619866|566015817|FG001|Weeks 13 - 24|Protocol Deviation|0|||
156798634|NCT00619866|566015818|FG002|Weeks 13 - 24|Protocol Deviation|0|||
156798635|NCT00619866|566015819|FG003|Weeks 13 - 24|Protocol Deviation|1|||
156798636|NCT00619866|566015820|FG004|Weeks 13 - 24|Protocol Deviation|0|||
156798637|NCT00619866|566015816|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
156798638|NCT00619866|566015817|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
156798639|NCT00619866|566015818|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
156798640|NCT00619866|566015819|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
156798641|NCT00619866|566015820|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
156798642|NCT00619866|566015816|FG000|Weeks 13 - 24|Non-compliance|0|||
156798643|NCT00619866|566015817|FG001|Weeks 13 - 24|Non-compliance|1|||
156798644|NCT00619866|566015818|FG002|Weeks 13 - 24|Non-compliance|1|||
156798645|NCT00619866|566015819|FG003|Weeks 13 - 24|Non-compliance|0|||
156798646|NCT00619866|566015820|FG004|Weeks 13 - 24|Non-compliance|0|||
156798647|NCT00619866|566015816|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
156798648|NCT00619866|566015817|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
156798649|NCT00619866|566015818|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
156798650|NCT00619866|566015819|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
156798651|NCT00619866|566015820|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
156798652|NCT02520154|566015833|FG000|Overall Study|Death|1|||
156798653|NCT02520154|566015833|FG000|Overall Study|Withdrawal by Subject|2|||
156798654|NCT02520154|566015833|FG000|Overall Study|Physician Decision|2|||
156743567|NCT00454818|565809860|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
156743568|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743569|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
156743570|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743571|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
156743572|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
156743573|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Death|0|||
156743574|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Death|1|||
156743575|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Death|0|||
156743576|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Death|0|||
156743577|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Death|1|||
156743578|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743579|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743580|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
156743581|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
156743582|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
156743583|NCT00454818|565809856|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743584|NCT00454818|565809857|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743585|NCT00454818|565809858|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
156743586|NCT00454818|565809859|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
156743587|NCT00454818|565809860|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
156743588|NCT03181503|565809861|FG000|Overall Study|Adverse Event|2|||
156743589|NCT03181503|565809862|FG001|Overall Study|Adverse Event|2|||
156743590|NCT03181503|565809861|FG000|Overall Study|Protocol Violation|1|||
156743591|NCT03181503|565809862|FG001|Overall Study|Protocol Violation|0|||
156743592|NCT03181503|565809861|FG000|Overall Study|Withdrawal by Subject|3|||
156743593|NCT03181503|565809862|FG001|Overall Study|Withdrawal by Subject|0|||
156743594|NCT03181503|565809861|FG000|Overall Study|Lost to Follow-up|1|||
156743595|NCT03181503|565809862|FG001|Overall Study|Lost to Follow-up|1|||
156743596|NCT03435224|565809866|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
156743597|NCT03077659|565809869|FG000|Overall Study|Withdrawal by Subject|0|||
156743598|NCT03077659|565809870|FG001|Overall Study|Withdrawal by Subject|0|||
156743599|NCT03077659|565809871|FG002|Overall Study|Withdrawal by Subject|1|||
156743600|NCT02258542|565809878|FG000|Overall Study|eg. not made to the visit|7|||
156743601|NCT02258542|565809879|FG001|Overall Study|eg. not made to the visit|4|||
156743602|NCT02258542|565809880|FG002|Overall Study|eg. not made to the visit|0|||
156743603|NCT02258542|565809881|FG003|Overall Study|eg. not made to the visit|1|||
156743604|NCT02258542|565809878|FG000|Overall Study|study specific discount. criteria|1|||
156743605|NCT02258542|565809879|FG001|Overall Study|study specific discount. criteria|1|||
156743606|NCT02258542|565809880|FG002|Overall Study|study specific discount. criteria|0|||
156743607|NCT02258542|565809881|FG003|Overall Study|study specific discount. criteria|0|||
156743608|NCT02258542|565809878|FG000|Overall Study|Withdrawal by Subject|20|||
156743609|NCT02258542|565809879|FG001|Overall Study|Withdrawal by Subject|20|||
156743610|NCT02258542|565809880|FG002|Overall Study|Withdrawal by Subject|7|||
156743611|NCT02258542|565809881|FG003|Overall Study|Withdrawal by Subject|1|||
156743612|NCT02258542|565809878|FG000|Overall Study|Lost to Follow-up|5|||
156743613|NCT02258542|565809879|FG001|Overall Study|Lost to Follow-up|12|||
156743614|NCT02258542|565809880|FG002|Overall Study|Lost to Follow-up|1|||
156743615|NCT02258542|565809881|FG003|Overall Study|Lost to Follow-up|2|||
156743616|NCT02258542|565809878|FG000|Overall Study|Death|5|||
156743617|NCT02258542|565809879|FG001|Overall Study|Death|4|||
156743618|NCT02258542|565809880|FG002|Overall Study|Death|0|||
156798655|NCT06022107|566015834|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
156743619|NCT02258542|565809881|FG003|Overall Study|Death|1|||
156743620|NCT02258542|565809878|FG000|Overall Study|Adverse Event|3|||
156743621|NCT02258542|565809879|FG001|Overall Study|Adverse Event|4|||
156743622|NCT02258542|565809880|FG002|Overall Study|Adverse Event|0|||
156743623|NCT02258542|565809881|FG003|Overall Study|Adverse Event|0|||
156743624|NCT02258542|565809878|FG000|Overall Study|Protocol Violation|1|||
156743625|NCT02258542|565809879|FG001|Overall Study|Protocol Violation|2|||
156798656|NCT06022107|566015834|FG000|Overall Study|Dropped out of study for higher level of care|1|||
156798657|NCT06022107|566015834|FG000|Overall Study|Lost to Follow-up|2|||
156798658|NCT05943990|566015835|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798659|NCT05943990|566015836|FG001|Overall Study|Study Terminated by Sponsor|0|||
156798660|NCT05943990|566015837|FG002|Overall Study|Study Terminated by Sponsor|1|||
156798661|NCT02038647|566017164|FG000|Overall Study|Progressive Disease|50|||
156743626|NCT02258542|565809880|FG002|Overall Study|Protocol Violation|0|||
156743627|NCT02258542|565809881|FG003|Overall Study|Protocol Violation|0|||
156743628|NCT02258542|565809878|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156743629|NCT02258542|565809879|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
156743630|NCT02258542|565809880|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156743631|NCT02258542|565809881|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
156743632|NCT01032070|565809882|FG000|Overall Study|Disease progression|13|||
156743633|NCT01032070|565809883|FG001|Overall Study|Disease progression|8|||
156743634|NCT01032070|565809882|FG000|Overall Study|Medical or ethical reasons|0|||
156743635|NCT01032070|565809883|FG001|Overall Study|Medical or ethical reasons|2|||
156743636|NCT01032070|565809882|FG000|Overall Study|Withdrawal by Subject|0|||
156743637|NCT01032070|565809883|FG001|Overall Study|Withdrawal by Subject|2|||
156743638|NCT02554318|565809884|FG000|Overall Study|Withdrawal by Subject|10|||
156743639|NCT02554318|565809885|FG001|Overall Study|Withdrawal by Subject|8|||
156743640|NCT02332239|565809888|FG000|Overall Study|Lost to Follow-up|4|||
156743641|NCT02332239|565809889|FG001|Overall Study|Lost to Follow-up|6|||
156743642|NCT00894790|565809890|FG000|Overall Study|Protocol Violation|0|||
156743643|NCT00894790|565809891|FG001|Overall Study|Protocol Violation|1|||
156743644|NCT00894790|565809890|FG000|Overall Study|Lost to Follow-up|0|||
156743645|NCT00894790|565809891|FG001|Overall Study|Lost to Follow-up|1|||
156743646|NCT00894790|565809890|FG000|Overall Study|Did not meet entrance criteria|1|||
156743647|NCT00894790|565809891|FG001|Overall Study|Did not meet entrance criteria|0|||
156743648|NCT01472965|565809892|FG000|Overall Study|Withdrawal by Subject|1|||
156743649|NCT01472965|565809893|FG001|Overall Study|Withdrawal by Subject|0|||
156743650|NCT00980018|565809897|FG000|Overall Study|Adverse Event|8|||
156743651|NCT00980018|565809897|FG000|Overall Study|Patient withdrew consent|3|||
156798662|NCT02038647|566017165|FG001|Overall Study|Progressive Disease|59|||
156798663|NCT02038647|566017164|FG000|Overall Study|Adverse Event|18|||
156798664|NCT02038647|566017165|FG001|Overall Study|Adverse Event|10|||
156798665|NCT02038647|566017164|FG000|Overall Study|Symptomatic Deterioration|7|||
156798666|NCT02038647|566017165|FG001|Overall Study|Symptomatic Deterioration|7|||
156798667|NCT02038647|566017164|FG000|Overall Study|Withdrawal by Subject|5|||
156798668|NCT02038647|566017165|FG001|Overall Study|Withdrawal by Subject|2|||
156798669|NCT02038647|566017164|FG000|Overall Study|Not Reported|0|||
156798670|NCT02038647|566017165|FG001|Overall Study|Not Reported|1|||
156798671|NCT02038647|566017164|FG000|Overall Study|Ongoing at Datacut|9|||
156798672|NCT02038647|566017165|FG001|Overall Study|Ongoing at Datacut|10|||
156798673|NCT04462471|566017166|FG000|Overall Study|Adverse Event|0|||
156798674|NCT04462471|566017167|FG001|Overall Study|Adverse Event|1|||
156798675|NCT04462471|566017168|FG002|Overall Study|Adverse Event|0|||
156798676|NCT04462471|566017169|FG003|Overall Study|Adverse Event|0|||
156798677|NCT04462471|566017166|FG000|Overall Study|Disease progression|1|||
156798678|NCT04462471|566017167|FG001|Overall Study|Disease progression|0|||
156798679|NCT04462471|566017168|FG002|Overall Study|Disease progression|0|||
156798680|NCT04462471|566017169|FG003|Overall Study|Disease progression|0|||
156798681|NCT02526290|566017170|FG000|Overall Study|Adverse Event|3|||
156798682|NCT02526290|566017170|FG000|Overall Study|Withdrawal by Subject|4|||
156798683|NCT02526290|566017170|FG000|Overall Study|Physician Decision|1|||
156798684|NCT02706392|566017176|FG000|Overall Study|Death|1|||
156798685|NCT02706392|566017177|FG001|Overall Study|Death|0|||
156798686|NCT02706392|566017178|FG002|Overall Study|Death|2|||
156798687|NCT02706392|566017179|FG003|Overall Study|Death|2|||
156798688|NCT02706392|566017180|FG004|Overall Study|Death|5|||
156798689|NCT02706392|566017181|FG005|Overall Study|Death|2|||
156798690|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798691|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798692|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
156798693|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
156798694|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
156798695|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
156798696|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
156798697|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798698|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798699|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
156798700|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798701|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
156798702|NCT00265122|566017183|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
156798703|NCT00265122|566017184|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
156798704|NCT00265122|566017185|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
156798705|NCT00265122|566017186|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
156798706|NCT00265122|566017187|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
157142936|NCT01458340|567271161|FG000|Overall Study|Protocol Violation|6|||
156743652|NCT00980018|565809897|FG000|Overall Study|Lost to Follow-up|1|||
156798707|NCT00265122|566017188|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
156798708|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
156798709|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
156798710|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
156743653|NCT00551161|565809898|FG000|Overall Study|Withdrawal by Subject|1|||
156743654|NCT01256385|565809899|FG000|Overall Study|Physician Decision|1|||
156743655|NCT01256385|565809900|FG001|Overall Study|Physician Decision|1|||
156743656|NCT01256385|565809899|FG000|Overall Study|Withdrawal by Subject|2|||
156743657|NCT01256385|565809900|FG001|Overall Study|Withdrawal by Subject|2|||
156743658|NCT00926536|565809901|FG000|Overall Study|Physician Decision|1|||
156743659|NCT00926536|565809902|FG001|Overall Study|Physician Decision|2|||
156743660|NCT03301844|565809903|FG000|Overall Study|suspected colon cancer|1|||
156743661|NCT03301844|565809904|FG001|Overall Study|suspected colon cancer|1|||
156743662|NCT01267201|565809905|FG000|First Intervention Period|Withdrawal by Subject|1|||
156743663|NCT01267201|565809906|FG001|First Intervention Period|Withdrawal by Subject|0|||
156743664|NCT01267201|565809907|FG002|First Intervention Period|Withdrawal by Subject|0|||
156743665|NCT01267201|565809908|FG003|First Intervention Period|Withdrawal by Subject|0|||
156743666|NCT01267201|565809909|FG004|First Intervention Period|Withdrawal by Subject|0|||
156743667|NCT01267201|565809910|FG005|First Intervention Period|Withdrawal by Subject|0|||
156743668|NCT01267201|565809905|FG000|Second Intervention Period|Withdrawal by Subject|0|||
156743669|NCT01267201|565809906|FG001|Second Intervention Period|Withdrawal by Subject|1|||
156743670|NCT01267201|565809907|FG002|Second Intervention Period|Withdrawal by Subject|0|||
156743671|NCT01267201|565809908|FG003|Second Intervention Period|Withdrawal by Subject|0|||
156743672|NCT01267201|565809909|FG004|Second Intervention Period|Withdrawal by Subject|0|||
156743673|NCT01267201|565809910|FG005|Second Intervention Period|Withdrawal by Subject|0|||
156743674|NCT00483704|565809911|FG000|Randomization|Withdrawal by Subject|19|||
156743675|NCT00483704|565809912|FG001|Randomization|Withdrawal by Subject|28|||
156743676|NCT00483704|565809913|FG002|Randomization|Withdrawal by Subject|18|||
156743677|NCT00483704|565809911|FG000|Randomization|Protocol Violation|14|||
156743678|NCT00483704|565809912|FG001|Randomization|Protocol Violation|25|||
156743679|NCT00483704|565809913|FG002|Randomization|Protocol Violation|22|||
156743680|NCT00483704|565809911|FG000|Randomization|Lost to Follow-up|14|||
156743681|NCT00483704|565809912|FG001|Randomization|Lost to Follow-up|14|||
156743682|NCT00483704|565809913|FG002|Randomization|Lost to Follow-up|19|||
156743683|NCT00483704|565809911|FG000|Randomization|Pregnancy|1|||
156743684|NCT00483704|565809912|FG001|Randomization|Pregnancy|0|||
156743685|NCT00483704|565809913|FG002|Randomization|Pregnancy|0|||
156743686|NCT00483704|565809911|FG000|Randomization|Physician Decision|2|||
156743687|NCT00483704|565809912|FG001|Randomization|Physician Decision|4|||
156743688|NCT00483704|565809913|FG002|Randomization|Physician Decision|0|||
156743689|NCT00483704|565809911|FG000|Randomization|Progressive disease|0|||
156743690|NCT00483704|565809912|FG001|Randomization|Progressive disease|0|||
156743691|NCT00483704|565809913|FG002|Randomization|Progressive disease|1|||
156743692|NCT00483704|565809911|FG000|Randomization|Lack of qualifying migraines|21|||
156743693|NCT00483704|565809912|FG001|Randomization|Lack of qualifying migraines|25|||
156743694|NCT00483704|565809913|FG002|Randomization|Lack of qualifying migraines|31|||
156743695|NCT00483704|565809911|FG000|Treatment|Lack of qualifying migraines|101|||
156743696|NCT00483704|565809912|FG001|Treatment|Lack of qualifying migraines|99|||
156743697|NCT00483704|565809913|FG002|Treatment|Lack of qualifying migraines|116|||
156743698|NCT00483704|565809911|FG000|Treatment|Adverse Event|3|||
156743699|NCT00483704|565809912|FG001|Treatment|Adverse Event|5|||
156743700|NCT00483704|565809913|FG002|Treatment|Adverse Event|4|||
156743701|NCT00483704|565809911|FG000|Treatment|Withdrawal by Subject|16|||
156743702|NCT00483704|565809912|FG001|Treatment|Withdrawal by Subject|12|||
156743703|NCT00483704|565809913|FG002|Treatment|Withdrawal by Subject|21|||
156743704|NCT00483704|565809911|FG000|Treatment|Protocol Violation|6|||
156743705|NCT00483704|565809912|FG001|Treatment|Protocol Violation|3|||
156743706|NCT00483704|565809913|FG002|Treatment|Protocol Violation|5|||
156743707|NCT00483704|565809911|FG000|Treatment|Lost to Follow-up|2|||
156743708|NCT00483704|565809912|FG001|Treatment|Lost to Follow-up|7|||
156743709|NCT00483704|565809913|FG002|Treatment|Lost to Follow-up|5|||
156743710|NCT00483704|565809911|FG000|Treatment|Lack of Efficacy|1|||
156743711|NCT00483704|565809912|FG001|Treatment|Lack of Efficacy|1|||
156743712|NCT00483704|565809913|FG002|Treatment|Lack of Efficacy|1|||
156743713|NCT00483704|565809911|FG000|Treatment|Pregnancy|0|||
156743714|NCT00483704|565809912|FG001|Treatment|Pregnancy|1|||
156743715|NCT00483704|565809913|FG002|Treatment|Pregnancy|0|||
156743716|NCT00483704|565809911|FG000|Treatment|Physician Decision|0|||
156743717|NCT00483704|565809912|FG001|Treatment|Physician Decision|1|||
156743718|NCT00483704|565809913|FG002|Treatment|Physician Decision|4|||
156798711|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
157020581|NCT03763708|566828469|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156743719|NCT00819780|565809914|FG000|Overall Study|Did not receive study drug|3|||
156743720|NCT00819780|565809915|FG001|Overall Study|Did not receive study drug|4|||
156743721|NCT00819780|565809914|FG000|Overall Study|Still in treatment|25|||
156743722|NCT00819780|565809915|FG001|Overall Study|Still in treatment|17|||
156743723|NCT02637713|565809917|FG000|Overall Study|Screen Failure|2|||
156743724|NCT02847182|565809918|FG000|Overall Study|Withdrawal by Subject|0|||
156743725|NCT02847182|565809919|FG001|Overall Study|Withdrawal by Subject|1|||
156743726|NCT02345889|565809920|FG000|Overall Study|Inadequate Bowel Prep|17|||
156743727|NCT02345889|565809921|FG001|Overall Study|Inadequate Bowel Prep|16|||
156743728|NCT02345889|565809922|FG002|Overall Study|Inadequate Bowel Prep|18|||
156743729|NCT02345889|565809923|FG003|Overall Study|Inadequate Bowel Prep|14|||
156743730|NCT02345889|565809920|FG000|Overall Study|Polyposis identified during procedure|1|||
156743731|NCT02345889|565809921|FG001|Overall Study|Polyposis identified during procedure|1|||
156743732|NCT02345889|565809922|FG002|Overall Study|Polyposis identified during procedure|0|||
156743733|NCT02345889|565809923|FG003|Overall Study|Polyposis identified during procedure|1|||
156743734|NCT02345889|565809920|FG000|Overall Study|Recognized ineligible post-randomization|1|||
156743735|NCT02345889|565809921|FG001|Overall Study|Recognized ineligible post-randomization|0|||
156743736|NCT02345889|565809922|FG002|Overall Study|Recognized ineligible post-randomization|2|||
156743737|NCT02345889|565809923|FG003|Overall Study|Recognized ineligible post-randomization|1|||
156743738|NCT02345889|565809920|FG000|Overall Study|Ulcerative Colitis identified|1|||
156743739|NCT02345889|565809921|FG001|Overall Study|Ulcerative Colitis identified|0|||
156743740|NCT02345889|565809922|FG002|Overall Study|Ulcerative Colitis identified|0|||
156743741|NCT02345889|565809923|FG003|Overall Study|Ulcerative Colitis identified|0|||
156743742|NCT02345889|565809920|FG000|Overall Study|Cecum not intubated|1|||
156743743|NCT02345889|565809921|FG001|Overall Study|Cecum not intubated|0|||
156743744|NCT02345889|565809922|FG002|Overall Study|Cecum not intubated|0|||
156743745|NCT02345889|565809923|FG003|Overall Study|Cecum not intubated|0|||
156743746|NCT05072964|565809929|FG000|Overall Study|Withdrawal by Subject|4|||
156743747|NCT05072964|565809929|FG000|Overall Study|Death|1|||
156743748|NCT02987972|565809930|FG000|Overall Study|Adverse Event|1|||
156743749|NCT02987972|565809931|FG001|Overall Study|Adverse Event|1|||
156743750|NCT02987972|565809932|FG002|Overall Study|Adverse Event|0|||
156743751|NCT02987972|565809930|FG000|Overall Study|Death|1|||
156743752|NCT02987972|565809931|FG001|Overall Study|Death|0|||
156743753|NCT02987972|565809932|FG002|Overall Study|Death|0|||
156743754|NCT02987972|565809930|FG000|Overall Study|Lack of Efficacy|9|||
156743755|NCT02987972|565809931|FG001|Overall Study|Lack of Efficacy|12|||
156743756|NCT02987972|565809932|FG002|Overall Study|Lack of Efficacy|12|||
156743757|NCT02987972|565809930|FG000|Overall Study|Lost to Follow-up|7|||
156743758|NCT02987972|565809931|FG001|Overall Study|Lost to Follow-up|8|||
156743759|NCT02987972|565809932|FG002|Overall Study|Lost to Follow-up|4|||
156743760|NCT02987972|565809930|FG000|Overall Study|Physician Decision|1|||
156743761|NCT02987972|565809931|FG001|Overall Study|Physician Decision|6|||
156743762|NCT02987972|565809932|FG002|Overall Study|Physician Decision|0|||
156743763|NCT02987972|565809930|FG000|Overall Study|Protocol Violation|2|||
156743764|NCT02987972|565809931|FG001|Overall Study|Protocol Violation|1|||
156743765|NCT02987972|565809932|FG002|Overall Study|Protocol Violation|5|||
156743766|NCT02987972|565809930|FG000|Overall Study|Withdrawal by Subject|22|||
156743767|NCT02987972|565809931|FG001|Overall Study|Withdrawal by Subject|17|||
156743768|NCT02987972|565809932|FG002|Overall Study|Withdrawal by Subject|21|||
156743769|NCT02342548|565809933|FG000|Overall Study|Adverse Event|12|||
156743770|NCT02342548|565809934|FG001|Overall Study|Adverse Event|17|||
156743771|NCT02342548|565809935|FG002|Overall Study|Adverse Event|13|||
156743772|NCT02342548|565809933|FG000|Overall Study|Lost to Follow-up|0|||
156743773|NCT02342548|565809934|FG001|Overall Study|Lost to Follow-up|1|||
156743774|NCT02342548|565809935|FG002|Overall Study|Lost to Follow-up|0|||
156743775|NCT02342548|565809933|FG000|Overall Study|Study terminated by sponsor|20|||
156743776|NCT02342548|565809934|FG001|Overall Study|Study terminated by sponsor|39|||
156743777|NCT02342548|565809935|FG002|Overall Study|Study terminated by sponsor|25|||
156743778|NCT02342548|565809933|FG000|Overall Study|Protocol Violation|0|||
156743779|NCT02342548|565809934|FG001|Overall Study|Protocol Violation|1|||
156743780|NCT02342548|565809935|FG002|Overall Study|Protocol Violation|0|||
156743781|NCT02342548|565809933|FG000|Overall Study|Withdrawal by Subject|1|||
156743782|NCT02342548|565809934|FG001|Overall Study|Withdrawal by Subject|3|||
156743783|NCT02342548|565809935|FG002|Overall Study|Withdrawal by Subject|4|||
156743784|NCT02342548|565809933|FG000|Overall Study|Other|1|||
156743785|NCT02342548|565809934|FG001|Overall Study|Other|1|||
156743786|NCT02342548|565809935|FG002|Overall Study|Other|1|||
156743787|NCT02172040|565809937|FG000|Overall Study|Adverse Event|0|||
156743788|NCT02172040|565809938|FG001|Overall Study|Adverse Event|2|||
156743789|NCT02172040|565809939|FG002|Overall Study|Adverse Event|0|||
156743790|NCT02172040|565809940|FG003|Overall Study|Adverse Event|0|||
156743791|NCT02172040|565809937|FG000|Overall Study|Protocol Violation|0|||
156743792|NCT02172040|565809938|FG001|Overall Study|Protocol Violation|1|||
156743793|NCT02172040|565809939|FG002|Overall Study|Protocol Violation|0|||
157020582|NCT03763708|566828470|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
157020583|NCT03763708|566828471|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
157020584|NCT03763708|566828472|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
156743794|NCT02172040|565809940|FG003|Overall Study|Protocol Violation|0|||
157020585|NCT03763708|566828473|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
157020586|NCT03763708|566828465|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157020587|NCT03763708|566828466|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157020588|NCT03763708|566828467|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156743795|NCT02172040|565809937|FG000|Overall Study|Withdrawal by Subject|0|||
157020589|NCT03763708|566828468|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
156743796|NCT02172040|565809938|FG001|Overall Study|Withdrawal by Subject|0|||
156743797|NCT02172040|565809939|FG002|Overall Study|Withdrawal by Subject|1|||
156743798|NCT02172040|565809940|FG003|Overall Study|Withdrawal by Subject|0|||
156743799|NCT02172040|565809937|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
156743800|NCT02172040|565809938|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
156743801|NCT02172040|565809939|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
156743802|NCT02172040|565809940|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
156743803|NCT02172040|565809937|FG000|Overall Study|Family emergency abroad|0|||
156743804|NCT02172040|565809938|FG001|Overall Study|Family emergency abroad|0|||
156743805|NCT02172040|565809939|FG002|Overall Study|Family emergency abroad|0|||
156743806|NCT02172040|565809940|FG003|Overall Study|Family emergency abroad|1|||
156743807|NCT03976323|565809947|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
156743808|NCT03976323|565809948|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156743809|NCT03976323|565809949|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
156743810|NCT03976323|565809947|FG000|Induction Phase|Death|80|||
156743811|NCT03976323|565809948|FG001|Induction Phase|Death|0|||
156743812|NCT03976323|565809949|FG002|Induction Phase|Death|0|||
156743813|NCT03976323|565809947|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
156743814|NCT03976323|565809948|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
156743815|NCT03976323|565809949|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
156743816|NCT03976323|565809947|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156743817|NCT03976323|565809948|FG001|Maintenance Phase|Withdrawal by Subject|9|||
156743818|NCT03976323|565809949|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156743819|NCT03976323|565809947|FG000|Maintenance Phase|Physician Decision|0|||
156743820|NCT03976323|565809948|FG001|Maintenance Phase|Physician Decision|0|||
156743821|NCT03976323|565809949|FG002|Maintenance Phase|Physician Decision|1|||
156743822|NCT03976323|565809947|FG000|Maintenance Phase|Death|0|||
156743823|NCT03976323|565809948|FG001|Maintenance Phase|Death|228|||
156743824|NCT03976323|565809949|FG002|Maintenance Phase|Death|234|||
156743825|NCT02824562|565811429|FG000|Overall Study|Lost to Follow-up|3|||
156743826|NCT02824562|565811430|FG001|Overall Study|Lost to Follow-up|4|||
156743827|NCT02824562|565811429|FG000|Overall Study|Death|0|||
156743828|NCT02824562|565811430|FG001|Overall Study|Death|1|||
156743829|NCT05459558|565811431|FG000|Overall Study|Adverse Event|1|||
156743830|NCT05459558|565811432|FG001|Overall Study|Adverse Event|0|||
156743831|NCT05459558|565811433|FG002|Overall Study|Adverse Event|0|||
156743832|NCT05459558|565811431|FG000|Overall Study|Scheduling issue|0|||
156743833|NCT05459558|565811432|FG001|Overall Study|Scheduling issue|1|||
156743834|NCT05459558|565811433|FG002|Overall Study|Scheduling issue|3|||
156743835|NCT05459558|565811431|FG000|Overall Study|Withdrawal by Subject|0|||
156743836|NCT05459558|565811432|FG001|Overall Study|Withdrawal by Subject|0|||
156743837|NCT05459558|565811433|FG002|Overall Study|Withdrawal by Subject|2|||
156743838|NCT01887288|565811439|FG000|Overall Study|The study was terminated and the PI has|16|||
156743839|NCT01092637|565811440|FG000|Overall Study|Death|47|||
156743840|NCT01092637|565811441|FG001|Overall Study|Death|49|||
156743841|NCT02921750|565811442|FG000|Overall Study|Adverse Event|1|||
156743842|NCT02921750|565811443|FG001|Overall Study|Adverse Event|2|||
156743843|NCT02921750|565811442|FG000|Overall Study|Withdrawal by Subject|1|||
156743844|NCT02921750|565811443|FG001|Overall Study|Withdrawal by Subject|1|||
156743845|NCT02921750|565811442|FG000|Overall Study|Lost to Follow-up|3|||
156743846|NCT02921750|565811443|FG001|Overall Study|Lost to Follow-up|3|||
156743847|NCT02921750|565811442|FG000|Overall Study|Wound healed|3|||
156743848|NCT02921750|565811443|FG001|Overall Study|Wound healed|3|||
156743849|NCT02921750|565811442|FG000|Overall Study|Serious Adverse Event|1|||
156743850|NCT02921750|565811443|FG001|Overall Study|Serious Adverse Event|2|||
156743851|NCT03309696|565811448|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
156743852|NCT03309696|565811449|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
156743853|NCT03309696|565811450|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
156743854|NCT03309696|565811451|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
156743855|NCT04643964|565811452|FG000|Overall Study|Lost to Follow-up|55|||
156743856|NCT04643964|565811453|FG001|Overall Study|Lost to Follow-up|59|||
156743857|NCT04643964|565811454|FG002|Overall Study|Lost to Follow-up|54|||
156743858|NCT04643964|565811455|FG003|Overall Study|Lost to Follow-up|129|||
156743859|NCT04643964|565811456|FG004|Overall Study|Lost to Follow-up|48|||
156743860|NCT04643964|565811452|FG000|Overall Study|Failed attention check|1|||
156743861|NCT04643964|565811453|FG001|Overall Study|Failed attention check|8|||
156743862|NCT04643964|565811454|FG002|Overall Study|Failed attention check|2|||
156743863|NCT04643964|565811455|FG003|Overall Study|Failed attention check|14|||
156743864|NCT04643964|565811456|FG004|Overall Study|Failed attention check|11|||
156743865|NCT02638129|565811457|FG000|Overall Study|Study terminated|28|||
156743866|NCT02638129|565811458|FG001|Overall Study|Study terminated|30|||
156743867|NCT02949908|565811459|FG000|Overall Study|Study termination|2|||
156743868|NCT02368210|565811462|FG000|Overall Study|Withdrawal by Subject|1|||
156743869|NCT02368210|565811463|FG001|Overall Study|Withdrawal by Subject|0|||
156743870|NCT02368210|565811462|FG000|Overall Study|Adverse Event|0|||
156743871|NCT02368210|565811463|FG001|Overall Study|Adverse Event|1|||
156743872|NCT00590538|565811464|FG000|Overall Study|Study terminated before completed|2|||
156743873|NCT02539134|565811465|FG000|Overall Study|Lost to Follow-up|1|||
156743874|NCT02539134|565811466|FG001|Overall Study|Lost to Follow-up|0|||
156743875|NCT02539134|565811467|FG002|Overall Study|Lost to Follow-up|0|||
156743876|NCT02539134|565811468|FG003|Overall Study|Lost to Follow-up|0|||
156743877|NCT02539134|565811469|FG004|Overall Study|Lost to Follow-up|0|||
156743878|NCT02539134|565811470|FG005|Overall Study|Lost to Follow-up|0|||
156743879|NCT02604550|565811472|FG000|Overall Study|Lost to Follow-up|7|||
156743880|NCT02604550|565811473|FG001|Overall Study|Lost to Follow-up|6|||
156743881|NCT02604550|565811472|FG000|Overall Study|Withdrawal by Subject|0|||
156743882|NCT02604550|565811473|FG001|Overall Study|Withdrawal by Subject|1|||
156743883|NCT02604550|565811472|FG000|Overall Study|Incomplete data using paper journal|18|||
156743884|NCT02604550|565811473|FG001|Overall Study|Incomplete data using paper journal|19|||
156743885|NCT00908076|565811474|FG000|Overall Study|Lack of Efficacy|1|||
156743886|NCT00908076|565811475|FG001|Overall Study|Lack of Efficacy|1|||
156743887|NCT02609724|565811476|FG000|Overall Study|Death|2|||
156743888|NCT02609724|565811477|FG001|Overall Study|Death|0|||
156743889|NCT02609724|565811478|FG002|Overall Study|Death|1|||
156743890|NCT02609724|565811476|FG000|Overall Study|Withdrawal by Subject|1|||
156743891|NCT02609724|565811477|FG001|Overall Study|Withdrawal by Subject|2|||
156743892|NCT02609724|565811478|FG002|Overall Study|Withdrawal by Subject|3|||
156743893|NCT02609724|565811476|FG000|Overall Study|Illness|2|||
156743894|NCT02609724|565811477|FG001|Overall Study|Illness|1|||
156743895|NCT02609724|565811478|FG002|Overall Study|Illness|0|||
156743896|NCT02382796|565811479|FG000|Overall Study|Global deterioration of health status|1|||
156743897|NCT02382796|565811479|FG000|Overall Study|Objective progression or relapse|3|||
156743898|NCT02382796|565811479|FG000|Overall Study|Commercial dacomitinib became available|3|||
156743899|NCT04007107|565811480|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743900|NCT04007107|565811481|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
156743901|NCT04007107|565811482|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743902|NCT04007107|565811483|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
156743903|NCT04068688|565811484|FG000|Overall Study|Lost to Follow-up|1|||
156743904|NCT04068688|565811485|FG001|Overall Study|Lost to Follow-up|1|||
156743905|NCT04068688|565811486|FG002|Overall Study|Lost to Follow-up|0|||
156743906|NCT04068688|565811487|FG003|Overall Study|Lost to Follow-up|0|||
156743907|NCT04068688|565811488|FG004|Overall Study|Lost to Follow-up|5|||
156743908|NCT04068688|565811489|FG005|Overall Study|Lost to Follow-up|5|||
156743909|NCT04068688|565811490|FG006|Overall Study|Lost to Follow-up|0|||
156743910|NCT04068688|565811491|FG007|Overall Study|Lost to Follow-up|0|||
156743911|NCT04068688|565811492|FG008|Overall Study|Lost to Follow-up|1|||
156743912|NCT04068688|565811493|FG009|Overall Study|Lost to Follow-up|0|||
156743913|NCT04068688|565811484|FG000|Overall Study|Withdrawal by Subject|1|||
156743914|NCT04068688|565811485|FG001|Overall Study|Withdrawal by Subject|1|||
156743915|NCT04068688|565811486|FG002|Overall Study|Withdrawal by Subject|0|||
156743916|NCT04068688|565811487|FG003|Overall Study|Withdrawal by Subject|0|||
156743917|NCT04068688|565811488|FG004|Overall Study|Withdrawal by Subject|0|||
156743918|NCT04068688|565811489|FG005|Overall Study|Withdrawal by Subject|0|||
156743919|NCT04068688|565811490|FG006|Overall Study|Withdrawal by Subject|0|||
156743920|NCT04068688|565811491|FG007|Overall Study|Withdrawal by Subject|0|||
156743921|NCT04068688|565811492|FG008|Overall Study|Withdrawal by Subject|0|||
156743922|NCT04068688|565811493|FG009|Overall Study|Withdrawal by Subject|0|||
156743923|NCT04068688|565811484|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
156743924|NCT04068688|565811485|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
156743925|NCT04068688|565811486|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743926|NCT04068688|565811487|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743927|NCT04068688|565811488|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743928|NCT04068688|565811489|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743929|NCT04068688|565811490|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743930|NCT04068688|565811491|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156879080|NCT02152956|566316493|FG002|Overall Study|Study terminated by sponsor|0|||
157142937|NCT01458340|567271162|FG001|Overall Study|Protocol Violation|6|||
156743931|NCT04068688|565811492|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743932|NCT04068688|565811493|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
156743933|NCT04679051|565811494|FG000|Overall Study|felt tired after restricted time in bed|3|||
156743934|NCT04679051|565811495|FG001|Overall Study|felt tired after restricted time in bed|0|||
156743935|NCT04679051|565811494|FG000|Overall Study|discomfort with blood pressure cuff|2|||
156743936|NCT04679051|565811495|FG001|Overall Study|discomfort with blood pressure cuff|0|||
156743937|NCT04679051|565811494|FG000|Overall Study|scheduling conflict|1|||
156743938|NCT04679051|565811495|FG001|Overall Study|scheduling conflict|1|||
156743939|NCT04679051|565811494|FG000|Overall Study|Protocol Violation|0|||
156743940|NCT04679051|565811495|FG001|Overall Study|Protocol Violation|4|||
156743941|NCT00396877|565811496|FG000|Overall Study|Lost to Follow-up|2|||
156743942|NCT00396877|565811497|FG001|Overall Study|Lost to Follow-up|1|||
156743943|NCT00396877|565811496|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
156743944|NCT00396877|565811497|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
156743945|NCT00934856|565811503|FG000|Feasibility Part|Progressive disease|4|||
156743946|NCT00934856|565811504|FG001|Feasibility Part|Progressive disease|4|||
156743947|NCT00934856|565811505|FG002|Feasibility Part|Progressive disease|2|||
156879081|NCT02152956|566316494|FG003|Overall Study|Study terminated by sponsor|0|||
156743948|NCT00934856|565811506|FG003|Feasibility Part|Progressive disease|3|||
156743949|NCT00934856|565811507|FG004|Feasibility Part|Progressive disease|0|||
156743950|NCT00934856|565811508|FG005|Feasibility Part|Progressive disease|0|||
156743951|NCT00934856|565811503|FG000|Feasibility Part|Physician Decision|0|||
156743952|NCT00934856|565811504|FG001|Feasibility Part|Physician Decision|0|||
156743953|NCT00934856|565811505|FG002|Feasibility Part|Physician Decision|1|||
156743954|NCT00934856|565811506|FG003|Feasibility Part|Physician Decision|0|||
156743955|NCT00934856|565811507|FG004|Feasibility Part|Physician Decision|0|||
157218768|NCT01809314|567547511|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
157218769|NCT01809314|567547511|FG000|Overall Study|Adverse Event|6|||
157218770|NCT01809314|567547511|FG000|Overall Study|Insufficient Therapeutic Response|14|||
157218771|NCT01809314|567547511|FG000|Overall Study|Lost to Follow-up|724|||
157218772|NCT00297479|567547512|FG000|Overall Study|Lost to Follow-up|37|||
157218773|NCT00297479|567547513|FG001|Overall Study|Lost to Follow-up|54|||
157218774|NCT00297479|567547514|FG002|Overall Study|Lost to Follow-up|51|||
157218775|NCT01092702|567547515|FG000|Overall Study|Withdrawal by Subject|7|||
156743956|NCT00934856|565811508|FG005|Feasibility Part|Physician Decision|0|||
156743957|NCT00934856|565811503|FG000|Feasibility Part|Adverse Event|1|||
156743958|NCT00934856|565811504|FG001|Feasibility Part|Adverse Event|1|||
156743959|NCT00934856|565811505|FG002|Feasibility Part|Adverse Event|0|||
156743960|NCT00934856|565811506|FG003|Feasibility Part|Adverse Event|1|||
156743961|NCT00934856|565811507|FG004|Feasibility Part|Adverse Event|0|||
157218776|NCT01092702|567547515|FG000|Overall Study|Lost to Follow-up|2|||
157218777|NCT03263819|567547516|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
157218778|NCT03263819|567547517|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
157218779|NCT00863057|567547518|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
157218780|NCT00863057|567547519|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
156743962|NCT00934856|565811508|FG005|Feasibility Part|Adverse Event|2|||
156743963|NCT00934856|565811503|FG000|Feasibility Part|Withdrawal by Subject|0|||
156743964|NCT00934856|565811504|FG001|Feasibility Part|Withdrawal by Subject|0|||
156743965|NCT00934856|565811505|FG002|Feasibility Part|Withdrawal by Subject|0|||
156743966|NCT00934856|565811506|FG003|Feasibility Part|Withdrawal by Subject|1|||
156743967|NCT00934856|565811507|FG004|Feasibility Part|Withdrawal by Subject|0|||
156743968|NCT00934856|565811508|FG005|Feasibility Part|Withdrawal by Subject|1|||
156743969|NCT00934856|565811503|FG000|Extension Part|Adverse Event|0|||
156743970|NCT00934856|565811504|FG001|Extension Part|Adverse Event|0|||
156743971|NCT00934856|565811505|FG002|Extension Part|Adverse Event|0|||
156743972|NCT00934856|565811506|FG003|Extension Part|Adverse Event|1|||
156743973|NCT00934856|565811507|FG004|Extension Part|Adverse Event|4|||
156743974|NCT00934856|565811508|FG005|Extension Part|Adverse Event|4|||
156743975|NCT00934856|565811503|FG000|Extension Part|Progressive disease|0|||
156743976|NCT00934856|565811504|FG001|Extension Part|Progressive disease|0|||
156743977|NCT00934856|565811505|FG002|Extension Part|Progressive disease|0|||
156743978|NCT00934856|565811506|FG003|Extension Part|Progressive disease|1|||
156743979|NCT00934856|565811507|FG004|Extension Part|Progressive disease|0|||
156743980|NCT00934856|565811508|FG005|Extension Part|Progressive disease|0|||
156743981|NCT00934856|565811503|FG000|Extension Part|Non-compliance with drug|0|||
156743982|NCT00934856|565811504|FG001|Extension Part|Non-compliance with drug|0|||
156743983|NCT00934856|565811505|FG002|Extension Part|Non-compliance with drug|0|||
156743984|NCT00934856|565811506|FG003|Extension Part|Non-compliance with drug|0|||
156743985|NCT00934856|565811507|FG004|Extension Part|Non-compliance with drug|0|||
156743986|NCT00934856|565811508|FG005|Extension Part|Non-compliance with drug|1|||
156743987|NCT00932451|565811516|FG000|Overall Study|Withdrawal by Subject|69|||
156743988|NCT00932451|565811516|FG000|Overall Study|Lost to Follow-up|22|||
156798712|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
156798713|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
156798714|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
157218781|NCT00863057|567547520|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
156743989|NCT00932451|565811516|FG000|Overall Study|Death|726|||
156743990|NCT00932451|565811516|FG000|Overall Study|Other reasons|5|||
156743991|NCT04272606|565811517|FG000|Overall Study|Protocol Violation|1|||
156798715|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
157218782|NCT00863057|567547521|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
157218783|NCT00863057|567547518|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
156743992|NCT04272606|565811518|FG001|Overall Study|Protocol Violation|1|||
156743993|NCT04272606|565811517|FG000|Overall Study|Physician Decision|0|||
156743994|NCT04272606|565811518|FG001|Overall Study|Physician Decision|1|||
157218784|NCT00863057|567547519|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
156743995|NCT00725101|565811519|FG000|Overall Study|Death|3|||
156743996|NCT00725101|565811519|FG000|Overall Study|Lost to Follow-up|353|||
156743997|NCT00725101|565811519|FG000|Overall Study|Protocol Violation|1|||
156743998|NCT00725101|565811519|FG000|Overall Study|Withdrawal by Subject|127|||
156743999|NCT00725101|565811519|FG000|Overall Study|not specified/no reason given|11|||
156744000|NCT03912428|565811522|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744001|NCT03912428|565811523|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
156744002|NCT03912428|565811524|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744003|NCT03912428|565811525|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
156744004|NCT03912428|565811522|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
156744005|NCT03912428|565811523|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
156744006|NCT03912428|565811524|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
156744007|NCT03912428|565811525|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
156744008|NCT03912428|565811522|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744009|NCT03912428|565811523|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744010|NCT03912428|565811524|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
156744011|NCT03912428|565811525|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
156744012|NCT00962091|565811526|FG000|Overall Study|Withdrawal by Subject|1|||
156744013|NCT00962091|565811527|FG001|Overall Study|Withdrawal by Subject|2|||
156744014|NCT00962091|565811528|FG002|Overall Study|Withdrawal by Subject|1|||
156744015|NCT00962091|565811529|FG003|Overall Study|Withdrawal by Subject|1|||
156744016|NCT00962091|565811530|FG004|Overall Study|Withdrawal by Subject|0|||
156744017|NCT00962091|565811531|FG005|Overall Study|Withdrawal by Subject|1|||
156744018|NCT00962091|565811532|FG006|Overall Study|Withdrawal by Subject|0|||
156744019|NCT00962091|565811526|FG000|Overall Study|Adverse Event|0|||
156744020|NCT00962091|565811527|FG001|Overall Study|Adverse Event|0|||
156744021|NCT00962091|565811528|FG002|Overall Study|Adverse Event|0|||
156744022|NCT00962091|565811529|FG003|Overall Study|Adverse Event|0|||
156744023|NCT00962091|565811530|FG004|Overall Study|Adverse Event|0|||
156744024|NCT00962091|565811531|FG005|Overall Study|Adverse Event|0|||
156744025|NCT00962091|565811532|FG006|Overall Study|Adverse Event|1|||
156744026|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744027|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744028|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
156744029|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744030|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744031|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744032|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744033|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744034|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744035|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744036|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744037|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744038|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744039|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
156744040|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
156744041|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744042|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744043|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744044|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744045|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744046|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744047|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744048|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744049|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744050|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744051|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156798716|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
156798717|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
156798718|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
156798719|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
156798720|NCT00265122|566017183|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
156798721|NCT00265122|566017184|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798722|NCT00265122|566017185|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
156798723|NCT00265122|566017186|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
156744052|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744053|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
156744054|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156744055|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
156744056|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744057|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744058|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744059|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744060|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744061|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
157218785|NCT00863057|567547520|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
157218786|NCT00863057|567547521|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
157218787|NCT00863057|567547518|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
157218788|NCT00863057|567547519|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
157218789|NCT00863057|567547520|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
156744062|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744063|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744064|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744065|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744066|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744067|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
156744068|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
156744069|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
156744070|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744071|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744072|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744073|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744074|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744075|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744076|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744077|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744078|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744079|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744080|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744081|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
156744082|NCT02326298|565811533|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744083|NCT02326298|565811534|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744084|NCT02326298|565811535|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
156744085|NCT02326298|565811536|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744086|NCT02326298|565811537|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744087|NCT02326298|565811538|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744088|NCT02326298|565811539|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744089|NCT02326298|565811540|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744090|NCT02326298|565811541|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744091|NCT02326298|565811542|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744092|NCT02326298|565811543|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744093|NCT02326298|565811544|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744094|NCT02326298|565811545|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744095|NCT02326298|565811546|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
156744096|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744097|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744098|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744099|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744100|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744101|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156798724|NCT00265122|566017187|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798725|NCT00265122|566017188|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
156798726|NCT04716894|566017189|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
156798727|NCT04716894|566017189|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
156798728|NCT05205616|566017196|FG000|Overall Study|Lost to Follow-up|4|||
156798729|NCT05205616|566017197|FG001|Overall Study|Lost to Follow-up|4|||
156798730|NCT01467466|566017206|FG000|Overall Study|Withdrawal by Subject|15|||
156798731|NCT01467466|566017207|FG001|Overall Study|Withdrawal by Subject|18|||
156798732|NCT01467466|566017208|FG002|Overall Study|Withdrawal by Subject|13|||
156798733|NCT01467466|566017209|FG003|Overall Study|Withdrawal by Subject|11|||
156798734|NCT01467466|566017206|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
156798735|NCT01467466|566017207|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
156798736|NCT01467466|566017208|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
156798737|NCT01467466|566017209|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
156798738|NCT01467466|566017206|FG000|Overall Study|Procedure Cancelled|46|||
156798739|NCT01467466|566017207|FG001|Overall Study|Procedure Cancelled|45|||
157020590|NCT03763708|566828469|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157020591|NCT03763708|566828470|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157218790|NCT00863057|567547521|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
156879082|NCT02152956|566316495|FG004|Overall Study|Study terminated by sponsor|0|||
157020592|NCT03763708|566828471|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
156798740|NCT01467466|566017208|FG002|Overall Study|Procedure Cancelled|25|||
156798741|NCT01467466|566017209|FG003|Overall Study|Procedure Cancelled|29|||
156798742|NCT01467466|566017206|FG000|Overall Study|No Endpoint Blood Draw|38|||
156798743|NCT01467466|566017207|FG001|Overall Study|No Endpoint Blood Draw|32|||
156798744|NCT01467466|566017208|FG002|Overall Study|No Endpoint Blood Draw|51|||
156798745|NCT01467466|566017209|FG003|Overall Study|No Endpoint Blood Draw|43|||
156798746|NCT00982280|566017220|FG000|Observation Period|Not eligible to be dosed|19|||
156798747|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
156798748|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
156798749|NCT00982280|566017220|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
156798750|NCT00982280|566017220|FG000|Maintenance Period|Adverse Event|1|||
156798751|NCT04724837|566017221|FG000|Overall Study|Other|4|||
156798752|NCT04724837|566017222|FG001|Overall Study|Other|16|||
156798753|NCT04724837|566017223|FG002|Overall Study|Other|0|||
156798754|NCT04724837|566017221|FG000|Overall Study|Withdrawal by Subject|2|||
156798755|NCT04724837|566017222|FG001|Overall Study|Withdrawal by Subject|9|||
156798756|NCT04724837|566017223|FG002|Overall Study|Withdrawal by Subject|9|||
156798757|NCT04724837|566017221|FG000|Overall Study|Adverse Event|2|||
156798758|NCT04724837|566017222|FG001|Overall Study|Adverse Event|7|||
156798759|NCT04724837|566017223|FG002|Overall Study|Adverse Event|4|||
156798760|NCT04724837|566017221|FG000|Overall Study|Lost to Follow-up|0|||
156798761|NCT04724837|566017222|FG001|Overall Study|Lost to Follow-up|1|||
156798762|NCT04724837|566017223|FG002|Overall Study|Lost to Follow-up|3|||
156798763|NCT04724837|566017221|FG000|Overall Study|Physician Decision|1|||
156798764|NCT04724837|566017222|FG001|Overall Study|Physician Decision|2|||
156798765|NCT04724837|566017223|FG002|Overall Study|Physician Decision|0|||
156798766|NCT04724837|566017221|FG000|Overall Study|Death|0|||
156798767|NCT04724837|566017222|FG001|Overall Study|Death|0|||
156798768|NCT04724837|566017223|FG002|Overall Study|Death|1|||
156798769|NCT04724837|566017221|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
156798770|NCT04724837|566017222|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
156798771|NCT04724837|566017223|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
156798772|NCT04724837|566017221|FG000|Overall Study|Study Terminated by Sponsor|0|||
156798773|NCT04724837|566017222|FG001|Overall Study|Study Terminated by Sponsor|1|||
156798774|NCT04724837|566017223|FG002|Overall Study|Study Terminated by Sponsor|0|||
156798775|NCT03213509|566017224|FG000|Overall Study|Did not consent for verbal autopsy|4|||
156798776|NCT03213509|566017225|FG001|Overall Study|Did not consent for verbal autopsy|5|||
156798777|NCT03620981|566017226|FG000|Overall Study|Adverse Event|14|||
156798778|NCT03620981|566017227|FG001|Overall Study|Adverse Event|38|||
156798779|NCT03620981|566017228|FG002|Overall Study|Adverse Event|25|||
156798780|NCT03620981|566017226|FG000|Overall Study|Lack of Efficacy|2|||
156798781|NCT03620981|566017227|FG001|Overall Study|Lack of Efficacy|1|||
156879083|NCT02152956|566316496|FG005|Overall Study|Study terminated by sponsor|0|||
156879084|NCT02152956|566316497|FG006|Overall Study|Study terminated by sponsor|0|||
156879085|NCT02152956|566316498|FG007|Overall Study|Study terminated by sponsor|0|||
156744102|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
156744103|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744104|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744105|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156744106|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744107|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744108|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744109|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156744110|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744111|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744112|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744113|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744114|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744115|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
156744116|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
156744117|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
157142938|NCT01458340|567271163|FG002|Overall Study|Protocol Violation|5|||
157142939|NCT01458340|567271161|FG000|Overall Study|Withdrawal by Subject|12|||
156744118|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
156798782|NCT03620981|566017228|FG002|Overall Study|Lack of Efficacy|1|||
156798783|NCT03620981|566017226|FG000|Overall Study|Physician Decision|7|||
156798784|NCT03620981|566017227|FG001|Overall Study|Physician Decision|4|||
156798785|NCT03620981|566017228|FG002|Overall Study|Physician Decision|4|||
156798786|NCT03620981|566017226|FG000|Overall Study|Protocol Violation|1|||
156798787|NCT03620981|566017227|FG001|Overall Study|Protocol Violation|2|||
156798788|NCT03620981|566017228|FG002|Overall Study|Protocol Violation|1|||
156879086|NCT02152956|566316499|FG008|Overall Study|Study terminated by sponsor|0|||
156744119|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744120|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744121|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744122|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744123|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
156744124|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744125|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744126|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744127|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744128|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744129|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
156744130|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744131|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744132|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744133|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744134|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744135|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156879087|NCT02152956|566316500|FG009|Overall Study|Study terminated by sponsor|0|||
156879088|NCT02152956|566316501|FG010|Overall Study|Study terminated by sponsor|0|||
156744136|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744137|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
156744138|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744139|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744140|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744141|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744142|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744143|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744144|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
156744145|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744146|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744147|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744148|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744149|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744150|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744151|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
156744152|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744153|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744154|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744155|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744156|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744157|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744158|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744159|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
156744160|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744161|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744162|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744163|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744164|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744165|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
156744166|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744167|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744168|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744169|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744170|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744171|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744172|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
156879089|NCT02152956|566316502|FG011|Overall Study|Study terminated by sponsor|29|||
156879090|NCT02152956|566316503|FG012|Overall Study|Study terminated by sponsor|0|||
156879091|NCT02152956|566316491|FG000|Overall Study|progressive disease|0|||
156879092|NCT02152956|566316492|FG001|Overall Study|progressive disease|0|||
156879093|NCT02152956|566316493|FG002|Overall Study|progressive disease|0|||
156879094|NCT02152956|566316494|FG003|Overall Study|progressive disease|0|||
156879095|NCT02152956|566316495|FG004|Overall Study|progressive disease|0|||
156744173|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
156744174|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744175|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744176|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744177|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744178|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744179|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156744180|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744181|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744182|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744183|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744184|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744185|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744186|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744187|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156744188|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744189|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744190|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744191|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744192|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744193|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156744194|NCT02326298|565811533|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744195|NCT02326298|565811534|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744196|NCT02326298|565811535|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744197|NCT02326298|565811536|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744198|NCT02326298|565811537|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744199|NCT02326298|565811538|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
156744200|NCT02326298|565811539|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744201|NCT02326298|565811540|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744202|NCT02326298|565811541|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744203|NCT02326298|565811542|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744204|NCT02326298|565811543|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744205|NCT02326298|565811544|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744206|NCT02326298|565811545|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744207|NCT02326298|565811546|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
156744208|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
156744209|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
156744210|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
156744211|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
156744212|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
156744213|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
156744214|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
156744215|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
156744216|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
156744217|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
156744218|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
156744219|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
156744220|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
156744221|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
156744222|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156879096|NCT02152956|566316496|FG005|Overall Study|progressive disease|0|||
156879097|NCT02152956|566316497|FG006|Overall Study|progressive disease|0|||
156879098|NCT02152956|566316498|FG007|Overall Study|progressive disease|0|||
156879099|NCT02152956|566316499|FG008|Overall Study|progressive disease|1|||
157142940|NCT01458340|567271162|FG001|Overall Study|Withdrawal by Subject|6|||
156744223|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744224|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744225|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744226|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156879100|NCT02152956|566316500|FG009|Overall Study|progressive disease|0|||
156879101|NCT02152956|566316501|FG010|Overall Study|progressive disease|0|||
156879102|NCT02152956|566316502|FG011|Overall Study|progressive disease|1|||
156879103|NCT02152956|566316503|FG012|Overall Study|progressive disease|0|||
157020593|NCT03763708|566828472|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157142941|NCT01458340|567271163|FG002|Overall Study|Withdrawal by Subject|4|||
157142942|NCT03126227|567271164|FG000|Overall Study|Adverse Event|43|||
156744227|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744228|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744229|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744230|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744231|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744232|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744233|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156744234|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
156744235|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
156744236|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744237|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744238|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744239|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744240|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744241|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744242|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744243|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744244|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744245|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744246|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744247|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156744248|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156744249|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156744250|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744251|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744252|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744253|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744254|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744255|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744256|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744257|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744258|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744259|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744260|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744261|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744262|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
156744263|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
156744264|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744265|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744266|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744267|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744268|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744269|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744270|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744271|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744272|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744273|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744274|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156744275|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
156744276|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
156744277|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156744278|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744279|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744280|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744281|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744282|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744283|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744284|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744285|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744286|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744287|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156744288|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
156798789|NCT03620981|566017226|FG000|Overall Study|Withdrawal by Legal Representative|2|||
156744289|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
156744290|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
156744291|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
156744292|NCT02326298|565811533|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744293|NCT02326298|565811534|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744294|NCT02326298|565811535|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744295|NCT02326298|565811536|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744296|NCT02326298|565811537|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744297|NCT02326298|565811538|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744298|NCT02326298|565811539|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744299|NCT02326298|565811540|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744300|NCT02326298|565811541|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744301|NCT02326298|565811542|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744302|NCT02326298|565811543|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156744303|NCT02326298|565811544|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
156744304|NCT02326298|565811545|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
156744305|NCT02326298|565811546|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156744306|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744307|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744308|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744309|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744310|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
156744311|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
156744312|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744313|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744314|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744315|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744316|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
156744317|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
156744318|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Adverse Event|0|||
156744319|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Adverse Event|0|||
156744320|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Adverse Event|0|||
156744321|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Adverse Event|0|||
156744322|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Adverse Event|0|||
156744323|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Adverse Event|2|||
156744324|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744325|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744326|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744327|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744328|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
156744329|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
156744330|NCT03191864|565811547|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744331|NCT03191864|565811548|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744332|NCT03191864|565811549|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744333|NCT03191864|565811550|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744334|NCT03191864|565811551|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
156744335|NCT03191864|565811552|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
156744336|NCT03191864|565811547|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744337|NCT03191864|565811548|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744338|NCT03191864|565811549|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
156744339|NCT03191864|565811550|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744340|NCT03191864|565811551|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
156744341|NCT03191864|565811552|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
156744342|NCT03191864|565811547|FG000|Part 1 - Induction|Adverse Event|0|||
156744343|NCT03191864|565811548|FG001|Part 1 - Induction|Adverse Event|2|||
156744344|NCT03191864|565811549|FG002|Part 1 - Induction|Adverse Event|0|||
156744345|NCT03191864|565811550|FG003|Part 1 - Induction|Adverse Event|1|||
156744346|NCT03191864|565811551|FG004|Part 1 - Induction|Adverse Event|0|||
156744347|NCT03191864|565811552|FG005|Part 1 - Induction|Adverse Event|2|||
156744348|NCT03191864|565811547|FG000|Part 1 - Induction|Randomized but never dosed|0|||
156744349|NCT03191864|565811548|FG001|Part 1 - Induction|Randomized but never dosed|0|||
156744350|NCT03191864|565811549|FG002|Part 1 - Induction|Randomized but never dosed|1|||
156744351|NCT03191864|565811550|FG003|Part 1 - Induction|Randomized but never dosed|0|||
156744352|NCT03191864|565811551|FG004|Part 1 - Induction|Randomized but never dosed|0|||
156744353|NCT03191864|565811552|FG005|Part 1 - Induction|Randomized but never dosed|0|||
156744354|NCT03191864|565811547|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
156744355|NCT03191864|565811548|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
156744356|NCT03191864|565811549|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
156744357|NCT03191864|565811550|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
156744358|NCT03191864|565811551|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
156744359|NCT03191864|565811552|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
156744360|NCT03191864|565811547|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744361|NCT03191864|565811548|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744362|NCT03191864|565811549|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
156744363|NCT03191864|565811550|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744364|NCT03191864|565811551|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744365|NCT03191864|565811552|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
156744366|NCT03191864|565811547|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
156744367|NCT03191864|565811548|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744368|NCT03191864|565811549|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744369|NCT03191864|565811550|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744370|NCT03191864|565811551|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744371|NCT03191864|565811552|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
156744372|NCT03191864|565811547|FG000|Part 2 - Maintenance|Physician Decision|1|||
156744373|NCT03191864|565811548|FG001|Part 2 - Maintenance|Physician Decision|0|||
156744374|NCT03191864|565811549|FG002|Part 2 - Maintenance|Physician Decision|0|||
156744375|NCT03191864|565811550|FG003|Part 2 - Maintenance|Physician Decision|0|||
156744376|NCT03191864|565811551|FG004|Part 2 - Maintenance|Physician Decision|0|||
156744377|NCT03191864|565811552|FG005|Part 2 - Maintenance|Physician Decision|0|||
156744378|NCT03191864|565811547|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
156744379|NCT03191864|565811548|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
156744380|NCT03191864|565811549|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
156744381|NCT03191864|565811550|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
156744382|NCT03191864|565811551|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
156744383|NCT03191864|565811552|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
156744384|NCT03191864|565811547|FG000|Part 2 - Maintenance|Adverse Event|0|||
156744385|NCT03191864|565811548|FG001|Part 2 - Maintenance|Adverse Event|0|||
156744386|NCT03191864|565811549|FG002|Part 2 - Maintenance|Adverse Event|0|||
156744387|NCT03191864|565811550|FG003|Part 2 - Maintenance|Adverse Event|0|||
156744388|NCT03191864|565811551|FG004|Part 2 - Maintenance|Adverse Event|1|||
156744389|NCT03191864|565811552|FG005|Part 2 - Maintenance|Adverse Event|0|||
156744390|NCT03191864|565811547|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
156744391|NCT03191864|565811548|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744392|NCT03191864|565811549|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744393|NCT03191864|565811550|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744394|NCT03191864|565811551|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
156744395|NCT03191864|565811552|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
156744396|NCT03191864|565811547|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744397|NCT03191864|565811548|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744398|NCT03191864|565811549|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744399|NCT03191864|565811550|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744400|NCT03191864|565811551|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
156744401|NCT03191864|565811552|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
156744402|NCT00415597|565811555|FG000|Enrollment|Withdrawal by Subject|1|||
156744403|NCT00415597|565811555|FG000|Enrollment|Protocol Violation|1|||
156744404|NCT00415597|565811555|FG000|Treatment|Adverse Event|110|||
156744405|NCT00415597|565811555|FG000|Treatment|Lack of Efficacy|39|||
156744406|NCT00415597|565811555|FG000|Treatment|Protocol Violation|67|||
156744407|NCT00415597|565811555|FG000|Treatment|Physician Decision|3|||
156798790|NCT03620981|566017227|FG001|Overall Study|Withdrawal by Legal Representative|1|||
156798791|NCT03620981|566017228|FG002|Overall Study|Withdrawal by Legal Representative|1|||
156798792|NCT03620981|566017226|FG000|Overall Study|Withdrawal by Care Giver|2|||
156798793|NCT03620981|566017227|FG001|Overall Study|Withdrawal by Care Giver|0|||
156744408|NCT00415597|565811555|FG000|Treatment|Withdrawal by Subject|51|||
156798794|NCT03620981|566017228|FG002|Overall Study|Withdrawal by Care Giver|1|||
156798795|NCT03620981|566017226|FG000|Overall Study|Non-compliance with Study Drug|1|||
156798796|NCT03620981|566017227|FG001|Overall Study|Non-compliance with Study Drug|1|||
156798797|NCT03620981|566017228|FG002|Overall Study|Non-compliance with Study Drug|0|||
156798798|NCT06071104|566017229|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
156798799|NCT01344226|566017234|FG000|Overall Study|Protocol Violation|2|||
156798800|NCT01344226|566017234|FG000|Overall Study|Withdrawal by Subject|3|||
156798801|NCT01344226|566017234|FG000|Overall Study|Lack of Efficacy|3|||
156798802|NCT02420717|566017240|FG000|Overall Study|Did not receive all study medication|2|||
156879104|NCT00530816|566316504|FG000|Overall Study|Progressive Disease|16|||
156744409|NCT00415597|565811555|FG000|Treatment|Lost to Follow-up|28|||
156744410|NCT00415597|565811555|FG000|Treatment|Drug Screen|2|||
156744411|NCT00415597|565811555|FG000|Treatment|Administrative|3|||
156744412|NCT00415597|565811555|FG000|Treatment|Sponsor Decision|1|||
156744413|NCT00415597|565811555|FG000|Treatment|Multiple Reasons|1|||
156744414|NCT01447927|565811556|FG000|Overall Study|Adverse Event|4|||
156744415|NCT01447927|565811557|FG001|Overall Study|Adverse Event|3|||
156744416|NCT01447927|565811556|FG000|Overall Study|Withdrawal by Subject|1|||
156744417|NCT01447927|565811557|FG001|Overall Study|Withdrawal by Subject|0|||
156744418|NCT04102865|565811558|FG000|Overall Study|Adverse Event|4|||
156744419|NCT04102865|565811559|FG001|Overall Study|Adverse Event|0|||
156744420|NCT04102865|565811558|FG000|Overall Study|Lost to Follow-up|1|||
156744421|NCT04102865|565811559|FG001|Overall Study|Lost to Follow-up|0|||
156744422|NCT04102865|565811558|FG000|Overall Study|Withdrawal by Subject|2|||
156744423|NCT04102865|565811559|FG001|Overall Study|Withdrawal by Subject|0|||
156744424|NCT04506905|565811567|FG000|Overall Study|Lost to Follow-up|1|||
156744425|NCT04506905|565811568|FG001|Overall Study|Lost to Follow-up|0|||
156744426|NCT04506905|565811569|FG002|Overall Study|Lost to Follow-up|0|||
156744427|NCT04506905|565811570|FG003|Overall Study|Lost to Follow-up|1|||
156744428|NCT04506905|565811571|FG004|Overall Study|Lost to Follow-up|0|||
156744429|NCT04506905|565811572|FG005|Overall Study|Lost to Follow-up|0|||
156744430|NCT04506905|565811573|FG006|Overall Study|Lost to Follow-up|0|||
156744431|NCT04506905|565811574|FG007|Overall Study|Lost to Follow-up|0|||
156744432|NCT04506905|565811575|FG008|Overall Study|Lost to Follow-up|0|||
156744433|NCT04506905|565811567|FG000|Overall Study|Withdrawal by Subject|0|||
156744434|NCT04506905|565811568|FG001|Overall Study|Withdrawal by Subject|0|||
156744435|NCT04506905|565811569|FG002|Overall Study|Withdrawal by Subject|0|||
156744436|NCT04506905|565811570|FG003|Overall Study|Withdrawal by Subject|2|||
156744437|NCT04506905|565811571|FG004|Overall Study|Withdrawal by Subject|0|||
156744438|NCT04506905|565811572|FG005|Overall Study|Withdrawal by Subject|0|||
156744439|NCT04506905|565811573|FG006|Overall Study|Withdrawal by Subject|0|||
156744440|NCT04506905|565811574|FG007|Overall Study|Withdrawal by Subject|0|||
156744441|NCT04506905|565811575|FG008|Overall Study|Withdrawal by Subject|0|||
156744442|NCT02093390|565811576|FG000|Overall Study|Withdrawal by Subject|0|||
156744443|NCT02093390|565811577|FG001|Overall Study|Withdrawal by Subject|1|||
156744444|NCT00073983|565811578|FG000|Overall Study|not evaluable|1|||
156744445|NCT03800836|565811579|FG000|Overall Study|Other|2|||
156744446|NCT03800836|565811580|FG001|Overall Study|Other|1|||
156744447|NCT03800836|565811581|FG002|Overall Study|Other|0|||
156744448|NCT03800836|565811582|FG003|Overall Study|Other|2|||
156744449|NCT03800836|565811583|FG004|Overall Study|Other|0|||
156744450|NCT03800836|565811584|FG005|Overall Study|Other|1|||
156744451|NCT03800836|565811579|FG000|Overall Study|Lost to Follow-up|2|||
156744452|NCT03800836|565811580|FG001|Overall Study|Lost to Follow-up|0|||
156744453|NCT03800836|565811581|FG002|Overall Study|Lost to Follow-up|1|||
156744454|NCT03800836|565811582|FG003|Overall Study|Lost to Follow-up|1|||
156744455|NCT03800836|565811583|FG004|Overall Study|Lost to Follow-up|3|||
156744456|NCT03800836|565811584|FG005|Overall Study|Lost to Follow-up|0|||
156744457|NCT03800836|565811579|FG000|Overall Study|Withdrawal by Subject|1|||
156744458|NCT03800836|565811580|FG001|Overall Study|Withdrawal by Subject|0|||
156744459|NCT03800836|565811581|FG002|Overall Study|Withdrawal by Subject|0|||
156744460|NCT03800836|565811582|FG003|Overall Study|Withdrawal by Subject|0|||
156744461|NCT03800836|565811583|FG004|Overall Study|Withdrawal by Subject|0|||
156744462|NCT03800836|565811584|FG005|Overall Study|Withdrawal by Subject|0|||
156744463|NCT03800836|565811579|FG000|Overall Study|Physician Decision|31|||
156744464|NCT03800836|565811580|FG001|Overall Study|Physician Decision|3|||
156744465|NCT03800836|565811581|FG002|Overall Study|Physician Decision|6|||
156744466|NCT03800836|565811582|FG003|Overall Study|Physician Decision|4|||
156744467|NCT03800836|565811583|FG004|Overall Study|Physician Decision|4|||
156744468|NCT03800836|565811584|FG005|Overall Study|Physician Decision|5|||
156744469|NCT03800836|565811579|FG000|Overall Study|Death|34|||
156744470|NCT03800836|565811580|FG001|Overall Study|Death|16|||
156798803|NCT02420717|566017241|FG001|Overall Study|Did not receive all study medication|0|||
156744471|NCT03800836|565811581|FG002|Overall Study|Death|5|||
156744472|NCT03800836|565811582|FG003|Overall Study|Death|5|||
156744473|NCT03800836|565811583|FG004|Overall Study|Death|10|||
156744474|NCT03800836|565811584|FG005|Overall Study|Death|0|||
156744475|NCT03800836|565811579|FG000|Overall Study|Symptomatic Deterioration|1|||
156744476|NCT03800836|565811580|FG001|Overall Study|Symptomatic Deterioration|0|||
156744477|NCT03800836|565811581|FG002|Overall Study|Symptomatic Deterioration|1|||
156744478|NCT03800836|565811582|FG003|Overall Study|Symptomatic Deterioration|0|||
156744479|NCT03800836|565811583|FG004|Overall Study|Symptomatic Deterioration|0|||
156744480|NCT03800836|565811584|FG005|Overall Study|Symptomatic Deterioration|0|||
156744481|NCT01709864|565813219|FG000|Overall Study|Physician Decision|0|||
156744482|NCT01709864|565813220|FG001|Overall Study|Physician Decision|1|||
156744483|NCT01709864|565813219|FG000|Overall Study|subject/guardian decision|5|||
156744484|NCT01709864|565813220|FG001|Overall Study|subject/guardian decision|6|||
156744485|NCT01709864|565813219|FG000|Overall Study|Lost to Follow-up|1|||
156744486|NCT01709864|565813220|FG001|Overall Study|Lost to Follow-up|0|||
156744487|NCT01709864|565813219|FG000|Overall Study|non-compliance with study treatment|1|||
156744488|NCT01709864|565813220|FG001|Overall Study|non-compliance with study treatment|1|||
156744489|NCT01709864|565813219|FG000|Overall Study|Adverse Event|0|||
156798804|NCT02420717|566017242|FG002|Overall Study|Did not receive all study medication|0|||
156798805|NCT03781570|566017243|FG000|Overall Study|Technical Issues (equipment failure)|31|||
156798806|NCT03781570|566017243|FG000|Overall Study|Withdrawal by Subject|7|||
156798807|NCT03781570|566017243|FG000|Overall Study|Physical Constraints|11|||
156798808|NCT06028464|566017247|FG000|Washout|Positive drug test.|1|||
156798809|NCT03636022|566017248|FG000|Overall Study|Withdrawal by Subject|1|||
156798810|NCT03636022|566017249|FG001|Overall Study|Withdrawal by Subject|3|||
156798811|NCT03330847|566017252|FG000|Overall Study|Patients ongoing study|62|||
156744490|NCT01709864|565813220|FG001|Overall Study|Adverse Event|2|||
156744491|NCT01709864|565813219|FG000|Overall Study|Death|0|||
156744492|NCT01709864|565813220|FG001|Overall Study|Death|1|||
156744493|NCT01066793|565813221|FG000|Overall Study|Death|4|||
156744494|NCT01066793|565813222|FG001|Overall Study|Death|1|||
156744495|NCT01066793|565813223|FG002|Overall Study|Death|1|||
156744496|NCT01066793|565813224|FG003|Overall Study|Death|0|||
156744497|NCT01066793|565813225|FG004|Overall Study|Death|0|||
156744498|NCT01066793|565813226|FG005|Overall Study|Death|0|||
156744499|NCT01066793|565813221|FG000|Overall Study|Lack of Efficacy|2|||
156744500|NCT01066793|565813222|FG001|Overall Study|Lack of Efficacy|1|||
156798812|NCT03330847|566017253|FG001|Overall Study|Patients ongoing study|65|||
156744501|NCT01066793|565813223|FG002|Overall Study|Lack of Efficacy|0|||
156744502|NCT01066793|565813224|FG003|Overall Study|Lack of Efficacy|0|||
156744503|NCT01066793|565813225|FG004|Overall Study|Lack of Efficacy|0|||
156744504|NCT01066793|565813226|FG005|Overall Study|Lack of Efficacy|0|||
156744505|NCT01066793|565813221|FG000|Overall Study|Lost to Follow-up|180|||
156744506|NCT01066793|565813222|FG001|Overall Study|Lost to Follow-up|39|||
156744507|NCT01066793|565813223|FG002|Overall Study|Lost to Follow-up|82|||
156744508|NCT01066793|565813224|FG003|Overall Study|Lost to Follow-up|16|||
156744509|NCT01066793|565813225|FG004|Overall Study|Lost to Follow-up|0|||
156744510|NCT01066793|565813226|FG005|Overall Study|Lost to Follow-up|1|||
156744511|NCT01066793|565813221|FG000|Overall Study|Physician Decision|3|||
156744512|NCT01066793|565813222|FG001|Overall Study|Physician Decision|0|||
156744513|NCT01066793|565813223|FG002|Overall Study|Physician Decision|0|||
156798813|NCT03330847|566017254|FG002|Overall Study|Patients ongoing study|15|||
156798814|NCT02769481|566017257|FG000|Overall Study|Protocol Violation|1|||
156798815|NCT02769481|566017258|FG001|Overall Study|Protocol Violation|0|||
156798816|NCT02769481|566017257|FG000|Overall Study|Adverse Event|3|||
156798817|NCT02769481|566017258|FG001|Overall Study|Adverse Event|6|||
156798818|NCT02769481|566017257|FG000|Overall Study|Entry Criteria Not Met|1|||
156798819|NCT02769481|566017258|FG001|Overall Study|Entry Criteria Not Met|2|||
156798820|NCT02769481|566017257|FG000|Overall Study|Withdrawal by Subject|14|||
156798821|NCT02769481|566017258|FG001|Overall Study|Withdrawal by Subject|16|||
157020594|NCT03763708|566828473|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
157020595|NCT03763708|566828465|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
157020596|NCT03763708|566828466|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
156879105|NCT00530816|566316505|FG001|Overall Study|Progressive Disease|24|||
156879106|NCT00530816|566316506|FG002|Overall Study|Progressive Disease|24|||
156744514|NCT01066793|565813224|FG003|Overall Study|Physician Decision|0|||
156744515|NCT01066793|565813225|FG004|Overall Study|Physician Decision|0|||
156744516|NCT01066793|565813226|FG005|Overall Study|Physician Decision|0|||
156744517|NCT01066793|565813221|FG000|Overall Study|Protocol Violation|3|||
156744518|NCT01066793|565813222|FG001|Overall Study|Protocol Violation|2|||
156744519|NCT01066793|565813223|FG002|Overall Study|Protocol Violation|2|||
156744520|NCT01066793|565813224|FG003|Overall Study|Protocol Violation|0|||
156744521|NCT01066793|565813225|FG004|Overall Study|Protocol Violation|0|||
156744522|NCT01066793|565813226|FG005|Overall Study|Protocol Violation|0|||
156744523|NCT01066793|565813221|FG000|Overall Study|Withdrawal by Subject|7|||
156744524|NCT01066793|565813222|FG001|Overall Study|Withdrawal by Subject|4|||
156798822|NCT02769481|566017257|FG000|Overall Study|Lost to Follow-up|9|||
156879107|NCT00530816|566316504|FG000|Overall Study|Adverse Event|6|||
156879108|NCT00530816|566316505|FG001|Overall Study|Adverse Event|13|||
156879109|NCT00530816|566316506|FG002|Overall Study|Adverse Event|7|||
156879110|NCT00530816|566316504|FG000|Overall Study|Other|3|||
156879111|NCT00530816|566316505|FG001|Overall Study|Other|3|||
156744525|NCT01066793|565813223|FG002|Overall Study|Withdrawal by Subject|1|||
157020597|NCT03763708|566828467|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
156744526|NCT01066793|565813224|FG003|Overall Study|Withdrawal by Subject|0|||
156744527|NCT01066793|565813225|FG004|Overall Study|Withdrawal by Subject|0|||
156744528|NCT01066793|565813226|FG005|Overall Study|Withdrawal by Subject|0|||
156744529|NCT01066793|565813221|FG000|Overall Study|Early Termination|3|||
156744530|NCT01066793|565813222|FG001|Overall Study|Early Termination|0|||
156744531|NCT01066793|565813223|FG002|Overall Study|Early Termination|0|||
156744532|NCT01066793|565813224|FG003|Overall Study|Early Termination|0|||
156744533|NCT01066793|565813225|FG004|Overall Study|Early Termination|0|||
156798823|NCT02769481|566017258|FG001|Overall Study|Lost to Follow-up|9|||
156798824|NCT02769481|566017257|FG000|Overall Study|Physician Decision|0|||
156744534|NCT01066793|565813226|FG005|Overall Study|Early Termination|0|||
156744535|NCT01066793|565813221|FG000|Overall Study|Lab test not done|7|||
156879112|NCT00530816|566316506|FG002|Overall Study|Other|4|||
156879113|NCT00530816|566316504|FG000|Overall Study|Withdrawal by Subject|1|||
156744536|NCT01066793|565813222|FG001|Overall Study|Lab test not done|0|||
156744537|NCT01066793|565813223|FG002|Overall Study|Lab test not done|0|||
156744538|NCT01066793|565813224|FG003|Overall Study|Lab test not done|1|||
156744539|NCT01066793|565813225|FG004|Overall Study|Lab test not done|0|||
156744540|NCT01066793|565813226|FG005|Overall Study|Lab test not done|0|||
156744541|NCT01066793|565813221|FG000|Overall Study|Miscellaneous|4|||
156744542|NCT01066793|565813222|FG001|Overall Study|Miscellaneous|5|||
156744543|NCT01066793|565813223|FG002|Overall Study|Miscellaneous|6|||
156744544|NCT01066793|565813224|FG003|Overall Study|Miscellaneous|0|||
156744545|NCT01066793|565813225|FG004|Overall Study|Miscellaneous|0|||
156744546|NCT01066793|565813226|FG005|Overall Study|Miscellaneous|0|||
156744547|NCT01066793|565813221|FG000|Overall Study|Non-responders|104|||
156744548|NCT01066793|565813222|FG001|Overall Study|Non-responders|5|||
156744549|NCT01066793|565813223|FG002|Overall Study|Non-responders|11|||
156744550|NCT01066793|565813224|FG003|Overall Study|Non-responders|25|||
156744551|NCT01066793|565813225|FG004|Overall Study|Non-responders|0|||
156744552|NCT01066793|565813226|FG005|Overall Study|Non-responders|0|||
156744553|NCT01066793|565813221|FG000|Overall Study|Other|15|||
156744554|NCT01066793|565813222|FG001|Overall Study|Other|5|||
156744555|NCT01066793|565813223|FG002|Overall Study|Other|6|||
156744556|NCT01066793|565813224|FG003|Overall Study|Other|2|||
156744557|NCT01066793|565813225|FG004|Overall Study|Other|0|||
156744558|NCT01066793|565813226|FG005|Overall Study|Other|0|||
156744559|NCT01066793|565813221|FG000|Overall Study|Relapse|20|||
156744560|NCT01066793|565813222|FG001|Overall Study|Relapse|8|||
156744561|NCT01066793|565813223|FG002|Overall Study|Relapse|2|||
156744562|NCT01066793|565813224|FG003|Overall Study|Relapse|3|||
156744563|NCT01066793|565813225|FG004|Overall Study|Relapse|0|||
156744564|NCT01066793|565813226|FG005|Overall Study|Relapse|0|||
156744565|NCT01066793|565813221|FG000|Overall Study|Result Not Available|1|||
156744566|NCT01066793|565813222|FG001|Overall Study|Result Not Available|0|||
156744567|NCT01066793|565813223|FG002|Overall Study|Result Not Available|0|||
156744568|NCT01066793|565813224|FG003|Overall Study|Result Not Available|0|||
156744569|NCT01066793|565813225|FG004|Overall Study|Result Not Available|0|||
156744570|NCT01066793|565813226|FG005|Overall Study|Result Not Available|0|||
156744571|NCT01066793|565813221|FG000|Overall Study|Treatment Interrupted|1|||
156744572|NCT01066793|565813222|FG001|Overall Study|Treatment Interrupted|1|||
156744573|NCT01066793|565813223|FG002|Overall Study|Treatment Interrupted|0|||
157020598|NCT03763708|566828468|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
156744574|NCT01066793|565813224|FG003|Overall Study|Treatment Interrupted|0|||
156744575|NCT01066793|565813225|FG004|Overall Study|Treatment Interrupted|0|||
156744576|NCT01066793|565813226|FG005|Overall Study|Treatment Interrupted|0|||
157020599|NCT03763708|566828469|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
157020600|NCT03763708|566828470|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
157020601|NCT03763708|566828471|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
157020602|NCT03763708|566828472|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
157020603|NCT03763708|566828473|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
157020604|NCT03763708|566828465|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
157020605|NCT03763708|566828466|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
157020606|NCT03763708|566828467|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
157020607|NCT03763708|566828468|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
157020608|NCT03763708|566828469|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
157020609|NCT03763708|566828470|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
157020610|NCT03763708|566828471|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
157020611|NCT03763708|566828472|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
157020612|NCT03763708|566828473|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
157142943|NCT03126227|567271165|FG001|Overall Study|Adverse Event|4|||
157142944|NCT03126227|567271164|FG000|Overall Study|Death|0|||
157142945|NCT03126227|567271165|FG001|Overall Study|Death|1|||
157142946|NCT03126227|567271164|FG000|Overall Study|Lost to Follow-up|0|||
157142947|NCT03126227|567271165|FG001|Overall Study|Lost to Follow-up|1|||
157142948|NCT03126227|567271164|FG000|Overall Study|Physician Decision|2|||
157142949|NCT03126227|567271165|FG001|Overall Study|Physician Decision|0|||
157142950|NCT03126227|567271164|FG000|Overall Study|Protocol Violation|1|||
157142951|NCT03126227|567271165|FG001|Overall Study|Protocol Violation|0|||
157142952|NCT03126227|567271164|FG000|Overall Study|Withdrawal by Subject|19|||
157142953|NCT03126227|567271165|FG001|Overall Study|Withdrawal by Subject|3|||
157142954|NCT03126227|567271164|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
157142955|NCT03126227|567271165|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
156744577|NCT01066793|565813221|FG000|Overall Study|Treatment Never Started|18|||
156744578|NCT01066793|565813222|FG001|Overall Study|Treatment Never Started|5|||
156744579|NCT01066793|565813223|FG002|Overall Study|Treatment Never Started|4|||
156744580|NCT01066793|565813224|FG003|Overall Study|Treatment Never Started|1|||
156744581|NCT01066793|565813225|FG004|Overall Study|Treatment Never Started|0|||
156744582|NCT01066793|565813226|FG005|Overall Study|Treatment Never Started|0|||
156744583|NCT01066793|565813221|FG000|Overall Study|Treatment Stopped|2|||
156744584|NCT01066793|565813222|FG001|Overall Study|Treatment Stopped|1|||
157020613|NCT03763708|566828465|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
157218791|NCT00863057|567547518|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
157218792|NCT00863057|567547519|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
157218793|NCT00863057|567547520|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
157218794|NCT00863057|567547521|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
157218795|NCT01698320|567547528|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
157218796|NCT01698320|567547529|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
157218797|NCT01698320|567547530|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
157218798|NCT01698320|567547528|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
157218799|NCT01698320|567547529|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
157218800|NCT01698320|567547530|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
157218801|NCT01698320|567547528|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
157218802|NCT01698320|567547529|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
157218803|NCT01698320|567547530|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
157218804|NCT01698320|567547528|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
157218805|NCT01698320|567547529|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
157218806|NCT01698320|567547530|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
157218807|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Adverse Event|0|||
157218808|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Adverse Event|1|||
157218809|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Adverse Event|1|||
157218810|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
157218811|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
157218812|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
157218813|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
157218814|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
157218815|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
157218816|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Pregnancy|0|||
157218817|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Pregnancy|1|||
157218818|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Pregnancy|1|||
157218819|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
157218820|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
157218821|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
157218822|NCT01698320|567547528|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
157218823|NCT01698320|567547529|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
157218824|NCT01698320|567547530|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
157218825|NCT01698320|567547528|FG000|40-Week Open-Label Period|Adverse Event|0|||
157218826|NCT01698320|567547529|FG001|40-Week Open-Label Period|Adverse Event|3|||
157218827|NCT01698320|567547530|FG002|40-Week Open-Label Period|Adverse Event|2|||
157218828|NCT01698320|567547528|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
157218829|NCT01698320|567547529|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
157218830|NCT01698320|567547530|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
157218831|NCT01698320|567547528|FG000|40-Week Open-Label Period|Pregnancy|0|||
157218832|NCT01698320|567547529|FG001|40-Week Open-Label Period|Pregnancy|2|||
157218833|NCT01698320|567547530|FG002|40-Week Open-Label Period|Pregnancy|1|||
157218834|NCT01698320|567547528|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
157218835|NCT01698320|567547529|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
157218836|NCT01698320|567547530|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
157218837|NCT01698320|567547528|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
157218838|NCT01698320|567547529|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
157218839|NCT01698320|567547530|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
157218840|NCT00686920|567547534|FG000|Overall Study|Death|45|||
157218841|NCT00686920|567547535|FG001|Overall Study|Death|14|||
157218842|NCT00686920|567547534|FG000|Overall Study|Liver Transplant|23|||
157218843|NCT00686920|567547535|FG001|Overall Study|Liver Transplant|8|||
157218844|NCT00686920|567547534|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
157218845|NCT00686920|567547535|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
157218846|NCT00686920|567547534|FG000|Overall Study|Withdrawal by Subject|23|||
157218847|NCT00686920|567547535|FG001|Overall Study|Withdrawal by Subject|5|||
157218848|NCT00686920|567547534|FG000|Overall Study|Protocol Violation|2|||
157218849|NCT00686920|567547535|FG001|Overall Study|Protocol Violation|1|||
157218850|NCT00686920|567547534|FG000|Overall Study|Adverse Event|10|||
157218851|NCT00686920|567547535|FG001|Overall Study|Adverse Event|2|||
157218852|NCT00686920|567547534|FG000|Overall Study|Personal Reason|0|||
157218853|NCT00686920|567547535|FG001|Overall Study|Personal Reason|1|||
157218854|NCT00686920|567547534|FG000|Overall Study|Lost to Follow-up|15|||
157218855|NCT00686920|567547535|FG001|Overall Study|Lost to Follow-up|3|||
157218856|NCT00686920|567547534|FG000|Overall Study|Moved to Another State|1|||
156798825|NCT02769481|566017258|FG001|Overall Study|Physician Decision|1|||
157218857|NCT00686920|567547535|FG001|Overall Study|Moved to Another State|0|||
157218858|NCT00686920|567547534|FG000|Overall Study|Transferred to Nursing Home|1|||
157218859|NCT00686920|567547535|FG001|Overall Study|Transferred to Nursing Home|0|||
157218860|NCT00686920|567547534|FG000|Overall Study|Noncompliance|9|||
157218861|NCT00686920|567547535|FG001|Overall Study|Noncompliance|0|||
157218862|NCT00686920|567547534|FG000|Overall Study|Principal Investigator Decision|2|||
157218863|NCT00686920|567547535|FG001|Overall Study|Principal Investigator Decision|0|||
157218864|NCT02087046|567547539|FG000|Overall Study|Adverse Event|4|||
157218865|NCT02087046|567547539|FG000|Overall Study|Death|1|||
157218866|NCT02087046|567547539|FG000|Overall Study|Lost to Follow-up|3|||
157218867|NCT02087046|567547539|FG000|Overall Study|Withdrawal by Subject|2|||
157218868|NCT02087046|567547539|FG000|Overall Study|Physician Decision|1|||
157218869|NCT01107535|567547540|FG000|Overall Study|Death|5|||
157218870|NCT02444533|567547541|FG000|Overall Study|Not able to complete forms|0|||
157218871|NCT02444533|567547542|FG001|Overall Study|Not able to complete forms|2|||
157218872|NCT02444533|567547541|FG000|Overall Study|Only gave post-procedure complications|2|||
157218873|NCT02444533|567547542|FG001|Overall Study|Only gave post-procedure complications|2|||
157218874|NCT03567057|567547543|FG000|Overall Study|Adverse Event|56|||
157218875|NCT03567057|567547544|FG001|Overall Study|Adverse Event|53|||
157218876|NCT03567057|567547545|FG002|Overall Study|Adverse Event|28|||
157218877|NCT03567057|567547543|FG000|Overall Study|Withdrawal by Subject|22|||
157218878|NCT03567057|567547544|FG001|Overall Study|Withdrawal by Subject|24|||
157218879|NCT03567057|567547545|FG002|Overall Study|Withdrawal by Subject|13|||
157218880|NCT03567057|567547543|FG000|Overall Study|Lost to Follow-up|3|||
157218881|NCT03567057|567547544|FG001|Overall Study|Lost to Follow-up|5|||
157218882|NCT03567057|567547545|FG002|Overall Study|Lost to Follow-up|2|||
157218883|NCT03567057|567547543|FG000|Overall Study|COVID-19 pandemic|4|||
157218884|NCT03567057|567547544|FG001|Overall Study|COVID-19 pandemic|3|||
157218885|NCT03567057|567547545|FG002|Overall Study|COVID-19 pandemic|0|||
157218886|NCT03567057|567547543|FG000|Overall Study|Non-compliance with study drug|4|||
157218887|NCT03567057|567547544|FG001|Overall Study|Non-compliance with study drug|2|||
157218888|NCT03567057|567547545|FG002|Overall Study|Non-compliance with study drug|0|||
157218889|NCT03567057|567547543|FG000|Overall Study|Lack of Efficacy|3|||
157218890|NCT03567057|567547544|FG001|Overall Study|Lack of Efficacy|0|||
157218891|NCT03567057|567547545|FG002|Overall Study|Lack of Efficacy|1|||
157218892|NCT03567057|567547543|FG000|Overall Study|Death|1|||
157218893|NCT03567057|567547544|FG001|Overall Study|Death|0|||
157218894|NCT03567057|567547545|FG002|Overall Study|Death|0|||
157218895|NCT03567057|567547543|FG000|Overall Study|Physician Decision|1|||
157218896|NCT03567057|567547544|FG001|Overall Study|Physician Decision|0|||
157218897|NCT03567057|567547545|FG002|Overall Study|Physician Decision|0|||
157218898|NCT03567057|567547543|FG000|Overall Study|Unstable medical condition|1|||
157218899|NCT03567057|567547544|FG001|Overall Study|Unstable medical condition|0|||
157218900|NCT03567057|567547545|FG002|Overall Study|Unstable medical condition|0|||
157218901|NCT03567057|567547543|FG000|Overall Study|Medical history event|0|||
157218902|NCT03567057|567547544|FG001|Overall Study|Medical history event|0|||
157218903|NCT03567057|567547545|FG002|Overall Study|Medical history event|1|||
157218904|NCT03567057|567547543|FG000|Overall Study|Other|0|||
157218905|NCT03567057|567547544|FG001|Overall Study|Other|0|||
157218906|NCT03567057|567547545|FG002|Overall Study|Other|1|||
157218907|NCT01155583|567547546|FG000|Phase I|Screen failure - did not start treatment|0|||
157218908|NCT01155583|567547547|FG001|Phase I|Screen failure - did not start treatment|0|||
157218909|NCT01155583|567547548|FG002|Phase I|Screen failure - did not start treatment|0|||
157218910|NCT01155583|567547549|FG003|Phase I|Screen failure - did not start treatment|0|||
157218911|NCT01155583|567547550|FG004|Phase I|Screen failure - did not start treatment|1|||
157218912|NCT01155583|567547551|FG005|Phase I|Screen failure - did not start treatment|0|||
157218913|NCT01155583|567547552|FG006|Phase I|Screen failure - did not start treatment|0|||
157218914|NCT01155583|567547553|FG007|Phase I|Screen failure - did not start treatment|2|||
157218915|NCT01155583|567547554|FG008|Phase I|Screen failure - did not start treatment|0|||
157218916|NCT01155583|567547546|FG000|Phase I|Withdrawal by Subject|0|||
157218917|NCT01155583|567547547|FG001|Phase I|Withdrawal by Subject|0|||
157218918|NCT01155583|567547548|FG002|Phase I|Withdrawal by Subject|0|||
157218919|NCT01155583|567547549|FG003|Phase I|Withdrawal by Subject|0|||
157218920|NCT01155583|567547550|FG004|Phase I|Withdrawal by Subject|0|||
157218921|NCT01155583|567547551|FG005|Phase I|Withdrawal by Subject|0|||
157218922|NCT01155583|567547552|FG006|Phase I|Withdrawal by Subject|0|||
157218923|NCT01155583|567547553|FG007|Phase I|Withdrawal by Subject|1|||
157218924|NCT01155583|567547554|FG008|Phase I|Withdrawal by Subject|0|||
157218925|NCT00886483|567547561|FG000|Overall Study|Lost to Follow-up|0|||
157218926|NCT00886483|567547562|FG001|Overall Study|Lost to Follow-up|1|||
156798826|NCT02769481|566017257|FG000|Overall Study|Terminated by Sponsor|1|||
157218927|NCT00886483|567547561|FG000|Overall Study|Pursue medications|1|||
157218928|NCT00886483|567547562|FG001|Overall Study|Pursue medications|2|||
157218929|NCT00886483|567547561|FG000|Overall Study|Distance to center, poor grades|1|||
157218930|NCT00886483|567547562|FG001|Overall Study|Distance to center, poor grades|0|||
157218931|NCT02040766|567547563|FG000|Overall Study|Adverse Event|1|||
157218932|NCT02040766|567547564|FG001|Overall Study|Adverse Event|1|||
157218933|NCT02040766|567547565|FG002|Overall Study|Adverse Event|1|||
157218934|NCT02040766|567547566|FG003|Overall Study|Adverse Event|0|||
157218935|NCT02040766|567547567|FG004|Overall Study|Adverse Event|2|||
157218936|NCT02040766|567547563|FG000|Overall Study|Withdrawal by Subject|4|||
157218937|NCT02040766|567547564|FG001|Overall Study|Withdrawal by Subject|3|||
157218938|NCT02040766|567547565|FG002|Overall Study|Withdrawal by Subject|2|||
156744585|NCT01066793|565813223|FG002|Overall Study|Treatment Stopped|0|||
156744586|NCT01066793|565813224|FG003|Overall Study|Treatment Stopped|1|||
156744587|NCT01066793|565813225|FG004|Overall Study|Treatment Stopped|0|||
156744588|NCT01066793|565813226|FG005|Overall Study|Treatment Stopped|0|||
156744589|NCT03334422|565813228|FG000|Overall Study|Adverse Event|1|||
156744590|NCT03334422|565813229|FG001|Overall Study|Adverse Event|3|||
156744591|NCT03334422|565813230|FG002|Overall Study|Adverse Event|2|||
156744592|NCT03334422|565813231|FG003|Overall Study|Adverse Event|2|||
156744593|NCT03334422|565813228|FG000|Overall Study|Lack of Efficacy|10|||
156744594|NCT03334422|565813229|FG001|Overall Study|Lack of Efficacy|2|||
156744595|NCT03334422|565813230|FG002|Overall Study|Lack of Efficacy|7|||
156744596|NCT03334422|565813231|FG003|Overall Study|Lack of Efficacy|3|||
156744597|NCT03334422|565813228|FG000|Overall Study|Withdrawal by Subject|8|||
156744598|NCT03334422|565813229|FG001|Overall Study|Withdrawal by Subject|3|||
156744599|NCT03334422|565813230|FG002|Overall Study|Withdrawal by Subject|1|||
156744600|NCT03334422|565813231|FG003|Overall Study|Withdrawal by Subject|0|||
156744601|NCT03334422|565813228|FG000|Overall Study|Lost to Follow-up|0|||
156744602|NCT03334422|565813229|FG001|Overall Study|Lost to Follow-up|0|||
156744603|NCT03334422|565813230|FG002|Overall Study|Lost to Follow-up|0|||
156744604|NCT03334422|565813231|FG003|Overall Study|Lost to Follow-up|1|||
156744605|NCT03334422|565813228|FG000|Overall Study|Inability to obtain laboratory samples|0|||
156744606|NCT03334422|565813229|FG001|Overall Study|Inability to obtain laboratory samples|1|||
156744607|NCT03334422|565813230|FG002|Overall Study|Inability to obtain laboratory samples|0|||
156744608|NCT03334422|565813231|FG003|Overall Study|Inability to obtain laboratory samples|0|||
156744609|NCT03334422|565813228|FG000|Overall Study|Pregnancy|0|||
156744610|NCT03334422|565813229|FG001|Overall Study|Pregnancy|1|||
156744611|NCT03334422|565813230|FG002|Overall Study|Pregnancy|0|||
156744612|NCT03334422|565813231|FG003|Overall Study|Pregnancy|0|||
156798827|NCT02769481|566017258|FG001|Overall Study|Terminated by Sponsor|0|||
156798828|NCT02769481|566017257|FG000|Overall Study|Death|0|||
156798829|NCT02769481|566017258|FG001|Overall Study|Death|1|||
156798830|NCT02769481|566017257|FG000|Overall Study|Undefined|4|||
156798831|NCT02769481|566017258|FG001|Overall Study|Undefined|1|||
156798832|NCT01346592|566017259|FG000|Overall Study|Lost to Follow-up|62|||
156798833|NCT01346592|566017260|FG001|Overall Study|Lost to Follow-up|29|||
156798834|NCT01346592|566017261|FG002|Overall Study|Lost to Follow-up|29|||
156798835|NCT01346592|566017259|FG000|Overall Study|Protocol Violation|2|||
156798836|NCT01346592|566017260|FG001|Overall Study|Protocol Violation|1|||
156798837|NCT01346592|566017261|FG002|Overall Study|Protocol Violation|0|||
156798838|NCT01346592|566017259|FG000|Overall Study|Death|1|||
156798839|NCT01346592|566017260|FG001|Overall Study|Death|3|||
156798840|NCT01346592|566017261|FG002|Overall Study|Death|4|||
156798841|NCT01346592|566017259|FG000|Overall Study|Adverse Event|0|||
156798842|NCT01346592|566017260|FG001|Overall Study|Adverse Event|1|||
156798843|NCT01346592|566017261|FG002|Overall Study|Adverse Event|0|||
156798844|NCT01346592|566017259|FG000|Overall Study|Withdrawal by Subject|77|||
156798845|NCT01346592|566017260|FG001|Overall Study|Withdrawal by Subject|51|||
156798846|NCT01346592|566017261|FG002|Overall Study|Withdrawal by Subject|38|||
156798847|NCT01346592|566017259|FG000|Overall Study|Inappropriate enrollment|3|||
156798848|NCT01346592|566017260|FG001|Overall Study|Inappropriate enrollment|1|||
156798849|NCT01346592|566017261|FG002|Overall Study|Inappropriate enrollment|1|||
156798850|NCT01346592|566017259|FG000|Overall Study|Administrative reason|1|||
156798851|NCT01346592|566017260|FG001|Overall Study|Administrative reason|0|||
156798852|NCT01346592|566017261|FG002|Overall Study|Administrative reason|0|||
156798853|NCT01346592|566017259|FG000|Overall Study|Unable to Classify|7|||
156798854|NCT01346592|566017260|FG001|Overall Study|Unable to Classify|3|||
156798855|NCT01346592|566017261|FG002|Overall Study|Unable to Classify|6|||
156798856|NCT00643279|566017264|FG000|Overall Study|Death|13|||
156798857|NCT00643279|566017265|FG001|Overall Study|Death|11|||
156798858|NCT00643279|566017264|FG000|Overall Study|Withdrawal by Subject|3|||
156798859|NCT00643279|566017265|FG001|Overall Study|Withdrawal by Subject|0|||
156798860|NCT00643279|566017264|FG000|Overall Study|Lost to Follow-up|0|||
156798861|NCT00643279|566017265|FG001|Overall Study|Lost to Follow-up|1|||
156798862|NCT00643279|566017264|FG000|Overall Study|Physician Decision|0|||
156798863|NCT00643279|566017265|FG001|Overall Study|Physician Decision|1|||
156798864|NCT06272383|566017266|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
156744613|NCT01313221|565813232|FG000|Overall Study|Protocol Violation|0|||
156798865|NCT06272383|566017267|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
156744614|NCT01313221|565813233|FG001|Overall Study|Protocol Violation|1|||
156744615|NCT01313221|565813234|FG002|Overall Study|Protocol Violation|1|||
156744616|NCT01313221|565813232|FG000|Overall Study|Non-compliance|3|||
156744617|NCT01313221|565813233|FG001|Overall Study|Non-compliance|0|||
156744618|NCT01313221|565813234|FG002|Overall Study|Non-compliance|2|||
156798866|NCT05715827|566017268|FG000|Overall Study|Physician Decision|0|||
157020614|NCT03763708|566828466|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
156744619|NCT01313221|565813232|FG000|Overall Study|Withdrawal by Subject|2|||
156744620|NCT01313221|565813233|FG001|Overall Study|Withdrawal by Subject|3|||
156744621|NCT01313221|565813234|FG002|Overall Study|Withdrawal by Subject|5|||
156744622|NCT01313221|565813232|FG000|Overall Study|Requirement for alternative therapy|0|||
156744623|NCT01313221|565813233|FG001|Overall Study|Requirement for alternative therapy|1|||
156744624|NCT01313221|565813234|FG002|Overall Study|Requirement for alternative therapy|1|||
157020615|NCT03763708|566828467|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
157020616|NCT03763708|566828468|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
157142956|NCT03126227|567271164|FG000|Overall Study|Lack of dosing compliance|2|||
156879114|NCT00530816|566316505|FG001|Overall Study|Withdrawal by Subject|2|||
156879115|NCT00530816|566316506|FG002|Overall Study|Withdrawal by Subject|6|||
156879116|NCT01014910|566316507|FG000|Overall Study|Withdrawal by Subject|0|||
156879117|NCT01014910|566316508|FG001|Overall Study|Withdrawal by Subject|2|||
156879118|NCT02445794|566316509|FG000|Overall Study|Adverse Event|0|||
156879119|NCT02445794|566316510|FG001|Overall Study|Adverse Event|0|||
156879120|NCT02445794|566316511|FG002|Overall Study|Adverse Event|2|||
156879121|NCT02445794|566316512|FG003|Overall Study|Adverse Event|0|||
156879122|NCT01136785|566316513|FG000|Overall Study|Protocol Violation|2|||
156879123|NCT01136785|566316514|FG001|Overall Study|Protocol Violation|1|||
156879124|NCT01388985|566316515|FG000|Overall Study|Death|0|||
156879125|NCT01388985|566316516|FG001|Overall Study|Death|1|||
156879126|NCT01388985|566316515|FG000|Overall Study|Lost to Follow-up|30|||
156879127|NCT01388985|566316516|FG001|Overall Study|Lost to Follow-up|30|||
156879128|NCT01388985|566316515|FG000|Overall Study|Withdrawal by Subject|13|||
156879129|NCT01388985|566316516|FG001|Overall Study|Withdrawal by Subject|4|||
156879130|NCT01388985|566316515|FG000|Overall Study|Subject unavailable|1|||
156879131|NCT01388985|566316516|FG001|Overall Study|Subject unavailable|1|||
156879132|NCT01388985|566316515|FG000|Overall Study|Other (no reason)|0|||
157020617|NCT03763708|566828469|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
157142957|NCT03126227|567271165|FG001|Overall Study|Lack of dosing compliance|0|||
157142958|NCT03126227|567271164|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
157142959|NCT03126227|567271165|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
157142960|NCT03126227|567271164|FG000|Overall Study|Scheduling conflict|1|||
157142961|NCT03126227|567271165|FG001|Overall Study|Scheduling conflict|0|||
157142962|NCT01021007|567271168|FG000|Overall Study|Lost to Follow-up|1|||
157142963|NCT01021007|567271169|FG001|Overall Study|Lost to Follow-up|1|||
157142964|NCT01021007|567271168|FG000|Overall Study|Adverse Event|1|||
157142965|NCT01021007|567271169|FG001|Overall Study|Adverse Event|3|||
157142966|NCT03293030|567271172|FG000|Overall Study|Withdrawal by Subject|3|||
157142967|NCT02318602|567271177|FG000|Overall Study|Adverse Event|0|||
157142968|NCT02318602|567271178|FG001|Overall Study|Adverse Event|1|||
156744625|NCT01313221|565813232|FG000|Overall Study|Lost to Follow-up|6|||
156744626|NCT01313221|565813233|FG001|Overall Study|Lost to Follow-up|3|||
156744627|NCT01313221|565813234|FG002|Overall Study|Lost to Follow-up|1|||
156744628|NCT01313221|565813232|FG000|Overall Study|Other|1|||
156744629|NCT01313221|565813233|FG001|Overall Study|Other|0|||
156744630|NCT01313221|565813234|FG002|Overall Study|Other|0|||
156744631|NCT01313221|565813232|FG000|Overall Study|Adverse Event|0|||
156744632|NCT01313221|565813233|FG001|Overall Study|Adverse Event|0|||
156744633|NCT01313221|565813234|FG002|Overall Study|Adverse Event|7|||
156798867|NCT05715827|566017269|FG001|Overall Study|Physician Decision|1|||
156798868|NCT05715827|566017268|FG000|Overall Study|console communication error|0|||
156798869|NCT05715827|566017269|FG001|Overall Study|console communication error|1|||
156798870|NCT04846868|566017270|FG000|Overall Study|Adverse Event|12|||
156798871|NCT04846868|566017271|FG001|Overall Study|Adverse Event|11|||
156798872|NCT04846868|566017270|FG000|Overall Study|Protocol deviation|6|||
156798873|NCT04846868|566017271|FG001|Overall Study|Protocol deviation|2|||
156798874|NCT04846868|566017270|FG000|Overall Study|Perceived lack of efficacy|3|||
156798875|NCT04846868|566017271|FG001|Overall Study|Perceived lack of efficacy|2|||
156798876|NCT04846868|566017270|FG000|Overall Study|Change of residence|2|||
156798877|NCT04846868|566017271|FG001|Overall Study|Change of residence|3|||
156798878|NCT04846868|566017270|FG000|Overall Study|Burden of study procedures|1|||
156798879|NCT04846868|566017271|FG001|Overall Study|Burden of study procedures|1|||
156798880|NCT04846868|566017270|FG000|Overall Study|No reason available|2|||
156798881|NCT04846868|566017271|FG001|Overall Study|No reason available|5|||
156798882|NCT04846868|566017270|FG000|Overall Study|Other reason listed|20|||
156798883|NCT04846868|566017271|FG001|Overall Study|Other reason listed|10|||
156798884|NCT04846868|566017270|FG000|Overall Study|Not treated|0|||
156798885|NCT04846868|566017271|FG001|Overall Study|Not treated|1|||
156798886|NCT04890509|566017272|FG000|Overall Study|Death|4|||
156798887|NCT04890509|566017273|FG001|Overall Study|Death|4|||
156744634|NCT01313221|565813232|FG000|Overall Study|Disease progression|0|||
156879133|NCT01388985|566316516|FG001|Overall Study|Other (no reason)|1|||
156879134|NCT01388985|566316515|FG000|Overall Study|Error of nurse|5|||
156879135|NCT01388985|566316516|FG001|Overall Study|Error of nurse|1|||
156879136|NCT01519167|566316519|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
156879137|NCT01519167|566316520|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
156879138|NCT01519167|566316519|FG000|Overall Study|Adverse Event|0|||
157142969|NCT02318602|567271179|FG002|Overall Study|Adverse Event|1|||
157142970|NCT02318602|567271177|FG000|Overall Study|Withdrawal by Subject|0|||
157142971|NCT02318602|567271178|FG001|Overall Study|Withdrawal by Subject|3|||
157142972|NCT02318602|567271179|FG002|Overall Study|Withdrawal by Subject|0|||
156744635|NCT01313221|565813233|FG001|Overall Study|Disease progression|0|||
156744636|NCT01313221|565813234|FG002|Overall Study|Disease progression|2|||
156744637|NCT01313221|565813232|FG000|Overall Study|Physician Decision|0|||
156744638|NCT01313221|565813233|FG001|Overall Study|Physician Decision|0|||
156744639|NCT01313221|565813234|FG002|Overall Study|Physician Decision|2|||
156744640|NCT01313221|565813232|FG000|Overall Study|Pregnancy|0|||
156744641|NCT01313221|565813233|FG001|Overall Study|Pregnancy|0|||
156744642|NCT01313221|565813234|FG002|Overall Study|Pregnancy|2|||
156744643|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744644|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
156744645|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744646|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
156744647|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744648|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744649|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
156744650|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
156744651|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
156744652|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744653|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744654|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
156744655|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
156744656|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
156744657|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
156744658|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
156744659|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744660|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744661|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
156744662|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
156744663|NCT00994214|565813235|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
156744664|NCT00994214|565813236|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
156744665|NCT00994214|565813237|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
156744666|NCT00994214|565813238|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
156744667|NCT03246061|565813239|FG000|Overall Study|Still in follow-up|15|||
156744668|NCT03246061|565813240|FG001|Overall Study|Still in follow-up|21|||
156744669|NCT02864316|565813245|FG000|Overall Study|Progressive Disease|2|||
156744670|NCT02864316|565813246|FG001|Overall Study|Progressive Disease|1|||
156744671|NCT02864316|565813245|FG000|Overall Study|Adverse Event|0|||
156744672|NCT02864316|565813246|FG001|Overall Study|Adverse Event|1|||
156744673|NCT04710368|565813247|FG000|Overall Study|Withdrawal by Subject|9|||
156744674|NCT04710368|565813247|FG000|Overall Study|Lost to Follow-up|4|||
156744675|NCT04710368|565813247|FG000|Overall Study|Death|2|||
156744676|NCT04710368|565813247|FG000|Overall Study|Patient preference|11|||
156744677|NCT04710368|565813247|FG000|Overall Study|Treatment discontinuation|1|||
156744678|NCT05625477|565813248|FG000|Overall Study|Lost to Follow-up|2|||
156744679|NCT05625477|565813249|FG001|Overall Study|Lost to Follow-up|2|||
156744680|NCT05625477|565813250|FG002|Overall Study|Lost to Follow-up|1|||
156744681|NCT05625477|565813251|FG003|Overall Study|Lost to Follow-up|1|||
156744682|NCT05625477|565813252|FG004|Overall Study|Lost to Follow-up|0|||
156744683|NCT05625477|565813248|FG000|Overall Study|Covid quarantine|1|||
156744684|NCT05625477|565813249|FG001|Overall Study|Covid quarantine|0|||
156744685|NCT05625477|565813250|FG002|Overall Study|Covid quarantine|0|||
156744686|NCT05625477|565813251|FG003|Overall Study|Covid quarantine|0|||
156744687|NCT05625477|565813252|FG004|Overall Study|Covid quarantine|0|||
156744688|NCT05916131|565813253|FG000|Overall Study|Lost to Follow-up|0|||
156744689|NCT05916131|565813254|FG001|Overall Study|Lost to Follow-up|0|||
156744690|NCT05916131|565813255|FG002|Overall Study|Lost to Follow-up|1|||
156744691|NCT05916131|565813256|FG003|Overall Study|Lost to Follow-up|0|||
156744692|NCT03030118|565813257|FG000|Overall Study|Achieved SLE Diagnosis|11|||
156744693|NCT03030118|565813258|FG001|Overall Study|Achieved SLE Diagnosis|10|||
156744694|NCT03030118|565813257|FG000|Overall Study|Adverse Event|1|||
156798888|NCT05212168|566017274|FG000|Overall Study|Lost to Follow-up|0|||
156798889|NCT05212168|566017275|FG001|Overall Study|Lost to Follow-up|3|||
156798890|NCT05212168|566017274|FG000|Overall Study|Study terminated by sponsor|30|||
156798891|NCT05212168|566017275|FG001|Overall Study|Study terminated by sponsor|27|||
157142973|NCT02318602|567271177|FG000|Overall Study|Death|1|||
156744695|NCT03030118|565813258|FG001|Overall Study|Adverse Event|1|||
156744696|NCT03030118|565813257|FG000|Overall Study|Pregnancy|2|||
156744697|NCT03030118|565813258|FG001|Overall Study|Pregnancy|2|||
156744698|NCT03030118|565813257|FG000|Overall Study|Lost to Follow-up|5|||
156744699|NCT03030118|565813258|FG001|Overall Study|Lost to Follow-up|6|||
156744700|NCT03030118|565813257|FG000|Overall Study|Concomitant Medications|1|||
156744701|NCT03030118|565813258|FG001|Overall Study|Concomitant Medications|1|||
156744702|NCT03030118|565813257|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
156798892|NCT05212168|566017274|FG000|Overall Study|Other|4|||
156744703|NCT03030118|565813258|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
156744704|NCT03030118|565813257|FG000|Overall Study|Other|2|||
156744705|NCT03030118|565813258|FG001|Overall Study|Other|0|||
156744706|NCT03030118|565813257|FG000|Overall Study|Withdrawal by Subject|26|||
156744707|NCT03030118|565813258|FG001|Overall Study|Withdrawal by Subject|21|||
156744708|NCT03030118|565813257|FG000|Overall Study|Protocol Violation|1|||
156744709|NCT03030118|565813258|FG001|Overall Study|Protocol Violation|6|||
156744710|NCT02607280|565813260|FG000|Overall Study|Adverse Event|4|||
156744711|NCT02607280|565813261|FG001|Overall Study|Adverse Event|0|||
156744712|NCT02607280|565813260|FG000|Overall Study|Decrease in CrCl <15|0|||
156744713|NCT02607280|565813261|FG001|Overall Study|Decrease in CrCl <15|1|||
156744714|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
156744715|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156744716|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156744717|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156798893|NCT05212168|566017275|FG001|Overall Study|Other|7|||
156798894|NCT03274466|566017276|FG000|Overall Study|Withdrawal by Subject|7|||
156798895|NCT03274466|566017277|FG001|Overall Study|Withdrawal by Subject|3|||
156798896|NCT03274466|566017276|FG000|Overall Study|Protocol Specified Withdrawal|5|||
156798897|NCT03274466|566017277|FG001|Overall Study|Protocol Specified Withdrawal|11|||
156798898|NCT03274466|566017276|FG000|Overall Study|Lost to Follow-up|5|||
156798899|NCT03274466|566017277|FG001|Overall Study|Lost to Follow-up|7|||
156798900|NCT03274466|566017276|FG000|Overall Study|Subject Non-compliance|0|||
156798901|NCT03274466|566017277|FG001|Overall Study|Subject Non-compliance|1|||
156798902|NCT03274466|566017276|FG000|Overall Study|Adverse Event|3|||
156798903|NCT03274466|566017277|FG001|Overall Study|Adverse Event|3|||
156798904|NCT03274466|566017276|FG000|Overall Study|Physician Decision|0|||
156798905|NCT03274466|566017277|FG001|Overall Study|Physician Decision|1|||
156798906|NCT03274466|566017276|FG000|Overall Study|Protocol Violation|3|||
156798907|NCT03274466|566017277|FG001|Overall Study|Protocol Violation|3|||
156879139|NCT01519167|566316520|FG001|Overall Study|Adverse Event|1|||
156879140|NCT01519167|566316519|FG000|Overall Study|Lack of Efficacy|0|||
157142974|NCT02318602|567271178|FG001|Overall Study|Death|0|||
157142975|NCT02318602|567271179|FG002|Overall Study|Death|0|||
157142976|NCT02318602|567271177|FG000|Overall Study|Guardian decision to withdraw|0|||
157142977|NCT02318602|567271178|FG001|Overall Study|Guardian decision to withdraw|0|||
156798908|NCT00618787|566017280|FG000|Overall Study|Adverse Event|0|||
156798909|NCT00618787|566017281|FG001|Overall Study|Adverse Event|1|||
156798910|NCT00618787|566017280|FG000|Overall Study|Withdrawal by Subject|2|||
156798911|NCT00618787|566017281|FG001|Overall Study|Withdrawal by Subject|1|||
156798912|NCT00618787|566017280|FG000|Overall Study|Lost to Follow-up|1|||
156798913|NCT00618787|566017281|FG001|Overall Study|Lost to Follow-up|0|||
156798914|NCT01107886|566017282|FG000|Overall Study|Lost to Follow-up|15|||
156798915|NCT01107886|566017283|FG001|Overall Study|Lost to Follow-up|13|||
156798916|NCT01107886|566017282|FG000|Overall Study|Withdrawal by Subject|180|||
156798917|NCT01107886|566017283|FG001|Overall Study|Withdrawal by Subject|196|||
156798918|NCT01107886|566017282|FG000|Overall Study|Administrative withdrawal of consent|7|||
156798919|NCT01107886|566017283|FG001|Overall Study|Administrative withdrawal of consent|5|||
156798920|NCT01346176|566017284|FG000|Recruited|Protocol Violation|1|||
156798921|NCT01346176|566017285|FG001|Recruited|Protocol Violation|0|||
156798922|NCT01346176|566017286|FG002|Recruited|Protocol Violation|0|||
156798923|NCT01346176|566017284|FG000|Completed Advance Directive|Death|3|||
156798924|NCT01346176|566017285|FG001|Completed Advance Directive|Death|2|||
156798925|NCT01346176|566017286|FG002|Completed Advance Directive|Death|2|||
156798926|NCT01346176|566017284|FG000|Completed Advance Directive|Became Ineligible|3|||
156798927|NCT01346176|566017285|FG001|Completed Advance Directive|Became Ineligible|0|||
156798928|NCT01346176|566017286|FG002|Completed Advance Directive|Became Ineligible|1|||
156798929|NCT01346176|566017284|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
156798930|NCT01346176|566017285|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
156798931|NCT01346176|566017286|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
157142978|NCT02318602|567271179|FG002|Overall Study|Guardian decision to withdraw|1|||
157142979|NCT01193335|567271183|FG000|After Infant Series|Lost to Follow-up|1|||
156798932|NCT01346176|566017284|FG000|Completed Satisfaction Survey|Death|3|||
156798933|NCT01346176|566017285|FG001|Completed Satisfaction Survey|Death|0|||
156798934|NCT01346176|566017286|FG002|Completed Satisfaction Survey|Death|2|||
156798935|NCT01346176|566017284|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
156798936|NCT01346176|566017285|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
156798937|NCT01346176|566017286|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
156798938|NCT01994876|566017287|FG000|Test Period 1|Withdrawal by Subject|0|||
156744718|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
156798939|NCT01994876|566017288|FG001|Test Period 1|Withdrawal by Subject|1|||
156879141|NCT01519167|566316520|FG001|Overall Study|Lack of Efficacy|1|||
156879142|NCT01519167|566316519|FG000|Overall Study|Medical condition changes&deep sedation|0|||
156744719|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
157142980|NCT01193335|567271184|FG001|After Infant Series|Lost to Follow-up|2|||
157218939|NCT02040766|567547566|FG003|Overall Study|Withdrawal by Subject|3|||
157218940|NCT02040766|567547567|FG004|Overall Study|Withdrawal by Subject|2|||
157218941|NCT02040766|567547563|FG000|Overall Study|Non-compliance|0|||
157218942|NCT02040766|567547564|FG001|Overall Study|Non-compliance|1|||
157218943|NCT02040766|567547565|FG002|Overall Study|Non-compliance|0|||
157218944|NCT02040766|567547566|FG003|Overall Study|Non-compliance|0|||
157218945|NCT02040766|567547567|FG004|Overall Study|Non-compliance|0|||
157218946|NCT02040766|567547563|FG000|Overall Study|Protocol Violation|2|||
157218947|NCT02040766|567547564|FG001|Overall Study|Protocol Violation|1|||
157218948|NCT02040766|567547565|FG002|Overall Study|Protocol Violation|2|||
157218949|NCT02040766|567547566|FG003|Overall Study|Protocol Violation|3|||
157218950|NCT02040766|567547567|FG004|Overall Study|Protocol Violation|0|||
157218951|NCT02040766|567547563|FG000|Overall Study|Lost to Follow-up|4|||
157218952|NCT02040766|567547564|FG001|Overall Study|Lost to Follow-up|1|||
157218953|NCT02040766|567547565|FG002|Overall Study|Lost to Follow-up|3|||
157218954|NCT02040766|567547566|FG003|Overall Study|Lost to Follow-up|1|||
157218955|NCT02040766|567547567|FG004|Overall Study|Lost to Follow-up|4|||
157218956|NCT02040766|567547563|FG000|Overall Study|Not reported|1|||
157218957|NCT02040766|567547564|FG001|Overall Study|Not reported|0|||
157218958|NCT02040766|567547565|FG002|Overall Study|Not reported|0|||
157218959|NCT02040766|567547566|FG003|Overall Study|Not reported|0|||
157218960|NCT02040766|567547567|FG004|Overall Study|Not reported|0|||
157218961|NCT02040766|567547563|FG000|Overall Study|Lack of Efficacy|6|||
157218962|NCT02040766|567547564|FG001|Overall Study|Lack of Efficacy|3|||
157218963|NCT02040766|567547565|FG002|Overall Study|Lack of Efficacy|4|||
157218964|NCT02040766|567547566|FG003|Overall Study|Lack of Efficacy|6|||
157218965|NCT02040766|567547567|FG004|Overall Study|Lack of Efficacy|5|||
157218966|NCT01138150|567547568|FG000|Overall Study|blood unable to be processed|0|||
157218967|NCT01138150|567547569|FG001|Overall Study|blood unable to be processed|1|||
157218968|NCT01138150|567547568|FG000|Overall Study|Physician Decision|1|||
157218969|NCT01138150|567547569|FG001|Overall Study|Physician Decision|0|||
157218970|NCT01208402|567547573|FG000|Overall Study|Withdrawal by Subject|1|||
157218971|NCT01208402|567547574|FG001|Overall Study|Withdrawal by Subject|0|||
157218972|NCT01571635|567547575|FG000|Overall Study|Adverse Event|3|||
157218973|NCT01571635|567547576|FG001|Overall Study|Adverse Event|0|||
157218974|NCT01571635|567547577|FG002|Overall Study|Adverse Event|2|||
157218975|NCT01571635|567547578|FG003|Overall Study|Adverse Event|3|||
157218976|NCT01571635|567547579|FG004|Overall Study|Adverse Event|5|||
157218977|NCT01571635|567547575|FG000|Overall Study|Other reasons|2|||
157218978|NCT01571635|567547576|FG001|Overall Study|Other reasons|1|||
157218979|NCT01571635|567547577|FG002|Overall Study|Other reasons|2|||
157218980|NCT01571635|567547578|FG003|Overall Study|Other reasons|2|||
157218981|NCT01571635|567547579|FG004|Overall Study|Other reasons|1|||
157218982|NCT01571635|567547575|FG000|Overall Study|Study terminated by sponsor|0|||
157218983|NCT01571635|567547576|FG001|Overall Study|Study terminated by sponsor|4|||
157218984|NCT01571635|567547577|FG002|Overall Study|Study terminated by sponsor|1|||
157218985|NCT01571635|567547578|FG003|Overall Study|Study terminated by sponsor|3|||
157218986|NCT01571635|567547579|FG004|Overall Study|Study terminated by sponsor|1|||
157218987|NCT01571635|567547575|FG000|Overall Study|Withdrew consent|1|||
157218988|NCT01571635|567547576|FG001|Overall Study|Withdrew consent|1|||
157218989|NCT01571635|567547577|FG002|Overall Study|Withdrew consent|2|||
157218990|NCT01571635|567547578|FG003|Overall Study|Withdrew consent|3|||
157218991|NCT01571635|567547579|FG004|Overall Study|Withdrew consent|0|||
157218992|NCT01571635|567547575|FG000|Overall Study|Lack of Efficacy|0|||
157218993|NCT01571635|567547576|FG001|Overall Study|Lack of Efficacy|2|||
156744720|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744721|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744722|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744723|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
156744724|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
156744725|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744726|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744727|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744728|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
156744729|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
156798940|NCT01994876|566017287|FG000|Test Period 1|Adverse Event|0|||
156798941|NCT01994876|566017288|FG001|Test Period 1|Adverse Event|1|||
157218994|NCT01571635|567547577|FG002|Overall Study|Lack of Efficacy|0|||
157218995|NCT01571635|567547578|FG003|Overall Study|Lack of Efficacy|1|||
157218996|NCT01571635|567547579|FG004|Overall Study|Lack of Efficacy|2|||
157218997|NCT01335464|567547580|FG000|Overall Study|Adverse Event|15|||
157218998|NCT01335464|567547581|FG001|Overall Study|Adverse Event|25|||
157218999|NCT01335464|567547580|FG000|Overall Study|Non compliant with protocol|2|||
157219000|NCT01335464|567547581|FG001|Overall Study|Non compliant with protocol|0|||
157219001|NCT01335464|567547580|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
157219002|NCT01335464|567547581|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
157219003|NCT01335464|567547580|FG000|Overall Study|Not treated|2|||
156879143|NCT01519167|566316520|FG001|Overall Study|Medical condition changes&deep sedation|2|||
156879144|NCT01519167|566316519|FG000|Overall Study|Physician Decision|0|||
156879145|NCT01519167|566316520|FG001|Overall Study|Physician Decision|1|||
156879146|NCT02055118|566316523|FG000|Overall Study|Withdrawal by Subject|0|||
156879147|NCT02055118|566316524|FG001|Overall Study|Withdrawal by Subject|2|||
156879148|NCT02055118|566316525|FG002|Overall Study|Withdrawal by Subject|0|||
156879149|NCT01516034|566316527|FG000|Overall Study|Physician Decision|1|||
156879150|NCT01516034|566316527|FG000|Overall Study|Lack of Efficacy|7|||
156879151|NCT00870584|566316533|FG000|Overall Study|Adverse Event|3|||
156879152|NCT00870584|566316534|FG001|Overall Study|Adverse Event|3|||
156879153|NCT00870584|566316533|FG000|Overall Study|Withdrawal by Subject|6|||
156879154|NCT00870584|566316534|FG001|Overall Study|Withdrawal by Subject|7|||
156879155|NCT00870584|566316533|FG000|Overall Study|Lost to Follow-up|5|||
156879156|NCT00870584|566316534|FG001|Overall Study|Lost to Follow-up|1|||
156879157|NCT00870584|566316533|FG000|Overall Study|Protocol Deviation|2|||
156879158|NCT00870584|566316534|FG001|Overall Study|Protocol Deviation|2|||
156879159|NCT01497366|566316535|FG000|Overall Study|Virologic failure|2|||
156879160|NCT01497366|566316536|FG001|Overall Study|Virologic failure|50|||
156879161|NCT01497366|566316535|FG000|Overall Study|Lost to Follow-up|11|||
156879162|NCT01497366|566316536|FG001|Overall Study|Lost to Follow-up|10|||
156879163|NCT01497366|566316535|FG000|Overall Study|Withdrawal by Subject|6|||
156879164|NCT01497366|566316536|FG001|Overall Study|Withdrawal by Subject|6|||
156879165|NCT01497366|566316535|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
156879166|NCT01497366|566316536|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
156879167|NCT01497366|566316535|FG000|Overall Study|Other|5|||
156879168|NCT01497366|566316536|FG001|Overall Study|Other|0|||
156879169|NCT01497366|566316535|FG000|Overall Study|Death|1|||
156879170|NCT01497366|566316536|FG001|Overall Study|Death|1|||
156879171|NCT01497366|566316535|FG000|Overall Study|Randomized but not treated|7|||
156879172|NCT01497366|566316536|FG001|Overall Study|Randomized but not treated|21|||
156879173|NCT02703337|566316537|FG000|Period One (Part A)|Withdrawal by Subject|0|||
156879174|NCT02703337|566316538|FG001|Period One (Part A)|Withdrawal by Subject|0|||
156879175|NCT02703337|566316539|FG002|Period One (Part A)|Withdrawal by Subject|0|||
156879176|NCT02703337|566316540|FG003|Period One (Part A)|Withdrawal by Subject|0|||
156879177|NCT02703337|566316541|FG004|Period One (Part A)|Withdrawal by Subject|1|||
156879178|NCT02703337|566316542|FG005|Period One (Part A)|Withdrawal by Subject|0|||
156879179|NCT02703337|566316543|FG006|Period One (Part A)|Withdrawal by Subject|0|||
156879180|NCT02703337|566316544|FG007|Period One (Part A)|Withdrawal by Subject|0|||
156879181|NCT00472030|566316552|FG000|Overall Study|Physician Decision|1|||
156879182|NCT00472030|566316553|FG001|Overall Study|Physician Decision|0|||
156879183|NCT00829504|566316554|FG000|First Intervention|Adverse Event|1|||
156879184|NCT00829504|566316555|FG001|First Intervention|Adverse Event|0|||
156879185|NCT00829504|566316554|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156879186|NCT00829504|566316555|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156879187|NCT00829504|566316554|FG000|Second Intervention|Physician Decision|1|||
156879188|NCT00829504|566316555|FG001|Second Intervention|Physician Decision|0|||
156879189|NCT03844945|566318055|FG000|Overall Study|Adverse Event|1|||
156879190|NCT03844945|566318056|FG001|Overall Study|Adverse Event|1|||
156879191|NCT03844945|566318057|FG002|Overall Study|Adverse Event|4|||
156879192|NCT03844945|566318058|FG003|Overall Study|Adverse Event|0|||
156879193|NCT03844945|566318055|FG000|Overall Study|Withdrawal by Subject|0|||
156879194|NCT03844945|566318056|FG001|Overall Study|Withdrawal by Subject|0|||
156879195|NCT03844945|566318057|FG002|Overall Study|Withdrawal by Subject|1|||
156879196|NCT03844945|566318058|FG003|Overall Study|Withdrawal by Subject|0|||
156879197|NCT03844945|566318055|FG000|Overall Study|Lack of Efficacy|0|||
156879198|NCT03844945|566318056|FG001|Overall Study|Lack of Efficacy|0|||
156879199|NCT03844945|566318057|FG002|Overall Study|Lack of Efficacy|0|||
156879200|NCT03844945|566318058|FG003|Overall Study|Lack of Efficacy|1|||
156879201|NCT01696929|566318059|FG000|Overall Study|Physician Decision|1|||
156879202|NCT01794338|566318072|FG000|Overall Study|Death|2|||
156879203|NCT01794338|566318073|FG001|Overall Study|Death|0|||
156879204|NCT01794338|566318072|FG000|Overall Study|Lost to Follow-up|6|||
156879205|NCT01794338|566318073|FG001|Overall Study|Lost to Follow-up|9|||
156879206|NCT01754402|566318074|FG000|Overall Study|Death|0|||
157020618|NCT03763708|566828470|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
156879207|NCT01754402|566318075|FG001|Overall Study|Death|0|||
156879208|NCT01754402|566318076|FG002|Overall Study|Death|1|||
156879209|NCT01754402|566318074|FG000|Overall Study|Adverse Event|2|||
157142981|NCT01193335|567271183|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
156879210|NCT01754402|566318075|FG001|Overall Study|Adverse Event|2|||
156879211|NCT01754402|566318076|FG002|Overall Study|Adverse Event|1|||
156879212|NCT01754402|566318074|FG000|Overall Study|Withdrawal by Subject|0|||
156879213|NCT01754402|566318075|FG001|Overall Study|Withdrawal by Subject|0|||
156879214|NCT01754402|566318076|FG002|Overall Study|Withdrawal by Subject|1|||
156879215|NCT01754402|566318074|FG000|Overall Study|Lack of Efficacy|0|||
156879216|NCT01754402|566318075|FG001|Overall Study|Lack of Efficacy|0|||
156879217|NCT01754402|566318076|FG002|Overall Study|Lack of Efficacy|1|||
156879218|NCT01282463|566318077|FG000|Overall Study|Lost to Follow-up|1|||
156879219|NCT01282463|566318078|FG001|Overall Study|Lost to Follow-up|0|||
156744730|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744731|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744732|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744733|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
156744734|NCT01004432|565813262|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
156744735|NCT01004432|565813263|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156744736|NCT01004432|565813264|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156744737|NCT01004432|565813265|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
157142982|NCT01193335|567271184|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
157142983|NCT01193335|567271183|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
157142984|NCT01193335|567271184|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
157142985|NCT01193335|567271183|FG000|1-Year Follow-up|Lost to Follow-up|4|||
157142986|NCT01193335|567271184|FG001|1-Year Follow-up|Lost to Follow-up|0|||
156744738|NCT01004432|565813266|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
156879220|NCT01282463|566318079|FG002|Overall Study|Lost to Follow-up|0|||
156879221|NCT01282463|566318077|FG000|Overall Study|Withdrawal by Subject|6|||
156879222|NCT01282463|566318078|FG001|Overall Study|Withdrawal by Subject|2|||
156879223|NCT01282463|566318079|FG002|Overall Study|Withdrawal by Subject|3|||
156879224|NCT01282463|566318077|FG000|Overall Study|"Never Treated Death"|0|||
156879225|NCT01282463|566318078|FG001|Overall Study|"Never Treated Death"|1|||
156879226|NCT01282463|566318079|FG002|Overall Study|"Never Treated Death"|0|||
156879227|NCT01282463|566318077|FG000|Overall Study|"Never Treated PD"|0|||
156879228|NCT01282463|566318078|FG001|Overall Study|"Never Treated PD"|1|||
156879229|NCT01282463|566318079|FG002|Overall Study|"Never Treated PD"|0|||
156879230|NCT01282463|566318077|FG000|Overall Study|Protocol Violation|0|||
156879231|NCT01282463|566318078|FG001|Overall Study|Protocol Violation|0|||
156879232|NCT01282463|566318079|FG002|Overall Study|Protocol Violation|1|||
156879233|NCT01282463|566318077|FG000|Overall Study|Physician Decision|1|||
156879234|NCT01282463|566318078|FG001|Overall Study|Physician Decision|0|||
156879235|NCT01282463|566318079|FG002|Overall Study|Physician Decision|0|||
156879236|NCT02051933|566318080|FG000|Overall Study|Physician Decision|0|||
156879237|NCT02051933|566318081|FG001|Overall Study|Physician Decision|1|||
156879238|NCT01954927|566318082|FG000|Overall Study|Withdrawal by Subject|3|||
156879239|NCT01954927|566318083|FG001|Overall Study|Withdrawal by Subject|1|||
156879240|NCT02156271|566318084|FG000|Overall Study|Physician Decision|4|||
156879241|NCT02156271|566318085|FG001|Overall Study|Physician Decision|3|||
156879242|NCT03320824|566318086|FG000|Overall Study|Withdrawal by Subject|8|||
156879243|NCT03320824|566318087|FG001|Overall Study|Withdrawal by Subject|1|||
156879244|NCT03320824|566318086|FG000|Overall Study|Lost to Follow-up|10|||
156879245|NCT03320824|566318087|FG001|Overall Study|Lost to Follow-up|1|||
156879246|NCT03320824|566318086|FG000|Overall Study|moved out of state|0|||
156879247|NCT03320824|566318087|FG001|Overall Study|moved out of state|1|||
156879248|NCT03320824|566318086|FG000|Overall Study|could not complete final visit|0|||
156879249|NCT03320824|566318087|FG001|Overall Study|could not complete final visit|1|||
156879250|NCT00955305|566318088|FG000|Overall Study|Disease progression|39|||
156879251|NCT00955305|566318089|FG001|Overall Study|Disease progression|41|||
156879252|NCT00955305|566318088|FG000|Overall Study|Adverse Event|22|||
156879253|NCT00955305|566318089|FG001|Overall Study|Adverse Event|22|||
156879254|NCT00955305|566318088|FG000|Overall Study|Death|2|||
156879255|NCT00955305|566318089|FG001|Overall Study|Death|1|||
156879256|NCT00955305|566318088|FG000|Overall Study|Withdrawal by Subject|5|||
156879257|NCT00955305|566318089|FG001|Overall Study|Withdrawal by Subject|4|||
156879258|NCT00955305|566318088|FG000|Overall Study|Alternative therapy|4|||
156879259|NCT00955305|566318089|FG001|Overall Study|Alternative therapy|0|||
156879260|NCT00955305|566318088|FG000|Overall Study|Other complicating disease|2|||
156879261|NCT00955305|566318089|FG001|Overall Study|Other complicating disease|4|||
156879262|NCT00955305|566318088|FG000|Overall Study|Physician Decision|1|||
156879263|NCT00955305|566318089|FG001|Overall Study|Physician Decision|0|||
156744739|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
156879264|NCT00955305|566318088|FG000|Overall Study|Continued presence of residual disease|0|||
156879265|NCT00955305|566318089|FG001|Overall Study|Continued presence of residual disease|1|||
156879266|NCT00955305|566318088|FG000|Overall Study|Functional decline|2|||
156879267|NCT00955305|566318089|FG001|Overall Study|Functional decline|0|||
156879268|NCT00955305|566318088|FG000|Overall Study|Maximum response achieved|0|||
156879269|NCT00955305|566318089|FG001|Overall Study|Maximum response achieved|1|||
156879270|NCT00955305|566318088|FG000|Overall Study|Lost to Follow-up|0|||
156879271|NCT00955305|566318089|FG001|Overall Study|Lost to Follow-up|1|||
156879272|NCT00955305|566318088|FG000|Overall Study|No off-treatment reason submitted|1|||
156879273|NCT00955305|566318089|FG001|Overall Study|No off-treatment reason submitted|0|||
156879274|NCT00955305|566318088|FG000|Overall Study|Never started protocol treatment|5|||
156879275|NCT00955305|566318089|FG001|Overall Study|Never started protocol treatment|5|||
156879276|NCT00955305|566318088|FG000|Overall Study|Ineligible|5|||
156879277|NCT00955305|566318089|FG001|Overall Study|Ineligible|7|||
156879278|NCT00109590|566318090|FG000|Overall Study|Lost to Follow-up|1|||
156879279|NCT00109590|566318091|FG001|Overall Study|Lost to Follow-up|0|||
157142987|NCT01193335|567271183|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
156879280|NCT00109590|566318092|FG002|Overall Study|Lost to Follow-up|1|||
156879281|NCT00109590|566318090|FG000|Overall Study|Never Started Treatment|1|||
156879282|NCT00109590|566318091|FG001|Overall Study|Never Started Treatment|2|||
156879283|NCT00109590|566318092|FG002|Overall Study|Never Started Treatment|3|||
156879284|NCT01221285|566318093|FG000|Overall Study|Withdrawal by Subject|1|||
156879285|NCT02123251|566318094|FG000|Overall Study|Death|1|||
156879286|NCT02123251|566318095|FG001|Overall Study|Death|1|||
156879287|NCT02123251|566318094|FG000|Overall Study|Withdrawal by Subject|0|||
156879288|NCT02123251|566318095|FG001|Overall Study|Withdrawal by Subject|3|||
156879289|NCT02123251|566318094|FG000|Overall Study|Lost Medicaid eligibility|29|||
156879290|NCT02123251|566318095|FG001|Overall Study|Lost Medicaid eligibility|22|||
156879291|NCT02123251|566318094|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
156879292|NCT02123251|566318095|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
156879293|NCT00588861|566318102|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
156879294|NCT00588861|566318103|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
156879295|NCT00588861|566318102|FG000|6 Months|Patients did not return for follow-up|98|||
156879296|NCT00588861|566318103|FG001|6 Months|Patients did not return for follow-up|73|||
156879297|NCT00588861|566318102|FG000|1 Year|Patients did not return for follow-up|89|||
156879298|NCT00588861|566318103|FG001|1 Year|Patients did not return for follow-up|82|||
156879299|NCT00588861|566318102|FG000|2 Years|Patients did not return for follow-up|92|||
156879300|NCT00588861|566318103|FG001|2 Years|Patients did not return for follow-up|87|||
156879301|NCT00588861|566318102|FG000|4 Years|Patients did not return for follow-up|91|||
156879302|NCT00588861|566318103|FG001|4 Years|Patients did not return for follow-up|103|||
156879303|NCT00588861|566318102|FG000|6 Years|Patients did not return for follow-up|104|||
156879304|NCT00588861|566318103|FG001|6 Years|Patients did not return for follow-up|109|||
156879305|NCT00588861|566318102|FG000|8 Years|Patients did not return for follow-up|105|||
156879306|NCT00588861|566318103|FG001|8 Years|Patients did not return for follow-up|114|||
156879307|NCT00588861|566318102|FG000|10 Years|Incomplete due to study termination|107|||
156879308|NCT00588861|566318103|FG001|10 Years|Incomplete due to study termination|114|||
156879309|NCT00375609|566318104|FG000|Overall Study|Did not receive treatment|1|||
156879310|NCT00375609|566318105|FG001|Overall Study|Did not receive treatment|0|||
156879311|NCT00375609|566318106|FG002|Overall Study|Did not receive treatment|0|||
156879312|NCT00375609|566318104|FG000|Overall Study|Adverse Event|0|||
156879313|NCT00375609|566318105|FG001|Overall Study|Adverse Event|3|||
156879314|NCT00375609|566318106|FG002|Overall Study|Adverse Event|0|||
156879315|NCT00375609|566318104|FG000|Overall Study|Lost to Follow-up|1|||
156879316|NCT00375609|566318105|FG001|Overall Study|Lost to Follow-up|0|||
156879317|NCT00375609|566318106|FG002|Overall Study|Lost to Follow-up|0|||
156879318|NCT00375609|566318104|FG000|Overall Study|Physician Decision|0|||
156879319|NCT00375609|566318105|FG001|Overall Study|Physician Decision|0|||
156879320|NCT00375609|566318106|FG002|Overall Study|Physician Decision|1|||
156879321|NCT00375609|566318104|FG000|Overall Study|Withdrawal by Subject|1|||
156879322|NCT00375609|566318105|FG001|Overall Study|Withdrawal by Subject|4|||
156879323|NCT00375609|566318106|FG002|Overall Study|Withdrawal by Subject|0|||
156879324|NCT00375609|566318104|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
156879325|NCT00375609|566318105|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
156879326|NCT00375609|566318106|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
156879327|NCT02864862|566318113|FG000|Overall Study|Lost to Follow-up|1|||
156879328|NCT02864862|566318114|FG001|Overall Study|Lost to Follow-up|0|||
156879329|NCT02864862|566318115|FG002|Overall Study|Lost to Follow-up|1|||
156879330|NCT02864862|566318113|FG000|Overall Study|Protocol Violation|0|||
156879331|NCT02864862|566318114|FG001|Overall Study|Protocol Violation|0|||
156879332|NCT02864862|566318115|FG002|Overall Study|Protocol Violation|1|||
156879333|NCT01523275|566318116|FG000|Overall Study|Lost to Follow-up|1|||
156879334|NCT01523275|566318117|FG001|Overall Study|Lost to Follow-up|2|||
156879335|NCT01523275|566318116|FG000|Overall Study|Withdrawal by Subject|1|||
156879336|NCT01523275|566318117|FG001|Overall Study|Withdrawal by Subject|0|||
156879337|NCT00966875|566318119|FG000|Part A|Adverse Event|2|||
156879338|NCT00966875|566318120|FG001|Part A|Adverse Event|1|||
156879339|NCT00966875|566318121|FG002|Part A|Adverse Event|0|||
156879340|NCT00966875|566318122|FG003|Part A|Adverse Event|1|||
156879341|NCT00966875|566318123|FG004|Part A|Adverse Event|0|||
156879342|NCT00966875|566318124|FG005|Part A|Adverse Event|1|||
156879343|NCT00966875|566318125|FG006|Part A|Adverse Event|0|||
156879344|NCT00966875|566318126|FG007|Part A|Adverse Event|3|||
156879345|NCT00966875|566318127|FG008|Part A|Adverse Event|3|||
156879346|NCT00966875|566318119|FG000|Part A|Entry Criteria|0|||
156879347|NCT00966875|566318120|FG001|Part A|Entry Criteria|0|||
156879348|NCT00966875|566318121|FG002|Part A|Entry Criteria|0|||
156879349|NCT00966875|566318122|FG003|Part A|Entry Criteria|0|||
156879350|NCT00966875|566318123|FG004|Part A|Entry Criteria|0|||
156879351|NCT00966875|566318124|FG005|Part A|Entry Criteria|2|||
156879352|NCT00966875|566318125|FG006|Part A|Entry Criteria|0|||
156879353|NCT00966875|566318126|FG007|Part A|Entry Criteria|0|||
156879354|NCT00966875|566318127|FG008|Part A|Entry Criteria|0|||
156879355|NCT00966875|566318119|FG000|Part A|Lack of Efficacy|0|||
156879356|NCT00966875|566318120|FG001|Part A|Lack of Efficacy|1|||
156879357|NCT00966875|566318121|FG002|Part A|Lack of Efficacy|0|||
157219004|NCT01335464|567547581|FG001|Overall Study|Not treated|0|||
157219005|NCT01335464|567547580|FG000|Overall Study|Reason other than those stated above|1|||
157219006|NCT01335464|567547581|FG001|Overall Study|Reason other than those stated above|1|||
157219007|NCT01841359|567547585|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
157219008|NCT01841359|567547585|FG000|Overall Study|Concommitant medical issues|2|||
157219009|NCT01841359|567547585|FG000|Overall Study|Adverse Event|3|||
156744740|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
156744741|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
156744742|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
156744743|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
156744744|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
157219010|NCT01841359|567547585|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
157219011|NCT00931385|567547586|FG000|Overall Study|Adverse Event|2|||
157219012|NCT00931385|567547587|FG001|Overall Study|Adverse Event|1|||
157219013|NCT00931385|567547588|FG002|Overall Study|Adverse Event|0|||
157219014|NCT00931385|567547589|FG003|Overall Study|Adverse Event|3|||
157219015|NCT00931385|567547586|FG000|Overall Study|Protocol Violation|0|||
156744745|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
156879358|NCT00966875|566318122|FG003|Part A|Lack of Efficacy|0|||
157219016|NCT00931385|567547587|FG001|Overall Study|Protocol Violation|0|||
157219017|NCT00931385|567547588|FG002|Overall Study|Protocol Violation|1|||
157219018|NCT00931385|567547589|FG003|Overall Study|Protocol Violation|0|||
157219019|NCT00931385|567547586|FG000|Overall Study|Withdrawal by Subject|0|||
156879359|NCT00966875|566318123|FG004|Part A|Lack of Efficacy|0|||
156879360|NCT00966875|566318124|FG005|Part A|Lack of Efficacy|0|||
156879361|NCT00966875|566318125|FG006|Part A|Lack of Efficacy|4|||
156879362|NCT00966875|566318126|FG007|Part A|Lack of Efficacy|0|||
156879363|NCT00966875|566318127|FG008|Part A|Lack of Efficacy|0|||
156879364|NCT00966875|566318119|FG000|Part A|Lost to Follow-up|2|||
156879365|NCT00966875|566318120|FG001|Part A|Lost to Follow-up|0|||
156879366|NCT00966875|566318121|FG002|Part A|Lost to Follow-up|0|||
156879367|NCT00966875|566318122|FG003|Part A|Lost to Follow-up|0|||
156879368|NCT00966875|566318123|FG004|Part A|Lost to Follow-up|0|||
156879369|NCT00966875|566318124|FG005|Part A|Lost to Follow-up|1|||
156879370|NCT00966875|566318125|FG006|Part A|Lost to Follow-up|0|||
156879371|NCT00966875|566318126|FG007|Part A|Lost to Follow-up|0|||
156879372|NCT00966875|566318127|FG008|Part A|Lost to Follow-up|0|||
156879373|NCT00966875|566318119|FG000|Part A|Parent/Caregiver Decision|0|||
156879374|NCT00966875|566318120|FG001|Part A|Parent/Caregiver Decision|0|||
156879375|NCT00966875|566318121|FG002|Part A|Parent/Caregiver Decision|0|||
156879376|NCT00966875|566318122|FG003|Part A|Parent/Caregiver Decision|1|||
156879377|NCT00966875|566318123|FG004|Part A|Parent/Caregiver Decision|0|||
156879378|NCT00966875|566318124|FG005|Part A|Parent/Caregiver Decision|0|||
156879379|NCT00966875|566318125|FG006|Part A|Parent/Caregiver Decision|0|||
156879380|NCT00966875|566318126|FG007|Part A|Parent/Caregiver Decision|0|||
156879381|NCT00966875|566318127|FG008|Part A|Parent/Caregiver Decision|0|||
156879382|NCT00966875|566318119|FG000|Part A|Physician Decision|0|||
156879383|NCT00966875|566318120|FG001|Part A|Physician Decision|0|||
156879384|NCT00966875|566318121|FG002|Part A|Physician Decision|0|||
156879385|NCT00966875|566318122|FG003|Part A|Physician Decision|0|||
156879386|NCT00966875|566318123|FG004|Part A|Physician Decision|1|||
156879387|NCT00966875|566318124|FG005|Part A|Physician Decision|0|||
156879388|NCT00966875|566318125|FG006|Part A|Physician Decision|1|||
156879389|NCT00966875|566318126|FG007|Part A|Physician Decision|0|||
156879390|NCT00966875|566318127|FG008|Part A|Physician Decision|2|||
156879391|NCT00966875|566318119|FG000|Part A|Sponsor Decision|0|||
156879392|NCT00966875|566318120|FG001|Part A|Sponsor Decision|0|||
156879393|NCT00966875|566318121|FG002|Part A|Sponsor Decision|1|||
156879394|NCT00966875|566318122|FG003|Part A|Sponsor Decision|0|||
156879395|NCT00966875|566318123|FG004|Part A|Sponsor Decision|1|||
156879396|NCT00966875|566318124|FG005|Part A|Sponsor Decision|0|||
156879397|NCT00966875|566318125|FG006|Part A|Sponsor Decision|0|||
156879398|NCT00966875|566318126|FG007|Part A|Sponsor Decision|2|||
156879399|NCT00966875|566318127|FG008|Part A|Sponsor Decision|1|||
156879400|NCT00966875|566318119|FG000|Part A|Withdrawal by Subject|2|||
156879401|NCT00966875|566318120|FG001|Part A|Withdrawal by Subject|2|||
156879402|NCT00966875|566318121|FG002|Part A|Withdrawal by Subject|1|||
156879403|NCT00966875|566318122|FG003|Part A|Withdrawal by Subject|1|||
156879404|NCT00966875|566318123|FG004|Part A|Withdrawal by Subject|3|||
157219020|NCT00931385|567547587|FG001|Overall Study|Withdrawal by Subject|1|||
156744746|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
156879405|NCT00966875|566318124|FG005|Part A|Withdrawal by Subject|0|||
156879406|NCT00966875|566318125|FG006|Part A|Withdrawal by Subject|5|||
156879407|NCT00966875|566318126|FG007|Part A|Withdrawal by Subject|1|||
156879408|NCT00966875|566318127|FG008|Part A|Withdrawal by Subject|1|||
156879409|NCT00966875|566318119|FG000|Part A|Protocol Violation|0|||
156879410|NCT00966875|566318120|FG001|Part A|Protocol Violation|0|||
156879411|NCT00966875|566318121|FG002|Part A|Protocol Violation|0|||
156879412|NCT00966875|566318122|FG003|Part A|Protocol Violation|0|||
156879413|NCT00966875|566318123|FG004|Part A|Protocol Violation|0|||
156879414|NCT00966875|566318124|FG005|Part A|Protocol Violation|0|||
156744747|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
156744748|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
156744749|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
156744750|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
156744751|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
156744752|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
156744753|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
156744754|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744755|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744756|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744757|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
156798942|NCT01994876|566017287|FG000|Test Period 2|Adverse Event|1|||
156798943|NCT01994876|566017288|FG001|Test Period 2|Adverse Event|0|||
156798944|NCT01994876|566017287|FG000|Test Period 2|Protocol Violation|0|||
156798945|NCT01994876|566017288|FG001|Test Period 2|Protocol Violation|1|||
156798946|NCT05819398|566017289|FG000|Overall Study|Withdrawal by Subject|11|||
156798947|NCT05819398|566017290|FG001|Overall Study|Withdrawal by Subject|7|||
156798948|NCT05819398|566017291|FG002|Overall Study|Withdrawal by Subject|6|||
156798949|NCT05819398|566017292|FG003|Overall Study|Withdrawal by Subject|6|||
156798950|NCT05819398|566017289|FG000|Overall Study|Lost to Follow-up|0|||
156798951|NCT05819398|566017290|FG001|Overall Study|Lost to Follow-up|2|||
156798952|NCT05819398|566017291|FG002|Overall Study|Lost to Follow-up|0|||
156798953|NCT05819398|566017292|FG003|Overall Study|Lost to Follow-up|1|||
156798954|NCT05819398|566017289|FG000|Overall Study|Adverse Event|1|||
156798955|NCT05819398|566017290|FG001|Overall Study|Adverse Event|3|||
156798956|NCT05819398|566017291|FG002|Overall Study|Adverse Event|4|||
156798957|NCT05819398|566017292|FG003|Overall Study|Adverse Event|5|||
156798958|NCT05819398|566017289|FG000|Overall Study|Other than listed|0|||
156798959|NCT05819398|566017290|FG001|Overall Study|Other than listed|2|||
156798960|NCT05819398|566017291|FG002|Overall Study|Other than listed|2|||
156798961|NCT05819398|566017292|FG003|Overall Study|Other than listed|0|||
156798962|NCT05819398|566017289|FG000|Overall Study|Lack of Efficacy|0|||
156798963|NCT05819398|566017290|FG001|Overall Study|Lack of Efficacy|1|||
156798964|NCT05819398|566017291|FG002|Overall Study|Lack of Efficacy|0|||
156798965|NCT05819398|566017292|FG003|Overall Study|Lack of Efficacy|0|||
156798966|NCT05819398|566017289|FG000|Overall Study|Study terminated by sponsor|20|||
156798967|NCT05819398|566017290|FG001|Overall Study|Study terminated by sponsor|18|||
156798968|NCT05819398|566017291|FG002|Overall Study|Study terminated by sponsor|20|||
156798969|NCT05819398|566017292|FG003|Overall Study|Study terminated by sponsor|22|||
156798970|NCT02776735|566017293|FG000|Overall Study|Adverse Event|0|||
156798971|NCT02776735|566017294|FG001|Overall Study|Adverse Event|0|||
156879415|NCT00966875|566318125|FG006|Part A|Protocol Violation|2|||
156879416|NCT00966875|566318126|FG007|Part A|Protocol Violation|1|||
156879417|NCT00966875|566318127|FG008|Part A|Protocol Violation|1|||
156879418|NCT00966875|566318119|FG000|Part B|Adverse Event|0|||
156879419|NCT00966875|566318120|FG001|Part B|Adverse Event|1|||
157142988|NCT01193335|567271184|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
157142989|NCT01193335|567271183|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
157142990|NCT01193335|567271184|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
157142991|NCT01733329|567271185|FG000|Overall Study|Protocol Violation|1|||
157142992|NCT01733329|567271186|FG001|Overall Study|Protocol Violation|1|||
157142993|NCT01733329|567271185|FG000|Overall Study|Uterine artery injury|1|||
157142994|NCT01733329|567271186|FG001|Overall Study|Uterine artery injury|0|||
157142995|NCT00542828|567271187|FG000|Overall Study|Physician Decision|1|||
157142996|NCT00542828|567271187|FG000|Overall Study|Need for Prohibited Treatment|3|||
157142997|NCT00542828|567271187|FG000|Overall Study|Study Prematurely Discontinued|7|||
157142998|NCT00542828|567271187|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
157142999|NCT00095303|567271188|FG000|Main Study|Lost to Follow-up|91|||
157143000|NCT00095303|567271189|FG001|Main Study|Lost to Follow-up|87|||
157143001|NCT00095303|567271188|FG000|Follow Up Study|Lost to Follow-up|59|||
157143002|NCT00095303|567271189|FG001|Follow Up Study|Lost to Follow-up|58|||
157143003|NCT01364467|567271190|FG000|Overall Study|Lost to Follow-up|1|||
157143004|NCT01364467|567271191|FG001|Overall Study|Lost to Follow-up|2|||
157143005|NCT03953118|567271196|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
157143006|NCT03953118|567271197|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
157143007|NCT05139030|567271200|FG000|Overall Study|Withdrawal by Subject|1|||
157143008|NCT05139030|567271201|FG001|Overall Study|Withdrawal by Subject|3|||
156798972|NCT02776735|566017295|FG002|Overall Study|Adverse Event|0|||
156798973|NCT02776735|566017296|FG003|Overall Study|Adverse Event|1|||
156798974|NCT02776735|566017297|FG004|Overall Study|Adverse Event|0|||
156879420|NCT00966875|566318121|FG002|Part B|Adverse Event|1|||
156798975|NCT02776735|566017298|FG005|Overall Study|Adverse Event|1|||
156798976|NCT02776735|566017293|FG000|Overall Study|Lost to Follow-up|0|||
156798977|NCT02776735|566017294|FG001|Overall Study|Lost to Follow-up|0|||
156879421|NCT00966875|566318122|FG003|Part B|Adverse Event|0|||
156879422|NCT00966875|566318123|FG004|Part B|Adverse Event|1|||
156879423|NCT00966875|566318124|FG005|Part B|Adverse Event|0|||
156879424|NCT00966875|566318125|FG006|Part B|Adverse Event|5|||
156879425|NCT00966875|566318126|FG007|Part B|Adverse Event|2|||
156879426|NCT00966875|566318127|FG008|Part B|Adverse Event|2|||
156879427|NCT00966875|566318119|FG000|Part B|Death|0|||
156879428|NCT00966875|566318120|FG001|Part B|Death|0|||
156879429|NCT00966875|566318121|FG002|Part B|Death|1|||
156879430|NCT00966875|566318122|FG003|Part B|Death|0|||
156879431|NCT00966875|566318123|FG004|Part B|Death|0|||
156879432|NCT00966875|566318124|FG005|Part B|Death|0|||
156879433|NCT00966875|566318125|FG006|Part B|Death|0|||
156879434|NCT00966875|566318126|FG007|Part B|Death|1|||
156879435|NCT00966875|566318127|FG008|Part B|Death|0|||
156879436|NCT00966875|566318119|FG000|Part B|Lack of Efficacy|2|||
156879437|NCT00966875|566318120|FG001|Part B|Lack of Efficacy|1|||
156879438|NCT00966875|566318121|FG002|Part B|Lack of Efficacy|1|||
156879439|NCT00966875|566318122|FG003|Part B|Lack of Efficacy|1|||
156879440|NCT00966875|566318123|FG004|Part B|Lack of Efficacy|2|||
156879441|NCT00966875|566318124|FG005|Part B|Lack of Efficacy|3|||
156879442|NCT00966875|566318125|FG006|Part B|Lack of Efficacy|12|||
156879443|NCT00966875|566318126|FG007|Part B|Lack of Efficacy|9|||
156879444|NCT00966875|566318127|FG008|Part B|Lack of Efficacy|6|||
156879445|NCT00966875|566318119|FG000|Part B|Lost to Follow-up|0|||
156879446|NCT00966875|566318120|FG001|Part B|Lost to Follow-up|0|||
156879447|NCT00966875|566318121|FG002|Part B|Lost to Follow-up|0|||
156879448|NCT00966875|566318122|FG003|Part B|Lost to Follow-up|1|||
156879449|NCT00966875|566318123|FG004|Part B|Lost to Follow-up|0|||
156879450|NCT00966875|566318124|FG005|Part B|Lost to Follow-up|0|||
156879451|NCT00966875|566318125|FG006|Part B|Lost to Follow-up|0|||
156879452|NCT00966875|566318126|FG007|Part B|Lost to Follow-up|0|||
156879453|NCT00966875|566318127|FG008|Part B|Lost to Follow-up|1|||
156879454|NCT00966875|566318119|FG000|Part B|Physician Decision|0|||
156879455|NCT00966875|566318120|FG001|Part B|Physician Decision|0|||
156879456|NCT00966875|566318121|FG002|Part B|Physician Decision|1|||
156879457|NCT00966875|566318122|FG003|Part B|Physician Decision|0|||
156879458|NCT00966875|566318123|FG004|Part B|Physician Decision|2|||
156879459|NCT00966875|566318124|FG005|Part B|Physician Decision|1|||
156879460|NCT00966875|566318125|FG006|Part B|Physician Decision|0|||
156879461|NCT00966875|566318126|FG007|Part B|Physician Decision|0|||
156879462|NCT00966875|566318127|FG008|Part B|Physician Decision|2|||
156879463|NCT00966875|566318119|FG000|Part B|Sponsor Decision|1|||
156879464|NCT00966875|566318120|FG001|Part B|Sponsor Decision|0|||
156879465|NCT00966875|566318121|FG002|Part B|Sponsor Decision|0|||
156879466|NCT00966875|566318122|FG003|Part B|Sponsor Decision|0|||
156879467|NCT00966875|566318123|FG004|Part B|Sponsor Decision|0|||
156879468|NCT00966875|566318124|FG005|Part B|Sponsor Decision|1|||
156879469|NCT00966875|566318125|FG006|Part B|Sponsor Decision|0|||
156879470|NCT00966875|566318126|FG007|Part B|Sponsor Decision|2|||
156879471|NCT00966875|566318127|FG008|Part B|Sponsor Decision|1|||
156879472|NCT00966875|566318119|FG000|Part B|Withdrawal by Subject|2|||
156879473|NCT00966875|566318120|FG001|Part B|Withdrawal by Subject|1|||
156879474|NCT00966875|566318121|FG002|Part B|Withdrawal by Subject|2|||
157020619|NCT03763708|566828471|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
157143009|NCT05139030|567271200|FG000|Overall Study|Adverse Event|0|||
157143010|NCT05139030|567271201|FG001|Overall Study|Adverse Event|1|||
157143011|NCT05139030|567271200|FG000|Overall Study|Failure to meet continuation criteria|0|||
157143012|NCT05139030|567271201|FG001|Overall Study|Failure to meet continuation criteria|1|||
157143013|NCT03772327|567271202|FG000|Overall Study|Lost to Follow-up|3|||
157143014|NCT03772327|567271203|FG001|Overall Study|Lost to Follow-up|4|||
157143015|NCT03772327|567271202|FG000|Overall Study|Withdrawal by Subject|2|||
157143016|NCT03772327|567271203|FG001|Overall Study|Withdrawal by Subject|3|||
157143017|NCT00816036|567271210|FG000|Overall Study|Death|47|||
157143018|NCT00816036|567271211|FG001|Overall Study|Death|28|||
157143019|NCT00816036|567271210|FG000|Overall Study|Lost to Follow-up|75|||
157143020|NCT00816036|567271211|FG001|Overall Study|Lost to Follow-up|57|||
157143021|NCT00816036|567271210|FG000|Overall Study|Withdrawal by Subject|54|||
157143022|NCT00816036|567271211|FG001|Overall Study|Withdrawal by Subject|23|||
157143023|NCT00004980|567271212|FG000|Overall Study|Withdrawal by Subject|1|||
157143024|NCT00004980|567271213|FG001|Overall Study|Withdrawal by Subject|0|||
156879475|NCT00966875|566318122|FG003|Part B|Withdrawal by Subject|1|||
156879476|NCT00966875|566318123|FG004|Part B|Withdrawal by Subject|2|||
156879477|NCT00966875|566318124|FG005|Part B|Withdrawal by Subject|1|||
157020620|NCT03763708|566828472|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
157143025|NCT00004980|567271212|FG000|Overall Study|memory difficulties|1|||
157143026|NCT00004980|567271213|FG001|Overall Study|memory difficulties|1|||
156879478|NCT00966875|566318125|FG006|Part B|Withdrawal by Subject|4|||
156879479|NCT00966875|566318126|FG007|Part B|Withdrawal by Subject|5|||
156879480|NCT00966875|566318127|FG008|Part B|Withdrawal by Subject|5|||
156879481|NCT00966875|566318119|FG000|Part B|Entry Criteria|0|||
156879482|NCT00966875|566318120|FG001|Part B|Entry Criteria|0|||
156879483|NCT00966875|566318121|FG002|Part B|Entry Criteria|0|||
156879484|NCT00966875|566318122|FG003|Part B|Entry Criteria|0|||
156879485|NCT00966875|566318123|FG004|Part B|Entry Criteria|0|||
156879486|NCT00966875|566318124|FG005|Part B|Entry Criteria|0|||
156879487|NCT00966875|566318125|FG006|Part B|Entry Criteria|1|||
157219021|NCT00931385|567547588|FG002|Overall Study|Withdrawal by Subject|0|||
157219022|NCT00931385|567547589|FG003|Overall Study|Withdrawal by Subject|1|||
157219023|NCT00931385|567547586|FG000|Overall Study|Lost to Follow-up|0|||
157219024|NCT00931385|567547587|FG001|Overall Study|Lost to Follow-up|0|||
157219025|NCT00931385|567547588|FG002|Overall Study|Lost to Follow-up|0|||
157219026|NCT00931385|567547589|FG003|Overall Study|Lost to Follow-up|1|||
157219027|NCT02884206|567549280|FG000|Valsartan Run-in Period|Death|1|||
157219028|NCT02884206|567549281|FG001|Valsartan Run-in Period|Death|0|||
157219029|NCT02884206|567549282|FG002|Valsartan Run-in Period|Death|0|||
157219030|NCT02884206|567549280|FG000|Valsartan Run-in Period|Adverse Event|31|||
157219031|NCT02884206|567549281|FG001|Valsartan Run-in Period|Adverse Event|0|||
157219032|NCT02884206|567549282|FG002|Valsartan Run-in Period|Adverse Event|0|||
157219033|NCT02884206|567549280|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
156879488|NCT00966875|566318126|FG007|Part B|Entry Criteria|0|||
156879489|NCT00966875|566318127|FG008|Part B|Entry Criteria|1|||
156879490|NCT01206322|566318128|FG000|Overall Study|Adverse Event|0|||
156879491|NCT01206322|566318129|FG001|Overall Study|Adverse Event|0|||
156879492|NCT01206322|566318130|FG002|Overall Study|Adverse Event|0|||
156879493|NCT01206322|566318131|FG003|Overall Study|Adverse Event|1|||
156879494|NCT00689117|566318132|FG000|Overall Study|Adverse Event|6|||
156879495|NCT00689117|566318133|FG001|Overall Study|Adverse Event|0|||
156879496|NCT00689117|566318134|FG002|Overall Study|Adverse Event|5|||
156879497|NCT00689117|566318135|FG003|Overall Study|Adverse Event|0|||
156879498|NCT00689117|566318132|FG000|Overall Study|Lost to Follow-up|26|||
156879499|NCT00689117|566318133|FG001|Overall Study|Lost to Follow-up|19|||
156879500|NCT00689117|566318134|FG002|Overall Study|Lost to Follow-up|17|||
156879501|NCT00689117|566318135|FG003|Overall Study|Lost to Follow-up|11|||
156879502|NCT00689117|566318132|FG000|Overall Study|Lack of Efficacy|1|||
156879503|NCT00689117|566318133|FG001|Overall Study|Lack of Efficacy|2|||
156879504|NCT00689117|566318134|FG002|Overall Study|Lack of Efficacy|2|||
156879505|NCT00689117|566318135|FG003|Overall Study|Lack of Efficacy|2|||
156879506|NCT00689117|566318132|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
156879507|NCT00689117|566318133|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
156879508|NCT00689117|566318134|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
156879509|NCT00689117|566318135|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
156879510|NCT00689117|566318132|FG000|Overall Study|Withdrawal by Subject|19|||
156879511|NCT00689117|566318133|FG001|Overall Study|Withdrawal by Subject|18|||
156879512|NCT00689117|566318134|FG002|Overall Study|Withdrawal by Subject|26|||
156879513|NCT00689117|566318135|FG003|Overall Study|Withdrawal by Subject|13|||
156879514|NCT00689117|566318132|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
156879515|NCT00689117|566318133|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
156879516|NCT00689117|566318134|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
156879517|NCT00689117|566318135|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
156879518|NCT00689117|566318132|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156879519|NCT00689117|566318133|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
156879520|NCT00689117|566318134|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156879521|NCT00689117|566318135|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156879522|NCT00689117|566318132|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
156879523|NCT00689117|566318133|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
156879524|NCT00689117|566318134|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
156879525|NCT00689117|566318135|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
156879526|NCT00689117|566318132|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
156879527|NCT00689117|566318133|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
156879528|NCT00689117|566318134|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
156879529|NCT00689117|566318135|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
156879530|NCT00689117|566318132|FG000|Overall Study|Use of Prohibitive Medication|2|||
157219034|NCT02884206|567549281|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
156744758|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
156744759|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
156744760|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
156744761|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
156744762|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
156744763|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
156744764|NCT01004432|565813262|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
156879531|NCT00689117|566318133|FG001|Overall Study|Use of Prohibitive Medication|1|||
156879532|NCT00689117|566318134|FG002|Overall Study|Use of Prohibitive Medication|3|||
156879533|NCT00689117|566318135|FG003|Overall Study|Use of Prohibitive Medication|0|||
156879534|NCT00689117|566318132|FG000|Overall Study|Pregnancy|0|||
156879535|NCT00689117|566318133|FG001|Overall Study|Pregnancy|2|||
156879536|NCT00689117|566318134|FG002|Overall Study|Pregnancy|0|||
156879537|NCT00689117|566318135|FG003|Overall Study|Pregnancy|2|||
157219035|NCT02884206|567549282|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
156879538|NCT00689117|566318132|FG000|Overall Study|Incarceration|2|||
157219036|NCT02884206|567549280|FG000|Valsartan Run-in Period|Protocol deviation|4|||
156744765|NCT01004432|565813263|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
156744766|NCT01004432|565813264|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
156744767|NCT01004432|565813265|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
156744768|NCT01004432|565813266|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
156744769|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
157143027|NCT00004980|567271212|FG000|Overall Study|Physician Decision|0|||
157143028|NCT00004980|567271213|FG001|Overall Study|Physician Decision|1|||
157143029|NCT00820040|567271214|FG000|Overall Study|Death|1|||
157143030|NCT00820040|567271214|FG000|Overall Study|Sponsor terminated study|1|||
157143031|NCT00820040|567271214|FG000|Overall Study|Screen failure|1|||
157143032|NCT01259466|567271219|FG000|Overall Study|Withdrawal by Subject|1|||
157143033|NCT01259466|567271220|FG001|Overall Study|Withdrawal by Subject|9|||
157143034|NCT01824602|567271225|FG000|Overall Study|Withdrawal by Subject|0|||
157143035|NCT01824602|567271226|FG001|Overall Study|Withdrawal by Subject|0|||
157143036|NCT01824602|567271227|FG002|Overall Study|Withdrawal by Subject|1|||
157143037|NCT01824602|567271228|FG003|Overall Study|Withdrawal by Subject|2|||
157143038|NCT01824602|567271225|FG000|Overall Study|Patient non-compliance|0|||
157143039|NCT01824602|567271226|FG001|Overall Study|Patient non-compliance|0|||
157143040|NCT01824602|567271227|FG002|Overall Study|Patient non-compliance|1|||
157143041|NCT01824602|567271228|FG003|Overall Study|Patient non-compliance|0|||
157143042|NCT01824602|567271225|FG000|Overall Study|Adverse Event|1|||
157143043|NCT01824602|567271226|FG001|Overall Study|Adverse Event|0|||
157143044|NCT01824602|567271227|FG002|Overall Study|Adverse Event|2|||
157143045|NCT01824602|567271228|FG003|Overall Study|Adverse Event|2|||
157143046|NCT01824602|567271225|FG000|Overall Study|Treatment failure|0|||
157143047|NCT01824602|567271226|FG001|Overall Study|Treatment failure|0|||
157143048|NCT01824602|567271227|FG002|Overall Study|Treatment failure|0|||
157143049|NCT01824602|567271228|FG003|Overall Study|Treatment failure|1|||
157143050|NCT00184054|567271229|FG000|Overall Study|Adverse Event|1|||
157143051|NCT03885284|567271230|FG000|Overall Study|Disease Progression|1|||
157143052|NCT03885284|567271231|FG001|Overall Study|Disease Progression|3|||
157143053|NCT03885284|567271230|FG000|Overall Study|Physician Decision|0|||
157143054|NCT03885284|567271231|FG001|Overall Study|Physician Decision|1|||
157143055|NCT00002850|567271234|FG000|Overall Study|Death|4|||
157143056|NCT00002850|567271235|FG001|Overall Study|Death|1|||
157143057|NCT00002850|567271236|FG002|Overall Study|Death|3|||
157143058|NCT00002850|567271234|FG000|Overall Study|Protocol Violation|1|||
157143059|NCT00002850|567271235|FG001|Overall Study|Protocol Violation|0|||
157143060|NCT00002850|567271236|FG002|Overall Study|Protocol Violation|1|||
157143061|NCT00002850|567271234|FG000|Overall Study|Withdrawal by Subject|0|||
157143062|NCT00002850|567271235|FG001|Overall Study|Withdrawal by Subject|1|||
157143063|NCT00002850|567271236|FG002|Overall Study|Withdrawal by Subject|0|||
157143064|NCT01450540|567271237|FG000|Overall Study|Withdrawal by Subject|19|||
157143065|NCT01450540|567271238|FG001|Overall Study|Withdrawal by Subject|13|||
157143066|NCT01450540|567271237|FG000|Overall Study|protocol deviation|3|||
157143067|NCT01450540|567271238|FG001|Overall Study|protocol deviation|23|||
157143068|NCT01887210|567271239|FG000|Overall Study|Withdrawal by Subject|1|||
157143069|NCT01887210|567271240|FG001|Overall Study|Withdrawal by Subject|3|||
157143070|NCT01887210|567271239|FG000|Overall Study|Lost to Follow-up|0|||
157143071|NCT01887210|567271240|FG001|Overall Study|Lost to Follow-up|1|||
157143072|NCT00840463|567271244|FG000|Overall Study|Adverse Event|1|||
157143073|NCT00840463|567271245|FG001|Overall Study|Adverse Event|0|||
157143074|NCT00957372|567271252|FG000|PART I|Lost to Follow-up|0|||
157143075|NCT00957372|567271253|FG001|PART I|Lost to Follow-up|0|||
157219037|NCT02884206|567549281|FG001|Valsartan Run-in Period|Protocol deviation|0|||
157219038|NCT02884206|567549282|FG002|Valsartan Run-in Period|Protocol deviation|0|||
156744770|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744771|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744772|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
156744773|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
156744774|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744775|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744776|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744777|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
156744778|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
156798978|NCT02776735|566017295|FG002|Overall Study|Lost to Follow-up|0|||
157143076|NCT00957372|567271254|FG002|PART I|Lost to Follow-up|1|||
157143077|NCT00957372|567271255|FG003|PART I|Lost to Follow-up|0|||
156744779|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
157143078|NCT00957372|567271252|FG000|PART II|Withdrawal by Subject|0|||
157143079|NCT00957372|567271253|FG001|PART II|Withdrawal by Subject|0|||
157143080|NCT00957372|567271254|FG002|PART II|Withdrawal by Subject|0|||
157143081|NCT00957372|567271255|FG003|PART II|Withdrawal by Subject|8|||
157143082|NCT00957372|567271252|FG000|PART II|Physician Decision|0|||
157143083|NCT00957372|567271253|FG001|PART II|Physician Decision|0|||
157143084|NCT00957372|567271254|FG002|PART II|Physician Decision|0|||
157219039|NCT02884206|567549280|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
157219040|NCT02884206|567549281|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
157219041|NCT02884206|567549282|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
157219042|NCT02884206|567549280|FG000|Valsartan Run-in Period|Physician Decision|1|||
157219043|NCT02884206|567549281|FG001|Valsartan Run-in Period|Physician Decision|0|||
157219044|NCT02884206|567549282|FG002|Valsartan Run-in Period|Physician Decision|0|||
157219045|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Adverse Event|38|||
157219046|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Adverse Event|0|||
157219047|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Adverse Event|0|||
157219048|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Death|2|||
157219049|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Death|0|||
157219050|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Death|0|||
157219051|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
157219052|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
157219053|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
157219054|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
157219055|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
157219056|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
157219057|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
157219058|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
157219059|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
157219060|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Physician Decision|1|||
157219061|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Physician Decision|0|||
157219062|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Physician Decision|0|||
157219063|NCT02884206|567549280|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
157219064|NCT02884206|567549281|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
157219065|NCT02884206|567549282|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
157219066|NCT02884206|567549280|FG000|Double-Blind Period|Death|0|||
157219067|NCT02884206|567549281|FG001|Double-Blind Period|Death|28|||
157219068|NCT02884206|567549282|FG002|Double-Blind Period|Death|39|||
157219069|NCT02884206|567549280|FG000|Double-Blind Period|Patient/guardian decision|0|||
157219070|NCT02884206|567549281|FG001|Double-Blind Period|Patient/guardian decision|10|||
157219071|NCT02884206|567549282|FG002|Double-Blind Period|Patient/guardian decision|13|||
157219072|NCT02884206|567549280|FG000|Double-Blind Period|Lost to Follow-up|0|||
157219073|NCT02884206|567549281|FG001|Double-Blind Period|Lost to Follow-up|4|||
157219074|NCT02884206|567549282|FG002|Double-Blind Period|Lost to Follow-up|4|||
157219075|NCT02884206|567549280|FG000|Double-Blind Period|Physician Decision|0|||
157219076|NCT02884206|567549281|FG001|Double-Blind Period|Physician Decision|2|||
157219077|NCT02884206|567549282|FG002|Double-Blind Period|Physician Decision|0|||
157219078|NCT02884206|567549280|FG000|Double-Blind Period|Adverse Event|0|||
157219079|NCT02884206|567549281|FG001|Double-Blind Period|Adverse Event|0|||
157219080|NCT02884206|567549282|FG002|Double-Blind Period|Adverse Event|3|||
157219081|NCT02884206|567549280|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
157219082|NCT02884206|567549281|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
157219083|NCT02884206|567549282|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
157219084|NCT02322879|567549283|FG000|First Intervention|Physician Decision|1|||
157219085|NCT02322879|567549284|FG001|First Intervention|Physician Decision|0|||
157219086|NCT03487796|567549285|FG000|Overall Study|Lost to Follow-up|18|||
157219087|NCT03487796|567549286|FG001|Overall Study|Lost to Follow-up|6|||
157219088|NCT05487456|567549287|FG000|Overall Study|Withdrawal by Subject|0|||
157219089|NCT05487456|567549288|FG001|Overall Study|Withdrawal by Subject|0|||
157219090|NCT05487456|567549289|FG002|Overall Study|Withdrawal by Subject|1|||
157219091|NCT05487456|567549290|FG003|Overall Study|Withdrawal by Subject|0|||
157219092|NCT02711956|567549291|FG000|Overall Study|Adverse Event|0|||
157219093|NCT02711956|567549292|FG001|Overall Study|Adverse Event|0|||
157219094|NCT02711956|567549293|FG002|Overall Study|Adverse Event|0|||
157219095|NCT02711956|567549294|FG003|Overall Study|Adverse Event|1|||
157219096|NCT02711956|567549295|FG004|Overall Study|Adverse Event|2|||
157219097|NCT02711956|567549296|FG005|Overall Study|Adverse Event|0|||
157219098|NCT02711956|567549297|FG006|Overall Study|Adverse Event|0|||
157219099|NCT02711956|567549298|FG007|Overall Study|Adverse Event|1|||
157219100|NCT02711956|567549299|FG008|Overall Study|Adverse Event|1|||
157219101|NCT02711956|567549300|FG009|Overall Study|Adverse Event|1|||
157219102|NCT02711956|567549301|FG010|Overall Study|Adverse Event|1|||
157219103|NCT02711956|567549302|FG011|Overall Study|Adverse Event|0|||
157219104|NCT02711956|567549303|FG012|Overall Study|Adverse Event|0|||
156744780|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
156744781|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
157219105|NCT02711956|567549304|FG013|Overall Study|Adverse Event|0|||
157219106|NCT02711956|567549305|FG014|Overall Study|Adverse Event|2|||
157219107|NCT02711956|567549291|FG000|Overall Study|Physician Decision|0|||
157219108|NCT02711956|567549292|FG001|Overall Study|Physician Decision|0|||
157219109|NCT02711956|567549293|FG002|Overall Study|Physician Decision|0|||
157219110|NCT02711956|567549294|FG003|Overall Study|Physician Decision|2|||
156744782|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
157219111|NCT02711956|567549295|FG004|Overall Study|Physician Decision|0|||
157219112|NCT02711956|567549296|FG005|Overall Study|Physician Decision|0|||
157219113|NCT02711956|567549297|FG006|Overall Study|Physician Decision|0|||
157219114|NCT02711956|567549298|FG007|Overall Study|Physician Decision|0|||
157219115|NCT02711956|567549299|FG008|Overall Study|Physician Decision|0|||
157219116|NCT02711956|567549300|FG009|Overall Study|Physician Decision|0|||
157219117|NCT02711956|567549301|FG010|Overall Study|Physician Decision|0|||
157219118|NCT02711956|567549302|FG011|Overall Study|Physician Decision|0|||
157219119|NCT02711956|567549303|FG012|Overall Study|Physician Decision|0|||
157219120|NCT02711956|567549304|FG013|Overall Study|Physician Decision|0|||
157219121|NCT02711956|567549305|FG014|Overall Study|Physician Decision|0|||
157219122|NCT02711956|567549291|FG000|Overall Study|Withdrawal by Subject|0|||
157219123|NCT02711956|567549292|FG001|Overall Study|Withdrawal by Subject|0|||
157219124|NCT02711956|567549293|FG002|Overall Study|Withdrawal by Subject|0|||
157219125|NCT02711956|567549294|FG003|Overall Study|Withdrawal by Subject|0|||
157219126|NCT02711956|567549295|FG004|Overall Study|Withdrawal by Subject|0|||
157219127|NCT02711956|567549296|FG005|Overall Study|Withdrawal by Subject|0|||
157219128|NCT02711956|567549297|FG006|Overall Study|Withdrawal by Subject|1|||
157219129|NCT02711956|567549298|FG007|Overall Study|Withdrawal by Subject|0|||
157219130|NCT02711956|567549299|FG008|Overall Study|Withdrawal by Subject|0|||
157219131|NCT02711956|567549300|FG009|Overall Study|Withdrawal by Subject|0|||
157219132|NCT02711956|567549301|FG010|Overall Study|Withdrawal by Subject|0|||
157219133|NCT02711956|567549302|FG011|Overall Study|Withdrawal by Subject|1|||
157219134|NCT02711956|567549303|FG012|Overall Study|Withdrawal by Subject|6|||
157219135|NCT02711956|567549304|FG013|Overall Study|Withdrawal by Subject|0|||
157219136|NCT02711956|567549305|FG014|Overall Study|Withdrawal by Subject|1|||
157219137|NCT02711956|567549291|FG000|Overall Study|Clinical progression|1|||
157219138|NCT02711956|567549292|FG001|Overall Study|Clinical progression|0|||
157219139|NCT02711956|567549293|FG002|Overall Study|Clinical progression|0|||
157219140|NCT02711956|567549294|FG003|Overall Study|Clinical progression|0|||
157219141|NCT02711956|567549295|FG004|Overall Study|Clinical progression|0|||
157219142|NCT02711956|567549296|FG005|Overall Study|Clinical progression|0|||
157219143|NCT02711956|567549297|FG006|Overall Study|Clinical progression|1|||
157219144|NCT02711956|567549298|FG007|Overall Study|Clinical progression|0|||
157219145|NCT02711956|567549299|FG008|Overall Study|Clinical progression|1|||
157219146|NCT02711956|567549300|FG009|Overall Study|Clinical progression|0|||
157219147|NCT02711956|567549301|FG010|Overall Study|Clinical progression|0|||
157219148|NCT02711956|567549302|FG011|Overall Study|Clinical progression|2|||
157219149|NCT02711956|567549303|FG012|Overall Study|Clinical progression|4|||
157219150|NCT02711956|567549304|FG013|Overall Study|Clinical progression|1|||
157219151|NCT02711956|567549305|FG014|Overall Study|Clinical progression|1|||
157219152|NCT02711956|567549291|FG000|Overall Study|Radiographic progression|1|||
157219153|NCT02711956|567549292|FG001|Overall Study|Radiographic progression|1|||
157219154|NCT02711956|567549293|FG002|Overall Study|Radiographic progression|2|||
157219155|NCT02711956|567549294|FG003|Overall Study|Radiographic progression|0|||
157219156|NCT02711956|567549295|FG004|Overall Study|Radiographic progression|1|||
157219157|NCT02711956|567549296|FG005|Overall Study|Radiographic progression|0|||
157219158|NCT02711956|567549297|FG006|Overall Study|Radiographic progression|0|||
157219159|NCT02711956|567549298|FG007|Overall Study|Radiographic progression|0|||
157219160|NCT02711956|567549299|FG008|Overall Study|Radiographic progression|2|||
157219161|NCT02711956|567549300|FG009|Overall Study|Radiographic progression|1|||
157219162|NCT02711956|567549301|FG010|Overall Study|Radiographic progression|0|||
157219163|NCT02711956|567549302|FG011|Overall Study|Radiographic progression|5|||
157219164|NCT02711956|567549303|FG012|Overall Study|Radiographic progression|3|||
157219165|NCT02711956|567549304|FG013|Overall Study|Radiographic progression|0|||
157219166|NCT02711956|567549305|FG014|Overall Study|Radiographic progression|1|||
157219167|NCT02711956|567549291|FG000|Overall Study|PSA progression with clinical progression|0|||
157219168|NCT02711956|567549292|FG001|Overall Study|PSA progression with clinical progression|0|||
157219169|NCT02711956|567549293|FG002|Overall Study|PSA progression with clinical progression|0|||
157219170|NCT02711956|567549294|FG003|Overall Study|PSA progression with clinical progression|0|||
157219171|NCT02711956|567549295|FG004|Overall Study|PSA progression with clinical progression|1|||
157219172|NCT02711956|567549296|FG005|Overall Study|PSA progression with clinical progression|0|||
157219173|NCT02711956|567549297|FG006|Overall Study|PSA progression with clinical progression|0|||
157219174|NCT02711956|567549298|FG007|Overall Study|PSA progression with clinical progression|0|||
157219175|NCT02711956|567549299|FG008|Overall Study|PSA progression with clinical progression|0|||
156744783|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
156744784|NCT01004432|565813262|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
156744785|NCT01004432|565813263|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
157219176|NCT02711956|567549300|FG009|Overall Study|PSA progression with clinical progression|0|||
157219177|NCT02711956|567549301|FG010|Overall Study|PSA progression with clinical progression|0|||
157219178|NCT02711956|567549302|FG011|Overall Study|PSA progression with clinical progression|0|||
157219179|NCT02711956|567549303|FG012|Overall Study|PSA progression with clinical progression|1|||
156744786|NCT01004432|565813264|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
157219180|NCT02711956|567549304|FG013|Overall Study|PSA progression with clinical progression|1|||
157219181|NCT02711956|567549305|FG014|Overall Study|PSA progression with clinical progression|0|||
157219182|NCT02711956|567549291|FG000|Overall Study|PSA progression with radiographic progression|0|||
157219183|NCT02711956|567549292|FG001|Overall Study|PSA progression with radiographic progression|1|||
157219184|NCT02711956|567549293|FG002|Overall Study|PSA progression with radiographic progression|0|||
157219185|NCT02711956|567549294|FG003|Overall Study|PSA progression with radiographic progression|0|||
157219186|NCT02711956|567549295|FG004|Overall Study|PSA progression with radiographic progression|0|||
157219187|NCT02711956|567549296|FG005|Overall Study|PSA progression with radiographic progression|2|||
157219188|NCT02711956|567549297|FG006|Overall Study|PSA progression with radiographic progression|2|||
157219189|NCT02711956|567549298|FG007|Overall Study|PSA progression with radiographic progression|1|||
157219190|NCT02711956|567549299|FG008|Overall Study|PSA progression with radiographic progression|0|||
157219191|NCT02711956|567549300|FG009|Overall Study|PSA progression with radiographic progression|1|||
157219192|NCT02711956|567549301|FG010|Overall Study|PSA progression with radiographic progression|0|||
157219193|NCT02711956|567549302|FG011|Overall Study|PSA progression with radiographic progression|1|||
157219194|NCT02711956|567549303|FG012|Overall Study|PSA progression with radiographic progression|2|||
157219195|NCT02711956|567549304|FG013|Overall Study|PSA progression with radiographic progression|3|||
157219196|NCT02711956|567549305|FG014|Overall Study|PSA progression with radiographic progression|3|||
157219197|NCT02043366|567549308|FG000|Overall Study|Lost to Follow-up|2|||
157219198|NCT02043366|567549309|FG001|Overall Study|Lost to Follow-up|2|||
157219199|NCT02043366|567549310|FG002|Overall Study|Lost to Follow-up|2|||
157219200|NCT02043366|567549311|FG003|Overall Study|Lost to Follow-up|2|||
157219201|NCT02043366|567549312|FG004|Overall Study|Lost to Follow-up|2|||
157219202|NCT02043366|567549313|FG005|Overall Study|Lost to Follow-up|2|||
157219203|NCT03294538|567549316|FG000|Overall Study|Adverse Event|0|||
157219204|NCT03294538|567549317|FG001|Overall Study|Adverse Event|1|||
157219205|NCT03294538|567549318|FG002|Overall Study|Adverse Event|1|||
157219206|NCT03294538|567549316|FG000|Overall Study|Lost to Follow-up|1|||
157219207|NCT03294538|567549317|FG001|Overall Study|Lost to Follow-up|0|||
157219208|NCT03294538|567549318|FG002|Overall Study|Lost to Follow-up|0|||
157219209|NCT03294538|567549316|FG000|Overall Study|Outside of Visit Window|4|||
157219210|NCT03294538|567549317|FG001|Overall Study|Outside of Visit Window|4|||
157219211|NCT03294538|567549318|FG002|Overall Study|Outside of Visit Window|1|||
157219212|NCT01489956|567549320|FG000|Overall Study|Lost to Follow-up|1|||
157219213|NCT01489956|567549321|FG001|Overall Study|Lost to Follow-up|0|||
157219214|NCT01489956|567549322|FG002|Overall Study|Lost to Follow-up|0|||
157219215|NCT01489956|567549320|FG000|Overall Study|Withdrawal by Subject|0|||
157219216|NCT01489956|567549321|FG001|Overall Study|Withdrawal by Subject|0|||
157219217|NCT01489956|567549322|FG002|Overall Study|Withdrawal by Subject|1|||
157219218|NCT01090765|567549324|FG000|Overall Study|Patient withdrew consent|0|||
157219219|NCT01090765|567549325|FG001|Overall Study|Patient withdrew consent|0|||
157219220|NCT01090765|567549326|FG002|Overall Study|Patient withdrew consent|0|||
157219221|NCT01090765|567549327|FG003|Overall Study|Patient withdrew consent|0|||
157219222|NCT01090765|567549328|FG004|Overall Study|Patient withdrew consent|1|||
157219223|NCT01090765|567549329|FG005|Overall Study|Patient withdrew consent|1|||
157219224|NCT01090765|567549324|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
157219225|NCT01090765|567549325|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
157219226|NCT01090765|567549326|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
157219227|NCT01090765|567549327|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
157219228|NCT01090765|567549328|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
157219229|NCT01090765|567549329|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
157219230|NCT01090765|567549324|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
157219231|NCT01090765|567549325|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
157219232|NCT01090765|567549326|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
157219233|NCT01090765|567549327|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
157219234|NCT01090765|567549328|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
157219235|NCT01090765|567549329|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
156798979|NCT02776735|566017296|FG003|Overall Study|Lost to Follow-up|1|||
156798980|NCT02776735|566017297|FG004|Overall Study|Lost to Follow-up|0|||
156798981|NCT02776735|566017298|FG005|Overall Study|Lost to Follow-up|0|||
156798982|NCT02776735|566017293|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157219236|NCT00678392|567549330|FG000|Overall Study|Adverse Event|0|||
157219237|NCT00678392|567549331|FG001|Overall Study|Adverse Event|6|||
157219238|NCT00678392|567549330|FG000|Overall Study|Death|280|||
157219239|NCT00678392|567549331|FG001|Overall Study|Death|269|||
157219240|NCT00678392|567549330|FG000|Overall Study|Lost to Follow-up|15|||
157219241|NCT00678392|567549331|FG001|Overall Study|Lost to Follow-up|13|||
157219242|NCT00678392|567549330|FG000|Overall Study|Objective Progression or Relapse|3|||
157219243|NCT00678392|567549331|FG001|Overall Study|Objective Progression or Relapse|8|||
156798983|NCT02776735|566017294|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157020621|NCT03763708|566828473|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
156798984|NCT02776735|566017295|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156798985|NCT02776735|566017296|FG003|Overall Study|Withdrawal by parent/guardian|2|||
156798986|NCT02776735|566017297|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156798987|NCT02776735|566017298|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156798988|NCT02776735|566017293|FG000|Overall Study|Withdrawal by Subject|1|||
156798989|NCT02776735|566017294|FG001|Overall Study|Withdrawal by Subject|0|||
156798990|NCT02776735|566017295|FG002|Overall Study|Withdrawal by Subject|0|||
156798991|NCT02776735|566017296|FG003|Overall Study|Withdrawal by Subject|0|||
156798992|NCT02776735|566017297|FG004|Overall Study|Withdrawal by Subject|0|||
156798993|NCT02776735|566017298|FG005|Overall Study|Withdrawal by Subject|1|||
156798994|NCT02776735|566017293|FG000|Overall Study|Other|0|||
156798995|NCT02776735|566017294|FG001|Overall Study|Other|0|||
156798996|NCT02776735|566017295|FG002|Overall Study|Other|3|||
156798997|NCT02776735|566017296|FG003|Overall Study|Other|0|||
156798998|NCT02776735|566017297|FG004|Overall Study|Other|0|||
156798999|NCT02776735|566017298|FG005|Overall Study|Other|0|||
156799000|NCT05847686|566018879|FG000|Overall Study|Withdrawal by Subject|3|||
156799001|NCT01323192|566018880|FG000|Overall Study|Adverse Event|6|||
156799002|NCT01323192|566018881|FG001|Overall Study|Adverse Event|1|||
156799003|NCT01323192|566018880|FG000|Overall Study|Withdrawal by Subject|3|||
156799004|NCT01323192|566018881|FG001|Overall Study|Withdrawal by Subject|1|||
156799005|NCT01323192|566018880|FG000|Overall Study|Noncompliance with study medication|0|||
156799006|NCT01323192|566018881|FG001|Overall Study|Noncompliance with study medication|3|||
156799007|NCT01323192|566018880|FG000|Overall Study|Nonmedical reasons|0|||
156799008|NCT01323192|566018881|FG001|Overall Study|Nonmedical reasons|1|||
156799009|NCT03698279|566018882|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156799010|NCT03698279|566018883|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156799011|NCT03698279|566018884|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156799012|NCT03698279|566018885|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156799013|NCT03698279|566018886|FG004|Overall Study|Withdrawal by parent/guardian|0|||
156799014|NCT03698279|566018887|FG005|Overall Study|Withdrawal by parent/guardian|0|||
156799015|NCT03698279|566018882|FG000|Overall Study|Protocol deviation|1|||
156799016|NCT03698279|566018883|FG001|Overall Study|Protocol deviation|0|||
156799017|NCT03698279|566018884|FG002|Overall Study|Protocol deviation|1|||
156799018|NCT03698279|566018885|FG003|Overall Study|Protocol deviation|0|||
156799019|NCT03698279|566018886|FG004|Overall Study|Protocol deviation|0|||
156799020|NCT03698279|566018887|FG005|Overall Study|Protocol deviation|0|||
156799021|NCT03698279|566018882|FG000|Overall Study|Withdrawal by Subject|0|||
156799022|NCT03698279|566018883|FG001|Overall Study|Withdrawal by Subject|0|||
156799023|NCT03698279|566018884|FG002|Overall Study|Withdrawal by Subject|1|||
156799024|NCT03698279|566018885|FG003|Overall Study|Withdrawal by Subject|0|||
156799025|NCT03698279|566018886|FG004|Overall Study|Withdrawal by Subject|0|||
156799026|NCT03698279|566018887|FG005|Overall Study|Withdrawal by Subject|0|||
156799027|NCT03698279|566018882|FG000|Overall Study|Lost to Follow-up|3|||
156799028|NCT03698279|566018883|FG001|Overall Study|Lost to Follow-up|1|||
156799029|NCT03698279|566018884|FG002|Overall Study|Lost to Follow-up|4|||
156799030|NCT03698279|566018885|FG003|Overall Study|Lost to Follow-up|5|||
156799031|NCT03698279|566018886|FG004|Overall Study|Lost to Follow-up|0|||
156799032|NCT03698279|566018887|FG005|Overall Study|Lost to Follow-up|0|||
156799033|NCT03309202|566018891|FG000|Overall Study|Lost to Follow-up|1|||
156799034|NCT03309202|566018892|FG001|Overall Study|Lost to Follow-up|0|||
156799035|NCT03309202|566018893|FG002|Overall Study|Lost to Follow-up|0|||
156799036|NCT03309202|566018894|FG003|Overall Study|Lost to Follow-up|0|||
156799037|NCT00573768|566018895|FG000|Overall Study|Adverse Event|1|||
156799038|NCT00573768|566018896|FG001|Overall Study|Adverse Event|1|||
156799039|NCT00573768|566018897|FG002|Overall Study|Adverse Event|2|||
156799040|NCT00573768|566018895|FG000|Overall Study|Protocol Violation|1|||
156799041|NCT00573768|566018896|FG001|Overall Study|Protocol Violation|0|||
156799042|NCT00573768|566018897|FG002|Overall Study|Protocol Violation|1|||
156799043|NCT00573768|566018895|FG000|Overall Study|Withdrawal by Subject|0|||
156799044|NCT00573768|566018896|FG001|Overall Study|Withdrawal by Subject|1|||
156799045|NCT00573768|566018897|FG002|Overall Study|Withdrawal by Subject|0|||
156799046|NCT00573768|566018895|FG000|Overall Study|Lost to Follow-up|0|||
156799047|NCT00573768|566018896|FG001|Overall Study|Lost to Follow-up|0|||
156799048|NCT00573768|566018897|FG002|Overall Study|Lost to Follow-up|1|||
156799049|NCT01500317|566018902|FG000|Overall Study|Withdrawal by Subject|3|||
156799050|NCT01500317|566018903|FG001|Overall Study|Withdrawal by Subject|2|||
156799051|NCT01500317|566018904|FG002|Overall Study|Withdrawal by Subject|0|||
156879539|NCT00689117|566318133|FG001|Overall Study|Incarceration|0|||
156879540|NCT00689117|566318134|FG002|Overall Study|Incarceration|0|||
156879541|NCT00689117|566318135|FG003|Overall Study|Incarceration|0|||
156879542|NCT00689117|566318132|FG000|Overall Study|Fear of Birth Defects|0|||
156799052|NCT00976456|566018905|FG000|Overall Study|Adverse Event|17|||
156879543|NCT00689117|566318133|FG001|Overall Study|Fear of Birth Defects|0|||
156879544|NCT00689117|566318134|FG002|Overall Study|Fear of Birth Defects|1|||
156879545|NCT00689117|566318135|FG003|Overall Study|Fear of Birth Defects|0|||
156799053|NCT00976456|566018906|FG001|Overall Study|Adverse Event|22|||
156799054|NCT00976456|566018905|FG000|Overall Study|Death|7|||
156799055|NCT00976456|566018906|FG001|Overall Study|Death|9|||
156879546|NCT00689117|566318132|FG000|Overall Study|Transportation|1|||
156879547|NCT00689117|566318133|FG001|Overall Study|Transportation|0|||
156879548|NCT00689117|566318134|FG002|Overall Study|Transportation|0|||
156879549|NCT00689117|566318135|FG003|Overall Study|Transportation|0|||
156879550|NCT00689117|566318132|FG000|Overall Study|Patient Withdrew from Study|0|||
156879551|NCT00689117|566318133|FG001|Overall Study|Patient Withdrew from Study|0|||
156879552|NCT00689117|566318134|FG002|Overall Study|Patient Withdrew from Study|0|||
156879553|NCT00689117|566318135|FG003|Overall Study|Patient Withdrew from Study|1|||
156879554|NCT00689117|566318132|FG000|Overall Study|Personal Reason|0|||
156879555|NCT00689117|566318133|FG001|Overall Study|Personal Reason|1|||
156879556|NCT00689117|566318134|FG002|Overall Study|Personal Reason|0|||
156879557|NCT00689117|566318135|FG003|Overall Study|Personal Reason|0|||
156879558|NCT00689117|566318132|FG000|Overall Study|Dispensing Error|0|||
156879559|NCT00689117|566318133|FG001|Overall Study|Dispensing Error|1|||
156879560|NCT00689117|566318134|FG002|Overall Study|Dispensing Error|0|||
156879561|NCT00689117|566318135|FG003|Overall Study|Dispensing Error|0|||
156879562|NCT00444678|566318136|FG000|Overall Study|Toxicity|11|||
156879563|NCT00444678|566318136|FG000|Overall Study|Disease Progression|12|||
156879564|NCT00444678|566318136|FG000|Overall Study|Death|3|||
156879565|NCT00444678|566318136|FG000|Overall Study|Physician Decision|3|||
156879566|NCT00444678|566318136|FG000|Overall Study|Withdrawal by Subject|2|||
156879567|NCT01589653|566318142|FG000|Overall Study|Protocol Violation|3|||
156879568|NCT01589653|566318143|FG001|Overall Study|Protocol Violation|1|||
156879569|NCT01589653|566318142|FG000|Overall Study|Withdrawal criteria|4|||
156879570|NCT01589653|566318143|FG001|Overall Study|Withdrawal criteria|7|||
156879571|NCT01589653|566318142|FG000|Overall Study|Unclassified|0|||
156879572|NCT01589653|566318143|FG001|Overall Study|Unclassified|3|||
156879573|NCT01536067|566318144|FG000|Overall Study|Disease Progression|1|||
156879574|NCT04657666|566318147|FG000|Period 1|Withdrawal of participant consent|2|||
156879575|NCT04657666|566318148|FG001|Period 1|Withdrawal of participant consent|1|||
156879576|NCT04657666|566318147|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
156879577|NCT04657666|566318148|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
156879578|NCT04657666|566318147|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
156879579|NCT04657666|566318148|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
156879580|NCT04657666|566318147|FG000|Period 2|Other|2|||
156879581|NCT04657666|566318148|FG001|Period 2|Other|0|||
156879582|NCT04657666|566318147|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
156879583|NCT04657666|566318148|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
156879584|NCT02386189|566318149|FG000|Overall Study|Lost to Follow-up|2|||
156879585|NCT02386189|566318150|FG001|Overall Study|Lost to Follow-up|3|||
156879586|NCT02386189|566318149|FG000|Overall Study|Withdrawal by Subject|1|||
156879587|NCT02386189|566318150|FG001|Overall Study|Withdrawal by Subject|0|||
156879588|NCT02386189|566318149|FG000|Overall Study|Death|1|||
156879589|NCT02386189|566318150|FG001|Overall Study|Death|0|||
156879590|NCT00606905|566318151|FG000|Overall Study|No Pregnancy|9|||
156879591|NCT00606905|566318152|FG001|Overall Study|No Pregnancy|6|||
156879592|NCT00606905|566318151|FG000|Overall Study|Non-Index Pregnancy|1|||
156879593|NCT00606905|566318152|FG001|Overall Study|Non-Index Pregnancy|4|||
156879594|NCT00606905|566318151|FG000|Overall Study|Withdrew|5|||
156879595|NCT00606905|566318152|FG001|Overall Study|Withdrew|5|||
156879596|NCT03120351|566318153|FG000|Overall Study|Physician Decision|1|||
156879597|NCT03120351|566318154|FG001|Overall Study|Physician Decision|1|||
156879598|NCT01022398|566318163|FG000|Overall Study|Study terminated|2|||
156879599|NCT01022398|566318164|FG001|Overall Study|Study terminated|2|||
156879600|NCT03319745|566318166|FG000|Overall Study|Death|1|||
156879601|NCT03319745|566318166|FG000|Overall Study|Toxicity Precluding Surgery|1|||
156879602|NCT00870103|566318167|FG000|Overall Study|Physician Decision|2|||
156879603|NCT00870103|566318167|FG000|Overall Study|Lost to Follow-up|2|||
156879604|NCT01317550|566318168|FG000|Overall Study|Withdrawal by Subject|1|||
156879605|NCT01317550|566318169|FG001|Overall Study|Withdrawal by Subject|0|||
156879606|NCT01317550|566318170|FG002|Overall Study|Withdrawal by Subject|0|||
156879607|NCT01317550|566318171|FG003|Overall Study|Withdrawal by Subject|0|||
156879608|NCT01317550|566318168|FG000|Overall Study|Lack of compliance study med|1|||
156879609|NCT01317550|566318169|FG001|Overall Study|Lack of compliance study med|0|||
156879610|NCT01317550|566318170|FG002|Overall Study|Lack of compliance study med|0|||
157143085|NCT00957372|567271255|FG003|PART II|Physician Decision|1|||
156879611|NCT01317550|566318171|FG003|Overall Study|Lack of compliance study med|0|||
156879612|NCT01086358|566318172|FG000|First Intervention|Lost to Follow-up|9|||
156879613|NCT01086358|566318173|FG001|First Intervention|Lost to Follow-up|4|||
156879614|NCT01086358|566318172|FG000|First Intervention|Withdrawal by Subject|0|||
156879615|NCT01086358|566318173|FG001|First Intervention|Withdrawal by Subject|1|||
156879616|NCT01086358|566318172|FG000|Second Intervention|Lost to Follow-up|4|||
156879617|NCT01086358|566318173|FG001|Second Intervention|Lost to Follow-up|4|||
156879618|NCT00833417|566318174|FG000|Overall Study|Adverse Event|5|||
156879619|NCT00833417|566318175|FG001|Overall Study|Adverse Event|16|||
156879620|NCT00833417|566318174|FG000|Overall Study|Death|1|||
156879621|NCT00833417|566318175|FG001|Overall Study|Death|3|||
156879622|NCT00833417|566318174|FG000|Overall Study|Lost to Follow-up|1|||
157143086|NCT00957372|567271252|FG000|PART II|Pregnancy|0|||
157219244|NCT00678392|567549330|FG000|Overall Study|Sponsor's Decision|1|||
157219245|NCT00678392|567549331|FG001|Overall Study|Sponsor's Decision|2|||
157219246|NCT00678392|567549330|FG000|Overall Study|Withdrawal by Subject|4|||
157219247|NCT00678392|567549331|FG001|Overall Study|Withdrawal by Subject|4|||
157219248|NCT00678392|567549330|FG000|Overall Study|Randomized But Not Treated|2|||
157219249|NCT00678392|567549331|FG001|Overall Study|Randomized But Not Treated|7|||
157219250|NCT00678392|567549330|FG000|Overall Study|Other|56|||
157219251|NCT00678392|567549331|FG001|Overall Study|Other|53|||
157219252|NCT00718159|567549336|FG000|Overall Study|Progressive Disease|3|||
157219253|NCT00718159|567549337|FG001|Overall Study|Progressive Disease|3|||
157219254|NCT00718159|567549338|FG002|Overall Study|Progressive Disease|2|||
157219255|NCT00718159|567549339|FG003|Overall Study|Progressive Disease|0|||
157219256|NCT00718159|567549340|FG004|Overall Study|Progressive Disease|6|||
157219257|NCT00718159|567549341|FG005|Overall Study|Progressive Disease|0|||
157219258|NCT00718159|567549342|FG006|Overall Study|Progressive Disease|0|||
157219259|NCT00718159|567549336|FG000|Overall Study|Death due to Adverse Event|0|||
157219260|NCT00718159|567549337|FG001|Overall Study|Death due to Adverse Event|0|||
157219261|NCT00718159|567549338|FG002|Overall Study|Death due to Adverse Event|0|||
157219262|NCT00718159|567549339|FG003|Overall Study|Death due to Adverse Event|2|||
157219263|NCT00718159|567549340|FG004|Overall Study|Death due to Adverse Event|2|||
157219264|NCT00718159|567549341|FG005|Overall Study|Death due to Adverse Event|0|||
157219265|NCT00718159|567549342|FG006|Overall Study|Death due to Adverse Event|0|||
157219266|NCT00718159|567549336|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
157219267|NCT00718159|567549337|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
157219268|NCT00718159|567549338|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
157219269|NCT00718159|567549339|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
157219270|NCT00718159|567549340|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
157219271|NCT00718159|567549341|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
157219272|NCT00718159|567549342|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
157219273|NCT00718159|567549336|FG000|Overall Study|Investigator Decision|0|||
157219274|NCT00718159|567549337|FG001|Overall Study|Investigator Decision|0|||
157219275|NCT00718159|567549338|FG002|Overall Study|Investigator Decision|0|||
157219276|NCT00718159|567549339|FG003|Overall Study|Investigator Decision|0|||
157219277|NCT00718159|567549340|FG004|Overall Study|Investigator Decision|0|||
157219278|NCT00718159|567549341|FG005|Overall Study|Investigator Decision|1|||
157219279|NCT00718159|567549342|FG006|Overall Study|Investigator Decision|1|||
157219280|NCT01401478|567549345|FG000|Overall Study|Study drug not available|6|||
157219281|NCT01401478|567549345|FG000|Overall Study|Adverse Event|5|||
157219282|NCT01401478|567549345|FG000|Overall Study|Hyperphosphatemia|5|||
157219283|NCT01401478|567549345|FG000|Overall Study|Lost to Follow-up|5|||
157219284|NCT01401478|567549345|FG000|Overall Study|Kidney transplantation|3|||
157219285|NCT01401478|567549345|FG000|Overall Study|Withdrawal by Subject|3|||
157219286|NCT01401478|567549345|FG000|Overall Study|Blood samples not available|1|||
157219287|NCT01401478|567549345|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
157219288|NCT01401478|567549345|FG000|Overall Study|Low intact parathyroid hormone|1|||
157219289|NCT01401478|567549345|FG000|Overall Study|Serious adverse event|1|||
157219290|NCT01427803|567549346|FG000|Overall Study|Lost to Follow-up|32|||
157219291|NCT01427803|567549347|FG001|Overall Study|Lost to Follow-up|26|||
157219292|NCT01427803|567549346|FG000|Overall Study|Withdrawal by Subject|20|||
157219293|NCT01427803|567549347|FG001|Overall Study|Withdrawal by Subject|0|||
157219294|NCT01427803|567549346|FG000|Overall Study|Unable to complete full treatment period|6|||
157219295|NCT01427803|567549347|FG001|Overall Study|Unable to complete full treatment period|0|||
157219296|NCT01427803|567549346|FG000|Overall Study|Protocol Violation|1|||
157219297|NCT01427803|567549347|FG001|Overall Study|Protocol Violation|0|||
157219298|NCT01427803|567549346|FG000|Overall Study|Physician Decision|3|||
157219299|NCT01427803|567549347|FG001|Overall Study|Physician Decision|0|||
157219300|NCT01427803|567549346|FG000|Overall Study|did not take product|1|||
157219301|NCT01427803|567549347|FG001|Overall Study|did not take product|0|||
157219302|NCT03412019|567549348|FG000|Overall Study|Withdrawal by Subject|1|||
157219303|NCT03412019|567549349|FG001|Overall Study|Withdrawal by Subject|1|||
157219304|NCT01001169|567549350|FG000|Overall Study|Withdrawal by Subject|2|||
157219305|NCT01001169|567549351|FG001|Overall Study|Withdrawal by Subject|1|||
157219306|NCT02168270|567549352|FG000|Overall Study|Lack of Efficacy|4|||
156744787|NCT01004432|565813265|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
157219307|NCT00706706|567549353|FG000|Overall Study|Death|53|||
157219308|NCT00706706|567549353|FG000|Overall Study|Lost to Follow-up|7|||
157219309|NCT00706706|567549353|FG000|Overall Study|Study endpoint had reached|45|||
157219310|NCT01752920|567549354|FG000|Overall Study|Adverse Event|1|||
157219311|NCT01752920|567549355|FG001|Overall Study|Adverse Event|0|||
156744788|NCT01004432|565813266|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
156744789|NCT04526574|565813268|FG000|Overall Study|Protocol Violation|3|||
157219312|NCT01752920|567549356|FG002|Overall Study|Adverse Event|5|||
157219313|NCT01752920|567549357|FG003|Overall Study|Adverse Event|10|||
157219314|NCT01752920|567549354|FG000|Overall Study|Clinical Disease Progression|6|||
157219315|NCT01752920|567549355|FG001|Overall Study|Clinical Disease Progression|4|||
156744790|NCT04526574|565813269|FG001|Overall Study|Protocol Violation|1|||
156799056|NCT00976456|566018905|FG000|Overall Study|Lack of Efficacy|5|||
156799057|NCT00976456|566018906|FG001|Overall Study|Lack of Efficacy|2|||
156799058|NCT00976456|566018905|FG000|Overall Study|Withdrawal by Subject|3|||
156799059|NCT00976456|566018906|FG001|Overall Study|Withdrawal by Subject|1|||
156799060|NCT00976456|566018905|FG000|Overall Study|screening failure, unknown|11|||
156799061|NCT00976456|566018906|FG001|Overall Study|screening failure, unknown|4|||
156799062|NCT00335829|566018907|FG000|Overall Study|Withdrawal by Subject|1|||
156799063|NCT00335829|566018907|FG000|Overall Study|Lost to Follow-up|1|||
156799064|NCT00335829|566018907|FG000|Overall Study|Adverse Event|1|||
156799065|NCT02090764|566018910|FG000|Overall Study|Adverse Event|1|||
156799066|NCT02090764|566018911|FG001|Overall Study|Adverse Event|3|||
156799067|NCT02090764|566018910|FG000|Overall Study|Lack of Efficacy|0|||
156799068|NCT02090764|566018911|FG001|Overall Study|Lack of Efficacy|13|||
156799069|NCT02090764|566018910|FG000|Overall Study|Withdrawal by Subject|2|||
156799070|NCT02090764|566018911|FG001|Overall Study|Withdrawal by Subject|1|||
156799071|NCT02090764|566018910|FG000|Overall Study|Intercurrent illness and other|1|||
156799072|NCT02090764|566018911|FG001|Overall Study|Intercurrent illness and other|1|||
156799073|NCT02090764|566018910|FG000|Overall Study|Lost to Follow-up|2|||
156799074|NCT02090764|566018911|FG001|Overall Study|Lost to Follow-up|2|||
156799075|NCT04617860|566018912|FG000|Overall Study|Adverse Event|0|||
156799076|NCT04617860|566018913|FG001|Overall Study|Adverse Event|2|||
156799077|NCT04617860|566018914|FG002|Overall Study|Adverse Event|2|||
156799078|NCT04617860|566018912|FG000|Overall Study|Withdrawal by Subject|0|||
156799079|NCT04617860|566018913|FG001|Overall Study|Withdrawal by Subject|0|||
156799080|NCT04617860|566018914|FG002|Overall Study|Withdrawal by Subject|2|||
156799081|NCT04617860|566018912|FG000|Overall Study|Physician Decision|0|||
156799082|NCT04617860|566018913|FG001|Overall Study|Physician Decision|1|||
156799083|NCT04617860|566018914|FG002|Overall Study|Physician Decision|0|||
156799084|NCT04617860|566018912|FG000|Overall Study|Sponsor Decision|0|||
156799085|NCT04617860|566018913|FG001|Overall Study|Sponsor Decision|3|||
156799086|NCT04617860|566018914|FG002|Overall Study|Sponsor Decision|1|||
156799087|NCT04617860|566018912|FG000|Overall Study|Termination of Study by Sponsor|8|||
156799088|NCT04617860|566018913|FG001|Overall Study|Termination of Study by Sponsor|4|||
156799089|NCT04617860|566018914|FG002|Overall Study|Termination of Study by Sponsor|13|||
156799090|NCT00673920|566018925|FG000|Baseline up to Week 48|Withdrew consent|1|||
156799091|NCT00673920|566018926|FG001|Baseline up to Week 48|Withdrew consent|0|||
156799092|NCT00673920|566018927|FG002|Baseline up to Week 48|Withdrew consent|2|||
156799093|NCT00673920|566018928|FG003|Baseline up to Week 48|Withdrew consent|0|||
156799094|NCT00673920|566018929|FG004|Baseline up to Week 48|Withdrew consent|0|||
156799095|NCT00673920|566018930|FG005|Baseline up to Week 48|Withdrew consent|0|||
156799096|NCT00673920|566018931|FG006|Baseline up to Week 48|Withdrew consent|0|||
156799097|NCT00673920|566018932|FG007|Baseline up to Week 48|Withdrew consent|0|||
156799098|NCT00673920|566018925|FG000|Baseline up to Week 48|Refused treatment|1|||
156799099|NCT00673920|566018926|FG001|Baseline up to Week 48|Refused treatment|0|||
156799100|NCT00673920|566018927|FG002|Baseline up to Week 48|Refused treatment|0|||
156799101|NCT00673920|566018928|FG003|Baseline up to Week 48|Refused treatment|0|||
156799102|NCT00673920|566018929|FG004|Baseline up to Week 48|Refused treatment|0|||
156799103|NCT00673920|566018930|FG005|Baseline up to Week 48|Refused treatment|0|||
156799104|NCT00673920|566018931|FG006|Baseline up to Week 48|Refused treatment|0|||
156799105|NCT00673920|566018932|FG007|Baseline up to Week 48|Refused treatment|0|||
156799106|NCT00673920|566018925|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
156799107|NCT00673920|566018926|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
156799108|NCT00673920|566018927|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799109|NCT00673920|566018928|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799110|NCT00673920|566018929|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799111|NCT00673920|566018930|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799112|NCT00673920|566018931|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799113|NCT00673920|566018932|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
156799114|NCT00673920|566018925|FG000|Baseline up to Week 48|Protocol Violation|0|||
156799115|NCT00673920|566018926|FG001|Baseline up to Week 48|Protocol Violation|0|||
156799116|NCT00673920|566018927|FG002|Baseline up to Week 48|Protocol Violation|1|||
156799117|NCT00673920|566018928|FG003|Baseline up to Week 48|Protocol Violation|0|||
156799118|NCT00673920|566018929|FG004|Baseline up to Week 48|Protocol Violation|0|||
156799119|NCT00673920|566018930|FG005|Baseline up to Week 48|Protocol Violation|0|||
156799120|NCT00673920|566018931|FG006|Baseline up to Week 48|Protocol Violation|0|||
156799121|NCT00673920|566018932|FG007|Baseline up to Week 48|Protocol Violation|0|||
156799122|NCT00673920|566018925|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799123|NCT00673920|566018926|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799124|NCT00673920|566018927|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
156799125|NCT00673920|566018928|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799126|NCT00673920|566018929|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799127|NCT00673920|566018930|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799128|NCT00673920|566018931|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156879623|NCT00833417|566318175|FG001|Overall Study|Lost to Follow-up|2|||
157219316|NCT01752920|567549356|FG002|Overall Study|Clinical Disease Progression|1|||
157219317|NCT01752920|567549357|FG003|Overall Study|Clinical Disease Progression|13|||
157219318|NCT01752920|567549354|FG000|Overall Study|Physician Decision|1|||
157219319|NCT01752920|567549355|FG001|Overall Study|Physician Decision|0|||
157219320|NCT01752920|567549356|FG002|Overall Study|Physician Decision|0|||
157219321|NCT01752920|567549357|FG003|Overall Study|Physician Decision|3|||
157219322|NCT01752920|567549354|FG000|Overall Study|Radiographic Disease Progression|20|||
157219323|NCT01752920|567549355|FG001|Overall Study|Radiographic Disease Progression|7|||
157219324|NCT01752920|567549356|FG002|Overall Study|Radiographic Disease Progression|12|||
157219325|NCT01752920|567549357|FG003|Overall Study|Radiographic Disease Progression|29|||
157219326|NCT01752920|567549354|FG000|Overall Study|Study Terminated by Sponsor|0|||
157219327|NCT01752920|567549355|FG001|Overall Study|Study Terminated by Sponsor|0|||
157219328|NCT01752920|567549356|FG002|Overall Study|Study Terminated by Sponsor|0|||
157219329|NCT01752920|567549357|FG003|Overall Study|Study Terminated by Sponsor|1|||
157219330|NCT01752920|567549354|FG000|Overall Study|Withdrawal by Subject|0|||
157219331|NCT01752920|567549355|FG001|Overall Study|Withdrawal by Subject|1|||
157219332|NCT01752920|567549356|FG002|Overall Study|Withdrawal by Subject|0|||
157219333|NCT01752920|567549357|FG003|Overall Study|Withdrawal by Subject|1|||
157219334|NCT01752920|567549354|FG000|Overall Study|Lack of clinical benefit|1|||
157219335|NCT01752920|567549355|FG001|Overall Study|Lack of clinical benefit|1|||
157219336|NCT01752920|567549356|FG002|Overall Study|Lack of clinical benefit|1|||
157219337|NCT01752920|567549357|FG003|Overall Study|Lack of clinical benefit|1|||
157219338|NCT00947856|567549364|FG000|Treatment Period|Progressive Disease|33|||
157219339|NCT00947856|567549365|FG001|Treatment Period|Progressive Disease|12|||
157219340|NCT00947856|567549364|FG000|Treatment Period|Adverse Event|15|||
157219341|NCT00947856|567549365|FG001|Treatment Period|Adverse Event|9|||
157219342|NCT00947856|567549364|FG000|Treatment Period|Physician Decision|14|||
156879624|NCT00833417|566318174|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
156879625|NCT00833417|566318175|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
156879626|NCT00833417|566318174|FG000|Overall Study|Patient Decision to Withdraw|4|||
156879627|NCT00833417|566318175|FG001|Overall Study|Patient Decision to Withdraw|23|||
156879628|NCT00833417|566318174|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
156879629|NCT00833417|566318175|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
156879630|NCT00833417|566318174|FG000|Overall Study|Disease Progression|18|||
156879631|NCT00833417|566318175|FG001|Overall Study|Disease Progression|17|||
156879632|NCT00833417|566318174|FG000|Overall Study|Reason Not Specified|0|||
156879633|NCT00833417|566318175|FG001|Overall Study|Reason Not Specified|1|||
156879634|NCT01327482|566318176|FG000|Overall Study|Adverse Event|1|||
156879635|NCT00312195|566318177|FG000|Overall Study|Adverse Event|4|||
156879636|NCT00312195|566318178|FG001|Overall Study|Adverse Event|6|||
156879637|NCT00312195|566318177|FG000|Overall Study|Lost to Follow-up|1|||
156879638|NCT00312195|566318178|FG001|Overall Study|Lost to Follow-up|0|||
156879639|NCT00312195|566318177|FG000|Overall Study|Protocol Violation|1|||
156879640|NCT00312195|566318178|FG001|Overall Study|Protocol Violation|0|||
156879641|NCT01018810|566318179|FG000|Overall Study|Withdrawal by Subject|0|||
156879642|NCT01018810|566318180|FG001|Overall Study|Withdrawal by Subject|1|||
156879643|NCT01018810|566318181|FG002|Overall Study|Withdrawal by Subject|0|||
156879644|NCT01018810|566318182|FG003|Overall Study|Withdrawal by Subject|0|||
156879645|NCT01018810|566318183|FG004|Overall Study|Withdrawal by Subject|0|||
156879646|NCT01018810|566318179|FG000|Overall Study|Sponsor Decision|2|||
156879647|NCT01018810|566318180|FG001|Overall Study|Sponsor Decision|0|||
156879648|NCT01018810|566318181|FG002|Overall Study|Sponsor Decision|1|||
156879649|NCT01018810|566318182|FG003|Overall Study|Sponsor Decision|1|||
156879650|NCT01018810|566318183|FG004|Overall Study|Sponsor Decision|1|||
156879651|NCT02872935|566318188|FG000|Overall Study|Other|0|||
156879652|NCT02872935|566318189|FG001|Overall Study|Other|1|||
156879653|NCT03179319|566318192|FG000|Overall Study|Lost to Follow-up|6|||
156879654|NCT03179319|566318193|FG001|Overall Study|Lost to Follow-up|0|||
156879655|NCT01120717|566318194|FG000|Overall Study|Withdrawal by Subject|11|||
156879656|NCT01120717|566318195|FG001|Overall Study|Withdrawal by Subject|6|||
156879657|NCT01120717|566318194|FG000|Overall Study|Adverse Event|10|||
157020622|NCT03332017|566828479|FG000|Overall Study|Lost to Follow-up|1|||
157020623|NCT03332017|566828480|FG001|Overall Study|Lost to Follow-up|2|||
157219343|NCT00947856|567549365|FG001|Treatment Period|Physician Decision|6|||
157219344|NCT00947856|567549364|FG000|Treatment Period|Study Stopped by Sponsor|4|||
157219345|NCT00947856|567549365|FG001|Treatment Period|Study Stopped by Sponsor|4|||
157219346|NCT00947856|567549364|FG000|Treatment Period|Withdrawal by Subject|12|||
157219347|NCT00947856|567549365|FG001|Treatment Period|Withdrawal by Subject|1|||
156879658|NCT01120717|566318195|FG001|Overall Study|Adverse Event|6|||
156879659|NCT01120717|566318194|FG000|Overall Study|Protocol Deviation|2|||
156879660|NCT01120717|566318195|FG001|Overall Study|Protocol Deviation|5|||
156879661|NCT01120717|566318194|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
156879662|NCT01120717|566318195|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
157020624|NCT03332017|566828479|FG000|Overall Study|Death|17|||
156879663|NCT01120717|566318194|FG000|Overall Study|Lost to Follow-up|2|||
157219348|NCT00947856|567549364|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
157219349|NCT00947856|567549365|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
157219350|NCT00947856|567549364|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
157219351|NCT00947856|567549365|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
157219352|NCT00947856|567549364|FG000|Follow-up Period|Lost to Follow-up|7|||
157219353|NCT00947856|567549365|FG001|Follow-up Period|Lost to Follow-up|0|||
157219354|NCT00947856|567549364|FG000|Follow-up Period|Patient unavailable for site visits|1|||
157219355|NCT00947856|567549365|FG001|Follow-up Period|Patient unavailable for site visits|0|||
157219356|NCT00947856|567549364|FG000|Follow-up Period|Withdrawal by Subject|1|||
157219357|NCT00947856|567549365|FG001|Follow-up Period|Withdrawal by Subject|0|||
157219358|NCT00771901|567549366|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
157219359|NCT00771901|567549367|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
157219360|NCT00771901|567549368|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
157219361|NCT02280356|567549369|FG000|Overall Study|Not Treated|2|||
157219362|NCT02280356|567549369|FG000|Overall Study|Withdrawal by Subject|1|||
157219363|NCT02280356|567549369|FG000|Overall Study|Not evaluable|2|||
157219364|NCT03493698|567549377|FG000|Treatment Period C|Adverse Event|1|||
157219365|NCT03493698|567549377|FG000|Treatment Period C|Withdrawal by Subject|1|||
157219366|NCT00291330|567549378|FG000|Overall Study|Adverse Event|47|||
157219367|NCT00291330|567549379|FG001|Overall Study|Adverse Event|40|||
157219368|NCT00291330|567549378|FG000|Overall Study|Protocol Violation|13|||
157219369|NCT00291330|567549379|FG001|Overall Study|Protocol Violation|20|||
157219370|NCT00291330|567549378|FG000|Overall Study|Lost to Follow-up|16|||
157219371|NCT00291330|567549379|FG001|Overall Study|Lost to Follow-up|11|||
157219372|NCT00291330|567549378|FG000|Overall Study|Withdrawal by Subject|22|||
157219373|NCT00291330|567549379|FG001|Overall Study|Withdrawal by Subject|25|||
157219374|NCT00291330|567549378|FG000|Overall Study|Other|3|||
157219375|NCT00291330|567549379|FG001|Overall Study|Other|1|||
157219376|NCT02629965|567549382|FG000|Period 1|Adverse Event|1|||
157219377|NCT02629965|567549383|FG001|Period 1|Adverse Event|0|||
157219378|NCT02629965|567549382|FG000|Period 1|Unexpected worsening of disease|2|||
157219379|NCT02629965|567549383|FG001|Period 1|Unexpected worsening of disease|0|||
157219380|NCT02629965|567549382|FG000|Period 1|Other than listed above|1|||
157219381|NCT02629965|567549383|FG001|Period 1|Other than listed above|2|||
157219382|NCT02629965|567549382|FG000|Period 2|Adverse Event|1|||
157219383|NCT02629965|567549383|FG001|Period 2|Adverse Event|0|||
157219384|NCT03443869|567549384|FG000|Overall Study|Death|3|||
157219385|NCT03443869|567549385|FG001|Overall Study|Death|3|||
157219386|NCT03443869|567549384|FG000|Overall Study|Withdrawal by Subject|34|||
157219387|NCT03443869|567549385|FG001|Overall Study|Withdrawal by Subject|22|||
157219388|NCT03443869|567549384|FG000|Overall Study|Lost to Follow-up|1|||
157219389|NCT03443869|567549385|FG001|Overall Study|Lost to Follow-up|2|||
157219390|NCT03443869|567549384|FG000|Overall Study|Physician Decision|3|||
157219391|NCT03443869|567549385|FG001|Overall Study|Physician Decision|3|||
157219392|NCT03443869|567549384|FG000|Overall Study|Other|4|||
157219393|NCT03443869|567549385|FG001|Overall Study|Other|4|||
157219394|NCT02390219|567549386|FG000|Overall Study|Death|1|||
157219395|NCT02390219|567549386|FG000|Overall Study|Physician Decision|1|||
157219396|NCT02390219|567549386|FG000|Overall Study|Adverse Event|6|||
157219397|NCT02390219|567549386|FG000|Overall Study|Withdrawal by Subject|1|||
157219398|NCT02390219|567549386|FG000|Overall Study|Lost to Follow-up|2|||
157219399|NCT02390219|567549386|FG000|Overall Study|Other|2|||
157219400|NCT00299728|567549387|FG000|Overall Study|Lost to Follow-up|0|||
157219401|NCT00299728|567549388|FG001|Overall Study|Lost to Follow-up|1|||
157219402|NCT00299728|567549387|FG000|Overall Study|Withdrawal by Subject|0|||
157219403|NCT00299728|567549388|FG001|Overall Study|Withdrawal by Subject|1|||
157219404|NCT00299728|567549387|FG000|Overall Study|Progressive disease|0|||
157219405|NCT00299728|567549388|FG001|Overall Study|Progressive disease|1|||
157219406|NCT01855126|567549391|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
157219407|NCT01855126|567549392|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
157219408|NCT01855126|567549391|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
157219409|NCT01855126|567549392|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
157219410|NCT02230085|567549395|FG000|Overall Study|Physician Decision|1|||
157219411|NCT02230085|567549395|FG000|Overall Study|Withdrawal by Subject|3|||
157219412|NCT00580983|567549396|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
157219413|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
157219414|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
157219415|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
157219416|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
157219417|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
157219418|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Adverse Event|60|||
157219419|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Adverse Event|0|||
157219420|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Adverse Event|0|||
157219421|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Adverse Event|0|||
157219422|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Adverse Event|0|||
157219423|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
157219424|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
157219425|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
157219426|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
156879664|NCT01120717|566318195|FG001|Overall Study|Lost to Follow-up|3|||
156879665|NCT01120717|566318194|FG000|Overall Study|Death|3|||
156879666|NCT01120717|566318195|FG001|Overall Study|Death|1|||
157020625|NCT03332017|566828480|FG001|Overall Study|Death|16|||
157020626|NCT03332017|566828479|FG000|Overall Study|Withdrawal by Subject|6|||
157020627|NCT03332017|566828480|FG001|Overall Study|Withdrawal by Subject|14|||
157143087|NCT00957372|567271253|FG001|PART II|Pregnancy|0|||
157143088|NCT00957372|567271254|FG002|PART II|Pregnancy|0|||
157143089|NCT00957372|567271255|FG003|PART II|Pregnancy|1|||
157143090|NCT00957372|567271252|FG000|PART II|Not Know|0|||
157143091|NCT00957372|567271253|FG001|PART II|Not Know|0|||
157143092|NCT00957372|567271254|FG002|PART II|Not Know|0|||
157143093|NCT00957372|567271255|FG003|PART II|Not Know|20|||
157143094|NCT00957372|567271252|FG000|PART II|Adverse Event|0|||
157143095|NCT00957372|567271253|FG001|PART II|Adverse Event|0|||
157143096|NCT00957372|567271254|FG002|PART II|Adverse Event|0|||
157143097|NCT00957372|567271255|FG003|PART II|Adverse Event|10|||
157143098|NCT00957372|567271252|FG000|PART II|Patient non-compliance|0|||
157143099|NCT00957372|567271253|FG001|PART II|Patient non-compliance|0|||
157143100|NCT00957372|567271254|FG002|PART II|Patient non-compliance|0|||
157143101|NCT00957372|567271255|FG003|PART II|Patient non-compliance|4|||
157143102|NCT01444391|567271258|FG000|Overall Study|Death|1|||
157143103|NCT00630032|567271261|FG000|Overall Study|Death|55|||
157143104|NCT00630032|567271262|FG001|Overall Study|Death|49|||
157143105|NCT00630032|567271261|FG000|Overall Study|Withdrawal by Subject|3|||
157143106|NCT00630032|567271262|FG001|Overall Study|Withdrawal by Subject|2|||
157143107|NCT00630032|567271261|FG000|Overall Study|Lost to Follow-up|18|||
157143108|NCT00630032|567271262|FG001|Overall Study|Lost to Follow-up|31|||
157143109|NCT00630032|567271261|FG000|Overall Study|Protocol Violation|1|||
157143110|NCT00630032|567271262|FG001|Overall Study|Protocol Violation|0|||
157143111|NCT00630032|567271261|FG000|Overall Study|Patient has moved|1|||
157143112|NCT00630032|567271262|FG001|Overall Study|Patient has moved|1|||
157143113|NCT00630032|567271261|FG000|Overall Study|Disease progression|1|||
157143114|NCT00630032|567271262|FG001|Overall Study|Disease progression|1|||
157143115|NCT00630032|567271261|FG000|Overall Study|End of monitoring in US centers|11|||
157143116|NCT00630032|567271262|FG001|Overall Study|End of monitoring in US centers|11|||
157143117|NCT02332915|567271263|FG000|Overall Study|Moved out of region|3|||
157143118|NCT02332915|567271264|FG001|Overall Study|Moved out of region|0|||
157143119|NCT02332915|567271263|FG000|Overall Study|Unrelated illness|1|||
157143120|NCT02332915|567271264|FG001|Overall Study|Unrelated illness|1|||
157143121|NCT02332915|567271263|FG000|Overall Study|Travel distance prohibitive|0|||
157143122|NCT02332915|567271264|FG001|Overall Study|Travel distance prohibitive|1|||
157143123|NCT02332915|567271263|FG000|Overall Study|did not meet inclusion criteria|2|||
157143124|NCT02332915|567271264|FG001|Overall Study|did not meet inclusion criteria|4|||
157143125|NCT01901328|567271265|FG000|Overall Study|Lost to Follow-up|1|||
157143126|NCT01901328|567271266|FG001|Overall Study|Lost to Follow-up|0|||
157143127|NCT01901328|567271265|FG000|Overall Study|Physician Decision|0|||
157143128|NCT01901328|567271266|FG001|Overall Study|Physician Decision|1|||
157143129|NCT01901328|567271265|FG000|Overall Study|Protocol Violation|1|||
157143130|NCT01901328|567271266|FG001|Overall Study|Protocol Violation|1|||
157143131|NCT01901328|567271265|FG000|Overall Study|Study Terminated by Sponsor|19|||
157143132|NCT01901328|567271266|FG001|Overall Study|Study Terminated by Sponsor|16|||
157143133|NCT01901328|567271265|FG000|Overall Study|Withdrawal by Subject|1|||
157143134|NCT01901328|567271266|FG001|Overall Study|Withdrawal by Subject|2|||
157143135|NCT01901328|567271265|FG000|Overall Study|Lack of Efficacy|0|||
157143136|NCT01901328|567271266|FG001|Overall Study|Lack of Efficacy|1|||
157143137|NCT02462889|567271267|FG000|Overall Study|Withdrawal by Subject|2|||
157143138|NCT02462889|567271268|FG001|Overall Study|Withdrawal by Subject|6|||
157143139|NCT02462889|567271267|FG000|Overall Study|Death|1|||
157143140|NCT02462889|567271268|FG001|Overall Study|Death|5|||
157143141|NCT03439345|567272753|FG000|Overall Study|Lost to Follow-up|0|||
157143142|NCT03439345|567272754|FG001|Overall Study|Lost to Follow-up|1|||
157143143|NCT03439345|567272753|FG000|Overall Study|Consent withdrawn|0|||
157143144|NCT03439345|567272754|FG001|Overall Study|Consent withdrawn|1|||
157143145|NCT05405166|567272755|FG000|Overall Study|Death|49|||
157143146|NCT05405166|567272756|FG001|Overall Study|Death|50|||
157143147|NCT05405166|567272755|FG000|Overall Study|Withdrawal by Subject|10|||
157143148|NCT05405166|567272756|FG001|Overall Study|Withdrawal by Subject|3|||
157143149|NCT05405166|567272755|FG000|Overall Study|Ongoing at the time of PCD|209|||
157143150|NCT05405166|567272756|FG001|Overall Study|Ongoing at the time of PCD|210|||
157143151|NCT03311126|567272758|FG000|Induction|Death|1|||
157143152|NCT03311126|567272758|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
157143153|NCT03113500|567272759|FG000|Overall Study|Withdrawal by Subject|1|||
157143154|NCT01348919|567272760|FG000|Overall Study|Adverse Event|3|||
157143155|NCT01348919|567272761|FG001|Overall Study|Adverse Event|1|||
157143156|NCT01348919|567272762|FG002|Overall Study|Adverse Event|0|||
157143157|NCT01348919|567272760|FG000|Overall Study|Withdrawal by Subject|0|||
157143158|NCT01348919|567272761|FG001|Overall Study|Withdrawal by Subject|1|||
157143159|NCT01348919|567272762|FG002|Overall Study|Withdrawal by Subject|0|||
157143160|NCT01348919|567272760|FG000|Overall Study|Disease progression|0|||
157143161|NCT01348919|567272761|FG001|Overall Study|Disease progression|1|||
157219427|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
157219428|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Physician Decision|10|||
157219429|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Physician Decision|0|||
157219430|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Physician Decision|0|||
157219431|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Physician Decision|0|||
157219432|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Physician Decision|0|||
157219433|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
157219434|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
157219435|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
157219436|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
157219437|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
157219438|NCT01360632|567549399|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
157219439|NCT01360632|567549400|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
157219440|NCT01360632|567549401|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
157219441|NCT01360632|567549402|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
157219442|NCT01360632|567549403|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
157219443|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
157219444|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
157219445|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
157219446|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
157219447|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
157219448|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Adverse Event|0|||
157219449|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Adverse Event|3|||
157219450|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Adverse Event|9|||
157219451|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Adverse Event|3|||
157219452|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Adverse Event|0|||
157219453|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
157219454|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
157219455|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
157219456|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
157219457|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
157219458|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Physician Decision|0|||
157219459|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Physician Decision|0|||
157219460|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Physician Decision|0|||
157219461|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Physician Decision|1|||
157219462|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Physician Decision|0|||
157219463|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
157219464|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
157219465|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
157219466|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
157219467|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
157219468|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
157219469|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
157219470|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
157219471|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
157219472|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
157219473|NCT01360632|567549399|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
157219474|NCT01360632|567549400|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
157219475|NCT01360632|567549401|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
157219476|NCT01360632|567549402|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
157219477|NCT01360632|567549403|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
157219478|NCT01360632|567549399|FG000|Phase A+|Lost to Follow-up|0|||
157219479|NCT01360632|567549400|FG001|Phase A+|Lost to Follow-up|0|||
157219480|NCT01360632|567549401|FG002|Phase A+|Lost to Follow-up|0|||
157219481|NCT01360632|567549402|FG003|Phase A+|Lost to Follow-up|0|||
157219482|NCT01360632|567549403|FG004|Phase A+|Lost to Follow-up|2|||
157219483|NCT01360632|567549399|FG000|Phase A+|Adverse Event|0|||
157219484|NCT01360632|567549400|FG001|Phase A+|Adverse Event|0|||
157219485|NCT01360632|567549401|FG002|Phase A+|Adverse Event|0|||
157219486|NCT01360632|567549402|FG003|Phase A+|Adverse Event|0|||
157219487|NCT01360632|567549403|FG004|Phase A+|Adverse Event|2|||
157219488|NCT01360632|567549399|FG000|Phase A+|Met Withdrawal Criteria|0|||
157219489|NCT01360632|567549400|FG001|Phase A+|Met Withdrawal Criteria|0|||
157219490|NCT01360632|567549401|FG002|Phase A+|Met Withdrawal Criteria|0|||
157219491|NCT01360632|567549402|FG003|Phase A+|Met Withdrawal Criteria|0|||
156744791|NCT04526574|565813268|FG000|Overall Study|Withdrawal by Subject|12|||
156744792|NCT04526574|565813269|FG001|Overall Study|Withdrawal by Subject|9|||
156744793|NCT04526574|565813268|FG000|Overall Study|Other|1|||
156744794|NCT04526574|565813269|FG001|Overall Study|Other|2|||
156744795|NCT04526574|565813268|FG000|Overall Study|Adverse Event|1|||
157219492|NCT01360632|567549403|FG004|Phase A+|Met Withdrawal Criteria|7|||
157219493|NCT01360632|567549399|FG000|Phase A+|Physician Decision|0|||
157219494|NCT01360632|567549400|FG001|Phase A+|Physician Decision|0|||
157219495|NCT01360632|567549401|FG002|Phase A+|Physician Decision|0|||
157219496|NCT01360632|567549402|FG003|Phase A+|Physician Decision|0|||
157219497|NCT01360632|567549403|FG004|Phase A+|Physician Decision|3|||
157219498|NCT01360632|567549399|FG000|Phase A+|Withdrawal by Subject|0|||
157219499|NCT01360632|567549400|FG001|Phase A+|Withdrawal by Subject|0|||
157219500|NCT01360632|567549401|FG002|Phase A+|Withdrawal by Subject|0|||
157219501|NCT01360632|567549402|FG003|Phase A+|Withdrawal by Subject|0|||
157219502|NCT01360632|567549403|FG004|Phase A+|Withdrawal by Subject|8|||
157219503|NCT01360632|567549399|FG000|Phase A+|Protocol Deviation|0|||
157219504|NCT01360632|567549400|FG001|Phase A+|Protocol Deviation|0|||
157219505|NCT01360632|567549401|FG002|Phase A+|Protocol Deviation|0|||
157219506|NCT01360632|567549402|FG003|Phase A+|Protocol Deviation|0|||
157219507|NCT01360632|567549403|FG004|Phase A+|Protocol Deviation|3|||
157219508|NCT01298596|567549404|FG000|Overall Study|Withdrawal by Subject|1|||
157219509|NCT01298596|567549405|FG001|Overall Study|Withdrawal by Subject|1|||
157219510|NCT01298596|567549404|FG000|Overall Study|Death|5|||
157219511|NCT01298596|567549405|FG001|Overall Study|Death|3|||
157219512|NCT01298596|567549404|FG000|Overall Study|Lost to Follow-up|6|||
157219513|NCT01298596|567549405|FG001|Overall Study|Lost to Follow-up|14|||
157219514|NCT01298596|567549404|FG000|Overall Study|Referred for further management|16|||
157219515|NCT01298596|567549405|FG001|Overall Study|Referred for further management|15|||
157219516|NCT02173301|567549406|FG000|Overall Study|Adverse Event|7|||
157219517|NCT02173301|567549407|FG001|Overall Study|Adverse Event|8|||
157219518|NCT02173301|567549408|FG002|Overall Study|Adverse Event|13|||
157219519|NCT02173301|567549409|FG003|Overall Study|Adverse Event|5|||
157219520|NCT02173301|567549406|FG000|Overall Study|Withdrawal by Subject|8|||
157219521|NCT02173301|567549407|FG001|Overall Study|Withdrawal by Subject|10|||
157219522|NCT02173301|567549408|FG002|Overall Study|Withdrawal by Subject|4|||
157219523|NCT02173301|567549409|FG003|Overall Study|Withdrawal by Subject|8|||
157219524|NCT02173301|567549406|FG000|Overall Study|Lost to Follow-up|4|||
157219525|NCT02173301|567549407|FG001|Overall Study|Lost to Follow-up|4|||
157219526|NCT02173301|567549408|FG002|Overall Study|Lost to Follow-up|2|||
157219527|NCT02173301|567549409|FG003|Overall Study|Lost to Follow-up|2|||
157219528|NCT02173301|567549406|FG000|Overall Study|Protocol Violation|0|||
157219529|NCT02173301|567549407|FG001|Overall Study|Protocol Violation|1|||
157219530|NCT02173301|567549408|FG002|Overall Study|Protocol Violation|0|||
157219531|NCT02173301|567549409|FG003|Overall Study|Protocol Violation|0|||
157219532|NCT02173301|567549406|FG000|Overall Study|Physician Decision|0|||
157219533|NCT02173301|567549407|FG001|Overall Study|Physician Decision|0|||
157219534|NCT02173301|567549408|FG002|Overall Study|Physician Decision|1|||
157219535|NCT02173301|567549409|FG003|Overall Study|Physician Decision|0|||
157219536|NCT02173301|567549406|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
157219537|NCT02173301|567549407|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
157219538|NCT02173301|567549408|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
157219539|NCT02173301|567549409|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
157219540|NCT03740100|567549410|FG000|Overall Study|Adverse Event|1|||
157219541|NCT03740100|567549410|FG000|Overall Study|Death|1|||
157219542|NCT02046369|567549411|FG000|Overall Study|Adverse Event|3|||
157219543|NCT02046369|567549412|FG001|Overall Study|Adverse Event|3|||
157219544|NCT02046369|567549411|FG000|Overall Study|Lack of Efficacy|3|||
157219545|NCT02046369|567549412|FG001|Overall Study|Lack of Efficacy|3|||
157219546|NCT02046369|567549411|FG000|Overall Study|Lost to Follow-up|3|||
157219547|NCT02046369|567549412|FG001|Overall Study|Lost to Follow-up|3|||
157219548|NCT02046369|567549411|FG000|Overall Study|Protocol Violation|1|||
157219549|NCT02046369|567549412|FG001|Overall Study|Protocol Violation|2|||
157219550|NCT02046369|567549411|FG000|Overall Study|Withdrawal by Subject|3|||
157219551|NCT02046369|567549412|FG001|Overall Study|Withdrawal by Subject|6|||
157219552|NCT02046369|567549411|FG000|Overall Study|never received study drug|0|||
157219553|NCT02046369|567549412|FG001|Overall Study|never received study drug|1|||
157219554|NCT02046369|567549411|FG000|Overall Study|non compliance|1|||
157219555|NCT02046369|567549412|FG001|Overall Study|non compliance|0|||
157219556|NCT03120520|567549413|FG000|Overall Study|Lost to Follow-up|1|||
157219557|NCT03120520|567549414|FG001|Overall Study|Lost to Follow-up|1|||
157219558|NCT03120520|567549415|FG002|Overall Study|Lost to Follow-up|1|||
157219559|NCT03120520|567549416|FG003|Overall Study|Lost to Follow-up|1|||
157219560|NCT03120520|567549413|FG000|Overall Study|Withdrawal by Subject|3|||
157219561|NCT03120520|567549414|FG001|Overall Study|Withdrawal by Subject|2|||
157219562|NCT03120520|567549415|FG002|Overall Study|Withdrawal by Subject|3|||
157219563|NCT03120520|567549416|FG003|Overall Study|Withdrawal by Subject|2|||
157219564|NCT03120520|567549413|FG000|Overall Study|Other|0|||
157219565|NCT03120520|567549414|FG001|Overall Study|Other|1|||
156744796|NCT04526574|565813269|FG001|Overall Study|Adverse Event|1|||
156744797|NCT04526574|565813268|FG000|Overall Study|Death|2|||
157219566|NCT03120520|567549415|FG002|Overall Study|Other|0|||
157219567|NCT03120520|567549416|FG003|Overall Study|Other|0|||
157219568|NCT04345471|567549418|FG000|Overall Study|Adverse Event|8|||
157219569|NCT04345471|567549419|FG001|Overall Study|Adverse Event|5|||
157219570|NCT04345471|567549420|FG002|Overall Study|Adverse Event|6|||
157219571|NCT04345471|567549418|FG000|Overall Study|Lack of Efficacy|1|||
157219572|NCT04345471|567549419|FG001|Overall Study|Lack of Efficacy|1|||
157219573|NCT04345471|567549420|FG002|Overall Study|Lack of Efficacy|0|||
157219574|NCT04345471|567549418|FG000|Overall Study|Protocol Violation|0|||
157143162|NCT01348919|567272762|FG002|Overall Study|Disease progression|1|||
157143163|NCT01009463|567272766|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
157143164|NCT01009463|567272767|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157143165|NCT01009463|567272768|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157143166|NCT01009463|567272769|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157143167|NCT01009463|567272770|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
157143168|NCT01009463|567272766|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
157143169|NCT01009463|567272767|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
157143170|NCT01009463|567272768|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
157143171|NCT01009463|567272769|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
157143172|NCT01009463|567272770|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
157143173|NCT01009463|567272766|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
157143174|NCT01009463|567272767|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157143175|NCT01009463|567272768|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157143176|NCT01009463|567272769|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157143177|NCT01009463|567272770|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
157143178|NCT01009463|567272766|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
157143179|NCT01009463|567272767|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
157143180|NCT01009463|567272768|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
157143181|NCT01009463|567272769|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
157143182|NCT01009463|567272770|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
157143183|NCT01009463|567272766|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
157143184|NCT01009463|567272767|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157143185|NCT01009463|567272768|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157143186|NCT01009463|567272769|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157143187|NCT01009463|567272770|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
157143188|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
157143189|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
157143190|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
157143191|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
157143192|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
157143193|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
157143194|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
157143195|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
157143196|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
157143197|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
157143198|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
157143199|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
157143200|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
157143201|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
157143202|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
157143203|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
157143204|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
157143205|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
157143206|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
157143207|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
157143208|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
157143209|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
157143210|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
157143211|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
157143212|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
157143213|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157143214|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
157143215|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157143216|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
157143217|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
157143218|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157143219|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
157143220|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
157143221|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
157143222|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
157143223|NCT01009463|567272766|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
157143224|NCT01009463|567272767|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
157143225|NCT01009463|567272768|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
156879667|NCT01120717|566318194|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156879668|NCT01120717|566318195|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156879669|NCT00329797|566318200|FG000|Overall Study|Protocol Violation|1|||
156879670|NCT00329797|566318201|FG001|Overall Study|Protocol Violation|0|||
156879671|NCT00329797|566318200|FG000|Overall Study|Withdrawal by Subject|6|||
156879672|NCT00329797|566318201|FG001|Overall Study|Withdrawal by Subject|6|||
156879673|NCT00910299|566318211|FG000|Overall Study|Withdrawal by Subject|16|||
156879674|NCT00910299|566318212|FG001|Overall Study|Withdrawal by Subject|13|||
156879675|NCT00910299|566318211|FG000|Overall Study|Sponsor Decision|58|||
156879676|NCT00910299|566318212|FG001|Overall Study|Sponsor Decision|60|||
156879677|NCT00910299|566318211|FG000|Overall Study|Didn't receive any study drug|2|||
156879678|NCT00910299|566318212|FG001|Overall Study|Didn't receive any study drug|1|||
156879679|NCT04530136|566318213|FG000|Overall Study|Lost to Follow-up|2|||
156879680|NCT04530136|566318214|FG001|Overall Study|Lost to Follow-up|3|||
156879681|NCT04530136|566318213|FG000|Overall Study|Withdrawal by Subject|1|||
156879682|NCT04530136|566318214|FG001|Overall Study|Withdrawal by Subject|0|||
156879683|NCT04530136|566318213|FG000|Overall Study|Death|0|||
156879684|NCT04530136|566318214|FG001|Overall Study|Death|1|||
156879685|NCT01057589|566318217|FG000|Overall Study|Disease Progression|35|||
156879686|NCT01057589|566318217|FG000|Overall Study|Adverse Event|10|||
156879687|NCT01057589|566318217|FG000|Overall Study|Physician Decision|8|||
156879688|NCT01057589|566318217|FG000|Overall Study|Withdrawal by Subject|3|||
156879689|NCT01057589|566318217|FG000|Overall Study|Sponsor Decision|1|||
156879690|NCT01057589|566318217|FG000|Overall Study|Death|8|||
156879691|NCT01057589|566318217|FG000|Overall Study|Lost to Follow-up|1|||
156879692|NCT02281383|566318218|FG000|Overall Study|Progressive Disease|1|||
156879693|NCT02281383|566318218|FG000|Overall Study|Withdrawal by Subject|6|||
156879694|NCT02281383|566318218|FG000|Overall Study|Protocol Violation|2|||
156879695|NCT02281383|566318218|FG000|Overall Study|Death|1|||
156879696|NCT02281383|566318218|FG000|Overall Study|Adverse Event|2|||
156879697|NCT04189224|566318229|FG000|Period 2|Adverse Event|0|||
156879698|NCT04189224|566318230|FG001|Period 2|Adverse Event|1|||
156879699|NCT00490529|566319783|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
156879700|NCT00490529|566319783|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
156879701|NCT00490529|566319783|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
156879702|NCT00490529|566319783|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
156879703|NCT00490529|566319783|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
156879704|NCT00490529|566319783|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
156879705|NCT02248675|566319791|FG000|Overall Study|Lost to Follow-up|3|||
156879706|NCT02248675|566319792|FG001|Overall Study|Lost to Follow-up|1|||
156879707|NCT00830869|566319793|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
156879708|NCT00830869|566319794|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
157143226|NCT01009463|567272769|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
157143227|NCT01009463|567272770|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
157143228|NCT04430348|567272773|FG000|Overall Study|Death|3|||
157143229|NCT04430348|567272774|FG001|Overall Study|Death|2|||
157143230|NCT04430348|567272775|FG002|Overall Study|Death|2|||
157143231|NCT04430348|567272776|FG003|Overall Study|Death|2|||
157143232|NCT04430348|567272777|FG004|Overall Study|Death|2|||
157143233|NCT04430348|567272778|FG005|Overall Study|Death|3|||
157143234|NCT04430348|567272773|FG000|Overall Study|Lost to Follow-up|0|||
157143235|NCT04430348|567272774|FG001|Overall Study|Lost to Follow-up|0|||
157143236|NCT04430348|567272775|FG002|Overall Study|Lost to Follow-up|0|||
157143237|NCT04430348|567272776|FG003|Overall Study|Lost to Follow-up|1|||
157143238|NCT04430348|567272777|FG004|Overall Study|Lost to Follow-up|0|||
157143239|NCT04430348|567272778|FG005|Overall Study|Lost to Follow-up|0|||
157143240|NCT04430348|567272773|FG000|Overall Study|Adverse Event|0|||
157143241|NCT04430348|567272774|FG001|Overall Study|Adverse Event|0|||
157143242|NCT04430348|567272775|FG002|Overall Study|Adverse Event|0|||
157143243|NCT04430348|567272776|FG003|Overall Study|Adverse Event|0|||
157143244|NCT04430348|567272777|FG004|Overall Study|Adverse Event|0|||
157143245|NCT04430348|567272778|FG005|Overall Study|Adverse Event|1|||
157143246|NCT04430348|567272773|FG000|Overall Study|Withdrawal by Subject|0|||
157143247|NCT04430348|567272774|FG001|Overall Study|Withdrawal by Subject|1|||
156879709|NCT00830869|566319795|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
156879710|NCT00830869|566319796|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
156879711|NCT00830869|566319797|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
156744798|NCT04526574|565813269|FG001|Overall Study|Death|3|||
156744799|NCT04526574|565813268|FG000|Overall Study|Lost to Follow-up|9|||
156879712|NCT00830869|566319798|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
156879713|NCT00830869|566319799|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
156879714|NCT00830869|566319800|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
157143248|NCT04430348|567272775|FG002|Overall Study|Withdrawal by Subject|0|||
157143249|NCT04430348|567272776|FG003|Overall Study|Withdrawal by Subject|0|||
157143250|NCT04430348|567272777|FG004|Overall Study|Withdrawal by Subject|0|||
157143251|NCT04430348|567272778|FG005|Overall Study|Withdrawal by Subject|1|||
157219575|NCT04345471|567549419|FG001|Overall Study|Protocol Violation|1|||
157219576|NCT04345471|567549420|FG002|Overall Study|Protocol Violation|2|||
157219577|NCT04345471|567549418|FG000|Overall Study|Withdrawal by Subject|10|||
157219578|NCT04345471|567549419|FG001|Overall Study|Withdrawal by Subject|5|||
157219579|NCT04345471|567549420|FG002|Overall Study|Withdrawal by Subject|10|||
157219580|NCT02378506|567549424|FG000|Overall Study|Lack of Efficacy|3|||
157219581|NCT02378506|567549424|FG000|Overall Study|Withdrawal by Subject|4|||
157219582|NCT02378506|567549424|FG000|Overall Study|Protocol Violation|2|||
157219583|NCT02378506|567549424|FG000|Overall Study|Death|1|||
157219584|NCT02378506|567549424|FG000|Overall Study|Adverse Event|14|||
157219585|NCT02378506|567549424|FG000|Overall Study|Randomized But Not Treated|1|||
157219586|NCT03387059|567549425|FG000|Overall Study|Study termination|5|||
157219587|NCT03387059|567549426|FG001|Overall Study|Study termination|4|||
157219588|NCT01606137|567549427|FG000|Overall Study|Adverse Event|85|||
157219589|NCT01606137|567549427|FG000|Overall Study|Withdrawal by Subject|74|||
157219590|NCT01606137|567549427|FG000|Overall Study|Lack of Efficacy|56|||
157219591|NCT01606137|567549427|FG000|Overall Study|Lost to Follow-up|15|||
157219592|NCT01606137|567549427|FG000|Overall Study|Protocol Violation|1|||
157219593|NCT01606137|567549427|FG000|Overall Study|Patient non-compliance|9|||
157219594|NCT01606137|567549427|FG000|Overall Study|Death|1|||
157219595|NCT01606137|567549427|FG000|Overall Study|Decreased/no pain|4|||
157219596|NCT01606137|567549427|FG000|Overall Study|Issues with driving|4|||
157219597|NCT01606137|567549427|FG000|Overall Study|multiple sclerosis less stable|1|||
157219598|NCT01606137|567549427|FG000|Overall Study|Increased bilirubin|1|||
157219599|NCT01606137|567549427|FG000|Overall Study|Spray causes nausea|1|||
157219600|NCT01606137|567549427|FG000|Overall Study|Not enough improvement|4|||
157219601|NCT01606137|567549427|FG000|Overall Study|Wanted to try another treatment|1|||
157219602|NCT01606137|567549427|FG000|Overall Study|Patient leaving country|1|||
157219603|NCT01606137|567549427|FG000|Overall Study|Personal reasons|1|||
157219604|NCT01606137|567549427|FG000|Overall Study|Unable to tolerate study med. taste|1|||
157219605|NCT01606137|567549427|FG000|Overall Study|Patient moving|1|||
157219606|NCT01606137|567549427|FG000|Overall Study|Unable to collect consistent data|1|||
157219607|NCT01070394|567549429|FG000|Overall Study|Adverse Event|6|||
157219608|NCT01070394|567549429|FG000|Overall Study|Withdrawal by Subject|1|||
157219609|NCT01715415|567549441|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
157219610|NCT01715415|567549442|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
157219611|NCT01715415|567549441|FG000|Double-blind Treatment|Adverse Event|3|||
157219612|NCT01715415|567549442|FG001|Double-blind Treatment|Adverse Event|0|||
157219613|NCT01715415|567549441|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
157219614|NCT01715415|567549442|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
157219615|NCT01715415|567549441|FG000|Double-blind Treatment|Other|1|||
157219616|NCT01715415|567549442|FG001|Double-blind Treatment|Other|0|||
157219617|NCT01715415|567549441|FG000|Open-label Treatment|Adverse Event|0|||
157219618|NCT01715415|567549442|FG001|Open-label Treatment|Adverse Event|1|||
157219619|NCT01715415|567549441|FG000|Open-label Treatment|Subject Noncompliant|0|||
157219620|NCT01715415|567549442|FG001|Open-label Treatment|Subject Noncompliant|1|||
157219621|NCT01015612|567549443|FG000|Overall Study|Death|113|||
157219622|NCT01015612|567549443|FG000|Overall Study|Withdrawal by Subject|40|||
157219623|NCT00066807|567549444|FG000|Overall Study|Study was terminated early|14|||
157219624|NCT00066807|567549445|FG001|Overall Study|Study was terminated early|15|||
157219625|NCT03586830|567549447|FG000|Overall Study|Site terminated by Sponsor|1|||
157219626|NCT03586830|567549448|FG001|Overall Study|Site terminated by Sponsor|4|||
157219627|NCT03586830|567549449|FG002|Overall Study|Site terminated by Sponsor|3|||
157219628|NCT03586830|567549450|FG003|Overall Study|Site terminated by Sponsor|3|||
157219629|NCT03586830|567549447|FG000|Overall Study|Lost to Follow-up|0|||
157219630|NCT03586830|567549448|FG001|Overall Study|Lost to Follow-up|2|||
157219631|NCT03586830|567549449|FG002|Overall Study|Lost to Follow-up|2|||
157219632|NCT03586830|567549450|FG003|Overall Study|Lost to Follow-up|1|||
157219633|NCT03586830|567549447|FG000|Overall Study|Withdrawal by Subject|1|||
157219634|NCT03586830|567549448|FG001|Overall Study|Withdrawal by Subject|0|||
156879715|NCT00830869|566319801|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
157219635|NCT03586830|567549449|FG002|Overall Study|Withdrawal by Subject|3|||
157219636|NCT03586830|567549450|FG003|Overall Study|Withdrawal by Subject|1|||
157219637|NCT04578548|567549451|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
156879716|NCT00830869|566319802|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
157219638|NCT04578548|567549452|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
157219639|NCT04578548|567549451|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
157219640|NCT04578548|567549452|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
157219641|NCT04578548|567549451|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
157219642|NCT04578548|567549452|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
157219643|NCT04578548|567549451|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
157219644|NCT04578548|567549452|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
157219645|NCT04578548|567549451|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
157219646|NCT04578548|567549452|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
157219647|NCT04578548|567549451|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
157219648|NCT04578548|567549452|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
157219649|NCT00972153|567549455|FG000|Overall Study|Equipment malfunction during case|0|||
157219650|NCT00972153|567549456|FG001|Overall Study|Equipment malfunction during case|1|||
157219651|NCT00972153|567549457|FG002|Overall Study|Equipment malfunction during case|0|||
157219652|NCT01077713|567549462|FG000|Overall Study|Withdrawal by Subject|1|||
156879717|NCT00830869|566319803|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
157020628|NCT03332017|566828479|FG000|Overall Study|Other|1|||
157020629|NCT03332017|566828480|FG001|Overall Study|Other|3|||
156744800|NCT04526574|565813269|FG001|Overall Study|Lost to Follow-up|9|||
156744801|NCT04526574|565813268|FG000|Overall Study|No longer meets eligibility criteria|8|||
156744802|NCT04526574|565813269|FG001|Overall Study|No longer meets eligibility criteria|8|||
156744803|NCT00006305|565813270|FG000|Overall Study|Withdrawal by Subject|17|||
156744804|NCT00006305|565813271|FG001|Overall Study|Withdrawal by Subject|10|||
156744805|NCT00006305|565813272|FG002|Overall Study|Withdrawal by Subject|15|||
156744806|NCT00006305|565813273|FG003|Overall Study|Withdrawal by Subject|14|||
156744807|NCT00662558|565813274|FG000|Overall Study|Adverse Event|21|||
156744808|NCT00662558|565813275|FG001|Overall Study|Adverse Event|59|||
156799129|NCT00673920|566018932|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
156799130|NCT00673920|566018925|FG000|Baseline up to Week 48|Administrative/Other|0|||
156799131|NCT00673920|566018926|FG001|Baseline up to Week 48|Administrative/Other|1|||
156799132|NCT00673920|566018927|FG002|Baseline up to Week 48|Administrative/Other|2|||
156799133|NCT00673920|566018928|FG003|Baseline up to Week 48|Administrative/Other|0|||
156799134|NCT00673920|566018929|FG004|Baseline up to Week 48|Administrative/Other|0|||
156799135|NCT00673920|566018930|FG005|Baseline up to Week 48|Administrative/Other|0|||
156799136|NCT00673920|566018931|FG006|Baseline up to Week 48|Administrative/Other|0|||
156799137|NCT00673920|566018932|FG007|Baseline up to Week 48|Administrative/Other|0|||
156799138|NCT00673920|566018925|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799139|NCT00673920|566018926|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
156799140|NCT00673920|566018927|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
156799141|NCT00673920|566018928|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799142|NCT00673920|566018929|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799143|NCT00673920|566018930|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799144|NCT00673920|566018931|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799145|NCT00673920|566018932|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
156799146|NCT00673920|566018925|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799147|NCT00673920|566018926|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799148|NCT00673920|566018927|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799149|NCT00673920|566018928|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799150|NCT00673920|566018929|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799151|NCT00673920|566018930|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799152|NCT00673920|566018931|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
156799153|NCT00673920|566018932|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
156799154|NCT00673920|566018925|FG000|Week 24 to Week 48|Failure to return|0|||
156799155|NCT00673920|566018926|FG001|Week 24 to Week 48|Failure to return|0|||
156799156|NCT00673920|566018927|FG002|Week 24 to Week 48|Failure to return|0|||
156799157|NCT00673920|566018928|FG003|Week 24 to Week 48|Failure to return|0|||
156799158|NCT00673920|566018929|FG004|Week 24 to Week 48|Failure to return|0|||
156799159|NCT00673920|566018930|FG005|Week 24 to Week 48|Failure to return|1|||
156799160|NCT00673920|566018931|FG006|Week 24 to Week 48|Failure to return|0|||
156799161|NCT00673920|566018932|FG007|Week 24 to Week 48|Failure to return|0|||
156799162|NCT00673920|566018925|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799163|NCT00673920|566018926|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799164|NCT00673920|566018927|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799165|NCT00673920|566018928|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799166|NCT00673920|566018929|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799167|NCT00673920|566018930|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
156799168|NCT00673920|566018931|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799169|NCT00673920|566018932|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
156799170|NCT00673920|566018925|FG000|Week 24 to Week 48|Death|0|||
156799171|NCT00673920|566018926|FG001|Week 24 to Week 48|Death|0|||
156799172|NCT00673920|566018927|FG002|Week 24 to Week 48|Death|0|||
156799173|NCT00673920|566018928|FG003|Week 24 to Week 48|Death|0|||
156799174|NCT00673920|566018929|FG004|Week 24 to Week 48|Death|0|||
156799175|NCT00673920|566018930|FG005|Week 24 to Week 48|Death|1|||
156799176|NCT00673920|566018931|FG006|Week 24 to Week 48|Death|0|||
156799177|NCT00673920|566018932|FG007|Week 24 to Week 48|Death|0|||
156799178|NCT00673920|566018925|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
156799179|NCT00673920|566018926|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
156799180|NCT00673920|566018927|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
157020630|NCT03332017|566828479|FG000|Overall Study|Remained in Study (Ongoing)|47|||
157219653|NCT01077713|567549463|FG001|Overall Study|Withdrawal by Subject|2|||
157219654|NCT01077713|567549462|FG000|Overall Study|Progressive Disease (PD)|0|||
157219655|NCT01077713|567549463|FG001|Overall Study|Progressive Disease (PD)|1|||
157219656|NCT01077713|567549462|FG000|Overall Study|Death|28|||
157219657|NCT01077713|567549463|FG001|Overall Study|Death|29|||
157219658|NCT01077713|567549462|FG000|Overall Study|Lost to Follow-up|1|||
157219659|NCT01077713|567549463|FG001|Overall Study|Lost to Follow-up|1|||
157219660|NCT01077713|567549462|FG000|Overall Study|Adverse Event|2|||
157219661|NCT01077713|567549463|FG001|Overall Study|Adverse Event|1|||
157219662|NCT01077713|567549462|FG000|Overall Study|Other|4|||
157219663|NCT01077713|567549463|FG001|Overall Study|Other|2|||
157219664|NCT04136626|567549464|FG000|Treatment Phase|Withdrawal by Subject|1|||
157219665|NCT04136626|567549465|FG001|Treatment Phase|Withdrawal by Subject|9|||
157219666|NCT04136626|567549464|FG000|Treatment Phase|Adverse Event|1|||
157219667|NCT04136626|567549465|FG001|Treatment Phase|Adverse Event|0|||
157219668|NCT04136626|567549464|FG000|Treatment Phase|Lost to Follow-up|1|||
157219669|NCT04136626|567549465|FG001|Treatment Phase|Lost to Follow-up|5|||
157219670|NCT04136626|567549464|FG000|12-month Follow-up|Lost to Follow-up|8|||
157219671|NCT04136626|567549465|FG001|12-month Follow-up|Lost to Follow-up|7|||
157219672|NCT00628745|567549466|FG000|Overall Study|Withdrawal by Subject|63|||
157219673|NCT00628745|567549467|FG001|Overall Study|Withdrawal by Subject|3|||
157219674|NCT00628745|567549468|FG002|Overall Study|Withdrawal by Subject|9|||
157219675|NCT00628745|567549469|FG003|Overall Study|Withdrawal by Subject|2|||
157219676|NCT00628745|567549470|FG004|Overall Study|Withdrawal by Subject|69|||
157219677|NCT00628745|567549466|FG000|Overall Study|Does not meet inclusion criteria|0|||
157219678|NCT00628745|567549467|FG001|Overall Study|Does not meet inclusion criteria|12|||
157219679|NCT00628745|567549468|FG002|Overall Study|Does not meet inclusion criteria|0|||
157219680|NCT00628745|567549469|FG003|Overall Study|Does not meet inclusion criteria|0|||
157219681|NCT00628745|567549470|FG004|Overall Study|Does not meet inclusion criteria|18|||
157219682|NCT00628745|567549466|FG000|Overall Study|Participation in an interventional clinical trial|81|||
157219683|NCT00628745|567549467|FG001|Overall Study|Participation in an interventional clinical trial|4|||
157219684|NCT00628745|567549468|FG002|Overall Study|Participation in an interventional clinical trial|7|||
157219685|NCT00628745|567549469|FG003|Overall Study|Participation in an interventional clinical trial|0|||
157219686|NCT00628745|567549470|FG004|Overall Study|Participation in an interventional clinical trial|63|||
157219687|NCT00628745|567549466|FG000|Overall Study|Physician Decision|8|||
157219688|NCT00628745|567549467|FG001|Overall Study|Physician Decision|4|||
157219689|NCT00628745|567549468|FG002|Overall Study|Physician Decision|3|||
157219690|NCT00628745|567549469|FG003|Overall Study|Physician Decision|0|||
157219691|NCT00628745|567549470|FG004|Overall Study|Physician Decision|30|||
157219692|NCT00628745|567549466|FG000|Overall Study|Lost to Follow-up|109|||
157219693|NCT00628745|567549467|FG001|Overall Study|Lost to Follow-up|7|||
157219694|NCT00628745|567549468|FG002|Overall Study|Lost to Follow-up|7|||
157219695|NCT00628745|567549469|FG003|Overall Study|Lost to Follow-up|0|||
157219696|NCT00628745|567549470|FG004|Overall Study|Lost to Follow-up|498|||
157219697|NCT00628745|567549466|FG000|Overall Study|Death|197|||
157219698|NCT00628745|567549467|FG001|Overall Study|Death|81|||
157219699|NCT00628745|567549468|FG002|Overall Study|Death|12|||
157219700|NCT00628745|567549469|FG003|Overall Study|Death|4|||
157219701|NCT00628745|567549470|FG004|Overall Study|Death|939|||
157219702|NCT00628745|567549466|FG000|Overall Study|Participant transferred to another THAOS site|6|||
157219703|NCT00628745|567549467|FG001|Overall Study|Participant transferred to another THAOS site|0|||
157219704|NCT00628745|567549468|FG002|Overall Study|Participant transferred to another THAOS site|0|||
157219705|NCT00628745|567549469|FG003|Overall Study|Participant transferred to another THAOS site|0|||
157219706|NCT00628745|567549470|FG004|Overall Study|Participant transferred to another THAOS site|7|||
156799181|NCT00673920|566018928|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
156799182|NCT00673920|566018929|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
156799183|NCT00673920|566018930|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
156799184|NCT00673920|566018931|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
156799185|NCT00673920|566018932|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
156799186|NCT02300233|566018936|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
156799187|NCT02300233|566018937|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
156799188|NCT02300233|566018938|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
156799189|NCT02300233|566018936|FG000|Overall Study|Withdrawal by Subject|1|||
156799190|NCT02300233|566018937|FG001|Overall Study|Withdrawal by Subject|0|||
156799191|NCT02300233|566018938|FG002|Overall Study|Withdrawal by Subject|3|||
156799192|NCT02300233|566018936|FG000|Overall Study|Investigator Judgement|0|||
156799193|NCT02300233|566018937|FG001|Overall Study|Investigator Judgement|0|||
156879718|NCT00830869|566319804|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
157219707|NCT00628745|567549466|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
157219708|NCT00628745|567549467|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
157219709|NCT00628745|567549468|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
157219710|NCT00628745|567549469|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
156799194|NCT02300233|566018938|FG002|Overall Study|Investigator Judgement|1|||
156799195|NCT02300233|566018936|FG000|Overall Study|Reason Not Specified|0|||
156799196|NCT02300233|566018937|FG001|Overall Study|Reason Not Specified|0|||
156799197|NCT02300233|566018938|FG002|Overall Study|Reason Not Specified|5|||
156799198|NCT00833690|566018939|FG000|Overall Study|Withdrawal by Subject|1|||
156799199|NCT00833690|566018940|FG001|Overall Study|Withdrawal by Subject|0|||
156799200|NCT00833690|566018941|FG002|Overall Study|Withdrawal by Subject|0|||
156799201|NCT00833690|566018939|FG000|Overall Study|Discontinued study drug|3|||
156799202|NCT00833690|566018940|FG001|Overall Study|Discontinued study drug|2|||
156799203|NCT00833690|566018941|FG002|Overall Study|Discontinued study drug|0|||
156799204|NCT05448950|566018947|FG000|Overall Study|Death|2|||
156799205|NCT05448950|566018947|FG000|Overall Study|Withdrawal by Subject|1|||
156799206|NCT05448950|566018947|FG000|Overall Study|AVG abandoned|4|||
156799207|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799208|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
156799209|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799210|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
156799211|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
156799212|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
156799213|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
156799214|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
156799215|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
156799216|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
156799217|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
156799218|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
156799219|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799220|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156799221|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799222|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156799223|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799224|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
156799225|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799226|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
156799227|NCT02836249|566018948|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
156799228|NCT02836249|566018949|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799229|NCT02836249|566018950|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799230|NCT02836249|566018951|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
156799231|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156799232|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
156799233|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
156799234|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
156799235|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156879719|NCT00830869|566319793|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
156744809|NCT00662558|565813274|FG000|Overall Study|Lack of Efficacy|4|||
156744810|NCT00662558|565813275|FG001|Overall Study|Lack of Efficacy|7|||
156744811|NCT00662558|565813274|FG000|Overall Study|Lost to Follow-up|13|||
156744812|NCT00662558|565813275|FG001|Overall Study|Lost to Follow-up|10|||
156744813|NCT00662558|565813274|FG000|Overall Study|Other|9|||
156744814|NCT00662558|565813275|FG001|Overall Study|Other|14|||
156744815|NCT00662558|565813274|FG000|Overall Study|Withdrawal by Subject|7|||
156744816|NCT00662558|565813275|FG001|Overall Study|Withdrawal by Subject|12|||
156744817|NCT00662558|565813274|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
156744818|NCT00662558|565813275|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
156744819|NCT00329641|565813276|FG000|Overall Study|Did not start treatment|1|||
156744820|NCT00329641|565813276|FG000|Overall Study|Not eligible|1|||
156744821|NCT00329641|565813276|FG000|Overall Study|Adverse Event|3|||
156744822|NCT00329641|565813276|FG000|Overall Study|Other reason, not protocol specified|1|||
156744823|NCT02631070|565813286|FG000|Overall Study|Withdrawal by Subject|35|||
156744824|NCT02631070|565813287|FG001|Overall Study|Withdrawal by Subject|13|||
156744825|NCT02631070|565813286|FG000|Overall Study|Death|45|||
156799236|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
156799237|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
156799238|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
156799239|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Death|0|||
156799240|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Death|0|||
156744826|NCT02631070|565813287|FG001|Overall Study|Death|24|||
156799241|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Death|1|||
156799242|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Death|0|||
156799243|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799244|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799245|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
156744827|NCT02631070|565813286|FG000|Overall Study|Lost to Follow-up|5|||
156799246|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
156799247|NCT02836249|566018948|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
156744828|NCT02631070|565813287|FG001|Overall Study|Lost to Follow-up|1|||
156744829|NCT02631070|565813286|FG000|Overall Study|Transition to rollover protocol|52|||
156744830|NCT02631070|565813287|FG001|Overall Study|Transition to rollover protocol|21|||
156744831|NCT02631070|565813286|FG000|Overall Study|Other reasons|12|||
156744832|NCT02631070|565813287|FG001|Overall Study|Other reasons|5|||
156744833|NCT03329248|565813288|FG000|Overall Study|Progressive Disease|6|||
156744834|NCT00987402|565813289|FG000|Overall Study|Insufficient data entry|86|||
156744835|NCT00987402|565813290|FG001|Overall Study|Insufficient data entry|98|||
156744836|NCT03000530|565813291|FG000|Overall Study|Adverse Event|0|||
156744837|NCT03000530|565813292|FG001|Overall Study|Adverse Event|0|||
156744838|NCT03000530|565813293|FG002|Overall Study|Adverse Event|2|||
156744839|NCT03000530|565813291|FG000|Overall Study|Lost to Follow-up|0|||
156744840|NCT03000530|565813292|FG001|Overall Study|Lost to Follow-up|3|||
156744841|NCT03000530|565813293|FG002|Overall Study|Lost to Follow-up|1|||
156744842|NCT03000530|565813291|FG000|Overall Study|Withdrawal by Subject|0|||
156744843|NCT03000530|565813292|FG001|Overall Study|Withdrawal by Subject|2|||
156799248|NCT02836249|566018949|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
156799249|NCT02836249|566018950|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
156799250|NCT02836249|566018951|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
156799251|NCT03605693|566018952|FG000|Overall Study|Lost to Follow-up|4|||
156799252|NCT03605693|566018953|FG001|Overall Study|Lost to Follow-up|0|||
156799253|NCT03605693|566018952|FG000|Overall Study|Physician Decision|1|||
156799254|NCT03605693|566018953|FG001|Overall Study|Physician Decision|0|||
156799255|NCT04752566|566018954|FG000|Overall Study|Protocol Violation|0|||
156799256|NCT04752566|566018955|FG001|Overall Study|Protocol Violation|1|||
156799257|NCT04752566|566018954|FG000|Overall Study|Death|1|||
156799258|NCT04752566|566018955|FG001|Overall Study|Death|0|||
156799259|NCT04752566|566018954|FG000|Overall Study|Adverse Event|1|||
156799260|NCT04752566|566018955|FG001|Overall Study|Adverse Event|0|||
156799261|NCT04752566|566018954|FG000|Overall Study|Withdrawal by Subject|2|||
156744844|NCT03000530|565813293|FG002|Overall Study|Withdrawal by Subject|1|||
156744845|NCT01672294|565813300|FG000|Overall Study|Withdrawal by Subject|4|||
156744846|NCT01672294|565813301|FG001|Overall Study|Withdrawal by Subject|4|||
156744847|NCT01672294|565813302|FG002|Overall Study|Withdrawal by Subject|4|||
156744848|NCT01672294|565813303|FG003|Overall Study|Withdrawal by Subject|4|||
156744849|NCT01672294|565813300|FG000|Overall Study|Excluded by study|1|||
156744850|NCT01672294|565813301|FG001|Overall Study|Excluded by study|1|||
156744851|NCT01672294|565813302|FG002|Overall Study|Excluded by study|0|||
156744852|NCT01672294|565813303|FG003|Overall Study|Excluded by study|0|||
156744853|NCT01672294|565813300|FG000|Overall Study|Lost to Follow-up|1|||
156744854|NCT01672294|565813301|FG001|Overall Study|Lost to Follow-up|16|||
156744855|NCT01672294|565813302|FG002|Overall Study|Lost to Follow-up|7|||
156744856|NCT01672294|565813303|FG003|Overall Study|Lost to Follow-up|9|||
156744857|NCT01285492|565813304|FG000|Overall Study|Adverse Event|11|||
156744858|NCT01285492|565813305|FG001|Overall Study|Adverse Event|0|||
156744859|NCT01285492|565813304|FG000|Overall Study|Protocol Violation|3|||
156744860|NCT01285492|565813305|FG001|Overall Study|Protocol Violation|0|||
156744861|NCT01285492|565813304|FG000|Overall Study|Withdrawal by Subject|2|||
156744862|NCT01285492|565813305|FG001|Overall Study|Withdrawal by Subject|1|||
156744863|NCT01285492|565813304|FG000|Overall Study|Death|1|||
156744864|NCT01285492|565813305|FG001|Overall Study|Death|0|||
156744865|NCT01606202|565813307|FG000|Overall Study|Adverse Event|5|||
156744866|NCT01606202|565813308|FG001|Overall Study|Adverse Event|0|||
156744867|NCT01606202|565813307|FG000|Overall Study|Withdrawal by Subject|2|||
156744868|NCT01606202|565813308|FG001|Overall Study|Withdrawal by Subject|1|||
156744869|NCT01606202|565813307|FG000|Overall Study|Personal problems|0|||
156744870|NCT01606202|565813308|FG001|Overall Study|Personal problems|1|||
156744871|NCT01606202|565813307|FG000|Overall Study|Problems with administration|0|||
156799262|NCT04752566|566018955|FG001|Overall Study|Withdrawal by Subject|0|||
156799263|NCT04752566|566018954|FG000|Overall Study|Physician Decision|1|||
156799264|NCT04752566|566018955|FG001|Overall Study|Physician Decision|1|||
157143252|NCT04430348|567272773|FG000|Overall Study|Study Terminated by Sponsor|0|||
156744872|NCT01606202|565813308|FG001|Overall Study|Problems with administration|1|||
157143253|NCT04430348|567272774|FG001|Overall Study|Study Terminated by Sponsor|0|||
157143254|NCT04430348|567272775|FG002|Overall Study|Study Terminated by Sponsor|2|||
156744873|NCT02273908|565813309|FG000|Overall Study|Adverse Event|16|||
156744874|NCT02273908|565813310|FG001|Overall Study|Adverse Event|0|||
156799265|NCT04562116|566018956|FG000|Overall Study|Lost to Follow-up|1|||
156799266|NCT04562116|566018956|FG000|Overall Study|Withdrawal by Subject|3|||
156799267|NCT03331354|566018957|FG000|Overall Study|Withdrawal by Subject|1|||
156799268|NCT03331354|566018958|FG001|Overall Study|Withdrawal by Subject|3|||
156799269|NCT03331354|566018957|FG000|Overall Study|Lost to Follow-up|3|||
156744875|NCT02273908|565813309|FG000|Overall Study|Lost to Follow-up|10|||
156744876|NCT02273908|565813310|FG001|Overall Study|Lost to Follow-up|1|||
156744877|NCT02273908|565813309|FG000|Overall Study|Did not meet entrance criteria|3|||
156799270|NCT03331354|566018958|FG001|Overall Study|Lost to Follow-up|3|||
156744878|NCT02273908|565813310|FG001|Overall Study|Did not meet entrance criteria|2|||
156744879|NCT02273908|565813309|FG000|Overall Study|Withdrawal by Subject|4|||
156744880|NCT02273908|565813310|FG001|Overall Study|Withdrawal by Subject|2|||
156744881|NCT00369161|565813311|FG000|Overall Study|Adverse Event|15|||
156744882|NCT00369161|565813312|FG001|Overall Study|Adverse Event|13|||
156744883|NCT00369161|565813311|FG000|Overall Study|Abnormal laboratory value|0|||
156744884|NCT00369161|565813312|FG001|Overall Study|Abnormal laboratory value|1|||
156744885|NCT00369161|565813311|FG000|Overall Study|Lack of Efficacy|3|||
156744886|NCT00369161|565813312|FG001|Overall Study|Lack of Efficacy|1|||
156744887|NCT00369161|565813311|FG000|Overall Study|Protocol Violation|0|||
156744888|NCT00369161|565813312|FG001|Overall Study|Protocol Violation|2|||
156744889|NCT00369161|565813311|FG000|Overall Study|Withdrawal by Subject|2|||
156744890|NCT00369161|565813312|FG001|Overall Study|Withdrawal by Subject|3|||
156744891|NCT00369161|565813311|FG000|Overall Study|Death|1|||
156744892|NCT00369161|565813312|FG001|Overall Study|Death|2|||
156744893|NCT00369161|565813311|FG000|Overall Study|Graft loss|4|||
156744894|NCT00369161|565813312|FG001|Overall Study|Graft loss|0|||
156744895|NCT00369161|565813311|FG000|Overall Study|Administrative Problem|2|||
156744896|NCT00369161|565813312|FG001|Overall Study|Administrative Problem|2|||
156744897|NCT01870297|565813315|FG000|Overall Study|Adverse Event|0|||
156744898|NCT01870297|565813316|FG001|Overall Study|Adverse Event|0|||
156744899|NCT01870297|565813317|FG002|Overall Study|Adverse Event|0|||
156744900|NCT01870297|565813318|FG003|Overall Study|Adverse Event|0|||
156744901|NCT01870297|565813319|FG004|Overall Study|Adverse Event|2|||
156744902|NCT01870297|565813320|FG005|Overall Study|Adverse Event|0|||
156744903|NCT01870297|565813321|FG006|Overall Study|Adverse Event|0|||
156744904|NCT01870297|565813315|FG000|Overall Study|Lost to Follow-up|0|||
156744905|NCT01870297|565813316|FG001|Overall Study|Lost to Follow-up|1|||
156744906|NCT01870297|565813317|FG002|Overall Study|Lost to Follow-up|1|||
156744907|NCT01870297|565813318|FG003|Overall Study|Lost to Follow-up|0|||
156744908|NCT01870297|565813319|FG004|Overall Study|Lost to Follow-up|0|||
156744909|NCT01870297|565813320|FG005|Overall Study|Lost to Follow-up|0|||
156744910|NCT01870297|565813321|FG006|Overall Study|Lost to Follow-up|0|||
156744911|NCT01870297|565813315|FG000|Overall Study|Withdrawal by Subject|0|||
156744912|NCT01870297|565813316|FG001|Overall Study|Withdrawal by Subject|0|||
156744913|NCT01870297|565813317|FG002|Overall Study|Withdrawal by Subject|0|||
156744914|NCT01870297|565813318|FG003|Overall Study|Withdrawal by Subject|0|||
156744915|NCT01870297|565813319|FG004|Overall Study|Withdrawal by Subject|1|||
156744916|NCT01870297|565813320|FG005|Overall Study|Withdrawal by Subject|1|||
156744917|NCT01870297|565813321|FG006|Overall Study|Withdrawal by Subject|1|||
156744918|NCT01870297|565813315|FG000|Overall Study|Sponsor Decision|0|||
156744919|NCT01870297|565813316|FG001|Overall Study|Sponsor Decision|6|||
156744920|NCT01870297|565813317|FG002|Overall Study|Sponsor Decision|0|||
156744921|NCT01870297|565813318|FG003|Overall Study|Sponsor Decision|0|||
156744922|NCT01870297|565813319|FG004|Overall Study|Sponsor Decision|0|||
156744923|NCT01870297|565813320|FG005|Overall Study|Sponsor Decision|0|||
156744924|NCT01870297|565813321|FG006|Overall Study|Sponsor Decision|1|||
156744925|NCT00422422|565813322|FG000|Overall Study|Lack of Efficacy|1|||
156744926|NCT00422422|565813322|FG000|Overall Study|Protocol Violation|1|||
156744927|NCT00422422|565813322|FG000|Overall Study|Withdrawal by Subject|2|||
156744928|NCT00422422|565813322|FG000|Overall Study|SAE, non-fatal|1|||
156744929|NCT00422422|565813322|FG000|Overall Study|AE, non-serious non-fatal|5|||
156744930|NCT01593254|565813323|FG000|Overall Study|Disease progression|2|||
156744931|NCT01593254|565813324|FG001|Overall Study|Disease progression|7|||
156744932|NCT01593254|565813323|FG000|Overall Study|Study drug toxicity|6|||
156744933|NCT01593254|565813324|FG001|Overall Study|Study drug toxicity|20|||
156744934|NCT01593254|565813323|FG000|Overall Study|Death|3|||
156744935|NCT01593254|565813324|FG001|Overall Study|Death|3|||
156744936|NCT01593254|565813323|FG000|Overall Study|AE unrelated to study drug|0|||
156744937|NCT01593254|565813324|FG001|Overall Study|AE unrelated to study drug|1|||
156744938|NCT01593254|565813323|FG000|Overall Study|participant request to discontinue study treatment|1|||
156744939|NCT01593254|565813324|FG001|Overall Study|participant request to discontinue study treatment|3|||
156744940|NCT01593254|565813323|FG000|Overall Study|participant withdrew consent|0|||
156744941|NCT01593254|565813324|FG001|Overall Study|participant withdrew consent|9|||
156744942|NCT01593254|565813323|FG000|Overall Study|lost to follow up|1|||
156744943|NCT01593254|565813324|FG001|Overall Study|lost to follow up|6|||
156744944|NCT01593254|565813323|FG000|Overall Study|maximum clinical benefit|1|||
156744945|NCT01593254|565813324|FG001|Overall Study|maximum clinical benefit|2|||
156744946|NCT01593254|565813323|FG000|Overall Study|Poor/non compliance|1|||
156744947|NCT01593254|565813324|FG001|Overall Study|Poor/non compliance|1|||
156744948|NCT01593254|565813323|FG000|Overall Study|Pregnancy|0|||
156744949|NCT01593254|565813324|FG001|Overall Study|Pregnancy|3|||
156744950|NCT01593254|565813323|FG000|Overall Study|participant no longer meets study criteria|1|||
156744951|NCT01593254|565813324|FG001|Overall Study|participant no longer meets study criteria|1|||
156744952|NCT01593254|565813323|FG000|Overall Study|Admin reason by sponsor|7|||
156744953|NCT01593254|565813324|FG001|Overall Study|Admin reason by sponsor|3|||
156744954|NCT01593254|565813323|FG000|Overall Study|Imatinib treatment failure|2|||
156744955|NCT01593254|565813324|FG001|Overall Study|Imatinib treatment failure|0|||
157219711|NCT00628745|567549470|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
157219712|NCT00628745|567549466|FG000|Overall Study|Site closure|152|||
157219713|NCT00628745|567549467|FG001|Overall Study|Site closure|146|||
157219714|NCT00628745|567549468|FG002|Overall Study|Site closure|6|||
157219715|NCT00628745|567549469|FG003|Overall Study|Site closure|8|||
157219716|NCT00628745|567549470|FG004|Overall Study|Site closure|691|||
156744956|NCT01593254|565813323|FG000|Overall Study|Other Reasons|61|||
156744957|NCT01593254|565813324|FG001|Overall Study|Other Reasons|115|||
157219717|NCT00628745|567549466|FG000|Overall Study|Duplicate participant|0|||
157219718|NCT00628745|567549467|FG001|Overall Study|Duplicate participant|0|||
157219719|NCT00628745|567549468|FG002|Overall Study|Duplicate participant|0|||
156744958|NCT00501059|565813325|FG000|Overall Study|Protocol Violation|80|||
156744959|NCT00501059|565813326|FG001|Overall Study|Protocol Violation|69|||
156744960|NCT00501059|565813325|FG000|Overall Study|Death|140|||
156744961|NCT00501059|565813326|FG001|Overall Study|Death|137|||
156744962|NCT00501059|565813325|FG000|Overall Study|Other|236|||
156744963|NCT00501059|565813326|FG001|Overall Study|Other|239|||
156744964|NCT00501059|565813325|FG000|Overall Study|Missing end-of-study page|91|||
156744965|NCT00501059|565813326|FG001|Overall Study|Missing end-of-study page|92|||
156744966|NCT00501059|565813325|FG000|Overall Study|Clinical endpoint reached|110|||
156744967|NCT00501059|565813326|FG001|Overall Study|Clinical endpoint reached|123|||
156744968|NCT00501059|565813325|FG000|Overall Study|Insufficient therapeutic effect|4|||
156744969|NCT00501059|565813326|FG001|Overall Study|Insufficient therapeutic effect|5|||
156744970|NCT00501059|565813325|FG000|Overall Study|Consent withdrawn by subject|817|||
156744971|NCT00501059|565813326|FG001|Overall Study|Consent withdrawn by subject|873|||
156744972|NCT00501059|565813325|FG000|Overall Study|Non-compliant with study treatment|23|||
156744973|NCT00501059|565813326|FG001|Overall Study|Non-compliant with study treatment|16|||
156744974|NCT00501059|565813325|FG000|Overall Study|Reason not given|3|||
156744975|NCT00501059|565813326|FG001|Overall Study|Reason not given|1|||
156744976|NCT00501059|565813325|FG000|Overall Study|Adverse Event|129|||
156744977|NCT00501059|565813326|FG001|Overall Study|Adverse Event|122|||
156744978|NCT00501059|565813325|FG000|Overall Study|Lost to Follow-up|210|||
156744979|NCT00501059|565813326|FG001|Overall Study|Lost to Follow-up|198|||
156744980|NCT00501059|565813325|FG000|Overall Study|Not treated|25|||
156744981|NCT00501059|565813326|FG001|Overall Study|Not treated|17|||
156744982|NCT04249622|565813329|FG000|Overall Study|Withdrawal by Subject|1|||
156744983|NCT04249622|565813330|FG001|Overall Study|Withdrawal by Subject|1|||
156744984|NCT04249622|565813329|FG000|Overall Study|Alternative therapy|1|||
156744985|NCT04249622|565813330|FG001|Overall Study|Alternative therapy|0|||
156744986|NCT04249622|565813329|FG000|Overall Study|Discontinuation of pertuzumab|1|||
156744987|NCT04249622|565813330|FG001|Overall Study|Discontinuation of pertuzumab|0|||
156744988|NCT03689543|565813333|FG000|Overall Study|Adverse Event|0|||
156744989|NCT03689543|565813334|FG001|Overall Study|Adverse Event|0|||
156744990|NCT03689543|565813335|FG002|Overall Study|Adverse Event|1|||
156744991|NCT01294371|565813336|FG000|Overall Study|Adverse Event|1|||
156744992|NCT01294371|565813336|FG000|Overall Study|Withdrawal by Subject|12|||
156744993|NCT01294371|565813336|FG000|Overall Study|Lost to Follow-up|6|||
156744994|NCT01294371|565813336|FG000|Overall Study|Administrative Reason|1|||
156744995|NCT01294371|565813336|FG000|Overall Study|Other|14|||
156744996|NCT05619536|565813337|FG000|Overall Study|Withdrawal by Subject|0|||
156744997|NCT05619536|565813338|FG001|Overall Study|Withdrawal by Subject|1|||
156744998|NCT05619536|565813339|FG002|Overall Study|Withdrawal by Subject|0|||
156744999|NCT05619536|565813340|FG003|Overall Study|Withdrawal by Subject|1|||
156745000|NCT05619536|565813337|FG000|Overall Study|Lost to Follow-up|0|||
156745001|NCT05619536|565813338|FG001|Overall Study|Lost to Follow-up|1|||
156745002|NCT05619536|565813339|FG002|Overall Study|Lost to Follow-up|1|||
156745003|NCT05619536|565813340|FG003|Overall Study|Lost to Follow-up|0|||
156745004|NCT00622336|565813343|FG000|Treatment Phase|Progression of Disease|181|||
156745005|NCT00622336|565813343|FG000|Treatment Phase|Adverse Event|46|||
156745006|NCT00622336|565813343|FG000|Treatment Phase|Other|40|||
156745007|NCT00622336|565813343|FG000|Treatment Phase|Death|14|||
156745008|NCT00622336|565813343|FG000|Treatment Phase|Lack of therapeutic effect|13|||
156745009|NCT00622336|565813343|FG000|Treatment Phase|Withdrawal by Subject|13|||
156745010|NCT00622336|565813343|FG000|Treatment Phase|Lost to Follow-up|2|||
156745011|NCT00622336|565813343|FG000|Extension Phase|Adverse Event|2|||
156745012|NCT00622336|565813343|FG000|Extension Phase|Progressive Disease|6|||
156745013|NCT00622336|565813343|FG000|Extension Phase|Lack of therapeutic effect|2|||
156745014|NCT00622336|565813343|FG000|Extension Phase|Withdrawal by Subject|1|||
156745015|NCT00622336|565813343|FG000|Extension Phase|Lost to Follow-up|1|||
156745016|NCT00622336|565813343|FG000|Extension Phase|Other|9|||
156745017|NCT00157248|565813348|FG000|Overall Study|Adverse Event|36|||
156745018|NCT00157248|565813349|FG001|Overall Study|Adverse Event|25|||
156745019|NCT00157248|565813350|FG002|Overall Study|Adverse Event|13|||
157219720|NCT00628745|567549469|FG003|Overall Study|Duplicate participant|0|||
156745020|NCT00157248|565813351|FG003|Overall Study|Adverse Event|33|||
156745021|NCT00157248|565813348|FG000|Overall Study|Protocol Violation|4|||
156745022|NCT00157248|565813349|FG001|Overall Study|Protocol Violation|0|||
156745023|NCT00157248|565813350|FG002|Overall Study|Protocol Violation|2|||
157219721|NCT00628745|567549470|FG004|Overall Study|Duplicate participant|1|||
157219722|NCT00628745|567549466|FG000|Overall Study|Missing|4|||
156745024|NCT00157248|565813351|FG003|Overall Study|Protocol Violation|2|||
156745025|NCT00157248|565813348|FG000|Overall Study|Lost to Follow-up|0|||
156745026|NCT00157248|565813349|FG001|Overall Study|Lost to Follow-up|1|||
156745027|NCT00157248|565813350|FG002|Overall Study|Lost to Follow-up|0|||
156745028|NCT00157248|565813351|FG003|Overall Study|Lost to Follow-up|0|||
156745029|NCT00157248|565813348|FG000|Overall Study|Withdrawal by Subject|1|||
156745030|NCT00157248|565813349|FG001|Overall Study|Withdrawal by Subject|4|||
157219723|NCT00628745|567549467|FG001|Overall Study|Missing|3|||
157219724|NCT00628745|567549468|FG002|Overall Study|Missing|0|||
157219725|NCT00628745|567549469|FG003|Overall Study|Missing|0|||
157219726|NCT00628745|567549470|FG004|Overall Study|Missing|10|||
157219727|NCT00628745|567549466|FG000|Overall Study|Othe reasons|987|||
157219728|NCT00628745|567549467|FG001|Overall Study|Othe reasons|373|||
157219729|NCT00628745|567549468|FG002|Overall Study|Othe reasons|105|||
157219730|NCT00628745|567549469|FG003|Overall Study|Othe reasons|1|||
157219731|NCT00628745|567549470|FG004|Overall Study|Othe reasons|1772|||
157219732|NCT00982410|567551058|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
157219733|NCT00982410|567551059|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
157219734|NCT00982410|567551058|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
157219735|NCT00982410|567551059|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
157219736|NCT00982410|567551058|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
157219737|NCT00982410|567551059|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
157219738|NCT00982410|567551058|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
157219739|NCT00982410|567551059|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
157219740|NCT00982410|567551058|FG000|6-month Follow-up Assessment|participant no transportation|1|||
157219741|NCT00982410|567551059|FG001|6-month Follow-up Assessment|participant no transportation|0|||
156745031|NCT00157248|565813350|FG002|Overall Study|Withdrawal by Subject|3|||
156745032|NCT00157248|565813351|FG003|Overall Study|Withdrawal by Subject|3|||
156745033|NCT00157248|565813348|FG000|Overall Study|site closures, subject moving|7|||
156745034|NCT00157248|565813349|FG001|Overall Study|site closures, subject moving|7|||
156745035|NCT00157248|565813350|FG002|Overall Study|site closures, subject moving|3|||
157219742|NCT00982410|567551058|FG000|6-month Follow-up Assessment|incarceration|0|||
157219743|NCT00982410|567551059|FG001|6-month Follow-up Assessment|incarceration|2|||
157219744|NCT00982410|567551058|FG000|6-month Follow-up Assessment|patent surgery|0|||
157219745|NCT00982410|567551059|FG001|6-month Follow-up Assessment|patent surgery|1|||
156745036|NCT00157248|565813351|FG003|Overall Study|site closures, subject moving|9|||
156745037|NCT01911793|565815603|FG000|Overall Study|Physician Decision|1|||
156745038|NCT01911793|565815604|FG001|Overall Study|Physician Decision|5|||
156745039|NCT03774394|565815605|FG000|Overall Study|Withdrawal by Subject|2|||
156745040|NCT03774394|565815606|FG001|Overall Study|Withdrawal by Subject|0|||
156745041|NCT02697916|565815607|FG000|Overall Study|Death|357|||
156745042|NCT02697916|565815608|FG001|Overall Study|Death|315|||
156745043|NCT02697916|565815607|FG000|Overall Study|Withdrawal by Subject|221|||
156745044|NCT02697916|565815608|FG001|Overall Study|Withdrawal by Subject|393|||
156745045|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
156745046|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
156745047|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
156745048|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
156745049|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
156745050|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
156745051|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
156745052|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
156745053|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
156745054|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
156745055|NCT01777139|565815609|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
156745056|NCT01777139|565815610|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
156745057|NCT01777139|565815609|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
156745058|NCT01777139|565815610|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
156745059|NCT01777139|565815609|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
156745060|NCT01777139|565815610|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
156745061|NCT00290693|565815612|FG000|Overall Study|Withdrawal by Subject|2|||
156745062|NCT04849416|565815613|FG000|Overall Study|Ongoing Treatment|12|||
156745063|NCT04849416|565815614|FG001|Overall Study|Ongoing Treatment|5|||
156745064|NCT04849416|565815615|FG002|Overall Study|Ongoing Treatment|3|||
156745065|NCT04849416|565815613|FG000|Overall Study|On Post-Treatment Follow-up|8|||
156745066|NCT04849416|565815614|FG001|Overall Study|On Post-Treatment Follow-up|9|||
156745067|NCT04849416|565815615|FG002|Overall Study|On Post-Treatment Follow-up|10|||
156745068|NCT04849416|565815613|FG000|Overall Study|Withdrawal by Subject|0|||
157143255|NCT04430348|567272776|FG003|Overall Study|Study Terminated by Sponsor|0|||
157143256|NCT04430348|567272777|FG004|Overall Study|Study Terminated by Sponsor|1|||
156879720|NCT00830869|566319794|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
156879721|NCT00830869|566319795|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
156879722|NCT00830869|566319796|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
156879723|NCT00830869|566319797|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
156879724|NCT00830869|566319798|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
156879725|NCT00830869|566319799|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
156879726|NCT00830869|566319800|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
156879727|NCT00830869|566319801|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
156879728|NCT00830869|566319802|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
156879729|NCT00830869|566319803|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
156879730|NCT00830869|566319804|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
156879731|NCT00830869|566319793|FG000|Period 1: Part 1|Adverse Event|0|||
156879732|NCT00830869|566319794|FG001|Period 1: Part 1|Adverse Event|0|||
156879733|NCT00830869|566319795|FG002|Period 1: Part 1|Adverse Event|0|||
156879734|NCT00830869|566319796|FG003|Period 1: Part 1|Adverse Event|0|||
156879735|NCT00830869|566319797|FG004|Period 1: Part 1|Adverse Event|0|||
156879736|NCT00830869|566319798|FG005|Period 1: Part 1|Adverse Event|1|||
156879737|NCT00830869|566319799|FG006|Period 1: Part 1|Adverse Event|1|||
156879738|NCT00830869|566319800|FG007|Period 1: Part 1|Adverse Event|0|||
156879739|NCT00830869|566319801|FG008|Period 1: Part 1|Adverse Event|0|||
156879740|NCT00830869|566319802|FG009|Period 1: Part 1|Adverse Event|0|||
156879741|NCT00830869|566319803|FG010|Period 1: Part 1|Adverse Event|0|||
156879742|NCT00830869|566319804|FG011|Period 1: Part 1|Adverse Event|0|||
156879743|NCT00830869|566319793|FG000|Period 1: Part 1|Progressive disease|1|||
156879744|NCT00830869|566319794|FG001|Period 1: Part 1|Progressive disease|0|||
156879745|NCT00830869|566319795|FG002|Period 1: Part 1|Progressive disease|1|||
156879746|NCT00830869|566319796|FG003|Period 1: Part 1|Progressive disease|6|||
156879747|NCT00830869|566319797|FG004|Period 1: Part 1|Progressive disease|4|||
156879748|NCT00830869|566319798|FG005|Period 1: Part 1|Progressive disease|4|||
156879749|NCT00830869|566319799|FG006|Period 1: Part 1|Progressive disease|1|||
156879750|NCT00830869|566319800|FG007|Period 1: Part 1|Progressive disease|0|||
156879751|NCT00830869|566319801|FG008|Period 1: Part 1|Progressive disease|0|||
156879752|NCT00830869|566319802|FG009|Period 1: Part 1|Progressive disease|0|||
156879753|NCT00830869|566319803|FG010|Period 1: Part 1|Progressive disease|0|||
156879754|NCT00830869|566319804|FG011|Period 1: Part 1|Progressive disease|0|||
156879755|NCT00830869|566319793|FG000|Period 2: Part 2|Protocol Violation|0|||
156879756|NCT00830869|566319794|FG001|Period 2: Part 2|Protocol Violation|0|||
156879757|NCT00830869|566319795|FG002|Period 2: Part 2|Protocol Violation|0|||
156879758|NCT00830869|566319796|FG003|Period 2: Part 2|Protocol Violation|0|||
156879759|NCT00830869|566319797|FG004|Period 2: Part 2|Protocol Violation|0|||
156879760|NCT00830869|566319798|FG005|Period 2: Part 2|Protocol Violation|0|||
156879761|NCT00830869|566319799|FG006|Period 2: Part 2|Protocol Violation|0|||
156879762|NCT00830869|566319800|FG007|Period 2: Part 2|Protocol Violation|1|||
156879763|NCT00830869|566319801|FG008|Period 2: Part 2|Protocol Violation|0|||
156879764|NCT00830869|566319802|FG009|Period 2: Part 2|Protocol Violation|1|||
156879765|NCT00830869|566319803|FG010|Period 2: Part 2|Protocol Violation|0|||
156879766|NCT00830869|566319804|FG011|Period 2: Part 2|Protocol Violation|0|||
156879767|NCT00830869|566319793|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
156879768|NCT00830869|566319794|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
156879769|NCT00830869|566319795|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
156879770|NCT00830869|566319796|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
156879771|NCT00830869|566319797|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
156879772|NCT00830869|566319798|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
156879773|NCT00830869|566319799|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
156879774|NCT00830869|566319800|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
156879775|NCT00830869|566319801|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
156879776|NCT00830869|566319802|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
156879777|NCT00830869|566319803|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
156879778|NCT00830869|566319804|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
156879779|NCT00830869|566319793|FG000|Period 2: Part 2|Adverse Event|0|||
156879780|NCT00830869|566319794|FG001|Period 2: Part 2|Adverse Event|0|||
156879781|NCT00830869|566319795|FG002|Period 2: Part 2|Adverse Event|0|||
156879782|NCT00830869|566319796|FG003|Period 2: Part 2|Adverse Event|0|||
156879783|NCT00830869|566319797|FG004|Period 2: Part 2|Adverse Event|0|||
156879784|NCT00830869|566319798|FG005|Period 2: Part 2|Adverse Event|0|||
156879785|NCT00830869|566319799|FG006|Period 2: Part 2|Adverse Event|0|||
156879786|NCT00830869|566319800|FG007|Period 2: Part 2|Adverse Event|4|||
156879787|NCT00830869|566319801|FG008|Period 2: Part 2|Adverse Event|3|||
156879788|NCT00830869|566319802|FG009|Period 2: Part 2|Adverse Event|2|||
156879789|NCT00830869|566319803|FG010|Period 2: Part 2|Adverse Event|2|||
156879790|NCT00830869|566319804|FG011|Period 2: Part 2|Adverse Event|0|||
157143257|NCT04430348|567272778|FG005|Overall Study|Study Terminated by Sponsor|1|||
156879791|NCT00830869|566319793|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
156879792|NCT00830869|566319794|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
157143258|NCT02037919|567272779|FG000|Overall Study|Lost to Follow-up|30|||
157219746|NCT00982410|567551058|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
157219747|NCT00982410|567551059|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
157219748|NCT00982410|567551058|FG000|12-month Follow-up Assessment|Death|0|||
157219749|NCT00982410|567551059|FG001|12-month Follow-up Assessment|Death|2|||
157219750|NCT00982410|567551058|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
157219751|NCT00982410|567551059|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
157219752|NCT00982410|567551058|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
157219753|NCT00982410|567551059|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
157219754|NCT00982410|567551058|FG000|12-month Follow-up Assessment|incarceration|2|||
157219755|NCT00982410|567551059|FG001|12-month Follow-up Assessment|incarceration|1|||
157219756|NCT00982410|567551058|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
157219757|NCT00982410|567551059|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
157219758|NCT02034799|567551062|FG000|Overall Study|Withdrawal by Subject|0|||
157219759|NCT02034799|567551063|FG001|Overall Study|Withdrawal by Subject|2|||
156879793|NCT00830869|566319795|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
156879794|NCT00830869|566319796|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
156879795|NCT00830869|566319797|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
156879796|NCT00830869|566319798|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
156879797|NCT00830869|566319799|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
156879798|NCT00830869|566319800|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
156879799|NCT00830869|566319801|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
157219760|NCT02034799|567551062|FG000|Overall Study|Lost to Follow-up|0|||
157219761|NCT02034799|567551063|FG001|Overall Study|Lost to Follow-up|1|||
156745069|NCT04849416|565815614|FG001|Overall Study|Withdrawal by Subject|0|||
156745070|NCT04849416|565815615|FG002|Overall Study|Withdrawal by Subject|1|||
156745071|NCT04849416|565815613|FG000|Overall Study|Lost to Follow-up|1|||
156745072|NCT04849416|565815614|FG001|Overall Study|Lost to Follow-up|0|||
156745073|NCT04849416|565815615|FG002|Overall Study|Lost to Follow-up|0|||
156745074|NCT00981058|565815626|FG000|Overall Study|Progressive Disease|38|||
156745075|NCT00981058|565815627|FG001|Overall Study|Progressive Disease|31|||
156745076|NCT00981058|565815626|FG000|Overall Study|Lost to Follow-up|3|||
156745077|NCT00981058|565815627|FG001|Overall Study|Lost to Follow-up|2|||
156745078|NCT00981058|565815626|FG000|Overall Study|Physician Decision|4|||
156745079|NCT00981058|565815627|FG001|Overall Study|Physician Decision|5|||
156745080|NCT00981058|565815626|FG000|Overall Study|Randomization Error|0|||
156745081|NCT00981058|565815627|FG001|Overall Study|Randomization Error|1|||
156745082|NCT00981058|565815626|FG000|Overall Study|Withdrawal by Subject|24|||
156745083|NCT00981058|565815627|FG001|Overall Study|Withdrawal by Subject|22|||
156745084|NCT02667587|565815628|FG000|Pre-Treatment|Not reported|1|||
156745085|NCT02667587|565815629|FG001|Pre-Treatment|Not reported|0|||
156745086|NCT02667587|565815628|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156745087|NCT02667587|565815629|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
156745088|NCT02667587|565815628|FG000|Pre-Treatment|Participant withdrew consent|0|||
156745089|NCT02667587|565815629|FG001|Pre-Treatment|Participant withdrew consent|1|||
156745090|NCT02667587|565815628|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
156745091|NCT02667587|565815629|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
156799271|NCT03331354|566018957|FG000|Overall Study|Found employment before initiated active intervention|0|||
156799272|NCT03331354|566018958|FG001|Overall Study|Found employment before initiated active intervention|4|||
156799273|NCT01646827|566018959|FG000|Overall Study|Lost to Follow-up|0|||
156799274|NCT01646827|566018960|FG001|Overall Study|Lost to Follow-up|3|||
156799275|NCT01646827|566018959|FG000|Overall Study|Physician Decision|1|||
156799276|NCT01646827|566018960|FG001|Overall Study|Physician Decision|2|||
156799277|NCT01646827|566018959|FG000|Overall Study|Withdrawal by Subject|1|||
156799278|NCT01646827|566018960|FG001|Overall Study|Withdrawal by Subject|0|||
156799279|NCT05134649|566018961|FG000|Overall Study|Lost to Follow-up|12|||
156799280|NCT05134649|566018961|FG000|Overall Study|Withdrawal by Subject|14|||
156799281|NCT05134649|566018961|FG000|Overall Study|Pregnancy|1|||
156799282|NCT05134649|566018961|FG000|Overall Study|Other, not specified|3|||
156799283|NCT00928668|566018962|FG000|Overall Study|Adverse Event|1|||
156799284|NCT00928668|566018963|FG001|Overall Study|Adverse Event|0|||
156799285|NCT00928668|566018964|FG002|Overall Study|Adverse Event|0|||
156799286|NCT00928668|566018965|FG003|Overall Study|Adverse Event|0|||
156799287|NCT00928668|566018966|FG004|Overall Study|Adverse Event|0|||
156799288|NCT00928668|566018962|FG000|Overall Study|Protocol Violation|0|||
156799289|NCT00928668|566018963|FG001|Overall Study|Protocol Violation|0|||
156799290|NCT00928668|566018964|FG002|Overall Study|Protocol Violation|0|||
156799291|NCT00928668|566018965|FG003|Overall Study|Protocol Violation|0|||
156799292|NCT00928668|566018966|FG004|Overall Study|Protocol Violation|1|||
156799293|NCT00928668|566018962|FG000|Overall Study|Withdrawal by Subject|0|||
156799294|NCT00928668|566018963|FG001|Overall Study|Withdrawal by Subject|1|||
156879800|NCT00830869|566319802|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
156879801|NCT00830869|566319803|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
156799295|NCT00928668|566018964|FG002|Overall Study|Withdrawal by Subject|1|||
156799296|NCT00928668|566018965|FG003|Overall Study|Withdrawal by Subject|0|||
157219762|NCT02034799|567551062|FG000|Overall Study|Death|2|||
156799297|NCT00928668|566018966|FG004|Overall Study|Withdrawal by Subject|0|||
156799298|NCT00928668|566018962|FG000|Overall Study|Other reasons not listed above|0|||
156799299|NCT00928668|566018963|FG001|Overall Study|Other reasons not listed above|0|||
156799300|NCT00928668|566018964|FG002|Overall Study|Other reasons not listed above|0|||
156799301|NCT00928668|566018965|FG003|Overall Study|Other reasons not listed above|1|||
156799302|NCT00928668|566018966|FG004|Overall Study|Other reasons not listed above|0|||
156799303|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
156799304|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
156799305|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
156799306|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
156799307|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799308|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
156799309|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799310|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
156799311|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
156799312|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
156799313|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
156799314|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
156799315|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
156799316|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
156799317|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
156799318|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
156799319|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
156799320|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
156799321|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
156799322|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
156799323|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
156799324|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
156799325|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
156799326|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
156799327|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
156799328|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
156799329|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
156799330|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
156799331|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
156799332|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
156799333|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
156799334|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
156799335|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
156799336|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
156799337|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
156799338|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
156799339|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
156799340|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
156799341|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
156799342|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
156799343|NCT04392154|566018967|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799344|NCT04392154|566018968|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
156799345|NCT04392154|566018969|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799346|NCT04392154|566018970|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
156799347|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799348|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799349|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
156799350|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
156799351|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799352|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799353|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
156799354|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
156799355|NCT04392154|566018967|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799356|NCT04392154|566018968|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799357|NCT04392154|566018969|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
156799358|NCT04392154|566018970|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
156799359|NCT02757430|566018981|FG000|Overall Study|Physician Decision|6|||
156799360|NCT02757430|566018981|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
156879802|NCT00830869|566319804|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
156745092|NCT02667587|565815628|FG000|End of Treatment|Disease Progression|193|||
156745093|NCT02667587|565815629|FG001|End of Treatment|Disease Progression|226|||
156745094|NCT02667587|565815628|FG000|End of Treatment|Study Drug Toxicity|75|||
156745095|NCT02667587|565815629|FG001|End of Treatment|Study Drug Toxicity|19|||
156745096|NCT02667587|565815628|FG000|End of Treatment|Death|2|||
156745097|NCT02667587|565815629|FG001|End of Treatment|Death|1|||
156745098|NCT02667587|565815628|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
156745099|NCT02667587|565815629|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
156745100|NCT02667587|565815628|FG000|End of Treatment|participant request to discontinue treatment|33|||
156745101|NCT02667587|565815629|FG001|End of Treatment|participant request to discontinue treatment|35|||
156745102|NCT02667587|565815628|FG000|End of Treatment|participant withdrew consent|5|||
156745103|NCT02667587|565815629|FG001|End of Treatment|participant withdrew consent|6|||
156745104|NCT02667587|565815628|FG000|End of Treatment|Lost to Follow-up|1|||
156745105|NCT02667587|565815629|FG001|End of Treatment|Lost to Follow-up|2|||
156745106|NCT02667587|565815628|FG000|End of Treatment|maximum clinical benefit|4|||
156745107|NCT02667587|565815629|FG001|End of Treatment|maximum clinical benefit|4|||
156745108|NCT02667587|565815628|FG000|End of Treatment|poor or non compliant|0|||
156745109|NCT02667587|565815629|FG001|End of Treatment|poor or non compliant|1|||
156745110|NCT02667587|565815628|FG000|End of Treatment|participant no longer meets study criteria|1|||
156745111|NCT02667587|565815629|FG001|End of Treatment|participant no longer meets study criteria|1|||
156745112|NCT02667587|565815628|FG000|End of Treatment|administrative reason by sponsor|1|||
156745113|NCT02667587|565815629|FG001|End of Treatment|administrative reason by sponsor|29|||
156745114|NCT02667587|565815628|FG000|End of Treatment|other reasonse|21|||
156745115|NCT02667587|565815629|FG001|End of Treatment|other reasonse|10|||
156745116|NCT02542293|565815630|FG000|Overall Study|Death|367|||
156745117|NCT02542293|565815631|FG001|Overall Study|Death|377|||
156745118|NCT02542293|565815630|FG000|Overall Study|Withdrawal by Subject|8|||
156745119|NCT02542293|565815631|FG001|Overall Study|Withdrawal by Subject|19|||
156745120|NCT04529850|565815632|FG000|Overall Study|Death|2|||
156745121|NCT04529850|565815632|FG000|Overall Study|Physician Decision|1|||
156745122|NCT04529850|565815632|FG000|Overall Study|Withdrawal by Subject|2|||
156745123|NCT02278367|565815635|FG000|Overall Study|Physician Decision|5|||
156745124|NCT02278367|565815636|FG001|Overall Study|Physician Decision|0|||
156745125|NCT02278367|565815635|FG000|Overall Study|Withdrawal by Subject|5|||
156745126|NCT02278367|565815636|FG001|Overall Study|Withdrawal by Subject|0|||
156745127|NCT01472939|565815640|FG000|Overall Study|Adverse Event|3|||
156745128|NCT01472939|565815641|FG001|Overall Study|Adverse Event|7|||
156745129|NCT01472939|565815642|FG002|Overall Study|Adverse Event|7|||
156745130|NCT01472939|565815643|FG003|Overall Study|Adverse Event|14|||
156745131|NCT01472939|565815640|FG000|Overall Study|Lack of Efficacy|1|||
156745132|NCT01472939|565815641|FG001|Overall Study|Lack of Efficacy|0|||
156745133|NCT01472939|565815642|FG002|Overall Study|Lack of Efficacy|0|||
156745134|NCT01472939|565815643|FG003|Overall Study|Lack of Efficacy|1|||
156745135|NCT01472939|565815640|FG000|Overall Study|Lost to Follow-up|3|||
156745136|NCT01472939|565815641|FG001|Overall Study|Lost to Follow-up|0|||
156745137|NCT01472939|565815642|FG002|Overall Study|Lost to Follow-up|2|||
156745138|NCT01472939|565815643|FG003|Overall Study|Lost to Follow-up|0|||
156745139|NCT01472939|565815640|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
156745140|NCT01472939|565815641|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
157143259|NCT02037919|567272780|FG001|Overall Study|Lost to Follow-up|45|||
156745141|NCT01472939|565815642|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
156745142|NCT01472939|565815643|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
156745143|NCT01472939|565815640|FG000|Overall Study|Prohibited Medication|0|||
156745144|NCT01472939|565815641|FG001|Overall Study|Prohibited Medication|1|||
156745145|NCT01472939|565815642|FG002|Overall Study|Prohibited Medication|0|||
156745146|NCT01472939|565815643|FG003|Overall Study|Prohibited Medication|0|||
156745147|NCT01472939|565815640|FG000|Overall Study|Withdrawal By PI|1|||
156745148|NCT01472939|565815641|FG001|Overall Study|Withdrawal By PI|0|||
156799361|NCT02757430|566018981|FG000|Overall Study|No informed consent|1|||
156799362|NCT02757430|566018981|FG000|Overall Study|No procedure performed|2|||
156799363|NCT03502200|566018982|FG000|Overall Study|Adverse Event|1|||
156799364|NCT03502200|566018983|FG001|Overall Study|Adverse Event|0|||
156799365|NCT03502200|566018982|FG000|Overall Study|Lost to Follow-up|36|||
156799366|NCT03502200|566018983|FG001|Overall Study|Lost to Follow-up|38|||
156799367|NCT03502200|566018982|FG000|Overall Study|Study Team Decision|1|||
156799368|NCT03502200|566018983|FG001|Overall Study|Study Team Decision|1|||
156799369|NCT03502200|566018982|FG000|Overall Study|Withdrawal by Subject|5|||
156799370|NCT03502200|566018983|FG001|Overall Study|Withdrawal by Subject|7|||
156745149|NCT01472939|565815642|FG002|Overall Study|Withdrawal By PI|0|||
156745150|NCT01472939|565815643|FG003|Overall Study|Withdrawal By PI|0|||
156745151|NCT01472939|565815640|FG000|Overall Study|Protocol Violation|3|||
156745152|NCT01472939|565815641|FG001|Overall Study|Protocol Violation|3|||
156745153|NCT01472939|565815642|FG002|Overall Study|Protocol Violation|0|||
156745154|NCT01472939|565815643|FG003|Overall Study|Protocol Violation|1|||
156799371|NCT03502200|566018982|FG000|Overall Study|Death|0|||
156799372|NCT03502200|566018983|FG001|Overall Study|Death|2|||
156799373|NCT03097289|566018985|FG000|Overall Study|Adverse Event|1|||
156799374|NCT03097289|566018985|FG000|Overall Study|Equipment failure|2|||
156799375|NCT03097289|566018985|FG000|Overall Study|Collected platelet product unusable|3|||
157020631|NCT03332017|566828480|FG001|Overall Study|Remained in Study (Ongoing)|110|||
157020632|NCT04177823|566828485|FG000|Overall Study|Physician Decision|1|||
157020633|NCT04177823|566828485|FG000|Overall Study|Withdrawal by Subject|1|||
156745155|NCT01472939|565815640|FG000|Overall Study|Withdrawal by Subject|9|||
156745156|NCT01472939|565815641|FG001|Overall Study|Withdrawal by Subject|3|||
156745157|NCT01472939|565815642|FG002|Overall Study|Withdrawal by Subject|1|||
156745158|NCT01472939|565815643|FG003|Overall Study|Withdrawal by Subject|4|||
156745159|NCT00114738|565815644|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
156745160|NCT00114738|565815645|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
156745161|NCT00114738|565815646|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
156745162|NCT00114738|565815644|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
156745163|NCT00114738|565815645|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
156745164|NCT00114738|565815646|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
156745165|NCT00114738|565815644|FG000|Screening for Randomization|Neuropathy|17|||
157020634|NCT04229992|566828486|FG000|Overall Study|Withdrawal by Subject|0|||
157020635|NCT04229992|566828487|FG001|Overall Study|Withdrawal by Subject|2|||
157020636|NCT04229992|566828488|FG002|Overall Study|Withdrawal by Subject|1|||
157020637|NCT04229992|566828489|FG003|Overall Study|Withdrawal by Subject|1|||
157020638|NCT04229992|566828486|FG000|Overall Study|Adverse Event|1|||
157020639|NCT04229992|566828487|FG001|Overall Study|Adverse Event|1|||
157020640|NCT04229992|566828488|FG002|Overall Study|Adverse Event|3|||
157020641|NCT04229992|566828489|FG003|Overall Study|Adverse Event|1|||
157020642|NCT04229992|566828486|FG000|Overall Study|Lost to Follow-up|0|||
157020643|NCT04229992|566828487|FG001|Overall Study|Lost to Follow-up|0|||
157020644|NCT04229992|566828488|FG002|Overall Study|Lost to Follow-up|0|||
157020645|NCT04229992|566828489|FG003|Overall Study|Lost to Follow-up|1|||
157020646|NCT03720795|566828491|FG000|Phase 1|Lost to Follow-up|4|||
157020647|NCT03720795|566828491|FG000|Phase 1|Withdrawal by Subject|6|||
157020648|NCT03720795|566828491|FG000|Phase 1|Protocol Violation|1|||
157020649|NCT03720795|566828491|FG000|Phase 1|Other|1|||
157020650|NCT03720795|566828491|FG000|Phase 2|Lost to Follow-up|5|||
157020651|NCT03720795|566828491|FG000|Phase 2|Withdrawal by Subject|10|||
157020652|NCT03720795|566828491|FG000|Phase 2|Protocol Violation|2|||
157020653|NCT03720795|566828491|FG000|3 Month Follow Up|Lost to Follow-up|2|||
157020654|NCT04322643|566828492|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
157020655|NCT05486078|566828493|FG000|Overall Study|4 drop out and one withdrawn|5|||
157020656|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Other|0|||
157020657|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Other|0|||
157020658|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Other|0|||
157020659|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Other|0|||
157020660|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Other|0|||
157020661|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Other|0|||
157020662|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Other|0|||
157020663|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Other|0|||
157020664|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Other|0|||
156745166|NCT00114738|565815645|FG001|Screening for Randomization|Neuropathy|0|||
156799376|NCT00049543|566018988|FG000|Overall Study|still on treatment|2|||
156799377|NCT00049543|566018989|FG001|Overall Study|still on treatment|9|||
156799378|NCT04251533|566018999|FG000|Overall Study|Progressive disease|33|||
157020665|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Other|0|||
157020666|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Other|1|||
156799379|NCT04251533|566019000|FG001|Overall Study|Progressive disease|29|||
156799380|NCT04251533|566019001|FG002|Overall Study|Progressive disease|22|||
156799381|NCT04251533|566018999|FG000|Overall Study|Death|5|||
156799382|NCT04251533|566019000|FG001|Overall Study|Death|1|||
156799383|NCT04251533|566019001|FG002|Overall Study|Death|3|||
156799384|NCT04251533|566018999|FG000|Overall Study|Physician Decision|3|||
156799385|NCT04251533|566019000|FG001|Overall Study|Physician Decision|2|||
156799386|NCT04251533|566019001|FG002|Overall Study|Physician Decision|4|||
156799387|NCT04251533|566018999|FG000|Overall Study|Participant decision|1|||
156799388|NCT04251533|566019000|FG001|Overall Study|Participant decision|3|||
156879803|NCT00830869|566319793|FG000|Period 2: Part 2|Progressive disease|0|||
157020667|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Other|1|||
157020668|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Other|1|||
156745167|NCT00114738|565815646|FG002|Screening for Randomization|Neuropathy|0|||
156799389|NCT04251533|566019001|FG002|Overall Study|Participant decision|1|||
156799390|NCT04251533|566018999|FG000|Overall Study|Adverse Event|2|||
156799391|NCT04251533|566019000|FG001|Overall Study|Adverse Event|1|||
156799392|NCT04251533|566019001|FG002|Overall Study|Adverse Event|1|||
157020669|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Other|0|||
157020670|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Other|3|||
157020671|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Other|1|||
157020672|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Other|1|||
157020673|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Other|0|||
157020674|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
157143260|NCT01575548|567272781|FG000|Overall Study|Adverse Event|15|||
156745168|NCT00114738|565815644|FG000|Screening for Randomization|Progressive disease|2|||
156745169|NCT00114738|565815645|FG001|Screening for Randomization|Progressive disease|0|||
156745170|NCT00114738|565815646|FG002|Screening for Randomization|Progressive disease|0|||
156745171|NCT00114738|565815644|FG000|Screening for Randomization|CNS Hemorrhage|1|||
156745172|NCT00114738|565815645|FG001|Screening for Randomization|CNS Hemorrhage|0|||
156745173|NCT00114738|565815646|FG002|Screening for Randomization|CNS Hemorrhage|0|||
156745174|NCT00114738|565815644|FG000|Screening for Randomization|Other|1|||
156745175|NCT00114738|565815645|FG001|Screening for Randomization|Other|0|||
156745176|NCT00114738|565815646|FG002|Screening for Randomization|Other|0|||
156745177|NCT00316914|565815648|FG000|Overall Study|Withdrawal by Subject|5|||
156745178|NCT00316914|565815649|FG001|Overall Study|Withdrawal by Subject|3|||
156745179|NCT00316914|565815648|FG000|Overall Study|Adverse Event|8|||
156745180|NCT00316914|565815649|FG001|Overall Study|Adverse Event|7|||
156745181|NCT00316914|565815648|FG000|Overall Study|Other Problems|6|||
156745182|NCT00316914|565815649|FG001|Overall Study|Other Problems|11|||
156745183|NCT00316914|565815648|FG000|Overall Study|Missing end of treatment documentation|14|||
156745184|NCT00316914|565815649|FG001|Overall Study|Missing end of treatment documentation|15|||
156745185|NCT04105010|565815650|FG000|Overall Study|Death|3|||
156745186|NCT04105010|565815651|FG001|Overall Study|Death|1|||
156745187|NCT04105010|565815652|FG002|Overall Study|Death|1|||
157143261|NCT01575548|567272782|FG001|Overall Study|Adverse Event|2|||
157143262|NCT01575548|567272781|FG000|Overall Study|Disease progression|12|||
157143263|NCT01575548|567272782|FG001|Overall Study|Disease progression|25|||
157143264|NCT01575548|567272781|FG000|Overall Study|Death|1|||
157143265|NCT01575548|567272782|FG001|Overall Study|Death|0|||
157143266|NCT01575548|567272781|FG000|Overall Study|Other complicating disease|1|||
157143267|NCT01575548|567272782|FG001|Overall Study|Other complicating disease|0|||
157143268|NCT01575548|567272781|FG000|Overall Study|Withdrawal by Subject|7|||
157143269|NCT01575548|567272782|FG001|Overall Study|Withdrawal by Subject|3|||
157143270|NCT01575548|567272781|FG000|Overall Study|Noncompliance|1|||
157143271|NCT01575548|567272782|FG001|Overall Study|Noncompliance|0|||
157143272|NCT01575548|567272781|FG000|Overall Study|Anticipated surgery|0|||
157143273|NCT01575548|567272782|FG001|Overall Study|Anticipated surgery|1|||
157143274|NCT01575548|567272781|FG000|Overall Study|Never started protocol therapy|3|||
157143275|NCT01575548|567272782|FG001|Overall Study|Never started protocol therapy|2|||
157143276|NCT04899271|567272783|FG000|Overall Study|Lost to Follow-up|1|||
157143277|NCT04899271|567272784|FG001|Overall Study|Lost to Follow-up|0|||
157143278|NCT04899271|567272783|FG000|Overall Study|Subject request/consent withdrawal|2|||
157143279|NCT04899271|567272784|FG001|Overall Study|Subject request/consent withdrawal|0|||
157143280|NCT00693706|567272787|FG000|Overall Study|Protocol Violation|0|||
157143281|NCT00693706|567272788|FG001|Overall Study|Protocol Violation|1|||
157143282|NCT02498652|567272789|FG000|Overall Study|Protocol Violation|0|||
157143283|NCT02498652|567272790|FG001|Overall Study|Protocol Violation|1|||
157143284|NCT00730236|567272791|FG000|Overall Study|Adverse Event|4|||
157143285|NCT00730236|567272791|FG000|Overall Study|Withdrawal by Subject|1|||
157143286|NCT00730236|567272791|FG000|Overall Study|Non-compliance|1|||
157143287|NCT01184989|567272794|FG000|Overall Study|Adverse Event|11|||
157143288|NCT01184989|567272794|FG000|Overall Study|Withdrawal by Subject|1|||
157143289|NCT00465569|567272795|FG000|Overall Study|persistent eczema during dose escalation|1|||
157143290|NCT00465569|567272796|FG001|Overall Study|persistent eczema during dose escalation|0|||
157143291|NCT01985321|567272798|FG000|Overall Study|Protocol Violation|4|||
157143292|NCT01985321|567272799|FG001|Overall Study|Protocol Violation|3|||
157143293|NCT01985321|567272798|FG000|Overall Study|Withdrawal by Subject|1|||
157143294|NCT01985321|567272799|FG001|Overall Study|Withdrawal by Subject|0|||
157143295|NCT01985321|567272798|FG000|Overall Study|Lost to Follow-up|5|||
157143296|NCT01985321|567272799|FG001|Overall Study|Lost to Follow-up|2|||
157143297|NCT01985321|567272798|FG000|Overall Study|Subject treated wrong type of sore|1|||
157143298|NCT01985321|567272799|FG001|Overall Study|Subject treated wrong type of sore|0|||
157143299|NCT04786210|567272800|FG000|Overall Study|Lost to Follow-up|2|||
157143300|NCT04786210|567272800|FG000|Overall Study|Withdrawal by Subject|4|||
157143301|NCT03826914|567272801|FG000|Overall Study|Withdrawal by Subject|1|||
157143302|NCT03826914|567272802|FG001|Overall Study|Withdrawal by Subject|1|||
157143303|NCT04334148|567272806|FG000|Overall Study|positive nasal swab at baseline|0|||
157143304|NCT04334148|567272807|FG001|Overall Study|positive nasal swab at baseline|1|||
157143305|NCT05370157|567272808|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
157143306|NCT05370157|567272809|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
157143307|NCT05370157|567272808|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
157143308|NCT05370157|567272809|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
157143309|NCT01508676|567272810|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
157143310|NCT01508676|567272811|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
157143311|NCT01508676|567272810|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
157143312|NCT01508676|567272811|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
156745188|NCT04105010|565815653|FG003|Overall Study|Death|54|||
156745189|NCT04105010|565815650|FG000|Overall Study|Lost to Follow-up|0|||
156745190|NCT04105010|565815651|FG001|Overall Study|Lost to Follow-up|0|||
157143313|NCT01508676|567272810|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
156745191|NCT04105010|565815652|FG002|Overall Study|Lost to Follow-up|0|||
156745192|NCT04105010|565815653|FG003|Overall Study|Lost to Follow-up|4|||
156745193|NCT04105010|565815650|FG000|Overall Study|Withdrawal by Subject|8|||
156745194|NCT04105010|565815651|FG001|Overall Study|Withdrawal by Subject|1|||
156745195|NCT04105010|565815652|FG002|Overall Study|Withdrawal by Subject|1|||
156745196|NCT04105010|565815653|FG003|Overall Study|Withdrawal by Subject|4|||
156745197|NCT04105010|565815650|FG000|Overall Study|Other reason|4|||
156745198|NCT04105010|565815651|FG001|Overall Study|Other reason|7|||
156745199|NCT04105010|565815652|FG002|Overall Study|Other reason|0|||
156745200|NCT04105010|565815653|FG003|Overall Study|Other reason|19|||
156745201|NCT01211483|565815654|FG000|Phase 1b|Death|6|||
156745202|NCT01211483|565815655|FG001|Phase 1b|Death|0|||
156745203|NCT01211483|565815656|FG002|Phase 1b|Death|0|||
156799393|NCT02303821|566019004|FG000|Overall Study|Withdrawal by Subject|0|||
156799394|NCT02303821|566019005|FG001|Overall Study|Withdrawal by Subject|0|||
156799395|NCT02303821|566019006|FG002|Overall Study|Withdrawal by Subject|0|||
156799396|NCT02303821|566019007|FG003|Overall Study|Withdrawal by Subject|0|||
156799397|NCT02303821|566019008|FG004|Overall Study|Withdrawal by Subject|0|||
156799398|NCT02303821|566019009|FG005|Overall Study|Withdrawal by Subject|0|||
156799399|NCT02303821|566019010|FG006|Overall Study|Withdrawal by Subject|0|||
156799400|NCT02303821|566019011|FG007|Overall Study|Withdrawal by Subject|2|||
156799401|NCT02303821|566019004|FG000|Overall Study|Death|0|||
156799402|NCT02303821|566019005|FG001|Overall Study|Death|2|||
156799403|NCT02303821|566019006|FG002|Overall Study|Death|0|||
156799404|NCT02303821|566019007|FG003|Overall Study|Death|0|||
156799405|NCT02303821|566019008|FG004|Overall Study|Death|0|||
156799406|NCT02303821|566019009|FG005|Overall Study|Death|3|||
156799407|NCT02303821|566019010|FG006|Overall Study|Death|41|||
156799408|NCT02303821|566019011|FG007|Overall Study|Death|29|||
156799409|NCT02303821|566019004|FG000|Overall Study|Lost to Follow-up|0|||
156799410|NCT02303821|566019005|FG001|Overall Study|Lost to Follow-up|0|||
156799411|NCT02303821|566019006|FG002|Overall Study|Lost to Follow-up|0|||
156799412|NCT02303821|566019007|FG003|Overall Study|Lost to Follow-up|0|||
157143314|NCT01508676|567272811|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
157143315|NCT01508676|567272810|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
157143316|NCT01508676|567272811|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
157143317|NCT01508676|567272810|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
157143318|NCT01508676|567272811|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
157143319|NCT00498173|567272812|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
157143320|NCT00498173|567272813|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
157143321|NCT00498173|567272814|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
157143322|NCT04689828|567272815|FG000|Overall Study|Subject decision|5|||
157143323|NCT04689828|567272816|FG001|Overall Study|Subject decision|5|||
157143324|NCT04689828|567272815|FG000|Overall Study|Adverse Event|12|||
157143325|NCT04689828|567272816|FG001|Overall Study|Adverse Event|12|||
157143326|NCT04689828|567272815|FG000|Overall Study|Physician Decision|24|||
157143327|NCT04689828|567272816|FG001|Overall Study|Physician Decision|32|||
157143328|NCT04689828|567272815|FG000|Overall Study|Progressive disease|54|||
157143329|NCT04689828|567272816|FG001|Overall Study|Progressive disease|173|||
157143330|NCT04689828|567272815|FG000|Overall Study|Death|0|||
157143331|NCT04689828|567272816|FG001|Overall Study|Death|1|||
157143332|NCT04689828|567272815|FG000|Overall Study|Lost to Follow-up|1|||
157143333|NCT04689828|567272816|FG001|Overall Study|Lost to Follow-up|0|||
157143334|NCT04689828|567272815|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
157143335|NCT04689828|567272816|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
157143336|NCT04689828|567272815|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
157143337|NCT04689828|567272816|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
157143338|NCT04689828|567272815|FG000|Overall Study|Participants not treated|7|||
157143339|NCT04689828|567272816|FG001|Overall Study|Participants not treated|2|||
157143340|NCT00104871|567272817|FG000|Overall Study|Not evaluable|1|||
157143341|NCT00519532|567272822|FG000|Overall Study|Adverse Event|11|||
157143342|NCT00519532|567272822|FG000|Overall Study|Withdrawal by Subject|5|||
157143343|NCT00519532|567272822|FG000|Overall Study|Lost to Follow-up|2|||
157143344|NCT00457639|567272825|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
157143345|NCT00457639|567272826|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
157143346|NCT00457639|567272825|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
157143347|NCT00457639|567272826|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
157143348|NCT00457639|567272825|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
157143349|NCT00457639|567272826|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
156745204|NCT01211483|565815657|FG003|Phase 1b|Death|0|||
156799413|NCT02303821|566019008|FG004|Overall Study|Lost to Follow-up|0|||
156745205|NCT01211483|565815654|FG000|Phase 1b|Withdrawal by Subject|1|||
156799414|NCT02303821|566019009|FG005|Overall Study|Lost to Follow-up|0|||
156799415|NCT02303821|566019010|FG006|Overall Study|Lost to Follow-up|1|||
156799416|NCT02303821|566019011|FG007|Overall Study|Lost to Follow-up|0|||
156745206|NCT01211483|565815655|FG001|Phase 1b|Withdrawal by Subject|0|||
156745207|NCT01211483|565815656|FG002|Phase 1b|Withdrawal by Subject|0|||
157219763|NCT02034799|567551063|FG001|Overall Study|Death|1|||
157219764|NCT04582266|567551075|FG000|Overall Study|Lost to Follow-up|7|||
157219765|NCT04582266|567551076|FG001|Overall Study|Lost to Follow-up|5|||
157219766|NCT04582266|567551075|FG000|Overall Study|Withdrawal by Subject|1|||
157219767|NCT04582266|567551076|FG001|Overall Study|Withdrawal by Subject|0|||
157219768|NCT04582266|567551075|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
157219769|NCT04582266|567551076|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
157219770|NCT02224456|567551077|FG000|Overall Study|Lack of Efficacy|1|||
157219771|NCT02224456|567551077|FG000|Overall Study|Lost to Follow-up|15|||
157219772|NCT02224456|567551077|FG000|Overall Study|Withdrawal by Subject|9|||
157219773|NCT02224456|567551077|FG000|Overall Study|Physician Decision|3|||
157219774|NCT02224456|567551077|FG000|Overall Study|Death|2|||
157219775|NCT02224456|567551077|FG000|Overall Study|Pregnancy|4|||
157219776|NCT02224456|567551077|FG000|Overall Study|Protocol Violation|1|||
157219777|NCT02224456|567551077|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
157219778|NCT01241461|567551078|FG000|Overall Study|Progressive Disease|3|||
157219779|NCT01241461|567551079|FG001|Overall Study|Progressive Disease|6|||
157219780|NCT01379781|567551080|FG000|Overall Study|Lost to Follow-up|11|||
157219781|NCT01379781|567551081|FG001|Overall Study|Lost to Follow-up|8|||
157219782|NCT02247479|567551082|FG000|Overall Study|Adverse Event|8|||
157219783|NCT02247479|567551083|FG001|Overall Study|Adverse Event|9|||
157219784|NCT02247479|567551084|FG002|Overall Study|Adverse Event|8|||
157219785|NCT02247479|567551082|FG000|Overall Study|Death|5|||
157219786|NCT02247479|567551083|FG001|Overall Study|Death|4|||
157219787|NCT02247479|567551084|FG002|Overall Study|Death|6|||
157219788|NCT02247479|567551082|FG000|Overall Study|Lost to Follow-up|3|||
157219789|NCT02247479|567551083|FG001|Overall Study|Lost to Follow-up|3|||
157219790|NCT02247479|567551084|FG002|Overall Study|Lost to Follow-up|1|||
157219791|NCT02247479|567551082|FG000|Overall Study|Non-compliance|0|||
157219792|NCT02247479|567551083|FG001|Overall Study|Non-compliance|0|||
157020675|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020676|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
157219793|NCT02247479|567551084|FG002|Overall Study|Non-compliance|1|||
157219794|NCT02247479|567551082|FG000|Overall Study|Withdrawal by Subject|25|||
157219795|NCT02247479|567551083|FG001|Overall Study|Withdrawal by Subject|29|||
157219796|NCT02247479|567551084|FG002|Overall Study|Withdrawal by Subject|24|||
157219797|NCT02247479|567551082|FG000|Overall Study|Study Terminated by Sponsor|98|||
157219798|NCT02247479|567551083|FG001|Overall Study|Study Terminated by Sponsor|88|||
157219799|NCT02247479|567551084|FG002|Overall Study|Study Terminated by Sponsor|94|||
157219800|NCT02247479|567551082|FG000|Overall Study|Physician Decision|1|||
157219801|NCT02247479|567551083|FG001|Overall Study|Physician Decision|0|||
157219802|NCT02247479|567551084|FG002|Overall Study|Physician Decision|2|||
157219803|NCT02247479|567551082|FG000|Overall Study|Unspecified Reason|2|||
157219804|NCT02247479|567551083|FG001|Overall Study|Unspecified Reason|5|||
157219805|NCT02247479|567551084|FG002|Overall Study|Unspecified Reason|2|||
157219806|NCT03740698|567551085|FG000|Overall Study|Physician Decision|0|||
157219807|NCT03740698|567551086|FG001|Overall Study|Physician Decision|1|||
157219808|NCT03740698|567551087|FG002|Overall Study|Physician Decision|1|||
157219809|NCT01007916|567551090|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
157219810|NCT01007916|567551091|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
157219811|NCT01007916|567551090|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
157219812|NCT01007916|567551091|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
157219813|NCT00671879|567551092|FG000|Overall Study|Withdrawal by Subject|0|||
157219814|NCT00671879|567551093|FG001|Overall Study|Withdrawal by Subject|4|||
157219815|NCT00671879|567551094|FG002|Overall Study|Withdrawal by Subject|6|||
157219816|NCT01628120|567551095|FG000|Overall Study|Withdrawal by Subject|7|||
157219817|NCT01628120|567551095|FG000|Overall Study|Adverse Event|12|||
157219818|NCT01628120|567551095|FG000|Overall Study|Lost to Follow-up|1|||
157219819|NCT01628120|567551095|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
157219820|NCT01628120|567551095|FG000|Overall Study|Non-compliant with Study Procedures|1|||
157020677|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
157219821|NCT01628120|567551095|FG000|Overall Study|Not Treated|3|||
157219822|NCT01628120|567551095|FG000|Overall Study|Sponsor Decision|5|||
156745208|NCT01211483|565815657|FG003|Phase 1b|Withdrawal by Subject|0|||
156745209|NCT01211483|565815654|FG000|Phase 2|Lost to Follow-up|0|||
156745210|NCT01211483|565815655|FG001|Phase 2|Lost to Follow-up|1|||
157219823|NCT01628120|567551095|FG000|Overall Study|Switched Dialysis Method|2|||
157219824|NCT01628120|567551095|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
156745211|NCT01211483|565815656|FG002|Phase 2|Lost to Follow-up|1|||
156745212|NCT01211483|565815657|FG003|Phase 2|Lost to Follow-up|2|||
156745213|NCT01211483|565815654|FG000|Phase 2|Death|0|||
157219825|NCT01628120|567551095|FG000|Overall Study|Moved or Relocated|5|||
157219826|NCT01628120|567551095|FG000|Overall Study|Kidney Transplant|2|||
157219827|NCT01628120|567551095|FG000|Overall Study|Use of Standard of Care|1|||
157219828|NCT01927757|567551098|FG000|Overall Study|Withdrawal by Subject|14|||
157219829|NCT01927757|567551098|FG000|Overall Study|Lost to Follow-up|2|||
157219830|NCT01927757|567551098|FG000|Overall Study|Decision by Sponsor|2|||
157219831|NCT01927757|567551098|FG000|Overall Study|Other|1|||
157219832|NCT01927757|567551098|FG000|Overall Study|Ethical Reasons|4|||
157219833|NCT00444795|567551099|FG000|Overall Study|Not Treated|1|||
157219834|NCT00444795|567551099|FG000|Overall Study|Treated Prior to the Contract Date|2|||
157219835|NCT00988169|567551100|FG000|Overall Study|Withdrawal by Subject|1|||
157219836|NCT00704418|567551102|FG000|Overall Study|Withdrawal by Subject|2|||
157219837|NCT00704418|567551103|FG001|Overall Study|Withdrawal by Subject|0|||
157219838|NCT00704418|567551102|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
156745214|NCT01211483|565815655|FG001|Phase 2|Death|64|||
156745215|NCT01211483|565815656|FG002|Phase 2|Death|53|||
156745216|NCT01211483|565815657|FG003|Phase 2|Death|53|||
156745217|NCT01211483|565815654|FG000|Phase 2|Withdrawal by Subject|0|||
157219839|NCT00704418|567551103|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
157219840|NCT02637076|567551104|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
157219841|NCT02637076|567551105|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
157219842|NCT02637076|567551104|FG000|Overall Study|Withdrawal by Subject|0|||
157219843|NCT02637076|567551105|FG001|Overall Study|Withdrawal by Subject|4|||
157219844|NCT00130520|567551106|FG000|Overall Study|Adverse Event|11|||
156745218|NCT01211483|565815655|FG001|Phase 2|Withdrawal by Subject|1|||
156745219|NCT01211483|565815656|FG002|Phase 2|Withdrawal by Subject|10|||
156745220|NCT01211483|565815657|FG003|Phase 2|Withdrawal by Subject|5|||
156745221|NCT01211483|565815654|FG000|Phase 2|Study terminated by Sponsor|0|||
156745222|NCT01211483|565815655|FG001|Phase 2|Study terminated by Sponsor|6|||
156745223|NCT01211483|565815656|FG002|Phase 2|Study terminated by Sponsor|8|||
156745224|NCT01211483|565815657|FG003|Phase 2|Study terminated by Sponsor|11|||
156745225|NCT01675154|565815658|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745226|NCT01675154|565815659|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
156745227|NCT01675154|565815660|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745228|NCT01675154|565815661|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
156745229|NCT02971800|565815664|FG000|Overall Study|Protocol Violation|1|||
156745230|NCT02971800|565815664|FG000|Overall Study|Withdrawal by Subject|1|||
156745231|NCT02971800|565815664|FG000|Overall Study|Exclusion criteria prior intervention|1|||
156745232|NCT02971800|565815664|FG000|Overall Study|Number evaluable participant already reached|4|||
156745233|NCT01149421|565815666|FG000|Overall Study|Adverse Event|22|||
156745234|NCT01149421|565815667|FG001|Overall Study|Adverse Event|6|||
157219845|NCT00130520|567551106|FG000|Overall Study|Death|1|||
157219846|NCT00130520|567551106|FG000|Overall Study|Physician Decision|1|||
157219847|NCT00130520|567551106|FG000|Overall Study|Withdrawal by Subject|1|||
157219848|NCT00130520|567551106|FG000|Overall Study|Disease Progression|23|||
157219849|NCT00130520|567551106|FG000|Overall Study|Protocol non-compliance|1|||
157219850|NCT00130520|567551106|FG000|Overall Study|Did not meet re-treatment criteria|1|||
157219851|NCT03341507|567551107|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
157219852|NCT00415532|567551118|FG000|Treatment Period|Adverse Event|2|||
157219853|NCT00415532|567551119|FG001|Treatment Period|Adverse Event|3|||
157219854|NCT00415532|567551118|FG000|Treatment Period|Death|2|||
156745235|NCT01149421|565815668|FG002|Overall Study|Adverse Event|11|||
156745236|NCT01149421|565815666|FG000|Overall Study|Withdrawal by Subject|20|||
156745237|NCT01149421|565815667|FG001|Overall Study|Withdrawal by Subject|12|||
156745238|NCT01149421|565815668|FG002|Overall Study|Withdrawal by Subject|13|||
156745239|NCT01149421|565815666|FG000|Overall Study|Sponsor Decision|0|||
156745240|NCT01149421|565815667|FG001|Overall Study|Sponsor Decision|1|||
156745241|NCT01149421|565815668|FG002|Overall Study|Sponsor Decision|1|||
156745242|NCT01149421|565815666|FG000|Overall Study|Lost to Follow-up|2|||
156745243|NCT01149421|565815667|FG001|Overall Study|Lost to Follow-up|4|||
156745244|NCT01149421|565815668|FG002|Overall Study|Lost to Follow-up|5|||
156879804|NCT00830869|566319794|FG001|Period 2: Part 2|Progressive disease|0|||
156879805|NCT00830869|566319795|FG002|Period 2: Part 2|Progressive disease|0|||
156879806|NCT00830869|566319796|FG003|Period 2: Part 2|Progressive disease|0|||
156879807|NCT00830869|566319797|FG004|Period 2: Part 2|Progressive disease|0|||
156879808|NCT00830869|566319798|FG005|Period 2: Part 2|Progressive disease|0|||
156879809|NCT00830869|566319799|FG006|Period 2: Part 2|Progressive disease|0|||
156879810|NCT00830869|566319800|FG007|Period 2: Part 2|Progressive disease|14|||
156879811|NCT00830869|566319801|FG008|Period 2: Part 2|Progressive disease|11|||
156879812|NCT00830869|566319802|FG009|Period 2: Part 2|Progressive disease|12|||
156879813|NCT00830869|566319803|FG010|Period 2: Part 2|Progressive disease|8|||
156879814|NCT00830869|566319804|FG011|Period 2: Part 2|Progressive disease|15|||
156879815|NCT00830869|566319793|FG000|Period 2: Part 2|Other|0|||
156879816|NCT00830869|566319794|FG001|Period 2: Part 2|Other|0|||
156745245|NCT01149421|565815666|FG000|Overall Study|Physician Decision|5|||
156745246|NCT01149421|565815667|FG001|Overall Study|Physician Decision|3|||
157219855|NCT00415532|567551119|FG001|Treatment Period|Death|1|||
156879817|NCT00830869|566319795|FG002|Period 2: Part 2|Other|0|||
157219856|NCT00415532|567551118|FG000|Treatment Period|Lost to Follow-up|1|||
157219857|NCT00415532|567551119|FG001|Treatment Period|Lost to Follow-up|1|||
156745247|NCT01149421|565815668|FG002|Overall Study|Physician Decision|6|||
156745248|NCT01149421|565815666|FG000|Overall Study|Entry Criteria Not Met|1|||
156745249|NCT01149421|565815667|FG001|Overall Study|Entry Criteria Not Met|1|||
156745250|NCT01149421|565815668|FG002|Overall Study|Entry Criteria Not Met|2|||
156745251|NCT01149421|565815666|FG000|Overall Study|Protocol Violation|2|||
156745252|NCT01149421|565815667|FG001|Overall Study|Protocol Violation|2|||
156745253|NCT01149421|565815668|FG002|Overall Study|Protocol Violation|6|||
156745254|NCT00616603|565815669|FG000|Overall Study|Physician Decision|2|||
156879818|NCT00830869|566319796|FG003|Period 2: Part 2|Other|0|||
156879819|NCT00830869|566319797|FG004|Period 2: Part 2|Other|0|||
156879820|NCT00830869|566319798|FG005|Period 2: Part 2|Other|0|||
156879821|NCT00830869|566319799|FG006|Period 2: Part 2|Other|0|||
156879822|NCT00830869|566319800|FG007|Period 2: Part 2|Other|0|||
156879823|NCT00830869|566319801|FG008|Period 2: Part 2|Other|0|||
156879824|NCT00830869|566319802|FG009|Period 2: Part 2|Other|1|||
156879825|NCT00830869|566319803|FG010|Period 2: Part 2|Other|0|||
156879826|NCT00830869|566319804|FG011|Period 2: Part 2|Other|0|||
156879827|NCT00617669|566319805|FG000|Overall Study|Withdrawal by Subject|71|||
156879828|NCT00617669|566319806|FG001|Overall Study|Withdrawal by Subject|77|||
156879829|NCT00617669|566319805|FG000|Overall Study|Lost to Follow-up|3|||
156879830|NCT00617669|566319806|FG001|Overall Study|Lost to Follow-up|2|||
156879831|NCT00617669|566319805|FG000|Overall Study|Adverse Event|87|||
156879832|NCT00617669|566319806|FG001|Overall Study|Adverse Event|76|||
156879833|NCT00617669|566319805|FG000|Overall Study|Protocol Violation|2|||
156879834|NCT00617669|566319806|FG001|Overall Study|Protocol Violation|3|||
156879835|NCT00617669|566319805|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
156879836|NCT00617669|566319806|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
156879837|NCT00617669|566319805|FG000|Overall Study|Patients randomized but not treated|2|||
156879838|NCT00617669|566319806|FG001|Overall Study|Patients randomized but not treated|3|||
156879839|NCT03745820|566319809|FG000|Overall Study|Adverse Event|0|||
156879840|NCT03745820|566319810|FG001|Overall Study|Adverse Event|3|||
156879841|NCT03745820|566319811|FG002|Overall Study|Adverse Event|2|||
156879842|NCT03745820|566319809|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156879843|NCT03745820|566319810|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156879844|NCT03745820|566319811|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156879845|NCT03745820|566319809|FG000|Overall Study|Withdrawal by Subject|4|||
156879846|NCT03745820|566319810|FG001|Overall Study|Withdrawal by Subject|4|||
156879847|NCT03745820|566319811|FG002|Overall Study|Withdrawal by Subject|4|||
156879848|NCT03745820|566319809|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
156879849|NCT03745820|566319810|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
156879850|NCT03745820|566319811|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
156879851|NCT03745820|566319809|FG000|Overall Study|Lost to Follow-up|2|||
156879852|NCT03745820|566319810|FG001|Overall Study|Lost to Follow-up|0|||
156879853|NCT03745820|566319811|FG002|Overall Study|Lost to Follow-up|3|||
156879854|NCT03745820|566319809|FG000|Overall Study|Reason not Specified|2|||
156879855|NCT03745820|566319810|FG001|Overall Study|Reason not Specified|4|||
156879856|NCT03745820|566319811|FG002|Overall Study|Reason not Specified|1|||
156879857|NCT00281658|566319812|FG000|Randomized Phase|Adverse Event|0|||
156879858|NCT00281658|566319813|FG001|Randomized Phase|Adverse Event|2|||
156879859|NCT00281658|566319814|FG002|Randomized Phase|Adverse Event|0|||
156879860|NCT00281658|566319815|FG003|Randomized Phase|Adverse Event|0|||
156879861|NCT00281658|566319812|FG000|Randomized Phase|Lost to Follow-up|34|||
156879862|NCT00281658|566319813|FG001|Randomized Phase|Lost to Follow-up|27|||
156879863|NCT00281658|566319814|FG002|Randomized Phase|Lost to Follow-up|0|||
156879864|NCT00281658|566319815|FG003|Randomized Phase|Lost to Follow-up|0|||
156879865|NCT00281658|566319812|FG000|Randomized Phase|Withdrawal by Subject|8|||
156879866|NCT00281658|566319813|FG001|Randomized Phase|Withdrawal by Subject|7|||
156879867|NCT00281658|566319814|FG002|Randomized Phase|Withdrawal by Subject|0|||
156879868|NCT00281658|566319815|FG003|Randomized Phase|Withdrawal by Subject|0|||
156879869|NCT00281658|566319812|FG000|Randomized Phase|Study closed/terminated|1|||
156879870|NCT00281658|566319813|FG001|Randomized Phase|Study closed/terminated|1|||
156879871|NCT00281658|566319814|FG002|Randomized Phase|Study closed/terminated|0|||
156879872|NCT00281658|566319815|FG003|Randomized Phase|Study closed/terminated|0|||
156879873|NCT00281658|566319812|FG000|Randomized Phase|Disease progression|36|||
156745255|NCT00616603|565815670|FG001|Overall Study|Physician Decision|0|||
156879874|NCT00281658|566319813|FG001|Randomized Phase|Disease progression|27|||
156879875|NCT00281658|566319814|FG002|Randomized Phase|Disease progression|0|||
156745256|NCT00616603|565815671|FG002|Overall Study|Physician Decision|2|||
156879876|NCT00281658|566319815|FG003|Randomized Phase|Disease progression|0|||
156879877|NCT00281658|566319812|FG000|Randomized Phase|Physician Decision|1|||
156879878|NCT00281658|566319813|FG001|Randomized Phase|Physician Decision|1|||
156879879|NCT00281658|566319814|FG002|Randomized Phase|Physician Decision|0|||
156879880|NCT00281658|566319815|FG003|Randomized Phase|Physician Decision|0|||
156745257|NCT03570554|565815674|FG000|Overall Study|Non-compliance with study drug|0|||
156745258|NCT03570554|565815675|FG001|Overall Study|Non-compliance with study drug|0|||
156879881|NCT00281658|566319812|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
156879882|NCT00281658|566319813|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
156879883|NCT00281658|566319814|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
156745259|NCT03570554|565815676|FG002|Overall Study|Non-compliance with study drug|1|||
156745260|NCT03570554|565815677|FG003|Overall Study|Non-compliance with study drug|0|||
156745261|NCT03570554|565815674|FG000|Overall Study|Adverse Event|0|||
156745262|NCT03570554|565815675|FG001|Overall Study|Adverse Event|0|||
156745263|NCT03570554|565815676|FG002|Overall Study|Adverse Event|0|||
156745264|NCT03570554|565815677|FG003|Overall Study|Adverse Event|1|||
156745265|NCT03738800|565815678|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
156745266|NCT03738800|565815679|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156745267|NCT03738800|565815680|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156745268|NCT03738800|565815678|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
156745269|NCT03738800|565815679|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
156745270|NCT03738800|565815680|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
156745271|NCT03738800|565815678|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
156745272|NCT03738800|565815679|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156745273|NCT03738800|565815680|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
156745274|NCT02719353|565815683|FG000|First Intervention|Physician Decision|0|||
156745275|NCT02719353|565815684|FG001|First Intervention|Physician Decision|1|||
156745276|NCT00766467|565815685|FG000|Overall Study|Withdrawal by Subject|7|||
156745277|NCT00766467|565815686|FG001|Overall Study|Withdrawal by Subject|2|||
156745278|NCT00766467|565815685|FG000|Overall Study|Adverse Event|1|||
156745279|NCT00766467|565815686|FG001|Overall Study|Adverse Event|1|||
156745280|NCT00766467|565815685|FG000|Overall Study|Protocol Violation|2|||
156745281|NCT00766467|565815686|FG001|Overall Study|Protocol Violation|4|||
156745282|NCT00766467|565815685|FG000|Overall Study|Tumor Progression on Study|0|||
156745283|NCT00766467|565815686|FG001|Overall Study|Tumor Progression on Study|1|||
156745284|NCT00766467|565815685|FG000|Overall Study|Physician Decision|1|||
156745285|NCT00766467|565815686|FG001|Overall Study|Physician Decision|0|||
156745286|NCT02223819|565815689|FG000|Overall Study|Lost to Follow-up|2|||
156745287|NCT01917344|565815692|FG000|Overall Study|Withdrawal by Subject|1|||
156745288|NCT00367484|565815693|FG000|Overall Study|Adverse Event|7|||
156745289|NCT00367484|565815693|FG000|Overall Study|Withdrew informed consent|5|||
156745290|NCT00367484|565815693|FG000|Overall Study|Travel to USA|1|||
156745291|NCT00367484|565815693|FG000|Overall Study|Lost to Follow-up|1|||
156745292|NCT00367484|565815693|FG000|Overall Study|Protocol Violation|1|||
156745293|NCT00367484|565815693|FG000|Overall Study|The choice of the patient|1|||
156745294|NCT00367484|565815693|FG000|Overall Study|Lack of Efficacy|1|||
156745295|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
156745296|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
156745297|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
156745298|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
156745299|NCT00943670|565815694|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
156745300|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
156745301|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
156745302|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
156745303|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
156745304|NCT00943670|565815694|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
156745305|NCT01777295|565815695|FG000|Overall Study|Withdrawal by Subject|2|||
156745306|NCT01777295|565815696|FG001|Overall Study|Withdrawal by Subject|2|||
156745307|NCT01777295|565815695|FG000|Overall Study|Pregnancy|0|||
156745308|NCT01777295|565815696|FG001|Overall Study|Pregnancy|1|||
156745309|NCT01777295|565815695|FG000|Overall Study|Personal problem|1|||
156745310|NCT01777295|565815696|FG001|Overall Study|Personal problem|0|||
156745311|NCT01777295|565815695|FG000|Overall Study|Investigator call for AEs check|1|||
156745312|NCT01777295|565815696|FG001|Overall Study|Investigator call for AEs check|0|||
156745313|NCT00426660|565815697|FG000|Overall Study|Death|14|||
156745314|NCT00426660|565815697|FG000|Overall Study|Adverse Event|23|||
156745315|NCT00426660|565815697|FG000|Overall Study|Insufficient Clinical Response|22|||
156745316|NCT00426660|565815697|FG000|Overall Study|Lost to Follow-up|15|||
156745317|NCT00426660|565815697|FG000|Overall Study|Other|23|||
156745318|NCT00426660|565815697|FG000|Overall Study|Withdrawal by Subject|18|||
156745319|NCT00426660|565815697|FG000|Overall Study|Protocol Violation|1|||
156745320|NCT00426660|565815697|FG000|Overall Study|Enrolled Not Treated|15|||
156745321|NCT01398410|565815698|FG000|Overall Study|Adverse Event|12|||
156745322|NCT01398410|565815699|FG001|Overall Study|Adverse Event|16|||
156745323|NCT01398410|565815698|FG000|Overall Study|Participants Choice|8|||
156745324|NCT01398410|565815699|FG001|Overall Study|Participants Choice|11|||
156745325|NCT01398410|565815698|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
156745326|NCT01398410|565815699|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
156745327|NCT01398410|565815698|FG000|Overall Study|Other|36|||
156745328|NCT01398410|565815699|FG001|Overall Study|Other|29|||
156745329|NCT02470403|565815700|FG000|Overall Study|Adverse Event|1|||
156745330|NCT02470403|565815701|FG001|Overall Study|Adverse Event|0|||
156745331|NCT02470403|565815702|FG002|Overall Study|Adverse Event|0|||
156745332|NCT02470403|565815703|FG003|Overall Study|Adverse Event|0|||
156745333|NCT02470403|565815704|FG004|Overall Study|Adverse Event|0|||
157020678|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020679|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020680|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
157020681|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020682|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
156745334|NCT02470403|565815700|FG000|Overall Study|Lost to Follow-up|0|||
156799417|NCT02303821|566019004|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156879884|NCT00281658|566319815|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
156879885|NCT00281658|566319812|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
156879886|NCT00281658|566319813|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
156879887|NCT00281658|566319814|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
156879888|NCT00281658|566319815|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
156879889|NCT00281658|566319812|FG000|Randomized Phase|Treatment ongoing|1|||
156879890|NCT00281658|566319813|FG001|Randomized Phase|Treatment ongoing|0|||
156879891|NCT00281658|566319814|FG002|Randomized Phase|Treatment ongoing|0|||
156879892|NCT00281658|566319815|FG003|Randomized Phase|Treatment ongoing|0|||
156879893|NCT00281658|566319812|FG000|Open Label Phase|Adverse Event|0|||
156879894|NCT00281658|566319813|FG001|Open Label Phase|Adverse Event|0|||
156879895|NCT00281658|566319814|FG002|Open Label Phase|Adverse Event|1|||
156879896|NCT00281658|566319815|FG003|Open Label Phase|Adverse Event|0|||
156879897|NCT00281658|566319812|FG000|Open Label Phase|Lost to Follow-up|0|||
156879898|NCT00281658|566319813|FG001|Open Label Phase|Lost to Follow-up|0|||
157020683|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
156745335|NCT02470403|565815701|FG001|Overall Study|Lost to Follow-up|1|||
156745336|NCT02470403|565815702|FG002|Overall Study|Lost to Follow-up|0|||
156745337|NCT02470403|565815703|FG003|Overall Study|Lost to Follow-up|0|||
156745338|NCT02470403|565815704|FG004|Overall Study|Lost to Follow-up|0|||
156745339|NCT02470403|565815700|FG000|Overall Study|Subject/guardian decision|1|||
156745340|NCT02470403|565815701|FG001|Overall Study|Subject/guardian decision|0|||
156745341|NCT02470403|565815702|FG002|Overall Study|Subject/guardian decision|0|||
156745342|NCT02470403|565815703|FG003|Overall Study|Subject/guardian decision|4|||
156745343|NCT02470403|565815704|FG004|Overall Study|Subject/guardian decision|0|||
156745344|NCT01522235|565815705|FG000|Overall Study|Physician Decision|1|||
156745345|NCT01522235|565815706|FG001|Overall Study|Physician Decision|1|||
156745346|NCT03769194|565815707|FG000|Overall Study|Withdrawal by Subject|0|||
156745347|NCT03769194|565815708|FG001|Overall Study|Withdrawal by Subject|7|||
156745348|NCT03769194|565815709|FG002|Overall Study|Withdrawal by Subject|4|||
156745349|NCT03769194|565815710|FG003|Overall Study|Withdrawal by Subject|1|||
156745350|NCT03769194|565815707|FG000|Overall Study|moved from study area|0|||
156745351|NCT03769194|565815708|FG001|Overall Study|moved from study area|2|||
156745352|NCT03769194|565815709|FG002|Overall Study|moved from study area|1|||
156745353|NCT03769194|565815710|FG003|Overall Study|moved from study area|1|||
156745354|NCT03769194|565815707|FG000|Overall Study|Lost to Follow-up|3|||
156745355|NCT03769194|565815708|FG001|Overall Study|Lost to Follow-up|6|||
156745356|NCT03769194|565815709|FG002|Overall Study|Lost to Follow-up|3|||
156745357|NCT03769194|565815710|FG003|Overall Study|Lost to Follow-up|6|||
156745358|NCT03769194|565815707|FG000|Overall Study|other|1|||
156745359|NCT03769194|565815708|FG001|Overall Study|other|3|||
156745360|NCT03769194|565815709|FG002|Overall Study|other|0|||
156745361|NCT03769194|565815710|FG003|Overall Study|other|1|||
156745362|NCT01430624|565815713|FG000|Overall Study|Lost to Follow-up|23|||
156799418|NCT02303821|566019005|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799419|NCT02303821|566019006|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799420|NCT02303821|566019007|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799421|NCT02303821|566019008|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799422|NCT02303821|566019009|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799423|NCT02303821|566019010|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
156799424|NCT02303821|566019011|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
156799425|NCT02303821|566019004|FG000|Overall Study|Decision by sponsor|0|||
156799426|NCT02303821|566019005|FG001|Overall Study|Decision by sponsor|0|||
156799427|NCT02303821|566019006|FG002|Overall Study|Decision by sponsor|0|||
156799428|NCT02303821|566019007|FG003|Overall Study|Decision by sponsor|0|||
156799429|NCT02303821|566019008|FG004|Overall Study|Decision by sponsor|0|||
156799430|NCT02303821|566019009|FG005|Overall Study|Decision by sponsor|1|||
156799431|NCT02303821|566019010|FG006|Overall Study|Decision by sponsor|0|||
156799432|NCT02303821|566019011|FG007|Overall Study|Decision by sponsor|0|||
156799433|NCT02303821|566019004|FG000|Overall Study|Protocol-specified criteria|0|||
156799434|NCT02303821|566019005|FG001|Overall Study|Protocol-specified criteria|1|||
156799435|NCT02303821|566019006|FG002|Overall Study|Protocol-specified criteria|0|||
156799436|NCT02303821|566019007|FG003|Overall Study|Protocol-specified criteria|0|||
156799437|NCT02303821|566019008|FG004|Overall Study|Protocol-specified criteria|0|||
156799438|NCT02303821|566019009|FG005|Overall Study|Protocol-specified criteria|1|||
156879899|NCT00281658|566319814|FG002|Open Label Phase|Lost to Follow-up|16|||
156745363|NCT01430624|565815714|FG001|Overall Study|Lost to Follow-up|29|||
156745364|NCT01430624|565815715|FG002|Overall Study|Lost to Follow-up|27|||
157219858|NCT00415532|567551118|FG000|Treatment Period|Protocol Violation|1|||
157219859|NCT00415532|567551119|FG001|Treatment Period|Protocol Violation|0|||
156745365|NCT01430624|565815713|FG000|Overall Study|technical or eligibility|5|||
156745366|NCT01430624|565815714|FG001|Overall Study|technical or eligibility|5|||
156745367|NCT01430624|565815715|FG002|Overall Study|technical or eligibility|2|||
156745368|NCT01362517|565815716|FG000|Overall Study|Protocol Violation|1|||
156745369|NCT01362517|565815716|FG000|Overall Study|Lost to Follow-up|1|||
156745370|NCT01133288|565815719|FG000|Eligibility Assessment|met exclusion criteria|5|||
156745371|NCT01133288|565815719|FG000|Intervention Allocation|study terminated|2|||
156745372|NCT02565706|565815724|FG000|Overall Study|Withdrawal by Subject|5|||
156745373|NCT02565706|565815725|FG001|Overall Study|Withdrawal by Subject|7|||
156745374|NCT02565706|565815726|FG002|Overall Study|Withdrawal by Subject|7|||
156745375|NCT02565706|565815727|FG003|Overall Study|Withdrawal by Subject|11|||
156745376|NCT02565706|565815724|FG000|Overall Study|Lost to Follow-up|72|||
156745377|NCT02565706|565815725|FG001|Overall Study|Lost to Follow-up|75|||
156745378|NCT02565706|565815726|FG002|Overall Study|Lost to Follow-up|82|||
156745379|NCT02565706|565815727|FG003|Overall Study|Lost to Follow-up|74|||
156745380|NCT03379792|565815729|FG000|Overall Study|Physician Decision|0|||
156745381|NCT03379792|565815730|FG001|Overall Study|Physician Decision|0|||
156745382|NCT03379792|565815731|FG002|Overall Study|Physician Decision|0|||
156745383|NCT03379792|565815732|FG003|Overall Study|Physician Decision|1|||
156745384|NCT03379792|565815733|FG004|Overall Study|Physician Decision|0|||
156745385|NCT03379792|565815734|FG005|Overall Study|Physician Decision|0|||
156745386|NCT03379792|565815729|FG000|Overall Study|Withdrawal by Subject|0|||
156745387|NCT03379792|565815730|FG001|Overall Study|Withdrawal by Subject|0|||
156745388|NCT03379792|565815731|FG002|Overall Study|Withdrawal by Subject|0|||
156745389|NCT03379792|565815732|FG003|Overall Study|Withdrawal by Subject|0|||
156745390|NCT03379792|565815733|FG004|Overall Study|Withdrawal by Subject|1|||
156745391|NCT03379792|565815734|FG005|Overall Study|Withdrawal by Subject|1|||
156745392|NCT01121536|565815735|FG000|Overall Study|Adverse Event|63|||
156745393|NCT01121536|565815735|FG000|Overall Study|Lack of Efficacy|35|||
156745394|NCT01121536|565815735|FG000|Overall Study|Withdrawal by Subject|65|||
156745395|NCT01121536|565815735|FG000|Overall Study|Protocol Violation|20|||
156745396|NCT01121536|565815735|FG000|Overall Study|Noncompliance with study medication|12|||
156745397|NCT01121536|565815735|FG000|Overall Study|Noncompliance with study procedures|9|||
156799439|NCT02303821|566019010|FG006|Overall Study|Protocol-specified criteria|0|||
156799440|NCT02303821|566019011|FG007|Overall Study|Protocol-specified criteria|0|||
156799441|NCT04116489|566019015|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
156799442|NCT04116489|566019015|FG000|Overall Study|Withdrawal by Subject|1|||
157219860|NCT00415532|567551118|FG000|Treatment Period|Withdrawal by Subject|6|||
157219861|NCT00415532|567551119|FG001|Treatment Period|Withdrawal by Subject|6|||
157219862|NCT00415532|567551118|FG000|Treatment Period|Other|2|||
157219863|NCT00415532|567551119|FG001|Treatment Period|Other|2|||
157219864|NCT00415532|567551118|FG000|Treatment Period|Ineligibility determined|1|||
157219865|NCT00415532|567551119|FG001|Treatment Period|Ineligibility determined|1|||
157219866|NCT00415532|567551118|FG000|Treatment Period|Noncompliance|1|||
157219867|NCT00415532|567551119|FG001|Treatment Period|Noncompliance|1|||
157219868|NCT00415532|567551118|FG000|Treatment Period|Requirement for alternative therapy|1|||
157219869|NCT00415532|567551119|FG001|Treatment Period|Requirement for alternative therapy|0|||
157219870|NCT00415532|567551118|FG000|Safety Follow Up Period|Adverse Event|1|||
157219871|NCT00415532|567551119|FG001|Safety Follow Up Period|Adverse Event|3|||
157219872|NCT00415532|567551118|FG000|Safety Follow Up Period|Death|3|||
157219873|NCT00415532|567551119|FG001|Safety Follow Up Period|Death|0|||
157219874|NCT00415532|567551118|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
157219875|NCT00415532|567551119|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
157219876|NCT00415532|567551118|FG000|Safety Follow Up Period|Other|1|||
157219877|NCT00415532|567551119|FG001|Safety Follow Up Period|Other|4|||
157219878|NCT00415532|567551118|FG000|Safety Follow Up Period|Ineligibility determined|1|||
157219879|NCT00415532|567551119|FG001|Safety Follow Up Period|Ineligibility determined|1|||
157219880|NCT00415532|567551118|FG000|Safety Follow Up Period|Noncompliance|1|||
156745398|NCT01121536|565815735|FG000|Overall Study|Lost to Follow-up|39|||
156745399|NCT01121536|565815735|FG000|Overall Study|Other|118|||
156745400|NCT00401960|565815736|FG000|Overall Study|Lost to Follow-up|3|||
156745401|NCT00401960|565815737|FG001|Overall Study|Lost to Follow-up|0|||
156799443|NCT03138564|566019016|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
156799444|NCT03138564|566019017|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
156799445|NCT03138564|566019016|FG000|Overall Study|Lost to Follow-up|16|||
157219881|NCT00415532|567551119|FG001|Safety Follow Up Period|Noncompliance|0|||
157219882|NCT00415532|567551118|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
157219883|NCT00415532|567551119|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
157219884|NCT01798485|567551120|FG000|Overall Study|Adverse Event|32|||
157219885|NCT01798485|567551121|FG001|Overall Study|Adverse Event|40|||
156745402|NCT00401960|565815736|FG000|Overall Study|Death|2|||
156745403|NCT00401960|565815737|FG001|Overall Study|Death|0|||
156745404|NCT02649426|565815738|FG000|Overall Study|Follow-up on going|1|||
157219886|NCT01798485|567551120|FG000|Overall Study|Withdrawal by Subject|27|||
157219887|NCT01798485|567551121|FG001|Overall Study|Withdrawal by Subject|31|||
157219888|NCT01798485|567551120|FG000|Overall Study|Lost to Follow-up|0|||
157219889|NCT01798485|567551121|FG001|Overall Study|Lost to Follow-up|3|||
157219890|NCT01798485|567551120|FG000|Overall Study|Physician Decision|14|||
157219891|NCT01798485|567551121|FG001|Overall Study|Physician Decision|10|||
157219892|NCT01798485|567551120|FG000|Overall Study|Objective Disease Progression|152|||
157219893|NCT01798485|567551121|FG001|Overall Study|Objective Disease Progression|106|||
157219894|NCT01798485|567551120|FG000|Overall Study|Death|25|||
157219895|NCT01798485|567551121|FG001|Overall Study|Death|22|||
157219896|NCT01798485|567551120|FG000|Overall Study|Sponsor Decision|61|||
157219897|NCT01798485|567551121|FG001|Overall Study|Sponsor Decision|54|||
157219898|NCT01798485|567551120|FG000|Overall Study|Clinical Progression|35|||
157219899|NCT01798485|567551121|FG001|Overall Study|Clinical Progression|24|||
157219900|NCT01952574|567551122|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
157219901|NCT01952574|567551123|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
157219902|NCT01952574|567551124|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
157219903|NCT01952574|567551125|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
157219904|NCT01952574|567551126|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
157219905|NCT01952574|567551127|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
157219906|NCT01952574|567551128|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
157219907|NCT01952574|567551122|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
157219908|NCT01952574|567551123|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
157219909|NCT01952574|567551124|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
157219910|NCT01952574|567551125|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
157219911|NCT01952574|567551126|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
157219912|NCT01952574|567551127|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
157219913|NCT01952574|567551128|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
157219914|NCT01952574|567551122|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
157219915|NCT01952574|567551123|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
157219916|NCT01952574|567551124|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
157219917|NCT01952574|567551125|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
157219918|NCT01952574|567551126|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
157219919|NCT01952574|567551127|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
157219920|NCT01952574|567551128|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
157219921|NCT01952574|567551122|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219922|NCT01952574|567551123|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219923|NCT01952574|567551124|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219924|NCT01952574|567551125|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219925|NCT01952574|567551126|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
157219926|NCT01952574|567551127|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219927|NCT01952574|567551128|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
157219928|NCT01952574|567551122|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
157219929|NCT01952574|567551123|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
157219930|NCT01952574|567551124|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
157219931|NCT01952574|567551125|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
157219932|NCT01952574|567551126|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
157219933|NCT01952574|567551127|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
157219934|NCT01952574|567551128|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
157219935|NCT01952574|567551122|FG000|Open-label Treatment Phase|Missing|0|||
157219936|NCT01952574|567551123|FG001|Open-label Treatment Phase|Missing|0|||
157219937|NCT01952574|567551124|FG002|Open-label Treatment Phase|Missing|0|||
157219938|NCT01952574|567551125|FG003|Open-label Treatment Phase|Missing|0|||
157219939|NCT01952574|567551126|FG004|Open-label Treatment Phase|Missing|4|||
157219940|NCT01952574|567551127|FG005|Open-label Treatment Phase|Missing|0|||
157219941|NCT01952574|567551128|FG006|Open-label Treatment Phase|Missing|0|||
157219942|NCT01952574|567551122|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
157219943|NCT01952574|567551123|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
157219944|NCT01952574|567551124|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
156799446|NCT03138564|566019017|FG001|Overall Study|Lost to Follow-up|2|||
156799447|NCT03138564|566019016|FG000|Overall Study|Withdrawal by Subject|48|||
156799448|NCT03138564|566019017|FG001|Overall Study|Withdrawal by Subject|4|||
157219945|NCT01952574|567551125|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
157219946|NCT01952574|567551126|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
157219947|NCT01952574|567551127|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
157219948|NCT01952574|567551128|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
157219949|NCT01952574|567551122|FG000|Open-label Treatment Phase|Death|0|||
156799449|NCT03138564|566019016|FG000|Overall Study|No longer met eligibility criteria|2|||
157219950|NCT01952574|567551123|FG001|Open-label Treatment Phase|Death|0|||
157219951|NCT01952574|567551124|FG002|Open-label Treatment Phase|Death|0|||
157219952|NCT01952574|567551125|FG003|Open-label Treatment Phase|Death|0|||
157219953|NCT01952574|567551126|FG004|Open-label Treatment Phase|Death|1|||
157219954|NCT01952574|567551127|FG005|Open-label Treatment Phase|Death|0|||
157219955|NCT01952574|567551128|FG006|Open-label Treatment Phase|Death|0|||
156799450|NCT03138564|566019017|FG001|Overall Study|No longer met eligibility criteria|0|||
156799451|NCT03138564|566019016|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
156799452|NCT03138564|566019017|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
156799453|NCT03138564|566019016|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
156799454|NCT03138564|566019017|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
156799455|NCT03138564|566019016|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
156799456|NCT03138564|566019017|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
156799457|NCT03138564|566019016|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
156799458|NCT03138564|566019017|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
156799459|NCT05177354|566019019|FG000|Implant to 30-day Visit|Physician Decision|1|||
156799460|NCT05177354|566019019|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
156799461|NCT05177354|566019019|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
156799462|NCT05177354|566019019|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
156799463|NCT02581930|566019027|FG000|Overall Study|Withdrawal by Subject|1|||
156799464|NCT02581930|566019027|FG000|Overall Study|patient declined further treatment|1|||
156799465|NCT01649869|566019028|FG000|Overall Study|Family member illness|1|||
156799466|NCT01649869|566019029|FG001|Overall Study|Family member illness|0|||
156799467|NCT01649869|566019028|FG000|Overall Study|Required treatment outside protocol|1|||
156799468|NCT01649869|566019029|FG001|Overall Study|Required treatment outside protocol|0|||
156799469|NCT01649869|566019028|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
156799470|NCT01649869|566019029|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
156799471|NCT02276040|566021309|FG000|Overall Study|Physician Decision|15|||
156799472|NCT02835690|566021310|FG000|Overall Study|Death|12|||
156799473|NCT02835690|566021311|FG001|Overall Study|Death|11|||
156799474|NCT02835690|566021312|FG002|Overall Study|Death|13|||
156799475|NCT02835690|566021310|FG000|Overall Study|Transferred to Extension Study|2|||
156799476|NCT02835690|566021311|FG001|Overall Study|Transferred to Extension Study|2|||
156799477|NCT02835690|566021312|FG002|Overall Study|Transferred to Extension Study|1|||
156799478|NCT02835690|566021310|FG000|Overall Study|Did Not Continue on Extension Study|0|||
156799479|NCT02835690|566021311|FG001|Overall Study|Did Not Continue on Extension Study|0|||
156799480|NCT02835690|566021312|FG002|Overall Study|Did Not Continue on Extension Study|1|||
156799481|NCT02835690|566021310|FG000|Overall Study|Not Treated|0|||
156799482|NCT02835690|566021311|FG001|Overall Study|Not Treated|2|||
156799483|NCT02835690|566021312|FG002|Overall Study|Not Treated|0|||
156799484|NCT00582907|566021313|FG000|1st Course|Withdrawal by Subject|1|||
156799485|NCT00582907|566021314|FG001|1st Course|Withdrawal by Subject|0|||
156799486|NCT00582907|566021315|FG002|1st Course|Withdrawal by Subject|0|||
156799487|NCT00582907|566021316|FG003|1st Course|Withdrawal by Subject|0|||
156799488|NCT00582907|566021313|FG000|1st Course|Lost to Follow-up|0|||
156799489|NCT00582907|566021314|FG001|1st Course|Lost to Follow-up|0|||
156799490|NCT00582907|566021315|FG002|1st Course|Lost to Follow-up|0|||
156799491|NCT00582907|566021316|FG003|1st Course|Lost to Follow-up|1|||
156799492|NCT00582907|566021313|FG000|2nd Course|Lack of Efficacy|1|||
156799493|NCT00582907|566021314|FG001|2nd Course|Lack of Efficacy|0|||
156799494|NCT00582907|566021315|FG002|2nd Course|Lack of Efficacy|0|||
156799495|NCT00582907|566021316|FG003|2nd Course|Lack of Efficacy|0|||
156799496|NCT04622592|566021317|FG000|Overall Study|Death|0|||
156799497|NCT04622592|566021318|FG001|Overall Study|Death|0|||
156799498|NCT04622592|566021319|FG002|Overall Study|Death|1|||
156799499|NCT04622592|566021320|FG003|Overall Study|Death|0|||
156799500|NCT04622592|566021321|FG004|Overall Study|Death|0|||
156799501|NCT04622592|566021322|FG005|Overall Study|Death|0|||
156799502|NCT04622592|566021323|FG006|Overall Study|Death|0|||
156799503|NCT04622592|566021324|FG007|Overall Study|Death|1|||
156745405|NCT02649426|565815739|FG001|Overall Study|Follow-up on going|26|||
156745406|NCT02649426|565815740|FG002|Overall Study|Follow-up on going|28|||
156745407|NCT02649426|565815741|FG003|Overall Study|Follow-up on going|31|||
156745408|NCT00306787|565815742|FG000|Overall Study|Discontinued without taking study drug|208|||
156745409|NCT00306787|565815743|FG001|Overall Study|Discontinued without taking study drug|215|||
156745410|NCT00306787|565815742|FG000|Overall Study|Adverse Event|1|||
156745411|NCT00306787|565815743|FG001|Overall Study|Adverse Event|1|||
156745412|NCT00306787|565815742|FG000|Overall Study|Lack of Efficacy|1|||
156745413|NCT00306787|565815743|FG001|Overall Study|Lack of Efficacy|0|||
156745414|NCT00306787|565815742|FG000|Overall Study|Protocol Violation|8|||
156745415|NCT00306787|565815743|FG001|Overall Study|Protocol Violation|10|||
156745416|NCT00306787|565815742|FG000|Overall Study|Withdrawal by Subject|2|||
156745417|NCT00306787|565815743|FG001|Overall Study|Withdrawal by Subject|9|||
156745418|NCT00306787|565815742|FG000|Overall Study|Lost to Follow-up|9|||
156745419|NCT00306787|565815743|FG001|Overall Study|Lost to Follow-up|6|||
156745420|NCT00306787|565815742|FG000|Overall Study|Administrative problems|4|||
156745421|NCT00306787|565815743|FG001|Overall Study|Administrative problems|0|||
156745422|NCT00306787|565815742|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156799504|NCT04622592|566021317|FG000|Overall Study|Lost to Follow-up|0|||
156799505|NCT04622592|566021318|FG001|Overall Study|Lost to Follow-up|0|||
157143350|NCT02117687|567272829|FG000|Overall Study|Lost to Follow-up|0|||
157143351|NCT02117687|567272830|FG001|Overall Study|Lost to Follow-up|1|||
157143352|NCT02117687|567272829|FG000|Overall Study|Adverse Event|0|||
157143353|NCT02117687|567272830|FG001|Overall Study|Adverse Event|2|||
157143354|NCT02117687|567272829|FG000|Overall Study|Other Reasons|1|||
157143355|NCT02117687|567272830|FG001|Overall Study|Other Reasons|1|||
157143356|NCT02932267|567272837|FG000|Overall Study|Withdrawal by Subject|3|||
157143357|NCT02932267|567272837|FG000|Overall Study|Lost to Follow-up|4|||
157143358|NCT02932267|567272837|FG000|Overall Study|Pregnancy|1|||
157143359|NCT01687673|567272843|FG000|Overall Study|Physician Decision|1|||
157143360|NCT02234622|567272844|FG000|Overall Study|Withdrawal by Subject|16|||
157143361|NCT02234622|567272845|FG001|Overall Study|Withdrawal by Subject|22|||
157143362|NCT02234622|567272844|FG000|Overall Study|Lost to Follow-up|27|||
157143363|NCT02234622|567272845|FG001|Overall Study|Lost to Follow-up|14|||
157143364|NCT03476239|567272846|FG000|Overall Study|Withdrawal by Subject|10|||
157143365|NCT03476239|567272846|FG000|Overall Study|Death|80|||
157143366|NCT03476239|567272846|FG000|Overall Study|Lost to Follow-up|8|||
157143367|NCT00618956|567272847|FG000|Overall Study|Adverse Event|10|||
157143368|NCT00618956|567272848|FG001|Overall Study|Adverse Event|34|||
157143369|NCT00618956|567272847|FG000|Overall Study|Lack of Efficacy|2|||
157143370|NCT00618956|567272848|FG001|Overall Study|Lack of Efficacy|1|||
157143371|NCT00618956|567272847|FG000|Overall Study|Withdrawal by Subject|5|||
157143372|NCT00618956|567272848|FG001|Overall Study|Withdrawal by Subject|7|||
157143373|NCT00618956|567272847|FG000|Overall Study|Lost to Follow-up|4|||
157143374|NCT00618956|567272848|FG001|Overall Study|Lost to Follow-up|5|||
157143375|NCT00618956|567272847|FG000|Overall Study|Protocol Violation|2|||
157143376|NCT00618956|567272848|FG001|Overall Study|Protocol Violation|2|||
157143377|NCT00618956|567272847|FG000|Overall Study|did not meet criteria, non-compliance|2|||
157143378|NCT00618956|567272848|FG001|Overall Study|did not meet criteria, non-compliance|1|||
157143379|NCT03598777|567272849|FG000|Overall Study|Study Terminated by Sponsor|3|||
157143380|NCT03598777|567272850|FG001|Overall Study|Study Terminated by Sponsor|0|||
157143381|NCT03598777|567272851|FG002|Overall Study|Study Terminated by Sponsor|0|||
157143382|NCT03598777|567272852|FG003|Overall Study|Study Terminated by Sponsor|0|||
157143383|NCT03598777|567272853|FG004|Overall Study|Study Terminated by Sponsor|15|||
157143384|NCT03598777|567272849|FG000|Overall Study|Withdrawal by Subject|1|||
157143385|NCT03598777|567272850|FG001|Overall Study|Withdrawal by Subject|1|||
157143386|NCT03598777|567272851|FG002|Overall Study|Withdrawal by Subject|0|||
156799506|NCT04622592|566021319|FG002|Overall Study|Lost to Follow-up|0|||
156799507|NCT04622592|566021320|FG003|Overall Study|Lost to Follow-up|3|||
156799508|NCT04622592|566021321|FG004|Overall Study|Lost to Follow-up|1|||
156799509|NCT04622592|566021322|FG005|Overall Study|Lost to Follow-up|0|||
156799510|NCT04622592|566021323|FG006|Overall Study|Lost to Follow-up|2|||
156799511|NCT04622592|566021324|FG007|Overall Study|Lost to Follow-up|2|||
156799512|NCT04622592|566021317|FG000|Overall Study|Physician Decision|0|||
156799513|NCT04622592|566021318|FG001|Overall Study|Physician Decision|0|||
156799514|NCT04622592|566021319|FG002|Overall Study|Physician Decision|0|||
156799515|NCT04622592|566021320|FG003|Overall Study|Physician Decision|0|||
156799516|NCT04622592|566021321|FG004|Overall Study|Physician Decision|1|||
156799517|NCT04622592|566021322|FG005|Overall Study|Physician Decision|0|||
156799518|NCT04622592|566021323|FG006|Overall Study|Physician Decision|0|||
156799519|NCT04622592|566021324|FG007|Overall Study|Physician Decision|0|||
156799520|NCT04622592|566021317|FG000|Overall Study|Withdrawal by Subject|1|||
156799521|NCT04622592|566021318|FG001|Overall Study|Withdrawal by Subject|0|||
156799522|NCT04622592|566021319|FG002|Overall Study|Withdrawal by Subject|2|||
156799523|NCT04622592|566021320|FG003|Overall Study|Withdrawal by Subject|0|||
156799524|NCT04622592|566021321|FG004|Overall Study|Withdrawal by Subject|0|||
156799525|NCT04622592|566021322|FG005|Overall Study|Withdrawal by Subject|0|||
156799526|NCT04622592|566021323|FG006|Overall Study|Withdrawal by Subject|1|||
156799527|NCT04622592|566021324|FG007|Overall Study|Withdrawal by Subject|4|||
156799528|NCT04622592|566021317|FG000|Overall Study|Other than specified above|0|||
156799529|NCT04622592|566021318|FG001|Overall Study|Other than specified above|0|||
156799530|NCT04622592|566021319|FG002|Overall Study|Other than specified above|1|||
156799531|NCT04622592|566021320|FG003|Overall Study|Other than specified above|0|||
156799532|NCT04622592|566021321|FG004|Overall Study|Other than specified above|0|||
157143387|NCT03598777|567272852|FG003|Overall Study|Withdrawal by Subject|0|||
157143388|NCT03598777|567272853|FG004|Overall Study|Withdrawal by Subject|0|||
157143389|NCT03598777|567272849|FG000|Overall Study|Adverse Event|1|||
157143390|NCT03598777|567272850|FG001|Overall Study|Adverse Event|0|||
157143391|NCT03598777|567272851|FG002|Overall Study|Adverse Event|0|||
157143392|NCT03598777|567272852|FG003|Overall Study|Adverse Event|0|||
157143393|NCT03598777|567272853|FG004|Overall Study|Adverse Event|0|||
157143394|NCT03598777|567272849|FG000|Overall Study|Lost to Follow-up|1|||
156799533|NCT04622592|566021322|FG005|Overall Study|Other than specified above|0|||
156799534|NCT04622592|566021323|FG006|Overall Study|Other than specified above|0|||
156799535|NCT04622592|566021324|FG007|Overall Study|Other than specified above|0|||
156799536|NCT00415636|566021325|FG000|Overall Study|Symptomatic deterioration|1|||
156799537|NCT00415636|566021326|FG001|Overall Study|Symptomatic deterioration|0|||
156799538|NCT00415636|566021327|FG002|Overall Study|Symptomatic deterioration|1|||
157219956|NCT01952574|567551122|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219957|NCT01952574|567551123|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219958|NCT01952574|567551124|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219959|NCT01952574|567551125|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219960|NCT01952574|567551126|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219961|NCT01952574|567551127|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
157219962|NCT01952574|567551128|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
157219963|NCT01952574|567551122|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
157219964|NCT01952574|567551123|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
157219965|NCT01952574|567551124|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
157219966|NCT01952574|567551125|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
157219967|NCT01952574|567551126|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
157219968|NCT01952574|567551127|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
157219969|NCT01952574|567551128|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
157219970|NCT00770991|567551132|FG000|Overall Study|Physician Decision|2|||
157219971|NCT00770991|567551133|FG001|Overall Study|Physician Decision|0|||
157219972|NCT00770991|567551132|FG000|Overall Study|Withdrawal by Subject|1|||
157219973|NCT00770991|567551133|FG001|Overall Study|Withdrawal by Subject|0|||
157219974|NCT00770991|567551132|FG000|Overall Study|Adverse Event|1|||
157219975|NCT00770991|567551133|FG001|Overall Study|Adverse Event|5|||
157219976|NCT00770991|567551132|FG000|Overall Study|Pregnancy|1|||
157219977|NCT00770991|567551133|FG001|Overall Study|Pregnancy|0|||
157219978|NCT03687125|567551134|FG000|Overall Study|Progressive Disease|2|||
157219979|NCT03687125|567551135|FG001|Overall Study|Progressive Disease|1|||
157219980|NCT03687125|567551134|FG000|Overall Study|Protocol Violation|1|||
157219981|NCT03687125|567551135|FG001|Overall Study|Protocol Violation|0|||
157219982|NCT01992107|567551136|FG000|Overall Study|Administrative reasons|2|||
157219983|NCT01992107|567551137|FG001|Overall Study|Administrative reasons|0|||
157219984|NCT01992107|567551138|FG002|Overall Study|Administrative reasons|0|||
157219985|NCT01992107|567551136|FG000|Overall Study|Adverse Event|0|||
157219986|NCT01992107|567551137|FG001|Overall Study|Adverse Event|1|||
157219987|NCT01992107|567551138|FG002|Overall Study|Adverse Event|0|||
157219988|NCT01992107|567551136|FG000|Overall Study|Lost to Follow-up|46|||
157219989|NCT01992107|567551137|FG001|Overall Study|Lost to Follow-up|22|||
157219990|NCT01992107|567551138|FG002|Overall Study|Lost to Follow-up|26|||
157219991|NCT01992107|567551136|FG000|Overall Study|noncompliance and were unavailable|7|||
157219992|NCT01992107|567551137|FG001|Overall Study|noncompliance and were unavailable|3|||
157219993|NCT01992107|567551138|FG002|Overall Study|noncompliance and were unavailable|2|||
157219994|NCT01992107|567551136|FG000|Overall Study|Withdrawal by Subject|13|||
157219995|NCT01992107|567551137|FG001|Overall Study|Withdrawal by Subject|7|||
157219996|NCT01992107|567551138|FG002|Overall Study|Withdrawal by Subject|8|||
157219997|NCT02022007|567551139|FG000|Overall Study|Withdrawal by Subject|1|||
157219998|NCT02022007|567551140|FG001|Overall Study|Withdrawal by Subject|1|||
157219999|NCT02022007|567551141|FG002|Overall Study|Withdrawal by Subject|1|||
157220000|NCT02022007|567551139|FG000|Overall Study|Noncompliant|0|||
157220001|NCT02022007|567551140|FG001|Overall Study|Noncompliant|0|||
157220002|NCT02022007|567551141|FG002|Overall Study|Noncompliant|1|||
157220003|NCT01214603|567551143|FG000|Overall Study|Adverse Event|0|||
157220004|NCT01214603|567551144|FG001|Overall Study|Adverse Event|0|||
157220005|NCT01214603|567551145|FG002|Overall Study|Adverse Event|1|||
157220006|NCT01214603|567551143|FG000|Overall Study|Death|1|||
157220007|NCT01214603|567551144|FG001|Overall Study|Death|0|||
157220008|NCT01214603|567551145|FG002|Overall Study|Death|0|||
157220009|NCT01214603|567551143|FG000|Overall Study|Progressive Disease|4|||
157220010|NCT01214603|567551144|FG001|Overall Study|Progressive Disease|1|||
157220011|NCT01214603|567551145|FG002|Overall Study|Progressive Disease|3|||
157220012|NCT02536378|567551148|FG000|Overall Study|Physician Decision|0|||
157220013|NCT02536378|567551149|FG001|Overall Study|Physician Decision|2|||
157220014|NCT02536378|567551148|FG000|Overall Study|Withdrawal by Subject|0|||
157220015|NCT02536378|567551149|FG001|Overall Study|Withdrawal by Subject|1|||
157220016|NCT02536378|567551148|FG000|Overall Study|Death|1|||
157220017|NCT02536378|567551149|FG001|Overall Study|Death|2|||
156799539|NCT00415636|566021328|FG003|Overall Study|Symptomatic deterioration|2|||
157220018|NCT02536378|567551148|FG000|Overall Study|Patient refused further follow up|6|||
157220019|NCT02536378|567551149|FG001|Overall Study|Patient refused further follow up|2|||
157020684|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
157220020|NCT01271933|567551150|FG000|Single-Blind Phase|Lack of Efficacy|37|||
157220021|NCT01271933|567551151|FG001|Single-Blind Phase|Lack of Efficacy|0|||
157220022|NCT01271933|567551152|FG002|Single-Blind Phase|Lack of Efficacy|0|||
157220023|NCT01271933|567551150|FG000|Single-Blind Phase|Lost to Follow-up|10|||
157220024|NCT01271933|567551151|FG001|Single-Blind Phase|Lost to Follow-up|0|||
157220025|NCT01271933|567551152|FG002|Single-Blind Phase|Lost to Follow-up|0|||
157220026|NCT01271933|567551150|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
157220027|NCT01271933|567551151|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
157220028|NCT01271933|567551152|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
157220029|NCT01271933|567551150|FG000|Single-Blind Phase|Protocol Violation|3|||
157220030|NCT01271933|567551151|FG001|Single-Blind Phase|Protocol Violation|0|||
157220031|NCT01271933|567551152|FG002|Single-Blind Phase|Protocol Violation|0|||
157220032|NCT01271933|567551150|FG000|Single-Blind Phase|Adverse Event|52|||
157220033|NCT01271933|567551151|FG001|Single-Blind Phase|Adverse Event|0|||
157220034|NCT01271933|567551152|FG002|Single-Blind Phase|Adverse Event|0|||
157220035|NCT01271933|567551150|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
157220036|NCT01271933|567551151|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
157220037|NCT01271933|567551152|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
157220038|NCT01271933|567551150|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
157220039|NCT01271933|567551151|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
157220040|NCT01271933|567551152|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
157220041|NCT01271933|567551150|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
157220042|NCT01271933|567551151|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
157220043|NCT01271933|567551152|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
157220044|NCT01271933|567551150|FG000|Double-Blind Phase|Randomized but not treated|0|||
157220045|NCT01271933|567551151|FG001|Double-Blind Phase|Randomized but not treated|0|||
157220046|NCT01271933|567551152|FG002|Double-Blind Phase|Randomized but not treated|1|||
157220047|NCT01271933|567551150|FG000|Double-Blind Phase|Lack of Efficacy|0|||
157220048|NCT01271933|567551151|FG001|Double-Blind Phase|Lack of Efficacy|6|||
157220049|NCT01271933|567551152|FG002|Double-Blind Phase|Lack of Efficacy|9|||
157220050|NCT01271933|567551150|FG000|Double-Blind Phase|Lost to Follow-up|0|||
157220051|NCT01271933|567551151|FG001|Double-Blind Phase|Lost to Follow-up|1|||
157220052|NCT01271933|567551152|FG002|Double-Blind Phase|Lost to Follow-up|1|||
157220053|NCT01271933|567551150|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
157220054|NCT01271933|567551151|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
157220055|NCT01271933|567551152|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
157220056|NCT01271933|567551150|FG000|Double-Blind Phase|Adverse Event|0|||
157220057|NCT01271933|567551151|FG001|Double-Blind Phase|Adverse Event|3|||
157220058|NCT01271933|567551152|FG002|Double-Blind Phase|Adverse Event|0|||
157220059|NCT01271933|567551150|FG000|Double-Blind Phase|Participant request-personal reason|0|||
157220060|NCT01271933|567551151|FG001|Double-Blind Phase|Participant request-personal reason|1|||
157220061|NCT01271933|567551152|FG002|Double-Blind Phase|Participant request-personal reason|0|||
157220062|NCT01620983|567551153|FG000|Overall Study|Lost to Follow-up|8|||
157220063|NCT01620983|567551154|FG001|Overall Study|Lost to Follow-up|4|||
157220064|NCT01620983|567551155|FG002|Overall Study|Lost to Follow-up|9|||
157220065|NCT01620983|567551153|FG000|Overall Study|Withdrawal by Subject|6|||
157220066|NCT01620983|567551154|FG001|Overall Study|Withdrawal by Subject|8|||
157220067|NCT01620983|567551155|FG002|Overall Study|Withdrawal by Subject|1|||
157220068|NCT01620983|567551153|FG000|Overall Study|Death|2|||
157220069|NCT01620983|567551154|FG001|Overall Study|Death|0|||
157220070|NCT01620983|567551155|FG002|Overall Study|Death|0|||
156799540|NCT00415636|566021329|FG004|Overall Study|Symptomatic deterioration|0|||
157143395|NCT03598777|567272850|FG001|Overall Study|Lost to Follow-up|0|||
157143396|NCT03598777|567272851|FG002|Overall Study|Lost to Follow-up|0|||
157143397|NCT03598777|567272852|FG003|Overall Study|Lost to Follow-up|0|||
157143398|NCT03598777|567272853|FG004|Overall Study|Lost to Follow-up|0|||
157143399|NCT02006576|567272854|FG000|Overall Study|Withdrawal by Subject|4|||
157143400|NCT02006576|567272855|FG001|Overall Study|Withdrawal by Subject|6|||
157143401|NCT02006576|567272856|FG002|Overall Study|Withdrawal by Subject|2|||
157143402|NCT02006576|567272854|FG000|Overall Study|Death|0|||
157143403|NCT02006576|567272855|FG001|Overall Study|Death|0|||
157143404|NCT02006576|567272856|FG002|Overall Study|Death|1|||
157143405|NCT02006576|567272854|FG000|Overall Study|Lost to Follow-up|1|||
157143406|NCT02006576|567272855|FG001|Overall Study|Lost to Follow-up|0|||
157143407|NCT02006576|567272856|FG002|Overall Study|Lost to Follow-up|1|||
157143408|NCT02006576|567272854|FG000|Overall Study|Screen Failure, too sick, other|13|||
157143409|NCT02006576|567272855|FG001|Overall Study|Screen Failure, too sick, other|1|||
157143410|NCT02006576|567272856|FG002|Overall Study|Screen Failure, too sick, other|13|||
157143411|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
157143412|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
157143413|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
157143414|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
157143415|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
157143416|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
157143417|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
157143418|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
157143419|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
157143420|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
157220071|NCT01620983|567551153|FG000|Overall Study|Physician Decision|3|||
157143421|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
157143422|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
157143423|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
157143424|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
157220072|NCT01620983|567551154|FG001|Overall Study|Physician Decision|10|||
157220073|NCT01620983|567551155|FG002|Overall Study|Physician Decision|5|||
157220074|NCT00798889|567551157|FG000|Overall Study|Adverse Event|53|||
157220075|NCT00798889|567551157|FG000|Overall Study|Protocol Violation|2|||
157220076|NCT00798889|567551157|FG000|Overall Study|Withdrawal by Subject|31|||
157220077|NCT00798889|567551157|FG000|Overall Study|Lost to Follow-up|1|||
157220078|NCT00798889|567551157|FG000|Overall Study|Lack of Efficacy|213|||
157220079|NCT00798889|567551157|FG000|Overall Study|Decision of Sponsor|11|||
157220080|NCT00798889|567551157|FG000|Overall Study|Enrolled, Not treated|3|||
157220081|NCT00617461|567551158|FG000|First Treatment Intervention Period|Adverse Event|2|||
157220082|NCT00617461|567551159|FG001|First Treatment Intervention Period|Adverse Event|0|||
157220083|NCT00617461|567551158|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
157220084|NCT00617461|567551159|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
157220085|NCT00617461|567551158|FG000|First Treatment Intervention Period|Protocol Violation|2|||
157220086|NCT00617461|567551159|FG001|First Treatment Intervention Period|Protocol Violation|1|||
157220087|NCT00617461|567551158|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
157220088|NCT00617461|567551159|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
157220089|NCT00617461|567551158|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
157220090|NCT00617461|567551159|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
157220091|NCT00617461|567551158|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
157220092|NCT00617461|567551159|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
157220093|NCT00617461|567551158|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
157220094|NCT00617461|567551159|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
157220095|NCT00617461|567551158|FG000|Second Treatment Intervention Period|Adverse Event|0|||
157220096|NCT00617461|567551159|FG001|Second Treatment Intervention Period|Adverse Event|1|||
157220097|NCT00617461|567551158|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
157220098|NCT00617461|567551159|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
157220099|NCT00617461|567551158|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
157220100|NCT00617461|567551159|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
157220101|NCT00617461|567551158|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
157220102|NCT00617461|567551159|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
157220103|NCT01724359|567551160|FG000|Overall Study|Adverse Event|10|||
157220104|NCT01724359|567551160|FG000|Overall Study|Death|1|||
157220105|NCT01724359|567551160|FG000|Overall Study|Other|20|||
157220106|NCT05085964|567551161|FG000|Overall Study|Premature termination of study|21|||
157220107|NCT05085964|567551162|FG001|Overall Study|Premature termination of study|0|||
157220108|NCT03156270|567551167|FG000|Overall Study|Failed pre-treatment screening|1|||
157220109|NCT03156270|567551167|FG000|Overall Study|Lost to Follow-up|1|||
157220110|NCT00591253|567551168|FG000|Overall Study|Adverse Event|3|||
157220111|NCT00591253|567551169|FG001|Overall Study|Adverse Event|3|||
157220112|NCT00591253|567551170|FG002|Overall Study|Adverse Event|1|||
157220113|NCT00591253|567551168|FG000|Overall Study|Protocol Violation|2|||
157220114|NCT00591253|567551169|FG001|Overall Study|Protocol Violation|2|||
157220115|NCT00591253|567551170|FG002|Overall Study|Protocol Violation|2|||
157220116|NCT00591253|567551168|FG000|Overall Study|Lost to Follow-up|2|||
157220117|NCT00591253|567551169|FG001|Overall Study|Lost to Follow-up|4|||
157220118|NCT00591253|567551170|FG002|Overall Study|Lost to Follow-up|0|||
157220119|NCT00591253|567551168|FG000|Overall Study|Withdrawal by Subject|1|||
157220120|NCT00591253|567551169|FG001|Overall Study|Withdrawal by Subject|7|||
157220121|NCT00591253|567551170|FG002|Overall Study|Withdrawal by Subject|6|||
157220122|NCT00591253|567551168|FG000|Overall Study|Lack of Efficacy|1|||
157220123|NCT00591253|567551169|FG001|Overall Study|Lack of Efficacy|0|||
157220124|NCT00591253|567551170|FG002|Overall Study|Lack of Efficacy|3|||
157220125|NCT00591253|567551168|FG000|Overall Study|Other|5|||
157220126|NCT00591253|567551169|FG001|Overall Study|Other|5|||
157220127|NCT00591253|567551170|FG002|Overall Study|Other|3|||
157220128|NCT00871169|567551171|FG000|Overall Study|Protocol Violation|1|||
157220129|NCT00871169|567551171|FG000|Overall Study|Patient did not receive study treatment|2|||
157220130|NCT00252187|567551172|FG000|Overall Study|Adverse Event|3|||
157220131|NCT00252187|567551173|FG001|Overall Study|Adverse Event|1|||
157220132|NCT00252187|567551172|FG000|Overall Study|Withdrawal by Subject|1|||
157220133|NCT00252187|567551173|FG001|Overall Study|Withdrawal by Subject|0|||
157220134|NCT02175966|567551176|FG000|Follow-up Period|Lack of Efficacy|10|||
157220135|NCT02175966|567551177|FG001|Follow-up Period|Lack of Efficacy|6|||
157220136|NCT01738581|567551178|FG000|Overall Study|Lost to Follow-up|1|||
157220137|NCT01738581|567551179|FG001|Overall Study|Lost to Follow-up|0|||
157220138|NCT02191579|567551180|FG000|Treatment 1|Multiple Reasons Specified|27|||
157220139|NCT02191579|567551181|FG001|Treatment 1|Multiple Reasons Specified|58|||
157220140|NCT02191579|567551180|FG000|Treatment 2|Multiple Reasons Specified|0|||
157220141|NCT02191579|567551181|FG001|Treatment 2|Multiple Reasons Specified|25|||
157220142|NCT02862535|567551184|FG000|Overall Study|Death|7|||
157220143|NCT02862535|567551185|FG001|Overall Study|Death|3|||
157220144|NCT02862535|567551186|FG002|Overall Study|Death|2|||
157220145|NCT02862535|567551187|FG003|Overall Study|Death|5|||
157220146|NCT02862535|567551184|FG000|Overall Study|Study Terminated by Sponsor|1|||
157220147|NCT02862535|567551185|FG001|Overall Study|Study Terminated by Sponsor|3|||
157220148|NCT02862535|567551186|FG002|Overall Study|Study Terminated by Sponsor|8|||
156879900|NCT00281658|566319815|FG003|Open Label Phase|Lost to Follow-up|2|||
156879901|NCT00281658|566319812|FG000|Open Label Phase|Withdrawal by Subject|0|||
156879902|NCT00281658|566319813|FG001|Open Label Phase|Withdrawal by Subject|0|||
156879903|NCT00281658|566319814|FG002|Open Label Phase|Withdrawal by Subject|3|||
156879904|NCT00281658|566319815|FG003|Open Label Phase|Withdrawal by Subject|2|||
156879905|NCT00281658|566319812|FG000|Open Label Phase|Disease progression|0|||
156879906|NCT00281658|566319813|FG001|Open Label Phase|Disease progression|0|||
156879907|NCT00281658|566319814|FG002|Open Label Phase|Disease progression|18|||
156879908|NCT00281658|566319815|FG003|Open Label Phase|Disease progression|0|||
156879909|NCT00281658|566319812|FG000|Open Label Phase|Physician Decision|0|||
156879910|NCT00281658|566319813|FG001|Open Label Phase|Physician Decision|0|||
156879911|NCT00281658|566319814|FG002|Open Label Phase|Physician Decision|1|||
156879912|NCT00281658|566319815|FG003|Open Label Phase|Physician Decision|0|||
156879913|NCT00281658|566319812|FG000|Open Label Phase|Relocation of patient|0|||
156879914|NCT00281658|566319813|FG001|Open Label Phase|Relocation of patient|0|||
156879915|NCT00281658|566319814|FG002|Open Label Phase|Relocation of patient|1|||
156879916|NCT00281658|566319815|FG003|Open Label Phase|Relocation of patient|0|||
156879917|NCT00281658|566319812|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
156879918|NCT00281658|566319813|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
156879919|NCT00281658|566319814|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
156879920|NCT00281658|566319815|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
156879921|NCT00507728|566319816|FG000|Randomization to Month 3|Lost to Follow-up|15|||
156879922|NCT00507728|566319817|FG001|Randomization to Month 3|Lost to Follow-up|14|||
156879923|NCT00507728|566319818|FG002|Randomization to Month 3|Lost to Follow-up|20|||
156879924|NCT00507728|566319816|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
156879925|NCT00507728|566319817|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
156879926|NCT00507728|566319818|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
156879927|NCT02151773|566319819|FG000|Overall Study|Protocol Deviation|64|||
156879928|NCT00095940|566319823|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
156879929|NCT00095940|566319824|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
156879930|NCT00095940|566319825|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
156879931|NCT00095940|566319826|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
156879932|NCT00095940|566319827|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
156879933|NCT00095940|566319828|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
156879934|NCT00095940|566319829|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
156879935|NCT00095940|566319830|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
156879936|NCT00095940|566319831|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
156879937|NCT00095940|566319823|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156879938|NCT00095940|566319824|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156879939|NCT00095940|566319825|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156879940|NCT00095940|566319826|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156879941|NCT00095940|566319827|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156879942|NCT00095940|566319828|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156879943|NCT00095940|566319829|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156879944|NCT00095940|566319830|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
156879945|NCT00095940|566319831|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
156879946|NCT00095940|566319823|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879947|NCT00095940|566319824|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879948|NCT00095940|566319825|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879949|NCT00095940|566319826|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879950|NCT00095940|566319827|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879951|NCT00095940|566319828|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879952|NCT00095940|566319829|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879953|NCT00095940|566319830|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
156879954|NCT00095940|566319831|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
156879955|NCT04250077|566319832|FG000|Overall Study|Withdrawal by Subject|0|||
156879956|NCT04250077|566319833|FG001|Overall Study|Withdrawal by Subject|1|||
156879957|NCT04250077|566319834|FG002|Overall Study|Withdrawal by Subject|0|||
156879958|NCT04250077|566319832|FG000|Overall Study|Lost to Follow-up|2|||
156879959|NCT04250077|566319833|FG001|Overall Study|Lost to Follow-up|3|||
156879960|NCT04250077|566319834|FG002|Overall Study|Lost to Follow-up|0|||
156879961|NCT03255629|566319835|FG000|Overall Study|Adverse Event|1|||
156879962|NCT03255629|566319836|FG001|Overall Study|Adverse Event|0|||
156879963|NCT03255629|566319835|FG000|Overall Study|did not experience hypoglycemia|2|||
156879964|NCT03255629|566319836|FG001|Overall Study|did not experience hypoglycemia|1|||
156879965|NCT01767142|566319837|FG000|Overall Study|Lost to Follow-up|3|||
156879966|NCT00926029|566319838|FG000|Overall Study|Lost to Follow-up|2|||
156879967|NCT00926029|566319839|FG001|Overall Study|Lost to Follow-up|1|||
156879968|NCT00926029|566319840|FG002|Overall Study|Lost to Follow-up|1|||
156879969|NCT02471612|566319841|FG000|Overall Study|Lost to Follow-up|2|||
156745423|NCT00306787|565815743|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157220149|NCT02862535|567551187|FG003|Overall Study|Study Terminated by Sponsor|5|||
157220150|NCT02862535|567551184|FG000|Overall Study|Enrolled, not Treated|1|||
157220151|NCT02862535|567551185|FG001|Overall Study|Enrolled, not Treated|0|||
157220152|NCT02862535|567551186|FG002|Overall Study|Enrolled, not Treated|0|||
157220153|NCT02862535|567551187|FG003|Overall Study|Enrolled, not Treated|1|||
157220154|NCT01086215|567551190|FG000|Overall Study|Death|14|||
157220155|NCT01086215|567551191|FG001|Overall Study|Death|8|||
157220156|NCT01086215|567551192|FG002|Overall Study|Death|8|||
157220157|NCT01086215|567551193|FG003|Overall Study|Death|1|||
157220158|NCT01086215|567551190|FG000|Overall Study|Lost to Follow-up|22|||
157220159|NCT01086215|567551191|FG001|Overall Study|Lost to Follow-up|39|||
157220160|NCT01086215|567551192|FG002|Overall Study|Lost to Follow-up|18|||
157220161|NCT01086215|567551193|FG003|Overall Study|Lost to Follow-up|2|||
157220162|NCT01965652|567551194|FG000|Overall Study|Adverse Event|40|||
157220163|NCT01965652|567551195|FG001|Overall Study|Adverse Event|37|||
157220164|NCT01965652|567551194|FG000|Overall Study|Withdrawal by Subject|62|||
157220165|NCT01965652|567551195|FG001|Overall Study|Withdrawal by Subject|69|||
157220166|NCT01965652|567551194|FG000|Overall Study|Lost to Follow-up|53|||
157220167|NCT01965652|567551195|FG001|Overall Study|Lost to Follow-up|40|||
157220168|NCT01965652|567551194|FG000|Overall Study|Protocol Violation|34|||
157220169|NCT01965652|567551195|FG001|Overall Study|Protocol Violation|38|||
157220170|NCT01965652|567551194|FG000|Overall Study|Death|3|||
157220171|NCT01965652|567551195|FG001|Overall Study|Death|4|||
157220172|NCT01965652|567551194|FG000|Overall Study|Other - Miscellaneous|18|||
157220173|NCT01965652|567551195|FG001|Overall Study|Other - Miscellaneous|21|||
157220174|NCT01965652|567551194|FG000|Overall Study|Pregnancy|0|||
157220175|NCT01965652|567551195|FG001|Overall Study|Pregnancy|1|||
157220176|NCT00566709|567551196|FG000|Overall Study|Protocol Violation|5|||
157220177|NCT00566709|567551197|FG001|Overall Study|Protocol Violation|0|||
157220178|NCT01829295|567551198|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
157220179|NCT01829295|567551199|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
157220180|NCT01829295|567551200|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
157220181|NCT01829295|567551201|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
157220182|NCT01829295|567551198|FG000|6-12 Months|Adverse Event|0|||
157220183|NCT01829295|567551199|FG001|6-12 Months|Adverse Event|0|||
157220184|NCT01829295|567551200|FG002|6-12 Months|Adverse Event|3|||
157220185|NCT01829295|567551201|FG003|6-12 Months|Adverse Event|2|||
157220186|NCT01829295|567551198|FG000|6-12 Months|Lost to Follow-up|2|||
157220187|NCT01829295|567551199|FG001|6-12 Months|Lost to Follow-up|0|||
157220188|NCT01829295|567551200|FG002|6-12 Months|Lost to Follow-up|0|||
157220189|NCT01829295|567551201|FG003|6-12 Months|Lost to Follow-up|0|||
157220190|NCT01829295|567551198|FG000|6-12 Months|Withdrawal by Subject|2|||
157220191|NCT01829295|567551199|FG001|6-12 Months|Withdrawal by Subject|2|||
157220192|NCT01829295|567551200|FG002|6-12 Months|Withdrawal by Subject|0|||
157220193|NCT01829295|567551201|FG003|6-12 Months|Withdrawal by Subject|0|||
157220194|NCT02123459|567551202|FG000|Washout Period (1 Day)|Adverse Event|1|||
157220195|NCT02123459|567551203|FG001|Washout Period (1 Day)|Adverse Event|0|||
157220196|NCT02196506|567551208|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
157220197|NCT02196506|567551209|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
157220198|NCT02196506|567551210|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
157220199|NCT02196506|567551211|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
157220200|NCT02196506|567551208|FG000|Phase A|Withdrawal by Subject|34|||
157220201|NCT02196506|567551209|FG001|Phase A|Withdrawal by Subject|0|||
157220202|NCT02196506|567551210|FG002|Phase A|Withdrawal by Subject|0|||
157220203|NCT02196506|567551211|FG003|Phase A|Withdrawal by Subject|0|||
157220204|NCT02196506|567551208|FG000|Phase A|Adverse Event|22|||
157220205|NCT02196506|567551209|FG001|Phase A|Adverse Event|0|||
157220206|NCT02196506|567551210|FG002|Phase A|Adverse Event|0|||
157220207|NCT02196506|567551211|FG003|Phase A|Adverse Event|0|||
157220208|NCT02196506|567551208|FG000|Phase A|Lost to Follow-up|9|||
157220209|NCT02196506|567551209|FG001|Phase A|Lost to Follow-up|0|||
157220210|NCT02196506|567551210|FG002|Phase A|Lost to Follow-up|0|||
157220211|NCT02196506|567551211|FG003|Phase A|Lost to Follow-up|0|||
157220212|NCT02196506|567551208|FG000|Phase A|Protocol deviation|12|||
157220213|NCT02196506|567551209|FG001|Phase A|Protocol deviation|0|||
157220214|NCT02196506|567551210|FG002|Phase A|Protocol deviation|0|||
157220215|NCT02196506|567551211|FG003|Phase A|Protocol deviation|0|||
157220216|NCT02196506|567551208|FG000|Phase A|Participant withdrawn by investigator|10|||
156745424|NCT00337779|565815744|FG000|Overall Study|Withdrawal by Subject|10|||
157220217|NCT02196506|567551209|FG001|Phase A|Participant withdrawn by investigator|0|||
157220218|NCT02196506|567551210|FG002|Phase A|Participant withdrawn by investigator|0|||
157220219|NCT02196506|567551211|FG003|Phase A|Participant withdrawn by investigator|0|||
157220220|NCT02196506|567551208|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
157220221|NCT02196506|567551209|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
157220222|NCT02196506|567551210|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
157220223|NCT02196506|567551211|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
157220224|NCT02196506|567551208|FG000|Phase B|Lack of Efficacy|0|||
157220225|NCT02196506|567551209|FG001|Phase B|Lack of Efficacy|1|||
157220226|NCT02196506|567551210|FG002|Phase B|Lack of Efficacy|2|||
157220227|NCT02196506|567551211|FG003|Phase B|Lack of Efficacy|0|||
157220228|NCT02196506|567551208|FG000|Phase B|Withdrawal by Participant|0|||
157220229|NCT02196506|567551209|FG001|Phase B|Withdrawal by Participant|8|||
157220230|NCT02196506|567551210|FG002|Phase B|Withdrawal by Participant|1|||
157220231|NCT02196506|567551211|FG003|Phase B|Withdrawal by Participant|0|||
157220232|NCT02196506|567551208|FG000|Phase B|Adverse Event|0|||
157220233|NCT02196506|567551209|FG001|Phase B|Adverse Event|4|||
157220234|NCT02196506|567551210|FG002|Phase B|Adverse Event|1|||
157220235|NCT02196506|567551211|FG003|Phase B|Adverse Event|0|||
157220236|NCT02196506|567551208|FG000|Phase B|Lost to Follow-up|0|||
157220237|NCT02196506|567551209|FG001|Phase B|Lost to Follow-up|2|||
157220238|NCT02196506|567551210|FG002|Phase B|Lost to Follow-up|1|||
157220239|NCT02196506|567551211|FG003|Phase B|Lost to Follow-up|0|||
157220240|NCT02196506|567551208|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
157220241|NCT02196506|567551209|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
157220242|NCT02196506|567551210|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
157220243|NCT02196506|567551211|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
157220244|NCT02196506|567551208|FG000|Phase A+|Withdrawal by Participant|0|||
157220245|NCT02196506|567551209|FG001|Phase A+|Withdrawal by Participant|0|||
157220246|NCT02196506|567551210|FG002|Phase A+|Withdrawal by Participant|0|||
157220247|NCT02196506|567551211|FG003|Phase A+|Withdrawal by Participant|5|||
157220248|NCT02196506|567551208|FG000|Phase A+|Adverse Event|0|||
157220249|NCT02196506|567551209|FG001|Phase A+|Adverse Event|0|||
157220250|NCT02196506|567551210|FG002|Phase A+|Adverse Event|0|||
157220251|NCT02196506|567551211|FG003|Phase A+|Adverse Event|1|||
157220252|NCT02196506|567551208|FG000|Phase A+|Lost to Follow-up|0|||
157220253|NCT02196506|567551209|FG001|Phase A+|Lost to Follow-up|0|||
157220254|NCT02196506|567551210|FG002|Phase A+|Lost to Follow-up|0|||
157220255|NCT02196506|567551211|FG003|Phase A+|Lost to Follow-up|6|||
157220256|NCT02196506|567551208|FG000|Phase A+|Participant withdrawn by investigator|0|||
157220257|NCT02196506|567551209|FG001|Phase A+|Participant withdrawn by investigator|0|||
157220258|NCT02196506|567551210|FG002|Phase A+|Participant withdrawn by investigator|0|||
157220259|NCT02196506|567551211|FG003|Phase A+|Participant withdrawn by investigator|1|||
157220260|NCT00254397|567551212|FG000|Overall Study|Disease Progression|4|||
157220261|NCT00254397|567551213|FG001|Overall Study|Disease Progression|1|||
157220262|NCT00254397|567551214|FG002|Overall Study|Disease Progression|16|||
157220263|NCT00254397|567551215|FG003|Overall Study|Disease Progression|23|||
157220264|NCT00254397|567551212|FG000|Overall Study|Non-Compliant|0|||
157220265|NCT00254397|567551213|FG001|Overall Study|Non-Compliant|0|||
157220266|NCT00254397|567551214|FG002|Overall Study|Non-Compliant|0|||
157220267|NCT00254397|567551215|FG003|Overall Study|Non-Compliant|1|||
157220268|NCT00254397|567551212|FG000|Overall Study|Adverse Event|2|||
157220269|NCT00254397|567551213|FG001|Overall Study|Adverse Event|0|||
157220270|NCT00254397|567551214|FG002|Overall Study|Adverse Event|3|||
157220271|NCT00254397|567551215|FG003|Overall Study|Adverse Event|1|||
157220272|NCT05028751|567551216|FG000|Overall Study|Study Terminated by Sponsor|3|||
157220273|NCT05028751|567551217|FG001|Overall Study|Study Terminated by Sponsor|0|||
157220274|NCT05028751|567551218|FG002|Overall Study|Study Terminated by Sponsor|0|||
157220275|NCT05028751|567551219|FG003|Overall Study|Study Terminated by Sponsor|0|||
157220276|NCT05028751|567551216|FG000|Overall Study|Death|9|||
157220277|NCT05028751|567551217|FG001|Overall Study|Death|3|||
157220278|NCT05028751|567551218|FG002|Overall Study|Death|2|||
157220279|NCT05028751|567551219|FG003|Overall Study|Death|4|||
157220280|NCT05028751|567551216|FG000|Overall Study|Withdrawal by Subject|0|||
157220281|NCT05028751|567551217|FG001|Overall Study|Withdrawal by Subject|0|||
157220282|NCT05028751|567551218|FG002|Overall Study|Withdrawal by Subject|1|||
157220283|NCT05028751|567551219|FG003|Overall Study|Withdrawal by Subject|0|||
157220284|NCT05028751|567551216|FG000|Overall Study|Miscellaneous|2|||
157220285|NCT05028751|567551217|FG001|Overall Study|Miscellaneous|0|||
157220286|NCT05028751|567551218|FG002|Overall Study|Miscellaneous|0|||
157220287|NCT05028751|567551219|FG003|Overall Study|Miscellaneous|0|||
157220288|NCT00395083|567551220|FG000|Overall Study|Withdrawal by Subject|6|||
157220289|NCT00395083|567551221|FG001|Overall Study|Withdrawal by Subject|5|||
157220290|NCT00395083|567551220|FG000|Overall Study|Developed another disease|4|||
156799541|NCT00415636|566021330|FG005|Overall Study|Symptomatic deterioration|1|||
157220291|NCT00395083|567551221|FG001|Overall Study|Developed another disease|3|||
157220292|NCT00658320|567553260|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
157220293|NCT00658320|567553261|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
157220294|NCT00658320|567553260|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
157220295|NCT00658320|567553261|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
157220296|NCT00658320|567553260|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
157220297|NCT00658320|567553261|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
157220298|NCT00658320|567553260|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
157220299|NCT00658320|567553261|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
157220300|NCT03433001|567553275|FG000|Overall Study|Lack of Efficacy|109|||
157220301|NCT03433001|567553275|FG000|Overall Study|Adverse Event|69|||
157220302|NCT03433001|567553275|FG000|Overall Study|Withdrawal by Subject|10|||
157220303|NCT03433001|567553275|FG000|Overall Study|Death|12|||
157220304|NCT03433001|567553275|FG000|Overall Study|Lost to Follow-up|4|||
157220305|NCT03433001|567553275|FG000|Overall Study|Other|25|||
157220306|NCT01299038|567553279|FG000|Overall Study|Withdrawal by Subject|1|||
157220307|NCT01299038|567553280|FG001|Overall Study|Withdrawal by Subject|0|||
157220308|NCT01162499|567553285|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
157220309|NCT01162499|567553286|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
157220310|NCT00322556|567553287|FG000|Overall Study|Adverse Event|1|||
157220311|NCT00322556|567553287|FG000|Overall Study|Withdrawal by Subject|1|||
157220312|NCT00322556|567553287|FG000|Overall Study|Lost to Follow-up|3|||
157220313|NCT00322556|567553287|FG000|Overall Study|Other Reason|7|||
157220314|NCT02040428|567553288|FG000|Overall Study|Death|4|||
157220315|NCT02040428|567553289|FG001|Overall Study|Death|3|||
157220316|NCT02040428|567553288|FG000|Overall Study|Withdrawal by Subject|1|||
157220317|NCT02040428|567553289|FG001|Overall Study|Withdrawal by Subject|1|||
157220318|NCT02058628|567553290|FG000|Overall Study|Adverse Event|1|||
157220319|NCT02058628|567553291|FG001|Overall Study|Adverse Event|0|||
156799542|NCT00415636|566021325|FG000|Overall Study|Adverse Event|0|||
156799543|NCT00415636|566021326|FG001|Overall Study|Adverse Event|0|||
156799544|NCT00415636|566021327|FG002|Overall Study|Adverse Event|0|||
156799545|NCT00415636|566021328|FG003|Overall Study|Adverse Event|1|||
156799546|NCT00415636|566021329|FG004|Overall Study|Adverse Event|1|||
156799547|NCT00415636|566021330|FG005|Overall Study|Adverse Event|0|||
157220320|NCT02058628|567553290|FG000|Overall Study|Withdrawal by Subject|2|||
157220321|NCT02058628|567553291|FG001|Overall Study|Withdrawal by Subject|2|||
157220322|NCT02058628|567553290|FG000|Overall Study|Lost to Follow-up|2|||
157220323|NCT02058628|567553291|FG001|Overall Study|Lost to Follow-up|4|||
157220324|NCT02058628|567553290|FG000|Overall Study|Not in time schedule|0|||
157220325|NCT02058628|567553291|FG001|Overall Study|Not in time schedule|1|||
157220326|NCT02058628|567553290|FG000|Overall Study|The visit date was not in timeline|0|||
157220327|NCT02058628|567553291|FG001|Overall Study|The visit date was not in timeline|1|||
157220328|NCT02058628|567553290|FG000|Overall Study|A lot of time for study for participant|1|||
157220329|NCT02058628|567553291|FG001|Overall Study|A lot of time for study for participant|0|||
157220330|NCT02058628|567553290|FG000|Overall Study|Non compliance|1|||
157220331|NCT02058628|567553291|FG001|Overall Study|Non compliance|0|||
157220332|NCT01464827|567553292|FG000|Overall Study|Adverse Event|0|||
156799548|NCT00415636|566021325|FG000|Overall Study|Withdrawal by Subject|0|||
156799549|NCT00415636|566021326|FG001|Overall Study|Withdrawal by Subject|0|||
156799550|NCT00415636|566021327|FG002|Overall Study|Withdrawal by Subject|0|||
156799551|NCT00415636|566021328|FG003|Overall Study|Withdrawal by Subject|0|||
156799552|NCT00415636|566021329|FG004|Overall Study|Withdrawal by Subject|1|||
156799553|NCT00415636|566021330|FG005|Overall Study|Withdrawal by Subject|0|||
156799554|NCT00415636|566021325|FG000|Overall Study|Disease progression|0|||
156799555|NCT00415636|566021326|FG001|Overall Study|Disease progression|0|||
156799556|NCT00415636|566021327|FG002|Overall Study|Disease progression|0|||
156799557|NCT00415636|566021328|FG003|Overall Study|Disease progression|3|||
156799558|NCT00415636|566021329|FG004|Overall Study|Disease progression|0|||
156799559|NCT00415636|566021330|FG005|Overall Study|Disease progression|1|||
156799560|NCT02138825|566021331|FG000|Main Study Treatment|Adverse Event|11|||
156799561|NCT02138825|566021332|FG001|Main Study Treatment|Adverse Event|3|||
156799562|NCT02138825|566021331|FG000|Main Study Treatment|Death|1|||
156799563|NCT02138825|566021332|FG001|Main Study Treatment|Death|2|||
156799564|NCT02138825|566021331|FG000|Main Study Treatment|Protocol Violation|2|||
156799565|NCT02138825|566021332|FG001|Main Study Treatment|Protocol Violation|2|||
156799566|NCT02138825|566021331|FG000|Main Study Treatment|Sponsor decision|12|||
156799567|NCT02138825|566021332|FG001|Main Study Treatment|Sponsor decision|18|||
156799568|NCT02138825|566021331|FG000|Main Study Treatment|Study terminated by sponsor|10|||
156799569|NCT02138825|566021332|FG001|Main Study Treatment|Study terminated by sponsor|9|||
156799570|NCT02138825|566021331|FG000|Main Study Treatment|Withdrawal by Subject|3|||
156799571|NCT02138825|566021332|FG001|Main Study Treatment|Withdrawal by Subject|1|||
156799572|NCT02138825|566021331|FG000|Main Study Treatment|Medical decision|1|||
156799573|NCT02138825|566021332|FG001|Main Study Treatment|Medical decision|0|||
156799574|NCT02138825|566021331|FG000|Long-term Extension|Study termination by sponsor|32|||
157020685|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020686|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
156799575|NCT02138825|566021332|FG001|Long-term Extension|Study termination by sponsor|38|||
156799576|NCT02138825|566021331|FG000|Safety Follow-up|Adverse Event|4|||
157020687|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
157220333|NCT01464827|567553293|FG001|Overall Study|Adverse Event|0|||
157220334|NCT01464827|567553294|FG002|Overall Study|Adverse Event|0|||
157220335|NCT01464827|567553295|FG003|Overall Study|Adverse Event|0|||
157220336|NCT01464827|567553296|FG004|Overall Study|Adverse Event|0|||
157220337|NCT01464827|567553297|FG005|Overall Study|Adverse Event|0|||
156799577|NCT02138825|566021332|FG001|Safety Follow-up|Adverse Event|3|||
156799578|NCT02138825|566021331|FG000|Safety Follow-up|Death|11|||
156799579|NCT02138825|566021332|FG001|Safety Follow-up|Death|5|||
156799580|NCT02138825|566021331|FG000|Safety Follow-up|Withdrawal by Subject|5|||
157220338|NCT01464827|567553298|FG006|Overall Study|Adverse Event|0|||
157220339|NCT01464827|567553299|FG007|Overall Study|Adverse Event|0|||
157220340|NCT01464827|567553300|FG008|Overall Study|Adverse Event|0|||
157220341|NCT01464827|567553301|FG009|Overall Study|Adverse Event|0|||
157220342|NCT01464827|567553302|FG010|Overall Study|Adverse Event|0|||
157220343|NCT01464827|567553303|FG011|Overall Study|Adverse Event|0|||
157220344|NCT01464827|567553304|FG012|Overall Study|Adverse Event|1|||
157220345|NCT01464827|567553305|FG013|Overall Study|Adverse Event|0|||
157220346|NCT01464827|567553292|FG000|Overall Study|Withdrawal by Subject|1|||
157220347|NCT01464827|567553293|FG001|Overall Study|Withdrawal by Subject|0|||
157220348|NCT01464827|567553294|FG002|Overall Study|Withdrawal by Subject|0|||
157220349|NCT01464827|567553295|FG003|Overall Study|Withdrawal by Subject|0|||
157220350|NCT01464827|567553296|FG004|Overall Study|Withdrawal by Subject|1|||
156879970|NCT03206788|566319842|FG000|Overall Study|Withdrawal by Subject|0|||
156879971|NCT03206788|566319843|FG001|Overall Study|Withdrawal by Subject|1|||
156879972|NCT03206788|566319842|FG000|Overall Study|Adverse Event|0|||
156879973|NCT03206788|566319843|FG001|Overall Study|Adverse Event|1|||
156879974|NCT03206788|566319842|FG000|Overall Study|Physician Decision|0|||
156879975|NCT03206788|566319843|FG001|Overall Study|Physician Decision|1|||
156879976|NCT01137604|566319846|FG000|Overall Study|Adverse Event|3|||
156879977|NCT01137604|566319847|FG001|Overall Study|Adverse Event|6|||
156879978|NCT01137604|566319848|FG002|Overall Study|Adverse Event|9|||
156879979|NCT01137604|566319849|FG003|Overall Study|Adverse Event|9|||
156879980|NCT01137604|566319846|FG000|Overall Study|Participant Choice|0|||
156879981|NCT01137604|566319847|FG001|Overall Study|Participant Choice|2|||
156879982|NCT01137604|566319848|FG002|Overall Study|Participant Choice|2|||
156879983|NCT01137604|566319849|FG003|Overall Study|Participant Choice|0|||
156879984|NCT01137604|566319846|FG000|Overall Study|Withdrawal of consent|0|||
156879985|NCT01137604|566319847|FG001|Overall Study|Withdrawal of consent|0|||
156879986|NCT01137604|566319848|FG002|Overall Study|Withdrawal of consent|0|||
156879987|NCT01137604|566319849|FG003|Overall Study|Withdrawal of consent|2|||
156879988|NCT01137604|566319846|FG000|Overall Study|Clinical progression/deterioration|1|||
156879989|NCT01137604|566319847|FG001|Overall Study|Clinical progression/deterioration|2|||
156879990|NCT01137604|566319848|FG002|Overall Study|Clinical progression/deterioration|2|||
156879991|NCT01137604|566319849|FG003|Overall Study|Clinical progression/deterioration|0|||
156879992|NCT00591318|566319850|FG000|Overall Study|Lack of Efficacy|2|||
156879993|NCT00591318|566319851|FG001|Overall Study|Lack of Efficacy|0|||
156879994|NCT00591318|566319850|FG000|Overall Study|Adverse Event|2|||
156879995|NCT00591318|566319851|FG001|Overall Study|Adverse Event|0|||
156879996|NCT00567255|566319854|FG000|Overall Study|Adverse Event|241|||
156879997|NCT00567255|566319855|FG001|Overall Study|Adverse Event|68|||
156879998|NCT00567255|566319854|FG000|Overall Study|Lost to Follow-up|77|||
156879999|NCT00567255|566319855|FG001|Overall Study|Lost to Follow-up|48|||
156880000|NCT00567255|566319854|FG000|Overall Study|Withdrawal by Subject|75|||
156880001|NCT00567255|566319855|FG001|Overall Study|Withdrawal by Subject|56|||
156880002|NCT00567255|566319854|FG000|Overall Study|Lack of Efficacy|19|||
156880003|NCT00567255|566319855|FG001|Overall Study|Lack of Efficacy|33|||
156880004|NCT00567255|566319854|FG000|Overall Study|Protocol Violation|20|||
156880005|NCT00567255|566319855|FG001|Overall Study|Protocol Violation|8|||
156880006|NCT00567255|566319854|FG000|Overall Study|Pregnancy|6|||
156880007|NCT00567255|566319855|FG001|Overall Study|Pregnancy|0|||
156880008|NCT00567255|566319854|FG000|Overall Study|Drug noncompliance,moved,other|25|||
156880009|NCT00567255|566319855|FG001|Overall Study|Drug noncompliance,moved,other|15|||
156880010|NCT04145219|566319858|FG000|Overall Study|Adverse Event|18|||
156880011|NCT04145219|566319859|FG001|Overall Study|Adverse Event|6|||
156880012|NCT04145219|566319858|FG000|Overall Study|Lost to Follow-up|2|||
156880013|NCT04145219|566319859|FG001|Overall Study|Lost to Follow-up|3|||
156880014|NCT04145219|566319858|FG000|Overall Study|Physician Decision|0|||
156880015|NCT04145219|566319859|FG001|Overall Study|Physician Decision|2|||
156880016|NCT04145219|566319858|FG000|Overall Study|Withdrawal by Subject|12|||
156880017|NCT04145219|566319859|FG001|Overall Study|Withdrawal by Subject|8|||
156880018|NCT04145219|566319858|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
156880019|NCT04145219|566319859|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
156880020|NCT02657408|566319860|FG000|Overall Study|Adverse Event|3|||
157220351|NCT01464827|567553297|FG005|Overall Study|Withdrawal by Subject|0|||
157220352|NCT01464827|567553298|FG006|Overall Study|Withdrawal by Subject|0|||
157220353|NCT01464827|567553299|FG007|Overall Study|Withdrawal by Subject|1|||
156880021|NCT02657408|566319861|FG001|Overall Study|Adverse Event|7|||
156880022|NCT03672097|566319862|FG000|Period 1|Withdrawal by Subject|2|||
156880023|NCT03672097|566319862|FG000|Period 1|Adverse Event|1|||
157220354|NCT01464827|567553300|FG008|Overall Study|Withdrawal by Subject|0|||
156880024|NCT03672097|566319862|FG000|Period 1|Did not receive treatment|1|||
156880025|NCT03672097|566319862|FG000|Period 2|Withdrawal by Subject|3|||
156880026|NCT03672097|566319862|FG000|Period 2|Other|1|||
156880027|NCT02160041|566319864|FG000|Overall Study|Adverse Event|11|||
156880028|NCT02160041|566319864|FG000|Overall Study|Death|2|||
156880029|NCT02160041|566319864|FG000|Overall Study|disease progression|57|||
156880030|NCT02160041|566319864|FG000|Overall Study|Protocol Violation|1|||
156880031|NCT02160041|566319864|FG000|Overall Study|non-compliance with study|1|||
156880032|NCT02160041|566319864|FG000|Overall Study|Physician Decision|3|||
156880033|NCT02160041|566319864|FG000|Overall Study|Withdrawal by Subject|8|||
156880034|NCT02160041|566319864|FG000|Overall Study|study terminated by by sponsor|1|||
156880035|NCT01403948|566319865|FG000|Overall Study|Progressive disease|0|||
156880036|NCT01403948|566319866|FG001|Overall Study|Progressive disease|2|||
156880037|NCT01403948|566319867|FG002|Overall Study|Progressive disease|2|||
156880038|NCT01403948|566319868|FG003|Overall Study|Progressive disease|4|||
156880039|NCT01403948|566319869|FG004|Overall Study|Progressive disease|2|||
156880040|NCT01403948|566319870|FG005|Overall Study|Progressive disease|6|||
156880041|NCT01403948|566319871|FG006|Overall Study|Progressive disease|2|||
156880042|NCT01403948|566319872|FG007|Overall Study|Progressive disease|4|||
156880043|NCT01403948|566319873|FG008|Overall Study|Progressive disease|5|||
156880044|NCT01403948|566319874|FG009|Overall Study|Progressive disease|5|||
156880045|NCT01403948|566319865|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880046|NCT01403948|566319866|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880047|NCT01403948|566319867|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880048|NCT01403948|566319868|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880049|NCT01403948|566319869|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
156880050|NCT01403948|566319870|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880051|NCT01403948|566319871|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
156880052|NCT01403948|566319872|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880053|NCT01403948|566319873|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
156880054|NCT01403948|566319874|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
156880055|NCT01403948|566319865|FG000|Overall Study|Lost to Follow-up|0|||
156880056|NCT01403948|566319866|FG001|Overall Study|Lost to Follow-up|0|||
157143425|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
156880057|NCT01403948|566319867|FG002|Overall Study|Lost to Follow-up|0|||
156880058|NCT01403948|566319868|FG003|Overall Study|Lost to Follow-up|0|||
156880059|NCT01403948|566319869|FG004|Overall Study|Lost to Follow-up|0|||
156880060|NCT01403948|566319870|FG005|Overall Study|Lost to Follow-up|0|||
156880061|NCT01403948|566319871|FG006|Overall Study|Lost to Follow-up|0|||
156880062|NCT01403948|566319872|FG007|Overall Study|Lost to Follow-up|0|||
156880063|NCT01403948|566319873|FG008|Overall Study|Lost to Follow-up|0|||
156880064|NCT01403948|566319874|FG009|Overall Study|Lost to Follow-up|1|||
156880065|NCT01403948|566319865|FG000|Overall Study|Refused cont. medication|0|||
156880066|NCT01403948|566319866|FG001|Overall Study|Refused cont. medication|0|||
156880067|NCT01403948|566319867|FG002|Overall Study|Refused cont. medication|0|||
156880068|NCT01403948|566319868|FG003|Overall Study|Refused cont. medication|0|||
156880069|NCT01403948|566319869|FG004|Overall Study|Refused cont. medication|1|||
156880070|NCT01403948|566319870|FG005|Overall Study|Refused cont. medication|0|||
156880071|NCT01403948|566319871|FG006|Overall Study|Refused cont. medication|0|||
157143426|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
157143427|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
157143428|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
157143429|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
157143430|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
157143431|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
157143432|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
157143433|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
157143434|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
157143435|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
157143436|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
157143437|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
157143438|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
157143439|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
157143440|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
157143441|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
157143442|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
157143443|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
157143444|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
157143445|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
157143446|NCT00785577|567272857|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
157143447|NCT00785577|567272858|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
157143448|NCT00785577|567272859|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
157143449|NCT00785577|567272860|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
157143450|NCT00785577|567272861|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
157143451|NCT00785577|567272857|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
156880072|NCT01403948|566319872|FG007|Overall Study|Refused cont. medication|0|||
156880073|NCT01403948|566319873|FG008|Overall Study|Refused cont. medication|0|||
156880074|NCT01403948|566319874|FG009|Overall Study|Refused cont. medication|1|||
156880075|NCT01403948|566319865|FG000|Overall Study|other than above|1|||
156880076|NCT01403948|566319866|FG001|Overall Study|other than above|2|||
157220355|NCT01464827|567553301|FG009|Overall Study|Withdrawal by Subject|0|||
157220356|NCT01464827|567553302|FG010|Overall Study|Withdrawal by Subject|0|||
157220357|NCT01464827|567553303|FG011|Overall Study|Withdrawal by Subject|0|||
157220358|NCT01464827|567553304|FG012|Overall Study|Withdrawal by Subject|0|||
156745425|NCT00337779|565815745|FG001|Overall Study|Withdrawal by Subject|12|||
156745426|NCT00337779|565815744|FG000|Overall Study|Sponsor decision|1|||
156745427|NCT00337779|565815745|FG001|Overall Study|Sponsor decision|1|||
156745428|NCT00337779|565815744|FG000|Overall Study|Physician Decision|3|||
156745429|NCT00337779|565815745|FG001|Overall Study|Physician Decision|6|||
156745430|NCT00337779|565815744|FG000|Overall Study|Protocol Violation|1|||
156745431|NCT00337779|565815745|FG001|Overall Study|Protocol Violation|1|||
156745432|NCT00337779|565815744|FG000|Overall Study|Lost to Follow-up|6|||
156745433|NCT00337779|565815745|FG001|Overall Study|Lost to Follow-up|5|||
156745434|NCT00337779|565815744|FG000|Overall Study|Adverse Event|28|||
156745435|NCT00337779|565815745|FG001|Overall Study|Adverse Event|51|||
156745436|NCT00337779|565815744|FG000|Overall Study|Pregnancy|3|||
156745437|NCT00337779|565815745|FG001|Overall Study|Pregnancy|2|||
156745438|NCT00337779|565815744|FG000|Overall Study|Death|0|||
156745439|NCT00337779|565815745|FG001|Overall Study|Death|1|||
156745440|NCT03008278|565815748|FG000|Overall Study|Progressive Disease|0|||
156745441|NCT03008278|565815749|FG001|Overall Study|Progressive Disease|0|||
156745442|NCT03008278|565815750|FG002|Overall Study|Progressive Disease|32|||
156745443|NCT03008278|565815748|FG000|Overall Study|Adverse Event|0|||
156745444|NCT03008278|565815749|FG001|Overall Study|Adverse Event|0|||
156745445|NCT03008278|565815750|FG002|Overall Study|Adverse Event|4|||
156745446|NCT03008278|565815748|FG000|Overall Study|Withdrawal by Subject|0|||
156745447|NCT03008278|565815749|FG001|Overall Study|Withdrawal by Subject|0|||
156745448|NCT03008278|565815750|FG002|Overall Study|Withdrawal by Subject|3|||
156745449|NCT03008278|565815748|FG000|Overall Study|Physician Decision|0|||
156745450|NCT03008278|565815749|FG001|Overall Study|Physician Decision|2|||
156745451|NCT03008278|565815750|FG002|Overall Study|Physician Decision|0|||
156799581|NCT02138825|566021332|FG001|Safety Follow-up|Withdrawal by Subject|3|||
156799582|NCT02138825|566021331|FG000|Safety Follow-up|clinic worsening|1|||
156799583|NCT02138825|566021332|FG001|Safety Follow-up|clinic worsening|0|||
156799584|NCT02138825|566021331|FG000|Safety Follow-up|withdrawal by PI|1|||
156799585|NCT02138825|566021332|FG001|Safety Follow-up|withdrawal by PI|0|||
156799586|NCT02138825|566021331|FG000|Safety Follow-up|logistical difficulties|0|||
156799587|NCT02138825|566021332|FG001|Safety Follow-up|logistical difficulties|1|||
156799588|NCT02138825|566021331|FG000|Safety Follow-up|progressive disease|0|||
156799589|NCT02138825|566021332|FG001|Safety Follow-up|progressive disease|2|||
156799590|NCT02138825|566021331|FG000|Safety Follow-up|too unwell to attend the visit|0|||
156799591|NCT02138825|566021332|FG001|Safety Follow-up|too unwell to attend the visit|1|||
156799592|NCT02138825|566021331|FG000|Safety Follow-up|treatment unblinded|0|||
156799593|NCT02138825|566021332|FG001|Safety Follow-up|treatment unblinded|1|||
156799594|NCT02138825|566021331|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
156799595|NCT02138825|566021332|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
156799596|NCT01702298|566021335|FG000|Overall Study|Withdrawal by Subject|1|||
156799597|NCT01664624|566021341|FG000|Overall Study|Adverse Event|0|||
156799598|NCT01664624|566021342|FG001|Overall Study|Adverse Event|1|||
156799599|NCT01664624|566021343|FG002|Overall Study|Adverse Event|0|||
156799600|NCT01664624|566021344|FG003|Overall Study|Adverse Event|0|||
156745452|NCT01074255|565815751|FG000|Overall Study|Did not receive EMEND|2|||
156745453|NCT01389258|565815752|FG000|Overall Study|Lost to Follow-up|5|||
156745454|NCT03313310|565815753|FG000|Phase 2|Lost to Follow-up|4|||
156745455|NCT03313310|565815754|FG001|Phase 2|Lost to Follow-up|0|||
156745456|NCT03313310|565815753|FG000|Phase 3|Lost to Follow-up|0|||
156745457|NCT03313310|565815754|FG001|Phase 3|Lost to Follow-up|1|||
156745458|NCT02124759|565815760|FG000|Overall Study|Withdrawal by Subject|3|||
156745459|NCT02124759|565815761|FG001|Overall Study|Withdrawal by Subject|1|||
156745460|NCT02124759|565815762|FG002|Overall Study|Withdrawal by Subject|1|||
156745461|NCT02124759|565815760|FG000|Overall Study|Screen Fail|2|||
156745462|NCT02124759|565815761|FG001|Overall Study|Screen Fail|2|||
156745463|NCT02124759|565815762|FG002|Overall Study|Screen Fail|3|||
156745464|NCT00314132|565815765|FG000|Overall Study|Lost to Follow-up|3|||
156745465|NCT00314132|565815766|FG001|Overall Study|Lost to Follow-up|13|||
156880077|NCT01403948|566319867|FG002|Overall Study|other than above|1|||
157220359|NCT01464827|567553305|FG013|Overall Study|Withdrawal by Subject|0|||
156745466|NCT00314132|565815765|FG000|Overall Study|Withdrawal by Subject|3|||
156745467|NCT00314132|565815766|FG001|Overall Study|Withdrawal by Subject|5|||
156745468|NCT00314132|565815765|FG000|Overall Study|Adverse Event|1|||
156745469|NCT00314132|565815766|FG001|Overall Study|Adverse Event|0|||
156745470|NCT00314132|565815765|FG000|Overall Study|Physician Decision|1|||
156880078|NCT01403948|566319868|FG003|Overall Study|other than above|0|||
156745471|NCT00314132|565815766|FG001|Overall Study|Physician Decision|0|||
156745472|NCT03627416|565815784|FG000|Overall Study|Adverse Event|0|||
156745473|NCT03627416|565815785|FG001|Overall Study|Adverse Event|1|||
156745474|NCT02968433|565815786|FG000|Overall Study|Withdrawal by Subject|1|||
156745475|NCT00875433|565815787|FG000|Overall Study|Progressive disease|41|||
156799601|NCT00560508|566021345|FG000|12 Week Double-blind Period|Adverse Event|3|||
157220360|NCT01464827|567553292|FG000|Overall Study|Lost to Follow-up|0|||
157220361|NCT01464827|567553293|FG001|Overall Study|Lost to Follow-up|2|||
157220362|NCT01464827|567553294|FG002|Overall Study|Lost to Follow-up|0|||
157220363|NCT01464827|567553295|FG003|Overall Study|Lost to Follow-up|2|||
157220364|NCT01464827|567553296|FG004|Overall Study|Lost to Follow-up|3|||
157220365|NCT01464827|567553297|FG005|Overall Study|Lost to Follow-up|1|||
157220366|NCT01464827|567553298|FG006|Overall Study|Lost to Follow-up|2|||
157220367|NCT01464827|567553299|FG007|Overall Study|Lost to Follow-up|2|||
157220368|NCT01464827|567553300|FG008|Overall Study|Lost to Follow-up|0|||
157220369|NCT01464827|567553301|FG009|Overall Study|Lost to Follow-up|0|||
157220370|NCT01464827|567553302|FG010|Overall Study|Lost to Follow-up|0|||
157220371|NCT01464827|567553303|FG011|Overall Study|Lost to Follow-up|1|||
157220372|NCT01464827|567553304|FG012|Overall Study|Lost to Follow-up|0|||
157220373|NCT01464827|567553305|FG013|Overall Study|Lost to Follow-up|1|||
157220374|NCT01464827|567553292|FG000|Overall Study|Other|2|||
156745476|NCT00875433|565815787|FG000|Overall Study|Other Adverse Event|14|||
156745477|NCT00875433|565815787|FG000|Overall Study|Withdrawal by Subject|2|||
156745478|NCT00875433|565815787|FG000|Overall Study|Other|3|||
156745479|NCT00637806|565815788|FG000|Double-blind Phase|Study Discontinued|2|||
156745480|NCT00637806|565815789|FG001|Double-blind Phase|Study Discontinued|0|||
156745481|NCT00637806|565815790|FG002|Double-blind Phase|Study Discontinued|1|||
156745482|NCT00637806|565815791|FG003|Double-blind Phase|Study Discontinued|0|||
156745483|NCT00637806|565815788|FG000|Extension Phase|Study Discontinued|0|||
156745484|NCT00637806|565815789|FG001|Extension Phase|Study Discontinued|0|||
156745485|NCT00637806|565815790|FG002|Extension Phase|Study Discontinued|0|||
156745486|NCT00637806|565815791|FG003|Extension Phase|Study Discontinued|1|||
156745487|NCT04148287|565815793|FG000|Overall Study|Death|2|||
156745488|NCT02240069|565815795|FG000|Overall Study|Withdrawal by Subject|5|||
156745489|NCT02240069|565815796|FG001|Overall Study|Withdrawal by Subject|5|||
156745490|NCT02240069|565815797|FG002|Overall Study|Withdrawal by Subject|2|||
156745491|NCT00106639|565815798|FG000|Overall Study|Adverse Event|3|||
156745492|NCT00106639|565815799|FG001|Overall Study|Adverse Event|4|||
156745493|NCT00106639|565815800|FG002|Overall Study|Adverse Event|1|||
156745494|NCT00106639|565815798|FG000|Overall Study|Protocol Violation|0|||
156745495|NCT00106639|565815799|FG001|Overall Study|Protocol Violation|1|||
156745496|NCT00106639|565815800|FG002|Overall Study|Protocol Violation|0|||
156745497|NCT00106639|565815798|FG000|Overall Study|Withdrawal by Subject|0|||
156745498|NCT00106639|565815799|FG001|Overall Study|Withdrawal by Subject|1|||
156745499|NCT00106639|565815800|FG002|Overall Study|Withdrawal by Subject|0|||
156745500|NCT00106639|565815798|FG000|Overall Study|Participant defaulted|0|||
156745501|NCT00106639|565815799|FG001|Overall Study|Participant defaulted|1|||
156745502|NCT00106639|565815800|FG002|Overall Study|Participant defaulted|1|||
157220375|NCT01464827|567553293|FG001|Overall Study|Other|3|||
157220376|NCT01464827|567553294|FG002|Overall Study|Other|0|||
157220377|NCT01464827|567553295|FG003|Overall Study|Other|2|||
157220378|NCT01464827|567553296|FG004|Overall Study|Other|3|||
157220379|NCT01464827|567553297|FG005|Overall Study|Other|0|||
157220380|NCT01464827|567553298|FG006|Overall Study|Other|1|||
157220381|NCT01464827|567553299|FG007|Overall Study|Other|0|||
157220382|NCT01464827|567553300|FG008|Overall Study|Other|3|||
157220383|NCT01464827|567553301|FG009|Overall Study|Other|1|||
157220384|NCT01464827|567553302|FG010|Overall Study|Other|2|||
157220385|NCT01464827|567553303|FG011|Overall Study|Other|0|||
157220386|NCT01464827|567553304|FG012|Overall Study|Other|1|||
157220387|NCT01464827|567553305|FG013|Overall Study|Other|0|||
157220388|NCT01464827|567553292|FG000|Overall Study|Not Treated|0|||
157220389|NCT01464827|567553293|FG001|Overall Study|Not Treated|2|||
156745503|NCT01096589|565815801|FG000|Overall Study|Adverse Event|2|||
156880079|NCT01403948|566319869|FG004|Overall Study|other than above|1|||
156880080|NCT01403948|566319870|FG005|Overall Study|other than above|1|||
156880081|NCT01403948|566319871|FG006|Overall Study|other than above|2|||
156880082|NCT01403948|566319872|FG007|Overall Study|other than above|0|||
156880083|NCT01403948|566319873|FG008|Overall Study|other than above|0|||
157020688|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
157220390|NCT01464827|567553294|FG002|Overall Study|Not Treated|0|||
157220391|NCT01464827|567553295|FG003|Overall Study|Not Treated|0|||
157220392|NCT01464827|567553296|FG004|Overall Study|Not Treated|1|||
157220393|NCT01464827|567553297|FG005|Overall Study|Not Treated|0|||
157220394|NCT01464827|567553298|FG006|Overall Study|Not Treated|1|||
157220395|NCT01464827|567553299|FG007|Overall Study|Not Treated|0|||
156745504|NCT01096589|565815802|FG001|Overall Study|Adverse Event|1|||
156745505|NCT01096589|565815803|FG002|Overall Study|Adverse Event|2|||
156745506|NCT01096589|565815804|FG003|Overall Study|Adverse Event|1|||
156745507|NCT01096589|565815801|FG000|Overall Study|Withdrawal by Subject|2|||
156745508|NCT01096589|565815802|FG001|Overall Study|Withdrawal by Subject|1|||
156745509|NCT01096589|565815803|FG002|Overall Study|Withdrawal by Subject|1|||
156745510|NCT01096589|565815804|FG003|Overall Study|Withdrawal by Subject|1|||
157020689|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
157220396|NCT01464827|567553300|FG008|Overall Study|Not Treated|0|||
157220397|NCT01464827|567553301|FG009|Overall Study|Not Treated|2|||
157220398|NCT01464827|567553302|FG010|Overall Study|Not Treated|0|||
156745511|NCT01096589|565815801|FG000|Overall Study|Compliance with protocol|0|||
156745512|NCT01096589|565815802|FG001|Overall Study|Compliance with protocol|0|||
156745513|NCT01096589|565815803|FG002|Overall Study|Compliance with protocol|1|||
156745514|NCT01096589|565815804|FG003|Overall Study|Compliance with protocol|0|||
156745515|NCT01096589|565815801|FG000|Overall Study|found treatment exhausting|0|||
156745516|NCT01096589|565815802|FG001|Overall Study|found treatment exhausting|0|||
156745517|NCT01096589|565815803|FG002|Overall Study|found treatment exhausting|0|||
156745518|NCT01096589|565815804|FG003|Overall Study|found treatment exhausting|1|||
156745519|NCT02923245|565815805|FG000|Overall Study|ultrasound order was cancelled|2|||
156745520|NCT02923245|565815806|FG001|Overall Study|ultrasound order was cancelled|1|||
156745521|NCT00948506|565815807|FG000|Overall Study|Withdrawal by Subject|3|||
156745522|NCT00948506|565815808|FG001|Overall Study|Withdrawal by Subject|1|||
156745523|NCT03233204|565815810|FG000|Overall Study|Adverse Event|1|||
156745524|NCT03233204|565815810|FG000|Overall Study|Death|1|||
156745525|NCT03233204|565815810|FG000|Overall Study|Withdrawal by Subject|1|||
156745526|NCT03233204|565815810|FG000|Overall Study|Progressive Disease|3|||
156745527|NCT02680834|565815811|FG000|Overall Study|Physician Decision|5|||
156745528|NCT02680834|565815812|FG001|Overall Study|Physician Decision|2|||
156745529|NCT02680834|565815811|FG000|Overall Study|Withdrawal by Subject|6|||
156745530|NCT02680834|565815812|FG001|Overall Study|Withdrawal by Subject|0|||
156745531|NCT02680834|565815811|FG000|Overall Study|Lost to Follow-up|0|||
156745532|NCT02680834|565815812|FG001|Overall Study|Lost to Follow-up|1|||
156745533|NCT02520427|565815813|FG000|Overall Study|Decision by sponsor|0|||
156745534|NCT02520427|565815814|FG001|Overall Study|Decision by sponsor|0|||
156745535|NCT02520427|565815815|FG002|Overall Study|Decision by sponsor|0|||
156745536|NCT02520427|565815816|FG003|Overall Study|Decision by sponsor|0|||
156745537|NCT02520427|565815817|FG004|Overall Study|Decision by sponsor|0|||
156745538|NCT02520427|565815818|FG005|Overall Study|Decision by sponsor|0|||
156745539|NCT02520427|565815819|FG006|Overall Study|Decision by sponsor|0|||
156745540|NCT02520427|565815820|FG007|Overall Study|Decision by sponsor|0|||
156745541|NCT02520427|565815821|FG008|Overall Study|Decision by sponsor|1|||
156745542|NCT02520427|565815822|FG009|Overall Study|Decision by sponsor|1|||
156745543|NCT02520427|565815823|FG010|Overall Study|Decision by sponsor|0|||
156745544|NCT02520427|565815824|FG011|Overall Study|Decision by sponsor|0|||
156745545|NCT02520427|565815825|FG012|Overall Study|Decision by sponsor|0|||
156745546|NCT02520427|565815826|FG013|Overall Study|Decision by sponsor|0|||
156745547|NCT02520427|565815827|FG014|Overall Study|Decision by sponsor|0|||
156745548|NCT02520427|565815828|FG015|Overall Study|Decision by sponsor|0|||
156745549|NCT02520427|565815829|FG016|Overall Study|Decision by sponsor|0|||
156745550|NCT02520427|565815830|FG017|Overall Study|Decision by sponsor|0|||
156745551|NCT02520427|565815831|FG018|Overall Study|Decision by sponsor|0|||
156745552|NCT02520427|565815832|FG019|Overall Study|Decision by sponsor|0|||
156745553|NCT02520427|565815833|FG020|Overall Study|Decision by sponsor|0|||
156745554|NCT02520427|565815834|FG021|Overall Study|Decision by sponsor|0|||
156745555|NCT02520427|565815835|FG022|Overall Study|Decision by sponsor|0|||
156745556|NCT02520427|565815836|FG023|Overall Study|Decision by sponsor|0|||
156745557|NCT02520427|565815837|FG024|Overall Study|Decision by sponsor|0|||
156745558|NCT02520427|565815838|FG025|Overall Study|Decision by sponsor|0|||
156745559|NCT02520427|565815813|FG000|Overall Study|Withdrawal by Subject|0|||
156745560|NCT02520427|565815814|FG001|Overall Study|Withdrawal by Subject|0|||
156745561|NCT02520427|565815815|FG002|Overall Study|Withdrawal by Subject|1|||
156745562|NCT02520427|565815816|FG003|Overall Study|Withdrawal by Subject|0|||
156745563|NCT02520427|565815817|FG004|Overall Study|Withdrawal by Subject|0|||
156745564|NCT02520427|565815818|FG005|Overall Study|Withdrawal by Subject|0|||
156745565|NCT02520427|565815819|FG006|Overall Study|Withdrawal by Subject|0|||
156745566|NCT02520427|565815820|FG007|Overall Study|Withdrawal by Subject|0|||
156745567|NCT02520427|565815821|FG008|Overall Study|Withdrawal by Subject|0|||
156745568|NCT02520427|565815822|FG009|Overall Study|Withdrawal by Subject|0|||
156745569|NCT02520427|565815823|FG010|Overall Study|Withdrawal by Subject|0|||
156745570|NCT02520427|565815824|FG011|Overall Study|Withdrawal by Subject|0|||
156745571|NCT02520427|565815825|FG012|Overall Study|Withdrawal by Subject|1|||
156745572|NCT02520427|565815826|FG013|Overall Study|Withdrawal by Subject|1|||
156745573|NCT02520427|565815827|FG014|Overall Study|Withdrawal by Subject|1|||
156745574|NCT02520427|565815828|FG015|Overall Study|Withdrawal by Subject|0|||
156745575|NCT02520427|565815829|FG016|Overall Study|Withdrawal by Subject|1|||
156745576|NCT02520427|565815830|FG017|Overall Study|Withdrawal by Subject|0|||
156745577|NCT02520427|565815831|FG018|Overall Study|Withdrawal by Subject|0|||
156745578|NCT02520427|565815832|FG019|Overall Study|Withdrawal by Subject|3|||
156745579|NCT02520427|565815833|FG020|Overall Study|Withdrawal by Subject|2|||
156745580|NCT02520427|565815834|FG021|Overall Study|Withdrawal by Subject|0|||
156745581|NCT02520427|565815835|FG022|Overall Study|Withdrawal by Subject|0|||
156745582|NCT02520427|565815836|FG023|Overall Study|Withdrawal by Subject|0|||
156745583|NCT02520427|565815837|FG024|Overall Study|Withdrawal by Subject|0|||
156745584|NCT02520427|565815838|FG025|Overall Study|Withdrawal by Subject|0|||
156745585|NCT02520427|565815813|FG000|Overall Study|Death|1|||
156745586|NCT02520427|565815814|FG001|Overall Study|Death|0|||
156745587|NCT02520427|565815815|FG002|Overall Study|Death|0|||
156745588|NCT02520427|565815816|FG003|Overall Study|Death|0|||
156745589|NCT02520427|565815817|FG004|Overall Study|Death|0|||
156745590|NCT02520427|565815818|FG005|Overall Study|Death|0|||
156745591|NCT02520427|565815819|FG006|Overall Study|Death|0|||
156745592|NCT02520427|565815820|FG007|Overall Study|Death|0|||
156745593|NCT02520427|565815821|FG008|Overall Study|Death|0|||
156745594|NCT02520427|565815822|FG009|Overall Study|Death|0|||
156745595|NCT02520427|565815823|FG010|Overall Study|Death|0|||
156745596|NCT02520427|565815824|FG011|Overall Study|Death|0|||
156745597|NCT02520427|565815825|FG012|Overall Study|Death|0|||
156745598|NCT02520427|565815826|FG013|Overall Study|Death|0|||
156745599|NCT02520427|565815827|FG014|Overall Study|Death|0|||
156745600|NCT02520427|565815828|FG015|Overall Study|Death|0|||
156745601|NCT02520427|565815829|FG016|Overall Study|Death|2|||
156745602|NCT02520427|565815830|FG017|Overall Study|Death|1|||
156745603|NCT02520427|565815831|FG018|Overall Study|Death|3|||
156745604|NCT02520427|565815832|FG019|Overall Study|Death|2|||
156745605|NCT02520427|565815833|FG020|Overall Study|Death|0|||
156745606|NCT02520427|565815834|FG021|Overall Study|Death|0|||
156745607|NCT02520427|565815835|FG022|Overall Study|Death|1|||
156745608|NCT02520427|565815836|FG023|Overall Study|Death|0|||
156745609|NCT02520427|565815837|FG024|Overall Study|Death|1|||
156745610|NCT02520427|565815838|FG025|Overall Study|Death|0|||
156745611|NCT02168777|565818149|FG000|Overall Study|Withdrawal by Subject|1|||
156745612|NCT02168777|565818150|FG001|Overall Study|Withdrawal by Subject|0|||
156745613|NCT02168777|565818151|FG002|Overall Study|Withdrawal by Subject|2|||
156745614|NCT02168777|565818149|FG000|Overall Study|Adverse Event|1|||
156745615|NCT02168777|565818150|FG001|Overall Study|Adverse Event|0|||
156745616|NCT02168777|565818151|FG002|Overall Study|Adverse Event|1|||
156745617|NCT02168777|565818149|FG000|Overall Study|Disease recurrence|0|||
156745618|NCT02168777|565818150|FG001|Overall Study|Disease recurrence|0|||
156745619|NCT02168777|565818151|FG002|Overall Study|Disease recurrence|1|||
156745620|NCT02168777|565818149|FG000|Overall Study|Radiological disease progression|0|||
156745621|NCT02168777|565818150|FG001|Overall Study|Radiological disease progression|5|||
156745622|NCT02168777|565818151|FG002|Overall Study|Radiological disease progression|5|||
157143452|NCT00785577|567272858|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
157143453|NCT00785577|567272859|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
157143454|NCT00785577|567272860|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
157143455|NCT00785577|567272861|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
157143456|NCT00785577|567272857|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
157143457|NCT00785577|567272858|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
157143458|NCT00785577|567272859|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
157143459|NCT00785577|567272860|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
157143460|NCT00785577|567272861|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
157143461|NCT01650805|567272864|FG000|Overall Study|Withdrawal by Subject|1|||
157143462|NCT01650805|567272865|FG001|Overall Study|Withdrawal by Subject|0|||
157143463|NCT02515669|567272868|FG000|228 Week Open-Label Phase|Other|0|||
157143464|NCT02515669|567272869|FG001|228 Week Open-Label Phase|Other|0|||
157143465|NCT02515669|567272870|FG002|228 Week Open-Label Phase|Other|1|||
157143466|NCT02515669|567272871|FG003|228 Week Open-Label Phase|Other|4|||
157143467|NCT02515669|567272868|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
157143468|NCT02515669|567272869|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
157143469|NCT02515669|567272870|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
157143470|NCT02515669|567272871|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
157143471|NCT02515669|567272868|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
157143472|NCT02515669|567272869|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
157143473|NCT02515669|567272870|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
157143474|NCT02515669|567272871|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
157143475|NCT02515669|567272868|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
157143476|NCT02515669|567272869|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
157143477|NCT02515669|567272870|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
157143478|NCT02515669|567272871|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
157143479|NCT02515669|567272868|FG000|228 Week Open-Label Phase|Missing|0|||
157143480|NCT02515669|567272869|FG001|228 Week Open-Label Phase|Missing|2|||
157143481|NCT02515669|567272870|FG002|228 Week Open-Label Phase|Missing|2|||
157143482|NCT02515669|567272871|FG003|228 Week Open-Label Phase|Missing|2|||
157143483|NCT03750838|567272872|FG000|Overall Study|Lost to Follow-up|10|||
157143484|NCT03750838|567272873|FG001|Overall Study|Lost to Follow-up|6|||
157143485|NCT04070378|567272877|FG000|Overall Study|Withdrawal by Subject|2|||
157143486|NCT04070378|567272877|FG000|Overall Study|Screen Failure|6|||
157143487|NCT04070378|567272877|FG000|Overall Study|Physician Decision|1|||
157143488|NCT04070378|567272877|FG000|Overall Study|Adverse Event|1|||
156745623|NCT02168777|565818149|FG000|Overall Study|Clinical disease progression|0|||
156745624|NCT02168777|565818150|FG001|Overall Study|Clinical disease progression|1|||
156745625|NCT02168777|565818151|FG002|Overall Study|Clinical disease progression|2|||
156745626|NCT02168777|565818149|FG000|Overall Study|Other reason|0|||
156745627|NCT02168777|565818150|FG001|Overall Study|Other reason|1|||
156745628|NCT02168777|565818151|FG002|Overall Study|Other reason|0|||
156745629|NCT00441363|565818152|FG000|Overall Study|Adverse Event|4|||
156745630|NCT00441363|565818153|FG001|Overall Study|Adverse Event|2|||
156745631|NCT00441363|565818152|FG000|Overall Study|Withdrawal by Subject|3|||
156745632|NCT00441363|565818153|FG001|Overall Study|Withdrawal by Subject|4|||
156745633|NCT00441363|565818152|FG000|Overall Study|Physician Decision|6|||
156745634|NCT00441363|565818153|FG001|Overall Study|Physician Decision|7|||
156745635|NCT00441363|565818152|FG000|Overall Study|Lost to Follow-up|2|||
156745636|NCT00441363|565818153|FG001|Overall Study|Lost to Follow-up|2|||
156745637|NCT00441363|565818152|FG000|Overall Study|Other|2|||
156745638|NCT00441363|565818153|FG001|Overall Study|Other|0|||
156745639|NCT02437188|565818154|FG000|Overall Study|Randomized but did not receive surgery|4|||
156745640|NCT02437188|565818155|FG001|Overall Study|Randomized but did not receive surgery|8|||
156745641|NCT02437188|565818154|FG000|Overall Study|Adverse Event|0|||
156745642|NCT02437188|565818155|FG001|Overall Study|Adverse Event|1|||
156745643|NCT00593606|565818166|FG000|Overall Study|Adverse Event|13|||
156745644|NCT00593606|565818166|FG000|Overall Study|Withdrawal by Subject|1|||
156745645|NCT00593606|565818166|FG000|Overall Study|Protocol Violation|3|||
156745646|NCT00593606|565818166|FG000|Overall Study|Lost to Follow-up|2|||
156745647|NCT00593606|565818166|FG000|Overall Study|Run-In Failure|5|||
157220399|NCT01464827|567553303|FG011|Overall Study|Not Treated|1|||
156745648|NCT00593606|565818166|FG000|Overall Study|Screen Failure|3|||
156745649|NCT05940077|565818167|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
156745650|NCT00388297|565818168|FG000|Overall Study|Lost to Follow-up|16|||
156745651|NCT00388297|565818169|FG001|Overall Study|Lost to Follow-up|12|||
156745652|NCT00388297|565818170|FG002|Overall Study|Lost to Follow-up|11|||
156745653|NCT00388297|565818171|FG003|Overall Study|Lost to Follow-up|8|||
156745654|NCT01492101|565818172|FG000|Overall Study|Death|323|||
156745655|NCT01492101|565818173|FG001|Overall Study|Death|322|||
156745656|NCT01492101|565818172|FG000|Overall Study|Withdrawal by Subject|14|||
156745657|NCT01492101|565818173|FG001|Overall Study|Withdrawal by Subject|18|||
156745658|NCT01492101|565818172|FG000|Overall Study|Lost to Follow-up|0|||
156745659|NCT01492101|565818173|FG001|Overall Study|Lost to Follow-up|2|||
156745660|NCT00412217|565818179|FG000|Overall Study|Insufficient Data Available|8|||
156745661|NCT00412217|565818180|FG001|Overall Study|Insufficient Data Available|3|||
156745662|NCT00412217|565818179|FG000|Overall Study|Death|5|||
156745663|NCT00412217|565818180|FG001|Overall Study|Death|4|||
156745664|NCT00412217|565818179|FG000|Overall Study|Disease Progression|2|||
156745665|NCT00412217|565818180|FG001|Overall Study|Disease Progression|3|||
156745666|NCT00412217|565818179|FG000|Overall Study|Investigator Decision|1|||
156745667|NCT00412217|565818180|FG001|Overall Study|Investigator Decision|0|||
156745668|NCT00412217|565818179|FG000|Overall Study|Withdrawal by Subject|2|||
156745669|NCT00412217|565818180|FG001|Overall Study|Withdrawal by Subject|0|||
156745670|NCT00412217|565818179|FG000|Overall Study|Lost to Follow-up|1|||
156745671|NCT00412217|565818180|FG001|Overall Study|Lost to Follow-up|4|||
156745672|NCT00412217|565818179|FG000|Overall Study|Study Terminated by Sponsor|26|||
156745673|NCT00412217|565818180|FG001|Overall Study|Study Terminated by Sponsor|33|||
156745674|NCT00412217|565818179|FG000|Overall Study|Other|1|||
156745675|NCT00412217|565818180|FG001|Overall Study|Other|1|||
156745676|NCT00980174|565818190|FG000|Overall Study|Withdrawal by Subject|1|||
156745677|NCT00980174|565818191|FG001|Overall Study|Withdrawal by Subject|4|||
157220400|NCT01464827|567553304|FG012|Overall Study|Not Treated|0|||
157220401|NCT01464827|567553305|FG013|Overall Study|Not Treated|2|||
156745678|NCT00980174|565818190|FG000|Overall Study|Adverse Event|0|||
156745679|NCT00980174|565818191|FG001|Overall Study|Adverse Event|3|||
156745680|NCT00980174|565818190|FG000|Overall Study|Ineligibility determined|2|||
156745681|NCT00980174|565818191|FG001|Overall Study|Ineligibility determined|1|||
156745682|NCT00980174|565818190|FG000|Overall Study|Death|1|||
156745683|NCT00980174|565818191|FG001|Overall Study|Death|1|||
156745684|NCT00980174|565818190|FG000|Overall Study|Other|0|||
156745685|NCT00980174|565818191|FG001|Overall Study|Other|1|||
157220402|NCT00613574|567553306|FG000|Overall Study|Adverse Event|3|||
157220403|NCT00613574|567553306|FG000|Overall Study|Lost to Follow-up|2|||
157220404|NCT00613574|567553306|FG000|Overall Study|Other|1|||
156745686|NCT03114657|565818192|FG000|Overall Study|Adverse Event|9|||
156745687|NCT03114657|565818193|FG001|Overall Study|Adverse Event|6|||
156745688|NCT03114657|565818192|FG000|Overall Study|Death|4|||
156745689|NCT03114657|565818193|FG001|Overall Study|Death|0|||
156745690|NCT03114657|565818192|FG000|Overall Study|Multiple Reasons|1|||
156745691|NCT03114657|565818193|FG001|Overall Study|Multiple Reasons|2|||
156745692|NCT03114657|565818192|FG000|Overall Study|Physician Decision|2|||
156745693|NCT03114657|565818193|FG001|Overall Study|Physician Decision|2|||
156745694|NCT03114657|565818192|FG000|Overall Study|Study Terminated By Sponsor|355|||
157220405|NCT04604184|567553308|FG000|Overall Study|Adverse Event|5|||
157220406|NCT04604184|567553309|FG001|Overall Study|Adverse Event|5|||
156745695|NCT03114657|565818193|FG001|Overall Study|Study Terminated By Sponsor|374|||
156745696|NCT03114657|565818192|FG000|Overall Study|Symptomatic Deterioration|0|||
156745697|NCT03114657|565818193|FG001|Overall Study|Symptomatic Deterioration|1|||
156745698|NCT03114657|565818192|FG000|Overall Study|Withdrawal by Subject|28|||
157220407|NCT04604184|567553308|FG000|Overall Study|Death|2|||
156745699|NCT03114657|565818193|FG001|Overall Study|Withdrawal by Subject|22|||
156745700|NCT00115037|565818194|FG000|Phase1|Lost to Follow-up|16|||
156745701|NCT00115037|565818195|FG001|Phase1|Lost to Follow-up|23|||
156745702|NCT00115037|565818196|FG002|Phase1|Lost to Follow-up|0|||
156745703|NCT00115037|565818197|FG003|Phase1|Lost to Follow-up|0|||
156745704|NCT00115037|565818198|FG004|Phase1|Lost to Follow-up|0|||
156745705|NCT00115037|565818199|FG005|Phase1|Lost to Follow-up|0|||
156745706|NCT00115037|565818194|FG000|Phase1|Withdrawal by Subject|9|||
156745707|NCT00115037|565818195|FG001|Phase1|Withdrawal by Subject|4|||
156745708|NCT00115037|565818196|FG002|Phase1|Withdrawal by Subject|0|||
156745709|NCT00115037|565818197|FG003|Phase1|Withdrawal by Subject|0|||
156745710|NCT00115037|565818198|FG004|Phase1|Withdrawal by Subject|0|||
156745711|NCT00115037|565818199|FG005|Phase1|Withdrawal by Subject|0|||
156745712|NCT00115037|565818194|FG000|Phase2|Death|0|||
156745713|NCT00115037|565818195|FG001|Phase2|Death|0|||
156745714|NCT00115037|565818196|FG002|Phase2|Death|1|||
156745715|NCT00115037|565818197|FG003|Phase2|Death|0|||
156745716|NCT00115037|565818198|FG004|Phase2|Death|0|||
156745717|NCT00115037|565818199|FG005|Phase2|Death|1|||
156745718|NCT00115037|565818194|FG000|Phase2|Withdrawal by Subject|0|||
156745719|NCT00115037|565818195|FG001|Phase2|Withdrawal by Subject|0|||
156745720|NCT00115037|565818196|FG002|Phase2|Withdrawal by Subject|2|||
156745721|NCT00115037|565818197|FG003|Phase2|Withdrawal by Subject|1|||
156745722|NCT00115037|565818198|FG004|Phase2|Withdrawal by Subject|2|||
156745723|NCT00115037|565818199|FG005|Phase2|Withdrawal by Subject|1|||
156745724|NCT00115037|565818194|FG000|Phase2|Lost to Follow-up|0|||
156745725|NCT00115037|565818195|FG001|Phase2|Lost to Follow-up|0|||
156745726|NCT00115037|565818196|FG002|Phase2|Lost to Follow-up|12|||
156745727|NCT00115037|565818197|FG003|Phase2|Lost to Follow-up|14|||
156745728|NCT00115037|565818198|FG004|Phase2|Lost to Follow-up|4|||
156745729|NCT00115037|565818199|FG005|Phase2|Lost to Follow-up|10|||
156745730|NCT01546038|565818200|FG000|Overall Study|Death|15|||
157143489|NCT03232073|567272880|FG000|Overall Study|Death|1|||
157143490|NCT03232073|567272881|FG001|Overall Study|Death|0|||
157143491|NCT03232073|567272880|FG000|Overall Study|Adverse Event|7|||
157143492|NCT03232073|567272881|FG001|Overall Study|Adverse Event|12|||
157143493|NCT03232073|567272880|FG000|Overall Study|Lost to Follow-up|6|||
157143494|NCT03232073|567272881|FG001|Overall Study|Lost to Follow-up|6|||
157143495|NCT03232073|567272880|FG000|Overall Study|Lack of Efficacy|10|||
157143496|NCT03232073|567272881|FG001|Overall Study|Lack of Efficacy|8|||
157143497|NCT03232073|567272880|FG000|Overall Study|Physician Decision|9|||
157143498|NCT03232073|567272881|FG001|Overall Study|Physician Decision|2|||
157143499|NCT03232073|567272880|FG000|Overall Study|Withdrawal by Subject|54|||
157143500|NCT03232073|567272881|FG001|Overall Study|Withdrawal by Subject|39|||
157143501|NCT02032875|567272882|FG000|Treatment Period|Adverse Event|1|||
157143502|NCT02032875|567272883|FG001|Treatment Period|Adverse Event|0|||
157143503|NCT02032875|567272882|FG000|Treatment Period|Liver transplant, No extension needed|0|||
157143504|NCT02032875|567272883|FG001|Treatment Period|Liver transplant, No extension needed|1|||
157143505|NCT02032875|567272882|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
157143506|NCT02032875|567272883|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
157143507|NCT02032875|567272882|FG000|Follow-up Period|Death|0|||
157143508|NCT02032875|567272883|FG001|Follow-up Period|Death|1|||
157143509|NCT02032875|567272882|FG000|Follow-up Period|Virologic Relapse|3|||
157143510|NCT02032875|567272883|FG001|Follow-up Period|Virologic Relapse|10|||
157143511|NCT03191786|567272888|FG000|Overall Study|Death|236|||
157143512|NCT03191786|567272889|FG001|Overall Study|Death|127|||
157143513|NCT03191786|567272888|FG000|Overall Study|Lost to Follow-up|9|||
157143514|NCT03191786|567272889|FG001|Overall Study|Lost to Follow-up|3|||
157143515|NCT03191786|567272888|FG000|Overall Study|Physician Decision|1|||
157143516|NCT03191786|567272889|FG001|Overall Study|Physician Decision|0|||
157143517|NCT03191786|567272888|FG000|Overall Study|Moved to Post Trial Access Program|30|||
157143518|NCT03191786|567272889|FG001|Overall Study|Moved to Post Trial Access Program|5|||
157143519|NCT03191786|567272888|FG000|Overall Study|Withdrawal by Subject|26|||
157143520|NCT03191786|567272889|FG001|Overall Study|Withdrawal by Subject|16|||
157143521|NCT05847881|567272890|FG000|Overall Study|Principal Investigator Decision|8|||
156745731|NCT01546038|565818201|FG001|Overall Study|Death|6|||
157143522|NCT05847881|567272890|FG000|Overall Study|Withdrawal by Subject|2|||
157143523|NCT05781542|567274202|FG000|Overall Study|Lost to Follow-up|1|||
157143524|NCT05781542|567274203|FG001|Overall Study|Lost to Follow-up|0|||
157143525|NCT05781542|567274204|FG002|Overall Study|Lost to Follow-up|1|||
157143526|NCT00955110|567274205|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
157143527|NCT00955110|567274205|FG000|Treatment Phase|Adverse Event|2|||
157143528|NCT00955110|567274205|FG000|Treatment Phase|Administrative reasons|2|||
157220408|NCT04604184|567553309|FG001|Overall Study|Death|1|||
156745732|NCT01546038|565818202|FG002|Overall Study|Death|4|||
156745733|NCT01546038|565818203|FG003|Overall Study|Death|2|||
156745734|NCT01546038|565818204|FG004|Overall Study|Death|9|||
156745735|NCT01546038|565818205|FG005|Overall Study|Death|3|||
156745736|NCT01546038|565818206|FG006|Overall Study|Death|46|||
156745737|NCT01546038|565818207|FG007|Overall Study|Death|76|||
156745738|NCT01546038|565818208|FG008|Overall Study|Death|39|||
156745739|NCT01546038|565818200|FG000|Overall Study|Lost to Follow-up|0|||
156745740|NCT01546038|565818201|FG001|Overall Study|Lost to Follow-up|0|||
156745741|NCT01546038|565818202|FG002|Overall Study|Lost to Follow-up|0|||
156745742|NCT01546038|565818203|FG003|Overall Study|Lost to Follow-up|0|||
156745743|NCT01546038|565818204|FG004|Overall Study|Lost to Follow-up|1|||
156745744|NCT01546038|565818205|FG005|Overall Study|Lost to Follow-up|0|||
156745745|NCT01546038|565818206|FG006|Overall Study|Lost to Follow-up|2|||
156745746|NCT01546038|565818207|FG007|Overall Study|Lost to Follow-up|1|||
156745747|NCT01546038|565818208|FG008|Overall Study|Lost to Follow-up|0|||
156745748|NCT01546038|565818200|FG000|Overall Study|Withdrawal by Subject|1|||
156745749|NCT01546038|565818201|FG001|Overall Study|Withdrawal by Subject|0|||
156745750|NCT01546038|565818202|FG002|Overall Study|Withdrawal by Subject|0|||
156745751|NCT01546038|565818203|FG003|Overall Study|Withdrawal by Subject|1|||
156745752|NCT01546038|565818204|FG004|Overall Study|Withdrawal by Subject|0|||
156745753|NCT01546038|565818205|FG005|Overall Study|Withdrawal by Subject|1|||
156745754|NCT01546038|565818206|FG006|Overall Study|Withdrawal by Subject|3|||
156745755|NCT01546038|565818207|FG007|Overall Study|Withdrawal by Subject|3|||
156745756|NCT01546038|565818208|FG008|Overall Study|Withdrawal by Subject|1|||
156745757|NCT01546038|565818200|FG000|Overall Study|: Randomized, not treated|0|||
156745758|NCT01546038|565818201|FG001|Overall Study|: Randomized, not treated|0|||
156745759|NCT01546038|565818202|FG002|Overall Study|: Randomized, not treated|0|||
156745760|NCT01546038|565818203|FG003|Overall Study|: Randomized, not treated|0|||
156745761|NCT01546038|565818204|FG004|Overall Study|: Randomized, not treated|0|||
156745762|NCT01546038|565818205|FG005|Overall Study|: Randomized, not treated|0|||
156745763|NCT01546038|565818206|FG006|Overall Study|: Randomized, not treated|2|||
156745764|NCT01546038|565818207|FG007|Overall Study|: Randomized, not treated|4|||
156745765|NCT01546038|565818208|FG008|Overall Study|: Randomized, not treated|3|||
156745766|NCT04245202|565818209|FG000|Overall Study|Lack of Efficacy|10|||
156745767|NCT04245202|565818210|FG001|Overall Study|Lack of Efficacy|1|||
156745768|NCT00717275|565818211|FG000|Overall Study|Premature study termination.|3|||
156745769|NCT03515629|565818215|FG000|Overall Study|Death|0|||
156745770|NCT03515629|565818216|FG001|Overall Study|Death|1|||
156745771|NCT03515629|565818217|FG002|Overall Study|Death|1|||
156745772|NCT03515629|565818215|FG000|Overall Study|Progressive disease|0|||
156745773|NCT03515629|565818216|FG001|Overall Study|Progressive disease|1|||
156745774|NCT03515629|565818217|FG002|Overall Study|Progressive disease|0|||
156745775|NCT01254721|565818218|FG000|Overall Study|Lost to Follow-up|0|||
156745776|NCT01254721|565818219|FG001|Overall Study|Lost to Follow-up|4|||
156745777|NCT01254721|565818218|FG000|Overall Study|Lack of Efficacy|4|||
156745778|NCT01254721|565818219|FG001|Overall Study|Lack of Efficacy|2|||
156745779|NCT01254721|565818218|FG000|Overall Study|Death|0|||
156745780|NCT01254721|565818219|FG001|Overall Study|Death|1|||
156745781|NCT01254721|565818218|FG000|Overall Study|technical problum|1|||
156745782|NCT01254721|565818219|FG001|Overall Study|technical problum|0|||
156745783|NCT01254721|565818218|FG000|Overall Study|Adverse Event|2|||
156745784|NCT01254721|565818219|FG001|Overall Study|Adverse Event|3|||
156745785|NCT01254721|565818218|FG000|Overall Study|Withdrawal by Subject|8|||
156745786|NCT01254721|565818219|FG001|Overall Study|Withdrawal by Subject|11|||
156745787|NCT01254721|565818218|FG000|Overall Study|Wrongly randomization|0|||
156745788|NCT01254721|565818219|FG001|Overall Study|Wrongly randomization|1|||
156745789|NCT00424021|565818220|FG000|NCT00046319 Study Period|Adverse Event|1|||
156745790|NCT00424021|565818221|FG001|NCT00046319 Study Period|Adverse Event|0|||
156745791|NCT00424021|565818222|FG002|NCT00046319 Study Period|Adverse Event|1|||
156745792|NCT00424021|565818223|FG003|NCT00046319 Study Period|Adverse Event|1|||
156745793|NCT00424021|565818220|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
156745794|NCT00424021|565818221|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
156745795|NCT00424021|565818222|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
156880084|NCT01403948|566319874|FG009|Overall Study|other than above|0|||
157020690|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
157020691|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
157143529|NCT00955110|567274205|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
156745796|NCT00424021|565818223|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
156745797|NCT00424021|565818220|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
156745798|NCT00424021|565818221|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
156745799|NCT00424021|565818222|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
156745800|NCT00424021|565818223|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
156745801|NCT00424021|565818220|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
156745802|NCT00424021|565818221|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
156745803|NCT00424021|565818222|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
156745804|NCT00424021|565818223|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
156745805|NCT00424021|565818220|FG000|AMB-220-E Study Period|Adverse Event|1|||
156745806|NCT00424021|565818221|FG001|AMB-220-E Study Period|Adverse Event|1|||
156745807|NCT00424021|565818222|FG002|AMB-220-E Study Period|Adverse Event|3|||
156745808|NCT00424021|565818223|FG003|AMB-220-E Study Period|Adverse Event|7|||
156745809|NCT00424021|565818220|FG000|AMB-220-E Study Period|Death|0|||
156745810|NCT00424021|565818221|FG001|AMB-220-E Study Period|Death|0|||
156745811|NCT00424021|565818222|FG002|AMB-220-E Study Period|Death|1|||
156745812|NCT00424021|565818223|FG003|AMB-220-E Study Period|Death|1|||
156745813|NCT00424021|565818220|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
156745814|NCT00424021|565818221|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
156745815|NCT00424021|565818222|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
156745816|NCT00424021|565818223|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
156745817|NCT00424021|565818220|FG000|AMB-220-E Study Period|Physician Decision|0|||
156745818|NCT00424021|565818221|FG001|AMB-220-E Study Period|Physician Decision|0|||
156745819|NCT00424021|565818222|FG002|AMB-220-E Study Period|Physician Decision|0|||
156745820|NCT00424021|565818223|FG003|AMB-220-E Study Period|Physician Decision|1|||
156745821|NCT00312572|565818224|FG000|Overall Study|Adverse Event|10|||
156745822|NCT00312572|565818225|FG001|Overall Study|Adverse Event|16|||
156745823|NCT00312572|565818224|FG000|Overall Study|Lost to Follow-up|1|||
156745824|NCT00312572|565818225|FG001|Overall Study|Lost to Follow-up|1|||
156745825|NCT00312572|565818224|FG000|Overall Study|Administrative|4|||
156745826|NCT00312572|565818225|FG001|Overall Study|Administrative|2|||
156745827|NCT00312572|565818224|FG000|Overall Study|Lack of Efficacy|1|||
156745828|NCT00312572|565818225|FG001|Overall Study|Lack of Efficacy|2|||
156745829|NCT03597022|565818226|FG000|Overall Study|Premature termination of the study|7|||
156745830|NCT03597022|565818227|FG001|Overall Study|Premature termination of the study|7|||
156745831|NCT03597022|565818228|FG002|Overall Study|Premature termination of the study|8|||
156745832|NCT03597022|565818226|FG000|Overall Study|Serious adverse event|1|||
156745833|NCT03597022|565818227|FG001|Overall Study|Serious adverse event|1|||
156745834|NCT03597022|565818228|FG002|Overall Study|Serious adverse event|0|||
156745835|NCT05385224|565818229|FG000|Overall Study|Unable to swallow capsule|2|||
156745836|NCT05385224|565818229|FG000|Overall Study|Withdrawal by Subject|2|||
156745837|NCT05385224|565818229|FG000|Overall Study|Did not meet study criteria|1|||
156745838|NCT04521114|565818232|FG000|Overall Study|Lost to Follow-up|1|||
156745839|NCT04521114|565818233|FG001|Overall Study|Lost to Follow-up|2|||
156745840|NCT04521114|565818234|FG002|Overall Study|Lost to Follow-up|0|||
156745841|NCT04521114|565818232|FG000|Overall Study|Withdrawal by Subject|1|||
156745842|NCT04521114|565818233|FG001|Overall Study|Withdrawal by Subject|2|||
156745843|NCT04521114|565818234|FG002|Overall Study|Withdrawal by Subject|2|||
156745844|NCT04521114|565818232|FG000|Overall Study|Adverse Event|1|||
156745845|NCT04521114|565818233|FG001|Overall Study|Adverse Event|0|||
156745846|NCT04521114|565818234|FG002|Overall Study|Adverse Event|0|||
156745847|NCT04521114|565818232|FG000|Overall Study|Sponsor Wish|1|||
156745848|NCT04521114|565818233|FG001|Overall Study|Sponsor Wish|0|||
156745849|NCT04521114|565818234|FG002|Overall Study|Sponsor Wish|0|||
156745850|NCT04521114|565818232|FG000|Overall Study|Withdrawal of Consent|2|||
156745851|NCT04521114|565818233|FG001|Overall Study|Withdrawal of Consent|2|||
156745852|NCT04521114|565818234|FG002|Overall Study|Withdrawal of Consent|0|||
156745853|NCT02614131|565818235|FG000|Overall Study|Withdrawal by Subject|1|||
157220409|NCT04604184|567553308|FG000|Overall Study|Withdrawal by Subject|1|||
157220410|NCT04604184|567553309|FG001|Overall Study|Withdrawal by Subject|3|||
157220411|NCT04604184|567553308|FG000|Overall Study|Not treated|2|||
157220412|NCT04604184|567553309|FG001|Overall Study|Not treated|2|||
157220413|NCT04604184|567553308|FG000|Overall Study|Due to sponsor decision|9|||
157220414|NCT04604184|567553309|FG001|Overall Study|Due to sponsor decision|7|||
157220415|NCT04604184|567553308|FG000|Overall Study|Physician Decision|0|||
157220416|NCT04604184|567553309|FG001|Overall Study|Physician Decision|1|||
157220417|NCT04604184|567553308|FG000|Overall Study|Transfer to healthcare|1|||
157220418|NCT04604184|567553309|FG001|Overall Study|Transfer to healthcare|0|||
157220419|NCT00582036|567553310|FG000|Overall Study|Withdrawal by Subject|0|||
157220420|NCT00582036|567553311|FG001|Overall Study|Withdrawal by Subject|1|||
156745854|NCT02614131|565818236|FG001|Overall Study|Withdrawal by Subject|0|||
156745855|NCT02614131|565818237|FG002|Overall Study|Withdrawal by Subject|0|||
156745856|NCT02614131|565818238|FG003|Overall Study|Withdrawal by Subject|0|||
156745857|NCT02614131|565818239|FG004|Overall Study|Withdrawal by Subject|0|||
156745858|NCT02614131|565818240|FG005|Overall Study|Withdrawal by Subject|0|||
156745859|NCT02614131|565818241|FG006|Overall Study|Withdrawal by Subject|0|||
156745860|NCT02614131|565818235|FG000|Overall Study|Adverse Event|0|||
156799602|NCT00560508|566021346|FG001|12 Week Double-blind Period|Adverse Event|2|||
156799603|NCT00560508|566021345|FG000|12 Week Double-blind Period|Protocol Violation|1|||
156799604|NCT00560508|566021346|FG001|12 Week Double-blind Period|Protocol Violation|0|||
157220421|NCT01625377|567553312|FG000|Overall Study|Death|1|||
156745861|NCT02614131|565818236|FG001|Overall Study|Adverse Event|0|||
156745862|NCT02614131|565818237|FG002|Overall Study|Adverse Event|0|||
156745863|NCT02614131|565818238|FG003|Overall Study|Adverse Event|0|||
156745864|NCT02614131|565818239|FG004|Overall Study|Adverse Event|0|||
156745865|NCT02614131|565818240|FG005|Overall Study|Adverse Event|0|||
156745866|NCT02614131|565818241|FG006|Overall Study|Adverse Event|1|||
156745867|NCT03209518|565818242|FG000|Overall Study|Case Report Forms Uncollected|1|||
156745868|NCT03209518|565818242|FG000|Overall Study|Protocol Deviation|1|||
156745869|NCT02854605|565818243|FG000|Overall Study|Adverse Event|1|||
156745870|NCT02854605|565818244|FG001|Overall Study|Adverse Event|5|||
156745871|NCT02854605|565818245|FG002|Overall Study|Adverse Event|2|||
156745872|NCT02854605|565818243|FG000|Overall Study|Lost to Follow-up|0|||
157220422|NCT01625377|567553313|FG001|Overall Study|Death|1|||
157220423|NCT01625377|567553312|FG000|Overall Study|Administrative Problem|1|||
157220424|NCT01625377|567553313|FG001|Overall Study|Administrative Problem|1|||
157220425|NCT01625377|567553312|FG000|Overall Study|Protocol Violation|0|||
157220426|NCT01625377|567553313|FG001|Overall Study|Protocol Violation|3|||
157220427|NCT01625377|567553312|FG000|Overall Study|Adverse Event|3|||
157220428|NCT01625377|567553313|FG001|Overall Study|Adverse Event|16|||
157220429|NCT01625377|567553312|FG000|Overall Study|Graft loss|1|||
157220430|NCT01625377|567553313|FG001|Overall Study|Graft loss|0|||
157220431|NCT01625377|567553312|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157220432|NCT01625377|567553313|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156745873|NCT02854605|565818244|FG001|Overall Study|Lost to Follow-up|2|||
156745874|NCT02854605|565818245|FG002|Overall Study|Lost to Follow-up|0|||
156745875|NCT02854605|565818243|FG000|Overall Study|Withdrew Consent|1|||
156745876|NCT02854605|565818244|FG001|Overall Study|Withdrew Consent|0|||
156745877|NCT02854605|565818245|FG002|Overall Study|Withdrew Consent|1|||
156745878|NCT02854605|565818243|FG000|Overall Study|Investigator's Discretion|1|||
156745879|NCT02854605|565818244|FG001|Overall Study|Investigator's Discretion|0|||
156745880|NCT02854605|565818245|FG002|Overall Study|Investigator's Discretion|0|||
156745881|NCT02854605|565818243|FG000|Overall Study|Protocol Violation|0|||
156799605|NCT00560508|566021345|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
157220433|NCT01625377|567553312|FG000|Overall Study|Abnormal laboratory values|1|||
157220434|NCT01625377|567553313|FG001|Overall Study|Abnormal laboratory values|0|||
157220435|NCT01787825|567553316|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
157220436|NCT01787825|567553317|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
157220437|NCT01787825|567553316|FG000|Overall Study|Data Not Analyzable|5|||
157220438|NCT01787825|567553317|FG001|Overall Study|Data Not Analyzable|1|||
157220439|NCT01238848|567553319|FG000|Overall Study|Physician Decision|13|||
157220440|NCT01238848|567553320|FG001|Overall Study|Physician Decision|5|||
157220441|NCT00782509|567553321|FG000|Overall Study|Adverse Event|20|||
157220442|NCT00782509|567553322|FG001|Overall Study|Adverse Event|10|||
157220443|NCT00782509|567553323|FG002|Overall Study|Adverse Event|20|||
157220444|NCT00782509|567553321|FG000|Overall Study|Lost to Follow-up|1|||
157220445|NCT00782509|567553322|FG001|Overall Study|Lost to Follow-up|2|||
157220446|NCT00782509|567553323|FG002|Overall Study|Lost to Follow-up|3|||
157220447|NCT00782509|567553321|FG000|Overall Study|Withdrawal by Subject|3|||
157220448|NCT00782509|567553322|FG001|Overall Study|Withdrawal by Subject|5|||
157220449|NCT00782509|567553323|FG002|Overall Study|Withdrawal by Subject|8|||
157220450|NCT00782509|567553321|FG000|Overall Study|Non compliance with protocol|2|||
157220451|NCT00782509|567553322|FG001|Overall Study|Non compliance with protocol|0|||
157220452|NCT00782509|567553323|FG002|Overall Study|Non compliance with protocol|0|||
157220453|NCT00782509|567553321|FG000|Overall Study|Other reasons not stated above|5|||
157220454|NCT00782509|567553322|FG001|Overall Study|Other reasons not stated above|2|||
157220455|NCT00782509|567553323|FG002|Overall Study|Other reasons not stated above|3|||
157220456|NCT00782509|567553321|FG000|Overall Study|Lack of Efficacy|10|||
157220457|NCT00782509|567553322|FG001|Overall Study|Lack of Efficacy|5|||
157220458|NCT00782509|567553323|FG002|Overall Study|Lack of Efficacy|2|||
157220459|NCT03222141|567553324|FG000|Overall Study|Death|15|||
157220460|NCT03222141|567553324|FG000|Overall Study|Lost to Follow-up|3|||
157220461|NCT01814137|567553325|FG000|Overall Study|Adverse Event|0|||
157220462|NCT01814137|567553326|FG001|Overall Study|Adverse Event|1|||
157220463|NCT01814137|567553325|FG000|Overall Study|Withdrawal by Subject|2|||
157220464|NCT01814137|567553326|FG001|Overall Study|Withdrawal by Subject|2|||
157220465|NCT01814137|567553325|FG000|Overall Study|Physician Decision|1|||
157220466|NCT01814137|567553326|FG001|Overall Study|Physician Decision|1|||
157220467|NCT01814137|567553325|FG000|Overall Study|Unclassified|2|||
157220468|NCT01814137|567553326|FG001|Overall Study|Unclassified|1|||
157220469|NCT01821625|567553337|FG000|Overall Study|Withdrawal by Subject|2|||
157220470|NCT01821625|567553337|FG000|Overall Study|Lack of Efficacy|2|||
157220471|NCT01821625|567553337|FG000|Overall Study|Adverse Event|1|||
156745882|NCT02854605|565818244|FG001|Overall Study|Protocol Violation|0|||
156745883|NCT02854605|565818245|FG002|Overall Study|Protocol Violation|1|||
156799606|NCT00560508|566021346|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
156799607|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
156799608|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
156799609|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
157220472|NCT01821625|567553337|FG000|Overall Study|Medical contraindication|1|||
157220473|NCT00457665|567553343|FG000|12 Months|Drug allergy|1|||
157220474|NCT00457665|567553344|FG001|12 Months|Drug allergy|1|||
157220475|NCT00457665|567553343|FG000|12 Months|High HIV viral load|5|||
157220476|NCT00457665|567553344|FG001|12 Months|High HIV viral load|1|||
157220477|NCT00457665|567553343|FG000|12 Months|Lipodystrophy|2|||
156745884|NCT01897571|565818246|FG000|Overall Study|Lost to Follow-up|3|||
156799610|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
156745885|NCT01897571|565818247|FG001|Overall Study|Lost to Follow-up|0|||
157220478|NCT00457665|567553344|FG001|12 Months|Lipodystrophy|0|||
157220479|NCT00457665|567553343|FG000|12 Months|Withdrawal by Subject|0|||
157220480|NCT00457665|567553344|FG001|12 Months|Withdrawal by Subject|2|||
157220481|NCT00457665|567553343|FG000|12 Months|Abnormal Liver function tests|0|||
156745886|NCT01897571|565818248|FG002|Overall Study|Lost to Follow-up|0|||
156745887|NCT01897571|565818249|FG003|Overall Study|Lost to Follow-up|0|||
156745888|NCT01897571|565818250|FG004|Overall Study|Lost to Follow-up|2|||
156745889|NCT01897571|565818251|FG005|Overall Study|Lost to Follow-up|0|||
156745890|NCT01897571|565818252|FG006|Overall Study|Lost to Follow-up|0|||
156745891|NCT01897571|565818253|FG007|Overall Study|Lost to Follow-up|0|||
156745892|NCT01897571|565818254|FG008|Overall Study|Lost to Follow-up|1|||
156745893|NCT01897571|565818255|FG009|Overall Study|Lost to Follow-up|2|||
156745894|NCT01897571|565818256|FG010|Overall Study|Lost to Follow-up|4|||
156745895|NCT01897571|565818246|FG000|Overall Study|Withdrawal by Subject|0|||
156745896|NCT01897571|565818247|FG001|Overall Study|Withdrawal by Subject|0|||
156745897|NCT01897571|565818248|FG002|Overall Study|Withdrawal by Subject|0|||
156745898|NCT01897571|565818249|FG003|Overall Study|Withdrawal by Subject|0|||
156745899|NCT01897571|565818250|FG004|Overall Study|Withdrawal by Subject|0|||
156745900|NCT01897571|565818251|FG005|Overall Study|Withdrawal by Subject|0|||
156745901|NCT01897571|565818252|FG006|Overall Study|Withdrawal by Subject|0|||
156745902|NCT01897571|565818253|FG007|Overall Study|Withdrawal by Subject|1|||
156745903|NCT01897571|565818254|FG008|Overall Study|Withdrawal by Subject|4|||
157220482|NCT00457665|567553344|FG001|12 Months|Abnormal Liver function tests|5|||
156745904|NCT01897571|565818255|FG009|Overall Study|Withdrawal by Subject|3|||
156745905|NCT01897571|565818256|FG010|Overall Study|Withdrawal by Subject|1|||
156745906|NCT01897571|565818246|FG000|Overall Study|Other|1|||
156745907|NCT01897571|565818247|FG001|Overall Study|Other|0|||
156745908|NCT01897571|565818248|FG002|Overall Study|Other|0|||
156745909|NCT01897571|565818249|FG003|Overall Study|Other|3|||
157220483|NCT00457665|567553343|FG000|24 Months|Withdrawal by Subject|3|||
157220484|NCT00457665|567553344|FG001|24 Months|Withdrawal by Subject|2|||
157220485|NCT00457665|567553343|FG000|24 Months|Lipodystrophy|1|||
156745910|NCT01897571|565818250|FG004|Overall Study|Other|3|||
156745911|NCT01897571|565818251|FG005|Overall Study|Other|4|||
156745912|NCT01897571|565818252|FG006|Overall Study|Other|7|||
156745913|NCT01897571|565818253|FG007|Overall Study|Other|0|||
156745914|NCT01897571|565818254|FG008|Overall Study|Other|0|||
156745915|NCT01897571|565818255|FG009|Overall Study|Other|0|||
156745916|NCT01897571|565818256|FG010|Overall Study|Other|0|||
156745917|NCT01897571|565818246|FG000|Overall Study|Enrolled in rollover study|0|||
156745918|NCT01897571|565818247|FG001|Overall Study|Enrolled in rollover study|0|||
156745919|NCT01897571|565818248|FG002|Overall Study|Enrolled in rollover study|0|||
156745920|NCT01897571|565818249|FG003|Overall Study|Enrolled in rollover study|0|||
156745921|NCT01897571|565818250|FG004|Overall Study|Enrolled in rollover study|0|||
156745922|NCT01897571|565818251|FG005|Overall Study|Enrolled in rollover study|0|||
156745923|NCT01897571|565818252|FG006|Overall Study|Enrolled in rollover study|0|||
156745924|NCT01897571|565818253|FG007|Overall Study|Enrolled in rollover study|9|||
156745925|NCT01897571|565818254|FG008|Overall Study|Enrolled in rollover study|7|||
156745926|NCT01897571|565818255|FG009|Overall Study|Enrolled in rollover study|9|||
156745927|NCT01897571|565818256|FG010|Overall Study|Enrolled in rollover study|1|||
156745928|NCT01897571|565818246|FG000|Overall Study|Death|2|||
156745929|NCT01897571|565818247|FG001|Overall Study|Death|2|||
156745930|NCT01897571|565818248|FG002|Overall Study|Death|3|||
156799611|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
156799612|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
156799613|NCT00560508|566021345|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
156799614|NCT00560508|566021346|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
156799615|NCT03493958|566021347|FG000|Overall Study|Withdrawal by Subject|6|||
157220486|NCT00457665|567553344|FG001|24 Months|Lipodystrophy|1|||
156745931|NCT01897571|565818249|FG003|Overall Study|Death|6|||
156745932|NCT01897571|565818250|FG004|Overall Study|Death|7|||
156745933|NCT01897571|565818251|FG005|Overall Study|Death|9|||
156745934|NCT01897571|565818252|FG006|Overall Study|Death|5|||
156745935|NCT01897571|565818253|FG007|Overall Study|Death|22|||
156745936|NCT01897571|565818254|FG008|Overall Study|Death|23|||
156745937|NCT01897571|565818255|FG009|Overall Study|Death|129|||
156745938|NCT01897571|565818256|FG010|Overall Study|Death|59|||
156745939|NCT05268016|565818257|FG000|Overall Study|Unacceptable toxicity or AE|2|||
156745940|NCT05268016|565818258|FG001|Overall Study|Unacceptable toxicity or AE|2|||
156745941|NCT05268016|565818259|FG002|Overall Study|Unacceptable toxicity or AE|4|||
156745942|NCT05268016|565818260|FG003|Overall Study|Unacceptable toxicity or AE|3|||
156745943|NCT05268016|565818261|FG004|Overall Study|Unacceptable toxicity or AE|1|||
156745944|NCT05268016|565818257|FG000|Overall Study|Withdrawal by Subject|1|||
156745945|NCT05268016|565818258|FG001|Overall Study|Withdrawal by Subject|3|||
156745946|NCT05268016|565818259|FG002|Overall Study|Withdrawal by Subject|2|||
157220487|NCT00457665|567553343|FG000|24 Months|Abnormal liver function tests|1|||
157220488|NCT00457665|567553344|FG001|24 Months|Abnormal liver function tests|5|||
156745947|NCT05268016|565818260|FG003|Overall Study|Withdrawal by Subject|2|||
156745948|NCT05268016|565818261|FG004|Overall Study|Withdrawal by Subject|1|||
156745949|NCT05268016|565818257|FG000|Overall Study|Lost to Follow-up|4|||
156745950|NCT05268016|565818258|FG001|Overall Study|Lost to Follow-up|7|||
156745951|NCT05268016|565818259|FG002|Overall Study|Lost to Follow-up|1|||
156745952|NCT05268016|565818260|FG003|Overall Study|Lost to Follow-up|3|||
156745953|NCT05268016|565818261|FG004|Overall Study|Lost to Follow-up|5|||
156745954|NCT05268016|565818257|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
156745955|NCT05268016|565818258|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745956|NCT05268016|565818259|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745957|NCT05268016|565818260|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
156745958|NCT05268016|565818261|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
156745959|NCT05268016|565818257|FG000|Overall Study|Lack of Efficacy|0|||
156745960|NCT05268016|565818258|FG001|Overall Study|Lack of Efficacy|0|||
156745961|NCT05268016|565818259|FG002|Overall Study|Lack of Efficacy|0|||
156745962|NCT05268016|565818260|FG003|Overall Study|Lack of Efficacy|0|||
156745963|NCT05268016|565818261|FG004|Overall Study|Lack of Efficacy|4|||
156745964|NCT05268016|565818257|FG000|Overall Study|Physician Decision|0|||
156745965|NCT05268016|565818258|FG001|Overall Study|Physician Decision|0|||
156745966|NCT05268016|565818259|FG002|Overall Study|Physician Decision|0|||
156745967|NCT05268016|565818260|FG003|Overall Study|Physician Decision|1|||
156745968|NCT05268016|565818261|FG004|Overall Study|Physician Decision|0|||
156745969|NCT05268016|565818257|FG000|Overall Study|Other|1|||
156745970|NCT05268016|565818258|FG001|Overall Study|Other|0|||
156745971|NCT05268016|565818259|FG002|Overall Study|Other|1|||
156745972|NCT05268016|565818260|FG003|Overall Study|Other|2|||
156745973|NCT05268016|565818261|FG004|Overall Study|Other|0|||
156745974|NCT03170609|565818265|FG000|Overall Study|Death|0|||
156745975|NCT03170609|565818266|FG001|Overall Study|Death|0|||
156745976|NCT03170609|565818267|FG002|Overall Study|Death|1|||
156745977|NCT03170609|565818268|FG003|Overall Study|Death|0|||
156745978|NCT03170609|565818269|FG004|Overall Study|Death|0|||
156745979|NCT03170609|565818270|FG005|Overall Study|Death|0|||
156745980|NCT03170609|565818271|FG006|Overall Study|Death|0|||
156745981|NCT03170609|565818265|FG000|Overall Study|Withdrawal by Subject|1|||
156745982|NCT03170609|565818266|FG001|Overall Study|Withdrawal by Subject|2|||
156745983|NCT03170609|565818267|FG002|Overall Study|Withdrawal by Subject|0|||
156745984|NCT03170609|565818268|FG003|Overall Study|Withdrawal by Subject|0|||
156745985|NCT03170609|565818269|FG004|Overall Study|Withdrawal by Subject|0|||
156745986|NCT03170609|565818270|FG005|Overall Study|Withdrawal by Subject|0|||
156745987|NCT03170609|565818271|FG006|Overall Study|Withdrawal by Subject|1|||
156745988|NCT03170609|565818265|FG000|Overall Study|Lost to Follow-up|1|||
156745989|NCT03170609|565818266|FG001|Overall Study|Lost to Follow-up|0|||
156745990|NCT03170609|565818267|FG002|Overall Study|Lost to Follow-up|5|||
156745991|NCT03170609|565818268|FG003|Overall Study|Lost to Follow-up|2|||
156745992|NCT03170609|565818269|FG004|Overall Study|Lost to Follow-up|1|||
156745993|NCT03170609|565818270|FG005|Overall Study|Lost to Follow-up|1|||
156745994|NCT03170609|565818271|FG006|Overall Study|Lost to Follow-up|0|||
156745995|NCT03170609|565818265|FG000|Overall Study|Other|1|||
156745996|NCT03170609|565818266|FG001|Overall Study|Other|0|||
156745997|NCT03170609|565818267|FG002|Overall Study|Other|0|||
156745998|NCT03170609|565818268|FG003|Overall Study|Other|0|||
156745999|NCT03170609|565818269|FG004|Overall Study|Other|0|||
156746000|NCT03170609|565818270|FG005|Overall Study|Other|1|||
156746001|NCT03170609|565818271|FG006|Overall Study|Other|0|||
156746002|NCT01281956|565818272|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
156746003|NCT01281956|565818273|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
156746004|NCT00586508|565818287|FG000|Overall Study|Progressive disease|52|||
156746005|NCT00586508|565818288|FG001|Overall Study|Progressive disease|8|||
156746006|NCT00586508|565818287|FG000|Overall Study|Death|0|||
156746007|NCT00586508|565818288|FG001|Overall Study|Death|1|||
156746008|NCT00586508|565818287|FG000|Overall Study|Adverse Event|12|||
156746009|NCT00586508|565818288|FG001|Overall Study|Adverse Event|4|||
156746010|NCT00586508|565818287|FG000|Overall Study|Withdrawal by Subject|4|||
156746011|NCT00586508|565818288|FG001|Overall Study|Withdrawal by Subject|0|||
156746012|NCT02918552|565818289|FG000|Overall Study|Failed Pharmacokinetics|1|||
156746013|NCT02918552|565818290|FG001|Overall Study|Failed Pharmacokinetics|0|||
156746014|NCT02918552|565818289|FG000|Overall Study|Withdrawal by Subject|0|||
156746015|NCT02918552|565818290|FG001|Overall Study|Withdrawal by Subject|1|||
156746016|NCT02918552|565818289|FG000|Overall Study|Lost to Follow-up|0|||
156746017|NCT02918552|565818290|FG001|Overall Study|Lost to Follow-up|1|||
156746018|NCT03325894|565818291|FG000|Overall Study|Adverse Event|2|||
156746019|NCT03325894|565818292|FG001|Overall Study|Adverse Event|3|||
156746020|NCT03325894|565818291|FG000|Overall Study|Protocol Violation|1|||
156746021|NCT03325894|565818292|FG001|Overall Study|Protocol Violation|2|||
156746022|NCT03325894|565818291|FG000|Overall Study|Withdrawal by Subject|10|||
156746023|NCT03325894|565818292|FG001|Overall Study|Withdrawal by Subject|6|||
156746024|NCT03325894|565818291|FG000|Overall Study|Lost to Follow-up|4|||
156746025|NCT03325894|565818292|FG001|Overall Study|Lost to Follow-up|9|||
156746026|NCT03325894|565818291|FG000|Overall Study|Lack of Efficacy|8|||
156746027|NCT03325894|565818292|FG001|Overall Study|Lack of Efficacy|14|||
156746028|NCT03325894|565818291|FG000|Overall Study|Study Terminated by Sponsor|38|||
156746029|NCT03325894|565818292|FG001|Overall Study|Study Terminated by Sponsor|43|||
156746030|NCT03325894|565818291|FG000|Overall Study|Other (Not received Treatment)|1|||
156746031|NCT03325894|565818292|FG001|Overall Study|Other (Not received Treatment)|0|||
156746032|NCT01592292|565818293|FG000|Overall Study|Follow-up loss|3|||
156746033|NCT01592292|565818294|FG001|Overall Study|Follow-up loss|3|||
156746034|NCT01592292|565818295|FG002|Overall Study|Follow-up loss|1|||
156746035|NCT01592292|565818296|FG003|Overall Study|Follow-up loss|0|||
156746036|NCT01592292|565818293|FG000|Overall Study|Withdrew consent|2|||
156746037|NCT01592292|565818294|FG001|Overall Study|Withdrew consent|1|||
156746038|NCT01592292|565818295|FG002|Overall Study|Withdrew consent|0|||
156746039|NCT01592292|565818296|FG003|Overall Study|Withdrew consent|0|||
156746040|NCT01592292|565818293|FG000|Overall Study|Other|1|||
156746041|NCT01592292|565818294|FG001|Overall Study|Other|1|||
156746042|NCT01592292|565818295|FG002|Overall Study|Other|2|||
156746043|NCT01592292|565818296|FG003|Overall Study|Other|1|||
156746044|NCT00335959|565818299|FG000|Overall Study|Adverse Event|2|||
156746045|NCT00335959|565818299|FG000|Overall Study|Ineligible|1|||
156746046|NCT02028169|565818300|FG000|Overall Study|Lost to Follow-up|21|||
156746047|NCT02028169|565818300|FG000|Overall Study|Lack of Efficacy|2|||
156746048|NCT02028169|565818300|FG000|Overall Study|Withdrawal by Subject|2|||
156746049|NCT02028169|565818300|FG000|Overall Study|Adverse Event|1|||
156746050|NCT02028169|565818300|FG000|Overall Study|Cessation of Drug|1|||
156746051|NCT02028169|565818300|FG000|Overall Study|Concomitant Medication Usage|1|||
156746052|NCT03482167|565818301|FG000|Allocated to Intervention|Physician Decision|1|||
156746053|NCT03482167|565818302|FG001|Allocated to Intervention|Physician Decision|2|||
156746054|NCT03482167|565818301|FG000|Received Intervention|Adverse Event|3|||
156746055|NCT03482167|565818302|FG001|Received Intervention|Adverse Event|1|||
156746056|NCT03482167|565818301|FG000|Received Intervention|Physician Decision|1|||
156746057|NCT03482167|565818302|FG001|Received Intervention|Physician Decision|1|||
156746058|NCT03482167|565818301|FG000|Received Intervention|Withdrawal by Subject|1|||
156746059|NCT03482167|565818302|FG001|Received Intervention|Withdrawal by Subject|0|||
156746060|NCT01001598|565818303|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
156746061|NCT01001598|565818303|FG000|Overall Study|Adverse Event|1|||
156746062|NCT01876979|565818311|FG000|Overall Study|Physician Decision|2|||
156746063|NCT01876979|565818312|FG001|Overall Study|Physician Decision|3|||
156746064|NCT00824382|565818313|FG000|Overall Study|Adverse Event|4|||
156799616|NCT03493958|566021347|FG000|Overall Study|Lost to Follow-up|7|||
156799617|NCT03493958|566021347|FG000|Overall Study|Did not complete all required study procedures|2|||
156799618|NCT02367456|566021348|FG000|Overall Study|Death|8|||
156799619|NCT02367456|566021349|FG001|Overall Study|Death|24|||
156799620|NCT02367456|566021350|FG002|Overall Study|Death|17|||
156799621|NCT02367456|566021348|FG000|Overall Study|Lost to Follow-up|1|||
156799622|NCT02367456|566021349|FG001|Overall Study|Lost to Follow-up|3|||
156799623|NCT02367456|566021350|FG002|Overall Study|Lost to Follow-up|1|||
156799624|NCT02367456|566021348|FG000|Overall Study|Other reason|3|||
156799625|NCT02367456|566021349|FG001|Overall Study|Other reason|3|||
156799626|NCT02367456|566021350|FG002|Overall Study|Other reason|9|||
156799627|NCT02367456|566021348|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
156799628|NCT02367456|566021349|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
156799629|NCT02367456|566021350|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
156799630|NCT01645176|566021352|FG000|Overall Study|Lack of Efficacy|4|||
156799631|NCT01645176|566021352|FG000|Overall Study|did not complete final MRI|1|||
156799636|NCT00904371|566021356|FG000|Overall Study|Adverse Event|2|||
156799637|NCT00904371|566021356|FG000|Overall Study|Lost to Follow-up|4|||
156799638|NCT00904371|566021356|FG000|Overall Study|Discontinued at target blood pressure|2|||
156799639|NCT00904371|566021356|FG000|Overall Study|Continued with Tritace|1|||
156799640|NCT01668004|566021359|FG000|Overall Study|Adverse Event|7|||
156799641|NCT01668004|566021359|FG000|Overall Study|Withdrawal by Subject|2|||
156799642|NCT01668004|566021359|FG000|Overall Study|Lost to Follow-up|5|||
156799643|NCT01668004|566021359|FG000|Overall Study|Lack of Efficacy|9|||
156799644|NCT01668004|566021359|FG000|Overall Study|Non-compliance with treatment|2|||
156799645|NCT02735200|566021361|FG000|Overall Study|Lost to Follow-up|0|||
156799646|NCT02735200|566021362|FG001|Overall Study|Lost to Follow-up|5|||
156799647|NCT02735200|566021361|FG000|Overall Study|Withdrawal by Subject|8|||
156799648|NCT02735200|566021362|FG001|Overall Study|Withdrawal by Subject|0|||
156799649|NCT04856527|566021365|FG000|Overall Study|Unable to complete experimental task|2|||
156799650|NCT04856527|566021366|FG001|Overall Study|Unable to complete experimental task|0|||
156880085|NCT01090323|566319875|FG000|Overall Study|Adverse Event|12|||
156880086|NCT01090323|566319876|FG001|Overall Study|Adverse Event|2|||
156746065|NCT00824382|565818314|FG001|Overall Study|Adverse Event|1|||
156746066|NCT00824382|565818315|FG002|Overall Study|Adverse Event|1|||
156746067|NCT00824382|565818316|FG003|Overall Study|Adverse Event|4|||
156746068|NCT00824382|565818313|FG000|Overall Study|Protocol Violation|1|||
156746069|NCT00824382|565818314|FG001|Overall Study|Protocol Violation|0|||
156799651|NCT02115321|566021367|FG000|Overall Study|Death|1|||
156799652|NCT02115321|566021368|FG001|Overall Study|Death|0|||
156880087|NCT01090323|566319875|FG000|Overall Study|Abnormal Lab Values|3|||
156880088|NCT01090323|566319876|FG001|Overall Study|Abnormal Lab Values|1|||
156880089|NCT01090323|566319875|FG000|Overall Study|Abnormal Test Procedure Results|2|||
156880090|NCT01090323|566319876|FG001|Overall Study|Abnormal Test Procedure Results|0|||
156880091|NCT01090323|566319875|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156746070|NCT00824382|565818315|FG002|Overall Study|Protocol Violation|0|||
156746071|NCT00824382|565818316|FG003|Overall Study|Protocol Violation|1|||
156746072|NCT00824382|565818313|FG000|Overall Study|Investigator's decision|0|||
156746073|NCT00824382|565818314|FG001|Overall Study|Investigator's decision|1|||
156746074|NCT00824382|565818315|FG002|Overall Study|Investigator's decision|2|||
156746075|NCT00824382|565818316|FG003|Overall Study|Investigator's decision|0|||
156746076|NCT00793624|565818317|FG000|Overall Study|Adverse Event|18|||
156746077|NCT00793624|565818318|FG001|Overall Study|Adverse Event|16|||
156746078|NCT00793624|565818319|FG002|Overall Study|Adverse Event|15|||
156746079|NCT00793624|565818320|FG003|Overall Study|Adverse Event|20|||
156746080|NCT00793624|565818317|FG000|Overall Study|Lost to Follow-up|2|||
156746081|NCT00793624|565818318|FG001|Overall Study|Lost to Follow-up|2|||
156746082|NCT00793624|565818319|FG002|Overall Study|Lost to Follow-up|4|||
156746083|NCT00793624|565818320|FG003|Overall Study|Lost to Follow-up|0|||
156799653|NCT01463527|566021371|FG000|Overall Study|Protocol Violation|1|||
156799654|NCT01463527|566021372|FG001|Overall Study|Protocol Violation|1|||
157020692|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156799655|NCT01463527|566021371|FG000|Overall Study|Crying >20% of sedation|5|||
156799656|NCT01463527|566021372|FG001|Overall Study|Crying >20% of sedation|6|||
156799657|NCT01493414|566021373|FG000|Overall Study|Adverse Event|405|||
156799658|NCT01493414|566021373|FG000|Overall Study|Disease progression|204|||
156799659|NCT01493414|566021373|FG000|Overall Study|Death|101|||
156799660|NCT01493414|566021373|FG000|Overall Study|Physician Decision|93|||
156799661|NCT01493414|566021373|FG000|Overall Study|Withdrawal by Subject|79|||
156799662|NCT01493414|566021373|FG000|Overall Study|Protocol deviation|27|||
156799663|NCT01493414|566021373|FG000|Overall Study|Administrative problems|25|||
156799664|NCT01493414|566021373|FG000|Overall Study|Lost to Follow-up|16|||
156799665|NCT04403919|566021374|FG000|Overall Study|Lost to Follow-up|0|||
156799666|NCT04403919|566021375|FG001|Overall Study|Lost to Follow-up|0|||
156799667|NCT04403919|566021376|FG002|Overall Study|Lost to Follow-up|0|||
156799668|NCT04403919|566021377|FG003|Overall Study|Lost to Follow-up|1|||
156799669|NCT03746015|566021378|FG000|Overall Study|Withdrawal of Consent|1|||
156799670|NCT03746015|566021379|FG001|Overall Study|Withdrawal of Consent|0|||
156799671|NCT03746015|566021380|FG002|Overall Study|Withdrawal of Consent|0|||
156799672|NCT02303262|566021383|FG000|Overall Study|Withdrawal by Subject|2|||
156799673|NCT01143402|566021386|FG000|Overall Study|Rapid clinical decline|1|||
156799674|NCT01143402|566021387|FG001|Overall Study|Rapid clinical decline|1|||
156799675|NCT01143402|566021388|FG002|Overall Study|Rapid clinical decline|0|||
156799676|NCT01143402|566021386|FG000|Overall Study|Not Treated|0|||
156799677|NCT01143402|566021387|FG001|Overall Study|Not Treated|0|||
156799678|NCT01143402|566021388|FG002|Overall Study|Not Treated|1|||
156799679|NCT00397540|566021396|FG000|Overall Study|short follow-up duration < 12 months|1|||
156799680|NCT00397540|566021397|FG001|Overall Study|short follow-up duration < 12 months|0|||
156799681|NCT01656161|566021398|FG000|Overall Study|Death|3|||
156799682|NCT01656161|566021398|FG000|Overall Study|Adverse Event|2|||
156799683|NCT01656161|566021398|FG000|Overall Study|Protocol Violation|1|||
156799684|NCT01656161|566021398|FG000|Overall Study|Withdrawal by Subject|1|||
156799685|NCT01968980|566021405|FG000|Overall Study|Death|0|||
156799686|NCT01968980|566021406|FG001|Overall Study|Death|1|||
156799687|NCT01968980|566021405|FG000|Overall Study|Adverse Event|1|||
156799688|NCT01968980|566021406|FG001|Overall Study|Adverse Event|3|||
156799689|NCT01968980|566021405|FG000|Overall Study|Does not meet entry criteria|1|||
156799690|NCT01968980|566021406|FG001|Overall Study|Does not meet entry criteria|3|||
156799691|NCT01968980|566021405|FG000|Overall Study|Withdrawal by Subject|13|||
156799692|NCT01968980|566021406|FG001|Overall Study|Withdrawal by Subject|5|||
156799693|NCT01968980|566021405|FG000|Overall Study|Other unspecified|1|||
156799694|NCT01968980|566021406|FG001|Overall Study|Other unspecified|2|||
156799695|NCT00776230|566021407|FG000|Overall Study|Lost to Follow-up|2|||
156799696|NCT00776230|566021408|FG001|Overall Study|Lost to Follow-up|1|||
156799697|NCT00776230|566021409|FG002|Overall Study|Lost to Follow-up|5|||
156799698|NCT00776230|566021407|FG000|Overall Study|Not vaccinated at Day 0|1|||
156799699|NCT00776230|566021408|FG001|Overall Study|Not vaccinated at Day 0|0|||
156799700|NCT00776230|566021409|FG002|Overall Study|Not vaccinated at Day 0|0|||
156799701|NCT00776230|566021407|FG000|Overall Study|Withdrawal by Subject|0|||
156799702|NCT00776230|566021408|FG001|Overall Study|Withdrawal by Subject|1|||
156799703|NCT00776230|566021409|FG002|Overall Study|Withdrawal by Subject|0|||
156799704|NCT00776230|566021407|FG000|Overall Study|Subject missed Visit 4|0|||
156799705|NCT00776230|566021408|FG001|Overall Study|Subject missed Visit 4|1|||
157020693|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156799706|NCT00776230|566021409|FG002|Overall Study|Subject missed Visit 4|0|||
156746084|NCT00793624|565818317|FG000|Overall Study|Withdrawal by Subject|20|||
156746085|NCT00793624|565818318|FG001|Overall Study|Withdrawal by Subject|9|||
156746086|NCT00793624|565818319|FG002|Overall Study|Withdrawal by Subject|11|||
156746087|NCT00793624|565818320|FG003|Overall Study|Withdrawal by Subject|14|||
156799707|NCT01215851|566021410|FG000|Treatment Period|Adverse Event|1|||
156799708|NCT01215851|566021411|FG001|Treatment Period|Adverse Event|1|||
156799709|NCT01215851|566021412|FG002|Treatment Period|Adverse Event|1|||
156746088|NCT00793624|565818317|FG000|Overall Study|Lack of Efficacy|9|||
156746089|NCT00793624|565818318|FG001|Overall Study|Lack of Efficacy|2|||
156746090|NCT00793624|565818319|FG002|Overall Study|Lack of Efficacy|1|||
156746091|NCT00793624|565818320|FG003|Overall Study|Lack of Efficacy|3|||
156746092|NCT00793624|565818317|FG000|Overall Study|Non compliance with protocol|2|||
156746093|NCT00793624|565818318|FG001|Overall Study|Non compliance with protocol|3|||
156746094|NCT00793624|565818319|FG002|Overall Study|Non compliance with protocol|2|||
156746095|NCT00793624|565818320|FG003|Overall Study|Non compliance with protocol|3|||
156746096|NCT00793624|565818317|FG000|Overall Study|Other reason not described above|6|||
156746097|NCT00793624|565818318|FG001|Overall Study|Other reason not described above|4|||
156746098|NCT00793624|565818319|FG002|Overall Study|Other reason not described above|6|||
156746099|NCT00793624|565818320|FG003|Overall Study|Other reason not described above|3|||
156746100|NCT03467763|565818323|FG000|Overall Study|Lost to Follow-up|1|||
156746101|NCT03467763|565818323|FG000|Overall Study|Protocol Violation|2|||
156746102|NCT02908074|565818324|FG000|Overall Study|sponsor/ICON decision|0|||
156746103|NCT02908074|565818325|FG001|Overall Study|sponsor/ICON decision|0|||
156746104|NCT02908074|565818326|FG002|Overall Study|sponsor/ICON decision|1|||
156746105|NCT02908074|565818327|FG003|Overall Study|sponsor/ICON decision|0|||
156746106|NCT02908074|565818328|FG004|Overall Study|sponsor/ICON decision|0|||
156746107|NCT02908074|565818329|FG005|Overall Study|sponsor/ICON decision|0|||
156746108|NCT02908074|565818324|FG000|Overall Study|Protocol Violation|0|||
156746109|NCT02908074|565818325|FG001|Overall Study|Protocol Violation|1|||
156746110|NCT02908074|565818326|FG002|Overall Study|Protocol Violation|0|||
156746111|NCT02908074|565818327|FG003|Overall Study|Protocol Violation|0|||
156746112|NCT02908074|565818328|FG004|Overall Study|Protocol Violation|0|||
156746113|NCT02908074|565818329|FG005|Overall Study|Protocol Violation|0|||
156746114|NCT02908074|565818324|FG000|Overall Study|Adverse Event|5|||
157220489|NCT00446654|567553345|FG000|Overall Study|Withdrawal by Subject|1|||
157220490|NCT00446654|567553346|FG001|Overall Study|Withdrawal by Subject|0|||
157220491|NCT00446654|567553345|FG000|Overall Study|Adverse Event|1|||
157220492|NCT00446654|567553346|FG001|Overall Study|Adverse Event|0|||
157220493|NCT02535000|567553347|FG000|Overall Study|Cancellation of surgery.|1|||
157220494|NCT02535000|567553348|FG001|Overall Study|Cancellation of surgery.|2|||
157220495|NCT01620489|567553353|FG000|Overall Study|Adverse Event|17|||
157220496|NCT01620489|567553354|FG001|Overall Study|Adverse Event|4|||
156746115|NCT02908074|565818325|FG001|Overall Study|Adverse Event|2|||
156746116|NCT02908074|565818326|FG002|Overall Study|Adverse Event|0|||
156746117|NCT02908074|565818327|FG003|Overall Study|Adverse Event|0|||
156746118|NCT02908074|565818328|FG004|Overall Study|Adverse Event|1|||
156746119|NCT02908074|565818329|FG005|Overall Study|Adverse Event|0|||
156746120|NCT02908074|565818324|FG000|Overall Study|AESI|1|||
156746121|NCT02908074|565818325|FG001|Overall Study|AESI|0|||
156746122|NCT02908074|565818326|FG002|Overall Study|AESI|1|||
156746123|NCT02908074|565818327|FG003|Overall Study|AESI|0|||
156746124|NCT02908074|565818328|FG004|Overall Study|AESI|1|||
156746125|NCT02908074|565818329|FG005|Overall Study|AESI|0|||
156746126|NCT02908074|565818324|FG000|Overall Study|Discontinuation criteria per protocol|0|||
156746127|NCT02908074|565818325|FG001|Overall Study|Discontinuation criteria per protocol|0|||
156746128|NCT02908074|565818326|FG002|Overall Study|Discontinuation criteria per protocol|1|||
156746129|NCT02908074|565818327|FG003|Overall Study|Discontinuation criteria per protocol|0|||
156746130|NCT02908074|565818328|FG004|Overall Study|Discontinuation criteria per protocol|0|||
156746131|NCT02908074|565818329|FG005|Overall Study|Discontinuation criteria per protocol|1|||
156746132|NCT02908074|565818324|FG000|Overall Study|Withdrawal by Subject|3|||
156746133|NCT02908074|565818325|FG001|Overall Study|Withdrawal by Subject|2|||
156746134|NCT02908074|565818326|FG002|Overall Study|Withdrawal by Subject|2|||
156746135|NCT02908074|565818327|FG003|Overall Study|Withdrawal by Subject|2|||
156746136|NCT02908074|565818328|FG004|Overall Study|Withdrawal by Subject|2|||
156746137|NCT02908074|565818329|FG005|Overall Study|Withdrawal by Subject|2|||
156746138|NCT02908074|565818324|FG000|Overall Study|Lost to Follow-up|0|||
156746139|NCT02908074|565818325|FG001|Overall Study|Lost to Follow-up|1|||
156799710|NCT01215851|566021413|FG003|Treatment Period|Adverse Event|3|||
156799711|NCT01215851|566021414|FG004|Treatment Period|Adverse Event|0|||
156799712|NCT01215851|566021415|FG005|Treatment Period|Adverse Event|1|||
157220497|NCT01620489|567553353|FG000|Overall Study|Protocol Violation|0|||
156746140|NCT02908074|565818326|FG002|Overall Study|Lost to Follow-up|1|||
156746141|NCT02908074|565818327|FG003|Overall Study|Lost to Follow-up|1|||
156746142|NCT02908074|565818328|FG004|Overall Study|Lost to Follow-up|0|||
156746143|NCT02908074|565818329|FG005|Overall Study|Lost to Follow-up|1|||
156746144|NCT02073565|565818331|FG000|Cohort A|Withdrawal by Subject|1|||
156799713|NCT01215851|566021410|FG000|Follow up Period|Lost to Follow-up|0|||
156799714|NCT01215851|566021411|FG001|Follow up Period|Lost to Follow-up|0|||
156799715|NCT01215851|566021412|FG002|Follow up Period|Lost to Follow-up|0|||
156746145|NCT02073565|565818332|FG001|Cohort A|Withdrawal by Subject|0|||
156746146|NCT02073565|565818331|FG000|Cohort B|Withdrawal by Subject|1|||
156799716|NCT01215851|566021413|FG003|Follow up Period|Lost to Follow-up|0|||
156799717|NCT01215851|566021414|FG004|Follow up Period|Lost to Follow-up|0|||
157220498|NCT01620489|567553354|FG001|Overall Study|Protocol Violation|3|||
156746147|NCT02073565|565818332|FG001|Cohort B|Withdrawal by Subject|2|||
156746148|NCT02073565|565818331|FG000|Cohort C|Withdrawal by Subject|0|||
156746149|NCT02073565|565818332|FG001|Cohort C|Withdrawal by Subject|2|||
156746150|NCT02073565|565818331|FG000|Cohort C|Lost to Follow-up|0|||
156746151|NCT02073565|565818332|FG001|Cohort C|Lost to Follow-up|2|||
156746152|NCT01764997|565818333|FG000|Run-in Period|Adverse Event|15|||
156746153|NCT01764997|565818334|FG001|Run-in Period|Adverse Event|0|||
156746154|NCT01764997|565818335|FG002|Run-in Period|Adverse Event|0|||
156746155|NCT01764997|565818336|FG003|Run-in Period|Adverse Event|0|||
156746156|NCT01764997|565818337|FG004|Run-in Period|Adverse Event|0|||
156746157|NCT01764997|565818333|FG000|Run-in Period|Lack of Efficacy|5|||
156746158|NCT01764997|565818334|FG001|Run-in Period|Lack of Efficacy|0|||
156746159|NCT01764997|565818335|FG002|Run-in Period|Lack of Efficacy|0|||
156746160|NCT01764997|565818336|FG003|Run-in Period|Lack of Efficacy|0|||
156746161|NCT01764997|565818337|FG004|Run-in Period|Lack of Efficacy|0|||
156746162|NCT01764997|565818333|FG000|Run-in Period|Poor compliance to protocol|1|||
156746163|NCT01764997|565818334|FG001|Run-in Period|Poor compliance to protocol|0|||
156746164|NCT01764997|565818335|FG002|Run-in Period|Poor compliance to protocol|0|||
156746165|NCT01764997|565818336|FG003|Run-in Period|Poor compliance to protocol|0|||
156746166|NCT01764997|565818337|FG004|Run-in Period|Poor compliance to protocol|0|||
156746167|NCT01764997|565818333|FG000|Run-in Period|Other than specified above|17|||
156746168|NCT01764997|565818334|FG001|Run-in Period|Other than specified above|0|||
156746169|NCT01764997|565818335|FG002|Run-in Period|Other than specified above|0|||
156746170|NCT01764997|565818336|FG003|Run-in Period|Other than specified above|0|||
156746171|NCT01764997|565818337|FG004|Run-in Period|Other than specified above|0|||
156746172|NCT01764997|565818333|FG000|Study Drug Treatment Period|Adverse Event|0|||
156746173|NCT01764997|565818334|FG001|Study Drug Treatment Period|Adverse Event|1|||
156746174|NCT01764997|565818335|FG002|Study Drug Treatment Period|Adverse Event|0|||
156746175|NCT01764997|565818336|FG003|Study Drug Treatment Period|Adverse Event|0|||
156746176|NCT01764997|565818337|FG004|Study Drug Treatment Period|Adverse Event|24|||
156746177|NCT01764997|565818333|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
156746178|NCT01764997|565818334|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
156746179|NCT01764997|565818335|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
156746180|NCT01764997|565818336|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
156746181|NCT01764997|565818337|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
156746182|NCT01764997|565818333|FG000|Study Drug Treatment Period|Other than specified above|0|||
156746183|NCT01764997|565818334|FG001|Study Drug Treatment Period|Other than specified above|0|||
156746184|NCT01764997|565818335|FG002|Study Drug Treatment Period|Other than specified above|0|||
156746185|NCT01764997|565818336|FG003|Study Drug Treatment Period|Other than specified above|0|||
156746186|NCT01764997|565818337|FG004|Study Drug Treatment Period|Other than specified above|10|||
156746187|NCT02227368|565819930|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
156746188|NCT02227368|565819931|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
156746189|NCT02227368|565819930|FG000|Overall Study|Lost to Follow-up|1|||
156746190|NCT02227368|565819931|FG001|Overall Study|Lost to Follow-up|0|||
156746191|NCT02227368|565819930|FG000|Overall Study|Adverse Event|1|||
156746192|NCT02227368|565819931|FG001|Overall Study|Adverse Event|0|||
156746193|NCT03046056|565819933|FG000|Overall Study|Non-responder at Week 10|6|||
156746194|NCT03046056|565819934|FG001|Overall Study|Non-responder at Week 10|6|||
156746195|NCT03046056|565819935|FG002|Overall Study|Non-responder at Week 10|4|||
156746196|NCT03046056|565819933|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
156746197|NCT03046056|565819934|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
156746198|NCT03046056|565819935|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
156746199|NCT03046056|565819933|FG000|Overall Study|Adverse Event|1|||
156746200|NCT03046056|565819934|FG001|Overall Study|Adverse Event|5|||
156746201|NCT03046056|565819935|FG002|Overall Study|Adverse Event|0|||
156746202|NCT03046056|565819933|FG000|Overall Study|Non-compliance With Study Drug|0|||
156746203|NCT03046056|565819934|FG001|Overall Study|Non-compliance With Study Drug|0|||
156746204|NCT03046056|565819935|FG002|Overall Study|Non-compliance With Study Drug|2|||
156746205|NCT03046056|565819933|FG000|Overall Study|Protocol Violation|1|||
156746206|NCT03046056|565819934|FG001|Overall Study|Protocol Violation|1|||
156746207|NCT03046056|565819935|FG002|Overall Study|Protocol Violation|0|||
156746208|NCT03046056|565819933|FG000|Overall Study|Investigator's Discretion|0|||
156746209|NCT03046056|565819934|FG001|Overall Study|Investigator's Discretion|1|||
157020694|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156746210|NCT03046056|565819935|FG002|Overall Study|Investigator's Discretion|0|||
157020695|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157143530|NCT00955110|567274205|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
156746211|NCT03046056|565819933|FG000|Overall Study|Withdrew Consent|1|||
156746212|NCT03046056|565819934|FG001|Overall Study|Withdrew Consent|0|||
156746213|NCT03046056|565819935|FG002|Overall Study|Withdrew Consent|0|||
156746214|NCT02913105|565819936|FG000|Overall Study|Adverse Event|11|||
157020696|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156746215|NCT02913105|565819937|FG001|Overall Study|Adverse Event|0|||
157020697|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156746216|NCT02913105|565819938|FG002|Overall Study|Adverse Event|4|||
156746217|NCT02913105|565819936|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156746218|NCT02913105|565819937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156746219|NCT02913105|565819938|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156746220|NCT02913105|565819936|FG000|Overall Study|Reason Not Specified|3|||
156746221|NCT02913105|565819937|FG001|Overall Study|Reason Not Specified|1|||
156746222|NCT02913105|565819938|FG002|Overall Study|Reason Not Specified|1|||
156746223|NCT02913105|565819936|FG000|Overall Study|Physician Decision|1|||
156746224|NCT02913105|565819937|FG001|Overall Study|Physician Decision|1|||
156746225|NCT02913105|565819938|FG002|Overall Study|Physician Decision|0|||
156746226|NCT02913105|565819936|FG000|Overall Study|Withdrawal by Subject|0|||
156746227|NCT02913105|565819937|FG001|Overall Study|Withdrawal by Subject|3|||
156746228|NCT02913105|565819938|FG002|Overall Study|Withdrawal by Subject|1|||
156746229|NCT05243563|565819939|FG000|Overall Study|Withdrawal by Subject|1|||
156746230|NCT05243563|565819940|FG001|Overall Study|Withdrawal by Subject|0|||
156746231|NCT05243563|565819939|FG000|Overall Study|Physician Decision|1|||
156746232|NCT05243563|565819940|FG001|Overall Study|Physician Decision|0|||
156746233|NCT01663857|565819943|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
156746234|NCT01663857|565819944|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
156746235|NCT01663857|565819945|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
156746236|NCT01663857|565819946|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
156746237|NCT01663857|565819943|FG000|Overall Study|Lost to Follow-up|0|||
156746238|NCT01663857|565819944|FG001|Overall Study|Lost to Follow-up|0|||
156746239|NCT01663857|565819945|FG002|Overall Study|Lost to Follow-up|3|||
156746240|NCT01663857|565819946|FG003|Overall Study|Lost to Follow-up|1|||
156746241|NCT01172808|565819949|FG000|Overall Study|Adverse Event|8|||
156746242|NCT01172808|565819950|FG001|Overall Study|Adverse Event|4|||
156746243|NCT01172808|565819951|FG002|Overall Study|Adverse Event|8|||
156746244|NCT01172808|565819952|FG003|Overall Study|Adverse Event|3|||
156746245|NCT01172808|565819949|FG000|Overall Study|Lack of Efficacy|1|||
156746246|NCT01172808|565819950|FG001|Overall Study|Lack of Efficacy|0|||
156746247|NCT01172808|565819951|FG002|Overall Study|Lack of Efficacy|0|||
156746248|NCT01172808|565819952|FG003|Overall Study|Lack of Efficacy|0|||
156746249|NCT01172808|565819949|FG000|Overall Study|Protocol Violation|2|||
156746250|NCT01172808|565819950|FG001|Overall Study|Protocol Violation|2|||
156746251|NCT01172808|565819951|FG002|Overall Study|Protocol Violation|2|||
156746252|NCT01172808|565819952|FG003|Overall Study|Protocol Violation|0|||
156746253|NCT01172808|565819949|FG000|Overall Study|Lost to Follow-up|0|||
156746254|NCT01172808|565819950|FG001|Overall Study|Lost to Follow-up|1|||
156746255|NCT01172808|565819951|FG002|Overall Study|Lost to Follow-up|1|||
156746256|NCT01172808|565819952|FG003|Overall Study|Lost to Follow-up|3|||
156746257|NCT01172808|565819949|FG000|Overall Study|Withdrawal by Subject|4|||
156746258|NCT01172808|565819950|FG001|Overall Study|Withdrawal by Subject|1|||
156746259|NCT01172808|565819951|FG002|Overall Study|Withdrawal by Subject|3|||
156746260|NCT01172808|565819952|FG003|Overall Study|Withdrawal by Subject|2|||
156746261|NCT01172808|565819949|FG000|Overall Study|Other|6|||
156746262|NCT01172808|565819950|FG001|Overall Study|Other|5|||
156746263|NCT01172808|565819951|FG002|Overall Study|Other|9|||
156746264|NCT01172808|565819952|FG003|Overall Study|Other|7|||
156746265|NCT00703326|565819953|FG000|Overall Study|Lost to Follow-up|47|||
156746266|NCT00703326|565819954|FG001|Overall Study|Lost to Follow-up|18|||
156746267|NCT00703326|565819953|FG000|Overall Study|Withdrawal by Subject|54|||
156746268|NCT00703326|565819954|FG001|Overall Study|Withdrawal by Subject|20|||
157143531|NCT01981187|567274206|FG000|Overall Study|Participant/guardian decision|2|||
157143532|NCT01981187|567274206|FG000|Overall Study|Physician Decision|1|||
157143533|NCT01981187|567274206|FG000|Overall Study|Disease progression|2|||
157143534|NCT01981187|567274206|FG000|Overall Study|Adverse Event|7|||
157143535|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
157143536|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
157143537|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
157143538|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
157143539|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
157143540|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
157143541|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
156746269|NCT00703326|565819953|FG000|Overall Study|Adverse Event|1|||
156746270|NCT00703326|565819954|FG001|Overall Study|Adverse Event|0|||
156746271|NCT02661061|565819956|FG000|Overall Study|Lack of Efficacy|1|||
156746272|NCT02661061|565819957|FG001|Overall Study|Lack of Efficacy|1|||
156746273|NCT02661061|565819956|FG000|Overall Study|Withdrawal by Subject|1|||
156746274|NCT02661061|565819957|FG001|Overall Study|Withdrawal by Subject|1|||
156746275|NCT02578940|565819958|FG000|Overall Study|Screening failure|5|||
156799718|NCT01215851|566021415|FG005|Follow up Period|Lost to Follow-up|1|||
156799719|NCT03510273|566021418|FG000|Overall Study|Withdrawal by Subject|2|||
156746276|NCT02578940|565819958|FG000|Overall Study|Lost to Follow-up|1|||
156746277|NCT03959488|565819967|FG000|Season 1|Other|6|||
156746278|NCT03959488|565819968|FG001|Season 1|Other|7|||
156746279|NCT03959488|565819969|FG002|Season 1|Other|0|||
156746280|NCT03959488|565819970|FG003|Season 1|Other|0|||
156746281|NCT03959488|565819971|FG004|Season 1|Other|0|||
156746282|NCT03959488|565819967|FG000|Season 1|Withdrawal by parent/guardian|43|||
156746283|NCT03959488|565819968|FG001|Season 1|Withdrawal by parent/guardian|28|||
156746284|NCT03959488|565819969|FG002|Season 1|Withdrawal by parent/guardian|0|||
156746285|NCT03959488|565819970|FG003|Season 1|Withdrawal by parent/guardian|0|||
156880092|NCT01090323|566319876|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156880093|NCT01090323|566319875|FG000|Overall Study|Condition no longer requires drug|5|||
156746286|NCT03959488|565819971|FG004|Season 1|Withdrawal by parent/guardian|0|||
156746287|NCT03959488|565819967|FG000|Season 1|Due to COVID-19 pandemic|2|||
156746288|NCT03959488|565819968|FG001|Season 1|Due to COVID-19 pandemic|3|||
156746289|NCT03959488|565819969|FG002|Season 1|Due to COVID-19 pandemic|0|||
156746290|NCT03959488|565819970|FG003|Season 1|Due to COVID-19 pandemic|0|||
156746291|NCT03959488|565819971|FG004|Season 1|Due to COVID-19 pandemic|0|||
156746292|NCT03959488|565819967|FG000|Season 1|Lost to Follow-up|17|||
156746293|NCT03959488|565819968|FG001|Season 1|Lost to Follow-up|7|||
156746294|NCT03959488|565819969|FG002|Season 1|Lost to Follow-up|0|||
156746295|NCT03959488|565819970|FG003|Season 1|Lost to Follow-up|0|||
156746296|NCT03959488|565819971|FG004|Season 1|Lost to Follow-up|0|||
156746297|NCT03959488|565819967|FG000|Season 1|Death|5|||
156746298|NCT03959488|565819968|FG001|Season 1|Death|1|||
156746299|NCT03959488|565819969|FG002|Season 1|Death|0|||
156746300|NCT03959488|565819970|FG003|Season 1|Death|0|||
156746301|NCT03959488|565819971|FG004|Season 1|Death|0|||
156746302|NCT03959488|565819967|FG000|Season 2|Other|0|||
156746303|NCT03959488|565819968|FG001|Season 2|Other|0|||
156746304|NCT03959488|565819969|FG002|Season 2|Other|2|||
156746305|NCT03959488|565819970|FG003|Season 2|Other|0|||
156746306|NCT03959488|565819971|FG004|Season 2|Other|0|||
156746307|NCT03959488|565819967|FG000|Season 2|Withdrawal by parent/guardian|0|||
156746308|NCT03959488|565819968|FG001|Season 2|Withdrawal by parent/guardian|0|||
156746309|NCT03959488|565819969|FG002|Season 2|Withdrawal by parent/guardian|3|||
156746310|NCT03959488|565819970|FG003|Season 2|Withdrawal by parent/guardian|1|||
156746311|NCT03959488|565819971|FG004|Season 2|Withdrawal by parent/guardian|1|||
156746312|NCT03959488|565819967|FG000|Season 2|Lost to Follow-up|0|||
156746313|NCT03959488|565819968|FG001|Season 2|Lost to Follow-up|0|||
156746314|NCT03959488|565819969|FG002|Season 2|Lost to Follow-up|1|||
156746315|NCT03959488|565819970|FG003|Season 2|Lost to Follow-up|0|||
156746316|NCT03959488|565819971|FG004|Season 2|Lost to Follow-up|1|||
156746317|NCT03341936|565819973|FG000|Overall Study|Ineligible|1|||
156746318|NCT03341936|565819973|FG000|Overall Study|Disease Progression|2|||
156746319|NCT03341936|565819973|FG000|Overall Study|Withdrew Consent|4|||
156746320|NCT03341936|565819973|FG000|Overall Study|Non-Compliance|1|||
156799720|NCT03510273|566021418|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
156799721|NCT03510273|566021418|FG000|Overall Study|Moved away from study area|4|||
156799722|NCT02589938|566021422|FG000|Overall Study|Withdrawal by Subject|11|||
156799723|NCT02589938|566021423|FG001|Overall Study|Withdrawal by Subject|5|||
156799724|NCT02589938|566021424|FG002|Overall Study|Withdrawal by Subject|6|||
156799725|NCT02589938|566021422|FG000|Overall Study|Lost to Follow-up|3|||
156799726|NCT02589938|566021423|FG001|Overall Study|Lost to Follow-up|3|||
156799727|NCT02589938|566021424|FG002|Overall Study|Lost to Follow-up|3|||
156799728|NCT02589938|566021422|FG000|Overall Study|Death|1|||
156799729|NCT02589938|566021423|FG001|Overall Study|Death|0|||
156799730|NCT02589938|566021424|FG002|Overall Study|Death|1|||
156799731|NCT02589938|566021422|FG000|Overall Study|Protocol Violation|6|||
156799732|NCT02589938|566021423|FG001|Overall Study|Protocol Violation|2|||
156799733|NCT02589938|566021424|FG002|Overall Study|Protocol Violation|3|||
156799734|NCT02589938|566021422|FG000|Overall Study|Physician Decision|1|||
156799735|NCT02589938|566021423|FG001|Overall Study|Physician Decision|0|||
156799736|NCT02589938|566021424|FG002|Overall Study|Physician Decision|0|||
157020698|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156746321|NCT03341936|565819973|FG000|Overall Study|Physician Decision|1|||
156746322|NCT03341936|565819973|FG000|Overall Study|Withdrawal by Subject|1|||
156746323|NCT03341936|565819973|FG000|Overall Study|Other|1|||
156746324|NCT02290925|565819976|FG000|First Period of Three Months|Lost to Follow-up|2|||
156799737|NCT02589938|566021422|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
156799738|NCT02589938|566021423|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
156799739|NCT02589938|566021424|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
157020699|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
156746325|NCT02290925|565819977|FG001|First Period of Three Months|Lost to Follow-up|1|||
156746326|NCT02290925|565819976|FG000|First Period of Three Months|Death|1|||
156746327|NCT02290925|565819977|FG001|First Period of Three Months|Death|0|||
156746328|NCT02290925|565819976|FG000|First Period of Three Months|Insulin Started|1|||
156746329|NCT02290925|565819977|FG001|First Period of Three Months|Insulin Started|1|||
156746330|NCT02290925|565819976|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
156746331|NCT02290925|565819977|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
156746332|NCT02290925|565819976|FG000|Second Period of 3 Months|insulin started|0|||
156746333|NCT02290925|565819977|FG001|Second Period of 3 Months|insulin started|1|||
156746334|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
156746335|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746336|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746337|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746338|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746339|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
156746340|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746341|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
156799740|NCT01276106|566021425|FG000|Overall Study|Adverse Event|3|||
156799741|NCT01276106|566021426|FG001|Overall Study|Adverse Event|3|||
156799742|NCT01276106|566021427|FG002|Overall Study|Adverse Event|11|||
156799743|NCT01276106|566021428|FG003|Overall Study|Adverse Event|3|||
156799744|NCT01276106|566021425|FG000|Overall Study|Withdrawal by Subject|6|||
156799745|NCT01276106|566021426|FG001|Overall Study|Withdrawal by Subject|3|||
156799746|NCT01276106|566021427|FG002|Overall Study|Withdrawal by Subject|1|||
156799747|NCT01276106|566021428|FG003|Overall Study|Withdrawal by Subject|6|||
157020700|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157143542|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
157143543|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
157143544|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
157143545|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
157143546|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
157143547|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
157143548|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
157143549|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
157143550|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
157143551|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
157143552|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
157143553|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Death|0|||
157143554|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Death|1|||
157143555|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Death|0|||
157143556|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
157143557|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
157143558|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
157143559|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
157143560|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
157143561|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
157143562|NCT00430781|567274208|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
157143563|NCT00430781|567274209|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
157143564|NCT00430781|567274210|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
157143565|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
157143566|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
157143567|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
157143568|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
157143569|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
157143570|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
157143571|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
157143572|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
157143573|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
157143574|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
157143575|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
157143576|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
157143577|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Other|0|||
157143578|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Other|1|||
157143579|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Other|0|||
157143580|NCT00430781|567274208|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
157143581|NCT00430781|567274209|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
157143582|NCT00430781|567274210|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
157143583|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
157143584|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
157143585|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
157143586|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
157143587|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
157143588|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
156746342|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
156746343|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746344|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
156799748|NCT01276106|566021425|FG000|Overall Study|Lack of Efficacy|0|||
156880094|NCT01090323|566319876|FG001|Overall Study|Condition no longer requires drug|4|||
156880095|NCT01090323|566319875|FG000|Overall Study|Protocol Violation|2|||
156746345|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746346|NCT01716520|565819978|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746347|NCT01716520|565819979|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156746348|NCT01716520|565819980|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746349|NCT01716520|565819981|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746350|NCT01716520|565819982|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746351|NCT01716520|565819983|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156746352|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746353|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
156746354|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746355|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746356|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746357|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
156746358|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746359|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746360|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746361|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746362|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156746363|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
156746364|NCT01716520|565819978|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746365|NCT01716520|565819979|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746366|NCT01716520|565819980|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
156746367|NCT01716520|565819981|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746368|NCT01716520|565819982|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
156746369|NCT01716520|565819983|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
156746370|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746371|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746372|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746373|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746374|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
156746375|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
156746376|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746377|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746378|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746379|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746380|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156746381|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156746382|NCT01716520|565819978|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746383|NCT01716520|565819979|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746384|NCT01716520|565819980|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746385|NCT01716520|565819981|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
156746386|NCT01716520|565819982|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746387|NCT01716520|565819983|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
156746388|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
156746389|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746390|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
156746391|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746392|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
156746393|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
157143589|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
156746394|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
156746395|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746396|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746397|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746398|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746399|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
156746400|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746401|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746402|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746403|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746404|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
156746405|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
156746406|NCT01716520|565819978|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
157143590|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
157143591|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
156746407|NCT01716520|565819979|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
156746408|NCT01716520|565819980|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746409|NCT01716520|565819981|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746410|NCT01716520|565819982|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746411|NCT01716520|565819983|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
156746412|NCT01716520|565819978|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746413|NCT01716520|565819979|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746414|NCT01716520|565819980|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746415|NCT01716520|565819981|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746416|NCT01716520|565819982|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156746417|NCT01716520|565819983|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
156746418|NCT01716520|565819978|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746419|NCT01716520|565819979|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746420|NCT01716520|565819980|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
156746421|NCT01716520|565819981|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746422|NCT01716520|565819982|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746423|NCT01716520|565819983|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156746424|NCT00869557|565819992|FG000|Randomized Phase|Lost to Follow-up|2|||
156746425|NCT00869557|565819993|FG001|Randomized Phase|Lost to Follow-up|1|||
156746426|NCT00869557|565819992|FG000|Randomized Phase|Investigator's Discretion|1|||
156746427|NCT00869557|565819993|FG001|Randomized Phase|Investigator's Discretion|0|||
156799749|NCT01276106|566021426|FG001|Overall Study|Lack of Efficacy|1|||
156799750|NCT01276106|566021427|FG002|Overall Study|Lack of Efficacy|0|||
156799751|NCT01276106|566021428|FG003|Overall Study|Lack of Efficacy|1|||
156799752|NCT01276106|566021425|FG000|Overall Study|Lost to Follow-up|2|||
156799753|NCT01276106|566021426|FG001|Overall Study|Lost to Follow-up|1|||
156799754|NCT01276106|566021427|FG002|Overall Study|Lost to Follow-up|1|||
156799755|NCT01276106|566021428|FG003|Overall Study|Lost to Follow-up|0|||
156799756|NCT01276106|566021425|FG000|Overall Study|Physician Decision|0|||
156799757|NCT01276106|566021426|FG001|Overall Study|Physician Decision|0|||
156799758|NCT01276106|566021427|FG002|Overall Study|Physician Decision|1|||
156799759|NCT01276106|566021428|FG003|Overall Study|Physician Decision|1|||
156799760|NCT01276106|566021425|FG000|Overall Study|Protocol Violation|1|||
156799761|NCT01276106|566021426|FG001|Overall Study|Protocol Violation|1|||
156799762|NCT01276106|566021427|FG002|Overall Study|Protocol Violation|0|||
156799763|NCT01276106|566021428|FG003|Overall Study|Protocol Violation|2|||
156799764|NCT01276106|566021425|FG000|Overall Study|Insufficient therapeutic effects|0|||
156799765|NCT01276106|566021426|FG001|Overall Study|Insufficient therapeutic effects|0|||
156799766|NCT01276106|566021427|FG002|Overall Study|Insufficient therapeutic effects|2|||
156799767|NCT01276106|566021428|FG003|Overall Study|Insufficient therapeutic effects|0|||
156799768|NCT01242514|566021431|FG000|Overall Study|e.g., project closure|1042|||
156799769|NCT01242514|566021432|FG001|Overall Study|e.g., project closure|305|||
156799770|NCT01242514|566021433|FG002|Overall Study|e.g., project closure|171|||
156799771|NCT01242514|566021431|FG000|Overall Study|Subject decision|33|||
156799772|NCT01242514|566021432|FG001|Overall Study|Subject decision|8|||
156799773|NCT01242514|566021433|FG002|Overall Study|Subject decision|2|||
156799774|NCT01242514|566021431|FG000|Overall Study|Severe non-compliance to protocol|5|||
156799775|NCT01242514|566021432|FG001|Overall Study|Severe non-compliance to protocol|2|||
156799776|NCT01242514|566021433|FG002|Overall Study|Severe non-compliance to protocol|1|||
156799777|NCT01242514|566021431|FG000|Overall Study|Lack of therapeutic response|99|||
156799778|NCT01242514|566021432|FG001|Overall Study|Lack of therapeutic response|16|||
156799779|NCT01242514|566021433|FG002|Overall Study|Lack of therapeutic response|10|||
156799780|NCT01242514|566021431|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
156799781|NCT01242514|566021432|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
156799782|NCT01242514|566021433|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
156799783|NCT01242514|566021431|FG000|Overall Study|Lost to Follow-up|14|||
156799784|NCT01242514|566021432|FG001|Overall Study|Lost to Follow-up|5|||
156799785|NCT01242514|566021433|FG002|Overall Study|Lost to Follow-up|4|||
156799786|NCT01242514|566021431|FG000|Overall Study|Adverse Event|129|||
156799787|NCT01242514|566021432|FG001|Overall Study|Adverse Event|18|||
156799788|NCT01242514|566021433|FG002|Overall Study|Adverse Event|19|||
156799789|NCT00862940|566021435|FG000|Overall Study|Adverse Event|15|||
156799790|NCT00862940|566021436|FG001|Overall Study|Adverse Event|12|||
156799791|NCT00862940|566021435|FG000|Overall Study|Lack of Efficacy|1|||
156799792|NCT00862940|566021436|FG001|Overall Study|Lack of Efficacy|3|||
156799793|NCT00862940|566021435|FG000|Overall Study|Protocol Violation|2|||
156799794|NCT00862940|566021436|FG001|Overall Study|Protocol Violation|5|||
156799795|NCT00862940|566021435|FG000|Overall Study|Withdrawal by Subject|4|||
156799796|NCT00862940|566021436|FG001|Overall Study|Withdrawal by Subject|6|||
156799797|NCT00862940|566021435|FG000|Overall Study|Non-compliance|4|||
156799798|NCT00862940|566021436|FG001|Overall Study|Non-compliance|0|||
156799799|NCT00862940|566021435|FG000|Overall Study|Lost to Follow-up|0|||
156799800|NCT00862940|566021436|FG001|Overall Study|Lost to Follow-up|1|||
156799801|NCT00862940|566021435|FG000|Overall Study|Administrative or other reason(s)|4|||
156746428|NCT00869557|565819992|FG000|Randomized Phase|Withdrew Consent|0|||
156746429|NCT00869557|565819993|FG001|Randomized Phase|Withdrew Consent|1|||
156746430|NCT00869557|565819992|FG000|Extension Phase|Adverse Event|2|||
156746431|NCT00869557|565819993|FG001|Extension Phase|Adverse Event|2|||
156746432|NCT00869557|565819992|FG000|Extension Phase|Lack of Efficacy|1|||
156746433|NCT00869557|565819993|FG001|Extension Phase|Lack of Efficacy|0|||
156746434|NCT00869557|565819992|FG000|Extension Phase|Lost to Follow-up|3|||
156746435|NCT00869557|565819993|FG001|Extension Phase|Lost to Follow-up|1|||
156746436|NCT00869557|565819992|FG000|Extension Phase|Investigator's Discretion|2|||
156746437|NCT00869557|565819993|FG001|Extension Phase|Investigator's Discretion|0|||
156746438|NCT00869557|565819992|FG000|Extension Phase|Withdrew Consent|2|||
156746439|NCT00869557|565819993|FG001|Extension Phase|Withdrew Consent|0|||
156746440|NCT02305446|565819994|FG000|Overall Study|Adverse Event|1|||
156746441|NCT02696434|565819999|FG000|Overall Study|Adverse Event|3|||
156746442|NCT02696434|565820000|FG001|Overall Study|Adverse Event|1|||
156746443|NCT02696434|565819999|FG000|Overall Study|Lost to Follow-up|5|||
156746444|NCT02696434|565820000|FG001|Overall Study|Lost to Follow-up|4|||
156746445|NCT02696434|565819999|FG000|Overall Study|Withdrawal by Subject|14|||
156746446|NCT02696434|565820000|FG001|Overall Study|Withdrawal by Subject|12|||
156746447|NCT02696434|565819999|FG000|Overall Study|Physician Decision|0|||
156746448|NCT02696434|565820000|FG001|Overall Study|Physician Decision|1|||
156746449|NCT02956057|565820010|FG000|Overall Study|Discontinued intervention|14|||
156746450|NCT02956057|565820011|FG001|Overall Study|Discontinued intervention|10|||
156746451|NCT02956057|565820012|FG002|Overall Study|Discontinued intervention|7|||
156746452|NCT02956057|565820013|FG003|Overall Study|Discontinued intervention|14|||
156746453|NCT02956057|565820014|FG004|Overall Study|Discontinued intervention|4|||
156746454|NCT02956057|565820015|FG005|Overall Study|Discontinued intervention|17|||
156746455|NCT02956057|565820010|FG000|Overall Study|Lost to Follow-up|0|||
156746456|NCT02956057|565820011|FG001|Overall Study|Lost to Follow-up|2|||
156746457|NCT02956057|565820012|FG002|Overall Study|Lost to Follow-up|1|||
156746458|NCT02956057|565820013|FG003|Overall Study|Lost to Follow-up|1|||
156746459|NCT02956057|565820014|FG004|Overall Study|Lost to Follow-up|1|||
156746460|NCT02956057|565820015|FG005|Overall Study|Lost to Follow-up|0|||
156746461|NCT01420679|565820020|FG000|Overall Study|Disease Progression|3|||
156746462|NCT01420679|565820021|FG001|Overall Study|Disease Progression|2|||
156746463|NCT01420679|565820020|FG000|Overall Study|Adverse Event|4|||
156746464|NCT01420679|565820021|FG001|Overall Study|Adverse Event|0|||
156746465|NCT01420679|565820020|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
156746466|NCT01420679|565820021|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
156746467|NCT01420679|565820020|FG000|Overall Study|Patient Decision|1|||
156746468|NCT01420679|565820021|FG001|Overall Study|Patient Decision|0|||
156746469|NCT01420679|565820020|FG000|Overall Study|Investigator Decision|1|||
156746470|NCT01420679|565820021|FG001|Overall Study|Investigator Decision|2|||
156746471|NCT01420679|565820020|FG000|Overall Study|Sponsor Decision|3|||
156746472|NCT01420679|565820021|FG001|Overall Study|Sponsor Decision|3|||
156746473|NCT01420679|565820020|FG000|Overall Study|Other|1|||
156746474|NCT01420679|565820021|FG001|Overall Study|Other|0|||
156746475|NCT03956615|565820022|FG000|Overall Study|No multiple myeloma confirmed|2|||
156746476|NCT03956615|565820022|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
156746477|NCT03956615|565820022|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
156746478|NCT03956615|565820022|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
156746479|NCT01069419|565820023|FG000|Overall Study|Adverse Event|233|||
156746480|NCT01069419|565820023|FG000|Overall Study|Lack of Efficacy|332|||
156746481|NCT01069419|565820023|FG000|Overall Study|Lost to Follow-up|49|||
156746482|NCT01069419|565820023|FG000|Overall Study|Remission of disease|11|||
156746483|NCT01069419|565820023|FG000|Overall Study|Withdrawal by Subject|34|||
156746484|NCT01069419|565820023|FG000|Overall Study|Other Reason|43|||
156799802|NCT00862940|566021436|FG001|Overall Study|Administrative or other reason(s)|3|||
156799803|NCT00787150|566021437|FG000|Overall Study|Adverse Event|4|||
156799804|NCT00787150|566021438|FG001|Overall Study|Adverse Event|4|||
156799805|NCT00787150|566021439|FG002|Overall Study|Adverse Event|4|||
156799806|NCT00787150|566021437|FG000|Overall Study|Physician Decision|1|||
156746485|NCT01069419|565820023|FG000|Overall Study|Missing termination information|13|||
156746486|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
156746487|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
156746488|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
156746489|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
156746490|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
156746491|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746492|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746493|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
156746494|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
156746495|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
156746496|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
156799807|NCT00787150|566021438|FG001|Overall Study|Physician Decision|2|||
156746497|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
156746498|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Death|0|||
157020701|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157020702|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157220499|NCT01620489|567553353|FG000|Overall Study|Withdrawal Criteria|17|||
156746499|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Death|0|||
156746500|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Death|1|||
156746501|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Death|0|||
156746502|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746503|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
156746504|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746505|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
156746506|NCT01179737|565820027|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
156746507|NCT01179737|565820028|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746508|NCT01179737|565820029|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746509|NCT01179737|565820030|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
156746510|NCT01179737|565820027|FG000|Extension|The study was terminated|3|||
156746511|NCT01179737|565820028|FG001|Extension|The study was terminated|0|||
156746512|NCT01179737|565820029|FG002|Extension|The study was terminated|0|||
156746513|NCT01179737|565820030|FG003|Extension|The study was terminated|0|||
156746514|NCT00568334|565820032|FG000|Overall Study|Withdrawal by Subject|0|||
156746515|NCT00568334|565820033|FG001|Overall Study|Withdrawal by Subject|1|||
156746516|NCT00568334|565820032|FG000|Overall Study|Lost to Follow-up|1|||
156746517|NCT00568334|565820033|FG001|Overall Study|Lost to Follow-up|0|||
156746518|NCT03217968|565820036|FG000|Overall Study|Withdrawal by Subject|4|||
156746519|NCT03217968|565820036|FG000|Overall Study|Lost to Follow-up|1|||
156746520|NCT03217968|565820036|FG000|Overall Study|Protocol Violation|6|||
156746521|NCT01904903|565820037|FG000|Overall Study|Withdrawal by Subject|1|||
156746522|NCT03677934|565820038|FG000|Overall Study|Adverse Event|1|||
156746523|NCT03677934|565820039|FG001|Overall Study|Adverse Event|1|||
156746524|NCT03677934|565820038|FG000|Overall Study|Death|8|||
156746525|NCT03677934|565820039|FG001|Overall Study|Death|4|||
156746526|NCT03677934|565820038|FG000|Overall Study|Lost to Follow-up|3|||
156746527|NCT03677934|565820039|FG001|Overall Study|Lost to Follow-up|0|||
156746528|NCT03677934|565820038|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156746529|NCT03677934|565820039|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156746530|NCT03677934|565820038|FG000|Overall Study|Physician Decision|0|||
156746531|NCT03677934|565820039|FG001|Overall Study|Physician Decision|1|||
156746532|NCT03677934|565820038|FG000|Overall Study|Withdrawal by Subject|1|||
156746533|NCT03677934|565820039|FG001|Overall Study|Withdrawal by Subject|7|||
156746534|NCT04769739|565820056|FG000|Overall Study|Colorectal cancer obstruction|2|||
156746535|NCT04769739|565820057|FG001|Overall Study|Colorectal cancer obstruction|0|||
156746536|NCT04769739|565820058|FG002|Overall Study|Colorectal cancer obstruction|0|||
156746537|NCT04769739|565820059|FG003|Overall Study|Colorectal cancer obstruction|0|||
156746538|NCT04769739|565820056|FG000|Overall Study|Failed cecal intubation|1|||
156746539|NCT04769739|565820057|FG001|Overall Study|Failed cecal intubation|0|||
156746540|NCT04769739|565820058|FG002|Overall Study|Failed cecal intubation|0|||
156746541|NCT04769739|565820059|FG003|Overall Study|Failed cecal intubation|1|||
156746542|NCT04769739|565820056|FG000|Overall Study|Poor bowel preparation|0|||
156746543|NCT04769739|565820057|FG001|Overall Study|Poor bowel preparation|0|||
156746544|NCT04769739|565820058|FG002|Overall Study|Poor bowel preparation|0|||
156746545|NCT04769739|565820059|FG003|Overall Study|Poor bowel preparation|1|||
156746546|NCT01260584|565820060|FG000|Period 1|Protocol Violation|0|||
156746547|NCT01260584|565820061|FG001|Period 1|Protocol Violation|0|||
156746548|NCT01260584|565820062|FG002|Period 1|Protocol Violation|1|||
156746549|NCT01260584|565820063|FG003|Period 1|Protocol Violation|1|||
156746550|NCT01260584|565820060|FG000|Period 1|Adverse Event|0|||
156746551|NCT01260584|565820061|FG001|Period 1|Adverse Event|0|||
156746552|NCT01260584|565820062|FG002|Period 1|Adverse Event|1|||
156746553|NCT01260584|565820063|FG003|Period 1|Adverse Event|0|||
156746554|NCT01260584|565820060|FG000|Period 2|Protocol Violation|0|||
156746555|NCT01260584|565820061|FG001|Period 2|Protocol Violation|2|||
156746556|NCT01260584|565820062|FG002|Period 2|Protocol Violation|3|||
156746557|NCT01260584|565820063|FG003|Period 2|Protocol Violation|1|||
156746558|NCT01260584|565820060|FG000|Period 2|Adverse Event|1|||
156746559|NCT01260584|565820061|FG001|Period 2|Adverse Event|0|||
156746560|NCT01260584|565820062|FG002|Period 2|Adverse Event|2|||
156746561|NCT01260584|565820063|FG003|Period 2|Adverse Event|0|||
156746562|NCT01260584|565820060|FG000|Period 2|Withdrawal by Subject|0|||
156746563|NCT01260584|565820061|FG001|Period 2|Withdrawal by Subject|1|||
156746564|NCT01260584|565820062|FG002|Period 2|Withdrawal by Subject|0|||
156746565|NCT01260584|565820063|FG003|Period 2|Withdrawal by Subject|0|||
156746566|NCT00045734|565820064|FG000|Overall Study|Protocol Violation|1|||
156746567|NCT02069093|565820065|FG000|Overall Study|Disease progression|14|||
156746568|NCT02069093|565820065|FG000|Overall Study|New cancer therapy|1|||
156746569|NCT02069093|565820065|FG000|Overall Study|Death|1|||
156746570|NCT02069093|565820065|FG000|Overall Study|Administrative problems|1|||
156746571|NCT02069093|565820065|FG000|Overall Study|Withdrawal by Subject|2|||
156746572|NCT02069093|565820065|FG000|Overall Study|Abnormal laboratory values|1|||
156746573|NCT02069093|565820065|FG000|Overall Study|Adverse Event|10|||
156880096|NCT01090323|566319876|FG001|Overall Study|Protocol Violation|1|||
156880097|NCT01090323|566319875|FG000|Overall Study|Withdrew consent|33|||
156880098|NCT01090323|566319876|FG001|Overall Study|Withdrew consent|11|||
156880099|NCT01090323|566319875|FG000|Overall Study|Lost to Follow-up|11|||
156880100|NCT01090323|566319876|FG001|Overall Study|Lost to Follow-up|6|||
156880101|NCT01090323|566319875|FG000|Overall Study|Administrative problems|6|||
156746574|NCT01634659|565820066|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
156746575|NCT01634659|565820067|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
156746576|NCT01634659|565820066|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
156746577|NCT01634659|565820067|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
156746578|NCT02079636|565820068|FG000|Overall Study|Death|2|||
156746579|NCT02079636|565820069|FG001|Overall Study|Death|1|||
156746580|NCT02079636|565820070|FG002|Overall Study|Death|0|||
156746581|NCT02079636|565820071|FG003|Overall Study|Death|5|||
156746582|NCT02079636|565820072|FG004|Overall Study|Death|1|||
156746583|NCT02079636|565820073|FG005|Overall Study|Death|2|||
156746584|NCT02079636|565820074|FG006|Overall Study|Death|1|||
156746585|NCT02079636|565820075|FG007|Overall Study|Death|0|||
156746586|NCT02079636|565820076|FG008|Overall Study|Death|0|||
156746587|NCT02079636|565820077|FG009|Overall Study|Death|0|||
156746588|NCT02079636|565820078|FG010|Overall Study|Death|0|||
156746589|NCT02079636|565820079|FG011|Overall Study|Death|1|||
156746590|NCT02079636|565820080|FG012|Overall Study|Death|1|||
156746591|NCT02079636|565820081|FG013|Overall Study|Death|0|||
156746592|NCT02079636|565820082|FG014|Overall Study|Death|2|||
156746593|NCT02079636|565820068|FG000|Overall Study|Adverse Event|1|||
156746594|NCT02079636|565820069|FG001|Overall Study|Adverse Event|1|||
156746595|NCT02079636|565820070|FG002|Overall Study|Adverse Event|0|||
156746596|NCT02079636|565820071|FG003|Overall Study|Adverse Event|1|||
156746597|NCT02079636|565820072|FG004|Overall Study|Adverse Event|1|||
156746598|NCT02079636|565820073|FG005|Overall Study|Adverse Event|2|||
156746599|NCT02079636|565820074|FG006|Overall Study|Adverse Event|0|||
156746600|NCT02079636|565820075|FG007|Overall Study|Adverse Event|0|||
156746601|NCT02079636|565820076|FG008|Overall Study|Adverse Event|0|||
156746602|NCT02079636|565820077|FG009|Overall Study|Adverse Event|0|||
156746603|NCT02079636|565820078|FG010|Overall Study|Adverse Event|0|||
156746604|NCT02079636|565820079|FG011|Overall Study|Adverse Event|0|||
156746605|NCT02079636|565820080|FG012|Overall Study|Adverse Event|0|||
156746606|NCT02079636|565820081|FG013|Overall Study|Adverse Event|0|||
156746607|NCT02079636|565820082|FG014|Overall Study|Adverse Event|0|||
156746608|NCT02079636|565820068|FG000|Overall Study|Progressive disease|0|||
156746609|NCT02079636|565820069|FG001|Overall Study|Progressive disease|0|||
156746610|NCT02079636|565820070|FG002|Overall Study|Progressive disease|0|||
156746611|NCT02079636|565820071|FG003|Overall Study|Progressive disease|2|||
156746612|NCT02079636|565820072|FG004|Overall Study|Progressive disease|0|||
156746613|NCT02079636|565820073|FG005|Overall Study|Progressive disease|0|||
156746614|NCT02079636|565820074|FG006|Overall Study|Progressive disease|0|||
156746615|NCT02079636|565820075|FG007|Overall Study|Progressive disease|0|||
156746616|NCT02079636|565820076|FG008|Overall Study|Progressive disease|0|||
156746617|NCT02079636|565820077|FG009|Overall Study|Progressive disease|0|||
156746618|NCT02079636|565820078|FG010|Overall Study|Progressive disease|0|||
156746619|NCT02079636|565820079|FG011|Overall Study|Progressive disease|0|||
156746620|NCT02079636|565820080|FG012|Overall Study|Progressive disease|1|||
156746621|NCT02079636|565820081|FG013|Overall Study|Progressive disease|0|||
156746622|NCT02079636|565820082|FG014|Overall Study|Progressive disease|0|||
156746623|NCT02079636|565820068|FG000|Overall Study|Withdrawal by Subject|0|||
156746624|NCT02079636|565820069|FG001|Overall Study|Withdrawal by Subject|0|||
156746625|NCT02079636|565820070|FG002|Overall Study|Withdrawal by Subject|0|||
156746626|NCT02079636|565820071|FG003|Overall Study|Withdrawal by Subject|4|||
156746627|NCT02079636|565820072|FG004|Overall Study|Withdrawal by Subject|0|||
156746628|NCT02079636|565820073|FG005|Overall Study|Withdrawal by Subject|1|||
156746629|NCT02079636|565820074|FG006|Overall Study|Withdrawal by Subject|0|||
156746630|NCT02079636|565820075|FG007|Overall Study|Withdrawal by Subject|0|||
157143592|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
157143593|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
156746631|NCT02079636|565820076|FG008|Overall Study|Withdrawal by Subject|0|||
156746632|NCT02079636|565820077|FG009|Overall Study|Withdrawal by Subject|2|||
156746633|NCT02079636|565820078|FG010|Overall Study|Withdrawal by Subject|1|||
156746634|NCT02079636|565820079|FG011|Overall Study|Withdrawal by Subject|1|||
156746635|NCT02079636|565820080|FG012|Overall Study|Withdrawal by Subject|1|||
156746636|NCT02079636|565820081|FG013|Overall Study|Withdrawal by Subject|0|||
156746637|NCT02079636|565820082|FG014|Overall Study|Withdrawal by Subject|2|||
156746638|NCT02079636|565820068|FG000|Overall Study|Physician Decision|0|||
156746639|NCT02079636|565820069|FG001|Overall Study|Physician Decision|0|||
156746640|NCT02079636|565820070|FG002|Overall Study|Physician Decision|0|||
156746641|NCT02079636|565820071|FG003|Overall Study|Physician Decision|0|||
156880102|NCT01090323|566319876|FG001|Overall Study|Administrative problems|4|||
156880103|NCT01090323|566319875|FG000|Overall Study|Death|1|||
157143594|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
157220500|NCT01620489|567553354|FG001|Overall Study|Withdrawal Criteria|25|||
157220501|NCT01620489|567553353|FG000|Overall Study|Unclassified|1|||
157220502|NCT01620489|567553354|FG001|Overall Study|Unclassified|2|||
157220503|NCT01102777|567553355|FG000|Overall Study|Death|2|||
157220504|NCT01102777|567553356|FG001|Overall Study|Death|6|||
157220505|NCT01102777|567553355|FG000|Overall Study|Lost to Follow-up|7|||
157020703|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157220506|NCT01102777|567553356|FG001|Overall Study|Lost to Follow-up|10|||
157220507|NCT01875445|567553357|FG000|Overall Study|Lost to Follow-up|5|||
157220508|NCT01875445|567553358|FG001|Overall Study|Lost to Follow-up|0|||
157220509|NCT01875445|567553357|FG000|Overall Study|Withdrawal by Subject|2|||
157220510|NCT01875445|567553358|FG001|Overall Study|Withdrawal by Subject|0|||
157220511|NCT00593333|567553363|FG000|Overall Study|Lost to Follow-up|10|||
157220512|NCT00593333|567553364|FG001|Overall Study|Lost to Follow-up|11|||
157220513|NCT00210626|567553365|FG000|Overall Study|Adverse Event|1|||
157220514|NCT00210626|567553366|FG001|Overall Study|Adverse Event|2|||
157220515|NCT00210626|567553365|FG000|Overall Study|Protocol Violation|1|||
157220516|NCT00210626|567553366|FG001|Overall Study|Protocol Violation|5|||
157220517|NCT00210626|567553365|FG000|Overall Study|Lost to Follow-up|11|||
157220518|NCT00210626|567553366|FG001|Overall Study|Lost to Follow-up|11|||
157220519|NCT00210626|567553365|FG000|Overall Study|Death|1|||
157220520|NCT00210626|567553366|FG001|Overall Study|Death|0|||
157220521|NCT00210626|567553365|FG000|Overall Study|Withdrawal by Subject|29|||
157220522|NCT00210626|567553366|FG001|Overall Study|Withdrawal by Subject|20|||
157220523|NCT00210626|567553365|FG000|Overall Study|Physician Decision|0|||
157220524|NCT00210626|567553366|FG001|Overall Study|Physician Decision|2|||
157220525|NCT00210626|567553365|FG000|Overall Study|Sponser Request|1|||
157220526|NCT00210626|567553366|FG001|Overall Study|Sponser Request|0|||
157220527|NCT00210626|567553365|FG000|Overall Study|Other|4|||
157220528|NCT00210626|567553366|FG001|Overall Study|Other|5|||
157220529|NCT01121900|567553367|FG000|First Intervention Period|Adverse Event|1|||
157220530|NCT01121900|567553368|FG001|First Intervention Period|Adverse Event|1|||
157220531|NCT01121900|567553367|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
157220532|NCT01121900|567553368|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
157220533|NCT03469271|567553369|FG000|Overall Study|Withdrawal by Subject|2|||
157220534|NCT03469271|567553370|FG001|Overall Study|Withdrawal by Subject|0|||
157220535|NCT03469271|567553371|FG002|Overall Study|Withdrawal by Subject|0|||
157020704|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157220536|NCT03469271|567553372|FG003|Overall Study|Withdrawal by Subject|1|||
157220537|NCT01328054|567553375|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
157220538|NCT01328054|567553376|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
156799808|NCT00787150|566021439|FG002|Overall Study|Physician Decision|1|||
156799809|NCT00787150|566021437|FG000|Overall Study|Withdrawal by Subject|2|||
156799810|NCT00787150|566021438|FG001|Overall Study|Withdrawal by Subject|1|||
156799811|NCT00787150|566021439|FG002|Overall Study|Withdrawal by Subject|0|||
156799812|NCT00787150|566021437|FG000|Overall Study|Dosing incorrect study durg|2|||
156799813|NCT00787150|566021438|FG001|Overall Study|Dosing incorrect study durg|0|||
156799814|NCT00787150|566021439|FG002|Overall Study|Dosing incorrect study durg|0|||
156799815|NCT00879398|566021442|FG000|Overall Study|Visit Stop|399|||
156799816|NCT00879398|566021442|FG000|Overall Study|Lack of Efficacy|64|||
156799817|NCT00879398|566021442|FG000|Overall Study|Adverse Event|41|||
156799818|NCT00879398|566021442|FG000|Overall Study|Other Reasons|171|||
156799819|NCT01121757|566021450|FG000|First Drug|Death|1|||
156799820|NCT01121757|566021451|FG001|First Drug|Death|0|||
156799821|NCT01121757|566021450|FG000|First Drug|Disease Progression|0|||
156799822|NCT01121757|566021451|FG001|First Drug|Disease Progression|2|||
156799823|NCT01121757|566021450|FG000|Combination|Physician Decision|0|||
156799824|NCT01121757|566021451|FG001|Combination|Physician Decision|1|||
156799825|NCT01121757|566021450|FG000|Combination|Disease Progression|2|||
156799826|NCT01121757|566021451|FG001|Combination|Disease Progression|0|||
156799827|NCT03773484|566021452|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
156799828|NCT04222673|566021453|FG000|Overall Study|Lost to Follow-up|5|||
156799829|NCT04398706|566021464|FG000|Overall Study|Adverse Event|0|||
156799830|NCT04398706|566021465|FG001|Overall Study|Adverse Event|0|||
156799831|NCT04398706|566021466|FG002|Overall Study|Adverse Event|0|||
156799832|NCT04398706|566021467|FG003|Overall Study|Adverse Event|0|||
156799833|NCT04398706|566021468|FG004|Overall Study|Adverse Event|0|||
156799834|NCT04398706|566021469|FG005|Overall Study|Adverse Event|1|||
156799835|NCT04398706|566021470|FG006|Overall Study|Adverse Event|1|||
156799836|NCT04398706|566021471|FG007|Overall Study|Adverse Event|0|||
156799837|NCT04398706|566021464|FG000|Overall Study|Lost to Follow-up|0|||
156799838|NCT04398706|566021465|FG001|Overall Study|Lost to Follow-up|1|||
156799839|NCT04398706|566021466|FG002|Overall Study|Lost to Follow-up|2|||
157220539|NCT01328054|567553375|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
157220540|NCT01328054|567553376|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
157220541|NCT01328054|567553375|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
157220542|NCT01328054|567553376|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
157220543|NCT03361956|567553377|FG000|Overall Study|Adverse Event|1|||
156880104|NCT01090323|566319876|FG001|Overall Study|Death|2|||
156880105|NCT01090323|566319875|FG000|Overall Study|Stopped end of core|7|||
156880106|NCT01090323|566319876|FG001|Overall Study|Stopped end of core|0|||
156880107|NCT01090323|566319875|FG000|Overall Study|Stopped end of extension 1#|3|||
156880108|NCT01090323|566319876|FG001|Overall Study|Stopped end of extension 1#|1|||
156880109|NCT05498701|566319877|FG000|Period 3|Adverse Event|1|||
156880110|NCT05498701|566319878|FG001|Period 3|Adverse Event|0|||
156880111|NCT02424578|566319879|FG000|Overall Study|Withdrawal by Subject|0|||
156880112|NCT02424578|566319880|FG001|Overall Study|Withdrawal by Subject|1|||
156880113|NCT00862082|566319881|FG000|Overall Study|Sponsor decision to terminate the study|5|||
156880114|NCT00862082|566319882|FG001|Overall Study|Sponsor decision to terminate the study|0|||
156880115|NCT00862082|566319881|FG000|Overall Study|Withdrawal by Subject|0|||
156880116|NCT00862082|566319882|FG001|Overall Study|Withdrawal by Subject|1|||
156880117|NCT03091348|566319893|FG000|Overall Study|Lost to Follow-up|2|||
156880118|NCT03091348|566319894|FG001|Overall Study|Lost to Follow-up|1|||
156880119|NCT04534686|566319895|FG000|Baseline Measurement|Lost to Follow-up|4|||
156880120|NCT04534686|566319896|FG001|Baseline Measurement|Lost to Follow-up|6|||
156880121|NCT04534686|566319895|FG000|Baseline Measurement|Withdrawal by Subject|3|||
156880122|NCT04534686|566319896|FG001|Baseline Measurement|Withdrawal by Subject|1|||
156880123|NCT04534686|566319895|FG000|Intervention|Withdrawal by Subject|2|||
156880124|NCT04534686|566319896|FG001|Intervention|Withdrawal by Subject|2|||
156880125|NCT03179605|566319897|FG000|Overall Study|Withdrawal by Subject|1|||
156880126|NCT00635999|566319898|FG000|Overall Study|Withdrawal by Subject|4|||
156880127|NCT00635999|566319899|FG001|Overall Study|Withdrawal by Subject|2|||
156880128|NCT00635999|566319900|FG002|Overall Study|Withdrawal by Subject|1|||
156880129|NCT00711477|566319901|FG000|Overall Study|Adverse Event|3|||
156880130|NCT00711477|566319902|FG001|Overall Study|Adverse Event|1|||
156880131|NCT00711477|566319901|FG000|Overall Study|Lost to Follow-up|0|||
156880132|NCT00711477|566319902|FG001|Overall Study|Lost to Follow-up|1|||
156880133|NCT00711477|566319901|FG000|Overall Study|Noncompliance|0|||
156880134|NCT00711477|566319902|FG001|Overall Study|Noncompliance|1|||
156880135|NCT01396070|566319903|FG000|Overall Study|Withdrawal by Subject|2|||
156880136|NCT01396070|566319903|FG000|Overall Study|Death|2|||
156880137|NCT01396070|566319903|FG000|Overall Study|Adverse Event|8|||
156880138|NCT01396070|566319903|FG000|Overall Study|Physician Decision|3|||
156880139|NCT01396070|566319903|FG000|Overall Study|Lack of Efficacy|4|||
156880140|NCT04254913|566319905|FG000|Overall Study|Adverse Event|1|||
156880141|NCT02636361|566319906|FG000|Period 4|Physician Decision|0|||
156880142|NCT02636361|566319907|FG001|Period 4|Physician Decision|0|||
156880143|NCT02636361|566319908|FG002|Period 4|Physician Decision|0|||
156880144|NCT02636361|566319909|FG003|Period 4|Physician Decision|1|||
156880145|NCT02636361|566319910|FG004|Period 4|Physician Decision|0|||
156880146|NCT01396057|566319911|FG000|Overall Study|Adverse Event|2|||
156880147|NCT01396057|566319912|FG001|Overall Study|Adverse Event|6|||
156880148|NCT01396057|566319911|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156880149|NCT01396057|566319912|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156880150|NCT01396057|566319911|FG000|Overall Study|Protocol deviation|4|||
156880151|NCT01396057|566319912|FG001|Overall Study|Protocol deviation|4|||
156880152|NCT01396057|566319911|FG000|Overall Study|Consent withdrawn|3|||
156880153|NCT01396057|566319912|FG001|Overall Study|Consent withdrawn|2|||
156880154|NCT03037580|566319919|FG000|Overall Study|Withdrawal by Subject|3|||
156880155|NCT03037580|566319920|FG001|Overall Study|Withdrawal by Subject|0|||
156746642|NCT02079636|565820072|FG004|Overall Study|Physician Decision|0|||
156746643|NCT02079636|565820073|FG005|Overall Study|Physician Decision|1|||
156746644|NCT02079636|565820074|FG006|Overall Study|Physician Decision|0|||
156746645|NCT02079636|565820075|FG007|Overall Study|Physician Decision|0|||
156746646|NCT02079636|565820076|FG008|Overall Study|Physician Decision|0|||
156746647|NCT02079636|565820077|FG009|Overall Study|Physician Decision|1|||
156880156|NCT03037580|566319919|FG000|Overall Study|Adverse Event|1|||
156880157|NCT03037580|566319920|FG001|Overall Study|Adverse Event|0|||
156880158|NCT03037580|566319919|FG000|Overall Study|Study Terminated by Sponsor|12|||
156880159|NCT03037580|566319920|FG001|Overall Study|Study Terminated by Sponsor|15|||
156880160|NCT03037580|566319919|FG000|Overall Study|Death|0|||
156880161|NCT03037580|566319920|FG001|Overall Study|Death|1|||
156880162|NCT02036853|566319923|FG000|Overall Study|Adverse Event|0|||
156880163|NCT02036853|566319924|FG001|Overall Study|Adverse Event|2|||
156880164|NCT02036853|566319923|FG000|Overall Study|Lack of Efficacy|0|||
156880165|NCT02036853|566319924|FG001|Overall Study|Lack of Efficacy|2|||
156880166|NCT02036853|566319923|FG000|Overall Study|Physician Decision|0|||
156880167|NCT02036853|566319924|FG001|Overall Study|Physician Decision|1|||
156880168|NCT02036853|566319923|FG000|Overall Study|Withdrawal by Subject|0|||
156880169|NCT02036853|566319924|FG001|Overall Study|Withdrawal by Subject|1|||
156880170|NCT00228553|566319925|FG000|Overall Study|Adverse Event|112|||
156880171|NCT00228553|566319925|FG000|Overall Study|Lack of Efficacy|34|||
156746648|NCT02079636|565820078|FG010|Overall Study|Physician Decision|1|||
156880172|NCT00228553|566319925|FG000|Overall Study|Lost to Follow-up|67|||
156880173|NCT00228553|566319925|FG000|Overall Study|Physician Decision|48|||
156880174|NCT00228553|566319925|FG000|Overall Study|Protocol Violation|6|||
156880175|NCT00228553|566319925|FG000|Overall Study|Withdrawal by Subject|115|||
156746649|NCT02079636|565820079|FG011|Overall Study|Physician Decision|0|||
156746650|NCT02079636|565820080|FG012|Overall Study|Physician Decision|0|||
156746651|NCT02079636|565820081|FG013|Overall Study|Physician Decision|0|||
157020705|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157020706|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156746652|NCT02079636|565820082|FG014|Overall Study|Physician Decision|1|||
156880176|NCT00228553|566319925|FG000|Overall Study|Pregnancy|2|||
156880177|NCT00228553|566319925|FG000|Overall Study|Miscellaneous|46|||
156880178|NCT03500224|566319929|FG000|Overall Study|Withdrawal by Subject|2|||
156880179|NCT01324401|566319930|FG000|Overall Study|Withdrawn before any treatment|0|||
156880180|NCT01324401|566319931|FG001|Overall Study|Withdrawn before any treatment|3|||
156880181|NCT01324401|566319930|FG000|Overall Study|Adverse Event|1|||
156880182|NCT01324401|566319931|FG001|Overall Study|Adverse Event|3|||
156880183|NCT00335764|566319932|FG000|Overall Study|wrong histology|1|||
156880184|NCT00335764|566319933|FG001|Overall Study|wrong histology|0|||
156880185|NCT00335764|566319934|FG002|Overall Study|wrong histology|0|||
156880186|NCT00335764|566319935|FG003|Overall Study|wrong histology|0|||
156880187|NCT00335764|566319936|FG004|Overall Study|wrong histology|1|||
156880188|NCT02873429|566319939|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
156880189|NCT02873429|566319940|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
156880190|NCT02873429|566319939|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
156880191|NCT02873429|566319940|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
156880192|NCT02873429|566319939|FG000|16 Weeks|Lost to Follow-up|3|||
156880193|NCT02873429|566319940|FG001|16 Weeks|Lost to Follow-up|0|||
156880194|NCT00744042|566319941|FG000|Overall Study|Withdrawal by Subject|1|||
156880195|NCT00853567|566319942|FG000|Overall Study|Study prematurely terminated|71|||
156880196|NCT02252939|566319946|FG000|Overall Study|Lost to Follow-up|3|||
156880197|NCT01033448|566319947|FG000|Overall Study|Withdrawal by Subject|4|||
156746653|NCT02079636|565820068|FG000|Overall Study|Lost to Follow-up|0|||
156746654|NCT02079636|565820069|FG001|Overall Study|Lost to Follow-up|0|||
156746655|NCT02079636|565820070|FG002|Overall Study|Lost to Follow-up|0|||
156746656|NCT02079636|565820071|FG003|Overall Study|Lost to Follow-up|0|||
156746657|NCT02079636|565820072|FG004|Overall Study|Lost to Follow-up|0|||
156746658|NCT02079636|565820073|FG005|Overall Study|Lost to Follow-up|0|||
156746659|NCT02079636|565820074|FG006|Overall Study|Lost to Follow-up|0|||
156746660|NCT02079636|565820075|FG007|Overall Study|Lost to Follow-up|1|||
156746661|NCT02079636|565820076|FG008|Overall Study|Lost to Follow-up|0|||
156746662|NCT02079636|565820077|FG009|Overall Study|Lost to Follow-up|0|||
156746663|NCT02079636|565820078|FG010|Overall Study|Lost to Follow-up|0|||
156746664|NCT02079636|565820079|FG011|Overall Study|Lost to Follow-up|0|||
156746665|NCT02079636|565820080|FG012|Overall Study|Lost to Follow-up|0|||
156746666|NCT02079636|565820081|FG013|Overall Study|Lost to Follow-up|0|||
156746667|NCT02079636|565820082|FG014|Overall Study|Lost to Follow-up|0|||
156746668|NCT00561470|565820083|FG000|Overall Study|Adverse Event|74|||
156746669|NCT00561470|565820084|FG001|Overall Study|Adverse Event|163|||
156746670|NCT00561470|565820083|FG000|Overall Study|Disease progression|437|||
156746671|NCT00561470|565820084|FG001|Overall Study|Disease progression|305|||
156746672|NCT00561470|565820083|FG000|Overall Study|poor compliance to protocol|4|||
156799840|NCT04398706|566021467|FG003|Overall Study|Lost to Follow-up|1|||
156799841|NCT04398706|566021468|FG004|Overall Study|Lost to Follow-up|6|||
156799842|NCT04398706|566021469|FG005|Overall Study|Lost to Follow-up|3|||
156799843|NCT04398706|566021470|FG006|Overall Study|Lost to Follow-up|8|||
156799844|NCT04398706|566021471|FG007|Overall Study|Lost to Follow-up|2|||
156799845|NCT04398706|566021464|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156799846|NCT04398706|566021465|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156799847|NCT04398706|566021466|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156799848|NCT04398706|566021467|FG003|Overall Study|Withdrawal by parent/guardian|2|||
156799849|NCT04398706|566021468|FG004|Overall Study|Withdrawal by parent/guardian|19|||
156799850|NCT04398706|566021469|FG005|Overall Study|Withdrawal by parent/guardian|23|||
156799851|NCT04398706|566021470|FG006|Overall Study|Withdrawal by parent/guardian|13|||
156799852|NCT04398706|566021471|FG007|Overall Study|Withdrawal by parent/guardian|11|||
156799853|NCT04398706|566021464|FG000|Overall Study|Protocol deviation|0|||
156880198|NCT01033448|566319947|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
156880199|NCT01033448|566319947|FG000|Overall Study|Lost to Follow-up|3|||
157020707|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157020708|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
156799854|NCT04398706|566021465|FG001|Overall Study|Protocol deviation|1|||
156799855|NCT04398706|566021466|FG002|Overall Study|Protocol deviation|0|||
156799856|NCT04398706|566021467|FG003|Overall Study|Protocol deviation|0|||
156880200|NCT01033448|566319947|FG000|Overall Study|Withdrew due to other reasons|3|||
156746673|NCT00561470|565820084|FG001|Overall Study|poor compliance to protocol|4|||
156746674|NCT00561470|565820083|FG000|Overall Study|Lost to Follow-up|2|||
156746675|NCT00561470|565820084|FG001|Overall Study|Lost to Follow-up|0|||
156746676|NCT00561470|565820083|FG000|Overall Study|Physician Decision|21|||
156746677|NCT00561470|565820084|FG001|Overall Study|Physician Decision|20|||
156746678|NCT00561470|565820083|FG000|Overall Study|Consent Withdrawn|2|||
156746679|NCT00561470|565820084|FG001|Overall Study|Consent Withdrawn|6|||
156799857|NCT04398706|566021468|FG004|Overall Study|Protocol deviation|6|||
156799858|NCT04398706|566021469|FG005|Overall Study|Protocol deviation|4|||
156799859|NCT04398706|566021470|FG006|Overall Study|Protocol deviation|6|||
156799860|NCT04398706|566021471|FG007|Overall Study|Protocol deviation|3|||
156799861|NCT04116853|566021472|FG000|Overall Study|Adverse Event|1|||
156799862|NCT04116853|566021473|FG001|Overall Study|Adverse Event|3|||
156799863|NCT04116853|566021472|FG000|Overall Study|Lost to Follow-up|2|||
156799864|NCT04116853|566021473|FG001|Overall Study|Lost to Follow-up|0|||
156799865|NCT04116853|566021472|FG000|Overall Study|Incarceration|0|||
156799866|NCT04116853|566021473|FG001|Overall Study|Incarceration|1|||
156799867|NCT04116853|566021472|FG000|Overall Study|Pregnancy|1|||
156799868|NCT04116853|566021473|FG001|Overall Study|Pregnancy|1|||
156799869|NCT04116853|566021472|FG000|Overall Study|Began Other Weight Loss program|4|||
156799870|NCT04116853|566021473|FG001|Overall Study|Began Other Weight Loss program|8|||
156799871|NCT04116853|566021472|FG000|Overall Study|Began Anti-Obesity Medication|3|||
156799872|NCT04116853|566021473|FG001|Overall Study|Began Anti-Obesity Medication|3|||
156799873|NCT04116853|566021472|FG000|Overall Study|Protocol Violation|0|||
156799874|NCT04116853|566021473|FG001|Overall Study|Protocol Violation|1|||
156799875|NCT04522973|566021475|FG000|Overall Study|Lost to Follow-up|4|||
156799876|NCT04522973|566021475|FG000|Overall Study|Could not adhere to study schedule|1|||
156799877|NCT04696146|566023288|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
156799878|NCT04696146|566023289|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
156799879|NCT04696146|566023288|FG000|Overall Study|Off hours issue with product|1|||
156799880|NCT04696146|566023289|FG001|Overall Study|Off hours issue with product|0|||
156799881|NCT03021486|566023291|FG000|Overall Study|Withdrawal by Subject|1|||
156799882|NCT03021486|566023292|FG001|Overall Study|Withdrawal by Subject|1|||
156799883|NCT03021486|566023293|FG002|Overall Study|Withdrawal by Subject|3|||
156799884|NCT03021486|566023291|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
156799885|NCT03021486|566023292|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
156799886|NCT03021486|566023293|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
156799887|NCT04043286|566023294|FG000|Overall Study|Withdrawal by Subject|2|||
156799888|NCT04043286|566023295|FG001|Overall Study|Withdrawal by Subject|2|||
156799889|NCT01276704|566023301|FG000|Overall Study|Lost to Follow-up|2|||
156799890|NCT01276704|566023302|FG001|Overall Study|Lost to Follow-up|3|||
156799891|NCT01276704|566023301|FG000|Overall Study|Non-compliant|2|||
156799892|NCT01276704|566023302|FG001|Overall Study|Non-compliant|2|||
156799893|NCT01276704|566023301|FG000|Overall Study|Withdrawal by Subject|7|||
156799894|NCT01276704|566023302|FG001|Overall Study|Withdrawal by Subject|1|||
156799895|NCT01276704|566023301|FG000|Overall Study|Physician Decision|3|||
156799896|NCT01276704|566023302|FG001|Overall Study|Physician Decision|5|||
156799897|NCT03728933|566023303|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156799898|NCT03728933|566023304|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156799899|NCT03728933|566023305|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156799900|NCT03728933|566023303|FG000|Overall Study|Withdrawal by Subject|0|||
156799901|NCT03728933|566023304|FG001|Overall Study|Withdrawal by Subject|0|||
156799902|NCT03728933|566023305|FG002|Overall Study|Withdrawal by Subject|1|||
156799903|NCT03728933|566023303|FG000|Overall Study|Lost to Follow-up|0|||
156799904|NCT03728933|566023304|FG001|Overall Study|Lost to Follow-up|1|||
156799905|NCT03728933|566023305|FG002|Overall Study|Lost to Follow-up|0|||
156799906|NCT03728933|566023303|FG000|Overall Study|Adverse Event|1|||
156799907|NCT03728933|566023304|FG001|Overall Study|Adverse Event|0|||
156799908|NCT03728933|566023305|FG002|Overall Study|Adverse Event|0|||
156799909|NCT03674281|566023306|FG000|Overall Study|screen failure|2|||
156799910|NCT03674281|566023307|FG001|Overall Study|screen failure|0|||
156799911|NCT03674281|566023308|FG002|Overall Study|screen failure|0|||
156799912|NCT03674281|566023306|FG000|Overall Study|Withdrawal by Subject|1|||
156799913|NCT03674281|566023307|FG001|Overall Study|Withdrawal by Subject|3|||
156799914|NCT03674281|566023308|FG002|Overall Study|Withdrawal by Subject|3|||
156799915|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
156799916|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
156799917|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
156799918|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
156799919|NCT01441960|566023309|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
156799920|NCT01441960|566023310|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
156799921|NCT00276419|566023314|FG000|First Intervention|Adverse Event|1|||
156799922|NCT00276419|566023315|FG001|First Intervention|Adverse Event|0|||
156799923|NCT00276419|566023314|FG000|First Intervention|Withdrawal by Subject|0|||
156799924|NCT00276419|566023315|FG001|First Intervention|Withdrawal by Subject|2|||
156799925|NCT03186638|566023316|FG000|Overall Study|Withdrawal by Subject|4|||
156799926|NCT03186638|566023317|FG001|Overall Study|Withdrawal by Subject|4|||
156799927|NCT03186638|566023316|FG000|Overall Study|Withdrawn due to medical problem|3|||
156799928|NCT03186638|566023317|FG001|Overall Study|Withdrawn due to medical problem|2|||
156880201|NCT01033448|566319947|FG000|Overall Study|Unknown disposition|1|||
156880202|NCT02560025|566319948|FG000|Overall Study|Ineligible after consent/ registration|3|||
156880203|NCT02745080|566319953|FG000|Overall Study|Adverse Event|13|||
156880204|NCT02745080|566319954|FG001|Overall Study|Adverse Event|21|||
156880205|NCT02745080|566319953|FG000|Overall Study|Lack of Efficacy|11|||
156880206|NCT02745080|566319954|FG001|Overall Study|Lack of Efficacy|23|||
156799929|NCT03186638|566023316|FG000|Overall Study|Lost to Follow-up|1|||
156880207|NCT02745080|566319953|FG000|Overall Study|Lost to Follow-up|3|||
156880208|NCT02745080|566319954|FG001|Overall Study|Lost to Follow-up|3|||
156880209|NCT02745080|566319953|FG000|Overall Study|Physician Decision|3|||
156880210|NCT02745080|566319954|FG001|Overall Study|Physician Decision|0|||
156880211|NCT02745080|566319953|FG000|Overall Study|Protocol Violation|3|||
156880212|NCT02745080|566319954|FG001|Overall Study|Protocol Violation|1|||
156880213|NCT02745080|566319953|FG000|Overall Study|Withdrawal by Subject|22|||
156880214|NCT02745080|566319954|FG001|Overall Study|Withdrawal by Subject|41|||
156880215|NCT04237116|566319956|FG000|Overall Study|Adverse Event|0|||
156880216|NCT04237116|566319957|FG001|Overall Study|Adverse Event|1|||
156880217|NCT04237116|566319956|FG000|Overall Study|Study terminated by Sponsor|4|||
156880218|NCT04237116|566319957|FG001|Overall Study|Study terminated by Sponsor|1|||
156880219|NCT01821560|566319958|FG000|Overall Study|Lost to Follow-up|5|||
156880220|NCT01821560|566319959|FG001|Overall Study|Lost to Follow-up|5|||
156880221|NCT01821560|566319958|FG000|Overall Study|Withdrawal by Subject|1|||
156880222|NCT01821560|566319959|FG001|Overall Study|Withdrawal by Subject|1|||
156880223|NCT01821560|566319958|FG000|Overall Study|Protocol Violation|0|||
156880224|NCT01821560|566319959|FG001|Overall Study|Protocol Violation|1|||
156880225|NCT03338959|566321213|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
156880226|NCT03338959|566321213|FG000|Overall Study|Physician Decision|1|||
156799930|NCT03186638|566023317|FG001|Overall Study|Lost to Follow-up|0|||
156799931|NCT03801525|566023318|FG000|Overall Study|Adverse Event|17|||
156799932|NCT03801525|566023319|FG001|Overall Study|Adverse Event|1|||
156799933|NCT03801525|566023320|FG002|Overall Study|Adverse Event|0|||
156799934|NCT03801525|566023318|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
156799935|NCT03801525|566023319|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
156799936|NCT03801525|566023320|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
156799937|NCT03801525|566023318|FG000|Overall Study|Death|29|||
156799938|NCT03801525|566023319|FG001|Overall Study|Death|1|||
156799939|NCT03801525|566023320|FG002|Overall Study|Death|4|||
156799940|NCT03801525|566023318|FG000|Overall Study|Disease Progression|6|||
156799941|NCT03801525|566023319|FG001|Overall Study|Disease Progression|0|||
156799942|NCT03801525|566023320|FG002|Overall Study|Disease Progression|1|||
156799943|NCT03801525|566023318|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
156799944|NCT03801525|566023319|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
156799945|NCT03801525|566023320|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
156799946|NCT03801525|566023318|FG000|Overall Study|Investigator Decision|18|||
156799947|NCT03801525|566023319|FG001|Overall Study|Investigator Decision|1|||
156799948|NCT03801525|566023320|FG002|Overall Study|Investigator Decision|0|||
156799949|NCT03801525|566023318|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
156799950|NCT03801525|566023319|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
156799951|NCT03801525|566023320|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
156799952|NCT03801525|566023318|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
156799953|NCT03801525|566023319|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
156799954|NCT03801525|566023320|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
156799955|NCT03801525|566023318|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
156799956|NCT03801525|566023319|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
156799957|NCT03801525|566023320|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
156799958|NCT03801525|566023318|FG000|Overall Study|Withdrawal of Subject Consent|38|||
156799959|NCT03801525|566023319|FG001|Overall Study|Withdrawal of Subject Consent|2|||
156799960|NCT03801525|566023320|FG002|Overall Study|Withdrawal of Subject Consent|1|||
156799961|NCT03801525|566023318|FG000|Overall Study|Reason not Specified|4|||
156799962|NCT03801525|566023319|FG001|Overall Study|Reason not Specified|0|||
156799963|NCT03801525|566023320|FG002|Overall Study|Reason not Specified|4|||
156880227|NCT02184455|566321216|FG000|Overall Study|Lost to Follow-up|1|||
156880228|NCT02894502|566321219|FG000|Baseline|Withdrawal by Subject|24|||
156880229|NCT02894502|566321220|FG001|Baseline|Withdrawal by Subject|31|||
156799964|NCT01263119|566023321|FG000|Period 1|Protocol Violation|2|||
156799965|NCT01263119|566023321|FG000|Period 2|Adverse Event|2|||
156799966|NCT05201807|566023325|FG000|Overall Study|Adverse Event|1|||
156799967|NCT05201807|566023325|FG000|Overall Study|COVID-19 Related|1|||
156799968|NCT01029535|566023328|FG000|Overall Study|Lost to Follow-up|24|||
156880230|NCT02894502|566321221|FG002|Baseline|Withdrawal by Subject|36|||
156880231|NCT02894502|566321219|FG000|Baseline|Death|3|||
156880232|NCT02894502|566321220|FG001|Baseline|Death|1|||
156880233|NCT02894502|566321221|FG002|Baseline|Death|9|||
156880234|NCT02894502|566321219|FG000|First Follow up|Withdrawal by Subject|32|||
156880235|NCT02894502|566321220|FG001|First Follow up|Withdrawal by Subject|29|||
156746680|NCT00561470|565820083|FG000|Overall Study|Subject request|43|||
156880236|NCT02894502|566321221|FG002|First Follow up|Withdrawal by Subject|37|||
156880237|NCT02894502|566321219|FG000|First Follow up|Death|2|||
156880238|NCT02894502|566321220|FG001|First Follow up|Death|2|||
156880239|NCT02894502|566321221|FG002|First Follow up|Death|3|||
156880240|NCT02894502|566321219|FG000|Second Follow up|Withdrawal by Subject|13|||
156880241|NCT02894502|566321220|FG001|Second Follow up|Withdrawal by Subject|15|||
156880242|NCT02894502|566321221|FG002|Second Follow up|Withdrawal by Subject|13|||
156880243|NCT02894502|566321219|FG000|Second Follow up|Death|2|||
156880244|NCT02894502|566321220|FG001|Second Follow up|Death|3|||
156880245|NCT02894502|566321221|FG002|Second Follow up|Death|1|||
156880246|NCT02894502|566321219|FG000|Third Follow up|Withdrawal by Subject|5|||
156880247|NCT02894502|566321220|FG001|Third Follow up|Withdrawal by Subject|6|||
156880248|NCT02894502|566321221|FG002|Third Follow up|Withdrawal by Subject|3|||
156880249|NCT02894502|566321219|FG000|Third Follow up|Death|1|||
156880250|NCT02894502|566321220|FG001|Third Follow up|Death|1|||
156880251|NCT02894502|566321221|FG002|Third Follow up|Death|0|||
156880252|NCT03317405|566321222|FG000|Overall Study|Withdrawal by Subject|1|||
156880253|NCT03317405|566321223|FG001|Overall Study|Withdrawal by Subject|0|||
156880254|NCT03317405|566321224|FG002|Overall Study|Withdrawal by Subject|0|||
156880255|NCT03317405|566321222|FG000|Overall Study|Physician Decision|0|||
156880256|NCT03317405|566321223|FG001|Overall Study|Physician Decision|0|||
156880257|NCT03317405|566321224|FG002|Overall Study|Physician Decision|1|||
156880258|NCT03317405|566321222|FG000|Overall Study|Surgery Rescheduled|0|||
156880259|NCT03317405|566321223|FG001|Overall Study|Surgery Rescheduled|1|||
156880260|NCT03317405|566321224|FG002|Overall Study|Surgery Rescheduled|0|||
156880261|NCT01024309|566321225|FG000|Overall Study|Physician Decision|4|||
156880262|NCT01024309|566321226|FG001|Overall Study|Physician Decision|0|||
156880263|NCT01024309|566321225|FG000|Overall Study|Withdrawal by Subject|4|||
156880264|NCT01024309|566321226|FG001|Overall Study|Withdrawal by Subject|4|||
156880265|NCT00435045|566321227|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
156880266|NCT00435045|566321228|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
156880267|NCT00435045|566321227|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
156880268|NCT00435045|566321228|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
156880269|NCT00435045|566321227|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
156880270|NCT00435045|566321228|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
156880271|NCT00435045|566321227|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
156880272|NCT00435045|566321228|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
156880273|NCT00435045|566321227|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
156880274|NCT00435045|566321228|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
156880275|NCT00435045|566321227|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
156880276|NCT00435045|566321228|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
156880277|NCT00435045|566321227|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
156880278|NCT00435045|566321228|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
156880279|NCT00435045|566321227|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
156880280|NCT00435045|566321228|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
156880281|NCT00435045|566321227|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
156880282|NCT00435045|566321228|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
156880283|NCT00435045|566321227|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
156880284|NCT00435045|566321228|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
156880285|NCT00435045|566321227|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
156880286|NCT00435045|566321228|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
156880287|NCT01743001|566321231|FG000|Overall Study|Physician Decision|1|||
156880288|NCT01743001|566321232|FG001|Overall Study|Physician Decision|0|||
156880289|NCT01743001|566321231|FG000|Overall Study|Pregnancy|1|||
156880290|NCT01743001|566321232|FG001|Overall Study|Pregnancy|0|||
156880291|NCT01743001|566321231|FG000|Overall Study|Death|1|||
156880292|NCT01743001|566321232|FG001|Overall Study|Death|0|||
156880293|NCT03052426|566321233|FG000|Overall Study|Withdrawal by Subject|0|||
156880294|NCT03052426|566321234|FG001|Overall Study|Withdrawal by Subject|1|||
156880295|NCT03052426|566321235|FG002|Overall Study|Withdrawal by Subject|0|||
156880296|NCT03052426|566321233|FG000|Overall Study|Lost to Follow-up|2|||
156880297|NCT03052426|566321234|FG001|Overall Study|Lost to Follow-up|0|||
156880298|NCT03052426|566321235|FG002|Overall Study|Lost to Follow-up|1|||
156880299|NCT03083990|566321238|FG000|Overall Study|Adverse Event|1|||
156746681|NCT00561470|565820084|FG001|Overall Study|Subject request|77|||
156746682|NCT00561470|565820083|FG000|Overall Study|Metastatic surgery|10|||
156746683|NCT00561470|565820084|FG001|Overall Study|Metastatic surgery|12|||
156746684|NCT00561470|565820083|FG000|Overall Study|Unauthorized procedure|3|||
156880300|NCT03083990|566321239|FG001|Overall Study|Adverse Event|0|||
156880301|NCT01640314|566321240|FG000|Overall Study|Protocol Violation|0|||
156880302|NCT01640314|566321241|FG001|Overall Study|Protocol Violation|1|||
156880303|NCT01290796|566321242|FG000|Overall Study|Lost to Follow-up|21|||
156880304|NCT01290796|566321242|FG000|Overall Study|Withdrawal by Subject|4|||
156880305|NCT01290796|566321242|FG000|Overall Study|Physician Decision|2|||
156880306|NCT01290796|566321242|FG000|Overall Study|Secondary Surgical Intervention|2|||
157220544|NCT03361956|567553378|FG001|Overall Study|Adverse Event|0|||
157220545|NCT03361956|567553379|FG002|Overall Study|Adverse Event|1|||
157220546|NCT03361956|567553380|FG003|Overall Study|Adverse Event|1|||
157220547|NCT03361956|567553381|FG004|Overall Study|Adverse Event|0|||
157220548|NCT03361956|567553377|FG000|Overall Study|Other|0|||
157220549|NCT03361956|567553378|FG001|Overall Study|Other|0|||
157220550|NCT03361956|567553379|FG002|Overall Study|Other|0|||
157220551|NCT03361956|567553380|FG003|Overall Study|Other|1|||
156746685|NCT00561470|565820084|FG001|Overall Study|Unauthorized procedure|1|||
156746686|NCT00561470|565820083|FG000|Overall Study|Randomized but not treated|5|||
156746687|NCT00561470|565820084|FG001|Overall Study|Randomized but not treated|5|||
156746688|NCT00561470|565820083|FG000|Overall Study|Missed visit window|1|||
156746689|NCT00561470|565820084|FG001|Overall Study|Missed visit window|4|||
156746690|NCT00561470|565820083|FG000|Overall Study|Planning surgery|1|||
156746691|NCT00561470|565820084|FG001|Overall Study|Planning surgery|1|||
156746692|NCT00561470|565820083|FG000|Overall Study|Ongoing Treatment|11|||
156746693|NCT00561470|565820084|FG001|Overall Study|Ongoing Treatment|14|||
156746694|NCT01362244|565820086|FG000|Overall Study|Adverse Event|3|||
156746695|NCT01362244|565820087|FG001|Overall Study|Adverse Event|5|||
156746696|NCT01362244|565820086|FG000|Overall Study|Lack of Efficacy|5|||
156746697|NCT01362244|565820087|FG001|Overall Study|Lack of Efficacy|11|||
156746698|NCT01362244|565820086|FG000|Overall Study|Lost to Follow-up|0|||
156746699|NCT01362244|565820087|FG001|Overall Study|Lost to Follow-up|2|||
156746700|NCT01362244|565820086|FG000|Overall Study|Protocol Violation|5|||
156746701|NCT01362244|565820087|FG001|Overall Study|Protocol Violation|1|||
156746702|NCT01362244|565820086|FG000|Overall Study|Withdrawal by Subject|2|||
156746703|NCT01362244|565820087|FG001|Overall Study|Withdrawal by Subject|1|||
156746704|NCT01362244|565820086|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
156746705|NCT01362244|565820087|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
156746706|NCT01362244|565820086|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
156746707|NCT01362244|565820087|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
156746708|NCT01712334|565820088|FG000|Treatment Period 1|Randomized in Error|0|||
156746709|NCT01712334|565820089|FG001|Treatment Period 1|Randomized in Error|2|||
156746710|NCT00232596|565820090|FG000|6-Week Titration Phase|Adverse Event|6|||
156746711|NCT00232596|565820091|FG001|6-Week Titration Phase|Adverse Event|19|||
156746712|NCT00232596|565820090|FG000|6-Week Titration Phase|Failed to Return|2|||
156746713|NCT00232596|565820091|FG001|6-Week Titration Phase|Failed to Return|1|||
156746714|NCT00232596|565820090|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
156746715|NCT00232596|565820091|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
156746716|NCT00232596|565820090|FG000|6-Week Titration Phase|Protocol Violation|1|||
156746717|NCT00232596|565820091|FG001|6-Week Titration Phase|Protocol Violation|3|||
156746718|NCT00232596|565820090|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
156746719|NCT00232596|565820091|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
156746720|NCT00232596|565820090|FG000|6-Week Titration Phase|Other|3|||
156746721|NCT00232596|565820091|FG001|6-Week Titration Phase|Other|3|||
156746722|NCT00232596|565820090|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
156746723|NCT00232596|565820091|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
156746724|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Adverse Event|7|||
156746725|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Adverse Event|22|||
156746726|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
156746727|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
156746728|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
156746729|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
156746730|NCT00232596|565820090|FG000|12-Week Maintenance Phase|Other|1|||
156746731|NCT00232596|565820091|FG001|12-Week Maintenance Phase|Other|3|||
156746732|NCT01253174|565820092|FG000|Period 1|Randomized but not treated|0|||
156746733|NCT01253174|565820093|FG001|Period 1|Randomized but not treated|1|||
156746734|NCT01253174|565820094|FG002|Period 1|Randomized but not treated|1|||
156746735|NCT01253174|565820095|FG003|Period 1|Randomized but not treated|0|||
156746736|NCT01253174|565820096|FG004|Period 1|Randomized but not treated|1|||
156746737|NCT01253174|565820097|FG005|Period 1|Randomized but not treated|0|||
156746738|NCT01253174|565820092|FG000|Period 2|Adverse Event|0|||
156746739|NCT01253174|565820093|FG001|Period 2|Adverse Event|0|||
157220552|NCT03361956|567553381|FG004|Overall Study|Other|0|||
157220553|NCT03361956|567553377|FG000|Overall Study|Withdrawal by Subject|2|||
156746740|NCT01253174|565820094|FG002|Period 2|Adverse Event|1|||
156746741|NCT01253174|565820095|FG003|Period 2|Adverse Event|0|||
156746742|NCT01253174|565820096|FG004|Period 2|Adverse Event|0|||
156746743|NCT01253174|565820097|FG005|Period 2|Adverse Event|0|||
156746744|NCT01253174|565820092|FG000|Period 3|Withdrawal by Subject|0|||
156746745|NCT01253174|565820093|FG001|Period 3|Withdrawal by Subject|1|||
156746746|NCT01253174|565820094|FG002|Period 3|Withdrawal by Subject|0|||
156746747|NCT01253174|565820095|FG003|Period 3|Withdrawal by Subject|0|||
156746748|NCT01253174|565820096|FG004|Period 3|Withdrawal by Subject|1|||
156746749|NCT01253174|565820097|FG005|Period 3|Withdrawal by Subject|0|||
157220554|NCT03361956|567553378|FG001|Overall Study|Withdrawal by Subject|2|||
157220555|NCT03361956|567553379|FG002|Overall Study|Withdrawal by Subject|2|||
156880307|NCT01290796|566321242|FG000|Overall Study|Withdrawal by Sponsor|1|||
156880308|NCT02709538|566321244|FG000|Overall Study|Adverse Event|13|||
156880309|NCT02709538|566321245|FG001|Overall Study|Adverse Event|2|||
156880310|NCT02709538|566321246|FG002|Overall Study|Adverse Event|3|||
156880311|NCT02709538|566321244|FG000|Overall Study|Lack of Efficacy|1|||
156880312|NCT02709538|566321245|FG001|Overall Study|Lack of Efficacy|0|||
156880313|NCT02709538|566321246|FG002|Overall Study|Lack of Efficacy|0|||
156880314|NCT02709538|566321244|FG000|Overall Study|Lost to Follow-up|24|||
156880315|NCT02709538|566321245|FG001|Overall Study|Lost to Follow-up|8|||
156880316|NCT02709538|566321246|FG002|Overall Study|Lost to Follow-up|4|||
156880317|NCT02709538|566321244|FG000|Overall Study|Physician Decision|1|||
156880318|NCT02709538|566321245|FG001|Overall Study|Physician Decision|0|||
156880319|NCT02709538|566321246|FG002|Overall Study|Physician Decision|0|||
156880320|NCT02709538|566321244|FG000|Overall Study|Withdrawal by Subject|40|||
156880321|NCT02709538|566321245|FG001|Overall Study|Withdrawal by Subject|7|||
156746750|NCT01253174|565820092|FG000|Period 3|Pregnancy|0|||
156746751|NCT01253174|565820093|FG001|Period 3|Pregnancy|0|||
156746752|NCT01253174|565820094|FG002|Period 3|Pregnancy|1|||
156746753|NCT01253174|565820095|FG003|Period 3|Pregnancy|0|||
156746754|NCT01253174|565820096|FG004|Period 3|Pregnancy|0|||
156746755|NCT01253174|565820097|FG005|Period 3|Pregnancy|0|||
156746756|NCT02407054|565820098|FG000|Overall Study|Adverse Event|1|||
156746757|NCT02407054|565820099|FG001|Overall Study|Adverse Event|4|||
156746758|NCT02407054|565820100|FG002|Overall Study|Adverse Event|1|||
156746759|NCT02407054|565820098|FG000|Overall Study|Non-compliance with Study|0|||
156746760|NCT02407054|565820099|FG001|Overall Study|Non-compliance with Study|2|||
156746761|NCT02407054|565820100|FG002|Overall Study|Non-compliance with Study|1|||
156746762|NCT02407054|565820098|FG000|Overall Study|Physician Decision|1|||
156746763|NCT02407054|565820099|FG001|Overall Study|Physician Decision|3|||
156746764|NCT02407054|565820100|FG002|Overall Study|Physician Decision|3|||
156746765|NCT02407054|565820098|FG000|Overall Study|Withdrawal by Subject|5|||
156746766|NCT02407054|565820099|FG001|Overall Study|Withdrawal by Subject|9|||
156746767|NCT02407054|565820100|FG002|Overall Study|Withdrawal by Subject|2|||
156746768|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
156746769|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746770|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746771|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
156746772|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
156746773|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
156746774|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
156799969|NCT01029535|566023328|FG000|Overall Study|Protocol Violation|2|||
156799970|NCT01029535|566023328|FG000|Overall Study|Participant Withdrew Consent|2|||
156799971|NCT01029535|566023328|FG000|Overall Study|Adverse Event|1|||
156799972|NCT01029535|566023328|FG000|Overall Study|Use of Another Treatment|1|||
156799973|NCT01029535|566023328|FG000|Overall Study|Death|1|||
156799974|NCT02862574|566023329|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156799975|NCT02862574|566023330|FG001|Double-Blind Treatment Period|Adverse Event|1|||
156799976|NCT02862574|566023331|FG002|Double-Blind Treatment Period|Adverse Event|0|||
156799977|NCT02862574|566023329|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
156799978|NCT02862574|566023330|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
156799979|NCT02862574|566023331|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
156799980|NCT02862574|566023329|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
156799981|NCT02862574|566023330|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
156799982|NCT02862574|566023331|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
156799983|NCT01870869|566023346|FG000|Overall Study|Implanted with nonstudy device|1|||
156880322|NCT02709538|566321246|FG002|Overall Study|Withdrawal by Subject|4|||
156880323|NCT02709538|566321244|FG000|Overall Study|Non-compliance with study procedures|5|||
157143595|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
157143596|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
156746775|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746776|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
156799984|NCT01870869|566023347|FG001|Overall Study|Implanted with nonstudy device|3|||
156799985|NCT01870869|566023348|FG002|Overall Study|Implanted with nonstudy device|14|||
156799986|NCT01870869|566023349|FG003|Overall Study|Implanted with nonstudy device|4|||
156799987|NCT01870869|566023346|FG000|Overall Study|Death|0|||
156799988|NCT01870869|566023347|FG001|Overall Study|Death|0|||
156799989|NCT01870869|566023348|FG002|Overall Study|Death|7|||
156799990|NCT01870869|566023349|FG003|Overall Study|Death|1|||
156880324|NCT02709538|566321245|FG001|Overall Study|Non-compliance with study procedures|0|||
156746777|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746778|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
156746779|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746780|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746781|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
157143597|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
156746782|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746783|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746784|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746785|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
156746786|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746787|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746788|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746789|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
156746790|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
156746791|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
156746792|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
156746793|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
156746794|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
156746795|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
156746796|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
156746797|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
156746798|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
156746799|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
156746800|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
156746801|NCT00932698|565820103|FG000|Part 1 (Dose Escalation)|Other|0|||
156746802|NCT00932698|565820104|FG001|Part 1 (Dose Escalation)|Other|0|||
156746803|NCT00932698|565820105|FG002|Part 1 (Dose Escalation)|Other|1|||
156746804|NCT00932698|565820106|FG003|Part 1 (Dose Escalation)|Other|0|||
156746805|NCT00932698|565820107|FG004|Part 1 (Dose Escalation)|Other|0|||
156746806|NCT00932698|565820108|FG005|Part 1 (Dose Escalation)|Other|0|||
156746807|NCT00932698|565820109|FG006|Part 1 (Dose Escalation)|Other|1|||
156746808|NCT00932698|565820110|FG007|Part 1 (Dose Escalation)|Other|0|||
156746809|NCT00932698|565820111|FG008|Part 1 (Dose Escalation)|Other|0|||
156746810|NCT00932698|565820112|FG009|Part 1 (Dose Escalation)|Other|0|||
156746811|NCT00932698|565820113|FG010|Part 1 (Dose Escalation)|Other|0|||
156746812|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746813|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746814|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746815|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746816|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746817|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746818|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
156746819|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
156746820|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
156746821|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
156746822|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
156746823|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746824|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746825|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746826|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746827|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746828|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746829|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746830|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
156746831|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
156746832|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
156746833|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
156746834|NCT00932698|565820103|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
156746835|NCT00932698|565820104|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
156746836|NCT00932698|565820105|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
156746837|NCT00932698|565820106|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
156746838|NCT00932698|565820107|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
156746839|NCT00932698|565820108|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
156746840|NCT00932698|565820109|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
156746841|NCT00932698|565820110|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
156880325|NCT02709538|566321246|FG002|Overall Study|Non-compliance with study procedures|0|||
156880326|NCT02709538|566321244|FG000|Overall Study|Non-compliance with study drug|2|||
156880327|NCT02709538|566321245|FG001|Overall Study|Non-compliance with study drug|0|||
156880328|NCT02709538|566321246|FG002|Overall Study|Non-compliance with study drug|0|||
156746842|NCT00932698|565820111|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
156746843|NCT00932698|565820112|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
156746844|NCT00932698|565820113|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
156746845|NCT02510820|565821864|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156880329|NCT02709538|566321244|FG000|Overall Study|Protocol deviation|10|||
156880330|NCT02709538|566321245|FG001|Overall Study|Protocol deviation|4|||
156880331|NCT02709538|566321246|FG002|Overall Study|Protocol deviation|4|||
156746846|NCT02510820|565821865|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156746847|NCT02510820|565821864|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156746848|NCT02510820|565821865|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156746849|NCT03089853|565821866|FG000|Overall Study|Lost to Follow-up|2|||
156746850|NCT03089853|565821867|FG001|Overall Study|Lost to Follow-up|1|||
156746851|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
156746852|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
156746853|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
156746854|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
156746855|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
156746856|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
156746857|NCT04114656|565821872|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
156746858|NCT04114656|565821873|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
156746859|NCT04114656|565821872|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
156746860|NCT04114656|565821873|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
156746861|NCT01393106|565821874|FG000|Overall Study|Adverse Event|3|||
156746862|NCT01393106|565821874|FG000|Overall Study|Withdrawal by Subject|1|||
156746863|NCT01393106|565821874|FG000|Overall Study|Lack of Efficacy|1|||
156746864|NCT03052920|565821875|FG000|Overall Study|Withdrawal by Subject|1|||
156746865|NCT01698268|565821876|FG000|Overall Study|Physician Decision|2|||
156746866|NCT01698268|565821877|FG001|Overall Study|Physician Decision|1|||
156746867|NCT02263729|565821878|FG000|Overall Study|Lost to Follow-up|1|||
156746868|NCT02263729|565821879|FG001|Overall Study|Lost to Follow-up|1|||
156746869|NCT04591015|565821880|FG000|Overall Study|Death|6|||
156746870|NCT04591015|565821881|FG001|Overall Study|Death|4|||
156746871|NCT04591015|565821880|FG000|Overall Study|Withdrawal by Subject|6|||
156746872|NCT04591015|565821881|FG001|Overall Study|Withdrawal by Subject|3|||
156746873|NCT04591015|565821880|FG000|Overall Study|Lost to Follow-up|16|||
156746874|NCT04591015|565821881|FG001|Overall Study|Lost to Follow-up|11|||
156746875|NCT02509078|565821882|FG000|Overall Study|Protocol Violation|1|||
156746876|NCT02509078|565821883|FG001|Overall Study|Protocol Violation|1|||
156799991|NCT01870869|566023346|FG000|Overall Study|Subject choice|6|||
156799992|NCT01870869|566023347|FG001|Overall Study|Subject choice|2|||
156799993|NCT01870869|566023348|FG002|Overall Study|Subject choice|22|||
156799994|NCT01870869|566023349|FG003|Overall Study|Subject choice|8|||
156799995|NCT01870869|566023346|FG000|Overall Study|Lost to Follow-up|10|||
156799996|NCT01870869|566023347|FG001|Overall Study|Lost to Follow-up|2|||
156799997|NCT01870869|566023348|FG002|Overall Study|Lost to Follow-up|25|||
156799998|NCT01870869|566023349|FG003|Overall Study|Lost to Follow-up|3|||
156799999|NCT01870869|566023346|FG000|Overall Study|Reason not Specified|1|||
156800000|NCT01870869|566023347|FG001|Overall Study|Reason not Specified|2|||
156800001|NCT01870869|566023348|FG002|Overall Study|Reason not Specified|20|||
156800002|NCT01870869|566023349|FG003|Overall Study|Reason not Specified|4|||
156800003|NCT01870869|566023346|FG000|Overall Study|Not evaluable|10|||
156800004|NCT01870869|566023347|FG001|Overall Study|Not evaluable|5|||
156800005|NCT01870869|566023348|FG002|Overall Study|Not evaluable|42|||
156800006|NCT01870869|566023349|FG003|Overall Study|Not evaluable|10|||
156800007|NCT02569853|566023350|FG000|Overall Study|Adverse Event|2|||
156800008|NCT02569853|566023351|FG001|Overall Study|Adverse Event|0|||
156800009|NCT02569853|566023350|FG000|Overall Study|Withdrawal by Subject|3|||
156800010|NCT02569853|566023351|FG001|Overall Study|Withdrawal by Subject|2|||
156800011|NCT02569853|566023350|FG000|Overall Study|Lost to Follow-up|3|||
156800012|NCT02569853|566023351|FG001|Overall Study|Lost to Follow-up|3|||
156800013|NCT02569853|566023350|FG000|Overall Study|Protocol Violation|1|||
156800014|NCT02569853|566023351|FG001|Overall Study|Protocol Violation|1|||
156800015|NCT02569853|566023350|FG000|Overall Study|Did not experience migraine attack|10|||
156800016|NCT02569853|566023351|FG001|Overall Study|Did not experience migraine attack|7|||
156800017|NCT02569853|566023350|FG000|Overall Study|Physician Decision|1|||
156800018|NCT02569853|566023351|FG001|Overall Study|Physician Decision|1|||
156746877|NCT03594955|565821884|FG000|Overall Study|Adverse Event|1|||
156746878|NCT03594955|565821884|FG000|Overall Study|Progressive disease|5|||
156800019|NCT00402987|566023352|FG000|Overall Study|Lack of Efficacy|0|||
156800020|NCT00402987|566023353|FG001|Overall Study|Lack of Efficacy|0|||
156800021|NCT00402987|566023354|FG002|Overall Study|Lack of Efficacy|1|||
156800022|NCT00402987|566023355|FG003|Overall Study|Lack of Efficacy|0|||
156800023|NCT00419744|566023356|FG000|Overall Study|Adverse Event|39|||
156800024|NCT00419744|566023357|FG001|Overall Study|Adverse Event|40|||
156800025|NCT00419744|566023358|FG002|Overall Study|Adverse Event|50|||
156800026|NCT00419744|566023356|FG000|Overall Study|Withdrawal by Subject|45|||
156800027|NCT00419744|566023357|FG001|Overall Study|Withdrawal by Subject|49|||
156800028|NCT00419744|566023358|FG002|Overall Study|Withdrawal by Subject|52|||
156800029|NCT00419744|566023356|FG000|Overall Study|Lost to Follow-up|8|||
156800030|NCT00419744|566023357|FG001|Overall Study|Lost to Follow-up|10|||
156800031|NCT00419744|566023358|FG002|Overall Study|Lost to Follow-up|6|||
156800032|NCT00419744|566023356|FG000|Overall Study|Protocol Violation|4|||
156800033|NCT00419744|566023357|FG001|Overall Study|Protocol Violation|7|||
156800034|NCT00419744|566023358|FG002|Overall Study|Protocol Violation|8|||
156746879|NCT03594955|565821884|FG000|Overall Study|Sponsor's decision|1|||
156746880|NCT03539484|565821886|FG000|Overall Study|Death|1|||
156746881|NCT03539484|565821887|FG001|Overall Study|Death|0|||
156746882|NCT03539484|565821888|FG002|Overall Study|Death|0|||
156746883|NCT03539484|565821889|FG003|Overall Study|Death|2|||
156746884|NCT03539484|565821890|FG004|Overall Study|Death|8|||
156746885|NCT03539484|565821891|FG005|Overall Study|Death|3|||
156746886|NCT03539484|565821892|FG006|Overall Study|Death|0|||
156746887|NCT03539484|565821886|FG000|Overall Study|Lost to Follow-up|0|||
156746888|NCT03539484|565821887|FG001|Overall Study|Lost to Follow-up|1|||
156746889|NCT03539484|565821888|FG002|Overall Study|Lost to Follow-up|0|||
156746890|NCT03539484|565821889|FG003|Overall Study|Lost to Follow-up|0|||
156746891|NCT03539484|565821890|FG004|Overall Study|Lost to Follow-up|1|||
156746892|NCT03539484|565821891|FG005|Overall Study|Lost to Follow-up|0|||
156746893|NCT03539484|565821892|FG006|Overall Study|Lost to Follow-up|0|||
156746894|NCT03539484|565821886|FG000|Overall Study|Withdrawal by Subject|0|||
156746895|NCT03539484|565821887|FG001|Overall Study|Withdrawal by Subject|0|||
156746896|NCT03539484|565821888|FG002|Overall Study|Withdrawal by Subject|0|||
156746897|NCT03539484|565821889|FG003|Overall Study|Withdrawal by Subject|0|||
156746898|NCT03539484|565821890|FG004|Overall Study|Withdrawal by Subject|2|||
156746899|NCT03539484|565821891|FG005|Overall Study|Withdrawal by Subject|0|||
156746900|NCT03539484|565821892|FG006|Overall Study|Withdrawal by Subject|1|||
156746901|NCT03539484|565821886|FG000|Overall Study|Study Terminated by Sponsor|0|||
156746902|NCT03539484|565821887|FG001|Overall Study|Study Terminated by Sponsor|0|||
156746903|NCT03539484|565821888|FG002|Overall Study|Study Terminated by Sponsor|1|||
156746904|NCT03539484|565821889|FG003|Overall Study|Study Terminated by Sponsor|1|||
156746905|NCT03539484|565821890|FG004|Overall Study|Study Terminated by Sponsor|2|||
156746906|NCT03539484|565821891|FG005|Overall Study|Study Terminated by Sponsor|2|||
156746907|NCT03539484|565821892|FG006|Overall Study|Study Terminated by Sponsor|1|||
156746908|NCT02131636|565821896|FG000|Overall Study|Personal Reasons|4|||
156746909|NCT02131636|565821897|FG001|Overall Study|Personal Reasons|4|||
156746910|NCT02131636|565821896|FG000|Overall Study|Lost to Follow-up|4|||
156746911|NCT02131636|565821897|FG001|Overall Study|Lost to Follow-up|0|||
156746912|NCT02131636|565821896|FG000|Overall Study|Adverse Event|4|||
156746913|NCT02131636|565821897|FG001|Overall Study|Adverse Event|1|||
156746914|NCT02173379|565821898|FG000|Overall Study|Lost to Follow-up|89|||
156746915|NCT02173379|565821899|FG001|Overall Study|Lost to Follow-up|81|||
156746916|NCT02173379|565821898|FG000|Overall Study|Withdrawal by Subject|24|||
156746917|NCT02173379|565821899|FG001|Overall Study|Withdrawal by Subject|29|||
156746918|NCT02173379|565821898|FG000|Overall Study|Physician Decision|8|||
156746919|NCT02173379|565821899|FG001|Overall Study|Physician Decision|8|||
156746920|NCT02173379|565821898|FG000|Overall Study|Death|75|||
156746921|NCT02173379|565821899|FG001|Overall Study|Death|72|||
156746922|NCT02173379|565821898|FG000|Overall Study|Other Reason|1|||
156746923|NCT02173379|565821899|FG001|Overall Study|Other Reason|0|||
156746924|NCT06226649|565821901|FG000|Overall Study|Withdrawal by Subject|4|||
156746925|NCT06226649|565821902|FG001|Overall Study|Withdrawal by Subject|1|||
156746926|NCT00631163|565821907|FG000|Number of Participants in Year 1|Adverse Event|12|||
156746927|NCT00631163|565821907|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
156746928|NCT00631163|565821907|FG000|Number of Participants in Year 1|Death|6|||
156746929|NCT00631163|565821907|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
156746930|NCT00631163|565821907|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
156746931|NCT00631163|565821907|FG000|Number of Participants in Year 1|Administrative problems|6|||
156746932|NCT00631163|565821907|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
156746933|NCT00631163|565821907|FG000|Number of Participants in Year 2|Adverse Event|1|||
156746934|NCT00631163|565821907|FG000|Number of Participants in Year 2|Protocol Violation|1|||
156746935|NCT00631163|565821907|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
156746936|NCT01636947|565821911|FG000|Overall Study|Not Treated|2|||
156746937|NCT01636947|565821912|FG001|Overall Study|Not Treated|2|||
156746938|NCT01636947|565821911|FG000|Overall Study|Lost to Follow-up|4|||
156746939|NCT01636947|565821912|FG001|Overall Study|Lost to Follow-up|0|||
156746940|NCT01636947|565821911|FG000|Overall Study|Protocol Violation|1|||
156746941|NCT01636947|565821912|FG001|Overall Study|Protocol Violation|1|||
156746942|NCT01636947|565821911|FG000|Overall Study|Withdrawal by Subject|3|||
156746943|NCT01636947|565821912|FG001|Overall Study|Withdrawal by Subject|3|||
156746944|NCT01636947|565821911|FG000|Overall Study|Adverse Event|1|||
156746945|NCT01636947|565821912|FG001|Overall Study|Adverse Event|1|||
156746946|NCT01636947|565821911|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156746947|NCT01636947|565821912|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
157220556|NCT03361956|567553380|FG003|Overall Study|Withdrawal by Subject|0|||
156746948|NCT00427999|565821935|FG000|Overall Study|Adverse Event|6|||
156746949|NCT00427999|565821935|FG000|Overall Study|Abnormal laboratory values|1|||
156746950|NCT00427999|565821935|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
156746951|NCT00427999|565821935|FG000|Overall Study|Protocol Violation|2|||
156746952|NCT00427999|565821935|FG000|Overall Study|Withdrawal by Subject|9|||
156746953|NCT00427999|565821935|FG000|Overall Study|Death|1|||
156746954|NCT02284568|565821936|FG000|Overall Study|Adverse Event|2|||
156746955|NCT02284568|565821937|FG001|Overall Study|Adverse Event|9|||
156746956|NCT02284568|565821938|FG002|Overall Study|Adverse Event|4|||
156746957|NCT02284568|565821936|FG000|Overall Study|Withdrawal by Subject|22|||
156746958|NCT02284568|565821937|FG001|Overall Study|Withdrawal by Subject|21|||
156746959|NCT02284568|565821938|FG002|Overall Study|Withdrawal by Subject|1|||
156746960|NCT02284568|565821936|FG000|Overall Study|Noncompliance with study drug admin|1|||
156746961|NCT02284568|565821937|FG001|Overall Study|Noncompliance with study drug admin|2|||
156746962|NCT02284568|565821938|FG002|Overall Study|Noncompliance with study drug admin|0|||
156746963|NCT02284568|565821936|FG000|Overall Study|Noncompliance|1|||
156746964|NCT02284568|565821937|FG001|Overall Study|Noncompliance|0|||
156746965|NCT02284568|565821938|FG002|Overall Study|Noncompliance|0|||
156746966|NCT02284568|565821936|FG000|Overall Study|Protocol Violation|0|||
156746967|NCT02284568|565821937|FG001|Overall Study|Protocol Violation|1|||
156746968|NCT02284568|565821938|FG002|Overall Study|Protocol Violation|0|||
156746969|NCT02284568|565821936|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
156746970|NCT02284568|565821937|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
156746971|NCT02284568|565821938|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
156746972|NCT02284568|565821936|FG000|Overall Study|Lost to Follow-up|0|||
156746973|NCT02284568|565821937|FG001|Overall Study|Lost to Follow-up|3|||
156746974|NCT02284568|565821938|FG002|Overall Study|Lost to Follow-up|0|||
156746975|NCT02284568|565821936|FG000|Overall Study|Lack of Efficacy|4|||
156746976|NCT02284568|565821937|FG001|Overall Study|Lack of Efficacy|7|||
156746977|NCT02284568|565821938|FG002|Overall Study|Lack of Efficacy|0|||
156746978|NCT02284568|565821936|FG000|Overall Study|Other|1|||
156746979|NCT02284568|565821937|FG001|Overall Study|Other|2|||
156746980|NCT02284568|565821938|FG002|Overall Study|Other|0|||
156746981|NCT02284568|565821936|FG000|Overall Study|Withdrew before taking study drug|0|||
156746982|NCT02284568|565821937|FG001|Overall Study|Withdrew before taking study drug|1|||
156746983|NCT02284568|565821938|FG002|Overall Study|Withdrew before taking study drug|0|||
156746984|NCT00460265|565821939|FG000|Overall Study|Lost to Follow-up|14|||
156746985|NCT00460265|565821940|FG001|Overall Study|Lost to Follow-up|15|||
156746986|NCT00460265|565821939|FG000|Overall Study|Physician Decision|1|||
156746987|NCT00460265|565821940|FG001|Overall Study|Physician Decision|2|||
156746988|NCT00460265|565821939|FG000|Overall Study|Withdrawal by Subject|10|||
156746989|NCT00460265|565821940|FG001|Overall Study|Withdrawal by Subject|25|||
156746990|NCT00460265|565821939|FG000|Overall Study|Ongoing|60|||
156746991|NCT00460265|565821940|FG001|Overall Study|Ongoing|47|||
156746992|NCT01955109|565821950|FG000|Overall Study|Adverse Event|2|||
156746993|NCT01955109|565821951|FG001|Overall Study|Adverse Event|0|||
156746994|NCT01955109|565821950|FG000|Overall Study|Participant unwilling to continue|35|||
156746995|NCT01955109|565821951|FG001|Overall Study|Participant unwilling to continue|7|||
156746996|NCT01955109|565821950|FG000|Overall Study|Physician Decision|2|||
156746997|NCT01955109|565821951|FG001|Overall Study|Physician Decision|0|||
156746998|NCT01955109|565821950|FG000|Overall Study|Lost to Follow-up|3|||
156746999|NCT01955109|565821951|FG001|Overall Study|Lost to Follow-up|1|||
156747000|NCT01955109|565821950|FG000|Overall Study|Non-compliance|3|||
156747001|NCT01955109|565821951|FG001|Overall Study|Non-compliance|1|||
156747002|NCT00904839|565821952|FG000|Overall Study|Adverse Event|0|||
156747003|NCT00904839|565821953|FG001|Overall Study|Adverse Event|5|||
156747004|NCT00904839|565821954|FG002|Overall Study|Adverse Event|4|||
156747005|NCT00904839|565821952|FG000|Overall Study|Protocol Violation|0|||
156747006|NCT00904839|565821953|FG001|Overall Study|Protocol Violation|1|||
156747007|NCT00904839|565821954|FG002|Overall Study|Protocol Violation|1|||
156747008|NCT00904839|565821952|FG000|Overall Study|Lost to Follow-up|0|||
156747009|NCT00904839|565821953|FG001|Overall Study|Lost to Follow-up|1|||
156747010|NCT00904839|565821954|FG002|Overall Study|Lost to Follow-up|2|||
156747011|NCT00904839|565821952|FG000|Overall Study|Withdrawal by Subject|0|||
156747012|NCT00904839|565821953|FG001|Overall Study|Withdrawal by Subject|2|||
156747013|NCT00904839|565821954|FG002|Overall Study|Withdrawal by Subject|0|||
156747014|NCT00904839|565821952|FG000|Overall Study|Not treated|1|||
156747015|NCT00904839|565821953|FG001|Overall Study|Not treated|0|||
156747016|NCT00904839|565821954|FG002|Overall Study|Not treated|1|||
156747017|NCT00904839|565821952|FG000|Overall Study|Other than above|0|||
156747018|NCT00904839|565821953|FG001|Overall Study|Other than above|9|||
156747019|NCT00904839|565821954|FG002|Overall Study|Other than above|7|||
156747020|NCT01853696|565821961|FG000|Overall Study|Withdrawal by Subject|1|||
156747021|NCT01853696|565821962|FG001|Overall Study|Withdrawal by Subject|1|||
156747022|NCT01853696|565821961|FG000|Overall Study|Lost to Follow-up|5|||
156747023|NCT01853696|565821962|FG001|Overall Study|Lost to Follow-up|4|||
156747024|NCT00553358|565821963|FG000|Overall Study|Randomized but did not receive treatment|3|||
156747025|NCT00553358|565821964|FG001|Overall Study|Randomized but did not receive treatment|3|||
156747026|NCT00553358|565821965|FG002|Overall Study|Randomized but did not receive treatment|1|||
156747027|NCT00553358|565821963|FG000|Overall Study|Lost to Follow-up|22|||
156747028|NCT00553358|565821964|FG001|Overall Study|Lost to Follow-up|26|||
156747029|NCT00553358|565821965|FG002|Overall Study|Lost to Follow-up|18|||
156747030|NCT00553358|565821963|FG000|Overall Study|Withdrew completely|23|||
156747031|NCT00553358|565821964|FG001|Overall Study|Withdrew completely|33|||
156747032|NCT00553358|565821965|FG002|Overall Study|Withdrew completely|34|||
156747033|NCT00553358|565821963|FG000|Overall Study|Died during clinical follow-up|25|||
156747034|NCT00553358|565821964|FG001|Overall Study|Died during clinical follow-up|29|||
156747035|NCT00553358|565821965|FG002|Overall Study|Died during clinical follow-up|32|||
156747036|NCT00553358|565821963|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
156747037|NCT00553358|565821964|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
156747038|NCT00553358|565821965|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
156747039|NCT00553358|565821963|FG000|Overall Study|Died after clinical follow-up ended|1|||
156747040|NCT00553358|565821964|FG001|Overall Study|Died after clinical follow-up ended|2|||
156747041|NCT00553358|565821965|FG002|Overall Study|Died after clinical follow-up ended|0|||
156747042|NCT00553358|565821963|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747043|NCT00553358|565821964|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747044|NCT00553358|565821965|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
156747045|NCT01832818|565821966|FG000|Overall Study|Lost to Follow-up|6|||
156747046|NCT00236899|565821967|FG000|Overall Study|Adverse Event (Study Related)|1|||
156747047|NCT00236899|565821968|FG001|Overall Study|Adverse Event (Study Related)|1|||
156747048|NCT00236899|565821969|FG002|Overall Study|Adverse Event (Study Related)|2|||
156747049|NCT00236899|565821970|FG003|Overall Study|Adverse Event (Study Related)|1|||
156747050|NCT00236899|565821967|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
156747051|NCT00236899|565821968|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
156747052|NCT00236899|565821969|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
156747053|NCT00236899|565821970|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
156747054|NCT00236899|565821967|FG000|Overall Study|Death (Study Disease)|1|||
156747055|NCT00236899|565821968|FG001|Overall Study|Death (Study Disease)|4|||
156747056|NCT00236899|565821969|FG002|Overall Study|Death (Study Disease)|0|||
156747057|NCT00236899|565821970|FG003|Overall Study|Death (Study Disease)|0|||
156747058|NCT00236899|565821967|FG000|Overall Study|Death (Not Study Related)|2|||
156747059|NCT00236899|565821968|FG001|Overall Study|Death (Not Study Related)|0|||
156747060|NCT00236899|565821969|FG002|Overall Study|Death (Not Study Related)|0|||
156747061|NCT00236899|565821970|FG003|Overall Study|Death (Not Study Related)|0|||
156747062|NCT00236899|565821967|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
156747063|NCT00236899|565821968|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
156747064|NCT00236899|565821969|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
156747065|NCT00236899|565821970|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
156747066|NCT00236899|565821967|FG000|Overall Study|Lost to Follow-up|0|||
156747067|NCT00236899|565821968|FG001|Overall Study|Lost to Follow-up|1|||
156747068|NCT00236899|565821969|FG002|Overall Study|Lost to Follow-up|0|||
156747069|NCT00236899|565821970|FG003|Overall Study|Lost to Follow-up|0|||
156747070|NCT00236899|565821967|FG000|Overall Study|Entry Criteria Exclusion|0|||
156747071|NCT00236899|565821968|FG001|Overall Study|Entry Criteria Exclusion|1|||
156747072|NCT00236899|565821969|FG002|Overall Study|Entry Criteria Exclusion|1|||
156747073|NCT00236899|565821970|FG003|Overall Study|Entry Criteria Exclusion|0|||
156747074|NCT00236899|565821967|FG000|Overall Study|Protocol Violation|1|||
156747075|NCT00236899|565821968|FG001|Overall Study|Protocol Violation|0|||
156747076|NCT00236899|565821969|FG002|Overall Study|Protocol Violation|0|||
156747077|NCT00236899|565821970|FG003|Overall Study|Protocol Violation|0|||
156747078|NCT00236899|565821967|FG000|Overall Study|Withdrawal by Subject|6|||
156747079|NCT00236899|565821968|FG001|Overall Study|Withdrawal by Subject|4|||
156747080|NCT00236899|565821969|FG002|Overall Study|Withdrawal by Subject|5|||
156747081|NCT00236899|565821970|FG003|Overall Study|Withdrawal by Subject|2|||
156747082|NCT00236899|565821967|FG000|Overall Study|Physician Decision|7|||
156747083|NCT00236899|565821968|FG001|Overall Study|Physician Decision|8|||
156747084|NCT00236899|565821969|FG002|Overall Study|Physician Decision|7|||
156747085|NCT00236899|565821970|FG003|Overall Study|Physician Decision|6|||
156747086|NCT00236899|565821967|FG000|Overall Study|Satisfactory Response|2|||
156747087|NCT00236899|565821968|FG001|Overall Study|Satisfactory Response|0|||
156747088|NCT00236899|565821969|FG002|Overall Study|Satisfactory Response|0|||
156800035|NCT00419744|566023356|FG000|Overall Study|Randomized in error|9|||
156800036|NCT00419744|566023357|FG001|Overall Study|Randomized in error|6|||
156800037|NCT00419744|566023358|FG002|Overall Study|Randomized in error|7|||
156800038|NCT00419744|566023356|FG000|Overall Study|Moving out of state|2|||
156800039|NCT00419744|566023357|FG001|Overall Study|Moving out of state|0|||
156800040|NCT00419744|566023358|FG002|Overall Study|Moving out of state|1|||
156800041|NCT00419744|566023356|FG000|Overall Study|Physician Decision|10|||
156800042|NCT00419744|566023357|FG001|Overall Study|Physician Decision|5|||
156800043|NCT00419744|566023358|FG002|Overall Study|Physician Decision|6|||
156800044|NCT00419744|566023356|FG000|Overall Study|Spirometry mouthpiece issues|0|||
156800045|NCT00419744|566023357|FG001|Overall Study|Spirometry mouthpiece issues|1|||
156800046|NCT00419744|566023358|FG002|Overall Study|Spirometry mouthpiece issues|2|||
156747089|NCT00236899|565821970|FG003|Overall Study|Satisfactory Response|1|||
156747090|NCT00236899|565821967|FG000|Overall Study|Lack of Efficacy|18|||
156747091|NCT00236899|565821968|FG001|Overall Study|Lack of Efficacy|18|||
156747092|NCT00236899|565821969|FG002|Overall Study|Lack of Efficacy|25|||
156747093|NCT00236899|565821970|FG003|Overall Study|Lack of Efficacy|23|||
156747094|NCT01797094|565821973|FG000|Overall Study|Adverse Event|1|||
156747095|NCT01797094|565821974|FG001|Overall Study|Adverse Event|1|||
156747096|NCT01797094|565821973|FG000|Overall Study|Personal Reasons|4|||
156747097|NCT01797094|565821974|FG001|Overall Study|Personal Reasons|0|||
156747098|NCT01797094|565821973|FG000|Overall Study|Protocol Violation|0|||
156747099|NCT01797094|565821974|FG001|Overall Study|Protocol Violation|1|||
156747100|NCT01797094|565821973|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156747101|NCT01797094|565821974|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156747102|NCT02147067|565821975|FG000|Overall Study|Withdrawal by Subject|2|||
156747103|NCT02147067|565821976|FG001|Overall Study|Withdrawal by Subject|2|||
156747104|NCT02943785|565821977|FG000|Overall Study|Adverse Event|112|||
156747105|NCT02943785|565821978|FG001|Overall Study|Adverse Event|97|||
156747106|NCT02943785|565821977|FG000|Overall Study|Withdrawal by Subject|63|||
156747107|NCT02943785|565821978|FG001|Overall Study|Withdrawal by Subject|126|||
156747108|NCT02943785|565821977|FG000|Overall Study|Physician Decision|23|||
156747109|NCT02943785|565821978|FG001|Overall Study|Physician Decision|47|||
156747110|NCT02943785|565821977|FG000|Overall Study|Death|46|||
156747111|NCT02943785|565821978|FG001|Overall Study|Death|46|||
156747112|NCT02943785|565821977|FG000|Overall Study|Lost to Follow-up|1|||
156747113|NCT02943785|565821978|FG001|Overall Study|Lost to Follow-up|0|||
156747114|NCT02943785|565821977|FG000|Overall Study|Other|16|||
156747115|NCT02943785|565821978|FG001|Overall Study|Other|19|||
156747116|NCT02943785|565821977|FG000|Overall Study|Did not receive any study medication|21|||
156747117|NCT02943785|565821978|FG001|Overall Study|Did not receive any study medication|28|||
156747118|NCT03578146|565821979|FG000|Overall Study|Did Not Receive Treatment|1|||
156747119|NCT03578146|565821980|FG001|Overall Study|Did Not Receive Treatment|0|||
156747120|NCT03578146|565821981|FG002|Overall Study|Did Not Receive Treatment|0|||
156747121|NCT03578146|565821982|FG003|Overall Study|Did Not Receive Treatment|0|||
156747122|NCT03578146|565821983|FG004|Overall Study|Did Not Receive Treatment|0|||
156747123|NCT03578146|565821984|FG005|Overall Study|Did Not Receive Treatment|2|||
156747124|NCT03578146|565821979|FG000|Overall Study|Lost to Follow-up|0|||
156747125|NCT03578146|565821980|FG001|Overall Study|Lost to Follow-up|1|||
156747126|NCT03578146|565821981|FG002|Overall Study|Lost to Follow-up|1|||
156747127|NCT03578146|565821982|FG003|Overall Study|Lost to Follow-up|0|||
156747128|NCT03578146|565821983|FG004|Overall Study|Lost to Follow-up|0|||
156747129|NCT03578146|565821984|FG005|Overall Study|Lost to Follow-up|1|||
156747130|NCT00634049|565821985|FG000|Overall Study|Never received study drug|1|||
156747131|NCT00634049|565821985|FG000|Overall Study|Died prior to receiving study drug|1|||
156747132|NCT00634049|565821985|FG000|Overall Study|Screening failure|1|||
156747133|NCT04395274|565821988|FG000|Overall Study|Lost to Follow-up|20|||
156747134|NCT04395274|565821989|FG001|Overall Study|Lost to Follow-up|11|||
156747135|NCT04395274|565821988|FG000|Overall Study|Withdrawal by Subject|13|||
156747136|NCT04395274|565821989|FG001|Overall Study|Withdrawal by Subject|10|||
156747137|NCT04395274|565821988|FG000|Overall Study|Moved Abroad|0|||
156747138|NCT04395274|565821989|FG001|Overall Study|Moved Abroad|1|||
156747139|NCT02919267|565821991|FG000|Overall Study|Protocol Violation|0|||
156747140|NCT02919267|565821992|FG001|Overall Study|Protocol Violation|3|||
156747141|NCT02919267|565821993|FG002|Overall Study|Protocol Violation|3|||
156747142|NCT02919267|565821994|FG003|Overall Study|Protocol Violation|4|||
156747143|NCT04438499|565821997|FG000|Overall Study|Lack of Efficacy|3|||
156747144|NCT00642954|565823873|FG000|Overall Study|Progressive Disease|3|||
156747145|NCT00642954|565823874|FG001|Overall Study|Progressive Disease|3|||
156747146|NCT00642954|565823875|FG002|Overall Study|Progressive Disease|3|||
156747147|NCT00642954|565823876|FG003|Overall Study|Progressive Disease|3|||
156747148|NCT00642954|565823877|FG004|Overall Study|Progressive Disease|9|||
156747149|NCT00642954|565823873|FG000|Overall Study|Withdrawal by Subject|0|||
156747150|NCT00642954|565823874|FG001|Overall Study|Withdrawal by Subject|0|||
156747151|NCT00642954|565823875|FG002|Overall Study|Withdrawal by Subject|0|||
156747152|NCT00642954|565823876|FG003|Overall Study|Withdrawal by Subject|0|||
156747153|NCT00642954|565823877|FG004|Overall Study|Withdrawal by Subject|1|||
156747154|NCT00642954|565823873|FG000|Overall Study|Adverse Event|1|||
156747155|NCT00642954|565823874|FG001|Overall Study|Adverse Event|1|||
156747156|NCT00642954|565823875|FG002|Overall Study|Adverse Event|0|||
156747157|NCT00642954|565823876|FG003|Overall Study|Adverse Event|0|||
156747158|NCT00642954|565823877|FG004|Overall Study|Adverse Event|6|||
156747159|NCT01317004|565823878|FG000|Overall Study|Withdrawal by Subject|1|||
156747160|NCT01317004|565823879|FG001|Overall Study|Withdrawal by Subject|4|||
156747161|NCT01317004|565823878|FG000|Overall Study|Protocol Violation|0|||
156747162|NCT01317004|565823879|FG001|Overall Study|Protocol Violation|2|||
156747163|NCT01317004|565823878|FG000|Overall Study|Adverse Event|3|||
156747164|NCT01317004|565823879|FG001|Overall Study|Adverse Event|3|||
156747165|NCT01890759|565823880|FG000|Overall Study|Protocol Violation|0|||
156747166|NCT01890759|565823881|FG001|Overall Study|Protocol Violation|2|||
156747167|NCT01890759|565823880|FG000|Overall Study|Lost to Follow-up|0|||
156747168|NCT01890759|565823881|FG001|Overall Study|Lost to Follow-up|2|||
156747169|NCT01890759|565823880|FG000|Overall Study|Withdrawal by Subject|2|||
156747170|NCT01890759|565823881|FG001|Overall Study|Withdrawal by Subject|8|||
156747171|NCT01344759|565823882|FG000|Overall Study|Patients failed to reach sedation level|0|||
156747172|NCT01344759|565823883|FG001|Overall Study|Patients failed to reach sedation level|2|||
156747173|NCT02732015|565823884|FG000|Overall Study|Lost to Follow-up|0|||
156747174|NCT02732015|565823885|FG001|Overall Study|Lost to Follow-up|1|||
156747175|NCT01980628|565823886|FG000|Overall Study|Adverse Event|12|||
156747176|NCT01980628|565823886|FG000|Overall Study|Physician Decision|5|||
156747177|NCT01980628|565823886|FG000|Overall Study|Withdrawal by Subject|4|||
156747178|NCT01980628|565823886|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
156747179|NCT05437640|565823889|FG000|Washout (1 Week)|Adverse Event|1|||
156747180|NCT05437640|565823890|FG001|Washout (1 Week)|Adverse Event|0|||
156747181|NCT02474355|565823891|FG000|Overall Study|Other|43|||
156747182|NCT02474355|565823891|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
156747183|NCT02474355|565823891|FG000|Overall Study|Lost to Follow-up|98|||
156747184|NCT02474355|565823891|FG000|Overall Study|Withdrawal by Subject|124|||
156747185|NCT02474355|565823891|FG000|Overall Study|Death|1361|||
156747186|NCT03015194|565823893|FG000|Overall Study|Death|10|||
156747187|NCT03015194|565823893|FG000|Overall Study|Withdrawal by Subject|2|||
156747188|NCT01937715|565823897|FG000|Overall Study|Death|0|||
156747189|NCT01937715|565823898|FG001|Overall Study|Death|0|||
156747190|NCT01937715|565823899|FG002|Overall Study|Death|0|||
156747191|NCT01937715|565823900|FG003|Overall Study|Death|1|||
156747192|NCT01937715|565823901|FG004|Overall Study|Death|0|||
156747193|NCT01937715|565823897|FG000|Overall Study|Withdrawal by Subject|0|||
156747194|NCT01937715|565823898|FG001|Overall Study|Withdrawal by Subject|1|||
156747195|NCT01937715|565823899|FG002|Overall Study|Withdrawal by Subject|0|||
156747196|NCT01937715|565823900|FG003|Overall Study|Withdrawal by Subject|0|||
156747197|NCT01937715|565823901|FG004|Overall Study|Withdrawal by Subject|2|||
156747198|NCT01937715|565823897|FG000|Overall Study|Other|0|||
156747199|NCT01937715|565823898|FG001|Overall Study|Other|0|||
156747200|NCT01937715|565823899|FG002|Overall Study|Other|0|||
156747201|NCT01937715|565823900|FG003|Overall Study|Other|3|||
156747202|NCT01937715|565823901|FG004|Overall Study|Other|0|||
156747203|NCT00433017|565823904|FG000|Overall Study|Adverse Event|5|||
156747204|NCT00433017|565823905|FG001|Overall Study|Adverse Event|3|||
156747205|NCT00433017|565823904|FG000|Overall Study|Withdrawal by Subject|4|||
156747206|NCT00433017|565823905|FG001|Overall Study|Withdrawal by Subject|5|||
156747207|NCT00433017|565823904|FG000|Overall Study|Lost to Follow-up|3|||
156747208|NCT00433017|565823905|FG001|Overall Study|Lost to Follow-up|4|||
156747209|NCT00433017|565823904|FG000|Overall Study|Administrative problems|80|||
156747210|NCT00433017|565823905|FG001|Overall Study|Administrative problems|86|||
156747211|NCT00433017|565823904|FG000|Overall Study|Protocol Violation|1|||
156747212|NCT00433017|565823905|FG001|Overall Study|Protocol Violation|0|||
156747213|NCT00433017|565823904|FG000|Overall Study|Death|2|||
156747214|NCT00433017|565823905|FG001|Overall Study|Death|2|||
156747215|NCT00433017|565823904|FG000|Overall Study|Subject no longer requires study drug|1|||
156747216|NCT00433017|565823905|FG001|Overall Study|Subject no longer requires study drug|1|||
156747217|NCT00153816|565823906|FG000|Overall Study|Death|6|||
156747218|NCT00153816|565823907|FG001|Overall Study|Death|5|||
156747219|NCT00153816|565823908|FG002|Overall Study|Death|4|||
156747220|NCT00153816|565823909|FG003|Overall Study|Death|6|||
156747221|NCT00153816|565823910|FG004|Overall Study|Death|0|||
156747222|NCT00153816|565823911|FG005|Overall Study|Death|2|||
156747223|NCT00153816|565823906|FG000|Overall Study|Lost to Follow-up|7|||
156747224|NCT00153816|565823907|FG001|Overall Study|Lost to Follow-up|8|||
156747225|NCT00153816|565823908|FG002|Overall Study|Lost to Follow-up|5|||
156747226|NCT00153816|565823909|FG003|Overall Study|Lost to Follow-up|8|||
156747227|NCT00153816|565823910|FG004|Overall Study|Lost to Follow-up|7|||
156747228|NCT00153816|565823911|FG005|Overall Study|Lost to Follow-up|9|||
156747229|NCT00153816|565823906|FG000|Overall Study|Withdrawal by Subject|9|||
156747230|NCT00153816|565823907|FG001|Overall Study|Withdrawal by Subject|9|||
156747231|NCT00153816|565823908|FG002|Overall Study|Withdrawal by Subject|9|||
156747232|NCT00153816|565823909|FG003|Overall Study|Withdrawal by Subject|4|||
156747233|NCT00153816|565823910|FG004|Overall Study|Withdrawal by Subject|1|||
156800047|NCT00419744|566023356|FG000|Overall Study|Incorrect medication kit dispensed|0|||
156800048|NCT00419744|566023357|FG001|Overall Study|Incorrect medication kit dispensed|0|||
156800049|NCT00419744|566023358|FG002|Overall Study|Incorrect medication kit dispensed|1|||
156800050|NCT02448381|566023360|FG000|Overall Study|Adverse Event|2|||
156800051|NCT02448381|566023361|FG001|Overall Study|Adverse Event|0|||
156800052|NCT02448381|566023360|FG000|Overall Study|Lost to Follow-up|16|||
156747234|NCT00153816|565823911|FG005|Overall Study|Withdrawal by Subject|5|||
156747235|NCT00153816|565823906|FG000|Overall Study|Follow-up exam not done|8|||
156747236|NCT00153816|565823907|FG001|Overall Study|Follow-up exam not done|7|||
156747237|NCT00153816|565823908|FG002|Overall Study|Follow-up exam not done|11|||
156747238|NCT00153816|565823909|FG003|Overall Study|Follow-up exam not done|10|||
156747239|NCT00153816|565823910|FG004|Overall Study|Follow-up exam not done|8|||
156747240|NCT00153816|565823911|FG005|Overall Study|Follow-up exam not done|9|||
156747241|NCT00153816|565823906|FG000|Overall Study|Follow-up exam done, histology missing|2|||
156747242|NCT00153816|565823907|FG001|Overall Study|Follow-up exam done, histology missing|3|||
156747243|NCT00153816|565823908|FG002|Overall Study|Follow-up exam done, histology missing|3|||
156800053|NCT02448381|566023361|FG001|Overall Study|Lost to Follow-up|9|||
156747244|NCT00153816|565823909|FG003|Overall Study|Follow-up exam done, histology missing|3|||
156747245|NCT00153816|565823910|FG004|Overall Study|Follow-up exam done, histology missing|1|||
156747246|NCT00153816|565823911|FG005|Overall Study|Follow-up exam done, histology missing|2|||
156747247|NCT01937884|565823914|FG000|Overall Study|Withdrawal by Subject|1|||
156747248|NCT01937884|565823915|FG001|Overall Study|Withdrawal by Subject|0|||
156747249|NCT01167634|565823922|FG000|Overall Study|Lost to Follow-up|1|||
156747250|NCT01167634|565823923|FG001|Overall Study|Lost to Follow-up|3|||
156747251|NCT01167634|565823924|FG002|Overall Study|Lost to Follow-up|3|||
156747252|NCT01167634|565823925|FG003|Overall Study|Lost to Follow-up|4|||
156747253|NCT01167634|565823922|FG000|Overall Study|Withdrawal by Subject|1|||
156747254|NCT01167634|565823923|FG001|Overall Study|Withdrawal by Subject|1|||
156747255|NCT01167634|565823924|FG002|Overall Study|Withdrawal by Subject|0|||
156747256|NCT01167634|565823925|FG003|Overall Study|Withdrawal by Subject|0|||
156747257|NCT00821015|565823930|FG000|Overall Study|Lost to Follow-up|12|||
156747258|NCT01887678|565823936|FG000|Overall Study|Adverse Event|4|||
156747259|NCT01887678|565823937|FG001|Overall Study|Adverse Event|6|||
156747260|NCT01887678|565823936|FG000|Overall Study|Exceeded rescue medication dosage|4|||
156747261|NCT01887678|565823937|FG001|Overall Study|Exceeded rescue medication dosage|5|||
156747262|NCT01887678|565823936|FG000|Overall Study|Withdrawal of consent|3|||
156747263|NCT01887678|565823937|FG001|Overall Study|Withdrawal of consent|4|||
156747264|NCT01887678|565823936|FG000|Overall Study|Lost to Follow-up|4|||
156747265|NCT01887678|565823937|FG001|Overall Study|Lost to Follow-up|2|||
156747266|NCT01887678|565823936|FG000|Overall Study|Deterioration of clinical condition|0|||
156747267|NCT01887678|565823937|FG001|Overall Study|Deterioration of clinical condition|4|||
156747268|NCT01887678|565823936|FG000|Overall Study|Lack of Efficacy|1|||
156747269|NCT01887678|565823937|FG001|Overall Study|Lack of Efficacy|2|||
156747270|NCT01887678|565823936|FG000|Overall Study|Non-compliance|0|||
156747271|NCT01887678|565823937|FG001|Overall Study|Non-compliance|3|||
156747272|NCT01887678|565823936|FG000|Overall Study|Specified|1|||
156747273|NCT01887678|565823937|FG001|Overall Study|Specified|2|||
156747274|NCT03013985|565823938|FG000|Overall Study|Protocol Violation|2|||
156747275|NCT03013985|565823939|FG001|Overall Study|Protocol Violation|2|||
156747276|NCT03013985|565823938|FG000|Overall Study|Withdrawal by Subject|14|||
156747277|NCT03013985|565823939|FG001|Overall Study|Withdrawal by Subject|17|||
156747278|NCT03411902|565823940|FG000|Overall Study|Lost to Follow-up|3|||
156747279|NCT03411902|565823941|FG001|Overall Study|Lost to Follow-up|0|||
156747280|NCT00791492|565823944|FG000|Overall Study|Withdrawal by Subject|1|||
156747281|NCT00791492|565823945|FG001|Overall Study|Withdrawal by Subject|2|||
156747282|NCT00791492|565823944|FG000|Overall Study|Liver transplantation|5|||
156747283|NCT00791492|565823945|FG001|Overall Study|Liver transplantation|1|||
156747284|NCT00076999|565823950|FG000|Overall Study|Adverse Event|2|||
157220557|NCT03361956|567553381|FG004|Overall Study|Withdrawal by Subject|3|||
157220558|NCT03361956|567553377|FG000|Overall Study|Disease Relapse|0|||
157220559|NCT03361956|567553378|FG001|Overall Study|Disease Relapse|0|||
157220560|NCT03361956|567553379|FG002|Overall Study|Disease Relapse|1|||
157220561|NCT03361956|567553380|FG003|Overall Study|Disease Relapse|0|||
157220562|NCT03361956|567553381|FG004|Overall Study|Disease Relapse|0|||
157220563|NCT03361956|567553377|FG000|Overall Study|Physician Decision|0|||
156800054|NCT02448381|566023360|FG000|Overall Study|Physician Decision|1|||
156800055|NCT02448381|566023361|FG001|Overall Study|Physician Decision|1|||
156800056|NCT02448381|566023360|FG000|Overall Study|Pregnancy|1|||
156800057|NCT02448381|566023361|FG001|Overall Study|Pregnancy|0|||
156800058|NCT02448381|566023360|FG000|Overall Study|Withdrawal by Subject|13|||
156800059|NCT02448381|566023361|FG001|Overall Study|Withdrawal by Subject|9|||
156800060|NCT02448381|566023360|FG000|Overall Study|Noncompliance with Study Procedures|2|||
157220564|NCT03361956|567553378|FG001|Overall Study|Physician Decision|2|||
157220565|NCT03361956|567553379|FG002|Overall Study|Physician Decision|0|||
157220566|NCT03361956|567553380|FG003|Overall Study|Physician Decision|1|||
157220567|NCT03361956|567553381|FG004|Overall Study|Physician Decision|0|||
157220568|NCT03361956|567553377|FG000|Overall Study|Lost to Follow-up|0|||
157220569|NCT03361956|567553378|FG001|Overall Study|Lost to Follow-up|0|||
157220570|NCT03361956|567553379|FG002|Overall Study|Lost to Follow-up|1|||
157220571|NCT03361956|567553380|FG003|Overall Study|Lost to Follow-up|1|||
157220572|NCT03361956|567553381|FG004|Overall Study|Lost to Follow-up|2|||
156800061|NCT02448381|566023361|FG001|Overall Study|Noncompliance with Study Procedures|0|||
157220573|NCT03760510|567553382|FG000|Overall Study|Not ventilated for 24 hours|105|||
157220574|NCT03760510|567553383|FG001|Overall Study|Not ventilated for 24 hours|97|||
157220575|NCT00871728|567553385|FG000|Overall Study|Adverse Event|1|||
157220576|NCT00871728|567553385|FG000|Overall Study|Protocol Violation|7|||
157220577|NCT00871728|567553385|FG000|Overall Study|Lost to Follow-up|2|||
157220578|NCT00871728|567553385|FG000|Overall Study|Failed to Visit Hospital|4|||
156747285|NCT00076999|565823951|FG001|Overall Study|Adverse Event|8|||
156747286|NCT00076999|565823952|FG002|Overall Study|Adverse Event|6|||
156747287|NCT00076999|565823953|FG003|Overall Study|Adverse Event|0|||
156800062|NCT00583219|566023362|FG000|Phase 2|Withdrawal by Subject|1|||
157220579|NCT00871728|567553385|FG000|Overall Study|Participant Non-compliance|1|||
157220580|NCT00871728|567553385|FG000|Overall Study|Withdrawal of Informed Consent|5|||
157220581|NCT04147715|567553386|FG000|Overall Study|Adverse Event|0|||
157220582|NCT04147715|567553387|FG001|Overall Study|Adverse Event|0|||
157220583|NCT04147715|567553388|FG002|Overall Study|Adverse Event|0|||
157220584|NCT04147715|567553389|FG003|Overall Study|Adverse Event|0|||
157220585|NCT04147715|567553390|FG004|Overall Study|Adverse Event|0|||
157220586|NCT04147715|567553391|FG005|Overall Study|Adverse Event|0|||
157220587|NCT04147715|567553392|FG006|Overall Study|Adverse Event|0|||
157220588|NCT04147715|567553393|FG007|Overall Study|Adverse Event|2|||
157220589|NCT04147715|567553394|FG008|Overall Study|Adverse Event|1|||
157220590|NCT04147715|567553395|FG009|Overall Study|Adverse Event|0|||
156747288|NCT00076999|565823954|FG004|Overall Study|Adverse Event|2|||
157220591|NCT04147715|567553396|FG010|Overall Study|Adverse Event|0|||
157220592|NCT04147715|567553397|FG011|Overall Study|Adverse Event|0|||
157220593|NCT02418910|567553401|FG000|Overall Study|Lost to Follow-up|3|||
157220594|NCT02418910|567553401|FG000|Overall Study|Withdrawal by Subject|4|||
157220595|NCT02472977|567553406|FG000|Overall Study|Disease progression|4|||
157220596|NCT02472977|567553407|FG001|Overall Study|Disease progression|25|||
157220597|NCT02472977|567553408|FG002|Overall Study|Disease progression|6|||
157220598|NCT02472977|567553406|FG000|Overall Study|Withdrawal by Subject|0|||
157220599|NCT02472977|567553407|FG001|Overall Study|Withdrawal by Subject|1|||
157220600|NCT02472977|567553408|FG002|Overall Study|Withdrawal by Subject|0|||
157220601|NCT02472977|567553406|FG000|Overall Study|Study drug toxicity|2|||
157220602|NCT02472977|567553407|FG001|Overall Study|Study drug toxicity|0|||
157220603|NCT02472977|567553408|FG002|Overall Study|Study drug toxicity|2|||
157220604|NCT02472977|567553406|FG000|Overall Study|Subject request to discontinue treatment|0|||
157220605|NCT02472977|567553407|FG001|Overall Study|Subject request to discontinue treatment|1|||
157220606|NCT02472977|567553408|FG002|Overall Study|Subject request to discontinue treatment|0|||
157220607|NCT03775681|567553414|FG000|Overall Study|Physician Decision|3|||
157220608|NCT00616928|567553415|FG000|Overall Study|Adverse Event|6|||
157220609|NCT00616928|567553416|FG001|Overall Study|Adverse Event|3|||
157220610|NCT00616928|567553417|FG002|Overall Study|Adverse Event|2|||
157220611|NCT00616928|567553418|FG003|Overall Study|Adverse Event|2|||
157220612|NCT00616928|567553415|FG000|Overall Study|Other|51|||
157220613|NCT00616928|567553416|FG001|Overall Study|Other|8|||
157220614|NCT00616928|567553417|FG002|Overall Study|Other|15|||
157220615|NCT00616928|567553418|FG003|Overall Study|Other|5|||
157220616|NCT00616928|567553415|FG000|Overall Study|Lost to Follow-up|5|||
157220617|NCT00616928|567553416|FG001|Overall Study|Lost to Follow-up|7|||
157220618|NCT00616928|567553417|FG002|Overall Study|Lost to Follow-up|0|||
157220619|NCT00616928|567553418|FG003|Overall Study|Lost to Follow-up|0|||
157220620|NCT00895583|567553419|FG000|Overall Study|Adverse Event|28|||
157220621|NCT00895583|567553420|FG001|Overall Study|Adverse Event|4|||
157220622|NCT00895583|567553419|FG000|Overall Study|Death|2|||
157220623|NCT00895583|567553420|FG001|Overall Study|Death|1|||
157220624|NCT00895583|567553419|FG000|Overall Study|Physician Decision|3|||
157220625|NCT00895583|567553420|FG001|Overall Study|Physician Decision|1|||
157220626|NCT00895583|567553419|FG000|Overall Study|Lost to Follow-up|1|||
157220627|NCT00895583|567553420|FG001|Overall Study|Lost to Follow-up|3|||
157220628|NCT00895583|567553419|FG000|Overall Study|Protocol Violation|1|||
157220629|NCT00895583|567553420|FG001|Overall Study|Protocol Violation|0|||
157220630|NCT00895583|567553419|FG000|Overall Study|Withdrawal by Subject|4|||
157220631|NCT00895583|567553420|FG001|Overall Study|Withdrawal by Subject|2|||
157220632|NCT00895583|567553419|FG000|Overall Study|Lack of Efficacy|5|||
157220633|NCT00895583|567553420|FG001|Overall Study|Lack of Efficacy|0|||
157220634|NCT00895583|567553419|FG000|Overall Study|Other|0|||
157220635|NCT00895583|567553420|FG001|Overall Study|Other|1|||
157220636|NCT04535583|567553431|FG000|Overall Study|Lost to Follow-up|1|||
157220637|NCT04535583|567553431|FG000|Overall Study|Physician Decision|1|||
157220638|NCT04535583|567553431|FG000|Overall Study|Withdrawal by Subject|1|||
157220639|NCT01078090|567553432|FG000|Overall Study|Lost to Follow-up|2363|||
157220640|NCT01078090|567553432|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
157220641|NCT01078090|567553432|FG000|Overall Study|Lack of Efficacy|1193|||
157220642|NCT01078090|567553432|FG000|Overall Study|ADR and lack of efficacy|61|||
157220643|NCT01078090|567553432|FG000|Overall Study|Other|523|||
157220644|NCT01748890|567553434|FG000|Overall Study|Insufficient recruitment for analysis|4|||
157220645|NCT02669264|567553435|FG000|Overall Study|Death|5|||
157220646|NCT02669264|567553436|FG001|Overall Study|Death|5|||
157220647|NCT02669264|567553437|FG002|Overall Study|Death|3|||
157220648|NCT02669264|567553438|FG003|Overall Study|Death|3|||
156747289|NCT00076999|565823950|FG000|Overall Study|Protocol Violation|0|||
156747290|NCT00076999|565823951|FG001|Overall Study|Protocol Violation|3|||
156747291|NCT00076999|565823952|FG002|Overall Study|Protocol Violation|4|||
156747292|NCT00076999|565823953|FG003|Overall Study|Protocol Violation|0|||
157220649|NCT02669264|567553439|FG004|Overall Study|Death|3|||
157220650|NCT02669264|567553440|FG005|Overall Study|Death|6|||
157220651|NCT02669264|567553441|FG006|Overall Study|Death|3|||
157220652|NCT02669264|567553435|FG000|Overall Study|Withdrawal by Subject|0|||
157220653|NCT02669264|567553436|FG001|Overall Study|Withdrawal by Subject|1|||
156747293|NCT00076999|565823954|FG004|Overall Study|Protocol Violation|9|||
157220654|NCT02669264|567553437|FG002|Overall Study|Withdrawal by Subject|0|||
157220655|NCT02669264|567553438|FG003|Overall Study|Withdrawal by Subject|0|||
156747294|NCT00076999|565823950|FG000|Overall Study|Lost to Follow-up|2|||
156747295|NCT00076999|565823951|FG001|Overall Study|Lost to Follow-up|1|||
156747296|NCT00076999|565823952|FG002|Overall Study|Lost to Follow-up|0|||
156747297|NCT00076999|565823953|FG003|Overall Study|Lost to Follow-up|0|||
156747298|NCT00076999|565823954|FG004|Overall Study|Lost to Follow-up|0|||
156747299|NCT00076999|565823950|FG000|Overall Study|Withdrawal by Subject|0|||
156747300|NCT00076999|565823951|FG001|Overall Study|Withdrawal by Subject|4|||
156747301|NCT00076999|565823952|FG002|Overall Study|Withdrawal by Subject|3|||
156747302|NCT00076999|565823953|FG003|Overall Study|Withdrawal by Subject|0|||
156747303|NCT00076999|565823954|FG004|Overall Study|Withdrawal by Subject|1|||
156747304|NCT00076999|565823950|FG000|Overall Study|Other reason (not specified)|8|||
156747305|NCT00076999|565823951|FG001|Overall Study|Other reason (not specified)|8|||
156747306|NCT00076999|565823952|FG002|Overall Study|Other reason (not specified)|4|||
156747307|NCT00076999|565823953|FG003|Overall Study|Other reason (not specified)|1|||
156747308|NCT00076999|565823954|FG004|Overall Study|Other reason (not specified)|13|||
156747309|NCT01217385|565823957|FG000|Overall Study|Withdrawal by Subject|3|||
156747310|NCT01217385|565823957|FG000|Overall Study|DOSI not performed/not eval|12|||
156747311|NCT01217385|565823957|FG000|Overall Study|Central Path not Available|1|||
156747312|NCT01217385|565823957|FG000|Overall Study|Normal Breast TOI not available|10|||
156747313|NCT00090987|565823958|FG000|Overall Study|Adverse Event|5|||
156747314|NCT00090987|565823958|FG000|Overall Study|Lack of Efficacy|7|||
156747315|NCT00090987|565823958|FG000|Overall Study|Withdrawal by Subject|3|||
156747316|NCT00090987|565823958|FG000|Overall Study|alternative therapy|1|||
156747317|NCT00090987|565823958|FG000|Overall Study|Non-compliance|4|||
156747318|NCT00090987|565823958|FG000|Overall Study|Incarcerated|1|||
156747319|NCT00990665|565823963|FG000|Overall Study|Unsuccessful Implant|8|||
156747320|NCT00990665|565823963|FG000|Overall Study|Death|29|||
156747321|NCT00990665|565823963|FG000|Overall Study|Heart Transplant|1|||
156747322|NCT00990665|565823963|FG000|Overall Study|Withdrawal by Subject|6|||
156747323|NCT00990665|565823963|FG000|Overall Study|Lost to Follow-up|1|||
156747324|NCT00990665|565823963|FG000|Overall Study|System Explant|3|||
156747325|NCT02603562|565823964|FG000|Overall Study|Lost to Follow-up|1|||
156747326|NCT00270231|565823965|FG000|First Intervention|Lost to Follow-up|1|||
156747327|NCT00270231|565823966|FG001|First Intervention|Lost to Follow-up|1|||
156747328|NCT00270231|565823965|FG000|Washout Period|Lost to Follow-up|1|||
156747329|NCT00270231|565823966|FG001|Washout Period|Lost to Follow-up|0|||
156747330|NCT00270231|565823965|FG000|Second Intervention|Lost to Follow-up|0|||
156747331|NCT00270231|565823966|FG001|Second Intervention|Lost to Follow-up|1|||
156747332|NCT01534208|565823971|FG000|Overall Study|Lost to Follow-up|19|||
156747333|NCT01534208|565823972|FG001|Overall Study|Lost to Follow-up|14|||
156747334|NCT01534208|565823971|FG000|Overall Study|Withdrawal by Subject|6|||
156747335|NCT01534208|565823972|FG001|Overall Study|Withdrawal by Subject|20|||
156747336|NCT01534208|565823971|FG000|Overall Study|Adverse Event|15|||
156747337|NCT01534208|565823972|FG001|Overall Study|Adverse Event|8|||
156747338|NCT01534208|565823971|FG000|Overall Study|Physician Decision|2|||
156747339|NCT01534208|565823972|FG001|Overall Study|Physician Decision|0|||
156747340|NCT01534208|565823971|FG000|Overall Study|Lack of Efficacy|0|||
156747341|NCT01534208|565823972|FG001|Overall Study|Lack of Efficacy|3|||
156747342|NCT01534208|565823971|FG000|Overall Study|Protocol Violation|2|||
156747343|NCT01534208|565823972|FG001|Overall Study|Protocol Violation|2|||
156747344|NCT01534208|565823971|FG000|Overall Study|Sponsor decision|4|||
156747345|NCT01534208|565823972|FG001|Overall Study|Sponsor decision|1|||
156747346|NCT01534208|565823971|FG000|Overall Study|Subject relocation|2|||
156747347|NCT01534208|565823972|FG001|Overall Study|Subject relocation|0|||
156747348|NCT01534208|565823971|FG000|Overall Study|Lab assessment|2|||
156747349|NCT01534208|565823972|FG001|Overall Study|Lab assessment|1|||
156747350|NCT01534208|565823971|FG000|Overall Study|Eligibility error|3|||
156800063|NCT02037529|566023363|FG000|Overall Study|Withdrawal by Subject|1|||
156800064|NCT02037529|566023364|FG001|Overall Study|Withdrawal by Subject|3|||
156800065|NCT02037529|566023363|FG000|Overall Study|Adverse Event|0|||
156800066|NCT02037529|566023364|FG001|Overall Study|Adverse Event|1|||
156800067|NCT02131766|566023365|FG000|Overall Study|Withdrawal by Subject|4|||
156800068|NCT00754572|566023366|FG000|Overall Study|Adverse Event|19|||
156800069|NCT00754572|566023366|FG000|Overall Study|Other|39|||
156747351|NCT01534208|565823972|FG001|Overall Study|Eligibility error|0|||
156800070|NCT00754572|566023366|FG000|Overall Study|Protocol Violation|3|||
156747352|NCT01534208|565823971|FG000|Overall Study|PCP decision|1|||
156747353|NCT01534208|565823972|FG001|Overall Study|PCP decision|0|||
156747354|NCT01534208|565823971|FG000|Overall Study|Needed prohibited meds|1|||
156747355|NCT01534208|565823972|FG001|Overall Study|Needed prohibited meds|0|||
156747356|NCT02117713|565823983|FG000|Week 48|Adverse Event|4|||
156747357|NCT02117713|565823983|FG000|Week 48|Withdrawal by caregiver|2|||
156747358|NCT02117713|565823983|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
156747359|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
156747360|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
156747361|NCT02117713|565823983|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
156800071|NCT00754572|566023366|FG000|Overall Study|Withdrawal by Subject|3|||
156800072|NCT00754572|566023366|FG000|Overall Study|Lack of Efficacy|2|||
156800073|NCT00754572|566023366|FG000|Overall Study|Death|1|||
156800074|NCT00754572|566023366|FG000|Overall Study|Administrative Reason|3|||
156800075|NCT00754572|566023366|FG000|Overall Study|Lost to Follow-up|1|||
156800076|NCT00718315|566023368|FG000|Overall Study|Adverse Event|1|||
156800077|NCT00718315|566023369|FG001|Overall Study|Adverse Event|2|||
156800078|NCT00718315|566023370|FG002|Overall Study|Adverse Event|3|||
157220656|NCT02669264|567553439|FG004|Overall Study|Withdrawal by Subject|1|||
156747362|NCT00574795|565823984|FG000|Infant Series|Withdrawal by Subject|2|||
156747363|NCT00574795|565823984|FG000|Infant Series|Protocol Violation|2|||
156747364|NCT00574795|565823984|FG000|Infant Series|Adverse Event|1|||
156747365|NCT00574795|565823984|FG000|After Infant Series|Withdrawal by Subject|1|||
156747366|NCT00574795|565823984|FG000|After Infant Series|Adverse Event|2|||
156747367|NCT00574795|565823984|FG000|Toddler Dose|Withdrawal by Subject|1|||
156747368|NCT00672841|565823985|FG000|Overall Study|Comfort care|1|||
156747369|NCT00672841|565823986|FG001|Overall Study|Comfort care|4|||
156747370|NCT00672841|565823985|FG000|Overall Study|icteric specimens|0|||
156747371|NCT00672841|565823986|FG001|Overall Study|icteric specimens|3|||
156747372|NCT00672841|565823985|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
156747373|NCT00672841|565823986|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
156747374|NCT00672841|565823985|FG000|Overall Study|Adverse Event|0|||
156747375|NCT00672841|565823986|FG001|Overall Study|Adverse Event|3|||
156747376|NCT00672841|565823985|FG000|Overall Study|Pregnancy|0|||
156747377|NCT00672841|565823986|FG001|Overall Study|Pregnancy|1|||
156747378|NCT02638259|565823987|FG000|Treatment Period 1|Adverse Event|1|||
156747379|NCT02638259|565823988|FG001|Treatment Period 1|Adverse Event|5|||
156747380|NCT02638259|565823987|FG000|Treatment Period 1|Death|0|||
156747381|NCT02638259|565823988|FG001|Treatment Period 1|Death|1|||
156747382|NCT02638259|565823987|FG000|Treatment Period 1|Lack of Efficacy|0|||
156747383|NCT02638259|565823988|FG001|Treatment Period 1|Lack of Efficacy|1|||
156747384|NCT02638259|565823987|FG000|Treatment Period 1|Protocol Violation|0|||
156747385|NCT02638259|565823988|FG001|Treatment Period 1|Protocol Violation|3|||
156747386|NCT02638259|565823987|FG000|Treatment Period 1|Withdrawal by Subject|4|||
156747387|NCT02638259|565823988|FG001|Treatment Period 1|Withdrawal by Subject|6|||
156747388|NCT02638259|565823987|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
156747389|NCT02638259|565823988|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
156747390|NCT02638259|565823987|FG000|Treatment Period 2|Adverse Event|5|||
156747391|NCT02638259|565823988|FG001|Treatment Period 2|Adverse Event|4|||
156747392|NCT02638259|565823987|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156747393|NCT02638259|565823988|FG001|Treatment Period 2|Withdrawal by Subject|7|||
156747394|NCT04299048|565823989|FG000|Overall Study|Death|1|||
156747395|NCT04299048|565823989|FG000|Overall Study|Global deterioration of health status|2|||
156747396|NCT04299048|565823989|FG000|Overall Study|Enrolled and not treated|1|||
156747397|NCT01094782|565823991|FG000|Overall Study|Withdrawal by Subject|5|||
156747398|NCT01094782|565823992|FG001|Overall Study|Withdrawal by Subject|5|||
156747399|NCT01094782|565823993|FG002|Overall Study|Withdrawal by Subject|1|||
156747400|NCT01094782|565823994|FG003|Overall Study|Withdrawal by Subject|5|||
156747401|NCT01094782|565823995|FG004|Overall Study|Withdrawal by Subject|5|||
156747402|NCT01094782|565823996|FG005|Overall Study|Withdrawal by Subject|0|||
156747403|NCT01094782|565823991|FG000|Overall Study|Lost to Follow-up|1|||
156747404|NCT01094782|565823992|FG001|Overall Study|Lost to Follow-up|0|||
156747405|NCT01094782|565823993|FG002|Overall Study|Lost to Follow-up|0|||
156747406|NCT01094782|565823994|FG003|Overall Study|Lost to Follow-up|2|||
156747407|NCT01094782|565823995|FG004|Overall Study|Lost to Follow-up|1|||
156747408|NCT01094782|565823996|FG005|Overall Study|Lost to Follow-up|4|||
156747409|NCT01094782|565823991|FG000|Overall Study|Positive Drug Screen|2|||
156747410|NCT01094782|565823992|FG001|Overall Study|Positive Drug Screen|2|||
156747411|NCT01094782|565823993|FG002|Overall Study|Positive Drug Screen|1|||
156747412|NCT01094782|565823994|FG003|Overall Study|Positive Drug Screen|1|||
156747413|NCT01094782|565823995|FG004|Overall Study|Positive Drug Screen|3|||
156747414|NCT01094782|565823996|FG005|Overall Study|Positive Drug Screen|2|||
156747415|NCT01094782|565823991|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
156747416|NCT01094782|565823992|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
156747417|NCT01094782|565823993|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
156747418|NCT01094782|565823994|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
156800079|NCT00718315|566023368|FG000|Overall Study|Death|6|||
156747419|NCT01094782|565823995|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
156747420|NCT01094782|565823996|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
156747421|NCT01094782|565823991|FG000|Overall Study|Unable to Complete Questionnaires|0|||
156747422|NCT01094782|565823992|FG001|Overall Study|Unable to Complete Questionnaires|1|||
156747423|NCT01094782|565823993|FG002|Overall Study|Unable to Complete Questionnaires|0|||
156747424|NCT01094782|565823994|FG003|Overall Study|Unable to Complete Questionnaires|0|||
156747425|NCT01094782|565823995|FG004|Overall Study|Unable to Complete Questionnaires|0|||
156747426|NCT01094782|565823996|FG005|Overall Study|Unable to Complete Questionnaires|0|||
156747427|NCT01094782|565823991|FG000|Overall Study|Healthy Subject Had Pain|0|||
156747428|NCT01094782|565823992|FG001|Overall Study|Healthy Subject Had Pain|1|||
156800080|NCT00718315|566023369|FG001|Overall Study|Death|6|||
157143598|NCT00430781|567274208|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
156747429|NCT01094782|565823993|FG002|Overall Study|Healthy Subject Had Pain|0|||
156747430|NCT01094782|565823994|FG003|Overall Study|Healthy Subject Had Pain|0|||
156747431|NCT01094782|565823995|FG004|Overall Study|Healthy Subject Had Pain|0|||
156747432|NCT01094782|565823996|FG005|Overall Study|Healthy Subject Had Pain|0|||
156747433|NCT01094782|565823991|FG000|Overall Study|Hypertension|0|||
156747434|NCT01094782|565823992|FG001|Overall Study|Hypertension|0|||
156747435|NCT01094782|565823993|FG002|Overall Study|Hypertension|1|||
156747436|NCT01094782|565823994|FG003|Overall Study|Hypertension|0|||
156747437|NCT01094782|565823995|FG004|Overall Study|Hypertension|0|||
156747438|NCT01094782|565823996|FG005|Overall Study|Hypertension|0|||
156747439|NCT01094782|565823991|FG000|Overall Study|Wrong Pain Condition|0|||
156747440|NCT01094782|565823992|FG001|Overall Study|Wrong Pain Condition|0|||
156747441|NCT01094782|565823993|FG002|Overall Study|Wrong Pain Condition|0|||
156747442|NCT01094782|565823994|FG003|Overall Study|Wrong Pain Condition|2|||
156747443|NCT01094782|565823995|FG004|Overall Study|Wrong Pain Condition|1|||
156747444|NCT01094782|565823996|FG005|Overall Study|Wrong Pain Condition|1|||
156747445|NCT01094782|565823991|FG000|Overall Study|Recent Interventional Injection|0|||
156747446|NCT01094782|565823992|FG001|Overall Study|Recent Interventional Injection|0|||
156747447|NCT01094782|565823993|FG002|Overall Study|Recent Interventional Injection|0|||
156747448|NCT01094782|565823994|FG003|Overall Study|Recent Interventional Injection|0|||
156747449|NCT01094782|565823995|FG004|Overall Study|Recent Interventional Injection|0|||
156747450|NCT01094782|565823996|FG005|Overall Study|Recent Interventional Injection|1|||
156747451|NCT01094782|565823991|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747452|NCT01094782|565823992|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747453|NCT01094782|565823993|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747454|NCT01094782|565823994|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747455|NCT01094782|565823995|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
156747456|NCT01094782|565823996|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
156747457|NCT01094782|565823991|FG000|Overall Study|Noncompliance With Study Schedule|0|||
156747458|NCT01094782|565823992|FG001|Overall Study|Noncompliance With Study Schedule|0|||
156747459|NCT01094782|565823993|FG002|Overall Study|Noncompliance With Study Schedule|0|||
156747460|NCT01094782|565823994|FG003|Overall Study|Noncompliance With Study Schedule|1|||
156747461|NCT01094782|565823995|FG004|Overall Study|Noncompliance With Study Schedule|0|||
156747462|NCT01094782|565823996|FG005|Overall Study|Noncompliance With Study Schedule|0|||
156747463|NCT01717391|565823999|FG000|Overall Study|Withdrawal by Subject|5|||
156747464|NCT01717391|565823999|FG000|Overall Study|Physician Decision|1|||
156747465|NCT01717391|565823999|FG000|Overall Study|FLT technical failure|3|||
156747466|NCT00957905|565824000|FG000|Part B|Not Treated|0|||
156747467|NCT00957905|565824001|FG001|Part B|Not Treated|1|||
156747468|NCT00957905|565824000|FG000|Part B|Physician Decision|0|||
156747469|NCT00957905|565824001|FG001|Part B|Physician Decision|1|||
156747470|NCT00957905|565824000|FG000|Part B|Death|0|||
156747471|NCT00957905|565824001|FG001|Part B|Death|1|||
156747472|NCT00957905|565824000|FG000|Part B|Protocol Violation|0|||
156747473|NCT00957905|565824001|FG001|Part B|Protocol Violation|1|||
156747474|NCT03434249|565824004|FG000|Overall Study|Adverse Event|1|||
156747475|NCT03434249|565824005|FG001|Overall Study|Adverse Event|0|||
156747476|NCT03434249|565824004|FG000|Overall Study|Lost to Follow-up|0|||
156747477|NCT03434249|565824005|FG001|Overall Study|Lost to Follow-up|1|||
156747478|NCT03434249|565824004|FG000|Overall Study|Non-compliance of family|2|||
156747479|NCT03434249|565824005|FG001|Overall Study|Non-compliance of family|1|||
156747480|NCT03434249|565824004|FG000|Overall Study|Difficulties in completing daily diary|2|||
156747481|NCT03434249|565824005|FG001|Overall Study|Difficulties in completing daily diary|1|||
156747482|NCT02450552|565824006|FG000|Overall Study|Withdrawal by Subject|4|||
156747483|NCT02450552|565824007|FG001|Overall Study|Withdrawal by Subject|0|||
156747484|NCT02450552|565824008|FG002|Overall Study|Withdrawal by Subject|4|||
156747485|NCT02450552|565824006|FG000|Overall Study|Physician Decision|1|||
156747486|NCT02450552|565824007|FG001|Overall Study|Physician Decision|0|||
157143599|NCT00430781|567274209|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
156747487|NCT02450552|565824008|FG002|Overall Study|Physician Decision|1|||
156747488|NCT01969084|565824012|FG000|Overall Study|Adverse Event|0|||
156747489|NCT01969084|565824013|FG001|Overall Study|Adverse Event|1|||
156747490|NCT05079230|565824014|FG000|Overall Study|Study Terminated by Sponsor|101|||
156747491|NCT05079230|565824015|FG001|Overall Study|Study Terminated by Sponsor|102|||
156747492|NCT05079230|565824014|FG000|Overall Study|Death|72|||
156800081|NCT00718315|566023370|FG002|Overall Study|Death|5|||
156800082|NCT00718315|566023368|FG000|Overall Study|Lost to Follow-up|2|||
156800083|NCT00718315|566023369|FG001|Overall Study|Lost to Follow-up|3|||
156800084|NCT00718315|566023370|FG002|Overall Study|Lost to Follow-up|4|||
156800085|NCT00718315|566023368|FG000|Overall Study|Protocol Violation|5|||
157143600|NCT00430781|567274210|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
156800086|NCT00718315|566023369|FG001|Overall Study|Protocol Violation|5|||
156747493|NCT05079230|565824015|FG001|Overall Study|Death|66|||
156747494|NCT05079230|565824014|FG000|Overall Study|Withdrew Consent|16|||
156747495|NCT05079230|565824015|FG001|Overall Study|Withdrew Consent|18|||
157143601|NCT05408858|567274211|FG000|Overall Study|no longer met eligibility criteria|1|||
157020709|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
157020710|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
156747496|NCT05079230|565824014|FG000|Overall Study|Lost to Follow-up|0|||
156747497|NCT05079230|565824015|FG001|Overall Study|Lost to Follow-up|3|||
156747498|NCT02920177|565824016|FG000|Overall Study|Withdrawal by Subject|1|||
156747499|NCT02920177|565824017|FG001|Overall Study|Withdrawal by Subject|1|||
156747500|NCT02920177|565824016|FG000|Overall Study|Physician Decision|1|||
156747501|NCT02920177|565824017|FG001|Overall Study|Physician Decision|0|||
156747502|NCT02920177|565824016|FG000|Overall Study|Lost to Follow-up|0|||
156747503|NCT02920177|565824017|FG001|Overall Study|Lost to Follow-up|1|||
156747504|NCT03164265|565824018|FG000|Overall Study|Physician Decision|3|||
156747505|NCT03053427|565824019|FG000|Overall Study|Adverse Event|4|||
156747506|NCT03053427|565824020|FG001|Overall Study|Adverse Event|4|||
156747507|NCT03053427|565824019|FG000|Overall Study|Lack of Efficacy|1|||
156747508|NCT03053427|565824020|FG001|Overall Study|Lack of Efficacy|3|||
156747509|NCT03053427|565824019|FG000|Overall Study|Lost to Follow-up|2|||
156747510|NCT03053427|565824020|FG001|Overall Study|Lost to Follow-up|2|||
156747511|NCT03053427|565824019|FG000|Overall Study|Worsening of the target disease|0|||
156747512|NCT03053427|565824020|FG001|Overall Study|Worsening of the target disease|1|||
156747513|NCT03053427|565824019|FG000|Overall Study|Protocol Deviation|3|||
156747514|NCT03053427|565824020|FG001|Overall Study|Protocol Deviation|3|||
156747515|NCT03053427|565824019|FG000|Overall Study|Withdrawal by Subject|3|||
156747516|NCT03053427|565824020|FG001|Overall Study|Withdrawal by Subject|2|||
156747517|NCT03053427|565824019|FG000|Overall Study|Miscellaneous|0|||
156747518|NCT03053427|565824020|FG001|Overall Study|Miscellaneous|1|||
156747519|NCT02607306|565824029|FG000|Overall Study|Adverse Event|8|||
156747520|NCT02607306|565824030|FG001|Overall Study|Adverse Event|6|||
156747521|NCT02607306|565824031|FG002|Overall Study|Adverse Event|6|||
156747522|NCT02607306|565824029|FG000|Overall Study|Unclassified|1|||
156747523|NCT02607306|565824030|FG001|Overall Study|Unclassified|4|||
156747524|NCT02607306|565824031|FG002|Overall Study|Unclassified|0|||
156747525|NCT02607306|565824029|FG000|Overall Study|Withdrawal by Subject|8|||
156747526|NCT02607306|565824030|FG001|Overall Study|Withdrawal by Subject|10|||
156747527|NCT02607306|565824031|FG002|Overall Study|Withdrawal by Subject|2|||
156747528|NCT02607306|565824029|FG000|Overall Study|Lack of Efficacy|0|||
156747529|NCT02607306|565824030|FG001|Overall Study|Lack of Efficacy|1|||
156747530|NCT02607306|565824031|FG002|Overall Study|Lack of Efficacy|1|||
156747531|NCT02607306|565824029|FG000|Overall Study|Protocol Violation|4|||
156747532|NCT02607306|565824030|FG001|Overall Study|Protocol Violation|2|||
156747533|NCT02607306|565824031|FG002|Overall Study|Protocol Violation|1|||
156747534|NCT02360475|565824032|FG000|Overall Study|Lost to Follow-up|4|||
156747535|NCT02360475|565824033|FG001|Overall Study|Lost to Follow-up|12|||
156747536|NCT02360475|565824034|FG002|Overall Study|Lost to Follow-up|6|||
156747537|NCT02360475|565824035|FG003|Overall Study|Lost to Follow-up|4|||
156747538|NCT02360475|565824032|FG000|Overall Study|Withdrawal by Subject|0|||
156747539|NCT02360475|565824033|FG001|Overall Study|Withdrawal by Subject|1|||
156747540|NCT02360475|565824034|FG002|Overall Study|Withdrawal by Subject|2|||
156747541|NCT02360475|565824035|FG003|Overall Study|Withdrawal by Subject|0|||
156747542|NCT02360475|565824032|FG000|Overall Study|Migrated/moved from study area|0|||
156747543|NCT02360475|565824033|FG001|Overall Study|Migrated/moved from study area|0|||
156747544|NCT02360475|565824034|FG002|Overall Study|Migrated/moved from study area|0|||
156747545|NCT02360475|565824035|FG003|Overall Study|Migrated/moved from study area|1|||
156747546|NCT03759366|565824037|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
156747547|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
156747548|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
156747549|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
156747550|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
156747551|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
156747552|NCT03759366|565824037|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
156747553|NCT00539032|565824038|FG000|Overall Study|Withdrawal by Subject|2|||
156747554|NCT00539032|565824039|FG001|Overall Study|Withdrawal by Subject|1|||
156747555|NCT01760447|565825305|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
156747556|NCT01760447|565825306|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
156747557|NCT01760447|565825307|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
156747558|NCT01760447|565825308|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
156747559|NCT01760447|565825305|FG000|Weeks 0-20|Withdrawal by Subject|2|||
156747560|NCT01760447|565825306|FG001|Weeks 0-20|Withdrawal by Subject|0|||
156747561|NCT01760447|565825307|FG002|Weeks 0-20|Withdrawal by Subject|1|||
156747562|NCT01760447|565825308|FG003|Weeks 0-20|Withdrawal by Subject|0|||
156747563|NCT01760447|565825305|FG000|Weeks 0-20|Lost to Follow-up|1|||
156747564|NCT01760447|565825306|FG001|Weeks 0-20|Lost to Follow-up|0|||
156800087|NCT00718315|566023370|FG002|Overall Study|Protocol Violation|3|||
156800088|NCT00718315|566023368|FG000|Overall Study|Erlotinib dose decreased|4|||
156800089|NCT00718315|566023369|FG001|Overall Study|Erlotinib dose decreased|3|||
157020711|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020712|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
156800090|NCT00718315|566023370|FG002|Overall Study|Erlotinib dose decreased|1|||
156800091|NCT00718315|566023368|FG000|Overall Study|Use of Minocyclin|1|||
156800092|NCT00718315|566023369|FG001|Overall Study|Use of Minocyclin|1|||
156800093|NCT00718315|566023370|FG002|Overall Study|Use of Minocyclin|1|||
156800094|NCT00718315|566023368|FG000|Overall Study|Disease progression|0|||
156800095|NCT00718315|566023369|FG001|Overall Study|Disease progression|1|||
156800096|NCT00718315|566023370|FG002|Overall Study|Disease progression|1|||
156800097|NCT00718315|566023368|FG000|Overall Study|Other|0|||
156800098|NCT00718315|566023369|FG001|Overall Study|Other|0|||
156800099|NCT00718315|566023370|FG002|Overall Study|Other|1|||
156800100|NCT00718315|566023368|FG000|Overall Study|Use of ATB and Corticoids|0|||
156800101|NCT00718315|566023369|FG001|Overall Study|Use of ATB and Corticoids|1|||
156800102|NCT00718315|566023370|FG002|Overall Study|Use of ATB and Corticoids|2|||
156800103|NCT02271880|566023372|FG000|Overall Study|Premature discontinuation of study|3|||
156800104|NCT02271880|566023373|FG001|Overall Study|Premature discontinuation of study|4|||
156800105|NCT00474903|566023375|FG000|Overall Study|Protocol Violation|1|||
156800106|NCT00474903|566023376|FG001|Overall Study|Protocol Violation|5|||
156800107|NCT00474903|566023377|FG002|Overall Study|Protocol Violation|2|||
156800108|NCT02519842|566023378|FG000|Base Study: Cycle 1|Screening Failure|1|||
156800109|NCT02519842|566023379|FG001|Base Study: Cycle 1|Screening Failure|1|||
156800110|NCT02519842|566023380|FG002|Base Study: Cycle 1|Screening Failure|0|||
156800111|NCT02519842|566023378|FG000|Base Study: Cycle 1|Adverse Event|1|||
156800112|NCT02519842|566023379|FG001|Base Study: Cycle 1|Adverse Event|0|||
156800113|NCT02519842|566023380|FG002|Base Study: Cycle 1|Adverse Event|0|||
156800114|NCT02519842|566023378|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
156800115|NCT02519842|566023379|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
156880332|NCT02709538|566321244|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
156880333|NCT02709538|566321245|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
156880334|NCT02709538|566321246|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
156880335|NCT02709538|566321244|FG000|Overall Study|Other|16|||
156880336|NCT02709538|566321245|FG001|Overall Study|Other|7|||
156880337|NCT02709538|566321246|FG002|Overall Study|Other|5|||
156880338|NCT00835211|566321248|FG000|First Intervention|Withdrawal by Subject|0|||
156880339|NCT00835211|566321249|FG001|First Intervention|Withdrawal by Subject|1|||
156880340|NCT00835211|566321248|FG000|Washout: 7 Days|Adverse Event|2|||
156880341|NCT00835211|566321249|FG001|Washout: 7 Days|Adverse Event|1|||
156880342|NCT00835211|566321248|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
156880343|NCT00835211|566321249|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
156880344|NCT02343549|566321250|FG000|Overall Study|Death|11|||
156880345|NCT02343549|566321250|FG000|Overall Study|Withdrawal by Subject|2|||
156880346|NCT03087617|566321251|FG000|Overall Study|Lost to Follow-up|32|||
156880347|NCT03087617|566321252|FG001|Overall Study|Lost to Follow-up|30|||
156880348|NCT03087617|566321253|FG002|Overall Study|Lost to Follow-up|30|||
156880349|NCT03087617|566321254|FG003|Overall Study|Lost to Follow-up|39|||
156880350|NCT04450381|566321256|FG000|Overall Study|Protocol Violation|4|||
156880351|NCT04450381|566321256|FG000|Overall Study|Wrong device setting|2|||
156880352|NCT01864005|566321257|FG000|Overall Study|Protocol Violation|0|||
156880353|NCT01864005|566321258|FG001|Overall Study|Protocol Violation|1|||
156880354|NCT01864005|566321257|FG000|Overall Study|Withdrawal by Subject|0|||
156880355|NCT01864005|566321258|FG001|Overall Study|Withdrawal by Subject|1|||
156880356|NCT01864005|566321257|FG000|Overall Study|Incorrect enrolment|1|||
156880357|NCT01864005|566321258|FG001|Overall Study|Incorrect enrolment|0|||
156880358|NCT01864005|566321257|FG000|Overall Study|Disease need|1|||
156880359|NCT01864005|566321258|FG001|Overall Study|Disease need|1|||
156880360|NCT01864005|566321257|FG000|Overall Study|Need GP IIb/IIIa|1|||
156880361|NCT01864005|566321258|FG001|Overall Study|Need GP IIb/IIIa|3|||
156880362|NCT00763698|566321262|FG000|Overall Study|Unsuccessful Implant|5|||
156880363|NCT00763698|566321262|FG000|Overall Study|Death|4|||
156880364|NCT00763698|566321262|FG000|Overall Study|Withdrawal by Subject|1|||
156880365|NCT02184572|566321263|FG000|Overall Study|Lost to Follow-up|29|||
156880366|NCT02184572|566321264|FG001|Overall Study|Lost to Follow-up|21|||
156880367|NCT02184572|566321263|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
156880368|NCT02184572|566321264|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
156880369|NCT02184572|566321263|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
156880370|NCT02184572|566321264|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
156880371|NCT02184572|566321263|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
156880372|NCT02184572|566321264|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
156880373|NCT02184572|566321263|FG000|Overall Study|Traveling Outside The Country|1|||
156880374|NCT02184572|566321264|FG001|Overall Study|Traveling Outside The Country|0|||
156800116|NCT02519842|566023380|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
156800117|NCT02519842|566023378|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
156800118|NCT02519842|566023379|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
156800119|NCT02519842|566023380|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
156800120|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
156880375|NCT02184572|566321263|FG000|Overall Study|Withdrawal by Subject|14|||
156880376|NCT02184572|566321264|FG001|Overall Study|Withdrawal by Subject|9|||
156747565|NCT01760447|565825307|FG002|Weeks 0-20|Lost to Follow-up|1|||
156747566|NCT01760447|565825308|FG003|Weeks 0-20|Lost to Follow-up|1|||
156747567|NCT01760447|565825305|FG000|Weeks 0-20|Randomized but not treated|0|||
157020713|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020714|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020715|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020716|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020717|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020718|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
156880377|NCT03679754|566321268|FG000|Overall Study|Investigator request|1|||
156880378|NCT00964171|566321269|FG000|Overall Study|Death|5|||
156880379|NCT00080899|566321270|FG000|Overall Study|Adverse Event|1|||
156880380|NCT05343624|566321271|FG000|Overall Study|Chart review not completed|1|||
156747568|NCT01760447|565825306|FG001|Weeks 0-20|Randomized but not treated|0|||
156747569|NCT01760447|565825307|FG002|Weeks 0-20|Randomized but not treated|2|||
156747570|NCT01760447|565825308|FG003|Weeks 0-20|Randomized but not treated|0|||
156747571|NCT01760447|565825305|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747572|NCT01760447|565825306|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747573|NCT01760447|565825307|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
156747574|NCT01760447|565825308|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
156747575|NCT01760447|565825305|FG000|Weeks 20-54|Withdrawal by Subject|2|||
156747576|NCT01760447|565825306|FG001|Weeks 20-54|Withdrawal by Subject|1|||
156747577|NCT01760447|565825307|FG002|Weeks 20-54|Withdrawal by Subject|1|||
156747578|NCT01760447|565825308|FG003|Weeks 20-54|Withdrawal by Subject|2|||
156747579|NCT01760447|565825305|FG000|Weeks 20-54|Lost to Follow-up|0|||
156747580|NCT01760447|565825306|FG001|Weeks 20-54|Lost to Follow-up|0|||
156747581|NCT01760447|565825307|FG002|Weeks 20-54|Lost to Follow-up|1|||
156747582|NCT01760447|565825308|FG003|Weeks 20-54|Lost to Follow-up|2|||
156747583|NCT02636699|565825314|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
156880381|NCT02640508|566321272|FG000|Overall Study|Death|19|||
156880382|NCT02640508|566321272|FG000|Overall Study|Withdrawal by Subject|8|||
156880383|NCT02640508|566321272|FG000|Overall Study|Physician Decision|1|||
156880384|NCT02640508|566321272|FG000|Overall Study|Lost to Follow-up|1|||
156880385|NCT05405257|566321273|FG000|Overall Study|Withdrawal by Subject|1|||
156880386|NCT00776919|566321274|FG000|Overall Study|Withdrawal by Subject|16|||
156880387|NCT00776919|566321275|FG001|Overall Study|Withdrawal by Subject|14|||
156880388|NCT00776919|566321276|FG002|Overall Study|Withdrawal by Subject|15|||
156880389|NCT00776919|566321277|FG003|Overall Study|Withdrawal by Subject|26|||
156880390|NCT00776919|566321274|FG000|Overall Study|Lost to Follow-up|8|||
156880391|NCT00776919|566321275|FG001|Overall Study|Lost to Follow-up|12|||
156880392|NCT00776919|566321276|FG002|Overall Study|Lost to Follow-up|11|||
156880393|NCT00776919|566321277|FG003|Overall Study|Lost to Follow-up|8|||
156880394|NCT00776919|566321274|FG000|Overall Study|Adverse Event|1|||
156880395|NCT00776919|566321275|FG001|Overall Study|Adverse Event|0|||
156880396|NCT00776919|566321276|FG002|Overall Study|Adverse Event|2|||
156880397|NCT00776919|566321277|FG003|Overall Study|Adverse Event|2|||
156880398|NCT00776919|566321274|FG000|Overall Study|Protocol Violation|1|||
156880399|NCT00776919|566321275|FG001|Overall Study|Protocol Violation|2|||
156747584|NCT02636699|565825315|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
156747585|NCT02636699|565825316|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
156880400|NCT00776919|566321276|FG002|Overall Study|Protocol Violation|0|||
157020719|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
157020720|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
156747586|NCT02636699|565825314|FG000|Screening Period|Withdrawal by Subject|0|||
156747587|NCT02636699|565825315|FG001|Screening Period|Withdrawal by Subject|0|||
156747588|NCT02636699|565825316|FG002|Screening Period|Withdrawal by Subject|23|||
156747589|NCT02636699|565825314|FG000|Screening Period|Adverse Event|0|||
156747590|NCT02636699|565825315|FG001|Screening Period|Adverse Event|0|||
156747591|NCT02636699|565825316|FG002|Screening Period|Adverse Event|1|||
156747592|NCT02636699|565825314|FG000|Screening Period|Other not specified|0|||
156747593|NCT02636699|565825315|FG001|Screening Period|Other not specified|0|||
156747594|NCT02636699|565825316|FG002|Screening Period|Other not specified|3|||
156747595|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
156747596|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
156747597|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
156747598|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
156747599|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
156747600|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
156880401|NCT00776919|566321277|FG003|Overall Study|Protocol Violation|1|||
157020721|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020722|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
156880402|NCT00776919|566321274|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
156880403|NCT00776919|566321275|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
156880404|NCT00776919|566321276|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
156880405|NCT00776919|566321277|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
156880406|NCT00499590|566321278|FG000|Overall Study|Study Terminated|112|||
157220657|NCT02669264|567553440|FG005|Overall Study|Withdrawal by Subject|0|||
157220658|NCT02669264|567553441|FG006|Overall Study|Withdrawal by Subject|0|||
157220659|NCT02669264|567553435|FG000|Overall Study|Lost to Follow-up|0|||
157220660|NCT02669264|567553436|FG001|Overall Study|Lost to Follow-up|0|||
157220661|NCT02669264|567553437|FG002|Overall Study|Lost to Follow-up|0|||
157220662|NCT02669264|567553438|FG003|Overall Study|Lost to Follow-up|0|||
157220663|NCT02669264|567553439|FG004|Overall Study|Lost to Follow-up|1|||
157220664|NCT02669264|567553440|FG005|Overall Study|Lost to Follow-up|0|||
157220665|NCT02669264|567553441|FG006|Overall Study|Lost to Follow-up|0|||
157220666|NCT02669264|567553435|FG000|Overall Study|Miscellaneous|0|||
157220667|NCT02669264|567553436|FG001|Overall Study|Miscellaneous|0|||
157220668|NCT02669264|567553437|FG002|Overall Study|Miscellaneous|0|||
157220669|NCT02669264|567553438|FG003|Overall Study|Miscellaneous|0|||
157220670|NCT02669264|567553439|FG004|Overall Study|Miscellaneous|0|||
157220671|NCT02669264|567553440|FG005|Overall Study|Miscellaneous|0|||
157220672|NCT02669264|567553441|FG006|Overall Study|Miscellaneous|2|||
157220673|NCT03529955|567553442|FG000|Overall Study|Adverse Event|1|||
157220674|NCT03529955|567553442|FG000|Overall Study|Lack of Efficacy|1|||
157220675|NCT03016078|567553446|FG000|Overall Study|Protocol Violation|1|||
157220676|NCT03016078|567553446|FG000|Overall Study|Protocol Violation|1|||
157220677|NCT03507439|567553447|FG000|Overall Study|Other|2|||
157220678|NCT03507439|567553448|FG001|Overall Study|Other|1|||
157220679|NCT03507439|567553447|FG000|Overall Study|Withdrawal by Subject|1|||
156747601|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
156880407|NCT00499590|566321279|FG001|Overall Study|Study Terminated|112|||
156880408|NCT00499590|566321280|FG002|Overall Study|Study Terminated|112|||
156747602|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
156747603|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
156747604|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
156880409|NCT00499590|566321278|FG000|Overall Study|Not treated|1|||
156880410|NCT00499590|566321279|FG001|Overall Study|Not treated|0|||
156880411|NCT00499590|566321280|FG002|Overall Study|Not treated|1|||
156880412|NCT03753789|566321281|FG000|Overall Study|Withdrawal by Subject|2|||
156880413|NCT00612807|566321284|FG000|Overall Study|Withdrawal by Subject|2|||
156747605|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
156747606|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
156747607|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
156747608|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
156747609|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
156747610|NCT02636699|565825314|FG000|Treatment and Follow-up Periods|Other|3|||
156747611|NCT02636699|565825315|FG001|Treatment and Follow-up Periods|Other|1|||
156747612|NCT02636699|565825316|FG002|Treatment and Follow-up Periods|Other|0|||
156747613|NCT00624832|565825317|FG000|Overall Study|Adverse Event|0|||
156747614|NCT00624832|565825318|FG001|Overall Study|Adverse Event|1|||
156747615|NCT00624832|565825319|FG002|Overall Study|Adverse Event|0|||
156747616|NCT00624832|565825320|FG003|Overall Study|Adverse Event|1|||
156747617|NCT00624832|565825317|FG000|Overall Study|Abnormal Laboratory Value|2|||
156747618|NCT00624832|565825318|FG001|Overall Study|Abnormal Laboratory Value|0|||
156747619|NCT00624832|565825319|FG002|Overall Study|Abnormal Laboratory Value|0|||
156747620|NCT00624832|565825320|FG003|Overall Study|Abnormal Laboratory Value|0|||
156747621|NCT01939223|565825321|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
156747622|NCT01939223|565825322|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
156747623|NCT01939223|565825321|FG000|Overall Study|Disease recurrence (radiological)|1|||
156747624|NCT01939223|565825322|FG001|Overall Study|Disease recurrence (radiological)|3|||
156747625|NCT01939223|565825321|FG000|Overall Study|Study stopped by Sponsor|5|||
156747626|NCT01939223|565825322|FG001|Overall Study|Study stopped by Sponsor|7|||
156747627|NCT01939223|565825321|FG000|Overall Study|Withdrawal by Subject|6|||
156747628|NCT01939223|565825322|FG001|Overall Study|Withdrawal by Subject|0|||
156747629|NCT04379700|565825323|FG000|Overall Study|Withdrawal by Subject|10|||
156747630|NCT04379700|565825323|FG000|Overall Study|Screen Fail|4|||
156747631|NCT04379700|565825323|FG000|Overall Study|Lost to Follow-up|3|||
156747632|NCT03004924|565825326|FG000|Overall Study|Adverse Event|6|||
156747633|NCT03004924|565825327|FG001|Overall Study|Adverse Event|5|||
156747634|NCT03004924|565825328|FG002|Overall Study|Adverse Event|10|||
156747635|NCT03004924|565825326|FG000|Overall Study|Protocol Violation|4|||
156747636|NCT03004924|565825327|FG001|Overall Study|Protocol Violation|0|||
157220680|NCT03507439|567553448|FG001|Overall Study|Withdrawal by Subject|0|||
157220681|NCT03507439|567553447|FG000|Overall Study|Death|1|||
157220682|NCT03507439|567553448|FG001|Overall Study|Death|1|||
157220683|NCT03381248|567554813|FG000|0-6 Months|Withdrawal by Subject|4|||
156747637|NCT03004924|565825328|FG002|Overall Study|Protocol Violation|1|||
156747638|NCT03004924|565825326|FG000|Overall Study|Withdrawal by Subject|5|||
156880414|NCT00612807|566321285|FG001|Overall Study|Withdrawal by Subject|0|||
156880415|NCT00782834|566321294|FG000|Treatment Phase|fibrous tumor not GIST|1|||
157220684|NCT03381248|567554814|FG001|0-6 Months|Withdrawal by Subject|1|||
157220685|NCT03381248|567554813|FG000|0-6 Months|Lost to Follow-up|3|||
156747639|NCT03004924|565825327|FG001|Overall Study|Withdrawal by Subject|3|||
156747640|NCT03004924|565825328|FG002|Overall Study|Withdrawal by Subject|5|||
156747641|NCT03004924|565825326|FG000|Overall Study|Lost to Follow-up|6|||
156747642|NCT03004924|565825327|FG001|Overall Study|Lost to Follow-up|1|||
156747643|NCT03004924|565825328|FG002|Overall Study|Lost to Follow-up|4|||
156747644|NCT03004924|565825326|FG000|Overall Study|Lack of Efficacy|2|||
156747645|NCT03004924|565825327|FG001|Overall Study|Lack of Efficacy|4|||
156747646|NCT03004924|565825328|FG002|Overall Study|Lack of Efficacy|2|||
156747647|NCT03004924|565825326|FG000|Overall Study|Physician Decision|1|||
156747648|NCT03004924|565825327|FG001|Overall Study|Physician Decision|0|||
156747649|NCT03004924|565825328|FG002|Overall Study|Physician Decision|1|||
156747650|NCT03004924|565825326|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156747651|NCT03004924|565825327|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156747652|NCT03004924|565825328|FG002|Overall Study|Withdrawal by parent/guardian|2|||
156747653|NCT03004924|565825326|FG000|Overall Study|Screen Failure|1|||
156747654|NCT03004924|565825327|FG001|Overall Study|Screen Failure|0|||
156747655|NCT03004924|565825328|FG002|Overall Study|Screen Failure|0|||
156747656|NCT03004924|565825326|FG000|Overall Study|Pregnancy|0|||
156747657|NCT03004924|565825327|FG001|Overall Study|Pregnancy|1|||
156747658|NCT03004924|565825328|FG002|Overall Study|Pregnancy|0|||
156800121|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
156800122|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
156800123|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
156800124|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
156800125|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
156800126|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156800127|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
156800128|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
156800129|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
156800130|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
156800131|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
156800132|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Death|0|||
156800133|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Death|0|||
156800134|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Death|1|||
156800135|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
156800136|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
156800137|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
156800138|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
156800139|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
156800140|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
156800141|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
156800142|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
156800143|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
156800144|NCT02519842|566023378|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
156800145|NCT02519842|566023379|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
156800146|NCT02519842|566023380|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
156800147|NCT00744861|566023381|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
156800148|NCT00744861|566023382|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
156800149|NCT00744861|566023383|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
156800150|NCT00744861|566023384|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
156800151|NCT00744861|566023381|FG000|Feasibility Stage 1|Pregnancy|0|||
156800152|NCT00744861|566023382|FG001|Feasibility Stage 1|Pregnancy|1|||
156800153|NCT00744861|566023383|FG002|Feasibility Stage 1|Pregnancy|0|||
156800154|NCT00744861|566023384|FG003|Feasibility Stage 1|Pregnancy|0|||
156800155|NCT00744861|566023381|FG000|Pivotal Stage 2|Adverse Event|0|||
156800156|NCT00744861|566023382|FG001|Pivotal Stage 2|Adverse Event|0|||
156800157|NCT00744861|566023383|FG002|Pivotal Stage 2|Adverse Event|6|||
156800158|NCT00744861|566023384|FG003|Pivotal Stage 2|Adverse Event|11|||
156800159|NCT00744861|566023381|FG000|Pivotal Stage 2|Death|0|||
156800160|NCT00744861|566023382|FG001|Pivotal Stage 2|Death|0|||
156800161|NCT00744861|566023383|FG002|Pivotal Stage 2|Death|0|||
156800162|NCT00744861|566023384|FG003|Pivotal Stage 2|Death|1|||
156800163|NCT00744861|566023381|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
156800164|NCT00744861|566023382|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
156747659|NCT03004924|565825326|FG000|Overall Study|Terminated by Sponsor|0|||
156747660|NCT03004924|565825327|FG001|Overall Study|Terminated by Sponsor|0|||
156800165|NCT00744861|566023383|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
156747661|NCT03004924|565825328|FG002|Overall Study|Terminated by Sponsor|1|||
156747662|NCT03004924|565825326|FG000|Overall Study|Missed Study Visit|0|||
156800166|NCT00744861|566023384|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
156800167|NCT00744861|566023381|FG000|Pivotal Stage 2|Physician Decision|0|||
156800168|NCT00744861|566023382|FG001|Pivotal Stage 2|Physician Decision|0|||
156800169|NCT00744861|566023383|FG002|Pivotal Stage 2|Physician Decision|3|||
156747663|NCT03004924|565825327|FG001|Overall Study|Missed Study Visit|0|||
156747664|NCT03004924|565825328|FG002|Overall Study|Missed Study Visit|2|||
156747665|NCT03004924|565825326|FG000|Overall Study|HSV1 Positive|1|||
156747666|NCT03004924|565825327|FG001|Overall Study|HSV1 Positive|0|||
156747667|NCT03004924|565825328|FG002|Overall Study|HSV1 Positive|0|||
156747668|NCT03003000|565825338|FG000|Overall Study|Adverse Event|1|||
156747669|NCT03003000|565825339|FG001|Overall Study|Adverse Event|2|||
156747670|NCT03003000|565825340|FG002|Overall Study|Adverse Event|3|||
156747671|NCT03003000|565825338|FG000|Overall Study|Lack of Efficacy|1|||
156747672|NCT03003000|565825339|FG001|Overall Study|Lack of Efficacy|0|||
156747673|NCT03003000|565825340|FG002|Overall Study|Lack of Efficacy|0|||
156747674|NCT03003000|565825338|FG000|Overall Study|Non-compliant with protocol|0|||
156747675|NCT03003000|565825339|FG001|Overall Study|Non-compliant with protocol|1|||
156747676|NCT03003000|565825340|FG002|Overall Study|Non-compliant with protocol|1|||
156747677|NCT03003000|565825338|FG000|Overall Study|Refused to continue medication|2|||
156747678|NCT03003000|565825339|FG001|Overall Study|Refused to continue medication|0|||
156747679|NCT03003000|565825340|FG002|Overall Study|Refused to continue medication|0|||
156747680|NCT03003000|565825338|FG000|Overall Study|Other than listed|1|||
156747681|NCT03003000|565825339|FG001|Overall Study|Other than listed|1|||
156747682|NCT03003000|565825340|FG002|Overall Study|Other than listed|1|||
156747683|NCT04933617|565825342|FG000|Dose Escalation|Early closure of study|0|||
156747684|NCT04933617|565825343|FG001|Dose Escalation|Early closure of study|3|||
156747685|NCT04933617|565825344|FG002|Dose Escalation|Early closure of study|0|||
156747686|NCT04933617|565825345|FG003|Dose Escalation|Early closure of study|0|||
156747687|NCT04933617|565825346|FG004|Dose Escalation|Early closure of study|0|||
156747688|NCT02191046|565825352|FG000|Overall Study|low compliance|5|||
156747689|NCT02191046|565825353|FG001|Overall Study|low compliance|1|||
156747690|NCT01964716|565825354|FG000|Overall Study|Withdrawal by Subject|2|||
156747691|NCT01964716|565825355|FG001|Overall Study|Withdrawal by Subject|3|||
156747692|NCT01964716|565825354|FG000|Overall Study|Lost to Follow-up|1|||
156747693|NCT01964716|565825355|FG001|Overall Study|Lost to Follow-up|2|||
156747694|NCT01964716|565825354|FG000|Overall Study|No longer met eligibility criteria|1|||
156747695|NCT01964716|565825355|FG001|Overall Study|No longer met eligibility criteria|1|||
156747696|NCT01964716|565825354|FG000|Overall Study|Death|1|||
156747697|NCT01964716|565825355|FG001|Overall Study|Death|0|||
156747698|NCT00089635|565825356|FG000|Overall Study|Adverse Event|2|||
156747699|NCT00089635|565825356|FG000|Overall Study|Death|17|||
156747700|NCT00089635|565825356|FG000|Overall Study|Disease Progression|12|||
156747701|NCT00089635|565825356|FG000|Overall Study|Lost to Follow-up|3|||
156747702|NCT00089635|565825356|FG000|Overall Study|Withdrawal by Subject|6|||
156747703|NCT00089635|565825356|FG000|Overall Study|Ineligibility determined|1|||
156747704|NCT00089635|565825356|FG000|Overall Study|Other|2|||
156747705|NCT02603107|565825357|FG000|Randomized Phase|Withdrew consent|8|||
156747706|NCT02603107|565825358|FG001|Randomized Phase|Withdrew consent|15|||
156747707|NCT02603107|565825357|FG000|Randomized Phase|Lost to Follow-up|1|||
156747708|NCT02603107|565825358|FG001|Randomized Phase|Lost to Follow-up|3|||
156747709|NCT02603107|565825357|FG000|Randomized Phase|Adverse Event|2|||
156747710|NCT02603107|565825358|FG001|Randomized Phase|Adverse Event|0|||
156747711|NCT02603107|565825357|FG000|Randomized Phase|Death|1|||
156747712|NCT02603107|565825358|FG001|Randomized Phase|Death|1|||
156747713|NCT02603107|565825357|FG000|Randomized Phase|Non-compliance with study drug|1|||
156747714|NCT02603107|565825358|FG001|Randomized Phase|Non-compliance with study drug|1|||
156747715|NCT02603107|565825357|FG000|Randomized Phase|Investigator's discretion|0|||
156747716|NCT02603107|565825358|FG001|Randomized Phase|Investigator's discretion|1|||
156747717|NCT02603107|565825357|FG000|Randomized Phase|Lack of Efficacy|1|||
156747718|NCT02603107|565825358|FG001|Randomized Phase|Lack of Efficacy|0|||
156747719|NCT02603107|565825357|FG000|Randomized Phase|Protocol Violation|1|||
156747720|NCT02603107|565825358|FG001|Randomized Phase|Protocol Violation|0|||
156747721|NCT02603107|565825357|FG000|Optional Extension Phase|Lost to Follow-up|3|||
156747722|NCT02603107|565825358|FG001|Optional Extension Phase|Lost to Follow-up|3|||
156747723|NCT02603107|565825357|FG000|Optional Extension Phase|Withdrew consent|3|||
156747724|NCT02603107|565825358|FG001|Optional Extension Phase|Withdrew consent|2|||
156747725|NCT02603107|565825357|FG000|Optional Extension Phase|Investigator's discretion|2|||
156747726|NCT02603107|565825358|FG001|Optional Extension Phase|Investigator's discretion|2|||
156747727|NCT02603107|565825357|FG000|Optional Extension Phase|Pregnancy|0|||
156747728|NCT02603107|565825358|FG001|Optional Extension Phase|Pregnancy|3|||
157020723|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
156747729|NCT02603107|565825357|FG000|Optional Extension Phase|Adverse Event|0|||
156800170|NCT00744861|566023384|FG003|Pivotal Stage 2|Physician Decision|1|||
156747730|NCT02603107|565825358|FG001|Optional Extension Phase|Adverse Event|2|||
156747731|NCT02603107|565825357|FG000|Optional Extension Phase|Not treated in extension phase|0|||
156747732|NCT02603107|565825358|FG001|Optional Extension Phase|Not treated in extension phase|1|||
156747733|NCT02603107|565825357|FG000|Optional Extension Phase|Protocol Violation|1|||
156747734|NCT02603107|565825358|FG001|Optional Extension Phase|Protocol Violation|0|||
156747735|NCT01370616|565825360|FG000|Overall Study|Adverse Event|11|||
156747736|NCT01370616|565825361|FG001|Overall Study|Adverse Event|16|||
156747737|NCT01370616|565825360|FG000|Overall Study|Death|1|||
156747738|NCT01370616|565825361|FG001|Overall Study|Death|0|||
156747739|NCT01370616|565825360|FG000|Overall Study|Lack of Efficacy|6|||
156747740|NCT01370616|565825361|FG001|Overall Study|Lack of Efficacy|2|||
156747741|NCT01370616|565825360|FG000|Overall Study|Lost to Follow-up|0|||
156747742|NCT01370616|565825361|FG001|Overall Study|Lost to Follow-up|3|||
156747743|NCT01370616|565825360|FG000|Overall Study|Physician Decision|6|||
156747744|NCT01370616|565825361|FG001|Overall Study|Physician Decision|6|||
156747745|NCT01370616|565825360|FG000|Overall Study|Progressive Disease|0|||
156747746|NCT01370616|565825361|FG001|Overall Study|Progressive Disease|1|||
156747747|NCT01370616|565825360|FG000|Overall Study|Recovery|1|||
156747748|NCT01370616|565825361|FG001|Overall Study|Recovery|0|||
156747749|NCT01370616|565825360|FG000|Overall Study|Technical Problems|3|||
156747750|NCT01370616|565825361|FG001|Overall Study|Technical Problems|5|||
156747751|NCT01370616|565825360|FG000|Overall Study|Withdrawal by Subject|34|||
156747752|NCT01370616|565825361|FG001|Overall Study|Withdrawal by Subject|34|||
156747753|NCT00419159|565825362|FG000|Overall Study|Adverse Event|7|||
156747754|NCT00419159|565825363|FG001|Overall Study|Adverse Event|15|||
156747755|NCT00419159|565825362|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156747756|NCT00419159|565825363|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156747757|NCT00419159|565825362|FG000|Overall Study|Subject's no longer requires study drug|0|||
156747758|NCT00419159|565825363|FG001|Overall Study|Subject's no longer requires study drug|1|||
156747759|NCT00419159|565825362|FG000|Overall Study|Protocol Violation|1|||
156747760|NCT00419159|565825363|FG001|Overall Study|Protocol Violation|0|||
156747761|NCT00419159|565825362|FG000|Overall Study|Withdrawal by Subject|10|||
156747762|NCT00419159|565825363|FG001|Overall Study|Withdrawal by Subject|3|||
156747763|NCT00419159|565825362|FG000|Overall Study|Lost to Follow-up|0|||
156747764|NCT00419159|565825363|FG001|Overall Study|Lost to Follow-up|1|||
156747765|NCT00419159|565825362|FG000|Overall Study|Death|2|||
156747766|NCT00419159|565825363|FG001|Overall Study|Death|2|||
156747767|NCT00419159|565825362|FG000|Overall Study|Disease progression|79|||
156747768|NCT00419159|565825363|FG001|Overall Study|Disease progression|76|||
156747769|NCT01693185|565825364|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
156747770|NCT01693185|565825365|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
156747771|NCT01017601|565825368|FG000|Overall Study|Disease Progression|12|||
156747772|NCT01017601|565825369|FG001|Overall Study|Disease Progression|12|||
156747773|NCT01017601|565825368|FG000|Overall Study|Withdrawal by Subject|0|||
156747774|NCT01017601|565825369|FG001|Overall Study|Withdrawal by Subject|1|||
156747775|NCT01857102|565825370|FG000|Period 1|No longer meets Eligibility Criteria|0|||
156747776|NCT01857102|565825371|FG001|Period 1|No longer meets Eligibility Criteria|2|||
156747777|NCT01857102|565825370|FG000|Period 1|Lost to Follow-up|0|||
156747778|NCT01857102|565825371|FG001|Period 1|Lost to Follow-up|3|||
156747779|NCT01857102|565825370|FG000|Period 1|Unsatisfactory Lens Fit|1|||
156747780|NCT01857102|565825371|FG001|Period 1|Unsatisfactory Lens Fit|0|||
156747781|NCT01857102|565825370|FG000|Period 1|Unsatisfactory Visual Response|1|||
156747782|NCT01857102|565825371|FG001|Period 1|Unsatisfactory Visual Response|0|||
156747783|NCT01857102|565825370|FG000|Period 1|Physician Decision|1|||
156747784|NCT01857102|565825371|FG001|Period 1|Physician Decision|0|||
156747785|NCT01857102|565825370|FG000|Period 2|Lens Discomfort|1|||
156747786|NCT01857102|565825371|FG001|Period 2|Lens Discomfort|0|||
156747787|NCT01857102|565825370|FG000|Period 2|Unsatisfactory Lens Fit|1|||
156747788|NCT01857102|565825371|FG001|Period 2|Unsatisfactory Lens Fit|0|||
156747789|NCT02073656|565825374|FG000|Primary Study|Lost to Follow-up|6|||
156747790|NCT02073656|565825374|FG000|Primary Study|Death|1|||
156747791|NCT02073656|565825374|FG000|Primary Study|Withdrew Consent|1|||
156747792|NCT01524783|565825381|FG000|Blinded Period|Adverse Event|64|||
156747793|NCT01524783|565825382|FG001|Blinded Period|Adverse Event|7|||
156747794|NCT01524783|565825383|FG002|Blinded Period|Adverse Event|0|||
156747795|NCT01524783|565825381|FG000|Blinded Period|Disease Progression|89|||
156800171|NCT00744861|566023381|FG000|Pivotal Stage 2|Protocol Violation|0|||
156800172|NCT00744861|566023382|FG001|Pivotal Stage 2|Protocol Violation|0|||
156800173|NCT00744861|566023383|FG002|Pivotal Stage 2|Protocol Violation|0|||
156800174|NCT00744861|566023384|FG003|Pivotal Stage 2|Protocol Violation|1|||
156800175|NCT00744861|566023381|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
156800176|NCT00744861|566023382|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
157220686|NCT03381248|567554814|FG001|0-6 Months|Lost to Follow-up|2|||
157220687|NCT03381248|567554813|FG000|0-6 Months|Lack of Efficacy|1|||
157220688|NCT03381248|567554814|FG001|0-6 Months|Lack of Efficacy|0|||
157220689|NCT03381248|567554813|FG000|0-6 Months|Adverse Event|1|||
156747796|NCT01524783|565825382|FG001|Blinded Period|Disease Progression|75|||
156747797|NCT01524783|565825383|FG002|Blinded Period|Disease Progression|0|||
156747798|NCT01524783|565825381|FG000|Blinded Period|Withdrawal by Subject|19|||
156747799|NCT01524783|565825382|FG001|Blinded Period|Withdrawal by Subject|6|||
156747800|NCT01524783|565825383|FG002|Blinded Period|Withdrawal by Subject|0|||
156747801|NCT01524783|565825381|FG000|Blinded Period|Protocol deviation|2|||
156747802|NCT01524783|565825382|FG001|Blinded Period|Protocol deviation|1|||
156747803|NCT01524783|565825383|FG002|Blinded Period|Protocol deviation|0|||
156747804|NCT01524783|565825381|FG000|Blinded Period|Death|5|||
156747805|NCT01524783|565825382|FG001|Blinded Period|Death|2|||
157220690|NCT03381248|567554814|FG001|0-6 Months|Adverse Event|0|||
156747806|NCT01524783|565825383|FG002|Blinded Period|Death|0|||
156880416|NCT01215097|566321296|FG000|Overall Study|Adverse Event|1|||
156880417|NCT01215097|566321297|FG001|Overall Study|Adverse Event|3|||
156880418|NCT01215097|566321296|FG000|Overall Study|Protocol Violation|0|||
157220691|NCT03381248|567554813|FG000|0-6 Months|Protocol Violation|2|||
157220692|NCT03381248|567554814|FG001|0-6 Months|Protocol Violation|1|||
157220693|NCT03381248|567554813|FG000|0-6 Months|Physician Decision|1|||
156747807|NCT01524783|565825381|FG000|Open-label Period|Disease progression|13|||
156747808|NCT01524783|565825382|FG001|Open-label Period|Disease progression|0|||
156880419|NCT01215097|566321297|FG001|Overall Study|Protocol Violation|2|||
156880420|NCT01215097|566321296|FG000|Overall Study|Lost to Follow-up|2|||
156747809|NCT01524783|565825383|FG002|Open-label Period|Disease progression|2|||
156747810|NCT01524783|565825381|FG000|Open-label Period|Administrative problems|5|||
156747811|NCT01524783|565825382|FG001|Open-label Period|Administrative problems|0|||
156747812|NCT01524783|565825383|FG002|Open-label Period|Administrative problems|2|||
157220694|NCT03381248|567554814|FG001|0-6 Months|Physician Decision|0|||
157220695|NCT03381248|567554813|FG000|0-6 Months|Planning another procedure|1|||
157220696|NCT03381248|567554814|FG001|0-6 Months|Planning another procedure|2|||
157220697|NCT03381248|567554813|FG000|6-12 Months|Withdrawal by Subject|1|||
157220698|NCT03381248|567554814|FG001|6-12 Months|Withdrawal by Subject|3|||
157220699|NCT03381248|567554813|FG000|6-12 Months|Lost to Follow-up|0|||
157220700|NCT03381248|567554814|FG001|6-12 Months|Lost to Follow-up|2|||
157220701|NCT03381248|567554813|FG000|6-12 Months|Protocol Violation|3|||
157220702|NCT03381248|567554814|FG001|6-12 Months|Protocol Violation|2|||
157220703|NCT03381248|567554813|FG000|6-12 Months|Planning another procedure|6|||
157220704|NCT03381248|567554814|FG001|6-12 Months|Planning another procedure|2|||
157220705|NCT03381248|567554813|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
157220706|NCT03381248|567554814|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
157220707|NCT03381248|567554813|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
157220708|NCT03381248|567554814|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
157220709|NCT03381248|567554813|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
157220710|NCT03381248|567554814|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
157220711|NCT05188521|567554815|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
157220712|NCT05188521|567554816|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
157220713|NCT01341639|567554817|FG000|Infant Series|Protocol Violation|1|||
157220714|NCT01341639|567554818|FG001|Infant Series|Protocol Violation|0|||
157220715|NCT01341639|567554817|FG000|Infant Series|Not Vaccinated|0|||
157220716|NCT01341639|567554818|FG001|Infant Series|Not Vaccinated|1|||
157220717|NCT01341639|567554817|FG000|Infant Series|Adverse Event|0|||
157220718|NCT01341639|567554818|FG001|Infant Series|Adverse Event|5|||
157220719|NCT01341639|567554817|FG000|Infant Series|Withdrawal by Subject|11|||
157220720|NCT01341639|567554818|FG001|Infant Series|Withdrawal by Subject|8|||
157220721|NCT01341639|567554817|FG000|Infant Series|Lost to Follow-up|0|||
157220722|NCT01341639|567554818|FG001|Infant Series|Lost to Follow-up|2|||
156747813|NCT01524783|565825381|FG000|Open-label Period|Adverse Event|5|||
156747814|NCT01524783|565825382|FG001|Open-label Period|Adverse Event|0|||
156747815|NCT01524783|565825383|FG002|Open-label Period|Adverse Event|1|||
156747816|NCT01524783|565825381|FG000|Open-label Period|Withdrawal by Subject|2|||
156747817|NCT01524783|565825382|FG001|Open-label Period|Withdrawal by Subject|0|||
156747818|NCT01524783|565825383|FG002|Open-label Period|Withdrawal by Subject|1|||
156747819|NCT01524783|565825381|FG000|Open-label Period|Protocol deviation|1|||
156747820|NCT01524783|565825382|FG001|Open-label Period|Protocol deviation|0|||
156747821|NCT01524783|565825383|FG002|Open-label Period|Protocol deviation|0|||
156747822|NCT02054910|565825385|FG000|Overall Study|Lost to Follow-up|4|||
156747823|NCT02054910|565825386|FG001|Overall Study|Lost to Follow-up|1|||
156747824|NCT01625689|565825387|FG000|Overall Study|Migration|2|||
156747825|NCT01625689|565825388|FG001|Overall Study|Migration|1|||
156747826|NCT04907227|565825393|FG000|Overall Study|Death|12|||
156747827|NCT04907227|565825394|FG001|Overall Study|Death|8|||
156747828|NCT04907227|565825393|FG000|Overall Study|Withdrawal by Subject|2|||
156747829|NCT04907227|565825394|FG001|Overall Study|Withdrawal by Subject|2|||
156747830|NCT04907227|565825393|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
156880421|NCT01215097|566321297|FG001|Overall Study|Lost to Follow-up|0|||
156880422|NCT01215097|566321296|FG000|Overall Study|Withdrawal by Subject|6|||
156880423|NCT01215097|566321297|FG001|Overall Study|Withdrawal by Subject|3|||
156747831|NCT04907227|565825394|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156747832|NCT04907227|565825393|FG000|Overall Study|Sponsor Decision|25|||
156747833|NCT04907227|565825394|FG001|Overall Study|Sponsor Decision|30|||
157220723|NCT01341639|567554817|FG000|Infant Series|Site 0048 Participants|17|||
157220724|NCT01341639|567554818|FG001|Infant Series|Site 0048 Participants|16|||
157220725|NCT01341639|567554817|FG000|Interim Period|Withdrawal by Subject|6|||
157220726|NCT01341639|567554818|FG001|Interim Period|Withdrawal by Subject|7|||
157220727|NCT01341639|567554817|FG000|Interim Period|Lost to Follow-up|2|||
157220728|NCT01341639|567554818|FG001|Interim Period|Lost to Follow-up|0|||
156880424|NCT01215097|566321296|FG000|Overall Study|Lack of Efficacy|0|||
156880425|NCT01215097|566321297|FG001|Overall Study|Lack of Efficacy|3|||
157220729|NCT01341639|567554817|FG000|Interim Period|Physician Decision|0|||
157220730|NCT01341639|567554818|FG001|Interim Period|Physician Decision|1|||
156880426|NCT01215097|566321296|FG000|Overall Study|patient's refusal to come|2|||
156880427|NCT01215097|566321297|FG001|Overall Study|patient's refusal to come|2|||
156880428|NCT01215097|566321296|FG000|Overall Study|patient's private reason|1|||
156880429|NCT01215097|566321297|FG001|Overall Study|patient's private reason|1|||
156880430|NCT02259088|566321298|FG000|Overall Study|Adverse Event|6|||
156747834|NCT04907227|565825393|FG000|Overall Study|Physician Decision|1|||
156747835|NCT04907227|565825394|FG001|Overall Study|Physician Decision|0|||
156747836|NCT03723070|565825395|FG000|Overall Study|Lost to Follow-up|2|||
156747837|NCT03723070|565825395|FG000|Overall Study|Physician Decision|1|||
156747838|NCT03723070|565825395|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
156880431|NCT02259088|566321299|FG001|Overall Study|Adverse Event|4|||
156880432|NCT02259088|566321298|FG000|Overall Study|Lost to Follow-up|2|||
156880433|NCT02259088|566321299|FG001|Overall Study|Lost to Follow-up|0|||
156880434|NCT02259088|566321298|FG000|Overall Study|Death|2|||
156880435|NCT02259088|566321299|FG001|Overall Study|Death|0|||
156880436|NCT02259088|566321298|FG000|Overall Study|Physician Decision|5|||
156880437|NCT02259088|566321299|FG001|Overall Study|Physician Decision|2|||
156880438|NCT02259088|566321298|FG000|Overall Study|Protocol deviation|5|||
156880439|NCT02259088|566321299|FG001|Overall Study|Protocol deviation|0|||
156880440|NCT02259088|566321298|FG000|Overall Study|Subject/guardian decision|8|||
156880441|NCT02259088|566321299|FG001|Overall Study|Subject/guardian decision|8|||
156880442|NCT01818752|566321301|FG000|Overall Study|Adverse Event|64|||
156880443|NCT01818752|566321302|FG001|Overall Study|Adverse Event|74|||
156880444|NCT01818752|566321301|FG000|Overall Study|Death|14|||
156880445|NCT01818752|566321302|FG001|Overall Study|Death|18|||
156880446|NCT01818752|566321301|FG000|Overall Study|Non-compliance|16|||
156880447|NCT01818752|566321302|FG001|Overall Study|Non-compliance|20|||
156880448|NCT01818752|566321301|FG000|Overall Study|Withdrawal by Subject|15|||
156880449|NCT01818752|566321302|FG001|Overall Study|Withdrawal by Subject|14|||
156880450|NCT01818752|566321301|FG000|Overall Study|Physician Decision|9|||
156880451|NCT01818752|566321302|FG001|Overall Study|Physician Decision|8|||
156880452|NCT01818752|566321301|FG000|Overall Study|Disease Progression|54|||
156880453|NCT01818752|566321302|FG001|Overall Study|Disease Progression|48|||
156880454|NCT01818752|566321301|FG000|Overall Study|Other|7|||
156880455|NCT01818752|566321302|FG001|Overall Study|Other|8|||
156880456|NCT01818752|566321301|FG000|Overall Study|Continuing Treatment|1|||
156880457|NCT01818752|566321302|FG001|Overall Study|Continuing Treatment|4|||
156880458|NCT01818752|566321301|FG000|Overall Study|Randomized but not Dosed|7|||
156880459|NCT01818752|566321302|FG001|Overall Study|Randomized but not Dosed|4|||
156880460|NCT04270370|566321303|FG000|Overall Study|Lost to Follow-up|1|||
156880461|NCT04270370|566321304|FG001|Overall Study|Lost to Follow-up|0|||
156880462|NCT04270370|566321305|FG002|Overall Study|Lost to Follow-up|0|||
156880463|NCT04270370|566321306|FG003|Overall Study|Lost to Follow-up|0|||
156880464|NCT04270370|566321307|FG004|Overall Study|Lost to Follow-up|0|||
156880465|NCT04270370|566321308|FG005|Overall Study|Lost to Follow-up|0|||
156880466|NCT04270370|566321309|FG006|Overall Study|Lost to Follow-up|0|||
156880467|NCT04270370|566321310|FG007|Overall Study|Lost to Follow-up|0|||
156880468|NCT04270370|566321311|FG008|Overall Study|Lost to Follow-up|1|||
156880469|NCT04270370|566321312|FG009|Overall Study|Lost to Follow-up|0|||
156880470|NCT04270370|566321313|FG010|Overall Study|Lost to Follow-up|0|||
156880471|NCT04270370|566321314|FG011|Overall Study|Lost to Follow-up|0|||
156880472|NCT01324141|566321315|FG000|Overall Study|Declined to participate before treatment started|1|||
156747839|NCT02208050|565825396|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
156747840|NCT02208050|565825397|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
156747841|NCT00721279|565825401|FG000|Overall Study|Lack of Efficacy|6|||
156747842|NCT00721279|565825402|FG001|Overall Study|Lack of Efficacy|3|||
156747843|NCT00721279|565825401|FG000|Overall Study|Tolerability insufficient|5|||
156880473|NCT01324141|566321315|FG000|Overall Study|Disease progression on study|1|||
156880474|NCT01001325|566321316|FG000|Overall Study|Lost to Follow-up|16|||
156880475|NCT01001325|566321317|FG001|Overall Study|Lost to Follow-up|10|||
157143602|NCT01451515|567274214|FG000|Overall Study|Death|0|||
156747844|NCT00721279|565825402|FG001|Overall Study|Tolerability insufficient|2|||
156747845|NCT00721279|565825401|FG000|Overall Study|Withdrawal by Subject|13|||
156747846|NCT00721279|565825402|FG001|Overall Study|Withdrawal by Subject|3|||
156747847|NCT00721279|565825401|FG000|Overall Study|Other|12|||
156880476|NCT01001325|566321316|FG000|Overall Study|Protocol Violation|2|||
156880477|NCT01001325|566321317|FG001|Overall Study|Protocol Violation|0|||
156880478|NCT03212144|566321320|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
156880479|NCT03212144|566321321|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
156880480|NCT03212144|566321320|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
156880481|NCT03212144|566321321|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
156880482|NCT00899431|566321322|FG000|Overall Study|Physician Decision|1|||
156880483|NCT00899431|566321323|FG001|Overall Study|Physician Decision|0|||
156880484|NCT00899431|566321324|FG002|Overall Study|Physician Decision|0|||
156880485|NCT00661427|566321325|FG000|Overall Study|Adverse Event|5|||
156880486|NCT00661427|566321326|FG001|Overall Study|Adverse Event|5|||
156880487|NCT00661427|566321325|FG000|Overall Study|Patient not treated|0|||
156880488|NCT00661427|566321326|FG001|Overall Study|Patient not treated|2|||
157143603|NCT01451515|567274215|FG001|Overall Study|Death|1|||
156747848|NCT00721279|565825402|FG001|Overall Study|Other|16|||
156747849|NCT03673345|565825403|FG000|Overall Study|Lost to Follow-up|1|||
156747850|NCT03673345|565825404|FG001|Overall Study|Lost to Follow-up|0|||
156747851|NCT03673345|565825405|FG002|Overall Study|Lost to Follow-up|3|||
156747852|NCT03673345|565825406|FG003|Overall Study|Lost to Follow-up|3|||
156747853|NCT03673345|565825407|FG004|Overall Study|Lost to Follow-up|2|||
156747854|NCT03673345|565825408|FG005|Overall Study|Lost to Follow-up|1|||
156747855|NCT03673345|565825409|FG006|Overall Study|Lost to Follow-up|0|||
156747856|NCT03673345|565825410|FG007|Overall Study|Lost to Follow-up|0|||
156747857|NCT03673345|565825403|FG000|Overall Study|Withdrawal by Subject|1|||
156747858|NCT03673345|565825404|FG001|Overall Study|Withdrawal by Subject|0|||
156747859|NCT03673345|565825405|FG002|Overall Study|Withdrawal by Subject|4|||
156747860|NCT03673345|565825406|FG003|Overall Study|Withdrawal by Subject|2|||
156747861|NCT03673345|565825407|FG004|Overall Study|Withdrawal by Subject|0|||
156747862|NCT03673345|565825408|FG005|Overall Study|Withdrawal by Subject|0|||
156747863|NCT03673345|565825409|FG006|Overall Study|Withdrawal by Subject|0|||
156747864|NCT03673345|565825410|FG007|Overall Study|Withdrawal by Subject|0|||
156747865|NCT03673345|565825403|FG000|Overall Study|Physician Decision|0|||
156747866|NCT03673345|565825404|FG001|Overall Study|Physician Decision|0|||
156747867|NCT03673345|565825405|FG002|Overall Study|Physician Decision|2|||
156747868|NCT03673345|565825406|FG003|Overall Study|Physician Decision|0|||
156747869|NCT03673345|565825407|FG004|Overall Study|Physician Decision|0|||
156747870|NCT03673345|565825408|FG005|Overall Study|Physician Decision|0|||
156747871|NCT03673345|565825409|FG006|Overall Study|Physician Decision|0|||
156747872|NCT03673345|565825410|FG007|Overall Study|Physician Decision|0|||
156747873|NCT05153148|565825411|FG000|Overall Study|Adverse Event|1|||
156747874|NCT05153148|565825412|FG001|Overall Study|Adverse Event|0|||
156747875|NCT05153148|565825413|FG002|Overall Study|Adverse Event|3|||
156747876|NCT05153148|565825414|FG003|Overall Study|Adverse Event|5|||
156747877|NCT05153148|565825411|FG000|Overall Study|Lost to Follow-up|1|||
156747878|NCT05153148|565825412|FG001|Overall Study|Lost to Follow-up|1|||
156747879|NCT05153148|565825413|FG002|Overall Study|Lost to Follow-up|2|||
156747880|NCT05153148|565825414|FG003|Overall Study|Lost to Follow-up|0|||
156747881|NCT05153148|565825411|FG000|Overall Study|Withdrawal by Subject|6|||
156747882|NCT05153148|565825412|FG001|Overall Study|Withdrawal by Subject|8|||
156747883|NCT05153148|565825413|FG002|Overall Study|Withdrawal by Subject|6|||
156747884|NCT05153148|565825414|FG003|Overall Study|Withdrawal by Subject|8|||
156747885|NCT05153148|565825411|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747886|NCT05153148|565825412|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747887|NCT05153148|565825413|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
156747888|NCT05153148|565825414|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
156747889|NCT05153148|565825411|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747890|NCT05153148|565825412|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747891|NCT05153148|565825413|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
156747892|NCT05153148|565825414|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
156747893|NCT05153148|565825411|FG000|Overall Study|Reason not Specified|1|||
156747894|NCT05153148|565825412|FG001|Overall Study|Reason not Specified|1|||
156747895|NCT05153148|565825413|FG002|Overall Study|Reason not Specified|1|||
156747896|NCT05153148|565825414|FG003|Overall Study|Reason not Specified|1|||
156747897|NCT02267135|565825415|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
156747898|NCT02267135|565825416|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
156747899|NCT02267135|565825415|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
156747900|NCT02267135|565825416|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
156747901|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
156747902|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
156747903|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
156747904|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
156747905|NCT02267135|565825415|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
156747906|NCT02267135|565825416|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
156747907|NCT03806231|565825417|FG000|Overall Study|Physician Decision|1|||
156747908|NCT03806231|565825418|FG001|Overall Study|Physician Decision|0|||
156747909|NCT03806231|565825417|FG000|Overall Study|Withdrawal by Subject|1|||
156747910|NCT03806231|565825418|FG001|Overall Study|Withdrawal by Subject|0|||
156747911|NCT00900731|565825419|FG000|Overall Study|Adverse Event|31|||
156800177|NCT00744861|566023383|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
156800178|NCT00744861|566023384|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
156880489|NCT00599339|566321327|FG000|Overall Study|Adverse Event|79|||
156747912|NCT00900731|565825420|FG001|Overall Study|Adverse Event|27|||
156747913|NCT00900731|565825419|FG000|Overall Study|Withdrawal by Subject|8|||
156747914|NCT00900731|565825420|FG001|Overall Study|Withdrawal by Subject|7|||
156747915|NCT00900731|565825419|FG000|Overall Study|Protocol Deviation|8|||
156747916|NCT00900731|565825420|FG001|Overall Study|Protocol Deviation|11|||
156747917|NCT00900731|565825419|FG000|Overall Study|Administrative Problems|5|||
156747918|NCT00900731|565825420|FG001|Overall Study|Administrative Problems|4|||
156747919|NCT00900731|565825419|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
156747920|NCT00900731|565825420|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156747921|NCT00900731|565825419|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
156747922|NCT00900731|565825420|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
156747923|NCT00900731|565825419|FG000|Overall Study|Lost to Follow-up|2|||
156747924|NCT00900731|565825420|FG001|Overall Study|Lost to Follow-up|3|||
156747925|NCT00900731|565825419|FG000|Overall Study|Lack of Efficacy|1|||
156747926|NCT00900731|565825420|FG001|Overall Study|Lack of Efficacy|3|||
156747927|NCT00900731|565825419|FG000|Overall Study|Death|0|||
156747928|NCT00900731|565825420|FG001|Overall Study|Death|2|||
156747929|NCT04608344|565825421|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
156747930|NCT04608344|565825422|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
156747931|NCT04608344|565825421|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
156747932|NCT04608344|565825422|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
156747933|NCT00131365|565825423|FG000|Overall Study|Withdrawal by Subject|1|||
156747934|NCT00131365|565825423|FG000|Overall Study|Alternative treatment|3|||
156747935|NCT00467961|565825424|FG000|Overall Study|Technical Failures|5|||
156747936|NCT00467961|565825424|FG000|Overall Study|Disease Progression|2|||
156747937|NCT05249127|565825425|FG000|Overall Study|Protocol Violation|13|||
156747938|NCT05249127|565825425|FG000|Overall Study|Physician Decision|4|||
156747939|NCT05249127|565825425|FG000|Overall Study|Withdrawal by Subject|2|||
156747940|NCT05249127|565825425|FG000|Overall Study|Participant Non-compliance|1|||
156747941|NCT02429310|565825427|FG000|Overall Study|Lost to Follow-up|1|||
156747942|NCT02429310|565825428|FG001|Overall Study|Lost to Follow-up|2|||
156747943|NCT02429310|565825427|FG000|Overall Study|Protocol Violation|1|||
156747944|NCT02429310|565825428|FG001|Overall Study|Protocol Violation|1|||
156747945|NCT00394433|565825429|FG000|Overall Study|Adverse Event|2|||
156747946|NCT00394433|565825429|FG000|Overall Study|Alternative Therapy|1|||
156747947|NCT03646305|565825430|FG000|Overall Study|Lost to Follow-up|4|||
156747948|NCT03646305|565825431|FG001|Overall Study|Lost to Follow-up|2|||
156747949|NCT03646305|565825432|FG002|Overall Study|Lost to Follow-up|2|||
156747950|NCT03646305|565825433|FG003|Overall Study|Lost to Follow-up|1|||
156747951|NCT03646305|565825430|FG000|Overall Study|Withdrawal by Subject|1|||
156747952|NCT03646305|565825431|FG001|Overall Study|Withdrawal by Subject|0|||
156747953|NCT03646305|565825432|FG002|Overall Study|Withdrawal by Subject|0|||
156747954|NCT03646305|565825433|FG003|Overall Study|Withdrawal by Subject|1|||
156747955|NCT01554176|565825434|FG000|Treatment Phase|Protocol Violation|1|||
156747956|NCT01554176|565825435|FG001|Treatment Phase|Protocol Violation|2|||
156747957|NCT01554176|565825436|FG002|Treatment Phase|Protocol Violation|0|||
156747958|NCT01554176|565825437|FG003|Treatment Phase|Protocol Violation|0|||
156747959|NCT01554176|565825438|FG004|Treatment Phase|Protocol Violation|0|||
156747960|NCT01554176|565825434|FG000|Treatment Phase|Physician Decision|1|||
156747961|NCT01554176|565825435|FG001|Treatment Phase|Physician Decision|1|||
156747962|NCT01554176|565825436|FG002|Treatment Phase|Physician Decision|0|||
156747963|NCT01554176|565825437|FG003|Treatment Phase|Physician Decision|0|||
156747964|NCT01554176|565825438|FG004|Treatment Phase|Physician Decision|0|||
156747965|NCT01554176|565825434|FG000|Treatment Phase|Lack of Efficacy|0|||
156747966|NCT01554176|565825435|FG001|Treatment Phase|Lack of Efficacy|1|||
156747967|NCT01554176|565825436|FG002|Treatment Phase|Lack of Efficacy|0|||
156747968|NCT01554176|565825437|FG003|Treatment Phase|Lack of Efficacy|0|||
156747969|NCT01554176|565825438|FG004|Treatment Phase|Lack of Efficacy|0|||
156747970|NCT01554176|565825434|FG000|Treatment Phase|Adverse event, non-fatal|1|||
156747971|NCT01554176|565825435|FG001|Treatment Phase|Adverse event, non-fatal|1|||
156747972|NCT01554176|565825436|FG002|Treatment Phase|Adverse event, non-fatal|0|||
156747973|NCT01554176|565825437|FG003|Treatment Phase|Adverse event, non-fatal|0|||
156747974|NCT01554176|565825438|FG004|Treatment Phase|Adverse event, non-fatal|0|||
156747975|NCT01554176|565825434|FG000|Treatment Phase|Non-compliance with study drug|1|||
156747976|NCT01554176|565825435|FG001|Treatment Phase|Non-compliance with study drug|0|||
156747977|NCT01554176|565825436|FG002|Treatment Phase|Non-compliance with study drug|0|||
156747978|NCT01554176|565825437|FG003|Treatment Phase|Non-compliance with study drug|0|||
156747979|NCT01554176|565825438|FG004|Treatment Phase|Non-compliance with study drug|0|||
156747980|NCT01554176|565825434|FG000|Treatment Phase|Withdrawal by Subject|1|||
156747981|NCT01554176|565825435|FG001|Treatment Phase|Withdrawal by Subject|0|||
156747982|NCT01554176|565825436|FG002|Treatment Phase|Withdrawal by Subject|0|||
156747983|NCT01554176|565825437|FG003|Treatment Phase|Withdrawal by Subject|0|||
156747984|NCT01554176|565825438|FG004|Treatment Phase|Withdrawal by Subject|0|||
156747985|NCT01554176|565825434|FG000|Treatment Phase|Lost to Follow-up|3|||
156747986|NCT01554176|565825435|FG001|Treatment Phase|Lost to Follow-up|0|||
156747987|NCT01554176|565825436|FG002|Treatment Phase|Lost to Follow-up|0|||
156747988|NCT01554176|565825437|FG003|Treatment Phase|Lost to Follow-up|0|||
156747989|NCT01554176|565825438|FG004|Treatment Phase|Lost to Follow-up|0|||
156747990|NCT01554176|565825434|FG000|Run-out Phase|Protocol Violation|0|||
156747991|NCT01554176|565825435|FG001|Run-out Phase|Protocol Violation|0|||
156747992|NCT01554176|565825436|FG002|Run-out Phase|Protocol Violation|0|||
156747993|NCT01554176|565825437|FG003|Run-out Phase|Protocol Violation|1|||
156747994|NCT01554176|565825438|FG004|Run-out Phase|Protocol Violation|0|||
156747995|NCT02678000|565825439|FG000|PART 2|Adverse Event|0|||
156747996|NCT02678000|565825440|FG001|PART 2|Adverse Event|0|||
156747997|NCT02678000|565825441|FG002|PART 2|Adverse Event|2|||
156880490|NCT00599339|566321327|FG000|Overall Study|Withdrawal by Subject|137|||
156880491|NCT00599339|566321327|FG000|Overall Study|Other Reason|179|||
156747998|NCT02678000|565825442|FG003|PART 2|Adverse Event|1|||
156747999|NCT02678000|565825443|FG004|PART 2|Adverse Event|0|||
156748000|NCT02678000|565825439|FG000|PART 2|Withdrawal by Subject|0|||
156748001|NCT02678000|565825440|FG001|PART 2|Withdrawal by Subject|0|||
156748002|NCT02678000|565825441|FG002|PART 2|Withdrawal by Subject|1|||
156748003|NCT02678000|565825442|FG003|PART 2|Withdrawal by Subject|0|||
156748004|NCT02678000|565825443|FG004|PART 2|Withdrawal by Subject|0|||
156748005|NCT01859949|565827674|FG000|Overall Study|Family Matters|0|||
156748006|NCT01859949|565827675|FG001|Overall Study|Family Matters|1|||
156748007|NCT01859949|565827674|FG000|Overall Study|Physician Decision|2|||
156748008|NCT01859949|565827675|FG001|Overall Study|Physician Decision|4|||
156748009|NCT01859949|565827674|FG000|Overall Study|Withdrawal by Subject|11|||
156748010|NCT01859949|565827675|FG001|Overall Study|Withdrawal by Subject|10|||
156748011|NCT01859949|565827674|FG000|Overall Study|Protocol Violation|1|||
156748012|NCT01859949|565827675|FG001|Overall Study|Protocol Violation|1|||
156748013|NCT01859949|565827674|FG000|Overall Study|Adverse Event|0|||
156748014|NCT01859949|565827675|FG001|Overall Study|Adverse Event|1|||
156748015|NCT01153009|565827676|FG000|Overall Study|Adverse Event|4|||
156748016|NCT01153009|565827677|FG001|Overall Study|Adverse Event|14|||
156748017|NCT01153009|565827678|FG002|Overall Study|Adverse Event|14|||
156748018|NCT01153009|565827679|FG003|Overall Study|Adverse Event|10|||
156748019|NCT01153009|565827676|FG000|Overall Study|Lack of Efficacy|9|||
156748020|NCT01153009|565827677|FG001|Overall Study|Lack of Efficacy|0|||
156748021|NCT01153009|565827678|FG002|Overall Study|Lack of Efficacy|2|||
156748022|NCT01153009|565827679|FG003|Overall Study|Lack of Efficacy|1|||
156748023|NCT01153009|565827676|FG000|Overall Study|Noncompliance with Study Medication|1|||
156748024|NCT01153009|565827677|FG001|Overall Study|Noncompliance with Study Medication|3|||
156748025|NCT01153009|565827678|FG002|Overall Study|Noncompliance with Study Medication|4|||
156748026|NCT01153009|565827679|FG003|Overall Study|Noncompliance with Study Medication|1|||
156748027|NCT01153009|565827676|FG000|Overall Study|Protocol Deviations|4|||
156748028|NCT01153009|565827677|FG001|Overall Study|Protocol Deviations|3|||
156748029|NCT01153009|565827678|FG002|Overall Study|Protocol Deviations|3|||
156748030|NCT01153009|565827679|FG003|Overall Study|Protocol Deviations|2|||
156748031|NCT01153009|565827676|FG000|Overall Study|Withdrawal of Consent|5|||
156748032|NCT01153009|565827677|FG001|Overall Study|Withdrawal of Consent|5|||
156748033|NCT01153009|565827678|FG002|Overall Study|Withdrawal of Consent|4|||
156748034|NCT01153009|565827679|FG003|Overall Study|Withdrawal of Consent|6|||
156748035|NCT01153009|565827676|FG000|Overall Study|Lost to Follow-up|8|||
156748036|NCT01153009|565827677|FG001|Overall Study|Lost to Follow-up|8|||
156748037|NCT01153009|565827678|FG002|Overall Study|Lost to Follow-up|11|||
156748038|NCT01153009|565827679|FG003|Overall Study|Lost to Follow-up|15|||
156880492|NCT00599339|566321327|FG000|Overall Study|Lost to Follow-up|221|||
156880493|NCT00599339|566321327|FG000|Overall Study|No valid data consent|36|||
156880494|NCT00599339|566321327|FG000|Overall Study|Study Termination Status Unknown|12|||
156880495|NCT05564052|566321328|FG000|Overall Study|Withdrawal by Subject|0|||
156880496|NCT05564052|566321329|FG001|Overall Study|Withdrawal by Subject|0|||
156880497|NCT05564052|566321330|FG002|Overall Study|Withdrawal by Subject|0|||
156880498|NCT05564052|566321331|FG003|Overall Study|Withdrawal by Subject|1|||
156880499|NCT05477108|566321332|FG000|Overall Study|Participants randomized, not treated|1|||
156880500|NCT05477108|566321333|FG001|Overall Study|Participants randomized, not treated|1|||
156880501|NCT05477108|566321334|FG002|Overall Study|Participants randomized, not treated|1|||
157143604|NCT01451515|567274216|FG002|Overall Study|Death|0|||
157143605|NCT01451515|567274214|FG000|Overall Study|Withdrawal by Subject|0|||
156748039|NCT01153009|565827676|FG000|Overall Study|Other|1|||
156748040|NCT01153009|565827677|FG001|Overall Study|Other|1|||
156748041|NCT01153009|565827678|FG002|Overall Study|Other|3|||
156748042|NCT01153009|565827679|FG003|Overall Study|Other|2|||
156748043|NCT03307837|565827682|FG000|Overall Study|Withdrawal by Subject|0|||
156748044|NCT03307837|565827683|FG001|Overall Study|Withdrawal by Subject|0|||
156748045|NCT03307837|565827684|FG002|Overall Study|Withdrawal by Subject|1|||
157143606|NCT01451515|567274215|FG001|Overall Study|Withdrawal by Subject|1|||
157143607|NCT01451515|567274216|FG002|Overall Study|Withdrawal by Subject|0|||
157143608|NCT01451515|567274214|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
156748046|NCT03307837|565827685|FG003|Overall Study|Withdrawal by Subject|0|||
156748047|NCT03307837|565827686|FG004|Overall Study|Withdrawal by Subject|0|||
156748048|NCT03307837|565827687|FG005|Overall Study|Withdrawal by Subject|1|||
156748049|NCT03307837|565827682|FG000|Overall Study|Lost to Follow-up|1|||
156748050|NCT03307837|565827683|FG001|Overall Study|Lost to Follow-up|1|||
156748051|NCT03307837|565827684|FG002|Overall Study|Lost to Follow-up|0|||
156880502|NCT05477108|566321332|FG000|Overall Study|Physician Decision|0|||
157143609|NCT01451515|567274215|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
156748052|NCT03307837|565827685|FG003|Overall Study|Lost to Follow-up|0|||
156748053|NCT03307837|565827686|FG004|Overall Study|Lost to Follow-up|0|||
156748054|NCT03307837|565827687|FG005|Overall Study|Lost to Follow-up|1|||
156748055|NCT03041467|565827688|FG000|Overall Study|Death|46|||
157145172|NCT05755438|567278012|FG000|40-week OLE Period|Sponsor Decision|3|||
156880503|NCT05477108|566321333|FG001|Overall Study|Physician Decision|0|||
156880504|NCT05477108|566321334|FG002|Overall Study|Physician Decision|1|||
156748056|NCT03041467|565827689|FG001|Overall Study|Death|39|||
156748057|NCT03041467|565827688|FG000|Overall Study|Withdrawal by Subject|36|||
156748058|NCT03041467|565827689|FG001|Overall Study|Withdrawal by Subject|37|||
156748059|NCT03041467|565827688|FG000|Overall Study|Lost to Follow-up|6|||
156748060|NCT03041467|565827689|FG001|Overall Study|Lost to Follow-up|8|||
156748061|NCT03041467|565827688|FG000|Overall Study|Declined consent for study extension|21|||
156748062|NCT03041467|565827689|FG001|Overall Study|Declined consent for study extension|33|||
156748063|NCT03041467|565827688|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
156748064|NCT03041467|565827689|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
156748065|NCT04228965|565827693|FG000|Overall Study|Lost to Follow-up|26|||
156748066|NCT04228965|565827694|FG001|Overall Study|Lost to Follow-up|11|||
156748067|NCT04228965|565827693|FG000|Overall Study|Withdrawal by Subject|18|||
156748068|NCT04228965|565827694|FG001|Overall Study|Withdrawal by Subject|5|||
156748069|NCT00734656|565827697|FG000|Lab Session 1|Withdrawal by Subject|2|||
156748070|NCT00734656|565827698|FG001|Lab Session 1|Withdrawal by Subject|0|||
156748071|NCT00734656|565827699|FG002|Lab Session 1|Withdrawal by Subject|0|||
156748072|NCT00734656|565827700|FG003|Lab Session 1|Withdrawal by Subject|0|||
156748073|NCT00734656|565827697|FG000|Washout 1|Withdrawal by Subject|1|||
156748074|NCT00734656|565827698|FG001|Washout 1|Withdrawal by Subject|5|||
156748075|NCT00734656|565827699|FG002|Washout 1|Withdrawal by Subject|2|||
156748076|NCT00734656|565827700|FG003|Washout 1|Withdrawal by Subject|3|||
156748077|NCT00734656|565827697|FG000|Lab Session 2|Withdrawal by Subject|1|||
156748078|NCT00734656|565827698|FG001|Lab Session 2|Withdrawal by Subject|0|||
156748079|NCT00734656|565827699|FG002|Lab Session 2|Withdrawal by Subject|0|||
156748080|NCT00734656|565827700|FG003|Lab Session 2|Withdrawal by Subject|1|||
156748081|NCT00734656|565827697|FG000|Washout 2|Withdrawal by Subject|1|||
156748082|NCT00734656|565827698|FG001|Washout 2|Withdrawal by Subject|1|||
156748083|NCT00734656|565827699|FG002|Washout 2|Withdrawal by Subject|1|||
156748084|NCT00734656|565827700|FG003|Washout 2|Withdrawal by Subject|0|||
156748085|NCT00734656|565827697|FG000|Washout 3|Withdrawal by Subject|1|||
156748086|NCT00734656|565827698|FG001|Washout 3|Withdrawal by Subject|0|||
156748087|NCT00734656|565827699|FG002|Washout 3|Withdrawal by Subject|0|||
156748088|NCT00734656|565827700|FG003|Washout 3|Withdrawal by Subject|1|||
156748089|NCT00734656|565827697|FG000|Lab Session 4|Withdrawal by Subject|0|||
156748090|NCT00734656|565827698|FG001|Lab Session 4|Withdrawal by Subject|0|||
156748091|NCT00734656|565827699|FG002|Lab Session 4|Withdrawal by Subject|0|||
156748092|NCT00734656|565827700|FG003|Lab Session 4|Withdrawal by Subject|1|||
156748093|NCT03214679|565827701|FG000|Overall Study|Lost to Follow-up|12|||
156748094|NCT03214679|565827702|FG001|Overall Study|Lost to Follow-up|14|||
156748095|NCT03214679|565827701|FG000|Overall Study|not eligible|2|||
156748096|NCT03214679|565827702|FG001|Overall Study|not eligible|0|||
156748097|NCT03915626|565827703|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
156748098|NCT01754766|565827711|FG000|Overall Study|Personal reasons|1|||
156748099|NCT01754766|565827712|FG001|Overall Study|Personal reasons|1|||
156880505|NCT05477108|566321332|FG000|Overall Study|withdrawn from study|0|||
156880506|NCT05477108|566321333|FG001|Overall Study|withdrawn from study|0|||
156880507|NCT05477108|566321334|FG002|Overall Study|withdrawn from study|1|||
156880508|NCT01253577|566321337|FG000|Overall Study|Lost to Follow-up|3|||
156880509|NCT05688670|566321338|FG000|Overall Study|Change in surgery plan|1|||
156880510|NCT05688670|566321339|FG001|Overall Study|Change in surgery plan|4|||
156748100|NCT01754766|565827713|FG002|Overall Study|Personal reasons|0|||
156748101|NCT02469168|565827714|FG000|Overall Study|Trial closed|1|||
156748102|NCT02469168|565827715|FG001|Overall Study|Trial closed|0|||
156748103|NCT00298363|565827716|FG000|Overall Study|Lost to Follow-up|0|||
156748104|NCT00298363|565827717|FG001|Overall Study|Lost to Follow-up|0|||
156748105|NCT00298363|565827718|FG002|Overall Study|Lost to Follow-up|1|||
156748106|NCT00298363|565827716|FG000|Overall Study|Physician Decision|4|||
156748107|NCT00298363|565827717|FG001|Overall Study|Physician Decision|1|||
156748108|NCT00298363|565827718|FG002|Overall Study|Physician Decision|0|||
156748109|NCT00298363|565827716|FG000|Overall Study|Protocol Violation|1|||
156748110|NCT00298363|565827717|FG001|Overall Study|Protocol Violation|1|||
156748111|NCT00298363|565827718|FG002|Overall Study|Protocol Violation|0|||
156748112|NCT00298363|565827716|FG000|Overall Study|Withdrawal by Subject|5|||
156748113|NCT00298363|565827717|FG001|Overall Study|Withdrawal by Subject|1|||
156748114|NCT00298363|565827718|FG002|Overall Study|Withdrawal by Subject|3|||
156748115|NCT00298363|565827716|FG000|Overall Study|Adverse Event|5|||
156748116|NCT00298363|565827717|FG001|Overall Study|Adverse Event|2|||
156880511|NCT05688670|566321338|FG000|Overall Study|Inability to extubate|1|||
156748117|NCT00298363|565827718|FG002|Overall Study|Adverse Event|2|||
156748118|NCT00298363|565827716|FG000|Overall Study|Lack of Efficacy|2|||
156748119|NCT00298363|565827717|FG001|Overall Study|Lack of Efficacy|3|||
156748120|NCT00298363|565827718|FG002|Overall Study|Lack of Efficacy|0|||
156880512|NCT05688670|566321339|FG001|Overall Study|Inability to extubate|2|||
156748121|NCT00135356|565827719|FG000|Overall Study|Adverse Event|6|||
156748122|NCT00135356|565827720|FG001|Overall Study|Adverse Event|2|||
157020724|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020725|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
156748123|NCT00135356|565827719|FG000|Overall Study|Lack of Efficacy|2|||
156748124|NCT00135356|565827720|FG001|Overall Study|Lack of Efficacy|0|||
156748125|NCT00135356|565827719|FG000|Overall Study|Lost to Follow-up|3|||
156748126|NCT00135356|565827720|FG001|Overall Study|Lost to Follow-up|1|||
156748127|NCT00135356|565827719|FG000|Overall Study|Surgery for abdominal fat|1|||
156748128|NCT00135356|565827720|FG001|Overall Study|Surgery for abdominal fat|0|||
156748129|NCT00135356|565827719|FG000|Overall Study|Change in antiviral regimen|0|||
156748130|NCT00135356|565827720|FG001|Overall Study|Change in antiviral regimen|1|||
156748131|NCT00135356|565827719|FG000|Overall Study|Poor/noncompliance|1|||
156748132|NCT00135356|565827720|FG001|Overall Study|Poor/noncompliance|1|||
156748133|NCT00135356|565827719|FG000|Overall Study|No longer meets study criteria|2|||
156748134|NCT00135356|565827720|FG001|Overall Study|No longer meets study criteria|0|||
156748135|NCT00135356|565827719|FG000|Overall Study|Withdrawal by Subject|2|||
156748136|NCT00135356|565827720|FG001|Overall Study|Withdrawal by Subject|4|||
156748137|NCT01533688|565827721|FG000|Overall Study|Withdrawal by Subject|5|||
156748138|NCT01533688|565827722|FG001|Overall Study|Withdrawal by Subject|4|||
156748139|NCT01533688|565827723|FG002|Overall Study|Withdrawal by Subject|3|||
156748140|NCT01533688|565827721|FG000|Overall Study|Medically unstable|1|||
156748141|NCT01533688|565827722|FG001|Overall Study|Medically unstable|3|||
156748142|NCT01533688|565827723|FG002|Overall Study|Medically unstable|3|||
156748143|NCT01533688|565827721|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
156748144|NCT01533688|565827722|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
156748145|NCT01533688|565827723|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
156748146|NCT01306214|565827725|FG000|Overall Study|Death|0|||
156748147|NCT01306214|565827726|FG001|Overall Study|Death|0|||
156748148|NCT01306214|565827727|FG002|Overall Study|Death|1|||
156748149|NCT01306214|565827725|FG000|Overall Study|Lost to Follow-up|3|||
156748150|NCT01306214|565827726|FG001|Overall Study|Lost to Follow-up|5|||
156748151|NCT01306214|565827727|FG002|Overall Study|Lost to Follow-up|4|||
156748152|NCT01306214|565827725|FG000|Overall Study|Withdrawal by Subject|24|||
156748153|NCT01306214|565827726|FG001|Overall Study|Withdrawal by Subject|22|||
156748154|NCT01306214|565827727|FG002|Overall Study|Withdrawal by Subject|16|||
156748155|NCT01306214|565827725|FG000|Overall Study|Not treated|1|||
156748156|NCT01306214|565827726|FG001|Overall Study|Not treated|1|||
156748157|NCT01306214|565827727|FG002|Overall Study|Not treated|1|||
156748158|NCT02686814|565827728|FG000|Overall Study|Physician Decision|14|||
156748159|NCT02686814|565827728|FG000|Overall Study|Withdrawal by Subject|4|||
156748160|NCT02686814|565827728|FG000|Overall Study|Death|1|||
156748161|NCT01026818|565827731|FG000|Screening Period|Entry Criteria Not Met|105|||
156748162|NCT01026818|565827732|FG001|Screening Period|Entry Criteria Not Met|0|||
156748163|NCT01026818|565827733|FG002|Screening Period|Entry Criteria Not Met|0|||
156748164|NCT01026818|565827734|FG003|Screening Period|Entry Criteria Not Met|0|||
156748165|NCT01026818|565827731|FG000|Screening Period|Withdrawal by Subject|49|||
156748166|NCT01026818|565827732|FG001|Screening Period|Withdrawal by Subject|0|||
156748167|NCT01026818|565827733|FG002|Screening Period|Withdrawal by Subject|0|||
156748168|NCT01026818|565827734|FG003|Screening Period|Withdrawal by Subject|0|||
156748169|NCT01026818|565827731|FG000|Screening Period|Protocol Deviation|3|||
156748170|NCT01026818|565827732|FG001|Screening Period|Protocol Deviation|0|||
156748171|NCT01026818|565827733|FG002|Screening Period|Protocol Deviation|0|||
156748172|NCT01026818|565827734|FG003|Screening Period|Protocol Deviation|0|||
156748173|NCT01026818|565827731|FG000|Screening Period|Adverse Event|2|||
156748174|NCT01026818|565827732|FG001|Screening Period|Adverse Event|0|||
156748175|NCT01026818|565827733|FG002|Screening Period|Adverse Event|0|||
156748176|NCT01026818|565827734|FG003|Screening Period|Adverse Event|0|||
156748177|NCT01026818|565827731|FG000|Screening Period|Physician Decision|1|||
156748178|NCT01026818|565827732|FG001|Screening Period|Physician Decision|0|||
156748179|NCT01026818|565827733|FG002|Screening Period|Physician Decision|0|||
156748180|NCT01026818|565827734|FG003|Screening Period|Physician Decision|0|||
156748181|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
156748182|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
157020726|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
157020727|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
156748183|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
156748184|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
156748185|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
156748186|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
157020728|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Death|0|||
157020729|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Death|0|||
156748187|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
156748188|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
156748189|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
156748190|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
156748191|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
156748192|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
156880513|NCT05688670|566321338|FG000|Overall Study|Day of surgery cancellation|0|||
156880514|NCT05688670|566321339|FG001|Overall Study|Day of surgery cancellation|1|||
156880515|NCT05688670|566321338|FG000|Overall Study|Reintubated on PCICU arrival|0|||
156880516|NCT05688670|566321339|FG001|Overall Study|Reintubated on PCICU arrival|1|||
156880517|NCT00488683|566321340|FG000|Overall Study|Withdrawal by Subject|1|||
156880518|NCT00488683|566321341|FG001|Overall Study|Withdrawal by Subject|2|||
156880519|NCT00488683|566321342|FG002|Overall Study|Withdrawal by Subject|2|||
156880520|NCT00488683|566321340|FG000|Overall Study|Lost to Follow-up|5|||
156880521|NCT00488683|566321341|FG001|Overall Study|Lost to Follow-up|3|||
156880522|NCT00488683|566321342|FG002|Overall Study|Lost to Follow-up|0|||
156880523|NCT00488683|566321340|FG000|Overall Study|Protocol Violation|5|||
156880524|NCT00488683|566321341|FG001|Overall Study|Protocol Violation|1|||
156880525|NCT00488683|566321342|FG002|Overall Study|Protocol Violation|0|||
156880526|NCT00488683|566321340|FG000|Overall Study|Unable to Classify|1|||
156880527|NCT00488683|566321341|FG001|Overall Study|Unable to Classify|0|||
156880528|NCT00488683|566321342|FG002|Overall Study|Unable to Classify|0|||
156880529|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
156880530|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
156880531|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
156880532|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
156880533|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
156880534|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156880535|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156880536|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
156880537|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
156880538|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156880539|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156880540|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
156880541|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
156880542|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156880543|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156880544|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
156880545|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
156880546|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
156880547|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
157143610|NCT01451515|567274216|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
156748193|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
156748194|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
156748195|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
156748196|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
156748197|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
156748198|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
156748199|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
156748200|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
156748201|NCT01026818|565827731|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
156748202|NCT01026818|565827732|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
156748203|NCT01026818|565827733|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
156748204|NCT01026818|565827734|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
156748205|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
156748206|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
156748207|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
156748208|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
156748209|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
156748210|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
156748211|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
156748212|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
156748213|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748214|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
156748215|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748216|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
156748217|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
156748218|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
156748219|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
156748220|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
156748221|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
156748222|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
156880548|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
156880549|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
156880550|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
157020730|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Death|0|||
157220731|NCT01341639|567554817|FG000|Interim Period|Protocol Violation|0|||
157220732|NCT01341639|567554818|FG001|Interim Period|Protocol Violation|1|||
157220733|NCT01341639|567554817|FG000|Post-Treatment|Withdrawal by Subject|0|||
157220734|NCT01341639|567554818|FG001|Post-Treatment|Withdrawal by Subject|1|||
157220735|NCT01341639|567554817|FG000|Post-Treatment|Adverse Event|0|||
157220736|NCT01341639|567554818|FG001|Post-Treatment|Adverse Event|2|||
157220737|NCT02497391|567554824|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
157220738|NCT02497391|567554825|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
157220739|NCT02497391|567554826|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
157220740|NCT02497391|567554827|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
157220741|NCT02497391|567554828|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
157220742|NCT02497391|567554829|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
157220743|NCT02497391|567554824|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
157220744|NCT02497391|567554825|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
157220745|NCT02497391|567554826|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
157220746|NCT02497391|567554827|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
157220747|NCT02497391|567554828|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
157220748|NCT02497391|567554829|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
157220749|NCT02497391|567554824|FG000|Period 3 (14 Days)|Adverse Event|0|||
157220750|NCT02497391|567554825|FG001|Period 3 (14 Days)|Adverse Event|1|||
157220751|NCT02497391|567554826|FG002|Period 3 (14 Days)|Adverse Event|0|||
157220752|NCT02497391|567554827|FG003|Period 3 (14 Days)|Adverse Event|0|||
157220753|NCT02497391|567554828|FG004|Period 3 (14 Days)|Adverse Event|0|||
157220754|NCT02497391|567554829|FG005|Period 3 (14 Days)|Adverse Event|0|||
157220755|NCT02497391|567554824|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
157220756|NCT02497391|567554825|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
157220757|NCT02497391|567554826|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
157220758|NCT02497391|567554827|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
157220759|NCT02497391|567554828|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
157220760|NCT02497391|567554829|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
157220761|NCT02497391|567554824|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
157220762|NCT02497391|567554825|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
157220763|NCT02497391|567554826|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
157220764|NCT02497391|567554827|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
157220765|NCT02497391|567554828|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
157220766|NCT02497391|567554829|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
157220767|NCT01664052|567554830|FG000|Phase 1|No device placement|6|||
157220768|NCT01664052|567554831|FG001|Phase 1|No device placement|0|||
157220769|NCT01664052|567554830|FG000|Phase 1|No HSG 1 hr post placement|1|||
157220770|NCT01664052|567554831|FG001|Phase 1|No HSG 1 hr post placement|0|||
157220771|NCT01664052|567554830|FG000|Phase 2|No device placement|0|||
157220772|NCT01664052|567554831|FG001|Phase 2|No device placement|4|||
157220773|NCT05216978|567554842|FG000|Overall Study|Withdrawal by Subject|3|||
157220774|NCT05216978|567554842|FG000|Overall Study|Lost to Follow-up|5|||
157220775|NCT02410252|567554848|FG000|Overall Study|Withdrawal by Subject|4|||
157220776|NCT02410252|567554848|FG000|Overall Study|Physician Decision|2|||
157220777|NCT00832078|567554849|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
157220778|NCT00832078|567554850|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
156748223|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
156748224|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
156748225|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748226|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
156748227|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748228|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
156748229|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
156800179|NCT00744861|566023381|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
156800180|NCT00744861|566023382|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
156800181|NCT00744861|566023383|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
156800182|NCT00744861|566023384|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
156800183|NCT02493764|566023385|FG000|Overall Study|Adverse Event|2|||
157220779|NCT00832078|567554849|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
157220780|NCT00832078|567554850|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
157220781|NCT02961920|567554851|FG000|Overall Study|did not achive stydy protocol schedule|1|||
157220782|NCT02961920|567554852|FG001|Overall Study|did not achive stydy protocol schedule|1|||
157220783|NCT01452529|567554853|FG000|Run-in Period|Adverse Event|96|||
157220784|NCT01452529|567554854|FG001|Run-in Period|Adverse Event|0|||
157220785|NCT01452529|567554855|FG002|Run-in Period|Adverse Event|0|||
157220786|NCT01452529|567554853|FG000|Run-in Period|Withdrawal by Subject|49|||
157220787|NCT01452529|567554854|FG001|Run-in Period|Withdrawal by Subject|0|||
157220788|NCT01452529|567554855|FG002|Run-in Period|Withdrawal by Subject|0|||
157220789|NCT01452529|567554853|FG000|Run-in Period|Lost to Follow-up|19|||
157220790|NCT01452529|567554854|FG001|Run-in Period|Lost to Follow-up|0|||
157220791|NCT01452529|567554855|FG002|Run-in Period|Lost to Follow-up|0|||
157220792|NCT01452529|567554853|FG000|Run-in Period|Lack of Efficacy|46|||
157220793|NCT01452529|567554854|FG001|Run-in Period|Lack of Efficacy|0|||
156748230|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
156748231|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
156748232|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
156748233|NCT01026818|565827731|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748234|NCT01026818|565827732|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748235|NCT01026818|565827733|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
156748236|NCT01026818|565827734|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
156748237|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748238|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
156748239|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748240|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
156748241|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748242|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
156748243|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748244|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
156748245|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
156748246|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
156748247|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
156748248|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
156748249|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
156748250|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
156748251|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
156748252|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
156748253|NCT01026818|565827731|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
156748254|NCT01026818|565827732|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
156748255|NCT01026818|565827733|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
156748256|NCT01026818|565827734|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
156748257|NCT03300050|565827737|FG000|Overall Study|Lost to Follow-up|2|||
156748258|NCT03300050|565827738|FG001|Overall Study|Lost to Follow-up|1|||
156748259|NCT03300050|565827739|FG002|Overall Study|Lost to Follow-up|0|||
156748260|NCT03300050|565827740|FG003|Overall Study|Lost to Follow-up|0|||
156748261|NCT03300050|565827741|FG004|Overall Study|Lost to Follow-up|1|||
156748262|NCT03300050|565827737|FG000|Overall Study|Withdrawal by Subject|1|||
156748263|NCT03300050|565827738|FG001|Overall Study|Withdrawal by Subject|1|||
156748264|NCT03300050|565827739|FG002|Overall Study|Withdrawal by Subject|1|||
156748265|NCT03300050|565827740|FG003|Overall Study|Withdrawal by Subject|0|||
156748266|NCT03300050|565827741|FG004|Overall Study|Withdrawal by Subject|0|||
156748267|NCT03300050|565827737|FG000|Overall Study|Death|0|||
156748268|NCT03300050|565827738|FG001|Overall Study|Death|0|||
156748269|NCT03300050|565827739|FG002|Overall Study|Death|1|||
156800184|NCT02493764|566023386|FG001|Overall Study|Adverse Event|2|||
156800185|NCT02493764|566023385|FG000|Overall Study|Death|44|||
156800186|NCT02493764|566023386|FG001|Overall Study|Death|58|||
157143611|NCT01451515|567274214|FG000|Overall Study|Relapse (except CNS)|1|||
157143612|NCT01451515|567274215|FG001|Overall Study|Relapse (except CNS)|1|||
157143613|NCT01451515|567274216|FG002|Overall Study|Relapse (except CNS)|0|||
157143614|NCT00635102|567274227|FG000|Overall Study|Withdrawal by Subject|7|||
157143615|NCT00635102|567274228|FG001|Overall Study|Withdrawal by Subject|8|||
157143616|NCT00440401|567274230|FG000|Overall Study|Adverse Event|2|||
157143617|NCT00440401|567274231|FG001|Overall Study|Adverse Event|1|||
157143618|NCT00440401|567274230|FG000|Overall Study|Other|2|||
157143619|NCT00440401|567274231|FG001|Overall Study|Other|5|||
157143620|NCT01925703|567274232|FG000|Overall Study|Physician Decision|1|||
157143621|NCT01925703|567274232|FG000|Overall Study|Lost to Follow-up|2|||
157143622|NCT01925703|567274232|FG000|Overall Study|Discharge prior to full iron repletion|1|||
157143623|NCT01938625|567274233|FG000|Overall Study|Withdrawal by Subject|0|||
157143624|NCT01938625|567274234|FG001|Overall Study|Withdrawal by Subject|1|||
157143625|NCT01938625|567274233|FG000|Overall Study|Adverse Event|0|||
157143626|NCT01938625|567274234|FG001|Overall Study|Adverse Event|1|||
157143627|NCT01937312|567274235|FG000|Overall Study|Adverse Event|10|||
157143628|NCT01937312|567274236|FG001|Overall Study|Adverse Event|1|||
157143629|NCT01937312|567274235|FG000|Overall Study|Lack of Efficacy|0|||
157143630|NCT01937312|567274236|FG001|Overall Study|Lack of Efficacy|1|||
156748270|NCT03300050|565827740|FG003|Overall Study|Death|0|||
156748271|NCT03300050|565827741|FG004|Overall Study|Death|0|||
156748272|NCT03300050|565827737|FG000|Overall Study|Not Eligible at Randomization|0|||
156748273|NCT03300050|565827738|FG001|Overall Study|Not Eligible at Randomization|0|||
156748274|NCT03300050|565827739|FG002|Overall Study|Not Eligible at Randomization|1|||
156748275|NCT03300050|565827740|FG003|Overall Study|Not Eligible at Randomization|1|||
156800187|NCT02493764|566023385|FG000|Overall Study|Lost to Follow-up|2|||
157143631|NCT01937312|567274235|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
157143632|NCT01937312|567274236|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
157143633|NCT00091793|567274237|FG000|Overall Study|Adverse Event|1|||
157143634|NCT00091793|567274238|FG001|Overall Study|Adverse Event|2|||
156880551|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
156880552|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
156880553|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
156880554|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156880555|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156880556|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
156880557|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
156880558|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156880559|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156880560|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
156880561|NCT03818035|566321343|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
156880562|NCT03818035|566321344|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
156880563|NCT03818035|566321345|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
156880564|NCT03818035|566321346|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
156880565|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156880566|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156880567|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
156880568|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
156880569|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
156880570|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
156880571|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
156880572|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
156880573|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156880574|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156880575|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
156880576|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
156880577|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
156880578|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
156880579|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
156880580|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
156880581|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
156880582|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
156880583|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
156880584|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
156880585|NCT03818035|566321343|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
156880586|NCT03818035|566321344|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
156880587|NCT03818035|566321345|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
156880588|NCT03818035|566321346|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
156880589|NCT01948193|566322836|FG000|Overall Study|Serious event|2|||
156880590|NCT01948193|566322836|FG000|Overall Study|Lost to Follow-up|7|||
156880591|NCT00843778|566322837|FG000|Overall Study|Adverse Event|15|||
156880592|NCT00843778|566322837|FG000|Overall Study|Lack of Efficacy|14|||
156880593|NCT00843778|566322837|FG000|Overall Study|Loss of efficacy|2|||
156880594|NCT00843778|566322837|FG000|Overall Study|Withdrawal by Subject|4|||
156880595|NCT00409331|566322838|FG000|Overall Study|Physician Decision|1|||
156880596|NCT00730028|566322846|FG000|Overall Study|Adverse Event|23|||
156880597|NCT00730028|566322847|FG001|Overall Study|Adverse Event|26|||
156880598|NCT00730028|566322848|FG002|Overall Study|Adverse Event|16|||
156880599|NCT00730028|566322849|FG003|Overall Study|Adverse Event|20|||
156880600|NCT00730028|566322850|FG004|Overall Study|Adverse Event|43|||
156880601|NCT00730028|566322846|FG000|Overall Study|Lost to Follow-up|13|||
156880602|NCT00730028|566322847|FG001|Overall Study|Lost to Follow-up|26|||
156880603|NCT00730028|566322848|FG002|Overall Study|Lost to Follow-up|22|||
156880604|NCT00730028|566322849|FG003|Overall Study|Lost to Follow-up|26|||
156880605|NCT00730028|566322850|FG004|Overall Study|Lost to Follow-up|25|||
156880606|NCT00730028|566322846|FG000|Overall Study|Protocol Violation|6|||
156880607|NCT00730028|566322847|FG001|Overall Study|Protocol Violation|1|||
156880608|NCT00730028|566322848|FG002|Overall Study|Protocol Violation|1|||
156880609|NCT00730028|566322849|FG003|Overall Study|Protocol Violation|2|||
156880610|NCT00730028|566322850|FG004|Overall Study|Protocol Violation|0|||
156880611|NCT00730028|566322846|FG000|Overall Study|Withdrawal by Subject|9|||
157020731|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Death|0|||
156880612|NCT00730028|566322847|FG001|Overall Study|Withdrawal by Subject|5|||
156880613|NCT00730028|566322848|FG002|Overall Study|Withdrawal by Subject|4|||
157020732|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Death|0|||
157020733|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Death|0|||
157020734|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Death|0|||
156880614|NCT00730028|566322849|FG003|Overall Study|Withdrawal by Subject|5|||
156880615|NCT00730028|566322850|FG004|Overall Study|Withdrawal by Subject|9|||
156880616|NCT00730028|566322846|FG000|Overall Study|Physician Decision|3|||
156880617|NCT00730028|566322847|FG001|Overall Study|Physician Decision|3|||
156880618|NCT00730028|566322848|FG002|Overall Study|Physician Decision|2|||
156880619|NCT00730028|566322849|FG003|Overall Study|Physician Decision|3|||
156880620|NCT00730028|566322850|FG004|Overall Study|Physician Decision|2|||
156880621|NCT00730028|566322846|FG000|Overall Study|Treatment Failure|5|||
156880622|NCT00730028|566322847|FG001|Overall Study|Treatment Failure|5|||
156880623|NCT00730028|566322848|FG002|Overall Study|Treatment Failure|0|||
156880624|NCT00730028|566322849|FG003|Overall Study|Treatment Failure|0|||
156880625|NCT00730028|566322850|FG004|Overall Study|Treatment Failure|1|||
156880626|NCT00730028|566322846|FG000|Overall Study|Randomization Error|1|||
156880627|NCT00730028|566322847|FG001|Overall Study|Randomization Error|0|||
156880628|NCT00730028|566322848|FG002|Overall Study|Randomization Error|0|||
156880629|NCT00730028|566322849|FG003|Overall Study|Randomization Error|0|||
156880630|NCT00730028|566322850|FG004|Overall Study|Randomization Error|2|||
156880631|NCT03680742|566322851|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
156880632|NCT01410357|566322852|FG000|Overall Study|Death|2|||
156880633|NCT01410357|566322853|FG001|Overall Study|Death|1|||
156880634|NCT01410357|566322852|FG000|Overall Study|Withdrawal by Subject|1|||
156880635|NCT01410357|566322853|FG001|Overall Study|Withdrawal by Subject|2|||
156880636|NCT01410357|566322852|FG000|Overall Study|Lost to Follow-up|23|||
156880637|NCT01410357|566322853|FG001|Overall Study|Lost to Follow-up|21|||
156880638|NCT00615901|566322854|FG000|Overall Study|Withdrawal by Subject|2|||
156880639|NCT00615901|566322854|FG000|Overall Study|Adverse Event|7|||
156880640|NCT01250496|566322861|FG000|Overall Study|Study terminated|124|||
156880641|NCT01250496|566322862|FG001|Overall Study|Study terminated|124|||
156880642|NCT00003590|566322863|FG000|Overall Study|Ineligible Patient|1|||
156880643|NCT00003590|566322863|FG000|Overall Study|Adverse Event|7|||
156880644|NCT00003590|566322863|FG000|Overall Study|Withdrawal by Subject|1|||
156880645|NCT00003590|566322863|FG000|Overall Study|Lack of Efficacy|11|||
156880646|NCT00003590|566322863|FG000|Overall Study|Death|1|||
156880647|NCT00003590|566322863|FG000|Overall Study|Physician Decision|1|||
156880648|NCT01425463|566322869|FG000|Overall Study|Adverse Event|5|||
156880649|NCT01425463|566322870|FG001|Overall Study|Adverse Event|7|||
156880650|NCT01425463|566322869|FG000|Overall Study|Lack of Efficacy|1|||
156880651|NCT01425463|566322870|FG001|Overall Study|Lack of Efficacy|1|||
156880652|NCT01425463|566322869|FG000|Overall Study|Protocol Violation|2|||
156880653|NCT01425463|566322870|FG001|Overall Study|Protocol Violation|2|||
156880654|NCT01425463|566322869|FG000|Overall Study|Lost to Follow-up|5|||
156880655|NCT01425463|566322870|FG001|Overall Study|Lost to Follow-up|2|||
156880656|NCT01425463|566322869|FG000|Overall Study|Withdrawal by Subject|7|||
156880657|NCT01425463|566322870|FG001|Overall Study|Withdrawal by Subject|5|||
156880658|NCT01425463|566322869|FG000|Overall Study|Unknown Reason|4|||
156880659|NCT01425463|566322870|FG001|Overall Study|Unknown Reason|7|||
156880660|NCT00668733|566322873|FG000|Overall Study|Lost to Follow-up|2|||
156880661|NCT00668733|566322874|FG001|Overall Study|Lost to Follow-up|3|||
156880662|NCT00668733|566322873|FG000|Overall Study|Withdrawal by Subject|0|||
156880663|NCT00668733|566322874|FG001|Overall Study|Withdrawal by Subject|4|||
156880664|NCT03467152|566322875|FG000|Overall Study|Adverse Event|4|||
156880665|NCT03467152|566322876|FG001|Overall Study|Adverse Event|5|||
156880666|NCT03467152|566322877|FG002|Overall Study|Adverse Event|0|||
156880667|NCT03467152|566322875|FG000|Overall Study|Subject Choice|1|||
156880668|NCT03467152|566322876|FG001|Overall Study|Subject Choice|3|||
156880669|NCT03467152|566322877|FG002|Overall Study|Subject Choice|0|||
156880670|NCT03467152|566322875|FG000|Overall Study|Lost to Follow-up|1|||
156880671|NCT03467152|566322876|FG001|Overall Study|Lost to Follow-up|0|||
156880672|NCT03467152|566322877|FG002|Overall Study|Lost to Follow-up|0|||
156880673|NCT03467152|566322875|FG000|Overall Study|Withdrawal by Subject|4|||
156880674|NCT03467152|566322876|FG001|Overall Study|Withdrawal by Subject|2|||
156880675|NCT03467152|566322877|FG002|Overall Study|Withdrawal by Subject|0|||
156880676|NCT03467152|566322875|FG000|Overall Study|Others|3|||
156880677|NCT03467152|566322876|FG001|Overall Study|Others|0|||
156880678|NCT03467152|566322877|FG002|Overall Study|Others|0|||
156880679|NCT03467152|566322875|FG000|Overall Study|Not treated|3|||
156880680|NCT03467152|566322876|FG001|Overall Study|Not treated|1|||
156880681|NCT03467152|566322877|FG002|Overall Study|Not treated|6|||
156880682|NCT00945906|566322879|FG000|Overall Study|Withdrawal by Subject|1|||
156880683|NCT00945906|566322879|FG000|Overall Study|Did not want to return for last visit|2|||
156880684|NCT00945906|566322879|FG000|Overall Study|Unable to return for last visit|2|||
156880685|NCT00945906|566322879|FG000|Overall Study|Moved to another country|2|||
157020735|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Death|0|||
156880686|NCT01236547|566322880|FG000|Overall Study|Protocol Violation|0|||
156880687|NCT01236547|566322881|FG001|Overall Study|Protocol Violation|1|||
156880688|NCT01236547|566322882|FG002|Overall Study|Protocol Violation|1|||
156880689|NCT01236547|566322883|FG003|Overall Study|Protocol Violation|6|||
156880690|NCT01236547|566322884|FG004|Overall Study|Protocol Violation|12|||
157020736|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Death|0|||
156880691|NCT03700684|566322885|FG000|Overall Study|COVID-19|0|||
156880692|NCT03700684|566322886|FG001|Overall Study|COVID-19|0|||
156880693|NCT03700684|566322887|FG002|Overall Study|COVID-19|2|||
156880694|NCT01120782|566322888|FG000|Overall Study|Test article shipping error|11|||
156880695|NCT04140227|566322889|FG000|Overall Study|Withdrawal by Subject|26|||
156880696|NCT04140227|566322889|FG000|Overall Study|Lost to Follow-up|8|||
156880697|NCT04140227|566322889|FG000|Overall Study|Adverse Event|8|||
156880698|NCT04140227|566322889|FG000|Overall Study|Death|1|||
156880699|NCT04140227|566322889|FG000|Overall Study|Other|3|||
156880700|NCT04140227|566322889|FG000|Overall Study|Protocol Violation|2|||
156880701|NCT00361634|566322894|FG000|Overall Study|Lost to Follow-up|1|||
156880702|NCT00361634|566322894|FG000|Overall Study|Withdrawal by Subject|1|||
156880703|NCT00635219|566322895|FG000|Overall Study|Adverse Event|12|||
156880704|NCT00635219|566322896|FG001|Overall Study|Adverse Event|10|||
156880705|NCT00635219|566322897|FG002|Overall Study|Adverse Event|18|||
156880706|NCT00635219|566322898|FG003|Overall Study|Adverse Event|15|||
156880707|NCT00635219|566322899|FG004|Overall Study|Adverse Event|19|||
156880708|NCT00635219|566322895|FG000|Overall Study|Lack of Efficacy|5|||
156880709|NCT00635219|566322896|FG001|Overall Study|Lack of Efficacy|6|||
156880710|NCT00635219|566322897|FG002|Overall Study|Lack of Efficacy|3|||
156880711|NCT00635219|566322898|FG003|Overall Study|Lack of Efficacy|4|||
156880712|NCT00635219|566322899|FG004|Overall Study|Lack of Efficacy|6|||
156880713|NCT00635219|566322895|FG000|Overall Study|Non-compliance With Study Product|0|||
156880714|NCT00635219|566322896|FG001|Overall Study|Non-compliance With Study Product|0|||
156880715|NCT00635219|566322897|FG002|Overall Study|Non-compliance With Study Product|0|||
156748276|NCT03300050|565827741|FG004|Overall Study|Not Eligible at Randomization|0|||
156748277|NCT01214668|565827742|FG000|Overall Study|Adverse Event|0|||
156748278|NCT01214668|565827743|FG001|Overall Study|Adverse Event|1|||
156748279|NCT01214668|565827744|FG002|Overall Study|Adverse Event|0|||
156880716|NCT00635219|566322898|FG003|Overall Study|Non-compliance With Study Product|2|||
156880717|NCT00635219|566322899|FG004|Overall Study|Non-compliance With Study Product|1|||
156748280|NCT01214668|565827745|FG003|Overall Study|Adverse Event|2|||
156748281|NCT01214668|565827746|FG004|Overall Study|Adverse Event|1|||
156748282|NCT01214668|565827747|FG005|Overall Study|Adverse Event|1|||
156880718|NCT00635219|566322895|FG000|Overall Study|Protocol Violation|0|||
156880719|NCT00635219|566322896|FG001|Overall Study|Protocol Violation|2|||
156880720|NCT00635219|566322897|FG002|Overall Study|Protocol Violation|3|||
156880721|NCT00635219|566322898|FG003|Overall Study|Protocol Violation|2|||
156880722|NCT00635219|566322899|FG004|Overall Study|Protocol Violation|4|||
156880723|NCT00635219|566322895|FG000|Overall Study|Withdrawal of Consent|8|||
156880724|NCT00635219|566322896|FG001|Overall Study|Withdrawal of Consent|6|||
156880725|NCT00635219|566322897|FG002|Overall Study|Withdrawal of Consent|8|||
156880726|NCT00635219|566322898|FG003|Overall Study|Withdrawal of Consent|11|||
156880727|NCT00635219|566322899|FG004|Overall Study|Withdrawal of Consent|8|||
156880728|NCT00635219|566322895|FG000|Overall Study|Lost to Follow-up|0|||
156880729|NCT00635219|566322896|FG001|Overall Study|Lost to Follow-up|0|||
156880730|NCT00635219|566322897|FG002|Overall Study|Lost to Follow-up|2|||
156880731|NCT00635219|566322898|FG003|Overall Study|Lost to Follow-up|0|||
156880732|NCT00635219|566322899|FG004|Overall Study|Lost to Follow-up|3|||
156880733|NCT00635219|566322895|FG000|Overall Study|Administrative or Other Reasons|0|||
156880734|NCT00635219|566322896|FG001|Overall Study|Administrative or Other Reasons|1|||
156880735|NCT00635219|566322897|FG002|Overall Study|Administrative or Other Reasons|1|||
156880736|NCT00635219|566322898|FG003|Overall Study|Administrative or Other Reasons|0|||
156880737|NCT00635219|566322899|FG004|Overall Study|Administrative or Other Reasons|1|||
156880738|NCT01598129|566322900|FG000|Overall Study|Disease progression|6|||
156880739|NCT01598129|566322900|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
156880740|NCT01598129|566322900|FG000|Overall Study|Withdrawal by Subject|1|||
156880741|NCT04093024|566322901|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
156880742|NCT04093024|566322902|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
156880743|NCT04093024|566322901|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
156880744|NCT04093024|566322902|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
156880745|NCT04093024|566322901|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
156880746|NCT04093024|566322902|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
156880747|NCT04093024|566322901|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
156880748|NCT04093024|566322902|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
156880749|NCT00647270|566322903|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
156880750|NCT00647270|566322904|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
156880751|NCT00647270|566322905|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
156748283|NCT01214668|565827742|FG000|Overall Study|Death|0|||
156880752|NCT00647270|566322903|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
156880753|NCT00647270|566322904|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
156880754|NCT00647270|566322905|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
156880755|NCT00647270|566322903|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
156880756|NCT00647270|566322904|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
156880757|NCT00647270|566322905|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
156880758|NCT00647270|566322903|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
156880759|NCT00647270|566322904|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
156880760|NCT00647270|566322905|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
156880761|NCT00647270|566322903|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
156880762|NCT00647270|566322904|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
157220794|NCT01452529|567554855|FG002|Run-in Period|Lack of Efficacy|0|||
156748284|NCT01214668|565827743|FG001|Overall Study|Death|0|||
157220795|NCT01452529|567554853|FG000|Run-in Period|Confirmed or suspected diversion|23|||
156748285|NCT01214668|565827744|FG002|Overall Study|Death|1|||
156748286|NCT01214668|565827745|FG003|Overall Study|Death|0|||
156748287|NCT01214668|565827746|FG004|Overall Study|Death|0|||
156748288|NCT01214668|565827747|FG005|Overall Study|Death|0|||
156748289|NCT01214668|565827742|FG000|Overall Study|Progressive Disease|4|||
156748290|NCT01214668|565827743|FG001|Overall Study|Progressive Disease|2|||
156748291|NCT01214668|565827744|FG002|Overall Study|Progressive Disease|5|||
156748292|NCT01214668|565827745|FG003|Overall Study|Progressive Disease|4|||
156748293|NCT01214668|565827746|FG004|Overall Study|Progressive Disease|4|||
156748294|NCT01214668|565827747|FG005|Overall Study|Progressive Disease|5|||
156748295|NCT01214668|565827742|FG000|Overall Study|Withdrawal by Subject|0|||
156748296|NCT01214668|565827743|FG001|Overall Study|Withdrawal by Subject|0|||
156748297|NCT01214668|565827744|FG002|Overall Study|Withdrawal by Subject|0|||
156748298|NCT01214668|565827745|FG003|Overall Study|Withdrawal by Subject|0|||
156748299|NCT01214668|565827746|FG004|Overall Study|Withdrawal by Subject|1|||
156748300|NCT01214668|565827747|FG005|Overall Study|Withdrawal by Subject|0|||
156748301|NCT02907619|565827748|FG000|Overall Study|Study terminated by sponsor|18|||
156748302|NCT02907619|565827749|FG001|Overall Study|Study terminated by sponsor|18|||
156748303|NCT02907619|565827750|FG002|Overall Study|Study terminated by sponsor|19|||
156748304|NCT02907619|565827748|FG000|Overall Study|Death|0|||
156748305|NCT02907619|565827749|FG001|Overall Study|Death|0|||
156748306|NCT02907619|565827750|FG002|Overall Study|Death|1|||
156748307|NCT02907619|565827748|FG000|Overall Study|Withdrawal by Subject|1|||
156748308|NCT02907619|565827749|FG001|Overall Study|Withdrawal by Subject|1|||
156748309|NCT02907619|565827750|FG002|Overall Study|Withdrawal by Subject|0|||
156748310|NCT02907619|565827748|FG000|Overall Study|Other|0|||
156748311|NCT02907619|565827749|FG001|Overall Study|Other|1|||
156748312|NCT02907619|565827750|FG002|Overall Study|Other|0|||
156748313|NCT03326518|565827751|FG000|Overall Study|Protocol Violation|1|||
156748314|NCT03326518|565827752|FG001|Overall Study|Protocol Violation|0|||
156748315|NCT03326518|565827753|FG002|Overall Study|Protocol Violation|0|||
156748316|NCT03326518|565827751|FG000|Overall Study|Withdrawal by Subject|1|||
156748317|NCT03326518|565827752|FG001|Overall Study|Withdrawal by Subject|0|||
156748318|NCT03326518|565827753|FG002|Overall Study|Withdrawal by Subject|0|||
156748319|NCT03326518|565827751|FG000|Overall Study|Lost to Follow-up|1|||
156748320|NCT03326518|565827752|FG001|Overall Study|Lost to Follow-up|0|||
156748321|NCT03326518|565827753|FG002|Overall Study|Lost to Follow-up|1|||
156748322|NCT01375374|565827754|FG000|Overall Study|Adverse Event|1|||
156748323|NCT01908582|565827755|FG000|Period 2|Physician Decision|1|||
156748324|NCT01908582|565827755|FG000|Period 2|Withdrawal by Subject|1|||
156748325|NCT02065518|565827756|FG000|Overall Study|Lost to Follow-up|3|||
156748326|NCT02065518|565827757|FG001|Overall Study|Lost to Follow-up|4|||
156748327|NCT02065518|565827758|FG002|Overall Study|Lost to Follow-up|0|||
156748328|NCT02065518|565827759|FG003|Overall Study|Lost to Follow-up|3|||
156748329|NCT02065518|565827756|FG000|Overall Study|Withdrawal by Subject|3|||
156748330|NCT02065518|565827757|FG001|Overall Study|Withdrawal by Subject|4|||
156748331|NCT02065518|565827758|FG002|Overall Study|Withdrawal by Subject|9|||
156748332|NCT02065518|565827759|FG003|Overall Study|Withdrawal by Subject|2|||
156748333|NCT01066663|565827761|FG000|Overall Study|Adverse Event|0|||
156748334|NCT01066663|565827762|FG001|Overall Study|Adverse Event|0|||
156748335|NCT01066663|565827763|FG002|Overall Study|Adverse Event|1|||
156748336|NCT01090050|565827764|FG000|Overall Study|Lost to Follow-up|0|||
156748337|NCT01090050|565827765|FG001|Overall Study|Lost to Follow-up|1|||
156748338|NCT01090050|565827764|FG000|Overall Study|Lack of Efficacy|1|||
156748339|NCT01090050|565827765|FG001|Overall Study|Lack of Efficacy|5|||
156748340|NCT01090050|565827764|FG000|Overall Study|Physician Decision|0|||
156748341|NCT01090050|565827765|FG001|Overall Study|Physician Decision|1|||
157220796|NCT01452529|567554854|FG001|Run-in Period|Confirmed or suspected diversion|0|||
156748342|NCT02232061|565827766|FG000|Overall Study|Administrative problems|1|||
156748343|NCT02232061|565827766|FG000|Overall Study|Withdrawal by Subject|1|||
156748344|NCT00571103|565827767|FG000|Overall Study|Withdrawal by Subject|1|||
157220797|NCT01452529|567554855|FG002|Run-in Period|Confirmed or suspected diversion|0|||
156748345|NCT00571103|565827767|FG000|Overall Study|Lost to Follow-up|1|||
156748346|NCT06439095|565827768|FG000|Overall Study|Lost to Follow-up|2|||
156748347|NCT02368886|565827769|FG000|Overall Study|Cancel|1|||
156748348|NCT02368886|565827770|FG001|Overall Study|Cancel|1|||
156748349|NCT02368886|565827771|FG002|Overall Study|Cancel|1|||
156748350|NCT02368886|565827772|FG003|Overall Study|Cancel|3|||
156748351|NCT02368886|565827769|FG000|Overall Study|Ineligible|0|||
156748352|NCT02368886|565827770|FG001|Overall Study|Ineligible|0|||
156748353|NCT02368886|565827771|FG002|Overall Study|Ineligible|0|||
156748354|NCT02368886|565827772|FG003|Overall Study|Ineligible|1|||
156748355|NCT03484403|565827774|FG000|Overall Study|Withdrawal by Subject|6|||
156748356|NCT03484403|565827775|FG001|Overall Study|Withdrawal by Subject|4|||
156748357|NCT04278924|565827776|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
156748358|NCT04278924|565827777|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
156748359|NCT04278924|565827778|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748360|NCT04278924|565827779|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
156748361|NCT04278924|565827780|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748362|NCT04278924|565827781|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748363|NCT04278924|565827782|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
156748364|NCT04278924|565827776|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748365|NCT04278924|565827777|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
156748366|NCT04278924|565827778|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748367|NCT04278924|565827779|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748368|NCT04278924|565827780|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748369|NCT04278924|565827781|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748370|NCT04278924|565827782|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
156748371|NCT04767529|565827783|FG000|Overall Study|Adverse Event|0|||
156748372|NCT04767529|565827784|FG001|Overall Study|Adverse Event|4|||
156748373|NCT04767529|565827785|FG002|Overall Study|Adverse Event|3|||
156748374|NCT04767529|565827783|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
156748375|NCT04767529|565827784|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
156748376|NCT04767529|565827785|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
156748377|NCT04767529|565827783|FG000|Overall Study|Required use of a prohibited medication|0|||
156748378|NCT04767529|565827784|FG001|Overall Study|Required use of a prohibited medication|1|||
156748379|NCT04767529|565827785|FG002|Overall Study|Required use of a prohibited medication|0|||
156748380|NCT04767529|565827783|FG000|Overall Study|Withdrawal by Subject|7|||
156748381|NCT04767529|565827784|FG001|Overall Study|Withdrawal by Subject|5|||
156748382|NCT04767529|565827785|FG002|Overall Study|Withdrawal by Subject|4|||
156748383|NCT04767529|565827783|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
156748384|NCT04767529|565827784|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
156748385|NCT04767529|565827785|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
156748386|NCT04767529|565827783|FG000|Overall Study|Lost to Follow-up|0|||
156748387|NCT04767529|565827784|FG001|Overall Study|Lost to Follow-up|2|||
156748388|NCT04767529|565827785|FG002|Overall Study|Lost to Follow-up|3|||
156748389|NCT00253370|565827786|FG000|Overall Study|Adverse Event|18|||
156748390|NCT00253370|565827786|FG000|Overall Study|Disease progression|13|||
156748391|NCT00253370|565827786|FG000|Overall Study|Death|2|||
156748392|NCT00253370|565827786|FG000|Overall Study|Withdrawal by Subject|6|||
156748393|NCT00253370|565827786|FG000|Overall Study|Non-protocol therapy|1|||
156748394|NCT00253370|565827786|FG000|Overall Study|Physician Decision|1|||
156748395|NCT00253370|565827786|FG000|Overall Study|Protocol Violation|1|||
156748396|NCT00253370|565827786|FG000|Overall Study|Abdominal pain due to disease|1|||
156748397|NCT02697591|565827787|FG000|Overall Study|Lost to Follow-up|0|||
156748398|NCT02697591|565827788|FG001|Overall Study|Lost to Follow-up|0|||
156748399|NCT02697591|565827789|FG002|Overall Study|Lost to Follow-up|0|||
156748400|NCT02697591|565827790|FG003|Overall Study|Lost to Follow-up|0|||
156748401|NCT02697591|565827791|FG004|Overall Study|Lost to Follow-up|0|||
156748402|NCT02697591|565827792|FG005|Overall Study|Lost to Follow-up|1|||
156748403|NCT02697591|565827793|FG006|Overall Study|Lost to Follow-up|1|||
156748404|NCT02697591|565827794|FG007|Overall Study|Lost to Follow-up|0|||
156748405|NCT02697591|565827795|FG008|Overall Study|Lost to Follow-up|0|||
156748406|NCT02697591|565827796|FG009|Overall Study|Lost to Follow-up|1|||
156748407|NCT02697591|565827787|FG000|Overall Study|Withdrawal by Subject|1|||
156748408|NCT02697591|565827788|FG001|Overall Study|Withdrawal by Subject|1|||
156748409|NCT02697591|565827789|FG002|Overall Study|Withdrawal by Subject|2|||
156748410|NCT02697591|565827790|FG003|Overall Study|Withdrawal by Subject|1|||
156748411|NCT02697591|565827791|FG004|Overall Study|Withdrawal by Subject|7|||
156748412|NCT02697591|565827792|FG005|Overall Study|Withdrawal by Subject|6|||
156748413|NCT02697591|565827793|FG006|Overall Study|Withdrawal by Subject|9|||
156748414|NCT02697591|565827794|FG007|Overall Study|Withdrawal by Subject|1|||
156748415|NCT02697591|565827795|FG008|Overall Study|Withdrawal by Subject|6|||
156748416|NCT02697591|565827796|FG009|Overall Study|Withdrawal by Subject|10|||
156748417|NCT02697591|565827787|FG000|Overall Study|Physician Decision|1|||
156748418|NCT02697591|565827788|FG001|Overall Study|Physician Decision|0|||
156748419|NCT02697591|565827789|FG002|Overall Study|Physician Decision|0|||
156748420|NCT02697591|565827790|FG003|Overall Study|Physician Decision|0|||
156748421|NCT02697591|565827791|FG004|Overall Study|Physician Decision|1|||
156748422|NCT02697591|565827792|FG005|Overall Study|Physician Decision|2|||
156748423|NCT02697591|565827793|FG006|Overall Study|Physician Decision|0|||
156748424|NCT02697591|565827794|FG007|Overall Study|Physician Decision|0|||
156748425|NCT02697591|565827795|FG008|Overall Study|Physician Decision|1|||
156748426|NCT02697591|565827796|FG009|Overall Study|Physician Decision|1|||
156748427|NCT02697591|565827787|FG000|Overall Study|Death|2|||
156748428|NCT02697591|565827788|FG001|Overall Study|Death|3|||
156748429|NCT02697591|565827789|FG002|Overall Study|Death|1|||
156748430|NCT02697591|565827790|FG003|Overall Study|Death|1|||
156748431|NCT02697591|565827791|FG004|Overall Study|Death|4|||
156748432|NCT02697591|565827792|FG005|Overall Study|Death|5|||
156748433|NCT02697591|565827793|FG006|Overall Study|Death|3|||
156748434|NCT02697591|565827794|FG007|Overall Study|Death|1|||
156748435|NCT02697591|565827795|FG008|Overall Study|Death|1|||
156748436|NCT02697591|565827796|FG009|Overall Study|Death|5|||
156748437|NCT02697591|565827787|FG000|Overall Study|Reason not Specified|0|||
156748438|NCT02697591|565827788|FG001|Overall Study|Reason not Specified|0|||
156748439|NCT02697591|565827789|FG002|Overall Study|Reason not Specified|0|||
156748440|NCT02697591|565827790|FG003|Overall Study|Reason not Specified|1|||
156748441|NCT02697591|565827791|FG004|Overall Study|Reason not Specified|1|||
156748442|NCT02697591|565827792|FG005|Overall Study|Reason not Specified|2|||
156748443|NCT02697591|565827793|FG006|Overall Study|Reason not Specified|3|||
156748444|NCT02697591|565827794|FG007|Overall Study|Reason not Specified|1|||
156748445|NCT02697591|565827795|FG008|Overall Study|Reason not Specified|1|||
156748446|NCT02697591|565827796|FG009|Overall Study|Reason not Specified|3|||
156748447|NCT00004088|565827798|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
156748448|NCT00004088|565827798|FG000|Overall Study|Withdrawal by Subject|1|||
156748449|NCT00004088|565827798|FG000|Overall Study|Protocol Violation|3|||
156748450|NCT00004088|565827798|FG000|Overall Study|Physician Decision|1|||
156748451|NCT03624569|565827800|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156748452|NCT03624569|565827801|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
156748453|NCT03624569|565827800|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
156748454|NCT03624569|565827801|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
156880763|NCT00647270|566322905|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
156880764|NCT00647270|566322903|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
156880765|NCT00647270|566322904|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
156880766|NCT00647270|566322905|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
156880767|NCT00647270|566322903|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
156748455|NCT00803205|565827802|FG000|Overall Study|Adverse Event|7|||
156748456|NCT00803205|565827803|FG001|Overall Study|Adverse Event|2|||
156748457|NCT00803205|565827802|FG000|Overall Study|Lost to Follow-up|1|||
156748458|NCT00803205|565827803|FG001|Overall Study|Lost to Follow-up|0|||
156748459|NCT00803205|565827802|FG000|Overall Study|Withdrawal by Subject|9|||
156880768|NCT00647270|566322904|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
156880769|NCT00647270|566322905|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
156880770|NCT03615040|566322906|FG000|Overall Study|Withdrawal by Subject|2|||
156880771|NCT03615040|566322907|FG001|Overall Study|Withdrawal by Subject|1|||
156880772|NCT03615040|566322906|FG000|Overall Study|Physician Decision|2|||
156880773|NCT03615040|566322907|FG001|Overall Study|Physician Decision|2|||
156880774|NCT03615040|566322906|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
156880775|NCT03615040|566322907|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
156880776|NCT03615040|566322906|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
156880777|NCT03615040|566322907|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
156880778|NCT03615040|566322906|FG000|Overall Study|Death|0|||
156880779|NCT03615040|566322907|FG001|Overall Study|Death|2|||
156880780|NCT01541397|566322910|FG000|Overall Study|Study ended prior to data collection|4|||
156880781|NCT01541397|566322911|FG001|Overall Study|Study ended prior to data collection|2|||
156880782|NCT00006409|566322919|FG000|Baseline|Protocol Violation|48|||
157020737|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Death|1|||
156748460|NCT00803205|565827803|FG001|Overall Study|Withdrawal by Subject|9|||
156748461|NCT00803205|565827802|FG000|Overall Study|Physician Decision|1|||
156748462|NCT00803205|565827803|FG001|Overall Study|Physician Decision|0|||
156748463|NCT00803205|565827802|FG000|Overall Study|Protocol Violation|1|||
156748464|NCT00803205|565827803|FG001|Overall Study|Protocol Violation|1|||
156748465|NCT00803205|565827802|FG000|Overall Study|Medical Monitor Decision|1|||
156748466|NCT00803205|565827803|FG001|Overall Study|Medical Monitor Decision|0|||
156748467|NCT00803205|565827802|FG000|Overall Study|Acquired a Lung Infection|0|||
156748468|NCT00803205|565827803|FG001|Overall Study|Acquired a Lung Infection|1|||
156748469|NCT00803205|565827802|FG000|Overall Study|Sponsor Decision|0|||
156748470|NCT00803205|565827803|FG001|Overall Study|Sponsor Decision|1|||
156748471|NCT02735096|565827809|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
156748472|NCT01080391|565827817|FG000|Overall Study|Randomized but not treated|7|||
156748473|NCT01080391|565827818|FG001|Overall Study|Randomized but not treated|4|||
156748474|NCT02083653|565827819|FG000|Overall Study|Randomized but not Treated|0|||
156748475|NCT02083653|565827820|FG001|Overall Study|Randomized but not Treated|2|||
156748476|NCT02083653|565827821|FG002|Overall Study|Randomized but not Treated|7|||
156748477|NCT02083653|565827819|FG000|Overall Study|Adverse Event|12|||
156748478|NCT02083653|565827820|FG001|Overall Study|Adverse Event|5|||
156748479|NCT02083653|565827821|FG002|Overall Study|Adverse Event|4|||
156748480|NCT02083653|565827819|FG000|Overall Study|Lost to Follow-up|1|||
156748481|NCT02083653|565827820|FG001|Overall Study|Lost to Follow-up|0|||
156880783|NCT00006409|566322920|FG001|Baseline|Protocol Violation|70|||
156880784|NCT00006409|566322921|FG002|Baseline|Protocol Violation|0|||
156880785|NCT00006409|566322922|FG003|Baseline|Protocol Violation|0|||
156880786|NCT00006409|566322923|FG004|Baseline|Protocol Violation|0|||
156880787|NCT00006409|566322924|FG005|Baseline|Protocol Violation|0|||
156880788|NCT00006409|566322919|FG000|Post-2 Year Intervention|Protocol Violation|0|||
156880789|NCT00006409|566322920|FG001|Post-2 Year Intervention|Protocol Violation|0|||
156748482|NCT02083653|565827821|FG002|Overall Study|Lost to Follow-up|0|||
156748483|NCT02083653|565827819|FG000|Overall Study|Death|2|||
156748484|NCT02083653|565827820|FG001|Overall Study|Death|2|||
156748485|NCT02083653|565827821|FG002|Overall Study|Death|2|||
156748486|NCT02083653|565827819|FG000|Overall Study|Progressive Disease|65|||
156748487|NCT02083653|565827820|FG001|Overall Study|Progressive Disease|73|||
156748488|NCT02083653|565827821|FG002|Overall Study|Progressive Disease|63|||
156748489|NCT02083653|565827819|FG000|Overall Study|Withdrawal by Subject|2|||
156748490|NCT02083653|565827820|FG001|Overall Study|Withdrawal by Subject|1|||
156748491|NCT02083653|565827821|FG002|Overall Study|Withdrawal by Subject|2|||
156748492|NCT02083653|565827819|FG000|Overall Study|Other Events|0|||
156748493|NCT02083653|565827820|FG001|Overall Study|Other Events|2|||
156748494|NCT02083653|565827821|FG002|Overall Study|Other Events|2|||
156748495|NCT02083653|565827819|FG000|Overall Study|Reason Missing|0|||
156748496|NCT02083653|565827820|FG001|Overall Study|Reason Missing|0|||
156748497|NCT02083653|565827821|FG002|Overall Study|Reason Missing|4|||
156748498|NCT02536781|565827822|FG000|Overall Study|Lost to Follow-up|2|||
156748499|NCT02536781|565827823|FG001|Overall Study|Lost to Follow-up|0|||
156748500|NCT03423147|565827824|FG000|Overall Study|Lost to Follow-up|5|||
156748501|NCT03423147|565827825|FG001|Overall Study|Lost to Follow-up|8|||
156748502|NCT03423147|565827824|FG000|Overall Study|Withdrawal by Subject|1|||
156748503|NCT03423147|565827825|FG001|Overall Study|Withdrawal by Subject|0|||
156748504|NCT03423147|565827824|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
156748505|NCT03423147|565827825|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
156748506|NCT03423147|565827824|FG000|Overall Study|Age < 18|1|||
156748507|NCT03423147|565827825|FG001|Overall Study|Age < 18|0|||
156748508|NCT03423147|565827824|FG000|Overall Study|No Trial of Labor|0|||
156748509|NCT03423147|565827825|FG001|Overall Study|No Trial of Labor|1|||
156748510|NCT01048099|565827826|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
156748511|NCT01048099|565827826|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
156748512|NCT00508157|565827827|FG000|Overall Study|Adverse Event|0|||
156748513|NCT00508157|565827828|FG001|Overall Study|Adverse Event|1|||
156748514|NCT00508157|565827827|FG000|Overall Study|Subject Withdrew Consent|1|||
156748515|NCT00508157|565827828|FG001|Overall Study|Subject Withdrew Consent|0|||
156748516|NCT00508157|565827827|FG000|Overall Study|Lost to Follow-up|1|||
156748517|NCT00508157|565827828|FG001|Overall Study|Lost to Follow-up|0|||
156748518|NCT00508157|565827827|FG000|Overall Study|Subject no longer met study criteria|0|||
156748519|NCT00508157|565827828|FG001|Overall Study|Subject no longer met study criteria|1|||
156748520|NCT00508157|565827827|FG000|Overall Study|Other known cause|0|||
156748521|NCT00508157|565827828|FG001|Overall Study|Other known cause|1|||
156748522|NCT01324570|565827829|FG000|Overall Study|Adverse Event|4|||
156748523|NCT01324570|565827830|FG001|Overall Study|Adverse Event|7|||
156748524|NCT01324570|565827829|FG000|Overall Study|Withdrawal by Subject|0|||
156748525|NCT01324570|565827830|FG001|Overall Study|Withdrawal by Subject|3|||
156748526|NCT01324570|565827829|FG000|Overall Study|Lack of Efficacy|0|||
156748527|NCT01324570|565827830|FG001|Overall Study|Lack of Efficacy|1|||
156748528|NCT01324570|565827829|FG000|Overall Study|Confirmed or suspected diversion|0|||
156748529|NCT01324570|565827830|FG001|Overall Study|Confirmed or suspected diversion|1|||
156748530|NCT01324570|565827829|FG000|Overall Study|Administrative|0|||
156748531|NCT01324570|565827830|FG001|Overall Study|Administrative|2|||
156748532|NCT00207727|565827831|FG000|Overall Study|Withdrawal by Subject|0|||
156748533|NCT00207727|565827832|FG001|Overall Study|Withdrawal by Subject|0|||
156748534|NCT00207727|565827833|FG002|Overall Study|Withdrawal by Subject|0|||
156748535|NCT00207727|565827834|FG003|Overall Study|Withdrawal by Subject|0|||
156748536|NCT00207727|565827835|FG004|Overall Study|Withdrawal by Subject|1|||
156748537|NCT00207727|565827831|FG000|Overall Study|Lost to Follow-up|0|||
156748538|NCT00207727|565827832|FG001|Overall Study|Lost to Follow-up|1|||
156748539|NCT00207727|565827833|FG002|Overall Study|Lost to Follow-up|0|||
156748540|NCT00207727|565827834|FG003|Overall Study|Lost to Follow-up|0|||
156748541|NCT00207727|565827835|FG004|Overall Study|Lost to Follow-up|0|||
156748542|NCT00207727|565827831|FG000|Overall Study|Other|38|||
156748543|NCT00207727|565827832|FG001|Overall Study|Other|41|||
156800188|NCT02493764|566023386|FG001|Overall Study|Lost to Follow-up|1|||
156800189|NCT02493764|566023385|FG000|Overall Study|Protocol Violation|6|||
156800190|NCT02493764|566023386|FG001|Overall Study|Protocol Violation|7|||
156800191|NCT02493764|566023385|FG000|Overall Study|Physician Decision|1|||
156748544|NCT00207727|565827833|FG002|Overall Study|Other|41|||
156748545|NCT00207727|565827834|FG003|Overall Study|Other|37|||
156748546|NCT00207727|565827835|FG004|Overall Study|Other|33|||
156748547|NCT03611582|565827841|FG000|Overall Study|Adverse Event|26|||
156748548|NCT03611582|565827842|FG001|Overall Study|Adverse Event|6|||
156748549|NCT03611582|565827841|FG000|Overall Study|Protocol Violation|0|||
156748550|NCT03611582|565827842|FG001|Overall Study|Protocol Violation|1|||
156748551|NCT03611582|565827841|FG000|Overall Study|Pregnancy|1|||
156748552|NCT03611582|565827842|FG001|Overall Study|Pregnancy|2|||
156800192|NCT02493764|566023386|FG001|Overall Study|Physician Decision|1|||
156748553|NCT03611582|565827841|FG000|Overall Study|Lack of Efficacy|0|||
156748554|NCT03611582|565827842|FG001|Overall Study|Lack of Efficacy|1|||
156800193|NCT02493764|566023385|FG000|Overall Study|Participant moved|17|||
156800194|NCT02493764|566023386|FG001|Overall Study|Participant moved|5|||
156800195|NCT02493764|566023385|FG000|Overall Study|Withdrawal parent/guardian|0|||
156800196|NCT02493764|566023386|FG001|Overall Study|Withdrawal parent/guardian|1|||
156800197|NCT02493764|566023385|FG000|Overall Study|Withdrawal by Subject|11|||
156800198|NCT02493764|566023386|FG001|Overall Study|Withdrawal by Subject|7|||
156800199|NCT01561976|566023387|FG000|Period 1|Adverse Event|0|||
156800200|NCT01561976|566023388|FG001|Period 1|Adverse Event|0|||
156800201|NCT01561976|566023389|FG002|Period 1|Adverse Event|1|||
156800202|NCT01561976|566023390|FG003|Period 1|Adverse Event|0|||
156800203|NCT01561976|566023391|FG004|Period 1|Adverse Event|0|||
156800204|NCT01561976|566023392|FG005|Period 1|Adverse Event|0|||
156800205|NCT01561976|566023387|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156800206|NCT01561976|566023388|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
156800207|NCT01561976|566023389|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156800208|NCT01561976|566023390|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
156800209|NCT01561976|566023391|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
156800210|NCT01561976|566023392|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
156800211|NCT01561976|566023387|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800212|NCT01561976|566023388|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800213|NCT01561976|566023389|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800214|NCT01561976|566023390|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800215|NCT01561976|566023391|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
156800216|NCT01561976|566023392|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
156800217|NCT01561976|566023387|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
156800218|NCT01561976|566023388|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
156800219|NCT01561976|566023389|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
156800220|NCT01561976|566023390|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
156800221|NCT01561976|566023391|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
156800222|NCT01561976|566023392|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
156800223|NCT01977222|566023399|FG000|Overall Study|Withdrawal by Subject|1|||
156800224|NCT04846231|566023403|FG000|Overall Study|Lost to Follow-up|1|||
156800225|NCT04846231|566023404|FG001|Overall Study|Lost to Follow-up|0|||
156800226|NCT04846231|566023405|FG002|Overall Study|Lost to Follow-up|0|||
156800227|NCT04846231|566023406|FG003|Overall Study|Lost to Follow-up|0|||
156800228|NCT04846231|566023407|FG004|Overall Study|Lost to Follow-up|0|||
156800229|NCT04846231|566023408|FG005|Overall Study|Lost to Follow-up|0|||
156800230|NCT04846231|566023409|FG006|Overall Study|Lost to Follow-up|0|||
156800231|NCT04846231|566023410|FG007|Overall Study|Lost to Follow-up|1|||
156800232|NCT04846231|566023403|FG000|Overall Study|Withdrawal by Subject|0|||
156800233|NCT04846231|566023404|FG001|Overall Study|Withdrawal by Subject|1|||
156800234|NCT04846231|566023405|FG002|Overall Study|Withdrawal by Subject|2|||
156800235|NCT04846231|566023406|FG003|Overall Study|Withdrawal by Subject|1|||
156800236|NCT04846231|566023407|FG004|Overall Study|Withdrawal by Subject|0|||
156800237|NCT04846231|566023408|FG005|Overall Study|Withdrawal by Subject|0|||
156800238|NCT04846231|566023409|FG006|Overall Study|Withdrawal by Subject|0|||
156800239|NCT04846231|566023410|FG007|Overall Study|Withdrawal by Subject|0|||
156800240|NCT04846231|566023403|FG000|Overall Study|Protocol Violation|0|||
156800241|NCT04846231|566023404|FG001|Overall Study|Protocol Violation|1|||
156800242|NCT04846231|566023405|FG002|Overall Study|Protocol Violation|0|||
156800243|NCT04846231|566023406|FG003|Overall Study|Protocol Violation|0|||
156800244|NCT04846231|566023407|FG004|Overall Study|Protocol Violation|0|||
156800245|NCT04846231|566023408|FG005|Overall Study|Protocol Violation|0|||
156800246|NCT04846231|566023409|FG006|Overall Study|Protocol Violation|0|||
156800247|NCT04846231|566023410|FG007|Overall Study|Protocol Violation|0|||
156800248|NCT04846231|566023403|FG000|Overall Study|Adverse Event|0|||
156800249|NCT04846231|566023404|FG001|Overall Study|Adverse Event|0|||
156800250|NCT04846231|566023405|FG002|Overall Study|Adverse Event|0|||
156800251|NCT04846231|566023406|FG003|Overall Study|Adverse Event|0|||
156800252|NCT04846231|566023407|FG004|Overall Study|Adverse Event|0|||
156800253|NCT04846231|566023408|FG005|Overall Study|Adverse Event|0|||
156800254|NCT04846231|566023409|FG006|Overall Study|Adverse Event|1|||
156800255|NCT04846231|566023410|FG007|Overall Study|Adverse Event|1|||
156800256|NCT02980107|566023411|FG000|Overall Study|Withdrawal by Subject|51|||
156800257|NCT02980107|566023412|FG001|Overall Study|Withdrawal by Subject|62|||
156800258|NCT02412670|566023413|FG000|Overall Study|Adverse Event|4|||
156800259|NCT02412670|566023414|FG001|Overall Study|Adverse Event|1|||
156800260|NCT02412670|566023413|FG000|Overall Study|Physician Decision|1|||
156800261|NCT02412670|566023414|FG001|Overall Study|Physician Decision|0|||
156800262|NCT02412670|566023413|FG000|Overall Study|Withdrawal by Subject|1|||
156800263|NCT02412670|566023414|FG001|Overall Study|Withdrawal by Subject|0|||
156800264|NCT02412670|566023413|FG000|Overall Study|Ineligible|1|||
156800265|NCT02412670|566023414|FG001|Overall Study|Ineligible|0|||
156800266|NCT05901636|566023417|FG000|Overall Study|Lost to Follow-up|0|||
156800267|NCT05901636|566023418|FG001|Overall Study|Lost to Follow-up|1|||
156800268|NCT05901636|566023419|FG002|Overall Study|Lost to Follow-up|0|||
156800269|NCT05901636|566023420|FG003|Overall Study|Lost to Follow-up|1|||
156800270|NCT05901636|566023421|FG004|Overall Study|Lost to Follow-up|1|||
156800271|NCT05901636|566023422|FG005|Overall Study|Lost to Follow-up|3|||
156800272|NCT05901636|566023423|FG006|Overall Study|Lost to Follow-up|1|||
156880790|NCT00006409|566322921|FG002|Post-2 Year Intervention|Protocol Violation|251|||
156880791|NCT00006409|566322922|FG003|Post-2 Year Intervention|Protocol Violation|168|||
156880792|NCT00006409|566322923|FG004|Post-2 Year Intervention|Protocol Violation|0|||
156880793|NCT00006409|566322924|FG005|Post-2 Year Intervention|Protocol Violation|0|||
156880794|NCT00006409|566322919|FG000|Post-3 Year Intervention|Protocol Violation|0|||
156880795|NCT00006409|566322920|FG001|Post-3 Year Intervention|Protocol Violation|0|||
156880796|NCT00006409|566322921|FG002|Post-3 Year Intervention|Protocol Violation|0|||
156880797|NCT00006409|566322922|FG003|Post-3 Year Intervention|Protocol Violation|0|||
156880798|NCT00006409|566322923|FG004|Post-3 Year Intervention|Protocol Violation|62|||
156880799|NCT00006409|566322924|FG005|Post-3 Year Intervention|Protocol Violation|62|||
156880800|NCT01989208|566322926|FG000|200 mg (7 Days)|Protocol Violation|0|||
156880801|NCT01989208|566322927|FG001|200 mg (7 Days)|Protocol Violation|1|||
156880802|NCT01276054|566322932|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
156880803|NCT01276054|566322933|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
156880804|NCT04343235|566322934|FG000|Overall Study|Lost to Follow-up|3|||
156880805|NCT04343235|566322935|FG001|Overall Study|Lost to Follow-up|2|||
156880806|NCT00787267|566322936|FG000|Overall Study|Screen failure/Ineligible|10|||
156880807|NCT00787267|566322936|FG000|Overall Study|No Reason Provided|1|||
156880808|NCT00787267|566322936|FG000|Overall Study|Withdrawal by Subject|1|||
156880809|NCT01763996|566322937|FG000|Treatment Period 2|Adverse Event|0|||
156880810|NCT01763996|566322938|FG001|Treatment Period 2|Adverse Event|1|||
156880811|NCT00865280|566322939|FG000|Overall Study|Withdrawal by Subject|4|||
156880812|NCT00865280|566322940|FG001|Overall Study|Withdrawal by Subject|1|||
156880813|NCT00865280|566322939|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
156880814|NCT00865280|566322940|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
156880815|NCT00865280|566322939|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
156880816|NCT00865280|566322940|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
156880817|NCT00865280|566322939|FG000|Overall Study|Exclusion Condition|1|||
156880818|NCT00865280|566322940|FG001|Overall Study|Exclusion Condition|0|||
156880819|NCT00865280|566322939|FG000|Overall Study|Adverse Event|0|||
156880820|NCT00865280|566322940|FG001|Overall Study|Adverse Event|1|||
156880821|NCT01788215|566322946|FG000|Overall Study|Withdrawal by Subject|0|||
156880822|NCT01788215|566322947|FG001|Overall Study|Withdrawal by Subject|1|||
156880823|NCT01788215|566322946|FG000|Overall Study|Lost to Follow-up|2|||
156880824|NCT01788215|566322947|FG001|Overall Study|Lost to Follow-up|0|||
156880825|NCT03116152|566322948|FG000|Overall Study|Disease Progression|49|||
156880826|NCT03116152|566322949|FG001|Overall Study|Disease Progression|47|||
156880827|NCT03116152|566322948|FG000|Overall Study|Death|5|||
156880828|NCT03116152|566322949|FG001|Overall Study|Death|2|||
156880829|NCT03116152|566322948|FG000|Overall Study|Adverse Event|21|||
156880830|NCT03116152|566322949|FG001|Overall Study|Adverse Event|7|||
156880831|NCT03116152|566322948|FG000|Overall Study|Protocol Violation|2|||
156880832|NCT03116152|566322949|FG001|Overall Study|Protocol Violation|2|||
156880833|NCT03116152|566322948|FG000|Overall Study|Withdrawal by Subject|0|||
156880834|NCT03116152|566322949|FG001|Overall Study|Withdrawal by Subject|1|||
156880835|NCT03116152|566322948|FG000|Overall Study|Physician Decision|3|||
156880836|NCT03116152|566322949|FG001|Overall Study|Physician Decision|2|||
156880837|NCT03116152|566322948|FG000|Overall Study|other|11|||
156880838|NCT03116152|566322949|FG001|Overall Study|other|34|||
156880839|NCT01578850|566322950|FG000|Period 1|Insufficient Clinical Response|1|||
156880840|NCT01578850|566322951|FG001|Period 1|Insufficient Clinical Response|0|||
156880841|NCT01578850|566322952|FG002|Period 1|Insufficient Clinical Response|0|||
156880842|NCT01578850|566322950|FG000|Period 1|Adverse Event|11|||
156880843|NCT01578850|566322951|FG001|Period 1|Adverse Event|0|||
156880844|NCT01578850|566322952|FG002|Period 1|Adverse Event|0|||
156880845|NCT01578850|566322950|FG000|Period 1|Death|1|||
156880846|NCT01578850|566322951|FG001|Period 1|Death|0|||
156880847|NCT01578850|566322952|FG002|Period 1|Death|0|||
156880848|NCT01578850|566322950|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
156880849|NCT01578850|566322951|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
156880850|NCT01578850|566322952|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
156880851|NCT01578850|566322950|FG000|Period 1|Withdrawal by Subject|9|||
156880852|NCT01578850|566322951|FG001|Period 1|Withdrawal by Subject|0|||
156880853|NCT01578850|566322952|FG002|Period 1|Withdrawal by Subject|0|||
156880854|NCT01578850|566322950|FG000|Period 1|Study Terminated by Sponsor|3|||
156880855|NCT01578850|566322951|FG001|Period 1|Study Terminated by Sponsor|0|||
156880856|NCT01578850|566322952|FG002|Period 1|Study Terminated by Sponsor|0|||
156880857|NCT01578850|566322950|FG000|Period 2|Insufficient Clinical Response|0|||
156880858|NCT01578850|566322951|FG001|Period 2|Insufficient Clinical Response|1|||
156880859|NCT01578850|566322952|FG002|Period 2|Insufficient Clinical Response|0|||
156880860|NCT01578850|566322950|FG000|Period 2|Adverse Event|0|||
156880861|NCT01578850|566322951|FG001|Period 2|Adverse Event|3|||
156880862|NCT01578850|566322952|FG002|Period 2|Adverse Event|6|||
156880863|NCT01578850|566322950|FG000|Period 2|Lost to Follow-up|0|||
156880864|NCT01578850|566322951|FG001|Period 2|Lost to Follow-up|1|||
156880865|NCT01578850|566322952|FG002|Period 2|Lost to Follow-up|2|||
156880866|NCT01578850|566322950|FG000|Period 2|Withdrawal by Subject|0|||
156880867|NCT01578850|566322951|FG001|Period 2|Withdrawal by Subject|2|||
156880868|NCT01578850|566322952|FG002|Period 2|Withdrawal by Subject|2|||
156880869|NCT01578850|566322950|FG000|Period 2|Study Terminated by Sponsor|0|||
156880870|NCT01578850|566322951|FG001|Period 2|Study Terminated by Sponsor|5|||
156880871|NCT01578850|566322952|FG002|Period 2|Study Terminated by Sponsor|4|||
156880872|NCT01578850|566322950|FG000|Period 2|Unspecified Reasons|0|||
156880873|NCT01578850|566322951|FG001|Period 2|Unspecified Reasons|1|||
156880874|NCT01578850|566322952|FG002|Period 2|Unspecified Reasons|0|||
156880875|NCT04629066|566322961|FG000|Overall Study|Lost to Follow-up|3|||
156880876|NCT04629066|566322962|FG001|Overall Study|Lost to Follow-up|2|||
156880877|NCT00282308|566322963|FG000|Treatment Period|Lost to Follow-up|1|||
156880878|NCT00282308|566322964|FG001|Treatment Period|Lost to Follow-up|0|||
156880879|NCT00282308|566322965|FG002|Treatment Period|Lost to Follow-up|0|||
156880880|NCT00282308|566322963|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
156880881|NCT00282308|566322964|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
156880882|NCT00282308|566322965|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
156880883|NCT00282308|566322963|FG000|Treatment Period|Adverse Event|0|||
156880884|NCT00282308|566322964|FG001|Treatment Period|Adverse Event|2|||
156880885|NCT00282308|566322965|FG002|Treatment Period|Adverse Event|0|||
156880886|NCT00282308|566322963|FG000|Treatment Period|Not Treated with Study Drug|1|||
156880887|NCT00282308|566322964|FG001|Treatment Period|Not Treated with Study Drug|0|||
157020738|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Death|0|||
157020739|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Death|1|||
157020740|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Death|0|||
157020741|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Death|1|||
156748555|NCT03611582|565827841|FG000|Overall Study|At the discretion of the investigator|1|||
156748556|NCT03611582|565827842|FG001|Overall Study|At the discretion of the investigator|0|||
156748557|NCT03611582|565827841|FG000|Overall Study|Safety concern as judged by the investigator|1|||
156748558|NCT03611582|565827842|FG001|Overall Study|Safety concern as judged by the investigator|2|||
156748559|NCT03611582|565827841|FG000|Overall Study|Withdrawal by Subject|4|||
156748560|NCT03611582|565827842|FG001|Overall Study|Withdrawal by Subject|3|||
156748561|NCT03611582|565827841|FG000|Overall Study|Lost to Follow-up|18|||
156748562|NCT03611582|565827842|FG001|Overall Study|Lost to Follow-up|7|||
156748563|NCT03611582|565827841|FG000|Overall Study|other|17|||
156748564|NCT03611582|565827842|FG001|Overall Study|other|16|||
156748565|NCT01783821|565827843|FG000|Overall Study|Screen Failure|1|||
156748566|NCT01783821|565827844|FG001|Overall Study|Screen Failure|1|||
156748567|NCT02333383|565827845|FG000|Overall Study|Adalimumab discontinuation|21|||
156748568|NCT02333383|565827845|FG000|Overall Study|Lost to Follow-up|15|||
156748569|NCT02333383|565827845|FG000|Overall Study|Withdrawal by Subject|3|||
156748570|NCT02333383|565827845|FG000|Overall Study|Transfer to another hospital|2|||
156748571|NCT01653327|565827846|FG000|Overall Study|Withdrawal by Subject|1|||
156748572|NCT01744483|565829469|FG000|Overall Study|Death|9|||
156748573|NCT01744483|565829470|FG001|Overall Study|Death|4|||
156748574|NCT01744483|565829471|FG002|Overall Study|Death|11|||
156748575|NCT01744483|565829469|FG000|Overall Study|Lost to Follow-up|8|||
156748576|NCT01744483|565829470|FG001|Overall Study|Lost to Follow-up|9|||
156748577|NCT01744483|565829471|FG002|Overall Study|Lost to Follow-up|11|||
156748578|NCT01744483|565829469|FG000|Overall Study|Protocol Violation|1|||
156748579|NCT01744483|565829470|FG001|Overall Study|Protocol Violation|2|||
156748580|NCT01744483|565829471|FG002|Overall Study|Protocol Violation|1|||
156748581|NCT01744483|565829469|FG000|Overall Study|Withdrawal by Subject|4|||
156748582|NCT01744483|565829470|FG001|Overall Study|Withdrawal by Subject|6|||
156748583|NCT01744483|565829471|FG002|Overall Study|Withdrawal by Subject|2|||
156748584|NCT01744483|565829469|FG000|Overall Study|No ICU Admit|5|||
156748585|NCT01744483|565829470|FG001|Overall Study|No ICU Admit|1|||
156748586|NCT01744483|565829471|FG002|Overall Study|No ICU Admit|2|||
156880888|NCT00282308|566322965|FG002|Treatment Period|Not Treated with Study Drug|0|||
157020742|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Death|0|||
156748587|NCT01744483|565829469|FG000|Overall Study|Routed to OSH|2|||
156748588|NCT01744483|565829470|FG001|Overall Study|Routed to OSH|0|||
156748589|NCT01744483|565829471|FG002|Overall Study|Routed to OSH|1|||
156748590|NCT02335346|565829479|FG000|Overall Study|Adverse Event|11|||
156748591|NCT02335346|565829479|FG000|Overall Study|Withdrawal by Subject|1|||
156748592|NCT00560703|565829482|FG000|Overall Study|Adverse Event|0|||
156880889|NCT00282308|566322963|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
156880890|NCT00282308|566322964|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
156880891|NCT00282308|566322965|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
157020743|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Death|0|||
156748593|NCT00560703|565829483|FG001|Overall Study|Adverse Event|2|||
156748594|NCT00560703|565829482|FG000|Overall Study|Protocol Violation|0|||
156748595|NCT00560703|565829483|FG001|Overall Study|Protocol Violation|2|||
157020744|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Death|2|||
156748596|NCT00560703|565829482|FG000|Overall Study|Withdrawal by Subject|0|||
156748597|NCT00560703|565829483|FG001|Overall Study|Withdrawal by Subject|1|||
157020745|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Death|0|||
156748598|NCT00560703|565829482|FG000|Overall Study|non-compliance|0|||
156748599|NCT00560703|565829483|FG001|Overall Study|non-compliance|1|||
156880892|NCT00282308|566322963|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
156880893|NCT00282308|566322964|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
156880894|NCT00282308|566322965|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
156880895|NCT00282308|566322963|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
156880896|NCT00282308|566322964|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
156880897|NCT00282308|566322965|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
156880898|NCT00282308|566322963|FG000|Safety Follow-up Period|Adverse Event|0|||
156880899|NCT00282308|566322964|FG001|Safety Follow-up Period|Adverse Event|0|||
156880900|NCT00282308|566322965|FG002|Safety Follow-up Period|Adverse Event|1|||
156880901|NCT00282308|566322963|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
156880902|NCT00282308|566322964|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
156880903|NCT00282308|566322965|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
156880904|NCT00282308|566322963|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
156880905|NCT00282308|566322964|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
156880906|NCT00282308|566322965|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
156880907|NCT00282308|566322963|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
156748600|NCT06010732|565829489|FG000|Crossover Period 1|Protocol Violation|0|||
156748601|NCT06010732|565829490|FG001|Crossover Period 1|Protocol Violation|0|||
156748602|NCT06010732|565829491|FG002|Crossover Period 1|Protocol Violation|1|||
156748603|NCT06010732|565829492|FG003|Crossover Period 1|Protocol Violation|0|||
156748604|NCT06010732|565829493|FG004|Crossover Period 1|Protocol Violation|1|||
156748605|NCT06010732|565829494|FG005|Crossover Period 1|Protocol Violation|0|||
156748606|NCT06010732|565829489|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748607|NCT06010732|565829490|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
156748608|NCT06010732|565829491|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748609|NCT06010732|565829492|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748610|NCT06010732|565829493|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748611|NCT06010732|565829494|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
156748612|NCT06010732|565829489|FG000|Crossover Period 2|Adverse Event|0|||
156748613|NCT06010732|565829490|FG001|Crossover Period 2|Adverse Event|1|||
156748614|NCT06010732|565829491|FG002|Crossover Period 2|Adverse Event|0|||
156748615|NCT06010732|565829492|FG003|Crossover Period 2|Adverse Event|0|||
156748616|NCT06010732|565829493|FG004|Crossover Period 2|Adverse Event|0|||
156748617|NCT06010732|565829494|FG005|Crossover Period 2|Adverse Event|0|||
156748618|NCT06010732|565829489|FG000|Crossover Period 2|broken denture|0|||
156748619|NCT06010732|565829490|FG001|Crossover Period 2|broken denture|0|||
156748620|NCT06010732|565829491|FG002|Crossover Period 2|broken denture|1|||
156748621|NCT06010732|565829492|FG003|Crossover Period 2|broken denture|0|||
156748622|NCT06010732|565829493|FG004|Crossover Period 2|broken denture|0|||
156748623|NCT06010732|565829494|FG005|Crossover Period 2|broken denture|0|||
156748624|NCT04942210|565829495|FG000|Overall Study|Adverse Event|0|||
156748625|NCT04942210|565829496|FG001|Overall Study|Adverse Event|1|||
156748626|NCT04942210|565829495|FG000|Overall Study|Protocol Deviation|4|||
156748627|NCT04942210|565829496|FG001|Overall Study|Protocol Deviation|1|||
156748628|NCT04942210|565829495|FG000|Overall Study|Withdrawal by Subject|5|||
156748629|NCT04942210|565829496|FG001|Overall Study|Withdrawal by Subject|2|||
156748630|NCT04942210|565829495|FG000|Overall Study|Lost to Follow-up|16|||
156748631|NCT04942210|565829496|FG001|Overall Study|Lost to Follow-up|7|||
156748632|NCT04942210|565829495|FG000|Overall Study|Ongoing at the time of DBL date|60|||
156748633|NCT04942210|565829496|FG001|Overall Study|Ongoing at the time of DBL date|25|||
156748634|NCT04942210|565829495|FG000|Overall Study|Randomized but did not receive vaccination|3|||
156748635|NCT04942210|565829496|FG001|Overall Study|Randomized but did not receive vaccination|0|||
156748636|NCT04122625|565829497|FG000|Part A (up to 2.92 Years)|Death|2|||
156748637|NCT04122625|565829498|FG001|Part A (up to 2.92 Years)|Death|4|||
156748638|NCT04122625|565829499|FG002|Part A (up to 2.92 Years)|Death|0|||
156748639|NCT04122625|565829500|FG003|Part A (up to 2.92 Years)|Death|0|||
156748640|NCT04122625|565829501|FG004|Part A (up to 2.92 Years)|Death|0|||
156748641|NCT04122625|565829502|FG005|Part A (up to 2.92 Years)|Death|0|||
156748642|NCT04122625|565829497|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748643|NCT04122625|565829498|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748644|NCT04122625|565829499|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
156748645|NCT04122625|565829500|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
156748646|NCT04122625|565829501|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
156748647|NCT04122625|565829502|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
156748648|NCT04122625|565829497|FG000|Part B (up to 2.33 Years)|Death|0|||
156748649|NCT04122625|565829498|FG001|Part B (up to 2.33 Years)|Death|0|||
157220798|NCT01452529|567554853|FG000|Run-in Period|Administrative|21|||
156748650|NCT04122625|565829499|FG002|Part B (up to 2.33 Years)|Death|5|||
156748651|NCT04122625|565829500|FG003|Part B (up to 2.33 Years)|Death|7|||
156748652|NCT04122625|565829501|FG004|Part B (up to 2.33 Years)|Death|6|||
156748653|NCT04122625|565829502|FG005|Part B (up to 2.33 Years)|Death|7|||
156748654|NCT04348500|565829503|FG000|Overall Study|Death|2|||
156748655|NCT04348500|565829504|FG001|Overall Study|Death|2|||
156748656|NCT04348500|565829503|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
156748657|NCT04348500|565829504|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
156748658|NCT02776670|565829505|FG000|Overall Study|Adverse Event|0|||
156748659|NCT02776670|565829506|FG001|Overall Study|Adverse Event|2|||
156748660|NCT02776670|565829505|FG000|Overall Study|Protocol Violation|0|||
156748661|NCT02776670|565829506|FG001|Overall Study|Protocol Violation|2|||
156748662|NCT02776670|565829505|FG000|Overall Study|Withdrawal by Subject|0|||
156748663|NCT02776670|565829506|FG001|Overall Study|Withdrawal by Subject|1|||
156748664|NCT02776670|565829505|FG000|Overall Study|Other - Reason not given|0|||
156748665|NCT02776670|565829506|FG001|Overall Study|Other - Reason not given|1|||
156748666|NCT03699540|565829507|FG000|Overall Study|Lost to Follow-up|1|||
156748667|NCT01618916|565829510|FG000|Overall Study|Adverse Event|1|||
156748668|NCT01618916|565829511|FG001|Overall Study|Adverse Event|0|||
156748669|NCT01618916|565829512|FG002|Overall Study|Adverse Event|0|||
156748670|NCT01618916|565829513|FG003|Overall Study|Adverse Event|0|||
156748671|NCT01618916|565829514|FG004|Overall Study|Adverse Event|0|||
156748672|NCT01618916|565829515|FG005|Overall Study|Adverse Event|0|||
156748673|NCT01618916|565829510|FG000|Overall Study|Withdrawal by Subject|0|||
156748674|NCT01618916|565829511|FG001|Overall Study|Withdrawal by Subject|1|||
156748675|NCT01618916|565829512|FG002|Overall Study|Withdrawal by Subject|1|||
156748676|NCT01618916|565829513|FG003|Overall Study|Withdrawal by Subject|0|||
156748677|NCT01618916|565829514|FG004|Overall Study|Withdrawal by Subject|1|||
156748678|NCT01618916|565829515|FG005|Overall Study|Withdrawal by Subject|0|||
156748679|NCT01618916|565829510|FG000|Overall Study|Lost to Follow-up|1|||
156748680|NCT01618916|565829511|FG001|Overall Study|Lost to Follow-up|0|||
156748681|NCT01618916|565829512|FG002|Overall Study|Lost to Follow-up|0|||
156748682|NCT01618916|565829513|FG003|Overall Study|Lost to Follow-up|2|||
156748683|NCT01618916|565829514|FG004|Overall Study|Lost to Follow-up|0|||
156748684|NCT01618916|565829515|FG005|Overall Study|Lost to Follow-up|0|||
156748685|NCT04527978|565829524|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
156748686|NCT04527978|565829525|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
156748687|NCT00055497|565829526|FG000|Overall Study|Adverse Event|1|||
156800273|NCT05901636|566023417|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
156800274|NCT05901636|566023418|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
156800275|NCT05901636|566023419|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
156800276|NCT05901636|566023420|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
156800277|NCT05901636|566023421|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
156800278|NCT05901636|566023422|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
156800279|NCT05901636|566023423|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
156800280|NCT05901636|566023417|FG000|Overall Study|Withdrawal by Subject|1|||
156800281|NCT05901636|566023418|FG001|Overall Study|Withdrawal by Subject|1|||
156800282|NCT05901636|566023419|FG002|Overall Study|Withdrawal by Subject|0|||
156800283|NCT05901636|566023420|FG003|Overall Study|Withdrawal by Subject|0|||
156800284|NCT05901636|566023421|FG004|Overall Study|Withdrawal by Subject|1|||
156800285|NCT05901636|566023422|FG005|Overall Study|Withdrawal by Subject|1|||
156800286|NCT05901636|566023423|FG006|Overall Study|Withdrawal by Subject|0|||
156800287|NCT05901636|566023417|FG000|Overall Study|Other|0|||
156800288|NCT05901636|566023418|FG001|Overall Study|Other|0|||
156800289|NCT05901636|566023419|FG002|Overall Study|Other|1|||
156800290|NCT05901636|566023420|FG003|Overall Study|Other|1|||
156800291|NCT05901636|566023421|FG004|Overall Study|Other|0|||
156800292|NCT05901636|566023422|FG005|Overall Study|Other|0|||
156800293|NCT05901636|566023423|FG006|Overall Study|Other|0|||
156800294|NCT02302222|566023429|FG000|Overall Study|Physician Decision|0|||
156800295|NCT02302222|566023430|FG001|Overall Study|Physician Decision|4|||
156800296|NCT02302222|566023429|FG000|Overall Study|Lost to Follow-up|1|||
156800297|NCT02302222|566023430|FG001|Overall Study|Lost to Follow-up|0|||
156800298|NCT02302222|566023429|FG000|Overall Study|Treatment discontinued before day 5|0|||
156800299|NCT02302222|566023430|FG001|Overall Study|Treatment discontinued before day 5|1|||
156748688|NCT00055497|565829527|FG001|Overall Study|Adverse Event|1|||
156748689|NCT00055497|565829528|FG002|Overall Study|Adverse Event|1|||
156748690|NCT00055497|565829529|FG003|Overall Study|Adverse Event|28|||
156748691|NCT00055497|565829526|FG000|Overall Study|Withdrawal by Subject|3|||
156748692|NCT00055497|565829527|FG001|Overall Study|Withdrawal by Subject|1|||
156748693|NCT00055497|565829528|FG002|Overall Study|Withdrawal by Subject|1|||
156748694|NCT00055497|565829529|FG003|Overall Study|Withdrawal by Subject|15|||
156800300|NCT02302222|566023429|FG000|Overall Study|Withdrawn prior to any treatment|0|||
156800301|NCT02302222|566023430|FG001|Overall Study|Withdrawn prior to any treatment|1|||
156800302|NCT00016354|566023433|FG000|Overall Study|Lack of Efficacy|0|||
156800303|NCT00016354|566023434|FG001|Overall Study|Lack of Efficacy|0|||
156800304|NCT00016354|566023435|FG002|Overall Study|Lack of Efficacy|0|||
156800305|NCT00016354|566023436|FG003|Overall Study|Lack of Efficacy|0|||
156800306|NCT00016354|566023437|FG004|Overall Study|Lack of Efficacy|0|||
156800307|NCT00016354|566023438|FG005|Overall Study|Lack of Efficacy|0|||
156800308|NCT00016354|566023439|FG006|Overall Study|Lack of Efficacy|0|||
156800309|NCT00016354|566023440|FG007|Overall Study|Lack of Efficacy|1|||
156800310|NCT03110562|566023441|FG000|Initial Treatment Period|Disease Progression|1|||
157220799|NCT01452529|567554854|FG001|Run-in Period|Administrative|0|||
157220800|NCT01452529|567554855|FG002|Run-in Period|Administrative|0|||
157220801|NCT01452529|567554853|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
157220802|NCT01452529|567554854|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
157220803|NCT01452529|567554855|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
157220804|NCT01452529|567554853|FG000|Double-blind (DB) Period|Adverse Event|0|||
157220805|NCT01452529|567554854|FG001|Double-blind (DB) Period|Adverse Event|18|||
157220806|NCT01452529|567554855|FG002|Double-blind (DB) Period|Adverse Event|11|||
157220807|NCT01452529|567554853|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
157220808|NCT01452529|567554854|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
157220809|NCT01452529|567554855|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
157220810|NCT01452529|567554853|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
157220811|NCT01452529|567554854|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
157220812|NCT01452529|567554855|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
157220813|NCT01452529|567554853|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
157220814|NCT01452529|567554854|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
157220815|NCT01452529|567554855|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
157220816|NCT01452529|567554853|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
157220817|NCT01452529|567554854|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
157220818|NCT01452529|567554855|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
157220819|NCT01452529|567554853|FG000|Double-blind (DB) Period|Administrative|0|||
157220820|NCT01452529|567554854|FG001|Double-blind (DB) Period|Administrative|11|||
157220821|NCT01452529|567554855|FG002|Double-blind (DB) Period|Administrative|7|||
157220822|NCT03551730|567554856|FG000|Overall Study|Adverse Event|1|||
157220823|NCT03551730|567554857|FG001|Overall Study|Adverse Event|0|||
157220824|NCT03551730|567554858|FG002|Overall Study|Adverse Event|0|||
157220825|NCT03551730|567554859|FG003|Overall Study|Adverse Event|0|||
157220826|NCT04527471|567554862|FG000|Overall Study|Adverse Event|1|||
157220827|NCT04527471|567554863|FG001|Overall Study|Adverse Event|0|||
157220828|NCT04527471|567554862|FG000|Overall Study|Lost to Follow-up|1|||
157220829|NCT04527471|567554863|FG001|Overall Study|Lost to Follow-up|0|||
157220830|NCT01165996|567554869|FG000|Overall Study|Death|1|||
157220831|NCT01165996|567554869|FG000|Overall Study|Physician Decision|1|||
157220832|NCT00096265|567554870|FG000|Overall Study|Ineligible|1|||
157220833|NCT00096265|567554871|FG001|Overall Study|Ineligible|0|||
157220834|NCT00096265|567554872|FG002|Overall Study|Ineligible|0|||
157220835|NCT01506323|567554873|FG000|Overall Study|Lost to Follow-up|5|||
157220836|NCT01506323|567554874|FG001|Overall Study|Lost to Follow-up|4|||
157220837|NCT01506323|567554873|FG000|Overall Study|Withdrawal by Subject|4|||
157220838|NCT01506323|567554874|FG001|Overall Study|Withdrawal by Subject|4|||
157220839|NCT01506323|567554873|FG000|Overall Study|Lack of Efficacy|1|||
157220840|NCT01506323|567554874|FG001|Overall Study|Lack of Efficacy|3|||
157220841|NCT01506323|567554873|FG000|Overall Study|Moved out of area|5|||
157220842|NCT01506323|567554874|FG001|Overall Study|Moved out of area|2|||
157220843|NCT01506323|567554873|FG000|Overall Study|Schedule or Transportation conflict|8|||
157220844|NCT01506323|567554874|FG001|Overall Study|Schedule or Transportation conflict|0|||
157220845|NCT01506323|567554873|FG000|Overall Study|Started another treatment|1|||
157220846|NCT01506323|567554874|FG001|Overall Study|Started another treatment|0|||
157220847|NCT02232074|567554875|FG000|Overall Study|Withdrawal by Subject|5|||
157220848|NCT02232074|567554876|FG001|Overall Study|Withdrawal by Subject|3|||
157220849|NCT02232074|567554875|FG000|Overall Study|No legal concerns at baseline|36|||
157220850|NCT02232074|567554876|FG001|Overall Study|No legal concerns at baseline|41|||
157220851|NCT02232074|567554875|FG000|Overall Study|deemed ineligible|0|||
157220852|NCT02232074|567554876|FG001|Overall Study|deemed ineligible|1|||
157220853|NCT04081337|567554878|FG000|Overall Study|Adverse Event|0|||
157220854|NCT04081337|567554879|FG001|Overall Study|Adverse Event|1|||
157220855|NCT04081337|567554878|FG000|Overall Study|Withdrawal by Subject|2|||
157220856|NCT04081337|567554879|FG001|Overall Study|Withdrawal by Subject|0|||
156748695|NCT00055497|565829526|FG000|Overall Study|Lost to Follow-up|0|||
156748696|NCT00055497|565829527|FG001|Overall Study|Lost to Follow-up|1|||
156748697|NCT00055497|565829528|FG002|Overall Study|Lost to Follow-up|0|||
156748698|NCT00055497|565829529|FG003|Overall Study|Lost to Follow-up|5|||
156748699|NCT00055497|565829526|FG000|Overall Study|Protocol Violation|0|||
156748700|NCT00055497|565829527|FG001|Overall Study|Protocol Violation|0|||
156748701|NCT00055497|565829528|FG002|Overall Study|Protocol Violation|0|||
156748702|NCT00055497|565829529|FG003|Overall Study|Protocol Violation|3|||
156748703|NCT00055497|565829526|FG000|Overall Study|Lack of Efficacy|1|||
156748704|NCT00055497|565829527|FG001|Overall Study|Lack of Efficacy|0|||
157220857|NCT04081337|567554878|FG000|Overall Study|Physician Decision|1|||
157220858|NCT04081337|567554879|FG001|Overall Study|Physician Decision|2|||
157220859|NCT04081337|567554878|FG000|Overall Study|Lost to Follow-up|1|||
157220860|NCT04081337|567554879|FG001|Overall Study|Lost to Follow-up|0|||
157220861|NCT01579474|567554880|FG000|Overall Study|Adverse Event|1|||
157220862|NCT01579474|567554881|FG001|Overall Study|Adverse Event|13|||
156748705|NCT00055497|565829528|FG002|Overall Study|Lack of Efficacy|0|||
156748706|NCT00055497|565829529|FG003|Overall Study|Lack of Efficacy|27|||
156748707|NCT00055497|565829526|FG000|Overall Study|Administrative Reasons|0|||
156748708|NCT00055497|565829527|FG001|Overall Study|Administrative Reasons|0|||
156748709|NCT00055497|565829528|FG002|Overall Study|Administrative Reasons|0|||
156748710|NCT00055497|565829529|FG003|Overall Study|Administrative Reasons|1|||
156748711|NCT00055497|565829526|FG000|Overall Study|Other|0|||
156748712|NCT00055497|565829527|FG001|Overall Study|Other|0|||
156748713|NCT00055497|565829528|FG002|Overall Study|Other|0|||
156880908|NCT00282308|566322964|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
156880909|NCT00282308|566322965|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
156880910|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
156880911|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156880912|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156880913|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156880914|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
156880915|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
156880916|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
156880917|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
156880918|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
156880919|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
156880920|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
156748714|NCT00055497|565829529|FG003|Overall Study|Other|11|||
156748715|NCT00048165|565829530|FG000|Completed 6 Months Study|Administration/Other|8|||
156748716|NCT00048165|565829531|FG001|Completed 6 Months Study|Administration/Other|8|||
156748717|NCT00048165|565829530|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
156748718|NCT00048165|565829531|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
156748719|NCT00048165|565829530|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
156748720|NCT00048165|565829531|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
156748721|NCT00048165|565829530|FG000|Completed 6 Months Study|Death|12|||
156748722|NCT00048165|565829531|FG001|Completed 6 Months Study|Death|6|||
156748723|NCT00048165|565829530|FG000|Completed 6 Months Study|Insufficient therapy|1|||
156748724|NCT00048165|565829531|FG001|Completed 6 Months Study|Insufficient therapy|4|||
156748725|NCT00048165|565829530|FG000|Completed 6 Months Study|Other violation|4|||
156748726|NCT00048165|565829531|FG001|Completed 6 Months Study|Other violation|6|||
156748727|NCT00048165|565829530|FG000|Completed 6 Months Study|Refused treatment|5|||
156800311|NCT03110562|566023442|FG001|Initial Treatment Period|Disease Progression|1|||
156800312|NCT03110562|566023443|FG002|Initial Treatment Period|Disease Progression|0|||
156800313|NCT03110562|566023444|FG003|Initial Treatment Period|Disease Progression|0|||
156800314|NCT03110562|566023441|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
156800315|NCT03110562|566023442|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
156800316|NCT03110562|566023443|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
156800317|NCT03110562|566023444|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
156800318|NCT03110562|566023441|FG000|Initial Treatment Period|Adverse Event|1|||
156800319|NCT03110562|566023442|FG001|Initial Treatment Period|Adverse Event|0|||
156800320|NCT03110562|566023443|FG002|Initial Treatment Period|Adverse Event|0|||
156800321|NCT03110562|566023444|FG003|Initial Treatment Period|Adverse Event|0|||
156800322|NCT03110562|566023441|FG000|Initial Treatment Period|Death|74|||
156800323|NCT03110562|566023442|FG001|Initial Treatment Period|Death|82|||
156800324|NCT03110562|566023443|FG002|Initial Treatment Period|Death|0|||
156800325|NCT03110562|566023444|FG003|Initial Treatment Period|Death|0|||
156800326|NCT03110562|566023441|FG000|Initial Treatment Period|Lost to Follow-up|13|||
156800327|NCT03110562|566023442|FG001|Initial Treatment Period|Lost to Follow-up|8|||
156800328|NCT03110562|566023443|FG002|Initial Treatment Period|Lost to Follow-up|0|||
156800329|NCT03110562|566023444|FG003|Initial Treatment Period|Lost to Follow-up|0|||
156800330|NCT03110562|566023441|FG000|Initial Treatment Period|Protocol Deviation|1|||
156800331|NCT03110562|566023442|FG001|Initial Treatment Period|Protocol Deviation|0|||
156800332|NCT03110562|566023443|FG002|Initial Treatment Period|Protocol Deviation|0|||
156800333|NCT03110562|566023444|FG003|Initial Treatment Period|Protocol Deviation|0|||
156800334|NCT03110562|566023441|FG000|Initial Treatment Period|Physician Decision|2|||
156800335|NCT03110562|566023442|FG001|Initial Treatment Period|Physician Decision|1|||
156800336|NCT03110562|566023443|FG002|Initial Treatment Period|Physician Decision|0|||
156800337|NCT03110562|566023444|FG003|Initial Treatment Period|Physician Decision|0|||
156800338|NCT03110562|566023441|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
156800339|NCT03110562|566023442|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
156880921|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156880922|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156748728|NCT00048165|565829531|FG001|Completed 6 Months Study|Refused treatment|5|||
156880923|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156880924|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
156880925|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
157020746|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
156748729|NCT00048165|565829530|FG000|Completed 6 Months Study|Violation criteria|0|||
156748730|NCT00048165|565829531|FG001|Completed 6 Months Study|Violation criteria|2|||
156748731|NCT00048165|565829530|FG000|Completed 6 Months Study|Did not receive study drug|6|||
156880926|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
156880927|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
156880928|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
156880929|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
156880930|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
156880931|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156748732|NCT00048165|565829531|FG001|Completed 6 Months Study|Did not receive study drug|6|||
156748733|NCT00048165|565829530|FG000|Completed 12 Months Study|Administration/Other|0|||
156748734|NCT00048165|565829531|FG001|Completed 12 Months Study|Administration/Other|2|||
156748735|NCT00048165|565829530|FG000|Completed 12 Months Study|Death|2|||
156748736|NCT00048165|565829531|FG001|Completed 12 Months Study|Death|1|||
156748737|NCT00048165|565829530|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
156748738|NCT00048165|565829531|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
156748739|NCT00731731|565829532|FG000|Overall Study|Protocol Violation|0|||
156748740|NCT00731731|565829533|FG001|Overall Study|Protocol Violation|0|||
156748741|NCT00731731|565829534|FG002|Overall Study|Protocol Violation|1|||
156748742|NCT00731731|565829532|FG000|Overall Study|Cancel prior to treatment|0|||
156748743|NCT00731731|565829533|FG001|Overall Study|Cancel prior to treatment|0|||
156748744|NCT00731731|565829534|FG002|Overall Study|Cancel prior to treatment|2|||
156748745|NCT01084538|565829536|FG000|Overall Study|Drug not available|30|||
156748746|NCT01084538|565829536|FG000|Overall Study|Adverse Event|9|||
156748747|NCT01084538|565829536|FG000|Overall Study|Kidney transplant|6|||
156748748|NCT01084538|565829536|FG000|Overall Study|Serious Adverse Event|3|||
156748749|NCT01084538|565829536|FG000|Overall Study|Lack of effectiveness|2|||
156748750|NCT01084538|565829536|FG000|Overall Study|Patient noncompliance|2|||
156748751|NCT01084538|565829536|FG000|Overall Study|Hyperphosphatemia|2|||
156748752|NCT01084538|565829536|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
156748753|NCT01084538|565829536|FG000|Overall Study|Change of residence|2|||
156748754|NCT01084538|565829536|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
156748755|NCT01084538|565829536|FG000|Overall Study|Reason unknown|8|||
156800340|NCT03110562|566023443|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
156800341|NCT03110562|566023444|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
156800342|NCT03110562|566023441|FG000|Initial Treatment Period|Other|5|||
156800343|NCT03110562|566023442|FG001|Initial Treatment Period|Other|4|||
156800344|NCT03110562|566023443|FG002|Initial Treatment Period|Other|0|||
156800345|NCT03110562|566023444|FG003|Initial Treatment Period|Other|0|||
156800346|NCT03110562|566023441|FG000|Initial Treatment Period|Randomized but never treated|0|||
156800347|NCT03110562|566023442|FG001|Initial Treatment Period|Randomized but never treated|3|||
156800348|NCT03110562|566023443|FG002|Initial Treatment Period|Randomized but never treated|0|||
156800349|NCT03110562|566023444|FG003|Initial Treatment Period|Randomized but never treated|0|||
156800350|NCT03110562|566023441|FG000|Crossover Period|Disease Progression|0|||
156800351|NCT03110562|566023442|FG001|Crossover Period|Disease Progression|0|||
156800352|NCT03110562|566023443|FG002|Crossover Period|Disease Progression|1|||
156800353|NCT03110562|566023444|FG003|Crossover Period|Disease Progression|0|||
156800354|NCT03110562|566023441|FG000|Crossover Period|Withdrawal by Subject|0|||
156800355|NCT03110562|566023442|FG001|Crossover Period|Withdrawal by Subject|0|||
156800356|NCT03110562|566023443|FG002|Crossover Period|Withdrawal by Subject|8|||
156800357|NCT03110562|566023444|FG003|Crossover Period|Withdrawal by Subject|6|||
156800358|NCT03110562|566023441|FG000|Crossover Period|Death|0|||
156800359|NCT03110562|566023442|FG001|Crossover Period|Death|0|||
156800360|NCT03110562|566023443|FG002|Crossover Period|Death|37|||
156880932|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156880933|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156880934|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
156880935|NCT01584440|566322966|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156880936|NCT01584440|566322967|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
156880937|NCT01584440|566322968|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156880938|NCT01584440|566322969|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156880939|NCT01584440|566322970|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
156880940|NCT01584440|566322966|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156880941|NCT01584440|566322967|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156880942|NCT01584440|566322968|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
156880943|NCT01584440|566322969|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
156880944|NCT01584440|566322970|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
156880945|NCT01584440|566322966|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
156880946|NCT01584440|566322967|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
156880947|NCT01584440|566322968|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
156880948|NCT01584440|566322969|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
156880949|NCT01584440|566322970|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
157220863|NCT01579474|567554882|FG002|Overall Study|Adverse Event|2|||
156748756|NCT00187278|565829537|FG000|Overall Study|Protocol Violation|10|||
156748757|NCT00187278|565829538|FG001|Overall Study|Protocol Violation|13|||
156748758|NCT01490697|565829545|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
156800361|NCT03110562|566023444|FG003|Crossover Period|Death|3|||
156800362|NCT03110562|566023441|FG000|Crossover Period|Lost to Follow-up|0|||
157020747|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
157020748|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
157020749|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
156880950|NCT01584440|566322966|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156880951|NCT01584440|566322967|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156880952|NCT01584440|566322968|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
156748759|NCT01490697|565829546|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
156748760|NCT00090584|565829547|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
156748761|NCT00090584|565829548|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
156748762|NCT00090584|565829547|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
156748763|NCT00090584|565829548|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
156748764|NCT00379808|565829549|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
156748765|NCT00379808|565829550|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
156748766|NCT03742258|565829556|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
156748767|NCT03742258|565829557|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
156748768|NCT03742258|565829558|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
156748769|NCT03742258|565829556|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
156748770|NCT03742258|565829557|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
156748771|NCT03742258|565829558|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
156748772|NCT03742258|565829556|FG000|Survival Follow-Up|Still in Follow-up|0|||
156748773|NCT03742258|565829557|FG001|Survival Follow-Up|Still in Follow-up|0|||
156748774|NCT03742258|565829558|FG002|Survival Follow-Up|Still in Follow-up|2|||
156748775|NCT01987232|565829563|FG000|Overall Study|Ongoing in Study|0|||
156748776|NCT01987232|565829564|FG001|Overall Study|Ongoing in Study|0|||
156748777|NCT01987232|565829565|FG002|Overall Study|Ongoing in Study|0|||
156748778|NCT01987232|565829566|FG003|Overall Study|Ongoing in Study|1|||
156748779|NCT01987232|565829567|FG004|Overall Study|Ongoing in Study|0|||
156748780|NCT01731470|565829569|FG000|Overall Study|Withdrawal by Subject|1|||
156748781|NCT01731470|565829569|FG000|Overall Study|Did not meet study criteria|1|||
156748782|NCT02258334|565829572|FG000|Overall Study|Adverse Event|1|||
156748783|NCT02258334|565829573|FG001|Overall Study|Adverse Event|0|||
156748784|NCT02258334|565829574|FG002|Overall Study|Adverse Event|0|||
156748785|NCT02258334|565829575|FG003|Overall Study|Adverse Event|0|||
156748786|NCT03564795|565829578|FG000|Overall Study|Withdrawal by Subject|3|||
156748787|NCT03564795|565829578|FG000|Overall Study|Lost to Follow-up|6|||
156748788|NCT03564795|565829578|FG000|Overall Study|Physician Decision|2|||
156748789|NCT00564395|565829583|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
156748790|NCT00564395|565829584|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
156748791|NCT00564395|565829583|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
156748792|NCT00564395|565829584|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
156748793|NCT01333956|565829589|FG000|Overall Study|Lost to Follow-up|1|||
156748794|NCT01333956|565829590|FG001|Overall Study|Lost to Follow-up|2|||
156748795|NCT01333956|565829591|FG002|Overall Study|Lost to Follow-up|0|||
156748796|NCT01333956|565829592|FG003|Overall Study|Lost to Follow-up|1|||
156748797|NCT01333956|565829589|FG000|Overall Study|Unable to complete study procedure|1|||
156748798|NCT01333956|565829590|FG001|Overall Study|Unable to complete study procedure|0|||
156748799|NCT01333956|565829591|FG002|Overall Study|Unable to complete study procedure|0|||
156748800|NCT01333956|565829592|FG003|Overall Study|Unable to complete study procedure|1|||
156748801|NCT01333956|565829589|FG000|Overall Study|Withdrawal by Subject|0|||
156748802|NCT01333956|565829590|FG001|Overall Study|Withdrawal by Subject|2|||
156748803|NCT01333956|565829591|FG002|Overall Study|Withdrawal by Subject|1|||
156748804|NCT01333956|565829592|FG003|Overall Study|Withdrawal by Subject|0|||
156748805|NCT02134353|565829593|FG000|Overall Study|Adverse Event|10|||
156880953|NCT01584440|566322969|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156880954|NCT01584440|566322970|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
156880955|NCT01338298|566322974|FG000|Overall Study|Withdrawal by Subject|1|||
156880956|NCT01338298|566322975|FG001|Overall Study|Withdrawal by Subject|1|||
157020750|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
156880957|NCT01338298|566322974|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
156880958|NCT01338298|566322975|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
156880959|NCT01338298|566322974|FG000|Overall Study|Administrative error|0|||
156880960|NCT01338298|566322975|FG001|Overall Study|Administrative error|1|||
156880961|NCT01338298|566322974|FG000|Overall Study|Positive symptom worsening|1|||
156880962|NCT01338298|566322975|FG001|Overall Study|Positive symptom worsening|0|||
156880963|NCT01338298|566322974|FG000|Overall Study|Depressive symptoms and nausea|1|||
157020751|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
156748806|NCT02134353|565829594|FG001|Overall Study|Adverse Event|6|||
156748807|NCT02134353|565829593|FG000|Overall Study|Lost to Follow-up|1|||
156748808|NCT02134353|565829594|FG001|Overall Study|Lost to Follow-up|1|||
156748809|NCT02134353|565829593|FG000|Overall Study|Lack of Efficacy|2|||
156748810|NCT02134353|565829594|FG001|Overall Study|Lack of Efficacy|1|||
156748811|NCT02134353|565829593|FG000|Overall Study|Withdrawal by Subject|12|||
156748812|NCT02134353|565829594|FG001|Overall Study|Withdrawal by Subject|13|||
156748813|NCT02134353|565829593|FG000|Overall Study|Death|0|||
156748814|NCT02134353|565829594|FG001|Overall Study|Death|1|||
156748815|NCT02134353|565829593|FG000|Overall Study|Pregnancy|0|||
156748816|NCT02134353|565829594|FG001|Overall Study|Pregnancy|1|||
156748817|NCT02134353|565829593|FG000|Overall Study|Relocation|1|||
156748818|NCT02134353|565829594|FG001|Overall Study|Relocation|0|||
156748819|NCT02134353|565829593|FG000|Overall Study|Other - Patient's Choice|0|||
156748820|NCT02134353|565829594|FG001|Overall Study|Other - Patient's Choice|1|||
156748821|NCT00477607|565829595|FG000|Overall Study|Lost to Follow-up|7|||
156748822|NCT00477607|565829596|FG001|Overall Study|Lost to Follow-up|7|||
156748823|NCT01732471|565829599|FG000|Overall Study|Withdrawal by Subject|1|||
156748824|NCT00474786|565829600|FG000|Overall Study|Not Meeting Study Criteria|0|||
156748825|NCT00474786|565829601|FG001|Overall Study|Not Meeting Study Criteria|1|||
156748826|NCT00474786|565829600|FG000|Overall Study|Investigator Request|2|||
156748827|NCT00474786|565829601|FG001|Overall Study|Investigator Request|1|||
156748828|NCT00474786|565829600|FG000|Overall Study|Death|189|||
156748829|NCT00474786|565829601|FG001|Overall Study|Death|170|||
157020752|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
157020753|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
157020754|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
157020755|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
157020756|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
157020757|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
157020758|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
157020759|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
157020760|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
157020761|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
157020762|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
157020763|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
157020764|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Adverse Event|0|||
157020765|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Adverse Event|0|||
157020766|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Adverse Event|0|||
157220864|NCT01579474|567554883|FG003|Overall Study|Adverse Event|0|||
157220865|NCT01579474|567554884|FG004|Overall Study|Adverse Event|0|||
156748830|NCT00474786|565829600|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
157020767|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Adverse Event|0|||
157020768|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Adverse Event|0|||
157020769|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Adverse Event|0|||
157020770|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Adverse Event|2|||
157020771|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Adverse Event|0|||
157020772|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Adverse Event|0|||
157020773|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Adverse Event|0|||
157020774|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Adverse Event|1|||
156748831|NCT00474786|565829601|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
156748832|NCT00474786|565829600|FG000|Overall Study|Lost to Follow-up|4|||
156748833|NCT00474786|565829601|FG001|Overall Study|Lost to Follow-up|7|||
156748834|NCT00474786|565829600|FG000|Overall Study|Protocol Violation|2|||
156748835|NCT00474786|565829601|FG001|Overall Study|Protocol Violation|0|||
156748836|NCT00474786|565829600|FG000|Overall Study|Withdrawal by Subject|15|||
156748837|NCT00474786|565829601|FG001|Overall Study|Withdrawal by Subject|15|||
156748838|NCT00474786|565829600|FG000|Overall Study|Other|5|||
156748839|NCT00474786|565829601|FG001|Overall Study|Other|0|||
156748840|NCT02892513|565829602|FG000|Overall Study|Withdrawal by Subject|0|||
156748841|NCT02892513|565829603|FG001|Overall Study|Withdrawal by Subject|1|||
156748842|NCT00432276|565829604|FG000|Overall Study|Hyperglycemic Rescue|44|||
156748843|NCT00432276|565829605|FG001|Overall Study|Hyperglycemic Rescue|87|||
156748844|NCT00432276|565829604|FG000|Overall Study|Adverse Event|13|||
156748845|NCT00432276|565829605|FG001|Overall Study|Adverse Event|16|||
156748846|NCT00432276|565829604|FG000|Overall Study|Protocol Violation|25|||
156748847|NCT00432276|565829605|FG001|Overall Study|Protocol Violation|20|||
156748848|NCT00432276|565829604|FG000|Overall Study|Lost to Follow-up|6|||
156748849|NCT00432276|565829605|FG001|Overall Study|Lost to Follow-up|2|||
156748850|NCT00432276|565829604|FG000|Overall Study|Withdrawal by Subject|25|||
156748851|NCT00432276|565829605|FG001|Overall Study|Withdrawal by Subject|20|||
156748852|NCT00432276|565829604|FG000|Overall Study|Physician Decision|6|||
156748853|NCT00432276|565829605|FG001|Overall Study|Physician Decision|8|||
156748854|NCT00432276|565829604|FG000|Overall Study|Other|2|||
156748855|NCT00432276|565829605|FG001|Overall Study|Other|3|||
157020775|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Adverse Event|2|||
157020776|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Adverse Event|0|||
157020777|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Adverse Event|1|||
157020778|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Adverse Event|0|||
156748856|NCT00594386|565829606|FG000|Overall Study|Major protocol violation|2|||
156748857|NCT00594386|565829606|FG000|Overall Study|Lack of Efficacy|12|||
156748858|NCT00594386|565829606|FG000|Overall Study|Adverse Event|68|||
156748859|NCT00594386|565829606|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
156748860|NCT00594386|565829606|FG000|Overall Study|Subject withdrew consent|35|||
156748861|NCT00594386|565829606|FG000|Overall Study|Study ended per sponsor|115|||
156880964|NCT01338298|566322975|FG001|Overall Study|Depressive symptoms and nausea|0|||
156880965|NCT01338298|566322974|FG000|Overall Study|Non-adherence|1|||
156748862|NCT00594386|565829606|FG000|Overall Study|Lost to Follow-up|6|||
156748863|NCT00594386|565829606|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
156748864|NCT00594386|565829606|FG000|Overall Study|Other: Subject moved to Seattle|1|||
156748865|NCT00594386|565829606|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
156748866|NCT00594386|565829606|FG000|Overall Study|Other: Study terminated per investigator|2|||
156748867|NCT00594386|565829606|FG000|Overall Study|Other: Sponsor closure of study|1|||
156748868|NCT00594386|565829606|FG000|Overall Study|Other: Site terminated participation|1|||
156748869|NCT00594386|565829606|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
156748870|NCT00594386|565829606|FG000|Overall Study|Other: Loss of drivers license|1|||
156748871|NCT04459598|565829611|FG000|Overall Study|Adverse Event|1|||
156748872|NCT04459598|565829612|FG001|Overall Study|Adverse Event|1|||
156748873|NCT00463840|565829614|FG000|Overall Study|Disease progression|7|||
156748874|NCT00463840|565829614|FG000|Overall Study|Withdrawal by Subject|2|||
156748875|NCT00463840|565829614|FG000|Overall Study|Adverse Event|3|||
156748876|NCT00866333|565829620|FG000|Overall Study|Withdrawal of consent|0|||
156748877|NCT00866333|565829621|FG001|Overall Study|Withdrawal of consent|1|||
156748878|NCT00866333|565829622|FG002|Overall Study|Withdrawal of consent|2|||
156748879|NCT00866333|565829620|FG000|Overall Study|Reason not Specified|3|||
156880966|NCT01338298|566322975|FG001|Overall Study|Non-adherence|0|||
156880967|NCT02872285|566322976|FG000|Overall Study|Withdrawal by Subject|2|||
156880968|NCT02872285|566322977|FG001|Overall Study|Withdrawal by Subject|0|||
156880969|NCT02872285|566322976|FG000|Overall Study|Lost to Follow-up|2|||
156880970|NCT02872285|566322977|FG001|Overall Study|Lost to Follow-up|2|||
156880971|NCT02872285|566322976|FG000|Overall Study|Discontinued due to back surgery|1|||
156880972|NCT02872285|566322977|FG001|Overall Study|Discontinued due to back surgery|0|||
156880973|NCT00531427|566322978|FG000|Overall Study|Withdrawal by Subject|7|||
156880974|NCT00531427|566322979|FG001|Overall Study|Withdrawal by Subject|13|||
156748880|NCT00866333|565829621|FG001|Overall Study|Reason not Specified|1|||
156748881|NCT00866333|565829622|FG002|Overall Study|Reason not Specified|1|||
156880975|NCT00531427|566322978|FG000|Overall Study|Adverse Event|44|||
156880976|NCT00531427|566322979|FG001|Overall Study|Adverse Event|30|||
156880977|NCT00531427|566322978|FG000|Overall Study|Lost to Follow-up|4|||
156880978|NCT00531427|566322979|FG001|Overall Study|Lost to Follow-up|3|||
156880979|NCT00531427|566322978|FG000|Overall Study|Lack of Efficacy|14|||
156880980|NCT00531427|566322979|FG001|Overall Study|Lack of Efficacy|39|||
156880981|NCT00531427|566322978|FG000|Overall Study|Administrative|4|||
156880982|NCT00531427|566322979|FG001|Overall Study|Administrative|9|||
156880983|NCT00721968|566322980|FG000|Overall Study|Lost to Follow-up|2|||
156880984|NCT00721968|566322981|FG001|Overall Study|Lost to Follow-up|0|||
156880985|NCT00336856|566325320|FG000|Overall Study|Withdrawal by Subject|3|||
156748882|NCT00866333|565829620|FG000|Overall Study|Study Terminated by Sponsor|2|||
156880986|NCT00336856|566325320|FG000|Overall Study|Found ineligible at time of analysis|1|||
156880987|NCT01332799|566325326|FG000|Overall Study|Insufficient funding|10|||
156880988|NCT01332799|566325327|FG001|Overall Study|Insufficient funding|10|||
156880989|NCT00538785|566325328|FG000|Overall Study|Death|9|||
156880990|NCT00538785|566325329|FG001|Overall Study|Death|10|||
156880991|NCT00538785|566325328|FG000|Overall Study|Withdrawal of consent|9|||
156880992|NCT00538785|566325329|FG001|Overall Study|Withdrawal of consent|7|||
156880993|NCT00538785|566325328|FG000|Overall Study|Lost to Follow-up|1|||
156880994|NCT00538785|566325329|FG001|Overall Study|Lost to Follow-up|0|||
156880995|NCT04022733|566325330|FG000|Overall Study|conversion to open surgery|3|||
156880996|NCT04022733|566325331|FG001|Overall Study|conversion to open surgery|2|||
156880997|NCT04022733|566325330|FG000|Overall Study|bradycardia|0|||
156880998|NCT04022733|566325331|FG001|Overall Study|bradycardia|1|||
156880999|NCT05315908|566325335|FG000|Overall Study|Lost to Follow-up|4477|||
156881000|NCT05315908|566325336|FG001|Overall Study|Lost to Follow-up|4606|||
156881001|NCT00505076|566325345|FG000|Overall Study|Adverse Event|1|||
156881002|NCT00505076|566325346|FG001|Overall Study|Adverse Event|0|||
156881003|NCT00505076|566325347|FG002|Overall Study|Adverse Event|1|||
156881004|NCT00505076|566325345|FG000|Overall Study|Protocol Violation|2|||
156881005|NCT00505076|566325346|FG001|Overall Study|Protocol Violation|1|||
156881006|NCT00505076|566325347|FG002|Overall Study|Protocol Violation|2|||
156881007|NCT00505076|566325345|FG000|Overall Study|Withdrawal by Subject|0|||
156881008|NCT00505076|566325346|FG001|Overall Study|Withdrawal by Subject|1|||
156881009|NCT00505076|566325347|FG002|Overall Study|Withdrawal by Subject|2|||
156881010|NCT01128621|566325356|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
156748883|NCT00866333|565829621|FG001|Overall Study|Study Terminated by Sponsor|5|||
156748884|NCT00866333|565829622|FG002|Overall Study|Study Terminated by Sponsor|9|||
156748885|NCT00422292|565829623|FG000|Overall Study|Serious adverse events|1|||
156748886|NCT00422292|565829624|FG001|Overall Study|Serious adverse events|4|||
156748887|NCT00422292|565829625|FG002|Overall Study|Serious adverse events|0|||
156881011|NCT01128621|566325357|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
156881012|NCT00233454|566325358|FG000|Overall Study|Death|6|||
156881013|NCT00388583|566325361|FG000|Overall Study|Protocol Violation|1|||
156748888|NCT00422292|565829626|FG003|Overall Study|Serious adverse events|0|||
156748889|NCT00422292|565829623|FG000|Overall Study|Adverse Event|1|||
156748890|NCT00422292|565829624|FG001|Overall Study|Adverse Event|0|||
156748891|NCT00422292|565829625|FG002|Overall Study|Adverse Event|1|||
156748892|NCT00422292|565829626|FG003|Overall Study|Adverse Event|0|||
156748893|NCT00422292|565829623|FG000|Overall Study|Protocol Violation|4|||
156748894|NCT00422292|565829624|FG001|Overall Study|Protocol Violation|25|||
156748895|NCT00422292|565829625|FG002|Overall Study|Protocol Violation|8|||
156748896|NCT00422292|565829626|FG003|Overall Study|Protocol Violation|5|||
156748897|NCT00422292|565829623|FG000|Overall Study|Lost to Follow-up|6|||
156748898|NCT00422292|565829624|FG001|Overall Study|Lost to Follow-up|12|||
156748899|NCT00422292|565829625|FG002|Overall Study|Lost to Follow-up|6|||
156748900|NCT00422292|565829626|FG003|Overall Study|Lost to Follow-up|6|||
156748901|NCT00422292|565829623|FG000|Overall Study|Withdrawal by Subject|6|||
156748902|NCT00422292|565829624|FG001|Overall Study|Withdrawal by Subject|25|||
156748903|NCT00422292|565829625|FG002|Overall Study|Withdrawal by Subject|7|||
156748904|NCT00422292|565829626|FG003|Overall Study|Withdrawal by Subject|13|||
156748905|NCT02669082|565829627|FG000|Overall Study|Adverse Event|1|||
156748906|NCT04918355|565829631|FG000|Overall Study|no qualifying health encounter|497|||
156748907|NCT04918355|565829632|FG001|Overall Study|no qualifying health encounter|192|||
156748908|NCT04918355|565829633|FG002|Overall Study|no qualifying health encounter|438|||
156748909|NCT04918355|565829634|FG003|Overall Study|no qualifying health encounter|424|||
156748910|NCT04683939|565829638|FG000|Overall Study|Study termination by the sponsor|0|||
156748911|NCT04683939|565829639|FG001|Overall Study|Study termination by the sponsor|1|||
156748912|NCT04683939|565829640|FG002|Overall Study|Study termination by the sponsor|2|||
156748913|NCT04683939|565829641|FG003|Overall Study|Study termination by the sponsor|2|||
156748914|NCT04683939|565829638|FG000|Overall Study|Death|1|||
156748915|NCT04683939|565829639|FG001|Overall Study|Death|1|||
156748916|NCT04683939|565829640|FG002|Overall Study|Death|2|||
156748917|NCT04683939|565829641|FG003|Overall Study|Death|1|||
156748918|NCT04683939|565829638|FG000|Overall Study|Withdrawal by Subject|1|||
156748919|NCT04683939|565829639|FG001|Overall Study|Withdrawal by Subject|0|||
156748920|NCT04683939|565829640|FG002|Overall Study|Withdrawal by Subject|0|||
156748921|NCT04683939|565829641|FG003|Overall Study|Withdrawal by Subject|0|||
156748922|NCT04683939|565829638|FG000|Overall Study|Physician Decision|1|||
156748923|NCT04683939|565829639|FG001|Overall Study|Physician Decision|0|||
156748924|NCT04683939|565829640|FG002|Overall Study|Physician Decision|0|||
156748925|NCT04683939|565829641|FG003|Overall Study|Physician Decision|0|||
156748926|NCT04683939|565829638|FG000|Overall Study|Lost to Follow-up|0|||
156748927|NCT04683939|565829639|FG001|Overall Study|Lost to Follow-up|1|||
156748928|NCT04683939|565829640|FG002|Overall Study|Lost to Follow-up|0|||
156748929|NCT04683939|565829641|FG003|Overall Study|Lost to Follow-up|0|||
156748930|NCT04852276|565829642|FG000|Overall Study|Death|2|||
156748931|NCT04852276|565829643|FG001|Overall Study|Death|0|||
156748932|NCT04852276|565829642|FG000|Overall Study|Lost to Follow-up|15|||
156748933|NCT04852276|565829643|FG001|Overall Study|Lost to Follow-up|9|||
156748934|NCT04852276|565829642|FG000|Overall Study|Withdrawal by Subject|26|||
156748935|NCT04852276|565829643|FG001|Overall Study|Withdrawal by Subject|6|||
156881014|NCT00388583|566325362|FG001|Overall Study|Protocol Violation|0|||
157143635|NCT00091793|567274237|FG000|Overall Study|Withdrawal by Subject|10|||
156748936|NCT01687283|565831533|FG000|Overall Study|Adverse Event|11|||
156748937|NCT01687283|565831534|FG001|Overall Study|Adverse Event|4|||
156748938|NCT01687283|565831533|FG000|Overall Study|Lack of Efficacy|3|||
156748939|NCT01687283|565831534|FG001|Overall Study|Lack of Efficacy|1|||
156748940|NCT01687283|565831533|FG000|Overall Study|Protocol Violation|1|||
156748941|NCT01687283|565831534|FG001|Overall Study|Protocol Violation|3|||
156748942|NCT01687283|565831533|FG000|Overall Study|protocol defined stopping criteria|8|||
156748943|NCT01687283|565831534|FG001|Overall Study|protocol defined stopping criteria|10|||
156748944|NCT01687283|565831533|FG000|Overall Study|Lost to Follow-up|1|||
156748945|NCT01687283|565831534|FG001|Overall Study|Lost to Follow-up|1|||
156748946|NCT01687283|565831533|FG000|Overall Study|Investigator discretion|2|||
156748947|NCT01687283|565831534|FG001|Overall Study|Investigator discretion|0|||
156748948|NCT01687283|565831533|FG000|Overall Study|Withdrawal by Subject|9|||
156748949|NCT01687283|565831534|FG001|Overall Study|Withdrawal by Subject|8|||
156748950|NCT00410072|565831538|FG000|Day 1 to Week 48|Adverse Event|1|||
156748951|NCT00410072|565831539|FG001|Day 1 to Week 48|Adverse Event|2|||
156748952|NCT00410072|565831538|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
156748953|NCT00410072|565831539|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
156748954|NCT00410072|565831538|FG000|Day 1 to Week 48|Other|0|||
156748955|NCT00410072|565831539|FG001|Day 1 to Week 48|Other|1|||
156748956|NCT00410072|565831538|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
156748957|NCT00410072|565831539|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
156748958|NCT00410072|565831538|FG000|Day 1 to Week 48|Pregnancy|0|||
156748959|NCT00410072|565831539|FG001|Day 1 to Week 48|Pregnancy|2|||
156748960|NCT00410072|565831538|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
156748961|NCT00410072|565831539|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
156748962|NCT00410072|565831538|FG000|After Week 48 to Week 96|Adverse Event|1|||
156748963|NCT00410072|565831539|FG001|After Week 48 to Week 96|Adverse Event|2|||
156748964|NCT00410072|565831538|FG000|After Week 48 to Week 96|Death|0|||
156748965|NCT00410072|565831539|FG001|After Week 48 to Week 96|Death|1|||
156881015|NCT00388583|566325361|FG000|Overall Study|Withdrawal by Subject|3|||
156881016|NCT00388583|566325362|FG001|Overall Study|Withdrawal by Subject|3|||
156748966|NCT00410072|565831538|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
156748967|NCT00410072|565831539|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
156748968|NCT00410072|565831538|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
156748969|NCT00410072|565831539|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
156748970|NCT00410072|565831538|FG000|After Week 48 to Week 96|Other|2|||
156748971|NCT00410072|565831539|FG001|After Week 48 to Week 96|Other|0|||
156748972|NCT00410072|565831538|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
156748973|NCT00410072|565831539|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
156748974|NCT00410072|565831538|FG000|After Week 48 to Week 96|Pregnancy|0|||
156748975|NCT00410072|565831539|FG001|After Week 48 to Week 96|Pregnancy|2|||
156748976|NCT00410072|565831538|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
156748977|NCT00410072|565831539|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
156748978|NCT04494425|565831542|FG000|Overall Study|Death|160|||
156748979|NCT04494425|565831543|FG001|Overall Study|Death|166|||
156748980|NCT04494425|565831542|FG000|Overall Study|Withdrawal by Subject|10|||
156748981|NCT04494425|565831543|FG001|Overall Study|Withdrawal by Subject|40|||
156881017|NCT00388583|566325361|FG000|Overall Study|Serious Adverse Event|2|||
156881018|NCT00388583|566325362|FG001|Overall Study|Serious Adverse Event|0|||
156881019|NCT00388583|566325361|FG000|Overall Study|Did not receive vaccine|0|||
156881020|NCT00388583|566325362|FG001|Overall Study|Did not receive vaccine|1|||
156881021|NCT05194579|566325363|FG000|Overall Study|Lost to Follow-up|2|||
156881022|NCT05194579|566325364|FG001|Overall Study|Lost to Follow-up|3|||
156881023|NCT05194579|566325363|FG000|Overall Study|Withdrawal by Subject|3|||
156881024|NCT05194579|566325364|FG001|Overall Study|Withdrawal by Subject|4|||
156748982|NCT04494425|565831542|FG000|Overall Study|Other|1|||
156748983|NCT04494425|565831543|FG001|Overall Study|Other|1|||
156748984|NCT04494425|565831542|FG000|Overall Study|Ongoing at the time of PCD|265|||
156748985|NCT04494425|565831543|FG001|Overall Study|Ongoing at the time of PCD|223|||
156748986|NCT01270321|565831545|FG000|Overall Study|Death|3|||
156748987|NCT01270321|565831546|FG001|Overall Study|Death|1|||
156748988|NCT01270321|565831547|FG002|Overall Study|Death|4|||
156748989|NCT01270321|565831545|FG000|Overall Study|Adverse Event|7|||
156748990|NCT01270321|565831546|FG001|Overall Study|Adverse Event|9|||
156748991|NCT01270321|565831547|FG002|Overall Study|Adverse Event|5|||
156748992|NCT04003623|565831551|FG000|Overall Study|Withdrawal by Subject|1|||
156748993|NCT04003623|565831552|FG001|Overall Study|Withdrawal by Subject|0|||
156748994|NCT01190189|565831556|FG000|Overall Study|Lost to Follow-up|4|||
156748995|NCT01190189|565831556|FG000|Overall Study|Withdrawal by Subject|1|||
156748996|NCT01190189|565831556|FG000|Overall Study|Migrated/moved from study area|1|||
156748997|NCT00904917|565831558|FG000|Overall Study|Lost to Follow-up|2|||
156748998|NCT00904917|565831559|FG001|Overall Study|Lost to Follow-up|2|||
156748999|NCT00904917|565831560|FG002|Overall Study|Lost to Follow-up|2|||
156749000|NCT00904917|565831561|FG003|Overall Study|Lost to Follow-up|2|||
156749001|NCT02442206|565831562|FG000|Period 1|Adverse Event|1|||
156749002|NCT02442206|565831563|FG001|Period 1|Adverse Event|1|||
156749003|NCT02442206|565831562|FG000|Period 1|withdrew consent|0|||
156749004|NCT02442206|565831563|FG001|Period 1|withdrew consent|1|||
156749005|NCT02442206|565831562|FG000|Period 1|COPD exacerbation|0|||
156749006|NCT02442206|565831563|FG001|Period 1|COPD exacerbation|1|||
156749007|NCT02442206|565831562|FG000|Period 2|Adverse Event|1|||
156749008|NCT02442206|565831563|FG001|Period 2|Adverse Event|0|||
156749009|NCT01471444|565831564|FG000|Overall Study|Physician Decision|3|||
156749010|NCT01471444|565831565|FG001|Overall Study|Physician Decision|2|||
156749011|NCT01471444|565831564|FG000|Overall Study|Withdrawal by Subject|0|||
156749012|NCT01471444|565831565|FG001|Overall Study|Withdrawal by Subject|1|||
156749013|NCT01709409|565831570|FG000|Overall Study|Protocol Violation|1|||
156749014|NCT01709409|565831571|FG001|Overall Study|Protocol Violation|0|||
156749015|NCT02412878|565831572|FG000|Overall Study|Withdrawal by Subject|19|||
156749016|NCT02412878|565831573|FG001|Overall Study|Withdrawal by Subject|10|||
156749017|NCT02412878|565831572|FG000|Overall Study|Lost to Follow-up|2|||
156749018|NCT02412878|565831573|FG001|Overall Study|Lost to Follow-up|3|||
156749019|NCT02190721|565831574|FG000|Overall Study|Patient was out of the city|0|||
156749020|NCT02190721|565831575|FG001|Overall Study|Patient was out of the city|1|||
156881025|NCT05194579|566325363|FG000|Overall Study|Refused further study procedures|0|||
156749021|NCT02190721|565831576|FG002|Overall Study|Patient was out of the city|0|||
156749022|NCT05025332|565831577|FG000|Screening|Screen failure|12|||
156749023|NCT05025332|565831577|FG000|Treatment & Follow Up|Protocol Violation|1|||
156749024|NCT05025332|565831577|FG000|Treatment & Follow Up|Adverse Event|4|||
156749025|NCT04676152|565831578|FG000|Overall Study|screen fail|9|||
156749026|NCT01928199|565831579|FG000|Overall Study|Lost to Follow-up|2|||
156749027|NCT01928199|565831580|FG001|Overall Study|Lost to Follow-up|1|||
156749028|NCT01928199|565831579|FG000|Overall Study|Withdrawal by Subject|3|||
156749029|NCT01928199|565831580|FG001|Overall Study|Withdrawal by Subject|5|||
156749030|NCT02107313|565831582|FG000|Overall Study|One participant did not do the FED cohor|0|||
156749031|NCT02107313|565831583|FG001|Overall Study|One participant did not do the FED cohor|1|||
156749032|NCT01031004|565831586|FG000|Overall Study|Protocol Violation|0|||
157220866|NCT01579474|567554885|FG005|Overall Study|Adverse Event|1|||
157220867|NCT01579474|567554880|FG000|Overall Study|Lack of Efficacy|1|||
157220868|NCT01579474|567554881|FG001|Overall Study|Lack of Efficacy|0|||
157220869|NCT01579474|567554882|FG002|Overall Study|Lack of Efficacy|0|||
157220870|NCT01579474|567554883|FG003|Overall Study|Lack of Efficacy|0|||
157220871|NCT01579474|567554884|FG004|Overall Study|Lack of Efficacy|1|||
157220872|NCT01579474|567554885|FG005|Overall Study|Lack of Efficacy|0|||
157220873|NCT01579474|567554880|FG000|Overall Study|Withdrawal by Subject|1|||
157220874|NCT01579474|567554881|FG001|Overall Study|Withdrawal by Subject|0|||
157220875|NCT01579474|567554882|FG002|Overall Study|Withdrawal by Subject|0|||
157220876|NCT01579474|567554883|FG003|Overall Study|Withdrawal by Subject|0|||
157220877|NCT01579474|567554884|FG004|Overall Study|Withdrawal by Subject|0|||
157220878|NCT01579474|567554885|FG005|Overall Study|Withdrawal by Subject|0|||
157220879|NCT02295774|567554887|FG000|Overall Study|Physician Decision|1|||
157220880|NCT02295774|567554887|FG000|Overall Study|Withdrawal by Subject|2|||
157220881|NCT01075763|567554888|FG000|Overall Study|Lost to Follow-up|2|||
157220882|NCT01075763|567554889|FG001|Overall Study|Lost to Follow-up|1|||
157220883|NCT01075763|567554888|FG000|Overall Study|Lack of Efficacy|0|||
157220884|NCT01075763|567554889|FG001|Overall Study|Lack of Efficacy|1|||
157220885|NCT01075763|567554888|FG000|Overall Study|Withdrawal by Subject|2|||
157220886|NCT01075763|567554889|FG001|Overall Study|Withdrawal by Subject|2|||
157220887|NCT00586521|567554890|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
157220888|NCT03083483|567554891|FG000|Overall Study|Adverse Event|1|||
157220889|NCT03083483|567554892|FG001|Overall Study|Adverse Event|1|||
157220890|NCT03083483|567554893|FG002|Overall Study|Adverse Event|1|||
157220891|NCT03083483|567554891|FG000|Overall Study|Lost to Follow-up|2|||
157220892|NCT03083483|567554892|FG001|Overall Study|Lost to Follow-up|1|||
157220893|NCT03083483|567554893|FG002|Overall Study|Lost to Follow-up|1|||
157220894|NCT03083483|567554891|FG000|Overall Study|technological issues|1|||
157220895|NCT03083483|567554892|FG001|Overall Study|technological issues|0|||
157220896|NCT03083483|567554893|FG002|Overall Study|technological issues|1|||
157220897|NCT02710071|567554897|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
157220898|NCT02710071|567554898|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
157220899|NCT02710071|567554897|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
157220900|NCT02710071|567554898|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
157220901|NCT00958256|567554906|FG000|Overall Study|Adverse Event|3|||
157220902|NCT00449072|567554907|FG000|Overall Study|Adverse Event|3|||
157220903|NCT00449072|567554908|FG001|Overall Study|Adverse Event|1|||
157220904|NCT00449072|567554907|FG000|Overall Study|Protocol Violation|14|||
157220905|NCT00449072|567554908|FG001|Overall Study|Protocol Violation|12|||
156749033|NCT01031004|565831587|FG001|Overall Study|Protocol Violation|1|||
156749034|NCT01031004|565831586|FG000|Overall Study|Lost to Follow-up|1|||
156749035|NCT01031004|565831587|FG001|Overall Study|Lost to Follow-up|0|||
156749036|NCT01641471|565831588|FG000|Overall Study|Withdrawal by Subject|19|||
156749037|NCT01641471|565831589|FG001|Overall Study|Withdrawal by Subject|19|||
156749038|NCT01641471|565831588|FG000|Overall Study|Lost to Follow-up|2|||
156749039|NCT01641471|565831589|FG001|Overall Study|Lost to Follow-up|4|||
156749040|NCT01641471|565831588|FG000|Overall Study|Protocol Violation|2|||
156749041|NCT01641471|565831589|FG001|Overall Study|Protocol Violation|4|||
156749042|NCT04575584|565831590|FG000|Overall Study|Death|6|||
156749043|NCT04575584|565831591|FG001|Overall Study|Death|4|||
156749044|NCT04575584|565831592|FG002|Overall Study|Death|6|||
156749045|NCT04575584|565831593|FG003|Overall Study|Death|2|||
156749046|NCT04575584|565831594|FG004|Overall Study|Death|0|||
156749047|NCT04575584|565831595|FG005|Overall Study|Death|0|||
156749048|NCT04575584|565831590|FG000|Overall Study|Lost to Follow-up|1|||
156749049|NCT04575584|565831591|FG001|Overall Study|Lost to Follow-up|1|||
156749050|NCT04575584|565831592|FG002|Overall Study|Lost to Follow-up|1|||
156749051|NCT04575584|565831593|FG003|Overall Study|Lost to Follow-up|1|||
156749052|NCT04575584|565831594|FG004|Overall Study|Lost to Follow-up|0|||
156749053|NCT04575584|565831595|FG005|Overall Study|Lost to Follow-up|0|||
157220906|NCT00449072|567554907|FG000|Overall Study|Lost to Follow-up|5|||
157220907|NCT00449072|567554908|FG001|Overall Study|Lost to Follow-up|7|||
157220908|NCT00449072|567554907|FG000|Overall Study|Withdrawal by Subject|11|||
157220909|NCT00449072|567554908|FG001|Overall Study|Withdrawal by Subject|8|||
157220910|NCT00449072|567554907|FG000|Overall Study|Lack of Efficacy|1|||
157220911|NCT00449072|567554908|FG001|Overall Study|Lack of Efficacy|1|||
157220912|NCT00449072|567554907|FG000|Overall Study|Physician Decision|1|||
156749054|NCT04575584|565831590|FG000|Overall Study|Physician Decision|0|||
156749055|NCT04575584|565831591|FG001|Overall Study|Physician Decision|1|||
156749056|NCT04575584|565831592|FG002|Overall Study|Physician Decision|1|||
156749057|NCT04575584|565831593|FG003|Overall Study|Physician Decision|1|||
156749058|NCT04575584|565831594|FG004|Overall Study|Physician Decision|0|||
156749059|NCT04575584|565831595|FG005|Overall Study|Physician Decision|0|||
157220913|NCT00449072|567554908|FG001|Overall Study|Physician Decision|0|||
157220914|NCT00449072|567554907|FG000|Overall Study|Not treated|0|||
156881026|NCT05194579|566325364|FG001|Overall Study|Refused further study procedures|1|||
156881027|NCT05194579|566325363|FG000|Overall Study|Protocol deviation|1|||
156881028|NCT05194579|566325364|FG001|Overall Study|Protocol deviation|0|||
157020779|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Adverse Event|0|||
157020780|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Adverse Event|1|||
157020781|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Adverse Event|0|||
157020782|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
157020783|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
157020784|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
157020785|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
157020786|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
157020787|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
157020788|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
157020789|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
157020790|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
156881029|NCT03595228|566325369|FG000|Overall Study|Death|2|||
156881030|NCT03595228|566325369|FG000|Overall Study|Lack of Efficacy|13|||
156881031|NCT03595228|566325369|FG000|Overall Study|Withdrawal by Subject|3|||
156881032|NCT03595228|566325369|FG000|Overall Study|Withdrawal by Sponsor|1|||
157020791|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
157020792|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
157020793|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
157020794|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
157020795|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
157020796|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
157020797|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
157020798|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
157020799|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
157020800|NCT03269136|566828498|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156881033|NCT01639729|566325370|FG000|Overall Study|Withdrawal by Subject|1|||
156881034|NCT01639729|566325371|FG001|Overall Study|Withdrawal by Subject|0|||
156881035|NCT01639729|566325372|FG002|Overall Study|Withdrawal by Subject|1|||
156881036|NCT01639729|566325373|FG003|Overall Study|Withdrawal by Subject|1|||
156881037|NCT01639729|566325374|FG004|Overall Study|Withdrawal by Subject|0|||
156881038|NCT01639729|566325375|FG005|Overall Study|Withdrawal by Subject|0|||
156881039|NCT03232333|566325376|FG000|Overall Study|Infection or Osteomyelitis|9|||
156881040|NCT03232333|566325376|FG000|Overall Study|Lost to Follow-up|4|||
156881041|NCT03232333|566325376|FG000|Overall Study|Withdrawal by Subject|2|||
156881042|NCT01253811|566325377|FG000|Overall Study|Withdrawal criteria|1|||
156881043|NCT00759564|566325378|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
156881044|NCT00759564|566325379|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
156881045|NCT00759564|566325380|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
156881046|NCT00759564|566325381|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
156881047|NCT00759564|566325382|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
156881048|NCT00862641|566325385|FG000|Overall Study|Randomized, but drug not received|1|||
156881049|NCT00862641|566325386|FG001|Overall Study|Randomized, but drug not received|4|||
156881050|NCT00862641|566325387|FG002|Overall Study|Randomized, but drug not received|1|||
156881051|NCT00862641|566325388|FG003|Overall Study|Randomized, but drug not received|4|||
156881052|NCT01419197|566325389|FG000|Overall Study|Death|247|||
156881053|NCT01419197|566325390|FG001|Overall Study|Death|122|||
156881054|NCT01419197|566325389|FG000|Overall Study|Physician Decision|4|||
156881055|NCT01419197|566325390|FG001|Overall Study|Physician Decision|4|||
156881056|NCT01419197|566325389|FG000|Overall Study|Non-compliance|3|||
156881057|NCT01419197|566325390|FG001|Overall Study|Non-compliance|1|||
156881058|NCT01419197|566325389|FG000|Overall Study|Withdrawal by Subject|33|||
156881059|NCT01419197|566325390|FG001|Overall Study|Withdrawal by Subject|32|||
156881060|NCT01419197|566325389|FG000|Overall Study|Study Completed by Sponsor|103|||
156881061|NCT01419197|566325390|FG001|Overall Study|Study Completed by Sponsor|34|||
156881062|NCT01419197|566325389|FG000|Overall Study|Reason Not Specified|0|||
156881063|NCT01419197|566325390|FG001|Overall Study|Reason Not Specified|1|||
156881064|NCT01419197|566325389|FG000|Overall Study|Lost to Follow-up|14|||
156881065|NCT01419197|566325390|FG001|Overall Study|Lost to Follow-up|4|||
156881066|NCT00146848|566325391|FG000|Pre-randomization|Death|19|||
156881067|NCT00146848|566325392|FG001|Pre-randomization|Death|0|||
157020801|NCT03269136|566828499|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156881068|NCT00146848|566325393|FG002|Pre-randomization|Death|0|||
156881069|NCT00146848|566325391|FG000|Pre-randomization|Lost to Follow-up|70|||
156881070|NCT00146848|566325392|FG001|Pre-randomization|Lost to Follow-up|0|||
156881071|NCT00146848|566325393|FG002|Pre-randomization|Lost to Follow-up|0|||
156881072|NCT00146848|566325391|FG000|Pre-randomization|Physician Decision|8|||
157020802|NCT03269136|566828500|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020803|NCT03269136|566828501|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156881073|NCT00146848|566325392|FG001|Pre-randomization|Physician Decision|0|||
156881074|NCT00146848|566325393|FG002|Pre-randomization|Physician Decision|0|||
156749060|NCT04575584|565831590|FG000|Overall Study|Withdrawal by Subject|7|||
156749061|NCT04575584|565831591|FG001|Overall Study|Withdrawal by Subject|9|||
156749062|NCT04575584|565831592|FG002|Overall Study|Withdrawal by Subject|5|||
156749063|NCT04575584|565831593|FG003|Overall Study|Withdrawal by Subject|3|||
156749064|NCT04575584|565831594|FG004|Overall Study|Withdrawal by Subject|0|||
156749065|NCT04575584|565831595|FG005|Overall Study|Withdrawal by Subject|0|||
156749066|NCT04575584|565831590|FG000|Overall Study|Not recorded|0|||
156749067|NCT04575584|565831591|FG001|Overall Study|Not recorded|0|||
156749068|NCT04575584|565831592|FG002|Overall Study|Not recorded|0|||
156749069|NCT04575584|565831593|FG003|Overall Study|Not recorded|1|||
156749070|NCT04575584|565831594|FG004|Overall Study|Not recorded|0|||
156749071|NCT04575584|565831595|FG005|Overall Study|Not recorded|0|||
156749072|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
156749073|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
156749074|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
156749075|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
156749076|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
156749077|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
156749078|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
156749079|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
156749080|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
156749081|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
156749082|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
156749083|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
156749084|NCT02634801|565831596|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
156749085|NCT02634801|565831597|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
156749086|NCT02634801|565831598|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
156749087|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
156749088|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
156749089|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
156749090|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
156749091|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
156749092|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
156749093|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749094|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749095|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
156749096|NCT02634801|565831596|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
156749097|NCT02634801|565831597|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
156749098|NCT02634801|565831598|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
156749099|NCT02634801|565831596|FG000|Follow-up Period|Lost to Follow-up|3|||
156749100|NCT02634801|565831597|FG001|Follow-up Period|Lost to Follow-up|1|||
156749101|NCT02634801|565831598|FG002|Follow-up Period|Lost to Follow-up|2|||
156749102|NCT02634801|565831596|FG000|Follow-up Period|Physician Decision|0|||
156749103|NCT02634801|565831597|FG001|Follow-up Period|Physician Decision|0|||
156749104|NCT02634801|565831598|FG002|Follow-up Period|Physician Decision|1|||
156749105|NCT02634801|565831596|FG000|Follow-up Period|Withdrawal by Subject|1|||
156749106|NCT02634801|565831597|FG001|Follow-up Period|Withdrawal by Subject|2|||
156749107|NCT02634801|565831598|FG002|Follow-up Period|Withdrawal by Subject|5|||
156749108|NCT02634801|565831596|FG000|Follow-up Period|Adverse Event|1|||
156749109|NCT02634801|565831597|FG001|Follow-up Period|Adverse Event|5|||
156749110|NCT02634801|565831598|FG002|Follow-up Period|Adverse Event|0|||
156749111|NCT01548768|565831619|FG000|Overall Study|Withdrawal by Subject|0|||
156749112|NCT01548768|565831620|FG001|Overall Study|Withdrawal by Subject|2|||
156749113|NCT01548768|565831621|FG002|Overall Study|Withdrawal by Subject|1|||
156749114|NCT01548768|565831622|FG003|Overall Study|Withdrawal by Subject|0|||
156749115|NCT01548768|565831619|FG000|Overall Study|Physician Decision|1|||
156749116|NCT01548768|565831620|FG001|Overall Study|Physician Decision|0|||
156749117|NCT01548768|565831621|FG002|Overall Study|Physician Decision|0|||
156749118|NCT01548768|565831622|FG003|Overall Study|Physician Decision|0|||
156749119|NCT01548768|565831619|FG000|Overall Study|Adverse Event|0|||
156749120|NCT01548768|565831620|FG001|Overall Study|Adverse Event|0|||
156749121|NCT01548768|565831621|FG002|Overall Study|Adverse Event|0|||
156749122|NCT01548768|565831622|FG003|Overall Study|Adverse Event|1|||
156749123|NCT01548768|565831619|FG000|Overall Study|Non-Compliance|0|||
156749124|NCT01548768|565831620|FG001|Overall Study|Non-Compliance|0|||
156749125|NCT01548768|565831621|FG002|Overall Study|Non-Compliance|0|||
156749126|NCT01548768|565831622|FG003|Overall Study|Non-Compliance|3|||
156749127|NCT01108237|565831623|FG000|Overall Study|No alignment data|2|||
156749128|NCT01108237|565831624|FG001|Overall Study|No alignment data|15|||
157220915|NCT00449072|567554908|FG001|Overall Study|Not treated|1|||
156749129|NCT01108237|565831623|FG000|Overall Study|Did not meet criteria for analysis|7|||
156749130|NCT01108237|565831624|FG001|Overall Study|Did not meet criteria for analysis|0|||
156749131|NCT02178358|565831627|FG000|Overall Study|Withdrawal by Subject|0|||
156749132|NCT02178358|565831628|FG001|Overall Study|Withdrawal by Subject|2|||
157220916|NCT00449072|567554907|FG000|Overall Study|Excluded medication|0|||
157220917|NCT00449072|567554908|FG001|Overall Study|Excluded medication|2|||
157220918|NCT00449072|567554907|FG000|Overall Study|Non-compliance|2|||
156749133|NCT02178358|565831629|FG002|Overall Study|Withdrawal by Subject|2|||
156749134|NCT02178358|565831627|FG000|Overall Study|Lost to Follow-up|1|||
156749135|NCT02178358|565831628|FG001|Overall Study|Lost to Follow-up|0|||
156749136|NCT02178358|565831629|FG002|Overall Study|Lost to Follow-up|0|||
156749137|NCT03297021|565831630|FG000|Overall Study|Incomplete/illegible data sheet|4|||
156749138|NCT03297021|565831631|FG001|Overall Study|Incomplete/illegible data sheet|2|||
156749139|NCT03297021|565831632|FG002|Overall Study|Incomplete/illegible data sheet|3|||
156749140|NCT03297021|565831630|FG000|Overall Study|Missing Post-Op Data|1|||
156749141|NCT03297021|565831631|FG001|Overall Study|Missing Post-Op Data|2|||
156749142|NCT03297021|565831632|FG002|Overall Study|Missing Post-Op Data|1|||
156749143|NCT02784288|565831633|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
156749144|NCT02734862|565831634|FG000|Part A|Death|3|||
156749145|NCT02734862|565831635|FG001|Part A|Death|4|||
156749146|NCT02734862|565831636|FG002|Part A|Death|6|||
156749147|NCT02734862|565831634|FG000|Part A|Lost to Follow-up|2|||
156749148|NCT02734862|565831635|FG001|Part A|Lost to Follow-up|1|||
156749149|NCT02734862|565831636|FG002|Part A|Lost to Follow-up|1|||
156749150|NCT02734862|565831634|FG000|Part A|Withdrawal by Subject|1|||
156749151|NCT02734862|565831635|FG001|Part A|Withdrawal by Subject|1|||
156749152|NCT02734862|565831636|FG002|Part A|Withdrawal by Subject|2|||
156749153|NCT02734862|565831634|FG000|Part A|Physician Decision|2|||
156749154|NCT02734862|565831635|FG001|Part A|Physician Decision|0|||
156749155|NCT02734862|565831636|FG002|Part A|Physician Decision|1|||
156749156|NCT02734862|565831634|FG000|Part A|Adverse Event|2|||
156749157|NCT02734862|565831635|FG001|Part A|Adverse Event|0|||
156749158|NCT02734862|565831636|FG002|Part A|Adverse Event|1|||
156749159|NCT02734862|565831634|FG000|Part A|Noncompliance|1|||
156749160|NCT02734862|565831635|FG001|Part A|Noncompliance|1|||
156749161|NCT02734862|565831636|FG002|Part A|Noncompliance|0|||
156749162|NCT02734862|565831634|FG000|Part A|Other|1|||
156749163|NCT02734862|565831635|FG001|Part A|Other|1|||
156749164|NCT02734862|565831636|FG002|Part A|Other|3|||
156749165|NCT02734862|565831634|FG000|Part B|Death|8|||
156749166|NCT02734862|565831635|FG001|Part B|Death|3|||
156749167|NCT02734862|565831636|FG002|Part B|Death|5|||
156749168|NCT02734862|565831634|FG000|Part B|Lost to Follow-up|2|||
156749169|NCT02734862|565831635|FG001|Part B|Lost to Follow-up|2|||
156749170|NCT02734862|565831636|FG002|Part B|Lost to Follow-up|0|||
156749171|NCT02734862|565831634|FG000|Part B|Withdrawal by Subject|3|||
156749172|NCT02734862|565831635|FG001|Part B|Withdrawal by Subject|1|||
156749173|NCT02734862|565831636|FG002|Part B|Withdrawal by Subject|0|||
156749174|NCT02734862|565831634|FG000|Part B|Other|0|||
156749175|NCT02734862|565831635|FG001|Part B|Other|1|||
156749176|NCT02734862|565831636|FG002|Part B|Other|0|||
156749177|NCT02757625|565831637|FG000|Overall Study|Investigator's discretion|0|||
156749178|NCT02757625|565831638|FG001|Overall Study|Investigator's discretion|0|||
156749179|NCT02757625|565831639|FG002|Overall Study|Investigator's discretion|1|||
156749180|NCT02757625|565831640|FG003|Overall Study|Investigator's discretion|0|||
156749181|NCT02757625|565831637|FG000|Overall Study|Adverse Event|0|||
156749182|NCT02757625|565831638|FG001|Overall Study|Adverse Event|0|||
156749183|NCT02757625|565831639|FG002|Overall Study|Adverse Event|1|||
156749184|NCT02757625|565831640|FG003|Overall Study|Adverse Event|0|||
156749185|NCT00564278|565831641|FG000|Overall Study|Lost to Follow-up|35|||
156749186|NCT00564278|565831642|FG001|Overall Study|Lost to Follow-up|33|||
157220919|NCT00449072|567554908|FG001|Overall Study|Non-compliance|5|||
157220920|NCT00449072|567554907|FG000|Overall Study|Sponsor decision|1|||
157220921|NCT00449072|567554908|FG001|Overall Study|Sponsor decision|3|||
157220922|NCT00449072|567554907|FG000|Overall Study|Relocation|3|||
156749187|NCT00564278|565831641|FG000|Overall Study|Physician Decision|1|||
156749188|NCT00564278|565831642|FG001|Overall Study|Physician Decision|2|||
156749189|NCT00564278|565831641|FG000|Overall Study|Withdrawal by Subject|11|||
156749190|NCT00564278|565831642|FG001|Overall Study|Withdrawal by Subject|7|||
156749191|NCT00645671|565831643|FG000|Overall Study|Protocol Violation|1|||
156749192|NCT00645671|565831644|FG001|Overall Study|Protocol Violation|0|||
156749193|NCT00645671|565831643|FG000|Overall Study|Withdrawal by Subject|0|||
156749194|NCT00645671|565831644|FG001|Overall Study|Withdrawal by Subject|4|||
156749195|NCT00645671|565831643|FG000|Overall Study|Adverse Event|0|||
156749196|NCT00645671|565831644|FG001|Overall Study|Adverse Event|1|||
156800363|NCT03110562|566023442|FG001|Crossover Period|Lost to Follow-up|0|||
157220923|NCT00449072|567554908|FG001|Overall Study|Relocation|2|||
156749197|NCT00645671|565831643|FG000|Overall Study|Physician Decision|0|||
156749198|NCT00645671|565831644|FG001|Overall Study|Physician Decision|1|||
156749199|NCT02095197|565831645|FG000|Overall Study|Lost to Follow-up|0|||
156749200|NCT02095197|565831646|FG001|Overall Study|Lost to Follow-up|3|||
156749201|NCT00493311|565831647|FG000|Overall Study|Need for rescue medication|2|||
156749202|NCT00493311|565831648|FG001|Overall Study|Need for rescue medication|2|||
156749203|NCT02779075|565831649|FG000|Overall Study|Withdrawal by Subject|1|||
157220924|NCT02623959|567554909|FG000|Overall Study|Progression|0|||
157220925|NCT02623959|567554910|FG001|Overall Study|Progression|1|||
156881075|NCT00146848|566325391|FG000|Pre-randomization|Protocol Violation|172|||
156881076|NCT00146848|566325392|FG001|Pre-randomization|Protocol Violation|0|||
156881077|NCT00146848|566325393|FG002|Pre-randomization|Protocol Violation|0|||
156881078|NCT00146848|566325391|FG000|Pre-randomization|Withdrawal by Subject|40|||
156881079|NCT00146848|566325392|FG001|Pre-randomization|Withdrawal by Subject|0|||
156881080|NCT00146848|566325393|FG002|Pre-randomization|Withdrawal by Subject|0|||
156881081|NCT00146848|566325391|FG000|Post-randomization|Lost to Follow-up|12|||
156881082|NCT00146848|566325392|FG001|Post-randomization|Lost to Follow-up|15|||
156881083|NCT00146848|566325393|FG002|Post-randomization|Lost to Follow-up|12|||
156881084|NCT00146848|566325391|FG000|Post-randomization|Withdrawn|26|||
157020804|NCT03269136|566828502|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156881085|NCT00146848|566325392|FG001|Post-randomization|Withdrawn|32|||
156881086|NCT00146848|566325393|FG002|Post-randomization|Withdrawn|27|||
156881087|NCT01798849|566325394|FG000|Overall Study|Physician Decision|0|||
156881088|NCT01798849|566325395|FG001|Overall Study|Physician Decision|0|||
156881089|NCT01798849|566325396|FG002|Overall Study|Physician Decision|1|||
156881090|NCT00717236|566325397|FG000|Double-Blind Period|Adverse Event|33|||
156881091|NCT00717236|566325398|FG001|Double-Blind Period|Adverse Event|6|||
156881092|NCT00717236|566325397|FG000|Double-Blind Period|Lack of Efficacy|6|||
157020805|NCT03269136|566828503|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020806|NCT03269136|566828504|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020807|NCT03269136|566828505|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020808|NCT03269136|566828506|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020809|NCT03269136|566828507|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156881093|NCT00717236|566325398|FG001|Double-Blind Period|Lack of Efficacy|6|||
156881094|NCT00717236|566325397|FG000|Double-Blind Period|Lost to Follow-up|3|||
156881095|NCT00717236|566325398|FG001|Double-Blind Period|Lost to Follow-up|5|||
156881096|NCT00717236|566325397|FG000|Double-Blind Period|Withdrawal by Subject|10|||
156881097|NCT00717236|566325398|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156881098|NCT00717236|566325397|FG000|Double-Blind Period|Loss of efficacy|3|||
156881099|NCT00717236|566325398|FG001|Double-Blind Period|Loss of efficacy|0|||
156881100|NCT00717236|566325397|FG000|Double-Blind Period|Other: Death|1|||
156881101|NCT00717236|566325398|FG001|Double-Blind Period|Other: Death|0|||
156881102|NCT00717236|566325397|FG000|Double-Blind Period|Other: Pregnancy|1|||
156881103|NCT00717236|566325398|FG001|Double-Blind Period|Other: Pregnancy|0|||
157020810|NCT03269136|566828508|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157143636|NCT00091793|567274238|FG001|Overall Study|Withdrawal by Subject|15|||
157143637|NCT00091793|567274237|FG000|Overall Study|Ineligibility determined|2|||
157143638|NCT00091793|567274238|FG001|Overall Study|Ineligibility determined|0|||
157143639|NCT00091793|567274237|FG000|Overall Study|Lost to Follow-up|7|||
157143640|NCT00091793|567274238|FG001|Overall Study|Lost to Follow-up|5|||
157143641|NCT00091793|567274237|FG000|Overall Study|Noncompliance|2|||
157143642|NCT00091793|567274238|FG001|Overall Study|Noncompliance|0|||
157143643|NCT00091793|567274237|FG000|Overall Study|Other|2|||
157143644|NCT00091793|567274238|FG001|Overall Study|Other|0|||
157143645|NCT05309083|567274240|FG000|Overall Study|Withdrawal by Subject|2|||
157143646|NCT01238120|567274241|FG000|Overall Study|Withdrawal by Subject|4|||
157143647|NCT01238120|567274242|FG001|Overall Study|Withdrawal by Subject|1|||
157143648|NCT01238120|567274243|FG002|Overall Study|Withdrawal by Subject|2|||
157143649|NCT01238120|567274244|FG003|Overall Study|Withdrawal by Subject|5|||
157143650|NCT01238120|567274241|FG000|Overall Study|Lost to Follow-up|2|||
157143651|NCT01238120|567274242|FG001|Overall Study|Lost to Follow-up|0|||
157143652|NCT01238120|567274243|FG002|Overall Study|Lost to Follow-up|1|||
157143653|NCT01238120|567274244|FG003|Overall Study|Lost to Follow-up|1|||
157143654|NCT01238120|567274241|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
157143655|NCT01238120|567274242|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
157143656|NCT01238120|567274243|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
156749204|NCT02779075|565831650|FG001|Overall Study|Withdrawal by Subject|3|||
156749205|NCT02779075|565831649|FG000|Overall Study|IV lost during 2nd study|1|||
156749206|NCT02779075|565831650|FG001|Overall Study|IV lost during 2nd study|0|||
156881104|NCT00717236|566325397|FG000|Double-Blind Period|Other: Protocol Violation|2|||
157020811|NCT03269136|566828509|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020812|NCT03269136|566828510|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
157143657|NCT01238120|567274244|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
156749207|NCT00790556|565831651|FG000|Treatment Period 1|Physician Decision|1|||
156749208|NCT00790556|565831652|FG001|Treatment Period 1|Physician Decision|0|||
156881105|NCT00717236|566325398|FG001|Double-Blind Period|Other: Protocol Violation|0|||
156881106|NCT00717236|566325397|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
156881107|NCT00717236|566325398|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
156881108|NCT00717236|566325397|FG000|Double-Blind Period|Other: Site withdrew|2|||
156881109|NCT00717236|566325398|FG001|Double-Blind Period|Other: Site withdrew|0|||
156881110|NCT00717236|566325397|FG000|Double-Blind Period|Other: Screening failure|1|||
157143658|NCT00881205|567274245|FG000|Overall Study|Adverse Event|8|||
157143659|NCT00881205|567274246|FG001|Overall Study|Adverse Event|3|||
157143660|NCT00881205|567274245|FG000|Overall Study|Withdrawal by Subject|1|||
157220926|NCT00989261|567554911|FG000|Overall Study|Still in follow up|12|||
157220927|NCT00989261|567554912|FG001|Overall Study|Still in follow up|21|||
157220928|NCT00989261|567554911|FG000|Overall Study|Withdrawal by Subject|0|||
157220929|NCT00989261|567554912|FG001|Overall Study|Withdrawal by Subject|1|||
157220930|NCT00989261|567554911|FG000|Overall Study|Lost to Follow-up|3|||
157220931|NCT00989261|567554912|FG001|Overall Study|Lost to Follow-up|0|||
157220932|NCT01418352|567554924|FG000|Overall Study|Lost to Follow-up|2|||
157220933|NCT01418352|567554925|FG001|Overall Study|Lost to Follow-up|0|||
157220934|NCT01418352|567554926|FG002|Overall Study|Lost to Follow-up|0|||
157220935|NCT01418352|567554927|FG003|Overall Study|Lost to Follow-up|0|||
157220936|NCT01418352|567554924|FG000|Overall Study|Adverse Event|0|||
157220937|NCT01418352|567554925|FG001|Overall Study|Adverse Event|1|||
157220938|NCT01418352|567554926|FG002|Overall Study|Adverse Event|0|||
157220939|NCT01418352|567554927|FG003|Overall Study|Adverse Event|0|||
157220940|NCT01418352|567554924|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
157220941|NCT01418352|567554925|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
157220942|NCT01418352|567554926|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
157220943|NCT01418352|567554927|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
157220944|NCT01418352|567554924|FG000|Overall Study|Subject Withdrew Consent|0|||
157220945|NCT01418352|567554925|FG001|Overall Study|Subject Withdrew Consent|1|||
157220946|NCT01418352|567554926|FG002|Overall Study|Subject Withdrew Consent|2|||
157220947|NCT01418352|567554927|FG003|Overall Study|Subject Withdrew Consent|1|||
157220948|NCT01418352|567554924|FG000|Overall Study|Protocol Deviation|0|||
157220949|NCT01418352|567554925|FG001|Overall Study|Protocol Deviation|0|||
157220950|NCT01418352|567554926|FG002|Overall Study|Protocol Deviation|1|||
157220951|NCT01418352|567554927|FG003|Overall Study|Protocol Deviation|0|||
157220952|NCT01418352|567554924|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
157220953|NCT01418352|567554925|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
157220954|NCT01418352|567554926|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
157220955|NCT01418352|567554927|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
157220956|NCT01507896|567554928|FG000|Overall Study|Withdrawal by Subject|1|||
157220957|NCT01507896|567554928|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
157220958|NCT00490061|567554929|FG000|Overall Study|Physician Decision|1|||
157220959|NCT00585351|567554934|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
156881111|NCT00717236|566325398|FG001|Double-Blind Period|Other: Screening failure|0|||
156881112|NCT00717236|566325397|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
156881113|NCT00717236|566325398|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
156881114|NCT00717236|566325397|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
156881115|NCT00717236|566325398|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
156881116|NCT00717236|566325397|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
156881117|NCT00717236|566325398|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
156881118|NCT00717236|566325397|FG000|Double-Blind Period|Other: History of cancer|1|||
156881119|NCT00717236|566325398|FG001|Double-Blind Period|Other: History of cancer|0|||
156881120|NCT00717236|566325397|FG000|Double-Blind Period|Other: Sponsor request|1|||
157143661|NCT00881205|567274246|FG001|Overall Study|Withdrawal by Subject|2|||
157143662|NCT00881205|567274245|FG000|Overall Study|Lost to Follow-up|0|||
157143663|NCT00881205|567274246|FG001|Overall Study|Lost to Follow-up|1|||
157143664|NCT00881205|567274245|FG000|Overall Study|Administrative problems|1|||
157143665|NCT00881205|567274246|FG001|Overall Study|Administrative problems|1|||
157143666|NCT00881205|567274245|FG000|Overall Study|Condition no longer requires drug|1|||
157143667|NCT00881205|567274246|FG001|Overall Study|Condition no longer requires drug|0|||
157143668|NCT00482001|567274251|FG000|Overall Study|Protocol Violation|1|||
157143669|NCT00482001|567274252|FG001|Overall Study|Protocol Violation|1|||
157143670|NCT02388776|567274253|FG000|Overall Study|Death|1|||
157143671|NCT02388776|567274253|FG000|Overall Study|Lost to Follow-up|1|||
157143672|NCT06129487|567274255|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
157143673|NCT06129487|567274256|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
157220960|NCT00585351|567554935|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
157220961|NCT00585351|567554936|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
157220962|NCT00585351|567554937|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
157220963|NCT00585351|567554938|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
157220964|NCT00585351|567554939|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
157220965|NCT00585351|567554940|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
156881121|NCT00717236|566325398|FG001|Double-Blind Period|Other: Sponsor request|0|||
156881122|NCT00717236|566325397|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
156881123|NCT00717236|566325398|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
157220966|NCT00585351|567554941|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
157143674|NCT04246047|567274257|FG000|Overall Study|Death|50|||
157143675|NCT04246047|567274258|FG001|Overall Study|Death|77|||
157143676|NCT04246047|567274257|FG000|Overall Study|Lost to Follow-up|1|||
157143677|NCT04246047|567274258|FG001|Overall Study|Lost to Follow-up|3|||
157143678|NCT04246047|567274257|FG000|Overall Study|Physician Decision|4|||
157143679|NCT04246047|567274258|FG001|Overall Study|Physician Decision|10|||
157143680|NCT04246047|567274257|FG000|Overall Study|Withdrawal by Subject|19|||
157143681|NCT04246047|567274258|FG001|Overall Study|Withdrawal by Subject|26|||
157143682|NCT04246047|567274257|FG000|Overall Study|Ongoing|169|||
157143683|NCT04246047|567274258|FG001|Overall Study|Ongoing|135|||
157143684|NCT00587223|567274274|FG000|Overall Study|Adverse Event|1|||
157143685|NCT00195351|567274275|FG000|Overall Study|Lost to Follow-up|9|||
157143686|NCT00195351|567274276|FG001|Overall Study|Lost to Follow-up|9|||
157143687|NCT00195351|567274275|FG000|Overall Study|Withdrawal by Subject|6|||
157143688|NCT00195351|567274276|FG001|Overall Study|Withdrawal by Subject|3|||
157143689|NCT00195351|567274275|FG000|Overall Study|Protocol Deviation|3|||
157143690|NCT00195351|567274276|FG001|Overall Study|Protocol Deviation|2|||
157143691|NCT00195351|567274275|FG000|Overall Study|Death|3|||
157143692|NCT00195351|567274276|FG001|Overall Study|Death|1|||
157143693|NCT00195351|567274275|FG000|Overall Study|Lack of Efficacy|0|||
157143694|NCT00195351|567274276|FG001|Overall Study|Lack of Efficacy|1|||
157143695|NCT04332419|567274279|FG000|Overall Study|Withdrawal by Subject|1|||
157143696|NCT02493751|567274280|FG000|Overall Study|Withdrawal by Subject|2|||
157143697|NCT02493751|567274281|FG001|Overall Study|Withdrawal by Subject|8|||
157143698|NCT02493751|567274280|FG000|Overall Study|Death|6|||
157143699|NCT02493751|567274281|FG001|Overall Study|Death|13|||
157143700|NCT02493751|567274280|FG000|Overall Study|Lost to Follow-up|2|||
157143701|NCT02493751|567274281|FG001|Overall Study|Lost to Follow-up|3|||
157143702|NCT02493751|567274280|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
157143703|NCT02493751|567274281|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
157143704|NCT00519623|567274282|FG000|Overall Study|Adverse Event|1|||
157143705|NCT03819140|567274285|FG000|Overall Study|Lost to Follow-up|1|||
157143706|NCT03819140|567274286|FG001|Overall Study|Lost to Follow-up|2|||
157143707|NCT03819140|567274285|FG000|Overall Study|Withdrawal by Subject|3|||
157143708|NCT03819140|567274286|FG001|Overall Study|Withdrawal by Subject|2|||
157143709|NCT03819140|567274285|FG000|Overall Study|Adverse Event|0|||
157143710|NCT03819140|567274286|FG001|Overall Study|Adverse Event|1|||
157143711|NCT03819140|567274285|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
157143712|NCT03819140|567274286|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
157143713|NCT03819140|567274285|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
157143714|NCT03819140|567274286|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
157143715|NCT02192359|567274287|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
157143716|NCT02192359|567274288|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
157143717|NCT02192359|567274289|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
157143718|NCT02192359|567274290|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
157143719|NCT02192359|567274287|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
156749209|NCT00790556|565831651|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156749210|NCT00790556|565831652|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156749211|NCT04847232|565831653|FG000|Overall Study|Death|123|||
156749212|NCT04847232|565831654|FG001|Overall Study|Death|115|||
156749213|NCT04847232|565831653|FG000|Overall Study|Lost to Follow-up|3|||
156749214|NCT04847232|565831654|FG001|Overall Study|Lost to Follow-up|10|||
156749215|NCT04847232|565831653|FG000|Overall Study|Withdrawal by Subject|73|||
156749216|NCT04847232|565831654|FG001|Overall Study|Withdrawal by Subject|101|||
156749217|NCT04847232|565831653|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
156749218|NCT04847232|565831654|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
156749219|NCT02476916|565831655|FG000|Core Period|Adverse Event|2|||
156749220|NCT02476916|565831656|FG001|Core Period|Adverse Event|2|||
156749221|NCT02476916|565831655|FG000|Core Period|Investigator decision|1|||
156749222|NCT02476916|565831656|FG001|Core Period|Investigator decision|1|||
156749223|NCT02476916|565831655|FG000|Core Period|Withdrawal by Subject|3|||
156749224|NCT02476916|565831656|FG001|Core Period|Withdrawal by Subject|0|||
156749225|NCT02476916|565831655|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
156749226|NCT02476916|565831656|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
156749227|NCT02476916|565831655|FG000|Extension Period|On Treatment|12|||
156749228|NCT02476916|565831656|FG001|Extension Period|On Treatment|17|||
156749229|NCT05600036|565831657|FG000|Overall Study|Adverse Event|0|||
156749230|NCT05600036|565831658|FG001|Overall Study|Adverse Event|2|||
156749231|NCT05600036|565831659|FG002|Overall Study|Adverse Event|1|||
156749232|NCT05600036|565831660|FG003|Overall Study|Adverse Event|0|||
156749233|NCT05600036|565831661|FG004|Overall Study|Adverse Event|1|||
156749234|NCT05600036|565831662|FG005|Overall Study|Adverse Event|0|||
156749235|NCT05600036|565831657|FG000|Overall Study|Lost to Follow-up|0|||
156749236|NCT05600036|565831658|FG001|Overall Study|Lost to Follow-up|2|||
157143720|NCT02192359|567274288|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
157143721|NCT02192359|567274289|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
156749237|NCT05600036|565831659|FG002|Overall Study|Lost to Follow-up|1|||
156749238|NCT05600036|565831660|FG003|Overall Study|Lost to Follow-up|1|||
156749239|NCT05600036|565831661|FG004|Overall Study|Lost to Follow-up|0|||
156749240|NCT05600036|565831662|FG005|Overall Study|Lost to Follow-up|0|||
156749241|NCT05600036|565831657|FG000|Overall Study|Protocol Violation|0|||
156749242|NCT05600036|565831658|FG001|Overall Study|Protocol Violation|0|||
156749243|NCT05600036|565831659|FG002|Overall Study|Protocol Violation|2|||
156749244|NCT05600036|565831660|FG003|Overall Study|Protocol Violation|0|||
156749245|NCT05600036|565831661|FG004|Overall Study|Protocol Violation|0|||
156749246|NCT05600036|565831662|FG005|Overall Study|Protocol Violation|0|||
156749247|NCT05600036|565831657|FG000|Overall Study|Withdrawal by Subject|0|||
156749248|NCT05600036|565831658|FG001|Overall Study|Withdrawal by Subject|1|||
156749249|NCT05600036|565831659|FG002|Overall Study|Withdrawal by Subject|2|||
156749250|NCT05600036|565831660|FG003|Overall Study|Withdrawal by Subject|0|||
156749251|NCT05600036|565831661|FG004|Overall Study|Withdrawal by Subject|3|||
156749252|NCT05600036|565831662|FG005|Overall Study|Withdrawal by Subject|5|||
156749253|NCT05600036|565831657|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749254|NCT05600036|565831658|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749255|NCT05600036|565831659|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749256|NCT05600036|565831660|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
156749257|NCT05600036|565831661|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749258|NCT05600036|565831662|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
156749259|NCT05600036|565831657|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749260|NCT05600036|565831658|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
156749261|NCT05600036|565831659|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749262|NCT05600036|565831660|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749263|NCT05600036|565831661|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749264|NCT05600036|565831662|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
156749265|NCT05600036|565831657|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749266|NCT05600036|565831658|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749267|NCT05600036|565831659|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749268|NCT05600036|565831660|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
156749269|NCT05600036|565831661|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749270|NCT05600036|565831662|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
156749271|NCT04401202|565831663|FG000|Overall Study|Lost to Follow-up|2|||
156749272|NCT04401202|565831664|FG001|Overall Study|Lost to Follow-up|2|||
156749273|NCT04401202|565831663|FG000|Overall Study|Adverse Event|0|||
156749274|NCT04401202|565831664|FG001|Overall Study|Adverse Event|1|||
156749275|NCT04401202|565831663|FG000|Overall Study|Hospitalized|4|||
156749276|NCT04401202|565831664|FG001|Overall Study|Hospitalized|1|||
156749277|NCT02714036|565831666|FG000|Overall Study|Adverse Event|9|||
156749278|NCT02714036|565831667|FG001|Overall Study|Adverse Event|2|||
156749279|NCT02714036|565831666|FG000|Overall Study|Withdrawal by Subject|3|||
156749280|NCT02714036|565831667|FG001|Overall Study|Withdrawal by Subject|2|||
156749281|NCT00715520|565831669|FG000|Overall Study|Screen failure|8|||
156749282|NCT00715520|565831670|FG001|Overall Study|Screen failure|1|||
156749283|NCT00715520|565831671|FG002|Overall Study|Screen failure|1|||
156749284|NCT00715520|565831669|FG000|Overall Study|Withdrawal by Subject|2|||
156749285|NCT00715520|565831670|FG001|Overall Study|Withdrawal by Subject|0|||
156749286|NCT00715520|565831671|FG002|Overall Study|Withdrawal by Subject|1|||
156800364|NCT03110562|566023443|FG002|Crossover Period|Lost to Follow-up|0|||
156800365|NCT03110562|566023444|FG003|Crossover Period|Lost to Follow-up|1|||
156800366|NCT03110562|566023441|FG000|Crossover Period|Other|0|||
156800367|NCT03110562|566023442|FG001|Crossover Period|Other|0|||
156800368|NCT03110562|566023443|FG002|Crossover Period|Other|1|||
156800369|NCT03110562|566023444|FG003|Crossover Period|Other|1|||
156800370|NCT03110562|566023441|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
156800371|NCT03110562|566023442|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
156800372|NCT03110562|566023443|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
156800373|NCT03110562|566023444|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
156800374|NCT05211596|566023447|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
156800375|NCT05211596|566023447|FG000|Baseline to 6 Months|Death|1|||
156800376|NCT05211596|566023447|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
156800377|NCT05211596|566023447|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
156800378|NCT02293551|566023448|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
156800379|NCT02293551|566023449|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
156800380|NCT02293551|566023450|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
156749287|NCT01006590|565831672|FG000|Overall Study|Adverse Event|2|||
156749288|NCT01006590|565831673|FG001|Overall Study|Adverse Event|3|||
156800381|NCT02293551|566023451|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
156800382|NCT02293551|566023452|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
156800383|NCT02293551|566023453|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
156800384|NCT02293551|566023448|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
156749289|NCT01006590|565831672|FG000|Overall Study|Death|1|||
156749290|NCT01006590|565831673|FG001|Overall Study|Death|1|||
156749291|NCT01006590|565831672|FG000|Overall Study|Lost to Follow-up|1|||
156749292|NCT01006590|565831673|FG001|Overall Study|Lost to Follow-up|1|||
156749293|NCT01006590|565831672|FG000|Overall Study|Protocol Violation|1|||
156749294|NCT01006590|565831673|FG001|Overall Study|Protocol Violation|0|||
156749295|NCT01006590|565831672|FG000|Overall Study|Withdrawal by Subject|4|||
156749296|NCT01006590|565831673|FG001|Overall Study|Withdrawal by Subject|2|||
156749297|NCT01006590|565831672|FG000|Overall Study|Study specific discontinuation criteria|16|||
156749298|NCT01006590|565831673|FG001|Overall Study|Study specific discontinuation criteria|23|||
156749299|NCT01006590|565831672|FG000|Overall Study|Other|3|||
156749300|NCT01006590|565831673|FG001|Overall Study|Other|2|||
156749301|NCT03332095|565831674|FG000|Overall Study|Lost to Follow-up|1|||
156749302|NCT03332095|565831675|FG001|Overall Study|Lost to Follow-up|0|||
156749303|NCT03332095|565831674|FG000|Overall Study|Pregnancy|0|||
156749304|NCT03332095|565831675|FG001|Overall Study|Pregnancy|1|||
156749305|NCT05697627|565831681|FG000|Overall Study|Adverse Event|1|||
156749306|NCT02722746|565831686|FG000|Overall Study|Withdrawal by Subject|0|||
156749307|NCT02722746|565831687|FG001|Overall Study|Withdrawal by Subject|1|||
156749308|NCT02722746|565831688|FG002|Overall Study|Withdrawal by Subject|0|||
156749309|NCT02722746|565831686|FG000|Overall Study|Protocol Violation|8|||
156749310|NCT02722746|565831687|FG001|Overall Study|Protocol Violation|4|||
156749311|NCT02722746|565831688|FG002|Overall Study|Protocol Violation|6|||
156749312|NCT01038752|565831693|FG000|Overall Study|Tumor Progression|2|||
156749313|NCT01038752|565831694|FG001|Overall Study|Tumor Progression|2|||
156749314|NCT01038752|565831693|FG000|Overall Study|Lost to Follow-up|3|||
156749315|NCT01038752|565831694|FG001|Overall Study|Lost to Follow-up|3|||
156749316|NCT02700698|565831697|FG000|Overall Study|Withdrawal by Subject|1|||
156749317|NCT02700698|565831698|FG001|Overall Study|Withdrawal by Subject|0|||
156749318|NCT00703118|565831699|FG000|Overall Study|Adverse Event|1|||
156749319|NCT00703118|565831700|FG001|Overall Study|Adverse Event|2|||
156749320|NCT00703118|565831701|FG002|Overall Study|Adverse Event|2|||
156749321|NCT00703118|565831699|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
156749322|NCT00703118|565831700|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
156749323|NCT00703118|565831701|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
156749324|NCT00703118|565831699|FG000|Overall Study|Lost to Follow-up|6|||
156749325|NCT00703118|565831700|FG001|Overall Study|Lost to Follow-up|4|||
156749326|NCT00703118|565831701|FG002|Overall Study|Lost to Follow-up|4|||
156749327|NCT00703118|565831699|FG000|Overall Study|Withdrawal by Subject|8|||
156749328|NCT00703118|565831700|FG001|Overall Study|Withdrawal by Subject|7|||
156749329|NCT00703118|565831701|FG002|Overall Study|Withdrawal by Subject|13|||
156749330|NCT00703118|565831699|FG000|Overall Study|Other|0|||
156749331|NCT00703118|565831700|FG001|Overall Study|Other|0|||
156749332|NCT00703118|565831701|FG002|Overall Study|Other|1|||
156749333|NCT04165135|565831704|FG000|Overall Study|Protocol Violation|10|||
156749334|NCT04165135|565831704|FG000|Overall Study|Participants withdrawal of consent|5|||
156749335|NCT05053035|565831711|FG000|Overall Study|Withdrawal by Subject|1|||
156749336|NCT05053035|565831712|FG001|Overall Study|Withdrawal by Subject|0|||
156749337|NCT02243046|565831715|FG000|Overall Study|Lost to Follow-up|1|||
156749338|NCT02243046|565831716|FG001|Overall Study|Lost to Follow-up|1|||
156749339|NCT02243046|565831717|FG002|Overall Study|Lost to Follow-up|4|||
156749340|NCT00762034|565833504|FG000|Induction Period|Protocol Violation|1|||
156749341|NCT00762034|565833505|FG001|Induction Period|Protocol Violation|2|||
156749342|NCT00762034|565833504|FG000|Induction Period|Entry Criterion Not Met|12|||
156749343|NCT00762034|565833505|FG001|Induction Period|Entry Criterion Not Met|11|||
156749344|NCT00762034|565833504|FG000|Induction Period|Adverse Event|27|||
156749345|NCT00762034|565833505|FG001|Induction Period|Adverse Event|38|||
156800385|NCT02293551|566023449|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
156800386|NCT02293551|566023450|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
156800387|NCT02293551|566023451|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
156800388|NCT02293551|566023452|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
156800389|NCT02293551|566023453|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
156800390|NCT02293551|566023448|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800391|NCT02293551|566023449|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800392|NCT02293551|566023450|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800393|NCT02293551|566023451|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
157220967|NCT00585351|567554934|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
156749346|NCT00762034|565833504|FG000|Induction Period|Lost to Follow-up|1|||
156749347|NCT00762034|565833505|FG001|Induction Period|Lost to Follow-up|1|||
156749348|NCT00762034|565833504|FG000|Induction Period|Progressive Disease|73|||
156749349|NCT00762034|565833505|FG001|Induction Period|Progressive Disease|55|||
156749350|NCT00762034|565833504|FG000|Induction Period|Physician Decision|21|||
156749351|NCT00762034|565833505|FG001|Induction Period|Physician Decision|20|||
156749352|NCT00762034|565833504|FG000|Induction Period|Withdrawal by Subject|15|||
156800394|NCT02293551|566023452|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
156800395|NCT02293551|566023453|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
156749353|NCT00762034|565833505|FG001|Induction Period|Withdrawal by Subject|19|||
156749354|NCT00762034|565833504|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
156749355|NCT00762034|565833505|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
156749356|NCT00762034|565833504|FG000|Induction Period|Deaths Due to Study Disease|9|||
156749357|NCT00762034|565833505|FG001|Induction Period|Deaths Due to Study Disease|9|||
156749358|NCT00762034|565833504|FG000|Maintenance Period|Protocol Violation|1|||
156749359|NCT00762034|565833505|FG001|Maintenance Period|Protocol Violation|3|||
156749360|NCT00762034|565833504|FG000|Maintenance Period|Entry Criterion Not Met|0|||
156749361|NCT00762034|565833505|FG001|Maintenance Period|Entry Criterion Not Met|2|||
156749362|NCT00762034|565833504|FG000|Maintenance Period|Adverse Event|42|||
156749363|NCT00762034|565833505|FG001|Maintenance Period|Adverse Event|26|||
156749364|NCT00762034|565833504|FG000|Maintenance Period|Progressive Disease|186|||
156749365|NCT00762034|565833505|FG001|Maintenance Period|Progressive Disease|224|||
156749366|NCT00762034|565833504|FG000|Maintenance Period|Physician Decision|25|||
156749367|NCT00762034|565833505|FG001|Maintenance Period|Physician Decision|20|||
156749368|NCT00762034|565833504|FG000|Maintenance Period|Withdrawal by Subject|34|||
156749369|NCT00762034|565833505|FG001|Maintenance Period|Withdrawal by Subject|14|||
156749370|NCT00762034|565833504|FG000|Maintenance Period|Death not due to study disease|2|||
156749371|NCT00762034|565833505|FG001|Maintenance Period|Death not due to study disease|5|||
156749372|NCT00762034|565833504|FG000|Maintenance Period|Death due to study disease|3|||
156749373|NCT00762034|565833505|FG001|Maintenance Period|Death due to study disease|3|||
156749374|NCT00762034|565833504|FG000|Maintenance Period|Other|1|||
156749375|NCT00762034|565833505|FG001|Maintenance Period|Other|1|||
156749376|NCT00497146|565833506|FG000|Treatment Period|Adverse Event|6|||
156749377|NCT00497146|565833507|FG001|Treatment Period|Adverse Event|2|||
156749378|NCT00497146|565833506|FG000|Treatment Period|Withdrawal by Subject|5|||
156749379|NCT00497146|565833507|FG001|Treatment Period|Withdrawal by Subject|9|||
156749380|NCT00497146|565833506|FG000|Treatment Period|Lost to Follow-up|1|||
156749381|NCT00497146|565833507|FG001|Treatment Period|Lost to Follow-up|3|||
156749382|NCT00497146|565833506|FG000|Treatment Period|Required dialysis|4|||
156749383|NCT00497146|565833507|FG001|Treatment Period|Required dialysis|1|||
156749384|NCT00497146|565833506|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
156749385|NCT00497146|565833507|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
156749386|NCT00497146|565833506|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
156749387|NCT00497146|565833507|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
156749388|NCT00497146|565833506|FG000|Treatment Period|Other Reason|2|||
156749389|NCT00497146|565833507|FG001|Treatment Period|Other Reason|3|||
156749390|NCT00497146|565833506|FG000|Long-term Follow-up Period|Adverse Event|2|||
156749391|NCT00497146|565833507|FG001|Long-term Follow-up Period|Adverse Event|2|||
156749392|NCT00497146|565833506|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
156749393|NCT00497146|565833507|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
156749394|NCT00497146|565833506|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
156749395|NCT00497146|565833507|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
156749396|NCT00497146|565833506|FG000|Long-term Follow-up Period|Other|0|||
156749397|NCT00497146|565833507|FG001|Long-term Follow-up Period|Other|1|||
156749398|NCT04571385|565833510|FG000|Overall Study|Participant non-compliance|1|||
156749399|NCT04571385|565833511|FG001|Overall Study|Participant non-compliance|0|||
156749400|NCT04571385|565833512|FG002|Overall Study|Participant non-compliance|0|||
156749401|NCT04571385|565833510|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
156749402|NCT04571385|565833511|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
156749403|NCT04571385|565833512|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
156749404|NCT04571385|565833510|FG000|Overall Study|Screen failure|0|||
156749405|NCT04571385|565833511|FG001|Overall Study|Screen failure|0|||
156749406|NCT04571385|565833512|FG002|Overall Study|Screen failure|1|||
156749407|NCT02499263|565833513|FG000|Overall Study|Lost to Follow-up|9|||
156749408|NCT02499263|565833513|FG000|Overall Study|Participant's withdrawal of consent|4|||
156749409|NCT02499263|565833513|FG000|Overall Study|Lack of Efficacy|22|||
156749410|NCT02499263|565833513|FG000|Overall Study|investigator's judgment|12|||
156749411|NCT02499263|565833513|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
156749412|NCT02499263|565833513|FG000|Overall Study|Participant's decision|3|||
156749413|NCT02499263|565833513|FG000|Overall Study|Pregnancy|1|||
156749414|NCT00424593|565833514|FG000|Acute Double-Blind Period|Adverse Event|16|||
156749415|NCT00424593|565833515|FG001|Acute Double-Blind Period|Adverse Event|7|||
156749416|NCT00424593|565833514|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
156749417|NCT00424593|565833515|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
156749418|NCT00424593|565833514|FG000|Acute Double-Blind Period|Protocol Violation|2|||
156749419|NCT00424593|565833515|FG001|Acute Double-Blind Period|Protocol Violation|2|||
156749420|NCT00424593|565833514|FG000|Acute Double-Blind Period|Physician Decision|1|||
156749421|NCT00424593|565833515|FG001|Acute Double-Blind Period|Physician Decision|2|||
156749422|NCT00424593|565833514|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
156749423|NCT00424593|565833515|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
156749424|NCT00424593|565833514|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
156749425|NCT00424593|565833515|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
157143722|NCT02192359|567274290|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
157143723|NCT02192359|567274287|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
157143724|NCT02192359|567274288|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
157143725|NCT02192359|567274289|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
157143726|NCT02192359|567274290|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
157143727|NCT00828451|567274291|FG000|Overall Study|Death|2|||
157143728|NCT00828451|567274291|FG000|Overall Study|Lack of intravenous line|7|||
157143729|NCT00828451|567274291|FG000|Overall Study|Withdrawal by Subject|1|||
156881124|NCT00717236|566325397|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
156881125|NCT00717236|566325398|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
156881126|NCT00717236|566325397|FG000|Double-Blind Period|Other: Subject moved|1|||
156881127|NCT00717236|566325398|FG001|Double-Blind Period|Other: Subject moved|1|||
156881128|NCT00717236|566325397|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
156881129|NCT00717236|566325398|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
156881130|NCT00717236|566325397|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
156881131|NCT00717236|566325398|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
156881132|NCT00717236|566325397|FG000|Double-Blind Period|Other: Transportation problems|0|||
156881133|NCT00717236|566325398|FG001|Double-Blind Period|Other: Transportation problems|1|||
156881134|NCT00717236|566325397|FG000|Double-Blind Period|Other: Investigator Decision|0|||
156881135|NCT00717236|566325398|FG001|Double-Blind Period|Other: Investigator Decision|1|||
156881136|NCT00717236|566325397|FG000|Open-Label Period|Adverse Event|29|||
156881137|NCT00717236|566325398|FG001|Open-Label Period|Adverse Event|4|||
156881138|NCT00717236|566325397|FG000|Open-Label Period|Lack of Efficacy|30|||
156881139|NCT00717236|566325398|FG001|Open-Label Period|Lack of Efficacy|8|||
156881140|NCT00717236|566325397|FG000|Open-Label Period|Lost to Follow-up|28|||
156881141|NCT00717236|566325398|FG001|Open-Label Period|Lost to Follow-up|4|||
156881142|NCT00717236|566325397|FG000|Open-Label Period|Withdrawal by Subject|20|||
156881143|NCT00717236|566325398|FG001|Open-Label Period|Withdrawal by Subject|2|||
156881144|NCT00717236|566325397|FG000|Open-Label Period|Loss of Efficacy|6|||
156881145|NCT00717236|566325398|FG001|Open-Label Period|Loss of Efficacy|1|||
156881146|NCT00717236|566325397|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
156881147|NCT00717236|566325398|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
156881148|NCT00717236|566325397|FG000|Open-Label Period|Other: Lack of Compliance|1|||
156881149|NCT00717236|566325398|FG001|Open-Label Period|Other: Lack of Compliance|1|||
156881150|NCT00717236|566325397|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
156881151|NCT00717236|566325398|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
156881152|NCT00717236|566325397|FG000|Open-Label Period|Other: Moved|1|||
156881153|NCT00717236|566325398|FG001|Open-Label Period|Other: Moved|0|||
156881154|NCT00717236|566325397|FG000|Open-Label Period|Other: Investigator Decision|1|||
156881155|NCT00717236|566325398|FG001|Open-Label Period|Other: Investigator Decision|0|||
156881156|NCT00717236|566325397|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
156881157|NCT00717236|566325398|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
156881158|NCT00717236|566325397|FG000|Open-Label Period|Other: Sponsor Request|3|||
156881159|NCT00717236|566325398|FG001|Open-Label Period|Other: Sponsor Request|0|||
156881160|NCT00717236|566325397|FG000|Open-Label Period|Other: Cataract Surgery|1|||
156881161|NCT00717236|566325398|FG001|Open-Label Period|Other: Cataract Surgery|0|||
156881162|NCT00717236|566325397|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
156881163|NCT00717236|566325398|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
156881164|NCT00717236|566325397|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
156881165|NCT00717236|566325398|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
156881166|NCT00717236|566325397|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
156881167|NCT00717236|566325398|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
156881168|NCT00743106|566325399|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
156881169|NCT00743106|566325400|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
156881170|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
156881171|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156881172|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156881173|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
156881174|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Death|3|||
156881175|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Death|0|||
156881176|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Death|0|||
156881177|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Death|0|||
156881178|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
156881179|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
156881180|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
156881181|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
157143730|NCT00828451|567274291|FG000|Overall Study|Deterioration in clinical status|1|||
157143731|NCT03914300|567274293|FG000|Overall Study|Adverse Event|1|||
157143732|NCT00624338|567274297|FG000|Overall Study|Adverse Event|14|||
157020813|NCT03269136|566828511|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
157020814|NCT03269136|566828512|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
157020815|NCT03269136|566828513|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020816|NCT03269136|566828514|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
157143733|NCT00624338|567274298|FG001|Overall Study|Adverse Event|14|||
157020817|NCT03269136|566828515|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157020818|NCT03269136|566828498|FG000|Part 2A: Dose Expansion|Other|0|||
157020819|NCT03269136|566828499|FG001|Part 2A: Dose Expansion|Other|0|||
157020820|NCT03269136|566828500|FG002|Part 2A: Dose Expansion|Other|0|||
157020821|NCT03269136|566828501|FG003|Part 2A: Dose Expansion|Other|0|||
157020822|NCT03269136|566828502|FG004|Part 2A: Dose Expansion|Other|0|||
157020823|NCT03269136|566828503|FG005|Part 2A: Dose Expansion|Other|0|||
157020824|NCT03269136|566828504|FG006|Part 2A: Dose Expansion|Other|0|||
157020825|NCT03269136|566828505|FG007|Part 2A: Dose Expansion|Other|0|||
157020826|NCT03269136|566828506|FG008|Part 2A: Dose Expansion|Other|0|||
157020827|NCT03269136|566828507|FG009|Part 2A: Dose Expansion|Other|0|||
157020828|NCT03269136|566828508|FG010|Part 2A: Dose Expansion|Other|0|||
157020829|NCT03269136|566828509|FG011|Part 2A: Dose Expansion|Other|0|||
157020830|NCT03269136|566828510|FG012|Part 2A: Dose Expansion|Other|0|||
157020831|NCT03269136|566828511|FG013|Part 2A: Dose Expansion|Other|0|||
157020832|NCT03269136|566828512|FG014|Part 2A: Dose Expansion|Other|0|||
157020833|NCT03269136|566828513|FG015|Part 2A: Dose Expansion|Other|0|||
157020834|NCT03269136|566828514|FG016|Part 2A: Dose Expansion|Other|0|||
157020835|NCT03269136|566828515|FG017|Part 2A: Dose Expansion|Other|1|||
157020836|NCT03269136|566828498|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020837|NCT03269136|566828499|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157143734|NCT00624338|567274299|FG002|Overall Study|Adverse Event|18|||
157143735|NCT00624338|567274297|FG000|Overall Study|Lost to Follow-up|1|||
157143736|NCT00624338|567274298|FG001|Overall Study|Lost to Follow-up|0|||
157143737|NCT00624338|567274299|FG002|Overall Study|Lost to Follow-up|0|||
157143738|NCT00624338|567274297|FG000|Overall Study|Lack of Efficacy|11|||
157143739|NCT00624338|567274298|FG001|Overall Study|Lack of Efficacy|3|||
157143740|NCT00624338|567274299|FG002|Overall Study|Lack of Efficacy|14|||
157143741|NCT00624338|567274297|FG000|Overall Study|Protocol Violation|3|||
157143742|NCT00624338|567274298|FG001|Overall Study|Protocol Violation|3|||
157143743|NCT00624338|567274299|FG002|Overall Study|Protocol Violation|2|||
157143744|NCT00624338|567274297|FG000|Overall Study|Death|0|||
157143745|NCT00624338|567274298|FG001|Overall Study|Death|2|||
157143746|NCT00624338|567274299|FG002|Overall Study|Death|0|||
157143747|NCT00624338|567274297|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
157143748|NCT00624338|567274298|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
157143749|NCT00624338|567274299|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
157143750|NCT00624338|567274297|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
157143751|NCT00624338|567274298|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
157143752|NCT00624338|567274299|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
157143753|NCT00624338|567274297|FG000|Overall Study|Other|15|||
157143754|NCT00624338|567274298|FG001|Overall Study|Other|5|||
157143755|NCT00624338|567274299|FG002|Overall Study|Other|9|||
157143756|NCT00624338|567274297|FG000|Overall Study|Randomized but not treated|2|||
157143757|NCT00624338|567274298|FG001|Overall Study|Randomized but not treated|1|||
157143758|NCT00624338|567274299|FG002|Overall Study|Randomized but not treated|3|||
156749426|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
156749427|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
156749428|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Adverse Event|18|||
156749429|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Adverse Event|0|||
156749430|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
156749431|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
156749432|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
156749433|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
156749434|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
156749435|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
156881182|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
156749436|NCT00424593|565833514|FG000|Dose-Blind Extension Period|Physician Decision|3|||
156749437|NCT00424593|565833515|FG001|Dose-Blind Extension Period|Physician Decision|0|||
156749438|NCT02496039|565833516|FG000|Overall Study|Adverse Event|3|||
156749439|NCT02496039|565833516|FG000|Overall Study|Protocol Violation|1|||
156749440|NCT00255840|565833517|FG000|Overall Study|Lost to Follow-up|10|||
157143759|NCT04358458|567274312|FG000|Overall Study|Death|1|||
157143760|NCT04358458|567274313|FG001|Overall Study|Death|1|||
157143761|NCT04358458|567274314|FG002|Overall Study|Death|3|||
156749441|NCT00255840|565833518|FG001|Overall Study|Lost to Follow-up|14|||
157020838|NCT03269136|566828500|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020839|NCT03269136|566828501|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020840|NCT03269136|566828502|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020841|NCT03269136|566828503|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020842|NCT03269136|566828504|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020843|NCT03269136|566828505|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020844|NCT03269136|566828506|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020845|NCT03269136|566828507|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020846|NCT03269136|566828508|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020847|NCT03269136|566828509|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020848|NCT03269136|566828510|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020849|NCT03269136|566828511|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020850|NCT03269136|566828512|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020851|NCT03269136|566828513|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020852|NCT03269136|566828514|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
157020853|NCT03269136|566828515|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
157143762|NCT04358458|567274315|FG003|Overall Study|Death|8|||
157143763|NCT04358458|567274316|FG004|Overall Study|Death|1|||
156800396|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
157143764|NCT04358458|567274317|FG005|Overall Study|Death|6|||
156800397|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
156800398|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
156800399|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
156800400|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
156800401|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
156800402|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
156800403|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
156800404|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
156800405|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
156800406|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
156800407|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
156800408|NCT04532749|566023454|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
156800409|NCT04532749|566023455|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
156800410|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
156800411|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
156800412|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
156800413|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
156800414|NCT04532749|566023454|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
156800415|NCT04532749|566023455|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
156800416|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800417|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800418|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800419|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800420|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800421|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
156800422|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800423|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800424|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800425|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
156800426|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Death|2|||
156800427|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Death|1|||
156800428|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Death|3|||
156800429|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Death|1|||
156800430|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Death|2|||
156800431|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Death|3|||
156800432|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Death|3|||
156800433|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Death|0|||
156800434|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Death|0|||
156800435|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Death|0|||
156800436|NCT02936323|566023456|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800437|NCT02936323|566023457|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800438|NCT02936323|566023458|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800439|NCT02936323|566023459|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800440|NCT02936323|566023460|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800441|NCT02936323|566023461|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
156800442|NCT02936323|566023462|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
157020854|NCT03269136|566828498|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
157020855|NCT03269136|566828499|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
157143765|NCT04358458|567274318|FG006|Overall Study|Death|2|||
157143766|NCT04358458|567274319|FG007|Overall Study|Death|3|||
157143767|NCT04358458|567274312|FG000|Overall Study|Lost to Follow-up|0|||
156800443|NCT02936323|566023463|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800444|NCT02936323|566023464|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800445|NCT02936323|566023465|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
156800446|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156749442|NCT00255840|565833517|FG000|Overall Study|Discontinued intervention|53|||
156749443|NCT00255840|565833518|FG001|Overall Study|Discontinued intervention|56|||
156749444|NCT01005901|565833521|FG000|Overall Study|Withdrawal by Subject|38|||
156749445|NCT01005901|565833522|FG001|Overall Study|Withdrawal by Subject|14|||
156749446|NCT01005901|565833521|FG000|Overall Study|Adverse Event|30|||
156749447|NCT01005901|565833522|FG001|Overall Study|Adverse Event|16|||
156749448|NCT01005901|565833521|FG000|Overall Study|Administrative problems|21|||
156749449|NCT01005901|565833522|FG001|Overall Study|Administrative problems|13|||
156749450|NCT01005901|565833521|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156749451|NCT01005901|565833522|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
156749452|NCT01005901|565833521|FG000|Overall Study|Protocol Violation|4|||
156749453|NCT01005901|565833522|FG001|Overall Study|Protocol Violation|3|||
156749454|NCT01005901|565833521|FG000|Overall Study|Death|2|||
156749455|NCT01005901|565833522|FG001|Overall Study|Death|3|||
156749456|NCT01005901|565833521|FG000|Overall Study|Lost to Follow-up|1|||
156749457|NCT01005901|565833522|FG001|Overall Study|Lost to Follow-up|2|||
156749458|NCT01005901|565833521|FG000|Overall Study|Patient's inability to use the device|1|||
156749459|NCT01005901|565833522|FG001|Overall Study|Patient's inability to use the device|1|||
156749460|NCT01005901|565833521|FG000|Overall Study|No longer requires study drug|0|||
156749461|NCT01005901|565833522|FG001|Overall Study|No longer requires study drug|1|||
156749462|NCT00957424|565833523|FG000|Overall Study|Lost to Follow-up|19|||
156749463|NCT00957424|565833523|FG000|Overall Study|Protocol Violation|3|||
156749464|NCT00957424|565833523|FG000|Overall Study|Withdrawal by Subject|1|||
156749465|NCT00530790|565833528|FG000|Overall Study|Adverse Event|2|||
156749466|NCT00530790|565833528|FG000|Overall Study|Withdrawal by Subject|2|||
156749467|NCT00530790|565833528|FG000|Overall Study|Physician Decision|1|||
156749468|NCT00438256|565833529|FG000|Overall Study|Ineligible for Resection|2|||
156749469|NCT00438256|565833530|FG001|Overall Study|Ineligible for Resection|1|||
156749470|NCT00438256|565833531|FG002|Overall Study|Ineligible for Resection|1|||
156749471|NCT00438256|565833532|FG003|Overall Study|Ineligible for Resection|7|||
156749472|NCT00438256|565833529|FG000|Overall Study|Excluded final Diagnosis|0|||
156749473|NCT00438256|565833530|FG001|Overall Study|Excluded final Diagnosis|0|||
156749474|NCT00438256|565833531|FG002|Overall Study|Excluded final Diagnosis|0|||
156749475|NCT00438256|565833532|FG003|Overall Study|Excluded final Diagnosis|2|||
156749476|NCT02005627|565833533|FG000|Overall Study|Lost to Follow-up|1|||
156749477|NCT02005627|565833534|FG001|Overall Study|Lost to Follow-up|2|||
156749478|NCT02005627|565833533|FG000|Overall Study|Withdrawal by Subject|1|||
156749479|NCT02005627|565833534|FG001|Overall Study|Withdrawal by Subject|2|||
156749480|NCT00849290|565833538|FG000|Overall Study|Adverse Event|3|||
156749481|NCT00849290|565833538|FG000|Overall Study|Death|14|||
156749482|NCT00849290|565833538|FG000|Overall Study|Withdrawal by Subject|11|||
156749483|NCT00849290|565833538|FG000|Overall Study|Lost to Follow-up|2|||
156749484|NCT00849290|565833538|FG000|Overall Study|Protocol Violation|5|||
156749485|NCT00849290|565833538|FG000|Overall Study|Disease Progression|20|||
156749486|NCT00938587|565833539|FG000|Overall Study|Adverse Event|2|||
156749487|NCT00938587|565833540|FG001|Overall Study|Adverse Event|0|||
156749488|NCT00938587|565833541|FG002|Overall Study|Adverse Event|0|||
156749489|NCT00938587|565833542|FG003|Overall Study|Adverse Event|2|||
156749490|NCT00938587|565833539|FG000|Overall Study|Did not meet entrance criteria|0|||
156749491|NCT00938587|565833540|FG001|Overall Study|Did not meet entrance criteria|0|||
156749492|NCT00938587|565833541|FG002|Overall Study|Did not meet entrance criteria|1|||
156749493|NCT00938587|565833542|FG003|Overall Study|Did not meet entrance criteria|0|||
156749494|NCT00938587|565833539|FG000|Overall Study|Withdrawal by Subject|1|||
156749495|NCT00938587|565833540|FG001|Overall Study|Withdrawal by Subject|1|||
156749496|NCT00938587|565833541|FG002|Overall Study|Withdrawal by Subject|0|||
156749497|NCT00938587|565833542|FG003|Overall Study|Withdrawal by Subject|0|||
157020856|NCT03269136|566828500|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
157020857|NCT03269136|566828501|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
157020858|NCT03269136|566828502|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
157020859|NCT03269136|566828503|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
157020860|NCT03269136|566828504|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
157020861|NCT03269136|566828505|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
157020862|NCT03269136|566828506|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
156749498|NCT01464619|565833549|FG000|Overall Study|Lost to Follow-up|3|||
156749499|NCT01464619|565833550|FG001|Overall Study|Lost to Follow-up|4|||
156749500|NCT03913104|565833551|FG000|Overall Study|Lost to Follow-up|20|||
156749501|NCT03913104|565833551|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
156749502|NCT03913104|565833551|FG000|Overall Study|Withdrawal by Subject|2|||
156749503|NCT00048997|565833554|FG000|Overall Study|Protocol Violation|7|||
156749504|NCT00048997|565833555|FG001|Overall Study|Protocol Violation|2|||
156749505|NCT00048997|565833554|FG000|Overall Study|Withdrawal by Subject|6|||
156749506|NCT00048997|565833555|FG001|Overall Study|Withdrawal by Subject|1|||
156749507|NCT02819440|565833556|FG000|Overall Study|Adverse Event|3|||
156749508|NCT02819440|565833557|FG001|Overall Study|Adverse Event|1|||
156749509|NCT02819440|565833556|FG000|Overall Study|Lost to Follow-up|1|||
156749510|NCT02819440|565833557|FG001|Overall Study|Lost to Follow-up|3|||
157020863|NCT03269136|566828507|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
157143768|NCT04358458|567274313|FG001|Overall Study|Lost to Follow-up|0|||
157143769|NCT04358458|567274314|FG002|Overall Study|Lost to Follow-up|0|||
157143770|NCT04358458|567274315|FG003|Overall Study|Lost to Follow-up|0|||
157143771|NCT04358458|567274316|FG004|Overall Study|Lost to Follow-up|0|||
157143772|NCT04358458|567274317|FG005|Overall Study|Lost to Follow-up|0|||
157143773|NCT04358458|567274318|FG006|Overall Study|Lost to Follow-up|0|||
157143774|NCT04358458|567274319|FG007|Overall Study|Lost to Follow-up|1|||
157143775|NCT04358458|567274312|FG000|Overall Study|Site is closing study participation|0|||
157143776|NCT04358458|567274313|FG001|Overall Study|Site is closing study participation|0|||
157143777|NCT04358458|567274314|FG002|Overall Study|Site is closing study participation|0|||
157143778|NCT04358458|567274315|FG003|Overall Study|Site is closing study participation|1|||
157143779|NCT04358458|567274316|FG004|Overall Study|Site is closing study participation|0|||
157143780|NCT04358458|567274317|FG005|Overall Study|Site is closing study participation|0|||
157143781|NCT04358458|567274318|FG006|Overall Study|Site is closing study participation|0|||
157143782|NCT04358458|567274319|FG007|Overall Study|Site is closing study participation|0|||
157143783|NCT04358458|567274312|FG000|Overall Study|Sponsor request|2|||
157143784|NCT04358458|567274313|FG001|Overall Study|Sponsor request|3|||
157143785|NCT04358458|567274314|FG002|Overall Study|Sponsor request|3|||
157143786|NCT04358458|567274315|FG003|Overall Study|Sponsor request|0|||
157143787|NCT04358458|567274316|FG004|Overall Study|Sponsor request|2|||
157143788|NCT04358458|567274317|FG005|Overall Study|Sponsor request|3|||
157143789|NCT04358458|567274318|FG006|Overall Study|Sponsor request|1|||
157143790|NCT04358458|567274319|FG007|Overall Study|Sponsor request|1|||
157143791|NCT04358458|567274312|FG000|Overall Study|Withdrawal by Subject|0|||
157143792|NCT04358458|567274313|FG001|Overall Study|Withdrawal by Subject|0|||
157143793|NCT04358458|567274314|FG002|Overall Study|Withdrawal by Subject|1|||
157143794|NCT04358458|567274315|FG003|Overall Study|Withdrawal by Subject|1|||
156749511|NCT02819440|565833556|FG000|Overall Study|Withdrawal by Subject|9|||
156749512|NCT02819440|565833557|FG001|Overall Study|Withdrawal by Subject|8|||
156749513|NCT00002525|565833563|FG000|Overall Study|Adverse Event|36|||
156749514|NCT00002525|565833564|FG001|Overall Study|Adverse Event|0|||
156749515|NCT00002525|565833563|FG000|Overall Study|Death|5|||
156749516|NCT00002525|565833564|FG001|Overall Study|Death|0|||
156749517|NCT00002525|565833563|FG000|Overall Study|Withdrawal by Subject|11|||
156749518|NCT00002525|565833564|FG001|Overall Study|Withdrawal by Subject|0|||
156749519|NCT00002525|565833563|FG000|Overall Study|Start non-protocol therapy|1|||
156749520|NCT00002525|565833564|FG001|Overall Study|Start non-protocol therapy|0|||
156749521|NCT00002525|565833563|FG000|Overall Study|Other complicating disease|1|||
156749522|NCT00002525|565833564|FG001|Overall Study|Other complicating disease|0|||
156749523|NCT00002525|565833563|FG000|Overall Study|Duke's A, B1, D disease|92|||
156749524|NCT00002525|565833564|FG001|Overall Study|Duke's A, B1, D disease|0|||
156749525|NCT00002525|565833563|FG000|Overall Study|Error|6|||
156749526|NCT00002525|565833564|FG001|Overall Study|Error|0|||
156749527|NCT00002525|565833563|FG000|Overall Study|Other|26|||
156749528|NCT00002525|565833564|FG001|Overall Study|Other|0|||
156749529|NCT00002525|565833563|FG000|Overall Study|Never start protocol therapy|8|||
156749530|NCT00002525|565833564|FG001|Overall Study|Never start protocol therapy|0|||
156749531|NCT03304184|565833565|FG000|Overall Study|Withdrawal by Subject|1|||
156749532|NCT03304184|565833566|FG001|Overall Study|Withdrawal by Subject|2|||
156749533|NCT03420222|565833571|FG000|Overall Study|Withdrawal by Subject|5|||
156749534|NCT03420222|565833572|FG001|Overall Study|Withdrawal by Subject|0|||
156749535|NCT03420222|565833571|FG000|Overall Study|Physician Decision|0|||
156749536|NCT03420222|565833572|FG001|Overall Study|Physician Decision|1|||
156749537|NCT02112877|565833575|FG000|Overall Study|Withdrawal by Subject|1|||
156749538|NCT02112877|565833576|FG001|Overall Study|Withdrawal by Subject|7|||
156749539|NCT02112877|565833575|FG000|Overall Study|Visit Missed|1|||
156749540|NCT02112877|565833576|FG001|Overall Study|Visit Missed|6|||
156749541|NCT01578499|565833589|FG000|Overall Study|Reason not Specified|0|||
156749542|NCT01578499|565833590|FG001|Overall Study|Reason not Specified|1|||
156749543|NCT01578499|565833589|FG000|Overall Study|Lost to Follow-up|2|||
156749544|NCT01578499|565833590|FG001|Overall Study|Lost to Follow-up|1|||
157143795|NCT04358458|567274316|FG004|Overall Study|Withdrawal by Subject|0|||
156749545|NCT01578499|565833589|FG000|Overall Study|Withdrawal by Subject|10|||
156749546|NCT01578499|565833590|FG001|Overall Study|Withdrawal by Subject|16|||
156749547|NCT01578499|565833589|FG000|Overall Study|Death|20|||
156749548|NCT01578499|565833590|FG001|Overall Study|Death|25|||
156749549|NCT01578499|565833589|FG000|Overall Study|Died and End of Study Page not Completed|2|||
156749550|NCT01578499|565833590|FG001|Overall Study|Died and End of Study Page not Completed|0|||
156749551|NCT01606748|565833591|FG000|Overall Study|Adverse Event|1|||
156749552|NCT01606748|565833592|FG001|Overall Study|Adverse Event|0|||
157143796|NCT04358458|567274317|FG005|Overall Study|Withdrawal by Subject|1|||
157143797|NCT04358458|567274318|FG006|Overall Study|Withdrawal by Subject|0|||
157143798|NCT04358458|567274319|FG007|Overall Study|Withdrawal by Subject|1|||
157143799|NCT01843374|567276317|FG000|Overall Study|Death|155|||
157143800|NCT01843374|567276318|FG001|Overall Study|Death|313|||
157143801|NCT01843374|567276317|FG000|Overall Study|Withdrawal by Subject|14|||
157143802|NCT01843374|567276318|FG001|Overall Study|Withdrawal by Subject|20|||
157020864|NCT03269136|566828508|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
156749553|NCT01606748|565833591|FG000|Overall Study|Progressive Disease|1|||
156749554|NCT01606748|565833592|FG001|Overall Study|Progressive Disease|0|||
156749555|NCT01606748|565833591|FG000|Overall Study|Withdrawal by Subject|1|||
156749556|NCT01606748|565833592|FG001|Overall Study|Withdrawal by Subject|0|||
156749557|NCT01380691|565833593|FG000|Washout (7 Days)|Protocol Violation|0|||
156749558|NCT01380691|565833594|FG001|Washout (7 Days)|Protocol Violation|0|||
156749559|NCT01380691|565833595|FG002|Washout (7 Days)|Protocol Violation|0|||
156749560|NCT01380691|565833596|FG003|Washout (7 Days)|Protocol Violation|1|||
156749561|NCT01380691|565833593|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156749562|NCT01380691|565833594|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
156749563|NCT01380691|565833595|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
156749564|NCT01380691|565833596|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
156749565|NCT01952080|565833598|FG000|Overall Study|Withdrawal by Subject|0|||
156749566|NCT01952080|565833599|FG001|Overall Study|Withdrawal by Subject|0|||
156749567|NCT01952080|565833600|FG002|Overall Study|Withdrawal by Subject|0|||
156749568|NCT01952080|565833601|FG003|Overall Study|Withdrawal by Subject|1|||
156749569|NCT01952080|565833598|FG000|Overall Study|Protocol Non-compliance|0|||
156749570|NCT01952080|565833599|FG001|Overall Study|Protocol Non-compliance|1|||
156749571|NCT01952080|565833600|FG002|Overall Study|Protocol Non-compliance|0|||
156749572|NCT01952080|565833601|FG003|Overall Study|Protocol Non-compliance|0|||
156749573|NCT03426436|565833602|FG000|Overall Study|Incorrect lead placement|12|||
156749574|NCT03426436|565833602|FG000|Overall Study|Withdrawal by Subject|2|||
156749575|NCT03426436|565833602|FG000|Overall Study|Consent issue|1|||
156749576|NCT03426436|565833602|FG000|Overall Study|ECGs not saved|4|||
156749577|NCT00655681|565833603|FG000|Overall Study|Lost to Follow-up|1|||
156749578|NCT00655681|565833604|FG001|Overall Study|Lost to Follow-up|1|||
156749579|NCT04776018|565833606|FG000|Overall Study|Death|0|||
156749580|NCT04776018|565833607|FG001|Overall Study|Death|1|||
156749581|NCT04776018|565833608|FG002|Overall Study|Death|4|||
156749582|NCT04776018|565833609|FG003|Overall Study|Death|1|||
156749583|NCT04776018|565833610|FG004|Overall Study|Death|4|||
156749584|NCT04776018|565833611|FG005|Overall Study|Death|0|||
156749585|NCT04776018|565833612|FG006|Overall Study|Death|0|||
156749586|NCT04776018|565833606|FG000|Overall Study|Study terminated by sponsor|2|||
156749587|NCT04776018|565833607|FG001|Overall Study|Study terminated by sponsor|1|||
156749588|NCT04776018|565833608|FG002|Overall Study|Study terminated by sponsor|4|||
156749589|NCT04776018|565833609|FG003|Overall Study|Study terminated by sponsor|0|||
156749590|NCT04776018|565833610|FG004|Overall Study|Study terminated by sponsor|3|||
156749591|NCT04776018|565833611|FG005|Overall Study|Study terminated by sponsor|0|||
156749592|NCT04776018|565833612|FG006|Overall Study|Study terminated by sponsor|0|||
156749593|NCT04776018|565833606|FG000|Overall Study|Withdrawal by Subject|1|||
156749594|NCT04776018|565833607|FG001|Overall Study|Withdrawal by Subject|0|||
156749595|NCT04776018|565833608|FG002|Overall Study|Withdrawal by Subject|0|||
156749596|NCT04776018|565833609|FG003|Overall Study|Withdrawal by Subject|2|||
156749597|NCT04776018|565833610|FG004|Overall Study|Withdrawal by Subject|1|||
156749598|NCT04776018|565833611|FG005|Overall Study|Withdrawal by Subject|0|||
156881183|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156881184|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156881185|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
156881186|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
156881187|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
156881188|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
156881189|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
156881190|NCT00884741|566325406|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
156881191|NCT00884741|566325407|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156881192|NCT00884741|566325408|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156881193|NCT00884741|566325409|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
156881194|NCT00884741|566325406|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
156881195|NCT00884741|566325407|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
156881196|NCT00884741|566325408|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
157020865|NCT03269136|566828509|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
157020866|NCT03269136|566828510|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
157020867|NCT03269136|566828511|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
157020868|NCT03269136|566828512|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
157020869|NCT03269136|566828513|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
156749599|NCT04776018|565833612|FG006|Overall Study|Withdrawal by Subject|0|||
156749600|NCT04776018|565833606|FG000|Overall Study|Other|0|||
156749601|NCT04776018|565833607|FG001|Overall Study|Other|1|||
156749602|NCT04776018|565833608|FG002|Overall Study|Other|1|||
156749603|NCT04776018|565833609|FG003|Overall Study|Other|0|||
156749604|NCT04776018|565833610|FG004|Overall Study|Other|0|||
156749605|NCT04776018|565833611|FG005|Overall Study|Other|0|||
156749606|NCT04776018|565833612|FG006|Overall Study|Other|0|||
156749607|NCT04776018|565833606|FG000|Overall Study|Lost to Follow-up|0|||
156749608|NCT04776018|565833607|FG001|Overall Study|Lost to Follow-up|0|||
156749609|NCT04776018|565833608|FG002|Overall Study|Lost to Follow-up|1|||
156749610|NCT04776018|565833609|FG003|Overall Study|Lost to Follow-up|0|||
156749611|NCT04776018|565833610|FG004|Overall Study|Lost to Follow-up|0|||
156749612|NCT04776018|565833611|FG005|Overall Study|Lost to Follow-up|0|||
156749613|NCT04776018|565833612|FG006|Overall Study|Lost to Follow-up|0|||
156749614|NCT03417024|565833615|FG000|Overall Study|Study Termination prior to follow-up|11|||
156749615|NCT03417024|565833615|FG000|Overall Study|Physician Decision|2|||
156749616|NCT03168919|565833616|FG000|Overall Study|Withdrawal by Subject|2|||
156749617|NCT01085136|565833617|FG000|Part A|Other Adverse event|223|||
156749618|NCT01085136|565833618|FG001|Part A|Other Adverse event|0|||
156749619|NCT01085136|565833619|FG002|Part A|Other Adverse event|0|||
156749620|NCT01085136|565833617|FG000|Part A|Protocol Violation|3|||
156749621|NCT01085136|565833618|FG001|Part A|Protocol Violation|0|||
156749622|NCT01085136|565833619|FG002|Part A|Protocol Violation|0|||
156749623|NCT01085136|565833617|FG000|Part A|Lost to Follow-up|3|||
156749624|NCT01085136|565833618|FG001|Part A|Lost to Follow-up|0|||
156749625|NCT01085136|565833619|FG002|Part A|Lost to Follow-up|0|||
156749626|NCT01085136|565833617|FG000|Part A|Refusal to continue trial medication|64|||
156749627|NCT01085136|565833618|FG001|Part A|Refusal to continue trial medication|0|||
156749628|NCT01085136|565833619|FG002|Part A|Refusal to continue trial medication|0|||
156749629|NCT01085136|565833617|FG000|Part A|Other reason not defined above|30|||
156749630|NCT01085136|565833618|FG001|Part A|Other reason not defined above|0|||
156749631|NCT01085136|565833619|FG002|Part A|Other reason not defined above|0|||
156749632|NCT01085136|565833617|FG000|Part B|Other AE|0|||
156749633|NCT01085136|565833618|FG001|Part B|Other AE|29|||
156749634|NCT01085136|565833619|FG002|Part B|Other AE|8|||
156749635|NCT01085136|565833617|FG000|Part B|Refusal to continue trial medication|0|||
156749636|NCT01085136|565833618|FG001|Part B|Refusal to continue trial medication|12|||
156749637|NCT01085136|565833619|FG002|Part B|Refusal to continue trial medication|7|||
156749638|NCT01085136|565833617|FG000|Part B|Not treated|0|||
156749639|NCT01085136|565833618|FG001|Part B|Not treated|4|||
156749640|NCT01085136|565833619|FG002|Part B|Not treated|8|||
156749641|NCT01085136|565833617|FG000|Part B|Other reason not defined above|0|||
156749642|NCT01085136|565833618|FG001|Part B|Other reason not defined above|6|||
156749643|NCT01085136|565833619|FG002|Part B|Other reason not defined above|3|||
156749644|NCT02195427|565833620|FG000|Overall Study|Did not consent to study extension|13|||
156749645|NCT02195427|565833621|FG001|Overall Study|Did not consent to study extension|9|||
156749646|NCT02195427|565833620|FG000|Overall Study|Withdrawal by Subject|4|||
156749647|NCT02195427|565833621|FG001|Overall Study|Withdrawal by Subject|2|||
156749648|NCT02195427|565833620|FG000|Overall Study|Lost to Follow-up|0|||
156749649|NCT02195427|565833621|FG001|Overall Study|Lost to Follow-up|1|||
156749650|NCT02195427|565833620|FG000|Overall Study|Protocol Violation|7|||
156749651|NCT02195427|565833621|FG001|Overall Study|Protocol Violation|14|||
156749652|NCT02195427|565833620|FG000|Overall Study|Conditional re-treatment at W52|2|||
156749653|NCT02195427|565833621|FG001|Overall Study|Conditional re-treatment at W52|1|||
156749654|NCT01210144|565833625|FG000|Overall Study|Lack of ovarian response|1|||
156749655|NCT01210144|565833626|FG001|Overall Study|Lack of ovarian response|0|||
156749656|NCT01210144|565833625|FG000|Overall Study|No fertilization|1|||
156749657|NCT01210144|565833626|FG001|Overall Study|No fertilization|0|||
156749658|NCT01210144|565833625|FG000|Overall Study|No transfer|1|||
156749659|NCT01210144|565833626|FG001|Overall Study|No transfer|0|||
156749660|NCT00386425|565833627|FG000|Overall Study|Physician Decision|3|||
156749661|NCT00386425|565833628|FG001|Overall Study|Physician Decision|0|||
156749662|NCT00386425|565833629|FG002|Overall Study|Physician Decision|0|||
156749663|NCT00386425|565833627|FG000|Overall Study|Withdrawal by Subject|0|||
156749664|NCT00386425|565833628|FG001|Overall Study|Withdrawal by Subject|1|||
156749665|NCT00386425|565833629|FG002|Overall Study|Withdrawal by Subject|0|||
156749666|NCT02655419|565833630|FG000|Overall Study|Enrolled but not treated|1|||
156749667|NCT02655419|565833631|FG001|Overall Study|Enrolled but not treated|5|||
156749668|NCT02655419|565833630|FG000|Overall Study|Withdrawal by Subject|4|||
156749669|NCT02655419|565833631|FG001|Overall Study|Withdrawal by Subject|1|||
156749670|NCT02655419|565833630|FG000|Overall Study|Other|0|||
156749671|NCT02655419|565833631|FG001|Overall Study|Other|1|||
156749672|NCT04226495|565833635|FG000|Overall Study|Withdrawal by Subject|3|||
156749673|NCT04226495|565833636|FG001|Overall Study|Withdrawal by Subject|3|||
156749674|NCT04226495|565833635|FG000|Overall Study|PI discretion|3|||
156749675|NCT04226495|565833636|FG001|Overall Study|PI discretion|4|||
156749676|NCT02440854|565833637|FG000|Overall Study|Relocation of patient|1|||
156749677|NCT02440854|565833637|FG000|Overall Study|Death|6|||
156749678|NCT02440854|565833637|FG000|Overall Study|Lost to Follow-up|10|||
156749679|NCT02440854|565833637|FG000|Overall Study|Afatinib discontinuation|46|||
156749680|NCT02440854|565833637|FG000|Overall Study|stopped study at earlier timepoint|14|||
157220968|NCT00585351|567554935|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
156749681|NCT02440854|565833637|FG000|Overall Study|Study medication not received|1|||
156749682|NCT02440854|565833637|FG000|Overall Study|Violation of inclusion criteria|2|||
156749683|NCT00660595|565835074|FG000|Overall Study|Lost to Follow-up|0|||
157220969|NCT00585351|567554936|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
156749684|NCT00660595|565835075|FG001|Overall Study|Lost to Follow-up|1|||
156749685|NCT00660595|565835074|FG000|Overall Study|Did not consent to participate in study|12|||
156749686|NCT00660595|565835075|FG001|Overall Study|Did not consent to participate in study|8|||
156749687|NCT00660595|565835074|FG000|Overall Study|Participant left hospital|1|||
156749688|NCT00660595|565835075|FG001|Overall Study|Participant left hospital|0|||
156749689|NCT00660595|565835074|FG000|Overall Study|Non Specified reasons|5|||
156749690|NCT00660595|565835075|FG001|Overall Study|Non Specified reasons|0|||
156749691|NCT01148459|565835076|FG000|Overall Study|Serious Adverse Event|5|||
156749692|NCT01148459|565835077|FG001|Overall Study|Serious Adverse Event|4|||
156749693|NCT01148459|565835076|FG000|Overall Study|Withdrawal by Subject|1|||
156749694|NCT01148459|565835077|FG001|Overall Study|Withdrawal by Subject|0|||
156749695|NCT01148459|565835076|FG000|Overall Study|Migrated/moved from study area|3|||
156749696|NCT01148459|565835077|FG001|Overall Study|Migrated/moved from study area|6|||
156749697|NCT01148459|565835076|FG000|Overall Study|Lost to Follow-up|2|||
156749698|NCT01148459|565835077|FG001|Overall Study|Lost to Follow-up|0|||
156749699|NCT01148459|565835076|FG000|Overall Study|Refusal|1|||
156749700|NCT01148459|565835077|FG001|Overall Study|Refusal|0|||
156749701|NCT01148459|565835076|FG000|Overall Study|Failure to comply with study procedures|0|||
156749702|NCT01148459|565835077|FG001|Overall Study|Failure to comply with study procedures|1|||
156749703|NCT03077607|565835078|FG000|Period 1 (15 Days)|Adverse Event|1|||
156749704|NCT03077607|565835079|FG001|Period 1 (15 Days)|Adverse Event|0|||
156749705|NCT03077607|565835078|FG000|Period 1 (15 Days)|Death|1|||
156749706|NCT03077607|565835079|FG001|Period 1 (15 Days)|Death|0|||
156749707|NCT03077607|565835078|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
156749708|NCT03077607|565835079|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
156749709|NCT03077607|565835078|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
156749710|NCT03077607|565835079|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
156749711|NCT00080483|565835080|FG000|Overall Study|Lost to Follow-up|1|||
156749712|NCT00080483|565835081|FG001|Overall Study|Lost to Follow-up|1|||
156749713|NCT00080483|565835080|FG000|Overall Study|Physician Decision|1|||
156749714|NCT00080483|565835081|FG001|Overall Study|Physician Decision|1|||
156749715|NCT01119846|565835084|FG000|Overall Study|Adverse Event|1|||
156749716|NCT01119846|565835085|FG001|Overall Study|Adverse Event|0|||
156749717|NCT01119846|565835086|FG002|Overall Study|Adverse Event|6|||
156749718|NCT01119846|565835084|FG000|Overall Study|Physician Decision|1|||
156749719|NCT01119846|565835085|FG001|Overall Study|Physician Decision|0|||
156749720|NCT01119846|565835086|FG002|Overall Study|Physician Decision|0|||
156749721|NCT01119846|565835084|FG000|Overall Study|Protocol Violation|0|||
156749722|NCT01119846|565835085|FG001|Overall Study|Protocol Violation|0|||
156749723|NCT01119846|565835086|FG002|Overall Study|Protocol Violation|1|||
156749724|NCT01119846|565835084|FG000|Overall Study|Withdrawal by Subject|0|||
156749725|NCT01119846|565835085|FG001|Overall Study|Withdrawal by Subject|0|||
156749726|NCT01119846|565835086|FG002|Overall Study|Withdrawal by Subject|4|||
156749727|NCT01404949|565835087|FG000|Overall Study|Not Treated|1|||
156749728|NCT02334384|565835088|FG000|Overall Study|Lost to Follow-up|1|||
156749729|NCT02334384|565835089|FG001|Overall Study|Lost to Follow-up|1|||
156749730|NCT02651688|565835090|FG000|Overall Study|Non-compliance|0|||
156749731|NCT02651688|565835091|FG001|Overall Study|Non-compliance|0|||
156749732|NCT02651688|565835092|FG002|Overall Study|Non-compliance|1|||
156749733|NCT02651688|565835090|FG000|Overall Study|Principal Investigator (PI) decision|0|||
156881197|NCT00884741|566325409|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
156881198|NCT00884741|566325406|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
156881199|NCT00884741|566325407|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
156881200|NCT00884741|566325408|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
156881201|NCT00884741|566325409|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
156881202|NCT00884741|566325406|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
156881203|NCT00884741|566325407|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
156881204|NCT00884741|566325408|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
156881205|NCT00884741|566325409|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
157143803|NCT01843374|567276317|FG000|Overall Study|Withdrawing due to Other reason|20|||
157143804|NCT01843374|567276318|FG001|Overall Study|Withdrawing due to Other reason|46|||
157143805|NCT01826214|567276319|FG000|Overall Study|Adverse Event|7|||
157143806|NCT01826214|567276320|FG001|Overall Study|Adverse Event|6|||
157143807|NCT01826214|567276319|FG000|Overall Study|Death|3|||
156749734|NCT02651688|565835091|FG001|Overall Study|Principal Investigator (PI) decision|2|||
156749735|NCT02651688|565835092|FG002|Overall Study|Principal Investigator (PI) decision|0|||
156749736|NCT02651688|565835090|FG000|Overall Study|Lost to Follow-up|1|||
156749737|NCT02651688|565835091|FG001|Overall Study|Lost to Follow-up|3|||
156749738|NCT02651688|565835092|FG002|Overall Study|Lost to Follow-up|0|||
156749739|NCT02651688|565835090|FG000|Overall Study|Withdrawal by Subject|1|||
156749740|NCT02651688|565835091|FG001|Overall Study|Withdrawal by Subject|0|||
156749741|NCT02651688|565835092|FG002|Overall Study|Withdrawal by Subject|2|||
156749742|NCT00625183|565835093|FG000|Overall Study|Disease Progression|1|||
157143808|NCT01826214|567276320|FG001|Overall Study|Death|1|||
157143809|NCT01826214|567276319|FG000|Overall Study|Lost to Follow-up|1|||
157143810|NCT01826214|567276320|FG001|Overall Study|Lost to Follow-up|0|||
156749743|NCT01863732|565835094|FG000|Overall Study|Adverse Event|2|||
156749744|NCT01863732|565835095|FG001|Overall Study|Adverse Event|0|||
156749745|NCT01863732|565835096|FG002|Overall Study|Adverse Event|3|||
156749746|NCT01863732|565835097|FG003|Overall Study|Adverse Event|3|||
156749747|NCT01863732|565835094|FG000|Overall Study|Lack of Efficacy|1|||
156749748|NCT01863732|565835095|FG001|Overall Study|Lack of Efficacy|0|||
156749749|NCT01863732|565835096|FG002|Overall Study|Lack of Efficacy|2|||
156749750|NCT01863732|565835097|FG003|Overall Study|Lack of Efficacy|1|||
156749751|NCT01863732|565835094|FG000|Overall Study|Lost to Follow-up|2|||
156749752|NCT01863732|565835095|FG001|Overall Study|Lost to Follow-up|2|||
156749753|NCT01863732|565835096|FG002|Overall Study|Lost to Follow-up|1|||
156749754|NCT01863732|565835097|FG003|Overall Study|Lost to Follow-up|1|||
156749755|NCT01863732|565835094|FG000|Overall Study|Physician Decision|1|||
156749756|NCT01863732|565835095|FG001|Overall Study|Physician Decision|0|||
156749757|NCT01863732|565835096|FG002|Overall Study|Physician Decision|1|||
156749758|NCT01863732|565835097|FG003|Overall Study|Physician Decision|0|||
156749759|NCT01863732|565835094|FG000|Overall Study|Pregnancy|0|||
156749760|NCT01863732|565835095|FG001|Overall Study|Pregnancy|0|||
156749761|NCT01863732|565835096|FG002|Overall Study|Pregnancy|0|||
156749762|NCT01863732|565835097|FG003|Overall Study|Pregnancy|1|||
156749763|NCT01863732|565835094|FG000|Overall Study|Technical problems|0|||
156749764|NCT01863732|565835095|FG001|Overall Study|Technical problems|1|||
156749765|NCT01863732|565835096|FG002|Overall Study|Technical problems|1|||
156749766|NCT01863732|565835097|FG003|Overall Study|Technical problems|0|||
156749767|NCT01863732|565835094|FG000|Overall Study|Subject/guardian decision|6|||
156749768|NCT01863732|565835095|FG001|Overall Study|Subject/guardian decision|9|||
156749769|NCT01863732|565835096|FG002|Overall Study|Subject/guardian decision|3|||
156749770|NCT01863732|565835097|FG003|Overall Study|Subject/guardian decision|1|||
156749771|NCT01863732|565835094|FG000|Overall Study|Death|1|||
156749772|NCT01863732|565835095|FG001|Overall Study|Death|0|||
156749773|NCT01863732|565835096|FG002|Overall Study|Death|0|||
156749774|NCT01863732|565835097|FG003|Overall Study|Death|1|||
156749775|NCT03084315|565835098|FG000|Overall Study|Lost to Follow-up|8|||
156749776|NCT03084315|565835099|FG001|Overall Study|Lost to Follow-up|7|||
156749777|NCT03084315|565835098|FG000|Overall Study|Withdrawal by Subject|2|||
156749778|NCT03084315|565835099|FG001|Overall Study|Withdrawal by Subject|2|||
156749779|NCT04424914|565835100|FG000|Overall Study|Other|0|||
156749780|NCT04424914|565835101|FG001|Overall Study|Other|0|||
156749781|NCT04424914|565835102|FG002|Overall Study|Other|28|||
156749782|NCT04424914|565835100|FG000|Overall Study|Withdrawal by Subject|3|||
156749783|NCT04424914|565835101|FG001|Overall Study|Withdrawal by Subject|0|||
156749784|NCT04424914|565835102|FG002|Overall Study|Withdrawal by Subject|0|||
156749785|NCT04424914|565835100|FG000|Overall Study|Study terminated by sponsor|23|||
156749786|NCT04424914|565835101|FG001|Overall Study|Study terminated by sponsor|7|||
156749787|NCT04424914|565835102|FG002|Overall Study|Study terminated by sponsor|0|||
156749788|NCT04424914|565835100|FG000|Overall Study|Lost to Follow-up|0|||
156749789|NCT04424914|565835101|FG001|Overall Study|Lost to Follow-up|0|||
156749790|NCT04424914|565835102|FG002|Overall Study|Lost to Follow-up|1|||
156749791|NCT04424914|565835100|FG000|Overall Study|Death|3|||
156749792|NCT04424914|565835101|FG001|Overall Study|Death|1|||
156749793|NCT04424914|565835102|FG002|Overall Study|Death|0|||
156749794|NCT00460746|565835103|FG000|Overall Study|Adverse Event|1|||
157143811|NCT01826214|567276319|FG000|Overall Study|Physician Decision|0|||
157143812|NCT01826214|567276320|FG001|Overall Study|Physician Decision|2|||
156749795|NCT00460746|565835103|FG000|Overall Study|Lost to Follow-up|1|||
156749796|NCT02791438|565835105|FG000|Treatment Period|Adverse Event|1|||
156749797|NCT02791438|565835106|FG001|Treatment Period|Adverse Event|0|||
156800447|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800448|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800449|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800450|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800451|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800452|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
156800453|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
156800454|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
156800455|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
156800456|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
156749798|NCT02791438|565835105|FG000|Treatment Period|Withdrawal by Subject|0|||
156749799|NCT02791438|565835106|FG001|Treatment Period|Withdrawal by Subject|1|||
156749800|NCT02791438|565835105|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
156749801|NCT02791438|565835106|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
156881206|NCT00884741|566325406|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
157143813|NCT01826214|567276319|FG000|Overall Study|Progressive disease|22|||
156749802|NCT01603394|565835108|FG000|Overall Study|Adverse Event|1|||
156749803|NCT00394771|565835111|FG000|Overall Study|Did not meet protocol requirements|1|||
156749804|NCT00394771|565835112|FG001|Overall Study|Did not meet protocol requirements|0|||
156749805|NCT00394771|565835113|FG002|Overall Study|Did not meet protocol requirements|2|||
156749806|NCT00394771|565835114|FG003|Overall Study|Did not meet protocol requirements|0|||
156749807|NCT00394771|565835111|FG000|Overall Study|Protocol Violation|2|||
156881207|NCT00884741|566325407|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
156881208|NCT00884741|566325408|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
156881209|NCT00884741|566325409|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
156881210|NCT00884741|566325406|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156881211|NCT00884741|566325407|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
156881212|NCT00884741|566325408|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156881213|NCT00884741|566325409|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
156881214|NCT00884741|566325406|FG000|Randomization|Protocol Violation|0|||
156749808|NCT00394771|565835112|FG001|Overall Study|Protocol Violation|4|||
156749809|NCT00394771|565835113|FG002|Overall Study|Protocol Violation|9|||
156749810|NCT00394771|565835114|FG003|Overall Study|Protocol Violation|7|||
156749811|NCT00394771|565835111|FG000|Overall Study|Withdrawal by Subject|10|||
156749812|NCT00394771|565835112|FG001|Overall Study|Withdrawal by Subject|6|||
156749813|NCT00394771|565835113|FG002|Overall Study|Withdrawal by Subject|8|||
156749814|NCT00394771|565835114|FG003|Overall Study|Withdrawal by Subject|12|||
156749815|NCT00394771|565835111|FG000|Overall Study|Adverse Event|10|||
156749816|NCT00394771|565835112|FG001|Overall Study|Adverse Event|5|||
156749817|NCT00394771|565835113|FG002|Overall Study|Adverse Event|12|||
156749818|NCT00394771|565835114|FG003|Overall Study|Adverse Event|8|||
156881215|NCT00884741|566325407|FG001|Randomization|Protocol Violation|0|||
156881216|NCT00884741|566325408|FG002|Randomization|Protocol Violation|8|||
156881217|NCT00884741|566325409|FG003|Randomization|Protocol Violation|8|||
156881218|NCT01994889|566325410|FG000|Overall Study|Adverse Event|5|||
156881219|NCT01994889|566325411|FG001|Overall Study|Adverse Event|12|||
156749819|NCT00394771|565835111|FG000|Overall Study|Participant pregnant|0|||
156749820|NCT00394771|565835112|FG001|Overall Study|Participant pregnant|1|||
156749821|NCT00394771|565835113|FG002|Overall Study|Participant pregnant|2|||
156749822|NCT00394771|565835114|FG003|Overall Study|Participant pregnant|2|||
156749823|NCT00394771|565835111|FG000|Overall Study|Lost to Follow-up|15|||
156749824|NCT00394771|565835112|FG001|Overall Study|Lost to Follow-up|15|||
156749825|NCT00394771|565835113|FG002|Overall Study|Lost to Follow-up|13|||
156749826|NCT00394771|565835114|FG003|Overall Study|Lost to Follow-up|10|||
156749827|NCT00394771|565835111|FG000|Overall Study|Other|3|||
156749828|NCT00394771|565835112|FG001|Overall Study|Other|3|||
156749829|NCT00394771|565835113|FG002|Overall Study|Other|1|||
156749830|NCT00394771|565835114|FG003|Overall Study|Other|0|||
156749831|NCT00862459|565835117|FG000|Overall Study|Lost to Follow-up|1|||
156749832|NCT00862459|565835118|FG001|Overall Study|Lost to Follow-up|2|||
156749833|NCT00862459|565835119|FG002|Overall Study|Lost to Follow-up|2|||
156749834|NCT00862459|565835117|FG000|Overall Study|Protocol Violation|1|||
156749835|NCT00862459|565835118|FG001|Overall Study|Protocol Violation|0|||
156749836|NCT00862459|565835119|FG002|Overall Study|Protocol Violation|0|||
156749837|NCT00862459|565835117|FG000|Overall Study|Withdrawal by Subject|1|||
156749838|NCT00862459|565835118|FG001|Overall Study|Withdrawal by Subject|1|||
156749839|NCT00862459|565835119|FG002|Overall Study|Withdrawal by Subject|3|||
156749840|NCT00862459|565835117|FG000|Overall Study|Adverse Event|0|||
156749841|NCT00862459|565835118|FG001|Overall Study|Adverse Event|1|||
157143814|NCT01826214|567276320|FG001|Overall Study|Progressive disease|21|||
157143815|NCT01826214|567276319|FG000|Overall Study|Study terminated by Sponsor|0|||
157143816|NCT01826214|567276320|FG001|Overall Study|Study terminated by Sponsor|1|||
157143817|NCT01826214|567276319|FG000|Overall Study|Subject/guardian decision|2|||
156749842|NCT00862459|565835119|FG002|Overall Study|Adverse Event|0|||
156749843|NCT00862459|565835117|FG000|Overall Study|Personal reasons|1|||
156749844|NCT00862459|565835118|FG001|Overall Study|Personal reasons|0|||
156749845|NCT00862459|565835119|FG002|Overall Study|Personal reasons|0|||
156749846|NCT00862459|565835117|FG000|Overall Study|Operation|1|||
156749847|NCT00862459|565835118|FG001|Overall Study|Operation|1|||
156800457|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
156800458|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
156800459|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
156800460|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
156800461|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
156800462|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
156800463|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
156800464|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
156800465|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
156800466|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800467|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800468|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800469|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800470|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156881220|NCT01994889|566325412|FG002|Overall Study|Adverse Event|11|||
156881221|NCT01994889|566325410|FG000|Overall Study|Cardiac Device Implantation|0|||
157143818|NCT01826214|567276320|FG001|Overall Study|Subject/guardian decision|3|||
156749848|NCT00862459|565835119|FG002|Overall Study|Operation|0|||
156749849|NCT00862459|565835117|FG000|Overall Study|Intravenous (IV) site problems|1|||
156800471|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156749850|NCT00862459|565835118|FG001|Overall Study|Intravenous (IV) site problems|0|||
156749851|NCT00862459|565835119|FG002|Overall Study|Intravenous (IV) site problems|1|||
156749852|NCT00862459|565835117|FG000|Overall Study|Unable to hold still for imaging|0|||
156749853|NCT00862459|565835118|FG001|Overall Study|Unable to hold still for imaging|1|||
156749854|NCT00862459|565835119|FG002|Overall Study|Unable to hold still for imaging|0|||
156749855|NCT00862459|565835117|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156749856|NCT00862459|565835118|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156749857|NCT00862459|565835119|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156749858|NCT00862459|565835117|FG000|Overall Study|Administrative problems|0|||
156749859|NCT00862459|565835118|FG001|Overall Study|Administrative problems|1|||
156749860|NCT00862459|565835119|FG002|Overall Study|Administrative problems|0|||
156749861|NCT02906033|565835120|FG000|Baseline|Protocol Violation|37|||
156749862|NCT02906033|565835121|FG001|Baseline|Protocol Violation|33|||
156749863|NCT02906033|565835120|FG000|Follow-up|Lost to Follow-up|46|||
156749864|NCT02906033|565835121|FG001|Follow-up|Lost to Follow-up|62|||
156749865|NCT00358956|565835132|FG000|Overall Study|Adverse Event|3|||
156749866|NCT00358956|565835132|FG000|Overall Study|condition under investigation worsened|4|||
156749867|NCT00358956|565835132|FG000|Overall Study|Withdrawal by Subject|1|||
156749868|NCT03782974|565835139|FG000|Overall Study|Withdrawal by Subject|7|||
156749869|NCT03782974|565835140|FG001|Overall Study|Withdrawal by Subject|7|||
156749870|NCT03782974|565835139|FG000|Overall Study|Pregnancy|1|||
156749871|NCT03782974|565835140|FG001|Overall Study|Pregnancy|0|||
156749872|NCT00505661|565835143|FG000|Overall Study|Not Eligible|4|||
156749873|NCT01907217|565835145|FG000|Overall Study|Withdrawal by Subject|0|||
156749874|NCT01907217|565835146|FG001|Overall Study|Withdrawal by Subject|2|||
156749875|NCT01764659|565835151|FG000|Overall Study|Death|1|||
156749876|NCT01764659|565835151|FG000|Overall Study|Physician Decision|1|||
156749877|NCT01210352|565835153|FG000|Overall Study|Adverse Event|0|||
156749878|NCT01210352|565835154|FG001|Overall Study|Adverse Event|0|||
156749879|NCT01210352|565835155|FG002|Overall Study|Adverse Event|0|||
156749880|NCT01210352|565835156|FG003|Overall Study|Adverse Event|0|||
156749881|NCT01210352|565835157|FG004|Overall Study|Adverse Event|0|||
156749882|NCT01210352|565835158|FG005|Overall Study|Adverse Event|0|||
156749883|NCT01210352|565835159|FG006|Overall Study|Adverse Event|0|||
156749884|NCT01210352|565835160|FG007|Overall Study|Adverse Event|2|||
156749885|NCT01210352|565835161|FG008|Overall Study|Adverse Event|1|||
156749886|NCT01210352|565835153|FG000|Overall Study|Lack of Efficacy|0|||
156749887|NCT01210352|565835154|FG001|Overall Study|Lack of Efficacy|0|||
156749888|NCT01210352|565835155|FG002|Overall Study|Lack of Efficacy|0|||
156749889|NCT01210352|565835156|FG003|Overall Study|Lack of Efficacy|0|||
156749890|NCT01210352|565835157|FG004|Overall Study|Lack of Efficacy|0|||
156749891|NCT01210352|565835158|FG005|Overall Study|Lack of Efficacy|0|||
156749892|NCT01210352|565835159|FG006|Overall Study|Lack of Efficacy|1|||
156749893|NCT01210352|565835160|FG007|Overall Study|Lack of Efficacy|0|||
156749894|NCT01210352|565835161|FG008|Overall Study|Lack of Efficacy|0|||
156749895|NCT01210352|565835153|FG000|Overall Study|Physician Decision|0|||
156749896|NCT01210352|565835154|FG001|Overall Study|Physician Decision|0|||
156749897|NCT01210352|565835155|FG002|Overall Study|Physician Decision|0|||
156749898|NCT01210352|565835156|FG003|Overall Study|Physician Decision|0|||
156749899|NCT01210352|565835157|FG004|Overall Study|Physician Decision|0|||
156749900|NCT01210352|565835158|FG005|Overall Study|Physician Decision|0|||
156749901|NCT01210352|565835159|FG006|Overall Study|Physician Decision|0|||
156749902|NCT01210352|565835160|FG007|Overall Study|Physician Decision|1|||
156749903|NCT01210352|565835161|FG008|Overall Study|Physician Decision|2|||
156749904|NCT01210352|565835153|FG000|Overall Study|Withdrawal by Subject|0|||
156749905|NCT01210352|565835154|FG001|Overall Study|Withdrawal by Subject|0|||
156749906|NCT01210352|565835155|FG002|Overall Study|Withdrawal by Subject|1|||
156749907|NCT01210352|565835156|FG003|Overall Study|Withdrawal by Subject|0|||
156749908|NCT01210352|565835157|FG004|Overall Study|Withdrawal by Subject|0|||
156749909|NCT01210352|565835158|FG005|Overall Study|Withdrawal by Subject|0|||
156749910|NCT01210352|565835159|FG006|Overall Study|Withdrawal by Subject|1|||
156749911|NCT01210352|565835160|FG007|Overall Study|Withdrawal by Subject|0|||
156800472|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156800473|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
156800474|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
156800475|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
156749912|NCT01210352|565835161|FG008|Overall Study|Withdrawal by Subject|1|||
156749913|NCT01210352|565835153|FG000|Overall Study|Patient Discharged Early|0|||
156749914|NCT01210352|565835154|FG001|Overall Study|Patient Discharged Early|0|||
156800476|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156749915|NCT01210352|565835155|FG002|Overall Study|Patient Discharged Early|1|||
156749916|NCT01210352|565835156|FG003|Overall Study|Patient Discharged Early|0|||
156749917|NCT01210352|565835157|FG004|Overall Study|Patient Discharged Early|0|||
156749918|NCT01210352|565835158|FG005|Overall Study|Patient Discharged Early|0|||
156749919|NCT01210352|565835159|FG006|Overall Study|Patient Discharged Early|0|||
156749920|NCT01210352|565835160|FG007|Overall Study|Patient Discharged Early|0|||
156800477|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156749921|NCT01210352|565835161|FG008|Overall Study|Patient Discharged Early|0|||
156749922|NCT03338569|565835162|FG000|Overall Study|Physician Decision|8|||
156749923|NCT03338569|565835163|FG001|Overall Study|Physician Decision|3|||
156749924|NCT03338569|565835162|FG000|Overall Study|Withdrawal by Subject|0|||
156749925|NCT03338569|565835163|FG001|Overall Study|Withdrawal by Subject|1|||
156749926|NCT03338569|565835162|FG000|Overall Study|Lost to Follow-up|0|||
156749927|NCT03338569|565835163|FG001|Overall Study|Lost to Follow-up|1|||
156749928|NCT04607980|565835164|FG000|Overall Study|Adverse Event|3|||
156749929|NCT04607980|565835165|FG001|Overall Study|Adverse Event|4|||
156749930|NCT04607980|565835164|FG000|Overall Study|Death|0|||
156749931|NCT04607980|565835165|FG001|Overall Study|Death|1|||
156749932|NCT04607980|565835164|FG000|Overall Study|Withdrawal by Subject|2|||
156749933|NCT04607980|565835165|FG001|Overall Study|Withdrawal by Subject|5|||
156749934|NCT04607980|565835164|FG000|Overall Study|Lost to Follow-up|4|||
156749935|NCT04607980|565835165|FG001|Overall Study|Lost to Follow-up|8|||
156749936|NCT04607980|565835164|FG000|Overall Study|Protocol Violation|0|||
156749937|NCT04607980|565835165|FG001|Overall Study|Protocol Violation|3|||
156749938|NCT04607980|565835164|FG000|Overall Study|Other|3|||
156749939|NCT04607980|565835165|FG001|Overall Study|Other|0|||
156749940|NCT00448812|565835167|FG000|Year 2|Missed visit but remained in study|4|||
156749941|NCT00448812|565835168|FG001|Year 2|Missed visit but remained in study|1|||
156749942|NCT00448812|565835167|FG000|Year 3|Withdrawal by Subject|1|||
156749943|NCT00448812|565835168|FG001|Year 3|Withdrawal by Subject|3|||
156749944|NCT00448812|565835167|FG000|Year 3|Lost to Follow-up|1|||
156749945|NCT00448812|565835168|FG001|Year 3|Lost to Follow-up|0|||
156800478|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800479|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800480|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800481|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800482|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800483|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800484|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
156800485|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
156800486|NCT02936323|566023456|FG000|Phase 2a Dose Expansion|Death|0|||
156800487|NCT02936323|566023457|FG001|Phase 2a Dose Expansion|Death|0|||
156800488|NCT02936323|566023458|FG002|Phase 2a Dose Expansion|Death|0|||
156800489|NCT02936323|566023459|FG003|Phase 2a Dose Expansion|Death|0|||
156800490|NCT02936323|566023460|FG004|Phase 2a Dose Expansion|Death|0|||
156800491|NCT02936323|566023461|FG005|Phase 2a Dose Expansion|Death|0|||
156800492|NCT02936323|566023462|FG006|Phase 2a Dose Expansion|Death|0|||
156800493|NCT02936323|566023463|FG007|Phase 2a Dose Expansion|Death|4|||
156800494|NCT02936323|566023464|FG008|Phase 2a Dose Expansion|Death|8|||
156800495|NCT02936323|566023465|FG009|Phase 2a Dose Expansion|Death|10|||
156800496|NCT05239221|566023466|FG000|Overall Study|Adverse Event|0|||
156800497|NCT05239221|566023467|FG001|Overall Study|Adverse Event|0|||
156800498|NCT05239221|566023468|FG002|Overall Study|Adverse Event|0|||
156800499|NCT05239221|566023469|FG003|Overall Study|Adverse Event|0|||
156800500|NCT05239221|566023470|FG004|Overall Study|Adverse Event|0|||
156800501|NCT05239221|566023471|FG005|Overall Study|Adverse Event|0|||
156800502|NCT05239221|566023472|FG006|Overall Study|Adverse Event|1|||
156800503|NCT05239221|566023473|FG007|Overall Study|Adverse Event|0|||
156800504|NCT05239221|566023474|FG008|Overall Study|Adverse Event|0|||
156800505|NCT05239221|566023475|FG009|Overall Study|Adverse Event|0|||
156800506|NCT05239221|566023476|FG010|Overall Study|Adverse Event|1|||
156800507|NCT05239221|566023477|FG011|Overall Study|Adverse Event|1|||
156800508|NCT05239221|566023478|FG012|Overall Study|Adverse Event|0|||
156800509|NCT05239221|566023479|FG013|Overall Study|Adverse Event|0|||
156800510|NCT05239221|566023480|FG014|Overall Study|Adverse Event|0|||
156800511|NCT05239221|566023481|FG015|Overall Study|Adverse Event|0|||
156800512|NCT05239221|566023466|FG000|Overall Study|Withdrawal by Subject|0|||
156800513|NCT05239221|566023467|FG001|Overall Study|Withdrawal by Subject|0|||
156800514|NCT05239221|566023468|FG002|Overall Study|Withdrawal by Subject|0|||
156800515|NCT05239221|566023469|FG003|Overall Study|Withdrawal by Subject|0|||
156800516|NCT05239221|566023470|FG004|Overall Study|Withdrawal by Subject|0|||
156800517|NCT05239221|566023471|FG005|Overall Study|Withdrawal by Subject|0|||
156800518|NCT05239221|566023472|FG006|Overall Study|Withdrawal by Subject|0|||
156749946|NCT00448812|565835167|FG000|Year 3|Missed visit but remained in study|2|||
156749947|NCT00448812|565835168|FG001|Year 3|Missed visit but remained in study|0|||
156800519|NCT05239221|566023473|FG007|Overall Study|Withdrawal by Subject|0|||
156749948|NCT00448812|565835167|FG000|Year 5|Missed visit but remained in study|1|||
156800520|NCT05239221|566023474|FG008|Overall Study|Withdrawal by Subject|0|||
156800521|NCT05239221|566023475|FG009|Overall Study|Withdrawal by Subject|0|||
156800522|NCT05239221|566023476|FG010|Overall Study|Withdrawal by Subject|1|||
156800523|NCT05239221|566023477|FG011|Overall Study|Withdrawal by Subject|0|||
156800524|NCT05239221|566023478|FG012|Overall Study|Withdrawal by Subject|0|||
156800525|NCT05239221|566023479|FG013|Overall Study|Withdrawal by Subject|0|||
156800526|NCT05239221|566023480|FG014|Overall Study|Withdrawal by Subject|0|||
157143819|NCT03704051|567276325|FG000|Overall Study|Withdrawal by Subject|4|||
157143820|NCT03704051|567276326|FG001|Overall Study|Withdrawal by Subject|0|||
156749949|NCT00448812|565835168|FG001|Year 5|Missed visit but remained in study|0|||
156749950|NCT01854879|565835171|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
156749951|NCT01854879|565835171|FG000|Overall Study|screen fail|3|||
156749952|NCT01854879|565835171|FG000|Overall Study|incomplete data set|1|||
156749953|NCT02012959|565835172|FG000|Treatment Phase A|Adverse Event|2|||
156749954|NCT02012959|565835173|FG001|Treatment Phase A|Adverse Event|0|||
156749955|NCT02012959|565835174|FG002|Treatment Phase A|Adverse Event|0|||
156749956|NCT02012959|565835175|FG003|Treatment Phase A|Adverse Event|0|||
156749957|NCT02012959|565835176|FG004|Treatment Phase A|Adverse Event|0|||
156800527|NCT05239221|566023481|FG015|Overall Study|Withdrawal by Subject|1|||
156800528|NCT01400412|566023482|FG000|Overall Study|Lost to Follow-up|4|||
156800529|NCT01400412|566023483|FG001|Overall Study|Lost to Follow-up|7|||
156800530|NCT01400412|566023482|FG000|Overall Study|Withdrawal by Subject|3|||
156800531|NCT01400412|566023483|FG001|Overall Study|Withdrawal by Subject|4|||
156800532|NCT01400412|566023482|FG000|Overall Study|Unable to complete|3|||
156800533|NCT01400412|566023483|FG001|Overall Study|Unable to complete|3|||
156800534|NCT01400412|566023482|FG000|Overall Study|Never started study treatment|0|||
156800535|NCT01400412|566023483|FG001|Overall Study|Never started study treatment|3|||
156800536|NCT01334918|566025314|FG000|Overall Study|Did not receive study drug|6|||
156800537|NCT01334918|566025315|FG001|Overall Study|Did not receive study drug|0|||
156800538|NCT01334918|566025314|FG000|Overall Study|Adverse Event|2|||
156800539|NCT01334918|566025315|FG001|Overall Study|Adverse Event|0|||
156800540|NCT01334918|566025314|FG000|Overall Study|Withdrawal by Subject|0|||
156800541|NCT01334918|566025315|FG001|Overall Study|Withdrawal by Subject|1|||
156800542|NCT01576783|566025319|FG000|Overall Study|Change in Medical Care|1|||
156800543|NCT01576783|566025320|FG001|Overall Study|Change in Medical Care|0|||
156800544|NCT01576783|566025319|FG000|Overall Study|Lost to Follow-up|14|||
156800545|NCT01576783|566025320|FG001|Overall Study|Lost to Follow-up|16|||
156800546|NCT01576783|566025319|FG000|Overall Study|Withdrawal by Subject|5|||
156800547|NCT01576783|566025320|FG001|Overall Study|Withdrawal by Subject|1|||
156800548|NCT05489328|566025322|FG000|Overall Study|Lost to Follow-up|0|||
156800549|NCT05489328|566025323|FG001|Overall Study|Lost to Follow-up|0|||
156800550|NCT05489328|566025324|FG002|Overall Study|Lost to Follow-up|1|||
156800551|NCT05489328|566025325|FG003|Overall Study|Lost to Follow-up|0|||
156800552|NCT05489328|566025326|FG004|Overall Study|Lost to Follow-up|2|||
156800553|NCT05489328|566025327|FG005|Overall Study|Lost to Follow-up|0|||
156800554|NCT05489328|566025328|FG006|Overall Study|Lost to Follow-up|0|||
156800555|NCT05489328|566025329|FG007|Overall Study|Lost to Follow-up|1|||
156800556|NCT05489328|566025330|FG008|Overall Study|Lost to Follow-up|0|||
156800557|NCT05489328|566025322|FG000|Overall Study|Withdrawal by Subject|0|||
156800558|NCT05489328|566025323|FG001|Overall Study|Withdrawal by Subject|0|||
156800559|NCT05489328|566025324|FG002|Overall Study|Withdrawal by Subject|0|||
156800560|NCT05489328|566025325|FG003|Overall Study|Withdrawal by Subject|0|||
156800561|NCT05489328|566025326|FG004|Overall Study|Withdrawal by Subject|0|||
156800562|NCT05489328|566025327|FG005|Overall Study|Withdrawal by Subject|0|||
156800563|NCT05489328|566025328|FG006|Overall Study|Withdrawal by Subject|1|||
156800564|NCT05489328|566025329|FG007|Overall Study|Withdrawal by Subject|1|||
156800565|NCT05489328|566025330|FG008|Overall Study|Withdrawal by Subject|0|||
156800566|NCT05489328|566025322|FG000|Overall Study|Other|0|||
156800567|NCT05489328|566025323|FG001|Overall Study|Other|0|||
156800568|NCT05489328|566025324|FG002|Overall Study|Other|0|||
156800569|NCT05489328|566025325|FG003|Overall Study|Other|0|||
156800570|NCT05489328|566025326|FG004|Overall Study|Other|0|||
156800571|NCT05489328|566025327|FG005|Overall Study|Other|0|||
156800572|NCT05489328|566025328|FG006|Overall Study|Other|0|||
156800573|NCT05489328|566025329|FG007|Overall Study|Other|1|||
156800574|NCT05489328|566025330|FG008|Overall Study|Other|1|||
156800575|NCT01083602|566025331|FG000|Overall Study|Adverse Event|11|||
156800576|NCT01083602|566025331|FG000|Overall Study|New Cancer Therapy|2|||
156800577|NCT01083602|566025331|FG000|Overall Study|Death|1|||
156800578|NCT01083602|566025331|FG000|Overall Study|Withdrawal by Subject|5|||
156800579|NCT01083602|566025331|FG000|Overall Study|Lack of Efficacy|36|||
156800580|NCT01657370|566025333|FG000|Overall Study|Withdrawal by Subject|0|||
156800581|NCT01657370|566025334|FG001|Overall Study|Withdrawal by Subject|0|||
156800582|NCT01657370|566025335|FG002|Overall Study|Withdrawal by Subject|1|||
156800583|NCT01657370|566025336|FG003|Overall Study|Withdrawal by Subject|0|||
156800584|NCT01657370|566025337|FG004|Overall Study|Withdrawal by Subject|0|||
156800585|NCT01657370|566025338|FG005|Overall Study|Withdrawal by Subject|1|||
156800586|NCT01657370|566025333|FG000|Overall Study|Physician Decision|2|||
156800587|NCT01657370|566025334|FG001|Overall Study|Physician Decision|3|||
156800588|NCT01657370|566025335|FG002|Overall Study|Physician Decision|1|||
156800589|NCT01657370|566025336|FG003|Overall Study|Physician Decision|2|||
156800590|NCT01657370|566025337|FG004|Overall Study|Physician Decision|5|||
156800591|NCT01657370|566025338|FG005|Overall Study|Physician Decision|0|||
156800592|NCT01657370|566025333|FG000|Overall Study|Lack of Qualifying Event|1|||
157143821|NCT03167619|567276337|FG000|Overall Study|Death|11|||
157143822|NCT03167619|567276338|FG001|Overall Study|Death|8|||
157020870|NCT03269136|566828514|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
157020871|NCT03269136|566828515|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
157020872|NCT03269136|566828498|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
157020873|NCT03269136|566828499|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
157020874|NCT03269136|566828500|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
157020875|NCT03269136|566828501|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
157020876|NCT03269136|566828502|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
157020877|NCT03269136|566828503|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
157020878|NCT03269136|566828504|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
157020879|NCT03269136|566828505|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
157020880|NCT03269136|566828506|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
157020881|NCT03269136|566828507|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
157020882|NCT03269136|566828508|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
157020883|NCT03269136|566828509|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
157020884|NCT03269136|566828510|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
157020885|NCT03269136|566828511|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
157020886|NCT03269136|566828512|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
157020887|NCT03269136|566828513|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
157020888|NCT03269136|566828514|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
157020889|NCT03269136|566828515|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
157020890|NCT03269136|566828498|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
157020891|NCT03269136|566828499|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
157020892|NCT03269136|566828500|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
157020893|NCT03269136|566828501|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
157020894|NCT03269136|566828502|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
157020895|NCT03269136|566828503|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
157020896|NCT03269136|566828504|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
156881222|NCT01994889|566325411|FG001|Overall Study|Cardiac Device Implantation|2|||
156881223|NCT01994889|566325412|FG002|Overall Study|Cardiac Device Implantation|0|||
156881224|NCT01994889|566325410|FG000|Overall Study|Organ Transplantation|1|||
156881225|NCT01994889|566325411|FG001|Overall Study|Organ Transplantation|5|||
156881226|NCT01994889|566325412|FG002|Overall Study|Organ Transplantation|5|||
156881227|NCT01994889|566325410|FG000|Overall Study|No longer willing to participate|8|||
156881228|NCT01994889|566325411|FG001|Overall Study|No longer willing to participate|17|||
156881229|NCT01994889|566325412|FG002|Overall Study|No longer willing to participate|37|||
156881230|NCT01994889|566325410|FG000|Overall Study|Lost to Follow-up|0|||
156881231|NCT01994889|566325411|FG001|Overall Study|Lost to Follow-up|1|||
157020897|NCT03269136|566828505|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
157020898|NCT03269136|566828506|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
157020899|NCT03269136|566828507|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
157020900|NCT03269136|566828508|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
157020901|NCT03269136|566828509|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
157020902|NCT03269136|566828510|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
157020903|NCT03269136|566828511|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
157020904|NCT03269136|566828512|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
157020905|NCT03269136|566828513|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
157020906|NCT03269136|566828514|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
157020907|NCT03269136|566828515|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
157020908|NCT04952909|566828516|FG000|Overall Study|Death|3|||
157020909|NCT04856163|566828523|FG000|Overall Study|Lost to Follow-up|97|||
156800593|NCT01657370|566025334|FG001|Overall Study|Lack of Qualifying Event|0|||
156800594|NCT01657370|566025335|FG002|Overall Study|Lack of Qualifying Event|3|||
156800595|NCT01657370|566025336|FG003|Overall Study|Lack of Qualifying Event|2|||
156800596|NCT01657370|566025337|FG004|Overall Study|Lack of Qualifying Event|1|||
156800597|NCT01657370|566025338|FG005|Overall Study|Lack of Qualifying Event|2|||
156800598|NCT01657370|566025333|FG000|Overall Study|Adverse Event|0|||
156800599|NCT01657370|566025334|FG001|Overall Study|Adverse Event|0|||
156800600|NCT01657370|566025335|FG002|Overall Study|Adverse Event|0|||
156800601|NCT01657370|566025336|FG003|Overall Study|Adverse Event|0|||
156881232|NCT01994889|566325412|FG002|Overall Study|Lost to Follow-up|0|||
156800602|NCT01657370|566025337|FG004|Overall Study|Adverse Event|1|||
156881233|NCT01994889|566325410|FG000|Overall Study|Protocol Violation|0|||
156881234|NCT01994889|566325411|FG001|Overall Study|Protocol Violation|1|||
156881235|NCT01994889|566325412|FG002|Overall Study|Protocol Violation|1|||
157020910|NCT04856163|566828524|FG001|Overall Study|Lost to Follow-up|100|||
157020911|NCT04359108|566828525|FG000|Overall Study|Withdrawal by Subject|1|||
157020912|NCT04359108|566828526|FG001|Overall Study|Withdrawal by Subject|0|||
156881236|NCT01994889|566325410|FG000|Overall Study|Death|14|||
156881237|NCT01994889|566325411|FG001|Overall Study|Death|25|||
157020913|NCT04359108|566828525|FG000|Overall Study|Unable or too feeble to walk independently|0|||
157020914|NCT04359108|566828526|FG001|Overall Study|Unable or too feeble to walk independently|2|||
157020915|NCT04359108|566828525|FG000|Overall Study|Argus II system stopped functioning|0|||
157020916|NCT04359108|566828526|FG001|Overall Study|Argus II system stopped functioning|1|||
156800603|NCT01657370|566025338|FG005|Overall Study|Adverse Event|0|||
156800604|NCT01657370|566025333|FG000|Overall Study|Protocol Violation|1|||
156800605|NCT01657370|566025334|FG001|Overall Study|Protocol Violation|1|||
156800606|NCT01657370|566025335|FG002|Overall Study|Protocol Violation|1|||
156800607|NCT01657370|566025336|FG003|Overall Study|Protocol Violation|1|||
156800608|NCT01657370|566025337|FG004|Overall Study|Protocol Violation|0|||
156800609|NCT01657370|566025338|FG005|Overall Study|Protocol Violation|0|||
156800610|NCT01657370|566025333|FG000|Overall Study|Lost to Follow-up|2|||
156800611|NCT01657370|566025334|FG001|Overall Study|Lost to Follow-up|0|||
156800612|NCT01657370|566025335|FG002|Overall Study|Lost to Follow-up|1|||
156800613|NCT01657370|566025336|FG003|Overall Study|Lost to Follow-up|0|||
156800614|NCT01657370|566025337|FG004|Overall Study|Lost to Follow-up|0|||
156800615|NCT01657370|566025338|FG005|Overall Study|Lost to Follow-up|1|||
156800616|NCT02777086|566025339|FG000|Overall Study|Lost to Follow-up|96|||
156800617|NCT02777086|566025340|FG001|Overall Study|Lost to Follow-up|99|||
156800618|NCT01133665|566025341|FG000|Overall Study|Physician Decision|2|||
156800619|NCT01819272|566025342|FG000|Overall Study|Adverse Event|1|||
156800620|NCT01819272|566025343|FG001|Overall Study|Adverse Event|0|||
156800621|NCT01819272|566025344|FG002|Overall Study|Adverse Event|0|||
156800622|NCT01819272|566025345|FG003|Overall Study|Adverse Event|2|||
156800623|NCT01819272|566025346|FG004|Overall Study|Adverse Event|0|||
156800624|NCT01819272|566025347|FG005|Overall Study|Adverse Event|0|||
156800625|NCT01819272|566025342|FG000|Overall Study|Lost to Follow-up|3|||
156800626|NCT01819272|566025343|FG001|Overall Study|Lost to Follow-up|0|||
156800627|NCT01819272|566025344|FG002|Overall Study|Lost to Follow-up|1|||
156800628|NCT01819272|566025345|FG003|Overall Study|Lost to Follow-up|0|||
156800629|NCT01819272|566025346|FG004|Overall Study|Lost to Follow-up|0|||
156800630|NCT01819272|566025347|FG005|Overall Study|Lost to Follow-up|3|||
156800631|NCT01819272|566025342|FG000|Overall Study|Protocol Violation|0|||
156800632|NCT01819272|566025343|FG001|Overall Study|Protocol Violation|0|||
156800633|NCT01819272|566025344|FG002|Overall Study|Protocol Violation|0|||
156800634|NCT01819272|566025345|FG003|Overall Study|Protocol Violation|1|||
156800635|NCT01819272|566025346|FG004|Overall Study|Protocol Violation|2|||
156800636|NCT01819272|566025347|FG005|Overall Study|Protocol Violation|3|||
156800637|NCT01819272|566025342|FG000|Overall Study|Physician Decision|0|||
156800638|NCT01819272|566025343|FG001|Overall Study|Physician Decision|1|||
156800639|NCT01819272|566025344|FG002|Overall Study|Physician Decision|0|||
156800640|NCT01819272|566025345|FG003|Overall Study|Physician Decision|0|||
156800641|NCT01819272|566025346|FG004|Overall Study|Physician Decision|0|||
156800642|NCT01819272|566025347|FG005|Overall Study|Physician Decision|0|||
156800643|NCT01819272|566025342|FG000|Overall Study|Withdrawal of Consent|0|||
156800644|NCT01819272|566025343|FG001|Overall Study|Withdrawal of Consent|1|||
156800645|NCT01819272|566025344|FG002|Overall Study|Withdrawal of Consent|2|||
156800646|NCT01819272|566025345|FG003|Overall Study|Withdrawal of Consent|1|||
156800647|NCT01819272|566025346|FG004|Overall Study|Withdrawal of Consent|0|||
156800648|NCT01819272|566025347|FG005|Overall Study|Withdrawal of Consent|1|||
156800649|NCT01819272|566025342|FG000|Overall Study|Loss of Glucose Control|2|||
156800650|NCT01819272|566025343|FG001|Overall Study|Loss of Glucose Control|1|||
156800651|NCT01819272|566025344|FG002|Overall Study|Loss of Glucose Control|0|||
156800652|NCT01819272|566025345|FG003|Overall Study|Loss of Glucose Control|1|||
156800653|NCT01819272|566025346|FG004|Overall Study|Loss of Glucose Control|2|||
156800654|NCT01819272|566025347|FG005|Overall Study|Loss of Glucose Control|0|||
156800655|NCT00805389|566025348|FG000|Overall Study|Adverse Event|0|||
156800656|NCT00805389|566025349|FG001|Overall Study|Adverse Event|0|||
156800657|NCT00805389|566025350|FG002|Overall Study|Adverse Event|1|||
156800658|NCT00805389|566025351|FG003|Overall Study|Adverse Event|2|||
156800659|NCT00805389|566025352|FG004|Overall Study|Adverse Event|0|||
156800660|NCT00805389|566025348|FG000|Overall Study|Lost to Follow-up|4|||
156800661|NCT00805389|566025349|FG001|Overall Study|Lost to Follow-up|3|||
156800662|NCT00805389|566025350|FG002|Overall Study|Lost to Follow-up|6|||
156800663|NCT00805389|566025351|FG003|Overall Study|Lost to Follow-up|10|||
156800664|NCT00805389|566025352|FG004|Overall Study|Lost to Follow-up|9|||
156800665|NCT00805389|566025348|FG000|Overall Study|Protocol Violation|0|||
156800666|NCT00805389|566025349|FG001|Overall Study|Protocol Violation|0|||
156800667|NCT00805389|566025350|FG002|Overall Study|Protocol Violation|1|||
156800668|NCT00805389|566025351|FG003|Overall Study|Protocol Violation|0|||
156800669|NCT00805389|566025352|FG004|Overall Study|Protocol Violation|0|||
156800670|NCT00805389|566025348|FG000|Overall Study|Withdrawal by Subject|3|||
156881238|NCT01994889|566325412|FG002|Overall Study|Death|38|||
156881239|NCT00145977|566325416|FG000|Overall Study|Lack of Efficacy|0|||
156800671|NCT00805389|566025349|FG001|Overall Study|Withdrawal by Subject|2|||
156800672|NCT00805389|566025350|FG002|Overall Study|Withdrawal by Subject|4|||
156800673|NCT00805389|566025351|FG003|Overall Study|Withdrawal by Subject|5|||
156800674|NCT00805389|566025352|FG004|Overall Study|Withdrawal by Subject|4|||
156800675|NCT01359956|566025355|FG000|Overall Study|Death|58|||
156800676|NCT01359956|566025356|FG001|Overall Study|Death|60|||
156800677|NCT01359956|566025357|FG002|Overall Study|Death|66|||
156800678|NCT01359956|566025358|FG003|Overall Study|Death|57|||
156800679|NCT01359956|566025355|FG000|Overall Study|Lost to Follow-up|3|||
156800680|NCT01359956|566025356|FG001|Overall Study|Lost to Follow-up|4|||
156800681|NCT01359956|566025357|FG002|Overall Study|Lost to Follow-up|1|||
156800682|NCT01359956|566025358|FG003|Overall Study|Lost to Follow-up|1|||
156800683|NCT01784029|566025359|FG000|Overall Study|Lost to Follow-up|19|||
156800684|NCT01784029|566025360|FG001|Overall Study|Lost to Follow-up|20|||
156800685|NCT01784029|566025361|FG002|Overall Study|Lost to Follow-up|22|||
156800686|NCT01209767|566025366|FG000|Overall Study|Withdrawal by Subject|1|||
156800687|NCT01209767|566025366|FG000|Overall Study|Lost to Follow-up|3|||
156800688|NCT02410772|566025370|FG000|Overall Study|Death|3|||
156800689|NCT02410772|566025371|FG001|Overall Study|Death|4|||
156800690|NCT02410772|566025372|FG002|Overall Study|Death|8|||
156800691|NCT02410772|566025370|FG000|Overall Study|Lost to Follow-up|31|||
156800692|NCT02410772|566025371|FG001|Overall Study|Lost to Follow-up|23|||
156800693|NCT02410772|566025372|FG002|Overall Study|Lost to Follow-up|22|||
156800694|NCT02410772|566025370|FG000|Overall Study|Pregnancy|8|||
156800695|NCT02410772|566025371|FG001|Overall Study|Pregnancy|4|||
156800696|NCT02410772|566025372|FG002|Overall Study|Pregnancy|5|||
156800697|NCT02410772|566025370|FG000|Overall Study|Protocol Violation|8|||
156800698|NCT02410772|566025371|FG001|Overall Study|Protocol Violation|8|||
156800699|NCT02410772|566025372|FG002|Overall Study|Protocol Violation|4|||
156800700|NCT02410772|566025370|FG000|Overall Study|Baseline Drug Resistance|49|||
156800701|NCT02410772|566025371|FG001|Overall Study|Baseline Drug Resistance|40|||
156800702|NCT02410772|566025372|FG002|Overall Study|Baseline Drug Resistance|51|||
156800703|NCT02410772|566025370|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
156800704|NCT02410772|566025371|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
156800705|NCT02410772|566025372|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
156800706|NCT02410772|566025370|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
156800707|NCT02410772|566025371|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
156800708|NCT02410772|566025372|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
156800709|NCT04573972|566025373|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
156800710|NCT04573972|566025374|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
156800711|NCT01517984|566025375|FG000|Overall Study|Lost to Follow-up|0|||
156800712|NCT01517984|566025376|FG001|Overall Study|Lost to Follow-up|1|||
156800713|NCT01517984|566025377|FG002|Overall Study|Lost to Follow-up|0|||
156800714|NCT01517984|566025378|FG003|Overall Study|Lost to Follow-up|0|||
156800715|NCT01517984|566025375|FG000|Overall Study|Withdrawal by Subject|1|||
156800716|NCT01517984|566025376|FG001|Overall Study|Withdrawal by Subject|8|||
156800717|NCT01517984|566025377|FG002|Overall Study|Withdrawal by Subject|4|||
156800718|NCT01517984|566025378|FG003|Overall Study|Withdrawal by Subject|1|||
156800719|NCT01517984|566025375|FG000|Overall Study|Screen Failure|4|||
156800720|NCT01517984|566025376|FG001|Overall Study|Screen Failure|0|||
156800721|NCT01517984|566025377|FG002|Overall Study|Screen Failure|0|||
156800722|NCT01517984|566025378|FG003|Overall Study|Screen Failure|0|||
156800723|NCT01517984|566025375|FG000|Overall Study|Ineligible for randomization|0|||
157020917|NCT04359108|566828525|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
156881240|NCT00145977|566325417|FG001|Overall Study|Lack of Efficacy|4|||
156881241|NCT00145977|566325416|FG000|Overall Study|Lost to Follow-up|1|||
157020918|NCT04359108|566828526|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
156800724|NCT01517984|566025376|FG001|Overall Study|Ineligible for randomization|14|||
156800725|NCT01517984|566025377|FG002|Overall Study|Ineligible for randomization|0|||
156800726|NCT01517984|566025378|FG003|Overall Study|Ineligible for randomization|0|||
156800727|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
156800728|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
156800729|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
156800730|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
156800731|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
156800732|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
156800733|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
156800734|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
156800735|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
156800736|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
156800737|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
156800738|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
156800739|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
157143823|NCT03167619|567276337|FG000|Overall Study|Withdrawal by Subject|1|||
156800740|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800741|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800742|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
156800743|NCT05067335|566025379|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
156800744|NCT05067335|566025380|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
156800745|NCT05067335|566025381|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
156800746|NCT05067335|566025382|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
157020919|NCT02515773|566828527|FG000|Overall Study|Withdrawal by Subject|12|||
157020920|NCT02515773|566828528|FG001|Overall Study|Withdrawal by Subject|2|||
157020921|NCT02515773|566828527|FG000|Overall Study|Lost to Follow-up|119|||
157020922|NCT02515773|566828528|FG001|Overall Study|Lost to Follow-up|126|||
157020923|NCT02515773|566828527|FG000|Overall Study|Discharged from Clinic Services|53|||
157020924|NCT02515773|566828528|FG001|Overall Study|Discharged from Clinic Services|84|||
157020925|NCT02515773|566828527|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
157020926|NCT02515773|566828528|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
157020927|NCT02515773|566828527|FG000|Overall Study|Follow-up at non-study site|8|||
157020928|NCT02515773|566828528|FG001|Overall Study|Follow-up at non-study site|16|||
157020929|NCT02515773|566828527|FG000|Overall Study|Moved from area|9|||
157020930|NCT02515773|566828528|FG001|Overall Study|Moved from area|14|||
157020931|NCT04176965|566828529|FG000|Overall Study|Death|1|||
157020932|NCT04176965|566828530|FG001|Overall Study|Death|2|||
157020933|NCT04176965|566828529|FG000|Overall Study|Lost to Follow-up|10|||
157020934|NCT04176965|566828530|FG001|Overall Study|Lost to Follow-up|2|||
157020935|NCT04176965|566828529|FG000|Overall Study|Withdrawal by Subject|6|||
157020936|NCT04176965|566828530|FG001|Overall Study|Withdrawal by Subject|1|||
157020937|NCT03468218|566828531|FG000|Overall Study|Adverse Event|5|||
157020938|NCT03468218|566828531|FG000|Overall Study|Progressive Disease|16|||
157020939|NCT03468218|566828531|FG000|Overall Study|Death|1|||
157020940|NCT03468218|566828531|FG000|Overall Study|Alternate therapy|1|||
157020941|NCT03468218|566828531|FG000|Overall Study|Withdrawal by Subject|2|||
157020942|NCT03033576|566828532|FG000|Overall Study|Ineligible|1|||
157020943|NCT03033576|566828533|FG001|Overall Study|Ineligible|1|||
157020944|NCT03033576|566828532|FG000|Overall Study|Adverse Event|4|||
157020945|NCT03033576|566828533|FG001|Overall Study|Adverse Event|20|||
157020946|NCT03033576|566828532|FG000|Overall Study|Progression/relapse|9|||
157020947|NCT03033576|566828533|FG001|Overall Study|Progression/relapse|36|||
157020948|NCT03033576|566828532|FG000|Overall Study|Death|1|||
157020949|NCT03033576|566828533|FG001|Overall Study|Death|1|||
157020950|NCT03033576|566828532|FG000|Overall Study|Patient refusal|1|||
157020951|NCT03033576|566828533|FG001|Overall Study|Patient refusal|6|||
157020952|NCT03033576|566828532|FG000|Overall Study|Other, unspecified reasons|0|||
157020953|NCT03033576|566828533|FG001|Overall Study|Other, unspecified reasons|4|||
157020954|NCT03033576|566828532|FG000|Overall Study|Currently on protocol therapy|0|||
157020955|NCT03033576|566828533|FG001|Overall Study|Currently on protocol therapy|2|||
157020956|NCT01214616|566828534|FG000|Overall Study|Progressive disease|2|||
157020957|NCT01214616|566828535|FG001|Overall Study|Progressive disease|2|||
157020958|NCT01214616|566828536|FG002|Overall Study|Progressive disease|2|||
157020959|NCT01214616|566828537|FG003|Overall Study|Progressive disease|4|||
157020960|NCT01214616|566828534|FG000|Overall Study|Dose limiting toxicity|0|||
157020961|NCT01214616|566828535|FG001|Overall Study|Dose limiting toxicity|2|||
157020962|NCT01214616|566828536|FG002|Overall Study|Dose limiting toxicity|0|||
157020963|NCT01214616|566828537|FG003|Overall Study|Dose limiting toxicity|0|||
157020964|NCT01214616|566828534|FG000|Overall Study|Other adverse events|0|||
157020965|NCT01214616|566828535|FG001|Overall Study|Other adverse events|1|||
157020966|NCT01214616|566828536|FG002|Overall Study|Other adverse events|1|||
157020967|NCT01214616|566828537|FG003|Overall Study|Other adverse events|1|||
157020968|NCT01214616|566828534|FG000|Overall Study|Withdrawal by Subject|1|||
157020969|NCT01214616|566828535|FG001|Overall Study|Withdrawal by Subject|0|||
157020970|NCT01214616|566828536|FG002|Overall Study|Withdrawal by Subject|0|||
157020971|NCT01214616|566828537|FG003|Overall Study|Withdrawal by Subject|1|||
157020972|NCT02949362|566828538|FG000|Retrospective Period|Inform consent not signed by participant|4|||
157020973|NCT02949362|566828539|FG001|Retrospective Period|Inform consent not signed by participant|1|||
157020974|NCT02949362|566828540|FG002|Retrospective Period|Inform consent not signed by participant|0|||
157020975|NCT02949362|566828541|FG003|Retrospective Period|Inform consent not signed by participant|0|||
157020976|NCT02949362|566828538|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
156881242|NCT00145977|566325417|FG001|Overall Study|Lost to Follow-up|0|||
156881243|NCT00145977|566325416|FG000|Overall Study|Withdrawal by Subject|1|||
156881244|NCT00145977|566325417|FG001|Overall Study|Withdrawal by Subject|0|||
156881245|NCT01711216|566325418|FG000|Overall Study|Adverse Event|4|||
156881246|NCT01711216|566325418|FG000|Overall Study|Pregnancy|56|||
156881247|NCT01711216|566325418|FG000|Overall Study|Withdrawal by Subject|6|||
156881248|NCT01711216|566325418|FG000|Overall Study|Lost to Follow-up|46|||
157020977|NCT02949362|566828539|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
157020978|NCT02949362|566828540|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
156881249|NCT01711216|566325418|FG000|Overall Study|variety of other minor reasons|83|||
156881250|NCT01711216|566325418|FG000|Overall Study|no reason specified|22|||
156881251|NCT03060551|566325419|FG000|Overall Study|Withdrawal by Subject|1|||
156881252|NCT03060551|566325419|FG000|Overall Study|Adverse Event|1|||
157020979|NCT02949362|566828541|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
157020980|NCT02949362|566828538|FG000|Prospective Period|Other|0|||
157020981|NCT02949362|566828539|FG001|Prospective Period|Other|0|||
157020982|NCT02949362|566828540|FG002|Prospective Period|Other|0|||
156800747|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
156800748|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
156800749|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
156800750|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
156800751|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800752|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800753|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
156800754|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
156800755|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800756|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800757|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
156800758|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
156800759|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800760|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800761|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
156800762|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
156800763|NCT05067335|566025379|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800764|NCT05067335|566025380|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800765|NCT05067335|566025381|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
156800766|NCT05067335|566025382|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
156800767|NCT02724839|566025383|FG000|Overall Study|Withdrawal by Subject|1|||
156800768|NCT02724839|566025384|FG001|Overall Study|Withdrawal by Subject|1|||
156800769|NCT02724839|566025385|FG002|Overall Study|Withdrawal by Subject|0|||
156800770|NCT02724839|566025383|FG000|Overall Study|Lost to Follow-up|0|||
156800771|NCT02724839|566025384|FG001|Overall Study|Lost to Follow-up|3|||
156800772|NCT02724839|566025385|FG002|Overall Study|Lost to Follow-up|2|||
156800773|NCT02724839|566025383|FG000|Overall Study|Physician Decision|0|||
156800774|NCT02724839|566025384|FG001|Overall Study|Physician Decision|0|||
156800775|NCT02724839|566025385|FG002|Overall Study|Physician Decision|3|||
156800776|NCT00949533|566025387|FG000|Overall Study|Lost to Follow-up|0|||
156800777|NCT00949533|566025388|FG001|Overall Study|Lost to Follow-up|1|||
156800778|NCT01948427|566025391|FG000|Overall Study|Serious Adverse Event|3|||
156800779|NCT01948427|566025392|FG001|Overall Study|Serious Adverse Event|0|||
156800780|NCT01948427|566025393|FG002|Overall Study|Serious Adverse Event|0|||
156800781|NCT01948427|566025394|FG003|Overall Study|Serious Adverse Event|0|||
156800782|NCT01948427|566025395|FG004|Overall Study|Serious Adverse Event|1|||
156800783|NCT01948427|566025391|FG000|Overall Study|Investigator Request|0|||
156800784|NCT01948427|566025392|FG001|Overall Study|Investigator Request|8|||
156800785|NCT01948427|566025393|FG002|Overall Study|Investigator Request|0|||
156800786|NCT01948427|566025394|FG003|Overall Study|Investigator Request|0|||
156800787|NCT01948427|566025395|FG004|Overall Study|Investigator Request|6|||
156800788|NCT01948427|566025391|FG000|Overall Study|Lost to Follow-up|1|||
156800789|NCT01948427|566025392|FG001|Overall Study|Lost to Follow-up|0|||
156800790|NCT01948427|566025393|FG002|Overall Study|Lost to Follow-up|0|||
156800791|NCT01948427|566025394|FG003|Overall Study|Lost to Follow-up|0|||
156800792|NCT01948427|566025395|FG004|Overall Study|Lost to Follow-up|4|||
156800793|NCT01948427|566025391|FG000|Overall Study|Withdrawal by Subject|2|||
156800794|NCT01948427|566025392|FG001|Overall Study|Withdrawal by Subject|0|||
156800795|NCT01948427|566025393|FG002|Overall Study|Withdrawal by Subject|0|||
156800796|NCT01948427|566025394|FG003|Overall Study|Withdrawal by Subject|0|||
156800797|NCT01948427|566025395|FG004|Overall Study|Withdrawal by Subject|1|||
156800798|NCT01948427|566025391|FG000|Overall Study|Other, Not Specified|1|||
156800799|NCT01948427|566025392|FG001|Overall Study|Other, Not Specified|9|||
156800800|NCT01948427|566025393|FG002|Overall Study|Other, Not Specified|0|||
156800801|NCT01948427|566025394|FG003|Overall Study|Other, Not Specified|0|||
156800802|NCT01948427|566025395|FG004|Overall Study|Other, Not Specified|2|||
156800803|NCT02434081|566025396|FG000|Overall Study|Death (never started treatment)|2|||
156800804|NCT02434081|566025396|FG000|Overall Study|Death|2|||
156800805|NCT02434081|566025396|FG000|Overall Study|Progression|20|||
156800806|NCT02434081|566025396|FG000|Overall Study|Adverse Event|20|||
156800807|NCT02434081|566025396|FG000|Overall Study|Physician Decision|2|||
156800808|NCT02434081|566025396|FG000|Overall Study|Withdrawal by Subject|1|||
156800809|NCT02434081|566025396|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
156800810|NCT02006927|566025403|FG000|Overall Study|Adverse Event|2|||
156800811|NCT02006927|566025403|FG000|Overall Study|Withdrawal by Subject|1|||
157143824|NCT03167619|567276338|FG001|Overall Study|Withdrawal by Subject|2|||
157143825|NCT03167619|567276337|FG000|Overall Study|Physician Decision|0|||
156800812|NCT02943473|566025410|FG000|Overall Study|enrolled but not dosed|1|||
156800813|NCT02943473|566025410|FG000|Overall Study|screen failure|1|||
156800814|NCT02943473|566025410|FG000|Overall Study|Physician Decision|4|||
156800815|NCT01728246|566025411|FG000|Overall Study|Participant needed rescue medication|1|||
156800816|NCT01728246|566025412|FG001|Overall Study|Participant needed rescue medication|5|||
156800817|NCT01728246|566025411|FG000|Overall Study|Protocol Violation|1|||
156800818|NCT01728246|566025412|FG001|Overall Study|Protocol Violation|0|||
156800819|NCT01728246|566025411|FG000|Overall Study|Withdrawal by Subject|2|||
156800820|NCT01728246|566025412|FG001|Overall Study|Withdrawal by Subject|3|||
156800821|NCT01728246|566025411|FG000|Overall Study|Lost to Follow-up|23|||
156800822|NCT01728246|566025412|FG001|Overall Study|Lost to Follow-up|22|||
156800823|NCT01728246|566025411|FG000|Overall Study|Lack of Efficacy|1|||
156800824|NCT01728246|566025412|FG001|Overall Study|Lack of Efficacy|1|||
156800825|NCT01728246|566025411|FG000|Overall Study|Adverse Event|8|||
156800826|NCT01728246|566025412|FG001|Overall Study|Adverse Event|5|||
156800827|NCT05805150|566025413|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
156800828|NCT05805150|566025414|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
156800829|NCT00431964|566025417|FG000|Overall Study|Adverse Event|1|||
156800830|NCT00431964|566025418|FG001|Overall Study|Adverse Event|0|||
156800831|NCT00431964|566025417|FG000|Overall Study|Lost to Follow-up|1|||
156800832|NCT00431964|566025418|FG001|Overall Study|Lost to Follow-up|2|||
156800833|NCT00431964|566025417|FG000|Overall Study|Physician Decision|2|||
156800834|NCT00431964|566025418|FG001|Overall Study|Physician Decision|2|||
156800835|NCT00431964|566025417|FG000|Overall Study|Withdrawal by Subject|2|||
156800836|NCT00431964|566025418|FG001|Overall Study|Withdrawal by Subject|1|||
156800837|NCT00431964|566025417|FG000|Overall Study|Parental Consent Withdrawn|0|||
156800838|NCT00431964|566025418|FG001|Overall Study|Parental Consent Withdrawn|2|||
156800839|NCT00431964|566025417|FG000|Overall Study|Due to Unstable Health|0|||
156800840|NCT00431964|566025418|FG001|Overall Study|Due to Unstable Health|1|||
156800841|NCT04138056|566025422|FG000|Primary Study|Lost to Follow-up|3|||
156800842|NCT04138056|566025423|FG001|Primary Study|Lost to Follow-up|4|||
156800843|NCT04138056|566025424|FG002|Primary Study|Lost to Follow-up|1|||
156800844|NCT04138056|566025425|FG003|Primary Study|Lost to Follow-up|1|||
156800845|NCT04138056|566025426|FG004|Primary Study|Lost to Follow-up|4|||
156800846|NCT04138056|566025422|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
156800847|NCT04138056|566025423|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
156800848|NCT04138056|566025424|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
156800849|NCT04138056|566025425|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
156800850|NCT04138056|566025426|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
156800851|NCT04138056|566025422|FG000|Extension Study|Lost to Follow-up|1|||
156800852|NCT04138056|566025423|FG001|Extension Study|Lost to Follow-up|2|||
156800853|NCT04138056|566025424|FG002|Extension Study|Lost to Follow-up|1|||
156800854|NCT04138056|566025425|FG003|Extension Study|Lost to Follow-up|0|||
156800855|NCT04138056|566025426|FG004|Extension Study|Lost to Follow-up|1|||
156800856|NCT01959932|566025428|FG000|Overall Study|Withdrawal by Subject|1|||
156800857|NCT01959932|566025429|FG001|Overall Study|Withdrawal by Subject|0|||
156800858|NCT01959932|566025430|FG002|Overall Study|Withdrawal by Subject|0|||
156800859|NCT00485173|566025438|FG000|Overall Study|Death|4|||
156800860|NCT00485173|566025439|FG001|Overall Study|Death|3|||
156800861|NCT00485173|566025438|FG000|Overall Study|Lost to Follow-up|32|||
156800862|NCT00485173|566025439|FG001|Overall Study|Lost to Follow-up|61|||
156800863|NCT00829244|566025442|FG000|Overall Study|Adverse Event|1|||
156800864|NCT00829244|566025443|FG001|Overall Study|Adverse Event|3|||
156800865|NCT00829244|566025442|FG000|Overall Study|Protocol Violation|1|||
156800866|NCT00829244|566025443|FG001|Overall Study|Protocol Violation|0|||
156800867|NCT00829244|566025442|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
156800868|NCT00829244|566025443|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
156800869|NCT00829244|566025442|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
156800870|NCT00829244|566025443|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
156800871|NCT00829244|566025442|FG000|Overall Study|No fertilization|2|||
156800872|NCT00829244|566025443|FG001|Overall Study|No fertilization|2|||
156800873|NCT00829244|566025442|FG000|Overall Study|All embryos discarded|0|||
156800874|NCT00829244|566025443|FG001|Overall Study|All embryos discarded|3|||
156800875|NCT00829244|566025442|FG000|Overall Study|No embryo cleavage|0|||
156800876|NCT00829244|566025443|FG001|Overall Study|No embryo cleavage|2|||
156800877|NCT02297412|566025444|FG000|Overall Study|Canceled|1|||
156800878|NCT02297412|566025445|FG001|Overall Study|Canceled|1|||
156800879|NCT04583618|566025452|FG000|Overall Study|Adverse Event|0|||
156800880|NCT04583618|566025453|FG001|Overall Study|Adverse Event|0|||
156800881|NCT04583618|566025454|FG002|Overall Study|Adverse Event|1|||
156800882|NCT04583618|566025455|FG003|Overall Study|Adverse Event|0|||
156800883|NCT04583618|566025456|FG004|Overall Study|Adverse Event|0|||
156800884|NCT04583618|566025452|FG000|Overall Study|Protocol deviation|1|||
156800885|NCT04583618|566025453|FG001|Overall Study|Protocol deviation|1|||
156800886|NCT04583618|566025454|FG002|Overall Study|Protocol deviation|1|||
156800887|NCT04583618|566025455|FG003|Overall Study|Protocol deviation|0|||
156800888|NCT04583618|566025456|FG004|Overall Study|Protocol deviation|0|||
156800889|NCT04583618|566025452|FG000|Overall Study|Withdrawal by Subject|2|||
156800890|NCT04583618|566025453|FG001|Overall Study|Withdrawal by Subject|1|||
156800891|NCT04583618|566025454|FG002|Overall Study|Withdrawal by Subject|3|||
156800892|NCT04583618|566025455|FG003|Overall Study|Withdrawal by Subject|1|||
156800893|NCT04583618|566025456|FG004|Overall Study|Withdrawal by Subject|1|||
156800894|NCT04583618|566025452|FG000|Overall Study|Lost to Follow-up|0|||
156800895|NCT04583618|566025453|FG001|Overall Study|Lost to Follow-up|1|||
156800896|NCT04583618|566025454|FG002|Overall Study|Lost to Follow-up|3|||
156800897|NCT04583618|566025455|FG003|Overall Study|Lost to Follow-up|1|||
156800898|NCT04583618|566025456|FG004|Overall Study|Lost to Follow-up|1|||
156800899|NCT03193801|566025461|FG000|Overall Study|Physician Decision|2|||
156800900|NCT03193801|566025461|FG000|Overall Study|Withdrawal by Subject|1|||
156800901|NCT00529633|566027207|FG000|Overall Study|Withdrawal by Subject|1|||
156800902|NCT00529633|566027208|FG001|Overall Study|Withdrawal by Subject|1|||
156800903|NCT02114177|566027209|FG000|Overall Study|Lost to Follow-up|1|||
156800904|NCT02114177|566027210|FG001|Overall Study|Lost to Follow-up|2|||
156800905|NCT02114177|566027209|FG000|Overall Study|Withdrawal by Subject|6|||
156800906|NCT02114177|566027210|FG001|Overall Study|Withdrawal by Subject|1|||
156800907|NCT02114177|566027209|FG000|Overall Study|Other|2|||
156800908|NCT02114177|566027210|FG001|Overall Study|Other|1|||
156800909|NCT01897493|566027211|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
156800910|NCT01732536|566027216|FG000|Overall Study|Withdrawal by Subject|1|||
156800911|NCT01732536|566027217|FG001|Overall Study|Withdrawal by Subject|1|||
156800912|NCT01246960|566027218|FG000|Overall Study|Lost to Follow-up|3|||
156800913|NCT01246960|566027219|FG001|Overall Study|Lost to Follow-up|1|||
156800914|NCT01246960|566027218|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
156800915|NCT01246960|566027219|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
156800916|NCT05111145|566027220|FG000|Overall Study|Commercial drug is available for participant|76|||
156800917|NCT05111145|566027220|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
156800918|NCT02336815|566027223|FG000|Overall Study|Disease Progression|45|||
156800919|NCT02336815|566027224|FG001|Overall Study|Disease Progression|70|||
156800920|NCT02336815|566027223|FG000|Overall Study|Adverse Event|18|||
156800921|NCT02336815|566027224|FG001|Overall Study|Adverse Event|39|||
156800922|NCT02336815|566027223|FG000|Overall Study|Physician Decision|11|||
156800923|NCT02336815|566027224|FG001|Overall Study|Physician Decision|4|||
156800924|NCT02336815|566027223|FG000|Overall Study|Withdrawal by Subject|3|||
156800925|NCT02336815|566027224|FG001|Overall Study|Withdrawal by Subject|2|||
156800926|NCT02336815|566027223|FG000|Overall Study|Lost to Follow-up|1|||
156800927|NCT02336815|566027224|FG001|Overall Study|Lost to Follow-up|3|||
156800928|NCT02336815|566027223|FG000|Overall Study|Other|1|||
156800929|NCT02336815|566027224|FG001|Overall Study|Other|5|||
156800930|NCT03376516|566027225|FG000|Overall Study|Not treated|1|||
156800931|NCT03376516|566027225|FG000|Overall Study|Consent withdrawn|1|||
156800932|NCT01581684|566027226|FG000|Overall Study|Other reason not defined|0|||
156800933|NCT01581684|566027227|FG001|Overall Study|Other reason not defined|0|||
156800934|NCT01581684|566027228|FG002|Overall Study|Other reason not defined|0|||
156800935|NCT01581684|566027229|FG003|Overall Study|Other reason not defined|0|||
156800936|NCT01581684|566027230|FG004|Overall Study|Other reason not defined|0|||
156800937|NCT01581684|566027231|FG005|Overall Study|Other reason not defined|0|||
156800938|NCT01581684|566027232|FG006|Overall Study|Other reason not defined|0|||
156800939|NCT01581684|566027233|FG007|Overall Study|Other reason not defined|0|||
156800940|NCT01581684|566027234|FG008|Overall Study|Other reason not defined|1|||
156800941|NCT01581684|566027235|FG009|Overall Study|Other reason not defined|0|||
156800942|NCT03235050|566027236|FG000|Overall Study|Adverse Event|0|||
156800943|NCT03235050|566027237|FG001|Overall Study|Adverse Event|0|||
156800944|NCT03235050|566027238|FG002|Overall Study|Adverse Event|1|||
156800945|NCT03235050|566027239|FG003|Overall Study|Adverse Event|4|||
156800946|NCT03235050|566027240|FG004|Overall Study|Adverse Event|1|||
156800947|NCT03235050|566027236|FG000|Overall Study|Death|0|||
156800948|NCT03235050|566027237|FG001|Overall Study|Death|0|||
156800949|NCT03235050|566027238|FG002|Overall Study|Death|0|||
156800950|NCT03235050|566027239|FG003|Overall Study|Death|2|||
156881253|NCT02660983|566325422|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
156881254|NCT02660983|566325423|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
156881255|NCT02660983|566325422|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
156881256|NCT02660983|566325423|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
156881257|NCT02660983|566325422|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
156881258|NCT02660983|566325423|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
156881259|NCT02660983|566325422|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
156800951|NCT03235050|566027240|FG004|Overall Study|Death|1|||
156800952|NCT03235050|566027236|FG000|Overall Study|Lost to Follow-up|1|||
156800953|NCT03235050|566027237|FG001|Overall Study|Lost to Follow-up|2|||
156800954|NCT03235050|566027238|FG002|Overall Study|Lost to Follow-up|1|||
156800955|NCT03235050|566027239|FG003|Overall Study|Lost to Follow-up|2|||
156800956|NCT03235050|566027240|FG004|Overall Study|Lost to Follow-up|0|||
156800957|NCT03235050|566027236|FG000|Overall Study|Withdrawal by Subject|3|||
156800958|NCT03235050|566027237|FG001|Overall Study|Withdrawal by Subject|2|||
156800959|NCT03235050|566027238|FG002|Overall Study|Withdrawal by Subject|2|||
157020983|NCT02949362|566828541|FG003|Prospective Period|Other|4|||
157020984|NCT02471638|566828545|FG000|Overall Study|Early Term Withdrawal|10|||
157020985|NCT03376321|566830777|FG000|Overall Study|Other|5|||
157020986|NCT03376321|566830778|FG001|Overall Study|Other|1|||
157020987|NCT03376321|566830777|FG000|Overall Study|Withdrawal by Subject|8|||
157020988|NCT03376321|566830778|FG001|Overall Study|Withdrawal by Subject|14|||
157020989|NCT03376321|566830777|FG000|Overall Study|Lost to Follow-up|1|||
157020990|NCT03376321|566830778|FG001|Overall Study|Lost to Follow-up|7|||
157020991|NCT03376321|566830777|FG000|Overall Study|Death|4|||
157020992|NCT03376321|566830778|FG001|Overall Study|Death|0|||
157020993|NCT03376321|566830777|FG000|Overall Study|Randomized, not treated|5|||
157143826|NCT03167619|567276338|FG001|Overall Study|Physician Decision|1|||
157143827|NCT02082184|567276340|FG000|Overall Study|Adverse Event|1|||
156800960|NCT03235050|566027239|FG003|Overall Study|Withdrawal by Subject|5|||
156800961|NCT03235050|566027240|FG004|Overall Study|Withdrawal by Subject|7|||
156800962|NCT03235050|566027236|FG000|Overall Study|Other reasons|0|||
156800963|NCT03235050|566027237|FG001|Overall Study|Other reasons|1|||
156800964|NCT03235050|566027238|FG002|Overall Study|Other reasons|0|||
156800965|NCT03235050|566027239|FG003|Overall Study|Other reasons|1|||
156800966|NCT03235050|566027240|FG004|Overall Study|Other reasons|2|||
156800967|NCT00370292|566027241|FG000|Overall Study|Disease Progression|4|||
156800968|NCT00370292|566027241|FG000|Overall Study|Adverse Event|7|||
156800969|NCT00370292|566027241|FG000|Overall Study|Physician Decision|2|||
156800970|NCT02986074|566027242|FG000|First Trial Period|Adverse Event|1|||
156800971|NCT02986074|566027243|FG001|First Trial Period|Adverse Event|0|||
156800972|NCT02986074|566027244|FG002|First Trial Period|Adverse Event|0|||
156800973|NCT02986074|566027245|FG003|First Trial Period|Adverse Event|0|||
156800974|NCT02986074|566027242|FG000|Follow up Period|system explant|0|||
156800975|NCT02986074|566027243|FG001|Follow up Period|system explant|0|||
156800976|NCT02986074|566027244|FG002|Follow up Period|system explant|1|||
156800977|NCT02986074|566027245|FG003|Follow up Period|system explant|2|||
156800978|NCT02986074|566027242|FG000|Follow up Period|Physician Decision|0|||
156800979|NCT02986074|566027243|FG001|Follow up Period|Physician Decision|0|||
156800980|NCT02986074|566027244|FG002|Follow up Period|Physician Decision|0|||
156800981|NCT02986074|566027245|FG003|Follow up Period|Physician Decision|1|||
156800982|NCT00069641|566027248|FG000|Overall Study|Death|1|||
156800983|NCT00069641|566027249|FG001|Overall Study|Death|0|||
156800984|NCT00069641|566027250|FG002|Overall Study|Death|1|||
156800985|NCT02239926|566027251|FG000|Overall Study|Withdrawal by Subject|0|||
156800986|NCT02239926|566027252|FG001|Overall Study|Withdrawal by Subject|1|||
156800987|NCT02704208|566027253|FG000|Overall Study|Lost to Follow-up|42|||
156800988|NCT02704208|566027254|FG001|Overall Study|Lost to Follow-up|37|||
156800989|NCT04099277|566027255|FG000|Overall Study|Physician Decision|1|||
156800990|NCT04099277|566027255|FG000|Overall Study|Withdrawal by Subject|1|||
156800991|NCT00598650|566027256|FG000|Overall Study|Withdrawal by Subject|3|||
156800992|NCT00598650|566027256|FG000|Overall Study|Adverse Event|18|||
156800993|NCT00598650|566027256|FG000|Overall Study|No treatment for 3 weeks|1|||
156800994|NCT00598650|566027256|FG000|Overall Study|Not eligible|1|||
156800995|NCT00598650|566027256|FG000|Overall Study|Prohibited Concomitant Medication|2|||
156800996|NCT00598650|566027256|FG000|Overall Study|Physician Decision|2|||
156800997|NCT03545672|566027257|FG000|Overall Study|Uncertain diagnosis|2|||
156800998|NCT03545672|566027258|FG001|Overall Study|Uncertain diagnosis|1|||
156800999|NCT03545672|566027257|FG000|Overall Study|Protocol Violation|2|||
156801000|NCT03545672|566027258|FG001|Overall Study|Protocol Violation|2|||
156801001|NCT01628913|566027259|FG000|Overall Study|Adverse Event|12|||
156801002|NCT01628913|566027260|FG001|Overall Study|Adverse Event|5|||
156801003|NCT01628913|566027259|FG000|Overall Study|Disease Progression|11|||
156801004|NCT01628913|566027260|FG001|Overall Study|Disease Progression|14|||
156801005|NCT01628913|566027259|FG000|Overall Study|Protocol Violation|1|||
156801006|NCT01628913|566027260|FG001|Overall Study|Protocol Violation|0|||
156801007|NCT01628913|566027259|FG000|Overall Study|Death|1|||
157143828|NCT02082184|567276341|FG001|Overall Study|Adverse Event|0|||
156801008|NCT01628913|566027260|FG001|Overall Study|Death|0|||
156801009|NCT01628913|566027259|FG000|Overall Study|study terminated by Sponsor|4|||
156801010|NCT01628913|566027260|FG001|Overall Study|study terminated by Sponsor|9|||
156801011|NCT01628913|566027259|FG000|Overall Study|Withdrawal by Subject|1|||
156801012|NCT01628913|566027260|FG001|Overall Study|Withdrawal by Subject|0|||
156801013|NCT01628913|566027259|FG000|Overall Study|Physician Decision|1|||
156801014|NCT01628913|566027260|FG001|Overall Study|Physician Decision|3|||
156801015|NCT02415556|566027264|FG000|Overall Study|Adverse Event|3|||
156801016|NCT02415556|566027265|FG001|Overall Study|Adverse Event|4|||
156801017|NCT02415556|566027266|FG002|Overall Study|Adverse Event|2|||
156801018|NCT02415556|566027267|FG003|Overall Study|Adverse Event|4|||
156801019|NCT02415556|566027264|FG000|Overall Study|Lost to Follow-up|4|||
157020994|NCT03376321|566830778|FG001|Overall Study|Randomized, not treated|3|||
157020995|NCT02995434|566830779|FG000|Overall Study|Adverse Event|1|||
157020996|NCT02995434|566830780|FG001|Overall Study|Adverse Event|0|||
157020997|NCT02995434|566830779|FG000|Overall Study|Withdrawal by Subject|6|||
157020998|NCT02995434|566830780|FG001|Overall Study|Withdrawal by Subject|3|||
157020999|NCT05273749|566830783|FG000|Overall Study|Adverse Event|14|||
156801020|NCT02415556|566027265|FG001|Overall Study|Lost to Follow-up|5|||
156801021|NCT02415556|566027266|FG002|Overall Study|Lost to Follow-up|4|||
156801022|NCT02415556|566027267|FG003|Overall Study|Lost to Follow-up|1|||
156801023|NCT02415556|566027264|FG000|Overall Study|Withdrawal by Subject|13|||
156801024|NCT02415556|566027265|FG001|Overall Study|Withdrawal by Subject|4|||
156801025|NCT02415556|566027266|FG002|Overall Study|Withdrawal by Subject|14|||
156801026|NCT02415556|566027267|FG003|Overall Study|Withdrawal by Subject|12|||
156801027|NCT02415556|566027264|FG000|Overall Study|Physician Decision|1|||
156801028|NCT02415556|566027265|FG001|Overall Study|Physician Decision|3|||
156801029|NCT02415556|566027266|FG002|Overall Study|Physician Decision|1|||
156801030|NCT02415556|566027267|FG003|Overall Study|Physician Decision|2|||
156801031|NCT02415556|566027264|FG000|Overall Study|Censored - study completion|4|||
156801032|NCT02415556|566027265|FG001|Overall Study|Censored - study completion|5|||
156801033|NCT02415556|566027266|FG002|Overall Study|Censored - study completion|1|||
156801034|NCT02415556|566027267|FG003|Overall Study|Censored - study completion|0|||
156801035|NCT02415556|566027264|FG000|Overall Study|Family-related issues|0|||
156801036|NCT02415556|566027265|FG001|Overall Study|Family-related issues|0|||
156801037|NCT02415556|566027266|FG002|Overall Study|Family-related issues|0|||
156801038|NCT02415556|566027267|FG003|Overall Study|Family-related issues|1|||
156801039|NCT01621178|566027268|FG000|Overall Study|Adverse Event|5|||
156801040|NCT01621178|566027269|FG001|Overall Study|Adverse Event|2|||
156801041|NCT01621178|566027270|FG002|Overall Study|Adverse Event|8|||
156801042|NCT01621178|566027268|FG000|Overall Study|Death|6|||
156801043|NCT01621178|566027269|FG001|Overall Study|Death|7|||
156801044|NCT01621178|566027270|FG002|Overall Study|Death|2|||
156801045|NCT01621178|566027268|FG000|Overall Study|Lost to Follow-up|1|||
156801046|NCT01621178|566027269|FG001|Overall Study|Lost to Follow-up|2|||
156801047|NCT01621178|566027270|FG002|Overall Study|Lost to Follow-up|1|||
156801048|NCT01621178|566027268|FG000|Overall Study|Withdrawal by Subject|14|||
156801049|NCT01621178|566027269|FG001|Overall Study|Withdrawal by Subject|17|||
156801050|NCT01621178|566027270|FG002|Overall Study|Withdrawal by Subject|18|||
156801051|NCT01621178|566027268|FG000|Overall Study|Physician Decision|5|||
156801052|NCT01621178|566027269|FG001|Overall Study|Physician Decision|2|||
156801053|NCT01621178|566027270|FG002|Overall Study|Physician Decision|7|||
156801054|NCT00105534|566027271|FG000|Overall Study|Adverse Event|2|||
156801055|NCT00105534|566027272|FG001|Overall Study|Adverse Event|5|||
156801056|NCT00105534|566027271|FG000|Overall Study|Protocol Violation|1|||
156801057|NCT00105534|566027272|FG001|Overall Study|Protocol Violation|4|||
156801058|NCT00105534|566027271|FG000|Overall Study|Withdrawal by Subject|6|||
156801059|NCT00105534|566027272|FG001|Overall Study|Withdrawal by Subject|6|||
156801060|NCT00105534|566027271|FG000|Overall Study|Lost to Follow-up|5|||
156801061|NCT00105534|566027272|FG001|Overall Study|Lost to Follow-up|1|||
156801062|NCT00105534|566027271|FG000|Overall Study|Lack of Efficacy|7|||
156801063|NCT00105534|566027272|FG001|Overall Study|Lack of Efficacy|15|||
156801064|NCT00105534|566027271|FG000|Overall Study|Treatment unmasked|1|||
156801065|NCT00105534|566027272|FG001|Overall Study|Treatment unmasked|0|||
156801066|NCT00105534|566027271|FG000|Overall Study|Other Reason|0|||
156801067|NCT00105534|566027272|FG001|Overall Study|Other Reason|2|||
156801068|NCT04102007|566027274|FG000|Overall Study|Adverse Event|4|||
156801069|NCT04102007|566027274|FG000|Overall Study|Lost to Follow-up|3|||
156801070|NCT04102007|566027274|FG000|Overall Study|Withdrawal by Subject|12|||
156801071|NCT04102007|566027274|FG000|Overall Study|Eligibility Violation|5|||
156801072|NCT04102007|566027274|FG000|Overall Study|Lack of Efficacy|6|||
156801073|NCT04102007|566027274|FG000|Overall Study|Protocol Deviation|5|||
156801074|NCT04102007|566027274|FG000|Overall Study|Protocol Compliance|1|||
156801075|NCT04102007|566027274|FG000|Overall Study|Withdrew Treatment|2|||
156801076|NCT04102007|566027274|FG000|Overall Study|Pregnancy|1|||
156881260|NCT02660983|566325423|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
156881261|NCT02660983|566325422|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
156881262|NCT02660983|566325423|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
156801077|NCT05173974|566027275|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801078|NCT05173974|566027276|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801079|NCT05173974|566027277|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
156801080|NCT05173974|566027278|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
156801081|NCT05173974|566027275|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156881263|NCT02660983|566325422|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
156801082|NCT05173974|566027276|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
156801083|NCT05173974|566027277|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156801084|NCT05173974|566027278|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
156801085|NCT03289143|566027279|FG000|Overall Study|Caregiver Unavailability|1|||
156801086|NCT03289143|566027280|FG001|Overall Study|Caregiver Unavailability|1|||
156801087|NCT03289143|566027281|FG002|Overall Study|Caregiver Unavailability|0|||
156801088|NCT03289143|566027282|FG003|Overall Study|Caregiver Unavailability|0|||
156801089|NCT03289143|566027279|FG000|Overall Study|Research Department Closure|0|||
156801090|NCT03289143|566027280|FG001|Overall Study|Research Department Closure|0|||
156801091|NCT03289143|566027281|FG002|Overall Study|Research Department Closure|1|||
156801092|NCT03289143|566027282|FG003|Overall Study|Research Department Closure|0|||
156801093|NCT03289143|566027279|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801094|NCT03289143|566027280|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801095|NCT03289143|566027281|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
156801096|NCT03289143|566027282|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
156801097|NCT03289143|566027279|FG000|Overall Study|Medical Monitor Decision|1|||
156801098|NCT03289143|566027280|FG001|Overall Study|Medical Monitor Decision|0|||
156801099|NCT03289143|566027281|FG002|Overall Study|Medical Monitor Decision|0|||
156801100|NCT03289143|566027282|FG003|Overall Study|Medical Monitor Decision|0|||
156801101|NCT03289143|566027279|FG000|Overall Study|Participant Non-Compliance|0|||
156801102|NCT03289143|566027280|FG001|Overall Study|Participant Non-Compliance|0|||
156801103|NCT03289143|566027281|FG002|Overall Study|Participant Non-Compliance|1|||
156881264|NCT02660983|566325423|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
156881265|NCT02660983|566325422|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
156881266|NCT02660983|566325423|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
156881267|NCT00334113|566325425|FG000|Overall Study|Lost to Follow-up|2|||
156881268|NCT00334113|566325426|FG001|Overall Study|Lost to Follow-up|2|||
156881269|NCT00334113|566325425|FG000|Overall Study|Withdrawal by Subject|0|||
156881270|NCT00334113|566325426|FG001|Overall Study|Withdrawal by Subject|1|||
156881271|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
156881272|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
156881273|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
156881274|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
156881275|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Other|2|||
156881276|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
156881277|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
156881278|NCT02509026|566325431|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
156881279|NCT02509026|566325431|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
156881280|NCT02509026|566325431|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
156881281|NCT02509026|566325431|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
156881282|NCT02509026|566325431|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
156881283|NCT02509026|566325431|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
156881284|NCT00243841|566325435|FG000|Overall Study|Physician Decision|0|||
156881285|NCT00243841|566325436|FG001|Overall Study|Physician Decision|0|||
156881286|NCT00243841|566325437|FG002|Overall Study|Physician Decision|1|||
156881287|NCT00243841|566325438|FG003|Overall Study|Physician Decision|0|||
156881288|NCT00243841|566325439|FG004|Overall Study|Physician Decision|0|||
156881289|NCT00243841|566325440|FG005|Overall Study|Physician Decision|2|||
156881290|NCT05601544|566325441|FG000|Phase 2 Period 1|Adverse Event|0|||
156881291|NCT05601544|566325442|FG001|Phase 2 Period 1|Adverse Event|1|||
156881292|NCT05601544|566325443|FG002|Phase 2 Period 1|Adverse Event|0|||
156881293|NCT05601544|566325444|FG003|Phase 2 Period 1|Adverse Event|0|||
156881294|NCT05601544|566325445|FG004|Phase 2 Period 1|Adverse Event|0|||
156881295|NCT05601544|566325446|FG005|Phase 2 Period 1|Adverse Event|0|||
156881296|NCT04303195|566325447|FG000|Overall Study|Adverse Event|1|||
156801104|NCT03289143|566027282|FG003|Overall Study|Participant Non-Compliance|0|||
156801105|NCT03289143|566027279|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156801106|NCT03289143|566027280|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156801107|NCT03289143|566027281|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
156881297|NCT04303195|566325448|FG001|Overall Study|Adverse Event|3|||
156881298|NCT04303195|566325449|FG002|Overall Study|Adverse Event|7|||
156881299|NCT04303195|566325450|FG003|Overall Study|Adverse Event|0|||
156881300|NCT04303195|566325447|FG000|Overall Study|Lost to Follow-up|1|||
156881301|NCT04303195|566325448|FG001|Overall Study|Lost to Follow-up|0|||
156881302|NCT04303195|566325449|FG002|Overall Study|Lost to Follow-up|1|||
156881303|NCT04303195|566325450|FG003|Overall Study|Lost to Follow-up|4|||
156881304|NCT04303195|566325447|FG000|Overall Study|Withdrawal by Subject|3|||
156881305|NCT04303195|566325448|FG001|Overall Study|Withdrawal by Subject|1|||
156881306|NCT04303195|566325449|FG002|Overall Study|Withdrawal by Subject|1|||
156881307|NCT04303195|566325450|FG003|Overall Study|Withdrawal by Subject|1|||
156881308|NCT04303195|566325447|FG000|Overall Study|No study drug administered or protocol deviation|0|||
156881309|NCT04303195|566325448|FG001|Overall Study|No study drug administered or protocol deviation|2|||
156801108|NCT03289143|566027282|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
156881310|NCT04303195|566325449|FG002|Overall Study|No study drug administered or protocol deviation|0|||
156881311|NCT04303195|566325450|FG003|Overall Study|No study drug administered or protocol deviation|2|||
156881312|NCT01064947|566325451|FG000|Overall Study|negative culture|41|||
156881313|NCT02970942|566325452|FG000|Overall Study|Death|0|||
156881314|NCT02970942|566325453|FG001|Overall Study|Death|1|||
156881315|NCT02970942|566325454|FG002|Overall Study|Death|0|||
156881316|NCT02970942|566325455|FG003|Overall Study|Death|0|||
156881317|NCT02970942|566325452|FG000|Overall Study|Lost to Follow-up|1|||
156881318|NCT02970942|566325453|FG001|Overall Study|Lost to Follow-up|0|||
156881319|NCT02970942|566325454|FG002|Overall Study|Lost to Follow-up|2|||
156881320|NCT02970942|566325455|FG003|Overall Study|Lost to Follow-up|1|||
156801109|NCT03289143|566027279|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801110|NCT03289143|566027280|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801111|NCT03289143|566027281|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
156801112|NCT03289143|566027282|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
156801113|NCT03289143|566027279|FG000|Overall Study|Caregiver Passed Away|1|||
156801114|NCT03289143|566027280|FG001|Overall Study|Caregiver Passed Away|0|||
156801115|NCT03289143|566027281|FG002|Overall Study|Caregiver Passed Away|0|||
156801116|NCT03289143|566027282|FG003|Overall Study|Caregiver Passed Away|0|||
156801117|NCT03289143|566027279|FG000|Overall Study|Physician Decision|0|||
156801118|NCT03289143|566027280|FG001|Overall Study|Physician Decision|2|||
156801119|NCT03289143|566027281|FG002|Overall Study|Physician Decision|2|||
156801120|NCT03289143|566027282|FG003|Overall Study|Physician Decision|2|||
156801121|NCT03289143|566027279|FG000|Overall Study|Protocol Deviation|2|||
156801122|NCT03289143|566027280|FG001|Overall Study|Protocol Deviation|1|||
156801123|NCT03289143|566027281|FG002|Overall Study|Protocol Deviation|3|||
156801124|NCT03289143|566027282|FG003|Overall Study|Protocol Deviation|1|||
156801125|NCT03289143|566027279|FG000|Overall Study|Study Terminated By Sponsor|101|||
156801126|NCT03289143|566027280|FG001|Overall Study|Study Terminated By Sponsor|75|||
156801127|NCT03289143|566027281|FG002|Overall Study|Study Terminated By Sponsor|100|||
156801128|NCT03289143|566027282|FG003|Overall Study|Study Terminated By Sponsor|69|||
156801129|NCT03289143|566027279|FG000|Overall Study|Withdrawal by Subject|14|||
156801130|NCT03289143|566027280|FG001|Overall Study|Withdrawal by Subject|6|||
156801131|NCT03289143|566027281|FG002|Overall Study|Withdrawal by Subject|14|||
156801132|NCT03289143|566027282|FG003|Overall Study|Withdrawal by Subject|12|||
156801133|NCT03289143|566027279|FG000|Overall Study|Adverse Event|10|||
156801134|NCT03289143|566027280|FG001|Overall Study|Adverse Event|7|||
156801135|NCT03289143|566027281|FG002|Overall Study|Adverse Event|6|||
156801136|NCT03289143|566027282|FG003|Overall Study|Adverse Event|5|||
156801137|NCT03289143|566027279|FG000|Overall Study|Death|2|||
156801138|NCT03289143|566027280|FG001|Overall Study|Death|0|||
156801139|NCT03289143|566027281|FG002|Overall Study|Death|2|||
156801140|NCT03289143|566027282|FG003|Overall Study|Death|1|||
156801141|NCT03289143|566027279|FG000|Overall Study|Lost to Follow-up|2|||
156801142|NCT03289143|566027280|FG001|Overall Study|Lost to Follow-up|1|||
156801143|NCT03289143|566027281|FG002|Overall Study|Lost to Follow-up|1|||
156801144|NCT03289143|566027282|FG003|Overall Study|Lost to Follow-up|0|||
156801145|NCT03289143|566027279|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
156801146|NCT03289143|566027280|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
156801147|NCT03289143|566027281|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
156801148|NCT03289143|566027282|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
156801149|NCT03289143|566027279|FG000|Overall Study|Withdrawal by Caregiver|0|||
156801150|NCT03289143|566027280|FG001|Overall Study|Withdrawal by Caregiver|1|||
156801151|NCT03289143|566027281|FG002|Overall Study|Withdrawal by Caregiver|0|||
156801152|NCT03289143|566027282|FG003|Overall Study|Withdrawal by Caregiver|0|||
156801153|NCT03289143|566027279|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801154|NCT03289143|566027280|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801155|NCT03289143|566027281|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
156801156|NCT03289143|566027282|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
156801157|NCT03289143|566027279|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801158|NCT03289143|566027280|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801159|NCT03289143|566027281|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
156801160|NCT03289143|566027282|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
157021000|NCT05273749|566830784|FG001|Overall Study|Adverse Event|8|||
157021001|NCT05273749|566830783|FG000|Overall Study|Lack of Efficacy|2|||
156801161|NCT00948688|566027283|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
156801162|NCT00948688|566027284|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
156801163|NCT00948688|566027283|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
156801164|NCT00948688|566027284|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
156801165|NCT00948688|566027283|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
156801166|NCT00948688|566027284|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
156801167|NCT00730756|566027285|FG000|Overall Study|Adverse Event|2|||
156801168|NCT00730756|566027286|FG001|Overall Study|Adverse Event|0|||
156801169|NCT00730756|566027285|FG000|Overall Study|Lack of Efficacy|1|||
156801170|NCT00730756|566027286|FG001|Overall Study|Lack of Efficacy|1|||
156801171|NCT00730756|566027285|FG000|Overall Study|Protocol Deviation|1|||
157021002|NCT05273749|566830784|FG001|Overall Study|Lack of Efficacy|8|||
156801172|NCT00730756|566027286|FG001|Overall Study|Protocol Deviation|2|||
156801173|NCT00730756|566027285|FG000|Overall Study|Lost to Follow-up|0|||
156801174|NCT00730756|566027286|FG001|Overall Study|Lost to Follow-up|1|||
156801175|NCT00730756|566027285|FG000|Overall Study|Withdrew Consent|0|||
156801176|NCT00730756|566027286|FG001|Overall Study|Withdrew Consent|1|||
156881321|NCT02970942|566325452|FG000|Overall Study|Withdrawal by Subject|3|||
157021003|NCT05273749|566830783|FG000|Overall Study|Physician Decision|0|||
157021004|NCT05273749|566830784|FG001|Overall Study|Physician Decision|2|||
156801177|NCT04388826|566027287|FG000|Overall Study|Lost to Follow-up|3|||
156801178|NCT04388826|566027288|FG001|Overall Study|Lost to Follow-up|2|||
156801179|NCT04388826|566027287|FG000|Overall Study|Adverse Event|1|||
156801180|NCT04388826|566027288|FG001|Overall Study|Adverse Event|0|||
156801181|NCT01146613|566027291|FG000|Overall Study|Lost to Follow-up|3|||
156801182|NCT01146613|566027292|FG001|Overall Study|Lost to Follow-up|8|||
156801183|NCT01146613|566027291|FG000|Overall Study|Lack of Efficacy|0|||
156801184|NCT01146613|566027292|FG001|Overall Study|Lack of Efficacy|1|||
156801185|NCT01146613|566027291|FG000|Overall Study|Death|1|||
156801186|NCT01146613|566027292|FG001|Overall Study|Death|0|||
156801187|NCT01146613|566027291|FG000|Overall Study|Physician Decision|1|||
156881322|NCT02970942|566325453|FG001|Overall Study|Withdrawal by Subject|5|||
156881323|NCT02970942|566325454|FG002|Overall Study|Withdrawal by Subject|3|||
156881324|NCT02970942|566325455|FG003|Overall Study|Withdrawal by Subject|2|||
156881325|NCT06457204|566325456|FG000|Washout|Adverse Event|0|||
156881326|NCT06457204|566325457|FG001|Washout|Adverse Event|2|||
156881327|NCT01065454|566325460|FG000|Treatment|Adverse Event|7|||
156881328|NCT01065454|566325461|FG001|Treatment|Adverse Event|4|||
156881329|NCT01065454|566325462|FG002|Treatment|Adverse Event|3|||
156881330|NCT01065454|566325463|FG003|Treatment|Adverse Event|6|||
156881331|NCT01065454|566325460|FG000|Treatment|Death|1|||
156881332|NCT01065454|566325461|FG001|Treatment|Death|0|||
156881333|NCT01065454|566325462|FG002|Treatment|Death|0|||
156881334|NCT01065454|566325463|FG003|Treatment|Death|0|||
156881335|NCT01065454|566325460|FG000|Treatment|Non-compliance|1|||
156881336|NCT01065454|566325461|FG001|Treatment|Non-compliance|0|||
156881337|NCT01065454|566325462|FG002|Treatment|Non-compliance|0|||
156881338|NCT01065454|566325463|FG003|Treatment|Non-compliance|1|||
156881339|NCT01065454|566325460|FG000|Treatment|Protocol Decision|0|||
156881340|NCT01065454|566325461|FG001|Treatment|Protocol Decision|0|||
156881341|NCT01065454|566325462|FG002|Treatment|Protocol Decision|3|||
156881342|NCT01065454|566325463|FG003|Treatment|Protocol Decision|2|||
156881343|NCT01065454|566325460|FG000|Treatment|Protocol Violation|1|||
156881344|NCT01065454|566325461|FG001|Treatment|Protocol Violation|0|||
156881345|NCT01065454|566325462|FG002|Treatment|Protocol Violation|1|||
156881346|NCT01065454|566325463|FG003|Treatment|Protocol Violation|0|||
156881347|NCT01065454|566325460|FG000|Treatment|Withdrawal by Subject|3|||
156881348|NCT01065454|566325461|FG001|Treatment|Withdrawal by Subject|1|||
156881349|NCT01065454|566325462|FG002|Treatment|Withdrawal by Subject|2|||
156881350|NCT01065454|566325463|FG003|Treatment|Withdrawal by Subject|3|||
156881351|NCT01065454|566325460|FG000|Follow up|Adverse Event|1|||
156881352|NCT01065454|566325461|FG001|Follow up|Adverse Event|0|||
156801188|NCT01146613|566027292|FG001|Overall Study|Physician Decision|0|||
156801189|NCT01146613|566027291|FG000|Overall Study|Withdrawal by Subject|0|||
156801190|NCT01146613|566027292|FG001|Overall Study|Withdrawal by Subject|3|||
156801191|NCT01146613|566027291|FG000|Overall Study|schedule conflict|1|||
156801192|NCT01146613|566027292|FG001|Overall Study|schedule conflict|0|||
156801193|NCT01146613|566027291|FG000|Overall Study|Outpatient detox|1|||
156801194|NCT01146613|566027292|FG001|Overall Study|Outpatient detox|0|||
156801195|NCT05878067|566027293|FG000|Overall Study|Lost to Follow-up|2|||
156801196|NCT01198587|566027296|FG000|Overall Study|Lost to Follow-up|8|||
156801197|NCT01198587|566027297|FG001|Overall Study|Lost to Follow-up|0|||
156801198|NCT01198587|566027298|FG002|Overall Study|Lost to Follow-up|9|||
156801199|NCT01198587|566027299|FG003|Overall Study|Lost to Follow-up|0|||
156801200|NCT01493089|566027300|FG000|Overall Study|Protocol Violation|2|||
156801201|NCT01493089|566027301|FG001|Overall Study|Protocol Violation|2|||
156801202|NCT01493089|566027300|FG000|Overall Study|Withdrawal by Subject|1|||
156801203|NCT01493089|566027301|FG001|Overall Study|Withdrawal by Subject|0|||
156801204|NCT01493089|566027300|FG000|Overall Study|Physician Decision|0|||
156801205|NCT01493089|566027301|FG001|Overall Study|Physician Decision|1|||
156801206|NCT02234362|566027302|FG000|Overall Study|Not eligible after first screening visit|17|||
156801207|NCT02234362|566027302|FG000|Overall Study|Lost to Follow-up|6|||
156801208|NCT02234362|566027302|FG000|Overall Study|Withdrawal by Subject|3|||
156801209|NCT01959529|566027303|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
156801210|NCT01959529|566027304|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
156801211|NCT01959529|566027303|FG000|Overall Study|Lost to Follow-up|4|||
156881353|NCT01065454|566325462|FG002|Follow up|Adverse Event|0|||
156881354|NCT01065454|566325463|FG003|Follow up|Adverse Event|1|||
156881355|NCT01065454|566325460|FG000|Follow up|Death|0|||
156881356|NCT01065454|566325461|FG001|Follow up|Death|1|||
156801212|NCT01959529|566027304|FG001|Overall Study|Lost to Follow-up|1|||
156881357|NCT01065454|566325462|FG002|Follow up|Death|1|||
156801213|NCT01959529|566027303|FG000|Overall Study|Other|70|||
156801214|NCT01959529|566027304|FG001|Overall Study|Other|68|||
156801215|NCT01959529|566027303|FG000|Overall Study|Hypoglycaemia|1|||
156801216|NCT01959529|566027304|FG001|Overall Study|Hypoglycaemia|1|||
156801217|NCT01959529|566027303|FG000|Overall Study|Lack of glycaemic control|1|||
156801218|NCT01959529|566027304|FG001|Overall Study|Lack of glycaemic control|1|||
156801219|NCT00560417|566027312|FG000|Overall Study|Adverse Event|3|||
156881358|NCT01065454|566325463|FG003|Follow up|Death|0|||
156881359|NCT01065454|566325460|FG000|Follow up|Lost to Follow-up|0|||
156881360|NCT01065454|566325461|FG001|Follow up|Lost to Follow-up|0|||
156881361|NCT01065454|566325462|FG002|Follow up|Lost to Follow-up|0|||
157143829|NCT02082184|567276340|FG000|Overall Study|Medical diagnosis|1|||
157143830|NCT02082184|567276341|FG001|Overall Study|Medical diagnosis|2|||
157143831|NCT02082184|567276340|FG000|Overall Study|Device associated symptoms|5|||
157143832|NCT02082184|567276341|FG001|Overall Study|Device associated symptoms|0|||
157143833|NCT02082184|567276340|FG000|Overall Study|Withdrawal by Subject|3|||
157143834|NCT02082184|567276341|FG001|Overall Study|Withdrawal by Subject|2|||
157143835|NCT02082184|567276340|FG000|Overall Study|Protocol Violation|0|||
157143836|NCT02082184|567276341|FG001|Overall Study|Protocol Violation|6|||
157143837|NCT02082184|567276340|FG000|Overall Study|Lost to Follow-up|0|||
156881362|NCT01065454|566325463|FG003|Follow up|Lost to Follow-up|1|||
156881363|NCT01065454|566325460|FG000|Follow up|Progressive disease|0|||
156881364|NCT01065454|566325461|FG001|Follow up|Progressive disease|0|||
156881365|NCT01065454|566325462|FG002|Follow up|Progressive disease|0|||
156881366|NCT01065454|566325463|FG003|Follow up|Progressive disease|1|||
156881367|NCT01065454|566325460|FG000|Follow up|Withdrawal by Subject|1|||
156881368|NCT01065454|566325461|FG001|Follow up|Withdrawal by Subject|1|||
156881369|NCT01065454|566325462|FG002|Follow up|Withdrawal by Subject|1|||
156881370|NCT01065454|566325463|FG003|Follow up|Withdrawal by Subject|0|||
156881371|NCT01065454|566325460|FG000|Follow up|study ongoing|37|||
156881372|NCT01065454|566325461|FG001|Follow up|study ongoing|22|||
156881373|NCT01065454|566325462|FG002|Follow up|study ongoing|15|||
156881374|NCT01065454|566325463|FG003|Follow up|study ongoing|41|||
156881375|NCT01601652|566325465|FG000|Overall Study|Death|1|||
156881376|NCT01097005|566325482|FG000|Overall Study|Case Report Form not collected|18|||
156881377|NCT01097005|566325482|FG000|Overall Study|Subjects cannot visit the hospital|1|||
156881378|NCT01097005|566325482|FG000|Overall Study|Poor medication compliance|1|||
156881379|NCT01097005|566325482|FG000|Overall Study|No examination data available|244|||
156881380|NCT01097005|566325482|FG000|Overall Study|Deviation from exclusion criteria|37|||
156881381|NCT01097005|566325482|FG000|Overall Study|Adverse Event|14|||
156881382|NCT01097005|566325482|FG000|Overall Study|Discontinuance by complication|50|||
156881383|NCT04614324|566325487|FG000|Overall Study|Lost to Follow-up|3|||
156881384|NCT04614324|566325487|FG000|Overall Study|Physician Decision|1|||
156881385|NCT04614324|566325487|FG000|Overall Study|Withdrawal by Subject|2|||
156881386|NCT04614324|566325487|FG000|Overall Study|Remaining in Follow up|123|||
156881387|NCT03374202|566325490|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
156881388|NCT03374202|566325491|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
156881389|NCT03374202|566325492|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
156881390|NCT03374202|566325490|FG000|Five Year Long Term Follow Up|Death|0|||
156881391|NCT03374202|566325491|FG001|Five Year Long Term Follow Up|Death|1|||
156881392|NCT03374202|566325492|FG002|Five Year Long Term Follow Up|Death|0|||
156881393|NCT01325337|566326928|FG000|Overall Study|Adverse Event|0|||
156881394|NCT01325337|566326929|FG001|Overall Study|Adverse Event|2|||
156881395|NCT01325337|566326930|FG002|Overall Study|Adverse Event|2|||
156881396|NCT01325337|566326931|FG003|Overall Study|Adverse Event|1|||
156881397|NCT01325337|566326932|FG004|Overall Study|Adverse Event|2|||
156881398|NCT01325337|566326928|FG000|Overall Study|Lost to Follow-up|2|||
156881399|NCT01325337|566326929|FG001|Overall Study|Lost to Follow-up|2|||
156881400|NCT01325337|566326930|FG002|Overall Study|Lost to Follow-up|2|||
156881401|NCT01325337|566326931|FG003|Overall Study|Lost to Follow-up|1|||
156881402|NCT01325337|566326932|FG004|Overall Study|Lost to Follow-up|2|||
156881403|NCT01325337|566326928|FG000|Overall Study|Personal Reasons|2|||
156881404|NCT01325337|566326929|FG001|Overall Study|Personal Reasons|5|||
156881405|NCT01325337|566326930|FG002|Overall Study|Personal Reasons|4|||
156881406|NCT01325337|566326931|FG003|Overall Study|Personal Reasons|8|||
156881407|NCT01325337|566326932|FG004|Overall Study|Personal Reasons|3|||
156881408|NCT01325337|566326928|FG000|Overall Study|Withdrawal by Subject|1|||
156881409|NCT01325337|566326929|FG001|Overall Study|Withdrawal by Subject|0|||
156881410|NCT01325337|566326930|FG002|Overall Study|Withdrawal by Subject|1|||
156881411|NCT01325337|566326931|FG003|Overall Study|Withdrawal by Subject|0|||
156881412|NCT01325337|566326932|FG004|Overall Study|Withdrawal by Subject|1|||
156881413|NCT04224688|566326950|FG000|Overall Study|Withdrawal by Subject|1|||
156881414|NCT04224688|566326951|FG001|Overall Study|Withdrawal by Subject|3|||
157143838|NCT02082184|567276341|FG001|Overall Study|Lost to Follow-up|2|||
157143839|NCT02082184|567276340|FG000|Overall Study|Subject non-compliance|0|||
157143840|NCT02082184|567276341|FG001|Overall Study|Subject non-compliance|1|||
157143841|NCT01943539|567276344|FG000|Overall Study|Non-compliance with at-home intervention|4|||
156881415|NCT04224688|566326950|FG000|Overall Study|Lack of Efficacy|1|||
156881416|NCT04224688|566326951|FG001|Overall Study|Lack of Efficacy|1|||
156881417|NCT04224688|566326950|FG000|Overall Study|Adverse event, not fatal|0|||
156881418|NCT04224688|566326951|FG001|Overall Study|Adverse event, not fatal|2|||
156881419|NCT04224688|566326950|FG000|Overall Study|COVID-19|0|||
156881420|NCT04224688|566326951|FG001|Overall Study|COVID-19|1|||
156881421|NCT04074161|566326952|FG000|Overall Study|Withdrawal by Subject|2|||
156881422|NCT04074161|566326953|FG001|Overall Study|Withdrawal by Subject|4|||
156881423|NCT04074161|566326954|FG002|Overall Study|Withdrawal by Subject|1|||
157143842|NCT01943539|567276345|FG001|Overall Study|Non-compliance with at-home intervention|0|||
157143843|NCT01362322|567276346|FG000|Overall Study|Withdrawal by Subject|3|||
156881424|NCT04074161|566326952|FG000|Overall Study|Lost to Follow-up|4|||
156881425|NCT04074161|566326953|FG001|Overall Study|Lost to Follow-up|5|||
156881426|NCT04074161|566326954|FG002|Overall Study|Lost to Follow-up|3|||
156881427|NCT00796445|566326957|FG000|Overall Study|Protocol Violation|5|||
156881428|NCT00796445|566326958|FG001|Overall Study|Protocol Violation|3|||
156881429|NCT00796445|566326957|FG000|Overall Study|Adverse event, serious fatal|10|||
157143844|NCT01362322|567276347|FG001|Overall Study|Withdrawal by Subject|1|||
157143845|NCT01362322|567276346|FG000|Overall Study|Lost to Follow-up|2|||
157143846|NCT01362322|567276347|FG001|Overall Study|Lost to Follow-up|6|||
156881430|NCT00796445|566326958|FG001|Overall Study|Adverse event, serious fatal|5|||
156881431|NCT00796445|566326957|FG000|Overall Study|Adverse event, non-fatal|4|||
156881432|NCT00796445|566326958|FG001|Overall Study|Adverse event, non-fatal|0|||
156881433|NCT00796445|566326957|FG000|Overall Study|Disease progression/recurrence|537|||
157143847|NCT02413398|567276350|FG000|Overall Study|Lost to Follow-up|2|||
157143848|NCT02413398|567276351|FG001|Overall Study|Lost to Follow-up|4|||
157143849|NCT02413398|567276350|FG000|Overall Study|Withdrawal by Subject|1|||
157143850|NCT02413398|567276351|FG001|Overall Study|Withdrawal by Subject|1|||
157143851|NCT02413398|567276350|FG000|Overall Study|Other Eligibility criteria|1|||
157143852|NCT02413398|567276351|FG001|Overall Study|Other Eligibility criteria|2|||
157143853|NCT00537940|567276354|FG000|Overall Study|Adverse Event|20|||
157143854|NCT00537940|567276355|FG001|Overall Study|Adverse Event|19|||
156881434|NCT00796445|566326958|FG001|Overall Study|Disease progression/recurrence|268|||
156881435|NCT00796445|566326957|FG000|Overall Study|Other|10|||
156881436|NCT00796445|566326958|FG001|Overall Study|Other|7|||
156881437|NCT00796445|566326957|FG000|Overall Study|Withdrawal by Subject|18|||
156881438|NCT00796445|566326958|FG001|Overall Study|Withdrawal by Subject|9|||
156881439|NCT00796445|566326957|FG000|Overall Study|Invalid Informed Consent Form|1|||
156881440|NCT00796445|566326958|FG001|Overall Study|Invalid Informed Consent Form|0|||
156881441|NCT02500056|566326959|FG000|Overall Study|Lost to Follow-up|3|||
156881442|NCT02500056|566326960|FG001|Overall Study|Lost to Follow-up|7|||
156881443|NCT02500056|566326959|FG000|Overall Study|Recurrence|1|||
156881444|NCT02500056|566326960|FG001|Overall Study|Recurrence|0|||
156881445|NCT02500056|566326959|FG000|Overall Study|Death|3|||
156881446|NCT02500056|566326960|FG001|Overall Study|Death|1|||
156881447|NCT01087736|566326961|FG000|Overall Study|Lost to Follow-up|1|||
156881448|NCT01087736|566326962|FG001|Overall Study|Lost to Follow-up|0|||
157143855|NCT00537940|567276354|FG000|Overall Study|Lack of Efficacy|8|||
157143856|NCT00537940|567276355|FG001|Overall Study|Lack of Efficacy|16|||
157143857|NCT00537940|567276354|FG000|Overall Study|Lost to Follow-up|23|||
157143858|NCT00537940|567276355|FG001|Overall Study|Lost to Follow-up|29|||
157143859|NCT00537940|567276354|FG000|Overall Study|Withdrawal by Subject|113|||
157143860|NCT00537940|567276355|FG001|Overall Study|Withdrawal by Subject|95|||
157143861|NCT00537940|567276354|FG000|Overall Study|Protocol Violation|6|||
156801220|NCT00560417|566027313|FG001|Overall Study|Adverse Event|2|||
156801221|NCT00560417|566027312|FG000|Overall Study|Entry Criteria Not Met|1|||
156801222|NCT00560417|566027313|FG001|Overall Study|Entry Criteria Not Met|0|||
156801223|NCT00560417|566027312|FG000|Overall Study|Lost to Follow-up|0|||
156801224|NCT00560417|566027313|FG001|Overall Study|Lost to Follow-up|1|||
156801225|NCT00560417|566027312|FG000|Overall Study|Physician Decision|2|||
156801226|NCT00560417|566027313|FG001|Overall Study|Physician Decision|6|||
156801227|NCT00560417|566027312|FG000|Overall Study|Protocol Violation|6|||
156801228|NCT00560417|566027313|FG001|Overall Study|Protocol Violation|5|||
156801229|NCT00560417|566027312|FG000|Overall Study|Sponsor Decision|2|||
156801230|NCT00560417|566027313|FG001|Overall Study|Sponsor Decision|0|||
156801231|NCT00560417|566027312|FG000|Overall Study|Withdrawal by Subject|3|||
156801232|NCT00560417|566027313|FG001|Overall Study|Withdrawal by Subject|3|||
156881449|NCT01087736|566326961|FG000|Overall Study|Death|0|||
156881450|NCT01087736|566326962|FG001|Overall Study|Death|1|||
156881451|NCT01087736|566326961|FG000|Overall Study|Withdrawal by Subject|0|||
156881452|NCT01087736|566326962|FG001|Overall Study|Withdrawal by Subject|1|||
156881453|NCT01565343|566326964|FG000|Overall Study|Administrative decision/technical issues|1|||
156881454|NCT01565343|566326965|FG001|Overall Study|Administrative decision/technical issues|0|||
156881455|NCT01565343|566326966|FG002|Overall Study|Administrative decision/technical issues|0|||
156881456|NCT01853839|566326972|FG000|Overall Study|Violated inclusion criteria|2|||
156881457|NCT01853839|566326972|FG000|Overall Study|Not meet ITT population definition|58|||
156881458|NCT01853839|566326972|FG000|Overall Study|End of treatment visit too early|33|||
156881459|NCT01853839|566326972|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
156881460|NCT00638183|566326973|FG000|Overall Study|Adverse Event|23|||
156881461|NCT00638183|566326973|FG000|Overall Study|Lack of Efficacy|14|||
156881462|NCT00638183|566326973|FG000|Overall Study|Physician Decision|9|||
157143862|NCT00537940|567276355|FG001|Overall Study|Protocol Violation|4|||
157143863|NCT00537940|567276354|FG000|Overall Study|Pregnancy|1|||
157143864|NCT00537940|567276355|FG001|Overall Study|Pregnancy|1|||
157143865|NCT00537940|567276354|FG000|Overall Study|Study terminated by sponsor|2|||
156801233|NCT02164864|566027314|FG000|Overall Study|Trial disease worsening|7|||
156801234|NCT02164864|566027315|FG001|Overall Study|Trial disease worsening|5|||
156801235|NCT02164864|566027316|FG002|Overall Study|Trial disease worsening|1|||
156801236|NCT02164864|566027314|FG000|Overall Study|Other pre-existing disease worsening|6|||
156881463|NCT00638183|566326973|FG000|Overall Study|Lost to Follow-up|46|||
156801237|NCT02164864|566027315|FG001|Overall Study|Other pre-existing disease worsening|4|||
156801238|NCT02164864|566027316|FG002|Overall Study|Other pre-existing disease worsening|9|||
156801239|NCT02164864|566027314|FG000|Overall Study|Other Adverse Event (AE)|52|||
156801240|NCT02164864|566027315|FG001|Overall Study|Other Adverse Event (AE)|32|||
156801241|NCT02164864|566027316|FG002|Overall Study|Other Adverse Event (AE)|49|||
156801242|NCT02164864|566027314|FG000|Overall Study|Protocol Violation|2|||
156801243|NCT02164864|566027315|FG001|Overall Study|Protocol Violation|4|||
156801244|NCT02164864|566027316|FG002|Overall Study|Protocol Violation|1|||
156801245|NCT02164864|566027314|FG000|Overall Study|Lost to Follow-up|4|||
156801246|NCT02164864|566027315|FG001|Overall Study|Lost to Follow-up|3|||
156801247|NCT02164864|566027316|FG002|Overall Study|Lost to Follow-up|2|||
156801248|NCT02164864|566027314|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
156801249|NCT02164864|566027315|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
156801250|NCT02164864|566027316|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
156801251|NCT02164864|566027314|FG000|Overall Study|Other than stated|3|||
156801252|NCT02164864|566027315|FG001|Overall Study|Other than stated|4|||
156801253|NCT02164864|566027316|FG002|Overall Study|Other than stated|14|||
156801254|NCT00652834|566027317|FG000|Overall Study|Withdrawal by Subject|3|||
156801255|NCT00652834|566027317|FG000|Overall Study|Lost to Follow-up|2|||
156801256|NCT00320606|566027318|FG000|Overall Study|Adverse Event|1|||
156801257|NCT00320606|566027318|FG000|Overall Study|Protocol Violation|1|||
156801258|NCT00320606|566027318|FG000|Overall Study|Withdrawal by Subject|1|||
156801259|NCT03984825|566027319|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
156801260|NCT03984825|566027319|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
156801261|NCT03984825|566027319|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
156801262|NCT00261833|566027320|FG000|Overall Study|Death|1|||
156801263|NCT00261833|566027321|FG001|Overall Study|Death|3|||
156801264|NCT00261833|566027320|FG000|Overall Study|Adverse Event|1|||
156801265|NCT00261833|566027321|FG001|Overall Study|Adverse Event|4|||
156801266|NCT00261833|566027320|FG000|Overall Study|Withdrawal by Subject|5|||
156801267|NCT00261833|566027321|FG001|Overall Study|Withdrawal by Subject|7|||
156801268|NCT00261833|566027320|FG000|Overall Study|Protocol Violation|0|||
156801269|NCT00261833|566027321|FG001|Overall Study|Protocol Violation|1|||
156801270|NCT00261833|566027320|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
156801271|NCT00261833|566027321|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
156801272|NCT00261833|566027320|FG000|Overall Study|Lung transplantation|1|||
156801273|NCT00261833|566027321|FG001|Overall Study|Lung transplantation|1|||
156801274|NCT00261833|566027320|FG000|Overall Study|Missing reason|1|||
156801275|NCT00261833|566027321|FG001|Overall Study|Missing reason|0|||
156801276|NCT00261833|566027320|FG000|Overall Study|Not interested in being participant|0|||
156801277|NCT00261833|566027321|FG001|Overall Study|Not interested in being participant|1|||
156801278|NCT00622726|566027322|FG000|March, 2008 to August, 2010|Death|5|||
156801279|NCT00622726|566027323|FG001|March, 2008 to August, 2010|Death|2|||
156801280|NCT00622726|566027322|FG000|August, 2010 to April, 2013|Death|1|||
156801281|NCT00622726|566027323|FG001|August, 2010 to April, 2013|Death|5|||
156801282|NCT00854360|566027326|FG000|Overall Study|Adverse Event|0|||
156801283|NCT00854360|566027327|FG001|Overall Study|Adverse Event|1|||
156801284|NCT00854360|566027328|FG002|Overall Study|Adverse Event|2|||
156801285|NCT00854360|566027329|FG003|Overall Study|Adverse Event|6|||
156801286|NCT00854360|566027326|FG000|Overall Study|Withdrawal by Subject|0|||
156801287|NCT00854360|566027327|FG001|Overall Study|Withdrawal by Subject|0|||
156801288|NCT00854360|566027328|FG002|Overall Study|Withdrawal by Subject|0|||
156801289|NCT00854360|566027329|FG003|Overall Study|Withdrawal by Subject|1|||
156801290|NCT00854360|566027326|FG000|Overall Study|Pregnancy|0|||
156801291|NCT00854360|566027327|FG001|Overall Study|Pregnancy|1|||
156801292|NCT00854360|566027328|FG002|Overall Study|Pregnancy|0|||
156801293|NCT00854360|566027329|FG003|Overall Study|Pregnancy|0|||
156801294|NCT00854360|566027326|FG000|Overall Study|Lack of Efficacy|2|||
156801295|NCT00854360|566027327|FG001|Overall Study|Lack of Efficacy|1|||
156801296|NCT00854360|566027328|FG002|Overall Study|Lack of Efficacy|0|||
156801297|NCT00854360|566027329|FG003|Overall Study|Lack of Efficacy|0|||
156801298|NCT00854360|566027326|FG000|Overall Study|Other|0|||
156801299|NCT00854360|566027327|FG001|Overall Study|Other|0|||
156801300|NCT00854360|566027328|FG002|Overall Study|Other|0|||
156801301|NCT00854360|566027329|FG003|Overall Study|Other|3|||
157220970|NCT00585351|567554937|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
156801302|NCT00399529|566027330|FG000|Overall Study|Off Study Prior to Treatment|2|||
156801303|NCT01170663|566027331|FG000|Overall Study|Lost to Follow-up|3|||
156801304|NCT01170663|566027332|FG001|Overall Study|Lost to Follow-up|9|||
156801305|NCT01170663|566027331|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
156801306|NCT01170663|566027332|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
156801307|NCT03189719|566027333|FG000|Overall Study|Death|325|||
156801308|NCT03189719|566027334|FG001|Overall Study|Death|361|||
156881464|NCT00638183|566326973|FG000|Overall Study|Other reason not defined above|27|||
157220971|NCT00585351|567554938|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
156801309|NCT03189719|566027333|FG000|Overall Study|Physician Decision|1|||
156801310|NCT03189719|566027334|FG001|Overall Study|Physician Decision|0|||
157021005|NCT05273749|566830783|FG000|Overall Study|Withdrawal by Subject|14|||
157021006|NCT05273749|566830784|FG001|Overall Study|Withdrawal by Subject|16|||
157021007|NCT05273749|566830783|FG000|Overall Study|Lost to Follow-up|10|||
157021008|NCT05273749|566830784|FG001|Overall Study|Lost to Follow-up|10|||
157021009|NCT05273749|566830783|FG000|Overall Study|Pregnancy|1|||
157021010|NCT05273749|566830784|FG001|Overall Study|Pregnancy|0|||
157021011|NCT05273749|566830783|FG000|Overall Study|Non-Compliance|3|||
157021012|NCT05273749|566830784|FG001|Overall Study|Non-Compliance|2|||
157021013|NCT05273749|566830783|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
157021014|NCT05273749|566830784|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
157021015|NCT02543281|566830789|FG000|Overall Study|Lost to Follow-up|0|||
157021016|NCT02543281|566830790|FG001|Overall Study|Lost to Follow-up|0|||
157021017|NCT02543281|566830791|FG002|Overall Study|Lost to Follow-up|1|||
157021018|NCT02530671|566830792|FG000|Overall Study|Lost to Follow-up|2|||
157021019|NCT02530671|566830793|FG001|Overall Study|Lost to Follow-up|0|||
157021020|NCT02530671|566830792|FG000|Overall Study|Withdrawal by Subject|1|||
157021021|NCT02530671|566830793|FG001|Overall Study|Withdrawal by Subject|0|||
157021022|NCT05247489|566830794|FG000|Overall Study|Lost to Follow-up|5|||
157021023|NCT05247489|566830795|FG001|Overall Study|Lost to Follow-up|1|||
157021024|NCT05247489|566830794|FG000|Overall Study|Withdrawal by Subject|6|||
157021025|NCT05247489|566830795|FG001|Overall Study|Withdrawal by Subject|7|||
157021026|NCT05247489|566830794|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
157021027|NCT05247489|566830795|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
157021028|NCT05247489|566830794|FG000|Overall Study|Left Country|1|||
157021029|NCT05247489|566830795|FG001|Overall Study|Left Country|0|||
156801311|NCT03189719|566027333|FG000|Overall Study|Sponsor Decision|40|||
156801312|NCT03189719|566027334|FG001|Overall Study|Sponsor Decision|12|||
156801313|NCT03189719|566027333|FG000|Overall Study|Withdrawal by Subject|7|||
156801314|NCT03189719|566027334|FG001|Overall Study|Withdrawal by Subject|3|||
156801315|NCT03012880|566027335|FG000|Overall Study|Withdrawal by Subject|1|||
156801316|NCT03012880|566027336|FG001|Overall Study|Withdrawal by Subject|0|||
156801317|NCT03012880|566027335|FG000|Overall Study|Ineligible|1|||
156801318|NCT03012880|566027336|FG001|Overall Study|Ineligible|0|||
156801319|NCT01355627|566027337|FG000|Overall Study|Request By the Patient to Discontinue|5|||
156801320|NCT01355627|566027338|FG001|Overall Study|Request By the Patient to Discontinue|7|||
156801321|NCT01355627|566027337|FG000|Overall Study|Lost to Follow-up|8|||
156801322|NCT01355627|566027338|FG001|Overall Study|Lost to Follow-up|7|||
156801323|NCT01355627|566027337|FG000|Overall Study|Fatal Adverse Event|19|||
156801324|NCT01355627|566027338|FG001|Overall Study|Fatal Adverse Event|23|||
156801325|NCT01355627|566027337|FG000|Overall Study|Other|1|||
156801326|NCT01355627|566027338|FG001|Overall Study|Other|1|||
156801327|NCT02781558|566027339|FG000|Overall Study|Lost to Follow-up|2|||
156801328|NCT02781558|566027340|FG001|Overall Study|Lost to Follow-up|2|||
156801329|NCT02781558|566027339|FG000|Overall Study|Adverse Event|1|||
156801330|NCT02781558|566027340|FG001|Overall Study|Adverse Event|0|||
156801331|NCT04756531|566027345|FG000|Overall Study|Adverse Event|0|||
156801332|NCT04756531|566027346|FG001|Overall Study|Adverse Event|0|||
156801333|NCT04756531|566027347|FG002|Overall Study|Adverse Event|0|||
156801334|NCT04756531|566027348|FG003|Overall Study|Adverse Event|0|||
156801335|NCT04756531|566027349|FG004|Overall Study|Adverse Event|1|||
156801336|NCT04756531|566027350|FG005|Overall Study|Adverse Event|0|||
156801337|NCT04756531|566027351|FG006|Overall Study|Adverse Event|0|||
156801338|NCT04756531|566027352|FG007|Overall Study|Adverse Event|0|||
156801339|NCT04756531|566027353|FG008|Overall Study|Adverse Event|0|||
156801340|NCT04756531|566027354|FG009|Overall Study|Adverse Event|0|||
156801341|NCT04756531|566027355|FG010|Overall Study|Adverse Event|0|||
156801342|NCT04756531|566027356|FG011|Overall Study|Adverse Event|0|||
156801343|NCT04756531|566027357|FG012|Overall Study|Adverse Event|0|||
156801344|NCT04756531|566027358|FG013|Overall Study|Adverse Event|0|||
156801345|NCT04756531|566027359|FG014|Overall Study|Adverse Event|0|||
156801346|NCT04756531|566027360|FG015|Overall Study|Adverse Event|0|||
156801347|NCT04756531|566027361|FG016|Overall Study|Adverse Event|0|||
156801348|NCT04756531|566027362|FG017|Overall Study|Adverse Event|0|||
156801349|NCT04756531|566027345|FG000|Overall Study|Withdrawal by Subject|0|||
156801350|NCT04756531|566027346|FG001|Overall Study|Withdrawal by Subject|0|||
156801351|NCT04756531|566027347|FG002|Overall Study|Withdrawal by Subject|0|||
156801352|NCT04756531|566027348|FG003|Overall Study|Withdrawal by Subject|0|||
156801353|NCT04756531|566027349|FG004|Overall Study|Withdrawal by Subject|0|||
156801354|NCT04756531|566027350|FG005|Overall Study|Withdrawal by Subject|0|||
156801355|NCT04756531|566027351|FG006|Overall Study|Withdrawal by Subject|1|||
156801356|NCT04756531|566027352|FG007|Overall Study|Withdrawal by Subject|0|||
156801357|NCT04756531|566027353|FG008|Overall Study|Withdrawal by Subject|0|||
156801358|NCT04756531|566027354|FG009|Overall Study|Withdrawal by Subject|0|||
156801359|NCT04756531|566027355|FG010|Overall Study|Withdrawal by Subject|0|||
156801360|NCT04756531|566027356|FG011|Overall Study|Withdrawal by Subject|0|||
156801361|NCT04756531|566027357|FG012|Overall Study|Withdrawal by Subject|0|||
157021030|NCT05247489|566830794|FG000|Overall Study|Noncompliance with Investigational Product|1|||
156881465|NCT02059291|566326974|FG000|Epoch 2|Lack of Efficacy|0|||
156881466|NCT02059291|566326975|FG001|Epoch 2|Lack of Efficacy|0|||
156801362|NCT04756531|566027358|FG013|Overall Study|Withdrawal by Subject|0|||
156801363|NCT04756531|566027359|FG014|Overall Study|Withdrawal by Subject|0|||
156801364|NCT04756531|566027360|FG015|Overall Study|Withdrawal by Subject|0|||
156801365|NCT04756531|566027361|FG016|Overall Study|Withdrawal by Subject|0|||
156801366|NCT04756531|566027362|FG017|Overall Study|Withdrawal by Subject|0|||
156801367|NCT02257528|566027363|FG000|Overall Study|Never received study treatment|1|||
156801368|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
156801369|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
156801370|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
156801371|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
156801372|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801373|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801374|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
156801375|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
156801376|NCT04237584|566027366|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801377|NCT04237584|566027367|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801378|NCT04237584|566027368|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
156801379|NCT04237584|566027369|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
156801380|NCT04237584|566027366|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
156801381|NCT04237584|566027367|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
156801382|NCT04237584|566027368|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
156801383|NCT04237584|566027369|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
156801384|NCT04237584|566027366|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801385|NCT04237584|566027367|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801386|NCT04237584|566027368|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
156801387|NCT04237584|566027369|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
156801388|NCT02465931|566029187|FG000|Overall Study|Lost to Follow-up|9|||
156801389|NCT02465931|566029188|FG001|Overall Study|Lost to Follow-up|11|||
156801390|NCT02465931|566029187|FG000|Overall Study|Protocol Violation|1|||
156801391|NCT02465931|566029188|FG001|Overall Study|Protocol Violation|0|||
156801392|NCT02465931|566029187|FG000|Overall Study|Withdrawal by Subject|1|||
156801393|NCT02465931|566029188|FG001|Overall Study|Withdrawal by Subject|0|||
156801394|NCT04778592|566029192|FG000|Overall Study|Adverse Event|1|||
156801395|NCT04778592|566029193|FG001|Overall Study|Adverse Event|2|||
156801396|NCT04778592|566029192|FG000|Overall Study|Withdrawal by Subject|1|||
156801397|NCT04778592|566029193|FG001|Overall Study|Withdrawal by Subject|2|||
156801398|NCT03423121|566029194|FG000|Overall Study|Lost to Follow-up|2|||
156801399|NCT03423121|566029195|FG001|Overall Study|Lost to Follow-up|6|||
156801400|NCT03423121|566029194|FG000|Overall Study|Adverse Event|1|||
156801401|NCT03423121|566029195|FG001|Overall Study|Adverse Event|0|||
156801402|NCT01354223|566029196|FG000|Overall Study|Withdrawal by Subject|3|||
156801403|NCT01354223|566029197|FG001|Overall Study|Withdrawal by Subject|1|||
156801404|NCT00524121|566029207|FG000|Overall Study|Disease progression|6|||
156801405|NCT00524121|566029207|FG000|Overall Study|Adverse Event|4|||
156801406|NCT00524121|566029207|FG000|Overall Study|Patient refused|2|||
156801407|NCT00524121|566029207|FG000|Overall Study|Other|1|||
156801408|NCT00524121|566029207|FG000|Overall Study|Death|1|||
156801409|NCT00524121|566029207|FG000|Overall Study|Not treated (became ineligible)|4|||
156801410|NCT00524121|566029207|FG000|Overall Study|Not treated (changed mind)|1|||
156801411|NCT04047446|566029208|FG000|Overall Study|Physician Decision|1|||
156801412|NCT04047446|566029209|FG001|Overall Study|Physician Decision|0|||
156801413|NCT01840943|566029210|FG000|Overall Study|Withdrawal by Subject|5|||
156801414|NCT01840943|566029211|FG001|Overall Study|Withdrawal by Subject|6|||
156801415|NCT01840943|566029210|FG000|Overall Study|Physician Decision|4|||
156801416|NCT01840943|566029211|FG001|Overall Study|Physician Decision|2|||
156801417|NCT01840943|566029210|FG000|Overall Study|Lost to Follow-up|4|||
156801418|NCT01840943|566029211|FG001|Overall Study|Lost to Follow-up|4|||
156801419|NCT00329420|566029212|FG000|Re-induction Phase|Lack of Efficacy|0|||
156801420|NCT00329420|566029213|FG001|Re-induction Phase|Lack of Efficacy|1|||
156801421|NCT00329420|566029214|FG002|Re-induction Phase|Lack of Efficacy|0|||
156881467|NCT02059291|566326976|FG002|Epoch 2|Lack of Efficacy|0|||
156881468|NCT02059291|566326977|FG003|Epoch 2|Lack of Efficacy|1|||
157021031|NCT05247489|566830795|FG001|Overall Study|Noncompliance with Investigational Product|0|||
157021032|NCT05247489|566830794|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
156801422|NCT00329420|566029212|FG000|Re-induction Phase|Withdrawal of Consent|0|||
157220972|NCT00585351|567554939|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
156801423|NCT00329420|566029213|FG001|Re-induction Phase|Withdrawal of Consent|0|||
156801424|NCT00329420|566029214|FG002|Re-induction Phase|Withdrawal of Consent|1|||
156801425|NCT00329420|566029212|FG000|Re-induction Phase|Did not respond to re-induction|6|||
156881469|NCT02059291|566326978|FG004|Epoch 2|Lack of Efficacy|0|||
156801426|NCT00329420|566029213|FG001|Re-induction Phase|Did not respond to re-induction|5|||
156801427|NCT00329420|566029214|FG002|Re-induction Phase|Did not respond to re-induction|7|||
156801428|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
156801429|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
156801430|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
156801431|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
156801432|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
156801433|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
156801434|NCT00329420|566029212|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
156801435|NCT00329420|566029213|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
156801436|NCT00329420|566029214|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
156801437|NCT01446874|566029215|FG000|Overall Study|Not eligible|1|||
156801438|NCT01446874|566029216|FG001|Overall Study|Not eligible|0|||
156801439|NCT01446874|566029217|FG002|Overall Study|Not eligible|0|||
156801440|NCT01446874|566029215|FG000|Overall Study|No surgery/No qualifying surgery|1|||
156801441|NCT01446874|566029216|FG001|Overall Study|No surgery/No qualifying surgery|0|||
156801442|NCT01446874|566029217|FG002|Overall Study|No surgery/No qualifying surgery|12|||
156801443|NCT01446874|566029215|FG000|Overall Study|Non-compliance|0|||
156801444|NCT01446874|566029216|FG001|Overall Study|Non-compliance|4|||
156801445|NCT01446874|566029217|FG002|Overall Study|Non-compliance|0|||
156801446|NCT01446874|566029215|FG000|Overall Study|Antibiotics for pre-op infection|0|||
156801447|NCT01446874|566029216|FG001|Overall Study|Antibiotics for pre-op infection|0|||
156801448|NCT01446874|566029217|FG002|Overall Study|Antibiotics for pre-op infection|2|||
156801449|NCT01446874|566029215|FG000|Overall Study|Withdrawal by Subject|0|||
156801450|NCT01446874|566029216|FG001|Overall Study|Withdrawal by Subject|0|||
156801451|NCT01446874|566029217|FG002|Overall Study|Withdrawal by Subject|4|||
156801452|NCT02746809|566029218|FG000|Enrollment|Inclusion Exclusion not met|9|||
156801453|NCT02746809|566029218|FG000|Enrollment|Withdrawal by Subject|1|||
156801454|NCT02746809|566029218|FG000|Enrollment|Expected Enrollment Met|2|||
156801455|NCT02746809|566029218|FG000|Procedure|Death|1|||
156801456|NCT02746809|566029218|FG000|1-Month|Death|5|||
156801457|NCT02746809|566029218|FG000|6-Month|Death|2|||
156801458|NCT02746809|566029218|FG000|6-Month|Withdrawal by Subject|1|||
156801459|NCT02746809|566029218|FG000|12-Month|Death|3|||
156801460|NCT02746809|566029218|FG000|12-Month|Withdrawal by Subject|2|||
156801461|NCT02746809|566029218|FG000|24-Month|Death|1|||
156801462|NCT02746809|566029218|FG000|24-Month|Withdrawal by Subject|1|||
156801463|NCT02746809|566029218|FG000|36-Month|Death|8|||
156801464|NCT02746809|566029218|FG000|36-Month|Withdrawal by Subject|1|||
156801465|NCT02746809|566029218|FG000|48-Month|Death|7|||
156801466|NCT02746809|566029218|FG000|48-Month|Withdrawal by Subject|1|||
156801467|NCT02746809|566029218|FG000|60-Month|Death|1|||
156801468|NCT02746809|566029218|FG000|60-Month|Lost to Follow-up|2|||
156801469|NCT00742625|566029222|FG000|Remission Induction|Progression|6|||
156801470|NCT00742625|566029222|FG000|Remission Induction|Failed induction|8|||
156801471|NCT00742625|566029222|FG000|Remission Induction|Adverse Event|3|||
156801472|NCT00742625|566029222|FG000|Remission Induction|Death|10|||
156801473|NCT00742625|566029222|FG000|Remission Induction|Refusal|5|||
156801474|NCT00742625|566029222|FG000|Remission Induction|Non protocol treatment|17|||
156801475|NCT00742625|566029222|FG000|Remission Induction|Other, not specified|5|||
156801476|NCT00742625|566029222|FG000|Consolidation|Progression|5|||
156801477|NCT00742625|566029222|FG000|Consolidation|Adverse Event|1|||
156801478|NCT00742625|566029222|FG000|Consolidation|Death|1|||
156801479|NCT00742625|566029222|FG000|Consolidation|Refused|1|||
156801480|NCT00742625|566029222|FG000|Consolidation|Non protocol therapy|13|||
156801481|NCT01164007|566029223|FG000|Overall Study|Adverse Event|5|||
156801482|NCT01164007|566029223|FG000|Overall Study|Progression of Disease|30|||
156801483|NCT01164007|566029223|FG000|Overall Study|Protocol Violation|1|||
156801484|NCT01164007|566029223|FG000|Overall Study|Withdrawal by Subject|1|||
156801485|NCT01164007|566029223|FG000|Overall Study|Medical Decision|3|||
156801486|NCT00894387|566029224|FG000|Overall Study|Adverse Event|44|||
156801487|NCT00894387|566029225|FG001|Overall Study|Adverse Event|45|||
156801488|NCT00894387|566029224|FG000|Overall Study|Abnormal Laboratory values|2|||
156801489|NCT00894387|566029225|FG001|Overall Study|Abnormal Laboratory values|2|||
156801490|NCT00894387|566029224|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156801491|NCT00894387|566029225|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156801492|NCT00894387|566029224|FG000|Overall Study|Lost to Follow-up|3|||
156801493|NCT00894387|566029225|FG001|Overall Study|Lost to Follow-up|5|||
156801494|NCT00894387|566029224|FG000|Overall Study|Administrative problems|2|||
156801495|NCT00894387|566029225|FG001|Overall Study|Administrative problems|2|||
156801496|NCT00894387|566029224|FG000|Overall Study|Death|77|||
156801497|NCT00894387|566029225|FG001|Overall Study|Death|76|||
156801498|NCT00894387|566029224|FG000|Overall Study|Protocol Deviation|4|||
156801499|NCT00894387|566029225|FG001|Overall Study|Protocol Deviation|0|||
156801500|NCT00894387|566029224|FG000|Overall Study|Patient's request|25|||
156801501|NCT00894387|566029225|FG001|Overall Study|Patient's request|30|||
156801502|NCT00894387|566029224|FG000|Overall Study|Other (Missing)|5|||
156801503|NCT00894387|566029225|FG001|Overall Study|Other (Missing)|3|||
156801504|NCT00894387|566029224|FG000|Overall Study|Mis-randomized|13|||
156801505|NCT00894387|566029225|FG001|Overall Study|Mis-randomized|9|||
156801506|NCT00894387|566029224|FG000|Overall Study|GCP non-compliance|0|||
156801507|NCT00894387|566029225|FG001|Overall Study|GCP non-compliance|2|||
156801508|NCT01076010|566029226|FG000|Overall Study|Death|15|||
156801509|NCT01076010|566029227|FG001|Overall Study|Death|1|||
156801510|NCT01076010|566029228|FG002|Overall Study|Death|0|||
156801511|NCT01076010|566029226|FG000|Overall Study|Adverse Event|7|||
156881470|NCT02059291|566326979|FG005|Epoch 2|Lack of Efficacy|1|||
156801512|NCT01076010|566029227|FG001|Overall Study|Adverse Event|2|||
156801513|NCT01076010|566029228|FG002|Overall Study|Adverse Event|0|||
156801514|NCT01076010|566029226|FG000|Overall Study|Progressive disease|90|||
156801515|NCT01076010|566029227|FG001|Overall Study|Progressive disease|30|||
156801516|NCT01076010|566029228|FG002|Overall Study|Progressive disease|1|||
156801517|NCT01076010|566029226|FG000|Overall Study|Lack of Efficacy|4|||
156801518|NCT01076010|566029227|FG001|Overall Study|Lack of Efficacy|0|||
156801519|NCT01076010|566029228|FG002|Overall Study|Lack of Efficacy|0|||
156801520|NCT01076010|566029226|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
156801521|NCT01076010|566029227|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
156801522|NCT01076010|566029228|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
156801523|NCT01076010|566029226|FG000|Overall Study|Significant Surgical Procedure|0|||
156801524|NCT01076010|566029227|FG001|Overall Study|Significant Surgical Procedure|1|||
156801525|NCT01076010|566029228|FG002|Overall Study|Significant Surgical Procedure|0|||
156801526|NCT01076010|566029226|FG000|Overall Study|Protocol Violation|0|||
156801527|NCT01076010|566029227|FG001|Overall Study|Protocol Violation|1|||
156801528|NCT01076010|566029228|FG002|Overall Study|Protocol Violation|0|||
156801529|NCT01076010|566029226|FG000|Overall Study|Noncompliance|1|||
156801530|NCT01076010|566029227|FG001|Overall Study|Noncompliance|1|||
156801531|NCT01076010|566029228|FG002|Overall Study|Noncompliance|0|||
156801532|NCT01076010|566029226|FG000|Overall Study|Withdrawal by Subject|3|||
156801533|NCT01076010|566029227|FG001|Overall Study|Withdrawal by Subject|0|||
156801534|NCT01076010|566029228|FG002|Overall Study|Withdrawal by Subject|1|||
156801535|NCT01076010|566029226|FG000|Overall Study|Other|5|||
156801536|NCT01076010|566029227|FG001|Overall Study|Other|2|||
156801537|NCT01076010|566029228|FG002|Overall Study|Other|0|||
156801538|NCT01612676|566029229|FG000|Overall Study|Adverse Event|2|||
156801539|NCT01612676|566029230|FG001|Overall Study|Adverse Event|3|||
156801540|NCT01612676|566029231|FG002|Overall Study|Adverse Event|1|||
156801541|NCT01612676|566029232|FG003|Overall Study|Adverse Event|3|||
156801542|NCT01612676|566029229|FG000|Overall Study|Protocol Violation|0|||
156801543|NCT01612676|566029230|FG001|Overall Study|Protocol Violation|1|||
156801544|NCT01612676|566029231|FG002|Overall Study|Protocol Violation|0|||
156801545|NCT01612676|566029232|FG003|Overall Study|Protocol Violation|0|||
156801546|NCT01156844|566029235|FG000|Overall Study|Adverse Event|0|||
156801547|NCT01156844|566029236|FG001|Overall Study|Adverse Event|0|||
156801548|NCT01156844|566029237|FG002|Overall Study|Adverse Event|1|||
156801549|NCT01156844|566029238|FG003|Overall Study|Adverse Event|1|||
156801550|NCT01156844|566029235|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156801551|NCT01156844|566029236|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156801552|NCT01156844|566029237|FG002|Overall Study|Abnormal test procedure result(s)|2|||
156801553|NCT01156844|566029238|FG003|Overall Study|Abnormal test procedure result(s)|2|||
156801554|NCT01156844|566029235|FG000|Overall Study|Withdrawal by Subject|0|||
156801555|NCT01156844|566029236|FG001|Overall Study|Withdrawal by Subject|0|||
156801556|NCT01156844|566029237|FG002|Overall Study|Withdrawal by Subject|2|||
156801557|NCT01156844|566029238|FG003|Overall Study|Withdrawal by Subject|2|||
156801558|NCT01156844|566029235|FG000|Overall Study|Lost to Follow-up|0|||
156881471|NCT02059291|566326980|FG006|Epoch 2|Lack of Efficacy|0|||
156881472|NCT02059291|566326981|FG007|Epoch 2|Lack of Efficacy|0|||
156881473|NCT02059291|566326982|FG008|Epoch 2|Lack of Efficacy|0|||
156881474|NCT02059291|566326983|FG009|Epoch 2|Lack of Efficacy|0|||
156881475|NCT02059291|566326984|FG010|Epoch 2|Lack of Efficacy|0|||
156881476|NCT02059291|566326985|FG011|Epoch 2|Lack of Efficacy|0|||
156881477|NCT02059291|566326986|FG012|Epoch 2|Lack of Efficacy|0|||
156881478|NCT02059291|566326987|FG013|Epoch 2|Lack of Efficacy|0|||
156881479|NCT02059291|566326988|FG014|Epoch 2|Lack of Efficacy|0|||
157220973|NCT00585351|567554940|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
156801559|NCT01156844|566029236|FG001|Overall Study|Lost to Follow-up|0|||
156801560|NCT01156844|566029237|FG002|Overall Study|Lost to Follow-up|1|||
156801561|NCT01156844|566029238|FG003|Overall Study|Lost to Follow-up|0|||
156801562|NCT01156844|566029235|FG000|Overall Study|Administrative problems|0|||
156801563|NCT01156844|566029236|FG001|Overall Study|Administrative problems|1|||
156801564|NCT01156844|566029237|FG002|Overall Study|Administrative problems|0|||
156801565|NCT01156844|566029238|FG003|Overall Study|Administrative problems|1|||
156801566|NCT01156844|566029235|FG000|Overall Study|Protocol deviation|2|||
156881480|NCT02059291|566326989|FG015|Epoch 2|Lack of Efficacy|0|||
156881481|NCT02059291|566326990|FG016|Epoch 2|Lack of Efficacy|0|||
156881482|NCT02059291|566326991|FG017|Epoch 2|Lack of Efficacy|0|||
156801567|NCT01156844|566029236|FG001|Overall Study|Protocol deviation|0|||
156881483|NCT02059291|566326992|FG018|Epoch 2|Lack of Efficacy|0|||
156881484|NCT02059291|566326993|FG019|Epoch 2|Lack of Efficacy|0|||
156801568|NCT01156844|566029237|FG002|Overall Study|Protocol deviation|0|||
156801569|NCT01156844|566029238|FG003|Overall Study|Protocol deviation|0|||
156801570|NCT01130337|566029242|FG000|Overall Study|Withdrawal by Subject|3|||
156801571|NCT01130337|566029242|FG000|Overall Study|Principal investigator decision|1|||
156801572|NCT01130337|566029242|FG000|Overall Study|Death|1|||
156801573|NCT01130337|566029242|FG000|Overall Study|Disease progression|1|||
156801574|NCT01130337|566029242|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
156801575|NCT01130337|566029242|FG000|Overall Study|Surgical resection (R2)|1|||
156801576|NCT03886493|566029243|FG000|Overall Study|Adverse Event|1|||
156801577|NCT04661033|566029244|FG000|Overall Study|Adverse Event|0|||
156801578|NCT04661033|566029245|FG001|Overall Study|Adverse Event|0|||
156801579|NCT04661033|566029246|FG002|Overall Study|Adverse Event|1|||
156801580|NCT04661033|566029247|FG003|Overall Study|Adverse Event|0|||
156801581|NCT04661033|566029244|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
156801582|NCT04661033|566029245|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801583|NCT04661033|566029246|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801584|NCT04661033|566029247|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
156801585|NCT04661033|566029244|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
156801586|NCT04661033|566029245|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
156801587|NCT04661033|566029246|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
156801588|NCT04661033|566029247|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
156801589|NCT04661033|566029244|FG000|Overall Study|Early discontinuation as per PI|1|||
157220974|NCT00585351|567554941|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
156801590|NCT04661033|566029245|FG001|Overall Study|Early discontinuation as per PI|0|||
156801591|NCT04661033|566029246|FG002|Overall Study|Early discontinuation as per PI|0|||
156801592|NCT04661033|566029247|FG003|Overall Study|Early discontinuation as per PI|0|||
156801593|NCT05200845|566029250|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
156801594|NCT05200845|566029251|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
156801595|NCT05200845|566029252|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
156801596|NCT05200845|566029253|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
156801597|NCT05200845|566029250|FG000|Overall Study|Withdrawal by Subject|0|||
156801598|NCT05200845|566029251|FG001|Overall Study|Withdrawal by Subject|1|||
156801599|NCT05200845|566029252|FG002|Overall Study|Withdrawal by Subject|1|||
156801600|NCT05200845|566029253|FG003|Overall Study|Withdrawal by Subject|0|||
156801601|NCT00565409|566029258|FG000|Period 1 Open Label|Adverse Event|17|||
156801602|NCT00565409|566029259|FG001|Period 1 Open Label|Adverse Event|0|||
156801603|NCT00565409|566029260|FG002|Period 1 Open Label|Adverse Event|0|||
156801604|NCT00565409|566029261|FG003|Period 1 Open Label|Adverse Event|0|||
156801605|NCT00565409|566029258|FG000|Period 1 Open Label|Death|2|||
156801606|NCT00565409|566029259|FG001|Period 1 Open Label|Death|0|||
156801607|NCT00565409|566029260|FG002|Period 1 Open Label|Death|0|||
156801608|NCT00565409|566029261|FG003|Period 1 Open Label|Death|0|||
156801609|NCT00565409|566029258|FG000|Period 1 Open Label|Lost to Follow-up|1|||
156801610|NCT00565409|566029259|FG001|Period 1 Open Label|Lost to Follow-up|0|||
156801611|NCT00565409|566029260|FG002|Period 1 Open Label|Lost to Follow-up|0|||
156801612|NCT00565409|566029261|FG003|Period 1 Open Label|Lost to Follow-up|0|||
156801613|NCT00565409|566029258|FG000|Period 1 Open Label|Other|21|||
156801614|NCT00565409|566029259|FG001|Period 1 Open Label|Other|0|||
156801615|NCT00565409|566029260|FG002|Period 1 Open Label|Other|0|||
156801616|NCT00565409|566029261|FG003|Period 1 Open Label|Other|0|||
156801617|NCT00565409|566029258|FG000|Period 1 Open Label|Protocol Violation|14|||
156801618|NCT00565409|566029259|FG001|Period 1 Open Label|Protocol Violation|0|||
156801619|NCT00565409|566029260|FG002|Period 1 Open Label|Protocol Violation|0|||
156801620|NCT00565409|566029261|FG003|Period 1 Open Label|Protocol Violation|0|||
156801621|NCT00565409|566029258|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
156801622|NCT00565409|566029259|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801623|NCT00565409|566029260|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801624|NCT00565409|566029261|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
156801625|NCT00565409|566029258|FG000|Period 1 Open Label|no conclusion of participation record|1|||
156801626|NCT00565409|566029259|FG001|Period 1 Open Label|no conclusion of participation record|0|||
156801627|NCT00565409|566029260|FG002|Period 1 Open Label|no conclusion of participation record|0|||
156801628|NCT00565409|566029261|FG003|Period 1 Open Label|no conclusion of participation record|0|||
156801629|NCT00565409|566029258|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
156801630|NCT00565409|566029259|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801631|NCT00565409|566029260|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801632|NCT00565409|566029261|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
156801633|NCT00565409|566029258|FG000|Period 2 Double-Blind|Adverse Event|0|||
156801634|NCT00565409|566029259|FG001|Period 2 Double-Blind|Adverse Event|7|||
156801635|NCT00565409|566029260|FG002|Period 2 Double-Blind|Adverse Event|4|||
156801636|NCT00565409|566029261|FG003|Period 2 Double-Blind|Adverse Event|5|||
156801637|NCT00565409|566029258|FG000|Period 2 Double-Blind|Death|0|||
156801638|NCT00565409|566029259|FG001|Period 2 Double-Blind|Death|2|||
157221660|NCT02207621|567558474|FG000|Overall Study|Withdrawal by Subject|9|||
157143866|NCT00537940|567276355|FG001|Overall Study|Study terminated by sponsor|3|||
157143867|NCT00537940|567276354|FG000|Overall Study|Other|10|||
156801639|NCT00565409|566029260|FG002|Period 2 Double-Blind|Death|0|||
156801640|NCT00565409|566029261|FG003|Period 2 Double-Blind|Death|0|||
156801641|NCT00565409|566029258|FG000|Period 2 Double-Blind|Protocol Violation|0|||
156801642|NCT00565409|566029259|FG001|Period 2 Double-Blind|Protocol Violation|4|||
156801643|NCT00565409|566029260|FG002|Period 2 Double-Blind|Protocol Violation|6|||
156801644|NCT00565409|566029261|FG003|Period 2 Double-Blind|Protocol Violation|2|||
156801645|NCT00565409|566029258|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
156801646|NCT00565409|566029259|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
156801647|NCT00565409|566029260|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
156801648|NCT00565409|566029261|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
156801649|NCT00565409|566029258|FG000|Period 2 Double-Blind|Other|0|||
156801650|NCT00565409|566029259|FG001|Period 2 Double-Blind|Other|4|||
156801651|NCT00565409|566029260|FG002|Period 2 Double-Blind|Other|5|||
156801652|NCT00565409|566029261|FG003|Period 2 Double-Blind|Other|9|||
156801653|NCT00565409|566029258|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
156801654|NCT00565409|566029259|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
156801655|NCT00565409|566029260|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
156801656|NCT00565409|566029261|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
156801657|NCT03440008|566029264|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
156801658|NCT03440008|566029265|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
156801659|NCT03440008|566029264|FG000|Overall Study|Withdrawal by Subject|1|||
156801660|NCT03440008|566029265|FG001|Overall Study|Withdrawal by Subject|0|||
156801661|NCT04064905|566029268|FG000|Overall Study|Lost to Follow-up|0|||
156801662|NCT04064905|566029269|FG001|Overall Study|Lost to Follow-up|3|||
156801663|NCT04064905|566029270|FG002|Overall Study|Lost to Follow-up|1|||
156801664|NCT04064905|566029271|FG003|Overall Study|Lost to Follow-up|4|||
156801665|NCT04064905|566029272|FG004|Overall Study|Lost to Follow-up|2|||
156801666|NCT03961308|566029278|FG000|Overall Study|Withdrawal by Subject|1|||
156801667|NCT03961308|566029279|FG001|Overall Study|Withdrawal by Subject|0|||
156801668|NCT03961308|566029278|FG000|Overall Study|Other|1|||
156801669|NCT03961308|566029279|FG001|Overall Study|Other|0|||
156801670|NCT03961308|566029278|FG000|Overall Study|Lost to Follow-up|0|||
156801671|NCT03961308|566029279|FG001|Overall Study|Lost to Follow-up|1|||
156801672|NCT03961308|566029278|FG000|Overall Study|Adverse Event|0|||
156801673|NCT03961308|566029279|FG001|Overall Study|Adverse Event|1|||
156801674|NCT05643495|566029284|FG000|Overall Study|Adverse Event|0|||
156801675|NCT05643495|566029285|FG001|Overall Study|Adverse Event|1|||
156801676|NCT05643495|566029284|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156801677|NCT05643495|566029285|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156801678|NCT01729039|566029286|FG000|Overall Study|disqualified|2|||
156801679|NCT01729039|566029287|FG001|Overall Study|disqualified|5|||
156801680|NCT01729039|566029286|FG000|Overall Study|Withdrawal by Subject|8|||
156801681|NCT01729039|566029287|FG001|Overall Study|Withdrawal by Subject|7|||
156801682|NCT00404248|566029290|FG000|Overall Study|pts declining status|0|||
156801683|NCT00404248|566029291|FG001|Overall Study|pts declining status|1|||
156801684|NCT00404248|566029292|FG002|Overall Study|pts declining status|0|||
156801685|NCT00404248|566029293|FG003|Overall Study|pts declining status|0|||
156801686|NCT00404248|566029294|FG004|Overall Study|pts declining status|0|||
156801687|NCT00404248|566029295|FG005|Overall Study|pts declining status|0|||
156801688|NCT00404248|566029296|FG006|Overall Study|pts declining status|0|||
156801689|NCT00404248|566029297|FG007|Overall Study|pts declining status|0|||
156801690|NCT00404248|566029298|FG008|Overall Study|pts declining status|0|||
156801691|NCT00789555|566029299|FG000|Overall Study|Protocol Amendment|78|||
156801692|NCT00789555|566029300|FG001|Overall Study|Protocol Amendment|76|||
156801693|NCT00789555|566029301|FG002|Overall Study|Protocol Amendment|80|||
156801694|NCT00789555|566029299|FG000|Overall Study|Adverse Event|17|||
156801695|NCT00789555|566029300|FG001|Overall Study|Adverse Event|7|||
156801696|NCT00789555|566029301|FG002|Overall Study|Adverse Event|10|||
156801697|NCT00789555|566029299|FG000|Overall Study|Lost to Follow-up|9|||
156801698|NCT00789555|566029300|FG001|Overall Study|Lost to Follow-up|10|||
156801699|NCT00789555|566029301|FG002|Overall Study|Lost to Follow-up|18|||
156801700|NCT00789555|566029299|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
156801701|NCT00789555|566029300|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
156801702|NCT00789555|566029301|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
156801703|NCT00789555|566029299|FG000|Overall Study|Treatment failure|11|||
156801704|NCT00789555|566029300|FG001|Overall Study|Treatment failure|8|||
156801705|NCT00789555|566029301|FG002|Overall Study|Treatment failure|12|||
156801706|NCT00789555|566029299|FG000|Overall Study|Protocol Violation|6|||
156801707|NCT00789555|566029300|FG001|Overall Study|Protocol Violation|9|||
156801708|NCT00789555|566029301|FG002|Overall Study|Protocol Violation|13|||
156801709|NCT00698841|566029302|FG000|Overall Study|Withdrawal by Subject|2|||
157143868|NCT00537940|567276355|FG001|Overall Study|Other|12|||
157143869|NCT03715465|567276359|FG000|Overall Study|Withdrawal by Subject|1|||
157143870|NCT03715465|567276360|FG001|Overall Study|Withdrawal by Subject|2|||
156881485|NCT02059291|566326994|FG020|Epoch 2|Lack of Efficacy|0|||
156881486|NCT02059291|566326995|FG021|Epoch 2|Lack of Efficacy|0|||
156881487|NCT02059291|566326996|FG022|Epoch 2|Lack of Efficacy|0|||
156881488|NCT02059291|566326997|FG023|Epoch 2|Lack of Efficacy|0|||
156881489|NCT02059291|566326998|FG024|Epoch 2|Lack of Efficacy|0|||
156881490|NCT02059291|566326974|FG000|Epoch 2|Adverse Event|0|||
156881491|NCT02059291|566326975|FG001|Epoch 2|Adverse Event|0|||
156881492|NCT02059291|566326976|FG002|Epoch 2|Adverse Event|1|||
156881493|NCT02059291|566326977|FG003|Epoch 2|Adverse Event|1|||
156881494|NCT02059291|566326978|FG004|Epoch 2|Adverse Event|0|||
156881495|NCT02059291|566326979|FG005|Epoch 2|Adverse Event|0|||
156881496|NCT02059291|566326980|FG006|Epoch 2|Adverse Event|0|||
156881497|NCT02059291|566326981|FG007|Epoch 2|Adverse Event|1|||
156881498|NCT02059291|566326982|FG008|Epoch 2|Adverse Event|1|||
156881499|NCT02059291|566326983|FG009|Epoch 2|Adverse Event|0|||
156881500|NCT02059291|566326984|FG010|Epoch 2|Adverse Event|0|||
156881501|NCT02059291|566326985|FG011|Epoch 2|Adverse Event|0|||
156881502|NCT02059291|566326986|FG012|Epoch 2|Adverse Event|0|||
156881503|NCT02059291|566326987|FG013|Epoch 2|Adverse Event|0|||
156881504|NCT02059291|566326988|FG014|Epoch 2|Adverse Event|0|||
156881505|NCT02059291|566326989|FG015|Epoch 2|Adverse Event|0|||
156881506|NCT02059291|566326990|FG016|Epoch 2|Adverse Event|0|||
156881507|NCT02059291|566326991|FG017|Epoch 2|Adverse Event|0|||
156881508|NCT02059291|566326992|FG018|Epoch 2|Adverse Event|0|||
156881509|NCT02059291|566326993|FG019|Epoch 2|Adverse Event|0|||
156881510|NCT02059291|566326994|FG020|Epoch 2|Adverse Event|0|||
156881511|NCT02059291|566326995|FG021|Epoch 2|Adverse Event|0|||
156881512|NCT02059291|566326996|FG022|Epoch 2|Adverse Event|0|||
156881513|NCT02059291|566326997|FG023|Epoch 2|Adverse Event|0|||
156881514|NCT02059291|566326998|FG024|Epoch 2|Adverse Event|0|||
156881515|NCT02059291|566326974|FG000|Epoch 2|Withdrawal by Subject|0|||
156881516|NCT02059291|566326975|FG001|Epoch 2|Withdrawal by Subject|1|||
156881517|NCT02059291|566326976|FG002|Epoch 2|Withdrawal by Subject|0|||
156881518|NCT02059291|566326977|FG003|Epoch 2|Withdrawal by Subject|0|||
156881519|NCT02059291|566326978|FG004|Epoch 2|Withdrawal by Subject|0|||
156881520|NCT02059291|566326979|FG005|Epoch 2|Withdrawal by Subject|1|||
156881521|NCT02059291|566326980|FG006|Epoch 2|Withdrawal by Subject|0|||
156881522|NCT02059291|566326981|FG007|Epoch 2|Withdrawal by Subject|0|||
156881523|NCT02059291|566326982|FG008|Epoch 2|Withdrawal by Subject|1|||
156881524|NCT02059291|566326983|FG009|Epoch 2|Withdrawal by Subject|0|||
156881525|NCT02059291|566326984|FG010|Epoch 2|Withdrawal by Subject|0|||
156881526|NCT02059291|566326985|FG011|Epoch 2|Withdrawal by Subject|0|||
156881527|NCT02059291|566326986|FG012|Epoch 2|Withdrawal by Subject|0|||
156881528|NCT02059291|566326987|FG013|Epoch 2|Withdrawal by Subject|0|||
156881529|NCT02059291|566326988|FG014|Epoch 2|Withdrawal by Subject|0|||
156881530|NCT02059291|566326989|FG015|Epoch 2|Withdrawal by Subject|0|||
156881531|NCT02059291|566326990|FG016|Epoch 2|Withdrawal by Subject|0|||
156881532|NCT02059291|566326991|FG017|Epoch 2|Withdrawal by Subject|0|||
156881533|NCT02059291|566326992|FG018|Epoch 2|Withdrawal by Subject|0|||
156881534|NCT02059291|566326993|FG019|Epoch 2|Withdrawal by Subject|0|||
156881535|NCT02059291|566326994|FG020|Epoch 2|Withdrawal by Subject|0|||
156881536|NCT02059291|566326995|FG021|Epoch 2|Withdrawal by Subject|0|||
156881537|NCT02059291|566326996|FG022|Epoch 2|Withdrawal by Subject|0|||
156881538|NCT02059291|566326997|FG023|Epoch 2|Withdrawal by Subject|0|||
156881539|NCT02059291|566326998|FG024|Epoch 2|Withdrawal by Subject|0|||
156881540|NCT02059291|566326974|FG000|Epoch 3|Physician Decision|0|||
156881541|NCT02059291|566326975|FG001|Epoch 3|Physician Decision|0|||
156881542|NCT02059291|566326976|FG002|Epoch 3|Physician Decision|0|||
156881543|NCT02059291|566326977|FG003|Epoch 3|Physician Decision|0|||
156881544|NCT02059291|566326978|FG004|Epoch 3|Physician Decision|0|||
156881545|NCT02059291|566326979|FG005|Epoch 3|Physician Decision|0|||
156881546|NCT02059291|566326980|FG006|Epoch 3|Physician Decision|0|||
156881547|NCT02059291|566326981|FG007|Epoch 3|Physician Decision|0|||
156881548|NCT02059291|566326982|FG008|Epoch 3|Physician Decision|0|||
156881549|NCT02059291|566326983|FG009|Epoch 3|Physician Decision|0|||
156881550|NCT02059291|566326984|FG010|Epoch 3|Physician Decision|0|||
157021033|NCT05247489|566830795|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
156881551|NCT02059291|566326985|FG011|Epoch 3|Physician Decision|0|||
156881552|NCT02059291|566326986|FG012|Epoch 3|Physician Decision|0|||
156881553|NCT02059291|566326987|FG013|Epoch 3|Physician Decision|1|||
156881554|NCT02059291|566326988|FG014|Epoch 3|Physician Decision|0|||
156881555|NCT02059291|566326989|FG015|Epoch 3|Physician Decision|1|||
156881556|NCT02059291|566326990|FG016|Epoch 3|Physician Decision|0|||
156881557|NCT02059291|566326991|FG017|Epoch 3|Physician Decision|0|||
156881558|NCT02059291|566326992|FG018|Epoch 3|Physician Decision|0|||
156881559|NCT02059291|566326993|FG019|Epoch 3|Physician Decision|0|||
156881560|NCT02059291|566326994|FG020|Epoch 3|Physician Decision|0|||
156881561|NCT02059291|566326995|FG021|Epoch 3|Physician Decision|0|||
156881562|NCT02059291|566326996|FG022|Epoch 3|Physician Decision|0|||
156881563|NCT02059291|566326997|FG023|Epoch 3|Physician Decision|0|||
156881564|NCT02059291|566326998|FG024|Epoch 3|Physician Decision|0|||
156881565|NCT02059291|566326974|FG000|Epoch 3|Adverse Event|0|||
156881566|NCT02059291|566326975|FG001|Epoch 3|Adverse Event|0|||
156801710|NCT00698841|566029302|FG000|Overall Study|Adverse Event|3|||
156801711|NCT00698841|566029302|FG000|Overall Study|Disease progression|7|||
156801712|NCT00698841|566029302|FG000|Overall Study|Failure to meet eligibility criteria|2|||
156801713|NCT00698841|566029302|FG000|Overall Study|Study drug toxicity|2|||
156801714|NCT00698841|566029302|FG000|Overall Study|Other|2|||
156801715|NCT04646005|566029306|FG000|Overall Study|Adverse Event|1|||
156801716|NCT04646005|566029306|FG000|Overall Study|Progressive Disease|71|||
156801717|NCT04646005|566029306|FG000|Overall Study|Death|20|||
156801718|NCT04646005|566029306|FG000|Overall Study|Withdrawal by Subject|12|||
156801719|NCT04646005|566029306|FG000|Overall Study|Sponsor Request|9|||
156801720|NCT02661672|566029318|FG000|Overall Study|Lost to Follow-up|1|||
156801721|NCT02661672|566029318|FG000|Overall Study|Death|4|||
156801722|NCT02935192|566030693|FG000|Overall Study|Withdrawal by Subject|8|||
156801723|NCT02935192|566030694|FG001|Overall Study|Withdrawal by Subject|4|||
156801724|NCT00492557|566030696|FG000|Overall Study|Subject request|12|||
156801725|NCT00492557|566030697|FG001|Overall Study|Subject request|11|||
156801726|NCT00492557|566030696|FG000|Overall Study|Protocol Violation|7|||
156801727|NCT00492557|566030697|FG001|Overall Study|Protocol Violation|8|||
156801728|NCT00492557|566030696|FG000|Overall Study|Other|2|||
156801729|NCT00492557|566030697|FG001|Overall Study|Other|2|||
156801730|NCT00492557|566030696|FG000|Overall Study|Death|1|||
156801731|NCT00492557|566030697|FG001|Overall Study|Death|1|||
156801732|NCT00492557|566030696|FG000|Overall Study|Adverse Event|1|||
156801733|NCT00492557|566030697|FG001|Overall Study|Adverse Event|0|||
156801734|NCT00492557|566030696|FG000|Overall Study|Failed to return|1|||
156801735|NCT00492557|566030697|FG001|Overall Study|Failed to return|0|||
156801736|NCT00492557|566030696|FG000|Overall Study|Lost to Follow-up|0|||
156801737|NCT00492557|566030697|FG001|Overall Study|Lost to Follow-up|1|||
156801738|NCT01135992|566030699|FG000|Overall Study|Adverse Event|1|||
156801739|NCT01135992|566030699|FG000|Overall Study|Lack of Efficacy|1|||
156801740|NCT01135992|566030699|FG000|Overall Study|Protocol Violation|2|||
156801741|NCT01135992|566030699|FG000|Overall Study|Withdrawal criteria|10|||
156801742|NCT01135992|566030699|FG000|Overall Study|Unclassified|7|||
156801743|NCT01977898|566030700|FG000|Overall Study|Non functioning catheter|1|||
156801744|NCT01977898|566030701|FG001|Overall Study|Non functioning catheter|1|||
156801745|NCT03983421|566030706|FG000|Overall Study|Lost to Follow-up|1|||
156801746|NCT03386773|566030707|FG000|Overall Study|Lost to Follow-up|24|||
156801747|NCT03386773|566030708|FG001|Overall Study|Lost to Follow-up|33|||
156801748|NCT03386773|566030707|FG000|Overall Study|Withdrawal by Subject|3|||
156801749|NCT03386773|566030708|FG001|Overall Study|Withdrawal by Subject|2|||
156801750|NCT03639610|566030709|FG000|Overall Study|Adverse Event|7|||
156801751|NCT03639610|566030710|FG001|Overall Study|Adverse Event|1|||
156801752|NCT03639610|566030711|FG002|Overall Study|Adverse Event|0|||
156801753|NCT03639610|566030709|FG000|Overall Study|Physician Decision|3|||
156801754|NCT03639610|566030710|FG001|Overall Study|Physician Decision|1|||
156801755|NCT03639610|566030711|FG002|Overall Study|Physician Decision|0|||
156801756|NCT03639610|566030709|FG000|Overall Study|Disease progression|8|||
156801757|NCT03639610|566030710|FG001|Overall Study|Disease progression|5|||
156801758|NCT03639610|566030711|FG002|Overall Study|Disease progression|3|||
156801759|NCT03639610|566030709|FG000|Overall Study|Study terminated by sponsor|2|||
156801760|NCT03639610|566030710|FG001|Overall Study|Study terminated by sponsor|1|||
156801761|NCT03639610|566030711|FG002|Overall Study|Study terminated by sponsor|1|||
156801762|NCT03639610|566030709|FG000|Overall Study|Patient request to stop treatment|1|||
156801763|NCT03639610|566030710|FG001|Overall Study|Patient request to stop treatment|2|||
156801764|NCT03639610|566030711|FG002|Overall Study|Patient request to stop treatment|0|||
156801765|NCT02660229|566030712|FG000|Overall Study|Adverse Event|2|||
156801766|NCT02660229|566030713|FG001|Overall Study|Adverse Event|0|||
156801767|NCT02660229|566030712|FG000|Overall Study|Withdrawal by Subject|0|||
156801768|NCT02660229|566030713|FG001|Overall Study|Withdrawal by Subject|1|||
156801769|NCT01049373|566030717|FG000|Overall Study|Protocol Violation|9|||
156801770|NCT01049373|566030718|FG001|Overall Study|Protocol Violation|9|||
156801771|NCT01049373|566030717|FG000|Overall Study|Withdrawal by Subject|8|||
156801772|NCT01049373|566030718|FG001|Overall Study|Withdrawal by Subject|5|||
156801773|NCT01049373|566030717|FG000|Overall Study|Adverse Event|3|||
156801774|NCT01049373|566030718|FG001|Overall Study|Adverse Event|3|||
156801775|NCT01049373|566030717|FG000|Overall Study|Lost to Follow-up|9|||
156801776|NCT01049373|566030718|FG001|Overall Study|Lost to Follow-up|4|||
156801777|NCT01049373|566030717|FG000|Overall Study|no evaluable study values|9|||
156801778|NCT01049373|566030718|FG001|Overall Study|no evaluable study values|21|||
156801779|NCT01049373|566030717|FG000|Overall Study|Other|1|||
156801780|NCT01049373|566030718|FG001|Overall Study|Other|1|||
156801781|NCT01049373|566030717|FG000|Overall Study|Non-cooperation|0|||
156801782|NCT01049373|566030718|FG001|Overall Study|Non-cooperation|1|||
156801783|NCT03610048|566030719|FG000|Overall Study|Study terminated by sponsor|84|||
156801784|NCT03610048|566030719|FG000|Overall Study|Adverse Event|32|||
156801785|NCT03610048|566030719|FG000|Overall Study|Withdrawal by Subject|31|||
156801786|NCT03610048|566030719|FG000|Overall Study|Lost to Follow-up|8|||
156801787|NCT03610048|566030719|FG000|Overall Study|Other|4|||
156801788|NCT03610048|566030719|FG000|Overall Study|Physician Decision|1|||
156801789|NCT03610048|566030719|FG000|Overall Study|Pregnancy|1|||
156801790|NCT01155050|566030720|FG000|Overall Study|Lost to Follow-up|15|||
156801791|NCT01155050|566030721|FG001|Overall Study|Lost to Follow-up|20|||
156801792|NCT01155050|566030722|FG002|Overall Study|Lost to Follow-up|19|||
156801793|NCT01155050|566030723|FG003|Overall Study|Lost to Follow-up|22|||
156801794|NCT02136914|566030724|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
156801795|NCT02136914|566030725|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
156801796|NCT02136914|566030724|FG000|Overall Study|Withdrawal by Subject|3|||
156801797|NCT02136914|566030725|FG001|Overall Study|Withdrawal by Subject|10|||
156801798|NCT02136914|566030724|FG000|Overall Study|Subject Unwilling to Proceed|7|||
156801799|NCT02136914|566030725|FG001|Overall Study|Subject Unwilling to Proceed|2|||
156801800|NCT02136914|566030724|FG000|Overall Study|Lost to Follow-up|1|||
156801801|NCT02136914|566030725|FG001|Overall Study|Lost to Follow-up|1|||
156801802|NCT02136914|566030724|FG000|Overall Study|Did Not Receive Study Drug|2|||
156801803|NCT02136914|566030725|FG001|Overall Study|Did Not Receive Study Drug|0|||
156801804|NCT02136914|566030724|FG000|Overall Study|Lack of Efficacy|1|||
156801805|NCT02136914|566030725|FG001|Overall Study|Lack of Efficacy|0|||
156801806|NCT02136914|566030724|FG000|Overall Study|Death|0|||
156801807|NCT02136914|566030725|FG001|Overall Study|Death|1|||
156801808|NCT01496287|566030728|FG000|Overall Study|Lost to Follow-up|1|||
156801809|NCT01496287|566030728|FG000|Overall Study|Incomplete anesthesia|5|||
156801810|NCT00329030|566030729|FG000|Overall Study|Withdrawal by Subject|1|||
156801811|NCT00329030|566030730|FG001|Overall Study|Withdrawal by Subject|3|||
156801812|NCT00329030|566030729|FG000|Overall Study|Progressive Disease|6|||
156801813|NCT00329030|566030730|FG001|Overall Study|Progressive Disease|2|||
156801814|NCT00329030|566030729|FG000|Overall Study|Ineligible Pathology|1|||
156801815|NCT00329030|566030730|FG001|Overall Study|Ineligible Pathology|1|||
156801816|NCT00557193|566030731|FG000|Induction|Adverse Event|2|||
156801817|NCT00557193|566030732|FG001|Induction|Adverse Event|0|||
156801818|NCT00557193|566030733|FG002|Induction|Adverse Event|0|||
156801819|NCT00557193|566030734|FG003|Induction|Adverse Event|0|||
156801820|NCT00557193|566030735|FG004|Induction|Adverse Event|0|||
156801821|NCT00557193|566030736|FG005|Induction|Adverse Event|0|||
156801822|NCT00557193|566030731|FG000|Induction|Death|6|||
156801823|NCT00557193|566030732|FG001|Induction|Death|0|||
156801824|NCT00557193|566030733|FG002|Induction|Death|0|||
156801825|NCT00557193|566030734|FG003|Induction|Death|0|||
156801826|NCT00557193|566030735|FG004|Induction|Death|0|||
156801827|NCT00557193|566030736|FG005|Induction|Death|0|||
156801828|NCT00557193|566030731|FG000|Induction|Physician Decision|3|||
156801829|NCT00557193|566030732|FG001|Induction|Physician Decision|0|||
156801830|NCT00557193|566030733|FG002|Induction|Physician Decision|0|||
156801831|NCT00557193|566030734|FG003|Induction|Physician Decision|0|||
156801832|NCT00557193|566030735|FG004|Induction|Physician Decision|0|||
156801833|NCT00557193|566030736|FG005|Induction|Physician Decision|0|||
156801834|NCT00557193|566030731|FG000|Induction|Withdrawal by Subject|1|||
156801835|NCT00557193|566030732|FG001|Induction|Withdrawal by Subject|0|||
156801836|NCT00557193|566030733|FG002|Induction|Withdrawal by Subject|0|||
156801837|NCT00557193|566030734|FG003|Induction|Withdrawal by Subject|0|||
156801838|NCT00557193|566030735|FG004|Induction|Withdrawal by Subject|0|||
156801839|NCT00557193|566030736|FG005|Induction|Withdrawal by Subject|0|||
156801840|NCT00557193|566030731|FG000|Induction|Refusal of Further Protocol Therapy|2|||
156801841|NCT00557193|566030732|FG001|Induction|Refusal of Further Protocol Therapy|0|||
156801842|NCT00557193|566030733|FG002|Induction|Refusal of Further Protocol Therapy|0|||
156801843|NCT00557193|566030734|FG003|Induction|Refusal of Further Protocol Therapy|0|||
156801844|NCT00557193|566030735|FG004|Induction|Refusal of Further Protocol Therapy|0|||
156801845|NCT00557193|566030736|FG005|Induction|Refusal of Further Protocol Therapy|0|||
156801846|NCT00557193|566030731|FG000|Induction|Ineligible|8|||
156801847|NCT00557193|566030732|FG001|Induction|Ineligible|0|||
156801848|NCT00557193|566030733|FG002|Induction|Ineligible|0|||
156801849|NCT00557193|566030734|FG003|Induction|Ineligible|0|||
156801850|NCT00557193|566030735|FG004|Induction|Ineligible|0|||
156801851|NCT00557193|566030736|FG005|Induction|Ineligible|0|||
156801852|NCT00557193|566030731|FG000|Induction|Inevaluable for post Induction|2|||
156801853|NCT00557193|566030732|FG001|Induction|Inevaluable for post Induction|0|||
156801854|NCT00557193|566030733|FG002|Induction|Inevaluable for post Induction|0|||
156801855|NCT00557193|566030734|FG003|Induction|Inevaluable for post Induction|0|||
156801856|NCT00557193|566030735|FG004|Induction|Inevaluable for post Induction|0|||
156801857|NCT00557193|566030736|FG005|Induction|Inevaluable for post Induction|0|||
156801858|NCT00557193|566030731|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
156801859|NCT00557193|566030732|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801860|NCT00557193|566030733|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801861|NCT00557193|566030734|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801862|NCT00557193|566030735|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801863|NCT00557193|566030736|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
156801864|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156801865|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
156801866|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
156801867|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
156801868|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
156801869|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
156801870|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
156801871|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
156801872|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
156801873|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
156801874|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
156801875|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
156801876|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
156801877|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
156801878|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
156801879|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
156801880|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
156801881|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
156801882|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
156801883|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
156801884|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
156801885|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
156801886|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
156801887|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
156801888|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
156801889|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
156801890|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
156801891|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
156801892|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
156801893|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
156801894|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801895|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801896|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
156801897|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801898|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801899|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
156801900|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801901|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801902|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
156801903|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801904|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801905|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
156801906|NCT00557193|566030731|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801907|NCT00557193|566030732|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801908|NCT00557193|566030733|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
156801909|NCT00557193|566030734|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801910|NCT00557193|566030735|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
156801911|NCT00557193|566030736|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
156801912|NCT03036852|566030737|FG000|Overall Study|Death|2|||
156801913|NCT03036852|566030737|FG000|Overall Study|Lack of Efficacy|2|||
156801914|NCT03036852|566030737|FG000|Overall Study|Adverse Event|1|||
156801915|NCT03036852|566030737|FG000|Overall Study|Lost to Follow-up|1|||
156801916|NCT02639390|566030749|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
156801917|NCT02639390|566030750|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
156801918|NCT01531998|566030754|FG000|Overall Study|Withdrawal by Subject|3|||
156801919|NCT02581891|566030755|FG000|Overall Study|Adverse Event|4|||
156801920|NCT02581891|566030756|FG001|Overall Study|Adverse Event|6|||
156801921|NCT02581891|566030755|FG000|Overall Study|Death|3|||
156801922|NCT02581891|566030756|FG001|Overall Study|Death|4|||
156801923|NCT02581891|566030755|FG000|Overall Study|Lost to Follow-up|1|||
156801924|NCT02581891|566030756|FG001|Overall Study|Lost to Follow-up|2|||
156801925|NCT02581891|566030755|FG000|Overall Study|Physician Decision|0|||
156801926|NCT02581891|566030756|FG001|Overall Study|Physician Decision|1|||
156801927|NCT02581891|566030755|FG000|Overall Study|Withdrawal by Subject|4|||
156801928|NCT02581891|566030756|FG001|Overall Study|Withdrawal by Subject|5|||
156801929|NCT02581891|566030755|FG000|Overall Study|Other Reasons|3|||
156801930|NCT02581891|566030756|FG001|Overall Study|Other Reasons|1|||
156801931|NCT02581891|566030755|FG000|Overall Study|Discontinued during followup|1|||
156801932|NCT02581891|566030756|FG001|Overall Study|Discontinued during followup|0|||
156801933|NCT04067011|566030758|FG000|Overall Study|Not Treated|8|||
156801934|NCT04067011|566030759|FG001|Overall Study|Not Treated|7|||
156801935|NCT04067011|566030760|FG002|Overall Study|Not Treated|5|||
156801936|NCT04067011|566030758|FG000|Overall Study|Adverse Event|2|||
156801937|NCT04067011|566030759|FG001|Overall Study|Adverse Event|1|||
156801938|NCT04067011|566030760|FG002|Overall Study|Adverse Event|0|||
156801939|NCT04067011|566030758|FG000|Overall Study|Withdrawal by Subject|6|||
156801940|NCT04067011|566030759|FG001|Overall Study|Withdrawal by Subject|2|||
156801941|NCT04067011|566030760|FG002|Overall Study|Withdrawal by Subject|1|||
156801942|NCT04067011|566030758|FG000|Overall Study|Lost to Follow-up|0|||
156801943|NCT04067011|566030759|FG001|Overall Study|Lost to Follow-up|0|||
156801944|NCT04067011|566030760|FG002|Overall Study|Lost to Follow-up|1|||
156801945|NCT04067011|566030758|FG000|Overall Study|Physician Decision|1|||
156801946|NCT04067011|566030759|FG001|Overall Study|Physician Decision|1|||
156801947|NCT04067011|566030760|FG002|Overall Study|Physician Decision|0|||
156801948|NCT04067011|566030758|FG000|Overall Study|Other Reasons|2|||
156801949|NCT04067011|566030759|FG001|Overall Study|Other Reasons|0|||
156801950|NCT04067011|566030760|FG002|Overall Study|Other Reasons|1|||
156801951|NCT04067011|566030758|FG000|Overall Study|Missing|0|||
156801952|NCT04067011|566030759|FG001|Overall Study|Missing|2|||
156801953|NCT04067011|566030760|FG002|Overall Study|Missing|0|||
156801954|NCT00760552|566030761|FG000|Overall Study|Death|2|||
156801955|NCT00760552|566030762|FG001|Overall Study|Death|0|||
156801956|NCT00760552|566030761|FG000|Overall Study|Lost to Follow-up|11|||
156801957|NCT00760552|566030762|FG001|Overall Study|Lost to Follow-up|10|||
156801958|NCT01038323|566030763|FG000|Overall Study|Withdrawal by Subject|3|||
156801959|NCT01038323|566030764|FG001|Overall Study|Withdrawal by Subject|2|||
156801960|NCT01038323|566030765|FG002|Overall Study|Withdrawal by Subject|4|||
156801961|NCT04211363|566030767|FG000|Overall Study|Adverse Event|5|||
156801962|NCT04211363|566030768|FG001|Overall Study|Adverse Event|2|||
156801963|NCT04211363|566030767|FG000|Overall Study|Physician Decision|0|||
156801964|NCT04211363|566030768|FG001|Overall Study|Physician Decision|1|||
156801965|NCT04211363|566030767|FG000|Overall Study|Protocol Violation|1|||
156801966|NCT04211363|566030768|FG001|Overall Study|Protocol Violation|0|||
156801967|NCT04211363|566030767|FG000|Overall Study|Pregnancy|1|||
156801968|NCT04211363|566030768|FG001|Overall Study|Pregnancy|0|||
156801969|NCT04211363|566030767|FG000|Overall Study|Lost to Follow-up|12|||
156801970|NCT04211363|566030768|FG001|Overall Study|Lost to Follow-up|4|||
156801971|NCT04211363|566030767|FG000|Overall Study|Withdrawal by Subject|11|||
156801972|NCT04211363|566030768|FG001|Overall Study|Withdrawal by Subject|11|||
156801973|NCT04211363|566030767|FG000|Overall Study|Other|1|||
156801974|NCT04211363|566030768|FG001|Overall Study|Other|2|||
156801975|NCT01736917|566030769|FG000|Overall Study|Adverse Event|1|||
156801976|NCT01736917|566030769|FG000|Overall Study|Protocol Violation|10|||
156801977|NCT01734902|566030770|FG000|Overall Study|Other than listed|0|||
156801978|NCT01734902|566030771|FG001|Overall Study|Other than listed|2|||
156801979|NCT00060944|566030772|FG000|Overall Study|Adverse Event|12|||
156801980|NCT00060944|566030773|FG001|Overall Study|Adverse Event|10|||
156801981|NCT00060944|566030772|FG000|Overall Study|Death|2|||
156801982|NCT00060944|566030773|FG001|Overall Study|Death|3|||
156801983|NCT00060944|566030772|FG000|Overall Study|Withdrawal by Subject|18|||
156801984|NCT00060944|566030773|FG001|Overall Study|Withdrawal by Subject|5|||
156801985|NCT00060944|566030772|FG000|Overall Study|Disease Progression|93|||
156801986|NCT00060944|566030773|FG001|Overall Study|Disease Progression|94|||
156801987|NCT00060944|566030772|FG000|Overall Study|Lost to Follow-up|1|||
156801988|NCT00060944|566030773|FG001|Overall Study|Lost to Follow-up|0|||
156801989|NCT00060944|566030772|FG000|Overall Study|Subject Ineligible To Continue|2|||
156801990|NCT00060944|566030773|FG001|Overall Study|Subject Ineligible To Continue|1|||
156801991|NCT00060944|566030772|FG000|Overall Study|Treatment Switch|0|||
156801992|NCT00060944|566030773|FG001|Overall Study|Treatment Switch|13|||
156801993|NCT00060944|566030772|FG000|Overall Study|Other|2|||
156801994|NCT00060944|566030773|FG001|Overall Study|Other|4|||
156801995|NCT00060944|566030772|FG000|Overall Study|randomized but not treated|6|||
156801996|NCT00060944|566030773|FG001|Overall Study|randomized but not treated|4|||
156801997|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
156801998|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
156801999|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
156802000|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Death|0|||
156802001|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Death|0|||
156802002|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Death|1|||
156802003|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
156802004|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
156802005|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
156802006|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
156802007|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
156802008|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
156802009|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
156802010|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
156802011|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
157021034|NCT03126019|566830796|FG000|Overall Study|Death|5|||
157021035|NCT03126019|566830797|FG001|Overall Study|Death|27|||
157021036|NCT03126019|566830796|FG000|Overall Study|Lost to Follow-up|2|||
157021037|NCT03126019|566830797|FG001|Overall Study|Lost to Follow-up|4|||
157021038|NCT03126019|566830796|FG000|Overall Study|Withdrawal by Subject|1|||
157021039|NCT03126019|566830797|FG001|Overall Study|Withdrawal by Subject|9|||
157021040|NCT03126019|566830796|FG000|Overall Study|Physician Decision|1|||
157021041|NCT03126019|566830797|FG001|Overall Study|Physician Decision|0|||
157021042|NCT03126019|566830796|FG000|Overall Study|Transitioned to Rollover Study|0|||
156881567|NCT02059291|566326976|FG002|Epoch 3|Adverse Event|0|||
156881568|NCT02059291|566326977|FG003|Epoch 3|Adverse Event|0|||
156881569|NCT02059291|566326978|FG004|Epoch 3|Adverse Event|0|||
156881570|NCT02059291|566326979|FG005|Epoch 3|Adverse Event|0|||
156881571|NCT02059291|566326980|FG006|Epoch 3|Adverse Event|0|||
156881572|NCT02059291|566326981|FG007|Epoch 3|Adverse Event|0|||
156881573|NCT02059291|566326982|FG008|Epoch 3|Adverse Event|0|||
156881574|NCT02059291|566326983|FG009|Epoch 3|Adverse Event|0|||
156881575|NCT02059291|566326984|FG010|Epoch 3|Adverse Event|0|||
156881576|NCT02059291|566326985|FG011|Epoch 3|Adverse Event|0|||
156881577|NCT02059291|566326986|FG012|Epoch 3|Adverse Event|0|||
156881578|NCT02059291|566326987|FG013|Epoch 3|Adverse Event|0|||
156802012|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Graft loss|0|||
156802013|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Graft loss|0|||
156802014|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Graft loss|7|||
156802015|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
156802016|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
156802017|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
156802018|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
156802019|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
156802020|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
156802021|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
156802022|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
156802023|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
156802024|NCT00956293|566030777|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
156802025|NCT00956293|566030778|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
156802026|NCT00956293|566030779|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
156802027|NCT00956293|566030777|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
156802028|NCT00956293|566030778|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
156802029|NCT00956293|566030779|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
156802030|NCT00956293|566030777|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
156802031|NCT00956293|566030778|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
156802032|NCT00956293|566030779|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
156802033|NCT00956293|566030777|FG000|Main Period (Randomization)|Adverse Event|0|||
156881579|NCT02059291|566326988|FG014|Epoch 3|Adverse Event|0|||
156881580|NCT02059291|566326989|FG015|Epoch 3|Adverse Event|1|||
156881581|NCT02059291|566326990|FG016|Epoch 3|Adverse Event|0|||
156881582|NCT02059291|566326991|FG017|Epoch 3|Adverse Event|0|||
156881583|NCT02059291|566326992|FG018|Epoch 3|Adverse Event|0|||
156881584|NCT02059291|566326993|FG019|Epoch 3|Adverse Event|0|||
156881585|NCT02059291|566326994|FG020|Epoch 3|Adverse Event|0|||
156881586|NCT02059291|566326995|FG021|Epoch 3|Adverse Event|0|||
156802034|NCT00956293|566030778|FG001|Main Period (Randomization)|Adverse Event|15|||
156802035|NCT00956293|566030779|FG002|Main Period (Randomization)|Adverse Event|0|||
156802036|NCT00956293|566030777|FG000|Follow-up Period|Follow-up period was terminated.|20|||
156802037|NCT00956293|566030778|FG001|Follow-up Period|Follow-up period was terminated.|32|||
156802038|NCT00956293|566030779|FG002|Follow-up Period|Follow-up period was terminated.|0|||
156802039|NCT03383666|566030780|FG000|Overall Study|Withdrawal by Subject|2|||
156802040|NCT03383666|566030780|FG000|Overall Study|Lost to Follow-up|2|||
156802041|NCT02536664|566030781|FG000|Overall Study|Inadequate completion of documentation|2|||
156802042|NCT02536664|566030782|FG001|Overall Study|Inadequate completion of documentation|4|||
156802043|NCT02536664|566030781|FG000|Overall Study|Progression|13|||
156802044|NCT02536664|566030782|FG001|Overall Study|Progression|18|||
156802045|NCT02536664|566030781|FG000|Overall Study|Death due to lymphoma|2|||
156802046|NCT02536664|566030782|FG001|Overall Study|Death due to lymphoma|1|||
156881587|NCT02059291|566326996|FG022|Epoch 3|Adverse Event|0|||
156881588|NCT02059291|566326997|FG023|Epoch 3|Adverse Event|0|||
156881589|NCT02059291|566326998|FG024|Epoch 3|Adverse Event|0|||
156881590|NCT02059291|566326974|FG000|Epoch 3|Lack of Efficacy|0|||
156881591|NCT02059291|566326975|FG001|Epoch 3|Lack of Efficacy|0|||
157021043|NCT03126019|566830797|FG001|Overall Study|Transitioned to Rollover Study|11|||
157143871|NCT02158533|567276364|FG000|Stage 1|Adverse Event|6|||
156802047|NCT02536664|566030781|FG000|Overall Study|Death due to other reason|3|||
156802048|NCT02536664|566030782|FG001|Overall Study|Death due to other reason|2|||
156881592|NCT02059291|566326976|FG002|Epoch 3|Lack of Efficacy|0|||
156881593|NCT02059291|566326977|FG003|Epoch 3|Lack of Efficacy|0|||
156881594|NCT02059291|566326978|FG004|Epoch 3|Lack of Efficacy|0|||
156881595|NCT02059291|566326979|FG005|Epoch 3|Lack of Efficacy|0|||
157143872|NCT02158533|567276365|FG001|Stage 1|Adverse Event|4|||
157143873|NCT02158533|567276366|FG002|Stage 1|Adverse Event|7|||
157143874|NCT02158533|567276367|FG003|Stage 1|Adverse Event|0|||
156802049|NCT02536664|566030781|FG000|Overall Study|Intolerability|8|||
156802050|NCT02536664|566030782|FG001|Overall Study|Intolerability|6|||
156802051|NCT02536664|566030781|FG000|Overall Study|Withdrawal by Subject|8|||
156802052|NCT02536664|566030782|FG001|Overall Study|Withdrawal by Subject|5|||
156802053|NCT02536664|566030781|FG000|Overall Study|Other|18|||
156802054|NCT02536664|566030782|FG001|Overall Study|Other|24|||
156802055|NCT02536664|566030781|FG000|Overall Study|Missing|53|||
156802056|NCT02536664|566030782|FG001|Overall Study|Missing|20|||
156802057|NCT00659425|566030784|FG000|Overall Study|Disease progression|1|||
156802058|NCT00659425|566030785|FG001|Overall Study|Disease progression|0|||
156802059|NCT00659425|566030786|FG002|Overall Study|Disease progression|0|||
156802060|NCT00659425|566030787|FG003|Overall Study|Disease progression|1|||
156802061|NCT00659425|566030788|FG004|Overall Study|Disease progression|0|||
156802062|NCT00659425|566030789|FG005|Overall Study|Disease progression|2|||
156802063|NCT00659425|566030790|FG006|Overall Study|Disease progression|4|||
156802064|NCT00659425|566030791|FG007|Overall Study|Disease progression|3|||
156802065|NCT00659425|566030792|FG008|Overall Study|Disease progression|5|||
156802066|NCT00659425|566030793|FG009|Overall Study|Disease progression|3|||
156802067|NCT00659425|566030784|FG000|Overall Study|Death|0|||
156802068|NCT00659425|566030785|FG001|Overall Study|Death|0|||
156802069|NCT00659425|566030786|FG002|Overall Study|Death|0|||
156802070|NCT00659425|566030787|FG003|Overall Study|Death|1|||
156802071|NCT00659425|566030788|FG004|Overall Study|Death|0|||
156802072|NCT00659425|566030789|FG005|Overall Study|Death|0|||
156802073|NCT00659425|566030790|FG006|Overall Study|Death|1|||
156802074|NCT00659425|566030791|FG007|Overall Study|Death|0|||
156802075|NCT00659425|566030792|FG008|Overall Study|Death|0|||
156802076|NCT00659425|566030793|FG009|Overall Study|Death|0|||
156802077|NCT00659425|566030784|FG000|Overall Study|Adverse Event|0|||
156802078|NCT00659425|566030785|FG001|Overall Study|Adverse Event|0|||
156802079|NCT00659425|566030786|FG002|Overall Study|Adverse Event|0|||
156802080|NCT00659425|566030787|FG003|Overall Study|Adverse Event|0|||
156802081|NCT00659425|566030788|FG004|Overall Study|Adverse Event|0|||
156802082|NCT00659425|566030789|FG005|Overall Study|Adverse Event|1|||
156802083|NCT00659425|566030790|FG006|Overall Study|Adverse Event|0|||
156802084|NCT00659425|566030791|FG007|Overall Study|Adverse Event|3|||
156802085|NCT00659425|566030792|FG008|Overall Study|Adverse Event|1|||
156802086|NCT00659425|566030793|FG009|Overall Study|Adverse Event|4|||
156802087|NCT00659425|566030784|FG000|Overall Study|Investigator Discretion|0|||
156802088|NCT00659425|566030785|FG001|Overall Study|Investigator Discretion|0|||
156802089|NCT00659425|566030786|FG002|Overall Study|Investigator Discretion|0|||
156802090|NCT00659425|566030787|FG003|Overall Study|Investigator Discretion|0|||
156802091|NCT00659425|566030788|FG004|Overall Study|Investigator Discretion|0|||
156802092|NCT00659425|566030789|FG005|Overall Study|Investigator Discretion|1|||
156802093|NCT00659425|566030790|FG006|Overall Study|Investigator Discretion|0|||
156802094|NCT00659425|566030791|FG007|Overall Study|Investigator Discretion|3|||
156802095|NCT00659425|566030792|FG008|Overall Study|Investigator Discretion|0|||
156802096|NCT00659425|566030793|FG009|Overall Study|Investigator Discretion|0|||
156802097|NCT00659425|566030784|FG000|Overall Study|Other|0|||
156802098|NCT00659425|566030785|FG001|Overall Study|Other|1|||
156802099|NCT00659425|566030786|FG002|Overall Study|Other|1|||
156802100|NCT00659425|566030787|FG003|Overall Study|Other|2|||
156802101|NCT00659425|566030788|FG004|Overall Study|Other|4|||
156802102|NCT00659425|566030789|FG005|Overall Study|Other|0|||
156802103|NCT00659425|566030790|FG006|Overall Study|Other|3|||
156802104|NCT00659425|566030791|FG007|Overall Study|Other|2|||
156802105|NCT00659425|566030792|FG008|Overall Study|Other|0|||
156802106|NCT00659425|566030793|FG009|Overall Study|Other|6|||
156802107|NCT03358030|566030794|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
156802108|NCT03358030|566030795|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
156802109|NCT03358030|566030796|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
156802110|NCT03358030|566030797|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
156802111|NCT03358030|566030794|FG000|Overall Study|Ineligibility|0|||
156802112|NCT03358030|566030795|FG001|Overall Study|Ineligibility|0|||
156802113|NCT03358030|566030796|FG002|Overall Study|Ineligibility|0|||
156802114|NCT03358030|566030797|FG003|Overall Study|Ineligibility|2|||
156802115|NCT03358030|566030794|FG000|Overall Study|Voluntary Withdrawal|1|||
156802116|NCT03358030|566030795|FG001|Overall Study|Voluntary Withdrawal|1|||
156802117|NCT03358030|566030796|FG002|Overall Study|Voluntary Withdrawal|3|||
156802118|NCT03358030|566030797|FG003|Overall Study|Voluntary Withdrawal|1|||
156802119|NCT03358030|566030794|FG000|Overall Study|Other|0|||
156802120|NCT03358030|566030795|FG001|Overall Study|Other|0|||
156802121|NCT03358030|566030796|FG002|Overall Study|Other|1|||
156802122|NCT03358030|566030797|FG003|Overall Study|Other|0|||
156802123|NCT03342560|566030798|FG000|Overall Study|Lost to Follow-up|2|||
156802124|NCT03770286|566030799|FG000|Overall Study|Lost to Follow-up|6|||
156802125|NCT03770286|566030800|FG001|Overall Study|Lost to Follow-up|4|||
156802126|NCT03770286|566030801|FG002|Overall Study|Lost to Follow-up|3|||
156802127|NCT03770286|566030799|FG000|Overall Study|Protocol Violation|1|||
156802128|NCT03770286|566030800|FG001|Overall Study|Protocol Violation|0|||
156802129|NCT03770286|566030801|FG002|Overall Study|Protocol Violation|2|||
156802130|NCT02505425|566030802|FG000|Overall Study|Lost to Follow-up|41|||
156802131|NCT02505425|566030803|FG001|Overall Study|Lost to Follow-up|61|||
156802132|NCT02505425|566030804|FG002|Overall Study|Lost to Follow-up|31|||
156802133|NCT02505425|566030805|FG003|Overall Study|Lost to Follow-up|19|||
156802134|NCT02505425|566030802|FG000|Overall Study|Withdrawal by Subject|39|||
156802135|NCT02505425|566030803|FG001|Overall Study|Withdrawal by Subject|9|||
156802136|NCT02505425|566030804|FG002|Overall Study|Withdrawal by Subject|19|||
156802137|NCT02505425|566030805|FG003|Overall Study|Withdrawal by Subject|7|||
156802138|NCT02505425|566030802|FG000|Overall Study|Death|8|||
156802139|NCT02505425|566030803|FG001|Overall Study|Death|12|||
156802140|NCT02505425|566030804|FG002|Overall Study|Death|0|||
156802141|NCT02505425|566030805|FG003|Overall Study|Death|0|||
156802142|NCT00545779|566030811|FG000|Overall Study|Violation of selection criteria at entry|8|||
156802143|NCT00545779|566030811|FG000|Overall Study|Other protocol violation|1|||
156802144|NCT00545779|566030811|FG000|Overall Study|Did not cooperate|7|||
156802145|NCT00545779|566030811|FG000|Overall Study|Withdrawal by Subject|20|||
156802146|NCT00545779|566030811|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
156802147|NCT00545779|566030811|FG000|Overall Study|Failure to return|3|||
156802148|NCT01405196|566030812|FG000|Overall Study|Study Terminated by Sponsor|0|||
156802149|NCT01405196|566030813|FG001|Overall Study|Study Terminated by Sponsor|0|||
156802150|NCT01405196|566030814|FG002|Overall Study|Study Terminated by Sponsor|9|||
156802151|NCT01405196|566030815|FG003|Overall Study|Study Terminated by Sponsor|0|||
156802152|NCT01405196|566030812|FG000|Overall Study|Other|2|||
156802153|NCT01405196|566030813|FG001|Overall Study|Other|2|||
156802154|NCT01405196|566030814|FG002|Overall Study|Other|5|||
156802155|NCT01405196|566030815|FG003|Overall Study|Other|0|||
156802156|NCT01405196|566030812|FG000|Overall Study|Withdrawal by Subject|4|||
156802157|NCT01405196|566030813|FG001|Overall Study|Withdrawal by Subject|6|||
156802158|NCT01405196|566030814|FG002|Overall Study|Withdrawal by Subject|3|||
156802159|NCT01405196|566030815|FG003|Overall Study|Withdrawal by Subject|6|||
156802160|NCT01405196|566030812|FG000|Overall Study|Adverse Event|2|||
156802161|NCT01405196|566030813|FG001|Overall Study|Adverse Event|2|||
156802162|NCT01405196|566030814|FG002|Overall Study|Adverse Event|0|||
156802163|NCT01405196|566030815|FG003|Overall Study|Adverse Event|2|||
156802164|NCT01405196|566030812|FG000|Overall Study|Death|1|||
156802165|NCT01405196|566030813|FG001|Overall Study|Death|0|||
156802166|NCT01405196|566030814|FG002|Overall Study|Death|3|||
156802167|NCT01405196|566030815|FG003|Overall Study|Death|0|||
156802168|NCT01405196|566030812|FG000|Overall Study|Lost to Follow-up|2|||
156802169|NCT01405196|566030813|FG001|Overall Study|Lost to Follow-up|2|||
156802170|NCT01405196|566030814|FG002|Overall Study|Lost to Follow-up|3|||
156802171|NCT01405196|566030815|FG003|Overall Study|Lost to Follow-up|1|||
156802172|NCT01542788|566030816|FG000|Overall Study|Randomized but Not Treated|2|||
156802173|NCT01542788|566030817|FG001|Overall Study|Randomized but Not Treated|0|||
156802174|NCT01542788|566030816|FG000|Overall Study|Lack of Efficacy|41|||
156802175|NCT01542788|566030817|FG001|Overall Study|Lack of Efficacy|71|||
156802176|NCT01542788|566030816|FG000|Overall Study|Lost to Follow-up|5|||
156802177|NCT01542788|566030817|FG001|Overall Study|Lost to Follow-up|0|||
156802178|NCT01542788|566030816|FG000|Overall Study|Death|3|||
156802179|NCT01542788|566030817|FG001|Overall Study|Death|0|||
156802180|NCT01542788|566030816|FG000|Overall Study|Protocol Violation|2|||
156802181|NCT01542788|566030817|FG001|Overall Study|Protocol Violation|0|||
156802182|NCT01542788|566030816|FG000|Overall Study|Physician Decision|1|||
156802183|NCT01542788|566030817|FG001|Overall Study|Physician Decision|0|||
156881596|NCT02059291|566326980|FG006|Epoch 3|Lack of Efficacy|0|||
156881597|NCT02059291|566326981|FG007|Epoch 3|Lack of Efficacy|0|||
156881598|NCT02059291|566326982|FG008|Epoch 3|Lack of Efficacy|0|||
156881599|NCT02059291|566326983|FG009|Epoch 3|Lack of Efficacy|0|||
156881600|NCT02059291|566326984|FG010|Epoch 3|Lack of Efficacy|0|||
156881601|NCT02059291|566326985|FG011|Epoch 3|Lack of Efficacy|0|||
156881602|NCT02059291|566326986|FG012|Epoch 3|Lack of Efficacy|0|||
156802184|NCT01542788|566030816|FG000|Overall Study|Withdrawal by Subject|1|||
156802185|NCT01542788|566030817|FG001|Overall Study|Withdrawal by Subject|0|||
156802186|NCT05788991|566030818|FG000|Overall Study|Not treated with study medication|1|||
156802187|NCT05788991|566030819|FG001|Overall Study|Not treated with study medication|3|||
156802188|NCT05788991|566030818|FG000|Overall Study|Withdrawal by Subject|1|||
156802189|NCT05788991|566030819|FG001|Overall Study|Withdrawal by Subject|0|||
156802190|NCT05788991|566030818|FG000|Overall Study|Lack of Efficacy|0|||
156802191|NCT05788991|566030819|FG001|Overall Study|Lack of Efficacy|1|||
156802192|NCT05788991|566030818|FG000|Overall Study|Protocol Violation|1|||
156802193|NCT05788991|566030819|FG001|Overall Study|Protocol Violation|2|||
156802194|NCT04464473|566030820|FG000|Overall Study|New piercing could not be removed for scanning|0|||
156802195|NCT04464473|566030821|FG001|Overall Study|New piercing could not be removed for scanning|0|||
156802196|NCT04464473|566030822|FG002|Overall Study|New piercing could not be removed for scanning|0|||
156802197|NCT04464473|566030823|FG003|Overall Study|New piercing could not be removed for scanning|1|||
156802198|NCT04464473|566030824|FG004|Overall Study|New piercing could not be removed for scanning|0|||
156881603|NCT02059291|566326987|FG013|Epoch 3|Lack of Efficacy|0|||
156802199|NCT04464473|566030825|FG005|Overall Study|New piercing could not be removed for scanning|0|||
156802200|NCT04464473|566030820|FG000|Overall Study|Adverse Event|0|||
156802201|NCT04464473|566030821|FG001|Overall Study|Adverse Event|0|||
156802202|NCT04464473|566030822|FG002|Overall Study|Adverse Event|0|||
156802203|NCT04464473|566030823|FG003|Overall Study|Adverse Event|1|||
156802204|NCT04464473|566030824|FG004|Overall Study|Adverse Event|0|||
156802205|NCT04464473|566030825|FG005|Overall Study|Adverse Event|0|||
156802206|NCT04464473|566030820|FG000|Overall Study|Lost to Follow-up|0|||
156802207|NCT04464473|566030821|FG001|Overall Study|Lost to Follow-up|0|||
156802208|NCT04464473|566030822|FG002|Overall Study|Lost to Follow-up|0|||
156802209|NCT04464473|566030823|FG003|Overall Study|Lost to Follow-up|1|||
156802210|NCT04464473|566030824|FG004|Overall Study|Lost to Follow-up|0|||
156802211|NCT04464473|566030825|FG005|Overall Study|Lost to Follow-up|0|||
156802212|NCT03802396|566030826|FG000|Overall Study|Withdrawal by Subject|2|||
156802213|NCT03802396|566030827|FG001|Overall Study|Withdrawal by Subject|0|||
156802214|NCT03802396|566030826|FG000|Overall Study|Surgery Cancelled|1|||
156802215|NCT03802396|566030827|FG001|Overall Study|Surgery Cancelled|0|||
156802216|NCT03549338|566032176|FG000|Overall Study|Progressive Disease|1|||
156802217|NCT03549338|566032177|FG001|Overall Study|Progressive Disease|0|||
156802218|NCT03549338|566032178|FG002|Overall Study|Progressive Disease|0|||
156802219|NCT03549338|566032176|FG000|Overall Study|Clinical Progression|0|||
156802220|NCT03549338|566032177|FG001|Overall Study|Clinical Progression|1|||
156802221|NCT03549338|566032178|FG002|Overall Study|Clinical Progression|0|||
156802222|NCT01492426|566032179|FG000|Treatment|Death|0|||
156802223|NCT01492426|566032180|FG001|Treatment|Death|1|||
156802224|NCT01492426|566032179|FG000|Treatment|Other|1|||
156802225|NCT01492426|566032180|FG001|Treatment|Other|0|||
156802226|NCT01492426|566032179|FG000|Treatment|Adverse Event|25|||
156802227|NCT01492426|566032180|FG001|Treatment|Adverse Event|25|||
156802228|NCT01492426|566032179|FG000|Treatment|Lack of Efficacy|38|||
156802229|NCT01492426|566032180|FG001|Treatment|Lack of Efficacy|5|||
156802230|NCT01492426|566032179|FG000|Treatment|Participant withdrew consent|1|||
156802231|NCT01492426|566032180|FG001|Treatment|Participant withdrew consent|2|||
156802232|NCT01492426|566032179|FG000|Treatment|Poor compliance/noncompliance|1|||
156802233|NCT01492426|566032180|FG001|Treatment|Poor compliance/noncompliance|0|||
156802234|NCT01492426|566032179|FG000|Treatment|Subject requested discontinue study drug|7|||
156802235|NCT01492426|566032180|FG001|Treatment|Subject requested discontinue study drug|3|||
156802236|NCT01492426|566032179|FG000|Treatment|Lost to Follow-up|9|||
156802237|NCT01492426|566032180|FG001|Treatment|Lost to Follow-up|4|||
156802238|NCT01492426|566032179|FG000|Treatment|Participant does not meet study criteria|1|||
156802239|NCT01492426|566032180|FG001|Treatment|Participant does not meet study criteria|0|||
156802240|NCT01492426|566032179|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
156802241|NCT01492426|566032180|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
156802242|NCT01492426|566032179|FG000|Follow-Up|Death|1|||
156802243|NCT01492426|566032180|FG001|Follow-Up|Death|0|||
156802244|NCT01492426|566032179|FG000|Follow-Up|Other|4|||
156802245|NCT01492426|566032180|FG001|Follow-Up|Other|2|||
156802246|NCT01492426|566032179|FG000|Follow-Up|Participant Withdrew Consent|6|||
156802247|NCT01492426|566032180|FG001|Follow-Up|Participant Withdrew Consent|1|||
156802248|NCT01492426|566032179|FG000|Follow-Up|Lost to Follow-up|12|||
156802249|NCT01492426|566032180|FG001|Follow-Up|Lost to Follow-up|6|||
156802250|NCT00269113|566032181|FG000|Overall Study|Adverse Event|14|||
156802251|NCT00269113|566032182|FG001|Overall Study|Adverse Event|7|||
156802252|NCT00269113|566032181|FG000|Overall Study|Lack of Efficacy|35|||
156802253|NCT00269113|566032182|FG001|Overall Study|Lack of Efficacy|18|||
156802254|NCT00269113|566032181|FG000|Overall Study|Early Improvement|2|||
156802255|NCT00269113|566032182|FG001|Overall Study|Early Improvement|0|||
156881604|NCT02059291|566326988|FG014|Epoch 3|Lack of Efficacy|0|||
156881605|NCT02059291|566326989|FG015|Epoch 3|Lack of Efficacy|3|||
156881606|NCT02059291|566326990|FG016|Epoch 3|Lack of Efficacy|0|||
156881607|NCT02059291|566326991|FG017|Epoch 3|Lack of Efficacy|0|||
156881608|NCT02059291|566326992|FG018|Epoch 3|Lack of Efficacy|0|||
156802256|NCT00269113|566032181|FG000|Overall Study|Withdrawal by Subject|0|||
156802257|NCT00269113|566032182|FG001|Overall Study|Withdrawal by Subject|2|||
156802258|NCT00269113|566032181|FG000|Overall Study|Death|6|||
156802259|NCT00269113|566032182|FG001|Overall Study|Death|2|||
156802260|NCT00269113|566032181|FG000|Overall Study|Lost to Follow-up|2|||
156802261|NCT00269113|566032182|FG001|Overall Study|Lost to Follow-up|1|||
156802262|NCT00269113|566032181|FG000|Overall Study|Protocol Violation|15|||
156802263|NCT00269113|566032182|FG001|Overall Study|Protocol Violation|5|||
156802264|NCT00269113|566032181|FG000|Overall Study|Other|0|||
156802265|NCT00269113|566032182|FG001|Overall Study|Other|2|||
156802266|NCT01770743|566032183|FG000|Overall Study|Adverse Event|1|||
156802267|NCT01770743|566032184|FG001|Overall Study|Adverse Event|0|||
156802268|NCT01770743|566032185|FG002|Overall Study|Adverse Event|0|||
156802269|NCT01770743|566032186|FG003|Overall Study|Adverse Event|0|||
156802270|NCT01770743|566032187|FG004|Overall Study|Adverse Event|0|||
156802271|NCT01770743|566032183|FG000|Overall Study|Withdrawal by Subject|0|||
156802272|NCT01770743|566032184|FG001|Overall Study|Withdrawal by Subject|0|||
156881609|NCT02059291|566326993|FG019|Epoch 3|Lack of Efficacy|0|||
156802273|NCT01770743|566032185|FG002|Overall Study|Withdrawal by Subject|1|||
156802274|NCT01770743|566032186|FG003|Overall Study|Withdrawal by Subject|1|||
156802275|NCT01770743|566032187|FG004|Overall Study|Withdrawal by Subject|1|||
156802276|NCT01770743|566032183|FG000|Overall Study|Lost to Follow-up|0|||
156802277|NCT01770743|566032184|FG001|Overall Study|Lost to Follow-up|2|||
156802278|NCT01770743|566032185|FG002|Overall Study|Lost to Follow-up|0|||
156802279|NCT01770743|566032186|FG003|Overall Study|Lost to Follow-up|0|||
156802280|NCT01770743|566032187|FG004|Overall Study|Lost to Follow-up|1|||
156802281|NCT01770743|566032183|FG000|Overall Study|Sponsor Terminated Subject|1|||
156802282|NCT01770743|566032184|FG001|Overall Study|Sponsor Terminated Subject|0|||
156802283|NCT01770743|566032185|FG002|Overall Study|Sponsor Terminated Subject|0|||
156802284|NCT01770743|566032186|FG003|Overall Study|Sponsor Terminated Subject|1|||
156802285|NCT01770743|566032187|FG004|Overall Study|Sponsor Terminated Subject|0|||
156802286|NCT01770743|566032183|FG000|Overall Study|Moving Out of State|0|||
156802287|NCT01770743|566032184|FG001|Overall Study|Moving Out of State|1|||
156802288|NCT01770743|566032185|FG002|Overall Study|Moving Out of State|0|||
156802289|NCT01770743|566032186|FG003|Overall Study|Moving Out of State|0|||
156802290|NCT01770743|566032187|FG004|Overall Study|Moving Out of State|0|||
156802291|NCT01585025|566032190|FG000|Overall Study|Withdrawal by Subject|0|||
156802292|NCT01585025|566032191|FG001|Overall Study|Withdrawal by Subject|3|||
156802293|NCT01585025|566032192|FG002|Overall Study|Withdrawal by Subject|4|||
156802294|NCT00503984|566032193|FG000|Overall Study|Protocol Violation|0|||
156802295|NCT00503984|566032194|FG001|Overall Study|Protocol Violation|1|||
156802296|NCT00503984|566032195|FG002|Overall Study|Protocol Violation|0|||
156802297|NCT00503984|566032196|FG003|Overall Study|Protocol Violation|0|||
156802298|NCT00503984|566032197|FG004|Overall Study|Protocol Violation|0|||
156802299|NCT00503984|566032198|FG005|Overall Study|Protocol Violation|0|||
156802300|NCT00503984|566032193|FG000|Overall Study|Adverse Event|0|||
156802301|NCT00503984|566032194|FG001|Overall Study|Adverse Event|1|||
156802302|NCT00503984|566032195|FG002|Overall Study|Adverse Event|0|||
156802303|NCT00503984|566032196|FG003|Overall Study|Adverse Event|0|||
156802304|NCT00503984|566032197|FG004|Overall Study|Adverse Event|0|||
156802305|NCT00503984|566032198|FG005|Overall Study|Adverse Event|0|||
156802306|NCT00503984|566032193|FG000|Overall Study|Death|0|||
156802307|NCT00503984|566032194|FG001|Overall Study|Death|0|||
156802308|NCT00503984|566032195|FG002|Overall Study|Death|0|||
156802309|NCT00503984|566032196|FG003|Overall Study|Death|0|||
156802310|NCT00503984|566032197|FG004|Overall Study|Death|1|||
156802311|NCT00503984|566032198|FG005|Overall Study|Death|0|||
156802312|NCT02122380|566032202|FG000|First Intervention (30 Days)|Adverse Event|1|||
156802313|NCT02122380|566032203|FG001|First Intervention (30 Days)|Adverse Event|0|||
156802314|NCT02122380|566032202|FG000|First Intervention (30 Days)|Physician Decision|0|||
156802315|NCT02122380|566032203|FG001|First Intervention (30 Days)|Physician Decision|1|||
156802316|NCT02122380|566032202|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
156802317|NCT02122380|566032203|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
156802318|NCT02122380|566032202|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
156802319|NCT02122380|566032203|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
156802320|NCT02122380|566032202|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
156802321|NCT02122380|566032203|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
156802322|NCT00952705|566032204|FG000|Overall Study|Lost to Follow-up|24|||
156802323|NCT00952705|566032205|FG001|Overall Study|Lost to Follow-up|8|||
156802324|NCT00952705|566032206|FG002|Overall Study|Lost to Follow-up|9|||
156802325|NCT00952705|566032204|FG000|Overall Study|Withdrawal by Subject|2|||
156802326|NCT00952705|566032205|FG001|Overall Study|Withdrawal by Subject|1|||
156802327|NCT00952705|566032206|FG002|Overall Study|Withdrawal by Subject|1|||
156802328|NCT00952705|566032204|FG000|Overall Study|Death|2|||
156802329|NCT00952705|566032205|FG001|Overall Study|Death|0|||
156802330|NCT00952705|566032206|FG002|Overall Study|Death|0|||
156802331|NCT00952705|566032204|FG000|Overall Study|Incarcerated post dose|5|||
156802332|NCT00952705|566032205|FG001|Overall Study|Incarcerated post dose|0|||
156802333|NCT00952705|566032206|FG002|Overall Study|Incarcerated post dose|0|||
156802334|NCT00952705|566032204|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
156802335|NCT00952705|566032205|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
156802336|NCT00952705|566032206|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
156802337|NCT00140140|566032207|FG000|Overall Study|Unacceptable toxicity|1|||
156802338|NCT00140140|566032208|FG001|Overall Study|Unacceptable toxicity|1|||
156802339|NCT00140140|566032209|FG002|Overall Study|Unacceptable toxicity|2|||
156802340|NCT00140140|566032207|FG000|Overall Study|Physician Decision|1|||
156802341|NCT00140140|566032208|FG001|Overall Study|Physician Decision|1|||
156802342|NCT00140140|566032209|FG002|Overall Study|Physician Decision|0|||
156802343|NCT00639457|566032210|FG000|Overall Study|Withdrawal by Subject|2|||
156802344|NCT00639457|566032211|FG001|Overall Study|Withdrawal by Subject|3|||
156802345|NCT01126190|566032212|FG000|Double-Blind Phase|Death|0|||
156802346|NCT01126190|566032213|FG001|Double-Blind Phase|Death|1|||
156802347|NCT01126190|566032214|FG002|Double-Blind Phase|Death|0|||
156802348|NCT01126190|566032212|FG000|Double-Blind Phase|Adverse Event|1|||
156802349|NCT01126190|566032213|FG001|Double-Blind Phase|Adverse Event|2|||
156802350|NCT01126190|566032214|FG002|Double-Blind Phase|Adverse Event|0|||
156802351|NCT01126190|566032212|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156802352|NCT01126190|566032213|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
156802353|NCT01126190|566032214|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156802354|NCT01126190|566032212|FG000|Double-Blind Phase|Request of Investigator|1|||
156802355|NCT01126190|566032213|FG001|Double-Blind Phase|Request of Investigator|0|||
156802356|NCT01126190|566032214|FG002|Double-Blind Phase|Request of Investigator|0|||
156802357|NCT01126190|566032212|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
156802358|NCT01126190|566032213|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
156802359|NCT01126190|566032214|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
156802360|NCT01126190|566032212|FG000|Double-Blind Phase|Non-compliance|1|||
156802361|NCT01126190|566032213|FG001|Double-Blind Phase|Non-compliance|0|||
156802362|NCT01126190|566032214|FG002|Double-Blind Phase|Non-compliance|0|||
156802363|NCT01126190|566032212|FG000|Double-Blind Phase|Lost to Follow-up|1|||
156802364|NCT01126190|566032213|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156802365|NCT01126190|566032214|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156802366|NCT01126190|566032212|FG000|Open-Label Phase|Death|0|||
156802367|NCT01126190|566032213|FG001|Open-Label Phase|Death|0|||
156802368|NCT01126190|566032214|FG002|Open-Label Phase|Death|1|||
156802369|NCT01126190|566032212|FG000|Open-Label Phase|Adverse Event|0|||
156802370|NCT01126190|566032213|FG001|Open-Label Phase|Adverse Event|0|||
156802371|NCT01126190|566032214|FG002|Open-Label Phase|Adverse Event|4|||
156802372|NCT01126190|566032212|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156802373|NCT01126190|566032213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156802374|NCT01126190|566032214|FG002|Open-Label Phase|Withdrawal by Subject|6|||
156802375|NCT00892008|566032217|FG000|Overall Study|Death|5|||
156802376|NCT00892008|566032217|FG000|Overall Study|Lack of Efficacy|3|||
156802377|NCT00892008|566032217|FG000|Overall Study|Lost to Follow-up|142|||
156802378|NCT00892008|566032217|FG000|Overall Study|Other|378|||
156802379|NCT00892008|566032217|FG000|Overall Study|Adverse Event|37|||
156802380|NCT01466491|566032218|FG000|Overall Study|Protocol Violation|0|||
156802381|NCT01466491|566032219|FG001|Overall Study|Protocol Violation|3|||
156802382|NCT01466491|566032220|FG002|Overall Study|Protocol Violation|2|||
156802383|NCT01466491|566032221|FG003|Overall Study|Protocol Violation|0|||
156802384|NCT01466491|566032218|FG000|Overall Study|Missing Data|0|||
156802385|NCT01466491|566032219|FG001|Overall Study|Missing Data|0|||
156802386|NCT01466491|566032220|FG002|Overall Study|Missing Data|1|||
156802387|NCT01466491|566032221|FG003|Overall Study|Missing Data|0|||
156802388|NCT02727322|566032222|FG000|Overall Study|Withdrawal by Subject|1|||
156802389|NCT02727322|566032223|FG001|Overall Study|Withdrawal by Subject|1|||
156802390|NCT02727322|566032222|FG000|Overall Study|Protocol Violation|1|||
156802391|NCT02727322|566032223|FG001|Overall Study|Protocol Violation|0|||
156802392|NCT03435380|566032224|FG000|Overall Study|Death|1|||
156802393|NCT03435380|566032225|FG001|Overall Study|Death|2|||
156802394|NCT03435380|566032226|FG002|Overall Study|Death|1|||
156802395|NCT03435380|566032224|FG000|Overall Study|Lost to Follow-up|12|||
156802396|NCT03435380|566032225|FG001|Overall Study|Lost to Follow-up|8|||
156802397|NCT03435380|566032226|FG002|Overall Study|Lost to Follow-up|6|||
156802398|NCT03435380|566032224|FG000|Overall Study|Physician Decision|1|||
156802399|NCT03435380|566032225|FG001|Overall Study|Physician Decision|0|||
156802400|NCT03435380|566032226|FG002|Overall Study|Physician Decision|0|||
156802401|NCT03435380|566032224|FG000|Overall Study|Withdrawal by Subject|0|||
156802402|NCT03435380|566032225|FG001|Overall Study|Withdrawal by Subject|1|||
156802403|NCT03435380|566032226|FG002|Overall Study|Withdrawal by Subject|1|||
156802404|NCT03435380|566032224|FG000|Overall Study|Ineligible|0|||
156802405|NCT03435380|566032225|FG001|Overall Study|Ineligible|1|||
156802406|NCT03435380|566032226|FG002|Overall Study|Ineligible|1|||
156802407|NCT02431325|566032227|FG000|Overall Study|Adverse Event|3|||
156802408|NCT02431325|566032228|FG001|Overall Study|Adverse Event|0|||
156802409|NCT02431325|566032227|FG000|Overall Study|Lost to Follow-up|0|||
156802410|NCT02431325|566032228|FG001|Overall Study|Lost to Follow-up|1|||
156802411|NCT02431325|566032227|FG000|Overall Study|Withdrawal by Subject|1|||
157143875|NCT02158533|567276368|FG004|Stage 1|Adverse Event|0|||
157021044|NCT03126019|566830796|FG000|Overall Study|Did Not Return to Site for Care|0|||
157143876|NCT02158533|567276369|FG005|Stage 1|Adverse Event|0|||
157143877|NCT02158533|567276364|FG000|Stage 1|Withdrawal by Subject|3|||
157143878|NCT02158533|567276365|FG001|Stage 1|Withdrawal by Subject|2|||
156802412|NCT02431325|566032228|FG001|Overall Study|Withdrawal by Subject|2|||
156802413|NCT02431325|566032227|FG000|Overall Study|Declined to take study medication|1|||
156802414|NCT02431325|566032228|FG001|Overall Study|Declined to take study medication|0|||
156802415|NCT02431325|566032227|FG000|Overall Study|Withdrew before starting study medication|1|||
156802416|NCT02431325|566032228|FG001|Overall Study|Withdrew before starting study medication|0|||
156802417|NCT02431325|566032227|FG000|Overall Study|Placebo shortage|2|||
156802418|NCT02431325|566032228|FG001|Overall Study|Placebo shortage|0|||
156802419|NCT01917318|566032229|FG000|First Treatment|Withdrawal by Subject|0|||
156802420|NCT01917318|566032230|FG001|First Treatment|Withdrawal by Subject|1|||
156802421|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Physician Decision|2|||
156802422|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Physician Decision|0|||
156802423|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Physician Decision|0|||
156802424|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Adverse Event|33|||
156802425|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Adverse Event|0|||
156802426|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Adverse Event|0|||
156802427|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
156802428|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156802429|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
156802430|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
156802431|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156802432|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
156802433|NCT01008618|566032231|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
156802434|NCT01008618|566032232|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
156802435|NCT01008618|566032233|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
156802436|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
156802437|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
156802438|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
156802439|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
156802440|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
156802441|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
156802442|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
156802443|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
156802444|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
156802445|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
156802446|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
156802447|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
156802448|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156802449|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
156802450|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
156802451|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
156802452|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
156802453|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
156802454|NCT01008618|566032231|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
156802455|NCT01008618|566032232|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
156802456|NCT01008618|566032233|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
156802457|NCT01128569|566032234|FG000|Washout Period 1|Adverse Event|0|||
156802458|NCT01128569|566032235|FG001|Washout Period 1|Adverse Event|0|||
156802459|NCT01128569|566032236|FG002|Washout Period 1|Adverse Event|1|||
156802460|NCT01128569|566032237|FG003|Washout Period 1|Adverse Event|0|||
156802461|NCT01128569|566032238|FG004|Washout Period 1|Adverse Event|0|||
156802462|NCT01128569|566032239|FG005|Washout Period 1|Adverse Event|0|||
156802463|NCT01128569|566032234|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156802464|NCT01128569|566032235|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156802465|NCT01128569|566032236|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156802466|NCT01128569|566032237|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156802467|NCT01128569|566032238|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156802468|NCT01128569|566032239|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156802469|NCT03338400|566032240|FG000|Overall Study|Lost to Follow-up|1|||
156802470|NCT03338400|566032241|FG001|Overall Study|Lost to Follow-up|2|||
156802471|NCT00487981|566032242|FG000|Overall Study|Hypothyroidism diagnosis|1|||
156802472|NCT01865487|566032245|FG000|Overall Study|Lost to Follow-up|0|||
156802473|NCT01865487|566032246|FG001|Overall Study|Lost to Follow-up|0|||
156802474|NCT01865487|566032247|FG002|Overall Study|Lost to Follow-up|0|||
156802475|NCT01865487|566032248|FG003|Overall Study|Lost to Follow-up|1|||
156802476|NCT01865487|566032249|FG004|Overall Study|Lost to Follow-up|0|||
156802477|NCT01865487|566032250|FG005|Overall Study|Lost to Follow-up|0|||
156802478|NCT01865487|566032251|FG006|Overall Study|Lost to Follow-up|1|||
156802479|NCT01865487|566032252|FG007|Overall Study|Lost to Follow-up|0|||
156802480|NCT01865487|566032253|FG008|Overall Study|Lost to Follow-up|0|||
156802481|NCT01865487|566032254|FG009|Overall Study|Lost to Follow-up|0|||
156802482|NCT01865487|566032245|FG000|Overall Study|Withdrawal by Subject|0|||
156802483|NCT01865487|566032246|FG001|Overall Study|Withdrawal by Subject|0|||
156802484|NCT01865487|566032247|FG002|Overall Study|Withdrawal by Subject|0|||
156802485|NCT01865487|566032248|FG003|Overall Study|Withdrawal by Subject|0|||
156802486|NCT01865487|566032249|FG004|Overall Study|Withdrawal by Subject|1|||
156802487|NCT01865487|566032250|FG005|Overall Study|Withdrawal by Subject|0|||
156802488|NCT01865487|566032251|FG006|Overall Study|Withdrawal by Subject|0|||
156802489|NCT01865487|566032252|FG007|Overall Study|Withdrawal by Subject|0|||
156802490|NCT01865487|566032253|FG008|Overall Study|Withdrawal by Subject|0|||
156802491|NCT01865487|566032254|FG009|Overall Study|Withdrawal by Subject|0|||
156802492|NCT01627691|566032259|FG000|Overall Study|Death|11|||
156802493|NCT01627691|566032259|FG000|Overall Study|Lost to Follow-up|3|||
156802494|NCT01627691|566032259|FG000|Overall Study|Withdrawal by Subject|1|||
156802495|NCT01627691|566032259|FG000|Overall Study|Missed the visit|3|||
156802496|NCT01908140|566032260|FG000|Overall Study|Other or Progressive Disease|5|||
156802497|NCT01908140|566032261|FG001|Overall Study|Other or Progressive Disease|12|||
156802498|NCT01908140|566032260|FG000|Overall Study|Lack of Efficacy|7|||
156802499|NCT01908140|566032261|FG001|Overall Study|Lack of Efficacy|5|||
156802500|NCT01908140|566032260|FG000|Overall Study|Withdrawal by Subject|23|||
156802501|NCT01908140|566032261|FG001|Overall Study|Withdrawal by Subject|24|||
156802502|NCT01908140|566032260|FG000|Overall Study|Lost to Follow-up|1|||
156802503|NCT01908140|566032261|FG001|Overall Study|Lost to Follow-up|6|||
156802504|NCT01908140|566032260|FG000|Overall Study|Protocol Violation|8|||
156802505|NCT01908140|566032261|FG001|Overall Study|Protocol Violation|9|||
156802506|NCT01908140|566032260|FG000|Overall Study|Adverse Event|22|||
156802507|NCT01908140|566032261|FG001|Overall Study|Adverse Event|23|||
156802508|NCT01307449|566032262|FG000|Overall Study|Adverse Event|1|||
156802509|NCT01307449|566032263|FG001|Overall Study|Adverse Event|0|||
156802510|NCT01307449|566032264|FG002|Overall Study|Adverse Event|0|||
156802511|NCT01307449|566032265|FG003|Overall Study|Adverse Event|0|||
156802512|NCT03218917|566032266|FG000|Overall Study|Adverse Event|3|||
156802513|NCT03218917|566032267|FG001|Overall Study|Adverse Event|3|||
156802514|NCT03218917|566032268|FG002|Overall Study|Adverse Event|2|||
156802515|NCT03218917|566032266|FG000|Overall Study|Subject withdrew consent|2|||
156802516|NCT03218917|566032267|FG001|Overall Study|Subject withdrew consent|4|||
156802517|NCT03218917|566032268|FG002|Overall Study|Subject withdrew consent|10|||
156802518|NCT03218917|566032266|FG000|Overall Study|Physician Decision|0|||
156802519|NCT03218917|566032267|FG001|Overall Study|Physician Decision|1|||
156802520|NCT03218917|566032268|FG002|Overall Study|Physician Decision|1|||
156802521|NCT03218917|566032266|FG000|Overall Study|Lost to Follow-up|1|||
156802522|NCT03218917|566032267|FG001|Overall Study|Lost to Follow-up|0|||
156802523|NCT03218917|566032268|FG002|Overall Study|Lost to Follow-up|0|||
156802524|NCT03218917|566032266|FG000|Overall Study|Reason Missing|0|||
156802525|NCT03218917|566032267|FG001|Overall Study|Reason Missing|2|||
156802526|NCT03218917|566032268|FG002|Overall Study|Reason Missing|0|||
156802527|NCT03218917|566032266|FG000|Overall Study|Death|0|||
156802528|NCT03218917|566032267|FG001|Overall Study|Death|1|||
156802529|NCT03218917|566032268|FG002|Overall Study|Death|0|||
156802530|NCT03218917|566032266|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156802531|NCT03218917|566032267|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156802532|NCT03218917|566032268|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156802533|NCT02927795|566032271|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
156802534|NCT02927795|566032271|FG000|Overall Study|Not Treated|4|||
156802535|NCT05525910|566032273|FG000|Period 4|Per sponsor due to study timelines|0|||
156802536|NCT05525910|566032274|FG001|Period 4|Per sponsor due to study timelines|0|||
156802537|NCT05525910|566032275|FG002|Period 4|Per sponsor due to study timelines|1|||
156802538|NCT05525910|566032276|FG003|Period 4|Per sponsor due to study timelines|1|||
156802539|NCT05525910|566032277|FG004|Period 4|Per sponsor due to study timelines|1|||
156802540|NCT00181844|566032279|FG000|Signed Consent|Withdrawal by Subject|5|||
156802541|NCT00181844|566032279|FG000|Signed Consent|Did not meet entrance criteria|7|||
156802542|NCT00181844|566032279|FG000|Exposed to Study Medication|Adverse Event|10|||
156802543|NCT00181844|566032279|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
156802544|NCT00181844|566032279|FG000|Exposed to Study Medication|Non-compliance|2|||
156802545|NCT00181844|566032279|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
156802546|NCT00181844|566032279|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
156802547|NCT00107276|566032281|FG000|Overall Study|Progression|46|||
156802548|NCT00107276|566032281|FG000|Overall Study|Adverse Event|6|||
156802549|NCT00107276|566032281|FG000|Overall Study|M.D. decision|2|||
156802550|NCT00107276|566032281|FG000|Overall Study|Patient refusal|1|||
156802551|NCT00107276|566032281|FG000|Overall Study|Death|1|||
156802552|NCT00107276|566032281|FG000|Overall Study|Ineligible|16|||
156802553|NCT05209386|566032282|FG000|Overall Study|Withdrawal by Subject|8|||
156802554|NCT05209386|566032282|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
156802555|NCT03179761|566032283|FG000|Overall Study|Death|2|||
156802556|NCT03179761|566032284|FG001|Overall Study|Death|5|||
156802557|NCT03179761|566032283|FG000|Overall Study|Lost to Follow-up|2|||
156802558|NCT03179761|566032284|FG001|Overall Study|Lost to Follow-up|2|||
156802559|NCT03179761|566032283|FG000|Overall Study|Protocol Violation|1|||
156802560|NCT03179761|566032284|FG001|Overall Study|Protocol Violation|0|||
156802561|NCT03179761|566032283|FG000|Overall Study|Withdrawal by Subject|1|||
156802562|NCT03179761|566032284|FG001|Overall Study|Withdrawal by Subject|4|||
156802563|NCT03179761|566032283|FG000|Overall Study|Investigator Request|0|||
156802564|NCT03179761|566032284|FG001|Overall Study|Investigator Request|2|||
156802565|NCT02284191|566032285|FG000|Overall Study|Withdrawal by Subject|1|||
156802566|NCT02284191|566032286|FG001|Overall Study|Withdrawal by Subject|3|||
156802567|NCT02284191|566032285|FG000|Overall Study|Lost to Follow-up|1|||
156802568|NCT02284191|566032286|FG001|Overall Study|Lost to Follow-up|0|||
156802569|NCT02257684|566032289|FG000|Overall Study|Adverse Event|2|||
156802570|NCT02257684|566032289|FG000|Overall Study|Lack of Efficacy|1|||
156802571|NCT02257684|566032289|FG000|Overall Study|Sponsor's Decision|1|||
156802572|NCT02170064|566032293|FG000|Overall Study|Withdrawal by Subject|5|||
156802573|NCT02170064|566032294|FG001|Overall Study|Withdrawal by Subject|1|||
156802574|NCT02170064|566032295|FG002|Overall Study|Withdrawal by Subject|1|||
156802575|NCT02170064|566032293|FG000|Overall Study|Physician Decision|1|||
156802576|NCT02170064|566032294|FG001|Overall Study|Physician Decision|1|||
156802577|NCT02170064|566032295|FG002|Overall Study|Physician Decision|0|||
156802578|NCT02359903|566032296|FG000|Overall Study|Adverse Event|0|||
156802579|NCT02359903|566032297|FG001|Overall Study|Adverse Event|2|||
156802580|NCT03507127|566032305|FG000|Overall Study|Withdrawal by Subject|1|||
156802581|NCT03507127|566032306|FG001|Overall Study|Withdrawal by Subject|0|||
156802582|NCT03507127|566032305|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
156802583|NCT03507127|566032306|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
156802584|NCT01240863|566032307|FG000|Open-label Titration Period|Adverse Event|47|||
156802585|NCT01240863|566032308|FG001|Open-label Titration Period|Adverse Event|0|||
156802586|NCT01240863|566032309|FG002|Open-label Titration Period|Adverse Event|0|||
156802587|NCT01240863|566032307|FG000|Open-label Titration Period|Lack of Efficacy|19|||
156802588|NCT01240863|566032308|FG001|Open-label Titration Period|Lack of Efficacy|0|||
156802589|NCT01240863|566032309|FG002|Open-label Titration Period|Lack of Efficacy|0|||
156802590|NCT01240863|566032307|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
156802591|NCT01240863|566032308|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156802592|NCT01240863|566032309|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
156802593|NCT01240863|566032307|FG000|Open-label Titration Period|Protocol Violation|7|||
156802594|NCT01240863|566032308|FG001|Open-label Titration Period|Protocol Violation|0|||
156802595|NCT01240863|566032309|FG002|Open-label Titration Period|Protocol Violation|0|||
156802596|NCT01240863|566032307|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
156802597|NCT01240863|566032308|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
156802598|NCT01240863|566032309|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
156802599|NCT01240863|566032307|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
156802600|NCT01240863|566032308|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
156802601|NCT01240863|566032309|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
156802602|NCT01240863|566032307|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
156802603|NCT01240863|566032308|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
156802604|NCT01240863|566032309|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
156802605|NCT01240863|566032307|FG000|Open-label Titration Period|Other|7|||
156802606|NCT01240863|566032308|FG001|Open-label Titration Period|Other|0|||
156802607|NCT01240863|566032309|FG002|Open-label Titration Period|Other|0|||
156802608|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
156802609|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
156802610|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
156802611|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156802612|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
156802613|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
156802614|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156802615|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
156802616|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156802617|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156802618|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
156802619|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
156802620|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
156802621|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
156802622|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
156802623|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
156802624|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
156802625|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
156802626|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
156881610|NCT02059291|566326994|FG020|Epoch 3|Lack of Efficacy|0|||
156802627|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
156881611|NCT02059291|566326995|FG021|Epoch 3|Lack of Efficacy|0|||
156802628|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
156802629|NCT01240863|566032307|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
156802630|NCT01240863|566032308|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
156802631|NCT01240863|566032309|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
156802632|NCT00746811|566032312|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
156802633|NCT00746811|566032313|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
156802634|NCT02604511|566032314|FG000|Overall Study|Adverse Event|3|||
156802635|NCT02604511|566032314|FG000|Overall Study|Disease Progression|4|||
156802636|NCT02604511|566032314|FG000|Overall Study|Withdrawal by Subject|3|||
156881612|NCT02059291|566326996|FG022|Epoch 3|Lack of Efficacy|0|||
156802637|NCT02604511|566032314|FG000|Overall Study|Participant ineligible|1|||
156802638|NCT02604511|566032314|FG000|Overall Study|Intercurrent illness|1|||
156802639|NCT02561962|566032318|FG000|Overall Study|Withdrawal by Subject|1|||
156802640|NCT02561962|566032319|FG001|Overall Study|Withdrawal by Subject|0|||
156802641|NCT02561962|566032320|FG002|Overall Study|Withdrawal by Subject|0|||
156802642|NCT02561962|566032321|FG003|Overall Study|Withdrawal by Subject|0|||
156802643|NCT02561962|566032322|FG004|Overall Study|Withdrawal by Subject|1|||
156802644|NCT02561962|566032323|FG005|Overall Study|Withdrawal by Subject|1|||
156802645|NCT02561962|566032324|FG006|Overall Study|Withdrawal by Subject|2|||
156802646|NCT02561962|566032325|FG007|Overall Study|Withdrawal by Subject|1|||
156802647|NCT02561962|566032326|FG008|Overall Study|Withdrawal by Subject|0|||
156802648|NCT02561962|566032318|FG000|Overall Study|Decision by sponsor|0|||
156802649|NCT02561962|566032319|FG001|Overall Study|Decision by sponsor|0|||
156802650|NCT02561962|566032320|FG002|Overall Study|Decision by sponsor|0|||
156802651|NCT02561962|566032321|FG003|Overall Study|Decision by sponsor|0|||
156802652|NCT02561962|566032322|FG004|Overall Study|Decision by sponsor|1|||
156802653|NCT02561962|566032323|FG005|Overall Study|Decision by sponsor|1|||
156802654|NCT02561962|566032324|FG006|Overall Study|Decision by sponsor|0|||
156802655|NCT02561962|566032325|FG007|Overall Study|Decision by sponsor|3|||
156802656|NCT02561962|566032326|FG008|Overall Study|Decision by sponsor|0|||
156802657|NCT02561962|566032318|FG000|Overall Study|Lost to Follow-up|0|||
156802658|NCT02561962|566032319|FG001|Overall Study|Lost to Follow-up|0|||
156802659|NCT02561962|566032320|FG002|Overall Study|Lost to Follow-up|0|||
156802660|NCT02561962|566032321|FG003|Overall Study|Lost to Follow-up|0|||
156802661|NCT02561962|566032322|FG004|Overall Study|Lost to Follow-up|0|||
156802662|NCT02561962|566032323|FG005|Overall Study|Lost to Follow-up|1|||
156802663|NCT02561962|566032324|FG006|Overall Study|Lost to Follow-up|0|||
156802664|NCT02561962|566032325|FG007|Overall Study|Lost to Follow-up|0|||
156802665|NCT02561962|566032326|FG008|Overall Study|Lost to Follow-up|0|||
156802666|NCT03586973|566032327|FG000|Overall Study|Death|15|||
156802667|NCT03586973|566032328|FG001|Overall Study|Death|8|||
156802668|NCT03586973|566032327|FG000|Overall Study|Site Terminated by Sponsor|3|||
156802669|NCT03586973|566032328|FG001|Overall Study|Site Terminated by Sponsor|6|||
156802670|NCT03586973|566032327|FG000|Overall Study|Withdrawal by Subject|1|||
156802671|NCT03586973|566032328|FG001|Overall Study|Withdrawal by Subject|0|||
156802672|NCT03586973|566032327|FG000|Overall Study|Lost to Follow-up|1|||
156802673|NCT03586973|566032328|FG001|Overall Study|Lost to Follow-up|0|||
156802674|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
156802675|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
156802676|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
156802677|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
156802678|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
156802679|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
156802680|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
156802681|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
156802682|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
156802683|NCT01150357|566032334|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
156802684|NCT01150357|566032335|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
156802685|NCT01150357|566032336|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
156802686|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
156802687|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
156802688|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
156802689|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
156802690|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
156802691|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
156802692|NCT01150357|566032334|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
156802693|NCT01150357|566032335|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
156802694|NCT01150357|566032336|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
156802695|NCT00652743|566033979|FG000|Months 12-18|Lost to Follow-up|1|||
156802696|NCT00652743|566033980|FG001|Months 12-18|Lost to Follow-up|2|||
156802697|NCT00652743|566033981|FG002|Months 12-18|Lost to Follow-up|7|||
156802698|NCT00652743|566033979|FG000|Months 24-30|Other|5|||
156802699|NCT00652743|566033980|FG001|Months 24-30|Other|1|||
156802700|NCT00652743|566033981|FG002|Months 24-30|Other|11|||
156802701|NCT00652743|566033979|FG000|Months 36-42|Serious Adverse Events|0|||
156802702|NCT00652743|566033980|FG001|Months 36-42|Serious Adverse Events|1|||
156802703|NCT00652743|566033981|FG002|Months 36-42|Serious Adverse Events|1|||
156802704|NCT00652743|566033979|FG000|Months 36-42|Withdrawal by Subject|1|||
156802705|NCT00652743|566033980|FG001|Months 36-42|Withdrawal by Subject|1|||
156802706|NCT00652743|566033981|FG002|Months 36-42|Withdrawal by Subject|0|||
156802707|NCT00652743|566033979|FG000|Months 36-42|Lost to Follow-up|0|||
156802708|NCT00652743|566033980|FG001|Months 36-42|Lost to Follow-up|1|||
156802709|NCT00652743|566033981|FG002|Months 36-42|Lost to Follow-up|0|||
156802710|NCT00652743|566033979|FG000|Months 36-42|Migrated/moved from study area|1|||
156802711|NCT00652743|566033980|FG001|Months 36-42|Migrated/moved from study area|0|||
156802712|NCT00652743|566033981|FG002|Months 36-42|Migrated/moved from study area|0|||
156802713|NCT00652743|566033979|FG000|Months 36-42|Other|4|||
156802714|NCT00652743|566033980|FG001|Months 36-42|Other|2|||
156802715|NCT00652743|566033981|FG002|Months 36-42|Other|8|||
156802716|NCT01114737|566033986|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156802717|NCT01114737|566033987|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156802718|NCT01114737|566033986|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
156802719|NCT01114737|566033987|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
156802720|NCT01114737|566033986|FG000|Randomized Treatment Period|Pregnancy|1|||
156802721|NCT01114737|566033987|FG001|Randomized Treatment Period|Pregnancy|0|||
156802722|NCT01114737|566033986|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
156802723|NCT01114737|566033987|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
156802724|NCT01114737|566033986|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
156802725|NCT01114737|566033987|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
156802726|NCT01114737|566033986|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
156802727|NCT01114737|566033987|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
156802728|NCT01123148|566033988|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
156802729|NCT01123148|566033988|FG000|Overall Study|Didn't meet milestone criteria|1|||
156802730|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
156802731|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
156802732|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
156802733|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
156802734|NCT02286895|566033989|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
156802735|NCT02286895|566033990|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
156802736|NCT00256126|566033991|FG000|Overall Study|Adverse Event|1|||
156802737|NCT00256126|566033992|FG001|Overall Study|Adverse Event|0|||
156802738|NCT00256126|566033991|FG000|Overall Study|Other|1|||
156802739|NCT00256126|566033992|FG001|Overall Study|Other|2|||
156802740|NCT00399035|566033993|FG000|Overall Study|Death|289|||
156802741|NCT00399035|566033994|FG001|Overall Study|Death|141|||
156802742|NCT00399035|566033995|FG002|Overall Study|Death|234|||
156802743|NCT00399035|566033993|FG000|Overall Study|Lost to Follow-up|2|||
156802744|NCT00399035|566033994|FG001|Overall Study|Lost to Follow-up|1|||
156802745|NCT00399035|566033995|FG002|Overall Study|Lost to Follow-up|5|||
156802746|NCT00399035|566033993|FG000|Overall Study|Withdrawal by Subject|19|||
156802747|NCT00399035|566033994|FG001|Overall Study|Withdrawal by Subject|15|||
156802748|NCT00399035|566033995|FG002|Overall Study|Withdrawal by Subject|12|||
156802749|NCT00399035|566033993|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
156802750|NCT00399035|566033994|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
156802751|NCT00399035|566033995|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
156802752|NCT00399035|566033993|FG000|Overall Study|Severe non-compliance with protocol|2|||
156802753|NCT00399035|566033994|FG001|Overall Study|Severe non-compliance with protocol|1|||
156802754|NCT00399035|566033995|FG002|Overall Study|Severe non-compliance with protocol|0|||
156802755|NCT02949011|566033998|FG000|Overall Study|Adverse Event|6|||
156802756|NCT02949011|566033999|FG001|Overall Study|Adverse Event|7|||
156802757|NCT02949011|566034000|FG002|Overall Study|Adverse Event|3|||
156802758|NCT02949011|566033998|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156802759|NCT02949011|566033999|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156802760|NCT02949011|566034000|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
156802761|NCT02949011|566033998|FG000|Overall Study|Protocol Deviation|5|||
156802762|NCT02949011|566033999|FG001|Overall Study|Protocol Deviation|3|||
156802763|NCT02949011|566034000|FG002|Overall Study|Protocol Deviation|3|||
156802764|NCT02949011|566033998|FG000|Overall Study|Lack of Efficacy|0|||
156802765|NCT02949011|566033999|FG001|Overall Study|Lack of Efficacy|2|||
156802766|NCT02949011|566034000|FG002|Overall Study|Lack of Efficacy|0|||
156802767|NCT02949011|566033998|FG000|Overall Study|Withdrawal by Subject|13|||
156802768|NCT02949011|566033999|FG001|Overall Study|Withdrawal by Subject|13|||
156802769|NCT02949011|566034000|FG002|Overall Study|Withdrawal by Subject|21|||
156802770|NCT02949011|566033998|FG000|Overall Study|Lost to Follow-up|7|||
156802771|NCT02949011|566033999|FG001|Overall Study|Lost to Follow-up|5|||
156802772|NCT02949011|566034000|FG002|Overall Study|Lost to Follow-up|5|||
156802773|NCT02949011|566033998|FG000|Overall Study|Death|0|||
156802774|NCT02949011|566033999|FG001|Overall Study|Death|0|||
156802775|NCT02949011|566034000|FG002|Overall Study|Death|1|||
156802776|NCT02949011|566033998|FG000|Overall Study|Miscellaneous|2|||
156802777|NCT02949011|566033999|FG001|Overall Study|Miscellaneous|4|||
156802778|NCT02949011|566034000|FG002|Overall Study|Miscellaneous|6|||
156802779|NCT04108273|566034001|FG000|Overall Study|COVID Pandemic|1|||
156802780|NCT04108273|566034002|FG001|Overall Study|COVID Pandemic|0|||
156802781|NCT01541371|566034003|FG000|Overall Study|Withdrawal by Subject|14|||
156802782|NCT01541371|566034003|FG000|Overall Study|Lost to Follow-up|21|||
156802783|NCT01541371|566034003|FG000|Overall Study|Adverse Event|15|||
156802784|NCT01541371|566034003|FG000|Overall Study|Lack of Efficacy|12|||
156802785|NCT01541371|566034003|FG000|Overall Study|Protocol Violation|6|||
156802786|NCT01541371|566034003|FG000|Overall Study|Study medication non-compliance|3|||
156802787|NCT01541371|566034003|FG000|Overall Study|Other|6|||
156802788|NCT02441218|566034004|FG000|Overall Study|Death|503|||
156802789|NCT02441218|566034005|FG001|Overall Study|Death|553|||
156802790|NCT02441218|566034004|FG000|Overall Study|Withdrawal by Subject|73|||
156802791|NCT02441218|566034005|FG001|Overall Study|Withdrawal by Subject|58|||
156802792|NCT02441218|566034004|FG000|Overall Study|Lost to Follow-up|2|||
156802793|NCT02441218|566034005|FG001|Overall Study|Lost to Follow-up|1|||
156802794|NCT00163189|566034008|FG000|Overall Study|Other|6|||
156802795|NCT00163189|566034008|FG000|Overall Study|Lost to Follow-up|1|||
156802796|NCT00163189|566034008|FG000|Overall Study|Protocol Violation|2|||
156802797|NCT00163189|566034008|FG000|Overall Study|Death|3|||
156802798|NCT00163189|566034008|FG000|Overall Study|Adverse Event|6|||
156802799|NCT00163189|566034008|FG000|Overall Study|Lack of Efficacy|7|||
156802800|NCT00163189|566034008|FG000|Overall Study|Study terminated by sponsor|11|||
156802801|NCT00163189|566034008|FG000|Overall Study|Withdrawal by Subject|11|||
156802802|NCT00163189|566034008|FG000|Overall Study|Did not meet continuation criterion|16|||
156802803|NCT04460183|566034009|FG000|Overall Study|Lost to Follow-up|3|||
156802804|NCT04460183|566034010|FG001|Overall Study|Lost to Follow-up|1|||
156802805|NCT04460183|566034009|FG000|Overall Study|Withdrawal by Subject|1|||
156802806|NCT04460183|566034010|FG001|Overall Study|Withdrawal by Subject|0|||
156802807|NCT01213082|566034011|FG000|Overall Study|Lost to Follow-up|6|||
157021045|NCT03126019|566830797|FG001|Overall Study|Did Not Return to Site for Care|1|||
157021046|NCT03126019|566830796|FG000|Overall Study|Site Closed|0|||
156802808|NCT01213082|566034012|FG001|Overall Study|Lost to Follow-up|7|||
156802809|NCT01213082|566034013|FG002|Overall Study|Lost to Follow-up|4|||
156802810|NCT01213082|566034011|FG000|Overall Study|Physician Decision|0|||
156802811|NCT01213082|566034012|FG001|Overall Study|Physician Decision|0|||
156802812|NCT01213082|566034013|FG002|Overall Study|Physician Decision|1|||
156802813|NCT00698828|566034024|FG000|Overall Study|Adverse Event|3|||
156802814|NCT00698828|566034025|FG001|Overall Study|Adverse Event|4|||
156802815|NCT00698828|566034026|FG002|Overall Study|Adverse Event|4|||
156802816|NCT00698828|566034024|FG000|Overall Study|Death|0|||
156802817|NCT00698828|566034025|FG001|Overall Study|Death|0|||
156802818|NCT00698828|566034026|FG002|Overall Study|Death|1|||
156802819|NCT00698828|566034024|FG000|Overall Study|Exacerbation of COPD|1|||
156802820|NCT00698828|566034025|FG001|Overall Study|Exacerbation of COPD|3|||
156802821|NCT00698828|566034026|FG002|Overall Study|Exacerbation of COPD|0|||
156802822|NCT00698828|566034024|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
156802823|NCT00698828|566034025|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
156802824|NCT00698828|566034026|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
156802825|NCT00698828|566034024|FG000|Overall Study|Investigator/Sponsor decision|1|||
156802826|NCT00698828|566034025|FG001|Overall Study|Investigator/Sponsor decision|0|||
156802827|NCT00698828|566034026|FG002|Overall Study|Investigator/Sponsor decision|2|||
156802828|NCT00698828|566034024|FG000|Overall Study|Lost to Follow-up|1|||
156802829|NCT00698828|566034025|FG001|Overall Study|Lost to Follow-up|1|||
156802830|NCT00698828|566034026|FG002|Overall Study|Lost to Follow-up|0|||
156802831|NCT00698828|566034024|FG000|Overall Study|Withdrew consent|0|||
156802832|NCT00698828|566034025|FG001|Overall Study|Withdrew consent|7|||
156802833|NCT00698828|566034026|FG002|Overall Study|Withdrew consent|4|||
156802834|NCT00698828|566034024|FG000|Overall Study|Withdrew consent (not treated)|2|||
156802835|NCT00698828|566034025|FG001|Overall Study|Withdrew consent (not treated)|0|||
156802836|NCT00698828|566034026|FG002|Overall Study|Withdrew consent (not treated)|0|||
156802837|NCT02013609|566034027|FG000|Overall Study|Withdrawal by Subject|9|||
156802838|NCT02013609|566034027|FG000|Overall Study|Lost to Follow-up|3|||
156802839|NCT02013609|566034027|FG000|Overall Study|Adverse Event|3|||
156802840|NCT02013609|566034027|FG000|Overall Study|Met Withdrawal Criteria|3|||
156802841|NCT01816295|566034028|FG000|Double Blind Phase|Adverse Event|11|||
156802842|NCT01816295|566034029|FG001|Double Blind Phase|Adverse Event|8|||
156802843|NCT01816295|566034028|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
156802844|NCT01816295|566034029|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
156802845|NCT01816295|566034028|FG000|Double Blind Phase|Lost to Follow-up|3|||
156802846|NCT01816295|566034029|FG001|Double Blind Phase|Lost to Follow-up|5|||
156802847|NCT01816295|566034028|FG000|Double Blind Phase|Physician Decision|2|||
157021047|NCT03126019|566830797|FG001|Overall Study|Site Closed|1|||
156802848|NCT01816295|566034029|FG001|Double Blind Phase|Physician Decision|2|||
156802849|NCT01816295|566034028|FG000|Double Blind Phase|Protocol Violation|17|||
156881613|NCT02059291|566326997|FG023|Epoch 3|Lack of Efficacy|0|||
156802850|NCT01816295|566034029|FG001|Double Blind Phase|Protocol Violation|11|||
156802851|NCT01816295|566034028|FG000|Double Blind Phase|Sponsor Decision|8|||
156802852|NCT01816295|566034029|FG001|Double Blind Phase|Sponsor Decision|8|||
156802853|NCT01816295|566034028|FG000|Double Blind Phase|Withdrawal by Subject|22|||
156802854|NCT01816295|566034029|FG001|Double Blind Phase|Withdrawal by Subject|20|||
157021048|NCT00170573|566830801|FG000|Overall Study|Violation of inclusion criteria|13|||
156802855|NCT01816295|566034028|FG000|OLE Phase|Adverse Event|17|||
156802856|NCT01816295|566034029|FG001|OLE Phase|Adverse Event|15|||
156802857|NCT01816295|566034028|FG000|OLE Phase|Death|1|||
156802858|NCT01816295|566034029|FG001|OLE Phase|Death|0|||
156802859|NCT01816295|566034028|FG000|OLE Phase|Entry Criteria Not Met|3|||
156802860|NCT01816295|566034029|FG001|OLE Phase|Entry Criteria Not Met|5|||
156802861|NCT01816295|566034028|FG000|OLE Phase|Lost to Follow-up|5|||
156802862|NCT01816295|566034029|FG001|OLE Phase|Lost to Follow-up|5|||
156802863|NCT01816295|566034028|FG000|OLE Phase|Physician Decision|3|||
156802864|NCT01816295|566034029|FG001|OLE Phase|Physician Decision|1|||
156802865|NCT01816295|566034028|FG000|OLE Phase|Protocol Violation|4|||
156802866|NCT01816295|566034029|FG001|OLE Phase|Protocol Violation|4|||
156802867|NCT01816295|566034028|FG000|OLE Phase|Sponsor Decision|7|||
156802868|NCT01816295|566034029|FG001|OLE Phase|Sponsor Decision|9|||
156802869|NCT01816295|566034028|FG000|OLE Phase|Withdrawal by Subject|10|||
156802870|NCT01816295|566034029|FG001|OLE Phase|Withdrawal by Subject|10|||
156802871|NCT01816295|566034028|FG000|OLE Phase|Lack of Efficacy|3|||
156802872|NCT01816295|566034029|FG001|OLE Phase|Lack of Efficacy|7|||
156802873|NCT01119287|566034030|FG000|Overall Study|Patient Decision, not related to AE|0|||
156802874|NCT01119287|566034031|FG001|Overall Study|Patient Decision, not related to AE|0|||
156802875|NCT01119287|566034032|FG002|Overall Study|Patient Decision, not related to AE|2|||
156802876|NCT01119287|566034033|FG003|Overall Study|Patient Decision, not related to AE|2|||
156802877|NCT01119287|566034034|FG004|Overall Study|Patient Decision, not related to AE|1|||
156802878|NCT01119287|566034035|FG005|Overall Study|Patient Decision, not related to AE|0|||
156802879|NCT01534481|566034048|FG000|Overall Study|Lost to Follow-up|29|||
156802880|NCT01534481|566034049|FG001|Overall Study|Lost to Follow-up|24|||
156802881|NCT01534481|566034048|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
156802882|NCT01534481|566034049|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
156802883|NCT00945659|566034050|FG000|Overall Study|Lost to Follow-up|7|||
156802884|NCT00945659|566034051|FG001|Overall Study|Lost to Follow-up|20|||
156802885|NCT00945659|566034052|FG002|Overall Study|Lost to Follow-up|17|||
156802886|NCT03498716|566034067|FG000|Overall Study|Withdrawal by Subject|88|||
156802887|NCT03498716|566034068|FG001|Overall Study|Withdrawal by Subject|73|||
156802888|NCT03498716|566034067|FG000|Overall Study|Study Terminated By Sponsor|933|||
156802889|NCT03498716|566034068|FG001|Overall Study|Study Terminated By Sponsor|927|||
156802890|NCT03498716|566034067|FG000|Overall Study|Lost to Follow-up|15|||
156802891|NCT03498716|566034068|FG001|Overall Study|Lost to Follow-up|26|||
156802892|NCT03498716|566034067|FG000|Overall Study|Disease Relapse|0|||
156802893|NCT03498716|566034068|FG001|Overall Study|Disease Relapse|1|||
156802894|NCT03498716|566034067|FG000|Overall Study|Death|58|||
156802895|NCT03498716|566034068|FG001|Overall Study|Death|72|||
156802896|NCT03498716|566034067|FG000|Overall Study|Physician Decision|4|||
156802897|NCT03498716|566034068|FG001|Overall Study|Physician Decision|2|||
156802898|NCT01448616|566034069|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
156802899|NCT01448616|566034070|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
157220975|NCT00585351|567554934|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
157220976|NCT00585351|567554935|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
157220977|NCT00585351|567554936|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
157220978|NCT00585351|567554937|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
157220979|NCT00585351|567554938|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
157220980|NCT00585351|567554939|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
157220981|NCT00585351|567554940|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
157220982|NCT00585351|567554941|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
157220983|NCT00585351|567554934|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
157220984|NCT00585351|567554935|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
157220985|NCT00585351|567554936|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
157220986|NCT00585351|567554937|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
157220987|NCT00585351|567554938|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156802900|NCT01448616|566034071|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
156802901|NCT01448616|566034072|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
156802902|NCT01448616|566034069|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
156802903|NCT01448616|566034070|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802904|NCT01448616|566034071|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802905|NCT01448616|566034072|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
156802906|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
156802907|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
156802908|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
156802909|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
156802910|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
156802911|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
156802912|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
156802913|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
156802914|NCT01448616|566034069|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
156802915|NCT01448616|566034070|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
156802916|NCT01448616|566034071|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
156802917|NCT01448616|566034072|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
156802918|NCT01570387|566034073|FG000|Overall Study|Adverse Event|1|||
156802919|NCT01570387|566034074|FG001|Overall Study|Adverse Event|0|||
156802920|NCT01570387|566034075|FG002|Overall Study|Adverse Event|0|||
156802921|NCT01570387|566034076|FG003|Overall Study|Adverse Event|0|||
156802922|NCT01570387|566034073|FG000|Overall Study|Death|0|||
156802923|NCT01570387|566034074|FG001|Overall Study|Death|0|||
156802924|NCT01570387|566034075|FG002|Overall Study|Death|0|||
156802925|NCT01570387|566034076|FG003|Overall Study|Death|1|||
156802926|NCT01570387|566034073|FG000|Overall Study|Withdrawal by Subject|0|||
156802927|NCT01570387|566034074|FG001|Overall Study|Withdrawal by Subject|0|||
156802928|NCT01570387|566034075|FG002|Overall Study|Withdrawal by Subject|0|||
156802929|NCT01570387|566034076|FG003|Overall Study|Withdrawal by Subject|1|||
156802930|NCT03139448|566034077|FG000|Overall Study|Lack of Efficacy|6|||
156802931|NCT03139448|566034078|FG001|Overall Study|Lack of Efficacy|7|||
156802932|NCT03139448|566034077|FG000|Overall Study|Location of procedure changed|2|||
156802933|NCT03139448|566034078|FG001|Overall Study|Location of procedure changed|8|||
156802934|NCT03139448|566034077|FG000|Overall Study|Withdrawal by Subject|3|||
156802935|NCT03139448|566034078|FG001|Overall Study|Withdrawal by Subject|6|||
156802936|NCT03139448|566034077|FG000|Overall Study|Screen fail|1|||
156802937|NCT03139448|566034078|FG001|Overall Study|Screen fail|3|||
156802938|NCT03139448|566034077|FG000|Overall Study|Physician Decision|0|||
156802939|NCT03139448|566034078|FG001|Overall Study|Physician Decision|2|||
156802940|NCT01987557|566034079|FG000|Overall Study|Protocol Violation|1|||
156802941|NCT01987557|566034080|FG001|Overall Study|Protocol Violation|0|||
156802942|NCT01987557|566034081|FG002|Overall Study|Protocol Violation|1|||
156802943|NCT01987557|566034079|FG000|Overall Study|Withdrawal by Subject|2|||
156802944|NCT01987557|566034080|FG001|Overall Study|Withdrawal by Subject|1|||
156802945|NCT01987557|566034081|FG002|Overall Study|Withdrawal by Subject|2|||
156802946|NCT01987557|566034079|FG000|Overall Study|Adverse Event|0|||
156802947|NCT01987557|566034080|FG001|Overall Study|Adverse Event|2|||
156802948|NCT01987557|566034081|FG002|Overall Study|Adverse Event|0|||
156802949|NCT03323164|566034084|FG000|Overall Study|Poor quality imaging/scans|2|||
156802950|NCT03323164|566034085|FG001|Overall Study|Poor quality imaging/scans|2|||
156802951|NCT00461708|566034088|FG000|Overall Study|Adverse Event|17|||
156802952|NCT00461708|566034089|FG001|Overall Study|Adverse Event|7|||
156802953|NCT00461708|566034088|FG000|Overall Study|Lack of Efficacy|68|||
156802954|NCT00461708|566034089|FG001|Overall Study|Lack of Efficacy|20|||
156802955|NCT00461708|566034088|FG000|Overall Study|Physician Decision|10|||
156802956|NCT00461708|566034089|FG001|Overall Study|Physician Decision|4|||
156802957|NCT00461708|566034088|FG000|Overall Study|Withdrawal by Subject|8|||
156802958|NCT00461708|566034089|FG001|Overall Study|Withdrawal by Subject|2|||
156802959|NCT00461708|566034088|FG000|Overall Study|Other|4|||
156802960|NCT00461708|566034089|FG001|Overall Study|Other|4|||
156802961|NCT00461708|566034088|FG000|Overall Study|Death|8|||
156802962|NCT00461708|566034089|FG001|Overall Study|Death|1|||
156802963|NCT02394561|566034090|FG000|CORE Phase|Adverse Event|7|||
156802964|NCT02394561|566034091|FG001|CORE Phase|Adverse Event|9|||
156802965|NCT02394561|566034090|FG000|CORE Phase|Death|0|||
156802966|NCT02394561|566034091|FG001|CORE Phase|Death|1|||
156802967|NCT02394561|566034090|FG000|CORE Phase|Pregnancy|1|||
156802968|NCT02394561|566034091|FG001|CORE Phase|Pregnancy|0|||
156802969|NCT02394561|566034090|FG000|CORE Phase|Lost to Follow-up|1|||
156802970|NCT02394561|566034091|FG001|CORE Phase|Lost to Follow-up|0|||
156802971|NCT02394561|566034090|FG000|CORE Phase|Physician Decision|1|||
156802972|NCT02394561|566034091|FG001|CORE Phase|Physician Decision|1|||
156802973|NCT02394561|566034090|FG000|CORE Phase|Withdrawal by Subject|2|||
156802974|NCT02394561|566034091|FG001|CORE Phase|Withdrawal by Subject|2|||
156802975|NCT02394561|566034090|FG000|CORE Phase|Lack of Efficacy|1|||
156802976|NCT02394561|566034091|FG001|CORE Phase|Lack of Efficacy|6|||
156802977|NCT02394561|566034090|FG000|Extension Phase|Adverse Event|6|||
157143879|NCT02158533|567276366|FG002|Stage 1|Withdrawal by Subject|1|||
157143880|NCT02158533|567276367|FG003|Stage 1|Withdrawal by Subject|0|||
156802978|NCT02394561|566034091|FG001|Extension Phase|Adverse Event|1|||
156802979|NCT02394561|566034090|FG000|Extension Phase|Death|0|||
156802980|NCT02394561|566034091|FG001|Extension Phase|Death|1|||
156802981|NCT02394561|566034090|FG000|Extension Phase|Protocol Violation|1|||
156802982|NCT02394561|566034091|FG001|Extension Phase|Protocol Violation|0|||
156802983|NCT02394561|566034090|FG000|Extension Phase|Lost to Follow-up|1|||
156802984|NCT02394561|566034091|FG001|Extension Phase|Lost to Follow-up|0|||
156802985|NCT02394561|566034090|FG000|Extension Phase|Physician Decision|0|||
156802986|NCT02394561|566034091|FG001|Extension Phase|Physician Decision|2|||
156802987|NCT02394561|566034090|FG000|Extension Phase|Withdrawal by Subject|0|||
156802988|NCT02394561|566034091|FG001|Extension Phase|Withdrawal by Subject|5|||
156802989|NCT02394561|566034090|FG000|Extension Phase|Lack of Efficacy|3|||
156802990|NCT02394561|566034091|FG001|Extension Phase|Lack of Efficacy|3|||
156802991|NCT00501644|566034092|FG000|Overall Study|Adverse Event|4|||
157143881|NCT02158533|567276368|FG004|Stage 1|Withdrawal by Subject|0|||
156802992|NCT00501644|566034092|FG000|Overall Study|Withdrawal by Subject|1|||
156802993|NCT01854528|566034097|FG000|Overall Study|Adverse Event|0|||
156802994|NCT01854528|566034098|FG001|Overall Study|Adverse Event|4|||
157143882|NCT02158533|567276369|FG005|Stage 1|Withdrawal by Subject|0|||
156802995|NCT01854528|566034097|FG000|Overall Study|Withdrawal by Subject|0|||
156802996|NCT01854528|566034098|FG001|Overall Study|Withdrawal by Subject|2|||
156802997|NCT01854528|566034097|FG000|Overall Study|Virologic Failure|0|||
157021049|NCT05563246|566830847|FG000|Overall Study|Withdrawal by Subject|1|||
156802998|NCT01854528|566034098|FG001|Overall Study|Virologic Failure|9|||
156802999|NCT03710889|566034107|FG000|Overall Study|Adverse Event|2|||
156803000|NCT03710889|566034107|FG000|Overall Study|Protocol Deviation|1|||
156803001|NCT02850978|566034109|FG000|Overall Study|Uncollectable CRF|27|||
156803002|NCT02850978|566034109|FG000|Overall Study|No visit since the first visit|35|||
156803003|NCT02850978|566034109|FG000|Overall Study|Adverse Event|81|||
156803004|NCT02850978|566034109|FG000|Overall Study|Lack of Efficacy|40|||
156803005|NCT02850978|566034109|FG000|Overall Study|Improvement in condition|34|||
156803006|NCT02850978|566034109|FG000|Overall Study|Lost to Follow-up|121|||
156803007|NCT02850978|566034109|FG000|Overall Study|Reason not listed|88|||
156803008|NCT01538199|566034110|FG000|Overall Study|Lost to Follow-up|1|||
156803009|NCT01538199|566034111|FG001|Overall Study|Lost to Follow-up|2|||
156803010|NCT01538199|566034112|FG002|Overall Study|Lost to Follow-up|1|||
156803011|NCT01538199|566034113|FG003|Overall Study|Lost to Follow-up|0|||
156803012|NCT01538199|566034110|FG000|Overall Study|participant did not have time|1|||
156803013|NCT01538199|566034111|FG001|Overall Study|participant did not have time|0|||
156803014|NCT01538199|566034112|FG002|Overall Study|participant did not have time|0|||
156803015|NCT01538199|566034113|FG003|Overall Study|participant did not have time|2|||
156803016|NCT01538199|566034110|FG000|Overall Study|Lack of Efficacy|0|||
156803017|NCT01538199|566034111|FG001|Overall Study|Lack of Efficacy|1|||
156803018|NCT01538199|566034112|FG002|Overall Study|Lack of Efficacy|0|||
156803019|NCT01538199|566034113|FG003|Overall Study|Lack of Efficacy|0|||
156803020|NCT02081586|566034114|FG000|Overall Study|Lost to Follow-up|0|||
156803021|NCT02081586|566034115|FG001|Overall Study|Lost to Follow-up|1|||
156803022|NCT02081586|566034116|FG002|Overall Study|Lost to Follow-up|0|||
156803023|NCT02081586|566034117|FG003|Overall Study|Lost to Follow-up|1|||
156803024|NCT02081586|566034114|FG000|Overall Study|Head injury not related to study|0|||
156803025|NCT02081586|566034115|FG001|Overall Study|Head injury not related to study|0|||
156803026|NCT02081586|566034116|FG002|Overall Study|Head injury not related to study|1|||
156803027|NCT02081586|566034117|FG003|Overall Study|Head injury not related to study|0|||
156803028|NCT00636181|566034120|FG000|Overall Study|Withdrawal by Subject|8|||
156803029|NCT00636181|566034121|FG001|Overall Study|Withdrawal by Subject|6|||
156803030|NCT00636181|566034122|FG002|Overall Study|Withdrawal by Subject|10|||
156803031|NCT04549454|566034128|FG000|T1 to T2|Lost to Follow-up|22|||
156803032|NCT04549454|566034129|FG001|T1 to T2|Lost to Follow-up|26|||
156803033|NCT04549454|566034128|FG000|T1 to T3|Lost to Follow-up|31|||
156803034|NCT04549454|566034129|FG001|T1 to T3|Lost to Follow-up|36|||
156803035|NCT04712669|566034140|FG000|Double Blind Phase|Adverse Event|4|||
156803036|NCT04712669|566034141|FG001|Double Blind Phase|Adverse Event|4|||
156803037|NCT04712669|566034142|FG002|Double Blind Phase|Adverse Event|3|||
156803038|NCT04712669|566034143|FG003|Double Blind Phase|Adverse Event|0|||
156803039|NCT04712669|566034144|FG004|Double Blind Phase|Adverse Event|0|||
156803040|NCT04712669|566034145|FG005|Double Blind Phase|Adverse Event|0|||
156803041|NCT04712669|566034146|FG006|Double Blind Phase|Adverse Event|0|||
156803042|NCT04712669|566034147|FG007|Double Blind Phase|Adverse Event|0|||
156803043|NCT04712669|566034140|FG000|Double Blind Phase|Physician Decision|1|||
156803044|NCT04712669|566034141|FG001|Double Blind Phase|Physician Decision|0|||
156803045|NCT04712669|566034142|FG002|Double Blind Phase|Physician Decision|0|||
156803046|NCT04712669|566034143|FG003|Double Blind Phase|Physician Decision|0|||
156803047|NCT04712669|566034144|FG004|Double Blind Phase|Physician Decision|0|||
156803048|NCT04712669|566034145|FG005|Double Blind Phase|Physician Decision|0|||
156803049|NCT04712669|566034146|FG006|Double Blind Phase|Physician Decision|0|||
156803050|NCT04712669|566034147|FG007|Double Blind Phase|Physician Decision|0|||
156803051|NCT04712669|566034140|FG000|Double Blind Phase|Withdrawal by Subject|3|||
156803052|NCT04712669|566034141|FG001|Double Blind Phase|Withdrawal by Subject|6|||
156803053|NCT04712669|566034142|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156803054|NCT04712669|566034143|FG003|Double Blind Phase|Withdrawal by Subject|0|||
156803055|NCT04712669|566034144|FG004|Double Blind Phase|Withdrawal by Subject|0|||
156803056|NCT04712669|566034145|FG005|Double Blind Phase|Withdrawal by Subject|0|||
156803057|NCT04712669|566034146|FG006|Double Blind Phase|Withdrawal by Subject|0|||
156803058|NCT04712669|566034147|FG007|Double Blind Phase|Withdrawal by Subject|0|||
156803059|NCT04712669|566034140|FG000|Double Blind Phase|Termination by Sponsor|0|||
156803060|NCT04712669|566034141|FG001|Double Blind Phase|Termination by Sponsor|0|||
156803061|NCT04712669|566034142|FG002|Double Blind Phase|Termination by Sponsor|1|||
156803062|NCT04712669|566034143|FG003|Double Blind Phase|Termination by Sponsor|0|||
156803063|NCT04712669|566034144|FG004|Double Blind Phase|Termination by Sponsor|0|||
156803064|NCT04712669|566034145|FG005|Double Blind Phase|Termination by Sponsor|0|||
156803065|NCT04712669|566034146|FG006|Double Blind Phase|Termination by Sponsor|0|||
156803066|NCT04712669|566034147|FG007|Double Blind Phase|Termination by Sponsor|0|||
156803067|NCT04712669|566034140|FG000|Open Label Phase|Adverse Event|0|||
156803068|NCT04712669|566034141|FG001|Open Label Phase|Adverse Event|0|||
157021050|NCT05563246|566830848|FG001|Overall Study|Withdrawal by Subject|2|||
156803069|NCT04712669|566034142|FG002|Open Label Phase|Adverse Event|0|||
156803070|NCT04712669|566034143|FG003|Open Label Phase|Adverse Event|1|||
156803071|NCT04712669|566034144|FG004|Open Label Phase|Adverse Event|1|||
157021051|NCT05563246|566830849|FG002|Overall Study|Withdrawal by Subject|0|||
157021052|NCT05563246|566830850|FG003|Overall Study|Withdrawal by Subject|0|||
157021053|NCT05563246|566830847|FG000|Overall Study|Protocol Deviation|0|||
157021054|NCT05563246|566830848|FG001|Overall Study|Protocol Deviation|1|||
157021055|NCT05563246|566830849|FG002|Overall Study|Protocol Deviation|0|||
157021056|NCT05563246|566830850|FG003|Overall Study|Protocol Deviation|0|||
157021057|NCT05563246|566830847|FG000|Overall Study|Physician Decision|0|||
157021058|NCT05563246|566830848|FG001|Overall Study|Physician Decision|1|||
157021059|NCT05563246|566830849|FG002|Overall Study|Physician Decision|0|||
157021060|NCT05563246|566830850|FG003|Overall Study|Physician Decision|0|||
157021061|NCT05563246|566830847|FG000|Overall Study|Adverse Event|0|||
157021062|NCT05563246|566830848|FG001|Overall Study|Adverse Event|0|||
157021063|NCT05563246|566830849|FG002|Overall Study|Adverse Event|2|||
157021064|NCT05563246|566830850|FG003|Overall Study|Adverse Event|0|||
157021065|NCT05563246|566830847|FG000|Overall Study|Lost to Follow-up|0|||
157021066|NCT05563246|566830848|FG001|Overall Study|Lost to Follow-up|0|||
157021067|NCT05563246|566830849|FG002|Overall Study|Lost to Follow-up|1|||
157021068|NCT05563246|566830850|FG003|Overall Study|Lost to Follow-up|0|||
157021069|NCT03138512|566830851|FG000|Randomization|Participants withdrew consent|0|||
157021070|NCT03138512|566830852|FG001|Randomization|Participants withdrew consent|1|||
157021071|NCT03138512|566830853|FG002|Randomization|Participants withdrew consent|1|||
157021072|NCT03138512|566830854|FG003|Randomization|Participants withdrew consent|0|||
157021073|NCT03138512|566830855|FG004|Randomization|Participants withdrew consent|0|||
157021074|NCT03138512|566830851|FG000|Randomization|Participant no longer meets study criteria|0|||
157021075|NCT03138512|566830852|FG001|Randomization|Participant no longer meets study criteria|3|||
157021076|NCT03138512|566830853|FG002|Randomization|Participant no longer meets study criteria|1|||
157021077|NCT03138512|566830854|FG003|Randomization|Participant no longer meets study criteria|1|||
157021078|NCT03138512|566830855|FG004|Randomization|Participant no longer meets study criteria|3|||
157021079|NCT03138512|566830851|FG000|Randomization|Other reasons|1|||
157021080|NCT03138512|566830852|FG001|Randomization|Other reasons|0|||
157021081|NCT03138512|566830853|FG002|Randomization|Other reasons|0|||
157021082|NCT03138512|566830854|FG003|Randomization|Other reasons|0|||
157021083|NCT03138512|566830855|FG004|Randomization|Other reasons|0|||
157021084|NCT03138512|566830851|FG000|Treatment Part A|Disease recurrence|10|||
157021085|NCT03138512|566830852|FG001|Treatment Part A|Disease recurrence|20|||
157021086|NCT03138512|566830853|FG002|Treatment Part A|Disease recurrence|0|||
157021087|NCT03138512|566830854|FG003|Treatment Part A|Disease recurrence|0|||
157021088|NCT03138512|566830855|FG004|Treatment Part A|Disease recurrence|0|||
157021089|NCT03138512|566830851|FG000|Treatment Part A|Study Drug Toxicity|132|||
157021090|NCT03138512|566830852|FG001|Treatment Part A|Study Drug Toxicity|5|||
157021091|NCT03138512|566830853|FG002|Treatment Part A|Study Drug Toxicity|0|||
157021092|NCT03138512|566830854|FG003|Treatment Part A|Study Drug Toxicity|0|||
157021093|NCT03138512|566830855|FG004|Treatment Part A|Study Drug Toxicity|0|||
157021094|NCT03138512|566830851|FG000|Treatment Part A|Death|1|||
157021095|NCT03138512|566830852|FG001|Treatment Part A|Death|0|||
157021096|NCT03138512|566830853|FG002|Treatment Part A|Death|0|||
157021097|NCT03138512|566830854|FG003|Treatment Part A|Death|0|||
157021098|NCT03138512|566830855|FG004|Treatment Part A|Death|0|||
157021099|NCT03138512|566830851|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
157021100|NCT03138512|566830852|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
157021101|NCT03138512|566830853|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
156803072|NCT04712669|566034145|FG005|Open Label Phase|Adverse Event|3|||
156803073|NCT04712669|566034146|FG006|Open Label Phase|Adverse Event|1|||
156803074|NCT04712669|566034147|FG007|Open Label Phase|Adverse Event|2|||
156803075|NCT04712669|566034140|FG000|Open Label Phase|Death|0|||
156803076|NCT04712669|566034141|FG001|Open Label Phase|Death|0|||
156803077|NCT04712669|566034142|FG002|Open Label Phase|Death|0|||
156803078|NCT04712669|566034143|FG003|Open Label Phase|Death|1|||
156803079|NCT04712669|566034144|FG004|Open Label Phase|Death|0|||
156803080|NCT04712669|566034145|FG005|Open Label Phase|Death|0|||
156803081|NCT04712669|566034146|FG006|Open Label Phase|Death|0|||
156803082|NCT04712669|566034147|FG007|Open Label Phase|Death|0|||
156803083|NCT04712669|566034140|FG000|Open Label Phase|Lack of Efficacy|0|||
157021102|NCT03138512|566830854|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
157021103|NCT03138512|566830855|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
157021104|NCT03138512|566830851|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
157021105|NCT03138512|566830852|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
157021106|NCT03138512|566830853|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
157021107|NCT03138512|566830854|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
157021108|NCT03138512|566830855|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
157220988|NCT00585351|567554939|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156803084|NCT04712669|566034141|FG001|Open Label Phase|Lack of Efficacy|0|||
156803085|NCT04712669|566034142|FG002|Open Label Phase|Lack of Efficacy|0|||
156803086|NCT04712669|566034143|FG003|Open Label Phase|Lack of Efficacy|0|||
156803087|NCT04712669|566034144|FG004|Open Label Phase|Lack of Efficacy|1|||
156803088|NCT04712669|566034145|FG005|Open Label Phase|Lack of Efficacy|0|||
156803089|NCT04712669|566034146|FG006|Open Label Phase|Lack of Efficacy|0|||
156803090|NCT04712669|566034147|FG007|Open Label Phase|Lack of Efficacy|0|||
156803091|NCT04712669|566034140|FG000|Open Label Phase|Lost to Follow-up|0|||
156803092|NCT04712669|566034141|FG001|Open Label Phase|Lost to Follow-up|0|||
156803093|NCT04712669|566034142|FG002|Open Label Phase|Lost to Follow-up|0|||
156803094|NCT04712669|566034143|FG003|Open Label Phase|Lost to Follow-up|0|||
156803095|NCT04712669|566034144|FG004|Open Label Phase|Lost to Follow-up|0|||
156803096|NCT04712669|566034145|FG005|Open Label Phase|Lost to Follow-up|0|||
156803097|NCT04712669|566034146|FG006|Open Label Phase|Lost to Follow-up|1|||
156803098|NCT04712669|566034147|FG007|Open Label Phase|Lost to Follow-up|1|||
156803099|NCT04712669|566034140|FG000|Open Label Phase|Physician Decision|0|||
156803100|NCT04712669|566034141|FG001|Open Label Phase|Physician Decision|0|||
156803101|NCT04712669|566034142|FG002|Open Label Phase|Physician Decision|0|||
156803102|NCT04712669|566034143|FG003|Open Label Phase|Physician Decision|1|||
156803103|NCT04712669|566034144|FG004|Open Label Phase|Physician Decision|0|||
156803104|NCT04712669|566034145|FG005|Open Label Phase|Physician Decision|0|||
156803105|NCT04712669|566034146|FG006|Open Label Phase|Physician Decision|0|||
156803106|NCT04712669|566034147|FG007|Open Label Phase|Physician Decision|0|||
156803107|NCT04712669|566034140|FG000|Open Label Phase|Withdrawal by Subject|0|||
156803108|NCT04712669|566034141|FG001|Open Label Phase|Withdrawal by Subject|0|||
156803109|NCT04712669|566034142|FG002|Open Label Phase|Withdrawal by Subject|0|||
156803110|NCT04712669|566034143|FG003|Open Label Phase|Withdrawal by Subject|1|||
156803111|NCT04712669|566034144|FG004|Open Label Phase|Withdrawal by Subject|5|||
156803112|NCT04712669|566034145|FG005|Open Label Phase|Withdrawal by Subject|5|||
156803113|NCT04712669|566034146|FG006|Open Label Phase|Withdrawal by Subject|0|||
156803114|NCT04712669|566034147|FG007|Open Label Phase|Withdrawal by Subject|4|||
156803115|NCT04712669|566034140|FG000|Open Label Phase|Termination by Sponsor|0|||
156803116|NCT04712669|566034141|FG001|Open Label Phase|Termination by Sponsor|0|||
156803117|NCT04712669|566034142|FG002|Open Label Phase|Termination by Sponsor|0|||
156803118|NCT04712669|566034143|FG003|Open Label Phase|Termination by Sponsor|11|||
156803119|NCT04712669|566034144|FG004|Open Label Phase|Termination by Sponsor|9|||
156803120|NCT04712669|566034145|FG005|Open Label Phase|Termination by Sponsor|14|||
156803121|NCT04712669|566034146|FG006|Open Label Phase|Termination by Sponsor|0|||
156803122|NCT04712669|566034147|FG007|Open Label Phase|Termination by Sponsor|14|||
156803123|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
156803124|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
156803125|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
156803126|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
156803127|NCT02735421|566035918|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
156803128|NCT02735421|566035918|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
156803129|NCT02735421|566035918|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
156803130|NCT01978145|566035920|FG000|Treatment Period 1|Adverse Event|1|||
156803131|NCT01978145|566035921|FG001|Treatment Period 1|Adverse Event|9|||
156803132|NCT01978145|566035920|FG000|Treatment Period 1|Physician Decision|1|||
156803133|NCT01978145|566035921|FG001|Treatment Period 1|Physician Decision|0|||
156803134|NCT01978145|566035920|FG000|Treatment Period 1|Withdrawal by Subject|5|||
156803135|NCT01978145|566035921|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156803136|NCT01978145|566035920|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
156803137|NCT01978145|566035921|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
156881614|NCT02059291|566326998|FG024|Epoch 3|Lack of Efficacy|0|||
156881615|NCT02059291|566326974|FG000|Epoch 3|Withdrawal by Subject|0|||
156803138|NCT01978145|566035920|FG000|Washout Period 1|Adverse Event|0|||
156803139|NCT01978145|566035921|FG001|Washout Period 1|Adverse Event|1|||
156803140|NCT01978145|566035920|FG000|Washout Period 1|Withdrawal by Subject|1|||
156803141|NCT01978145|566035921|FG001|Washout Period 1|Withdrawal by Subject|1|||
156803142|NCT01978145|566035920|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
156803143|NCT01978145|566035921|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
156803144|NCT01978145|566035920|FG000|Treatment Period 2|Adverse Event|3|||
156803145|NCT01978145|566035921|FG001|Treatment Period 2|Adverse Event|3|||
156803146|NCT01978145|566035920|FG000|Treatment Period 2|Protocol Violation|0|||
156881616|NCT02059291|566326975|FG001|Epoch 3|Withdrawal by Subject|0|||
156881617|NCT02059291|566326976|FG002|Epoch 3|Withdrawal by Subject|0|||
156803147|NCT01978145|566035921|FG001|Treatment Period 2|Protocol Violation|1|||
156803148|NCT01978145|566035920|FG000|Treatment Period 2|Lost to Follow-up|1|||
156803149|NCT01978145|566035921|FG001|Treatment Period 2|Lost to Follow-up|1|||
156803150|NCT01978145|566035920|FG000|Treatment Period 2|Withdrawal by Subject|7|||
156803151|NCT01978145|566035921|FG001|Treatment Period 2|Withdrawal by Subject|4|||
156803152|NCT01978145|566035920|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
156881618|NCT02059291|566326977|FG003|Epoch 3|Withdrawal by Subject|0|||
156803153|NCT01978145|566035921|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
156803154|NCT00322049|566035922|FG000|Overall Study|Moved out of area|0|||
156803155|NCT00322049|566035923|FG001|Overall Study|Moved out of area|0|||
156881619|NCT02059291|566326978|FG004|Epoch 3|Withdrawal by Subject|0|||
156881620|NCT02059291|566326979|FG005|Epoch 3|Withdrawal by Subject|0|||
156881621|NCT02059291|566326980|FG006|Epoch 3|Withdrawal by Subject|0|||
156881622|NCT02059291|566326981|FG007|Epoch 3|Withdrawal by Subject|0|||
156881623|NCT02059291|566326982|FG008|Epoch 3|Withdrawal by Subject|0|||
156881624|NCT02059291|566326983|FG009|Epoch 3|Withdrawal by Subject|0|||
156881625|NCT02059291|566326984|FG010|Epoch 3|Withdrawal by Subject|0|||
156881626|NCT02059291|566326985|FG011|Epoch 3|Withdrawal by Subject|0|||
156803156|NCT00322049|566035924|FG002|Overall Study|Moved out of area|0|||
156803157|NCT00322049|566035925|FG003|Overall Study|Moved out of area|1|||
156803158|NCT00322049|566035922|FG000|Overall Study|Infected with Dengue during study|0|||
156803159|NCT00322049|566035923|FG001|Overall Study|Infected with Dengue during study|1|||
156803160|NCT00322049|566035924|FG002|Overall Study|Infected with Dengue during study|0|||
156803161|NCT00322049|566035925|FG003|Overall Study|Infected with Dengue during study|0|||
156803162|NCT01250054|566035926|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
156803163|NCT01250054|566035927|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
156803164|NCT00755807|566035930|FG000|Acute Phase|Adverse Event|16|||
156803165|NCT00755807|566035931|FG001|Acute Phase|Adverse Event|5|||
156803166|NCT00755807|566035930|FG000|Acute Phase|Protocol Violation|1|||
156881627|NCT02059291|566326986|FG012|Epoch 3|Withdrawal by Subject|0|||
156881628|NCT02059291|566326987|FG013|Epoch 3|Withdrawal by Subject|0|||
156881629|NCT02059291|566326988|FG014|Epoch 3|Withdrawal by Subject|0|||
156881630|NCT02059291|566326989|FG015|Epoch 3|Withdrawal by Subject|1|||
156803167|NCT00755807|566035931|FG001|Acute Phase|Protocol Violation|3|||
156803168|NCT00755807|566035930|FG000|Acute Phase|Withdrawal by Subject|1|||
156803169|NCT00755807|566035931|FG001|Acute Phase|Withdrawal by Subject|2|||
156803170|NCT00755807|566035930|FG000|Acute Phase|Lack of Efficacy|0|||
156803171|NCT00755807|566035931|FG001|Acute Phase|Lack of Efficacy|1|||
156803172|NCT00755807|566035930|FG000|Acute Phase|Physician Decision|0|||
156803173|NCT00755807|566035931|FG001|Acute Phase|Physician Decision|1|||
156803174|NCT00755807|566035930|FG000|Open-label Extension Phase|Adverse Event|7|||
156803175|NCT00755807|566035931|FG001|Open-label Extension Phase|Adverse Event|7|||
156803176|NCT00755807|566035930|FG000|Open-label Extension Phase|Protocol Violation|5|||
156803177|NCT00755807|566035931|FG001|Open-label Extension Phase|Protocol Violation|2|||
156803178|NCT00755807|566035930|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
156803179|NCT00755807|566035931|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
156803180|NCT00755807|566035930|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
156803181|NCT00755807|566035931|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
156803182|NCT00755807|566035930|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
156881631|NCT02059291|566326990|FG016|Epoch 3|Withdrawal by Subject|0|||
156881632|NCT02059291|566326991|FG017|Epoch 3|Withdrawal by Subject|0|||
156881633|NCT02059291|566326992|FG018|Epoch 3|Withdrawal by Subject|0|||
156881634|NCT02059291|566326993|FG019|Epoch 3|Withdrawal by Subject|0|||
156881635|NCT02059291|566326994|FG020|Epoch 3|Withdrawal by Subject|0|||
156881636|NCT02059291|566326995|FG021|Epoch 3|Withdrawal by Subject|0|||
156881637|NCT02059291|566326996|FG022|Epoch 3|Withdrawal by Subject|0|||
156881638|NCT02059291|566326997|FG023|Epoch 3|Withdrawal by Subject|0|||
156881639|NCT02059291|566326998|FG024|Epoch 3|Withdrawal by Subject|0|||
156881640|NCT02059291|566326974|FG000|Epoch 4|Adverse Event|0|||
156881641|NCT02059291|566326975|FG001|Epoch 4|Adverse Event|0|||
156881642|NCT02059291|566326976|FG002|Epoch 4|Adverse Event|0|||
156881643|NCT02059291|566326977|FG003|Epoch 4|Adverse Event|0|||
156881644|NCT02059291|566326978|FG004|Epoch 4|Adverse Event|0|||
156881645|NCT02059291|566326979|FG005|Epoch 4|Adverse Event|0|||
156881646|NCT02059291|566326980|FG006|Epoch 4|Adverse Event|0|||
156881647|NCT02059291|566326981|FG007|Epoch 4|Adverse Event|0|||
156881648|NCT02059291|566326982|FG008|Epoch 4|Adverse Event|0|||
156881649|NCT02059291|566326983|FG009|Epoch 4|Adverse Event|0|||
156881650|NCT02059291|566326984|FG010|Epoch 4|Adverse Event|0|||
157143883|NCT02158533|567276364|FG000|Stage 1|Lack of Efficacy|1|||
157143884|NCT02158533|567276365|FG001|Stage 1|Lack of Efficacy|0|||
157143885|NCT02158533|567276366|FG002|Stage 1|Lack of Efficacy|0|||
157143886|NCT02158533|567276367|FG003|Stage 1|Lack of Efficacy|0|||
156803183|NCT00755807|566035931|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
156803184|NCT00755807|566035930|FG000|Open-label Extension Phase|Sponsor Decision|0|||
156803185|NCT00755807|566035931|FG001|Open-label Extension Phase|Sponsor Decision|1|||
156803186|NCT00939107|566035932|FG000|Overall Study|Lost to Follow-up|14|||
156803187|NCT00939107|566035933|FG001|Overall Study|Lost to Follow-up|12|||
156803188|NCT00427011|566035936|FG000|Overall Study|Adverse Event|10|||
156803189|NCT00427011|566035936|FG000|Overall Study|Withdrawal by Subject|1|||
156881651|NCT02059291|566326985|FG011|Epoch 4|Adverse Event|0|||
156881652|NCT02059291|566326986|FG012|Epoch 4|Adverse Event|0|||
156881653|NCT02059291|566326987|FG013|Epoch 4|Adverse Event|0|||
156881654|NCT02059291|566326988|FG014|Epoch 4|Adverse Event|0|||
156881655|NCT02059291|566326989|FG015|Epoch 4|Adverse Event|0|||
156881656|NCT02059291|566326990|FG016|Epoch 4|Adverse Event|1|||
156881657|NCT02059291|566326991|FG017|Epoch 4|Adverse Event|0|||
156881658|NCT02059291|566326992|FG018|Epoch 4|Adverse Event|0|||
156881659|NCT02059291|566326993|FG019|Epoch 4|Adverse Event|0|||
156881660|NCT02059291|566326994|FG020|Epoch 4|Adverse Event|0|||
157143887|NCT02158533|567276368|FG004|Stage 1|Lack of Efficacy|0|||
157143888|NCT02158533|567276369|FG005|Stage 1|Lack of Efficacy|0|||
156803190|NCT00427011|566035936|FG000|Overall Study|Lack of Efficacy|2|||
156803191|NCT00427011|566035936|FG000|Overall Study|Other|12|||
156803192|NCT01192126|566035937|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
156803193|NCT01192126|566035938|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
156803194|NCT01192126|566035937|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
156803195|NCT01192126|566035938|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
156803196|NCT01248793|566035939|FG000|Overall Study|Lost to Follow-up|0|||
156803197|NCT01248793|566035940|FG001|Overall Study|Lost to Follow-up|1|||
156803198|NCT01248793|566035939|FG000|Overall Study|Adverse Event|1|||
156803199|NCT01248793|566035940|FG001|Overall Study|Adverse Event|1|||
156803200|NCT01248793|566035939|FG000|Overall Study|Protocol Violation|0|||
156803201|NCT01248793|566035940|FG001|Overall Study|Protocol Violation|1|||
156803202|NCT01248793|566035939|FG000|Overall Study|Withdrawal by Subject|3|||
156803203|NCT01248793|566035940|FG001|Overall Study|Withdrawal by Subject|3|||
156803204|NCT00517699|566035941|FG000|Overall Study|Withdrawal by Subject|1|||
156803205|NCT00517699|566035941|FG000|Overall Study|Lack of Efficacy|1|||
156803206|NCT00517699|566035941|FG000|Overall Study|Administrative error|1|||
156803207|NCT00517699|566035941|FG000|Overall Study|Study terminated by Sponsor|2|||
156803208|NCT02580877|566035942|FG000|Overall Study|Withdrawal by Subject|1|||
156803209|NCT02580877|566035943|FG001|Overall Study|Withdrawal by Subject|3|||
156803210|NCT02580877|566035942|FG000|Overall Study|Adverse Event|0|||
156881661|NCT02059291|566326995|FG021|Epoch 4|Adverse Event|0|||
156881662|NCT02059291|566326996|FG022|Epoch 4|Adverse Event|1|||
156881663|NCT02059291|566326997|FG023|Epoch 4|Adverse Event|0|||
156803211|NCT02580877|566035943|FG001|Overall Study|Adverse Event|1|||
156803212|NCT00355030|566035944|FG000|Study Period 1 Treatment|Adverse Event|1|||
156803213|NCT00355030|566035945|FG001|Study Period 1 Treatment|Adverse Event|1|||
156803214|NCT00355030|566035944|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
156803215|NCT00355030|566035945|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
156803216|NCT00355030|566035944|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
156803217|NCT00355030|566035945|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
156803218|NCT00355030|566035944|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
156803219|NCT00355030|566035945|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
156803220|NCT00355030|566035944|FG000|Study Period 1 Treatment|Physician Decision|0|||
156803221|NCT00355030|566035945|FG001|Study Period 1 Treatment|Physician Decision|1|||
156803222|NCT00355030|566035944|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
156803223|NCT00355030|566035945|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
156803224|NCT00355030|566035944|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
156803225|NCT00355030|566035945|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
156803226|NCT00355030|566035944|FG000|Study Period 1 Treatment|Other|2|||
156803227|NCT00355030|566035945|FG001|Study Period 1 Treatment|Other|6|||
156803228|NCT00355030|566035944|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
156803229|NCT00355030|566035945|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
156803230|NCT00355030|566035944|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
156803231|NCT00355030|566035945|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
156803232|NCT01693367|566035946|FG000|Overall Study|Withdrawal by Subject|1|||
156803233|NCT01693367|566035947|FG001|Overall Study|Withdrawal by Subject|1|||
156803234|NCT01693367|566035946|FG000|Overall Study|Physician Decision|0|||
156803235|NCT01693367|566035947|FG001|Overall Study|Physician Decision|1|||
156803236|NCT00325143|566035948|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
156803237|NCT00325143|566035948|FG000|Overall Study|Migrated/moved from study area|1|||
156803238|NCT00325143|566035948|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
156803239|NCT00325143|566035948|FG000|Overall Study|Withdrawal by Subject|8|||
156803240|NCT02154061|566035951|FG000|Overall Study|Pregnancy|1|||
156803241|NCT02154061|566035952|FG001|Overall Study|Pregnancy|0|||
156803242|NCT02154061|566035951|FG000|Overall Study|enrolled but not vaccinated|1|||
156803243|NCT02154061|566035952|FG001|Overall Study|enrolled but not vaccinated|0|||
156803244|NCT00506142|566035953|FG000|Overall Study|Adverse Event|8|||
156803245|NCT00506142|566035954|FG001|Overall Study|Adverse Event|7|||
156803246|NCT00506142|566035953|FG000|Overall Study|Lack of Efficacy|21|||
156803247|NCT00506142|566035954|FG001|Overall Study|Lack of Efficacy|7|||
156803248|NCT00506142|566035953|FG000|Overall Study|Withdrawal by Subject|4|||
156803249|NCT00506142|566035954|FG001|Overall Study|Withdrawal by Subject|5|||
156803250|NCT00506142|566035953|FG000|Overall Study|Physician Decision|1|||
156803251|NCT00506142|566035954|FG001|Overall Study|Physician Decision|0|||
156881664|NCT02059291|566326998|FG024|Epoch 4|Adverse Event|0|||
156803252|NCT00506142|566035953|FG000|Overall Study|New health condition|1|||
156803253|NCT00506142|566035954|FG001|Overall Study|New health condition|0|||
156803254|NCT01936831|566035955|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803255|NCT01936831|566035956|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803256|NCT01936831|566035957|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803257|NCT01936831|566035958|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156881665|NCT02059291|566326974|FG000|Epoch 4|Pregnancy|0|||
156881666|NCT02059291|566326975|FG001|Epoch 4|Pregnancy|0|||
156881667|NCT02059291|566326976|FG002|Epoch 4|Pregnancy|0|||
156881668|NCT02059291|566326977|FG003|Epoch 4|Pregnancy|0|||
156803258|NCT01936831|566035959|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803259|NCT01936831|566035960|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
156803260|NCT01936831|566035961|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803261|NCT01936831|566035962|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803262|NCT01936831|566035963|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
156803263|NCT02133573|566035969|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
156803264|NCT02133573|566035970|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
156803265|NCT02133573|566035969|FG000|Overall Study|Child Deaths|3|||
156803266|NCT02133573|566035970|FG001|Overall Study|Child Deaths|5|||
156803267|NCT02133573|566035969|FG000|Overall Study|Child Declined Follow Ups|2|||
156803268|NCT02133573|566035970|FG001|Overall Study|Child Declined Follow Ups|1|||
156803269|NCT02133573|566035969|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
156803270|NCT02133573|566035970|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
156803271|NCT00454116|566035971|FG000|Overall Study|Adverse Event|5|||
156803272|NCT00454116|566035972|FG001|Overall Study|Adverse Event|11|||
156803273|NCT00454116|566035973|FG002|Overall Study|Adverse Event|9|||
156803274|NCT00454116|566035971|FG000|Overall Study|Condition under investigation worsened|17|||
156803275|NCT00454116|566035972|FG001|Overall Study|Condition under investigation worsened|13|||
156803276|NCT00454116|566035973|FG002|Overall Study|Condition under investigation worsened|18|||
156803277|NCT00454116|566035971|FG000|Overall Study|Withdrawal by Subject|3|||
156803278|NCT00454116|566035972|FG001|Overall Study|Withdrawal by Subject|3|||
156803279|NCT00454116|566035973|FG002|Overall Study|Withdrawal by Subject|1|||
156803280|NCT00454116|566035971|FG000|Overall Study|Other|2|||
156803281|NCT00454116|566035972|FG001|Overall Study|Other|2|||
156803282|NCT00454116|566035973|FG002|Overall Study|Other|0|||
156803283|NCT03500211|566035978|FG000|Overall Study|Withdrawal by Subject|1|||
156803284|NCT03500211|566035979|FG001|Overall Study|Withdrawal by Subject|1|||
156803285|NCT01832727|566035985|FG000|Overall Study|Adverse Event|4|||
156803286|NCT01832727|566035986|FG001|Overall Study|Adverse Event|6|||
156803287|NCT01832727|566035987|FG002|Overall Study|Adverse Event|1|||
156803288|NCT01832727|566035988|FG003|Overall Study|Adverse Event|0|||
156803289|NCT01832727|566035989|FG004|Overall Study|Adverse Event|1|||
156803290|NCT01832727|566035990|FG005|Overall Study|Adverse Event|1|||
156803291|NCT01832727|566035991|FG006|Overall Study|Adverse Event|2|||
156803292|NCT01832727|566035992|FG007|Overall Study|Adverse Event|1|||
156803293|NCT01832727|566035993|FG008|Overall Study|Adverse Event|9|||
156803294|NCT01832727|566035985|FG000|Overall Study|Disease progression|3|||
156803295|NCT01832727|566035986|FG001|Overall Study|Disease progression|0|||
156803296|NCT01832727|566035987|FG002|Overall Study|Disease progression|2|||
156803297|NCT01832727|566035988|FG003|Overall Study|Disease progression|1|||
156803298|NCT01832727|566035989|FG004|Overall Study|Disease progression|3|||
156803299|NCT01832727|566035990|FG005|Overall Study|Disease progression|3|||
156803300|NCT01832727|566035991|FG006|Overall Study|Disease progression|6|||
156803301|NCT01832727|566035992|FG007|Overall Study|Disease progression|2|||
156803302|NCT01832727|566035993|FG008|Overall Study|Disease progression|7|||
156803303|NCT01832727|566035985|FG000|Overall Study|Lost to Follow-up|0|||
156803304|NCT01832727|566035986|FG001|Overall Study|Lost to Follow-up|0|||
156803305|NCT01832727|566035987|FG002|Overall Study|Lost to Follow-up|0|||
156803306|NCT01832727|566035988|FG003|Overall Study|Lost to Follow-up|1|||
156803307|NCT01832727|566035989|FG004|Overall Study|Lost to Follow-up|0|||
156803308|NCT01832727|566035990|FG005|Overall Study|Lost to Follow-up|0|||
156803309|NCT01832727|566035991|FG006|Overall Study|Lost to Follow-up|0|||
156803310|NCT01832727|566035992|FG007|Overall Study|Lost to Follow-up|0|||
156803311|NCT01832727|566035993|FG008|Overall Study|Lost to Follow-up|0|||
156803312|NCT01832727|566035985|FG000|Overall Study|Physician Decision|1|||
156803313|NCT01832727|566035986|FG001|Overall Study|Physician Decision|0|||
156803314|NCT01832727|566035987|FG002|Overall Study|Physician Decision|0|||
156803315|NCT01832727|566035988|FG003|Overall Study|Physician Decision|1|||
156803316|NCT01832727|566035989|FG004|Overall Study|Physician Decision|0|||
156803317|NCT01832727|566035990|FG005|Overall Study|Physician Decision|1|||
156803318|NCT01832727|566035991|FG006|Overall Study|Physician Decision|0|||
156803319|NCT01832727|566035992|FG007|Overall Study|Physician Decision|0|||
156803320|NCT01832727|566035993|FG008|Overall Study|Physician Decision|0|||
156803321|NCT01832727|566035985|FG000|Overall Study|Withdrawal by Subject|1|||
156803322|NCT01832727|566035986|FG001|Overall Study|Withdrawal by Subject|1|||
156803323|NCT01832727|566035987|FG002|Overall Study|Withdrawal by Subject|0|||
157143889|NCT02158533|567276364|FG000|Stage 1|Lost to Follow-up|3|||
157143890|NCT02158533|567276365|FG001|Stage 1|Lost to Follow-up|1|||
157143891|NCT02158533|567276366|FG002|Stage 1|Lost to Follow-up|0|||
157143892|NCT02158533|567276367|FG003|Stage 1|Lost to Follow-up|0|||
157143893|NCT02158533|567276368|FG004|Stage 1|Lost to Follow-up|0|||
157143894|NCT02158533|567276369|FG005|Stage 1|Lost to Follow-up|0|||
157143895|NCT02158533|567276364|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
157143896|NCT02158533|567276365|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
157143897|NCT02158533|567276366|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
157143898|NCT02158533|567276367|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
157143899|NCT02158533|567276368|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
157021109|NCT03138512|566830851|FG000|Treatment Part A|Participant withdrew consent|2|||
157021110|NCT03138512|566830852|FG001|Treatment Part A|Participant withdrew consent|4|||
157021111|NCT03138512|566830853|FG002|Treatment Part A|Participant withdrew consent|0|||
157021112|NCT03138512|566830854|FG003|Treatment Part A|Participant withdrew consent|0|||
157021113|NCT03138512|566830855|FG004|Treatment Part A|Participant withdrew consent|0|||
157021114|NCT03138512|566830851|FG000|Treatment Part A|Lost to Follow-up|0|||
157021115|NCT03138512|566830852|FG001|Treatment Part A|Lost to Follow-up|1|||
157021116|NCT03138512|566830853|FG002|Treatment Part A|Lost to Follow-up|0|||
157021117|NCT03138512|566830854|FG003|Treatment Part A|Lost to Follow-up|0|||
157021118|NCT03138512|566830855|FG004|Treatment Part A|Lost to Follow-up|0|||
157021119|NCT03138512|566830851|FG000|Treatment Part A|Poor/non-compliance|1|||
157021120|NCT03138512|566830852|FG001|Treatment Part A|Poor/non-compliance|0|||
157021121|NCT03138512|566830853|FG002|Treatment Part A|Poor/non-compliance|0|||
157021122|NCT03138512|566830854|FG003|Treatment Part A|Poor/non-compliance|0|||
157021123|NCT03138512|566830855|FG004|Treatment Part A|Poor/non-compliance|0|||
157021124|NCT03138512|566830851|FG000|Treatment Part A|Pregnancy|0|||
157021125|NCT03138512|566830852|FG001|Treatment Part A|Pregnancy|1|||
157021126|NCT03138512|566830853|FG002|Treatment Part A|Pregnancy|0|||
157021127|NCT03138512|566830854|FG003|Treatment Part A|Pregnancy|0|||
157021128|NCT03138512|566830855|FG004|Treatment Part A|Pregnancy|0|||
157021129|NCT03138512|566830851|FG000|Treatment Part A|Other reasons|11|||
157021130|NCT03138512|566830852|FG001|Treatment Part A|Other reasons|8|||
157021131|NCT03138512|566830853|FG002|Treatment Part A|Other reasons|0|||
157021132|NCT03138512|566830854|FG003|Treatment Part A|Other reasons|0|||
157021133|NCT03138512|566830855|FG004|Treatment Part A|Other reasons|0|||
157021134|NCT03138512|566830851|FG000|Treatment Part B|Disease recurrence|0|||
157021135|NCT03138512|566830852|FG001|Treatment Part B|Disease recurrence|0|||
156803324|NCT01832727|566035988|FG003|Overall Study|Withdrawal by Subject|1|||
156803325|NCT01832727|566035989|FG004|Overall Study|Withdrawal by Subject|0|||
156803326|NCT01832727|566035990|FG005|Overall Study|Withdrawal by Subject|1|||
156803327|NCT01832727|566035991|FG006|Overall Study|Withdrawal by Subject|0|||
156803328|NCT01832727|566035992|FG007|Overall Study|Withdrawal by Subject|2|||
156803329|NCT01832727|566035993|FG008|Overall Study|Withdrawal by Subject|1|||
156803330|NCT01832727|566035985|FG000|Overall Study|Study terminated by sponsor|0|||
156803331|NCT01832727|566035986|FG001|Overall Study|Study terminated by sponsor|0|||
156803332|NCT01832727|566035987|FG002|Overall Study|Study terminated by sponsor|0|||
156803333|NCT01832727|566035988|FG003|Overall Study|Study terminated by sponsor|0|||
156803334|NCT01832727|566035989|FG004|Overall Study|Study terminated by sponsor|0|||
156803335|NCT01832727|566035990|FG005|Overall Study|Study terminated by sponsor|0|||
156803336|NCT01832727|566035991|FG006|Overall Study|Study terminated by sponsor|0|||
156803337|NCT01832727|566035992|FG007|Overall Study|Study terminated by sponsor|1|||
156803338|NCT01832727|566035993|FG008|Overall Study|Study terminated by sponsor|1|||
156803339|NCT02553629|566035994|FG000|Overall Study|Logistic reasons|3|||
156803340|NCT02553629|566035995|FG001|Overall Study|Logistic reasons|6|||
156803341|NCT03434834|566035996|FG000|Overall Study|unable to swallow OCT probe|16|||
156803342|NCT01823289|566035997|FG000|Overall Study|Lost to Follow-up|5|||
156803343|NCT01823289|566035997|FG000|Overall Study|Adverse Event|5|||
156803344|NCT01823289|566035997|FG000|Overall Study|Lack of Efficacy|1|||
156803345|NCT01823289|566035997|FG000|Overall Study|Physician Decision|9|||
156803346|NCT01823289|566035997|FG000|Overall Study|Administered contraindicated medicine|1|||
156803347|NCT01823289|566035997|FG000|Overall Study|Transaminase increased more than 3 times|1|||
156803348|NCT01823289|566035997|FG000|Overall Study|Drug affected efficacy and safety|1|||
156803349|NCT01823289|566035997|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
156803350|NCT01812057|566036005|FG000|Overall Study|Protocol Violation|1|||
156803351|NCT01812057|566036006|FG001|Overall Study|Protocol Violation|0|||
156803352|NCT01812057|566036005|FG000|Overall Study|Physician Decision|1|||
156803353|NCT01812057|566036006|FG001|Overall Study|Physician Decision|0|||
156803354|NCT01911260|566036008|FG000|Supplementation Period|transference or evasion of school|7|||
156803355|NCT01911260|566036009|FG001|Supplementation Period|transference or evasion of school|9|||
156803356|NCT01911260|566036010|FG002|Supplementation Period|transference or evasion of school|7|||
156803357|NCT01911260|566036011|FG003|Supplementation Period|transference or evasion of school|6|||
156803358|NCT01911260|566036008|FG000|Supplementation Period|Adverse Event|2|||
156803359|NCT01911260|566036009|FG001|Supplementation Period|Adverse Event|0|||
156803360|NCT01911260|566036010|FG002|Supplementation Period|Adverse Event|1|||
156803361|NCT01911260|566036011|FG003|Supplementation Period|Adverse Event|0|||
156803362|NCT01911260|566036008|FG000|Supplementation Period|refused to receive supplement|1|||
156803363|NCT01911260|566036009|FG001|Supplementation Period|refused to receive supplement|0|||
156803364|NCT01911260|566036010|FG002|Supplementation Period|refused to receive supplement|1|||
157021136|NCT03138512|566830853|FG002|Treatment Part B|Disease recurrence|6|||
156803365|NCT01911260|566036011|FG003|Supplementation Period|refused to receive supplement|0|||
156803366|NCT01911260|566036008|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
156803367|NCT01911260|566036009|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
156803368|NCT01911260|566036010|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
157021137|NCT03138512|566830854|FG003|Treatment Part B|Disease recurrence|12|||
156881669|NCT02059291|566326978|FG004|Epoch 4|Pregnancy|0|||
156881670|NCT02059291|566326979|FG005|Epoch 4|Pregnancy|0|||
156881671|NCT02059291|566326980|FG006|Epoch 4|Pregnancy|0|||
156881672|NCT02059291|566326981|FG007|Epoch 4|Pregnancy|0|||
156881673|NCT02059291|566326982|FG008|Epoch 4|Pregnancy|0|||
156881674|NCT02059291|566326983|FG009|Epoch 4|Pregnancy|0|||
156881675|NCT02059291|566326984|FG010|Epoch 4|Pregnancy|0|||
156881676|NCT02059291|566326985|FG011|Epoch 4|Pregnancy|0|||
156881677|NCT02059291|566326986|FG012|Epoch 4|Pregnancy|0|||
156881678|NCT02059291|566326987|FG013|Epoch 4|Pregnancy|0|||
156881679|NCT02059291|566326988|FG014|Epoch 4|Pregnancy|0|||
156881680|NCT02059291|566326989|FG015|Epoch 4|Pregnancy|0|||
156881681|NCT02059291|566326990|FG016|Epoch 4|Pregnancy|1|||
156881682|NCT02059291|566326991|FG017|Epoch 4|Pregnancy|0|||
156881683|NCT02059291|566326992|FG018|Epoch 4|Pregnancy|0|||
156881684|NCT02059291|566326993|FG019|Epoch 4|Pregnancy|0|||
156881685|NCT02059291|566326994|FG020|Epoch 4|Pregnancy|0|||
156881686|NCT02059291|566326995|FG021|Epoch 4|Pregnancy|0|||
156881687|NCT02059291|566326996|FG022|Epoch 4|Pregnancy|0|||
156881688|NCT02059291|566326997|FG023|Epoch 4|Pregnancy|0|||
156881689|NCT02059291|566326998|FG024|Epoch 4|Pregnancy|0|||
156881690|NCT02059291|566326974|FG000|Epoch 4|Withdrawal by Subject|0|||
156881691|NCT02059291|566326975|FG001|Epoch 4|Withdrawal by Subject|0|||
156881692|NCT02059291|566326976|FG002|Epoch 4|Withdrawal by Subject|0|||
156881693|NCT02059291|566326977|FG003|Epoch 4|Withdrawal by Subject|0|||
156881694|NCT02059291|566326978|FG004|Epoch 4|Withdrawal by Subject|0|||
156803369|NCT01911260|566036011|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
156803370|NCT01911260|566036008|FG000|Follow-up Period|transference or evasion of school|13|||
156803371|NCT01911260|566036009|FG001|Follow-up Period|transference or evasion of school|20|||
156803372|NCT01911260|566036010|FG002|Follow-up Period|transference or evasion of school|15|||
156803373|NCT01911260|566036011|FG003|Follow-up Period|transference or evasion of school|12|||
156803374|NCT00654732|566036012|FG000|Overall Study|Adverse Event|4|||
156803375|NCT00654732|566036013|FG001|Overall Study|Adverse Event|6|||
156803376|NCT04436744|566036020|FG000|Overall Study|Adverse Event|1|||
156803377|NCT04436744|566036021|FG001|Overall Study|Adverse Event|1|||
156803378|NCT04436744|566036020|FG000|Overall Study|Death|1|||
156803379|NCT04436744|566036021|FG001|Overall Study|Death|0|||
156803380|NCT04436744|566036020|FG000|Overall Study|Lost to Follow-up|0|||
156803381|NCT04436744|566036021|FG001|Overall Study|Lost to Follow-up|2|||
156803382|NCT04436744|566036020|FG000|Overall Study|Physician Decision|0|||
156803383|NCT04436744|566036021|FG001|Overall Study|Physician Decision|1|||
156803384|NCT04436744|566036020|FG000|Overall Study|Progressive Disease|0|||
156803385|NCT04436744|566036021|FG001|Overall Study|Progressive Disease|4|||
156803386|NCT04436744|566036020|FG000|Overall Study|Protocol Deviation|1|||
156803387|NCT04436744|566036021|FG001|Overall Study|Protocol Deviation|1|||
156803388|NCT04436744|566036020|FG000|Overall Study|Withdrawal by Subject|1|||
156803389|NCT04436744|566036021|FG001|Overall Study|Withdrawal by Subject|2|||
156803390|NCT01133847|566036022|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
156803391|NCT01133847|566036023|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
156803392|NCT01133847|566036024|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
156803393|NCT01133847|566036022|FG000|Follow-Up Phase|Lost to Follow-up|1|||
156803394|NCT01133847|566036023|FG001|Follow-Up Phase|Lost to Follow-up|3|||
156803395|NCT01133847|566036024|FG002|Follow-Up Phase|Lost to Follow-up|7|||
156803396|NCT01880957|566036025|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
156803397|NCT01880957|566036026|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
156803398|NCT01880957|566036025|FG000|Overall Study|Lost to Follow-up|11|||
156803399|NCT01880957|566036026|FG001|Overall Study|Lost to Follow-up|0|||
156803400|NCT01880957|566036025|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
156803401|NCT01880957|566036026|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
156803402|NCT01378117|566036027|FG000|Overall Study|withdrawal|2|||
156803403|NCT01378117|566036028|FG001|Overall Study|withdrawal|1|||
156803404|NCT01378117|566036029|FG002|Overall Study|withdrawal|2|||
156803405|NCT01378117|566036027|FG000|Overall Study|discharged before med given|2|||
156803406|NCT01378117|566036028|FG001|Overall Study|discharged before med given|0|||
156803407|NCT01378117|566036029|FG002|Overall Study|discharged before med given|1|||
156803408|NCT01463033|566036030|FG000|Overall Study|Lost to Follow-up|4|||
156803409|NCT01463033|566036031|FG001|Overall Study|Lost to Follow-up|4|||
156803410|NCT01463033|566036030|FG000|Overall Study|Death|3|||
156881695|NCT02059291|566326979|FG005|Epoch 4|Withdrawal by Subject|0|||
156881696|NCT02059291|566326980|FG006|Epoch 4|Withdrawal by Subject|0|||
156881697|NCT02059291|566326981|FG007|Epoch 4|Withdrawal by Subject|0|||
156803411|NCT01463033|566036031|FG001|Overall Study|Death|2|||
156803412|NCT00421148|566036034|FG000|Overall Study|Lost to Follow-up|0|||
156881698|NCT02059291|566326982|FG008|Epoch 4|Withdrawal by Subject|0|||
156881699|NCT02059291|566326983|FG009|Epoch 4|Withdrawal by Subject|0|||
156881700|NCT02059291|566326984|FG010|Epoch 4|Withdrawal by Subject|0|||
156881701|NCT02059291|566326985|FG011|Epoch 4|Withdrawal by Subject|0|||
156881702|NCT02059291|566326986|FG012|Epoch 4|Withdrawal by Subject|0|||
156881703|NCT02059291|566326987|FG013|Epoch 4|Withdrawal by Subject|0|||
156881704|NCT02059291|566326988|FG014|Epoch 4|Withdrawal by Subject|0|||
156881705|NCT02059291|566326989|FG015|Epoch 4|Withdrawal by Subject|0|||
156803413|NCT00421148|566036035|FG001|Overall Study|Lost to Follow-up|0|||
156803414|NCT00421148|566036036|FG002|Overall Study|Lost to Follow-up|0|||
156803415|NCT00421148|566036037|FG003|Overall Study|Lost to Follow-up|0|||
156803416|NCT00421148|566036038|FG004|Overall Study|Lost to Follow-up|0|||
156803417|NCT00421148|566036039|FG005|Overall Study|Lost to Follow-up|0|||
156803418|NCT00421148|566036040|FG006|Overall Study|Lost to Follow-up|0|||
156803419|NCT00421148|566036041|FG007|Overall Study|Lost to Follow-up|0|||
156803420|NCT00421148|566036042|FG008|Overall Study|Lost to Follow-up|0|||
156803421|NCT00421148|566036043|FG009|Overall Study|Lost to Follow-up|0|||
156803422|NCT00421148|566036044|FG010|Overall Study|Lost to Follow-up|0|||
156803423|NCT00421148|566036045|FG011|Overall Study|Lost to Follow-up|0|||
156803424|NCT00421148|566036046|FG012|Overall Study|Lost to Follow-up|0|||
156803425|NCT00421148|566036047|FG013|Overall Study|Lost to Follow-up|0|||
156803426|NCT00421148|566036048|FG014|Overall Study|Lost to Follow-up|0|||
156803427|NCT00421148|566036049|FG015|Overall Study|Lost to Follow-up|0|||
156803428|NCT00421148|566036050|FG016|Overall Study|Lost to Follow-up|0|||
156803429|NCT00421148|566036051|FG017|Overall Study|Lost to Follow-up|1|||
156803430|NCT00421148|566036052|FG018|Overall Study|Lost to Follow-up|0|||
156803431|NCT00421148|566036053|FG019|Overall Study|Lost to Follow-up|0|||
156803432|NCT00421148|566036034|FG000|Overall Study|Withdrawal by Subject|0|||
156803433|NCT00421148|566036035|FG001|Overall Study|Withdrawal by Subject|0|||
156803434|NCT00421148|566036036|FG002|Overall Study|Withdrawal by Subject|0|||
156803435|NCT00421148|566036037|FG003|Overall Study|Withdrawal by Subject|0|||
156803436|NCT00421148|566036038|FG004|Overall Study|Withdrawal by Subject|0|||
156803437|NCT00421148|566036039|FG005|Overall Study|Withdrawal by Subject|0|||
156803438|NCT00421148|566036040|FG006|Overall Study|Withdrawal by Subject|0|||
156803439|NCT00421148|566036041|FG007|Overall Study|Withdrawal by Subject|0|||
156803440|NCT00421148|566036042|FG008|Overall Study|Withdrawal by Subject|0|||
156803441|NCT00421148|566036043|FG009|Overall Study|Withdrawal by Subject|0|||
156803442|NCT00421148|566036044|FG010|Overall Study|Withdrawal by Subject|0|||
156803443|NCT00421148|566036045|FG011|Overall Study|Withdrawal by Subject|0|||
156803444|NCT00421148|566036046|FG012|Overall Study|Withdrawal by Subject|0|||
156803445|NCT00421148|566036047|FG013|Overall Study|Withdrawal by Subject|0|||
156803446|NCT00421148|566036048|FG014|Overall Study|Withdrawal by Subject|0|||
156803447|NCT00421148|566036049|FG015|Overall Study|Withdrawal by Subject|0|||
156803448|NCT00421148|566036050|FG016|Overall Study|Withdrawal by Subject|0|||
156803449|NCT00421148|566036051|FG017|Overall Study|Withdrawal by Subject|1|||
156803450|NCT00421148|566036052|FG018|Overall Study|Withdrawal by Subject|0|||
156803451|NCT00421148|566036053|FG019|Overall Study|Withdrawal by Subject|0|||
156803452|NCT00421148|566036034|FG000|Overall Study|Protocol Violation|0|||
156803453|NCT00421148|566036035|FG001|Overall Study|Protocol Violation|0|||
156803454|NCT00421148|566036036|FG002|Overall Study|Protocol Violation|0|||
156803455|NCT00421148|566036037|FG003|Overall Study|Protocol Violation|0|||
156803456|NCT00421148|566036038|FG004|Overall Study|Protocol Violation|0|||
156803457|NCT00421148|566036039|FG005|Overall Study|Protocol Violation|1|||
156803458|NCT00421148|566036040|FG006|Overall Study|Protocol Violation|0|||
156803459|NCT00421148|566036041|FG007|Overall Study|Protocol Violation|0|||
156803460|NCT00421148|566036042|FG008|Overall Study|Protocol Violation|0|||
156803461|NCT00421148|566036043|FG009|Overall Study|Protocol Violation|0|||
156803462|NCT00421148|566036044|FG010|Overall Study|Protocol Violation|0|||
156803463|NCT00421148|566036045|FG011|Overall Study|Protocol Violation|0|||
156803464|NCT00421148|566036046|FG012|Overall Study|Protocol Violation|0|||
156803465|NCT00421148|566036047|FG013|Overall Study|Protocol Violation|0|||
156803466|NCT00421148|566036048|FG014|Overall Study|Protocol Violation|0|||
156803467|NCT00421148|566036049|FG015|Overall Study|Protocol Violation|0|||
156803468|NCT00421148|566036050|FG016|Overall Study|Protocol Violation|0|||
156803469|NCT00421148|566036051|FG017|Overall Study|Protocol Violation|0|||
156803470|NCT00421148|566036052|FG018|Overall Study|Protocol Violation|1|||
156803471|NCT00421148|566036053|FG019|Overall Study|Protocol Violation|0|||
156803472|NCT04881760|566036054|FG000|Overall Study|Adverse Event|0|||
156803473|NCT04881760|566036055|FG001|Overall Study|Adverse Event|1|||
156803474|NCT04881760|566036056|FG002|Overall Study|Adverse Event|1|||
156803475|NCT04881760|566036057|FG003|Overall Study|Adverse Event|0|||
156803476|NCT04881760|566036058|FG004|Overall Study|Adverse Event|1|||
156803477|NCT04881760|566036059|FG005|Overall Study|Adverse Event|1|||
156803478|NCT04881760|566036060|FG006|Overall Study|Adverse Event|2|||
156803479|NCT04881760|566036054|FG000|Overall Study|Death|0|||
156803480|NCT04881760|566036055|FG001|Overall Study|Death|0|||
156803481|NCT04881760|566036056|FG002|Overall Study|Death|0|||
156803482|NCT04881760|566036057|FG003|Overall Study|Death|1|||
156803483|NCT04881760|566036058|FG004|Overall Study|Death|0|||
156803484|NCT04881760|566036059|FG005|Overall Study|Death|0|||
156803485|NCT04881760|566036060|FG006|Overall Study|Death|0|||
156803486|NCT04881760|566036054|FG000|Overall Study|Lost to Follow-up|5|||
156803487|NCT04881760|566036055|FG001|Overall Study|Lost to Follow-up|7|||
156803488|NCT04881760|566036056|FG002|Overall Study|Lost to Follow-up|5|||
156803489|NCT04881760|566036057|FG003|Overall Study|Lost to Follow-up|1|||
156803490|NCT04881760|566036058|FG004|Overall Study|Lost to Follow-up|2|||
156803491|NCT04881760|566036059|FG005|Overall Study|Lost to Follow-up|4|||
156803492|NCT04881760|566036060|FG006|Overall Study|Lost to Follow-up|4|||
156803493|NCT04881760|566036054|FG000|Overall Study|Withdrawal by Subject|13|||
156803494|NCT04881760|566036055|FG001|Overall Study|Withdrawal by Subject|1|||
156803495|NCT04881760|566036056|FG002|Overall Study|Withdrawal by Subject|1|||
156803496|NCT04881760|566036057|FG003|Overall Study|Withdrawal by Subject|4|||
156803497|NCT04881760|566036058|FG004|Overall Study|Withdrawal by Subject|2|||
156803498|NCT04881760|566036059|FG005|Overall Study|Withdrawal by Subject|1|||
156803499|NCT04881760|566036060|FG006|Overall Study|Withdrawal by Subject|2|||
156803500|NCT04881760|566036054|FG000|Overall Study|Randomized but Never Treated|0|||
156803501|NCT04881760|566036055|FG001|Overall Study|Randomized but Never Treated|0|||
156803502|NCT04881760|566036056|FG002|Overall Study|Randomized but Never Treated|0|||
156803503|NCT04881760|566036057|FG003|Overall Study|Randomized but Never Treated|1|||
156803504|NCT04881760|566036058|FG004|Overall Study|Randomized but Never Treated|0|||
156803505|NCT04881760|566036059|FG005|Overall Study|Randomized but Never Treated|0|||
156803506|NCT04881760|566036060|FG006|Overall Study|Randomized but Never Treated|0|||
156803507|NCT04881760|566036054|FG000|Overall Study|Inadvertent Enrollment|2|||
156803508|NCT04881760|566036055|FG001|Overall Study|Inadvertent Enrollment|0|||
156803509|NCT04881760|566036056|FG002|Overall Study|Inadvertent Enrollment|0|||
156803510|NCT04881760|566036057|FG003|Overall Study|Inadvertent Enrollment|0|||
156803511|NCT04881760|566036058|FG004|Overall Study|Inadvertent Enrollment|0|||
156803512|NCT04881760|566036059|FG005|Overall Study|Inadvertent Enrollment|0|||
156803513|NCT04881760|566036060|FG006|Overall Study|Inadvertent Enrollment|0|||
156803514|NCT04881760|566036054|FG000|Overall Study|Site Closure|0|||
156803515|NCT04881760|566036055|FG001|Overall Study|Site Closure|0|||
156803516|NCT04881760|566036056|FG002|Overall Study|Site Closure|0|||
156803517|NCT04881760|566036057|FG003|Overall Study|Site Closure|1|||
156803518|NCT04881760|566036058|FG004|Overall Study|Site Closure|0|||
156803519|NCT04881760|566036059|FG005|Overall Study|Site Closure|0|||
156803520|NCT04881760|566036060|FG006|Overall Study|Site Closure|0|||
156803521|NCT04540367|566036069|FG000|Overall Study|Withdrawal by Subject|0|||
156803522|NCT04540367|566036070|FG001|Overall Study|Withdrawal by Subject|0|||
156803523|NCT04540367|566036071|FG002|Overall Study|Withdrawal by Subject|0|||
157021138|NCT03138512|566830855|FG004|Treatment Part B|Disease recurrence|10|||
157021139|NCT03138512|566830851|FG000|Treatment Part B|Study drug toxicity|0|||
157021140|NCT03138512|566830852|FG001|Treatment Part B|Study drug toxicity|0|||
156803524|NCT04540367|566036072|FG003|Overall Study|Withdrawal by Subject|2|||
156803525|NCT04540367|566036069|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
156803526|NCT04540367|566036070|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
156803527|NCT04540367|566036071|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
156803528|NCT04540367|566036072|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
156803529|NCT04540367|566036069|FG000|Overall Study|Adverse Event|0|||
156803530|NCT04540367|566036070|FG001|Overall Study|Adverse Event|0|||
156803531|NCT04540367|566036071|FG002|Overall Study|Adverse Event|1|||
156803532|NCT04540367|566036072|FG003|Overall Study|Adverse Event|1|||
156803533|NCT00165789|566036076|FG000|Overall Study|Adverse Event|0|||
156803534|NCT00165789|566036077|FG001|Overall Study|Adverse Event|3|||
156803535|NCT00165789|566036078|FG002|Overall Study|Adverse Event|0|||
156803536|NCT00165789|566036079|FG003|Overall Study|Adverse Event|12|||
156803537|NCT00165789|566036076|FG000|Overall Study|Withdrawal by Subject|0|||
156803538|NCT00165789|566036077|FG001|Overall Study|Withdrawal by Subject|1|||
156803539|NCT00165789|566036078|FG002|Overall Study|Withdrawal by Subject|1|||
156803540|NCT00165789|566036079|FG003|Overall Study|Withdrawal by Subject|2|||
156803541|NCT02031302|566036080|FG000|Overall Study|Death|115|||
156803542|NCT02031302|566036081|FG001|Overall Study|Death|0|||
156803543|NCT02031302|566036080|FG000|Overall Study|Not treated with study valve system|18|||
156803544|NCT02031302|566036081|FG001|Overall Study|Not treated with study valve system|0|||
156803545|NCT02031302|566036080|FG000|Overall Study|Missed Follow Up|27|||
156803546|NCT02031302|566036081|FG001|Overall Study|Missed Follow Up|0|||
156803547|NCT02031302|566036080|FG000|Overall Study|Lost to Follow-up|4|||
156803548|NCT02031302|566036081|FG001|Overall Study|Lost to Follow-up|0|||
156803549|NCT01816984|566036082|FG000|Overall Study|declining health status|1|||
157021141|NCT03138512|566830853|FG002|Treatment Part B|Study drug toxicity|63|||
156803550|NCT05899829|566036083|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
156803551|NCT05899829|566036084|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
156803552|NCT05899829|566036083|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
156803553|NCT05899829|566036084|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
156803554|NCT02121509|566036089|FG000|Washout Period (35 Days)|Adverse Event|1|||
156803555|NCT02121509|566036090|FG001|Washout Period (35 Days)|Adverse Event|1|||
157021142|NCT03138512|566830854|FG003|Treatment Part B|Study drug toxicity|3|||
156803556|NCT02121509|566036091|FG002|Washout Period (35 Days)|Adverse Event|0|||
156803557|NCT02121509|566036092|FG003|Washout Period (35 Days)|Adverse Event|0|||
157021143|NCT03138512|566830855|FG004|Treatment Part B|Study drug toxicity|45|||
157021144|NCT03138512|566830851|FG000|Treatment Part B|Death|0|||
157021145|NCT03138512|566830852|FG001|Treatment Part B|Death|0|||
156803558|NCT02121509|566036089|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803559|NCT02121509|566036090|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
156803560|NCT02121509|566036091|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803561|NCT02121509|566036092|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
156803562|NCT02121509|566036089|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
156803563|NCT02121509|566036090|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803564|NCT02121509|566036091|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803565|NCT02121509|566036092|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
156803566|NCT00867035|566036095|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
156803567|NCT00867035|566036096|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
156803568|NCT00867035|566036095|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
156803569|NCT00867035|566036096|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
156803570|NCT05076045|566036097|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
156803571|NCT05076045|566036098|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
156803572|NCT04704193|566036105|FG000|Overall Study|Withdrawal by Subject|1|||
156803573|NCT00542178|566036106|FG000|Overall Study|did not complete year 4 follow-up|75|||
156803574|NCT00542178|566036107|FG001|Overall Study|did not complete year 4 follow-up|80|||
156803575|NCT00542178|566036108|FG002|Overall Study|did not complete year 4 follow-up|74|||
156803576|NCT00542178|566036109|FG003|Overall Study|did not complete year 4 follow-up|62|||
156803577|NCT00542178|566036110|FG004|Overall Study|did not complete year 4 follow-up|64|||
156803578|NCT00542178|566036111|FG005|Overall Study|did not complete year 4 follow-up|89|||
156803579|NCT00542178|566036112|FG006|Overall Study|did not complete year 4 follow-up|87|||
156803580|NCT00542178|566036113|FG007|Overall Study|did not complete year 4 follow-up|85|||
156803581|NCT05270863|566036114|FG000|Visit 2 First Intervention|Randomization error|0|||
156803582|NCT05270863|566036115|FG001|Visit 2 First Intervention|Randomization error|0|||
156803583|NCT05270863|566036116|FG002|Visit 2 First Intervention|Randomization error|0|||
156803584|NCT05270863|566036117|FG003|Visit 2 First Intervention|Randomization error|1|||
156803585|NCT05270863|566036118|FG004|Visit 2 First Intervention|Randomization error|0|||
156803586|NCT05270863|566036119|FG005|Visit 2 First Intervention|Randomization error|0|||
156803587|NCT05270863|566036114|FG000|First Washout|Withdrawal by Subject|0|||
156803588|NCT05270863|566036115|FG001|First Washout|Withdrawal by Subject|0|||
156803589|NCT05270863|566036116|FG002|First Washout|Withdrawal by Subject|0|||
156803590|NCT05270863|566036117|FG003|First Washout|Withdrawal by Subject|0|||
156803591|NCT05270863|566036118|FG004|First Washout|Withdrawal by Subject|1|||
156803592|NCT05270863|566036119|FG005|First Washout|Withdrawal by Subject|1|||
156803593|NCT05270863|566036114|FG000|First Washout|Lost to Follow-up|0|||
156803594|NCT05270863|566036115|FG001|First Washout|Lost to Follow-up|0|||
156803595|NCT05270863|566036116|FG002|First Washout|Lost to Follow-up|0|||
156803596|NCT05270863|566036117|FG003|First Washout|Lost to Follow-up|0|||
156803597|NCT05270863|566036118|FG004|First Washout|Lost to Follow-up|0|||
156803598|NCT05270863|566036119|FG005|First Washout|Lost to Follow-up|1|||
156803599|NCT05270863|566036114|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
156803600|NCT05270863|566036115|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803601|NCT05270863|566036116|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
156803602|NCT05270863|566036117|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803603|NCT05270863|566036118|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803604|NCT05270863|566036119|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
156803605|NCT05270863|566036114|FG000|Second Washout|Withdrawal by Subject|1|||
156803606|NCT05270863|566036115|FG001|Second Washout|Withdrawal by Subject|1|||
156803607|NCT05270863|566036116|FG002|Second Washout|Withdrawal by Subject|0|||
156803608|NCT05270863|566036117|FG003|Second Washout|Withdrawal by Subject|0|||
156803609|NCT05270863|566036118|FG004|Second Washout|Withdrawal by Subject|0|||
156803610|NCT05270863|566036119|FG005|Second Washout|Withdrawal by Subject|0|||
156803611|NCT05270863|566036114|FG000|Second Washout|Lost to Follow-up|0|||
156803612|NCT05270863|566036115|FG001|Second Washout|Lost to Follow-up|0|||
156803613|NCT05270863|566036116|FG002|Second Washout|Lost to Follow-up|0|||
156803614|NCT05270863|566036117|FG003|Second Washout|Lost to Follow-up|1|||
156803615|NCT05270863|566036118|FG004|Second Washout|Lost to Follow-up|0|||
156803616|NCT05270863|566036119|FG005|Second Washout|Lost to Follow-up|0|||
156803617|NCT03384875|566036120|FG000|Overall Study|Death|1|||
156803618|NCT03384875|566036121|FG001|Overall Study|Death|1|||
156803619|NCT03384875|566036122|FG002|Overall Study|Death|0|||
156803620|NCT03384875|566036120|FG000|Overall Study|Reason not provided|1|||
156803621|NCT03384875|566036121|FG001|Overall Study|Reason not provided|0|||
156803622|NCT03384875|566036122|FG002|Overall Study|Reason not provided|0|||
156803623|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
156803624|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
156803625|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
156803626|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
156803627|NCT02026011|566037516|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
156803628|NCT02026011|566037517|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
156803629|NCT02026011|566037516|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
156803630|NCT02026011|566037517|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
156803631|NCT05010070|566037518|FG000|Overall Study|Lost to Follow-up|1|||
156803632|NCT05010070|566037518|FG000|Overall Study|Withdrawal by Subject|1|||
156803633|NCT00529243|566037520|FG000|Overall Study|Adverse Event|1|||
156803634|NCT00529243|566037520|FG000|Overall Study|Death|1|||
156803635|NCT00529243|566037520|FG000|Overall Study|Relocated|1|||
156803636|NCT01783444|566037521|FG000|Treatment Phase|Adverse Event|9|||
156803637|NCT01783444|566037522|FG001|Treatment Phase|Adverse Event|20|||
156803638|NCT01783444|566037523|FG002|Treatment Phase|Adverse Event|19|||
156803639|NCT01783444|566037521|FG000|Treatment Phase|Disease Progression|76|||
156803640|NCT01783444|566037522|FG001|Treatment Phase|Disease Progression|66|||
156803641|NCT01783444|566037523|FG002|Treatment Phase|Disease Progression|64|||
156803642|NCT01783444|566037521|FG000|Treatment Phase|Death|2|||
156803643|NCT01783444|566037522|FG001|Treatment Phase|Death|2|||
156803644|NCT01783444|566037523|FG002|Treatment Phase|Death|2|||
156803645|NCT01783444|566037521|FG000|Treatment Phase|Protocol Violation|1|||
156803646|NCT01783444|566037522|FG001|Treatment Phase|Protocol Violation|1|||
156803647|NCT01783444|566037523|FG002|Treatment Phase|Protocol Violation|2|||
156803648|NCT01783444|566037521|FG000|Treatment Phase|Withdrawal by Subject|6|||
156803649|NCT01783444|566037522|FG001|Treatment Phase|Withdrawal by Subject|8|||
156803650|NCT01783444|566037523|FG002|Treatment Phase|Withdrawal by Subject|9|||
156803651|NCT01783444|566037521|FG000|Treatment Phase|Administrative problems|2|||
156803652|NCT01783444|566037522|FG001|Treatment Phase|Administrative problems|0|||
156803653|NCT01783444|566037523|FG002|Treatment Phase|Administrative problems|1|||
156803654|NCT01783444|566037521|FG000|Treatment Phase|Physician Decision|8|||
156803655|NCT01783444|566037522|FG001|Treatment Phase|Physician Decision|6|||
156803656|NCT01783444|566037523|FG002|Treatment Phase|Physician Decision|5|||
156803657|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
156803658|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
156803659|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
156803660|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
156803661|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
156803662|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
156803663|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
156803664|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
156803665|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
156803666|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
156803667|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
156803668|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
156803669|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
156803670|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
156803671|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
156803672|NCT01783444|566037521|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
156803673|NCT01783444|566037522|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
156803674|NCT01783444|566037523|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
156803675|NCT02921789|566037524|FG000|Overall Study|Adverse Event|0|||
156803676|NCT02921789|566037525|FG001|Overall Study|Adverse Event|1|||
156803677|NCT02921789|566037524|FG000|Overall Study|Lost to Follow-up|1|||
156803678|NCT02921789|566037525|FG001|Overall Study|Lost to Follow-up|0|||
156803679|NCT02921789|566037524|FG000|Overall Study|Protocol Deviation|2|||
156803680|NCT02921789|566037525|FG001|Overall Study|Protocol Deviation|0|||
156803681|NCT02921789|566037524|FG000|Overall Study|Withdrawal by Subject|2|||
156803682|NCT02921789|566037525|FG001|Overall Study|Withdrawal by Subject|1|||
156803683|NCT02921789|566037524|FG000|Overall Study|Miscellaneous|3|||
156803684|NCT02921789|566037525|FG001|Overall Study|Miscellaneous|2|||
156803685|NCT03759600|566037526|FG000|Overall Study|Adverse Event|2|||
156803686|NCT03759600|566037526|FG000|Overall Study|Progressive Disease|15|||
156803687|NCT03759600|566037526|FG000|Overall Study|Site Terminated by Sponsor|3|||
156803688|NCT02332187|566037527|FG000|Overall Study|Withdrawal by Subject|2|||
156803689|NCT02332187|566037528|FG001|Overall Study|Withdrawal by Subject|2|||
156803690|NCT02332187|566037527|FG000|Overall Study|Adverse Event|0|||
156803691|NCT02332187|566037528|FG001|Overall Study|Adverse Event|1|||
156803692|NCT00339040|566037529|FG000|Stage I|Not able to attend clinic|1|||
157221661|NCT02207621|567558475|FG001|Overall Study|Withdrawal by Subject|9|||
156803693|NCT00339040|566037530|FG001|Stage I|Not able to attend clinic|0|||
156803694|NCT00339040|566037529|FG000|Stage I|Protocol Violation|1|||
156803695|NCT00339040|566037530|FG001|Stage I|Protocol Violation|1|||
156803696|NCT00339040|566037529|FG000|Stage II|Lost to Follow-up|3|||
156803697|NCT00339040|566037530|FG001|Stage II|Lost to Follow-up|0|||
156803698|NCT00339040|566037529|FG000|Stage II|Withdrawal by Subject|1|||
156803699|NCT00339040|566037530|FG001|Stage II|Withdrawal by Subject|2|||
156803700|NCT00339040|566037529|FG000|Stage II|Protocol Violation|3|||
156803701|NCT00339040|566037530|FG001|Stage II|Protocol Violation|0|||
156803702|NCT00339040|566037529|FG000|Stage II|Not able to attend clinic|1|||
156803703|NCT00339040|566037530|FG001|Stage II|Not able to attend clinic|0|||
156803704|NCT00339040|566037529|FG000|Stage II|Site closing|2|||
156803705|NCT00339040|566037530|FG001|Stage II|Site closing|0|||
156803706|NCT01462929|566037531|FG000|Overall Study|Adverse Event|3|||
156803707|NCT01462929|566037532|FG001|Overall Study|Adverse Event|3|||
156803708|NCT01462929|566037533|FG002|Overall Study|Adverse Event|4|||
156803709|NCT01462929|566037531|FG000|Overall Study|Withdrawal by Subject|2|||
156803710|NCT01462929|566037532|FG001|Overall Study|Withdrawal by Subject|1|||
156803711|NCT01462929|566037533|FG002|Overall Study|Withdrawal by Subject|0|||
156803712|NCT01462929|566037531|FG000|Overall Study|Lack of Efficacy|0|||
156803713|NCT01462929|566037532|FG001|Overall Study|Lack of Efficacy|0|||
156803714|NCT01462929|566037533|FG002|Overall Study|Lack of Efficacy|1|||
156803715|NCT02808897|566037536|FG000|Overall Study|Lost to Follow-up|9|||
156803716|NCT02808897|566037537|FG001|Overall Study|Lost to Follow-up|11|||
156803717|NCT01990742|566037543|FG000|Overall Study|Withdrawal by facility|407|||
156803718|NCT01990742|566037544|FG001|Overall Study|Withdrawal by facility|1083|||
156803719|NCT01990742|566037543|FG000|Overall Study|Facility closed|0|||
156803720|NCT01990742|566037544|FG001|Overall Study|Facility closed|270|||
156803721|NCT03848416|566037547|FG000|Overall Study|Withdrawal by Subject|1|||
156803722|NCT03848416|566037548|FG001|Overall Study|Withdrawal by Subject|0|||
156803723|NCT03848416|566037549|FG002|Overall Study|Withdrawal by Subject|0|||
156803724|NCT03848416|566037547|FG000|Overall Study|Death|0|||
156803725|NCT03848416|566037548|FG001|Overall Study|Death|0|||
156803726|NCT03848416|566037549|FG002|Overall Study|Death|1|||
156803727|NCT02808429|566037550|FG000|Overall Study|Lost to Follow-up|1|||
156803728|NCT02808429|566037551|FG001|Overall Study|Lost to Follow-up|0|||
156803729|NCT02808429|566037552|FG002|Overall Study|Lost to Follow-up|0|||
156803730|NCT02808429|566037550|FG000|Overall Study|Protocol Violation|0|||
156803731|NCT02808429|566037551|FG001|Overall Study|Protocol Violation|1|||
156803732|NCT02808429|566037552|FG002|Overall Study|Protocol Violation|0|||
156803733|NCT02808429|566037550|FG000|Overall Study|Premature study termination by sponsor|2|||
156803734|NCT02808429|566037551|FG001|Overall Study|Premature study termination by sponsor|0|||
156803735|NCT02808429|566037552|FG002|Overall Study|Premature study termination by sponsor|1|||
156803736|NCT02808429|566037550|FG000|Overall Study|Relocation|0|||
156803737|NCT02808429|566037551|FG001|Overall Study|Relocation|0|||
156803738|NCT02808429|566037552|FG002|Overall Study|Relocation|1|||
156803739|NCT00856609|566037556|FG000|Overall Study|Adverse Event|1|||
156803740|NCT00856609|566037557|FG001|Overall Study|Adverse Event|0|||
156803741|NCT01788943|566037558|FG000|Overall Study|Withdrawal by Subject|1|||
156803742|NCT01788943|566037559|FG001|Overall Study|Withdrawal by Subject|0|||
156803743|NCT00783432|566037560|FG000|Overall Study|Adverse Event|22|||
157220989|NCT00585351|567554940|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156803744|NCT00783432|566037561|FG001|Overall Study|Adverse Event|17|||
156803745|NCT00783432|566037560|FG000|Overall Study|Lack of Efficacy|20|||
156803746|NCT00783432|566037561|FG001|Overall Study|Lack of Efficacy|21|||
156803747|NCT00783432|566037560|FG000|Overall Study|Lost to Follow-up|11|||
156803748|NCT00783432|566037561|FG001|Overall Study|Lost to Follow-up|6|||
156803749|NCT00783432|566037560|FG000|Overall Study|Withdrawal by Subject|23|||
156803750|NCT00783432|566037561|FG001|Overall Study|Withdrawal by Subject|20|||
156803751|NCT00783432|566037560|FG000|Overall Study|subject moved|3|||
156803752|NCT00783432|566037561|FG001|Overall Study|subject moved|5|||
156803753|NCT00783432|566037560|FG000|Overall Study|Protocol Violation|6|||
156803754|NCT00783432|566037561|FG001|Overall Study|Protocol Violation|9|||
156803755|NCT00110214|566037562|FG000|Overall Study|Never started treatment|21|||
156803756|NCT00110214|566037563|FG001|Overall Study|Never started treatment|20|||
156803757|NCT00110214|566037562|FG000|Overall Study|Disease progression or death|260|||
156803758|NCT00110214|566037563|FG001|Overall Study|Disease progression or death|151|||
156803759|NCT00110214|566037562|FG000|Overall Study|Adverse Event|115|||
156803760|NCT00110214|566037563|FG001|Overall Study|Adverse Event|192|||
156803761|NCT00110214|566037562|FG000|Overall Study|Refused further treatment|52|||
156803762|NCT00110214|566037563|FG001|Overall Study|Refused further treatment|65|||
156803763|NCT00110214|566037562|FG000|Overall Study|Other (not specified)|61|||
156803764|NCT00110214|566037563|FG001|Overall Study|Other (not specified)|75|||
156803765|NCT01847092|566037564|FG000|Overall Study|Adverse Event|12|||
156803766|NCT01847092|566037565|FG001|Overall Study|Adverse Event|3|||
156803767|NCT01847092|566037564|FG000|Overall Study|Withdrawal by Subject|5|||
156803768|NCT01847092|566037565|FG001|Overall Study|Withdrawal by Subject|5|||
157021146|NCT03138512|566830853|FG002|Treatment Part B|Death|1|||
156803769|NCT01847092|566037564|FG000|Overall Study|Protocol Specified|8|||
156803770|NCT01847092|566037565|FG001|Overall Study|Protocol Specified|0|||
156803771|NCT01847092|566037564|FG000|Overall Study|Physician Decision|1|||
156803772|NCT01847092|566037565|FG001|Overall Study|Physician Decision|1|||
156803773|NCT01847092|566037564|FG000|Overall Study|Protocol Violation|0|||
156803774|NCT01847092|566037565|FG001|Overall Study|Protocol Violation|2|||
156803775|NCT01567722|566037578|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
156803776|NCT01567722|566037579|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
156803777|NCT01567722|566037580|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
156881706|NCT02059291|566326990|FG016|Epoch 4|Withdrawal by Subject|0|||
156881707|NCT02059291|566326991|FG017|Epoch 4|Withdrawal by Subject|0|||
156881708|NCT02059291|566326992|FG018|Epoch 4|Withdrawal by Subject|0|||
156881709|NCT02059291|566326993|FG019|Epoch 4|Withdrawal by Subject|0|||
156803778|NCT01567722|566037578|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
156803779|NCT01567722|566037579|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
156803780|NCT01567722|566037580|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
156803781|NCT01567722|566037578|FG000|Overall Study|Protocol closure by the OCG|2|||
156803782|NCT01567722|566037579|FG001|Overall Study|Protocol closure by the OCG|0|||
156803783|NCT01567722|566037580|FG002|Overall Study|Protocol closure by the OCG|0|||
156803784|NCT01567722|566037578|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
156803785|NCT01567722|566037579|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
156803786|NCT01567722|566037580|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
156803787|NCT02259114|566037585|FG000|Overall Study|Progressive Disease|14|||
156803788|NCT02259114|566037586|FG001|Overall Study|Progressive Disease|2|||
156803789|NCT02259114|566037587|FG002|Overall Study|Progressive Disease|10|||
156803790|NCT02259114|566037588|FG003|Overall Study|Progressive Disease|2|||
156803791|NCT02259114|566037589|FG004|Overall Study|Progressive Disease|5|||
156803792|NCT02259114|566037585|FG000|Overall Study|Adverse Event|2|||
156803793|NCT02259114|566037586|FG001|Overall Study|Adverse Event|1|||
156803794|NCT02259114|566037587|FG002|Overall Study|Adverse Event|0|||
156803795|NCT02259114|566037588|FG003|Overall Study|Adverse Event|0|||
156803796|NCT02259114|566037589|FG004|Overall Study|Adverse Event|1|||
156803797|NCT02259114|566037585|FG000|Overall Study|Death|3|||
156803798|NCT02259114|566037586|FG001|Overall Study|Death|0|||
156803799|NCT02259114|566037587|FG002|Overall Study|Death|1|||
156803800|NCT02259114|566037588|FG003|Overall Study|Death|0|||
156803801|NCT02259114|566037589|FG004|Overall Study|Death|0|||
156803802|NCT02259114|566037585|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803803|NCT02259114|566037586|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803804|NCT02259114|566037587|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
156803805|NCT02259114|566037588|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803806|NCT02259114|566037589|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
156803807|NCT02259114|566037585|FG000|Overall Study|Withdrawal by Subject|0|||
156803808|NCT02259114|566037586|FG001|Overall Study|Withdrawal by Subject|0|||
156803809|NCT02259114|566037587|FG002|Overall Study|Withdrawal by Subject|1|||
156803810|NCT02259114|566037588|FG003|Overall Study|Withdrawal by Subject|1|||
156803811|NCT02259114|566037589|FG004|Overall Study|Withdrawal by Subject|0|||
156803812|NCT02259114|566037585|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
156803813|NCT02259114|566037586|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
156803814|NCT02259114|566037587|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803815|NCT02259114|566037588|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803816|NCT02259114|566037589|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
156803817|NCT02259114|566037585|FG000|Overall Study|Not Treated|1|||
156803818|NCT02259114|566037586|FG001|Overall Study|Not Treated|0|||
156803819|NCT02259114|566037587|FG002|Overall Study|Not Treated|0|||
156803820|NCT02259114|566037588|FG003|Overall Study|Not Treated|0|||
156803821|NCT02259114|566037589|FG004|Overall Study|Not Treated|0|||
156803822|NCT03937479|566037590|FG000|Overall Study|Adverse Event|2|||
156803823|NCT03937479|566037591|FG001|Overall Study|Adverse Event|3|||
156803824|NCT03937479|566037592|FG002|Overall Study|Adverse Event|0|||
156803825|NCT03937479|566037593|FG003|Overall Study|Adverse Event|0|||
156803826|NCT03937479|566037594|FG004|Overall Study|Adverse Event|1|||
156803827|NCT03937479|566037590|FG000|Overall Study|Withdrawal by Subject|3|||
156803828|NCT03937479|566037591|FG001|Overall Study|Withdrawal by Subject|5|||
156803829|NCT03937479|566037592|FG002|Overall Study|Withdrawal by Subject|2|||
156803830|NCT03937479|566037593|FG003|Overall Study|Withdrawal by Subject|2|||
156803831|NCT03937479|566037594|FG004|Overall Study|Withdrawal by Subject|1|||
156803832|NCT03937479|566037590|FG000|Overall Study|Protocol Violation|5|||
156803833|NCT03937479|566037591|FG001|Overall Study|Protocol Violation|6|||
156803834|NCT03937479|566037592|FG002|Overall Study|Protocol Violation|4|||
156803835|NCT03937479|566037593|FG003|Overall Study|Protocol Violation|3|||
156803836|NCT03937479|566037594|FG004|Overall Study|Protocol Violation|2|||
156803837|NCT03937479|566037590|FG000|Overall Study|Lost to Follow-up|0|||
156803838|NCT03937479|566037591|FG001|Overall Study|Lost to Follow-up|1|||
156803839|NCT03937479|566037592|FG002|Overall Study|Lost to Follow-up|0|||
156803840|NCT03937479|566037593|FG003|Overall Study|Lost to Follow-up|1|||
156803841|NCT03937479|566037594|FG004|Overall Study|Lost to Follow-up|0|||
156803842|NCT03937479|566037590|FG000|Overall Study|Physician Decision|0|||
156881710|NCT02059291|566326994|FG020|Epoch 4|Withdrawal by Subject|1|||
156881711|NCT02059291|566326995|FG021|Epoch 4|Withdrawal by Subject|0|||
156803843|NCT03937479|566037591|FG001|Overall Study|Physician Decision|0|||
156881712|NCT02059291|566326996|FG022|Epoch 4|Withdrawal by Subject|0|||
156881713|NCT02059291|566326997|FG023|Epoch 4|Withdrawal by Subject|0|||
156803844|NCT03937479|566037592|FG002|Overall Study|Physician Decision|1|||
156803845|NCT03937479|566037593|FG003|Overall Study|Physician Decision|0|||
156881714|NCT02059291|566326998|FG024|Epoch 4|Withdrawal by Subject|0|||
156803846|NCT03937479|566037594|FG004|Overall Study|Physician Decision|1|||
156803847|NCT02712788|566037597|FG000|Overall Study|Physician Decision|1|||
156803848|NCT02712788|566037598|FG001|Overall Study|Physician Decision|0|||
156803849|NCT02712788|566037597|FG000|Overall Study|Protocol Violation|1|||
156803850|NCT02712788|566037598|FG001|Overall Study|Protocol Violation|0|||
156803851|NCT00940602|566037602|FG000|Overall Study|Administrative problems|1|||
156803852|NCT00940602|566037603|FG001|Overall Study|Administrative problems|1|||
156803853|NCT00940602|566037602|FG000|Overall Study|Patient/guardian decision|13|||
156803854|NCT00940602|566037603|FG001|Overall Study|Patient/guardian decision|28|||
156803855|NCT00940602|566037602|FG000|Overall Study|Physician Decision|8|||
156803856|NCT00940602|566037603|FG001|Overall Study|Physician Decision|5|||
156803857|NCT00940602|566037602|FG000|Overall Study|Pregnancy|1|||
156803858|NCT00940602|566037603|FG001|Overall Study|Pregnancy|0|||
156803859|NCT00940602|566037602|FG000|Overall Study|Protocol Deviation (untreated)|1|||
156803860|NCT00940602|566037603|FG001|Overall Study|Protocol Deviation (untreated)|0|||
156803861|NCT00940602|566037602|FG000|Overall Study|Disease progression|8|||
156803862|NCT00940602|566037603|FG001|Overall Study|Disease progression|2|||
156803863|NCT00940602|566037602|FG000|Overall Study|Death|38|||
156803864|NCT00940602|566037603|FG001|Overall Study|Death|19|||
156803865|NCT00940602|566037602|FG000|Overall Study|Lost to Follow-up|3|||
156803866|NCT00940602|566037603|FG001|Overall Study|Lost to Follow-up|1|||
156803867|NCT00940602|566037602|FG000|Overall Study|Patient withdrew consent|26|||
156803868|NCT00940602|566037603|FG001|Overall Study|Patient withdrew consent|13|||
156803869|NCT00940602|566037602|FG000|Overall Study|Adverse Event|7|||
156803870|NCT00940602|566037603|FG001|Overall Study|Adverse Event|2|||
156803871|NCT00940602|566037602|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
156803872|NCT00940602|566037603|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
156803873|NCT02961244|566037605|FG000|Overall Study|Protocol Violation|0|||
156803874|NCT02961244|566037606|FG001|Overall Study|Protocol Violation|1|||
156803875|NCT02961244|566037605|FG000|Overall Study|Withdrawal by Subject|1|||
156803876|NCT02961244|566037606|FG001|Overall Study|Withdrawal by Subject|2|||
156803877|NCT02961244|566037605|FG000|Overall Study|Surgery plan change after study approval|0|||
156803878|NCT02961244|566037606|FG001|Overall Study|Surgery plan change after study approval|2|||
156803879|NCT02961244|566037605|FG000|Overall Study|Lost to Follow-up|0|||
156803880|NCT02961244|566037606|FG001|Overall Study|Lost to Follow-up|2|||
156803881|NCT02961244|566037605|FG000|Overall Study|İnadequate data|0|||
156803882|NCT02961244|566037606|FG001|Overall Study|İnadequate data|2|||
156803883|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
156803884|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
156803885|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
156803886|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
156803887|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
156803888|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
156803889|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
156803890|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
156803891|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
156803892|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
156803893|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
156803894|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
156803895|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
156803896|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
156803897|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
156803898|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
156803899|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
156803900|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
156803901|NCT03789292|566037607|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
157021147|NCT03138512|566830854|FG003|Treatment Part B|Death|0|||
157021148|NCT03138512|566830855|FG004|Treatment Part B|Death|0|||
157021149|NCT03138512|566830851|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
157021150|NCT03138512|566830852|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
156803902|NCT03789292|566037608|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
156803903|NCT03789292|566037609|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
156803904|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
156803905|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
156803906|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
156803907|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
156803908|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
156803909|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
156803910|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
156803911|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
156803912|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
156803913|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
156803914|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
156803915|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
156803916|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
156803917|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
156803918|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
156803919|NCT03789292|566037607|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
156803920|NCT03789292|566037608|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
156803921|NCT03789292|566037609|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
156803922|NCT01696643|566037610|FG000|Overall Study|Adverse Event|15|||
156803923|NCT01696643|566037611|FG001|Overall Study|Adverse Event|7|||
156803924|NCT01696643|566037610|FG000|Overall Study|Death|1|||
156803925|NCT01696643|566037611|FG001|Overall Study|Death|2|||
156803926|NCT01696643|566037610|FG000|Overall Study|Lack of Efficacy|3|||
156803927|NCT01696643|566037611|FG001|Overall Study|Lack of Efficacy|0|||
156803928|NCT01696643|566037610|FG000|Overall Study|Lost to Follow-up|67|||
156803929|NCT01696643|566037611|FG001|Overall Study|Lost to Follow-up|67|||
156803930|NCT01696643|566037610|FG000|Overall Study|Physician Decision|3|||
156803931|NCT01696643|566037611|FG001|Overall Study|Physician Decision|2|||
156803932|NCT01696643|566037610|FG000|Overall Study|Pregnancy|0|||
156803933|NCT01696643|566037611|FG001|Overall Study|Pregnancy|1|||
156803934|NCT01696643|566037610|FG000|Overall Study|Protocol Violation|7|||
156803935|NCT01696643|566037611|FG001|Overall Study|Protocol Violation|7|||
156803936|NCT01696643|566037610|FG000|Overall Study|Study Terminated by Sponsor|286|||
156803937|NCT01696643|566037611|FG001|Overall Study|Study Terminated by Sponsor|294|||
156803938|NCT01696643|566037610|FG000|Overall Study|Withdrawal by Subject|142|||
156803939|NCT01696643|566037611|FG001|Overall Study|Withdrawal by Subject|149|||
156803940|NCT01696643|566037610|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
156803941|NCT01696643|566037611|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
156803942|NCT01696643|566037610|FG000|Overall Study|Site Error|2|||
156803943|NCT01696643|566037611|FG001|Overall Study|Site Error|1|||
156803944|NCT01696643|566037610|FG000|Overall Study|Participant Incarcerated|0|||
156803945|NCT01696643|566037611|FG001|Overall Study|Participant Incarcerated|1|||
156803946|NCT01696643|566037610|FG000|Overall Study|Medical Monitor Decision|0|||
156803947|NCT01696643|566037611|FG001|Overall Study|Medical Monitor Decision|2|||
156803948|NCT01696643|566037610|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
156803949|NCT01696643|566037611|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
156803950|NCT00518180|566037616|FG000|Overall Study|Withdrawal by Subject|29|||
156803951|NCT00518180|566037617|FG001|Overall Study|Withdrawal by Subject|30|||
156803952|NCT00518180|566037618|FG002|Overall Study|Withdrawal by Subject|42|||
156803953|NCT00518180|566037616|FG000|Overall Study|Lost to Follow-up|30|||
156803954|NCT00518180|566037617|FG001|Overall Study|Lost to Follow-up|28|||
156803955|NCT00518180|566037618|FG002|Overall Study|Lost to Follow-up|34|||
156803956|NCT00518180|566037616|FG000|Overall Study|Administrative reason|0|||
156803957|NCT00518180|566037617|FG001|Overall Study|Administrative reason|2|||
156803958|NCT00518180|566037618|FG002|Overall Study|Administrative reason|2|||
156803959|NCT00518180|566037616|FG000|Overall Study|Protocol Violation|5|||
156803960|NCT00518180|566037617|FG001|Overall Study|Protocol Violation|7|||
156803961|NCT00518180|566037618|FG002|Overall Study|Protocol Violation|4|||
156803962|NCT00518180|566037616|FG000|Overall Study|Unable to classify|0|||
156803963|NCT00518180|566037617|FG001|Overall Study|Unable to classify|2|||
156803964|NCT00518180|566037618|FG002|Overall Study|Unable to classify|0|||
156803965|NCT00518180|566037616|FG000|Overall Study|Adverse Event|1|||
156803966|NCT00518180|566037617|FG001|Overall Study|Adverse Event|0|||
156803967|NCT00518180|566037618|FG002|Overall Study|Adverse Event|0|||
156803968|NCT01368614|566037619|FG000|Screening Period|Screen Failure|58|||
156803969|NCT01368614|566037620|FG001|Screening Period|Screen Failure|0|||
156803970|NCT01368614|566037621|FG002|Screening Period|Screen Failure|0|||
156803971|NCT01368614|566037622|FG003|Screening Period|Screen Failure|0|||
156803972|NCT01368614|566037619|FG000|Study Period|Withdrawal by Subject|0|||
156803973|NCT01368614|566037620|FG001|Study Period|Withdrawal by Subject|1|||
156803974|NCT01368614|566037621|FG002|Study Period|Withdrawal by Subject|1|||
156803975|NCT01368614|566037622|FG003|Study Period|Withdrawal by Subject|3|||
156803976|NCT01368614|566037619|FG000|Study Period|Lost to Follow-up|0|||
156803977|NCT01368614|566037620|FG001|Study Period|Lost to Follow-up|0|||
156803978|NCT01368614|566037621|FG002|Study Period|Lost to Follow-up|1|||
156803979|NCT01368614|566037622|FG003|Study Period|Lost to Follow-up|0|||
156803980|NCT02951780|566037623|FG000|Period 1|Adverse Event|0|||
156803981|NCT02951780|566037624|FG001|Period 1|Adverse Event|0|||
156803982|NCT02951780|566037625|FG002|Period 1|Adverse Event|0|||
156803983|NCT02951780|566037626|FG003|Period 1|Adverse Event|1|||
156803984|NCT02951780|566037627|FG004|Period 1|Adverse Event|0|||
156803985|NCT02951780|566037628|FG005|Period 1|Adverse Event|0|||
156803986|NCT02951780|566037629|FG006|Period 1|Adverse Event|0|||
156803987|NCT02951780|566037630|FG007|Period 1|Adverse Event|0|||
156803988|NCT02951780|566037631|FG008|Period 1|Adverse Event|0|||
156803989|NCT02951780|566037623|FG000|Period 1|Scheduling Conflicts|0|||
156803990|NCT02951780|566037624|FG001|Period 1|Scheduling Conflicts|0|||
156803991|NCT02951780|566037625|FG002|Period 1|Scheduling Conflicts|0|||
156803992|NCT02951780|566037626|FG003|Period 1|Scheduling Conflicts|0|||
156803993|NCT02951780|566037627|FG004|Period 1|Scheduling Conflicts|0|||
156803994|NCT02951780|566037628|FG005|Period 1|Scheduling Conflicts|0|||
156803995|NCT02951780|566037629|FG006|Period 1|Scheduling Conflicts|0|||
156803996|NCT02951780|566037630|FG007|Period 1|Scheduling Conflicts|1|||
156803997|NCT02951780|566037631|FG008|Period 1|Scheduling Conflicts|0|||
156803998|NCT02951780|566037623|FG000|Period 2|Scheduling Conflicts|0|||
156803999|NCT02951780|566037624|FG001|Period 2|Scheduling Conflicts|0|||
156804000|NCT02951780|566037625|FG002|Period 2|Scheduling Conflicts|0|||
156804001|NCT02951780|566037626|FG003|Period 2|Scheduling Conflicts|0|||
156804002|NCT02951780|566037627|FG004|Period 2|Scheduling Conflicts|0|||
156804003|NCT02951780|566037628|FG005|Period 2|Scheduling Conflicts|0|||
156804004|NCT02951780|566037629|FG006|Period 2|Scheduling Conflicts|0|||
156804005|NCT02951780|566037630|FG007|Period 2|Scheduling Conflicts|1|||
156804006|NCT02951780|566037631|FG008|Period 2|Scheduling Conflicts|0|||
156804007|NCT00508482|566037632|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
156804008|NCT00508482|566037633|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
156804009|NCT00508482|566037634|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
156804010|NCT00508482|566037632|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
156804011|NCT00508482|566037633|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
156804012|NCT00508482|566037634|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
156804013|NCT00508482|566037632|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
156804014|NCT00508482|566037633|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
156804015|NCT00508482|566037634|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
156804016|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
156804017|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
156804018|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
156804019|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
156804020|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
156804021|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
156804022|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
156804023|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
156804024|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
156804025|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
156804026|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
156804027|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
156804028|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
156804029|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
156804030|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
156804031|NCT00546481|566037635|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
156804032|NCT00546481|566037636|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
156804033|NCT00546481|566037637|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
156804034|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
156804035|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
156804036|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
156804037|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
156804038|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
156804039|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
156804040|NCT00546481|566037635|FG000|Maintenance Phase (CERA)|Other Reason|0|||
156804041|NCT00546481|566037636|FG001|Maintenance Phase (CERA)|Other Reason|0|||
156804042|NCT00546481|566037637|FG002|Maintenance Phase (CERA)|Other Reason|1|||
156804043|NCT00244621|566037638|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156804044|NCT00244621|566037639|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156804045|NCT00244621|566037640|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
156804046|NCT00244621|566037638|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
157021151|NCT03138512|566830853|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
157021152|NCT03138512|566830854|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
157021153|NCT03138512|566830855|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
156804047|NCT00244621|566037639|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
156804048|NCT00244621|566037640|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156804049|NCT00244621|566037638|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156804050|NCT00244621|566037639|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
156804051|NCT00244621|566037640|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
156804052|NCT00244621|566037638|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
156804053|NCT00244621|566037639|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
156804054|NCT00244621|566037640|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
156804055|NCT00244621|566037638|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
156804056|NCT00244621|566037639|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
156804057|NCT00244621|566037640|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
156804058|NCT00244621|566037638|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
156804059|NCT00244621|566037639|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156804060|NCT00244621|566037640|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
156804061|NCT00244621|566037638|FG000|Open-label Treatment Period|Adverse Event|0|||
156804062|NCT00244621|566037639|FG001|Open-label Treatment Period|Adverse Event|0|||
156804063|NCT00244621|566037640|FG002|Open-label Treatment Period|Adverse Event|1|||
156804064|NCT00244621|566037638|FG000|Open-label Treatment Period|Moved abroad|0|||
156804065|NCT00244621|566037639|FG001|Open-label Treatment Period|Moved abroad|0|||
156804066|NCT00244621|566037640|FG002|Open-label Treatment Period|Moved abroad|1|||
156804067|NCT01193101|566037644|FG000|Overall Study|Adverse Event|0|||
156804068|NCT01193101|566037645|FG001|Overall Study|Adverse Event|1|||
156804069|NCT01193101|566037646|FG002|Overall Study|Adverse Event|1|||
156804070|NCT01193101|566037647|FG003|Overall Study|Adverse Event|3|||
156804071|NCT01193101|566037644|FG000|Overall Study|Lack of Efficacy|3|||
156804072|NCT01193101|566037645|FG001|Overall Study|Lack of Efficacy|1|||
156804073|NCT01193101|566037646|FG002|Overall Study|Lack of Efficacy|0|||
156804074|NCT01193101|566037647|FG003|Overall Study|Lack of Efficacy|8|||
156804075|NCT01193101|566037644|FG000|Overall Study|Withdrawal by Subject|2|||
156804076|NCT01193101|566037645|FG001|Overall Study|Withdrawal by Subject|4|||
156804077|NCT01193101|566037646|FG002|Overall Study|Withdrawal by Subject|1|||
156804078|NCT01193101|566037647|FG003|Overall Study|Withdrawal by Subject|1|||
156804079|NCT01193101|566037644|FG000|Overall Study|Administrative problems|0|||
156804080|NCT01193101|566037645|FG001|Overall Study|Administrative problems|0|||
156804081|NCT01193101|566037646|FG002|Overall Study|Administrative problems|1|||
156804082|NCT01193101|566037647|FG003|Overall Study|Administrative problems|0|||
156804083|NCT01193101|566037644|FG000|Overall Study|Abnormal test procedure results|0|||
156804084|NCT01193101|566037645|FG001|Overall Study|Abnormal test procedure results|1|||
156804085|NCT01193101|566037646|FG002|Overall Study|Abnormal test procedure results|0|||
156804086|NCT01193101|566037647|FG003|Overall Study|Abnormal test procedure results|0|||
156804087|NCT02347085|566037648|FG000|Overall Study|Adverse Event|2|||
156804088|NCT02347085|566037648|FG000|Overall Study|Lack of Efficacy|1|||
156804089|NCT02347085|566037648|FG000|Overall Study|Withdrawal by Subject|4|||
156804090|NCT02347085|566037648|FG000|Overall Study|Lost to Follow-up|1|||
156804091|NCT02347085|566037648|FG000|Overall Study|Protocol Criteria|2|||
156804092|NCT02271529|566037649|FG000|Overall Study|Withdrawal by Subject|1|||
156804093|NCT03508050|566037651|FG000|Overall Study|Pleural adhesions|1|||
156804094|NCT03508050|566037652|FG001|Overall Study|Pleural adhesions|0|||
156804095|NCT03508050|566037651|FG000|Overall Study|Mucus plug|1|||
156804096|NCT03508050|566037652|FG001|Overall Study|Mucus plug|0|||
156804097|NCT03508050|566037651|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
156804098|NCT03508050|566037652|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
156804099|NCT03508050|566037651|FG000|Overall Study|Sustained desaturation|0|||
156804100|NCT03508050|566037652|FG001|Overall Study|Sustained desaturation|1|||
156804101|NCT01957865|566037653|FG000|Overall Study|Found HIV negative|0|||
156804102|NCT01957865|566037654|FG001|Overall Study|Found HIV negative|0|||
156804103|NCT01957865|566037655|FG002|Overall Study|Found HIV negative|1|||
156804104|NCT01957865|566037653|FG000|Overall Study|Lost to Follow-up|0|||
156804105|NCT01957865|566037654|FG001|Overall Study|Lost to Follow-up|2|||
156804106|NCT01957865|566037655|FG002|Overall Study|Lost to Follow-up|2|||
156804107|NCT01082614|566037656|FG000|Overall Study|Adverse Event|1|||
156804108|NCT01082614|566037657|FG001|Overall Study|Adverse Event|4|||
156804109|NCT01082614|566037656|FG000|Overall Study|Equipment Malfunction|0|||
156804110|NCT01082614|566037657|FG001|Overall Study|Equipment Malfunction|1|||
156804111|NCT01082614|566037656|FG000|Overall Study|Physician Decision|2|||
156804112|NCT01082614|566037657|FG001|Overall Study|Physician Decision|0|||
156804113|NCT00811720|566037658|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
156804114|NCT00811720|566037659|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
156804115|NCT00811720|566037658|FG000|All Treated Patients|Adverse Event|20|||
156804116|NCT00811720|566037659|FG001|All Treated Patients|Adverse Event|62|||
156804117|NCT00811720|566037658|FG000|All Treated Patients|Lack of Efficacy|22|||
156804118|NCT00811720|566037659|FG001|All Treated Patients|Lack of Efficacy|18|||
156804119|NCT00811720|566037658|FG000|All Treated Patients|Non-compliance|0|||
156804120|NCT00811720|566037659|FG001|All Treated Patients|Non-compliance|14|||
156804121|NCT00811720|566037658|FG000|All Treated Patients|Protocol Violation|9|||
156804122|NCT00811720|566037659|FG001|All Treated Patients|Protocol Violation|16|||
156804123|NCT00811720|566037658|FG000|All Treated Patients|Withdrawal by Subject|28|||
156804124|NCT00811720|566037659|FG001|All Treated Patients|Withdrawal by Subject|34|||
156804125|NCT00811720|566037658|FG000|All Treated Patients|Lost to Follow-up|10|||
156804126|NCT00811720|566037659|FG001|All Treated Patients|Lost to Follow-up|16|||
156804127|NCT00811720|566037658|FG000|All Treated Patients|Other Reason|7|||
156804128|NCT00811720|566037659|FG001|All Treated Patients|Other Reason|4|||
156804129|NCT00950651|566037663|FG000|Overall Study|Adverse Event|17|||
156804130|NCT00950651|566037664|FG001|Overall Study|Adverse Event|20|||
156804131|NCT00950651|566037663|FG000|Overall Study|Death|1|||
156804132|NCT00950651|566037664|FG001|Overall Study|Death|0|||
156804133|NCT00950651|566037663|FG000|Overall Study|Lack of Efficacy|2|||
156804134|NCT00950651|566037664|FG001|Overall Study|Lack of Efficacy|2|||
156804135|NCT00950651|566037663|FG000|Overall Study|Protocol Violation|3|||
156804136|NCT00950651|566037664|FG001|Overall Study|Protocol Violation|4|||
156804137|NCT00950651|566037663|FG000|Overall Study|Withdrawal by Subject|8|||
156804138|NCT00950651|566037664|FG001|Overall Study|Withdrawal by Subject|9|||
156804139|NCT03783780|566037665|FG000|Overall Study|Withdrawn prior to completion|1|||
156804140|NCT03768427|566037666|FG000|Overall Study|Death|0|||
156804141|NCT03768427|566037667|FG001|Overall Study|Death|0|||
156804142|NCT03768427|566037668|FG002|Overall Study|Death|1|||
156804143|NCT03768427|566037669|FG003|Overall Study|Death|0|||
156804144|NCT03768427|566037666|FG000|Overall Study|Lost to Follow-up|2|||
156804145|NCT03768427|566037667|FG001|Overall Study|Lost to Follow-up|0|||
156804146|NCT03768427|566037668|FG002|Overall Study|Lost to Follow-up|0|||
156804147|NCT03768427|566037669|FG003|Overall Study|Lost to Follow-up|0|||
156804148|NCT03768427|566037666|FG000|Overall Study|Physician Decision|3|||
156804149|NCT03768427|566037667|FG001|Overall Study|Physician Decision|2|||
156804150|NCT03768427|566037668|FG002|Overall Study|Physician Decision|4|||
156804151|NCT03768427|566037669|FG003|Overall Study|Physician Decision|4|||
156804152|NCT03768427|566037666|FG000|Overall Study|Withdrawal by Subject|7|||
156804153|NCT03768427|566037667|FG001|Overall Study|Withdrawal by Subject|2|||
156804154|NCT03768427|566037668|FG002|Overall Study|Withdrawal by Subject|6|||
156804155|NCT03768427|566037669|FG003|Overall Study|Withdrawal by Subject|7|||
156804156|NCT00776789|566037674|FG000|Overall Study|Consent refusal|2|||
156804157|NCT00776789|566037675|FG001|Overall Study|Consent refusal|2|||
156804158|NCT00776789|566037674|FG000|Overall Study|Poor quality video|1|||
156804159|NCT00776789|566037675|FG001|Overall Study|Poor quality video|1|||
156804160|NCT02993263|566037676|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
156804161|NCT00829998|566037677|FG000|Washout|Adverse Event|0|||
156804162|NCT00829998|566037678|FG001|Washout|Adverse Event|1|||
156804163|NCT02896257|566039656|FG000|Providers|Without eligible patients|21|||
156804164|NCT02896257|566039657|FG001|Providers|Without eligible patients|28|||
156804165|NCT02896257|566039656|FG000|Patients|PFT entry criteria not met|43|||
156804166|NCT02896257|566039657|FG001|Patients|PFT entry criteria not met|50|||
156804167|NCT02896257|566039656|FG000|Patients|No capacity to review|8|||
156804168|NCT02896257|566039657|FG001|Patients|No capacity to review|11|||
156804169|NCT02896257|566039656|FG000|Patients|Appointment rescheduled/cancelled|5|||
156804170|NCT02896257|566039657|FG001|Patients|Appointment rescheduled/cancelled|7|||
156804171|NCT02896257|566039656|FG000|Patients|PCP not assigned a clinic|4|||
156804172|NCT02896257|566039657|FG001|Patients|PCP not assigned a clinic|0|||
156804173|NCT02896257|566039656|FG000|Patients|No history of COPD|0|||
156804174|NCT02896257|566039657|FG001|Patients|No history of COPD|1|||
156804175|NCT02896257|566039656|FG000|Patients|Deceased between review and index date|0|||
156804176|NCT02896257|566039657|FG001|Patients|Deceased between review and index date|1|||
156804177|NCT02896257|566039656|FG000|Patients|No ICS Rx upon review|1|||
156804178|NCT02896257|566039657|FG001|Patients|No ICS Rx upon review|1|||
156804179|NCT02896257|566039656|FG000|Patients|Protocol Violation|2|||
156804180|NCT02896257|566039657|FG001|Patients|Protocol Violation|1|||
156804181|NCT02896257|566039656|FG000|Patients|Hospice care|0|||
156804182|NCT02896257|566039657|FG001|Patients|Hospice care|1|||
156804183|NCT03257358|566039662|FG000|Overall Study|Adverse Event|25|||
156804184|NCT03257358|566039663|FG001|Overall Study|Adverse Event|12|||
156881715|NCT02059291|566326974|FG000|Epoch 4|Lack of Efficacy|0|||
156881716|NCT02059291|566326975|FG001|Epoch 4|Lack of Efficacy|0|||
156804185|NCT03257358|566039662|FG000|Overall Study|Lack of Efficacy|1|||
156804186|NCT03257358|566039663|FG001|Overall Study|Lack of Efficacy|1|||
156804187|NCT03257358|566039662|FG000|Overall Study|Lost to Follow-up|12|||
156804188|NCT03257358|566039663|FG001|Overall Study|Lost to Follow-up|4|||
156804189|NCT03257358|566039662|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
156804190|NCT03257358|566039663|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
156804191|NCT03257358|566039662|FG000|Overall Study|Physician Decision|2|||
156804192|NCT03257358|566039663|FG001|Overall Study|Physician Decision|2|||
156804193|NCT03257358|566039662|FG000|Overall Study|Protocol Violation|5|||
157220990|NCT00585351|567554941|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
156804194|NCT03257358|566039663|FG001|Overall Study|Protocol Violation|3|||
156804195|NCT03257358|566039662|FG000|Overall Study|Technical problems|4|||
156804196|NCT03257358|566039663|FG001|Overall Study|Technical problems|1|||
156804197|NCT03257358|566039662|FG000|Overall Study|Withdrawal by Subject|8|||
156804198|NCT03257358|566039663|FG001|Overall Study|Withdrawal by Subject|3|||
156804199|NCT03257358|566039662|FG000|Overall Study|Withdrawal of informed consent|9|||
156804200|NCT03257358|566039663|FG001|Overall Study|Withdrawal of informed consent|5|||
156804201|NCT03257358|566039662|FG000|Overall Study|New therapy for study indication|1|||
156804202|NCT03257358|566039663|FG001|Overall Study|New therapy for study indication|0|||
156804203|NCT03257358|566039662|FG000|Overall Study|No longer requires treatment|0|||
156804204|NCT03257358|566039663|FG001|Overall Study|No longer requires treatment|1|||
156881717|NCT02059291|566326976|FG002|Epoch 4|Lack of Efficacy|0|||
156804205|NCT01669902|566039664|FG000|Overall Study|Adverse Event|11|||
156804206|NCT01669902|566039664|FG000|Overall Study|Lack of Efficacy|10|||
156804207|NCT01669902|566039664|FG000|Overall Study|Other|8|||
156804208|NCT02852967|566039665|FG000|Overall Study|Adverse Event|3|||
156804209|NCT02852967|566039666|FG001|Overall Study|Adverse Event|1|||
156804210|NCT02852967|566039667|FG002|Overall Study|Adverse Event|0|||
156804211|NCT02852967|566039668|FG003|Overall Study|Adverse Event|1|||
156804212|NCT02852967|566039669|FG004|Overall Study|Adverse Event|0|||
156804213|NCT02852967|566039665|FG000|Overall Study|Death|1|||
156804214|NCT02852967|566039666|FG001|Overall Study|Death|0|||
156804215|NCT02852967|566039667|FG002|Overall Study|Death|0|||
156804216|NCT02852967|566039668|FG003|Overall Study|Death|0|||
156804217|NCT02852967|566039669|FG004|Overall Study|Death|0|||
156804218|NCT02852967|566039665|FG000|Overall Study|Lost to Follow-up|1|||
156804219|NCT02852967|566039666|FG001|Overall Study|Lost to Follow-up|2|||
156804220|NCT02852967|566039667|FG002|Overall Study|Lost to Follow-up|3|||
156804221|NCT02852967|566039668|FG003|Overall Study|Lost to Follow-up|4|||
156804222|NCT02852967|566039669|FG004|Overall Study|Lost to Follow-up|4|||
156804223|NCT02852967|566039665|FG000|Overall Study|Withdrawal by Subject|6|||
156804224|NCT02852967|566039666|FG001|Overall Study|Withdrawal by Subject|12|||
156804225|NCT02852967|566039667|FG002|Overall Study|Withdrawal by Subject|7|||
156804226|NCT02852967|566039668|FG003|Overall Study|Withdrawal by Subject|10|||
156804227|NCT02852967|566039669|FG004|Overall Study|Withdrawal by Subject|10|||
156804228|NCT02852967|566039665|FG000|Overall Study|SAE|0|||
156804229|NCT02852967|566039666|FG001|Overall Study|SAE|0|||
156804230|NCT02852967|566039667|FG002|Overall Study|SAE|0|||
156804231|NCT02852967|566039668|FG003|Overall Study|SAE|3|||
156804232|NCT02852967|566039669|FG004|Overall Study|SAE|0|||
156804233|NCT02852967|566039665|FG000|Overall Study|Elevated Liver Enzymes|2|||
156804234|NCT02852967|566039666|FG001|Overall Study|Elevated Liver Enzymes|0|||
156804235|NCT02852967|566039667|FG002|Overall Study|Elevated Liver Enzymes|0|||
156804236|NCT02852967|566039668|FG003|Overall Study|Elevated Liver Enzymes|2|||
156804237|NCT02852967|566039669|FG004|Overall Study|Elevated Liver Enzymes|2|||
156804238|NCT02852967|566039665|FG000|Overall Study|Physician Decision|0|||
156804239|NCT02852967|566039666|FG001|Overall Study|Physician Decision|0|||
156804240|NCT02852967|566039667|FG002|Overall Study|Physician Decision|0|||
156804241|NCT02852967|566039668|FG003|Overall Study|Physician Decision|1|||
156804242|NCT02852967|566039669|FG004|Overall Study|Physician Decision|0|||
156804243|NCT02852967|566039665|FG000|Overall Study|Lack of Efficacy|0|||
156804244|NCT02852967|566039666|FG001|Overall Study|Lack of Efficacy|1|||
156804245|NCT02852967|566039667|FG002|Overall Study|Lack of Efficacy|0|||
156804246|NCT02852967|566039668|FG003|Overall Study|Lack of Efficacy|0|||
156804247|NCT02852967|566039669|FG004|Overall Study|Lack of Efficacy|0|||
156804248|NCT02852967|566039665|FG000|Overall Study|Non-compliance|0|||
156804249|NCT02852967|566039666|FG001|Overall Study|Non-compliance|0|||
156804250|NCT02852967|566039667|FG002|Overall Study|Non-compliance|1|||
156804251|NCT02852967|566039668|FG003|Overall Study|Non-compliance|1|||
156804252|NCT02852967|566039669|FG004|Overall Study|Non-compliance|0|||
156804253|NCT02852967|566039665|FG000|Overall Study|Dispensing Drug Violation|0|||
156804254|NCT02852967|566039666|FG001|Overall Study|Dispensing Drug Violation|0|||
156804255|NCT02852967|566039667|FG002|Overall Study|Dispensing Drug Violation|1|||
156804256|NCT02852967|566039668|FG003|Overall Study|Dispensing Drug Violation|0|||
156804257|NCT02852967|566039669|FG004|Overall Study|Dispensing Drug Violation|0|||
156804258|NCT02852967|566039665|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
156804259|NCT02852967|566039666|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
156804260|NCT02852967|566039667|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
156804261|NCT02852967|566039668|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
156804262|NCT02852967|566039669|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
156804263|NCT02903823|566039670|FG000|Overall Study|Physician Decision|5|||
156804264|NCT02903823|566039670|FG000|Overall Study|Could not advance catheter|1|||
156804265|NCT02903823|566039670|FG000|Overall Study|Catheter dislodgement|1|||
156804266|NCT00887159|566039677|FG000|Overall Study|Disease progression|6|||
156804267|NCT00887159|566039678|FG001|Overall Study|Disease progression|39|||
156804268|NCT00887159|566039679|FG002|Overall Study|Disease progression|33|||
156804269|NCT00887159|566039677|FG000|Overall Study|Adverse Event|3|||
156804270|NCT00887159|566039678|FG001|Overall Study|Adverse Event|4|||
156804271|NCT00887159|566039679|FG002|Overall Study|Adverse Event|17|||
156804272|NCT00887159|566039677|FG000|Overall Study|Death|2|||
156804273|NCT00887159|566039678|FG001|Overall Study|Death|2|||
156804274|NCT00887159|566039679|FG002|Overall Study|Death|0|||
156804275|NCT00887159|566039677|FG000|Overall Study|Withdrawal by Subject|4|||
156804276|NCT00887159|566039678|FG001|Overall Study|Withdrawal by Subject|4|||
156804277|NCT00887159|566039679|FG002|Overall Study|Withdrawal by Subject|2|||
156804278|NCT00887159|566039677|FG000|Overall Study|Alternative therapy|2|||
156804279|NCT00887159|566039678|FG001|Overall Study|Alternative therapy|0|||
156804280|NCT00887159|566039679|FG002|Overall Study|Alternative therapy|0|||
156804281|NCT00887159|566039677|FG000|Overall Study|Physician Decision|1|||
156804282|NCT00887159|566039678|FG001|Overall Study|Physician Decision|1|||
156804283|NCT00887159|566039679|FG002|Overall Study|Physician Decision|0|||
156804284|NCT00887159|566039677|FG000|Overall Study|Sympomatic deterioration|1|||
156804285|NCT00887159|566039678|FG001|Overall Study|Sympomatic deterioration|0|||
156804286|NCT00887159|566039679|FG002|Overall Study|Sympomatic deterioration|0|||
156804287|NCT00887159|566039677|FG000|Overall Study|Treatment delayed|1|||
156804288|NCT00887159|566039678|FG001|Overall Study|Treatment delayed|1|||
156804289|NCT00887159|566039679|FG002|Overall Study|Treatment delayed|0|||
156804290|NCT00887159|566039677|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
156804291|NCT00887159|566039678|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
156804292|NCT00887159|566039679|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
156804293|NCT00887159|566039677|FG000|Overall Study|Received more tx instead of observation|1|||
156804294|NCT00887159|566039678|FG001|Overall Study|Received more tx instead of observation|0|||
156804295|NCT00887159|566039679|FG002|Overall Study|Received more tx instead of observation|0|||
156804296|NCT00887159|566039677|FG000|Overall Study|Ineligible|5|||
156804297|NCT00887159|566039678|FG001|Overall Study|Ineligible|1|||
156804298|NCT00887159|566039679|FG002|Overall Study|Ineligible|0|||
156804299|NCT00887159|566039677|FG000|Overall Study|Never started assigned therapy|3|||
156804300|NCT00887159|566039678|FG001|Overall Study|Never started assigned therapy|3|||
156804301|NCT00887159|566039679|FG002|Overall Study|Never started assigned therapy|4|||
156804302|NCT00688467|566039680|FG000|Treatment Period 1|Adverse Event|2|||
156804303|NCT00688467|566039681|FG001|Treatment Period 1|Adverse Event|1|||
156804304|NCT00688467|566039680|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
156804305|NCT00688467|566039681|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
156804306|NCT00688467|566039680|FG000|Treatment Period 2|Protocol Violation|0|||
156804307|NCT00688467|566039681|FG001|Treatment Period 2|Protocol Violation|1|||
156804308|NCT00688467|566039680|FG000|Treatment Period 2|Adverse Event|0|||
156804309|NCT00688467|566039681|FG001|Treatment Period 2|Adverse Event|1|||
156804310|NCT00690794|566039682|FG000|Overall Study|Adverse Event|12|||
156804311|NCT00690794|566039683|FG001|Overall Study|Adverse Event|10|||
156804312|NCT00690794|566039682|FG000|Overall Study|Lost to Follow-up|1|||
156804313|NCT00690794|566039683|FG001|Overall Study|Lost to Follow-up|4|||
156804314|NCT00690794|566039682|FG000|Overall Study|Withdrawal by Subject|0|||
156804315|NCT00690794|566039683|FG001|Overall Study|Withdrawal by Subject|9|||
156804316|NCT00690794|566039682|FG000|Overall Study|Protocol Violation|6|||
156804317|NCT00690794|566039683|FG001|Overall Study|Protocol Violation|7|||
156804318|NCT00690794|566039682|FG000|Overall Study|Noncompliance|1|||
156804319|NCT00690794|566039683|FG001|Overall Study|Noncompliance|2|||
156804320|NCT00690794|566039682|FG000|Overall Study|Other not specified|1|||
156804321|NCT00690794|566039683|FG001|Overall Study|Other not specified|3|||
156804322|NCT00305448|566039684|FG000|Overall Study|Protocol Violation|0|||
156804323|NCT00305448|566039685|FG001|Overall Study|Protocol Violation|1|||
156804324|NCT00305448|566039686|FG002|Overall Study|Protocol Violation|0|||
156804325|NCT00305448|566039684|FG000|Overall Study|Withdrawal by Subject|2|||
156804326|NCT00305448|566039685|FG001|Overall Study|Withdrawal by Subject|0|||
156804327|NCT00305448|566039686|FG002|Overall Study|Withdrawal by Subject|1|||
156804328|NCT00305448|566039684|FG000|Overall Study|Adverse Event|1|||
156804329|NCT00305448|566039685|FG001|Overall Study|Adverse Event|0|||
156804330|NCT00305448|566039686|FG002|Overall Study|Adverse Event|1|||
156804331|NCT00305448|566039684|FG000|Overall Study|Disease Progression|27|||
156804332|NCT00305448|566039685|FG001|Overall Study|Disease Progression|31|||
156804333|NCT00305448|566039686|FG002|Overall Study|Disease Progression|28|||
156804334|NCT00305448|566039684|FG000|Overall Study|Subjective Disease Progression|1|||
156804335|NCT00305448|566039685|FG001|Overall Study|Subjective Disease Progression|2|||
156804336|NCT00305448|566039686|FG002|Overall Study|Subjective Disease Progression|2|||
156804337|NCT00305448|566039684|FG000|Overall Study|Tumor Marker Elevation|0|||
156804338|NCT00305448|566039685|FG001|Overall Study|Tumor Marker Elevation|0|||
156804339|NCT00305448|566039686|FG002|Overall Study|Tumor Marker Elevation|1|||
156804340|NCT00002766|566039687|FG000|Overall Study|Withdrawal by Subject|0|||
156804341|NCT00002766|566039688|FG001|Overall Study|Withdrawal by Subject|1|||
157021154|NCT03138512|566830851|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
157021155|NCT03138512|566830852|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
157021156|NCT03138512|566830853|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
157021157|NCT03138512|566830854|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
157021158|NCT03138512|566830855|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
157021159|NCT03138512|566830851|FG000|Treatment Part B|Participant withdrew consent|0|||
156804342|NCT00002766|566039687|FG000|Overall Study|Patient Not Treated|1|||
156804343|NCT00002766|566039688|FG001|Overall Study|Patient Not Treated|2|||
156804344|NCT00002766|566039687|FG000|Overall Study|Adverse Event|1|||
156804345|NCT00002766|566039688|FG001|Overall Study|Adverse Event|1|||
156804346|NCT00002766|566039687|FG000|Overall Study|Protocol Violation|1|||
156804347|NCT00002766|566039688|FG001|Overall Study|Protocol Violation|0|||
156881718|NCT02059291|566326977|FG003|Epoch 4|Lack of Efficacy|0|||
156804348|NCT01343888|566039689|FG000|Overall Study|Adverse Event|12|||
156804349|NCT01343888|566039690|FG001|Overall Study|Adverse Event|22|||
156804350|NCT01343888|566039691|FG002|Overall Study|Adverse Event|5|||
156804351|NCT01343888|566039689|FG000|Overall Study|Lack of Efficacy|9|||
156881719|NCT02059291|566326978|FG004|Epoch 4|Lack of Efficacy|0|||
156804352|NCT01343888|566039690|FG001|Overall Study|Lack of Efficacy|9|||
156804353|NCT01343888|566039691|FG002|Overall Study|Lack of Efficacy|13|||
156804354|NCT01343888|566039689|FG000|Overall Study|Lost to Follow-up|0|||
156804355|NCT01343888|566039690|FG001|Overall Study|Lost to Follow-up|2|||
156804356|NCT01343888|566039691|FG002|Overall Study|Lost to Follow-up|1|||
156804357|NCT01343888|566039689|FG000|Overall Study|Protocol Violation|0|||
156804358|NCT01343888|566039690|FG001|Overall Study|Protocol Violation|2|||
156804359|NCT01343888|566039691|FG002|Overall Study|Protocol Violation|0|||
156804360|NCT01343888|566039689|FG000|Overall Study|Withdrawal by Subject|4|||
156804361|NCT01343888|566039690|FG001|Overall Study|Withdrawal by Subject|4|||
156804362|NCT01343888|566039691|FG002|Overall Study|Withdrawal by Subject|2|||
156804363|NCT01343888|566039689|FG000|Overall Study|other than stated above|0|||
156804364|NCT01343888|566039690|FG001|Overall Study|other than stated above|0|||
156804365|NCT01343888|566039691|FG002|Overall Study|other than stated above|1|||
156804366|NCT00387088|566039692|FG000|Overall Study|Adverse Event|143|||
156804367|NCT00387088|566039693|FG001|Overall Study|Adverse Event|156|||
156804368|NCT00387088|566039692|FG000|Overall Study|Protocol Violation|47|||
156804369|NCT00387088|566039693|FG001|Overall Study|Protocol Violation|35|||
156804370|NCT00387088|566039692|FG000|Overall Study|Withdrawal by Subject|20|||
156804371|NCT00387088|566039693|FG001|Overall Study|Withdrawal by Subject|35|||
156804372|NCT00387088|566039692|FG000|Overall Study|Lack of Efficacy|28|||
156804373|NCT00387088|566039693|FG001|Overall Study|Lack of Efficacy|67|||
156804374|NCT00387088|566039692|FG000|Overall Study|Lost to Follow-up|22|||
156804375|NCT00387088|566039693|FG001|Overall Study|Lost to Follow-up|28|||
156804376|NCT00387088|566039692|FG000|Overall Study|Other|58|||
156804377|NCT00387088|566039693|FG001|Overall Study|Other|52|||
156804378|NCT03443687|566039694|FG000|Overall Study|Lost to Follow-up|3|||
156804379|NCT03443687|566039695|FG001|Overall Study|Lost to Follow-up|5|||
156804380|NCT03443687|566039694|FG000|Overall Study|Withdrawal by Subject|1|||
156804381|NCT03443687|566039695|FG001|Overall Study|Withdrawal by Subject|0|||
156804382|NCT03443687|566039694|FG000|Overall Study|Discontinued intervention|1|||
156804383|NCT03443687|566039695|FG001|Overall Study|Discontinued intervention|1|||
156881720|NCT02059291|566326979|FG005|Epoch 4|Lack of Efficacy|0|||
156881721|NCT02059291|566326980|FG006|Epoch 4|Lack of Efficacy|0|||
156881722|NCT02059291|566326981|FG007|Epoch 4|Lack of Efficacy|0|||
156881723|NCT02059291|566326982|FG008|Epoch 4|Lack of Efficacy|0|||
156881724|NCT02059291|566326983|FG009|Epoch 4|Lack of Efficacy|0|||
156881725|NCT02059291|566326984|FG010|Epoch 4|Lack of Efficacy|0|||
156881726|NCT02059291|566326985|FG011|Epoch 4|Lack of Efficacy|0|||
156881727|NCT02059291|566326986|FG012|Epoch 4|Lack of Efficacy|0|||
156881728|NCT02059291|566326987|FG013|Epoch 4|Lack of Efficacy|0|||
156881729|NCT02059291|566326988|FG014|Epoch 4|Lack of Efficacy|0|||
156881730|NCT02059291|566326989|FG015|Epoch 4|Lack of Efficacy|0|||
156881731|NCT02059291|566326990|FG016|Epoch 4|Lack of Efficacy|0|||
156881732|NCT02059291|566326991|FG017|Epoch 4|Lack of Efficacy|0|||
156881733|NCT02059291|566326992|FG018|Epoch 4|Lack of Efficacy|0|||
156881734|NCT02059291|566326993|FG019|Epoch 4|Lack of Efficacy|0|||
156881735|NCT02059291|566326994|FG020|Epoch 4|Lack of Efficacy|0|||
156881736|NCT02059291|566326995|FG021|Epoch 4|Lack of Efficacy|0|||
156881737|NCT02059291|566326996|FG022|Epoch 4|Lack of Efficacy|0|||
156881738|NCT02059291|566326997|FG023|Epoch 4|Lack of Efficacy|1|||
156881739|NCT02059291|566326998|FG024|Epoch 4|Lack of Efficacy|0|||
156881740|NCT04975438|566327003|FG000|Overall Study|Lost to Follow-up|1|||
156881741|NCT04975438|566327004|FG001|Overall Study|Lost to Follow-up|0|||
156881742|NCT04975438|566327005|FG002|Overall Study|Lost to Follow-up|1|||
156881743|NCT04975438|566327006|FG003|Overall Study|Lost to Follow-up|0|||
157021160|NCT03138512|566830852|FG001|Treatment Part B|Participant withdrew consent|0|||
157143900|NCT02158533|567276369|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
157143901|NCT02158533|567276364|FG000|Stage 1|Non-compliance with study visits|1|||
157143902|NCT02158533|567276365|FG001|Stage 1|Non-compliance with study visits|0|||
156881744|NCT04975438|566327003|FG000|Overall Study|Withdrawal by Subject|1|||
156881745|NCT04975438|566327004|FG001|Overall Study|Withdrawal by Subject|0|||
156881746|NCT04975438|566327005|FG002|Overall Study|Withdrawal by Subject|0|||
156881747|NCT04975438|566327006|FG003|Overall Study|Withdrawal by Subject|0|||
156881748|NCT04973436|566327007|FG000|Overall Study|Lost to Follow-up|3|||
156881749|NCT04973436|566327007|FG000|Overall Study|Withdrawal by Subject|1|||
156881750|NCT04973436|566327007|FG000|Overall Study|Death|2|||
156804384|NCT00800735|566039696|FG000|Overall Study|Administrative/Other|2|||
156804385|NCT00800735|566039696|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156804386|NCT00800735|566039696|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
156804387|NCT00800735|566039696|FG000|Overall Study|Withdrew Consent|3|||
156804388|NCT02805790|566039697|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
156881751|NCT02410343|566327008|FG000|Core Period (24 Weeks)|Adverse Event|1|||
156881752|NCT02410343|566327009|FG001|Core Period (24 Weeks)|Adverse Event|0|||
156804389|NCT02805790|566039698|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
156804390|NCT01436110|566039706|FG000|Overall Study|Lack of Efficacy|23|||
156881753|NCT02410343|566327008|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
156881754|NCT02410343|566327009|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
156881755|NCT02410343|566327008|FG000|Extension Period (12 Months)|Adverse Event|1|||
156804391|NCT01436110|566039707|FG001|Overall Study|Lack of Efficacy|14|||
156804392|NCT01436110|566039708|FG002|Overall Study|Lack of Efficacy|9|||
156804393|NCT01436110|566039706|FG000|Overall Study|Withdrawal by Subject|6|||
156804394|NCT01436110|566039707|FG001|Overall Study|Withdrawal by Subject|8|||
156804395|NCT01436110|566039708|FG002|Overall Study|Withdrawal by Subject|4|||
156804396|NCT01436110|566039706|FG000|Overall Study|Adverse Event|2|||
156804397|NCT01436110|566039707|FG001|Overall Study|Adverse Event|1|||
156804398|NCT01436110|566039708|FG002|Overall Study|Adverse Event|2|||
156804399|NCT01436110|566039706|FG000|Overall Study|Physician Decision|3|||
156804400|NCT01436110|566039707|FG001|Overall Study|Physician Decision|1|||
156804401|NCT01436110|566039708|FG002|Overall Study|Physician Decision|1|||
156804402|NCT01436110|566039706|FG000|Overall Study|Lost to Follow-up|1|||
156804403|NCT01436110|566039707|FG001|Overall Study|Lost to Follow-up|1|||
156804404|NCT01436110|566039708|FG002|Overall Study|Lost to Follow-up|3|||
156804405|NCT01436110|566039706|FG000|Overall Study|Protocol Violation|3|||
156804406|NCT01436110|566039707|FG001|Overall Study|Protocol Violation|1|||
156804407|NCT01436110|566039708|FG002|Overall Study|Protocol Violation|1|||
156804408|NCT01436110|566039706|FG000|Overall Study|Did Not Receive Trial Medication|1|||
156804409|NCT01436110|566039707|FG001|Overall Study|Did Not Receive Trial Medication|0|||
156804410|NCT01436110|566039708|FG002|Overall Study|Did Not Receive Trial Medication|3|||
156804411|NCT03273907|566039709|FG000|Overall Study|Death|1|||
156804412|NCT03273907|566039709|FG000|Overall Study|Lost to Follow-up|4|||
156804413|NCT03273907|566039709|FG000|Overall Study|Withdrawal by Subject|2|||
156804414|NCT03273907|566039709|FG000|Overall Study|COVID 19|2|||
156804415|NCT01088503|566039710|FG000|Overall Study|Withdrawal by Subject|118|||
156804416|NCT01088503|566039711|FG001|Overall Study|Withdrawal by Subject|327|||
156804417|NCT01088503|566039712|FG002|Overall Study|Withdrawal by Subject|10|||
156804418|NCT01088503|566039710|FG000|Overall Study|Death|64|||
156804419|NCT01088503|566039711|FG001|Overall Study|Death|358|||
156804420|NCT01088503|566039712|FG002|Overall Study|Death|7|||
156804421|NCT03604497|566039714|FG000|Overall Study|Protocol Violation|52|||
156804422|NCT00811954|566039715|FG000|Overall Study|Death|10|||
156804423|NCT00811954|566039716|FG001|Overall Study|Death|6|||
156804424|NCT00811954|566039717|FG002|Overall Study|Death|13|||
156804425|NCT00811954|566039715|FG000|Overall Study|Lost to Follow-up|29|||
156804426|NCT00811954|566039716|FG001|Overall Study|Lost to Follow-up|23|||
156804427|NCT00811954|566039717|FG002|Overall Study|Lost to Follow-up|34|||
156804428|NCT00811954|566039715|FG000|Overall Study|Not able to get to clinic|28|||
156804429|NCT00811954|566039716|FG001|Overall Study|Not able to get to clinic|35|||
156804430|NCT00811954|566039717|FG002|Overall Study|Not able to get to clinic|30|||
156804431|NCT00811954|566039715|FG000|Overall Study|Not willing to adhere to requirements|12|||
156804432|NCT00811954|566039716|FG001|Overall Study|Not willing to adhere to requirements|2|||
156804433|NCT00811954|566039717|FG002|Overall Study|Not willing to adhere to requirements|16|||
156804434|NCT00811954|566039715|FG000|Overall Study|Withdraw consent prior study completion|4|||
156804435|NCT00811954|566039716|FG001|Overall Study|Withdraw consent prior study completion|6|||
156804436|NCT00811954|566039717|FG002|Overall Study|Withdraw consent prior study completion|5|||
156804437|NCT00811954|566039715|FG000|Overall Study|Site Closure|4|||
156804438|NCT00811954|566039716|FG001|Overall Study|Site Closure|0|||
156804439|NCT00811954|566039717|FG002|Overall Study|Site Closure|1|||
156804440|NCT00811954|566039715|FG000|Overall Study|Severe Debilitation|2|||
156804441|NCT00811954|566039716|FG001|Overall Study|Severe Debilitation|0|||
156804442|NCT00811954|566039717|FG002|Overall Study|Severe Debilitation|1|||
156804443|NCT00811954|566039715|FG000|Overall Study|Complete Protocol: No follow-up|0|||
156804444|NCT00811954|566039716|FG001|Overall Study|Complete Protocol: No follow-up|0|||
156804445|NCT00811954|566039717|FG002|Overall Study|Complete Protocol: No follow-up|1|||
156804446|NCT01016067|566039718|FG000|Overall Study|Lost to Follow-up|1|||
156804447|NCT01016067|566039719|FG001|Overall Study|Lost to Follow-up|2|||
156804448|NCT01016067|566039718|FG000|Overall Study|Physician Decision|1|||
156804449|NCT01016067|566039719|FG001|Overall Study|Physician Decision|1|||
156804450|NCT01016067|566039718|FG000|Overall Study|Withdrew due to Relocation|0|||
156804451|NCT01016067|566039719|FG001|Overall Study|Withdrew due to Relocation|1|||
156804452|NCT00186628|566039720|FG000|Overall Study|Death|2|||
156804453|NCT00186628|566039720|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
157143903|NCT02158533|567276366|FG002|Stage 1|Non-compliance with study visits|0|||
156804454|NCT01331681|566039721|FG000|Overall Study|Adverse Event|10|||
156804455|NCT01331681|566039722|FG001|Overall Study|Adverse Event|13|||
156804456|NCT01331681|566039723|FG002|Overall Study|Adverse Event|10|||
156804457|NCT01331681|566039721|FG000|Overall Study|Death|6|||
156804458|NCT01331681|566039722|FG001|Overall Study|Death|6|||
157143904|NCT02158533|567276367|FG003|Stage 1|Non-compliance with study visits|0|||
157143905|NCT02158533|567276368|FG004|Stage 1|Non-compliance with study visits|0|||
156804459|NCT01331681|566039723|FG002|Overall Study|Death|2|||
156804460|NCT01331681|566039721|FG000|Overall Study|Lack of Efficacy|0|||
157143906|NCT02158533|567276369|FG005|Stage 1|Non-compliance with study visits|0|||
156804461|NCT01331681|566039722|FG001|Overall Study|Lack of Efficacy|1|||
156804462|NCT01331681|566039723|FG002|Overall Study|Lack of Efficacy|0|||
156804463|NCT01331681|566039721|FG000|Overall Study|Withdrawal by Subject|12|||
156881756|NCT02410343|566327009|FG001|Extension Period (12 Months)|Adverse Event|0|||
156804464|NCT01331681|566039722|FG001|Overall Study|Withdrawal by Subject|8|||
156804465|NCT01331681|566039723|FG002|Overall Study|Withdrawal by Subject|15|||
156804466|NCT01331681|566039721|FG000|Overall Study|Protocol Violation|1|||
156804467|NCT01331681|566039722|FG001|Overall Study|Protocol Violation|1|||
156804468|NCT01331681|566039723|FG002|Overall Study|Protocol Violation|0|||
156804469|NCT01331681|566039721|FG000|Overall Study|Lost to Follow-up|2|||
156804470|NCT01331681|566039722|FG001|Overall Study|Lost to Follow-up|4|||
156804471|NCT01331681|566039723|FG002|Overall Study|Lost to Follow-up|1|||
156804472|NCT01331681|566039721|FG000|Overall Study|Physician Decision|2|||
156804473|NCT01331681|566039722|FG001|Overall Study|Physician Decision|0|||
156804474|NCT01331681|566039723|FG002|Overall Study|Physician Decision|4|||
156804475|NCT01331681|566039721|FG000|Overall Study|Therapeutic procedure required|1|||
156804476|NCT01331681|566039722|FG001|Overall Study|Therapeutic procedure required|0|||
156804477|NCT01331681|566039723|FG002|Overall Study|Therapeutic procedure required|0|||
156804478|NCT01331681|566039721|FG000|Overall Study|Sponsor decision|1|||
156804479|NCT01331681|566039722|FG001|Overall Study|Sponsor decision|1|||
156804480|NCT01331681|566039723|FG002|Overall Study|Sponsor decision|0|||
156804481|NCT01331681|566039721|FG000|Overall Study|Switching to other therapy|0|||
156804482|NCT01331681|566039722|FG001|Overall Study|Switching to other therapy|0|||
156804483|NCT01331681|566039723|FG002|Overall Study|Switching to other therapy|1|||
156804484|NCT01331681|566039721|FG000|Overall Study|Not Received Study Treatment|0|||
156804485|NCT01331681|566039722|FG001|Overall Study|Not Received Study Treatment|0|||
156804486|NCT01331681|566039723|FG002|Overall Study|Not Received Study Treatment|2|||
156804487|NCT00658541|566039726|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804488|NCT00658541|566039727|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804489|NCT00658541|566039726|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
156804490|NCT00658541|566039727|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
156804491|NCT04828707|566039728|FG000|Overall Study|Lost to Follow-up|3|||
156804492|NCT04828707|566039729|FG001|Overall Study|Lost to Follow-up|2|||
156804493|NCT04828707|566039728|FG000|Overall Study|Withdrawal by Subject|2|||
156804494|NCT04828707|566039729|FG001|Overall Study|Withdrawal by Subject|1|||
156804495|NCT01188967|566039734|FG000|Overall Study|Withdrawal by Subject|1|||
156804496|NCT01188967|566039735|FG001|Overall Study|Withdrawal by Subject|1|||
156804497|NCT01188967|566039734|FG000|Overall Study|Physician Decision|1|||
156804498|NCT01188967|566039735|FG001|Overall Study|Physician Decision|1|||
156804499|NCT01188967|566039734|FG000|Overall Study|Lost to Follow-up|3|||
156804500|NCT01188967|566039735|FG001|Overall Study|Lost to Follow-up|2|||
156804501|NCT01876381|566039736|FG000|Overall Study|Lack of Efficacy|5|||
156804502|NCT01876381|566039736|FG000|Overall Study|Physician Decision|1|||
156804503|NCT01876381|566039736|FG000|Overall Study|Withdrawal by Subject|1|||
156804504|NCT00523978|566039737|FG000|Overall Study|Withdrawal by Subject|3|||
156804505|NCT00523978|566039738|FG001|Overall Study|Withdrawal by Subject|7|||
156804506|NCT00523978|566039737|FG000|Overall Study|Screen Failures|5|||
156804507|NCT00523978|566039738|FG001|Overall Study|Screen Failures|1|||
156804508|NCT00523978|566039737|FG000|Overall Study|Death|1|||
156804509|NCT00523978|566039738|FG001|Overall Study|Death|0|||
156804510|NCT00382174|566039739|FG000|Overall Study|Lost to Follow-up|1|||
156804511|NCT00382174|566039740|FG001|Overall Study|Lost to Follow-up|4|||
156804512|NCT00382174|566039741|FG002|Overall Study|Lost to Follow-up|5|||
156804513|NCT00382174|566039739|FG000|Overall Study|Adverse Event|1|||
156804514|NCT00382174|566039740|FG001|Overall Study|Adverse Event|4|||
156804515|NCT00382174|566039741|FG002|Overall Study|Adverse Event|5|||
156804516|NCT00382174|566039739|FG000|Overall Study|Withdrawal by Subject|1|||
156804517|NCT00382174|566039740|FG001|Overall Study|Withdrawal by Subject|4|||
156804518|NCT00382174|566039741|FG002|Overall Study|Withdrawal by Subject|5|||
156804519|NCT00382174|566039739|FG000|Overall Study|Non compliance|1|||
156804520|NCT00382174|566039740|FG001|Overall Study|Non compliance|0|||
156804521|NCT00382174|566039741|FG002|Overall Study|Non compliance|1|||
156804522|NCT00382174|566039739|FG000|Overall Study|Physician Decision|0|||
156804523|NCT00382174|566039740|FG001|Overall Study|Physician Decision|2|||
156804524|NCT00382174|566039741|FG002|Overall Study|Physician Decision|2|||
156804525|NCT00382174|566039739|FG000|Overall Study|Failed to meet criteria|0|||
156804526|NCT00382174|566039740|FG001|Overall Study|Failed to meet criteria|1|||
157220991|NCT00585351|567554934|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156804527|NCT00382174|566039741|FG002|Overall Study|Failed to meet criteria|1|||
156804528|NCT00382174|566039739|FG000|Overall Study|Wounds merged|0|||
156804529|NCT00382174|566039740|FG001|Overall Study|Wounds merged|2|||
156804530|NCT00382174|566039741|FG002|Overall Study|Wounds merged|2|||
156804531|NCT04577781|566039744|FG000|Overall Study|Adverse Event|2|||
156804532|NCT04577781|566039745|FG001|Overall Study|Adverse Event|2|||
156804533|NCT04577781|566039744|FG000|Overall Study|Physician Decision|1|||
156804534|NCT04577781|566039745|FG001|Overall Study|Physician Decision|0|||
156804535|NCT01464879|566039746|FG000|Overall Study|Physician Decision|1|||
156804536|NCT01464879|566039746|FG000|Overall Study|Non-compliance|1|||
156804537|NCT01657305|566039748|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
156804538|NCT01657305|566039748|FG000|Overall Study|Withdrawal by Subject|4|||
156804539|NCT01657305|566039748|FG000|Overall Study|Adverse Event|1|||
156804540|NCT01657305|566039748|FG000|Overall Study|Lost to Follow-up|1|||
156804541|NCT01657305|566039748|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
156804542|NCT00696878|566039751|FG000|Overall Study|Adverse Event|8|||
156804543|NCT00696878|566039751|FG000|Overall Study|Withdrawal by Subject|87|||
156804544|NCT00696878|566039751|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
156804545|NCT00696878|566039751|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
156804546|NCT00696878|566039751|FG000|Overall Study|Trial stopped|32|||
156804547|NCT00696878|566039751|FG000|Overall Study|Other reason (not specified)|55|||
156804548|NCT04103450|566039752|FG000|Overall Study|Adverse Event|4|||
156804549|NCT04103450|566039753|FG001|Overall Study|Adverse Event|2|||
156804550|NCT04103450|566039752|FG000|Overall Study|Lack of Efficacy|3|||
156804551|NCT04103450|566039753|FG001|Overall Study|Lack of Efficacy|0|||
156804552|NCT04103450|566039752|FG000|Overall Study|Withdrawal by Subject|5|||
156804553|NCT04103450|566039753|FG001|Overall Study|Withdrawal by Subject|3|||
156804554|NCT04103450|566039752|FG000|Overall Study|Lost to Follow-up|1|||
156804555|NCT04103450|566039753|FG001|Overall Study|Lost to Follow-up|2|||
156804556|NCT04103450|566039752|FG000|Overall Study|Physician Decision|1|||
156804557|NCT04103450|566039753|FG001|Overall Study|Physician Decision|2|||
156804558|NCT04103450|566039752|FG000|Overall Study|Protocol Violation|1|||
156804559|NCT04103450|566039753|FG001|Overall Study|Protocol Violation|0|||
156804560|NCT04103450|566039752|FG000|Overall Study|Other|1|||
156804561|NCT04103450|566039753|FG001|Overall Study|Other|1|||
156804562|NCT00967616|566039756|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
156804563|NCT00967616|566039757|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
156804564|NCT00967616|566039756|FG000|Overall Study|Death|0|||
156804565|NCT00967616|566039757|FG001|Overall Study|Death|3|||
156804566|NCT00967616|566039756|FG000|Overall Study|Withdrawal by Subject|8|||
156804567|NCT00967616|566039757|FG001|Overall Study|Withdrawal by Subject|4|||
156804568|NCT00967616|566039756|FG000|Overall Study|Progressive Disease|31|||
156804569|NCT00967616|566039757|FG001|Overall Study|Progressive Disease|18|||
156804570|NCT00967616|566039756|FG000|Overall Study|Other|8|||
156804571|NCT00967616|566039757|FG001|Overall Study|Other|8|||
156804572|NCT00967616|566039756|FG000|Overall Study|Protocol Violation|1|||
156804573|NCT00967616|566039757|FG001|Overall Study|Protocol Violation|0|||
156804574|NCT00575666|566039758|FG000|Overall Study|Withdrawal by Subject|3|||
156804575|NCT00575666|566039759|FG001|Overall Study|Withdrawal by Subject|2|||
156804576|NCT00575666|566039758|FG000|Overall Study|Physician Decision|1|||
156804577|NCT00575666|566039759|FG001|Overall Study|Physician Decision|1|||
156804578|NCT01374425|566039760|FG000|Overall Study|Radiographic Disease Progression|86|||
156804579|NCT01374425|566039761|FG001|Overall Study|Radiographic Disease Progression|81|||
156804580|NCT01374425|566039760|FG000|Overall Study|Clinical Disease Progression|9|||
156804581|NCT01374425|566039761|FG001|Overall Study|Clinical Disease Progression|6|||
156804582|NCT01374425|566039760|FG000|Overall Study|Adverse Event|29|||
156804583|NCT01374425|566039761|FG001|Overall Study|Adverse Event|18|||
156804584|NCT01374425|566039760|FG000|Overall Study|Death (Progression of Disease)|1|||
156804585|NCT01374425|566039761|FG001|Overall Study|Death (Progression of Disease)|0|||
156804586|NCT01374425|566039760|FG000|Overall Study|Death (Adverse Event)|2|||
156804587|NCT01374425|566039761|FG001|Overall Study|Death (Adverse Event)|4|||
156804588|NCT01374425|566039760|FG000|Overall Study|Withdrawal by Subject|6|||
156804589|NCT01374425|566039761|FG001|Overall Study|Withdrawal by Subject|7|||
156804590|NCT01374425|566039760|FG000|Overall Study|Refused Treatment|10|||
156804591|NCT01374425|566039761|FG001|Overall Study|Refused Treatment|24|||
156804592|NCT01374425|566039760|FG000|Overall Study|Protocol Violation|2|||
156804593|NCT01374425|566039761|FG001|Overall Study|Protocol Violation|3|||
156804594|NCT01374425|566039760|FG000|Overall Study|Sponsor Decision|0|||
156804595|NCT01374425|566039761|FG001|Overall Study|Sponsor Decision|1|||
156804596|NCT01374425|566039760|FG000|Overall Study|Lost to Follow-up|2|||
156804597|NCT01374425|566039761|FG001|Overall Study|Lost to Follow-up|1|||
156804598|NCT01374425|566039760|FG000|Overall Study|Other|41|||
156804599|NCT01374425|566039761|FG001|Overall Study|Other|43|||
156804600|NCT02289469|566039762|FG000|Overall Study|Unable to match a control|6|||
156804601|NCT02289469|566039763|FG001|Overall Study|Unable to match a control|0|||
156804602|NCT02750930|566039766|FG000|Overall Study|Study closed/terminated|8|||
156804603|NCT00553631|566039768|FG000|Overall Study|Withdrawal by Subject|0|||
156804604|NCT00553631|566039769|FG001|Overall Study|Withdrawal by Subject|1|||
156804605|NCT00553631|566039768|FG000|Overall Study|Lost to Follow-up|1|||
156804606|NCT00553631|566039769|FG001|Overall Study|Lost to Follow-up|0|||
156804607|NCT02761642|566039770|FG000|Overall Study|Did not Receive Study Treatment|3|||
156804608|NCT02761642|566039770|FG000|Overall Study|Adverse Event|13|||
156804609|NCT02761642|566039770|FG000|Overall Study|Withdrawal by Subject|2|||
156804610|NCT02761642|566039770|FG000|Overall Study|Non-compliant|7|||
156881757|NCT02410343|566327008|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
156804611|NCT02761642|566039770|FG000|Overall Study|Death|3|||
156804612|NCT02761642|566039770|FG000|Overall Study|Lack of Efficacy|20|||
156804613|NCT02761642|566039770|FG000|Overall Study|Physician Decision|1|||
156804614|NCT02761642|566039770|FG000|Overall Study|Reason Unspecified|21|||
156804615|NCT04940130|566039775|FG000|Overall Study|Travel|1|||
156804616|NCT04940130|566039776|FG001|Overall Study|Travel|0|||
156804617|NCT04940130|566039777|FG002|Overall Study|Travel|2|||
156804618|NCT04940130|566039775|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
156804619|NCT04940130|566039776|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
156804620|NCT04940130|566039777|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
156804621|NCT04940130|566039775|FG000|Overall Study|Adverse Event|0|||
156804622|NCT04940130|566039776|FG001|Overall Study|Adverse Event|0|||
156804623|NCT04940130|566039777|FG002|Overall Study|Adverse Event|2|||
156804624|NCT04940130|566039775|FG000|Overall Study|Disease progression/treatment failure|0|||
156804625|NCT04940130|566039776|FG001|Overall Study|Disease progression/treatment failure|0|||
156804626|NCT04940130|566039777|FG002|Overall Study|Disease progression/treatment failure|1|||
156804627|NCT04940130|566039775|FG000|Overall Study|Participant refusal|0|||
156804628|NCT04940130|566039776|FG001|Overall Study|Participant refusal|0|||
156804629|NCT04940130|566039777|FG002|Overall Study|Participant refusal|1|||
156804630|NCT00114127|566039778|FG000|Overall Study|Adverse Event|2|||
156804631|NCT00114127|566039779|FG001|Overall Study|Adverse Event|1|||
156804632|NCT00114127|566039778|FG000|Overall Study|Lost to Follow-up|1|||
156804633|NCT00114127|566039779|FG001|Overall Study|Lost to Follow-up|0|||
156804634|NCT00114127|566039778|FG000|Overall Study|Withdrawal by Subject|1|||
156804635|NCT00114127|566039779|FG001|Overall Study|Withdrawal by Subject|3|||
156804636|NCT00570713|566039780|FG000|Overall Study|Adverse Event|16|||
156804637|NCT00570713|566039781|FG001|Overall Study|Adverse Event|9|||
156804638|NCT00570713|566039780|FG000|Overall Study|Death|7|||
156804639|NCT00570713|566039781|FG001|Overall Study|Death|7|||
156804640|NCT00570713|566039780|FG000|Overall Study|Lack of Efficacy|40|||
156804641|NCT00570713|566039781|FG001|Overall Study|Lack of Efficacy|49|||
156804642|NCT00570713|566039780|FG000|Overall Study|Physician Decision|2|||
156804643|NCT00570713|566039781|FG001|Overall Study|Physician Decision|2|||
156804644|NCT00570713|566039780|FG000|Overall Study|Withdrawal by Subject|3|||
156804645|NCT00570713|566039781|FG001|Overall Study|Withdrawal by Subject|3|||
156804646|NCT00570713|566039780|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
156804647|NCT00570713|566039781|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
156804648|NCT00469833|566039782|FG000|Overall Study|No IV access|2|||
156804649|NCT03289533|566039783|FG000|Overall Study|Death|12|||
156804650|NCT03289533|566039783|FG000|Overall Study|Terminated from study by sponsor|10|||
156804651|NCT00539240|566039784|FG000|Overall Study|Withdrawal by Subject|0|||
156804652|NCT00539240|566039785|FG001|Overall Study|Withdrawal by Subject|2|||
156804653|NCT00539240|566039786|FG002|Overall Study|Withdrawal by Subject|0|||
156804654|NCT00539240|566039784|FG000|Overall Study|Protocol Violation|1|||
156804655|NCT00539240|566039785|FG001|Overall Study|Protocol Violation|1|||
156804656|NCT00539240|566039786|FG002|Overall Study|Protocol Violation|4|||
156804657|NCT00539240|566039784|FG000|Overall Study|Lost to Follow-up|2|||
156804658|NCT00539240|566039785|FG001|Overall Study|Lost to Follow-up|3|||
156804659|NCT00539240|566039786|FG002|Overall Study|Lost to Follow-up|1|||
156804660|NCT00539240|566039784|FG000|Overall Study|Adverse Event|3|||
156804661|NCT00539240|566039785|FG001|Overall Study|Adverse Event|1|||
156804662|NCT00539240|566039786|FG002|Overall Study|Adverse Event|10|||
156804663|NCT00902330|566039791|FG000|Overall Study|Too overwhelmed by treatment|2|||
156804664|NCT00902330|566039792|FG001|Overall Study|Too overwhelmed by treatment|5|||
156804665|NCT00902330|566039791|FG000|Overall Study|Adverse Event|1|||
156804666|NCT00902330|566039792|FG001|Overall Study|Adverse Event|0|||
156804667|NCT00902330|566039791|FG000|Overall Study|No post baseline data|1|||
156804668|NCT00902330|566039792|FG001|Overall Study|No post baseline data|0|||
156804669|NCT01816048|566039793|FG000|Overall Study|Adverse Event|1|||
156804670|NCT01816048|566039793|FG000|Overall Study|Death|1|||
156804671|NCT01816048|566039793|FG000|Overall Study|Withdrawal by Subject|1|||
156804672|NCT01816048|566039793|FG000|Overall Study|Disease Progression|3|||
156804673|NCT01847443|566039794|FG000|Study Period 1|Withdrawal by Subject|0|||
156804674|NCT01847443|566039795|FG001|Study Period 1|Withdrawal by Subject|1|||
156804675|NCT01847443|566039796|FG002|Study Period 1|Withdrawal by Subject|0|||
156804676|NCT01847443|566039797|FG003|Study Period 1|Withdrawal by Subject|0|||
156804677|NCT01847443|566039794|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
156804678|NCT01847443|566039795|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
156804679|NCT01847443|566039796|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
156804680|NCT01847443|566039797|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
156804681|NCT01847443|566039794|FG000|Washout Period Before Study Period 2|Other reason|1|||
156804682|NCT01847443|566039795|FG001|Washout Period Before Study Period 2|Other reason|0|||
156804683|NCT01847443|566039796|FG002|Washout Period Before Study Period 2|Other reason|0|||
156804684|NCT01847443|566039797|FG003|Washout Period Before Study Period 2|Other reason|0|||
156804685|NCT01847443|566039794|FG000|Washout Period Before Study Period 3|Other reason|1|||
156804686|NCT01847443|566039795|FG001|Washout Period Before Study Period 3|Other reason|0|||
156804687|NCT01847443|566039796|FG002|Washout Period Before Study Period 3|Other reason|0|||
156804688|NCT01847443|566039797|FG003|Washout Period Before Study Period 3|Other reason|0|||
156804689|NCT01847443|566039794|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
156804690|NCT01847443|566039795|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
156804691|NCT01847443|566039796|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
157021161|NCT03138512|566830853|FG002|Treatment Part B|Participant withdrew consent|1|||
156804692|NCT01847443|566039797|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
156804693|NCT01847443|566039794|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
156804694|NCT01847443|566039795|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804695|NCT01847443|566039796|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804696|NCT01847443|566039797|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
156804697|NCT03571971|566039798|FG000|Overall Study|Lost to Follow-up|2|||
156804698|NCT03571971|566039799|FG001|Overall Study|Lost to Follow-up|2|||
156804699|NCT03571971|566039798|FG000|Overall Study|Protocol Violation|2|||
156804700|NCT03571971|566039799|FG001|Overall Study|Protocol Violation|3|||
156804701|NCT03571971|566039798|FG000|Overall Study|Withdrawal by Subject|2|||
156804702|NCT03571971|566039799|FG001|Overall Study|Withdrawal by Subject|0|||
156804703|NCT03571971|566039798|FG000|Overall Study|Incomplete primary outcome data|2|||
156804704|NCT03571971|566039799|FG001|Overall Study|Incomplete primary outcome data|0|||
156804705|NCT04067492|566039800|FG000|Overall Study|Lost to Follow-up|0|||
156804706|NCT04067492|566039801|FG001|Overall Study|Lost to Follow-up|0|||
156804707|NCT04067492|566039802|FG002|Overall Study|Lost to Follow-up|0|||
156804708|NCT04067492|566039803|FG003|Overall Study|Lost to Follow-up|0|||
156804709|NCT04067492|566039804|FG004|Overall Study|Lost to Follow-up|0|||
156804710|NCT04067492|566039805|FG005|Overall Study|Lost to Follow-up|1|||
156804711|NCT04067492|566039800|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804712|NCT04067492|566039801|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
156804713|NCT04067492|566039802|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804714|NCT04067492|566039803|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804715|NCT04067492|566039804|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804716|NCT04067492|566039805|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
156804717|NCT04067492|566039800|FG000|Overall Study|COVID-19 epidemiological situation|0|||
156804718|NCT04067492|566039801|FG001|Overall Study|COVID-19 epidemiological situation|0|||
156804719|NCT04067492|566039802|FG002|Overall Study|COVID-19 epidemiological situation|0|||
156804720|NCT04067492|566039803|FG003|Overall Study|COVID-19 epidemiological situation|1|||
156804721|NCT04067492|566039804|FG004|Overall Study|COVID-19 epidemiological situation|0|||
156804722|NCT04067492|566039805|FG005|Overall Study|COVID-19 epidemiological situation|0|||
156881758|NCT02410343|566327009|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
156881759|NCT04556383|566327012|FG000|PCP|Lack of Efficacy|28|||
156881760|NCT04556383|566327013|FG001|PCP|Lack of Efficacy|23|||
156881761|NCT04556383|566327014|FG002|PCP|Lack of Efficacy|23|||
156881762|NCT04556383|566327015|FG003|PCP|Lack of Efficacy|0|||
156881763|NCT04556383|566327012|FG000|PCP|Study terminated by sponsor|15|||
156881764|NCT04556383|566327013|FG001|PCP|Study terminated by sponsor|13|||
156881765|NCT04556383|566327014|FG002|PCP|Study terminated by sponsor|16|||
156881766|NCT04556383|566327015|FG003|PCP|Study terminated by sponsor|0|||
156881767|NCT04556383|566327012|FG000|PCP|Withdrawal by Subject|8|||
156881768|NCT04556383|566327013|FG001|PCP|Withdrawal by Subject|6|||
156881769|NCT04556383|566327014|FG002|PCP|Withdrawal by Subject|6|||
156881770|NCT04556383|566327015|FG003|PCP|Withdrawal by Subject|0|||
156881771|NCT04556383|566327012|FG000|PCP|Adverse Event|1|||
156881772|NCT04556383|566327013|FG001|PCP|Adverse Event|7|||
156881773|NCT04556383|566327014|FG002|PCP|Adverse Event|7|||
156881774|NCT04556383|566327015|FG003|PCP|Adverse Event|0|||
156881775|NCT04556383|566327012|FG000|PCP|Other, Not Specified|1|||
156881776|NCT04556383|566327013|FG001|PCP|Other, Not Specified|2|||
156804723|NCT03950856|566039813|FG000|Overall Study|Death|1|||
156804724|NCT03950856|566039814|FG001|Overall Study|Death|2|||
156804725|NCT03950856|566039815|FG002|Overall Study|Death|0|||
156881777|NCT04556383|566327014|FG002|PCP|Other, Not Specified|1|||
156881778|NCT04556383|566327015|FG003|PCP|Other, Not Specified|0|||
156881779|NCT04556383|566327012|FG000|PCP|Protocol Violation|1|||
157143907|NCT02158533|567276364|FG000|Stage 2|Adverse Event|0|||
156804726|NCT03950856|566039816|FG003|Overall Study|Death|0|||
156804727|NCT03950856|566039813|FG000|Overall Study|Lost to Follow-up|5|||
156804728|NCT03950856|566039814|FG001|Overall Study|Lost to Follow-up|6|||
156804729|NCT03950856|566039815|FG002|Overall Study|Lost to Follow-up|8|||
156804730|NCT03950856|566039816|FG003|Overall Study|Lost to Follow-up|2|||
156804731|NCT03950856|566039813|FG000|Overall Study|Protocol Violation|2|||
156881780|NCT04556383|566327013|FG001|PCP|Protocol Violation|0|||
156881781|NCT04556383|566327014|FG002|PCP|Protocol Violation|1|||
156881782|NCT04556383|566327015|FG003|PCP|Protocol Violation|0|||
156881783|NCT04556383|566327012|FG000|PCP|Lost to Follow-up|1|||
156881784|NCT04556383|566327013|FG001|PCP|Lost to Follow-up|0|||
156881785|NCT04556383|566327014|FG002|PCP|Lost to Follow-up|0|||
156881786|NCT04556383|566327015|FG003|PCP|Lost to Follow-up|0|||
156881787|NCT04556383|566327012|FG000|PCP|Physician Decision|0|||
156881788|NCT04556383|566327013|FG001|PCP|Physician Decision|1|||
156881789|NCT04556383|566327014|FG002|PCP|Physician Decision|0|||
157143908|NCT02158533|567276365|FG001|Stage 2|Adverse Event|0|||
156881790|NCT04556383|566327015|FG003|PCP|Physician Decision|0|||
156881791|NCT04556383|566327012|FG000|PCP|Site terminated by sponsor|0|||
156881792|NCT04556383|566327013|FG001|PCP|Site terminated by sponsor|1|||
156881793|NCT04556383|566327014|FG002|PCP|Site terminated by sponsor|0|||
156804732|NCT03950856|566039814|FG001|Overall Study|Protocol Violation|0|||
156804733|NCT03950856|566039815|FG002|Overall Study|Protocol Violation|0|||
156804734|NCT03950856|566039816|FG003|Overall Study|Protocol Violation|1|||
156804735|NCT03950856|566039813|FG000|Overall Study|Withdrawal by Subject|4|||
156804736|NCT03950856|566039814|FG001|Overall Study|Withdrawal by Subject|1|||
156804737|NCT03950856|566039815|FG002|Overall Study|Withdrawal by Subject|3|||
156804738|NCT03950856|566039816|FG003|Overall Study|Withdrawal by Subject|1|||
156804739|NCT03950856|566039813|FG000|Overall Study|Unable to phone|7|||
156804740|NCT03950856|566039814|FG001|Overall Study|Unable to phone|6|||
156804741|NCT03950856|566039815|FG002|Overall Study|Unable to phone|7|||
156804742|NCT03950856|566039816|FG003|Overall Study|Unable to phone|2|||
156804743|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
156804744|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
156804745|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
156804746|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
156804747|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
156804748|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
156804749|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
156804750|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
156804751|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
156804752|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
156804753|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
156804754|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
156804755|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
156804756|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
156804757|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
156804758|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
156804759|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
156804760|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
156804761|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
156804762|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
156804763|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
156804764|NCT04021290|566039819|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
156804765|NCT04021290|566039820|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
156804766|NCT04021290|566039821|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
156804767|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
156804768|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
156804769|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
156804770|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
156804771|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
156804772|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
156804773|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
156804774|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
156804775|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
156804776|NCT04021290|566039819|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
156804777|NCT04021290|566039820|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
156804778|NCT04021290|566039821|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
156804779|NCT03391882|566039822|FG000|Study Overall|Adverse Event|3|||
156804780|NCT03391882|566039823|FG001|Study Overall|Adverse Event|6|||
156804781|NCT03391882|566039824|FG002|Study Overall|Adverse Event|1|||
156804782|NCT03391882|566039825|FG003|Study Overall|Adverse Event|1|||
156804783|NCT03391882|566039826|FG004|Study Overall|Adverse Event|3|||
156804784|NCT03391882|566039827|FG005|Study Overall|Adverse Event|1|||
156804785|NCT03391882|566039822|FG000|Study Overall|Lack of Efficacy|13|||
156804786|NCT03391882|566039823|FG001|Study Overall|Lack of Efficacy|9|||
156804787|NCT03391882|566039824|FG002|Study Overall|Lack of Efficacy|0|||
156804788|NCT03391882|566039825|FG003|Study Overall|Lack of Efficacy|0|||
156804789|NCT03391882|566039826|FG004|Study Overall|Lack of Efficacy|0|||
156804790|NCT03391882|566039827|FG005|Study Overall|Lack of Efficacy|0|||
156804791|NCT03391882|566039822|FG000|Study Overall|Withdrawal by Subject|3|||
156804792|NCT03391882|566039823|FG001|Study Overall|Withdrawal by Subject|3|||
156804793|NCT03391882|566039824|FG002|Study Overall|Withdrawal by Subject|2|||
156804794|NCT03391882|566039825|FG003|Study Overall|Withdrawal by Subject|2|||
156804795|NCT03391882|566039826|FG004|Study Overall|Withdrawal by Subject|1|||
156804796|NCT03391882|566039827|FG005|Study Overall|Withdrawal by Subject|3|||
156804797|NCT03391882|566039822|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804798|NCT03391882|566039823|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
156804799|NCT03391882|566039824|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804800|NCT03391882|566039825|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804801|NCT03391882|566039826|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156804802|NCT03391882|566039827|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
156881794|NCT04556383|566327015|FG003|PCP|Site terminated by sponsor|0|||
156881795|NCT04556383|566327012|FG000|OLE|Study terminated by sponsor|0|||
156881796|NCT04556383|566327013|FG001|OLE|Study terminated by sponsor|0|||
156881797|NCT04556383|566327014|FG002|OLE|Study terminated by sponsor|0|||
156881798|NCT04556383|566327015|FG003|OLE|Study terminated by sponsor|68|||
156881799|NCT04556383|566327012|FG000|OLE|Withdrawal by Subject|0|||
156881800|NCT04556383|566327013|FG001|OLE|Withdrawal by Subject|0|||
156881801|NCT04556383|566327014|FG002|OLE|Withdrawal by Subject|0|||
156881802|NCT04556383|566327015|FG003|OLE|Withdrawal by Subject|10|||
156881803|NCT04556383|566327012|FG000|OLE|Lack of Efficacy|0|||
156881804|NCT04556383|566327013|FG001|OLE|Lack of Efficacy|0|||
156881805|NCT04556383|566327014|FG002|OLE|Lack of Efficacy|0|||
156881806|NCT04556383|566327015|FG003|OLE|Lack of Efficacy|7|||
156881807|NCT04556383|566327012|FG000|OLE|Adverse Event|0|||
156881808|NCT04556383|566327013|FG001|OLE|Adverse Event|0|||
156881809|NCT04556383|566327014|FG002|OLE|Adverse Event|0|||
156881810|NCT04556383|566327015|FG003|OLE|Adverse Event|2|||
156881811|NCT04556383|566327012|FG000|OLE|Other, Not Specified|0|||
156881812|NCT04556383|566327013|FG001|OLE|Other, Not Specified|0|||
156881813|NCT04556383|566327014|FG002|OLE|Other, Not Specified|0|||
156881814|NCT04556383|566327015|FG003|OLE|Other, Not Specified|2|||
156881815|NCT04556383|566327012|FG000|OLE|Death|0|||
156881816|NCT04556383|566327013|FG001|OLE|Death|0|||
156881817|NCT04556383|566327014|FG002|OLE|Death|0|||
156881818|NCT04556383|566327015|FG003|OLE|Death|1|||
156881819|NCT04556383|566327012|FG000|OLE|Lost to Follow-up|0|||
156881820|NCT04556383|566327013|FG001|OLE|Lost to Follow-up|0|||
156881821|NCT04556383|566327014|FG002|OLE|Lost to Follow-up|0|||
156881822|NCT04556383|566327015|FG003|OLE|Lost to Follow-up|1|||
156881823|NCT02720042|566327016|FG000|Overall Study|Death|3|||
156881824|NCT02720042|566327016|FG000|Overall Study|Lost to Follow-up|4|||
156881825|NCT02720042|566327016|FG000|Overall Study|Withdrawal by Subject|1|||
156881826|NCT02720042|566327016|FG000|Overall Study|Physician Decision|3|||
156881827|NCT02720042|566327016|FG000|Overall Study|Phasix Mesh explanted|1|||
156881828|NCT02720042|566327016|FG000|Overall Study|unable due to non-study-related illness|3|||
156881829|NCT03704636|566327017|FG000|Overall Study|Inadequate Venous Flow|3|||
156881830|NCT00539188|566327018|FG000|Overall Study|Withdrawal by Subject|1|||
156881831|NCT00539188|566327019|FG001|Overall Study|Withdrawal by Subject|0|||
156881832|NCT00539188|566327018|FG000|Overall Study|Lost to Follow-up|2|||
156881833|NCT00539188|566327019|FG001|Overall Study|Lost to Follow-up|1|||
156881834|NCT04784442|566327022|FG000|Overall Study|Adverse Event|1|||
156881835|NCT04784442|566327023|FG001|Overall Study|Adverse Event|0|||
156881836|NCT04784442|566327024|FG002|Overall Study|Adverse Event|2|||
156881837|NCT04784442|566327025|FG003|Overall Study|Adverse Event|1|||
156881838|NCT04784442|566327022|FG000|Overall Study|Protocol Violation|1|||
156881839|NCT04784442|566327023|FG001|Overall Study|Protocol Violation|0|||
156881840|NCT04784442|566327024|FG002|Overall Study|Protocol Violation|0|||
156881841|NCT04784442|566327025|FG003|Overall Study|Protocol Violation|0|||
156881842|NCT04784442|566327022|FG000|Overall Study|Non-compliance with study drug|1|||
156881843|NCT04784442|566327023|FG001|Overall Study|Non-compliance with study drug|0|||
156881844|NCT04784442|566327024|FG002|Overall Study|Non-compliance with study drug|0|||
156881845|NCT04784442|566327025|FG003|Overall Study|Non-compliance with study drug|0|||
156881846|NCT00509145|566327026|FG000|Overall Study|Death|0|||
156881847|NCT00509145|566327027|FG001|Overall Study|Death|2|||
156881848|NCT00509145|566327026|FG000|Overall Study|Adverse Event|42|||
156881849|NCT00509145|566327027|FG001|Overall Study|Adverse Event|28|||
156881850|NCT00509145|566327026|FG000|Overall Study|Withdrawal by Subject|32|||
156881851|NCT00509145|566327027|FG001|Overall Study|Withdrawal by Subject|38|||
156881852|NCT00509145|566327026|FG000|Overall Study|Physician Decision|11|||
156881853|NCT00509145|566327027|FG001|Overall Study|Physician Decision|14|||
156881854|NCT00509145|566327026|FG000|Overall Study|Protocol Violation|1|||
156881855|NCT00509145|566327027|FG001|Overall Study|Protocol Violation|6|||
156881856|NCT00509145|566327026|FG000|Overall Study|Pregnancy|3|||
157143909|NCT02158533|567276366|FG002|Stage 2|Adverse Event|0|||
157143910|NCT02158533|567276367|FG003|Stage 2|Adverse Event|0|||
156881857|NCT00509145|566327027|FG001|Overall Study|Pregnancy|8|||
156881858|NCT00509145|566327026|FG000|Overall Study|Lost to Follow-up|6|||
156881859|NCT00509145|566327027|FG001|Overall Study|Lost to Follow-up|5|||
156881860|NCT00509145|566327026|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
156881861|NCT00509145|566327027|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
156881862|NCT00509145|566327026|FG000|Overall Study|Other|6|||
156881863|NCT00509145|566327027|FG001|Overall Study|Other|6|||
156881864|NCT00246740|566327028|FG000|Initial Enrollment|Death|1|||
156881865|NCT00246740|566327029|FG001|Initial Enrollment|Death|0|||
156881866|NCT00246740|566327028|FG000|Initial Enrollment|Additional surgery scheduled|0|||
156881867|NCT00246740|566327029|FG001|Initial Enrollment|Additional surgery scheduled|2|||
156881868|NCT00246740|566327028|FG000|Initial Enrollment|Surgery schedule change|4|||
156881869|NCT00246740|566327029|FG001|Initial Enrollment|Surgery schedule change|4|||
156881870|NCT00246740|566327028|FG000|Initial Enrollment|Other|1|||
156881871|NCT00246740|566327029|FG001|Initial Enrollment|Other|2|||
156881872|NCT00101452|566327032|FG000|Overall Study|Adverse Event|2|||
156881873|NCT00101452|566327033|FG001|Overall Study|Adverse Event|0|||
156804803|NCT03391882|566039822|FG000|Study Overall|Protocol Violation|1|||
156804804|NCT03391882|566039823|FG001|Study Overall|Protocol Violation|0|||
156804805|NCT03391882|566039824|FG002|Study Overall|Protocol Violation|0|||
156804806|NCT03391882|566039825|FG003|Study Overall|Protocol Violation|0|||
156804807|NCT03391882|566039826|FG004|Study Overall|Protocol Violation|0|||
156804808|NCT03391882|566039827|FG005|Study Overall|Protocol Violation|0|||
156804809|NCT03391882|566039822|FG000|Part A - Titration Phase|Adverse Event|3|||
156804810|NCT03391882|566039823|FG001|Part A - Titration Phase|Adverse Event|6|||
156804811|NCT03391882|566039824|FG002|Part A - Titration Phase|Adverse Event|0|||
156804812|NCT03391882|566039825|FG003|Part A - Titration Phase|Adverse Event|0|||
156804813|NCT03391882|566039826|FG004|Part A - Titration Phase|Adverse Event|0|||
156804814|NCT03391882|566039827|FG005|Part A - Titration Phase|Adverse Event|0|||
156804815|NCT03391882|566039822|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
156804816|NCT03391882|566039823|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
156804817|NCT03391882|566039824|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
156804818|NCT03391882|566039825|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
156804819|NCT03391882|566039826|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
156804820|NCT03391882|566039827|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
156804821|NCT03391882|566039822|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
156804822|NCT03391882|566039823|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
156804823|NCT03391882|566039824|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
156804824|NCT03391882|566039825|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
156804825|NCT03391882|566039826|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
156804826|NCT03391882|566039827|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
156804827|NCT03391882|566039822|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804828|NCT03391882|566039823|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
156804829|NCT03391882|566039824|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804830|NCT03391882|566039825|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804831|NCT03391882|566039826|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804832|NCT03391882|566039827|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
156804833|NCT03391882|566039822|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
156804834|NCT03391882|566039823|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
156804835|NCT03391882|566039824|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804836|NCT03391882|566039825|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804837|NCT03391882|566039826|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804838|NCT03391882|566039827|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
156804839|NCT03391882|566039822|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
156804840|NCT03391882|566039823|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
156804841|NCT03391882|566039824|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
156804842|NCT03391882|566039825|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
156804843|NCT03391882|566039826|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
156804844|NCT03391882|566039827|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
156804845|NCT03391882|566039822|FG000|Part B - Treatment Phase|Adverse Event|0|||
156804846|NCT03391882|566039823|FG001|Part B - Treatment Phase|Adverse Event|0|||
156804847|NCT03391882|566039824|FG002|Part B - Treatment Phase|Adverse Event|1|||
156804848|NCT03391882|566039825|FG003|Part B - Treatment Phase|Adverse Event|1|||
156804849|NCT03391882|566039826|FG004|Part B - Treatment Phase|Adverse Event|3|||
156804850|NCT03391882|566039827|FG005|Part B - Treatment Phase|Adverse Event|1|||
156804851|NCT03391882|566039822|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
156804852|NCT03391882|566039823|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
156804853|NCT03391882|566039824|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
156804854|NCT03391882|566039825|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
156804855|NCT03391882|566039826|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
156804856|NCT03391882|566039827|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
156804857|NCT03092479|566039828|FG000|Overall Study|Lost to Follow-up|3|||
156804858|NCT03092479|566039829|FG001|Overall Study|Lost to Follow-up|2|||
156804859|NCT03092479|566039828|FG000|Overall Study|Withdrawal by Subject|4|||
156804860|NCT03092479|566039829|FG001|Overall Study|Withdrawal by Subject|0|||
156804861|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
156804862|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
156804863|NCT04422431|566039832|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
156804864|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
156804865|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
156804866|NCT04422431|566039832|FG000|Extension Period (48 Weeks)|Other than specified|2|||
156804867|NCT03913130|566039833|FG000|Overall Study|Sponsor Decision|1|||
156804868|NCT01174563|566039836|FG000|Overall Study|Progressive Disease|45|||
157143911|NCT02158533|567276368|FG004|Stage 2|Adverse Event|0|||
156804869|NCT01174563|566039836|FG000|Overall Study|Death|5|||
156804870|NCT01174563|566039836|FG000|Overall Study|Investigator's Discretion|5|||
156804871|NCT01174563|566039836|FG000|Overall Study|Participant Withdrew Consent|3|||
156804872|NCT01174563|566039836|FG000|Overall Study|Rash Adverse Event|1|||
156804873|NCT01174563|566039836|FG000|Overall Study|Sponsor's decision|1|||
156804874|NCT03402841|566039837|FG000|Overall Study|Withdrawal by Subject|3|||
156804875|NCT03402841|566039837|FG000|Overall Study|Lost to Follow-up|2|||
157220992|NCT00585351|567554935|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156804876|NCT03402841|566039837|FG000|Overall Study|Death|146|||
156804877|NCT01173679|566041753|FG000|Overall Study|Death|1|||
156804878|NCT03247829|566041758|FG000|Overall Study|Death|3|||
156804879|NCT03247829|566041759|FG001|Overall Study|Death|4|||
156804880|NCT03247829|566041758|FG000|Overall Study|Enter Hospice Care|1|||
156804881|NCT03247829|566041759|FG001|Overall Study|Enter Hospice Care|0|||
156804882|NCT03247829|566041758|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
156804883|NCT03247829|566041759|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
156804884|NCT03247829|566041758|FG000|Overall Study|LVAD Explant|1|||
156804885|NCT03247829|566041759|FG001|Overall Study|LVAD Explant|1|||
156804886|NCT03247829|566041758|FG000|Overall Study|Transplant|1|||
156804887|NCT03247829|566041759|FG001|Overall Study|Transplant|1|||
156804888|NCT00441272|566041760|FG000|Overall Study|Study terminated prior to enrollment|25|||
156804889|NCT00441272|566041761|FG001|Overall Study|Study terminated prior to enrollment|25|||
156804890|NCT00443703|566041762|FG000|Overall Study|Never Treated|3|||
156804891|NCT00443703|566041763|FG001|Overall Study|Never Treated|1|||
156804892|NCT00443703|566041762|FG000|Overall Study|Adverse Event|7|||
156804893|NCT00443703|566041763|FG001|Overall Study|Adverse Event|3|||
156804894|NCT00443703|566041762|FG000|Overall Study|Lack of Efficacy|3|||
156804895|NCT00443703|566041763|FG001|Overall Study|Lack of Efficacy|1|||
156804896|NCT00443703|566041762|FG000|Overall Study|Lost to Follow-up|0|||
156804897|NCT00443703|566041763|FG001|Overall Study|Lost to Follow-up|4|||
156804898|NCT00443703|566041762|FG000|Overall Study|Physician Decision|4|||
156804899|NCT00443703|566041763|FG001|Overall Study|Physician Decision|2|||
156804900|NCT00443703|566041762|FG000|Overall Study|Protocol Violation|1|||
156804901|NCT00443703|566041763|FG001|Overall Study|Protocol Violation|1|||
156804902|NCT00443703|566041762|FG000|Overall Study|Withdrawal by Subject|9|||
156804903|NCT00443703|566041763|FG001|Overall Study|Withdrawal by Subject|6|||
156804904|NCT00443703|566041762|FG000|Overall Study|Progressive Disease|1|||
156804905|NCT00443703|566041763|FG001|Overall Study|Progressive Disease|0|||
156804906|NCT01047007|566041764|FG000|Overall Study|Adverse Event|0|||
156804907|NCT01047007|566041765|FG001|Overall Study|Adverse Event|2|||
156804908|NCT01047007|566041766|FG002|Overall Study|Adverse Event|1|||
156804909|NCT01047007|566041767|FG003|Overall Study|Adverse Event|0|||
156804910|NCT01047007|566041764|FG000|Overall Study|Progressive Disease|2|||
156804911|NCT01047007|566041765|FG001|Overall Study|Progressive Disease|4|||
156804912|NCT01047007|566041766|FG002|Overall Study|Progressive Disease|1|||
156804913|NCT01047007|566041767|FG003|Overall Study|Progressive Disease|0|||
156804914|NCT03423602|566041771|FG000|Overall Study|Death|1|||
156804915|NCT03423602|566041771|FG000|Overall Study|Lost to Follow-up|6|||
156804916|NCT03423602|566041771|FG000|Overall Study|Protocol Violation|1|||
156804917|NCT03423602|566041771|FG000|Overall Study|Withdrawal by Subject|4|||
156804918|NCT01747915|566041775|FG000|Overall Study|Other|1|||
157220993|NCT00585351|567554936|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
157220994|NCT00585351|567554937|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
156804919|NCT01747915|566041776|FG001|Overall Study|Other|1|||
156804920|NCT01747915|566041777|FG002|Overall Study|Other|1|||
156804921|NCT01747915|566041775|FG000|Overall Study|Adverse Event|8|||
156804922|NCT01747915|566041776|FG001|Overall Study|Adverse Event|5|||
156804923|NCT01747915|566041777|FG002|Overall Study|Adverse Event|2|||
156804924|NCT01747915|566041775|FG000|Overall Study|Death|0|||
156804925|NCT01747915|566041776|FG001|Overall Study|Death|0|||
156804926|NCT01747915|566041777|FG002|Overall Study|Death|1|||
156804927|NCT01747915|566041775|FG000|Overall Study|Lack of Efficacy|0|||
156804928|NCT01747915|566041776|FG001|Overall Study|Lack of Efficacy|1|||
156804929|NCT01747915|566041777|FG002|Overall Study|Lack of Efficacy|0|||
156804930|NCT01747915|566041775|FG000|Overall Study|Lost to Follow-up|1|||
156804931|NCT01747915|566041776|FG001|Overall Study|Lost to Follow-up|0|||
156804932|NCT01747915|566041777|FG002|Overall Study|Lost to Follow-up|0|||
156804933|NCT01747915|566041775|FG000|Overall Study|Withdrawal by Subject|4|||
156804934|NCT01747915|566041776|FG001|Overall Study|Withdrawal by Subject|4|||
156804935|NCT01747915|566041777|FG002|Overall Study|Withdrawal by Subject|1|||
156804936|NCT01747915|566041775|FG000|Overall Study|Protocol Violation|1|||
156804937|NCT01747915|566041776|FG001|Overall Study|Protocol Violation|0|||
156804938|NCT01747915|566041777|FG002|Overall Study|Protocol Violation|0|||
156804939|NCT01747915|566041775|FG000|Overall Study|Pregnancy|0|||
156804940|NCT01747915|566041776|FG001|Overall Study|Pregnancy|0|||
156804941|NCT01747915|566041777|FG002|Overall Study|Pregnancy|1|||
156804942|NCT03341637|566041778|FG000|Overall Study|Lost to Follow-up|1|||
156804943|NCT03341637|566041779|FG001|Overall Study|Lost to Follow-up|0|||
156804944|NCT03341637|566041778|FG000|Overall Study|Withdrawal by Subject|3|||
156804945|NCT03341637|566041779|FG001|Overall Study|Withdrawal by Subject|3|||
156804946|NCT03341637|566041778|FG000|Overall Study|Reason not Specified|1|||
156804947|NCT03341637|566041779|FG001|Overall Study|Reason not Specified|1|||
156804948|NCT06164691|566041783|FG000|Overall Study|Withdrawal by Subject|2|||
156804949|NCT06164691|566041784|FG001|Overall Study|Withdrawal by Subject|0|||
156804950|NCT06164691|566041785|FG002|Overall Study|Withdrawal by Subject|0|||
156804951|NCT02391311|566041786|FG000|Overall Study|Lost to Follow-up|2|||
156804952|NCT02391311|566041787|FG001|Overall Study|Lost to Follow-up|1|||
156881874|NCT00101452|566327034|FG002|Overall Study|Adverse Event|1|||
156881875|NCT00101452|566327032|FG000|Overall Study|Lost to Follow-up|13|||
156881876|NCT00101452|566327033|FG001|Overall Study|Lost to Follow-up|8|||
156881877|NCT00101452|566327034|FG002|Overall Study|Lost to Follow-up|14|||
156881878|NCT00101452|566327032|FG000|Overall Study|Withdrawal by Subject|10|||
156881879|NCT00101452|566327033|FG001|Overall Study|Withdrawal by Subject|14|||
156881880|NCT00101452|566327034|FG002|Overall Study|Withdrawal by Subject|9|||
156881881|NCT00101452|566327032|FG000|Overall Study|Baseline Fail|2|||
156881882|NCT00101452|566327033|FG001|Overall Study|Baseline Fail|1|||
156881883|NCT00101452|566327034|FG002|Overall Study|Baseline Fail|2|||
156881884|NCT00101452|566327032|FG000|Overall Study|Physician Decision|0|||
156881885|NCT00101452|566327033|FG001|Overall Study|Physician Decision|3|||
156881886|NCT00101452|566327034|FG002|Overall Study|Physician Decision|2|||
156881887|NCT00101452|566327032|FG000|Overall Study|Protocol Violation|2|||
156881888|NCT00101452|566327033|FG001|Overall Study|Protocol Violation|1|||
156881889|NCT00101452|566327034|FG002|Overall Study|Protocol Violation|3|||
156881890|NCT00101452|566327032|FG000|Overall Study|Other|15|||
156881891|NCT00101452|566327033|FG001|Overall Study|Other|16|||
156881892|NCT00101452|566327034|FG002|Overall Study|Other|12|||
156881893|NCT02969655|566327035|FG000|Overall Study|Withdrawal by Subject|3|||
156881894|NCT02969655|566327036|FG001|Overall Study|Withdrawal by Subject|2|||
156881895|NCT02969655|566327035|FG000|Overall Study|Physician Decision|4|||
156881896|NCT02969655|566327036|FG001|Overall Study|Physician Decision|3|||
156881897|NCT02969655|566327035|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
156881898|NCT02969655|566327036|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
156881899|NCT02969655|566327035|FG000|Overall Study|Adverse Event|10|||
156881900|NCT02969655|566327036|FG001|Overall Study|Adverse Event|8|||
156881901|NCT00929643|566327039|FG000|Overall Study|Protocol Violation|2|||
156881902|NCT01536392|566327040|FG000|Overall Study|Adverse Event|2|||
156881903|NCT01536392|566327041|FG001|Overall Study|Adverse Event|2|||
156881904|NCT01536392|566327040|FG000|Overall Study|Physician Decision|2|||
156881905|NCT01536392|566327041|FG001|Overall Study|Physician Decision|3|||
156881906|NCT01536392|566327040|FG000|Overall Study|Withdrawal by Subject|3|||
156881907|NCT01536392|566327041|FG001|Overall Study|Withdrawal by Subject|6|||
156881908|NCT01536392|566327040|FG000|Overall Study|Non Compliance|3|||
156881909|NCT01536392|566327041|FG001|Overall Study|Non Compliance|4|||
156881910|NCT01536392|566327040|FG000|Overall Study|Completed therapy early|3|||
156881911|NCT01536392|566327041|FG001|Overall Study|Completed therapy early|0|||
156881912|NCT04525885|566327043|FG000|Overall Study|Screen Failure|1|||
156881913|NCT04525885|566327044|FG001|Overall Study|Screen Failure|0|||
156881914|NCT04525885|566327045|FG002|Overall Study|Screen Failure|0|||
156881915|NCT04525885|566327043|FG000|Overall Study|Withdrawal by Subject|14|||
156881916|NCT04525885|566327044|FG001|Overall Study|Withdrawal by Subject|6|||
156881917|NCT04525885|566327045|FG002|Overall Study|Withdrawal by Subject|20|||
156881918|NCT04525885|566327043|FG000|Overall Study|Physician Decision|1|||
156881919|NCT04525885|566327044|FG001|Overall Study|Physician Decision|0|||
156881920|NCT04525885|566327045|FG002|Overall Study|Physician Decision|1|||
156881921|NCT02717832|566327046|FG000|Overall Study|Inability to place IV|3|||
156881922|NCT02744040|566327047|FG000|Overall Study|Withdrawal by Subject|3|||
156881923|NCT02744040|566327048|FG001|Overall Study|Withdrawal by Subject|2|||
156881924|NCT02744040|566327049|FG002|Overall Study|Withdrawal by Subject|2|||
156881925|NCT02744040|566327047|FG000|Overall Study|Physician Decision|0|||
156881926|NCT02744040|566327048|FG001|Overall Study|Physician Decision|8|||
156881927|NCT02744040|566327049|FG002|Overall Study|Physician Decision|13|||
156881928|NCT02744040|566327047|FG000|Overall Study|Lost to Follow-up|3|||
156881929|NCT02744040|566327048|FG001|Overall Study|Lost to Follow-up|1|||
156881930|NCT02744040|566327049|FG002|Overall Study|Lost to Follow-up|7|||
156881931|NCT00750152|566327050|FG000|Overall Study|Adverse Event|2|||
156881932|NCT00750152|566327051|FG001|Overall Study|Adverse Event|1|||
156881933|NCT00750152|566327050|FG000|Overall Study|Lost to Follow-up|8|||
156881934|NCT00750152|566327051|FG001|Overall Study|Lost to Follow-up|13|||
156881935|NCT00750152|566327050|FG000|Overall Study|Withdrawal by Subject|3|||
156881936|NCT00750152|566327051|FG001|Overall Study|Withdrawal by Subject|3|||
156881937|NCT00750152|566327050|FG000|Overall Study|Physician Decision|1|||
156881938|NCT00750152|566327051|FG001|Overall Study|Physician Decision|1|||
156881939|NCT00750152|566327050|FG000|Overall Study|Non-compliance|0|||
156881940|NCT00750152|566327051|FG001|Overall Study|Non-compliance|1|||
156881941|NCT00750152|566327050|FG000|Overall Study|Termination by sponsor|1|||
156881942|NCT00750152|566327051|FG001|Overall Study|Termination by sponsor|0|||
156881943|NCT00750152|566327050|FG000|Overall Study|Other|7|||
156881944|NCT00750152|566327051|FG001|Overall Study|Other|8|||
156881945|NCT01642615|566327052|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
156881946|NCT01642615|566327053|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156881947|NCT01642615|566327054|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156881948|NCT01642615|566327052|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
156881949|NCT01642615|566327053|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
156881950|NCT01642615|566327054|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
156881951|NCT01642615|566327052|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
156804953|NCT02391311|566041786|FG000|Overall Study|deemed ineligible after baseline|1|||
156804954|NCT02391311|566041787|FG001|Overall Study|deemed ineligible after baseline|1|||
156804955|NCT03046446|566041790|FG000|Overall Study|Lack of Efficacy|7|||
156804956|NCT03046446|566041790|FG000|Overall Study|Adverse Event|6|||
156804957|NCT03046446|566041790|FG000|Overall Study|Lost to Follow-up|3|||
156804958|NCT03046446|566041790|FG000|Overall Study|Withdrawal by Subject|14|||
156804959|NCT03046446|566041790|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
156804960|NCT03046446|566041790|FG000|Overall Study|Disease Progression (see caveats)|25|||
156804961|NCT03046446|566041790|FG000|Overall Study|Non OA related knee surgery|1|||
156804962|NCT03183063|566041791|FG000|Overall Study|Withdrawal by Subject|2|||
156804963|NCT03183063|566041792|FG001|Overall Study|Withdrawal by Subject|0|||
156804964|NCT03183063|566041793|FG002|Overall Study|Withdrawal by Subject|0|||
156804965|NCT03183063|566041791|FG000|Overall Study|Physician Decision|3|||
156804966|NCT03183063|566041792|FG001|Overall Study|Physician Decision|4|||
156804967|NCT03183063|566041793|FG002|Overall Study|Physician Decision|4|||
156804968|NCT00925002|566041796|FG000|Overall Study|Other|1|||
156804969|NCT00925002|566041797|FG001|Overall Study|Other|4|||
156804970|NCT00925002|566041798|FG002|Overall Study|Other|0|||
156804971|NCT00925002|566041796|FG000|Overall Study|Death|1|||
156804972|NCT00925002|566041797|FG001|Overall Study|Death|1|||
156804973|NCT00925002|566041798|FG002|Overall Study|Death|5|||
156804974|NCT00925002|566041796|FG000|Overall Study|Adverse Event|3|||
156804975|NCT00925002|566041797|FG001|Overall Study|Adverse Event|1|||
156804976|NCT00925002|566041798|FG002|Overall Study|Adverse Event|2|||
156804977|NCT00925002|566041796|FG000|Overall Study|Participant withdrew consent|1|||
156804978|NCT00925002|566041797|FG001|Overall Study|Participant withdrew consent|3|||
156804979|NCT00925002|566041798|FG002|Overall Study|Participant withdrew consent|3|||
156804980|NCT03012334|566041801|FG000|Period 1|Withdrawal by Subject|0|||
156804981|NCT03012334|566041802|FG001|Period 1|Withdrawal by Subject|0|||
156804982|NCT03012334|566041803|FG002|Period 1|Withdrawal by Subject|0|||
156804983|NCT03012334|566041804|FG003|Period 1|Withdrawal by Subject|0|||
156804984|NCT03012334|566041805|FG004|Period 1|Withdrawal by Subject|0|||
156804985|NCT03012334|566041806|FG005|Period 1|Withdrawal by Subject|0|||
156804986|NCT03012334|566041807|FG006|Period 1|Withdrawal by Subject|0|||
156804987|NCT03012334|566041808|FG007|Period 1|Withdrawal by Subject|0|||
156804988|NCT03012334|566041809|FG008|Period 1|Withdrawal by Subject|0|||
156804989|NCT03012334|566041810|FG009|Period 1|Withdrawal by Subject|1|||
156804990|NCT03012334|566041801|FG000|Period 2|Withdrawal by Subject|0|||
156804991|NCT03012334|566041802|FG001|Period 2|Withdrawal by Subject|1|||
156804992|NCT03012334|566041803|FG002|Period 2|Withdrawal by Subject|0|||
156804993|NCT03012334|566041804|FG003|Period 2|Withdrawal by Subject|0|||
156804994|NCT03012334|566041805|FG004|Period 2|Withdrawal by Subject|0|||
156804995|NCT03012334|566041806|FG005|Period 2|Withdrawal by Subject|0|||
156804996|NCT03012334|566041807|FG006|Period 2|Withdrawal by Subject|0|||
156804997|NCT03012334|566041808|FG007|Period 2|Withdrawal by Subject|0|||
156804998|NCT03012334|566041809|FG008|Period 2|Withdrawal by Subject|0|||
156804999|NCT03012334|566041810|FG009|Period 2|Withdrawal by Subject|0|||
156805000|NCT03012334|566041801|FG000|Period 2|Protocol Violation|0|||
156805001|NCT03012334|566041802|FG001|Period 2|Protocol Violation|0|||
156805002|NCT03012334|566041803|FG002|Period 2|Protocol Violation|1|||
156805003|NCT03012334|566041804|FG003|Period 2|Protocol Violation|0|||
156805004|NCT03012334|566041805|FG004|Period 2|Protocol Violation|0|||
156805005|NCT03012334|566041806|FG005|Period 2|Protocol Violation|0|||
156805006|NCT03012334|566041807|FG006|Period 2|Protocol Violation|0|||
156805007|NCT03012334|566041808|FG007|Period 2|Protocol Violation|1|||
156805008|NCT03012334|566041809|FG008|Period 2|Protocol Violation|0|||
156805009|NCT03012334|566041810|FG009|Period 2|Protocol Violation|0|||
156805010|NCT03012334|566041801|FG000|Period 4|Non-Compliance|0|||
156805011|NCT03012334|566041802|FG001|Period 4|Non-Compliance|0|||
156805012|NCT03012334|566041803|FG002|Period 4|Non-Compliance|0|||
156805013|NCT03012334|566041804|FG003|Period 4|Non-Compliance|0|||
156805014|NCT03012334|566041805|FG004|Period 4|Non-Compliance|0|||
156805015|NCT03012334|566041806|FG005|Period 4|Non-Compliance|0|||
156805016|NCT03012334|566041807|FG006|Period 4|Non-Compliance|1|||
156805017|NCT03012334|566041808|FG007|Period 4|Non-Compliance|0|||
156805018|NCT03012334|566041809|FG008|Period 4|Non-Compliance|0|||
156805019|NCT03012334|566041810|FG009|Period 4|Non-Compliance|0|||
156805020|NCT03012334|566041801|FG000|Period 4|Adverse Event|0|||
156805021|NCT03012334|566041802|FG001|Period 4|Adverse Event|0|||
156805022|NCT03012334|566041803|FG002|Period 4|Adverse Event|0|||
156805023|NCT03012334|566041804|FG003|Period 4|Adverse Event|0|||
156805024|NCT03012334|566041805|FG004|Period 4|Adverse Event|0|||
156805025|NCT03012334|566041806|FG005|Period 4|Adverse Event|0|||
156805026|NCT03012334|566041807|FG006|Period 4|Adverse Event|0|||
156805027|NCT03012334|566041808|FG007|Period 4|Adverse Event|0|||
156805028|NCT03012334|566041809|FG008|Period 4|Adverse Event|1|||
156805029|NCT03012334|566041810|FG009|Period 4|Adverse Event|0|||
156805030|NCT01823107|566041811|FG000|Overall Study|Withdrawal by Subject|1|||
156805031|NCT01073293|566041812|FG000|Overall Study|Lost to Follow-up|0|||
156805032|NCT01073293|566041813|FG001|Overall Study|Lost to Follow-up|1|||
156805033|NCT01073293|566041812|FG000|Overall Study|Withdrawal by Subject|5|||
156805034|NCT01073293|566041813|FG001|Overall Study|Withdrawal by Subject|10|||
156805035|NCT00328172|566041816|FG000|Overall Study|Adverse Event|3|||
156805036|NCT00328172|566041817|FG001|Overall Study|Adverse Event|2|||
156805037|NCT00328172|566041818|FG002|Overall Study|Adverse Event|1|||
156805038|NCT00328172|566041819|FG003|Overall Study|Adverse Event|2|||
156805039|NCT00328172|566041820|FG004|Overall Study|Adverse Event|1|||
156805040|NCT00328172|566041816|FG000|Overall Study|Protocol Violation|0|||
156805041|NCT00328172|566041817|FG001|Overall Study|Protocol Violation|1|||
156805042|NCT00328172|566041818|FG002|Overall Study|Protocol Violation|1|||
156805043|NCT00328172|566041819|FG003|Overall Study|Protocol Violation|0|||
156805044|NCT00328172|566041820|FG004|Overall Study|Protocol Violation|0|||
156805045|NCT00328172|566041816|FG000|Overall Study|Lost to Follow-up|1|||
156805046|NCT00328172|566041817|FG001|Overall Study|Lost to Follow-up|1|||
156805047|NCT00328172|566041818|FG002|Overall Study|Lost to Follow-up|2|||
156805048|NCT00328172|566041819|FG003|Overall Study|Lost to Follow-up|1|||
156805049|NCT00328172|566041820|FG004|Overall Study|Lost to Follow-up|1|||
156805050|NCT00328172|566041816|FG000|Overall Study|Withdrawal by Subject|1|||
156805051|NCT00328172|566041817|FG001|Overall Study|Withdrawal by Subject|1|||
156805052|NCT00328172|566041818|FG002|Overall Study|Withdrawal by Subject|1|||
156805053|NCT00328172|566041819|FG003|Overall Study|Withdrawal by Subject|6|||
156805054|NCT00328172|566041820|FG004|Overall Study|Withdrawal by Subject|0|||
156805055|NCT00328172|566041816|FG000|Overall Study|Lack of Efficacy|14|||
156805056|NCT00328172|566041817|FG001|Overall Study|Lack of Efficacy|9|||
156805057|NCT00328172|566041818|FG002|Overall Study|Lack of Efficacy|4|||
156805058|NCT00328172|566041819|FG003|Overall Study|Lack of Efficacy|4|||
156805059|NCT00328172|566041820|FG004|Overall Study|Lack of Efficacy|3|||
156805060|NCT00328172|566041816|FG000|Overall Study|Other reason (not specified)|3|||
156805061|NCT00328172|566041817|FG001|Overall Study|Other reason (not specified)|0|||
156805062|NCT00328172|566041818|FG002|Overall Study|Other reason (not specified)|1|||
156805063|NCT00328172|566041819|FG003|Overall Study|Other reason (not specified)|0|||
156805064|NCT00328172|566041820|FG004|Overall Study|Other reason (not specified)|0|||
156805065|NCT00077974|566041821|FG000|Overall Study|Adverse Event|22|||
156805066|NCT00077974|566041821|FG000|Overall Study|Protocol Violation|1|||
156805067|NCT00077974|566041821|FG000|Overall Study|Withdrawal by Subject|3|||
156805068|NCT00077974|566041821|FG000|Overall Study|Lack of Efficacy|76|||
156805069|NCT00077974|566041821|FG000|Overall Study|Decision of Sponsor|2|||
156805070|NCT00558636|566041827|FG000|Treatment|Adverse Event|9|||
156805071|NCT00558636|566041828|FG001|Treatment|Adverse Event|2|||
156805072|NCT00558636|566041827|FG000|Treatment|Withdrawal by Subject|2|||
156805073|NCT00558636|566041828|FG001|Treatment|Withdrawal by Subject|0|||
156805074|NCT00558636|566041827|FG000|Treatment|Premature termination of the study|35|||
156805075|NCT00558636|566041828|FG001|Treatment|Premature termination of the study|37|||
156805076|NCT00558636|566041827|FG000|Treatment|Disease progression|1|||
156805077|NCT00558636|566041828|FG001|Treatment|Disease progression|5|||
156805078|NCT00558636|566041827|FG000|Follow-up|Premature termination of the study|12|||
156805079|NCT00558636|566041828|FG001|Follow-up|Premature termination of the study|7|||
156805080|NCT02897115|566041831|FG000|Overall Study|Early termination of study by sponsor|11|||
156805081|NCT02897115|566041832|FG001|Overall Study|Early termination of study by sponsor|8|||
156805082|NCT02071771|566041833|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
156805083|NCT02071771|566041834|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
156805084|NCT02071771|566041833|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
156805085|NCT02071771|566041834|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
156805086|NCT02078752|566041835|FG000|Overall Study|Death|0|||
156805087|NCT02078752|566041836|FG001|Overall Study|Death|3|||
156805088|NCT02078752|566041837|FG002|Overall Study|Death|0|||
156805089|NCT02078752|566041838|FG003|Overall Study|Death|0|||
156805090|NCT02078752|566041839|FG004|Overall Study|Death|0|||
156805091|NCT02078752|566041840|FG005|Overall Study|Death|1|||
156805092|NCT02078752|566041841|FG006|Overall Study|Death|0|||
156805093|NCT02078752|566041842|FG007|Overall Study|Death|1|||
156805094|NCT02078752|566041843|FG008|Overall Study|Death|0|||
156805095|NCT02078752|566041844|FG009|Overall Study|Death|4|||
156805096|NCT02078752|566041835|FG000|Overall Study|Lost to Follow-up|1|||
156805097|NCT02078752|566041836|FG001|Overall Study|Lost to Follow-up|0|||
156805098|NCT02078752|566041837|FG002|Overall Study|Lost to Follow-up|0|||
156805099|NCT02078752|566041838|FG003|Overall Study|Lost to Follow-up|1|||
156805100|NCT02078752|566041839|FG004|Overall Study|Lost to Follow-up|0|||
156805101|NCT02078752|566041840|FG005|Overall Study|Lost to Follow-up|0|||
156805102|NCT02078752|566041841|FG006|Overall Study|Lost to Follow-up|0|||
156805103|NCT02078752|566041842|FG007|Overall Study|Lost to Follow-up|0|||
156805104|NCT02078752|566041843|FG008|Overall Study|Lost to Follow-up|0|||
156805105|NCT02078752|566041844|FG009|Overall Study|Lost to Follow-up|0|||
156805106|NCT02078752|566041835|FG000|Overall Study|Withdrawal by Subject|1|||
156805107|NCT02078752|566041836|FG001|Overall Study|Withdrawal by Subject|1|||
156805108|NCT02078752|566041837|FG002|Overall Study|Withdrawal by Subject|1|||
156805109|NCT02078752|566041838|FG003|Overall Study|Withdrawal by Subject|1|||
156805110|NCT02078752|566041839|FG004|Overall Study|Withdrawal by Subject|0|||
156805111|NCT02078752|566041840|FG005|Overall Study|Withdrawal by Subject|3|||
156805112|NCT02078752|566041841|FG006|Overall Study|Withdrawal by Subject|2|||
157143912|NCT02158533|567276369|FG005|Stage 2|Adverse Event|1|||
157021162|NCT03138512|566830854|FG003|Treatment Part B|Participant withdrew consent|1|||
156805113|NCT02078752|566041842|FG007|Overall Study|Withdrawal by Subject|1|||
156805114|NCT02078752|566041843|FG008|Overall Study|Withdrawal by Subject|0|||
156805115|NCT02078752|566041844|FG009|Overall Study|Withdrawal by Subject|1|||
156805116|NCT02078752|566041835|FG000|Overall Study|Other|0|||
156805117|NCT02078752|566041836|FG001|Overall Study|Other|3|||
156805118|NCT02078752|566041837|FG002|Overall Study|Other|0|||
156805119|NCT02078752|566041838|FG003|Overall Study|Other|0|||
156805120|NCT02078752|566041839|FG004|Overall Study|Other|1|||
156805121|NCT02078752|566041840|FG005|Overall Study|Other|0|||
156805122|NCT02078752|566041841|FG006|Overall Study|Other|0|||
156805123|NCT02078752|566041842|FG007|Overall Study|Other|1|||
156805124|NCT02078752|566041843|FG008|Overall Study|Other|0|||
156805125|NCT02078752|566041844|FG009|Overall Study|Other|0|||
156805126|NCT02078752|566041835|FG000|Overall Study|Study terminated by sponsor|0|||
156805127|NCT02078752|566041836|FG001|Overall Study|Study terminated by sponsor|0|||
156805128|NCT02078752|566041837|FG002|Overall Study|Study terminated by sponsor|0|||
156805129|NCT02078752|566041838|FG003|Overall Study|Study terminated by sponsor|0|||
156805130|NCT02078752|566041839|FG004|Overall Study|Study terminated by sponsor|0|||
156805131|NCT02078752|566041840|FG005|Overall Study|Study terminated by sponsor|0|||
156805132|NCT02078752|566041841|FG006|Overall Study|Study terminated by sponsor|0|||
156805133|NCT02078752|566041842|FG007|Overall Study|Study terminated by sponsor|0|||
156805134|NCT02078752|566041843|FG008|Overall Study|Study terminated by sponsor|0|||
156805135|NCT02078752|566041844|FG009|Overall Study|Study terminated by sponsor|5|||
156805136|NCT02776683|566041855|FG000|Pre-switch Period|Protocol Violation|1|||
156805137|NCT02776683|566041856|FG001|Pre-switch Period|Protocol Violation|0|||
156805138|NCT02776683|566041855|FG000|Pre-switch Period|Adverse Event|21|||
156805139|NCT02776683|566041856|FG001|Pre-switch Period|Adverse Event|0|||
156805140|NCT02776683|566041855|FG000|Pre-switch Period|Withdrawal by Subject|9|||
156805141|NCT02776683|566041856|FG001|Pre-switch Period|Withdrawal by Subject|0|||
156805142|NCT02776683|566041855|FG000|Pre-switch Period|Physician Decision|7|||
156805143|NCT02776683|566041856|FG001|Pre-switch Period|Physician Decision|0|||
156805144|NCT02776683|566041855|FG000|Pre-switch Period|Progressive disease|39|||
156805145|NCT02776683|566041856|FG001|Pre-switch Period|Progressive disease|0|||
156805146|NCT02776683|566041855|FG000|Pre-switch Period|Other than listed|3|||
156805147|NCT02776683|566041856|FG001|Pre-switch Period|Other than listed|0|||
156805148|NCT02776683|566041855|FG000|Post-switch Period|Adverse Event|0|||
156805149|NCT02776683|566041856|FG001|Post-switch Period|Adverse Event|3|||
156805150|NCT02776683|566041855|FG000|Post-switch Period|Withdrawal by Subject|0|||
156805151|NCT02776683|566041856|FG001|Post-switch Period|Withdrawal by Subject|2|||
156805152|NCT02776683|566041855|FG000|Post-switch Period|Physician Decision|0|||
156805153|NCT02776683|566041856|FG001|Post-switch Period|Physician Decision|3|||
156805154|NCT02776683|566041855|FG000|Post-switch Period|Progressive disease|0|||
156805155|NCT02776683|566041856|FG001|Post-switch Period|Progressive disease|20|||
156805156|NCT02776683|566041855|FG000|Post-switch Period|Other than listed|0|||
156805157|NCT02776683|566041856|FG001|Post-switch Period|Other than listed|15|||
156805158|NCT00616642|566041857|FG000|Overall Study|Withdrawal by Subject|0|||
156805159|NCT00616642|566041858|FG001|Overall Study|Withdrawal by Subject|1|||
156805160|NCT01664247|566041861|FG000|Overall Study|Adverse Event|5|||
156805161|NCT01664247|566041862|FG001|Overall Study|Adverse Event|3|||
156805162|NCT01664247|566041861|FG000|Overall Study|Protocol Violation|3|||
156805163|NCT01664247|566041862|FG001|Overall Study|Protocol Violation|5|||
156805164|NCT01664247|566041861|FG000|Overall Study|Withdrawal Criteria|1|||
156805165|NCT01664247|566041862|FG001|Overall Study|Withdrawal Criteria|4|||
156805166|NCT01664247|566041861|FG000|Overall Study|Unclassified|5|||
156805167|NCT01664247|566041862|FG001|Overall Study|Unclassified|29|||
156805168|NCT01000506|566041863|FG000|Overall Study|Adverse Event|6|||
156805169|NCT01000506|566041864|FG001|Overall Study|Adverse Event|5|||
156805170|NCT01000506|566041865|FG002|Overall Study|Adverse Event|8|||
156805171|NCT01000506|566041866|FG003|Overall Study|Adverse Event|9|||
156805172|NCT01000506|566041863|FG000|Overall Study|Lack of Efficacy|8|||
156805173|NCT01000506|566041864|FG001|Overall Study|Lack of Efficacy|6|||
156805174|NCT01000506|566041865|FG002|Overall Study|Lack of Efficacy|4|||
156805175|NCT01000506|566041866|FG003|Overall Study|Lack of Efficacy|4|||
156805176|NCT01000506|566041863|FG000|Overall Study|Protocol Violation|1|||
156805177|NCT01000506|566041864|FG001|Overall Study|Protocol Violation|1|||
156805178|NCT01000506|566041865|FG002|Overall Study|Protocol Violation|0|||
156805179|NCT01000506|566041866|FG003|Overall Study|Protocol Violation|0|||
156805180|NCT01000506|566041863|FG000|Overall Study|Lost to Follow-up|1|||
156805181|NCT01000506|566041864|FG001|Overall Study|Lost to Follow-up|1|||
156805182|NCT01000506|566041865|FG002|Overall Study|Lost to Follow-up|4|||
156805183|NCT01000506|566041866|FG003|Overall Study|Lost to Follow-up|0|||
156805184|NCT01000506|566041863|FG000|Overall Study|Physician Decision|1|||
156805185|NCT01000506|566041864|FG001|Overall Study|Physician Decision|3|||
156805186|NCT01000506|566041865|FG002|Overall Study|Physician Decision|3|||
156805187|NCT01000506|566041866|FG003|Overall Study|Physician Decision|3|||
156805188|NCT01000506|566041863|FG000|Overall Study|Withdrawal by Subject|11|||
156805189|NCT01000506|566041864|FG001|Overall Study|Withdrawal by Subject|8|||
156805190|NCT01000506|566041865|FG002|Overall Study|Withdrawal by Subject|2|||
156881952|NCT01642615|566327053|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
156881953|NCT01642615|566327054|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
156881954|NCT01642615|566327052|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
156881955|NCT01642615|566327053|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
156881956|NCT01642615|566327054|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
156881957|NCT01642615|566327052|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
156805191|NCT01000506|566041866|FG003|Overall Study|Withdrawal by Subject|7|||
156805192|NCT03188263|566041877|FG000|Overall Study|Withdrawal by Subject|3|||
156805193|NCT03188263|566041878|FG001|Overall Study|Withdrawal by Subject|0|||
156805194|NCT03188263|566041877|FG000|Overall Study|Physician Decision|1|||
156805195|NCT03188263|566041878|FG001|Overall Study|Physician Decision|0|||
156805196|NCT00699413|566041879|FG000|Overall Study|Withdrawal by Subject|0|||
156805197|NCT00699413|566041880|FG001|Overall Study|Withdrawal by Subject|2|||
156805198|NCT00699413|566041879|FG000|Overall Study|Study terminated by sponsor|4|||
156805199|NCT00699413|566041880|FG001|Overall Study|Study terminated by sponsor|2|||
156805200|NCT02779777|566041881|FG000|Overall Study|Disease Progression|1|||
156805201|NCT02779777|566041882|FG001|Overall Study|Disease Progression|0|||
156805202|NCT02779777|566041883|FG002|Overall Study|Disease Progression|0|||
156805203|NCT02779777|566041881|FG000|Overall Study|Adverse Event|3|||
156805204|NCT02779777|566041882|FG001|Overall Study|Adverse Event|1|||
156805205|NCT02779777|566041883|FG002|Overall Study|Adverse Event|0|||
156805206|NCT02779777|566041881|FG000|Overall Study|Physician Decision|9|||
156805207|NCT02779777|566041882|FG001|Overall Study|Physician Decision|0|||
156881958|NCT01642615|566327053|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
156881959|NCT01642615|566327054|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
156881960|NCT01642615|566327052|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
156881961|NCT01642615|566327053|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
156881962|NCT01642615|566327054|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
156881963|NCT01642615|566327052|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
156881964|NCT01642615|566327053|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
156881965|NCT01642615|566327054|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
156881966|NCT01642615|566327052|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156881967|NCT01642615|566327053|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
156881968|NCT01642615|566327054|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
156881969|NCT01642615|566327052|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
156881970|NCT01642615|566327053|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
156881971|NCT01642615|566327054|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
156881972|NCT00402740|566327057|FG000|Overall Study|Withdrawal by Subject|18|||
156881973|NCT00402740|566327057|FG000|Overall Study|Death|50|||
156881974|NCT00402740|566327057|FG000|Overall Study|Lost to Follow-up|6|||
156881975|NCT00402740|566327057|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
156881976|NCT00402740|566327057|FG000|Overall Study|Subject disposition unknown.|1|||
156881977|NCT01214395|566327060|FG000|Overall Study|All patients had infection|5|||
156881978|NCT03698591|566327064|FG000|Overall Study|Withdrawal by Subject|2|||
156881979|NCT03698591|566327065|FG001|Overall Study|Withdrawal by Subject|2|||
156881980|NCT03698591|566327064|FG000|Overall Study|Failed drug screen|1|||
156881981|NCT03698591|566327065|FG001|Overall Study|Failed drug screen|1|||
156881982|NCT03698591|566327064|FG000|Overall Study|Failed health screen|0|||
156881983|NCT03698591|566327065|FG001|Overall Study|Failed health screen|1|||
156881984|NCT03698591|566327064|FG000|Overall Study|Ineligible for financial compensation|1|||
156881985|NCT03698591|566327065|FG001|Overall Study|Ineligible for financial compensation|0|||
156881986|NCT03698591|566327064|FG000|Overall Study|Equipment Error|1|||
156805208|NCT02779777|566041883|FG002|Overall Study|Physician Decision|1|||
156805209|NCT02779777|566041881|FG000|Overall Study|Withdrawal by Subject|1|||
156881987|NCT03698591|566327065|FG001|Overall Study|Equipment Error|0|||
156881988|NCT03698591|566327064|FG000|Overall Study|Could not establish TMS dosage|0|||
156881989|NCT03698591|566327065|FG001|Overall Study|Could not establish TMS dosage|1|||
156881990|NCT01165216|566327072|FG000|Overall Study|Adverse Event|6|||
156881991|NCT01165216|566327073|FG001|Overall Study|Adverse Event|3|||
156881992|NCT01165216|566327072|FG000|Overall Study|Withdrawal by Subject|1|||
156881993|NCT01165216|566327073|FG001|Overall Study|Withdrawal by Subject|1|||
156881994|NCT01165216|566327072|FG000|Overall Study|Disease progression|1|||
156881995|NCT01165216|566327073|FG001|Overall Study|Disease progression|3|||
156881996|NCT03255083|566327074|FG000|Overall Study|Clinical progression|1|||
156881997|NCT03255083|566327075|FG001|Overall Study|Clinical progression|0|||
156881998|NCT03255083|566327076|FG002|Overall Study|Clinical progression|0|||
156881999|NCT03255083|566327077|FG003|Overall Study|Clinical progression|0|||
156882000|NCT03255083|566327074|FG000|Overall Study|Adverse Event|0|||
156882001|NCT03255083|566327075|FG001|Overall Study|Adverse Event|1|||
156805210|NCT02779777|566041882|FG001|Overall Study|Withdrawal by Subject|0|||
156805211|NCT02779777|566041883|FG002|Overall Study|Withdrawal by Subject|0|||
156805212|NCT00251693|566041884|FG000|Overall Study|Adverse Event|17|||
156805213|NCT00251693|566041885|FG001|Overall Study|Adverse Event|9|||
156882002|NCT03255083|566327076|FG002|Overall Study|Adverse Event|0|||
156882003|NCT03255083|566327077|FG003|Overall Study|Adverse Event|0|||
156805214|NCT00251693|566041886|FG002|Overall Study|Adverse Event|9|||
156805215|NCT00251693|566041884|FG000|Overall Study|Protocol Violation|2|||
156805216|NCT00251693|566041885|FG001|Overall Study|Protocol Violation|0|||
156805217|NCT00251693|566041886|FG002|Overall Study|Protocol Violation|2|||
156882004|NCT03255083|566327074|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
156882005|NCT03255083|566327075|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
156882006|NCT03255083|566327076|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
156882007|NCT03255083|566327077|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
156882008|NCT03255083|566327074|FG000|Overall Study|Withdrawal by Subject|1|||
156882009|NCT03255083|566327075|FG001|Overall Study|Withdrawal by Subject|1|||
156882010|NCT03255083|566327076|FG002|Overall Study|Withdrawal by Subject|1|||
156882011|NCT03255083|566327077|FG003|Overall Study|Withdrawal by Subject|0|||
156882012|NCT01457352|566327082|FG000|Period 1|Adverse Event|2|||
156882013|NCT01457352|566327083|FG001|Period 1|Adverse Event|0|||
156882014|NCT01457352|566327082|FG000|Period 1|Withdrawal by Subject|2|||
156882015|NCT01457352|566327083|FG001|Period 1|Withdrawal by Subject|0|||
156882016|NCT01457352|566327082|FG000|Period 1|Physician Decision|2|||
156882017|NCT01457352|566327083|FG001|Period 1|Physician Decision|0|||
156882018|NCT01457352|566327082|FG000|Period 1|MS related disease progression|1|||
156882019|NCT01457352|566327083|FG001|Period 1|MS related disease progression|0|||
156882020|NCT01457352|566327082|FG000|Period 1|Withdrawn|1|||
156882021|NCT01457352|566327083|FG001|Period 1|Withdrawn|0|||
156882022|NCT01457352|566327082|FG000|Period 1|withdrew per sponsor|1|||
156882023|NCT01457352|566327083|FG001|Period 1|withdrew per sponsor|0|||
156882024|NCT01457352|566327082|FG000|Period 1|Protocol Violation|4|||
156882025|NCT01457352|566327083|FG001|Period 1|Protocol Violation|0|||
156882026|NCT01457352|566327082|FG000|Period 1|Did not meet eligibility criteria|3|||
156805218|NCT00251693|566041884|FG000|Overall Study|Lost to Follow-up|12|||
156805219|NCT00251693|566041885|FG001|Overall Study|Lost to Follow-up|7|||
156805220|NCT00251693|566041886|FG002|Overall Study|Lost to Follow-up|8|||
156805221|NCT00251693|566041884|FG000|Overall Study|Withdrawal by Subject|11|||
156805222|NCT00251693|566041885|FG001|Overall Study|Withdrawal by Subject|17|||
156805223|NCT00251693|566041886|FG002|Overall Study|Withdrawal by Subject|14|||
156805224|NCT00251693|566041884|FG000|Overall Study|Lack of Efficacy|0|||
156805225|NCT00251693|566041885|FG001|Overall Study|Lack of Efficacy|1|||
156805226|NCT00251693|566041886|FG002|Overall Study|Lack of Efficacy|0|||
156805227|NCT00251693|566041884|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
156805228|NCT00251693|566041885|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
156805229|NCT00251693|566041886|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
156805230|NCT00251693|566041884|FG000|Overall Study|Noncompliant|0|||
156805231|NCT00251693|566041885|FG001|Overall Study|Noncompliant|0|||
156805232|NCT00251693|566041886|FG002|Overall Study|Noncompliant|2|||
156805233|NCT00251693|566041884|FG000|Overall Study|Possible Barrett's esophagus|3|||
156805234|NCT00251693|566041885|FG001|Overall Study|Possible Barrett's esophagus|5|||
156805235|NCT00251693|566041886|FG002|Overall Study|Possible Barrett's esophagus|2|||
156805236|NCT00251693|566041884|FG000|Overall Study|Subject request/subject unavailable|1|||
156805237|NCT00251693|566041885|FG001|Overall Study|Subject request/subject unavailable|2|||
156805238|NCT00251693|566041886|FG002|Overall Study|Subject request/subject unavailable|0|||
156805239|NCT00251693|566041884|FG000|Overall Study|Abnormal laboratory findings|0|||
156805240|NCT00251693|566041885|FG001|Overall Study|Abnormal laboratory findings|0|||
156805241|NCT00251693|566041886|FG002|Overall Study|Abnormal laboratory findings|1|||
156805242|NCT01030822|566041888|FG000|Overall Study|Moved/migrated from study area|6|||
156805243|NCT01030822|566041889|FG001|Overall Study|Moved/migrated from study area|7|||
156882027|NCT01457352|566327083|FG001|Period 1|Did not meet eligibility criteria|0|||
156805244|NCT01030822|566041890|FG002|Overall Study|Moved/migrated from study area|3|||
156805245|NCT01030822|566041888|FG000|Overall Study|Withdrawal by Subject|16|||
156805246|NCT01030822|566041889|FG001|Overall Study|Withdrawal by Subject|13|||
156805247|NCT01030822|566041890|FG002|Overall Study|Withdrawal by Subject|16|||
156805248|NCT01030822|566041888|FG000|Overall Study|Lost to Follow-up|9|||
156882028|NCT01457352|566327082|FG000|Period 2|Withdrawal by Subject|23|||
156882029|NCT01457352|566327083|FG001|Period 2|Withdrawal by Subject|0|||
156882030|NCT01457352|566327082|FG000|Period 2|Adverse Event|22|||
156805249|NCT01030822|566041889|FG001|Overall Study|Lost to Follow-up|4|||
156882031|NCT01457352|566327083|FG001|Period 2|Adverse Event|0|||
156882032|NCT01457352|566327082|FG000|Period 2|no analysis|10|||
156805250|NCT01030822|566041890|FG002|Overall Study|Lost to Follow-up|7|||
156805251|NCT01055613|566041892|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
156882033|NCT01457352|566327083|FG001|Period 2|no analysis|0|||
156882034|NCT01457352|566327082|FG000|Period 2|Lack of Efficacy|8|||
156805252|NCT01055613|566041893|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156805253|NCT01055613|566041892|FG000|Overall Study|Unacceptable lens fit|1|||
156882035|NCT01457352|566327083|FG001|Period 2|Lack of Efficacy|0|||
156882036|NCT01457352|566327082|FG000|Period 2|Protocol Violation|4|||
156882037|NCT01457352|566327083|FG001|Period 2|Protocol Violation|0|||
156805254|NCT01055613|566041893|FG001|Overall Study|Unacceptable lens fit|0|||
156805255|NCT01055613|566041892|FG000|Overall Study|Discomfort|2|||
156805256|NCT01055613|566041893|FG001|Overall Study|Discomfort|1|||
156805257|NCT01055613|566041892|FG000|Overall Study|Lost to Follow-up|1|||
156805258|NCT01055613|566041893|FG001|Overall Study|Lost to Follow-up|1|||
156805259|NCT01055613|566041892|FG000|Overall Study|Protocol Violation|1|||
156805260|NCT01055613|566041893|FG001|Overall Study|Protocol Violation|1|||
156805261|NCT01055613|566041892|FG000|Overall Study|Subject Disinterest|1|||
156805262|NCT01055613|566041893|FG001|Overall Study|Subject Disinterest|1|||
156805263|NCT00363311|566041896|FG000|Overall Study|Adverse Event|6|||
156805264|NCT00363311|566041897|FG001|Overall Study|Adverse Event|4|||
156805265|NCT00363311|566041896|FG000|Overall Study|Lost to Follow-up|3|||
156805266|NCT00363311|566041897|FG001|Overall Study|Lost to Follow-up|0|||
156805267|NCT00363311|566041896|FG000|Overall Study|Protocol Violation|1|||
156805268|NCT00363311|566041897|FG001|Overall Study|Protocol Violation|2|||
156805269|NCT00363311|566041896|FG000|Overall Study|Withdrawal by Subject|12|||
156805270|NCT00363311|566041897|FG001|Overall Study|Withdrawal by Subject|6|||
156805271|NCT00363311|566041896|FG000|Overall Study|Physician Decision|1|||
156805272|NCT00363311|566041897|FG001|Overall Study|Physician Decision|1|||
156805273|NCT00363311|566041896|FG000|Overall Study|Sponsor Terminated Study|2|||
156805274|NCT00363311|566041897|FG001|Overall Study|Sponsor Terminated Study|2|||
156805275|NCT00363311|566041896|FG000|Overall Study|Disease Progression|46|||
156805276|NCT00363311|566041897|FG001|Overall Study|Disease Progression|26|||
156805277|NCT00363311|566041896|FG000|Overall Study|Non-Compliance|1|||
156805278|NCT00363311|566041897|FG001|Overall Study|Non-Compliance|1|||
156805279|NCT00363311|566041896|FG000|Overall Study|Participant Refused Biopsy|1|||
156805280|NCT00363311|566041897|FG001|Overall Study|Participant Refused Biopsy|0|||
156805281|NCT00363311|566041896|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
156805282|NCT00363311|566041897|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
156805283|NCT00363311|566041896|FG000|Overall Study|Participant Opted for Treatment|1|||
156805284|NCT00363311|566041897|FG001|Overall Study|Participant Opted for Treatment|0|||
156805285|NCT00363311|566041896|FG000|Overall Study|Participant Moved to Another Country|1|||
156805286|NCT00363311|566041897|FG001|Overall Study|Participant Moved to Another Country|0|||
156805287|NCT00363311|566041896|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
156805288|NCT00363311|566041897|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
156805289|NCT00363311|566041896|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
156805290|NCT00363311|566041897|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
156805291|NCT00363311|566041896|FG000|Overall Study|Participant Moved to Louisiana|0|||
156805292|NCT00363311|566041897|FG001|Overall Study|Participant Moved to Louisiana|1|||
156805293|NCT00401843|566041898|FG000|Overall Study|Achieved Complete Response|1|||
156805294|NCT00401843|566041899|FG001|Overall Study|Achieved Complete Response|5|||
156805295|NCT00401843|566041900|FG002|Overall Study|Achieved Complete Response|11|||
156805296|NCT00401843|566041898|FG000|Overall Study|Adverse Event|7|||
156805297|NCT00401843|566041899|FG001|Overall Study|Adverse Event|26|||
156805298|NCT00401843|566041900|FG002|Overall Study|Adverse Event|27|||
156805299|NCT00401843|566041898|FG000|Overall Study|Death|0|||
156805300|NCT00401843|566041899|FG001|Overall Study|Death|8|||
156805301|NCT00401843|566041900|FG002|Overall Study|Death|10|||
156805302|NCT00401843|566041898|FG000|Overall Study|Disease progression|10|||
156805303|NCT00401843|566041899|FG001|Overall Study|Disease progression|60|||
156805304|NCT00401843|566041900|FG002|Overall Study|Disease progression|49|||
156805305|NCT00401843|566041898|FG000|Overall Study|End of Study|1|||
156805306|NCT00401843|566041899|FG001|Overall Study|End of Study|1|||
156805307|NCT00401843|566041900|FG002|Overall Study|End of Study|2|||
156805308|NCT00401843|566041898|FG000|Overall Study|Lost to Follow-up|0|||
156805309|NCT00401843|566041899|FG001|Overall Study|Lost to Follow-up|0|||
156805310|NCT00401843|566041900|FG002|Overall Study|Lost to Follow-up|2|||
156805311|NCT00401843|566041898|FG000|Overall Study|Other Unspecified|0|||
156805312|NCT00401843|566041899|FG001|Overall Study|Other Unspecified|3|||
156805313|NCT00401843|566041900|FG002|Overall Study|Other Unspecified|5|||
156805314|NCT00401843|566041898|FG000|Overall Study|Physician Decision|0|||
156805315|NCT00401843|566041899|FG001|Overall Study|Physician Decision|16|||
156805316|NCT00401843|566041900|FG002|Overall Study|Physician Decision|10|||
156805317|NCT00401843|566041898|FG000|Overall Study|Protocol Violation|0|||
156805318|NCT00401843|566041899|FG001|Overall Study|Protocol Violation|0|||
156805319|NCT00401843|566041900|FG002|Overall Study|Protocol Violation|1|||
156805320|NCT00401843|566041898|FG000|Overall Study|Withdrawal by Subject|1|||
156805321|NCT00401843|566041899|FG001|Overall Study|Withdrawal by Subject|5|||
156805322|NCT00401843|566041900|FG002|Overall Study|Withdrawal by Subject|5|||
156805323|NCT00401843|566041898|FG000|Overall Study|Withdrawal of consent to study agent|1|||
156805324|NCT00401843|566041899|FG001|Overall Study|Withdrawal of consent to study agent|15|||
156805325|NCT00401843|566041900|FG002|Overall Study|Withdrawal of consent to study agent|17|||
156805326|NCT00401843|566041898|FG000|Overall Study|Randomized but not Treated|0|||
156805327|NCT00401843|566041899|FG001|Overall Study|Randomized but not Treated|2|||
156805328|NCT00401843|566041900|FG002|Overall Study|Randomized but not Treated|3|||
156805329|NCT00401843|566041898|FG000|Overall Study|Received incorrect treatment|0|||
156805330|NCT00401843|566041899|FG001|Overall Study|Received incorrect treatment|3|||
156805331|NCT00401843|566041900|FG002|Overall Study|Received incorrect treatment|0|||
156805332|NCT01182298|566041905|FG000|Overall Study|Lack of Efficacy|4|||
156805333|NCT01182298|566041905|FG000|Overall Study|Withdrawal by Subject|2|||
156805334|NCT01595529|566041906|FG000|Overall Study|Adverse Event|2|||
156805335|NCT01595529|566041907|FG001|Overall Study|Adverse Event|0|||
156805336|NCT01595529|566041906|FG000|Overall Study|Subject Non-Compliant|2|||
156805337|NCT01595529|566041907|FG001|Overall Study|Subject Non-Compliant|0|||
156805338|NCT01595529|566041906|FG000|Overall Study|Lost to Follow-up|8|||
156805339|NCT01595529|566041907|FG001|Overall Study|Lost to Follow-up|14|||
156805340|NCT01595529|566041906|FG000|Overall Study|Protocol Violation|1|||
156805341|NCT01595529|566041907|FG001|Overall Study|Protocol Violation|2|||
156805342|NCT01595529|566041906|FG000|Overall Study|Physician Decision|1|||
156805343|NCT01595529|566041907|FG001|Overall Study|Physician Decision|0|||
156805344|NCT01595529|566041906|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
156805345|NCT01595529|566041907|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
156805346|NCT01595529|566041906|FG000|Overall Study|Administrative Decision|1|||
156805347|NCT01595529|566041907|FG001|Overall Study|Administrative Decision|0|||
156805348|NCT01595529|566041906|FG000|Overall Study|Entry Failure/Screening Failure|6|||
156805349|NCT01595529|566041907|FG001|Overall Study|Entry Failure/Screening Failure|1|||
156805350|NCT01508910|566041908|FG000|Treatment|Death|2|||
156805351|NCT01508910|566041909|FG001|Treatment|Death|3|||
156805352|NCT01508910|566041910|FG002|Treatment|Death|2|||
156805353|NCT01508910|566041911|FG003|Treatment|Death|0|||
156805354|NCT01508910|566041908|FG000|Treatment|Lost to Follow-up|0|||
156805355|NCT01508910|566041909|FG001|Treatment|Lost to Follow-up|0|||
156805356|NCT01508910|566041910|FG002|Treatment|Lost to Follow-up|2|||
156805357|NCT01508910|566041911|FG003|Treatment|Lost to Follow-up|1|||
156805358|NCT01508910|566041908|FG000|Treatment|Withdrawal by Subject|0|||
156805359|NCT01508910|566041909|FG001|Treatment|Withdrawal by Subject|1|||
156805360|NCT01508910|566041910|FG002|Treatment|Withdrawal by Subject|6|||
156805361|NCT01508910|566041911|FG003|Treatment|Withdrawal by Subject|1|||
156805362|NCT01508910|566041908|FG000|Treatment|Sponsor Decision|0|||
156805363|NCT01508910|566041909|FG001|Treatment|Sponsor Decision|0|||
156805364|NCT01508910|566041910|FG002|Treatment|Sponsor Decision|0|||
156805365|NCT01508910|566041911|FG003|Treatment|Sponsor Decision|1|||
156805366|NCT04016714|566041912|FG000|Overall Study|Death|1|||
156805367|NCT04016714|566041913|FG001|Overall Study|Death|0|||
156805368|NCT04016714|566041912|FG000|Overall Study|Lost to Follow-up|3|||
156805369|NCT04016714|566041913|FG001|Overall Study|Lost to Follow-up|1|||
156805370|NCT04016714|566041912|FG000|Overall Study|Physician Decision|3|||
156805371|NCT04016714|566041913|FG001|Overall Study|Physician Decision|3|||
156805372|NCT04016714|566041912|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
156805373|NCT04016714|566041913|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
156805374|NCT01677988|566041914|FG000|Overall Study|Lack of Efficacy|2|||
156805375|NCT00730886|566041915|FG000|Overall Study|Lost to Follow-up|1|||
156805376|NCT00730886|566041916|FG001|Overall Study|Lost to Follow-up|0|||
156805377|NCT00730886|566041915|FG000|Overall Study|Physician Decision|1|||
156805378|NCT00730886|566041916|FG001|Overall Study|Physician Decision|0|||
156805379|NCT00444106|566041917|FG000|Overall Study|Lost to Follow-up|2|||
156805380|NCT00444106|566041918|FG001|Overall Study|Lost to Follow-up|1|||
156805381|NCT00444106|566041919|FG002|Overall Study|Lost to Follow-up|0|||
156805382|NCT00444106|566041917|FG000|Overall Study|Abnormal Test Procedure Results|0|||
156805383|NCT00444106|566041918|FG001|Overall Study|Abnormal Test Procedure Results|0|||
156805384|NCT00444106|566041919|FG002|Overall Study|Abnormal Test Procedure Results|1|||
156805385|NCT02317627|566041922|FG000|Overall Study|Withdrawal by Subject|0|||
156805386|NCT02317627|566041923|FG001|Overall Study|Withdrawal by Subject|1|||
156805387|NCT02317627|566041924|FG002|Overall Study|Withdrawal by Subject|1|||
156805388|NCT02317627|566041922|FG000|Overall Study|Lost to Follow-up|2|||
156805389|NCT02317627|566041923|FG001|Overall Study|Lost to Follow-up|0|||
156805390|NCT02317627|566041924|FG002|Overall Study|Lost to Follow-up|0|||
156805391|NCT02317627|566041922|FG000|Overall Study|Stopped by Investigator|0|||
156805392|NCT02317627|566041923|FG001|Overall Study|Stopped by Investigator|1|||
156805393|NCT02317627|566041924|FG002|Overall Study|Stopped by Investigator|0|||
156805394|NCT02317627|566041922|FG000|Overall Study|Adverse Event|0|||
156805395|NCT02317627|566041923|FG001|Overall Study|Adverse Event|2|||
156805396|NCT02317627|566041924|FG002|Overall Study|Adverse Event|3|||
156805397|NCT02317627|566041922|FG000|Overall Study|Non-compliance with study drug|0|||
156805398|NCT02317627|566041923|FG001|Overall Study|Non-compliance with study drug|1|||
156805399|NCT02317627|566041924|FG002|Overall Study|Non-compliance with study drug|0|||
156805400|NCT00279214|566041925|FG000|Overall Study|Physician Decision|3|||
156805401|NCT00279214|566041926|FG001|Overall Study|Physician Decision|2|||
156805402|NCT01280968|566041927|FG000|Overall Study|Lost to Follow-up|8|||
156805403|NCT01280968|566041928|FG001|Overall Study|Lost to Follow-up|2|||
156805404|NCT01280968|566041927|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
156805405|NCT01280968|566041928|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
156805406|NCT01280968|566041927|FG000|Overall Study|Commuting Problems|2|||
156805407|NCT01280968|566041928|FG001|Overall Study|Commuting Problems|0|||
156805408|NCT01280968|566041927|FG000|Overall Study|Anxiety|2|||
156805409|NCT01280968|566041928|FG001|Overall Study|Anxiety|0|||
156805410|NCT01280968|566041927|FG000|Overall Study|Adverse Event|1|||
156805411|NCT01280968|566041928|FG001|Overall Study|Adverse Event|0|||
156805412|NCT01280968|566041927|FG000|Overall Study|Scheduling Conflicts|1|||
156805413|NCT01280968|566041928|FG001|Overall Study|Scheduling Conflicts|1|||
156805414|NCT01280968|566041927|FG000|Overall Study|Pre-existing Neurological Condition|1|||
156805415|NCT01280968|566041928|FG001|Overall Study|Pre-existing Neurological Condition|0|||
156805416|NCT01280968|566041927|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
156805417|NCT01280968|566041928|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
156805418|NCT00038948|566041929|FG000|Overall Study|Adverse Event|131|||
156805419|NCT00038948|566041930|FG001|Overall Study|Adverse Event|43|||
156805420|NCT00038948|566041929|FG000|Overall Study|Lost to Follow-up|4|||
156805421|NCT00038948|566041930|FG001|Overall Study|Lost to Follow-up|4|||
156805422|NCT00038948|566041929|FG000|Overall Study|Nonmedical event|5|||
156805423|NCT00038948|566041930|FG001|Overall Study|Nonmedical event|7|||
156805424|NCT00038948|566041929|FG000|Overall Study|Withdrawal by Subject|23|||
156805425|NCT00038948|566041930|FG001|Overall Study|Withdrawal by Subject|10|||
156805426|NCT00038948|566041929|FG000|Overall Study|Protocol Violation|3|||
156805427|NCT00038948|566041930|FG001|Overall Study|Protocol Violation|7|||
156805428|NCT00038948|566041929|FG000|Overall Study|Lack of Efficacy|3|||
156805429|NCT00038948|566041930|FG001|Overall Study|Lack of Efficacy|6|||
156805430|NCT03984188|566041933|FG000|Overall Study|Death|2|||
156805431|NCT03984188|566041934|FG001|Overall Study|Death|4|||
156805432|NCT03984188|566041933|FG000|Overall Study|Physician Decision|0|||
156805433|NCT03984188|566041934|FG001|Overall Study|Physician Decision|2|||
156805434|NCT03984188|566041933|FG000|Overall Study|Lost to Follow-up|3|||
156805435|NCT03984188|566041934|FG001|Overall Study|Lost to Follow-up|2|||
156805436|NCT03984188|566041933|FG000|Overall Study|Withdrawal by Subject|6|||
156805437|NCT03984188|566041934|FG001|Overall Study|Withdrawal by Subject|0|||
156805438|NCT00272792|566043656|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
156805439|NCT00272792|566043657|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
156805440|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
156805441|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
156805442|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
156805443|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
156805444|NCT00272792|566043656|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
156805445|NCT00272792|566043657|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
156805446|NCT00937495|566043662|FG000|Overall Study|Protocol Violation|2|||
156805447|NCT02549989|566043663|FG000|Overall Study|Adverse Event|4|||
156805448|NCT02549989|566043663|FG000|Overall Study|Death|1|||
156805449|NCT02549989|566043663|FG000|Overall Study|Lack of Efficacy|19|||
156805450|NCT02549989|566043663|FG000|Overall Study|Withdrawal by Subject|3|||
156805451|NCT01856322|566043664|FG000|Overall Study|off study due to lack of accrual|0|||
156805452|NCT01856322|566043665|FG001|Overall Study|off study due to lack of accrual|0|||
156805453|NCT01856322|566043666|FG002|Overall Study|off study due to lack of accrual|3|||
156805454|NCT00288015|566043670|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
156805455|NCT00288015|566043670|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
156805456|NCT00288015|566043670|FG000|First Response Assessment|Withdrawal by Subject|1|||
156805457|NCT00288015|566043670|FG000|First Response Assessment|Death|1|||
156805458|NCT00288015|566043670|FG000|First Response Assessment|Physician Decision|2|||
156805459|NCT00288015|566043670|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
156805460|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Death|13|||
156805461|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
156805462|NCT00288015|566043670|FG000|Follow up for Survival x 2 Years|Other|9|||
156805463|NCT04592341|566043673|FG000|Overall Study|Physician Decision|5|||
156805464|NCT04592341|566043673|FG000|Overall Study|Study Terminated by Sponsor|5|||
156805465|NCT04592341|566043673|FG000|Overall Study|Withdrawal by Subject|53|||
156805466|NCT04592341|566043673|FG000|Overall Study|Lost to Follow-up|3|||
156805467|NCT04592341|566043673|FG000|Overall Study|Death|1|||
156805468|NCT04592341|566043673|FG000|Overall Study|Adverse Event|5|||
156805469|NCT04592341|566043673|FG000|Overall Study|other|4|||
156805470|NCT01944020|566043674|FG000|Overall Study|Withdrawal by Subject|5|||
156805471|NCT01944020|566043675|FG001|Overall Study|Withdrawal by Subject|0|||
156805472|NCT00692003|566043676|FG000|Overall Study|Sponsor Decision|5|||
156805473|NCT00692003|566043677|FG001|Overall Study|Sponsor Decision|1|||
156882038|NCT01457352|566327082|FG000|Period 2|Sponsor's withdrawal|7|||
156805474|NCT01535287|566043678|FG000|Overall Study|drug not prepared in time|5|||
156805475|NCT01535287|566043679|FG001|Overall Study|drug not prepared in time|6|||
156805476|NCT00305877|566043680|FG000|Overall Study|Lack of Efficacy|6|||
156805477|NCT00305877|566043681|FG001|Overall Study|Lack of Efficacy|9|||
156805478|NCT00305877|566043680|FG000|Overall Study|Adverse Event|9|||
156805479|NCT00305877|566043681|FG001|Overall Study|Adverse Event|14|||
156805480|NCT00305877|566043680|FG000|Overall Study|Death|0|||
156805481|NCT00305877|566043681|FG001|Overall Study|Death|1|||
156805482|NCT00305877|566043680|FG000|Overall Study|Withdrawal by Subject|4|||
156805483|NCT00305877|566043681|FG001|Overall Study|Withdrawal by Subject|2|||
156805484|NCT00305877|566043680|FG000|Overall Study|Physician Decision|1|||
156805485|NCT00305877|566043681|FG001|Overall Study|Physician Decision|1|||
156805486|NCT00305877|566043680|FG000|Overall Study|Never start treatment|2|||
156805487|NCT00305877|566043681|FG001|Overall Study|Never start treatment|5|||
156805488|NCT00305877|566043680|FG000|Overall Study|Ineligible|2|||
156805489|NCT00305877|566043681|FG001|Overall Study|Ineligible|1|||
156805490|NCT00305877|566043680|FG000|Overall Study|Transportation issue with daily RT|0|||
156805491|NCT00305877|566043681|FG001|Overall Study|Transportation issue with daily RT|1|||
156805492|NCT00457392|566043682|FG000|Overall Study|Objective Progression or Relapse|229|||
156805493|NCT00457392|566043683|FG001|Overall Study|Objective Progression or Relapse|296|||
156805494|NCT00457392|566043682|FG000|Overall Study|Death|106|||
156805495|NCT00457392|566043683|FG001|Overall Study|Death|106|||
156805496|NCT00457392|566043682|FG000|Overall Study|Adverse Event|84|||
156805497|NCT00457392|566043683|FG001|Overall Study|Adverse Event|41|||
156805498|NCT00457392|566043682|FG000|Overall Study|Global Deterioration of Health Status|22|||
156805499|NCT00457392|566043683|FG001|Overall Study|Global Deterioration of Health Status|8|||
156805500|NCT00457392|566043682|FG000|Overall Study|Withdrawal by Subject|14|||
156805501|NCT00457392|566043683|FG001|Overall Study|Withdrawal by Subject|8|||
156805502|NCT00457392|566043682|FG000|Overall Study|Lost to Follow-up|6|||
156805503|NCT00457392|566043683|FG001|Overall Study|Lost to Follow-up|7|||
156805504|NCT00457392|566043682|FG000|Overall Study|Protocol Violation|4|||
156805505|NCT00457392|566043683|FG001|Overall Study|Protocol Violation|3|||
156805506|NCT00457392|566043682|FG000|Overall Study|Other|7|||
156805507|NCT00457392|566043683|FG001|Overall Study|Other|4|||
156805508|NCT00457392|566043682|FG000|Overall Study|Study Terminated by Sponsor|1|||
156805509|NCT00457392|566043683|FG001|Overall Study|Study Terminated by Sponsor|4|||
156805510|NCT00457392|566043682|FG000|Overall Study|Randomized, Not Treated|7|||
156805511|NCT00457392|566043683|FG001|Overall Study|Randomized, Not Treated|3|||
156805512|NCT00980148|566043684|FG000|Overall Study|Discharged from facility|89|||
156805513|NCT00980148|566043685|FG001|Overall Study|Discharged from facility|96|||
156805514|NCT00980148|566043684|FG000|Overall Study|Received other antichlamydia treatment|20|||
156805515|NCT00980148|566043685|FG001|Overall Study|Received other antichlamydia treatment|14|||
156805516|NCT00980148|566043684|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
156805517|NCT00980148|566043685|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
156805518|NCT00980148|566043684|FG000|Overall Study|Various other reasons|8|||
156805519|NCT00980148|566043685|FG001|Overall Study|Various other reasons|9|||
156805520|NCT00812955|566043693|FG000|Overall Study|Adverse Event|7|||
156805521|NCT00812955|566043694|FG001|Overall Study|Adverse Event|6|||
156805522|NCT00812955|566043695|FG002|Overall Study|Adverse Event|3|||
156805523|NCT00812955|566043696|FG003|Overall Study|Adverse Event|4|||
156805524|NCT00812955|566043693|FG000|Overall Study|Lost to Follow-up|2|||
156805525|NCT00812955|566043694|FG001|Overall Study|Lost to Follow-up|1|||
156805526|NCT00812955|566043695|FG002|Overall Study|Lost to Follow-up|1|||
156805527|NCT00812955|566043696|FG003|Overall Study|Lost to Follow-up|2|||
156805528|NCT00812955|566043693|FG000|Overall Study|Withdrawal by Subject|1|||
156805529|NCT00812955|566043694|FG001|Overall Study|Withdrawal by Subject|0|||
156882039|NCT01457352|566327083|FG001|Period 2|Sponsor's withdrawal|0|||
156882040|NCT01457352|566327082|FG000|Period 2|Lost to Follow-up|1|||
156882041|NCT01457352|566327083|FG001|Period 2|Lost to Follow-up|0|||
156882042|NCT01457352|566327082|FG000|Period 2|dose change|1|||
156882043|NCT01457352|566327083|FG001|Period 2|dose change|0|||
156882044|NCT01457352|566327082|FG000|Period 2|Physician Decision|1|||
156882045|NCT01457352|566327083|FG001|Period 2|Physician Decision|0|||
156882046|NCT01457352|566327082|FG000|Period 2|Did not meet eligibility criteria|3|||
156882047|NCT01457352|566327083|FG001|Period 2|Did not meet eligibility criteria|0|||
156882048|NCT01457352|566327082|FG000|Period 3|Adverse Event|1|||
156882049|NCT01457352|566327083|FG001|Period 3|Adverse Event|1|||
156882050|NCT01457352|566327082|FG000|Period 3|Withdrawal by Subject|0|||
156882051|NCT01457352|566327083|FG001|Period 3|Withdrawal by Subject|2|||
156882052|NCT01457352|566327082|FG000|Period 3|incorrect treatment|0|||
156882053|NCT01457352|566327083|FG001|Period 3|incorrect treatment|1|||
156882054|NCT01457352|566327082|FG000|Period 3|Sponsor's withdrawal|0|||
156882055|NCT01457352|566327083|FG001|Period 3|Sponsor's withdrawal|1|||
156882056|NCT02537015|566327084|FG000|Overall Study|Adverse Event|3|||
156882057|NCT02537015|566327084|FG000|Overall Study|Withdrawal by Subject|2|||
156805530|NCT00812955|566043695|FG002|Overall Study|Withdrawal by Subject|1|||
156805531|NCT00812955|566043696|FG003|Overall Study|Withdrawal by Subject|2|||
156805532|NCT00812955|566043693|FG000|Overall Study|randomized in error|0|||
156805533|NCT00812955|566043694|FG001|Overall Study|randomized in error|0|||
156805534|NCT00812955|566043695|FG002|Overall Study|randomized in error|1|||
156805535|NCT00812955|566043696|FG003|Overall Study|randomized in error|0|||
156805536|NCT01309204|566043697|FG000|Overall Study|Adverse Event|48|||
156805537|NCT01309204|566043698|FG001|Overall Study|Adverse Event|58|||
156805538|NCT01309204|566043697|FG000|Overall Study|Lost to Follow-up|2|||
156882058|NCT02537015|566327084|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156882059|NCT01808092|566327085|FG000|Overall Study|Death|39|||
156882060|NCT01808092|566327086|FG001|Overall Study|Death|29|||
156882061|NCT01808092|566327085|FG000|Overall Study|Lost to Follow-up|3|||
156882062|NCT01808092|566327086|FG001|Overall Study|Lost to Follow-up|7|||
156805539|NCT01309204|566043698|FG001|Overall Study|Lost to Follow-up|2|||
156805540|NCT01309204|566043697|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
156805541|NCT01309204|566043698|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
156805542|NCT01309204|566043697|FG000|Overall Study|Inadequate control of IOP|4|||
156805543|NCT01309204|566043698|FG001|Overall Study|Inadequate control of IOP|4|||
156805544|NCT01309204|566043697|FG000|Overall Study|Other|4|||
156805545|NCT01309204|566043698|FG001|Overall Study|Other|1|||
156805546|NCT04512001|566043700|FG000|Week 0 to Week 24|Adverse Event|14|||
156805547|NCT04512001|566043701|FG001|Week 0 to Week 24|Adverse Event|10|||
156805548|NCT04512001|566043702|FG002|Week 0 to Week 24|Adverse Event|0|||
156805549|NCT04512001|566043703|FG003|Week 0 to Week 24|Adverse Event|0|||
156805550|NCT04512001|566043704|FG004|Week 0 to Week 24|Adverse Event|0|||
156805551|NCT04512001|566043700|FG000|Week 0 to Week 24|Death|0|||
156805552|NCT04512001|566043701|FG001|Week 0 to Week 24|Death|2|||
156805553|NCT04512001|566043702|FG002|Week 0 to Week 24|Death|0|||
156805554|NCT04512001|566043703|FG003|Week 0 to Week 24|Death|0|||
156805555|NCT04512001|566043704|FG004|Week 0 to Week 24|Death|0|||
156805556|NCT04512001|566043700|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
156805557|NCT04512001|566043701|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
156805558|NCT04512001|566043702|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
156805559|NCT04512001|566043703|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
156805560|NCT04512001|566043704|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
156805561|NCT04512001|566043700|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
156805562|NCT04512001|566043701|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
156805563|NCT04512001|566043702|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805564|NCT04512001|566043703|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805565|NCT04512001|566043704|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
156805566|NCT04512001|566043700|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
156805567|NCT04512001|566043701|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805568|NCT04512001|566043702|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805569|NCT04512001|566043703|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805570|NCT04512001|566043704|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
156805571|NCT04512001|566043700|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805572|NCT04512001|566043701|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
156805573|NCT04512001|566043702|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805574|NCT04512001|566043703|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805575|NCT04512001|566043704|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
156805576|NCT04512001|566043700|FG000|Week 24 to Week 63|Adverse Event|0|||
156805577|NCT04512001|566043701|FG001|Week 24 to Week 63|Adverse Event|0|||
156805578|NCT04512001|566043702|FG002|Week 24 to Week 63|Adverse Event|13|||
156805579|NCT04512001|566043703|FG003|Week 24 to Week 63|Adverse Event|8|||
156805580|NCT04512001|566043704|FG004|Week 24 to Week 63|Adverse Event|6|||
156805581|NCT04512001|566043700|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
156805582|NCT04512001|566043701|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
156805583|NCT04512001|566043702|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
156805584|NCT04512001|566043703|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
156805585|NCT04512001|566043704|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
156805586|NCT04512001|566043700|FG000|Week 24 to Week 63|Death|0|||
156805587|NCT04512001|566043701|FG001|Week 24 to Week 63|Death|0|||
156805588|NCT04512001|566043702|FG002|Week 24 to Week 63|Death|0|||
156805589|NCT04512001|566043703|FG003|Week 24 to Week 63|Death|1|||
156805590|NCT04512001|566043704|FG004|Week 24 to Week 63|Death|1|||
156805591|NCT04512001|566043700|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
156805592|NCT04512001|566043701|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
156805593|NCT04512001|566043702|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
156805594|NCT04512001|566043703|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
156805595|NCT04512001|566043704|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
156805596|NCT04512001|566043700|FG000|Week 24 to Week 63|Miscellaneous|0|||
156805597|NCT04512001|566043701|FG001|Week 24 to Week 63|Miscellaneous|0|||
156805598|NCT04512001|566043702|FG002|Week 24 to Week 63|Miscellaneous|3|||
156805599|NCT04512001|566043703|FG003|Week 24 to Week 63|Miscellaneous|2|||
156882063|NCT01808092|566327085|FG000|Overall Study|Withdrawal by Subject|9|||
156882064|NCT01808092|566327086|FG001|Overall Study|Withdrawal by Subject|4|||
156882065|NCT01808092|566327085|FG000|Overall Study|Other Eligibility criteria|3|||
156882066|NCT01808092|566327086|FG001|Overall Study|Other Eligibility criteria|5|||
156882067|NCT02626624|566327089|FG000|Overall Study|Adverse Event|1|||
156805600|NCT04512001|566043704|FG004|Week 24 to Week 63|Miscellaneous|1|||
156805601|NCT04232943|566043705|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
156805602|NCT04232943|566043706|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
156805603|NCT04232943|566043707|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
156805604|NCT04232943|566043705|FG000|Overall Study|Withdrawal by Subject|1|||
156805605|NCT04232943|566043706|FG001|Overall Study|Withdrawal by Subject|1|||
156805606|NCT04232943|566043707|FG002|Overall Study|Withdrawal by Subject|0|||
156805607|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Physician Decision|0|||
156805608|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Physician Decision|0|||
156805609|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Physician Decision|1|||
156805610|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Physician Decision|0|||
156805611|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
156805612|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
156805613|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
156805614|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
156805615|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
156805616|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
156805617|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
156805618|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
156805619|NCT02266147|566043708|FG000|PART 1: Dose Escalation|Other|1|||
156805620|NCT02266147|566043709|FG001|PART 1: Dose Escalation|Other|1|||
156805621|NCT02266147|566043710|FG002|PART 1: Dose Escalation|Other|0|||
156805622|NCT02266147|566043711|FG003|PART 1: Dose Escalation|Other|0|||
156805623|NCT02266147|566043708|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
156805624|NCT02266147|566043709|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
156805625|NCT02266147|566043710|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
156805626|NCT02266147|566043711|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
156805627|NCT02266147|566043708|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
156805628|NCT02266147|566043709|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
156805629|NCT02266147|566043710|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
156805630|NCT02266147|566043711|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
156805631|NCT00573391|566043712|FG000|Overall Study|study stopped|2|||
156805632|NCT00573391|566043713|FG001|Overall Study|study stopped|2|||
156805633|NCT00573391|566043712|FG000|Overall Study|Death|1|||
156805634|NCT00573391|566043713|FG001|Overall Study|Death|0|||
156805635|NCT03896477|566043716|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
156805636|NCT03896477|566043717|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
156805637|NCT03896477|566043718|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
156805638|NCT03896477|566043716|FG000|Overall Study|Parent Requested Withdrawal|8|||
156805639|NCT03896477|566043717|FG001|Overall Study|Parent Requested Withdrawal|12|||
156805640|NCT03896477|566043718|FG002|Overall Study|Parent Requested Withdrawal|9|||
156805641|NCT03896477|566043716|FG000|Overall Study|Adverse Event|0|||
156805642|NCT03896477|566043717|FG001|Overall Study|Adverse Event|0|||
156805643|NCT03896477|566043718|FG002|Overall Study|Adverse Event|1|||
156805644|NCT03896477|566043716|FG000|Overall Study|Death|1|||
156805645|NCT03896477|566043717|FG001|Overall Study|Death|0|||
156805646|NCT03896477|566043718|FG002|Overall Study|Death|0|||
156805647|NCT03896477|566043716|FG000|Overall Study|Other|5|||
156805648|NCT03896477|566043717|FG001|Overall Study|Other|6|||
156805649|NCT03896477|566043718|FG002|Overall Study|Other|7|||
156805650|NCT03896477|566043716|FG000|Overall Study|Lost to Follow-up|2|||
156805651|NCT03896477|566043717|FG001|Overall Study|Lost to Follow-up|1|||
156805652|NCT03896477|566043718|FG002|Overall Study|Lost to Follow-up|1|||
156805653|NCT01023217|566043720|FG000|Overall Study|Withdrawal by Subject|1|||
156805654|NCT01023217|566043721|FG001|Overall Study|Withdrawal by Subject|0|||
156805655|NCT01673646|566043722|FG000|Overall Study|Adverse Event|2|||
156805656|NCT01673646|566043723|FG001|Overall Study|Adverse Event|1|||
156805657|NCT01673646|566043724|FG002|Overall Study|Adverse Event|1|||
156805658|NCT01673646|566043722|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156882068|NCT02626624|566327089|FG000|Overall Study|Lost to Follow-up|3|||
156805659|NCT01673646|566043723|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156805660|NCT01673646|566043724|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156805661|NCT01673646|566043722|FG000|Overall Study|Condition no longer requires study drug|0|||
156805662|NCT01673646|566043723|FG001|Overall Study|Condition no longer requires study drug|1|||
156805663|NCT01673646|566043724|FG002|Overall Study|Condition no longer requires study drug|0|||
156805664|NCT01673646|566043722|FG000|Overall Study|Withdrawal by Subject|0|||
156805665|NCT01673646|566043723|FG001|Overall Study|Withdrawal by Subject|2|||
156882069|NCT02626624|566327089|FG000|Overall Study|Protocol Violation|4|||
157220995|NCT00585351|567554938|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
157220996|NCT00585351|567554939|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
157220997|NCT00585351|567554940|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
157220998|NCT00585351|567554941|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
157220999|NCT00585351|567554934|FG000|Enrollment Period (Intervention)|Death|0|||
157221000|NCT00585351|567554935|FG001|Enrollment Period (Intervention)|Death|0|||
157221001|NCT00585351|567554936|FG002|Enrollment Period (Intervention)|Death|0|||
157221002|NCT00585351|567554937|FG003|Enrollment Period (Intervention)|Death|0|||
156805666|NCT01673646|566043724|FG002|Overall Study|Withdrawal by Subject|2|||
156805667|NCT01673646|566043722|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
156805668|NCT01673646|566043723|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
156805669|NCT01673646|566043724|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
156805670|NCT03064074|566043725|FG000|Overall Study|Physician Decision|0|||
156805671|NCT03064074|566043726|FG001|Overall Study|Physician Decision|0|||
156882070|NCT02626624|566327089|FG000|Overall Study|Death|2|||
157221003|NCT00585351|567554938|FG004|Enrollment Period (Intervention)|Death|1|||
156805672|NCT03064074|566043727|FG002|Overall Study|Physician Decision|0|||
156805673|NCT03064074|566043728|FG003|Overall Study|Physician Decision|1|||
156805674|NCT01063348|566043730|FG000|Overall Study|Lost to Follow-up|3|||
156805675|NCT01063348|566043731|FG001|Overall Study|Lost to Follow-up|10|||
156805676|NCT01118780|566043732|FG000|Overall Study|Adverse Event|15|||
156805677|NCT01118780|566043733|FG001|Overall Study|Adverse Event|15|||
156805678|NCT01118780|566043732|FG000|Overall Study|Death|1|||
156805679|NCT01118780|566043733|FG001|Overall Study|Death|0|||
156805680|NCT01118780|566043732|FG000|Overall Study|Lack of Efficacy|2|||
156805681|NCT01118780|566043733|FG001|Overall Study|Lack of Efficacy|6|||
156805682|NCT01118780|566043732|FG000|Overall Study|Physician Decision|2|||
156805683|NCT01118780|566043733|FG001|Overall Study|Physician Decision|0|||
156805684|NCT01118780|566043732|FG000|Overall Study|Protocol Violation|3|||
156805685|NCT01118780|566043733|FG001|Overall Study|Protocol Violation|6|||
156805686|NCT01118780|566043732|FG000|Overall Study|Withdrawal by Subject|13|||
156805687|NCT01118780|566043733|FG001|Overall Study|Withdrawal by Subject|8|||
156805688|NCT05518461|566043734|FG000|Overall Study|Lost to Follow-up|25|||
156805689|NCT00269087|566043735|FG000|Overall Study|Adverse Event|20|||
156805690|NCT00269087|566043735|FG000|Overall Study|Withdrawal by Subject|1|||
156805691|NCT00269087|566043735|FG000|Overall Study|Exacerbation of COPD|13|||
156805692|NCT00332696|566043740|FG000|Overall Study|Death|24|||
156805693|NCT00332696|566043741|FG001|Overall Study|Death|14|||
156805694|NCT00332696|566043740|FG000|Overall Study|Insufficient therapeutic effect|4|||
156805695|NCT00332696|566043741|FG001|Overall Study|Insufficient therapeutic effect|11|||
156805696|NCT00332696|566043740|FG000|Overall Study|Adverse Event|1|||
156805697|NCT00332696|566043741|FG001|Overall Study|Adverse Event|2|||
156805698|NCT00332696|566043740|FG000|Overall Study|Condition does not justify treatment|0|||
156805699|NCT00332696|566043741|FG001|Overall Study|Condition does not justify treatment|2|||
156805700|NCT00332696|566043740|FG000|Overall Study|Lost to Follow-up|0|||
156805701|NCT00332696|566043741|FG001|Overall Study|Lost to Follow-up|1|||
156805702|NCT00332696|566043740|FG000|Overall Study|Withdrawal by Subject|1|||
156805703|NCT00332696|566043741|FG001|Overall Study|Withdrawal by Subject|0|||
156805704|NCT02216526|566043742|FG000|Overall Study|Adverse Event|1|||
156805705|NCT02216526|566043743|FG001|Overall Study|Adverse Event|1|||
156805706|NCT02216526|566043744|FG002|Overall Study|Adverse Event|0|||
156805707|NCT02216526|566043742|FG000|Overall Study|Death|0|||
156805708|NCT02216526|566043743|FG001|Overall Study|Death|1|||
156805709|NCT02216526|566043744|FG002|Overall Study|Death|3|||
156805710|NCT02216526|566043742|FG000|Overall Study|Protocol Violation|2|||
156805711|NCT02216526|566043743|FG001|Overall Study|Protocol Violation|0|||
156805712|NCT02216526|566043744|FG002|Overall Study|Protocol Violation|2|||
156805713|NCT02216526|566043742|FG000|Overall Study|Hospitalization|2|||
156805714|NCT02216526|566043743|FG001|Overall Study|Hospitalization|1|||
156805715|NCT02216526|566043744|FG002|Overall Study|Hospitalization|3|||
156805716|NCT03824392|566043747|FG000|Overall Study|Adverse Event|1|||
156805717|NCT03824392|566043748|FG001|Overall Study|Adverse Event|0|||
156805718|NCT03824392|566043749|FG002|Overall Study|Adverse Event|0|||
156805719|NCT03824392|566043750|FG003|Overall Study|Adverse Event|0|||
156805720|NCT03824392|566043747|FG000|Overall Study|Investigator Decision|0|||
156805721|NCT03824392|566043748|FG001|Overall Study|Investigator Decision|1|||
156805722|NCT03824392|566043749|FG002|Overall Study|Investigator Decision|0|||
156805723|NCT03824392|566043750|FG003|Overall Study|Investigator Decision|0|||
156805724|NCT03824392|566043747|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
156805725|NCT03824392|566043748|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
156805726|NCT03824392|566043749|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
156805727|NCT03824392|566043750|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
156805728|NCT02230189|566043751|FG000|Overall Study|Withdrawal by Subject|3|||
156805729|NCT02230189|566043752|FG001|Overall Study|Withdrawal by Subject|0|||
156805730|NCT02230189|566043753|FG002|Overall Study|Withdrawal by Subject|1|||
156805731|NCT02230189|566043751|FG000|Overall Study|Lost to Follow-up|1|||
156805732|NCT02230189|566043752|FG001|Overall Study|Lost to Follow-up|0|||
156805733|NCT02230189|566043753|FG002|Overall Study|Lost to Follow-up|0|||
156805734|NCT02230189|566043751|FG000|Overall Study|Physician Decision|1|||
156805735|NCT02230189|566043752|FG001|Overall Study|Physician Decision|0|||
156805736|NCT02230189|566043753|FG002|Overall Study|Physician Decision|0|||
156805737|NCT01847755|566043754|FG000|Overall Study|Adverse Event|2|||
156805738|NCT01847755|566043754|FG000|Overall Study|Withdrawal by Subject|2|||
156805739|NCT01847755|566043754|FG000|Overall Study|Physician Decision|1|||
156805740|NCT01904721|566043759|FG000|Overall Study|Other Reasons|0|||
156805741|NCT01904721|566043760|FG001|Overall Study|Other Reasons|0|||
156805742|NCT01904721|566043761|FG002|Overall Study|Other Reasons|1|||
156805743|NCT01904721|566043762|FG003|Overall Study|Other Reasons|1|||
156805744|NCT01904721|566043763|FG004|Overall Study|Other Reasons|2|||
156805745|NCT01904721|566043764|FG005|Overall Study|Other Reasons|2|||
156805746|NCT01904721|566043765|FG006|Overall Study|Other Reasons|2|||
156805747|NCT01904721|566043759|FG000|Overall Study|Personal Reasons|0|||
157021163|NCT03138512|566830855|FG004|Treatment Part B|Participant withdrew consent|2|||
157021164|NCT03138512|566830851|FG000|Treatment Part B|Lost to Follow-up|0|||
157021165|NCT03138512|566830852|FG001|Treatment Part B|Lost to Follow-up|0|||
157021166|NCT03138512|566830853|FG002|Treatment Part B|Lost to Follow-up|0|||
157021167|NCT03138512|566830854|FG003|Treatment Part B|Lost to Follow-up|1|||
157021168|NCT03138512|566830855|FG004|Treatment Part B|Lost to Follow-up|0|||
157021169|NCT03138512|566830851|FG000|Treatment Part B|Poor/non-compliance|0|||
157021170|NCT03138512|566830852|FG001|Treatment Part B|Poor/non-compliance|0|||
157021171|NCT03138512|566830853|FG002|Treatment Part B|Poor/non-compliance|1|||
157021172|NCT03138512|566830854|FG003|Treatment Part B|Poor/non-compliance|1|||
157021173|NCT03138512|566830855|FG004|Treatment Part B|Poor/non-compliance|1|||
157021174|NCT03138512|566830851|FG000|Treatment Part B|Other reasons|0|||
157021175|NCT03138512|566830852|FG001|Treatment Part B|Other reasons|0|||
157021176|NCT03138512|566830853|FG002|Treatment Part B|Other reasons|3|||
157021177|NCT03138512|566830854|FG003|Treatment Part B|Other reasons|1|||
157021178|NCT03138512|566830855|FG004|Treatment Part B|Other reasons|5|||
157021179|NCT01580488|566830859|FG000|Overall Study|Withdrawal by Subject|1|||
157021180|NCT02783300|566830869|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021181|NCT02783300|566830870|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021182|NCT02783300|566830871|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021183|NCT02783300|566830872|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021184|NCT02783300|566830873|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021185|NCT02783300|566830874|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021186|NCT02783300|566830875|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
157021187|NCT02783300|566830876|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021188|NCT02783300|566830877|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021189|NCT02783300|566830878|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021190|NCT02783300|566830879|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021191|NCT02783300|566830880|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021192|NCT02783300|566830881|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021193|NCT02783300|566830882|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021194|NCT02783300|566830883|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021195|NCT02783300|566830884|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021196|NCT02783300|566830885|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021197|NCT02783300|566830886|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021198|NCT02783300|566830887|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021199|NCT02783300|566830888|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021200|NCT02783300|566830889|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021201|NCT02783300|566830890|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021202|NCT02783300|566830891|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021203|NCT02783300|566830892|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
156805748|NCT01904721|566043760|FG001|Overall Study|Personal Reasons|0|||
156805749|NCT01904721|566043761|FG002|Overall Study|Personal Reasons|0|||
156805750|NCT01904721|566043762|FG003|Overall Study|Personal Reasons|0|||
156805751|NCT01904721|566043763|FG004|Overall Study|Personal Reasons|2|||
156805752|NCT01904721|566043764|FG005|Overall Study|Personal Reasons|3|||
156805753|NCT01904721|566043765|FG006|Overall Study|Personal Reasons|3|||
156805754|NCT01904721|566043759|FG000|Overall Study|Lost to Follow-up|0|||
156805755|NCT01904721|566043760|FG001|Overall Study|Lost to Follow-up|0|||
156805756|NCT01904721|566043761|FG002|Overall Study|Lost to Follow-up|0|||
156805757|NCT01904721|566043762|FG003|Overall Study|Lost to Follow-up|0|||
156805758|NCT01904721|566043763|FG004|Overall Study|Lost to Follow-up|1|||
156805759|NCT01904721|566043764|FG005|Overall Study|Lost to Follow-up|3|||
156805760|NCT01904721|566043765|FG006|Overall Study|Lost to Follow-up|1|||
156805761|NCT01904721|566043759|FG000|Overall Study|Lack of Efficacy|0|||
156805762|NCT01904721|566043760|FG001|Overall Study|Lack of Efficacy|0|||
156805763|NCT01904721|566043761|FG002|Overall Study|Lack of Efficacy|0|||
156805764|NCT01904721|566043762|FG003|Overall Study|Lack of Efficacy|0|||
156805765|NCT01904721|566043763|FG004|Overall Study|Lack of Efficacy|0|||
156805766|NCT01904721|566043764|FG005|Overall Study|Lack of Efficacy|0|||
156805767|NCT01904721|566043765|FG006|Overall Study|Lack of Efficacy|1|||
156805768|NCT01904721|566043759|FG000|Overall Study|Adverse Event|0|||
156805769|NCT01904721|566043760|FG001|Overall Study|Adverse Event|0|||
156805770|NCT01904721|566043761|FG002|Overall Study|Adverse Event|0|||
156805771|NCT01904721|566043762|FG003|Overall Study|Adverse Event|0|||
156805772|NCT01904721|566043763|FG004|Overall Study|Adverse Event|3|||
156805773|NCT01904721|566043764|FG005|Overall Study|Adverse Event|1|||
156805774|NCT01904721|566043765|FG006|Overall Study|Adverse Event|0|||
156805775|NCT00532844|566043769|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
156805776|NCT00532844|566043770|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
156805777|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
156805778|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
156882071|NCT03425253|566327090|FG000|Overall Study|Adverse Event|2|||
156805779|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
156805780|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
156805781|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
156805782|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
156805783|NCT00532844|566043769|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
156805784|NCT00532844|566043770|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
156805785|NCT01077063|566043772|FG000|Overall Study|Adverse Event|3|||
156805786|NCT01077063|566043773|FG001|Overall Study|Adverse Event|0|||
156805787|NCT01077063|566043772|FG000|Overall Study|Death|1|||
156805788|NCT01077063|566043773|FG001|Overall Study|Death|1|||
156805789|NCT01077063|566043772|FG000|Overall Study|Withdrawal by Subject|0|||
156805790|NCT01077063|566043773|FG001|Overall Study|Withdrawal by Subject|2|||
156805791|NCT03894891|566043774|FG000|Overall Study|Withdrawal by Subject|1|||
156805792|NCT03894891|566043774|FG000|Overall Study|Completed protocol treatment per protocol|5|||
156805793|NCT04389866|566043778|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
156805794|NCT04389866|566043779|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
156805795|NCT01644643|566043783|FG000|Overall Study|Death|1|||
156805796|NCT01644643|566043784|FG001|Overall Study|Death|0|||
156805797|NCT01644643|566043785|FG002|Overall Study|Death|3|||
156805798|NCT01644643|566043786|FG003|Overall Study|Death|3|||
156805799|NCT01644643|566043783|FG000|Overall Study|Lost to Follow-up|0|||
156805800|NCT01644643|566043784|FG001|Overall Study|Lost to Follow-up|0|||
156882072|NCT03425253|566327090|FG000|Overall Study|Lost to Follow-up|3|||
156882073|NCT03425253|566327090|FG000|Overall Study|Withdrew Consent|6|||
156882074|NCT03425253|566327090|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
156882075|NCT04174365|566327091|FG000|Overall Study|Lost to Follow-up|1|||
156882076|NCT04174365|566327092|FG001|Overall Study|Lost to Follow-up|2|||
156882077|NCT04174365|566327091|FG000|Overall Study|Adverse Event|2|||
156882078|NCT04174365|566327092|FG001|Overall Study|Adverse Event|1|||
156882079|NCT04174365|566327091|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
156882080|NCT04174365|566327092|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
156882081|NCT04174365|566327091|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
156882082|NCT04174365|566327092|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
156882083|NCT04174365|566327091|FG000|Overall Study|Protocol Deviation|1|||
156882084|NCT04174365|566327092|FG001|Overall Study|Protocol Deviation|0|||
156882085|NCT04174365|566327091|FG000|Overall Study|Lack of Efficacy|0|||
156882086|NCT04174365|566327092|FG001|Overall Study|Lack of Efficacy|2|||
156882087|NCT04174365|566327091|FG000|Overall Study|Disease Relapse|1|||
156882088|NCT04174365|566327092|FG001|Overall Study|Disease Relapse|0|||
156882089|NCT04174365|566327091|FG000|Overall Study|Reason Not Specified|0|||
156882090|NCT04174365|566327092|FG001|Overall Study|Reason Not Specified|1|||
156882091|NCT05141448|566327093|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156805801|NCT01644643|566043785|FG002|Overall Study|Lost to Follow-up|0|||
156805802|NCT01644643|566043786|FG003|Overall Study|Lost to Follow-up|4|||
156805803|NCT01644643|566043783|FG000|Overall Study|Withdrawal by Subject|1|||
156805804|NCT01644643|566043784|FG001|Overall Study|Withdrawal by Subject|0|||
156805805|NCT01644643|566043785|FG002|Overall Study|Withdrawal by Subject|2|||
156805806|NCT01644643|566043786|FG003|Overall Study|Withdrawal by Subject|1|||
156805807|NCT01644643|566043783|FG000|Overall Study|Other Eligibility criteria|0|||
156805808|NCT01644643|566043784|FG001|Overall Study|Other Eligibility criteria|0|||
156805809|NCT01644643|566043785|FG002|Overall Study|Other Eligibility criteria|0|||
156805810|NCT01644643|566043786|FG003|Overall Study|Other Eligibility criteria|2|||
156805811|NCT01490918|566043791|FG000|Overall Study|Lost to Follow-up|2|||
156805812|NCT01490918|566043792|FG001|Overall Study|Lost to Follow-up|1|||
156805813|NCT01490918|566043793|FG002|Overall Study|Lost to Follow-up|0|||
156805814|NCT01490918|566043791|FG000|Overall Study|Withdrawal by Subject|7|||
156805815|NCT01490918|566043792|FG001|Overall Study|Withdrawal by Subject|8|||
156805816|NCT01490918|566043793|FG002|Overall Study|Withdrawal by Subject|3|||
156805817|NCT01490918|566043791|FG000|Overall Study|Adverse Event|0|||
156805818|NCT01490918|566043792|FG001|Overall Study|Adverse Event|0|||
156882092|NCT05141448|566327094|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
156805819|NCT01490918|566043793|FG002|Overall Study|Adverse Event|1|||
156805820|NCT01490918|566043791|FG000|Overall Study|other cause|4|||
156805821|NCT01490918|566043792|FG001|Overall Study|other cause|5|||
156805822|NCT01490918|566043793|FG002|Overall Study|other cause|8|||
156805823|NCT00648037|566043794|FG000|Overall Study|Not Treated|1|||
156805824|NCT00648037|566043794|FG000|Overall Study|Withdrawal by Subject|1|||
156805825|NCT00648037|566043794|FG000|Overall Study|Adverse Event|11|||
156805826|NCT00648037|566043794|FG000|Overall Study|Relapse|2|||
156805827|NCT00648037|566043794|FG000|Overall Study|Other|1|||
156805828|NCT02967679|566043795|FG000|Overall Study|Adverse Event|1|||
156805829|NCT01284959|566043798|FG000|Overall Study|Withdrawal by Subject|1|||
156805830|NCT01284959|566043799|FG001|Overall Study|Withdrawal by Subject|0|||
156805831|NCT01284959|566043800|FG002|Overall Study|Withdrawal by Subject|0|||
156882093|NCT05141448|566327095|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
157143913|NCT02158533|567276364|FG000|Stage 2|Lack of Efficacy|0|||
156805832|NCT01284959|566043798|FG000|Overall Study|Adverse Event|0|||
156805833|NCT01284959|566043799|FG001|Overall Study|Adverse Event|0|||
156882094|NCT05141448|566327096|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156882095|NCT05141448|566327097|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156805834|NCT01284959|566043800|FG002|Overall Study|Adverse Event|1|||
156805835|NCT02765399|566043801|FG000|Overall Study|Nausea|1|||
156805836|NCT02765399|566043802|FG001|Overall Study|Nausea|0|||
156805837|NCT00120627|566043807|FG000|Overall Study|Withdrawal by Subject|5|||
156805838|NCT00120627|566043808|FG001|Overall Study|Withdrawal by Subject|5|||
156805839|NCT02629861|566043821|FG000|Overall Study|Adverse Event|7|||
156805840|NCT02629861|566043822|FG001|Overall Study|Adverse Event|5|||
156805841|NCT02629861|566043823|FG002|Overall Study|Adverse Event|4|||
156805842|NCT02629861|566043821|FG000|Overall Study|Withdrawal by Subject|5|||
156805843|NCT02629861|566043822|FG001|Overall Study|Withdrawal by Subject|8|||
156805844|NCT02629861|566043823|FG002|Overall Study|Withdrawal by Subject|13|||
156805845|NCT02629861|566043821|FG000|Overall Study|Protocol Violation|2|||
156805846|NCT02629861|566043822|FG001|Overall Study|Protocol Violation|3|||
156805847|NCT02629861|566043823|FG002|Overall Study|Protocol Violation|7|||
156805848|NCT02629861|566043821|FG000|Overall Study|Lost to Follow-up|12|||
156805849|NCT02629861|566043822|FG001|Overall Study|Lost to Follow-up|9|||
156805850|NCT02629861|566043823|FG002|Overall Study|Lost to Follow-up|4|||
156805851|NCT02629861|566043821|FG000|Overall Study|Other|1|||
156805852|NCT02629861|566043822|FG001|Overall Study|Other|1|||
156805853|NCT02629861|566043823|FG002|Overall Study|Other|0|||
156882096|NCT05141448|566327098|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156882097|NCT05141448|566327093|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156882098|NCT05141448|566327094|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156882099|NCT05141448|566327095|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156882100|NCT05141448|566327096|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156882101|NCT05141448|566327097|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
156882102|NCT05141448|566327098|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156882103|NCT05141448|566327093|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156882104|NCT05141448|566327094|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156882105|NCT05141448|566327095|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156805854|NCT02629861|566043821|FG000|Overall Study|Pregnancy|2|||
156805855|NCT02629861|566043822|FG001|Overall Study|Pregnancy|1|||
156805856|NCT02629861|566043823|FG002|Overall Study|Pregnancy|0|||
156805857|NCT00271544|566043824|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
156805858|NCT00271544|566043824|FG000|Overall Study|Model 4196 lead not attempted|9|||
156805859|NCT00271544|566043824|FG000|Overall Study|Implant not attempted|4|||
156882106|NCT05141448|566327096|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156882107|NCT05141448|566327097|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156882108|NCT05141448|566327098|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156882109|NCT05141448|566327093|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156882110|NCT05141448|566327094|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156882111|NCT05141448|566327095|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156882112|NCT05141448|566327096|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156882113|NCT05141448|566327097|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156882114|NCT05141448|566327098|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156882115|NCT05141448|566327093|FG000|Period 2|COVID-19 Related|0|||
156882116|NCT05141448|566327094|FG001|Period 2|COVID-19 Related|0|||
156882117|NCT05141448|566327095|FG002|Period 2|COVID-19 Related|0|||
156882118|NCT05141448|566327096|FG003|Period 2|COVID-19 Related|1|||
156805860|NCT01822665|566043825|FG000|Overall Study|Adverse Event|3|||
156805861|NCT01822665|566043825|FG000|Overall Study|Other Reason|5|||
156805862|NCT00907621|566043826|FG000|Overall Study|Lost to Follow-up|6|||
156805863|NCT00907621|566043827|FG001|Overall Study|Lost to Follow-up|3|||
156805864|NCT00907621|566043826|FG000|Overall Study|intercurrent febrile illness|1|||
156805865|NCT00907621|566043827|FG001|Overall Study|intercurrent febrile illness|1|||
156805866|NCT04290624|566043828|FG000|Overall Study|Adverse Event|1|||
156805867|NCT04290624|566043829|FG001|Overall Study|Adverse Event|0|||
156805868|NCT00656370|566043830|FG000|Overall Study|Screen Failures|7|||
156805869|NCT00656370|566043830|FG000|Overall Study|Alternates|3|||
156805870|NCT00552071|566045432|FG000|Overall Study|Adverse Event|1|||
156805871|NCT00552071|566045433|FG001|Overall Study|Adverse Event|0|||
156805872|NCT00552071|566045432|FG000|Overall Study|Lack of Efficacy|1|||
156805873|NCT00552071|566045433|FG001|Overall Study|Lack of Efficacy|0|||
156805874|NCT00552071|566045432|FG000|Overall Study|Physician Decision|1|||
156805875|NCT00552071|566045433|FG001|Overall Study|Physician Decision|0|||
156805876|NCT00552071|566045432|FG000|Overall Study|Pregnancy|1|||
156805877|NCT00552071|566045433|FG001|Overall Study|Pregnancy|0|||
156805878|NCT00552071|566045432|FG000|Overall Study|Death|0|||
156805879|NCT00552071|566045433|FG001|Overall Study|Death|1|||
156805880|NCT00552071|566045432|FG000|Overall Study|Withdrawal by Subject|0|||
156882119|NCT05141448|566327097|FG004|Period 2|COVID-19 Related|0|||
157021204|NCT02783300|566830893|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021205|NCT02783300|566830894|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021206|NCT02783300|566830895|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
157021207|NCT02783300|566830869|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021208|NCT02783300|566830870|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156805881|NCT00552071|566045433|FG001|Overall Study|Withdrawal by Subject|1|||
156805882|NCT04723355|566045436|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
156805883|NCT04723355|566045436|FG000|Overall Study|Errors in the informed consent form|2|||
156805884|NCT03374358|566045437|FG000|Overall Study|Withdrawal by Subject|0|||
156805885|NCT03374358|566045438|FG001|Overall Study|Withdrawal by Subject|2|||
156805886|NCT01127633|566045439|FG000|Overall Study|Adverse Event|74|||
156805887|NCT01127633|566045440|FG001|Overall Study|Adverse Event|73|||
156805888|NCT01127633|566045439|FG000|Overall Study|Death|40|||
157021209|NCT02783300|566830871|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021210|NCT02783300|566830872|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
157021211|NCT02783300|566830873|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021212|NCT02783300|566830874|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021213|NCT02783300|566830875|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021214|NCT02783300|566830876|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021215|NCT02783300|566830877|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021216|NCT02783300|566830878|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021217|NCT02783300|566830879|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021218|NCT02783300|566830880|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021219|NCT02783300|566830881|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021220|NCT02783300|566830882|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021221|NCT02783300|566830883|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021222|NCT02783300|566830884|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021223|NCT02783300|566830885|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021224|NCT02783300|566830886|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021225|NCT02783300|566830887|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021226|NCT02783300|566830888|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021227|NCT02783300|566830889|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021228|NCT02783300|566830890|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
156805889|NCT01127633|566045440|FG001|Overall Study|Death|43|||
156805890|NCT01127633|566045439|FG000|Overall Study|Lost to Follow-up|4|||
157021229|NCT02783300|566830891|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021230|NCT02783300|566830892|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021231|NCT02783300|566830893|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021232|NCT02783300|566830894|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021233|NCT02783300|566830895|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
157021234|NCT02783300|566830869|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
156805891|NCT01127633|566045440|FG001|Overall Study|Lost to Follow-up|0|||
156805892|NCT01127633|566045439|FG000|Overall Study|Parent/Caregiver Decision|246|||
156805893|NCT01127633|566045440|FG001|Overall Study|Parent/Caregiver Decision|228|||
156805894|NCT01127633|566045439|FG000|Overall Study|Physician Decision|60|||
156805895|NCT01127633|566045440|FG001|Overall Study|Physician Decision|45|||
156805896|NCT01127633|566045439|FG000|Overall Study|Withdrawal by Subject|57|||
156805897|NCT01127633|566045440|FG001|Overall Study|Withdrawal by Subject|72|||
156805898|NCT01127633|566045439|FG000|Overall Study|Sponsor Decision|163|||
156805899|NCT01127633|566045440|FG001|Overall Study|Sponsor Decision|195|||
156805900|NCT01127633|566045439|FG000|Overall Study|Protocol Violation|8|||
156805901|NCT01127633|566045440|FG001|Overall Study|Protocol Violation|16|||
156805902|NCT01127633|566045439|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
156805903|NCT01127633|566045440|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
156805904|NCT01127633|566045439|FG000|Overall Study|Not treated|1|||
156805905|NCT01127633|566045440|FG001|Overall Study|Not treated|0|||
156805906|NCT00399568|566045442|FG000|Overall Study|Adverse Event|1|||
156805907|NCT00399568|566045443|FG001|Overall Study|Adverse Event|2|||
156805908|NCT00399568|566045442|FG000|Overall Study|Withdrawal by Subject|7|||
156805909|NCT00399568|566045443|FG001|Overall Study|Withdrawal by Subject|3|||
156805910|NCT00399568|566045442|FG000|Overall Study|Protocol non-compliance|2|||
156805911|NCT00399568|566045443|FG001|Overall Study|Protocol non-compliance|2|||
156805912|NCT00399568|566045442|FG000|Overall Study|Lost to Follow-up|2|||
156805913|NCT00399568|566045443|FG001|Overall Study|Lost to Follow-up|2|||
156805914|NCT00420381|566045449|FG000|Overall Study|Protocol Violation|1|||
156805915|NCT03432494|566045464|FG000|Overall Study|Death|1|||
156805916|NCT03432494|566045464|FG000|Overall Study|Noncompliance|1|||
156805917|NCT00775268|566045465|FG000|Baseline|Drug not synthesize dose|1|||
156805918|NCT00775268|566045466|FG001|Baseline|Drug not synthesize dose|0|||
156805919|NCT00775268|566045465|FG000|Baseline|Not treated-ineligible per CT|0|||
157021235|NCT02783300|566830870|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
157021236|NCT02783300|566830871|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
156805920|NCT00775268|566045466|FG001|Baseline|Not treated-ineligible per CT|1|||
156805921|NCT00775268|566045465|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
157021237|NCT02783300|566830872|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
157021238|NCT02783300|566830873|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
157021239|NCT02783300|566830874|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
157021240|NCT02783300|566830875|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
157021241|NCT02783300|566830876|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
157021242|NCT02783300|566830877|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
157021243|NCT02783300|566830878|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
157021244|NCT02783300|566830879|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
157021245|NCT02783300|566830880|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
157021246|NCT02783300|566830881|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
157021247|NCT02783300|566830882|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
157021248|NCT02783300|566830883|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
157021249|NCT02783300|566830884|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
157021250|NCT02783300|566830885|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
157021251|NCT02783300|566830886|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
157021252|NCT02783300|566830887|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
157021253|NCT02783300|566830888|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
157021254|NCT02783300|566830889|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
156805922|NCT00775268|566045466|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
156805923|NCT00775268|566045465|FG000|After Completion|Participant missed scan appointment|1|||
156805924|NCT00775268|566045466|FG001|After Completion|Participant missed scan appointment|0|||
156805925|NCT00592631|566045467|FG000|Overall Study|Lost to Follow-up|0|||
156805926|NCT00592631|566045468|FG001|Overall Study|Lost to Follow-up|2|||
156805927|NCT01244035|566045469|FG000|Part 1: Period 1|Adverse Event|0|||
156805928|NCT01244035|566045470|FG001|Part 1: Period 1|Adverse Event|0|||
156805929|NCT01244035|566045471|FG002|Part 1: Period 1|Adverse Event|0|||
156805930|NCT01244035|566045472|FG003|Part 1: Period 1|Adverse Event|0|||
156805931|NCT01244035|566045473|FG004|Part 1: Period 1|Adverse Event|0|||
156805932|NCT01244035|566045474|FG005|Part 1: Period 1|Adverse Event|1|||
156805933|NCT01244035|566045469|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
156805934|NCT01244035|566045470|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
156805935|NCT01244035|566045471|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
156805936|NCT01244035|566045472|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
156805937|NCT01244035|566045473|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
156805938|NCT01244035|566045474|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
156805939|NCT01244035|566045469|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805940|NCT01244035|566045470|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
156805941|NCT01244035|566045471|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
156805942|NCT01244035|566045472|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
156805943|NCT01244035|566045473|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805944|NCT01244035|566045474|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
156805945|NCT01244035|566045469|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805946|NCT01244035|566045470|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805947|NCT01244035|566045471|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
156805948|NCT01244035|566045472|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805949|NCT01244035|566045473|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805950|NCT01244035|566045474|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
156805951|NCT01244035|566045469|FG000|Part 1: Period 3|Adverse Event|0|||
156805952|NCT01244035|566045470|FG001|Part 1: Period 3|Adverse Event|0|||
156805953|NCT01244035|566045471|FG002|Part 1: Period 3|Adverse Event|0|||
156805954|NCT01244035|566045472|FG003|Part 1: Period 3|Adverse Event|0|||
156805955|NCT01244035|566045473|FG004|Part 1: Period 3|Adverse Event|0|||
156805956|NCT01244035|566045474|FG005|Part 1: Period 3|Adverse Event|1|||
156805957|NCT01244035|566045469|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
156805958|NCT01244035|566045470|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
156805959|NCT01244035|566045471|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
156805960|NCT01244035|566045472|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
156805961|NCT01244035|566045473|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
156805962|NCT01244035|566045474|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
156805963|NCT01244035|566045469|FG000|Part 1: Period 3|Protocol Deviation|0|||
156805964|NCT01244035|566045470|FG001|Part 1: Period 3|Protocol Deviation|1|||
156805965|NCT01244035|566045471|FG002|Part 1: Period 3|Protocol Deviation|0|||
156805966|NCT01244035|566045472|FG003|Part 1: Period 3|Protocol Deviation|0|||
156805967|NCT01244035|566045473|FG004|Part 1: Period 3|Protocol Deviation|0|||
156805968|NCT01244035|566045474|FG005|Part 1: Period 3|Protocol Deviation|0|||
156805969|NCT03389308|566045475|FG000|Overall Study|Withdrawal by Subject|5|||
156805970|NCT03389308|566045475|FG000|Overall Study|Lost to Follow-up|3|||
156805971|NCT03389308|566045475|FG000|Overall Study|Adverse Event|2|||
156805972|NCT03389308|566045475|FG000|Overall Study|Sponsor Request|2|||
156805973|NCT00570323|566045477|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
156805974|NCT00570323|566045478|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
156805975|NCT00570323|566045477|FG000|Started Treatment After Randomization|Protocol Violation|1|||
156805976|NCT00570323|566045478|FG001|Started Treatment After Randomization|Protocol Violation|0|||
156805977|NCT00570323|566045477|FG000|Started Treatment After Randomization|Physician Decision|1|||
156805978|NCT00570323|566045478|FG001|Started Treatment After Randomization|Physician Decision|0|||
156805979|NCT00570323|566045477|FG000|Complete Study After Start|Lost to Follow-up|0|||
156805980|NCT00570323|566045478|FG001|Complete Study After Start|Lost to Follow-up|1|||
156805981|NCT00570323|566045477|FG000|Complete Study After Start|Withdrawal by Subject|2|||
156805982|NCT00570323|566045478|FG001|Complete Study After Start|Withdrawal by Subject|0|||
157221004|NCT00585351|567554939|FG005|Enrollment Period (Intervention)|Death|0|||
156805983|NCT00570323|566045477|FG000|Complete Study After Start|Physician Decision|1|||
156805984|NCT00570323|566045478|FG001|Complete Study After Start|Physician Decision|0|||
156805985|NCT04263766|566045479|FG000|Overall Study|Withdrawal by Subject|6|||
156805986|NCT04263766|566045480|FG001|Overall Study|Withdrawal by Subject|4|||
156805987|NCT04263766|566045479|FG000|Overall Study|Lack of Efficacy|1|||
156805988|NCT04263766|566045480|FG001|Overall Study|Lack of Efficacy|3|||
156805989|NCT02639247|566045483|FG000|Overall Study|Lost to Follow-up|2|||
156805990|NCT02639247|566045484|FG001|Overall Study|Lost to Follow-up|1|||
156805991|NCT02639247|566045483|FG000|Overall Study|Death|2|||
156805992|NCT02639247|566045484|FG001|Overall Study|Death|0|||
156805993|NCT02639247|566045483|FG000|Overall Study|Withdrew Consent|0|||
156805994|NCT02639247|566045484|FG001|Overall Study|Withdrew Consent|1|||
156805995|NCT02639247|566045483|FG000|Overall Study|Protocol Violation|1|||
156805996|NCT02639247|566045484|FG001|Overall Study|Protocol Violation|0|||
156805997|NCT01891396|566045485|FG000|Overall Study|Withdrawal by Subject|4|||
156805998|NCT01891396|566045486|FG001|Overall Study|Withdrawal by Subject|4|||
156805999|NCT01891396|566045487|FG002|Overall Study|Withdrawal by Subject|3|||
156806000|NCT01891396|566045485|FG000|Overall Study|Lost to Follow-up|0|||
156806001|NCT01891396|566045486|FG001|Overall Study|Lost to Follow-up|1|||
156806002|NCT01891396|566045487|FG002|Overall Study|Lost to Follow-up|0|||
156806003|NCT00400517|566045492|FG000|Overall Study|Withdrawal by Subject|1|||
156806004|NCT00400517|566045492|FG000|Overall Study|Physician Decision|1|||
156806005|NCT01106157|566045493|FG000|Overall Study|Withdrawal by Subject|1|||
156806006|NCT01106157|566045494|FG001|Overall Study|Withdrawal by Subject|0|||
156806007|NCT01881009|566045498|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
156806008|NCT01881009|566045499|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
156806009|NCT02457247|566045501|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
156806010|NCT02457247|566045502|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
156806011|NCT02457247|566045503|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
156806012|NCT02457247|566045504|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
156806013|NCT02457247|566045501|FG000|Period 1|Significant Protocol Deviation|1|||
156806014|NCT02457247|566045502|FG001|Period 1|Significant Protocol Deviation|1|||
156806015|NCT02457247|566045503|FG002|Period 1|Significant Protocol Deviation|0|||
156806016|NCT02457247|566045504|FG003|Period 1|Significant Protocol Deviation|0|||
156806017|NCT02457247|566045501|FG000|Period 1|Voluntary Withdrawal|1|||
156806018|NCT02457247|566045502|FG001|Period 1|Voluntary Withdrawal|0|||
156806019|NCT02457247|566045503|FG002|Period 1|Voluntary Withdrawal|0|||
156806020|NCT02457247|566045504|FG003|Period 1|Voluntary Withdrawal|0|||
156806021|NCT02457247|566045501|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
156806022|NCT02457247|566045502|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
156806023|NCT02457247|566045503|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
156806024|NCT02457247|566045504|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
156806025|NCT02457247|566045501|FG000|Period 2|Significant Protocol Deviation|1|||
156806026|NCT02457247|566045502|FG001|Period 2|Significant Protocol Deviation|0|||
156806027|NCT02457247|566045503|FG002|Period 2|Significant Protocol Deviation|0|||
156806028|NCT02457247|566045504|FG003|Period 2|Significant Protocol Deviation|0|||
156806029|NCT02457247|566045501|FG000|Period 2|Lost to Follow-up|0|||
156806030|NCT02457247|566045502|FG001|Period 2|Lost to Follow-up|1|||
156806031|NCT02457247|566045503|FG002|Period 2|Lost to Follow-up|0|||
156806032|NCT02457247|566045504|FG003|Period 2|Lost to Follow-up|0|||
156806033|NCT02457247|566045501|FG000|Period 2|Voluntary Withdrawal|1|||
156806034|NCT02457247|566045502|FG001|Period 2|Voluntary Withdrawal|1|||
156806035|NCT02457247|566045503|FG002|Period 2|Voluntary Withdrawal|0|||
156806036|NCT02457247|566045504|FG003|Period 2|Voluntary Withdrawal|0|||
157221005|NCT00585351|567554940|FG006|Enrollment Period (Intervention)|Death|1|||
156806037|NCT02750514|566045507|FG000|Track 1|Disease progression|20|||
156806038|NCT02750514|566045508|FG001|Track 1|Disease progression|1|||
156806039|NCT02750514|566045509|FG002|Track 1|Disease progression|0|||
156806040|NCT02750514|566045510|FG003|Track 1|Disease progression|1|||
156806041|NCT02750514|566045511|FG004|Track 1|Disease progression|0|||
156806042|NCT02750514|566045507|FG000|Track 1|Adverse event unrelated to study drug|1|||
156806043|NCT02750514|566045508|FG001|Track 1|Adverse event unrelated to study drug|0|||
156806044|NCT02750514|566045509|FG002|Track 1|Adverse event unrelated to study drug|0|||
156806045|NCT02750514|566045510|FG003|Track 1|Adverse event unrelated to study drug|0|||
156806046|NCT02750514|566045511|FG004|Track 1|Adverse event unrelated to study drug|0|||
156806047|NCT02750514|566045507|FG000|Track 1|Study drug toxicity|4|||
156806048|NCT02750514|566045508|FG001|Track 1|Study drug toxicity|1|||
156806049|NCT02750514|566045509|FG002|Track 1|Study drug toxicity|0|||
156806050|NCT02750514|566045510|FG003|Track 1|Study drug toxicity|1|||
157021255|NCT02783300|566830890|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
157021256|NCT02783300|566830891|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
157021257|NCT02783300|566830892|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
157021258|NCT02783300|566830893|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
157021259|NCT02783300|566830894|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
157021260|NCT02783300|566830895|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
157021261|NCT02783300|566830869|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021262|NCT02783300|566830870|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021263|NCT02783300|566830871|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021264|NCT02783300|566830872|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021265|NCT02783300|566830873|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021266|NCT02783300|566830874|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021267|NCT02783300|566830875|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
157021268|NCT02783300|566830876|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156806051|NCT02750514|566045511|FG004|Track 1|Study drug toxicity|0|||
156806052|NCT02750514|566045507|FG000|Track 1|Participant request to discontinue|1|||
156806053|NCT02750514|566045508|FG001|Track 1|Participant request to discontinue|0|||
156806054|NCT02750514|566045509|FG002|Track 1|Participant request to discontinue|0|||
157021269|NCT02783300|566830877|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021270|NCT02783300|566830878|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021271|NCT02783300|566830879|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156806055|NCT02750514|566045510|FG003|Track 1|Participant request to discontinue|0|||
156806056|NCT02750514|566045511|FG004|Track 1|Participant request to discontinue|0|||
156806057|NCT02750514|566045507|FG000|Track 1|Other reasons|1|||
156806058|NCT02750514|566045508|FG001|Track 1|Other reasons|0|||
156806059|NCT02750514|566045509|FG002|Track 1|Other reasons|0|||
156806060|NCT02750514|566045510|FG003|Track 1|Other reasons|0|||
156806061|NCT02750514|566045511|FG004|Track 1|Other reasons|0|||
156806062|NCT02750514|566045507|FG000|Track 2|Disease progression|4|||
157021272|NCT02783300|566830880|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021273|NCT02783300|566830881|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
157021274|NCT02783300|566830882|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156806063|NCT02750514|566045508|FG001|Track 2|Disease progression|5|||
156806064|NCT02750514|566045509|FG002|Track 2|Disease progression|2|||
156806065|NCT02750514|566045510|FG003|Track 2|Disease progression|5|||
156806066|NCT02750514|566045511|FG004|Track 2|Disease progression|0|||
156806067|NCT02750514|566045507|FG000|Track 2|Adverse event unrelated to study drug|1|||
156806068|NCT02750514|566045508|FG001|Track 2|Adverse event unrelated to study drug|0|||
156806069|NCT02750514|566045509|FG002|Track 2|Adverse event unrelated to study drug|0|||
156806070|NCT02750514|566045510|FG003|Track 2|Adverse event unrelated to study drug|0|||
156806071|NCT02750514|566045511|FG004|Track 2|Adverse event unrelated to study drug|0|||
156806072|NCT02750514|566045507|FG000|Track 2|Study drug toxicity|1|||
156806073|NCT02750514|566045508|FG001|Track 2|Study drug toxicity|2|||
156806074|NCT02750514|566045509|FG002|Track 2|Study drug toxicity|0|||
156806075|NCT02750514|566045510|FG003|Track 2|Study drug toxicity|2|||
156806076|NCT02750514|566045511|FG004|Track 2|Study drug toxicity|0|||
156806077|NCT02750514|566045507|FG000|Track 2|Participant withdrew consent|0|||
156806078|NCT02750514|566045508|FG001|Track 2|Participant withdrew consent|1|||
156806079|NCT02750514|566045509|FG002|Track 2|Participant withdrew consent|0|||
156806080|NCT02750514|566045510|FG003|Track 2|Participant withdrew consent|0|||
156806081|NCT02750514|566045511|FG004|Track 2|Participant withdrew consent|0|||
156806082|NCT02750514|566045507|FG000|Track 3|Disease progression|0|||
156806083|NCT02750514|566045508|FG001|Track 3|Disease progression|24|||
156806084|NCT02750514|566045509|FG002|Track 3|Disease progression|13|||
156806085|NCT02750514|566045510|FG003|Track 3|Disease progression|14|||
156806086|NCT02750514|566045511|FG004|Track 3|Disease progression|0|||
156806087|NCT02750514|566045507|FG000|Track 3|Adverse event unrelated to study drug|0|||
156806088|NCT02750514|566045508|FG001|Track 3|Adverse event unrelated to study drug|1|||
156806089|NCT02750514|566045509|FG002|Track 3|Adverse event unrelated to study drug|1|||
156806090|NCT02750514|566045510|FG003|Track 3|Adverse event unrelated to study drug|1|||
156806091|NCT02750514|566045511|FG004|Track 3|Adverse event unrelated to study drug|0|||
156806092|NCT02750514|566045507|FG000|Track 3|Study drug toxicity|0|||
156806093|NCT02750514|566045508|FG001|Track 3|Study drug toxicity|3|||
156806094|NCT02750514|566045509|FG002|Track 3|Study drug toxicity|0|||
157021275|NCT02783300|566830883|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156806095|NCT02750514|566045510|FG003|Track 3|Study drug toxicity|1|||
156806096|NCT02750514|566045511|FG004|Track 3|Study drug toxicity|0|||
156806097|NCT02750514|566045507|FG000|Track 3|Participant request to discontinue|0|||
156806098|NCT02750514|566045508|FG001|Track 3|Participant request to discontinue|2|||
156806099|NCT02750514|566045509|FG002|Track 3|Participant request to discontinue|0|||
156806100|NCT02750514|566045510|FG003|Track 3|Participant request to discontinue|0|||
156806101|NCT02750514|566045511|FG004|Track 3|Participant request to discontinue|0|||
156806102|NCT02750514|566045507|FG000|Track 3|Participant withdrew consent|0|||
156806103|NCT02750514|566045508|FG001|Track 3|Participant withdrew consent|3|||
156806104|NCT02750514|566045509|FG002|Track 3|Participant withdrew consent|1|||
156806105|NCT02750514|566045510|FG003|Track 3|Participant withdrew consent|0|||
156806106|NCT02750514|566045511|FG004|Track 3|Participant withdrew consent|0|||
156806107|NCT02750514|566045507|FG000|Track 3|Other reasons|0|||
156806108|NCT02750514|566045508|FG001|Track 3|Other reasons|3|||
156806109|NCT02750514|566045509|FG002|Track 3|Other reasons|0|||
156806110|NCT02750514|566045510|FG003|Track 3|Other reasons|0|||
156806111|NCT02750514|566045511|FG004|Track 3|Other reasons|0|||
156806112|NCT02750514|566045507|FG000|Track 4|Study drug toxicity|0|||
156806113|NCT02750514|566045508|FG001|Track 4|Study drug toxicity|6|||
156806114|NCT02750514|566045509|FG002|Track 4|Study drug toxicity|0|||
156806115|NCT02750514|566045510|FG003|Track 4|Study drug toxicity|5|||
156806116|NCT02750514|566045511|FG004|Track 4|Study drug toxicity|0|||
156806117|NCT02750514|566045507|FG000|Track 4|Participant request to discontinue|0|||
156806118|NCT02750514|566045508|FG001|Track 4|Participant request to discontinue|1|||
156806119|NCT02750514|566045509|FG002|Track 4|Participant request to discontinue|0|||
156806120|NCT02750514|566045510|FG003|Track 4|Participant request to discontinue|1|||
156806121|NCT02750514|566045511|FG004|Track 4|Participant request to discontinue|0|||
156806122|NCT02750514|566045507|FG000|Track 4|Participant withdrew consent|0|||
156806123|NCT02750514|566045508|FG001|Track 4|Participant withdrew consent|1|||
156806124|NCT02750514|566045509|FG002|Track 4|Participant withdrew consent|0|||
156806125|NCT02750514|566045510|FG003|Track 4|Participant withdrew consent|0|||
156806126|NCT02750514|566045511|FG004|Track 4|Participant withdrew consent|0|||
156806127|NCT02750514|566045507|FG000|Track 4|Other reasons|0|||
156806128|NCT02750514|566045508|FG001|Track 4|Other reasons|5|||
156806129|NCT02750514|566045509|FG002|Track 4|Other reasons|0|||
156806130|NCT02750514|566045510|FG003|Track 4|Other reasons|3|||
156806131|NCT02750514|566045511|FG004|Track 4|Other reasons|0|||
156806132|NCT02750514|566045507|FG000|Track 4|Disease progression|0|||
156806133|NCT02750514|566045508|FG001|Track 4|Disease progression|33|||
156806134|NCT02750514|566045509|FG002|Track 4|Disease progression|0|||
156806135|NCT02750514|566045510|FG003|Track 4|Disease progression|32|||
156806136|NCT02750514|566045511|FG004|Track 4|Disease progression|0|||
156806137|NCT02750514|566045507|FG000|Track 4|Adverse event unrelated to study drug|0|||
156806138|NCT02750514|566045508|FG001|Track 4|Adverse event unrelated to study drug|5|||
156806139|NCT02750514|566045509|FG002|Track 4|Adverse event unrelated to study drug|0|||
156806140|NCT02750514|566045510|FG003|Track 4|Adverse event unrelated to study drug|0|||
156806141|NCT02750514|566045511|FG004|Track 4|Adverse event unrelated to study drug|0|||
156806142|NCT02750514|566045507|FG000|Track 4|Death|0|||
156806143|NCT02750514|566045508|FG001|Track 4|Death|0|||
156806144|NCT02750514|566045509|FG002|Track 4|Death|0|||
156806145|NCT02750514|566045510|FG003|Track 4|Death|1|||
156806146|NCT02750514|566045511|FG004|Track 4|Death|0|||
156806147|NCT02750514|566045507|FG000|Track 5|Disease progression|0|||
156806148|NCT02750514|566045508|FG001|Track 5|Disease progression|0|||
156806149|NCT02750514|566045509|FG002|Track 5|Disease progression|0|||
156806150|NCT02750514|566045510|FG003|Track 5|Disease progression|0|||
156806151|NCT02750514|566045511|FG004|Track 5|Disease progression|34|||
156806152|NCT02750514|566045507|FG000|Track 5|Adverse event unrelated to study drug|0|||
156806153|NCT02750514|566045508|FG001|Track 5|Adverse event unrelated to study drug|0|||
156806154|NCT02750514|566045509|FG002|Track 5|Adverse event unrelated to study drug|0|||
156806155|NCT02750514|566045510|FG003|Track 5|Adverse event unrelated to study drug|0|||
156806156|NCT02750514|566045511|FG004|Track 5|Adverse event unrelated to study drug|2|||
156806157|NCT02750514|566045507|FG000|Track 5|Study drug toxicity|0|||
156806158|NCT02750514|566045508|FG001|Track 5|Study drug toxicity|0|||
156806159|NCT02750514|566045509|FG002|Track 5|Study drug toxicity|0|||
156806160|NCT02750514|566045510|FG003|Track 5|Study drug toxicity|0|||
156806161|NCT02750514|566045511|FG004|Track 5|Study drug toxicity|2|||
156806162|NCT02750514|566045507|FG000|Track 5|Participant request to discontinue|0|||
156806163|NCT02750514|566045508|FG001|Track 5|Participant request to discontinue|0|||
156806164|NCT02750514|566045509|FG002|Track 5|Participant request to discontinue|0|||
156806165|NCT02750514|566045510|FG003|Track 5|Participant request to discontinue|0|||
156806166|NCT02750514|566045511|FG004|Track 5|Participant request to discontinue|3|||
156806167|NCT02750514|566045507|FG000|Track 5|Other reasons|0|||
156806168|NCT02750514|566045508|FG001|Track 5|Other reasons|0|||
156806169|NCT02750514|566045509|FG002|Track 5|Other reasons|0|||
156806170|NCT02750514|566045510|FG003|Track 5|Other reasons|0|||
156806171|NCT02750514|566045511|FG004|Track 5|Other reasons|2|||
156806172|NCT01882465|566045512|FG000|Period 1|Lens Discomfort|0|||
156806173|NCT01882465|566045513|FG001|Period 1|Lens Discomfort|0|||
156806174|NCT01882465|566045514|FG002|Period 1|Lens Discomfort|0|||
156806175|NCT01882465|566045515|FG003|Period 1|Lens Discomfort|1|||
156806176|NCT01882465|566045516|FG004|Period 1|Lens Discomfort|0|||
156806177|NCT01882465|566045517|FG005|Period 1|Lens Discomfort|0|||
156806178|NCT01882465|566045518|FG006|Period 1|Lens Discomfort|0|||
156806179|NCT01882465|566045512|FG000|Period 1|Withdrawal by Subject|0|||
156806180|NCT01882465|566045513|FG001|Period 1|Withdrawal by Subject|0|||
156806181|NCT01882465|566045514|FG002|Period 1|Withdrawal by Subject|0|||
156806182|NCT01882465|566045515|FG003|Period 1|Withdrawal by Subject|0|||
156882120|NCT05141448|566327098|FG005|Period 2|COVID-19 Related|1|||
156882121|NCT05141448|566327093|FG000|3|Covid-19 related|2|||
156882122|NCT05141448|566327094|FG001|3|Covid-19 related|0|||
156882123|NCT05141448|566327095|FG002|3|Covid-19 related|0|||
156882124|NCT05141448|566327096|FG003|3|Covid-19 related|0|||
156882125|NCT05141448|566327097|FG004|3|Covid-19 related|0|||
156882126|NCT05141448|566327098|FG005|3|Covid-19 related|1|||
156806183|NCT01882465|566045516|FG004|Period 1|Withdrawal by Subject|0|||
156806184|NCT01882465|566045517|FG005|Period 1|Withdrawal by Subject|0|||
156806185|NCT01882465|566045518|FG006|Period 1|Withdrawal by Subject|1|||
156806186|NCT01882465|566045512|FG000|Period 2|Protocol Violation|0|||
156806187|NCT01882465|566045513|FG001|Period 2|Protocol Violation|0|||
156806188|NCT01882465|566045514|FG002|Period 2|Protocol Violation|0|||
156806189|NCT01882465|566045515|FG003|Period 2|Protocol Violation|0|||
156806190|NCT01882465|566045516|FG004|Period 2|Protocol Violation|1|||
156806191|NCT01882465|566045517|FG005|Period 2|Protocol Violation|0|||
156806192|NCT01882465|566045518|FG006|Period 2|Protocol Violation|0|||
156806193|NCT00800982|566045519|FG000|Overall Study|Lost to Follow-up|1|||
156806194|NCT00800982|566045520|FG001|Overall Study|Lost to Follow-up|2|||
156806195|NCT00800982|566045519|FG000|Overall Study|Withdrawal by Subject|0|||
156806196|NCT00800982|566045520|FG001|Overall Study|Withdrawal by Subject|1|||
156806197|NCT00800982|566045519|FG000|Overall Study|Patient moved out of state|1|||
156806198|NCT00800982|566045520|FG001|Overall Study|Patient moved out of state|0|||
156806199|NCT01824290|566045521|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
156806200|NCT01824290|566045522|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806201|NCT01824290|566045523|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806202|NCT01824290|566045524|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
156806203|NCT01824290|566045521|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
156806204|NCT01824290|566045522|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
156806205|NCT01824290|566045523|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
156806206|NCT01824290|566045524|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
156806207|NCT01824290|566045521|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
156806208|NCT01824290|566045522|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
156882127|NCT05141448|566327093|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
156882128|NCT05141448|566327094|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
156882129|NCT05141448|566327095|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
156882130|NCT05141448|566327096|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
156882131|NCT05141448|566327097|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
156882132|NCT05141448|566327098|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
156882133|NCT04627285|566327099|FG000|Overall Study|Adverse Event|0|||
156882134|NCT04627285|566327100|FG001|Overall Study|Adverse Event|2|||
156882135|NCT04627285|566327099|FG000|Overall Study|Lost to Follow-up|1|||
156882136|NCT04627285|566327100|FG001|Overall Study|Lost to Follow-up|0|||
156882137|NCT04627285|566327099|FG000|Overall Study|Withdrawal by Subject|1|||
156882138|NCT04627285|566327100|FG001|Overall Study|Withdrawal by Subject|1|||
156882139|NCT04627285|566327099|FG000|Overall Study|Sponsor decision|5|||
156882140|NCT04627285|566327100|FG001|Overall Study|Sponsor decision|0|||
156882141|NCT04627285|566327099|FG000|Overall Study|Participant left country; aunt informed the site|0|||
156882142|NCT04627285|566327100|FG001|Overall Study|Participant left country; aunt informed the site|1|||
156882143|NCT01106092|566329305|FG000|Overall Study|Withdrawal by Subject|0|||
156882144|NCT01106092|566329306|FG001|Overall Study|Withdrawal by Subject|0|||
156882145|NCT01106092|566329307|FG002|Overall Study|Withdrawal by Subject|0|||
156882146|NCT01106092|566329308|FG003|Overall Study|Withdrawal by Subject|1|||
156882147|NCT02434471|566329311|FG000|Overall Study|Physician Decision|9|||
156882148|NCT01604278|566329316|FG000|Overall Study|Lack of Efficacy|0|||
156882149|NCT01604278|566329317|FG001|Overall Study|Lack of Efficacy|1|||
156882150|NCT01604278|566329316|FG000|Overall Study|Lost to Follow-up|1|||
156882151|NCT01604278|566329317|FG001|Overall Study|Lost to Follow-up|0|||
156882152|NCT01604278|566329316|FG000|Overall Study|Administrative problems|2|||
156882153|NCT01604278|566329317|FG001|Overall Study|Administrative problems|1|||
156882154|NCT01604278|566329316|FG000|Overall Study|Withdrawal by Subject|3|||
156882155|NCT01604278|566329317|FG001|Overall Study|Withdrawal by Subject|3|||
156882156|NCT01604278|566329316|FG000|Overall Study|Adverse Event|3|||
156882157|NCT01604278|566329317|FG001|Overall Study|Adverse Event|5|||
156882158|NCT01604278|566329316|FG000|Overall Study|Protocol Deviation|5|||
156882159|NCT01604278|566329317|FG001|Overall Study|Protocol Deviation|3|||
156882160|NCT02870933|566329318|FG000|Overall Study|Death|2|||
156806209|NCT01824290|566045523|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
156806210|NCT01824290|566045524|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
156806211|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
156806212|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
156806213|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
156882161|NCT02870933|566329319|FG001|Overall Study|Death|1|||
156882162|NCT02870933|566329318|FG000|Overall Study|Withdrawal by Subject|0|||
156882163|NCT02870933|566329319|FG001|Overall Study|Withdrawal by Subject|1|||
156882164|NCT01659554|566329321|FG000|Overall Study|Study Termination|4|||
156806214|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
156806215|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
156806216|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
156806217|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
156806218|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
156806219|NCT01824290|566045521|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
156806220|NCT01824290|566045522|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
156806221|NCT01824290|566045523|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
156882165|NCT00097981|566329333|FG000|Overall Study|Adverse Event|31|||
156882166|NCT00097981|566329334|FG001|Overall Study|Adverse Event|44|||
156882167|NCT00097981|566329333|FG000|Overall Study|Withdrawal by Subject|10|||
156882168|NCT00097981|566329334|FG001|Overall Study|Withdrawal by Subject|8|||
156882169|NCT00097981|566329333|FG000|Overall Study|Protocol Violation|1|||
156882170|NCT00097981|566329334|FG001|Overall Study|Protocol Violation|1|||
156882171|NCT00097981|566329333|FG000|Overall Study|Death|2|||
156882172|NCT00097981|566329334|FG001|Overall Study|Death|4|||
156882173|NCT00097981|566329333|FG000|Overall Study|Physician Decision|7|||
156882174|NCT00097981|566329334|FG001|Overall Study|Physician Decision|1|||
156882175|NCT00097981|566329333|FG000|Overall Study|Disease Progression|8|||
156882176|NCT00097981|566329334|FG001|Overall Study|Disease Progression|2|||
156882177|NCT00097981|566329333|FG000|Overall Study|Transplant planned|28|||
156806222|NCT01824290|566045524|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
156806223|NCT02756403|566045525|FG000|Overall Study|Unable to swallow medication|0|||
156806224|NCT02756403|566045526|FG001|Overall Study|Unable to swallow medication|1|||
156806225|NCT02756403|566045527|FG002|Overall Study|Unable to swallow medication|1|||
156882178|NCT00097981|566329334|FG001|Overall Study|Transplant planned|27|||
156806226|NCT02756403|566045528|FG003|Overall Study|Unable to swallow medication|1|||
156806227|NCT02756403|566045525|FG000|Overall Study|Did not complete Procedure|0|||
156806228|NCT02756403|566045526|FG001|Overall Study|Did not complete Procedure|1|||
156806229|NCT02756403|566045527|FG002|Overall Study|Did not complete Procedure|0|||
156806230|NCT02756403|566045528|FG003|Overall Study|Did not complete Procedure|0|||
156806231|NCT02756403|566045525|FG000|Overall Study|Changed Mind About Procedure|0|||
156806232|NCT02756403|566045526|FG001|Overall Study|Changed Mind About Procedure|0|||
156806233|NCT02756403|566045527|FG002|Overall Study|Changed Mind About Procedure|1|||
156806234|NCT02756403|566045528|FG003|Overall Study|Changed Mind About Procedure|0|||
156806235|NCT02756403|566045525|FG000|Overall Study|Protocol Violation|0|||
156806236|NCT02756403|566045526|FG001|Overall Study|Protocol Violation|1|||
156806237|NCT02756403|566045527|FG002|Overall Study|Protocol Violation|0|||
156806238|NCT02756403|566045528|FG003|Overall Study|Protocol Violation|1|||
156806239|NCT00527618|566045529|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
156806240|NCT00527618|566045530|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
156806241|NCT00527618|566045529|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
156806242|NCT00527618|566045530|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
156806243|NCT00527618|566045529|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
156806244|NCT00527618|566045530|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
156806245|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
156806246|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
156806247|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
156806248|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
156806249|NCT00527618|566045529|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
156806250|NCT00527618|566045530|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
156806251|NCT02240121|566045531|FG000|Overall Study|Protocol Violation|1|||
156806252|NCT02240121|566045532|FG001|Overall Study|Protocol Violation|2|||
156806253|NCT02240121|566045531|FG000|Overall Study|Physician Decision|0|||
156806254|NCT02240121|566045532|FG001|Overall Study|Physician Decision|1|||
156806255|NCT02240121|566045531|FG000|Overall Study|Change in protocol interpretation|1|||
156806256|NCT02240121|566045532|FG001|Overall Study|Change in protocol interpretation|0|||
156806257|NCT02240121|566045531|FG000|Overall Study|Lack of Efficacy|2|||
156806258|NCT02240121|566045532|FG001|Overall Study|Lack of Efficacy|3|||
156806259|NCT02240121|566045531|FG000|Overall Study|Site closed|1|||
156806260|NCT02240121|566045532|FG001|Overall Study|Site closed|1|||
156806261|NCT02240121|566045531|FG000|Overall Study|Pregnancy|1|||
156806262|NCT02240121|566045532|FG001|Overall Study|Pregnancy|0|||
156882179|NCT00097981|566329333|FG000|Overall Study|Other|19|||
156882180|NCT00097981|566329334|FG001|Overall Study|Other|13|||
156882181|NCT00412373|566329335|FG000|Overall Study|Adverse Event|8|||
156806263|NCT02240121|566045531|FG000|Overall Study|Adverse Event|2|||
156806264|NCT02240121|566045532|FG001|Overall Study|Adverse Event|4|||
156806265|NCT02240121|566045531|FG000|Overall Study|Withdrawal by Subject|6|||
156806266|NCT02240121|566045532|FG001|Overall Study|Withdrawal by Subject|2|||
156806267|NCT02240121|566045531|FG000|Overall Study|Lost to Follow-up|3|||
157021276|NCT02783300|566830884|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
156806268|NCT02240121|566045532|FG001|Overall Study|Lost to Follow-up|4|||
156806269|NCT02240121|566045531|FG000|Overall Study|Other than specified|1|||
156882182|NCT00412373|566329336|FG001|Overall Study|Adverse Event|13|||
156806270|NCT02240121|566045532|FG001|Overall Study|Other than specified|3|||
157021277|NCT02783300|566830885|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021278|NCT02783300|566830886|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021279|NCT02783300|566830887|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021280|NCT02783300|566830888|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021281|NCT02783300|566830889|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021282|NCT02783300|566830890|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021283|NCT02783300|566830891|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021284|NCT02783300|566830892|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021285|NCT02783300|566830893|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021286|NCT02783300|566830894|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021287|NCT02783300|566830895|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
157021288|NCT02783300|566830869|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021289|NCT02783300|566830870|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021290|NCT02783300|566830871|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021291|NCT02783300|566830872|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021292|NCT02783300|566830873|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
157021293|NCT02783300|566830874|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021294|NCT02783300|566830875|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
157021295|NCT02783300|566830876|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021296|NCT02783300|566830877|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021297|NCT02783300|566830878|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
157021298|NCT02783300|566830879|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021299|NCT02783300|566830880|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021300|NCT02783300|566830881|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
157021301|NCT02783300|566830882|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021302|NCT02783300|566830883|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021303|NCT02783300|566830884|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021304|NCT02783300|566830885|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021305|NCT02783300|566830886|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021306|NCT02783300|566830887|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021307|NCT02783300|566830888|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021308|NCT02783300|566830889|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021309|NCT02783300|566830890|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021310|NCT02783300|566830891|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021311|NCT02783300|566830892|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021312|NCT02783300|566830893|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021313|NCT02783300|566830894|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021314|NCT02783300|566830895|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
157021315|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021316|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021317|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157221006|NCT00585351|567554941|FG007|Enrollment Period (Intervention)|Death|0|||
157221007|NCT00585351|567554934|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
156806271|NCT00846846|566045533|FG000|Overall Study|Death|56|||
156806272|NCT00846846|566045533|FG000|Overall Study|Withdrawal by Subject|19|||
156806273|NCT02103062|566045538|FG000|Overall Study|Adverse Event|1|||
156806274|NCT02103062|566045539|FG001|Overall Study|Adverse Event|2|||
156806275|NCT02103062|566045538|FG000|Overall Study|Progressive Disease|17|||
156806276|NCT02103062|566045539|FG001|Overall Study|Progressive Disease|20|||
156806277|NCT02103062|566045538|FG000|Overall Study|Death|0|||
156806278|NCT02103062|566045539|FG001|Overall Study|Death|1|||
156806279|NCT03386435|566045540|FG000|Overall Study|Protocol Violation|5|||
156806280|NCT03386435|566045541|FG001|Overall Study|Protocol Violation|7|||
156806281|NCT00959907|566045544|FG000|Overall Study|Protocol Violation|0|||
156806282|NCT00959907|566045545|FG001|Overall Study|Protocol Violation|1|||
156806283|NCT00959907|566045544|FG000|Overall Study|Adverse Event|1|||
156806284|NCT00959907|566045545|FG001|Overall Study|Adverse Event|0|||
156806285|NCT00959907|566045544|FG000|Overall Study|Withdrawal by Subject|2|||
156806286|NCT00959907|566045545|FG001|Overall Study|Withdrawal by Subject|0|||
156806287|NCT03958331|566045546|FG000|Overall Study|Withdrawal by Subject|3|||
156806288|NCT03958331|566045547|FG001|Overall Study|Withdrawal by Subject|1|||
156806289|NCT03958331|566045548|FG002|Overall Study|Withdrawal by Subject|5|||
156806290|NCT03958331|566045546|FG000|Overall Study|Weaned from medicine|2|||
156806291|NCT03958331|566045547|FG001|Overall Study|Weaned from medicine|0|||
156806292|NCT03958331|566045548|FG002|Overall Study|Weaned from medicine|0|||
156806293|NCT03958331|566045546|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
156806294|NCT03958331|566045547|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
156882183|NCT00412373|566329335|FG000|Overall Study|Lack of Efficacy|16|||
157021318|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021319|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021320|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021321|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021322|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021323|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021324|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021325|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021326|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021327|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021328|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021329|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021330|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
157021331|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021332|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
157021333|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
157021334|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
157021335|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021336|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021337|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021338|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021339|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
157021340|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021341|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
157021342|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021343|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021344|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021345|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021346|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021347|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021348|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021349|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021350|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021351|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021352|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021353|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021354|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021355|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021356|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021357|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021358|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
157021359|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021360|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
157021361|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
157021362|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021363|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021364|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021365|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021366|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021367|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021368|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
157021369|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021370|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021371|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021372|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157143914|NCT02158533|567276365|FG001|Stage 2|Lack of Efficacy|0|||
157143915|NCT02158533|567276366|FG002|Stage 2|Lack of Efficacy|0|||
157143916|NCT02158533|567276367|FG003|Stage 2|Lack of Efficacy|0|||
157143917|NCT02158533|567276368|FG004|Stage 2|Lack of Efficacy|1|||
157143918|NCT02158533|567276369|FG005|Stage 2|Lack of Efficacy|0|||
157143919|NCT02158533|567276364|FG000|Stage 2|Lost to Follow-up|0|||
157143920|NCT02158533|567276365|FG001|Stage 2|Lost to Follow-up|0|||
156882184|NCT00412373|566329336|FG001|Overall Study|Lack of Efficacy|22|||
156882185|NCT00412373|566329335|FG000|Overall Study|Lost to Follow-up|7|||
156882186|NCT00412373|566329336|FG001|Overall Study|Lost to Follow-up|13|||
156882187|NCT00412373|566329335|FG000|Overall Study|Withdrawal by Subject|8|||
156882188|NCT00412373|566329336|FG001|Overall Study|Withdrawal by Subject|27|||
156882189|NCT00412373|566329335|FG000|Overall Study|Other|2|||
156882190|NCT00412373|566329336|FG001|Overall Study|Other|2|||
156882191|NCT01252667|566329343|FG000|Overall Study|Transplant aborted post-conditioning|0|||
156882192|NCT01252667|566329344|FG001|Overall Study|Transplant aborted post-conditioning|0|||
156882193|NCT01252667|566329345|FG002|Overall Study|Transplant aborted post-conditioning|0|||
156882194|NCT01252667|566329346|FG003|Overall Study|Transplant aborted post-conditioning|0|||
156882195|NCT01252667|566329347|FG004|Overall Study|Transplant aborted post-conditioning|0|||
156882196|NCT01252667|566329348|FG005|Overall Study|Transplant aborted post-conditioning|1|||
156882197|NCT03032380|566329349|FG000|Overall Study|Adverse Event|0|||
156882198|NCT03032380|566329350|FG001|Overall Study|Adverse Event|1|||
156882199|NCT03032380|566329349|FG000|Overall Study|Lack of Efficacy|1|||
156882200|NCT03032380|566329350|FG001|Overall Study|Lack of Efficacy|0|||
156882201|NCT03032380|566329349|FG000|Overall Study|Withdrawal by Subject|2|||
156882202|NCT03032380|566329350|FG001|Overall Study|Withdrawal by Subject|3|||
156882203|NCT03032380|566329349|FG000|Overall Study|Recovery|0|||
156882204|NCT03032380|566329350|FG001|Overall Study|Recovery|1|||
156882205|NCT03032380|566329349|FG000|Overall Study|Death|39|||
156882206|NCT03032380|566329350|FG001|Overall Study|Death|34|||
156882207|NCT03032380|566329349|FG000|Overall Study|Other - Miscellaneous|0|||
156882208|NCT03032380|566329350|FG001|Overall Study|Other - Miscellaneous|1|||
156882209|NCT00294762|566329351|FG000|Overall Study|Did not receive study treatment|3|||
156882210|NCT00294762|566329352|FG001|Overall Study|Did not receive study treatment|3|||
156882211|NCT02937584|566329353|FG000|Period 1|Adverse Event|1|||
156882212|NCT02937584|566329354|FG001|Period 1|Adverse Event|2|||
156882213|NCT02937584|566329353|FG000|Washout|Adverse Event|0|||
156882214|NCT02937584|566329354|FG001|Washout|Adverse Event|1|||
156882215|NCT02238080|566329355|FG000|Overall Study|Death|13|||
156882216|NCT02238080|566329355|FG000|Overall Study|Treatment interrupted|6|||
156882217|NCT02238080|566329355|FG000|Overall Study|Withdrawal by Subject|2|||
156882218|NCT02238080|566329355|FG000|Overall Study|Other|4|||
156882219|NCT01738646|566329356|FG000|Overall Study|Still Receiving Treatment|2|||
156882220|NCT03642132|566329357|FG000|Chemotherapy Period|Adverse Event|1|||
156882221|NCT03642132|566329358|FG001|Chemotherapy Period|Adverse Event|1|||
156882222|NCT03642132|566329359|FG002|Chemotherapy Period|Adverse Event|0|||
156882223|NCT03642132|566329357|FG000|Chemotherapy Period|Physician's decision|4|||
156882224|NCT03642132|566329358|FG001|Chemotherapy Period|Physician's decision|1|||
156882225|NCT03642132|566329359|FG002|Chemotherapy Period|Physician's decision|0|||
156882226|NCT03642132|566329357|FG000|Chemotherapy Period|Progressive disease|0|||
156882227|NCT03642132|566329358|FG001|Chemotherapy Period|Progressive disease|0|||
156882228|NCT03642132|566329359|FG002|Chemotherapy Period|Progressive disease|1|||
156882229|NCT03642132|566329357|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
156882230|NCT03642132|566329358|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
156882231|NCT03642132|566329359|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
156882232|NCT03642132|566329357|FG000|Chemotherapy Period|Other|1|||
156882233|NCT03642132|566329358|FG001|Chemotherapy Period|Other|0|||
156882234|NCT03642132|566329359|FG002|Chemotherapy Period|Other|2|||
156882235|NCT03642132|566329357|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
156882236|NCT03642132|566329358|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
156882237|NCT03642132|566329359|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
156882238|NCT03642132|566329357|FG000|Maintenance Period|Adverse Event|1|||
156882239|NCT03642132|566329358|FG001|Maintenance Period|Adverse Event|2|||
156882240|NCT03642132|566329359|FG002|Maintenance Period|Adverse Event|0|||
156882241|NCT03642132|566329357|FG000|Maintenance Period|Non-compliance with study drug|0|||
156882242|NCT03642132|566329358|FG001|Maintenance Period|Non-compliance with study drug|0|||
156882243|NCT03642132|566329359|FG002|Maintenance Period|Non-compliance with study drug|1|||
156882244|NCT03642132|566329357|FG000|Maintenance Period|Physician's decision|2|||
156882245|NCT03642132|566329358|FG001|Maintenance Period|Physician's decision|2|||
156882246|NCT03642132|566329359|FG002|Maintenance Period|Physician's decision|2|||
156882247|NCT03642132|566329357|FG000|Maintenance Period|Progressive disease|9|||
156882248|NCT03642132|566329358|FG001|Maintenance Period|Progressive disease|3|||
156882249|NCT03642132|566329359|FG002|Maintenance Period|Progressive disease|6|||
156882250|NCT03642132|566329357|FG000|Maintenance Period|Other|0|||
156882251|NCT03642132|566329358|FG001|Maintenance Period|Other|0|||
156882252|NCT03642132|566329359|FG002|Maintenance Period|Other|3|||
156882253|NCT03642132|566329357|FG000|Maintenance Period|Withdrawal by Subject|1|||
156882254|NCT03642132|566329358|FG001|Maintenance Period|Withdrawal by Subject|1|||
156882255|NCT03642132|566329359|FG002|Maintenance Period|Withdrawal by Subject|2|||
156882256|NCT03642132|566329357|FG000|Follow-up Period|Other|0|||
156882257|NCT03642132|566329358|FG001|Follow-up Period|Other|0|||
156882258|NCT03642132|566329359|FG002|Follow-up Period|Other|1|||
156882259|NCT03642132|566329357|FG000|Follow-up Period|Withdrawal by Subject|1|||
156882260|NCT03642132|566329358|FG001|Follow-up Period|Withdrawal by Subject|2|||
156882261|NCT03642132|566329359|FG002|Follow-up Period|Withdrawal by Subject|0|||
157143921|NCT02158533|567276366|FG002|Stage 2|Lost to Follow-up|0|||
157143922|NCT02158533|567276367|FG003|Stage 2|Lost to Follow-up|1|||
157143923|NCT02158533|567276368|FG004|Stage 2|Lost to Follow-up|1|||
156806295|NCT03958331|566045548|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
156806296|NCT01991483|566045549|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
156806297|NCT01991483|566045550|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
156806298|NCT01991483|566045551|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
156806299|NCT01991483|566045552|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
156806300|NCT01991483|566045549|FG000|Dose Level 600 mg|Physician Decision|0|||
156806301|NCT01991483|566045550|FG001|Dose Level 600 mg|Physician Decision|0|||
156806302|NCT01991483|566045551|FG002|Dose Level 600 mg|Physician Decision|1|||
156806303|NCT01991483|566045552|FG003|Dose Level 600 mg|Physician Decision|0|||
156806304|NCT01991483|566045549|FG000|Dose Level 1000 mg|Protocol Violation|0|||
156806305|NCT01991483|566045550|FG001|Dose Level 1000 mg|Protocol Violation|0|||
156806306|NCT01991483|566045551|FG002|Dose Level 1000 mg|Protocol Violation|0|||
156806307|NCT01991483|566045552|FG003|Dose Level 1000 mg|Protocol Violation|1|||
156806308|NCT02030821|566045555|FG000|Overall Study|Physician Decision|2|||
156806309|NCT02030821|566045556|FG001|Overall Study|Physician Decision|2|||
156806310|NCT02030821|566045557|FG002|Overall Study|Physician Decision|5|||
156806311|NCT02030821|566045558|FG003|Overall Study|Physician Decision|2|||
156806312|NCT00543985|566045572|FG000|Overall Study|Withdrawal by Subject|4|||
156806313|NCT01634152|566045573|FG000|Overall Study|Adverse Event|2|||
156806314|NCT01634152|566045574|FG001|Overall Study|Adverse Event|0|||
156806315|NCT01634152|566045575|FG002|Overall Study|Adverse Event|2|||
156806316|NCT01634152|566045573|FG000|Overall Study|Consent withdrawn not due to AE|1|||
156806317|NCT01634152|566045574|FG001|Overall Study|Consent withdrawn not due to AE|0|||
156806318|NCT01634152|566045575|FG002|Overall Study|Consent withdrawn not due to AE|1|||
156806319|NCT01634152|566045573|FG000|Overall Study|Not treated|0|||
156806320|NCT01634152|566045574|FG001|Overall Study|Not treated|1|||
156806321|NCT01634152|566045575|FG002|Overall Study|Not treated|0|||
156806322|NCT01634152|566045573|FG000|Overall Study|Other reason not defined above|1|||
156806323|NCT01634152|566045574|FG001|Overall Study|Other reason not defined above|0|||
156806324|NCT01634152|566045575|FG002|Overall Study|Other reason not defined above|1|||
156806325|NCT01900665|566045576|FG000|Placebo Controlled Period|Death|9|||
156806326|NCT01900665|566045577|FG001|Placebo Controlled Period|Death|16|||
156806327|NCT01900665|566045576|FG000|Placebo Controlled Period|Adverse Event|48|||
156806328|NCT01900665|566045577|FG001|Placebo Controlled Period|Adverse Event|39|||
156806329|NCT01900665|566045576|FG000|Placebo Controlled Period|Protocol Violation|1|||
156806330|NCT01900665|566045577|FG001|Placebo Controlled Period|Protocol Violation|7|||
156806331|NCT01900665|566045576|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
156806332|NCT01900665|566045577|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
156806333|NCT01900665|566045576|FG000|Placebo Controlled Period|Physician Decision|11|||
156806334|NCT01900665|566045577|FG001|Placebo Controlled Period|Physician Decision|7|||
156806335|NCT01900665|566045576|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
156806336|NCT01900665|566045577|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
156806337|NCT01900665|566045576|FG000|Placebo Controlled Period|Caregiver Decision|33|||
156806338|NCT01900665|566045577|FG001|Placebo Controlled Period|Caregiver Decision|41|||
156806339|NCT01900665|566045576|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
156806340|NCT01900665|566045577|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
156806341|NCT01900665|566045576|FG000|Open Label Period|Adverse Event|16|||
156806342|NCT01900665|566045577|FG001|Open Label Period|Adverse Event|20|||
156806343|NCT01900665|566045576|FG000|Open Label Period|Death|5|||
156806344|NCT01900665|566045577|FG001|Open Label Period|Death|6|||
156806345|NCT01900665|566045576|FG000|Open Label Period|Lost to Follow-up|1|||
156806346|NCT01900665|566045577|FG001|Open Label Period|Lost to Follow-up|1|||
156806347|NCT01900665|566045576|FG000|Open Label Period|Parent/Caregiver Decision|33|||
156806348|NCT01900665|566045577|FG001|Open Label Period|Parent/Caregiver Decision|34|||
156806349|NCT01900665|566045576|FG000|Open Label Period|Physician Decision|4|||
156806350|NCT01900665|566045577|FG001|Open Label Period|Physician Decision|4|||
156806351|NCT01900665|566045576|FG000|Open Label Period|Protocol Violation|0|||
156806352|NCT01900665|566045577|FG001|Open Label Period|Protocol Violation|1|||
156806353|NCT01900665|566045576|FG000|Open Label Period|Sponsor Decision|802|||
156806354|NCT01900665|566045577|FG001|Open Label Period|Sponsor Decision|765|||
156806355|NCT01900665|566045576|FG000|Open Label Period|Withdrawal by Subject|20|||
156806356|NCT01900665|566045577|FG001|Open Label Period|Withdrawal by Subject|28|||
156806357|NCT04749914|566045579|FG000|Period 1|Adverse Event|1|||
156806358|NCT04749914|566045580|FG001|Period 1|Adverse Event|0|||
157143924|NCT02158533|567276369|FG005|Stage 2|Lost to Follow-up|2|||
157143925|NCT02158533|567276364|FG000|Stage 2|Withdrawal by Subject|0|||
156806359|NCT04749914|566045581|FG002|Period 1|Adverse Event|0|||
156806360|NCT04749914|566045582|FG003|Period 1|Adverse Event|0|||
156806361|NCT04749914|566045579|FG000|Period 1|Withdrawal by Subject|1|||
156806362|NCT04749914|566045580|FG001|Period 1|Withdrawal by Subject|0|||
156806363|NCT04749914|566045581|FG002|Period 1|Withdrawal by Subject|1|||
157143926|NCT02158533|567276365|FG001|Stage 2|Withdrawal by Subject|0|||
157143927|NCT02158533|567276366|FG002|Stage 2|Withdrawal by Subject|0|||
156882262|NCT03642132|566329357|FG000|Follow-up Period|Study terminated by sponsor|1|||
156882263|NCT03642132|566329358|FG001|Follow-up Period|Study terminated by sponsor|0|||
156882264|NCT03642132|566329359|FG002|Follow-up Period|Study terminated by sponsor|1|||
156882265|NCT03642132|566329357|FG000|Follow-up Period|Lack of Efficacy|1|||
156882266|NCT03642132|566329358|FG001|Follow-up Period|Lack of Efficacy|0|||
156882267|NCT03642132|566329359|FG002|Follow-up Period|Lack of Efficacy|0|||
156882268|NCT03642132|566329357|FG000|Follow-up Period|Death|1|||
156882269|NCT03642132|566329358|FG001|Follow-up Period|Death|0|||
156882270|NCT03642132|566329359|FG002|Follow-up Period|Death|2|||
156882271|NCT03642132|566329357|FG000|Follow-up Period|Adverse Event|1|||
156882272|NCT03642132|566329358|FG001|Follow-up Period|Adverse Event|0|||
156882273|NCT03642132|566329359|FG002|Follow-up Period|Adverse Event|0|||
156882274|NCT02577887|566329361|FG000|Overall Study|Death|93|||
156882275|NCT02577887|566329361|FG000|Overall Study|Protocol Violation|125|||
156882276|NCT02577887|566329361|FG000|Overall Study|Withdrawal by Subject|80|||
156882277|NCT00864916|566329365|FG000|Overall Study|Lost to Follow-up|4|||
156882278|NCT00864916|566329366|FG001|Overall Study|Lost to Follow-up|4|||
156806364|NCT04749914|566045582|FG003|Period 1|Withdrawal by Subject|0|||
156806365|NCT04046939|566045583|FG000|Primary Assessment Period|Adverse Event|1|||
156806366|NCT04046939|566045584|FG001|Primary Assessment Period|Adverse Event|0|||
156806367|NCT04046939|566045585|FG002|Primary Assessment Period|Adverse Event|0|||
156882279|NCT00864916|566329365|FG000|Overall Study|Protocol Violation|1|||
156806368|NCT04046939|566045586|FG003|Primary Assessment Period|Adverse Event|0|||
156806369|NCT04046939|566045583|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
156806370|NCT04046939|566045584|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
156806371|NCT04046939|566045585|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
156806372|NCT04046939|566045586|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
156806373|NCT04046939|566045583|FG000|Primary Assessment Period|Physician Decision|0|||
156806374|NCT04046939|566045584|FG001|Primary Assessment Period|Physician Decision|0|||
156806375|NCT04046939|566045585|FG002|Primary Assessment Period|Physician Decision|1|||
156806376|NCT04046939|566045586|FG003|Primary Assessment Period|Physician Decision|0|||
156806377|NCT04046939|566045583|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
156806378|NCT04046939|566045584|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
156882280|NCT00864916|566329366|FG001|Overall Study|Protocol Violation|0|||
156882281|NCT00864916|566329365|FG000|Overall Study|Withdrawal by Subject|1|||
156882282|NCT00864916|566329366|FG001|Overall Study|Withdrawal by Subject|0|||
156882283|NCT03890666|566329368|FG000|Overall Study|Withdrawal by Subject|0|||
156882284|NCT03890666|566329369|FG001|Overall Study|Withdrawal by Subject|1|||
156882285|NCT03890666|566329368|FG000|Overall Study|Protocol deviation|1|||
156882286|NCT03890666|566329369|FG001|Overall Study|Protocol deviation|4|||
156882287|NCT03890666|566329368|FG000|Overall Study|Lost to Follow-up|2|||
156882288|NCT03890666|566329369|FG001|Overall Study|Lost to Follow-up|5|||
156882289|NCT03890666|566329368|FG000|Overall Study|Other than specified|1|||
156882290|NCT03890666|566329369|FG001|Overall Study|Other than specified|8|||
156882291|NCT01155011|566329374|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
156882292|NCT01155011|566329375|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
156882293|NCT01155011|566329374|FG000|Baseline to 6 Months|investigator decision, moved|4|||
156882294|NCT01155011|566329375|FG001|Baseline to 6 Months|investigator decision, moved|5|||
156882295|NCT01155011|566329374|FG000|Baseline to 6 Months|Death|0|||
156882296|NCT01155011|566329375|FG001|Baseline to 6 Months|Death|1|||
156882297|NCT01155011|566329374|FG000|6 to 12 Months|Withdrawal by Subject|8|||
156882298|NCT01155011|566329375|FG001|6 to 12 Months|Withdrawal by Subject|5|||
156882299|NCT01155011|566329374|FG000|6 to 12 Months|Death|1|||
156882300|NCT01155011|566329375|FG001|6 to 12 Months|Death|5|||
156882301|NCT02122783|566329376|FG000|Overall Study|Adverse Event|0|||
156882302|NCT02122783|566329377|FG001|Overall Study|Adverse Event|1|||
156882303|NCT03180619|566329378|FG000|Overall Study|Withdrew Consent|5|||
156882304|NCT03180619|566329379|FG001|Overall Study|Withdrew Consent|0|||
156882305|NCT03180619|566329380|FG002|Overall Study|Withdrew Consent|2|||
156882306|NCT03180619|566329378|FG000|Overall Study|Death|2|||
156882307|NCT03180619|566329379|FG001|Overall Study|Death|1|||
156882308|NCT03180619|566329380|FG002|Overall Study|Death|2|||
156882309|NCT03180619|566329378|FG000|Overall Study|Adverse Event|2|||
156882310|NCT03180619|566329379|FG001|Overall Study|Adverse Event|0|||
156882311|NCT03180619|566329380|FG002|Overall Study|Adverse Event|1|||
156882312|NCT03180619|566329378|FG000|Overall Study|Investigator's discretion|2|||
157143928|NCT02158533|567276367|FG003|Stage 2|Withdrawal by Subject|0|||
156882313|NCT03180619|566329379|FG001|Overall Study|Investigator's discretion|0|||
156882314|NCT03180619|566329380|FG002|Overall Study|Investigator's discretion|1|||
156882315|NCT01433289|566329381|FG000|Overall Study|Pregnancy|0|||
156882316|NCT01433289|566329382|FG001|Overall Study|Pregnancy|1|||
156882317|NCT01433289|566329383|FG002|Overall Study|Pregnancy|0|||
156806379|NCT04046939|566045585|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
156806380|NCT04046939|566045586|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
156806381|NCT01897532|566045588|FG000|Discontinuation From Treatment|Not Treated|7|||
156882318|NCT01433289|566329384|FG003|Overall Study|Pregnancy|0|||
156882319|NCT00561977|566329387|FG000|Overall Study|Withdrawal by Subject|0|||
157143929|NCT02158533|567276368|FG004|Stage 2|Withdrawal by Subject|1|||
156806382|NCT01897532|566045589|FG001|Discontinuation From Treatment|Not Treated|5|||
156806383|NCT01897532|566045588|FG000|Discontinuation From Treatment|Other reason than specified|196|||
156806384|NCT01897532|566045589|FG001|Discontinuation From Treatment|Other reason than specified|176|||
156806385|NCT01897532|566045588|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
156806386|NCT01897532|566045589|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
156806387|NCT01897532|566045588|FG000|Discontinuation From Treatment|Non compliance|24|||
156806388|NCT01897532|566045589|FG001|Discontinuation From Treatment|Non compliance|15|||
157143930|NCT02158533|567276369|FG005|Stage 2|Withdrawal by Subject|2|||
157143931|NCT02158533|567276364|FG000|Stage 2|Physician Decision|0|||
157143932|NCT02158533|567276365|FG001|Stage 2|Physician Decision|0|||
156806389|NCT01897532|566045588|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
156806390|NCT01897532|566045589|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
156806391|NCT01897532|566045588|FG000|Discontinuation From Trial|Not Treated|7|||
156806392|NCT01897532|566045589|FG001|Discontinuation From Trial|Not Treated|5|||
156806393|NCT01897532|566045588|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
156806394|NCT01897532|566045589|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
156806395|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
156806396|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
156806397|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
156806398|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
156806399|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806400|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
156806401|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806402|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
156806403|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806404|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
156806405|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806406|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
156806407|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806408|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
156806409|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806410|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
156806411|NCT00953706|566045596|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806412|NCT00953706|566045597|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
156806413|NCT00953706|566045598|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806414|NCT00953706|566045599|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
156806415|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806416|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806417|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
156806418|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
156806419|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806420|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806421|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
156806422|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
156806423|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806424|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806425|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
156806426|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
156806427|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
156806428|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
156806429|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
156806430|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
156806431|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
156806432|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
156806433|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
156806434|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
156806435|NCT00953706|566045596|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
156806436|NCT00953706|566045597|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
156806437|NCT00953706|566045598|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
156806438|NCT00953706|566045599|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
156806439|NCT01214837|566045600|FG000|Overall Study|Death|0|||
156806440|NCT01214837|566045601|FG001|Overall Study|Death|0|||
157143933|NCT02158533|567276366|FG002|Stage 2|Physician Decision|0|||
157143934|NCT02158533|567276367|FG003|Stage 2|Physician Decision|0|||
156882320|NCT00561977|566329388|FG001|Overall Study|Withdrawal by Subject|2|||
156882321|NCT00561977|566329389|FG002|Overall Study|Withdrawal by Subject|1|||
156882322|NCT00561977|566329387|FG000|Overall Study|Pregnancy|0|||
156882323|NCT00561977|566329388|FG001|Overall Study|Pregnancy|1|||
156882324|NCT00561977|566329389|FG002|Overall Study|Pregnancy|1|||
156882325|NCT00566696|566329390|FG000|Overall Study|Met Exclusion Criteria|2|||
156882326|NCT00566696|566329390|FG000|Overall Study|Muromonab not available|1|||
156882327|NCT00566696|566329390|FG000|Overall Study|Health Status Change|1|||
156882328|NCT00566696|566329390|FG000|Overall Study|Physician Decision|1|||
156882329|NCT00566696|566329390|FG000|Overall Study|Non-Patient Donors|37|||
156882330|NCT00275340|566329392|FG000|Overall Study|Lost to Follow-up|2|||
156882331|NCT00275340|566329393|FG001|Overall Study|Lost to Follow-up|4|||
156882332|NCT01950013|566329394|FG000|Overall Study|Withdrawal by Subject|0|||
156882333|NCT01950013|566329395|FG001|Overall Study|Withdrawal by Subject|2|||
156882334|NCT01950013|566329396|FG002|Overall Study|Withdrawal by Subject|0|||
156882335|NCT02365480|566329397|FG000|Overall Study|Withdrawal by Subject|2|||
156882336|NCT02365480|566329398|FG001|Overall Study|Withdrawal by Subject|0|||
156882337|NCT00706342|566329399|FG000|Overall Study|Adverse Event|3|||
156882338|NCT00706342|566329399|FG000|Overall Study|Not responding to treatment|2|||
156882339|NCT00706342|566329399|FG000|Overall Study|Withdrawn due to failure to respond|1|||
156882340|NCT00706342|566329399|FG000|Overall Study|Death|1|||
156882341|NCT00706342|566329399|FG000|Overall Study|Withdrew from the study on his own.|1|||
156882342|NCT00706342|566329399|FG000|Overall Study|Investigator discretion|2|||
156882343|NCT00706342|566329399|FG000|Overall Study|Non-responder Week 12|1|||
156882344|NCT00706342|566329399|FG000|Overall Study|Ongoing|6|||
156882345|NCT00706342|566329399|FG000|Overall Study|WIthdrawal of consent|1|||
156882346|NCT01781299|566329404|FG000|Overall Study|Withdrawal by Subject|0|||
156882347|NCT01781299|566329405|FG001|Overall Study|Withdrawal by Subject|1|||
156882348|NCT02395172|566329410|FG000|Overall Study|Participants randomized but not treated|3|||
156882349|NCT02395172|566329411|FG001|Overall Study|Participants randomized but not treated|31|||
156882350|NCT00653939|566329412|FG000|Overall Study|Adverse Event|1|||
156882351|NCT00653939|566329413|FG001|Overall Study|Adverse Event|3|||
156882352|NCT00653939|566329412|FG000|Overall Study|Withdrawal by Subject|3|||
156882353|NCT00653939|566329413|FG001|Overall Study|Withdrawal by Subject|3|||
156882354|NCT00653939|566329412|FG000|Overall Study|Physician Decision|4|||
156882355|NCT00653939|566329413|FG001|Overall Study|Physician Decision|0|||
156882356|NCT00653939|566329412|FG000|Overall Study|Disease Progression|2|||
157021373|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021374|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021375|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156882357|NCT00653939|566329413|FG001|Overall Study|Disease Progression|3|||
156882358|NCT00653939|566329412|FG000|Overall Study|Other|2|||
157021376|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021377|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156882359|NCT00653939|566329413|FG001|Overall Study|Other|6|||
156882360|NCT02032238|566329414|FG000|Overall Study|Lost to Follow-up|2|||
156882361|NCT02032238|566329415|FG001|Overall Study|Lost to Follow-up|0|||
156882362|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
156882363|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
156882364|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
156882365|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
156882366|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
156882367|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
156882368|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
156882369|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
156882370|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
156882371|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
156882372|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
156882373|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
156882374|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
156882375|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
156882376|NCT00612105|566329416|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
156882377|NCT00612105|566329417|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
156882378|NCT00612105|566329416|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
156882379|NCT00612105|566329417|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
156882380|NCT00612105|566329416|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
156882381|NCT00612105|566329417|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
156882382|NCT00612105|566329416|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
157021378|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021379|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021380|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157143935|NCT02158533|567276368|FG004|Stage 2|Physician Decision|1|||
157143936|NCT02158533|567276369|FG005|Stage 2|Physician Decision|0|||
157143937|NCT02158533|567276364|FG000|Stage 2|Pregnancy|0|||
157143938|NCT02158533|567276365|FG001|Stage 2|Pregnancy|0|||
157143939|NCT02158533|567276366|FG002|Stage 2|Pregnancy|0|||
157143940|NCT02158533|567276367|FG003|Stage 2|Pregnancy|1|||
157143941|NCT02158533|567276368|FG004|Stage 2|Pregnancy|0|||
157143942|NCT02158533|567276369|FG005|Stage 2|Pregnancy|0|||
157143943|NCT02158533|567276364|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
157143944|NCT02158533|567276365|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
157143945|NCT02158533|567276366|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
157143946|NCT02158533|567276367|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
157143947|NCT02158533|567276368|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
157143948|NCT02158533|567276369|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
157143949|NCT02158533|567276364|FG000|Stage 2|Non-adherence with study visits|0|||
157143950|NCT02158533|567276365|FG001|Stage 2|Non-adherence with study visits|0|||
157143951|NCT02158533|567276366|FG002|Stage 2|Non-adherence with study visits|0|||
157143952|NCT02158533|567276367|FG003|Stage 2|Non-adherence with study visits|0|||
157143953|NCT02158533|567276368|FG004|Stage 2|Non-adherence with study visits|0|||
157143954|NCT02158533|567276369|FG005|Stage 2|Non-adherence with study visits|1|||
157143955|NCT00384956|567276370|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
157143956|NCT01389128|567276376|FG000|Overall Study|Fetal distress|1|||
157143957|NCT01389128|567276377|FG001|Overall Study|Fetal distress|0|||
156806441|NCT01214837|566045602|FG002|Overall Study|Death|1|||
156806442|NCT01214837|566045600|FG000|Overall Study|Adverse Event|1|||
156806443|NCT01214837|566045601|FG001|Overall Study|Adverse Event|2|||
156882383|NCT00612105|566329417|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
156882384|NCT00612105|566329416|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
156882385|NCT00612105|566329417|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
156806444|NCT01214837|566045602|FG002|Overall Study|Adverse Event|1|||
156806445|NCT01214837|566045600|FG000|Overall Study|Withdrawal by Subject|27|||
156806446|NCT01214837|566045601|FG001|Overall Study|Withdrawal by Subject|36|||
156806447|NCT01214837|566045602|FG002|Overall Study|Withdrawal by Subject|28|||
156806448|NCT01214837|566045600|FG000|Overall Study|Lost to Follow-up|20|||
156806449|NCT01214837|566045601|FG001|Overall Study|Lost to Follow-up|15|||
156806450|NCT01214837|566045602|FG002|Overall Study|Lost to Follow-up|21|||
156806451|NCT01214837|566045600|FG000|Overall Study|Inappropriate Enrolment|0|||
156806452|NCT01214837|566045601|FG001|Overall Study|Inappropriate Enrolment|1|||
156806453|NCT01214837|566045602|FG002|Overall Study|Inappropriate Enrolment|2|||
156806454|NCT01214837|566045600|FG000|Overall Study|Administrative Reason|2|||
156806455|NCT01214837|566045601|FG001|Overall Study|Administrative Reason|6|||
156806456|NCT01214837|566045602|FG002|Overall Study|Administrative Reason|4|||
156806457|NCT01214837|566045600|FG000|Overall Study|Protocol Violation|3|||
156806458|NCT01214837|566045601|FG001|Overall Study|Protocol Violation|1|||
156806459|NCT01214837|566045602|FG002|Overall Study|Protocol Violation|5|||
156806460|NCT01214837|566045600|FG000|Overall Study|Unable to Classify|1|||
156806461|NCT01214837|566045601|FG001|Overall Study|Unable to Classify|3|||
156806462|NCT01214837|566045602|FG002|Overall Study|Unable to Classify|0|||
156806463|NCT05414175|566045603|FG000|Overall Study|Withdrawal by Subject|1|||
156806464|NCT05414175|566045603|FG000|Overall Study|Other Reasons|1|||
156806465|NCT00027560|566045604|FG000|Overall Study|Withdrawal by Subject|1|||
156806466|NCT03559270|566045606|FG000|Overall Study|Adverse Event|6|||
156806467|NCT03559270|566045607|FG001|Overall Study|Adverse Event|5|||
156806468|NCT03559270|566045608|FG002|Overall Study|Adverse Event|3|||
156806469|NCT03559270|566045609|FG003|Overall Study|Adverse Event|0|||
156806470|NCT03559270|566045606|FG000|Overall Study|Lack of Efficacy|34|||
156806471|NCT03559270|566045607|FG001|Overall Study|Lack of Efficacy|52|||
156806472|NCT03559270|566045608|FG002|Overall Study|Lack of Efficacy|37|||
156806473|NCT03559270|566045609|FG003|Overall Study|Lack of Efficacy|2|||
156806474|NCT03559270|566045606|FG000|Overall Study|Death|0|||
156882386|NCT00475982|566329418|FG000|Overall Study|surgery rescheduled|7|||
156882387|NCT00475982|566329419|FG001|Overall Study|surgery rescheduled|3|||
156882388|NCT01105767|566329420|FG000|Overall Study|Lost to Follow-up|1160|||
156882389|NCT01105767|566329421|FG001|Overall Study|Lost to Follow-up|1614|||
156882390|NCT01105767|566329422|FG002|Overall Study|Lost to Follow-up|1184|||
156882391|NCT02874144|566329427|FG000|Overall Study|Lost to Follow-up|3|||
157143958|NCT01389128|567276376|FG000|Overall Study|Cervix dilation stop|1|||
157143959|NCT01389128|567276377|FG001|Overall Study|Cervix dilation stop|2|||
157143960|NCT01389128|567276376|FG000|Overall Study|Rapid labor evolution|3|||
156806475|NCT03559270|566045607|FG001|Overall Study|Death|2|||
156806476|NCT03559270|566045608|FG002|Overall Study|Death|0|||
156806477|NCT03559270|566045609|FG003|Overall Study|Death|0|||
156806478|NCT03559270|566045606|FG000|Overall Study|Lost to Follow-up|16|||
157021381|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
156882392|NCT02874144|566329428|FG001|Overall Study|Lost to Follow-up|5|||
156882393|NCT00852371|566329432|FG000|Overall Study|Lost to Follow-up|2|||
156806479|NCT03559270|566045607|FG001|Overall Study|Lost to Follow-up|4|||
156806480|NCT03559270|566045608|FG002|Overall Study|Lost to Follow-up|12|||
157143961|NCT01389128|567276377|FG001|Overall Study|Rapid labor evolution|2|||
157143962|NCT01389128|567276376|FG000|Overall Study|Intolerance to procedure|0|||
156806481|NCT03559270|566045609|FG003|Overall Study|Lost to Follow-up|3|||
156806482|NCT03559270|566045606|FG000|Overall Study|Sponsor Decision|38|||
156806483|NCT03559270|566045607|FG001|Overall Study|Sponsor Decision|31|||
156806484|NCT03559270|566045608|FG002|Overall Study|Sponsor Decision|35|||
156806485|NCT03559270|566045609|FG003|Overall Study|Sponsor Decision|18|||
156806486|NCT03559270|566045606|FG000|Overall Study|Withdrawal by Subject|19|||
156806487|NCT03559270|566045607|FG001|Overall Study|Withdrawal by Subject|21|||
156806488|NCT03559270|566045608|FG002|Overall Study|Withdrawal by Subject|18|||
156806489|NCT03559270|566045609|FG003|Overall Study|Withdrawal by Subject|7|||
156806490|NCT03559270|566045606|FG000|Overall Study|Physician Decision|3|||
156806491|NCT03559270|566045607|FG001|Overall Study|Physician Decision|2|||
156806492|NCT03559270|566045608|FG002|Overall Study|Physician Decision|1|||
156806493|NCT03559270|566045609|FG003|Overall Study|Physician Decision|0|||
156806494|NCT03559270|566045606|FG000|Overall Study|Pregnancy|0|||
156806495|NCT03559270|566045607|FG001|Overall Study|Pregnancy|1|||
156806496|NCT03559270|566045608|FG002|Overall Study|Pregnancy|0|||
156806497|NCT03559270|566045609|FG003|Overall Study|Pregnancy|0|||
156806498|NCT03559270|566045606|FG000|Overall Study|Protocol Violation|1|||
156806499|NCT03559270|566045607|FG001|Overall Study|Protocol Violation|0|||
156806500|NCT03559270|566045608|FG002|Overall Study|Protocol Violation|2|||
156806501|NCT03559270|566045609|FG003|Overall Study|Protocol Violation|0|||
156806502|NCT00810277|566047434|FG000|Overall Study|Adverse Event|1|||
156806503|NCT00678288|566047441|FG000|Overall Study|Adverse Event|0|||
156806504|NCT00678288|566047442|FG001|Overall Study|Adverse Event|2|||
156806505|NCT00678288|566047441|FG000|Overall Study|Withdrawal by Subject|1|||
156806506|NCT00678288|566047442|FG001|Overall Study|Withdrawal by Subject|1|||
156806507|NCT00678288|566047441|FG000|Overall Study|Study terminated by the sponsor|2|||
156806508|NCT00678288|566047442|FG001|Overall Study|Study terminated by the sponsor|0|||
156806509|NCT00678288|566047441|FG000|Overall Study|Not compliant with study medication|0|||
156806510|NCT00678288|566047442|FG001|Overall Study|Not compliant with study medication|1|||
156806511|NCT00678288|566047441|FG000|Overall Study|Switch to commercial drug|0|||
156806512|NCT00678288|566047442|FG001|Overall Study|Switch to commercial drug|1|||
156806513|NCT00678288|566047441|FG000|Overall Study|Reason not reported|1|||
156806514|NCT00678288|566047442|FG001|Overall Study|Reason not reported|0|||
156806515|NCT00678288|566047441|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
156806516|NCT00678288|566047442|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
156806517|NCT04472650|566047453|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
156806518|NCT04472650|566047454|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
156806519|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
156806520|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806521|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806522|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806523|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806524|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806525|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806526|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806527|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
156806528|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806529|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
156806530|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
156806531|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806532|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806533|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156882394|NCT00852371|566329433|FG001|Overall Study|Lost to Follow-up|3|||
156882395|NCT00852371|566329434|FG002|Overall Study|Lost to Follow-up|4|||
157143963|NCT01389128|567276377|FG001|Overall Study|Intolerance to procedure|2|||
157143964|NCT00174941|567276382|FG000|Overall Study|Adverse Event|1|||
157143965|NCT00174941|567276383|FG001|Overall Study|Adverse Event|10|||
157143966|NCT00174941|567276384|FG002|Overall Study|Adverse Event|2|||
157143967|NCT00174941|567276385|FG003|Overall Study|Adverse Event|13|||
157143968|NCT00174941|567276382|FG000|Overall Study|Protocol Violation|0|||
157143969|NCT00174941|567276383|FG001|Overall Study|Protocol Violation|1|||
157143970|NCT00174941|567276384|FG002|Overall Study|Protocol Violation|0|||
157143971|NCT00174941|567276385|FG003|Overall Study|Protocol Violation|1|||
157143972|NCT00174941|567276382|FG000|Overall Study|Lost to Follow-up|0|||
157143973|NCT00174941|567276383|FG001|Overall Study|Lost to Follow-up|3|||
157143974|NCT00174941|567276384|FG002|Overall Study|Lost to Follow-up|2|||
157143975|NCT00174941|567276385|FG003|Overall Study|Lost to Follow-up|5|||
157143976|NCT00174941|567276382|FG000|Overall Study|Personal Reason(s)|0|||
157143977|NCT00174941|567276383|FG001|Overall Study|Personal Reason(s)|14|||
157143978|NCT00174941|567276384|FG002|Overall Study|Personal Reason(s)|8|||
157143979|NCT00174941|567276385|FG003|Overall Study|Personal Reason(s)|22|||
157143980|NCT00174941|567276382|FG000|Overall Study|Gout Flare|0|||
157143981|NCT00174941|567276383|FG001|Overall Study|Gout Flare|4|||
157143982|NCT00174941|567276384|FG002|Overall Study|Gout Flare|4|||
157143983|NCT00174941|567276385|FG003|Overall Study|Gout Flare|8|||
157143984|NCT00174941|567276382|FG000|Overall Study|Reason Not Specified|1|||
157143985|NCT00174941|567276383|FG001|Overall Study|Reason Not Specified|6|||
157143986|NCT00174941|567276384|FG002|Overall Study|Reason Not Specified|2|||
157143987|NCT00174941|567276385|FG003|Overall Study|Reason Not Specified|9|||
157143988|NCT03230097|567276391|FG000|Overall Study|Adverse Event|2|||
157143989|NCT03230097|567276392|FG001|Overall Study|Adverse Event|1|||
157143990|NCT03230097|567276391|FG000|Overall Study|non-compliance|0|||
157143991|NCT03230097|567276392|FG001|Overall Study|non-compliance|1|||
157143992|NCT03230097|567276391|FG000|Overall Study|Lost to Follow-up|2|||
157143993|NCT03230097|567276392|FG001|Overall Study|Lost to Follow-up|4|||
157143994|NCT03230097|567276391|FG000|Overall Study|Withdrawal by Subject|7|||
157143995|NCT03230097|567276392|FG001|Overall Study|Withdrawal by Subject|3|||
157143996|NCT03230097|567276391|FG000|Overall Study|Trial termination|4|||
157143997|NCT03230097|567276392|FG001|Overall Study|Trial termination|5|||
157143998|NCT03230097|567276391|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
157143999|NCT03230097|567276392|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
157144000|NCT03230097|567276391|FG000|Overall Study|outcome event|0|||
157144001|NCT03230097|567276392|FG001|Overall Study|outcome event|1|||
157144002|NCT01702805|567276399|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
157144003|NCT01702805|567276400|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
157144004|NCT01702805|567276399|FG000|Overall Study|Incomplete Follow-up|18|||
157144005|NCT01702805|567276400|FG001|Overall Study|Incomplete Follow-up|15|||
157144006|NCT01702805|567276399|FG000|Overall Study|Vital Status Assessment Only|40|||
157144007|NCT01702805|567276400|FG001|Overall Study|Vital Status Assessment Only|39|||
157144008|NCT01702805|567276399|FG000|Overall Study|Lost to Follow-up|5|||
157144009|NCT01702805|567276400|FG001|Overall Study|Lost to Follow-up|5|||
157144010|NCT01588197|567276409|FG000|Overall Study|Lack of Efficacy|0|||
157144011|NCT01588197|567276410|FG001|Overall Study|Lack of Efficacy|1|||
156806534|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806535|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806536|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
156806537|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
156806538|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
156806539|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
156806540|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806541|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806542|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806543|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806544|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806545|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806546|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
156806547|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
156806548|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
156806549|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806550|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806551|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806552|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806553|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806554|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
156806555|NCT02628444|566047457|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
156806556|NCT02628444|566047458|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
156806557|NCT02628444|566047459|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
156806558|NCT02628444|566047460|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806559|NCT02628444|566047461|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806560|NCT02628444|566047462|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806561|NCT02628444|566047463|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806562|NCT02628444|566047464|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806563|NCT02628444|566047465|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
156806564|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806565|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
157144012|NCT01588197|567276409|FG000|Overall Study|No MRI|1|||
157144013|NCT01588197|567276410|FG001|Overall Study|No MRI|0|||
157144014|NCT02111369|567276414|FG000|Overall Study|Lost to Follow-up|2|||
157144015|NCT02111369|567276414|FG000|Overall Study|Withdrawal by Subject|1|||
156882396|NCT00852371|566329435|FG003|Overall Study|Lost to Follow-up|2|||
156882397|NCT03158285|566329436|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
156882398|NCT03158285|566329437|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
156882399|NCT03158285|566329438|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
156882400|NCT03158285|566329436|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
156882401|NCT03158285|566329437|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
156882402|NCT03158285|566329438|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
156882403|NCT03158285|566329436|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156882404|NCT03158285|566329437|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156882405|NCT03158285|566329438|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
157144016|NCT01480180|567276415|FG000|Main Phase|Withdrawal criteria|12|||
157144017|NCT01480180|567276416|FG001|Main Phase|Withdrawal criteria|1|||
157144018|NCT01480180|567276417|FG002|Main Phase|Withdrawal criteria|0|||
157144019|NCT01480180|567276418|FG003|Main Phase|Withdrawal criteria|0|||
157144020|NCT01480180|567276419|FG004|Main Phase|Withdrawal criteria|0|||
156882406|NCT03158285|566329436|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156882407|NCT03158285|566329437|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
156882408|NCT03158285|566329438|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156882409|NCT03158285|566329436|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
156882410|NCT03158285|566329437|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
156882411|NCT03158285|566329438|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
156882412|NCT03158285|566329436|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
157144021|NCT01480180|567276420|FG005|Main Phase|Withdrawal criteria|0|||
157144022|NCT01480180|567276415|FG000|Main Phase|Lack of Efficacy|1|||
157144023|NCT01480180|567276416|FG001|Main Phase|Lack of Efficacy|0|||
157144024|NCT01480180|567276417|FG002|Main Phase|Lack of Efficacy|0|||
157144025|NCT01480180|567276418|FG003|Main Phase|Lack of Efficacy|0|||
157144026|NCT01480180|567276419|FG004|Main Phase|Lack of Efficacy|0|||
157144027|NCT01480180|567276420|FG005|Main Phase|Lack of Efficacy|0|||
157144028|NCT01480180|567276415|FG000|Main Phase|Non-compliance|3|||
157144029|NCT01480180|567276416|FG001|Main Phase|Non-compliance|0|||
157144030|NCT01480180|567276417|FG002|Main Phase|Non-compliance|0|||
157144031|NCT01480180|567276418|FG003|Main Phase|Non-compliance|0|||
157144032|NCT01480180|567276419|FG004|Main Phase|Non-compliance|0|||
157144033|NCT01480180|567276420|FG005|Main Phase|Non-compliance|0|||
157144034|NCT01480180|567276415|FG000|Main Phase|Unclassified|3|||
157144035|NCT01480180|567276416|FG001|Main Phase|Unclassified|0|||
157144036|NCT01480180|567276417|FG002|Main Phase|Unclassified|0|||
157144037|NCT01480180|567276418|FG003|Main Phase|Unclassified|0|||
157144038|NCT01480180|567276419|FG004|Main Phase|Unclassified|0|||
157144039|NCT01480180|567276420|FG005|Main Phase|Unclassified|0|||
157144040|NCT01480180|567276415|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
157144041|NCT01480180|567276416|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
157144042|NCT01480180|567276417|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
157144043|NCT01480180|567276418|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
157144044|NCT01480180|567276419|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
157144045|NCT01480180|567276420|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
157144046|NCT01480180|567276415|FG000|Extension Phase, Part 1|Unclassified|0|||
157144047|NCT01480180|567276416|FG001|Extension Phase, Part 1|Unclassified|0|||
157144048|NCT01480180|567276417|FG002|Extension Phase, Part 1|Unclassified|1|||
157144049|NCT01480180|567276418|FG003|Extension Phase, Part 1|Unclassified|0|||
157144050|NCT01480180|567276419|FG004|Extension Phase, Part 1|Unclassified|0|||
157144051|NCT01480180|567276420|FG005|Extension Phase, Part 1|Unclassified|0|||
157144052|NCT01480180|567276415|FG000|Extension Phase, Part 1|Adverse Event|0|||
157144053|NCT01480180|567276416|FG001|Extension Phase, Part 1|Adverse Event|0|||
157144054|NCT01480180|567276417|FG002|Extension Phase, Part 1|Adverse Event|4|||
157144055|NCT01480180|567276418|FG003|Extension Phase, Part 1|Adverse Event|1|||
157144056|NCT01480180|567276419|FG004|Extension Phase, Part 1|Adverse Event|0|||
157144057|NCT01480180|567276420|FG005|Extension Phase, Part 1|Adverse Event|0|||
157144058|NCT01480180|567276415|FG000|Extension Phase, Part 1|Change of treatment|0|||
157144059|NCT01480180|567276416|FG001|Extension Phase, Part 1|Change of treatment|0|||
157144060|NCT01480180|567276417|FG002|Extension Phase, Part 1|Change of treatment|0|||
157144061|NCT01480180|567276418|FG003|Extension Phase, Part 1|Change of treatment|9|||
157144062|NCT01480180|567276419|FG004|Extension Phase, Part 1|Change of treatment|0|||
157144063|NCT01480180|567276420|FG005|Extension Phase, Part 1|Change of treatment|0|||
157144064|NCT01480180|567276415|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
157144065|NCT01480180|567276416|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
156882413|NCT03158285|566329437|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
157144066|NCT01480180|567276417|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
156882414|NCT03158285|566329438|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
156882415|NCT03158285|566329436|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
157144067|NCT01480180|567276418|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
157144068|NCT01480180|567276419|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
157144069|NCT01480180|567276420|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
157144070|NCT01480180|567276415|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
157144071|NCT01480180|567276416|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
157144072|NCT01480180|567276417|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
157144073|NCT01480180|567276418|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
157144074|NCT01480180|567276419|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
157144075|NCT01480180|567276420|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
157144076|NCT01480180|567276415|FG000|Extension Phase, Part 2|Unclassified|0|||
157144077|NCT01480180|567276416|FG001|Extension Phase, Part 2|Unclassified|0|||
157144078|NCT01480180|567276417|FG002|Extension Phase, Part 2|Unclassified|3|||
157144079|NCT01480180|567276418|FG003|Extension Phase, Part 2|Unclassified|1|||
157144080|NCT01480180|567276419|FG004|Extension Phase, Part 2|Unclassified|1|||
157144081|NCT01480180|567276420|FG005|Extension Phase, Part 2|Unclassified|0|||
157144082|NCT00658333|567276421|FG000|Overall Study|Adverse Event|2|||
157144083|NCT00658333|567276422|FG001|Overall Study|Adverse Event|1|||
157144084|NCT03519178|567276423|FG000|PF-06873600 Treatment|Adverse Event|0|||
157144085|NCT03519178|567276424|FG001|PF-06873600 Treatment|Adverse Event|0|||
157144086|NCT03519178|567276425|FG002|PF-06873600 Treatment|Adverse Event|0|||
157144087|NCT03519178|567276426|FG003|PF-06873600 Treatment|Adverse Event|0|||
157144088|NCT03519178|567276427|FG004|PF-06873600 Treatment|Adverse Event|0|||
157144089|NCT03519178|567276428|FG005|PF-06873600 Treatment|Adverse Event|0|||
157144090|NCT03519178|567276429|FG006|PF-06873600 Treatment|Adverse Event|0|||
157221008|NCT00585351|567554935|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
157221009|NCT00585351|567554936|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
157221010|NCT00585351|567554937|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
157221011|NCT00585351|567554938|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
157221012|NCT00585351|567554939|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
157221013|NCT00585351|567554940|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
157221014|NCT00585351|567554941|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
157221015|NCT02330081|567554944|FG000|Overall Study|Adverse Event|1|||
157221016|NCT02330081|567554944|FG000|Overall Study|Donation did not meet criteria|1|||
157221017|NCT02330081|567554944|FG000|Overall Study|Protocol Violation|6|||
157221018|NCT02277769|567554945|FG000|Overall Study|Protocol Violation|3|||
157221019|NCT02277769|567554946|FG001|Overall Study|Protocol Violation|3|||
157221020|NCT02277769|567554947|FG002|Overall Study|Protocol Violation|5|||
157221021|NCT02277769|567554945|FG000|Overall Study|Lack of Efficacy|17|||
157221022|NCT02277769|567554946|FG001|Overall Study|Lack of Efficacy|0|||
157221023|NCT02277769|567554947|FG002|Overall Study|Lack of Efficacy|4|||
157221024|NCT02277769|567554945|FG000|Overall Study|Adverse Event|14|||
157221025|NCT02277769|567554946|FG001|Overall Study|Adverse Event|2|||
157221026|NCT02277769|567554947|FG002|Overall Study|Adverse Event|4|||
157221027|NCT02277769|567554945|FG000|Overall Study|Other than specified above|12|||
157221028|NCT02277769|567554946|FG001|Overall Study|Other than specified above|8|||
157221029|NCT02277769|567554947|FG002|Overall Study|Other than specified above|5|||
157221030|NCT02668302|567554948|FG000|Overall Study|Withdrawal by Subject|1|||
157221031|NCT02668302|567554949|FG001|Overall Study|Withdrawal by Subject|0|||
157221032|NCT03558997|567554950|FG000|Overall Study|Adverse Event|0|||
157221033|NCT03558997|567554951|FG001|Overall Study|Adverse Event|2|||
157221034|NCT03558997|567554952|FG002|Overall Study|Adverse Event|5|||
157221035|NCT03558997|567554953|FG003|Overall Study|Adverse Event|1|||
157221036|NCT03558997|567554950|FG000|Overall Study|Physician Decision|0|||
157221037|NCT03558997|567554951|FG001|Overall Study|Physician Decision|0|||
156806566|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
157144091|NCT03519178|567276430|FG007|PF-06873600 Treatment|Adverse Event|2|||
157144092|NCT03519178|567276431|FG008|PF-06873600 Treatment|Adverse Event|1|||
156806567|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
156806568|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806569|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
157021382|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021383|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157144093|NCT03519178|567276432|FG009|PF-06873600 Treatment|Adverse Event|0|||
157221038|NCT03558997|567554952|FG002|Overall Study|Physician Decision|1|||
157221039|NCT03558997|567554953|FG003|Overall Study|Physician Decision|0|||
157221040|NCT03558997|567554950|FG000|Overall Study|Withdrawal by Subject|1|||
157221041|NCT03558997|567554951|FG001|Overall Study|Withdrawal by Subject|0|||
157221042|NCT03558997|567554952|FG002|Overall Study|Withdrawal by Subject|1|||
157221043|NCT03558997|567554953|FG003|Overall Study|Withdrawal by Subject|1|||
157221044|NCT03558997|567554950|FG000|Overall Study|Lost to Follow-up|0|||
157221045|NCT03558997|567554951|FG001|Overall Study|Lost to Follow-up|0|||
157221046|NCT03558997|567554952|FG002|Overall Study|Lost to Follow-up|1|||
157221047|NCT03558997|567554953|FG003|Overall Study|Lost to Follow-up|0|||
157221048|NCT01626885|567554954|FG000|Overall Study|Adverse Event|8|||
157221049|NCT01626885|567554954|FG000|Overall Study|Withdrawal by Subject|4|||
157221050|NCT03035227|567554958|FG000|Overall Study|study stopped due to PI leaving institut|1|||
157221051|NCT03035227|567554959|FG001|Overall Study|study stopped due to PI leaving institut|1|||
156806570|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806571|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806572|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
156806573|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806574|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806575|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
156806576|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806577|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806578|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
156806579|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
156806580|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
156806581|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
156806582|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806583|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806584|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
156806585|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
156806586|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
156806587|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
156806588|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
156806589|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
156806590|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
156806591|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806592|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806593|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806594|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806595|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
156806596|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806597|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
156806598|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
156806599|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
156806600|NCT02628444|566047457|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
157144094|NCT03519178|567276433|FG010|PF-06873600 Treatment|Adverse Event|0|||
157144095|NCT03519178|567276434|FG011|PF-06873600 Treatment|Adverse Event|0|||
157144096|NCT03519178|567276435|FG012|PF-06873600 Treatment|Adverse Event|1|||
157144097|NCT03519178|567276436|FG013|PF-06873600 Treatment|Adverse Event|3|||
157144098|NCT03519178|567276437|FG014|PF-06873600 Treatment|Adverse Event|2|||
157144099|NCT03519178|567276423|FG000|PF-06873600 Treatment|Death|0|||
157144100|NCT03519178|567276424|FG001|PF-06873600 Treatment|Death|0|||
157144101|NCT03519178|567276425|FG002|PF-06873600 Treatment|Death|0|||
157144102|NCT03519178|567276426|FG003|PF-06873600 Treatment|Death|0|||
157144103|NCT03519178|567276427|FG004|PF-06873600 Treatment|Death|0|||
157144104|NCT03519178|567276428|FG005|PF-06873600 Treatment|Death|0|||
157144105|NCT03519178|567276429|FG006|PF-06873600 Treatment|Death|0|||
157144106|NCT03519178|567276430|FG007|PF-06873600 Treatment|Death|0|||
157144107|NCT03519178|567276431|FG008|PF-06873600 Treatment|Death|1|||
157144108|NCT03519178|567276432|FG009|PF-06873600 Treatment|Death|1|||
157144109|NCT03519178|567276433|FG010|PF-06873600 Treatment|Death|0|||
157144110|NCT03519178|567276434|FG011|PF-06873600 Treatment|Death|0|||
157144111|NCT03519178|567276435|FG012|PF-06873600 Treatment|Death|0|||
157144112|NCT03519178|567276436|FG013|PF-06873600 Treatment|Death|0|||
157144113|NCT03519178|567276437|FG014|PF-06873600 Treatment|Death|1|||
157144114|NCT03519178|567276423|FG000|PF-06873600 Treatment|Physician Decision|0|||
157144115|NCT03519178|567276424|FG001|PF-06873600 Treatment|Physician Decision|0|||
157144116|NCT03519178|567276425|FG002|PF-06873600 Treatment|Physician Decision|0|||
157144117|NCT03519178|567276426|FG003|PF-06873600 Treatment|Physician Decision|0|||
157144118|NCT03519178|567276427|FG004|PF-06873600 Treatment|Physician Decision|0|||
157144119|NCT03519178|567276428|FG005|PF-06873600 Treatment|Physician Decision|0|||
157144120|NCT03519178|567276429|FG006|PF-06873600 Treatment|Physician Decision|0|||
157144121|NCT03519178|567276430|FG007|PF-06873600 Treatment|Physician Decision|1|||
157144122|NCT03519178|567276431|FG008|PF-06873600 Treatment|Physician Decision|0|||
157144123|NCT03519178|567276432|FG009|PF-06873600 Treatment|Physician Decision|0|||
157144124|NCT03519178|567276433|FG010|PF-06873600 Treatment|Physician Decision|1|||
157144125|NCT03519178|567276434|FG011|PF-06873600 Treatment|Physician Decision|0|||
157144126|NCT03519178|567276435|FG012|PF-06873600 Treatment|Physician Decision|0|||
157144127|NCT03519178|567276436|FG013|PF-06873600 Treatment|Physician Decision|4|||
157144128|NCT03519178|567276437|FG014|PF-06873600 Treatment|Physician Decision|1|||
157144129|NCT03519178|567276423|FG000|PF-06873600 Treatment|Progressive disease|1|||
157221052|NCT02100956|567554960|FG000|At Least One Week Between Injections|Adverse Event|0|||
157221053|NCT02100956|567554961|FG001|At Least One Week Between Injections|Adverse Event|1|||
157144130|NCT03519178|567276424|FG001|PF-06873600 Treatment|Progressive disease|1|||
157144131|NCT03519178|567276425|FG002|PF-06873600 Treatment|Progressive disease|1|||
157144132|NCT03519178|567276426|FG003|PF-06873600 Treatment|Progressive disease|1|||
157144133|NCT03519178|567276427|FG004|PF-06873600 Treatment|Progressive disease|6|||
157144134|NCT03519178|567276428|FG005|PF-06873600 Treatment|Progressive disease|7|||
157144135|NCT03519178|567276429|FG006|PF-06873600 Treatment|Progressive disease|3|||
157144136|NCT03519178|567276430|FG007|PF-06873600 Treatment|Progressive disease|7|||
156806601|NCT02628444|566047458|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
156806602|NCT02628444|566047459|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
156806603|NCT02628444|566047460|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806604|NCT02628444|566047461|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806605|NCT02628444|566047462|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
156806606|NCT02628444|566047463|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
156806607|NCT02628444|566047464|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
156806608|NCT02628444|566047465|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
156806609|NCT01333722|566047466|FG000|Overall Study|Lack of Efficacy|0|||
156806610|NCT01333722|566047467|FG001|Overall Study|Lack of Efficacy|2|||
156806611|NCT01333722|566047466|FG000|Overall Study|Withdrawal by Subject|0|||
156806612|NCT01333722|566047467|FG001|Overall Study|Withdrawal by Subject|1|||
156806613|NCT02079909|566047468|FG000|Overall Study|Adverse Event|23|||
156806614|NCT02079909|566047469|FG001|Overall Study|Adverse Event|23|||
156806615|NCT02079909|566047470|FG002|Overall Study|Adverse Event|7|||
156806616|NCT02079909|566047468|FG000|Overall Study|Withdrawal by Subject|9|||
156806617|NCT02079909|566047469|FG001|Overall Study|Withdrawal by Subject|17|||
156806618|NCT02079909|566047470|FG002|Overall Study|Withdrawal by Subject|4|||
156806619|NCT02079909|566047468|FG000|Overall Study|Lost to Follow-up|2|||
156806620|NCT02079909|566047469|FG001|Overall Study|Lost to Follow-up|3|||
156806621|NCT02079909|566047470|FG002|Overall Study|Lost to Follow-up|1|||
156806622|NCT02079909|566047468|FG000|Overall Study|Death|2|||
156806623|NCT02079909|566047469|FG001|Overall Study|Death|2|||
156806624|NCT02079909|566047470|FG002|Overall Study|Death|0|||
156806625|NCT02079909|566047468|FG000|Overall Study|Lack of Efficacy|0|||
156806626|NCT02079909|566047469|FG001|Overall Study|Lack of Efficacy|0|||
156806627|NCT02079909|566047470|FG002|Overall Study|Lack of Efficacy|1|||
156806628|NCT02079909|566047468|FG000|Overall Study|Protocol Violation|0|||
156806629|NCT02079909|566047469|FG001|Overall Study|Protocol Violation|1|||
156806630|NCT02079909|566047470|FG002|Overall Study|Protocol Violation|1|||
156806631|NCT02079909|566047468|FG000|Overall Study|Physician Decision|0|||
156806632|NCT02079909|566047469|FG001|Overall Study|Physician Decision|1|||
156806633|NCT02079909|566047470|FG002|Overall Study|Physician Decision|1|||
156806634|NCT02079909|566047468|FG000|Overall Study|Relocation etc.|2|||
156806635|NCT02079909|566047469|FG001|Overall Study|Relocation etc.|2|||
156806636|NCT02079909|566047470|FG002|Overall Study|Relocation etc.|3|||
156806637|NCT00720356|566047475|FG000|Registration to Study|Determined to have methylated MGMT|67|||
156806638|NCT00720356|566047475|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
156806639|NCT00720356|566047475|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
156806640|NCT00720356|566047475|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
156806641|NCT00720356|566047475|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
156806642|NCT00720356|566047475|FG000|Follow up Until Death|Withdrawal by Subject|1|||
156806643|NCT00720356|566047475|FG000|Follow up Until Death|Alive at last data collection|4|||
156806644|NCT02237001|566047478|FG000|Overall Study|Lost to Follow-up|2|||
156806645|NCT02237001|566047478|FG000|Overall Study|Withdrawal by Subject|1|||
156806646|NCT02237001|566047478|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
156806647|NCT02237001|566047478|FG000|Overall Study|Re-operation|4|||
157021384|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157144137|NCT03519178|567276431|FG008|PF-06873600 Treatment|Progressive disease|3|||
157144138|NCT03519178|567276432|FG009|PF-06873600 Treatment|Progressive disease|5|||
157144139|NCT03519178|567276433|FG010|PF-06873600 Treatment|Progressive disease|4|||
157144140|NCT03519178|567276434|FG011|PF-06873600 Treatment|Progressive disease|3|||
157144141|NCT03519178|567276435|FG012|PF-06873600 Treatment|Progressive disease|4|||
157144142|NCT03519178|567276436|FG013|PF-06873600 Treatment|Progressive disease|28|||
157144143|NCT03519178|567276437|FG014|PF-06873600 Treatment|Progressive disease|8|||
157144144|NCT03519178|567276423|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144145|NCT03519178|567276424|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144146|NCT03519178|567276425|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
157144147|NCT03519178|567276426|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144148|NCT03519178|567276427|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
157144149|NCT03519178|567276428|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144150|NCT03519178|567276429|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144151|NCT03519178|567276430|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
157144152|NCT03519178|567276431|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
157144153|NCT03519178|567276432|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
157144154|NCT03519178|567276433|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
157144155|NCT03519178|567276434|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
157221054|NCT02220907|567554962|FG000|Overall Study|Adverse Event|7|||
157221055|NCT02220907|567554962|FG000|Overall Study|Physician Decision|1|||
157221056|NCT02220907|567554962|FG000|Overall Study|Withdrawal by Subject|2|||
157144156|NCT03519178|567276435|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
157144157|NCT03519178|567276436|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
157144158|NCT03519178|567276437|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
157144159|NCT03519178|567276423|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
157144160|NCT03519178|567276424|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
157144161|NCT03519178|567276425|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
157144162|NCT03519178|567276426|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
157144163|NCT03519178|567276427|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
157144164|NCT03519178|567276428|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
157144165|NCT03519178|567276429|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
157144166|NCT03519178|567276430|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
157144167|NCT03519178|567276431|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
157144168|NCT03519178|567276432|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
157144169|NCT03519178|567276433|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
157144170|NCT03519178|567276434|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
157144171|NCT03519178|567276435|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
157144172|NCT03519178|567276436|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
157144173|NCT03519178|567276437|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
157144174|NCT03519178|567276423|FG000|PF-06873600 Treatment|Refused further treatment|0|||
157144175|NCT03519178|567276424|FG001|PF-06873600 Treatment|Refused further treatment|1|||
157144176|NCT03519178|567276425|FG002|PF-06873600 Treatment|Refused further treatment|0|||
157144177|NCT03519178|567276426|FG003|PF-06873600 Treatment|Refused further treatment|0|||
157144178|NCT03519178|567276427|FG004|PF-06873600 Treatment|Refused further treatment|1|||
157144179|NCT03519178|567276428|FG005|PF-06873600 Treatment|Refused further treatment|0|||
157144180|NCT03519178|567276429|FG006|PF-06873600 Treatment|Refused further treatment|0|||
157144181|NCT03519178|567276430|FG007|PF-06873600 Treatment|Refused further treatment|0|||
157144182|NCT03519178|567276431|FG008|PF-06873600 Treatment|Refused further treatment|0|||
157144183|NCT03519178|567276432|FG009|PF-06873600 Treatment|Refused further treatment|0|||
157144184|NCT03519178|567276433|FG010|PF-06873600 Treatment|Refused further treatment|0|||
157144185|NCT03519178|567276434|FG011|PF-06873600 Treatment|Refused further treatment|0|||
157144186|NCT03519178|567276435|FG012|PF-06873600 Treatment|Refused further treatment|0|||
157144187|NCT03519178|567276436|FG013|PF-06873600 Treatment|Refused further treatment|0|||
157144188|NCT03519178|567276437|FG014|PF-06873600 Treatment|Refused further treatment|1|||
157144189|NCT03519178|567276423|FG000|PF-06873600 Treatment|Other|0|||
157144190|NCT03519178|567276424|FG001|PF-06873600 Treatment|Other|0|||
157144191|NCT03519178|567276425|FG002|PF-06873600 Treatment|Other|0|||
157144192|NCT03519178|567276426|FG003|PF-06873600 Treatment|Other|0|||
157144193|NCT03519178|567276427|FG004|PF-06873600 Treatment|Other|0|||
157144194|NCT03519178|567276428|FG005|PF-06873600 Treatment|Other|0|||
157144195|NCT03519178|567276429|FG006|PF-06873600 Treatment|Other|0|||
157144196|NCT03519178|567276430|FG007|PF-06873600 Treatment|Other|0|||
157144197|NCT03519178|567276431|FG008|PF-06873600 Treatment|Other|1|||
157144198|NCT03519178|567276432|FG009|PF-06873600 Treatment|Other|0|||
157144199|NCT03519178|567276433|FG010|PF-06873600 Treatment|Other|0|||
157144200|NCT03519178|567276434|FG011|PF-06873600 Treatment|Other|0|||
157144201|NCT03519178|567276435|FG012|PF-06873600 Treatment|Other|0|||
157144202|NCT03519178|567276436|FG013|PF-06873600 Treatment|Other|1|||
157144203|NCT03519178|567276437|FG014|PF-06873600 Treatment|Other|3|||
157144204|NCT03519178|567276423|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
157144205|NCT03519178|567276424|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
157144206|NCT03519178|567276425|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
157221057|NCT02220907|567554962|FG000|Overall Study|Conflict with the stopping criteria|1|||
157221058|NCT04128696|567554963|FG000|Overall Study|Lost to Follow-up|3|||
157221059|NCT04128696|567554964|FG001|Overall Study|Lost to Follow-up|7|||
157221060|NCT04128696|567554963|FG000|Overall Study|Withdrawal by Subject|12|||
157221061|NCT04128696|567554964|FG001|Overall Study|Withdrawal by Subject|11|||
157221062|NCT04128696|567554963|FG000|Overall Study|Study Closed/Terminated|26|||
157221063|NCT04128696|567554964|FG001|Overall Study|Study Closed/Terminated|38|||
157221064|NCT04128696|567554963|FG000|Overall Study|Physician Decision|2|||
157221065|NCT04128696|567554964|FG001|Overall Study|Physician Decision|3|||
157221066|NCT01098240|567554965|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
157221067|NCT01098240|567554966|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
157221068|NCT01098240|567554967|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
157221069|NCT01098240|567554965|FG000|Open-Label Phase|Protocol Violation|4|||
157144207|NCT03519178|567276426|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
157144208|NCT03519178|567276427|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
157144209|NCT03519178|567276428|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
157221070|NCT01098240|567554966|FG001|Open-Label Phase|Protocol Violation|0|||
157221071|NCT01098240|567554967|FG002|Open-Label Phase|Protocol Violation|0|||
157144210|NCT03519178|567276429|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
157144211|NCT03519178|567276430|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
157144212|NCT03519178|567276431|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
157144213|NCT03519178|567276432|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
157144214|NCT03519178|567276433|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
157144215|NCT03519178|567276434|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
157144216|NCT03519178|567276435|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
157144217|NCT03519178|567276436|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
157144218|NCT03519178|567276437|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
157144219|NCT03519178|567276423|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144220|NCT03519178|567276424|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144221|NCT03519178|567276425|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144222|NCT03519178|567276426|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144223|NCT03519178|567276427|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144224|NCT03519178|567276428|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
157221072|NCT01098240|567554965|FG000|Open-Label Phase|Lost to Follow-up|13|||
157221073|NCT01098240|567554966|FG001|Open-Label Phase|Lost to Follow-up|0|||
157221074|NCT01098240|567554967|FG002|Open-Label Phase|Lost to Follow-up|0|||
157221075|NCT01098240|567554965|FG000|Open-Label Phase|Other|19|||
157221076|NCT01098240|567554966|FG001|Open-Label Phase|Other|0|||
157221077|NCT01098240|567554967|FG002|Open-Label Phase|Other|0|||
157221078|NCT01098240|567554965|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
157221079|NCT01098240|567554966|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
157221080|NCT01098240|567554967|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
157221081|NCT01098240|567554965|FG000|Open-Label Phase|Pregnancy|1|||
157221082|NCT01098240|567554966|FG001|Open-Label Phase|Pregnancy|0|||
157221083|NCT01098240|567554967|FG002|Open-Label Phase|Pregnancy|0|||
157221084|NCT01098240|567554965|FG000|Open-Label Phase|Withdrawal by Subject|9|||
157221085|NCT01098240|567554966|FG001|Open-Label Phase|Withdrawal by Subject|0|||
157221086|NCT01098240|567554967|FG002|Open-Label Phase|Withdrawal by Subject|0|||
157221087|NCT01098240|567554965|FG000|Open-Label Phase|Adverse Event|12|||
157144225|NCT03519178|567276429|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144226|NCT03519178|567276430|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144227|NCT03519178|567276431|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144228|NCT03519178|567276432|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
157221088|NCT01098240|567554966|FG001|Open-Label Phase|Adverse Event|0|||
157144229|NCT03519178|567276433|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144230|NCT03519178|567276434|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
157221089|NCT01098240|567554967|FG002|Open-Label Phase|Adverse Event|0|||
157221090|NCT01098240|567554965|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
156806648|NCT02237001|566047478|FG000|Overall Study|Incarceration|1|||
156806649|NCT01713582|566047479|FG000|Overall Study|Disease progression|3|||
156806650|NCT01713582|566047480|FG001|Overall Study|Disease progression|3|||
156806651|NCT01713582|566047481|FG002|Overall Study|Disease progression|3|||
156806652|NCT01713582|566047482|FG003|Overall Study|Disease progression|2|||
156806653|NCT01713582|566047483|FG004|Overall Study|Disease progression|3|||
156806654|NCT01713582|566047484|FG005|Overall Study|Disease progression|3|||
156806655|NCT01713582|566047485|FG006|Overall Study|Disease progression|3|||
156806656|NCT01713582|566047486|FG007|Overall Study|Disease progression|3|||
156806657|NCT01713582|566047487|FG008|Overall Study|Disease progression|3|||
156806658|NCT01713582|566047488|FG009|Overall Study|Disease progression|11|||
156806659|NCT01713582|566047489|FG010|Overall Study|Disease progression|10|||
156806660|NCT01713582|566047490|FG011|Overall Study|Disease progression|5|||
156806661|NCT01713582|566047491|FG012|Overall Study|Disease progression|3|||
156806662|NCT01713582|566047492|FG013|Overall Study|Disease progression|3|||
156806663|NCT01713582|566047493|FG014|Overall Study|Disease progression|6|||
156806664|NCT01713582|566047494|FG015|Overall Study|Disease progression|6|||
156806665|NCT01713582|566047495|FG016|Overall Study|Disease progression|5|||
156806666|NCT01713582|566047496|FG017|Overall Study|Disease progression|2|||
156806667|NCT01713582|566047497|FG018|Overall Study|Disease progression|3|||
156806668|NCT01713582|566047498|FG019|Overall Study|Disease progression|5|||
156806669|NCT01713582|566047499|FG020|Overall Study|Disease progression|15|||
156806670|NCT01713582|566047479|FG000|Overall Study|Death|0|||
156806671|NCT01713582|566047480|FG001|Overall Study|Death|0|||
156806672|NCT01713582|566047481|FG002|Overall Study|Death|0|||
156806673|NCT01713582|566047482|FG003|Overall Study|Death|1|||
156806674|NCT01713582|566047483|FG004|Overall Study|Death|1|||
156806675|NCT01713582|566047484|FG005|Overall Study|Death|3|||
156806676|NCT01713582|566047485|FG006|Overall Study|Death|3|||
156806677|NCT01713582|566047486|FG007|Overall Study|Death|2|||
156806678|NCT01713582|566047487|FG008|Overall Study|Death|3|||
156806679|NCT01713582|566047488|FG009|Overall Study|Death|4|||
156806680|NCT01713582|566047489|FG010|Overall Study|Death|3|||
156806681|NCT01713582|566047490|FG011|Overall Study|Death|0|||
156806682|NCT01713582|566047491|FG012|Overall Study|Death|0|||
156806683|NCT01713582|566047492|FG013|Overall Study|Death|0|||
156806684|NCT01713582|566047493|FG014|Overall Study|Death|0|||
156806685|NCT01713582|566047494|FG015|Overall Study|Death|0|||
156806686|NCT01713582|566047495|FG016|Overall Study|Death|0|||
157021385|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
157021386|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021387|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
157021388|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
157021389|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
157021390|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021391|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021392|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021393|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021394|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021395|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
157021396|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021397|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021398|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021399|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021400|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021401|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021402|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021403|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021404|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021405|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021406|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021407|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021408|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021409|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021410|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021411|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
157021412|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021413|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021414|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157144231|NCT03519178|567276435|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
157144232|NCT03519178|567276436|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
157144233|NCT03519178|567276437|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
157144234|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Adverse Event|0|||
157144235|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Adverse Event|0|||
157144236|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Adverse Event|0|||
157144237|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Adverse Event|0|||
157144238|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Adverse Event|0|||
157144239|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Adverse Event|0|||
157144240|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Adverse Event|0|||
157144241|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Adverse Event|0|||
157144242|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Adverse Event|0|||
157144243|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Adverse Event|0|||
157144244|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Adverse Event|0|||
157144245|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Adverse Event|0|||
157144246|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Adverse Event|0|||
157144247|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Adverse Event|1|||
157144248|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Adverse Event|0|||
157144249|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Death|0|||
157144250|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Death|0|||
157144251|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Death|0|||
157144252|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Death|0|||
157144253|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Death|0|||
156806687|NCT01713582|566047496|FG017|Overall Study|Death|0|||
156806688|NCT01713582|566047497|FG018|Overall Study|Death|0|||
157021415|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021416|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021417|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021418|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
157021419|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021420|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021421|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157021422|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
157144254|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Death|0|||
157144255|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Death|0|||
157144256|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Death|0|||
157144257|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Death|0|||
157144258|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Death|1|||
157144259|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Death|0|||
157144260|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Death|0|||
157144261|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Death|0|||
157144262|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Death|0|||
157144263|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Death|1|||
157144264|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144265|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144266|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
156806689|NCT01713582|566047498|FG019|Overall Study|Death|0|||
156806690|NCT01713582|566047499|FG020|Overall Study|Death|0|||
156806691|NCT01713582|566047479|FG000|Overall Study|Adverse event-related|0|||
156806692|NCT01713582|566047480|FG001|Overall Study|Adverse event-related|0|||
156806693|NCT01713582|566047481|FG002|Overall Study|Adverse event-related|0|||
156806694|NCT01713582|566047482|FG003|Overall Study|Adverse event-related|0|||
156806695|NCT01713582|566047483|FG004|Overall Study|Adverse event-related|0|||
156806696|NCT01713582|566047484|FG005|Overall Study|Adverse event-related|0|||
156806697|NCT01713582|566047485|FG006|Overall Study|Adverse event-related|0|||
156806698|NCT01713582|566047486|FG007|Overall Study|Adverse event-related|0|||
156806699|NCT01713582|566047487|FG008|Overall Study|Adverse event-related|0|||
156806700|NCT01713582|566047488|FG009|Overall Study|Adverse event-related|1|||
156806701|NCT01713582|566047489|FG010|Overall Study|Adverse event-related|1|||
156806702|NCT01713582|566047490|FG011|Overall Study|Adverse event-related|0|||
156806703|NCT01713582|566047491|FG012|Overall Study|Adverse event-related|0|||
156806704|NCT01713582|566047492|FG013|Overall Study|Adverse event-related|0|||
156806705|NCT01713582|566047493|FG014|Overall Study|Adverse event-related|0|||
156806706|NCT01713582|566047494|FG015|Overall Study|Adverse event-related|0|||
156806707|NCT01713582|566047495|FG016|Overall Study|Adverse event-related|0|||
156806708|NCT01713582|566047496|FG017|Overall Study|Adverse event-related|0|||
156806709|NCT01713582|566047497|FG018|Overall Study|Adverse event-related|1|||
156806710|NCT01713582|566047498|FG019|Overall Study|Adverse event-related|0|||
156806711|NCT01713582|566047499|FG020|Overall Study|Adverse event-related|0|||
156806712|NCT01713582|566047479|FG000|Overall Study|Adverse event-unrelated|0|||
156806713|NCT01713582|566047480|FG001|Overall Study|Adverse event-unrelated|0|||
156806714|NCT01713582|566047481|FG002|Overall Study|Adverse event-unrelated|0|||
156806715|NCT01713582|566047482|FG003|Overall Study|Adverse event-unrelated|0|||
156806716|NCT01713582|566047483|FG004|Overall Study|Adverse event-unrelated|0|||
156806717|NCT01713582|566047484|FG005|Overall Study|Adverse event-unrelated|1|||
156806718|NCT01713582|566047485|FG006|Overall Study|Adverse event-unrelated|1|||
156806719|NCT01713582|566047486|FG007|Overall Study|Adverse event-unrelated|1|||
156806720|NCT01713582|566047487|FG008|Overall Study|Adverse event-unrelated|0|||
156806721|NCT01713582|566047488|FG009|Overall Study|Adverse event-unrelated|0|||
156806722|NCT01713582|566047489|FG010|Overall Study|Adverse event-unrelated|0|||
156806723|NCT01713582|566047490|FG011|Overall Study|Adverse event-unrelated|0|||
156806724|NCT01713582|566047491|FG012|Overall Study|Adverse event-unrelated|0|||
156806725|NCT01713582|566047492|FG013|Overall Study|Adverse event-unrelated|1|||
156806726|NCT01713582|566047493|FG014|Overall Study|Adverse event-unrelated|1|||
156806727|NCT01713582|566047494|FG015|Overall Study|Adverse event-unrelated|0|||
156806728|NCT01713582|566047495|FG016|Overall Study|Adverse event-unrelated|0|||
156806729|NCT01713582|566047496|FG017|Overall Study|Adverse event-unrelated|0|||
156806730|NCT01713582|566047497|FG018|Overall Study|Adverse event-unrelated|0|||
156806731|NCT01713582|566047498|FG019|Overall Study|Adverse event-unrelated|0|||
156806732|NCT01713582|566047499|FG020|Overall Study|Adverse event-unrelated|0|||
156806733|NCT01713582|566047479|FG000|Overall Study|Withdrawal of consent|0|||
156806734|NCT01713582|566047480|FG001|Overall Study|Withdrawal of consent|0|||
156806735|NCT01713582|566047481|FG002|Overall Study|Withdrawal of consent|1|||
157144267|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144268|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144269|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144270|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144271|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144272|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144273|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144274|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144275|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144276|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
157144277|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
156806736|NCT01713582|566047482|FG003|Overall Study|Withdrawal of consent|0|||
156806737|NCT01713582|566047483|FG004|Overall Study|Withdrawal of consent|0|||
156806738|NCT01713582|566047484|FG005|Overall Study|Withdrawal of consent|1|||
156806739|NCT01713582|566047485|FG006|Overall Study|Withdrawal of consent|0|||
156806740|NCT01713582|566047486|FG007|Overall Study|Withdrawal of consent|0|||
156806741|NCT01713582|566047487|FG008|Overall Study|Withdrawal of consent|0|||
157144278|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
157144279|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Physician Decision|0|||
157144280|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Physician Decision|0|||
157221091|NCT01098240|567554966|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
157021423|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021424|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021425|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021426|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021427|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021428|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021429|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021430|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021431|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021432|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021433|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021434|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021435|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021436|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
157021437|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
157021438|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
157021439|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
157021440|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021441|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
157021442|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
157021443|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021444|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021445|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021446|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021447|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021448|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021449|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
157021450|NCT02783300|566830869|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021451|NCT02783300|566830870|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021452|NCT02783300|566830871|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021453|NCT02783300|566830872|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021454|NCT02783300|566830873|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021455|NCT02783300|566830874|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021456|NCT02783300|566830875|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021457|NCT02783300|566830876|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021458|NCT02783300|566830877|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021459|NCT02783300|566830878|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021460|NCT02783300|566830879|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021461|NCT02783300|566830880|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021462|NCT02783300|566830881|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157021463|NCT02783300|566830882|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
157021464|NCT02783300|566830883|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
157021465|NCT02783300|566830884|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
157021466|NCT02783300|566830885|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
157021467|NCT02783300|566830886|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
157144281|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Physician Decision|0|||
157144282|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Physician Decision|0|||
157144283|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Physician Decision|0|||
157144284|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Physician Decision|0|||
157144285|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Physician Decision|0|||
157144286|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Physician Decision|0|||
157144287|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Physician Decision|0|||
156806742|NCT01713582|566047488|FG009|Overall Study|Withdrawal of consent|1|||
156806743|NCT01713582|566047489|FG010|Overall Study|Withdrawal of consent|0|||
156806744|NCT01713582|566047490|FG011|Overall Study|Withdrawal of consent|0|||
156806745|NCT01713582|566047491|FG012|Overall Study|Withdrawal of consent|0|||
156806746|NCT01713582|566047492|FG013|Overall Study|Withdrawal of consent|0|||
156806747|NCT01713582|566047493|FG014|Overall Study|Withdrawal of consent|0|||
156806748|NCT01713582|566047494|FG015|Overall Study|Withdrawal of consent|0|||
156806749|NCT01713582|566047495|FG016|Overall Study|Withdrawal of consent|0|||
156806750|NCT01713582|566047496|FG017|Overall Study|Withdrawal of consent|0|||
156806751|NCT01713582|566047497|FG018|Overall Study|Withdrawal of consent|1|||
156806752|NCT01713582|566047498|FG019|Overall Study|Withdrawal of consent|0|||
156806753|NCT01713582|566047499|FG020|Overall Study|Withdrawal of consent|0|||
157144288|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Physician Decision|0|||
157144289|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Physician Decision|0|||
157144290|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Physician Decision|0|||
157144291|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Physician Decision|0|||
157144292|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Physician Decision|4|||
157144293|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Physician Decision|2|||
157144294|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Progressive disease|0|||
157144295|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Progressive disease|0|||
157144296|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Progressive disease|0|||
157144297|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Progressive disease|0|||
157144298|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Progressive disease|0|||
157144299|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Progressive disease|0|||
157144300|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Progressive disease|0|||
157144301|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Progressive disease|0|||
157144302|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Progressive disease|0|||
157144303|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Progressive disease|5|||
157144304|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Progressive disease|0|||
157144305|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Progressive disease|0|||
157144306|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Progressive disease|0|||
157144307|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Progressive disease|30|||
157144308|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Progressive disease|8|||
157144309|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144310|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144311|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144312|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144313|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144314|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144315|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144316|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144317|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144318|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144319|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144320|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144321|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
157144322|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
157144323|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
157144324|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144325|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144326|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144327|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144328|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144329|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144330|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144331|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144332|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144333|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
157144334|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144335|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144336|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
157144337|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
157144338|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
157144339|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144340|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144341|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144342|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144343|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144344|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144345|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144346|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144347|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
156806754|NCT01713582|566047479|FG000|Overall Study|Lack of Efficacy|0|||
156806755|NCT01713582|566047480|FG001|Overall Study|Lack of Efficacy|0|||
156806756|NCT01713582|566047481|FG002|Overall Study|Lack of Efficacy|0|||
156806757|NCT01713582|566047482|FG003|Overall Study|Lack of Efficacy|0|||
156806758|NCT01713582|566047483|FG004|Overall Study|Lack of Efficacy|0|||
156806759|NCT01713582|566047484|FG005|Overall Study|Lack of Efficacy|0|||
156806760|NCT01713582|566047485|FG006|Overall Study|Lack of Efficacy|0|||
156806761|NCT01713582|566047486|FG007|Overall Study|Lack of Efficacy|0|||
156806762|NCT01713582|566047487|FG008|Overall Study|Lack of Efficacy|0|||
156806763|NCT01713582|566047488|FG009|Overall Study|Lack of Efficacy|1|||
157021468|NCT02783300|566830887|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
157021469|NCT02783300|566830888|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
157021470|NCT02783300|566830889|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
157021471|NCT02783300|566830890|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
157021472|NCT02783300|566830891|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
157021473|NCT02783300|566830892|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
157144348|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
157144349|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144350|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
157221092|NCT01098240|567554967|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
157221093|NCT01098240|567554965|FG000|Double-Blind Phase|Protocol Violation|0|||
157221094|NCT01098240|567554966|FG001|Double-Blind Phase|Protocol Violation|2|||
157221095|NCT01098240|567554967|FG002|Double-Blind Phase|Protocol Violation|4|||
157221096|NCT01098240|567554965|FG000|Double-Blind Phase|Lost to Follow-up|0|||
157144351|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144352|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
157144353|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
157144354|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
157144355|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
157144356|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
157144357|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
157144358|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
157144359|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
157144360|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
157144361|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
157144362|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
157144363|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
157144364|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
157144365|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
157144366|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
157144367|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
157144368|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
157144369|NCT03519178|567276423|FG000|Fulvestrant. Treatment|Other|0|||
157144370|NCT03519178|567276424|FG001|Fulvestrant. Treatment|Other|0|||
157144371|NCT03519178|567276425|FG002|Fulvestrant. Treatment|Other|0|||
157144372|NCT03519178|567276426|FG003|Fulvestrant. Treatment|Other|0|||
157144373|NCT03519178|567276427|FG004|Fulvestrant. Treatment|Other|0|||
157144374|NCT03519178|567276428|FG005|Fulvestrant. Treatment|Other|0|||
157144375|NCT03519178|567276429|FG006|Fulvestrant. Treatment|Other|0|||
157144376|NCT03519178|567276430|FG007|Fulvestrant. Treatment|Other|0|||
157144377|NCT03519178|567276431|FG008|Fulvestrant. Treatment|Other|0|||
157144378|NCT03519178|567276432|FG009|Fulvestrant. Treatment|Other|0|||
157144379|NCT03519178|567276433|FG010|Fulvestrant. Treatment|Other|0|||
157221097|NCT01098240|567554966|FG001|Double-Blind Phase|Lost to Follow-up|2|||
157221098|NCT01098240|567554967|FG002|Double-Blind Phase|Lost to Follow-up|0|||
157221099|NCT01098240|567554965|FG000|Double-Blind Phase|Other|0|||
157221100|NCT01098240|567554966|FG001|Double-Blind Phase|Other|2|||
157221101|NCT01098240|567554967|FG002|Double-Blind Phase|Other|2|||
157221102|NCT01098240|567554965|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
157221103|NCT01098240|567554966|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
157221104|NCT01098240|567554967|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
157221105|NCT01098240|567554965|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
157221106|NCT01098240|567554966|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
157221107|NCT01098240|567554967|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
157221108|NCT01098240|567554965|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
157221109|NCT01098240|567554966|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
157221110|NCT01098240|567554967|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
157221111|NCT01098240|567554965|FG000|Double-Blind Phase|Adverse Event|0|||
157221112|NCT01098240|567554966|FG001|Double-Blind Phase|Adverse Event|3|||
157144380|NCT03519178|567276434|FG011|Fulvestrant. Treatment|Other|0|||
157144381|NCT03519178|567276435|FG012|Fulvestrant. Treatment|Other|0|||
157144382|NCT03519178|567276436|FG013|Fulvestrant. Treatment|Other|1|||
157144383|NCT03519178|567276437|FG014|Fulvestrant. Treatment|Other|3|||
157144384|NCT03519178|567276423|FG000|Letrozole Treatment|Physician Decision|0|||
157144385|NCT03519178|567276424|FG001|Letrozole Treatment|Physician Decision|0|||
157144386|NCT03519178|567276425|FG002|Letrozole Treatment|Physician Decision|0|||
157221113|NCT01098240|567554967|FG002|Double-Blind Phase|Adverse Event|3|||
157221114|NCT03705351|567556722|FG000|Overall Study|Study termination|3|||
157221115|NCT03705351|567556722|FG000|Overall Study|Death|1|||
157221116|NCT03705351|567556722|FG000|Overall Study|Lack of Efficacy|2|||
157221117|NCT03705351|567556722|FG000|Overall Study|Withdrawal by Subject|1|||
157221118|NCT00633152|567556727|FG000|Overall Study|Adverse Event|1|||
156806764|NCT01713582|566047489|FG010|Overall Study|Lack of Efficacy|2|||
157021474|NCT02783300|566830893|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
157021475|NCT02783300|566830894|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
157021476|NCT02783300|566830895|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
157144387|NCT03519178|567276426|FG003|Letrozole Treatment|Physician Decision|0|||
157144388|NCT03519178|567276427|FG004|Letrozole Treatment|Physician Decision|0|||
157144389|NCT03519178|567276428|FG005|Letrozole Treatment|Physician Decision|0|||
157144390|NCT03519178|567276429|FG006|Letrozole Treatment|Physician Decision|0|||
157144391|NCT03519178|567276430|FG007|Letrozole Treatment|Physician Decision|0|||
157144392|NCT03519178|567276431|FG008|Letrozole Treatment|Physician Decision|0|||
157144393|NCT03519178|567276432|FG009|Letrozole Treatment|Physician Decision|0|||
157144394|NCT03519178|567276433|FG010|Letrozole Treatment|Physician Decision|1|||
157144395|NCT03519178|567276434|FG011|Letrozole Treatment|Physician Decision|0|||
157144396|NCT03519178|567276435|FG012|Letrozole Treatment|Physician Decision|0|||
157144397|NCT03519178|567276436|FG013|Letrozole Treatment|Physician Decision|0|||
157144398|NCT03519178|567276437|FG014|Letrozole Treatment|Physician Decision|0|||
157144399|NCT03519178|567276423|FG000|Letrozole Treatment|Progressive disease|0|||
157144400|NCT03519178|567276424|FG001|Letrozole Treatment|Progressive disease|0|||
157144401|NCT03519178|567276425|FG002|Letrozole Treatment|Progressive disease|0|||
157144402|NCT03519178|567276426|FG003|Letrozole Treatment|Progressive disease|0|||
157144403|NCT03519178|567276427|FG004|Letrozole Treatment|Progressive disease|0|||
157144404|NCT03519178|567276428|FG005|Letrozole Treatment|Progressive disease|0|||
157144405|NCT03519178|567276429|FG006|Letrozole Treatment|Progressive disease|0|||
157144406|NCT03519178|567276430|FG007|Letrozole Treatment|Progressive disease|0|||
157144407|NCT03519178|567276431|FG008|Letrozole Treatment|Progressive disease|0|||
157144408|NCT03519178|567276432|FG009|Letrozole Treatment|Progressive disease|0|||
157144409|NCT03519178|567276433|FG010|Letrozole Treatment|Progressive disease|4|||
157144410|NCT03519178|567276434|FG011|Letrozole Treatment|Progressive disease|0|||
157144411|NCT03519178|567276435|FG012|Letrozole Treatment|Progressive disease|0|||
157144412|NCT03519178|567276436|FG013|Letrozole Treatment|Progressive disease|0|||
157144413|NCT03519178|567276437|FG014|Letrozole Treatment|Progressive disease|0|||
157144414|NCT03519178|567276423|FG000|Letrozole Treatment|Global deterioration of health status|0|||
157144415|NCT03519178|567276424|FG001|Letrozole Treatment|Global deterioration of health status|0|||
157144416|NCT03519178|567276425|FG002|Letrozole Treatment|Global deterioration of health status|0|||
157144417|NCT03519178|567276426|FG003|Letrozole Treatment|Global deterioration of health status|0|||
157144418|NCT03519178|567276427|FG004|Letrozole Treatment|Global deterioration of health status|0|||
157144419|NCT03519178|567276428|FG005|Letrozole Treatment|Global deterioration of health status|0|||
157144420|NCT03519178|567276429|FG006|Letrozole Treatment|Global deterioration of health status|0|||
156882416|NCT03158285|566329437|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
156882417|NCT03158285|566329438|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
156882418|NCT03158285|566329436|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
156882419|NCT03158285|566329437|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
156882420|NCT03158285|566329438|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
156882421|NCT03158285|566329436|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
156882422|NCT03158285|566329437|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
156882423|NCT03158285|566329438|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
156882424|NCT03158285|566329436|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
156882425|NCT03158285|566329437|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
156882426|NCT03158285|566329438|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
156882427|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
156882428|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
156882429|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
156882430|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
156882431|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
156882432|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
156882433|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
156882434|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
156882435|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
156882436|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
156882437|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
156882438|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
157144421|NCT03519178|567276430|FG007|Letrozole Treatment|Global deterioration of health status|0|||
157144422|NCT03519178|567276431|FG008|Letrozole Treatment|Global deterioration of health status|0|||
157144423|NCT03519178|567276432|FG009|Letrozole Treatment|Global deterioration of health status|0|||
157144424|NCT03519178|567276433|FG010|Letrozole Treatment|Global deterioration of health status|2|||
157221119|NCT00633152|567556728|FG001|Overall Study|Adverse Event|0|||
156882439|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Death|1|||
156882440|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Death|0|||
157144425|NCT03519178|567276434|FG011|Letrozole Treatment|Global deterioration of health status|0|||
157144426|NCT03519178|567276435|FG012|Letrozole Treatment|Global deterioration of health status|0|||
156806765|NCT01713582|566047490|FG011|Overall Study|Lack of Efficacy|0|||
156806766|NCT01713582|566047491|FG012|Overall Study|Lack of Efficacy|0|||
156806767|NCT01713582|566047492|FG013|Overall Study|Lack of Efficacy|0|||
157144427|NCT03519178|567276436|FG013|Letrozole Treatment|Global deterioration of health status|0|||
157144428|NCT03519178|567276437|FG014|Letrozole Treatment|Global deterioration of health status|0|||
157144429|NCT03519178|567276423|FG000|Follow-Up|Death|0|||
156806768|NCT01713582|566047493|FG014|Overall Study|Lack of Efficacy|0|||
156806769|NCT01713582|566047494|FG015|Overall Study|Lack of Efficacy|0|||
156806770|NCT01713582|566047495|FG016|Overall Study|Lack of Efficacy|0|||
156806771|NCT01713582|566047496|FG017|Overall Study|Lack of Efficacy|0|||
156806772|NCT01713582|566047497|FG018|Overall Study|Lack of Efficacy|0|||
156806773|NCT01713582|566047498|FG019|Overall Study|Lack of Efficacy|0|||
156806774|NCT01713582|566047499|FG020|Overall Study|Lack of Efficacy|0|||
156806775|NCT01713582|566047479|FG000|Overall Study|Withdrawal by Subject|0|||
156806776|NCT01713582|566047480|FG001|Overall Study|Withdrawal by Subject|0|||
156806777|NCT01713582|566047481|FG002|Overall Study|Withdrawal by Subject|0|||
156806778|NCT01713582|566047482|FG003|Overall Study|Withdrawal by Subject|0|||
156806779|NCT01713582|566047483|FG004|Overall Study|Withdrawal by Subject|0|||
156806780|NCT01713582|566047484|FG005|Overall Study|Withdrawal by Subject|0|||
156806781|NCT01713582|566047485|FG006|Overall Study|Withdrawal by Subject|0|||
156806782|NCT01713582|566047486|FG007|Overall Study|Withdrawal by Subject|0|||
156806783|NCT01713582|566047487|FG008|Overall Study|Withdrawal by Subject|0|||
156806784|NCT01713582|566047488|FG009|Overall Study|Withdrawal by Subject|0|||
156806785|NCT01713582|566047489|FG010|Overall Study|Withdrawal by Subject|0|||
156806786|NCT01713582|566047490|FG011|Overall Study|Withdrawal by Subject|0|||
156806787|NCT01713582|566047491|FG012|Overall Study|Withdrawal by Subject|0|||
156806788|NCT01713582|566047492|FG013|Overall Study|Withdrawal by Subject|0|||
156806789|NCT01713582|566047493|FG014|Overall Study|Withdrawal by Subject|0|||
156806790|NCT01713582|566047494|FG015|Overall Study|Withdrawal by Subject|0|||
156806791|NCT01713582|566047495|FG016|Overall Study|Withdrawal by Subject|0|||
156806792|NCT01713582|566047496|FG017|Overall Study|Withdrawal by Subject|1|||
156806793|NCT01713582|566047497|FG018|Overall Study|Withdrawal by Subject|0|||
156806794|NCT01713582|566047498|FG019|Overall Study|Withdrawal by Subject|0|||
156806795|NCT01713582|566047499|FG020|Overall Study|Withdrawal by Subject|0|||
156806796|NCT01713582|566047479|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
156806797|NCT01713582|566047480|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
156806798|NCT01713582|566047481|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
156806799|NCT01713582|566047482|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
156806800|NCT01713582|566047483|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
156806801|NCT01713582|566047484|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
156806802|NCT01713582|566047485|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
156806803|NCT01713582|566047486|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
156806804|NCT01713582|566047487|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
156806805|NCT01713582|566047488|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
156806806|NCT01713582|566047489|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
156806807|NCT01713582|566047490|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
156806808|NCT01713582|566047491|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
156806809|NCT01713582|566047492|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
156806810|NCT01713582|566047493|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
156806811|NCT01713582|566047494|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
156806812|NCT01713582|566047495|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
156806813|NCT01713582|566047496|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
156806814|NCT01713582|566047497|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
156806815|NCT01713582|566047498|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
156806816|NCT01713582|566047499|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
156806817|NCT01713582|566047479|FG000|Overall Study|Disease progression and adverse event|0|||
156806818|NCT01713582|566047480|FG001|Overall Study|Disease progression and adverse event|0|||
156806819|NCT01713582|566047481|FG002|Overall Study|Disease progression and adverse event|0|||
156806820|NCT01713582|566047482|FG003|Overall Study|Disease progression and adverse event|0|||
156806821|NCT01713582|566047483|FG004|Overall Study|Disease progression and adverse event|0|||
156806822|NCT01713582|566047484|FG005|Overall Study|Disease progression and adverse event|0|||
156806823|NCT01713582|566047485|FG006|Overall Study|Disease progression and adverse event|0|||
156806824|NCT01713582|566047486|FG007|Overall Study|Disease progression and adverse event|0|||
156806825|NCT01713582|566047487|FG008|Overall Study|Disease progression and adverse event|0|||
156806826|NCT01713582|566047488|FG009|Overall Study|Disease progression and adverse event|0|||
156806827|NCT01713582|566047489|FG010|Overall Study|Disease progression and adverse event|0|||
156806828|NCT01713582|566047490|FG011|Overall Study|Disease progression and adverse event|0|||
156806829|NCT01713582|566047491|FG012|Overall Study|Disease progression and adverse event|0|||
156806830|NCT01713582|566047492|FG013|Overall Study|Disease progression and adverse event|0|||
156806831|NCT01713582|566047493|FG014|Overall Study|Disease progression and adverse event|0|||
157144430|NCT03519178|567276424|FG001|Follow-Up|Death|0|||
157144431|NCT03519178|567276425|FG002|Follow-Up|Death|0|||
157144432|NCT03519178|567276426|FG003|Follow-Up|Death|0|||
157144433|NCT03519178|567276427|FG004|Follow-Up|Death|0|||
157144434|NCT03519178|567276428|FG005|Follow-Up|Death|0|||
157144435|NCT03519178|567276429|FG006|Follow-Up|Death|0|||
157144436|NCT03519178|567276430|FG007|Follow-Up|Death|0|||
157144437|NCT03519178|567276431|FG008|Follow-Up|Death|3|||
157144438|NCT03519178|567276432|FG009|Follow-Up|Death|1|||
157144439|NCT03519178|567276433|FG010|Follow-Up|Death|0|||
157144440|NCT03519178|567276434|FG011|Follow-Up|Death|0|||
157144441|NCT03519178|567276435|FG012|Follow-Up|Death|2|||
157144442|NCT03519178|567276436|FG013|Follow-Up|Death|0|||
157144443|NCT03519178|567276437|FG014|Follow-Up|Death|0|||
157144444|NCT03519178|567276423|FG000|Follow-Up|Lost to Follow-up|0|||
157144445|NCT03519178|567276424|FG001|Follow-Up|Lost to Follow-up|0|||
157144446|NCT03519178|567276425|FG002|Follow-Up|Lost to Follow-up|0|||
157144447|NCT03519178|567276426|FG003|Follow-Up|Lost to Follow-up|0|||
157144448|NCT03519178|567276427|FG004|Follow-Up|Lost to Follow-up|0|||
157144449|NCT03519178|567276428|FG005|Follow-Up|Lost to Follow-up|3|||
157144450|NCT03519178|567276429|FG006|Follow-Up|Lost to Follow-up|1|||
157144451|NCT03519178|567276430|FG007|Follow-Up|Lost to Follow-up|4|||
157144452|NCT03519178|567276431|FG008|Follow-Up|Lost to Follow-up|1|||
157144453|NCT03519178|567276432|FG009|Follow-Up|Lost to Follow-up|0|||
157144454|NCT03519178|567276433|FG010|Follow-Up|Lost to Follow-up|0|||
157144455|NCT03519178|567276434|FG011|Follow-Up|Lost to Follow-up|0|||
157144456|NCT03519178|567276435|FG012|Follow-Up|Lost to Follow-up|0|||
157144457|NCT03519178|567276436|FG013|Follow-Up|Lost to Follow-up|0|||
157144458|NCT03519178|567276437|FG014|Follow-Up|Lost to Follow-up|0|||
157144459|NCT03519178|567276423|FG000|Follow-Up|Withdrawal by Subject|1|||
157144460|NCT03519178|567276424|FG001|Follow-Up|Withdrawal by Subject|2|||
157144461|NCT03519178|567276425|FG002|Follow-Up|Withdrawal by Subject|2|||
157144462|NCT03519178|567276426|FG003|Follow-Up|Withdrawal by Subject|3|||
157144463|NCT03519178|567276427|FG004|Follow-Up|Withdrawal by Subject|5|||
157144464|NCT03519178|567276428|FG005|Follow-Up|Withdrawal by Subject|1|||
157144465|NCT03519178|567276429|FG006|Follow-Up|Withdrawal by Subject|2|||
157144466|NCT03519178|567276430|FG007|Follow-Up|Withdrawal by Subject|6|||
157144467|NCT03519178|567276431|FG008|Follow-Up|Withdrawal by Subject|5|||
157144468|NCT03519178|567276432|FG009|Follow-Up|Withdrawal by Subject|2|||
157144469|NCT03519178|567276433|FG010|Follow-Up|Withdrawal by Subject|3|||
157144470|NCT03519178|567276434|FG011|Follow-Up|Withdrawal by Subject|5|||
157144471|NCT03519178|567276435|FG012|Follow-Up|Withdrawal by Subject|2|||
157144472|NCT03519178|567276436|FG013|Follow-Up|Withdrawal by Subject|0|||
157144473|NCT03519178|567276437|FG014|Follow-Up|Withdrawal by Subject|0|||
157144474|NCT03519178|567276423|FG000|Follow-Up|Other|0|||
157144475|NCT03519178|567276424|FG001|Follow-Up|Other|0|||
157144476|NCT03519178|567276425|FG002|Follow-Up|Other|0|||
157144477|NCT03519178|567276426|FG003|Follow-Up|Other|0|||
157144478|NCT03519178|567276427|FG004|Follow-Up|Other|0|||
157144479|NCT03519178|567276428|FG005|Follow-Up|Other|0|||
157144480|NCT03519178|567276429|FG006|Follow-Up|Other|0|||
157144481|NCT03519178|567276430|FG007|Follow-Up|Other|1|||
157144482|NCT03519178|567276431|FG008|Follow-Up|Other|0|||
157144483|NCT03519178|567276432|FG009|Follow-Up|Other|0|||
157144484|NCT03519178|567276433|FG010|Follow-Up|Other|0|||
157144485|NCT03519178|567276434|FG011|Follow-Up|Other|0|||
157144486|NCT03519178|567276435|FG012|Follow-Up|Other|0|||
157144487|NCT03519178|567276436|FG013|Follow-Up|Other|0|||
156806832|NCT01713582|566047494|FG015|Overall Study|Disease progression and adverse event|0|||
156806833|NCT01713582|566047495|FG016|Overall Study|Disease progression and adverse event|1|||
156806834|NCT01713582|566047496|FG017|Overall Study|Disease progression and adverse event|0|||
157144488|NCT03519178|567276437|FG014|Follow-Up|Other|0|||
157144489|NCT03519178|567276423|FG000|Long-term Follow-up|Death|0|||
157144490|NCT03519178|567276424|FG001|Long-term Follow-up|Death|0|||
157144491|NCT03519178|567276425|FG002|Long-term Follow-up|Death|0|||
157144492|NCT03519178|567276426|FG003|Long-term Follow-up|Death|0|||
157144493|NCT03519178|567276427|FG004|Long-term Follow-up|Death|0|||
157144494|NCT03519178|567276428|FG005|Long-term Follow-up|Death|0|||
157144495|NCT03519178|567276429|FG006|Long-term Follow-up|Death|0|||
157144496|NCT03519178|567276430|FG007|Long-term Follow-up|Death|0|||
157144497|NCT03519178|567276431|FG008|Long-term Follow-up|Death|0|||
157144498|NCT03519178|567276432|FG009|Long-term Follow-up|Death|0|||
157144499|NCT03519178|567276433|FG010|Long-term Follow-up|Death|0|||
156806835|NCT01713582|566047497|FG018|Overall Study|Disease progression and adverse event|0|||
157144500|NCT03519178|567276434|FG011|Long-term Follow-up|Death|0|||
157144501|NCT03519178|567276435|FG012|Long-term Follow-up|Death|0|||
157144502|NCT03519178|567276436|FG013|Long-term Follow-up|Death|4|||
157144503|NCT03519178|567276437|FG014|Long-term Follow-up|Death|4|||
157144504|NCT03519178|567276423|FG000|Long-term Follow-up|Lost to Follow-up|0|||
157144505|NCT03519178|567276424|FG001|Long-term Follow-up|Lost to Follow-up|0|||
157144506|NCT03519178|567276425|FG002|Long-term Follow-up|Lost to Follow-up|0|||
157144507|NCT03519178|567276426|FG003|Long-term Follow-up|Lost to Follow-up|0|||
157144508|NCT03519178|567276427|FG004|Long-term Follow-up|Lost to Follow-up|0|||
157144509|NCT03519178|567276428|FG005|Long-term Follow-up|Lost to Follow-up|0|||
157144510|NCT03519178|567276429|FG006|Long-term Follow-up|Lost to Follow-up|0|||
157144511|NCT03519178|567276430|FG007|Long-term Follow-up|Lost to Follow-up|0|||
157144512|NCT03519178|567276431|FG008|Long-term Follow-up|Lost to Follow-up|0|||
157144513|NCT03519178|567276432|FG009|Long-term Follow-up|Lost to Follow-up|0|||
157144514|NCT03519178|567276433|FG010|Long-term Follow-up|Lost to Follow-up|0|||
157144515|NCT03519178|567276434|FG011|Long-term Follow-up|Lost to Follow-up|0|||
157144516|NCT03519178|567276435|FG012|Long-term Follow-up|Lost to Follow-up|0|||
157144517|NCT03519178|567276436|FG013|Long-term Follow-up|Lost to Follow-up|1|||
157144518|NCT03519178|567276437|FG014|Long-term Follow-up|Lost to Follow-up|1|||
157144519|NCT03519178|567276423|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
157144520|NCT03519178|567276424|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
157144521|NCT03519178|567276425|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
157144522|NCT03519178|567276426|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
157144523|NCT03519178|567276427|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
157144524|NCT03519178|567276428|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
157144525|NCT03519178|567276429|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
157144526|NCT03519178|567276430|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
157144527|NCT03519178|567276431|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
157144528|NCT03519178|567276432|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
157144529|NCT03519178|567276433|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
157144530|NCT03519178|567276434|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
157144531|NCT03519178|567276435|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
157144532|NCT03519178|567276436|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
157144533|NCT03519178|567276437|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
157144534|NCT03519178|567276423|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
157144535|NCT03519178|567276424|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
157144536|NCT03519178|567276425|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
157144537|NCT03519178|567276426|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
157144538|NCT03519178|567276427|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
157144539|NCT03519178|567276428|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
157144540|NCT03519178|567276429|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
157144541|NCT03519178|567276430|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
157144542|NCT03519178|567276431|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
157144543|NCT03519178|567276432|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
157144544|NCT03519178|567276433|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
157144545|NCT03519178|567276434|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
157144546|NCT03519178|567276435|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
157144547|NCT03519178|567276436|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
157144548|NCT03519178|567276437|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
157144549|NCT03519178|567276423|FG000|Long-term Follow-up|Other|0|||
157144550|NCT03519178|567276424|FG001|Long-term Follow-up|Other|0|||
157144551|NCT03519178|567276425|FG002|Long-term Follow-up|Other|0|||
157144552|NCT03519178|567276426|FG003|Long-term Follow-up|Other|0|||
157144553|NCT03519178|567276427|FG004|Long-term Follow-up|Other|0|||
157144554|NCT03519178|567276428|FG005|Long-term Follow-up|Other|0|||
157144555|NCT03519178|567276429|FG006|Long-term Follow-up|Other|0|||
157144556|NCT03519178|567276430|FG007|Long-term Follow-up|Other|0|||
157144557|NCT03519178|567276431|FG008|Long-term Follow-up|Other|0|||
157144558|NCT03519178|567276432|FG009|Long-term Follow-up|Other|0|||
157144559|NCT03519178|567276433|FG010|Long-term Follow-up|Other|0|||
157144560|NCT03519178|567276434|FG011|Long-term Follow-up|Other|0|||
157144561|NCT03519178|567276435|FG012|Long-term Follow-up|Other|0|||
157144562|NCT03519178|567276436|FG013|Long-term Follow-up|Other|0|||
157144563|NCT03519178|567276437|FG014|Long-term Follow-up|Other|1|||
157144564|NCT03519178|567276423|FG000|Long-term Follow-up|Global deterioration of health status|0|||
157144565|NCT03519178|567276424|FG001|Long-term Follow-up|Global deterioration of health status|0|||
157144566|NCT03519178|567276425|FG002|Long-term Follow-up|Global deterioration of health status|0|||
156882441|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Death|0|||
156882442|NCT03158285|566329436|FG000|Active Treatment Period: Week 52-100|Other|4|||
156882443|NCT03158285|566329437|FG001|Active Treatment Period: Week 52-100|Other|1|||
156882444|NCT03158285|566329438|FG002|Active Treatment Period: Week 52-100|Other|0|||
156882445|NCT00946153|566329441|FG000|Phase 2|Adverse Event|0|||
156882446|NCT00946153|566329442|FG001|Phase 2|Adverse Event|0|||
156882447|NCT00946153|566329443|FG002|Phase 2|Adverse Event|0|||
157144567|NCT03519178|567276426|FG003|Long-term Follow-up|Global deterioration of health status|0|||
157144568|NCT03519178|567276427|FG004|Long-term Follow-up|Global deterioration of health status|0|||
157144569|NCT03519178|567276428|FG005|Long-term Follow-up|Global deterioration of health status|0|||
157144570|NCT03519178|567276429|FG006|Long-term Follow-up|Global deterioration of health status|0|||
157144571|NCT03519178|567276430|FG007|Long-term Follow-up|Global deterioration of health status|0|||
157144572|NCT03519178|567276431|FG008|Long-term Follow-up|Global deterioration of health status|0|||
157144573|NCT03519178|567276432|FG009|Long-term Follow-up|Global deterioration of health status|0|||
156882448|NCT00946153|566329444|FG003|Phase 2|Adverse Event|0|||
157144574|NCT03519178|567276433|FG010|Long-term Follow-up|Global deterioration of health status|0|||
157144575|NCT03519178|567276434|FG011|Long-term Follow-up|Global deterioration of health status|0|||
157144576|NCT03519178|567276435|FG012|Long-term Follow-up|Global deterioration of health status|0|||
157144577|NCT03519178|567276436|FG013|Long-term Follow-up|Global deterioration of health status|1|||
157144578|NCT03519178|567276437|FG014|Long-term Follow-up|Global deterioration of health status|0|||
157144579|NCT03256539|567276442|FG000|Overall Study|Withdrawal by Subject|0|||
157144580|NCT03256539|567276443|FG001|Overall Study|Withdrawal by Subject|3|||
157144581|NCT03256539|567276442|FG000|Overall Study|Unexpected closure of study components|8|||
157144582|NCT03256539|567276443|FG001|Overall Study|Unexpected closure of study components|4|||
157144583|NCT01919411|567276457|FG000|Overall Study|Lost to Follow-up|2|||
157144584|NCT01919411|567276458|FG001|Overall Study|Lost to Follow-up|4|||
157144585|NCT01919411|567276457|FG000|Overall Study|Physician Decision|1|||
157144586|NCT01919411|567276458|FG001|Overall Study|Physician Decision|0|||
157144587|NCT01919411|567276457|FG000|Overall Study|Protocol Violation|2|||
157144588|NCT01919411|567276458|FG001|Overall Study|Protocol Violation|1|||
157144589|NCT00144300|567276459|FG000|Overall Study|Adverse Event|18|||
157144590|NCT00144300|567276460|FG001|Overall Study|Adverse Event|16|||
157144591|NCT00144300|567276459|FG000|Overall Study|Protocol Violation|1|||
157144592|NCT00144300|567276460|FG001|Overall Study|Protocol Violation|3|||
157144593|NCT00144300|567276459|FG000|Overall Study|Lost to Follow-up|3|||
157144594|NCT00144300|567276460|FG001|Overall Study|Lost to Follow-up|0|||
157144595|NCT00144300|567276459|FG000|Overall Study|Withdrawal by Subject|6|||
157144596|NCT00144300|567276460|FG001|Overall Study|Withdrawal by Subject|6|||
157144597|NCT00144300|567276459|FG000|Overall Study|Other reason (not specified)|1|||
157144598|NCT00144300|567276460|FG001|Overall Study|Other reason (not specified)|3|||
157144599|NCT00095121|567276461|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
157144600|NCT00095121|567276462|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
157144601|NCT00095121|567276461|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
157144602|NCT00095121|567276462|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
157144603|NCT04636177|567276466|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
157144604|NCT04636177|567276467|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
157144605|NCT04636177|567276466|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
157144606|NCT04636177|567276467|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
157144607|NCT04636177|567276466|FG000|Single-arm portion|Withdrawal by Subject|1|||
157144608|NCT04636177|567276467|FG001|Single-arm portion|Withdrawal by Subject|0|||
157144609|NCT04636177|567276466|FG000|Single-arm portion|Adverse Event|1|||
157144610|NCT04636177|567276467|FG001|Single-arm portion|Adverse Event|0|||
157144611|NCT02495077|567277885|FG000|Overall Study|Adverse Event|0|||
157144612|NCT02495077|567277886|FG001|Overall Study|Adverse Event|1|||
157144613|NCT02495077|567277887|FG002|Overall Study|Adverse Event|1|||
157144614|NCT02495077|567277888|FG003|Overall Study|Adverse Event|0|||
157144615|NCT02495077|567277885|FG000|Overall Study|Death|3|||
157144616|NCT02495077|567277886|FG001|Overall Study|Death|5|||
157144617|NCT02495077|567277887|FG002|Overall Study|Death|0|||
157144618|NCT02495077|567277888|FG003|Overall Study|Death|0|||
157144619|NCT02495077|567277885|FG000|Overall Study|Lost to Follow-up|6|||
157144620|NCT02495077|567277886|FG001|Overall Study|Lost to Follow-up|4|||
157144621|NCT02495077|567277887|FG002|Overall Study|Lost to Follow-up|0|||
157144622|NCT02495077|567277888|FG003|Overall Study|Lost to Follow-up|0|||
157144623|NCT02495077|567277885|FG000|Overall Study|Physician Decision|2|||
157144624|NCT02495077|567277886|FG001|Overall Study|Physician Decision|1|||
157144625|NCT02495077|567277887|FG002|Overall Study|Physician Decision|4|||
157144626|NCT02495077|567277888|FG003|Overall Study|Physician Decision|0|||
157144627|NCT02495077|567277885|FG000|Overall Study|Protocol Violation|0|||
157144628|NCT02495077|567277886|FG001|Overall Study|Protocol Violation|1|||
157144629|NCT02495077|567277887|FG002|Overall Study|Protocol Violation|0|||
157144630|NCT02495077|567277888|FG003|Overall Study|Protocol Violation|0|||
157144631|NCT02495077|567277885|FG000|Overall Study|Screen Failure|0|||
157144632|NCT02495077|567277886|FG001|Overall Study|Screen Failure|0|||
157144633|NCT02495077|567277887|FG002|Overall Study|Screen Failure|0|||
157144634|NCT02495077|567277888|FG003|Overall Study|Screen Failure|48|||
157144635|NCT02495077|567277885|FG000|Overall Study|Withdrawal by Subject|7|||
157144636|NCT02495077|567277886|FG001|Overall Study|Withdrawal by Subject|7|||
157144637|NCT02495077|567277887|FG002|Overall Study|Withdrawal by Subject|7|||
157144638|NCT02495077|567277888|FG003|Overall Study|Withdrawal by Subject|0|||
157221120|NCT00633152|567556727|FG000|Overall Study|Randomized, did not receive study drug|5|||
157144639|NCT02495077|567277885|FG000|Overall Study|Covid-19 research restrictions|1|||
157144640|NCT02495077|567277886|FG001|Overall Study|Covid-19 research restrictions|0|||
157144641|NCT02495077|567277887|FG002|Overall Study|Covid-19 research restrictions|0|||
157221121|NCT00633152|567556728|FG001|Overall Study|Randomized, did not receive study drug|2|||
157221122|NCT00633152|567556727|FG000|Overall Study|Withdrawal by Subject|1|||
157144642|NCT02495077|567277888|FG003|Overall Study|Covid-19 research restrictions|0|||
157144643|NCT02495077|567277885|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
157144644|NCT02495077|567277886|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
157144645|NCT02495077|567277887|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
157144646|NCT02495077|567277888|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
157144647|NCT02495077|567277885|FG000|Overall Study|Incarcerated|0|||
157144648|NCT02495077|567277886|FG001|Overall Study|Incarcerated|1|||
157144649|NCT02495077|567277887|FG002|Overall Study|Incarcerated|0|||
157144650|NCT02495077|567277888|FG003|Overall Study|Incarcerated|0|||
156806836|NCT01713582|566047498|FG019|Overall Study|Disease progression and adverse event|0|||
156806837|NCT01713582|566047499|FG020|Overall Study|Disease progression and adverse event|0|||
156806838|NCT04776161|566047501|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
156806839|NCT04776161|566047502|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
156806840|NCT04776161|566047503|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
156806841|NCT04776161|566047501|FG000|Overall Study|Withdrawal by Subject|1|||
156882449|NCT00946153|566329445|FG004|Phase 2|Adverse Event|6|||
156882450|NCT00946153|566329441|FG000|Phase 2|Need more reduction of dose|0|||
157144651|NCT02495077|567277885|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
157144652|NCT02495077|567277886|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
157144653|NCT02495077|567277887|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
157144654|NCT02495077|567277888|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
157144655|NCT02495077|567277885|FG000|Overall Study|Timing of transplant and randomization|0|||
157144656|NCT02495077|567277886|FG001|Overall Study|Timing of transplant and randomization|0|||
157144657|NCT02495077|567277887|FG002|Overall Study|Timing of transplant and randomization|5|||
157144658|NCT02495077|567277888|FG003|Overall Study|Timing of transplant and randomization|0|||
157144659|NCT02742649|567277889|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
157144660|NCT02742649|567277890|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
157144661|NCT02742649|567277891|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
157144662|NCT02742649|567277892|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
157144663|NCT02742649|567277893|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
157144664|NCT02742649|567277889|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157144665|NCT02742649|567277890|FG001|Double-Blind Treatment Period|Adverse Event|1|||
157144666|NCT02742649|567277891|FG002|Double-Blind Treatment Period|Adverse Event|0|||
157144667|NCT02742649|567277892|FG003|Double-Blind Treatment Period|Adverse Event|0|||
157144668|NCT02742649|567277893|FG004|Double-Blind Treatment Period|Adverse Event|0|||
157144669|NCT02742649|567277889|FG000|Open-Label Period|Lost to Follow-up|0|||
157144670|NCT02742649|567277890|FG001|Open-Label Period|Lost to Follow-up|0|||
157144671|NCT02742649|567277891|FG002|Open-Label Period|Lost to Follow-up|0|||
157144672|NCT02742649|567277892|FG003|Open-Label Period|Lost to Follow-up|0|||
157144673|NCT02742649|567277893|FG004|Open-Label Period|Lost to Follow-up|1|||
157144674|NCT00443560|567277894|FG000|Overall Study|No intrathecal dose|58|||
157144675|NCT00443560|567277895|FG001|Overall Study|No intrathecal dose|26|||
157144676|NCT00443560|567277894|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
157144677|NCT00443560|567277895|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
157144678|NCT01059812|567277898|FG000|Overall Study|Adverse Event|9|||
157144679|NCT01059812|567277899|FG001|Overall Study|Adverse Event|5|||
157144680|NCT01059812|567277898|FG000|Overall Study|Lack of Efficacy|2|||
157144681|NCT01059812|567277899|FG001|Overall Study|Lack of Efficacy|2|||
157144682|NCT01059812|567277898|FG000|Overall Study|Protocol Violation|3|||
157144683|NCT01059812|567277899|FG001|Overall Study|Protocol Violation|1|||
157144684|NCT01059812|567277898|FG000|Overall Study|Withdrawal Criteria|9|||
157144685|NCT01059812|567277899|FG001|Overall Study|Withdrawal Criteria|4|||
157144686|NCT01059812|567277898|FG000|Overall Study|Unclassified|14|||
157144687|NCT01059812|567277899|FG001|Overall Study|Unclassified|4|||
157144688|NCT00756002|567277903|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
157144689|NCT00756002|567277904|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
157144690|NCT00756002|567277903|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
157144691|NCT00756002|567277904|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
157144692|NCT00756002|567277903|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
157144693|NCT00756002|567277904|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
157144694|NCT00756002|567277903|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
157144695|NCT00756002|567277904|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
157144696|NCT00756002|567277903|FG000|Double-Blind Treatment Period|Other|2|||
157144697|NCT00756002|567277904|FG001|Double-Blind Treatment Period|Other|2|||
157144698|NCT04329923|567277908|FG000|Overall Study|Withdrawal by Subject|1|||
157144699|NCT04329923|567277909|FG001|Overall Study|Withdrawal by Subject|4|||
157144700|NCT04329923|567277910|FG002|Overall Study|Withdrawal by Subject|1|||
157144701|NCT04329923|567277911|FG003|Overall Study|Withdrawal by Subject|1|||
157144702|NCT04329923|567277912|FG004|Overall Study|Withdrawal by Subject|1|||
157144703|NCT04329923|567277913|FG005|Overall Study|Withdrawal by Subject|1|||
156806842|NCT04776161|566047502|FG001|Overall Study|Withdrawal by Subject|0|||
156882451|NCT00946153|566329442|FG001|Phase 2|Need more reduction of dose|0|||
157144704|NCT04329923|567277908|FG000|Overall Study|early termination of study|0|||
157144705|NCT04329923|567277909|FG001|Overall Study|early termination of study|0|||
157144706|NCT04329923|567277910|FG002|Overall Study|early termination of study|0|||
157144707|NCT04329923|567277911|FG003|Overall Study|early termination of study|0|||
157144708|NCT04329923|567277912|FG004|Overall Study|early termination of study|1|||
157144709|NCT04329923|567277913|FG005|Overall Study|early termination of study|2|||
157144710|NCT04329923|567277908|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
157144711|NCT04329923|567277909|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
156806843|NCT04776161|566047503|FG002|Overall Study|Withdrawal by Subject|1|||
157144712|NCT04329923|567277910|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
157144713|NCT04329923|567277911|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
157144714|NCT04329923|567277912|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
157144715|NCT04329923|567277913|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
157144716|NCT03334214|567277914|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
157144717|NCT03334214|567277915|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
157144718|NCT03334214|567277914|FG000|Overall Study|Withdrawal by Subject|0|||
157144719|NCT03334214|567277915|FG001|Overall Study|Withdrawal by Subject|1|||
157144720|NCT03334214|567277914|FG000|Overall Study|Other|1|||
157144721|NCT03334214|567277915|FG001|Overall Study|Other|0|||
157144722|NCT01260181|567277920|FG000|Overall Study|Decision of Investigator|1|||
157144723|NCT01844076|567277921|FG000|Overall Study|Adverse Event|1|||
157144724|NCT01844076|567277922|FG001|Overall Study|Adverse Event|0|||
157144725|NCT01844076|567277923|FG002|Overall Study|Adverse Event|0|||
157144726|NCT01844076|567277924|FG003|Overall Study|Adverse Event|0|||
157144727|NCT01844076|567277921|FG000|Overall Study|Withdrawal by Subject|1|||
157144728|NCT01844076|567277922|FG001|Overall Study|Withdrawal by Subject|0|||
157144729|NCT01844076|567277923|FG002|Overall Study|Withdrawal by Subject|0|||
157144730|NCT01844076|567277924|FG003|Overall Study|Withdrawal by Subject|0|||
157144731|NCT02088034|567277929|FG000|Overall Study|Lost to Follow-up|1|||
157144732|NCT02088034|567277930|FG001|Overall Study|Lost to Follow-up|1|||
157144733|NCT02088034|567277931|FG002|Overall Study|Lost to Follow-up|0|||
156806844|NCT04776161|566047501|FG000|Overall Study|Adverse Event|0|||
156806845|NCT04776161|566047502|FG001|Overall Study|Adverse Event|1|||
156806846|NCT04776161|566047503|FG002|Overall Study|Adverse Event|1|||
156806847|NCT00342628|566047504|FG000|Overall Study|Withdrawal by Subject|19|||
156806848|NCT00342628|566047505|FG001|Overall Study|Withdrawal by Subject|19|||
156806849|NCT00342628|566047506|FG002|Overall Study|Withdrawal by Subject|18|||
156806850|NCT00342628|566047504|FG000|Overall Study|Death|1|||
156806851|NCT00342628|566047505|FG001|Overall Study|Death|1|||
156806852|NCT00342628|566047506|FG002|Overall Study|Death|0|||
156806853|NCT00342628|566047504|FG000|Overall Study|moved residence|0|||
156806854|NCT00342628|566047505|FG001|Overall Study|moved residence|1|||
156806855|NCT00342628|566047506|FG002|Overall Study|moved residence|1|||
156806856|NCT04551898|566047507|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
156806857|NCT04551898|566047508|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
156806858|NCT04551898|566047509|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
156806859|NCT04551898|566047510|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
156806860|NCT04551898|566047507|FG000|Overall Study|Withdrawal by Subject|5|||
156806861|NCT04551898|566047508|FG001|Overall Study|Withdrawal by Subject|1|||
156806862|NCT04551898|566047509|FG002|Overall Study|Withdrawal by Subject|2|||
156806863|NCT04551898|566047510|FG003|Overall Study|Withdrawal by Subject|2|||
156806864|NCT04551898|566047507|FG000|Overall Study|Lost to Follow-up|2|||
156806865|NCT04551898|566047508|FG001|Overall Study|Lost to Follow-up|1|||
156806866|NCT04551898|566047509|FG002|Overall Study|Lost to Follow-up|2|||
156806867|NCT04551898|566047510|FG003|Overall Study|Lost to Follow-up|2|||
156806868|NCT04551898|566047507|FG000|Overall Study|Death|1|||
156806869|NCT04551898|566047508|FG001|Overall Study|Death|0|||
156806870|NCT04551898|566047509|FG002|Overall Study|Death|0|||
156806871|NCT04551898|566047510|FG003|Overall Study|Death|0|||
156806872|NCT04551898|566047507|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806873|NCT04551898|566047508|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806874|NCT04551898|566047509|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
156806875|NCT04551898|566047510|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
156806876|NCT03427814|566047511|FG000|Overall Study|Withdrawal by Subject|4|||
156806877|NCT03427814|566047512|FG001|Overall Study|Withdrawal by Subject|4|||
156806878|NCT03427814|566047511|FG000|Overall Study|Lost to Follow-up|0|||
156806879|NCT03427814|566047512|FG001|Overall Study|Lost to Follow-up|2|||
156806880|NCT03427814|566047511|FG000|Overall Study|Death|42|||
156806881|NCT03427814|566047512|FG001|Overall Study|Death|31|||
156882452|NCT00946153|566329443|FG002|Phase 2|Need more reduction of dose|0|||
157021477|NCT02783300|566830869|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021478|NCT02783300|566830870|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021479|NCT02783300|566830871|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157144734|NCT02088034|567277929|FG000|Overall Study|Pregnancy|2|||
156806882|NCT03427814|566047511|FG000|Overall Study|Sponsor's Decision|1|||
156806883|NCT03427814|566047512|FG001|Overall Study|Sponsor's Decision|0|||
156806884|NCT03427814|566047511|FG000|Overall Study|Investigator's Decision|1|||
157144735|NCT02088034|567277930|FG001|Overall Study|Pregnancy|1|||
156806885|NCT03427814|566047512|FG001|Overall Study|Investigator's Decision|2|||
157144736|NCT02088034|567277931|FG002|Overall Study|Pregnancy|2|||
157221123|NCT00633152|567556728|FG001|Overall Study|Withdrawal by Subject|1|||
157144737|NCT00308620|567277932|FG000|Overall Study|Death|1|||
157144738|NCT00308620|567277933|FG001|Overall Study|Death|1|||
157144739|NCT00308620|567277934|FG002|Overall Study|Death|0|||
157144740|NCT00308620|567277932|FG000|Overall Study|Lost to Follow-up|0|||
156806886|NCT03427814|566047511|FG000|Overall Study|Disease progression|1|||
156806887|NCT03427814|566047512|FG001|Overall Study|Disease progression|0|||
156806888|NCT03427814|566047511|FG000|Overall Study|Treatment Completed|0|||
156806889|NCT03427814|566047512|FG001|Overall Study|Treatment Completed|1|||
157144741|NCT00308620|567277933|FG001|Overall Study|Lost to Follow-up|0|||
157144742|NCT00308620|567277934|FG002|Overall Study|Lost to Follow-up|1|||
157144743|NCT00550238|567277941|FG000|Overall Study|Adverse Event|88|||
157144744|NCT00550238|567277941|FG000|Overall Study|Death|34|||
157144745|NCT00550238|567277941|FG000|Overall Study|Disease progression|46|||
157144746|NCT00550238|567277941|FG000|Overall Study|Withdrawal by Subject|167|||
157144747|NCT00550238|567277941|FG000|Overall Study|Physician Decision|31|||
157144748|NCT00550238|567277941|FG000|Overall Study|Patient noncompliance|25|||
157144749|NCT00550238|567277941|FG000|Overall Study|Lost to Follow-up|13|||
157144750|NCT00550238|567277941|FG000|Overall Study|Sponsor decision|55|||
157144751|NCT03133481|567277942|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
157144752|NCT03133481|567277943|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
157144753|NCT01486238|567277949|FG000|Overall Study|Death|0|||
157144754|NCT01486238|567277950|FG001|Overall Study|Death|2|||
157144755|NCT01486238|567277949|FG000|Overall Study|Withdrawal by Subject|2|||
157144756|NCT01486238|567277950|FG001|Overall Study|Withdrawal by Subject|1|||
157144757|NCT01486238|567277949|FG000|Overall Study|Lost to Follow-up|0|||
157144758|NCT01486238|567277950|FG001|Overall Study|Lost to Follow-up|3|||
157144759|NCT00637728|567277951|FG000|Double-blind Phase|Adverse Event|1|||
157144760|NCT00637728|567277952|FG001|Double-blind Phase|Adverse Event|0|||
157144761|NCT00637728|567277953|FG002|Double-blind Phase|Adverse Event|0|||
157144762|NCT00637728|567277951|FG000|Double-blind Phase|Non-compliance|2|||
157144763|NCT00637728|567277952|FG001|Double-blind Phase|Non-compliance|0|||
157144764|NCT00637728|567277953|FG002|Double-blind Phase|Non-compliance|0|||
157144765|NCT00637728|567277951|FG000|Double-blind Phase|Study Discontinued|1|||
157144766|NCT00637728|567277952|FG001|Double-blind Phase|Study Discontinued|1|||
157144767|NCT00637728|567277953|FG002|Double-blind Phase|Study Discontinued|0|||
157144768|NCT01050062|567277954|FG000|Overall Study|Adverse Event|75|||
157144769|NCT01050062|567277955|FG001|Overall Study|Adverse Event|22|||
157144770|NCT01050062|567277954|FG000|Overall Study|Lost to Follow-up|83|||
157144771|NCT01050062|567277955|FG001|Overall Study|Lost to Follow-up|35|||
157144772|NCT01050062|567277954|FG000|Overall Study|Lack of Efficacy|22|||
156806890|NCT03427814|566047511|FG000|Overall Study|Sponsor's Decision to End study|21|||
156806891|NCT03427814|566047512|FG001|Overall Study|Sponsor's Decision to End study|25|||
156806892|NCT03427814|566047511|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
156806893|NCT03427814|566047512|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
156806894|NCT03846427|566047513|FG000|Overall Study|Death|13|||
156806895|NCT03846427|566047513|FG000|Overall Study|Withdrawal by Subject|3|||
156806896|NCT03846427|566047513|FG000|Overall Study|Physician Decision|1|||
156806897|NCT01334554|566047514|FG000|Overall Study|Adverse Event|4|||
156806898|NCT01334554|566047515|FG001|Overall Study|Adverse Event|2|||
156806899|NCT02393859|566047517|FG000|Overall Study|Decision by Sponsor|2|||
156806900|NCT02393859|566047518|FG001|Overall Study|Decision by Sponsor|4|||
156806901|NCT02393859|566047517|FG000|Overall Study|Withdrawal by Subject|11|||
156806902|NCT02393859|566047518|FG001|Overall Study|Withdrawal by Subject|6|||
156806903|NCT02393859|566047517|FG000|Overall Study|Death|27|||
156806904|NCT02393859|566047518|FG001|Overall Study|Death|10|||
156806905|NCT02393859|566047517|FG000|Overall Study|Lost to Follow-up|1|||
156806906|NCT02393859|566047518|FG001|Overall Study|Lost to Follow-up|1|||
156806907|NCT00954447|566047519|FG000|Overall Study|Adverse Event|33|||
156806908|NCT00954447|566047520|FG001|Overall Study|Adverse Event|25|||
156806909|NCT00954447|566047519|FG000|Overall Study|Lack of Efficacy|17|||
156806910|NCT00954447|566047520|FG001|Overall Study|Lack of Efficacy|3|||
156806911|NCT00954447|566047519|FG000|Overall Study|Protocol Violation|5|||
156806912|NCT00954447|566047520|FG001|Overall Study|Protocol Violation|7|||
156806913|NCT00954447|566047519|FG000|Overall Study|Lost to Follow-up|8|||
156806914|NCT00954447|566047520|FG001|Overall Study|Lost to Follow-up|14|||
156806915|NCT00954447|566047519|FG000|Overall Study|Withdrawal by Subject|26|||
156806916|NCT00954447|566047520|FG001|Overall Study|Withdrawal by Subject|21|||
156806917|NCT00954447|566047519|FG000|Overall Study|Other|21|||
156806918|NCT00954447|566047520|FG001|Overall Study|Other|18|||
156806919|NCT01979614|566047521|FG000|Overall Study|Adverse Event|1|||
157144773|NCT01050062|567277955|FG001|Overall Study|Lack of Efficacy|35|||
157144774|NCT01050062|567277954|FG000|Overall Study|Physician Decision|74|||
157144775|NCT01050062|567277955|FG001|Overall Study|Physician Decision|9|||
157144776|NCT01050062|567277954|FG000|Overall Study|Others|17|||
157144777|NCT01050062|567277955|FG001|Overall Study|Others|11|||
157144778|NCT01873950|567277956|FG000|Period 5|Withdrawal by Subject|0|||
157144779|NCT01873950|567277957|FG001|Period 5|Withdrawal by Subject|0|||
156806920|NCT01979614|566047522|FG001|Overall Study|Adverse Event|1|||
157144780|NCT01873950|567277958|FG002|Period 5|Withdrawal by Subject|0|||
157144781|NCT01873950|567277959|FG003|Period 5|Withdrawal by Subject|1|||
157144782|NCT01873950|567277960|FG004|Period 5|Withdrawal by Subject|0|||
157144783|NCT03894540|567277962|FG000|Overall Study|Adverse Event|0|||
157021480|NCT02783300|566830872|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021481|NCT02783300|566830873|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021482|NCT02783300|566830874|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021483|NCT02783300|566830875|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021484|NCT02783300|566830876|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021485|NCT02783300|566830877|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021486|NCT02783300|566830878|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021487|NCT02783300|566830879|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021488|NCT02783300|566830880|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021489|NCT02783300|566830881|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021490|NCT02783300|566830882|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021491|NCT02783300|566830883|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021492|NCT02783300|566830884|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021493|NCT02783300|566830885|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021494|NCT02783300|566830886|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021495|NCT02783300|566830887|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021496|NCT02783300|566830888|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021497|NCT02783300|566830889|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021498|NCT02783300|566830890|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021499|NCT02783300|566830891|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157221124|NCT00633152|567556727|FG000|Overall Study|Lost to Follow-up|4|||
157221125|NCT00633152|567556728|FG001|Overall Study|Lost to Follow-up|1|||
157221126|NCT00633152|567556727|FG000|Overall Study|Miscellaneous Other|3|||
157221127|NCT00633152|567556728|FG001|Overall Study|Miscellaneous Other|2|||
157221128|NCT02180061|567556729|FG000|Overall Study|Adverse Event|4|||
157221129|NCT02180061|567556730|FG001|Overall Study|Adverse Event|2|||
157221130|NCT02180061|567556729|FG000|Overall Study|Clinical Progression|5|||
157221131|NCT02180061|567556730|FG001|Overall Study|Clinical Progression|1|||
157221132|NCT02180061|567556729|FG000|Overall Study|Progressive Disease|15|||
157221133|NCT02180061|567556730|FG001|Overall Study|Progressive Disease|5|||
157221134|NCT02180061|567556729|FG000|Overall Study|Physician Decision|1|||
157221135|NCT02180061|567556730|FG001|Overall Study|Physician Decision|0|||
157221136|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
157221137|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
157221138|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
157221139|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
157221140|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
157221141|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
157221142|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
157221143|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
157221144|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
157221145|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
157221146|NCT00056160|567556733|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
157221147|NCT00056160|567556734|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
157221148|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
157221149|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
157221150|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
156806921|NCT00488514|566047523|FG000|Overall Study|Adverse Event|41|||
156806922|NCT00488514|566047523|FG000|Overall Study|Lost to Follow-up|44|||
156806923|NCT00488514|566047523|FG000|Overall Study|Protocol Violation|32|||
156806924|NCT00488514|566047523|FG000|Overall Study|Withdrawal by Subject|106|||
156806925|NCT00488514|566047523|FG000|Overall Study|Lack of Efficacy|28|||
156806926|NCT00488514|566047523|FG000|Overall Study|Did not meet criteria for treatment|30|||
156806927|NCT00488514|566047523|FG000|Overall Study|Postive drug screen|1|||
156806928|NCT00488514|566047523|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
156806929|NCT00488514|566047523|FG000|Overall Study|Investigator decision|1|||
156806930|NCT00488514|566047523|FG000|Overall Study|Participant had too few migraines|5|||
156806931|NCT00488514|566047523|FG000|Overall Study|Increase in number of migraines|2|||
156806932|NCT00488514|566047523|FG000|Overall Study|Increased use of concomitant medication|1|||
156806933|NCT00628446|566047526|FG000|Overall Study|Lost to Follow-up|3|||
156806934|NCT00628446|566047526|FG000|Overall Study|Withdrawal by Subject|1|||
156806935|NCT00628446|566047526|FG000|Overall Study|Protocol Violation|3|||
156806936|NCT00756275|566047527|FG000|Overall Study|Lost to Follow-up|25|||
156806937|NCT00756275|566047528|FG001|Overall Study|Lost to Follow-up|21|||
156806938|NCT00756275|566047527|FG000|Overall Study|Withdrawal by Subject|4|||
156806939|NCT00756275|566047528|FG001|Overall Study|Withdrawal by Subject|7|||
156806940|NCT04971967|566047531|FG000|Overall Study|Lost to Follow-up|6|||
156806941|NCT04971967|566047532|FG001|Overall Study|Lost to Follow-up|7|||
156806942|NCT00682929|566047539|FG000|Overall Study|Adverse Event|4|||
156806943|NCT00682929|566047540|FG001|Overall Study|Adverse Event|1|||
156806944|NCT00682929|566047541|FG002|Overall Study|Adverse Event|1|||
156882453|NCT00946153|566329444|FG003|Phase 2|Need more reduction of dose|0|||
157221151|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
156806945|NCT00682929|566047539|FG000|Overall Study|Withdrawal by Subject|1|||
157221152|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
157221153|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
157221154|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
157221155|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
157221156|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
157221157|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
157221158|NCT00056160|567556733|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
157221159|NCT00056160|567556734|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
157221160|NCT00056160|567556733|FG000|Final Follow-up|Transferred into expanded access study.|3|||
157221161|NCT00056160|567556734|FG001|Final Follow-up|Transferred into expanded access study.|0|||
157221162|NCT00056160|567556733|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
157221163|NCT00056160|567556734|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
157221164|NCT00056160|567556733|FG000|Final Follow-up|Adverse Event|1|||
157221165|NCT00056160|567556734|FG001|Final Follow-up|Adverse Event|0|||
157221166|NCT01469364|567556735|FG000|Overall Study|Adverse Event|1|||
157221167|NCT01469364|567556735|FG000|Overall Study|Withdrawal by Subject|1|||
157221168|NCT01590433|567556739|FG000|Overall Study|Lost to Follow-up|20|||
157221169|NCT01590433|567556740|FG001|Overall Study|Lost to Follow-up|8|||
157221170|NCT01590433|567556739|FG000|Overall Study|Withdrawal by Subject|21|||
157221171|NCT01590433|567556740|FG001|Overall Study|Withdrawal by Subject|11|||
157221172|NCT01590433|567556739|FG000|Overall Study|Adverse Event|11|||
157221173|NCT01590433|567556740|FG001|Overall Study|Adverse Event|3|||
157221174|NCT00555009|567556741|FG000|Overall Study|Withdrawal by Subject|0|||
157221175|NCT00555009|567556742|FG001|Overall Study|Withdrawal by Subject|1|||
157221176|NCT00555009|567556741|FG000|Overall Study|Terminated by Sponsor|2|||
157221177|NCT00555009|567556742|FG001|Overall Study|Terminated by Sponsor|5|||
157221178|NCT03731182|567556751|FG000|Overall Study|Lost to Follow-up|2|||
157221179|NCT03731182|567556752|FG001|Overall Study|Lost to Follow-up|0|||
157221180|NCT03731182|567556751|FG000|Overall Study|Physician Decision|1|||
157221181|NCT03731182|567556752|FG001|Overall Study|Physician Decision|0|||
157221182|NCT03731182|567556751|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
157221183|NCT03731182|567556752|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
157221184|NCT01751412|567556753|FG000|Overall Study|Disease Progression Before Treatment|1|||
157221185|NCT03734237|567556756|FG000|Overall Study|Lost to Follow-up|1|||
157221186|NCT03734237|567556757|FG001|Overall Study|Lost to Follow-up|3|||
157221187|NCT03734237|567556758|FG002|Overall Study|Lost to Follow-up|0|||
157221188|NCT03734237|567556756|FG000|Overall Study|Withdrawal by Subject|7|||
157221189|NCT03734237|567556757|FG001|Overall Study|Withdrawal by Subject|9|||
157221190|NCT03734237|567556758|FG002|Overall Study|Withdrawal by Subject|10|||
157221191|NCT01844583|567556759|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
157221192|NCT01844583|567556760|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
157221193|NCT03036579|567556764|FG000|2 Years|Lost to Follow-up|1|||
157221194|NCT03036579|567556765|FG001|2 Years|Lost to Follow-up|0|||
157221195|NCT03036579|567556764|FG000|3 Years|Lost to Follow-up|0|||
157221196|NCT03036579|567556765|FG001|3 Years|Lost to Follow-up|1|||
157221197|NCT05431153|567556766|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157221198|NCT05431153|567556767|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157221199|NCT05431153|567556768|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
156806946|NCT00682929|566047540|FG001|Overall Study|Withdrawal by Subject|2|||
156806947|NCT00682929|566047541|FG002|Overall Study|Withdrawal by Subject|1|||
156806948|NCT00682929|566047539|FG000|Overall Study|dosing compliance < 80%|0|||
156806949|NCT00682929|566047540|FG001|Overall Study|dosing compliance < 80%|2|||
156806950|NCT00682929|566047541|FG002|Overall Study|dosing compliance < 80%|0|||
156806951|NCT00682929|566047539|FG000|Overall Study|lag in DEA renewal|1|||
156806952|NCT00682929|566047540|FG001|Overall Study|lag in DEA renewal|0|||
156806953|NCT00682929|566047541|FG002|Overall Study|lag in DEA renewal|0|||
156806954|NCT00938912|566047542|FG000|Overall Study|Withdrawal by Subject|28|||
156806955|NCT00938912|566047542|FG000|Overall Study|Lost to Follow-up|4|||
156806956|NCT00938912|566047542|FG000|Overall Study|Lack of Efficacy|43|||
156806957|NCT00938912|566047542|FG000|Overall Study|Adverse event, non-fatal|24|||
156806958|NCT00938912|566047542|FG000|Overall Study|Adverse event, fatal|1|||
156806959|NCT00938912|566047542|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
156806960|NCT00938912|566047542|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
156806961|NCT00938912|566047542|FG000|Overall Study|Participant needed prohibit medication|1|||
156806962|NCT00938912|566047542|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
156882454|NCT00946153|566329445|FG004|Phase 2|Need more reduction of dose|2|||
157221200|NCT05431153|567556769|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157221201|NCT05431153|567556770|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
157221202|NCT05431153|567556771|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157221203|NCT04041570|567556774|FG000|Overall Study|Moved from Area|0|||
157221204|NCT04041570|567556775|FG001|Overall Study|Moved from Area|2|||
157221205|NCT00441584|567556776|FG000|Overall Study|Lack of Efficacy|79|||
157144784|NCT03894540|567277963|FG001|Overall Study|Adverse Event|0|||
156806963|NCT00938912|566047542|FG000|Overall Study|Did not meet Eligibility criteria|1|||
156806964|NCT00938912|566047542|FG000|Overall Study|Participant relocated not related to AE|1|||
156806965|NCT00938912|566047542|FG000|Overall Study|Participant moved to another city|1|||
156806966|NCT00938912|566047542|FG000|Overall Study|Participant experienced break through seizures|1|||
156806967|NCT00938912|566047542|FG000|Overall Study|No longer wished to participate in the study|1|||
157144785|NCT03894540|567277964|FG002|Overall Study|Adverse Event|0|||
156806968|NCT00938912|566047542|FG000|Overall Study|Protocol Deviation|2|||
156806969|NCT01772550|566047545|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
156806970|NCT01772550|566047546|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
156806971|NCT01772550|566047547|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
156806972|NCT01772550|566047545|FG000|Overall Study|Adverse Event|0|||
156806973|NCT01772550|566047546|FG001|Overall Study|Adverse Event|0|||
156806974|NCT01772550|566047547|FG002|Overall Study|Adverse Event|1|||
156806975|NCT00559104|566047548|FG000|Overall Study|Lack of Efficacy|9|||
156806976|NCT00559104|566047549|FG001|Overall Study|Lack of Efficacy|0|||
156806977|NCT01694433|566047554|FG000|Overall Study|Adverse Event|7|||
156806978|NCT01694433|566047555|FG001|Overall Study|Adverse Event|0|||
156806979|NCT01694433|566047554|FG000|Overall Study|Physician Decision|1|||
156806980|NCT01694433|566047555|FG001|Overall Study|Physician Decision|0|||
156806981|NCT01694433|566047554|FG000|Overall Study|Withdrawal by Subject|3|||
156806982|NCT01694433|566047555|FG001|Overall Study|Withdrawal by Subject|4|||
156806983|NCT00374595|566047556|FG000|Overall Study|Death|23|||
156806984|NCT00374595|566047556|FG000|Overall Study|Withdrawal by Subject|39|||
156806985|NCT00374595|566047556|FG000|Overall Study|Lost to Follow-up|3|||
156806986|NCT00374595|566047556|FG000|Overall Study|too much time commitment|1|||
156806987|NCT00374595|566047556|FG000|Overall Study|transfer care to other clinical site|1|||
156806988|NCT00374595|566047556|FG000|Overall Study|relocation|3|||
156806989|NCT03745768|566047558|FG000|Overall Study|discontinued study|2|||
156806990|NCT03745768|566047559|FG001|Overall Study|discontinued study|0|||
157144786|NCT03894540|567277965|FG003|Overall Study|Adverse Event|0|||
157144787|NCT03894540|567277966|FG004|Overall Study|Adverse Event|1|||
157144788|NCT03894540|567277967|FG005|Overall Study|Adverse Event|0|||
157144789|NCT03894540|567277962|FG000|Overall Study|Withdrawal by Subject|0|||
157144790|NCT03894540|567277963|FG001|Overall Study|Withdrawal by Subject|0|||
157144791|NCT03894540|567277964|FG002|Overall Study|Withdrawal by Subject|0|||
157144792|NCT03894540|567277965|FG003|Overall Study|Withdrawal by Subject|0|||
157144793|NCT03894540|567277966|FG004|Overall Study|Withdrawal by Subject|1|||
157144794|NCT03894540|567277967|FG005|Overall Study|Withdrawal by Subject|0|||
157144795|NCT03894540|567277962|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
157144796|NCT03894540|567277963|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
157144797|NCT03894540|567277964|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
157144798|NCT03894540|567277965|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
157144799|NCT03894540|567277966|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
157144800|NCT03894540|567277967|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
157221206|NCT00441584|567556776|FG000|Overall Study|Withdrawal by Subject|8|||
157221207|NCT00441584|567556776|FG000|Overall Study|Adverse Event|6|||
157221208|NCT00441584|567556776|FG000|Overall Study|Protocol Violation|5|||
157221209|NCT00441584|567556776|FG000|Overall Study|Lost to Follow-up|4|||
157221210|NCT00441584|567556776|FG000|Overall Study|Failure to meet eligibility criteria|3|||
157221211|NCT03532009|567556777|FG000|Overall Study|Other|1|||
156806991|NCT00443118|566047560|FG000|Overall Study|unknown primary outcome|3|||
156806992|NCT00443118|566047561|FG001|Overall Study|unknown primary outcome|1|||
156806993|NCT00443118|566047562|FG002|Overall Study|unknown primary outcome|0|||
156806994|NCT00443118|566047560|FG000|Overall Study|Withdrawal by Subject|1|||
156806995|NCT00443118|566047561|FG001|Overall Study|Withdrawal by Subject|0|||
156806996|NCT00443118|566047562|FG002|Overall Study|Withdrawal by Subject|0|||
156806997|NCT02298868|566047570|FG000|Overall Study|Adverse Event|1|||
156806998|NCT02298868|566047570|FG000|Overall Study|Death|1|||
156806999|NCT02298868|566047570|FG000|Overall Study|Patient underwent transplant|1|||
156807000|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
156807001|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807002|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807003|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807004|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
156807005|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
156807006|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156882455|NCT00946153|566329441|FG000|Phase 2|Physician Decision|0|||
156882456|NCT00946153|566329442|FG001|Phase 2|Physician Decision|0|||
157144801|NCT03894540|567277962|FG000|Overall Study|Progressive Disease Clinical|1|||
157221212|NCT03532009|567556778|FG001|Overall Study|Other|1|||
157221213|NCT03532009|567556777|FG000|Overall Study|Death|1|||
157144802|NCT03894540|567277963|FG001|Overall Study|Progressive Disease Clinical|1|||
157144803|NCT03894540|567277964|FG002|Overall Study|Progressive Disease Clinical|0|||
157144804|NCT03894540|567277965|FG003|Overall Study|Progressive Disease Clinical|1|||
157144805|NCT03894540|567277966|FG004|Overall Study|Progressive Disease Clinical|5|||
157144806|NCT03894540|567277967|FG005|Overall Study|Progressive Disease Clinical|1|||
157144807|NCT03894540|567277962|FG000|Overall Study|Study termination by sponsor|0|||
157144808|NCT03894540|567277963|FG001|Overall Study|Study termination by sponsor|0|||
157144809|NCT03894540|567277964|FG002|Overall Study|Study termination by sponsor|0|||
157144810|NCT03894540|567277965|FG003|Overall Study|Study termination by sponsor|0|||
157144811|NCT03894540|567277966|FG004|Overall Study|Study termination by sponsor|2|||
157144812|NCT03894540|567277967|FG005|Overall Study|Study termination by sponsor|0|||
157144813|NCT03000452|567277968|FG000|Treatment Period|Death|1|||
157144814|NCT03000452|567277968|FG000|Treatment Period|Progressive Disease (PD)|14|||
157144815|NCT03000452|567277968|FG000|Treatment Period|Physician Decision|1|||
157144816|NCT03000452|567277968|FG000|Treatment Period|Miscellaneous|2|||
157144817|NCT03000452|567277968|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
157144818|NCT03000452|567277968|FG000|Follow-Up Period|Death|3|||
157144819|NCT03000452|567277968|FG000|Follow-Up Period|Withdrawal by Subject|3|||
157144820|NCT03043365|567277969|FG000|Weeks 0 to Week 8|Adverse Event|1|||
157144821|NCT03043365|567277970|FG001|Weeks 0 to Week 8|Adverse Event|3|||
157144822|NCT03043365|567277969|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
157144823|NCT03043365|567277970|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
157144824|NCT03043365|567277969|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
157144825|NCT03043365|567277970|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
157144826|NCT00593112|567277971|FG000|Overall Study|Scan Anxiety|3|||
157144827|NCT00593112|567277972|FG001|Overall Study|Scan Anxiety|0|||
157144828|NCT00593112|567277971|FG000|Overall Study|Abnormal Scan|1|||
157144829|NCT00593112|567277972|FG001|Overall Study|Abnormal Scan|0|||
157144830|NCT00593112|567277971|FG000|Overall Study|Unreadable Scan|1|||
157144831|NCT00593112|567277972|FG001|Overall Study|Unreadable Scan|0|||
157144832|NCT00593112|567277971|FG000|Overall Study|Withdrawal by Subject|5|||
157144833|NCT00593112|567277972|FG001|Overall Study|Withdrawal by Subject|0|||
157144834|NCT00849212|567277973|FG000|Overall Study|Lack of Efficacy|1|||
157144835|NCT00849212|567277973|FG000|Overall Study|Withdrawal by Subject|3|||
157144836|NCT00849212|567277973|FG000|Overall Study|Adverse Event|2|||
157144837|NCT00849212|567277973|FG000|Overall Study|Miscellaneous|1|||
157144838|NCT04407507|567277974|FG000|Overall Study|Withdrawal by Subject|0|||
157144839|NCT04407507|567277975|FG001|Overall Study|Withdrawal by Subject|1|||
157144840|NCT01499576|567277976|FG000|Overall Study|Physician Decision|12|||
157144841|NCT01499576|567277976|FG000|Overall Study|Withdrawal by Subject|9|||
157144842|NCT03396471|567277979|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
157144843|NCT03396471|567277979|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
157144844|NCT03396471|567277979|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
157144845|NCT03396471|567277979|FG000|Study Treatment - Up to 22 Months|Death|2|||
157144846|NCT03396471|567277979|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
157144847|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|Death|9|||
157144848|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
157144849|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
157144850|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|study terminated|1|||
157144851|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
157144852|NCT03396471|567277979|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
157144853|NCT00923091|567277980|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
157144854|NCT00923091|567277981|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
157144855|NCT00923091|567277982|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
156807007|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807008|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807009|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
156807010|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
156807011|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807012|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807013|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
156807014|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
157144856|NCT00923091|567277983|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
157144857|NCT00923091|567277984|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
157144858|NCT00923091|567277985|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
157144859|NCT00923091|567277986|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
157144860|NCT00923091|567277987|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
157144861|NCT00923091|567277988|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
157144862|NCT00923091|567277989|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
157144863|NCT00923091|567277990|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
157221214|NCT03532009|567556778|FG001|Overall Study|Death|1|||
157144864|NCT00923091|567277991|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
157144865|NCT00923091|567277992|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
157144866|NCT00923091|567277980|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
157144867|NCT00923091|567277981|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
157144868|NCT00923091|567277982|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
157144869|NCT00923091|567277983|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
157144870|NCT00923091|567277984|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
157144871|NCT00923091|567277985|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
157144872|NCT00923091|567277986|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
157144873|NCT00923091|567277987|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
157144874|NCT00923091|567277988|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
157144875|NCT00923091|567277989|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
157144876|NCT00923091|567277990|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
157144877|NCT00923091|567277991|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
157144878|NCT00923091|567277992|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
157144879|NCT00923091|567277980|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
157144880|NCT00923091|567277981|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
157144881|NCT00923091|567277982|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
157144882|NCT00923091|567277983|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
157144883|NCT00923091|567277984|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
157144884|NCT00923091|567277985|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
157144885|NCT00923091|567277986|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
157144886|NCT00923091|567277987|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
157144887|NCT00923091|567277988|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
157144888|NCT00923091|567277989|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
157144889|NCT00923091|567277990|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
157144890|NCT00923091|567277991|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
157144891|NCT00923091|567277992|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
157144892|NCT00923091|567277980|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144893|NCT00923091|567277981|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144894|NCT00923091|567277982|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144895|NCT00923091|567277983|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144896|NCT00923091|567277984|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144897|NCT00923091|567277985|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
157144898|NCT00923091|567277986|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144899|NCT00923091|567277987|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144900|NCT00923091|567277988|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144901|NCT00923091|567277989|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156807015|NCT01194245|566047571|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
156807016|NCT01194245|566047572|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807017|NCT01194245|566047573|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807018|NCT01194245|566047574|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807019|NCT01194245|566047575|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
156807020|NCT01194245|566047571|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807021|NCT01194245|566047572|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807022|NCT01194245|566047573|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807023|NCT01194245|566047574|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156807024|NCT01194245|566047575|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156807025|NCT01194245|566047571|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156807026|NCT01194245|566047572|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156807027|NCT01194245|566047573|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807028|NCT01194245|566047574|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807029|NCT01194245|566047575|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
156807030|NCT03962855|566047576|FG000|Overall Study|Death|0|||
156807031|NCT03962855|566047577|FG001|Overall Study|Death|1|||
156807032|NCT03962855|566047576|FG000|Overall Study|Lost to Follow-up|0|||
156807033|NCT03962855|566047577|FG001|Overall Study|Lost to Follow-up|1|||
156807034|NCT03962855|566047576|FG000|Overall Study|Adverse Event|0|||
156807035|NCT03962855|566047577|FG001|Overall Study|Adverse Event|1|||
156807036|NCT03962855|566047576|FG000|Overall Study|Physician Decision|0|||
156807037|NCT03962855|566047577|FG001|Overall Study|Physician Decision|2|||
156882457|NCT00946153|566329443|FG002|Phase 2|Physician Decision|0|||
156882458|NCT00946153|566329444|FG003|Phase 2|Physician Decision|0|||
156882459|NCT00946153|566329445|FG004|Phase 2|Physician Decision|1|||
157144902|NCT00923091|567277990|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144903|NCT00923091|567277991|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
156807038|NCT03326063|566047578|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
156807039|NCT03326063|566047579|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
156807040|NCT00881894|566047580|FG000|Overall Study|Consent withdrawn|0|||
156807041|NCT00881894|566047581|FG001|Overall Study|Consent withdrawn|1|||
156807042|NCT00881894|566047580|FG000|Overall Study|Other reasons for premature termination|1|||
156807043|NCT00881894|566047581|FG001|Overall Study|Other reasons for premature termination|2|||
156807044|NCT01253369|566047582|FG000|Overall Study|Adverse Event|4|||
156807045|NCT01253369|566047582|FG000|Overall Study|Withdrawal by Subject|2|||
156807046|NCT01253369|566047582|FG000|Overall Study|Death|1|||
156807047|NCT01253369|566047582|FG000|Overall Study|Progressive disease|23|||
156807048|NCT01253369|566047582|FG000|Overall Study|Not Evaluable|3|||
156807049|NCT01220401|566047587|FG000|Overall Study|Withdrawal by Subject|2|||
156807050|NCT01220401|566047587|FG000|Overall Study|Protocol Violation|1|||
156807051|NCT01853462|566047588|FG000|Overall Study|Withdrawal by Subject|1|||
156807052|NCT01853462|566047589|FG001|Overall Study|Withdrawal by Subject|1|||
156807053|NCT04068922|566047590|FG000|Overall Study|Lost to Follow-up|5|||
156807054|NCT04068922|566047590|FG000|Overall Study|Withdrawal by Subject|7|||
156807055|NCT04068922|566047590|FG000|Overall Study|Adverse Event|1|||
156807056|NCT03192137|566047593|FG000|Overall Study|Adverse Event|10|||
156807057|NCT03192137|566047594|FG001|Overall Study|Adverse Event|11|||
156807058|NCT03192137|566047593|FG000|Overall Study|Physician Decision|1|||
156807059|NCT03192137|566047594|FG001|Overall Study|Physician Decision|0|||
156807060|NCT03192137|566047593|FG000|Overall Study|Lack of Efficacy|20|||
156807061|NCT03192137|566047594|FG001|Overall Study|Lack of Efficacy|37|||
156807062|NCT03192137|566047593|FG000|Overall Study|Withdrawal by Subject|3|||
156807063|NCT03192137|566047594|FG001|Overall Study|Withdrawal by Subject|3|||
156807064|NCT03192137|566047593|FG000|Overall Study|Protocol Violation|4|||
156807065|NCT03192137|566047594|FG001|Overall Study|Protocol Violation|3|||
156807066|NCT03192137|566047593|FG000|Overall Study|Surgery Cancelled|4|||
156807067|NCT03192137|566047594|FG001|Overall Study|Surgery Cancelled|1|||
156807068|NCT03192137|566047593|FG000|Overall Study|Other - Various Administrative Reasons|8|||
156807069|NCT03192137|566047594|FG001|Overall Study|Other - Various Administrative Reasons|3|||
156807070|NCT01261975|566047599|FG000|Overall Study|Surgical complication|1|||
156807071|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
156807072|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807073|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807074|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807075|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807076|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
156807077|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
156807078|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
156807079|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
156807080|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
156807081|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
156807082|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
156807083|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
156807084|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807085|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
157144904|NCT00923091|567277992|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
157144905|NCT00923091|567277980|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144906|NCT00923091|567277981|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
157144907|NCT00923091|567277982|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144908|NCT00923091|567277983|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
157144909|NCT00923091|567277984|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144910|NCT00923091|567277985|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
157144911|NCT00923091|567277986|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144912|NCT00923091|567277987|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144913|NCT00923091|567277988|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157221215|NCT03532009|567556777|FG000|Overall Study|Withdrawal by Patient|0|||
157221216|NCT03532009|567556778|FG001|Overall Study|Withdrawal by Patient|2|||
156807086|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807087|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807088|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
156807089|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
156807090|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
156807091|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
156807092|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
156807093|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
156807094|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
156807095|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
156807096|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
156807097|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807098|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807099|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807100|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
156807101|NCT00716274|566047600|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807102|NCT00716274|566047601|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
156807103|NCT00716274|566047602|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807104|NCT00716274|566047603|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807105|NCT00716274|566047604|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807106|NCT00716274|566047605|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
156807107|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807108|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807109|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
156807110|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807111|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807112|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
156807113|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
156807114|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
156807115|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
156807116|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
156807117|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
156807118|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
156807119|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807120|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807121|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807122|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
156807123|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
156807124|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
156807125|NCT00716274|566047600|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
156807126|NCT00716274|566047601|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
156807127|NCT00716274|566047602|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
156807128|NCT00716274|566047603|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
156807129|NCT00716274|566047604|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
156807130|NCT00716274|566047605|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
156807131|NCT01932788|566047606|FG000|Overall Study|Protocol Violation|18|||
156807132|NCT01932788|566047607|FG001|Overall Study|Protocol Violation|0|||
156807133|NCT01932788|566047606|FG000|Overall Study|Lost to Follow-up|18|||
156807134|NCT01932788|566047607|FG001|Overall Study|Lost to Follow-up|46|||
156807135|NCT01932788|566047606|FG000|Overall Study|Lack of Efficacy|2|||
156807136|NCT01932788|566047607|FG001|Overall Study|Lack of Efficacy|0|||
156807137|NCT01932788|566047606|FG000|Overall Study|Withdrawal by Subject|0|||
156807138|NCT01932788|566047607|FG001|Overall Study|Withdrawal by Subject|5|||
156807139|NCT04790279|566049532|FG000|Overall Study|Did not meet medication start criteria|27|||
156807140|NCT04790279|566049533|FG001|Overall Study|Did not meet medication start criteria|15|||
156807141|NCT04790279|566049532|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
156807142|NCT04790279|566049533|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
156807143|NCT04790279|566049532|FG000|Overall Study|Protocol Violation|8|||
156807144|NCT04790279|566049533|FG001|Overall Study|Protocol Violation|3|||
156807145|NCT04790279|566049532|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
156807146|NCT04790279|566049533|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
156807147|NCT00784368|566049536|FG000|Overall Study|Physician Decision|0|||
156807148|NCT00784368|566049537|FG001|Overall Study|Physician Decision|0|||
156807149|NCT00784368|566049538|FG002|Overall Study|Physician Decision|6|||
156807150|NCT00784368|566049536|FG000|Overall Study|Lack of Efficacy|2|||
156807151|NCT00784368|566049537|FG001|Overall Study|Lack of Efficacy|0|||
156807152|NCT00784368|566049538|FG002|Overall Study|Lack of Efficacy|1|||
156807153|NCT00784368|566049536|FG000|Overall Study|Adverse Event|6|||
156807154|NCT00784368|566049537|FG001|Overall Study|Adverse Event|9|||
156807155|NCT00784368|566049538|FG002|Overall Study|Adverse Event|2|||
156807156|NCT00784368|566049536|FG000|Overall Study|Diagnosis of fever|0|||
156807157|NCT00784368|566049537|FG001|Overall Study|Diagnosis of fever|0|||
156807158|NCT00784368|566049538|FG002|Overall Study|Diagnosis of fever|1|||
156807159|NCT00784368|566049536|FG000|Overall Study|Worsening of complications|0|||
156807160|NCT00784368|566049537|FG001|Overall Study|Worsening of complications|0|||
156807161|NCT00784368|566049538|FG002|Overall Study|Worsening of complications|1|||
156807162|NCT00784368|566049536|FG000|Overall Study|Worsening of symptoms|0|||
156807163|NCT00784368|566049537|FG001|Overall Study|Worsening of symptoms|1|||
156807164|NCT00784368|566049538|FG002|Overall Study|Worsening of symptoms|0|||
156807165|NCT00784368|566049536|FG000|Overall Study|Withdrawal of informed consent|0|||
156807166|NCT00784368|566049537|FG001|Overall Study|Withdrawal of informed consent|1|||
156807167|NCT00784368|566049538|FG002|Overall Study|Withdrawal of informed consent|0|||
156807168|NCT01475721|566049544|FG000|Overall Study|Death|3|||
156807169|NCT01475721|566049545|FG001|Overall Study|Death|6|||
156882460|NCT00946153|566329441|FG000|Phase 2|14 days washout for recovery due to AE|0|||
156882461|NCT00946153|566329442|FG001|Phase 2|14 days washout for recovery due to AE|0|||
156882462|NCT00946153|566329443|FG002|Phase 2|14 days washout for recovery due to AE|0|||
156882463|NCT00946153|566329444|FG003|Phase 2|14 days washout for recovery due to AE|0|||
156882464|NCT00946153|566329445|FG004|Phase 2|14 days washout for recovery due to AE|4|||
156882465|NCT03472547|566329452|FG000|Overall Study|Withdrawal by Subject|30|||
156882466|NCT03865316|566330802|FG000|Overall Study|Procedure Cancelled|4|||
156882467|NCT03865316|566330802|FG000|Overall Study|Equipment failure|4|||
156882468|NCT03135119|566330807|FG000|Overall Study|Lost to Follow-up|2|||
156882469|NCT03135119|566330808|FG001|Overall Study|Lost to Follow-up|0|||
156882470|NCT03135119|566330807|FG000|Overall Study|Physician Decision|1|||
156882471|NCT03135119|566330808|FG001|Overall Study|Physician Decision|1|||
156882472|NCT03135119|566330807|FG000|Overall Study|COVID-19 Shutdown|2|||
156882473|NCT03135119|566330808|FG001|Overall Study|COVID-19 Shutdown|2|||
156882474|NCT01478048|566330809|FG000|Overall Study|Disease Progression|52|||
157144914|NCT00923091|567277989|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144915|NCT00923091|567277990|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144916|NCT00923091|567277991|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144917|NCT00923091|567277992|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
157144918|NCT00923091|567277980|FG000|Period III (Single-Blind)|Adverse Event|5|||
157144919|NCT00923091|567277981|FG001|Period III (Single-Blind)|Adverse Event|0|||
157144920|NCT00923091|567277982|FG002|Period III (Single-Blind)|Adverse Event|0|||
156807170|NCT01475721|566049544|FG000|Overall Study|Withdrawal by Subject|8|||
156807171|NCT01475721|566049545|FG001|Overall Study|Withdrawal by Subject|8|||
156807172|NCT00803738|566049547|FG000|Overall Study|Adverse Event|3|||
156807173|NCT00803738|566049548|FG001|Overall Study|Adverse Event|5|||
156807174|NCT00803738|566049547|FG000|Overall Study|Lost to Follow-up|4|||
156807175|NCT00803738|566049548|FG001|Overall Study|Lost to Follow-up|4|||
156807176|NCT00803738|566049547|FG000|Overall Study|Protocol Violation|18|||
156807177|NCT00803738|566049548|FG001|Overall Study|Protocol Violation|10|||
156807178|NCT00803738|566049547|FG000|Overall Study|Withdrawal by Subject|1|||
156807179|NCT00803738|566049548|FG001|Overall Study|Withdrawal by Subject|4|||
156807180|NCT00803738|566049547|FG000|Overall Study|Lack of Efficacy|10|||
156807181|NCT00803738|566049548|FG001|Overall Study|Lack of Efficacy|16|||
156807182|NCT00803738|566049547|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
156807183|NCT00803738|566049548|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
156807184|NCT00803738|566049547|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
156807185|NCT00803738|566049548|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
156807186|NCT01048242|566049549|FG000|Overall Study|See study flow chart|4|||
156807187|NCT01048242|566049550|FG001|Overall Study|See study flow chart|2|||
156807188|NCT02364037|566049551|FG000|Overall Study|Withdrawal by Subject|7|||
156807189|NCT02364037|566049552|FG001|Overall Study|Withdrawal by Subject|4|||
156807190|NCT02364037|566049551|FG000|Overall Study|Lost to Follow-up|37|||
156807191|NCT02364037|566049552|FG001|Overall Study|Lost to Follow-up|49|||
156807192|NCT01453036|566049553|FG000|Overall Study|Lost to Follow-up|26|||
156807193|NCT01453036|566049554|FG001|Overall Study|Lost to Follow-up|115|||
156807194|NCT01453036|566049555|FG002|Overall Study|Lost to Follow-up|31|||
156807195|NCT01815424|566049557|FG000|Week 0 to 16|Adverse Event|1|||
156807196|NCT01815424|566049558|FG001|Week 0 to 16|Adverse Event|3|||
156807197|NCT01815424|566049559|FG002|Week 0 to 16|Adverse Event|3|||
156807198|NCT01815424|566049560|FG003|Week 0 to 16|Adverse Event|0|||
156807199|NCT01815424|566049561|FG004|Week 0 to 16|Adverse Event|0|||
156807200|NCT01815424|566049557|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
156807201|NCT01815424|566049558|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807202|NCT01815424|566049559|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807203|NCT01815424|566049560|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807204|NCT01815424|566049561|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
156807205|NCT01815424|566049557|FG000|Week 0 to 16|Lost to Follow-up|0|||
156807206|NCT01815424|566049558|FG001|Week 0 to 16|Lost to Follow-up|1|||
156807207|NCT01815424|566049559|FG002|Week 0 to 16|Lost to Follow-up|0|||
156807208|NCT01815424|566049560|FG003|Week 0 to 16|Lost to Follow-up|0|||
156807209|NCT01815424|566049561|FG004|Week 0 to 16|Lost to Follow-up|0|||
156807210|NCT01815424|566049557|FG000|Week 0 to 16|Withdrawal by Subject|0|||
156807211|NCT01815424|566049558|FG001|Week 0 to 16|Withdrawal by Subject|0|||
156807212|NCT01815424|566049559|FG002|Week 0 to 16|Withdrawal by Subject|1|||
156882475|NCT01478048|566330810|FG001|Overall Study|Disease Progression|35|||
156882476|NCT01478048|566330809|FG000|Overall Study|study drug toxicity|11|||
156882477|NCT01478048|566330810|FG001|Overall Study|study drug toxicity|14|||
156882478|NCT01478048|566330809|FG000|Overall Study|Adverse Event|2|||
156807213|NCT01815424|566049560|FG003|Week 0 to 16|Withdrawal by Subject|0|||
156807214|NCT01815424|566049561|FG004|Week 0 to 16|Withdrawal by Subject|0|||
156807215|NCT01815424|566049557|FG000|Week 0 to 16|Other|1|||
156807216|NCT01815424|566049558|FG001|Week 0 to 16|Other|0|||
156807217|NCT01815424|566049559|FG002|Week 0 to 16|Other|3|||
156807218|NCT01815424|566049560|FG003|Week 0 to 16|Other|0|||
156807219|NCT01815424|566049561|FG004|Week 0 to 16|Other|0|||
156882479|NCT01478048|566330810|FG001|Overall Study|Adverse Event|11|||
156807220|NCT01815424|566049557|FG000|Week 0 to 16|Protocol Violation|1|||
156807221|NCT01815424|566049558|FG001|Week 0 to 16|Protocol Violation|0|||
156807222|NCT01815424|566049559|FG002|Week 0 to 16|Protocol Violation|0|||
156807223|NCT01815424|566049560|FG003|Week 0 to 16|Protocol Violation|0|||
156807224|NCT01815424|566049561|FG004|Week 0 to 16|Protocol Violation|0|||
156807225|NCT01815424|566049557|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
156807226|NCT01815424|566049558|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
156807227|NCT01815424|566049559|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
156807228|NCT01815424|566049560|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
156807229|NCT01815424|566049561|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
156807230|NCT01815424|566049557|FG000|Week 16 to 52|Other|0|||
156807231|NCT01815424|566049558|FG001|Week 16 to 52|Other|1|||
156807232|NCT01815424|566049559|FG002|Week 16 to 52|Other|0|||
156807233|NCT01815424|566049560|FG003|Week 16 to 52|Other|0|||
156807234|NCT01815424|566049561|FG004|Week 16 to 52|Other|0|||
156807235|NCT01815424|566049557|FG000|Week 16 to 52|Adverse Event|0|||
156807236|NCT01815424|566049558|FG001|Week 16 to 52|Adverse Event|0|||
156807237|NCT01815424|566049559|FG002|Week 16 to 52|Adverse Event|0|||
156807238|NCT01815424|566049560|FG003|Week 16 to 52|Adverse Event|0|||
156807239|NCT01815424|566049561|FG004|Week 16 to 52|Adverse Event|1|||
156807240|NCT01815424|566049557|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
156807241|NCT01815424|566049558|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
156807242|NCT01815424|566049559|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
156807243|NCT01815424|566049560|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
156807244|NCT01815424|566049561|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
156807245|NCT01815424|566049557|FG000|Week 16 to 52|Lost to Follow-up|0|||
156807246|NCT01815424|566049558|FG001|Week 16 to 52|Lost to Follow-up|2|||
156807247|NCT01815424|566049559|FG002|Week 16 to 52|Lost to Follow-up|0|||
156807248|NCT01815424|566049560|FG003|Week 16 to 52|Lost to Follow-up|2|||
156807249|NCT01815424|566049561|FG004|Week 16 to 52|Lost to Follow-up|1|||
156807250|NCT01815424|566049557|FG000|Week 16 to 52|Withdrawal by Subject|1|||
156807251|NCT01815424|566049558|FG001|Week 16 to 52|Withdrawal by Subject|2|||
156807252|NCT01815424|566049559|FG002|Week 16 to 52|Withdrawal by Subject|0|||
156807253|NCT01815424|566049560|FG003|Week 16 to 52|Withdrawal by Subject|0|||
156807254|NCT01815424|566049561|FG004|Week 16 to 52|Withdrawal by Subject|0|||
156807255|NCT04072835|566049562|FG000|Overall Study|Overall trial ended|603|||
156807256|NCT04072835|566049562|FG000|Overall Study|Ablation|97|||
156807257|NCT04072835|566049562|FG000|Overall Study|Withdrawal of consent|66|||
156807258|NCT04072835|566049562|FG000|Overall Study|Physician Decision|50|||
156807259|NCT04072835|566049562|FG000|Overall Study|Lost to Follow-up|39|||
156807260|NCT04072835|566049562|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
156807261|NCT04072835|566049562|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
156807262|NCT04072835|566049562|FG000|Overall Study|Adverse Event|25|||
156807263|NCT04072835|566049562|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
156807264|NCT04072835|566049562|FG000|Overall Study|Death|11|||
156807265|NCT04072835|566049562|FG000|Overall Study|Participant felt the drug did not work|8|||
156807266|NCT04072835|566049562|FG000|Overall Study|Participant tolerability|5|||
156807267|NCT04072835|566049562|FG000|Overall Study|Missing|5|||
156807268|NCT04072835|566049562|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
156807269|NCT04072835|566049562|FG000|Overall Study|Pregnancy|3|||
156807270|NCT02477527|566049563|FG000|Overall Study|Lost to Follow-up|2|||
156807271|NCT02477527|566049563|FG000|Overall Study|Withdrawal by Subject|1|||
156807272|NCT02477527|566049563|FG000|Overall Study|Screen Failure|3|||
156807273|NCT01976299|566049564|FG000|Overall Study|Withdrawal by Subject|3|||
156807274|NCT01976299|566049565|FG001|Overall Study|Withdrawal by Subject|1|||
156807275|NCT01976299|566049564|FG000|Overall Study|Death|4|||
156807276|NCT01976299|566049565|FG001|Overall Study|Death|2|||
156807277|NCT01976299|566049564|FG000|Overall Study|Lost to Follow-up|7|||
156807278|NCT01976299|566049565|FG001|Overall Study|Lost to Follow-up|1|||
156807279|NCT01976299|566049564|FG000|Overall Study|See clarification above in comments|9|||
156807280|NCT01976299|566049565|FG001|Overall Study|See clarification above in comments|2|||
156807281|NCT03692403|566049566|FG000|Overall Study|Withdrawal by Subject|1|||
156807282|NCT03692403|566049567|FG001|Overall Study|Withdrawal by Subject|0|||
156807283|NCT03692403|566049568|FG002|Overall Study|Withdrawal by Subject|1|||
156807284|NCT03692403|566049569|FG003|Overall Study|Withdrawal by Subject|0|||
157144921|NCT00923091|567277983|FG003|Period III (Single-Blind)|Adverse Event|0|||
156807285|NCT03692403|566049566|FG000|Overall Study|Adverse Event|0|||
156807286|NCT03692403|566049567|FG001|Overall Study|Adverse Event|0|||
156807287|NCT03692403|566049568|FG002|Overall Study|Adverse Event|0|||
156807288|NCT03692403|566049569|FG003|Overall Study|Adverse Event|1|||
156807289|NCT03692403|566049566|FG000|Overall Study|Pregnancy|0|||
156807290|NCT03692403|566049567|FG001|Overall Study|Pregnancy|1|||
156807291|NCT03692403|566049568|FG002|Overall Study|Pregnancy|0|||
156807292|NCT03692403|566049569|FG003|Overall Study|Pregnancy|0|||
156807293|NCT03692403|566049566|FG000|Overall Study|Other|0|||
156807294|NCT03692403|566049567|FG001|Overall Study|Other|0|||
156807295|NCT03692403|566049568|FG002|Overall Study|Other|1|||
156807296|NCT03692403|566049569|FG003|Overall Study|Other|0|||
156807297|NCT04567524|566049570|FG000|Overall Study|Adverse Event|1|||
156807298|NCT04567524|566049571|FG001|Overall Study|Adverse Event|1|||
157144922|NCT00923091|567277984|FG004|Period III (Single-Blind)|Adverse Event|0|||
157144923|NCT00923091|567277985|FG005|Period III (Single-Blind)|Adverse Event|0|||
157144924|NCT00923091|567277986|FG006|Period III (Single-Blind)|Adverse Event|0|||
157144925|NCT00923091|567277987|FG007|Period III (Single-Blind)|Adverse Event|0|||
157144926|NCT00923091|567277988|FG008|Period III (Single-Blind)|Adverse Event|0|||
157144927|NCT00923091|567277989|FG009|Period III (Single-Blind)|Adverse Event|0|||
156807299|NCT04567524|566049572|FG002|Overall Study|Adverse Event|0|||
156807300|NCT04567524|566049573|FG003|Overall Study|Adverse Event|0|||
156807301|NCT04567524|566049570|FG000|Overall Study|Withdrawal by Subject|2|||
156807302|NCT04567524|566049571|FG001|Overall Study|Withdrawal by Subject|0|||
156807303|NCT04567524|566049572|FG002|Overall Study|Withdrawal by Subject|0|||
156807304|NCT04567524|566049573|FG003|Overall Study|Withdrawal by Subject|1|||
156807305|NCT00856323|566049575|FG000|Overall Study|Withdrawal by Subject|2|||
156807306|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
156807307|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
156807308|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Adverse Event|2|||
156807309|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Adverse Event|1|||
156807310|NCT02848092|566049576|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
156807311|NCT02848092|566049577|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
156807312|NCT02848092|566049576|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
156807313|NCT02848092|566049577|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
156807314|NCT02848092|566049576|FG000|1-month Post-training Follow-up|fatigue|0|||
156807315|NCT02848092|566049577|FG001|1-month Post-training Follow-up|fatigue|1|||
156807316|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
156807317|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
156807318|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Adverse Event|1|||
156807319|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Adverse Event|1|||
156807320|NCT02848092|566049576|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
156807321|NCT02848092|566049577|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
156807322|NCT02848092|566049576|FG000|6-month Post-training Follow-up|frustrated with task|1|||
156807323|NCT02848092|566049577|FG001|6-month Post-training Follow-up|frustrated with task|0|||
156807324|NCT02848092|566049576|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
156807325|NCT02848092|566049577|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
156807326|NCT02848092|566049576|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
156807327|NCT02848092|566049577|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
156807328|NCT01639469|566049582|FG000|Overall Study|Death|4|||
156807329|NCT01639469|566049583|FG001|Overall Study|Death|2|||
156882480|NCT01478048|566330809|FG000|Overall Study|subject request to discontinue treatment|3|||
156882481|NCT01478048|566330810|FG001|Overall Study|subject request to discontinue treatment|5|||
156882482|NCT01478048|566330809|FG000|Overall Study|Withdrawal by Subject|2|||
156882483|NCT01478048|566330810|FG001|Overall Study|Withdrawal by Subject|5|||
156882484|NCT01478048|566330809|FG000|Overall Study|non-specified|6|||
156882485|NCT01478048|566330810|FG001|Overall Study|non-specified|4|||
156882486|NCT01478048|566330809|FG000|Overall Study|poor/non-compliance|0|||
156882487|NCT01478048|566330810|FG001|Overall Study|poor/non-compliance|1|||
157144928|NCT00923091|567277990|FG010|Period III (Single-Blind)|Adverse Event|0|||
157144929|NCT00923091|567277991|FG011|Period III (Single-Blind)|Adverse Event|0|||
157144930|NCT00923091|567277992|FG012|Period III (Single-Blind)|Adverse Event|0|||
157144931|NCT00923091|567277980|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
157144932|NCT00923091|567277981|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144933|NCT00923091|567277982|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
156807330|NCT01639469|566049582|FG000|Overall Study|Lost to Follow-up|1|||
156807331|NCT01639469|566049583|FG001|Overall Study|Lost to Follow-up|1|||
156807332|NCT01119443|566049584|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
156807333|NCT01119443|566049585|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
156807334|NCT02329743|566049588|FG000|Overall Study|Adverse Event|1|||
156807335|NCT02329743|566049589|FG001|Overall Study|Adverse Event|1|||
156807336|NCT02329743|566049590|FG002|Overall Study|Adverse Event|3|||
157144934|NCT00923091|567277983|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
157221217|NCT00368966|567556779|FG000|Infant Series|Withdrawal by Subject|11|||
156807337|NCT02329743|566049588|FG000|Overall Study|Lost to Follow-up|1|||
156807338|NCT02329743|566049589|FG001|Overall Study|Lost to Follow-up|0|||
156807339|NCT02329743|566049590|FG002|Overall Study|Lost to Follow-up|1|||
156882488|NCT01478048|566330809|FG000|Overall Study|no longer meets study criteria|1|||
156882489|NCT01478048|566330810|FG001|Overall Study|no longer meets study criteria|0|||
157144935|NCT00923091|567277984|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
156807340|NCT02329743|566049588|FG000|Overall Study|Withdrawal by Subject|4|||
156807341|NCT02329743|566049589|FG001|Overall Study|Withdrawal by Subject|4|||
156807342|NCT02329743|566049590|FG002|Overall Study|Withdrawal by Subject|1|||
156807343|NCT02329743|566049588|FG000|Overall Study|Other|0|||
157221218|NCT00368966|567556780|FG001|Infant Series|Withdrawal by Subject|6|||
157021500|NCT02783300|566830892|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021501|NCT02783300|566830893|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021502|NCT02783300|566830894|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
157021503|NCT02783300|566830895|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
157021504|NCT02783300|566830869|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021505|NCT02783300|566830870|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021506|NCT02783300|566830871|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021507|NCT02783300|566830872|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021508|NCT02783300|566830873|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021509|NCT02783300|566830874|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021510|NCT02783300|566830875|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021511|NCT02783300|566830876|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021512|NCT02783300|566830877|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021513|NCT02783300|566830878|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021514|NCT02783300|566830879|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021515|NCT02783300|566830880|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021516|NCT02783300|566830881|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021517|NCT02783300|566830882|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021518|NCT02783300|566830883|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021519|NCT02783300|566830884|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021520|NCT02783300|566830885|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021521|NCT02783300|566830886|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021522|NCT02783300|566830887|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021523|NCT02783300|566830888|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021524|NCT02783300|566830889|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021525|NCT02783300|566830890|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021526|NCT02783300|566830891|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021527|NCT02783300|566830892|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021528|NCT02783300|566830893|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021529|NCT02783300|566830894|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
157021530|NCT02783300|566830895|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
157021531|NCT03535272|566830896|FG000|Overall Study|Lost to Follow-up|71|||
157021532|NCT03535272|566830897|FG001|Overall Study|Lost to Follow-up|73|||
157021533|NCT01744782|566830898|FG000|Overall Study|Death|1|||
157021534|NCT04169373|566830899|FG000|Week 1 to Week 14|Adverse Event|1|||
157021535|NCT04169373|566830900|FG001|Week 1 to Week 14|Adverse Event|0|||
157021536|NCT04169373|566830901|FG002|Week 1 to Week 14|Adverse Event|1|||
157021537|NCT04169373|566830902|FG003|Week 1 to Week 14|Adverse Event|2|||
157021538|NCT04169373|566830899|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
157021539|NCT04169373|566830900|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
157221219|NCT00368966|567556779|FG000|Infant Series|Protocol Violation|2|||
157221220|NCT00368966|567556780|FG001|Infant Series|Protocol Violation|1|||
157221221|NCT00368966|567556779|FG000|Infant Series|Lost to Follow-up|2|||
157221222|NCT00368966|567556780|FG001|Infant Series|Lost to Follow-up|0|||
156807344|NCT02329743|566049589|FG001|Overall Study|Other|2|||
156807345|NCT02329743|566049590|FG002|Overall Study|Other|3|||
156807346|NCT01147393|566049597|FG000|Dose Level 1|Dose limiting Toxicity|2|||
156807347|NCT01147393|566049597|FG000|Dose Level -1|Dose Limited Toxicity|1|||
156807348|NCT01428219|566049604|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
156807349|NCT00825994|566049605|FG000|Overall Study|Withdrawal by Subject|2|||
156807350|NCT00825994|566049605|FG000|Overall Study|Lost to Follow-up|1|||
156807351|NCT00825994|566049605|FG000|Overall Study|Protocol Violation|1|||
156807352|NCT00825994|566049605|FG000|Overall Study|Placebo Responder at V2|1|||
156807353|NCT01833494|566049609|FG000|Overall Study|Adverse Event|24|||
156807354|NCT01833494|566049609|FG000|Overall Study|Physician Decision|6|||
156807355|NCT01833494|566049609|FG000|Overall Study|Withdrawal by Subject|6|||
156807356|NCT01833494|566049609|FG000|Overall Study|Decrease in serum phosphorus|4|||
156807357|NCT01833494|566049609|FG000|Overall Study|Decrease in serum calcium|4|||
156807358|NCT01833494|566049609|FG000|Overall Study|Increase in serum ferritin|1|||
156807359|NCT00600067|566049614|FG000|Overall Study|Adverse Event|0|||
156807360|NCT00600067|566049615|FG001|Overall Study|Adverse Event|1|||
156807361|NCT00600067|566049614|FG000|Overall Study|Lost to Follow-up|2|||
156807362|NCT00600067|566049615|FG001|Overall Study|Lost to Follow-up|3|||
157221223|NCT00368966|567556779|FG000|Infant Series|Randomization error|0|||
156807363|NCT00600067|566049614|FG000|Overall Study|protocol non-compliance|0|||
156807364|NCT00600067|566049615|FG001|Overall Study|protocol non-compliance|3|||
156807365|NCT00600067|566049614|FG000|Overall Study|Lack of Efficacy|1|||
156807366|NCT00600067|566049615|FG001|Overall Study|Lack of Efficacy|0|||
156807367|NCT04571060|566049619|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
157021540|NCT04169373|566830901|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
157021541|NCT04169373|566830902|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
157021542|NCT04169373|566830899|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
156807368|NCT04571060|566049620|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
156807369|NCT04571060|566049619|FG000|Overall Study|Never treated migraine|47|||
156807370|NCT04571060|566049620|FG001|Overall Study|Never treated migraine|36|||
156807371|NCT04571060|566049619|FG000|Overall Study|Protocol Violation|4|||
156807372|NCT04571060|566049620|FG001|Overall Study|Protocol Violation|2|||
156807373|NCT04571060|566049619|FG000|Overall Study|Withdrawal by Subject|6|||
156807374|NCT04571060|566049620|FG001|Overall Study|Withdrawal by Subject|2|||
156807375|NCT04571060|566049619|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
156807376|NCT04571060|566049620|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
156807377|NCT00625586|566049626|FG000|Overall Study|Adverse Event|1|||
156807378|NCT00625586|566049626|FG000|Overall Study|Progressive disease|1|||
156807379|NCT01171677|566049629|FG000|Overall Study|Withdrawal by Subject|0|||
156807380|NCT01171677|566049630|FG001|Overall Study|Withdrawal by Subject|3|||
156807381|NCT01171677|566049629|FG000|Overall Study|Adverse Event|1|||
156807382|NCT01171677|566049630|FG001|Overall Study|Adverse Event|0|||
156807383|NCT01171677|566049629|FG000|Overall Study|completed <70% IntenSati classes|5|||
156807384|NCT01171677|566049630|FG001|Overall Study|completed <70% IntenSati classes|0|||
156807385|NCT04819113|566049631|FG000|Overall Study|Withdrawal by parent/guardian|3|||
156807386|NCT04819113|566049631|FG000|Overall Study|Lost to Follow-up|1|||
156807387|NCT04819113|566049631|FG000|Overall Study|Withdrawn before vaccination|2|||
156807388|NCT00437268|566049632|FG000|Overall Study|Adverse Event|1|||
156807389|NCT00437268|566049633|FG001|Overall Study|Adverse Event|1|||
156807390|NCT00437268|566049632|FG000|Overall Study|Withdrawal by Subject|2|||
156807391|NCT00437268|566049633|FG001|Overall Study|Withdrawal by Subject|2|||
156807392|NCT00437268|566049632|FG000|Overall Study|Progressive disease|9|||
156807393|NCT00437268|566049633|FG001|Overall Study|Progressive disease|9|||
156807394|NCT00437268|566049632|FG000|Overall Study|Physician Decision|1|||
156807395|NCT00437268|566049633|FG001|Overall Study|Physician Decision|0|||
156807396|NCT00437268|566049632|FG000|Overall Study|Death|0|||
156807397|NCT00437268|566049633|FG001|Overall Study|Death|1|||
156807398|NCT00833027|566049638|FG000|Overall Study|Adverse Event|33|||
156807399|NCT00833027|566049638|FG000|Overall Study|Death|1|||
156807400|NCT00833027|566049638|FG000|Overall Study|Lack of Efficacy|12|||
156807401|NCT00833027|566049638|FG000|Overall Study|Lost to Follow-up|24|||
156807402|NCT00833027|566049638|FG000|Overall Study|Protocol Violation|115|||
156807403|NCT00833027|566049638|FG000|Overall Study|Withdrawal by Subject|16|||
156807404|NCT00833027|566049638|FG000|Overall Study|Missing|10|||
156807405|NCT00444925|566049639|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
156807406|NCT00444925|566049640|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
156807407|NCT00444925|566049641|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
156807408|NCT00444925|566049639|FG000|Double-blind Treatment Period|Death|2|||
156807409|NCT00444925|566049640|FG001|Double-blind Treatment Period|Death|0|||
156807410|NCT00444925|566049641|FG002|Double-blind Treatment Period|Death|0|||
156807411|NCT00444925|566049639|FG000|Double-blind Treatment Period|Adverse Event|6|||
156807412|NCT00444925|566049640|FG001|Double-blind Treatment Period|Adverse Event|28|||
156807413|NCT00444925|566049641|FG002|Double-blind Treatment Period|Adverse Event|44|||
156807414|NCT00444925|566049639|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
156807415|NCT00444925|566049640|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
156807416|NCT00444925|566049641|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
156807417|NCT00444925|566049639|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
156807418|NCT00444925|566049640|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
156807419|NCT00444925|566049641|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
156807420|NCT00444925|566049639|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
156807421|NCT00444925|566049640|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
156807422|NCT00444925|566049641|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
156807423|NCT00444925|566049639|FG000|Double-blind Treatment Period|Other|7|||
156807424|NCT00444925|566049640|FG001|Double-blind Treatment Period|Other|7|||
156807425|NCT00444925|566049641|FG002|Double-blind Treatment Period|Other|12|||
156807426|NCT01342094|566049645|FG000|Overall Study|Adverse Event|5|||
156807427|NCT01342094|566049646|FG001|Overall Study|Adverse Event|0|||
156807428|NCT01342094|566049645|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
156807429|NCT01342094|566049646|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
156807430|NCT01342094|566049645|FG000|Overall Study|Withdrawal by Subject|0|||
156807431|NCT01342094|566049646|FG001|Overall Study|Withdrawal by Subject|2|||
156807432|NCT02806414|566049649|FG000|Overall Study|Lost to Follow-up|2|||
156807433|NCT05653700|566049658|FG000|Overall Study|Non Responders|9|||
156807434|NCT05653700|566049659|FG001|Overall Study|Non Responders|0|||
156807435|NCT01085214|566049662|FG000|Overall Study|Alternate treatment required|1|||
156807436|NCT01985022|566049677|FG000|Overall Study|Lost to Follow-up|0|||
156807437|NCT01985022|566049678|FG001|Overall Study|Lost to Follow-up|1|||
156807438|NCT01985022|566049677|FG000|Overall Study|Protocol Violation|0|||
156807439|NCT01985022|566049678|FG001|Overall Study|Protocol Violation|1|||
156807440|NCT01985022|566049677|FG000|Overall Study|Withdrawal by Subject|4|||
156807441|NCT01985022|566049678|FG001|Overall Study|Withdrawal by Subject|1|||
157144936|NCT00923091|567277985|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144937|NCT00923091|567277986|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144938|NCT00923091|567277987|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144939|NCT00923091|567277988|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144940|NCT00923091|567277989|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144941|NCT00923091|567277990|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144942|NCT00923091|567277991|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144943|NCT00923091|567277992|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
157144944|NCT00923091|567277980|FG000|Period III (Single-Blind)|Protocol Violation|3|||
157144945|NCT00923091|567277981|FG001|Period III (Single-Blind)|Protocol Violation|0|||
157144946|NCT00923091|567277982|FG002|Period III (Single-Blind)|Protocol Violation|0|||
157144947|NCT00923091|567277983|FG003|Period III (Single-Blind)|Protocol Violation|0|||
157144948|NCT00923091|567277984|FG004|Period III (Single-Blind)|Protocol Violation|0|||
157144949|NCT00923091|567277985|FG005|Period III (Single-Blind)|Protocol Violation|0|||
157144950|NCT00923091|567277986|FG006|Period III (Single-Blind)|Protocol Violation|0|||
157144951|NCT00923091|567277987|FG007|Period III (Single-Blind)|Protocol Violation|0|||
157144952|NCT00923091|567277988|FG008|Period III (Single-Blind)|Protocol Violation|0|||
157144953|NCT00923091|567277989|FG009|Period III (Single-Blind)|Protocol Violation|0|||
157144954|NCT00923091|567277990|FG010|Period III (Single-Blind)|Protocol Violation|0|||
157144955|NCT00923091|567277991|FG011|Period III (Single-Blind)|Protocol Violation|0|||
157144956|NCT00923091|567277992|FG012|Period III (Single-Blind)|Protocol Violation|0|||
157144957|NCT00923091|567277980|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
157144958|NCT00923091|567277981|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
157144959|NCT00923091|567277982|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
157144960|NCT00923091|567277983|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
157144961|NCT00923091|567277984|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
157144962|NCT00923091|567277985|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
157144963|NCT00923091|567277986|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
157144964|NCT00923091|567277987|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
157144965|NCT00923091|567277988|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
157144966|NCT00923091|567277989|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
157144967|NCT00923091|567277990|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
157144968|NCT00923091|567277991|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
157144969|NCT00923091|567277992|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
157144970|NCT00923091|567277980|FG000|Period IV (Double-Blind)|Adverse Event|2|||
157144971|NCT00923091|567277981|FG001|Period IV (Double-Blind)|Adverse Event|0|||
157144972|NCT00923091|567277982|FG002|Period IV (Double-Blind)|Adverse Event|0|||
157144973|NCT00923091|567277983|FG003|Period IV (Double-Blind)|Adverse Event|0|||
157144974|NCT00923091|567277984|FG004|Period IV (Double-Blind)|Adverse Event|0|||
157144975|NCT00923091|567277985|FG005|Period IV (Double-Blind)|Adverse Event|0|||
157144976|NCT00923091|567277986|FG006|Period IV (Double-Blind)|Adverse Event|0|||
157144977|NCT00923091|567277987|FG007|Period IV (Double-Blind)|Adverse Event|0|||
157144978|NCT00923091|567277988|FG008|Period IV (Double-Blind)|Adverse Event|0|||
157144979|NCT00923091|567277989|FG009|Period IV (Double-Blind)|Adverse Event|0|||
157144980|NCT00923091|567277990|FG010|Period IV (Double-Blind)|Adverse Event|0|||
157144981|NCT00923091|567277991|FG011|Period IV (Double-Blind)|Adverse Event|0|||
157144982|NCT00923091|567277992|FG012|Period IV (Double-Blind)|Adverse Event|0|||
156807442|NCT01152437|566049679|FG000|Overall Study|Other Adverse Event|8|||
156807443|NCT01152437|566049680|FG001|Overall Study|Other Adverse Event|1|||
156807444|NCT01152437|566049681|FG002|Overall Study|Other Adverse Event|7|||
156807445|NCT01152437|566049679|FG000|Overall Study|Not treated|0|||
156807446|NCT01152437|566049680|FG001|Overall Study|Not treated|1|||
156807447|NCT01152437|566049681|FG002|Overall Study|Not treated|2|||
156807448|NCT01152437|566049679|FG000|Overall Study|Progressive disease|27|||
156807449|NCT01152437|566049680|FG001|Overall Study|Progressive disease|13|||
156807450|NCT01152437|566049681|FG002|Overall Study|Progressive disease|32|||
156807451|NCT01152437|566049679|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
156807452|NCT01152437|566049680|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
156807453|NCT01152437|566049681|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
156807454|NCT02015039|566049682|FG000|Overall Study|Not eligible|0|||
156807455|NCT02015039|566049683|FG001|Overall Study|Not eligible|1|||
156807456|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Not Eligible|3|||
156807457|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
156807458|NCT00403130|566049690|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
156807459|NCT00403130|566049690|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
157021543|NCT04169373|566830900|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
157144983|NCT00923091|567277980|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156807460|NCT00806260|566049691|FG000|Period 1 (1 Day)|Adverse Event|0|||
156807461|NCT00806260|566049692|FG001|Period 1 (1 Day)|Adverse Event|0|||
156807462|NCT00806260|566049693|FG002|Period 1 (1 Day)|Adverse Event|0|||
157144984|NCT00923091|567277981|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
157144985|NCT00923091|567277982|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144986|NCT00923091|567277983|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
156807463|NCT00806260|566049694|FG003|Period 1 (1 Day)|Adverse Event|0|||
156807464|NCT00806260|566049695|FG004|Period 1 (1 Day)|Adverse Event|3|||
156807465|NCT00806260|566049696|FG005|Period 1 (1 Day)|Adverse Event|0|||
156807466|NCT00806260|566049691|FG000|Period 2|Adverse Event|0|||
156807467|NCT00806260|566049692|FG001|Period 2|Adverse Event|0|||
156807468|NCT00806260|566049693|FG002|Period 2|Adverse Event|0|||
156807469|NCT00806260|566049694|FG003|Period 2|Adverse Event|1|||
156807470|NCT00806260|566049695|FG004|Period 2|Adverse Event|0|||
156807471|NCT00806260|566049696|FG005|Period 2|Adverse Event|0|||
156807472|NCT00806260|566049691|FG000|Period 2|Protocol Violation|1|||
156807473|NCT00806260|566049692|FG001|Period 2|Protocol Violation|0|||
156807474|NCT00806260|566049693|FG002|Period 2|Protocol Violation|1|||
156807475|NCT00806260|566049694|FG003|Period 2|Protocol Violation|0|||
156807476|NCT00806260|566049695|FG004|Period 2|Protocol Violation|0|||
156807477|NCT00806260|566049696|FG005|Period 2|Protocol Violation|0|||
156807478|NCT00806260|566049691|FG000|Period 2|Need to take concomitant medication|1|||
156807479|NCT00806260|566049692|FG001|Period 2|Need to take concomitant medication|0|||
156807480|NCT00806260|566049693|FG002|Period 2|Need to take concomitant medication|0|||
156807481|NCT00806260|566049694|FG003|Period 2|Need to take concomitant medication|0|||
156807482|NCT00806260|566049695|FG004|Period 2|Need to take concomitant medication|0|||
156807483|NCT00806260|566049696|FG005|Period 2|Need to take concomitant medication|0|||
156807484|NCT00806260|566049691|FG000|Period 2|sponsor request|0|||
156807485|NCT00806260|566049692|FG001|Period 2|sponsor request|0|||
156807486|NCT00806260|566049693|FG002|Period 2|sponsor request|1|||
156807487|NCT00806260|566049694|FG003|Period 2|sponsor request|1|||
156807488|NCT00806260|566049695|FG004|Period 2|sponsor request|0|||
156807489|NCT00806260|566049696|FG005|Period 2|sponsor request|0|||
156807490|NCT00806260|566049691|FG000|Period 3|Protocol Violation|0|||
156807491|NCT00806260|566049692|FG001|Period 3|Protocol Violation|1|||
156807492|NCT00806260|566049693|FG002|Period 3|Protocol Violation|1|||
156807493|NCT00806260|566049694|FG003|Period 3|Protocol Violation|0|||
156807494|NCT00806260|566049695|FG004|Period 3|Protocol Violation|0|||
156807495|NCT00806260|566049696|FG005|Period 3|Protocol Violation|0|||
156807496|NCT00806260|566049691|FG000|Period 3|Pregnancy|1|||
156807497|NCT00806260|566049692|FG001|Period 3|Pregnancy|0|||
156807498|NCT00806260|566049693|FG002|Period 3|Pregnancy|0|||
156807499|NCT00806260|566049694|FG003|Period 3|Pregnancy|0|||
156807500|NCT00806260|566049695|FG004|Period 3|Pregnancy|0|||
156807501|NCT00806260|566049696|FG005|Period 3|Pregnancy|0|||
156807502|NCT02670473|566049697|FG000|Overall Study|Withdrawal by Subject|1|||
156807503|NCT01404234|566049698|FG000|Overall Study|Withdrawal by Subject|2|||
156808889|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
156808890|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
156808891|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
156808892|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
156808893|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
156808894|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
156808895|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808896|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808897|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
156808898|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
156808899|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
156808900|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
156808901|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
156808902|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
156808903|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
156808904|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
156808905|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
156808906|NCT02831855|566054502|FG000|Open Label Phase (24 Weeks)|Other|4|||
156808907|NCT02831855|566054503|FG001|Open Label Phase (24 Weeks)|Other|0|||
156808908|NCT02831855|566054504|FG002|Open Label Phase (24 Weeks)|Other|0|||
156808909|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
156808910|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
156808911|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
156808912|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Death|0|||
156808913|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Death|0|||
156808914|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Death|2|||
156808915|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
156808916|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
156808917|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
156808918|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
157021544|NCT04169373|566830901|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
157021545|NCT04169373|566830902|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
156808919|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
156808920|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
156808921|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
156807504|NCT03145064|566051097|FG000|Overall Study|Death|24|||
156807505|NCT03145064|566051097|FG000|Overall Study|Lost to Follow-up|3|||
156807506|NCT03145064|566051097|FG000|Overall Study|Withdrawal by Subject|6|||
156807507|NCT03145064|566051097|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
156807508|NCT03145064|566051097|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
156807509|NCT00661830|566051098|FG000|Overall Study|Death|37|||
156807510|NCT00661830|566051099|FG001|Overall Study|Death|33|||
156807511|NCT00661830|566051098|FG000|Overall Study|Lost to Follow-up|1|||
156807512|NCT00661830|566051099|FG001|Overall Study|Lost to Follow-up|3|||
156807513|NCT00661830|566051098|FG000|Overall Study|Withdrawal by Subject|1|||
156807514|NCT00661830|566051099|FG001|Overall Study|Withdrawal by Subject|1|||
156807515|NCT00661830|566051098|FG000|Overall Study|Other reason|1|||
156807516|NCT00661830|566051099|FG001|Overall Study|Other reason|5|||
156807517|NCT00551031|566051103|FG000|Overall Study|Adverse Event|0|||
156807518|NCT00551031|566051104|FG001|Overall Study|Adverse Event|1|||
156807519|NCT00551031|566051105|FG002|Overall Study|Adverse Event|0|||
156807520|NCT00551031|566051106|FG003|Overall Study|Adverse Event|0|||
156807521|NCT00551031|566051107|FG004|Overall Study|Adverse Event|0|||
156807522|NCT00551031|566051103|FG000|Overall Study|Protocol Violation|1|||
156807523|NCT00551031|566051104|FG001|Overall Study|Protocol Violation|1|||
156807524|NCT00551031|566051105|FG002|Overall Study|Protocol Violation|0|||
156807525|NCT00551031|566051106|FG003|Overall Study|Protocol Violation|0|||
156807526|NCT00551031|566051107|FG004|Overall Study|Protocol Violation|0|||
156807527|NCT00551031|566051103|FG000|Overall Study|Lost to Follow-up|0|||
156807528|NCT00551031|566051104|FG001|Overall Study|Lost to Follow-up|1|||
156807529|NCT00551031|566051105|FG002|Overall Study|Lost to Follow-up|0|||
156807530|NCT00551031|566051106|FG003|Overall Study|Lost to Follow-up|1|||
156807531|NCT00551031|566051107|FG004|Overall Study|Lost to Follow-up|1|||
156807532|NCT00551031|566051103|FG000|Overall Study|Withdrawal by Subject|0|||
156807533|NCT00551031|566051104|FG001|Overall Study|Withdrawal by Subject|4|||
156807534|NCT00551031|566051105|FG002|Overall Study|Withdrawal by Subject|1|||
156807535|NCT00551031|566051106|FG003|Overall Study|Withdrawal by Subject|2|||
156807536|NCT00551031|566051107|FG004|Overall Study|Withdrawal by Subject|0|||
156807537|NCT00551031|566051103|FG000|Overall Study|Serious Adverse Event|0|||
156807538|NCT00551031|566051104|FG001|Overall Study|Serious Adverse Event|2|||
156807539|NCT00551031|566051105|FG002|Overall Study|Serious Adverse Event|1|||
156807540|NCT00551031|566051106|FG003|Overall Study|Serious Adverse Event|0|||
156807541|NCT00551031|566051107|FG004|Overall Study|Serious Adverse Event|0|||
156807542|NCT00551031|566051103|FG000|Overall Study|Did not receive vaccine|1|||
156807543|NCT00551031|566051104|FG001|Overall Study|Did not receive vaccine|2|||
156807544|NCT00551031|566051105|FG002|Overall Study|Did not receive vaccine|0|||
156807545|NCT00551031|566051106|FG003|Overall Study|Did not receive vaccine|0|||
156807546|NCT00551031|566051107|FG004|Overall Study|Did not receive vaccine|0|||
156807547|NCT01650831|566051111|FG000|Overall Study|Screen failure|1|||
156807548|NCT00456755|566051114|FG000|Overall Study|Lost to Follow-up|2|||
156807549|NCT00456755|566051115|FG001|Overall Study|Lost to Follow-up|1|||
156807550|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
156807551|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807552|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807553|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
156807554|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807555|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
156807556|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807557|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
156807558|NCT02964273|566051116|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
156807559|NCT02964273|566051117|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
156807560|NCT02964273|566051118|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
156807561|NCT02964273|566051119|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
156807562|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807563|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807564|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
156807565|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
156807566|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
156807567|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
156807568|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
156807569|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
156807570|NCT02964273|566051116|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
156807571|NCT02964273|566051117|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
156807572|NCT02964273|566051118|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
156807573|NCT02964273|566051119|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
156807574|NCT01336712|566051121|FG000|Overall Study|Death|2|||
156807575|NCT01336712|566051121|FG000|Overall Study|Lack of Efficacy|1|||
157144987|NCT00923091|567277984|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144988|NCT00923091|567277985|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144989|NCT00923091|567277986|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144990|NCT00923091|567277987|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144991|NCT00923091|567277988|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144992|NCT00923091|567277989|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144993|NCT00923091|567277990|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144994|NCT00923091|567277991|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144995|NCT00923091|567277992|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
157144996|NCT00923091|567277980|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
157144997|NCT00923091|567277981|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
157144998|NCT00923091|567277982|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
157144999|NCT00923091|567277983|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
157145000|NCT00923091|567277984|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
157145001|NCT00923091|567277985|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
157145002|NCT00923091|567277986|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
157145003|NCT00923091|567277987|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
157145004|NCT00923091|567277988|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
157145005|NCT00923091|567277989|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
157145006|NCT00923091|567277990|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
157145007|NCT00923091|567277991|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
157145008|NCT00923091|567277992|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
157145009|NCT00923091|567277980|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145010|NCT00923091|567277981|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145011|NCT00923091|567277982|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145012|NCT00923091|567277983|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145013|NCT00923091|567277984|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
156807576|NCT03073525|566051123|FG000|Overall Study|Withdrawal by Subject|0|||
156807577|NCT03073525|566051124|FG001|Overall Study|Withdrawal by Subject|0|||
156807578|NCT03073525|566051125|FG002|Overall Study|Withdrawal by Subject|3|||
156807579|NCT00856635|566051126|FG000|Overall Study|Lost to Follow-up|2|||
156807580|NCT00856635|566051127|FG001|Overall Study|Lost to Follow-up|5|||
156807581|NCT00856635|566051126|FG000|Overall Study|Pregnancy|1|||
156807582|NCT00856635|566051127|FG001|Overall Study|Pregnancy|0|||
156807583|NCT00856635|566051126|FG000|Overall Study|Withdrawal by Subject|3|||
156807584|NCT00856635|566051127|FG001|Overall Study|Withdrawal by Subject|1|||
156807585|NCT00856635|566051126|FG000|Overall Study|Serious Adverse Event|1|||
156807586|NCT00856635|566051127|FG001|Overall Study|Serious Adverse Event|0|||
156807587|NCT00856635|566051126|FG000|Overall Study|Other|1|||
156807588|NCT00856635|566051127|FG001|Overall Study|Other|0|||
156807589|NCT00856635|566051126|FG000|Overall Study|Discontinued at Randomization|2|||
156807590|NCT00856635|566051127|FG001|Overall Study|Discontinued at Randomization|2|||
156807591|NCT02383862|566051128|FG000|3 Month Follow up|Lost to Follow-up|23|||
156807592|NCT02383862|566051129|FG001|3 Month Follow up|Lost to Follow-up|21|||
156807593|NCT01665911|566051130|FG000|Overall Study|Protocol Violation|4|||
156807594|NCT01665911|566051130|FG000|Overall Study|Withdrawal by Subject|1|||
156807595|NCT01665911|566051130|FG000|Overall Study|Adverse Event|1|||
156807596|NCT00506779|566051131|FG000|Overall Study|Withdrawal by Subject|1|||
156807597|NCT00506779|566051132|FG001|Overall Study|Withdrawal by Subject|0|||
156807598|NCT00506779|566051133|FG002|Overall Study|Withdrawal by Subject|1|||
156807599|NCT00506779|566051134|FG003|Overall Study|Withdrawal by Subject|0|||
156807600|NCT00506779|566051131|FG000|Overall Study|Adverse Event|0|||
156807601|NCT00506779|566051132|FG001|Overall Study|Adverse Event|1|||
156807602|NCT00506779|566051133|FG002|Overall Study|Adverse Event|1|||
156807603|NCT00506779|566051134|FG003|Overall Study|Adverse Event|1|||
156807604|NCT03198767|566051135|FG000|Overall Study|Protocol Violation|0|||
157145014|NCT00923091|567277985|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
156807605|NCT03198767|566051136|FG001|Overall Study|Protocol Violation|0|||
156807606|NCT03198767|566051137|FG002|Overall Study|Protocol Violation|0|||
156807607|NCT03198767|566051138|FG003|Overall Study|Protocol Violation|6|||
156807608|NCT03198767|566051139|FG004|Overall Study|Protocol Violation|0|||
156807609|NCT03198767|566051140|FG005|Overall Study|Protocol Violation|0|||
156807610|NCT03198767|566051141|FG006|Overall Study|Protocol Violation|0|||
156807611|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
156807612|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
156807613|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807614|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
157145015|NCT00923091|567277986|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145016|NCT00923091|567277987|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
156807615|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807616|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
156807617|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
156807618|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
156807619|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807620|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807621|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807622|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
156807623|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807624|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
157145017|NCT00923091|567277988|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
157145018|NCT00923091|567277989|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145019|NCT00923091|567277990|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145020|NCT00923091|567277991|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
157145021|NCT00923091|567277992|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
156807625|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807626|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807627|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807628|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
156807629|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
156807630|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
156807631|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807632|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807633|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807634|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
156807635|NCT02820844|566051142|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
156807636|NCT02820844|566051143|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807637|NCT02820844|566051144|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807638|NCT02820844|566051145|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807639|NCT02820844|566051146|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807640|NCT02820844|566051147|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
156807641|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807642|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807643|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
156807644|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
156807645|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807646|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
156807647|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807648|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807649|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
156807650|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807651|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807652|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
156807653|NCT02820844|566051142|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807654|NCT02820844|566051143|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807655|NCT02820844|566051144|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
156807656|NCT02820844|566051145|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
156807657|NCT02820844|566051146|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807658|NCT02820844|566051147|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807659|NCT02820844|566051142|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807660|NCT02820844|566051143|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807661|NCT02820844|566051144|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807662|NCT02820844|566051145|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807663|NCT02820844|566051146|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
156807664|NCT02820844|566051147|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
156807665|NCT02820844|566051142|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807666|NCT02820844|566051143|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807667|NCT02820844|566051144|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807668|NCT02820844|566051145|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807669|NCT02820844|566051146|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
156807670|NCT02820844|566051147|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
156807671|NCT00739310|566051148|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
156807672|NCT00739310|566051148|FG000|Overall Study|Withdrawal by Subject|1|||
156807673|NCT00739310|566051148|FG000|Overall Study|Lost to Follow-up|2|||
156807674|NCT02954887|566051149|FG000|Overall Study|Withdrawal by Subject|3|||
156807675|NCT02954887|566051149|FG000|Overall Study|Lack of Efficacy|3|||
156807676|NCT02954887|566051149|FG000|Overall Study|Other|1|||
156807677|NCT01492088|566051150|FG000|Overall Study|Withdrawal by Patient|0|||
156807678|NCT01492088|566051151|FG001|Overall Study|Withdrawal by Patient|2|||
156807679|NCT01492088|566051152|FG002|Overall Study|Withdrawal by Patient|0|||
156807680|NCT01492088|566051150|FG000|Overall Study|Death|1|||
156807681|NCT01492088|566051151|FG001|Overall Study|Death|6|||
156807682|NCT01492088|566051152|FG002|Overall Study|Death|2|||
156807683|NCT01492088|566051150|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
156807684|NCT01492088|566051151|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
156807685|NCT01492088|566051152|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
156807686|NCT01492088|566051150|FG000|Overall Study|Alive at Last Follow-up|0|||
156807687|NCT01492088|566051151|FG001|Overall Study|Alive at Last Follow-up|6|||
156807688|NCT01492088|566051152|FG002|Overall Study|Alive at Last Follow-up|11|||
156807689|NCT02803203|566051153|FG000|Overall Study|Adverse Event|4|||
156807690|NCT02803203|566051153|FG000|Overall Study|Death|4|||
156807691|NCT02803203|566051153|FG000|Overall Study|Progressive disease|29|||
156807692|NCT02803203|566051153|FG000|Overall Study|Withdrawal by Subject|8|||
156807693|NCT02803203|566051153|FG000|Overall Study|Complete resection of target disease|2|||
156807694|NCT02803203|566051153|FG000|Overall Study|Switched to commercial Osi|1|||
156807695|NCT02803203|566051153|FG000|Overall Study|Participant moved away|1|||
156807696|NCT00590967|566051154|FG000|Overall Study|Withdrawal by Subject|1|||
156807697|NCT00590967|566051155|FG001|Overall Study|Withdrawal by Subject|1|||
156807698|NCT00590967|566051154|FG000|Overall Study|Ineligible|1|||
156807699|NCT00590967|566051155|FG001|Overall Study|Ineligible|0|||
156807700|NCT00590967|566051154|FG000|Overall Study|Poor performance status|0|||
156807701|NCT00590967|566051155|FG001|Overall Study|Poor performance status|1|||
156807702|NCT00590967|566051154|FG000|Overall Study|Non-compliant|0|||
156807703|NCT00590967|566051155|FG001|Overall Study|Non-compliant|2|||
156807704|NCT00590967|566051154|FG000|Overall Study|Did not sign consent form|0|||
156807705|NCT00590967|566051155|FG001|Overall Study|Did not sign consent form|1|||
156807706|NCT00590967|566051154|FG000|Overall Study|Did not receive chemo per protocol|1|||
156807707|NCT00590967|566051155|FG001|Overall Study|Did not receive chemo per protocol|0|||
156807708|NCT01881789|566051156|FG000|Overall Study|Withdrawal by Subject|0|||
156807709|NCT01881789|566051157|FG001|Overall Study|Withdrawal by Subject|2|||
156807710|NCT01881789|566051158|FG002|Overall Study|Withdrawal by Subject|1|||
156807711|NCT01881789|566051159|FG003|Overall Study|Withdrawal by Subject|0|||
156807712|NCT01881789|566051160|FG004|Overall Study|Withdrawal by Subject|1|||
156807713|NCT01881789|566051161|FG005|Overall Study|Withdrawal by Subject|1|||
156807714|NCT01881789|566051156|FG000|Overall Study|Study Terminated by Sponsor|0|||
156807715|NCT01881789|566051157|FG001|Overall Study|Study Terminated by Sponsor|0|||
156807716|NCT01881789|566051158|FG002|Overall Study|Study Terminated by Sponsor|0|||
156807717|NCT01881789|566051159|FG003|Overall Study|Study Terminated by Sponsor|0|||
156807718|NCT01881789|566051160|FG004|Overall Study|Study Terminated by Sponsor|0|||
156807719|NCT01881789|566051161|FG005|Overall Study|Study Terminated by Sponsor|1|||
156807720|NCT01881789|566051156|FG000|Overall Study|Other|3|||
156807721|NCT01881789|566051157|FG001|Overall Study|Other|5|||
156807722|NCT01881789|566051158|FG002|Overall Study|Other|2|||
156807723|NCT01881789|566051159|FG003|Overall Study|Other|3|||
156807724|NCT01881789|566051160|FG004|Overall Study|Other|1|||
156807725|NCT01881789|566051161|FG005|Overall Study|Other|1|||
156807726|NCT01887717|566051162|FG000|Overall Study|Withdrawal by Subject|1|||
156807727|NCT01887717|566051163|FG001|Overall Study|Withdrawal by Subject|7|||
156807728|NCT01887717|566051162|FG000|Overall Study|Physician Decision|0|||
156807729|NCT01887717|566051163|FG001|Overall Study|Physician Decision|2|||
156807730|NCT01887717|566051162|FG000|Overall Study|Administrative reasons|5|||
156807731|NCT01887717|566051163|FG001|Overall Study|Administrative reasons|2|||
156807732|NCT00920556|566051164|FG000|Overall Study|Adverse Event|16|||
156807733|NCT00920556|566051164|FG000|Overall Study|Physician Decision|7|||
156807734|NCT00920556|566051164|FG000|Overall Study|Withdrawal by Subject|1|||
156807735|NCT01299389|566051165|FG000|Double-blind|Adverse Event|45|||
156807736|NCT01299389|566051166|FG001|Double-blind|Adverse Event|27|||
156807737|NCT01299389|566051167|FG002|Double-blind|Adverse Event|0|||
156807738|NCT01299389|566051168|FG003|Double-blind|Adverse Event|0|||
156807739|NCT01299389|566051165|FG000|Double-blind|Lack of Efficacy|45|||
156807740|NCT01299389|566051166|FG001|Double-blind|Lack of Efficacy|21|||
156807741|NCT01299389|566051167|FG002|Double-blind|Lack of Efficacy|0|||
156807742|NCT01299389|566051168|FG003|Double-blind|Lack of Efficacy|0|||
156807743|NCT01299389|566051165|FG000|Double-blind|Lost to Follow-up|2|||
156807744|NCT01299389|566051166|FG001|Double-blind|Lost to Follow-up|1|||
156807745|NCT01299389|566051167|FG002|Double-blind|Lost to Follow-up|0|||
156807746|NCT01299389|566051168|FG003|Double-blind|Lost to Follow-up|0|||
156807747|NCT01299389|566051165|FG000|Double-blind|Withdrawal by Subject|16|||
156807748|NCT01299389|566051166|FG001|Double-blind|Withdrawal by Subject|13|||
156807749|NCT01299389|566051167|FG002|Double-blind|Withdrawal by Subject|0|||
156807750|NCT01299389|566051168|FG003|Double-blind|Withdrawal by Subject|0|||
156807751|NCT01299389|566051165|FG000|Double-blind|Other|1|||
156807752|NCT01299389|566051166|FG001|Double-blind|Other|1|||
156807753|NCT01299389|566051167|FG002|Double-blind|Other|0|||
156807754|NCT01299389|566051168|FG003|Double-blind|Other|0|||
156807755|NCT01299389|566051165|FG000|Double-blind|"fail to meet study population criteria"|0|||
156807756|NCT01299389|566051166|FG001|Double-blind|"fail to meet study population criteria"|1|||
157145022|NCT00923091|567277980|FG000|Period V (Double -Blind)|Protocol Violation|0|||
157145023|NCT00923091|567277981|FG001|Period V (Double -Blind)|Protocol Violation|0|||
157145024|NCT00923091|567277982|FG002|Period V (Double -Blind)|Protocol Violation|0|||
157145025|NCT00923091|567277983|FG003|Period V (Double -Blind)|Protocol Violation|0|||
157145026|NCT00923091|567277984|FG004|Period V (Double -Blind)|Protocol Violation|0|||
157145027|NCT00923091|567277985|FG005|Period V (Double -Blind)|Protocol Violation|0|||
157145028|NCT00923091|567277986|FG006|Period V (Double -Blind)|Protocol Violation|0|||
156807757|NCT01299389|566051167|FG002|Double-blind|"fail to meet study population criteria"|0|||
156807758|NCT01299389|566051168|FG003|Double-blind|"fail to meet study population criteria"|0|||
156807759|NCT01299389|566051165|FG000|Post-observational|Other|0|||
156807760|NCT01299389|566051166|FG001|Post-observational|Other|0|||
156807761|NCT01299389|566051167|FG002|Post-observational|Other|12|||
156807762|NCT01299389|566051168|FG003|Post-observational|Other|6|||
156807763|NCT03637491|566051169|FG000|Overall Study|Death|9|||
156807764|NCT03637491|566051170|FG001|Overall Study|Death|9|||
156807765|NCT03637491|566051171|FG002|Overall Study|Death|5|||
156807766|NCT03637491|566051172|FG003|Overall Study|Death|3|||
156807767|NCT03637491|566051169|FG000|Overall Study|Lost to Follow-up|0|||
156807768|NCT03637491|566051170|FG001|Overall Study|Lost to Follow-up|1|||
156807769|NCT03637491|566051171|FG002|Overall Study|Lost to Follow-up|0|||
156807770|NCT03637491|566051172|FG003|Overall Study|Lost to Follow-up|1|||
156807771|NCT03637491|566051169|FG000|Overall Study|Study Terminated By Sponsor|0|||
156807772|NCT03637491|566051170|FG001|Overall Study|Study Terminated By Sponsor|2|||
156807773|NCT03637491|566051171|FG002|Overall Study|Study Terminated By Sponsor|1|||
156807774|NCT03637491|566051172|FG003|Overall Study|Study Terminated By Sponsor|0|||
156807775|NCT03637491|566051169|FG000|Overall Study|Withdrawal by Subject|1|||
156807776|NCT03637491|566051170|FG001|Overall Study|Withdrawal by Subject|0|||
156807777|NCT03637491|566051171|FG002|Overall Study|Withdrawal by Subject|1|||
156807778|NCT03637491|566051172|FG003|Overall Study|Withdrawal by Subject|2|||
156807779|NCT00889707|566051174|FG000|Overall Study|Adverse Event|1|||
156807780|NCT00889707|566051175|FG001|Overall Study|Adverse Event|0|||
156807781|NCT00889707|566051174|FG000|Overall Study|Withdrawal by Subject|4|||
156807782|NCT00889707|566051175|FG001|Overall Study|Withdrawal by Subject|3|||
156807783|NCT00889707|566051174|FG000|Overall Study|Lost to Follow-up|0|||
156807784|NCT00889707|566051175|FG001|Overall Study|Lost to Follow-up|2|||
156807785|NCT00889707|566051174|FG000|Overall Study|Lack of Efficacy|2|||
156807786|NCT00889707|566051175|FG001|Overall Study|Lack of Efficacy|5|||
156807787|NCT02185534|566051176|FG000|First Period|Withdrawal by Subject|0|||
156807788|NCT02185534|566051177|FG001|First Period|Withdrawal by Subject|0|||
156807789|NCT02185534|566051178|FG002|First Period|Withdrawal by Subject|0|||
156807790|NCT02185534|566051179|FG003|First Period|Withdrawal by Subject|1|||
156807791|NCT02185534|566051180|FG004|First Period|Withdrawal by Subject|0|||
156807792|NCT02185534|566051181|FG005|First Period|Withdrawal by Subject|0|||
156807793|NCT02185534|566051176|FG000|First Washout Period|Withdrawal by Subject|1|||
156807794|NCT02185534|566051177|FG001|First Washout Period|Withdrawal by Subject|0|||
156807795|NCT02185534|566051178|FG002|First Washout Period|Withdrawal by Subject|0|||
156807796|NCT02185534|566051179|FG003|First Washout Period|Withdrawal by Subject|0|||
156807797|NCT02185534|566051180|FG004|First Washout Period|Withdrawal by Subject|1|||
156807798|NCT02185534|566051181|FG005|First Washout Period|Withdrawal by Subject|0|||
156807799|NCT02185534|566051176|FG000|First Washout Period|Protocol Violation|0|||
156807800|NCT02185534|566051177|FG001|First Washout Period|Protocol Violation|0|||
156807801|NCT02185534|566051178|FG002|First Washout Period|Protocol Violation|0|||
156807802|NCT02185534|566051179|FG003|First Washout Period|Protocol Violation|0|||
156807803|NCT02185534|566051180|FG004|First Washout Period|Protocol Violation|0|||
156807804|NCT02185534|566051181|FG005|First Washout Period|Protocol Violation|1|||
156807805|NCT01151020|566051185|FG000|Overall Study|Death|25|||
156807806|NCT01151020|566051185|FG000|Overall Study|Conversion to open repair|1|||
156807807|NCT01151020|566051185|FG000|Overall Study|Lost to Follow-up|4|||
156807808|NCT01151020|566051185|FG000|Overall Study|Withdrawal by Subject|22|||
156807809|NCT01151020|566051185|FG000|Overall Study|Patients did not receive the device|2|||
156807810|NCT01635998|566051186|FG000|Overall Study|Death|1|||
156807811|NCT01635998|566051187|FG001|Overall Study|Death|1|||
156807812|NCT01635998|566051186|FG000|Overall Study|Lost to Follow-up|2|||
156807813|NCT01635998|566051187|FG001|Overall Study|Lost to Follow-up|1|||
157145029|NCT00923091|567277987|FG007|Period V (Double -Blind)|Protocol Violation|0|||
156807814|NCT01635998|566051186|FG000|Overall Study|Withdrawal by Subject|1|||
156807815|NCT01635998|566051187|FG001|Overall Study|Withdrawal by Subject|5|||
156807816|NCT04419467|566051188|FG000|Overall Study|Not treated with IP|0|||
156807817|NCT04419467|566051189|FG001|Overall Study|Not treated with IP|0|||
157145030|NCT00923091|567277988|FG008|Period V (Double -Blind)|Protocol Violation|0|||
156807818|NCT04419467|566051190|FG002|Overall Study|Not treated with IP|2|||
156807819|NCT04419467|566051188|FG000|Overall Study|Adverse Event|0|||
156807820|NCT04419467|566051189|FG001|Overall Study|Adverse Event|2|||
156807821|NCT04419467|566051190|FG002|Overall Study|Adverse Event|0|||
156807822|NCT04419467|566051188|FG000|Overall Study|Death|1|||
156807823|NCT04419467|566051189|FG001|Overall Study|Death|0|||
156807824|NCT04419467|566051190|FG002|Overall Study|Death|0|||
156807825|NCT04419467|566051188|FG000|Overall Study|Lost to Follow-up|0|||
156807826|NCT04419467|566051189|FG001|Overall Study|Lost to Follow-up|1|||
156807827|NCT04419467|566051190|FG002|Overall Study|Lost to Follow-up|2|||
156807828|NCT04419467|566051188|FG000|Overall Study|Withdrawal by Subject|0|||
156807829|NCT04419467|566051189|FG001|Overall Study|Withdrawal by Subject|0|||
156807830|NCT04419467|566051190|FG002|Overall Study|Withdrawal by Subject|4|||
156807831|NCT04419467|566051188|FG000|Overall Study|Pandemic related|0|||
156807832|NCT04419467|566051189|FG001|Overall Study|Pandemic related|0|||
156807833|NCT04419467|566051190|FG002|Overall Study|Pandemic related|1|||
157145031|NCT00923091|567277989|FG009|Period V (Double -Blind)|Protocol Violation|0|||
157145032|NCT00923091|567277990|FG010|Period V (Double -Blind)|Protocol Violation|0|||
157145033|NCT00923091|567277991|FG011|Period V (Double -Blind)|Protocol Violation|0|||
157145034|NCT00923091|567277992|FG012|Period V (Double -Blind)|Protocol Violation|1|||
157145035|NCT00923091|567277980|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
157145036|NCT00923091|567277981|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
157145037|NCT00923091|567277982|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
157145038|NCT00923091|567277983|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
157145039|NCT00923091|567277984|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
157145040|NCT00923091|567277985|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
156807834|NCT04419467|566051188|FG000|Overall Study|Reason not known|1|||
156807835|NCT04419467|566051189|FG001|Overall Study|Reason not known|0|||
156807836|NCT04419467|566051190|FG002|Overall Study|Reason not known|0|||
156807837|NCT00003631|566051195|FG000|Overall Study|Patient not treated|1|||
156807838|NCT00003631|566051196|FG001|Overall Study|Patient not treated|0|||
156807839|NCT00003631|566051197|FG002|Overall Study|Patient not treated|1|||
156807840|NCT00003631|566051195|FG000|Overall Study|Protocol Violation|1|||
156807841|NCT00003631|566051196|FG001|Overall Study|Protocol Violation|0|||
156807842|NCT00003631|566051197|FG002|Overall Study|Protocol Violation|0|||
156807843|NCT00003631|566051195|FG000|Overall Study|Adverse Event|1|||
156807844|NCT00003631|566051196|FG001|Overall Study|Adverse Event|1|||
156807845|NCT00003631|566051197|FG002|Overall Study|Adverse Event|5|||
156807846|NCT00003631|566051195|FG000|Overall Study|Death|0|||
156807847|NCT00003631|566051196|FG001|Overall Study|Death|0|||
156807848|NCT00003631|566051197|FG002|Overall Study|Death|1|||
156807849|NCT00003631|566051195|FG000|Overall Study|Evaluable for toxicity only|0|||
156807850|NCT00003631|566051196|FG001|Overall Study|Evaluable for toxicity only|0|||
156807851|NCT00003631|566051197|FG002|Overall Study|Evaluable for toxicity only|2|||
156807852|NCT03943290|566051207|FG000|Overall Study|Sponsor Terminated Study|6|||
156807853|NCT03943290|566051208|FG001|Overall Study|Sponsor Terminated Study|1|||
156807854|NCT03943290|566051209|FG002|Overall Study|Sponsor Terminated Study|11|||
156807855|NCT03943290|566051210|FG003|Overall Study|Sponsor Terminated Study|6|||
156807856|NCT03943290|566051211|FG004|Overall Study|Sponsor Terminated Study|7|||
156807857|NCT03943290|566051212|FG005|Overall Study|Sponsor Terminated Study|6|||
156807858|NCT03943290|566051213|FG006|Overall Study|Sponsor Terminated Study|6|||
156807859|NCT03943290|566051214|FG007|Overall Study|Sponsor Terminated Study|7|||
156807860|NCT03943290|566051215|FG008|Overall Study|Sponsor Terminated Study|8|||
156807861|NCT03943290|566051207|FG000|Overall Study|Lost to Follow-up|1|||
156807862|NCT03943290|566051208|FG001|Overall Study|Lost to Follow-up|0|||
156807863|NCT03943290|566051209|FG002|Overall Study|Lost to Follow-up|1|||
156807864|NCT03943290|566051210|FG003|Overall Study|Lost to Follow-up|0|||
156807865|NCT03943290|566051211|FG004|Overall Study|Lost to Follow-up|0|||
156807866|NCT03943290|566051212|FG005|Overall Study|Lost to Follow-up|0|||
156807867|NCT03943290|566051213|FG006|Overall Study|Lost to Follow-up|0|||
156807868|NCT03943290|566051214|FG007|Overall Study|Lost to Follow-up|1|||
156807869|NCT03943290|566051215|FG008|Overall Study|Lost to Follow-up|0|||
156807870|NCT03943290|566051207|FG000|Overall Study|Withdrawal by Subject|0|||
156807871|NCT03943290|566051208|FG001|Overall Study|Withdrawal by Subject|0|||
156807872|NCT03943290|566051209|FG002|Overall Study|Withdrawal by Subject|1|||
156807873|NCT03943290|566051210|FG003|Overall Study|Withdrawal by Subject|0|||
156807874|NCT03943290|566051211|FG004|Overall Study|Withdrawal by Subject|0|||
156807875|NCT03943290|566051212|FG005|Overall Study|Withdrawal by Subject|0|||
156882490|NCT01369329|566330812|FG000|Overall Study|Withdrawal by Subject|8|||
157145041|NCT00923091|567277986|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
157145042|NCT00923091|567277987|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
157145043|NCT00923091|567277988|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
157145044|NCT00923091|567277989|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
156807876|NCT03943290|566051213|FG006|Overall Study|Withdrawal by Subject|0|||
156807877|NCT03943290|566051214|FG007|Overall Study|Withdrawal by Subject|0|||
156807878|NCT03943290|566051215|FG008|Overall Study|Withdrawal by Subject|0|||
156807879|NCT02737501|566051216|FG000|Randomized Phase|Died|41|||
156807880|NCT02737501|566051217|FG001|Randomized Phase|Died|29|||
156807881|NCT02737501|566051218|FG002|Randomized Phase|Died|0|||
156807882|NCT02737501|566051216|FG000|Randomized Phase|Withdrawal by Subject|16|||
156807883|NCT02737501|566051217|FG001|Randomized Phase|Withdrawal by Subject|6|||
156807884|NCT02737501|566051218|FG002|Randomized Phase|Withdrawal by Subject|0|||
156807885|NCT02737501|566051216|FG000|Randomized Phase|Lost to Follow-up|0|||
157145045|NCT00923091|567277990|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
157145046|NCT00923091|567277991|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
157145047|NCT00923091|567277992|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
157145048|NCT00923091|567277980|FG000|Period VI (Open-Label)|Adverse Event|17|||
157145049|NCT00923091|567277981|FG001|Period VI (Open-Label)|Adverse Event|0|||
157145050|NCT00923091|567277982|FG002|Period VI (Open-Label)|Adverse Event|4|||
157145051|NCT00923091|567277983|FG003|Period VI (Open-Label)|Adverse Event|1|||
157145052|NCT00923091|567277984|FG004|Period VI (Open-Label)|Adverse Event|1|||
157145053|NCT00923091|567277985|FG005|Period VI (Open-Label)|Adverse Event|0|||
156807886|NCT02737501|566051217|FG001|Randomized Phase|Lost to Follow-up|1|||
156807887|NCT02737501|566051218|FG002|Randomized Phase|Lost to Follow-up|0|||
156807888|NCT02737501|566051216|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
156807889|NCT02737501|566051217|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
156807890|NCT02737501|566051218|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
156807891|NCT02737501|566051216|FG000|Randomized Phase|Reason not Specified|1|||
156807892|NCT02737501|566051217|FG001|Randomized Phase|Reason not Specified|1|||
156807893|NCT02737501|566051218|FG002|Randomized Phase|Reason not Specified|0|||
156807894|NCT02737501|566051216|FG000|Randomized Phase|Never Treated|1|||
156807895|NCT02737501|566051217|FG001|Randomized Phase|Never Treated|1|||
156807896|NCT02737501|566051218|FG002|Randomized Phase|Never Treated|0|||
156807897|NCT02737501|566051216|FG000|Crossover Phase|Died|0|||
156807898|NCT02737501|566051217|FG001|Crossover Phase|Died|0|||
156807899|NCT02737501|566051218|FG002|Crossover Phase|Died|22|||
156807900|NCT02737501|566051216|FG000|Crossover Phase|Withdrew Consent|0|||
156807901|NCT02737501|566051217|FG001|Crossover Phase|Withdrew Consent|0|||
156807902|NCT02737501|566051218|FG002|Crossover Phase|Withdrew Consent|9|||
156807903|NCT02737501|566051216|FG000|Crossover Phase|Physician Decision|0|||
156807904|NCT02737501|566051217|FG001|Crossover Phase|Physician Decision|0|||
156807905|NCT02737501|566051218|FG002|Crossover Phase|Physician Decision|1|||
156807906|NCT02737501|566051216|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
156807907|NCT02737501|566051217|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
156807908|NCT02737501|566051218|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
156807909|NCT01913327|566051219|FG000|Overall Study|Withdrawal by Subject|0|||
156807910|NCT01913327|566051220|FG001|Overall Study|Withdrawal by Subject|1|||
156807911|NCT01074931|566051221|FG000|Overall Study|Economic reasons|1|||
156807912|NCT01074931|566051221|FG000|Overall Study|Death|5|||
156807913|NCT05223673|566051222|FG000|Overall Study|Protocol Violation|1|||
156807914|NCT05223673|566051222|FG000|Overall Study|Study termination|6|||
156807915|NCT01088906|566051223|FG000|Overall Study|Inclusion error|1|||
156807916|NCT01088906|566051223|FG000|Overall Study|Did not receive study treatment|3|||
156807917|NCT01088906|566051223|FG000|Overall Study|Missing data|1|||
156807918|NCT00457626|566051224|FG000|Overall Study|Adverse Event|3|||
156807919|NCT00457626|566051224|FG000|Overall Study|Administrative Problems|2|||
157145054|NCT00923091|567277986|FG006|Period VI (Open-Label)|Adverse Event|0|||
157145055|NCT00923091|567277987|FG007|Period VI (Open-Label)|Adverse Event|0|||
157145056|NCT00923091|567277988|FG008|Period VI (Open-Label)|Adverse Event|0|||
157145057|NCT00923091|567277989|FG009|Period VI (Open-Label)|Adverse Event|0|||
157145058|NCT00923091|567277990|FG010|Period VI (Open-Label)|Adverse Event|0|||
157145059|NCT00923091|567277991|FG011|Period VI (Open-Label)|Adverse Event|0|||
157145060|NCT00923091|567277992|FG012|Period VI (Open-Label)|Adverse Event|0|||
157145061|NCT00923091|567277980|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
156807920|NCT00457626|566051224|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
156807921|NCT00532129|566052612|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
156807922|NCT00532129|566052612|FG000|Treatment Period|Physician Decision|15|||
156807923|NCT00532129|566052612|FG000|Treatment Period|Disease progression|3|||
156807924|NCT00532129|566052612|FG000|Treatment Period|Protocol Violation|1|||
156807925|NCT00532129|566052612|FG000|Treatment Period|Other|5|||
156807926|NCT00532129|566052612|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
156807927|NCT00532129|566052612|FG000|Follow-up Period|Disease progression|57|||
156807928|NCT00532129|566052612|FG000|Follow-up Period|Lost to Follow-up|1|||
156807929|NCT00532129|566052612|FG000|Follow-up Period|Other|6|||
156807930|NCT00841776|566052613|FG000|Overall Study|Lack of Efficacy|0|||
156807931|NCT00841776|566052614|FG001|Overall Study|Lack of Efficacy|1|||
156807932|NCT00841776|566052613|FG000|Overall Study|Lost to Follow-up|2|||
156807933|NCT00841776|566052614|FG001|Overall Study|Lost to Follow-up|1|||
156807934|NCT00841776|566052613|FG000|Overall Study|Withdrawal by Subject|0|||
156807935|NCT00841776|566052614|FG001|Overall Study|Withdrawal by Subject|1|||
156807936|NCT00355368|566052617|FG000|Overall Study|Protocol Violation|8|||
156807937|NCT00355368|566052618|FG001|Overall Study|Protocol Violation|7|||
156807938|NCT00355368|566052617|FG000|Overall Study|cardiac arrest prior to intubation|2|||
156807939|NCT00355368|566052618|FG001|Overall Study|cardiac arrest prior to intubation|2|||
156807940|NCT01349673|566052619|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
156807941|NCT01349673|566052619|FG000|Overall Study|No Longer Qualified For Study|1|||
156807942|NCT01349673|566052619|FG000|Overall Study|Site Closure|10|||
156807943|NCT01349673|566052619|FG000|Overall Study|Withdrawal by Subject|21|||
156807944|NCT01349673|566052619|FG000|Overall Study|Lost to Follow-up|6|||
156807945|NCT01349673|566052619|FG000|Overall Study|Adverse Event|17|||
156807946|NCT01349673|566052619|FG000|Overall Study|Study Terminated By Sponsor|50|||
156807947|NCT01349673|566052619|FG000|Overall Study|Lack of Efficacy|8|||
156807948|NCT00347932|566052622|FG000|Overall Study|Adverse Event|4|||
156807949|NCT00347932|566052623|FG001|Overall Study|Adverse Event|5|||
156807950|NCT00347932|566052622|FG000|Overall Study|Lack of Efficacy|3|||
156807951|NCT00347932|566052623|FG001|Overall Study|Lack of Efficacy|14|||
156807952|NCT00347932|566052622|FG000|Overall Study|Lost to Follow-up|10|||
156807953|NCT00347932|566052623|FG001|Overall Study|Lost to Follow-up|9|||
156807954|NCT00347932|566052622|FG000|Overall Study|Withdrawal by Subject|10|||
156807955|NCT00347932|566052623|FG001|Overall Study|Withdrawal by Subject|16|||
156807956|NCT00347932|566052622|FG000|Overall Study|Did not meet inclusion criteria|4|||
156807957|NCT00347932|566052623|FG001|Overall Study|Did not meet inclusion criteria|8|||
156807958|NCT03462758|566052624|FG000|Overall Study|Chose no or other method of contraception|20|||
156807959|NCT03462758|566052625|FG001|Overall Study|Chose no or other method of contraception|23|||
156807960|NCT03462758|566052624|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
156807961|NCT03462758|566052625|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
156807962|NCT03462758|566052624|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
156807963|NCT03462758|566052625|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
156807964|NCT03462758|566052624|FG000|Overall Study|Medical contraindication|2|||
156807965|NCT03462758|566052625|FG001|Overall Study|Medical contraindication|2|||
156807966|NCT03462758|566052624|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
156807967|NCT03462758|566052625|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
156807968|NCT00413660|566052626|FG000|Up To Week 12|Adverse Event|1|||
156807969|NCT00413660|566052627|FG001|Up To Week 12|Adverse Event|3|||
156807970|NCT00413660|566052628|FG002|Up To Week 12|Adverse Event|1|||
156807971|NCT00413660|566052629|FG003|Up To Week 12|Adverse Event|4|||
156807972|NCT00413660|566052630|FG004|Up To Week 12|Adverse Event|6|||
156807973|NCT00413660|566052631|FG005|Up To Week 12|Adverse Event|4|||
156807974|NCT00413660|566052632|FG006|Up To Week 12|Adverse Event|1|||
156807975|NCT00413660|566052633|FG007|Up To Week 12|Adverse Event|0|||
156807976|NCT00413660|566052634|FG008|Up To Week 12|Adverse Event|0|||
156807977|NCT00413660|566052635|FG009|Up To Week 12|Adverse Event|0|||
156807978|NCT00413660|566052636|FG010|Up To Week 12|Adverse Event|0|||
156807979|NCT00413660|566052626|FG000|Up To Week 12|Lack of Efficacy|2|||
156807980|NCT00413660|566052627|FG001|Up To Week 12|Lack of Efficacy|0|||
156807981|NCT00413660|566052628|FG002|Up To Week 12|Lack of Efficacy|0|||
156807982|NCT00413660|566052629|FG003|Up To Week 12|Lack of Efficacy|0|||
156807983|NCT00413660|566052630|FG004|Up To Week 12|Lack of Efficacy|0|||
156807984|NCT00413660|566052631|FG005|Up To Week 12|Lack of Efficacy|0|||
156807985|NCT00413660|566052632|FG006|Up To Week 12|Lack of Efficacy|5|||
156807986|NCT00413660|566052633|FG007|Up To Week 12|Lack of Efficacy|0|||
156807987|NCT00413660|566052634|FG008|Up To Week 12|Lack of Efficacy|0|||
156807988|NCT00413660|566052635|FG009|Up To Week 12|Lack of Efficacy|0|||
156807989|NCT00413660|566052636|FG010|Up To Week 12|Lack of Efficacy|0|||
156807990|NCT00413660|566052626|FG000|Up To Week 12|Lost to Follow-up|0|||
156807991|NCT00413660|566052627|FG001|Up To Week 12|Lost to Follow-up|1|||
156807992|NCT00413660|566052628|FG002|Up To Week 12|Lost to Follow-up|0|||
156807993|NCT00413660|566052629|FG003|Up To Week 12|Lost to Follow-up|0|||
156807994|NCT00413660|566052630|FG004|Up To Week 12|Lost to Follow-up|1|||
156807995|NCT00413660|566052631|FG005|Up To Week 12|Lost to Follow-up|0|||
156807996|NCT00413660|566052632|FG006|Up To Week 12|Lost to Follow-up|0|||
156807997|NCT00413660|566052633|FG007|Up To Week 12|Lost to Follow-up|0|||
156807998|NCT00413660|566052634|FG008|Up To Week 12|Lost to Follow-up|0|||
156807999|NCT00413660|566052635|FG009|Up To Week 12|Lost to Follow-up|0|||
156808000|NCT00413660|566052636|FG010|Up To Week 12|Lost to Follow-up|0|||
156808001|NCT00413660|566052626|FG000|Up To Week 12|Withdrawal by Subject|0|||
156808002|NCT00413660|566052627|FG001|Up To Week 12|Withdrawal by Subject|2|||
156808003|NCT00413660|566052628|FG002|Up To Week 12|Withdrawal by Subject|0|||
156808004|NCT00413660|566052629|FG003|Up To Week 12|Withdrawal by Subject|2|||
156808005|NCT00413660|566052630|FG004|Up To Week 12|Withdrawal by Subject|0|||
156808006|NCT00413660|566052631|FG005|Up To Week 12|Withdrawal by Subject|2|||
156808007|NCT00413660|566052632|FG006|Up To Week 12|Withdrawal by Subject|2|||
156808008|NCT00413660|566052633|FG007|Up To Week 12|Withdrawal by Subject|0|||
156808009|NCT00413660|566052634|FG008|Up To Week 12|Withdrawal by Subject|0|||
156808010|NCT00413660|566052635|FG009|Up To Week 12|Withdrawal by Subject|0|||
156808011|NCT00413660|566052636|FG010|Up To Week 12|Withdrawal by Subject|0|||
156808012|NCT00413660|566052626|FG000|Up To Week 12|Randomized, Not Treated|1|||
156808013|NCT00413660|566052627|FG001|Up To Week 12|Randomized, Not Treated|0|||
156808014|NCT00413660|566052628|FG002|Up To Week 12|Randomized, Not Treated|0|||
156808015|NCT00413660|566052629|FG003|Up To Week 12|Randomized, Not Treated|1|||
156808016|NCT00413660|566052630|FG004|Up To Week 12|Randomized, Not Treated|0|||
156808017|NCT00413660|566052631|FG005|Up To Week 12|Randomized, Not Treated|0|||
156808018|NCT00413660|566052632|FG006|Up To Week 12|Randomized, Not Treated|0|||
156808019|NCT00413660|566052633|FG007|Up To Week 12|Randomized, Not Treated|0|||
156808020|NCT00413660|566052634|FG008|Up To Week 12|Randomized, Not Treated|0|||
156808021|NCT00413660|566052635|FG009|Up To Week 12|Randomized, Not Treated|0|||
156808022|NCT00413660|566052636|FG010|Up To Week 12|Randomized, Not Treated|0|||
156808023|NCT00413660|566052626|FG000|Up To Week 12|Other|3|||
156808024|NCT00413660|566052627|FG001|Up To Week 12|Other|1|||
157021546|NCT04169373|566830899|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
157221224|NCT00368966|567556780|FG001|Infant Series|Randomization error|1|||
156808025|NCT00413660|566052628|FG002|Up To Week 12|Other|6|||
156808026|NCT00413660|566052629|FG003|Up To Week 12|Other|1|||
156808027|NCT00413660|566052630|FG004|Up To Week 12|Other|2|||
156808028|NCT00413660|566052631|FG005|Up To Week 12|Other|4|||
156808029|NCT00413660|566052632|FG006|Up To Week 12|Other|3|||
156808030|NCT00413660|566052633|FG007|Up To Week 12|Other|0|||
156808031|NCT00413660|566052634|FG008|Up To Week 12|Other|0|||
156808032|NCT00413660|566052635|FG009|Up To Week 12|Other|0|||
156808033|NCT00413660|566052636|FG010|Up To Week 12|Other|0|||
156808034|NCT00413660|566052626|FG000|Post Week 12|Adverse Event|2|||
156808035|NCT00413660|566052627|FG001|Post Week 12|Adverse Event|0|||
156808036|NCT00413660|566052628|FG002|Post Week 12|Adverse Event|2|||
156808037|NCT00413660|566052629|FG003|Post Week 12|Adverse Event|1|||
156808038|NCT00413660|566052630|FG004|Post Week 12|Adverse Event|4|||
156808039|NCT00413660|566052631|FG005|Post Week 12|Adverse Event|2|||
156808040|NCT00413660|566052632|FG006|Post Week 12|Adverse Event|2|||
156808041|NCT00413660|566052633|FG007|Post Week 12|Adverse Event|0|||
156808042|NCT00413660|566052634|FG008|Post Week 12|Adverse Event|0|||
156808043|NCT00413660|566052635|FG009|Post Week 12|Adverse Event|0|||
156808044|NCT00413660|566052636|FG010|Post Week 12|Adverse Event|0|||
156808045|NCT00413660|566052626|FG000|Post Week 12|Lack of Efficacy|0|||
156808046|NCT00413660|566052627|FG001|Post Week 12|Lack of Efficacy|0|||
156808047|NCT00413660|566052628|FG002|Post Week 12|Lack of Efficacy|1|||
156808048|NCT00413660|566052629|FG003|Post Week 12|Lack of Efficacy|0|||
156808049|NCT00413660|566052630|FG004|Post Week 12|Lack of Efficacy|0|||
156808050|NCT00413660|566052631|FG005|Post Week 12|Lack of Efficacy|0|||
156808051|NCT00413660|566052632|FG006|Post Week 12|Lack of Efficacy|0|||
156808052|NCT00413660|566052633|FG007|Post Week 12|Lack of Efficacy|0|||
156808053|NCT00413660|566052634|FG008|Post Week 12|Lack of Efficacy|0|||
156808054|NCT00413660|566052635|FG009|Post Week 12|Lack of Efficacy|1|||
156808055|NCT00413660|566052636|FG010|Post Week 12|Lack of Efficacy|0|||
156808056|NCT00413660|566052626|FG000|Post Week 12|Lost to Follow-up|0|||
156808057|NCT00413660|566052627|FG001|Post Week 12|Lost to Follow-up|1|||
156808058|NCT00413660|566052628|FG002|Post Week 12|Lost to Follow-up|1|||
156808059|NCT00413660|566052629|FG003|Post Week 12|Lost to Follow-up|0|||
156808060|NCT00413660|566052630|FG004|Post Week 12|Lost to Follow-up|0|||
156808061|NCT00413660|566052631|FG005|Post Week 12|Lost to Follow-up|0|||
156808062|NCT00413660|566052632|FG006|Post Week 12|Lost to Follow-up|0|||
156808063|NCT00413660|566052633|FG007|Post Week 12|Lost to Follow-up|0|||
156808064|NCT00413660|566052634|FG008|Post Week 12|Lost to Follow-up|0|||
156808065|NCT00413660|566052635|FG009|Post Week 12|Lost to Follow-up|0|||
156808066|NCT00413660|566052636|FG010|Post Week 12|Lost to Follow-up|0|||
156808067|NCT00413660|566052626|FG000|Post Week 12|Withdrawal by Subject|0|||
156808068|NCT00413660|566052627|FG001|Post Week 12|Withdrawal by Subject|1|||
156808069|NCT00413660|566052628|FG002|Post Week 12|Withdrawal by Subject|1|||
156808070|NCT00413660|566052629|FG003|Post Week 12|Withdrawal by Subject|0|||
156808071|NCT00413660|566052630|FG004|Post Week 12|Withdrawal by Subject|1|||
156808072|NCT00413660|566052631|FG005|Post Week 12|Withdrawal by Subject|0|||
156808073|NCT00413660|566052632|FG006|Post Week 12|Withdrawal by Subject|0|||
156808074|NCT00413660|566052633|FG007|Post Week 12|Withdrawal by Subject|0|||
156808075|NCT00413660|566052634|FG008|Post Week 12|Withdrawal by Subject|0|||
156808076|NCT00413660|566052635|FG009|Post Week 12|Withdrawal by Subject|0|||
156808077|NCT00413660|566052636|FG010|Post Week 12|Withdrawal by Subject|1|||
156808078|NCT00413660|566052626|FG000|Post Week 12|Other|1|||
156808079|NCT00413660|566052627|FG001|Post Week 12|Other|2|||
156808080|NCT00413660|566052628|FG002|Post Week 12|Other|3|||
156808081|NCT00413660|566052629|FG003|Post Week 12|Other|0|||
156808082|NCT00413660|566052630|FG004|Post Week 12|Other|1|||
156808083|NCT00413660|566052631|FG005|Post Week 12|Other|1|||
156808084|NCT00413660|566052632|FG006|Post Week 12|Other|1|||
156808085|NCT00413660|566052633|FG007|Post Week 12|Other|0|||
156808086|NCT00413660|566052634|FG008|Post Week 12|Other|0|||
156808087|NCT00413660|566052635|FG009|Post Week 12|Other|0|||
156808088|NCT00413660|566052636|FG010|Post Week 12|Other|0|||
156808089|NCT01791517|566052637|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
156808090|NCT01791517|566052638|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
156808091|NCT01791517|566052639|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
156808092|NCT01791517|566052640|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
156808093|NCT01791517|566052641|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
156808094|NCT01791517|566052642|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
156808095|NCT01791517|566052643|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
156808096|NCT01791517|566052644|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
156808097|NCT01791517|566052645|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
156808098|NCT01791517|566052646|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
156808099|NCT01791517|566052647|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
156808100|NCT01791517|566052648|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
157221225|NCT00368966|567556779|FG000|Infant Series|Failed to meet eligibility criteria|0|||
157221226|NCT00368966|567556780|FG001|Infant Series|Failed to meet eligibility criteria|1|||
157221227|NCT00368966|567556779|FG000|Infant Series|Adverse Event|0|||
157221228|NCT00368966|567556780|FG001|Infant Series|Adverse Event|1|||
157221229|NCT00368966|567556779|FG000|Infant Series|Failed to return|1|||
157221230|NCT00368966|567556780|FG001|Infant Series|Failed to return|0|||
157221231|NCT00368966|567556779|FG000|After Infant|Failed to return|3|||
157221232|NCT00368966|567556780|FG001|After Infant|Failed to return|1|||
157221233|NCT00368966|567556779|FG000|After Infant|Adverse Event|1|||
157221234|NCT00368966|567556780|FG001|After Infant|Adverse Event|2|||
157221235|NCT00368966|567556779|FG000|After Infant|Withdrawal by Subject|1|||
157221236|NCT00368966|567556780|FG001|After Infant|Withdrawal by Subject|1|||
157221237|NCT00368966|567556779|FG000|After Infant|Death|1|||
157221238|NCT00368966|567556780|FG001|After Infant|Death|0|||
157221239|NCT00368966|567556779|FG000|After Infant|Lost to Follow-up|0|||
157221240|NCT00368966|567556780|FG001|After Infant|Lost to Follow-up|1|||
157221241|NCT00368966|567556779|FG000|Toddler Dose|Withdrawal by Subject|1|||
157221242|NCT00368966|567556780|FG001|Toddler Dose|Withdrawal by Subject|1|||
157221243|NCT00368966|567556779|FG000|Toddler Dose|Lost to Follow-up|0|||
157221244|NCT00368966|567556780|FG001|Toddler Dose|Lost to Follow-up|2|||
157221245|NCT02866175|567556785|FG000|Overall Study|Adverse Event|56|||
157221246|NCT02866175|567556786|FG001|Overall Study|Adverse Event|54|||
157221247|NCT02866175|567556785|FG000|Overall Study|Withdrawal by Subject|31|||
157221248|NCT02866175|567556786|FG001|Overall Study|Withdrawal by Subject|52|||
157221249|NCT02866175|567556785|FG000|Overall Study|Death|30|||
157221250|NCT02866175|567556786|FG001|Overall Study|Death|23|||
157221251|NCT02866175|567556785|FG000|Overall Study|Other|7|||
157221252|NCT02866175|567556786|FG001|Overall Study|Other|14|||
157221253|NCT02866175|567556785|FG000|Overall Study|Progressive disease|1|||
157221254|NCT02866175|567556786|FG001|Overall Study|Progressive disease|1|||
157221255|NCT02866175|567556785|FG000|Overall Study|Lost to Follow-up|2|||
157221256|NCT02866175|567556786|FG001|Overall Study|Lost to Follow-up|0|||
157221257|NCT02866175|567556785|FG000|Overall Study|Lack of Efficacy|0|||
157221258|NCT02866175|567556786|FG001|Overall Study|Lack of Efficacy|1|||
157221259|NCT02866175|567556785|FG000|Overall Study|Physician Decision|3|||
157221260|NCT02866175|567556786|FG001|Overall Study|Physician Decision|15|||
157221261|NCT02866175|567556785|FG000|Overall Study|Did not receive treatment|5|||
157221262|NCT02866175|567556786|FG001|Overall Study|Did not receive treatment|15|||
157221263|NCT01694485|567556789|FG000|Overall Study|Withdrawal by Subject|20|||
157221264|NCT01694485|567556790|FG001|Overall Study|Withdrawal by Subject|6|||
157221265|NCT01694485|567556791|FG002|Overall Study|Withdrawal by Subject|7|||
157221266|NCT01694485|567556792|FG003|Overall Study|Withdrawal by Subject|25|||
157221267|NCT01694485|567556793|FG004|Overall Study|Withdrawal by Subject|18|||
157221268|NCT01694485|567556789|FG000|Overall Study|Sponsor Decision|3|||
157221269|NCT01694485|567556790|FG001|Overall Study|Sponsor Decision|0|||
157221270|NCT01694485|567556791|FG002|Overall Study|Sponsor Decision|0|||
157221271|NCT01694485|567556792|FG003|Overall Study|Sponsor Decision|2|||
157221272|NCT01694485|567556793|FG004|Overall Study|Sponsor Decision|0|||
157221273|NCT01694485|567556789|FG000|Overall Study|Lost to Follow-up|9|||
157221274|NCT01694485|567556790|FG001|Overall Study|Lost to Follow-up|1|||
157221275|NCT01694485|567556791|FG002|Overall Study|Lost to Follow-up|6|||
157221276|NCT01694485|567556792|FG003|Overall Study|Lost to Follow-up|10|||
157221277|NCT01694485|567556793|FG004|Overall Study|Lost to Follow-up|7|||
157221278|NCT01694485|567556789|FG000|Overall Study|Death|1|||
157221279|NCT01694485|567556790|FG001|Overall Study|Death|0|||
157221280|NCT01694485|567556791|FG002|Overall Study|Death|0|||
157221281|NCT01694485|567556792|FG003|Overall Study|Death|1|||
157221282|NCT01694485|567556793|FG004|Overall Study|Death|0|||
157221283|NCT02907203|567556794|FG000|Overall Study|Death|1|||
157221284|NCT02907203|567556794|FG000|Overall Study|Lost to Follow-up|3|||
157221285|NCT02907203|567556794|FG000|Overall Study|Withdrawal by Subject|3|||
157221286|NCT02907203|567556794|FG000|Overall Study|Surgical bypass|1|||
157221287|NCT00619619|567556795|FG000|Overall Study|Physician Decision|0|||
157221288|NCT00619619|567556796|FG001|Overall Study|Physician Decision|0|||
157221289|NCT00619619|567556797|FG002|Overall Study|Physician Decision|1|||
157221290|NCT00619619|567556798|FG003|Overall Study|Physician Decision|0|||
157221291|NCT00619619|567556799|FG004|Overall Study|Physician Decision|0|||
157221292|NCT00619619|567556800|FG005|Overall Study|Physician Decision|0|||
157221293|NCT00619619|567556801|FG006|Overall Study|Physician Decision|0|||
157221294|NCT00619619|567556802|FG007|Overall Study|Physician Decision|0|||
157221295|NCT00619619|567556795|FG000|Overall Study|Protocol Violation|0|||
157221296|NCT00619619|567556796|FG001|Overall Study|Protocol Violation|0|||
157021795|NCT03623321|566832972|FG000|Overall Study|Noncompliance with study drug|6|||
157221297|NCT00619619|567556797|FG002|Overall Study|Protocol Violation|0|||
157221298|NCT00619619|567556798|FG003|Overall Study|Protocol Violation|1|||
157221299|NCT00619619|567556799|FG004|Overall Study|Protocol Violation|0|||
157221300|NCT00619619|567556800|FG005|Overall Study|Protocol Violation|0|||
157221301|NCT00619619|567556801|FG006|Overall Study|Protocol Violation|1|||
157221302|NCT00619619|567556802|FG007|Overall Study|Protocol Violation|1|||
157221303|NCT00619619|567556795|FG000|Overall Study|Adverse Event|0|||
157221304|NCT00619619|567556796|FG001|Overall Study|Adverse Event|0|||
156808101|NCT01791517|566052637|FG000|Phase I: Period 1|Adverse Event|0|||
156808102|NCT01791517|566052638|FG001|Phase I: Period 1|Adverse Event|0|||
156808103|NCT01791517|566052639|FG002|Phase I: Period 1|Adverse Event|1|||
156808104|NCT01791517|566052640|FG003|Phase I: Period 1|Adverse Event|1|||
156808105|NCT01791517|566052641|FG004|Phase I: Period 1|Adverse Event|0|||
156808106|NCT01791517|566052642|FG005|Phase I: Period 1|Adverse Event|0|||
156808107|NCT01791517|566052643|FG006|Phase I: Period 1|Adverse Event|0|||
156808108|NCT01791517|566052644|FG007|Phase I: Period 1|Adverse Event|0|||
156808109|NCT01791517|566052645|FG008|Phase I: Period 1|Adverse Event|0|||
156808110|NCT01791517|566052646|FG009|Phase I: Period 1|Adverse Event|0|||
156808111|NCT01791517|566052647|FG010|Phase I: Period 1|Adverse Event|0|||
156808112|NCT01791517|566052648|FG011|Phase I: Period 1|Adverse Event|0|||
156808113|NCT01791517|566052637|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
156808114|NCT01791517|566052638|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808115|NCT01791517|566052639|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808116|NCT01791517|566052640|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808117|NCT01791517|566052641|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
157021547|NCT04169373|566830900|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
157021548|NCT04169373|566830901|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
157221305|NCT00619619|567556797|FG002|Overall Study|Adverse Event|0|||
156808118|NCT01791517|566052642|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808119|NCT01791517|566052643|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808120|NCT01791517|566052644|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808121|NCT01791517|566052645|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808122|NCT01791517|566052646|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808123|NCT01791517|566052647|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808124|NCT01791517|566052648|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
156808125|NCT01791517|566052637|FG000|Phase I: Period 1|Protocol Violation|0|||
156808126|NCT01791517|566052638|FG001|Phase I: Period 1|Protocol Violation|1|||
156808127|NCT01791517|566052639|FG002|Phase I: Period 1|Protocol Violation|0|||
156808128|NCT01791517|566052640|FG003|Phase I: Period 1|Protocol Violation|0|||
156808129|NCT01791517|566052641|FG004|Phase I: Period 1|Protocol Violation|0|||
156808130|NCT01791517|566052642|FG005|Phase I: Period 1|Protocol Violation|0|||
156808131|NCT01791517|566052643|FG006|Phase I: Period 1|Protocol Violation|0|||
156808132|NCT01791517|566052644|FG007|Phase I: Period 1|Protocol Violation|0|||
156808133|NCT01791517|566052645|FG008|Phase I: Period 1|Protocol Violation|0|||
156808134|NCT01791517|566052646|FG009|Phase I: Period 1|Protocol Violation|0|||
156808135|NCT01791517|566052647|FG010|Phase I: Period 1|Protocol Violation|0|||
156808136|NCT01791517|566052648|FG011|Phase I: Period 1|Protocol Violation|0|||
156808137|NCT01791517|566052637|FG000|Phase I: Period 1|Lost to Follow-up|0|||
156808138|NCT01791517|566052638|FG001|Phase I: Period 1|Lost to Follow-up|0|||
156808139|NCT01791517|566052639|FG002|Phase I: Period 1|Lost to Follow-up|0|||
156808140|NCT01791517|566052640|FG003|Phase I: Period 1|Lost to Follow-up|1|||
156808141|NCT01791517|566052641|FG004|Phase I: Period 1|Lost to Follow-up|0|||
156808142|NCT01791517|566052642|FG005|Phase I: Period 1|Lost to Follow-up|0|||
156808143|NCT01791517|566052643|FG006|Phase I: Period 1|Lost to Follow-up|1|||
156808144|NCT01791517|566052644|FG007|Phase I: Period 1|Lost to Follow-up|0|||
156808145|NCT01791517|566052645|FG008|Phase I: Period 1|Lost to Follow-up|1|||
156808146|NCT01791517|566052646|FG009|Phase I: Period 1|Lost to Follow-up|1|||
156808147|NCT01791517|566052647|FG010|Phase I: Period 1|Lost to Follow-up|0|||
156808148|NCT01791517|566052648|FG011|Phase I: Period 1|Lost to Follow-up|0|||
156808149|NCT01791517|566052637|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808150|NCT01791517|566052638|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808151|NCT01791517|566052639|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808152|NCT01791517|566052640|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808153|NCT01791517|566052641|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808154|NCT01791517|566052642|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808155|NCT01791517|566052643|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808156|NCT01791517|566052644|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808157|NCT01791517|566052645|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808158|NCT01791517|566052646|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808159|NCT01791517|566052647|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
156808160|NCT01791517|566052648|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
156808161|NCT01791517|566052637|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
156808162|NCT01791517|566052638|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808163|NCT01791517|566052639|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808164|NCT01791517|566052640|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808165|NCT01791517|566052641|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808166|NCT01791517|566052642|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808167|NCT01791517|566052643|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808168|NCT01791517|566052644|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808169|NCT01791517|566052645|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808170|NCT01791517|566052646|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808171|NCT01791517|566052647|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156882491|NCT01369329|566330813|FG001|Overall Study|Withdrawal by Subject|6|||
156882492|NCT01369329|566330814|FG002|Overall Study|Withdrawal by Subject|10|||
156882493|NCT01369329|566330812|FG000|Overall Study|Lost to Follow-up|2|||
156882494|NCT01369329|566330813|FG001|Overall Study|Lost to Follow-up|2|||
156882495|NCT01369329|566330814|FG002|Overall Study|Lost to Follow-up|2|||
156882496|NCT01369329|566330812|FG000|Overall Study|Other|2|||
156882497|NCT01369329|566330813|FG001|Overall Study|Other|3|||
156882498|NCT01369329|566330814|FG002|Overall Study|Other|2|||
156882499|NCT04644315|566330815|FG000|Overall Study|Subject withdrawal of consent|1|||
156882500|NCT01836276|566330816|FG000|Overall Study|Lost to Follow-up|28|||
156882501|NCT01836276|566330817|FG001|Overall Study|Lost to Follow-up|51|||
156882502|NCT00913458|566330823|FG000|Phase 1|Non-Responder|54|||
156882503|NCT00913458|566330824|FG001|Phase 1|Non-Responder|0|||
156882504|NCT00913458|566330825|FG002|Phase 1|Non-Responder|0|||
156882505|NCT00913458|566330826|FG003|Phase 1|Non-Responder|0|||
156882506|NCT00913458|566330827|FG004|Phase 1|Non-Responder|0|||
156882507|NCT00913458|566330828|FG005|Phase 1|Non-Responder|0|||
156808172|NCT01791517|566052648|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
156808173|NCT01791517|566052637|FG000|Phase I: Period 2|Protocol Violation|0|||
156808174|NCT01791517|566052638|FG001|Phase I: Period 2|Protocol Violation|0|||
156808175|NCT01791517|566052639|FG002|Phase I: Period 2|Protocol Violation|0|||
156808176|NCT01791517|566052640|FG003|Phase I: Period 2|Protocol Violation|1|||
156808177|NCT01791517|566052641|FG004|Phase I: Period 2|Protocol Violation|0|||
156808178|NCT01791517|566052642|FG005|Phase I: Period 2|Protocol Violation|0|||
156808179|NCT01791517|566052643|FG006|Phase I: Period 2|Protocol Violation|0|||
156808180|NCT01791517|566052644|FG007|Phase I: Period 2|Protocol Violation|0|||
156808181|NCT01791517|566052645|FG008|Phase I: Period 2|Protocol Violation|0|||
156808182|NCT01791517|566052646|FG009|Phase I: Period 2|Protocol Violation|0|||
156808183|NCT01791517|566052647|FG010|Phase I: Period 2|Protocol Violation|0|||
156808184|NCT01791517|566052648|FG011|Phase I: Period 2|Protocol Violation|0|||
156808185|NCT01791517|566052637|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
156808186|NCT01791517|566052638|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
156808187|NCT01791517|566052639|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
156808188|NCT01791517|566052640|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
156808189|NCT01791517|566052641|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
156808190|NCT01791517|566052642|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
156808191|NCT01791517|566052643|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
156808192|NCT01791517|566052644|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
156808193|NCT01791517|566052645|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
156808194|NCT01791517|566052646|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
156808195|NCT01791517|566052647|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
156808196|NCT01791517|566052648|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
156808197|NCT01791517|566052637|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808198|NCT01791517|566052638|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808199|NCT01791517|566052639|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808200|NCT01791517|566052640|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808201|NCT01791517|566052641|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808202|NCT01791517|566052642|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808203|NCT01791517|566052643|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808204|NCT01791517|566052644|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808205|NCT01791517|566052645|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808206|NCT01791517|566052646|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808207|NCT01791517|566052647|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
156808208|NCT01791517|566052648|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
156808209|NCT01791517|566052637|FG000|Phase I: Period 2|Lens Discomfort|0|||
156808210|NCT01791517|566052638|FG001|Phase I: Period 2|Lens Discomfort|0|||
156808211|NCT01791517|566052639|FG002|Phase I: Period 2|Lens Discomfort|0|||
156808212|NCT01791517|566052640|FG003|Phase I: Period 2|Lens Discomfort|0|||
156882508|NCT00913458|566330829|FG006|Phase 1|Non-Responder|0|||
156808213|NCT01791517|566052641|FG004|Phase I: Period 2|Lens Discomfort|0|||
156808214|NCT01791517|566052642|FG005|Phase I: Period 2|Lens Discomfort|1|||
156808215|NCT01791517|566052643|FG006|Phase I: Period 2|Lens Discomfort|0|||
156808216|NCT01791517|566052644|FG007|Phase I: Period 2|Lens Discomfort|0|||
156808217|NCT01791517|566052645|FG008|Phase I: Period 2|Lens Discomfort|0|||
156808218|NCT01791517|566052646|FG009|Phase I: Period 2|Lens Discomfort|0|||
156808219|NCT01791517|566052647|FG010|Phase I: Period 2|Lens Discomfort|0|||
156808220|NCT01791517|566052648|FG011|Phase I: Period 2|Lens Discomfort|0|||
156808221|NCT01791517|566052637|FG000|Phase I: Period 2|Lost to Follow-up|0|||
156808222|NCT01791517|566052638|FG001|Phase I: Period 2|Lost to Follow-up|3|||
156808223|NCT01791517|566052639|FG002|Phase I: Period 2|Lost to Follow-up|2|||
156808224|NCT01791517|566052640|FG003|Phase I: Period 2|Lost to Follow-up|0|||
156882509|NCT00913458|566330823|FG000|Phase 1|Subject Request|17|||
156882510|NCT00913458|566330824|FG001|Phase 1|Subject Request|0|||
156882511|NCT00913458|566330825|FG002|Phase 1|Subject Request|0|||
156882512|NCT00913458|566330826|FG003|Phase 1|Subject Request|0|||
156882513|NCT00913458|566330827|FG004|Phase 1|Subject Request|0|||
156882514|NCT00913458|566330828|FG005|Phase 1|Subject Request|0|||
156882515|NCT00913458|566330829|FG006|Phase 1|Subject Request|0|||
157221306|NCT00619619|567556798|FG003|Overall Study|Adverse Event|0|||
157221307|NCT00619619|567556799|FG004|Overall Study|Adverse Event|2|||
157221308|NCT00619619|567556800|FG005|Overall Study|Adverse Event|0|||
157221309|NCT00619619|567556801|FG006|Overall Study|Adverse Event|0|||
157221310|NCT00619619|567556802|FG007|Overall Study|Adverse Event|2|||
157221311|NCT01689974|567556803|FG000|Overall Study|Termination of Study|5|||
157221312|NCT01689974|567556804|FG001|Overall Study|Termination of Study|5|||
157221313|NCT01388647|567556807|FG000|Overall Study|Adverse Event|1|||
157221314|NCT01388647|567556808|FG001|Overall Study|Adverse Event|2|||
157221315|NCT01006707|567556809|FG000|Study Session 1|Lost to Follow-up|2|||
157221316|NCT01006707|567556810|FG001|Study Session 1|Lost to Follow-up|0|||
157221317|NCT01006707|567556811|FG002|Study Session 1|Lost to Follow-up|0|||
157221318|NCT01006707|567556809|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
157221319|NCT01006707|567556810|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
157221320|NCT01006707|567556811|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
157221321|NCT00952484|567556812|FG000|Overall Study|Withdrawal by Subject|0|||
157221322|NCT00952484|567556813|FG001|Overall Study|Withdrawal by Subject|1|||
157221323|NCT00952484|567556814|FG002|Overall Study|Withdrawal by Subject|0|||
157221324|NCT02750306|567556815|FG000|Overall Study|Withdrawal by Subject|5|||
157221325|NCT02750306|567556816|FG001|Overall Study|Withdrawal by Subject|2|||
157221326|NCT02750306|567556815|FG000|Overall Study|Protocol Violation|1|||
157221327|NCT02750306|567556816|FG001|Overall Study|Protocol Violation|0|||
157221328|NCT00192296|567556819|FG000|Overall Study|Withdrawal by Subject|0|||
157221329|NCT00192296|567556820|FG001|Overall Study|Withdrawal by Subject|1|||
156808225|NCT01791517|566052641|FG004|Phase I: Period 2|Lost to Follow-up|0|||
156808226|NCT01791517|566052642|FG005|Phase I: Period 2|Lost to Follow-up|0|||
156808227|NCT01791517|566052643|FG006|Phase I: Period 2|Lost to Follow-up|0|||
156808228|NCT01791517|566052644|FG007|Phase I: Period 2|Lost to Follow-up|0|||
156808229|NCT01791517|566052645|FG008|Phase I: Period 2|Lost to Follow-up|0|||
156808230|NCT01791517|566052646|FG009|Phase I: Period 2|Lost to Follow-up|0|||
156808231|NCT01791517|566052647|FG010|Phase I: Period 2|Lost to Follow-up|0|||
156808232|NCT01791517|566052648|FG011|Phase I: Period 2|Lost to Follow-up|0|||
156808233|NCT01791517|566052637|FG000|Phase I: Period 3|Lens Discomfort|0|||
156808234|NCT01791517|566052638|FG001|Phase I: Period 3|Lens Discomfort|0|||
156808235|NCT01791517|566052639|FG002|Phase I: Period 3|Lens Discomfort|0|||
156808236|NCT01791517|566052640|FG003|Phase I: Period 3|Lens Discomfort|0|||
156808237|NCT01791517|566052641|FG004|Phase I: Period 3|Lens Discomfort|0|||
156808238|NCT01791517|566052642|FG005|Phase I: Period 3|Lens Discomfort|0|||
156808239|NCT01791517|566052643|FG006|Phase I: Period 3|Lens Discomfort|0|||
156808240|NCT01791517|566052644|FG007|Phase I: Period 3|Lens Discomfort|0|||
156808241|NCT01791517|566052645|FG008|Phase I: Period 3|Lens Discomfort|0|||
156808242|NCT01791517|566052646|FG009|Phase I: Period 3|Lens Discomfort|0|||
157021549|NCT04169373|566830902|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
156808243|NCT01791517|566052647|FG010|Phase I: Period 3|Lens Discomfort|0|||
156808244|NCT01791517|566052648|FG011|Phase I: Period 3|Lens Discomfort|1|||
156808245|NCT01791517|566052637|FG000|Phase I: Period 3|Lost to Follow-up|0|||
156808246|NCT01791517|566052638|FG001|Phase I: Period 3|Lost to Follow-up|1|||
156808247|NCT01791517|566052639|FG002|Phase I: Period 3|Lost to Follow-up|0|||
156808248|NCT01791517|566052640|FG003|Phase I: Period 3|Lost to Follow-up|0|||
156808249|NCT01791517|566052641|FG004|Phase I: Period 3|Lost to Follow-up|1|||
156808250|NCT01791517|566052642|FG005|Phase I: Period 3|Lost to Follow-up|0|||
156808251|NCT01791517|566052643|FG006|Phase I: Period 3|Lost to Follow-up|0|||
156808252|NCT01791517|566052644|FG007|Phase I: Period 3|Lost to Follow-up|0|||
156808253|NCT01791517|566052645|FG008|Phase I: Period 3|Lost to Follow-up|0|||
156808254|NCT01791517|566052646|FG009|Phase I: Period 3|Lost to Follow-up|0|||
156808255|NCT01791517|566052647|FG010|Phase I: Period 3|Lost to Follow-up|0|||
156808256|NCT01791517|566052648|FG011|Phase I: Period 3|Lost to Follow-up|0|||
156808257|NCT01791517|566052637|FG000|Phase I: Period 3|Adverse Event|0|||
156808258|NCT01791517|566052638|FG001|Phase I: Period 3|Adverse Event|0|||
156808259|NCT01791517|566052639|FG002|Phase I: Period 3|Adverse Event|0|||
157021550|NCT04169373|566830899|FG000|Week 1 to Week 14|Other|1|||
157221330|NCT00192296|567556821|FG002|Overall Study|Withdrawal by Subject|0|||
157221331|NCT00192296|567556822|FG003|Overall Study|Withdrawal by Subject|0|||
156808260|NCT01791517|566052640|FG003|Phase I: Period 3|Adverse Event|1|||
156808261|NCT01791517|566052641|FG004|Phase I: Period 3|Adverse Event|0|||
156808262|NCT01791517|566052642|FG005|Phase I: Period 3|Adverse Event|0|||
156808263|NCT01791517|566052643|FG006|Phase I: Period 3|Adverse Event|0|||
157221332|NCT04317781|567556826|FG000|Overall Study|Adverse Event|1|||
157221333|NCT04317781|567556826|FG000|Overall Study|Disease relapse|1|||
156808264|NCT01791517|566052644|FG007|Phase I: Period 3|Adverse Event|0|||
156808265|NCT01791517|566052645|FG008|Phase I: Period 3|Adverse Event|0|||
156808266|NCT01791517|566052646|FG009|Phase I: Period 3|Adverse Event|0|||
156808267|NCT01791517|566052647|FG010|Phase I: Period 3|Adverse Event|0|||
156808268|NCT01791517|566052648|FG011|Phase I: Period 3|Adverse Event|0|||
156808269|NCT01791517|566052637|FG000|Phase II|Lost to Follow-up|1|||
157021551|NCT04169373|566830900|FG001|Week 1 to Week 14|Other|3|||
157221334|NCT04317781|567556826|FG000|Overall Study|Withdrawal by Subject|1|||
157221335|NCT02087059|567556828|FG000|Overall Study|Disease Progression|1|||
156882516|NCT00913458|566330823|FG000|Phase 1|Adverse Event|20|||
156882517|NCT00913458|566330824|FG001|Phase 1|Adverse Event|0|||
156882518|NCT00913458|566330825|FG002|Phase 1|Adverse Event|0|||
156882519|NCT00913458|566330826|FG003|Phase 1|Adverse Event|0|||
156882520|NCT00913458|566330827|FG004|Phase 1|Adverse Event|0|||
156882521|NCT00913458|566330828|FG005|Phase 1|Adverse Event|0|||
156882522|NCT00913458|566330829|FG006|Phase 1|Adverse Event|0|||
156882523|NCT00913458|566330823|FG000|Phase 1|Lost to Follow-up|2|||
156882524|NCT00913458|566330824|FG001|Phase 1|Lost to Follow-up|0|||
156882525|NCT00913458|566330825|FG002|Phase 1|Lost to Follow-up|0|||
156882526|NCT00913458|566330826|FG003|Phase 1|Lost to Follow-up|0|||
156882527|NCT00913458|566330827|FG004|Phase 1|Lost to Follow-up|0|||
156882528|NCT00913458|566330828|FG005|Phase 1|Lost to Follow-up|0|||
156882529|NCT00913458|566330829|FG006|Phase 1|Lost to Follow-up|0|||
156882530|NCT00913458|566330823|FG000|Phase 1|Protocol Violation|10|||
156882531|NCT00913458|566330824|FG001|Phase 1|Protocol Violation|0|||
156882532|NCT00913458|566330825|FG002|Phase 1|Protocol Violation|0|||
156882533|NCT00913458|566330826|FG003|Phase 1|Protocol Violation|0|||
156882534|NCT00913458|566330827|FG004|Phase 1|Protocol Violation|0|||
156882535|NCT00913458|566330828|FG005|Phase 1|Protocol Violation|0|||
156882536|NCT00913458|566330829|FG006|Phase 1|Protocol Violation|0|||
156882537|NCT00913458|566330823|FG000|Phase 1|Sponsor|2|||
156882538|NCT00913458|566330824|FG001|Phase 1|Sponsor|0|||
156882539|NCT00913458|566330825|FG002|Phase 1|Sponsor|0|||
156882540|NCT00913458|566330826|FG003|Phase 1|Sponsor|0|||
156882541|NCT00913458|566330827|FG004|Phase 1|Sponsor|0|||
156882542|NCT00913458|566330828|FG005|Phase 1|Sponsor|0|||
156882543|NCT00913458|566330829|FG006|Phase 1|Sponsor|0|||
157021552|NCT04169373|566830901|FG002|Week 1 to Week 14|Other|3|||
157221336|NCT02087059|567556828|FG000|Overall Study|Adverse Event|5|||
157221337|NCT02087059|567556828|FG000|Overall Study|Lost to Follow-up|1|||
157221338|NCT01851590|567556830|FG000|Overall Study|Withdrawal by Subject|0|||
157221339|NCT01851590|567556831|FG001|Overall Study|Withdrawal by Subject|0|||
156808270|NCT01791517|566052638|FG001|Phase II|Lost to Follow-up|0|||
156808271|NCT01791517|566052639|FG002|Phase II|Lost to Follow-up|1|||
156808272|NCT01791517|566052640|FG003|Phase II|Lost to Follow-up|0|||
156808273|NCT01791517|566052641|FG004|Phase II|Lost to Follow-up|1|||
156808274|NCT01791517|566052642|FG005|Phase II|Lost to Follow-up|2|||
156808275|NCT01791517|566052643|FG006|Phase II|Lost to Follow-up|0|||
156808276|NCT01791517|566052644|FG007|Phase II|Lost to Follow-up|1|||
156808277|NCT01791517|566052645|FG008|Phase II|Lost to Follow-up|1|||
156808278|NCT01791517|566052646|FG009|Phase II|Lost to Follow-up|1|||
156808279|NCT01791517|566052647|FG010|Phase II|Lost to Follow-up|0|||
156808280|NCT01791517|566052648|FG011|Phase II|Lost to Follow-up|0|||
156808281|NCT01791517|566052637|FG000|Phase II|Withdrawal by Subject|1|||
156808282|NCT01791517|566052638|FG001|Phase II|Withdrawal by Subject|0|||
156808283|NCT01791517|566052639|FG002|Phase II|Withdrawal by Subject|0|||
156808284|NCT01791517|566052640|FG003|Phase II|Withdrawal by Subject|0|||
156808285|NCT01791517|566052641|FG004|Phase II|Withdrawal by Subject|0|||
156808286|NCT01791517|566052642|FG005|Phase II|Withdrawal by Subject|2|||
156808287|NCT01791517|566052643|FG006|Phase II|Withdrawal by Subject|0|||
156808288|NCT01791517|566052644|FG007|Phase II|Withdrawal by Subject|1|||
156808289|NCT01791517|566052645|FG008|Phase II|Withdrawal by Subject|0|||
156808290|NCT01791517|566052646|FG009|Phase II|Withdrawal by Subject|0|||
156808291|NCT01791517|566052647|FG010|Phase II|Withdrawal by Subject|1|||
156808292|NCT01791517|566052648|FG011|Phase II|Withdrawal by Subject|0|||
156808293|NCT01791517|566052637|FG000|Phase II|Lack of Efficacy|0|||
157221340|NCT01851590|567556832|FG002|Overall Study|Withdrawal by Subject|1|||
156808294|NCT01791517|566052638|FG001|Phase II|Lack of Efficacy|0|||
156808295|NCT01791517|566052639|FG002|Phase II|Lack of Efficacy|0|||
156808296|NCT01791517|566052640|FG003|Phase II|Lack of Efficacy|0|||
156808297|NCT01791517|566052641|FG004|Phase II|Lack of Efficacy|1|||
156808298|NCT01791517|566052642|FG005|Phase II|Lack of Efficacy|0|||
156808299|NCT01791517|566052643|FG006|Phase II|Lack of Efficacy|0|||
156882544|NCT00913458|566330823|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
156882545|NCT00913458|566330824|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
156882546|NCT00913458|566330825|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
156882547|NCT00913458|566330826|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
156882548|NCT00913458|566330827|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
157221341|NCT01851590|567556830|FG000|Overall Study|Adverse Event|0|||
156808300|NCT01791517|566052644|FG007|Phase II|Lack of Efficacy|0|||
156808301|NCT01791517|566052645|FG008|Phase II|Lack of Efficacy|0|||
156808302|NCT01791517|566052646|FG009|Phase II|Lack of Efficacy|0|||
156808303|NCT01791517|566052647|FG010|Phase II|Lack of Efficacy|0|||
156808304|NCT01791517|566052648|FG011|Phase II|Lack of Efficacy|0|||
156808305|NCT01791517|566052637|FG000|Phase II|Adverse Event|0|||
156808306|NCT01791517|566052638|FG001|Phase II|Adverse Event|0|||
156808307|NCT01791517|566052639|FG002|Phase II|Adverse Event|0|||
156882549|NCT00913458|566330828|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
156882550|NCT00913458|566330829|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
156882551|NCT00913458|566330823|FG000|Phase 2|Non-Responder|0|||
156882552|NCT00913458|566330824|FG001|Phase 2|Non-Responder|5|||
156882553|NCT00913458|566330825|FG002|Phase 2|Non-Responder|7|||
157021553|NCT04169373|566830902|FG003|Week 1 to Week 14|Other|5|||
156808308|NCT01791517|566052640|FG003|Phase II|Adverse Event|0|||
156808309|NCT01791517|566052641|FG004|Phase II|Adverse Event|0|||
156808310|NCT01791517|566052642|FG005|Phase II|Adverse Event|0|||
156808311|NCT01791517|566052643|FG006|Phase II|Adverse Event|2|||
156808312|NCT01791517|566052644|FG007|Phase II|Adverse Event|1|||
156808313|NCT01791517|566052645|FG008|Phase II|Adverse Event|0|||
156808314|NCT01791517|566052646|FG009|Phase II|Adverse Event|1|||
156808315|NCT01791517|566052647|FG010|Phase II|Adverse Event|0|||
156808316|NCT01791517|566052648|FG011|Phase II|Adverse Event|0|||
156808317|NCT01791517|566052637|FG000|Phase II|Lens Handling Difficulties|0|||
156808318|NCT01791517|566052638|FG001|Phase II|Lens Handling Difficulties|0|||
156808319|NCT01791517|566052639|FG002|Phase II|Lens Handling Difficulties|0|||
156808320|NCT01791517|566052640|FG003|Phase II|Lens Handling Difficulties|0|||
156808321|NCT01791517|566052641|FG004|Phase II|Lens Handling Difficulties|0|||
156808322|NCT01791517|566052642|FG005|Phase II|Lens Handling Difficulties|0|||
156808323|NCT01791517|566052643|FG006|Phase II|Lens Handling Difficulties|0|||
156808324|NCT01791517|566052644|FG007|Phase II|Lens Handling Difficulties|0|||
156808325|NCT01791517|566052645|FG008|Phase II|Lens Handling Difficulties|1|||
156808326|NCT01791517|566052646|FG009|Phase II|Lens Handling Difficulties|0|||
156808327|NCT01791517|566052647|FG010|Phase II|Lens Handling Difficulties|0|||
156808328|NCT01791517|566052648|FG011|Phase II|Lens Handling Difficulties|0|||
156808329|NCT01791517|566052637|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
156808330|NCT01791517|566052638|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
156808331|NCT01791517|566052639|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
156808332|NCT01791517|566052640|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
156808333|NCT01791517|566052641|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
156808334|NCT01791517|566052642|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
156808335|NCT01791517|566052643|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
156808336|NCT01791517|566052644|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
156808337|NCT01791517|566052645|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
156808338|NCT01791517|566052646|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
156808339|NCT01791517|566052647|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
156808340|NCT01791517|566052648|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
156808341|NCT01791517|566052637|FG000|Phase II|Pre-Existing Ocular Issue|0|||
156808342|NCT01791517|566052638|FG001|Phase II|Pre-Existing Ocular Issue|0|||
156808343|NCT01791517|566052639|FG002|Phase II|Pre-Existing Ocular Issue|0|||
156808344|NCT01791517|566052640|FG003|Phase II|Pre-Existing Ocular Issue|0|||
156808345|NCT01791517|566052641|FG004|Phase II|Pre-Existing Ocular Issue|0|||
156808346|NCT01791517|566052642|FG005|Phase II|Pre-Existing Ocular Issue|0|||
156808347|NCT01791517|566052643|FG006|Phase II|Pre-Existing Ocular Issue|0|||
156808348|NCT01791517|566052644|FG007|Phase II|Pre-Existing Ocular Issue|0|||
156808349|NCT01791517|566052645|FG008|Phase II|Pre-Existing Ocular Issue|0|||
156808350|NCT01791517|566052646|FG009|Phase II|Pre-Existing Ocular Issue|0|||
156808351|NCT01791517|566052647|FG010|Phase II|Pre-Existing Ocular Issue|0|||
156808352|NCT01791517|566052648|FG011|Phase II|Pre-Existing Ocular Issue|1|||
156808353|NCT03230318|566052650|FG000|Overall Study|Radiographic disease progression|72|||
156808354|NCT03230318|566052651|FG001|Overall Study|Radiographic disease progression|19|||
156808355|NCT03230318|566052650|FG000|Overall Study|Clinical progression|17|||
156808356|NCT03230318|566052651|FG001|Overall Study|Clinical progression|7|||
156808357|NCT03230318|566052650|FG000|Overall Study|Adverse Event|5|||
156808358|NCT03230318|566052651|FG001|Overall Study|Adverse Event|3|||
156808359|NCT03230318|566052650|FG000|Overall Study|Physician Decision|2|||
156808360|NCT03230318|566052651|FG001|Overall Study|Physician Decision|3|||
156808361|NCT03230318|566052650|FG000|Overall Study|Death|3|||
156808362|NCT03230318|566052651|FG001|Overall Study|Death|2|||
156808363|NCT03230318|566052650|FG000|Overall Study|Lost to Follow-up|1|||
156808364|NCT03230318|566052651|FG001|Overall Study|Lost to Follow-up|0|||
156808365|NCT03230318|566052650|FG000|Overall Study|Withdrawal by Subject|1|||
156808366|NCT03230318|566052651|FG001|Overall Study|Withdrawal by Subject|3|||
156808367|NCT03230318|566052650|FG000|Overall Study|Other|3|||
156808368|NCT03230318|566052651|FG001|Overall Study|Other|7|||
156808369|NCT02141672|566052652|FG000|Overall Study|Adverse Event|0|||
156808370|NCT02141672|566052653|FG001|Overall Study|Adverse Event|1|||
156808371|NCT02141672|566052654|FG002|Overall Study|Adverse Event|0|||
156808372|NCT02141672|566052652|FG000|Overall Study|Death|10|||
156808373|NCT02141672|566052653|FG001|Overall Study|Death|2|||
156808374|NCT02141672|566052654|FG002|Overall Study|Death|1|||
156808375|NCT02141672|566052652|FG000|Overall Study|Lack of Efficacy|0|||
156808376|NCT02141672|566052653|FG001|Overall Study|Lack of Efficacy|0|||
156808377|NCT02141672|566052654|FG002|Overall Study|Lack of Efficacy|2|||
156808378|NCT02141672|566052652|FG000|Overall Study|Lost to Follow-up|1|||
156808379|NCT02141672|566052653|FG001|Overall Study|Lost to Follow-up|1|||
156808380|NCT02141672|566052654|FG002|Overall Study|Lost to Follow-up|3|||
156808381|NCT02141672|566052652|FG000|Overall Study|Physician Decision|1|||
156808382|NCT02141672|566052653|FG001|Overall Study|Physician Decision|2|||
156808383|NCT02141672|566052654|FG002|Overall Study|Physician Decision|5|||
156808384|NCT02141672|566052652|FG000|Overall Study|Protocol Violation|0|||
156808385|NCT02141672|566052653|FG001|Overall Study|Protocol Violation|0|||
156808386|NCT02141672|566052654|FG002|Overall Study|Protocol Violation|1|||
156882554|NCT00913458|566330826|FG003|Phase 2|Non-Responder|12|||
156882555|NCT00913458|566330827|FG004|Phase 2|Non-Responder|0|||
156882556|NCT00913458|566330828|FG005|Phase 2|Non-Responder|0|||
156882557|NCT00913458|566330829|FG006|Phase 2|Non-Responder|0|||
156882558|NCT00913458|566330823|FG000|Phase 2|Subject Request|0|||
156882559|NCT00913458|566330824|FG001|Phase 2|Subject Request|0|||
156882560|NCT00913458|566330825|FG002|Phase 2|Subject Request|1|||
156882561|NCT00913458|566330826|FG003|Phase 2|Subject Request|2|||
156882562|NCT00913458|566330827|FG004|Phase 2|Subject Request|0|||
156882563|NCT00913458|566330828|FG005|Phase 2|Subject Request|0|||
156882564|NCT00913458|566330829|FG006|Phase 2|Subject Request|0|||
156882565|NCT00913458|566330823|FG000|Phase 2|Adverse Event|0|||
156882566|NCT00913458|566330824|FG001|Phase 2|Adverse Event|3|||
156882567|NCT00913458|566330825|FG002|Phase 2|Adverse Event|0|||
156882568|NCT00913458|566330826|FG003|Phase 2|Adverse Event|1|||
156882569|NCT00913458|566330827|FG004|Phase 2|Adverse Event|0|||
156882570|NCT00913458|566330828|FG005|Phase 2|Adverse Event|0|||
156882571|NCT00913458|566330829|FG006|Phase 2|Adverse Event|0|||
156882572|NCT00913458|566330823|FG000|Phase 2|Lost to Follow-up|0|||
156882573|NCT00913458|566330824|FG001|Phase 2|Lost to Follow-up|0|||
156882574|NCT00913458|566330825|FG002|Phase 2|Lost to Follow-up|0|||
156882575|NCT00913458|566330826|FG003|Phase 2|Lost to Follow-up|1|||
156808387|NCT02141672|566052652|FG000|Overall Study|Withdrawal by Subject|3|||
156808388|NCT02141672|566052653|FG001|Overall Study|Withdrawal by Subject|2|||
156808389|NCT02141672|566052654|FG002|Overall Study|Withdrawal by Subject|5|||
156808390|NCT02141672|566052652|FG000|Overall Study|refused to follow-up|1|||
156808391|NCT02141672|566052653|FG001|Overall Study|refused to follow-up|0|||
156808392|NCT02141672|566052654|FG002|Overall Study|refused to follow-up|1|||
156808393|NCT00075764|566052655|FG000|Overall Study|Adverse Event|5|||
156808394|NCT00075764|566052656|FG001|Overall Study|Adverse Event|12|||
156808395|NCT00075764|566052655|FG000|Overall Study|Death|4|||
156808396|NCT00075764|566052656|FG001|Overall Study|Death|8|||
156808397|NCT00075764|566052655|FG000|Overall Study|Withdrawal by Subject|28|||
156808398|NCT00075764|566052656|FG001|Overall Study|Withdrawal by Subject|18|||
156808399|NCT00075764|566052655|FG000|Overall Study|Progression|269|||
156808400|NCT00075764|566052656|FG001|Overall Study|Progression|274|||
156808401|NCT00075764|566052655|FG000|Overall Study|Still on treatment|8|||
156808402|NCT00075764|566052656|FG001|Overall Study|Still on treatment|15|||
156882576|NCT00913458|566330827|FG004|Phase 2|Lost to Follow-up|0|||
156882577|NCT00913458|566330828|FG005|Phase 2|Lost to Follow-up|0|||
156882578|NCT00913458|566330829|FG006|Phase 2|Lost to Follow-up|0|||
156882579|NCT00913458|566330823|FG000|Phase 2|Protocol Violation|0|||
156882580|NCT00913458|566330824|FG001|Phase 2|Protocol Violation|2|||
156882581|NCT00913458|566330825|FG002|Phase 2|Protocol Violation|0|||
156882582|NCT00913458|566330826|FG003|Phase 2|Protocol Violation|0|||
156882583|NCT00913458|566330827|FG004|Phase 2|Protocol Violation|0|||
156882584|NCT00913458|566330828|FG005|Phase 2|Protocol Violation|0|||
156882585|NCT00913458|566330829|FG006|Phase 2|Protocol Violation|0|||
156882586|NCT00913458|566330823|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
156882587|NCT00913458|566330824|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
156882588|NCT00913458|566330825|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
156882589|NCT00913458|566330826|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
156882590|NCT00913458|566330827|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
156882591|NCT00913458|566330828|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
156882592|NCT00913458|566330829|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
156882593|NCT00913458|566330823|FG000|Phase 3|Adverse Event|0|||
156882594|NCT00913458|566330824|FG001|Phase 3|Adverse Event|0|||
156882595|NCT00913458|566330825|FG002|Phase 3|Adverse Event|0|||
156882596|NCT00913458|566330826|FG003|Phase 3|Adverse Event|0|||
156882597|NCT00913458|566330827|FG004|Phase 3|Adverse Event|5|||
156882598|NCT00913458|566330828|FG005|Phase 3|Adverse Event|4|||
156882599|NCT00913458|566330829|FG006|Phase 3|Adverse Event|1|||
156882600|NCT00913458|566330823|FG000|Phase 3|Lost to Follow-up|0|||
156882601|NCT00913458|566330824|FG001|Phase 3|Lost to Follow-up|0|||
157021554|NCT04169373|566830899|FG000|Week 14 to Week 52|Adverse Event|1|||
156882602|NCT00913458|566330825|FG002|Phase 3|Lost to Follow-up|0|||
156882603|NCT00913458|566330826|FG003|Phase 3|Lost to Follow-up|0|||
156882604|NCT00913458|566330827|FG004|Phase 3|Lost to Follow-up|2|||
156882605|NCT00913458|566330828|FG005|Phase 3|Lost to Follow-up|0|||
156882606|NCT00913458|566330829|FG006|Phase 3|Lost to Follow-up|0|||
156882607|NCT00913458|566330823|FG000|Phase 3|Non-Responder|0|||
157021555|NCT04169373|566830900|FG001|Week 14 to Week 52|Adverse Event|0|||
156808403|NCT00075764|566052655|FG000|Overall Study|Delinquent|4|||
156808404|NCT00075764|566052656|FG001|Overall Study|Delinquent|2|||
156808405|NCT00075764|566052655|FG000|Overall Study|Not protocol specified|27|||
156808406|NCT00075764|566052656|FG001|Overall Study|Not protocol specified|19|||
156808407|NCT00075764|566052655|FG000|Overall Study|Under review|0|||
156882608|NCT00913458|566330824|FG001|Phase 3|Non-Responder|0|||
156882609|NCT00913458|566330825|FG002|Phase 3|Non-Responder|0|||
156882610|NCT00913458|566330826|FG003|Phase 3|Non-Responder|0|||
156882611|NCT00913458|566330827|FG004|Phase 3|Non-Responder|0|||
156882612|NCT00913458|566330828|FG005|Phase 3|Non-Responder|1|||
156882613|NCT00913458|566330829|FG006|Phase 3|Non-Responder|3|||
156882614|NCT00913458|566330823|FG000|Phase 3|Withdrawal by Subject|0|||
156882615|NCT00913458|566330824|FG001|Phase 3|Withdrawal by Subject|0|||
156882616|NCT00913458|566330825|FG002|Phase 3|Withdrawal by Subject|0|||
156882617|NCT00913458|566330826|FG003|Phase 3|Withdrawal by Subject|0|||
156882618|NCT00913458|566330827|FG004|Phase 3|Withdrawal by Subject|1|||
156882619|NCT00913458|566330828|FG005|Phase 3|Withdrawal by Subject|2|||
156882620|NCT00913458|566330829|FG006|Phase 3|Withdrawal by Subject|0|||
156882621|NCT00913458|566330823|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
156882622|NCT00913458|566330824|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
156882623|NCT00913458|566330825|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
156882624|NCT00913458|566330826|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
156882625|NCT00913458|566330827|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
156882626|NCT00913458|566330828|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
156882627|NCT00913458|566330829|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
156882628|NCT02366091|566330830|FG000|Overall Study|Withdrawal by Subject|3|||
156882629|NCT02366091|566330831|FG001|Overall Study|Withdrawal by Subject|7|||
156882630|NCT02366091|566330832|FG002|Overall Study|Withdrawal by Subject|3|||
156882631|NCT02366091|566330833|FG003|Overall Study|Withdrawal by Subject|1|||
156882632|NCT02338232|566330834|FG000|Overall Study|Screen Failure|3|||
156882633|NCT02338232|566330834|FG000|Overall Study|Withdrawal by Subject|6|||
156882634|NCT02338232|566330834|FG000|Overall Study|Adverse Event|2|||
156882635|NCT00322621|566330837|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
156882636|NCT00322621|566330838|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
156882637|NCT00322621|566330839|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
156882638|NCT00322621|566330837|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
156882639|NCT00322621|566330838|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
156882640|NCT00322621|566330839|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
156882641|NCT00322621|566330837|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
156882642|NCT00322621|566330838|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
156882643|NCT00322621|566330839|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
156882644|NCT00322621|566330837|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
156882645|NCT00322621|566330838|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
156882646|NCT00322621|566330839|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
156882647|NCT00322621|566330837|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
156882648|NCT00322621|566330838|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
156882649|NCT00322621|566330839|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
156882650|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
156882651|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
156882652|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
156882653|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
156882654|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
156882655|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
156882656|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
156882657|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
156882658|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
156882659|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
156882660|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
156882661|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
156882662|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
156882663|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
156882664|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
156882665|NCT00322621|566330837|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
156882666|NCT00322621|566330838|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
156882667|NCT00322621|566330839|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
156882668|NCT01038869|566330842|FG000|Overall Study|Withdrawal by Subject|1|||
156808408|NCT00075764|566052656|FG001|Overall Study|Under review|1|||
156808409|NCT02817594|566052660|FG000|Overall Study|Withdrawal by Subject|1|||
156808410|NCT02817594|566052660|FG000|Overall Study|Other|1|||
156808411|NCT02817594|566052660|FG000|Overall Study|Did Not Receive Treatment|1|||
156808412|NCT02010593|566052661|FG000|Overall Study|Lost to Follow-up|1|||
156808413|NCT02010593|566052662|FG001|Overall Study|Lost to Follow-up|0|||
156808414|NCT02010593|566052661|FG000|Overall Study|Physician Decision|1|||
156808415|NCT02010593|566052662|FG001|Overall Study|Physician Decision|0|||
156808416|NCT02010593|566052661|FG000|Overall Study|Unable to adhere to visit schedule|0|||
156882669|NCT01038869|566330842|FG000|Overall Study|Lost to Follow-up|6|||
156882670|NCT02238067|566330843|FG000|Overall Study|Not completed survey at Month 6|45|||
156882671|NCT02213133|566330847|FG000|Overall Study|Participant discontinued study therapy|2|||
157021556|NCT04169373|566830901|FG002|Week 14 to Week 52|Adverse Event|0|||
156808417|NCT02010593|566052662|FG001|Overall Study|Unable to adhere to visit schedule|2|||
156808418|NCT01773967|566052663|FG000|Overall Study|Lost to Follow-up|15|||
156808419|NCT01773967|566052664|FG001|Overall Study|Lost to Follow-up|13|||
157221342|NCT01851590|567556831|FG001|Overall Study|Adverse Event|0|||
157221343|NCT01851590|567556832|FG002|Overall Study|Adverse Event|2|||
157221344|NCT01851590|567556830|FG000|Overall Study|Lack of Efficacy|0|||
157221345|NCT01851590|567556831|FG001|Overall Study|Lack of Efficacy|1|||
157221346|NCT01851590|567556832|FG002|Overall Study|Lack of Efficacy|0|||
157221347|NCT00696709|567556834|FG000|Overall Study|Withdrawal by Subject|1|||
157221348|NCT00696709|567556835|FG001|Overall Study|Withdrawal by Subject|2|||
157221349|NCT00696709|567556836|FG002|Overall Study|Withdrawal by Subject|1|||
157221350|NCT00696709|567556837|FG003|Overall Study|Withdrawal by Subject|4|||
157221351|NCT00696709|567556838|FG004|Overall Study|Withdrawal by Subject|3|||
157221352|NCT00696709|567556834|FG000|Overall Study|Protocol Violation|1|||
157221353|NCT00696709|567556835|FG001|Overall Study|Protocol Violation|0|||
157221354|NCT00696709|567556836|FG002|Overall Study|Protocol Violation|0|||
157221355|NCT00696709|567556837|FG003|Overall Study|Protocol Violation|0|||
157221356|NCT00696709|567556838|FG004|Overall Study|Protocol Violation|0|||
157221357|NCT00696709|567556834|FG000|Overall Study|Lost to Follow-up|1|||
157221358|NCT00696709|567556835|FG001|Overall Study|Lost to Follow-up|1|||
157221359|NCT00696709|567556836|FG002|Overall Study|Lost to Follow-up|0|||
157221360|NCT00696709|567556837|FG003|Overall Study|Lost to Follow-up|0|||
157221361|NCT00696709|567556838|FG004|Overall Study|Lost to Follow-up|0|||
157221362|NCT00696709|567556834|FG000|Overall Study|Adverse Event|0|||
157221363|NCT00696709|567556835|FG001|Overall Study|Adverse Event|0|||
157221364|NCT00696709|567556836|FG002|Overall Study|Adverse Event|0|||
157221365|NCT00696709|567556837|FG003|Overall Study|Adverse Event|1|||
157221366|NCT00696709|567556838|FG004|Overall Study|Adverse Event|0|||
157221367|NCT00310856|567556839|FG000|Overall Study|Withdrawal by Subject|2|||
157221368|NCT00310856|567556840|FG001|Overall Study|Withdrawal by Subject|2|||
157221369|NCT00310856|567556841|FG002|Overall Study|Withdrawal by Subject|2|||
157221370|NCT00310856|567556839|FG000|Overall Study|Lost to Follow-up|1|||
157221371|NCT00310856|567556840|FG001|Overall Study|Lost to Follow-up|2|||
157221372|NCT00310856|567556841|FG002|Overall Study|Lost to Follow-up|6|||
157221373|NCT00310856|567556839|FG000|Overall Study|Inappropriate enrollment|1|||
157221374|NCT00310856|567556840|FG001|Overall Study|Inappropriate enrollment|1|||
157221375|NCT00310856|567556841|FG002|Overall Study|Inappropriate enrollment|0|||
157221376|NCT00310856|567556839|FG000|Overall Study|Unable to classify|1|||
157221377|NCT00310856|567556840|FG001|Overall Study|Unable to classify|0|||
157221378|NCT00310856|567556841|FG002|Overall Study|Unable to classify|0|||
157221379|NCT00321711|567556845|FG000|Part A|Adverse Event|3|||
157221380|NCT00321711|567556846|FG001|Part A|Adverse Event|3|||
157221381|NCT00321711|567556847|FG002|Part A|Adverse Event|2|||
156882672|NCT02213133|566330848|FG001|Overall Study|Participant discontinued study therapy|0|||
156882673|NCT02213133|566330849|FG002|Overall Study|Participant discontinued study therapy|0|||
156882674|NCT02213133|566330847|FG000|Overall Study|Participant withdrew informed consent|2|||
156882675|NCT02213133|566330848|FG001|Overall Study|Participant withdrew informed consent|1|||
156882676|NCT02213133|566330849|FG002|Overall Study|Participant withdrew informed consent|2|||
156882677|NCT02213133|566330847|FG000|Overall Study|Disease progression|11|||
156882678|NCT02213133|566330848|FG001|Overall Study|Disease progression|2|||
156882679|NCT02213133|566330849|FG002|Overall Study|Disease progression|0|||
156882680|NCT02213133|566330847|FG000|Overall Study|Adverse Event (AE)|1|||
156882681|NCT02213133|566330848|FG001|Overall Study|Adverse Event (AE)|0|||
156882682|NCT02213133|566330849|FG002|Overall Study|Adverse Event (AE)|0|||
156882683|NCT02213133|566330847|FG000|Overall Study|Death|16|||
156882684|NCT02213133|566330848|FG001|Overall Study|Death|2|||
156882685|NCT02213133|566330849|FG002|Overall Study|Death|1|||
156882686|NCT02213133|566330847|FG000|Overall Study|Other|5|||
156882687|NCT02213133|566330848|FG001|Overall Study|Other|0|||
156882688|NCT02213133|566330849|FG002|Overall Study|Other|0|||
156882689|NCT02350764|566330850|FG000|Overall Study|Adverse Event|4|||
156882690|NCT02350764|566330850|FG000|Overall Study|Death|3|||
156882691|NCT02350764|566330850|FG000|Overall Study|Physician Decision|2|||
156882692|NCT02350764|566330850|FG000|Overall Study|Withdrawal by Subject|2|||
156882693|NCT02743611|566330851|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
157221382|NCT00321711|567556848|FG003|Part A|Adverse Event|0|||
157221383|NCT00321711|567556849|FG004|Part A|Adverse Event|0|||
157221384|NCT00321711|567556845|FG000|Part A|Withdrawal by Subject|1|||
157221385|NCT00321711|567556846|FG001|Part A|Withdrawal by Subject|1|||
157221386|NCT00321711|567556847|FG002|Part A|Withdrawal by Subject|1|||
157221387|NCT00321711|567556848|FG003|Part A|Withdrawal by Subject|0|||
156882694|NCT02743611|566330852|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
156882695|NCT02743611|566330853|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
156882696|NCT02743611|566330854|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
156882697|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
156882698|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
156882699|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
156882700|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
157221388|NCT00321711|567556849|FG004|Part A|Withdrawal by Subject|0|||
157221389|NCT00321711|567556845|FG000|Part A|Disease progression|0|||
157221390|NCT00321711|567556846|FG001|Part A|Disease progression|1|||
157221391|NCT00321711|567556847|FG002|Part A|Disease progression|0|||
157221392|NCT00321711|567556848|FG003|Part A|Disease progression|0|||
157221393|NCT00321711|567556849|FG004|Part A|Disease progression|0|||
157221394|NCT00321711|567556845|FG000|Part A|Requirement for alternative therapy|0|||
157221395|NCT00321711|567556846|FG001|Part A|Requirement for alternative therapy|2|||
157221396|NCT00321711|567556847|FG002|Part A|Requirement for alternative therapy|1|||
157221397|NCT00321711|567556848|FG003|Part A|Requirement for alternative therapy|0|||
157221398|NCT00321711|567556849|FG004|Part A|Requirement for alternative therapy|0|||
157221399|NCT00321711|567556845|FG000|Part A|Physician Decision|0|||
157221400|NCT00321711|567556846|FG001|Part A|Physician Decision|1|||
157221401|NCT00321711|567556847|FG002|Part A|Physician Decision|3|||
157221402|NCT00321711|567556848|FG003|Part A|Physician Decision|0|||
157221403|NCT00321711|567556849|FG004|Part A|Physician Decision|0|||
156808420|NCT02655887|566052669|FG000|Overall Study|Lost to Follow-up|3|||
156808421|NCT02655887|566052669|FG000|Overall Study|Death|4|||
156808422|NCT02655887|566052669|FG000|Overall Study|Withdrawal by Subject|3|||
156808423|NCT02655887|566052669|FG000|Overall Study|Missed 12-month follow-up visit|4|||
157221404|NCT00321711|567556845|FG000|Part A|Other|1|||
157221405|NCT00321711|567556846|FG001|Part A|Other|2|||
157221406|NCT00321711|567556847|FG002|Part A|Other|3|||
157221407|NCT00321711|567556848|FG003|Part A|Other|0|||
157221408|NCT00321711|567556849|FG004|Part A|Other|0|||
157221409|NCT00321711|567556845|FG000|Part A|Protocol deviation|0|||
157221410|NCT00321711|567556846|FG001|Part A|Protocol deviation|0|||
157221411|NCT00321711|567556847|FG002|Part A|Protocol deviation|1|||
157221412|NCT00321711|567556848|FG003|Part A|Protocol deviation|0|||
157221413|NCT00321711|567556849|FG004|Part A|Protocol deviation|0|||
157221414|NCT00321711|567556845|FG000|Part B|Noncompliance|0|||
157221415|NCT00321711|567556846|FG001|Part B|Noncompliance|0|||
157221416|NCT00321711|567556847|FG002|Part B|Noncompliance|0|||
157221417|NCT00321711|567556848|FG003|Part B|Noncompliance|0|||
157221418|NCT00321711|567556849|FG004|Part B|Noncompliance|1|||
157221419|NCT00321711|567556845|FG000|Part B|Adverse Event|0|||
157221420|NCT00321711|567556846|FG001|Part B|Adverse Event|0|||
157221421|NCT00321711|567556847|FG002|Part B|Adverse Event|0|||
157221422|NCT00321711|567556848|FG003|Part B|Adverse Event|2|||
157221423|NCT00321711|567556849|FG004|Part B|Adverse Event|1|||
157221424|NCT00321711|567556845|FG000|Part B|Disease progression|0|||
157221425|NCT00321711|567556846|FG001|Part B|Disease progression|0|||
157221426|NCT00321711|567556847|FG002|Part B|Disease progression|0|||
157221427|NCT00321711|567556848|FG003|Part B|Disease progression|1|||
157221428|NCT00321711|567556849|FG004|Part B|Disease progression|0|||
157221429|NCT00321711|567556845|FG000|Part B|Physician Decision|0|||
156808424|NCT02834819|566052670|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
156808425|NCT02834819|566052671|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
156808426|NCT02041299|566052673|FG000|Overall Study|Adverse Event|9|||
156808427|NCT02041299|566052674|FG001|Overall Study|Adverse Event|3|||
156808428|NCT02041299|566052673|FG000|Overall Study|Lost to Follow-up|4|||
156808429|NCT02041299|566052674|FG001|Overall Study|Lost to Follow-up|1|||
156808430|NCT02041299|566052673|FG000|Overall Study|Physician Decision|1|||
156808431|NCT02041299|566052674|FG001|Overall Study|Physician Decision|1|||
156808432|NCT02041299|566052673|FG000|Overall Study|Withdrawal by Subject|13|||
156808433|NCT02041299|566052674|FG001|Overall Study|Withdrawal by Subject|7|||
156808434|NCT02041299|566052673|FG000|Overall Study|Protocol Violation|11|||
156808435|NCT02041299|566052674|FG001|Overall Study|Protocol Violation|4|||
156808436|NCT02041299|566052673|FG000|Overall Study|Termination of the study|7|||
156808437|NCT02041299|566052674|FG001|Overall Study|Termination of the study|3|||
156808438|NCT02041299|566052673|FG000|Overall Study|Required bone marrow transplant|0|||
156808439|NCT02041299|566052674|FG001|Overall Study|Required bone marrow transplant|1|||
156808440|NCT02041299|566052673|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
156808441|NCT02041299|566052674|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
156808442|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156808443|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156808444|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156808445|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
156882701|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
157221430|NCT00321711|567556846|FG001|Part B|Physician Decision|0|||
157221431|NCT00321711|567556847|FG002|Part B|Physician Decision|0|||
156808446|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
156808447|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
156882702|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
157221432|NCT00321711|567556848|FG003|Part B|Physician Decision|1|||
157221433|NCT00321711|567556849|FG004|Part B|Physician Decision|2|||
157221434|NCT00321711|567556845|FG000|Part B|Death|0|||
157221435|NCT00321711|567556846|FG001|Part B|Death|0|||
157221436|NCT00321711|567556847|FG002|Part B|Death|0|||
157221437|NCT00321711|567556848|FG003|Part B|Death|2|||
157221438|NCT00321711|567556849|FG004|Part B|Death|1|||
157221439|NCT02843074|567556850|FG000|Overall Study|Withdrawal by Subject|5|||
157221440|NCT02843074|567556850|FG000|Overall Study|Progressive disease|1|||
156882703|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156882704|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
156882705|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
156808448|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
156808449|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
156808450|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
156808451|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
156808452|NCT01925768|566052675|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
156808453|NCT01925768|566052676|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
156808454|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
156808455|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
156808456|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
156808457|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
156808458|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
156808459|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
156808460|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
156808461|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
156808462|NCT01925768|566052675|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
156808463|NCT01925768|566052676|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
156808464|NCT00087698|566052680|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
156808465|NCT00087698|566052680|FG000|Overall Study|Death from Other Causes|3|||
156808466|NCT00087698|566052680|FG000|Overall Study|Adverse Event|4|||
156808467|NCT00087698|566052680|FG000|Overall Study|Withdrawal by Subject|4|||
156808468|NCT00087698|566052680|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
156808469|NCT00087698|566052680|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
156808470|NCT00087698|566052680|FG000|Overall Study|Clinical Relapse|1|||
156808471|NCT00087698|566052680|FG000|Overall Study|Death from Study Disease|2|||
156808472|NCT00087698|566052680|FG000|Overall Study|Death from Study Drug Toxicity|2|||
156808473|NCT00087698|566052680|FG000|Overall Study|Protocol Violation|1|||
156808474|NCT04179305|566052681|FG000|Overall Study|Death|1|||
156808475|NCT04179305|566052682|FG001|Overall Study|Death|1|||
156808476|NCT04179305|566052683|FG002|Overall Study|Death|0|||
156808477|NCT04179305|566052684|FG003|Overall Study|Death|0|||
156808478|NCT04179305|566052681|FG000|Overall Study|Lost to Follow-up|1|||
156808479|NCT04179305|566052682|FG001|Overall Study|Lost to Follow-up|1|||
156808480|NCT04179305|566052683|FG002|Overall Study|Lost to Follow-up|0|||
156808481|NCT04179305|566052684|FG003|Overall Study|Lost to Follow-up|0|||
156808482|NCT04179305|566052681|FG000|Overall Study|Withdrawal by Subject|0|||
156808483|NCT04179305|566052682|FG001|Overall Study|Withdrawal by Subject|1|||
156808484|NCT04179305|566052683|FG002|Overall Study|Withdrawal by Subject|0|||
156808485|NCT04179305|566052684|FG003|Overall Study|Withdrawal by Subject|0|||
156808486|NCT04179305|566052681|FG000|Overall Study|Did not have scan|1|||
156808487|NCT04179305|566052682|FG001|Overall Study|Did not have scan|0|||
156808488|NCT04179305|566052683|FG002|Overall Study|Did not have scan|0|||
156808489|NCT04179305|566052684|FG003|Overall Study|Did not have scan|0|||
156808490|NCT04179305|566052681|FG000|Overall Study|In hospice care|3|||
156808491|NCT04179305|566052682|FG001|Overall Study|In hospice care|0|||
156808492|NCT04179305|566052683|FG002|Overall Study|In hospice care|0|||
156808493|NCT04179305|566052684|FG003|Overall Study|In hospice care|0|||
156808494|NCT01737762|566052687|FG000|Overall Study|Adverse Event|2|||
156808495|NCT01737762|566052688|FG001|Overall Study|Adverse Event|2|||
156808496|NCT01737762|566052687|FG000|Overall Study|Lost to Follow-up|1|||
156808497|NCT01737762|566052688|FG001|Overall Study|Lost to Follow-up|0|||
156808498|NCT01737762|566052687|FG000|Overall Study|Withdrawal by Subject|2|||
156808499|NCT01737762|566052688|FG001|Overall Study|Withdrawal by Subject|2|||
156808500|NCT01737762|566052687|FG000|Overall Study|Progressive disease|1|||
156808501|NCT01737762|566052688|FG001|Overall Study|Progressive disease|2|||
156808502|NCT01737762|566052687|FG000|Overall Study|Physician Decision|1|||
156808503|NCT01737762|566052688|FG001|Overall Study|Physician Decision|1|||
156808504|NCT01737762|566052687|FG000|Overall Study|Moved from area|2|||
156808505|NCT01737762|566052688|FG001|Overall Study|Moved from area|1|||
156808506|NCT01737762|566052687|FG000|Overall Study|Trial termination|11|||
156808507|NCT01737762|566052688|FG001|Overall Study|Trial termination|9|||
156808508|NCT01964378|566052689|FG000|Overall Study|Disc. due to death before first dosing|0|||
156808509|NCT01964378|566052690|FG001|Overall Study|Disc. due to death before first dosing|1|||
156808510|NCT01964378|566052689|FG000|Overall Study|Disc. due to AE before first dosing|1|||
156808511|NCT01964378|566052690|FG001|Overall Study|Disc. due to AE before first dosing|0|||
156882706|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156882707|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156882708|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
157021557|NCT04169373|566830902|FG003|Week 14 to Week 52|Adverse Event|1|||
156808512|NCT01964378|566052689|FG000|Overall Study|Death|3|||
156882709|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156882710|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156882711|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
156882712|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156882713|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
156882714|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
156882715|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
156882716|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156882717|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156882718|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156882719|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156882720|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
156882721|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
156882722|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
156882723|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
156882724|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
156882725|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
156882726|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
156882727|NCT00600119|566330855|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
157221441|NCT02843074|567556850|FG000|Overall Study|Physician Decision|1|||
157221442|NCT02843074|567556850|FG000|Overall Study|Lost to Follow-up|1|||
157221443|NCT02843074|567556850|FG000|Overall Study|Death|9|||
157221444|NCT01564758|567556851|FG000|Overall Study|Death|8|||
157221445|NCT01564758|567556851|FG000|Overall Study|Adverse Event|3|||
157221446|NCT01564758|567556851|FG000|Overall Study|Other|3|||
157221447|NCT01186978|567556852|FG000|Overall Study|Withdrawal by Subject|1|||
157221448|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
157221449|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
156882728|NCT00600119|566330856|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
156882729|NCT00600119|566330857|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156882730|NCT00600119|566330858|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156882731|NCT00600119|566330859|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156882732|NCT00600119|566330860|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
156882733|NCT00600119|566330855|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
156882734|NCT00600119|566330856|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
156882735|NCT00600119|566330857|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156882736|NCT00600119|566330858|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
156882737|NCT00600119|566330859|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
156882738|NCT00600119|566330860|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
156882739|NCT00600119|566330855|FG000|Double-blind Treatment Period|Other|0|||
156882740|NCT00600119|566330856|FG001|Double-blind Treatment Period|Other|0|||
156882741|NCT00600119|566330857|FG002|Double-blind Treatment Period|Other|0|||
156882742|NCT00600119|566330858|FG003|Double-blind Treatment Period|Other|0|||
156882743|NCT00600119|566330859|FG004|Double-blind Treatment Period|Other|2|||
156882744|NCT00600119|566330860|FG005|Double-blind Treatment Period|Other|1|||
156882745|NCT00600119|566330855|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156882746|NCT00600119|566330856|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
156882747|NCT00600119|566330857|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156882748|NCT00600119|566330858|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156882749|NCT00600119|566330859|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
156882750|NCT00600119|566330860|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
156882751|NCT00600119|566330855|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156882752|NCT00600119|566330856|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
156882753|NCT00600119|566330857|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
157221450|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
157221451|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
157221452|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
157221453|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
156882754|NCT00600119|566330858|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156882755|NCT00600119|566330859|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156882756|NCT00600119|566330860|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
156882757|NCT00600119|566330855|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
157021558|NCT04169373|566830899|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
157221454|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
157221455|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
157221456|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
157221457|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
157221458|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
157221459|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
157221460|NCT01227668|567556853|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
157221461|NCT01227668|567556854|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
157221462|NCT01227668|567556853|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
157221463|NCT01227668|567556854|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
157221464|NCT01227668|567556853|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
157221465|NCT01227668|567556854|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
157221466|NCT01227668|567556853|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
157221467|NCT01227668|567556854|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
157221468|NCT01227668|567556853|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
157221469|NCT01227668|567556854|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
157221470|NCT01227668|567556853|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
157221471|NCT01227668|567556854|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
157221472|NCT01306253|567556858|FG000|Overall Study|Lost to Follow-up|1|||
157221473|NCT01306253|567556859|FG001|Overall Study|Lost to Follow-up|1|||
157221474|NCT01261325|567556860|FG000|Overall Study|Lack of Efficacy|1|||
157221475|NCT01261325|567556861|FG001|Overall Study|Lack of Efficacy|1|||
157221476|NCT01261325|567556862|FG002|Overall Study|Lack of Efficacy|0|||
157221477|NCT01261325|567556860|FG000|Overall Study|Withdrawal by Subject|2|||
157221478|NCT01261325|567556861|FG001|Overall Study|Withdrawal by Subject|2|||
157221479|NCT01261325|567556862|FG002|Overall Study|Withdrawal by Subject|4|||
157221480|NCT01261325|567556860|FG000|Overall Study|SAE, non-fatal|1|||
157221481|NCT01261325|567556861|FG001|Overall Study|SAE, non-fatal|5|||
157221482|NCT01261325|567556862|FG002|Overall Study|SAE, non-fatal|1|||
157221483|NCT01261325|567556860|FG000|Overall Study|AE, non-serious non-fatal|9|||
157221484|NCT01261325|567556861|FG001|Overall Study|AE, non-serious non-fatal|15|||
157221485|NCT01261325|567556862|FG002|Overall Study|AE, non-serious non-fatal|13|||
157221486|NCT01261325|567556860|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
157221487|NCT01261325|567556861|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
157221488|NCT01261325|567556862|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
157221489|NCT01261325|567556860|FG000|Overall Study|Non Compliance|2|||
157221490|NCT01261325|567556861|FG001|Overall Study|Non Compliance|0|||
157221491|NCT01261325|567556862|FG002|Overall Study|Non Compliance|0|||
157221492|NCT01261325|567556860|FG000|Overall Study|Patient Randomized by Mistake|0|||
157221493|NCT01261325|567556861|FG001|Overall Study|Patient Randomized by Mistake|1|||
157221494|NCT01261325|567556862|FG002|Overall Study|Patient Randomized by Mistake|0|||
157221495|NCT01261325|567556860|FG000|Overall Study|Erroneously Randomized|1|||
157221496|NCT01261325|567556861|FG001|Overall Study|Erroneously Randomized|0|||
157221497|NCT01261325|567556862|FG002|Overall Study|Erroneously Randomized|0|||
157221498|NCT01261325|567556860|FG000|Overall Study|Screen Failure|1|||
157221499|NCT01261325|567556861|FG001|Overall Study|Screen Failure|0|||
157221500|NCT01261325|567556862|FG002|Overall Study|Screen Failure|0|||
157221501|NCT01261325|567556860|FG000|Overall Study|Randomized in Error|0|||
157221502|NCT01261325|567556861|FG001|Overall Study|Randomized in Error|0|||
157221503|NCT01261325|567556862|FG002|Overall Study|Randomized in Error|1|||
157221504|NCT01261325|567556860|FG000|Overall Study|Protocol Violation|0|||
157221505|NCT01261325|567556861|FG001|Overall Study|Protocol Violation|3|||
157221506|NCT01261325|567556862|FG002|Overall Study|Protocol Violation|1|||
157221507|NCT01261325|567556860|FG000|Overall Study|Lost to Follow-up|0|||
157221508|NCT01261325|567556861|FG001|Overall Study|Lost to Follow-up|1|||
157221509|NCT01261325|567556862|FG002|Overall Study|Lost to Follow-up|3|||
157221510|NCT01261325|567556860|FG000|Overall Study|AE, serious fatal|0|||
157221511|NCT01261325|567556861|FG001|Overall Study|AE, serious fatal|0|||
157221512|NCT01261325|567556862|FG002|Overall Study|AE, serious fatal|2|||
157221513|NCT00543439|567556863|FG000|Period 1|Adverse Event|0|||
157221514|NCT00543439|567556864|FG001|Period 1|Adverse Event|2|||
157221515|NCT00543439|567556865|FG002|Period 1|Adverse Event|1|||
157221516|NCT00543439|567556863|FG000|Period 1|Withdrawal by Subject|1|||
157221517|NCT00543439|567556864|FG001|Period 1|Withdrawal by Subject|1|||
157221518|NCT00543439|567556865|FG002|Period 1|Withdrawal by Subject|0|||
157221519|NCT00543439|567556863|FG000|Period 1|Physician Decision|0|||
157221520|NCT00543439|567556864|FG001|Period 1|Physician Decision|0|||
157221521|NCT00543439|567556865|FG002|Period 1|Physician Decision|1|||
157221522|NCT00543439|567556863|FG000|Period 2|Protocol Violation|1|||
157221523|NCT00543439|567556864|FG001|Period 2|Protocol Violation|0|||
157221524|NCT00543439|567556865|FG002|Period 2|Protocol Violation|1|||
157221525|NCT00543439|567556863|FG000|Period 2|Adverse Event|0|||
157221526|NCT00543439|567556864|FG001|Period 2|Adverse Event|1|||
157221527|NCT00543439|567556865|FG002|Period 2|Adverse Event|1|||
157221528|NCT01193517|567556879|FG000|Overall Study|Early Progression|1|||
157221529|NCT01193517|567556880|FG001|Overall Study|Early Progression|0|||
157221530|NCT01193517|567556881|FG002|Overall Study|Early Progression|0|||
157221531|NCT00526890|567556882|FG000|Overall Study|Adverse Event|2|||
157221532|NCT01688037|567556883|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
157221533|NCT01688037|567556884|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
157221534|NCT01688037|567556885|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
157221535|NCT01688037|567556883|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
157221536|NCT01688037|567556884|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
157221537|NCT01688037|567556885|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
157221538|NCT01688037|567556883|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
157221539|NCT01688037|567556884|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
157221540|NCT01688037|567556885|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
157221541|NCT01688037|567556883|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
157221542|NCT01688037|567556884|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
156882758|NCT00600119|566330856|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
156882759|NCT00600119|566330857|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
156882760|NCT00600119|566330858|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
156882761|NCT00600119|566330859|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
156882762|NCT00600119|566330860|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
156882763|NCT00600119|566330855|FG000|Double-blind Treatment Period|Physician Decision|2|||
156882764|NCT00600119|566330856|FG001|Double-blind Treatment Period|Physician Decision|0|||
156882765|NCT00600119|566330857|FG002|Double-blind Treatment Period|Physician Decision|0|||
156882766|NCT00600119|566330858|FG003|Double-blind Treatment Period|Physician Decision|0|||
156882767|NCT00600119|566330859|FG004|Double-blind Treatment Period|Physician Decision|0|||
157021559|NCT04169373|566830900|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
156882768|NCT00600119|566330860|FG005|Double-blind Treatment Period|Physician Decision|0|||
157221543|NCT01688037|567556885|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
157221544|NCT01688037|567556883|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
157221545|NCT01688037|567556884|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
157221546|NCT01688037|567556885|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
157221547|NCT01688037|567556883|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
157221548|NCT01688037|567556884|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
157221549|NCT01688037|567556885|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
157221550|NCT01688037|567556883|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
157221551|NCT01688037|567556884|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
157221552|NCT01688037|567556885|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
157221553|NCT01688037|567556883|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
157221554|NCT01688037|567556884|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
157221555|NCT01688037|567556885|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
157221556|NCT01688037|567556883|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
157221557|NCT01688037|567556884|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
157221558|NCT01688037|567556885|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
157221559|NCT01688037|567556883|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
157221560|NCT01688037|567556884|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
157221561|NCT01688037|567556885|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
157221562|NCT03280537|567556890|FG000|Overall Study|Withdrawal by Subject|2|||
157221563|NCT03280537|567556891|FG001|Overall Study|Withdrawal by Subject|4|||
157221564|NCT01588106|567556892|FG000|Overall Study|Withdrawal by Subject|5|||
157221565|NCT01588106|567556893|FG001|Overall Study|Withdrawal by Subject|4|||
157221566|NCT03083132|567556894|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
157221567|NCT03083132|567556895|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
157221568|NCT03083132|567556894|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
157221569|NCT03083132|567556895|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
157221570|NCT03083132|567556894|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
157221571|NCT03083132|567556895|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
157221572|NCT02995837|567556896|FG000|Overall Study|Lost to Follow-up|9|||
157221573|NCT02995837|567556897|FG001|Overall Study|Lost to Follow-up|8|||
157221574|NCT03118739|567556898|FG000|Overall Study|Physician Decision|0|||
156882769|NCT00600119|566330855|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
156882770|NCT00600119|566330856|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
156882771|NCT00600119|566330857|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
156882772|NCT00600119|566330858|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
156882773|NCT00600119|566330859|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
156882774|NCT00600119|566330860|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
156882775|NCT00600119|566330855|FG000|Double-blind Treatment Period|Adverse Event|1|||
156882776|NCT00600119|566330856|FG001|Double-blind Treatment Period|Adverse Event|1|||
156882777|NCT00600119|566330857|FG002|Double-blind Treatment Period|Adverse Event|0|||
157021560|NCT04169373|566830901|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
157221575|NCT03118739|567556899|FG001|Overall Study|Physician Decision|1|||
157221576|NCT03118739|567556898|FG000|Overall Study|Withdrawal by Subject|5|||
157221577|NCT03118739|567556899|FG001|Overall Study|Withdrawal by Subject|3|||
157221578|NCT03118739|567556898|FG000|Overall Study|Lost to Follow-up|2|||
156882778|NCT00600119|566330858|FG003|Double-blind Treatment Period|Adverse Event|1|||
156882779|NCT00600119|566330859|FG004|Double-blind Treatment Period|Adverse Event|2|||
156882780|NCT00600119|566330860|FG005|Double-blind Treatment Period|Adverse Event|10|||
156882781|NCT00600119|566330855|FG000|Follow-up Period|Adverse Event|0|||
156882782|NCT00600119|566330856|FG001|Follow-up Period|Adverse Event|0|||
156882783|NCT00600119|566330857|FG002|Follow-up Period|Adverse Event|0|||
156882784|NCT00600119|566330858|FG003|Follow-up Period|Adverse Event|0|||
156882785|NCT00600119|566330859|FG004|Follow-up Period|Adverse Event|0|||
156882786|NCT00600119|566330860|FG005|Follow-up Period|Adverse Event|1|||
156882787|NCT00600119|566330855|FG000|Follow-up Period|Other|1|||
156882788|NCT00600119|566330856|FG001|Follow-up Period|Other|0|||
156882789|NCT00600119|566330857|FG002|Follow-up Period|Other|0|||
156882790|NCT00600119|566330858|FG003|Follow-up Period|Other|0|||
156882791|NCT00600119|566330859|FG004|Follow-up Period|Other|0|||
156882792|NCT00600119|566330860|FG005|Follow-up Period|Other|0|||
156882793|NCT00729469|566330861|FG000|Overall Study|Adverse Event|14|||
156882794|NCT00729469|566330862|FG001|Overall Study|Adverse Event|25|||
156882795|NCT00729469|566330861|FG000|Overall Study|Lost to Follow-up|9|||
156882796|NCT00729469|566330862|FG001|Overall Study|Lost to Follow-up|9|||
156882797|NCT00729469|566330861|FG000|Overall Study|Protocol Violation|2|||
156882798|NCT00729469|566330862|FG001|Overall Study|Protocol Violation|1|||
156882799|NCT00729469|566330861|FG000|Overall Study|Withdrawal by Subject|19|||
156882800|NCT00729469|566330862|FG001|Overall Study|Withdrawal by Subject|8|||
156882801|NCT00729469|566330861|FG000|Overall Study|Other-Not mentioned|9|||
156882802|NCT00729469|566330862|FG001|Overall Study|Other-Not mentioned|4|||
156882803|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
156882804|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
156882805|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Adverse Event|7|||
156882806|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Adverse Event|6|||
156882807|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
156882808|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
156882809|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Physician Decision|4|||
156882810|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Physician Decision|4|||
156882811|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
156882812|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
156882813|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
156882814|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
156882815|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
156882816|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
156882817|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Non-compliance|1|||
156882818|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Non-compliance|0|||
156882819|NCT00470834|566330863|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
156882820|NCT00470834|566330864|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
156882821|NCT00470834|566330863|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
156882822|NCT00470834|566330864|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
156882823|NCT00470834|566330863|FG000|Extension Period (24 Months)|Adverse Event|3|||
156882824|NCT00470834|566330864|FG001|Extension Period (24 Months)|Adverse Event|4|||
156882825|NCT00470834|566330863|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
156882826|NCT00470834|566330864|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
156882827|NCT00470834|566330863|FG000|Extension Period (24 Months)|Physician Decision|4|||
156882828|NCT00470834|566330864|FG001|Extension Period (24 Months)|Physician Decision|3|||
156882829|NCT00470834|566330863|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
156882830|NCT00470834|566330864|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
156882831|NCT00470834|566330863|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
156882832|NCT00470834|566330864|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
156882833|NCT00470834|566330863|FG000|Extension Period (24 Months)|Non-compliance|0|||
156882834|NCT00470834|566330864|FG001|Extension Period (24 Months)|Non-compliance|1|||
156882835|NCT00470834|566330863|FG000|Extension Period (24 Months)|Disease Progression|0|||
156882836|NCT00470834|566330864|FG001|Extension Period (24 Months)|Disease Progression|1|||
156882837|NCT00977080|566330865|FG000|Overall Study|Adverse Event|2|||
156882838|NCT00977080|566330866|FG001|Overall Study|Adverse Event|7|||
156882839|NCT00977080|566330867|FG002|Overall Study|Adverse Event|7|||
156882840|NCT00977080|566330868|FG003|Overall Study|Adverse Event|7|||
156882841|NCT00977080|566330865|FG000|Overall Study|Withdrawal by Subject|1|||
156882842|NCT00977080|566330866|FG001|Overall Study|Withdrawal by Subject|5|||
156882843|NCT00977080|566330867|FG002|Overall Study|Withdrawal by Subject|1|||
156882844|NCT00977080|566330868|FG003|Overall Study|Withdrawal by Subject|5|||
156882845|NCT00977080|566330865|FG000|Overall Study|Protocol Violation|7|||
156882846|NCT00977080|566330866|FG001|Overall Study|Protocol Violation|3|||
156882847|NCT00977080|566330867|FG002|Overall Study|Protocol Violation|4|||
156882848|NCT00977080|566330868|FG003|Overall Study|Protocol Violation|3|||
156882849|NCT00977080|566330865|FG000|Overall Study|Noncompliance|0|||
156882850|NCT00977080|566330866|FG001|Overall Study|Noncompliance|2|||
156882851|NCT00977080|566330867|FG002|Overall Study|Noncompliance|1|||
157021561|NCT04169373|566830902|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
157221579|NCT03118739|567556899|FG001|Overall Study|Lost to Follow-up|0|||
156882852|NCT00977080|566330868|FG003|Overall Study|Noncompliance|0|||
156882853|NCT00977080|566330865|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156882854|NCT00977080|566330866|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156882855|NCT00977080|566330867|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
156882856|NCT00977080|566330868|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
156882857|NCT00977080|566330865|FG000|Overall Study|Required kidney transplantation|1|||
157021562|NCT04169373|566830899|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
156882858|NCT00977080|566330866|FG001|Overall Study|Required kidney transplantation|3|||
156882859|NCT00977080|566330867|FG002|Overall Study|Required kidney transplantation|3|||
156882860|NCT00977080|566330868|FG003|Overall Study|Required kidney transplantation|1|||
156882861|NCT00977080|566330865|FG000|Overall Study|Travel for family reasons|1|||
156882862|NCT00977080|566330866|FG001|Overall Study|Travel for family reasons|0|||
156882863|NCT00977080|566330867|FG002|Overall Study|Travel for family reasons|0|||
156882864|NCT00977080|566330868|FG003|Overall Study|Travel for family reasons|0|||
156882865|NCT00783198|566330875|FG000|Overall Study|Adverse Event|15|||
156882866|NCT00783198|566330876|FG001|Overall Study|Adverse Event|19|||
156882867|NCT00783198|566330877|FG002|Overall Study|Adverse Event|3|||
156882868|NCT00783198|566330875|FG000|Overall Study|Lost to Follow-up|11|||
156882869|NCT00783198|566330876|FG001|Overall Study|Lost to Follow-up|1|||
156882870|NCT00783198|566330877|FG002|Overall Study|Lost to Follow-up|7|||
156882871|NCT00783198|566330875|FG000|Overall Study|Withdrawal by Subject|22|||
156882872|NCT00783198|566330876|FG001|Overall Study|Withdrawal by Subject|14|||
156882873|NCT00783198|566330877|FG002|Overall Study|Withdrawal by Subject|20|||
156882874|NCT00783198|566330875|FG000|Overall Study|Noncompliance with protocol|7|||
156882875|NCT00783198|566330876|FG001|Overall Study|Noncompliance with protocol|7|||
156882876|NCT00783198|566330877|FG002|Overall Study|Noncompliance with protocol|10|||
156882877|NCT00783198|566330875|FG000|Overall Study|Did not meet protocol eligibility|0|||
156882878|NCT00783198|566330876|FG001|Overall Study|Did not meet protocol eligibility|1|||
156882879|NCT00783198|566330877|FG002|Overall Study|Did not meet protocol eligibility|0|||
156882880|NCT00783198|566330875|FG000|Overall Study|Administrative|2|||
156882881|NCT00783198|566330876|FG001|Overall Study|Administrative|1|||
156882882|NCT00783198|566330877|FG002|Overall Study|Administrative|2|||
156882883|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
156882884|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
156882885|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
156882886|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
156882887|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
156882888|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
156882889|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
156882890|NCT00946985|566330878|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
156882891|NCT00946985|566330878|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
156882892|NCT00271505|566330879|FG000|Overall Study|Screen Failure|3|||
156882893|NCT00271505|566330879|FG000|Overall Study|Adverse Event|1|||
156882894|NCT00271505|566330879|FG000|Overall Study|Death|1|||
156882895|NCT00119678|566330880|FG000|Double-blind Treatment Period|Death|1|||
156882896|NCT00119678|566330881|FG001|Double-blind Treatment Period|Death|0|||
156882897|NCT00119678|566330880|FG000|Double-blind Treatment Period|Adverse Event|7|||
156882898|NCT00119678|566330881|FG001|Double-blind Treatment Period|Adverse Event|1|||
156882899|NCT00119678|566330880|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
156882900|NCT00119678|566330881|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
156882901|NCT00119678|566330880|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156882902|NCT00119678|566330881|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
156882903|NCT00119678|566330880|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
156882904|NCT00119678|566330881|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
156882905|NCT00119678|566330880|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
156882906|NCT00119678|566330881|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
156882907|NCT00119678|566330880|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
156882908|NCT00119678|566330881|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
156882909|NCT00119678|566330880|FG000|Double-blind Treatment Period|Pregnancy|0|||
156882910|NCT00119678|566330881|FG001|Double-blind Treatment Period|Pregnancy|2|||
156882911|NCT00119678|566330880|FG000|Double-blind Treatment Period|Not treated|1|||
156882912|NCT00119678|566330881|FG001|Double-blind Treatment Period|Not treated|2|||
156882913|NCT00119678|566330880|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
156882914|NCT00119678|566330881|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
156882915|NCT00119678|566330880|FG000|Open-label Treatment Period|Death|1|||
156882916|NCT00119678|566330881|FG001|Open-label Treatment Period|Death|0|||
156882917|NCT00119678|566330880|FG000|Open-label Treatment Period|Adverse Event|3|||
156882918|NCT00119678|566330881|FG001|Open-label Treatment Period|Adverse Event|0|||
156882919|NCT00119678|566330880|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
156882920|NCT00119678|566330881|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
156882921|NCT00119678|566330880|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
156882922|NCT00119678|566330881|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156882923|NCT00119678|566330880|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
156882924|NCT00119678|566330881|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
156882925|NCT00119678|566330880|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
156882926|NCT00119678|566330881|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
156882927|NCT00119678|566330880|FG000|Open-label Treatment Period|Pregnancy|1|||
156882928|NCT00119678|566330881|FG001|Open-label Treatment Period|Pregnancy|0|||
156882929|NCT00119678|566330880|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
156882930|NCT00119678|566330881|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
156882931|NCT00313781|566330882|FG000|Before Crossover|Death|22|||
156882932|NCT00313781|566330883|FG001|Before Crossover|Death|8|||
156882933|NCT00313781|566330884|FG002|Before Crossover|Death|0|||
156882934|NCT00313781|566330882|FG000|Before Crossover|Lost to Follow-up|0|||
156882935|NCT00313781|566330883|FG001|Before Crossover|Lost to Follow-up|3|||
156882936|NCT00313781|566330884|FG002|Before Crossover|Lost to Follow-up|0|||
156882937|NCT00313781|566330882|FG000|Before Crossover|Withdrawal by Subject|3|||
156882938|NCT00313781|566330883|FG001|Before Crossover|Withdrawal by Subject|1|||
156882939|NCT00313781|566330884|FG002|Before Crossover|Withdrawal by Subject|0|||
156882940|NCT00313781|566330882|FG000|Before Crossover|Other|45|||
156882941|NCT00313781|566330883|FG001|Before Crossover|Other|30|||
156882942|NCT00313781|566330884|FG002|Before Crossover|Other|0|||
156882943|NCT00313781|566330882|FG000|Before Crossover|Crossover|0|||
156882944|NCT00313781|566330883|FG001|Before Crossover|Crossover|37|||
156882945|NCT00313781|566330884|FG002|Before Crossover|Crossover|0|||
156882946|NCT00313781|566330882|FG000|Before Crossover|Randomized, not treated|5|||
156882947|NCT00313781|566330883|FG001|Before Crossover|Randomized, not treated|0|||
156882948|NCT00313781|566330884|FG002|Before Crossover|Randomized, not treated|0|||
156882949|NCT00313781|566330882|FG000|After Crossover|Death|0|||
156882950|NCT00313781|566330883|FG001|After Crossover|Death|0|||
156882951|NCT00313781|566330884|FG002|After Crossover|Death|6|||
156882952|NCT00313781|566330882|FG000|After Crossover|Withdrawal by Subject|0|||
156882953|NCT00313781|566330883|FG001|After Crossover|Withdrawal by Subject|0|||
156882954|NCT00313781|566330884|FG002|After Crossover|Withdrawal by Subject|3|||
156882955|NCT00313781|566330882|FG000|After Crossover|Other|0|||
156882956|NCT00313781|566330883|FG001|After Crossover|Other|0|||
156882957|NCT00313781|566330884|FG002|After Crossover|Other|18|||
156882958|NCT01546623|566330887|FG000|Overall Study|Adverse Event|2|||
156882959|NCT01546623|566330888|FG001|Overall Study|Adverse Event|3|||
156882960|NCT01546623|566330887|FG000|Overall Study|Major Protocol Deviation|1|||
156882961|NCT01546623|566330888|FG001|Overall Study|Major Protocol Deviation|1|||
156882962|NCT01546623|566330887|FG000|Overall Study|High Prostate specific antigen|2|||
156882963|NCT01546623|566330888|FG001|Overall Study|High Prostate specific antigen|1|||
156882964|NCT01546623|566330887|FG000|Overall Study|Did Not Receive Study Drug|1|||
156882965|NCT01546623|566330888|FG001|Overall Study|Did Not Receive Study Drug|1|||
156882966|NCT03567343|566330889|FG000|Overall Study|Lost to Follow-up|2|||
156882967|NCT03567343|566330890|FG001|Overall Study|Lost to Follow-up|1|||
156882968|NCT03567343|566330889|FG000|Overall Study|No longer eligible|2|||
156882969|NCT03567343|566330890|FG001|Overall Study|No longer eligible|1|||
156882970|NCT03567343|566330889|FG000|Overall Study|Adverse Event|1|||
156882971|NCT03567343|566330890|FG001|Overall Study|Adverse Event|0|||
156882972|NCT03567343|566330889|FG000|Overall Study|Protocol Violation|1|||
156882973|NCT03567343|566330890|FG001|Overall Study|Protocol Violation|1|||
156882974|NCT01134705|566330891|FG000|Overall Study|Adverse Event|1|||
156882975|NCT01134705|566330892|FG001|Overall Study|Adverse Event|7|||
156882976|NCT01134705|566330891|FG000|Overall Study|Withdrawal by Subject|6|||
156882977|NCT01134705|566330892|FG001|Overall Study|Withdrawal by Subject|6|||
156882978|NCT01134705|566330891|FG000|Overall Study|Pregnancy|1|||
156882979|NCT01134705|566330892|FG001|Overall Study|Pregnancy|0|||
156882980|NCT01134705|566330891|FG000|Overall Study|Lost to Follow-up|5|||
156882981|NCT01134705|566330892|FG001|Overall Study|Lost to Follow-up|2|||
156882982|NCT01134705|566330891|FG000|Overall Study|Protocol Violation|1|||
156882983|NCT01134705|566330892|FG001|Overall Study|Protocol Violation|1|||
156882984|NCT01134705|566330891|FG000|Overall Study|Other|1|||
156882985|NCT01134705|566330892|FG001|Overall Study|Other|6|||
156882986|NCT01510769|566330893|FG000|Overall Study|Adverse Event|7|||
156882987|NCT01510769|566330894|FG001|Overall Study|Adverse Event|6|||
156882988|NCT01510769|566330895|FG002|Overall Study|Adverse Event|4|||
157221580|NCT01859702|567556900|FG000|Overall Study|Protocol deviation|3|||
156882989|NCT01510769|566330893|FG000|Overall Study|Gout Flare|0|||
157221581|NCT01859702|567556900|FG000|Overall Study|Adverse Event|2|||
156882990|NCT01510769|566330894|FG001|Overall Study|Gout Flare|3|||
156882991|NCT01510769|566330895|FG002|Overall Study|Gout Flare|1|||
156882992|NCT01510769|566330893|FG000|Overall Study|Protocol Violation|11|||
156882993|NCT01510769|566330894|FG001|Overall Study|Protocol Violation|10|||
156882994|NCT01510769|566330895|FG002|Overall Study|Protocol Violation|9|||
156882995|NCT01510769|566330893|FG000|Overall Study|Lost to Follow-up|5|||
156882996|NCT01510769|566330894|FG001|Overall Study|Lost to Follow-up|1|||
156882997|NCT01510769|566330895|FG002|Overall Study|Lost to Follow-up|5|||
156882998|NCT01510769|566330893|FG000|Overall Study|Withdrawal by Subject|3|||
157221582|NCT01893138|567556901|FG000|Double-Blind Period|Withdrawal by Subject|1|||
157221583|NCT01893138|567556902|FG001|Double-Blind Period|Withdrawal by Subject|1|||
157221584|NCT01893138|567556901|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
157221585|NCT01893138|567556902|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
157221586|NCT01893138|567556901|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
157221587|NCT01893138|567556902|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
157221588|NCT01893138|567556901|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
157221589|NCT01893138|567556902|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
157221590|NCT01893138|567556901|FG000|Open Label - Unblinded Period|Adverse Event|1|||
157221591|NCT01893138|567556902|FG001|Open Label - Unblinded Period|Adverse Event|0|||
157221592|NCT01326026|567556903|FG000|Overall Study|Adverse Event|4|||
157221593|NCT01326026|567556904|FG001|Overall Study|Adverse Event|3|||
157221594|NCT01326026|567556903|FG000|Overall Study|Withdrawal Criteria|5|||
157221595|NCT01326026|567556904|FG001|Overall Study|Withdrawal Criteria|7|||
157221596|NCT01326026|567556903|FG000|Overall Study|Other|3|||
157221597|NCT01326026|567556904|FG001|Overall Study|Other|3|||
157221598|NCT04317053|567556908|FG000|Overall Study|Withdrawn (screen failure)|4|||
157221599|NCT04317053|567556909|FG001|Overall Study|Withdrawn (screen failure)|2|||
157221600|NCT00289458|567556910|FG000|Overall Study|Death|1|||
157221601|NCT00289458|567556911|FG001|Overall Study|Death|0|||
157221602|NCT00289458|567556912|FG002|Overall Study|Death|0|||
156882999|NCT01510769|566330894|FG001|Overall Study|Withdrawal by Subject|4|||
156883000|NCT01510769|566330895|FG002|Overall Study|Withdrawal by Subject|3|||
156883001|NCT01510769|566330893|FG000|Overall Study|Death|1|||
156883002|NCT01510769|566330894|FG001|Overall Study|Death|1|||
156883003|NCT01510769|566330895|FG002|Overall Study|Death|0|||
156883004|NCT02674204|566330896|FG000|Overall Study|Adverse Event|1|||
156883005|NCT02674204|566330897|FG001|Overall Study|Adverse Event|0|||
156883006|NCT02466659|566330898|FG000|Overall Study|Lost to Follow-up|5|||
156883007|NCT02466659|566330899|FG001|Overall Study|Lost to Follow-up|2|||
156883008|NCT00486811|566330902|FG000|Overall Study|Adverse Event|28|||
156883009|NCT00486811|566330903|FG001|Overall Study|Adverse Event|60|||
156883010|NCT00486811|566330904|FG002|Overall Study|Adverse Event|135|||
156883011|NCT00486811|566330902|FG000|Overall Study|Lack of Efficacy|34|||
156883012|NCT00486811|566330903|FG001|Overall Study|Lack of Efficacy|14|||
156883013|NCT00486811|566330904|FG002|Overall Study|Lack of Efficacy|7|||
156883014|NCT00486811|566330902|FG000|Overall Study|Lost to Follow-up|4|||
156883015|NCT00486811|566330903|FG001|Overall Study|Lost to Follow-up|6|||
156883016|NCT00486811|566330904|FG002|Overall Study|Lost to Follow-up|4|||
156883017|NCT00486811|566330902|FG000|Overall Study|Withdrawal by Subject|33|||
156883018|NCT00486811|566330903|FG001|Overall Study|Withdrawal by Subject|44|||
156883019|NCT00486811|566330904|FG002|Overall Study|Withdrawal by Subject|58|||
156883020|NCT00486811|566330902|FG000|Overall Study|Study drug non-compliant|5|||
156883021|NCT00486811|566330903|FG001|Overall Study|Study drug non-compliant|6|||
156883022|NCT00486811|566330904|FG002|Overall Study|Study drug non-compliant|3|||
156883023|NCT00486811|566330902|FG000|Overall Study|All other|18|||
156883024|NCT00486811|566330903|FG001|Overall Study|All other|11|||
156883025|NCT00486811|566330904|FG002|Overall Study|All other|7|||
156883026|NCT00096356|566330907|FG000|Overall Study|Adverse Event|11|||
156883027|NCT00096356|566330908|FG001|Overall Study|Adverse Event|9|||
156883028|NCT00096356|566330907|FG000|Overall Study|Physician Decision|5|||
156883029|NCT00096356|566330908|FG001|Overall Study|Physician Decision|3|||
156883030|NCT00096356|566330907|FG000|Overall Study|Withdrawal by Subject|17|||
156883031|NCT00096356|566330908|FG001|Overall Study|Withdrawal by Subject|23|||
156883032|NCT00096356|566330907|FG000|Overall Study|Lack of Efficacy|1|||
156883033|NCT00096356|566330908|FG001|Overall Study|Lack of Efficacy|0|||
156883034|NCT00096356|566330907|FG000|Overall Study|multiple reasons|10|||
156883035|NCT00096356|566330908|FG001|Overall Study|multiple reasons|18|||
156883036|NCT01008423|566330909|FG000|Overall Study|Adverse Event|13|||
156883037|NCT01008423|566330910|FG001|Overall Study|Adverse Event|6|||
156883038|NCT01008423|566330909|FG000|Overall Study|Withdrawal by Subject|4|||
156883039|NCT01008423|566330910|FG001|Overall Study|Withdrawal by Subject|7|||
157221603|NCT00289458|567556910|FG000|Overall Study|Physician Decision|3|||
157221604|NCT00289458|567556911|FG001|Overall Study|Physician Decision|4|||
157221605|NCT00289458|567556912|FG002|Overall Study|Physician Decision|2|||
157221606|NCT00289458|567556910|FG000|Overall Study|Withdrawal by Subject|2|||
157221607|NCT00289458|567556911|FG001|Overall Study|Withdrawal by Subject|2|||
157221608|NCT00289458|567556912|FG002|Overall Study|Withdrawal by Subject|4|||
157221609|NCT04274192|567556913|FG000|Overall Study|Protocol Violation|1|||
156883040|NCT01008423|566330909|FG000|Overall Study|Lost to Follow-up|0|||
156883041|NCT01008423|566330910|FG001|Overall Study|Lost to Follow-up|2|||
156883042|NCT01008423|566330909|FG000|Overall Study|Low Cortisol|0|||
156883043|NCT01008423|566330910|FG001|Overall Study|Low Cortisol|1|||
156883044|NCT01008423|566330909|FG000|Overall Study|Lack of Efficacy|0|||
156883045|NCT01008423|566330910|FG001|Overall Study|Lack of Efficacy|5|||
156883046|NCT01008423|566330909|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
156883047|NCT01008423|566330910|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
156883048|NCT01008423|566330909|FG000|Overall Study|Personal Conflict|1|||
156883049|NCT01008423|566330910|FG001|Overall Study|Personal Conflict|0|||
157221610|NCT04274192|567556914|FG001|Overall Study|Protocol Violation|0|||
157221611|NCT00874757|567556915|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
157221612|NCT04014959|567558447|FG000|Baseline MRI and Assessments|Physician Decision|2|||
157221613|NCT04014959|567558447|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
157221614|NCT04014959|567558447|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
157221615|NCT02004847|567558449|FG000|Overall Study|Protocol Violation|1|||
157221616|NCT02004847|567558450|FG001|Overall Study|Protocol Violation|1|||
157221617|NCT01132118|567558451|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
157221618|NCT01132118|567558452|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
157221619|NCT01132118|567558451|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156883050|NCT01008423|566330909|FG000|Overall Study|Other|0|||
156883051|NCT01008423|566330910|FG001|Overall Study|Other|1|||
156883052|NCT00978757|566330916|FG000|Overall Study|Physician Decision|1|||
156883053|NCT00978757|566330917|FG001|Overall Study|Physician Decision|3|||
156883054|NCT01028300|566330918|FG000|Overall Study|Study Terminated|4|||
156883055|NCT00715910|566330919|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
156883056|NCT00715910|566330920|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
156883057|NCT00715910|566330921|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
156883058|NCT00715910|566330922|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
157221620|NCT01132118|567558452|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
157221621|NCT01132118|567558451|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
156808513|NCT01964378|566052690|FG001|Overall Study|Death|2|||
156808514|NCT01964378|566052689|FG000|Overall Study|Adverse Event|12|||
156808515|NCT01964378|566052690|FG001|Overall Study|Adverse Event|5|||
156808516|NCT01964378|566052689|FG000|Overall Study|Lack of Efficacy|0|||
156808517|NCT01964378|566052690|FG001|Overall Study|Lack of Efficacy|1|||
156808518|NCT01964378|566052689|FG000|Overall Study|Protocol Violation|0|||
156808519|NCT01964378|566052690|FG001|Overall Study|Protocol Violation|1|||
156808520|NCT01964378|566052689|FG000|Overall Study|Lost to Follow-up|0|||
156808521|NCT01964378|566052690|FG001|Overall Study|Lost to Follow-up|1|||
156808522|NCT01964378|566052689|FG000|Overall Study|Withdrawal by Subject|7|||
156808523|NCT01964378|566052690|FG001|Overall Study|Withdrawal by Subject|5|||
156808524|NCT01964378|566052689|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156808525|NCT01964378|566052690|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
156808526|NCT01964378|566052689|FG000|Overall Study|Other|1|||
156808527|NCT01964378|566052690|FG001|Overall Study|Other|2|||
156808528|NCT00326599|566052691|FG000|Overall Study|Withdrawal by Subject|1|||
156808529|NCT00326599|566052692|FG001|Overall Study|Withdrawal by Subject|0|||
156808530|NCT00326599|566052693|FG002|Overall Study|Withdrawal by Subject|5|||
156808531|NCT00326599|566052694|FG003|Overall Study|Withdrawal by Subject|2|||
156808532|NCT00326599|566052691|FG000|Overall Study|Adverse Event|1|||
156808533|NCT00326599|566052692|FG001|Overall Study|Adverse Event|0|||
156808534|NCT00326599|566052693|FG002|Overall Study|Adverse Event|32|||
156808535|NCT00326599|566052694|FG003|Overall Study|Adverse Event|3|||
156808536|NCT00326599|566052691|FG000|Overall Study|Disease Progression|3|||
156808537|NCT00326599|566052692|FG001|Overall Study|Disease Progression|1|||
156808538|NCT00326599|566052693|FG002|Overall Study|Disease Progression|13|||
156808539|NCT00326599|566052694|FG003|Overall Study|Disease Progression|11|||
156808540|NCT00326599|566052691|FG000|Overall Study|Alternate Treatment|1|||
156808541|NCT00326599|566052692|FG001|Overall Study|Alternate Treatment|0|||
156808542|NCT00326599|566052693|FG002|Overall Study|Alternate Treatment|0|||
156808543|NCT00326599|566052694|FG003|Overall Study|Alternate Treatment|0|||
156808544|NCT00326599|566052691|FG000|Overall Study|Death|0|||
156808545|NCT00326599|566052692|FG001|Overall Study|Death|0|||
156808546|NCT00326599|566052693|FG002|Overall Study|Death|1|||
156808547|NCT00326599|566052694|FG003|Overall Study|Death|2|||
156808548|NCT00326599|566052691|FG000|Overall Study|Other Unspecified Reason|0|||
156808549|NCT00326599|566052692|FG001|Overall Study|Other Unspecified Reason|0|||
156808550|NCT00326599|566052693|FG002|Overall Study|Other Unspecified Reason|2|||
156808551|NCT00326599|566052694|FG003|Overall Study|Other Unspecified Reason|1|||
156808552|NCT03542266|566052695|FG000|Treatment Phase|Withdrawal by Subject|1|||
156808553|NCT03542266|566052695|FG000|Treatment Phase|Adverse Event|1|||
156808554|NCT03542266|566052695|FG000|Treatment Phase|PD|1|||
156808555|NCT00657267|566052712|FG000|Overall Study|Progressive disease|45|||
156808556|NCT00657267|566052712|FG000|Overall Study|Adverse Event|9|||
156808557|NCT01070979|566052715|FG000|Overall Study|Adverse Event|2|||
156808558|NCT01070979|566052716|FG001|Overall Study|Adverse Event|3|||
156808559|NCT01070979|566052717|FG002|Overall Study|Adverse Event|3|||
156883059|NCT00715910|566330923|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
156808560|NCT01070979|566052715|FG000|Overall Study|Lost to Follow-up|2|||
156808561|NCT01070979|566052716|FG001|Overall Study|Lost to Follow-up|1|||
156808562|NCT01070979|566052717|FG002|Overall Study|Lost to Follow-up|1|||
156808563|NCT01070979|566052715|FG000|Overall Study|Protocol Violation|0|||
156808564|NCT01070979|566052716|FG001|Overall Study|Protocol Violation|2|||
156808565|NCT01070979|566052717|FG002|Overall Study|Protocol Violation|6|||
156883060|NCT00715910|566330924|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
156883061|NCT00715910|566330919|FG000|Booster and ESFU Phase|Other|0|||
156883062|NCT00715910|566330920|FG001|Booster and ESFU Phase|Other|0|||
157221622|NCT01132118|567558452|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
157221662|NCT02207621|567558476|FG002|Overall Study|Withdrawal by Subject|13|||
157221663|NCT02207621|567558474|FG000|Overall Study|Non-Compliant|3|||
157221664|NCT02207621|567558475|FG001|Overall Study|Non-Compliant|3|||
157221665|NCT02207621|567558476|FG002|Overall Study|Non-Compliant|1|||
157221666|NCT02207621|567558474|FG000|Overall Study|Lost to Follow-up|1|||
157221667|NCT02207621|567558475|FG001|Overall Study|Lost to Follow-up|0|||
157221668|NCT02207621|567558476|FG002|Overall Study|Lost to Follow-up|3|||
157221669|NCT02207621|567558474|FG000|Overall Study|Lack of Efficacy|10|||
157221670|NCT02207621|567558475|FG001|Overall Study|Lack of Efficacy|2|||
157221671|NCT02207621|567558476|FG002|Overall Study|Lack of Efficacy|4|||
157221672|NCT02207621|567558474|FG000|Overall Study|Disallowed Concurrent Medication|2|||
157221673|NCT02207621|567558475|FG001|Overall Study|Disallowed Concurrent Medication|5|||
157221674|NCT02207621|567558476|FG002|Overall Study|Disallowed Concurrent Medication|2|||
157221675|NCT02207621|567558474|FG000|Overall Study|Physician Decision|1|||
157221676|NCT02207621|567558475|FG001|Overall Study|Physician Decision|2|||
157221677|NCT02207621|567558476|FG002|Overall Study|Physician Decision|2|||
157221678|NCT02207621|567558474|FG000|Overall Study|Protocol Violation|4|||
157221679|NCT02207621|567558475|FG001|Overall Study|Protocol Violation|10|||
157221680|NCT02207621|567558476|FG002|Overall Study|Protocol Violation|6|||
157221681|NCT02207621|567558474|FG000|Overall Study|Death|2|||
157221682|NCT02207621|567558475|FG001|Overall Study|Death|0|||
157221683|NCT02207621|567558476|FG002|Overall Study|Death|0|||
157221684|NCT02207621|567558474|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
157221685|NCT02207621|567558475|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
157221686|NCT02207621|567558476|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
157221687|NCT02848599|567558479|FG000|Overall Study|Protocol Violation|7|||
157221688|NCT02848599|567558480|FG001|Overall Study|Protocol Violation|9|||
157221689|NCT04828161|567558481|FG000|Overall Study|Withdrawal by Subject|0|||
157221690|NCT04828161|567558482|FG001|Overall Study|Withdrawal by Subject|3|||
157221691|NCT04828161|567558483|FG002|Overall Study|Withdrawal by Subject|3|||
157221692|NCT04828161|567558484|FG003|Overall Study|Withdrawal by Subject|4|||
157221693|NCT04828161|567558481|FG000|Overall Study|Lost to Follow-up|1|||
157221694|NCT04828161|567558482|FG001|Overall Study|Lost to Follow-up|4|||
157221695|NCT04828161|567558483|FG002|Overall Study|Lost to Follow-up|2|||
157221696|NCT04828161|567558484|FG003|Overall Study|Lost to Follow-up|2|||
157221697|NCT04828161|567558481|FG000|Overall Study|Other|2|||
157221698|NCT04828161|567558482|FG001|Overall Study|Other|0|||
157221699|NCT04828161|567558483|FG002|Overall Study|Other|2|||
157221700|NCT04828161|567558484|FG003|Overall Study|Other|0|||
157221701|NCT04828161|567558481|FG000|Overall Study|Death|0|||
157221702|NCT04828161|567558482|FG001|Overall Study|Death|0|||
157221703|NCT04828161|567558483|FG002|Overall Study|Death|0|||
157221704|NCT04828161|567558484|FG003|Overall Study|Death|2|||
157221705|NCT02352337|567558485|FG000|Overall Study|Patients never treated|4|||
157221706|NCT02352337|567558486|FG001|Overall Study|Patients never treated|1|||
157221707|NCT02352337|567558487|FG002|Overall Study|Patients never treated|2|||
157221708|NCT02458638|567558490|FG000|Overall Study|Death|309|||
157221709|NCT02458638|567558490|FG000|Overall Study|End of Cohort/End of Study|67|||
157221710|NCT02458638|567558490|FG000|Overall Study|Lost to Follow-up|31|||
157221711|NCT02458638|567558490|FG000|Overall Study|Other Reasons|4|||
157221712|NCT02458638|567558490|FG000|Overall Study|Physician Decision|1|||
157221713|NCT02458638|567558490|FG000|Overall Study|Withdrawal by Subject|47|||
157221714|NCT00135707|567558504|FG000|Overall Study|Lost to Follow-up|94|||
157221715|NCT00135707|567558505|FG001|Overall Study|Lost to Follow-up|89|||
157221716|NCT00135707|567558504|FG000|Overall Study|Withdrawal by Subject|0|||
157221717|NCT00135707|567558505|FG001|Overall Study|Withdrawal by Subject|1|||
157221718|NCT00135707|567558504|FG000|Overall Study|Institutional review board request|1|||
157221719|NCT00135707|567558505|FG001|Overall Study|Institutional review board request|0|||
157221720|NCT00576901|567558516|FG000|Overall Study|Withdrawal by Subject|1|||
157221721|NCT00576901|567558516|FG000|Overall Study|Disease course|1|||
157221722|NCT00576901|567558516|FG000|Overall Study|Protocol Violation|1|||
157221723|NCT02398188|567558517|FG000|Overall Study|Adverse Event|2|||
157221724|NCT02398188|567558518|FG001|Overall Study|Adverse Event|3|||
157221725|NCT02398188|567558517|FG000|Overall Study|Lost to Follow-up|5|||
157221726|NCT02398188|567558518|FG001|Overall Study|Lost to Follow-up|0|||
157221727|NCT02398188|567558517|FG000|Overall Study|Non-compliance|4|||
157221728|NCT02398188|567558518|FG001|Overall Study|Non-compliance|4|||
157221729|NCT02398188|567558517|FG000|Overall Study|Protocol Violation|6|||
157221730|NCT02398188|567558518|FG001|Overall Study|Protocol Violation|10|||
157221731|NCT02398188|567558517|FG000|Overall Study|Sponsor Decision|2|||
157221732|NCT02398188|567558518|FG001|Overall Study|Sponsor Decision|1|||
157221733|NCT02398188|567558517|FG000|Overall Study|Pregnancy|1|||
157221734|NCT02398188|567558518|FG001|Overall Study|Pregnancy|0|||
157221735|NCT02398188|567558517|FG000|Overall Study|Withdrawal by Subject|7|||
157221736|NCT02398188|567558518|FG001|Overall Study|Withdrawal by Subject|16|||
157221737|NCT01259869|567558519|FG000|Overall Study|Duplicated registration|1|||
157221738|NCT03209570|567558520|FG000|Overall Study|Death|1|||
157221739|NCT03209570|567558521|FG001|Overall Study|Death|0|||
157221740|NCT03209570|567558520|FG000|Overall Study|Incomplete Data|8|||
157221741|NCT03209570|567558521|FG001|Overall Study|Incomplete Data|10|||
157221742|NCT03209570|567558520|FG000|Overall Study|Protocol Violation|1|||
157221743|NCT03209570|567558521|FG001|Overall Study|Protocol Violation|0|||
157221744|NCT03209570|567558520|FG000|Overall Study|Withdrawal by Subject|0|||
157221745|NCT03209570|567558521|FG001|Overall Study|Withdrawal by Subject|3|||
157221746|NCT00220701|567558522|FG000|Overall Study|Lost to Follow-up|5|||
157221747|NCT00220701|567558523|FG001|Overall Study|Lost to Follow-up|4|||
157221748|NCT01612000|567558526|FG000|Overall Study|Lost to Follow-up|6|||
157221749|NCT01612000|567558527|FG001|Overall Study|Lost to Follow-up|4|||
157221750|NCT01612000|567558528|FG002|Overall Study|Lost to Follow-up|4|||
157221751|NCT01612000|567558529|FG003|Overall Study|Lost to Follow-up|8|||
157221752|NCT01612000|567558526|FG000|Overall Study|Physician Decision|0|||
157221753|NCT01612000|567558527|FG001|Overall Study|Physician Decision|0|||
157221754|NCT01612000|567558528|FG002|Overall Study|Physician Decision|1|||
157221755|NCT01612000|567558529|FG003|Overall Study|Physician Decision|0|||
157221756|NCT01612000|567558526|FG000|Overall Study|Withdrawal by Subject|3|||
157221757|NCT01612000|567558527|FG001|Overall Study|Withdrawal by Subject|1|||
157221758|NCT01612000|567558528|FG002|Overall Study|Withdrawal by Subject|2|||
157221759|NCT01612000|567558529|FG003|Overall Study|Withdrawal by Subject|2|||
157221760|NCT00634907|567558535|FG000|Overall Study|Withdrawal by Subject|3|||
157221761|NCT00634907|567558536|FG001|Overall Study|Withdrawal by Subject|0|||
157221762|NCT00634907|567558535|FG000|Overall Study|Physician Decision|3|||
157221763|NCT00634907|567558536|FG001|Overall Study|Physician Decision|9|||
157221764|NCT00634907|567558535|FG000|Overall Study|Withdrawal by Subject|11|||
157221765|NCT00634907|567558536|FG001|Overall Study|Withdrawal by Subject|8|||
157221766|NCT01180244|567558543|FG000|Overall Study|Lack of Efficacy|0|||
157221767|NCT01180244|567558544|FG001|Overall Study|Lack of Efficacy|7|||
157221768|NCT01180244|567558543|FG000|Overall Study|Physician Decision|3|||
157221769|NCT01180244|567558544|FG001|Overall Study|Physician Decision|0|||
157221770|NCT01180244|567558543|FG000|Overall Study|Adverse Event|1|||
157221771|NCT01180244|567558544|FG001|Overall Study|Adverse Event|0|||
157221772|NCT01180244|567558543|FG000|Overall Study|Withdrawal by Subject|0|||
157221773|NCT01180244|567558544|FG001|Overall Study|Withdrawal by Subject|1|||
157221774|NCT01180244|567558543|FG000|Overall Study|Protocol Violation|1|||
157221775|NCT01180244|567558544|FG001|Overall Study|Protocol Violation|0|||
157221776|NCT01180244|567558543|FG000|Overall Study|Lost to Follow-up|1|||
157221777|NCT01180244|567558544|FG001|Overall Study|Lost to Follow-up|0|||
157221778|NCT01338636|567558545|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
157221779|NCT02385526|567558546|FG000|Overall Study|Withdrawal by Subject|0|||
157221780|NCT02385526|567558547|FG001|Overall Study|Withdrawal by Subject|2|||
157221781|NCT02385526|567558548|FG002|Overall Study|Withdrawal by Subject|0|||
157221782|NCT02385526|567558546|FG000|Overall Study|Lost to Follow-up|0|||
157221783|NCT02385526|567558547|FG001|Overall Study|Lost to Follow-up|1|||
157221784|NCT02385526|567558548|FG002|Overall Study|Lost to Follow-up|0|||
157221785|NCT02385526|567558546|FG000|Overall Study|Physician Decision|1|||
157221786|NCT02385526|567558547|FG001|Overall Study|Physician Decision|0|||
157221787|NCT02385526|567558548|FG002|Overall Study|Physician Decision|0|||
157221788|NCT02385526|567558546|FG000|Overall Study|Protocol Violation|1|||
157221789|NCT02385526|567558547|FG001|Overall Study|Protocol Violation|0|||
157221790|NCT02385526|567558548|FG002|Overall Study|Protocol Violation|0|||
157221791|NCT00620763|567558551|FG000|Period: First Intervention|Withdrawal by Subject|0|||
157221792|NCT00620763|567558552|FG001|Period: First Intervention|Withdrawal by Subject|2|||
157221793|NCT00620763|567558551|FG000|Period: First Intervention|Protocol Violation|0|||
157221794|NCT00620763|567558552|FG001|Period: First Intervention|Protocol Violation|3|||
157021796|NCT03623321|566832972|FG000|Overall Study|Use of prohibited medication|3|||
157021797|NCT03623321|566832972|FG000|Overall Study|Physician Decision|5|||
157021798|NCT03623321|566832972|FG000|Overall Study|Protocol Violation|1|||
157021799|NCT03623321|566832972|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
157021800|NCT03623321|566832972|FG000|Overall Study|Not further specified|43|||
157021801|NCT04241068|566832977|FG000|Core Treatment Period|Adverse Event|91|||
157021802|NCT04241068|566832977|FG000|Core Treatment Period|Change of Treatment|4|||
157021803|NCT04241068|566832977|FG000|Core Treatment Period|Consent Withdrawn|143|||
157021804|NCT04241068|566832977|FG000|Core Treatment Period|Death|26|||
157021805|NCT04241068|566832977|FG000|Core Treatment Period|Disease Progression|67|||
157021806|NCT04241068|566832977|FG000|Core Treatment Period|Investigator Decision|40|||
157021807|NCT04241068|566832977|FG000|Core Treatment Period|Loss of Capacity|9|||
157221795|NCT00620763|567558551|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
157221796|NCT00620763|567558552|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
157221797|NCT01595009|567558555|FG000|Core|Patients completed per protocol|85|||
157221798|NCT01595009|567558556|FG001|Core|Patients completed per protocol|44|||
157221799|NCT01595009|567558557|FG002|Core|Patients completed per protocol|0|||
157221800|NCT01595009|567558558|FG003|Core|Patients completed per protocol|0|||
157021808|NCT04241068|566832977|FG000|Core Treatment Period|Lost to Follow-up|11|||
157021809|NCT04241068|566832977|FG000|Core Treatment Period|Relocation|4|||
157221801|NCT01595009|567558555|FG000|Core|Adverse Event|19|||
157221802|NCT01595009|567558556|FG001|Core|Adverse Event|23|||
157221803|NCT01595009|567558557|FG002|Core|Adverse Event|0|||
157221804|NCT01595009|567558558|FG003|Core|Adverse Event|0|||
157221805|NCT01595009|567558555|FG000|Core|Disease progression|14|||
157221806|NCT01595009|567558556|FG001|Core|Disease progression|26|||
157221807|NCT01595009|567558557|FG002|Core|Disease progression|0|||
157221808|NCT01595009|567558558|FG003|Core|Disease progression|0|||
157221809|NCT01595009|567558555|FG000|Core|Withdrawal by Subject|4|||
157221810|NCT01595009|567558556|FG001|Core|Withdrawal by Subject|17|||
157221811|NCT01595009|567558557|FG002|Core|Withdrawal by Subject|0|||
157221812|NCT01595009|567558558|FG003|Core|Withdrawal by Subject|0|||
157221813|NCT01595009|567558555|FG000|Core|Death|3|||
157221814|NCT01595009|567558556|FG001|Core|Death|6|||
157221815|NCT01595009|567558557|FG002|Core|Death|0|||
157221816|NCT01595009|567558558|FG003|Core|Death|0|||
157221817|NCT01595009|567558555|FG000|Core|Lost to Follow-up|1|||
157221818|NCT01595009|567558556|FG001|Core|Lost to Follow-up|2|||
157221819|NCT01595009|567558557|FG002|Core|Lost to Follow-up|0|||
157221820|NCT01595009|567558558|FG003|Core|Lost to Follow-up|0|||
157221821|NCT01595009|567558555|FG000|Core|Protocol deviation|0|||
157221822|NCT01595009|567558556|FG001|Core|Protocol deviation|1|||
157221823|NCT01595009|567558557|FG002|Core|Protocol deviation|0|||
157221824|NCT01595009|567558558|FG003|Core|Protocol deviation|0|||
157221825|NCT01595009|567558555|FG000|Core|Administrative problems|0|||
157221826|NCT01595009|567558556|FG001|Core|Administrative problems|1|||
157221827|NCT01595009|567558557|FG002|Core|Administrative problems|0|||
157221828|NCT01595009|567558558|FG003|Core|Administrative problems|0|||
157221829|NCT01595009|567558555|FG000|Extension|Administrative problems|0|||
157221830|NCT01595009|567558556|FG001|Extension|Administrative problems|0|||
157221831|NCT01595009|567558557|FG002|Extension|Administrative problems|0|||
157221832|NCT01595009|567558558|FG003|Extension|Administrative problems|1|||
157221833|NCT01595009|567558555|FG000|Extension|Patients completed per protocol|0|||
157221834|NCT01595009|567558556|FG001|Extension|Patients completed per protocol|0|||
157221835|NCT01595009|567558557|FG002|Extension|Patients completed per protocol|0|||
157221836|NCT01595009|567558558|FG003|Extension|Patients completed per protocol|2|||
157221837|NCT01595009|567558555|FG000|Extension|Disease progression|0|||
157221838|NCT01595009|567558556|FG001|Extension|Disease progression|0|||
157221839|NCT01595009|567558557|FG002|Extension|Disease progression|4|||
157221840|NCT01595009|567558558|FG003|Extension|Disease progression|7|||
157221841|NCT01595009|567558555|FG000|Extension|Adverse Event|0|||
157221842|NCT01595009|567558556|FG001|Extension|Adverse Event|0|||
157221843|NCT01595009|567558557|FG002|Extension|Adverse Event|0|||
157221844|NCT01595009|567558558|FG003|Extension|Adverse Event|1|||
157221845|NCT00729859|567558559|FG000|Overall Study|Adverse Event|0|||
157221846|NCT00729859|567558560|FG001|Overall Study|Adverse Event|1|||
157221847|NCT00729859|567558561|FG002|Overall Study|Adverse Event|0|||
157221848|NCT00729859|567558559|FG000|Overall Study|Withdrawal by Subject|0|||
157221849|NCT00729859|567558560|FG001|Overall Study|Withdrawal by Subject|1|||
157221850|NCT00729859|567558561|FG002|Overall Study|Withdrawal by Subject|0|||
157221851|NCT04956666|567558562|FG000|Overall Study|Adverse Event|18|||
157221852|NCT04956666|567558562|FG000|Overall Study|Physician Decision|5|||
157221853|NCT00681863|567558568|FG000|Overall Study|Adverse Event|1|||
157221854|NCT00681863|567558568|FG000|Overall Study|Lost to Follow-up|2|||
157221855|NCT00681863|567558568|FG000|Overall Study|Lack of Efficacy|2|||
157221856|NCT00681863|567558568|FG000|Overall Study|Other|18|||
157221857|NCT01333033|567558572|FG000|Overall Study|Ineligible|0|||
157221858|NCT01333033|567558573|FG001|Overall Study|Ineligible|0|||
157221859|NCT01333033|567558574|FG002|Overall Study|Ineligible|0|||
157221860|NCT01333033|567558575|FG003|Overall Study|Ineligible|0|||
157221861|NCT01333033|567558576|FG004|Overall Study|Ineligible|6|||
157221862|NCT01333033|567558577|FG005|Overall Study|Ineligible|8|||
157221863|NCT01333033|567558572|FG000|Overall Study|Withdrawal by Subject|0|||
157221864|NCT01333033|567558573|FG001|Overall Study|Withdrawal by Subject|0|||
157221865|NCT01333033|567558574|FG002|Overall Study|Withdrawal by Subject|0|||
157221866|NCT01333033|567558575|FG003|Overall Study|Withdrawal by Subject|0|||
157221867|NCT01333033|567558576|FG004|Overall Study|Withdrawal by Subject|4|||
157221868|NCT01333033|567558577|FG005|Overall Study|Withdrawal by Subject|2|||
157221869|NCT01333033|567558572|FG000|Overall Study|PET inevaluable|0|||
157221870|NCT01333033|567558573|FG001|Overall Study|PET inevaluable|0|||
157221871|NCT01333033|567558574|FG002|Overall Study|PET inevaluable|0|||
157221872|NCT01333033|567558575|FG003|Overall Study|PET inevaluable|0|||
157221873|NCT01333033|567558576|FG004|Overall Study|PET inevaluable|2|||
157221874|NCT01333033|567558577|FG005|Overall Study|PET inevaluable|4|||
157221875|NCT01333033|567558572|FG000|Overall Study|Adverse Event|0|||
157221876|NCT01333033|567558573|FG001|Overall Study|Adverse Event|0|||
157221877|NCT01333033|567558574|FG002|Overall Study|Adverse Event|0|||
157221878|NCT01333033|567558575|FG003|Overall Study|Adverse Event|0|||
157221879|NCT01333033|567558576|FG004|Overall Study|Adverse Event|2|||
157221880|NCT01333033|567558577|FG005|Overall Study|Adverse Event|1|||
157221881|NCT01333033|567558572|FG000|Overall Study|Progression|0|||
157221882|NCT01333033|567558573|FG001|Overall Study|Progression|0|||
157221883|NCT01333033|567558574|FG002|Overall Study|Progression|0|||
157221884|NCT01333033|567558575|FG003|Overall Study|Progression|0|||
157221885|NCT01333033|567558576|FG004|Overall Study|Progression|0|||
157221886|NCT01333033|567558577|FG005|Overall Study|Progression|1|||
157221887|NCT01333033|567558572|FG000|Overall Study|MD Decision|0|||
157221888|NCT01333033|567558573|FG001|Overall Study|MD Decision|0|||
157221889|NCT01333033|567558574|FG002|Overall Study|MD Decision|0|||
157221890|NCT01333033|567558575|FG003|Overall Study|MD Decision|0|||
157221891|NCT01333033|567558576|FG004|Overall Study|MD Decision|0|||
157221892|NCT01333033|567558577|FG005|Overall Study|MD Decision|2|||
157221893|NCT00760383|567558578|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
157221894|NCT00760383|567558579|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
157221895|NCT01842958|567558580|FG000|Overall Study|Lost to Follow-up|1|||
157221896|NCT01842958|567558581|FG001|Overall Study|Lost to Follow-up|1|||
157221897|NCT01829477|567558582|FG000|Overall Study|Study Terminated by Sponsor|15|||
157221898|NCT01829477|567558583|FG001|Overall Study|Study Terminated by Sponsor|15|||
157221899|NCT01829477|567558582|FG000|Overall Study|Withdrawal by Subject|1|||
157221900|NCT01829477|567558583|FG001|Overall Study|Withdrawal by Subject|0|||
157221901|NCT03465891|567558584|FG000|Overall Study|Withdrawal by Subject|0|||
157221902|NCT03465891|567558585|FG001|Overall Study|Withdrawal by Subject|1|||
157221903|NCT03465891|567558584|FG000|Overall Study|Disease progression|1|||
157221904|NCT03465891|567558585|FG001|Overall Study|Disease progression|0|||
157221905|NCT02737306|567558587|FG000|Overall Study|Adverse Event|3|||
157221906|NCT02737306|567558588|FG001|Overall Study|Adverse Event|0|||
157221907|NCT02737306|567558587|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
157221908|NCT02737306|567558588|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
157221909|NCT03361423|567558589|FG000|Overall Study|Withdrawal by Subject|4|||
157221910|NCT03361423|567558590|FG001|Overall Study|Withdrawal by Subject|3|||
157221911|NCT03361423|567558589|FG000|Overall Study|Did not treat|19|||
157221912|NCT03361423|567558590|FG001|Overall Study|Did not treat|18|||
157221913|NCT03361423|567558589|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
157221914|NCT03361423|567558590|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
157221915|NCT03361423|567558589|FG000|Overall Study|Missing data|4|||
157221916|NCT03361423|567558590|FG001|Overall Study|Missing data|1|||
157221917|NCT01336894|567558591|FG000|Follow-up|Study terminated prematurely|2|||
157221918|NCT01336894|567558592|FG001|Follow-up|Study terminated prematurely|7|||
157221919|NCT05034731|567558593|FG000|Overall Study|Screen fail|1|||
157221920|NCT05034731|567558594|FG001|Overall Study|Screen fail|1|||
157221921|NCT00818623|567558595|FG000|Overall Study|Adverse Event|1|||
157221922|NCT00818623|567558596|FG001|Overall Study|Adverse Event|0|||
157221923|NCT00818623|567558597|FG002|Overall Study|Adverse Event|1|||
157221924|NCT00818623|567558598|FG003|Overall Study|Adverse Event|0|||
157221925|NCT00818623|567558599|FG004|Overall Study|Adverse Event|0|||
157221926|NCT00818623|567558600|FG005|Overall Study|Adverse Event|1|||
157221927|NCT00818623|567558601|FG006|Overall Study|Adverse Event|0|||
157221928|NCT00818623|567558602|FG007|Overall Study|Adverse Event|0|||
157221929|NCT00818623|567558595|FG000|Overall Study|Bad prostate specific antigen response|0|||
157221930|NCT00818623|567558596|FG001|Overall Study|Bad prostate specific antigen response|3|||
157221931|NCT00818623|567558597|FG002|Overall Study|Bad prostate specific antigen response|2|||
157221932|NCT00818623|567558598|FG003|Overall Study|Bad prostate specific antigen response|5|||
157221933|NCT00818623|567558599|FG004|Overall Study|Bad prostate specific antigen response|0|||
157221934|NCT00818623|567558600|FG005|Overall Study|Bad prostate specific antigen response|1|||
157221935|NCT00818623|567558601|FG006|Overall Study|Bad prostate specific antigen response|0|||
157221936|NCT00818623|567558602|FG007|Overall Study|Bad prostate specific antigen response|0|||
157221937|NCT00818623|567558595|FG000|Overall Study|Withdrawal by Subject|0|||
157221938|NCT00818623|567558596|FG001|Overall Study|Withdrawal by Subject|1|||
157221939|NCT00818623|567558597|FG002|Overall Study|Withdrawal by Subject|1|||
157221940|NCT00818623|567558598|FG003|Overall Study|Withdrawal by Subject|0|||
157221941|NCT00818623|567558599|FG004|Overall Study|Withdrawal by Subject|0|||
157221942|NCT00818623|567558600|FG005|Overall Study|Withdrawal by Subject|1|||
157221943|NCT00818623|567558601|FG006|Overall Study|Withdrawal by Subject|1|||
157221944|NCT00818623|567558602|FG007|Overall Study|Withdrawal by Subject|1|||
157221945|NCT00818623|567558595|FG000|Overall Study|Protocol Violation|1|||
157221946|NCT00818623|567558596|FG001|Overall Study|Protocol Violation|0|||
157221947|NCT00818623|567558597|FG002|Overall Study|Protocol Violation|0|||
157221948|NCT00818623|567558598|FG003|Overall Study|Protocol Violation|0|||
157221949|NCT00818623|567558599|FG004|Overall Study|Protocol Violation|1|||
157221950|NCT00818623|567558600|FG005|Overall Study|Protocol Violation|0|||
157221951|NCT00818623|567558601|FG006|Overall Study|Protocol Violation|1|||
157221952|NCT00818623|567558602|FG007|Overall Study|Protocol Violation|0|||
156808922|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
156808923|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
157021810|NCT04241068|566832977|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
157021811|NCT04241068|566832977|FG000|Core Treatment Period|Study Visit Burden|40|||
157221953|NCT00818623|567558595|FG000|Overall Study|Need of additional treatment|0|||
157221954|NCT00818623|567558596|FG001|Overall Study|Need of additional treatment|0|||
157221955|NCT00818623|567558597|FG002|Overall Study|Need of additional treatment|0|||
157221956|NCT00818623|567558598|FG003|Overall Study|Need of additional treatment|0|||
157221957|NCT00818623|567558599|FG004|Overall Study|Need of additional treatment|1|||
157221958|NCT00818623|567558600|FG005|Overall Study|Need of additional treatment|0|||
157221959|NCT00818623|567558601|FG006|Overall Study|Need of additional treatment|0|||
156808924|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Other|0|||
156808925|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Other|2|||
156808926|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Other|5|||
156808927|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
156808928|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
156808929|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
156808930|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
156808931|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
156808932|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
156808933|NCT02831855|566054502|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
156808934|NCT02831855|566054503|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
156808935|NCT02831855|566054504|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
156808936|NCT02688192|566054509|FG000|Overall Study|Lost to Follow-up|11|||
156883148|NCT01185353|566330926|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883149|NCT01185353|566330927|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883150|NCT01185353|566330928|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
156883151|NCT01185353|566330929|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883152|NCT01185353|566330930|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883153|NCT01185353|566330931|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
156883154|NCT01185353|566330932|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883155|NCT01185353|566330933|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883156|NCT01185353|566330934|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
156883157|NCT01185353|566330925|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883158|NCT01185353|566330926|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883159|NCT01185353|566330927|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
156883160|NCT01185353|566330928|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
156883161|NCT01185353|566330929|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883162|NCT01185353|566330930|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
156883163|NCT01185353|566330931|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
156883164|NCT01185353|566330932|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883165|NCT01185353|566330933|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883166|NCT01185353|566330934|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
156883167|NCT01185353|566330925|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883168|NCT01185353|566330926|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883169|NCT01185353|566330927|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883170|NCT01185353|566330928|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883171|NCT01185353|566330929|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883172|NCT01185353|566330930|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
157021812|NCT04241068|566832977|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
157145173|NCT05755438|567278013|FG001|40-week OLE Period|Sponsor Decision|0|||
157145174|NCT05755438|567278012|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
157145175|NCT05755438|567278013|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
157145176|NCT05755438|567278012|FG000|40-week OLE Period|Ongoing|46|||
157145177|NCT05755438|567278013|FG001|40-week OLE Period|Ongoing|58|||
157145178|NCT01548638|567278015|FG000|Overall Study|Protocol Violation|3|||
157145179|NCT01548638|567278015|FG000|Overall Study|Withdrawal by Subject|1|||
157145180|NCT01476787|567278018|FG000|Treatment|Progression|64|||
157145181|NCT01476787|567278019|FG001|Treatment|Progression|71|||
157145182|NCT01476787|567278018|FG000|Treatment|Toxicity|44|||
157145183|NCT01476787|567278019|FG001|Treatment|Toxicity|16|||
157145184|NCT01476787|567278018|FG000|Treatment|Death|0|||
157145185|NCT01476787|567278019|FG001|Treatment|Death|1|||
157021813|NCT04241068|566832977|FG000|Core Treatment Period|Missing|2|||
157021814|NCT04241068|566832977|FG000|Core Treatment Period|Reason Not Specified|41|||
157021815|NCT04241068|566832977|FG000|LTE Period|Adverse Event|19|||
157021816|NCT04241068|566832977|FG000|LTE Period|Change of Treatment|1|||
157021817|NCT04241068|566832977|FG000|LTE Period|Consent Withdrawn|71|||
157021818|NCT04241068|566832977|FG000|LTE Period|Death|8|||
157021819|NCT04241068|566832977|FG000|LTE Period|Disease Progression|11|||
157021820|NCT04241068|566832977|FG000|LTE Period|Investigator Decision|12|||
157021821|NCT04241068|566832977|FG000|LTE Period|Loss of Capacity|2|||
157021822|NCT04241068|566832977|FG000|LTE Period|Lost to Follow-up|7|||
157021823|NCT04241068|566832977|FG000|LTE Period|Relocation|6|||
157021824|NCT04241068|566832977|FG000|LTE Period|Site Terminated by Sponsor|26|||
157021825|NCT04241068|566832977|FG000|LTE Period|Study Terminated by Sponsor|276|||
157021826|NCT04241068|566832977|FG000|LTE Period|Study Visit Burden|10|||
157145186|NCT01476787|567278018|FG000|Treatment|Withdrawal by Subject|3|||
157145187|NCT01476787|567278019|FG001|Treatment|Withdrawal by Subject|14|||
157145188|NCT01476787|567278018|FG000|Treatment|Major protocol violation|1|||
157145189|NCT01476787|567278019|FG001|Treatment|Major protocol violation|6|||
156808937|NCT02688192|566054510|FG001|Overall Study|Lost to Follow-up|5|||
157145190|NCT01476787|567278018|FG000|Treatment|Other reasons|10|||
157145191|NCT01476787|567278019|FG001|Treatment|Other reasons|22|||
157221960|NCT00818623|567558602|FG007|Overall Study|Need of additional treatment|0|||
157221961|NCT00818623|567558595|FG000|Overall Study|Lack of trial drug at site|0|||
157221962|NCT00818623|567558596|FG001|Overall Study|Lack of trial drug at site|0|||
157221963|NCT00818623|567558597|FG002|Overall Study|Lack of trial drug at site|0|||
157221964|NCT00818623|567558598|FG003|Overall Study|Lack of trial drug at site|0|||
157221965|NCT00818623|567558599|FG004|Overall Study|Lack of trial drug at site|2|||
157221966|NCT00818623|567558600|FG005|Overall Study|Lack of trial drug at site|0|||
157221967|NCT00818623|567558601|FG006|Overall Study|Lack of trial drug at site|1|||
157221968|NCT00818623|567558602|FG007|Overall Study|Lack of trial drug at site|0|||
157221969|NCT00818623|567558595|FG000|Overall Study|Disease progression|0|||
157221970|NCT00818623|567558596|FG001|Overall Study|Disease progression|0|||
157221971|NCT00818623|567558597|FG002|Overall Study|Disease progression|0|||
157221972|NCT00818623|567558598|FG003|Overall Study|Disease progression|0|||
157221973|NCT00818623|567558599|FG004|Overall Study|Disease progression|0|||
157221974|NCT00818623|567558600|FG005|Overall Study|Disease progression|0|||
156808938|NCT02688192|566054509|FG000|Overall Study|Physician Decision|1|||
156808939|NCT02688192|566054510|FG001|Overall Study|Physician Decision|0|||
156808940|NCT02959463|566054511|FG000|Overall Study|Adverse Event|1|||
156808941|NCT02959463|566054512|FG001|Overall Study|Adverse Event|1|||
156808942|NCT02959463|566054511|FG000|Overall Study|Death|1|||
156808943|NCT02959463|566054512|FG001|Overall Study|Death|0|||
156808944|NCT02959463|566054511|FG000|Overall Study|Withdrawal by Subject|1|||
156808945|NCT02959463|566054512|FG001|Overall Study|Withdrawal by Subject|0|||
156808946|NCT00041470|566054524|FG000|Overall Study|Loss of Funding|38|||
156808947|NCT01459666|566054525|FG000|Overall Study|PI left institution|5|||
157221975|NCT00818623|567558601|FG006|Overall Study|Disease progression|1|||
156808948|NCT01459666|566054526|FG001|Overall Study|PI left institution|4|||
156808949|NCT01061385|566054528|FG000|Overall Study|Lost to Follow-up|1|||
156808950|NCT01061385|566054529|FG001|Overall Study|Lost to Follow-up|0|||
156808951|NCT01061385|566054528|FG000|Overall Study|subject decision not related to AE|0|||
156808952|NCT01061385|566054529|FG001|Overall Study|subject decision not related to AE|1|||
156808953|NCT00533429|566054530|FG000|Overall Study|Adverse Event|3|||
156808954|NCT00533429|566054531|FG001|Overall Study|Adverse Event|1|||
156808955|NCT00533429|566054530|FG000|Overall Study|Death|1|||
156808956|NCT00533429|566054531|FG001|Overall Study|Death|0|||
156808957|NCT00533429|566054530|FG000|Overall Study|Withdrawal by Subject|2|||
156808958|NCT00533429|566054531|FG001|Overall Study|Withdrawal by Subject|0|||
156808959|NCT00533429|566054530|FG000|Overall Study|Progressive Disease|12|||
156808960|NCT00533429|566054531|FG001|Overall Study|Progressive Disease|13|||
156808961|NCT00533429|566054530|FG000|Overall Study|Symptomatic deterioration|1|||
156808962|NCT00533429|566054531|FG001|Overall Study|Symptomatic deterioration|2|||
156808963|NCT02379052|566054538|FG000|Overall Study|Protocol Violation|0|||
156808964|NCT02379052|566054539|FG001|Overall Study|Protocol Violation|1|||
156808965|NCT02379052|566054538|FG000|Overall Study|Adverse Event|0|||
156808966|NCT02379052|566054539|FG001|Overall Study|Adverse Event|1|||
156808967|NCT02379052|566054538|FG000|Overall Study|Physician Decision|1|||
156808968|NCT02379052|566054539|FG001|Overall Study|Physician Decision|1|||
156808969|NCT02379052|566054538|FG000|Overall Study|Withdrawal by Subject|2|||
156808970|NCT02379052|566054539|FG001|Overall Study|Withdrawal by Subject|0|||
156808971|NCT02379052|566054538|FG000|Overall Study|Lost to Follow-up|2|||
156808972|NCT02379052|566054539|FG001|Overall Study|Lost to Follow-up|1|||
156808973|NCT02379052|566054538|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
156808974|NCT02379052|566054539|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
156808975|NCT02379052|566054538|FG000|Overall Study|Subject was Incarcerated|0|||
156808976|NCT02379052|566054539|FG001|Overall Study|Subject was Incarcerated|1|||
156808977|NCT00127855|566054540|FG000|Primary Vaccination Course|Adverse Event|0|||
156808978|NCT00127855|566054541|FG001|Primary Vaccination Course|Adverse Event|0|||
156808979|NCT00127855|566054542|FG002|Primary Vaccination Course|Adverse Event|1|||
156808980|NCT00127855|566054543|FG003|Primary Vaccination Course|Adverse Event|0|||
156808981|NCT00127855|566054544|FG004|Primary Vaccination Course|Adverse Event|0|||
156808982|NCT00127855|566054540|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
156808983|NCT00127855|566054541|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
156808984|NCT00127855|566054542|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
157021827|NCT04241068|566832977|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
157021828|NCT04241068|566832977|FG000|LTE Period|Reason Not Specified|65|||
157221976|NCT00818623|567558602|FG007|Overall Study|Disease progression|0|||
157221977|NCT01709383|567558607|FG000|Overall Study|Lost to Follow-up|1|||
157221978|NCT01709383|567558608|FG001|Overall Study|Lost to Follow-up|0|||
157221979|NCT03264066|567558609|FG000|Overall Study|Adverse Event|1|||
157221980|NCT03264066|567558610|FG001|Overall Study|Adverse Event|1|||
156808985|NCT00127855|566054543|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
156808986|NCT00127855|566054544|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
156808987|NCT00127855|566054540|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
156808988|NCT00127855|566054541|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
156808989|NCT00127855|566054542|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
156808990|NCT00127855|566054543|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
156808991|NCT00127855|566054544|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
157221981|NCT03264066|567558611|FG002|Overall Study|Adverse Event|0|||
157221982|NCT03264066|567558612|FG003|Overall Study|Adverse Event|0|||
157221983|NCT03264066|567558613|FG004|Overall Study|Adverse Event|0|||
157221984|NCT03264066|567558614|FG005|Overall Study|Adverse Event|0|||
157221985|NCT03264066|567558609|FG000|Overall Study|Death|12|||
157221986|NCT03264066|567558610|FG001|Overall Study|Death|12|||
157221987|NCT03264066|567558611|FG002|Overall Study|Death|8|||
157221988|NCT03264066|567558612|FG003|Overall Study|Death|10|||
157221989|NCT03264066|567558613|FG004|Overall Study|Death|6|||
157221990|NCT03264066|567558614|FG005|Overall Study|Death|1|||
157221991|NCT03264066|567558609|FG000|Overall Study|Lost to Follow-up|1|||
157221992|NCT03264066|567558610|FG001|Overall Study|Lost to Follow-up|0|||
157221993|NCT03264066|567558611|FG002|Overall Study|Lost to Follow-up|0|||
157221994|NCT03264066|567558612|FG003|Overall Study|Lost to Follow-up|0|||
157221995|NCT03264066|567558613|FG004|Overall Study|Lost to Follow-up|0|||
157221996|NCT03264066|567558614|FG005|Overall Study|Lost to Follow-up|0|||
157221997|NCT03264066|567558609|FG000|Overall Study|Progressive Disease|0|||
157221998|NCT03264066|567558610|FG001|Overall Study|Progressive Disease|2|||
157221999|NCT03264066|567558611|FG002|Overall Study|Progressive Disease|1|||
157222000|NCT03264066|567558612|FG003|Overall Study|Progressive Disease|0|||
157222001|NCT03264066|567558613|FG004|Overall Study|Progressive Disease|0|||
157222002|NCT03264066|567558614|FG005|Overall Study|Progressive Disease|0|||
157222003|NCT03264066|567558609|FG000|Overall Study|Study Terminated by Sponsor|5|||
157222004|NCT03264066|567558610|FG001|Overall Study|Study Terminated by Sponsor|5|||
157222005|NCT03264066|567558611|FG002|Overall Study|Study Terminated by Sponsor|8|||
157222006|NCT03264066|567558612|FG003|Overall Study|Study Terminated by Sponsor|5|||
157222007|NCT03264066|567558613|FG004|Overall Study|Study Terminated by Sponsor|1|||
157222008|NCT03264066|567558614|FG005|Overall Study|Study Terminated by Sponsor|2|||
157222009|NCT03264066|567558609|FG000|Overall Study|Withdrawal by Subject|1|||
157222010|NCT03264066|567558610|FG001|Overall Study|Withdrawal by Subject|0|||
157222011|NCT03264066|567558611|FG002|Overall Study|Withdrawal by Subject|0|||
157222012|NCT03264066|567558612|FG003|Overall Study|Withdrawal by Subject|5|||
157222013|NCT03264066|567558613|FG004|Overall Study|Withdrawal by Subject|0|||
157222014|NCT03264066|567558614|FG005|Overall Study|Withdrawal by Subject|0|||
157222015|NCT01484028|567558615|FG000|Period 1|Lost to Follow-up|0|||
157222016|NCT01484028|567558616|FG001|Period 1|Lost to Follow-up|1|||
157222017|NCT01484028|567558617|FG002|Period 1|Lost to Follow-up|0|||
157222018|NCT01484028|567558618|FG003|Period 1|Lost to Follow-up|0|||
157222019|NCT01484028|567558615|FG000|Period 1|Non-Compliance to Protocol|0|||
157222020|NCT01484028|567558616|FG001|Period 1|Non-Compliance to Protocol|1|||
157222021|NCT01484028|567558617|FG002|Period 1|Non-Compliance to Protocol|0|||
157222022|NCT01484028|567558618|FG003|Period 1|Non-Compliance to Protocol|1|||
157222023|NCT01484028|567558615|FG000|Period 1|Lens Discomfort|0|||
157222024|NCT01484028|567558616|FG001|Period 1|Lens Discomfort|1|||
157222025|NCT01484028|567558617|FG002|Period 1|Lens Discomfort|0|||
157222026|NCT01484028|567558618|FG003|Period 1|Lens Discomfort|0|||
157222027|NCT00759148|567560101|FG000|Overall Study|Adverse Event|1|||
157222028|NCT00759148|567560102|FG001|Overall Study|Adverse Event|6|||
157222029|NCT00759148|567560101|FG000|Overall Study|Withdrawal by Subject|3|||
157222030|NCT00759148|567560102|FG001|Overall Study|Withdrawal by Subject|7|||
157222031|NCT00759148|567560101|FG000|Overall Study|Lost to Follow-up|3|||
157222032|NCT00759148|567560102|FG001|Overall Study|Lost to Follow-up|9|||
157222033|NCT00759148|567560101|FG000|Overall Study|Treatment Failure|6|||
157021829|NCT04492007|566832983|FG000|Overall Study|Lost to Follow-up|1|||
157021830|NCT04492007|566832984|FG001|Overall Study|Lost to Follow-up|1|||
157021831|NCT04492007|566832985|FG002|Overall Study|Lost to Follow-up|2|||
157021832|NCT04492007|566832986|FG003|Overall Study|Lost to Follow-up|2|||
157021833|NCT04492007|566832983|FG000|Overall Study|Protocol Violation|1|||
157021834|NCT04492007|566832984|FG001|Overall Study|Protocol Violation|1|||
157021835|NCT04492007|566832985|FG002|Overall Study|Protocol Violation|1|||
157021836|NCT04492007|566832986|FG003|Overall Study|Protocol Violation|1|||
157021837|NCT04492007|566832983|FG000|Overall Study|Withdrawal by Subject|0|||
157021838|NCT04492007|566832984|FG001|Overall Study|Withdrawal by Subject|0|||
157021839|NCT04492007|566832985|FG002|Overall Study|Withdrawal by Subject|1|||
157021840|NCT04492007|566832986|FG003|Overall Study|Withdrawal by Subject|1|||
157021841|NCT05178316|566832987|FG000|Overall Study|Adverse Event|5|||
157222034|NCT00759148|567560102|FG001|Overall Study|Treatment Failure|10|||
157222035|NCT00759148|567560101|FG000|Overall Study|Reason not given|1|||
157222036|NCT00759148|567560102|FG001|Overall Study|Reason not given|0|||
157222037|NCT01073020|567560103|FG000|Overall Study|Withdrawal by Subject|6|||
157222038|NCT01073020|567560104|FG001|Overall Study|Withdrawal by Subject|4|||
157021842|NCT05178316|566832988|FG001|Overall Study|Adverse Event|4|||
157021843|NCT05178316|566832989|FG002|Overall Study|Adverse Event|9|||
157021844|NCT05178316|566832987|FG000|Overall Study|Enrolled in Error|1|||
157222039|NCT01073020|567560105|FG002|Overall Study|Withdrawal by Subject|1|||
157222040|NCT01073020|567560106|FG003|Overall Study|Withdrawal by Subject|2|||
157222041|NCT01073020|567560103|FG000|Overall Study|Physician Decision|1|||
157222042|NCT01073020|567560104|FG001|Overall Study|Physician Decision|0|||
157222043|NCT01073020|567560105|FG002|Overall Study|Physician Decision|2|||
157222044|NCT01073020|567560106|FG003|Overall Study|Physician Decision|0|||
157222045|NCT01073020|567560103|FG000|Overall Study|Death|0|||
157222046|NCT01073020|567560104|FG001|Overall Study|Death|1|||
157222047|NCT01073020|567560105|FG002|Overall Study|Death|0|||
157222048|NCT01073020|567560106|FG003|Overall Study|Death|0|||
157222049|NCT01829464|567560112|FG000|Overall Study|Adverse Event|1|||
157222050|NCT01829464|567560113|FG001|Overall Study|Adverse Event|0|||
157222051|NCT01829464|567560114|FG002|Overall Study|Adverse Event|0|||
157222052|NCT01829464|567560112|FG000|Overall Study|Lost to Follow-up|0|||
157222053|NCT01829464|567560113|FG001|Overall Study|Lost to Follow-up|0|||
157222054|NCT01829464|567560114|FG002|Overall Study|Lost to Follow-up|1|||
157222055|NCT01829464|567560112|FG000|Overall Study|Withdrawal by Subject|2|||
157222056|NCT01829464|567560113|FG001|Overall Study|Withdrawal by Subject|0|||
157222057|NCT01829464|567560114|FG002|Overall Study|Withdrawal by Subject|0|||
157222058|NCT01829464|567560112|FG000|Overall Study|Study terminated by sponsor|25|||
157222059|NCT01829464|567560113|FG001|Overall Study|Study terminated by sponsor|28|||
157222060|NCT01829464|567560114|FG002|Overall Study|Study terminated by sponsor|25|||
157222061|NCT01829464|567560112|FG000|Overall Study|Lack of Efficacy|0|||
157222062|NCT01829464|567560113|FG001|Overall Study|Lack of Efficacy|1|||
157222063|NCT01829464|567560114|FG002|Overall Study|Lack of Efficacy|0|||
157222064|NCT00635778|567560115|FG000|Overall Study|Adverse Event|1|||
157222065|NCT00635778|567560116|FG001|Overall Study|Adverse Event|0|||
157222066|NCT00635778|567560117|FG002|Overall Study|Adverse Event|0|||
157222067|NCT00635778|567560118|FG003|Overall Study|Adverse Event|3|||
157222068|NCT00635778|567560119|FG004|Overall Study|Adverse Event|3|||
157222069|NCT00635778|567560120|FG005|Overall Study|Adverse Event|6|||
157222070|NCT00635778|567560121|FG006|Overall Study|Adverse Event|1|||
157222071|NCT00635778|567560115|FG000|Overall Study|Withdrawal by Subject|0|||
157222072|NCT00635778|567560116|FG001|Overall Study|Withdrawal by Subject|0|||
157222073|NCT00635778|567560117|FG002|Overall Study|Withdrawal by Subject|0|||
157222074|NCT00635778|567560118|FG003|Overall Study|Withdrawal by Subject|1|||
157222075|NCT00635778|567560119|FG004|Overall Study|Withdrawal by Subject|0|||
157222076|NCT00635778|567560120|FG005|Overall Study|Withdrawal by Subject|1|||
157222077|NCT00635778|567560121|FG006|Overall Study|Withdrawal by Subject|1|||
157222078|NCT00635778|567560115|FG000|Overall Study|Progressive disease|0|||
157222079|NCT00635778|567560116|FG001|Overall Study|Progressive disease|3|||
157222080|NCT00635778|567560117|FG002|Overall Study|Progressive disease|3|||
157222081|NCT00635778|567560118|FG003|Overall Study|Progressive disease|4|||
157222082|NCT00635778|567560119|FG004|Overall Study|Progressive disease|5|||
157222083|NCT00635778|567560120|FG005|Overall Study|Progressive disease|14|||
157222084|NCT00635778|567560121|FG006|Overall Study|Progressive disease|4|||
157222085|NCT01884025|567560122|FG000|Overall Study|Lost to Follow-up|3|||
157222086|NCT01884025|567560123|FG001|Overall Study|Lost to Follow-up|4|||
157222087|NCT00755326|567560125|FG000|Overall Study|Lost to Follow-up|2|||
157222088|NCT00755326|567560126|FG001|Overall Study|Lost to Follow-up|3|||
157222089|NCT02173704|567560127|FG000|Overall Study|Adverse Event|1|||
157222090|NCT02173704|567560128|FG001|Overall Study|Adverse Event|0|||
157222091|NCT02173704|567560127|FG000|Overall Study|Lost to Follow-up|1|||
157222092|NCT02173704|567560128|FG001|Overall Study|Lost to Follow-up|0|||
157222093|NCT02173704|567560127|FG000|Overall Study|Other|1|||
157222094|NCT02173704|567560128|FG001|Overall Study|Other|0|||
157222095|NCT02173704|567560127|FG000|Overall Study|Protocol Violation|1|||
157222096|NCT02173704|567560128|FG001|Overall Study|Protocol Violation|0|||
157222097|NCT02173704|567560127|FG000|Overall Study|Withdrawal by Subject|9|||
157222098|NCT02173704|567560128|FG001|Overall Study|Withdrawal by Subject|4|||
157222099|NCT02623829|567560132|FG000|Overall Study|Lost to Follow-up|1|||
157222100|NCT02623829|567560133|FG001|Overall Study|Lost to Follow-up|1|||
157222101|NCT00662025|567560134|FG000|Overall Study|Objective progression or relapse|51|||
157222102|NCT00662025|567560134|FG000|Overall Study|Adverse Event|7|||
157222103|NCT00662025|567560134|FG000|Overall Study|Withdrawal by Subject|1|||
157222104|NCT00662025|567560134|FG000|Overall Study|Results of other clinical study|2|||
157222105|NCT00662025|567560134|FG000|Overall Study|Target lesion cannot be evaluated|1|||
157222106|NCT00662025|567560134|FG000|Overall Study|Domestic circumstances|1|||
157222107|NCT00622908|567560144|FG000|Overall Study|Protocol Violation|1|||
157222108|NCT00622908|567560145|FG001|Overall Study|Protocol Violation|0|||
157222109|NCT00622908|567560144|FG000|Overall Study|Adverse Event|0|||
157222110|NCT00622908|567560145|FG001|Overall Study|Adverse Event|1|||
157222111|NCT00622908|567560144|FG000|Overall Study|Lack of Efficacy|1|||
157222112|NCT00622908|567560145|FG001|Overall Study|Lack of Efficacy|7|||
157222113|NCT00622908|567560144|FG000|Overall Study|Lost to Follow-up|1|||
157222114|NCT00622908|567560145|FG001|Overall Study|Lost to Follow-up|0|||
157222115|NCT00622908|567560144|FG000|Overall Study|Refusal|0|||
157222116|NCT00622908|567560145|FG001|Overall Study|Refusal|1|||
157222117|NCT00622908|567560144|FG000|Overall Study|Termination by study sponser|0|||
157222118|NCT00622908|567560145|FG001|Overall Study|Termination by study sponser|1|||
157222119|NCT03937466|567560146|FG000|Overall Study|not eligbile after the 2-week diary|9|||
157222120|NCT03937466|567560146|FG000|Overall Study|never returned their diary|6|||
157222121|NCT03937466|567560146|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
157222122|NCT03937466|567560146|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
157222123|NCT00299156|567560149|FG000|Period 2 (Randomized)|Screen Failure|0|||
157222124|NCT00299156|567560150|FG001|Period 2 (Randomized)|Screen Failure|1|||
157222125|NCT00299156|567560151|FG002|Period 2 (Randomized)|Screen Failure|0|||
157222126|NCT01166568|567560157|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
157222127|NCT01166568|567560158|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
157222128|NCT01166568|567560159|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
157222129|NCT01166568|567560157|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
157222130|NCT01166568|567560158|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
157222131|NCT01166568|567560159|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
157222132|NCT01166568|567560157|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
157222133|NCT01166568|567560158|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
157222134|NCT01166568|567560159|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
157222135|NCT01725451|567560160|FG000|Period 1|Withdrawal by Subject|1|||
157222136|NCT01725451|567560161|FG001|Period 1|Withdrawal by Subject|0|||
157222137|NCT01725451|567560162|FG002|Period 1|Withdrawal by Subject|0|||
157222138|NCT01725451|567560163|FG003|Period 1|Withdrawal by Subject|0|||
157222139|NCT01725451|567560160|FG000|Washout From Period 3|Protocol Violation|0|||
157222140|NCT01725451|567560161|FG001|Washout From Period 3|Protocol Violation|0|||
157222141|NCT01725451|567560162|FG002|Washout From Period 3|Protocol Violation|1|||
157222142|NCT01725451|567560163|FG003|Washout From Period 3|Protocol Violation|0|||
157222143|NCT01725451|567560160|FG000|Washout From Period 3|Adverse Event|0|||
157222144|NCT01725451|567560161|FG001|Washout From Period 3|Adverse Event|1|||
157222145|NCT01725451|567560162|FG002|Washout From Period 3|Adverse Event|0|||
157222146|NCT01725451|567560163|FG003|Washout From Period 3|Adverse Event|0|||
157222147|NCT01725451|567560160|FG000|Period 4|Adverse Event|0|||
157222148|NCT01725451|567560161|FG001|Period 4|Adverse Event|0|||
157222149|NCT01725451|567560162|FG002|Period 4|Adverse Event|1|||
157222150|NCT01725451|567560163|FG003|Period 4|Adverse Event|0|||
157222151|NCT00358826|567560167|FG000|Core Study|Adverse Event|1|||
157222152|NCT00358826|567560168|FG001|Core Study|Adverse Event|3|||
157222153|NCT00358826|567560169|FG002|Core Study|Adverse Event|1|||
157222154|NCT00358826|567560170|FG003|Core Study|Adverse Event|1|||
157222155|NCT00358826|567560171|FG004|Core Study|Adverse Event|0|||
157222156|NCT00358826|567560172|FG005|Core Study|Adverse Event|0|||
157222157|NCT00358826|567560173|FG006|Core Study|Adverse Event|0|||
157222158|NCT00358826|567560174|FG007|Core Study|Adverse Event|0|||
157222159|NCT00358826|567560167|FG000|Core Study|Withdrawal by Subject|2|||
157222160|NCT00358826|567560168|FG001|Core Study|Withdrawal by Subject|2|||
157222161|NCT00358826|567560169|FG002|Core Study|Withdrawal by Subject|0|||
157222162|NCT00358826|567560170|FG003|Core Study|Withdrawal by Subject|0|||
157222163|NCT00358826|567560171|FG004|Core Study|Withdrawal by Subject|0|||
157222164|NCT00358826|567560172|FG005|Core Study|Withdrawal by Subject|0|||
157222165|NCT00358826|567560173|FG006|Core Study|Withdrawal by Subject|0|||
157222166|NCT00358826|567560174|FG007|Core Study|Withdrawal by Subject|0|||
157222167|NCT00358826|567560167|FG000|Core Study|Lost to Follow-up|0|||
157222168|NCT00358826|567560168|FG001|Core Study|Lost to Follow-up|0|||
157222169|NCT00358826|567560169|FG002|Core Study|Lost to Follow-up|0|||
157222170|NCT00358826|567560170|FG003|Core Study|Lost to Follow-up|1|||
157222171|NCT00358826|567560171|FG004|Core Study|Lost to Follow-up|0|||
157222172|NCT00358826|567560172|FG005|Core Study|Lost to Follow-up|0|||
157222173|NCT00358826|567560173|FG006|Core Study|Lost to Follow-up|0|||
157222174|NCT00358826|567560174|FG007|Core Study|Lost to Follow-up|0|||
157222175|NCT00358826|567560167|FG000|Core Study|Physician Decision|0|||
157222176|NCT00358826|567560168|FG001|Core Study|Physician Decision|0|||
157222177|NCT00358826|567560169|FG002|Core Study|Physician Decision|1|||
157222178|NCT00358826|567560170|FG003|Core Study|Physician Decision|0|||
157222179|NCT00358826|567560171|FG004|Core Study|Physician Decision|0|||
157222180|NCT00358826|567560172|FG005|Core Study|Physician Decision|0|||
157222181|NCT00358826|567560173|FG006|Core Study|Physician Decision|0|||
156883173|NCT01185353|566330931|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
156883174|NCT01185353|566330932|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883175|NCT01185353|566330933|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883176|NCT01185353|566330934|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
156883177|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
157222182|NCT00358826|567560174|FG007|Core Study|Physician Decision|0|||
157222183|NCT00358826|567560167|FG000|MDCT Substudy|Adverse Event|0|||
157222184|NCT00358826|567560168|FG001|MDCT Substudy|Adverse Event|0|||
156883178|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156883179|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
157222185|NCT00358826|567560169|FG002|MDCT Substudy|Adverse Event|0|||
157222186|NCT00358826|567560170|FG003|MDCT Substudy|Adverse Event|0|||
157222187|NCT00358826|567560171|FG004|MDCT Substudy|Adverse Event|1|||
157222188|NCT00358826|567560172|FG005|MDCT Substudy|Adverse Event|0|||
157222189|NCT00358826|567560173|FG006|MDCT Substudy|Adverse Event|0|||
157222190|NCT00358826|567560174|FG007|MDCT Substudy|Adverse Event|0|||
157222191|NCT00358826|567560167|FG000|MDCT Substudy|Lost to Follow-up|0|||
157222192|NCT00358826|567560168|FG001|MDCT Substudy|Lost to Follow-up|0|||
157222193|NCT00358826|567560169|FG002|MDCT Substudy|Lost to Follow-up|0|||
157021845|NCT05178316|566832988|FG001|Overall Study|Enrolled in Error|2|||
157021846|NCT05178316|566832989|FG002|Overall Study|Enrolled in Error|1|||
157021847|NCT05178316|566832987|FG000|Overall Study|Lost to Follow-up|3|||
157021848|NCT05178316|566832988|FG001|Overall Study|Lost to Follow-up|15|||
157021849|NCT05178316|566832989|FG002|Overall Study|Lost to Follow-up|11|||
157021850|NCT05178316|566832987|FG000|Overall Study|Noncompliance|1|||
157021851|NCT05178316|566832988|FG001|Overall Study|Noncompliance|3|||
157021852|NCT05178316|566832989|FG002|Overall Study|Noncompliance|1|||
157021853|NCT05178316|566832987|FG000|Overall Study|Other|0|||
157021854|NCT05178316|566832988|FG001|Overall Study|Other|1|||
157021855|NCT05178316|566832989|FG002|Overall Study|Other|0|||
157021856|NCT05178316|566832987|FG000|Overall Study|Physician Decision|0|||
157021857|NCT05178316|566832988|FG001|Overall Study|Physician Decision|3|||
157021858|NCT05178316|566832989|FG002|Overall Study|Physician Decision|2|||
157021859|NCT05178316|566832987|FG000|Overall Study|Protocol deviation|1|||
157021860|NCT05178316|566832988|FG001|Overall Study|Protocol deviation|0|||
157021861|NCT05178316|566832989|FG002|Overall Study|Protocol deviation|1|||
157021862|NCT05178316|566832987|FG000|Overall Study|Sponsor decision|1|||
157021863|NCT05178316|566832988|FG001|Overall Study|Sponsor decision|0|||
157021864|NCT05178316|566832989|FG002|Overall Study|Sponsor decision|1|||
157021865|NCT05178316|566832987|FG000|Overall Study|Withdrawal by Subject|5|||
157021866|NCT05178316|566832988|FG001|Overall Study|Withdrawal by Subject|11|||
157021867|NCT05178316|566832989|FG002|Overall Study|Withdrawal by Subject|5|||
157021868|NCT04347161|566832990|FG000|Overall Study|Death|0|||
157021869|NCT04347161|566832991|FG001|Overall Study|Death|2|||
157021870|NCT04347161|566832990|FG000|Overall Study|Withdrawal by Subject|1|||
157021871|NCT04347161|566832991|FG001|Overall Study|Withdrawal by Subject|0|||
157021872|NCT04347161|566832990|FG000|Overall Study|Lost to Follow-up|0|||
157021873|NCT04347161|566832991|FG001|Overall Study|Lost to Follow-up|1|||
157021874|NCT04347161|566832990|FG000|Overall Study|No longer on study medication|1|||
157021875|NCT04347161|566832991|FG001|Overall Study|No longer on study medication|1|||
157021876|NCT03907397|566832994|FG000|Overall Study|Lost to Follow-up|0|||
157021877|NCT03907397|566832995|FG001|Overall Study|Lost to Follow-up|1|||
157021878|NCT03907397|566832994|FG000|Overall Study|Physician Decision|2|||
157021879|NCT03907397|566832995|FG001|Overall Study|Physician Decision|1|||
157021880|NCT03907397|566832994|FG000|Overall Study|Withdrawal by Subject|5|||
157021881|NCT03907397|566832995|FG001|Overall Study|Withdrawal by Subject|4|||
157021882|NCT03907397|566832994|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
157021883|NCT03907397|566832995|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
157021884|NCT01413100|566832996|FG000|Overall Study|Withdrawal by Subject|1|||
157021885|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
157021886|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
157021887|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
157021888|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
157145192|NCT01476787|567278018|FG000|Treatment|Concurrent illness|12|||
157145193|NCT01476787|567278019|FG001|Treatment|Concurrent illness|9|||
157145194|NCT01476787|567278018|FG000|Treatment|Insufficient response|15|||
157145195|NCT01476787|567278019|FG001|Treatment|Insufficient response|3|||
157145196|NCT01476787|567278018|FG000|Treatment|Voluntary treatment discontinuation|8|||
157145197|NCT01476787|567278019|FG001|Treatment|Voluntary treatment discontinuation|4|||
157145198|NCT01591330|567278020|FG000|Period 1|Adverse Event|1|||
157222194|NCT00358826|567560170|FG003|MDCT Substudy|Lost to Follow-up|0|||
156808992|NCT00127855|566054540|FG000|Primary Vaccination Course|Other|0|||
156808993|NCT00127855|566054541|FG001|Primary Vaccination Course|Other|0|||
156808994|NCT00127855|566054542|FG002|Primary Vaccination Course|Other|0|||
156808995|NCT00127855|566054543|FG003|Primary Vaccination Course|Other|0|||
156808996|NCT00127855|566054544|FG004|Primary Vaccination Course|Other|1|||
156808997|NCT02343302|566054545|FG000|Overall Study|Physician Decision|1|||
156808998|NCT02343302|566054546|FG001|Overall Study|Physician Decision|1|||
156808999|NCT04245709|566054549|FG000|Overall Study|Adverse Event|13|||
156809000|NCT04245709|566054549|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
156809001|NCT02389465|566054556|FG000|Overall Study|Lost to Follow-up|1|||
156809002|NCT02389465|566054557|FG001|Overall Study|Lost to Follow-up|3|||
156809003|NCT02389465|566054558|FG002|Overall Study|Lost to Follow-up|3|||
156809004|NCT02389465|566054559|FG003|Overall Study|Lost to Follow-up|0|||
156809005|NCT02389465|566054556|FG000|Overall Study|Physician Decision|0|||
156809006|NCT02389465|566054557|FG001|Overall Study|Physician Decision|0|||
156809007|NCT02389465|566054558|FG002|Overall Study|Physician Decision|0|||
157021889|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
157021890|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
157021891|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
157021892|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
157021893|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
157145199|NCT01591330|567278021|FG001|Period 1|Adverse Event|0|||
156809008|NCT02389465|566054559|FG003|Overall Study|Physician Decision|1|||
156809009|NCT02389465|566054556|FG000|Overall Study|Withdrawal by Subject|0|||
157145200|NCT01591330|567278022|FG002|Period 1|Adverse Event|0|||
157021894|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
157021895|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
157021896|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
157021897|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
157021898|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
157021899|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
157021900|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
157021901|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
157021902|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
157021903|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
157021904|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
157021905|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
157021906|NCT05369403|566832997|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
157021907|NCT05369403|566832998|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
157021908|NCT05369403|566832999|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
157021909|NCT05369403|566832997|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
157021910|NCT05369403|566832998|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
157021911|NCT05369403|566832999|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
157145201|NCT01591330|567278023|FG003|Period 1|Adverse Event|0|||
157145202|NCT01591330|567278020|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
157145203|NCT01591330|567278021|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
157145204|NCT01591330|567278022|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
157145205|NCT01591330|567278023|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
157145206|NCT01591330|567278020|FG000|Period 2|Adverse Event|1|||
157145207|NCT01591330|567278021|FG001|Period 2|Adverse Event|0|||
157145208|NCT01591330|567278022|FG002|Period 2|Adverse Event|0|||
157145209|NCT01591330|567278023|FG003|Period 2|Adverse Event|0|||
157145210|NCT02782715|567278024|FG000|Overall Study|Withdrawal by Subject|1|||
157145211|NCT02403206|567278028|FG000|Overall Study|Lost to Follow-up|4|||
157145212|NCT02403206|567278029|FG001|Overall Study|Lost to Follow-up|3|||
157145213|NCT02403206|567278028|FG000|Overall Study|Physician Decision|2|||
157145214|NCT02403206|567278029|FG001|Overall Study|Physician Decision|0|||
157145215|NCT02403206|567278028|FG000|Overall Study|Withdrawal by Subject|3|||
157145216|NCT02403206|567278029|FG001|Overall Study|Withdrawal by Subject|3|||
157145217|NCT02403206|567278028|FG000|Overall Study|Reason not given|2|||
157145218|NCT02403206|567278029|FG001|Overall Study|Reason not given|4|||
157145219|NCT01676116|567278030|FG000|Overall Study|Withdrawal criteria|2|||
157145220|NCT01676116|567278031|FG001|Overall Study|Withdrawal criteria|14|||
157145221|NCT01676116|567278030|FG000|Overall Study|Adverse Event|1|||
157145222|NCT01676116|567278031|FG001|Overall Study|Adverse Event|2|||
157145223|NCT01676116|567278030|FG000|Overall Study|Unclassified|4|||
157145224|NCT01676116|567278031|FG001|Overall Study|Unclassified|10|||
157145225|NCT01676116|567278030|FG000|Overall Study|Protocol Violation|9|||
157145226|NCT01676116|567278031|FG001|Overall Study|Protocol Violation|3|||
157145227|NCT01877655|567278032|FG000|Overall Study|Death|57|||
157145228|NCT01877655|567278033|FG001|Overall Study|Death|52|||
157145229|NCT01877655|567278032|FG000|Overall Study|Withdrawal by Subject|18|||
157145230|NCT01877655|567278033|FG001|Overall Study|Withdrawal by Subject|26|||
157145231|NCT01877655|567278032|FG000|Overall Study|Physician Decision|11|||
157145232|NCT01877655|567278033|FG001|Overall Study|Physician Decision|10|||
157145233|NCT01877655|567278032|FG000|Overall Study|Miscellaneous|4|||
157145234|NCT01877655|567278033|FG001|Overall Study|Miscellaneous|4|||
157145235|NCT01877655|567278032|FG000|Overall Study|Randomized but Never Received Drug|8|||
157145236|NCT01877655|567278033|FG001|Overall Study|Randomized but Never Received Drug|5|||
157145237|NCT01821677|567278036|FG000|Overall Study|Adverse Event|4|||
157145238|NCT01821677|567278037|FG001|Overall Study|Adverse Event|6|||
157145239|NCT01821677|567278038|FG002|Overall Study|Adverse Event|5|||
157145240|NCT01821677|567278036|FG000|Overall Study|Physician Decision|1|||
157145241|NCT01821677|567278037|FG001|Overall Study|Physician Decision|4|||
157145242|NCT01821677|567278038|FG002|Overall Study|Physician Decision|1|||
157145243|NCT01821677|567278036|FG000|Overall Study|Non-compliance|0|||
157145244|NCT01821677|567278037|FG001|Overall Study|Non-compliance|1|||
157145245|NCT01821677|567278038|FG002|Overall Study|Non-compliance|2|||
157145246|NCT01821677|567278036|FG000|Overall Study|Lost to Follow-up|2|||
157145247|NCT01821677|567278037|FG001|Overall Study|Lost to Follow-up|1|||
157145248|NCT01821677|567278038|FG002|Overall Study|Lost to Follow-up|3|||
157222195|NCT00358826|567560171|FG004|MDCT Substudy|Lost to Follow-up|0|||
157145249|NCT01821677|567278036|FG000|Overall Study|Protocol Violation|0|||
157145250|NCT01821677|567278037|FG001|Overall Study|Protocol Violation|0|||
157145251|NCT01821677|567278038|FG002|Overall Study|Protocol Violation|2|||
157145252|NCT01821677|567278036|FG000|Overall Study|Withdrawal by Subject|7|||
157145253|NCT01821677|567278037|FG001|Overall Study|Withdrawal by Subject|3|||
157145254|NCT01821677|567278038|FG002|Overall Study|Withdrawal by Subject|2|||
156883180|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156883181|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156883182|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156883183|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
156883184|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
156883185|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
156883186|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
156883187|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
157145255|NCT01821677|567278036|FG000|Overall Study|Other|9|||
157145256|NCT01821677|567278037|FG001|Overall Study|Other|0|||
157145257|NCT01821677|567278038|FG002|Overall Study|Other|0|||
157145258|NCT03497689|567278039|FG000|Overall Study|Adverse Event|2|||
157145259|NCT03497689|567278039|FG000|Overall Study|Death|1|||
157145260|NCT03497689|567278039|FG000|Overall Study|Physician Decision|1|||
157145261|NCT03497689|567278039|FG000|Overall Study|Withdrawal by Subject|1|||
157145262|NCT03497689|567278039|FG000|Overall Study|Protocol Violation|2|||
157145263|NCT03567187|567278040|FG000|Overall Study|Lost to Follow-up|18|||
157145264|NCT03596645|567278043|FG000|Overall Study|Adverse Event|17|||
157145265|NCT03596645|567278044|FG001|Overall Study|Adverse Event|0|||
157145266|NCT03596645|567278043|FG000|Overall Study|Lack of Efficacy|8|||
157145267|NCT03596645|567278044|FG001|Overall Study|Lack of Efficacy|0|||
157145268|NCT03596645|567278043|FG000|Overall Study|Lost to Follow-up|1|||
157145269|NCT03596645|567278044|FG001|Overall Study|Lost to Follow-up|1|||
157145270|NCT03596645|567278043|FG000|Overall Study|Physician Decision|1|||
157145271|NCT03596645|567278044|FG001|Overall Study|Physician Decision|1|||
157145272|NCT03596645|567278043|FG000|Overall Study|Protocol Violation|1|||
157145273|NCT03596645|567278044|FG001|Overall Study|Protocol Violation|0|||
157145274|NCT03596645|567278043|FG000|Overall Study|Initiated Prohibited Medication|1|||
157145275|NCT03596645|567278044|FG001|Overall Study|Initiated Prohibited Medication|0|||
157145276|NCT03596645|567278043|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157145277|NCT03596645|567278044|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157145278|NCT03596645|567278043|FG000|Overall Study|No mucosal healing achieved|1|||
157145279|NCT03596645|567278044|FG001|Overall Study|No mucosal healing achieved|0|||
157145280|NCT03596645|567278043|FG000|Overall Study|Disease progression|1|||
157145281|NCT03596645|567278044|FG001|Overall Study|Disease progression|0|||
157145282|NCT03596645|567278043|FG000|Overall Study|Ongoing|37|||
157145283|NCT03596645|567278044|FG001|Overall Study|Ongoing|12|||
157145284|NCT03596645|567278043|FG000|Overall Study|Randomized but not treated|0|||
157145285|NCT03596645|567278044|FG001|Overall Study|Randomized but not treated|1|||
157145286|NCT05165394|567279681|FG000|Overall Study|Withdrawal by Subject|5|||
157145287|NCT05165394|567279682|FG001|Overall Study|Withdrawal by Subject|1|||
157145288|NCT05165394|567279681|FG000|Overall Study|Lost to Follow-up|1|||
157145289|NCT05165394|567279682|FG001|Overall Study|Lost to Follow-up|2|||
157145290|NCT05165394|567279681|FG000|Overall Study|Other Than Specified|0|||
157145291|NCT05165394|567279682|FG001|Overall Study|Other Than Specified|1|||
157145292|NCT02089737|567279684|FG000|Overall Study|Survey form not completed|5|||
157145293|NCT02089737|567279684|FG000|Overall Study|Not treated|1|||
157145294|NCT01123889|567279685|FG000|Overall Study|Lost to Follow-up|3|||
157145295|NCT01123889|567279686|FG001|Overall Study|Lost to Follow-up|1|||
157145296|NCT01494038|567279687|FG000|Overall Study|Protocol Violation|1|||
157145297|NCT01494038|567279688|FG001|Overall Study|Protocol Violation|1|||
157145298|NCT01494038|567279687|FG000|Overall Study|Lost to Follow-up|18|||
157145299|NCT01494038|567279688|FG001|Overall Study|Lost to Follow-up|20|||
157145300|NCT01494038|567279687|FG000|Overall Study|Withdrawal by Subject|44|||
157145301|NCT01494038|567279688|FG001|Overall Study|Withdrawal by Subject|34|||
157145302|NCT01494038|567279687|FG000|Overall Study|Not able to get to clinic|21|||
157145303|NCT01494038|567279688|FG001|Overall Study|Not able to get to clinic|15|||
157145304|NCT01494038|567279687|FG000|Overall Study|Not willing to adhere to reqs|2|||
157145305|NCT01494038|567279688|FG001|Overall Study|Not willing to adhere to reqs|9|||
157145306|NCT01494038|567279687|FG000|Overall Study|Death|2|||
157145307|NCT01494038|567279688|FG001|Overall Study|Death|4|||
157145308|NCT00685178|567279693|FG000|Overall Study|Adverse Event|1|||
157145309|NCT00685178|567279694|FG001|Overall Study|Adverse Event|5|||
156883188|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
157021912|NCT05369403|566832997|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
157145310|NCT00685178|567279695|FG002|Overall Study|Adverse Event|2|||
157145311|NCT00685178|567279696|FG003|Overall Study|Adverse Event|4|||
157145312|NCT00685178|567279693|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
157145313|NCT00685178|567279694|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
157145314|NCT00685178|567279695|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
157145315|NCT00685178|567279696|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
157145316|NCT00685178|567279693|FG000|Overall Study|voluntary study discharge|4|||
157145317|NCT00685178|567279694|FG001|Overall Study|voluntary study discharge|5|||
157145318|NCT00685178|567279695|FG002|Overall Study|voluntary study discharge|1|||
157145319|NCT00685178|567279696|FG003|Overall Study|voluntary study discharge|1|||
157145320|NCT00685178|567279693|FG000|Overall Study|incarcerated|1|||
157145321|NCT00685178|567279694|FG001|Overall Study|incarcerated|3|||
157222196|NCT00358826|567560172|FG005|MDCT Substudy|Lost to Follow-up|1|||
157145322|NCT00685178|567279695|FG002|Overall Study|incarcerated|7|||
157145323|NCT00685178|567279696|FG003|Overall Study|incarcerated|0|||
157145324|NCT00685178|567279693|FG000|Overall Study|administrative (disciplinary) discharge|0|||
157145325|NCT00685178|567279694|FG001|Overall Study|administrative (disciplinary) discharge|1|||
157145326|NCT00685178|567279695|FG002|Overall Study|administrative (disciplinary) discharge|0|||
157145327|NCT00685178|567279696|FG003|Overall Study|administrative (disciplinary) discharge|2|||
157145328|NCT00685178|567279693|FG000|Overall Study|Pregnancy|0|||
157145329|NCT00685178|567279694|FG001|Overall Study|Pregnancy|0|||
157145330|NCT00685178|567279695|FG002|Overall Study|Pregnancy|0|||
157145331|NCT00685178|567279696|FG003|Overall Study|Pregnancy|1|||
157145332|NCT00077623|567279704|FG000|Overall Study|Adverse Event|1|||
157145333|NCT00077623|567279705|FG001|Overall Study|Adverse Event|0|||
157145334|NCT00077623|567279706|FG002|Overall Study|Adverse Event|1|||
157145335|NCT00077623|567279704|FG000|Overall Study|Withdrawal by Subject|2|||
157145336|NCT00077623|567279705|FG001|Overall Study|Withdrawal by Subject|10|||
157145337|NCT00077623|567279706|FG002|Overall Study|Withdrawal by Subject|1|||
157145338|NCT00077623|567279704|FG000|Overall Study|Other-Non safety reason|18|||
157145339|NCT00077623|567279705|FG001|Overall Study|Other-Non safety reason|15|||
157145340|NCT00077623|567279706|FG002|Overall Study|Other-Non safety reason|19|||
157145341|NCT00077623|567279704|FG000|Overall Study|Insufficient therapeutic response|2|||
157145342|NCT00077623|567279705|FG001|Overall Study|Insufficient therapeutic response|0|||
157145343|NCT00077623|567279706|FG002|Overall Study|Insufficient therapeutic response|0|||
157145344|NCT00077623|567279704|FG000|Overall Study|Death|12|||
157145345|NCT00077623|567279705|FG001|Overall Study|Death|18|||
157145346|NCT00077623|567279706|FG002|Overall Study|Death|11|||
157145347|NCT00077623|567279704|FG000|Overall Study|Failure to return|1|||
157145348|NCT00077623|567279705|FG001|Overall Study|Failure to return|0|||
157145349|NCT00077623|567279706|FG002|Overall Study|Failure to return|0|||
157145350|NCT01334125|567279707|FG000|Overall Study|Lost to Follow-up|3|||
157145351|NCT01334125|567279708|FG001|Overall Study|Lost to Follow-up|3|||
157145352|NCT02138110|567279711|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
157145353|NCT02138110|567279711|FG000|Overall Scaffold Implantation|Death|3|||
157145354|NCT00882713|567279712|FG000|Overall Study|Adverse Event|2|||
157145355|NCT00882713|567279712|FG000|Overall Study|Death|3|||
157145356|NCT00882713|567279712|FG000|Overall Study|Administrative reasons|4|||
157145357|NCT00882713|567279712|FG000|Overall Study|refused treatment/withdrew consent|4|||
157145358|NCT00882713|567279712|FG000|Overall Study|Blood transfusion|2|||
157145359|NCT00882713|567279712|FG000|Overall Study|Insufficient therapeutic response|3|||
157145360|NCT00882713|567279712|FG000|Overall Study|Failure to return|2|||
157145361|NCT00882713|567279712|FG000|Overall Study|Other - Reasons|2|||
157145362|NCT00401973|567279715|FG000|Overall Study|Adverse Event|2|||
157145363|NCT00401973|567279716|FG001|Overall Study|Adverse Event|8|||
157145364|NCT00401973|567279717|FG002|Overall Study|Adverse Event|4|||
157145365|NCT00401973|567279715|FG000|Overall Study|Clinical Relapse|0|||
157145366|NCT00401973|567279716|FG001|Overall Study|Clinical Relapse|1|||
157145367|NCT00401973|567279717|FG002|Overall Study|Clinical Relapse|1|||
157145368|NCT00401973|567279715|FG000|Overall Study|Lack of Efficacy|0|||
157145369|NCT00401973|567279716|FG001|Overall Study|Lack of Efficacy|0|||
157145370|NCT00401973|567279717|FG002|Overall Study|Lack of Efficacy|3|||
157145371|NCT00401973|567279715|FG000|Overall Study|Lost to Follow-up|2|||
157145372|NCT00401973|567279716|FG001|Overall Study|Lost to Follow-up|2|||
157145373|NCT00401973|567279717|FG002|Overall Study|Lost to Follow-up|2|||
157145374|NCT00401973|567279715|FG000|Overall Study|Physician Decision|2|||
157145375|NCT00401973|567279716|FG001|Overall Study|Physician Decision|0|||
157145376|NCT00401973|567279717|FG002|Overall Study|Physician Decision|1|||
157145377|NCT00401973|567279715|FG000|Overall Study|Protocol Violation|1|||
157145378|NCT00401973|567279716|FG001|Overall Study|Protocol Violation|2|||
157145379|NCT00401973|567279717|FG002|Overall Study|Protocol Violation|3|||
157145380|NCT00401973|567279715|FG000|Overall Study|Sponsor Decision|0|||
157145381|NCT00401973|567279716|FG001|Overall Study|Sponsor Decision|1|||
157145382|NCT00401973|567279717|FG002|Overall Study|Sponsor Decision|0|||
157145383|NCT00401973|567279715|FG000|Overall Study|Withdrawal by Subject|4|||
157145384|NCT00401973|567279716|FG001|Overall Study|Withdrawal by Subject|12|||
157145385|NCT00401973|567279717|FG002|Overall Study|Withdrawal by Subject|9|||
157145386|NCT01335971|567279727|FG000|Overall Study|Withdrawal by Subject|1|||
157145387|NCT01335971|567279728|FG001|Overall Study|Withdrawal by Subject|0|||
157145388|NCT01335971|567279729|FG002|Overall Study|Withdrawal by Subject|0|||
157145389|NCT01335971|567279727|FG000|Overall Study|Did not complete bronchoscopy|1|||
157145390|NCT01335971|567279728|FG001|Overall Study|Did not complete bronchoscopy|1|||
157145391|NCT01335971|567279729|FG002|Overall Study|Did not complete bronchoscopy|1|||
157145392|NCT05299892|567279730|FG000|Overall Study|Withdrawal by Subject|2|||
157145393|NCT00149214|567279731|FG000|Overall Study|Adverse Event|12|||
157145394|NCT00149214|567279732|FG001|Overall Study|Adverse Event|9|||
157145395|NCT00149214|567279731|FG000|Overall Study|Withdrawal by Subject|4|||
157145396|NCT00149214|567279732|FG001|Overall Study|Withdrawal by Subject|1|||
157145397|NCT00149214|567279731|FG000|Overall Study|Physician Decision|3|||
157145398|NCT00149214|567279732|FG001|Overall Study|Physician Decision|3|||
156809010|NCT02389465|566054557|FG001|Overall Study|Withdrawal by Subject|1|||
156809011|NCT02389465|566054558|FG002|Overall Study|Withdrawal by Subject|2|||
156809012|NCT02389465|566054559|FG003|Overall Study|Withdrawal by Subject|2|||
156809013|NCT04339413|566054562|FG000|Overall Study|Reason Not Specified|2|||
156809014|NCT04339413|566054563|FG001|Overall Study|Reason Not Specified|7|||
156809015|NCT04339413|566054562|FG000|Overall Study|Study Terminated by Sponsor|30|||
156809016|NCT04339413|566054563|FG001|Overall Study|Study Terminated by Sponsor|33|||
156809017|NCT04339413|566054562|FG000|Overall Study|Progressive Disease|9|||
156809018|NCT04339413|566054563|FG001|Overall Study|Progressive Disease|6|||
156809019|NCT04339413|566054562|FG000|Overall Study|Withdrawal by Subject|9|||
156809020|NCT04339413|566054563|FG001|Overall Study|Withdrawal by Subject|10|||
156809021|NCT04339413|566054562|FG000|Overall Study|Physician Decision|3|||
156809022|NCT04339413|566054563|FG001|Overall Study|Physician Decision|1|||
156809023|NCT04339413|566054562|FG000|Overall Study|Death|2|||
156809024|NCT04339413|566054563|FG001|Overall Study|Death|0|||
156809025|NCT04339413|566054562|FG000|Overall Study|Adverse Event|3|||
156809026|NCT04339413|566054563|FG001|Overall Study|Adverse Event|0|||
156809027|NCT02012218|566054564|FG000|Overall Study|Withdrawal by Subject|1|||
156809028|NCT02012218|566054565|FG001|Overall Study|Withdrawal by Subject|0|||
156809029|NCT02012218|566054566|FG002|Overall Study|Withdrawal by Subject|1|||
156809030|NCT02012218|566054567|FG003|Overall Study|Withdrawal by Subject|1|||
156809031|NCT02012218|566054568|FG004|Overall Study|Withdrawal by Subject|1|||
156809032|NCT02012218|566054564|FG000|Overall Study|Adverse Event|1|||
156809033|NCT02012218|566054565|FG001|Overall Study|Adverse Event|0|||
156809034|NCT02012218|566054566|FG002|Overall Study|Adverse Event|0|||
156809035|NCT02012218|566054567|FG003|Overall Study|Adverse Event|1|||
156809036|NCT02012218|566054568|FG004|Overall Study|Adverse Event|0|||
156809037|NCT02012218|566054564|FG000|Overall Study|Lost to Follow-up|0|||
156809038|NCT02012218|566054565|FG001|Overall Study|Lost to Follow-up|1|||
156809039|NCT02012218|566054566|FG002|Overall Study|Lost to Follow-up|1|||
156809040|NCT02012218|566054567|FG003|Overall Study|Lost to Follow-up|0|||
156809041|NCT02012218|566054568|FG004|Overall Study|Lost to Follow-up|0|||
157145399|NCT00149214|567279731|FG000|Overall Study|Sponsor Decision|0|||
157145400|NCT00149214|567279732|FG001|Overall Study|Sponsor Decision|1|||
157145401|NCT00149214|567279731|FG000|Overall Study|Progressive Disease|7|||
157145402|NCT00149214|567279732|FG001|Overall Study|Progressive Disease|3|||
157145403|NCT01272180|567279733|FG000|Overall Study|Adverse Event|0|||
157145404|NCT01272180|567279734|FG001|Overall Study|Adverse Event|0|||
157145405|NCT01272180|567279735|FG002|Overall Study|Adverse Event|1|||
157145406|NCT01272180|567279736|FG003|Overall Study|Adverse Event|0|||
157145407|NCT01272180|567279733|FG000|Overall Study|Withdrawal by Subject|2|||
157145408|NCT01272180|567279734|FG001|Overall Study|Withdrawal by Subject|6|||
157145409|NCT01272180|567279735|FG002|Overall Study|Withdrawal by Subject|3|||
157145410|NCT01272180|567279736|FG003|Overall Study|Withdrawal by Subject|2|||
157145411|NCT01272180|567279733|FG000|Overall Study|Lost to Follow-up|15|||
157145412|NCT01272180|567279734|FG001|Overall Study|Lost to Follow-up|14|||
157145413|NCT01272180|567279735|FG002|Overall Study|Lost to Follow-up|8|||
157145414|NCT01272180|567279736|FG003|Overall Study|Lost to Follow-up|10|||
157145415|NCT01272180|567279733|FG000|Overall Study|Inappropriate enrollment|0|||
157145416|NCT01272180|567279734|FG001|Overall Study|Inappropriate enrollment|0|||
157145417|NCT01272180|567279735|FG002|Overall Study|Inappropriate enrollment|1|||
157145418|NCT01272180|567279736|FG003|Overall Study|Inappropriate enrollment|1|||
157145419|NCT01272180|567279733|FG000|Overall Study|Protocol Violation|0|||
157145420|NCT01272180|567279734|FG001|Overall Study|Protocol Violation|1|||
157145421|NCT01272180|567279735|FG002|Overall Study|Protocol Violation|0|||
157145422|NCT01272180|567279736|FG003|Overall Study|Protocol Violation|1|||
157145423|NCT03351244|567279737|FG000|Overall Study|Adverse Event|7|||
157145424|NCT03351244|567279738|FG001|Overall Study|Adverse Event|11|||
157145425|NCT03351244|567279739|FG002|Overall Study|Adverse Event|12|||
157145426|NCT03351244|567279737|FG000|Overall Study|Investigator's decision|0|||
157145427|NCT03351244|567279738|FG001|Overall Study|Investigator's decision|0|||
157145428|NCT03351244|567279739|FG002|Overall Study|Investigator's decision|2|||
157145429|NCT03351244|567279737|FG000|Overall Study|System error|0|||
157145430|NCT03351244|567279738|FG001|Overall Study|System error|0|||
157145431|NCT03351244|567279739|FG002|Overall Study|System error|2|||
157145432|NCT03351244|567279737|FG000|Overall Study|COVID-19 restrictions|3|||
157145433|NCT03351244|567279738|FG001|Overall Study|COVID-19 restrictions|0|||
157145434|NCT03351244|567279739|FG002|Overall Study|COVID-19 restrictions|1|||
156809042|NCT02012218|566054564|FG000|Overall Study|Protocol Specified|1|||
156883189|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
157145435|NCT03351244|567279737|FG000|Overall Study|Non-compliance|2|||
157222197|NCT00358826|567560173|FG006|MDCT Substudy|Lost to Follow-up|0|||
156809043|NCT02012218|566054565|FG001|Overall Study|Protocol Specified|0|||
156809044|NCT02012218|566054566|FG002|Overall Study|Protocol Specified|0|||
156809045|NCT02012218|566054567|FG003|Overall Study|Protocol Specified|0|||
157145436|NCT03351244|567279738|FG001|Overall Study|Non-compliance|5|||
157145437|NCT03351244|567279739|FG002|Overall Study|Non-compliance|0|||
157145438|NCT03351244|567279737|FG000|Overall Study|Withdrawal by Subject|11|||
157145439|NCT03351244|567279738|FG001|Overall Study|Withdrawal by Subject|16|||
157145440|NCT03351244|567279739|FG002|Overall Study|Withdrawal by Subject|13|||
157145441|NCT03351244|567279737|FG000|Overall Study|Lost to Follow-up|2|||
157145442|NCT03351244|567279738|FG001|Overall Study|Lost to Follow-up|6|||
156809046|NCT02012218|566054568|FG004|Overall Study|Protocol Specified|0|||
156809047|NCT02012218|566054564|FG000|Overall Study|Protocol Deviation|1|||
156809048|NCT02012218|566054565|FG001|Overall Study|Protocol Deviation|0|||
156809049|NCT02012218|566054566|FG002|Overall Study|Protocol Deviation|0|||
157021913|NCT05369403|566832998|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
157145443|NCT03351244|567279739|FG002|Overall Study|Lost to Follow-up|4|||
157145444|NCT03351244|567279737|FG000|Overall Study|Protocol Violation|2|||
157145445|NCT03351244|567279738|FG001|Overall Study|Protocol Violation|2|||
157145446|NCT03351244|567279739|FG002|Overall Study|Protocol Violation|0|||
157145447|NCT02424149|567279749|FG000|Overall Study|surgery cancelled|2|||
157145448|NCT02424149|567279750|FG001|Overall Study|surgery cancelled|0|||
157145449|NCT02424149|567279749|FG000|Overall Study|Withdrawal by Subject|0|||
157145450|NCT02424149|567279750|FG001|Overall Study|Withdrawal by Subject|1|||
157145451|NCT01025336|567279751|FG000|Overall Study|Protocol Violation|0|||
157145452|NCT01025336|567279752|FG001|Overall Study|Protocol Violation|0|||
157145453|NCT01025336|567279753|FG002|Overall Study|Protocol Violation|0|||
157145454|NCT01025336|567279754|FG003|Overall Study|Protocol Violation|2|||
157145455|NCT01025336|567279755|FG004|Overall Study|Protocol Violation|0|||
157145456|NCT03794986|567279756|FG000|Overall Study|0 Sessions Attended|34|||
157145457|NCT03794986|567279757|FG001|Overall Study|0 Sessions Attended|37|||
157145458|NCT03794986|567279756|FG000|Overall Study|Withdrawal by Subject|4|||
157145459|NCT03794986|567279757|FG001|Overall Study|Withdrawal by Subject|6|||
157145460|NCT03794986|567279756|FG000|Overall Study|Protocol Violation|1|||
157145461|NCT03794986|567279757|FG001|Overall Study|Protocol Violation|0|||
157145462|NCT00474253|567279760|FG000|Overall Study|Withdrew consent|2|||
157145463|NCT00474253|567279761|FG001|Overall Study|Withdrew consent|0|||
157145464|NCT00474253|567279760|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
157145465|NCT00474253|567279761|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
157145466|NCT00474253|567279760|FG000|Overall Study|Lost to Follow-up|1|||
157145467|NCT00474253|567279761|FG001|Overall Study|Lost to Follow-up|0|||
157145468|NCT00474253|567279760|FG000|Overall Study|Discharged prior to study completion|0|||
157145469|NCT00474253|567279761|FG001|Overall Study|Discharged prior to study completion|1|||
157145470|NCT01165229|567279762|FG000|Overall Study|Serious Adverse Event|456|||
157145471|NCT01165229|567279763|FG001|Overall Study|Serious Adverse Event|487|||
157145472|NCT01165229|567279762|FG000|Overall Study|Non-Serious Adverse Event|47|||
157145473|NCT01165229|567279763|FG001|Overall Study|Non-Serious Adverse Event|15|||
157145474|NCT01165229|567279762|FG000|Overall Study|Protocol Violation|6|||
157145475|NCT01165229|567279763|FG001|Overall Study|Protocol Violation|8|||
157145476|NCT01165229|567279762|FG000|Overall Study|Withdrawal by Subject|387|||
157145477|NCT01165229|567279763|FG001|Overall Study|Withdrawal by Subject|396|||
157145478|NCT01165229|567279762|FG000|Overall Study|Migrated/moved from study area|51|||
157145479|NCT01165229|567279763|FG001|Overall Study|Migrated/moved from study area|46|||
157145480|NCT01165229|567279762|FG000|Overall Study|Lost to Follow-up|123|||
157145481|NCT01165229|567279763|FG001|Overall Study|Lost to Follow-up|133|||
157145482|NCT01165229|567279762|FG000|Overall Study|Suspected HZ Episode|2|||
157145483|NCT01165229|567279763|FG001|Overall Study|Suspected HZ Episode|2|||
157145484|NCT01165229|567279762|FG000|Overall Study|No reason from the subject|108|||
157145485|NCT01165229|567279763|FG001|Overall Study|No reason from the subject|102|||
157145486|NCT01165229|567279762|FG000|Overall Study|Unknown completion status|0|||
157145487|NCT01165229|567279763|FG001|Overall Study|Unknown completion status|1|||
157145488|NCT02723630|567279771|FG000|Intervention Period 1|Adverse Event|1|||
157145489|NCT02723630|567279772|FG001|Intervention Period 1|Adverse Event|0|||
157145490|NCT02723630|567279773|FG002|Intervention Period 1|Adverse Event|0|||
157145491|NCT02723630|567279774|FG003|Intervention Period 1|Adverse Event|0|||
156809050|NCT02012218|566054567|FG003|Overall Study|Protocol Deviation|0|||
157021914|NCT05369403|566832999|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
157021915|NCT05369403|566832997|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
157021916|NCT05369403|566832998|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
157021917|NCT05369403|566832999|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
157021918|NCT03792256|566833004|FG000|Overall Study|Death|0|||
157021919|NCT03792256|566833005|FG001|Overall Study|Death|1|||
157021920|NCT03792256|566833004|FG000|Overall Study|Lack of Efficacy|0|||
157021921|NCT03792256|566833005|FG001|Overall Study|Lack of Efficacy|1|||
157021922|NCT03792256|566833004|FG000|Overall Study|Withdrawal by Subject|0|||
157021923|NCT03792256|566833005|FG001|Overall Study|Withdrawal by Subject|1|||
157021924|NCT04760678|566833010|FG000|Overall Study|Death|13|||
157021925|NCT04760678|566833010|FG000|Overall Study|Lost to Follow-up|48|||
157145492|NCT02723630|567279775|FG004|Intervention Period 1|Adverse Event|0|||
157145493|NCT02723630|567279776|FG005|Intervention Period 1|Adverse Event|0|||
157145494|NCT02723630|567279771|FG000|Intervention Period 3|consumption of restricted item|0|||
157145495|NCT02723630|567279772|FG001|Intervention Period 3|consumption of restricted item|1|||
157145496|NCT02723630|567279773|FG002|Intervention Period 3|consumption of restricted item|0|||
157145497|NCT02723630|567279774|FG003|Intervention Period 3|consumption of restricted item|0|||
157021926|NCT04760678|566833010|FG000|Overall Study|Withdrawal by Subject|1|||
157021927|NCT05368103|566833016|FG000|Overall Study|Withdrawal by Subject|4|||
157021928|NCT05368103|566833016|FG000|Overall Study|Lost to Follow-up|1|||
157021929|NCT05368103|566833016|FG000|Overall Study|Lack of Efficacy|3|||
157021930|NCT03675282|566833019|FG000|Overall Study|Lost to Follow-up|4|||
157021931|NCT03675282|566833020|FG001|Overall Study|Lost to Follow-up|8|||
157021932|NCT03675282|566833021|FG002|Overall Study|Lost to Follow-up|1|||
157021933|NCT03675282|566833022|FG003|Overall Study|Lost to Follow-up|0|||
157021934|NCT03675282|566833023|FG004|Overall Study|Lost to Follow-up|2|||
157021935|NCT03675282|566833024|FG005|Overall Study|Lost to Follow-up|7|||
157021936|NCT03675282|566833019|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
157021937|NCT03675282|566833020|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
157021938|NCT03675282|566833021|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
157021939|NCT03675282|566833022|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
157021940|NCT03675282|566833023|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
157021941|NCT03675282|566833024|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
157021942|NCT03675282|566833019|FG000|Overall Study|Physician Decision|1|||
157021943|NCT03675282|566833020|FG001|Overall Study|Physician Decision|0|||
157021944|NCT03675282|566833021|FG002|Overall Study|Physician Decision|0|||
157021945|NCT03675282|566833022|FG003|Overall Study|Physician Decision|0|||
157021946|NCT03675282|566833023|FG004|Overall Study|Physician Decision|0|||
157021947|NCT03675282|566833024|FG005|Overall Study|Physician Decision|0|||
157021948|NCT05784662|566833025|FG000|Overall Study|Lost to Follow-up|21|||
157021949|NCT05784662|566833026|FG001|Overall Study|Lost to Follow-up|17|||
157021950|NCT03232138|566833027|FG000|Overall Study|Physician Decision|1|||
157021951|NCT03232138|566833028|FG001|Overall Study|Physician Decision|0|||
157021952|NCT03232138|566833027|FG000|Overall Study|Adverse Event|2|||
157021953|NCT03232138|566833028|FG001|Overall Study|Adverse Event|0|||
157021954|NCT03232138|566833027|FG000|Overall Study|Withdrawal by Subject|1|||
157021955|NCT03232138|566833028|FG001|Overall Study|Withdrawal by Subject|2|||
157021956|NCT03920111|566833029|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
157021957|NCT03920111|566833030|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
157021958|NCT03920111|566833031|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
157021959|NCT01997840|566833035|FG000|Overall Study|Lost to Follow-up|0|||
157021960|NCT01997840|566833036|FG001|Overall Study|Lost to Follow-up|0|||
157021961|NCT01997840|566833037|FG002|Overall Study|Lost to Follow-up|1|||
157021962|NCT01997840|566833038|FG003|Overall Study|Lost to Follow-up|0|||
157021963|NCT01997840|566833035|FG000|Overall Study|Withdrawal by participant|0|||
157021964|NCT01997840|566833036|FG001|Overall Study|Withdrawal by participant|0|||
157021965|NCT01997840|566833037|FG002|Overall Study|Withdrawal by participant|8|||
157021966|NCT01997840|566833038|FG003|Overall Study|Withdrawal by participant|1|||
157021967|NCT01997840|566833035|FG000|Overall Study|Physician Decision|0|||
157021968|NCT01997840|566833036|FG001|Overall Study|Physician Decision|0|||
157021969|NCT01997840|566833037|FG002|Overall Study|Physician Decision|3|||
157021970|NCT01997840|566833038|FG003|Overall Study|Physician Decision|0|||
157021971|NCT01997840|566833035|FG000|Overall Study|Progressive disease|3|||
157021972|NCT01997840|566833036|FG001|Overall Study|Progressive disease|4|||
157021973|NCT01997840|566833037|FG002|Overall Study|Progressive disease|57|||
157021974|NCT01997840|566833038|FG003|Overall Study|Progressive disease|8|||
157021975|NCT01997840|566833035|FG000|Overall Study|Other reasons|0|||
157021976|NCT01997840|566833036|FG001|Overall Study|Other reasons|0|||
157021977|NCT01997840|566833037|FG002|Overall Study|Other reasons|1|||
157021978|NCT01997840|566833038|FG003|Overall Study|Other reasons|0|||
157021979|NCT01997840|566833035|FG000|Overall Study|Adverse Event|0|||
157021980|NCT01997840|566833036|FG001|Overall Study|Adverse Event|0|||
157021981|NCT01997840|566833037|FG002|Overall Study|Adverse Event|15|||
157021982|NCT01997840|566833038|FG003|Overall Study|Adverse Event|2|||
157021983|NCT03850678|566833041|FG000|Overall Study|Withdrawal by Subject|3|||
157021984|NCT03850678|566833042|FG001|Overall Study|Withdrawal by Subject|0|||
157021985|NCT03850678|566833041|FG000|Overall Study|Experimenter Error|1|||
157021986|NCT03850678|566833042|FG001|Overall Study|Experimenter Error|1|||
157021987|NCT03850678|566833041|FG000|Overall Study|Did Not Condition To Experiment|7|||
157021988|NCT03850678|566833042|FG001|Overall Study|Did Not Condition To Experiment|2|||
157021989|NCT05308004|566833051|FG000|Overall Study|Not seen by Palliative Care NP|0|||
157021990|NCT05308004|566833052|FG001|Overall Study|Not seen by Palliative Care NP|1|||
157021991|NCT03719443|566833054|FG000|Overall Study|Lost to Follow-up|0|||
157021992|NCT03719443|566833055|FG001|Overall Study|Lost to Follow-up|0|||
157021993|NCT03719443|566833056|FG002|Overall Study|Lost to Follow-up|1|||
157021994|NCT03719443|566833057|FG003|Overall Study|Lost to Follow-up|0|||
157021995|NCT03719443|566833058|FG004|Overall Study|Lost to Follow-up|1|||
157021996|NCT03719443|566833059|FG005|Overall Study|Lost to Follow-up|0|||
157021997|NCT03719443|566833060|FG006|Overall Study|Lost to Follow-up|1|||
157021998|NCT03719443|566833054|FG000|Overall Study|Withdrawal by Subject|0|||
157021999|NCT03719443|566833055|FG001|Overall Study|Withdrawal by Subject|0|||
157022000|NCT03719443|566833056|FG002|Overall Study|Withdrawal by Subject|1|||
157145498|NCT02723630|567279775|FG004|Intervention Period 3|consumption of restricted item|0|||
157145499|NCT02723630|567279776|FG005|Intervention Period 3|consumption of restricted item|0|||
157145500|NCT00852930|567279777|FG000|Overall Study|Withdrawal by Subject|1|||
156809051|NCT02012218|566054568|FG004|Overall Study|Protocol Deviation|0|||
156809052|NCT04417257|566054569|FG000|Pilot Phase 2|Adverse Event|2|||
156809053|NCT04417257|566054570|FG001|Pilot Phase 2|Adverse Event|0|||
156809054|NCT04417257|566054569|FG000|Pilot Phase 2|Death|14|||
156809055|NCT04417257|566054570|FG001|Pilot Phase 2|Death|11|||
156809056|NCT04417257|566054569|FG000|Pilot Phase 2|Lost to Follow-up|3|||
156809057|NCT04417257|566054570|FG001|Pilot Phase 2|Lost to Follow-up|5|||
156809058|NCT04417257|566054569|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
156809059|NCT04417257|566054570|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
156809060|NCT04417257|566054569|FG000|Pilot Phase 2|Hepatic impairment|1|||
156809061|NCT04417257|566054570|FG001|Pilot Phase 2|Hepatic impairment|0|||
157145501|NCT00852930|567279778|FG001|Overall Study|Withdrawal by Subject|1|||
157145502|NCT00852930|567279779|FG002|Overall Study|Withdrawal by Subject|1|||
157145503|NCT00852930|567279777|FG000|Overall Study|Physician Decision|0|||
157145504|NCT00852930|567279778|FG001|Overall Study|Physician Decision|0|||
157145505|NCT00852930|567279779|FG002|Overall Study|Physician Decision|1|||
157145506|NCT00537745|567279782|FG000|Overall Study|Did not meet eligibility criteria|2|||
157145507|NCT00537745|567279782|FG000|Overall Study|Withdrawal by Subject|2|||
157145508|NCT00537745|567279782|FG000|Overall Study|Subject unable to provide Interlock info|1|||
157145509|NCT01512368|567279783|FG000|Overall Study|Protocol Violation|3|||
157145510|NCT01570491|567279784|FG000|Overall Study|Lost to Follow-up|3|||
157145511|NCT01570491|567279785|FG001|Overall Study|Lost to Follow-up|1|||
157145512|NCT01570491|567279784|FG000|Overall Study|treatment: not given or discontinued|2|||
157145513|NCT01570491|567279785|FG001|Overall Study|treatment: not given or discontinued|0|||
157145514|NCT03700892|567279789|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
157145515|NCT03700892|567279790|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
157145516|NCT03700892|567279791|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
157145517|NCT01319929|567279792|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
157145518|NCT01319929|567279793|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
157145519|NCT01319929|567279792|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
157145520|NCT01319929|567279793|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
157145521|NCT01319929|567279792|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
157145522|NCT01319929|567279793|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
157145523|NCT01319929|567279792|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
157145524|NCT01319929|567279793|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
157145525|NCT01319929|567279792|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
157145526|NCT01319929|567279793|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
157145527|NCT01221233|567279794|FG000|Overall Study|Withdrawal by Subject|3|||
157145528|NCT01221233|567279795|FG001|Overall Study|Withdrawal by Subject|1|||
157145529|NCT02117050|567279798|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
157145530|NCT00754390|567279800|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
157145531|NCT00754390|567279800|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
157145532|NCT00754390|567279800|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
157145533|NCT00754390|567279800|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
157145534|NCT00847613|567279801|FG000|Overall Study|Ongoing at cut-off date|250|||
157145535|NCT00847613|567279802|FG001|Overall Study|Ongoing at cut-off date|265|||
157145536|NCT00847613|567279803|FG002|Overall Study|Ongoing at cut-off date|64|||
157145537|NCT00847613|567279804|FG003|Overall Study|Ongoing at cut-off date|64|||
157145538|NCT00847613|567279801|FG000|Overall Study|Death|1|||
157145539|NCT00847613|567279802|FG001|Overall Study|Death|1|||
157145540|NCT00847613|567279803|FG002|Overall Study|Death|0|||
157145541|NCT00847613|567279804|FG003|Overall Study|Death|0|||
157145542|NCT00847613|567279801|FG000|Overall Study|Adverse Event|36|||
157145543|NCT00847613|567279802|FG001|Overall Study|Adverse Event|26|||
157145544|NCT00847613|567279803|FG002|Overall Study|Adverse Event|5|||
157145545|NCT00847613|567279804|FG003|Overall Study|Adverse Event|6|||
157145546|NCT00847613|567279801|FG000|Overall Study|Lack of Efficacy|7|||
157145547|NCT00847613|567279802|FG001|Overall Study|Lack of Efficacy|3|||
157145548|NCT00847613|567279803|FG002|Overall Study|Lack of Efficacy|3|||
157145549|NCT00847613|567279804|FG003|Overall Study|Lack of Efficacy|1|||
157145550|NCT00847613|567279801|FG000|Overall Study|Study terminated by Sponsor|1|||
157145551|NCT00847613|567279802|FG001|Overall Study|Study terminated by Sponsor|0|||
157145552|NCT00847613|567279803|FG002|Overall Study|Study terminated by Sponsor|2|||
157145553|NCT00847613|567279804|FG003|Overall Study|Study terminated by Sponsor|1|||
157145554|NCT00847613|567279801|FG000|Overall Study|Lost to Follow-up|5|||
157145555|NCT00847613|567279802|FG001|Overall Study|Lost to Follow-up|0|||
156809062|NCT04417257|566054569|FG000|Pilot Phase 2|Unblinding|1|||
156809063|NCT04417257|566054570|FG001|Pilot Phase 2|Unblinding|0|||
156809064|NCT04417257|566054569|FG000|Pilot Phase 2|All other|0|||
156809065|NCT04417257|566054570|FG001|Pilot Phase 2|All other|2|||
156809066|NCT04417257|566054569|FG000|Phase 3 Extension|Death|3|||
156809067|NCT04417257|566054570|FG001|Phase 3 Extension|Death|1|||
157145556|NCT00847613|567279803|FG002|Overall Study|Lost to Follow-up|0|||
157145557|NCT00847613|567279804|FG003|Overall Study|Lost to Follow-up|3|||
157022001|NCT03719443|566833057|FG003|Overall Study|Withdrawal by Subject|0|||
157022002|NCT03719443|566833058|FG004|Overall Study|Withdrawal by Subject|0|||
157022003|NCT03719443|566833059|FG005|Overall Study|Withdrawal by Subject|0|||
157022004|NCT03719443|566833060|FG006|Overall Study|Withdrawal by Subject|0|||
157022005|NCT00554788|566833061|FG000|Overall Study|Adverse Event|0|||
157022006|NCT00554788|566833062|FG001|Overall Study|Adverse Event|1|||
157022007|NCT00554788|566833063|FG002|Overall Study|Adverse Event|2|||
157022008|NCT00554788|566833061|FG000|Overall Study|Lost to Follow-up|4|||
157022009|NCT00554788|566833062|FG001|Overall Study|Lost to Follow-up|3|||
157022010|NCT00554788|566833063|FG002|Overall Study|Lost to Follow-up|3|||
157022011|NCT00554788|566833061|FG000|Overall Study|Physician Decision|1|||
157022012|NCT00554788|566833062|FG001|Overall Study|Physician Decision|1|||
157022013|NCT00554788|566833063|FG002|Overall Study|Physician Decision|3|||
157022014|NCT00554788|566833061|FG000|Overall Study|Withdrawal by Subject|0|||
157022015|NCT00554788|566833062|FG001|Overall Study|Withdrawal by Subject|0|||
157022016|NCT00554788|566833063|FG002|Overall Study|Withdrawal by Subject|1|||
157022017|NCT00554788|566833061|FG000|Overall Study|Refusal of further protocol therapy|0|||
157022018|NCT00554788|566833062|FG001|Overall Study|Refusal of further protocol therapy|1|||
157022019|NCT00554788|566833063|FG002|Overall Study|Refusal of further protocol therapy|1|||
157022020|NCT00554788|566833061|FG000|Overall Study|Progressive disease|0|||
157022021|NCT00554788|566833062|FG001|Overall Study|Progressive disease|0|||
157022022|NCT00554788|566833063|FG002|Overall Study|Progressive disease|3|||
157022023|NCT00554788|566833061|FG000|Overall Study|Ineligible|2|||
157022024|NCT00554788|566833062|FG001|Overall Study|Ineligible|0|||
157022025|NCT00554788|566833063|FG002|Overall Study|Ineligible|1|||
157022026|NCT03197662|566833074|FG000|Overall Study|Withdrawn by family|0|||
157022027|NCT03197662|566833075|FG001|Overall Study|Withdrawn by family|2|||
157022028|NCT03721952|566833076|FG000|Overall Study|Lost to Follow-up|0|||
157022029|NCT03721952|566833077|FG001|Overall Study|Lost to Follow-up|0|||
157022030|NCT03721952|566833078|FG002|Overall Study|Lost to Follow-up|2|||
157022031|NCT03721952|566833079|FG003|Overall Study|Lost to Follow-up|0|||
157022032|NCT03721952|566833080|FG004|Overall Study|Lost to Follow-up|0|||
157022033|NCT03721952|566833076|FG000|Overall Study|Protocol Violation|0|||
157022034|NCT03721952|566833077|FG001|Overall Study|Protocol Violation|1|||
157022035|NCT03721952|566833078|FG002|Overall Study|Protocol Violation|0|||
157022036|NCT03721952|566833079|FG003|Overall Study|Protocol Violation|0|||
157022037|NCT03721952|566833080|FG004|Overall Study|Protocol Violation|0|||
157022038|NCT03721952|566833076|FG000|Overall Study|Withdrawal by Subject|1|||
157022039|NCT03721952|566833077|FG001|Overall Study|Withdrawal by Subject|0|||
157022040|NCT03721952|566833078|FG002|Overall Study|Withdrawal by Subject|40|||
157022041|NCT03721952|566833079|FG003|Overall Study|Withdrawal by Subject|28|||
157022042|NCT03721952|566833080|FG004|Overall Study|Withdrawal by Subject|0|||
157022043|NCT04495894|566833081|FG000|Overall Study|Withdrawal by Subject|2|||
157022044|NCT04495894|566833082|FG001|Overall Study|Withdrawal by Subject|0|||
157022045|NCT04495894|566833083|FG002|Overall Study|Withdrawal by Subject|2|||
157022046|NCT04495894|566833084|FG003|Overall Study|Withdrawal by Subject|3|||
157022047|NCT04495894|566833081|FG000|Overall Study|Early termination|0|||
157022048|NCT04495894|566833082|FG001|Overall Study|Early termination|0|||
157022049|NCT04495894|566833083|FG002|Overall Study|Early termination|3|||
157022050|NCT04495894|566833084|FG003|Overall Study|Early termination|0|||
157022051|NCT03364647|566833085|FG000|Overall Study|Withdrawal by Subject|3|||
157022052|NCT03364647|566833086|FG001|Overall Study|Withdrawal by Subject|1|||
157022053|NCT05746455|566833090|FG000|Overall Study|Discharged from Clinical Service|1|||
157022054|NCT05746455|566833090|FG000|Overall Study|Lost to Follow-up|1|||
157022055|NCT03447470|566833091|FG000|Overall Study|Death|0|||
157022056|NCT03447470|566833092|FG001|Overall Study|Death|1|||
157022057|NCT03447470|566833093|FG002|Overall Study|Death|3|||
157022058|NCT03447470|566833094|FG003|Overall Study|Death|0|||
157022059|NCT03447470|566833095|FG004|Overall Study|Death|1|||
157145558|NCT00847613|567279801|FG000|Overall Study|Protocol Violation|6|||
157022060|NCT03447470|566833096|FG005|Overall Study|Death|0|||
157022061|NCT03447470|566833097|FG006|Overall Study|Death|3|||
157022062|NCT03447470|566833098|FG007|Overall Study|Death|3|||
157022063|NCT03447470|566833099|FG008|Overall Study|Death|1|||
157022064|NCT03447470|566833091|FG000|Overall Study|Withdrawal by Subject|1|||
157022065|NCT03447470|566833092|FG001|Overall Study|Withdrawal by Subject|0|||
157022066|NCT03447470|566833093|FG002|Overall Study|Withdrawal by Subject|0|||
157022067|NCT03447470|566833094|FG003|Overall Study|Withdrawal by Subject|0|||
157022068|NCT03447470|566833095|FG004|Overall Study|Withdrawal by Subject|1|||
157022069|NCT03447470|566833096|FG005|Overall Study|Withdrawal by Subject|0|||
157022070|NCT03447470|566833097|FG006|Overall Study|Withdrawal by Subject|1|||
157022071|NCT03447470|566833098|FG007|Overall Study|Withdrawal by Subject|1|||
157022072|NCT03447470|566833099|FG008|Overall Study|Withdrawal by Subject|3|||
157022073|NCT03447470|566833091|FG000|Overall Study|Treatment discontinued|3|||
157022074|NCT03447470|566833092|FG001|Overall Study|Treatment discontinued|2|||
157022075|NCT03447470|566833093|FG002|Overall Study|Treatment discontinued|4|||
157022076|NCT03447470|566833094|FG003|Overall Study|Treatment discontinued|6|||
157145559|NCT00847613|567279802|FG001|Overall Study|Protocol Violation|6|||
157022077|NCT03447470|566833095|FG004|Overall Study|Treatment discontinued|2|||
156809068|NCT04417257|566054569|FG000|Phase 3 Extension|Lost to Follow-up|4|||
156809069|NCT04417257|566054570|FG001|Phase 3 Extension|Lost to Follow-up|2|||
156809070|NCT04417257|566054569|FG000|Phase 3 Extension|Patient withdrawal|2|||
156809071|NCT04417257|566054570|FG001|Phase 3 Extension|Patient withdrawal|2|||
156809072|NCT04417257|566054569|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
156809073|NCT04417257|566054570|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
157145560|NCT00847613|567279803|FG002|Overall Study|Protocol Violation|3|||
157145561|NCT00847613|567279804|FG003|Overall Study|Protocol Violation|1|||
157145562|NCT00847613|567279801|FG000|Overall Study|Pregnancy|1|||
157145563|NCT00847613|567279802|FG001|Overall Study|Pregnancy|1|||
157145564|NCT00847613|567279803|FG002|Overall Study|Pregnancy|0|||
157145565|NCT00847613|567279804|FG003|Overall Study|Pregnancy|0|||
157145566|NCT00847613|567279801|FG000|Overall Study|Site closure|1|||
157145567|NCT00847613|567279802|FG001|Overall Study|Site closure|0|||
157145568|NCT00847613|567279803|FG002|Overall Study|Site closure|0|||
157145569|NCT00847613|567279804|FG003|Overall Study|Site closure|1|||
157145570|NCT00847613|567279801|FG000|Overall Study|Withdrawal by Subject|8|||
157145571|NCT00847613|567279802|FG001|Overall Study|Withdrawal by Subject|11|||
157145572|NCT00847613|567279803|FG002|Overall Study|Withdrawal by Subject|2|||
157145573|NCT00847613|567279804|FG003|Overall Study|Withdrawal by Subject|2|||
157145574|NCT00847613|567279801|FG000|Overall Study|Participant moved|4|||
157145575|NCT00847613|567279802|FG001|Overall Study|Participant moved|1|||
157145576|NCT00847613|567279803|FG002|Overall Study|Participant moved|0|||
157145577|NCT00847613|567279804|FG003|Overall Study|Participant moved|0|||
157145578|NCT00847613|567279801|FG000|Overall Study|Sponsor request|0|||
157145579|NCT00847613|567279802|FG001|Overall Study|Sponsor request|1|||
157145580|NCT00847613|567279803|FG002|Overall Study|Sponsor request|0|||
157145581|NCT00847613|567279804|FG003|Overall Study|Sponsor request|0|||
157145582|NCT00847613|567279801|FG000|Overall Study|Randomized, but not treated|0|||
157145583|NCT00847613|567279802|FG001|Overall Study|Randomized, but not treated|3|||
157145584|NCT00847613|567279803|FG002|Overall Study|Randomized, but not treated|0|||
157145585|NCT00847613|567279804|FG003|Overall Study|Randomized, but not treated|0|||
157145586|NCT00847613|567279801|FG000|Overall Study|Other|1|||
157145587|NCT00847613|567279802|FG001|Overall Study|Other|1|||
157145588|NCT00847613|567279803|FG002|Overall Study|Other|2|||
157145589|NCT00847613|567279804|FG003|Overall Study|Other|0|||
157145590|NCT00971321|567279805|FG000|Up to Month 7|Withdrawal by Subject|1|||
157145591|NCT00971321|567279806|FG001|Up to Month 7|Withdrawal by Subject|0|||
157145592|NCT00971321|567279805|FG000|Up to Month 7|Migrated/moved from study area|3|||
157145593|NCT00971321|567279806|FG001|Up to Month 7|Migrated/moved from study area|2|||
157145594|NCT00971321|567279805|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
157145595|NCT00971321|567279806|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
157145596|NCT00971321|567279805|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
157145597|NCT00971321|567279806|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
157145598|NCT00971321|567279805|FG000|Up to Month 11-12|Lost to Follow-up|1|||
157145599|NCT00971321|567279806|FG001|Up to Month 11-12|Lost to Follow-up|0|||
157145600|NCT01662999|567279809|FG000|Period 3|Withdrawal by Subject|0|||
157145601|NCT01662999|567279810|FG001|Period 3|Withdrawal by Subject|1|||
157145602|NCT01662999|567279811|FG002|Period 3|Withdrawal by Subject|0|||
157145603|NCT01662999|567279812|FG003|Period 3|Withdrawal by Subject|0|||
157145604|NCT01662999|567279813|FG004|Period 3|Withdrawal by Subject|0|||
157145605|NCT01662999|567279814|FG005|Period 3|Withdrawal by Subject|0|||
157145606|NCT02190591|567279815|FG000|Overall Study|Withdrawal by Subject|1|||
157145607|NCT02190591|567279816|FG001|Overall Study|Withdrawal by Subject|8|||
157145608|NCT02190591|567279815|FG000|Overall Study|Protocol Violation|1|||
157145609|NCT02190591|567279816|FG001|Overall Study|Protocol Violation|0|||
157145610|NCT02190591|567279815|FG000|Overall Study|did not use peanut ball as instructed|0|||
157145611|NCT02190591|567279816|FG001|Overall Study|did not use peanut ball as instructed|2|||
157145612|NCT02190591|567279815|FG000|Overall Study|face presentation so she was ineligible|0|||
157145613|NCT02190591|567279816|FG001|Overall Study|face presentation so she was ineligible|1|||
157145614|NCT01933672|567279819|FG000|Metformin Run-in Period|Adverse Event|1|||
157145615|NCT01933672|567279820|FG001|Metformin Run-in Period|Adverse Event|0|||
157145616|NCT01933672|567279821|FG002|Metformin Run-in Period|Adverse Event|0|||
157145617|NCT01933672|567279822|FG003|Metformin Run-in Period|Adverse Event|0|||
157145618|NCT01933672|567279823|FG004|Metformin Run-in Period|Adverse Event|0|||
157145619|NCT01933672|567279824|FG005|Metformin Run-in Period|Adverse Event|0|||
157145620|NCT01933672|567279825|FG006|Metformin Run-in Period|Adverse Event|0|||
157145621|NCT01933672|567279819|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
156809074|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Death|2|||
156809075|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
156809076|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
157145622|NCT01933672|567279820|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
157145623|NCT01933672|567279821|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
157145624|NCT01933672|567279822|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
157145625|NCT01933672|567279823|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
156809077|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Physician Decision|1|||
156809078|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
156809079|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
156809080|NCT00786422|566054572|FG000|Rivaroxaban Treatment|Adverse Event|2|||
156809081|NCT00786422|566054572|FG000|Follow-up Period|Death|1|||
156809082|NCT00786422|566054572|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
156809083|NCT03484429|566054573|FG000|Overall Study|Withdrawal by Subject|1|||
156809084|NCT03484429|566054574|FG001|Overall Study|Withdrawal by Subject|0|||
156809085|NCT03484429|566054573|FG000|Overall Study|Adverse Event|2|||
156809086|NCT03484429|566054574|FG001|Overall Study|Adverse Event|0|||
156809087|NCT04466384|566054575|FG000|First Phase|Protocol Violation|1|||
156809088|NCT04466384|566054576|FG001|First Phase|Protocol Violation|0|||
156809089|NCT04466384|566054575|FG000|First Phase|Missing data|1|||
156809090|NCT04466384|566054576|FG001|First Phase|Missing data|0|||
156809091|NCT04466384|566054575|FG000|Cross Over Phase|Physician Decision|1|||
156809092|NCT04466384|566054576|FG001|Cross Over Phase|Physician Decision|0|||
156809093|NCT04466384|566054575|FG000|Cross Over Phase|Withdrawal by Subject|0|||
156809094|NCT04466384|566054576|FG001|Cross Over Phase|Withdrawal by Subject|1|||
156883190|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156883191|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156883192|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156883193|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
156883194|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
156883195|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
156883196|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
156883197|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156883198|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156883199|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
157022078|NCT03447470|566833096|FG005|Overall Study|Treatment discontinued|1|||
157022079|NCT03447470|566833097|FG006|Overall Study|Treatment discontinued|2|||
157022080|NCT03447470|566833098|FG007|Overall Study|Treatment discontinued|4|||
157022081|NCT03447470|566833099|FG008|Overall Study|Treatment discontinued|3|||
157022082|NCT04876118|566833102|FG000|Overall Study|Pregnancy|1|||
157022083|NCT04876118|566833102|FG000|Overall Study|Withdrawal by Subject|14|||
157022084|NCT05089734|566833103|FG000|Overall Study|Still on study|122|||
157022085|NCT05089734|566833104|FG001|Overall Study|Still on study|101|||
157022086|NCT05089734|566833103|FG000|Overall Study|Death|161|||
157022087|NCT05089734|566833104|FG001|Overall Study|Death|179|||
157022088|NCT05089734|566833103|FG000|Overall Study|Withdrew consent|11|||
157022089|NCT05089734|566833104|FG001|Overall Study|Withdrew consent|24|||
157022090|NCT05089734|566833103|FG000|Overall Study|Lost to Follow-up|5|||
157022091|NCT05089734|566833104|FG001|Overall Study|Lost to Follow-up|0|||
157022092|NCT04353661|566835103|FG000|Overall Study|Protocol Violation|0|||
157022093|NCT04353661|566835104|FG001|Overall Study|Protocol Violation|0|||
157022094|NCT04353661|566835105|FG002|Overall Study|Protocol Violation|1|||
157022095|NCT04353661|566835103|FG000|Overall Study|Study termination by the Sponsor|1|||
157022096|NCT04353661|566835104|FG001|Overall Study|Study termination by the Sponsor|1|||
157022097|NCT04353661|566835105|FG002|Overall Study|Study termination by the Sponsor|1|||
157022098|NCT03457142|566835106|FG000|Overall Study|Death|1|||
157022099|NCT03770273|566835107|FG000|Overall Study|Adverse Event|2|||
157022100|NCT03770273|566835108|FG001|Overall Study|Adverse Event|0|||
157022101|NCT03770273|566835107|FG000|Overall Study|Lost to Follow-up|1|||
157022102|NCT03770273|566835108|FG001|Overall Study|Lost to Follow-up|1|||
157022103|NCT00418886|566835109|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
157022104|NCT00418886|566835110|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
157022105|NCT00418886|566835109|FG000|Randomized Period|Death|122|||
157022106|NCT00418886|566835110|FG001|Randomized Period|Death|147|||
157022107|NCT00418886|566835109|FG000|Randomized Period|Withdrawal by Subject|9|||
157022108|NCT00418886|566835110|FG001|Randomized Period|Withdrawal by Subject|10|||
157022109|NCT00418886|566835109|FG000|Randomized Period|Lost to Follow-up|4|||
157022110|NCT00418886|566835110|FG001|Randomized Period|Lost to Follow-up|6|||
157022111|NCT00418886|566835109|FG000|Randomized Period|withdrawn due to other reason|1|||
157022112|NCT00418886|566835110|FG001|Randomized Period|withdrawn due to other reason|0|||
157022113|NCT00418886|566835109|FG000|Randomized Period|randomised but no treatment received|0|||
156809095|NCT00714948|566054579|FG000|Overall Study|Adverse Event|2|||
156809096|NCT02454530|566054584|FG000|Overall Study|Other|8|||
156809097|NCT02454530|566054585|FG001|Overall Study|Other|13|||
157022114|NCT00418886|566835110|FG001|Randomized Period|randomised but no treatment received|1|||
157022115|NCT04060654|566835111|FG000|Overall Study|Withdrawal by Subject|1|||
156809098|NCT02454530|566054584|FG000|Overall Study|Missing information|56|||
156809099|NCT02454530|566054585|FG001|Overall Study|Missing information|69|||
157022116|NCT04060654|566835111|FG000|Overall Study|Lost to Follow-up|5|||
157022117|NCT03707951|566835112|FG000|Overall Study|Lost to Follow-up|8|||
157022118|NCT03707951|566835113|FG001|Overall Study|Lost to Follow-up|17|||
157022119|NCT03707951|566835112|FG000|Overall Study|Withdrawal by Subject|6|||
156883200|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156809100|NCT02454530|566054584|FG000|Overall Study|Death|2|||
156809101|NCT02454530|566054585|FG001|Overall Study|Death|41|||
156809102|NCT02454530|566054584|FG000|Overall Study|Lost to Follow-up|4|||
156809103|NCT02454530|566054585|FG001|Overall Study|Lost to Follow-up|4|||
156809104|NCT00326001|566054586|FG000|Overall Study|Adverse Event|4|||
156809105|NCT00326001|566054587|FG001|Overall Study|Adverse Event|5|||
156809106|NCT00326001|566054586|FG000|Overall Study|Physician Decision|3|||
156809107|NCT00326001|566054587|FG001|Overall Study|Physician Decision|3|||
156809108|NCT01234480|566055685|FG000|Overall Study|Pregnancy|88|||
156809109|NCT01234480|566055685|FG000|Overall Study|>36/Normal History|50|||
156809110|NCT01234480|566055685|FG000|Overall Study|Age|3|||
156809111|NCT01234480|566055685|FG000|Overall Study|HPV Vaccine History|28|||
156809112|NCT01234480|566055685|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
156809113|NCT01234480|566055685|FG000|Overall Study|Hysterectomy|2|||
156809114|NCT01234480|566055685|FG000|Overall Study|Hysterectomy post enrollment|1|||
156883201|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156883202|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156883203|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
156883204|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
156883205|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
156883206|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
156883207|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883208|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883209|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883210|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883211|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883212|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883213|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883214|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883215|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
156883216|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
156883217|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Death|0|||
157022120|NCT03707951|566835113|FG001|Overall Study|Withdrawal by Subject|6|||
157022121|NCT04533347|566835115|FG000|Overall Study|Adverse Event|1|||
157022122|NCT04533347|566835116|FG001|Overall Study|Adverse Event|2|||
157022123|NCT04533347|566835115|FG000|Overall Study|Lost to Follow-up|2|||
157022124|NCT04533347|566835116|FG001|Overall Study|Lost to Follow-up|0|||
157022125|NCT04533347|566835115|FG000|Overall Study|Withdrawal by Subject|1|||
157022126|NCT04533347|566835116|FG001|Overall Study|Withdrawal by Subject|0|||
157022127|NCT05520190|566835117|FG000|Overall Study|Lost to Follow-up|7|||
157022128|NCT05520190|566835117|FG000|Overall Study|Withdrawal by Subject|2|||
157022129|NCT01999075|566835118|FG000|Overall Study|Lost to Follow-up|0|||
157022130|NCT01999075|566835119|FG001|Overall Study|Lost to Follow-up|2|||
157022131|NCT01999075|566835118|FG000|Overall Study|Withdrawal by Subject|2|||
157022132|NCT01999075|566835119|FG001|Overall Study|Withdrawal by Subject|7|||
157022133|NCT01999075|566835118|FG000|Overall Study|Enrolled in drug trial|3|||
157022134|NCT01999075|566835119|FG001|Overall Study|Enrolled in drug trial|1|||
157022135|NCT01999075|566835118|FG000|Overall Study|Became ineligible|0|||
157022136|NCT01999075|566835119|FG001|Overall Study|Became ineligible|2|||
157022137|NCT04896476|566835125|FG000|Overall Study|Withdrawal by Subject|1|||
157022138|NCT04896476|566835125|FG000|Overall Study|Lost to Follow-up|2|||
157022139|NCT03476187|566835126|FG000|Overall Study|Protocol Violation|7|||
157022140|NCT03476187|566835126|FG000|Overall Study|Physician Decision|5|||
157022141|NCT05948670|566835128|FG000|Overall Study|Protocol Violation|6|||
157022142|NCT05948670|566835129|FG001|Overall Study|Protocol Violation|8|||
157022143|NCT05948670|566835128|FG000|Overall Study|Withdrawal by Subject|0|||
157022144|NCT05948670|566835129|FG001|Overall Study|Withdrawal by Subject|1|||
157022145|NCT04562649|566835130|FG000|Overall Study|Withdrawal by Subject|11|||
157022146|NCT04562649|566835131|FG001|Overall Study|Withdrawal by Subject|8|||
157022147|NCT04562649|566835130|FG000|Overall Study|Lost to Follow-up|26|||
156809115|NCT01234480|566055685|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
157022148|NCT04562649|566835131|FG001|Overall Study|Lost to Follow-up|20|||
157022149|NCT03056040|566835135|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
156809116|NCT01234480|566055685|FG000|Overall Study|Informed Consent Form Violation|30|||
156883218|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Death|0|||
157022150|NCT03056040|566835136|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
157022151|NCT03056040|566835135|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
157022152|NCT03056040|566835136|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
157022153|NCT03056040|566835135|FG000|Primary Evaluation Period|Pregnancy|0|||
157022154|NCT03056040|566835136|FG001|Primary Evaluation Period|Pregnancy|1|||
157022155|NCT03056040|566835135|FG000|Primary Evaluation Period|Randomized, not treated|1|||
157022156|NCT03056040|566835136|FG001|Primary Evaluation Period|Randomized, not treated|1|||
157022157|NCT03056040|566835135|FG000|Extension Period|Physician Decision|3|||
156809117|NCT01234480|566055685|FG000|Overall Study|Incorrect Visit|3|||
156809118|NCT01234480|566055685|FG000|Overall Study|No Florida Lab License|20|||
156809119|NCT01234480|566055685|FG000|Overall Study|Out of Window|42|||
156809120|NCT01234480|566055685|FG000|Overall Study|Sample Processing/Storage|92|||
156809121|NCT01234480|566055685|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
156809122|NCT01234480|566055685|FG000|Overall Study|Site/Subject non-compliance|44|||
156809123|NCT01234480|566055685|FG000|Overall Study|Missing Sample|9|||
156809124|NCT01897727|566055686|FG000|Overall Study|Exclusion: central sleep apnea|0|||
156809125|NCT01897727|566055687|FG001|Overall Study|Exclusion: central sleep apnea|1|||
156809126|NCT01465386|566055692|FG000|Overall Study|Lack of Efficacy|3|||
156809127|NCT01465386|566055692|FG000|Overall Study|Adverse Event|1|||
156809128|NCT02479880|566055693|FG000|Overall Study|Study Terminated by Sponsor|13|||
156809129|NCT02479880|566055694|FG001|Overall Study|Study Terminated by Sponsor|12|||
156809130|NCT02479880|566055693|FG000|Overall Study|Pregnancy|0|||
156809131|NCT02479880|566055694|FG001|Overall Study|Pregnancy|1|||
156809132|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
156809133|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
156809134|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
156809135|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
156883219|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Death|0|||
157145626|NCT01933672|567279824|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
157145627|NCT01933672|567279825|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
157145628|NCT01933672|567279819|FG000|Metformin Run-in Period|Other|5|||
157145629|NCT01933672|567279820|FG001|Metformin Run-in Period|Other|0|||
157145630|NCT01933672|567279821|FG002|Metformin Run-in Period|Other|0|||
157145631|NCT01933672|567279822|FG003|Metformin Run-in Period|Other|0|||
157145632|NCT01933672|567279823|FG004|Metformin Run-in Period|Other|0|||
157145633|NCT01933672|567279824|FG005|Metformin Run-in Period|Other|0|||
157145634|NCT01933672|567279825|FG006|Metformin Run-in Period|Other|0|||
157145635|NCT01933672|567279819|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145636|NCT01933672|567279820|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145637|NCT01933672|567279821|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145638|NCT01933672|567279822|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145639|NCT01933672|567279823|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
157145640|NCT01933672|567279824|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145641|NCT01933672|567279825|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145642|NCT01933672|567279819|FG000|First Intervention Period (12-16 Days)|Other|0|||
157145643|NCT01933672|567279820|FG001|First Intervention Period (12-16 Days)|Other|0|||
157145644|NCT01933672|567279821|FG002|First Intervention Period (12-16 Days)|Other|1|||
157145645|NCT01933672|567279822|FG003|First Intervention Period (12-16 Days)|Other|0|||
157145646|NCT01933672|567279823|FG004|First Intervention Period (12-16 Days)|Other|0|||
157145647|NCT01933672|567279824|FG005|First Intervention Period (12-16 Days)|Other|1|||
157145648|NCT01933672|567279825|FG006|First Intervention Period (12-16 Days)|Other|0|||
157145649|NCT01933672|567279819|FG000|Second Intervention Period (12-16 Days)|Other|0|||
157145650|NCT01933672|567279820|FG001|Second Intervention Period (12-16 Days)|Other|1|||
157145651|NCT01933672|567279821|FG002|Second Intervention Period (12-16 Days)|Other|1|||
157145652|NCT01933672|567279822|FG003|Second Intervention Period (12-16 Days)|Other|0|||
157145653|NCT01933672|567279823|FG004|Second Intervention Period (12-16 Days)|Other|0|||
157145654|NCT01933672|567279824|FG005|Second Intervention Period (12-16 Days)|Other|0|||
157145655|NCT01933672|567279825|FG006|Second Intervention Period (12-16 Days)|Other|0|||
157145656|NCT01933672|567279819|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145657|NCT01933672|567279820|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145658|NCT01933672|567279821|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145659|NCT01933672|567279822|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
157145660|NCT01933672|567279823|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145661|NCT01933672|567279824|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145662|NCT01933672|567279825|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
157145663|NCT01933672|567279819|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145664|NCT01933672|567279820|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
157145665|NCT01933672|567279821|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145666|NCT01933672|567279822|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145667|NCT01933672|567279823|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145668|NCT01933672|567279824|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145669|NCT01933672|567279825|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
157145670|NCT00538733|567279833|FG000|Overall Study|Adverse Event|8|||
157145671|NCT00538733|567279833|FG000|Overall Study|Death|1|||
157145672|NCT00538733|567279833|FG000|Overall Study|declined to participate|2|||
157145673|NCT00538733|567279833|FG000|Overall Study|still on therapy|1|||
157145674|NCT00001259|567282034|FG000|Study 2|Adverse Event|0|||
157145675|NCT00001259|567282035|FG001|Study 2|Adverse Event|0|||
157145676|NCT00001259|567282036|FG002|Study 2|Adverse Event|0|||
157145677|NCT00001259|567282037|FG003|Study 2|Adverse Event|0|||
157145678|NCT00001259|567282038|FG004|Study 2|Adverse Event|2|||
156809136|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
156809137|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
156809138|NCT01279044|566055695|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
156809139|NCT01279044|566055696|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
156809140|NCT01279044|566055697|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
156809141|NCT02840253|566055700|FG000|Overall Study|Unsuccessful block|4|||
156809142|NCT00564733|566055703|FG000|Overall Study|Withdrawal by Subject|4|||
156809143|NCT00564733|566055703|FG000|Overall Study|Ineligible|5|||
156809144|NCT01456130|566055706|FG000|Overall Study|Adverse Event|4|||
156809145|NCT01456130|566055706|FG000|Overall Study|Voluntary Withdrawal|1|||
156809146|NCT01456130|566055706|FG000|Overall Study|Lack of Efficacy|4|||
156809147|NCT01456130|566055706|FG000|Overall Study|Other|1|||
156809148|NCT01135459|566055707|FG000|Overall Study|Adverse Event|8|||
156809149|NCT01135459|566055708|FG001|Overall Study|Adverse Event|10|||
156809150|NCT01135459|566055707|FG000|Overall Study|Lack of Efficacy|3|||
156809151|NCT01135459|566055708|FG001|Overall Study|Lack of Efficacy|1|||
156809152|NCT01135459|566055707|FG000|Overall Study|Withdrawal by Subject|2|||
157145679|NCT00001259|567282039|FG005|Study 2|Adverse Event|0|||
157145680|NCT00001259|567282040|FG006|Study 2|Adverse Event|0|||
157145681|NCT03705494|567282041|FG000|Overall Study|Lost to Follow-up|2|||
157145682|NCT03705494|567282042|FG001|Overall Study|Lost to Follow-up|1|||
157145683|NCT03705494|567282041|FG000|Overall Study|Withdrawal by Subject|5|||
157145684|NCT03705494|567282042|FG001|Overall Study|Withdrawal by Subject|2|||
157145685|NCT01582282|567282043|FG000|Overall Study|Adverse Event|1|||
157145686|NCT01582282|567282044|FG001|Overall Study|Adverse Event|1|||
157145687|NCT01582282|567282045|FG002|Overall Study|Adverse Event|0|||
157145688|NCT01582282|567282043|FG000|Overall Study|Lost to Follow-up|1|||
157145689|NCT01582282|567282044|FG001|Overall Study|Lost to Follow-up|0|||
157145690|NCT01582282|567282045|FG002|Overall Study|Lost to Follow-up|0|||
157145691|NCT01582282|567282043|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
157145692|NCT01582282|567282044|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
157145693|NCT01582282|567282045|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
157145694|NCT03937986|567282047|FG000|Overall Study|COVID-19 Pandemic|1|||
157145695|NCT02839746|567282048|FG000|Overall Study|Not met selection criteria|12|||
157145696|NCT02333331|567282053|FG000|Overall Study|Adverse Event|1|||
157145697|NCT02333331|567282054|FG001|Overall Study|Adverse Event|0|||
157145698|NCT02333331|567282055|FG002|Overall Study|Adverse Event|4|||
157145699|NCT02333331|567282056|FG003|Overall Study|Adverse Event|1|||
157145700|NCT02333331|567282053|FG000|Overall Study|Death|0|||
157145701|NCT02333331|567282054|FG001|Overall Study|Death|0|||
157145702|NCT02333331|567282055|FG002|Overall Study|Death|2|||
157145703|NCT02333331|567282056|FG003|Overall Study|Death|0|||
157145704|NCT02333331|567282053|FG000|Overall Study|Lost to Follow-up|0|||
157145705|NCT02333331|567282054|FG001|Overall Study|Lost to Follow-up|0|||
157145706|NCT02333331|567282055|FG002|Overall Study|Lost to Follow-up|1|||
157145707|NCT02333331|567282056|FG003|Overall Study|Lost to Follow-up|0|||
157145708|NCT02333331|567282053|FG000|Overall Study|Physician Decision|0|||
157145709|NCT02333331|567282054|FG001|Overall Study|Physician Decision|1|||
157145710|NCT02333331|567282055|FG002|Overall Study|Physician Decision|0|||
157145711|NCT02333331|567282056|FG003|Overall Study|Physician Decision|0|||
157145712|NCT02333331|567282053|FG000|Overall Study|Protocol Deviation|0|||
157145713|NCT02333331|567282054|FG001|Overall Study|Protocol Deviation|3|||
157145714|NCT02333331|567282055|FG002|Overall Study|Protocol Deviation|2|||
157145715|NCT02333331|567282056|FG003|Overall Study|Protocol Deviation|1|||
157145716|NCT02333331|567282053|FG000|Overall Study|Patient/Guardian Decision|1|||
157145717|NCT02333331|567282054|FG001|Overall Study|Patient/Guardian Decision|2|||
157145718|NCT02333331|567282055|FG002|Overall Study|Patient/Guardian Decision|9|||
157145719|NCT02333331|567282056|FG003|Overall Study|Patient/Guardian Decision|1|||
157145720|NCT02760602|567282059|FG000|Overall Study|Withdrawal by Subject|1|||
157145721|NCT02760602|567282060|FG001|Overall Study|Withdrawal by Subject|0|||
157145722|NCT02760602|567282059|FG000|Overall Study|Terminated by sponsor|12|||
157145723|NCT02760602|567282060|FG001|Overall Study|Terminated by sponsor|13|||
157145724|NCT03056287|567282062|FG000|Overall Study|Withdrawal by Subject|0|||
157145725|NCT03056287|567282063|FG001|Overall Study|Withdrawal by Subject|1|||
157145726|NCT03056287|567282064|FG002|Overall Study|Withdrawal by Subject|0|||
157145727|NCT03056287|567282065|FG003|Overall Study|Withdrawal by Subject|0|||
157145728|NCT03056287|567282062|FG000|Overall Study|move out of area|0|||
157145729|NCT03056287|567282063|FG001|Overall Study|move out of area|0|||
157145730|NCT03056287|567282064|FG002|Overall Study|move out of area|1|||
157145731|NCT03056287|567282065|FG003|Overall Study|move out of area|1|||
157145732|NCT01357239|567282068|FG000|Stratum: All Patients|Adverse Event|0|||
157145733|NCT01357239|567282069|FG001|Stratum: All Patients|Adverse Event|0|||
157145734|NCT01357239|567282070|FG002|Stratum: All Patients|Adverse Event|1|||
157145735|NCT01357239|567282071|FG003|Stratum: All Patients|Adverse Event|1|||
157145736|NCT01357239|567282068|FG000|Stratum: All Patients|Subject withdrew consent|0|||
157145737|NCT01357239|567282069|FG001|Stratum: All Patients|Subject withdrew consent|0|||
157145738|NCT01357239|567282070|FG002|Stratum: All Patients|Subject withdrew consent|1|||
156883220|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Death|0|||
156883221|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Death|0|||
156883222|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Death|0|||
156883223|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Death|0|||
156883224|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Death|0|||
156883225|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Death|0|||
156883226|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Death|1|||
156883227|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883228|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883229|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
157145739|NCT01357239|567282071|FG003|Stratum: All Patients|Subject withdrew consent|1|||
157145740|NCT01357239|567282068|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
157145741|NCT01357239|567282069|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
157145742|NCT01357239|567282070|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
157145743|NCT01357239|567282071|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
157145744|NCT01357239|567282068|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
157145745|NCT01357239|567282069|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
157145746|NCT01357239|567282070|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
157145747|NCT01357239|567282071|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
157145748|NCT01357239|567282068|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
157145749|NCT01357239|567282069|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
157145750|NCT01357239|567282070|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
157145751|NCT01357239|567282071|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
157145752|NCT00328198|567282072|FG000|Treatment|Adverse Event|21|||
157145753|NCT00328198|567282072|FG000|Treatment|Death|1|||
157145754|NCT00328198|567282072|FG000|Treatment|Physician Decision|5|||
157145755|NCT00328198|567282072|FG000|Treatment|Withdrawal by Subject|5|||
157145756|NCT00328198|567282072|FG000|Treatment|Evidence of disease progression|2|||
157145757|NCT00328198|567282072|FG000|Treatment|Non-compliance|1|||
157145758|NCT00328198|567282072|FG000|Treatment|Confirmed complete response, MRD -|3|||
157145759|NCT00328198|567282072|FG000|Follow-up|Lost to Follow-up|4|||
157145760|NCT00328198|567282072|FG000|Follow-up|Death|31|||
157145761|NCT02532543|567282073|FG000|Overall Study|Lost to Follow-up|0|||
157145762|NCT02532543|567282074|FG001|Overall Study|Lost to Follow-up|0|||
157145763|NCT02532543|567282075|FG002|Overall Study|Lost to Follow-up|1|||
157145764|NCT02532543|567282076|FG003|Overall Study|Lost to Follow-up|0|||
157145765|NCT02640612|567282077|FG000|Overall Study|Adverse Event|6|||
157145766|NCT02640612|567282078|FG001|Overall Study|Adverse Event|7|||
157145767|NCT02640612|567282079|FG002|Overall Study|Adverse Event|2|||
157145768|NCT02640612|567282077|FG000|Overall Study|Death|1|||
157145769|NCT02640612|567282078|FG001|Overall Study|Death|0|||
157145770|NCT02640612|567282079|FG002|Overall Study|Death|0|||
157145771|NCT02640612|567282077|FG000|Overall Study|Withdrawal by Subject|10|||
157145772|NCT02640612|567282078|FG001|Overall Study|Withdrawal by Subject|3|||
157145773|NCT02640612|567282079|FG002|Overall Study|Withdrawal by Subject|3|||
157145774|NCT02640612|567282077|FG000|Overall Study|Lost to Follow-up|4|||
157145775|NCT02640612|567282078|FG001|Overall Study|Lost to Follow-up|1|||
157145776|NCT02640612|567282079|FG002|Overall Study|Lost to Follow-up|1|||
157145777|NCT02640612|567282077|FG000|Overall Study|Protocol Violation|0|||
157145778|NCT02640612|567282078|FG001|Overall Study|Protocol Violation|2|||
157145779|NCT02640612|567282079|FG002|Overall Study|Protocol Violation|0|||
157145780|NCT02640612|567282077|FG000|Overall Study|Lack of Efficacy|1|||
157145781|NCT02640612|567282078|FG001|Overall Study|Lack of Efficacy|1|||
157145782|NCT02640612|567282079|FG002|Overall Study|Lack of Efficacy|0|||
157145783|NCT03865407|567282096|FG000|Overall Study|Adverse Event|1|||
157145784|NCT03865407|567282097|FG001|Overall Study|Adverse Event|0|||
157145785|NCT03865407|567282096|FG000|Overall Study|Withdrawal by Subject|1|||
157145786|NCT03865407|567282097|FG001|Overall Study|Withdrawal by Subject|0|||
157145787|NCT03865407|567282096|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
157145788|NCT03865407|567282097|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
157145789|NCT01645280|567282098|FG000|Overall Study|Death|0|||
157145790|NCT01645280|567282099|FG001|Overall Study|Death|1|||
157145791|NCT01645280|567282100|FG002|Overall Study|Death|0|||
157145792|NCT01645280|567282101|FG003|Overall Study|Death|0|||
157145793|NCT01645280|567282102|FG004|Overall Study|Death|0|||
157145794|NCT01645280|567282098|FG000|Overall Study|Withdrawal by Subject|4|||
157145795|NCT01645280|567282099|FG001|Overall Study|Withdrawal by Subject|0|||
157145796|NCT01645280|567282100|FG002|Overall Study|Withdrawal by Subject|2|||
157145797|NCT01645280|567282101|FG003|Overall Study|Withdrawal by Subject|4|||
157145798|NCT01645280|567282102|FG004|Overall Study|Withdrawal by Subject|5|||
157145799|NCT01645280|567282098|FG000|Overall Study|Lost to Follow-up|0|||
157222198|NCT00358826|567560174|FG007|MDCT Substudy|Lost to Follow-up|0|||
156883230|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
157145800|NCT01645280|567282099|FG001|Overall Study|Lost to Follow-up|0|||
157145801|NCT01645280|567282100|FG002|Overall Study|Lost to Follow-up|0|||
157145802|NCT01645280|567282101|FG003|Overall Study|Lost to Follow-up|2|||
157145803|NCT01645280|567282102|FG004|Overall Study|Lost to Follow-up|1|||
157145804|NCT01645280|567282098|FG000|Overall Study|Other|1|||
157145805|NCT01645280|567282099|FG001|Overall Study|Other|1|||
157145806|NCT01645280|567282100|FG002|Overall Study|Other|2|||
157145807|NCT01645280|567282101|FG003|Overall Study|Other|0|||
157145808|NCT01645280|567282102|FG004|Overall Study|Other|0|||
157145809|NCT01645280|567282098|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
157145810|NCT01645280|567282099|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
157145811|NCT01645280|567282100|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
157222199|NCT00358826|567560167|FG000|MDCT Substudy|Withdrawal by Subject|0|||
157222200|NCT00358826|567560168|FG001|MDCT Substudy|Withdrawal by Subject|0|||
157222201|NCT00358826|567560169|FG002|MDCT Substudy|Withdrawal by Subject|0|||
157222202|NCT00358826|567560170|FG003|MDCT Substudy|Withdrawal by Subject|0|||
157222203|NCT00358826|567560171|FG004|MDCT Substudy|Withdrawal by Subject|0|||
157222204|NCT00358826|567560172|FG005|MDCT Substudy|Withdrawal by Subject|1|||
157222205|NCT00358826|567560173|FG006|MDCT Substudy|Withdrawal by Subject|0|||
157222206|NCT00358826|567560174|FG007|MDCT Substudy|Withdrawal by Subject|0|||
157222207|NCT00903383|567560178|FG000|Overall Study|Adverse Event|1|||
157222208|NCT00903383|567560179|FG001|Overall Study|Adverse Event|2|||
157222209|NCT00903383|567560180|FG002|Overall Study|Adverse Event|3|||
157222210|NCT00903383|567560181|FG003|Overall Study|Adverse Event|1|||
157222211|NCT00903383|567560178|FG000|Overall Study|Physician Decision|1|||
156809153|NCT01135459|566055708|FG001|Overall Study|Withdrawal by Subject|3|||
156809154|NCT01135459|566055707|FG000|Overall Study|Protocol Violation|5|||
156809155|NCT01135459|566055708|FG001|Overall Study|Protocol Violation|3|||
156809156|NCT01135459|566055707|FG000|Overall Study|Lost to Follow-up|2|||
156809157|NCT01135459|566055708|FG001|Overall Study|Lost to Follow-up|1|||
156809158|NCT01135459|566055707|FG000|Overall Study|Non-compliance to study procedures|0|||
156809159|NCT01135459|566055708|FG001|Overall Study|Non-compliance to study procedures|1|||
156809160|NCT01135459|566055707|FG000|Overall Study|Other than specified|1|||
156809161|NCT01135459|566055708|FG001|Overall Study|Other than specified|1|||
156809162|NCT02236572|566055710|FG000|Overall Study|Withdrawal by Subject|1|||
156809163|NCT02236572|566055710|FG000|Overall Study|Protocol Violation|1|||
156809164|NCT02236572|566055710|FG000|Overall Study|Lost to Follow-up|1|||
156809165|NCT03465722|566055713|FG000|Overall Study|Withdrawal by Subject|21|||
156809166|NCT03465722|566055714|FG001|Overall Study|Withdrawal by Subject|14|||
156809167|NCT03465722|566055713|FG000|Overall Study|Death|89|||
156809168|NCT03465722|566055714|FG001|Overall Study|Death|87|||
156809169|NCT03465722|566055713|FG000|Overall Study|Lost to Follow-up|5|||
156809170|NCT03465722|566055714|FG001|Overall Study|Lost to Follow-up|3|||
156809171|NCT03465722|566055713|FG000|Overall Study|Administrative/Other|33|||
156809172|NCT03465722|566055714|FG001|Overall Study|Administrative/Other|32|||
156809173|NCT03465722|566055713|FG000|Overall Study|Not treated|1|||
156809174|NCT03465722|566055714|FG001|Overall Study|Not treated|2|||
156809175|NCT03465722|566055713|FG000|Overall Study|Sponsor decision|91|||
156809176|NCT03465722|566055714|FG001|Overall Study|Sponsor decision|98|||
156809177|NCT02948582|566055715|FG000|Washout Period 1|Adverse Event|0|||
156809178|NCT02948582|566055716|FG001|Washout Period 1|Adverse Event|2|||
156809179|NCT02948582|566055717|FG002|Washout Period 1|Adverse Event|0|||
156809180|NCT02948582|566055718|FG003|Washout Period 1|Adverse Event|0|||
156809181|NCT02948582|566055719|FG004|Washout Period 1|Adverse Event|0|||
156809182|NCT02948582|566055720|FG005|Washout Period 1|Adverse Event|0|||
156809183|NCT02948582|566055715|FG000|Washout Period 1|Protocol Violation|0|||
156809184|NCT02948582|566055716|FG001|Washout Period 1|Protocol Violation|0|||
156809185|NCT02948582|566055717|FG002|Washout Period 1|Protocol Violation|0|||
156809186|NCT02948582|566055718|FG003|Washout Period 1|Protocol Violation|0|||
156809187|NCT02948582|566055719|FG004|Washout Period 1|Protocol Violation|0|||
156809188|NCT02948582|566055720|FG005|Washout Period 1|Protocol Violation|1|||
156809189|NCT02948582|566055715|FG000|Washout Period 2|Adverse Event|0|||
157145812|NCT01645280|567282101|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
157222212|NCT00903383|567560179|FG001|Overall Study|Physician Decision|2|||
157222213|NCT00903383|567560180|FG002|Overall Study|Physician Decision|0|||
157222214|NCT00903383|567560181|FG003|Overall Study|Physician Decision|0|||
156809190|NCT02948582|566055716|FG001|Washout Period 2|Adverse Event|1|||
156809191|NCT02948582|566055717|FG002|Washout Period 2|Adverse Event|0|||
156809192|NCT02948582|566055718|FG003|Washout Period 2|Adverse Event|0|||
156809193|NCT02948582|566055719|FG004|Washout Period 2|Adverse Event|0|||
156809194|NCT02948582|566055720|FG005|Washout Period 2|Adverse Event|0|||
156809195|NCT02948582|566055715|FG000|Washout Period 2|personal reasons|0|||
156809196|NCT02948582|566055716|FG001|Washout Period 2|personal reasons|0|||
156809197|NCT02948582|566055717|FG002|Washout Period 2|personal reasons|0|||
156809198|NCT02948582|566055718|FG003|Washout Period 2|personal reasons|1|||
156809199|NCT02948582|566055719|FG004|Washout Period 2|personal reasons|0|||
156809200|NCT02948582|566055720|FG005|Washout Period 2|personal reasons|0|||
156809201|NCT02948582|566055715|FG000|Washout Period 4|Adverse Event|1|||
156809202|NCT02948582|566055716|FG001|Washout Period 4|Adverse Event|0|||
157145813|NCT01645280|567282102|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
157222215|NCT00903383|567560178|FG000|Overall Study|Lost to Follow-up|0|||
156809203|NCT02948582|566055717|FG002|Washout Period 4|Adverse Event|1|||
156809204|NCT02948582|566055718|FG003|Washout Period 4|Adverse Event|0|||
156809205|NCT02948582|566055719|FG004|Washout Period 4|Adverse Event|0|||
156809206|NCT02948582|566055720|FG005|Washout Period 4|Adverse Event|0|||
156809207|NCT00955474|566055728|FG000|Overall Study|Physician Decision|7|||
156809208|NCT00955474|566055729|FG001|Overall Study|Physician Decision|5|||
156809209|NCT04721158|566055731|FG000|Overall Study|Lost to Follow-up|4|||
156809210|NCT04721158|566055731|FG000|Overall Study|Device did not connect|1|||
156809211|NCT02382991|566055732|FG000|Overall Study|Adverse Event|1|||
156809212|NCT02382991|566055733|FG001|Overall Study|Adverse Event|2|||
156809213|NCT02382991|566055732|FG000|Overall Study|Lost to Follow-up|1|||
156809214|NCT02382991|566055733|FG001|Overall Study|Lost to Follow-up|0|||
156809215|NCT02382991|566055732|FG000|Overall Study|Withdrawal by Subject|0|||
156809216|NCT02382991|566055733|FG001|Overall Study|Withdrawal by Subject|1|||
156809217|NCT04162470|566055734|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
156809218|NCT03929913|566055737|FG000|Overall Study|Death|4|||
156809219|NCT03929913|566055737|FG000|Overall Study|Lost to Follow-up|1|||
156809220|NCT03929913|566055737|FG000|Overall Study|Failed Procedure|2|||
156809221|NCT03919929|566055740|FG000|Overall Study|Withdrawal by Subject|0|||
156809222|NCT03919929|566055741|FG001|Overall Study|Withdrawal by Subject|4|||
156809223|NCT03919929|566055740|FG000|Overall Study|Screen Failure|0|||
156809224|NCT03919929|566055741|FG001|Overall Study|Screen Failure|5|||
156809225|NCT04570384|566055744|FG000|Overall Study|Adverse Event|2|||
157145814|NCT00546819|567282107|FG000|Overall Study|Adverse Event|2|||
157145815|NCT00546819|567282108|FG001|Overall Study|Adverse Event|3|||
157145816|NCT00546819|567282107|FG000|Overall Study|Lost to Follow-up|2|||
157145817|NCT00546819|567282108|FG001|Overall Study|Lost to Follow-up|1|||
157145818|NCT00546819|567282107|FG000|Overall Study|Withdrawal by Subject|4|||
157145819|NCT00546819|567282108|FG001|Overall Study|Withdrawal by Subject|2|||
157145820|NCT03849560|567282109|FG000|Overall Study|Withdrawal by Subject|1|||
157145821|NCT03849560|567282110|FG001|Overall Study|Withdrawal by Subject|0|||
157145822|NCT03849560|567282111|FG002|Overall Study|Withdrawal by Subject|0|||
157145823|NCT01254344|567282118|FG000|Overall Study|Adverse Event|2|||
157145824|NCT01254344|567282119|FG001|Overall Study|Adverse Event|5|||
157145825|NCT01254344|567282118|FG000|Overall Study|Physician Decision|7|||
157145826|NCT01254344|567282119|FG001|Overall Study|Physician Decision|4|||
157145827|NCT01254344|567282118|FG000|Overall Study|Protocol Violation|1|||
157145828|NCT01254344|567282119|FG001|Overall Study|Protocol Violation|4|||
157145829|NCT01254344|567282118|FG000|Overall Study|Withdrawal by Subject|3|||
157145830|NCT01254344|567282119|FG001|Overall Study|Withdrawal by Subject|6|||
157145831|NCT00467649|567282120|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
157145832|NCT00467649|567282121|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
157145833|NCT00467649|567282122|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
157145834|NCT00467649|567282123|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
157145835|NCT00467649|567282124|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
157145836|NCT00467649|567282125|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
157145837|NCT00467649|567282120|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
157145838|NCT00467649|567282121|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
157145839|NCT00467649|567282122|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
157145840|NCT00467649|567282123|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
157145841|NCT00467649|567282124|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
157145842|NCT00467649|567282125|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
157145843|NCT00467649|567282120|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
157145844|NCT00467649|567282121|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
157145845|NCT00467649|567282122|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
157145846|NCT00467649|567282123|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
157145847|NCT00467649|567282124|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
157145848|NCT00467649|567282125|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
157145849|NCT00467649|567282120|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
157145850|NCT00467649|567282121|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
157145851|NCT00467649|567282122|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
157145852|NCT00467649|567282123|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
157145853|NCT00467649|567282124|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
157145854|NCT00467649|567282125|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
157222216|NCT00903383|567560179|FG001|Overall Study|Lost to Follow-up|0|||
157222217|NCT00903383|567560180|FG002|Overall Study|Lost to Follow-up|0|||
156809226|NCT04570384|566055745|FG001|Overall Study|Adverse Event|1|||
156809227|NCT04570384|566055744|FG000|Overall Study|Death|2|||
156809228|NCT04570384|566055745|FG001|Overall Study|Death|5|||
156809229|NCT04570384|566055744|FG000|Overall Study|Lost to Follow-up|1|||
156883231|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
157145855|NCT00467649|567282120|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
157145856|NCT00467649|567282121|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
156809230|NCT04570384|566055745|FG001|Overall Study|Lost to Follow-up|0|||
156809231|NCT04570384|566055744|FG000|Overall Study|Other|1|||
156809232|NCT04570384|566055745|FG001|Overall Study|Other|0|||
156809233|NCT04570384|566055744|FG000|Overall Study|Protocol Violation|0|||
156809234|NCT04570384|566055745|FG001|Overall Study|Protocol Violation|1|||
156809235|NCT04570384|566055744|FG000|Overall Study|Sponsor Decision|1|||
156809236|NCT04570384|566055745|FG001|Overall Study|Sponsor Decision|0|||
156809237|NCT04570384|566055744|FG000|Overall Study|Withdrawal by Subject|4|||
156809238|NCT04570384|566055745|FG001|Overall Study|Withdrawal by Subject|2|||
156809239|NCT02573948|566055746|FG000|Longitudinal Cohort|Death|9|||
156809240|NCT02573948|566055746|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
156809241|NCT02573948|566055746|FG000|Longitudinal Cohort|Incarcerated|25|||
156809242|NCT03654274|566055751|FG000|Overall Study|Adverse Event|19|||
156809243|NCT03654274|566055752|FG001|Overall Study|Adverse Event|23|||
156809244|NCT03654274|566055753|FG002|Overall Study|Adverse Event|24|||
156809245|NCT03654274|566055751|FG000|Overall Study|Protocol Deviation|0|||
156809246|NCT03654274|566055752|FG001|Overall Study|Protocol Deviation|2|||
156809247|NCT03654274|566055753|FG002|Overall Study|Protocol Deviation|0|||
156809248|NCT03654274|566055751|FG000|Overall Study|Lost to Follow-up|8|||
156809249|NCT03654274|566055752|FG001|Overall Study|Lost to Follow-up|6|||
156809250|NCT03654274|566055753|FG002|Overall Study|Lost to Follow-up|5|||
156809251|NCT03654274|566055751|FG000|Overall Study|Withdrawal by Subject|46|||
156809252|NCT03654274|566055752|FG001|Overall Study|Withdrawal by Subject|25|||
156809253|NCT03654274|566055753|FG002|Overall Study|Withdrawal by Subject|33|||
156809254|NCT03654274|566055751|FG000|Overall Study|Lack of Efficacy|4|||
156809255|NCT03654274|566055752|FG001|Overall Study|Lack of Efficacy|5|||
156809256|NCT03654274|566055753|FG002|Overall Study|Lack of Efficacy|7|||
156809257|NCT03654274|566055751|FG000|Overall Study|Pregnancy|2|||
156809258|NCT03654274|566055752|FG001|Overall Study|Pregnancy|2|||
156809259|NCT03654274|566055753|FG002|Overall Study|Pregnancy|1|||
156809260|NCT03654274|566055751|FG000|Overall Study|Other|27|||
156809261|NCT03654274|566055752|FG001|Overall Study|Other|29|||
156809262|NCT03654274|566055753|FG002|Overall Study|Other|32|||
156809263|NCT03654274|566055751|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
156809264|NCT03654274|566055752|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
156809265|NCT03654274|566055753|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
156809266|NCT01102491|566055754|FG000|Overall Study|Protocol Violation|11|||
156809267|NCT01102491|566055755|FG001|Overall Study|Protocol Violation|12|||
156809268|NCT01265992|566055756|FG000|Overall Study|Lost to Follow-up|1|||
156809269|NCT01265992|566055756|FG000|Overall Study|Withdrawal by Subject|1|||
156809270|NCT01265992|566055756|FG000|Overall Study|Adverse Event|1|||
156809271|NCT01265992|566055756|FG000|Overall Study|Administrative reasons|2|||
156809272|NCT01265992|566055756|FG000|Overall Study|Stopped treatment|3|||
156809273|NCT01265992|566055756|FG000|Overall Study|Did not receive treatment|1|||
156809274|NCT01837680|566055757|FG000|Overall Study|Lost to Follow-up|2|||
156809275|NCT01837680|566055758|FG001|Overall Study|Lost to Follow-up|2|||
156809276|NCT01837680|566055757|FG000|Overall Study|lack of insurance|0|||
156809277|NCT01837680|566055758|FG001|Overall Study|lack of insurance|2|||
156809278|NCT01837680|566055757|FG000|Overall Study|allergic reaction|6|||
156809279|NCT01837680|566055758|FG001|Overall Study|allergic reaction|0|||
156809280|NCT01837680|566055757|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
156809281|NCT01837680|566055758|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
156809282|NCT03265145|566055759|FG000|Overall Study|Protocol Violation|2|||
156809283|NCT03265145|566055760|FG001|Overall Study|Protocol Violation|0|||
156809284|NCT03265145|566055759|FG000|Overall Study|Adverse Event|1|||
156809285|NCT03265145|566055760|FG001|Overall Study|Adverse Event|0|||
156809286|NCT03265145|566055759|FG000|Overall Study|Withdrawal by Subject|23|||
156809287|NCT03265145|566055760|FG001|Overall Study|Withdrawal by Subject|19|||
156809288|NCT03265145|566055759|FG000|Overall Study|Death|12|||
156809289|NCT03265145|566055760|FG001|Overall Study|Death|12|||
156809290|NCT03265145|566055759|FG000|Overall Study|Lost to Follow-up|13|||
156809291|NCT03265145|566055760|FG001|Overall Study|Lost to Follow-up|9|||
156883232|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883233|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883234|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883235|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
156883236|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
156883237|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
157022158|NCT03056040|566835136|FG001|Extension Period|Physician Decision|3|||
156809292|NCT03265145|566055759|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
156809293|NCT03265145|566055760|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
156809294|NCT03265145|566055759|FG000|Overall Study|Switched back to previous medication|1|||
156809295|NCT03265145|566055760|FG001|Overall Study|Switched back to previous medication|0|||
156809296|NCT03265145|566055759|FG000|Overall Study|Did not want to take medication|1|||
156809297|NCT03265145|566055760|FG001|Overall Study|Did not want to take medication|0|||
156809298|NCT03265145|566055759|FG000|Overall Study|Subject could not afford medication|0|||
156809299|NCT03265145|566055760|FG001|Overall Study|Subject could not afford medication|1|||
156809300|NCT03265145|566055759|FG000|Overall Study|Site closed|2|||
156883238|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883239|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883240|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883241|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883242|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883243|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883244|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883245|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
156883246|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
156883247|NCT01185353|566330925|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883248|NCT01185353|566330926|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883249|NCT01185353|566330927|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883250|NCT01185353|566330928|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883251|NCT01185353|566330929|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883252|NCT01185353|566330930|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883253|NCT01185353|566330931|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883254|NCT01185353|566330932|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883255|NCT01185353|566330933|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
156883256|NCT01185353|566330934|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
156883257|NCT01185353|566330925|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883258|NCT01185353|566330926|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883259|NCT01185353|566330927|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883260|NCT01185353|566330928|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883261|NCT01185353|566330929|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883262|NCT01185353|566330930|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883263|NCT01185353|566330931|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883264|NCT01185353|566330932|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
156883265|NCT01185353|566330933|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
156883266|NCT01185353|566330934|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
156883267|NCT01185353|566330925|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883268|NCT01185353|566330926|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883269|NCT01185353|566330927|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883270|NCT01185353|566330928|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883271|NCT01185353|566330929|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883272|NCT01185353|566330930|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883273|NCT01185353|566330931|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
156883274|NCT01185353|566330932|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
156883275|NCT01185353|566330933|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
156883276|NCT01185353|566330934|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
156883277|NCT01185353|566330925|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883278|NCT01185353|566330926|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883279|NCT01185353|566330927|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883280|NCT01185353|566330928|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883281|NCT01185353|566330929|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883282|NCT01185353|566330930|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883283|NCT01185353|566330931|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883284|NCT01185353|566330932|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
156883285|NCT01185353|566330933|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
156883286|NCT01185353|566330934|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
156883287|NCT01030666|566330935|FG000|Overall Study|Lost to Follow-up|3|||
156883288|NCT01030666|566330936|FG001|Overall Study|Lost to Follow-up|2|||
156883289|NCT04002908|566330937|FG000|Overall Study|Death|41|||
156883290|NCT04002908|566330938|FG001|Overall Study|Death|0|||
156883291|NCT04002908|566330939|FG002|Overall Study|Death|0|||
156883292|NCT04002908|566330940|FG003|Overall Study|Death|0|||
156883293|NCT04002908|566330937|FG000|Overall Study|Withdrawal by Subject|112|||
156883294|NCT04002908|566330938|FG001|Overall Study|Withdrawal by Subject|0|||
156883295|NCT04002908|566330939|FG002|Overall Study|Withdrawal by Subject|0|||
156883296|NCT04002908|566330940|FG003|Overall Study|Withdrawal by Subject|0|||
156883297|NCT04002908|566330937|FG000|Overall Study|Lost to Follow-up|72|||
156883298|NCT04002908|566330938|FG001|Overall Study|Lost to Follow-up|0|||
156883299|NCT04002908|566330939|FG002|Overall Study|Lost to Follow-up|0|||
156883300|NCT04002908|566330940|FG003|Overall Study|Lost to Follow-up|0|||
156883301|NCT04002908|566330937|FG000|Overall Study|Infant died, so mother withdrawn|34|||
156883302|NCT04002908|566330938|FG001|Overall Study|Infant died, so mother withdrawn|0|||
156883303|NCT04002908|566330939|FG002|Overall Study|Infant died, so mother withdrawn|0|||
156883304|NCT04002908|566330940|FG003|Overall Study|Infant died, so mother withdrawn|0|||
156883305|NCT03952039|566330943|FG000|Overall Study|Adverse Event|22|||
156883306|NCT03952039|566330944|FG001|Overall Study|Adverse Event|8|||
156883307|NCT03952039|566330943|FG000|Overall Study|Withdrawal by Participant|17|||
156883308|NCT03952039|566330944|FG001|Overall Study|Withdrawal by Participant|12|||
156883309|NCT03952039|566330943|FG000|Overall Study|Death|13|||
156883310|NCT03952039|566330944|FG001|Overall Study|Death|6|||
156883311|NCT03952039|566330943|FG000|Overall Study|Lack of Efficacy|12|||
156883312|NCT03952039|566330944|FG001|Overall Study|Lack of Efficacy|2|||
156883313|NCT03952039|566330943|FG000|Overall Study|Physician Decision|9|||
156883314|NCT03952039|566330944|FG001|Overall Study|Physician Decision|3|||
156883315|NCT03952039|566330943|FG000|Overall Study|Progressive Disease|6|||
156883316|NCT03952039|566330944|FG001|Overall Study|Progressive Disease|4|||
156883317|NCT03952039|566330943|FG000|Overall Study|Other Reasons|12|||
156883318|NCT03952039|566330944|FG001|Overall Study|Other Reasons|4|||
156883319|NCT05009979|566330948|FG000|Overall Study|Withdrawal by Subject|1|||
157145857|NCT00467649|567282122|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
157145858|NCT00467649|567282123|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
157145859|NCT00467649|567282124|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
157145860|NCT00467649|567282125|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
157145861|NCT00467649|567282120|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
157145862|NCT00467649|567282121|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
157145863|NCT00467649|567282122|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
157145864|NCT00467649|567282123|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
157145865|NCT00467649|567282124|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
157145866|NCT00467649|567282125|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
157145867|NCT00467649|567282120|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
157145868|NCT00467649|567282121|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
157145869|NCT00467649|567282122|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
157145870|NCT00467649|567282123|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
157145871|NCT00467649|567282124|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
157145872|NCT00467649|567282125|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
157145873|NCT01633060|567282126|FG000|Randomization Phase|Protocol deviation|1|||
157145874|NCT01633060|567282127|FG001|Randomization Phase|Protocol deviation|2|||
157145875|NCT01633060|567282126|FG000|Randomization Phase|Technical problem|0|||
157145876|NCT01633060|567282127|FG001|Randomization Phase|Technical problem|1|||
157145877|NCT01633060|567282126|FG000|Treatment Phase|Adverse Event|24|||
157145878|NCT01633060|567282127|FG001|Treatment Phase|Adverse Event|3|||
157145879|NCT01633060|567282126|FG000|Treatment Phase|Lost to Follow-up|1|||
157145880|NCT01633060|567282127|FG001|Treatment Phase|Lost to Follow-up|0|||
157145881|NCT01633060|567282126|FG000|Treatment Phase|Physician Decision|16|||
157145882|NCT01633060|567282127|FG001|Treatment Phase|Physician Decision|7|||
157145883|NCT01633060|567282126|FG000|Treatment Phase|Progressive Disease|210|||
157145884|NCT01633060|567282127|FG001|Treatment Phase|Progressive Disease|120|||
157145885|NCT01633060|567282126|FG000|Treatment Phase|Protocol Deviation|1|||
157145886|NCT01633060|567282127|FG001|Treatment Phase|Protocol Deviation|0|||
157145887|NCT01633060|567282126|FG000|Treatment Phase|Study Terminated by sponsor|7|||
157145888|NCT01633060|567282127|FG001|Treatment Phase|Study Terminated by sponsor|3|||
157145889|NCT01633060|567282126|FG000|Treatment Phase|Subject/guardian decision|25|||
157145890|NCT01633060|567282127|FG001|Treatment Phase|Subject/guardian decision|4|||
157145891|NCT01633060|567282126|FG000|Treatment Phase|Death|4|||
157145892|NCT01633060|567282127|FG001|Treatment Phase|Death|3|||
157145893|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
157145894|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
157145895|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
157145896|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
157145897|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
157145898|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
157145899|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
157145900|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
157145901|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
157145902|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
157145903|NCT01633060|567282126|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
157145904|NCT01633060|567282127|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
157145905|NCT03233048|567282128|FG000|Overall Study|Withdrawal by Subject|1|||
157145906|NCT02859415|567282129|FG000|Overall Study|Physician Decision|1|||
156883320|NCT01330017|566332513|FG000|Overall Study|Adverse Event|0|||
156883321|NCT01330017|566332514|FG001|Overall Study|Adverse Event|1|||
156883322|NCT01330017|566332515|FG002|Overall Study|Adverse Event|1|||
156883323|NCT01330017|566332516|FG003|Overall Study|Adverse Event|4|||
156883324|NCT01330017|566332517|FG004|Overall Study|Adverse Event|0|||
156883325|NCT01330017|566332513|FG000|Overall Study|Withdrawal by Subject|0|||
156883326|NCT01330017|566332514|FG001|Overall Study|Withdrawal by Subject|0|||
157145907|NCT02859415|567282130|FG001|Overall Study|Physician Decision|0|||
156883327|NCT01330017|566332515|FG002|Overall Study|Withdrawal by Subject|1|||
156883328|NCT01330017|566332516|FG003|Overall Study|Withdrawal by Subject|0|||
156883329|NCT01330017|566332517|FG004|Overall Study|Withdrawal by Subject|1|||
156883330|NCT01330017|566332513|FG000|Overall Study|Lost to Follow-up|0|||
156883331|NCT01330017|566332514|FG001|Overall Study|Lost to Follow-up|0|||
156883332|NCT01330017|566332515|FG002|Overall Study|Lost to Follow-up|1|||
156883333|NCT01330017|566332516|FG003|Overall Study|Lost to Follow-up|0|||
156883334|NCT01330017|566332517|FG004|Overall Study|Lost to Follow-up|0|||
156883335|NCT01330017|566332513|FG000|Overall Study|Protocol Violation|0|||
156883336|NCT01330017|566332514|FG001|Overall Study|Protocol Violation|0|||
156883337|NCT01330017|566332515|FG002|Overall Study|Protocol Violation|0|||
156883338|NCT01330017|566332516|FG003|Overall Study|Protocol Violation|1|||
156883339|NCT01330017|566332517|FG004|Overall Study|Protocol Violation|0|||
156883340|NCT01330017|566332513|FG000|Overall Study|Unknown Reason|5|||
156883341|NCT01330017|566332514|FG001|Overall Study|Unknown Reason|3|||
156883342|NCT01330017|566332515|FG002|Overall Study|Unknown Reason|5|||
156883343|NCT01330017|566332516|FG003|Overall Study|Unknown Reason|7|||
156883344|NCT01330017|566332517|FG004|Overall Study|Unknown Reason|2|||
156883345|NCT03137069|566332519|FG000|Overall Study|Withdrawal by Subject|1|||
156883346|NCT03137069|566332520|FG001|Overall Study|Withdrawal by Subject|2|||
156883347|NCT03137069|566332521|FG002|Overall Study|Withdrawal by Subject|2|||
156883348|NCT03137069|566332522|FG003|Overall Study|Withdrawal by Subject|2|||
156883349|NCT03137069|566332523|FG004|Overall Study|Withdrawal by Subject|0|||
156883350|NCT03137069|566332524|FG005|Overall Study|Withdrawal by Subject|0|||
156883351|NCT03137069|566332519|FG000|Overall Study|Adverse Event|0|||
156883352|NCT03137069|566332520|FG001|Overall Study|Adverse Event|3|||
156883353|NCT03137069|566332521|FG002|Overall Study|Adverse Event|1|||
156883354|NCT03137069|566332522|FG003|Overall Study|Adverse Event|1|||
156809301|NCT03265145|566055760|FG001|Overall Study|Site closed|3|||
156809302|NCT03265145|566055759|FG000|Overall Study|Incorrectly randomized|16|||
156809303|NCT03265145|566055760|FG001|Overall Study|Incorrectly randomized|6|||
156809304|NCT03265145|566055759|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
156809305|NCT03265145|566055760|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
156809306|NCT03265145|566055759|FG000|Overall Study|Physician Decision|0|||
156809307|NCT03265145|566055760|FG001|Overall Study|Physician Decision|3|||
157022159|NCT03056040|566835135|FG000|Extension Period|Lost to Follow-up|0|||
157022160|NCT03056040|566835136|FG001|Extension Period|Lost to Follow-up|1|||
157022161|NCT03056040|566835135|FG000|Extension Period|Death|0|||
157022162|NCT03056040|566835136|FG001|Extension Period|Death|3|||
157022163|NCT03056040|566835135|FG000|Extension Period|Withdrawal by Subject|1|||
157022164|NCT03056040|566835136|FG001|Extension Period|Withdrawal by Subject|0|||
157022165|NCT05268393|566835141|FG000|Overall Study|Withdrawal by Subject|2|||
157022166|NCT05268393|566835142|FG001|Overall Study|Withdrawal by Subject|1|||
157022167|NCT02035787|566835144|FG000|Overall Study- 12 Months|Adverse Event|3|||
157022168|NCT02035787|566835145|FG001|Overall Study- 12 Months|Adverse Event|0|||
157022169|NCT02035787|566835144|FG000|Overall Study- 12 Months|Complete response|4|||
157022170|NCT02035787|566835145|FG001|Overall Study- 12 Months|Complete response|1|||
157022171|NCT02035787|566835144|FG000|Overall Study- 12 Months|Protocol Violation|1|||
157022172|NCT02035787|566835145|FG001|Overall Study- 12 Months|Protocol Violation|1|||
157022173|NCT03853746|566835146|FG000|Overall Study|Withdrawal by Subject|1|||
157022174|NCT01396278|566835147|FG000|Overall Study|Adverse Event|0|||
157022175|NCT01396278|566835148|FG001|Overall Study|Adverse Event|0|||
157022176|NCT01396278|566835149|FG002|Overall Study|Adverse Event|0|||
157022177|NCT01396278|566835150|FG003|Overall Study|Adverse Event|2|||
157022178|NCT01396278|566835151|FG004|Overall Study|Adverse Event|0|||
157022179|NCT01396278|566835147|FG000|Overall Study|Withdraw due to trial termination|2|||
157022180|NCT01396278|566835148|FG001|Overall Study|Withdraw due to trial termination|1|||
157022181|NCT01396278|566835149|FG002|Overall Study|Withdraw due to trial termination|1|||
157022182|NCT01396278|566835150|FG003|Overall Study|Withdraw due to trial termination|0|||
157022183|NCT01396278|566835151|FG004|Overall Study|Withdraw due to trial termination|2|||
157145908|NCT02859415|567282129|FG000|Overall Study|Off treatment due to cardiac event|0|||
157145909|NCT02859415|567282130|FG001|Overall Study|Off treatment due to cardiac event|1|||
157145910|NCT03114969|567282131|FG000|Overall Study|Lost to Follow-up|0|||
157145911|NCT03114969|567282132|FG001|Overall Study|Lost to Follow-up|0|||
157145912|NCT03114969|567282133|FG002|Overall Study|Lost to Follow-up|3|||
156809308|NCT03265145|566055759|FG000|Overall Study|Subject transferred to another facility|0|||
156809309|NCT03265145|566055760|FG001|Overall Study|Subject transferred to another facility|1|||
157022184|NCT00450658|566835152|FG000|Overall Study|Adverse Event|24|||
157022185|NCT00450658|566835153|FG001|Overall Study|Adverse Event|15|||
157022186|NCT00450658|566835152|FG000|Overall Study|Withdrawal by Subject|43|||
157022187|NCT00450658|566835153|FG001|Overall Study|Withdrawal by Subject|26|||
157145913|NCT03114969|567282134|FG003|Overall Study|Lost to Follow-up|2|||
157145914|NCT03114969|567282135|FG004|Overall Study|Lost to Follow-up|0|||
157145915|NCT03114969|567282136|FG005|Overall Study|Lost to Follow-up|0|||
156809310|NCT05005273|566055761|FG000|Overall Study|Study Terminated|1|||
156883355|NCT03137069|566332523|FG004|Overall Study|Adverse Event|0|||
156883356|NCT03137069|566332524|FG005|Overall Study|Adverse Event|1|||
156883357|NCT03137069|566332519|FG000|Overall Study|Protocol Violation|0|||
156883358|NCT03137069|566332520|FG001|Overall Study|Protocol Violation|1|||
156883359|NCT03137069|566332521|FG002|Overall Study|Protocol Violation|0|||
156809311|NCT05005273|566055762|FG001|Overall Study|Study Terminated|0|||
156809312|NCT04409834|566055763|FG000|Overall Study|Death|55|||
156809313|NCT04409834|566055764|FG001|Overall Study|Death|62|||
157222218|NCT00903383|567560181|FG003|Overall Study|Lost to Follow-up|1|||
157222219|NCT00903383|567560178|FG000|Overall Study|Decision of Sponsor|1|||
157222220|NCT00903383|567560179|FG001|Overall Study|Decision of Sponsor|0|||
157222221|NCT00903383|567560180|FG002|Overall Study|Decision of Sponsor|0|||
156809314|NCT02137070|566055765|FG000|Overall Study|Adverse Event|12|||
156809315|NCT02137070|566055766|FG001|Overall Study|Adverse Event|3|||
156809316|NCT02137070|566055765|FG000|Overall Study|Death|2|||
156809317|NCT02137070|566055766|FG001|Overall Study|Death|0|||
156809318|NCT02137070|566055765|FG000|Overall Study|Lost to Follow-up|24|||
156809319|NCT02137070|566055766|FG001|Overall Study|Lost to Follow-up|9|||
156809320|NCT02137070|566055765|FG000|Overall Study|Physician Decision|0|||
156809321|NCT02137070|566055766|FG001|Overall Study|Physician Decision|1|||
156809322|NCT02137070|566055765|FG000|Overall Study|Protocol Violation|18|||
156809323|NCT02137070|566055766|FG001|Overall Study|Protocol Violation|4|||
156809324|NCT02137070|566055765|FG000|Overall Study|Withdrawal by Subject|18|||
156809325|NCT02137070|566055766|FG001|Overall Study|Withdrawal by Subject|1|||
156809326|NCT02151786|566055767|FG000|Overall Study|Unavailability of Case Report Form|26|||
156809327|NCT02151786|566055767|FG000|Overall Study|Outside the Contract Period|1|||
156809328|NCT02151786|566055767|FG000|Overall Study|Randomized, not Treated|1|||
156809329|NCT02151786|566055767|FG000|Overall Study|Unavailability of Information|8|||
156809330|NCT02112656|566055771|FG000|Overall Study|Death|78|||
156809331|NCT02112656|566055772|FG001|Overall Study|Death|82|||
156809332|NCT02112656|566055771|FG000|Overall Study|Withdrawal by Subject|9|||
157222222|NCT00903383|567560181|FG003|Overall Study|Decision of Sponsor|0|||
156809333|NCT02112656|566055772|FG001|Overall Study|Withdrawal by Subject|11|||
156809334|NCT02112656|566055771|FG000|Overall Study|Lost to Follow-up|2|||
156809335|NCT02112656|566055772|FG001|Overall Study|Lost to Follow-up|4|||
156809336|NCT02112656|566055771|FG000|Overall Study|Noncompliance|1|||
156809337|NCT02112656|566055772|FG001|Overall Study|Noncompliance|2|||
156809338|NCT03761056|566055773|FG000|Overall Study|Death|8|||
156809339|NCT03761056|566055773|FG000|Overall Study|Enrolled but never treated|2|||
156809340|NCT03761056|566055773|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
156809341|NCT03761056|566055773|FG000|Overall Study|Investigator decision|1|||
156809342|NCT03941483|566055774|FG000|Overall Study|Miscellaneous|2|||
156809343|NCT03941483|566055775|FG001|Overall Study|Miscellaneous|3|||
156809344|NCT03941483|566055776|FG002|Overall Study|Miscellaneous|0|||
156809345|NCT03941483|566055774|FG000|Overall Study|Study Terminated by Sponsor|1|||
156809346|NCT03941483|566055775|FG001|Overall Study|Study Terminated by Sponsor|0|||
156809347|NCT03941483|566055776|FG002|Overall Study|Study Terminated by Sponsor|0|||
156809348|NCT03941483|566055774|FG000|Overall Study|Withdrawal by Subject|1|||
156809349|NCT03941483|566055775|FG001|Overall Study|Withdrawal by Subject|4|||
156809350|NCT03941483|566055776|FG002|Overall Study|Withdrawal by Subject|1|||
156809351|NCT03941483|566055774|FG000|Overall Study|Lost to Follow-up|2|||
156809352|NCT03941483|566055775|FG001|Overall Study|Lost to Follow-up|1|||
156809353|NCT03941483|566055776|FG002|Overall Study|Lost to Follow-up|8|||
156809354|NCT03941483|566055774|FG000|Overall Study|Death|3|||
156809355|NCT03941483|566055775|FG001|Overall Study|Death|2|||
156809356|NCT03941483|566055776|FG002|Overall Study|Death|6|||
156809357|NCT04749745|566055777|FG000|Overall Study|Withdrawal by Subject|1|||
156809358|NCT04749745|566055778|FG001|Overall Study|Withdrawal by Subject|0|||
156809359|NCT00617084|566056994|FG000|Overall Study|Withdrawal by Subject|5|||
156809360|NCT00617084|566056995|FG001|Overall Study|Withdrawal by Subject|7|||
156809361|NCT00617084|566056994|FG000|Overall Study|Missed 12 Months visit|16|||
156809362|NCT00617084|566056995|FG001|Overall Study|Missed 12 Months visit|19|||
157222223|NCT00903383|567560178|FG000|Overall Study|Withdrawal by Subject|4|||
157222224|NCT00903383|567560179|FG001|Overall Study|Withdrawal by Subject|1|||
157222225|NCT00903383|567560180|FG002|Overall Study|Withdrawal by Subject|0|||
156809363|NCT03370419|566056996|FG000|Overall Study|Lost to Follow-up|16|||
156809364|NCT01693250|566057001|FG000|Overall Study|Lost to Follow-up|2|||
156809365|NCT01693250|566057002|FG001|Overall Study|Lost to Follow-up|2|||
156809366|NCT01147965|566057003|FG000|Overall Study|Progressive Disease|3|||
156809367|NCT01147965|566057004|FG001|Overall Study|Progressive Disease|3|||
156809368|NCT01147965|566057005|FG002|Overall Study|Progressive Disease|5|||
156809369|NCT01147965|566057006|FG003|Overall Study|Progressive Disease|9|||
157222226|NCT00903383|567560181|FG003|Overall Study|Withdrawal by Subject|2|||
156809370|NCT01147965|566057007|FG004|Overall Study|Progressive Disease|5|||
156809371|NCT01147965|566057008|FG005|Overall Study|Progressive Disease|5|||
156809372|NCT01147965|566057003|FG000|Overall Study|Death|0|||
156809373|NCT01147965|566057004|FG001|Overall Study|Death|0|||
156809374|NCT01147965|566057005|FG002|Overall Study|Death|1|||
156809375|NCT01147965|566057006|FG003|Overall Study|Death|1|||
156809376|NCT01147965|566057007|FG004|Overall Study|Death|0|||
156809377|NCT01147965|566057008|FG005|Overall Study|Death|2|||
156809378|NCT01147965|566057003|FG000|Overall Study|Withdrawal by Subject|0|||
156809379|NCT01147965|566057004|FG001|Overall Study|Withdrawal by Subject|0|||
156809380|NCT01147965|566057005|FG002|Overall Study|Withdrawal by Subject|1|||
156809381|NCT01147965|566057006|FG003|Overall Study|Withdrawal by Subject|1|||
156809382|NCT01147965|566057007|FG004|Overall Study|Withdrawal by Subject|0|||
156809383|NCT01147965|566057008|FG005|Overall Study|Withdrawal by Subject|0|||
156809384|NCT01147965|566057003|FG000|Overall Study|Administration Of Alternative Therapy|0|||
156809385|NCT01147965|566057004|FG001|Overall Study|Administration Of Alternative Therapy|0|||
156809386|NCT01147965|566057005|FG002|Overall Study|Administration Of Alternative Therapy|0|||
156809387|NCT01147965|566057006|FG003|Overall Study|Administration Of Alternative Therapy|0|||
156809388|NCT01147965|566057007|FG004|Overall Study|Administration Of Alternative Therapy|0|||
156809389|NCT01147965|566057008|FG005|Overall Study|Administration Of Alternative Therapy|1|||
156809390|NCT01147965|566057003|FG000|Overall Study|Other|0|||
156809391|NCT01147965|566057004|FG001|Overall Study|Other|0|||
156809392|NCT01147965|566057005|FG002|Overall Study|Other|0|||
156809393|NCT01147965|566057006|FG003|Overall Study|Other|3|||
156809394|NCT01147965|566057007|FG004|Overall Study|Other|1|||
157022188|NCT00450658|566835152|FG000|Overall Study|Lost to Follow-up|22|||
157022189|NCT00450658|566835153|FG001|Overall Study|Lost to Follow-up|5|||
157022190|NCT00450658|566835152|FG000|Overall Study|UGI ulcer|33|||
157022191|NCT00450658|566835153|FG001|Overall Study|UGI ulcer|34|||
157022192|NCT00450658|566835152|FG000|Overall Study|misc|21|||
157145916|NCT03114969|567282137|FG006|Overall Study|Lost to Follow-up|0|||
156809395|NCT01147965|566057008|FG005|Overall Study|Other|0|||
156809396|NCT01273038|566057009|FG000|Second Intervention (14 Days)|Adverse Event|0|||
156809397|NCT01273038|566057010|FG001|Second Intervention (14 Days)|Adverse Event|1|||
156809398|NCT01273038|566057009|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156809399|NCT01273038|566057010|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156809400|NCT02197572|566057011|FG000|Overall Study|Progressive Disease|28|||
156809401|NCT02197572|566057011|FG000|Overall Study|Withdrawal by Subject|9|||
156809402|NCT02197572|566057011|FG000|Overall Study|Adverse Event|3|||
156809403|NCT02197572|566057011|FG000|Overall Study|Reason Not Specified|4|||
156809404|NCT01306643|566057012|FG000|Overall Study|Adverse Event|5|||
156809405|NCT01306643|566057012|FG000|Overall Study|Disease Progression|7|||
156809406|NCT01306643|566057012|FG000|Overall Study|Other: Change in Eligibility Status|1|||
156809407|NCT03783962|566057015|FG000|Overall Study|Lost to Follow-up|3|||
156809408|NCT03783962|566057016|FG001|Overall Study|Lost to Follow-up|6|||
156809409|NCT03783962|566057015|FG000|Overall Study|Protocol Violation|0|||
156809410|NCT03783962|566057016|FG001|Overall Study|Protocol Violation|1|||
156809411|NCT01724216|566057017|FG000|Overall Study|Scan was not completed|1|||
156809412|NCT04423939|566057018|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
156809413|NCT04423939|566057019|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
156809414|NCT04423939|566057018|FG000|Overall Study|Death|3|||
156809415|NCT04423939|566057019|FG001|Overall Study|Death|0|||
156809416|NCT04423939|566057018|FG000|Overall Study|Withdrawal by Subject|3|||
156809417|NCT04423939|566057019|FG001|Overall Study|Withdrawal by Subject|0|||
156809418|NCT04423939|566057018|FG000|Overall Study|Caregiver to patient who died|0|||
156809419|NCT04423939|566057019|FG001|Overall Study|Caregiver to patient who died|3|||
156809420|NCT04423939|566057018|FG000|Overall Study|Caregiver to patient who withdrew|0|||
156809421|NCT04423939|566057019|FG001|Overall Study|Caregiver to patient who withdrew|3|||
156809422|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
156809423|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
156809424|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
156809425|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
156809426|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
156809427|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
156809428|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
156809429|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
156809430|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
156809431|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
156809432|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
156809433|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
156809434|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
156809435|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
156809436|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
156809437|NCT01057693|566057020|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
156809438|NCT01057693|566057021|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
156809439|NCT01057693|566057022|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
156809440|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
156809441|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
157145917|NCT03114969|567282138|FG007|Overall Study|Lost to Follow-up|0|||
156809442|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
156809443|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
156809444|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
157022193|NCT00450658|566835153|FG001|Overall Study|misc|10|||
157022194|NCT05763823|566835155|FG000|Overall Study|Death|6|||
156809445|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
156809446|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
156809447|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
156809448|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
156809449|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
156809450|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
157022195|NCT05763823|566835155|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157022196|NCT05763823|566835155|FG000|Overall Study|Withdrawal by Subject|6|||
157022197|NCT00999804|566835158|FG000|Overall Study|Lack of Efficacy|9|||
157022198|NCT00999804|566835159|FG001|Overall Study|Lack of Efficacy|2|||
157022199|NCT00999804|566835158|FG000|Overall Study|Adverse Event|4|||
156809451|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
156809452|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
156809453|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
156809454|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
156809455|NCT01057693|566057020|FG000|Between Single-Blind and Double-Blind|Other|6|||
156809456|NCT01057693|566057021|FG001|Between Single-Blind and Double-Blind|Other|0|||
156809457|NCT01057693|566057022|FG002|Between Single-Blind and Double-Blind|Other|0|||
156809458|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
156809459|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
156809460|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
156809461|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
157022200|NCT00999804|566835159|FG001|Overall Study|Adverse Event|3|||
157022201|NCT00999804|566835158|FG000|Overall Study|Withdrawal by Subject|4|||
157022202|NCT00999804|566835159|FG001|Overall Study|Withdrawal by Subject|0|||
157022203|NCT00999804|566835158|FG000|Overall Study|Death|1|||
157022204|NCT00999804|566835159|FG001|Overall Study|Death|0|||
157022205|NCT00999804|566835158|FG000|Overall Study|Ineligible|3|||
157022206|NCT00999804|566835159|FG001|Overall Study|Ineligible|0|||
157022207|NCT05311384|566835160|FG000|Overall Study|Uncontrolled health conditions|2|||
157022208|NCT05311384|566835160|FG000|Overall Study|Withdrawal by Subject|1|||
157022209|NCT02724631|566835167|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
157022210|NCT03766009|566835170|FG000|Usual Care|Death|0|||
157022211|NCT03766009|566835171|FG001|Usual Care|Death|0|||
157022212|NCT03766009|566835172|FG002|Usual Care|Death|0|||
157022213|NCT03766009|566835173|FG003|Usual Care|Death|1|||
157022214|NCT03766009|566835174|FG004|Usual Care|Death|0|||
157022215|NCT03766009|566835175|FG005|Usual Care|Death|0|||
157022216|NCT03766009|566835170|FG000|Usual Care|Lost to Follow-up|0|||
157022217|NCT03766009|566835171|FG001|Usual Care|Lost to Follow-up|0|||
157022218|NCT03766009|566835172|FG002|Usual Care|Lost to Follow-up|0|||
157022219|NCT03766009|566835173|FG003|Usual Care|Lost to Follow-up|1|||
157022220|NCT03766009|566835174|FG004|Usual Care|Lost to Follow-up|0|||
157022221|NCT03766009|566835175|FG005|Usual Care|Lost to Follow-up|0|||
157022222|NCT03766009|566835170|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
157022223|NCT03766009|566835171|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
157022224|NCT03766009|566835172|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
157022225|NCT03766009|566835173|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
157022226|NCT03766009|566835174|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
157022227|NCT03766009|566835175|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
157022228|NCT03766009|566835170|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
157022229|NCT03766009|566835171|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
157022230|NCT03766009|566835172|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
157022231|NCT03766009|566835173|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
157022232|NCT03766009|566835174|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
157022233|NCT03766009|566835175|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
157022234|NCT03766009|566835170|FG000|Usual Care|No treatment or declined surgery|0|||
157022235|NCT03766009|566835171|FG001|Usual Care|No treatment or declined surgery|0|||
157022236|NCT03766009|566835172|FG002|Usual Care|No treatment or declined surgery|0|||
157022237|NCT03766009|566835173|FG003|Usual Care|No treatment or declined surgery|2|||
157022238|NCT03766009|566835174|FG004|Usual Care|No treatment or declined surgery|0|||
157022239|NCT03766009|566835175|FG005|Usual Care|No treatment or declined surgery|0|||
157022240|NCT03766009|566835170|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
157022241|NCT03766009|566835171|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
157022242|NCT03766009|566835172|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
157022243|NCT03766009|566835173|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
157022244|NCT03766009|566835174|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
157022245|NCT03766009|566835175|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
157022246|NCT03766009|566835170|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
156809462|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
156809463|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
156809464|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
156809465|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
156809466|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
156809467|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
157022247|NCT03766009|566835171|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
157022248|NCT03766009|566835172|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
157022249|NCT03766009|566835173|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
157022250|NCT03766009|566835174|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
157022251|NCT03766009|566835175|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
157022252|NCT03766009|566835170|FG000|Usual Care|Ineligible|0|||
157022253|NCT03766009|566835171|FG001|Usual Care|Ineligible|1|||
157022254|NCT03766009|566835172|FG002|Usual Care|Ineligible|0|||
157022255|NCT03766009|566835173|FG003|Usual Care|Ineligible|0|||
157022256|NCT03766009|566835174|FG004|Usual Care|Ineligible|0|||
157022257|NCT03766009|566835175|FG005|Usual Care|Ineligible|0|||
156809468|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
156809469|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
156809470|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
156809471|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
156809472|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
156809473|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
156809474|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
156809475|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
156809476|NCT01057693|566057020|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
156809477|NCT01057693|566057021|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
156809478|NCT01057693|566057022|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
156809479|NCT02413996|566057023|FG000|Overall Study|not comfortable with the intervention|9|||
156809480|NCT02413996|566057024|FG001|Overall Study|not comfortable with the intervention|2|||
156809481|NCT00709319|566057025|FG000|Overall Study|Death|4|||
156809482|NCT00709319|566057025|FG000|Overall Study|Withdrawal by Subject|2|||
156809483|NCT00579553|566057029|FG000|Overall Study|Lost to Follow-up|16|||
156809484|NCT00579553|566057030|FG001|Overall Study|Lost to Follow-up|13|||
156809485|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
156809486|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
156809487|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
156809488|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
157022258|NCT03766009|566835170|FG000|Usual Care|Other: Staff turnover|0|||
157022259|NCT03766009|566835171|FG001|Usual Care|Other: Staff turnover|0|||
157022260|NCT03766009|566835172|FG002|Usual Care|Other: Staff turnover|0|||
157022261|NCT03766009|566835173|FG003|Usual Care|Other: Staff turnover|0|||
157022262|NCT03766009|566835174|FG004|Usual Care|Other: Staff turnover|0|||
157022263|NCT03766009|566835175|FG005|Usual Care|Other: Staff turnover|2|||
157022264|NCT02924272|566835180|FG000|Overall Study|Site Terminated by Sponsor|4|||
157022265|NCT02924272|566835181|FG001|Overall Study|Site Terminated by Sponsor|1|||
157022266|NCT02924272|566835180|FG000|Overall Study|Withdrawal by Subject|2|||
157022267|NCT02924272|566835181|FG001|Overall Study|Withdrawal by Subject|0|||
157022268|NCT02924272|566835180|FG000|Overall Study|Adverse Event|3|||
157022269|NCT02924272|566835181|FG001|Overall Study|Adverse Event|0|||
157022270|NCT02924272|566835180|FG000|Overall Study|Progressive Disease|11|||
157022271|NCT02924272|566835181|FG001|Overall Study|Progressive Disease|8|||
157022272|NCT02924272|566835180|FG000|Overall Study|Clinical Deterioration|1|||
157022273|NCT02924272|566835181|FG001|Overall Study|Clinical Deterioration|0|||
156809489|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
156809490|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
156809491|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
156809492|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
156809493|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
156809494|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
156809495|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
156809496|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
156809497|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
157022274|NCT02924272|566835180|FG000|Overall Study|Death|1|||
156809498|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
157022275|NCT02924272|566835181|FG001|Overall Study|Death|0|||
157022276|NCT02924272|566835180|FG000|Overall Study|Reason Not Specified|1|||
157022277|NCT02924272|566835181|FG001|Overall Study|Reason Not Specified|0|||
156809499|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
156809500|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
157022278|NCT03575897|566835184|FG000|Overall Study|Lost to Follow-up|12|||
156809501|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
156809502|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
157145918|NCT03114969|567282139|FG008|Overall Study|Lost to Follow-up|0|||
157145919|NCT03114969|567282131|FG000|Overall Study|Adverse Event|0|||
157145920|NCT03114969|567282132|FG001|Overall Study|Adverse Event|0|||
157145921|NCT03114969|567282133|FG002|Overall Study|Adverse Event|1|||
157145922|NCT03114969|567282134|FG003|Overall Study|Adverse Event|0|||
157145923|NCT03114969|567282135|FG004|Overall Study|Adverse Event|0|||
157145924|NCT03114969|567282136|FG005|Overall Study|Adverse Event|1|||
157145925|NCT03114969|567282137|FG006|Overall Study|Adverse Event|1|||
157145926|NCT03114969|567282138|FG007|Overall Study|Adverse Event|0|||
157145927|NCT03114969|567282139|FG008|Overall Study|Adverse Event|2|||
157145928|NCT02168946|567282142|FG000|Overall Study|Adverse Event|8|||
157145929|NCT02168946|567282143|FG001|Overall Study|Adverse Event|5|||
157145930|NCT02168946|567282142|FG000|Overall Study|Lost to Follow-up|3|||
157145931|NCT02168946|567282143|FG001|Overall Study|Lost to Follow-up|0|||
157145932|NCT02168946|567282142|FG000|Overall Study|Subject unable to come back for visits|1|||
157145933|NCT02168946|567282143|FG001|Overall Study|Subject unable to come back for visits|0|||
157145934|NCT01743027|567282147|FG000|Overall Study|Adverse Event|2|||
157145935|NCT01743027|567282148|FG001|Overall Study|Adverse Event|0|||
157145936|NCT01743027|567282149|FG002|Overall Study|Adverse Event|0|||
157145937|NCT01743027|567282150|FG003|Overall Study|Adverse Event|0|||
157145938|NCT01743027|567282147|FG000|Overall Study|Lost to Follow-up|0|||
157145939|NCT01743027|567282148|FG001|Overall Study|Lost to Follow-up|0|||
157145940|NCT01743027|567282149|FG002|Overall Study|Lost to Follow-up|2|||
157145941|NCT01743027|567282150|FG003|Overall Study|Lost to Follow-up|0|||
157145942|NCT01743027|567282147|FG000|Overall Study|Progressive Disease|1|||
157145943|NCT01743027|567282148|FG001|Overall Study|Progressive Disease|4|||
157145944|NCT01743027|567282149|FG002|Overall Study|Progressive Disease|3|||
157145945|NCT01743027|567282150|FG003|Overall Study|Progressive Disease|0|||
157145946|NCT01743027|567282147|FG000|Overall Study|Protocol Violation|1|||
157145947|NCT01743027|567282148|FG001|Overall Study|Protocol Violation|1|||
157145948|NCT01743027|567282149|FG002|Overall Study|Protocol Violation|1|||
157145949|NCT01743027|567282150|FG003|Overall Study|Protocol Violation|0|||
157145950|NCT01743027|567282147|FG000|Overall Study|Withdrawal by Subject|1|||
157145951|NCT01743027|567282148|FG001|Overall Study|Withdrawal by Subject|0|||
157145952|NCT01743027|567282149|FG002|Overall Study|Withdrawal by Subject|3|||
157145953|NCT01743027|567282150|FG003|Overall Study|Withdrawal by Subject|1|||
157145954|NCT00450866|567282151|FG000|Overall Study|Adverse Event|0|||
157145955|NCT00450866|567282152|FG001|Overall Study|Adverse Event|1|||
157145956|NCT00450866|567282151|FG000|Overall Study|Withdrawal by Subject|5|||
157145957|NCT00450866|567282152|FG001|Overall Study|Withdrawal by Subject|2|||
157145958|NCT00450866|567282151|FG000|Overall Study|Death|1|||
157145959|NCT00450866|567282152|FG001|Overall Study|Death|0|||
157145960|NCT00450866|567282151|FG000|Overall Study|Physician Decision|1|||
157145961|NCT00450866|567282152|FG001|Overall Study|Physician Decision|0|||
157145962|NCT01753518|567282153|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
157145963|NCT01753518|567282154|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
157145964|NCT01753518|567282153|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
157145965|NCT01753518|567282154|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
157145966|NCT01753518|567282153|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
157145967|NCT01753518|567282154|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
157145968|NCT01753518|567282153|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
157145969|NCT01753518|567282154|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
157145970|NCT01971476|567282155|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
157145971|NCT01971476|567282156|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
157145972|NCT01971476|567282157|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
157145973|NCT01971476|567282155|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
157145974|NCT01971476|567282156|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
157145975|NCT01971476|567282157|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
157145976|NCT01971476|567282155|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
156809503|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
157145977|NCT01971476|567282156|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
157145978|NCT01971476|567282157|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
157145979|NCT00138151|567282158|FG000|Overall Study|Withdrawal by Subject|3|||
157145980|NCT00138151|567282158|FG000|Overall Study|Physician Decision|1|||
157145981|NCT04925570|567282161|FG000|Overall Study|Protocol Violation|24|||
157145982|NCT04925570|567282162|FG001|Overall Study|Protocol Violation|30|||
157145983|NCT04925570|567282161|FG000|Overall Study|Withdrawal by Subject|0|||
157145984|NCT04925570|567282162|FG001|Overall Study|Withdrawal by Subject|2|||
157145985|NCT02675517|567282163|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
157145986|NCT02675517|567282163|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
157145987|NCT03249350|567282166|FG000|Overall Study|Participant did not initiate treatment|5|||
157145988|NCT03249350|567282167|FG001|Overall Study|Participant did not initiate treatment|8|||
157145989|NCT01751646|567282180|FG000|Overall Study|Lost to Follow-up|5|||
157145990|NCT01751646|567282181|FG001|Overall Study|Lost to Follow-up|1|||
157145991|NCT01751646|567282180|FG000|Overall Study|Withdrawal by Subject|0|||
156809504|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
156809505|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
156809506|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
156809507|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
156809508|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
156809509|NCT01672879|566057031|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
156809510|NCT01672879|566057032|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
156809511|NCT01672879|566057033|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
156809512|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
156809513|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
156809514|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
156809515|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
156809516|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
156809517|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
156809518|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
156809519|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
156809520|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
156809521|NCT01672879|566057031|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
156809522|NCT01672879|566057032|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
156809523|NCT01672879|566057033|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
156809524|NCT04860869|566057034|FG000|Overall Study|Withdrawal by Subject|1|||
156809525|NCT04860869|566057035|FG001|Overall Study|Withdrawal by Subject|0|||
156809526|NCT02651116|566057038|FG000|Overall Study|Adverse Event|0|||
156809527|NCT02651116|566057039|FG001|Overall Study|Adverse Event|1|||
156809528|NCT02651116|566057038|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
156809529|NCT02651116|566057039|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
156809530|NCT01775553|566057040|FG000|Overall Study|Adverse Event|1|||
156809531|NCT01775553|566057040|FG000|Overall Study|Disease Progression|12|||
156809532|NCT04834726|566057043|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
156809533|NCT04834726|566057044|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
156809534|NCT04834726|566057045|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
156809535|NCT04834726|566057046|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
156809536|NCT04834726|566057047|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
156809537|NCT04834726|566057048|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
156809538|NCT04834726|566057049|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
156809539|NCT04834726|566057050|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
156809540|NCT04834726|566057051|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
156809541|NCT03810014|566057055|FG000|Overall Study|Pregnancy|2|||
156809542|NCT03810014|566057056|FG001|Overall Study|Pregnancy|2|||
156809543|NCT03810014|566057057|FG002|Overall Study|Pregnancy|0|||
156809544|NCT03810014|566057058|FG003|Overall Study|Pregnancy|2|||
156809545|NCT03606486|566057059|FG000|Overall Study|Unable to collect sample|5|||
156809546|NCT00442416|566057065|FG000|Overall Study|Adverse Event|4|||
156809547|NCT00442416|566057066|FG001|Overall Study|Adverse Event|1|||
156809548|NCT00442416|566057065|FG000|Overall Study|Death|1|||
156809549|NCT00442416|566057066|FG001|Overall Study|Death|0|||
156809550|NCT00442416|566057065|FG000|Overall Study|Lack of Efficacy|2|||
156809551|NCT00442416|566057066|FG001|Overall Study|Lack of Efficacy|0|||
156809552|NCT00442416|566057065|FG000|Overall Study|Protocol Violation|2|||
157222227|NCT00903383|567560178|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
157222228|NCT00903383|567560179|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
156809553|NCT00442416|566057066|FG001|Overall Study|Protocol Violation|3|||
156809554|NCT00442416|566057065|FG000|Overall Study|Withdrew consent|1|||
156809555|NCT00442416|566057066|FG001|Overall Study|Withdrew consent|2|||
156809556|NCT00442416|566057065|FG000|Overall Study|Administrative/Other|27|||
157145992|NCT01751646|567282181|FG001|Overall Study|Withdrawal by Subject|4|||
157145993|NCT01751646|567282180|FG000|Overall Study|Starting hormone therapy|1|||
157145994|NCT01751646|567282181|FG001|Overall Study|Starting hormone therapy|0|||
157145995|NCT01751646|567282180|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
157145996|NCT01751646|567282181|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
157145997|NCT01751646|567282180|FG000|Overall Study|Inadvertent enrollment|1|||
157145998|NCT01751646|567282181|FG001|Overall Study|Inadvertent enrollment|1|||
157145999|NCT01751646|567282180|FG000|Overall Study|Moved out of the area|1|||
157146000|NCT01751646|567282181|FG001|Overall Study|Moved out of the area|5|||
157146001|NCT01751646|567282180|FG000|Overall Study|Inability to attend required visits|0|||
157146002|NCT01751646|567282181|FG001|Overall Study|Inability to attend required visits|1|||
157146003|NCT01751646|567282180|FG000|Overall Study|Off study due to multiple obligations|0|||
157146004|NCT01751646|567282181|FG001|Overall Study|Off study due to multiple obligations|1|||
157146005|NCT01751646|567282180|FG000|Overall Study|Fails to comply with study requirements|0|||
156809557|NCT00442416|566057066|FG001|Overall Study|Administrative/Other|33|||
156809558|NCT00503425|566057076|FG000|Overall Study|Participant files lost|6|||
156809559|NCT00503425|566057076|FG000|Overall Study|Adverse Event|5|||
156809560|NCT00503425|566057076|FG000|Overall Study|Lack of Efficacy|25|||
156809561|NCT00503425|566057076|FG000|Overall Study|Withdrawal by Subject|8|||
156809562|NCT00503425|566057076|FG000|Overall Study|Lost to Follow-up|3|||
156809563|NCT00503425|566057076|FG000|Overall Study|Death|3|||
156809564|NCT00503425|566057076|FG000|Overall Study|Missing Data/Unknown|4|||
157222229|NCT00903383|567560180|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
157222230|NCT00903383|567560181|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
157222231|NCT00903383|567560178|FG000|Overall Study|Patient Decision|0|||
157222232|NCT00903383|567560179|FG001|Overall Study|Patient Decision|0|||
157222233|NCT00903383|567560180|FG002|Overall Study|Patient Decision|0|||
157222234|NCT00903383|567560181|FG003|Overall Study|Patient Decision|1|||
157222235|NCT02015793|567560186|FG000|Overall Study|Adverse Event|3|||
157222236|NCT02015793|567560187|FG001|Overall Study|Adverse Event|3|||
157222237|NCT02015793|567560186|FG000|Overall Study|Withdrawal by Subject|1|||
157222238|NCT02015793|567560187|FG001|Overall Study|Withdrawal by Subject|1|||
157222239|NCT00320593|567560188|FG000|Overall Study|Lost to Follow-up|3|||
157222240|NCT00320593|567560189|FG001|Overall Study|Lost to Follow-up|0|||
157222241|NCT00320593|567560188|FG000|Overall Study|Moved to another state|1|||
157222242|NCT00320593|567560189|FG001|Overall Study|Moved to another state|0|||
156809565|NCT02148263|566057077|FG000|Overall Study|Withdrawal by Subject|3|||
156809566|NCT02148263|566057078|FG001|Overall Study|Withdrawal by Subject|2|||
156809567|NCT00003869|566057079|FG000|Overall Study|Adverse Event|14|||
157222243|NCT00320593|567560188|FG000|Overall Study|Withdrawal by Subject|2|||
157222244|NCT00320593|567560189|FG001|Overall Study|Withdrawal by Subject|1|||
157222245|NCT00320593|567560188|FG000|Overall Study|Withdrawal by clinical center|1|||
157222246|NCT00320593|567560189|FG001|Overall Study|Withdrawal by clinical center|0|||
157222247|NCT00283686|567560190|FG000|Overall Study|Death|1|||
157222248|NCT00283686|567560191|FG001|Overall Study|Death|1|||
157222249|NCT00283686|567560192|FG002|Overall Study|Death|1|||
157222250|NCT00283686|567560193|FG003|Overall Study|Death|0|||
157222251|NCT00283686|567560190|FG000|Overall Study|Lost to Follow-up|21|||
157222252|NCT00283686|567560191|FG001|Overall Study|Lost to Follow-up|31|||
157222253|NCT00283686|567560192|FG002|Overall Study|Lost to Follow-up|26|||
157222254|NCT00283686|567560193|FG003|Overall Study|Lost to Follow-up|20|||
157222255|NCT00283686|567560190|FG000|Overall Study|Less than full participation|7|||
157222256|NCT00283686|567560191|FG001|Overall Study|Less than full participation|9|||
157222257|NCT00283686|567560192|FG002|Overall Study|Less than full participation|6|||
156809568|NCT00003869|566057080|FG001|Overall Study|Adverse Event|3|||
156809569|NCT00003869|566057079|FG000|Overall Study|Withdrawal by Subject|21|||
156809570|NCT00003869|566057080|FG001|Overall Study|Withdrawal by Subject|3|||
156809571|NCT00003869|566057079|FG000|Overall Study|Death|1|||
156809572|NCT00003869|566057080|FG001|Overall Study|Death|2|||
156809573|NCT00003869|566057079|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
156809574|NCT00003869|566057080|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
156809575|NCT03364231|566057081|FG000|Overall Study|Adverse Event|1|||
156809576|NCT03364231|566057082|FG001|Overall Study|Adverse Event|4|||
156809577|NCT03364231|566057081|FG000|Overall Study|Death|1|||
156809578|NCT03364231|566057082|FG001|Overall Study|Death|0|||
156809579|NCT03364231|566057081|FG000|Overall Study|Investigator Decision|2|||
156809580|NCT03364231|566057082|FG001|Overall Study|Investigator Decision|2|||
156809581|NCT03364231|566057081|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
156809582|NCT03364231|566057082|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
156809583|NCT03364231|566057081|FG000|Overall Study|Withdrawal of Subject Consent|1|||
156809584|NCT03364231|566057082|FG001|Overall Study|Withdrawal of Subject Consent|0|||
156809585|NCT03364231|566057081|FG000|Overall Study|Reason Not Specified|1|||
156809586|NCT03364231|566057082|FG001|Overall Study|Reason Not Specified|0|||
156809587|NCT03364231|566057081|FG000|Overall Study|Disease Progression|0|||
156809588|NCT03364231|566057082|FG001|Overall Study|Disease Progression|6|||
156809589|NCT02534883|566057089|FG000|Overall Study|Early Termination|8|||
156809590|NCT02534883|566057090|FG001|Overall Study|Early Termination|3|||
157222258|NCT00283686|567560193|FG003|Overall Study|Less than full participation|12|||
157222259|NCT01076166|567560194|FG000|Overall Study|Adverse Event|3|||
157222260|NCT01076166|567560194|FG000|Overall Study|Symptoms improved/resolved|6|||
157222261|NCT01716754|567560195|FG000|Overall Study|Death|0|||
157222262|NCT01716754|567560196|FG001|Overall Study|Death|0|||
157222263|NCT01716754|567560197|FG002|Overall Study|Death|0|||
156809591|NCT00886769|566057091|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156809592|NCT00886769|566057092|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
156809593|NCT03328832|566057093|FG000|Overall Study|Lost to Follow-up|0|||
156809594|NCT03328832|566057094|FG001|Overall Study|Lost to Follow-up|1|||
156809595|NCT00778336|566057095|FG000|Index Procedure-Discharge|Death|6|||
156809596|NCT00778336|566057096|FG001|Index Procedure-Discharge|Death|3|||
157222264|NCT01716754|567560198|FG003|Overall Study|Death|1|||
156809597|NCT00778336|566057097|FG002|Index Procedure-Discharge|Death|2|||
156809598|NCT00778336|566057098|FG003|Index Procedure-Discharge|Death|0|||
156809599|NCT00778336|566057095|FG000|3 Month Follow Up|Lost to Follow-up|15|||
156809600|NCT00778336|566057096|FG001|3 Month Follow Up|Lost to Follow-up|20|||
156809601|NCT00778336|566057097|FG002|3 Month Follow Up|Lost to Follow-up|3|||
156809602|NCT00778336|566057098|FG003|3 Month Follow Up|Lost to Follow-up|0|||
156809603|NCT00778336|566057095|FG000|3 Month Follow Up|Death|8|||
156809604|NCT00778336|566057096|FG001|3 Month Follow Up|Death|3|||
156809605|NCT00778336|566057097|FG002|3 Month Follow Up|Death|2|||
156809606|NCT00778336|566057098|FG003|3 Month Follow Up|Death|0|||
156809607|NCT00414076|566057101|FG000|Overall Study|Progression|1|||
156809608|NCT00414076|566057102|FG001|Overall Study|Progression|2|||
156809609|NCT00414076|566057101|FG000|Overall Study|Withdrawal by Subject|1|||
157146006|NCT01751646|567282181|FG001|Overall Study|Fails to comply with study requirements|1|||
157146007|NCT01751646|567282180|FG000|Overall Study|Childcare issues|1|||
157146008|NCT01751646|567282181|FG001|Overall Study|Childcare issues|1|||
157146009|NCT02973815|567282182|FG000|Post Intervention|Death|1|||
157146010|NCT02973815|567282183|FG001|Post Intervention|Death|0|||
157146011|NCT02973815|567282182|FG000|Post Intervention|Lost to Follow-up|7|||
157146012|NCT02973815|567282183|FG001|Post Intervention|Lost to Follow-up|24|||
157146013|NCT02973815|567282182|FG000|Follow-up|Lost to Follow-up|2|||
157146014|NCT02973815|567282183|FG001|Follow-up|Lost to Follow-up|0|||
157146015|NCT02426086|567282184|FG000|Overall Study|Death|33|||
157146016|NCT02426086|567282185|FG001|Overall Study|Death|36|||
157146017|NCT02426086|567282184|FG000|Overall Study|Lost to Follow-up|2|||
157146018|NCT02426086|567282185|FG001|Overall Study|Lost to Follow-up|0|||
157146019|NCT02426086|567282184|FG000|Overall Study|Study Terminated by Sponsor|5|||
157146020|NCT02426086|567282185|FG001|Overall Study|Study Terminated by Sponsor|14|||
157146021|NCT02426086|567282184|FG000|Overall Study|Withdrawal by Subject|8|||
157146022|NCT02426086|567282185|FG001|Overall Study|Withdrawal by Subject|9|||
157146023|NCT04542291|567282186|FG000|Overall Study|Adverse Event|1|||
157146024|NCT04542291|567282186|FG000|Overall Study|Physician Decision|2|||
157146025|NCT03478683|567282187|FG000|Overall Study|Adverse Event|5|||
157146026|NCT03478683|567282188|FG001|Overall Study|Adverse Event|3|||
157146027|NCT03478683|567282187|FG000|Overall Study|Lost to Follow-up|0|||
157146028|NCT03478683|567282188|FG001|Overall Study|Lost to Follow-up|5|||
157146029|NCT03478683|567282187|FG000|Overall Study|Physician Decision|1|||
157146030|NCT03478683|567282188|FG001|Overall Study|Physician Decision|3|||
157146031|NCT03478683|567282187|FG000|Overall Study|Withdrawal by Subject|7|||
157146032|NCT03478683|567282188|FG001|Overall Study|Withdrawal by Subject|7|||
157146033|NCT00524303|567282189|FG000|Overall Study|Lost to Follow-up|6|||
157146034|NCT00524303|567282190|FG001|Overall Study|Lost to Follow-up|0|||
157146035|NCT00524303|567282191|FG002|Overall Study|Lost to Follow-up|3|||
157146036|NCT00524303|567282189|FG000|Overall Study|Protocol Violation|0|||
157146037|NCT00524303|567282190|FG001|Overall Study|Protocol Violation|1|||
157146038|NCT00524303|567282191|FG002|Overall Study|Protocol Violation|1|||
157146039|NCT00524303|567282189|FG000|Overall Study|Withdrawal by Subject|3|||
157146040|NCT00524303|567282190|FG001|Overall Study|Withdrawal by Subject|0|||
157146041|NCT00524303|567282191|FG002|Overall Study|Withdrawal by Subject|4|||
157146042|NCT00524303|567282189|FG000|Overall Study|Death|0|||
157146043|NCT00524303|567282190|FG001|Overall Study|Death|2|||
157146044|NCT00524303|567282191|FG002|Overall Study|Death|3|||
157146045|NCT00524303|567282189|FG000|Overall Study|Adverse Event|1|||
157146046|NCT00524303|567282190|FG001|Overall Study|Adverse Event|2|||
157146047|NCT00524303|567282191|FG002|Overall Study|Adverse Event|3|||
157146048|NCT00524303|567282189|FG000|Overall Study|Did not Complete Study Dosing|1|||
157146049|NCT00524303|567282190|FG001|Overall Study|Did not Complete Study Dosing|0|||
157146050|NCT00524303|567282191|FG002|Overall Study|Did not Complete Study Dosing|0|||
157146051|NCT00524303|567282189|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
157146052|NCT00524303|567282190|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
156809610|NCT00414076|566057102|FG001|Overall Study|Withdrawal by Subject|3|||
156809611|NCT00414076|566057101|FG000|Overall Study|Adverse Event|1|||
156809612|NCT00414076|566057102|FG001|Overall Study|Adverse Event|0|||
156809613|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
156809614|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
156809615|NCT00049257|566057103|FG000|Carboplatin, Paclitaxel|Death|2|||
156883360|NCT03137069|566332522|FG003|Overall Study|Protocol Violation|1|||
157146053|NCT00524303|567282191|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
157146054|NCT00524303|567282189|FG000|Overall Study|Disease Progression|0|||
157222265|NCT01716754|567560195|FG000|Overall Study|Protocol deviation|0|||
156809616|NCT00049257|566057103|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
156809617|NCT02708680|566057104|FG000|Overall Study|Withdrawal by Subject|4|||
156809618|NCT02708680|566057105|FG001|Overall Study|Withdrawal by Subject|12|||
156809619|NCT02708680|566057106|FG002|Overall Study|Withdrawal by Subject|12|||
157146055|NCT00524303|567282190|FG001|Overall Study|Disease Progression|4|||
157146056|NCT00524303|567282191|FG002|Overall Study|Disease Progression|1|||
157146057|NCT00524303|567282189|FG000|Overall Study|Disease Recurrence|0|||
157146058|NCT00524303|567282190|FG001|Overall Study|Disease Recurrence|1|||
157146059|NCT00524303|567282191|FG002|Overall Study|Disease Recurrence|0|||
157146060|NCT00524303|567282189|FG000|Overall Study|Sponsor Request|0|||
157146061|NCT00524303|567282190|FG001|Overall Study|Sponsor Request|0|||
156809620|NCT02708680|566057104|FG000|Overall Study|Death|4|||
156809621|NCT02708680|566057105|FG001|Overall Study|Death|19|||
156809622|NCT02708680|566057106|FG002|Overall Study|Death|21|||
156809623|NCT02708680|566057104|FG000|Overall Study|Lost to Follow-up|0|||
156809624|NCT02708680|566057105|FG001|Overall Study|Lost to Follow-up|3|||
157146062|NCT00524303|567282191|FG002|Overall Study|Sponsor Request|1|||
157146063|NCT00524303|567282189|FG000|Overall Study|Physician Decision|0|||
157146064|NCT00524303|567282190|FG001|Overall Study|Physician Decision|0|||
157146065|NCT00524303|567282191|FG002|Overall Study|Physician Decision|1|||
157146066|NCT00524303|567282189|FG000|Overall Study|Completed 5 years|0|||
157146067|NCT00524303|567282190|FG001|Overall Study|Completed 5 years|0|||
157146068|NCT00524303|567282191|FG002|Overall Study|Completed 5 years|1|||
157146069|NCT01607892|567282197|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
157146070|NCT01607892|567282198|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
157146071|NCT01607892|567282199|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
157146072|NCT01607892|567282200|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
157146073|NCT01607892|567282201|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
157146074|NCT01607892|567282197|FG000|Overall Study|Death|4|||
157146075|NCT01607892|567282198|FG001|Overall Study|Death|2|||
157146076|NCT01607892|567282199|FG002|Overall Study|Death|8|||
157146077|NCT01607892|567282200|FG003|Overall Study|Death|10|||
157146078|NCT01607892|567282201|FG004|Overall Study|Death|3|||
157146079|NCT01607892|567282197|FG000|Overall Study|Investigator discretion|2|||
157146080|NCT01607892|567282198|FG001|Overall Study|Investigator discretion|4|||
156809625|NCT02708680|566057106|FG002|Overall Study|Lost to Follow-up|3|||
156809626|NCT02708680|566057104|FG000|Overall Study|Study Terminated By Sponsor|0|||
156809627|NCT02708680|566057105|FG001|Overall Study|Study Terminated By Sponsor|5|||
156809628|NCT02708680|566057106|FG002|Overall Study|Study Terminated By Sponsor|4|||
156809629|NCT02708680|566057104|FG000|Overall Study|Other than Specified|0|||
156809630|NCT02708680|566057105|FG001|Overall Study|Other than Specified|0|||
156809631|NCT02708680|566057106|FG002|Overall Study|Other than Specified|1|||
156809632|NCT02708680|566057104|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
156809633|NCT02708680|566057105|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
156809634|NCT02708680|566057106|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
156809635|NCT01342926|566057107|FG000|Overall Study|Adverse Event|5|||
156809636|NCT01342926|566057108|FG001|Overall Study|Adverse Event|8|||
156809637|NCT01342926|566057109|FG002|Overall Study|Adverse Event|10|||
156809638|NCT01342926|566057110|FG003|Overall Study|Adverse Event|7|||
156809639|NCT01342926|566057107|FG000|Overall Study|Lost to Follow-up|0|||
156809640|NCT01342926|566057108|FG001|Overall Study|Lost to Follow-up|1|||
156809641|NCT01342926|566057109|FG002|Overall Study|Lost to Follow-up|1|||
156809642|NCT01342926|566057110|FG003|Overall Study|Lost to Follow-up|0|||
156809643|NCT01342926|566057107|FG000|Overall Study|Investigator Discretion|2|||
156809644|NCT01342926|566057108|FG001|Overall Study|Investigator Discretion|2|||
156809645|NCT01342926|566057109|FG002|Overall Study|Investigator Discretion|0|||
156809646|NCT01342926|566057110|FG003|Overall Study|Investigator Discretion|0|||
156809647|NCT01342926|566057107|FG000|Overall Study|Withdrawal by Subject|2|||
156809648|NCT01342926|566057108|FG001|Overall Study|Withdrawal by Subject|4|||
156809649|NCT01342926|566057109|FG002|Overall Study|Withdrawal by Subject|3|||
156809650|NCT01342926|566057110|FG003|Overall Study|Withdrawal by Subject|5|||
156809651|NCT03382912|566057111|FG000|Overall Study|Physician Decision|0|||
156809652|NCT03382912|566057112|FG001|Overall Study|Physician Decision|1|||
156809653|NCT03382912|566057111|FG000|Overall Study|Sponsor Decision|6|||
156809654|NCT03382912|566057112|FG001|Overall Study|Sponsor Decision|6|||
156809655|NCT03382912|566057111|FG000|Overall Study|Withdrawal by Subject|0|||
156809656|NCT03382912|566057112|FG001|Overall Study|Withdrawal by Subject|5|||
156809657|NCT00996658|566057115|FG000|Overall Study|Adverse Event|2|||
156809658|NCT00996658|566057116|FG001|Overall Study|Adverse Event|5|||
157146081|NCT01607892|567282199|FG002|Overall Study|Investigator discretion|4|||
157146082|NCT01607892|567282200|FG003|Overall Study|Investigator discretion|8|||
157146083|NCT01607892|567282201|FG004|Overall Study|Investigator discretion|0|||
157022279|NCT03575897|566835185|FG001|Overall Study|Lost to Follow-up|13|||
157146084|NCT01607892|567282197|FG000|Overall Study|Other treatments became available|1|||
156809659|NCT00996658|566057115|FG000|Overall Study|Protocol Violation|0|||
156809660|NCT00996658|566057116|FG001|Overall Study|Protocol Violation|1|||
156809661|NCT00996658|566057115|FG000|Overall Study|Lost to Follow-up|2|||
156809662|NCT00996658|566057116|FG001|Overall Study|Lost to Follow-up|5|||
157146085|NCT01607892|567282198|FG001|Overall Study|Other treatments became available|1|||
157146086|NCT01607892|567282199|FG002|Overall Study|Other treatments became available|0|||
157146087|NCT01607892|567282200|FG003|Overall Study|Other treatments became available|0|||
157146088|NCT01607892|567282201|FG004|Overall Study|Other treatments became available|2|||
156809663|NCT00996658|566057115|FG000|Overall Study|Non-compliance issues|3|||
156809664|NCT00996658|566057116|FG001|Overall Study|Non-compliance issues|3|||
156809665|NCT00996658|566057115|FG000|Overall Study|Other|9|||
156809666|NCT00996658|566057116|FG001|Overall Study|Other|7|||
156809667|NCT02685826|566057122|FG000|Overall Study|Adverse Event|2|||
157146089|NCT01607892|567282197|FG000|Overall Study|Intercurrent illness|1|||
157146090|NCT01607892|567282198|FG001|Overall Study|Intercurrent illness|0|||
157146091|NCT01607892|567282199|FG002|Overall Study|Intercurrent illness|0|||
157146092|NCT01607892|567282200|FG003|Overall Study|Intercurrent illness|3|||
157146093|NCT01607892|567282201|FG004|Overall Study|Intercurrent illness|0|||
157146094|NCT01607892|567282197|FG000|Overall Study|Non-Compliance with study procedures|0|||
157146095|NCT01607892|567282198|FG001|Overall Study|Non-Compliance with study procedures|0|||
157146096|NCT01607892|567282199|FG002|Overall Study|Non-Compliance with study procedures|1|||
157146097|NCT01607892|567282200|FG003|Overall Study|Non-Compliance with study procedures|0|||
157146098|NCT01607892|567282201|FG004|Overall Study|Non-Compliance with study procedures|0|||
157146099|NCT01607892|567282197|FG000|Overall Study|Consent withdrawn by participant|9|||
157146100|NCT01607892|567282198|FG001|Overall Study|Consent withdrawn by participant|4|||
157146101|NCT01607892|567282199|FG002|Overall Study|Consent withdrawn by participant|24|||
157146102|NCT01607892|567282200|FG003|Overall Study|Consent withdrawn by participant|14|||
157146103|NCT01607892|567282201|FG004|Overall Study|Consent withdrawn by participant|4|||
157146104|NCT01607892|567282197|FG000|Overall Study|Disease progression|38|||
157146105|NCT01607892|567282198|FG001|Overall Study|Disease progression|13|||
157146106|NCT01607892|567282199|FG002|Overall Study|Disease progression|37|||
157146107|NCT01607892|567282200|FG003|Overall Study|Disease progression|57|||
157146108|NCT01607892|567282201|FG004|Overall Study|Disease progression|9|||
157146109|NCT01607892|567282197|FG000|Overall Study|Incidence or severity of Adverse events|3|||
157146110|NCT01607892|567282198|FG001|Overall Study|Incidence or severity of Adverse events|3|||
157146111|NCT01607892|567282199|FG002|Overall Study|Incidence or severity of Adverse events|7|||
157146112|NCT01607892|567282200|FG003|Overall Study|Incidence or severity of Adverse events|2|||
157146113|NCT01607892|567282201|FG004|Overall Study|Incidence or severity of Adverse events|6|||
157146114|NCT02273973|567282204|FG000|Overall Study|Adverse Event|4|||
157146115|NCT02273973|567282205|FG001|Overall Study|Adverse Event|0|||
157146116|NCT02273973|567282204|FG000|Overall Study|Withdrawal by Subject|2|||
157146117|NCT02273973|567282205|FG001|Overall Study|Withdrawal by Subject|3|||
157146118|NCT02273973|567282204|FG000|Overall Study|Death|1|||
157146119|NCT02273973|567282205|FG001|Overall Study|Death|0|||
157146120|NCT02273973|567282204|FG000|Overall Study|Non-compliance|1|||
157146121|NCT02273973|567282205|FG001|Overall Study|Non-compliance|0|||
157146122|NCT02273973|567282204|FG000|Overall Study|Protocol Violation|1|||
157146123|NCT02273973|567282205|FG001|Overall Study|Protocol Violation|0|||
157146124|NCT02273973|567282204|FG000|Overall Study|Progression of disease|0|||
157146125|NCT02273973|567282205|FG001|Overall Study|Progression of disease|2|||
157146126|NCT02273973|567282204|FG000|Overall Study|Lost to Follow-up|0|||
157146127|NCT02273973|567282205|FG001|Overall Study|Lost to Follow-up|1|||
157146128|NCT02273973|567282204|FG000|Overall Study|Physician Decision|0|||
157146129|NCT02273973|567282205|FG001|Overall Study|Physician Decision|1|||
157146130|NCT02273973|567282204|FG000|Overall Study|Reason not specified|0|||
157146131|NCT02273973|567282205|FG001|Overall Study|Reason not specified|1|||
157146132|NCT03022422|567282206|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
157146133|NCT03022422|567282207|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
157146134|NCT03022422|567282208|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
157146135|NCT03022422|567282209|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
157146136|NCT03022422|567282210|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
157146137|NCT03022422|567282211|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
157146138|NCT01287117|567282212|FG000|Overall Study|Adverse Event|2|||
157146139|NCT01287117|567282213|FG001|Overall Study|Adverse Event|1|||
157146140|NCT01287117|567282214|FG002|Overall Study|Adverse Event|1|||
157146141|NCT01287117|567282215|FG003|Overall Study|Adverse Event|1|||
157146142|NCT01287117|567282212|FG000|Overall Study|Lost to Follow-up|1|||
157146143|NCT01287117|567282213|FG001|Overall Study|Lost to Follow-up|1|||
157146144|NCT01287117|567282214|FG002|Overall Study|Lost to Follow-up|0|||
157146145|NCT01287117|567282215|FG003|Overall Study|Lost to Follow-up|0|||
157146146|NCT01287117|567282212|FG000|Overall Study|Physician Decision|0|||
157146147|NCT01287117|567282213|FG001|Overall Study|Physician Decision|1|||
157146148|NCT01287117|567282214|FG002|Overall Study|Physician Decision|1|||
156809668|NCT02685826|566057123|FG001|Overall Study|Adverse Event|0|||
156809669|NCT02685826|566057124|FG002|Overall Study|Adverse Event|1|||
156809670|NCT02685826|566057122|FG000|Overall Study|Progressive Disease|2|||
156809671|NCT02685826|566057123|FG001|Overall Study|Progressive Disease|1|||
156809672|NCT02685826|566057124|FG002|Overall Study|Progressive Disease|0|||
156809673|NCT02685826|566057122|FG000|Overall Study|Withdrawal by Subject|2|||
157146149|NCT01287117|567282215|FG003|Overall Study|Physician Decision|1|||
157146150|NCT01287117|567282212|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
157146151|NCT01287117|567282213|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
157146152|NCT01287117|567282214|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
157146153|NCT01287117|567282215|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
157146154|NCT01287117|567282212|FG000|Overall Study|Disease Progression|10|||
157146155|NCT01287117|567282213|FG001|Overall Study|Disease Progression|5|||
157146156|NCT01287117|567282214|FG002|Overall Study|Disease Progression|6|||
157146157|NCT01287117|567282215|FG003|Overall Study|Disease Progression|5|||
157146158|NCT01769404|567282221|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
157146159|NCT01769404|567282222|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
157146160|NCT01769404|567282221|FG000|Treatment Period 1|Withdrawal by Subject|3|||
157146161|NCT01769404|567282222|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157146162|NCT01769404|567282221|FG000|Treatment Period 1|Sponsor decision|1|||
157146163|NCT01769404|567282222|FG001|Treatment Period 1|Sponsor decision|0|||
157146164|NCT01769404|567282221|FG000|Treatment Period 2|Sponsor decision|7|||
157146165|NCT01769404|567282222|FG001|Treatment Period 2|Sponsor decision|0|||
157146166|NCT02606877|567282237|FG000|Overall Study|Adverse Event|3|||
157146167|NCT02606877|567282238|FG001|Overall Study|Adverse Event|0|||
157146168|NCT02606877|567282237|FG000|Overall Study|Non-compliance with protocol|0|||
157146169|NCT02606877|567282238|FG001|Overall Study|Non-compliance with protocol|1|||
157146170|NCT02606877|567282237|FG000|Overall Study|Other than listed above|1|||
157146171|NCT02606877|567282238|FG001|Overall Study|Other than listed above|0|||
157146172|NCT00778999|567282239|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
157146173|NCT00778999|567282240|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
157146174|NCT00778999|567282239|FG000|Overall Study|Did not receive recFSH|14|||
157146175|NCT00778999|567282240|FG001|Overall Study|Did not receive recFSH|20|||
157146176|NCT02032524|567282241|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
157146177|NCT02032524|567282242|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
157146178|NCT02032524|567282243|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
157146179|NCT02032524|567282244|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
157146180|NCT02032524|567282245|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
157146181|NCT02032524|567282246|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
157146182|NCT02032524|567282241|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
157146183|NCT02032524|567282242|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
157146184|NCT02032524|567282243|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
157146185|NCT02032524|567282244|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
157146186|NCT02032524|567282245|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
157146187|NCT02032524|567282246|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
157146188|NCT02032524|567282241|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
157146189|NCT02032524|567282242|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
157146190|NCT02032524|567282243|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
157146191|NCT02032524|567282244|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
157146192|NCT02032524|567282245|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
157146193|NCT02032524|567282246|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
157146194|NCT02032524|567282241|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
157146195|NCT02032524|567282242|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
157146196|NCT02032524|567282243|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
157146197|NCT02032524|567282244|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
157146198|NCT02032524|567282245|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
157146199|NCT02032524|567282246|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
157146200|NCT02032524|567282241|FG000|Period 2: LTS13769 Study|Other|0|||
157146201|NCT02032524|567282242|FG001|Period 2: LTS13769 Study|Other|0|||
157146202|NCT02032524|567282243|FG002|Period 2: LTS13769 Study|Other|0|||
157146203|NCT02032524|567282244|FG003|Period 2: LTS13769 Study|Other|0|||
157146204|NCT02032524|567282245|FG004|Period 2: LTS13769 Study|Other|0|||
157146205|NCT02032524|567282246|FG005|Period 2: LTS13769 Study|Other|1|||
157146206|NCT02277444|567282250|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
157146207|NCT02277444|567282250|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
157146208|NCT02277444|567282250|FG000|Treatment Period (Week 0-52)|Other|1|||
157146209|NCT02277444|567282250|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
157146210|NCT02277444|567282250|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
157146211|NCT02277444|567282250|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
157146212|NCT02277444|567282250|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
157146213|NCT02277444|567282250|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
157146214|NCT02277444|567282250|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
157146215|NCT04513158|567282251|FG000|Overall Study|Screen Failure|1|||
157146216|NCT05278104|567282252|FG000|Overall Study|Not treated|1|||
157146217|NCT05278104|567282253|FG001|Overall Study|Not treated|0|||
157146218|NCT05278104|567282252|FG000|Overall Study|Adverse Event|2|||
157146219|NCT05278104|567282253|FG001|Overall Study|Adverse Event|1|||
157146220|NCT05278104|567282252|FG000|Overall Study|Exclusion criteria not met|1|||
156883361|NCT03137069|566332523|FG004|Overall Study|Protocol Violation|1|||
157146221|NCT05278104|567282253|FG001|Overall Study|Exclusion criteria not met|0|||
157146222|NCT02031146|567283997|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
157146223|NCT02031146|567283998|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
157146224|NCT02031146|567283999|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
157146225|NCT02031146|567284000|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
157146226|NCT02031146|567284001|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
157146227|NCT02031146|567284002|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
157146228|NCT02031146|567284003|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
157146229|NCT02629393|567284006|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
157222266|NCT01716754|567560196|FG001|Overall Study|Protocol deviation|2|||
157222267|NCT01716754|567560197|FG002|Overall Study|Protocol deviation|7|||
157222268|NCT01716754|567560198|FG003|Overall Study|Protocol deviation|2|||
157222269|NCT01716754|567560195|FG000|Overall Study|Non-compliance with study treatment|0|||
157222270|NCT01716754|567560196|FG001|Overall Study|Non-compliance with study treatment|0|||
157222271|NCT01716754|567560197|FG002|Overall Study|Non-compliance with study treatment|1|||
157222272|NCT01716754|567560198|FG003|Overall Study|Non-compliance with study treatment|0|||
157222273|NCT01716754|567560195|FG000|Overall Study|Physician Decision|1|||
157222274|NCT01716754|567560196|FG001|Overall Study|Physician Decision|0|||
157222275|NCT01716754|567560197|FG002|Overall Study|Physician Decision|0|||
157222276|NCT01716754|567560198|FG003|Overall Study|Physician Decision|0|||
157222277|NCT01716754|567560195|FG000|Overall Study|Lost to Follow-up|1|||
157222278|NCT01716754|567560196|FG001|Overall Study|Lost to Follow-up|0|||
157222279|NCT01716754|567560197|FG002|Overall Study|Lost to Follow-up|0|||
157222280|NCT01716754|567560198|FG003|Overall Study|Lost to Follow-up|1|||
157222281|NCT01716754|567560195|FG000|Overall Study|Adverse Event|4|||
157222282|NCT01716754|567560196|FG001|Overall Study|Adverse Event|2|||
157222283|NCT01716754|567560197|FG002|Overall Study|Adverse Event|2|||
157222284|NCT01716754|567560198|FG003|Overall Study|Adverse Event|1|||
157222285|NCT01716754|567560195|FG000|Overall Study|Withdrawal by Subject|5|||
157222286|NCT01716754|567560196|FG001|Overall Study|Withdrawal by Subject|0|||
157222287|NCT01716754|567560197|FG002|Overall Study|Withdrawal by Subject|4|||
157222288|NCT01716754|567560198|FG003|Overall Study|Withdrawal by Subject|3|||
157222289|NCT02110706|567560216|FG000|Overall Study|Adverse Event|2|||
157222290|NCT02110706|567560217|FG001|Overall Study|Adverse Event|3|||
157222291|NCT02110706|567560216|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
157222292|NCT02110706|567560217|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
157222293|NCT01211769|567560222|FG000|Overall Study|Lost to Follow-up|7|||
157222294|NCT01211769|567560223|FG001|Overall Study|Lost to Follow-up|9|||
157222295|NCT01211769|567560224|FG002|Overall Study|Lost to Follow-up|5|||
157222296|NCT01211769|567560225|FG003|Overall Study|Lost to Follow-up|9|||
157222297|NCT01211769|567560222|FG000|Overall Study|Physician Decision|2|||
157222298|NCT01211769|567560223|FG001|Overall Study|Physician Decision|0|||
157222299|NCT01211769|567560224|FG002|Overall Study|Physician Decision|2|||
157222300|NCT01211769|567560225|FG003|Overall Study|Physician Decision|1|||
157222301|NCT01211769|567560222|FG000|Overall Study|Adverse Event|0|||
157222302|NCT01211769|567560223|FG001|Overall Study|Adverse Event|1|||
157222303|NCT01211769|567560224|FG002|Overall Study|Adverse Event|1|||
157222304|NCT01211769|567560225|FG003|Overall Study|Adverse Event|1|||
157222305|NCT00947427|567560226|FG000|Overall Study|Withdrawal by Subject|1|||
157146230|NCT02629393|567284006|FG000|Overall Study|Physician Decision|1|||
157146231|NCT01040832|567284010|FG000|Overall Study|Adverse Event|4|||
157146232|NCT01040832|567284011|FG001|Overall Study|Adverse Event|5|||
157146233|NCT01040832|567284010|FG000|Overall Study|Death|4|||
157146234|NCT01040832|567284011|FG001|Overall Study|Death|6|||
157146235|NCT01040832|567284010|FG000|Overall Study|Withdrawal by Subject|2|||
157146236|NCT01040832|567284011|FG001|Overall Study|Withdrawal by Subject|3|||
157146237|NCT01040832|567284010|FG000|Overall Study|Progressive disease|32|||
157146238|NCT01040832|567284011|FG001|Overall Study|Progressive disease|17|||
157146239|NCT01040832|567284010|FG000|Overall Study|Symptomatic deterioration|2|||
157146240|NCT01040832|567284011|FG001|Overall Study|Symptomatic deterioration|5|||
157146241|NCT01040832|567284010|FG000|Overall Study|Other|2|||
157146242|NCT01040832|567284011|FG001|Overall Study|Other|1|||
157146243|NCT00744055|567284012|FG000|Overall Study|Withdrawal by Subject|6|||
157146244|NCT00744055|567284013|FG001|Overall Study|Withdrawal by Subject|9|||
157146245|NCT00744055|567284012|FG000|Overall Study|Lack of Efficacy|0|||
157146246|NCT00744055|567284013|FG001|Overall Study|Lack of Efficacy|1|||
157222306|NCT00947427|567560227|FG001|Overall Study|Withdrawal by Subject|3|||
157222307|NCT00947427|567560226|FG000|Overall Study|Protocol Violation|0|||
157222308|NCT00947427|567560227|FG001|Overall Study|Protocol Violation|1|||
157222309|NCT01348542|567560231|FG000|Overall Study|Withdrawal by Subject|3|||
157222310|NCT01348542|567560232|FG001|Overall Study|Withdrawal by Subject|0|||
157222311|NCT02115256|567560239|FG000|Overall Study|Withdrawal by Subject|0|||
156809674|NCT02685826|566057123|FG001|Overall Study|Withdrawal by Subject|0|||
156809675|NCT02685826|566057124|FG002|Overall Study|Withdrawal by Subject|0|||
156809676|NCT02685826|566057122|FG000|Overall Study|Full Clinical Hold by FDA|19|||
157222312|NCT02115256|567560240|FG001|Overall Study|Withdrawal by Subject|1|||
156809677|NCT02685826|566057123|FG001|Overall Study|Full Clinical Hold by FDA|9|||
156809678|NCT02685826|566057124|FG002|Overall Study|Full Clinical Hold by FDA|20|||
156809679|NCT03154476|566057125|FG000|Overall Study|Lost to Follow-up|4|||
157222313|NCT00146770|567560243|FG000|Overall Study|Adverse Event|2|||
157222314|NCT00146770|567560244|FG001|Overall Study|Adverse Event|0|||
157146247|NCT00744055|567284012|FG000|Overall Study|Physician Decision|0|||
157146248|NCT00744055|567284013|FG001|Overall Study|Physician Decision|2|||
157146249|NCT00744055|567284012|FG000|Overall Study|Protocol Violation|1|||
157146250|NCT00744055|567284013|FG001|Overall Study|Protocol Violation|1|||
157222315|NCT00146770|567560243|FG000|Overall Study|Pregnancy|1|||
157222316|NCT00146770|567560244|FG001|Overall Study|Pregnancy|0|||
157222317|NCT00146770|567560243|FG000|Overall Study|Withdrawal by Subject|2|||
157222318|NCT00146770|567560244|FG001|Overall Study|Withdrawal by Subject|0|||
157222319|NCT02427607|567560245|FG000|Overall Study|Withdrawal by Subject|1|||
157222320|NCT01789320|567560246|FG000|Overall Study|Re-enrolled into study|1|||
156809680|NCT03154476|566057126|FG001|Overall Study|Lost to Follow-up|4|||
156809681|NCT01444430|566057128|FG000|Overall Study|Withdrawal by Subject|53|||
156809682|NCT01444430|566057129|FG001|Overall Study|Withdrawal by Subject|72|||
156809683|NCT01444430|566057128|FG000|Overall Study|Death|6|||
156809684|NCT01444430|566057129|FG001|Overall Study|Death|8|||
156809685|NCT01444430|566057128|FG000|Overall Study|Lost to Follow-up|2|||
156809686|NCT01444430|566057129|FG001|Overall Study|Lost to Follow-up|0|||
156809687|NCT01444430|566057128|FG000|Overall Study|CRF termination module not completed.|0|||
156809688|NCT01444430|566057129|FG001|Overall Study|CRF termination module not completed.|1|||
156809689|NCT02257242|566058689|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
156809690|NCT02257242|566058690|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809691|NCT02257242|566058691|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809692|NCT02257242|566058692|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809693|NCT02257242|566058693|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809694|NCT02257242|566058694|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809695|NCT02257242|566058695|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809696|NCT02257242|566058696|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809697|NCT02257242|566058697|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
156809698|NCT02522429|566058700|FG000|Overall Study|Lost to Follow-up|8|||
156809699|NCT02522429|566058700|FG000|Overall Study|Adverse Event|2|||
156809700|NCT02522429|566058700|FG000|Overall Study|Death|1|||
156809701|NCT02522429|566058700|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
156809702|NCT00600106|566058701|FG000|Overall Study|Withdrawal by Subject|1|||
156809703|NCT00600106|566058702|FG001|Overall Study|Withdrawal by Subject|1|||
156809704|NCT04667949|566058703|FG000|Overall Study|Adverse Event|0|||
156809705|NCT04667949|566058704|FG001|Overall Study|Adverse Event|2|||
156809706|NCT04667949|566058703|FG000|Overall Study|Lost to Follow-up|0|||
156809707|NCT04667949|566058704|FG001|Overall Study|Lost to Follow-up|1|||
156809708|NCT04667949|566058703|FG000|Overall Study|Physician Decision|0|||
156809709|NCT04667949|566058704|FG001|Overall Study|Physician Decision|2|||
156809710|NCT04667949|566058703|FG000|Overall Study|Subject decision|1|||
156809711|NCT04667949|566058704|FG001|Overall Study|Subject decision|7|||
156809712|NCT02763059|566058708|FG000|Overall Study|Lost to Follow-up|4|||
156809713|NCT02763059|566058709|FG001|Overall Study|Lost to Follow-up|1|||
156809714|NCT02763059|566058710|FG002|Overall Study|Lost to Follow-up|6|||
156809715|NCT02763059|566058708|FG000|Overall Study|Withdrawal by Subject|1|||
156809716|NCT02763059|566058709|FG001|Overall Study|Withdrawal by Subject|0|||
156809717|NCT02763059|566058710|FG002|Overall Study|Withdrawal by Subject|3|||
156809718|NCT02370368|566058711|FG000|Overall Study|Adverse Event|1|||
156809719|NCT02370368|566058712|FG001|Overall Study|Adverse Event|2|||
156809720|NCT02370368|566058711|FG000|Overall Study|Withdrawal by Subject|5|||
156809721|NCT02370368|566058712|FG001|Overall Study|Withdrawal by Subject|4|||
156809722|NCT04024436|566058713|FG000|Overall Study|Death|10|||
156809723|NCT04024436|566058714|FG001|Overall Study|Death|14|||
156809724|NCT04024436|566058715|FG002|Overall Study|Death|2|||
156809725|NCT04024436|566058716|FG003|Overall Study|Death|7|||
156809726|NCT04024436|566058713|FG000|Overall Study|Loss to follow up|1|||
156809727|NCT04024436|566058714|FG001|Overall Study|Loss to follow up|0|||
156809728|NCT04024436|566058715|FG002|Overall Study|Loss to follow up|0|||
156809729|NCT04024436|566058716|FG003|Overall Study|Loss to follow up|1|||
156809730|NCT04024436|566058713|FG000|Overall Study|Withdrawal of consent|2|||
156809731|NCT04024436|566058714|FG001|Overall Study|Withdrawal of consent|0|||
156809732|NCT04024436|566058715|FG002|Overall Study|Withdrawal of consent|0|||
156809733|NCT04024436|566058716|FG003|Overall Study|Withdrawal of consent|1|||
156809734|NCT04024436|566058713|FG000|Overall Study|Study termination by sponsor|4|||
157222321|NCT01789320|567560246|FG000|Overall Study|Lost to Follow-up|1|||
156809735|NCT04024436|566058714|FG001|Overall Study|Study termination by sponsor|6|||
156809736|NCT04024436|566058715|FG002|Overall Study|Study termination by sponsor|2|||
156809737|NCT04024436|566058716|FG003|Overall Study|Study termination by sponsor|11|||
156809738|NCT04024436|566058713|FG000|Overall Study|Reason Not Specified|0|||
156809739|NCT04024436|566058714|FG001|Overall Study|Reason Not Specified|1|||
156809740|NCT04024436|566058715|FG002|Overall Study|Reason Not Specified|0|||
156809741|NCT04024436|566058716|FG003|Overall Study|Reason Not Specified|2|||
156809742|NCT01169337|566058717|FG000|Overall Study|Lack of Efficacy|5|||
156809743|NCT01169337|566058718|FG001|Overall Study|Lack of Efficacy|7|||
156809744|NCT01169337|566058719|FG002|Overall Study|Lack of Efficacy|0|||
156809745|NCT01169337|566058717|FG000|Overall Study|Adverse Event|12|||
156809746|NCT01169337|566058718|FG001|Overall Study|Adverse Event|18|||
157146251|NCT00744055|567284012|FG000|Overall Study|Lost to Follow-up|0|||
157146252|NCT00744055|567284013|FG001|Overall Study|Lost to Follow-up|1|||
157146253|NCT04426630|567284014|FG000|Overall Study|Death|4|||
157146254|NCT04426630|567284014|FG000|Overall Study|Lost to Follow-up|2|||
157146255|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
157146256|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
157146257|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
157146258|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
157146259|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
157146260|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
157146261|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
157146262|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
157146263|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
157146264|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
157146265|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
157146266|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
157146267|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
157146268|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
157146269|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
157146270|NCT01330381|567284015|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
157146271|NCT01330381|567284016|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
157146272|NCT01330381|567284017|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
157146273|NCT01330381|567284015|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
157146274|NCT01330381|567284016|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
157146275|NCT01330381|567284017|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
157146276|NCT01330381|567284015|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
157146277|NCT01330381|567284016|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
157146278|NCT01330381|567284017|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
157146279|NCT01330381|567284015|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
157146280|NCT01330381|567284016|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
157146281|NCT01330381|567284017|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
157146282|NCT01330381|567284015|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
157146283|NCT01330381|567284016|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
157146284|NCT01330381|567284017|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
157146285|NCT02413255|567284020|FG000|Overall Study|Voluntary Withdrawal|0|||
157146286|NCT02413255|567284021|FG001|Overall Study|Voluntary Withdrawal|0|||
157146287|NCT02413255|567284022|FG002|Overall Study|Voluntary Withdrawal|0|||
157146288|NCT02413255|567284023|FG003|Overall Study|Voluntary Withdrawal|0|||
157146289|NCT02413255|567284024|FG004|Overall Study|Voluntary Withdrawal|0|||
157146290|NCT02413255|567284025|FG005|Overall Study|Voluntary Withdrawal|0|||
157146291|NCT02413255|567284026|FG006|Overall Study|Voluntary Withdrawal|0|||
157146292|NCT02413255|567284027|FG007|Overall Study|Voluntary Withdrawal|0|||
157146293|NCT02413255|567284028|FG008|Overall Study|Voluntary Withdrawal|0|||
157146294|NCT02413255|567284029|FG009|Overall Study|Voluntary Withdrawal|0|||
157146295|NCT02413255|567284030|FG010|Overall Study|Voluntary Withdrawal|0|||
157146296|NCT02413255|567284031|FG011|Overall Study|Voluntary Withdrawal|0|||
157146297|NCT02413255|567284032|FG012|Overall Study|Voluntary Withdrawal|0|||
157146298|NCT02413255|567284033|FG013|Overall Study|Voluntary Withdrawal|0|||
157146299|NCT02413255|567284034|FG014|Overall Study|Voluntary Withdrawal|1|||
157146300|NCT02413255|567284035|FG015|Overall Study|Voluntary Withdrawal|0|||
157146301|NCT02413255|567284036|FG016|Overall Study|Voluntary Withdrawal|0|||
157146302|NCT00779038|567284040|FG000|Overall Study|Study Prematurely Terminated|13|||
157146303|NCT05372315|567284041|FG000|Overall Study|Withdrawal by Subject|1|||
157146304|NCT05372315|567284042|FG001|Overall Study|Withdrawal by Subject|0|||
157146305|NCT00650585|567284043|FG000|Overall Study|Lost to Follow-up|505|||
157146306|NCT00650585|567284044|FG001|Overall Study|Lost to Follow-up|482|||
157146307|NCT00650585|567284043|FG000|Overall Study|No parental consent|935|||
157146308|NCT00650585|567284044|FG001|Overall Study|No parental consent|866|||
157146309|NCT00650585|567284043|FG000|Overall Study|Excluded/ruled ineligible|357|||
157146310|NCT00650585|567284044|FG001|Overall Study|Excluded/ruled ineligible|129|||
157146311|NCT03472534|567284045|FG000|Overall Study|Withdrawal by Subject|9|||
157146312|NCT03472534|567284045|FG000|Overall Study|Adverse Event|2|||
157146313|NCT01856673|567284051|FG000|Overall Study|Withdrawal by Subject|44|||
157222322|NCT02826603|567560247|FG000|Overall Study|Adverse Event|17|||
157222323|NCT02826603|567560248|FG001|Overall Study|Adverse Event|9|||
157146314|NCT01856673|567284052|FG001|Overall Study|Withdrawal by Subject|50|||
157146315|NCT01856673|567284053|FG002|Overall Study|Withdrawal by Subject|33|||
157146316|NCT01856673|567284051|FG000|Overall Study|Lost to Follow-up|31|||
157146317|NCT01856673|567284052|FG001|Overall Study|Lost to Follow-up|34|||
157146318|NCT01856673|567284053|FG002|Overall Study|Lost to Follow-up|0|||
157146319|NCT01856673|567284051|FG000|Overall Study|Unknown reasons|9|||
156809747|NCT01169337|566058719|FG002|Overall Study|Adverse Event|0|||
156809748|NCT01169337|566058717|FG000|Overall Study|Death|2|||
156809749|NCT01169337|566058718|FG001|Overall Study|Death|0|||
156809750|NCT01169337|566058719|FG002|Overall Study|Death|0|||
156809751|NCT01169337|566058717|FG000|Overall Study|Withdrawal by Subject|11|||
156809752|NCT01169337|566058718|FG001|Overall Study|Withdrawal by Subject|11|||
156809753|NCT01169337|566058719|FG002|Overall Study|Withdrawal by Subject|6|||
156809754|NCT01169337|566058717|FG000|Overall Study|Noncompliance|2|||
156809755|NCT01169337|566058718|FG001|Overall Study|Noncompliance|0|||
156809756|NCT01169337|566058719|FG002|Overall Study|Noncompliance|0|||
156809757|NCT01169337|566058717|FG000|Overall Study|Other complicating disease|1|||
156809758|NCT01169337|566058718|FG001|Overall Study|Other complicating disease|1|||
156809759|NCT01169337|566058719|FG002|Overall Study|Other complicating disease|0|||
156809760|NCT01169337|566058717|FG000|Overall Study|Physician Decision|1|||
156809761|NCT01169337|566058718|FG001|Overall Study|Physician Decision|5|||
156809762|NCT01169337|566058719|FG002|Overall Study|Physician Decision|0|||
156809763|NCT01169337|566058717|FG000|Overall Study|Alternative therapy|0|||
156809764|NCT01169337|566058718|FG001|Overall Study|Alternative therapy|2|||
156809765|NCT01169337|566058719|FG002|Overall Study|Alternative therapy|0|||
156809766|NCT01169337|566058717|FG000|Overall Study|Changed hospital|0|||
156809767|NCT01169337|566058718|FG001|Overall Study|Changed hospital|1|||
156809768|NCT01169337|566058719|FG002|Overall Study|Changed hospital|0|||
156809769|NCT01169337|566058717|FG000|Overall Study|Never started treatment|0|||
156809770|NCT01169337|566058718|FG001|Overall Study|Never started treatment|2|||
156809771|NCT01169337|566058719|FG002|Overall Study|Never started treatment|0|||
156809772|NCT01169337|566058717|FG000|Overall Study|Reason not reported|1|||
156809773|NCT01169337|566058718|FG001|Overall Study|Reason not reported|0|||
156809774|NCT01169337|566058719|FG002|Overall Study|Reason not reported|0|||
156809775|NCT01169337|566058717|FG000|Overall Study|Continuing lenalidomide|9|||
156809776|NCT01169337|566058718|FG001|Overall Study|Continuing lenalidomide|43|||
156809777|NCT01169337|566058719|FG002|Overall Study|Continuing lenalidomide|0|||
156809778|NCT01134614|566058720|FG000|Overall Study|Still on treatment as of March 2013|21|||
156809779|NCT01134614|566058721|FG001|Overall Study|Still on treatment as of March 2013|13|||
156809780|NCT01134614|566058720|FG000|Overall Study|Progressive disease|60|||
156809781|NCT01134614|566058721|FG001|Overall Study|Progressive disease|54|||
156809782|NCT01134614|566058720|FG000|Overall Study|Adverse Event|26|||
156809783|NCT01134614|566058721|FG001|Overall Study|Adverse Event|39|||
156809784|NCT01134614|566058720|FG000|Overall Study|Death|5|||
156809785|NCT01134614|566058721|FG001|Overall Study|Death|8|||
156809786|NCT01134614|566058720|FG000|Overall Study|Withdrawal by Subject|3|||
156809787|NCT01134614|566058721|FG001|Overall Study|Withdrawal by Subject|2|||
156809788|NCT01134614|566058720|FG000|Overall Study|Alternative therapy|2|||
156809789|NCT01134614|566058721|FG001|Overall Study|Alternative therapy|0|||
156809790|NCT01134614|566058720|FG000|Overall Study|Complicating disease|2|||
156809791|NCT01134614|566058721|FG001|Overall Study|Complicating disease|1|||
156809792|NCT01134614|566058720|FG000|Overall Study|Physician's decision|0|||
156809793|NCT01134614|566058721|FG001|Overall Study|Physician's decision|1|||
156809794|NCT01134614|566058720|FG000|Overall Study|Never started treatment|4|||
156809795|NCT01134614|566058721|FG001|Overall Study|Never started treatment|1|||
156809796|NCT01134614|566058720|FG000|Overall Study|Pt received tx not allowed on study|0|||
156809797|NCT01134614|566058721|FG001|Overall Study|Pt received tx not allowed on study|1|||
156809798|NCT01134614|566058720|FG000|Overall Study|Symptomatic deterioration|0|||
156809799|NCT01134614|566058721|FG001|Overall Study|Symptomatic deterioration|1|||
156809800|NCT01134614|566058720|FG000|Overall Study|Patient in hospice care|0|||
156809801|NCT01134614|566058721|FG001|Overall Study|Patient in hospice care|1|||
156809802|NCT00540592|566058722|FG000|Overall Study|Adverse Event|0|||
156809803|NCT00540592|566058723|FG001|Overall Study|Adverse Event|1|||
156809804|NCT00540592|566058724|FG002|Overall Study|Adverse Event|0|||
156809805|NCT00540592|566058725|FG003|Overall Study|Adverse Event|0|||
156809806|NCT00540592|566058726|FG004|Overall Study|Adverse Event|1|||
156809807|NCT00540592|566058727|FG005|Overall Study|Adverse Event|0|||
156809808|NCT00540592|566058728|FG006|Overall Study|Adverse Event|0|||
156809809|NCT00540592|566058729|FG007|Overall Study|Adverse Event|1|||
156809810|NCT00540592|566058730|FG008|Overall Study|Adverse Event|1|||
156809811|NCT00540592|566058731|FG009|Overall Study|Adverse Event|2|||
156809812|NCT00540592|566058722|FG000|Overall Study|Lost to Follow-up|2|||
156809813|NCT00540592|566058723|FG001|Overall Study|Lost to Follow-up|0|||
156809814|NCT00540592|566058724|FG002|Overall Study|Lost to Follow-up|0|||
156809815|NCT00540592|566058725|FG003|Overall Study|Lost to Follow-up|0|||
156809816|NCT00540592|566058726|FG004|Overall Study|Lost to Follow-up|0|||
156809817|NCT00540592|566058727|FG005|Overall Study|Lost to Follow-up|0|||
156809818|NCT00540592|566058728|FG006|Overall Study|Lost to Follow-up|0|||
156809819|NCT00540592|566058729|FG007|Overall Study|Lost to Follow-up|0|||
156809820|NCT00540592|566058730|FG008|Overall Study|Lost to Follow-up|0|||
156809821|NCT00540592|566058731|FG009|Overall Study|Lost to Follow-up|0|||
156809822|NCT00540592|566058722|FG000|Overall Study|Withdrawal by Subject|0|||
156809823|NCT00540592|566058723|FG001|Overall Study|Withdrawal by Subject|0|||
156809824|NCT00540592|566058724|FG002|Overall Study|Withdrawal by Subject|1|||
156809825|NCT00540592|566058725|FG003|Overall Study|Withdrawal by Subject|1|||
157146320|NCT01856673|567284052|FG001|Overall Study|Unknown reasons|0|||
157146321|NCT01856673|567284053|FG002|Overall Study|Unknown reasons|0|||
157146322|NCT01856673|567284051|FG000|Overall Study|Psychologist decision|1|||
157146323|NCT01856673|567284052|FG001|Overall Study|Psychologist decision|0|||
157146324|NCT01856673|567284053|FG002|Overall Study|Psychologist decision|0|||
157146325|NCT01856673|567284051|FG000|Overall Study|Paperwork errors|8|||
157146326|NCT01856673|567284052|FG001|Overall Study|Paperwork errors|0|||
157146327|NCT01856673|567284053|FG002|Overall Study|Paperwork errors|0|||
157146328|NCT01856673|567284051|FG000|Overall Study|Death|1|||
157146329|NCT01856673|567284052|FG001|Overall Study|Death|1|||
157146330|NCT01856673|567284053|FG002|Overall Study|Death|0|||
157146331|NCT01856673|567284051|FG000|Overall Study|Protocol Violation|1|||
157146332|NCT01856673|567284052|FG001|Overall Study|Protocol Violation|0|||
157146333|NCT01856673|567284053|FG002|Overall Study|Protocol Violation|1|||
157146334|NCT00491530|567284054|FG000|Overall Study|Adverse Event|6|||
157146335|NCT00491530|567284055|FG001|Overall Study|Adverse Event|1|||
157146336|NCT00491530|567284056|FG002|Overall Study|Adverse Event|2|||
157146337|NCT00491530|567284054|FG000|Overall Study|Withdrawal by Subject|3|||
157146338|NCT00491530|567284055|FG001|Overall Study|Withdrawal by Subject|0|||
157146339|NCT00491530|567284056|FG002|Overall Study|Withdrawal by Subject|0|||
157146340|NCT00491530|567284054|FG000|Overall Study|Lost to Follow-up|3|||
157146341|NCT00491530|567284055|FG001|Overall Study|Lost to Follow-up|2|||
157146342|NCT00491530|567284056|FG002|Overall Study|Lost to Follow-up|2|||
157146343|NCT00491530|567284054|FG000|Overall Study|Lack of Efficacy|0|||
157146344|NCT00491530|567284055|FG001|Overall Study|Lack of Efficacy|1|||
157146345|NCT00491530|567284056|FG002|Overall Study|Lack of Efficacy|0|||
157146346|NCT00491530|567284054|FG000|Overall Study|Investigator Discretion|0|||
157146347|NCT00491530|567284055|FG001|Overall Study|Investigator Discretion|1|||
156809826|NCT00540592|566058726|FG004|Overall Study|Withdrawal by Subject|0|||
156809827|NCT00540592|566058727|FG005|Overall Study|Withdrawal by Subject|0|||
156809828|NCT00540592|566058728|FG006|Overall Study|Withdrawal by Subject|0|||
156809829|NCT00540592|566058729|FG007|Overall Study|Withdrawal by Subject|0|||
157146348|NCT00491530|567284056|FG002|Overall Study|Investigator Discretion|0|||
156809830|NCT00540592|566058730|FG008|Overall Study|Withdrawal by Subject|0|||
156809831|NCT00540592|566058731|FG009|Overall Study|Withdrawal by Subject|0|||
157146349|NCT00491530|567284054|FG000|Overall Study|Patient Request|0|||
157146350|NCT00491530|567284055|FG001|Overall Study|Patient Request|1|||
157146351|NCT00491530|567284056|FG002|Overall Study|Patient Request|0|||
157146352|NCT00491530|567284054|FG000|Overall Study|Use of Prohibited Medication|0|||
157146353|NCT00491530|567284055|FG001|Overall Study|Use of Prohibited Medication|0|||
157146354|NCT00491530|567284056|FG002|Overall Study|Use of Prohibited Medication|1|||
157146355|NCT00883753|567284057|FG000|Overall Study|Adverse Event|37|||
157146356|NCT00883753|567284057|FG000|Overall Study|Death|2|||
157146357|NCT00883753|567284057|FG000|Overall Study|Insufficient therapeutic response|16|||
157146358|NCT00883753|567284057|FG000|Overall Study|Lost to Follow-up|4|||
157146359|NCT00883753|567284057|FG000|Overall Study|Violation of selection criteria at entry|7|||
157146360|NCT00883753|567284057|FG000|Overall Study|Protocol Violation|2|||
157146361|NCT00883753|567284057|FG000|Overall Study|Refused treatment|4|||
157146362|NCT00883753|567284057|FG000|Overall Study|Withdrew consent|10|||
157146363|NCT00883753|567284057|FG000|Overall Study|Investigator's decision|17|||
157146364|NCT00883753|567284057|FG000|Overall Study|Administrative/Other|8|||
157146365|NCT01396525|567284060|FG000|Overall Study|Withdrawal by Subject|8|||
157146366|NCT01396525|567284060|FG000|Overall Study|Death|14|||
157146367|NCT01396525|567284060|FG000|Overall Study|Lost to Follow-up|4|||
156809832|NCT04908683|566058733|FG000|Overall Study|Failure to meet continuation criteria|34|||
156809833|NCT04908683|566058734|FG001|Overall Study|Failure to meet continuation criteria|22|||
156809834|NCT04908683|566058733|FG000|Overall Study|Initiated prohibited medication|3|||
156809835|NCT04908683|566058734|FG001|Overall Study|Initiated prohibited medication|0|||
156809836|NCT04908683|566058733|FG000|Overall Study|Randomized by mistake|1|||
156809837|NCT04908683|566058734|FG001|Overall Study|Randomized by mistake|0|||
156809838|NCT04908683|566058733|FG000|Overall Study|Lost to Follow-up|679|||
156809839|NCT04908683|566058734|FG001|Overall Study|Lost to Follow-up|341|||
156809840|NCT04908683|566058733|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
156809841|NCT04908683|566058734|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
157146368|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Adverse Event|12|||
157146369|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Adverse Event|3|||
157146370|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Adverse Event|4|||
157146371|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Adverse Event|2|||
157146372|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
157146373|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
157146374|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
157146375|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
157146376|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
157146377|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
157146378|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
157146379|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
157022280|NCT03150810|566835189|FG000|Overall Study|Death|4|||
157022281|NCT03150810|566835190|FG001|Overall Study|Death|8|||
157022282|NCT03150810|566835191|FG002|Overall Study|Death|7|||
157022283|NCT03150810|566835192|FG003|Overall Study|Death|2|||
157022284|NCT03150810|566835193|FG004|Overall Study|Death|2|||
157022285|NCT03150810|566835194|FG005|Overall Study|Death|10|||
157022286|NCT03150810|566835195|FG006|Overall Study|Death|8|||
157022287|NCT03150810|566835196|FG007|Overall Study|Death|6|||
157022288|NCT03150810|566835197|FG008|Overall Study|Death|18|||
157022289|NCT03150810|566835198|FG009|Overall Study|Death|3|||
157022290|NCT03150810|566835199|FG010|Overall Study|Death|19|||
157022291|NCT03150810|566835200|FG011|Overall Study|Death|1|||
157022292|NCT03150810|566835201|FG012|Overall Study|Death|19|||
157022293|NCT03150810|566835189|FG000|Overall Study|Withdrawal by Subject|0|||
157022294|NCT03150810|566835190|FG001|Overall Study|Withdrawal by Subject|1|||
157022295|NCT03150810|566835191|FG002|Overall Study|Withdrawal by Subject|1|||
157022296|NCT03150810|566835192|FG003|Overall Study|Withdrawal by Subject|1|||
157022297|NCT03150810|566835193|FG004|Overall Study|Withdrawal by Subject|0|||
157022298|NCT03150810|566835194|FG005|Overall Study|Withdrawal by Subject|0|||
157022299|NCT03150810|566835195|FG006|Overall Study|Withdrawal by Subject|2|||
157022300|NCT03150810|566835196|FG007|Overall Study|Withdrawal by Subject|0|||
157022301|NCT03150810|566835197|FG008|Overall Study|Withdrawal by Subject|2|||
157022302|NCT03150810|566835198|FG009|Overall Study|Withdrawal by Subject|0|||
157022303|NCT03150810|566835199|FG010|Overall Study|Withdrawal by Subject|1|||
157022304|NCT03150810|566835200|FG011|Overall Study|Withdrawal by Subject|0|||
157022305|NCT03150810|566835201|FG012|Overall Study|Withdrawal by Subject|1|||
157022306|NCT03150810|566835189|FG000|Overall Study|Sponsor Decision|0|||
157022307|NCT03150810|566835190|FG001|Overall Study|Sponsor Decision|2|||
157022308|NCT03150810|566835191|FG002|Overall Study|Sponsor Decision|0|||
157022309|NCT03150810|566835192|FG003|Overall Study|Sponsor Decision|0|||
157022310|NCT03150810|566835193|FG004|Overall Study|Sponsor Decision|1|||
157022311|NCT03150810|566835194|FG005|Overall Study|Sponsor Decision|1|||
157022312|NCT03150810|566835195|FG006|Overall Study|Sponsor Decision|0|||
156809842|NCT04908683|566058733|FG000|Overall Study|Physician Decision|44|||
156809843|NCT04908683|566058734|FG001|Overall Study|Physician Decision|35|||
156809844|NCT04908683|566058733|FG000|Overall Study|Technical problems|12|||
156809845|NCT04908683|566058734|FG001|Overall Study|Technical problems|9|||
156809846|NCT04908683|566058733|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
156809847|NCT04908683|566058734|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
156809848|NCT04908683|566058733|FG000|Overall Study|Protocol Violation|2|||
156809849|NCT04908683|566058734|FG001|Overall Study|Protocol Violation|0|||
156809850|NCT04908683|566058733|FG000|Overall Study|Withdrawal by Subject|1188|||
156809851|NCT04908683|566058734|FG001|Overall Study|Withdrawal by Subject|570|||
156809852|NCT04908683|566058733|FG000|Overall Study|Site Closure by Sponsor|6|||
156809853|NCT04908683|566058734|FG001|Overall Study|Site Closure by Sponsor|3|||
156809854|NCT04908683|566058733|FG000|Overall Study|Adverse Event|21|||
156809855|NCT04908683|566058734|FG001|Overall Study|Adverse Event|11|||
156809856|NCT04908683|566058733|FG000|Overall Study|Death|101|||
156809857|NCT04908683|566058734|FG001|Overall Study|Death|61|||
156809858|NCT04908683|566058733|FG000|Overall Study|Sponsor's decision|14398|||
156809859|NCT04908683|566058734|FG001|Overall Study|Sponsor's decision|7205|||
156809860|NCT04908683|566058733|FG000|Overall Study|Other|92|||
156809861|NCT04908683|566058734|FG001|Overall Study|Other|50|||
156809862|NCT04908683|566058733|FG000|Overall Study|Randomized not vaccinated|108|||
156809863|NCT04908683|566058734|FG001|Overall Study|Randomized not vaccinated|52|||
156809864|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
156809865|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
156809866|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
156809867|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
156809868|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
156809869|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
156809870|NCT05507567|566058735|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
156809871|NCT05507567|566058736|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
156809872|NCT05507567|566058737|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
156809873|NCT05507567|566058735|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
156809874|NCT05507567|566058736|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
156809875|NCT05507567|566058737|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
156809876|NCT01722994|566058740|FG000|Overall Study|Missing data|25|||
156809877|NCT01722994|566058741|FG001|Overall Study|Missing data|17|||
156809878|NCT01206140|566058742|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
157022313|NCT03150810|566835196|FG007|Overall Study|Sponsor Decision|0|||
157146380|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
157022314|NCT03150810|566835197|FG008|Overall Study|Sponsor Decision|1|||
157022315|NCT03150810|566835198|FG009|Overall Study|Sponsor Decision|0|||
157022316|NCT03150810|566835199|FG010|Overall Study|Sponsor Decision|0|||
157022317|NCT03150810|566835200|FG011|Overall Study|Sponsor Decision|0|||
156809879|NCT01206140|566058743|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
156809880|NCT01803880|566058744|FG000|Overall Study|Adverse Event|1|||
156809881|NCT01803880|566058745|FG001|Overall Study|Adverse Event|0|||
157146381|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
157146382|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
157146383|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
157146384|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
157146385|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
157146386|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
157146387|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
157146388|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
157146389|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
157146390|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
157146391|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
157146392|NCT02436239|567284062|FG000|Open-Lable Treatment Period|Other Reason|1|||
157146393|NCT02436239|567284063|FG001|Open-Lable Treatment Period|Other Reason|1|||
157146394|NCT02436239|567284064|FG002|Open-Lable Treatment Period|Other Reason|0|||
157146395|NCT02436239|567284065|FG003|Open-Lable Treatment Period|Other Reason|0|||
157146396|NCT02436239|567284062|FG000|Down-Taper Period|Withdrawal by Subject|4|||
157146397|NCT02436239|567284063|FG001|Down-Taper Period|Withdrawal by Subject|4|||
157146398|NCT02436239|567284064|FG002|Down-Taper Period|Withdrawal by Subject|1|||
157146399|NCT02436239|567284065|FG003|Down-Taper Period|Withdrawal by Subject|2|||
157146400|NCT00940342|567284070|FG000|Overall Study|Adverse Event|0|||
157146401|NCT00940342|567284071|FG001|Overall Study|Adverse Event|2|||
157146402|NCT00940342|567284072|FG002|Overall Study|Adverse Event|1|||
157146403|NCT00793104|567284073|FG000|Overall Study|Lost to Follow-up|1|||
157146404|NCT03494725|567284076|FG000|Overall Study|Withdrawal by Subject|0|||
157146405|NCT03494725|567284077|FG001|Overall Study|Withdrawal by Subject|2|||
157146406|NCT03494725|567284076|FG000|Overall Study|Antibiotic use|1|||
157146407|NCT03494725|567284077|FG001|Overall Study|Antibiotic use|0|||
157146408|NCT02111811|567284078|FG000|Treatment Phase|Lost to Follow-up|22|||
157146409|NCT02111811|567284079|FG001|Treatment Phase|Lost to Follow-up|18|||
157146410|NCT02111811|567284078|FG000|Treatment Phase|Death|2|||
157146411|NCT02111811|567284079|FG001|Treatment Phase|Death|0|||
157146412|NCT02111811|567284078|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
157146413|NCT02111811|567284079|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
157146414|NCT02111811|567284078|FG000|Follow up Period (Aim 2)|Death|2|||
157146415|NCT02111811|567284079|FG001|Follow up Period (Aim 2)|Death|0|||
157146416|NCT03443024|567284082|FG000|Overall Study|Adverse Event|2|||
156809882|NCT01803880|566058746|FG002|Overall Study|Adverse Event|0|||
156809883|NCT01803880|566058744|FG000|Overall Study|Withdrawal by Subject|1|||
156809884|NCT01803880|566058745|FG001|Overall Study|Withdrawal by Subject|1|||
156809885|NCT01803880|566058746|FG002|Overall Study|Withdrawal by Subject|4|||
156809886|NCT01803880|566058744|FG000|Overall Study|Physician Decision|0|||
156809887|NCT01803880|566058745|FG001|Overall Study|Physician Decision|0|||
156809888|NCT01803880|566058746|FG002|Overall Study|Physician Decision|1|||
156809889|NCT01803880|566058744|FG000|Overall Study|Unable to return for follow-up visits|0|||
156809890|NCT01803880|566058745|FG001|Overall Study|Unable to return for follow-up visits|1|||
156809891|NCT01803880|566058746|FG002|Overall Study|Unable to return for follow-up visits|2|||
156809892|NCT01803880|566058744|FG000|Overall Study|Lost to Follow-up|1|||
156809893|NCT01803880|566058745|FG001|Overall Study|Lost to Follow-up|2|||
156809894|NCT01803880|566058746|FG002|Overall Study|Lost to Follow-up|3|||
156809895|NCT01803880|566058744|FG000|Overall Study|Protocol Violation|1|||
156809896|NCT01803880|566058745|FG001|Overall Study|Protocol Violation|0|||
156809897|NCT01803880|566058746|FG002|Overall Study|Protocol Violation|0|||
156809898|NCT01803880|566058744|FG000|Overall Study|Early study termination|0|||
156809899|NCT01803880|566058745|FG001|Overall Study|Early study termination|6|||
156809900|NCT01803880|566058746|FG002|Overall Study|Early study termination|5|||
156809901|NCT01803880|566058744|FG000|Overall Study|Incomplete data entry by sites|2|||
156809902|NCT01803880|566058745|FG001|Overall Study|Incomplete data entry by sites|0|||
156809903|NCT01803880|566058746|FG002|Overall Study|Incomplete data entry by sites|0|||
156809904|NCT01766037|566058748|FG000|Overall Study|Adverse Event|1|||
156809905|NCT01766037|566058749|FG001|Overall Study|Adverse Event|0|||
156809906|NCT01766037|566058748|FG000|Overall Study|Lack of Efficacy|1|||
157022318|NCT03150810|566835201|FG012|Overall Study|Sponsor Decision|5|||
157146417|NCT03443024|567284083|FG001|Overall Study|Adverse Event|4|||
156809907|NCT01766037|566058749|FG001|Overall Study|Lack of Efficacy|0|||
156809908|NCT01766037|566058748|FG000|Overall Study|Lost to Follow-up|0|||
156809909|NCT01766037|566058749|FG001|Overall Study|Lost to Follow-up|10|||
156809910|NCT01766037|566058748|FG000|Overall Study|Physician Decision|0|||
156809911|NCT01766037|566058749|FG001|Overall Study|Physician Decision|1|||
156809912|NCT01766037|566058748|FG000|Overall Study|Withdrawal by Subject|18|||
156809913|NCT01766037|566058749|FG001|Overall Study|Withdrawal by Subject|16|||
157146418|NCT03443024|567284084|FG002|Overall Study|Adverse Event|3|||
157146419|NCT03443024|567284085|FG003|Overall Study|Adverse Event|1|||
157146420|NCT03443024|567284082|FG000|Overall Study|Lost to Follow-up|9|||
157222324|NCT02826603|567560247|FG000|Overall Study|Lack of Efficacy|4|||
156809914|NCT01766037|566058748|FG000|Overall Study|Moved from area|5|||
156809915|NCT01766037|566058749|FG001|Overall Study|Moved from area|0|||
156809916|NCT01766037|566058748|FG000|Overall Study|medical - unrelated|1|||
156809917|NCT01766037|566058749|FG001|Overall Study|medical - unrelated|2|||
156809918|NCT01766037|566058748|FG000|Overall Study|nausea / discomfort|3|||
156809919|NCT01766037|566058749|FG001|Overall Study|nausea / discomfort|0|||
156809920|NCT05226598|566058752|FG000|Overall Study|Death|186|||
156809921|NCT05226598|566058753|FG001|Overall Study|Death|191|||
156809922|NCT05226598|566058752|FG000|Overall Study|Withdrawal by Subject|6|||
156809923|NCT05226598|566058753|FG001|Overall Study|Withdrawal by Subject|6|||
156809924|NCT05226598|566058752|FG000|Overall Study|Ongoing|174|||
156809925|NCT05226598|566058753|FG001|Overall Study|Ongoing|176|||
156809926|NCT00090779|566058754|FG000|Step 1|Withdrawal by Subject|4|||
156809927|NCT00090779|566058755|FG001|Step 1|Withdrawal by Subject|2|||
156809928|NCT00090779|566058754|FG000|Step 1|Lost to Follow-up|3|||
156809929|NCT00090779|566058755|FG001|Step 1|Lost to Follow-up|2|||
156809930|NCT00090779|566058754|FG000|Step 1|Death|0|||
156809931|NCT00090779|566058755|FG001|Step 1|Death|2|||
156809932|NCT00090779|566058754|FG000|Step 1|Physician Decision|1|||
156809933|NCT00090779|566058755|FG001|Step 1|Physician Decision|0|||
156809934|NCT00090779|566058754|FG000|Step 1|Pregnancy|1|||
156809935|NCT00090779|566058755|FG001|Step 1|Pregnancy|0|||
156809936|NCT00090779|566058754|FG000|Step 1|Non-compliance to study requirements|0|||
156809937|NCT00090779|566058755|FG001|Step 1|Non-compliance to study requirements|1|||
156809938|NCT00090779|566058754|FG000|Step 1|Subject relocated|2|||
156809939|NCT00090779|566058755|FG001|Step 1|Subject relocated|8|||
156809940|NCT00090779|566058754|FG000|Step 2|Off study per study closure|6|||
156809941|NCT00090779|566058755|FG001|Step 2|Off study per study closure|16|||
157022319|NCT03150810|566835189|FG000|Overall Study|Lost to Follow-up|0|||
157022320|NCT03150810|566835190|FG001|Overall Study|Lost to Follow-up|1|||
157022321|NCT03150810|566835191|FG002|Overall Study|Lost to Follow-up|1|||
157022322|NCT03150810|566835192|FG003|Overall Study|Lost to Follow-up|0|||
157022323|NCT03150810|566835193|FG004|Overall Study|Lost to Follow-up|0|||
157022324|NCT03150810|566835194|FG005|Overall Study|Lost to Follow-up|0|||
157022325|NCT03150810|566835195|FG006|Overall Study|Lost to Follow-up|1|||
157022326|NCT03150810|566835196|FG007|Overall Study|Lost to Follow-up|0|||
157022327|NCT03150810|566835197|FG008|Overall Study|Lost to Follow-up|0|||
157022328|NCT03150810|566835198|FG009|Overall Study|Lost to Follow-up|0|||
157022329|NCT03150810|566835199|FG010|Overall Study|Lost to Follow-up|1|||
157022330|NCT03150810|566835200|FG011|Overall Study|Lost to Follow-up|0|||
157022331|NCT03150810|566835201|FG012|Overall Study|Lost to Follow-up|0|||
157022332|NCT03150810|566835189|FG000|Overall Study|Physician Decision|0|||
157022333|NCT03150810|566835190|FG001|Overall Study|Physician Decision|0|||
157022334|NCT03150810|566835191|FG002|Overall Study|Physician Decision|0|||
157022335|NCT03150810|566835192|FG003|Overall Study|Physician Decision|0|||
157022336|NCT03150810|566835193|FG004|Overall Study|Physician Decision|0|||
157022337|NCT03150810|566835194|FG005|Overall Study|Physician Decision|1|||
157022338|NCT03150810|566835195|FG006|Overall Study|Physician Decision|1|||
157022339|NCT03150810|566835196|FG007|Overall Study|Physician Decision|0|||
157022340|NCT03150810|566835197|FG008|Overall Study|Physician Decision|0|||
157022341|NCT03150810|566835198|FG009|Overall Study|Physician Decision|0|||
157022342|NCT03150810|566835199|FG010|Overall Study|Physician Decision|0|||
157022343|NCT03150810|566835200|FG011|Overall Study|Physician Decision|0|||
157022344|NCT03150810|566835201|FG012|Overall Study|Physician Decision|0|||
157022345|NCT03150810|566835189|FG000|Overall Study|Site withdrawal from study|0|||
157022346|NCT03150810|566835190|FG001|Overall Study|Site withdrawal from study|1|||
157022347|NCT03150810|566835191|FG002|Overall Study|Site withdrawal from study|0|||
157022348|NCT03150810|566835192|FG003|Overall Study|Site withdrawal from study|0|||
157022349|NCT03150810|566835193|FG004|Overall Study|Site withdrawal from study|0|||
157022350|NCT03150810|566835194|FG005|Overall Study|Site withdrawal from study|0|||
157022351|NCT03150810|566835195|FG006|Overall Study|Site withdrawal from study|0|||
157022352|NCT03150810|566835196|FG007|Overall Study|Site withdrawal from study|0|||
157022353|NCT03150810|566835197|FG008|Overall Study|Site withdrawal from study|0|||
157022354|NCT03150810|566835198|FG009|Overall Study|Site withdrawal from study|1|||
157022355|NCT03150810|566835199|FG010|Overall Study|Site withdrawal from study|1|||
157022356|NCT03150810|566835200|FG011|Overall Study|Site withdrawal from study|0|||
156809942|NCT00090779|566058754|FG000|Step 2|Subject relocated|0|||
156809943|NCT00090779|566058755|FG001|Step 2|Subject relocated|1|||
156809944|NCT00090779|566058754|FG000|Step 2|Non-compliance to study requirements|0|||
156809945|NCT00090779|566058755|FG001|Step 2|Non-compliance to study requirements|1|||
156809946|NCT00090779|566058754|FG000|Step 3|Initiation of ART and off extended study|3|||
157022357|NCT03150810|566835201|FG012|Overall Study|Site withdrawal from study|0|||
157022358|NCT03150810|566835189|FG000|Overall Study|Hospice|0|||
157022359|NCT03150810|566835190|FG001|Overall Study|Hospice|0|||
157022360|NCT03150810|566835191|FG002|Overall Study|Hospice|0|||
157022361|NCT03150810|566835192|FG003|Overall Study|Hospice|0|||
157022362|NCT03150810|566835193|FG004|Overall Study|Hospice|0|||
157022363|NCT03150810|566835194|FG005|Overall Study|Hospice|1|||
157022364|NCT03150810|566835195|FG006|Overall Study|Hospice|0|||
157022365|NCT03150810|566835196|FG007|Overall Study|Hospice|0|||
157146421|NCT03443024|567284083|FG001|Overall Study|Lost to Follow-up|9|||
157146422|NCT03443024|567284084|FG002|Overall Study|Lost to Follow-up|7|||
157146423|NCT03443024|567284085|FG003|Overall Study|Lost to Follow-up|5|||
157146424|NCT03443024|567284082|FG000|Overall Study|Withdrawal by Subject|8|||
157146425|NCT03443024|567284083|FG001|Overall Study|Withdrawal by Subject|15|||
157146426|NCT03443024|567284084|FG002|Overall Study|Withdrawal by Subject|9|||
157146427|NCT03443024|567284085|FG003|Overall Study|Withdrawal by Subject|23|||
157146428|NCT03443024|567284082|FG000|Overall Study|Physician Decision|1|||
157146429|NCT03443024|567284083|FG001|Overall Study|Physician Decision|2|||
157146430|NCT03443024|567284084|FG002|Overall Study|Physician Decision|0|||
157146431|NCT03443024|567284085|FG003|Overall Study|Physician Decision|1|||
157146432|NCT03443024|567284082|FG000|Overall Study|Sponsor Decision|1|||
157146433|NCT03443024|567284083|FG001|Overall Study|Sponsor Decision|1|||
157146434|NCT03443024|567284084|FG002|Overall Study|Sponsor Decision|0|||
157146435|NCT03443024|567284085|FG003|Overall Study|Sponsor Decision|0|||
157146436|NCT03443024|567284082|FG000|Overall Study|Protocol Deviation|0|||
157146437|NCT03443024|567284083|FG001|Overall Study|Protocol Deviation|0|||
157146438|NCT03443024|567284084|FG002|Overall Study|Protocol Deviation|0|||
157146439|NCT03443024|567284085|FG003|Overall Study|Protocol Deviation|2|||
157146440|NCT01450137|567284086|FG000|Up to Week 12|Adverse Event|2|||
157146441|NCT01450137|567284087|FG001|Up to Week 12|Adverse Event|1|||
157146442|NCT01450137|567284086|FG000|Up to Week 12|Withdrawal by Subject|0|||
157146443|NCT01450137|567284087|FG001|Up to Week 12|Withdrawal by Subject|2|||
157146444|NCT01450137|567284086|FG000|Week 12 to Study End|Death|0|||
157146445|NCT01450137|567284087|FG001|Week 12 to Study End|Death|1|||
157146446|NCT01450137|567284086|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
157146447|NCT01450137|567284087|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
157146448|NCT01926886|567284088|FG000|Overall Study|Administrative/other|1|||
157146449|NCT01926886|567284089|FG001|Overall Study|Administrative/other|0|||
157146450|NCT01926886|567284088|FG000|Overall Study|Adverse event/intercurrent illness|4|||
157146451|NCT01926886|567284089|FG001|Overall Study|Adverse event/intercurrent illness|0|||
157146452|NCT01926886|567284088|FG000|Overall Study|Disease progression/recurrence|4|||
157146453|NCT01926886|567284089|FG001|Overall Study|Disease progression/recurrence|0|||
157146454|NCT01926886|567284088|FG000|Overall Study|Withdrawal by Subject|15|||
157146455|NCT01926886|567284089|FG001|Overall Study|Withdrawal by Subject|0|||
157146456|NCT01926886|567284088|FG000|Overall Study|Failure to return|3|||
157146457|NCT01926886|567284089|FG001|Overall Study|Failure to return|0|||
157146458|NCT01926886|567284088|FG000|Overall Study|Recurrence of disease|1|||
157146459|NCT01926886|567284089|FG001|Overall Study|Recurrence of disease|0|||
157146460|NCT01926886|567284088|FG000|Overall Study|Progression of disease|2|||
157146461|NCT01926886|567284089|FG001|Overall Study|Progression of disease|0|||
157146462|NCT01926886|567284088|FG000|Overall Study|Death|1|||
157146463|NCT01926886|567284089|FG001|Overall Study|Death|0|||
156809947|NCT00090779|566058755|FG001|Step 3|Initiation of ART and off extended study|2|||
156809948|NCT00090779|566058754|FG000|Step 3|Off extended study due to study closure|4|||
156809949|NCT00090779|566058755|FG001|Step 3|Off extended study due to study closure|3|||
156809950|NCT03951766|566058764|FG000|Treatment Phase|Lost to Follow-up|1|||
156809951|NCT03951766|566058764|FG000|Follow-up Phase|Lost to Follow-up|10|||
156809952|NCT04158375|566058767|FG000|Overall Study|Withdrawal by Subject|0|||
156809953|NCT04158375|566058768|FG001|Overall Study|Withdrawal by Subject|3|||
156809954|NCT04158375|566058769|FG002|Overall Study|Withdrawal by Subject|0|||
156809955|NCT04847843|566058770|FG000|Overall Study|Scheduling Conflicts|6|||
156809956|NCT04847843|566058771|FG001|Overall Study|Scheduling Conflicts|9|||
156809957|NCT04847843|566058770|FG000|Overall Study|Withdrawal by Subject|1|||
156809958|NCT04847843|566058771|FG001|Overall Study|Withdrawal by Subject|0|||
156809959|NCT04847843|566058770|FG000|Overall Study|Lost to Follow-up|1|||
156809960|NCT04847843|566058771|FG001|Overall Study|Lost to Follow-up|1|||
156809961|NCT04847843|566058770|FG000|Overall Study|Pregnancy|0|||
156809962|NCT04847843|566058771|FG001|Overall Study|Pregnancy|2|||
156809963|NCT04847843|566058770|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
157146464|NCT01926886|567284088|FG000|Overall Study|Did not cooperate|1|||
157146465|NCT01926886|567284089|FG001|Overall Study|Did not cooperate|0|||
157146466|NCT04458857|567284090|FG000|Overall Study|Adverse Event|0|||
157146467|NCT04458857|567284091|FG001|Overall Study|Adverse Event|1|||
156809964|NCT04847843|566058771|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
156809965|NCT02734004|566058772|FG000|Overall Study|Death|36|||
157146468|NCT04458857|567284092|FG002|Overall Study|Adverse Event|0|||
157146469|NCT04458857|567284090|FG000|Overall Study|Withdrawal by Subject|2|||
157146470|NCT04458857|567284091|FG001|Overall Study|Withdrawal by Subject|0|||
157146471|NCT04458857|567284092|FG002|Overall Study|Withdrawal by Subject|0|||
157146472|NCT04458857|567284090|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157146473|NCT04458857|567284091|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157146474|NCT04458857|567284092|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156809966|NCT02734004|566058773|FG001|Overall Study|Death|24|||
156809967|NCT02734004|566058774|FG002|Overall Study|Death|26|||
156809968|NCT02734004|566058775|FG003|Overall Study|Death|35|||
157146475|NCT04458857|567284090|FG000|Overall Study|Non-compliance with study drug|0|||
157146476|NCT04458857|567284091|FG001|Overall Study|Non-compliance with study drug|1|||
157146477|NCT04458857|567284092|FG002|Overall Study|Non-compliance with study drug|0|||
157146478|NCT04458857|567284090|FG000|Overall Study|Lost to Follow-up|4|||
157146479|NCT04458857|567284091|FG001|Overall Study|Lost to Follow-up|1|||
157146480|NCT04458857|567284092|FG002|Overall Study|Lost to Follow-up|0|||
157146481|NCT02609399|567284096|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
157146482|NCT02609399|567284097|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
157146483|NCT02609399|567284096|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
157146484|NCT02609399|567284097|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
157146485|NCT02609399|567284096|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
157146486|NCT02609399|567284097|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
157146487|NCT00069121|567284098|FG000|Overall Study|Death|286|||
157146488|NCT00069121|567284099|FG001|Overall Study|Death|242|||
157146489|NCT00069121|567284098|FG000|Overall Study|Withdrawal by Subject|18|||
157146490|NCT00069121|567284099|FG001|Overall Study|Withdrawal by Subject|20|||
157146491|NCT00069121|567284098|FG000|Overall Study|Lost to Follow-up|63|||
157146492|NCT00069121|567284099|FG001|Overall Study|Lost to Follow-up|63|||
157146493|NCT02986373|567284100|FG000|Overall Study|Adverse Event|4|||
157146494|NCT02986373|567284100|FG000|Overall Study|Lost to Follow-up|1|||
157146495|NCT02986373|567284100|FG000|Overall Study|Withdrawal by Subject|10|||
157146496|NCT02986373|567284100|FG000|Overall Study|Other|24|||
157146497|NCT04800315|567284101|FG000|Randomization|Did not receive study treatment|1|||
157146498|NCT04800315|567284102|FG001|Randomization|Did not receive study treatment|0|||
157146499|NCT04800315|567284103|FG002|Randomization|Did not receive study treatment|0|||
157146500|NCT04800315|567284104|FG003|Randomization|Did not receive study treatment|0|||
157146501|NCT04800315|567284101|FG000|Treatment Period|Adverse Event|4|||
157146502|NCT04800315|567284102|FG001|Treatment Period|Adverse Event|2|||
157146503|NCT04800315|567284103|FG002|Treatment Period|Adverse Event|1|||
157146504|NCT04800315|567284104|FG003|Treatment Period|Adverse Event|2|||
157146505|NCT04800315|567284101|FG000|Treatment Period|Lack of Efficacy|1|||
157146506|NCT04800315|567284102|FG001|Treatment Period|Lack of Efficacy|0|||
157146507|NCT04800315|567284103|FG002|Treatment Period|Lack of Efficacy|0|||
157146508|NCT04800315|567284104|FG003|Treatment Period|Lack of Efficacy|3|||
157146509|NCT04800315|567284101|FG000|Treatment Period|Lost to Follow-up|0|||
157146510|NCT04800315|567284102|FG001|Treatment Period|Lost to Follow-up|1|||
157146511|NCT04800315|567284103|FG002|Treatment Period|Lost to Follow-up|2|||
157146512|NCT04800315|567284104|FG003|Treatment Period|Lost to Follow-up|2|||
157146513|NCT04800315|567284101|FG000|Treatment Period|Withdrawal by participant|0|||
157146514|NCT04800315|567284102|FG001|Treatment Period|Withdrawal by participant|0|||
157146515|NCT04800315|567284103|FG002|Treatment Period|Withdrawal by participant|0|||
157146516|NCT04800315|567284104|FG003|Treatment Period|Withdrawal by participant|4|||
157146517|NCT04800315|567284101|FG000|Treatment Period|Other Reasons|0|||
157146518|NCT04800315|567284102|FG001|Treatment Period|Other Reasons|2|||
157146519|NCT04800315|567284103|FG002|Treatment Period|Other Reasons|0|||
157146520|NCT04800315|567284104|FG003|Treatment Period|Other Reasons|1|||
157146521|NCT00753922|567284105|FG000|Overall Study|Lost to Follow-up|155|||
157146522|NCT00753922|567284106|FG001|Overall Study|Lost to Follow-up|24|||
157146523|NCT00753922|567284107|FG002|Overall Study|Lost to Follow-up|28|||
157146524|NCT00753922|567284108|FG003|Overall Study|Lost to Follow-up|5|||
157146525|NCT00753922|567284105|FG000|Overall Study|Withdrawal by Subject|9|||
157222325|NCT02826603|567560248|FG001|Overall Study|Lack of Efficacy|9|||
156809969|NCT02734004|566058776|FG004|Overall Study|Death|13|||
156809970|NCT02734004|566058777|FG005|Overall Study|Death|17|||
156809971|NCT02734004|566058778|FG006|Overall Study|Death|20|||
156809972|NCT02734004|566058772|FG000|Overall Study|Lost to Follow-up|1|||
156809973|NCT02734004|566058773|FG001|Overall Study|Lost to Follow-up|1|||
156809974|NCT02734004|566058774|FG002|Overall Study|Lost to Follow-up|0|||
156809975|NCT02734004|566058775|FG003|Overall Study|Lost to Follow-up|0|||
156809976|NCT02734004|566058776|FG004|Overall Study|Lost to Follow-up|1|||
156809977|NCT02734004|566058777|FG005|Overall Study|Lost to Follow-up|0|||
156883362|NCT03137069|566332524|FG005|Overall Study|Protocol Violation|1|||
157222326|NCT02826603|567560247|FG000|Overall Study|Lost to Follow-up|13|||
156883363|NCT03137069|566332519|FG000|Overall Study|Physician Decision|0|||
156883364|NCT03137069|566332520|FG001|Overall Study|Physician Decision|0|||
157146526|NCT00753922|567284106|FG001|Overall Study|Withdrawal by Subject|11|||
156809978|NCT02734004|566058778|FG006|Overall Study|Lost to Follow-up|0|||
156809979|NCT02734004|566058772|FG000|Overall Study|Withdrawal by Subject|3|||
157146527|NCT00753922|567284107|FG002|Overall Study|Withdrawal by Subject|4|||
156809980|NCT02734004|566058773|FG001|Overall Study|Withdrawal by Subject|1|||
157146528|NCT00753922|567284108|FG003|Overall Study|Withdrawal by Subject|2|||
157146529|NCT00753922|567284105|FG000|Overall Study|Patient Non-compliance|55|||
157146530|NCT00753922|567284106|FG001|Overall Study|Patient Non-compliance|22|||
157146531|NCT00753922|567284107|FG002|Overall Study|Patient Non-compliance|14|||
157146532|NCT00753922|567284108|FG003|Overall Study|Patient Non-compliance|11|||
157146533|NCT00753922|567284105|FG000|Overall Study|Patients Not Completing Visit|11|||
157146534|NCT00753922|567284106|FG001|Overall Study|Patients Not Completing Visit|0|||
157146535|NCT00753922|567284107|FG002|Overall Study|Patients Not Completing Visit|1|||
156809981|NCT02734004|566058774|FG002|Overall Study|Withdrawal by Subject|1|||
156809982|NCT02734004|566058775|FG003|Overall Study|Withdrawal by Subject|1|||
156809983|NCT02734004|566058776|FG004|Overall Study|Withdrawal by Subject|3|||
156809984|NCT02734004|566058777|FG005|Overall Study|Withdrawal by Subject|0|||
156809985|NCT02734004|566058778|FG006|Overall Study|Withdrawal by Subject|2|||
156809986|NCT02734004|566058772|FG000|Overall Study|Other|0|||
156809987|NCT02734004|566058773|FG001|Overall Study|Other|8|||
156809988|NCT02734004|566058774|FG002|Overall Study|Other|7|||
156809989|NCT02734004|566058775|FG003|Overall Study|Other|4|||
156809990|NCT02734004|566058776|FG004|Overall Study|Other|34|||
156809991|NCT02734004|566058777|FG005|Overall Study|Other|14|||
156809992|NCT02734004|566058778|FG006|Overall Study|Other|10|||
156809993|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
156809994|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
156809995|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
156809996|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
156809997|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
156883365|NCT03137069|566332521|FG002|Overall Study|Physician Decision|0|||
156883366|NCT03137069|566332522|FG003|Overall Study|Physician Decision|1|||
156883367|NCT03137069|566332523|FG004|Overall Study|Physician Decision|0|||
156883368|NCT03137069|566332524|FG005|Overall Study|Physician Decision|0|||
156883369|NCT03137069|566332519|FG000|Overall Study|Study Terminated by Sponsor|0|||
156883370|NCT03137069|566332520|FG001|Overall Study|Study Terminated by Sponsor|0|||
156883371|NCT03137069|566332521|FG002|Overall Study|Study Terminated by Sponsor|0|||
156883372|NCT03137069|566332522|FG003|Overall Study|Study Terminated by Sponsor|0|||
156883373|NCT03137069|566332523|FG004|Overall Study|Study Terminated by Sponsor|1|||
156883374|NCT03137069|566332524|FG005|Overall Study|Study Terminated by Sponsor|0|||
156883375|NCT03137069|566332519|FG000|Overall Study|Data Entry Error|0|||
156883376|NCT03137069|566332520|FG001|Overall Study|Data Entry Error|0|||
156883377|NCT03137069|566332521|FG002|Overall Study|Data Entry Error|0|||
156883378|NCT03137069|566332522|FG003|Overall Study|Data Entry Error|1|||
156883379|NCT03137069|566332523|FG004|Overall Study|Data Entry Error|0|||
156883380|NCT03137069|566332524|FG005|Overall Study|Data Entry Error|0|||
156883381|NCT02043899|566332526|FG000|Overall Study|Adverse Event|3|||
156883382|NCT02043899|566332526|FG000|Overall Study|Physician Decision|1|||
156883383|NCT02043899|566332526|FG000|Overall Study|Withdrawal by Subject|2|||
156883384|NCT02043899|566332526|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
156883385|NCT02043899|566332526|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
156883386|NCT02043899|566332526|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
156883387|NCT02043899|566332526|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
156883388|NCT02043899|566332526|FG000|Overall Study|Treatment delayed|1|||
156883389|NCT02522624|566332528|FG000|Overall Study|Technical failure|1|||
156883390|NCT02522624|566332529|FG001|Overall Study|Technical failure|0|||
156883391|NCT00369629|566332530|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
156883392|NCT00369629|566332531|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
156883393|NCT00369629|566332532|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
156883394|NCT00369629|566332533|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
156883395|NCT00369629|566332530|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156883396|NCT00369629|566332531|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156883397|NCT00369629|566332532|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
156883398|NCT00369629|566332533|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
156883399|NCT00369629|566332530|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
156883400|NCT00369629|566332531|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156883401|NCT00369629|566332532|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156883402|NCT00369629|566332533|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
156883403|NCT00369629|566332530|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
156883404|NCT00369629|566332531|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
156883405|NCT00369629|566332532|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
156883406|NCT00369629|566332533|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
156883407|NCT00369629|566332530|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
156883408|NCT00369629|566332531|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
156883409|NCT00369629|566332532|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
156883410|NCT00369629|566332533|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
156883411|NCT00369629|566332530|FG000|Completed 4 More Cycles|Progressive disease|2|||
156883412|NCT00369629|566332531|FG001|Completed 4 More Cycles|Progressive disease|1|||
156809998|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
156809999|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
156810000|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
157146536|NCT00753922|567284108|FG003|Overall Study|Patients Not Completing Visit|0|||
156810001|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
156810002|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
156810003|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
156810004|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
156810005|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
156810006|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
156810007|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
156810008|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
156810009|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
156810010|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
156810011|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
156810012|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
156810013|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
156810014|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
156810015|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
156810016|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
156810017|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Other|6|||
156810018|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Other|0|||
156810019|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Other|0|||
157146537|NCT00753922|567284105|FG000|Overall Study|Death|2|||
157146538|NCT00753922|567284106|FG001|Overall Study|Death|23|||
157146539|NCT00753922|567284107|FG002|Overall Study|Death|2|||
157222327|NCT02826603|567560248|FG001|Overall Study|Lost to Follow-up|12|||
157222328|NCT02826603|567560247|FG000|Overall Study|Noncompliance with treatment|0|||
157222329|NCT02826603|567560248|FG001|Overall Study|Noncompliance with treatment|2|||
157222330|NCT02826603|567560247|FG000|Overall Study|Physician Decision|1|||
157222331|NCT02826603|567560248|FG001|Overall Study|Physician Decision|7|||
157222332|NCT02826603|567560247|FG000|Overall Study|Pregnancy|1|||
157222333|NCT02826603|567560248|FG001|Overall Study|Pregnancy|2|||
157222334|NCT02826603|567560247|FG000|Overall Study|Protocol Violation|3|||
157222335|NCT02826603|567560248|FG001|Overall Study|Protocol Violation|3|||
157146540|NCT00753922|567284108|FG003|Overall Study|Death|1|||
157146541|NCT00753922|567284105|FG000|Overall Study|Discontinuation Due to Explantation|14|||
157222336|NCT02826603|567560247|FG000|Overall Study|Withdrawal by Subject|20|||
157222337|NCT02826603|567560248|FG001|Overall Study|Withdrawal by Subject|19|||
157146542|NCT00753922|567284106|FG001|Overall Study|Discontinuation Due to Explantation|14|||
157146543|NCT00753922|567284107|FG002|Overall Study|Discontinuation Due to Explantation|14|||
157146544|NCT00753922|567284108|FG003|Overall Study|Discontinuation Due to Explantation|4|||
157146545|NCT00196937|567284109|FG000|Overall Study|Serious Adverse Event|1|||
157146546|NCT00196937|567284110|FG001|Overall Study|Serious Adverse Event|0|||
157146547|NCT00196937|567284111|FG002|Overall Study|Serious Adverse Event|0|||
157146548|NCT00196937|567284109|FG000|Overall Study|Non-serious adverse event|1|||
157146549|NCT00196937|567284110|FG001|Overall Study|Non-serious adverse event|1|||
157146550|NCT00196937|567284111|FG002|Overall Study|Non-serious adverse event|1|||
157146551|NCT00196937|567284109|FG000|Overall Study|Withdrawal by Subject|0|||
157146552|NCT00196937|567284110|FG001|Overall Study|Withdrawal by Subject|0|||
157146553|NCT00196937|567284111|FG002|Overall Study|Withdrawal by Subject|2|||
157146554|NCT00196937|567284109|FG000|Overall Study|Lost to Follow-up|4|||
157146555|NCT00196937|567284110|FG001|Overall Study|Lost to Follow-up|3|||
157222338|NCT02826603|567560247|FG000|Overall Study|Death|2|||
157222339|NCT02826603|567560248|FG001|Overall Study|Death|0|||
157222340|NCT02826603|567560247|FG000|Overall Study|New therapy for study indication|0|||
157222341|NCT02826603|567560248|FG001|Overall Study|New therapy for study indication|1|||
157222342|NCT00905489|567560249|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
157222343|NCT00905489|567560249|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
157222344|NCT00905489|567560249|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
157222345|NCT00583596|567560252|FG000|Overall Study|Lost to Follow-up|110|||
157222346|NCT00583596|567560252|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
157222347|NCT00583596|567560252|FG000|Overall Study|Death|2|||
157222348|NCT00583596|567560252|FG000|Overall Study|Withdrawal by Subject|6|||
157222349|NCT00583596|567560252|FG000|Overall Study|Lost to Follow-up|94|||
157222350|NCT00583596|567560252|FG000|Overall Study|Data not complete|1|||
157222351|NCT00583596|567560252|FG000|Overall Study|Not consented|15|||
157222352|NCT00583596|567560252|FG000|Overall Study|Outside f-up window|26|||
157222353|NCT01533428|567560255|FG000|Overall Study|Adverse Event|0|||
157146556|NCT00196937|567284111|FG002|Overall Study|Lost to Follow-up|3|||
157146557|NCT00196937|567284109|FG000|Overall Study|Other|3|||
157146558|NCT00196937|567284110|FG001|Overall Study|Other|1|||
157146559|NCT00196937|567284111|FG002|Overall Study|Other|1|||
157146560|NCT03368404|567284121|FG000|Overall Study|Adverse Event|2|||
157146561|NCT03368404|567284122|FG001|Overall Study|Adverse Event|1|||
157146562|NCT03368404|567284121|FG000|Overall Study|Withdrawal by Subject|1|||
157146563|NCT03368404|567284122|FG001|Overall Study|Withdrawal by Subject|1|||
157222354|NCT01533428|567560256|FG001|Overall Study|Adverse Event|1|||
156810020|NCT05615220|566058779|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
156810021|NCT05615220|566058780|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
156810022|NCT05615220|566058781|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
156810023|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
156810024|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
156810025|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
156810026|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
156810027|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
156810028|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
156810029|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
156810030|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
156810031|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
156810032|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
156810033|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
156810034|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
156810035|NCT05615220|566058779|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
156810036|NCT05615220|566058780|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
156810037|NCT05615220|566058781|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
156810038|NCT01282866|566058791|FG000|Overall Study|Adverse Event|1|||
156810039|NCT01541865|566058793|FG000|Overall Study|Lost to Follow-up|11|||
156810040|NCT01541865|566058793|FG000|Overall Study|Withdrawal by Subject|9|||
156810041|NCT01541865|566058793|FG000|Overall Study|Adverse Event|1|||
156810042|NCT01541865|566058793|FG000|Overall Study|Protocol Violation|1|||
156810043|NCT00049322|566058794|FG000|Overall Study|disease burden|0|||
156810044|NCT00049322|566058795|FG001|Overall Study|disease burden|3|||
156810045|NCT00049322|566058794|FG000|Overall Study|Adverse Event|1|||
156810046|NCT00049322|566058795|FG001|Overall Study|Adverse Event|0|||
156810047|NCT00049322|566058794|FG000|Overall Study|refused angio|0|||
156810048|NCT00049322|566058795|FG001|Overall Study|refused angio|3|||
156810049|NCT01162473|566058797|FG000|Overall Study|Adverse Event|2|||
156810050|NCT01162473|566058798|FG001|Overall Study|Adverse Event|1|||
156810051|NCT01162473|566058797|FG000|Overall Study|Withdrawal by Subject|0|||
156810052|NCT01162473|566058798|FG001|Overall Study|Withdrawal by Subject|4|||
156810053|NCT01144416|566058799|FG000|Intervention Period|Adverse Event|5|||
156810054|NCT01144416|566058800|FG001|Intervention Period|Adverse Event|6|||
156810055|NCT01144416|566058799|FG000|Intervention Period|Insufficient ovarian response|11|||
156810056|NCT01144416|566058800|FG001|Intervention Period|Insufficient ovarian response|17|||
156810057|NCT01144416|566058799|FG000|Intervention Period|Risk of OHSS|0|||
156810058|NCT01144416|566058800|FG001|Intervention Period|Risk of OHSS|1|||
156810059|NCT01144416|566058799|FG000|Intervention Period|Too high ovarian response|4|||
156810060|NCT01144416|566058800|FG001|Intervention Period|Too high ovarian response|2|||
156810061|NCT01144416|566058799|FG000|Intervention Period|No/too few/bad oocytes|7|||
156810062|NCT01144416|566058800|FG001|Intervention Period|No/too few/bad oocytes|5|||
156810063|NCT01144416|566058799|FG000|Intervention Period|No or abnormal fertilization|25|||
156810064|NCT01144416|566058800|FG001|Intervention Period|No or abnormal fertilization|10|||
156810065|NCT01144416|566058799|FG000|Intervention Period|No/too few/bad quality embryos|3|||
156810066|NCT01144416|566058800|FG001|Intervention Period|No/too few/bad quality embryos|3|||
156810067|NCT01144416|566058799|FG000|Intervention Period|Other|7|||
156810068|NCT01144416|566058800|FG001|Intervention Period|Other|5|||
156810069|NCT00124072|566058801|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
156810070|NCT00124072|566058802|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
156810071|NCT00124072|566058803|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
156810072|NCT00124072|566058804|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
156810073|NCT00124072|566058801|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
156810074|NCT00124072|566058802|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
156810075|NCT00124072|566058803|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
156810076|NCT00124072|566058804|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
156810077|NCT00124072|566058801|FG000|Overall Study|Death|499|||
157146564|NCT02983292|567284123|FG000|Overall Study|Participant unwell & cannot travel|2|||
157146565|NCT02983292|567284123|FG000|Overall Study|Lost to Follow-up|3|||
157146566|NCT02983292|567284123|FG000|Overall Study|Participant withdrew consent|2|||
156810078|NCT00124072|566058802|FG001|Overall Study|Death|484|||
156810079|NCT00124072|566058803|FG002|Overall Study|Death|471|||
156810080|NCT00124072|566058804|FG003|Overall Study|Death|480|||
156810081|NCT00132301|566058808|FG000|Overall Study|Death|7|||
156810082|NCT00132301|566058809|FG001|Overall Study|Death|6|||
156810083|NCT00132301|566058808|FG000|Overall Study|Withdrawal by Subject|5|||
156810084|NCT00132301|566058809|FG001|Overall Study|Withdrawal by Subject|2|||
156810085|NCT00132301|566058808|FG000|Overall Study|Physician Decision|1|||
156810086|NCT00132301|566058809|FG001|Overall Study|Physician Decision|1|||
156810087|NCT00132301|566058808|FG000|Overall Study|Lost to Follow-up|5|||
157146567|NCT02983292|567284123|FG000|Overall Study|Revision|7|||
157146568|NCT02983292|567284123|FG000|Overall Study|Death|1|||
157222355|NCT01533428|567560255|FG000|Overall Study|Lost to Follow-up|2|||
156810088|NCT00132301|566058809|FG001|Overall Study|Lost to Follow-up|3|||
156810089|NCT00132301|566058808|FG000|Overall Study|Other|1|||
156810090|NCT00132301|566058809|FG001|Overall Study|Other|1|||
156810091|NCT00132301|566058808|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
156810092|NCT00132301|566058809|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
156810093|NCT04872569|566058812|FG000|Overall Study|Withdrawal by Subject|2|||
156810094|NCT01890265|566058819|FG000|Overall Study|Other (Unspecified reason)|0|||
156810095|NCT01890265|566058820|FG001|Overall Study|Other (Unspecified reason)|1|||
156810096|NCT01890265|566058821|FG002|Overall Study|Other (Unspecified reason)|0|||
156810097|NCT01890265|566058822|FG003|Overall Study|Other (Unspecified reason)|0|||
156810098|NCT01890265|566058823|FG004|Overall Study|Other (Unspecified reason)|0|||
156810099|NCT01890265|566058824|FG005|Overall Study|Other (Unspecified reason)|0|||
156810100|NCT01890265|566058819|FG000|Overall Study|Progressive disease|6|||
156810101|NCT01890265|566058820|FG001|Overall Study|Progressive disease|6|||
156810102|NCT01890265|566058821|FG002|Overall Study|Progressive disease|0|||
156883413|NCT00369629|566332532|FG002|Completed 4 More Cycles|Progressive disease|2|||
156883414|NCT00369629|566332533|FG003|Completed 4 More Cycles|Progressive disease|0|||
156883415|NCT00369629|566332530|FG000|Follow up for 1 Year|Death|2|||
156883416|NCT00369629|566332531|FG001|Follow up for 1 Year|Death|1|||
156883417|NCT00369629|566332532|FG002|Follow up for 1 Year|Death|1|||
156883418|NCT00369629|566332533|FG003|Follow up for 1 Year|Death|0|||
156883419|NCT00369629|566332530|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
156883420|NCT00369629|566332531|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
156883421|NCT00369629|566332532|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
156883422|NCT00369629|566332533|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
156883423|NCT00369629|566332530|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
156883424|NCT00369629|566332531|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
156883425|NCT00369629|566332532|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
156883426|NCT00369629|566332533|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
156883427|NCT04839562|566332534|FG000|Overall Study|Withdrawal by Subject|0|||
156883428|NCT04839562|566332535|FG001|Overall Study|Withdrawal by Subject|1|||
156883429|NCT04839562|566332534|FG000|Overall Study|Physician Decision|0|||
156883430|NCT04839562|566332535|FG001|Overall Study|Physician Decision|1|||
157022366|NCT03150810|566835197|FG008|Overall Study|Hospice|0|||
157022367|NCT03150810|566835198|FG009|Overall Study|Hospice|0|||
157022368|NCT03150810|566835199|FG010|Overall Study|Hospice|0|||
156810103|NCT01890265|566058822|FG003|Overall Study|Progressive disease|0|||
156810104|NCT01890265|566058823|FG004|Overall Study|Progressive disease|0|||
156810105|NCT01890265|566058824|FG005|Overall Study|Progressive disease|0|||
156810106|NCT01890265|566058819|FG000|Overall Study|Adverse Event|2|||
156810107|NCT01890265|566058820|FG001|Overall Study|Adverse Event|1|||
156810108|NCT01890265|566058821|FG002|Overall Study|Adverse Event|0|||
156810109|NCT01890265|566058822|FG003|Overall Study|Adverse Event|0|||
156810110|NCT01890265|566058823|FG004|Overall Study|Adverse Event|0|||
156810111|NCT01890265|566058824|FG005|Overall Study|Adverse Event|0|||
156810112|NCT01890265|566058819|FG000|Overall Study|Death|2|||
156810113|NCT01890265|566058820|FG001|Overall Study|Death|3|||
156810114|NCT01890265|566058821|FG002|Overall Study|Death|1|||
156810115|NCT01890265|566058822|FG003|Overall Study|Death|0|||
156810116|NCT01890265|566058823|FG004|Overall Study|Death|0|||
156810117|NCT01890265|566058824|FG005|Overall Study|Death|0|||
156810118|NCT01890265|566058819|FG000|Overall Study|Withdrawal by Subject|0|||
156810119|NCT01890265|566058820|FG001|Overall Study|Withdrawal by Subject|2|||
156810120|NCT01890265|566058821|FG002|Overall Study|Withdrawal by Subject|3|||
156810121|NCT01890265|566058822|FG003|Overall Study|Withdrawal by Subject|0|||
156810122|NCT01890265|566058823|FG004|Overall Study|Withdrawal by Subject|2|||
156810123|NCT01890265|566058824|FG005|Overall Study|Withdrawal by Subject|0|||
156810124|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
156810125|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
156810126|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156810127|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156810128|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
156883431|NCT00877773|566332536|FG000|Overall Study|Disease Progression|44|||
156883432|NCT01347580|566332537|FG000|Overall Study|Withdrawal by Subject|13|||
156883433|NCT01347580|566332538|FG001|Overall Study|Withdrawal by Subject|23|||
157022369|NCT03150810|566835200|FG011|Overall Study|Hospice|0|||
156810129|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
156810130|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
156810131|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810132|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810133|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
156810134|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
156810135|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
157022370|NCT03150810|566835201|FG012|Overall Study|Hospice|0|||
157022371|NCT03150810|566835189|FG000|Overall Study|Participant relocated abroad.|0|||
156810136|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
157146569|NCT02983292|567284123|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
157146570|NCT02983292|567284123|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
157146571|NCT02983292|567284123|FG000|Overall Study|Participant relocation|1|||
157146572|NCT04725682|567284124|FG000|Overall Study|Withdrawal by Subject|7|||
157146573|NCT04725682|567284125|FG001|Overall Study|Withdrawal by Subject|5|||
157146574|NCT04725682|567284124|FG000|Overall Study|Failed to comply with the requirements|2|||
157146575|NCT04725682|567284125|FG001|Overall Study|Failed to comply with the requirements|1|||
156810137|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
156810138|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
156810139|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810140|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
156810141|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810142|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810143|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
156810144|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
156810145|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
156810146|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810147|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810148|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
156810149|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810150|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
156810151|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810152|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810153|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
156810154|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
156810155|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810156|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810157|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810158|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
156810159|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
156810160|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810161|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810162|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810163|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
156810164|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
156810165|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810166|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810167|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810168|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
156810169|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810170|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
156810171|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810172|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810173|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
156810174|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
156810175|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810176|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810177|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810178|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
156810179|NCT04951622|566058825|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810180|NCT04951622|566058826|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
156810181|NCT04951622|566058827|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810182|NCT04951622|566058828|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810183|NCT04951622|566058829|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
156810184|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
156810185|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
157146576|NCT04725682|567284124|FG000|Overall Study|Adverse Event|1|||
157146577|NCT04725682|567284125|FG001|Overall Study|Adverse Event|1|||
157146578|NCT04725682|567284124|FG000|Overall Study|Death|0|||
157146579|NCT04725682|567284125|FG001|Overall Study|Death|1|||
157146580|NCT00964795|567284126|FG000|Overall Study|Withdrawal by Subject|79|||
156810186|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
156810187|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
156810188|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
156883434|NCT01347580|566332537|FG000|Overall Study|Death|30|||
156883435|NCT01347580|566332538|FG001|Overall Study|Death|19|||
157146581|NCT00964795|567284126|FG000|Overall Study|Adverse Event|12|||
156810189|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810190|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810191|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
156810192|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
156810193|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
156810194|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
157146582|NCT00964795|567284126|FG000|Overall Study|Death|14|||
157146583|NCT00964795|567284126|FG000|Overall Study|Lost to Follow-up|7|||
157146584|NCT00964795|567284126|FG000|Overall Study|Termination of Study by Sponsor|169|||
157146585|NCT00964795|567284126|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
157146586|NCT00964795|567284126|FG000|Overall Study|Other|23|||
157146587|NCT00586690|567284133|FG000|Overall Study|Death|2|||
157146588|NCT00586690|567284134|FG001|Overall Study|Death|0|||
157146589|NCT00586690|567284133|FG000|Overall Study|Disease Progression|10|||
157146590|NCT00586690|567284134|FG001|Overall Study|Disease Progression|0|||
157146591|NCT00586690|567284133|FG000|Overall Study|Adverse Event|1|||
157146592|NCT00586690|567284134|FG001|Overall Study|Adverse Event|0|||
157146593|NCT00586690|567284133|FG000|Overall Study|Lack of Efficacy|2|||
157146594|NCT00586690|567284134|FG001|Overall Study|Lack of Efficacy|0|||
157146595|NCT00586690|567284133|FG000|Overall Study|Lab can't accommodate|1|||
157146596|NCT00586690|567284134|FG001|Overall Study|Lab can't accommodate|0|||
157146597|NCT02453841|567284135|FG000|Overall Study|Protocol Violation|1|||
157146598|NCT02453841|567284135|FG000|Overall Study|Unable to obtain blood samples|2|||
157146599|NCT00857246|567284136|FG000|Induction Regimen|Adverse Event|1|||
157146600|NCT00857246|567284136|FG000|Induction Regimen|disease-related complications|1|||
157146601|NCT00857246|567284136|FG000|Induction Regimen|Withdrawal by Subject|1|||
157146602|NCT00857246|567284136|FG000|Surgery (Curative)|disease progression|6|||
157146603|NCT00857246|567284136|FG000|ChemoRT|Withdrawal by Subject|1|||
157146604|NCT00857246|567284136|FG000|ChemoRT|Adverse Event|2|||
157146605|NCT03851510|567284137|FG000|Overall Study|Screen Fail|1|||
157146606|NCT03851510|567284137|FG000|Overall Study|Adverse Event|1|||
157146607|NCT03851510|567284137|FG000|Overall Study|Withdrawal by Subject|1|||
157146608|NCT01151137|567284140|FG000|Overall Study|Death|15|||
157146609|NCT01151137|567284141|FG001|Overall Study|Death|27|||
157146610|NCT01151137|567284140|FG000|Overall Study|Lost to Follow-up|1|||
157146611|NCT01151137|567284141|FG001|Overall Study|Lost to Follow-up|1|||
157146612|NCT00072189|567284142|FG000|Overall Study|Withdrawal by Subject|1|||
157146613|NCT00970294|567284145|FG000|Overall Study|Physician Decision|4|||
157146614|NCT00970294|567284145|FG000|Overall Study|Withdrawal by Subject|1|||
157146615|NCT01333189|567284146|FG000|Overall Study|Time constraints|1|||
157222356|NCT01533428|567560256|FG001|Overall Study|Lost to Follow-up|1|||
157222357|NCT01533428|567560255|FG000|Overall Study|Withdrawal by Subject|7|||
156810195|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
156810196|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
156810197|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
156810198|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
156810199|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810200|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810201|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
156810202|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
156810203|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
156810204|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810205|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810206|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
156810207|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810208|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
156810209|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
156810210|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
156810211|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
156810212|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
156810213|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
157222358|NCT01533428|567560256|FG001|Overall Study|Withdrawal by Subject|6|||
157222359|NCT00859469|567560258|FG000|Overall Study|Adverse Event|2|||
156810214|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
156810215|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
157146616|NCT01333189|567284147|FG001|Overall Study|Time constraints|0|||
157146617|NCT01333189|567284146|FG000|Overall Study|Adverse Event|1|||
157146618|NCT01333189|567284147|FG001|Overall Study|Adverse Event|0|||
157146619|NCT01333189|567284146|FG000|Overall Study|Transportation difficulties|0|||
157146620|NCT01333189|567284147|FG001|Overall Study|Transportation difficulties|1|||
157146621|NCT01333189|567284146|FG000|Overall Study|Moved from region|0|||
157146622|NCT01333189|567284147|FG001|Overall Study|Moved from region|1|||
157146623|NCT01739595|567284148|FG000|Overall Study|Adverse Event|3|||
157146624|NCT01739595|567284149|FG001|Overall Study|Adverse Event|0|||
156810216|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
156810217|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
156810218|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
156810219|NCT04951622|566058825|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810220|NCT04951622|566058826|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810221|NCT04951622|566058827|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810222|NCT04951622|566058828|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
156810223|NCT04951622|566058829|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
156810224|NCT03517436|566058832|FG000|Overall Study|Death|3|||
156810225|NCT03517436|566058832|FG000|Overall Study|Withdrawal by Subject|4|||
156810226|NCT03517436|566058832|FG000|Overall Study|Did not receive study valve.|1|||
156810227|NCT04271540|566058833|FG000|Overall Study|Lost to Follow-up|1|||
156810228|NCT04271540|566058833|FG000|Overall Study|Screen Fail|5|||
156810229|NCT04587869|566058836|FG000|Overall Study|Death|1|||
156810230|NCT04587869|566058837|FG001|Overall Study|Death|0|||
156810231|NCT04587869|566058836|FG000|Overall Study|Lost to Follow-up|27|||
156810232|NCT04587869|566058837|FG001|Overall Study|Lost to Follow-up|34|||
156810233|NCT04587869|566058836|FG000|Overall Study|Grant Termination|13|||
156810234|NCT04587869|566058837|FG001|Overall Study|Grant Termination|25|||
156810235|NCT04587869|566058836|FG000|Overall Study|too busy|2|||
157146625|NCT01739595|567284150|FG002|Overall Study|Adverse Event|0|||
157146626|NCT01739595|567284148|FG000|Overall Study|Lost to Follow-up|2|||
157146627|NCT01739595|567284149|FG001|Overall Study|Lost to Follow-up|0|||
157146628|NCT01739595|567284150|FG002|Overall Study|Lost to Follow-up|0|||
157146629|NCT01739595|567284148|FG000|Overall Study|Withdrawal by Subject|2|||
157146630|NCT01739595|567284149|FG001|Overall Study|Withdrawal by Subject|1|||
157146631|NCT01739595|567284150|FG002|Overall Study|Withdrawal by Subject|2|||
157146632|NCT01739595|567284148|FG000|Overall Study|Eligibility issue|3|||
157146633|NCT01739595|567284149|FG001|Overall Study|Eligibility issue|0|||
157146634|NCT01739595|567284150|FG002|Overall Study|Eligibility issue|0|||
157146635|NCT01739595|567284148|FG000|Overall Study|Protocol Violation|1|||
157146636|NCT01739595|567284149|FG001|Overall Study|Protocol Violation|0|||
157146637|NCT01739595|567284150|FG002|Overall Study|Protocol Violation|0|||
157146638|NCT01739595|567284148|FG000|Overall Study|Lab assessment|1|||
157146639|NCT01739595|567284149|FG001|Overall Study|Lab assessment|0|||
157146640|NCT01739595|567284150|FG002|Overall Study|Lab assessment|0|||
157146641|NCT01739595|567284148|FG000|Overall Study|Drug discrepancy|1|||
157146642|NCT01739595|567284149|FG001|Overall Study|Drug discrepancy|0|||
157146643|NCT01739595|567284150|FG002|Overall Study|Drug discrepancy|0|||
157146644|NCT02104180|567284151|FG000|Overall Study|Protocol Violation|1|||
157146645|NCT02104180|567284152|FG001|Overall Study|Protocol Violation|0|||
157146646|NCT00793585|567284153|FG000|Overall Study|Adverse Event|1|||
157146647|NCT00793585|567284154|FG001|Overall Study|Adverse Event|1|||
157146648|NCT00793585|567284153|FG000|Overall Study|Protocol Violation|1|||
157146649|NCT00793585|567284154|FG001|Overall Study|Protocol Violation|2|||
157146650|NCT00035815|567284155|FG000|Overall Study|Withdrawal by Subject|17|||
157146651|NCT00035815|567284156|FG001|Overall Study|Withdrawal by Subject|11|||
157146652|NCT04952389|567284158|FG000|Overall Study|Withdrawal by Subject|8|||
157146653|NCT04952389|567284159|FG001|Overall Study|Withdrawal by Subject|4|||
157146654|NCT05635838|567285882|FG000|16-Week DBVC Period|Adverse Event|2|||
157146655|NCT05635838|567285883|FG001|16-Week DBVC Period|Adverse Event|0|||
157146656|NCT05635838|567285884|FG002|16-Week DBVC Period|Adverse Event|0|||
157146657|NCT05635838|567285885|FG003|16-Week DBVC Period|Adverse Event|0|||
157146658|NCT05635838|567285882|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
157146659|NCT05635838|567285883|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
157146660|NCT05635838|567285884|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
157146661|NCT05635838|567285885|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
157146662|NCT05635838|567285882|FG000|16-Week DBVC Period|Physician Decision|0|||
156810236|NCT04587869|566058837|FG001|Overall Study|too busy|0|||
156810237|NCT04587869|566058836|FG000|Overall Study|Withdrawal by Subject|2|||
156810238|NCT04587869|566058837|FG001|Overall Study|Withdrawal by Subject|2|||
156810239|NCT04587869|566058836|FG000|Overall Study|Other|1|||
156810240|NCT04587869|566058837|FG001|Overall Study|Other|0|||
156810241|NCT00943761|566058840|FG000|Overall Study|Lost to Follow-up|2|||
156810242|NCT00943761|566058841|FG001|Overall Study|Lost to Follow-up|0|||
157146663|NCT05635838|567285883|FG001|16-Week DBVC Period|Physician Decision|1|||
157146664|NCT05635838|567285884|FG002|16-Week DBVC Period|Physician Decision|0|||
157146665|NCT05635838|567285885|FG003|16-Week DBVC Period|Physician Decision|0|||
157146666|NCT05635838|567285882|FG000|16-Week DBVC Period|Protocol Violation|1|||
157146667|NCT05635838|567285883|FG001|16-Week DBVC Period|Protocol Violation|0|||
157146668|NCT05635838|567285884|FG002|16-Week DBVC Period|Protocol Violation|0|||
157146669|NCT05635838|567285885|FG003|16-Week DBVC Period|Protocol Violation|0|||
157146670|NCT05635838|567285882|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
157146671|NCT05635838|567285883|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
156810243|NCT00943761|566058840|FG000|Overall Study|Withdrawal by Subject|2|||
156810244|NCT00943761|566058841|FG001|Overall Study|Withdrawal by Subject|1|||
156810245|NCT02268383|566058842|FG000|Overall Study|Death|12|||
156810246|NCT02268383|566058842|FG000|Overall Study|Lost to Follow-up|2|||
156810247|NCT02268383|566058842|FG000|Overall Study|Withdrawal by Subject|9|||
157146672|NCT05635838|567285884|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
157146673|NCT05635838|567285885|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
157146674|NCT05635838|567285882|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
157146675|NCT05635838|567285883|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
157146676|NCT05635838|567285884|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
157146677|NCT05635838|567285885|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
157146678|NCT05635838|567285882|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
157146679|NCT05635838|567285883|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
157146680|NCT05635838|567285884|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
157146681|NCT05635838|567285885|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
157146682|NCT05635838|567285882|FG000|16-Week OLE Period|Adverse Event|0|||
157146683|NCT05635838|567285883|FG001|16-Week OLE Period|Adverse Event|0|||
157146684|NCT05635838|567285884|FG002|16-Week OLE Period|Adverse Event|0|||
157146685|NCT05635838|567285885|FG003|16-Week OLE Period|Adverse Event|2|||
157146686|NCT05635838|567285882|FG000|16-Week OLE Period|Lost to Follow-up|0|||
157146687|NCT05635838|567285883|FG001|16-Week OLE Period|Lost to Follow-up|0|||
157146688|NCT05635838|567285884|FG002|16-Week OLE Period|Lost to Follow-up|1|||
157146689|NCT05635838|567285885|FG003|16-Week OLE Period|Lost to Follow-up|3|||
157146690|NCT05635838|567285882|FG000|16-Week OLE Period|Physician Decision|0|||
157146691|NCT05635838|567285883|FG001|16-Week OLE Period|Physician Decision|0|||
157146692|NCT05635838|567285884|FG002|16-Week OLE Period|Physician Decision|0|||
157146693|NCT05635838|567285885|FG003|16-Week OLE Period|Physician Decision|1|||
157146694|NCT05635838|567285882|FG000|16-Week OLE Period|Protocol Violation|0|||
157146695|NCT05635838|567285883|FG001|16-Week OLE Period|Protocol Violation|0|||
157146696|NCT05635838|567285884|FG002|16-Week OLE Period|Protocol Violation|1|||
157146697|NCT05635838|567285885|FG003|16-Week OLE Period|Protocol Violation|1|||
157146698|NCT05635838|567285882|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
157146699|NCT05635838|567285883|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
157146700|NCT05635838|567285884|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
157146701|NCT05635838|567285885|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
157146702|NCT05635838|567285882|FG000|16-Week OLE Period|Pregnancy|0|||
157146703|NCT05635838|567285883|FG001|16-Week OLE Period|Pregnancy|0|||
157146704|NCT05635838|567285884|FG002|16-Week OLE Period|Pregnancy|1|||
157146705|NCT05635838|567285885|FG003|16-Week OLE Period|Pregnancy|0|||
157146706|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
157146707|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
157146708|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
157146709|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
157146710|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
157146711|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157146712|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157146713|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157146714|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
157146715|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
157146716|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
157146717|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
157146718|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
157146719|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
157146720|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
157146721|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
157146722|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
157146723|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
157146724|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
157146725|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
157146726|NCT01894516|567285888|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
157146727|NCT01894516|567285889|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
157146728|NCT01894516|567285890|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
157146729|NCT01894516|567285891|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
157146730|NCT01894516|567285888|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
157146731|NCT01894516|567285889|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
157146732|NCT01894516|567285890|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
157146733|NCT01894516|567285891|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
157146734|NCT01894516|567285888|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
157146735|NCT01894516|567285889|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
156810248|NCT02268383|566058842|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
156810249|NCT02268383|566058842|FG000|Overall Study|Protocol deviation|3|||
156810250|NCT02268383|566058842|FG000|Overall Study|Sponsor decision|22|||
156810251|NCT02268383|566058842|FG000|Overall Study|Not reported|12|||
156810252|NCT01402869|566058845|FG000|Overall Study|Required Tooth Extraction|0|||
156810253|NCT01402869|566058846|FG001|Overall Study|Required Tooth Extraction|0|||
156810254|NCT01402869|566058847|FG002|Overall Study|Required Tooth Extraction|1|||
156810255|NCT01544348|566058848|FG000|Overall Study|Lost to Follow-up|1|||
156810256|NCT01544348|566058849|FG001|Overall Study|Lost to Follow-up|0|||
156810257|NCT01544348|566058850|FG002|Overall Study|Lost to Follow-up|0|||
156810258|NCT01544348|566058851|FG003|Overall Study|Lost to Follow-up|0|||
156810259|NCT01544348|566058852|FG004|Overall Study|Lost to Follow-up|0|||
156810260|NCT01544348|566058853|FG005|Overall Study|Lost to Follow-up|0|||
156810261|NCT01544348|566058854|FG006|Overall Study|Lost to Follow-up|1|||
156810262|NCT01544348|566058855|FG007|Overall Study|Lost to Follow-up|0|||
156810263|NCT01544348|566058848|FG000|Overall Study|Withdrawal by Subject|1|||
156810264|NCT01544348|566058849|FG001|Overall Study|Withdrawal by Subject|0|||
156810265|NCT01544348|566058850|FG002|Overall Study|Withdrawal by Subject|0|||
156810266|NCT01544348|566058851|FG003|Overall Study|Withdrawal by Subject|0|||
156810267|NCT01544348|566058852|FG004|Overall Study|Withdrawal by Subject|1|||
156810268|NCT01544348|566058853|FG005|Overall Study|Withdrawal by Subject|2|||
156810269|NCT01544348|566058854|FG006|Overall Study|Withdrawal by Subject|1|||
156810270|NCT01544348|566058855|FG007|Overall Study|Withdrawal by Subject|0|||
156810271|NCT01544348|566058848|FG000|Overall Study|Physician Decision|0|||
156810272|NCT01544348|566058849|FG001|Overall Study|Physician Decision|0|||
156810273|NCT01544348|566058850|FG002|Overall Study|Physician Decision|0|||
156810274|NCT01544348|566058851|FG003|Overall Study|Physician Decision|0|||
156810275|NCT01544348|566058852|FG004|Overall Study|Physician Decision|0|||
156810276|NCT01544348|566058853|FG005|Overall Study|Physician Decision|1|||
156810277|NCT01544348|566058854|FG006|Overall Study|Physician Decision|0|||
156810278|NCT01544348|566058855|FG007|Overall Study|Physician Decision|0|||
156810279|NCT00642707|566058856|FG000|Overall Study|Adverse Event|0|||
156810280|NCT00642707|566058857|FG001|Overall Study|Adverse Event|0|||
156810281|NCT00642707|566058858|FG002|Overall Study|Adverse Event|0|||
156810282|NCT00642707|566058859|FG003|Overall Study|Adverse Event|2|||
156810283|NCT00642707|566058856|FG000|Overall Study|Withdrawal by Subject|1|||
156810284|NCT00642707|566058857|FG001|Overall Study|Withdrawal by Subject|0|||
156810285|NCT00642707|566058858|FG002|Overall Study|Withdrawal by Subject|0|||
156810286|NCT00642707|566058859|FG003|Overall Study|Withdrawal by Subject|0|||
156810287|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
156810288|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
156810289|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
156810290|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810291|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810292|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810293|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810294|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810295|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810296|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810297|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810298|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810299|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810300|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810301|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810302|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
156810303|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156810304|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
156810305|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810306|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810307|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810308|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810309|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810310|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810311|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810312|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810313|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810314|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810315|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156883436|NCT01347580|566332537|FG000|Overall Study|Protocol Violation|10|||
156810316|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810317|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810318|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
156810319|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810320|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810321|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810322|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
157146736|NCT01894516|567285890|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
156810323|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810324|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810325|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810326|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810327|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810328|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810329|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810330|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810331|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810332|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810333|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810334|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
156810335|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810336|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810337|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
156810338|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810339|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810340|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810341|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810342|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810343|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810344|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810345|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810346|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810347|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810348|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810349|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810350|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
156810351|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810352|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810353|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810354|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
156810355|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810356|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810357|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810358|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810359|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810360|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810361|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810362|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810363|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810364|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810365|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810366|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
156810367|NCT02891226|566058860|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810368|NCT02891226|566058861|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810369|NCT02891226|566058862|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810370|NCT02891226|566058863|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
156810371|NCT02891226|566058864|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810372|NCT02891226|566058865|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810373|NCT02891226|566058866|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810374|NCT02891226|566058867|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810375|NCT02891226|566058868|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156883437|NCT01347580|566332538|FG001|Overall Study|Protocol Violation|7|||
156883438|NCT01347580|566332537|FG000|Overall Study|Lost to Follow-up|3|||
156883439|NCT01347580|566332538|FG001|Overall Study|Lost to Follow-up|1|||
157146737|NCT01894516|567285891|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
157146738|NCT02452970|567285894|FG000|Overall Study|Adverse Event|1|||
156883440|NCT01347580|566332537|FG000|Overall Study|Had other reason|9|||
156883441|NCT01347580|566332538|FG001|Overall Study|Had other reason|6|||
156883442|NCT01964755|566332539|FG000|Overall Study|Death|2|||
156883443|NCT01122264|566332540|FG000|Overall Study|Adverse Event|6|||
156883444|NCT01122264|566332541|FG001|Overall Study|Adverse Event|5|||
157146739|NCT01266148|567285895|FG000|Overall Study|Adverse Event|2|||
156883445|NCT01122264|566332542|FG002|Overall Study|Adverse Event|7|||
156810376|NCT02891226|566058869|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810377|NCT02891226|566058870|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810378|NCT02891226|566058871|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810379|NCT02891226|566058872|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810380|NCT02891226|566058873|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810381|NCT02891226|566058874|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156883446|NCT01122264|566332540|FG000|Overall Study|Death|1|||
156883447|NCT01122264|566332541|FG001|Overall Study|Death|0|||
156810382|NCT02891226|566058875|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
156810383|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810384|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810385|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810386|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810387|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810388|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810389|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
156810390|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
156810391|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
156810392|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
156810393|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810394|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810395|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810396|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810397|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810398|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
156810399|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810400|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810401|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810402|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810403|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810404|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
156810405|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810406|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810407|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810408|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
156810409|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810410|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810411|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810412|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810413|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810414|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
156810415|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810416|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810417|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810418|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810419|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810420|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810421|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
156810422|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
156810423|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
156810424|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
156810425|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810426|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810427|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810428|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810429|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810430|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
156810431|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810432|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810433|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810434|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
157022372|NCT03150810|566835190|FG001|Overall Study|Participant relocated abroad.|0|||
157022373|NCT03150810|566835191|FG002|Overall Study|Participant relocated abroad.|0|||
157022374|NCT03150810|566835192|FG003|Overall Study|Participant relocated abroad.|0|||
157022375|NCT03150810|566835193|FG004|Overall Study|Participant relocated abroad.|0|||
157022376|NCT03150810|566835194|FG005|Overall Study|Participant relocated abroad.|1|||
157022377|NCT03150810|566835195|FG006|Overall Study|Participant relocated abroad.|0|||
157022378|NCT03150810|566835196|FG007|Overall Study|Participant relocated abroad.|0|||
157022379|NCT03150810|566835197|FG008|Overall Study|Participant relocated abroad.|0|||
157022380|NCT03150810|566835198|FG009|Overall Study|Participant relocated abroad.|0|||
157022381|NCT03150810|566835199|FG010|Overall Study|Participant relocated abroad.|0|||
157022382|NCT03150810|566835200|FG011|Overall Study|Participant relocated abroad.|0|||
157022383|NCT03150810|566835201|FG012|Overall Study|Participant relocated abroad.|0|||
157022384|NCT03150810|566835189|FG000|Overall Study|Transferred care to oncologist|0|||
157022385|NCT03150810|566835190|FG001|Overall Study|Transferred care to oncologist|0|||
157022386|NCT03150810|566835191|FG002|Overall Study|Transferred care to oncologist|0|||
156810435|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
156883448|NCT01122264|566332542|FG002|Overall Study|Death|0|||
157022387|NCT03150810|566835192|FG003|Overall Study|Transferred care to oncologist|0|||
157222360|NCT00859469|567560258|FG000|Overall Study|Lack of Efficacy|9|||
157222361|NCT00859469|567560258|FG000|Overall Study|Withdrawal by Subject|1|||
157222362|NCT00859469|567560258|FG000|Overall Study|Death|16|||
157222363|NCT02102490|567560264|FG000|Overall Study|Death|6|||
157222364|NCT02102490|567560264|FG000|Overall Study|Lost to Follow-up|1|||
157222365|NCT00095199|567560265|FG000|Overall Study|Adverse Event|40|||
157222366|NCT00095199|567560266|FG001|Overall Study|Adverse Event|22|||
157222367|NCT00095199|567560267|FG002|Overall Study|Adverse Event|26|||
157222368|NCT00095199|567560268|FG003|Overall Study|Adverse Event|11|||
157222369|NCT00095199|567560265|FG000|Overall Study|Progressive disease|213|||
157222370|NCT00095199|567560266|FG001|Overall Study|Progressive disease|179|||
157222371|NCT00095199|567560267|FG002|Overall Study|Progressive disease|105|||
157222372|NCT00095199|567560268|FG003|Overall Study|Progressive disease|98|||
157222373|NCT00095199|567560265|FG000|Overall Study|Death|10|||
157222374|NCT00095199|567560266|FG001|Overall Study|Death|6|||
157222375|NCT00095199|567560267|FG002|Overall Study|Death|11|||
157222376|NCT00095199|567560268|FG003|Overall Study|Death|9|||
157222377|NCT00095199|567560265|FG000|Overall Study|Withdrawal by Subject|21|||
157222378|NCT00095199|567560266|FG001|Overall Study|Withdrawal by Subject|16|||
157222379|NCT00095199|567560267|FG002|Overall Study|Withdrawal by Subject|13|||
157222380|NCT00095199|567560268|FG003|Overall Study|Withdrawal by Subject|22|||
157222381|NCT00095199|567560265|FG000|Overall Study|Protocol Violation|4|||
157222382|NCT00095199|567560266|FG001|Overall Study|Protocol Violation|4|||
157222383|NCT00095199|567560267|FG002|Overall Study|Protocol Violation|2|||
156810436|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810437|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810438|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810439|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810440|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810441|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810442|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810443|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810444|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810445|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810446|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
156810447|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810448|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810449|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810450|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810451|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810452|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810453|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
156810454|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810455|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810456|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810457|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810458|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810459|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810460|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810461|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810462|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
156810463|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810464|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810465|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810466|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810467|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810468|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810469|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810470|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810471|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810472|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
156810473|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810474|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156883449|NCT01122264|566332540|FG000|Overall Study|Lost to Follow-up|5|||
156883450|NCT01122264|566332541|FG001|Overall Study|Lost to Follow-up|9|||
157222384|NCT00095199|567560268|FG003|Overall Study|Protocol Violation|0|||
157222385|NCT00095199|567560265|FG000|Overall Study|Liver function test results elevated|0|||
157222386|NCT00095199|567560266|FG001|Overall Study|Liver function test results elevated|0|||
157222387|NCT00095199|567560267|FG002|Overall Study|Liver function test results elevated|1|||
156883451|NCT01122264|566332542|FG002|Overall Study|Lost to Follow-up|13|||
156883452|NCT01122264|566332540|FG000|Overall Study|Entry Criteria Not Met|1|||
156883453|NCT01122264|566332541|FG001|Overall Study|Entry Criteria Not Met|0|||
156883454|NCT01122264|566332542|FG002|Overall Study|Entry Criteria Not Met|0|||
156883455|NCT01122264|566332540|FG000|Overall Study|Protocol Violation|7|||
156883456|NCT01122264|566332541|FG001|Overall Study|Protocol Violation|7|||
156883457|NCT01122264|566332542|FG002|Overall Study|Protocol Violation|9|||
156883458|NCT01122264|566332540|FG000|Overall Study|Withdrawal by Subject|6|||
156883459|NCT01122264|566332541|FG001|Overall Study|Withdrawal by Subject|6|||
156883460|NCT01122264|566332542|FG002|Overall Study|Withdrawal by Subject|16|||
156883461|NCT01122264|566332540|FG000|Overall Study|Physician Decision|3|||
156883462|NCT01122264|566332541|FG001|Overall Study|Physician Decision|1|||
156883463|NCT01122264|566332542|FG002|Overall Study|Physician Decision|1|||
156883464|NCT01122264|566332540|FG000|Overall Study|Lack of Efficacy|3|||
156883465|NCT01122264|566332541|FG001|Overall Study|Lack of Efficacy|1|||
156883466|NCT01122264|566332542|FG002|Overall Study|Lack of Efficacy|1|||
156883467|NCT00640224|566332543|FG000|Overall Study|Lost to Follow-up|5|||
156883468|NCT00640224|566332544|FG001|Overall Study|Lost to Follow-up|2|||
156810475|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810476|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810477|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810478|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
156810479|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810480|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810481|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810482|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810483|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810484|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810485|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810486|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
156810487|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810488|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810489|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810490|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810491|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810492|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810493|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810494|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
156810495|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810496|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810497|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156883469|NCT00640224|566332545|FG002|Overall Study|Lost to Follow-up|0|||
156883470|NCT00640224|566332546|FG003|Overall Study|Lost to Follow-up|0|||
156883471|NCT00640224|566332543|FG000|Overall Study|Withdrawal by Subject|1|||
156883472|NCT00640224|566332544|FG001|Overall Study|Withdrawal by Subject|0|||
156883473|NCT00640224|566332545|FG002|Overall Study|Withdrawal by Subject|0|||
156883474|NCT00640224|566332546|FG003|Overall Study|Withdrawal by Subject|0|||
156883475|NCT00640224|566332543|FG000|Overall Study|Headaches|0|||
156883476|NCT00640224|566332544|FG001|Overall Study|Headaches|1|||
156883477|NCT00640224|566332545|FG002|Overall Study|Headaches|0|||
156883478|NCT00640224|566332546|FG003|Overall Study|Headaches|0|||
156883479|NCT00422513|566332547|FG000|Overall Study|Lack of Efficacy|4|||
156883480|NCT00422513|566332548|FG001|Overall Study|Lack of Efficacy|5|||
156883481|NCT00422513|566332547|FG000|Overall Study|Protocol Violation|23|||
156883482|NCT00422513|566332548|FG001|Overall Study|Protocol Violation|7|||
156883483|NCT00422513|566332547|FG000|Overall Study|Refused Treatment|4|||
156883484|NCT00422513|566332548|FG001|Overall Study|Refused Treatment|2|||
156883485|NCT00422513|566332547|FG000|Overall Study|Withdrawal by Subject|2|||
156883486|NCT00422513|566332548|FG001|Overall Study|Withdrawal by Subject|1|||
156883487|NCT00422513|566332547|FG000|Overall Study|early termination of the study|67|||
156883488|NCT00422513|566332548|FG001|Overall Study|early termination of the study|80|||
156883489|NCT00422513|566332547|FG000|Overall Study|Adverse Event|4|||
156883490|NCT00422513|566332548|FG001|Overall Study|Adverse Event|4|||
156883491|NCT00422513|566332547|FG000|Overall Study|Death|3|||
156810498|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156883492|NCT00422513|566332548|FG001|Overall Study|Death|7|||
156883493|NCT00422084|566332556|FG000|Overall Study|Adverse Event|21|||
156883494|NCT00422084|566332557|FG001|Overall Study|Adverse Event|7|||
156883495|NCT00422084|566332556|FG000|Overall Study|Withdrawal by Subject|12|||
156883496|NCT00422084|566332557|FG001|Overall Study|Withdrawal by Subject|9|||
156883497|NCT00422084|566332556|FG000|Overall Study|Lost to Follow-up|14|||
156883498|NCT00422084|566332557|FG001|Overall Study|Lost to Follow-up|9|||
156883499|NCT00422084|566332556|FG000|Overall Study|Protocol Violation|4|||
156810499|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810500|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810501|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810502|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810503|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
156810504|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810505|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810506|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810507|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810508|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810509|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810510|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
156810511|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810512|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810513|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810514|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810515|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810516|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810517|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810518|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810519|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810520|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
156810521|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810522|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810523|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810524|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810525|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810526|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
156810527|NCT02891226|566058860|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810528|NCT02891226|566058861|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810529|NCT02891226|566058862|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810530|NCT02891226|566058863|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810531|NCT02891226|566058864|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810532|NCT02891226|566058865|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810533|NCT02891226|566058866|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810534|NCT02891226|566058867|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810535|NCT02891226|566058868|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810536|NCT02891226|566058869|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
156810537|NCT02891226|566058870|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810538|NCT02891226|566058871|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810539|NCT02891226|566058872|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810540|NCT02891226|566058873|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810541|NCT02891226|566058874|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810542|NCT02891226|566058875|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
156810543|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810544|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810545|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810546|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810547|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810548|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810549|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810550|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810551|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810552|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810553|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
156810554|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810555|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810556|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810557|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810558|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
156810559|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810560|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810561|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810562|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810563|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
157222388|NCT00095199|567560268|FG003|Overall Study|Liver function test results elevated|1|||
156810564|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810565|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810566|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810567|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810568|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810569|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
156810570|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810571|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810572|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810573|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810574|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
156810575|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810576|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810577|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810578|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810579|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810580|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810581|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810582|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810583|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810584|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810585|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
156810586|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810587|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810588|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810589|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810590|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
156810591|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810592|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810593|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810594|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810595|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810596|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810597|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810598|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810599|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810600|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810601|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
156810602|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810603|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810604|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810605|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810606|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
156810607|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810608|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810609|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810610|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810611|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810612|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810613|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810614|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810615|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810616|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810617|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
156810618|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810619|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810620|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810621|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810622|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
156810623|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810624|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810625|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810626|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
157222389|NCT00095199|567560265|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
157222390|NCT00095199|567560266|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
157222391|NCT00095199|567560267|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
157222392|NCT00095199|567560268|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
157222393|NCT00095199|567560265|FG000|Overall Study|Physician Decision|5|||
157222394|NCT00095199|567560266|FG001|Overall Study|Physician Decision|6|||
157222395|NCT00095199|567560267|FG002|Overall Study|Physician Decision|1|||
157222396|NCT00095199|567560268|FG003|Overall Study|Physician Decision|1|||
157222397|NCT00095199|567560265|FG000|Overall Study|Not eligible|1|||
157222398|NCT00095199|567560266|FG001|Overall Study|Not eligible|7|||
157222399|NCT00095199|567560267|FG002|Overall Study|Not eligible|0|||
157222400|NCT00095199|567560268|FG003|Overall Study|Not eligible|1|||
157222401|NCT00095199|567560265|FG000|Overall Study|Started Palliative Radiotherapy|1|||
157222402|NCT00095199|567560266|FG001|Overall Study|Started Palliative Radiotherapy|0|||
157222403|NCT00095199|567560267|FG002|Overall Study|Started Palliative Radiotherapy|0|||
157222404|NCT00095199|567560268|FG003|Overall Study|Started Palliative Radiotherapy|0|||
157222405|NCT00095199|567560265|FG000|Overall Study|Started radiotherapy regimen|0|||
157222406|NCT00095199|567560266|FG001|Overall Study|Started radiotherapy regimen|1|||
157222407|NCT00095199|567560267|FG002|Overall Study|Started radiotherapy regimen|0|||
157222408|NCT00095199|567560268|FG003|Overall Study|Started radiotherapy regimen|0|||
156810627|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810628|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810629|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810630|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810631|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810632|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810633|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
156810634|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810635|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156883500|NCT00422084|566332557|FG001|Overall Study|Protocol Violation|1|||
156883501|NCT00422084|566332556|FG000|Overall Study|Lack of Efficacy|40|||
156883502|NCT00422084|566332557|FG001|Overall Study|Lack of Efficacy|42|||
156883503|NCT00422084|566332556|FG000|Overall Study|P. vivax infection|3|||
156883504|NCT00422084|566332557|FG001|Overall Study|P. vivax infection|6|||
156883505|NCT00422084|566332556|FG000|Overall Study|Cyesis|1|||
156883506|NCT00422084|566332557|FG001|Overall Study|Cyesis|0|||
156883507|NCT00422084|566332556|FG000|Overall Study|Withdrawn from study accidentally|1|||
156883508|NCT00422084|566332557|FG001|Overall Study|Withdrawn from study accidentally|0|||
156883509|NCT00422084|566332556|FG000|Overall Study|Non-compliance|1|||
156883510|NCT00422084|566332557|FG001|Overall Study|Non-compliance|0|||
156883511|NCT00422084|566332556|FG000|Overall Study|Re-location|0|||
157146740|NCT01266148|567285896|FG001|Overall Study|Adverse Event|0|||
157146741|NCT01266148|567285895|FG000|Overall Study|Ongoing rejection|1|||
157146742|NCT01266148|567285896|FG001|Overall Study|Ongoing rejection|0|||
157146743|NCT01266148|567285895|FG000|Overall Study|2 2R rejections|1|||
157146744|NCT01266148|567285896|FG001|Overall Study|2 2R rejections|0|||
157146745|NCT01266148|567285895|FG000|Overall Study|Death|2|||
157146746|NCT01266148|567285896|FG001|Overall Study|Death|3|||
157146747|NCT01266148|567285895|FG000|Overall Study|missing mGFR value + AE|1|||
157146748|NCT01266148|567285896|FG001|Overall Study|missing mGFR value + AE|0|||
157146749|NCT01853228|567285897|FG000|Phase 1|Lack of Efficacy|8|||
157146750|NCT01853228|567285898|FG001|Phase 1|Lack of Efficacy|0|||
157146751|NCT01853228|567285897|FG000|Phase 1|Other|1|||
157146752|NCT01853228|567285898|FG001|Phase 1|Other|0|||
157146753|NCT01853228|567285897|FG000|Phase 2|Physician Decision|0|||
157146754|NCT01853228|567285898|FG001|Phase 2|Physician Decision|1|||
157146755|NCT01853228|567285897|FG000|Phase 2|Proceed To Transplant|0|||
157146756|NCT01853228|567285898|FG001|Phase 2|Proceed To Transplant|3|||
157146757|NCT01853228|567285897|FG000|Phase 2|Lack of Efficacy|0|||
157146758|NCT01853228|567285898|FG001|Phase 2|Lack of Efficacy|4|||
157146759|NCT01269125|567285899|FG000|Overall Study|Adverse Event|3|||
157146760|NCT01269125|567285900|FG001|Overall Study|Adverse Event|5|||
157146761|NCT01269125|567285901|FG002|Overall Study|Adverse Event|0|||
157146762|NCT01269125|567285899|FG000|Overall Study|Lost to Follow-up|4|||
157146763|NCT01269125|567285900|FG001|Overall Study|Lost to Follow-up|0|||
157146764|NCT01269125|567285901|FG002|Overall Study|Lost to Follow-up|0|||
157146765|NCT01300286|567285902|FG000|Overall Study|did not get dosed|1|||
157146766|NCT03635190|567285903|FG000|Overall Study|Lost to Follow-up|4|||
157146767|NCT03635190|567285903|FG000|Overall Study|Death|3|||
157146768|NCT03635190|567285903|FG000|Overall Study|Withdrawal by Subject|1|||
156810636|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810637|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156810638|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
156883512|NCT00422084|566332557|FG001|Overall Study|Re-location|1|||
156883513|NCT00422084|566332556|FG000|Overall Study|Not defined|1|||
157146769|NCT03635190|567285903|FG000|Overall Study|Patient moved and did not return for follow up|1|||
157146770|NCT02767570|567285906|FG000|Overall Study|Lost to Follow-up|3|||
157146771|NCT02767570|567285907|FG001|Overall Study|Lost to Follow-up|0|||
156810639|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810640|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810641|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810642|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810643|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810644|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810645|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810646|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810647|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810648|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810649|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
156810650|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810651|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810652|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810653|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810654|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
156810655|NCT02891226|566058860|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810656|NCT02891226|566058861|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810657|NCT02891226|566058862|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810658|NCT02891226|566058863|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810659|NCT02891226|566058864|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810660|NCT02891226|566058865|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810661|NCT02891226|566058866|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810662|NCT02891226|566058867|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810663|NCT02891226|566058868|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810664|NCT02891226|566058869|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810665|NCT02891226|566058870|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
156810666|NCT02891226|566058871|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810667|NCT02891226|566058872|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810668|NCT02891226|566058873|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810669|NCT02891226|566058874|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810670|NCT02891226|566058875|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
156810671|NCT02891226|566058860|FG000|Follow-up Period|Withdrawal by Subject|0|||
156810672|NCT02891226|566058861|FG001|Follow-up Period|Withdrawal by Subject|0|||
157022388|NCT03150810|566835193|FG004|Overall Study|Transferred care to oncologist|0|||
157146772|NCT02767570|567285906|FG000|Overall Study|COVID shutdown|2|||
157146773|NCT02767570|567285907|FG001|Overall Study|COVID shutdown|5|||
157146774|NCT02767570|567285906|FG000|Overall Study|Increased pain|2|||
157146775|NCT02767570|567285907|FG001|Overall Study|Increased pain|0|||
157146776|NCT02767570|567285906|FG000|Overall Study|Withdrawal by Subject|1|||
157146777|NCT02767570|567285907|FG001|Overall Study|Withdrawal by Subject|3|||
157146778|NCT02767570|567285906|FG000|Overall Study|Unrelated medical issue|1|||
157146779|NCT02767570|567285907|FG001|Overall Study|Unrelated medical issue|1|||
157146780|NCT02767570|567285906|FG000|Overall Study|Received intra-articular injection|0|||
157146781|NCT02767570|567285907|FG001|Overall Study|Received intra-articular injection|1|||
157146782|NCT00417612|567285908|FG000|Overall Study|Errant diagnosis|0|||
157146783|NCT00417612|567285909|FG001|Overall Study|Errant diagnosis|1|||
157146784|NCT00417612|567285908|FG000|Overall Study|Adverse Event|2|||
157146785|NCT00417612|567285909|FG001|Overall Study|Adverse Event|0|||
156810673|NCT02891226|566058862|FG002|Follow-up Period|Withdrawal by Subject|0|||
156810674|NCT02891226|566058863|FG003|Follow-up Period|Withdrawal by Subject|0|||
156810675|NCT02891226|566058864|FG004|Follow-up Period|Withdrawal by Subject|0|||
156810676|NCT02891226|566058865|FG005|Follow-up Period|Withdrawal by Subject|0|||
156810677|NCT02891226|566058866|FG006|Follow-up Period|Withdrawal by Subject|0|||
156810678|NCT02891226|566058867|FG007|Follow-up Period|Withdrawal by Subject|0|||
156810679|NCT02891226|566058868|FG008|Follow-up Period|Withdrawal by Subject|0|||
156810680|NCT02891226|566058869|FG009|Follow-up Period|Withdrawal by Subject|0|||
156810681|NCT02891226|566058870|FG010|Follow-up Period|Withdrawal by Subject|0|||
156810682|NCT02891226|566058871|FG011|Follow-up Period|Withdrawal by Subject|1|||
156810683|NCT02891226|566058872|FG012|Follow-up Period|Withdrawal by Subject|0|||
156810684|NCT02891226|566058873|FG013|Follow-up Period|Withdrawal by Subject|0|||
156810685|NCT02891226|566058874|FG014|Follow-up Period|Withdrawal by Subject|1|||
157146786|NCT00417612|567285908|FG000|Overall Study|Protocol Violation|0|||
157146787|NCT00417612|567285909|FG001|Overall Study|Protocol Violation|2|||
157146788|NCT00417612|567285908|FG000|Overall Study|Lost to Follow-up|1|||
157146789|NCT00417612|567285909|FG001|Overall Study|Lost to Follow-up|0|||
157146790|NCT01712438|567285912|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
157146791|NCT01712438|567285912|FG000|Overall Study|Ongoing ITI treatment|6|||
157146792|NCT01712438|567285912|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
157146793|NCT01712438|567285912|FG000|Overall Study|Prematurely Discontinued|25|||
157146794|NCT02786537|567285913|FG000|As Randomized|Adverse Event|0|||
157146795|NCT02786537|567285914|FG001|As Randomized|Adverse Event|11|||
157146796|NCT02786537|567285915|FG002|As Randomized|Adverse Event|0|||
157146797|NCT02786537|567285916|FG003|As Randomized|Adverse Event|4|||
157146798|NCT02786537|567285917|FG004|As Randomized|Adverse Event|6|||
157146799|NCT02786537|567285918|FG005|As Randomized|Adverse Event|2|||
157146800|NCT02786537|567285913|FG000|As Randomized|Lack of Efficacy|0|||
157146801|NCT02786537|567285914|FG001|As Randomized|Lack of Efficacy|0|||
157146802|NCT02786537|567285915|FG002|As Randomized|Lack of Efficacy|0|||
157146803|NCT02786537|567285916|FG003|As Randomized|Lack of Efficacy|1|||
157146804|NCT02786537|567285917|FG004|As Randomized|Lack of Efficacy|0|||
157146805|NCT02786537|567285918|FG005|As Randomized|Lack of Efficacy|0|||
157146806|NCT02786537|567285913|FG000|As Randomized|Withdrawal by Subject|1|||
157146807|NCT02786537|567285914|FG001|As Randomized|Withdrawal by Subject|2|||
157146808|NCT02786537|567285915|FG002|As Randomized|Withdrawal by Subject|0|||
157146809|NCT02786537|567285916|FG003|As Randomized|Withdrawal by Subject|1|||
157146810|NCT02786537|567285917|FG004|As Randomized|Withdrawal by Subject|1|||
157146811|NCT02786537|567285918|FG005|As Randomized|Withdrawal by Subject|0|||
157146812|NCT02786537|567285913|FG000|As Randomized|Death|0|||
157146813|NCT02786537|567285914|FG001|As Randomized|Death|2|||
157146814|NCT02786537|567285915|FG002|As Randomized|Death|0|||
157146815|NCT02786537|567285916|FG003|As Randomized|Death|3|||
157146816|NCT02786537|567285917|FG004|As Randomized|Death|1|||
157146817|NCT02786537|567285918|FG005|As Randomized|Death|0|||
157146818|NCT02786537|567285913|FG000|As Randomized|Non-compliance with study drug|1|||
157146819|NCT02786537|567285914|FG001|As Randomized|Non-compliance with study drug|11|||
157146820|NCT02786537|567285915|FG002|As Randomized|Non-compliance with study drug|0|||
157146821|NCT02786537|567285916|FG003|As Randomized|Non-compliance with study drug|1|||
157146822|NCT02786537|567285917|FG004|As Randomized|Non-compliance with study drug|0|||
157146823|NCT02786537|567285918|FG005|As Randomized|Non-compliance with study drug|1|||
157146824|NCT02786537|567285913|FG000|As Randomized|Lost to treatment follow-up|4|||
157146825|NCT02786537|567285914|FG001|As Randomized|Lost to treatment follow-up|32|||
157146826|NCT02786537|567285915|FG002|As Randomized|Lost to treatment follow-up|0|||
157146827|NCT02786537|567285916|FG003|As Randomized|Lost to treatment follow-up|24|||
157146828|NCT02786537|567285917|FG004|As Randomized|Lost to treatment follow-up|4|||
157146829|NCT02786537|567285918|FG005|As Randomized|Lost to treatment follow-up|4|||
157146830|NCT02786537|567285913|FG000|As Randomized|Incarceration|0|||
157146831|NCT02786537|567285914|FG001|As Randomized|Incarceration|1|||
157146832|NCT02786537|567285915|FG002|As Randomized|Incarceration|0|||
157146833|NCT02786537|567285916|FG003|As Randomized|Incarceration|0|||
157146834|NCT02786537|567285917|FG004|As Randomized|Incarceration|0|||
157146835|NCT02786537|567285918|FG005|As Randomized|Incarceration|0|||
157146836|NCT02786537|567285913|FG000|As Randomized|Opiate Dependency Relapse|0|||
157146837|NCT02786537|567285914|FG001|As Randomized|Opiate Dependency Relapse|1|||
157146838|NCT02786537|567285915|FG002|As Randomized|Opiate Dependency Relapse|0|||
157146839|NCT02786537|567285916|FG003|As Randomized|Opiate Dependency Relapse|0|||
157222409|NCT00095199|567560265|FG000|Overall Study|Primary tumor removed in other surgery|0|||
157222410|NCT00095199|567560266|FG001|Overall Study|Primary tumor removed in other surgery|1|||
157222411|NCT00095199|567560267|FG002|Overall Study|Primary tumor removed in other surgery|0|||
156810686|NCT02891226|566058875|FG015|Follow-up Period|Withdrawal by Subject|1|||
156810687|NCT01445847|566058876|FG000|Overall Study|Protocol Violation|13|||
156810688|NCT01445847|566058877|FG001|Overall Study|Protocol Violation|14|||
156810689|NCT01445847|566058876|FG000|Overall Study|Missed Data|1|||
156810690|NCT01445847|566058877|FG001|Overall Study|Missed Data|0|||
156810691|NCT00707993|566058878|FG000|Overall Study|Adverse Event|16|||
156810692|NCT00707993|566058879|FG001|Overall Study|Adverse Event|20|||
156810693|NCT00707993|566058878|FG000|Overall Study|Protocol Violation|4|||
157146840|NCT02786537|567285917|FG004|As Randomized|Opiate Dependency Relapse|0|||
157146841|NCT02786537|567285918|FG005|As Randomized|Opiate Dependency Relapse|0|||
157146842|NCT02786537|567285913|FG000|As Randomized|HCV drugs stolen from pt|0|||
157146843|NCT02786537|567285914|FG001|As Randomized|HCV drugs stolen from pt|1|||
157146844|NCT02786537|567285915|FG002|As Randomized|HCV drugs stolen from pt|0|||
157146845|NCT02786537|567285916|FG003|As Randomized|HCV drugs stolen from pt|0|||
157146846|NCT02786537|567285917|FG004|As Randomized|HCV drugs stolen from pt|0|||
157146847|NCT02786537|567285918|FG005|As Randomized|HCV drugs stolen from pt|0|||
157146848|NCT02786537|567285913|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
157146849|NCT02786537|567285914|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
157146850|NCT02786537|567285915|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
156810694|NCT00707993|566058879|FG001|Overall Study|Protocol Violation|7|||
156810695|NCT00707993|566058878|FG000|Overall Study|Lost to Follow-up|0|||
157146851|NCT02786537|567285916|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
156810696|NCT00707993|566058879|FG001|Overall Study|Lost to Follow-up|4|||
156810697|NCT00707993|566058878|FG000|Overall Study|Withdrawal by Subject|12|||
156810698|NCT00707993|566058879|FG001|Overall Study|Withdrawal by Subject|16|||
156810699|NCT00707993|566058878|FG000|Overall Study|Hyperglycemic Rescue|55|||
156810700|NCT00707993|566058879|FG001|Overall Study|Hyperglycemic Rescue|47|||
156810701|NCT00707993|566058878|FG000|Overall Study|Other|2|||
156810702|NCT00707993|566058879|FG001|Overall Study|Other|0|||
156810703|NCT03960684|566058880|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
156810704|NCT03816176|566058881|FG000|Overall Study|Miscellaneous|5|||
156810705|NCT03816176|566058881|FG000|Overall Study|Lack of Efficacy|4|||
156810706|NCT03816176|566058881|FG000|Overall Study|Adverse Event|3|||
156810707|NCT01142388|566060401|FG000|Overall Study|Lack of Efficacy|21|||
156810708|NCT01142388|566060402|FG001|Overall Study|Lack of Efficacy|31|||
156810709|NCT01142388|566060401|FG000|Overall Study|Adverse Event|9|||
156810710|NCT01142388|566060402|FG001|Overall Study|Adverse Event|5|||
156810711|NCT01142388|566060401|FG000|Overall Study|Death|3|||
156810712|NCT01142388|566060402|FG001|Overall Study|Death|2|||
156810713|NCT01142388|566060401|FG000|Overall Study|Withdrawal by Subject|5|||
156810714|NCT01142388|566060402|FG001|Overall Study|Withdrawal by Subject|3|||
156810715|NCT01142388|566060401|FG000|Overall Study|Alternative therapy|1|||
156810716|NCT01142388|566060402|FG001|Overall Study|Alternative therapy|0|||
156810717|NCT01142388|566060401|FG000|Overall Study|Other complications|0|||
156810718|NCT01142388|566060402|FG001|Overall Study|Other complications|2|||
156810719|NCT01142388|566060401|FG000|Overall Study|Other|1|||
156810720|NCT01142388|566060402|FG001|Overall Study|Other|1|||
156810721|NCT01142388|566060401|FG000|Overall Study|Never started therapy|7|||
156810722|NCT01142388|566060402|FG001|Overall Study|Never started therapy|3|||
156810723|NCT03640325|566060408|FG000|Overall Study|Withdrawal by Subject|4|||
156810724|NCT03640325|566060409|FG001|Overall Study|Withdrawal by Subject|1|||
156810725|NCT03640325|566060410|FG002|Overall Study|Withdrawal by Subject|0|||
156810726|NCT03640325|566060408|FG000|Overall Study|Lost to Follow-up|4|||
156810727|NCT03640325|566060409|FG001|Overall Study|Lost to Follow-up|5|||
156810728|NCT03640325|566060410|FG002|Overall Study|Lost to Follow-up|21|||
156810729|NCT03640325|566060408|FG000|Overall Study|Death|5|||
156810730|NCT03640325|566060409|FG001|Overall Study|Death|5|||
156810731|NCT03640325|566060410|FG002|Overall Study|Death|0|||
156810732|NCT05265728|566060411|FG000|Overall Study|Adverse Event|1|||
156810733|NCT05265728|566060411|FG000|Overall Study|Study Terminated by Sponsor|5|||
156810734|NCT05265728|566060411|FG000|Overall Study|Withdrawal by Subject|2|||
156810735|NCT03493451|566060412|FG000|Overall Study|Death|11|||
156810736|NCT03493451|566060413|FG001|Overall Study|Death|26|||
156810737|NCT03493451|566060414|FG002|Overall Study|Death|3|||
156810738|NCT03493451|566060412|FG000|Overall Study|Lost to Follow-up|1|||
156810739|NCT03493451|566060413|FG001|Overall Study|Lost to Follow-up|4|||
156810740|NCT03493451|566060414|FG002|Overall Study|Lost to Follow-up|1|||
156810741|NCT03493451|566060412|FG000|Overall Study|Withdrawal by Subject|1|||
156810742|NCT03493451|566060413|FG001|Overall Study|Withdrawal by Subject|1|||
156810743|NCT03493451|566060414|FG002|Overall Study|Withdrawal by Subject|2|||
156810744|NCT03493451|566060412|FG000|Overall Study|Progressive Disease|1|||
156810745|NCT03493451|566060413|FG001|Overall Study|Progressive Disease|0|||
156810746|NCT03493451|566060414|FG002|Overall Study|Progressive Disease|0|||
156810747|NCT03493451|566060412|FG000|Overall Study|Transferred to long term extension study|8|||
156810748|NCT03493451|566060413|FG001|Overall Study|Transferred to long term extension study|13|||
156810749|NCT03493451|566060414|FG002|Overall Study|Transferred to long term extension study|5|||
156810750|NCT01566149|566060417|FG000|Overall Study|Adverse Event|0|||
156810751|NCT01566149|566060418|FG001|Overall Study|Adverse Event|1|||
156810752|NCT01566149|566060417|FG000|Overall Study|Non-compliance with study medication|2|||
156810753|NCT01566149|566060418|FG001|Overall Study|Non-compliance with study medication|0|||
156810754|NCT01566149|566060417|FG000|Overall Study|Protocol Violation|0|||
156810755|NCT01566149|566060418|FG001|Overall Study|Protocol Violation|1|||
156810756|NCT01566149|566060417|FG000|Overall Study|Withdrawal by Subject|1|||
156810757|NCT01566149|566060418|FG001|Overall Study|Withdrawal by Subject|0|||
156810758|NCT03687957|566060423|FG000|Overall Study|Withdrawal by Subject|0|||
156810759|NCT03687957|566060424|FG001|Overall Study|Withdrawal by Subject|0|||
156810760|NCT03687957|566060425|FG002|Overall Study|Withdrawal by Subject|0|||
156810761|NCT03687957|566060426|FG003|Overall Study|Withdrawal by Subject|2|||
156810762|NCT03687957|566060427|FG004|Overall Study|Withdrawal by Subject|0|||
156810763|NCT03687957|566060428|FG005|Overall Study|Withdrawal by Subject|0|||
156810764|NCT03687957|566060429|FG006|Overall Study|Withdrawal by Subject|3|||
156810765|NCT03687957|566060430|FG007|Overall Study|Withdrawal by Subject|1|||
156810766|NCT03687957|566060431|FG008|Overall Study|Withdrawal by Subject|1|||
156810767|NCT03687957|566060432|FG009|Overall Study|Withdrawal by Subject|0|||
156810768|NCT03687957|566060423|FG000|Overall Study|Disease progression|0|||
156810769|NCT03687957|566060424|FG001|Overall Study|Disease progression|1|||
156810770|NCT03687957|566060425|FG002|Overall Study|Disease progression|1|||
156810771|NCT03687957|566060426|FG003|Overall Study|Disease progression|2|||
156810772|NCT03687957|566060427|FG004|Overall Study|Disease progression|2|||
156810773|NCT03687957|566060428|FG005|Overall Study|Disease progression|0|||
156810774|NCT03687957|566060429|FG006|Overall Study|Disease progression|2|||
156810775|NCT03687957|566060430|FG007|Overall Study|Disease progression|1|||
156810776|NCT03687957|566060431|FG008|Overall Study|Disease progression|0|||
156810777|NCT03687957|566060432|FG009|Overall Study|Disease progression|0|||
156810778|NCT03687957|566060423|FG000|Overall Study|Physician Decision|0|||
156810779|NCT03687957|566060424|FG001|Overall Study|Physician Decision|0|||
156810780|NCT03687957|566060425|FG002|Overall Study|Physician Decision|0|||
156810781|NCT03687957|566060426|FG003|Overall Study|Physician Decision|2|||
156810782|NCT03687957|566060427|FG004|Overall Study|Physician Decision|1|||
156810783|NCT03687957|566060428|FG005|Overall Study|Physician Decision|0|||
156810784|NCT03687957|566060429|FG006|Overall Study|Physician Decision|1|||
156810785|NCT03687957|566060430|FG007|Overall Study|Physician Decision|0|||
156810786|NCT03687957|566060431|FG008|Overall Study|Physician Decision|0|||
156810787|NCT03687957|566060432|FG009|Overall Study|Physician Decision|0|||
156810788|NCT03687957|566060423|FG000|Overall Study|New malignancy|0|||
156810789|NCT03687957|566060424|FG001|Overall Study|New malignancy|0|||
156810790|NCT03687957|566060425|FG002|Overall Study|New malignancy|0|||
156810791|NCT03687957|566060426|FG003|Overall Study|New malignancy|0|||
156810792|NCT03687957|566060427|FG004|Overall Study|New malignancy|1|||
156810793|NCT03687957|566060428|FG005|Overall Study|New malignancy|0|||
156810794|NCT03687957|566060429|FG006|Overall Study|New malignancy|0|||
156810795|NCT03687957|566060430|FG007|Overall Study|New malignancy|0|||
156810796|NCT03687957|566060431|FG008|Overall Study|New malignancy|0|||
156810797|NCT03687957|566060432|FG009|Overall Study|New malignancy|0|||
156810798|NCT03687957|566060423|FG000|Overall Study|Adverse Event|0|||
156810799|NCT03687957|566060424|FG001|Overall Study|Adverse Event|0|||
156810800|NCT03687957|566060425|FG002|Overall Study|Adverse Event|0|||
156810801|NCT03687957|566060426|FG003|Overall Study|Adverse Event|0|||
156810802|NCT03687957|566060427|FG004|Overall Study|Adverse Event|0|||
156810803|NCT03687957|566060428|FG005|Overall Study|Adverse Event|2|||
156810804|NCT03687957|566060429|FG006|Overall Study|Adverse Event|0|||
156810805|NCT03687957|566060430|FG007|Overall Study|Adverse Event|3|||
156810806|NCT03687957|566060431|FG008|Overall Study|Adverse Event|0|||
156810807|NCT03687957|566060432|FG009|Overall Study|Adverse Event|0|||
156810808|NCT03687957|566060423|FG000|Overall Study|Patient went on hospice|0|||
156810809|NCT03687957|566060424|FG001|Overall Study|Patient went on hospice|0|||
156810810|NCT03687957|566060425|FG002|Overall Study|Patient went on hospice|0|||
156810811|NCT03687957|566060426|FG003|Overall Study|Patient went on hospice|0|||
156810812|NCT03687957|566060427|FG004|Overall Study|Patient went on hospice|0|||
156810813|NCT03687957|566060428|FG005|Overall Study|Patient went on hospice|0|||
156810814|NCT03687957|566060429|FG006|Overall Study|Patient went on hospice|1|||
156810815|NCT03687957|566060430|FG007|Overall Study|Patient went on hospice|0|||
156810816|NCT03687957|566060431|FG008|Overall Study|Patient went on hospice|0|||
156810817|NCT03687957|566060432|FG009|Overall Study|Patient went on hospice|0|||
156810818|NCT03687957|566060423|FG000|Overall Study|Death|0|||
156810819|NCT03687957|566060424|FG001|Overall Study|Death|0|||
156810820|NCT03687957|566060425|FG002|Overall Study|Death|0|||
156810821|NCT03687957|566060426|FG003|Overall Study|Death|0|||
156810822|NCT03687957|566060427|FG004|Overall Study|Death|0|||
156810823|NCT03687957|566060428|FG005|Overall Study|Death|0|||
156810824|NCT03687957|566060429|FG006|Overall Study|Death|0|||
156810825|NCT03687957|566060430|FG007|Overall Study|Death|1|||
156810826|NCT03687957|566060431|FG008|Overall Study|Death|0|||
156810827|NCT03687957|566060432|FG009|Overall Study|Death|0|||
156810828|NCT03276728|566060433|FG000|Overall Study|Lost to Follow-up|0|||
156810829|NCT03276728|566060434|FG001|Overall Study|Lost to Follow-up|0|||
156810830|NCT03276728|566060435|FG002|Overall Study|Lost to Follow-up|2|||
156883514|NCT00422084|566332557|FG001|Overall Study|Not defined|1|||
156883515|NCT03774823|566332558|FG000|Overall Study|Withdrawal by Subject|1|||
156883516|NCT03774823|566332559|FG001|Overall Study|Withdrawal by Subject|1|||
156883517|NCT03726996|566332566|FG000|Overall Study|Parent's decision|2|||
156883518|NCT03726996|566332566|FG000|Overall Study|Study early termination|2|||
156883519|NCT03531632|566332571|FG000|Overall Study|Adverse Event|0|||
156810831|NCT03276728|566060436|FG003|Overall Study|Lost to Follow-up|2|||
156810832|NCT03276728|566060437|FG004|Overall Study|Lost to Follow-up|0|||
156810833|NCT03276728|566060438|FG005|Overall Study|Lost to Follow-up|0|||
156883520|NCT03531632|566332572|FG001|Overall Study|Adverse Event|0|||
157222412|NCT00095199|567560268|FG003|Overall Study|Primary tumor removed in other surgery|0|||
157222413|NCT00095199|567560265|FG000|Overall Study|Data inadvertently lost by site|1|||
157222414|NCT00095199|567560266|FG001|Overall Study|Data inadvertently lost by site|0|||
156810834|NCT03276728|566060439|FG006|Overall Study|Lost to Follow-up|0|||
156810835|NCT03276728|566060440|FG007|Overall Study|Lost to Follow-up|0|||
156810836|NCT03276728|566060433|FG000|Overall Study|Withdrawal by Subject|0|||
156810837|NCT03276728|566060434|FG001|Overall Study|Withdrawal by Subject|0|||
156810838|NCT03276728|566060435|FG002|Overall Study|Withdrawal by Subject|0|||
156810839|NCT03276728|566060436|FG003|Overall Study|Withdrawal by Subject|3|||
156810840|NCT03276728|566060437|FG004|Overall Study|Withdrawal by Subject|0|||
156810841|NCT03276728|566060438|FG005|Overall Study|Withdrawal by Subject|0|||
156810842|NCT03276728|566060439|FG006|Overall Study|Withdrawal by Subject|0|||
156883521|NCT03531632|566332573|FG002|Overall Study|Adverse Event|1|||
156810843|NCT03276728|566060440|FG007|Overall Study|Withdrawal by Subject|0|||
156810844|NCT03276728|566060433|FG000|Overall Study|Decision by sponsor|0|||
156810845|NCT03276728|566060434|FG001|Overall Study|Decision by sponsor|0|||
156810846|NCT03276728|566060435|FG002|Overall Study|Decision by sponsor|0|||
156810847|NCT03276728|566060436|FG003|Overall Study|Decision by sponsor|0|||
156810848|NCT03276728|566060437|FG004|Overall Study|Decision by sponsor|1|||
156810849|NCT03276728|566060438|FG005|Overall Study|Decision by sponsor|0|||
156810850|NCT03276728|566060439|FG006|Overall Study|Decision by sponsor|2|||
156810851|NCT03276728|566060440|FG007|Overall Study|Decision by sponsor|1|||
156810852|NCT02213926|566060443|FG000|Overall Study|Death|59|||
156810853|NCT02213926|566060443|FG000|Overall Study|Withdrawal by Subject|10|||
156810854|NCT02213926|566060443|FG000|Overall Study|study terminated by sponsor|51|||
156810855|NCT02213926|566060443|FG000|Overall Study|Lost to Follow-up|3|||
156810856|NCT02213926|566060443|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
156810857|NCT01188551|566060444|FG000|Overall Study|Pharmacy issues|1|||
156810858|NCT01188551|566060445|FG001|Overall Study|Pharmacy issues|0|||
156810859|NCT01188551|566060446|FG002|Overall Study|Pharmacy issues|0|||
156810860|NCT01188551|566060447|FG003|Overall Study|Pharmacy issues|0|||
156810861|NCT03458325|566060455|FG000|Overall Study|Withdrawal by Subject|1|||
156810862|NCT02630693|566060460|FG000|Overall Study|No receive treatment|0|||
156810863|NCT02630693|566060461|FG001|Overall Study|No receive treatment|1|||
156810864|NCT00175916|566060462|FG000|Overall Study|Death|19|||
156810865|NCT00175916|566060462|FG000|Overall Study|Adverse Event|81|||
156810866|NCT00175916|566060462|FG000|Overall Study|Lack of Efficacy|354|||
156810867|NCT00175916|566060462|FG000|Overall Study|Lost to Follow-up|17|||
156810868|NCT00175916|566060462|FG000|Overall Study|Subject Choice|98|||
156810869|NCT00175916|566060462|FG000|Overall Study|Lack of compliance|8|||
156810870|NCT00175916|566060462|FG000|Overall Study|Patient cannot record seizures|1|||
156810871|NCT00175916|566060462|FG000|Overall Study|Sponsor decision|17|||
156810872|NCT00175916|566060462|FG000|Overall Study|Vigabatrin intake|1|||
156810873|NCT00175916|566060462|FG000|Overall Study|Suicidal behaviour|1|||
156810874|NCT00175916|566060462|FG000|Overall Study|Withdrawal by Subject|1|||
156810875|NCT00175916|566060462|FG000|Overall Study|Seizure - free|4|||
156810876|NCT00175916|566060462|FG000|Overall Study|Administrative reason|1|||
156810877|NCT00175916|566060462|FG000|Overall Study|Pregnancy|1|||
156810878|NCT00175916|566060462|FG000|Overall Study|Patient's request|2|||
156810879|NCT00175916|566060462|FG000|Overall Study|Treating physiciant's choice|1|||
156810880|NCT00175916|566060462|FG000|Overall Study|Moved overseas|1|||
156810881|NCT00175916|566060462|FG000|Overall Study|Loss of job and economic burden|1|||
156810882|NCT00175916|566060462|FG000|Overall Study|Site was closed|9|||
156810883|NCT00175916|566060462|FG000|Overall Study|Patient went to prison|1|||
156810884|NCT00310375|566060463|FG000|Primary Reporting Phase|Adverse Event|28|||
156810885|NCT00310375|566060464|FG001|Primary Reporting Phase|Adverse Event|22|||
156810886|NCT00310375|566060465|FG002|Primary Reporting Phase|Adverse Event|0|||
156810887|NCT00310375|566060463|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
156810888|NCT00310375|566060464|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
156810889|NCT00310375|566060465|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
156810890|NCT00310375|566060463|FG000|Primary Reporting Phase|Pregnancy|2|||
156810891|NCT00310375|566060464|FG001|Primary Reporting Phase|Pregnancy|2|||
156810892|NCT00310375|566060465|FG002|Primary Reporting Phase|Pregnancy|0|||
156810893|NCT00310375|566060463|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
156810894|NCT00310375|566060464|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
156810895|NCT00310375|566060465|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
156810896|NCT00310375|566060463|FG000|Primary Reporting Phase|Protocol Violation|8|||
156810897|NCT00310375|566060464|FG001|Primary Reporting Phase|Protocol Violation|5|||
156810898|NCT00310375|566060465|FG002|Primary Reporting Phase|Protocol Violation|0|||
156810899|NCT00310375|566060463|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
156810900|NCT00310375|566060464|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
156810901|NCT00310375|566060465|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
156810902|NCT00310375|566060463|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
156810903|NCT00310375|566060464|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
156810904|NCT00310375|566060465|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
157146852|NCT02786537|567285917|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
157146853|NCT02786537|567285918|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
157146854|NCT02786537|567285913|FG000|As Randomized|Subject lost insurance|0|||
156810905|NCT00310375|566060463|FG000|Primary Reporting Phase|Physician Decision|5|||
156810906|NCT00310375|566060464|FG001|Primary Reporting Phase|Physician Decision|3|||
156810907|NCT00310375|566060465|FG002|Primary Reporting Phase|Physician Decision|0|||
156810908|NCT00310375|566060463|FG000|Primary Reporting Phase|Request of the sponsor|2|||
156810909|NCT00310375|566060464|FG001|Primary Reporting Phase|Request of the sponsor|2|||
156810910|NCT00310375|566060465|FG002|Primary Reporting Phase|Request of the sponsor|0|||
156810911|NCT00310375|566060463|FG000|Primary Reporting Phase|Failed to return|1|||
156810912|NCT00310375|566060464|FG001|Primary Reporting Phase|Failed to return|3|||
156810913|NCT00310375|566060465|FG002|Primary Reporting Phase|Failed to return|0|||
156883522|NCT03531632|566332571|FG000|Overall Study|Death|4|||
157146855|NCT02786537|567285914|FG001|As Randomized|Subject lost insurance|0|||
157146856|NCT02786537|567285915|FG002|As Randomized|Subject lost insurance|0|||
156810914|NCT00310375|566060463|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
156810915|NCT00310375|566060464|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
156810916|NCT00310375|566060465|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
156810917|NCT00310375|566060463|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
156810918|NCT00310375|566060464|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
156810919|NCT00310375|566060465|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
156810920|NCT00310375|566060463|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
156810921|NCT00310375|566060464|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
156810922|NCT00310375|566060465|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
156810923|NCT00310375|566060463|FG000|Primary Reporting Phase|Site closure|3|||
156810924|NCT00310375|566060464|FG001|Primary Reporting Phase|Site closure|0|||
156810925|NCT00310375|566060465|FG002|Primary Reporting Phase|Site closure|0|||
156810926|NCT00310375|566060463|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
156810927|NCT00310375|566060464|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
156810928|NCT00310375|566060465|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
156810929|NCT00310375|566060463|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
156810930|NCT00310375|566060464|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
156810931|NCT00310375|566060465|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
156810932|NCT00310375|566060463|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
156810933|NCT00310375|566060464|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
156810934|NCT00310375|566060465|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
156810935|NCT00310375|566060463|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
156810936|NCT00310375|566060464|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
156810937|NCT00310375|566060465|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
156810938|NCT05338710|566060466|FG000|Overall Study|Withdrawal by Subject|3|||
156810939|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
156810940|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
156810941|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810942|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810943|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810944|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810945|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810946|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810947|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810948|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
156810949|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
156810950|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
156810951|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810952|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810953|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810954|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810955|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810956|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810957|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810958|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
156810959|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
156810960|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810961|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810962|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810963|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810964|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810965|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810966|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810967|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810968|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
156810969|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
156810970|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
156810971|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810972|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156883523|NCT03531632|566332572|FG001|Overall Study|Death|0|||
156883524|NCT03531632|566332573|FG002|Overall Study|Death|14|||
156883525|NCT03531632|566332571|FG000|Overall Study|Study Terminated|1|||
157146857|NCT02786537|567285916|FG003|As Randomized|Subject lost insurance|1|||
157146858|NCT02786537|567285917|FG004|As Randomized|Subject lost insurance|0|||
157146859|NCT02786537|567285918|FG005|As Randomized|Subject lost insurance|0|||
156810973|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810974|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810975|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810976|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810977|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810978|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
156810979|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810980|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
156810981|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810982|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810983|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810984|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810985|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810986|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810987|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810988|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
156810989|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
156810990|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
156810991|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810992|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810993|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810994|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810995|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810996|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810997|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810998|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
156810999|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
156811000|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
156811001|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811002|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811003|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811004|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811005|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811006|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811007|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811008|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
156811009|NCT01194219|566060467|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
156811010|NCT01194219|566060468|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
156811011|NCT01194219|566060469|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811012|NCT01194219|566060470|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811013|NCT01194219|566060471|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811014|NCT01194219|566060472|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811015|NCT01194219|566060473|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811016|NCT01194219|566060474|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811017|NCT01194219|566060475|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811018|NCT01194219|566060476|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
156811019|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811020|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811021|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
156811022|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
156811023|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811024|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811025|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811026|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811027|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811028|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
156811029|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811030|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811031|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
156811032|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
156811033|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811034|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811035|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
157146860|NCT02786537|567285913|FG000|As Treated|Adverse Event|0|||
156811036|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
157146861|NCT02786537|567285914|FG001|As Treated|Adverse Event|11|||
157146862|NCT02786537|567285915|FG002|As Treated|Adverse Event|0|||
157146863|NCT02786537|567285916|FG003|As Treated|Adverse Event|4|||
157146864|NCT02786537|567285917|FG004|As Treated|Adverse Event|6|||
157146865|NCT02786537|567285918|FG005|As Treated|Adverse Event|2|||
156811037|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811038|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
156811039|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811040|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811041|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
156811042|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
156811043|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811044|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811045|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811046|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811047|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811048|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
156811049|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811050|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811051|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
156811052|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
156811053|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811054|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811055|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811056|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811057|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811058|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
156811059|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811060|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811061|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
156811062|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811063|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811064|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811065|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811066|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811067|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811068|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
156811069|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811070|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811071|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811072|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
156811073|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811074|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811075|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811076|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811077|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811078|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
156811079|NCT01194219|566060467|FG000|Maintenance Phase Weeks16-32|Other|0|||
156811080|NCT01194219|566060468|FG001|Maintenance Phase Weeks16-32|Other|0|||
156811081|NCT01194219|566060469|FG002|Maintenance Phase Weeks16-32|Other|2|||
156811082|NCT01194219|566060470|FG003|Maintenance Phase Weeks16-32|Other|1|||
156811083|NCT01194219|566060471|FG004|Maintenance Phase Weeks16-32|Other|0|||
156811084|NCT01194219|566060472|FG005|Maintenance Phase Weeks16-32|Other|0|||
156811085|NCT01194219|566060473|FG006|Maintenance Phase Weeks16-32|Other|0|||
156811086|NCT01194219|566060474|FG007|Maintenance Phase Weeks16-32|Other|0|||
156811087|NCT01194219|566060475|FG008|Maintenance Phase Weeks16-32|Other|0|||
156811088|NCT01194219|566060476|FG009|Maintenance Phase Weeks16-32|Other|0|||
156811089|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156883526|NCT03531632|566332572|FG001|Overall Study|Study Terminated|3|||
156883527|NCT03531632|566332573|FG002|Overall Study|Study Terminated|11|||
156883528|NCT01224782|566332576|FG000|Overall Study|Lost to Follow-up|177|||
156883529|NCT01224782|566332576|FG000|Overall Study|Withdrawal by Subject|16|||
156883530|NCT01224782|566332576|FG000|Overall Study|Death|14|||
156883531|NCT01224782|566332576|FG000|Overall Study|Improvement|13|||
156883532|NCT01224782|566332576|FG000|Overall Study|Adverse Event|12|||
156883533|NCT01224782|566332576|FG000|Overall Study|Adverse Reaction|11|||
156883534|NCT01224782|566332576|FG000|Overall Study|Noncompliance|10|||
156883535|NCT01224782|566332576|FG000|Overall Study|Other|4|||
157022389|NCT03150810|566835194|FG005|Overall Study|Transferred care to oncologist|0|||
157022390|NCT03150810|566835195|FG006|Overall Study|Transferred care to oncologist|2|||
157222415|NCT00095199|567560267|FG002|Overall Study|Data inadvertently lost by site|0|||
157222416|NCT00095199|567560268|FG003|Overall Study|Data inadvertently lost by site|0|||
156883536|NCT01224782|566332576|FG000|Overall Study|Start of Dialysis|3|||
156883537|NCT01224782|566332576|FG000|Overall Study|Change of Treatment|1|||
156883538|NCT01224782|566332576|FG000|Overall Study|Financial Reasons|1|||
156883539|NCT01224782|566332576|FG000|Overall Study|Deterioration|1|||
156811090|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811091|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811092|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811093|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811094|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
156811095|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
156811096|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
156811097|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811098|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
156811099|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811100|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811101|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811102|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811103|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
156811104|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
156811105|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
156811106|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
156811107|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811108|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
156811109|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811110|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811111|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811112|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811113|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
156811114|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811115|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
156811116|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811117|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811118|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
156811119|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811120|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811121|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811122|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811123|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
156811124|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811125|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
156811126|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
156811127|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811128|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
156811129|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811130|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811131|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811132|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811133|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
156811134|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
156811135|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
156811136|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811137|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811138|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
156811139|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811140|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811141|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811142|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811143|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811144|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811145|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811146|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
156811147|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811148|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
156811149|NCT01194219|566060467|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811150|NCT01194219|566060468|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811151|NCT01194219|566060469|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811152|NCT01194219|566060470|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811153|NCT01194219|566060471|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811154|NCT01194219|566060472|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811155|NCT01194219|566060473|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
156811156|NCT01194219|566060474|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811157|NCT01194219|566060475|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811158|NCT01194219|566060476|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
156811159|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811160|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811161|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811162|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811163|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811164|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811165|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811166|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
156811167|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
156811168|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
156811169|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811170|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811171|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811172|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811173|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811174|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811175|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811176|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
156811177|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
156811178|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
156811179|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811180|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811181|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811182|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811183|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811184|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811185|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811186|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
156811187|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
156811188|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
156811189|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811190|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811191|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811192|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811193|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811194|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811195|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811196|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
156811197|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
156811198|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
156811199|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
156811200|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
156811201|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
156811202|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
156811203|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
156811204|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
156811205|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
156811206|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
156811207|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
156883540|NCT01224782|566332576|FG000|Overall Study|Transplantation|1|||
156883541|NCT00065429|566332577|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156811208|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
156811209|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811210|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811211|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156883542|NCT00065429|566332578|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
157022391|NCT03150810|566835196|FG007|Overall Study|Transferred care to oncologist|0|||
157146866|NCT02786537|567285913|FG000|As Treated|Death|0|||
156811212|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811213|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811214|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
157146867|NCT02786537|567285914|FG001|As Treated|Death|2|||
157146868|NCT02786537|567285915|FG002|As Treated|Death|0|||
156811215|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811216|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
156811217|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
156811218|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
156811219|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811220|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811221|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811222|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811223|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811224|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811225|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811226|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
157146869|NCT02786537|567285916|FG003|As Treated|Death|3|||
157146870|NCT02786537|567285917|FG004|As Treated|Death|1|||
156811227|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
156811228|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
156811229|NCT01194219|566060467|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811230|NCT01194219|566060468|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811231|NCT01194219|566060469|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811232|NCT01194219|566060470|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811233|NCT01194219|566060471|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811234|NCT01194219|566060472|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811235|NCT01194219|566060473|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811236|NCT01194219|566060474|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
156811237|NCT01194219|566060475|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
156811238|NCT01194219|566060476|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
156811239|NCT01081951|566060477|FG000|Overall Study|Death|54|||
156811240|NCT01081951|566060478|FG001|Overall Study|Death|47|||
156811241|NCT01081951|566060477|FG000|Overall Study|Withdrawal by Subject|2|||
156811242|NCT01081951|566060478|FG001|Overall Study|Withdrawal by Subject|6|||
156811243|NCT01081951|566060477|FG000|Overall Study|Allocated treatment but did not take it|0|||
156811244|NCT01081951|566060478|FG001|Overall Study|Allocated treatment but did not take it|1|||
156811245|NCT01081951|566060477|FG000|Overall Study|Lost to Follow-up|0|||
156811246|NCT01081951|566060478|FG001|Overall Study|Lost to Follow-up|1|||
156811247|NCT05384834|566060481|FG000|Overall Study|Lost to Follow-up|43|||
156811248|NCT05384834|566060481|FG000|Overall Study|Withdrawal by Subject|5|||
156811249|NCT01871545|566060482|FG000|Overall Study|Death|2|||
156811250|NCT01871545|566060483|FG001|Overall Study|Death|0|||
156811251|NCT01871545|566060482|FG000|Overall Study|Lack of Efficacy|11|||
156811252|NCT01871545|566060483|FG001|Overall Study|Lack of Efficacy|2|||
156811253|NCT01871545|566060482|FG000|Overall Study|Physician Decision|4|||
156811254|NCT01871545|566060483|FG001|Overall Study|Physician Decision|0|||
156811255|NCT01871545|566060482|FG000|Overall Study|Withdrawal by Subject|0|||
156811256|NCT01871545|566060483|FG001|Overall Study|Withdrawal by Subject|1|||
156811257|NCT05710640|566060484|FG000|Overall Study|Physician Decision|0|||
156811258|NCT05710640|566060485|FG001|Overall Study|Physician Decision|1|||
156811259|NCT05710640|566060484|FG000|Overall Study|Withdrawal by Subject|1|||
156811260|NCT05710640|566060485|FG001|Overall Study|Withdrawal by Subject|0|||
156811261|NCT05710640|566060484|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
156811262|NCT05710640|566060485|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
156811263|NCT04188509|566060486|FG000|Overall Study|Adverse Event|2|||
156811264|NCT04188509|566060486|FG000|Overall Study|Lost to Follow-up|1|||
156811265|NCT04188509|566060486|FG000|Overall Study|Withdrawal of Consent|1|||
156811266|NCT04188509|566060486|FG000|Overall Study|Discretion of Investigator|1|||
156811267|NCT04188509|566060486|FG000|Overall Study|Noncompliance|3|||
156811268|NCT04188509|566060486|FG000|Overall Study|Sponsor Decision|127|||
156811269|NCT04188509|566060486|FG000|Overall Study|Other|2|||
156811270|NCT00763256|566060487|FG000|Overall Study|Didn't return for appointments|7|||
156811271|NCT00763256|566060488|FG001|Overall Study|Didn't return for appointments|10|||
156811272|NCT01272037|566060491|FG000|Overall Study|Death|25|||
156811273|NCT01272037|566060492|FG001|Overall Study|Death|28|||
156811274|NCT01272037|566060491|FG000|Overall Study|Adverse Event|12|||
157022392|NCT03150810|566835197|FG008|Overall Study|Transferred care to oncologist|0|||
157146871|NCT02786537|567285918|FG005|As Treated|Death|0|||
157146872|NCT02786537|567285913|FG000|As Treated|Lack of Efficacy|0|||
156811275|NCT01272037|566060492|FG001|Overall Study|Adverse Event|7|||
156811276|NCT01272037|566060491|FG000|Overall Study|Withdrawal by Subject|175|||
156811277|NCT01272037|566060492|FG001|Overall Study|Withdrawal by Subject|93|||
156811278|NCT01272037|566060491|FG000|Overall Study|Disease progression|70|||
156811279|NCT01272037|566060492|FG001|Overall Study|Disease progression|111|||
156811280|NCT01272037|566060491|FG000|Overall Study|Other reason|42|||
156811281|NCT01272037|566060492|FG001|Overall Study|Other reason|41|||
156811282|NCT01272037|566060491|FG000|Overall Study|Delinquent data|24|||
157146873|NCT02786537|567285914|FG001|As Treated|Lack of Efficacy|0|||
157146874|NCT02786537|567285915|FG002|As Treated|Lack of Efficacy|0|||
156811283|NCT01272037|566060492|FG001|Overall Study|Delinquent data|19|||
156811284|NCT01272037|566060491|FG000|Overall Study|Reason under review|33|||
156811285|NCT01272037|566060492|FG001|Overall Study|Reason under review|29|||
157146875|NCT02786537|567285916|FG003|As Treated|Lack of Efficacy|1|||
156811286|NCT01272037|566060491|FG000|Overall Study|On treatment|626|||
156811287|NCT01272037|566060492|FG001|Overall Study|On treatment|632|||
156811288|NCT01393899|566060493|FG000|Overall Study|Study terminated by sponsor|1|||
156811289|NCT01393899|566060494|FG001|Overall Study|Study terminated by sponsor|0|||
156811290|NCT01393899|566060495|FG002|Overall Study|Study terminated by sponsor|1|||
156811291|NCT01393899|566060493|FG000|Overall Study|Other|1|||
156811292|NCT01393899|566060494|FG001|Overall Study|Other|0|||
156811293|NCT01393899|566060495|FG002|Overall Study|Other|0|||
156811294|NCT01393899|566060493|FG000|Overall Study|Withdrawal by Subject|2|||
156811295|NCT01393899|566060494|FG001|Overall Study|Withdrawal by Subject|2|||
156811296|NCT01393899|566060495|FG002|Overall Study|Withdrawal by Subject|1|||
156811297|NCT01393899|566060493|FG000|Overall Study|Lost to Follow-up|0|||
156811298|NCT01393899|566060494|FG001|Overall Study|Lost to Follow-up|0|||
156811299|NCT01393899|566060495|FG002|Overall Study|Lost to Follow-up|1|||
156811300|NCT01393899|566060493|FG000|Overall Study|Does not meet entrance criteria|1|||
156811301|NCT01393899|566060494|FG001|Overall Study|Does not meet entrance criteria|0|||
156811302|NCT01393899|566060495|FG002|Overall Study|Does not meet entrance criteria|1|||
156811303|NCT01393899|566060493|FG000|Overall Study|Lack of Efficacy|26|||
156811304|NCT01393899|566060494|FG001|Overall Study|Lack of Efficacy|21|||
156811305|NCT01393899|566060495|FG002|Overall Study|Lack of Efficacy|16|||
156811306|NCT01393899|566060493|FG000|Overall Study|Adverse Event|1|||
156811307|NCT01393899|566060494|FG001|Overall Study|Adverse Event|5|||
156811308|NCT01393899|566060495|FG002|Overall Study|Adverse Event|3|||
156811309|NCT02503085|566060498|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
156811310|NCT02503085|566060499|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
156811311|NCT02503085|566060500|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
156811312|NCT02503085|566060501|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
156811313|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811314|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811315|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
156811316|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
156811317|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811318|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811319|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
156811320|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
156811321|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811322|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811323|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811324|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811325|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811326|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
156811327|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
156811328|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811329|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811330|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811331|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811332|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
156811333|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
157146876|NCT02786537|567285917|FG004|As Treated|Lack of Efficacy|0|||
157146877|NCT02786537|567285918|FG005|As Treated|Lack of Efficacy|0|||
157146878|NCT02786537|567285913|FG000|As Treated|Lost to Follow-up|4|||
157146879|NCT02786537|567285914|FG001|As Treated|Lost to Follow-up|32|||
157146880|NCT02786537|567285915|FG002|As Treated|Lost to Follow-up|0|||
157146881|NCT02786537|567285916|FG003|As Treated|Lost to Follow-up|25|||
156811334|NCT02720523|566060505|FG000|Period 1: Placebo-controlled Period|Other|0|||
156811335|NCT02720523|566060506|FG001|Period 1: Placebo-controlled Period|Other|0|||
156811336|NCT02720523|566060507|FG002|Period 1: Placebo-controlled Period|Other|1|||
157146882|NCT02786537|567285917|FG004|As Treated|Lost to Follow-up|4|||
157146883|NCT02786537|567285918|FG005|As Treated|Lost to Follow-up|4|||
157146884|NCT02786537|567285913|FG000|As Treated|Non-compliance with study drug|1|||
157146885|NCT02786537|567285914|FG001|As Treated|Non-compliance with study drug|11|||
157146886|NCT02786537|567285915|FG002|As Treated|Non-compliance with study drug|0|||
157146887|NCT02786537|567285916|FG003|As Treated|Non-compliance with study drug|1|||
157146888|NCT02786537|567285917|FG004|As Treated|Non-compliance with study drug|0|||
157146889|NCT02786537|567285918|FG005|As Treated|Non-compliance with study drug|1|||
157146890|NCT02786537|567285913|FG000|As Treated|Lost insurance|0|||
157222417|NCT03329027|567561978|FG000|Overall Study|Lost to Follow-up|1|||
156811337|NCT02720523|566060508|FG003|Period 1: Placebo-controlled Period|Other|1|||
156811338|NCT02720523|566060509|FG004|Period 1: Placebo-controlled Period|Other|0|||
157146891|NCT02786537|567285914|FG001|As Treated|Lost insurance|0|||
157146892|NCT02786537|567285915|FG002|As Treated|Lost insurance|0|||
157146893|NCT02786537|567285916|FG003|As Treated|Lost insurance|1|||
157146894|NCT02786537|567285917|FG004|As Treated|Lost insurance|0|||
156811339|NCT02720523|566060510|FG005|Period 1: Placebo-controlled Period|Other|0|||
156811340|NCT02720523|566060511|FG006|Period 1: Placebo-controlled Period|Other|0|||
156811341|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
156811342|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
156811343|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
156811344|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
156811345|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
156811346|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
156811347|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
156811348|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
156811349|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
156811350|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
156811351|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
156811352|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
156811353|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
156811354|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
156811355|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811356|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811357|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811358|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
156811359|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
156811360|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
156811361|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
156811362|NCT02720523|566060505|FG000|Period 2: Long-term Extension Period|Other|0|||
156811363|NCT02720523|566060506|FG001|Period 2: Long-term Extension Period|Other|0|||
156811364|NCT02720523|566060507|FG002|Period 2: Long-term Extension Period|Other|0|||
156811365|NCT02720523|566060508|FG003|Period 2: Long-term Extension Period|Other|0|||
156811366|NCT02720523|566060509|FG004|Period 2: Long-term Extension Period|Other|2|||
156811367|NCT02720523|566060510|FG005|Period 2: Long-term Extension Period|Other|0|||
156811368|NCT02720523|566060511|FG006|Period 2: Long-term Extension Period|Other|3|||
156811369|NCT03670355|566060512|FG000|Overall Study|Adverse Event|1|||
156811370|NCT03670355|566060513|FG001|Overall Study|Adverse Event|0|||
156811371|NCT03670355|566060512|FG000|Overall Study|Unable to comply with study procedures|0|||
156811372|NCT03670355|566060513|FG001|Overall Study|Unable to comply with study procedures|1|||
156811373|NCT03670355|566060512|FG000|Overall Study|Participant refused|0|||
156811374|NCT03670355|566060513|FG001|Overall Study|Participant refused|1|||
156811375|NCT03146663|566060514|FG000|Overall Study|Did not receive study treatment|1|||
156811376|NCT03146663|566060515|FG001|Overall Study|Did not receive study treatment|1|||
156811377|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811378|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
156811379|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
156811380|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811381|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811382|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
156811383|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Other|0|||
156811384|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Other|1|||
156811385|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Other|1|||
156811386|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Other|0|||
156811387|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Other|0|||
156811388|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Other|0|||
156811389|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
156811390|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
156811391|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
156811392|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811393|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811394|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
156811395|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811396|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811397|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
157146895|NCT02786537|567285918|FG005|As Treated|Lost insurance|0|||
157146896|NCT02786537|567285913|FG000|As Treated|Withdrawal by Subject|1|||
157146897|NCT02786537|567285914|FG001|As Treated|Withdrawal by Subject|2|||
157146898|NCT02786537|567285915|FG002|As Treated|Withdrawal by Subject|0|||
157146899|NCT02786537|567285916|FG003|As Treated|Withdrawal by Subject|0|||
157146900|NCT02786537|567285917|FG004|As Treated|Withdrawal by Subject|1|||
157146901|NCT02786537|567285918|FG005|As Treated|Withdrawal by Subject|0|||
157146902|NCT02786537|567285913|FG000|As Treated|Incarceration|0|||
157146903|NCT02786537|567285914|FG001|As Treated|Incarceration|1|||
157146904|NCT02786537|567285915|FG002|As Treated|Incarceration|0|||
157146905|NCT02786537|567285916|FG003|As Treated|Incarceration|0|||
157146906|NCT02786537|567285917|FG004|As Treated|Incarceration|0|||
156883543|NCT00065429|566332579|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156883544|NCT00065429|566332580|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
157222418|NCT03329027|567561979|FG001|Overall Study|Lost to Follow-up|0|||
157222419|NCT03329027|567561980|FG002|Overall Study|Lost to Follow-up|1|||
156811398|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811399|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811400|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
156811401|NCT03666988|566060516|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
156811402|NCT03666988|566060517|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811403|NCT03666988|566060518|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811404|NCT03666988|566060519|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811405|NCT03666988|566060520|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811406|NCT03666988|566060521|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
156811407|NCT05526521|566060527|FG000|Overall Study|Withdrawal by Subject|0|||
156811408|NCT05526521|566060528|FG001|Overall Study|Withdrawal by Subject|1|||
156811409|NCT05526521|566060529|FG002|Overall Study|Withdrawal by Subject|0|||
156811410|NCT05526521|566060530|FG003|Overall Study|Withdrawal by Subject|0|||
156811411|NCT00436436|566060536|FG000|Overall Study|Progression|4|||
156811412|NCT00436436|566060536|FG000|Overall Study|Adverse Event|2|||
156811413|NCT00436436|566060536|FG000|Overall Study|Death|6|||
156811414|NCT03008070|566060540|FG000|Overall Study|Adverse Event|3|||
156811415|NCT03008070|566060541|FG001|Overall Study|Adverse Event|3|||
156811416|NCT03008070|566060542|FG002|Overall Study|Adverse Event|3|||
156811417|NCT03008070|566060540|FG000|Overall Study|Lost to Follow-up|1|||
156811418|NCT03008070|566060541|FG001|Overall Study|Lost to Follow-up|1|||
156811419|NCT03008070|566060542|FG002|Overall Study|Lost to Follow-up|0|||
156811420|NCT03008070|566060540|FG000|Overall Study|Non compliance|0|||
156811421|NCT03008070|566060541|FG001|Overall Study|Non compliance|1|||
156811422|NCT03008070|566060542|FG002|Overall Study|Non compliance|1|||
156811423|NCT03008070|566060540|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
156811424|NCT03008070|566060541|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
156811425|NCT03008070|566060542|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
156811426|NCT03008070|566060540|FG000|Overall Study|Withdrawal by Subject|2|||
156811427|NCT03008070|566060541|FG001|Overall Study|Withdrawal by Subject|0|||
156811428|NCT03008070|566060542|FG002|Overall Study|Withdrawal by Subject|1|||
156811429|NCT03008070|566060540|FG000|Overall Study|Use of prohibited drug|0|||
156811430|NCT03008070|566060541|FG001|Overall Study|Use of prohibited drug|0|||
156811431|NCT03008070|566060542|FG002|Overall Study|Use of prohibited drug|2|||
156811432|NCT03533660|566060543|FG000|Overall Study|Withdrawal by Subject|2|||
156811433|NCT03533660|566060544|FG001|Overall Study|Withdrawal by Subject|2|||
156811434|NCT03533660|566060543|FG000|Overall Study|Death|2|||
156811435|NCT03533660|566060544|FG001|Overall Study|Death|4|||
156811436|NCT03533660|566060543|FG000|Overall Study|Adverse Event|0|||
156811437|NCT03533660|566060544|FG001|Overall Study|Adverse Event|2|||
156811438|NCT07214935|566060550|FG000|Overall Study|Adverse Event|1|||
156811439|NCT07214935|566060551|FG001|Overall Study|Adverse Event|1|||
156811440|NCT07214935|566060552|FG002|Overall Study|Adverse Event|1|||
156811441|NCT07214935|566060553|FG003|Overall Study|Adverse Event|0|||
156811442|NCT07214935|566060550|FG000|Overall Study|Lost to Follow-up|0|||
156811443|NCT07214935|566060551|FG001|Overall Study|Lost to Follow-up|1|||
156811444|NCT07214935|566060552|FG002|Overall Study|Lost to Follow-up|0|||
156811445|NCT07214935|566060553|FG003|Overall Study|Lost to Follow-up|0|||
156811446|NCT07214935|566060550|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
156811447|NCT07214935|566060551|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811448|NCT07214935|566060552|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811449|NCT07214935|566060553|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
156811450|NCT07214935|566060550|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
156811451|NCT07214935|566060551|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
156811452|NCT07214935|566060552|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
156811453|NCT07214935|566060553|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
156811454|NCT01133756|566062487|FG000|Overall Study|Adverse Event|1|||
156811455|NCT01133756|566062488|FG001|Overall Study|Adverse Event|2|||
156811456|NCT01133756|566062489|FG002|Overall Study|Adverse Event|1|||
156811457|NCT01133756|566062487|FG000|Overall Study|Investigator Decision|1|||
156811458|NCT01133756|566062488|FG001|Overall Study|Investigator Decision|0|||
156811459|NCT01133756|566062489|FG002|Overall Study|Investigator Decision|0|||
156811460|NCT01133756|566062487|FG000|Overall Study|Withdrawal by Subject|0|||
156883545|NCT00065429|566332581|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
156811461|NCT01133756|566062488|FG001|Overall Study|Withdrawal by Subject|1|||
156883546|NCT00065429|566332582|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
156811462|NCT01133756|566062489|FG002|Overall Study|Withdrawal by Subject|0|||
156811463|NCT01133756|566062487|FG000|Overall Study|Progression of Disease|0|||
156811464|NCT01133756|566062488|FG001|Overall Study|Progression of Disease|0|||
157146907|NCT02786537|567285918|FG005|As Treated|Incarceration|0|||
157146908|NCT02786537|567285913|FG000|As Treated|Opiate dependency relapse|0|||
157146909|NCT02786537|567285914|FG001|As Treated|Opiate dependency relapse|1|||
156811465|NCT01133756|566062489|FG002|Overall Study|Progression of Disease|1|||
156811466|NCT01945216|566062495|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
156811467|NCT01945216|566062495|FG000|Overall Study|Protocol Violation|42|||
156811468|NCT01945216|566062495|FG000|Overall Study|CRF not assured by investigators|5|||
156811469|NCT03941873|566062502|FG000|Overall Study|Death|0|||
156811470|NCT03941873|566062503|FG001|Overall Study|Death|12|||
156811471|NCT03941873|566062504|FG002|Overall Study|Death|2|||
156811472|NCT03941873|566062505|FG003|Overall Study|Death|53|||
156811473|NCT03941873|566062502|FG000|Overall Study|Withdrawal by Subject|1|||
156811474|NCT03941873|566062503|FG001|Overall Study|Withdrawal by Subject|1|||
156811475|NCT03941873|566062504|FG002|Overall Study|Withdrawal by Subject|0|||
156811476|NCT03941873|566062505|FG003|Overall Study|Withdrawal by Subject|5|||
156811477|NCT03941873|566062502|FG000|Overall Study|Lost to Follow-up|1|||
156811478|NCT03941873|566062503|FG001|Overall Study|Lost to Follow-up|2|||
156811479|NCT03941873|566062504|FG002|Overall Study|Lost to Follow-up|0|||
156811480|NCT03941873|566062505|FG003|Overall Study|Lost to Follow-up|0|||
156811481|NCT03941873|566062502|FG000|Overall Study|Sponsor Decision|0|||
156811482|NCT03941873|566062503|FG001|Overall Study|Sponsor Decision|6|||
156811483|NCT03941873|566062504|FG002|Overall Study|Sponsor Decision|0|||
156811484|NCT03941873|566062505|FG003|Overall Study|Sponsor Decision|15|||
156811485|NCT02574078|566062509|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811486|NCT02574078|566062510|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811487|NCT02574078|566062511|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811488|NCT02574078|566062512|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811489|NCT02574078|566062513|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811490|NCT02574078|566062514|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156811491|NCT02574078|566062515|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
156811492|NCT02574078|566062516|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811493|NCT02574078|566062517|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
156811494|NCT02574078|566062518|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811495|NCT02574078|566062519|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811496|NCT02574078|566062520|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811497|NCT02574078|566062521|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
156811498|NCT02574078|566062509|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
156811499|NCT02574078|566062510|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156811500|NCT02574078|566062511|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
156811501|NCT02574078|566062512|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
156811502|NCT02574078|566062513|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
156811503|NCT02574078|566062514|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
156811504|NCT02574078|566062515|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
156811505|NCT02574078|566062516|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
156811506|NCT02574078|566062517|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
156811507|NCT02574078|566062518|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
156811508|NCT02574078|566062519|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
156811509|NCT02574078|566062520|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
156811510|NCT02574078|566062521|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
156811511|NCT02574078|566062509|FG000|Pre-Treatment Period|Other reasons|0|||
156811512|NCT02574078|566062510|FG001|Pre-Treatment Period|Other reasons|0|||
156811513|NCT02574078|566062511|FG002|Pre-Treatment Period|Other reasons|0|||
156811514|NCT02574078|566062512|FG003|Pre-Treatment Period|Other reasons|0|||
156811515|NCT02574078|566062513|FG004|Pre-Treatment Period|Other reasons|0|||
156811516|NCT02574078|566062514|FG005|Pre-Treatment Period|Other reasons|0|||
156811517|NCT02574078|566062515|FG006|Pre-Treatment Period|Other reasons|2|||
156811518|NCT02574078|566062516|FG007|Pre-Treatment Period|Other reasons|0|||
156811519|NCT02574078|566062517|FG008|Pre-Treatment Period|Other reasons|0|||
156811520|NCT02574078|566062518|FG009|Pre-Treatment Period|Other reasons|0|||
156811521|NCT02574078|566062519|FG010|Pre-Treatment Period|Other reasons|2|||
156811522|NCT02574078|566062520|FG011|Pre-Treatment Period|Other reasons|0|||
156811523|NCT02574078|566062521|FG012|Pre-Treatment Period|Other reasons|0|||
156811524|NCT02574078|566062509|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
156811525|NCT02574078|566062510|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
156811526|NCT02574078|566062511|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
156811527|NCT02574078|566062512|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
156811528|NCT02574078|566062513|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
156811529|NCT02574078|566062514|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
157146910|NCT02786537|567285915|FG002|As Treated|Opiate dependency relapse|0|||
157146911|NCT02786537|567285916|FG003|As Treated|Opiate dependency relapse|0|||
157146912|NCT02786537|567285917|FG004|As Treated|Opiate dependency relapse|0|||
157146913|NCT02786537|567285918|FG005|As Treated|Opiate dependency relapse|0|||
157146914|NCT02786537|567285913|FG000|As Treated|Drugs stolen from patient|0|||
157146915|NCT02786537|567285914|FG001|As Treated|Drugs stolen from patient|1|||
157146916|NCT02786537|567285915|FG002|As Treated|Drugs stolen from patient|0|||
157146917|NCT02786537|567285916|FG003|As Treated|Drugs stolen from patient|0|||
157146918|NCT02786537|567285917|FG004|As Treated|Drugs stolen from patient|0|||
157146919|NCT02786537|567285918|FG005|As Treated|Drugs stolen from patient|0|||
157146920|NCT02786537|567285913|FG000|As Treated|Advised to stop tx after loss of meds|0|||
157146921|NCT02786537|567285914|FG001|As Treated|Advised to stop tx after loss of meds|1|||
157146922|NCT02786537|567285915|FG002|As Treated|Advised to stop tx after loss of meds|0|||
157146923|NCT02786537|567285916|FG003|As Treated|Advised to stop tx after loss of meds|0|||
157146924|NCT02786537|567285917|FG004|As Treated|Advised to stop tx after loss of meds|0|||
157146925|NCT02786537|567285918|FG005|As Treated|Advised to stop tx after loss of meds|0|||
157146926|NCT03060577|567285919|FG000|Overall Study|Withdrawal by Subject|25|||
157146927|NCT03060577|567285920|FG001|Overall Study|Withdrawal by Subject|5|||
157146928|NCT03060577|567285919|FG000|Overall Study|Physician Decision|4|||
157146929|NCT03060577|567285920|FG001|Overall Study|Physician Decision|3|||
157146930|NCT03060577|567285919|FG000|Overall Study|Lost to Follow-up|3|||
157146931|NCT03060577|567285920|FG001|Overall Study|Lost to Follow-up|0|||
157146932|NCT03060577|567285919|FG000|Overall Study|Death|7|||
157146933|NCT03060577|567285920|FG001|Overall Study|Death|1|||
157146934|NCT03060577|567285919|FG000|Overall Study|Adverse Event|9|||
157222420|NCT03329027|567561978|FG000|Overall Study|Protocol Violation|9|||
157222421|NCT03329027|567561979|FG001|Overall Study|Protocol Violation|5|||
157222422|NCT03329027|567561980|FG002|Overall Study|Protocol Violation|7|||
157222423|NCT02761980|567561983|FG000|Overall Study|Adverse Event|4|||
156811530|NCT02574078|566062515|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
156811531|NCT02574078|566062516|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
156811532|NCT02574078|566062517|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
156811533|NCT02574078|566062518|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
156811534|NCT02574078|566062519|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
156811535|NCT02574078|566062520|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
156811536|NCT02574078|566062521|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
156811537|NCT02574078|566062509|FG000|Treatment Period|Disease progression|6|||
156811538|NCT02574078|566062510|FG001|Treatment Period|Disease progression|4|||
156811539|NCT02574078|566062511|FG002|Treatment Period|Disease progression|7|||
156811540|NCT02574078|566062512|FG003|Treatment Period|Disease progression|18|||
156811541|NCT02574078|566062513|FG004|Treatment Period|Disease progression|16|||
156811542|NCT02574078|566062514|FG005|Treatment Period|Disease progression|26|||
156811543|NCT02574078|566062515|FG006|Treatment Period|Disease progression|5|||
156811544|NCT02574078|566062516|FG007|Treatment Period|Disease progression|9|||
156811545|NCT02574078|566062517|FG008|Treatment Period|Disease progression|8|||
156811546|NCT02574078|566062518|FG009|Treatment Period|Disease progression|5|||
156811547|NCT02574078|566062519|FG010|Treatment Period|Disease progression|20|||
156811548|NCT02574078|566062520|FG011|Treatment Period|Disease progression|29|||
156811549|NCT02574078|566062521|FG012|Treatment Period|Disease progression|2|||
156811550|NCT02574078|566062509|FG000|Treatment Period|Study drug toxicity|1|||
156811551|NCT02574078|566062510|FG001|Treatment Period|Study drug toxicity|1|||
156811552|NCT02574078|566062511|FG002|Treatment Period|Study drug toxicity|0|||
156811553|NCT02574078|566062512|FG003|Treatment Period|Study drug toxicity|5|||
156811554|NCT02574078|566062513|FG004|Treatment Period|Study drug toxicity|3|||
156811555|NCT02574078|566062514|FG005|Treatment Period|Study drug toxicity|1|||
156811556|NCT02574078|566062515|FG006|Treatment Period|Study drug toxicity|2|||
156811557|NCT02574078|566062516|FG007|Treatment Period|Study drug toxicity|0|||
156811558|NCT02574078|566062517|FG008|Treatment Period|Study drug toxicity|2|||
156811559|NCT02574078|566062518|FG009|Treatment Period|Study drug toxicity|1|||
156811560|NCT02574078|566062519|FG010|Treatment Period|Study drug toxicity|16|||
156811561|NCT02574078|566062520|FG011|Treatment Period|Study drug toxicity|2|||
156811562|NCT02574078|566062521|FG012|Treatment Period|Study drug toxicity|4|||
156811563|NCT02574078|566062509|FG000|Treatment Period|Death|2|||
156811564|NCT02574078|566062510|FG001|Treatment Period|Death|0|||
156811565|NCT02574078|566062511|FG002|Treatment Period|Death|0|||
156811566|NCT02574078|566062512|FG003|Treatment Period|Death|0|||
156811567|NCT02574078|566062513|FG004|Treatment Period|Death|1|||
156811568|NCT02574078|566062514|FG005|Treatment Period|Death|1|||
156811569|NCT02574078|566062515|FG006|Treatment Period|Death|1|||
156883547|NCT00065429|566332583|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
157146935|NCT03060577|567285920|FG001|Overall Study|Adverse Event|1|||
157146936|NCT03060577|567285919|FG000|Overall Study|Inclusion/Exclusion|1|||
157146937|NCT03060577|567285920|FG001|Overall Study|Inclusion/Exclusion|0|||
157146938|NCT03060577|567285919|FG000|Overall Study|Other|8|||
157146939|NCT03060577|567285920|FG001|Overall Study|Other|2|||
156811570|NCT02574078|566062516|FG007|Treatment Period|Death|1|||
156811571|NCT02574078|566062517|FG008|Treatment Period|Death|7|||
156811572|NCT02574078|566062518|FG009|Treatment Period|Death|1|||
156811573|NCT02574078|566062519|FG010|Treatment Period|Death|0|||
156811574|NCT02574078|566062520|FG011|Treatment Period|Death|2|||
156811575|NCT02574078|566062521|FG012|Treatment Period|Death|1|||
157146940|NCT03216265|567285921|FG000|Overall Study|Adverse Event|2|||
157146941|NCT03216265|567285922|FG001|Overall Study|Adverse Event|0|||
157146942|NCT03216265|567285923|FG002|Overall Study|Adverse Event|2|||
156811576|NCT02574078|566062509|FG000|Treatment Period|Adverse event unrelated to drug|0|||
156811577|NCT02574078|566062510|FG001|Treatment Period|Adverse event unrelated to drug|0|||
156811578|NCT02574078|566062511|FG002|Treatment Period|Adverse event unrelated to drug|1|||
156811579|NCT02574078|566062512|FG003|Treatment Period|Adverse event unrelated to drug|0|||
156811580|NCT02574078|566062513|FG004|Treatment Period|Adverse event unrelated to drug|2|||
156811581|NCT02574078|566062514|FG005|Treatment Period|Adverse event unrelated to drug|3|||
156811582|NCT02574078|566062515|FG006|Treatment Period|Adverse event unrelated to drug|0|||
156811583|NCT02574078|566062516|FG007|Treatment Period|Adverse event unrelated to drug|0|||
157146943|NCT03216265|567285921|FG000|Overall Study|Lost to Follow-up|0|||
157146944|NCT03216265|567285922|FG001|Overall Study|Lost to Follow-up|1|||
156811584|NCT02574078|566062517|FG008|Treatment Period|Adverse event unrelated to drug|1|||
156811585|NCT02574078|566062518|FG009|Treatment Period|Adverse event unrelated to drug|2|||
156811586|NCT02574078|566062519|FG010|Treatment Period|Adverse event unrelated to drug|4|||
156811587|NCT02574078|566062520|FG011|Treatment Period|Adverse event unrelated to drug|1|||
156811588|NCT02574078|566062521|FG012|Treatment Period|Adverse event unrelated to drug|0|||
156811589|NCT02574078|566062509|FG000|Treatment Period|Administrative reason by Sponsor|0|||
156811590|NCT02574078|566062510|FG001|Treatment Period|Administrative reason by Sponsor|1|||
156811591|NCT02574078|566062511|FG002|Treatment Period|Administrative reason by Sponsor|0|||
156811592|NCT02574078|566062512|FG003|Treatment Period|Administrative reason by Sponsor|0|||
156811593|NCT02574078|566062513|FG004|Treatment Period|Administrative reason by Sponsor|0|||
156811594|NCT02574078|566062514|FG005|Treatment Period|Administrative reason by Sponsor|0|||
156811595|NCT02574078|566062515|FG006|Treatment Period|Administrative reason by Sponsor|1|||
156811596|NCT02574078|566062516|FG007|Treatment Period|Administrative reason by Sponsor|0|||
156811597|NCT02574078|566062517|FG008|Treatment Period|Administrative reason by Sponsor|0|||
156811598|NCT02574078|566062518|FG009|Treatment Period|Administrative reason by Sponsor|0|||
156811599|NCT02574078|566062519|FG010|Treatment Period|Administrative reason by Sponsor|0|||
156811600|NCT02574078|566062520|FG011|Treatment Period|Administrative reason by Sponsor|0|||
156811601|NCT02574078|566062521|FG012|Treatment Period|Administrative reason by Sponsor|3|||
156811602|NCT02574078|566062509|FG000|Treatment Period|Other reasons|1|||
156811603|NCT02574078|566062510|FG001|Treatment Period|Other reasons|0|||
156811604|NCT02574078|566062511|FG002|Treatment Period|Other reasons|1|||
156811605|NCT02574078|566062512|FG003|Treatment Period|Other reasons|3|||
156811606|NCT02574078|566062513|FG004|Treatment Period|Other reasons|3|||
156811607|NCT02574078|566062514|FG005|Treatment Period|Other reasons|1|||
156811608|NCT02574078|566062515|FG006|Treatment Period|Other reasons|2|||
156811609|NCT02574078|566062516|FG007|Treatment Period|Other reasons|1|||
156811610|NCT02574078|566062517|FG008|Treatment Period|Other reasons|3|||
156811611|NCT02574078|566062518|FG009|Treatment Period|Other reasons|1|||
156811612|NCT02574078|566062519|FG010|Treatment Period|Other reasons|1|||
156811613|NCT02574078|566062520|FG011|Treatment Period|Other reasons|3|||
156811614|NCT02574078|566062521|FG012|Treatment Period|Other reasons|1|||
156811615|NCT02574078|566062509|FG000|Treatment Period|Participant request to stop drug|0|||
156811616|NCT02574078|566062510|FG001|Treatment Period|Participant request to stop drug|0|||
156811617|NCT02574078|566062511|FG002|Treatment Period|Participant request to stop drug|0|||
156811618|NCT02574078|566062512|FG003|Treatment Period|Participant request to stop drug|2|||
156811619|NCT02574078|566062513|FG004|Treatment Period|Participant request to stop drug|4|||
156811620|NCT02574078|566062514|FG005|Treatment Period|Participant request to stop drug|0|||
156811621|NCT02574078|566062515|FG006|Treatment Period|Participant request to stop drug|1|||
156811622|NCT02574078|566062516|FG007|Treatment Period|Participant request to stop drug|0|||
156811623|NCT02574078|566062517|FG008|Treatment Period|Participant request to stop drug|3|||
156811624|NCT02574078|566062518|FG009|Treatment Period|Participant request to stop drug|2|||
156811625|NCT02574078|566062519|FG010|Treatment Period|Participant request to stop drug|2|||
156811626|NCT02574078|566062520|FG011|Treatment Period|Participant request to stop drug|4|||
156811627|NCT02574078|566062521|FG012|Treatment Period|Participant request to stop drug|1|||
156811628|NCT02574078|566062509|FG000|Treatment Period|Participant withdrew consent|0|||
156811629|NCT02574078|566062510|FG001|Treatment Period|Participant withdrew consent|0|||
156811630|NCT02574078|566062511|FG002|Treatment Period|Participant withdrew consent|0|||
156811631|NCT02574078|566062512|FG003|Treatment Period|Participant withdrew consent|0|||
156811632|NCT02574078|566062513|FG004|Treatment Period|Participant withdrew consent|1|||
156811633|NCT02574078|566062514|FG005|Treatment Period|Participant withdrew consent|1|||
156811634|NCT02574078|566062515|FG006|Treatment Period|Participant withdrew consent|0|||
156811635|NCT02574078|566062516|FG007|Treatment Period|Participant withdrew consent|1|||
157146945|NCT03216265|567285923|FG002|Overall Study|Lost to Follow-up|0|||
157146946|NCT03216265|567285921|FG000|Overall Study|Withdrawal by Subject|0|||
156811636|NCT02574078|566062517|FG008|Treatment Period|Participant withdrew consent|0|||
156811637|NCT02574078|566062518|FG009|Treatment Period|Participant withdrew consent|2|||
156811638|NCT02574078|566062519|FG010|Treatment Period|Participant withdrew consent|1|||
156811639|NCT02574078|566062520|FG011|Treatment Period|Participant withdrew consent|4|||
156811640|NCT02574078|566062521|FG012|Treatment Period|Participant withdrew consent|1|||
156811641|NCT02574078|566062509|FG000|Treatment Period|Participant no longer meets criteria|0|||
157146947|NCT03216265|567285922|FG001|Overall Study|Withdrawal by Subject|0|||
156811642|NCT02574078|566062510|FG001|Treatment Period|Participant no longer meets criteria|0|||
156811643|NCT02574078|566062511|FG002|Treatment Period|Participant no longer meets criteria|0|||
156811644|NCT02574078|566062512|FG003|Treatment Period|Participant no longer meets criteria|0|||
156811645|NCT02574078|566062513|FG004|Treatment Period|Participant no longer meets criteria|1|||
156811646|NCT02574078|566062514|FG005|Treatment Period|Participant no longer meets criteria|0|||
156811647|NCT02574078|566062515|FG006|Treatment Period|Participant no longer meets criteria|0|||
156811648|NCT02574078|566062516|FG007|Treatment Period|Participant no longer meets criteria|0|||
156811649|NCT02574078|566062517|FG008|Treatment Period|Participant no longer meets criteria|0|||
156811650|NCT02574078|566062518|FG009|Treatment Period|Participant no longer meets criteria|1|||
156811651|NCT02574078|566062519|FG010|Treatment Period|Participant no longer meets criteria|1|||
156811652|NCT02574078|566062520|FG011|Treatment Period|Participant no longer meets criteria|1|||
156811653|NCT02574078|566062521|FG012|Treatment Period|Participant no longer meets criteria|0|||
156811654|NCT02574078|566062509|FG000|Treatment Period|Lost to Follow-up|0|||
156811655|NCT02574078|566062510|FG001|Treatment Period|Lost to Follow-up|0|||
156811656|NCT02574078|566062511|FG002|Treatment Period|Lost to Follow-up|0|||
156811657|NCT02574078|566062512|FG003|Treatment Period|Lost to Follow-up|0|||
156811658|NCT02574078|566062513|FG004|Treatment Period|Lost to Follow-up|0|||
156811659|NCT02574078|566062514|FG005|Treatment Period|Lost to Follow-up|0|||
156811660|NCT02574078|566062515|FG006|Treatment Period|Lost to Follow-up|0|||
156811661|NCT02574078|566062516|FG007|Treatment Period|Lost to Follow-up|0|||
156811662|NCT02574078|566062517|FG008|Treatment Period|Lost to Follow-up|0|||
156811663|NCT02574078|566062518|FG009|Treatment Period|Lost to Follow-up|1|||
156811664|NCT02574078|566062519|FG010|Treatment Period|Lost to Follow-up|0|||
156811665|NCT02574078|566062520|FG011|Treatment Period|Lost to Follow-up|1|||
156811666|NCT02574078|566062521|FG012|Treatment Period|Lost to Follow-up|0|||
156811667|NCT02574078|566062509|FG000|Treatment Period|Maximum clinical benefit|0|||
156811668|NCT02574078|566062510|FG001|Treatment Period|Maximum clinical benefit|0|||
156811669|NCT02574078|566062511|FG002|Treatment Period|Maximum clinical benefit|0|||
156811670|NCT02574078|566062512|FG003|Treatment Period|Maximum clinical benefit|0|||
156811671|NCT02574078|566062513|FG004|Treatment Period|Maximum clinical benefit|0|||
156811672|NCT02574078|566062514|FG005|Treatment Period|Maximum clinical benefit|0|||
156811673|NCT02574078|566062515|FG006|Treatment Period|Maximum clinical benefit|0|||
156811674|NCT02574078|566062516|FG007|Treatment Period|Maximum clinical benefit|0|||
156811675|NCT02574078|566062517|FG008|Treatment Period|Maximum clinical benefit|0|||
156811676|NCT02574078|566062518|FG009|Treatment Period|Maximum clinical benefit|1|||
156811677|NCT02574078|566062519|FG010|Treatment Period|Maximum clinical benefit|0|||
156811678|NCT02574078|566062520|FG011|Treatment Period|Maximum clinical benefit|0|||
156811679|NCT02574078|566062521|FG012|Treatment Period|Maximum clinical benefit|0|||
156811680|NCT00293813|566062528|FG000|Overall Study|Physician Decision|0|||
156811681|NCT00293813|566062529|FG001|Overall Study|Physician Decision|1|||
156811682|NCT00293813|566062530|FG002|Overall Study|Physician Decision|0|||
156811683|NCT00293813|566062528|FG000|Overall Study|Adverse Event|3|||
156811684|NCT00293813|566062529|FG001|Overall Study|Adverse Event|1|||
156811685|NCT00293813|566062530|FG002|Overall Study|Adverse Event|1|||
156811686|NCT00293813|566062528|FG000|Overall Study|Withdrawal by Subject|7|||
156811687|NCT00293813|566062529|FG001|Overall Study|Withdrawal by Subject|4|||
156811688|NCT00293813|566062530|FG002|Overall Study|Withdrawal by Subject|4|||
156811689|NCT00293813|566062528|FG000|Overall Study|Lost to Follow-up|3|||
156811690|NCT00293813|566062529|FG001|Overall Study|Lost to Follow-up|2|||
156811691|NCT00293813|566062530|FG002|Overall Study|Lost to Follow-up|3|||
156811692|NCT00293813|566062528|FG000|Overall Study|Noncompliance|0|||
156883548|NCT00065429|566332577|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156883549|NCT00065429|566332578|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156883550|NCT00065429|566332579|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
156883551|NCT00065429|566332580|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156883552|NCT00065429|566332581|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
157146948|NCT03216265|567285923|FG002|Overall Study|Withdrawal by Subject|1|||
157146949|NCT01306058|567285924|FG000|Overall Study|Death|1|||
157146950|NCT01306058|567285924|FG000|Overall Study|Enrolled but did not get treatment|1|||
157146951|NCT01539837|567285925|FG000|Overall Study|reduce neutrophil level|0|||
156811693|NCT00293813|566062529|FG001|Overall Study|Noncompliance|1|||
156811694|NCT00293813|566062530|FG002|Overall Study|Noncompliance|0|||
156811695|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
156811696|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811697|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811698|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
156811699|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
156883553|NCT00065429|566332582|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
157146952|NCT01539837|567285926|FG001|Overall Study|reduce neutrophil level|1|||
157146953|NCT01539837|567285927|FG002|Overall Study|reduce neutrophil level|1|||
156811700|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156811701|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157146954|NCT01539837|567285925|FG000|Overall Study|bad compliance|0|||
157146955|NCT01539837|567285926|FG001|Overall Study|bad compliance|0|||
157146956|NCT01539837|567285927|FG002|Overall Study|bad compliance|1|||
157146957|NCT00849693|567285928|FG000|Acute Treatment Phase|Adverse Event|12|||
157146958|NCT00849693|567285929|FG001|Acute Treatment Phase|Adverse Event|7|||
157146959|NCT00849693|567285930|FG002|Acute Treatment Phase|Adverse Event|6|||
157146960|NCT00849693|567285931|FG003|Acute Treatment Phase|Adverse Event|4|||
157146961|NCT00849693|567285928|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
157146962|NCT00849693|567285929|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
157146963|NCT00849693|567285930|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
157146964|NCT00849693|567285931|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
157146965|NCT00849693|567285928|FG000|Acute Treatment Phase|Protocol Violation|1|||
157146966|NCT00849693|567285929|FG001|Acute Treatment Phase|Protocol Violation|5|||
157146967|NCT00849693|567285930|FG002|Acute Treatment Phase|Protocol Violation|2|||
157146968|NCT00849693|567285931|FG003|Acute Treatment Phase|Protocol Violation|6|||
157146969|NCT00849693|567285928|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
157146970|NCT00849693|567285929|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
157146971|NCT00849693|567285930|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
157146972|NCT00849693|567285931|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
157146973|NCT00849693|567285928|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
157146974|NCT00849693|567285929|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
157146975|NCT00849693|567285930|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
157146976|NCT00849693|567285931|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
157146977|NCT00849693|567285928|FG000|Acute Treatment Phase|Physician Decision|2|||
157146978|NCT00849693|567285929|FG001|Acute Treatment Phase|Physician Decision|1|||
157146979|NCT00849693|567285930|FG002|Acute Treatment Phase|Physician Decision|2|||
157146980|NCT00849693|567285931|FG003|Acute Treatment Phase|Physician Decision|1|||
157146981|NCT00849693|567285928|FG000|Acute Treatment Phase|Sponsor decision|0|||
157146982|NCT00849693|567285929|FG001|Acute Treatment Phase|Sponsor decision|0|||
157146983|NCT00849693|567285930|FG002|Acute Treatment Phase|Sponsor decision|1|||
157146984|NCT00849693|567285931|FG003|Acute Treatment Phase|Sponsor decision|0|||
157146985|NCT00849693|567285928|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
157146986|NCT00849693|567285929|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
157146987|NCT00849693|567285930|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
157146988|NCT00849693|567285931|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
157146989|NCT00849693|567285928|FG000|Extension Phase|Adverse Event|4|||
157146990|NCT00849693|567285929|FG001|Extension Phase|Adverse Event|6|||
157146991|NCT00849693|567285930|FG002|Extension Phase|Adverse Event|3|||
157146992|NCT00849693|567285931|FG003|Extension Phase|Adverse Event|7|||
157146993|NCT00849693|567285928|FG000|Extension Phase|Lost to Follow-up|7|||
157146994|NCT00849693|567285929|FG001|Extension Phase|Lost to Follow-up|5|||
157146995|NCT00849693|567285930|FG002|Extension Phase|Lost to Follow-up|6|||
157146996|NCT00849693|567285931|FG003|Extension Phase|Lost to Follow-up|6|||
157146997|NCT00849693|567285928|FG000|Extension Phase|Protocol Violation|0|||
157146998|NCT00849693|567285929|FG001|Extension Phase|Protocol Violation|3|||
157146999|NCT00849693|567285930|FG002|Extension Phase|Protocol Violation|2|||
157147000|NCT00849693|567285931|FG003|Extension Phase|Protocol Violation|3|||
157147001|NCT00849693|567285928|FG000|Extension Phase|Withdrawal by Subject|6|||
157147002|NCT00849693|567285929|FG001|Extension Phase|Withdrawal by Subject|9|||
157147003|NCT00849693|567285930|FG002|Extension Phase|Withdrawal by Subject|10|||
157147004|NCT00849693|567285931|FG003|Extension Phase|Withdrawal by Subject|15|||
157147005|NCT00849693|567285928|FG000|Extension Phase|Parent or caregiver decision|9|||
157147006|NCT00849693|567285929|FG001|Extension Phase|Parent or caregiver decision|4|||
157147007|NCT00849693|567285930|FG002|Extension Phase|Parent or caregiver decision|10|||
157147008|NCT00849693|567285931|FG003|Extension Phase|Parent or caregiver decision|5|||
157147009|NCT00849693|567285928|FG000|Extension Phase|Physician Decision|1|||
157147010|NCT00849693|567285929|FG001|Extension Phase|Physician Decision|1|||
156811702|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
156811703|NCT00460655|566062531|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
156811704|NCT00460655|566062532|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
156811705|NCT00460655|566062533|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
156811706|NCT00460655|566062534|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
157147011|NCT00849693|567285930|FG002|Extension Phase|Physician Decision|2|||
157147012|NCT00849693|567285931|FG003|Extension Phase|Physician Decision|0|||
157147013|NCT00849693|567285928|FG000|Extension Phase|Sponsor decision|1|||
157147014|NCT00849693|567285929|FG001|Extension Phase|Sponsor decision|0|||
157147015|NCT00849693|567285930|FG002|Extension Phase|Sponsor decision|0|||
156811707|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157147016|NCT00849693|567285931|FG003|Extension Phase|Sponsor decision|1|||
157147017|NCT00849693|567285928|FG000|Extension Phase|Lack of Efficacy|2|||
157147018|NCT00849693|567285929|FG001|Extension Phase|Lack of Efficacy|2|||
157147019|NCT00849693|567285930|FG002|Extension Phase|Lack of Efficacy|2|||
157147020|NCT00849693|567285931|FG003|Extension Phase|Lack of Efficacy|1|||
157147021|NCT01978912|567285932|FG000|Overall Study|Adverse Event|0|||
157147022|NCT01978912|567285933|FG001|Overall Study|Adverse Event|1|||
157147023|NCT01978912|567285934|FG002|Overall Study|Adverse Event|0|||
157147024|NCT01978912|567285935|FG003|Overall Study|Adverse Event|0|||
157147025|NCT01978912|567285932|FG000|Overall Study|Lost to Follow-up|1|||
157147026|NCT01978912|567285933|FG001|Overall Study|Lost to Follow-up|1|||
157147027|NCT01978912|567285934|FG002|Overall Study|Lost to Follow-up|0|||
157147028|NCT01978912|567285935|FG003|Overall Study|Lost to Follow-up|1|||
157147029|NCT01978912|567285932|FG000|Overall Study|Withdrawal by Subject|1|||
157147030|NCT01978912|567285933|FG001|Overall Study|Withdrawal by Subject|0|||
157147031|NCT01978912|567285934|FG002|Overall Study|Withdrawal by Subject|2|||
157147032|NCT01978912|567285935|FG003|Overall Study|Withdrawal by Subject|2|||
157147033|NCT01978912|567285932|FG000|Overall Study|Lumbar Surgery|1|||
157147034|NCT01978912|567285933|FG001|Overall Study|Lumbar Surgery|0|||
157147035|NCT01978912|567285934|FG002|Overall Study|Lumbar Surgery|1|||
157147036|NCT01978912|567285935|FG003|Overall Study|Lumbar Surgery|0|||
157147037|NCT01978912|567285932|FG000|Overall Study|Intradiscal Steroid Injection|0|||
157147038|NCT01978912|567285933|FG001|Overall Study|Intradiscal Steroid Injection|1|||
157147039|NCT01978912|567285934|FG002|Overall Study|Intradiscal Steroid Injection|0|||
157147040|NCT01978912|567285935|FG003|Overall Study|Intradiscal Steroid Injection|0|||
157147041|NCT00224107|567285936|FG000|Overall Study|Adverse Event|20|||
157147042|NCT00224107|567285937|FG001|Overall Study|Adverse Event|6|||
157147043|NCT00224107|567285936|FG000|Overall Study|Protocol Violation|2|||
157147044|NCT00224107|567285937|FG001|Overall Study|Protocol Violation|3|||
157147045|NCT00224107|567285936|FG000|Overall Study|Withdrawal by Subject|1|||
157147046|NCT00224107|567285937|FG001|Overall Study|Withdrawal by Subject|4|||
157147047|NCT00224107|567285936|FG000|Overall Study|Lack of Efficacy|2|||
157147048|NCT00224107|567285937|FG001|Overall Study|Lack of Efficacy|0|||
157147049|NCT00224107|567285936|FG000|Overall Study|Lost to Follow-up|4|||
157147050|NCT00224107|567285937|FG001|Overall Study|Lost to Follow-up|0|||
157147051|NCT00224107|567285936|FG000|Overall Study|Physician Decision|1|||
157147052|NCT00224107|567285937|FG001|Overall Study|Physician Decision|0|||
157147053|NCT00224107|567285936|FG000|Overall Study|Other|1|||
157147054|NCT00224107|567285937|FG001|Overall Study|Other|1|||
157147055|NCT01408537|567285938|FG000|Overall Study|Withdrawal by Subject|2|||
157147056|NCT01408537|567285938|FG000|Overall Study|Protocol Violation|3|||
157147057|NCT01408537|567285938|FG000|Overall Study|Lost to Follow-up|3|||
157147058|NCT02584634|567285939|FG000|Overall Study|Adverse Event|3|||
157147059|NCT02584634|567285940|FG001|Overall Study|Adverse Event|5|||
157147060|NCT02584634|567285939|FG000|Overall Study|Death|0|||
157147061|NCT02584634|567285940|FG001|Overall Study|Death|1|||
157147062|NCT02584634|567285939|FG000|Overall Study|Lost to Follow-up|0|||
157147063|NCT02584634|567285940|FG001|Overall Study|Lost to Follow-up|1|||
157147064|NCT02584634|567285939|FG000|Overall Study|Physician Decision|1|||
157147065|NCT02584634|567285940|FG001|Overall Study|Physician Decision|2|||
157147066|NCT02584634|567285939|FG000|Overall Study|Progressive disease|7|||
157147067|NCT02584634|567285940|FG001|Overall Study|Progressive disease|15|||
157147068|NCT02584634|567285939|FG000|Overall Study|Withdrawal by Subject|1|||
157147069|NCT02584634|567285940|FG001|Overall Study|Withdrawal by Subject|1|||
157147070|NCT02584634|567285939|FG000|Overall Study|Other|0|||
157147071|NCT02584634|567285940|FG001|Overall Study|Other|6|||
157147072|NCT05523362|567285941|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
157147073|NCT05523362|567285941|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
157147074|NCT05523362|567285941|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
157147075|NCT05523362|567285941|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
157147076|NCT04075604|567285943|FG000|Overall Study|Adverse Event|0|||
157147077|NCT04075604|567285944|FG001|Overall Study|Adverse Event|0|||
157147078|NCT04075604|567285945|FG002|Overall Study|Adverse Event|3|||
157147079|NCT04075604|567285943|FG000|Overall Study|Participant request to discontinue study treatment|0|||
157147080|NCT04075604|567285944|FG001|Overall Study|Participant request to discontinue study treatment|0|||
157147081|NCT04075604|567285945|FG002|Overall Study|Participant request to discontinue study treatment|1|||
157147082|NCT04075604|567285943|FG000|Overall Study|Participant withdrew consent|0|||
157147083|NCT04075604|567285944|FG001|Overall Study|Participant withdrew consent|0|||
157147084|NCT04075604|567285945|FG002|Overall Study|Participant withdrew consent|1|||
157147085|NCT04075604|567285943|FG000|Overall Study|Other reasons|1|||
157147086|NCT04075604|567285944|FG001|Overall Study|Other reasons|0|||
157147087|NCT04075604|567285945|FG002|Overall Study|Other reasons|0|||
157147088|NCT04075604|567285943|FG000|Overall Study|Disease progression|0|||
157147089|NCT04075604|567285944|FG001|Overall Study|Disease progression|1|||
157147090|NCT04075604|567285945|FG002|Overall Study|Disease progression|0|||
157147091|NCT04075604|567285943|FG000|Overall Study|Study drug toxicity|0|||
156811708|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157147092|NCT04075604|567285944|FG001|Overall Study|Study drug toxicity|5|||
157147093|NCT04075604|567285945|FG002|Overall Study|Study drug toxicity|1|||
157147094|NCT00098345|567285946|FG000|Overall Study|Adverse Event|7|||
157147095|NCT00098345|567285946|FG000|Overall Study|Withdrawal by Subject|2|||
157147096|NCT00098345|567285946|FG000|Overall Study|progression|4|||
157147097|NCT01183858|567285947|FG000|Overall Study|Death not related to Progressive Disease|5|||
157147098|NCT01183858|567285948|FG001|Overall Study|Death not related to Progressive Disease|6|||
157147099|NCT01183858|567285947|FG000|Overall Study|Adverse Event|14|||
156811709|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
156811710|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
156811711|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156811712|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
156811713|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
156811714|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
156811715|NCT00460655|566062531|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811716|NCT00460655|566062532|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811717|NCT00460655|566062533|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
156811718|NCT00460655|566062534|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
156811719|NCT03650413|566062535|FG000|Overall Study|Adverse Event|1|||
156811720|NCT03650413|566062535|FG000|Overall Study|Lack of Efficacy|17|||
156811721|NCT03650413|566062535|FG000|Overall Study|Other|9|||
156811722|NCT03650413|566062535|FG000|Overall Study|Physician Decision|2|||
156811723|NCT03650413|566062535|FG000|Overall Study|Study Terminated By Sponsor|16|||
156811724|NCT03650413|566062535|FG000|Overall Study|Withdrawal by Subject|16|||
156811725|NCT02553928|566062536|FG000|Overall Study|Adverse Event|2|||
156811726|NCT02553928|566062537|FG001|Overall Study|Adverse Event|1|||
156811727|NCT02553928|566062536|FG000|Overall Study|Lost to Follow-up|0|||
156811728|NCT02553928|566062537|FG001|Overall Study|Lost to Follow-up|1|||
156811729|NCT02553928|566062536|FG000|Overall Study|Administrative reason(s)|0|||
156811730|NCT02553928|566062537|FG001|Overall Study|Administrative reason(s)|1|||
156811731|NCT00910910|566062538|FG000|Overall Study|Adverse Event|63|||
156811732|NCT00910910|566062539|FG001|Overall Study|Adverse Event|35|||
156811733|NCT00910910|566062538|FG000|Overall Study|PD without histologic change|27|||
156811734|NCT00910910|566062539|FG001|Overall Study|PD without histologic change|23|||
156811735|NCT00910910|566062538|FG000|Overall Study|PD with histologic change|0|||
156811736|NCT00910910|566062539|FG001|Overall Study|PD with histologic change|2|||
156811737|NCT00910910|566062538|FG000|Overall Study|Withdrawal by Subject|7|||
156811738|NCT00910910|566062539|FG001|Overall Study|Withdrawal by Subject|5|||
156811739|NCT00910910|566062538|FG000|Overall Study|Lost to Follow-up|2|||
156811740|NCT00910910|566062539|FG001|Overall Study|Lost to Follow-up|2|||
156811741|NCT00910910|566062538|FG000|Overall Study|Death|9|||
156811742|NCT00910910|566062539|FG001|Overall Study|Death|3|||
156811743|NCT00910910|566062538|FG000|Overall Study|Protocol Violation|2|||
156811744|NCT00910910|566062539|FG001|Overall Study|Protocol Violation|2|||
156811745|NCT00910910|566062538|FG000|Overall Study|Completed 13 cycles of treatment|0|||
156811746|NCT00910910|566062539|FG001|Overall Study|Completed 13 cycles of treatment|118|||
156811747|NCT00910910|566062538|FG000|Overall Study|Other|114|||
156811748|NCT00910910|566062539|FG001|Overall Study|Other|32|||
156811749|NCT00910910|566062538|FG000|Overall Study|Untreated before cycle 1|1|||
156811750|NCT00910910|566062539|FG001|Overall Study|Untreated before cycle 1|2|||
156811751|NCT01973231|566062540|FG000|Overall Study|Protocol Violation|1|||
156811752|NCT01973231|566062541|FG001|Overall Study|Protocol Violation|1|||
156811753|NCT01973231|566062540|FG000|Overall Study|Lost to Follow-up|1|||
156811754|NCT01973231|566062541|FG001|Overall Study|Lost to Follow-up|1|||
156811755|NCT01973231|566062540|FG000|Overall Study|unclassified|2|||
156811756|NCT01973231|566062541|FG001|Overall Study|unclassified|1|||
156811757|NCT01973231|566062540|FG000|Overall Study|Withdrawal by Subject|7|||
156811758|NCT01973231|566062541|FG001|Overall Study|Withdrawal by Subject|9|||
156811759|NCT01485796|566062542|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
156811760|NCT01485796|566062542|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
156811761|NCT01485796|566062542|FG000|Period 2: Epoch 2|Adverse Event|3|||
156811762|NCT01485796|566062542|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
156811763|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
156811764|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
156811765|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
156811766|NCT01485796|566062542|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
156811767|NCT04830215|566062543|FG000|Overall Study|Adverse Event|6|||
156811768|NCT04830215|566062543|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
156811769|NCT04830215|566062543|FG000|Overall Study|Withdrawal by Subject|3|||
156811770|NCT04830215|566062543|FG000|Overall Study|Protocol Deviation|1|||
156811771|NCT00770562|566062549|FG000|Overall Study|Did not take treatment|1|||
156811772|NCT00770562|566062550|FG001|Overall Study|Did not take treatment|1|||
156811773|NCT01643408|566062551|FG000|Overall Study|Adverse Event|12|||
156811774|NCT01643408|566062551|FG000|Overall Study|Other|2|||
156811775|NCT00292045|566062555|FG000|Core Study (Through Week 13)|Adverse Event|1|||
156811776|NCT00292045|566062555|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
156811777|NCT00606411|566062556|FG000|Overall Study|Adverse Event|1|||
156811778|NCT00606411|566062557|FG001|Overall Study|Adverse Event|2|||
156811779|NCT00606411|566062556|FG000|Overall Study|Lack of Adherence|1|||
156811780|NCT00606411|566062557|FG001|Overall Study|Lack of Adherence|1|||
156811781|NCT00606411|566062556|FG000|Overall Study|Lack of Efficacy|1|||
156811782|NCT00606411|566062557|FG001|Overall Study|Lack of Efficacy|1|||
156811783|NCT00606411|566062556|FG000|Overall Study|Withdrawal by Subject|2|||
157147100|NCT01183858|567285948|FG001|Overall Study|Adverse Event|11|||
157147101|NCT01183858|567285947|FG000|Overall Study|Investigator's Decision|0|||
157147102|NCT01183858|567285948|FG001|Overall Study|Investigator's Decision|3|||
157147103|NCT01183858|567285947|FG000|Overall Study|Insufficient Therapeutic Response|2|||
157147104|NCT01183858|567285948|FG001|Overall Study|Insufficient Therapeutic Response|0|||
157147105|NCT01183858|567285947|FG000|Overall Study|Refused Treatment|1|||
157147106|NCT01183858|567285948|FG001|Overall Study|Refused Treatment|4|||
157147107|NCT01183858|567285947|FG000|Overall Study|Withdrew Consent|4|||
157147108|NCT01183858|567285948|FG001|Overall Study|Withdrew Consent|4|||
157147109|NCT01183858|567285947|FG000|Overall Study|Discontinued Smoking|3|||
157147110|NCT01183858|567285948|FG001|Overall Study|Discontinued Smoking|1|||
157147111|NCT01183858|567285947|FG000|Overall Study|Protocol Violation|1|||
157147112|NCT01183858|567285948|FG001|Overall Study|Protocol Violation|0|||
157147113|NCT01183858|567285947|FG000|Overall Study|Administrative/Other|6|||
157147114|NCT01183858|567285948|FG001|Overall Study|Administrative/Other|6|||
157147115|NCT01183858|567285947|FG000|Overall Study|Progressive Disease|112|||
157147116|NCT01183858|567285948|FG001|Overall Study|Progressive Disease|115|||
157147117|NCT01183858|567285947|FG000|Overall Study|Death related to Progressive Disease|4|||
157147118|NCT01183858|567285948|FG001|Overall Study|Death related to Progressive Disease|5|||
157147119|NCT01183858|567285947|FG000|Overall Study|Lost to Follow-up|1|||
157147120|NCT01183858|567285948|FG001|Overall Study|Lost to Follow-up|1|||
157147121|NCT03707977|567285951|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
157147122|NCT03707977|567285952|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
157147123|NCT03707977|567285953|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
157147124|NCT03707977|567285951|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
157147125|NCT03707977|567285952|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
157147126|NCT03707977|567285953|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
157147127|NCT03069690|567285954|FG000|Pregnancy Intervention|Pregnancy loss|9|||
157147128|NCT03069690|567285955|FG001|Pregnancy Intervention|Pregnancy loss|4|||
157147129|NCT03069690|567285956|FG002|Pregnancy Intervention|Pregnancy loss|0|||
157147130|NCT03069690|567285957|FG003|Pregnancy Intervention|Pregnancy loss|0|||
157147131|NCT03069690|567285958|FG004|Pregnancy Intervention|Pregnancy loss|0|||
157147132|NCT03069690|567285959|FG005|Pregnancy Intervention|Pregnancy loss|0|||
157147133|NCT03069690|567285954|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
157147134|NCT03069690|567285955|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
157147135|NCT03069690|567285956|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
157147136|NCT03069690|567285957|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
157147137|NCT03069690|567285958|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
157147138|NCT03069690|567285959|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
157147139|NCT03069690|567285954|FG000|Postpartum Intervention|Lost to Follow-up|0|||
157147140|NCT03069690|567285955|FG001|Postpartum Intervention|Lost to Follow-up|0|||
157147141|NCT03069690|567285956|FG002|Postpartum Intervention|Lost to Follow-up|5|||
157147142|NCT03069690|567285957|FG003|Postpartum Intervention|Lost to Follow-up|5|||
157147143|NCT03069690|567285958|FG004|Postpartum Intervention|Lost to Follow-up|2|||
157147144|NCT03069690|567285959|FG005|Postpartum Intervention|Lost to Follow-up|4|||
157147145|NCT02564120|567285960|FG000|Overall Study|Did not return release forms|160|||
157147146|NCT02564120|567285960|FG000|Overall Study|Death|58|||
157147147|NCT02564120|567285960|FG000|Overall Study|Withdrawal by Subject|204|||
157147148|NCT02564120|567285960|FG000|Overall Study|Other medical condition|24|||
157147149|NCT03842709|567285961|FG000|Overall Study|Withdrawal by Subject|3|||
157147150|NCT03842709|567285962|FG001|Overall Study|Withdrawal by Subject|3|||
157147151|NCT03842709|567285961|FG000|Overall Study|Lost to Follow-up|1|||
157147152|NCT03842709|567285962|FG001|Overall Study|Lost to Follow-up|0|||
157147153|NCT00641147|567285963|FG000|Completed 4 Months.|Physician Decision|1|||
157147154|NCT00641147|567285964|FG001|Completed 4 Months.|Physician Decision|0|||
157147155|NCT00641147|567285963|FG000|Completed 4 Months.|Adverse Event|1|||
157147156|NCT00641147|567285964|FG001|Completed 4 Months.|Adverse Event|0|||
157147157|NCT00641147|567285963|FG000|Completed 8 Months.|Physician Decision|2|||
157147158|NCT00641147|567285964|FG001|Completed 8 Months.|Physician Decision|1|||
157147159|NCT00641147|567285963|FG000|Completed 8 Months.|non compliance|1|||
157147160|NCT00641147|567285964|FG001|Completed 8 Months.|non compliance|0|||
157147161|NCT00641147|567285963|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
157147162|NCT00641147|567285964|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
157147163|NCT00641147|567285963|FG000|Completed 12 Months.|Physician Decision|1|||
157147164|NCT00641147|567285964|FG001|Completed 12 Months.|Physician Decision|1|||
157147165|NCT00641147|567285963|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
157147166|NCT00641147|567285964|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
157147167|NCT00641147|567285963|FG000|Completed 16 Months.|Physician Decision|1|||
156811784|NCT00606411|566062557|FG001|Overall Study|Withdrawal by Subject|0|||
156811785|NCT00606411|566062556|FG000|Overall Study|Lost to Follow-up|1|||
156811786|NCT00606411|566062557|FG001|Overall Study|Lost to Follow-up|2|||
157022393|NCT03150810|566835198|FG009|Overall Study|Transferred care to oncologist|0|||
157147168|NCT00641147|567285964|FG001|Completed 16 Months.|Physician Decision|0|||
157222424|NCT02761980|567561984|FG001|Overall Study|Adverse Event|6|||
157222425|NCT02761980|567561985|FG002|Overall Study|Adverse Event|5|||
157222426|NCT02761980|567561986|FG003|Overall Study|Adverse Event|6|||
157222427|NCT02761980|567561983|FG000|Overall Study|Withdrawal by Subject|0|||
157222428|NCT02761980|567561984|FG001|Overall Study|Withdrawal by Subject|1|||
157222429|NCT02761980|567561985|FG002|Overall Study|Withdrawal by Subject|0|||
157222430|NCT02761980|567561986|FG003|Overall Study|Withdrawal by Subject|0|||
157222431|NCT02761980|567561983|FG000|Overall Study|Other|0|||
157222432|NCT02761980|567561984|FG001|Overall Study|Other|0|||
157222433|NCT02761980|567561985|FG002|Overall Study|Other|1|||
157222434|NCT02761980|567561986|FG003|Overall Study|Other|0|||
157222435|NCT00101582|567561993|FG000|Overall Study|Ineligibility determined|0|||
157222436|NCT00101582|567561994|FG001|Overall Study|Ineligibility determined|1|||
157222437|NCT00101582|567561993|FG000|Overall Study|Adverse Event|1|||
157222438|NCT00101582|567561994|FG001|Overall Study|Adverse Event|4|||
157222439|NCT00101582|567561993|FG000|Overall Study|Withdrawal by Subject|6|||
157222440|NCT00101582|567561994|FG001|Overall Study|Withdrawal by Subject|4|||
157222441|NCT00101582|567561993|FG000|Overall Study|Physician Decision|1|||
157222442|NCT00101582|567561994|FG001|Overall Study|Physician Decision|0|||
157222443|NCT00101582|567561993|FG000|Overall Study|Death|3|||
157222444|NCT00101582|567561994|FG001|Overall Study|Death|5|||
157222445|NCT00101582|567561993|FG000|Overall Study|Other|0|||
157222446|NCT00101582|567561994|FG001|Overall Study|Other|1|||
157222447|NCT01907087|567561995|FG000|Overall Study|Withdrawal by Subject|1|||
157222448|NCT01919190|567561997|FG000|Overall Study|Intra-op findings, etc.|3|||
157222449|NCT01919190|567561998|FG001|Overall Study|Intra-op findings, etc.|0|||
157222450|NCT01767597|567561999|FG000|Overall Study|Incomplete intervention|3|||
157222451|NCT01767597|567562000|FG001|Overall Study|Incomplete intervention|1|||
157222452|NCT01767597|567561999|FG000|Overall Study|Withdrawal by Subject|1|||
157222453|NCT01767597|567562000|FG001|Overall Study|Withdrawal by Subject|0|||
157222454|NCT03355742|567562001|FG000|Overall Study|Lost to Follow-up|4|||
157222455|NCT03355742|567562001|FG000|Overall Study|Withdrawal by Subject|29|||
157222456|NCT03355742|567562001|FG000|Overall Study|Physician Decision|6|||
157222457|NCT03355742|567562001|FG000|Overall Study|Death|55|||
157222458|NCT03355742|567562001|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
157222459|NCT00836927|567562002|FG000|Overall Study|Progressive disease|2|||
157222460|NCT00836927|567562003|FG001|Overall Study|Progressive disease|0|||
157222461|NCT00836927|567562004|FG002|Overall Study|Progressive disease|0|||
157222462|NCT00836927|567562005|FG003|Overall Study|Progressive disease|1|||
157222463|NCT00836927|567562006|FG004|Overall Study|Progressive disease|1|||
157222464|NCT00836927|567562002|FG000|Overall Study|Withdrawal by Subject|1|||
157222465|NCT00836927|567562003|FG001|Overall Study|Withdrawal by Subject|0|||
157222466|NCT00836927|567562004|FG002|Overall Study|Withdrawal by Subject|0|||
157222467|NCT00836927|567562005|FG003|Overall Study|Withdrawal by Subject|0|||
157222468|NCT00836927|567562006|FG004|Overall Study|Withdrawal by Subject|0|||
157222469|NCT00614055|567562010|FG000|Overall Study|Adverse Event|1|||
157222470|NCT00614055|567562011|FG001|Overall Study|Adverse Event|0|||
157222471|NCT00614055|567562012|FG002|Overall Study|Adverse Event|0|||
157222472|NCT00614055|567562010|FG000|Overall Study|Protocol Violation|2|||
157222473|NCT00614055|567562011|FG001|Overall Study|Protocol Violation|2|||
157147169|NCT00641147|567285963|FG000|Completed 16 Months.|Lost to Follow-up|1|||
157147170|NCT00641147|567285964|FG001|Completed 16 Months.|Lost to Follow-up|0|||
157147171|NCT00791128|567285965|FG000|Overall Study|Adverse Event|4|||
157147172|NCT00791128|567285965|FG000|Overall Study|Device migration|2|||
157147173|NCT00791128|567285965|FG000|Overall Study|non-compliance by subject|2|||
157147174|NCT00791128|567285965|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
157147175|NCT01629667|567285966|FG000|Overall Study|Lost to Follow-up|0|||
157147176|NCT01629667|567285967|FG001|Overall Study|Lost to Follow-up|1|||
157022394|NCT03150810|566835199|FG010|Overall Study|Transferred care to oncologist|0|||
157147177|NCT01629667|567285968|FG002|Overall Study|Lost to Follow-up|1|||
157147178|NCT01629667|567285966|FG000|Overall Study|Withdrawal by Subject|31|||
157147179|NCT01629667|567285967|FG001|Overall Study|Withdrawal by Subject|20|||
157147180|NCT01629667|567285968|FG002|Overall Study|Withdrawal by Subject|28|||
157147181|NCT01629667|567285966|FG000|Overall Study|Death|1|||
157222474|NCT00614055|567562012|FG002|Overall Study|Protocol Violation|1|||
157222475|NCT00614055|567562010|FG000|Overall Study|Lack of Efficacy|0|||
157222476|NCT00614055|567562011|FG001|Overall Study|Lack of Efficacy|0|||
157147182|NCT01629667|567285967|FG001|Overall Study|Death|5|||
157147183|NCT01629667|567285968|FG002|Overall Study|Death|3|||
157222477|NCT00614055|567562012|FG002|Overall Study|Lack of Efficacy|2|||
157222478|NCT00614055|567562010|FG000|Overall Study|Unclassified|1|||
157222479|NCT00614055|567562011|FG001|Overall Study|Unclassified|4|||
157222480|NCT00614055|567562012|FG002|Overall Study|Unclassified|2|||
157222481|NCT04820842|567562015|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
157147184|NCT01629667|567285966|FG000|Overall Study|Randomized, not treated|2|||
156811787|NCT00606411|566062556|FG000|Overall Study|Move out of state|0|||
157147185|NCT01629667|567285967|FG001|Overall Study|Randomized, not treated|1|||
157222482|NCT04820842|567562016|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
157147186|NCT01629667|567285968|FG002|Overall Study|Randomized, not treated|0|||
157147187|NCT01629667|567285966|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
157147188|NCT01629667|567285967|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
157147189|NCT01629667|567285968|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
157147190|NCT01629667|567285966|FG000|Overall Study|Requiring lung transplant|2|||
157147191|NCT01629667|567285967|FG001|Overall Study|Requiring lung transplant|1|||
157147192|NCT01629667|567285968|FG002|Overall Study|Requiring lung transplant|3|||
157147193|NCT01629667|567285966|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
157147194|NCT01629667|567285967|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
157147195|NCT01629667|567285968|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
157147196|NCT01629667|567285966|FG000|Overall Study|Started other medicine|1|||
157147197|NCT01629667|567285967|FG001|Overall Study|Started other medicine|0|||
157147198|NCT01629667|567285968|FG002|Overall Study|Started other medicine|1|||
157147199|NCT01629667|567285966|FG000|Overall Study|Site error in safety follow-up|0|||
157147200|NCT01629667|567285967|FG001|Overall Study|Site error in safety follow-up|0|||
157147201|NCT01629667|567285968|FG002|Overall Study|Site error in safety follow-up|1|||
157147202|NCT01629667|567285966|FG000|Overall Study|Enrolled in another clinical study|0|||
157147203|NCT01629667|567285967|FG001|Overall Study|Enrolled in another clinical study|1|||
157147204|NCT01629667|567285968|FG002|Overall Study|Enrolled in another clinical study|0|||
157147205|NCT01629667|567285966|FG000|Overall Study|Code break|1|||
157147206|NCT01629667|567285967|FG001|Overall Study|Code break|0|||
157147207|NCT01629667|567285968|FG002|Overall Study|Code break|0|||
157147208|NCT00984659|567285969|FG000|2-week Run-in Period|Adverse Event|8|||
157147209|NCT00984659|567285970|FG001|2-week Run-in Period|Adverse Event|0|||
157147210|NCT00984659|567285971|FG002|2-week Run-in Period|Adverse Event|0|||
157147211|NCT00984659|567285972|FG003|2-week Run-in Period|Adverse Event|0|||
157147212|NCT00984659|567285969|FG000|2-week Run-in Period|Protocol Violation|5|||
157147213|NCT00984659|567285970|FG001|2-week Run-in Period|Protocol Violation|0|||
157147214|NCT00984659|567285971|FG002|2-week Run-in Period|Protocol Violation|0|||
157147215|NCT00984659|567285972|FG003|2-week Run-in Period|Protocol Violation|0|||
157147216|NCT00984659|567285969|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
157147217|NCT00984659|567285970|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
157147218|NCT00984659|567285971|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
157147219|NCT00984659|567285972|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
157147220|NCT00984659|567285969|FG000|2-week Run-in Period|Lost to Follow-up|3|||
157147221|NCT00984659|567285970|FG001|2-week Run-in Period|Lost to Follow-up|0|||
157147222|NCT00984659|567285971|FG002|2-week Run-in Period|Lost to Follow-up|0|||
157147223|NCT00984659|567285972|FG003|2-week Run-in Period|Lost to Follow-up|0|||
157147224|NCT00984659|567285969|FG000|2-week Run-in Period|Physician Decision|10|||
157147225|NCT00984659|567285970|FG001|2-week Run-in Period|Physician Decision|0|||
157147226|NCT00984659|567285971|FG002|2-week Run-in Period|Physician Decision|0|||
157147227|NCT00984659|567285972|FG003|2-week Run-in Period|Physician Decision|0|||
157147228|NCT00984659|567285969|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
157147229|NCT00984659|567285970|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
157147230|NCT00984659|567285971|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
157147231|NCT00984659|567285972|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
157147232|NCT00984659|567285969|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
157147233|NCT00984659|567285970|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
157147234|NCT00984659|567285971|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
157147235|NCT00984659|567285972|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
157147236|NCT00984659|567285969|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
157147237|NCT00984659|567285970|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
157147238|NCT00984659|567285971|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
157147239|NCT00984659|567285972|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
157147240|NCT00984659|567285969|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
157147241|NCT00984659|567285970|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
157147242|NCT00984659|567285971|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
157147243|NCT00984659|567285972|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
157147244|NCT00984659|567285969|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
157147245|NCT00984659|567285970|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
157147246|NCT00984659|567285971|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
157147247|NCT00984659|567285972|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
157147248|NCT00984659|567285969|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
157147249|NCT00984659|567285970|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
157147250|NCT00984659|567285971|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
157147251|NCT00984659|567285972|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
157147252|NCT00984659|567285969|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
157147253|NCT00984659|567285970|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
157147254|NCT00984659|567285971|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
157147255|NCT00984659|567285972|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
157147256|NCT00891657|567285974|FG000|Overall Study|Withdrawal by Subject|1|||
157147257|NCT00891657|567285975|FG001|Overall Study|Withdrawal by Subject|1|||
157147258|NCT03455543|567285981|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
157147259|NCT03455543|567285982|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
157147260|NCT03455543|567285983|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
157147261|NCT03455543|567285981|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
157147262|NCT03455543|567285982|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
157147263|NCT03455543|567285983|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
157147264|NCT03455543|567285981|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
157147265|NCT03455543|567285982|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
157147266|NCT03455543|567285983|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
157147267|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
157147268|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
157147269|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
157147270|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
157147271|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
157147272|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
157147273|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
157147274|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
157147275|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
157147276|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
157147277|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
157147278|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
157147279|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
157147280|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
157147281|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
157147282|NCT03455543|567285981|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
157147283|NCT03455543|567285982|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
157147284|NCT03455543|567285983|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
157147285|NCT01720667|567285991|FG000|Overall Study|Adverse Event|1|||
157147286|NCT01720667|567285992|FG001|Overall Study|Adverse Event|1|||
157147287|NCT01720667|567285991|FG000|Overall Study|Withdrawal by Subject|3|||
157147288|NCT01720667|567285992|FG001|Overall Study|Withdrawal by Subject|0|||
157147289|NCT02614794|567285993|FG000|Overall Study|Death|258|||
157147290|NCT02614794|567285994|FG001|Overall Study|Death|151|||
157147291|NCT02614794|567285993|FG000|Overall Study|Study closure by Sponsor|119|||
157147292|NCT02614794|567285994|FG001|Overall Study|Study closure by Sponsor|45|||
157147293|NCT02614794|567285993|FG000|Overall Study|Withdrawal by Subject|24|||
157147294|NCT02614794|567285994|FG001|Overall Study|Withdrawal by Subject|5|||
157147295|NCT02614794|567285993|FG000|Overall Study|Lost to Follow-up|7|||
157147296|NCT02614794|567285994|FG001|Overall Study|Lost to Follow-up|0|||
157147297|NCT02614794|567285993|FG000|Overall Study|Physician Decision|1|||
157147298|NCT02614794|567285994|FG001|Overall Study|Physician Decision|1|||
157147299|NCT02614794|567285993|FG000|Overall Study|Hospital closure|1|||
157147300|NCT02614794|567285994|FG001|Overall Study|Hospital closure|0|||
157147301|NCT00234104|567285995|FG000|Overall Study|Adverse Event|4|||
157147302|NCT00234104|567285996|FG001|Overall Study|Adverse Event|0|||
157147303|NCT00234104|567285997|FG002|Overall Study|Adverse Event|3|||
157147304|NCT00234104|567285998|FG003|Overall Study|Adverse Event|5|||
157147305|NCT00234104|567285995|FG000|Overall Study|Protocol Violation|0|||
157147306|NCT00234104|567285996|FG001|Overall Study|Protocol Violation|0|||
157147307|NCT00234104|567285997|FG002|Overall Study|Protocol Violation|0|||
157147308|NCT00234104|567285998|FG003|Overall Study|Protocol Violation|1|||
157147309|NCT00234104|567285995|FG000|Overall Study|Physician Decision|0|||
157147310|NCT00234104|567285996|FG001|Overall Study|Physician Decision|1|||
157147311|NCT00234104|567285997|FG002|Overall Study|Physician Decision|2|||
156811788|NCT00606411|566062557|FG001|Overall Study|Move out of state|1|||
156811789|NCT04503551|566062558|FG000|Overall Study|Withdrawal by Subject|5|||
156811790|NCT04503551|566062559|FG001|Overall Study|Withdrawal by Subject|3|||
156811791|NCT04503551|566062558|FG000|Overall Study|Physician Decision|1|||
156811792|NCT04503551|566062559|FG001|Overall Study|Physician Decision|0|||
156811793|NCT04503551|566062558|FG000|Overall Study|Death|0|||
156811794|NCT04503551|566062559|FG001|Overall Study|Death|1|||
156811795|NCT04503551|566062558|FG000|Overall Study|Lost to Follow-up|1|||
156811796|NCT04503551|566062559|FG001|Overall Study|Lost to Follow-up|2|||
156811797|NCT04503551|566062558|FG000|Overall Study|Ongoing at Week 52|99|||
156811798|NCT04503551|566062559|FG001|Overall Study|Ongoing at Week 52|62|||
157022395|NCT03150810|566835200|FG011|Overall Study|Transferred care to oncologist|0|||
157147312|NCT00234104|567285998|FG003|Overall Study|Physician Decision|2|||
156811799|NCT03726658|566062560|FG000|Overall Study|Lost to Follow-up|0|||
157022396|NCT03150810|566835201|FG012|Overall Study|Transferred care to oncologist|0|||
156811800|NCT03726658|566062561|FG001|Overall Study|Lost to Follow-up|0|||
156883554|NCT00065429|566332583|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
156883555|NCT00065429|566332577|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
156883556|NCT00065429|566332578|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883557|NCT00065429|566332579|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883558|NCT00065429|566332580|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883559|NCT00065429|566332581|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883560|NCT00065429|566332582|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883561|NCT00065429|566332583|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
156883562|NCT00065429|566332577|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
156883563|NCT00065429|566332578|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
156883564|NCT00065429|566332579|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
156883565|NCT00065429|566332580|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
156883566|NCT00065429|566332581|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
156883567|NCT00065429|566332582|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
156883568|NCT00065429|566332583|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
156883569|NCT00065429|566332577|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156883570|NCT00065429|566332578|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156883571|NCT00065429|566332579|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156883572|NCT00065429|566332580|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
156883573|NCT00065429|566332581|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
156883574|NCT00065429|566332582|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
156883575|NCT00065429|566332583|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
156883576|NCT00065429|566332577|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883577|NCT00065429|566332578|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883578|NCT00065429|566332579|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883579|NCT00065429|566332580|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883580|NCT00065429|566332581|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
156883581|NCT00065429|566332582|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883582|NCT00065429|566332583|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
156883583|NCT00065429|566332577|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883584|NCT00065429|566332578|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883585|NCT00065429|566332579|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883586|NCT00065429|566332580|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883587|NCT00065429|566332581|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
156883588|NCT00065429|566332582|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883589|NCT00065429|566332583|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
156883590|NCT00441116|566332585|FG000|Overall Study|Adverse Event|1|||
156883591|NCT00441116|566332586|FG001|Overall Study|Adverse Event|1|||
156883592|NCT00441116|566332585|FG000|Overall Study|Withdrawal by Subject|1|||
156883593|NCT00441116|566332586|FG001|Overall Study|Withdrawal by Subject|0|||
156883594|NCT00441116|566332585|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
156883595|NCT00441116|566332586|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
156883596|NCT00636363|566332589|FG000|Overall Study|Conjunctivitis|0|||
156883597|NCT00636363|566332590|FG001|Overall Study|Conjunctivitis|0|||
156883598|NCT00636363|566332591|FG002|Overall Study|Conjunctivitis|1|||
156883599|NCT00636363|566332589|FG000|Overall Study|Adverse Event|0|||
156883600|NCT00636363|566332590|FG001|Overall Study|Adverse Event|0|||
156883601|NCT00636363|566332591|FG002|Overall Study|Adverse Event|1|||
156883602|NCT00636363|566332589|FG000|Overall Study|Positive slit lamp finding|0|||
156883603|NCT00636363|566332590|FG001|Overall Study|Positive slit lamp finding|2|||
156883604|NCT00636363|566332591|FG002|Overall Study|Positive slit lamp finding|1|||
156883605|NCT00636363|566332589|FG000|Overall Study|Study related symptoms/complaints|8|||
156883606|NCT00636363|566332590|FG001|Overall Study|Study related symptoms/complaints|7|||
156883607|NCT00636363|566332591|FG002|Overall Study|Study related symptoms/complaints|4|||
156883608|NCT00636363|566332589|FG000|Overall Study|Met ineligibility criteria|0|||
156883609|NCT00636363|566332590|FG001|Overall Study|Met ineligibility criteria|0|||
156883610|NCT00636363|566332591|FG002|Overall Study|Met ineligibility criteria|3|||
156883611|NCT00636363|566332589|FG000|Overall Study|Missed > 1 visit|0|||
156883612|NCT00636363|566332590|FG001|Overall Study|Missed > 1 visit|1|||
156883613|NCT00636363|566332591|FG002|Overall Study|Missed > 1 visit|3|||
156883614|NCT00636363|566332589|FG000|Overall Study|Lack of motivation|1|||
156883615|NCT00636363|566332590|FG001|Overall Study|Lack of motivation|0|||
156883616|NCT00636363|566332591|FG002|Overall Study|Lack of motivation|1|||
156883617|NCT00636363|566332589|FG000|Overall Study|Protocol Violation|0|||
156883618|NCT00636363|566332590|FG001|Overall Study|Protocol Violation|3|||
156883619|NCT00636363|566332591|FG002|Overall Study|Protocol Violation|0|||
156883620|NCT00636363|566332589|FG000|Overall Study|Lost to Follow-up|3|||
156883621|NCT00636363|566332590|FG001|Overall Study|Lost to Follow-up|4|||
156883622|NCT00636363|566332591|FG002|Overall Study|Lost to Follow-up|2|||
156883623|NCT00636363|566332589|FG000|Overall Study|Withdrawal by Subject|1|||
156883624|NCT00636363|566332590|FG001|Overall Study|Withdrawal by Subject|3|||
156883625|NCT00636363|566332591|FG002|Overall Study|Withdrawal by Subject|2|||
156883626|NCT00029146|566332594|FG000|Overall Study|Lost to Follow-up|2|||
156883627|NCT00029146|566332595|FG001|Overall Study|Lost to Follow-up|1|||
157222483|NCT04820842|567562017|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
157222484|NCT04820842|567562018|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
157222485|NCT04820842|567562019|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
157222486|NCT04820842|567562020|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
157222487|NCT04820842|567562021|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
157222488|NCT04820842|567562015|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
157222489|NCT04820842|567562016|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
157222490|NCT04820842|567562017|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
157222491|NCT04820842|567562018|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222492|NCT04820842|567562019|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222493|NCT04820842|567562020|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222494|NCT04820842|567562021|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222495|NCT04820842|567562015|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
157222496|NCT04820842|567562016|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
156811801|NCT03726658|566062562|FG002|Overall Study|Lost to Follow-up|2|||
156811802|NCT03726658|566062563|FG003|Overall Study|Lost to Follow-up|0|||
156811803|NCT03726658|566062564|FG004|Overall Study|Lost to Follow-up|0|||
157022397|NCT04526704|566835202|FG000|Overall Study|Adverse Event|1|||
157147313|NCT02052960|567286000|FG000|Overall Study|Adverse Event|19|||
157147314|NCT02052960|567286001|FG001|Overall Study|Adverse Event|17|||
157147315|NCT02052960|567286000|FG000|Overall Study|Protocol Violation|4|||
157147316|NCT02052960|567286001|FG001|Overall Study|Protocol Violation|3|||
157147317|NCT02052960|567286000|FG000|Overall Study|Withdrawal by Subject|6|||
157147318|NCT02052960|567286001|FG001|Overall Study|Withdrawal by Subject|11|||
157147319|NCT02052960|567286000|FG000|Overall Study|Other|25|||
157147320|NCT02052960|567286001|FG001|Overall Study|Other|15|||
157147321|NCT04045613|567286002|FG000|Overall Study|Adverse Event|2|||
157147322|NCT04045613|567286003|FG001|Overall Study|Adverse Event|2|||
157147323|NCT04045613|567286004|FG002|Overall Study|Adverse Event|1|||
157147324|NCT04045613|567286005|FG003|Overall Study|Adverse Event|1|||
157147325|NCT04045613|567286006|FG004|Overall Study|Adverse Event|0|||
157147326|NCT04045613|567286007|FG005|Overall Study|Adverse Event|0|||
157147327|NCT04045613|567286008|FG006|Overall Study|Adverse Event|1|||
157147328|NCT04045613|567286002|FG000|Overall Study|Withdrawal by Subject|0|||
157147329|NCT04045613|567286003|FG001|Overall Study|Withdrawal by Subject|5|||
157147330|NCT04045613|567286004|FG002|Overall Study|Withdrawal by Subject|0|||
157147331|NCT04045613|567286005|FG003|Overall Study|Withdrawal by Subject|0|||
157147332|NCT04045613|567286006|FG004|Overall Study|Withdrawal by Subject|0|||
157147333|NCT04045613|567286007|FG005|Overall Study|Withdrawal by Subject|1|||
157147334|NCT04045613|567286008|FG006|Overall Study|Withdrawal by Subject|0|||
157147335|NCT04045613|567286002|FG000|Overall Study|Physician Decision|2|||
157147336|NCT04045613|567286003|FG001|Overall Study|Physician Decision|0|||
157147337|NCT04045613|567286004|FG002|Overall Study|Physician Decision|0|||
157147338|NCT04045613|567286005|FG003|Overall Study|Physician Decision|0|||
157147339|NCT04045613|567286006|FG004|Overall Study|Physician Decision|1|||
157147340|NCT04045613|567286007|FG005|Overall Study|Physician Decision|0|||
157147341|NCT04045613|567286008|FG006|Overall Study|Physician Decision|0|||
157147342|NCT04045613|567286002|FG000|Overall Study|Death|3|||
157147343|NCT04045613|567286003|FG001|Overall Study|Death|0|||
157147344|NCT04045613|567286004|FG002|Overall Study|Death|0|||
157147345|NCT04045613|567286005|FG003|Overall Study|Death|0|||
157147346|NCT04045613|567286006|FG004|Overall Study|Death|0|||
157147347|NCT04045613|567286007|FG005|Overall Study|Death|0|||
157147348|NCT04045613|567286008|FG006|Overall Study|Death|1|||
157147349|NCT04045613|567286002|FG000|Overall Study|Other reasons|0|||
157147350|NCT04045613|567286003|FG001|Overall Study|Other reasons|1|||
157147351|NCT04045613|567286004|FG002|Overall Study|Other reasons|0|||
157147352|NCT04045613|567286005|FG003|Overall Study|Other reasons|0|||
157147353|NCT04045613|567286006|FG004|Overall Study|Other reasons|0|||
157147354|NCT04045613|567286007|FG005|Overall Study|Other reasons|0|||
157147355|NCT04045613|567286008|FG006|Overall Study|Other reasons|1|||
157147356|NCT04045613|567286002|FG000|Overall Study|Progressive disease: Clinical progression|1|||
157147357|NCT04045613|567286003|FG001|Overall Study|Progressive disease: Clinical progression|0|||
157147358|NCT04045613|567286004|FG002|Overall Study|Progressive disease: Clinical progression|3|||
156811804|NCT03726658|566062565|FG005|Overall Study|Lost to Follow-up|1|||
157147359|NCT04045613|567286005|FG003|Overall Study|Progressive disease: Clinical progression|1|||
157147360|NCT04045613|567286006|FG004|Overall Study|Progressive disease: Clinical progression|1|||
157147361|NCT04045613|567286007|FG005|Overall Study|Progressive disease: Clinical progression|3|||
157147362|NCT04045613|567286008|FG006|Overall Study|Progressive disease: Clinical progression|3|||
157147363|NCT04045613|567286002|FG000|Overall Study|Progressive disease: Radiological progression|24|||
156811805|NCT03726658|566062566|FG006|Overall Study|Lost to Follow-up|1|||
157147364|NCT04045613|567286003|FG001|Overall Study|Progressive disease: Radiological progression|6|||
157147365|NCT04045613|567286004|FG002|Overall Study|Progressive disease: Radiological progression|8|||
157147366|NCT04045613|567286005|FG003|Overall Study|Progressive disease: Radiological progression|0|||
157147367|NCT04045613|567286006|FG004|Overall Study|Progressive disease: Radiological progression|6|||
157147368|NCT04045613|567286007|FG005|Overall Study|Progressive disease: Radiological progression|6|||
157147369|NCT04045613|567286008|FG006|Overall Study|Progressive disease: Radiological progression|11|||
157147370|NCT03633331|567286019|FG000|Overall Study|Withdrawal by Subject|1|||
157147371|NCT03240081|567286020|FG000|Overall Study|Withdrawal by Subject|0|||
156811806|NCT03726658|566062560|FG000|Overall Study|Withdrawal by Subject|1|||
156811807|NCT03726658|566062561|FG001|Overall Study|Withdrawal by Subject|0|||
156811808|NCT03726658|566062562|FG002|Overall Study|Withdrawal by Subject|0|||
156811809|NCT03726658|566062563|FG003|Overall Study|Withdrawal by Subject|0|||
156811810|NCT03726658|566062564|FG004|Overall Study|Withdrawal by Subject|6|||
156811811|NCT03726658|566062565|FG005|Overall Study|Withdrawal by Subject|4|||
156811812|NCT03726658|566062566|FG006|Overall Study|Withdrawal by Subject|2|||
156811813|NCT03726658|566062560|FG000|Overall Study|Pregnancy|0|||
156811814|NCT03726658|566062561|FG001|Overall Study|Pregnancy|0|||
156811815|NCT03726658|566062562|FG002|Overall Study|Pregnancy|0|||
156811816|NCT03726658|566062563|FG003|Overall Study|Pregnancy|0|||
156811817|NCT03726658|566062564|FG004|Overall Study|Pregnancy|0|||
156811818|NCT03726658|566062565|FG005|Overall Study|Pregnancy|0|||
156811819|NCT03726658|566062566|FG006|Overall Study|Pregnancy|1|||
156811820|NCT03726658|566062560|FG000|Overall Study|Not Reported|0|||
156811821|NCT03726658|566062561|FG001|Overall Study|Not Reported|0|||
156811822|NCT03726658|566062562|FG002|Overall Study|Not Reported|0|||
156811823|NCT03726658|566062563|FG003|Overall Study|Not Reported|0|||
156811824|NCT03726658|566062564|FG004|Overall Study|Not Reported|0|||
156811825|NCT03726658|566062565|FG005|Overall Study|Not Reported|0|||
156811826|NCT03726658|566062566|FG006|Overall Study|Not Reported|1|||
156811827|NCT00412958|566062567|FG000|Overall Study|Withdrawal by Subject|3|||
156811828|NCT00412958|566062568|FG001|Overall Study|Withdrawal by Subject|0|||
156811829|NCT00412958|566062569|FG002|Overall Study|Withdrawal by Subject|0|||
156811830|NCT00412958|566062570|FG003|Overall Study|Withdrawal by Subject|1|||
156811831|NCT00412958|566062567|FG000|Overall Study|Adverse Event|0|||
156811832|NCT00412958|566062568|FG001|Overall Study|Adverse Event|1|||
156811833|NCT00412958|566062569|FG002|Overall Study|Adverse Event|0|||
156811834|NCT00412958|566062570|FG003|Overall Study|Adverse Event|0|||
156811835|NCT00412958|566062567|FG000|Overall Study|Lost to Follow-up|0|||
156811836|NCT00412958|566062568|FG001|Overall Study|Lost to Follow-up|1|||
156811837|NCT00412958|566062569|FG002|Overall Study|Lost to Follow-up|0|||
156811838|NCT00412958|566062570|FG003|Overall Study|Lost to Follow-up|0|||
156811839|NCT00412958|566062567|FG000|Overall Study|Death|0|||
156811840|NCT00412958|566062568|FG001|Overall Study|Death|1|||
156811841|NCT00412958|566062569|FG002|Overall Study|Death|0|||
156811842|NCT00412958|566062570|FG003|Overall Study|Death|0|||
156811843|NCT00412958|566062567|FG000|Overall Study|Transport issue|0|||
156811844|NCT00412958|566062568|FG001|Overall Study|Transport issue|1|||
156811845|NCT00412958|566062569|FG002|Overall Study|Transport issue|0|||
156811846|NCT00412958|566062570|FG003|Overall Study|Transport issue|0|||
156811847|NCT01318135|566062571|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
156811848|NCT01318135|566062572|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811849|NCT01318135|566062573|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811850|NCT01318135|566062574|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811851|NCT01318135|566062575|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811852|NCT01318135|566062576|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811853|NCT01318135|566062577|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811854|NCT01318135|566062578|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156811855|NCT01318135|566062571|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
156811856|NCT01318135|566062572|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811857|NCT01318135|566062573|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811858|NCT01318135|566062574|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811859|NCT01318135|566062575|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811860|NCT01318135|566062576|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
157147372|NCT03240081|567286021|FG001|Overall Study|Withdrawal by Subject|2|||
157147373|NCT03240081|567286020|FG000|Overall Study|Lost to Follow-up|0|||
157147374|NCT03240081|567286021|FG001|Overall Study|Lost to Follow-up|1|||
156811861|NCT01318135|566062577|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
156811862|NCT01318135|566062578|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
157147375|NCT00949650|567286022|FG000|Overall Study|Progressive disease|188|||
156811863|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
156811864|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
156811865|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
156811866|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
157222497|NCT04820842|567562017|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
157222498|NCT04820842|567562018|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
157222499|NCT04820842|567562019|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
157222500|NCT04820842|567562020|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
156883628|NCT01765218|566332596|FG000|Overall Study|Protocol Violation|1|||
156883629|NCT01765218|566332597|FG001|Overall Study|Protocol Violation|2|||
156883630|NCT01590758|566332598|FG000|Overall Study|Withdrawal by Subject|0|||
157022398|NCT04526704|566835203|FG001|Overall Study|Adverse Event|0|||
157147376|NCT00949650|567286023|FG001|Overall Study|Progressive disease|19|||
157147377|NCT00949650|567286022|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
157147378|NCT00949650|567286023|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
157147379|NCT00949650|567286022|FG000|Overall Study|Other Adverse Event (AE)|28|||
157147380|NCT00949650|567286023|FG001|Overall Study|Other Adverse Event (AE)|17|||
157147381|NCT00949650|567286022|FG000|Overall Study|Protocol Violation|1|||
157147382|NCT00949650|567286023|FG001|Overall Study|Protocol Violation|4|||
157147383|NCT00949650|567286022|FG000|Overall Study|Refusal to continue medication|7|||
157147384|NCT00949650|567286023|FG001|Overall Study|Refusal to continue medication|11|||
157147385|NCT00949650|567286022|FG000|Overall Study|Not treated|1|||
157147386|NCT00949650|567286023|FG001|Overall Study|Not treated|4|||
157147387|NCT00949650|567286022|FG000|Overall Study|Other not specified above|5|||
157147388|NCT00949650|567286023|FG001|Overall Study|Other not specified above|0|||
157147389|NCT03671369|567286026|FG000|Overall Study|Other|1|||
157147390|NCT03671369|567286026|FG000|Overall Study|Withdrawal by Subject|289|||
157147391|NCT03671369|567286026|FG000|Overall Study|Not willing to be vaccinated|1|||
157147392|NCT01507545|567286031|FG000|Overall Study|Withdrawal by Subject|6|||
157147393|NCT01507545|567286032|FG001|Overall Study|Withdrawal by Subject|2|||
157147394|NCT01507545|567286031|FG000|Overall Study|Lost to Follow-up|1|||
157147395|NCT01507545|567286032|FG001|Overall Study|Lost to Follow-up|0|||
157147396|NCT01507545|567286031|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
157147397|NCT01507545|567286032|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
157147398|NCT01507545|567286031|FG000|Overall Study|Progressive disease|60|||
157147399|NCT01507545|567286032|FG001|Overall Study|Progressive disease|27|||
157147400|NCT01507545|567286031|FG000|Overall Study|Other|6|||
157147401|NCT01507545|567286032|FG001|Overall Study|Other|4|||
157147402|NCT00790296|567286033|FG000|Overall Study|Did not meet study eligibility criteria|1|||
157147403|NCT00790296|567286034|FG001|Overall Study|Did not meet study eligibility criteria|1|||
157147404|NCT00790296|567286033|FG000|Overall Study|Adverse Event|0|||
157147405|NCT00790296|567286034|FG001|Overall Study|Adverse Event|1|||
157147406|NCT00553787|567286035|FG000|Overall Study|Adverse Event|34|||
157147407|NCT00553787|567286036|FG001|Overall Study|Adverse Event|21|||
157147408|NCT00553787|567286037|FG002|Overall Study|Adverse Event|67|||
157147409|NCT00553787|567286035|FG000|Overall Study|Lost to Follow-up|132|||
157147410|NCT00553787|567286036|FG001|Overall Study|Lost to Follow-up|44|||
157147411|NCT00553787|567286037|FG002|Overall Study|Lost to Follow-up|78|||
157147412|NCT00553787|567286035|FG000|Overall Study|Withdrawal by Subject|151|||
157147413|NCT00553787|567286036|FG001|Overall Study|Withdrawal by Subject|40|||
157147414|NCT00553787|567286037|FG002|Overall Study|Withdrawal by Subject|83|||
157147415|NCT00553787|567286035|FG000|Overall Study|Lack of Efficacy|31|||
157147416|NCT00553787|567286036|FG001|Overall Study|Lack of Efficacy|1|||
157147417|NCT00553787|567286037|FG002|Overall Study|Lack of Efficacy|3|||
157147418|NCT00553787|567286035|FG000|Overall Study|Pregnancy|0|||
157147419|NCT00553787|567286036|FG001|Overall Study|Pregnancy|1|||
157147420|NCT00553787|567286037|FG002|Overall Study|Pregnancy|2|||
157147421|NCT00553787|567286035|FG000|Overall Study|non compliance|4|||
157147422|NCT00553787|567286036|FG001|Overall Study|non compliance|0|||
157147423|NCT00553787|567286037|FG002|Overall Study|non compliance|11|||
157147424|NCT00553787|567286035|FG000|Overall Study|Requirement for restricted medication|8|||
157147425|NCT00553787|567286036|FG001|Overall Study|Requirement for restricted medication|7|||
157147426|NCT00553787|567286037|FG002|Overall Study|Requirement for restricted medication|5|||
157147427|NCT00553787|567286035|FG000|Overall Study|Other|18|||
157147428|NCT00553787|567286036|FG001|Overall Study|Other|10|||
157147429|NCT00553787|567286037|FG002|Overall Study|Other|13|||
157147430|NCT01088412|567286038|FG000|Overall Study|Adverse Event|38|||
157147431|NCT01088412|567286039|FG001|Overall Study|Adverse Event|0|||
157147432|NCT01088412|567286040|FG002|Overall Study|Adverse Event|0|||
157147433|NCT01088412|567286038|FG000|Overall Study|Death|42|||
157147434|NCT01088412|567286039|FG001|Overall Study|Death|6|||
157147435|NCT01088412|567286040|FG002|Overall Study|Death|0|||
157147436|NCT01088412|567286038|FG000|Overall Study|Other Reason per Case Report Form|2089|||
157147437|NCT01088412|567286039|FG001|Overall Study|Other Reason per Case Report Form|103|||
156883631|NCT01590758|566332599|FG001|Overall Study|Withdrawal by Subject|3|||
157147438|NCT01088412|567286040|FG002|Overall Study|Other Reason per Case Report Form|9|||
157147439|NCT01088412|567286038|FG000|Overall Study|Withdrawal by Subject|1761|||
157147440|NCT01088412|567286039|FG001|Overall Study|Withdrawal by Subject|25|||
157147441|NCT01088412|567286040|FG002|Overall Study|Withdrawal by Subject|1|||
157147442|NCT01088412|567286038|FG000|Overall Study|Received Another GH Product|79|||
157147443|NCT01088412|567286039|FG001|Overall Study|Received Another GH Product|0|||
156883632|NCT01590758|566332598|FG000|Overall Study|Physician Decision|1|||
156883633|NCT01590758|566332599|FG001|Overall Study|Physician Decision|2|||
156883634|NCT01590758|566332598|FG000|Overall Study|Lost to Follow-up|4|||
156883635|NCT01590758|566332599|FG001|Overall Study|Lost to Follow-up|2|||
156883636|NCT02756806|566332600|FG000|Overall Study|Study terminated early|5|||
156883637|NCT02228980|566332601|FG000|Overall Study|Adverse Event|14|||
156883638|NCT02228980|566332602|FG001|Overall Study|Adverse Event|0|||
156883639|NCT02228980|566332603|FG002|Overall Study|Adverse Event|0|||
156883640|NCT02228980|566332604|FG003|Overall Study|Adverse Event|0|||
156883641|NCT02228980|566332601|FG000|Overall Study|Protocol Violation|7|||
156883642|NCT02228980|566332602|FG001|Overall Study|Protocol Violation|0|||
156883643|NCT02228980|566332603|FG002|Overall Study|Protocol Violation|0|||
156883644|NCT02228980|566332604|FG003|Overall Study|Protocol Violation|0|||
156883645|NCT02228980|566332601|FG000|Overall Study|Withdrawal by Subject|3|||
156883646|NCT02228980|566332602|FG001|Overall Study|Withdrawal by Subject|3|||
156883647|NCT02228980|566332603|FG002|Overall Study|Withdrawal by Subject|2|||
156883648|NCT02228980|566332604|FG003|Overall Study|Withdrawal by Subject|3|||
157147444|NCT01088412|567286040|FG002|Overall Study|Received Another GH Product|0|||
157222501|NCT04820842|567562021|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
157222502|NCT04820842|567562015|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222503|NCT04820842|567562016|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222504|NCT04820842|567562017|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222505|NCT04820842|567562018|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
157222506|NCT04820842|567562019|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222507|NCT04820842|567562020|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
157222508|NCT04820842|567562021|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
157222509|NCT01691508|567562022|FG000|Overall Study|Adverse Event|3|||
157222510|NCT01691508|567562023|FG001|Overall Study|Adverse Event|3|||
157222511|NCT01691508|567562022|FG000|Overall Study|Withdrawal by Subject|1|||
157222512|NCT01691508|567562023|FG001|Overall Study|Withdrawal by Subject|0|||
157222513|NCT01296932|567562024|FG000|Overall Study|Dose limiting toxicity|0|||
157222514|NCT01296932|567562025|FG001|Overall Study|Dose limiting toxicity|0|||
157222515|NCT01296932|567562026|FG002|Overall Study|Dose limiting toxicity|0|||
157222516|NCT01296932|567562027|FG003|Overall Study|Dose limiting toxicity|0|||
157222517|NCT01296932|567562028|FG004|Overall Study|Dose limiting toxicity|0|||
157222518|NCT01296932|567562029|FG005|Overall Study|Dose limiting toxicity|0|||
157222519|NCT01296932|567562030|FG006|Overall Study|Dose limiting toxicity|1|||
157222520|NCT01296932|567562031|FG007|Overall Study|Dose limiting toxicity|0|||
157222521|NCT01296932|567562032|FG008|Overall Study|Dose limiting toxicity|1|||
157222522|NCT01296932|567562024|FG000|Overall Study|Progressive disease|2|||
157222523|NCT01296932|567562025|FG001|Overall Study|Progressive disease|0|||
157222524|NCT01296932|567562026|FG002|Overall Study|Progressive disease|1|||
157222525|NCT01296932|567562027|FG003|Overall Study|Progressive disease|1|||
157222526|NCT01296932|567562028|FG004|Overall Study|Progressive disease|2|||
157222527|NCT01296932|567562029|FG005|Overall Study|Progressive disease|3|||
156883649|NCT02929498|566332605|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
156883650|NCT02929498|566332606|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
157147445|NCT01088412|567286038|FG000|Overall Study|Participant Moved|601|||
157147446|NCT01088412|567286039|FG001|Overall Study|Participant Moved|21|||
157147447|NCT01088412|567286040|FG002|Overall Study|Participant Moved|2|||
157147448|NCT01088412|567286038|FG000|Overall Study|Physician Decision|1041|||
157147449|NCT01088412|567286039|FG001|Overall Study|Physician Decision|8|||
157147450|NCT01088412|567286040|FG002|Overall Study|Physician Decision|4|||
157147451|NCT01088412|567286038|FG000|Overall Study|Sponsor Decision|4467|||
157147452|NCT01088412|567286039|FG001|Overall Study|Sponsor Decision|79|||
157147453|NCT01088412|567286040|FG002|Overall Study|Sponsor Decision|23|||
157147454|NCT01088412|567286038|FG000|Overall Study|Third Party Required to Change Brand|487|||
157147455|NCT01088412|567286039|FG001|Overall Study|Third Party Required to Change Brand|0|||
157147456|NCT01088412|567286040|FG002|Overall Study|Third Party Required to Change Brand|0|||
157147457|NCT01088412|567286038|FG000|Overall Study|Lost to Follow-up|3052|||
157147458|NCT01088412|567286039|FG001|Overall Study|Lost to Follow-up|130|||
157147459|NCT01088412|567286040|FG002|Overall Study|Lost to Follow-up|11|||
157147460|NCT01088412|567286038|FG000|Overall Study|Study Summary Not Completed|4360|||
157147461|NCT01088412|567286039|FG001|Overall Study|Study Summary Not Completed|64|||
157147462|NCT01088412|567286040|FG002|Overall Study|Study Summary Not Completed|22|||
157147463|NCT02619253|567286041|FG000|Overall Study|Adverse Event|0|||
157147464|NCT02619253|567286042|FG001|Overall Study|Adverse Event|0|||
157147465|NCT02619253|567286043|FG002|Overall Study|Adverse Event|1|||
157147466|NCT02619253|567286044|FG003|Overall Study|Adverse Event|1|||
157147467|NCT02619253|567286045|FG004|Overall Study|Adverse Event|3|||
157147468|NCT02619253|567286041|FG000|Overall Study|Alternative Therapy|0|||
157222528|NCT01296932|567562030|FG006|Overall Study|Progressive disease|1|||
157022399|NCT04526704|566835202|FG000|Overall Study|Physician Decision|1|||
157147469|NCT02619253|567286042|FG001|Overall Study|Alternative Therapy|0|||
157147470|NCT02619253|567286043|FG002|Overall Study|Alternative Therapy|1|||
157147471|NCT02619253|567286044|FG003|Overall Study|Alternative Therapy|0|||
157147472|NCT02619253|567286045|FG004|Overall Study|Alternative Therapy|0|||
157147473|NCT02619253|567286041|FG000|Overall Study|Death|0|||
157147474|NCT02619253|567286042|FG001|Overall Study|Death|0|||
157147475|NCT02619253|567286043|FG002|Overall Study|Death|0|||
157147476|NCT02619253|567286044|FG003|Overall Study|Death|1|||
157147477|NCT02619253|567286045|FG004|Overall Study|Death|0|||
157147478|NCT02619253|567286041|FG000|Overall Study|Disease Progression|4|||
157147479|NCT02619253|567286042|FG001|Overall Study|Disease Progression|2|||
157147480|NCT02619253|567286043|FG002|Overall Study|Disease Progression|8|||
157147481|NCT02619253|567286044|FG003|Overall Study|Disease Progression|9|||
157147482|NCT02619253|567286045|FG004|Overall Study|Disease Progression|10|||
157147483|NCT02619253|567286041|FG000|Overall Study|Needed a disqualifying therapy|0|||
157147484|NCT02619253|567286042|FG001|Overall Study|Needed a disqualifying therapy|0|||
157147485|NCT02619253|567286043|FG002|Overall Study|Needed a disqualifying therapy|1|||
157147486|NCT02619253|567286044|FG003|Overall Study|Needed a disqualifying therapy|0|||
157147487|NCT02619253|567286045|FG004|Overall Study|Needed a disqualifying therapy|0|||
157147488|NCT02619253|567286041|FG000|Overall Study|Transferred to hospice|0|||
157147489|NCT02619253|567286042|FG001|Overall Study|Transferred to hospice|0|||
157147490|NCT02619253|567286043|FG002|Overall Study|Transferred to hospice|1|||
157147491|NCT02619253|567286044|FG003|Overall Study|Transferred to hospice|0|||
157147492|NCT02619253|567286045|FG004|Overall Study|Transferred to hospice|0|||
157147493|NCT02619253|567286041|FG000|Overall Study|Physician Decision|0|||
157147494|NCT02619253|567286042|FG001|Overall Study|Physician Decision|1|||
157147495|NCT02619253|567286043|FG002|Overall Study|Physician Decision|2|||
157147496|NCT02619253|567286044|FG003|Overall Study|Physician Decision|3|||
157147497|NCT02619253|567286045|FG004|Overall Study|Physician Decision|0|||
157147498|NCT02619253|567286041|FG000|Overall Study|Withdrawal by Subject|0|||
157147499|NCT02619253|567286042|FG001|Overall Study|Withdrawal by Subject|1|||
157147500|NCT02619253|567286043|FG002|Overall Study|Withdrawal by Subject|0|||
157147501|NCT02619253|567286044|FG003|Overall Study|Withdrawal by Subject|0|||
157147502|NCT02619253|567286045|FG004|Overall Study|Withdrawal by Subject|2|||
157147503|NCT00301067|567286046|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
157147504|NCT00301067|567286047|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
157147505|NCT00301067|567286048|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
157147506|NCT00301067|567286049|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
157147507|NCT00301067|567286046|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
157147508|NCT00301067|567286047|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
157147509|NCT00301067|567286048|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
157147510|NCT00301067|567286049|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
157147511|NCT00301067|567286046|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
157147512|NCT00301067|567286047|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
157147513|NCT00301067|567286048|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
157147514|NCT00301067|567286049|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
157222529|NCT01296932|567562031|FG007|Overall Study|Progressive disease|0|||
156811867|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
156811868|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
156811869|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
156811870|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
156811871|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811872|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811873|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811874|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811875|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
156811876|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811877|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811878|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
156811879|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811880|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811881|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
156811882|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156811883|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
157147515|NCT00301067|567286046|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
157147516|NCT00301067|567286047|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
157147517|NCT00301067|567286048|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
157147518|NCT00301067|567286049|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
157147519|NCT00301067|567286046|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
157147520|NCT00301067|567286047|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
156883651|NCT02929498|566332607|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
156883652|NCT02929498|566332605|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
156883653|NCT02929498|566332606|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
156883654|NCT02929498|566332607|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
156883655|NCT03288142|566332609|FG000|Overall Study|Lost to Follow-up|22|||
156883656|NCT03288142|566332610|FG001|Overall Study|Lost to Follow-up|15|||
156883657|NCT02034409|566332611|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
156883658|NCT02034409|566332612|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
157022400|NCT04526704|566835203|FG001|Overall Study|Physician Decision|0|||
157022401|NCT04526704|566835202|FG000|Overall Study|Withdrawal by Subject|2|||
157022402|NCT04526704|566835203|FG001|Overall Study|Withdrawal by Subject|0|||
157022403|NCT05116787|566835204|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
157147521|NCT00301067|567286048|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
157147522|NCT00301067|567286049|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
157147523|NCT00301067|567286046|FG000|Follow up Until Death|Alive at last data cut point|1|||
157147524|NCT00301067|567286047|FG001|Follow up Until Death|Alive at last data cut point|0|||
157147525|NCT00301067|567286048|FG002|Follow up Until Death|Alive at last data cut point|0|||
157147526|NCT00301067|567286049|FG003|Follow up Until Death|Alive at last data cut point|1|||
157147527|NCT00149825|567286050|FG000|Overall Study|Intolerance to medication side effects|1|||
157147528|NCT00149825|567286051|FG001|Overall Study|Intolerance to medication side effects|2|||
157147529|NCT00149825|567286050|FG000|Overall Study|Time commitments|2|||
157147530|NCT00149825|567286051|FG001|Overall Study|Time commitments|1|||
157147531|NCT00149825|567286050|FG000|Overall Study|Not liking insomnia therapy|1|||
157147532|NCT00149825|567286051|FG001|Overall Study|Not liking insomnia therapy|0|||
157147533|NCT00149825|567286050|FG000|Overall Study|Other|1|||
157147534|NCT00149825|567286051|FG001|Overall Study|Other|0|||
157147535|NCT05593432|567286052|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
157147536|NCT05593432|567286053|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
157147537|NCT05593432|567286054|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
157147538|NCT05593432|567286055|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
157147539|NCT05593432|567286052|FG000|16-Week OLE Period|Lack of Efficacy|0|||
157147540|NCT05593432|567286053|FG001|16-Week OLE Period|Lack of Efficacy|0|||
157147541|NCT05593432|567286054|FG002|16-Week OLE Period|Lack of Efficacy|0|||
157147542|NCT05593432|567286055|FG003|16-Week OLE Period|Lack of Efficacy|1|||
157147543|NCT05593432|567286052|FG000|16-Week OLE Period|Lost to Follow-up|0|||
157147544|NCT05593432|567286053|FG001|16-Week OLE Period|Lost to Follow-up|0|||
157147545|NCT05593432|567286054|FG002|16-Week OLE Period|Lost to Follow-up|1|||
157147546|NCT05593432|567286055|FG003|16-Week OLE Period|Lost to Follow-up|2|||
157147547|NCT05593432|567286052|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
157147548|NCT05593432|567286053|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
157147549|NCT05593432|567286054|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
157147550|NCT05593432|567286055|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
157147551|NCT05897853|567286057|FG000|Overall Study|Lost to Follow-up|2|||
157147552|NCT05897853|567286058|FG001|Overall Study|Lost to Follow-up|0|||
157147553|NCT05897853|567286057|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
157147554|NCT05897853|567286058|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
157147555|NCT02100657|567287132|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
157147556|NCT02100657|567287133|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
157147557|NCT02100657|567287134|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
157147558|NCT02100657|567287132|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
157147559|NCT02100657|567287133|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
157147560|NCT02100657|567287134|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
157147561|NCT02100657|567287132|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
157147562|NCT02100657|567287133|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
157147563|NCT02100657|567287134|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
157147564|NCT02100657|567287132|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
157147565|NCT02100657|567287133|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
157147566|NCT02100657|567287134|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
157147567|NCT02100657|567287132|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
157147568|NCT02100657|567287133|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
157147569|NCT02100657|567287134|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
157147570|NCT02100657|567287132|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
157147571|NCT02100657|567287133|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
157147572|NCT02100657|567287134|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
157147573|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
157147574|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
157147575|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
157147576|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Death|0|||
157147577|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Death|0|||
157147578|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Death|1|||
157147579|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
157022404|NCT05116787|566835205|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
157147580|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
157147581|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
157147582|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
157147583|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
157147584|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
157147585|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
157147586|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
157147587|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
157147588|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
157147589|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
157147590|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
157147591|NCT02100657|567287132|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
157147592|NCT02100657|567287133|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
157147593|NCT02100657|567287134|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
157147594|NCT01543490|567287141|FG000|Overall Study|Adverse Event|4|||
157147595|NCT01543490|567287142|FG001|Overall Study|Adverse Event|0|||
157147596|NCT01543490|567287141|FG000|Overall Study|Physician Decision|1|||
157147597|NCT01543490|567287142|FG001|Overall Study|Physician Decision|0|||
157147598|NCT01543490|567287141|FG000|Overall Study|Lack of Efficacy|3|||
157147599|NCT01543490|567287142|FG001|Overall Study|Lack of Efficacy|3|||
157147600|NCT01543490|567287141|FG000|Overall Study|Lost to Follow-up|5|||
157147601|NCT01543490|567287142|FG001|Overall Study|Lost to Follow-up|0|||
157147602|NCT01543490|567287141|FG000|Overall Study|Withdrawal by Subject|2|||
157147603|NCT01543490|567287142|FG001|Overall Study|Withdrawal by Subject|0|||
157147604|NCT01543490|567287141|FG000|Overall Study|Other-Various Administrative Reasons|1|||
157147605|NCT01543490|567287142|FG001|Overall Study|Other-Various Administrative Reasons|2|||
157147606|NCT04168645|567287144|FG000|Overall Study|Lost to Follow-up|23|||
157147607|NCT04168645|567287145|FG001|Overall Study|Lost to Follow-up|28|||
157147608|NCT04168645|567287146|FG002|Overall Study|Lost to Follow-up|15|||
157147609|NCT04168645|567287147|FG003|Overall Study|Lost to Follow-up|12|||
157147610|NCT04168645|567287144|FG000|Overall Study|Death|1|||
157147611|NCT04168645|567287145|FG001|Overall Study|Death|1|||
157222530|NCT01296932|567562032|FG008|Overall Study|Progressive disease|0|||
156811884|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156811885|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
156811886|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
156811887|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
156811888|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
156811889|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811890|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
156811891|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811892|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
156811893|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156811894|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
156811895|NCT01318135|566062571|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811896|NCT01318135|566062572|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811897|NCT01318135|566062573|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811898|NCT01318135|566062574|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811899|NCT01318135|566062575|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811900|NCT01318135|566062576|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811901|NCT01318135|566062577|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
156811902|NCT01318135|566062578|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
156811903|NCT00703963|566062584|FG000|Overall Study|Withdrawal by Subject|7|||
156811904|NCT00703963|566062585|FG001|Overall Study|Withdrawal by Subject|13|||
156811905|NCT00703963|566062584|FG000|Overall Study|Physician Decision|0|||
156811906|NCT00703963|566062585|FG001|Overall Study|Physician Decision|1|||
156811907|NCT03994211|566062592|FG000|Core Phase|Adverse Event|0|||
156811908|NCT03994211|566062593|FG001|Core Phase|Adverse Event|1|||
156811909|NCT03994211|566062594|FG002|Core Phase|Adverse Event|0|||
156811910|NCT03994211|566062592|FG000|Extension Phase|Adverse Event|0|||
156811911|NCT03994211|566062593|FG001|Extension Phase|Adverse Event|0|||
156811912|NCT03994211|566062594|FG002|Extension Phase|Adverse Event|1|||
156811913|NCT03994211|566062592|FG000|Extension Phase|Physician Decision|0|||
156811914|NCT03994211|566062593|FG001|Extension Phase|Physician Decision|0|||
156811915|NCT03994211|566062594|FG002|Extension Phase|Physician Decision|1|||
156811916|NCT03994211|566062592|FG000|Extension Phase|Progressive Disease|0|||
156811917|NCT03994211|566062593|FG001|Extension Phase|Progressive Disease|0|||
156811918|NCT03994211|566062594|FG002|Extension Phase|Progressive Disease|20|||
156811919|NCT03994211|566062592|FG000|Extension Phase|Withdrawal by Subject|0|||
156811920|NCT03994211|566062593|FG001|Extension Phase|Withdrawal by Subject|0|||
156811921|NCT03994211|566062594|FG002|Extension Phase|Withdrawal by Subject|2|||
156883659|NCT02034409|566332611|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
156883660|NCT02034409|566332612|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
156883661|NCT02034409|566332611|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
156883662|NCT02034409|566332612|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
156883663|NCT02034409|566332611|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
156883664|NCT02034409|566332612|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
156883665|NCT02034409|566332611|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
156883666|NCT02034409|566332612|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
156883667|NCT02034409|566332611|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
156883668|NCT02034409|566332612|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
156883669|NCT02270944|566332616|FG000|Overall Study|Lost to Follow-up|9|||
156883670|NCT02270944|566332617|FG001|Overall Study|Lost to Follow-up|4|||
156883671|NCT02270944|566332616|FG000|Overall Study|Withdrawal by Subject|2|||
156883672|NCT02270944|566332617|FG001|Overall Study|Withdrawal by Subject|1|||
156883673|NCT01144299|566332618|FG000|Overall Study|Lost to Follow-up|1|||
156883674|NCT01144299|566332619|FG001|Overall Study|Lost to Follow-up|0|||
156883675|NCT01144299|566332618|FG000|Overall Study|Withdrawal by Subject|1|||
156883676|NCT01144299|566332619|FG001|Overall Study|Withdrawal by Subject|0|||
156883677|NCT02342418|566332620|FG000|Overall Study|Adverse Event|0|||
156883678|NCT02342418|566332621|FG001|Overall Study|Adverse Event|1|||
156883679|NCT01699867|566332622|FG000|Overall Study|Screening Failure|3|||
156883680|NCT01011309|566332637|FG000|Overall Study|Adverse Event|2|||
156883681|NCT01011309|566332638|FG001|Overall Study|Adverse Event|1|||
156883682|NCT01011309|566332639|FG002|Overall Study|Adverse Event|2|||
156883683|NCT01011309|566332637|FG000|Overall Study|Lack of Efficacy|0|||
156883684|NCT01011309|566332638|FG001|Overall Study|Lack of Efficacy|1|||
156883685|NCT01011309|566332639|FG002|Overall Study|Lack of Efficacy|0|||
156883686|NCT01011309|566332637|FG000|Overall Study|Protocol Violation|0|||
156883687|NCT01011309|566332638|FG001|Overall Study|Protocol Violation|1|||
156883688|NCT01011309|566332639|FG002|Overall Study|Protocol Violation|3|||
156883689|NCT00530504|566332642|FG000|Overall Study|Death|54|||
156883690|NCT00530504|566332642|FG000|Overall Study|Lost to Follow-up|26|||
156883691|NCT00530504|566332642|FG000|Overall Study|Withdrawal by Subject|39|||
156883692|NCT00530504|566332642|FG000|Overall Study|Exited study due to other reasons|33|||
156883693|NCT00006289|566332643|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
156883694|NCT00006289|566332644|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
156883695|NCT00006289|566332643|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
156883696|NCT00006289|566332644|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
156883697|NCT04359901|566332653|FG000|Overall Study|Withdrawal by Subject|0|||
156883698|NCT04359901|566332654|FG001|Overall Study|Withdrawal by Subject|1|||
156883699|NCT04359901|566332653|FG000|Overall Study|Death|6|||
156883700|NCT04359901|566332654|FG001|Overall Study|Death|2|||
156883701|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156883702|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
156883703|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156883704|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
157147612|NCT04168645|567287146|FG002|Overall Study|Death|0|||
157147613|NCT04168645|567287147|FG003|Overall Study|Death|0|||
157147614|NCT04168645|567287144|FG000|Overall Study|Withdrawal by Subject|5|||
157147615|NCT04168645|567287145|FG001|Overall Study|Withdrawal by Subject|2|||
157147616|NCT04168645|567287146|FG002|Overall Study|Withdrawal by Subject|2|||
157147617|NCT04168645|567287147|FG003|Overall Study|Withdrawal by Subject|2|||
157147618|NCT04168645|567287144|FG000|Overall Study|Administrative Withdrawal|3|||
157147619|NCT04168645|567287145|FG001|Overall Study|Administrative Withdrawal|1|||
157147620|NCT04168645|567287146|FG002|Overall Study|Administrative Withdrawal|1|||
157147621|NCT04168645|567287147|FG003|Overall Study|Administrative Withdrawal|3|||
157147622|NCT03692910|567287155|FG000|Overall Study|Lost to Follow-up|4|||
157147623|NCT03692910|567287156|FG001|Overall Study|Lost to Follow-up|0|||
157147624|NCT03692910|567287157|FG002|Overall Study|Lost to Follow-up|0|||
157147625|NCT03692910|567287155|FG000|Overall Study|Withdrawal by Subject|2|||
157147626|NCT03692910|567287156|FG001|Overall Study|Withdrawal by Subject|0|||
157147627|NCT03692910|567287157|FG002|Overall Study|Withdrawal by Subject|0|||
156883705|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156883706|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
156883707|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
156883708|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
156883709|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
156883710|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
156883711|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883712|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
156883713|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883714|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
157147628|NCT00151411|567287158|FG000|Overall Study|Lost to Follow-up|15|||
157147629|NCT00151411|567287159|FG001|Overall Study|Lost to Follow-up|19|||
157147630|NCT00151411|567287158|FG000|Overall Study|Withdrawal by Subject|12|||
157147631|NCT00151411|567287159|FG001|Overall Study|Withdrawal by Subject|20|||
157147632|NCT00151411|567287158|FG000|Overall Study|Adverse Event|6|||
157147633|NCT00151411|567287159|FG001|Overall Study|Adverse Event|0|||
157147634|NCT00151411|567287158|FG000|Overall Study|Pregnancy|0|||
157147635|NCT00151411|567287159|FG001|Overall Study|Pregnancy|4|||
157147636|NCT01283581|567287160|FG000|Overall Study|Lost to Follow-up|8|||
157147637|NCT01283581|567287161|FG001|Overall Study|Lost to Follow-up|6|||
157147638|NCT01283581|567287162|FG002|Overall Study|Lost to Follow-up|8|||
157147639|NCT01283581|567287160|FG000|Overall Study|Withdrawal by Subject|2|||
157147640|NCT01283581|567287161|FG001|Overall Study|Withdrawal by Subject|5|||
157147641|NCT01283581|567287162|FG002|Overall Study|Withdrawal by Subject|2|||
157147642|NCT01283581|567287160|FG000|Overall Study|Adverse Event|1|||
157147643|NCT01283581|567287161|FG001|Overall Study|Adverse Event|1|||
157147644|NCT01283581|567287162|FG002|Overall Study|Adverse Event|4|||
157147645|NCT01283581|567287160|FG000|Overall Study|Physician Decision|0|||
157147646|NCT01283581|567287161|FG001|Overall Study|Physician Decision|1|||
157147647|NCT01283581|567287162|FG002|Overall Study|Physician Decision|2|||
157147648|NCT01283581|567287160|FG000|Overall Study|Protocol Violation|0|||
157147649|NCT01283581|567287161|FG001|Overall Study|Protocol Violation|1|||
157147650|NCT01283581|567287162|FG002|Overall Study|Protocol Violation|2|||
157147651|NCT01283581|567287160|FG000|Overall Study|Noncompliance|1|||
157147652|NCT01283581|567287161|FG001|Overall Study|Noncompliance|0|||
157147653|NCT01283581|567287162|FG002|Overall Study|Noncompliance|0|||
157147654|NCT01283581|567287160|FG000|Overall Study|Investigator unblinded|0|||
157147655|NCT01283581|567287161|FG001|Overall Study|Investigator unblinded|0|||
157147656|NCT01283581|567287162|FG002|Overall Study|Investigator unblinded|1|||
157147657|NCT01283581|567287160|FG000|Overall Study|"Early termination"|0|||
157147658|NCT01283581|567287161|FG001|Overall Study|"Early termination"|0|||
157147659|NCT01283581|567287162|FG002|Overall Study|"Early termination"|1|||
157147660|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
157147661|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
157147662|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
157147663|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
157147664|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
157147665|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
157147666|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
157147667|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
157147668|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
157147669|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
157147670|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
157147671|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
157147672|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
157147673|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
157147674|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
157147675|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
157147676|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
157147677|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
157147678|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
157147679|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
157147680|NCT01259492|567287163|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
157147681|NCT01259492|567287164|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
157147682|NCT01259492|567287165|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
157147683|NCT01259492|567287166|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
157147684|NCT01259492|567287163|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
157147685|NCT01259492|567287164|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
157147686|NCT01259492|567287165|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
157147687|NCT01259492|567287166|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
157147688|NCT01259492|567287163|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
157147689|NCT01259492|567287164|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
157147690|NCT01259492|567287165|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
157147691|NCT01259492|567287166|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
157147692|NCT01259492|567287163|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
157147693|NCT01259492|567287164|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
157147694|NCT01259492|567287165|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
157147695|NCT01259492|567287166|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
157147696|NCT01259492|567287163|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
156811922|NCT02528942|566062595|FG000|Overall Study|Did not meet imaging criteria|9|||
156811923|NCT02528942|566062595|FG000|Overall Study|Lost to Follow-up|25|||
157147697|NCT01259492|567287164|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
157147698|NCT01259492|567287165|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
157147699|NCT01259492|567287166|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
157147700|NCT01259492|567287163|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
157147701|NCT01259492|567287164|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
157147702|NCT01259492|567287165|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
157147703|NCT01259492|567287166|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
157147704|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
157147705|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
157147706|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
157147707|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
157147708|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
157147709|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
157147710|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
157147711|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
157147712|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
157147713|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
157147714|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
157147715|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
157147716|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
157147717|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
157147718|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
157147719|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
157147720|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
157147721|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
157147722|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
157147723|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
157147724|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
157147725|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
157147726|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
157147727|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
157147728|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
157147729|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
157147730|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
157147731|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
157147732|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
157147733|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
157147734|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
157147735|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
157147736|NCT01259492|567287163|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
157147737|NCT01259492|567287164|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
157147738|NCT01259492|567287165|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
157147739|NCT01259492|567287166|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
157147740|NCT00089843|567287167|FG000|Overall Study|Withdrawal by Subject|1|||
157147741|NCT00089843|567287168|FG001|Overall Study|Withdrawal by Subject|4|||
157147742|NCT00089843|567287169|FG002|Overall Study|Withdrawal by Subject|5|||
157147743|NCT00089843|567287170|FG003|Overall Study|Withdrawal by Subject|6|||
157147744|NCT00089843|567287167|FG000|Overall Study|Physician Decision|1|||
157147745|NCT00089843|567287168|FG001|Overall Study|Physician Decision|0|||
157147746|NCT00089843|567287169|FG002|Overall Study|Physician Decision|0|||
157147747|NCT00089843|567287170|FG003|Overall Study|Physician Decision|1|||
157147748|NCT03846947|567287171|FG000|Overall Study|technical issues with imaging sequence|2|||
157147749|NCT01295905|567287180|FG000|Overall Study|Did not meet inclusion criteria|1|||
157147750|NCT01295905|567287181|FG001|Overall Study|Did not meet inclusion criteria|0|||
157147751|NCT01295905|567287180|FG000|Overall Study|Met exclusion criteria|1|||
157147752|NCT01295905|567287181|FG001|Overall Study|Met exclusion criteria|0|||
157147753|NCT02717546|567287182|FG000|Overall Study|Lost to Follow-up|12|||
157147754|NCT00909090|567287183|FG000|Overall Study|Lost to Follow-up|17|||
157147755|NCT00909090|567287184|FG001|Overall Study|Lost to Follow-up|17|||
157147756|NCT01009294|567287185|FG000|Overall Study|Study discontinued by Sponsor|6|||
157147757|NCT00414440|567287188|FG000|Core Period|Withdrawal by Subject|70|||
157147758|NCT00414440|567287189|FG001|Core Period|Withdrawal by Subject|32|||
157147759|NCT00414440|567287188|FG000|Extension Period|Lost to Follow-up|44|||
157147760|NCT00414440|567287189|FG001|Extension Period|Lost to Follow-up|52|||
157147761|NCT00414440|567287188|FG000|Extension Period|Did not consent to continue follow up|61|||
157147762|NCT00414440|567287189|FG001|Extension Period|Did not consent to continue follow up|54|||
157147763|NCT00414440|567287188|FG000|Extension Period|Other|1|||
157147764|NCT00414440|567287189|FG001|Extension Period|Other|1|||
157147765|NCT00414440|567287188|FG000|Extension Period|Administrative|16|||
157147766|NCT00414440|567287189|FG001|Extension Period|Administrative|16|||
157147767|NCT00414440|567287188|FG000|Extension Period|Death|1|||
157147768|NCT00414440|567287189|FG001|Extension Period|Death|2|||
157147769|NCT00414440|567287188|FG000|Extension Period|Withdrawal by Subject|9|||
156883715|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883716|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883717|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883718|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
156883719|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
156883720|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
156883721|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
156883722|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
156883723|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
156883724|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
156883725|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
156883726|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
156883727|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
156883728|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|Other|0|||
156883729|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|Other|0|||
157022405|NCT05116787|566835204|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
157022406|NCT05116787|566835205|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
157022407|NCT05116787|566835204|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
157022408|NCT05116787|566835205|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
157022409|NCT05116787|566835204|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
157022410|NCT05116787|566835205|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
157147770|NCT00414440|567287189|FG001|Extension Period|Withdrawal by Subject|7|||
157147771|NCT00414440|567287188|FG000|Extension Period|Not included in follow up period|18|||
157147772|NCT00414440|567287189|FG001|Extension Period|Not included in follow up period|8|||
157147773|NCT04382651|567287190|FG000|Overall Study|Death|26|||
157147774|NCT04382651|567287191|FG001|Overall Study|Death|23|||
157147775|NCT04382651|567287190|FG000|Overall Study|Lost to Follow-up|3|||
157147776|NCT04382651|567287191|FG001|Overall Study|Lost to Follow-up|4|||
157147777|NCT04382651|567287190|FG000|Overall Study|Withdrawal by Subject|2|||
157147778|NCT04382651|567287191|FG001|Overall Study|Withdrawal by Subject|0|||
157147779|NCT04382651|567287190|FG000|Overall Study|Physician Decision|0|||
157147780|NCT04382651|567287191|FG001|Overall Study|Physician Decision|1|||
157147781|NCT02612077|567287193|FG000|Overall Study|Adverse Event|3|||
157147782|NCT02612077|567287193|FG000|Overall Study|Withdrawal by Subject|9|||
157147783|NCT02612077|567287193|FG000|Overall Study|Protocol Violation|28|||
157147784|NCT02612077|567287193|FG000|Overall Study|Lost to Follow-up|20|||
157147785|NCT02612077|567287193|FG000|Overall Study|Death|377|||
157147786|NCT02612077|567287193|FG000|Overall Study|Moved or Changed Medical Team|23|||
157147787|NCT02612077|567287193|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
157147788|NCT02612077|567287193|FG000|Overall Study|Disease Progression|3|||
157147789|NCT02612077|567287193|FG000|Overall Study|Unknown reason|2|||
157147790|NCT01716169|567287195|FG000|Overall Study|Adverse Event|1|||
157147791|NCT01716169|567287195|FG000|Overall Study|Lost to Follow-up|1|||
157147792|NCT01716169|567287195|FG000|Overall Study|Withdrawal by Subject|1|||
157147793|NCT01716169|567287195|FG000|Overall Study|inconsistent dressing application|1|||
157147794|NCT05121103|567287198|FG000|Overall Study|Progressive disease|2|||
157147795|NCT05121103|567287199|FG001|Overall Study|Progressive disease|1|||
157147796|NCT05121103|567287200|FG002|Overall Study|Progressive disease|6|||
157147797|NCT05121103|567287198|FG000|Overall Study|Physician Decision|2|||
157147798|NCT05121103|567287199|FG001|Overall Study|Physician Decision|1|||
157147799|NCT05121103|567287200|FG002|Overall Study|Physician Decision|0|||
157147800|NCT05121103|567287198|FG000|Overall Study|Withdrawal by Subject|0|||
157147801|NCT05121103|567287199|FG001|Overall Study|Withdrawal by Subject|1|||
157147802|NCT05121103|567287200|FG002|Overall Study|Withdrawal by Subject|0|||
157147803|NCT00514449|567287201|FG000|Overall Study|Withdrawal by Subject|1|||
157147804|NCT00514449|567287202|FG001|Overall Study|Withdrawal by Subject|2|||
157147805|NCT00514449|567287201|FG000|Overall Study|Protocol Violation|1|||
157147806|NCT00514449|567287202|FG001|Overall Study|Protocol Violation|2|||
157147807|NCT00514449|567287201|FG000|Overall Study|Lost to Follow-up|1|||
157147808|NCT00514449|567287202|FG001|Overall Study|Lost to Follow-up|0|||
157147809|NCT01359982|567287210|FG000|Overall Study|Adverse Event|2|||
157147810|NCT01359982|567287211|FG001|Overall Study|Adverse Event|0|||
157147811|NCT01359982|567287212|FG002|Overall Study|Adverse Event|0|||
157147812|NCT01359982|567287213|FG003|Overall Study|Adverse Event|1|||
157147813|NCT01359982|567287214|FG004|Overall Study|Adverse Event|0|||
156883730|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|Other|1|||
156883731|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|Other|1|||
156883732|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|Other|0|||
156883733|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|Other|0|||
156883734|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|Other|0|||
157147814|NCT01359982|567287215|FG005|Overall Study|Adverse Event|0|||
157147815|NCT01359982|567287210|FG000|Overall Study|Death|1|||
157147816|NCT01359982|567287211|FG001|Overall Study|Death|0|||
157147817|NCT01359982|567287212|FG002|Overall Study|Death|0|||
157147818|NCT01359982|567287213|FG003|Overall Study|Death|0|||
156883735|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|Other|1|||
156883736|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|Other|0|||
156883737|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|Death|0|||
156883738|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|Death|0|||
156883739|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|Death|0|||
156883740|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|Death|0|||
156883741|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|Death|0|||
156883742|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|Death|1|||
156883743|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|Death|0|||
156883744|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|Death|0|||
156883745|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|Death|0|||
156883746|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883747|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883748|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883749|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883750|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883751|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
156883752|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
156883753|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883754|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
156883755|NCT00557856|566332657|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
156883756|NCT00557856|566332658|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883757|NCT00557856|566332659|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883758|NCT00557856|566332660|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883759|NCT00557856|566332661|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883760|NCT00557856|566332662|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883761|NCT00557856|566332663|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883762|NCT00557856|566332664|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883763|NCT00557856|566332665|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
156883764|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883765|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883766|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883767|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883768|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883769|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883770|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
157022411|NCT02737436|566835206|FG000|Washout Period|Lost to Follow-up|5|||
157022412|NCT02737436|566835207|FG001|Washout Period|Lost to Follow-up|11|||
157022413|NCT02737436|566835206|FG000|Data Analysis|Scanning data problems|5|||
157147819|NCT01359982|567287214|FG004|Overall Study|Death|0|||
157147820|NCT01359982|567287215|FG005|Overall Study|Death|0|||
157147821|NCT00306891|567287219|FG000|Part A|Withdrawal by Subject|1|||
157147822|NCT00306891|567287220|FG001|Part A|Withdrawal by Subject|1|||
157147823|NCT00306891|567287221|FG002|Part A|Withdrawal by Subject|0|||
157147824|NCT00306891|567287222|FG003|Part A|Withdrawal by Subject|0|||
157147825|NCT00306891|567287219|FG000|Part A|Condition under investigation worsened|2|||
157147826|NCT00306891|567287220|FG001|Part A|Condition under investigation worsened|2|||
157147827|NCT00306891|567287221|FG002|Part A|Condition under investigation worsened|0|||
157147828|NCT00306891|567287222|FG003|Part A|Condition under investigation worsened|0|||
156811924|NCT00881530|566062596|FG000|Overall Study|Adverse Event|5|||
156811925|NCT00881530|566062597|FG001|Overall Study|Adverse Event|1|||
156811926|NCT00881530|566062598|FG002|Overall Study|Adverse Event|1|||
156811927|NCT00881530|566062599|FG003|Overall Study|Adverse Event|4|||
156811928|NCT00881530|566062600|FG004|Overall Study|Adverse Event|10|||
156811929|NCT00881530|566062601|FG005|Overall Study|Adverse Event|2|||
156811930|NCT00881530|566062596|FG000|Overall Study|Lack of Efficacy|1|||
156811931|NCT00881530|566062597|FG001|Overall Study|Lack of Efficacy|0|||
156811932|NCT00881530|566062598|FG002|Overall Study|Lack of Efficacy|0|||
156811933|NCT00881530|566062599|FG003|Overall Study|Lack of Efficacy|0|||
156811934|NCT00881530|566062600|FG004|Overall Study|Lack of Efficacy|1|||
156811935|NCT00881530|566062601|FG005|Overall Study|Lack of Efficacy|1|||
156811936|NCT00881530|566062596|FG000|Overall Study|Not compliant with the protocol|0|||
156811937|NCT00881530|566062597|FG001|Overall Study|Not compliant with the protocol|0|||
156811938|NCT00881530|566062598|FG002|Overall Study|Not compliant with the protocol|0|||
156811939|NCT00881530|566062599|FG003|Overall Study|Not compliant with the protocol|0|||
156811940|NCT00881530|566062600|FG004|Overall Study|Not compliant with the protocol|2|||
156811941|NCT00881530|566062601|FG005|Overall Study|Not compliant with the protocol|0|||
156811942|NCT00881530|566062596|FG000|Overall Study|Lost to Follow-up|0|||
156811943|NCT00881530|566062597|FG001|Overall Study|Lost to Follow-up|1|||
156811944|NCT00881530|566062598|FG002|Overall Study|Lost to Follow-up|1|||
156811945|NCT00881530|566062599|FG003|Overall Study|Lost to Follow-up|3|||
157222531|NCT01296932|567562024|FG000|Overall Study|Withdrawal by Subject|0|||
157222532|NCT01296932|567562025|FG001|Overall Study|Withdrawal by Subject|0|||
157222533|NCT01296932|567562026|FG002|Overall Study|Withdrawal by Subject|1|||
157222534|NCT01296932|567562027|FG003|Overall Study|Withdrawal by Subject|1|||
157222535|NCT01296932|567562028|FG004|Overall Study|Withdrawal by Subject|0|||
157222536|NCT01296932|567562029|FG005|Overall Study|Withdrawal by Subject|0|||
157222537|NCT01296932|567562030|FG006|Overall Study|Withdrawal by Subject|3|||
157222538|NCT01296932|567562031|FG007|Overall Study|Withdrawal by Subject|0|||
157222539|NCT01296932|567562032|FG008|Overall Study|Withdrawal by Subject|0|||
157222540|NCT01296932|567562024|FG000|Overall Study|Adverse Event|1|||
157222541|NCT01296932|567562025|FG001|Overall Study|Adverse Event|1|||
157222542|NCT01296932|567562026|FG002|Overall Study|Adverse Event|1|||
157222543|NCT01296932|567562027|FG003|Overall Study|Adverse Event|2|||
157222544|NCT01296932|567562028|FG004|Overall Study|Adverse Event|1|||
157222545|NCT01296932|567562029|FG005|Overall Study|Adverse Event|0|||
157222546|NCT01296932|567562030|FG006|Overall Study|Adverse Event|0|||
157222547|NCT01296932|567562031|FG007|Overall Study|Adverse Event|0|||
156883771|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
156883772|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
156883773|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
157022414|NCT02737436|566835207|FG001|Data Analysis|Scanning data problems|8|||
157147829|NCT00306891|567287219|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
157147830|NCT00306891|567287220|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
157147831|NCT00306891|567287221|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
157147832|NCT00306891|567287222|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
157147833|NCT00306891|567287219|FG000|Part A|Partial bowel obstruction|1|||
157147834|NCT00306891|567287220|FG001|Part A|Partial bowel obstruction|0|||
157147835|NCT00306891|567287221|FG002|Part A|Partial bowel obstruction|0|||
157147836|NCT00306891|567287222|FG003|Part A|Partial bowel obstruction|0|||
157147837|NCT00306891|567287219|FG000|Part A|Reaccumul. of ascites following drainage|0|||
157147838|NCT00306891|567287220|FG001|Part A|Reaccumul. of ascites following drainage|1|||
157147839|NCT00306891|567287221|FG002|Part A|Reaccumul. of ascites following drainage|0|||
157147840|NCT00306891|567287222|FG003|Part A|Reaccumul. of ascites following drainage|0|||
157147841|NCT00306891|567287219|FG000|Part A|Suspicion of second malignancy|0|||
157147842|NCT00306891|567287220|FG001|Part A|Suspicion of second malignancy|1|||
157147843|NCT00306891|567287221|FG002|Part A|Suspicion of second malignancy|0|||
157147844|NCT00306891|567287222|FG003|Part A|Suspicion of second malignancy|0|||
157147845|NCT00306891|567287219|FG000|Part A|QTC interval outwith elig. criteria|1|||
157147846|NCT00306891|567287220|FG001|Part A|QTC interval outwith elig. criteria|0|||
157147847|NCT00306891|567287221|FG002|Part A|QTC interval outwith elig. criteria|0|||
157147848|NCT00306891|567287222|FG003|Part A|QTC interval outwith elig. criteria|0|||
157147849|NCT00306891|567287219|FG000|Part B|Death|0|||
157147850|NCT00306891|567287220|FG001|Part B|Death|0|||
157147851|NCT00306891|567287221|FG002|Part B|Death|1|||
157147852|NCT00306891|567287222|FG003|Part B|Death|2|||
157147853|NCT00306891|567287219|FG000|Part B|Adverse Event|0|||
157147854|NCT00306891|567287220|FG001|Part B|Adverse Event|0|||
157147855|NCT00306891|567287221|FG002|Part B|Adverse Event|5|||
157147856|NCT00306891|567287222|FG003|Part B|Adverse Event|5|||
157147857|NCT00306891|567287219|FG000|Part B|Withdrawal by Subject|0|||
157147858|NCT00306891|567287220|FG001|Part B|Withdrawal by Subject|0|||
157147859|NCT00306891|567287221|FG002|Part B|Withdrawal by Subject|3|||
157147860|NCT00306891|567287222|FG003|Part B|Withdrawal by Subject|1|||
157147861|NCT00306891|567287219|FG000|Part B|Condition under investigation worsened|0|||
157147862|NCT00306891|567287220|FG001|Part B|Condition under investigation worsened|0|||
157147863|NCT00306891|567287221|FG002|Part B|Condition under investigation worsened|2|||
157147864|NCT00306891|567287222|FG003|Part B|Condition under investigation worsened|8|||
157147865|NCT00306891|567287219|FG000|Part B|Development of study specific disc crit.|0|||
157147866|NCT00306891|567287220|FG001|Part B|Development of study specific disc crit.|0|||
157147867|NCT00306891|567287221|FG002|Part B|Development of study specific disc crit.|0|||
157147868|NCT00306891|567287222|FG003|Part B|Development of study specific disc crit.|1|||
157147869|NCT00206518|567287224|FG000|Overall Study|Lack of Efficacy|6|||
157147870|NCT00206518|567287225|FG001|Overall Study|Lack of Efficacy|4|||
157147871|NCT00206518|567287224|FG000|Overall Study|Adverse Event|2|||
157147872|NCT00206518|567287225|FG001|Overall Study|Adverse Event|1|||
157222548|NCT01296932|567562032|FG008|Overall Study|Adverse Event|1|||
157022415|NCT06393088|566835208|FG000|Overall Study|Withdrawal by Subject|0|||
157147873|NCT00206518|567287224|FG000|Overall Study|Physician Decision|1|||
157147874|NCT00206518|567287225|FG001|Overall Study|Physician Decision|0|||
157147875|NCT00206518|567287224|FG000|Overall Study|Protocol Violation|1|||
157147876|NCT00206518|567287225|FG001|Overall Study|Protocol Violation|1|||
157147877|NCT02335450|567287226|FG000|Overall Study|Pregnancy|1|||
157147878|NCT02613572|567287227|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
157222549|NCT01296932|567562024|FG000|Overall Study|Investigator decision|0|||
157222550|NCT01296932|567562025|FG001|Overall Study|Investigator decision|1|||
157222551|NCT01296932|567562026|FG002|Overall Study|Investigator decision|0|||
157222552|NCT01296932|567562027|FG003|Overall Study|Investigator decision|1|||
157222553|NCT01296932|567562028|FG004|Overall Study|Investigator decision|0|||
157222554|NCT01296932|567562029|FG005|Overall Study|Investigator decision|0|||
157222555|NCT01296932|567562030|FG006|Overall Study|Investigator decision|1|||
157222556|NCT01296932|567562031|FG007|Overall Study|Investigator decision|0|||
157222557|NCT01296932|567562032|FG008|Overall Study|Investigator decision|1|||
157222558|NCT01296932|567562024|FG000|Overall Study|No clinical benefit anymore|0|||
157222559|NCT01296932|567562025|FG001|Overall Study|No clinical benefit anymore|1|||
157222560|NCT01296932|567562026|FG002|Overall Study|No clinical benefit anymore|0|||
157222561|NCT01296932|567562027|FG003|Overall Study|No clinical benefit anymore|0|||
157222562|NCT01296932|567562028|FG004|Overall Study|No clinical benefit anymore|0|||
157222563|NCT01296932|567562029|FG005|Overall Study|No clinical benefit anymore|0|||
157222564|NCT01296932|567562030|FG006|Overall Study|No clinical benefit anymore|0|||
157222565|NCT01296932|567562031|FG007|Overall Study|No clinical benefit anymore|0|||
157222566|NCT01296932|567562032|FG008|Overall Study|No clinical benefit anymore|0|||
157222567|NCT01296932|567562024|FG000|Overall Study|Physician Decision|0|||
157222568|NCT01296932|567562025|FG001|Overall Study|Physician Decision|0|||
157222569|NCT01296932|567562026|FG002|Overall Study|Physician Decision|1|||
157222570|NCT01296932|567562027|FG003|Overall Study|Physician Decision|0|||
157222571|NCT01296932|567562028|FG004|Overall Study|Physician Decision|0|||
157222572|NCT01296932|567562029|FG005|Overall Study|Physician Decision|0|||
157222573|NCT01296932|567562030|FG006|Overall Study|Physician Decision|0|||
157222574|NCT01296932|567562031|FG007|Overall Study|Physician Decision|0|||
157222575|NCT01296932|567562032|FG008|Overall Study|Physician Decision|0|||
157222576|NCT01296932|567562024|FG000|Overall Study|IV problems, administration not possible|0|||
157222577|NCT01296932|567562025|FG001|Overall Study|IV problems, administration not possible|0|||
157222578|NCT01296932|567562026|FG002|Overall Study|IV problems, administration not possible|1|||
157222579|NCT01296932|567562027|FG003|Overall Study|IV problems, administration not possible|0|||
157222580|NCT01296932|567562028|FG004|Overall Study|IV problems, administration not possible|0|||
157222581|NCT01296932|567562029|FG005|Overall Study|IV problems, administration not possible|0|||
157222582|NCT01296932|567562030|FG006|Overall Study|IV problems, administration not possible|0|||
157222583|NCT01296932|567562031|FG007|Overall Study|IV problems, administration not possible|0|||
157222584|NCT01296932|567562032|FG008|Overall Study|IV problems, administration not possible|0|||
157222585|NCT01296932|567562024|FG000|Overall Study|per protocol|0|||
157222586|NCT01296932|567562025|FG001|Overall Study|per protocol|0|||
157222587|NCT01296932|567562026|FG002|Overall Study|per protocol|1|||
157222588|NCT01296932|567562027|FG003|Overall Study|per protocol|1|||
157222589|NCT01296932|567562028|FG004|Overall Study|per protocol|0|||
157222590|NCT01296932|567562029|FG005|Overall Study|per protocol|0|||
157222591|NCT01296932|567562030|FG006|Overall Study|per protocol|0|||
157222592|NCT01296932|567562031|FG007|Overall Study|per protocol|0|||
157222593|NCT01296932|567562032|FG008|Overall Study|per protocol|0|||
157222594|NCT01296932|567562024|FG000|Overall Study|Low benefit and too many side effects|0|||
157222595|NCT01296932|567562025|FG001|Overall Study|Low benefit and too many side effects|0|||
157222596|NCT01296932|567562026|FG002|Overall Study|Low benefit and too many side effects|0|||
157222597|NCT01296932|567562027|FG003|Overall Study|Low benefit and too many side effects|0|||
157222598|NCT01296932|567562028|FG004|Overall Study|Low benefit and too many side effects|0|||
157222599|NCT01296932|567562029|FG005|Overall Study|Low benefit and too many side effects|0|||
157222600|NCT01296932|567562030|FG006|Overall Study|Low benefit and too many side effects|0|||
157222601|NCT01296932|567562031|FG007|Overall Study|Low benefit and too many side effects|1|||
157222602|NCT01296932|567562032|FG008|Overall Study|Low benefit and too many side effects|0|||
156883774|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
157147879|NCT02613572|567287228|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
157147880|NCT02613572|567287229|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
157147881|NCT02613572|567287227|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
157147882|NCT02613572|567287228|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
157147883|NCT02613572|567287229|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
157147884|NCT00231478|567287231|FG000|Overall Study|Protocol Violation|3|||
157147885|NCT00231478|567287232|FG001|Overall Study|Protocol Violation|2|||
157147886|NCT00231478|567287231|FG000|Overall Study|Refused Treatment|1|||
157147887|NCT00231478|567287232|FG001|Overall Study|Refused Treatment|1|||
157147888|NCT00231478|567287231|FG000|Overall Study|Withdrawal by Subject|1|||
157147889|NCT00231478|567287232|FG001|Overall Study|Withdrawal by Subject|0|||
157147890|NCT00231478|567287231|FG000|Overall Study|Adverse Event|0|||
157147891|NCT00231478|567287232|FG001|Overall Study|Adverse Event|1|||
157147892|NCT00231478|567287231|FG000|Overall Study|Administrative|3|||
157147893|NCT00231478|567287232|FG001|Overall Study|Administrative|2|||
157147894|NCT00853905|567287233|FG000|Overall Study|Lost to Follow-up|1|||
157222603|NCT01296932|567562024|FG000|Overall Study|No adequate treatment response|0|||
157222604|NCT01296932|567562025|FG001|Overall Study|No adequate treatment response|0|||
157222605|NCT01296932|567562026|FG002|Overall Study|No adequate treatment response|0|||
157222606|NCT01296932|567562027|FG003|Overall Study|No adequate treatment response|0|||
157222607|NCT01296932|567562028|FG004|Overall Study|No adequate treatment response|0|||
157147895|NCT00853905|567287234|FG001|Overall Study|Lost to Follow-up|3|||
157147896|NCT00853905|567287233|FG000|Overall Study|Withdrawal by Subject|0|||
157147897|NCT00853905|567287234|FG001|Overall Study|Withdrawal by Subject|1|||
157147898|NCT00853905|567287233|FG000|Overall Study|never had surgery|1|||
157147899|NCT00853905|567287234|FG001|Overall Study|never had surgery|0|||
157147900|NCT04538950|567287235|FG000|Overall Study|Pulmonary Issues|2|||
157147901|NCT04538950|567287235|FG000|Overall Study|illness|2|||
157147902|NCT00847561|567287236|FG000|Overall Study|Withdrawal by Subject|4|||
157147903|NCT00847561|567287237|FG001|Overall Study|Withdrawal by Subject|3|||
157147904|NCT00847561|567287236|FG000|Overall Study|Unable to schedule|9|||
157147905|NCT00847561|567287237|FG001|Overall Study|Unable to schedule|1|||
157147906|NCT00393458|567287239|FG000|Overall Study|Adverse Event|35|||
157147907|NCT00393458|567287240|FG001|Overall Study|Adverse Event|24|||
157147908|NCT00393458|567287241|FG002|Overall Study|Adverse Event|40|||
157147909|NCT00393458|567287242|FG003|Overall Study|Adverse Event|35|||
157147910|NCT00393458|567287239|FG000|Overall Study|Subject withdrew consent|27|||
157147911|NCT00393458|567287240|FG001|Overall Study|Subject withdrew consent|40|||
157147912|NCT00393458|567287241|FG002|Overall Study|Subject withdrew consent|33|||
157147913|NCT00393458|567287242|FG003|Overall Study|Subject withdrew consent|50|||
157147914|NCT00393458|567287239|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
157147915|NCT00393458|567287240|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
157147916|NCT00393458|567287241|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
157147917|NCT00393458|567287242|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
157147918|NCT00393458|567287239|FG000|Overall Study|Protocol deviation|11|||
157147919|NCT00393458|567287240|FG001|Overall Study|Protocol deviation|11|||
157147920|NCT00393458|567287241|FG002|Overall Study|Protocol deviation|11|||
157147921|NCT00393458|567287242|FG003|Overall Study|Protocol deviation|10|||
157147922|NCT00393458|567287239|FG000|Overall Study|Administrative problems|7|||
157147923|NCT00393458|567287240|FG001|Overall Study|Administrative problems|8|||
157147924|NCT00393458|567287241|FG002|Overall Study|Administrative problems|5|||
157147925|NCT00393458|567287242|FG003|Overall Study|Administrative problems|2|||
157147926|NCT00393458|567287239|FG000|Overall Study|Lost to Follow-up|5|||
157147927|NCT00393458|567287240|FG001|Overall Study|Lost to Follow-up|6|||
157147928|NCT00393458|567287241|FG002|Overall Study|Lost to Follow-up|5|||
157147929|NCT00393458|567287242|FG003|Overall Study|Lost to Follow-up|3|||
157147930|NCT00393458|567287239|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157147931|NCT00393458|567287240|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157147932|NCT00393458|567287241|FG002|Overall Study|Abnormal laboratory value(s)|0|||
157147933|NCT00393458|567287242|FG003|Overall Study|Abnormal laboratory value(s)|0|||
157147934|NCT00393458|567287239|FG000|Overall Study|Death|1|||
157147935|NCT00393458|567287240|FG001|Overall Study|Death|1|||
157147936|NCT00393458|567287241|FG002|Overall Study|Death|5|||
157147937|NCT00393458|567287242|FG003|Overall Study|Death|5|||
157147938|NCT00393458|567287239|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157147939|NCT00393458|567287240|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157147940|NCT00393458|567287241|FG002|Overall Study|Abnormal test procedure result(s)|1|||
157147941|NCT00393458|567287242|FG003|Overall Study|Abnormal test procedure result(s)|2|||
157147942|NCT00393458|567287239|FG000|Overall Study|Subject no longer requires study drug|0|||
157147943|NCT00393458|567287240|FG001|Overall Study|Subject no longer requires study drug|1|||
157147944|NCT00393458|567287241|FG002|Overall Study|Subject no longer requires study drug|0|||
157147945|NCT00393458|567287242|FG003|Overall Study|Subject no longer requires study drug|0|||
157147946|NCT00447421|567287252|FG000|Overall Study|Lack of Efficacy|1|||
157147947|NCT00447421|567287252|FG000|Overall Study|Adverse Event|3|||
157147948|NCT00447421|567287252|FG000|Overall Study|Sponsor Decision|2|||
157147949|NCT01707147|567287253|FG000|Overall Study|Administered Trajenta prior to contract|5|||
157147950|NCT01707147|567287253|FG000|Overall Study|Patients who have not taken Trajenta|1|||
157147951|NCT01707147|567287253|FG000|Overall Study|Follow-up failure|17|||
157147952|NCT01707147|567287253|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
157147953|NCT02725177|567287254|FG000|Overall Study|Physician Decision|4|||
157147954|NCT02725177|567287254|FG000|Overall Study|Adverse Event|1|||
157147955|NCT04285723|567287259|FG000|Overall Study|Subject decision|1|||
157147956|NCT04285723|567287260|FG001|Overall Study|Subject decision|2|||
157147957|NCT04285723|567287259|FG000|Overall Study|Physician Decision|1|||
157147958|NCT04285723|567287260|FG001|Overall Study|Physician Decision|0|||
157147959|NCT04285723|567287259|FG000|Overall Study|No efficiency|1|||
157147960|NCT04285723|567287260|FG001|Overall Study|No efficiency|0|||
157147961|NCT02903511|567287264|FG000|Overall Study|Withdrawal by Subject|1|||
157147962|NCT02903511|567287265|FG001|Overall Study|Withdrawal by Subject|0|||
157147963|NCT02903511|567287264|FG000|Overall Study|Lost to Follow-up|3|||
157147964|NCT02903511|567287265|FG001|Overall Study|Lost to Follow-up|2|||
157147965|NCT02699515|567288759|FG000|Overall Study|Death|3|||
157147966|NCT02699515|567288760|FG001|Overall Study|Death|3|||
157147967|NCT02699515|567288761|FG002|Overall Study|Death|3|||
157147968|NCT02699515|567288762|FG003|Overall Study|Death|23|||
157147969|NCT02699515|567288763|FG004|Overall Study|Death|22|||
157147970|NCT02699515|567288764|FG005|Overall Study|Death|23|||
157147971|NCT02699515|567288765|FG006|Overall Study|Death|3|||
157147972|NCT02699515|567288766|FG007|Overall Study|Death|5|||
157222608|NCT01296932|567562029|FG005|Overall Study|No adequate treatment response|0|||
157222609|NCT01296932|567562030|FG006|Overall Study|No adequate treatment response|0|||
157222610|NCT01296932|567562031|FG007|Overall Study|No adequate treatment response|1|||
157222611|NCT01296932|567562032|FG008|Overall Study|No adequate treatment response|0|||
157222612|NCT01296932|567562024|FG000|Overall Study|Dosage already reduced, AE still present|0|||
157222613|NCT01296932|567562025|FG001|Overall Study|Dosage already reduced, AE still present|0|||
157222614|NCT01296932|567562026|FG002|Overall Study|Dosage already reduced, AE still present|0|||
157222615|NCT01296932|567562027|FG003|Overall Study|Dosage already reduced, AE still present|0|||
157222616|NCT01296932|567562028|FG004|Overall Study|Dosage already reduced, AE still present|0|||
157222617|NCT01296932|567562029|FG005|Overall Study|Dosage already reduced, AE still present|0|||
157222618|NCT01296932|567562030|FG006|Overall Study|Dosage already reduced, AE still present|0|||
157222619|NCT01296932|567562031|FG007|Overall Study|Dosage already reduced, AE still present|0|||
157222620|NCT01296932|567562032|FG008|Overall Study|Dosage already reduced, AE still present|1|||
157222621|NCT02637557|567562037|FG000|Overall Study|Adverse Event|3|||
157222622|NCT02637557|567562038|FG001|Overall Study|Adverse Event|1|||
157222623|NCT02637557|567562039|FG002|Overall Study|Adverse Event|3|||
157222624|NCT02637557|567562040|FG003|Overall Study|Adverse Event|3|||
157222625|NCT02637557|567562037|FG000|Overall Study|Lost to Follow-up|1|||
157222626|NCT02637557|567562038|FG001|Overall Study|Lost to Follow-up|1|||
157222627|NCT02637557|567562039|FG002|Overall Study|Lost to Follow-up|0|||
157222628|NCT02637557|567562040|FG003|Overall Study|Lost to Follow-up|1|||
157222629|NCT02637557|567562037|FG000|Overall Study|Physician Decision|1|||
157222630|NCT02637557|567562038|FG001|Overall Study|Physician Decision|0|||
157222631|NCT02637557|567562039|FG002|Overall Study|Physician Decision|0|||
157222632|NCT02637557|567562040|FG003|Overall Study|Physician Decision|0|||
157222633|NCT02637557|567562037|FG000|Overall Study|Protocol Violation|2|||
157222634|NCT02637557|567562038|FG001|Overall Study|Protocol Violation|0|||
157222635|NCT02637557|567562039|FG002|Overall Study|Protocol Violation|2|||
157222636|NCT02637557|567562040|FG003|Overall Study|Protocol Violation|1|||
157222637|NCT02637557|567562037|FG000|Overall Study|Withdrawal by Subject|1|||
156811946|NCT00881530|566062600|FG004|Overall Study|Lost to Follow-up|1|||
156811947|NCT00881530|566062601|FG005|Overall Study|Lost to Follow-up|0|||
156811948|NCT00881530|566062596|FG000|Overall Study|Refused to continue medication|7|||
156811949|NCT00881530|566062597|FG001|Overall Study|Refused to continue medication|2|||
156811950|NCT00881530|566062598|FG002|Overall Study|Refused to continue medication|1|||
156811951|NCT00881530|566062599|FG003|Overall Study|Refused to continue medication|2|||
156811952|NCT00881530|566062600|FG004|Overall Study|Refused to continue medication|0|||
156811953|NCT00881530|566062601|FG005|Overall Study|Refused to continue medication|0|||
156811954|NCT00881530|566062596|FG000|Overall Study|Other reason not defined above|1|||
156811955|NCT00881530|566062597|FG001|Overall Study|Other reason not defined above|1|||
156811956|NCT00881530|566062598|FG002|Overall Study|Other reason not defined above|2|||
156811957|NCT00881530|566062599|FG003|Overall Study|Other reason not defined above|0|||
156811958|NCT00881530|566062600|FG004|Overall Study|Other reason not defined above|0|||
156811959|NCT00881530|566062601|FG005|Overall Study|Other reason not defined above|2|||
156811960|NCT03900728|566062602|FG000|Overall Study|No text responses|0|||
156811961|NCT03900728|566062603|FG001|Overall Study|No text responses|0|||
156811962|NCT03900728|566062604|FG002|Overall Study|No text responses|4|||
156811963|NCT04585269|566062610|FG000|Intervention|Withdrawal by Subject|9|||
156811964|NCT04585269|566062611|FG001|Intervention|Withdrawal by Subject|0|||
156811965|NCT04585269|566062610|FG000|Intervention|Unable to schedule|15|||
156811966|NCT04585269|566062611|FG001|Intervention|Unable to schedule|0|||
156811967|NCT04585269|566062610|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
156811968|NCT04585269|566062611|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
156811969|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Death|2|||
156811970|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Death|2|||
156811971|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
156811972|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
156811973|NCT04585269|566062610|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
156811974|NCT04585269|566062611|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
156811975|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
156811976|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
156811977|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
156811978|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
156811979|NCT04585269|566062610|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
156811980|NCT04585269|566062611|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
156811981|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
156883775|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156883776|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
157222638|NCT02637557|567562038|FG001|Overall Study|Withdrawal by Subject|3|||
157222639|NCT02637557|567562039|FG002|Overall Study|Withdrawal by Subject|4|||
157222640|NCT02637557|567562040|FG003|Overall Study|Withdrawal by Subject|2|||
157222641|NCT02006706|567562041|FG000|Overall Study|Lost to Follow-up|1|||
157222642|NCT01673009|567562042|FG000|Overall Study|Physician Decision|5|||
157022416|NCT06393088|566835209|FG001|Overall Study|Withdrawal by Subject|2|||
157022417|NCT03903146|566835210|FG000|Overall Study|Lost to Follow-up|6|||
157147973|NCT02699515|567288759|FG000|Overall Study|Withdrawal by Subject|0|||
157147974|NCT02699515|567288760|FG001|Overall Study|Withdrawal by Subject|0|||
157147975|NCT02699515|567288761|FG002|Overall Study|Withdrawal by Subject|3|||
157147976|NCT02699515|567288762|FG003|Overall Study|Withdrawal by Subject|1|||
157147977|NCT02699515|567288763|FG004|Overall Study|Withdrawal by Subject|5|||
157147978|NCT02699515|567288764|FG005|Overall Study|Withdrawal by Subject|3|||
157147979|NCT02699515|567288765|FG006|Overall Study|Withdrawal by Subject|0|||
157147980|NCT02699515|567288766|FG007|Overall Study|Withdrawal by Subject|1|||
157147981|NCT02699515|567288759|FG000|Overall Study|Other|1|||
157147982|NCT02699515|567288760|FG001|Overall Study|Other|0|||
157147983|NCT02699515|567288761|FG002|Overall Study|Other|1|||
157147984|NCT02699515|567288762|FG003|Overall Study|Other|6|||
157147985|NCT02699515|567288763|FG004|Overall Study|Other|4|||
157147986|NCT02699515|567288764|FG005|Overall Study|Other|3|||
157147987|NCT02699515|567288765|FG006|Overall Study|Other|0|||
157147988|NCT02699515|567288766|FG007|Overall Study|Other|0|||
157147989|NCT05243550|567288767|FG000|Overall Study|Ongoing in the Study|171|||
157147990|NCT05243550|567288767|FG000|Overall Study|Withdrawal by Subject|10|||
157147991|NCT05243550|567288767|FG000|Overall Study|Lost to Follow-up|7|||
157147992|NCT05243550|567288767|FG000|Overall Study|Adverse Event|3|||
157147993|NCT05243550|567288767|FG000|Overall Study|Noncompliance|1|||
157147994|NCT05243550|567288767|FG000|Overall Study|Physician Decision|1|||
157147995|NCT05243550|567288767|FG000|Overall Study|Other Reason|4|||
157147996|NCT01486316|567288768|FG000|Overall Study|Device explanted with/without re-implant|3|||
157147997|NCT01486316|567288769|FG001|Overall Study|Device explanted with/without re-implant|2|||
157147998|NCT01486316|567288770|FG002|Overall Study|Device explanted with/without re-implant|0|||
157147999|NCT01486316|567288771|FG003|Overall Study|Device explanted with/without re-implant|2|||
157148000|NCT01486316|567288768|FG000|Overall Study|Not meeting eligibility criteria|0|||
157148001|NCT01486316|567288769|FG001|Overall Study|Not meeting eligibility criteria|0|||
157148002|NCT01486316|567288770|FG002|Overall Study|Not meeting eligibility criteria|1|||
157148003|NCT01486316|567288771|FG003|Overall Study|Not meeting eligibility criteria|0|||
157148004|NCT01486316|567288768|FG000|Overall Study|Withdrawal by Subject|1|||
157148005|NCT01486316|567288769|FG001|Overall Study|Withdrawal by Subject|0|||
157148006|NCT01486316|567288770|FG002|Overall Study|Withdrawal by Subject|3|||
156811982|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811983|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811984|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811985|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811986|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811987|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811988|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811989|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811990|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811991|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811992|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811993|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
156811994|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
156811995|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
156811996|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811997|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811998|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156811999|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812000|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812001|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812002|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812003|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812004|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812005|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812006|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
156812007|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
156812008|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
156812009|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812010|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812011|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812012|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
156883777|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156883778|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
157022418|NCT03903146|566835211|FG001|Overall Study|Lost to Follow-up|4|||
157148007|NCT01486316|567288771|FG003|Overall Study|Withdrawal by Subject|0|||
156883779|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156883780|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
156883781|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
156883782|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
156883783|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
156883784|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
156883785|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
157022419|NCT03903146|566835210|FG000|Overall Study|Withdrawal by Subject|0|||
157022420|NCT03903146|566835211|FG001|Overall Study|Withdrawal by Subject|1|||
157022421|NCT05434078|566835212|FG000|Overall Study|Lost to Follow-up|2|||
157022422|NCT05434078|566835213|FG001|Overall Study|Lost to Follow-up|1|||
157022423|NCT05434078|566835212|FG000|Overall Study|Withdrawal by Subject|1|||
157022424|NCT05434078|566835213|FG001|Overall Study|Withdrawal by Subject|0|||
157022425|NCT03652688|566835215|FG000|Baseline|Withdrawal by Subject|0|||
157022426|NCT03652688|566835216|FG001|Baseline|Withdrawal by Subject|3|||
157022427|NCT03652688|566835215|FG000|Follow-up|Lost to Follow-up|56|||
157022428|NCT03652688|566835216|FG001|Follow-up|Lost to Follow-up|54|||
157222643|NCT01673009|567562042|FG000|Overall Study|Withdrawal by Subject|8|||
156812013|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812014|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812015|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812016|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812017|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812018|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812019|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
156812020|NCT03307785|566062616|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
157022429|NCT05551637|566835222|FG000|Overall Study|Lack of Efficacy|0|||
157022430|NCT05551637|566835223|FG001|Overall Study|Lack of Efficacy|6|||
157022431|NCT05551637|566835222|FG000|Overall Study|Lost to Follow-up|1|||
157022432|NCT05551637|566835223|FG001|Overall Study|Lost to Follow-up|1|||
157022433|NCT05179837|566835226|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
157022434|NCT05179837|566835226|FG000|Overall Study|Device malfunctioned|1|||
157022435|NCT05179837|566835226|FG000|Overall Study|Image quality too low|2|||
157022436|NCT05051124|566835227|FG000|Overall Study|Lost to Follow-up|2|||
157022437|NCT05051124|566835227|FG000|Overall Study|Withdrawal by Subject|1|||
157022438|NCT05051124|566835227|FG000|Overall Study|Residential relocation|2|||
157022439|NCT05051124|566835227|FG000|Overall Study|Death|1|||
157022440|NCT04782973|566835228|FG000|Overall Study|Withdrawal by Subject|5|||
157022441|NCT04782973|566835228|FG000|Overall Study|Protocol Violation|6|||
157022442|NCT04782973|566835228|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
157022443|NCT04924660|566835229|FG000|United States|Death|29|||
157022444|NCT04924660|566835230|FG001|United States|Death|32|||
157022445|NCT04924660|566835231|FG002|United States|Death|34|||
157022446|NCT04924660|566835232|FG003|United States|Death|25|||
157022447|NCT04924660|566835233|FG004|United States|Death|26|||
157022448|NCT04924660|566835234|FG005|United States|Death|23|||
157022449|NCT04924660|566835229|FG000|United States|Lost to Follow-up|15|||
157022450|NCT04924660|566835230|FG001|United States|Lost to Follow-up|10|||
157022451|NCT04924660|566835231|FG002|United States|Lost to Follow-up|13|||
157022452|NCT04924660|566835232|FG003|United States|Lost to Follow-up|5|||
157022453|NCT04924660|566835233|FG004|United States|Lost to Follow-up|19|||
157022454|NCT04924660|566835234|FG005|United States|Lost to Follow-up|20|||
157022455|NCT04924660|566835229|FG000|United States|Withdrawal by Subject|8|||
157022456|NCT04924660|566835230|FG001|United States|Withdrawal by Subject|3|||
157022457|NCT04924660|566835231|FG002|United States|Withdrawal by Subject|3|||
157022458|NCT04924660|566835232|FG003|United States|Withdrawal by Subject|3|||
157022459|NCT04924660|566835233|FG004|United States|Withdrawal by Subject|8|||
157022460|NCT04924660|566835234|FG005|United States|Withdrawal by Subject|4|||
157022461|NCT04924660|566835229|FG000|Spain|Death|0|||
157022462|NCT04924660|566835230|FG001|Spain|Death|0|||
157022463|NCT04924660|566835231|FG002|Spain|Death|0|||
157022464|NCT04924660|566835232|FG003|Spain|Death|0|||
157022465|NCT04924660|566835233|FG004|Spain|Death|0|||
157022466|NCT04924660|566835234|FG005|Spain|Death|2|||
157022467|NCT04924660|566835229|FG000|Spain|Lost to Follow-up|0|||
157022468|NCT04924660|566835230|FG001|Spain|Lost to Follow-up|0|||
157022469|NCT04924660|566835231|FG002|Spain|Lost to Follow-up|0|||
157022470|NCT04924660|566835232|FG003|Spain|Lost to Follow-up|0|||
157022471|NCT04924660|566835233|FG004|Spain|Lost to Follow-up|1|||
156883786|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
157022472|NCT04924660|566835234|FG005|Spain|Lost to Follow-up|0|||
157022473|NCT04924660|566835229|FG000|Brazil|Death|0|||
157022474|NCT04924660|566835230|FG001|Brazil|Death|0|||
157022475|NCT04924660|566835231|FG002|Brazil|Death|0|||
157022476|NCT04924660|566835232|FG003|Brazil|Death|0|||
157022477|NCT04924660|566835233|FG004|Brazil|Death|1|||
157022478|NCT04924660|566835234|FG005|Brazil|Death|0|||
157022479|NCT04924660|566835229|FG000|Italy|Lost to Follow-up|0|||
157022480|NCT04924660|566835230|FG001|Italy|Lost to Follow-up|0|||
157022481|NCT04924660|566835231|FG002|Italy|Lost to Follow-up|0|||
157148008|NCT01486316|567288768|FG000|Overall Study|Physician Decision|0|||
157148009|NCT01486316|567288769|FG001|Overall Study|Physician Decision|0|||
157148010|NCT01486316|567288770|FG002|Overall Study|Physician Decision|1|||
157148011|NCT01486316|567288771|FG003|Overall Study|Physician Decision|0|||
157148012|NCT01486316|567288768|FG000|Overall Study|Death|0|||
157148013|NCT01486316|567288769|FG001|Overall Study|Death|1|||
157148014|NCT01486316|567288770|FG002|Overall Study|Death|0|||
157148015|NCT01486316|567288771|FG003|Overall Study|Death|0|||
157148016|NCT00375934|567288780|FG000|Overall Study|Adverse Event|1|||
157148017|NCT00375934|567288781|FG001|Overall Study|Adverse Event|1|||
157148018|NCT00375934|567288780|FG000|Overall Study|Withdrawal by Subject|2|||
157148019|NCT00375934|567288781|FG001|Overall Study|Withdrawal by Subject|2|||
157148020|NCT00375934|567288780|FG000|Overall Study|Lack of Efficacy|0|||
157148021|NCT00375934|567288781|FG001|Overall Study|Lack of Efficacy|2|||
157148022|NCT00375934|567288780|FG000|Overall Study|Physician Decision|0|||
157148023|NCT00375934|567288781|FG001|Overall Study|Physician Decision|1|||
157148024|NCT03191396|567288783|FG000|Overall Study|Lost to Follow-up|0|||
157148025|NCT03191396|567288784|FG001|Overall Study|Lost to Follow-up|3|||
157148026|NCT03191396|567288783|FG000|Overall Study|Withdrawal by Subject|3|||
157148027|NCT03191396|567288784|FG001|Overall Study|Withdrawal by Subject|2|||
157148028|NCT05094154|567288785|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
157148029|NCT05094154|567288786|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
157148030|NCT05094154|567288785|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
157148031|NCT05094154|567288786|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
157148032|NCT00893113|567288793|FG000|Overall Study|Lost to Follow-up|4|||
157148033|NCT00893113|567288794|FG001|Overall Study|Lost to Follow-up|8|||
157148034|NCT00893113|567288793|FG000|Overall Study|Early Termination|1|||
157148035|NCT00893113|567288794|FG001|Overall Study|Early Termination|1|||
157148036|NCT00893113|567288793|FG000|Overall Study|Withdrew Consent|8|||
157148037|NCT00893113|567288794|FG001|Overall Study|Withdrew Consent|7|||
157148038|NCT02531035|567288797|FG000|Overall Study|Death|0|||
157148039|NCT02531035|567288798|FG001|Overall Study|Death|1|||
157148040|NCT02531035|567288797|FG000|Overall Study|Protocol Violation|1|||
157148041|NCT02531035|567288798|FG001|Overall Study|Protocol Violation|1|||
157148042|NCT02531035|567288797|FG000|Overall Study|Noncompliance with study drug|8|||
157148043|NCT02531035|567288798|FG001|Overall Study|Noncompliance with study drug|3|||
157148044|NCT02531035|567288797|FG000|Overall Study|Physician Decision|1|||
157148045|NCT02531035|567288798|FG001|Overall Study|Physician Decision|0|||
157148046|NCT02531035|567288797|FG000|Overall Study|Adverse Event|16|||
157148047|NCT02531035|567288798|FG001|Overall Study|Adverse Event|45|||
157148048|NCT02531035|567288797|FG000|Overall Study|Other|3|||
157148049|NCT02531035|567288798|FG001|Overall Study|Other|2|||
157148050|NCT02531035|567288797|FG000|Overall Study|Withdrawal by Subject|42|||
157148051|NCT02531035|567288798|FG001|Overall Study|Withdrawal by Subject|32|||
157148052|NCT02531035|567288797|FG000|Overall Study|Lost to Follow-up|8|||
157148053|NCT02531035|567288798|FG001|Overall Study|Lost to Follow-up|10|||
157148054|NCT02531035|567288797|FG000|Overall Study|Randomized, not treated|2|||
157148055|NCT02531035|567288798|FG001|Overall Study|Randomized, not treated|1|||
157148056|NCT01240811|567288799|FG000|Overall Study|Physician Decision|0|||
157148057|NCT01240811|567288800|FG001|Overall Study|Physician Decision|1|||
157148058|NCT01240811|567288801|FG002|Overall Study|Physician Decision|0|||
157148059|NCT01240811|567288799|FG000|Overall Study|Withdrawal by Subject|0|||
157148060|NCT01240811|567288800|FG001|Overall Study|Withdrawal by Subject|0|||
157148061|NCT01240811|567288801|FG002|Overall Study|Withdrawal by Subject|1|||
157148062|NCT02400346|567288812|FG000|Overall Study|Adverse Event|24|||
157148063|NCT02400346|567288812|FG000|Overall Study|Lack of Efficacy|9|||
157148064|NCT02400346|567288812|FG000|Overall Study|Non-compliance with IMP|1|||
157148065|NCT02400346|567288812|FG000|Overall Study|Withdrawal by Subject|7|||
157148066|NCT02400346|567288812|FG000|Overall Study|Administrative or other reason(s)|2|||
157148067|NCT02400346|567288812|FG000|Overall Study|Lost to Follow-up|1|||
157148068|NCT00486226|567288818|FG000|Overall Study|Death|3|||
157148069|NCT00486226|567288818|FG000|Overall Study|Adverse Event|1|||
157148070|NCT00486226|567288818|FG000|Overall Study|Withdrawal by Subject|1|||
157148071|NCT00486226|567288818|FG000|Overall Study|Lost to Follow-up|8|||
157148072|NCT01981122|567288823|FG000|Overall Study|Withdrawal by Subject|0|||
157148073|NCT01981122|567288824|FG001|Overall Study|Withdrawal by Subject|2|||
157148074|NCT01981122|567288823|FG000|Overall Study|Protocol Violation|0|||
157148075|NCT01981122|567288824|FG001|Overall Study|Protocol Violation|1|||
157148076|NCT01981122|567288823|FG000|Overall Study|Lost to Follow-up|0|||
157148077|NCT01981122|567288824|FG001|Overall Study|Lost to Follow-up|1|||
157148078|NCT01981122|567288823|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
157148079|NCT01981122|567288824|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
157148080|NCT01981122|567288823|FG000|Overall Study|Death|14|||
157148081|NCT01981122|567288824|FG001|Overall Study|Death|15|||
157148082|NCT02926573|567288826|FG000|Overall Study|Nausea|1|||
157148083|NCT02926573|567288827|FG001|Overall Study|Nausea|0|||
157148084|NCT02926573|567288826|FG000|Overall Study|Remain intubated|2|||
157148085|NCT02926573|567288827|FG001|Overall Study|Remain intubated|2|||
156883787|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
156883788|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
156883789|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
156883790|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
156883791|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|Other|0|||
156883792|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|Other|0|||
156883793|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|Other|0|||
156883794|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|Other|0|||
156883795|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|Other|0|||
156883796|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|Other|0|||
156883797|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|Other|0|||
156883798|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|Other|0|||
156883799|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|Other|1|||
156883800|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|Death|0|||
156883801|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|Death|0|||
156883802|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|Death|0|||
156883803|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|Death|0|||
156883804|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|Death|0|||
156883805|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|Death|0|||
156883806|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|Death|0|||
156883807|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|Death|0|||
156883808|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|Death|2|||
156883809|NCT00557856|566332657|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
156883810|NCT00557856|566332658|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
157148086|NCT02926573|567288826|FG000|Overall Study|Change in surgery plan|3|||
157148087|NCT02926573|567288827|FG001|Overall Study|Change in surgery plan|1|||
157148088|NCT02926573|567288826|FG000|Overall Study|Change to outpatient status|5|||
157148089|NCT02926573|567288827|FG001|Overall Study|Change to outpatient status|1|||
157148090|NCT02926573|567288826|FG000|Overall Study|Withdrawal by Subject|0|||
157148091|NCT02926573|567288827|FG001|Overall Study|Withdrawal by Subject|2|||
157148092|NCT02926573|567288826|FG000|Overall Study|Return to operating room|0|||
157148093|NCT02926573|567288827|FG001|Overall Study|Return to operating room|2|||
157148094|NCT02926573|567288826|FG000|Overall Study|Delirium|0|||
157148095|NCT02926573|567288827|FG001|Overall Study|Delirium|1|||
157148096|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
157148097|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
157148098|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
157148099|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
157148100|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157148101|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157148102|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
157148103|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
157148104|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
157148105|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
157148106|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157148107|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148108|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
157148109|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
157148110|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
157148111|NCT00611455|567288830|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
157148112|NCT00611455|567288831|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
157148113|NCT00611455|567288832|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
157148114|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
157148115|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
157148116|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
157148117|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
157148118|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
157148119|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
157148120|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
157148121|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
157148122|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
157148123|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
157148124|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
157148125|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
157148126|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
157222644|NCT04161144|567562043|FG000|Overall Study|Withdrawal by Subject|0|||
156883811|NCT00557856|566332659|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
156883812|NCT00557856|566332660|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
156883813|NCT00557856|566332661|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
156883814|NCT00557856|566332662|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
157022482|NCT04924660|566835232|FG003|Italy|Lost to Follow-up|0|||
157148127|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
157148128|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
157148129|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
157148130|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
157148131|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
157148132|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
157148133|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
157148134|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
157148135|NCT00611455|567288830|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
157148136|NCT00611455|567288831|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
157148137|NCT00611455|567288832|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
157148138|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
157148139|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
157148140|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
157148141|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
157148142|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
157148143|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
157148144|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
157148145|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
157148146|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
157148147|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
157148148|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
157148149|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
157148150|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
157148151|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
157148152|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
157148153|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
157148154|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
157148155|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
157148156|NCT00611455|567288830|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
157148157|NCT00611455|567288831|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
157148158|NCT00611455|567288832|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
156812021|NCT03307785|566062617|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
156812022|NCT03307785|566062618|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812023|NCT03307785|566062619|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812024|NCT03307785|566062620|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812025|NCT03307785|566062621|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812026|NCT03307785|566062622|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812027|NCT03307785|566062623|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812028|NCT03307785|566062624|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812029|NCT03307785|566062625|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812030|NCT03307785|566062626|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812031|NCT03307785|566062627|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812032|NCT03307785|566062628|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
156812033|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812034|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812035|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
156812036|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812037|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812038|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812039|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812040|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812041|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812042|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812043|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812044|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812045|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
156812046|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812047|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812048|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
156812049|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812050|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812051|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
156883815|NCT00557856|566332663|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
157222645|NCT04161144|567562044|FG001|Overall Study|Withdrawal by Subject|1|||
157222646|NCT04161144|567562043|FG000|Overall Study|Protocol Violation|1|||
157222647|NCT04161144|567562044|FG001|Overall Study|Protocol Violation|0|||
157222648|NCT03093454|567562048|FG000|Overall Study|Withdrawal by Subject|1|||
157222649|NCT03093454|567562049|FG001|Overall Study|Withdrawal by Subject|1|||
157222650|NCT03093454|567562048|FG000|Overall Study|Scheduling conflict|3|||
157222651|NCT03093454|567562049|FG001|Overall Study|Scheduling conflict|1|||
157222652|NCT03093454|567562048|FG000|Overall Study|Physician Decision|2|||
157222653|NCT03093454|567562049|FG001|Overall Study|Physician Decision|1|||
157222654|NCT02524379|567562050|FG000|Overall Study|Death|1|||
157222655|NCT00812253|567562051|FG000|Overall Study|Withdrawal by Subject|3|||
157222656|NCT00812253|567562052|FG001|Overall Study|Withdrawal by Subject|2|||
157222657|NCT00812253|567562051|FG000|Overall Study|Protocol Violation|1|||
157222658|NCT00812253|567562052|FG001|Overall Study|Protocol Violation|1|||
157222659|NCT00812253|567562051|FG000|Overall Study|Lost to Follow-up|2|||
157222660|NCT00812253|567562052|FG001|Overall Study|Lost to Follow-up|0|||
157222661|NCT00384033|567562056|FG000|Overall Study|Adverse Event|10|||
157222662|NCT00384033|567562057|FG001|Overall Study|Adverse Event|8|||
157222663|NCT00384033|567562058|FG002|Overall Study|Adverse Event|11|||
157222664|NCT00384033|567562059|FG003|Overall Study|Adverse Event|20|||
157222665|NCT00384033|567562056|FG000|Overall Study|Failed to return|1|||
157222666|NCT00384033|567562057|FG001|Overall Study|Failed to return|3|||
157222667|NCT00384033|567562058|FG002|Overall Study|Failed to return|2|||
157222668|NCT00384033|567562059|FG003|Overall Study|Failed to return|2|||
157222669|NCT00384033|567562056|FG000|Overall Study|Physician Decision|1|||
157222670|NCT00384033|567562057|FG001|Overall Study|Physician Decision|0|||
157222671|NCT00384033|567562058|FG002|Overall Study|Physician Decision|0|||
157222672|NCT00384033|567562059|FG003|Overall Study|Physician Decision|0|||
157222673|NCT00384033|567562056|FG000|Overall Study|Lost to Follow-up|6|||
157222674|NCT00384033|567562057|FG001|Overall Study|Lost to Follow-up|12|||
157222675|NCT00384033|567562058|FG002|Overall Study|Lost to Follow-up|7|||
157222676|NCT00384033|567562059|FG003|Overall Study|Lost to Follow-up|7|||
157222677|NCT00384033|567562056|FG000|Overall Study|Other|2|||
157222678|NCT00384033|567562057|FG001|Overall Study|Other|0|||
157222679|NCT00384033|567562058|FG002|Overall Study|Other|0|||
157222680|NCT00384033|567562059|FG003|Overall Study|Other|0|||
157222681|NCT00384033|567562056|FG000|Overall Study|Protocol Violation|5|||
157222682|NCT00384033|567562057|FG001|Overall Study|Protocol Violation|0|||
157222683|NCT00384033|567562058|FG002|Overall Study|Protocol Violation|5|||
157222684|NCT00384033|567562059|FG003|Overall Study|Protocol Violation|6|||
157222685|NCT00384033|567562056|FG000|Overall Study|Withdrawal by Subject|6|||
157222686|NCT00384033|567562057|FG001|Overall Study|Withdrawal by Subject|2|||
157222687|NCT00384033|567562058|FG002|Overall Study|Withdrawal by Subject|5|||
157222688|NCT00384033|567562059|FG003|Overall Study|Withdrawal by Subject|2|||
157222689|NCT00384033|567562056|FG000|Overall Study|Lack of Efficacy|7|||
157222690|NCT00384033|567562057|FG001|Overall Study|Lack of Efficacy|3|||
157222691|NCT00384033|567562058|FG002|Overall Study|Lack of Efficacy|3|||
157222692|NCT00384033|567562059|FG003|Overall Study|Lack of Efficacy|1|||
156812052|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812053|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812054|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812055|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812056|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812057|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812058|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
156812059|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812060|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812061|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
156812062|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812063|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812064|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812065|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
157222693|NCT00384033|567562056|FG000|Overall Study|Randomized but not treated|3|||
157222694|NCT00384033|567562057|FG001|Overall Study|Randomized but not treated|7|||
157222695|NCT00384033|567562058|FG002|Overall Study|Randomized but not treated|10|||
157222696|NCT00384033|567562059|FG003|Overall Study|Randomized but not treated|2|||
157222697|NCT03349333|567562060|FG000|Overall Study|Progression of Disease|36|||
157222698|NCT03349333|567562060|FG000|Overall Study|Adverse Event|11|||
157222699|NCT03349333|567562060|FG000|Overall Study|Other|6|||
157222700|NCT03349333|567562060|FG000|Overall Study|Withdrawal by Subject|5|||
157222701|NCT03349333|567562060|FG000|Overall Study|Conditions interfere with participation|2|||
157222702|NCT03349333|567562060|FG000|Overall Study|Physician Decision|2|||
157222703|NCT03349333|567562060|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
157222704|NCT03349333|567562060|FG000|Overall Study|Patients in treatment less than 24 month|8|||
157222705|NCT02985151|567562062|FG000|Original Randomization|Withdrawal by Subject|0|||
157222706|NCT02985151|567562063|FG001|Original Randomization|Withdrawal by Subject|1|||
157222707|NCT02752776|567562070|FG000|Overall Study|Adverse Event|15|||
157222708|NCT02752776|567562071|FG001|Overall Study|Adverse Event|23|||
157222709|NCT02752776|567562072|FG002|Overall Study|Adverse Event|11|||
157222710|NCT02752776|567562070|FG000|Overall Study|Lack of Efficacy|2|||
157222711|NCT02752776|567562071|FG001|Overall Study|Lack of Efficacy|6|||
157222712|NCT02752776|567562072|FG002|Overall Study|Lack of Efficacy|14|||
157222713|NCT02752776|567562070|FG000|Overall Study|Lost to Follow-up|11|||
157222714|NCT02752776|567562071|FG001|Overall Study|Lost to Follow-up|12|||
157222715|NCT02752776|567562072|FG002|Overall Study|Lost to Follow-up|4|||
157222716|NCT02752776|567562070|FG000|Overall Study|Non-compliance with study treatment|0|||
157222717|NCT02752776|567562071|FG001|Overall Study|Non-compliance with study treatment|0|||
157222718|NCT02752776|567562072|FG002|Overall Study|Non-compliance with study treatment|1|||
157222719|NCT02752776|567562070|FG000|Overall Study|Physician Decision|2|||
157222720|NCT02752776|567562071|FG001|Overall Study|Physician Decision|6|||
157222721|NCT02752776|567562072|FG002|Overall Study|Physician Decision|2|||
157222722|NCT02752776|567562070|FG000|Overall Study|Pregnancy|1|||
157222723|NCT02752776|567562071|FG001|Overall Study|Pregnancy|6|||
157222724|NCT02752776|567562072|FG002|Overall Study|Pregnancy|3|||
157222725|NCT02752776|567562070|FG000|Overall Study|Protocol Violation|10|||
157222726|NCT02752776|567562071|FG001|Overall Study|Protocol Violation|13|||
157222727|NCT02752776|567562072|FG002|Overall Study|Protocol Violation|6|||
157222728|NCT02752776|567562070|FG000|Overall Study|Subject/guardian decision|8|||
157222729|NCT02752776|567562071|FG001|Overall Study|Subject/guardian decision|6|||
157222730|NCT02752776|567562072|FG002|Overall Study|Subject/guardian decision|4|||
157222731|NCT02752776|567562070|FG000|Overall Study|Death|0|||
157222732|NCT02752776|567562071|FG001|Overall Study|Death|0|||
157222733|NCT02752776|567562072|FG002|Overall Study|Death|1|||
157222734|NCT02752776|567562070|FG000|Overall Study|Withdrawal by Subject|3|||
157222735|NCT02752776|567562071|FG001|Overall Study|Withdrawal by Subject|4|||
157222736|NCT02752776|567562072|FG002|Overall Study|Withdrawal by Subject|2|||
157222737|NCT01816477|567562073|FG000|Overall Study|Withdrawal by Subject|13|||
157222738|NCT01816477|567562074|FG001|Overall Study|Withdrawal by Subject|1|||
157222739|NCT01816477|567562073|FG000|Overall Study|Unable to tolerate catheter placement|3|||
157222740|NCT01816477|567562074|FG001|Overall Study|Unable to tolerate catheter placement|0|||
157222741|NCT02162758|567562075|FG000|Overall Study|Study termination|0|||
157222742|NCT02162758|567562076|FG001|Overall Study|Study termination|1|||
157222743|NCT02116803|567562077|FG000|Overall Study|Adverse Event|2|||
157222744|NCT02116803|567562078|FG001|Overall Study|Adverse Event|1|||
157222745|NCT02116803|567562077|FG000|Overall Study|Physician Decision|1|||
157222746|NCT02116803|567562078|FG001|Overall Study|Physician Decision|0|||
157222747|NCT02116803|567562077|FG000|Overall Study|Progressive disease|4|||
157222748|NCT02116803|567562078|FG001|Overall Study|Progressive disease|0|||
157222749|NCT02116803|567562077|FG000|Overall Study|Study terminated by sponsor|2|||
157222750|NCT02116803|567562078|FG001|Overall Study|Study terminated by sponsor|1|||
157222751|NCT02116803|567562077|FG000|Overall Study|Death|1|||
157222752|NCT02116803|567562078|FG001|Overall Study|Death|0|||
157222753|NCT03213210|567562079|FG000|Overall Study|Lost to Follow-up|2|||
157222754|NCT03213210|567562079|FG000|Overall Study|Study termination|3|||
157222755|NCT00481247|567562082|FG000|Overall Study|Death|0|||
157148159|NCT04601272|567288833|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
157148160|NCT04601272|567288834|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
157148161|NCT04601272|567288835|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
157148162|NCT00942708|567288837|FG000|Overall Study|Withdrawal by Subject|1|||
157148163|NCT00995371|567288838|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
157148164|NCT00995371|567288839|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
157148165|NCT00673673|567288840|FG000|Overall Study|Progressive disease|27|||
157148166|NCT00673673|567288840|FG000|Overall Study|Adverse Event|4|||
157148167|NCT00673673|567288840|FG000|Overall Study|Withdrawal by Subject|3|||
157148168|NCT00673673|567288840|FG000|Overall Study|Investigators' discretion|2|||
157148169|NCT04579393|567288853|FG000|Overall Study|Withdrawal by Subject|2|||
157148170|NCT04579393|567288854|FG001|Overall Study|Withdrawal by Subject|2|||
157148171|NCT04579393|567288853|FG000|Overall Study|Death|1|||
157222756|NCT00481247|567562083|FG001|Overall Study|Death|1|||
157222757|NCT00481247|567562082|FG000|Overall Study|Disease progression|18|||
157222758|NCT00481247|567562083|FG001|Overall Study|Disease progression|22|||
157022483|NCT04924660|566835233|FG004|Italy|Lost to Follow-up|0|||
157022484|NCT04924660|566835234|FG005|Italy|Lost to Follow-up|1|||
157222759|NCT00481247|567562082|FG000|Overall Study|Intolerance|42|||
157222760|NCT00481247|567562083|FG001|Overall Study|Intolerance|17|||
157222761|NCT00481247|567562082|FG000|Overall Study|Treatment failure|10|||
157222762|NCT00481247|567562083|FG001|Overall Study|Treatment failure|14|||
157222763|NCT00481247|567562082|FG000|Overall Study|AE unrelated to study drug|13|||
157222764|NCT00481247|567562083|FG001|Overall Study|AE unrelated to study drug|4|||
157148172|NCT04579393|567288854|FG001|Overall Study|Death|3|||
157222765|NCT00481247|567562082|FG000|Overall Study|Withdrawal by Subject|8|||
157222766|NCT00481247|567562083|FG001|Overall Study|Withdrawal by Subject|13|||
157022485|NCT04924660|566835229|FG000|South Africa|Death|0|||
157148173|NCT01282814|567288855|FG000|First Intervention|Emesis During Dosing Interval|0|||
157148174|NCT01282814|567288856|FG001|First Intervention|Emesis During Dosing Interval|3|||
157148175|NCT01282814|567288855|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
157148176|NCT01282814|567288856|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
157148177|NCT01524289|567288857|FG000|Overall Study|Lost to Follow-up|0|||
157148178|NCT01524289|567288858|FG001|Overall Study|Lost to Follow-up|1|||
157148179|NCT01524289|567288857|FG000|Overall Study|Physician Decision|1|||
157148180|NCT01524289|567288858|FG001|Overall Study|Physician Decision|0|||
157148181|NCT01524289|567288857|FG000|Overall Study|Protocol Violation|5|||
157148182|NCT01524289|567288858|FG001|Overall Study|Protocol Violation|1|||
157148183|NCT01524289|567288857|FG000|Overall Study|Withdrawal by Subject|11|||
157148184|NCT01524289|567288858|FG001|Overall Study|Withdrawal by Subject|7|||
157148185|NCT01524289|567288857|FG000|Overall Study|Adverse Event|12|||
157148186|NCT01524289|567288858|FG001|Overall Study|Adverse Event|5|||
157148187|NCT01524289|567288857|FG000|Overall Study|Did not take study medication|1|||
157148188|NCT01524289|567288858|FG001|Overall Study|Did not take study medication|0|||
157148189|NCT02519231|567288861|FG000|Overall Study|Lost to Follow-up|2|||
157148190|NCT02519231|567288862|FG001|Overall Study|Lost to Follow-up|5|||
157148191|NCT02519231|567288861|FG000|Overall Study|Withdrawal by Subject|0|||
157148192|NCT02519231|567288862|FG001|Overall Study|Withdrawal by Subject|1|||
157148193|NCT02704429|567288863|FG000|Part A: 24 Weeks|Adverse Event|3|||
157148194|NCT02704429|567288864|FG001|Part A: 24 Weeks|Adverse Event|0|||
157148195|NCT02704429|567288863|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
157148196|NCT02704429|567288864|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
157148197|NCT00104104|567288865|FG000|Overall Study|Adverse Event|8|||
157148198|NCT00104104|567288866|FG001|Overall Study|Adverse Event|8|||
157148199|NCT00104104|567288865|FG000|Overall Study|Abnormal laboratory value(s)|20|||
157148200|NCT00104104|567288866|FG001|Overall Study|Abnormal laboratory value(s)|14|||
157148201|NCT00104104|567288865|FG000|Overall Study|Lack of Efficacy|0|||
157148202|NCT00104104|567288866|FG001|Overall Study|Lack of Efficacy|3|||
157148203|NCT00104104|567288865|FG000|Overall Study|Condition no longer requires study drug|7|||
157148204|NCT00104104|567288866|FG001|Overall Study|Condition no longer requires study drug|4|||
157148205|NCT00104104|567288865|FG000|Overall Study|Protocol Violation|5|||
156812066|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812067|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812068|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812069|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812070|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812071|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
156812072|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812073|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812074|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
156812075|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812076|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812077|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812078|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812079|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812080|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812081|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812082|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812083|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812084|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
156812085|NCT03307785|566062616|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812086|NCT03307785|566062617|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812087|NCT03307785|566062618|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
156812088|NCT03307785|566062619|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812089|NCT03307785|566062620|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812090|NCT03307785|566062621|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812091|NCT03307785|566062622|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812092|NCT03307785|566062623|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812093|NCT03307785|566062624|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812094|NCT03307785|566062625|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812095|NCT03307785|566062626|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
157148206|NCT00104104|567288866|FG001|Overall Study|Protocol Violation|2|||
157148207|NCT00104104|567288865|FG000|Overall Study|Withdrawal by Subject|11|||
157148208|NCT00104104|567288866|FG001|Overall Study|Withdrawal by Subject|15|||
157148209|NCT00104104|567288865|FG000|Overall Study|Lost to Follow-up|3|||
157148210|NCT00104104|567288866|FG001|Overall Study|Lost to Follow-up|7|||
156812096|NCT03307785|566062627|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812097|NCT03307785|566062628|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
156812098|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812099|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812100|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812101|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
156812102|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
156812103|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812104|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812105|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812106|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812107|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812108|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812109|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812110|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
156812111|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812112|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812113|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812114|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
156812115|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
156812116|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812117|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812118|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812119|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812120|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812121|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812122|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812123|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
156812124|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812125|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812126|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812127|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
156812128|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812129|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812130|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812131|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812132|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812133|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812134|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812135|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812136|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
156812137|NCT03307785|566062616|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812138|NCT03307785|566062617|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812139|NCT03307785|566062618|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812140|NCT03307785|566062619|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812141|NCT03307785|566062620|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
156812142|NCT03307785|566062621|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812143|NCT03307785|566062622|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
157148211|NCT00104104|567288865|FG000|Overall Study|Administrative problems|12|||
157148212|NCT00104104|567288866|FG001|Overall Study|Administrative problems|13|||
157148213|NCT00104104|567288865|FG000|Overall Study|Death|9|||
157148214|NCT00104104|567288866|FG001|Overall Study|Death|6|||
157148215|NCT01326962|567288870|FG000|Overall Study|Adverse Event|1|||
157148216|NCT01326962|567288870|FG000|Overall Study|Withdrawal by Subject|1|||
157148217|NCT01326962|567288870|FG000|Overall Study|Lost to Follow-up|3|||
157148218|NCT01326962|567288870|FG000|Overall Study|Other|2|||
157148219|NCT02053246|567288871|FG000|Overall Study|Withdrawal by Subject|3|||
157148220|NCT02053246|567288871|FG000|Overall Study|Physician Decision|1|||
156812144|NCT03307785|566062623|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812145|NCT03307785|566062624|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156883816|NCT00557856|566332664|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
157148221|NCT02707757|567288872|FG000|Overall Study|Protocol Violation|3|||
157148222|NCT02707757|567288873|FG001|Overall Study|Protocol Violation|2|||
157148223|NCT02707757|567288872|FG000|Overall Study|Withdrawal by Subject|2|||
157148224|NCT02707757|567288873|FG001|Overall Study|Withdrawal by Subject|0|||
157148225|NCT02707757|567288872|FG000|Overall Study|Death|0|||
157148226|NCT02707757|567288873|FG001|Overall Study|Death|1|||
156812146|NCT03307785|566062625|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812147|NCT03307785|566062626|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812148|NCT03307785|566062627|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812149|NCT03307785|566062628|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
156812150|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812151|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812152|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812153|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812154|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156883817|NCT00557856|566332665|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
156883818|NCT05092360|566332666|FG000|Overall Study|Withdrawal by Subject|21|||
156883819|NCT05092360|566332667|FG001|Overall Study|Withdrawal by Subject|4|||
156883820|NCT05092360|566332668|FG002|Overall Study|Withdrawal by Subject|9|||
156883821|NCT05092360|566332669|FG003|Overall Study|Withdrawal by Subject|26|||
156883822|NCT05092360|566332666|FG000|Overall Study|Death|97|||
156883823|NCT05092360|566332667|FG001|Overall Study|Death|14|||
156883824|NCT05092360|566332668|FG002|Overall Study|Death|31|||
156883825|NCT05092360|566332669|FG003|Overall Study|Death|101|||
156883826|NCT05092360|566332666|FG000|Overall Study|Lost to Follow-up|1|||
156883827|NCT05092360|566332667|FG001|Overall Study|Lost to Follow-up|2|||
156883828|NCT05092360|566332668|FG002|Overall Study|Lost to Follow-up|2|||
156883829|NCT05092360|566332669|FG003|Overall Study|Lost to Follow-up|2|||
156883830|NCT05092360|566332666|FG000|Overall Study|Study terminated by sponsor|65|||
156883831|NCT05092360|566332667|FG001|Overall Study|Study terminated by sponsor|7|||
156883832|NCT05092360|566332668|FG002|Overall Study|Study terminated by sponsor|13|||
156883833|NCT05092360|566332669|FG003|Overall Study|Study terminated by sponsor|61|||
156883834|NCT01675167|566332670|FG000|Open-label Titration Phase|Adverse Event|81|||
156883835|NCT01675167|566332671|FG001|Open-label Titration Phase|Adverse Event|0|||
156883836|NCT01675167|566332672|FG002|Open-label Titration Phase|Adverse Event|0|||
156883837|NCT01675167|566332670|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
156883838|NCT01675167|566332671|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
156883839|NCT01675167|566332672|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
156883840|NCT01675167|566332670|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
156883841|NCT01675167|566332671|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
156883842|NCT01675167|566332672|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
156883843|NCT01675167|566332670|FG000|Open-label Titration Phase|Protocol Violation|43|||
156883844|NCT01675167|566332671|FG001|Open-label Titration Phase|Protocol Violation|0|||
156883845|NCT01675167|566332672|FG002|Open-label Titration Phase|Protocol Violation|0|||
156883846|NCT01675167|566332670|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
156883847|NCT01675167|566332671|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
156883848|NCT01675167|566332672|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
156883849|NCT01675167|566332670|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
156883850|NCT01675167|566332671|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
156883851|NCT01675167|566332672|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
156883852|NCT01675167|566332670|FG000|Open-label Titration Phase|Other|55|||
156883853|NCT01675167|566332671|FG001|Open-label Titration Phase|Other|0|||
156883854|NCT01675167|566332672|FG002|Open-label Titration Phase|Other|0|||
156883855|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156883856|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
156883857|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
156883858|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156883859|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156883860|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156883861|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156883862|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Adverse Event|5|||
156883863|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Adverse Event|13|||
156883864|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156883865|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
156883866|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
156883867|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
157148227|NCT02707757|567288872|FG000|Overall Study|Adverse Event|6|||
156883868|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
157022486|NCT04924660|566835230|FG001|South Africa|Death|0|||
156883869|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
156883870|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
156883871|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
156883872|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
156883873|NCT01675167|566332670|FG000|Double-blind Treatment Phase|Other|0|||
156883874|NCT01675167|566332671|FG001|Double-blind Treatment Phase|Other|7|||
156883875|NCT01675167|566332672|FG002|Double-blind Treatment Phase|Other|5|||
156812155|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
156812156|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812157|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812158|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812159|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812160|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812161|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812162|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
156812163|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812164|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812165|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812166|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812167|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812168|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
156812169|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812170|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812171|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812172|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812173|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812174|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812175|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
156812176|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812177|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812178|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812179|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812180|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812181|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
156812182|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812183|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812184|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812185|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812186|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812187|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812188|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
156812189|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812190|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812191|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812192|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812193|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812194|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
156812195|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812196|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812197|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812198|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812199|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812200|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812201|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
156812202|NCT03307785|566062616|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812203|NCT03307785|566062617|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812204|NCT03307785|566062618|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812205|NCT03307785|566062619|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812206|NCT03307785|566062620|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812207|NCT03307785|566062621|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
156812208|NCT03307785|566062622|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812209|NCT03307785|566062623|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812210|NCT03307785|566062624|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812211|NCT03307785|566062625|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812212|NCT03307785|566062626|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812213|NCT03307785|566062627|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812214|NCT03307785|566062628|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
156812215|NCT03307785|566062616|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812216|NCT03307785|566062617|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812217|NCT03307785|566062618|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812218|NCT03307785|566062619|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812219|NCT03307785|566062620|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812220|NCT03307785|566062621|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812221|NCT03307785|566062622|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
156812222|NCT03307785|566062623|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812223|NCT03307785|566062624|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812224|NCT03307785|566062625|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812225|NCT03307785|566062626|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812226|NCT03307785|566062627|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812227|NCT03307785|566062628|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
156812228|NCT03307785|566062616|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812229|NCT03307785|566062617|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812230|NCT03307785|566062618|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812231|NCT03307785|566062619|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812232|NCT03307785|566062620|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812233|NCT03307785|566062621|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812234|NCT03307785|566062622|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
156812235|NCT03307785|566062623|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812236|NCT03307785|566062624|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812237|NCT03307785|566062625|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812238|NCT03307785|566062626|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812239|NCT03307785|566062627|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812240|NCT03307785|566062628|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
156812241|NCT03307785|566062616|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812242|NCT03307785|566062617|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812243|NCT03307785|566062618|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812244|NCT03307785|566062619|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812245|NCT03307785|566062620|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812246|NCT03307785|566062621|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812247|NCT03307785|566062622|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812248|NCT03307785|566062623|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
156812249|NCT03307785|566062624|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812250|NCT03307785|566062625|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812251|NCT03307785|566062626|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812252|NCT03307785|566062627|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812253|NCT03307785|566062628|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
156812254|NCT03307785|566062616|FG000|PACT Phase: Up to 19 Months|Death|0|||
156812255|NCT03307785|566062617|FG001|PACT Phase: Up to 19 Months|Death|0|||
156812256|NCT03307785|566062618|FG002|PACT Phase: Up to 19 Months|Death|0|||
156812257|NCT03307785|566062619|FG003|PACT Phase: Up to 19 Months|Death|0|||
156812258|NCT03307785|566062620|FG004|PACT Phase: Up to 19 Months|Death|0|||
156812259|NCT03307785|566062621|FG005|PACT Phase: Up to 19 Months|Death|0|||
156812260|NCT03307785|566062622|FG006|PACT Phase: Up to 19 Months|Death|0|||
156812261|NCT03307785|566062623|FG007|PACT Phase: Up to 19 Months|Death|0|||
156812262|NCT03307785|566062624|FG008|PACT Phase: Up to 19 Months|Death|0|||
156812263|NCT03307785|566062625|FG009|PACT Phase: Up to 19 Months|Death|0|||
156812264|NCT03307785|566062626|FG010|PACT Phase: Up to 19 Months|Death|0|||
156812265|NCT03307785|566062627|FG011|PACT Phase: Up to 19 Months|Death|0|||
156812266|NCT03307785|566062628|FG012|PACT Phase: Up to 19 Months|Death|1|||
156812267|NCT05588440|566062630|FG000|Overall Study|Sponsor Decision|2|||
156812268|NCT05588440|566062631|FG001|Overall Study|Sponsor Decision|0|||
156812269|NCT05588440|566062632|FG002|Overall Study|Sponsor Decision|1|||
156812270|NCT05588440|566062630|FG000|Overall Study|Death|1|||
156812271|NCT05588440|566062631|FG001|Overall Study|Death|1|||
156812272|NCT05588440|566062632|FG002|Overall Study|Death|1|||
156812273|NCT05588440|566062630|FG000|Overall Study|Screen Fail|0|||
156812274|NCT05588440|566062631|FG001|Overall Study|Screen Fail|1|||
156812275|NCT05588440|566062632|FG002|Overall Study|Screen Fail|1|||
156812276|NCT05588440|566062630|FG000|Overall Study|Withdrawal by Subject|0|||
156812277|NCT05588440|566062631|FG001|Overall Study|Withdrawal by Subject|0|||
156812278|NCT05588440|566062632|FG002|Overall Study|Withdrawal by Subject|1|||
156812279|NCT03381287|566062634|FG000|Overall Study|Withdrawal by Subject|0|||
156812280|NCT03381287|566062635|FG001|Overall Study|Withdrawal by Subject|1|||
156812281|NCT03381287|566062636|FG002|Overall Study|Withdrawal by Subject|0|||
156812282|NCT03381287|566062637|FG003|Overall Study|Withdrawal by Subject|0|||
156812283|NCT03381287|566062634|FG000|Overall Study|Adverse Event|0|||
156812284|NCT03381287|566062635|FG001|Overall Study|Adverse Event|0|||
156812285|NCT03381287|566062636|FG002|Overall Study|Adverse Event|0|||
156812286|NCT03381287|566062637|FG003|Overall Study|Adverse Event|1|||
156812287|NCT03381287|566062634|FG000|Overall Study|Physician Decision|0|||
156812288|NCT03381287|566062635|FG001|Overall Study|Physician Decision|0|||
156812289|NCT03381287|566062636|FG002|Overall Study|Physician Decision|0|||
156812290|NCT03381287|566062637|FG003|Overall Study|Physician Decision|1|||
156812291|NCT00325130|566062671|FG000|Overall Study|Lost to Follow-up|6|||
156812292|NCT00325130|566062672|FG001|Overall Study|Lost to Follow-up|14|||
156812293|NCT00325130|566062671|FG000|Overall Study|Withdrawal by Subject|12|||
156812294|NCT00325130|566062672|FG001|Overall Study|Withdrawal by Subject|14|||
156812295|NCT00325130|566062671|FG000|Overall Study|Protocol Deviation|0|||
156812296|NCT00325130|566062672|FG001|Overall Study|Protocol Deviation|1|||
156812297|NCT00325130|566062671|FG000|Overall Study|Moved|0|||
156812298|NCT00325130|566062672|FG001|Overall Study|Moved|1|||
156812299|NCT00325130|566062671|FG000|Overall Study|Patient Discontinued for Other|1|||
156812300|NCT00325130|566062672|FG001|Overall Study|Patient Discontinued for Other|0|||
156812301|NCT01671956|566062675|FG000|Overall Study|Disease progression|0|||
156812302|NCT01671956|566062676|FG001|Overall Study|Disease progression|1|||
156812303|NCT01671956|566062675|FG000|Overall Study|Withdrawal by Subject|1|||
156812304|NCT01671956|566062676|FG001|Overall Study|Withdrawal by Subject|1|||
156812305|NCT01671956|566062675|FG000|Overall Study|Adverse Event|1|||
156812306|NCT01671956|566062676|FG001|Overall Study|Adverse Event|0|||
156812307|NCT04266912|566062682|FG000|Overall Study|Withdrawal by Subject|1|||
156812308|NCT04266912|566062683|FG001|Overall Study|Withdrawal by Subject|0|||
156812309|NCT04266912|566062684|FG002|Overall Study|Withdrawal by Subject|0|||
156812310|NCT04266912|566062685|FG003|Overall Study|Withdrawal by Subject|0|||
156812311|NCT04266912|566062682|FG000|Overall Study|Progression|6|||
156812312|NCT04266912|566062683|FG001|Overall Study|Progression|6|||
156812313|NCT04266912|566062684|FG002|Overall Study|Progression|0|||
156812314|NCT04266912|566062685|FG003|Overall Study|Progression|10|||
156812315|NCT02842086|566062692|FG000|Overall Study|Randomized but Never Treated|6|||
156812316|NCT02842086|566062693|FG001|Overall Study|Randomized but Never Treated|6|||
156812317|NCT02842086|566062692|FG000|Overall Study|Still in Double-Blind Phase|7|||
156812318|NCT02842086|566062693|FG001|Overall Study|Still in Double-Blind Phase|3|||
156812319|NCT02842086|566062692|FG000|Overall Study|Adverse Event|18|||
156812320|NCT02842086|566062693|FG001|Overall Study|Adverse Event|20|||
156812321|NCT02842086|566062692|FG000|Overall Study|Death|3|||
156812322|NCT02842086|566062693|FG001|Overall Study|Death|3|||
156812323|NCT02842086|566062692|FG000|Overall Study|Investigator's Discretion|9|||
156812324|NCT02842086|566062693|FG001|Overall Study|Investigator's Discretion|13|||
156812325|NCT02842086|566062692|FG000|Overall Study|Non-Compliance with Study Drug|9|||
156812326|NCT02842086|566062693|FG001|Overall Study|Non-Compliance with Study Drug|8|||
156812327|NCT02842086|566062692|FG000|Overall Study|Protocol Violation|8|||
156812328|NCT02842086|566062693|FG001|Overall Study|Protocol Violation|4|||
156812329|NCT02842086|566062692|FG000|Overall Study|Withdrew Consent|205|||
156812330|NCT02842086|566062693|FG001|Overall Study|Withdrew Consent|194|||
156812331|NCT02842086|566062692|FG000|Overall Study|Lost to Follow-up|274|||
156812332|NCT02842086|566062693|FG001|Overall Study|Lost to Follow-up|236|||
156812333|NCT02842086|566062692|FG000|Overall Study|HIV-1 Infection|5|||
156812334|NCT02842086|566062693|FG001|Overall Study|HIV-1 Infection|6|||
156812335|NCT03581292|566062694|FG000|Overall Study|Physician Decision|9|||
156812336|NCT03581292|566062695|FG001|Overall Study|Physician Decision|5|||
156812337|NCT03581292|566062694|FG000|Overall Study|Withdrawal by Subject|3|||
156812338|NCT03581292|566062695|FG001|Overall Study|Withdrawal by Subject|0|||
156812339|NCT03581292|566062694|FG000|Overall Study|Withdrawal before Therapy Start|1|||
156812340|NCT03581292|566062695|FG001|Overall Study|Withdrawal before Therapy Start|0|||
156883876|NCT01379508|566332673|FG000|Treatment to Week 104|Adverse Event|2|||
156883877|NCT01379508|566332674|FG001|Treatment to Week 104|Adverse Event|0|||
156883878|NCT01379508|566332675|FG002|Treatment to Week 104|Adverse Event|5|||
156883879|NCT01379508|566332676|FG003|Treatment to Week 104|Adverse Event|0|||
157022487|NCT04924660|566835231|FG002|South Africa|Death|0|||
156812341|NCT05823974|566064731|FG000|Overall Study|Lost to Follow-up|0|||
156812342|NCT05823974|566064732|FG001|Overall Study|Lost to Follow-up|3|||
156812343|NCT05823974|566064733|FG002|Overall Study|Lost to Follow-up|1|||
156812344|NCT05823974|566064734|FG003|Overall Study|Lost to Follow-up|0|||
156812345|NCT05823974|566064735|FG004|Overall Study|Lost to Follow-up|1|||
156812346|NCT05823974|566064736|FG005|Overall Study|Lost to Follow-up|0|||
156812347|NCT05823974|566064737|FG006|Overall Study|Lost to Follow-up|1|||
156812348|NCT05823974|566064738|FG007|Overall Study|Lost to Follow-up|0|||
156812349|NCT05823974|566064739|FG008|Overall Study|Lost to Follow-up|0|||
156812350|NCT05823974|566064740|FG009|Overall Study|Lost to Follow-up|1|||
156812351|NCT05823974|566064741|FG010|Overall Study|Lost to Follow-up|1|||
156812352|NCT05823974|566064742|FG011|Overall Study|Lost to Follow-up|0|||
156812353|NCT05823974|566064743|FG012|Overall Study|Lost to Follow-up|1|||
156812354|NCT05823974|566064744|FG013|Overall Study|Lost to Follow-up|2|||
156812355|NCT05823974|566064745|FG014|Overall Study|Lost to Follow-up|1|||
156812356|NCT05823974|566064746|FG015|Overall Study|Lost to Follow-up|1|||
156812357|NCT05823974|566064747|FG016|Overall Study|Lost to Follow-up|1|||
156812358|NCT05823974|566064748|FG017|Overall Study|Lost to Follow-up|0|||
156812359|NCT05823974|566064749|FG018|Overall Study|Lost to Follow-up|0|||
156812360|NCT05823974|566064750|FG019|Overall Study|Lost to Follow-up|2|||
156883880|NCT01379508|566332673|FG000|Treatment to Week 104|Abnormal lab value|1|||
156883881|NCT01379508|566332674|FG001|Treatment to Week 104|Abnormal lab value|0|||
156883882|NCT01379508|566332675|FG002|Treatment to Week 104|Abnormal lab value|0|||
156883883|NCT01379508|566332676|FG003|Treatment to Week 104|Abnormal lab value|0|||
156883884|NCT01379508|566332673|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
156883885|NCT01379508|566332674|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156883886|NCT01379508|566332675|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156883887|NCT01379508|566332676|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
156883888|NCT01379508|566332673|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
156883889|NCT01379508|566332674|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
156883890|NCT01379508|566332675|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
156883891|NCT01379508|566332676|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
156883892|NCT01379508|566332673|FG000|Treatment to Week 104|Lost to Follow-up|5|||
156883893|NCT01379508|566332674|FG001|Treatment to Week 104|Lost to Follow-up|0|||
156883894|NCT01379508|566332675|FG002|Treatment to Week 104|Lost to Follow-up|3|||
156883895|NCT01379508|566332676|FG003|Treatment to Week 104|Lost to Follow-up|0|||
156883896|NCT01379508|566332673|FG000|Treatment to Week 104|Administrative problems|3|||
156883897|NCT01379508|566332674|FG001|Treatment to Week 104|Administrative problems|1|||
156883898|NCT01379508|566332675|FG002|Treatment to Week 104|Administrative problems|0|||
156883899|NCT01379508|566332676|FG003|Treatment to Week 104|Administrative problems|0|||
156883900|NCT01379508|566332673|FG000|Treatment to Week 104|Protocol Violation|1|||
156883901|NCT01379508|566332674|FG001|Treatment to Week 104|Protocol Violation|1|||
156812361|NCT05823974|566064751|FG020|Overall Study|Lost to Follow-up|0|||
156812362|NCT05823974|566064731|FG000|Overall Study|Physician Decision|0|||
157148228|NCT02707757|567288873|FG001|Overall Study|Adverse Event|4|||
156812363|NCT05823974|566064732|FG001|Overall Study|Physician Decision|0|||
156812364|NCT05823974|566064733|FG002|Overall Study|Physician Decision|0|||
156812365|NCT05823974|566064734|FG003|Overall Study|Physician Decision|0|||
156812366|NCT05823974|566064735|FG004|Overall Study|Physician Decision|0|||
156812367|NCT05823974|566064736|FG005|Overall Study|Physician Decision|0|||
156812368|NCT05823974|566064737|FG006|Overall Study|Physician Decision|0|||
156812369|NCT05823974|566064738|FG007|Overall Study|Physician Decision|0|||
156812370|NCT05823974|566064739|FG008|Overall Study|Physician Decision|0|||
156812371|NCT05823974|566064740|FG009|Overall Study|Physician Decision|0|||
156812372|NCT05823974|566064741|FG010|Overall Study|Physician Decision|0|||
156812373|NCT05823974|566064742|FG011|Overall Study|Physician Decision|0|||
156812374|NCT05823974|566064743|FG012|Overall Study|Physician Decision|0|||
156812375|NCT05823974|566064744|FG013|Overall Study|Physician Decision|0|||
156812376|NCT05823974|566064745|FG014|Overall Study|Physician Decision|0|||
156812377|NCT05823974|566064746|FG015|Overall Study|Physician Decision|1|||
156812378|NCT05823974|566064747|FG016|Overall Study|Physician Decision|0|||
156812379|NCT05823974|566064748|FG017|Overall Study|Physician Decision|1|||
156812380|NCT05823974|566064749|FG018|Overall Study|Physician Decision|1|||
156812381|NCT05823974|566064750|FG019|Overall Study|Physician Decision|0|||
156812382|NCT05823974|566064751|FG020|Overall Study|Physician Decision|0|||
156812383|NCT05823974|566064731|FG000|Overall Study|Withdrawal by Subject|1|||
156812384|NCT05823974|566064732|FG001|Overall Study|Withdrawal by Subject|1|||
156812385|NCT05823974|566064733|FG002|Overall Study|Withdrawal by Subject|2|||
156812386|NCT05823974|566064734|FG003|Overall Study|Withdrawal by Subject|0|||
156812387|NCT05823974|566064735|FG004|Overall Study|Withdrawal by Subject|2|||
156812388|NCT05823974|566064736|FG005|Overall Study|Withdrawal by Subject|3|||
156812389|NCT05823974|566064737|FG006|Overall Study|Withdrawal by Subject|1|||
156812390|NCT05823974|566064738|FG007|Overall Study|Withdrawal by Subject|1|||
156812391|NCT05823974|566064739|FG008|Overall Study|Withdrawal by Subject|2|||
156883902|NCT01379508|566332675|FG002|Treatment to Week 104|Protocol Violation|1|||
156883903|NCT01379508|566332676|FG003|Treatment to Week 104|Protocol Violation|0|||
156883904|NCT01379508|566332673|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
156883905|NCT01379508|566332674|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
156883906|NCT01379508|566332675|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
156812392|NCT05823974|566064740|FG009|Overall Study|Withdrawal by Subject|1|||
156812393|NCT05823974|566064741|FG010|Overall Study|Withdrawal by Subject|1|||
156812394|NCT05823974|566064742|FG011|Overall Study|Withdrawal by Subject|0|||
156812395|NCT05823974|566064743|FG012|Overall Study|Withdrawal by Subject|0|||
156812396|NCT05823974|566064744|FG013|Overall Study|Withdrawal by Subject|1|||
157148229|NCT02707757|567288872|FG000|Overall Study|Renal transplant/elective operation|1|||
157148230|NCT02707757|567288873|FG001|Overall Study|Renal transplant/elective operation|5|||
156812397|NCT05823974|566064745|FG014|Overall Study|Withdrawal by Subject|1|||
156812398|NCT05823974|566064746|FG015|Overall Study|Withdrawal by Subject|3|||
156812399|NCT05823974|566064747|FG016|Overall Study|Withdrawal by Subject|0|||
156883907|NCT01379508|566332676|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
157148231|NCT01056523|567288874|FG000|Overall Study|Death|1|||
157148232|NCT01056523|567288875|FG001|Overall Study|Death|0|||
156812400|NCT05823974|566064748|FG017|Overall Study|Withdrawal by Subject|2|||
156883908|NCT01379508|566332673|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
156883909|NCT01379508|566332674|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
156883910|NCT01379508|566332675|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
156883911|NCT01379508|566332676|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
157148233|NCT01056523|567288876|FG002|Overall Study|Death|2|||
157148234|NCT01056523|567288877|FG003|Overall Study|Death|3|||
157148235|NCT01056523|567288878|FG004|Overall Study|Death|0|||
157148236|NCT01056523|567288879|FG005|Overall Study|Death|0|||
157148237|NCT01056523|567288880|FG006|Overall Study|Death|1|||
156812401|NCT05823974|566064749|FG018|Overall Study|Withdrawal by Subject|2|||
156812402|NCT05823974|566064750|FG019|Overall Study|Withdrawal by Subject|0|||
156812403|NCT05823974|566064751|FG020|Overall Study|Withdrawal by Subject|1|||
156812404|NCT05823974|566064731|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812405|NCT05823974|566064732|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812406|NCT05823974|566064733|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156812407|NCT05823974|566064734|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812408|NCT05823974|566064735|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812409|NCT05823974|566064736|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812410|NCT05823974|566064737|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812411|NCT05823974|566064738|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812412|NCT05823974|566064739|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812413|NCT05823974|566064740|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812414|NCT05823974|566064741|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812415|NCT05823974|566064742|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812416|NCT05823974|566064743|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812417|NCT05823974|566064744|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812418|NCT05823974|566064745|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156812419|NCT05823974|566064746|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812420|NCT05823974|566064747|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812421|NCT05823974|566064748|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812422|NCT05823974|566064749|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812423|NCT05823974|566064750|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812424|NCT05823974|566064751|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156812425|NCT05823974|566064731|FG000|Overall Study|Other|0|||
156812426|NCT05823974|566064732|FG001|Overall Study|Other|1|||
156812427|NCT05823974|566064733|FG002|Overall Study|Other|1|||
156812428|NCT05823974|566064734|FG003|Overall Study|Other|1|||
156812429|NCT05823974|566064735|FG004|Overall Study|Other|0|||
156812430|NCT05823974|566064736|FG005|Overall Study|Other|1|||
156812431|NCT05823974|566064737|FG006|Overall Study|Other|1|||
156812432|NCT05823974|566064738|FG007|Overall Study|Other|1|||
156812433|NCT05823974|566064739|FG008|Overall Study|Other|1|||
156812434|NCT05823974|566064740|FG009|Overall Study|Other|0|||
156812435|NCT05823974|566064741|FG010|Overall Study|Other|0|||
156812436|NCT05823974|566064742|FG011|Overall Study|Other|0|||
156812437|NCT05823974|566064743|FG012|Overall Study|Other|2|||
156812438|NCT05823974|566064744|FG013|Overall Study|Other|1|||
156812439|NCT05823974|566064745|FG014|Overall Study|Other|0|||
156812440|NCT05823974|566064746|FG015|Overall Study|Other|1|||
156812441|NCT05823974|566064747|FG016|Overall Study|Other|0|||
156812442|NCT05823974|566064748|FG017|Overall Study|Other|0|||
156812443|NCT05823974|566064749|FG018|Overall Study|Other|0|||
156812444|NCT05823974|566064750|FG019|Overall Study|Other|0|||
156812445|NCT05823974|566064751|FG020|Overall Study|Other|0|||
156812446|NCT02744612|566064752|FG000|Overall Study|Withdrawal by Subject|0|||
156812447|NCT02744612|566064753|FG001|Overall Study|Withdrawal by Subject|2|||
156812448|NCT00316706|566064754|FG000|Overall Study|Lost to Follow-up|38|||
156812449|NCT00316706|566064755|FG001|Overall Study|Lost to Follow-up|48|||
156812450|NCT00283803|566064757|FG000|Overall Study|Physician Decision|9|||
156812451|NCT00283803|566064757|FG000|Overall Study|Withdrawal by Subject|4|||
156812452|NCT01127607|566064758|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
156812453|NCT01127607|566064759|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
156812454|NCT01127607|566064758|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
156812455|NCT01127607|566064759|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
156812456|NCT02220855|566064760|FG000|Overall Study|Adverse Event|8|||
156812457|NCT02220855|566064760|FG000|Overall Study|Disease Progression|5|||
157148238|NCT03429556|567288881|FG000|Overall Study|Lost to Follow-up|0|||
157148239|NCT03429556|567288882|FG001|Overall Study|Lost to Follow-up|1|||
157148240|NCT03429556|567288883|FG002|Overall Study|Lost to Follow-up|0|||
157148241|NCT03429556|567288884|FG003|Overall Study|Lost to Follow-up|0|||
156812458|NCT02220855|566064760|FG000|Overall Study|Withdrawal by Subject|1|||
156812459|NCT03419897|566064761|FG000|Overall Study|Death|180|||
156812460|NCT03419897|566064761|FG000|Overall Study|Lost to Follow-up|1|||
156812461|NCT03419897|566064761|FG000|Overall Study|Withdrawal by Subject|6|||
156812462|NCT03419897|566064761|FG000|Overall Study|Sponsor Decision|61|||
156812463|NCT03419897|566064761|FG000|Overall Study|Physician Decision|1|||
156812464|NCT05730725|566064764|FG000|Overall Study|Withdrawal by Subject|3|||
156812465|NCT05730725|566064765|FG001|Overall Study|Withdrawal by Subject|0|||
157148242|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Adverse Event|37|||
156812466|NCT05730725|566064766|FG002|Overall Study|Withdrawal by Subject|0|||
157148243|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Adverse Event|0|||
156812467|NCT05730725|566064767|FG003|Overall Study|Withdrawal by Subject|1|||
156812468|NCT05730725|566064764|FG000|Overall Study|Not Reported|1|||
156812469|NCT05730725|566064765|FG001|Overall Study|Not Reported|1|||
156812470|NCT05730725|566064766|FG002|Overall Study|Not Reported|1|||
156812471|NCT05730725|566064767|FG003|Overall Study|Not Reported|1|||
156812472|NCT02982772|566064771|FG000|Intervention|Lost to Follow-up|19|||
156812473|NCT02982772|566064772|FG001|Intervention|Lost to Follow-up|13|||
156812474|NCT02982772|566064771|FG000|1M Follow-Up|Lost to Follow-up|21|||
156812475|NCT02982772|566064772|FG001|1M Follow-Up|Lost to Follow-up|18|||
156812476|NCT02982772|566064771|FG000|3M Follow-Up|Lost to Follow-up|17|||
156812477|NCT02982772|566064772|FG001|3M Follow-Up|Lost to Follow-up|11|||
156812478|NCT02982772|566064771|FG000|6M Follow-Up|Lost to Follow-up|11|||
156812479|NCT02982772|566064772|FG001|6M Follow-Up|Lost to Follow-up|9|||
156812480|NCT02982772|566064771|FG000|12M Follow-Up|Lost to Follow-up|11|||
156812481|NCT02982772|566064772|FG001|12M Follow-Up|Lost to Follow-up|5|||
156812482|NCT02974140|566064773|FG000|Overall Study|Adverse Event|2|||
156812483|NCT02974140|566064773|FG000|Overall Study|Lost to Follow-up|1|||
156812484|NCT02974140|566064773|FG000|Overall Study|Study Terminated by Sponsor|36|||
156812485|NCT01905943|566064774|FG000|Overall Study|Withdrawal of consent|90|||
156812486|NCT01905943|566064774|FG000|Overall Study|Lost to Follow-up|16|||
156812487|NCT01905943|566064774|FG000|Overall Study|Investigator discretion|7|||
156812488|NCT01905943|566064774|FG000|Overall Study|Death|186|||
156812489|NCT01905943|566064774|FG000|Overall Study|Adverse Event|3|||
156812490|NCT01905943|566064774|FG000|Overall Study|Other|12|||
156812491|NCT01238991|566064777|FG000|Overall Study|Adverse Event|1|||
156812492|NCT01238991|566064778|FG001|Overall Study|Adverse Event|0|||
156812493|NCT01238991|566064779|FG002|Overall Study|Adverse Event|3|||
156812494|NCT01238991|566064780|FG003|Overall Study|Adverse Event|1|||
156812495|NCT01238991|566064781|FG004|Overall Study|Adverse Event|1|||
156812496|NCT01238991|566064782|FG005|Overall Study|Adverse Event|0|||
156812497|NCT01238991|566064783|FG006|Overall Study|Adverse Event|1|||
156812498|NCT01238991|566064784|FG007|Overall Study|Adverse Event|1|||
156812499|NCT01238991|566064785|FG008|Overall Study|Adverse Event|0|||
156812500|NCT01238991|566064786|FG009|Overall Study|Adverse Event|0|||
156812501|NCT01238991|566064777|FG000|Overall Study|Death|0|||
156812502|NCT01238991|566064778|FG001|Overall Study|Death|0|||
156812503|NCT01238991|566064779|FG002|Overall Study|Death|0|||
156812504|NCT01238991|566064780|FG003|Overall Study|Death|1|||
156812505|NCT01238991|566064781|FG004|Overall Study|Death|0|||
156812506|NCT01238991|566064782|FG005|Overall Study|Death|0|||
156812507|NCT01238991|566064783|FG006|Overall Study|Death|0|||
156812508|NCT01238991|566064784|FG007|Overall Study|Death|0|||
156812509|NCT01238991|566064785|FG008|Overall Study|Death|0|||
156812510|NCT01238991|566064786|FG009|Overall Study|Death|0|||
156812511|NCT01238991|566064777|FG000|Overall Study|Lack of Efficacy|0|||
156812512|NCT01238991|566064778|FG001|Overall Study|Lack of Efficacy|0|||
156812513|NCT01238991|566064779|FG002|Overall Study|Lack of Efficacy|1|||
156812514|NCT01238991|566064780|FG003|Overall Study|Lack of Efficacy|0|||
156812515|NCT01238991|566064781|FG004|Overall Study|Lack of Efficacy|0|||
156812516|NCT01238991|566064782|FG005|Overall Study|Lack of Efficacy|0|||
156812517|NCT01238991|566064783|FG006|Overall Study|Lack of Efficacy|0|||
156812518|NCT01238991|566064784|FG007|Overall Study|Lack of Efficacy|0|||
156812519|NCT01238991|566064785|FG008|Overall Study|Lack of Efficacy|1|||
156812520|NCT01238991|566064786|FG009|Overall Study|Lack of Efficacy|0|||
156812521|NCT01238991|566064777|FG000|Overall Study|Withdrawal by Subject|0|||
156812522|NCT01238991|566064778|FG001|Overall Study|Withdrawal by Subject|0|||
156812523|NCT01238991|566064779|FG002|Overall Study|Withdrawal by Subject|1|||
156812524|NCT01238991|566064780|FG003|Overall Study|Withdrawal by Subject|0|||
156812525|NCT01238991|566064781|FG004|Overall Study|Withdrawal by Subject|0|||
156812526|NCT01238991|566064782|FG005|Overall Study|Withdrawal by Subject|0|||
156812527|NCT01238991|566064783|FG006|Overall Study|Withdrawal by Subject|0|||
156812528|NCT01238991|566064784|FG007|Overall Study|Withdrawal by Subject|0|||
156883912|NCT01379508|566332673|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
156883913|NCT01379508|566332674|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
156812529|NCT01238991|566064785|FG008|Overall Study|Withdrawal by Subject|0|||
156812530|NCT01238991|566064786|FG009|Overall Study|Withdrawal by Subject|0|||
157022488|NCT04924660|566835232|FG003|South Africa|Death|0|||
156812531|NCT01238991|566064777|FG000|Overall Study|Study Terminated by Sponsor|0|||
156812532|NCT01238991|566064778|FG001|Overall Study|Study Terminated by Sponsor|0|||
156812533|NCT01238991|566064779|FG002|Overall Study|Study Terminated by Sponsor|0|||
156812534|NCT01238991|566064780|FG003|Overall Study|Study Terminated by Sponsor|0|||
156812535|NCT01238991|566064781|FG004|Overall Study|Study Terminated by Sponsor|1|||
156812536|NCT01238991|566064782|FG005|Overall Study|Study Terminated by Sponsor|0|||
156812537|NCT01238991|566064783|FG006|Overall Study|Study Terminated by Sponsor|7|||
156812538|NCT01238991|566064784|FG007|Overall Study|Study Terminated by Sponsor|4|||
156812539|NCT01238991|566064785|FG008|Overall Study|Study Terminated by Sponsor|2|||
156812540|NCT01238991|566064786|FG009|Overall Study|Study Terminated by Sponsor|2|||
156812541|NCT01238991|566064777|FG000|Overall Study|Caregiver's request|0|||
156812542|NCT01238991|566064778|FG001|Overall Study|Caregiver's request|0|||
157022489|NCT04924660|566835233|FG004|South Africa|Death|0|||
156883914|NCT01379508|566332675|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
156883915|NCT01379508|566332676|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
156883916|NCT01379508|566332673|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
156883917|NCT01379508|566332674|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
156883918|NCT01379508|566332675|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
156883919|NCT01379508|566332676|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
156883920|NCT03658876|566333963|FG000|Overall Study|Protocol Violation|3|||
156883921|NCT03658876|566333964|FG001|Overall Study|Protocol Violation|2|||
156883922|NCT03658876|566333963|FG000|Overall Study|Withdrawal by Subject|2|||
156883923|NCT03658876|566333964|FG001|Overall Study|Withdrawal by Subject|0|||
156883924|NCT03658876|566333963|FG000|Overall Study|Death|0|||
156883925|NCT03658876|566333964|FG001|Overall Study|Death|1|||
156883926|NCT03658876|566333963|FG000|Overall Study|Intercurrent illness|6|||
156883927|NCT03658876|566333964|FG001|Overall Study|Intercurrent illness|4|||
156883928|NCT03658876|566333963|FG000|Overall Study|Transplantation/other operation|1|||
156883929|NCT03658876|566333964|FG001|Overall Study|Transplantation/other operation|5|||
156883930|NCT01771809|566333966|FG000|Overall Study|Adverse Event|4|||
156883931|NCT01771809|566333967|FG001|Overall Study|Adverse Event|12|||
156883932|NCT01771809|566333966|FG000|Overall Study|Protocol Violation|0|||
156883933|NCT01771809|566333967|FG001|Overall Study|Protocol Violation|1|||
156883934|NCT01771809|566333966|FG000|Overall Study|Withdrawal by Subject|34|||
156883935|NCT01771809|566333967|FG001|Overall Study|Withdrawal by Subject|42|||
156883936|NCT01771809|566333966|FG000|Overall Study|Lost to Follow-up|1|||
156883937|NCT01771809|566333967|FG001|Overall Study|Lost to Follow-up|3|||
156883938|NCT01771809|566333966|FG000|Overall Study|Other (Insufficient clinical response)|22|||
156883939|NCT01771809|566333967|FG001|Overall Study|Other (Insufficient clinical response)|20|||
156883940|NCT01771809|566333966|FG000|Overall Study|Death|1|||
156883941|NCT01771809|566333967|FG001|Overall Study|Death|0|||
156883942|NCT01771809|566333966|FG000|Overall Study|Other (other)|9|||
156883943|NCT01771809|566333967|FG001|Overall Study|Other (other)|5|||
156883944|NCT02168387|566333975|FG000|Overall Study|Planned exubation|6|||
156883945|NCT02168387|566333976|FG001|Overall Study|Planned exubation|3|||
156883946|NCT02168387|566333975|FG000|Overall Study|Death|1|||
156883947|NCT02168387|566333976|FG001|Overall Study|Death|0|||
156883948|NCT01350544|566333978|FG000|Overall Study|Administrative Withdrawal|0|||
156812543|NCT01238991|566064779|FG002|Overall Study|Caregiver's request|0|||
156812544|NCT01238991|566064780|FG003|Overall Study|Caregiver's request|0|||
156812545|NCT01238991|566064781|FG004|Overall Study|Caregiver's request|0|||
156812546|NCT01238991|566064782|FG005|Overall Study|Caregiver's request|0|||
156812547|NCT01238991|566064783|FG006|Overall Study|Caregiver's request|0|||
156812548|NCT01238991|566064784|FG007|Overall Study|Caregiver's request|0|||
156812549|NCT01238991|566064785|FG008|Overall Study|Caregiver's request|1|||
156812550|NCT01238991|566064786|FG009|Overall Study|Caregiver's request|0|||
156812551|NCT01238991|566064777|FG000|Overall Study|Admission to a nursing home|1|||
156812552|NCT01238991|566064778|FG001|Overall Study|Admission to a nursing home|0|||
156812553|NCT01238991|566064779|FG002|Overall Study|Admission to a nursing home|1|||
156812554|NCT01238991|566064780|FG003|Overall Study|Admission to a nursing home|0|||
156812555|NCT01238991|566064781|FG004|Overall Study|Admission to a nursing home|0|||
156812556|NCT01238991|566064782|FG005|Overall Study|Admission to a nursing home|0|||
156812557|NCT01238991|566064783|FG006|Overall Study|Admission to a nursing home|0|||
156812558|NCT01238991|566064784|FG007|Overall Study|Admission to a nursing home|0|||
156812559|NCT01238991|566064785|FG008|Overall Study|Admission to a nursing home|0|||
156812560|NCT01238991|566064786|FG009|Overall Study|Admission to a nursing home|0|||
156812561|NCT02222688|566064789|FG000|Overall Study|Withdrawal by Subject|0|||
156812562|NCT02222688|566064790|FG001|Overall Study|Withdrawal by Subject|0|||
156812563|NCT02222688|566064791|FG002|Overall Study|Withdrawal by Subject|0|||
156812564|NCT02222688|566064792|FG003|Overall Study|Withdrawal by Subject|2|||
156812565|NCT02222688|566064793|FG004|Overall Study|Withdrawal by Subject|1|||
156812566|NCT02222688|566064794|FG005|Overall Study|Withdrawal by Subject|0|||
156812567|NCT02222688|566064795|FG006|Overall Study|Withdrawal by Subject|1|||
156812568|NCT02222688|566064789|FG000|Overall Study|Disease progression|1|||
156812569|NCT02222688|566064790|FG001|Overall Study|Disease progression|0|||
156812570|NCT02222688|566064791|FG002|Overall Study|Disease progression|0|||
156812571|NCT02222688|566064792|FG003|Overall Study|Disease progression|0|||
156883949|NCT01350544|566333979|FG001|Overall Study|Administrative Withdrawal|1|||
157022490|NCT04924660|566835234|FG005|South Africa|Death|1|||
156812572|NCT02222688|566064793|FG004|Overall Study|Disease progression|0|||
156812573|NCT02222688|566064794|FG005|Overall Study|Disease progression|0|||
156812574|NCT02222688|566064795|FG006|Overall Study|Disease progression|0|||
156812575|NCT02297815|566064798|FG000|Overall Study|Lost to Follow-up|236|||
156883950|NCT01350544|566333978|FG000|Overall Study|Death|1|||
156883951|NCT01350544|566333979|FG001|Overall Study|Death|2|||
156883952|NCT01350544|566333978|FG000|Overall Study|Moved out of LA County|2|||
156883953|NCT01350544|566333979|FG001|Overall Study|Moved out of LA County|2|||
156883954|NCT01350544|566333978|FG000|Overall Study|Medical Issues|1|||
156883955|NCT01350544|566333979|FG001|Overall Study|Medical Issues|1|||
156883956|NCT01350544|566333978|FG000|Overall Study|Withdrawal by Subject|0|||
157022491|NCT04924660|566835229|FG000|South Africa|Lost to Follow-up|0|||
157148244|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Adverse Event|0|||
157148245|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Adverse Event|0|||
157148246|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Death|2|||
157148247|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Death|0|||
157148248|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Death|0|||
157148249|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Death|0|||
157148250|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
157148251|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
157148252|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
157148253|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
157148254|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
157148255|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
157148256|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
157148257|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
157148258|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
157148259|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
157148260|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
157148261|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
157148262|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
157148263|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
157148264|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
157148265|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
157148266|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Physician Decision|4|||
156812576|NCT02297815|566064799|FG001|Overall Study|Lost to Follow-up|140|||
157148267|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Physician Decision|0|||
157148268|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Physician Decision|0|||
157148269|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Physician Decision|0|||
157148270|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Pregnancy|1|||
157148271|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Pregnancy|0|||
157148272|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Pregnancy|0|||
157148273|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Pregnancy|0|||
157148274|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
157148275|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
157148276|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
157148277|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
157148278|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
157148279|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
157148280|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
157148281|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
156812577|NCT00294671|566064800|FG000|Overall Study|Lack of Efficacy|11|||
156812578|NCT00294671|566064801|FG001|Overall Study|Lack of Efficacy|23|||
156812579|NCT00294671|566064800|FG000|Overall Study|Liver transplant|7|||
156812580|NCT00294671|566064801|FG001|Overall Study|Liver transplant|9|||
156812581|NCT00294671|566064800|FG000|Overall Study|Drug related adverse event (AE)|4|||
156812582|NCT00294671|566064801|FG001|Overall Study|Drug related adverse event (AE)|2|||
156812583|NCT00294671|566064800|FG000|Overall Study|Non-drug related AE|3|||
156812584|NCT00294671|566064801|FG001|Overall Study|Non-drug related AE|2|||
156812585|NCT00294671|566064800|FG000|Overall Study|Lost to Follow-up|1|||
156812586|NCT00294671|566064801|FG001|Overall Study|Lost to Follow-up|3|||
156812587|NCT00294671|566064800|FG000|Overall Study|Non-compliance|1|||
157148282|NCT01855789|567288892|FG000|1) Baseline up to Week 24|Other|4|||
157148283|NCT01855789|567288893|FG001|1) Baseline up to Week 24|Other|0|||
157148284|NCT01855789|567288894|FG002|1) Baseline up to Week 24|Other|0|||
157148285|NCT01855789|567288895|FG003|1) Baseline up to Week 24|Other|0|||
157148286|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
157148287|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
157148288|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
157148289|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
157148290|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
157148291|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
157148292|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
157148293|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
157148294|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
157148295|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
157148296|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
157148297|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
157148298|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
157148299|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
157148300|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
157222767|NCT00481247|567562082|FG000|Overall Study|Pregnancy|2|||
156812588|NCT00294671|566064801|FG001|Overall Study|Non-compliance|0|||
156812589|NCT00294671|566064800|FG000|Overall Study|Death|0|||
156812590|NCT00294671|566064801|FG001|Overall Study|Death|1|||
156883957|NCT01350544|566333979|FG001|Overall Study|Withdrawal by Subject|1|||
157022492|NCT04924660|566835230|FG001|South Africa|Lost to Follow-up|0|||
157148301|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
157148302|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
157148303|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
157148304|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
157148305|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
157148306|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
157148307|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
157148308|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
157148309|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
157148310|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
157148311|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
157148312|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
157148313|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
157148314|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
157148315|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
157148316|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
157148317|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
157148318|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
157148319|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
157148320|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
157148321|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
157148322|NCT01855789|567288892|FG000|2) Week 24 up to End of Study|Other|0|||
157148323|NCT01855789|567288893|FG001|2) Week 24 up to End of Study|Other|0|||
157148324|NCT01855789|567288894|FG002|2) Week 24 up to End of Study|Other|0|||
157148325|NCT01855789|567288895|FG003|2) Week 24 up to End of Study|Other|1|||
157148326|NCT01863758|567288896|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
157148327|NCT01863758|567288896|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
157148328|NCT02369510|567288897|FG000|Overall Study|Spilled Medication|1|||
157148329|NCT02369510|567288898|FG001|Overall Study|Spilled Medication|2|||
157148330|NCT02369510|567288899|FG002|Overall Study|Spilled Medication|1|||
157148331|NCT02369510|567288897|FG000|Overall Study|Epidural Activation|1|||
157148332|NCT02369510|567288898|FG001|Overall Study|Epidural Activation|1|||
157148333|NCT02369510|567288899|FG002|Overall Study|Epidural Activation|5|||
157148334|NCT02050048|567288903|FG000|Overall Study|Lost to Follow-up|0|||
157148335|NCT02050048|567288904|FG001|Overall Study|Lost to Follow-up|1|||
157148336|NCT02050048|567288903|FG000|Overall Study|Death|1|||
157148337|NCT02050048|567288904|FG001|Overall Study|Death|0|||
157148338|NCT02050048|567288903|FG000|Overall Study|Ineligible after ERCP|4|||
157148339|NCT02050048|567288904|FG001|Overall Study|Ineligible after ERCP|1|||
157148340|NCT03067311|567288907|FG000|Overall Study|Lost to Follow-up|1|||
157148341|NCT03067311|567288908|FG001|Overall Study|Lost to Follow-up|1|||
157148342|NCT03067311|567288907|FG000|Overall Study|Moved away|1|||
157148343|NCT03067311|567288908|FG001|Overall Study|Moved away|1|||
157148344|NCT01089725|567288912|FG000|Overall Study|Adverse Event|1|||
157148345|NCT01089725|567288913|FG001|Overall Study|Adverse Event|1|||
157148346|NCT01089725|567288914|FG002|Overall Study|Adverse Event|0|||
157148347|NCT01089725|567288915|FG003|Overall Study|Adverse Event|0|||
157148348|NCT01089725|567288916|FG004|Overall Study|Adverse Event|2|||
157148349|NCT01089725|567288912|FG000|Overall Study|Lack of Efficacy|4|||
157148350|NCT01089725|567288913|FG001|Overall Study|Lack of Efficacy|3|||
157148351|NCT01089725|567288914|FG002|Overall Study|Lack of Efficacy|1|||
157148352|NCT01089725|567288915|FG003|Overall Study|Lack of Efficacy|0|||
157148353|NCT01089725|567288916|FG004|Overall Study|Lack of Efficacy|4|||
157148354|NCT01089725|567288912|FG000|Overall Study|Lost to Follow-up|2|||
157148355|NCT01089725|567288913|FG001|Overall Study|Lost to Follow-up|2|||
157148356|NCT01089725|567288914|FG002|Overall Study|Lost to Follow-up|0|||
157148357|NCT01089725|567288915|FG003|Overall Study|Lost to Follow-up|3|||
157148358|NCT01089725|567288916|FG004|Overall Study|Lost to Follow-up|0|||
157148359|NCT01089725|567288912|FG000|Overall Study|Protocol Violation|0|||
157148360|NCT01089725|567288913|FG001|Overall Study|Protocol Violation|0|||
157148361|NCT01089725|567288914|FG002|Overall Study|Protocol Violation|1|||
157148362|NCT01089725|567288915|FG003|Overall Study|Protocol Violation|1|||
157148363|NCT01089725|567288916|FG004|Overall Study|Protocol Violation|0|||
157148364|NCT01089725|567288912|FG000|Overall Study|Withdrawal by Subject|5|||
157148365|NCT01089725|567288913|FG001|Overall Study|Withdrawal by Subject|5|||
157148366|NCT01089725|567288914|FG002|Overall Study|Withdrawal by Subject|4|||
157148367|NCT01089725|567288915|FG003|Overall Study|Withdrawal by Subject|5|||
157148368|NCT01089725|567288916|FG004|Overall Study|Withdrawal by Subject|4|||
157148369|NCT01089725|567288912|FG000|Overall Study|Study Terminated by Sponsor|51|||
157148370|NCT01089725|567288913|FG001|Overall Study|Study Terminated by Sponsor|56|||
157148371|NCT01089725|567288914|FG002|Overall Study|Study Terminated by Sponsor|53|||
157148372|NCT01089725|567288915|FG003|Overall Study|Study Terminated by Sponsor|68|||
157148373|NCT01089725|567288916|FG004|Overall Study|Study Terminated by Sponsor|68|||
156883958|NCT01350544|566333978|FG000|Overall Study|Incarceration|1|||
157222768|NCT00481247|567562083|FG001|Overall Study|Pregnancy|1|||
157222769|NCT00481247|567562082|FG000|Overall Study|Lost to Follow-up|1|||
157222770|NCT00481247|567562083|FG001|Overall Study|Lost to Follow-up|2|||
157222771|NCT00481247|567562082|FG000|Overall Study|Poor compliance/noncompliance|1|||
157222772|NCT00481247|567562083|FG001|Overall Study|Poor compliance/noncompliance|7|||
157222773|NCT00481247|567562082|FG000|Overall Study|Administrative reason by sponsor|157|||
157222774|NCT00481247|567562083|FG001|Overall Study|Administrative reason by sponsor|162|||
157222775|NCT00481247|567562082|FG000|Overall Study|Varied|6|||
157222776|NCT00481247|567562083|FG001|Overall Study|Varied|15|||
157222777|NCT00481247|567562082|FG000|Overall Study|Did not receive treatment|1|||
157222778|NCT00481247|567562083|FG001|Overall Study|Did not receive treatment|2|||
157222779|NCT02649231|567562086|FG000|Overall Study|Adverse Event|0|||
157222780|NCT02649231|567562087|FG001|Overall Study|Adverse Event|0|||
157222781|NCT02649231|567562088|FG002|Overall Study|Adverse Event|0|||
157222782|NCT02649231|567562089|FG003|Overall Study|Adverse Event|1|||
157222783|NCT02649231|567562086|FG000|Overall Study|Lost to Follow-up|2|||
157222784|NCT02649231|567562087|FG001|Overall Study|Lost to Follow-up|1|||
157222785|NCT02649231|567562088|FG002|Overall Study|Lost to Follow-up|1|||
157222786|NCT02649231|567562089|FG003|Overall Study|Lost to Follow-up|0|||
157222787|NCT02649231|567562086|FG000|Overall Study|Withdrawal by Subject|0|||
157222788|NCT02649231|567562087|FG001|Overall Study|Withdrawal by Subject|1|||
157222789|NCT02649231|567562088|FG002|Overall Study|Withdrawal by Subject|0|||
157222790|NCT02649231|567562089|FG003|Overall Study|Withdrawal by Subject|1|||
157222791|NCT02649231|567562086|FG000|Overall Study|Protocol Violation|2|||
157222792|NCT02649231|567562087|FG001|Overall Study|Protocol Violation|1|||
157222793|NCT02649231|567562088|FG002|Overall Study|Protocol Violation|1|||
157222794|NCT02649231|567562089|FG003|Overall Study|Protocol Violation|0|||
157222795|NCT00876733|567562094|FG000|Overall Study|Adverse Event|34|||
157222796|NCT00876733|567562095|FG001|Overall Study|Adverse Event|20|||
157222797|NCT00876733|567562096|FG002|Overall Study|Adverse Event|10|||
157222798|NCT00876733|567562097|FG003|Overall Study|Adverse Event|3|||
157222799|NCT00876733|567562094|FG000|Overall Study|Lack of Efficacy|17|||
157222800|NCT00876733|567562095|FG001|Overall Study|Lack of Efficacy|9|||
157222801|NCT00876733|567562096|FG002|Overall Study|Lack of Efficacy|10|||
157222802|NCT00876733|567562097|FG003|Overall Study|Lack of Efficacy|1|||
157222803|NCT00876733|567562094|FG000|Overall Study|Lost to Follow-up|26|||
157222804|NCT00876733|567562095|FG001|Overall Study|Lost to Follow-up|10|||
157222805|NCT00876733|567562096|FG002|Overall Study|Lost to Follow-up|3|||
157222806|NCT00876733|567562097|FG003|Overall Study|Lost to Follow-up|2|||
157222807|NCT00876733|567562094|FG000|Overall Study|Data not available|14|||
157222808|NCT00876733|567562095|FG001|Overall Study|Data not available|3|||
157222809|NCT00876733|567562096|FG002|Overall Study|Data not available|7|||
157222810|NCT00876733|567562097|FG003|Overall Study|Data not available|1|||
157222811|NCT05476679|567562100|FG000|Overall Study|Withdrawal by Subject|0|||
157222812|NCT05476679|567562101|FG001|Overall Study|Withdrawal by Subject|0|||
157222813|NCT05476679|567562102|FG002|Overall Study|Withdrawal by Subject|0|||
157222814|NCT05476679|567562103|FG003|Overall Study|Withdrawal by Subject|1|||
157222815|NCT05476679|567562104|FG004|Overall Study|Withdrawal by Subject|0|||
157222816|NCT05476679|567562100|FG000|Overall Study|Lost to Follow-up|0|||
157222817|NCT05476679|567562101|FG001|Overall Study|Lost to Follow-up|0|||
157222818|NCT05476679|567562102|FG002|Overall Study|Lost to Follow-up|0|||
157222819|NCT05476679|567562103|FG003|Overall Study|Lost to Follow-up|1|||
157222820|NCT05476679|567562104|FG004|Overall Study|Lost to Follow-up|0|||
157222821|NCT01214330|567562105|FG000|Overall Study|Withdrawal by Subject|2|||
157222822|NCT01214330|567562105|FG000|Overall Study|Withdrawal by Subject|2|||
157222823|NCT00249821|567562106|FG000|Overall Study|Technical problem|0|||
157222824|NCT00249821|567562107|FG001|Overall Study|Technical problem|1|||
157222825|NCT00686036|567562110|FG000|Overall Study|Adverse Event|3|||
157222826|NCT00686036|567562111|FG001|Overall Study|Adverse Event|0|||
157222827|NCT00686036|567562110|FG000|Overall Study|Withdrawal by Subject|3|||
157222828|NCT00686036|567562111|FG001|Overall Study|Withdrawal by Subject|1|||
157222829|NCT00686036|567562110|FG000|Overall Study|Study terminated by AstraZeneca|2|||
157222830|NCT00686036|567562111|FG001|Overall Study|Study terminated by AstraZeneca|1|||
157222831|NCT00686036|567562110|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
157222832|NCT00686036|567562111|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
157222833|NCT00686036|567562110|FG000|Overall Study|Other reasons not identified|0|||
157222834|NCT00686036|567562111|FG001|Overall Study|Other reasons not identified|4|||
157222835|NCT00656019|567562114|FG000|Overall Study|Not Eligible|10|||
157222836|NCT00656019|567562115|FG001|Overall Study|Not Eligible|0|||
157222837|NCT00656019|567562116|FG002|Overall Study|Not Eligible|0|||
157222838|NCT00656019|567562117|FG003|Overall Study|Not Eligible|0|||
157222839|NCT00656019|567562114|FG000|Overall Study|Withdrawal by Subject|2|||
157222840|NCT00656019|567562115|FG001|Overall Study|Withdrawal by Subject|0|||
157222841|NCT00656019|567562116|FG002|Overall Study|Withdrawal by Subject|0|||
157222842|NCT00656019|567562117|FG003|Overall Study|Withdrawal by Subject|0|||
157222843|NCT00656019|567562114|FG000|Overall Study|Lost to Follow-up|2|||
157222844|NCT00656019|567562115|FG001|Overall Study|Lost to Follow-up|1|||
157222845|NCT00656019|567562116|FG002|Overall Study|Lost to Follow-up|0|||
157222846|NCT00656019|567562117|FG003|Overall Study|Lost to Follow-up|0|||
157148374|NCT01089725|567288912|FG000|Overall Study|Randomized, but not treated|0|||
157148375|NCT01089725|567288913|FG001|Overall Study|Randomized, but not treated|1|||
157148376|NCT01089725|567288914|FG002|Overall Study|Randomized, but not treated|2|||
157148377|NCT01089725|567288915|FG003|Overall Study|Randomized, but not treated|1|||
157148378|NCT01089725|567288916|FG004|Overall Study|Randomized, but not treated|2|||
157022493|NCT04924660|566835231|FG002|South Africa|Lost to Follow-up|0|||
157022494|NCT04924660|566835232|FG003|South Africa|Lost to Follow-up|0|||
157022495|NCT04924660|566835233|FG004|South Africa|Lost to Follow-up|0|||
157148379|NCT01089725|567288912|FG000|Overall Study|Other|3|||
157148380|NCT01089725|567288913|FG001|Overall Study|Other|0|||
157148381|NCT01089725|567288914|FG002|Overall Study|Other|0|||
157148382|NCT01089725|567288915|FG003|Overall Study|Other|1|||
157148383|NCT01089725|567288916|FG004|Overall Study|Other|0|||
157148384|NCT02114203|567290215|FG000|Overall Study|Adverse Event|0|||
157148385|NCT02114203|567290216|FG001|Overall Study|Adverse Event|1|||
157148386|NCT02114203|567290217|FG002|Overall Study|Adverse Event|0|||
157148387|NCT02114203|567290215|FG000|Overall Study|Withdrawal by Subject|0|||
157148388|NCT02114203|567290216|FG001|Overall Study|Withdrawal by Subject|1|||
157148389|NCT02114203|567290217|FG002|Overall Study|Withdrawal by Subject|0|||
157148390|NCT01518699|567290218|FG000|Period 2|Protocol Violation|1|||
157148391|NCT01518699|567290219|FG001|Period 2|Protocol Violation|1|||
157148392|NCT01518699|567290220|FG002|Period 2|Protocol Violation|0|||
157148393|NCT01518699|567290221|FG003|Period 2|Protocol Violation|0|||
157148394|NCT01518699|567290222|FG004|Period 2|Protocol Violation|0|||
157148395|NCT01518699|567290223|FG005|Period 2|Protocol Violation|0|||
157148396|NCT01518699|567290218|FG000|Period 2|Lost to Follow-up|0|||
157148397|NCT01518699|567290219|FG001|Period 2|Lost to Follow-up|1|||
157148398|NCT01518699|567290220|FG002|Period 2|Lost to Follow-up|0|||
157148399|NCT01518699|567290221|FG003|Period 2|Lost to Follow-up|0|||
157148400|NCT01518699|567290222|FG004|Period 2|Lost to Follow-up|0|||
157148401|NCT01518699|567290223|FG005|Period 2|Lost to Follow-up|0|||
157148402|NCT01518699|567290218|FG000|Period 2|Adverse Event|1|||
157148403|NCT01518699|567290219|FG001|Period 2|Adverse Event|0|||
157148404|NCT01518699|567290220|FG002|Period 2|Adverse Event|0|||
157148405|NCT01518699|567290221|FG003|Period 2|Adverse Event|0|||
157148406|NCT01518699|567290222|FG004|Period 2|Adverse Event|0|||
157148407|NCT01518699|567290223|FG005|Period 2|Adverse Event|0|||
157148408|NCT00500149|567290230|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
157148409|NCT00500149|567290231|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
157148410|NCT00500149|567290230|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
157148411|NCT00500149|567290231|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
157148412|NCT00500149|567290230|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
157148413|NCT00500149|567290231|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
157148414|NCT00500149|567290230|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
157148415|NCT00500149|567290231|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
157148416|NCT00500149|567290230|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
157148417|NCT00500149|567290231|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
157148418|NCT00500149|567290230|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
157148419|NCT00500149|567290231|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
157148420|NCT00500149|567290230|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
157148421|NCT00500149|567290231|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
157148422|NCT03666143|567290234|FG000|Overall Study|Death|158|||
157148423|NCT03666143|567290234|FG000|Overall Study|Sponsor Decision|31|||
157148424|NCT03666143|567290234|FG000|Overall Study|Withdrawal by Subject|11|||
157148425|NCT03666143|567290234|FG000|Overall Study|Lost to Follow-up|5|||
157148426|NCT03666143|567290234|FG000|Overall Study|Physician Decision|1|||
157148427|NCT03666143|567290234|FG000|Overall Study|Rolled into extension study|9|||
157148428|NCT03666143|567290234|FG000|Overall Study|Progressive Disease|1|||
157148429|NCT00915005|567290236|FG000|Overall Study|Withdrawal by Subject|4|||
157148430|NCT00915005|567290237|FG001|Overall Study|Withdrawal by Subject|4|||
157148431|NCT00915005|567290236|FG000|Overall Study|Patient preferred protons therapy|6|||
157148432|NCT00915005|567290237|FG001|Overall Study|Patient preferred protons therapy|0|||
157148433|NCT00915005|567290236|FG000|Overall Study|Insurance denial|3|||
157148434|NCT00915005|567290237|FG001|Overall Study|Insurance denial|15|||
157148435|NCT02397655|567290240|FG000|Overall Study|data not completed|1301|||
157148436|NCT01736683|567290241|FG000|Overall Study|Disease Relapse|0|||
157148437|NCT01736683|567290242|FG001|Overall Study|Disease Relapse|0|||
157148438|NCT01736683|567290243|FG002|Overall Study|Disease Relapse|2|||
157022496|NCT04924660|566835234|FG005|South Africa|Lost to Follow-up|1|||
157148439|NCT01736683|567290244|FG003|Overall Study|Disease Relapse|1|||
157148440|NCT01736683|567290245|FG004|Overall Study|Disease Relapse|0|||
157148441|NCT01736683|567290241|FG000|Overall Study|Adverse Event|0|||
157148442|NCT01736683|567290242|FG001|Overall Study|Adverse Event|2|||
157148443|NCT01736683|567290243|FG002|Overall Study|Adverse Event|2|||
157148444|NCT01736683|567290244|FG003|Overall Study|Adverse Event|3|||
157148445|NCT01736683|567290245|FG004|Overall Study|Adverse Event|2|||
157022497|NCT03557697|566835235|FG000|Overall Study|Withdrawal by Subject|2|||
157148446|NCT01736683|567290241|FG000|Overall Study|Withdrawal by Subject|0|||
157148447|NCT01736683|567290242|FG001|Overall Study|Withdrawal by Subject|0|||
157148448|NCT01736683|567290243|FG002|Overall Study|Withdrawal by Subject|3|||
157148449|NCT01736683|567290244|FG003|Overall Study|Withdrawal by Subject|1|||
157148450|NCT01736683|567290245|FG004|Overall Study|Withdrawal by Subject|1|||
157148451|NCT01736683|567290241|FG000|Overall Study|Lack of Therapeutic Effect|7|||
157222847|NCT01309919|567562128|FG000|Overall Study|Did not receive a postpartum IUD|17|||
157222848|NCT01309919|567562129|FG001|Overall Study|Did not receive a postpartum IUD|48|||
157222849|NCT03896490|567562130|FG000|Overall Study|Withdrawal by Subject|1|||
157222850|NCT03896490|567562131|FG001|Overall Study|Withdrawal by Subject|1|||
157222851|NCT01890707|567562132|FG000|Overall Study|Lost to Follow-up|1|||
157222852|NCT01890707|567562133|FG001|Overall Study|Lost to Follow-up|1|||
157222853|NCT00669955|567562134|FG000|Overall Study|Adverse Event|3|||
157222854|NCT00669955|567562135|FG001|Overall Study|Adverse Event|5|||
157222855|NCT00669955|567562134|FG000|Overall Study|Death|0|||
157222856|NCT00669955|567562135|FG001|Overall Study|Death|1|||
157222857|NCT00669955|567562134|FG000|Overall Study|Withdrawal by Subject|2|||
157222858|NCT00669955|567562135|FG001|Overall Study|Withdrawal by Subject|3|||
157222859|NCT00669955|567562134|FG000|Overall Study|Lost to Follow-up|5|||
157222860|NCT00669955|567562135|FG001|Overall Study|Lost to Follow-up|7|||
157222861|NCT00669955|567562134|FG000|Overall Study|Protocol Violation|2|||
157222862|NCT00669955|567562135|FG001|Overall Study|Protocol Violation|7|||
157222863|NCT00669955|567562134|FG000|Overall Study|Investigator Sponsor Judgement|0|||
157222864|NCT00669955|567562135|FG001|Overall Study|Investigator Sponsor Judgement|1|||
157222865|NCT00669955|567562134|FG000|Overall Study|not compliant with study drug/visit|2|||
157222866|NCT00669955|567562135|FG001|Overall Study|not compliant with study drug/visit|3|||
157222867|NCT00385541|567562138|FG000|Overall Study|severe pain, clinician requested unblind|0|||
157222868|NCT00385541|567562139|FG001|Overall Study|severe pain, clinician requested unblind|1|||
157222869|NCT00929708|567562140|FG000|Overall Study|Protocol Violation|2|||
157222870|NCT00929708|567562141|FG001|Overall Study|Protocol Violation|1|||
157222871|NCT00929708|567562142|FG002|Overall Study|Protocol Violation|1|||
157222872|NCT00929708|567562143|FG003|Overall Study|Protocol Violation|1|||
157222873|NCT00929708|567562144|FG004|Overall Study|Protocol Violation|1|||
157222874|NCT00929708|567562140|FG000|Overall Study|Withdrawal by Subject|2|||
157222875|NCT00929708|567562141|FG001|Overall Study|Withdrawal by Subject|0|||
157222876|NCT00929708|567562142|FG002|Overall Study|Withdrawal by Subject|0|||
157222877|NCT00929708|567562143|FG003|Overall Study|Withdrawal by Subject|2|||
157222878|NCT00929708|567562144|FG004|Overall Study|Withdrawal by Subject|1|||
157222879|NCT00929708|567562140|FG000|Overall Study|Adverse Event|0|||
157222880|NCT00929708|567562141|FG001|Overall Study|Adverse Event|0|||
157222881|NCT00929708|567562142|FG002|Overall Study|Adverse Event|0|||
157222882|NCT00929708|567562143|FG003|Overall Study|Adverse Event|0|||
157222883|NCT00929708|567562144|FG004|Overall Study|Adverse Event|3|||
157222884|NCT00929708|567562140|FG000|Overall Study|Physician Decision|0|||
157222885|NCT00929708|567562141|FG001|Overall Study|Physician Decision|2|||
157222886|NCT00929708|567562142|FG002|Overall Study|Physician Decision|2|||
157222887|NCT00929708|567562143|FG003|Overall Study|Physician Decision|2|||
157222888|NCT00929708|567562144|FG004|Overall Study|Physician Decision|1|||
157222889|NCT00929708|567562140|FG000|Overall Study|Lost to Follow-up|0|||
157222890|NCT00929708|567562141|FG001|Overall Study|Lost to Follow-up|0|||
157222891|NCT00929708|567562142|FG002|Overall Study|Lost to Follow-up|0|||
157222892|NCT00929708|567562143|FG003|Overall Study|Lost to Follow-up|1|||
157222893|NCT00929708|567562144|FG004|Overall Study|Lost to Follow-up|0|||
157222894|NCT03495869|567562145|FG000|Overall Study|Lost to Follow-up|4|||
157222895|NCT03495869|567562146|FG001|Overall Study|Lost to Follow-up|17|||
157222896|NCT03495869|567562147|FG002|Overall Study|Lost to Follow-up|8|||
157222897|NCT03495869|567562148|FG003|Overall Study|Lost to Follow-up|14|||
157222898|NCT03495869|567562145|FG000|Overall Study|Withdrawal by Subject|0|||
157222899|NCT03495869|567562146|FG001|Overall Study|Withdrawal by Subject|3|||
157222900|NCT03495869|567562147|FG002|Overall Study|Withdrawal by Subject|0|||
157222901|NCT03495869|567562148|FG003|Overall Study|Withdrawal by Subject|3|||
157222902|NCT03495869|567562145|FG000|Overall Study|Dropped from study|0|||
157222903|NCT03495869|567562146|FG001|Overall Study|Dropped from study|7|||
157222904|NCT03495869|567562147|FG002|Overall Study|Dropped from study|2|||
157222905|NCT03495869|567562148|FG003|Overall Study|Dropped from study|4|||
157222906|NCT02154529|567562149|FG000|Overall Study|Death|1|||
157222907|NCT02154529|567562150|FG001|Overall Study|Death|1|||
157148452|NCT01736683|567290242|FG001|Overall Study|Lack of Therapeutic Effect|4|||
157148453|NCT01736683|567290243|FG002|Overall Study|Lack of Therapeutic Effect|13|||
157148454|NCT01736683|567290244|FG003|Overall Study|Lack of Therapeutic Effect|20|||
157148455|NCT01736683|567290245|FG004|Overall Study|Lack of Therapeutic Effect|1|||
157148456|NCT01736683|567290241|FG000|Overall Study|Progressive Disease|0|||
157148457|NCT01736683|567290242|FG001|Overall Study|Progressive Disease|0|||
157148458|NCT01736683|567290243|FG002|Overall Study|Progressive Disease|0|||
157148459|NCT01736683|567290244|FG003|Overall Study|Progressive Disease|1|||
157222908|NCT02154529|567562151|FG002|Overall Study|Death|5|||
157222909|NCT02154529|567562152|FG003|Overall Study|Death|1|||
157222910|NCT02154529|567562149|FG000|Overall Study|Termination of study by sponsor|2|||
157148460|NCT01736683|567290245|FG004|Overall Study|Progressive Disease|0|||
157148461|NCT01736683|567290241|FG000|Overall Study|Other|0|||
157148462|NCT01736683|567290242|FG001|Overall Study|Other|0|||
157148463|NCT01736683|567290243|FG002|Overall Study|Other|1|||
157148464|NCT01736683|567290244|FG003|Overall Study|Other|9|||
157148465|NCT01736683|567290245|FG004|Overall Study|Other|1|||
157148466|NCT00283712|567290247|FG000|Overall Study|Death|0|||
157148467|NCT00283712|567290248|FG001|Overall Study|Death|1|||
157148468|NCT02046564|567290253|FG000|Overall Study|Adverse Event|6|||
157148469|NCT02046564|567290254|FG001|Overall Study|Adverse Event|3|||
157148470|NCT02046564|567290253|FG000|Overall Study|Physician Decision|0|||
157148471|NCT02046564|567290254|FG001|Overall Study|Physician Decision|1|||
157148472|NCT02046564|567290253|FG000|Overall Study|Protocol Violation|3|||
157148473|NCT02046564|567290254|FG001|Overall Study|Protocol Violation|1|||
157148474|NCT02046564|567290253|FG000|Overall Study|Withdrawal by Subject|4|||
157148475|NCT02046564|567290254|FG001|Overall Study|Withdrawal by Subject|10|||
157148476|NCT02046564|567290253|FG000|Overall Study|Subject met withdrawal criteria|2|||
157148477|NCT02046564|567290254|FG001|Overall Study|Subject met withdrawal criteria|5|||
157148478|NCT02747043|567290255|FG000|Overall Study|Other|1|||
157148479|NCT02747043|567290256|FG001|Overall Study|Other|1|||
157148480|NCT02747043|567290255|FG000|Overall Study|Adverse Event|3|||
157148481|NCT02747043|567290256|FG001|Overall Study|Adverse Event|1|||
157148482|NCT02747043|567290255|FG000|Overall Study|Withdrawal by Subject|1|||
157148483|NCT02747043|567290256|FG001|Overall Study|Withdrawal by Subject|1|||
157148484|NCT02747043|567290255|FG000|Overall Study|Physician Decision|1|||
157148485|NCT02747043|567290256|FG001|Overall Study|Physician Decision|1|||
157148486|NCT02747043|567290255|FG000|Overall Study|Protocol Violation|0|||
157148487|NCT02747043|567290256|FG001|Overall Study|Protocol Violation|1|||
157148488|NCT02747043|567290255|FG000|Overall Study|Disease progression|4|||
157148489|NCT02747043|567290256|FG001|Overall Study|Disease progression|0|||
157148490|NCT00553059|567290258|FG000|Overall Study|Deemed ineligible|1|||
157148491|NCT00553059|567290259|FG001|Overall Study|Deemed ineligible|1|||
157148492|NCT00553059|567290258|FG000|Overall Study|Drug supply not available|0|||
157148493|NCT00553059|567290259|FG001|Overall Study|Drug supply not available|1|||
157148494|NCT01966731|567290260|FG000|Overall Study|Death|2|||
157148495|NCT01966731|567290260|FG000|Overall Study|Lost to Follow-up|1|||
157148496|NCT01966731|567290260|FG000|Overall Study|Physician Decision|2|||
157148497|NCT01966731|567290260|FG000|Overall Study|Follow up is not complete|600|||
157148498|NCT01966731|567290260|FG000|Overall Study|Screening Failure|29|||
157148499|NCT01966731|567290260|FG000|Overall Study|Found to be ineligible|1|||
157148500|NCT00592683|567290261|FG000|Overall Study|Found ineligible|0|||
157148501|NCT00592683|567290262|FG001|Overall Study|Found ineligible|1|||
157148502|NCT00592683|567290261|FG000|Overall Study|Withdrawal by Subject|1|||
157148503|NCT00592683|567290262|FG001|Overall Study|Withdrawal by Subject|0|||
157148504|NCT00592683|567290261|FG000|Overall Study|Adverse Event|0|||
157148505|NCT00592683|567290262|FG001|Overall Study|Adverse Event|2|||
157148506|NCT00592683|567290261|FG000|Overall Study|Protocol Violation|1|||
157148507|NCT00592683|567290262|FG001|Overall Study|Protocol Violation|0|||
157148508|NCT00592683|567290261|FG000|Overall Study|Study drug expired|1|||
157148509|NCT00592683|567290262|FG001|Overall Study|Study drug expired|0|||
157148510|NCT00592683|567290261|FG000|Overall Study|Other|1|||
157148511|NCT00592683|567290262|FG001|Overall Study|Other|0|||
157148512|NCT00592683|567290261|FG000|Overall Study|Lost to Follow-up|0|||
157148513|NCT00592683|567290262|FG001|Overall Study|Lost to Follow-up|1|||
157148514|NCT00201201|567290263|FG000|Overall Study|Death|0|||
157148515|NCT00201201|567290264|FG001|Overall Study|Death|2|||
157148516|NCT00201201|567290263|FG000|Overall Study|Withdrawal by Subject|5|||
157148517|NCT00201201|567290264|FG001|Overall Study|Withdrawal by Subject|5|||
157148518|NCT00545818|567290270|FG000|Overall Study|Protocol Violation|1|||
157148519|NCT00545818|567290271|FG001|Overall Study|Protocol Violation|0|||
157148520|NCT00545818|567290270|FG000|Overall Study|Adverse Event|1|||
157148521|NCT00545818|567290271|FG001|Overall Study|Adverse Event|1|||
157148522|NCT00545818|567290270|FG000|Overall Study|Lost to Follow-up|1|||
157148523|NCT00545818|567290271|FG001|Overall Study|Lost to Follow-up|6|||
157148524|NCT00670111|567290272|FG000|Enrollment to One Month|Testing Failure|0|||
157148525|NCT00670111|567290273|FG001|Enrollment to One Month|Testing Failure|0|||
157148526|NCT00670111|567290274|FG002|Enrollment to One Month|Testing Failure|13|||
157148527|NCT00670111|567290272|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
157148528|NCT00670111|567290273|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
157148529|NCT00670111|567290274|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
157148530|NCT00670111|567290272|FG000|Enrollment to One Month|Physician Decision|1|||
157148531|NCT00670111|567290273|FG001|Enrollment to One Month|Physician Decision|0|||
157148532|NCT00670111|567290274|FG002|Enrollment to One Month|Physician Decision|0|||
157148533|NCT02623361|567290275|FG000|Overall Study|Protocol Violation|0|||
157148534|NCT02623361|567290276|FG001|Overall Study|Protocol Violation|1|||
157148535|NCT02623361|567290275|FG000|Overall Study|Withdrawal by Subject|0|||
157148536|NCT02623361|567290276|FG001|Overall Study|Withdrawal by Subject|1|||
157148537|NCT02441803|567290278|FG000|Overall Study|Physician Decision|0|||
157148538|NCT02441803|567290279|FG001|Overall Study|Physician Decision|2|||
157022498|NCT03557697|566835236|FG001|Overall Study|Withdrawal by Subject|4|||
157148539|NCT02441803|567290280|FG002|Overall Study|Physician Decision|2|||
157148540|NCT00537823|567290282|FG000|Overall Study|Adverse Event|2|||
157148541|NCT00537823|567290283|FG001|Overall Study|Adverse Event|0|||
157148542|NCT02873221|567290284|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
157148543|NCT02873221|567290285|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
157148544|NCT02873221|567290286|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
157148545|NCT02873221|567290284|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
157148546|NCT02873221|567290285|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
157148547|NCT02873221|567290286|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
157148548|NCT02873221|567290284|FG000|Treatment Period|Protocol Violation|2|||
157148549|NCT02873221|567290285|FG001|Treatment Period|Protocol Violation|5|||
157148550|NCT02873221|567290286|FG002|Treatment Period|Protocol Violation|8|||
157148551|NCT02873221|567290284|FG000|Treatment Period|Pregnancy|4|||
157148552|NCT02873221|567290285|FG001|Treatment Period|Pregnancy|6|||
157148553|NCT02873221|567290286|FG002|Treatment Period|Pregnancy|3|||
157148554|NCT02873221|567290284|FG000|Treatment Period|Lack of Qualifying Event|0|||
157148555|NCT02873221|567290285|FG001|Treatment Period|Lack of Qualifying Event|3|||
157148556|NCT02873221|567290286|FG002|Treatment Period|Lack of Qualifying Event|1|||
157148557|NCT02873221|567290284|FG000|Treatment Period|Withdrawal of Consent|52|||
157148558|NCT02873221|567290285|FG001|Treatment Period|Withdrawal of Consent|51|||
157148559|NCT02873221|567290286|FG002|Treatment Period|Withdrawal of Consent|41|||
157148560|NCT02873221|567290284|FG000|Treatment Period|Lack of Efficacy|0|||
157148561|NCT02873221|567290285|FG001|Treatment Period|Lack of Efficacy|17|||
157148562|NCT02873221|567290286|FG002|Treatment Period|Lack of Efficacy|12|||
157148563|NCT02873221|567290284|FG000|Treatment Period|Adverse Event|4|||
157148564|NCT02873221|567290285|FG001|Treatment Period|Adverse Event|9|||
157148565|NCT02873221|567290286|FG002|Treatment Period|Adverse Event|11|||
157148566|NCT02873221|567290284|FG000|Treatment Period|Lost to Follow-up|26|||
157148567|NCT02873221|567290285|FG001|Treatment Period|Lost to Follow-up|30|||
157148568|NCT02873221|567290286|FG002|Treatment Period|Lost to Follow-up|26|||
157148569|NCT02873221|567290284|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
157148570|NCT02873221|567290285|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
157148571|NCT02873221|567290286|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
157148572|NCT02873221|567290284|FG000|Safety Follow-up Period|Protocol Violation|0|||
157148573|NCT02873221|567290285|FG001|Safety Follow-up Period|Protocol Violation|0|||
157148574|NCT02873221|567290286|FG002|Safety Follow-up Period|Protocol Violation|1|||
157148575|NCT02873221|567290284|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
157148576|NCT02873221|567290285|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
157148577|NCT02873221|567290286|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
157148578|NCT02873221|567290284|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
157148579|NCT02873221|567290285|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
157148580|NCT02873221|567290286|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
157148581|NCT01325493|567290287|FG000|Overall Study|Protocol Violation|0|||
157148582|NCT01325493|567290288|FG001|Overall Study|Protocol Violation|1|||
157148583|NCT01325493|567290287|FG000|Overall Study|loss of neuromonitoring signals|0|||
157148584|NCT01325493|567290288|FG001|Overall Study|loss of neuromonitoring signals|2|||
157148585|NCT01325493|567290287|FG000|Overall Study|Allergy|1|||
157148586|NCT01325493|567290288|FG001|Overall Study|Allergy|0|||
157148587|NCT02732912|567290289|FG000|Overall Study|Discharged before night|2|||
157148588|NCT02732912|567290290|FG001|Overall Study|Discharged before night|6|||
157148589|NCT02732912|567290289|FG000|Overall Study|Incomplete completion of questionnaire|2|||
157148590|NCT02732912|567290290|FG001|Overall Study|Incomplete completion of questionnaire|3|||
157148591|NCT02732912|567290289|FG000|Overall Study|No outcome; discharged or refused|6|||
157148592|NCT02732912|567290290|FG001|Overall Study|No outcome; discharged or refused|9|||
157148593|NCT01873742|567290291|FG000|Overall Study|Lost to Follow-up|68|||
157148594|NCT01873742|567290292|FG001|Overall Study|Lost to Follow-up|76|||
157148595|NCT02498821|567290293|FG000|Overall Study|Screen failure|3|||
157148596|NCT02498821|567290294|FG001|Overall Study|Screen failure|5|||
157148597|NCT02285010|567290295|FG000|Overall Study|not abdominal hysterectomy|2|||
157148598|NCT02285010|567290296|FG001|Overall Study|not abdominal hysterectomy|0|||
157148599|NCT02285010|567290295|FG000|Overall Study|Not spinal anesthesia|3|||
157148600|NCT02285010|567290296|FG001|Overall Study|Not spinal anesthesia|1|||
157148601|NCT01457339|567290299|FG000|Period 3 (100 mg)|Adverse Event|0|||
157148602|NCT01457339|567290300|FG001|Period 3 (100 mg)|Adverse Event|1|||
157148603|NCT01457339|567290299|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
157148604|NCT01457339|567290300|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
157148605|NCT01457339|567290299|FG000|Period 6 (250 mg)|Family Emergency|1|||
157148606|NCT01457339|567290300|FG001|Period 6 (250 mg)|Family Emergency|0|||
157148607|NCT01457339|567290299|FG000|Period 6 (250 mg)|Personal appointment|0|||
157148608|NCT01457339|567290300|FG001|Period 6 (250 mg)|Personal appointment|1|||
157148609|NCT01164501|567290302|FG000|Overall Study|Not treated|2|||
157148610|NCT01164501|567290303|FG001|Overall Study|Not treated|0|||
157148611|NCT01164501|567290304|FG002|Overall Study|Not treated|1|||
157148612|NCT01164501|567290302|FG000|Overall Study|Adverse Event|18|||
157222911|NCT02154529|567562150|FG001|Overall Study|Termination of study by sponsor|2|||
157222912|NCT02154529|567562151|FG002|Overall Study|Termination of study by sponsor|3|||
157222913|NCT02154529|567562152|FG003|Overall Study|Termination of study by sponsor|1|||
157222914|NCT02154529|567562149|FG000|Overall Study|Lost to Follow-up|1|||
157222915|NCT02154529|567562150|FG001|Overall Study|Lost to Follow-up|0|||
157222916|NCT02154529|567562151|FG002|Overall Study|Lost to Follow-up|0|||
157222917|NCT02154529|567562152|FG003|Overall Study|Lost to Follow-up|0|||
157222918|NCT04680052|567563614|FG000|Overall Study|Ongoing|244|||
157222919|NCT04680052|567563615|FG001|Overall Study|Ongoing|229|||
157222920|NCT04680052|567563616|FG002|Overall Study|Ongoing|39|||
157222921|NCT04680052|567563617|FG003|Overall Study|Ongoing|46|||
157222922|NCT04680052|567563614|FG000|Overall Study|Death|15|||
157222923|NCT04680052|567563615|FG001|Overall Study|Death|22|||
157222924|NCT04680052|567563616|FG002|Overall Study|Death|7|||
157222925|NCT04680052|567563617|FG003|Overall Study|Death|1|||
157222926|NCT04680052|567563614|FG000|Overall Study|Lost to Follow-up|3|||
157222927|NCT04680052|567563615|FG001|Overall Study|Lost to Follow-up|2|||
157222928|NCT04680052|567563616|FG002|Overall Study|Lost to Follow-up|0|||
157222929|NCT04680052|567563617|FG003|Overall Study|Lost to Follow-up|1|||
157222930|NCT04680052|567563614|FG000|Overall Study|Withdrawal by Subject|11|||
157222931|NCT04680052|567563615|FG001|Overall Study|Withdrawal by Subject|19|||
157222932|NCT04680052|567563616|FG002|Overall Study|Withdrawal by Subject|7|||
157222933|NCT04680052|567563617|FG003|Overall Study|Withdrawal by Subject|5|||
157222934|NCT04680052|567563614|FG000|Overall Study|Missing|0|||
157222935|NCT04680052|567563615|FG001|Overall Study|Missing|1|||
157222936|NCT04680052|567563616|FG002|Overall Study|Missing|0|||
157222937|NCT04680052|567563617|FG003|Overall Study|Missing|0|||
157222938|NCT04680052|567563614|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
157222939|NCT04680052|567563615|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
157222940|NCT04680052|567563616|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
157222941|NCT04680052|567563617|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
157222942|NCT04680052|567563614|FG000|Overall Study|Physician Decision|0|||
157222943|NCT04680052|567563615|FG001|Overall Study|Physician Decision|1|||
157222944|NCT04680052|567563616|FG002|Overall Study|Physician Decision|0|||
157222945|NCT04680052|567563617|FG003|Overall Study|Physician Decision|0|||
157222946|NCT02146430|567563623|FG000|Overall Study|Protocol Violation|5|||
157222947|NCT02146430|567563624|FG001|Overall Study|Protocol Violation|4|||
157222948|NCT02146430|567563625|FG002|Overall Study|Protocol Violation|8|||
157222949|NCT02146430|567563626|FG003|Overall Study|Protocol Violation|6|||
157222950|NCT02146430|567563623|FG000|Overall Study|Lack of Efficacy|13|||
157222951|NCT02146430|567563624|FG001|Overall Study|Lack of Efficacy|11|||
157222952|NCT02146430|567563625|FG002|Overall Study|Lack of Efficacy|8|||
157222953|NCT02146430|567563626|FG003|Overall Study|Lack of Efficacy|5|||
157222954|NCT02146430|567563623|FG000|Overall Study|Adverse Event|20|||
157222955|NCT02146430|567563624|FG001|Overall Study|Adverse Event|40|||
157222956|NCT02146430|567563625|FG002|Overall Study|Adverse Event|32|||
157222957|NCT02146430|567563626|FG003|Overall Study|Adverse Event|49|||
157222958|NCT02146430|567563623|FG000|Overall Study|Reason missing or not reported|2|||
157222959|NCT02146430|567563624|FG001|Overall Study|Reason missing or not reported|3|||
157222960|NCT02146430|567563625|FG002|Overall Study|Reason missing or not reported|4|||
157222961|NCT02146430|567563626|FG003|Overall Study|Reason missing or not reported|5|||
157222962|NCT02146430|567563623|FG000|Overall Study|Withdrawal by Subject|27|||
157222963|NCT02146430|567563624|FG001|Overall Study|Withdrawal by Subject|29|||
157222964|NCT02146430|567563625|FG002|Overall Study|Withdrawal by Subject|30|||
157222965|NCT02146430|567563626|FG003|Overall Study|Withdrawal by Subject|34|||
157222966|NCT03312530|567563627|FG000|Overall Study|Death|5|||
157222967|NCT03312530|567563628|FG001|Overall Study|Death|5|||
157222968|NCT03312530|567563629|FG002|Overall Study|Death|4|||
157222969|NCT03312530|567563630|FG003|Overall Study|Death|10|||
157222970|NCT03312530|567563631|FG004|Overall Study|Death|8|||
157222971|NCT03312530|567563627|FG000|Overall Study|Lost to Follow-up|0|||
157222972|NCT03312530|567563628|FG001|Overall Study|Lost to Follow-up|0|||
157222973|NCT03312530|567563629|FG002|Overall Study|Lost to Follow-up|0|||
157222974|NCT03312530|567563630|FG003|Overall Study|Lost to Follow-up|1|||
157222975|NCT03312530|567563631|FG004|Overall Study|Lost to Follow-up|0|||
157222976|NCT03312530|567563627|FG000|Overall Study|Participant in another sponsor study.|0|||
157222977|NCT03312530|567563628|FG001|Overall Study|Participant in another sponsor study.|0|||
157222978|NCT03312530|567563629|FG002|Overall Study|Participant in another sponsor study.|0|||
157222979|NCT03312530|567563630|FG003|Overall Study|Participant in another sponsor study.|1|||
157222980|NCT03312530|567563631|FG004|Overall Study|Participant in another sponsor study.|0|||
157222981|NCT03312530|567563627|FG000|Overall Study|Study terminated by sponsor|1|||
157222982|NCT03312530|567563628|FG001|Overall Study|Study terminated by sponsor|0|||
157222983|NCT03312530|567563629|FG002|Overall Study|Study terminated by sponsor|2|||
157222984|NCT03312530|567563630|FG003|Overall Study|Study terminated by sponsor|3|||
157222985|NCT03312530|567563631|FG004|Overall Study|Study terminated by sponsor|7|||
157222986|NCT03312530|567563627|FG000|Overall Study|Withdrawal by Subject|0|||
157222987|NCT03312530|567563628|FG001|Overall Study|Withdrawal by Subject|1|||
156883959|NCT01350544|566333979|FG001|Overall Study|Incarceration|0|||
156883960|NCT01350544|566333978|FG000|Overall Study|Lost to Follow-up|18|||
156883961|NCT01350544|566333979|FG001|Overall Study|Lost to Follow-up|15|||
156883962|NCT01561898|566333982|FG000|Overall Study|Withdrawal by Subject|0|||
156883963|NCT01561898|566333983|FG001|Overall Study|Withdrawal by Subject|8|||
156883964|NCT01561898|566333984|FG002|Overall Study|Withdrawal by Subject|12|||
156883965|NCT01561898|566333985|FG003|Overall Study|Withdrawal by Subject|5|||
156883966|NCT01561898|566333982|FG000|Overall Study|Lack of Efficacy|0|||
156883967|NCT01561898|566333983|FG001|Overall Study|Lack of Efficacy|8|||
156883968|NCT01561898|566333984|FG002|Overall Study|Lack of Efficacy|10|||
156883969|NCT01561898|566333985|FG003|Overall Study|Lack of Efficacy|5|||
156883970|NCT01561898|566333982|FG000|Overall Study|Worsening of complications|0|||
156883971|NCT01561898|566333983|FG001|Overall Study|Worsening of complications|1|||
156883972|NCT01561898|566333984|FG002|Overall Study|Worsening of complications|0|||
157022499|NCT01000961|566835237|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
157022500|NCT01000961|566835238|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
157148613|NCT01164501|567290303|FG001|Overall Study|Adverse Event|4|||
157148614|NCT01164501|567290304|FG002|Overall Study|Adverse Event|21|||
157148615|NCT01164501|567290302|FG000|Overall Study|Lack of Efficacy|0|||
157148616|NCT01164501|567290303|FG001|Overall Study|Lack of Efficacy|0|||
157148617|NCT01164501|567290304|FG002|Overall Study|Lack of Efficacy|1|||
157148618|NCT01164501|567290302|FG000|Overall Study|Non compliant with protocol|1|||
157148619|NCT01164501|567290303|FG001|Overall Study|Non compliant with protocol|1|||
157148620|NCT01164501|567290304|FG002|Overall Study|Non compliant with protocol|4|||
157148621|NCT01164501|567290302|FG000|Overall Study|Lost to Follow-up|3|||
157148622|NCT01164501|567290303|FG001|Overall Study|Lost to Follow-up|0|||
157148623|NCT01164501|567290304|FG002|Overall Study|Lost to Follow-up|3|||
157148624|NCT01164501|567290302|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
157148625|NCT01164501|567290303|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
157148626|NCT01164501|567290304|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
157148627|NCT01164501|567290302|FG000|Overall Study|Other reason not defined above|9|||
157148628|NCT01164501|567290303|FG001|Overall Study|Other reason not defined above|1|||
157148629|NCT01164501|567290304|FG002|Overall Study|Other reason not defined above|4|||
157148630|NCT00312377|567290306|FG000|Overall Study|Death|403|||
157148631|NCT00312377|567290307|FG001|Overall Study|Death|418|||
157148632|NCT00312377|567290306|FG000|Overall Study|Withdrawal by Subject|23|||
157148633|NCT00312377|567290307|FG001|Overall Study|Withdrawal by Subject|30|||
157148634|NCT00312377|567290306|FG000|Overall Study|Lost to Follow-up|9|||
157148635|NCT00312377|567290307|FG001|Overall Study|Lost to Follow-up|12|||
157148636|NCT00312377|567290306|FG000|Overall Study|Non-compliance|0|||
157148637|NCT00312377|567290307|FG001|Overall Study|Non-compliance|2|||
157148638|NCT00312377|567290306|FG000|Overall Study|Randomised but never received treatment|6|||
157148639|NCT00312377|567290307|FG001|Overall Study|Randomised but never received treatment|6|||
157148640|NCT00312377|567290306|FG000|Overall Study|Discontinue treatment survival follow up|202|||
157148641|NCT00312377|567290307|FG001|Overall Study|Discontinue treatment survival follow up|200|||
157148642|NCT00312377|567290306|FG000|Overall Study|Site ended participation in study|1|||
157148643|NCT00312377|567290307|FG001|Overall Study|Site ended participation in study|0|||
157148644|NCT05258058|567290308|FG000|Overall Study|Withdrawal by Subject|2|||
157148645|NCT00408681|567290311|FG000|Overall Study|Lack of Efficacy|2|||
157148646|NCT00408681|567290311|FG000|Overall Study|Adverse Event|7|||
157148647|NCT01787591|567290313|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
157148648|NCT01787591|567290314|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
157148649|NCT01787591|567290315|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
157148650|NCT01787591|567290316|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
157148651|NCT02489630|567290319|FG000|Overall Study|Oversedation|1|||
157148652|NCT02489630|567290320|FG001|Overall Study|Oversedation|1|||
157148653|NCT02489630|567290319|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
157148654|NCT02489630|567290320|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
157148655|NCT00815308|567290321|FG000|Overall Study|Adverse Event|4|||
157148656|NCT00815308|567290321|FG000|Overall Study|Withdrawal by Subject|0|||
157148657|NCT00815308|567290321|FG000|Overall Study|Protocol Violation|6|||
157148658|NCT00377299|567290322|FG000|Overall Study|Lost to Follow-up|14|||
157148659|NCT00377299|567290323|FG001|Overall Study|Lost to Follow-up|19|||
157148660|NCT00377299|567290322|FG000|Overall Study|Adverse Event|0|||
157148661|NCT00377299|567290323|FG001|Overall Study|Adverse Event|1|||
157148662|NCT00377299|567290322|FG000|Overall Study|Withdrawal by Subject|5|||
157148663|NCT00377299|567290323|FG001|Overall Study|Withdrawal by Subject|4|||
156883973|NCT01561898|566333985|FG003|Overall Study|Worsening of complications|0|||
156883974|NCT01561898|566333982|FG000|Overall Study|Lost to Follow-up|0|||
156883975|NCT01561898|566333983|FG001|Overall Study|Lost to Follow-up|0|||
156883976|NCT01561898|566333984|FG002|Overall Study|Lost to Follow-up|1|||
156883977|NCT01561898|566333985|FG003|Overall Study|Lost to Follow-up|0|||
156883978|NCT01561898|566333982|FG000|Overall Study|Adverse Event|1|||
156883979|NCT01561898|566333983|FG001|Overall Study|Adverse Event|19|||
156883980|NCT01561898|566333984|FG002|Overall Study|Adverse Event|14|||
156883981|NCT01561898|566333985|FG003|Overall Study|Adverse Event|9|||
157022501|NCT01000961|566835237|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
157022502|NCT01000961|566835238|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
157222988|NCT03312530|567563629|FG002|Overall Study|Withdrawal by Subject|0|||
157222989|NCT03312530|567563630|FG003|Overall Study|Withdrawal by Subject|0|||
157222990|NCT03312530|567563631|FG004|Overall Study|Withdrawal by Subject|0|||
157222991|NCT03312530|567563627|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
157222992|NCT03312530|567563628|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
157222993|NCT03312530|567563629|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
157222994|NCT03312530|567563630|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
157222995|NCT03312530|567563631|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
157222996|NCT03093324|567563632|FG000|Overall Study|Adverse Event|4|||
157222997|NCT03093324|567563633|FG001|Overall Study|Adverse Event|15|||
157222998|NCT03093324|567563632|FG000|Overall Study|Lost to Follow-up|1|||
157222999|NCT03093324|567563633|FG001|Overall Study|Lost to Follow-up|0|||
157223000|NCT03093324|567563632|FG000|Overall Study|Protocol Deviation|2|||
157223001|NCT03093324|567563633|FG001|Overall Study|Protocol Deviation|2|||
157223002|NCT03093324|567563632|FG000|Overall Study|Withdrawal by Subject|2|||
157223003|NCT03093324|567563633|FG001|Overall Study|Withdrawal by Subject|2|||
157223004|NCT04583579|567563635|FG000|Overall Study|Lost to Follow-up|4|||
157223005|NCT02489318|567563636|FG000|Randomized|Withdrawal by Subject|0|||
157223006|NCT02489318|567563637|FG001|Randomized|Withdrawal by Subject|1|||
157223007|NCT02489318|567563636|FG000|Treated|Adverse Event|19|||
157223008|NCT02489318|567563637|FG001|Treated|Adverse Event|62|||
157223009|NCT02489318|567563636|FG000|Treated|Death|13|||
157223010|NCT02489318|567563637|FG001|Treated|Death|11|||
157223011|NCT02489318|567563636|FG000|Treated|Physician Decision|4|||
157223012|NCT02489318|567563637|FG001|Treated|Physician Decision|6|||
157223013|NCT02489318|567563636|FG000|Treated|Protocol Violation|1|||
157223014|NCT02489318|567563637|FG001|Treated|Protocol Violation|2|||
157223015|NCT02489318|567563636|FG000|Treated|Withdrawal by Subject|37|||
157223016|NCT02489318|567563637|FG001|Treated|Withdrawal by Subject|36|||
157223017|NCT02489318|567563636|FG000|Treated|Other: Progressive Disease|245|||
157223018|NCT02489318|567563637|FG001|Treated|Other: Progressive Disease|138|||
157223019|NCT02489318|567563636|FG000|Treated|Other|0|||
157223020|NCT02489318|567563637|FG001|Treated|Other|2|||
157223021|NCT02489318|567563636|FG000|Treated|Ongoing|0|||
157223022|NCT02489318|567563637|FG001|Treated|Ongoing|267|||
157223023|NCT05218655|567563642|FG000|Overall Study|Adverse Event|6|||
157223024|NCT05218655|567563642|FG000|Overall Study|Sponsor's decision|85|||
157223025|NCT05218655|567563642|FG000|Overall Study|Death|1|||
157223026|NCT05218655|567563642|FG000|Overall Study|Lost to Follow-up|3|||
157223027|NCT05218655|567563642|FG000|Overall Study|Withdrawal by Subject|3|||
157223028|NCT05218655|567563642|FG000|Overall Study|Other than specified|3|||
157223029|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
157223030|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
157223031|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
157223032|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
157223033|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
157223034|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
157223035|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
157223036|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
157223037|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
157223038|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
157223039|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
157223040|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
157223041|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
157223042|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
157223043|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
157223044|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
157223045|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
157223046|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
157223047|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
157223048|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
157223049|NCT04700449|567563645|FG000|Stage 1: Double-Blind Period|Other|0|||
157223050|NCT04700449|567563646|FG001|Stage 1: Double-Blind Period|Other|0|||
157223051|NCT04700449|567563647|FG002|Stage 1: Double-Blind Period|Other|1|||
157223052|NCT04700449|567563648|FG003|Stage 1: Double-Blind Period|Other|0|||
157223053|NCT04700449|567563645|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
157223054|NCT04700449|567563646|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
157223055|NCT04700449|567563647|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
157223056|NCT04700449|567563648|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
157223057|NCT04700449|567563645|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
157223058|NCT04700449|567563646|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
157148664|NCT02209597|567290326|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
157148665|NCT02209597|567290326|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
157148666|NCT02209597|567290326|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
157148667|NCT02209597|567290326|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
157148668|NCT04799782|567290328|FG000|Washout|Physician Decision|2|||
157148669|NCT04799782|567290329|FG001|Washout|Physician Decision|0|||
157148670|NCT04799782|567290328|FG000|Washout|Withdrawal by Subject|0|||
157148671|NCT04799782|567290329|FG001|Washout|Withdrawal by Subject|2|||
157148672|NCT04799782|567290328|FG000|Washout|Lost to Follow-up|0|||
157148673|NCT04799782|567290329|FG001|Washout|Lost to Follow-up|1|||
157148674|NCT01589094|567290332|FG000|Overall Study|Did not receive treatment|2|||
157148675|NCT02975349|567290333|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148676|NCT02975349|567290334|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148677|NCT02975349|567290335|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148678|NCT02975349|567290336|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157148679|NCT02975349|567290337|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157148680|NCT02975349|567290338|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148681|NCT02975349|567290339|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157148682|NCT02975349|567290333|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157148683|NCT02975349|567290334|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148684|NCT02975349|567290335|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148685|NCT02975349|567290336|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148686|NCT02975349|567290337|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148687|NCT02975349|567290338|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148688|NCT02975349|567290339|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157148689|NCT02975349|567290333|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
157148690|NCT02975349|567290334|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
157148691|NCT02975349|567290335|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
157148692|NCT02975349|567290336|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
157148693|NCT02975349|567290337|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
157148694|NCT02975349|567290338|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
157148695|NCT02975349|567290339|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
157148696|NCT02975349|567290333|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
157148697|NCT02975349|567290334|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
157148698|NCT02975349|567290335|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
157148699|NCT02975349|567290336|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
157148700|NCT02975349|567290337|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
157148701|NCT02975349|567290338|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
157148702|NCT02975349|567290339|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
157148703|NCT02975349|567290333|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
157148704|NCT02975349|567290334|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
157148705|NCT02975349|567290335|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
157148706|NCT02975349|567290336|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
157148707|NCT02975349|567290337|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
157148708|NCT02975349|567290338|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
157148709|NCT02975349|567290339|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
157148710|NCT02975349|567290333|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148711|NCT02975349|567290334|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148712|NCT02975349|567290335|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148713|NCT02975349|567290336|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
157148714|NCT02975349|567290337|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148715|NCT02975349|567290338|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148716|NCT02975349|567290339|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
157148717|NCT02975349|567290333|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148718|NCT02975349|567290334|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
157148719|NCT02975349|567290335|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148720|NCT02975349|567290336|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148721|NCT02975349|567290337|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148722|NCT02975349|567290338|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148723|NCT02975349|567290339|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
157148724|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
157148725|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
157148726|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
157148727|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
157148728|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
157148729|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
157148730|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
157148731|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148732|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148733|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148734|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148735|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
157148736|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148737|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
157148738|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
157148739|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
157148740|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
157148741|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
157148742|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
157148743|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
157148744|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
157148745|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
157148746|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
157148747|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
157148748|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
157148749|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
157148750|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
157148751|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
157148752|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
157148753|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
157148754|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
157148755|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
157148756|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
157148757|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
157148758|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
157148759|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
157148760|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
157148761|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
157148762|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
157148763|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
157148764|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
157148765|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
157148766|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
157148767|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
157148768|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
157148769|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
157148770|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
157148771|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
157148772|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
157148773|NCT02975349|567290333|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
157148774|NCT02975349|567290334|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
157148775|NCT02975349|567290335|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
157148776|NCT02975349|567290336|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
157148777|NCT02975349|567290337|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
157148778|NCT02975349|567290338|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
157148779|NCT02975349|567290339|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
157148780|NCT00969618|567290345|FG000|Overall Study|Adverse Event|29|||
157148781|NCT00969618|567290345|FG000|Overall Study|Entry Criteria Not Met|3|||
157148782|NCT00969618|567290345|FG000|Overall Study|Lack of Efficacy|2|||
157148783|NCT00969618|567290345|FG000|Overall Study|Lost to Follow-up|7|||
157148784|NCT00969618|567290345|FG000|Overall Study|Physician Decision|1|||
157148785|NCT00969618|567290345|FG000|Overall Study|Protocol Violation|9|||
157148786|NCT00969618|567290345|FG000|Overall Study|Withdrawal by Subject|27|||
157148787|NCT01988012|567292300|FG000|Overall Study|Adverse Event|5|||
157148788|NCT01988012|567292300|FG000|Overall Study|Insufficient Therapeutic Response|3|||
157148789|NCT01988012|567292300|FG000|Overall Study|Patient Withdrawal of Consent|4|||
157148790|NCT01988012|567292300|FG000|Overall Study|Lost to Follow-up|1|||
157148791|NCT01988012|567292300|FG000|Overall Study|Physician Decision|1|||
157148792|NCT01988012|567292300|FG000|Overall Study|Protocol Violation|1|||
157148793|NCT00521339|567292301|FG000|Treatment Phase|Adverse Event|2|||
157148794|NCT00521339|567292302|FG001|Treatment Phase|Adverse Event|0|||
157148795|NCT00521339|567292303|FG002|Treatment Phase|Adverse Event|0|||
157148796|NCT00521339|567292301|FG000|Treatment Phase|Intolerability to study drug|2|||
157148797|NCT00521339|567292302|FG001|Treatment Phase|Intolerability to study drug|0|||
157148798|NCT00521339|567292303|FG002|Treatment Phase|Intolerability to study drug|0|||
157148799|NCT00521339|567292301|FG000|Treatment Phase|Lack of Efficacy|3|||
156812591|NCT01061723|566064805|FG000|Overall Study|Adverse Event|0|||
156812592|NCT01061723|566064806|FG001|Overall Study|Adverse Event|2|||
156812593|NCT01061723|566064807|FG002|Overall Study|Adverse Event|5|||
156812594|NCT01061723|566064808|FG003|Overall Study|Adverse Event|5|||
156812595|NCT01061723|566064809|FG004|Overall Study|Adverse Event|2|||
156812596|NCT01061723|566064810|FG005|Overall Study|Adverse Event|6|||
156812597|NCT01061723|566064805|FG000|Overall Study|Lack of Efficacy|2|||
156812598|NCT01061723|566064806|FG001|Overall Study|Lack of Efficacy|3|||
156812599|NCT01061723|566064807|FG002|Overall Study|Lack of Efficacy|4|||
156812600|NCT01061723|566064808|FG003|Overall Study|Lack of Efficacy|2|||
156812601|NCT01061723|566064809|FG004|Overall Study|Lack of Efficacy|1|||
156812602|NCT01061723|566064810|FG005|Overall Study|Lack of Efficacy|1|||
156812603|NCT01061723|566064805|FG000|Overall Study|Randomized but not treated|0|||
156812604|NCT01061723|566064806|FG001|Overall Study|Randomized but not treated|0|||
156812605|NCT01061723|566064807|FG002|Overall Study|Randomized but not treated|0|||
156812606|NCT01061723|566064808|FG003|Overall Study|Randomized but not treated|0|||
156812607|NCT01061723|566064809|FG004|Overall Study|Randomized but not treated|0|||
156812608|NCT01061723|566064810|FG005|Overall Study|Randomized but not treated|1|||
156812609|NCT01061723|566064805|FG000|Overall Study|Other than specified above|2|||
156812610|NCT01061723|566064806|FG001|Overall Study|Other than specified above|1|||
156812611|NCT01061723|566064807|FG002|Overall Study|Other than specified above|1|||
156812612|NCT01061723|566064808|FG003|Overall Study|Other than specified above|1|||
156812613|NCT01061723|566064809|FG004|Overall Study|Other than specified above|0|||
156812614|NCT01061723|566064810|FG005|Overall Study|Other than specified above|1|||
156812615|NCT01734785|566064811|FG000|Open-Label Period|Adverse Event|0|||
156812616|NCT01734785|566064812|FG001|Open-Label Period|Adverse Event|0|||
156812617|NCT01734785|566064813|FG002|Open-Label Period|Adverse Event|0|||
156812618|NCT01734785|566064814|FG003|Open-Label Period|Adverse Event|9|||
156812619|NCT01734785|566064811|FG000|Open-Label Period|Lack of Efficacy|0|||
156812620|NCT01734785|566064812|FG001|Open-Label Period|Lack of Efficacy|0|||
156812621|NCT01734785|566064813|FG002|Open-Label Period|Lack of Efficacy|0|||
156812622|NCT01734785|566064814|FG003|Open-Label Period|Lack of Efficacy|1|||
156812623|NCT01734785|566064811|FG000|Open-Label Period|Protocol Violation|0|||
156812624|NCT01734785|566064812|FG001|Open-Label Period|Protocol Violation|0|||
156812625|NCT01734785|566064813|FG002|Open-Label Period|Protocol Violation|0|||
156812626|NCT01734785|566064814|FG003|Open-Label Period|Protocol Violation|13|||
156812627|NCT01734785|566064811|FG000|Open-Label Period|Lost to Follow-up|0|||
156812628|NCT01734785|566064812|FG001|Open-Label Period|Lost to Follow-up|0|||
156812629|NCT01734785|566064813|FG002|Open-Label Period|Lost to Follow-up|0|||
156812630|NCT01734785|566064814|FG003|Open-Label Period|Lost to Follow-up|14|||
156812631|NCT01734785|566064811|FG000|Open-Label Period|Withdrawal by Subject|0|||
156812632|NCT01734785|566064812|FG001|Open-Label Period|Withdrawal by Subject|0|||
156812633|NCT01734785|566064813|FG002|Open-Label Period|Withdrawal by Subject|0|||
156812634|NCT01734785|566064814|FG003|Open-Label Period|Withdrawal by Subject|12|||
156812635|NCT01734785|566064811|FG000|Open-Label Period|Other Reasons|0|||
157148800|NCT00521339|567292302|FG001|Treatment Phase|Lack of Efficacy|0|||
157148801|NCT00521339|567292303|FG002|Treatment Phase|Lack of Efficacy|0|||
157148802|NCT00521339|567292301|FG000|Treatment Phase|Withdrawal by Subject|3|||
157148803|NCT00521339|567292302|FG001|Treatment Phase|Withdrawal by Subject|0|||
157148804|NCT00521339|567292303|FG002|Treatment Phase|Withdrawal by Subject|0|||
157148805|NCT00521339|567292301|FG000|Treatment Phase|Lost to Follow-up|1|||
157148806|NCT00521339|567292302|FG001|Treatment Phase|Lost to Follow-up|0|||
157148807|NCT00521339|567292303|FG002|Treatment Phase|Lost to Follow-up|0|||
157148808|NCT00521339|567292301|FG000|Treatment Phase|Protocol Violation|1|||
157148809|NCT00521339|567292302|FG001|Treatment Phase|Protocol Violation|0|||
157148810|NCT00521339|567292303|FG002|Treatment Phase|Protocol Violation|0|||
157148811|NCT00521339|567292301|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
157148812|NCT00521339|567292302|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
157148813|NCT00521339|567292303|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
157148814|NCT00521339|567292301|FG000|Treatment Extension Phase|Death|0|||
157148815|NCT00521339|567292302|FG001|Treatment Extension Phase|Death|0|||
157148816|NCT00521339|567292303|FG002|Treatment Extension Phase|Death|1|||
157148817|NCT01058369|567292304|FG000|Overall Study|Adverse Event|1|||
157148818|NCT01058369|567292304|FG000|Overall Study|Early termination study|1|||
157148819|NCT03314519|567292305|FG000|Overall Study|Protocol Violation|3|||
156812636|NCT01734785|566064812|FG001|Open-Label Period|Other Reasons|0|||
157148820|NCT03314519|567292306|FG001|Overall Study|Protocol Violation|2|||
157148821|NCT01157169|567292309|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
157148822|NCT01157169|567292310|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
157148823|NCT01157169|567292309|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
156812637|NCT01734785|566064813|FG002|Open-Label Period|Other Reasons|0|||
156812638|NCT01734785|566064814|FG003|Open-Label Period|Other Reasons|224|||
156812639|NCT01734785|566064811|FG000|Double-Blind Period|Adverse Event|0|||
156812640|NCT01734785|566064812|FG001|Double-Blind Period|Adverse Event|3|||
156812641|NCT01734785|566064813|FG002|Double-Blind Period|Adverse Event|2|||
156812642|NCT01734785|566064814|FG003|Double-Blind Period|Adverse Event|0|||
156812643|NCT01734785|566064811|FG000|Double-Blind Period|Lack of Efficacy|0|||
156812644|NCT01734785|566064812|FG001|Double-Blind Period|Lack of Efficacy|1|||
156812645|NCT01734785|566064813|FG002|Double-Blind Period|Lack of Efficacy|0|||
156812646|NCT01734785|566064814|FG003|Double-Blind Period|Lack of Efficacy|0|||
156812647|NCT01734785|566064811|FG000|Double-Blind Period|Protocol Violation|0|||
156812648|NCT01734785|566064812|FG001|Double-Blind Period|Protocol Violation|1|||
156812649|NCT01734785|566064813|FG002|Double-Blind Period|Protocol Violation|1|||
156812650|NCT01734785|566064814|FG003|Double-Blind Period|Protocol Violation|0|||
156812651|NCT01734785|566064811|FG000|Double-Blind Period|Lost to Follow-up|2|||
156812652|NCT01734785|566064812|FG001|Double-Blind Period|Lost to Follow-up|4|||
156812653|NCT01734785|566064813|FG002|Double-Blind Period|Lost to Follow-up|2|||
156812654|NCT01734785|566064814|FG003|Double-Blind Period|Lost to Follow-up|0|||
156812655|NCT01734785|566064811|FG000|Double-Blind Period|Withdrawal by Subject|2|||
157148824|NCT01157169|567292310|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
157148825|NCT00663858|567292311|FG000|Overall Study|Adverse Event|9|||
157148826|NCT00663858|567292312|FG001|Overall Study|Adverse Event|1|||
157148827|NCT00663858|567292313|FG002|Overall Study|Adverse Event|6|||
156812656|NCT01734785|566064812|FG001|Double-Blind Period|Withdrawal by Subject|0|||
156812657|NCT01734785|566064813|FG002|Double-Blind Period|Withdrawal by Subject|0|||
156812658|NCT01734785|566064814|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156812659|NCT01734785|566064811|FG000|Double-Blind Period|Not treated|1|||
156812660|NCT01734785|566064812|FG001|Double-Blind Period|Not treated|0|||
156812661|NCT01734785|566064813|FG002|Double-Blind Period|Not treated|0|||
156812662|NCT01734785|566064814|FG003|Double-Blind Period|Not treated|0|||
156812663|NCT02397915|566064815|FG000|Period 1|Protocol Violation|0|||
156812664|NCT02397915|566064816|FG001|Period 1|Protocol Violation|1|||
156812665|NCT02397915|566064817|FG002|Period 1|Protocol Violation|0|||
156812666|NCT02397915|566064818|FG003|Period 1|Protocol Violation|0|||
156812667|NCT02397915|566064815|FG000|Period 1|Physician Decision|1|||
156812668|NCT02397915|566064816|FG001|Period 1|Physician Decision|0|||
156812669|NCT02397915|566064817|FG002|Period 1|Physician Decision|0|||
156812670|NCT02397915|566064818|FG003|Period 1|Physician Decision|0|||
156812671|NCT00368745|566064819|FG000|Double-blind Treatment Period|Adverse Event|6|||
156812672|NCT00368745|566064820|FG001|Double-blind Treatment Period|Adverse Event|6|||
156812673|NCT00368745|566064819|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
156812674|NCT00368745|566064820|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
156812675|NCT00368745|566064819|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
156812676|NCT00368745|566064820|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
156812677|NCT00368745|566064819|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
156812678|NCT00368745|566064820|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
156812679|NCT00368745|566064819|FG000|Double-blind Treatment Period|Other|7|||
156812680|NCT00368745|566064820|FG001|Double-blind Treatment Period|Other|6|||
156812681|NCT03292874|566064821|FG000|Overall Study|Due to pandemic|5|||
156812682|NCT01961297|566064827|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
156812683|NCT01961297|566064828|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
156812684|NCT02482298|566064829|FG000|Overall Study|Withdrawal by Subject|2|||
156812685|NCT02482298|566064830|FG001|Overall Study|Withdrawal by Subject|1|||
156812686|NCT02482298|566064831|FG002|Overall Study|Withdrawal by Subject|2|||
156812687|NCT02482298|566064829|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
156812688|NCT02482298|566064830|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
156812689|NCT02482298|566064831|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
156812690|NCT02482298|566064829|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
156812691|NCT02482298|566064830|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
156812692|NCT02482298|566064831|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
156812693|NCT02482298|566064829|FG000|Overall Study|Lost to Follow-up|0|||
156812694|NCT02482298|566064830|FG001|Overall Study|Lost to Follow-up|1|||
156812695|NCT02482298|566064831|FG002|Overall Study|Lost to Follow-up|0|||
156812696|NCT03053440|566064836|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
156812697|NCT03053440|566064837|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
156812698|NCT03053440|566064836|FG000|Overall Study|Death|18|||
156812699|NCT03053440|566064837|FG001|Overall Study|Death|14|||
156812700|NCT03053440|566064836|FG000|Overall Study|Withdrawal by Subject|9|||
156812701|NCT03053440|566064837|FG001|Overall Study|Withdrawal by Subject|8|||
156812702|NCT03053440|566064836|FG000|Overall Study|Lost to Follow-up|1|||
156812703|NCT03053440|566064837|FG001|Overall Study|Lost to Follow-up|0|||
156812704|NCT03053440|566064836|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
156812705|NCT03053440|566064837|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
156812706|NCT03053440|566064836|FG000|Overall Study|Physician Decision|2|||
157148828|NCT00663858|567292311|FG000|Overall Study|Lack of Efficacy|5|||
156812707|NCT03053440|566064837|FG001|Overall Study|Physician Decision|1|||
156812708|NCT03053440|566064836|FG000|Overall Study|Participant Randomized but died before dosing|1|||
156812709|NCT03053440|566064837|FG001|Overall Study|Participant Randomized but died before dosing|0|||
156812710|NCT01582009|566064838|FG000|Overall Study|Withdrawal by Subject|1|||
156812711|NCT01582009|566064838|FG000|Overall Study|Physician Decision|1|||
156812712|NCT01523743|566064841|FG000|Period 1|Adverse Event|1|||
156812713|NCT01523743|566064842|FG001|Period 1|Adverse Event|0|||
156883982|NCT01561898|566333982|FG000|Overall Study|Physician Decision|1|||
156883983|NCT01561898|566333983|FG001|Overall Study|Physician Decision|5|||
157148829|NCT00663858|567292312|FG001|Overall Study|Lack of Efficacy|1|||
157148830|NCT00663858|567292313|FG002|Overall Study|Lack of Efficacy|3|||
156883984|NCT01561898|566333984|FG002|Overall Study|Physician Decision|7|||
156883985|NCT01561898|566333985|FG003|Overall Study|Physician Decision|1|||
156883986|NCT00331552|566333986|FG000|Period 3: Phase II|Neurological Symptoms|1|||
156883987|NCT00331552|566333987|FG001|Period 3: Phase II|Neurological Symptoms|0|||
157148831|NCT00663858|567292311|FG000|Overall Study|Withdrawal by Subject|7|||
157148832|NCT00663858|567292312|FG001|Overall Study|Withdrawal by Subject|3|||
157148833|NCT00663858|567292313|FG002|Overall Study|Withdrawal by Subject|3|||
157148834|NCT00663858|567292311|FG000|Overall Study|Protocol Violation|5|||
157148835|NCT00663858|567292312|FG001|Overall Study|Protocol Violation|3|||
156812714|NCT01523743|566064841|FG000|Period 1|Withdrawal by Subject|6|||
156812715|NCT01523743|566064842|FG001|Period 1|Withdrawal by Subject|2|||
156812716|NCT01523743|566064841|FG000|Period 1|Lost to Follow-up|1|||
156812717|NCT01523743|566064842|FG001|Period 1|Lost to Follow-up|0|||
156812718|NCT01523743|566064841|FG000|Period 1|Lack of Efficacy|1|||
156812719|NCT01523743|566064842|FG001|Period 1|Lack of Efficacy|0|||
156812720|NCT01523743|566064841|FG000|Period 1|Felt unable to empty bladder|1|||
156812721|NCT01523743|566064842|FG001|Period 1|Felt unable to empty bladder|0|||
156812722|NCT01523743|566064841|FG000|Period 2|Withdrawal by Subject|0|||
156812723|NCT01523743|566064842|FG001|Period 2|Withdrawal by Subject|2|||
156812724|NCT01523743|566064841|FG000|Period 2|Adverse Event|1|||
156812725|NCT01523743|566064842|FG001|Period 2|Adverse Event|0|||
156812726|NCT02569476|566064843|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
156812727|NCT02569476|566064843|FG000|Overall Study|Death|33|||
156812728|NCT02569476|566064843|FG000|Overall Study|Withdrawal by Subject|9|||
156812729|NCT02569476|566064843|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
156812730|NCT02569476|566064843|FG000|Overall Study|Palliative care|1|||
156812731|NCT02569476|566064843|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
156812732|NCT02569476|566064843|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
156812733|NCT01071954|566064844|FG000|Overall Study|Noncompliance|4|||
156812734|NCT01071954|566064844|FG000|Overall Study|Adverse Event|1|||
156812735|NCT01071954|566064844|FG000|Overall Study|Withdrawal by Subject|11|||
156812736|NCT01071954|566064844|FG000|Overall Study|Requirement for Alternative Therapy|5|||
156812737|NCT01071954|566064844|FG000|Overall Study|Administrative Decision|5|||
156812738|NCT01071954|566064844|FG000|Overall Study|Protocol Specified Criteria|1|||
156812739|NCT01152788|566064845|FG000|Overall Study|Withdrawal by Subject|0|||
156812740|NCT01152788|566064846|FG001|Overall Study|Withdrawal by Subject|3|||
156812741|NCT01152788|566064845|FG000|Overall Study|No treatment|0|||
156812742|NCT01152788|566064846|FG001|Overall Study|No treatment|1|||
156812743|NCT01434654|566064848|FG000|Overall Study|Withdrawal by Subject|1|||
156812744|NCT01434654|566064849|FG001|Overall Study|Withdrawal by Subject|0|||
156812745|NCT01434654|566064848|FG000|Overall Study|Lost to Follow-up|1|||
156812746|NCT01434654|566064849|FG001|Overall Study|Lost to Follow-up|0|||
156812747|NCT03782064|566064852|FG000|Overall Study|Lack of Efficacy|2|||
156812748|NCT03782064|566064852|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
156812749|NCT00363142|566064853|FG000|Overall Study|Adverse Event|2|||
156812750|NCT00363142|566064854|FG001|Overall Study|Adverse Event|0|||
156812751|NCT00363142|566064853|FG000|Overall Study|Lack of Efficacy|0|||
156812752|NCT00363142|566064854|FG001|Overall Study|Lack of Efficacy|1|||
156812753|NCT00363142|566064853|FG000|Overall Study|Lost to Follow-up|1|||
156812754|NCT00363142|566064854|FG001|Overall Study|Lost to Follow-up|0|||
156812755|NCT00363142|566064853|FG000|Overall Study|Non-compliance|1|||
156812756|NCT00363142|566064854|FG001|Overall Study|Non-compliance|1|||
156812757|NCT00363142|566064853|FG000|Overall Study|Withdrawal by Subject|3|||
156812758|NCT00363142|566064854|FG001|Overall Study|Withdrawal by Subject|1|||
156812759|NCT02625220|566064856|FG000|Overall Study|Adverse Event|2|||
156812760|NCT02625220|566064856|FG000|Overall Study|Lost to Follow-up|2|||
156812761|NCT02625220|566064856|FG000|Overall Study|Protocol Violation|1|||
156812762|NCT02625220|566064856|FG000|Overall Study|Study discontinued at site|2|||
156883988|NCT00331552|566333986|FG000|Period 3: Phase II|Severe Nausea|1|||
156883989|NCT00331552|566333987|FG001|Period 3: Phase II|Severe Nausea|0|||
157022503|NCT03476460|566835241|FG000|Overall Study|Withdrawal by Subject|3|||
157148836|NCT00663858|567292313|FG002|Overall Study|Protocol Violation|4|||
157148837|NCT00663858|567292311|FG000|Overall Study|Other|8|||
157148838|NCT00663858|567292312|FG001|Overall Study|Other|2|||
157148839|NCT00663858|567292313|FG002|Overall Study|Other|4|||
157148840|NCT02940886|567292314|FG000|Overall Study|Adverse Event|7|||
157148841|NCT02940886|567292315|FG001|Overall Study|Adverse Event|3|||
157148842|NCT02940886|567292314|FG000|Overall Study|Protocol Violation|0|||
157148843|NCT02940886|567292315|FG001|Overall Study|Protocol Violation|2|||
156812763|NCT01140867|566064857|FG000|Overall Study|Adverse Event|22|||
156812764|NCT01140867|566064857|FG000|Overall Study|Lack of Efficacy|3|||
156812765|NCT01140867|566064857|FG000|Overall Study|Lost to Follow-up|2|||
156883990|NCT01883453|566333988|FG000|Overall Study|No episode of common cold|25|||
156883991|NCT01883453|566333989|FG001|Overall Study|No episode of common cold|23|||
157148844|NCT02940886|567292314|FG000|Overall Study|Withdrawal by Subject|28|||
157148845|NCT02940886|567292315|FG001|Overall Study|Withdrawal by Subject|20|||
157148846|NCT02940886|567292314|FG000|Overall Study|Death|1|||
157148847|NCT02940886|567292315|FG001|Overall Study|Death|0|||
157148848|NCT02940886|567292314|FG000|Overall Study|Lack of Efficacy|1|||
157148849|NCT02940886|567292315|FG001|Overall Study|Lack of Efficacy|0|||
157148850|NCT02940886|567292314|FG000|Overall Study|Lost to Follow-up|49|||
157148851|NCT02940886|567292315|FG001|Overall Study|Lost to Follow-up|21|||
157148852|NCT02940886|567292314|FG000|Overall Study|Physician Decision|9|||
157148853|NCT02940886|567292315|FG001|Overall Study|Physician Decision|4|||
157148854|NCT02940886|567292314|FG000|Overall Study|Sponsor decision|0|||
156812766|NCT01140867|566064857|FG000|Overall Study|Withdrawal by Subject|1|||
156812767|NCT01140867|566064857|FG000|Overall Study|Protocol Violation|1|||
156812768|NCT01140867|566064857|FG000|Overall Study|Uncooperative patient|2|||
156812769|NCT01140867|566064857|FG000|Overall Study|Medication Noncompliance|2|||
156812770|NCT01926444|566064858|FG000|Overall Study|Colonoscopy not performed|0|||
156812771|NCT01926444|566064859|FG001|Overall Study|Colonoscopy not performed|0|||
156812772|NCT01926444|566064860|FG002|Overall Study|Colonoscopy not performed|4|||
156812773|NCT01926444|566064861|FG003|Overall Study|Colonoscopy not performed|2|||
156812774|NCT00995436|566064865|FG000|Overall Study|Withdrawal by Subject|2|||
156812775|NCT00995436|566064866|FG001|Overall Study|Withdrawal by Subject|5|||
156812776|NCT00995436|566064867|FG002|Overall Study|Withdrawal by Subject|0|||
156812777|NCT03035864|566064870|FG000|Treatment Period|Adverse Event|1|||
156812778|NCT03035864|566064871|FG001|Treatment Period|Adverse Event|0|||
156812779|NCT03035864|566064870|FG000|Treatment Period|Other|3|||
156812780|NCT03035864|566064871|FG001|Treatment Period|Other|1|||
156812781|NCT03035864|566064870|FG000|Follow-up Period|Adverse Event|1|||
156812782|NCT03035864|566064871|FG001|Follow-up Period|Adverse Event|0|||
156812783|NCT03035864|566064870|FG000|Follow-up Period|Lost to Follow-up|6|||
156812784|NCT03035864|566064871|FG001|Follow-up Period|Lost to Follow-up|2|||
156812785|NCT03035864|566064870|FG000|Follow-up Period|Physician Decision|1|||
156812786|NCT03035864|566064871|FG001|Follow-up Period|Physician Decision|0|||
156812787|NCT03035864|566064870|FG000|Follow-up Period|Other|3|||
156812788|NCT03035864|566064871|FG001|Follow-up Period|Other|2|||
156812789|NCT01154452|566064875|FG000|Phase Ib|Not Treated|1|||
156812790|NCT01154452|566064876|FG001|Phase Ib|Not Treated|0|||
156812791|NCT01154452|566064877|FG002|Phase Ib|Not Treated|0|||
156812792|NCT01154452|566064878|FG003|Phase Ib|Not Treated|0|||
156812793|NCT01154452|566064875|FG000|Phase Ib|Adverse Event|2|||
156812794|NCT01154452|566064876|FG001|Phase Ib|Adverse Event|1|||
156812795|NCT01154452|566064877|FG002|Phase Ib|Adverse Event|0|||
156812796|NCT01154452|566064878|FG003|Phase Ib|Adverse Event|0|||
156812797|NCT01154452|566064875|FG000|Phase II|Withdrawal by Subject|0|||
156812798|NCT01154452|566064876|FG001|Phase II|Withdrawal by Subject|0|||
156812799|NCT01154452|566064877|FG002|Phase II|Withdrawal by Subject|1|||
156812800|NCT01154452|566064878|FG003|Phase II|Withdrawal by Subject|2|||
156812801|NCT01154452|566064875|FG000|Phase II|Adverse Event|0|||
156812802|NCT01154452|566064876|FG001|Phase II|Adverse Event|0|||
156812803|NCT01154452|566064877|FG002|Phase II|Adverse Event|4|||
156812804|NCT01154452|566064878|FG003|Phase II|Adverse Event|4|||
156812805|NCT00100802|566064883|FG000|Overall Study|Adverse Event|9|||
156812806|NCT00100802|566064883|FG000|Overall Study|Death|1|||
156812807|NCT00100802|566064883|FG000|Overall Study|Lack of Efficacy|47|||
156812808|NCT00100802|566064883|FG000|Overall Study|Physician Decision|5|||
156812809|NCT00100802|566064883|FG000|Overall Study|Protocol Violation|1|||
156812810|NCT00100802|566064883|FG000|Overall Study|Withdrawal by Subject|5|||
156812811|NCT00100802|566064883|FG000|Overall Study|Ineligible|12|||
156812812|NCT05935878|566066162|FG000|Overall Study|Death|1|||
156812813|NCT05935878|566066163|FG001|Overall Study|Death|2|||
156812814|NCT05935878|566066162|FG000|Overall Study|Withdrawal by Subject|5|||
156812815|NCT05935878|566066163|FG001|Overall Study|Withdrawal by Subject|5|||
156812816|NCT05935878|566066162|FG000|Overall Study|Revision of implant|1|||
156812817|NCT05935878|566066163|FG001|Overall Study|Revision of implant|1|||
156812818|NCT05935878|566066162|FG000|Overall Study|Mobile bearing dislocation|0|||
156812819|NCT05935878|566066163|FG001|Overall Study|Mobile bearing dislocation|1|||
156812820|NCT00662831|566066177|FG000|Overall Study|Death|4|||
156812821|NCT00662831|566066178|FG001|Overall Study|Death|1|||
156812822|NCT00662831|566066177|FG000|Overall Study|Lack of Efficacy|6|||
156812823|NCT00662831|566066178|FG001|Overall Study|Lack of Efficacy|6|||
156812824|NCT00662831|566066177|FG000|Overall Study|Lost to Follow-up|1|||
156812825|NCT00662831|566066178|FG001|Overall Study|Lost to Follow-up|0|||
156812826|NCT00662831|566066177|FG000|Overall Study|Withdrawal by Subject|2|||
156812827|NCT00662831|566066178|FG001|Overall Study|Withdrawal by Subject|1|||
156812828|NCT00662831|566066177|FG000|Overall Study|Other|62|||
156812829|NCT00662831|566066178|FG001|Overall Study|Other|31|||
156812830|NCT00662831|566066177|FG000|Overall Study|Protocol Violation|8|||
156812831|NCT00662831|566066178|FG001|Overall Study|Protocol Violation|4|||
156812832|NCT00662831|566066177|FG000|Overall Study|Adverse Event|23|||
156812833|NCT00662831|566066178|FG001|Overall Study|Adverse Event|16|||
156812834|NCT05002985|566066179|FG000|Overall Study|Withdrawal by Subject|1|||
156812835|NCT00735553|566066180|FG000|Overall Study|Study prematurely terminated|77|||
156812836|NCT05069597|566066181|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
156812837|NCT05069597|566066182|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
156812838|NCT02705105|566066183|FG000|Treatment|Objective Disease Progression|1|||
156812839|NCT02705105|566066184|FG001|Treatment|Objective Disease Progression|50|||
156812840|NCT02705105|566066183|FG000|Treatment|Withdrawal by Subject|3|||
156812841|NCT02705105|566066184|FG001|Treatment|Withdrawal by Subject|5|||
156812842|NCT02705105|566066183|FG000|Treatment|Adverse Event|0|||
156812843|NCT02705105|566066184|FG001|Treatment|Adverse Event|17|||
156812844|NCT02705105|566066183|FG000|Treatment|Clinical Disease Progression|0|||
156812845|NCT02705105|566066184|FG001|Treatment|Clinical Disease Progression|32|||
156812846|NCT02705105|566066183|FG000|Treatment|Physician Decision|0|||
156812847|NCT02705105|566066184|FG001|Treatment|Physician Decision|3|||
156812848|NCT02705105|566066183|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
156812849|NCT02705105|566066184|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
156812850|NCT02705105|566066183|FG000|Follow-Up|Death|3|||
156812851|NCT02705105|566066184|FG001|Follow-Up|Death|68|||
156812852|NCT02705105|566066183|FG000|Follow-Up|Withdrawal by Subject|1|||
156812853|NCT02705105|566066184|FG001|Follow-Up|Withdrawal by Subject|14|||
156812854|NCT02705105|566066183|FG000|Follow-Up|Study Terminated|0|||
156812855|NCT02705105|566066184|FG001|Follow-Up|Study Terminated|26|||
156812856|NCT02705105|566066183|FG000|Follow-Up|Discontinued per Amendment 3|0|||
156812857|NCT02705105|566066184|FG001|Follow-Up|Discontinued per Amendment 3|2|||
156812858|NCT02707965|566066186|FG000|Overall Study|Withdrawal by Subject|0|||
156812859|NCT02707965|566066187|FG001|Overall Study|Withdrawal by Subject|0|||
156812860|NCT02707965|566066188|FG002|Overall Study|Withdrawal by Subject|1|||
156812861|NCT02707965|566066189|FG003|Overall Study|Withdrawal by Subject|0|||
156812862|NCT02707965|566066190|FG004|Overall Study|Withdrawal by Subject|0|||
156812863|NCT02707965|566066191|FG005|Overall Study|Withdrawal by Subject|0|||
156812864|NCT02707965|566066192|FG006|Overall Study|Withdrawal by Subject|0|||
156812865|NCT02707965|566066193|FG007|Overall Study|Withdrawal by Subject|2|||
156812866|NCT02707965|566066194|FG008|Overall Study|Withdrawal by Subject|0|||
156812867|NCT02707965|566066195|FG009|Overall Study|Withdrawal by Subject|0|||
156812868|NCT02707965|566066196|FG010|Overall Study|Withdrawal by Subject|0|||
156812869|NCT02707965|566066197|FG011|Overall Study|Withdrawal by Subject|0|||
156812870|NCT02707965|566066198|FG012|Overall Study|Withdrawal by Subject|0|||
156812871|NCT02707965|566066199|FG013|Overall Study|Withdrawal by Subject|0|||
156812872|NCT02707965|566066200|FG014|Overall Study|Withdrawal by Subject|0|||
156812873|NCT02707965|566066201|FG015|Overall Study|Withdrawal by Subject|0|||
156812874|NCT02707965|566066186|FG000|Overall Study|PI decisions|0|||
156812875|NCT02707965|566066187|FG001|Overall Study|PI decisions|0|||
156812876|NCT02707965|566066188|FG002|Overall Study|PI decisions|0|||
156812877|NCT02707965|566066189|FG003|Overall Study|PI decisions|0|||
157148855|NCT02940886|567292315|FG001|Overall Study|Sponsor decision|1|||
156812878|NCT02707965|566066190|FG004|Overall Study|PI decisions|0|||
156812879|NCT02707965|566066191|FG005|Overall Study|PI decisions|0|||
156812880|NCT02707965|566066192|FG006|Overall Study|PI decisions|0|||
156812881|NCT02707965|566066193|FG007|Overall Study|PI decisions|0|||
156812882|NCT02707965|566066194|FG008|Overall Study|PI decisions|0|||
156812883|NCT02707965|566066195|FG009|Overall Study|PI decisions|0|||
156812884|NCT02707965|566066196|FG010|Overall Study|PI decisions|0|||
156812885|NCT02707965|566066197|FG011|Overall Study|PI decisions|0|||
156812886|NCT02707965|566066198|FG012|Overall Study|PI decisions|0|||
156812887|NCT02707965|566066199|FG013|Overall Study|PI decisions|0|||
156812888|NCT02707965|566066200|FG014|Overall Study|PI decisions|2|||
156812889|NCT02707965|566066201|FG015|Overall Study|PI decisions|0|||
156812890|NCT02707965|566066186|FG000|Overall Study|Protocol deviation|1|||
156812891|NCT02707965|566066187|FG001|Overall Study|Protocol deviation|1|||
156812892|NCT02707965|566066188|FG002|Overall Study|Protocol deviation|0|||
156812893|NCT02707965|566066189|FG003|Overall Study|Protocol deviation|0|||
156883992|NCT04493892|566333990|FG000|Overall Study|Withdrawal by Subject|15|||
156883993|NCT02267317|566333991|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
157022504|NCT03476460|566835242|FG001|Overall Study|Withdrawal by Subject|2|||
156812894|NCT02707965|566066190|FG004|Overall Study|Protocol deviation|0|||
156812895|NCT02707965|566066191|FG005|Overall Study|Protocol deviation|0|||
156812896|NCT02707965|566066192|FG006|Overall Study|Protocol deviation|0|||
156812897|NCT02707965|566066193|FG007|Overall Study|Protocol deviation|1|||
156812898|NCT02707965|566066194|FG008|Overall Study|Protocol deviation|0|||
156883994|NCT02267317|566333992|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156883995|NCT02267317|566333993|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156883996|NCT02267317|566333994|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156883997|NCT02267317|566333995|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
157148856|NCT02940886|567292314|FG000|Overall Study|No treatment|7|||
156812899|NCT02707965|566066195|FG009|Overall Study|Protocol deviation|0|||
156812900|NCT02707965|566066196|FG010|Overall Study|Protocol deviation|0|||
156812901|NCT02707965|566066197|FG011|Overall Study|Protocol deviation|0|||
156812902|NCT02707965|566066198|FG012|Overall Study|Protocol deviation|0|||
156812903|NCT02707965|566066199|FG013|Overall Study|Protocol deviation|0|||
156812904|NCT02707965|566066200|FG014|Overall Study|Protocol deviation|0|||
156812905|NCT02707965|566066201|FG015|Overall Study|Protocol deviation|0|||
156812906|NCT00485758|566066204|FG000|Overall Study|Adverse Event|102|||
156812907|NCT00485758|566066205|FG001|Overall Study|Adverse Event|31|||
156812908|NCT00485758|566066204|FG000|Overall Study|Death|0|||
156812909|NCT00485758|566066205|FG001|Overall Study|Death|1|||
156812910|NCT00485758|566066204|FG000|Overall Study|Lost to Follow-up|5|||
156812911|NCT00485758|566066205|FG001|Overall Study|Lost to Follow-up|1|||
156812912|NCT00485758|566066204|FG000|Overall Study|Physician Decision|3|||
156812913|NCT00485758|566066205|FG001|Overall Study|Physician Decision|3|||
156812914|NCT00485758|566066204|FG000|Overall Study|Protocol Violation|11|||
156812915|NCT00485758|566066205|FG001|Overall Study|Protocol Violation|2|||
156812916|NCT00485758|566066204|FG000|Overall Study|Withdrawal by Subject|32|||
156812917|NCT00485758|566066205|FG001|Overall Study|Withdrawal by Subject|27|||
156812918|NCT00485758|566066204|FG000|Overall Study|Study Terminated by Sponsor|3|||
156812919|NCT00485758|566066205|FG001|Overall Study|Study Terminated by Sponsor|0|||
156812920|NCT04556591|566066206|FG000|Overall Study|Lost to Follow-up|1|||
156812921|NCT04556591|566066207|FG001|Overall Study|Lost to Follow-up|0|||
156812922|NCT04556591|566066206|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
156812923|NCT04556591|566066207|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
156812924|NCT03332173|566066208|FG000|Overall Study|Death|7|||
156812925|NCT03332173|566066208|FG000|Overall Study|Withdrawal by Subject|6|||
156812926|NCT03332173|566066208|FG000|Overall Study|Lost to Follow-up|2|||
156812927|NCT03332173|566066208|FG000|Overall Study|Transferred to long-term extension study|29|||
156812928|NCT00211172|566066209|FG000|Overall Study|Died or lost health plan eligibility|39|||
156812929|NCT00211172|566066210|FG001|Overall Study|Died or lost health plan eligibility|32|||
156812930|NCT04474197|566066211|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812931|NCT04474197|566066212|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
156812932|NCT04474197|566066213|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812933|NCT04474197|566066214|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
156812934|NCT00624468|566066216|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
156812935|NCT00624468|566066217|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
156812936|NCT00624468|566066218|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
156812937|NCT00624468|566066219|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
156812938|NCT00624468|566066216|FG000|Double-blind Period|Withdrew Prematurely|1|||
156812939|NCT00624468|566066217|FG001|Double-blind Period|Withdrew Prematurely|1|||
156812940|NCT00624468|566066218|FG002|Double-blind Period|Withdrew Prematurely|0|||
156812941|NCT00624468|566066219|FG003|Double-blind Period|Withdrew Prematurely|0|||
156812942|NCT00624468|566066216|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
156812943|NCT00624468|566066217|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
156812944|NCT00624468|566066218|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
156812945|NCT00624468|566066219|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
156812946|NCT00624468|566066216|FG000|Safety Follow-up (SFU) Period|Other|0|||
156812947|NCT00624468|566066217|FG001|Safety Follow-up (SFU) Period|Other|0|||
156812948|NCT00624468|566066218|FG002|Safety Follow-up (SFU) Period|Other|1|||
156812949|NCT00624468|566066219|FG003|Safety Follow-up (SFU) Period|Other|1|||
156812950|NCT03072043|566066228|FG000|Overall Study|Death|0|||
156812951|NCT03072043|566066229|FG001|Overall Study|Death|0|||
156812952|NCT03072043|566066230|FG002|Overall Study|Death|3|||
156812953|NCT03072043|566066228|FG000|Overall Study|Adverse Event|0|||
156812954|NCT03072043|566066229|FG001|Overall Study|Adverse Event|0|||
156812955|NCT03072043|566066230|FG002|Overall Study|Adverse Event|2|||
156812956|NCT03072043|566066228|FG000|Overall Study|Withdrawal by Subject|0|||
156812957|NCT03072043|566066229|FG001|Overall Study|Withdrawal by Subject|0|||
156812958|NCT03072043|566066230|FG002|Overall Study|Withdrawal by Subject|4|||
156812959|NCT01340664|566066231|FG000|Overall Study|Adverse Event|0|||
156812960|NCT01340664|566066232|FG001|Overall Study|Adverse Event|1|||
156812961|NCT01340664|566066233|FG002|Overall Study|Adverse Event|7|||
156812962|NCT01340664|566066231|FG000|Overall Study|Lost to Follow-up|2|||
156812963|NCT01340664|566066232|FG001|Overall Study|Lost to Follow-up|0|||
156812964|NCT01340664|566066233|FG002|Overall Study|Lost to Follow-up|2|||
156812965|NCT01340664|566066231|FG000|Overall Study|Withdrawal by Subject|2|||
156812966|NCT01340664|566066232|FG001|Overall Study|Withdrawal by Subject|4|||
156812967|NCT01340664|566066233|FG002|Overall Study|Withdrawal by Subject|0|||
156812968|NCT01340664|566066231|FG000|Overall Study|Glycemic withdrawal criteria|2|||
156812969|NCT01340664|566066232|FG001|Overall Study|Glycemic withdrawal criteria|0|||
157022505|NCT03476460|566835241|FG000|Overall Study|Non-compliance with treatment|3|||
157148857|NCT02940886|567292315|FG001|Overall Study|No treatment|2|||
157022506|NCT03476460|566835242|FG001|Overall Study|Non-compliance with treatment|0|||
157022507|NCT03476460|566835241|FG000|Overall Study|Missing laboratory tests|5|||
157148858|NCT02940886|567292314|FG000|Overall Study|Enrolment error|0|||
156812970|NCT01340664|566066233|FG002|Overall Study|Glycemic withdrawal criteria|0|||
156812971|NCT01340664|566066231|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
156812972|NCT01340664|566066232|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
157148859|NCT02940886|567292315|FG001|Overall Study|Enrolment error|1|||
157148860|NCT03042611|567292316|FG000|Core Phase|Withdrawal by Subject|13|||
157148861|NCT03042611|567292317|FG001|Core Phase|Withdrawal by Subject|4|||
156812973|NCT01340664|566066233|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
156812974|NCT01340664|566066231|FG000|Overall Study|Other|1|||
156812975|NCT01340664|566066232|FG001|Overall Study|Other|2|||
156812976|NCT01340664|566066233|FG002|Overall Study|Other|2|||
156812977|NCT02923531|566066234|FG000|Overall Study|Adverse Event|4|||
156812978|NCT02923531|566066234|FG000|Overall Study|Clinical Deterioration|1|||
156812979|NCT02923531|566066234|FG000|Overall Study|Disease Progression|3|||
156812980|NCT02923531|566066234|FG000|Overall Study|Study Termination|1|||
156812981|NCT01823198|566066236|FG000|Overall Study|Physician Decision|0|||
156812982|NCT01823198|566066237|FG001|Overall Study|Physician Decision|1|||
156812983|NCT01823198|566066238|FG002|Overall Study|Physician Decision|0|||
156812984|NCT01823198|566066239|FG003|Overall Study|Physician Decision|0|||
156812985|NCT01823198|566066240|FG004|Overall Study|Physician Decision|0|||
156812986|NCT01823198|566066241|FG005|Overall Study|Physician Decision|3|||
156812987|NCT01823198|566066242|FG006|Overall Study|Physician Decision|3|||
156812988|NCT02517398|566066246|FG000|Overall Study|Death|2|||
156812989|NCT02517398|566066247|FG001|Overall Study|Death|3|||
156812990|NCT02517398|566066248|FG002|Overall Study|Death|4|||
156812991|NCT02517398|566066249|FG003|Overall Study|Death|2|||
156812992|NCT02517398|566066250|FG004|Overall Study|Death|3|||
156812993|NCT02517398|566066251|FG005|Overall Study|Death|8|||
156812994|NCT02517398|566066252|FG006|Overall Study|Death|3|||
156812995|NCT02517398|566066253|FG007|Overall Study|Death|2|||
156812996|NCT02517398|566066254|FG008|Overall Study|Death|6|||
156812997|NCT02517398|566066255|FG009|Overall Study|Death|24|||
156812998|NCT02517398|566066256|FG010|Overall Study|Death|53|||
156812999|NCT02517398|566066257|FG011|Overall Study|Death|25|||
157148862|NCT03042611|567292318|FG002|Core Phase|Withdrawal by Subject|0|||
157148863|NCT03042611|567292319|FG003|Core Phase|Withdrawal by Subject|0|||
157148864|NCT03042611|567292316|FG000|Core Phase|Death|232|||
157148865|NCT03042611|567292317|FG001|Core Phase|Death|110|||
157148866|NCT03042611|567292318|FG002|Core Phase|Death|0|||
157148867|NCT03042611|567292319|FG003|Core Phase|Death|0|||
157148868|NCT03042611|567292316|FG000|Core Phase|Lost to Follow-up|4|||
157148869|NCT03042611|567292317|FG001|Core Phase|Lost to Follow-up|7|||
157223059|NCT04700449|567563647|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
157223060|NCT04700449|567563648|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
157223061|NCT04700449|567563645|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
157223062|NCT04700449|567563646|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
157223063|NCT04700449|567563647|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
157223064|NCT04700449|567563648|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
157223065|NCT04700449|567563645|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
157223066|NCT04700449|567563646|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
157223067|NCT04700449|567563647|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
156813000|NCT02517398|566066258|FG012|Overall Study|Death|73|||
156813001|NCT02517398|566066259|FG013|Overall Study|Death|29|||
157148870|NCT03042611|567292318|FG002|Core Phase|Lost to Follow-up|0|||
157148871|NCT03042611|567292319|FG003|Core Phase|Lost to Follow-up|0|||
157148872|NCT03042611|567292316|FG000|Core Phase|Physician Decision|7|||
157148873|NCT03042611|567292317|FG001|Core Phase|Physician Decision|2|||
157148874|NCT03042611|567292318|FG002|Core Phase|Physician Decision|0|||
157148875|NCT03042611|567292319|FG003|Core Phase|Physician Decision|0|||
157148876|NCT03042611|567292316|FG000|Core Phase|Study Closed|0|||
157148877|NCT03042611|567292317|FG001|Core Phase|Study Closed|1|||
157223068|NCT04700449|567563648|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
157223069|NCT04700449|567563645|FG000|Stage 2 Sub-study 1|Other|1|||
157223070|NCT04700449|567563646|FG001|Stage 2 Sub-study 1|Other|2|||
157223071|NCT04700449|567563647|FG002|Stage 2 Sub-study 1|Other|0|||
157223072|NCT04700449|567563648|FG003|Stage 2 Sub-study 1|Other|0|||
156813002|NCT02517398|566066260|FG014|Overall Study|Death|26|||
156813003|NCT02517398|566066261|FG015|Overall Study|Death|23|||
156813004|NCT02517398|566066262|FG016|Overall Study|Death|26|||
156813005|NCT02517398|566066263|FG017|Overall Study|Death|25|||
157148878|NCT03042611|567292318|FG002|Core Phase|Study Closed|0|||
156813006|NCT02517398|566066264|FG018|Overall Study|Death|22|||
156813007|NCT02517398|566066265|FG019|Overall Study|Death|7|||
156813008|NCT02517398|566066266|FG020|Overall Study|Death|26|||
156813009|NCT02517398|566066267|FG021|Overall Study|Death|30|||
156813010|NCT02517398|566066268|FG022|Overall Study|Death|20|||
156813011|NCT02517398|566066246|FG000|Overall Study|Other|0|||
156813012|NCT02517398|566066247|FG001|Overall Study|Other|0|||
156813013|NCT02517398|566066248|FG002|Overall Study|Other|0|||
157148879|NCT03042611|567292319|FG003|Core Phase|Study Closed|0|||
157148880|NCT03042611|567292316|FG000|Extension Phase|Death|0|||
157148881|NCT03042611|567292317|FG001|Extension Phase|Death|0|||
157148882|NCT03042611|567292318|FG002|Extension Phase|Death|34|||
157148883|NCT03042611|567292319|FG003|Extension Phase|Death|16|||
157148884|NCT03042611|567292316|FG000|Extension Phase|Lost to Follow-up|0|||
157148885|NCT03042611|567292317|FG001|Extension Phase|Lost to Follow-up|0|||
157223073|NCT04700449|567563645|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
157223074|NCT04700449|567563646|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
156813014|NCT02517398|566066249|FG003|Overall Study|Other|1|||
156813015|NCT02517398|566066250|FG004|Overall Study|Other|0|||
156813016|NCT02517398|566066251|FG005|Overall Study|Other|0|||
156813017|NCT02517398|566066252|FG006|Overall Study|Other|0|||
156813018|NCT02517398|566066253|FG007|Overall Study|Other|0|||
156813019|NCT02517398|566066254|FG008|Overall Study|Other|0|||
156813020|NCT02517398|566066255|FG009|Overall Study|Other|1|||
156813021|NCT02517398|566066256|FG010|Overall Study|Other|0|||
156813022|NCT02517398|566066257|FG011|Overall Study|Other|0|||
156813023|NCT02517398|566066258|FG012|Overall Study|Other|0|||
156813024|NCT02517398|566066259|FG013|Overall Study|Other|1|||
156813025|NCT02517398|566066260|FG014|Overall Study|Other|0|||
156813026|NCT02517398|566066261|FG015|Overall Study|Other|1|||
156813027|NCT02517398|566066262|FG016|Overall Study|Other|1|||
156813028|NCT02517398|566066263|FG017|Overall Study|Other|0|||
156813029|NCT02517398|566066264|FG018|Overall Study|Other|0|||
156813030|NCT02517398|566066265|FG019|Overall Study|Other|1|||
156813031|NCT02517398|566066266|FG020|Overall Study|Other|0|||
156813032|NCT02517398|566066267|FG021|Overall Study|Other|0|||
156813033|NCT02517398|566066268|FG022|Overall Study|Other|0|||
156813034|NCT02517398|566066246|FG000|Overall Study|Lost to Follow-up|0|||
156813035|NCT02517398|566066247|FG001|Overall Study|Lost to Follow-up|0|||
156813036|NCT02517398|566066248|FG002|Overall Study|Lost to Follow-up|0|||
156813037|NCT02517398|566066249|FG003|Overall Study|Lost to Follow-up|0|||
156813038|NCT02517398|566066250|FG004|Overall Study|Lost to Follow-up|0|||
156813039|NCT02517398|566066251|FG005|Overall Study|Lost to Follow-up|0|||
156813040|NCT02517398|566066252|FG006|Overall Study|Lost to Follow-up|0|||
156813041|NCT02517398|566066253|FG007|Overall Study|Lost to Follow-up|0|||
156813042|NCT02517398|566066254|FG008|Overall Study|Lost to Follow-up|0|||
156813043|NCT02517398|566066255|FG009|Overall Study|Lost to Follow-up|1|||
156813044|NCT02517398|566066256|FG010|Overall Study|Lost to Follow-up|0|||
156813045|NCT02517398|566066257|FG011|Overall Study|Lost to Follow-up|2|||
156813046|NCT02517398|566066258|FG012|Overall Study|Lost to Follow-up|2|||
156813047|NCT02517398|566066259|FG013|Overall Study|Lost to Follow-up|0|||
156813048|NCT02517398|566066260|FG014|Overall Study|Lost to Follow-up|1|||
156813049|NCT02517398|566066261|FG015|Overall Study|Lost to Follow-up|1|||
156813050|NCT02517398|566066262|FG016|Overall Study|Lost to Follow-up|0|||
156813051|NCT02517398|566066263|FG017|Overall Study|Lost to Follow-up|3|||
156813052|NCT02517398|566066264|FG018|Overall Study|Lost to Follow-up|1|||
156813053|NCT02517398|566066265|FG019|Overall Study|Lost to Follow-up|0|||
157223075|NCT04700449|567563647|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
156813054|NCT02517398|566066266|FG020|Overall Study|Lost to Follow-up|1|||
156813055|NCT02517398|566066267|FG021|Overall Study|Lost to Follow-up|0|||
156813056|NCT02517398|566066268|FG022|Overall Study|Lost to Follow-up|2|||
156813057|NCT02517398|566066246|FG000|Overall Study|Withdrew Consent|0|||
156813058|NCT02517398|566066247|FG001|Overall Study|Withdrew Consent|0|||
156813059|NCT02517398|566066248|FG002|Overall Study|Withdrew Consent|0|||
156813060|NCT02517398|566066249|FG003|Overall Study|Withdrew Consent|0|||
156813061|NCT02517398|566066250|FG004|Overall Study|Withdrew Consent|0|||
156813062|NCT02517398|566066251|FG005|Overall Study|Withdrew Consent|0|||
156813063|NCT02517398|566066252|FG006|Overall Study|Withdrew Consent|1|||
156813064|NCT02517398|566066253|FG007|Overall Study|Withdrew Consent|0|||
156813065|NCT02517398|566066254|FG008|Overall Study|Withdrew Consent|0|||
156813066|NCT02517398|566066255|FG009|Overall Study|Withdrew Consent|2|||
156813067|NCT02517398|566066256|FG010|Overall Study|Withdrew Consent|7|||
156813068|NCT02517398|566066257|FG011|Overall Study|Withdrew Consent|1|||
156813069|NCT02517398|566066258|FG012|Overall Study|Withdrew Consent|5|||
156813070|NCT02517398|566066259|FG013|Overall Study|Withdrew Consent|4|||
156813071|NCT02517398|566066260|FG014|Overall Study|Withdrew Consent|2|||
156883998|NCT02267317|566333996|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
156883999|NCT02267317|566333991|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
156884000|NCT02267317|566333992|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156884001|NCT02267317|566333993|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156813072|NCT02517398|566066261|FG015|Overall Study|Withdrew Consent|5|||
156813073|NCT02517398|566066262|FG016|Overall Study|Withdrew Consent|4|||
156813074|NCT02517398|566066263|FG017|Overall Study|Withdrew Consent|2|||
156813075|NCT02517398|566066264|FG018|Overall Study|Withdrew Consent|3|||
156813076|NCT02517398|566066265|FG019|Overall Study|Withdrew Consent|2|||
156813077|NCT02517398|566066266|FG020|Overall Study|Withdrew Consent|9|||
156813078|NCT02517398|566066267|FG021|Overall Study|Withdrew Consent|3|||
156813079|NCT02517398|566066268|FG022|Overall Study|Withdrew Consent|1|||
156813080|NCT00130039|566066275|FG000|Overall Study|Withdrawal by Subject|15|||
156813081|NCT00130039|566066276|FG001|Overall Study|Withdrawal by Subject|11|||
156813082|NCT00130039|566066275|FG000|Overall Study|Lost to Follow-up|3|||
156813083|NCT00130039|566066276|FG001|Overall Study|Lost to Follow-up|1|||
156813084|NCT00130039|566066275|FG000|Overall Study|Adverse Event|4|||
156813085|NCT00130039|566066276|FG001|Overall Study|Adverse Event|2|||
156813086|NCT00130039|566066275|FG000|Overall Study|Physician Decision|3|||
156813087|NCT00130039|566066276|FG001|Overall Study|Physician Decision|0|||
156813088|NCT00130039|566066275|FG000|Overall Study|clinical events without follow up MRI|5|||
156813089|NCT00130039|566066276|FG001|Overall Study|clinical events without follow up MRI|4|||
156813090|NCT03706430|566066277|FG000|Overall Study|No A-Line placed|5|||
156813091|NCT03706430|566066277|FG000|Overall Study|Subject had gel nail polish|1|||
156813092|NCT03706430|566066277|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
156813093|NCT03706430|566066277|FG000|Overall Study|Cancelled Case|6|||
156813094|NCT03706430|566066277|FG000|Overall Study|Physician Decision|2|||
156813095|NCT00145626|566066278|FG000|Overall Study|Did not have NK infusions|2|||
156813096|NCT00145626|566066278|FG000|Overall Study|Turned 2 years old before treatment|1|||
156813097|NCT00145626|566066278|FG000|Overall Study|Death|1|||
156813098|NCT00145626|566066278|FG000|Overall Study|Withdrawal by Subject|1|||
156813099|NCT02709720|566066279|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
156813100|NCT02709720|566066279|FG000|Overall Study|Protocol Violation|1|||
156813101|NCT02709720|566066279|FG000|Overall Study|Not take study medication|1|||
156813102|NCT01198574|566066283|FG000|Overall Study|Resigned from schools|4|||
156813103|NCT01198574|566066284|FG001|Overall Study|Resigned from schools|1|||
156813104|NCT01198574|566066285|FG002|Overall Study|Resigned from schools|1|||
156813105|NCT01198574|566066286|FG003|Overall Study|Resigned from schools|4|||
156813106|NCT00200967|566066288|FG000|First Treatment Period|Withdrawal by Subject|5|||
156813107|NCT00200967|566066289|FG001|First Treatment Period|Withdrawal by Subject|1|||
156813108|NCT00200967|566066288|FG000|First Treatment Period|Pregnancy|1|||
156813109|NCT00200967|566066289|FG001|First Treatment Period|Pregnancy|0|||
156813110|NCT00200967|566066288|FG000|Wash-out Period|Lost to Follow-up|0|||
156813111|NCT00200967|566066289|FG001|Wash-out Period|Lost to Follow-up|1|||
156813112|NCT00200967|566066288|FG000|Second Treatment Period|Withdrawal by Subject|1|||
156813113|NCT00200967|566066289|FG001|Second Treatment Period|Withdrawal by Subject|2|||
156813114|NCT00200967|566066288|FG000|Run-out Period|Lost to Follow-up|1|||
156813115|NCT00200967|566066289|FG001|Run-out Period|Lost to Follow-up|0|||
156813116|NCT00980460|566066290|FG000|Overall Study|Death|0|||
156813117|NCT00980460|566066291|FG001|Overall Study|Death|0|||
156813118|NCT00980460|566066292|FG002|Overall Study|Death|1|||
156813119|NCT00980460|566066293|FG003|Overall Study|Death|2|||
156813120|NCT00980460|566066294|FG004|Overall Study|Death|1|||
157148886|NCT03042611|567292318|FG002|Extension Phase|Lost to Follow-up|1|||
157148887|NCT03042611|567292319|FG003|Extension Phase|Lost to Follow-up|1|||
157148888|NCT03042611|567292316|FG000|Extension Phase|Study Closed|0|||
156813121|NCT00980460|566066290|FG000|Overall Study|Lack of Efficacy|0|||
156813122|NCT00980460|566066291|FG001|Overall Study|Lack of Efficacy|0|||
156813123|NCT00980460|566066292|FG002|Overall Study|Lack of Efficacy|10|||
157022508|NCT03476460|566835242|FG001|Overall Study|Missing laboratory tests|5|||
157022509|NCT03476460|566835241|FG000|Overall Study|Adverse Event|0|||
157022510|NCT03476460|566835242|FG001|Overall Study|Adverse Event|1|||
157022511|NCT03307343|566835243|FG000|Overall Study|Withdrawal by Subject|1|||
157022512|NCT03307343|566835244|FG001|Overall Study|Withdrawal by Subject|2|||
157022513|NCT03307343|566835243|FG000|Overall Study|Pregnancy|0|||
157022514|NCT03307343|566835244|FG001|Overall Study|Pregnancy|2|||
157022515|NCT03307343|566835243|FG000|Overall Study|Physician Decision|1|||
157148889|NCT03042611|567292317|FG001|Extension Phase|Study Closed|0|||
157148890|NCT03042611|567292318|FG002|Extension Phase|Study Closed|17|||
157148891|NCT03042611|567292319|FG003|Extension Phase|Study Closed|11|||
157148892|NCT01277289|567292321|FG000|Overall Study|fragile vein|1|||
157148893|NCT01277289|567292322|FG001|Overall Study|fragile vein|0|||
157148894|NCT01277289|567292321|FG000|Overall Study|Physician Decision|1|||
156813124|NCT00980460|566066293|FG003|Overall Study|Lack of Efficacy|6|||
156813125|NCT00980460|566066294|FG004|Overall Study|Lack of Efficacy|8|||
156813126|NCT00980460|566066290|FG000|Overall Study|Lost to Follow-up|0|||
156813127|NCT00980460|566066291|FG001|Overall Study|Lost to Follow-up|0|||
156813128|NCT00980460|566066292|FG002|Overall Study|Lost to Follow-up|0|||
156813129|NCT00980460|566066293|FG003|Overall Study|Lost to Follow-up|1|||
156813130|NCT00980460|566066294|FG004|Overall Study|Lost to Follow-up|0|||
156813131|NCT00980460|566066290|FG000|Overall Study|Physician Decision|0|||
156813132|NCT00980460|566066291|FG001|Overall Study|Physician Decision|0|||
156813133|NCT00980460|566066292|FG002|Overall Study|Physician Decision|11|||
156813134|NCT00980460|566066293|FG003|Overall Study|Physician Decision|5|||
156813135|NCT00980460|566066294|FG004|Overall Study|Physician Decision|3|||
156813136|NCT00980460|566066290|FG000|Overall Study|Withdrawal by Subject|0|||
156813137|NCT00980460|566066291|FG001|Overall Study|Withdrawal by Subject|0|||
156813138|NCT00980460|566066292|FG002|Overall Study|Withdrawal by Subject|1|||
156813139|NCT00980460|566066293|FG003|Overall Study|Withdrawal by Subject|0|||
156813140|NCT00980460|566066294|FG004|Overall Study|Withdrawal by Subject|0|||
156813141|NCT00980460|566066290|FG000|Overall Study|Ineligible|0|||
156813142|NCT00980460|566066291|FG001|Overall Study|Ineligible|2|||
156813143|NCT00980460|566066292|FG002|Overall Study|Ineligible|3|||
156813144|NCT00980460|566066293|FG003|Overall Study|Ineligible|1|||
156813145|NCT00980460|566066294|FG004|Overall Study|Ineligible|4|||
156813146|NCT00980460|566066290|FG000|Overall Study|Refusal of further therapy|0|||
156813147|NCT00980460|566066291|FG001|Overall Study|Refusal of further therapy|2|||
156813148|NCT00980460|566066292|FG002|Overall Study|Refusal of further therapy|3|||
156813149|NCT00980460|566066293|FG003|Overall Study|Refusal of further therapy|2|||
157022516|NCT03307343|566835244|FG001|Overall Study|Physician Decision|0|||
157022517|NCT03307343|566835243|FG000|Overall Study|Lost to Follow-up|0|||
157148895|NCT01277289|567292322|FG001|Overall Study|Physician Decision|0|||
157148896|NCT01277289|567292321|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
157148897|NCT01277289|567292322|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
157148898|NCT01277289|567292321|FG000|Overall Study|Protocol Violation|1|||
157148899|NCT01277289|567292322|FG001|Overall Study|Protocol Violation|1|||
157148900|NCT01277289|567292321|FG000|Overall Study|Adverse Event|2|||
157148901|NCT01277289|567292322|FG001|Overall Study|Adverse Event|1|||
157148902|NCT01277289|567292321|FG000|Overall Study|consent withdrawn|1|||
157148903|NCT01277289|567292322|FG001|Overall Study|consent withdrawn|1|||
157148904|NCT01277289|567292321|FG000|Overall Study|premature closure of the study|4|||
157148905|NCT01277289|567292322|FG001|Overall Study|premature closure of the study|2|||
157148906|NCT00950690|567292327|FG000|Overall Study|Death|4|||
157148907|NCT00950690|567292327|FG000|Overall Study|Adverse Event|15|||
157148908|NCT00950690|567292327|FG000|Overall Study|Lack of Efficacy|22|||
157148909|NCT00950690|567292327|FG000|Overall Study|Lost to Follow-up|40|||
157148910|NCT00950690|567292327|FG000|Overall Study|Other|163|||
157148911|NCT01713036|567292328|FG000|Overall Study|Death|1|||
157148912|NCT00592358|567292329|FG000|Overall Study|Withdrawal by Subject|2|||
157148913|NCT00592358|567292329|FG000|Overall Study|Adverse Event|1|||
157148914|NCT00592358|567292329|FG000|Overall Study|Lack of Efficacy|2|||
157148915|NCT00592358|567292329|FG000|Overall Study|Inability to swallow pills|1|||
157148916|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
157148917|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
157148918|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
157148919|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
157148920|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
157148921|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
157148922|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
157148923|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
157148924|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
157148925|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
157148926|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
157148927|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
157148928|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
157148929|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
157148930|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
157148931|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
157148932|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
157148933|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
157148934|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
157148935|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
157148936|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
157148937|NCT00092547|567292330|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
157148938|NCT00092547|567292331|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
156813150|NCT00980460|566066294|FG004|Overall Study|Refusal of further therapy|0|||
156813151|NCT00980460|566066290|FG000|Overall Study|No therapy within 42 days of resection|0|||
156813152|NCT00980460|566066291|FG001|Overall Study|No therapy within 42 days of resection|0|||
156813153|NCT00980460|566066292|FG002|Overall Study|No therapy within 42 days of resection|3|||
156813154|NCT00980460|566066293|FG003|Overall Study|No therapy within 42 days of resection|1|||
156813155|NCT00980460|566066294|FG004|Overall Study|No therapy within 42 days of resection|0|||
156813156|NCT00980460|566066290|FG000|Overall Study|No transplant by protocol timepoints|0|||
156813157|NCT00980460|566066291|FG001|Overall Study|No transplant by protocol timepoints|0|||
156813158|NCT00980460|566066292|FG002|Overall Study|No transplant by protocol timepoints|3|||
156813159|NCT00980460|566066293|FG003|Overall Study|No transplant by protocol timepoints|0|||
156813160|NCT00980460|566066294|FG004|Overall Study|No transplant by protocol timepoints|0|||
156813161|NCT00928187|566066295|FG000|Overall Study|Death|1|||
156813162|NCT00928187|566066296|FG001|Overall Study|Death|2|||
156813163|NCT00928187|566066297|FG002|Overall Study|Death|3|||
156813164|NCT00928187|566066295|FG000|Overall Study|Lost to Follow-up|1|||
156813165|NCT00928187|566066296|FG001|Overall Study|Lost to Follow-up|2|||
157148939|NCT00092547|567292332|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
157148940|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
157148941|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
157148942|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
157148943|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
157148944|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
157148945|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
157148946|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
156813166|NCT00928187|566066297|FG002|Overall Study|Lost to Follow-up|1|||
156884002|NCT02267317|566333994|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156884003|NCT02267317|566333995|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156884004|NCT02267317|566333996|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
156884005|NCT02208063|566333999|FG000|Overall Study|Death|3|||
156884006|NCT02208063|566334000|FG001|Overall Study|Death|5|||
156884007|NCT02208063|566333999|FG000|Overall Study|Not Specified in report|3|||
156884008|NCT02208063|566334000|FG001|Overall Study|Not Specified in report|4|||
156884009|NCT02208063|566333999|FG000|Overall Study|Withdrawal by Subject|5|||
156884010|NCT02208063|566334000|FG001|Overall Study|Withdrawal by Subject|2|||
156884011|NCT02208063|566333999|FG000|Overall Study|Lost to Follow-up|1|||
156884012|NCT02208063|566334000|FG001|Overall Study|Lost to Follow-up|0|||
156884013|NCT03595618|566334001|FG000|Overall Study|Adverse Event|16|||
156884014|NCT03595618|566334002|FG001|Overall Study|Adverse Event|17|||
156884015|NCT03595618|566334003|FG002|Overall Study|Adverse Event|20|||
156884016|NCT03595618|566334004|FG003|Overall Study|Adverse Event|8|||
156884017|NCT03595618|566334001|FG000|Overall Study|Withdrawal by Subject|12|||
156884018|NCT03595618|566334002|FG001|Overall Study|Withdrawal by Subject|14|||
156884019|NCT03595618|566334003|FG002|Overall Study|Withdrawal by Subject|14|||
156884020|NCT03595618|566334004|FG003|Overall Study|Withdrawal by Subject|10|||
156884021|NCT03595618|566334001|FG000|Overall Study|Lost to Follow-up|6|||
156884022|NCT03595618|566334002|FG001|Overall Study|Lost to Follow-up|4|||
156884023|NCT03595618|566334003|FG002|Overall Study|Lost to Follow-up|5|||
156884024|NCT03595618|566334004|FG003|Overall Study|Lost to Follow-up|6|||
156884025|NCT03595618|566334001|FG000|Overall Study|Protocol Violation|2|||
156884026|NCT03595618|566334002|FG001|Overall Study|Protocol Violation|0|||
156884027|NCT03595618|566334003|FG002|Overall Study|Protocol Violation|6|||
156884028|NCT03595618|566334004|FG003|Overall Study|Protocol Violation|2|||
156884029|NCT03595618|566334001|FG000|Overall Study|Physician Decision|0|||
156884030|NCT03595618|566334002|FG001|Overall Study|Physician Decision|0|||
156884031|NCT03595618|566334003|FG002|Overall Study|Physician Decision|1|||
156884032|NCT03595618|566334004|FG003|Overall Study|Physician Decision|2|||
156884033|NCT03595618|566334001|FG000|Overall Study|Miscellaneous|7|||
156884034|NCT03595618|566334002|FG001|Overall Study|Miscellaneous|5|||
156813167|NCT00928187|566066295|FG000|Overall Study|Withdrawal by Subject|0|||
156813168|NCT00928187|566066296|FG001|Overall Study|Withdrawal by Subject|1|||
156813169|NCT00928187|566066297|FG002|Overall Study|Withdrawal by Subject|1|||
156813170|NCT00928187|566066295|FG000|Overall Study|Protocol Violation|0|||
156813171|NCT00928187|566066296|FG001|Overall Study|Protocol Violation|1|||
156813172|NCT00928187|566066297|FG002|Overall Study|Protocol Violation|0|||
156813173|NCT05200572|566066298|FG000|Overall Study|Withdrawal by Subject|14|||
156813174|NCT02524145|566066299|FG000|Overall Study|Withdrawal by Subject|2|||
156813175|NCT02524145|566066300|FG001|Overall Study|Withdrawal by Subject|2|||
156813176|NCT02524145|566066301|FG002|Overall Study|Withdrawal by Subject|3|||
156813177|NCT00131352|566068179|FG000|Initial Treatment Period|Adverse Event|1|||
156813178|NCT00131352|566068180|FG001|Initial Treatment Period|Adverse Event|3|||
156813179|NCT00131352|566068179|FG000|Initial Treatment Period|Non-compliant|1|||
156813180|NCT00131352|566068180|FG001|Initial Treatment Period|Non-compliant|2|||
156813181|NCT00131352|566068179|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
156813182|NCT00131352|566068180|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
156813183|NCT00131352|566068179|FG000|Initial Treatment Period|Lack of Efficacy|6|||
156813184|NCT00131352|566068180|FG001|Initial Treatment Period|Lack of Efficacy|4|||
156813185|NCT00131352|566068179|FG000|Initial Treatment Period|Other|0|||
156813186|NCT00131352|566068180|FG001|Initial Treatment Period|Other|2|||
156813187|NCT00131352|566068179|FG000|Repeat Treatment Period|Adverse Event|1|||
156813188|NCT00131352|566068180|FG001|Repeat Treatment Period|Adverse Event|0|||
156813189|NCT00131352|566068179|FG000|Repeat Treatment Period|Other|1|||
156813190|NCT00131352|566068180|FG001|Repeat Treatment Period|Other|0|||
156813191|NCT00383331|566068181|FG000|Overall Study|Protocol Violation|0|||
156813192|NCT00383331|566068182|FG001|Overall Study|Protocol Violation|1|||
156813193|NCT00135330|566068183|FG000|Overall Study|Adverse Event|2|||
156813194|NCT00135330|566068184|FG001|Overall Study|Adverse Event|5|||
156813195|NCT00135330|566068185|FG002|Overall Study|Adverse Event|1|||
156813196|NCT00135330|566068183|FG000|Overall Study|Lost to Follow-up|0|||
156884035|NCT03595618|566334003|FG002|Overall Study|Miscellaneous|10|||
157223076|NCT04700449|567563648|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
156813197|NCT00135330|566068184|FG001|Overall Study|Lost to Follow-up|2|||
156884036|NCT03595618|566334004|FG003|Overall Study|Miscellaneous|6|||
156884037|NCT02279407|566334005|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
156884038|NCT02279407|566334006|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
156884039|NCT02279407|566334007|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
156884040|NCT02279407|566334008|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
156813198|NCT00135330|566068185|FG002|Overall Study|Lost to Follow-up|3|||
156813199|NCT00135330|566068183|FG000|Overall Study|Physician Decision|1|||
156813200|NCT00135330|566068184|FG001|Overall Study|Physician Decision|1|||
156813201|NCT00135330|566068185|FG002|Overall Study|Physician Decision|0|||
156813202|NCT00135330|566068183|FG000|Overall Study|Protocol Violation|4|||
156884041|NCT02279407|566334005|FG000|Overall Study|Withdrawal by Subject|1|||
156884042|NCT02279407|566334006|FG001|Overall Study|Withdrawal by Subject|0|||
156884043|NCT02279407|566334007|FG002|Overall Study|Withdrawal by Subject|1|||
156884044|NCT02279407|566334008|FG003|Overall Study|Withdrawal by Subject|1|||
156884045|NCT02279407|566334005|FG000|Overall Study|Adverse Event|1|||
156884046|NCT02279407|566334006|FG001|Overall Study|Adverse Event|1|||
156884047|NCT02279407|566334007|FG002|Overall Study|Adverse Event|2|||
156884048|NCT02279407|566334008|FG003|Overall Study|Adverse Event|0|||
156884049|NCT01105065|566334009|FG000|Overall Study|Adverse Event|5|||
156884050|NCT01105065|566334009|FG000|Overall Study|Technical Problems|1|||
156884051|NCT00329849|566334012|FG000|Overall Study|Withdrawal by Subject|6|||
156884052|NCT00329849|566334013|FG001|Overall Study|Withdrawal by Subject|4|||
156884053|NCT03996369|566334014|FG000|Overall Study|Protocol deviation|1|||
156884054|NCT03996369|566334015|FG001|Overall Study|Protocol deviation|1|||
156884055|NCT03996369|566334014|FG000|Overall Study|Physician Decision|4|||
156884056|NCT03996369|566334015|FG001|Overall Study|Physician Decision|2|||
156884057|NCT03996369|566334014|FG000|Overall Study|Participant decision|0|||
156884058|NCT03996369|566334015|FG001|Overall Study|Participant decision|1|||
156884059|NCT03996369|566334014|FG000|Overall Study|Lack of Efficacy|4|||
156884060|NCT03996369|566334015|FG001|Overall Study|Lack of Efficacy|0|||
156884061|NCT03996369|566334014|FG000|Overall Study|Adverse Event|9|||
156884062|NCT03996369|566334015|FG001|Overall Study|Adverse Event|0|||
156884063|NCT03996369|566334014|FG000|Overall Study|Withdrawal by Subject|6|||
156884064|NCT03996369|566334015|FG001|Overall Study|Withdrawal by Subject|8|||
156884065|NCT03996369|566334014|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
156884066|NCT03996369|566334015|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
156884067|NCT03996369|566334014|FG000|Overall Study|Lost to Follow-up|0|||
156884068|NCT03996369|566334015|FG001|Overall Study|Lost to Follow-up|1|||
156884069|NCT01579812|566334021|FG000|Overall Study|Ineligible after treatment start|40|||
156884070|NCT01579812|566334021|FG000|Overall Study|Patient choice|3|||
156884071|NCT01579812|566334021|FG000|Overall Study|Noncompliance|3|||
156884072|NCT01579812|566334021|FG000|Overall Study|Withdrawal by Subject|6|||
156884073|NCT00653432|566334023|FG000|Overall Study|Adverse Event|4|||
156884074|NCT00653432|566334024|FG001|Overall Study|Adverse Event|1|||
156884075|NCT00653432|566334023|FG000|Overall Study|Withdrawal by Subject|4|||
156884076|NCT00653432|566334024|FG001|Overall Study|Withdrawal by Subject|5|||
156884077|NCT00653432|566334023|FG000|Overall Study|Lost to Follow-up|7|||
156884078|NCT00653432|566334024|FG001|Overall Study|Lost to Follow-up|6|||
156884079|NCT00653432|566334023|FG000|Overall Study|Use/Need of Con Therapy|2|||
156884080|NCT00653432|566334024|FG001|Overall Study|Use/Need of Con Therapy|1|||
156884081|NCT00653432|566334023|FG000|Overall Study|Other - Reason Not Provided|5|||
156884082|NCT00653432|566334024|FG001|Overall Study|Other - Reason Not Provided|3|||
156884083|NCT01133990|566334025|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
156884084|NCT01133990|566334026|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156884085|NCT01133990|566334027|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156884086|NCT01133990|566334028|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156884087|NCT01133990|566334029|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156884088|NCT01133990|566334030|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156884089|NCT01133990|566334025|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
156884090|NCT01133990|566334026|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156884091|NCT01133990|566334027|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
157022518|NCT03307343|566835244|FG001|Overall Study|Lost to Follow-up|2|||
157022519|NCT05184192|566835246|FG000|Overall Study|Lost to Follow-up|4|||
157022520|NCT05184192|566835247|FG001|Overall Study|Lost to Follow-up|7|||
157022521|NCT05184192|566835246|FG000|Overall Study|Adverse Event|1|||
156813203|NCT00135330|566068184|FG001|Overall Study|Protocol Violation|3|||
156813204|NCT00135330|566068185|FG002|Overall Study|Protocol Violation|3|||
156813205|NCT00135330|566068183|FG000|Overall Study|Patient Decision|5|||
156813206|NCT00135330|566068184|FG001|Overall Study|Patient Decision|1|||
156813207|NCT00135330|566068185|FG002|Overall Study|Patient Decision|4|||
156813208|NCT00135330|566068183|FG000|Overall Study|Sponsor Decision|0|||
156813209|NCT00135330|566068184|FG001|Overall Study|Sponsor Decision|1|||
156813210|NCT00135330|566068185|FG002|Overall Study|Sponsor Decision|0|||
156813211|NCT02253433|566068194|FG000|Overall Study|Unable to Contact|9|||
156813212|NCT02253433|566068195|FG001|Overall Study|Unable to Contact|16|||
156813213|NCT02253433|566068194|FG000|Overall Study|Death|1|||
156813214|NCT02253433|566068195|FG001|Overall Study|Death|1|||
156813215|NCT02253433|566068194|FG000|Overall Study|No Longer Interested|3|||
156813216|NCT02253433|566068195|FG001|Overall Study|No Longer Interested|15|||
156884092|NCT01133990|566334028|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156884093|NCT01133990|566334029|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156884094|NCT01133990|566334030|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
156884095|NCT01133990|566334025|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156884096|NCT01133990|566334026|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156884097|NCT01133990|566334027|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156884098|NCT01133990|566334028|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
157022522|NCT05184192|566835247|FG001|Overall Study|Adverse Event|4|||
157022523|NCT05184192|566835246|FG000|Overall Study|PI withdrawal|1|||
157148947|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
157148948|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
156813217|NCT02253433|566068194|FG000|Overall Study|Out of Study Area|2|||
156813218|NCT02253433|566068195|FG001|Overall Study|Out of Study Area|7|||
156813219|NCT02253433|566068194|FG000|Overall Study|Uncomfortable with home visitors|0|||
156813220|NCT02253433|566068195|FG001|Overall Study|Uncomfortable with home visitors|3|||
156813221|NCT02253433|566068194|FG000|Overall Study|Unstable Housing/Homeless|0|||
156813222|NCT02253433|566068195|FG001|Overall Study|Unstable Housing/Homeless|7|||
156813223|NCT02253433|566068194|FG000|Overall Study|Too Busy|0|||
156813224|NCT02253433|566068195|FG001|Overall Study|Too Busy|4|||
156813225|NCT02253433|566068194|FG000|Overall Study|Medical or Other Concerns|1|||
156813226|NCT02253433|566068195|FG001|Overall Study|Medical or Other Concerns|2|||
156813227|NCT02229825|566068198|FG000|Overall Study|Personal Reasons|0|||
156813228|NCT02229825|566068199|FG001|Overall Study|Personal Reasons|1|||
156813229|NCT02229825|566068198|FG000|Overall Study|Refused continuing medication|7|||
156813230|NCT02229825|566068199|FG001|Overall Study|Refused continuing medication|6|||
156813231|NCT02229825|566068198|FG000|Overall Study|Lost to Follow-up|1|||
156813232|NCT02229825|566068199|FG001|Overall Study|Lost to Follow-up|2|||
156813233|NCT02229825|566068198|FG000|Overall Study|Protocol Violation|1|||
156813234|NCT02229825|566068199|FG001|Overall Study|Protocol Violation|1|||
156813235|NCT02229825|566068198|FG000|Overall Study|Lack of Efficacy|4|||
156813236|NCT02229825|566068199|FG001|Overall Study|Lack of Efficacy|10|||
156813237|NCT02229825|566068198|FG000|Overall Study|Adverse Event|11|||
156884099|NCT01133990|566334029|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156884100|NCT01133990|566334030|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156884101|NCT01133990|566334025|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
156884102|NCT01133990|566334026|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156884103|NCT01133990|566334027|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156884104|NCT01133990|566334028|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156884105|NCT01133990|566334029|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156884106|NCT01133990|566334030|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
156884107|NCT05277337|566334031|FG000|Overall Study|Lost to Follow-up|2|||
156884108|NCT05277337|566334032|FG001|Overall Study|Lost to Follow-up|0|||
156884109|NCT05277337|566334031|FG000|Overall Study|Withdrawal by Subject|1|||
156884110|NCT05277337|566334032|FG001|Overall Study|Withdrawal by Subject|0|||
156884111|NCT01782469|566334033|FG000|Overall Study|Lost to Follow-up|1|||
156884112|NCT01185301|566334034|FG000|Overall Study|Adverse Event|3|||
156884113|NCT01185301|566334035|FG001|Overall Study|Adverse Event|0|||
156884114|NCT01185301|566334036|FG002|Overall Study|Adverse Event|2|||
156884115|NCT01185301|566334037|FG003|Overall Study|Adverse Event|3|||
156884116|NCT01185301|566334034|FG000|Overall Study|Withdrawal by Subject|7|||
156884117|NCT01185301|566334035|FG001|Overall Study|Withdrawal by Subject|5|||
156884118|NCT01185301|566334036|FG002|Overall Study|Withdrawal by Subject|2|||
156884119|NCT01185301|566334037|FG003|Overall Study|Withdrawal by Subject|3|||
156884120|NCT01185301|566334034|FG000|Overall Study|Lost to Follow-up|2|||
156884121|NCT01185301|566334035|FG001|Overall Study|Lost to Follow-up|0|||
156884122|NCT01185301|566334036|FG002|Overall Study|Lost to Follow-up|0|||
156884123|NCT01185301|566334037|FG003|Overall Study|Lost to Follow-up|1|||
156884124|NCT01185301|566334034|FG000|Overall Study|Other Reason|3|||
156884125|NCT01185301|566334035|FG001|Overall Study|Other Reason|2|||
156884126|NCT01185301|566334036|FG002|Overall Study|Other Reason|2|||
156884127|NCT01185301|566334037|FG003|Overall Study|Other Reason|2|||
156884128|NCT00357760|566334042|FG000|Overall Study|Disease progression|44|||
156884129|NCT00357760|566334043|FG001|Overall Study|Disease progression|17|||
156884130|NCT00357760|566334042|FG000|Overall Study|Adverse Event|10|||
156884131|NCT00357760|566334043|FG001|Overall Study|Adverse Event|7|||
156884132|NCT00357760|566334042|FG000|Overall Study|Death|0|||
156884133|NCT00357760|566334043|FG001|Overall Study|Death|3|||
156884134|NCT00357760|566334042|FG000|Overall Study|Alternative therapy|1|||
157148949|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
157148950|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
156813238|NCT02229825|566068199|FG001|Overall Study|Adverse Event|9|||
156813239|NCT02229825|566068198|FG000|Overall Study|Not treated|0|||
156813240|NCT02229825|566068199|FG001|Overall Study|Not treated|1|||
156884135|NCT00357760|566334043|FG001|Overall Study|Alternative therapy|0|||
156884136|NCT00357760|566334042|FG000|Overall Study|Withdrawal by Subject|0|||
156884137|NCT00357760|566334043|FG001|Overall Study|Withdrawal by Subject|2|||
156884138|NCT00357760|566334042|FG000|Overall Study|Never started treatment|2|||
156884139|NCT00357760|566334043|FG001|Overall Study|Never started treatment|1|||
156884140|NCT00357760|566334042|FG000|Overall Study|Ineligible|0|||
156884141|NCT00357760|566334043|FG001|Overall Study|Ineligible|2|||
156884142|NCT00357760|566334042|FG000|Overall Study|Physician Decision|2|||
156884143|NCT00357760|566334043|FG001|Overall Study|Physician Decision|1|||
156884144|NCT00357760|566334042|FG000|Overall Study|Protocol Violation|0|||
156813241|NCT01532921|566068202|FG000|Overall Study|Death|3|||
156813242|NCT01532921|566068202|FG000|Overall Study|Withdrawal by Subject|2|||
156813243|NCT01532921|566068202|FG000|Overall Study|Lost to Follow-up|3|||
156813244|NCT01532921|566068202|FG000|Overall Study|Physician Decision|7|||
156813245|NCT01532921|566068202|FG000|Overall Study|Device was explanted during procedure|1|||
156813246|NCT02526212|566068203|FG000|Overall Study|Incarceration|1|||
156813247|NCT02526212|566068204|FG001|Overall Study|Incarceration|0|||
156813248|NCT02526212|566068203|FG000|Overall Study|Lost to Follow-up|1|||
156813249|NCT02526212|566068204|FG001|Overall Study|Lost to Follow-up|0|||
156813250|NCT02526212|566068203|FG000|Overall Study|Death|0|||
156813251|NCT02526212|566068204|FG001|Overall Study|Death|1|||
156813252|NCT01390298|566068205|FG000|Overall Study|Death|1|||
156813253|NCT01390298|566068205|FG000|Overall Study|long term ICU admission|1|||
156813254|NCT01390298|566068205|FG000|Overall Study|Withdrawal by Subject|14|||
156813255|NCT01390298|566068205|FG000|Overall Study|Lost to Follow-up|7|||
156813256|NCT01390298|566068205|FG000|Overall Study|Surgery cancelled|1|||
156813257|NCT02443337|566068206|FG000|Overall Study|Adverse Event|0|||
156813258|NCT02443337|566068207|FG001|Overall Study|Adverse Event|1|||
156813259|NCT02443337|566068206|FG000|Overall Study|Clinical Progressive Disease|3|||
156813260|NCT02443337|566068207|FG001|Overall Study|Clinical Progressive Disease|0|||
156813261|NCT02443337|566068206|FG000|Overall Study|Withdrawal by Subject|2|||
156813262|NCT02443337|566068207|FG001|Overall Study|Withdrawal by Subject|1|||
156813263|NCT02096952|566068214|FG000|Overall Study|Adverse Event|1|||
156813264|NCT00040742|566068215|FG000|Overall Study|Death|0|||
156813265|NCT00040742|566068216|FG001|Overall Study|Death|0|||
156813266|NCT00040742|566068217|FG002|Overall Study|Death|1|||
156813267|NCT00040742|566068218|FG003|Overall Study|Death|0|||
156813268|NCT00040742|566068215|FG000|Overall Study|Adverse Event|15|||
156813269|NCT00040742|566068216|FG001|Overall Study|Adverse Event|16|||
156813270|NCT00040742|566068217|FG002|Overall Study|Adverse Event|21|||
156813271|NCT00040742|566068218|FG003|Overall Study|Adverse Event|9|||
156813272|NCT00040742|566068215|FG000|Overall Study|Withdrawal by Subject|7|||
156813273|NCT00040742|566068216|FG001|Overall Study|Withdrawal by Subject|15|||
156813274|NCT00040742|566068217|FG002|Overall Study|Withdrawal by Subject|10|||
156813275|NCT00040742|566068218|FG003|Overall Study|Withdrawal by Subject|13|||
156813276|NCT00040742|566068215|FG000|Overall Study|Chemotoxicity|4|||
156813277|NCT00040742|566068216|FG001|Overall Study|Chemotoxicity|3|||
156813278|NCT00040742|566068217|FG002|Overall Study|Chemotoxicity|5|||
156813279|NCT00040742|566068218|FG003|Overall Study|Chemotoxicity|2|||
156813280|NCT00040742|566068215|FG000|Overall Study|Incomplete Forms|6|||
156813281|NCT00040742|566068216|FG001|Overall Study|Incomplete Forms|10|||
156813282|NCT00040742|566068217|FG002|Overall Study|Incomplete Forms|4|||
156813283|NCT00040742|566068218|FG003|Overall Study|Incomplete Forms|5|||
156813284|NCT00040742|566068215|FG000|Overall Study|Other medical|7|||
156813285|NCT00040742|566068216|FG001|Overall Study|Other medical|5|||
156813286|NCT00040742|566068217|FG002|Overall Study|Other medical|5|||
156813287|NCT00040742|566068218|FG003|Overall Study|Other medical|5|||
156813288|NCT03520920|566068219|FG000|Overall Study|Death|13|||
156884145|NCT00357760|566334043|FG001|Overall Study|Protocol Violation|1|||
156884146|NCT00357760|566334042|FG000|Overall Study|To receive hospice care|0|||
157022524|NCT05184192|566835247|FG001|Overall Study|PI withdrawal|2|||
157148951|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
157148952|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
157148953|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
157148954|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
157148955|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
157148956|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
157148957|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
157148958|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
157148959|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
157148960|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
157148961|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
157148962|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
157148963|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
157148964|NCT00092547|567292330|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
157148965|NCT00092547|567292331|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
156813289|NCT03520920|566068220|FG001|Overall Study|Death|1|||
156813290|NCT03520920|566068221|FG002|Overall Study|Death|0|||
156813291|NCT03520920|566068219|FG000|Overall Study|Withdrawal by Subject|2|||
156813292|NCT03520920|566068220|FG001|Overall Study|Withdrawal by Subject|1|||
156813293|NCT03520920|566068221|FG002|Overall Study|Withdrawal by Subject|0|||
156813294|NCT03520920|566068219|FG000|Overall Study|Study Terminated by the Sponsor|5|||
156813295|NCT03520920|566068220|FG001|Overall Study|Study Terminated by the Sponsor|14|||
156813296|NCT03520920|566068221|FG002|Overall Study|Study Terminated by the Sponsor|5|||
156813297|NCT00372619|566068223|FG000|Overall Study|Ineligible|0|||
156813298|NCT00372619|566068224|FG001|Overall Study|Ineligible|0|||
156813299|NCT00372619|566068225|FG002|Overall Study|Ineligible|0|||
156813300|NCT00372619|566068226|FG003|Overall Study|Ineligible|0|||
156813301|NCT00372619|566068227|FG004|Overall Study|Ineligible|0|||
156813302|NCT00372619|566068228|FG005|Overall Study|Ineligible|2|||
156813303|NCT00372619|566068229|FG006|Overall Study|Ineligible|0|||
156813304|NCT00372619|566068223|FG000|Overall Study|Inevaluable|0|||
156813305|NCT00372619|566068224|FG001|Overall Study|Inevaluable|0|||
156813306|NCT00372619|566068225|FG002|Overall Study|Inevaluable|0|||
156813307|NCT00372619|566068226|FG003|Overall Study|Inevaluable|0|||
156813308|NCT00372619|566068227|FG004|Overall Study|Inevaluable|0|||
156813309|NCT00372619|566068228|FG005|Overall Study|Inevaluable|1|||
157148966|NCT00092547|567292332|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
157148967|NCT00092547|567292330|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
157148968|NCT00092547|567292331|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
157148969|NCT00092547|567292332|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
157148970|NCT00092547|567292330|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
156813310|NCT00372619|566068229|FG006|Overall Study|Inevaluable|0|||
156813311|NCT00066222|566068230|FG000|Overall Study|No protocol treatment received|1|||
156813312|NCT00635349|566068231|FG000|Overall Study|Other|8|||
156813313|NCT00635349|566068232|FG001|Overall Study|Other|6|||
156813314|NCT00635349|566068231|FG000|Overall Study|Protocol Violation|18|||
156813315|NCT00635349|566068232|FG001|Overall Study|Protocol Violation|22|||
156813316|NCT00635349|566068231|FG000|Overall Study|Withdrawal by Subject|3|||
156813317|NCT00635349|566068232|FG001|Overall Study|Withdrawal by Subject|8|||
156813318|NCT00635349|566068231|FG000|Overall Study|Lost to Follow-up|4|||
156813319|NCT00635349|566068232|FG001|Overall Study|Lost to Follow-up|3|||
156813320|NCT00635349|566068231|FG000|Overall Study|Adverse Event|11|||
156813321|NCT00635349|566068232|FG001|Overall Study|Adverse Event|9|||
156813322|NCT02446769|566068235|FG000|Screening Period|Screen Failure|11|||
156813323|NCT02446769|566068236|FG001|Screening Period|Screen Failure|0|||
156813324|NCT02446769|566068237|FG002|Screening Period|Screen Failure|0|||
156813325|NCT02446769|566068235|FG000|Study Period|Randomized in Error|0|||
156813326|NCT02446769|566068236|FG001|Study Period|Randomized in Error|2|||
156813327|NCT02446769|566068237|FG002|Study Period|Randomized in Error|0|||
156813328|NCT04482439|566068238|FG000|Overall Study|Lost to Follow-up|1|||
156813329|NCT04482439|566068238|FG000|Overall Study|Unrelated illness|1|||
156813330|NCT00645840|566068239|FG000|Overall Study|Protocol Violation|3|||
156813331|NCT00402324|566068240|FG000|Overall Study|Lost to Follow-up|11|||
156813332|NCT00402324|566068241|FG001|Overall Study|Lost to Follow-up|11|||
156813333|NCT00402324|566068240|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
156813334|NCT00402324|566068241|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
156813335|NCT00402324|566068240|FG000|Overall Study|Protocol Violation|8|||
156813336|NCT00402324|566068241|FG001|Overall Study|Protocol Violation|7|||
156813337|NCT00402324|566068240|FG000|Overall Study|Withdrawal by Subject|5|||
156813338|NCT00402324|566068241|FG001|Overall Study|Withdrawal by Subject|2|||
156813339|NCT00402324|566068240|FG000|Overall Study|Physician Decision|2|||
156813340|NCT00402324|566068241|FG001|Overall Study|Physician Decision|4|||
156813341|NCT00402324|566068240|FG000|Overall Study|Sponsor Decision|4|||
156813342|NCT00402324|566068241|FG001|Overall Study|Sponsor Decision|5|||
156813343|NCT00402324|566068240|FG000|Overall Study|Lack of Efficacy|1|||
156813344|NCT00402324|566068241|FG001|Overall Study|Lack of Efficacy|4|||
156813345|NCT00402324|566068240|FG000|Overall Study|Adverse Event|6|||
156813346|NCT00402324|566068241|FG001|Overall Study|Adverse Event|4|||
156813347|NCT00402324|566068240|FG000|Overall Study|Death|1|||
156813348|NCT00402324|566068241|FG001|Overall Study|Death|0|||
156813349|NCT01277822|566068242|FG000|Overall Study|Adverse Event|2|||
156813350|NCT01277822|566068243|FG001|Overall Study|Adverse Event|1|||
156813351|NCT01277822|566068242|FG000|Overall Study|Withdrawal by Subject|6|||
156813352|NCT01277822|566068243|FG001|Overall Study|Withdrawal by Subject|7|||
156813353|NCT01277822|566068242|FG000|Overall Study|Physician Decision|1|||
156813354|NCT01277822|566068243|FG001|Overall Study|Physician Decision|1|||
156813355|NCT01277822|566068242|FG000|Overall Study|Protocol Violation|1|||
156813356|NCT01277822|566068243|FG001|Overall Study|Protocol Violation|0|||
156884147|NCT00357760|566334043|FG001|Overall Study|To receive hospice care|1|||
156884148|NCT04136444|566334044|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
156884149|NCT04136444|566334045|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
156884150|NCT00869778|566334049|FG000|Overall Study|Adverse Event|2|||
156884151|NCT00869778|566334050|FG001|Overall Study|Adverse Event|0|||
156884152|NCT00869778|566334051|FG002|Overall Study|Adverse Event|0|||
156884153|NCT00869778|566334049|FG000|Overall Study|Withdrawal by Subject|3|||
156884154|NCT00869778|566334050|FG001|Overall Study|Withdrawal by Subject|4|||
156884155|NCT00869778|566334051|FG002|Overall Study|Withdrawal by Subject|5|||
156884156|NCT00869778|566334049|FG000|Overall Study|Pregnancy|1|||
156884157|NCT00869778|566334050|FG001|Overall Study|Pregnancy|0|||
156884158|NCT00869778|566334051|FG002|Overall Study|Pregnancy|0|||
156813357|NCT01277822|566068242|FG000|Overall Study|Lost to Follow-up|2|||
156813358|NCT01277822|566068243|FG001|Overall Study|Lost to Follow-up|1|||
156813359|NCT01277822|566068242|FG000|Overall Study|Contraindicated medication used|2|||
156813360|NCT01277822|566068243|FG001|Overall Study|Contraindicated medication used|1|||
156813361|NCT01277822|566068242|FG000|Overall Study|Participant moved|1|||
156813362|NCT01277822|566068243|FG001|Overall Study|Participant moved|0|||
156884159|NCT00869778|566334049|FG000|Overall Study|Protocol Violation|5|||
156813363|NCT00997984|566068244|FG000|Overall Study|Adverse Event|1|||
156813364|NCT00997984|566068245|FG001|Overall Study|Adverse Event|8|||
156813365|NCT00997984|566068246|FG002|Overall Study|Adverse Event|8|||
156813366|NCT00997984|566068244|FG000|Overall Study|Protocol Violation|1|||
156813367|NCT00997984|566068245|FG001|Overall Study|Protocol Violation|3|||
156813368|NCT00997984|566068246|FG002|Overall Study|Protocol Violation|0|||
156813369|NCT00997984|566068244|FG000|Overall Study|Withdrawal by Subject|6|||
156813370|NCT00997984|566068245|FG001|Overall Study|Withdrawal by Subject|9|||
156813371|NCT00997984|566068246|FG002|Overall Study|Withdrawal by Subject|5|||
156813372|NCT00997984|566068244|FG000|Overall Study|Lost to Follow-up|8|||
156813373|NCT00997984|566068245|FG001|Overall Study|Lost to Follow-up|5|||
156813374|NCT00997984|566068246|FG002|Overall Study|Lost to Follow-up|4|||
156813375|NCT00997984|566068244|FG000|Overall Study|Lack of Efficacy|20|||
156813376|NCT00997984|566068245|FG001|Overall Study|Lack of Efficacy|6|||
156813377|NCT00997984|566068246|FG002|Overall Study|Lack of Efficacy|3|||
156813378|NCT00997984|566068244|FG000|Overall Study|Met exclusion criteria|1|||
156813379|NCT00997984|566068245|FG001|Overall Study|Met exclusion criteria|0|||
156813380|NCT00997984|566068246|FG002|Overall Study|Met exclusion criteria|0|||
156813381|NCT00997984|566068244|FG000|Overall Study|non-compliance|0|||
156813382|NCT00997984|566068245|FG001|Overall Study|non-compliance|2|||
156813383|NCT00997984|566068246|FG002|Overall Study|non-compliance|3|||
156813384|NCT00997984|566068244|FG000|Overall Study|Wrong medication dispensed|0|||
156813385|NCT00997984|566068245|FG001|Overall Study|Wrong medication dispensed|1|||
156813386|NCT00997984|566068246|FG002|Overall Study|Wrong medication dispensed|0|||
156813387|NCT00997984|566068244|FG000|Overall Study|Suicidal ideation|0|||
156813388|NCT00997984|566068245|FG001|Overall Study|Suicidal ideation|0|||
156813389|NCT00997984|566068246|FG002|Overall Study|Suicidal ideation|1|||
156813390|NCT00997984|566068244|FG000|Overall Study|Work schedule|0|||
156813391|NCT00997984|566068245|FG001|Overall Study|Work schedule|0|||
156813392|NCT00997984|566068246|FG002|Overall Study|Work schedule|2|||
156813393|NCT02997865|566068248|FG000|Overall Study|Death|2|||
156813394|NCT02997865|566068249|FG001|Overall Study|Death|1|||
156813395|NCT02997865|566068248|FG000|Overall Study|Lost to Follow-up|6|||
156813396|NCT02997865|566068249|FG001|Overall Study|Lost to Follow-up|3|||
156813397|NCT02997865|566068248|FG000|Overall Study|Withdrawal by Subject|5|||
156813398|NCT02997865|566068249|FG001|Overall Study|Withdrawal by Subject|0|||
156813399|NCT01119066|566068250|FG000|Overall Study|Withdrawal by Subject|4|||
156813400|NCT01119066|566068251|FG001|Overall Study|Withdrawal by Subject|6|||
156813401|NCT01119066|566068252|FG002|Overall Study|Withdrawal by Subject|0|||
156813402|NCT01119066|566068253|FG003|Overall Study|Withdrawal by Subject|0|||
156884160|NCT00869778|566334050|FG001|Overall Study|Protocol Violation|3|||
156884161|NCT00869778|566334051|FG002|Overall Study|Protocol Violation|5|||
156884162|NCT00869778|566334049|FG000|Overall Study|Unblinding|1|||
156884163|NCT00869778|566334050|FG001|Overall Study|Unblinding|0|||
156884164|NCT00869778|566334051|FG002|Overall Study|Unblinding|0|||
156884165|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156884166|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156884167|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
156884168|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
156884169|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
156813403|NCT01119066|566068250|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
156813404|NCT01119066|566068251|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
156813405|NCT01119066|566068252|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
156813406|NCT01119066|566068253|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
156813407|NCT01119066|566068250|FG000|Overall Study|Relapse identified before transplant|1|||
156813408|NCT01119066|566068251|FG001|Overall Study|Relapse identified before transplant|0|||
156813409|NCT01119066|566068252|FG002|Overall Study|Relapse identified before transplant|0|||
156813410|NCT01119066|566068253|FG003|Overall Study|Relapse identified before transplant|0|||
156813411|NCT01119066|566068250|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813412|NCT01119066|566068251|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
156813413|NCT01119066|566068252|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813414|NCT01119066|566068253|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
156813415|NCT01119066|566068250|FG000|Overall Study|Relapse identified before transplant|0|||
156813416|NCT01119066|566068251|FG001|Overall Study|Relapse identified before transplant|4|||
156884170|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
156884171|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
157022525|NCT05184192|566835246|FG000|Overall Study|Withdrew due to adverse effect|1|||
156813417|NCT01119066|566068252|FG002|Overall Study|Relapse identified before transplant|0|||
157022526|NCT05184192|566835247|FG001|Overall Study|Withdrew due to adverse effect|0|||
156813418|NCT01119066|566068253|FG003|Overall Study|Relapse identified before transplant|0|||
156884172|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156884173|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
156884174|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
157148971|NCT00092547|567292331|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
157148972|NCT00092547|567292332|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
157148973|NCT00092547|567292330|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
157148974|NCT00092547|567292331|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
156813419|NCT02243371|566068260|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
156813420|NCT02243371|566068261|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
156813421|NCT02243371|566068260|FG000|Overall Study|Death (unrelated)|2|||
156813422|NCT02243371|566068261|FG001|Overall Study|Death (unrelated)|4|||
156813423|NCT02243371|566068260|FG000|Overall Study|Adverse Event (unrelated)|0|||
156813424|NCT02243371|566068261|FG001|Overall Study|Adverse Event (unrelated)|1|||
156813425|NCT02243371|566068260|FG000|Overall Study|Lack of Clinical Benefit|0|||
156813426|NCT02243371|566068261|FG001|Overall Study|Lack of Clinical Benefit|1|||
156813427|NCT02243371|566068260|FG000|Overall Study|Withdrawal by Subject|0|||
156813428|NCT02243371|566068261|FG001|Overall Study|Withdrawal by Subject|2|||
156813429|NCT02441101|566068262|FG000|Overall Study|Withdrawal by Subject|1|||
156813430|NCT02441101|566068263|FG001|Overall Study|Withdrawal by Subject|0|||
156813431|NCT02441101|566068262|FG000|Overall Study|Lost to Follow-up|1|||
156813432|NCT02441101|566068263|FG001|Overall Study|Lost to Follow-up|0|||
156813433|NCT02441101|566068262|FG000|Overall Study|PI relocated and study terminated|1|||
156813434|NCT02441101|566068263|FG001|Overall Study|PI relocated and study terminated|0|||
156813435|NCT00271856|566068266|FG000|Overall Study|Withdrawal by Subject|1|||
156813436|NCT00271856|566068267|FG001|Overall Study|Withdrawal by Subject|7|||
156813437|NCT00271856|566068266|FG000|Overall Study|Lost to Follow-up|10|||
156813438|NCT00271856|566068267|FG001|Overall Study|Lost to Follow-up|11|||
156813439|NCT04599803|566068268|FG000|Overall Study|Withdrawal by Subject|5|||
156813440|NCT04599803|566068268|FG000|Overall Study|Lost to Follow-up|26|||
156813441|NCT02544750|566068269|FG000|Overall Study|Physician Decision|3|||
156813442|NCT02544750|566068270|FG001|Overall Study|Physician Decision|1|||
156813443|NCT02544750|566068269|FG000|Overall Study|Other reasons|69|||
156813444|NCT02544750|566068270|FG001|Overall Study|Other reasons|39|||
156813445|NCT02544750|566068269|FG000|Overall Study|Met withdrawal criteria|2|||
156813446|NCT02544750|566068270|FG001|Overall Study|Met withdrawal criteria|2|||
156813447|NCT02544750|566068269|FG000|Overall Study|Transition To Commercial Product|1|||
156813448|NCT02544750|566068270|FG001|Overall Study|Transition To Commercial Product|0|||
156813449|NCT02544750|566068269|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
156813450|NCT02544750|566068270|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
156813451|NCT02544750|566068269|FG000|Overall Study|Adverse Event|8|||
156813452|NCT02544750|566068270|FG001|Overall Study|Adverse Event|10|||
156813453|NCT02544750|566068269|FG000|Overall Study|Withdrawal by Subject|10|||
156813454|NCT02544750|566068270|FG001|Overall Study|Withdrawal by Subject|4|||
156813455|NCT02544750|566068269|FG000|Overall Study|Lost to Follow-up|1|||
156813456|NCT02544750|566068270|FG001|Overall Study|Lost to Follow-up|0|||
156813457|NCT02366923|566068271|FG000|Overall Study|Withdrawal by Subject|1|||
156813458|NCT02366923|566068271|FG000|Overall Study|Positive Slit Lamp Findings|2|||
156813459|NCT02366923|566068271|FG000|Overall Study|High Astigmatism|3|||
156813460|NCT04677543|566068272|FG000|Overall Study|Withdrawal by Subject|4|||
156813461|NCT04677543|566068273|FG001|Overall Study|Withdrawal by Subject|1|||
156813462|NCT04677543|566068272|FG000|Overall Study|Physician Decision|0|||
156813463|NCT04677543|566068273|FG001|Overall Study|Physician Decision|1|||
156813464|NCT04677543|566068272|FG000|Overall Study|Adverse Event|0|||
156813465|NCT04677543|566068273|FG001|Overall Study|Adverse Event|1|||
156813466|NCT02689206|566068274|FG000|Overall Study|Adverse Event|0|||
156813467|NCT02689206|566068275|FG001|Overall Study|Adverse Event|0|||
156813468|NCT02689206|566068276|FG002|Overall Study|Adverse Event|1|||
156813469|NCT02689206|566068277|FG003|Overall Study|Adverse Event|0|||
156813470|NCT02689206|566068278|FG004|Overall Study|Adverse Event|2|||
157148975|NCT00092547|567292332|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
157148976|NCT00092547|567292330|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
157148977|NCT00092547|567292331|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
157148978|NCT00092547|567292332|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
157148979|NCT00084682|567292333|FG000|Overall Study|Withdrawal by Subject|1|||
157148980|NCT01166659|567292334|FG000|Overall Study|Subject Decision|8|||
157148981|NCT01166659|567292334|FG000|Overall Study|Investigator Decision|2|||
157148982|NCT01166659|567292334|FG000|Overall Study|Death|1|||
157148983|NCT01166659|567292334|FG000|Overall Study|Lost to Follow-up|1|||
157148984|NCT01166659|567292334|FG000|Overall Study|Study Closed at Site|1|||
157148985|NCT00634543|567292342|FG000|Overall Study|Other|1|||
156813471|NCT02689206|566068274|FG000|Overall Study|Protocol Violation|1|||
156813472|NCT02689206|566068275|FG001|Overall Study|Protocol Violation|0|||
156813473|NCT02689206|566068276|FG002|Overall Study|Protocol Violation|0|||
156813474|NCT02689206|566068277|FG003|Overall Study|Protocol Violation|1|||
156813475|NCT02689206|566068278|FG004|Overall Study|Protocol Violation|2|||
156813476|NCT02689206|566068274|FG000|Overall Study|Other: Reached stopping criteria|0|||
156813477|NCT02689206|566068275|FG001|Overall Study|Other: Reached stopping criteria|1|||
156813478|NCT02689206|566068276|FG002|Overall Study|Other: Reached stopping criteria|2|||
157223077|NCT04700449|567563645|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
157223078|NCT04700449|567563646|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
157223079|NCT04700449|567563647|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
157148986|NCT00634543|567292343|FG001|Overall Study|Other|2|||
157148987|NCT00634543|567292342|FG000|Overall Study|Protocol Violation|3|||
157148988|NCT00634543|567292343|FG001|Overall Study|Protocol Violation|3|||
157148989|NCT00634543|567292342|FG000|Overall Study|Adverse Event|11|||
157223080|NCT04700449|567563648|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
157223081|NCT04700449|567563645|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
157223082|NCT04700449|567563646|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
157223083|NCT04700449|567563647|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
157223084|NCT04700449|567563648|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
157223085|NCT04700449|567563645|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
157223086|NCT04700449|567563646|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
157223087|NCT04700449|567563647|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
157223088|NCT04700449|567563648|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
157223089|NCT04700449|567563645|FG000|Stage 2 Sub-study 2|Other|0|||
157223090|NCT04700449|567563646|FG001|Stage 2 Sub-study 2|Other|0|||
157223091|NCT04700449|567563647|FG002|Stage 2 Sub-study 2|Other|0|||
157223092|NCT04700449|567563648|FG003|Stage 2 Sub-study 2|Other|5|||
157223093|NCT00356200|567563649|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
157223094|NCT00356200|567563650|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
157223095|NCT00356200|567563649|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
156813479|NCT02689206|566068277|FG003|Overall Study|Other: Reached stopping criteria|3|||
156813480|NCT02689206|566068278|FG004|Overall Study|Other: Reached stopping criteria|4|||
156813481|NCT02689206|566068274|FG000|Overall Study|Physician Decision|1|||
156813482|NCT02689206|566068275|FG001|Overall Study|Physician Decision|0|||
156813483|NCT02689206|566068276|FG002|Overall Study|Physician Decision|0|||
156813484|NCT02689206|566068277|FG003|Overall Study|Physician Decision|0|||
156813485|NCT02689206|566068278|FG004|Overall Study|Physician Decision|0|||
156813486|NCT02689206|566068274|FG000|Overall Study|Withdrawal by Subject|1|||
156813487|NCT02689206|566068275|FG001|Overall Study|Withdrawal by Subject|0|||
156813488|NCT02689206|566068276|FG002|Overall Study|Withdrawal by Subject|1|||
156813489|NCT02689206|566068277|FG003|Overall Study|Withdrawal by Subject|0|||
156813490|NCT02689206|566068278|FG004|Overall Study|Withdrawal by Subject|0|||
156813491|NCT01437111|566068279|FG000|Overall Study|Adverse Event|2|||
156813492|NCT01437111|566068279|FG000|Overall Study|Withdrawal by Subject|4|||
156813493|NCT01437111|566068279|FG000|Overall Study|Not reported|5|||
156813494|NCT01437111|566068279|FG000|Overall Study|Physician Decision|1|||
156813495|NCT01437111|566068279|FG000|Overall Study|Lost to Follow-up|5|||
156813496|NCT01437111|566068279|FG000|Overall Study|Protocol Violation|1|||
156813497|NCT01232127|566068280|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
156813498|NCT01232127|566068281|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
156813499|NCT01232127|566068282|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
156813500|NCT02623205|566068285|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
156813501|NCT02623205|566068286|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
156813502|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
156813503|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
156813504|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
156813505|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
156813506|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
156813507|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
156813508|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
156813509|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
156813510|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
156813511|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
156813512|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156813513|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
156813514|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
157148990|NCT00634543|567292343|FG001|Overall Study|Adverse Event|11|||
157148991|NCT00634543|567292342|FG000|Overall Study|Withdrawal by Subject|4|||
157148992|NCT00634543|567292343|FG001|Overall Study|Withdrawal by Subject|4|||
157148993|NCT00634543|567292342|FG000|Overall Study|Lost to Follow-up|0|||
156813515|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
156813516|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
156813517|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
156813518|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
157148994|NCT00634543|567292343|FG001|Overall Study|Lost to Follow-up|1|||
157148995|NCT00641043|567292350|FG000|Overall Study|Adverse Event|6|||
157148996|NCT00641043|567292351|FG001|Overall Study|Adverse Event|4|||
157148997|NCT00641043|567292350|FG000|Overall Study|Protocol Violation|2|||
157223096|NCT00356200|567563650|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
157223097|NCT01000337|567563651|FG000|Overall Study|Lost to Follow-up|4|||
156813519|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
156813520|NCT03162796|566068287|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
156813521|NCT03162796|566068288|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
156813522|NCT03162796|566068289|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
156813523|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
156813524|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
156813525|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
156813526|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
156813527|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
156813528|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
156813529|NCT03162796|566068287|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
156813530|NCT03162796|566068288|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
156813531|NCT03162796|566068289|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
156813532|NCT03162796|566068287|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
156813533|NCT03162796|566068288|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
156813534|NCT03162796|566068289|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
156813535|NCT02375373|566068294|FG000|Overall Study|Withdrawal by Subject|11|||
156813536|NCT02725476|566068295|FG000|Overall Study|Physician Decision|2|||
156813537|NCT02725476|566068296|FG001|Overall Study|Physician Decision|0|||
156813538|NCT02725476|566068295|FG000|Overall Study|Adverse Event|1|||
156813539|NCT02725476|566068296|FG001|Overall Study|Adverse Event|1|||
156813540|NCT00289289|566068298|FG000|Overall Study|Withdrawal by Subject|5|||
156813541|NCT00289289|566068299|FG001|Overall Study|Withdrawal by Subject|3|||
156813542|NCT00289289|566068300|FG002|Overall Study|Withdrawal by Subject|15|||
156813543|NCT00289289|566068298|FG000|Overall Study|Lost to Follow-up|1|||
156813544|NCT00289289|566068299|FG001|Overall Study|Lost to Follow-up|0|||
156813545|NCT00289289|566068300|FG002|Overall Study|Lost to Follow-up|1|||
156813546|NCT00289289|566068298|FG000|Overall Study|Death|4|||
156813547|NCT00289289|566068299|FG001|Overall Study|Death|2|||
156813548|NCT00289289|566068300|FG002|Overall Study|Death|5|||
156813549|NCT00289289|566068298|FG000|Overall Study|No implant attempted|0|||
156813550|NCT00289289|566068299|FG001|Overall Study|No implant attempted|0|||
156813551|NCT00289289|566068300|FG002|Overall Study|No implant attempted|1|||
156813552|NCT00289289|566068298|FG000|Overall Study|Physician Decision|1|||
156813553|NCT00289289|566068299|FG001|Overall Study|Physician Decision|0|||
156813554|NCT00289289|566068300|FG002|Overall Study|Physician Decision|6|||
156813555|NCT00289289|566068298|FG000|Overall Study|Non-study device implanted|2|||
156813556|NCT00289289|566068299|FG001|Overall Study|Non-study device implanted|1|||
156813557|NCT00289289|566068300|FG002|Overall Study|Non-study device implanted|3|||
156813558|NCT00289289|566068298|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
156813559|NCT00289289|566068299|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
156813560|NCT00289289|566068300|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
156813561|NCT00289289|566068298|FG000|Overall Study|Other Exit Reason|6|||
156813562|NCT00289289|566068299|FG001|Overall Study|Other Exit Reason|4|||
156813563|NCT00289289|566068300|FG002|Overall Study|Other Exit Reason|12|||
156813564|NCT01445613|566068301|FG000|30-day Follow-up|Withdrawal by Subject|6|||
156813565|NCT01445613|566068301|FG000|30-day Follow-up|Physician Decision|3|||
156813566|NCT01445613|566068301|FG000|30-day Follow-up|Missed visit|23|||
156813567|NCT01445613|566068301|FG000|30-day Follow-up|Death|3|||
156813568|NCT01445613|566068301|FG000|1-year Follow-up|Withdrawal by Subject|12|||
156813569|NCT01445613|566068301|FG000|1-year Follow-up|Missed visit|29|||
156813570|NCT01445613|566068301|FG000|1-year Follow-up|Lost to Follow-up|2|||
156813571|NCT01445613|566068301|FG000|1-year Follow-up|Death|30|||
156813572|NCT01445613|566068301|FG000|1-year Follow-up|Physician Decision|2|||
156813573|NCT01445613|566068301|FG000|1-year Follow-up|Received a non-study stent|2|||
156813574|NCT03711370|566068302|FG000|Overall Study|Lost to Follow-up|16|||
156813575|NCT03711370|566068303|FG001|Overall Study|Lost to Follow-up|10|||
156813576|NCT03711370|566068302|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
156813577|NCT03711370|566068303|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
156813578|NCT00407602|566068304|FG000|Overall Study|Death - unrelated to device|1|||
156813579|NCT00407602|566068304|FG000|Overall Study|Device explanted|5|||
156813580|NCT00407602|566068304|FG000|Overall Study|Withdrawal by Subject|1|||
156813581|NCT01169701|566068305|FG000|Overall Study|Lost to Follow-up|1|||
156813582|NCT01169701|566068306|FG001|Overall Study|Lost to Follow-up|1|||
157223098|NCT01000337|567563652|FG001|Overall Study|Lost to Follow-up|3|||
156813583|NCT01169701|566068305|FG000|Overall Study|Withdrawal by Subject|1|||
156813584|NCT01169701|566068306|FG001|Overall Study|Withdrawal by Subject|3|||
156813585|NCT01169701|566068305|FG000|Overall Study|Adverse Event|1|||
156813586|NCT01169701|566068306|FG001|Overall Study|Adverse Event|2|||
156813587|NCT01169701|566068305|FG000|Overall Study|Exclusion criteria|2|||
156813588|NCT01169701|566068306|FG001|Overall Study|Exclusion criteria|0|||
156813589|NCT01169701|566068305|FG000|Overall Study|Death|0|||
156813590|NCT01169701|566068306|FG001|Overall Study|Death|1|||
156813591|NCT01169701|566068305|FG000|Overall Study|Administrative problems|0|||
157223099|NCT03901963|567563653|FG000|Overall Study|Lost to Follow-up|1|||
156813592|NCT01169701|566068306|FG001|Overall Study|Administrative problems|1|||
156813593|NCT01169701|566068305|FG000|Overall Study|Serious adverse event|0|||
156813594|NCT01169701|566068306|FG001|Overall Study|Serious adverse event|1|||
156813595|NCT01169701|566068305|FG000|Overall Study|Sponsor decision|0|||
156813596|NCT01169701|566068306|FG001|Overall Study|Sponsor decision|1|||
156813597|NCT00553436|566068307|FG000|Overall Study|Conversion to another procedure|1|||
156813598|NCT04188834|566068308|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
156813599|NCT02455336|566068311|FG000|Overall Study|Withdrawal by Subject|0|||
156813600|NCT02455336|566068312|FG001|Overall Study|Withdrawal by Subject|2|||
156813601|NCT02455336|566068311|FG000|Overall Study|Adverse Event|3|||
156813602|NCT02455336|566068312|FG001|Overall Study|Adverse Event|0|||
156813603|NCT02455336|566068311|FG000|Overall Study|Non-responder to treatment|2|||
156813604|NCT02455336|566068312|FG001|Overall Study|Non-responder to treatment|0|||
156813605|NCT00391430|566068313|FG000|Overall Study|Withdrawal by Subject|3|||
156813606|NCT00391430|566068314|FG001|Overall Study|Withdrawal by Subject|0|||
156813607|NCT00391430|566068315|FG002|Overall Study|Withdrawal by Subject|12|||
156813608|NCT00577707|566068316|FG000|Overall Study|Withdrawal by Subject|3|||
156813609|NCT03299244|566068317|FG000|Overall Study|Withdrawal by Subject|34|||
156813610|NCT03299244|566068318|FG001|Overall Study|Withdrawal by Subject|29|||
156813611|NCT03299244|566068317|FG000|Overall Study|Decision by Sponsor|4|||
156813612|NCT03299244|566068318|FG001|Overall Study|Decision by Sponsor|5|||
156813613|NCT03299244|566068317|FG000|Overall Study|Death|9|||
156813614|NCT03299244|566068318|FG001|Overall Study|Death|4|||
156813615|NCT01392573|566068322|FG000|Overall Study|Adverse Event|1|||
156813616|NCT01392573|566068323|FG001|Overall Study|Adverse Event|3|||
156813617|NCT01392573|566068322|FG000|Overall Study|Lack of Efficacy|1|||
156813618|NCT01392573|566068323|FG001|Overall Study|Lack of Efficacy|2|||
156813619|NCT01392573|566068322|FG000|Overall Study|Protocol Violation|0|||
156813620|NCT01392573|566068323|FG001|Overall Study|Protocol Violation|2|||
156813621|NCT01392573|566068322|FG000|Overall Study|Withdrawal Criteria|13|||
156813622|NCT01392573|566068323|FG001|Overall Study|Withdrawal Criteria|15|||
156813623|NCT01392573|566068322|FG000|Overall Study|Site closure|8|||
156813624|NCT01392573|566068323|FG001|Overall Study|Site closure|7|||
156813625|NCT01392573|566068322|FG000|Overall Study|Unclassified|9|||
156813626|NCT01392573|566068323|FG001|Overall Study|Unclassified|6|||
156813627|NCT05696444|566068326|FG000|Treatment|Physician Decision|0|||
156813628|NCT05696444|566068327|FG001|Treatment|Physician Decision|1|||
156813629|NCT05696444|566068328|FG002|Treatment|Physician Decision|0|||
156813630|NCT05696444|566068326|FG000|30 Days|Death|1|||
156813631|NCT05696444|566068327|FG001|30 Days|Death|1|||
156813632|NCT05696444|566068328|FG002|30 Days|Death|0|||
156813633|NCT05696444|566068326|FG000|30 Days|Missed Visit|1|||
156813634|NCT05696444|566068327|FG001|30 Days|Missed Visit|1|||
156813635|NCT05696444|566068328|FG002|30 Days|Missed Visit|1|||
156813636|NCT03744910|566069895|FG000|Overall Study|Withdrew Consent|1|||
156813637|NCT03744910|566069896|FG001|Overall Study|Withdrew Consent|8|||
156813638|NCT03744910|566069895|FG000|Overall Study|Physician Decision|5|||
156813639|NCT03744910|566069896|FG001|Overall Study|Physician Decision|4|||
156813640|NCT03744910|566069895|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
156813641|NCT03744910|566069896|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
156813642|NCT03744910|566069895|FG000|Overall Study|Lost to Follow-up|0|||
156813643|NCT03744910|566069896|FG001|Overall Study|Lost to Follow-up|1|||
156813644|NCT03744910|566069895|FG000|Overall Study|Other-unspecified|4|||
156813645|NCT03744910|566069896|FG001|Overall Study|Other-unspecified|1|||
156813646|NCT03280303|566069897|FG000|Overall Study|Death|505|||
156813647|NCT03280303|566069897|FG000|Overall Study|Study terminated by sponsor|383|||
156813648|NCT03280303|566069897|FG000|Overall Study|Other|148|||
156813649|NCT03280303|566069897|FG000|Overall Study|No longer willing to participate in study|101|||
156813650|NCT03280303|566069897|FG000|Overall Study|Lost to follow up|39|||
156813651|NCT03280303|566069897|FG000|Overall Study|Adverse Event|20|||
156813652|NCT00948857|566069898|FG000|Overall Study|Lost to Follow-up|1|||
156813653|NCT00948857|566069899|FG001|Overall Study|Lost to Follow-up|0|||
157223100|NCT03901963|567563654|FG001|Overall Study|Lost to Follow-up|1|||
156813654|NCT03430843|566069900|FG000|Overall Study|Death|233|||
156813655|NCT03430843|566069901|FG001|Overall Study|Death|233|||
156813656|NCT03430843|566069900|FG000|Overall Study|Sponsor Decision|17|||
156813657|NCT03430843|566069901|FG001|Overall Study|Sponsor Decision|6|||
156813658|NCT03430843|566069900|FG000|Overall Study|Withdrawal by Subject|5|||
156813659|NCT03430843|566069901|FG001|Overall Study|Withdrawal by Subject|14|||
156813660|NCT03430843|566069900|FG000|Overall Study|Lost to Follow-up|1|||
156813661|NCT03430843|566069901|FG001|Overall Study|Lost to Follow-up|3|||
156813662|NCT05360966|566069906|FG000|Overall Study|Adverse Event|5|||
156813663|NCT05360966|566069907|FG001|Overall Study|Adverse Event|5|||
156813664|NCT05360966|566069906|FG000|Overall Study|Withdrawal of Consent|5|||
156813665|NCT05360966|566069907|FG001|Overall Study|Withdrawal of Consent|3|||
156813666|NCT05360966|566069906|FG000|Overall Study|Noncompliance|2|||
156813667|NCT05360966|566069907|FG001|Overall Study|Noncompliance|1|||
156813668|NCT05360966|566069906|FG000|Overall Study|Lost to Follow-up|2|||
156813669|NCT05360966|566069907|FG001|Overall Study|Lost to Follow-up|3|||
156884175|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
156884176|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
156884177|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156884178|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156884179|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156884180|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156884181|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
156884182|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
156884183|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156884184|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
156884185|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156884186|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156884187|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
156884188|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
156884189|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
156884190|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156884191|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156884192|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156884193|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156884194|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156884195|NCT01328444|566334052|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157148998|NCT00641043|567292351|FG001|Overall Study|Protocol Violation|3|||
157148999|NCT00641043|567292350|FG000|Overall Study|Lost to Follow-up|3|||
156813670|NCT05360966|566069906|FG000|Overall Study|Protocol Deviation|2|||
156813671|NCT05360966|566069907|FG001|Overall Study|Protocol Deviation|1|||
156813672|NCT05360966|566069906|FG000|Overall Study|As specified in the Clinical Study Report|1|||
156813673|NCT05360966|566069907|FG001|Overall Study|As specified in the Clinical Study Report|3|||
156813674|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
156813675|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813676|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813677|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813678|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813679|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813680|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813681|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813682|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813683|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813684|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813685|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813686|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813687|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
156813688|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813689|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813690|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813691|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813692|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813693|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813694|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813695|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813696|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813697|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813698|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813699|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813700|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
156813701|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813702|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156884196|NCT01328444|566334053|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
156884197|NCT01328444|566334054|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156884198|NCT01328444|566334055|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
156884199|NCT01328444|566334056|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156884200|NCT01328444|566334057|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156884201|NCT01328444|566334052|FG000|Washout Period (14 Days)|Adverse Event|1|||
156884202|NCT01328444|566334053|FG001|Washout Period (14 Days)|Adverse Event|1|||
156884203|NCT01328444|566334054|FG002|Washout Period (14 Days)|Adverse Event|0|||
156884204|NCT01328444|566334055|FG003|Washout Period (14 Days)|Adverse Event|1|||
156884205|NCT01328444|566334056|FG004|Washout Period (14 Days)|Adverse Event|1|||
156884206|NCT01328444|566334057|FG005|Washout Period (14 Days)|Adverse Event|2|||
156813703|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813704|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
157149000|NCT00641043|567292351|FG001|Overall Study|Lost to Follow-up|2|||
157149001|NCT00641043|567292350|FG000|Overall Study|Withdrawal by Subject|4|||
157149002|NCT00641043|567292351|FG001|Overall Study|Withdrawal by Subject|4|||
157149003|NCT00641043|567292350|FG000|Overall Study|Other incl. lack of efficacy|4|||
157149004|NCT00641043|567292351|FG001|Overall Study|Other incl. lack of efficacy|2|||
157149005|NCT00474630|567292354|FG000|Overall Study|Adverse Event|98|||
157149006|NCT00474630|567292355|FG001|Overall Study|Adverse Event|26|||
156813705|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813706|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813707|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813708|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813709|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813710|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813711|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813712|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813713|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
156813714|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813715|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813716|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
156813717|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
156813718|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813719|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813720|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813721|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813722|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813723|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813724|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813725|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813726|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813727|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813728|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813729|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813730|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
156813731|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813732|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813733|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813734|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813735|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813736|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813737|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813738|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813739|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813740|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813741|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813742|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813743|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
156813744|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813745|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813746|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813747|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813748|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813749|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813750|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813751|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813752|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813753|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813754|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813755|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813756|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
156813757|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813758|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
157149007|NCT00474630|567292354|FG000|Overall Study|Lost to Follow-up|22|||
156884207|NCT01328444|566334052|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
156884208|NCT01328444|566334053|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
157149008|NCT00474630|567292355|FG001|Overall Study|Lost to Follow-up|15|||
156884209|NCT01328444|566334054|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
156884210|NCT01328444|566334055|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
156813759|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
156813760|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813761|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813762|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813763|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813764|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156884211|NCT01328444|566334056|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
156884212|NCT01328444|566334057|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
156813765|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813766|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813767|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813768|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813769|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813770|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813771|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813772|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813773|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813774|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813775|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813776|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813777|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813778|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813779|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813780|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813781|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813782|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813783|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813784|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813785|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813786|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
156813787|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813788|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813789|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813790|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813791|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813792|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813793|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813794|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813795|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813796|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813797|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813798|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813799|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
156813800|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813801|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813802|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
156813803|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813804|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813805|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813806|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813807|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813808|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813809|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813810|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813811|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813812|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156884213|NCT01328444|566334052|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
156884214|NCT01328444|566334053|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
156884215|NCT01328444|566334054|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
156884216|NCT01328444|566334055|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
156813813|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813814|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813815|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813816|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813817|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156884217|NCT01328444|566334056|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
156884218|NCT01328444|566334057|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
156813818|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813819|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813820|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813821|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813822|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813823|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813824|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813825|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813826|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813827|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813828|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813829|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
156813830|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813831|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813832|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813833|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813834|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813835|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813836|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813837|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813838|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813839|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813840|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813841|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813842|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
156813843|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813844|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813845|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
156813846|NCT05396014|566069908|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813847|NCT05396014|566069909|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813848|NCT05396014|566069910|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813849|NCT05396014|566069911|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813850|NCT05396014|566069912|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813851|NCT05396014|566069913|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813852|NCT05396014|566069914|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813853|NCT05396014|566069915|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813854|NCT05396014|566069916|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813855|NCT05396014|566069917|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813856|NCT05396014|566069918|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813857|NCT05396014|566069919|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813858|NCT05396014|566069920|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813859|NCT05396014|566069921|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813860|NCT05396014|566069922|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813861|NCT05396014|566069923|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813862|NCT05396014|566069924|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813863|NCT05396014|566069925|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813864|NCT05396014|566069926|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813865|NCT05396014|566069927|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813866|NCT05396014|566069928|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813867|NCT05396014|566069929|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813868|NCT05396014|566069930|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813869|NCT05396014|566069931|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813870|NCT05396014|566069932|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813871|NCT05396014|566069933|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813872|NCT05396014|566069934|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
156813873|NCT05396014|566069935|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813874|NCT05396014|566069936|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813875|NCT05396014|566069937|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813876|NCT05396014|566069938|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813877|NCT05396014|566069939|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813878|NCT05396014|566069940|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813879|NCT05396014|566069941|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813880|NCT05396014|566069942|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813881|NCT05396014|566069943|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813882|NCT05396014|566069944|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
157022527|NCT05184192|566835246|FG000|Overall Study|Medication schedule|1|||
156813883|NCT05396014|566069945|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813884|NCT05396014|566069946|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813885|NCT05396014|566069947|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813886|NCT05396014|566069948|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813887|NCT05396014|566069949|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813888|NCT05396014|566069950|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
156813889|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813890|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813891|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813892|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813893|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813894|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813895|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813896|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813897|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813898|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813899|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813900|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813901|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813902|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
156813903|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813904|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813905|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813906|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813907|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813908|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813909|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813910|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813911|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813912|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813913|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813914|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813915|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813916|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813917|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813918|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813919|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813920|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813921|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813922|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813923|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813924|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813925|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813926|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813927|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813928|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813929|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813930|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813931|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
156813932|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
156813933|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813934|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813935|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813936|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813937|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813938|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813939|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813940|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813941|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813942|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813943|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813944|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813945|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
157149009|NCT00474630|567292354|FG000|Overall Study|Withdrawal by Subject|21|||
156813946|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813947|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813948|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813949|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813950|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813951|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813952|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813953|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813954|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
157149010|NCT00474630|567292355|FG001|Overall Study|Withdrawal by Subject|15|||
157149011|NCT00474630|567292354|FG000|Overall Study|Protocol Violation|3|||
157149012|NCT00474630|567292355|FG001|Overall Study|Protocol Violation|4|||
157149013|NCT00474630|567292354|FG000|Overall Study|Lack of Efficacy|5|||
157149014|NCT00474630|567292355|FG001|Overall Study|Lack of Efficacy|6|||
157149015|NCT00474630|567292354|FG000|Overall Study|Drug noncompliance, other|11|||
157149016|NCT00474630|567292355|FG001|Overall Study|Drug noncompliance, other|4|||
157149017|NCT03515538|567292356|FG000|Overall Study|Lack of Efficacy|2|||
157149018|NCT03515538|567292357|FG001|Overall Study|Lack of Efficacy|0|||
156813955|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813956|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813957|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813958|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813959|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813960|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813961|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813962|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813963|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813964|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813965|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813966|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813967|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813968|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813969|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813970|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813971|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
156813972|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813973|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813974|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
156813975|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
156813976|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813977|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813978|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813979|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813980|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813981|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813982|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813983|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813984|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813985|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813986|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813987|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813988|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813989|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813990|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813991|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813992|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813993|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813994|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
157149019|NCT03515538|567292358|FG002|Overall Study|Lack of Efficacy|2|||
157149020|NCT03515538|567292359|FG003|Overall Study|Lack of Efficacy|0|||
157149021|NCT03515538|567292356|FG000|Overall Study|Death|0|||
157149022|NCT03515538|567292357|FG001|Overall Study|Death|0|||
157149023|NCT03515538|567292358|FG002|Overall Study|Death|1|||
157149024|NCT03515538|567292359|FG003|Overall Study|Death|0|||
157149025|NCT03515538|567292356|FG000|Overall Study|Protocol Violation|0|||
157149026|NCT03515538|567292357|FG001|Overall Study|Protocol Violation|0|||
157149027|NCT03515538|567292358|FG002|Overall Study|Protocol Violation|0|||
157149028|NCT03515538|567292359|FG003|Overall Study|Protocol Violation|1|||
156813995|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813996|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813997|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813998|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156813999|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814000|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814001|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
156814002|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814003|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814004|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814005|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814006|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814007|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814008|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814009|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814010|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814011|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814012|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814013|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814014|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814015|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814016|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814017|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
156814018|NCT05396014|566069908|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814019|NCT05396014|566069909|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814020|NCT05396014|566069910|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
157149029|NCT03515538|567292356|FG000|Overall Study|Screen failure (baseline dropout)|0|||
157149030|NCT03515538|567292357|FG001|Overall Study|Screen failure (baseline dropout)|1|||
157149031|NCT03515538|567292358|FG002|Overall Study|Screen failure (baseline dropout)|0|||
156814021|NCT05396014|566069911|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814022|NCT05396014|566069912|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814023|NCT05396014|566069913|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814024|NCT05396014|566069914|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814025|NCT05396014|566069915|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814026|NCT05396014|566069916|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814027|NCT05396014|566069917|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814028|NCT05396014|566069918|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814029|NCT05396014|566069919|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814030|NCT05396014|566069920|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814031|NCT05396014|566069921|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
156814032|NCT05396014|566069922|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814033|NCT05396014|566069923|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814034|NCT05396014|566069924|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814035|NCT05396014|566069925|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814036|NCT05396014|566069926|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814037|NCT05396014|566069927|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814038|NCT05396014|566069928|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814039|NCT05396014|566069929|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814040|NCT05396014|566069930|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814041|NCT05396014|566069931|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814042|NCT05396014|566069932|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814043|NCT05396014|566069933|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814044|NCT05396014|566069934|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814045|NCT05396014|566069935|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814046|NCT05396014|566069936|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814047|NCT05396014|566069937|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814048|NCT05396014|566069938|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814049|NCT05396014|566069939|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156884219|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
156884220|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
157149032|NCT03515538|567292359|FG003|Overall Study|Screen failure (baseline dropout)|0|||
157149033|NCT03515538|567292356|FG000|Overall Study|Withdrawal by Subject|2|||
157149034|NCT03515538|567292357|FG001|Overall Study|Withdrawal by Subject|2|||
157149035|NCT03515538|567292358|FG002|Overall Study|Withdrawal by Subject|1|||
157149036|NCT03515538|567292359|FG003|Overall Study|Withdrawal by Subject|3|||
157149037|NCT03515538|567292356|FG000|Overall Study|Physician Decision|1|||
156884221|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156814050|NCT05396014|566069940|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814051|NCT05396014|566069941|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814052|NCT05396014|566069942|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814053|NCT05396014|566069943|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814054|NCT05396014|566069944|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814055|NCT05396014|566069945|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814056|NCT05396014|566069946|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814057|NCT05396014|566069947|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814058|NCT05396014|566069948|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814059|NCT05396014|566069949|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814060|NCT05396014|566069950|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
156814061|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814062|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814063|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814064|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814065|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814066|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814067|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814068|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814069|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814070|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814071|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814072|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814073|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814074|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814075|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814076|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814077|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814078|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814079|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814080|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814081|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814082|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814083|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814084|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814085|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814086|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814087|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814088|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814089|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814090|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814091|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814092|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814093|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814094|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814095|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814096|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814097|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814098|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814099|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814100|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
156814101|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
156814102|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
156814103|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
156814104|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814105|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814106|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814107|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814108|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814109|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814110|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814111|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
157149038|NCT03515538|567292357|FG001|Overall Study|Physician Decision|0|||
157149039|NCT03515538|567292358|FG002|Overall Study|Physician Decision|0|||
156814112|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814113|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
157149040|NCT03515538|567292359|FG003|Overall Study|Physician Decision|1|||
157149041|NCT03088605|567292362|FG000|Overall Study|Withdrawal by Subject|1|||
157149042|NCT03088605|567292363|FG001|Overall Study|Withdrawal by Subject|0|||
157149043|NCT02225223|567292369|FG000|Overall Study|Death|10|||
157149044|NCT02225223|567292370|FG001|Overall Study|Death|1|||
157149045|NCT02225223|567292369|FG000|Overall Study|Lost to Follow-up|5|||
157149046|NCT02225223|567292370|FG001|Overall Study|Lost to Follow-up|0|||
157149047|NCT02225223|567292369|FG000|Overall Study|Other|1|||
157149048|NCT02225223|567292370|FG001|Overall Study|Other|2|||
157223101|NCT03901963|567563653|FG000|Overall Study|Physician Decision|1|||
157223102|NCT03901963|567563654|FG001|Overall Study|Physician Decision|2|||
157223103|NCT03901963|567563653|FG000|Overall Study|Protocol Violation|1|||
157223104|NCT03901963|567563654|FG001|Overall Study|Protocol Violation|1|||
157223105|NCT03901963|567563653|FG000|Overall Study|Withdrawal by Subject|4|||
157223106|NCT03901963|567563654|FG001|Overall Study|Withdrawal by Subject|11|||
157223107|NCT03901963|567563653|FG000|Overall Study|Ongoing|84|||
157223108|NCT03901963|567563654|FG001|Overall Study|Ongoing|73|||
157223109|NCT03901963|567563653|FG000|Overall Study|Randomized but not treated|3|||
157223110|NCT03901963|567563654|FG001|Overall Study|Randomized but not treated|3|||
157223111|NCT02854436|567563655|FG000|Overall Study|Adverse Event|1|||
157223112|NCT02854436|567563655|FG000|Overall Study|Death|208|||
157223113|NCT02854436|567563655|FG000|Overall Study|Lost to Follow-up|5|||
156814114|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814115|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814116|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814117|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814118|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814119|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814120|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814121|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814122|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814123|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814124|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814125|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814126|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814127|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814128|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814129|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814130|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814131|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814132|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814133|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814134|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814135|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814136|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814137|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814138|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814139|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
156814140|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814141|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814142|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814143|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
156814144|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814145|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
156814146|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
156814147|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814148|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814149|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814150|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814151|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814152|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814153|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814154|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814155|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
157149049|NCT02225223|567292369|FG000|Overall Study|Physician Decision|1|||
157149050|NCT02225223|567292370|FG001|Overall Study|Physician Decision|0|||
157149051|NCT02225223|567292369|FG000|Overall Study|Withdrawal by Subject|2|||
157149052|NCT02225223|567292370|FG001|Overall Study|Withdrawal by Subject|2|||
157149053|NCT01650779|567292371|FG000|Overall Study|Withdrawal by Subject|1|||
157223114|NCT02854436|567563655|FG000|Overall Study|Withdrawal by Subject|24|||
157223115|NCT02854436|567563655|FG000|Overall Study|Other|45|||
157223116|NCT02854436|567563655|FG000|Overall Study|Physician Decision|6|||
156814156|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814157|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814158|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814159|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814160|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156814161|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814162|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814163|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814164|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814165|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814166|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814167|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814168|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814169|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814170|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814171|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814172|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814173|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
157149054|NCT03567291|567292372|FG000|Period I|Adverse Event|14|||
157149055|NCT03567291|567292373|FG001|Period I|Adverse Event|0|||
157149056|NCT03567291|567292374|FG002|Period I|Adverse Event|0|||
157149057|NCT03567291|567292375|FG003|Period I|Adverse Event|0|||
157149058|NCT03567291|567292372|FG000|Period I|Protocol Violation|1|||
157149059|NCT03567291|567292373|FG001|Period I|Protocol Violation|0|||
157149060|NCT03567291|567292374|FG002|Period I|Protocol Violation|0|||
156814174|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814175|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
157149061|NCT03567291|567292375|FG003|Period I|Protocol Violation|0|||
157149062|NCT03567291|567292372|FG000|Period I|Withdrawal by Subject|23|||
157149063|NCT03567291|567292373|FG001|Period I|Withdrawal by Subject|0|||
157149064|NCT03567291|567292374|FG002|Period I|Withdrawal by Subject|0|||
157149065|NCT03567291|567292375|FG003|Period I|Withdrawal by Subject|0|||
157149066|NCT03567291|567292372|FG000|Period I|Lost to Follow-up|2|||
157149067|NCT03567291|567292373|FG001|Period I|Lost to Follow-up|0|||
157149068|NCT03567291|567292374|FG002|Period I|Lost to Follow-up|0|||
157149069|NCT03567291|567292375|FG003|Period I|Lost to Follow-up|0|||
157149070|NCT03567291|567292372|FG000|Period I|Terminated by sponsor|44|||
157149071|NCT03567291|567292373|FG001|Period I|Terminated by sponsor|0|||
157149072|NCT03567291|567292374|FG002|Period I|Terminated by sponsor|0|||
157149073|NCT03567291|567292375|FG003|Period I|Terminated by sponsor|0|||
157149074|NCT03567291|567292372|FG000|Period I|Missing or unknown|7|||
157149075|NCT03567291|567292373|FG001|Period I|Missing or unknown|0|||
157149076|NCT03567291|567292374|FG002|Period I|Missing or unknown|0|||
157149077|NCT03567291|567292375|FG003|Period I|Missing or unknown|0|||
157149078|NCT03567291|567292372|FG000|Period II|Adverse Event|0|||
157149079|NCT03567291|567292373|FG001|Period II|Adverse Event|1|||
157149080|NCT03567291|567292374|FG002|Period II|Adverse Event|0|||
157149081|NCT03567291|567292375|FG003|Period II|Adverse Event|0|||
157149082|NCT03567291|567292372|FG000|Period II|Missing or unknown|0|||
157149083|NCT03567291|567292373|FG001|Period II|Missing or unknown|2|||
157149084|NCT03567291|567292374|FG002|Period II|Missing or unknown|1|||
157149085|NCT03567291|567292375|FG003|Period II|Missing or unknown|0|||
157149086|NCT03567291|567292372|FG000|Period III|Adverse Event|0|||
157149087|NCT03567291|567292373|FG001|Period III|Adverse Event|0|||
157149088|NCT03567291|567292374|FG002|Period III|Adverse Event|0|||
157149089|NCT03567291|567292375|FG003|Period III|Adverse Event|4|||
157149090|NCT03567291|567292372|FG000|Period III|Withdrawal by Subject|0|||
157149091|NCT03567291|567292373|FG001|Period III|Withdrawal by Subject|0|||
157149092|NCT03567291|567292374|FG002|Period III|Withdrawal by Subject|0|||
157149093|NCT03567291|567292375|FG003|Period III|Withdrawal by Subject|4|||
157149094|NCT03567291|567292372|FG000|Period III|Lost to Follow-up|0|||
157149095|NCT03567291|567292373|FG001|Period III|Lost to Follow-up|0|||
157149096|NCT03567291|567292374|FG002|Period III|Lost to Follow-up|0|||
157149097|NCT03567291|567292375|FG003|Period III|Lost to Follow-up|1|||
157149098|NCT03567291|567292372|FG000|Period III|Terminated by sponsor|0|||
157149099|NCT03567291|567292373|FG001|Period III|Terminated by sponsor|0|||
157149100|NCT03567291|567292374|FG002|Period III|Terminated by sponsor|0|||
157149101|NCT03567291|567292375|FG003|Period III|Terminated by sponsor|68|||
157149102|NCT03567291|567292372|FG000|Period III|Missing or unknown|0|||
157149103|NCT03567291|567292373|FG001|Period III|Missing or unknown|0|||
157149104|NCT03567291|567292374|FG002|Period III|Missing or unknown|0|||
157149105|NCT03567291|567292375|FG003|Period III|Missing or unknown|8|||
157149106|NCT01103349|567292378|FG000|Overall Study|Adverse Event|8|||
157149107|NCT01103349|567292379|FG001|Overall Study|Adverse Event|5|||
157149108|NCT01103349|567292380|FG002|Overall Study|Adverse Event|3|||
157149109|NCT01103349|567292378|FG000|Overall Study|Consent withdrawn|1|||
157149110|NCT01103349|567292379|FG001|Overall Study|Consent withdrawn|0|||
157149111|NCT01103349|567292380|FG002|Overall Study|Consent withdrawn|0|||
157149112|NCT01103349|567292378|FG000|Overall Study|Incorrectly included in the trial|1|||
157223117|NCT01700621|567563656|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
157223118|NCT01700621|567563657|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
157223119|NCT01700621|567563656|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
157223120|NCT01700621|567563657|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
157223121|NCT01700621|567563656|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
157223122|NCT01700621|567563657|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
157223123|NCT02909673|567563658|FG000|Overall Study|Did not meet inclusion criteria|129|||
157223124|NCT02909673|567563659|FG001|Overall Study|Did not meet inclusion criteria|29|||
157223125|NCT02909673|567563658|FG000|Overall Study|Surveys lost by scanner|95|||
157223126|NCT02909673|567563659|FG001|Overall Study|Surveys lost by scanner|2|||
157223127|NCT02909673|567563658|FG000|Overall Study|Tracking info missing|0|||
157223128|NCT02909673|567563659|FG001|Overall Study|Tracking info missing|5|||
157223129|NCT02035137|567563662|FG000|Overall Study|Physician Decision|0|||
157223130|NCT02035137|567563663|FG001|Overall Study|Physician Decision|0|||
157223131|NCT02035137|567563664|FG002|Overall Study|Physician Decision|1|||
157223132|NCT02035137|567563662|FG000|Overall Study|Withdrawal by Subject|0|||
157223133|NCT02035137|567563663|FG001|Overall Study|Withdrawal by Subject|1|||
157223134|NCT02035137|567563664|FG002|Overall Study|Withdrawal by Subject|2|||
157223135|NCT02035137|567563662|FG000|Overall Study|Ineligible|0|||
157223136|NCT02035137|567563663|FG001|Overall Study|Ineligible|1|||
157223137|NCT02035137|567563664|FG002|Overall Study|Ineligible|2|||
157223138|NCT02035137|567563662|FG000|Overall Study|Disease progression prior to treatment start|2|||
157223139|NCT02035137|567563663|FG001|Overall Study|Disease progression prior to treatment start|0|||
157223140|NCT02035137|567563664|FG002|Overall Study|Disease progression prior to treatment start|0|||
157223141|NCT02540356|567563671|FG000|Overall Study|Terminated due to disease progression|1|||
157223142|NCT02540356|567563672|FG001|Overall Study|Terminated due to disease progression|0|||
157223143|NCT00684671|567563673|FG000|Overall Study|Adverse Event|1|||
157223144|NCT00684671|567563674|FG001|Overall Study|Adverse Event|0|||
157223145|NCT00684671|567563675|FG002|Overall Study|Adverse Event|0|||
157223146|NCT00684671|567563673|FG000|Overall Study|Lost to Follow-up|1|||
157223147|NCT00684671|567563674|FG001|Overall Study|Lost to Follow-up|0|||
157223148|NCT00684671|567563675|FG002|Overall Study|Lost to Follow-up|0|||
157223149|NCT00684671|567563673|FG000|Overall Study|Alcoholic dependance|1|||
157223150|NCT00684671|567563674|FG001|Overall Study|Alcoholic dependance|0|||
157223151|NCT00684671|567563675|FG002|Overall Study|Alcoholic dependance|0|||
157223152|NCT04128007|567563676|FG000|Overall Study|Withdrawal by Subject|9|||
157223153|NCT04128007|567563677|FG001|Overall Study|Withdrawal by Subject|6|||
157223154|NCT04128007|567563676|FG000|Overall Study|Protocol Violation|1|||
157223155|NCT04128007|567563677|FG001|Overall Study|Protocol Violation|0|||
157223156|NCT04128007|567563676|FG000|Overall Study|Lost to Follow-up|8|||
157223157|NCT04128007|567563677|FG001|Overall Study|Lost to Follow-up|7|||
157223158|NCT04128007|567563676|FG000|Overall Study|Adverse Event|5|||
157223159|NCT04128007|567563677|FG001|Overall Study|Adverse Event|2|||
157223160|NCT04128007|567563676|FG000|Overall Study|Not reported|0|||
157223161|NCT04128007|567563677|FG001|Overall Study|Not reported|2|||
157223162|NCT02970669|567563680|FG000|Double-blind Period|Adverse Event|4|||
157223163|NCT02970669|567563681|FG001|Double-blind Period|Adverse Event|0|||
157223164|NCT02970669|567563680|FG000|Double-blind Period|Death|1|||
157223165|NCT02970669|567563681|FG001|Double-blind Period|Death|0|||
157223166|NCT02970669|567563680|FG000|Double-blind Period|Study terminated by sponsor|1|||
157223167|NCT02970669|567563681|FG001|Double-blind Period|Study terminated by sponsor|2|||
157223168|NCT02970669|567563680|FG000|Double-blind Period|Physician Decision|0|||
157223169|NCT02970669|567563681|FG001|Double-blind Period|Physician Decision|2|||
157223170|NCT02970669|567563680|FG000|Double-blind Period|Withdrawal by Subject|2|||
157223171|NCT02970669|567563681|FG001|Double-blind Period|Withdrawal by Subject|2|||
157223172|NCT02970669|567563680|FG000|Open-label Period|Withdrawal by Subject|2|||
157223173|NCT02970669|567563681|FG001|Open-label Period|Withdrawal by Subject|2|||
157223174|NCT02970669|567563680|FG000|Open-label Period|Adverse Event|1|||
157223175|NCT02970669|567563681|FG001|Open-label Period|Adverse Event|0|||
157223176|NCT02970669|567563680|FG000|Open-label Period|Physician Decision|1|||
157223177|NCT02970669|567563681|FG001|Open-label Period|Physician Decision|0|||
157223178|NCT02611752|567563682|FG000|Overall Study|Adverse Event|0|||
157223179|NCT02611752|567563683|FG001|Overall Study|Adverse Event|1|||
157223180|NCT03521999|567563684|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
157223181|NCT03521999|567563685|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
157223182|NCT03521999|567563684|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
157223183|NCT03521999|567563685|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
157223184|NCT03521999|567563684|FG000|Completed 3 Month Follow up|Death|0|||
157223185|NCT03521999|567563685|FG001|Completed 3 Month Follow up|Death|1|||
157223186|NCT03521999|567563684|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
157223187|NCT03521999|567563685|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
157223188|NCT01411995|567563686|FG000|Overall Study|Failed IUD insertion|0|||
157223189|NCT01411995|567563687|FG001|Overall Study|Failed IUD insertion|1|||
157223190|NCT01937364|567563688|FG000|Overall Study|Adverse Event|2|||
157223191|NCT01937364|567563689|FG001|Overall Study|Adverse Event|1|||
157223192|NCT00467584|567563690|FG000|Overall Study|Withdrawal by Subject|4|||
156814176|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814177|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814178|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814179|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814180|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814181|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
157149113|NCT01103349|567292379|FG001|Overall Study|Incorrectly included in the trial|0|||
157149114|NCT01103349|567292380|FG002|Overall Study|Incorrectly included in the trial|0|||
157149115|NCT01103349|567292378|FG000|Overall Study|Withdrawal by Subject|1|||
157149116|NCT01103349|567292379|FG001|Overall Study|Withdrawal by Subject|1|||
157149117|NCT01103349|567292380|FG002|Overall Study|Withdrawal by Subject|0|||
157149118|NCT01103349|567292378|FG000|Overall Study|did not want to take trial medication|0|||
157149119|NCT01103349|567292379|FG001|Overall Study|did not want to take trial medication|1|||
157149120|NCT01103349|567292380|FG002|Overall Study|did not want to take trial medication|0|||
157149121|NCT01103349|567292378|FG000|Overall Study|forgot to take medication|0|||
157149122|NCT01103349|567292379|FG001|Overall Study|forgot to take medication|0|||
157149123|NCT01103349|567292380|FG002|Overall Study|forgot to take medication|1|||
157149124|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
157149125|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
157149126|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
157149127|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
157149128|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
157149129|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
157149130|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
157149131|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
157149132|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
157149133|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
157149134|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
157149135|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
157149136|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
157149137|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
157149138|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
157149139|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
157149140|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
157149141|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
157149142|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
156884222|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156884223|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
156884224|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
156884225|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
156884226|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156884227|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
156884228|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
156884229|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
156884230|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
156884231|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
156884232|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156884233|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156884234|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156884235|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
156884236|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
156884237|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156884238|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156884239|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156884240|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
156884241|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
156884242|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
156884243|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156884244|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
156884245|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156884246|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
157149143|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
157149144|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
157149145|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
157149146|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
156814182|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814183|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814184|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
157149147|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
157149148|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
157149149|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
157149150|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
156814185|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814186|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814187|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814188|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
156814189|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
156814190|NCT05396014|566069908|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814191|NCT05396014|566069909|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814192|NCT05396014|566069910|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814193|NCT05396014|566069911|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814194|NCT05396014|566069912|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814195|NCT05396014|566069913|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814196|NCT05396014|566069914|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814197|NCT05396014|566069915|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814198|NCT05396014|566069916|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814199|NCT05396014|566069917|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814200|NCT05396014|566069918|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814201|NCT05396014|566069919|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814202|NCT05396014|566069920|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814203|NCT05396014|566069921|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814204|NCT05396014|566069922|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814205|NCT05396014|566069923|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814206|NCT05396014|566069924|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814207|NCT05396014|566069925|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814208|NCT05396014|566069926|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814209|NCT05396014|566069927|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814210|NCT05396014|566069928|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814211|NCT05396014|566069929|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814212|NCT05396014|566069930|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814213|NCT05396014|566069931|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814214|NCT05396014|566069932|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814215|NCT05396014|566069933|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814216|NCT05396014|566069934|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
156814217|NCT05396014|566069935|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814218|NCT05396014|566069936|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814219|NCT05396014|566069937|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814220|NCT05396014|566069938|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814221|NCT05396014|566069939|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814222|NCT05396014|566069940|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814223|NCT05396014|566069941|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814224|NCT05396014|566069942|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814225|NCT05396014|566069943|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814226|NCT05396014|566069944|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814227|NCT05396014|566069945|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814228|NCT05396014|566069946|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814229|NCT05396014|566069947|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814230|NCT05396014|566069948|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814231|NCT05396014|566069949|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814232|NCT05396014|566069950|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
156814233|NCT04439539|566069951|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
156814234|NCT04439539|566069952|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
156814235|NCT04439539|566069953|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
156814236|NCT04439539|566069951|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
156814237|NCT04439539|566069952|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
156814238|NCT04439539|566069953|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
156814239|NCT04439539|566069951|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
156814240|NCT04439539|566069952|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
156814241|NCT04439539|566069953|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
156884247|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
156884248|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
156814242|NCT05258890|566069955|FG000|Overall Study|Patient withdrawal|6|||
156814243|NCT05258890|566069956|FG001|Overall Study|Patient withdrawal|7|||
157022528|NCT05184192|566835247|FG001|Overall Study|Medication schedule|0|||
156814244|NCT05258890|566069955|FG000|Overall Study|Patient lost to follow-up|10|||
156814245|NCT05258890|566069956|FG001|Overall Study|Patient lost to follow-up|3|||
156814246|NCT05258890|566069955|FG000|Overall Study|Social network member withdrawal|1|||
156814247|NCT05258890|566069956|FG001|Overall Study|Social network member withdrawal|0|||
156814248|NCT05258890|566069955|FG000|Overall Study|Social network member lost to follow-up|5|||
156814249|NCT05258890|566069956|FG001|Overall Study|Social network member lost to follow-up|0|||
156814250|NCT05959447|566069963|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
156814251|NCT05959447|566069964|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
156814252|NCT05959447|566069963|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
156814253|NCT05959447|566069964|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
156814254|NCT05959447|566069963|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
156814255|NCT05959447|566069964|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
156814256|NCT05959447|566069963|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
157149151|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
156814257|NCT05959447|566069964|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
156814258|NCT03015363|566069973|FG000|Overall Study|Physician Decision|14|||
156814259|NCT03015363|566069973|FG000|Overall Study|Withdrawal by Subject|3|||
156814260|NCT03107052|566069974|FG000|Overall Study|Adverse Event|6|||
156814261|NCT03107052|566069975|FG001|Overall Study|Adverse Event|1|||
156814262|NCT03107052|566069976|FG002|Overall Study|Adverse Event|2|||
156814263|NCT03107052|566069974|FG000|Overall Study|Withdrawal by Subject|9|||
156814264|NCT03107052|566069975|FG001|Overall Study|Withdrawal by Subject|5|||
156814265|NCT03107052|566069976|FG002|Overall Study|Withdrawal by Subject|8|||
156814266|NCT03107052|566069974|FG000|Overall Study|Protocol Violation|6|||
156814267|NCT03107052|566069975|FG001|Overall Study|Protocol Violation|0|||
156814268|NCT03107052|566069976|FG002|Overall Study|Protocol Violation|3|||
156814269|NCT03107052|566069974|FG000|Overall Study|Lost to Follow-up|4|||
156814270|NCT03107052|566069975|FG001|Overall Study|Lost to Follow-up|0|||
156814271|NCT03107052|566069976|FG002|Overall Study|Lost to Follow-up|1|||
156814272|NCT03107052|566069974|FG000|Overall Study|Lack of Efficacy|23|||
156814273|NCT03107052|566069975|FG001|Overall Study|Lack of Efficacy|7|||
156814274|NCT03107052|566069976|FG002|Overall Study|Lack of Efficacy|4|||
156814275|NCT03107052|566069974|FG000|Overall Study|Other than specified|4|||
156814276|NCT03107052|566069975|FG001|Overall Study|Other than specified|2|||
156814277|NCT03107052|566069976|FG002|Overall Study|Other than specified|0|||
157149152|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
157149153|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
157149154|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
157149155|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
157149156|NCT00958568|567292384|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
157149157|NCT00958568|567292385|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
157149158|NCT00958568|567292386|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
157149159|NCT00958568|567292387|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
157149160|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
157149161|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
157149162|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
157149163|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
157149164|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
157149165|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
157149166|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
157149167|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
157149168|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
157149169|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
157149170|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
157149171|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
157223193|NCT00467584|567563691|FG001|Overall Study|Withdrawal by Subject|5|||
157223194|NCT00467584|567563692|FG002|Overall Study|Withdrawal by Subject|1|||
157223195|NCT02482571|567563693|FG000|Overall Study|Adverse Event|1|||
157223196|NCT02482571|567563693|FG000|Overall Study|Scanner or Respiract failure|3|||
157223197|NCT02482571|567563693|FG000|Overall Study|Withdrawal by Subject|4|||
156814278|NCT03107052|566069974|FG000|Overall Study|Study terminated due to futility|67|||
156814279|NCT03107052|566069975|FG001|Overall Study|Study terminated due to futility|31|||
156814280|NCT03107052|566069976|FG002|Overall Study|Study terminated due to futility|23|||
156814281|NCT00958360|566069977|FG000|Overall Study|Withdrawal by Subject|3|||
156814282|NCT00958360|566069978|FG001|Overall Study|Withdrawal by Subject|1|||
156814283|NCT00958360|566069977|FG000|Overall Study|Death|6|||
156814284|NCT00958360|566069978|FG001|Overall Study|Death|7|||
156814285|NCT00958360|566069977|FG000|Overall Study|Physician Decision|2|||
156814286|NCT00958360|566069978|FG001|Overall Study|Physician Decision|1|||
156814287|NCT00958360|566069977|FG000|Overall Study|Lost to Follow-up|0|||
156814288|NCT00958360|566069978|FG001|Overall Study|Lost to Follow-up|1|||
156814289|NCT02263326|566069979|FG000|Overall Study|Lost to Follow-up|1|||
157149172|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
157149173|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
157149174|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
157149175|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
157149176|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
157149177|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
156814290|NCT02263326|566069980|FG001|Overall Study|Lost to Follow-up|1|||
156814291|NCT00500357|566069981|FG000|Overall Study|Death|1|||
156814292|NCT00078806|566069982|FG000|Part 1A|Adverse Event|2|||
156814293|NCT00078806|566069983|FG001|Part 1A|Adverse Event|0|||
156814294|NCT00078806|566069984|FG002|Part 1A|Adverse Event|0|||
156814295|NCT00078806|566069985|FG003|Part 1A|Adverse Event|0|||
156814296|NCT00078806|566069982|FG000|Part 1A|Lack of Efficacy|7|||
156814297|NCT00078806|566069983|FG001|Part 1A|Lack of Efficacy|0|||
156814298|NCT00078806|566069984|FG002|Part 1A|Lack of Efficacy|0|||
156814299|NCT00078806|566069985|FG003|Part 1A|Lack of Efficacy|0|||
156814300|NCT00078806|566069982|FG000|Part 1A|Other|1|||
156814301|NCT00078806|566069983|FG001|Part 1A|Other|0|||
156814302|NCT00078806|566069984|FG002|Part 1A|Other|0|||
156814303|NCT00078806|566069985|FG003|Part 1A|Other|0|||
156814304|NCT00078806|566069982|FG000|Part 1B|Adverse Event|1|||
156814305|NCT00078806|566069983|FG001|Part 1B|Adverse Event|0|||
156814306|NCT00078806|566069984|FG002|Part 1B|Adverse Event|0|||
156814307|NCT00078806|566069985|FG003|Part 1B|Adverse Event|0|||
156814308|NCT00078806|566069982|FG000|Part 1B|Lack of Efficacy|7|||
156814309|NCT00078806|566069983|FG001|Part 1B|Lack of Efficacy|0|||
156814310|NCT00078806|566069984|FG002|Part 1B|Lack of Efficacy|0|||
156814311|NCT00078806|566069985|FG003|Part 1B|Lack of Efficacy|0|||
156814312|NCT00078806|566069982|FG000|Part 2|Adverse Event|0|||
156814313|NCT00078806|566069983|FG001|Part 2|Adverse Event|1|||
156814314|NCT00078806|566069984|FG002|Part 2|Adverse Event|0|||
156814315|NCT00078806|566069985|FG003|Part 2|Adverse Event|0|||
156814316|NCT01893411|566069988|FG000|Overall Study|Protocol Violation|1|||
156814317|NCT01893411|566069989|FG001|Overall Study|Protocol Violation|0|||
156814318|NCT01893411|566069990|FG002|Overall Study|Protocol Violation|0|||
156814319|NCT01893411|566069988|FG000|Overall Study|Physician Decision|1|||
156814320|NCT01893411|566069989|FG001|Overall Study|Physician Decision|1|||
156814321|NCT01893411|566069990|FG002|Overall Study|Physician Decision|2|||
156814322|NCT01893411|566069988|FG000|Overall Study|Lack of Efficacy|2|||
156814323|NCT01893411|566069989|FG001|Overall Study|Lack of Efficacy|1|||
156814324|NCT01893411|566069990|FG002|Overall Study|Lack of Efficacy|0|||
156814325|NCT01893411|566069988|FG000|Overall Study|Other|3|||
156814326|NCT01893411|566069989|FG001|Overall Study|Other|1|||
156814327|NCT01893411|566069990|FG002|Overall Study|Other|3|||
156814328|NCT01893411|566069988|FG000|Overall Study|Adverse Event|1|||
156814329|NCT01893411|566069989|FG001|Overall Study|Adverse Event|0|||
156814330|NCT01893411|566069990|FG002|Overall Study|Adverse Event|0|||
156814331|NCT01893411|566069988|FG000|Overall Study|Withdrawal by Subject|7|||
156814332|NCT01893411|566069989|FG001|Overall Study|Withdrawal by Subject|4|||
156814333|NCT01893411|566069990|FG002|Overall Study|Withdrawal by Subject|3|||
156814334|NCT01893411|566069988|FG000|Overall Study|Lost to Follow-up|2|||
156814335|NCT01893411|566069989|FG001|Overall Study|Lost to Follow-up|0|||
156814336|NCT01893411|566069990|FG002|Overall Study|Lost to Follow-up|1|||
156814337|NCT00566982|566069991|FG000|Overall Study|Adverse Event|6|||
156814338|NCT00566982|566069992|FG001|Overall Study|Adverse Event|48|||
156814339|NCT00566982|566069991|FG000|Overall Study|Withdrawal by Subject|1|||
156814340|NCT00566982|566069992|FG001|Overall Study|Withdrawal by Subject|14|||
156814341|NCT00566982|566069991|FG000|Overall Study|Protocol Violation|1|||
156814342|NCT00566982|566069992|FG001|Overall Study|Protocol Violation|4|||
156814343|NCT00566982|566069991|FG000|Overall Study|Lost to Follow-up|0|||
156814344|NCT00566982|566069992|FG001|Overall Study|Lost to Follow-up|1|||
156814345|NCT00566982|566069991|FG000|Overall Study|Other-family problems & doctor's request|0|||
156814346|NCT00566982|566069992|FG001|Overall Study|Other-family problems & doctor's request|2|||
156814347|NCT00161616|566069993|FG000|Overall Study|Withdrawal by Subject|6|||
156814348|NCT00161616|566069994|FG001|Overall Study|Withdrawal by Subject|5|||
156814349|NCT00161616|566069993|FG000|Overall Study|Physician Decision|1|||
156814350|NCT00161616|566069994|FG001|Overall Study|Physician Decision|0|||
157149178|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
156814351|NCT00161616|566069993|FG000|Overall Study|Death|1|||
156814352|NCT00161616|566069994|FG001|Overall Study|Death|1|||
156884249|NCT01328444|566334052|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156814353|NCT00161616|566069993|FG000|Overall Study|Lost to Follow-up|17|||
156814354|NCT00161616|566069994|FG001|Overall Study|Lost to Follow-up|13|||
156814355|NCT00161616|566069993|FG000|Overall Study|Protocol deviation|1|||
156814356|NCT00161616|566069994|FG001|Overall Study|Protocol deviation|0|||
156814357|NCT02013778|566069995|FG000|Overall Study|Death|4|||
156814358|NCT02013778|566069995|FG000|Overall Study|Withdrawal by Subject|1|||
156814359|NCT02013778|566069995|FG000|Overall Study|Physician Decision|1|||
156814360|NCT02013778|566069995|FG000|Overall Study|Adverse Event|1|||
156814361|NCT02719691|566069996|FG000|Overall Study|Physician Decision|0|||
156814362|NCT02719691|566069997|FG001|Overall Study|Physician Decision|0|||
156814363|NCT02719691|566069998|FG002|Overall Study|Physician Decision|1|||
156814364|NCT02719691|566069999|FG003|Overall Study|Physician Decision|0|||
156814365|NCT02719691|566070000|FG004|Overall Study|Physician Decision|0|||
156814366|NCT02719691|566070001|FG005|Overall Study|Physician Decision|0|||
157149179|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
157149180|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
156814367|NCT02719691|566070002|FG006|Overall Study|Physician Decision|0|||
156814368|NCT02719691|566069996|FG000|Overall Study|Withdrawal by Subject|0|||
156814369|NCT02719691|566069997|FG001|Overall Study|Withdrawal by Subject|0|||
156814370|NCT02719691|566069998|FG002|Overall Study|Withdrawal by Subject|0|||
156814371|NCT02719691|566069999|FG003|Overall Study|Withdrawal by Subject|0|||
156814372|NCT02719691|566070000|FG004|Overall Study|Withdrawal by Subject|0|||
156814373|NCT02719691|566070001|FG005|Overall Study|Withdrawal by Subject|1|||
156814374|NCT02719691|566070002|FG006|Overall Study|Withdrawal by Subject|0|||
156814375|NCT00861757|566070005|FG000|Overall Study|Adverse Event|1|||
156814376|NCT00861757|566070006|FG001|Overall Study|Adverse Event|5|||
156814377|NCT00861757|566070007|FG002|Overall Study|Adverse Event|7|||
156814378|NCT00861757|566070008|FG003|Overall Study|Adverse Event|2|||
156814379|NCT00861757|566070005|FG000|Overall Study|Entry Criteria Not Met|1|||
156814380|NCT00861757|566070006|FG001|Overall Study|Entry Criteria Not Met|2|||
156814381|NCT00861757|566070007|FG002|Overall Study|Entry Criteria Not Met|1|||
156814382|NCT00861757|566070008|FG003|Overall Study|Entry Criteria Not Met|1|||
156814383|NCT00861757|566070005|FG000|Overall Study|Lack of Efficacy|3|||
156814384|NCT00861757|566070006|FG001|Overall Study|Lack of Efficacy|1|||
156814385|NCT00861757|566070007|FG002|Overall Study|Lack of Efficacy|0|||
156814386|NCT00861757|566070008|FG003|Overall Study|Lack of Efficacy|1|||
156814387|NCT00861757|566070005|FG000|Overall Study|Lost to Follow-up|1|||
156814388|NCT00861757|566070006|FG001|Overall Study|Lost to Follow-up|0|||
156814389|NCT00861757|566070007|FG002|Overall Study|Lost to Follow-up|1|||
156814390|NCT00861757|566070008|FG003|Overall Study|Lost to Follow-up|1|||
156814391|NCT00861757|566070005|FG000|Overall Study|Physician Decision|0|||
156814392|NCT00861757|566070006|FG001|Overall Study|Physician Decision|0|||
156814393|NCT00861757|566070007|FG002|Overall Study|Physician Decision|0|||
156814394|NCT00861757|566070008|FG003|Overall Study|Physician Decision|1|||
156814395|NCT00861757|566070005|FG000|Overall Study|Protocol Violation|2|||
156814396|NCT00861757|566070006|FG001|Overall Study|Protocol Violation|2|||
156814397|NCT00861757|566070007|FG002|Overall Study|Protocol Violation|4|||
156814398|NCT00861757|566070008|FG003|Overall Study|Protocol Violation|1|||
156814399|NCT00861757|566070005|FG000|Overall Study|Withdrawal by Subject|1|||
156814400|NCT00861757|566070006|FG001|Overall Study|Withdrawal by Subject|5|||
156814401|NCT00861757|566070007|FG002|Overall Study|Withdrawal by Subject|5|||
156814402|NCT00861757|566070008|FG003|Overall Study|Withdrawal by Subject|2|||
156814403|NCT02141633|566070011|FG000|Overall Study|Physician Decision|1|||
156814404|NCT02141633|566070012|FG001|Overall Study|Physician Decision|0|||
156814405|NCT02403817|566070015|FG000|Overall Study|Withdrawal by Subject|5|||
156814406|NCT02403817|566070016|FG001|Overall Study|Withdrawal by Subject|0|||
156814407|NCT00391053|566070022|FG000|Overall Study|Serious Adverse Events|1|||
156814408|NCT00391053|566070023|FG001|Overall Study|Serious Adverse Events|0|||
156814409|NCT00391053|566070024|FG002|Overall Study|Serious Adverse Events|1|||
156814410|NCT00391053|566070025|FG003|Overall Study|Serious Adverse Events|4|||
156814411|NCT00391053|566070022|FG000|Overall Study|Protocol Violation|2|||
157149181|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
157149182|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
157149183|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
156814412|NCT00391053|566070023|FG001|Overall Study|Protocol Violation|0|||
156814413|NCT00391053|566070024|FG002|Overall Study|Protocol Violation|0|||
156814414|NCT00391053|566070025|FG003|Overall Study|Protocol Violation|0|||
156814415|NCT00391053|566070022|FG000|Overall Study|Lost to Follow-up|1|||
156814416|NCT00391053|566070023|FG001|Overall Study|Lost to Follow-up|0|||
156814417|NCT00391053|566070024|FG002|Overall Study|Lost to Follow-up|0|||
156814418|NCT00391053|566070025|FG003|Overall Study|Lost to Follow-up|5|||
156814419|NCT00391053|566070022|FG000|Overall Study|Withdrawal by Subject|5|||
156814420|NCT00391053|566070023|FG001|Overall Study|Withdrawal by Subject|1|||
156814421|NCT00391053|566070024|FG002|Overall Study|Withdrawal by Subject|1|||
156814422|NCT00391053|566070025|FG003|Overall Study|Withdrawal by Subject|1|||
156814423|NCT00473889|566070027|FG000|Overall Study|Did not receive study medication|1|||
156814424|NCT00473889|566070028|FG001|Overall Study|Did not receive study medication|4|||
156814425|NCT00473889|566070027|FG000|Overall Study|Adverse Event|30|||
156814426|NCT00473889|566070028|FG001|Overall Study|Adverse Event|17|||
156814427|NCT00473889|566070027|FG000|Overall Study|Protocol Violation|4|||
156814428|NCT00473889|566070028|FG001|Overall Study|Protocol Violation|2|||
156814429|NCT00473889|566070027|FG000|Overall Study|Lack of Efficacy|28|||
156814430|NCT00473889|566070028|FG001|Overall Study|Lack of Efficacy|29|||
156814431|NCT00473889|566070027|FG000|Overall Study|Lost to Follow-up|2|||
156814432|NCT00473889|566070028|FG001|Overall Study|Lost to Follow-up|1|||
156814433|NCT00473889|566070027|FG000|Overall Study|Physician Decision|10|||
156814434|NCT00473889|566070028|FG001|Overall Study|Physician Decision|5|||
156814435|NCT00473889|566070027|FG000|Overall Study|Trial Terminated|3|||
156814436|NCT00473889|566070028|FG001|Overall Study|Trial Terminated|6|||
156814437|NCT00473889|566070027|FG000|Overall Study|Withdrawal by Subject|5|||
156814438|NCT00473889|566070028|FG001|Overall Study|Withdrawal by Subject|0|||
156814439|NCT02140970|566070029|FG000|Overall Study|Lost to Follow-up|1|||
156814440|NCT02140970|566070030|FG001|Overall Study|Lost to Follow-up|2|||
156814441|NCT02140970|566070029|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
156814442|NCT02140970|566070030|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
156814443|NCT02140970|566070029|FG000|Overall Study|Did not meet inclusion criteria|0|||
156814444|NCT02140970|566070030|FG001|Overall Study|Did not meet inclusion criteria|1|||
156814445|NCT01947283|566070034|FG000|Overall Study|Death|1|||
156814446|NCT01947283|566070035|FG001|Overall Study|Death|1|||
156814447|NCT01947283|566070036|FG002|Overall Study|Death|1|||
156814448|NCT01947283|566070037|FG003|Overall Study|Death|0|||
156814449|NCT01947283|566070038|FG004|Overall Study|Death|0|||
156814450|NCT01947283|566070039|FG005|Overall Study|Death|0|||
156814451|NCT01947283|566070040|FG006|Overall Study|Death|0|||
156814452|NCT01947283|566070034|FG000|Overall Study|Lost to Follow-up|4|||
157149184|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
157149185|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
157149186|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
157149187|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
157149188|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
157149189|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
157149190|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
157149191|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
157149192|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
157149193|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
157149194|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
157149195|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
157149196|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
157149197|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
157149198|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
157149199|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
157149200|NCT00958568|567292384|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
157149201|NCT00958568|567292385|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
157149202|NCT00958568|567292386|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
157149203|NCT00958568|567292387|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
157149204|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
157149205|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
157149206|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
157149207|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
157149208|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
157149209|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
157149210|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
157149211|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
157149212|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
157149213|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
157149214|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
157149215|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
157149216|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
157149217|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
157149218|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
157149219|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
157149220|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
157149221|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
157149222|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
156814453|NCT01947283|566070035|FG001|Overall Study|Lost to Follow-up|6|||
156814454|NCT01947283|566070036|FG002|Overall Study|Lost to Follow-up|5|||
156814455|NCT01947283|566070037|FG003|Overall Study|Lost to Follow-up|5|||
156814456|NCT01947283|566070038|FG004|Overall Study|Lost to Follow-up|0|||
156814457|NCT01947283|566070039|FG005|Overall Study|Lost to Follow-up|2|||
156814458|NCT01947283|566070040|FG006|Overall Study|Lost to Follow-up|5|||
156814459|NCT01947283|566070034|FG000|Overall Study|Withdrawal by Subject|10|||
156814460|NCT01947283|566070035|FG001|Overall Study|Withdrawal by Subject|8|||
156814461|NCT01947283|566070036|FG002|Overall Study|Withdrawal by Subject|4|||
156814462|NCT01947283|566070037|FG003|Overall Study|Withdrawal by Subject|1|||
156814463|NCT01947283|566070038|FG004|Overall Study|Withdrawal by Subject|0|||
156814464|NCT01947283|566070039|FG005|Overall Study|Withdrawal by Subject|0|||
156814465|NCT01947283|566070040|FG006|Overall Study|Withdrawal by Subject|2|||
156814466|NCT01947283|566070034|FG000|Overall Study|No Clinical Recording|12|||
156814467|NCT01947283|566070035|FG001|Overall Study|No Clinical Recording|6|||
156814468|NCT01947283|566070036|FG002|Overall Study|No Clinical Recording|8|||
156814469|NCT01947283|566070037|FG003|Overall Study|No Clinical Recording|10|||
156814470|NCT01947283|566070038|FG004|Overall Study|No Clinical Recording|0|||
156814471|NCT01947283|566070039|FG005|Overall Study|No Clinical Recording|0|||
156814472|NCT01947283|566070040|FG006|Overall Study|No Clinical Recording|0|||
156814473|NCT01947283|566070034|FG000|Overall Study|Non-coding Clinical Recording language|0|||
156814474|NCT01947283|566070035|FG001|Overall Study|Non-coding Clinical Recording language|0|||
156814475|NCT01947283|566070036|FG002|Overall Study|Non-coding Clinical Recording language|0|||
156814476|NCT01947283|566070037|FG003|Overall Study|Non-coding Clinical Recording language|1|||
156814477|NCT01947283|566070038|FG004|Overall Study|Non-coding Clinical Recording language|0|||
156814478|NCT01947283|566070039|FG005|Overall Study|Non-coding Clinical Recording language|0|||
156814479|NCT01947283|566070040|FG006|Overall Study|Non-coding Clinical Recording language|0|||
156814480|NCT01947283|566070034|FG000|Overall Study|Missing Follow-up Assessment|2|||
156814481|NCT01947283|566070035|FG001|Overall Study|Missing Follow-up Assessment|2|||
156814482|NCT01947283|566070036|FG002|Overall Study|Missing Follow-up Assessment|3|||
156814483|NCT01947283|566070037|FG003|Overall Study|Missing Follow-up Assessment|0|||
156814484|NCT01947283|566070038|FG004|Overall Study|Missing Follow-up Assessment|0|||
156814485|NCT01947283|566070039|FG005|Overall Study|Missing Follow-up Assessment|2|||
156814486|NCT01947283|566070040|FG006|Overall Study|Missing Follow-up Assessment|0|||
156814487|NCT01947283|566070034|FG000|Overall Study|No patients were enrolled in study|0|||
156814488|NCT01947283|566070035|FG001|Overall Study|No patients were enrolled in study|0|||
156814489|NCT01947283|566070036|FG002|Overall Study|No patients were enrolled in study|0|||
156814490|NCT01947283|566070037|FG003|Overall Study|No patients were enrolled in study|0|||
156814491|NCT01947283|566070038|FG004|Overall Study|No patients were enrolled in study|0|||
156814492|NCT01947283|566070039|FG005|Overall Study|No patients were enrolled in study|3|||
156814493|NCT01947283|566070040|FG006|Overall Study|No patients were enrolled in study|1|||
156814494|NCT01498692|566070041|FG000|Overall Study|Death|4|||
156814495|NCT01498692|566070041|FG000|Overall Study|Withdrawal by Subject|1|||
156814496|NCT01498692|566070041|FG000|Overall Study|Missed 12-month visit|3|||
156814497|NCT04729972|566070042|FG000|Overall Study|Adverse Event|1|||
156814498|NCT00430989|566070043|FG000|Overall Study|Lost to Follow-up|2|||
157149223|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
157149224|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
157149225|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
157149226|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
157149227|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
157149228|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
157149229|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
157149230|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
157149231|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
157149232|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
157149233|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
157149234|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
157149235|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
157149236|NCT00958568|567292384|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
157149237|NCT00958568|567292385|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
157149238|NCT00958568|567292386|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
157149239|NCT00958568|567292387|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
157149240|NCT00090285|567292393|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
157149241|NCT00090285|567292394|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
157149242|NCT00090285|567292395|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157149243|NCT00090285|567292396|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157149244|NCT00090285|567292397|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157149245|NCT00090285|567292398|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157149246|NCT00090285|567292393|FG000|Base Study Vaccination Period|Adverse Event|2|||
157149247|NCT00090285|567292394|FG001|Base Study Vaccination Period|Adverse Event|4|||
156814499|NCT00430989|566070044|FG001|Overall Study|Lost to Follow-up|3|||
156814500|NCT00430989|566070043|FG000|Overall Study|Withdrawal by Subject|15|||
156814501|NCT00430989|566070044|FG001|Overall Study|Withdrawal by Subject|14|||
156814502|NCT00430989|566070043|FG000|Overall Study|Protocol Violation|30|||
156814503|NCT00430989|566070044|FG001|Overall Study|Protocol Violation|37|||
156814504|NCT00430989|566070043|FG000|Overall Study|Not eligible|13|||
156814505|NCT00430989|566070044|FG001|Overall Study|Not eligible|6|||
156814506|NCT03782259|566070045|FG000|Overall Study|Lost to Follow-up|1|||
156814507|NCT03782259|566070046|FG001|Overall Study|Lost to Follow-up|1|||
156814508|NCT03782259|566070045|FG000|Overall Study|Moved out of state|0|||
156814509|NCT03782259|566070046|FG001|Overall Study|Moved out of state|2|||
156814510|NCT03782259|566070045|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
156814511|NCT03782259|566070046|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
156814512|NCT03782259|566070045|FG000|Overall Study|Subject discontinued intervention|1|||
156814513|NCT03782259|566070046|FG001|Overall Study|Subject discontinued intervention|0|||
156814514|NCT03050450|566070047|FG000|Overall Study|Physician Decision|1|||
156814515|NCT03050450|566070048|FG001|Overall Study|Physician Decision|0|||
156814516|NCT03050450|566070049|FG002|Overall Study|Physician Decision|0|||
156814517|NCT03050450|566070050|FG003|Overall Study|Physician Decision|0|||
156814518|NCT03050450|566070051|FG004|Overall Study|Physician Decision|0|||
156814519|NCT00590122|566070052|FG000|Overall Study|swallowed oral dissolving dose|1|||
156814520|NCT00590122|566070053|FG001|Overall Study|swallowed oral dissolving dose|0|||
156814521|NCT00603941|566070057|FG000|Overall Study|Disease progression|6|||
156814522|NCT00603941|566070058|FG001|Overall Study|Disease progression|7|||
156814523|NCT00603941|566070059|FG002|Overall Study|Disease progression|1|||
156814524|NCT00603941|566070057|FG000|Overall Study|Adverse Event|1|||
156814525|NCT00603941|566070058|FG001|Overall Study|Adverse Event|0|||
156814526|NCT00603941|566070059|FG002|Overall Study|Adverse Event|1|||
156814527|NCT00603941|566070057|FG000|Overall Study|Physician Decision|0|||
156814528|NCT00603941|566070058|FG001|Overall Study|Physician Decision|1|||
157022529|NCT05184192|566835246|FG000|Overall Study|Concern for adverse effects|0|||
157022530|NCT05184192|566835247|FG001|Overall Study|Concern for adverse effects|4|||
156814529|NCT00603941|566070059|FG002|Overall Study|Physician Decision|0|||
156814530|NCT00603941|566070057|FG000|Overall Study|Withdrawal by Subject|0|||
156814531|NCT00603941|566070058|FG001|Overall Study|Withdrawal by Subject|2|||
156814532|NCT00603941|566070059|FG002|Overall Study|Withdrawal by Subject|0|||
156814533|NCT03592771|566070060|FG000|Overall Study|Adverse Event|2|||
156814534|NCT03592771|566070061|FG001|Overall Study|Adverse Event|0|||
156814535|NCT03592771|566070062|FG002|Overall Study|Adverse Event|1|||
157149248|NCT00090285|567292395|FG002|Base Study Vaccination Period|Adverse Event|0|||
157149249|NCT00090285|567292396|FG003|Base Study Vaccination Period|Adverse Event|0|||
157149250|NCT00090285|567292397|FG004|Base Study Vaccination Period|Adverse Event|0|||
157149251|NCT00090285|567292398|FG005|Base Study Vaccination Period|Adverse Event|0|||
157149252|NCT00090285|567292393|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
157149253|NCT00090285|567292394|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
157149254|NCT00090285|567292395|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
157149255|NCT00090285|567292396|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
157149256|NCT00090285|567292397|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
157149257|NCT00090285|567292398|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
157149258|NCT00090285|567292393|FG000|Base Study Vaccination Period|Protocol Violation|2|||
157149259|NCT00090285|567292394|FG001|Base Study Vaccination Period|Protocol Violation|3|||
157149260|NCT00090285|567292395|FG002|Base Study Vaccination Period|Protocol Violation|0|||
157149261|NCT00090285|567292396|FG003|Base Study Vaccination Period|Protocol Violation|0|||
157149262|NCT00090285|567292397|FG004|Base Study Vaccination Period|Protocol Violation|0|||
157149263|NCT00090285|567292398|FG005|Base Study Vaccination Period|Protocol Violation|0|||
157149264|NCT00090285|567292393|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
157149265|NCT00090285|567292394|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
157149266|NCT00090285|567292395|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
157149267|NCT00090285|567292396|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
157149268|NCT00090285|567292397|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
157149269|NCT00090285|567292398|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
157149270|NCT00090285|567292393|FG000|Base Study Vaccination Period|Uncooperative|2|||
157149271|NCT00090285|567292394|FG001|Base Study Vaccination Period|Uncooperative|2|||
157149272|NCT00090285|567292395|FG002|Base Study Vaccination Period|Uncooperative|0|||
157149273|NCT00090285|567292396|FG003|Base Study Vaccination Period|Uncooperative|0|||
157149274|NCT00090285|567292397|FG004|Base Study Vaccination Period|Uncooperative|0|||
157149275|NCT00090285|567292398|FG005|Base Study Vaccination Period|Uncooperative|0|||
156814536|NCT03592771|566070060|FG000|Overall Study|Death|0|||
156814537|NCT03592771|566070061|FG001|Overall Study|Death|1|||
157149276|NCT00090285|567292393|FG000|Base Study Vaccination Period|Moved|20|||
156814538|NCT03592771|566070062|FG002|Overall Study|Death|1|||
156814539|NCT03592771|566070060|FG000|Overall Study|Lost to Follow-up|5|||
156814540|NCT03592771|566070061|FG001|Overall Study|Lost to Follow-up|11|||
156814541|NCT03592771|566070062|FG002|Overall Study|Lost to Follow-up|15|||
156814542|NCT03592771|566070060|FG000|Overall Study|Withdrawal by Subject|0|||
156814543|NCT03592771|566070061|FG001|Overall Study|Withdrawal by Subject|2|||
157022531|NCT04624633|566835248|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
157149277|NCT00090285|567292394|FG001|Base Study Vaccination Period|Moved|21|||
156814544|NCT03592771|566070062|FG002|Overall Study|Withdrawal by Subject|0|||
156814545|NCT01642901|566070063|FG000|12-month Follow-up|Withdrawal by Subject|1|||
156814546|NCT01642901|566070064|FG001|12-month Follow-up|Withdrawal by Subject|0|||
157223198|NCT01498484|567563694|FG000|Overall Study|Death|6|||
157223199|NCT01498484|567563695|FG001|Overall Study|Death|3|||
157223200|NCT01498484|567563696|FG002|Overall Study|Death|1|||
157223201|NCT01498484|567563697|FG003|Overall Study|Death|1|||
157223202|NCT01498484|567563698|FG004|Overall Study|Death|0|||
157223203|NCT01498484|567563699|FG005|Overall Study|Death|0|||
157223204|NCT01498484|567563700|FG006|Overall Study|Death|10|||
157223205|NCT01498484|567563701|FG007|Overall Study|Death|1|||
157223206|NCT01498484|567563702|FG008|Overall Study|Death|0|||
157223207|NCT01498484|567563694|FG000|Overall Study|Physician Decision|3|||
157223208|NCT01498484|567563695|FG001|Overall Study|Physician Decision|2|||
157223209|NCT01498484|567563696|FG002|Overall Study|Physician Decision|1|||
157223210|NCT01498484|567563697|FG003|Overall Study|Physician Decision|1|||
157223211|NCT01498484|567563698|FG004|Overall Study|Physician Decision|0|||
157223212|NCT01498484|567563699|FG005|Overall Study|Physician Decision|0|||
157223213|NCT01498484|567563700|FG006|Overall Study|Physician Decision|8|||
157223214|NCT01498484|567563701|FG007|Overall Study|Physician Decision|13|||
157223215|NCT01498484|567563702|FG008|Overall Study|Physician Decision|1|||
157223216|NCT01498484|567563694|FG000|Overall Study|Adverse Event|0|||
157223217|NCT01498484|567563695|FG001|Overall Study|Adverse Event|0|||
157223218|NCT01498484|567563696|FG002|Overall Study|Adverse Event|0|||
157223219|NCT01498484|567563697|FG003|Overall Study|Adverse Event|0|||
157223220|NCT01498484|567563698|FG004|Overall Study|Adverse Event|0|||
157223221|NCT01498484|567563699|FG005|Overall Study|Adverse Event|1|||
157223222|NCT01498484|567563700|FG006|Overall Study|Adverse Event|0|||
157223223|NCT01498484|567563701|FG007|Overall Study|Adverse Event|0|||
157223224|NCT01498484|567563702|FG008|Overall Study|Adverse Event|0|||
157223225|NCT01498484|567563694|FG000|Overall Study|Withdrawal by Subject|0|||
157223226|NCT01498484|567563695|FG001|Overall Study|Withdrawal by Subject|0|||
157223227|NCT01498484|567563696|FG002|Overall Study|Withdrawal by Subject|0|||
157223228|NCT01498484|567563697|FG003|Overall Study|Withdrawal by Subject|1|||
157223229|NCT01498484|567563698|FG004|Overall Study|Withdrawal by Subject|0|||
157223230|NCT01498484|567563699|FG005|Overall Study|Withdrawal by Subject|0|||
157223231|NCT01498484|567563700|FG006|Overall Study|Withdrawal by Subject|1|||
157223232|NCT01498484|567563701|FG007|Overall Study|Withdrawal by Subject|0|||
157223233|NCT01498484|567563702|FG008|Overall Study|Withdrawal by Subject|0|||
157223234|NCT01498484|567563694|FG000|Overall Study|Other|5|||
157223235|NCT01498484|567563695|FG001|Overall Study|Other|2|||
157223236|NCT01498484|567563696|FG002|Overall Study|Other|0|||
156814547|NCT00249808|566070067|FG000|Overall Study|Other|27|||
156814548|NCT00249808|566070067|FG000|Overall Study|Protocol Violation|3|||
156814549|NCT00249808|566070067|FG000|Overall Study|Lost to Follow-up|8|||
156814550|NCT00249808|566070067|FG000|Overall Study|Adverse Event|81|||
156814551|NCT00249808|566070067|FG000|Overall Study|Lack of Efficacy|52|||
156814552|NCT00249808|566070067|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
156814553|NCT00711594|566070068|FG000|Overall Study|Progressive disease|2|||
156814554|NCT00711594|566070069|FG001|Overall Study|Progressive disease|2|||
156814555|NCT00711594|566070070|FG002|Overall Study|Progressive disease|6|||
156814556|NCT00711594|566070071|FG003|Overall Study|Progressive disease|44|||
156814557|NCT00711594|566070068|FG000|Overall Study|Other Adverse Event|1|||
156814558|NCT00711594|566070069|FG001|Overall Study|Other Adverse Event|0|||
156814559|NCT00711594|566070070|FG002|Overall Study|Other Adverse Event|0|||
156814560|NCT00711594|566070071|FG003|Overall Study|Other Adverse Event|16|||
156814561|NCT00711594|566070068|FG000|Overall Study|Withdrawal by Subject|0|||
156814562|NCT00711594|566070069|FG001|Overall Study|Withdrawal by Subject|1|||
156814563|NCT00711594|566070070|FG002|Overall Study|Withdrawal by Subject|0|||
156814564|NCT00711594|566070071|FG003|Overall Study|Withdrawal by Subject|2|||
156814565|NCT00984165|566070078|FG000|Overall Study|Death on study|2|||
156814566|NCT00984165|566070079|FG001|Overall Study|Death on study|0|||
156814567|NCT00984165|566070080|FG002|Overall Study|Death on study|0|||
156814568|NCT00984165|566070081|FG003|Overall Study|Death on study|0|||
156814569|NCT00984165|566070078|FG000|Overall Study|Disease progression on study|5|||
156814570|NCT00984165|566070079|FG001|Overall Study|Disease progression on study|1|||
157223237|NCT01498484|567563697|FG003|Overall Study|Other|0|||
157223238|NCT01498484|567563698|FG004|Overall Study|Other|1|||
156814571|NCT00984165|566070080|FG002|Overall Study|Disease progression on study|0|||
156814572|NCT00984165|566070081|FG003|Overall Study|Disease progression on study|0|||
156814573|NCT00984165|566070078|FG000|Overall Study|Death of recipient|0|||
156814574|NCT00984165|566070079|FG001|Overall Study|Death of recipient|0|||
156814575|NCT00984165|566070080|FG002|Overall Study|Death of recipient|0|||
156814576|NCT00984165|566070081|FG003|Overall Study|Death of recipient|1|||
157223239|NCT01498484|567563699|FG005|Overall Study|Other|0|||
157223240|NCT01498484|567563700|FG006|Overall Study|Other|3|||
157223241|NCT01498484|567563701|FG007|Overall Study|Other|0|||
157223242|NCT01498484|567563702|FG008|Overall Study|Other|1|||
157223243|NCT01199601|567563703|FG000|Overall Study|Lost to Follow-up|47|||
157223244|NCT01199601|567563704|FG001|Overall Study|Lost to Follow-up|66|||
157223245|NCT01199601|567563703|FG000|Overall Study|Withdrawal by Subject|15|||
157223246|NCT01199601|567563704|FG001|Overall Study|Withdrawal by Subject|3|||
157223247|NCT01199601|567563703|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
157223248|NCT01199601|567563704|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
157223249|NCT01185288|567563705|FG000|Overall Study|Adverse Event|7|||
157223250|NCT01185288|567563706|FG001|Overall Study|Adverse Event|6|||
157223251|NCT01185288|567563705|FG000|Overall Study|Withdrawal by Subject|6|||
157223252|NCT01185288|567563706|FG001|Overall Study|Withdrawal by Subject|4|||
157223253|NCT01185288|567563705|FG000|Overall Study|Lost to Follow-up|2|||
157223254|NCT01185288|567563706|FG001|Overall Study|Lost to Follow-up|5|||
157223255|NCT01185288|567563705|FG000|Overall Study|Lack of Efficacy|2|||
157223256|NCT01185288|567563706|FG001|Overall Study|Lack of Efficacy|0|||
157223257|NCT01185288|567563705|FG000|Overall Study|Investigator discretion|1|||
157223258|NCT01185288|567563706|FG001|Overall Study|Investigator discretion|0|||
157223259|NCT01185288|567563705|FG000|Overall Study|Did not meet inclusion criteria|1|||
157223260|NCT01185288|567563706|FG001|Overall Study|Did not meet inclusion criteria|0|||
157223261|NCT01185288|567563705|FG000|Overall Study|Noncompliance|0|||
157223262|NCT01185288|567563706|FG001|Overall Study|Noncompliance|1|||
157223263|NCT00278512|567563707|FG000|Overall Study|Death|1|||
157223264|NCT00278512|567563708|FG001|Overall Study|Death|0|||
157223265|NCT01626859|567563709|FG000|Overall Study|Adverse Event|1|||
157223266|NCT01626859|567563710|FG001|Overall Study|Adverse Event|3|||
157223267|NCT01626859|567563711|FG002|Overall Study|Adverse Event|2|||
157223268|NCT01626859|567563709|FG000|Overall Study|Physician Decision|0|||
157223269|NCT01626859|567563710|FG001|Overall Study|Physician Decision|1|||
157223270|NCT01626859|567563711|FG002|Overall Study|Physician Decision|0|||
157223271|NCT01626859|567563709|FG000|Overall Study|Withdrawal by Subject|1|||
157223272|NCT01626859|567563710|FG001|Overall Study|Withdrawal by Subject|4|||
157223273|NCT01626859|567563711|FG002|Overall Study|Withdrawal by Subject|2|||
157223274|NCT01620177|567563712|FG000|Overall Study|Failure at Screening Visit|43|||
157223275|NCT01620177|567563712|FG000|Overall Study|Withdrawal by Subject|26|||
157223276|NCT01620177|567563712|FG000|Overall Study|Lost to Follow-up|7|||
157223277|NCT01620177|567563712|FG000|Overall Study|Physician Decision|2|||
156814577|NCT00984165|566070078|FG000|Overall Study|New protocol|0|||
156814578|NCT00984165|566070079|FG001|Overall Study|New protocol|0|||
156814579|NCT00984165|566070080|FG002|Overall Study|New protocol|0|||
156814580|NCT00984165|566070081|FG003|Overall Study|New protocol|1|||
156814581|NCT00984165|566070078|FG000|Overall Study|P+/donor pair removed from protocol|0|||
156814582|NCT00984165|566070079|FG001|Overall Study|P+/donor pair removed from protocol|0|||
156814583|NCT00984165|566070080|FG002|Overall Study|P+/donor pair removed from protocol|0|||
156814584|NCT00984165|566070081|FG003|Overall Study|P+/donor pair removed from protocol|1|||
156814585|NCT00984165|566070078|FG000|Overall Study|removed with a pair recipient|0|||
156814586|NCT00984165|566070079|FG001|Overall Study|removed with a pair recipient|0|||
156814587|NCT00984165|566070080|FG002|Overall Study|removed with a pair recipient|0|||
156814588|NCT00984165|566070081|FG003|Overall Study|removed with a pair recipient|1|||
156814589|NCT00700622|566070083|FG000|Overall Study|Adverse Event|4|||
156814590|NCT00700622|566070084|FG001|Overall Study|Adverse Event|0|||
156814591|NCT00700622|566070083|FG000|Overall Study|Lost to Follow-up|0|||
156814592|NCT00700622|566070084|FG001|Overall Study|Lost to Follow-up|1|||
156814593|NCT00700622|566070083|FG000|Overall Study|Physician Decision|2|||
156814594|NCT00700622|566070084|FG001|Overall Study|Physician Decision|1|||
156814595|NCT00700622|566070083|FG000|Overall Study|Protocol Violation|0|||
156814596|NCT00700622|566070084|FG001|Overall Study|Protocol Violation|1|||
156814597|NCT00700622|566070083|FG000|Overall Study|Withdrawal by Subject|4|||
156814598|NCT00700622|566070084|FG001|Overall Study|Withdrawal by Subject|1|||
156814599|NCT00700622|566070083|FG000|Overall Study|Other|3|||
156814600|NCT00700622|566070084|FG001|Overall Study|Other|1|||
156814601|NCT01309997|566070085|FG000|Overall Study|Adverse Event|1|||
156814602|NCT01309997|566070086|FG001|Overall Study|Adverse Event|0|||
156814603|NCT01309997|566070085|FG000|Overall Study|Death|1|||
156814604|NCT01309997|566070086|FG001|Overall Study|Death|3|||
156814605|NCT01309997|566070085|FG000|Overall Study|Lack of Efficacy|2|||
156814606|NCT01309997|566070086|FG001|Overall Study|Lack of Efficacy|2|||
156814607|NCT01309997|566070085|FG000|Overall Study|Withdrawal by Subject|1|||
156814608|NCT01309997|566070086|FG001|Overall Study|Withdrawal by Subject|1|||
156814609|NCT00282087|566070087|FG000|Overall Study|Death|1|||
157223278|NCT01620177|567563712|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
156814610|NCT00405392|566070090|FG000|Overall Study|Adverse Event|15|||
156814611|NCT00405392|566070091|FG001|Overall Study|Adverse Event|14|||
156814612|NCT00405392|566070090|FG000|Overall Study|Did not meet Eligibility criteria|7|||
157223279|NCT00814320|567563717|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
157223280|NCT00814320|567563718|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
157223281|NCT00814320|567563717|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
157223282|NCT00814320|567563718|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
157223283|NCT00814320|567563717|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
156814613|NCT00405392|566070091|FG001|Overall Study|Did not meet Eligibility criteria|2|||
156814614|NCT00405392|566070090|FG000|Overall Study|Withdrawal by Subject|4|||
156814615|NCT00405392|566070091|FG001|Overall Study|Withdrawal by Subject|3|||
156814616|NCT00405392|566070090|FG000|Overall Study|Lost to Follow-up|1|||
156814617|NCT00405392|566070091|FG001|Overall Study|Lost to Follow-up|2|||
156814618|NCT00405392|566070090|FG000|Overall Study|Data missing|2|||
156814619|NCT00405392|566070091|FG001|Overall Study|Data missing|0|||
156814620|NCT00405392|566070090|FG000|Overall Study|Non-compliance|0|||
156814621|NCT00405392|566070091|FG001|Overall Study|Non-compliance|1|||
156814622|NCT00405392|566070090|FG000|Overall Study|Other|1|||
156814623|NCT00405392|566070091|FG001|Overall Study|Other|5|||
156814624|NCT03012828|566070092|FG000|Overall Study|Lost to Follow-up|1|||
156814625|NCT03012828|566070093|FG001|Overall Study|Lost to Follow-up|0|||
156814626|NCT03012828|566070094|FG002|Overall Study|Lost to Follow-up|1|||
156814627|NCT03012828|566070095|FG003|Overall Study|Lost to Follow-up|0|||
156814628|NCT03012828|566070096|FG004|Overall Study|Lost to Follow-up|1|||
156814629|NCT03012828|566070097|FG005|Overall Study|Lost to Follow-up|0|||
156814630|NCT03012828|566070092|FG000|Overall Study|Withdrawal by Subject|0|||
156814631|NCT03012828|566070093|FG001|Overall Study|Withdrawal by Subject|0|||
156814632|NCT03012828|566070094|FG002|Overall Study|Withdrawal by Subject|1|||
156814633|NCT03012828|566070095|FG003|Overall Study|Withdrawal by Subject|0|||
156814634|NCT03012828|566070096|FG004|Overall Study|Withdrawal by Subject|0|||
156814635|NCT03012828|566070097|FG005|Overall Study|Withdrawal by Subject|1|||
156814636|NCT03012828|566070092|FG000|Overall Study|Non-compliance with protocol|0|||
157149278|NCT00090285|567292395|FG002|Base Study Vaccination Period|Moved|0|||
157149279|NCT00090285|567292396|FG003|Base Study Vaccination Period|Moved|0|||
157149280|NCT00090285|567292397|FG004|Base Study Vaccination Period|Moved|0|||
157149281|NCT00090285|567292398|FG005|Base Study Vaccination Period|Moved|0|||
157149282|NCT00090285|567292393|FG000|Base Study Vaccination Period|Site Terminated|1|||
156814637|NCT03012828|566070093|FG001|Overall Study|Non-compliance with protocol|0|||
156814638|NCT03012828|566070094|FG002|Overall Study|Non-compliance with protocol|0|||
156814639|NCT03012828|566070095|FG003|Overall Study|Non-compliance with protocol|0|||
156814640|NCT03012828|566070096|FG004|Overall Study|Non-compliance with protocol|1|||
156814641|NCT03012828|566070097|FG005|Overall Study|Non-compliance with protocol|0|||
156814642|NCT03012828|566070092|FG000|Overall Study|Delay to last visit would delay DBL|0|||
156814643|NCT03012828|566070093|FG001|Overall Study|Delay to last visit would delay DBL|0|||
156814644|NCT03012828|566070094|FG002|Overall Study|Delay to last visit would delay DBL|0|||
156814645|NCT03012828|566070095|FG003|Overall Study|Delay to last visit would delay DBL|0|||
156814646|NCT03012828|566070096|FG004|Overall Study|Delay to last visit would delay DBL|0|||
156814647|NCT03012828|566070097|FG005|Overall Study|Delay to last visit would delay DBL|1|||
156814648|NCT02520388|566070101|FG000|Overall Study|Physician Decision|1|||
156814649|NCT02520388|566070102|FG001|Overall Study|Physician Decision|0|||
157149283|NCT00090285|567292394|FG001|Base Study Vaccination Period|Site Terminated|0|||
156814650|NCT02520388|566070101|FG000|Overall Study|Subject or parent/guardian request|0|||
156814651|NCT02520388|566070102|FG001|Overall Study|Subject or parent/guardian request|6|||
156814652|NCT02520388|566070101|FG000|Overall Study|Adverse Event|1|||
156814653|NCT02520388|566070102|FG001|Overall Study|Adverse Event|4|||
157149284|NCT00090285|567292395|FG002|Base Study Vaccination Period|Site Terminated|0|||
157149285|NCT00090285|567292396|FG003|Base Study Vaccination Period|Site Terminated|0|||
157149286|NCT00090285|567292397|FG004|Base Study Vaccination Period|Site Terminated|0|||
156814654|NCT02520388|566070101|FG000|Overall Study|Lost to Follow-up|3|||
156814655|NCT02520388|566070102|FG001|Overall Study|Lost to Follow-up|2|||
156814656|NCT02520388|566070101|FG000|Overall Study|Other (reason not defined)|4|||
156814657|NCT02520388|566070102|FG001|Overall Study|Other (reason not defined)|4|||
156884250|NCT01328444|566334053|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157149287|NCT00090285|567292398|FG005|Base Study Vaccination Period|Site Terminated|0|||
157149288|NCT00090285|567292393|FG000|Base Study Vaccination Period|Other|2|||
157149289|NCT00090285|567292394|FG001|Base Study Vaccination Period|Other|2|||
157149290|NCT00090285|567292395|FG002|Base Study Vaccination Period|Other|0|||
157149291|NCT00090285|567292396|FG003|Base Study Vaccination Period|Other|0|||
157149292|NCT00090285|567292397|FG004|Base Study Vaccination Period|Other|0|||
157149293|NCT00090285|567292398|FG005|Base Study Vaccination Period|Other|0|||
157149294|NCT00090285|567292393|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
157149295|NCT00090285|567292394|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
157149296|NCT00090285|567292395|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
157149297|NCT00090285|567292396|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
157149298|NCT00090285|567292397|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
157149299|NCT00090285|567292398|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
157149300|NCT00090285|567292393|FG000|Base Study Vaccination Period|HIV positive|1|||
157149301|NCT00090285|567292394|FG001|Base Study Vaccination Period|HIV positive|1|||
157149302|NCT00090285|567292395|FG002|Base Study Vaccination Period|HIV positive|0|||
157149303|NCT00090285|567292396|FG003|Base Study Vaccination Period|HIV positive|0|||
157149304|NCT00090285|567292397|FG004|Base Study Vaccination Period|HIV positive|0|||
157149305|NCT00090285|567292398|FG005|Base Study Vaccination Period|HIV positive|0|||
157149306|NCT00090285|567292393|FG000|Base Study Follow-up Period|Adverse Event|3|||
157149307|NCT00090285|567292394|FG001|Base Study Follow-up Period|Adverse Event|10|||
156814658|NCT02342288|566070103|FG000|Overall Study|no protocol anesthesiologist available|3|||
156814659|NCT02342288|566070104|FG001|Overall Study|no protocol anesthesiologist available|2|||
156814660|NCT02342288|566070103|FG000|Overall Study|anesthesia leak in system|1|||
156814661|NCT02342288|566070104|FG001|Overall Study|anesthesia leak in system|0|||
156814662|NCT02342288|566070103|FG000|Overall Study|Withdrawal by Subject|1|||
156814663|NCT02342288|566070104|FG001|Overall Study|Withdrawal by Subject|0|||
156814664|NCT02342288|566070103|FG000|Overall Study|coordinator contaminated with blood|0|||
156814665|NCT02342288|566070104|FG001|Overall Study|coordinator contaminated with blood|1|||
156814666|NCT02342288|566070103|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
156814667|NCT02342288|566070104|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
156814668|NCT02342288|566070103|FG000|Overall Study|coordinator not available|0|||
156814669|NCT02342288|566070104|FG001|Overall Study|coordinator not available|2|||
156814670|NCT03037476|566071302|FG000|Overall Study|Lost to Follow-up|63|||
156814671|NCT03037476|566071303|FG001|Overall Study|Lost to Follow-up|46|||
156814672|NCT04908384|566071306|FG000|Overall Study|Lost to Follow-up|4|||
156814673|NCT04908384|566071307|FG001|Overall Study|Lost to Follow-up|4|||
156814674|NCT04908384|566071308|FG002|Overall Study|Lost to Follow-up|0|||
156814675|NCT04908384|566071309|FG003|Overall Study|Lost to Follow-up|0|||
156814676|NCT00833469|566071310|FG000|Overall Study|Withdrawal by Subject|1|||
156814677|NCT00833469|566071310|FG000|Overall Study|Lost to Follow-up|1|||
156814678|NCT01208324|566071311|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
156814679|NCT01208324|566071312|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
156814680|NCT01208324|566071313|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
156814681|NCT01208324|566071314|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
156814682|NCT02943070|566071315|FG000|Overall Study|Physician Decision|1|||
156814683|NCT02943070|566071315|FG000|Overall Study|Adverse Event|2|||
156814684|NCT02943070|566071315|FG000|Overall Study|Death|2|||
156814685|NCT02943070|566071315|FG000|Overall Study|Withdrawal by Subject|3|||
156814686|NCT02943070|566071315|FG000|Overall Study|Lost to Follow-up|4|||
156814687|NCT02943070|566071315|FG000|Overall Study|Retreatment or TURP|13|||
156814688|NCT02943070|566071315|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
156814689|NCT01701362|566071316|FG000|Overall Study|Adverse events not related to study drug|1|||
156814690|NCT01701362|566071317|FG001|Overall Study|Adverse events not related to study drug|6|||
156814691|NCT01701362|566071316|FG000|Overall Study|Adverse events related to study drug|12|||
156814692|NCT01701362|566071317|FG001|Overall Study|Adverse events related to study drug|10|||
156814693|NCT01701362|566071316|FG000|Overall Study|Protocol Violation|5|||
156814694|NCT01701362|566071317|FG001|Overall Study|Protocol Violation|3|||
156814695|NCT01701362|566071316|FG000|Overall Study|No longer willing to participate|8|||
156814696|NCT01701362|566071317|FG001|Overall Study|No longer willing to participate|14|||
156814697|NCT01701362|566071316|FG000|Overall Study|Lost to Follow-up|6|||
156814698|NCT01701362|566071317|FG001|Overall Study|Lost to Follow-up|9|||
156814699|NCT01701362|566071316|FG000|Overall Study|Insufficient clinical response|6|||
156814700|NCT01701362|566071317|FG001|Overall Study|Insufficient clinical response|6|||
156814701|NCT01701362|566071316|FG000|Overall Study|Death|0|||
156814702|NCT01701362|566071317|FG001|Overall Study|Death|1|||
156814703|NCT01701362|566071316|FG000|Overall Study|Randomized but not treated|1|||
156814704|NCT01701362|566071317|FG001|Overall Study|Randomized but not treated|2|||
156814705|NCT01701362|566071316|FG000|Overall Study|Reasons other than those mentioned above|3|||
156814706|NCT01701362|566071317|FG001|Overall Study|Reasons other than those mentioned above|5|||
157149308|NCT00090285|567292395|FG002|Base Study Follow-up Period|Adverse Event|0|||
157149309|NCT00090285|567292396|FG003|Base Study Follow-up Period|Adverse Event|0|||
157149310|NCT00090285|567292397|FG004|Base Study Follow-up Period|Adverse Event|0|||
157149311|NCT00090285|567292398|FG005|Base Study Follow-up Period|Adverse Event|0|||
157149312|NCT00090285|567292393|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
157149313|NCT00090285|567292394|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
157149314|NCT00090285|567292395|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
157149315|NCT00090285|567292396|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
157149316|NCT00090285|567292397|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
157149317|NCT00090285|567292398|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
157149318|NCT00090285|567292393|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
157149319|NCT00090285|567292394|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
157149320|NCT00090285|567292395|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
157149321|NCT00090285|567292396|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
157149322|NCT00090285|567292397|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
157149323|NCT00090285|567292398|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
157149324|NCT00090285|567292393|FG000|Base Study Follow-up Period|Moved|41|||
157149325|NCT00090285|567292394|FG001|Base Study Follow-up Period|Moved|36|||
156814707|NCT00570778|566071318|FG000|Overall Study|Protocol deviation|2|||
156814708|NCT00570778|566071319|FG001|Overall Study|Protocol deviation|1|||
156814709|NCT00570778|566071320|FG002|Overall Study|Protocol deviation|2|||
156814710|NCT00570778|566071321|FG003|Overall Study|Protocol deviation|2|||
157149326|NCT00090285|567292395|FG002|Base Study Follow-up Period|Moved|0|||
157149327|NCT00090285|567292396|FG003|Base Study Follow-up Period|Moved|0|||
156814711|NCT00570778|566071318|FG000|Overall Study|Adverse Event|0|||
156814712|NCT00570778|566071319|FG001|Overall Study|Adverse Event|1|||
157149328|NCT00090285|567292397|FG004|Base Study Follow-up Period|Moved|0|||
156814713|NCT00570778|566071320|FG002|Overall Study|Adverse Event|4|||
156814714|NCT00570778|566071321|FG003|Overall Study|Adverse Event|1|||
156814715|NCT00570778|566071318|FG000|Overall Study|Subject withdrew consent|0|||
156814716|NCT00570778|566071319|FG001|Overall Study|Subject withdrew consent|1|||
156814717|NCT00570778|566071320|FG002|Overall Study|Subject withdrew consent|0|||
156814718|NCT00570778|566071321|FG003|Overall Study|Subject withdrew consent|1|||
156814719|NCT00570778|566071318|FG000|Overall Study|Abnormal test procedure|1|||
156814720|NCT00570778|566071319|FG001|Overall Study|Abnormal test procedure|0|||
156814721|NCT00570778|566071320|FG002|Overall Study|Abnormal test procedure|0|||
156814722|NCT00570778|566071321|FG003|Overall Study|Abnormal test procedure|0|||
156814723|NCT00570778|566071318|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156814724|NCT00570778|566071319|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156814725|NCT00570778|566071320|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156814726|NCT00570778|566071321|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
156814727|NCT00570778|566071318|FG000|Overall Study|Lost to Follow-up|0|||
156814728|NCT00570778|566071319|FG001|Overall Study|Lost to Follow-up|0|||
156814729|NCT00570778|566071320|FG002|Overall Study|Lost to Follow-up|1|||
156814730|NCT00570778|566071321|FG003|Overall Study|Lost to Follow-up|0|||
156814731|NCT00570778|566071318|FG000|Overall Study|Subject no longer requires study drug|0|||
156814732|NCT00570778|566071319|FG001|Overall Study|Subject no longer requires study drug|1|||
156814733|NCT00570778|566071320|FG002|Overall Study|Subject no longer requires study drug|0|||
156814734|NCT00570778|566071321|FG003|Overall Study|Subject no longer requires study drug|0|||
156814735|NCT00443872|566071322|FG000|Overall Study|Protocol Violation|7|||
156814736|NCT00443872|566071322|FG000|Overall Study|Lost to Follow-up|2|||
156814737|NCT00443872|566071322|FG000|Overall Study|Adverse Event|8|||
156814738|NCT02789345|566071323|FG000|Overall Study|Adverse Event|0|||
156814739|NCT02789345|566071324|FG001|Overall Study|Adverse Event|0|||
156814740|NCT02789345|566071325|FG002|Overall Study|Adverse Event|1|||
156814741|NCT02789345|566071323|FG000|Overall Study|Death|0|||
156814742|NCT02789345|566071324|FG001|Overall Study|Death|0|||
156814743|NCT02789345|566071325|FG002|Overall Study|Death|1|||
156814744|NCT02789345|566071323|FG000|Overall Study|Physician Decision|2|||
156814745|NCT02789345|566071324|FG001|Overall Study|Physician Decision|0|||
156814746|NCT02789345|566071325|FG002|Overall Study|Physician Decision|1|||
156814747|NCT02789345|566071323|FG000|Overall Study|Progressive Disease|1|||
156814748|NCT02789345|566071324|FG001|Overall Study|Progressive Disease|3|||
156814749|NCT02789345|566071325|FG002|Overall Study|Progressive Disease|14|||
156814750|NCT00441142|566071343|FG000|Overall Study|Adverse Event|2|||
156814751|NCT00441142|566071344|FG001|Overall Study|Adverse Event|3|||
156814752|NCT00441142|566071345|FG002|Overall Study|Adverse Event|3|||
156814753|NCT00441142|566071346|FG003|Overall Study|Adverse Event|22|||
156814754|NCT00441142|566071343|FG000|Overall Study|Lack of Efficacy|3|||
156814755|NCT00441142|566071344|FG001|Overall Study|Lack of Efficacy|3|||
156814756|NCT00441142|566071345|FG002|Overall Study|Lack of Efficacy|17|||
156814757|NCT00441142|566071346|FG003|Overall Study|Lack of Efficacy|32|||
156814758|NCT00441142|566071343|FG000|Overall Study|Withdrawal by Subject|0|||
156814759|NCT00441142|566071344|FG001|Overall Study|Withdrawal by Subject|0|||
157149329|NCT00090285|567292398|FG005|Base Study Follow-up Period|Moved|0|||
157149330|NCT00090285|567292393|FG000|Base Study Follow-up Period|Other|2|||
156814760|NCT00441142|566071345|FG002|Overall Study|Withdrawal by Subject|2|||
156814761|NCT00441142|566071346|FG003|Overall Study|Withdrawal by Subject|10|||
156814762|NCT00441142|566071343|FG000|Overall Study|Patient still receiving active study tx|1|||
156814763|NCT00441142|566071344|FG001|Overall Study|Patient still receiving active study tx|0|||
156814764|NCT00441142|566071345|FG002|Overall Study|Patient still receiving active study tx|0|||
156814765|NCT00441142|566071346|FG003|Overall Study|Patient still receiving active study tx|2|||
156814766|NCT00441142|566071343|FG000|Overall Study|Physician Decision|0|||
156814767|NCT00441142|566071344|FG001|Overall Study|Physician Decision|1|||
156814768|NCT00441142|566071345|FG002|Overall Study|Physician Decision|0|||
156814769|NCT00441142|566071346|FG003|Overall Study|Physician Decision|1|||
156814770|NCT00441142|566071343|FG000|Overall Study|Death|0|||
156814771|NCT00441142|566071344|FG001|Overall Study|Death|0|||
156814772|NCT00441142|566071345|FG002|Overall Study|Death|0|||
156814773|NCT00441142|566071346|FG003|Overall Study|Death|1|||
156814774|NCT00988052|566071349|FG000|Overall Study|Missing|1|||
156814775|NCT00988052|566071350|FG001|Overall Study|Missing|0|||
156814776|NCT00988052|566071349|FG000|Overall Study|Teva requested subject withdrawal|3|||
156814777|NCT00988052|566071350|FG001|Overall Study|Teva requested subject withdrawal|1|||
156814778|NCT00988052|566071349|FG000|Overall Study|Death|1|||
156814779|NCT00988052|566071350|FG001|Overall Study|Death|3|||
156814780|NCT00988052|566071349|FG000|Overall Study|Protocol Violation|6|||
156814781|NCT00988052|566071350|FG001|Overall Study|Protocol Violation|5|||
156814782|NCT00988052|566071349|FG000|Overall Study|Pregnancy|6|||
156814783|NCT00988052|566071350|FG001|Overall Study|Pregnancy|6|||
156814784|NCT00988052|566071349|FG000|Overall Study|Lack of Efficacy|8|||
156814785|NCT00988052|566071350|FG001|Overall Study|Lack of Efficacy|7|||
156814786|NCT00988052|566071349|FG000|Overall Study|Lost to Follow-up|6|||
156814787|NCT00988052|566071350|FG001|Overall Study|Lost to Follow-up|11|||
156814788|NCT00988052|566071349|FG000|Overall Study|Physician Decision|27|||
156814789|NCT00988052|566071350|FG001|Overall Study|Physician Decision|28|||
156814790|NCT00988052|566071349|FG000|Overall Study|Adverse Event|35|||
156814791|NCT00988052|566071350|FG001|Overall Study|Adverse Event|28|||
156814792|NCT00988052|566071349|FG000|Overall Study|Withdrawal by Subject|90|||
156814793|NCT00988052|566071350|FG001|Overall Study|Withdrawal by Subject|91|||
156814794|NCT00988052|566071349|FG000|Overall Study|Study terminated by sponsor|240|||
156814795|NCT00988052|566071350|FG001|Overall Study|Study terminated by sponsor|236|||
156814796|NCT00295646|566071351|FG000|Overall Study|Protocol Violation|18|||
156814797|NCT00295646|566071352|FG001|Overall Study|Protocol Violation|20|||
156814798|NCT00295646|566071353|FG002|Overall Study|Protocol Violation|20|||
156814799|NCT00295646|566071354|FG003|Overall Study|Protocol Violation|18|||
156814800|NCT00295646|566071351|FG000|Overall Study|Withdrawal by Subject|8|||
156814801|NCT00295646|566071352|FG001|Overall Study|Withdrawal by Subject|9|||
156814802|NCT00295646|566071353|FG002|Overall Study|Withdrawal by Subject|11|||
156814803|NCT00295646|566071354|FG003|Overall Study|Withdrawal by Subject|14|||
156814804|NCT00295646|566071351|FG000|Overall Study|Lost to Follow-up|0|||
156814805|NCT00295646|566071352|FG001|Overall Study|Lost to Follow-up|5|||
156814806|NCT00295646|566071353|FG002|Overall Study|Lost to Follow-up|1|||
156814807|NCT00295646|566071354|FG003|Overall Study|Lost to Follow-up|5|||
156814808|NCT00295646|566071351|FG000|Overall Study|Death|9|||
156814809|NCT00295646|566071352|FG001|Overall Study|Death|7|||
156814810|NCT00295646|566071353|FG002|Overall Study|Death|18|||
156814811|NCT00295646|566071354|FG003|Overall Study|Death|8|||
156814812|NCT01509846|566071356|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156814813|NCT01509846|566071357|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
156814814|NCT01509846|566071358|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
156814815|NCT01509846|566071359|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
156814816|NCT01509846|566071360|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
156814817|NCT01509846|566071356|FG000|Received Vaccination 2|Illness|0|||
156814818|NCT01509846|566071357|FG001|Received Vaccination 2|Illness|0|||
156814819|NCT01509846|566071358|FG002|Received Vaccination 2|Illness|0|||
156814820|NCT01509846|566071359|FG003|Received Vaccination 2|Illness|0|||
156814821|NCT01509846|566071360|FG004|Received Vaccination 2|Illness|1|||
156814822|NCT01509846|566071356|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
156814823|NCT01509846|566071357|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
156814824|NCT01509846|566071358|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
156814825|NCT01509846|566071359|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
156814826|NCT01509846|566071360|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
156814827|NCT01509846|566071356|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
156814828|NCT01509846|566071357|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
156814829|NCT01509846|566071358|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
156814830|NCT01509846|566071359|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
156814831|NCT01509846|566071360|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
156814832|NCT01509846|566071356|FG000|Received Vaccination 3|Pregnancy|0|||
156814833|NCT01509846|566071357|FG001|Received Vaccination 3|Pregnancy|0|||
156814834|NCT01509846|566071358|FG002|Received Vaccination 3|Pregnancy|0|||
156814835|NCT01509846|566071359|FG003|Received Vaccination 3|Pregnancy|1|||
156814836|NCT01509846|566071360|FG004|Received Vaccination 3|Pregnancy|0|||
156814837|NCT01509846|566071356|FG000|Received Vaccination 3|Lost to Follow-up|0|||
156814838|NCT01509846|566071357|FG001|Received Vaccination 3|Lost to Follow-up|0|||
156814839|NCT01509846|566071358|FG002|Received Vaccination 3|Lost to Follow-up|1|||
156814840|NCT01509846|566071359|FG003|Received Vaccination 3|Lost to Follow-up|0|||
156814841|NCT01509846|566071360|FG004|Received Vaccination 3|Lost to Follow-up|0|||
156814842|NCT04396795|566071362|FG000|Month 1|Lost to Follow-up|2|||
156814843|NCT04396795|566071363|FG001|Month 1|Lost to Follow-up|3|||
156814844|NCT04396795|566071362|FG000|Month 3|Lost to Follow-up|1|||
156814845|NCT04396795|566071363|FG001|Month 3|Lost to Follow-up|3|||
156814846|NCT04396795|566071362|FG000|Month 6|Lost to Follow-up|3|||
156814847|NCT04396795|566071363|FG001|Month 6|Lost to Follow-up|3|||
156814848|NCT01637584|566071364|FG000|Overall Study|Withdrawal by Subject|1|||
156814849|NCT01637584|566071365|FG001|Overall Study|Withdrawal by Subject|3|||
157149331|NCT00090285|567292394|FG001|Base Study Follow-up Period|Other|0|||
156814850|NCT02484443|566071366|FG000|Overall Study|Lack of Efficacy|28|||
156814851|NCT02484443|566071366|FG000|Overall Study|Physician Decision|2|||
156814852|NCT02484443|566071366|FG000|Overall Study|Ineligible|2|||
156814853|NCT01970241|566071367|FG000|Overall Study|Withdrawal by Subject|2|||
156814854|NCT01970241|566071368|FG001|Overall Study|Withdrawal by Subject|0|||
156814855|NCT01970241|566071367|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
156814856|NCT01970241|566071368|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
156814857|NCT03472495|566071369|FG000|Overall Study|Treatment no longer indicated|1|||
156814858|NCT03472495|566071370|FG001|Overall Study|Treatment no longer indicated|2|||
156814859|NCT03472495|566071369|FG000|Overall Study|Physician Decision|0|||
156814860|NCT03472495|566071370|FG001|Overall Study|Physician Decision|2|||
156814861|NCT02595866|566071371|FG000|Overall Study|Adverse Event|2|||
156814862|NCT02595866|566071372|FG001|Overall Study|Adverse Event|5|||
156814863|NCT02595866|566071371|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
156814864|NCT02595866|566071372|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
156814865|NCT02595866|566071371|FG000|Overall Study|Death|0|||
156814866|NCT02595866|566071372|FG001|Overall Study|Death|1|||
156814867|NCT02595866|566071371|FG000|Overall Study|Incarceration|1|||
156814868|NCT02595866|566071372|FG001|Overall Study|Incarceration|0|||
156814869|NCT02595866|566071371|FG000|Overall Study|Lack of Efficacy|17|||
156814870|NCT02595866|566071372|FG001|Overall Study|Lack of Efficacy|7|||
156814871|NCT02595866|566071371|FG000|Overall Study|Physician Decision|4|||
156814872|NCT02595866|566071372|FG001|Overall Study|Physician Decision|3|||
156814873|NCT02595866|566071371|FG000|Overall Study|Switched to Alternative Treatment|1|||
156814874|NCT02595866|566071372|FG001|Overall Study|Switched to Alternative Treatment|0|||
156814875|NCT02595866|566071371|FG000|Overall Study|Study Terminated|0|||
156814876|NCT02595866|566071372|FG001|Overall Study|Study Terminated|4|||
156814877|NCT02595866|566071371|FG000|Overall Study|Withdrawal by Subject|6|||
156814878|NCT02595866|566071372|FG001|Overall Study|Withdrawal by Subject|1|||
156814879|NCT02131311|566071374|FG000|Overall Study|Adverse Event|2|||
156814880|NCT02131311|566071374|FG000|Overall Study|Protocol Violation|1|||
156814881|NCT02131311|566071374|FG000|Overall Study|Lost to Follow-up|1|||
156814882|NCT01479764|566071375|FG000|Randomized|Adverse Event|1|||
156814883|NCT01479764|566071376|FG001|Randomized|Adverse Event|1|||
156814884|NCT01479764|566071375|FG000|Randomized|Withdrawal by Subject|1|||
156814885|NCT01479764|566071376|FG001|Randomized|Withdrawal by Subject|0|||
156814886|NCT01479764|566071375|FG000|Treated|Lost to Follow-up|0|||
156814887|NCT01479764|566071376|FG001|Treated|Lost to Follow-up|2|||
156814888|NCT03082677|566071377|FG000|Overall Study|Not Treated|2|||
156814889|NCT00255723|566071382|FG000|Overall Study|Adverse Event|1|||
156814890|NCT00255723|566071383|FG001|Overall Study|Adverse Event|1|||
156814891|NCT00255723|566071382|FG000|Overall Study|Death|0|||
156814892|NCT00255723|566071383|FG001|Overall Study|Death|1|||
156814893|NCT00255723|566071382|FG000|Overall Study|Response Data Not Available|1|||
156814894|NCT00255723|566071383|FG001|Overall Study|Response Data Not Available|0|||
156814895|NCT00431444|566071384|FG000|Overall Study|Protocol Violation|1|||
156814896|NCT00431444|566071385|FG001|Overall Study|Protocol Violation|4|||
156814897|NCT00431444|566071384|FG000|Overall Study|Adverse Event|2|||
156814898|NCT00431444|566071385|FG001|Overall Study|Adverse Event|1|||
156814899|NCT00431444|566071384|FG000|Overall Study|Withdrawal by Subject|1|||
156814900|NCT00431444|566071385|FG001|Overall Study|Withdrawal by Subject|1|||
156814901|NCT00431444|566071384|FG000|Overall Study|Lost to Follow-up|1|||
156814902|NCT00431444|566071385|FG001|Overall Study|Lost to Follow-up|0|||
156814903|NCT00431444|566071384|FG000|Overall Study|Administrative Problems|0|||
156814904|NCT00431444|566071385|FG001|Overall Study|Administrative Problems|1|||
156814905|NCT03497039|566071389|FG000|Overall Study|Withdrawal by Subject|1|||
156814906|NCT03497039|566071390|FG001|Overall Study|Withdrawal by Subject|0|||
156814907|NCT03497039|566071389|FG000|Overall Study|Protocol Violation|0|||
156814908|NCT03497039|566071390|FG001|Overall Study|Protocol Violation|1|||
156814909|NCT03554018|566071392|FG000|Overall Study|Lost to Follow-up|3|||
156814910|NCT03554018|566071393|FG001|Overall Study|Lost to Follow-up|7|||
156814911|NCT02131662|566071394|FG000|Overall Study|Protocol Violation|1|||
156814912|NCT02131662|566071395|FG001|Overall Study|Protocol Violation|0|||
156814913|NCT02131662|566071396|FG002|Overall Study|Protocol Violation|0|||
156814914|NCT02131662|566071397|FG003|Overall Study|Protocol Violation|0|||
156814915|NCT02131662|566071398|FG004|Overall Study|Protocol Violation|0|||
156814916|NCT02131662|566071394|FG000|Overall Study|Other|2|||
156814917|NCT02131662|566071395|FG001|Overall Study|Other|4|||
156814918|NCT02131662|566071396|FG002|Overall Study|Other|3|||
156814919|NCT02131662|566071397|FG003|Overall Study|Other|3|||
156814920|NCT02131662|566071398|FG004|Overall Study|Other|4|||
156814921|NCT02131662|566071394|FG000|Overall Study|Adverse Event|0|||
156814922|NCT02131662|566071395|FG001|Overall Study|Adverse Event|1|||
156814923|NCT02131662|566071396|FG002|Overall Study|Adverse Event|1|||
156814924|NCT02131662|566071397|FG003|Overall Study|Adverse Event|1|||
156814925|NCT02131662|566071398|FG004|Overall Study|Adverse Event|3|||
156814926|NCT02131662|566071394|FG000|Overall Study|Pregnancy|0|||
156814927|NCT02131662|566071395|FG001|Overall Study|Pregnancy|1|||
156814928|NCT02131662|566071396|FG002|Overall Study|Pregnancy|0|||
156814929|NCT02131662|566071397|FG003|Overall Study|Pregnancy|1|||
156814930|NCT02131662|566071398|FG004|Overall Study|Pregnancy|0|||
156814931|NCT02131662|566071394|FG000|Overall Study|Wish for pregnancy|0|||
156814932|NCT02131662|566071395|FG001|Overall Study|Wish for pregnancy|0|||
156814933|NCT02131662|566071396|FG002|Overall Study|Wish for pregnancy|0|||
156814934|NCT02131662|566071397|FG003|Overall Study|Wish for pregnancy|0|||
156884251|NCT01328444|566334054|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156814935|NCT02131662|566071398|FG004|Overall Study|Wish for pregnancy|1|||
156884252|NCT01328444|566334055|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156814936|NCT02131662|566071394|FG000|Overall Study|Lack of Efficacy|1|||
156814937|NCT02131662|566071395|FG001|Overall Study|Lack of Efficacy|0|||
156814938|NCT02131662|566071396|FG002|Overall Study|Lack of Efficacy|0|||
156814939|NCT02131662|566071397|FG003|Overall Study|Lack of Efficacy|0|||
156814940|NCT02131662|566071398|FG004|Overall Study|Lack of Efficacy|1|||
156814941|NCT02131662|566071394|FG000|Overall Study|Withdrawal by Subject|1|||
156814942|NCT02131662|566071395|FG001|Overall Study|Withdrawal by Subject|5|||
156814943|NCT02131662|566071396|FG002|Overall Study|Withdrawal by Subject|1|||
156814944|NCT02131662|566071397|FG003|Overall Study|Withdrawal by Subject|5|||
156814945|NCT02131662|566071398|FG004|Overall Study|Withdrawal by Subject|6|||
156814946|NCT02131662|566071394|FG000|Overall Study|Lost to Follow-up|1|||
156814947|NCT02131662|566071395|FG001|Overall Study|Lost to Follow-up|3|||
156814948|NCT02131662|566071396|FG002|Overall Study|Lost to Follow-up|0|||
156814949|NCT02131662|566071397|FG003|Overall Study|Lost to Follow-up|9|||
156814950|NCT02131662|566071398|FG004|Overall Study|Lost to Follow-up|0|||
156814951|NCT02131662|566071394|FG000|Overall Study|Not treated|2|||
156814952|NCT02131662|566071395|FG001|Overall Study|Not treated|0|||
156814953|NCT02131662|566071396|FG002|Overall Study|Not treated|2|||
156814954|NCT02131662|566071397|FG003|Overall Study|Not treated|2|||
156814955|NCT02131662|566071398|FG004|Overall Study|Not treated|3|||
156814956|NCT01928433|566071400|FG000|Overall Study|Adverse Event|5|||
156814957|NCT01928433|566071401|FG001|Overall Study|Adverse Event|2|||
156814958|NCT01928433|566071402|FG002|Overall Study|Adverse Event|5|||
156814959|NCT01928433|566071400|FG000|Overall Study|Protocol Violation|0|||
156814960|NCT01928433|566071401|FG001|Overall Study|Protocol Violation|0|||
156814961|NCT01928433|566071402|FG002|Overall Study|Protocol Violation|2|||
156814962|NCT01928433|566071400|FG000|Overall Study|Lack of Efficacy|5|||
156814963|NCT01928433|566071401|FG001|Overall Study|Lack of Efficacy|4|||
156814964|NCT01928433|566071402|FG002|Overall Study|Lack of Efficacy|4|||
156814965|NCT01928433|566071400|FG000|Overall Study|Withdrawal by Subject|0|||
156814966|NCT01928433|566071401|FG001|Overall Study|Withdrawal by Subject|4|||
156814967|NCT01928433|566071402|FG002|Overall Study|Withdrawal by Subject|0|||
156814968|NCT01928433|566071400|FG000|Overall Study|Negative screening urine culture|7|||
156814969|NCT01928433|566071401|FG001|Overall Study|Negative screening urine culture|6|||
156814970|NCT01928433|566071402|FG002|Overall Study|Negative screening urine culture|10|||
156814971|NCT01928433|566071400|FG000|Overall Study|Lost to Follow-up|0|||
156814972|NCT01928433|566071401|FG001|Overall Study|Lost to Follow-up|2|||
156814973|NCT01928433|566071402|FG002|Overall Study|Lost to Follow-up|3|||
156814974|NCT01928433|566071400|FG000|Overall Study|Other reasons|3|||
156814975|NCT01928433|566071401|FG001|Overall Study|Other reasons|3|||
156814976|NCT01928433|566071402|FG002|Overall Study|Other reasons|4|||
156814977|NCT01740687|566071403|FG000|Overall Study|Lost to Follow-up|11|||
156814978|NCT01740687|566071403|FG000|Overall Study|Withdrawal by Subject|2|||
156814979|NCT01740687|566071403|FG000|Overall Study|other reason|22|||
156814980|NCT01740687|566071403|FG000|Overall Study|treatment not received|2|||
156814981|NCT01016132|566071406|FG000|Overall Study|Discomfort|1|||
156814982|NCT01451749|566071409|FG000|Overall Study|Protocol Violation|14|||
156814983|NCT01451749|566071410|FG001|Overall Study|Protocol Violation|7|||
156814984|NCT01451749|566071409|FG000|Overall Study|Lost to Follow-up|15|||
156814985|NCT01451749|566071410|FG001|Overall Study|Lost to Follow-up|5|||
156814986|NCT01451749|566071409|FG000|Overall Study|Meet the exclusion criteria,and|1|||
156814987|NCT01451749|566071410|FG001|Overall Study|Meet the exclusion criteria,and|1|||
156814988|NCT01451749|566071409|FG000|Overall Study|Adverse Event|2|||
156814989|NCT01451749|566071410|FG001|Overall Study|Adverse Event|0|||
156814990|NCT01451749|566071409|FG000|Overall Study|Withdrawal by Subject|0|||
156814991|NCT01451749|566071410|FG001|Overall Study|Withdrawal by Subject|1|||
156814992|NCT00972517|566071411|FG000|Overall Study|Adverse Event|0|||
156814993|NCT00972517|566071412|FG001|Overall Study|Adverse Event|0|||
156814994|NCT00972517|566071413|FG002|Overall Study|Adverse Event|0|||
156814995|NCT00972517|566071414|FG003|Overall Study|Adverse Event|1|||
156814996|NCT00972517|566071415|FG004|Overall Study|Adverse Event|0|||
156814997|NCT00972517|566071416|FG005|Overall Study|Adverse Event|0|||
156814998|NCT00972517|566071411|FG000|Overall Study|Withdrawal by Subject|0|||
156814999|NCT00972517|566071412|FG001|Overall Study|Withdrawal by Subject|1|||
156815000|NCT00972517|566071413|FG002|Overall Study|Withdrawal by Subject|0|||
156815001|NCT00972517|566071414|FG003|Overall Study|Withdrawal by Subject|2|||
156815002|NCT00972517|566071415|FG004|Overall Study|Withdrawal by Subject|1|||
156815003|NCT00972517|566071416|FG005|Overall Study|Withdrawal by Subject|0|||
156815004|NCT02311881|566071417|FG000|Overall Study|Did not meet the study criteria|2|||
156815005|NCT02311881|566071418|FG001|Overall Study|Did not meet the study criteria|2|||
156815006|NCT02311881|566071419|FG002|Overall Study|Did not meet the study criteria|0|||
156815007|NCT02311881|566071417|FG000|Overall Study|Adverse Event|7|||
156815008|NCT02311881|566071418|FG001|Overall Study|Adverse Event|15|||
156815009|NCT02311881|566071419|FG002|Overall Study|Adverse Event|8|||
156815010|NCT02311881|566071417|FG000|Overall Study|Lost to Follow-up|3|||
156815011|NCT02311881|566071418|FG001|Overall Study|Lost to Follow-up|3|||
156884253|NCT01328444|566334056|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
156815012|NCT02311881|566071419|FG002|Overall Study|Lost to Follow-up|2|||
156884254|NCT01328444|566334057|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
157149332|NCT00090285|567292395|FG002|Base Study Follow-up Period|Other|0|||
156815013|NCT02311881|566071417|FG000|Overall Study|Protocol Violation|1|||
156815014|NCT02311881|566071418|FG001|Overall Study|Protocol Violation|2|||
156815015|NCT02311881|566071419|FG002|Overall Study|Protocol Violation|3|||
156815016|NCT02311881|566071417|FG000|Overall Study|Withdrawal of consent|14|||
156815017|NCT02311881|566071418|FG001|Overall Study|Withdrawal of consent|16|||
156815018|NCT02311881|566071419|FG002|Overall Study|Withdrawal of consent|17|||
156815019|NCT02311881|566071417|FG000|Overall Study|Other|0|||
156815020|NCT02311881|566071418|FG001|Overall Study|Other|0|||
156815021|NCT02311881|566071419|FG002|Overall Study|Other|1|||
156815022|NCT02311881|566071417|FG000|Overall Study|Lack of Efficacy|1|||
156815023|NCT02311881|566071418|FG001|Overall Study|Lack of Efficacy|2|||
156815024|NCT02311881|566071419|FG002|Overall Study|Lack of Efficacy|0|||
156815025|NCT02311881|566071417|FG000|Overall Study|Subject has border line pregnancy test|1|||
156815026|NCT02311881|566071418|FG001|Overall Study|Subject has border line pregnancy test|0|||
156815027|NCT02311881|566071419|FG002|Overall Study|Subject has border line pregnancy test|0|||
156815028|NCT02311881|566071417|FG000|Overall Study|Withdrawal by Subject|3|||
156815029|NCT02311881|566071418|FG001|Overall Study|Withdrawal by Subject|1|||
156815030|NCT02311881|566071419|FG002|Overall Study|Withdrawal by Subject|4|||
156815031|NCT02311881|566071417|FG000|Overall Study|Sponsor Decision|1|||
156815032|NCT02311881|566071418|FG001|Overall Study|Sponsor Decision|1|||
156815033|NCT02311881|566071419|FG002|Overall Study|Sponsor Decision|1|||
156815034|NCT02311881|566071417|FG000|Overall Study|Protocol Deviation|1|||
156815035|NCT02311881|566071418|FG001|Overall Study|Protocol Deviation|0|||
156815036|NCT02311881|566071419|FG002|Overall Study|Protocol Deviation|0|||
156815037|NCT02311881|566071417|FG000|Overall Study|Non-Compliance|1|||
156815038|NCT02311881|566071418|FG001|Overall Study|Non-Compliance|0|||
156815039|NCT02311881|566071419|FG002|Overall Study|Non-Compliance|2|||
156815040|NCT02311881|566071417|FG000|Overall Study|Physician Decision|0|||
156815041|NCT02311881|566071418|FG001|Overall Study|Physician Decision|0|||
156815042|NCT02311881|566071419|FG002|Overall Study|Physician Decision|1|||
156815043|NCT02311881|566071417|FG000|Overall Study|Medical Monitor Discretion|0|||
156815044|NCT02311881|566071418|FG001|Overall Study|Medical Monitor Discretion|0|||
156815045|NCT02311881|566071419|FG002|Overall Study|Medical Monitor Discretion|1|||
156815046|NCT02311881|566071417|FG000|Overall Study|Participant taking another medication|0|||
156815047|NCT02311881|566071418|FG001|Overall Study|Participant taking another medication|0|||
156815048|NCT02311881|566071419|FG002|Overall Study|Participant taking another medication|1|||
156815049|NCT02311881|566071417|FG000|Overall Study|Serious Adverse Event|0|||
156815050|NCT02311881|566071418|FG001|Overall Study|Serious Adverse Event|1|||
156815051|NCT02311881|566071419|FG002|Overall Study|Serious Adverse Event|0|||
156815052|NCT00556439|566071423|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
156815053|NCT00556439|566071424|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
156815054|NCT00556439|566071425|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
156815055|NCT00556439|566071426|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
156815056|NCT00556439|566071423|FG000|Study Entry to Week 12|Physician Decision|1|||
156815057|NCT00556439|566071424|FG001|Study Entry to Week 12|Physician Decision|0|||
156815058|NCT00556439|566071425|FG002|Study Entry to Week 12|Physician Decision|0|||
156815059|NCT00556439|566071426|FG003|Study Entry to Week 12|Physician Decision|0|||
156815060|NCT00556439|566071423|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
156815061|NCT00556439|566071424|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
157149333|NCT00090285|567292396|FG003|Base Study Follow-up Period|Other|0|||
157149334|NCT00090285|567292397|FG004|Base Study Follow-up Period|Other|0|||
156815062|NCT00556439|566071425|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
156815063|NCT00556439|566071426|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
156815064|NCT00556439|566071423|FG000|Study Entry to Week 12|Recurrent infection|1|||
156815065|NCT00556439|566071424|FG001|Study Entry to Week 12|Recurrent infection|0|||
156815066|NCT00556439|566071425|FG002|Study Entry to Week 12|Recurrent infection|0|||
156815067|NCT00556439|566071426|FG003|Study Entry to Week 12|Recurrent infection|0|||
156815068|NCT00556439|566071423|FG000|Study Entry to Week 12|Malignancy|0|||
156815069|NCT00556439|566071424|FG001|Study Entry to Week 12|Malignancy|0|||
156815070|NCT00556439|566071425|FG002|Study Entry to Week 12|Malignancy|1|||
156815071|NCT00556439|566071426|FG003|Study Entry to Week 12|Malignancy|0|||
156815072|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
156815073|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
156815074|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
156815075|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
157149335|NCT00090285|567292398|FG005|Base Study Follow-up Period|Other|0|||
157149336|NCT00090285|567292393|FG000|Base Study Follow-up Period|Protocol Violation|1|||
157149337|NCT00090285|567292394|FG001|Base Study Follow-up Period|Protocol Violation|0|||
157149338|NCT00090285|567292395|FG002|Base Study Follow-up Period|Protocol Violation|0|||
156815076|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
156815077|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
156815078|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
157149339|NCT00090285|567292396|FG003|Base Study Follow-up Period|Protocol Violation|0|||
156815079|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
156815080|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
156815081|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
156815082|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
156815083|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
157149340|NCT00090285|567292397|FG004|Base Study Follow-up Period|Protocol Violation|0|||
156815084|NCT00556439|566071423|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
156815085|NCT00556439|566071424|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815086|NCT00556439|566071425|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815087|NCT00556439|566071426|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
156815088|NCT02100423|566071428|FG000|Overall Study|Death|1|||
156815089|NCT02100423|566071428|FG000|Overall Study|Withdrawal by Subject|3|||
156815090|NCT02100423|566071428|FG000|Overall Study|Adverse Event|1|||
156815091|NCT02100423|566071428|FG000|Overall Study|Physician Decision|1|||
156815092|NCT02949024|566071429|FG000|Overall Study|Withdrawal by Subject|0|||
156815093|NCT02949024|566071430|FG001|Overall Study|Withdrawal by Subject|1|||
156815094|NCT00854724|566072877|FG000|First Intervention|Withdrawal by Subject|1|||
156815095|NCT00854724|566072878|FG001|First Intervention|Withdrawal by Subject|1|||
156815096|NCT00854724|566072877|FG000|Washout|Protocol Violation|1|||
156815097|NCT00854724|566072878|FG001|Washout|Protocol Violation|0|||
156815098|NCT00854724|566072877|FG000|Washout|Withdrawal by Subject|0|||
156815099|NCT00854724|566072878|FG001|Washout|Withdrawal by Subject|1|||
156815100|NCT00854724|566072877|FG000|Second Intervention|Protocol Violation|1|||
156815101|NCT00854724|566072878|FG001|Second Intervention|Protocol Violation|0|||
156815102|NCT00854724|566072877|FG000|Second Intervention|Physician Decision|0|||
156815103|NCT00854724|566072878|FG001|Second Intervention|Physician Decision|1|||
156815104|NCT00933608|566072880|FG000|Overall Study|Adverse Event|4|||
156815105|NCT00933608|566072881|FG001|Overall Study|Adverse Event|2|||
156815106|NCT00933608|566072880|FG000|Overall Study|Physician Decision|1|||
156815107|NCT00933608|566072881|FG001|Overall Study|Physician Decision|0|||
156815108|NCT00336284|566072884|FG000|Overall Study|Death|52|||
156815109|NCT00336284|566072885|FG001|Overall Study|Death|26|||
156815110|NCT00336284|566072884|FG000|Overall Study|Lost to Follow-up|82|||
156815111|NCT00336284|566072885|FG001|Overall Study|Lost to Follow-up|61|||
156815112|NCT00336284|566072884|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
156815113|NCT00336284|566072885|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
156815114|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
156815115|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
156815116|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
156815117|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
156815118|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
156815119|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
156815120|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
156815121|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
156815122|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
156815123|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
156815124|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
156815125|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
156815126|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
156815127|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
156815128|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
156815129|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
156815130|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
156815131|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
156815132|NCT03308968|566072890|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
156815133|NCT03308968|566072891|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
156815134|NCT03308968|566072892|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
156815135|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
156884255|NCT03241368|566334062|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
156884256|NCT03241368|566334062|FG000|Overall Study|Lost to Follow-up|1|||
157149341|NCT00090285|567292398|FG005|Base Study Follow-up Period|Protocol Violation|0|||
157149342|NCT00090285|567292393|FG000|Base Study Follow-up Period|Uncooperative|3|||
157149343|NCT00090285|567292394|FG001|Base Study Follow-up Period|Uncooperative|4|||
157149344|NCT00090285|567292395|FG002|Base Study Follow-up Period|Uncooperative|0|||
157149345|NCT00090285|567292396|FG003|Base Study Follow-up Period|Uncooperative|0|||
157149346|NCT00090285|567292397|FG004|Base Study Follow-up Period|Uncooperative|0|||
157149347|NCT00090285|567292398|FG005|Base Study Follow-up Period|Uncooperative|0|||
157149348|NCT00090285|567292393|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
157149349|NCT00090285|567292394|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
157149350|NCT00090285|567292395|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
157149351|NCT00090285|567292396|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
157149352|NCT00090285|567292397|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
157149353|NCT00090285|567292398|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
157149354|NCT00090285|567292393|FG000|Extension 1|Adverse Event|0|||
157149355|NCT00090285|567292394|FG001|Extension 1|Adverse Event|0|||
156815136|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
156815137|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
157149356|NCT00090285|567292395|FG002|Extension 1|Adverse Event|2|||
157149357|NCT00090285|567292396|FG003|Extension 1|Adverse Event|0|||
156815138|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
156815139|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
156815140|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
156815141|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
156815142|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
156815143|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
156815144|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
156815145|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
156815146|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
156815147|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
156815148|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
156815149|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
156815150|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
156815151|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
156815152|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
156815153|NCT03308968|566072890|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
156815154|NCT03308968|566072891|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
156815155|NCT03308968|566072892|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
156815156|NCT01521923|566072896|FG000|Overall Study|AE, serious fatal|1|||
156815157|NCT01521923|566072897|FG001|Overall Study|AE, serious fatal|0|||
157149358|NCT00090285|567292397|FG004|Extension 1|Adverse Event|0|||
157149359|NCT00090285|567292398|FG005|Extension 1|Adverse Event|0|||
156815158|NCT01521923|566072898|FG002|Overall Study|AE, serious fatal|0|||
156815159|NCT01521923|566072899|FG003|Overall Study|AE, serious fatal|0|||
156815160|NCT01521923|566072896|FG000|Overall Study|SAE, non-fatal|0|||
156815161|NCT01521923|566072897|FG001|Overall Study|SAE, non-fatal|2|||
156815162|NCT01521923|566072898|FG002|Overall Study|SAE, non-fatal|2|||
156815163|NCT01521923|566072899|FG003|Overall Study|SAE, non-fatal|0|||
156815164|NCT01521923|566072896|FG000|Overall Study|AE, non-serious, non-fatal|1|||
156815165|NCT01521923|566072897|FG001|Overall Study|AE, non-serious, non-fatal|3|||
156815166|NCT01521923|566072898|FG002|Overall Study|AE, non-serious, non-fatal|6|||
156815167|NCT01521923|566072899|FG003|Overall Study|AE, non-serious, non-fatal|2|||
156815168|NCT01521923|566072896|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
156815169|NCT01521923|566072897|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
157149360|NCT00090285|567292393|FG000|Extension 1|Lost to Follow-up|0|||
157149361|NCT00090285|567292394|FG001|Extension 1|Lost to Follow-up|0|||
157149362|NCT00090285|567292395|FG002|Extension 1|Lost to Follow-up|35|||
157149363|NCT00090285|567292396|FG003|Extension 1|Lost to Follow-up|0|||
156815170|NCT01521923|566072898|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
156815171|NCT01521923|566072899|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
156815172|NCT01521923|566072896|FG000|Overall Study|Lack of Efficacy|1|||
156815173|NCT01521923|566072897|FG001|Overall Study|Lack of Efficacy|1|||
156815174|NCT01521923|566072898|FG002|Overall Study|Lack of Efficacy|0|||
156815175|NCT01521923|566072899|FG003|Overall Study|Lack of Efficacy|0|||
156815176|NCT01521923|566072896|FG000|Overall Study|Protocol Violation|0|||
156815177|NCT01521923|566072897|FG001|Overall Study|Protocol Violation|0|||
156815178|NCT01521923|566072898|FG002|Overall Study|Protocol Violation|1|||
156815179|NCT01521923|566072899|FG003|Overall Study|Protocol Violation|0|||
156815180|NCT01521923|566072896|FG000|Overall Study|Lost to Follow-up|1|||
156815181|NCT01521923|566072897|FG001|Overall Study|Lost to Follow-up|0|||
156815182|NCT01521923|566072898|FG002|Overall Study|Lost to Follow-up|2|||
156815183|NCT01521923|566072899|FG003|Overall Study|Lost to Follow-up|1|||
156815184|NCT01521923|566072896|FG000|Overall Study|Withdrawal by Subject|1|||
156815185|NCT01521923|566072897|FG001|Overall Study|Withdrawal by Subject|1|||
156815186|NCT01521923|566072898|FG002|Overall Study|Withdrawal by Subject|1|||
156815187|NCT01521923|566072899|FG003|Overall Study|Withdrawal by Subject|2|||
156815188|NCT01521923|566072896|FG000|Overall Study|Other|2|||
156815189|NCT01521923|566072897|FG001|Overall Study|Other|1|||
156815190|NCT01521923|566072898|FG002|Overall Study|Other|3|||
156815191|NCT01521923|566072899|FG003|Overall Study|Other|6|||
156815192|NCT01521923|566072896|FG000|Overall Study|AE, captured in Period 1|0|||
156815193|NCT01521923|566072897|FG001|Overall Study|AE, captured in Period 1|1|||
156815194|NCT01521923|566072898|FG002|Overall Study|AE, captured in Period 1|0|||
156815195|NCT01521923|566072899|FG003|Overall Study|AE, captured in Period 1|1|||
157022532|NCT04624633|566835249|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
156815196|NCT02836717|566072916|FG000|Test Phase|Lack of Efficacy|14|||
156815197|NCT02836717|566072917|FG001|Test Phase|Lack of Efficacy|8|||
156815198|NCT02836717|566072918|FG002|Test Phase|Lack of Efficacy|0|||
156815199|NCT02836717|566072916|FG000|Study Phase|Adverse Event|2|||
156815200|NCT02836717|566072917|FG001|Study Phase|Adverse Event|0|||
156815201|NCT02836717|566072918|FG002|Study Phase|Adverse Event|0|||
157022533|NCT04624633|566835248|FG000|Overall Study|Death|1|||
156815202|NCT02836717|566072916|FG000|Study Phase|Lack of Efficacy|8|||
156815203|NCT02836717|566072917|FG001|Study Phase|Lack of Efficacy|6|||
157149364|NCT00090285|567292397|FG004|Extension 1|Lost to Follow-up|0|||
157149365|NCT00090285|567292398|FG005|Extension 1|Lost to Follow-up|0|||
157149366|NCT00090285|567292393|FG000|Extension 1|Withdrawal by Subject|0|||
157149367|NCT00090285|567292394|FG001|Extension 1|Withdrawal by Subject|0|||
157149368|NCT00090285|567292395|FG002|Extension 1|Withdrawal by Subject|13|||
156815204|NCT02836717|566072918|FG002|Study Phase|Lack of Efficacy|1|||
156815205|NCT02836717|566072916|FG000|Study Phase|Withdrawal by Subject|1|||
156815206|NCT02836717|566072917|FG001|Study Phase|Withdrawal by Subject|0|||
156815207|NCT02836717|566072918|FG002|Study Phase|Withdrawal by Subject|0|||
156815208|NCT02836717|566072916|FG000|Study Phase|Death|1|||
156815209|NCT02836717|566072917|FG001|Study Phase|Death|0|||
156815210|NCT02836717|566072918|FG002|Study Phase|Death|0|||
156815211|NCT02836717|566072916|FG000|Study Phase|abdominal surgeries|2|||
156815212|NCT02836717|566072917|FG001|Study Phase|abdominal surgeries|1|||
156815213|NCT02836717|566072918|FG002|Study Phase|abdominal surgeries|0|||
156815214|NCT03226249|566072919|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
156815215|NCT03226249|566072919|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
156815216|NCT03226249|566072919|FG000|Survival Follow-up|Patients still in follow-up.|30|||
156815217|NCT00588237|566072922|FG000|Overall Study|Evaluable for toxicity only|3|||
156815218|NCT00588237|566072922|FG000|Overall Study|Patien not treated|1|||
156815219|NCT01703091|566072928|FG000|Overall Study|Adverse Event|5|||
156815220|NCT01703091|566072929|FG001|Overall Study|Adverse Event|3|||
156815221|NCT01703091|566072928|FG000|Overall Study|Physician Decision|2|||
156815222|NCT01703091|566072929|FG001|Overall Study|Physician Decision|1|||
156815223|NCT01703091|566072928|FG000|Overall Study|Withdrawal by Subject|1|||
156815224|NCT01703091|566072929|FG001|Overall Study|Withdrawal by Subject|0|||
156815225|NCT01703091|566072928|FG000|Overall Study|Sponsor Decision|1|||
156815226|NCT01703091|566072929|FG001|Overall Study|Sponsor Decision|0|||
156815227|NCT00022763|566072940|FG000|Overall Study|Adverse Event|1|||
156815228|NCT00022763|566072941|FG001|Overall Study|Adverse Event|2|||
156815229|NCT00022763|566072940|FG000|Overall Study|Injection Site Reactions|0|||
156815230|NCT00022763|566072941|FG001|Overall Study|Injection Site Reactions|2|||
156815231|NCT00022763|566072940|FG000|Overall Study|Death|0|||
156815232|NCT00022763|566072941|FG001|Overall Study|Death|1|||
156815233|NCT00022763|566072940|FG000|Overall Study|Lost to Follow-up|0|||
156815234|NCT00022763|566072941|FG001|Overall Study|Lost to Follow-up|3|||
156815235|NCT00022763|566072940|FG000|Overall Study|Withdrawal by Subject|4|||
156815236|NCT00022763|566072941|FG001|Overall Study|Withdrawal by Subject|7|||
156815237|NCT00022763|566072940|FG000|Overall Study|Insufficient Therapy|1|||
156815238|NCT00022763|566072941|FG001|Overall Study|Insufficient Therapy|0|||
156815239|NCT00022763|566072940|FG000|Overall Study|Admin|3|||
156815240|NCT00022763|566072941|FG001|Overall Study|Admin|2|||
156815241|NCT01524224|566072944|FG000|Overall Study|Progressive Disease|1|||
156815242|NCT01524224|566072945|FG001|Overall Study|Progressive Disease|0|||
156815243|NCT01524224|566072946|FG002|Overall Study|Progressive Disease|2|||
156815244|NCT01524224|566072947|FG003|Overall Study|Progressive Disease|1|||
156815245|NCT01524224|566072948|FG004|Overall Study|Progressive Disease|2|||
156815246|NCT01524224|566072949|FG005|Overall Study|Progressive Disease|1|||
156815247|NCT01524224|566072950|FG006|Overall Study|Progressive Disease|1|||
156815248|NCT01524224|566072951|FG007|Overall Study|Progressive Disease|5|||
156815249|NCT01524224|566072944|FG000|Overall Study|Withdrawal by Subject|2|||
156815250|NCT01524224|566072945|FG001|Overall Study|Withdrawal by Subject|0|||
156815251|NCT01524224|566072946|FG002|Overall Study|Withdrawal by Subject|0|||
156815252|NCT01524224|566072947|FG003|Overall Study|Withdrawal by Subject|0|||
156815253|NCT01524224|566072948|FG004|Overall Study|Withdrawal by Subject|0|||
156815254|NCT01524224|566072949|FG005|Overall Study|Withdrawal by Subject|0|||
156815255|NCT01524224|566072950|FG006|Overall Study|Withdrawal by Subject|2|||
156815256|NCT01524224|566072951|FG007|Overall Study|Withdrawal by Subject|0|||
156815257|NCT01524224|566072944|FG000|Overall Study|Adverse Event|0|||
156815258|NCT01524224|566072945|FG001|Overall Study|Adverse Event|1|||
157149369|NCT00090285|567292396|FG003|Extension 1|Withdrawal by Subject|1|||
157149370|NCT00090285|567292397|FG004|Extension 1|Withdrawal by Subject|0|||
157149371|NCT00090285|567292398|FG005|Extension 1|Withdrawal by Subject|0|||
156815259|NCT01524224|566072946|FG002|Overall Study|Adverse Event|0|||
156815260|NCT01524224|566072947|FG003|Overall Study|Adverse Event|0|||
156815261|NCT01524224|566072948|FG004|Overall Study|Adverse Event|0|||
156815262|NCT01524224|566072949|FG005|Overall Study|Adverse Event|1|||
156815263|NCT01524224|566072950|FG006|Overall Study|Adverse Event|0|||
156815264|NCT01524224|566072951|FG007|Overall Study|Adverse Event|0|||
156815265|NCT01524224|566072944|FG000|Overall Study|Physician Decision|0|||
156815266|NCT01524224|566072945|FG001|Overall Study|Physician Decision|0|||
156815267|NCT01524224|566072946|FG002|Overall Study|Physician Decision|0|||
156815268|NCT01524224|566072947|FG003|Overall Study|Physician Decision|1|||
156815269|NCT01524224|566072948|FG004|Overall Study|Physician Decision|1|||
156815270|NCT01524224|566072949|FG005|Overall Study|Physician Decision|0|||
156815271|NCT01524224|566072950|FG006|Overall Study|Physician Decision|0|||
156815272|NCT01524224|566072951|FG007|Overall Study|Physician Decision|1|||
156815273|NCT01524224|566072944|FG000|Overall Study|Sponsor Decision|0|||
156815274|NCT01524224|566072945|FG001|Overall Study|Sponsor Decision|0|||
156815275|NCT01524224|566072946|FG002|Overall Study|Sponsor Decision|0|||
157149372|NCT00090285|567292393|FG000|Extension 1|Other|0|||
157149373|NCT00090285|567292394|FG001|Extension 1|Other|0|||
156815276|NCT01524224|566072947|FG003|Overall Study|Sponsor Decision|0|||
156815277|NCT01524224|566072948|FG004|Overall Study|Sponsor Decision|1|||
156815278|NCT01524224|566072949|FG005|Overall Study|Sponsor Decision|0|||
156815279|NCT01524224|566072950|FG006|Overall Study|Sponsor Decision|0|||
156815280|NCT01524224|566072951|FG007|Overall Study|Sponsor Decision|0|||
156815281|NCT04283656|566072952|FG000|Overall Study|Adverse Event|1|||
156815282|NCT04283656|566072953|FG001|Overall Study|Adverse Event|0|||
156815283|NCT04283656|566072952|FG000|Overall Study|Lost to Follow-up|0|||
156815284|NCT04283656|566072953|FG001|Overall Study|Lost to Follow-up|1|||
156815285|NCT00803361|566072954|FG000|Overall Study|Adverse Event|13|||
156815286|NCT00803361|566072955|FG001|Overall Study|Adverse Event|3|||
156815287|NCT00803361|566072954|FG000|Overall Study|Lack of Efficacy|4|||
156815288|NCT00803361|566072955|FG001|Overall Study|Lack of Efficacy|13|||
156815289|NCT00803361|566072954|FG000|Overall Study|Lost to Follow-up|1|||
157223284|NCT00814320|567563718|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
157223285|NCT00814320|567563717|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
157223286|NCT00814320|567563718|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
157223287|NCT00814320|567563717|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
157223288|NCT00814320|567563718|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
157223289|NCT00814320|567563717|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
157223290|NCT00814320|567563718|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
157223291|NCT00814320|567563717|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
157223292|NCT00814320|567563718|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
157223293|NCT00814320|567563717|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
157223294|NCT00814320|567563718|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
157223295|NCT00814320|567563717|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
157223296|NCT00814320|567563718|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
157223297|NCT00814320|567563717|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
157223298|NCT00814320|567563718|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
157223299|NCT00491504|567563719|FG000|Overall Study|Adverse Event|0|||
157223300|NCT00491504|567563720|FG001|Overall Study|Adverse Event|1|||
157223301|NCT00491504|567563721|FG002|Overall Study|Adverse Event|0|||
157223302|NCT00491504|567563722|FG003|Overall Study|Adverse Event|0|||
157223303|NCT00491504|567563719|FG000|Overall Study|Withdrawal by Subject|0|||
157223304|NCT00491504|567563720|FG001|Overall Study|Withdrawal by Subject|0|||
157223305|NCT00491504|567563721|FG002|Overall Study|Withdrawal by Subject|1|||
157223306|NCT00491504|567563722|FG003|Overall Study|Withdrawal by Subject|2|||
157223307|NCT00491504|567563719|FG000|Overall Study|Protocol Violation|0|||
157223308|NCT00491504|567563720|FG001|Overall Study|Protocol Violation|0|||
156815290|NCT00803361|566072955|FG001|Overall Study|Lost to Follow-up|2|||
156815291|NCT00803361|566072954|FG000|Overall Study|Physician Decision|1|||
156815292|NCT00803361|566072955|FG001|Overall Study|Physician Decision|0|||
156815293|NCT00803361|566072954|FG000|Overall Study|Protocol Violation|2|||
156815294|NCT00803361|566072955|FG001|Overall Study|Protocol Violation|4|||
156815295|NCT00803361|566072954|FG000|Overall Study|Withdrawal by Subject|5|||
156815296|NCT00803361|566072955|FG001|Overall Study|Withdrawal by Subject|6|||
156815297|NCT04445519|566072956|FG000|Overall Study|Due to adaptive design|3|||
156815298|NCT04445519|566072957|FG001|Overall Study|Due to adaptive design|0|||
156815299|NCT04445519|566072958|FG002|Overall Study|Due to adaptive design|0|||
156815300|NCT04445519|566072956|FG000|Overall Study|Lost to Follow-up|0|||
156815301|NCT04445519|566072957|FG001|Overall Study|Lost to Follow-up|1|||
156884257|NCT03241368|566334062|FG000|Overall Study|Physician Decision|6|||
156884258|NCT03241368|566334062|FG000|Overall Study|Withdrawal by Subject|6|||
157149374|NCT00090285|567292395|FG002|Extension 1|Other|4|||
157149375|NCT00090285|567292396|FG003|Extension 1|Other|0|||
157149376|NCT00090285|567292397|FG004|Extension 1|Other|0|||
157149377|NCT00090285|567292398|FG005|Extension 1|Other|0|||
157149378|NCT00090285|567292393|FG000|Extension 1|Moved|0|||
157149379|NCT00090285|567292394|FG001|Extension 1|Moved|0|||
157149380|NCT00090285|567292395|FG002|Extension 1|Moved|3|||
157149381|NCT00090285|567292396|FG003|Extension 1|Moved|0|||
157149382|NCT00090285|567292397|FG004|Extension 1|Moved|0|||
157149383|NCT00090285|567292398|FG005|Extension 1|Moved|0|||
157149384|NCT00090285|567292393|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
157149385|NCT00090285|567292394|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
157223309|NCT00491504|567563721|FG002|Overall Study|Protocol Violation|3|||
156815302|NCT04445519|566072958|FG002|Overall Study|Lost to Follow-up|4|||
156815303|NCT04445519|566072956|FG000|Overall Study|Sponsor or IRB Decision|0|||
156815304|NCT04445519|566072957|FG001|Overall Study|Sponsor or IRB Decision|1|||
156815305|NCT04445519|566072958|FG002|Overall Study|Sponsor or IRB Decision|2|||
156815306|NCT04445519|566072956|FG000|Overall Study|Withdrawal by Subject|0|||
156815307|NCT04445519|566072957|FG001|Overall Study|Withdrawal by Subject|3|||
156815308|NCT04445519|566072958|FG002|Overall Study|Withdrawal by Subject|3|||
157149386|NCT00090285|567292395|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
157149387|NCT00090285|567292396|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
157149388|NCT00090285|567292397|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
157149389|NCT00090285|567292398|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
156815309|NCT04445519|566072956|FG000|Overall Study|Adverse Event|0|||
156815310|NCT04445519|566072957|FG001|Overall Study|Adverse Event|8|||
156815311|NCT04445519|566072958|FG002|Overall Study|Adverse Event|6|||
156815312|NCT04445519|566072956|FG000|Overall Study|Other Reason|0|||
156815313|NCT04445519|566072957|FG001|Overall Study|Other Reason|1|||
156815314|NCT04445519|566072958|FG002|Overall Study|Other Reason|1|||
156815315|NCT04445519|566072956|FG000|Overall Study|Protocol Violation|0|||
156815316|NCT04445519|566072957|FG001|Overall Study|Protocol Violation|0|||
156815317|NCT04445519|566072958|FG002|Overall Study|Protocol Violation|1|||
156815318|NCT02858440|566072963|FG000|Overall Study|Lost to Follow-up|3|||
156815319|NCT02858440|566072963|FG000|Overall Study|Protocol Violation|2|||
156815320|NCT02858440|566072963|FG000|Overall Study|Consent withdrawal|3|||
156815321|NCT02858440|566072963|FG000|Overall Study|Migrated/moved from study area|4|||
156815322|NCT04660552|566072964|FG000|Overall Study|Withdrawal by Subject|3|||
156815323|NCT04660552|566072965|FG001|Overall Study|Withdrawal by Subject|1|||
156815324|NCT00470262|566072966|FG000|Overall Study|Withdrawal by Subject|2|||
156815325|NCT00470262|566072967|FG001|Overall Study|Withdrawal by Subject|0|||
156815326|NCT01001767|566072970|FG000|Overall Study|no baseline study performed|1|||
156815327|NCT01001767|566072971|FG001|Overall Study|no baseline study performed|0|||
156815328|NCT01001767|566072970|FG000|Overall Study|Protocol Violation|1|||
156815329|NCT01001767|566072971|FG001|Overall Study|Protocol Violation|0|||
156815330|NCT01001767|566072970|FG000|Overall Study|Lost to Follow-up|1|||
156815331|NCT01001767|566072971|FG001|Overall Study|Lost to Follow-up|0|||
156815332|NCT01001767|566072970|FG000|Overall Study|Physician Decision|1|||
156815333|NCT01001767|566072971|FG001|Overall Study|Physician Decision|0|||
156815334|NCT01107392|566072972|FG000|Overall Study|Adverse Event|2|||
156815335|NCT01107392|566072973|FG001|Overall Study|Adverse Event|0|||
156815336|NCT01107392|566072972|FG000|Overall Study|Personal Reasons|2|||
156815337|NCT01107392|566072973|FG001|Overall Study|Personal Reasons|3|||
156815338|NCT01107392|566072972|FG000|Overall Study|Administrative decision|1|||
156815339|NCT01107392|566072973|FG001|Overall Study|Administrative decision|0|||
156815340|NCT02584452|566072974|FG000|Overall Study|Physician Decision|1|||
156815341|NCT02584452|566072975|FG001|Overall Study|Physician Decision|1|||
156815342|NCT02584452|566072974|FG000|Overall Study|Lost to Follow-up|1|||
156815343|NCT02584452|566072975|FG001|Overall Study|Lost to Follow-up|1|||
156815344|NCT00851552|566072976|FG000|Overall Study|Death|2|||
156815345|NCT00851552|566072976|FG000|Overall Study|Adverse Event|1|||
156815346|NCT00851552|566072976|FG000|Overall Study|Disease Progression|4|||
156815347|NCT00177294|566072977|FG000|Overall Study|Withdrawal by Subject|7|||
156815348|NCT00177294|566072978|FG001|Overall Study|Withdrawal by Subject|5|||
156815349|NCT02998671|566072979|FG000|Period 1|Study Terminated By Sponsor|2|||
156815350|NCT02998671|566072980|FG001|Period 1|Study Terminated By Sponsor|1|||
156815351|NCT02998671|566072981|FG002|Period 1|Study Terminated By Sponsor|0|||
156815352|NCT02998671|566072982|FG003|Period 1|Study Terminated By Sponsor|0|||
156815353|NCT02998671|566072983|FG004|Period 1|Study Terminated By Sponsor|1|||
156815354|NCT02998671|566072979|FG000|Period 1|Withdrawal by Subject|1|||
156815355|NCT02998671|566072980|FG001|Period 1|Withdrawal by Subject|2|||
156815356|NCT02998671|566072981|FG002|Period 1|Withdrawal by Subject|0|||
156815357|NCT02998671|566072982|FG003|Period 1|Withdrawal by Subject|0|||
156815358|NCT02998671|566072983|FG004|Period 1|Withdrawal by Subject|2|||
156815359|NCT02998671|566072979|FG000|Period 1|Pregnancy|1|||
156815360|NCT02998671|566072980|FG001|Period 1|Pregnancy|0|||
156815361|NCT02998671|566072981|FG002|Period 1|Pregnancy|0|||
156815362|NCT02998671|566072982|FG003|Period 1|Pregnancy|0|||
156815363|NCT02998671|566072983|FG004|Period 1|Pregnancy|0|||
156815364|NCT02998671|566072979|FG000|Period 1|Adverse Event|0|||
156815365|NCT02998671|566072980|FG001|Period 1|Adverse Event|0|||
156815366|NCT02998671|566072981|FG002|Period 1|Adverse Event|0|||
156815367|NCT02998671|566072982|FG003|Period 1|Adverse Event|0|||
156815368|NCT02998671|566072983|FG004|Period 1|Adverse Event|1|||
157149390|NCT00090285|567292393|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
156815369|NCT02998671|566072979|FG000|Period 2|Adverse Event|0|||
156815370|NCT02998671|566072980|FG001|Period 2|Adverse Event|1|||
156815371|NCT02998671|566072981|FG002|Period 2|Adverse Event|0|||
156815372|NCT02998671|566072982|FG003|Period 2|Adverse Event|0|||
156815373|NCT02998671|566072983|FG004|Period 2|Adverse Event|0|||
156815374|NCT02998671|566072979|FG000|Period 2|Study Terminated By Sponsor|3|||
156815375|NCT02998671|566072980|FG001|Period 2|Study Terminated By Sponsor|5|||
156815376|NCT02998671|566072981|FG002|Period 2|Study Terminated By Sponsor|1|||
156815377|NCT02998671|566072982|FG003|Period 2|Study Terminated By Sponsor|3|||
156815378|NCT02998671|566072983|FG004|Period 2|Study Terminated By Sponsor|0|||
156815379|NCT02998671|566072979|FG000|Period 2|Withdrawal by Subject|0|||
157149391|NCT00090285|567292394|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
157149392|NCT00090285|567292395|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
157149393|NCT00090285|567292396|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
157149394|NCT00090285|567292397|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
157149395|NCT00090285|567292398|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
157149396|NCT00090285|567292393|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
157149397|NCT00090285|567292394|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
156815380|NCT02998671|566072980|FG001|Period 2|Withdrawal by Subject|1|||
156815381|NCT02998671|566072981|FG002|Period 2|Withdrawal by Subject|0|||
156815382|NCT02998671|566072982|FG003|Period 2|Withdrawal by Subject|0|||
156815383|NCT02998671|566072983|FG004|Period 2|Withdrawal by Subject|0|||
156815384|NCT02998671|566072979|FG000|Period 2|Lost to Follow-up|0|||
156815385|NCT02998671|566072980|FG001|Period 2|Lost to Follow-up|0|||
156815386|NCT02998671|566072981|FG002|Period 2|Lost to Follow-up|0|||
156815387|NCT02998671|566072982|FG003|Period 2|Lost to Follow-up|1|||
156815388|NCT02998671|566072983|FG004|Period 2|Lost to Follow-up|0|||
156815389|NCT01558596|566072984|FG000|Overall Study|Withdrawal by Subject|1|||
156815390|NCT01558596|566072985|FG001|Overall Study|Withdrawal by Subject|0|||
156815391|NCT01558596|566072984|FG000|Overall Study|surgery elsewhere or cancelled|1|||
156815392|NCT01558596|566072985|FG001|Overall Study|surgery elsewhere or cancelled|1|||
156815393|NCT01558596|566072984|FG000|Overall Study|Protocol Violation|1|||
156815394|NCT01558596|566072985|FG001|Overall Study|Protocol Violation|0|||
156815395|NCT02038946|566072987|FG000|Overall Study|Death|5|||
156815396|NCT02038946|566072987|FG000|Overall Study|Withdrawal by Subject|3|||
156815397|NCT02038946|566072987|FG000|Overall Study|Lost to Follow-up|2|||
156815398|NCT02038946|566072987|FG000|Overall Study|Other reasons|2|||
156815399|NCT02473471|566072990|FG000|Overall Study|poor oral hygiene|2|||
156815400|NCT02473471|566072990|FG000|Overall Study|Lost to Follow-up|1|||
156815401|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
156815402|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
156815403|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
156815404|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
156815405|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
156815406|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
156815407|NCT00191945|566072994|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
156815408|NCT00191945|566072995|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
156815409|NCT02063984|566072997|FG000|Overall Study|Lost to Follow-up|6|||
156815410|NCT02063984|566072998|FG001|Overall Study|Lost to Follow-up|5|||
156815411|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
156815412|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
156815413|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
156815414|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
157149398|NCT00090285|567292395|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
157149399|NCT00090285|567292396|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
157149400|NCT00090285|567292397|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
157149401|NCT00090285|567292398|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
157149402|NCT00090285|567292393|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
157149403|NCT00090285|567292394|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
157149404|NCT00090285|567292395|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
157149405|NCT00090285|567292396|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
157149406|NCT00090285|567292397|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
157149407|NCT00090285|567292398|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
157149408|NCT00907478|567292401|FG000|Overall Study|Ineligibility determined|0|||
157149409|NCT00907478|567292402|FG001|Overall Study|Ineligibility determined|0|||
157149410|NCT00907478|567292403|FG002|Overall Study|Ineligibility determined|1|||
157149411|NCT00907478|567292401|FG000|Overall Study|Noncompliance|0|||
157149412|NCT00907478|567292402|FG001|Overall Study|Noncompliance|0|||
157149413|NCT00907478|567292403|FG002|Overall Study|Noncompliance|1|||
157149414|NCT00907478|567292401|FG000|Overall Study|Adverse Event|3|||
157149415|NCT00907478|567292402|FG001|Overall Study|Adverse Event|1|||
157149416|NCT00907478|567292403|FG002|Overall Study|Adverse Event|2|||
157149417|NCT00907478|567292401|FG000|Overall Study|Withdrawal by Subject|8|||
157149418|NCT00907478|567292402|FG001|Overall Study|Withdrawal by Subject|9|||
157149419|NCT00907478|567292403|FG002|Overall Study|Withdrawal by Subject|6|||
157149420|NCT00907478|567292401|FG000|Overall Study|Requirement for alternative therapy|1|||
157149421|NCT00907478|567292402|FG001|Overall Study|Requirement for alternative therapy|2|||
157149422|NCT00907478|567292403|FG002|Overall Study|Requirement for alternative therapy|3|||
157149423|NCT00907478|567292401|FG000|Overall Study|Physician Decision|2|||
157149424|NCT00907478|567292402|FG001|Overall Study|Physician Decision|0|||
157149425|NCT00907478|567292403|FG002|Overall Study|Physician Decision|3|||
157149426|NCT00907478|567292401|FG000|Overall Study|Death|4|||
156815415|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
157149427|NCT00907478|567292402|FG001|Overall Study|Death|2|||
157149428|NCT00907478|567292403|FG002|Overall Study|Death|1|||
156815416|NCT01536561|566073003|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
156815417|NCT01030952|566073004|FG000|Overall Study|Protocol Violation|0|||
156815418|NCT01030952|566073005|FG001|Overall Study|Protocol Violation|1|||
156815419|NCT01030952|566073004|FG000|Overall Study|Informed consent withdrawal|1|||
156815420|NCT01030952|566073005|FG001|Overall Study|Informed consent withdrawal|0|||
156815421|NCT01030952|566073004|FG000|Overall Study|Lost to Follow-up|0|||
157149429|NCT00907478|567292401|FG000|Overall Study|Protocol-specified criteria|5|||
157149430|NCT00907478|567292402|FG001|Overall Study|Protocol-specified criteria|2|||
156815422|NCT01030952|566073005|FG001|Overall Study|Lost to Follow-up|1|||
156815423|NCT01030952|566073004|FG000|Overall Study|Unexplained|1|||
156815424|NCT01030952|566073005|FG001|Overall Study|Unexplained|1|||
156815425|NCT03583359|566073006|FG000|Overall Study|Withdrawal by Subject|15|||
156815426|NCT03583359|566073007|FG001|Overall Study|Withdrawal by Subject|6|||
156815427|NCT03583359|566073006|FG000|Overall Study|Lost to Follow-up|12|||
156815428|NCT03583359|566073007|FG001|Overall Study|Lost to Follow-up|3|||
156815429|NCT03583359|566073006|FG000|Overall Study|Adverse Event|0|||
156815430|NCT03583359|566073007|FG001|Overall Study|Adverse Event|1|||
156815431|NCT03583359|566073006|FG000|Overall Study|Protocol Violation|0|||
156815432|NCT03583359|566073007|FG001|Overall Study|Protocol Violation|1|||
156815433|NCT03583359|566073006|FG000|Overall Study|Other|2|||
156815434|NCT03583359|566073007|FG001|Overall Study|Other|1|||
156815435|NCT00429182|566073014|FG000|Overall Study|Not evaluable, Disease Progression|2|||
156815436|NCT00429182|566073014|FG000|Overall Study|Not eligible|5|||
156815437|NCT02146131|566073018|FG000|Overall Study|Physician Decision|61|||
156815438|NCT02146131|566073019|FG001|Overall Study|Physician Decision|56|||
156815439|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Death|1|||
156815440|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Death|0|||
156815441|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Death|0|||
156815442|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
156815443|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
156815444|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
156815445|NCT02567799|566073020|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
156815446|NCT02567799|566073021|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
156815447|NCT02567799|566073022|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
156815448|NCT02567799|566073020|FG000|Follow-up|Death|1|||
156815449|NCT02567799|566073021|FG001|Follow-up|Death|0|||
156815450|NCT02567799|566073022|FG002|Follow-up|Death|1|||
156815451|NCT02567799|566073020|FG000|Follow-up|Progressive Disease|1|||
156815452|NCT02567799|566073021|FG001|Follow-up|Progressive Disease|1|||
156815453|NCT02567799|566073022|FG002|Follow-up|Progressive Disease|3|||
156815454|NCT01042158|566073025|FG000|Overall Study|Physician Decision|1|||
156815455|NCT01014767|566075276|FG000|Overall Study|PI left institution, data unavailable|12|||
156815456|NCT01014767|566075277|FG001|Overall Study|PI left institution, data unavailable|1|||
156815457|NCT01014767|566075278|FG002|Overall Study|PI left institution, data unavailable|4|||
156815458|NCT01014767|566075279|FG003|Overall Study|PI left institution, data unavailable|1|||
156815459|NCT01709110|566075280|FG000|Overall Study|Adverse Event|56|||
156815460|NCT01709110|566075281|FG001|Overall Study|Adverse Event|48|||
156815461|NCT01709110|566075280|FG000|Overall Study|Death|14|||
156815462|NCT01709110|566075281|FG001|Overall Study|Death|6|||
156815463|NCT01709110|566075280|FG000|Overall Study|Lost to Follow-up|7|||
156815464|NCT01709110|566075281|FG001|Overall Study|Lost to Follow-up|5|||
156815465|NCT01709110|566075280|FG000|Overall Study|Protocol Violation|4|||
156815466|NCT01709110|566075281|FG001|Overall Study|Protocol Violation|6|||
156815467|NCT01709110|566075280|FG000|Overall Study|Withdrawal by Subject|96|||
157149431|NCT00907478|567292403|FG002|Overall Study|Protocol-specified criteria|3|||
157149432|NCT00907478|567292401|FG000|Overall Study|Pregnancy|0|||
157149433|NCT00907478|567292402|FG001|Overall Study|Pregnancy|1|||
157149434|NCT00907478|567292403|FG002|Overall Study|Pregnancy|1|||
157149435|NCT00907478|567292401|FG000|Overall Study|Lost to Follow-up|1|||
157149436|NCT00907478|567292402|FG001|Overall Study|Lost to Follow-up|0|||
157149437|NCT00907478|567292403|FG002|Overall Study|Lost to Follow-up|0|||
157149438|NCT00907478|567292401|FG000|Overall Study|Other|3|||
157149439|NCT00907478|567292402|FG001|Overall Study|Other|0|||
157149440|NCT00907478|567292403|FG002|Overall Study|Other|1|||
157149441|NCT01936649|567292408|FG000|Overall Study|Withdrawal by Subject|4|||
157149442|NCT01936649|567292408|FG000|Overall Study|Physician Decision|2|||
157149443|NCT01936649|567292408|FG000|Overall Study|Protocol Violation|2|||
157149444|NCT01936649|567292408|FG000|Overall Study|Other than specified above|5|||
157149445|NCT03648476|567292416|FG000|Overall Study|Withdrawal by Subject|2|||
157149446|NCT03648476|567292417|FG001|Overall Study|Withdrawal by Subject|1|||
157149447|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
157149448|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
157149449|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
157149450|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157149451|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157149452|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157149453|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
156815468|NCT01709110|566075281|FG001|Overall Study|Withdrawal by Subject|89|||
157149454|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
157223310|NCT00491504|567563722|FG003|Overall Study|Protocol Violation|2|||
156815469|NCT01709110|566075280|FG000|Overall Study|Physician Decision|4|||
156815470|NCT01709110|566075281|FG001|Overall Study|Physician Decision|10|||
156815471|NCT01709110|566075280|FG000|Overall Study|Sponsor Decision|2|||
156815472|NCT01709110|566075281|FG001|Overall Study|Sponsor Decision|2|||
156815473|NCT01709110|566075280|FG000|Overall Study|Lack of Efficacy|1|||
156815474|NCT01709110|566075281|FG001|Overall Study|Lack of Efficacy|1|||
156815475|NCT01709110|566075280|FG000|Overall Study|Caregiver Decision|1|||
156815476|NCT01709110|566075281|FG001|Overall Study|Caregiver Decision|1|||
156815477|NCT04123093|566075285|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
156815478|NCT04123093|566075286|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
156815479|NCT04123093|566075285|FG000|Phase 2|Physician Decision|0|||
156815480|NCT04123093|566075286|FG001|Phase 2|Physician Decision|1|||
156815481|NCT04123093|566075285|FG000|Phase 2|Withdrawal by Subject|0|||
156815482|NCT04123093|566075286|FG001|Phase 2|Withdrawal by Subject|1|||
156815483|NCT01164891|566075291|FG000|Overall Study|Disease Progression|5|||
156815484|NCT01164891|566075291|FG000|Overall Study|Adverse Event|1|||
156815485|NCT00338286|566075292|FG000|Overall Study|Withdrawal by Subject|50|||
156815486|NCT00338286|566075293|FG001|Overall Study|Withdrawal by Subject|54|||
156815487|NCT00338286|566075292|FG000|Overall Study|Lost to Follow-up|80|||
156815488|NCT00338286|566075293|FG001|Overall Study|Lost to Follow-up|66|||
156815489|NCT00338286|566075292|FG000|Overall Study|Other|103|||
156815490|NCT00338286|566075293|FG001|Overall Study|Other|93|||
156815491|NCT01265563|566075294|FG000|Overall Study|Withdrawal by Subject|0|||
156815492|NCT01265563|566075295|FG001|Overall Study|Withdrawal by Subject|1|||
156815493|NCT01265563|566075296|FG002|Overall Study|Withdrawal by Subject|1|||
156815494|NCT01265563|566075297|FG003|Overall Study|Withdrawal by Subject|0|||
156815495|NCT01265563|566075298|FG004|Overall Study|Withdrawal by Subject|2|||
156815496|NCT04908865|566075299|FG000|Overall Study|Adverse Event|2|||
156815497|NCT04908865|566075299|FG000|Overall Study|Lack of Efficacy|5|||
156815498|NCT04908865|566075299|FG000|Overall Study|Lost to Follow-up|1|||
156815499|NCT02550288|566075300|FG000|Overall Study|Adverse Event|0|||
156815500|NCT02550288|566075301|FG001|Overall Study|Adverse Event|1|||
156815501|NCT02550288|566075302|FG002|Overall Study|Adverse Event|0|||
156815502|NCT02550288|566075303|FG003|Overall Study|Adverse Event|0|||
156815503|NCT02550288|566075304|FG004|Overall Study|Adverse Event|0|||
156815504|NCT02550288|566075300|FG000|Overall Study|Physician Decision|0|||
156815505|NCT02550288|566075301|FG001|Overall Study|Physician Decision|0|||
156815506|NCT02550288|566075302|FG002|Overall Study|Physician Decision|0|||
156815507|NCT02550288|566075303|FG003|Overall Study|Physician Decision|1|||
156815508|NCT02550288|566075304|FG004|Overall Study|Physician Decision|0|||
156815509|NCT02550288|566075300|FG000|Overall Study|Protocol Violation|2|||
156815510|NCT02550288|566075301|FG001|Overall Study|Protocol Violation|2|||
156815511|NCT02550288|566075302|FG002|Overall Study|Protocol Violation|1|||
156815512|NCT02550288|566075303|FG003|Overall Study|Protocol Violation|0|||
156815513|NCT02550288|566075304|FG004|Overall Study|Protocol Violation|3|||
156815514|NCT02550288|566075300|FG000|Overall Study|Participant moved|0|||
156815515|NCT02550288|566075301|FG001|Overall Study|Participant moved|0|||
156815516|NCT02550288|566075302|FG002|Overall Study|Participant moved|0|||
156815517|NCT02550288|566075303|FG003|Overall Study|Participant moved|1|||
156815518|NCT02550288|566075304|FG004|Overall Study|Participant moved|0|||
156815519|NCT02550288|566075300|FG000|Overall Study|Withdrawal by Subject|0|||
156815520|NCT02550288|566075301|FG001|Overall Study|Withdrawal by Subject|0|||
156815521|NCT02550288|566075302|FG002|Overall Study|Withdrawal by Subject|0|||
156815522|NCT02550288|566075303|FG003|Overall Study|Withdrawal by Subject|1|||
156815523|NCT02550288|566075304|FG004|Overall Study|Withdrawal by Subject|0|||
156815524|NCT05312697|566075305|FG000|Overall Study|Sponsor Terminated Trial|2|||
156815525|NCT05420961|566075306|FG000|Overall Study|Withdrawal by Subject|2|||
156815526|NCT05420961|566075307|FG001|Overall Study|Withdrawal by Subject|1|||
156815527|NCT05420961|566075308|FG002|Overall Study|Withdrawal by Subject|1|||
156815528|NCT05420961|566075309|FG003|Overall Study|Withdrawal by Subject|0|||
156815529|NCT05420961|566075310|FG004|Overall Study|Withdrawal by Subject|0|||
156815530|NCT05420961|566075306|FG000|Overall Study|Lost to Follow-up|0|||
156815531|NCT05420961|566075307|FG001|Overall Study|Lost to Follow-up|0|||
156815532|NCT05420961|566075308|FG002|Overall Study|Lost to Follow-up|1|||
156815533|NCT05420961|566075309|FG003|Overall Study|Lost to Follow-up|0|||
156815534|NCT05420961|566075310|FG004|Overall Study|Lost to Follow-up|0|||
156815535|NCT05420961|566075306|FG000|Overall Study|Randomized by mistake without study treatment|0|||
156815536|NCT05420961|566075307|FG001|Overall Study|Randomized by mistake without study treatment|0|||
156815537|NCT05420961|566075308|FG002|Overall Study|Randomized by mistake without study treatment|1|||
156815538|NCT05420961|566075309|FG003|Overall Study|Randomized by mistake without study treatment|0|||
156815539|NCT05420961|566075310|FG004|Overall Study|Randomized by mistake without study treatment|1|||
157149455|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
157149456|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
157149457|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
157149458|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157149459|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157149460|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157149461|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157149462|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
157149463|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
156815540|NCT00783835|566075311|FG000|Overall Study|Adverse Event|3|||
156815541|NCT00783835|566075311|FG000|Overall Study|Medical Criteria|1|||
156815542|NCT00783835|566075311|FG000|Overall Study|Withdrawal by Subject|2|||
156815543|NCT00783835|566075311|FG000|Overall Study|Lost to Follow-up|1|||
156815544|NCT00783835|566075311|FG000|Overall Study|Participant not Adherent|3|||
156815545|NCT01945996|566075312|FG000|Overall Study|Lost to Follow-up|3|||
156815546|NCT01945996|566075313|FG001|Overall Study|Lost to Follow-up|5|||
156815547|NCT03248167|566075314|FG000|Overall Study|Withdrawal by Subject|2|||
156815548|NCT03248167|566075315|FG001|Overall Study|Withdrawal by Subject|2|||
156815549|NCT03248167|566075314|FG000|Overall Study|Physician Decision|0|||
156815550|NCT03248167|566075315|FG001|Overall Study|Physician Decision|1|||
156815551|NCT03248167|566075314|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
156815552|NCT03248167|566075315|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
156815553|NCT03248167|566075314|FG000|Overall Study|Lost to Follow-up|1|||
156815554|NCT03248167|566075315|FG001|Overall Study|Lost to Follow-up|0|||
156815555|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Death|0|||
156815556|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Death|1|||
156815557|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Death|1|||
156815558|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Death|0|||
156815559|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Death|0|||
156815560|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Death|0|||
156815561|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Death|0|||
156815562|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Death|0|||
156815563|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815564|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815565|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
156815566|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815567|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
156815568|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815569|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815570|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
156815571|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815572|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815573|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815574|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
156815575|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815576|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815577|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815578|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
156815579|NCT02122146|566075316|FG000|Part 1: Dose Escalation|Other|1|||
156815580|NCT02122146|566075317|FG001|Part 1: Dose Escalation|Other|0|||
156815581|NCT02122146|566075318|FG002|Part 1: Dose Escalation|Other|0|||
156815582|NCT02122146|566075319|FG003|Part 1: Dose Escalation|Other|0|||
156815583|NCT02122146|566075320|FG004|Part 1: Dose Escalation|Other|0|||
156815584|NCT02122146|566075321|FG005|Part 1: Dose Escalation|Other|1|||
156815585|NCT02122146|566075322|FG006|Part 1: Dose Escalation|Other|1|||
156815586|NCT02122146|566075323|FG007|Part 1: Dose Escalation|Other|2|||
156815587|NCT00992056|566075328|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
156815588|NCT00992056|566075329|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
156815589|NCT00992056|566075328|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
156815590|NCT00992056|566075329|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
156815591|NCT02467192|566075337|FG000|Overall Study|Death|1|||
156815592|NCT02467192|566075337|FG000|Overall Study|revealed to have pneumonia before|2|||
156815593|NCT01814046|566075339|FG000|Drug Administration|Death due to complications of RSV|1|||
156815594|NCT01814046|566075340|FG001|Drug Administration|Death due to complications of RSV|0|||
156815595|NCT01814046|566075341|FG002|Drug Administration|Death due to complications of RSV|0|||
156815596|NCT00564902|566075342|FG000|Overall Study|Withdrawal by Subject|0|||
156815597|NCT00564902|566075343|FG001|Overall Study|Withdrawal by Subject|3|||
156815598|NCT00564902|566075344|FG002|Overall Study|Withdrawal by Subject|4|||
156815599|NCT00564902|566075342|FG000|Overall Study|Death|1|||
156815600|NCT00564902|566075343|FG001|Overall Study|Death|1|||
156815601|NCT00564902|566075344|FG002|Overall Study|Death|0|||
156815602|NCT00958347|566075345|FG000|Overall Study|Death|43|||
156815603|NCT00958347|566075345|FG000|Overall Study|Withdrawal by Subject|23|||
156815604|NCT00958347|566075345|FG000|Overall Study|Lost to Follow-up|15|||
156815605|NCT00958347|566075345|FG000|Overall Study|revision/removal|10|||
156815606|NCT00958347|566075345|FG000|Overall Study|study termination|135|||
157223311|NCT02789111|567563723|FG000|Overall Study|Withdrawal by Subject|1|||
156815607|NCT04552288|566075348|FG000|Overall Study|Death|3|||
156815608|NCT04552288|566075348|FG000|Overall Study|Lost to Follow-up|6|||
156815609|NCT04552288|566075348|FG000|Overall Study|Physician Decision|3|||
156815610|NCT04552288|566075348|FG000|Overall Study|Protocol Violation|9|||
156815611|NCT04552288|566075348|FG000|Overall Study|Withdrawal by Subject|6|||
156815612|NCT04552288|566075348|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
156815613|NCT01603043|566075349|FG000|Overall Study|Study Futility|7|||
156815614|NCT01603043|566075350|FG001|Overall Study|Study Futility|3|||
156815615|NCT03089047|566075351|FG000|Overall Study|Lost to Follow-up|1|||
156815616|NCT03089047|566075352|FG001|Overall Study|Lost to Follow-up|0|||
156815617|NCT03599518|566075367|FG000|Overall Study|Clinical progression|0|||
156815618|NCT03599518|566075368|FG001|Overall Study|Clinical progression|0|||
156815619|NCT03599518|566075369|FG002|Overall Study|Clinical progression|0|||
156815620|NCT03599518|566075370|FG003|Overall Study|Clinical progression|0|||
156815621|NCT03599518|566075371|FG004|Overall Study|Clinical progression|1|||
156815622|NCT03599518|566075367|FG000|Overall Study|Adverse Event|0|||
156815623|NCT03599518|566075368|FG001|Overall Study|Adverse Event|0|||
156815624|NCT03599518|566075369|FG002|Overall Study|Adverse Event|0|||
156815625|NCT03599518|566075370|FG003|Overall Study|Adverse Event|0|||
156815626|NCT03599518|566075371|FG004|Overall Study|Adverse Event|1|||
156815627|NCT03599518|566075367|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
156815628|NCT03599518|566075368|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
156815629|NCT03599518|566075369|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
157223312|NCT02789111|567563724|FG001|Overall Study|Withdrawal by Subject|4|||
156815630|NCT03599518|566075370|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
156815631|NCT03599518|566075371|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
156815632|NCT03599518|566075367|FG000|Overall Study|Participant withdrawal from study treatment|0|||
156815633|NCT03599518|566075368|FG001|Overall Study|Participant withdrawal from study treatment|0|||
156815634|NCT03599518|566075369|FG002|Overall Study|Participant withdrawal from study treatment|1|||
156884259|NCT03241368|566334062|FG000|Overall Study|Protocol Violation|1|||
157223313|NCT03271528|567563726|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
157223314|NCT03271528|567563727|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
157223315|NCT03271528|567563726|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
157223316|NCT03271528|567563727|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
157223317|NCT03271528|567563726|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
157223318|NCT03271528|567563727|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
157223319|NCT03271528|567563726|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
157223320|NCT03271528|567563727|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
157223321|NCT03271528|567563726|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
156815635|NCT03599518|566075370|FG003|Overall Study|Participant withdrawal from study treatment|0|||
156815636|NCT03599518|566075371|FG004|Overall Study|Participant withdrawal from study treatment|0|||
156815637|NCT00375505|566075372|FG000|Overall Study|Adverse Event|1|||
156815638|NCT00375505|566075373|FG001|Overall Study|Adverse Event|2|||
156815639|NCT01831466|566075377|FG000|Overall Study|Protocol Violation|1|||
156815640|NCT01831466|566075378|FG001|Overall Study|Protocol Violation|1|||
156815641|NCT01831466|566075379|FG002|Overall Study|Protocol Violation|2|||
156815642|NCT01831466|566075380|FG003|Overall Study|Protocol Violation|0|||
156815643|NCT01831466|566075381|FG004|Overall Study|Protocol Violation|0|||
156815644|NCT01831466|566075382|FG005|Overall Study|Protocol Violation|1|||
157223322|NCT03271528|567563727|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
157223323|NCT03271528|567563726|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
157223324|NCT03271528|567563727|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
157223325|NCT03271528|567563726|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
157223326|NCT03271528|567563727|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
157223327|NCT01618305|567563729|FG000|Overall Study|Death|0|||
157223328|NCT01618305|567563730|FG001|Overall Study|Death|1|||
157223329|NCT01618305|567563729|FG000|Overall Study|Lost to Follow-up|11|||
157223330|NCT01618305|567563730|FG001|Overall Study|Lost to Follow-up|7|||
157223331|NCT01618305|567563729|FG000|Overall Study|Protocol Violation|1|||
157223332|NCT01618305|567563730|FG001|Overall Study|Protocol Violation|0|||
157223333|NCT01618305|567563729|FG000|Overall Study|Withdrawal by Subject|3|||
157223334|NCT01618305|567563730|FG001|Overall Study|Withdrawal by Subject|2|||
157223335|NCT01960816|567563731|FG000|Overall Study|Lost to Follow-up|1|||
156815645|NCT01831466|566075383|FG006|Overall Study|Protocol Violation|0|||
156815646|NCT01831466|566075384|FG007|Overall Study|Protocol Violation|0|||
156815647|NCT01831466|566075385|FG008|Overall Study|Protocol Violation|0|||
156815648|NCT01831466|566075386|FG009|Overall Study|Protocol Violation|0|||
156815649|NCT01831466|566075387|FG010|Overall Study|Protocol Violation|0|||
156815650|NCT01831466|566075388|FG011|Overall Study|Protocol Violation|0|||
156815651|NCT01831466|566075377|FG000|Overall Study|Other|2|||
156815652|NCT01831466|566075378|FG001|Overall Study|Other|3|||
156815653|NCT01831466|566075379|FG002|Overall Study|Other|2|||
156815654|NCT01831466|566075380|FG003|Overall Study|Other|2|||
156815655|NCT01831466|566075381|FG004|Overall Study|Other|2|||
156815656|NCT01831466|566075382|FG005|Overall Study|Other|1|||
156815657|NCT01831466|566075383|FG006|Overall Study|Other|0|||
156815658|NCT01831466|566075384|FG007|Overall Study|Other|0|||
156815659|NCT01831466|566075385|FG008|Overall Study|Other|0|||
156815660|NCT01831466|566075386|FG009|Overall Study|Other|0|||
156815661|NCT01831466|566075387|FG010|Overall Study|Other|0|||
156815662|NCT01831466|566075388|FG011|Overall Study|Other|0|||
156815663|NCT01831466|566075377|FG000|Overall Study|Non-compliance with study treatment|2|||
156815664|NCT01831466|566075378|FG001|Overall Study|Non-compliance with study treatment|1|||
156815665|NCT01831466|566075379|FG002|Overall Study|Non-compliance with study treatment|1|||
156815666|NCT01831466|566075380|FG003|Overall Study|Non-compliance with study treatment|0|||
156815667|NCT01831466|566075381|FG004|Overall Study|Non-compliance with study treatment|0|||
156815668|NCT01831466|566075382|FG005|Overall Study|Non-compliance with study treatment|1|||
156815669|NCT01831466|566075383|FG006|Overall Study|Non-compliance with study treatment|0|||
156815670|NCT01831466|566075384|FG007|Overall Study|Non-compliance with study treatment|0|||
156815671|NCT01831466|566075385|FG008|Overall Study|Non-compliance with study treatment|0|||
156815672|NCT01831466|566075386|FG009|Overall Study|Non-compliance with study treatment|0|||
156815673|NCT01831466|566075387|FG010|Overall Study|Non-compliance with study treatment|0|||
157149464|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
157149465|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
157149466|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157149467|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
156815674|NCT01831466|566075388|FG011|Overall Study|Non-compliance with study treatment|0|||
156815675|NCT01831466|566075377|FG000|Overall Study|Death|0|||
156815676|NCT01831466|566075378|FG001|Overall Study|Death|1|||
156815677|NCT01831466|566075379|FG002|Overall Study|Death|0|||
156815678|NCT01831466|566075380|FG003|Overall Study|Death|0|||
156815679|NCT01831466|566075381|FG004|Overall Study|Death|0|||
157149468|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157149469|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157149470|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
157149471|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
157149472|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
157149473|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149474|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149475|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149476|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149477|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149478|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
157149479|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
157149480|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
157149481|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
157149482|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157149483|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157149484|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157149485|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157149486|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
157149487|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
157149488|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
157149489|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149490|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149491|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149492|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149493|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149494|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
157149495|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
157149496|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
157149497|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149498|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149499|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149500|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149501|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149502|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
157149503|NCT01097616|567292424|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149504|NCT01097616|567292425|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149505|NCT01097616|567292426|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
157149506|NCT01097616|567292427|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149507|NCT01097616|567292428|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149508|NCT01097616|567292429|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149509|NCT01097616|567292430|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149510|NCT01097616|567292431|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
157149511|NCT01097616|567292424|FG000|Optional DB EXT Phase|Adverse Event|0|||
157149512|NCT01097616|567292425|FG001|Optional DB EXT Phase|Adverse Event|7|||
157149513|NCT01097616|567292426|FG002|Optional DB EXT Phase|Adverse Event|2|||
157149514|NCT01097616|567292427|FG003|Optional DB EXT Phase|Adverse Event|0|||
156815680|NCT01831466|566075382|FG005|Overall Study|Death|0|||
156815681|NCT01831466|566075383|FG006|Overall Study|Death|0|||
156815682|NCT01831466|566075384|FG007|Overall Study|Death|0|||
156815683|NCT01831466|566075385|FG008|Overall Study|Death|0|||
156815684|NCT01831466|566075386|FG009|Overall Study|Death|0|||
156815685|NCT01831466|566075387|FG010|Overall Study|Death|0|||
156815686|NCT01831466|566075388|FG011|Overall Study|Death|0|||
156815687|NCT01831466|566075377|FG000|Overall Study|Withdrawal by Subject|6|||
156815688|NCT01831466|566075378|FG001|Overall Study|Withdrawal by Subject|3|||
156815689|NCT01831466|566075379|FG002|Overall Study|Withdrawal by Subject|3|||
156815690|NCT01831466|566075380|FG003|Overall Study|Withdrawal by Subject|3|||
156815691|NCT01831466|566075381|FG004|Overall Study|Withdrawal by Subject|3|||
156815692|NCT01831466|566075382|FG005|Overall Study|Withdrawal by Subject|5|||
156815693|NCT01831466|566075383|FG006|Overall Study|Withdrawal by Subject|0|||
156815694|NCT01831466|566075384|FG007|Overall Study|Withdrawal by Subject|0|||
156815695|NCT01831466|566075385|FG008|Overall Study|Withdrawal by Subject|0|||
156815696|NCT01831466|566075386|FG009|Overall Study|Withdrawal by Subject|1|||
156815697|NCT01831466|566075387|FG010|Overall Study|Withdrawal by Subject|0|||
156815698|NCT01831466|566075388|FG011|Overall Study|Withdrawal by Subject|1|||
157223336|NCT01736553|567563752|FG000|Overall Study|Death|12|||
157223337|NCT01736553|567563753|FG001|Overall Study|Death|0|||
157223338|NCT01736553|567563752|FG000|Overall Study|Withdrawal by Subject|5|||
157223339|NCT01736553|567563753|FG001|Overall Study|Withdrawal by Subject|2|||
157223340|NCT01736553|567563752|FG000|Overall Study|Lost to Follow-up|2|||
157223341|NCT01736553|567563753|FG001|Overall Study|Lost to Follow-up|2|||
157223342|NCT01896297|567563754|FG000|Overall Study|Died in post treatment phase|1|||
157223343|NCT00003782|567563755|FG000|Overall Study|No follow up data|30|||
157223344|NCT00003782|567563756|FG001|Overall Study|No follow up data|31|||
157223345|NCT00003782|567563757|FG002|Overall Study|No follow up data|26|||
157223346|NCT05342753|567565654|FG000|Overall Study|Withdrawal by Subject|6|||
156815699|NCT01831466|566075377|FG000|Overall Study|Lost to Follow-up|0|||
156815700|NCT01831466|566075378|FG001|Overall Study|Lost to Follow-up|1|||
156815701|NCT01831466|566075379|FG002|Overall Study|Lost to Follow-up|4|||
156815702|NCT01831466|566075380|FG003|Overall Study|Lost to Follow-up|2|||
156815703|NCT01831466|566075381|FG004|Overall Study|Lost to Follow-up|0|||
156815704|NCT01831466|566075382|FG005|Overall Study|Lost to Follow-up|3|||
156815705|NCT01831466|566075383|FG006|Overall Study|Lost to Follow-up|0|||
156815706|NCT01831466|566075384|FG007|Overall Study|Lost to Follow-up|0|||
156815707|NCT01831466|566075385|FG008|Overall Study|Lost to Follow-up|0|||
156815708|NCT01831466|566075386|FG009|Overall Study|Lost to Follow-up|1|||
156815709|NCT01831466|566075387|FG010|Overall Study|Lost to Follow-up|0|||
156884260|NCT04740905|566334063|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
156884261|NCT04740905|566334064|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
157149515|NCT01097616|567292428|FG004|Optional DB EXT Phase|Adverse Event|0|||
157149516|NCT01097616|567292429|FG005|Optional DB EXT Phase|Adverse Event|0|||
157149517|NCT01097616|567292430|FG006|Optional DB EXT Phase|Adverse Event|0|||
157149518|NCT01097616|567292431|FG007|Optional DB EXT Phase|Adverse Event|0|||
157149519|NCT01097616|567292424|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
157149520|NCT01097616|567292425|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
157149521|NCT01097616|567292426|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
157149522|NCT01097616|567292427|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
157149523|NCT01097616|567292428|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
157149524|NCT01097616|567292429|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
157149525|NCT01097616|567292430|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
157149526|NCT01097616|567292431|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
157149527|NCT01097616|567292424|FG000|Optional DB EXT Phase|Protocol Violation|0|||
157149528|NCT01097616|567292425|FG001|Optional DB EXT Phase|Protocol Violation|2|||
157149529|NCT01097616|567292426|FG002|Optional DB EXT Phase|Protocol Violation|3|||
157149530|NCT01097616|567292427|FG003|Optional DB EXT Phase|Protocol Violation|0|||
157149531|NCT01097616|567292428|FG004|Optional DB EXT Phase|Protocol Violation|0|||
157149532|NCT01097616|567292429|FG005|Optional DB EXT Phase|Protocol Violation|0|||
156815710|NCT01831466|566075388|FG011|Overall Study|Lost to Follow-up|1|||
156815711|NCT01831466|566075377|FG000|Overall Study|Lack of Efficacy|5|||
156815712|NCT01831466|566075378|FG001|Overall Study|Lack of Efficacy|8|||
156815713|NCT01831466|566075379|FG002|Overall Study|Lack of Efficacy|7|||
156815714|NCT01831466|566075380|FG003|Overall Study|Lack of Efficacy|6|||
157149533|NCT01097616|567292430|FG006|Optional DB EXT Phase|Protocol Violation|0|||
157149534|NCT01097616|567292431|FG007|Optional DB EXT Phase|Protocol Violation|0|||
157149535|NCT01097616|567292424|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
157149536|NCT01097616|567292425|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
157223347|NCT05342753|567565654|FG000|Overall Study|Lost to Follow-up|1|||
157223348|NCT05014204|567565655|FG000|Overall Study|Withdrawal by Subject|1|||
157223349|NCT05014204|567565655|FG000|Overall Study|Physician Decision|1|||
156815715|NCT01831466|566075381|FG004|Overall Study|Lack of Efficacy|9|||
156815716|NCT01831466|566075382|FG005|Overall Study|Lack of Efficacy|8|||
156884262|NCT04740905|566334063|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
156815717|NCT01831466|566075383|FG006|Overall Study|Lack of Efficacy|1|||
157223350|NCT04471935|567565656|FG000|Overall Study|Withdrawal by Subject|1|||
157223351|NCT04471935|567565656|FG000|Overall Study|Deemed ineligible to participate|1|||
157223352|NCT01399736|567565657|FG000|Overall Study|Withdrawal by Subject|4|||
157223353|NCT01399736|567565658|FG001|Overall Study|Withdrawal by Subject|2|||
157223354|NCT01399736|567565657|FG000|Overall Study|Lost to Follow-up|0|||
157223355|NCT01399736|567565658|FG001|Overall Study|Lost to Follow-up|2|||
157223356|NCT03335371|567565659|FG000|Overall Study|Lost to Follow-up|0|||
157223357|NCT03335371|567565660|FG001|Overall Study|Lost to Follow-up|0|||
157223358|NCT03335371|567565661|FG002|Overall Study|Lost to Follow-up|0|||
157223359|NCT03335371|567565662|FG003|Overall Study|Lost to Follow-up|0|||
157223360|NCT03335371|567565663|FG004|Overall Study|Lost to Follow-up|1|||
157223361|NCT03335371|567565659|FG000|Overall Study|Withdrawal by Subject|0|||
157223362|NCT03335371|567565660|FG001|Overall Study|Withdrawal by Subject|0|||
157223363|NCT03335371|567565661|FG002|Overall Study|Withdrawal by Subject|0|||
157223364|NCT03335371|567565662|FG003|Overall Study|Withdrawal by Subject|0|||
157223365|NCT03335371|567565663|FG004|Overall Study|Withdrawal by Subject|1|||
157223366|NCT03335371|567565659|FG000|Overall Study|Randomization Error|0|||
157223367|NCT03335371|567565660|FG001|Overall Study|Randomization Error|0|||
157223368|NCT03335371|567565661|FG002|Overall Study|Randomization Error|1|||
157223369|NCT03335371|567565662|FG003|Overall Study|Randomization Error|0|||
157223370|NCT03335371|567565663|FG004|Overall Study|Randomization Error|0|||
157223371|NCT02985957|567565664|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223372|NCT02985957|567565665|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223373|NCT02985957|567565666|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223374|NCT02985957|567565667|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223375|NCT02985957|567565668|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
157223376|NCT02985957|567565669|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223377|NCT02985957|567565670|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157223378|NCT02985957|567565664|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
157223379|NCT02985957|567565665|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
157223380|NCT02985957|567565666|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
157223381|NCT02985957|567565667|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
157223382|NCT02985957|567565668|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
157223383|NCT02985957|567565669|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
157223384|NCT02985957|567565670|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
157223385|NCT02985957|567565664|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223386|NCT02985957|567565665|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223387|NCT02985957|567565666|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223388|NCT02985957|567565667|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223389|NCT02985957|567565668|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223390|NCT02985957|567565669|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157223391|NCT02985957|567565670|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
157223392|NCT02985957|567565664|FG000|Treatment Period|Death|0|||
157223393|NCT02985957|567565665|FG001|Treatment Period|Death|0|||
157223394|NCT02985957|567565666|FG002|Treatment Period|Death|0|||
157223395|NCT02985957|567565667|FG003|Treatment Period|Death|0|||
157223396|NCT02985957|567565668|FG004|Treatment Period|Death|1|||
157223397|NCT02985957|567565669|FG005|Treatment Period|Death|0|||
157223398|NCT02985957|567565670|FG006|Treatment Period|Death|0|||
157223399|NCT02985957|567565664|FG000|Treatment Period|Participant withdrew consent|0|||
157223400|NCT02985957|567565665|FG001|Treatment Period|Participant withdrew consent|0|||
157223401|NCT02985957|567565666|FG002|Treatment Period|Participant withdrew consent|0|||
157223402|NCT02985957|567565667|FG003|Treatment Period|Participant withdrew consent|1|||
157223403|NCT02985957|567565668|FG004|Treatment Period|Participant withdrew consent|3|||
157223404|NCT02985957|567565669|FG005|Treatment Period|Participant withdrew consent|0|||
157223405|NCT02985957|567565670|FG006|Treatment Period|Participant withdrew consent|1|||
157223406|NCT02985957|567565664|FG000|Treatment Period|Lost to Follow-up|0|||
156884263|NCT04740905|566334064|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
156884264|NCT04740905|566334063|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
156884265|NCT04740905|566334064|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
157223407|NCT02985957|567565665|FG001|Treatment Period|Lost to Follow-up|0|||
157223408|NCT02985957|567565666|FG002|Treatment Period|Lost to Follow-up|0|||
157223409|NCT02985957|567565667|FG003|Treatment Period|Lost to Follow-up|0|||
157223410|NCT02985957|567565668|FG004|Treatment Period|Lost to Follow-up|1|||
157223411|NCT02985957|567565669|FG005|Treatment Period|Lost to Follow-up|0|||
157223412|NCT02985957|567565670|FG006|Treatment Period|Lost to Follow-up|0|||
157223413|NCT02985957|567565664|FG000|Treatment Period|Other reasons|0|||
157223414|NCT02985957|567565665|FG001|Treatment Period|Other reasons|0|||
157223415|NCT02985957|567565666|FG002|Treatment Period|Other reasons|1|||
157223416|NCT02985957|567565667|FG003|Treatment Period|Other reasons|3|||
157223417|NCT02985957|567565668|FG004|Treatment Period|Other reasons|5|||
157223418|NCT02985957|567565669|FG005|Treatment Period|Other reasons|0|||
156884266|NCT04740905|566334063|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
156815718|NCT01831466|566075384|FG007|Overall Study|Lack of Efficacy|1|||
156815719|NCT01831466|566075385|FG008|Overall Study|Lack of Efficacy|2|||
156815720|NCT01831466|566075386|FG009|Overall Study|Lack of Efficacy|2|||
156815721|NCT01831466|566075387|FG010|Overall Study|Lack of Efficacy|2|||
156815722|NCT01831466|566075388|FG011|Overall Study|Lack of Efficacy|0|||
156815723|NCT01831466|566075377|FG000|Overall Study|Adverse Event|0|||
156815724|NCT01831466|566075378|FG001|Overall Study|Adverse Event|0|||
156815725|NCT01831466|566075379|FG002|Overall Study|Adverse Event|4|||
156815726|NCT01831466|566075380|FG003|Overall Study|Adverse Event|6|||
156815727|NCT01831466|566075381|FG004|Overall Study|Adverse Event|3|||
156815728|NCT01831466|566075382|FG005|Overall Study|Adverse Event|7|||
156815729|NCT01831466|566075383|FG006|Overall Study|Adverse Event|0|||
156815730|NCT01831466|566075384|FG007|Overall Study|Adverse Event|1|||
156815731|NCT01831466|566075385|FG008|Overall Study|Adverse Event|1|||
156815732|NCT01831466|566075386|FG009|Overall Study|Adverse Event|1|||
156815733|NCT01831466|566075387|FG010|Overall Study|Adverse Event|0|||
156815734|NCT01831466|566075388|FG011|Overall Study|Adverse Event|2|||
156815735|NCT00005947|566075389|FG000|Overall Study|Death|54|||
156815736|NCT00005947|566075390|FG001|Overall Study|Death|40|||
156815737|NCT00005947|566075389|FG000|Overall Study|Patient Refused to Continue|2|||
156815738|NCT00005947|566075390|FG001|Overall Study|Patient Refused to Continue|1|||
156815739|NCT00005947|566075389|FG000|Overall Study|Site Closure|1|||
156815740|NCT00005947|566075390|FG001|Overall Study|Site Closure|0|||
156815741|NCT03335150|566075392|FG000|Overall Study|Withdrawal by Subject|10|||
156815742|NCT03335150|566075393|FG001|Overall Study|Withdrawal by Subject|4|||
156815743|NCT03335150|566075392|FG000|Overall Study|Adverse Event|0|||
156815744|NCT03335150|566075393|FG001|Overall Study|Adverse Event|1|||
156815745|NCT00861692|566075398|FG000|Overall Study|Death|6|||
156884267|NCT04740905|566334064|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
156884268|NCT04740905|566334063|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
156884269|NCT04740905|566334064|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
156884270|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
156884271|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
156884272|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
156884273|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
156884274|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
156884275|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
156884276|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
156884277|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
157149537|NCT01097616|567292426|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
157149538|NCT01097616|567292427|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
157149539|NCT01097616|567292428|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
157149540|NCT01097616|567292429|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
157149541|NCT01097616|567292430|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
157149542|NCT01097616|567292431|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
157149543|NCT01097616|567292424|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
157149544|NCT01097616|567292425|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
157149545|NCT01097616|567292426|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
157149546|NCT01097616|567292427|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
157149547|NCT01097616|567292428|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
157149548|NCT01097616|567292429|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
157149549|NCT01097616|567292430|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
157149550|NCT01097616|567292431|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
157149551|NCT01097616|567292424|FG000|Optional DB EXT Phase|Physician Decision|1|||
157149552|NCT01097616|567292425|FG001|Optional DB EXT Phase|Physician Decision|0|||
157149553|NCT01097616|567292426|FG002|Optional DB EXT Phase|Physician Decision|0|||
157149554|NCT01097616|567292427|FG003|Optional DB EXT Phase|Physician Decision|0|||
157149555|NCT01097616|567292428|FG004|Optional DB EXT Phase|Physician Decision|0|||
157149556|NCT01097616|567292429|FG005|Optional DB EXT Phase|Physician Decision|0|||
157223419|NCT02985957|567565670|FG006|Treatment Period|Other reasons|1|||
157223420|NCT02985957|567565664|FG000|Treatment Period|Not reported|0|||
157223421|NCT02985957|567565665|FG001|Treatment Period|Not reported|2|||
156815746|NCT02218697|566075401|FG000|Overall Study|Adverse Event|0|||
156815747|NCT02218697|566075402|FG001|Overall Study|Adverse Event|2|||
156815748|NCT02218697|566075401|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
156815749|NCT02218697|566075402|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
156815750|NCT02218697|566075401|FG000|Overall Study|Withdrawal by Subject|2|||
156884278|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
157149557|NCT01097616|567292430|FG006|Optional DB EXT Phase|Physician Decision|0|||
157149558|NCT01097616|567292431|FG007|Optional DB EXT Phase|Physician Decision|0|||
157149559|NCT01097616|567292424|FG000|DB RO Phase|Adverse Event|0|||
157223422|NCT02985957|567565666|FG002|Treatment Period|Not reported|2|||
157149560|NCT01097616|567292425|FG001|DB RO Phase|Adverse Event|0|||
156815751|NCT02218697|566075402|FG001|Overall Study|Withdrawal by Subject|3|||
156815752|NCT02142803|566075407|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
156815753|NCT02142803|566075408|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
157149561|NCT01097616|567292426|FG002|DB RO Phase|Adverse Event|0|||
157149562|NCT01097616|567292427|FG003|DB RO Phase|Adverse Event|0|||
157149563|NCT01097616|567292428|FG004|DB RO Phase|Adverse Event|0|||
157149564|NCT01097616|567292429|FG005|DB RO Phase|Adverse Event|0|||
157149565|NCT01097616|567292430|FG006|DB RO Phase|Adverse Event|1|||
157149566|NCT01097616|567292431|FG007|DB RO Phase|Adverse Event|0|||
157149567|NCT01097616|567292424|FG000|DB RO Phase|Withdrawal by Subject|0|||
157149568|NCT01097616|567292425|FG001|DB RO Phase|Withdrawal by Subject|0|||
156815754|NCT02142803|566075409|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
156815755|NCT02142803|566075410|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
156815756|NCT05111002|566075413|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
156815757|NCT05111002|566075414|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
156815758|NCT05111002|566075413|FG000|Secondary Outcome|Lost to Follow-up|1|||
157149569|NCT01097616|567292426|FG002|DB RO Phase|Withdrawal by Subject|0|||
157149570|NCT01097616|567292427|FG003|DB RO Phase|Withdrawal by Subject|0|||
157149571|NCT01097616|567292428|FG004|DB RO Phase|Withdrawal by Subject|0|||
157149572|NCT01097616|567292429|FG005|DB RO Phase|Withdrawal by Subject|1|||
157149573|NCT01097616|567292430|FG006|DB RO Phase|Withdrawal by Subject|0|||
157149574|NCT01097616|567292431|FG007|DB RO Phase|Withdrawal by Subject|0|||
157149575|NCT01097616|567292424|FG000|DB RO Phase|Lost to Follow-up|0|||
157149576|NCT01097616|567292425|FG001|DB RO Phase|Lost to Follow-up|0|||
157149577|NCT01097616|567292426|FG002|DB RO Phase|Lost to Follow-up|0|||
157149578|NCT01097616|567292427|FG003|DB RO Phase|Lost to Follow-up|1|||
157149579|NCT01097616|567292428|FG004|DB RO Phase|Lost to Follow-up|1|||
157149580|NCT01097616|567292429|FG005|DB RO Phase|Lost to Follow-up|0|||
157149581|NCT01097616|567292430|FG006|DB RO Phase|Lost to Follow-up|0|||
157149582|NCT01097616|567292431|FG007|DB RO Phase|Lost to Follow-up|1|||
157149583|NCT01097616|567292424|FG000|DB RO Phase|Not Treated in RO|0|||
157149584|NCT01097616|567292425|FG001|DB RO Phase|Not Treated in RO|0|||
157149585|NCT01097616|567292426|FG002|DB RO Phase|Not Treated in RO|0|||
157149586|NCT01097616|567292427|FG003|DB RO Phase|Not Treated in RO|0|||
157149587|NCT01097616|567292428|FG004|DB RO Phase|Not Treated in RO|0|||
157149588|NCT01097616|567292429|FG005|DB RO Phase|Not Treated in RO|1|||
157149589|NCT01097616|567292430|FG006|DB RO Phase|Not Treated in RO|0|||
157149590|NCT01097616|567292431|FG007|DB RO Phase|Not Treated in RO|0|||
157149591|NCT03952650|567292434|FG000|Overall Study|TRAVEL|0|||
157149592|NCT03952650|567292435|FG001|Overall Study|TRAVEL|4|||
157149593|NCT03952650|567292436|FG002|Overall Study|TRAVEL|0|||
157149594|NCT03952650|567292437|FG003|Overall Study|TRAVEL|4|||
157149595|NCT03952650|567292438|FG004|Overall Study|TRAVEL|0|||
157149596|NCT03952650|567292439|FG005|Overall Study|TRAVEL|3|||
157149597|NCT03952650|567292440|FG006|Overall Study|TRAVEL|2|||
157149598|NCT03952650|567292434|FG000|Overall Study|Withdrawal by Subject|0|||
157149599|NCT03952650|567292435|FG001|Overall Study|Withdrawal by Subject|2|||
157149600|NCT03952650|567292436|FG002|Overall Study|Withdrawal by Subject|0|||
157149601|NCT03952650|567292437|FG003|Overall Study|Withdrawal by Subject|3|||
157149602|NCT03952650|567292438|FG004|Overall Study|Withdrawal by Subject|0|||
157149603|NCT03952650|567292439|FG005|Overall Study|Withdrawal by Subject|1|||
157149604|NCT03952650|567292440|FG006|Overall Study|Withdrawal by Subject|1|||
157149605|NCT03952650|567292434|FG000|Overall Study|Lost to Follow-up|0|||
157149606|NCT03952650|567292435|FG001|Overall Study|Lost to Follow-up|1|||
157149607|NCT03952650|567292436|FG002|Overall Study|Lost to Follow-up|0|||
157149608|NCT03952650|567292437|FG003|Overall Study|Lost to Follow-up|0|||
157149609|NCT03952650|567292438|FG004|Overall Study|Lost to Follow-up|0|||
156815759|NCT05111002|566075414|FG001|Secondary Outcome|Lost to Follow-up|0|||
156815760|NCT04380753|566075415|FG000|Overall Study|Participants continuing study|4|||
156815761|NCT04380753|566075415|FG000|Overall Study|Death|2|||
156815762|NCT00809926|566075416|FG000|Overall Study|Adverse Event|18|||
156815763|NCT00809926|566075417|FG001|Overall Study|Adverse Event|10|||
156815764|NCT00809926|566075416|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156815765|NCT00809926|566075417|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
156815766|NCT00809926|566075416|FG000|Overall Study|Patient withdrew consent|8|||
156815767|NCT00809926|566075417|FG001|Overall Study|Patient withdrew consent|6|||
156815768|NCT00809926|566075416|FG000|Overall Study|Lost to Follow-up|2|||
157149610|NCT03952650|567292439|FG005|Overall Study|Lost to Follow-up|1|||
157149611|NCT03952650|567292440|FG006|Overall Study|Lost to Follow-up|1|||
157149612|NCT03952650|567292434|FG000|Overall Study|Received wrong vaccine and travelled|0|||
157149613|NCT03952650|567292435|FG001|Overall Study|Received wrong vaccine and travelled|0|||
156815769|NCT00809926|566075417|FG001|Overall Study|Lost to Follow-up|1|||
156815770|NCT00809926|566075416|FG000|Overall Study|Administrative Problems|0|||
156815771|NCT00809926|566075417|FG001|Overall Study|Administrative Problems|1|||
157149614|NCT03952650|567292436|FG002|Overall Study|Received wrong vaccine and travelled|0|||
157149615|NCT03952650|567292437|FG003|Overall Study|Received wrong vaccine and travelled|0|||
157149616|NCT03952650|567292438|FG004|Overall Study|Received wrong vaccine and travelled|0|||
157149617|NCT03952650|567292439|FG005|Overall Study|Received wrong vaccine and travelled|1|||
157149618|NCT03952650|567292440|FG006|Overall Study|Received wrong vaccine and travelled|0|||
157149619|NCT03952650|567292434|FG000|Overall Study|Unable to make study visit|0|||
157149620|NCT03952650|567292435|FG001|Overall Study|Unable to make study visit|0|||
156815772|NCT00809926|566075416|FG000|Overall Study|Protocol deviation|0|||
156815773|NCT00809926|566075417|FG001|Overall Study|Protocol deviation|2|||
156815774|NCT04776720|566075435|FG000|Overall Study|COVID Related|4|||
156815775|NCT04776720|566075436|FG001|Overall Study|COVID Related|2|||
156815776|NCT04776720|566075435|FG000|Overall Study|Adverse Event|2|||
156815777|NCT04776720|566075436|FG001|Overall Study|Adverse Event|0|||
156815778|NCT04776720|566075435|FG000|Overall Study|Serious Adverse Event|0|||
156815779|NCT04776720|566075436|FG001|Overall Study|Serious Adverse Event|1|||
156815780|NCT04776720|566075435|FG000|Overall Study|Too Busy|3|||
156815781|NCT04776720|566075436|FG001|Overall Study|Too Busy|1|||
156815782|NCT04776720|566075435|FG000|Overall Study|Lost to Follow-up|1|||
156815783|NCT04776720|566075436|FG001|Overall Study|Lost to Follow-up|2|||
156815784|NCT04776720|566075435|FG000|Overall Study|Family|2|||
156815785|NCT04776720|566075436|FG001|Overall Study|Family|2|||
156815786|NCT04776720|566075435|FG000|Overall Study|No remote technology access|0|||
156815787|NCT04776720|566075436|FG001|Overall Study|No remote technology access|1|||
156815788|NCT04776720|566075435|FG000|Overall Study|Withdrawal by Subject|1|||
156815789|NCT04776720|566075436|FG001|Overall Study|Withdrawal by Subject|0|||
156815790|NCT04776720|566075435|FG000|Overall Study|Cannot tolerate intervention|1|||
156815791|NCT04776720|566075436|FG001|Overall Study|Cannot tolerate intervention|0|||
156815792|NCT04776720|566075435|FG000|Overall Study|Incomplete outcome data|6|||
156815793|NCT04776720|566075436|FG001|Overall Study|Incomplete outcome data|1|||
156815794|NCT05356910|566075439|FG000|Overall Study|Lost to Follow-up|10|||
156815795|NCT05356910|566075440|FG001|Overall Study|Lost to Follow-up|19|||
156815796|NCT05356910|566075441|FG002|Overall Study|Lost to Follow-up|0|||
156815797|NCT05356910|566075442|FG003|Overall Study|Lost to Follow-up|0|||
156815798|NCT05356910|566075439|FG000|Overall Study|Withdrawal by Subject|4|||
156815799|NCT05356910|566075440|FG001|Overall Study|Withdrawal by Subject|2|||
156815800|NCT05356910|566075441|FG002|Overall Study|Withdrawal by Subject|0|||
156815801|NCT05356910|566075442|FG003|Overall Study|Withdrawal by Subject|0|||
156815802|NCT02712996|566075446|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
156815803|NCT02712996|566075447|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
156815804|NCT03306433|566075451|FG000|Overall Study|Lost to Follow-up|3|||
156815805|NCT03306433|566075451|FG000|Overall Study|Patient did not have teeth extracted|1|||
156815806|NCT03306433|566075451|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
156815807|NCT00819156|566075452|FG000|Overall Study|Adverse Event|1|||
156815808|NCT00819156|566075453|FG001|Overall Study|Adverse Event|4|||
156815809|NCT00819156|566075454|FG002|Overall Study|Adverse Event|2|||
156815810|NCT00819156|566075455|FG003|Overall Study|Adverse Event|1|||
156815811|NCT00819156|566075456|FG004|Overall Study|Adverse Event|2|||
156815812|NCT00819156|566075457|FG005|Overall Study|Adverse Event|3|||
156815813|NCT00819156|566075452|FG000|Overall Study|Withdrawal by Subject|0|||
156815814|NCT00819156|566075453|FG001|Overall Study|Withdrawal by Subject|3|||
156815815|NCT00819156|566075454|FG002|Overall Study|Withdrawal by Subject|2|||
156815816|NCT00819156|566075455|FG003|Overall Study|Withdrawal by Subject|0|||
156815817|NCT00819156|566075456|FG004|Overall Study|Withdrawal by Subject|1|||
156815818|NCT00819156|566075457|FG005|Overall Study|Withdrawal by Subject|0|||
156815819|NCT00819156|566075452|FG000|Overall Study|Protocol Violation|1|||
156815820|NCT00819156|566075453|FG001|Overall Study|Protocol Violation|0|||
156815821|NCT00819156|566075454|FG002|Overall Study|Protocol Violation|1|||
156815822|NCT00819156|566075455|FG003|Overall Study|Protocol Violation|0|||
156815823|NCT00819156|566075456|FG004|Overall Study|Protocol Violation|0|||
156815824|NCT00819156|566075457|FG005|Overall Study|Protocol Violation|1|||
156815825|NCT00819156|566075452|FG000|Overall Study|Lost to Follow-up|0|||
156815826|NCT00819156|566075453|FG001|Overall Study|Lost to Follow-up|1|||
156815827|NCT00819156|566075454|FG002|Overall Study|Lost to Follow-up|0|||
156815828|NCT00819156|566075455|FG003|Overall Study|Lost to Follow-up|0|||
156815829|NCT00819156|566075456|FG004|Overall Study|Lost to Follow-up|0|||
156815830|NCT00819156|566075457|FG005|Overall Study|Lost to Follow-up|2|||
156815831|NCT00819156|566075452|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
156815832|NCT00819156|566075453|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
156815833|NCT00819156|566075454|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815834|NCT00819156|566075455|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815835|NCT00819156|566075456|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
156815836|NCT00819156|566075457|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
156815837|NCT00819156|566075452|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
156815838|NCT00819156|566075453|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815839|NCT00819156|566075454|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815840|NCT00819156|566075455|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815841|NCT00819156|566075456|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
156815842|NCT00819156|566075457|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
156815843|NCT00819156|566075452|FG000|Overall Study|Prostate-specific antigen progression|0|||
156815844|NCT00819156|566075453|FG001|Overall Study|Prostate-specific antigen progression|0|||
156815845|NCT00819156|566075454|FG002|Overall Study|Prostate-specific antigen progression|0|||
156815846|NCT00819156|566075455|FG003|Overall Study|Prostate-specific antigen progression|0|||
157022534|NCT04624633|566835249|FG001|Overall Study|Death|0|||
157149621|NCT03952650|567292436|FG002|Overall Study|Unable to make study visit|0|||
157149622|NCT03952650|567292437|FG003|Overall Study|Unable to make study visit|0|||
157149623|NCT03952650|567292438|FG004|Overall Study|Unable to make study visit|0|||
157149624|NCT03952650|567292439|FG005|Overall Study|Unable to make study visit|1|||
157149625|NCT03952650|567292440|FG006|Overall Study|Unable to make study visit|0|||
156815847|NCT00819156|566075456|FG004|Overall Study|Prostate-specific antigen progression|1|||
156815848|NCT00819156|566075457|FG005|Overall Study|Prostate-specific antigen progression|0|||
156815849|NCT00790582|566075458|FG000|Overall Study|Death|14|||
156815850|NCT00790582|566075459|FG001|Overall Study|Death|32|||
156815851|NCT00790582|566075458|FG000|Overall Study|Physician Decision|7|||
156815852|NCT00790582|566075459|FG001|Overall Study|Physician Decision|1|||
156815853|NCT00790582|566075458|FG000|Overall Study|Lost to Follow-up|3|||
156815854|NCT00790582|566075459|FG001|Overall Study|Lost to Follow-up|3|||
156815855|NCT00790582|566075458|FG000|Overall Study|Withdrawal by Subject|7|||
156815856|NCT00790582|566075459|FG001|Overall Study|Withdrawal by Subject|51|||
156815857|NCT00803595|566075460|FG000|Overall Study|Adverse Event|3|||
156815858|NCT00803595|566075461|FG001|Overall Study|Adverse Event|4|||
156815859|NCT00803595|566075462|FG002|Overall Study|Adverse Event|1|||
156815860|NCT00803595|566075460|FG000|Overall Study|Protocol Violation|7|||
156815861|NCT00803595|566075461|FG001|Overall Study|Protocol Violation|2|||
156815862|NCT00803595|566075462|FG002|Overall Study|Protocol Violation|12|||
156815863|NCT00803595|566075460|FG000|Overall Study|Withdrawal by Subject|5|||
156815864|NCT00803595|566075461|FG001|Overall Study|Withdrawal by Subject|2|||
156815865|NCT00803595|566075462|FG002|Overall Study|Withdrawal by Subject|3|||
157149626|NCT01342640|567292441|FG000|Overall Study|Adverse Event|3|||
157149627|NCT01342640|567292441|FG000|Overall Study|Protocol Violation|16|||
157149628|NCT01342640|567292441|FG000|Overall Study|Lost to Follow-up|21|||
157149629|NCT01342640|567292441|FG000|Overall Study|Other|1|||
157149630|NCT02240628|567292446|FG000|Overall Study|Physician Decision|6|||
157149631|NCT02240628|567292447|FG001|Overall Study|Physician Decision|5|||
156815866|NCT00703846|566075464|FG000|Overall Study|Adverse Event|8|||
156815867|NCT00703846|566075464|FG000|Overall Study|Lost to Follow-up|55|||
156815868|NCT00703846|566075464|FG000|Overall Study|Lack of Efficacy|15|||
156815869|NCT00703846|566075464|FG000|Overall Study|Noncompliance with Study Treatment|2|||
156815870|NCT00703846|566075464|FG000|Overall Study|Withdrawal by Subject|40|||
156815871|NCT00703846|566075464|FG000|Overall Study|Death|1|||
156815872|NCT00703846|566075464|FG000|Overall Study|Other|14|||
156815873|NCT00703846|566075464|FG000|Overall Study|Did Not Receive Study Drug|2|||
157149632|NCT01749735|567292448|FG000|Overall Study|Withdrawal by Subject|1|||
157149633|NCT01749735|567292449|FG001|Overall Study|Withdrawal by Subject|0|||
157149634|NCT01208181|567292456|FG000|Part 1|Withdrawal by Subject|11|||
157149635|NCT01208181|567292457|FG001|Part 1|Withdrawal by Subject|10|||
157149636|NCT01208181|567292458|FG002|Part 1|Withdrawal by Subject|0|||
157149637|NCT01208181|567292459|FG003|Part 1|Withdrawal by Subject|0|||
157149638|NCT01208181|567292460|FG004|Part 1|Withdrawal by Subject|0|||
157149639|NCT01208181|567292456|FG000|Part 1|Technical problem|5|||
157149640|NCT01208181|567292457|FG001|Part 1|Technical problem|0|||
157149641|NCT01208181|567292458|FG002|Part 1|Technical problem|0|||
157149642|NCT01208181|567292459|FG003|Part 1|Technical problem|0|||
157149643|NCT01208181|567292460|FG004|Part 1|Technical problem|0|||
157149644|NCT01208181|567292456|FG000|Part 1|Protocol Violation|10|||
157149645|NCT01208181|567292457|FG001|Part 1|Protocol Violation|5|||
157149646|NCT01208181|567292458|FG002|Part 1|Protocol Violation|0|||
157149647|NCT01208181|567292459|FG003|Part 1|Protocol Violation|0|||
157149648|NCT01208181|567292460|FG004|Part 1|Protocol Violation|0|||
157149649|NCT01208181|567292456|FG000|Part 1|Physician Decision|4|||
157149650|NCT01208181|567292457|FG001|Part 1|Physician Decision|0|||
157149651|NCT01208181|567292458|FG002|Part 1|Physician Decision|0|||
157149652|NCT01208181|567292459|FG003|Part 1|Physician Decision|0|||
157149653|NCT01208181|567292460|FG004|Part 1|Physician Decision|0|||
157149654|NCT01208181|567292456|FG000|Part 1|Non-compliance with study drug|1|||
157149655|NCT01208181|567292457|FG001|Part 1|Non-compliance with study drug|1|||
157149656|NCT01208181|567292458|FG002|Part 1|Non-compliance with study drug|0|||
157149657|NCT01208181|567292459|FG003|Part 1|Non-compliance with study drug|0|||
157149658|NCT01208181|567292460|FG004|Part 1|Non-compliance with study drug|0|||
157149659|NCT01208181|567292456|FG000|Part 1|Lost to Follow-up|5|||
157149660|NCT01208181|567292457|FG001|Part 1|Lost to Follow-up|3|||
156815874|NCT02195700|566075465|FG000|Overall Study|Protocol Violation|0|||
157223423|NCT02985957|567565667|FG003|Treatment Period|Not reported|5|||
156815875|NCT02195700|566075466|FG001|Overall Study|Protocol Violation|2|||
156815876|NCT02195700|566075465|FG000|Overall Study|Noncompliance|1|||
156815877|NCT02195700|566075466|FG001|Overall Study|Noncompliance|0|||
156815878|NCT02195700|566075465|FG000|Overall Study|Adverse Event|1|||
157149661|NCT01208181|567292458|FG002|Part 1|Lost to Follow-up|0|||
157149662|NCT01208181|567292459|FG003|Part 1|Lost to Follow-up|0|||
157149663|NCT01208181|567292460|FG004|Part 1|Lost to Follow-up|1|||
157149664|NCT01208181|567292456|FG000|Part 1|Lack of Efficacy|37|||
157149665|NCT01208181|567292457|FG001|Part 1|Lack of Efficacy|12|||
157149666|NCT01208181|567292458|FG002|Part 1|Lack of Efficacy|0|||
157149667|NCT01208181|567292459|FG003|Part 1|Lack of Efficacy|0|||
157149668|NCT01208181|567292460|FG004|Part 1|Lack of Efficacy|17|||
157149669|NCT01208181|567292456|FG000|Part 1|Adverse Event|26|||
157149670|NCT01208181|567292457|FG001|Part 1|Adverse Event|24|||
157149671|NCT01208181|567292458|FG002|Part 1|Adverse Event|0|||
157149672|NCT01208181|567292459|FG003|Part 1|Adverse Event|0|||
157149673|NCT01208181|567292460|FG004|Part 1|Adverse Event|4|||
156815879|NCT02195700|566075466|FG001|Overall Study|Adverse Event|2|||
156815880|NCT02195700|566075465|FG000|Overall Study|Withdrawal by Subject|3|||
156815881|NCT02195700|566075466|FG001|Overall Study|Withdrawal by Subject|2|||
156815882|NCT02195700|566075465|FG000|Overall Study|Lost to Follow-up|1|||
156815883|NCT02195700|566075466|FG001|Overall Study|Lost to Follow-up|1|||
156815884|NCT04601532|566075467|FG000|Overall Study|Lost to Follow-up|1|||
156815885|NCT04601532|566075468|FG001|Overall Study|Lost to Follow-up|2|||
156815886|NCT04601532|566075467|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
156815887|NCT04601532|566075468|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
156815888|NCT01352221|566075469|FG000|Double-blind Phase|Adverse Event|6|||
156815889|NCT01352221|566075470|FG001|Double-blind Phase|Adverse Event|4|||
156815890|NCT01352221|566075471|FG002|Double-blind Phase|Adverse Event|0|||
156815891|NCT01352221|566075472|FG003|Double-blind Phase|Adverse Event|0|||
156815892|NCT01352221|566075469|FG000|Double-blind Phase|Withdrawal by Subject|3|||
156815893|NCT01352221|566075470|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156815894|NCT01352221|566075471|FG002|Double-blind Phase|Withdrawal by Subject|0|||
156815895|NCT01352221|566075472|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156815896|NCT01352221|566075469|FG000|Double-blind Phase|Lost to Follow-up|0|||
156815897|NCT01352221|566075470|FG001|Double-blind Phase|Lost to Follow-up|1|||
156815898|NCT01352221|566075471|FG002|Double-blind Phase|Lost to Follow-up|0|||
156815899|NCT01352221|566075472|FG003|Double-blind Phase|Lost to Follow-up|0|||
156815900|NCT01352221|566075469|FG000|Double-blind Phase|Protocol Violation|0|||
156815901|NCT01352221|566075470|FG001|Double-blind Phase|Protocol Violation|1|||
156815902|NCT01352221|566075471|FG002|Double-blind Phase|Protocol Violation|0|||
156815903|NCT01352221|566075472|FG003|Double-blind Phase|Protocol Violation|0|||
156815904|NCT01352221|566075469|FG000|Open-label Phase|Physician Decision|0|||
156815905|NCT01352221|566075470|FG001|Open-label Phase|Physician Decision|0|||
156815906|NCT01352221|566075471|FG002|Open-label Phase|Physician Decision|2|||
156815907|NCT01352221|566075472|FG003|Open-label Phase|Physician Decision|1|||
156815908|NCT01352221|566075469|FG000|Open-label Phase|Pregnancy|0|||
156815909|NCT01352221|566075470|FG001|Open-label Phase|Pregnancy|0|||
156815910|NCT01352221|566075471|FG002|Open-label Phase|Pregnancy|1|||
156815911|NCT01352221|566075472|FG003|Open-label Phase|Pregnancy|0|||
156815912|NCT01352221|566075469|FG000|Open-label Phase|Adverse Event|0|||
156815913|NCT01352221|566075470|FG001|Open-label Phase|Adverse Event|0|||
156815914|NCT01352221|566075471|FG002|Open-label Phase|Adverse Event|8|||
156815915|NCT01352221|566075472|FG003|Open-label Phase|Adverse Event|4|||
156815916|NCT01352221|566075469|FG000|Open-label Phase|Withdrawal by Subject|0|||
156815917|NCT01352221|566075470|FG001|Open-label Phase|Withdrawal by Subject|0|||
156815918|NCT01352221|566075471|FG002|Open-label Phase|Withdrawal by Subject|1|||
156815919|NCT01352221|566075472|FG003|Open-label Phase|Withdrawal by Subject|6|||
156815920|NCT01352221|566075469|FG000|Open-label Phase|Worsening of IBD|0|||
156815921|NCT01352221|566075470|FG001|Open-label Phase|Worsening of IBD|0|||
156815922|NCT01352221|566075471|FG002|Open-label Phase|Worsening of IBD|1|||
157149674|NCT01208181|567292456|FG000|Part 2|Adverse Event|0|||
157149675|NCT01208181|567292457|FG001|Part 2|Adverse Event|0|||
157149676|NCT01208181|567292458|FG002|Part 2|Adverse Event|6|||
157149677|NCT01208181|567292459|FG003|Part 2|Adverse Event|7|||
157149678|NCT01208181|567292460|FG004|Part 2|Adverse Event|0|||
156815923|NCT01352221|566075472|FG003|Open-label Phase|Worsening of IBD|0|||
156815924|NCT02566785|566075473|FG000|Overall Study|Lost to Follow-up|0|||
156815925|NCT02566785|566075474|FG001|Overall Study|Lost to Follow-up|2|||
157149679|NCT01208181|567292456|FG000|Part 2|Withdrawal by Subject|0|||
157149680|NCT01208181|567292457|FG001|Part 2|Withdrawal by Subject|0|||
157149681|NCT01208181|567292458|FG002|Part 2|Withdrawal by Subject|1|||
157149682|NCT01208181|567292459|FG003|Part 2|Withdrawal by Subject|1|||
157149683|NCT01208181|567292460|FG004|Part 2|Withdrawal by Subject|0|||
157149684|NCT01208181|567292456|FG000|Part 2|Protocol Violation|0|||
157149685|NCT01208181|567292457|FG001|Part 2|Protocol Violation|0|||
156815926|NCT02566785|566075473|FG000|Overall Study|Worsening condition|1|||
156815927|NCT02566785|566075474|FG001|Overall Study|Worsening condition|1|||
156815928|NCT01597908|566075475|FG000|Randomized Phase|Death|217|||
156815929|NCT01597908|566075476|FG001|Randomized Phase|Death|238|||
156815930|NCT01597908|566075477|FG002|Randomized Phase|Death|0|||
157149686|NCT01208181|567292458|FG002|Part 2|Protocol Violation|1|||
157149687|NCT01208181|567292459|FG003|Part 2|Protocol Violation|0|||
156815931|NCT01597908|566075475|FG000|Randomized Phase|Sponsor Decision|93|||
156815932|NCT01597908|566075476|FG001|Randomized Phase|Sponsor Decision|39|||
156815933|NCT01597908|566075477|FG002|Randomized Phase|Sponsor Decision|0|||
156815934|NCT01597908|566075475|FG000|Randomized Phase|Lost to Follow-up|9|||
156815935|NCT01597908|566075476|FG001|Randomized Phase|Lost to Follow-up|16|||
157149688|NCT01208181|567292460|FG004|Part 2|Protocol Violation|0|||
157149689|NCT01208181|567292456|FG000|Part 2|Physician Decision|0|||
157149690|NCT01208181|567292457|FG001|Part 2|Physician Decision|0|||
157149691|NCT01208181|567292458|FG002|Part 2|Physician Decision|1|||
156815936|NCT01597908|566075477|FG002|Randomized Phase|Lost to Follow-up|0|||
156815937|NCT01597908|566075475|FG000|Randomized Phase|Physician Decision|6|||
156815938|NCT01597908|566075476|FG001|Randomized Phase|Physician Decision|3|||
156815939|NCT01597908|566075477|FG002|Randomized Phase|Physician Decision|0|||
156815940|NCT01597908|566075475|FG000|Randomized Phase|Withdrawal by Subject|26|||
156815941|NCT01597908|566075476|FG001|Randomized Phase|Withdrawal by Subject|22|||
156815942|NCT01597908|566075477|FG002|Randomized Phase|Withdrawal by Subject|0|||
156815943|NCT01597908|566075475|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
156815944|NCT01597908|566075476|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
156815945|NCT01597908|566075477|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
156815946|NCT01597908|566075475|FG000|Crossover Phase|Death|0|||
156815947|NCT01597908|566075476|FG001|Crossover Phase|Death|0|||
156815948|NCT01597908|566075477|FG002|Crossover Phase|Death|11|||
156815949|NCT01597908|566075475|FG000|Crossover Phase|Withdrawal by Subject|0|||
156815950|NCT01597908|566075476|FG001|Crossover Phase|Withdrawal by Subject|0|||
156815951|NCT01597908|566075477|FG002|Crossover Phase|Withdrawal by Subject|3|||
156815952|NCT01597908|566075475|FG000|Crossover Phase|Sponsor Decision|0|||
156815953|NCT01597908|566075476|FG001|Crossover Phase|Sponsor Decision|0|||
156815954|NCT01597908|566075477|FG002|Crossover Phase|Sponsor Decision|20|||
156815955|NCT00837161|566075480|FG000|Overall Study|refused hysterectomy|2|||
156815956|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Adverse Event|21|||
156815957|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Adverse Event|34|||
156815958|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Adverse Event|14|||
156815959|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Adverse Event|17|||
156884279|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
157149692|NCT01208181|567292459|FG003|Part 2|Physician Decision|2|||
157149693|NCT01208181|567292460|FG004|Part 2|Physician Decision|0|||
157149694|NCT01208181|567292456|FG000|Part 2|Non-compliance with study drug|0|||
157149695|NCT01208181|567292457|FG001|Part 2|Non-compliance with study drug|0|||
157149696|NCT01208181|567292458|FG002|Part 2|Non-compliance with study drug|1|||
157149697|NCT01208181|567292459|FG003|Part 2|Non-compliance with study drug|1|||
157149698|NCT01208181|567292460|FG004|Part 2|Non-compliance with study drug|0|||
157149699|NCT01208181|567292456|FG000|Part 2|Lost to Follow-up|0|||
157149700|NCT01208181|567292457|FG001|Part 2|Lost to Follow-up|0|||
157149701|NCT01208181|567292458|FG002|Part 2|Lost to Follow-up|1|||
157149702|NCT01208181|567292459|FG003|Part 2|Lost to Follow-up|2|||
157149703|NCT01208181|567292460|FG004|Part 2|Lost to Follow-up|0|||
157149704|NCT01208181|567292456|FG000|Part 2|Lack of Efficacy|0|||
157149705|NCT01208181|567292457|FG001|Part 2|Lack of Efficacy|0|||
157149706|NCT01208181|567292458|FG002|Part 2|Lack of Efficacy|5|||
157149707|NCT01208181|567292459|FG003|Part 2|Lack of Efficacy|7|||
157149708|NCT01208181|567292460|FG004|Part 2|Lack of Efficacy|0|||
157149709|NCT01096667|567292463|FG000|Overall Study|Lost to Follow-up|1|||
157149710|NCT01096667|567292464|FG001|Overall Study|Lost to Follow-up|1|||
157149711|NCT01096667|567292465|FG002|Overall Study|Lost to Follow-up|1|||
157149712|NCT01096667|567292466|FG003|Overall Study|Lost to Follow-up|0|||
157149713|NCT01096667|567292467|FG004|Overall Study|Lost to Follow-up|0|||
157149714|NCT01096667|567292463|FG000|Overall Study|Withdrawal by Subject|1|||
157149715|NCT01096667|567292464|FG001|Overall Study|Withdrawal by Subject|0|||
157149716|NCT01096667|567292465|FG002|Overall Study|Withdrawal by Subject|0|||
157149717|NCT01096667|567292466|FG003|Overall Study|Withdrawal by Subject|1|||
157149718|NCT01096667|567292467|FG004|Overall Study|Withdrawal by Subject|0|||
157149719|NCT01096667|567292463|FG000|Overall Study|Reason not available|0|||
157149720|NCT01096667|567292464|FG001|Overall Study|Reason not available|1|||
157149721|NCT01096667|567292465|FG002|Overall Study|Reason not available|1|||
157149722|NCT01096667|567292466|FG003|Overall Study|Reason not available|1|||
157149723|NCT01096667|567292467|FG004|Overall Study|Reason not available|0|||
157149724|NCT01096667|567292463|FG000|Overall Study|Protocol Violation|0|||
157149725|NCT01096667|567292464|FG001|Overall Study|Protocol Violation|0|||
157149726|NCT01096667|567292465|FG002|Overall Study|Protocol Violation|0|||
157149727|NCT01096667|567292466|FG003|Overall Study|Protocol Violation|1|||
156815960|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Adverse Event|0|||
156815961|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
156884280|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
156884281|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
156884282|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
157149728|NCT01096667|567292467|FG004|Overall Study|Protocol Violation|0|||
157149729|NCT01096667|567292463|FG000|Overall Study|Not treated|1|||
157223424|NCT02985957|567565668|FG004|Treatment Period|Not reported|0|||
157149730|NCT01096667|567292464|FG001|Overall Study|Not treated|0|||
156815962|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
156884283|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
157149731|NCT01096667|567292465|FG002|Overall Study|Not treated|0|||
157149732|NCT01096667|567292466|FG003|Overall Study|Not treated|0|||
157149733|NCT01096667|567292467|FG004|Overall Study|Not treated|0|||
157149734|NCT01845077|567292468|FG000|Washout Period|Lost to Follow-up|0|||
157149735|NCT01845077|567292469|FG001|Washout Period|Lost to Follow-up|1|||
157149736|NCT01845077|567292470|FG002|Washout Period|Lost to Follow-up|0|||
157149737|NCT01845077|567292471|FG003|Washout Period|Lost to Follow-up|1|||
157149738|NCT01845077|567292472|FG004|Washout Period|Lost to Follow-up|0|||
157149739|NCT01845077|567292473|FG005|Washout Period|Lost to Follow-up|1|||
156815963|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
156815964|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
156815965|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
156815966|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
156815967|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
156815968|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
156815969|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
156815970|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
156815971|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Physician Decision|2|||
156815972|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Physician Decision|4|||
156815973|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Physician Decision|4|||
156815974|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Physician Decision|4|||
156815975|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Physician Decision|0|||
156815976|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
156815977|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
156815978|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
156815979|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
156815980|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
156815981|NCT00451958|566075481|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
156815982|NCT00451958|566075482|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
156815983|NCT00451958|566075483|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
156815984|NCT00451958|566075484|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
156815985|NCT00451958|566075485|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
156815986|NCT01027650|566075488|FG000|Overall Study|Personal Reasons|0|||
156815987|NCT01027650|566075489|FG001|Overall Study|Personal Reasons|0|||
156815988|NCT01027650|566075490|FG002|Overall Study|Personal Reasons|0|||
157149740|NCT01845077|567292468|FG000|Washout Period|Adverse Event|1|||
156815989|NCT01027650|566075491|FG003|Overall Study|Personal Reasons|0|||
156815990|NCT01027650|566075492|FG004|Overall Study|Personal Reasons|2|||
156815991|NCT01027650|566075493|FG005|Overall Study|Personal Reasons|1|||
156815992|NCT01027650|566075494|FG006|Overall Study|Personal Reasons|0|||
156815993|NCT01027650|566075495|FG007|Overall Study|Personal Reasons|0|||
156815994|NCT01027650|566075488|FG000|Overall Study|Lost to Follow-up|0|||
156815995|NCT01027650|566075489|FG001|Overall Study|Lost to Follow-up|0|||
156815996|NCT01027650|566075490|FG002|Overall Study|Lost to Follow-up|0|||
156815997|NCT01027650|566075491|FG003|Overall Study|Lost to Follow-up|0|||
156815998|NCT01027650|566075492|FG004|Overall Study|Lost to Follow-up|0|||
156815999|NCT01027650|566075493|FG005|Overall Study|Lost to Follow-up|0|||
156816000|NCT01027650|566075494|FG006|Overall Study|Lost to Follow-up|1|||
156816001|NCT01027650|566075495|FG007|Overall Study|Lost to Follow-up|0|||
156816002|NCT01027650|566075488|FG000|Overall Study|Lack of Efficacy|0|||
156816003|NCT01027650|566075489|FG001|Overall Study|Lack of Efficacy|0|||
156816004|NCT01027650|566075490|FG002|Overall Study|Lack of Efficacy|0|||
157149741|NCT01845077|567292469|FG001|Washout Period|Adverse Event|0|||
157149742|NCT01845077|567292470|FG002|Washout Period|Adverse Event|0|||
157149743|NCT01845077|567292471|FG003|Washout Period|Adverse Event|0|||
157149744|NCT01845077|567292472|FG004|Washout Period|Adverse Event|0|||
157149745|NCT01845077|567292473|FG005|Washout Period|Adverse Event|0|||
157149746|NCT01845077|567292468|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
157149747|NCT01845077|567292469|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
157149748|NCT01845077|567292470|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
157149749|NCT01845077|567292471|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
157149750|NCT01845077|567292472|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
157149751|NCT01845077|567292473|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
157149752|NCT01845077|567292468|FG000|Washout Period|Protocol Violation|0|||
157149753|NCT01845077|567292469|FG001|Washout Period|Protocol Violation|0|||
157149754|NCT01845077|567292470|FG002|Washout Period|Protocol Violation|0|||
157149755|NCT01845077|567292471|FG003|Washout Period|Protocol Violation|1|||
157149756|NCT01845077|567292472|FG004|Washout Period|Protocol Violation|1|||
157149757|NCT01845077|567292473|FG005|Washout Period|Protocol Violation|0|||
157149758|NCT00394914|567292476|FG000|Treatment Period|Adverse Event|0|||
157149759|NCT00394914|567292477|FG001|Treatment Period|Adverse Event|3|||
157149760|NCT00394914|567292478|FG002|Treatment Period|Adverse Event|1|||
156816005|NCT01027650|566075491|FG003|Overall Study|Lack of Efficacy|0|||
156816006|NCT01027650|566075492|FG004|Overall Study|Lack of Efficacy|0|||
156816007|NCT01027650|566075493|FG005|Overall Study|Lack of Efficacy|1|||
157149761|NCT00394914|567292476|FG000|Treatment Period|Lost to Follow-up|0|||
157149762|NCT00394914|567292477|FG001|Treatment Period|Lost to Follow-up|1|||
157149763|NCT00394914|567292478|FG002|Treatment Period|Lost to Follow-up|0|||
157149764|NCT00394914|567292476|FG000|Treatment Period|Withdrawal by Subject|0|||
156816008|NCT01027650|566075494|FG006|Overall Study|Lack of Efficacy|0|||
156816009|NCT01027650|566075495|FG007|Overall Study|Lack of Efficacy|0|||
156816010|NCT02175277|566075496|FG000|Overall Study|Protocol-specified Criteria|1|||
156816011|NCT01082081|566075497|FG000|Overall Study|Lost to Follow-up|0|||
156816012|NCT01082081|566075498|FG001|Overall Study|Lost to Follow-up|0|||
157223425|NCT02985957|567565669|FG005|Treatment Period|Not reported|0|||
157223426|NCT02985957|567565670|FG006|Treatment Period|Not reported|0|||
157223427|NCT02985957|567565664|FG000|Treatment Period|Maximum clinical benefit|0|||
157223428|NCT02985957|567565665|FG001|Treatment Period|Maximum clinical benefit|0|||
157223429|NCT02985957|567565666|FG002|Treatment Period|Maximum clinical benefit|1|||
157223430|NCT02985957|567565667|FG003|Treatment Period|Maximum clinical benefit|1|||
157223431|NCT02985957|567565668|FG004|Treatment Period|Maximum clinical benefit|0|||
157223432|NCT02985957|567565669|FG005|Treatment Period|Maximum clinical benefit|0|||
157223433|NCT02985957|567565670|FG006|Treatment Period|Maximum clinical benefit|2|||
157223434|NCT02985957|567565664|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
157223435|NCT02985957|567565665|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
157223436|NCT02985957|567565666|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
157223437|NCT02985957|567565667|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
157223438|NCT02985957|567565668|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
157223439|NCT02985957|567565669|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
157223440|NCT02985957|567565670|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
157223441|NCT02985957|567565664|FG000|Treatment Period|Study drug toxicity|1|||
157223442|NCT02985957|567565665|FG001|Treatment Period|Study drug toxicity|23|||
157223443|NCT02985957|567565666|FG002|Treatment Period|Study drug toxicity|20|||
157223444|NCT02985957|567565667|FG003|Treatment Period|Study drug toxicity|12|||
157223445|NCT02985957|567565668|FG004|Treatment Period|Study drug toxicity|20|||
157223446|NCT02985957|567565669|FG005|Treatment Period|Study drug toxicity|3|||
157223447|NCT02985957|567565670|FG006|Treatment Period|Study drug toxicity|5|||
157223448|NCT02985957|567565664|FG000|Treatment Period|Disease progression|0|||
157223449|NCT02985957|567565665|FG001|Treatment Period|Disease progression|16|||
157223450|NCT02985957|567565666|FG002|Treatment Period|Disease progression|20|||
157223451|NCT02985957|567565667|FG003|Treatment Period|Disease progression|40|||
157223452|NCT02985957|567565668|FG004|Treatment Period|Disease progression|29|||
157223453|NCT02985957|567565669|FG005|Treatment Period|Disease progression|11|||
157223454|NCT02985957|567565670|FG006|Treatment Period|Disease progression|28|||
157223455|NCT02985957|567565664|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
157223456|NCT02985957|567565665|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
157223457|NCT02985957|567565666|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
157223458|NCT02985957|567565667|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
157223459|NCT02985957|567565668|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
157223460|NCT02985957|567565669|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
157223461|NCT02985957|567565670|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
157223462|NCT02985957|567565664|FG000|Treatment Period|Poor/Non-Compliance|0|||
157223463|NCT02985957|567565665|FG001|Treatment Period|Poor/Non-Compliance|0|||
157223464|NCT02985957|567565666|FG002|Treatment Period|Poor/Non-Compliance|0|||
157223465|NCT02985957|567565667|FG003|Treatment Period|Poor/Non-Compliance|0|||
157223466|NCT02985957|567565668|FG004|Treatment Period|Poor/Non-Compliance|1|||
157223467|NCT02985957|567565669|FG005|Treatment Period|Poor/Non-Compliance|1|||
157223468|NCT02985957|567565670|FG006|Treatment Period|Poor/Non-Compliance|0|||
157223469|NCT05845645|567565671|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223470|NCT05845645|567565672|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223471|NCT05845645|567565673|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
157223472|NCT05845645|567565674|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223473|NCT05845645|567565675|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223474|NCT05845645|567565676|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223475|NCT05845645|567565677|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157149765|NCT00394914|567292477|FG001|Treatment Period|Withdrawal by Subject|2|||
157149766|NCT00394914|567292478|FG002|Treatment Period|Withdrawal by Subject|2|||
157149767|NCT00394914|567292476|FG000|Treatment Period|Noncompliance with protocol|0|||
157149768|NCT00394914|567292477|FG001|Treatment Period|Noncompliance with protocol|3|||
157149769|NCT00394914|567292478|FG002|Treatment Period|Noncompliance with protocol|2|||
157149770|NCT00394914|567292476|FG000|Treatment Period|Did not meet protocol eligibility|0|||
157149771|NCT00394914|567292477|FG001|Treatment Period|Did not meet protocol eligibility|1|||
157149772|NCT00394914|567292478|FG002|Treatment Period|Did not meet protocol eligibility|1|||
157149773|NCT02179398|567292486|FG000|Overall Study|Lack of obligatory data|3|||
157149774|NCT02179398|567292487|FG001|Overall Study|Lack of obligatory data|3|||
157149775|NCT02179398|567292486|FG000|Overall Study|Lost to Follow-up|0|||
157149776|NCT02179398|567292487|FG001|Overall Study|Lost to Follow-up|1|||
157223476|NCT05845645|567565678|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223477|NCT05845645|567565679|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223478|NCT05845645|567565680|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157149777|NCT00465738|567292494|FG000|Overall Study|Lost to Follow-up|2|||
157149778|NCT00465738|567292495|FG001|Overall Study|Lost to Follow-up|0|||
157223479|NCT05845645|567565681|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223480|NCT05845645|567565682|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
157223481|NCT05845645|567565671|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223482|NCT05845645|567565672|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223483|NCT05845645|567565673|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223484|NCT05845645|567565674|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223485|NCT05845645|567565675|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223486|NCT05845645|567565676|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223487|NCT05845645|567565677|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223488|NCT05845645|567565678|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223489|NCT05845645|567565679|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223490|NCT05845645|567565680|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
157223491|NCT05845645|567565681|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223492|NCT05845645|567565682|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
157223493|NCT03748641|567565686|FG000|Overall Study|Ongoing|155|||
157223494|NCT03748641|567565687|FG001|Overall Study|Ongoing|148|||
157223495|NCT03748641|567565688|FG002|Overall Study|Ongoing|66|||
157223496|NCT03748641|567565689|FG003|Overall Study|Ongoing|79|||
157223497|NCT03748641|567565690|FG004|Overall Study|Ongoing|84|||
157223498|NCT03748641|567565686|FG000|Overall Study|Death|54|||
157223499|NCT03748641|567565687|FG001|Overall Study|Death|59|||
157223500|NCT03748641|567565688|FG002|Overall Study|Death|51|||
157223501|NCT03748641|567565689|FG003|Overall Study|Death|42|||
157223502|NCT03748641|567565690|FG004|Overall Study|Death|9|||
157223503|NCT03748641|567565686|FG000|Overall Study|Lost to Follow-up|0|||
157223504|NCT03748641|567565687|FG001|Overall Study|Lost to Follow-up|2|||
157223505|NCT03748641|567565688|FG002|Overall Study|Lost to Follow-up|1|||
157223506|NCT03748641|567565689|FG003|Overall Study|Lost to Follow-up|0|||
157223507|NCT03748641|567565690|FG004|Overall Study|Lost to Follow-up|0|||
157223508|NCT03748641|567565686|FG000|Overall Study|Withdrawal by Subject|3|||
157223509|NCT03748641|567565687|FG001|Overall Study|Withdrawal by Subject|2|||
157223510|NCT03748641|567565688|FG002|Overall Study|Withdrawal by Subject|5|||
157223511|NCT03748641|567565689|FG003|Overall Study|Withdrawal by Subject|3|||
157223512|NCT03748641|567565690|FG004|Overall Study|Withdrawal by Subject|2|||
157223513|NCT00638157|567565691|FG000|Overall Study|Adverse Event|0|||
157223514|NCT00638157|567565692|FG001|Overall Study|Adverse Event|1|||
157223515|NCT00638157|567565691|FG000|Overall Study|Clinical (symptomatic) failure|1|||
157223516|NCT00638157|567565692|FG001|Overall Study|Clinical (symptomatic) failure|1|||
157223517|NCT00638157|567565691|FG000|Overall Study|Microbiological failure|1|||
157223518|NCT00638157|567565692|FG001|Overall Study|Microbiological failure|0|||
157223519|NCT00638157|567565691|FG000|Overall Study|Lost to Follow-up|1|||
157223520|NCT00638157|567565692|FG001|Overall Study|Lost to Follow-up|0|||
157223521|NCT00638157|567565691|FG000|Overall Study|Physician Decision|1|||
157223522|NCT00638157|567565692|FG001|Overall Study|Physician Decision|0|||
157223523|NCT00638157|567565691|FG000|Overall Study|Other|1|||
157223524|NCT00638157|567565692|FG001|Overall Study|Other|2|||
157223525|NCT00638157|567565691|FG000|Overall Study|Randomized, not treated|2|||
157223526|NCT00638157|567565692|FG001|Overall Study|Randomized, not treated|0|||
157223527|NCT00437281|567565693|FG000|Overall Study|Adverse Event|0|||
157223528|NCT00437281|567565694|FG001|Overall Study|Adverse Event|0|||
157223529|NCT00437281|567565695|FG002|Overall Study|Adverse Event|0|||
157223530|NCT00437281|567565696|FG003|Overall Study|Adverse Event|1|||
157223531|NCT00437281|567565697|FG004|Overall Study|Adverse Event|0|||
157223532|NCT00437281|567565698|FG005|Overall Study|Adverse Event|1|||
157223533|NCT00437281|567565699|FG006|Overall Study|Adverse Event|0|||
157223534|NCT00437281|567565700|FG007|Overall Study|Adverse Event|0|||
157223535|NCT00437281|567565701|FG008|Overall Study|Adverse Event|0|||
157223536|NCT00437281|567565702|FG009|Overall Study|Adverse Event|1|||
157223537|NCT00437281|567565703|FG010|Overall Study|Adverse Event|0|||
157223538|NCT00437281|567565704|FG011|Overall Study|Adverse Event|0|||
157223539|NCT00437281|567565705|FG012|Overall Study|Adverse Event|0|||
157223540|NCT00437281|567565706|FG013|Overall Study|Adverse Event|1|||
157223541|NCT00437281|567565707|FG014|Overall Study|Adverse Event|1|||
157223542|NCT00437281|567565708|FG015|Overall Study|Adverse Event|0|||
157223543|NCT00437281|567565709|FG016|Overall Study|Adverse Event|0|||
157223544|NCT00437281|567565710|FG017|Overall Study|Adverse Event|0|||
157223545|NCT00437281|567565711|FG018|Overall Study|Adverse Event|1|||
157223546|NCT00437281|567565712|FG019|Overall Study|Adverse Event|0|||
157223547|NCT00437281|567565693|FG000|Overall Study|Lost to Follow-up|0|||
157223548|NCT00437281|567565694|FG001|Overall Study|Lost to Follow-up|0|||
157223549|NCT00437281|567565695|FG002|Overall Study|Lost to Follow-up|0|||
157223550|NCT00437281|567565696|FG003|Overall Study|Lost to Follow-up|0|||
157223551|NCT00437281|567565697|FG004|Overall Study|Lost to Follow-up|0|||
157223552|NCT00437281|567565698|FG005|Overall Study|Lost to Follow-up|0|||
157223553|NCT00437281|567565699|FG006|Overall Study|Lost to Follow-up|0|||
157223554|NCT00437281|567565700|FG007|Overall Study|Lost to Follow-up|0|||
157223555|NCT00437281|567565701|FG008|Overall Study|Lost to Follow-up|0|||
157223556|NCT00437281|567565702|FG009|Overall Study|Lost to Follow-up|0|||
157223557|NCT00437281|567565703|FG010|Overall Study|Lost to Follow-up|0|||
157149779|NCT00465738|567292494|FG000|Overall Study|Adverse Event|0|||
156816013|NCT01082081|566075499|FG002|Overall Study|Lost to Follow-up|1|||
156816014|NCT01082081|566075497|FG000|Overall Study|Withdrawal by Subject|0|||
156816015|NCT01082081|566075498|FG001|Overall Study|Withdrawal by Subject|0|||
156816016|NCT01082081|566075499|FG002|Overall Study|Withdrawal by Subject|1|||
156816017|NCT01082081|566075497|FG000|Overall Study|Other Reason|0|||
156816018|NCT01082081|566075498|FG001|Overall Study|Other Reason|1|||
156816019|NCT01082081|566075499|FG002|Overall Study|Other Reason|0|||
156816020|NCT00670930|566075500|FG000|Overall Study|Adminstrative Problem|0|||
156816021|NCT00670930|566075501|FG001|Overall Study|Adminstrative Problem|1|||
156816022|NCT00670930|566075500|FG000|Overall Study|Lost to Follow-up|1|||
156816023|NCT00670930|566075501|FG001|Overall Study|Lost to Follow-up|0|||
157149780|NCT00465738|567292495|FG001|Overall Study|Adverse Event|1|||
157149781|NCT00465738|567292494|FG000|Overall Study|Withdrawal by Subject|2|||
157149782|NCT00465738|567292495|FG001|Overall Study|Withdrawal by Subject|0|||
157149783|NCT00465738|567292494|FG000|Overall Study|Other|2|||
157149784|NCT00465738|567292495|FG001|Overall Study|Other|5|||
157149785|NCT00907738|567292496|FG000|Overall Study|Adverse Event|2|||
157149786|NCT00907738|567292497|FG001|Overall Study|Adverse Event|0|||
157149787|NCT00907738|567292498|FG002|Overall Study|Adverse Event|1|||
157149788|NCT00907738|567292499|FG003|Overall Study|Adverse Event|0|||
157149789|NCT00907738|567292500|FG004|Overall Study|Adverse Event|0|||
157149790|NCT00907738|567292496|FG000|Overall Study|not specified or withdrew consent|3|||
157149791|NCT00907738|567292497|FG001|Overall Study|not specified or withdrew consent|0|||
157149792|NCT00907738|567292498|FG002|Overall Study|not specified or withdrew consent|0|||
157149793|NCT00907738|567292499|FG003|Overall Study|not specified or withdrew consent|0|||
157149794|NCT00907738|567292500|FG004|Overall Study|not specified or withdrew consent|0|||
157149795|NCT00907738|567292496|FG000|Overall Study|Disease progression|8|||
157149796|NCT00907738|567292497|FG001|Overall Study|Disease progression|1|||
157149797|NCT00907738|567292498|FG002|Overall Study|Disease progression|6|||
157149798|NCT00907738|567292499|FG003|Overall Study|Disease progression|4|||
157149799|NCT00907738|567292500|FG004|Overall Study|Disease progression|2|||
157149800|NCT05363293|567292501|FG000|Overall Study|Withdrawal by Subject|1|||
157149801|NCT05363293|567292502|FG001|Overall Study|Withdrawal by Subject|0|||
157149802|NCT05363293|567292503|FG002|Overall Study|Withdrawal by Subject|0|||
157149803|NCT05363293|567292504|FG003|Overall Study|Withdrawal by Subject|0|||
157149804|NCT05363293|567292505|FG004|Overall Study|Withdrawal by Subject|0|||
157149805|NCT05363293|567292506|FG005|Overall Study|Withdrawal by Subject|0|||
157149806|NCT05363293|567292507|FG006|Overall Study|Withdrawal by Subject|0|||
157149807|NCT05363293|567292508|FG007|Overall Study|Withdrawal by Subject|0|||
157149808|NCT05363293|567292509|FG008|Overall Study|Withdrawal by Subject|0|||
157149809|NCT05363293|567292510|FG009|Overall Study|Withdrawal by Subject|0|||
157149810|NCT04773041|567292511|FG000|Overall Study|Unable to data match|1|||
157149811|NCT04773041|567292512|FG001|Overall Study|Unable to data match|0|||
157149812|NCT04773041|567292513|FG002|Overall Study|Unable to data match|0|||
156816024|NCT02712983|566077424|FG000|Treatment Phase|Adverse Event|3|||
156816025|NCT02712983|566077425|FG001|Treatment Phase|Adverse Event|1|||
156816026|NCT02712983|566077426|FG002|Treatment Phase|Adverse Event|1|||
156816027|NCT02712983|566077427|FG003|Treatment Phase|Adverse Event|4|||
156816028|NCT02712983|566077428|FG004|Treatment Phase|Adverse Event|3|||
156816029|NCT02712983|566077429|FG005|Treatment Phase|Adverse Event|0|||
156816030|NCT02712983|566077430|FG006|Treatment Phase|Adverse Event|6|||
156816031|NCT02712983|566077431|FG007|Treatment Phase|Adverse Event|6|||
156816032|NCT02712983|566077432|FG008|Treatment Phase|Adverse Event|1|||
156816033|NCT02712983|566077424|FG000|Treatment Phase|Protocol Deviation|0|||
156816034|NCT02712983|566077425|FG001|Treatment Phase|Protocol Deviation|0|||
156816035|NCT02712983|566077426|FG002|Treatment Phase|Protocol Deviation|0|||
156816036|NCT02712983|566077427|FG003|Treatment Phase|Protocol Deviation|2|||
157149813|NCT01318902|567292514|FG000|Overall Study|Symptomatic Deterioration|0|||
157149814|NCT01318902|567292515|FG001|Overall Study|Symptomatic Deterioration|1|||
157149815|NCT01318902|567292516|FG002|Overall Study|Symptomatic Deterioration|1|||
157149816|NCT01318902|567292517|FG003|Overall Study|Symptomatic Deterioration|2|||
157149817|NCT01318902|567292514|FG000|Overall Study|Withdrawal by Patient|0|||
157149818|NCT01318902|567292515|FG001|Overall Study|Withdrawal by Patient|1|||
157149819|NCT01318902|567292516|FG002|Overall Study|Withdrawal by Patient|0|||
157149820|NCT01318902|567292517|FG003|Overall Study|Withdrawal by Patient|3|||
157149821|NCT01318902|567292514|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
157149822|NCT01318902|567292515|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
157149823|NCT01318902|567292516|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
157149824|NCT01318902|567292517|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
157149825|NCT01318902|567292514|FG000|Overall Study|Adverse Event|0|||
157149826|NCT01318902|567292515|FG001|Overall Study|Adverse Event|1|||
156816037|NCT02712983|566077428|FG004|Treatment Phase|Protocol Deviation|0|||
157149827|NCT01318902|567292516|FG002|Overall Study|Adverse Event|0|||
157149828|NCT01318902|567292517|FG003|Overall Study|Adverse Event|0|||
157149829|NCT01318902|567292514|FG000|Overall Study|Terminated by Sponsor|0|||
157149830|NCT01318902|567292515|FG001|Overall Study|Terminated by Sponsor|0|||
157149831|NCT01318902|567292516|FG002|Overall Study|Terminated by Sponsor|1|||
157149832|NCT01318902|567292517|FG003|Overall Study|Terminated by Sponsor|0|||
157205186|NCT00464308|567496056|FG001|Overall Study|Patient discontinued and other reasons|17|||
157205187|NCT00464308|567496057|FG002|Overall Study|Patient discontinued and other reasons|23|||
157205188|NCT00464308|567496055|FG000|Overall Study|Physician Decision|1|||
157205189|NCT00464308|567496056|FG001|Overall Study|Physician Decision|0|||
157205190|NCT00464308|567496057|FG002|Overall Study|Physician Decision|0|||
157205191|NCT01721200|567496058|FG000|Overall Study|Lost to Follow-up|3|||
157205192|NCT01721200|567496059|FG001|Overall Study|Lost to Follow-up|5|||
157205193|NCT01513759|567496060|FG000|Overall Study|Protocol Violation|4|||
157205194|NCT01513759|567496060|FG000|Overall Study|Death during catheter placement|1|||
157205195|NCT03926728|567496061|FG000|Overall Study|Withdrawal by Subject|0|||
157205196|NCT03926728|567496062|FG001|Overall Study|Withdrawal by Subject|1|||
157205197|NCT03926728|567496063|FG002|Overall Study|Withdrawal by Subject|1|||
157205198|NCT03926728|567496064|FG003|Overall Study|Withdrawal by Subject|0|||
157223558|NCT00437281|567565704|FG011|Overall Study|Lost to Follow-up|0|||
157223559|NCT00437281|567565705|FG012|Overall Study|Lost to Follow-up|0|||
157223560|NCT00437281|567565706|FG013|Overall Study|Lost to Follow-up|0|||
157223561|NCT00437281|567565707|FG014|Overall Study|Lost to Follow-up|0|||
157223562|NCT00437281|567565708|FG015|Overall Study|Lost to Follow-up|0|||
157223563|NCT00437281|567565709|FG016|Overall Study|Lost to Follow-up|0|||
157223564|NCT00437281|567565710|FG017|Overall Study|Lost to Follow-up|0|||
157223565|NCT00437281|567565711|FG018|Overall Study|Lost to Follow-up|0|||
157223566|NCT00437281|567565712|FG019|Overall Study|Lost to Follow-up|1|||
157223567|NCT03495986|567565713|FG000|Overall Study|Physician Decision|1|||
157223568|NCT03495986|567565714|FG001|Overall Study|Physician Decision|0|||
157223569|NCT03495986|567565713|FG000|Overall Study|Withdrawal by Subject|1|||
157223570|NCT03495986|567565714|FG001|Overall Study|Withdrawal by Subject|1|||
157223571|NCT03495986|567565713|FG000|Overall Study|Withdrawal by Subject|1|||
157223572|NCT03495986|567565714|FG001|Overall Study|Withdrawal by Subject|0|||
157223573|NCT04309474|567565715|FG000|Overall Study|Randomized but not treated|0|||
157223574|NCT04309474|567565716|FG001|Overall Study|Randomized but not treated|2|||
157223575|NCT04309474|567565715|FG000|Overall Study|Adverse Event|4|||
157223576|NCT04309474|567565716|FG001|Overall Study|Adverse Event|1|||
157223577|NCT04309474|567565715|FG000|Overall Study|Withdrawal by Subject|6|||
157223578|NCT04309474|567565716|FG001|Overall Study|Withdrawal by Subject|9|||
157223579|NCT04309474|567565715|FG000|Overall Study|Lost to Follow-up|1|||
157223580|NCT04309474|567565716|FG001|Overall Study|Lost to Follow-up|2|||
157223581|NCT04309474|567565715|FG000|Overall Study|Not disclosed|10|||
157223582|NCT04309474|567565716|FG001|Overall Study|Not disclosed|6|||
157223583|NCT04670068|567565717|FG000|Overall Study|Progressive Disease|1|||
157223584|NCT04670068|567565718|FG001|Overall Study|Progressive Disease|1|||
157223585|NCT04670068|567565717|FG000|Overall Study|Withdrawal by Subject|1|||
157223586|NCT04670068|567565718|FG001|Overall Study|Withdrawal by Subject|0|||
157223587|NCT04684524|567565719|FG000|Overall Study|Other|2|||
157223588|NCT04684524|567565720|FG001|Overall Study|Other|0|||
157223589|NCT04684524|567565719|FG000|Overall Study|Withdrawal by Subject|5|||
157223590|NCT04684524|567565720|FG001|Overall Study|Withdrawal by Subject|3|||
157223591|NCT04684524|567565719|FG000|Overall Study|Adverse Event|1|||
157223592|NCT04684524|567565720|FG001|Overall Study|Adverse Event|1|||
157223593|NCT04182204|567565724|FG000|Safety Run-in|Lost to Follow-up|1|||
157223594|NCT04182204|567565725|FG001|Safety Run-in|Lost to Follow-up|0|||
157223595|NCT04182204|567565726|FG002|Safety Run-in|Lost to Follow-up|0|||
157223596|NCT04182204|567565724|FG000|Safety Run-in|Withdrawal by Subject|2|||
157223597|NCT04182204|567565725|FG001|Safety Run-in|Withdrawal by Subject|0|||
157223598|NCT04182204|567565726|FG002|Safety Run-in|Withdrawal by Subject|0|||
157223599|NCT04182204|567565724|FG000|Safety Run-in|Death|7|||
157223600|NCT04182204|567565725|FG001|Safety Run-in|Death|0|||
157223601|NCT04182204|567565726|FG002|Safety Run-in|Death|0|||
157223602|NCT04182204|567565724|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
157223603|NCT04182204|567565725|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
157223604|NCT04182204|567565726|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
157223605|NCT04182204|567565724|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
157205199|NCT03926728|567496065|FG004|Overall Study|Withdrawal by Subject|0|||
157205200|NCT03926728|567496066|FG005|Overall Study|Withdrawal by Subject|1|||
157223606|NCT04182204|567565725|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
157223607|NCT04182204|567565726|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
157205201|NCT03926728|567496067|FG006|Overall Study|Withdrawal by Subject|1|||
157205202|NCT03926728|567496068|FG007|Overall Study|Withdrawal by Subject|0|||
157205203|NCT03926728|567496069|FG008|Overall Study|Withdrawal by Subject|0|||
157223608|NCT04182204|567565724|FG000|Randomized Controlled Trial|Death|0|||
157223609|NCT04182204|567565725|FG001|Randomized Controlled Trial|Death|83|||
157223610|NCT04182204|567565726|FG002|Randomized Controlled Trial|Death|66|||
157223611|NCT05876091|567565727|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
157223612|NCT03402893|567565728|FG000|Overall Study|Withdrawal by Subject|1|||
157223613|NCT03466411|567565729|FG000|Overall Study|Lost to Follow-up|0|||
157223614|NCT03466411|567565730|FG001|Overall Study|Lost to Follow-up|1|||
157223615|NCT03466411|567565731|FG002|Overall Study|Lost to Follow-up|1|||
157223616|NCT03466411|567565732|FG003|Overall Study|Lost to Follow-up|0|||
157223617|NCT03466411|567565733|FG004|Overall Study|Lost to Follow-up|0|||
157223618|NCT03466411|567565734|FG005|Overall Study|Lost to Follow-up|0|||
157223619|NCT03466411|567565735|FG006|Overall Study|Lost to Follow-up|1|||
157223620|NCT03466411|567565736|FG007|Overall Study|Lost to Follow-up|1|||
157223621|NCT03466411|567565737|FG008|Overall Study|Lost to Follow-up|0|||
157223622|NCT03466411|567565738|FG009|Overall Study|Lost to Follow-up|1|||
157223623|NCT03466411|567565739|FG010|Overall Study|Lost to Follow-up|1|||
157223624|NCT03466411|567565740|FG011|Overall Study|Lost to Follow-up|1|||
157223625|NCT03466411|567565741|FG012|Overall Study|Lost to Follow-up|0|||
157223626|NCT03466411|567565729|FG000|Overall Study|Withdrawal by Subject|14|||
157223627|NCT03466411|567565730|FG001|Overall Study|Withdrawal by Subject|7|||
157223628|NCT03466411|567565731|FG002|Overall Study|Withdrawal by Subject|8|||
157223629|NCT03466411|567565732|FG003|Overall Study|Withdrawal by Subject|4|||
157223630|NCT03466411|567565733|FG004|Overall Study|Withdrawal by Subject|6|||
157223631|NCT03466411|567565734|FG005|Overall Study|Withdrawal by Subject|3|||
157223632|NCT03466411|567565735|FG006|Overall Study|Withdrawal by Subject|6|||
157223633|NCT03466411|567565736|FG007|Overall Study|Withdrawal by Subject|9|||
157223634|NCT03466411|567565737|FG008|Overall Study|Withdrawal by Subject|6|||
157223635|NCT03466411|567565738|FG009|Overall Study|Withdrawal by Subject|11|||
157223636|NCT03466411|567565739|FG010|Overall Study|Withdrawal by Subject|14|||
157223637|NCT03466411|567565740|FG011|Overall Study|Withdrawal by Subject|12|||
157223638|NCT03466411|567565741|FG012|Overall Study|Withdrawal by Subject|7|||
157223639|NCT03466411|567565729|FG000|Overall Study|Other|1|||
157223640|NCT03466411|567565730|FG001|Overall Study|Other|1|||
157223641|NCT03466411|567565731|FG002|Overall Study|Other|0|||
157223642|NCT03466411|567565732|FG003|Overall Study|Other|1|||
157223643|NCT03466411|567565733|FG004|Overall Study|Other|2|||
157223644|NCT03466411|567565734|FG005|Overall Study|Other|0|||
157223645|NCT03466411|567565735|FG006|Overall Study|Other|0|||
156816038|NCT02712983|566077429|FG005|Treatment Phase|Protocol Deviation|0|||
156816039|NCT02712983|566077430|FG006|Treatment Phase|Protocol Deviation|1|||
156816040|NCT02712983|566077431|FG007|Treatment Phase|Protocol Deviation|0|||
156816041|NCT02712983|566077432|FG008|Treatment Phase|Protocol Deviation|0|||
157149833|NCT03270085|567294815|FG000|Overall Study|Withdrawal by Subject|1|||
157149834|NCT03270085|567294816|FG001|Overall Study|Withdrawal by Subject|0|||
157149835|NCT01912872|567294824|FG000|Overall Study|Lost to Follow-up|2|||
157149836|NCT01912872|567294825|FG001|Overall Study|Lost to Follow-up|3|||
157149837|NCT01912872|567294826|FG002|Overall Study|Lost to Follow-up|5|||
157149838|NCT01912872|567294827|FG003|Overall Study|Lost to Follow-up|5|||
157149839|NCT01912872|567294824|FG000|Overall Study|Other unspecified|3|||
157149840|NCT01912872|567294825|FG001|Overall Study|Other unspecified|1|||
157149841|NCT01912872|567294826|FG002|Overall Study|Other unspecified|3|||
157149842|NCT01912872|567294827|FG003|Overall Study|Other unspecified|0|||
157149843|NCT01912872|567294824|FG000|Overall Study|Informed consent withdrawn|0|||
157149844|NCT01912872|567294825|FG001|Overall Study|Informed consent withdrawn|0|||
157149845|NCT01912872|567294826|FG002|Overall Study|Informed consent withdrawn|1|||
157149846|NCT01912872|567294827|FG003|Overall Study|Informed consent withdrawn|1|||
157149847|NCT01912872|567294824|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
157149848|NCT01912872|567294825|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
157149849|NCT01912872|567294826|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
157149850|NCT01912872|567294827|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
157149851|NCT01912872|567294824|FG000|Overall Study|Protocol Violation|0|||
157149852|NCT01912872|567294825|FG001|Overall Study|Protocol Violation|0|||
157149853|NCT01912872|567294826|FG002|Overall Study|Protocol Violation|1|||
157149854|NCT01912872|567294827|FG003|Overall Study|Protocol Violation|0|||
157149855|NCT01912872|567294824|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157149856|NCT01912872|567294825|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157149857|NCT01912872|567294826|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
157149858|NCT01912872|567294827|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
157149859|NCT01912872|567294824|FG000|Overall Study|Withdrawal of study medication|0|||
157149860|NCT01912872|567294825|FG001|Overall Study|Withdrawal of study medication|0|||
157149861|NCT01912872|567294826|FG002|Overall Study|Withdrawal of study medication|0|||
157149862|NCT01912872|567294827|FG003|Overall Study|Withdrawal of study medication|2|||
157149863|NCT01912872|567294824|FG000|Overall Study|Missing|0|||
157223646|NCT03466411|567565736|FG007|Overall Study|Other|0|||
157223647|NCT03466411|567565737|FG008|Overall Study|Other|0|||
157223648|NCT03466411|567565738|FG009|Overall Study|Other|1|||
157223649|NCT03466411|567565739|FG010|Overall Study|Other|2|||
157223650|NCT03466411|567565740|FG011|Overall Study|Other|0|||
157223651|NCT03466411|567565741|FG012|Overall Study|Other|0|||
157223652|NCT03466411|567565729|FG000|Overall Study|Randomized but not Treated|0|||
157223653|NCT03466411|567565730|FG001|Overall Study|Randomized but not Treated|0|||
157223654|NCT03466411|567565731|FG002|Overall Study|Randomized but not Treated|0|||
157223655|NCT03466411|567565732|FG003|Overall Study|Randomized but not Treated|0|||
157223656|NCT03466411|567565733|FG004|Overall Study|Randomized but not Treated|0|||
157223657|NCT03466411|567565734|FG005|Overall Study|Randomized but not Treated|0|||
157223658|NCT03466411|567565735|FG006|Overall Study|Randomized but not Treated|1|||
157149864|NCT01912872|567294825|FG001|Overall Study|Missing|0|||
157149865|NCT01912872|567294826|FG002|Overall Study|Missing|0|||
157149866|NCT01912872|567294827|FG003|Overall Study|Missing|1|||
157149867|NCT01666444|567294831|FG000|Overall Study|Did not initiate treatment|2|||
157149868|NCT01666444|567294832|FG001|Overall Study|Did not initiate treatment|1|||
157149869|NCT04760314|567294833|FG000|Induction Period|Withdrawal by Subject|0|||
157149870|NCT04760314|567294834|FG001|Induction Period|Withdrawal by Subject|1|||
157149871|NCT04760314|567294835|FG002|Induction Period|Withdrawal by Subject|1|||
157149872|NCT04760314|567294836|FG003|Induction Period|Withdrawal by Subject|0|||
157149873|NCT04760314|567294837|FG004|Induction Period|Withdrawal by Subject|0|||
157149874|NCT04760314|567294838|FG005|Induction Period|Withdrawal by Subject|0|||
157149875|NCT04760314|567294839|FG006|Induction Period|Withdrawal by Subject|0|||
157149876|NCT04760314|567294840|FG007|Induction Period|Withdrawal by Subject|0|||
157149877|NCT04760314|567294841|FG008|Induction Period|Withdrawal by Subject|0|||
157149878|NCT04760314|567294842|FG009|Induction Period|Withdrawal by Subject|0|||
157149879|NCT04760314|567294843|FG010|Induction Period|Withdrawal by Subject|0|||
157149880|NCT04760314|567294833|FG000|Induction Period|Adverse Event|0|||
157149881|NCT04760314|567294834|FG001|Induction Period|Adverse Event|0|||
157149882|NCT04760314|567294835|FG002|Induction Period|Adverse Event|2|||
157149883|NCT04760314|567294836|FG003|Induction Period|Adverse Event|0|||
157149884|NCT04760314|567294837|FG004|Induction Period|Adverse Event|0|||
157149885|NCT04760314|567294838|FG005|Induction Period|Adverse Event|0|||
157149886|NCT04760314|567294839|FG006|Induction Period|Adverse Event|0|||
157149887|NCT04760314|567294840|FG007|Induction Period|Adverse Event|0|||
157149888|NCT04760314|567294841|FG008|Induction Period|Adverse Event|0|||
157149889|NCT04760314|567294842|FG009|Induction Period|Adverse Event|0|||
157149890|NCT04760314|567294843|FG010|Induction Period|Adverse Event|0|||
157149891|NCT04760314|567294833|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149892|NCT04760314|567294834|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149893|NCT04760314|567294835|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149894|NCT04760314|567294836|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
157149895|NCT04760314|567294837|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
157149896|NCT04760314|567294838|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
157149897|NCT04760314|567294839|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
157149898|NCT04760314|567294840|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149899|NCT04760314|567294841|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149900|NCT04760314|567294842|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149901|NCT04760314|567294843|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
157149902|NCT04760314|567294833|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149903|NCT04760314|567294834|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149904|NCT04760314|567294835|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149905|NCT04760314|567294836|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
157149906|NCT04760314|567294837|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149907|NCT04760314|567294838|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
157149908|NCT04760314|567294839|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
157149909|NCT04760314|567294840|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149910|NCT04760314|567294841|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149911|NCT04760314|567294842|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149912|NCT04760314|567294843|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
157149913|NCT04760314|567294833|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149914|NCT04760314|567294834|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149915|NCT04760314|567294835|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149916|NCT04760314|567294836|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149917|NCT04760314|567294837|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
157149918|NCT04760314|567294838|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149919|NCT04760314|567294839|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149920|NCT04760314|567294840|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149921|NCT04760314|567294841|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149922|NCT04760314|567294842|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149923|NCT04760314|567294843|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
157149924|NCT04760314|567294833|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
157149925|NCT04760314|567294834|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
157149926|NCT04760314|567294835|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
157149927|NCT04760314|567294836|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
157149928|NCT04760314|567294837|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
157149929|NCT04760314|567294838|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
157149930|NCT04760314|567294839|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
157149931|NCT04760314|567294840|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
157149932|NCT04760314|567294841|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
157149933|NCT04760314|567294842|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
157149934|NCT04760314|567294843|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
157149935|NCT04760314|567294833|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
156816042|NCT02712983|566077424|FG000|Treatment Phase|Technical Problems|0|||
156816043|NCT02712983|566077425|FG001|Treatment Phase|Technical Problems|0|||
156816044|NCT02712983|566077426|FG002|Treatment Phase|Technical Problems|0|||
156816045|NCT02712983|566077427|FG003|Treatment Phase|Technical Problems|0|||
156816046|NCT02712983|566077428|FG004|Treatment Phase|Technical Problems|0|||
156816047|NCT02712983|566077429|FG005|Treatment Phase|Technical Problems|0|||
156816048|NCT02712983|566077430|FG006|Treatment Phase|Technical Problems|1|||
156816049|NCT02712983|566077431|FG007|Treatment Phase|Technical Problems|0|||
156816050|NCT02712983|566077432|FG008|Treatment Phase|Technical Problems|0|||
156816051|NCT02712983|566077424|FG000|Treatment Phase|Physician Decision|0|||
156816052|NCT02712983|566077425|FG001|Treatment Phase|Physician Decision|0|||
156816053|NCT02712983|566077426|FG002|Treatment Phase|Physician Decision|0|||
156816054|NCT02712983|566077427|FG003|Treatment Phase|Physician Decision|0|||
156816055|NCT02712983|566077428|FG004|Treatment Phase|Physician Decision|0|||
156816056|NCT02712983|566077429|FG005|Treatment Phase|Physician Decision|0|||
156816057|NCT02712983|566077430|FG006|Treatment Phase|Physician Decision|0|||
156816058|NCT02712983|566077431|FG007|Treatment Phase|Physician Decision|1|||
156816059|NCT02712983|566077432|FG008|Treatment Phase|Physician Decision|1|||
156816060|NCT02712983|566077424|FG000|Treatment Phase|Subject Decision|2|||
156816061|NCT02712983|566077425|FG001|Treatment Phase|Subject Decision|0|||
156816062|NCT02712983|566077426|FG002|Treatment Phase|Subject Decision|0|||
156816063|NCT02712983|566077427|FG003|Treatment Phase|Subject Decision|2|||
156816064|NCT02712983|566077428|FG004|Treatment Phase|Subject Decision|1|||
156816065|NCT02712983|566077429|FG005|Treatment Phase|Subject Decision|0|||
156816066|NCT02712983|566077430|FG006|Treatment Phase|Subject Decision|1|||
156816067|NCT02712983|566077431|FG007|Treatment Phase|Subject Decision|2|||
156816068|NCT02712983|566077432|FG008|Treatment Phase|Subject Decision|0|||
156816069|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816070|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816071|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816072|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816073|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816074|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816075|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816076|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
156816077|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
156816078|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816079|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816080|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816081|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
156816082|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816083|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816084|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816085|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816086|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
156816087|NCT02712983|566077424|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816088|NCT02712983|566077425|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816089|NCT02712983|566077426|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816090|NCT02712983|566077427|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816091|NCT02712983|566077428|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
156816092|NCT02712983|566077429|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
156816093|NCT02712983|566077430|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
156816094|NCT02712983|566077431|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
156816095|NCT02712983|566077432|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
156816096|NCT00064259|566077433|FG000|Overall Study|Adverse Event|1|||
156816097|NCT00064259|566077434|FG001|Overall Study|Adverse Event|0|||
156816098|NCT00064259|566077435|FG002|Overall Study|Adverse Event|0|||
156816099|NCT00064259|566077436|FG003|Overall Study|Adverse Event|1|||
156816100|NCT01132651|566077439|FG000|Overall Study|Lost to Follow-up|1|||
156816101|NCT01132651|566077440|FG001|Overall Study|Lost to Follow-up|1|||
156816102|NCT03062280|566077451|FG000|Overall Study|Adverse Event|1|||
156816103|NCT03062280|566077451|FG000|Overall Study|Death|1|||
156816104|NCT03062280|566077451|FG000|Overall Study|Fertility Treatment|2|||
156816105|NCT03062280|566077451|FG000|Overall Study|Physician Decision|2|||
156816106|NCT03062280|566077451|FG000|Overall Study|Pregnancy|5|||
156816107|NCT03062280|566077451|FG000|Overall Study|Withdrawal by Subject|11|||
156816108|NCT03462641|566077452|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
156816109|NCT03462641|566077453|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
156816110|NCT03462641|566077452|FG000|Visit 2|Withdrawal by Subject|0|||
156816111|NCT03462641|566077453|FG001|Visit 2|Withdrawal by Subject|1|||
156816112|NCT01804049|566077454|FG000|Overall Study|Adverse Event|2|||
156816113|NCT01804049|566077455|FG001|Overall Study|Adverse Event|10|||
156816114|NCT01804049|566077454|FG000|Overall Study|Lost to Follow-up|2|||
156816115|NCT01804049|566077455|FG001|Overall Study|Lost to Follow-up|1|||
156816116|NCT01804049|566077454|FG000|Overall Study|Decreased interest/personal|4|||
156816117|NCT01804049|566077455|FG001|Overall Study|Decreased interest/personal|5|||
156816118|NCT01804049|566077454|FG000|Overall Study|Other health concerns|2|||
156816119|NCT01804049|566077455|FG001|Overall Study|Other health concerns|7|||
156816120|NCT01804049|566077454|FG000|Overall Study|Moved out of area|0|||
156816121|NCT01804049|566077455|FG001|Overall Study|Moved out of area|7|||
156816122|NCT01804049|566077454|FG000|Overall Study|other MD recommended|1|||
156816123|NCT01804049|566077455|FG001|Overall Study|other MD recommended|1|||
156816124|NCT01804049|566077454|FG000|Overall Study|Enrollment in dual studies|0|||
156816125|NCT01804049|566077455|FG001|Overall Study|Enrollment in dual studies|1|||
156816126|NCT00070109|566077456|FG000|Overall Study|Death|1|||
156816127|NCT00070109|566077457|FG001|Overall Study|Death|1|||
156816128|NCT00070109|566077458|FG002|Overall Study|Death|0|||
156816129|NCT00070109|566077459|FG003|Overall Study|Death|0|||
156816130|NCT00070109|566077460|FG004|Overall Study|Death|1|||
156816131|NCT00070109|566077456|FG000|Overall Study|Lack of Efficacy|6|||
156816132|NCT00070109|566077457|FG001|Overall Study|Lack of Efficacy|4|||
156816133|NCT00070109|566077458|FG002|Overall Study|Lack of Efficacy|5|||
156816134|NCT00070109|566077459|FG003|Overall Study|Lack of Efficacy|15|||
156816135|NCT00070109|566077460|FG004|Overall Study|Lack of Efficacy|5|||
156816136|NCT00070109|566077456|FG000|Overall Study|Physician Decision|1|||
156816137|NCT00070109|566077457|FG001|Overall Study|Physician Decision|0|||
156816138|NCT00070109|566077458|FG002|Overall Study|Physician Decision|0|||
156816139|NCT00070109|566077459|FG003|Overall Study|Physician Decision|0|||
156816140|NCT00070109|566077460|FG004|Overall Study|Physician Decision|0|||
157149936|NCT04760314|567294834|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149937|NCT04760314|567294835|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149938|NCT04760314|567294836|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149939|NCT04760314|567294837|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149940|NCT04760314|567294838|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149941|NCT04760314|567294839|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149942|NCT04760314|567294840|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
157149943|NCT04760314|567294841|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
157149944|NCT04760314|567294842|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
157149945|NCT04760314|567294843|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
157149946|NCT04760314|567294833|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149947|NCT04760314|567294834|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149948|NCT04760314|567294835|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149949|NCT04760314|567294836|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149950|NCT04760314|567294837|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156816141|NCT00070109|566077456|FG000|Overall Study|Withdrawal by Subject|0|||
156816142|NCT00070109|566077457|FG001|Overall Study|Withdrawal by Subject|1|||
156816143|NCT00070109|566077458|FG002|Overall Study|Withdrawal by Subject|1|||
157149951|NCT04760314|567294838|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149952|NCT04760314|567294839|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
157149953|NCT04760314|567294840|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
157149954|NCT04760314|567294841|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
157149955|NCT04760314|567294842|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
156816144|NCT00070109|566077459|FG003|Overall Study|Withdrawal by Subject|0|||
156816145|NCT00070109|566077460|FG004|Overall Study|Withdrawal by Subject|0|||
156816146|NCT00070109|566077456|FG000|Overall Study|Adverse Event|0|||
156816147|NCT00070109|566077457|FG001|Overall Study|Adverse Event|0|||
156816148|NCT00070109|566077458|FG002|Overall Study|Adverse Event|2|||
156816149|NCT00070109|566077459|FG003|Overall Study|Adverse Event|4|||
156816150|NCT00070109|566077460|FG004|Overall Study|Adverse Event|2|||
156816151|NCT00070109|566077456|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
156816152|NCT00070109|566077457|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
156816153|NCT00070109|566077458|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
156816154|NCT00070109|566077459|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
156816155|NCT00070109|566077460|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
156816156|NCT01147250|566077463|FG000|Overall Study|Lost to Follow-up|14|||
157149956|NCT04760314|567294843|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
156816157|NCT01147250|566077464|FG001|Overall Study|Lost to Follow-up|11|||
156816158|NCT01147250|566077463|FG000|Overall Study|Withdrawal by Subject|83|||
156816159|NCT01147250|566077464|FG001|Overall Study|Withdrawal by Subject|88|||
156816160|NCT01147250|566077463|FG000|Overall Study|Site termination by sponsor|13|||
156816161|NCT01147250|566077464|FG001|Overall Study|Site termination by sponsor|5|||
156816162|NCT01147250|566077463|FG000|Overall Study|Other than specified|0|||
156816163|NCT01147250|566077464|FG001|Overall Study|Other than specified|1|||
156816164|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
157149957|NCT04760314|567294833|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149958|NCT04760314|567294834|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156816165|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
156816166|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816167|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816168|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816169|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
156816170|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
156816171|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
156816172|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816173|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816174|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816175|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156816176|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
156816177|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
156816178|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816179|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816180|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816181|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156816182|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
156816183|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
156816184|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816185|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816186|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
156816187|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
157149959|NCT04760314|567294835|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149960|NCT04760314|567294836|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149961|NCT04760314|567294837|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149962|NCT04760314|567294838|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149963|NCT04760314|567294839|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
156816188|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816189|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
156816190|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816191|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816192|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816193|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156816194|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
156816195|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
156816196|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816197|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
157149964|NCT04760314|567294840|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
157223659|NCT03466411|567565736|FG007|Overall Study|Randomized but not Treated|0|||
157223660|NCT03466411|567565737|FG008|Overall Study|Randomized but not Treated|0|||
156816198|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816199|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
156816200|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
157149965|NCT04760314|567294841|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157223661|NCT03466411|567565738|FG009|Overall Study|Randomized but not Treated|0|||
157149966|NCT04760314|567294842|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157149967|NCT04760314|567294843|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
157223662|NCT03466411|567565739|FG010|Overall Study|Randomized but not Treated|0|||
157149968|NCT04760314|567294833|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149969|NCT04760314|567294834|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149970|NCT04760314|567294835|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149971|NCT04760314|567294836|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149972|NCT04760314|567294837|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149973|NCT04760314|567294838|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149974|NCT04760314|567294839|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149975|NCT04760314|567294840|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149976|NCT04760314|567294841|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
157149977|NCT04760314|567294842|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
157223663|NCT03466411|567565740|FG011|Overall Study|Randomized but not Treated|0|||
157223664|NCT03466411|567565741|FG012|Overall Study|Randomized but not Treated|0|||
157223665|NCT00926289|567565745|FG000|Overall Study|Adverse Event|9|||
157223666|NCT00926289|567565746|FG001|Overall Study|Adverse Event|11|||
157223667|NCT00926289|567565745|FG000|Overall Study|Protocol Violation|8|||
157223668|NCT00926289|567565746|FG001|Overall Study|Protocol Violation|12|||
157223669|NCT00926289|567565745|FG000|Overall Study|Lost to Follow-up|3|||
157223670|NCT00926289|567565746|FG001|Overall Study|Lost to Follow-up|6|||
156816201|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
157223671|NCT00926289|567565745|FG000|Overall Study|Withdrawal by Subject|4|||
157223672|NCT00926289|567565746|FG001|Overall Study|Withdrawal by Subject|4|||
157223673|NCT00926289|567565745|FG000|Overall Study|Other|1|||
157223674|NCT00926289|567565746|FG001|Overall Study|Other|3|||
157223675|NCT04104646|567565747|FG000|Overall Study|Withdrawal by Subject|1|||
157223676|NCT04104646|567565748|FG001|Overall Study|Withdrawal by Subject|1|||
157223677|NCT04104646|567565747|FG000|Overall Study|Lost to Follow-up|1|||
157223678|NCT04104646|567565748|FG001|Overall Study|Lost to Follow-up|0|||
157223679|NCT04104646|567565747|FG000|Overall Study|Physician Decision|2|||
157223680|NCT04104646|567565748|FG001|Overall Study|Physician Decision|0|||
157223681|NCT00319956|567565749|FG000|Overall Study|Death|20|||
157223682|NCT00319956|567565750|FG001|Overall Study|Death|24|||
156816202|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816203|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816204|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816205|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
156816206|NCT03985943|566077469|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816207|NCT03985943|566077470|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
157223683|NCT02607800|567565751|FG000|Overall Study|Lost to Follow-up|7|||
157223684|NCT02607800|567565752|FG001|Overall Study|Lost to Follow-up|10|||
157223685|NCT02607800|567565751|FG000|Overall Study|Withdrew Consent|2|||
157223686|NCT02607800|567565752|FG001|Overall Study|Withdrew Consent|0|||
157223687|NCT02607800|567565751|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
157223688|NCT02607800|567565752|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
157223689|NCT00753714|567565753|FG000|Overall Study|Lack of Efficacy|21|||
157223690|NCT00753714|567565754|FG001|Overall Study|Lack of Efficacy|34|||
157223691|NCT00753714|567565753|FG000|Overall Study|Adverse Event|26|||
157223692|NCT00753714|567565754|FG001|Overall Study|Adverse Event|18|||
156816208|NCT03985943|566077471|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816209|NCT03985943|566077472|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816210|NCT03985943|566077473|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816211|NCT03985943|566077474|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
156816212|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156816213|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156816214|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
156816215|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156816216|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
156816217|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
156816218|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156816219|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156816220|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816221|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156816222|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816223|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
156816224|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
156816225|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
156816226|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
156816227|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
156816228|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
156816229|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
156816230|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816231|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816232|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156816233|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156816234|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156816235|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
157223693|NCT00753714|567565753|FG000|Overall Study|Protocol Violation|1|||
157223694|NCT00753714|567565754|FG001|Overall Study|Protocol Violation|0|||
157223695|NCT00753714|567565753|FG000|Overall Study|Lost to Follow-up|0|||
157223696|NCT00753714|567565754|FG001|Overall Study|Lost to Follow-up|1|||
157223697|NCT00753714|567565753|FG000|Overall Study|Withdrawal by Subject|2|||
157223698|NCT00753714|567565754|FG001|Overall Study|Withdrawal by Subject|1|||
157223699|NCT00753714|567565753|FG000|Overall Study|Death|3|||
157223700|NCT00753714|567565754|FG001|Overall Study|Death|3|||
157223701|NCT00753714|567565753|FG000|Overall Study|Other|7|||
157223702|NCT00753714|567565754|FG001|Overall Study|Other|5|||
157223703|NCT03387098|567565755|FG000|Overall Study|progressive disease|1|||
157223704|NCT03387098|567565755|FG000|Overall Study|Withdrawal by Subject|2|||
157223705|NCT03387098|567565755|FG000|Overall Study|study terminated by sponsor|1|||
156816236|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816237|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816238|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
156816239|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816240|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
156816241|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
156816242|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
156816243|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
156816244|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
156816245|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
156816246|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
156816247|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
156816248|NCT03985943|566077469|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
156816249|NCT03985943|566077470|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
156816250|NCT03985943|566077471|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
156816251|NCT03985943|566077472|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
156816252|NCT03985943|566077473|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
156816253|NCT03985943|566077474|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
156816254|NCT00716482|566077475|FG000|Overall Study|Lost to Follow-up|6|||
156816255|NCT00716482|566077475|FG000|Overall Study|Inadequate acquisition or analysis|50|||
156816256|NCT00716482|566077475|FG000|Overall Study|no pathology obtained|10|||
156816257|NCT00716482|566077475|FG000|Overall Study|technical/machine error|28|||
156816258|NCT00716482|566077475|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
156816259|NCT03248531|566077476|FG000|Overall Study|Adverse Event|0|||
156816260|NCT03248531|566077477|FG001|Overall Study|Adverse Event|0|||
156816261|NCT03248531|566077478|FG002|Overall Study|Adverse Event|1|||
156816262|NCT03248531|566077476|FG000|Overall Study|Lost to Follow-up|1|||
156816263|NCT03248531|566077477|FG001|Overall Study|Lost to Follow-up|0|||
156816264|NCT03248531|566077478|FG002|Overall Study|Lost to Follow-up|5|||
156816265|NCT03248531|566077476|FG000|Overall Study|Withdrawal by Subject|3|||
156816266|NCT03248531|566077477|FG001|Overall Study|Withdrawal by Subject|3|||
156816267|NCT03248531|566077478|FG002|Overall Study|Withdrawal by Subject|2|||
156816268|NCT03248531|566077476|FG000|Overall Study|Sponsor Request|0|||
156816269|NCT03248531|566077477|FG001|Overall Study|Sponsor Request|2|||
156816270|NCT03248531|566077478|FG002|Overall Study|Sponsor Request|0|||
156816271|NCT04075513|566077481|FG000|Overall Study|Withdrawal by Subject|2|||
156816272|NCT04075513|566077482|FG001|Overall Study|Withdrawal by Subject|2|||
156816273|NCT04075513|566077481|FG000|Overall Study|Lack of Efficacy|1|||
156816274|NCT04075513|566077482|FG001|Overall Study|Lack of Efficacy|0|||
156816275|NCT04075513|566077481|FG000|Overall Study|Lost to Follow-up|4|||
156816276|NCT04075513|566077482|FG001|Overall Study|Lost to Follow-up|2|||
156816277|NCT04075513|566077481|FG000|Overall Study|Switch to insulin pump|1|||
156816278|NCT04075513|566077482|FG001|Overall Study|Switch to insulin pump|0|||
156816279|NCT03249909|566077483|FG000|Overall Study|Withdrawal by Subject|3|||
156816280|NCT03249909|566077484|FG001|Overall Study|Withdrawal by Subject|0|||
156816281|NCT03249909|566077485|FG002|Overall Study|Withdrawal by Subject|0|||
156816282|NCT03249909|566077483|FG000|Overall Study|Adverse Event|3|||
156816283|NCT03249909|566077484|FG001|Overall Study|Adverse Event|0|||
156816284|NCT03249909|566077485|FG002|Overall Study|Adverse Event|0|||
156816285|NCT03249909|566077483|FG000|Overall Study|Lost to Follow-up|0|||
156816286|NCT03249909|566077484|FG001|Overall Study|Lost to Follow-up|1|||
156816287|NCT03249909|566077485|FG002|Overall Study|Lost to Follow-up|0|||
156816288|NCT00842153|566077488|FG000|Overall Study|Adverse Event|0|||
156816289|NCT00842153|566077489|FG001|Overall Study|Adverse Event|1|||
156816290|NCT00842153|566077488|FG000|Overall Study|Lost to Follow-up|1|||
156816291|NCT00842153|566077489|FG001|Overall Study|Lost to Follow-up|2|||
156816292|NCT03517371|566077490|FG000|Overall Study|Adverse Event|8|||
156816293|NCT03517371|566077491|FG001|Overall Study|Adverse Event|9|||
156816294|NCT03517371|566077490|FG000|Overall Study|Lost to Follow-up|1|||
156816295|NCT03517371|566077491|FG001|Overall Study|Lost to Follow-up|2|||
156816296|NCT03517371|566077490|FG000|Overall Study|Withdrawal by Subject|4|||
156816297|NCT03517371|566077491|FG001|Overall Study|Withdrawal by Subject|4|||
156816298|NCT03517371|566077490|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
156816299|NCT03517371|566077491|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
156816300|NCT03517371|566077490|FG000|Overall Study|COVID restrictions|2|||
156816301|NCT03517371|566077491|FG001|Overall Study|COVID restrictions|0|||
156816302|NCT03517371|566077490|FG000|Overall Study|Receiving DBS Surgery|0|||
156816303|NCT03517371|566077491|FG001|Overall Study|Receiving DBS Surgery|1|||
156816304|NCT05411822|566077492|FG000|Overall Study|Withdrawal by Subject|2|||
156816305|NCT05411822|566077493|FG001|Overall Study|Withdrawal by Subject|1|||
156816306|NCT02201329|566077495|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
156816307|NCT02201329|566077495|FG000|Overall Study|Withdrawal by Subject|2|||
156816308|NCT01534351|566077496|FG000|Overall Study|Study Terminated Early|1|||
156816309|NCT01534351|566077497|FG001|Overall Study|Study Terminated Early|0|||
157022535|NCT01902173|566835250|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
157022536|NCT01902173|566835251|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
157022537|NCT01902173|566835252|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
157022538|NCT01902173|566835253|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
157022539|NCT01902173|566835254|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
157022540|NCT01902173|566835255|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
157022541|NCT01902173|566835250|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
157022542|NCT01902173|566835251|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
157022543|NCT01902173|566835252|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
157022544|NCT01902173|566835253|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
157022545|NCT01902173|566835254|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
157022546|NCT01902173|566835255|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
157022547|NCT01902173|566835250|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156816310|NCT01534351|566077498|FG002|Overall Study|Study Terminated Early|0|||
157149978|NCT04760314|567294843|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
157149979|NCT01013883|567294846|FG000|Overall Study|Lost to Follow-up|2|||
157149980|NCT01013883|567294847|FG001|Overall Study|Lost to Follow-up|2|||
157149981|NCT01371838|567294848|FG000|Overall Study|Withdrawal by Subject|27|||
156816311|NCT02702609|566077499|FG000|Overall Study|Lost to Follow-up|8|||
156816312|NCT02702609|566077500|FG001|Overall Study|Lost to Follow-up|4|||
156816313|NCT02702609|566077499|FG000|Overall Study|Physician Decision|1|||
156816314|NCT02702609|566077500|FG001|Overall Study|Physician Decision|0|||
156816315|NCT02674464|566077501|FG000|Overall Study|Death|10|||
156816316|NCT02674464|566077502|FG001|Overall Study|Death|21|||
156816317|NCT02674464|566077501|FG000|Overall Study|Withdrawal by Subject|24|||
156816318|NCT02674464|566077502|FG001|Overall Study|Withdrawal by Subject|44|||
156816319|NCT02674464|566077501|FG000|Overall Study|Lost to Follow-up|97|||
156816320|NCT02674464|566077502|FG001|Overall Study|Lost to Follow-up|92|||
156816321|NCT02674464|566077501|FG000|Overall Study|Outside survey window|6|||
156816322|NCT02674464|566077502|FG001|Overall Study|Outside survey window|3|||
156816323|NCT04153981|566077503|FG000|Overall Study|Death|1|||
156816324|NCT04153981|566077503|FG000|Overall Study|Withdrawal by Subject|24|||
156816325|NCT04153981|566077503|FG000|Overall Study|Lost to Follow-up|1|||
156816326|NCT04153981|566077503|FG000|Overall Study|Physician Decision|1|||
156816327|NCT04153981|566077503|FG000|Overall Study|Due to Unavailable Glucometer|1|||
156816328|NCT04153981|566077503|FG000|Overall Study|Covid 19|52|||
156816329|NCT04153981|566077503|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
156816330|NCT04153981|566077503|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
156816331|NCT01262638|566077504|FG000|Overall Study|Adverse Event|3|||
156816332|NCT01262638|566077505|FG001|Overall Study|Adverse Event|4|||
156816333|NCT01262638|566077506|FG002|Overall Study|Adverse Event|3|||
156816334|NCT01262638|566077507|FG003|Overall Study|Adverse Event|4|||
156816335|NCT01262638|566077504|FG000|Overall Study|Protocol Violation|1|||
156816336|NCT01262638|566077505|FG001|Overall Study|Protocol Violation|0|||
156816337|NCT01262638|566077506|FG002|Overall Study|Protocol Violation|0|||
156816338|NCT01262638|566077507|FG003|Overall Study|Protocol Violation|1|||
156816339|NCT01262638|566077504|FG000|Overall Study|Withdrawal by Subject|2|||
156816340|NCT01262638|566077505|FG001|Overall Study|Withdrawal by Subject|1|||
156816341|NCT01262638|566077506|FG002|Overall Study|Withdrawal by Subject|0|||
156816342|NCT01262638|566077507|FG003|Overall Study|Withdrawal by Subject|1|||
156816343|NCT01262638|566077504|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816344|NCT01262638|566077505|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816345|NCT01262638|566077506|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
156816346|NCT01262638|566077507|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156816347|NCT01262638|566077504|FG000|Overall Study|Lost to Follow-up|1|||
156816348|NCT01262638|566077505|FG001|Overall Study|Lost to Follow-up|1|||
156816349|NCT01262638|566077506|FG002|Overall Study|Lost to Follow-up|1|||
156816350|NCT01262638|566077507|FG003|Overall Study|Lost to Follow-up|1|||
156816351|NCT01262638|566077504|FG000|Overall Study|Participant Went Out of Town|0|||
156816352|NCT01262638|566077505|FG001|Overall Study|Participant Went Out of Town|0|||
156816353|NCT01262638|566077506|FG002|Overall Study|Participant Went Out of Town|1|||
156816354|NCT01262638|566077507|FG003|Overall Study|Participant Went Out of Town|0|||
156816355|NCT01369199|566077510|FG000|Overall Study|Withdrawal by Subject|1|||
156816356|NCT01369199|566077510|FG000|Overall Study|Lost to Follow-up|2|||
156816357|NCT01071252|566077511|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
157022548|NCT01902173|566835251|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
157149982|NCT01371838|567294849|FG001|Overall Study|Withdrawal by Subject|33|||
157149983|NCT01371838|567294848|FG000|Overall Study|Lost to Follow-up|10|||
156816358|NCT01071252|566077512|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
156816359|NCT01071252|566077513|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
156816360|NCT01071252|566077514|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
156816361|NCT01071252|566077515|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
157022549|NCT01902173|566835252|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
157149984|NCT01371838|567294849|FG001|Overall Study|Lost to Follow-up|20|||
157149985|NCT01371838|567294848|FG000|Overall Study|Death|3|||
157149986|NCT01371838|567294849|FG001|Overall Study|Death|4|||
157149987|NCT01371838|567294848|FG000|Overall Study|Protocol Violation|3|||
156816362|NCT01071252|566077511|FG000|Overall Study|Withdrawal by Subject|8|||
156816363|NCT01071252|566077512|FG001|Overall Study|Withdrawal by Subject|2|||
156816364|NCT01071252|566077513|FG002|Overall Study|Withdrawal by Subject|1|||
156816365|NCT01071252|566077514|FG003|Overall Study|Withdrawal by Subject|2|||
156816366|NCT01071252|566077515|FG004|Overall Study|Withdrawal by Subject|3|||
156816367|NCT01071252|566077511|FG000|Overall Study|administrative problems|1|||
156816368|NCT01071252|566077512|FG001|Overall Study|administrative problems|1|||
156816369|NCT01071252|566077513|FG002|Overall Study|administrative problems|0|||
156816370|NCT01071252|566077514|FG003|Overall Study|administrative problems|2|||
156816371|NCT01071252|566077515|FG004|Overall Study|administrative problems|1|||
156816372|NCT01071252|566077511|FG000|Overall Study|Lost to Follow-up|1|||
156816373|NCT01071252|566077512|FG001|Overall Study|Lost to Follow-up|0|||
156816374|NCT01071252|566077513|FG002|Overall Study|Lost to Follow-up|1|||
156816375|NCT01071252|566077514|FG003|Overall Study|Lost to Follow-up|2|||
156816376|NCT01071252|566077515|FG004|Overall Study|Lost to Follow-up|0|||
156816377|NCT01071252|566077511|FG000|Overall Study|Adverse Event|1|||
156816378|NCT01071252|566077512|FG001|Overall Study|Adverse Event|1|||
156816379|NCT01071252|566077513|FG002|Overall Study|Adverse Event|0|||
156816380|NCT01071252|566077514|FG003|Overall Study|Adverse Event|1|||
156816381|NCT01071252|566077515|FG004|Overall Study|Adverse Event|0|||
156816382|NCT01071252|566077511|FG000|Overall Study|Death|0|||
156816383|NCT01071252|566077512|FG001|Overall Study|Death|0|||
156816384|NCT01071252|566077513|FG002|Overall Study|Death|0|||
156816385|NCT01071252|566077514|FG003|Overall Study|Death|0|||
156816386|NCT01071252|566077515|FG004|Overall Study|Death|1|||
156816387|NCT01066104|566077516|FG000|Overall Study|Adverse Event|1|||
156816388|NCT01066104|566077517|FG001|Overall Study|Adverse Event|1|||
156816389|NCT01066104|566077516|FG000|Overall Study|Protocol Violation|1|||
156816390|NCT01066104|566077517|FG001|Overall Study|Protocol Violation|0|||
156816391|NCT02125838|566077518|FG000|Overall Study|Lost to Follow-up|4|||
156816392|NCT02125838|566077519|FG001|Overall Study|Lost to Follow-up|4|||
156816393|NCT00787839|566077520|FG000|Overall Study|Failure to have the OGTT was most common|404|||
156816394|NCT03902392|566077521|FG000|Overall Study|Lost to Follow-up|7|||
156816395|NCT03902392|566077522|FG001|Overall Study|Lost to Follow-up|7|||
156816396|NCT00244725|566077527|FG000|Overall Study|Lost to Follow-up|3|||
156816397|NCT00244725|566077528|FG001|Overall Study|Lost to Follow-up|4|||
156816398|NCT00244725|566077529|FG002|Overall Study|Lost to Follow-up|9|||
156816399|NCT00244725|566077530|FG003|Overall Study|Lost to Follow-up|2|||
156816400|NCT00244725|566077527|FG000|Overall Study|Withdrawal by Subject|9|||
156816401|NCT00244725|566077528|FG001|Overall Study|Withdrawal by Subject|7|||
156816402|NCT00244725|566077529|FG002|Overall Study|Withdrawal by Subject|7|||
156816403|NCT00244725|566077530|FG003|Overall Study|Withdrawal by Subject|8|||
156816404|NCT00244725|566077527|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
156816405|NCT00244725|566077528|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
156816406|NCT00244725|566077529|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
156816407|NCT00244725|566077530|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
156816408|NCT00244725|566077527|FG000|Overall Study|Physician Decision|3|||
156816409|NCT00244725|566077528|FG001|Overall Study|Physician Decision|0|||
156816410|NCT00244725|566077529|FG002|Overall Study|Physician Decision|1|||
156816411|NCT00244725|566077530|FG003|Overall Study|Physician Decision|2|||
156816412|NCT00244725|566077527|FG000|Overall Study|Adverse Events|3|||
156816413|NCT00244725|566077528|FG001|Overall Study|Adverse Events|1|||
156816414|NCT00244725|566077529|FG002|Overall Study|Adverse Events|4|||
156816415|NCT00244725|566077530|FG003|Overall Study|Adverse Events|4|||
156816416|NCT00244725|566077527|FG000|Overall Study|Withdrwal by participant|1|||
156816417|NCT00244725|566077528|FG001|Overall Study|Withdrwal by participant|0|||
156816418|NCT00244725|566077529|FG002|Overall Study|Withdrwal by participant|0|||
156816419|NCT00244725|566077530|FG003|Overall Study|Withdrwal by participant|1|||
156816420|NCT00244725|566077527|FG000|Overall Study|Liver function test abnormality|2|||
156816421|NCT00244725|566077528|FG001|Overall Study|Liver function test abnormality|0|||
156816422|NCT00244725|566077529|FG002|Overall Study|Liver function test abnormality|0|||
156816423|NCT00244725|566077530|FG003|Overall Study|Liver function test abnormality|1|||
156816424|NCT00244725|566077527|FG000|Overall Study|Sponsor withdrew the participant|1|||
156816425|NCT00244725|566077528|FG001|Overall Study|Sponsor withdrew the participant|0|||
156816426|NCT00244725|566077529|FG002|Overall Study|Sponsor withdrew the participant|0|||
156816427|NCT00244725|566077530|FG003|Overall Study|Sponsor withdrew the participant|1|||
156816428|NCT00244725|566077527|FG000|Overall Study|Mediciation Error|0|||
157149988|NCT01371838|567294849|FG001|Overall Study|Protocol Violation|0|||
156816429|NCT00244725|566077528|FG001|Overall Study|Mediciation Error|1|||
156816430|NCT00244725|566077529|FG002|Overall Study|Mediciation Error|0|||
156816431|NCT00244725|566077530|FG003|Overall Study|Mediciation Error|0|||
156816432|NCT00244725|566077527|FG000|Overall Study|Rehab Refused to allow participantion|0|||
156816433|NCT00244725|566077528|FG001|Overall Study|Rehab Refused to allow participantion|1|||
157149989|NCT01371838|567294848|FG000|Overall Study|Investigator Decision|3|||
156816434|NCT00244725|566077529|FG002|Overall Study|Rehab Refused to allow participantion|0|||
156816435|NCT00244725|566077530|FG003|Overall Study|Rehab Refused to allow participantion|0|||
156816436|NCT00244725|566077527|FG000|Overall Study|Headache|0|||
156816437|NCT00244725|566077528|FG001|Overall Study|Headache|1|||
156816438|NCT00244725|566077529|FG002|Overall Study|Headache|0|||
156816439|NCT00244725|566077530|FG003|Overall Study|Headache|0|||
156816440|NCT00244725|566077527|FG000|Overall Study|Received prohibited medication|0|||
156816441|NCT00244725|566077528|FG001|Overall Study|Received prohibited medication|1|||
156816442|NCT00244725|566077529|FG002|Overall Study|Received prohibited medication|0|||
156816443|NCT00244725|566077530|FG003|Overall Study|Received prohibited medication|1|||
156816444|NCT00244725|566077527|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816445|NCT00244725|566077528|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
156816446|NCT00244725|566077529|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816447|NCT00244725|566077530|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
156816448|NCT00244725|566077527|FG000|Overall Study|Administrative reason|0|||
156816449|NCT00244725|566077528|FG001|Overall Study|Administrative reason|0|||
156816450|NCT00244725|566077529|FG002|Overall Study|Administrative reason|1|||
157022550|NCT01902173|566835253|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156816451|NCT00244725|566077530|FG003|Overall Study|Administrative reason|0|||
156816452|NCT00244725|566077527|FG000|Overall Study|Vomit|0|||
156816453|NCT00244725|566077528|FG001|Overall Study|Vomit|0|||
156816454|NCT00244725|566077529|FG002|Overall Study|Vomit|1|||
156816455|NCT00244725|566077530|FG003|Overall Study|Vomit|0|||
156816456|NCT00244725|566077527|FG000|Overall Study|Failed to follow-up|0|||
156816457|NCT00244725|566077528|FG001|Overall Study|Failed to follow-up|0|||
156816458|NCT00244725|566077529|FG002|Overall Study|Failed to follow-up|1|||
156816459|NCT00244725|566077530|FG003|Overall Study|Failed to follow-up|1|||
156816460|NCT00335738|566077531|FG000|Overall Study|Physician Decision|6|||
156816461|NCT00335738|566077532|FG001|Overall Study|Physician Decision|0|||
156816462|NCT00335738|566077531|FG000|Overall Study|Withdrawal by Subject|2|||
156816463|NCT00335738|566077532|FG001|Overall Study|Withdrawal by Subject|0|||
156816464|NCT00335738|566077531|FG000|Overall Study|Ineligible|3|||
156816465|NCT00335738|566077532|FG001|Overall Study|Ineligible|4|||
156816466|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
156816467|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
156816468|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
156816469|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
156816470|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
156816471|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
156816472|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
156816473|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
156816474|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
157022551|NCT01902173|566835254|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
156816475|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
156816476|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
156816477|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
156816478|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816479|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816480|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
156816481|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816482|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816483|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
157022552|NCT01902173|566835255|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
157022553|NCT01902173|566835250|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
157022554|NCT01902173|566835251|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
157022555|NCT01902173|566835252|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
157149990|NCT01371838|567294849|FG001|Overall Study|Investigator Decision|8|||
157149991|NCT01371838|567294848|FG000|Overall Study|Last follow-up visit not conducted|2|||
157149992|NCT01371838|567294849|FG001|Overall Study|Last follow-up visit not conducted|0|||
157149993|NCT01371838|567294848|FG000|Overall Study|Lack of therapeutic response|0|||
157149994|NCT01371838|567294849|FG001|Overall Study|Lack of therapeutic response|1|||
157149995|NCT01371838|567294848|FG000|Overall Study|Surgery|1|||
157149996|NCT01371838|567294849|FG001|Overall Study|Surgery|0|||
157149997|NCT00972244|567294850|FG000|Overall Study|Incorrect Enrolment|1|||
156816484|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816485|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816486|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816487|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816488|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816489|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
156816490|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
156816491|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
156816492|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
156816493|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
157149998|NCT00972244|567294851|FG001|Overall Study|Incorrect Enrolment|0|||
156816494|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
156816495|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
156816496|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
156816497|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
156816498|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
156816499|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
156816500|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
156816501|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
156816502|NCT01667133|566077533|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816503|NCT01667133|566077534|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816504|NCT01667133|566077535|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816505|NCT01667133|566077536|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
156816506|NCT01667133|566077537|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816507|NCT01667133|566077538|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816508|NCT01667133|566077539|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816509|NCT01667133|566077540|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816510|NCT01667133|566077541|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816511|NCT01667133|566077542|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816512|NCT01667133|566077543|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816513|NCT01667133|566077544|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
156816514|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
156816515|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
156816516|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
156816517|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
156816518|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
156816519|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
156816520|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
156816521|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
156816522|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
156816523|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
156816524|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
156816525|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
156816526|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816527|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816528|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816529|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816530|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
157149999|NCT00972244|567294852|FG002|Overall Study|Incorrect Enrolment|0|||
157150000|NCT00972244|567294853|FG003|Overall Study|Incorrect Enrolment|0|||
157150001|NCT00972244|567294854|FG004|Overall Study|Incorrect Enrolment|0|||
156816531|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816532|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816533|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816534|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816535|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
156816536|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816537|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
156816538|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
156816539|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
156816540|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
156816541|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
156816542|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
156816543|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
156816544|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
156816545|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
156816546|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
156816547|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
156816548|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
156816549|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
156816550|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
157022556|NCT01902173|566835253|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
157022557|NCT01902173|566835254|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
157022558|NCT01902173|566835255|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
157150002|NCT00972244|567294850|FG000|Overall Study|Adverse Event|0|||
156816551|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816552|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816553|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816554|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816555|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
157022559|NCT01902173|566835250|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
157022560|NCT01902173|566835251|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
157150003|NCT00972244|567294851|FG001|Overall Study|Adverse Event|1|||
156816556|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816557|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816558|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816559|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
156816560|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816561|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
156816562|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Death|0|||
156816563|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Death|0|||
156816564|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Death|0|||
156816565|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Death|0|||
156816566|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Death|0|||
156816567|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Death|0|||
156816568|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Death|0|||
156816569|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Death|0|||
156816570|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Death|0|||
156816571|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Death|1|||
156816572|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Death|0|||
156816573|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Death|0|||
156816574|NCT01667133|566077533|FG000|Phase 2: Dose-expansion|Other|0|||
156816575|NCT01667133|566077534|FG001|Phase 2: Dose-expansion|Other|0|||
156816576|NCT01667133|566077535|FG002|Phase 2: Dose-expansion|Other|0|||
156816577|NCT01667133|566077536|FG003|Phase 2: Dose-expansion|Other|0|||
156816578|NCT01667133|566077537|FG004|Phase 2: Dose-expansion|Other|0|||
156816579|NCT01667133|566077538|FG005|Phase 2: Dose-expansion|Other|0|||
156816580|NCT01667133|566077539|FG006|Phase 2: Dose-expansion|Other|0|||
156816581|NCT01667133|566077540|FG007|Phase 2: Dose-expansion|Other|0|||
156816582|NCT01667133|566077541|FG008|Phase 2: Dose-expansion|Other|0|||
156816583|NCT01667133|566077542|FG009|Phase 2: Dose-expansion|Other|0|||
156816584|NCT01667133|566077543|FG010|Phase 2: Dose-expansion|Other|0|||
156816585|NCT01667133|566077544|FG011|Phase 2: Dose-expansion|Other|1|||
156816586|NCT01916824|566077547|FG000|Overall Study|Lost to Follow-up|3|||
156816587|NCT01916824|566077548|FG001|Overall Study|Lost to Follow-up|6|||
156816588|NCT01916824|566077547|FG000|Overall Study|Physician Decision|2|||
156816589|NCT01916824|566077548|FG001|Overall Study|Physician Decision|0|||
156816590|NCT01916824|566077547|FG000|Overall Study|Withdrawal by Subject|2|||
156816591|NCT01916824|566077548|FG001|Overall Study|Withdrawal by Subject|3|||
156816592|NCT00771927|566077551|FG000|Overall Study|Adverse Event|100|||
156816593|NCT00771927|566077552|FG001|Overall Study|Adverse Event|105|||
156816594|NCT00771927|566077551|FG000|Overall Study|Lack of Efficacy|70|||
156816595|NCT00771927|566077552|FG001|Overall Study|Lack of Efficacy|42|||
156816596|NCT00771927|566077551|FG000|Overall Study|Lost to Follow-up|46|||
156816597|NCT00771927|566077552|FG001|Overall Study|Lost to Follow-up|46|||
156816598|NCT00771927|566077551|FG000|Overall Study|Withdrawal by Subject|16|||
156816599|NCT00771927|566077552|FG001|Overall Study|Withdrawal by Subject|17|||
156816600|NCT00771927|566077551|FG000|Overall Study|Other reason|23|||
156816601|NCT00771927|566077552|FG001|Overall Study|Other reason|27|||
156816602|NCT03835481|566077553|FG000|Double-blind Period|Other not stated below|0|||
156816603|NCT03835481|566077554|FG001|Double-blind Period|Other not stated below|0|||
156816604|NCT03835481|566077555|FG002|Double-blind Period|Other not stated below|0|||
157150004|NCT00972244|567294852|FG002|Overall Study|Adverse Event|1|||
157150005|NCT00972244|567294853|FG003|Overall Study|Adverse Event|0|||
157150006|NCT00972244|567294854|FG004|Overall Study|Adverse Event|0|||
157150007|NCT00972244|567294850|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
157150008|NCT00972244|567294851|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
157150009|NCT00972244|567294852|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
157150010|NCT00972244|567294853|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
157150011|NCT00972244|567294854|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
157150012|NCT00972244|567294850|FG000|Overall Study|Withdrawal by Subject|1|||
157150013|NCT00972244|567294851|FG001|Overall Study|Withdrawal by Subject|2|||
157150014|NCT00972244|567294852|FG002|Overall Study|Withdrawal by Subject|1|||
157150015|NCT00972244|567294853|FG003|Overall Study|Withdrawal by Subject|0|||
157150016|NCT00972244|567294854|FG004|Overall Study|Withdrawal by Subject|1|||
157150017|NCT00972244|567294850|FG000|Overall Study|Safety|0|||
157150018|NCT00972244|567294851|FG001|Overall Study|Safety|0|||
157150019|NCT00972244|567294852|FG002|Overall Study|Safety|0|||
157150020|NCT00972244|567294853|FG003|Overall Study|Safety|0|||
157150021|NCT00972244|567294854|FG004|Overall Study|Safety|1|||
157150022|NCT00972244|567294850|FG000|Overall Study|Death|1|||
157150023|NCT00972244|567294851|FG001|Overall Study|Death|0|||
157150024|NCT00972244|567294852|FG002|Overall Study|Death|0|||
157150025|NCT00972244|567294853|FG003|Overall Study|Death|0|||
157150026|NCT00972244|567294854|FG004|Overall Study|Death|0|||
157150027|NCT00972244|567294850|FG000|Overall Study|Various|0|||
157150028|NCT00972244|567294851|FG001|Overall Study|Various|0|||
157150029|NCT00972244|567294852|FG002|Overall Study|Various|0|||
157150030|NCT00972244|567294853|FG003|Overall Study|Various|0|||
157150031|NCT00972244|567294854|FG004|Overall Study|Various|2|||
157150032|NCT03554005|567294857|FG000|Overall Study|Not in participant's best interest|0|||
157150033|NCT03554005|567294858|FG001|Overall Study|Not in participant's best interest|0|||
157150034|NCT03554005|567294859|FG002|Overall Study|Not in participant's best interest|0|||
157150035|NCT03554005|567294860|FG003|Overall Study|Not in participant's best interest|0|||
157150036|NCT03554005|567294861|FG004|Overall Study|Not in participant's best interest|0|||
157150037|NCT03554005|567294862|FG005|Overall Study|Not in participant's best interest|1|||
157150038|NCT03554005|567294857|FG000|Overall Study|Disease Progression|1|||
157150039|NCT03554005|567294858|FG001|Overall Study|Disease Progression|1|||
157150040|NCT03554005|567294859|FG002|Overall Study|Disease Progression|1|||
157150041|NCT03554005|567294860|FG003|Overall Study|Disease Progression|1|||
157150042|NCT03554005|567294861|FG004|Overall Study|Disease Progression|5|||
157150043|NCT03554005|567294862|FG005|Overall Study|Disease Progression|6|||
157223706|NCT02974153|567565756|FG000|Overall Study|Adverse Event|6|||
156816605|NCT03835481|566077556|FG003|Double-blind Period|Other not stated below|1|||
156816606|NCT03835481|566077557|FG004|Double-blind Period|Other not stated below|1|||
156816607|NCT03835481|566077553|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
156816608|NCT03835481|566077554|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
157223707|NCT02974153|567565757|FG001|Overall Study|Adverse Event|0|||
157223708|NCT02974153|567565758|FG002|Overall Study|Adverse Event|1|||
157223709|NCT02974153|567565756|FG000|Overall Study|Lack of Efficacy|6|||
157223710|NCT02974153|567565757|FG001|Overall Study|Lack of Efficacy|5|||
157223711|NCT02974153|567565758|FG002|Overall Study|Lack of Efficacy|10|||
157223712|NCT02974153|567565756|FG000|Overall Study|Lost to Follow-up|9|||
157223713|NCT02974153|567565757|FG001|Overall Study|Lost to Follow-up|10|||
157223714|NCT02974153|567565758|FG002|Overall Study|Lost to Follow-up|17|||
157223715|NCT02974153|567565756|FG000|Overall Study|Physician Decision|0|||
157223716|NCT02974153|567565757|FG001|Overall Study|Physician Decision|2|||
157223717|NCT02974153|567565758|FG002|Overall Study|Physician Decision|1|||
157223718|NCT02974153|567565756|FG000|Overall Study|Withdrawal by Subject|9|||
157223719|NCT02974153|567565757|FG001|Overall Study|Withdrawal by Subject|16|||
157223720|NCT02974153|567565758|FG002|Overall Study|Withdrawal by Subject|11|||
157223721|NCT02974153|567565756|FG000|Overall Study|Study Burden|8|||
157223722|NCT02974153|567565757|FG001|Overall Study|Study Burden|7|||
157223723|NCT02974153|567565758|FG002|Overall Study|Study Burden|3|||
157223724|NCT02974153|567565756|FG000|Overall Study|Other|14|||
157223725|NCT02974153|567565757|FG001|Overall Study|Other|8|||
157223726|NCT02974153|567565758|FG002|Overall Study|Other|7|||
157223727|NCT01202747|567565759|FG000|Overall Study|Withdrawal by Subject|1|||
157223728|NCT01446913|567565760|FG000|Overall Study|Significant illness|1|||
157223729|NCT01446913|567565761|FG001|Overall Study|Significant illness|1|||
157223730|NCT01446913|567565762|FG002|Overall Study|Significant illness|1|||
157223731|NCT01446913|567565760|FG000|Overall Study|Withdrawal by Subject|5|||
157223732|NCT01446913|567565761|FG001|Overall Study|Withdrawal by Subject|3|||
157223733|NCT01446913|567565762|FG002|Overall Study|Withdrawal by Subject|5|||
157223734|NCT01446913|567565760|FG000|Overall Study|Physician Decision|0|||
156816609|NCT03835481|566077555|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
156816610|NCT03835481|566077556|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
156816611|NCT03835481|566077557|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
156816612|NCT03835481|566077553|FG000|Double-blind Period|Withdrawal by Subject|0|||
156816613|NCT03835481|566077554|FG001|Double-blind Period|Withdrawal by Subject|0|||
156816614|NCT03835481|566077555|FG002|Double-blind Period|Withdrawal by Subject|1|||
156816615|NCT03835481|566077556|FG003|Double-blind Period|Withdrawal by Subject|0|||
156816616|NCT03835481|566077557|FG004|Double-blind Period|Withdrawal by Subject|5|||
156816617|NCT03835481|566077553|FG000|Double-blind Period|Lost to Follow-up|0|||
156816618|NCT03835481|566077554|FG001|Double-blind Period|Lost to Follow-up|0|||
156816619|NCT03835481|566077555|FG002|Double-blind Period|Lost to Follow-up|0|||
156816620|NCT03835481|566077556|FG003|Double-blind Period|Lost to Follow-up|1|||
157223735|NCT01446913|567565761|FG001|Overall Study|Physician Decision|0|||
157223736|NCT01446913|567565762|FG002|Overall Study|Physician Decision|2|||
157223737|NCT01446913|567565760|FG000|Overall Study|Lost to Follow-up|3|||
157223738|NCT01446913|567565761|FG001|Overall Study|Lost to Follow-up|5|||
156816621|NCT03835481|566077557|FG004|Double-blind Period|Lost to Follow-up|0|||
157150044|NCT03554005|567294857|FG000|Overall Study|Adverse Event|0|||
157150045|NCT03554005|567294858|FG001|Overall Study|Adverse Event|0|||
157150046|NCT03554005|567294859|FG002|Overall Study|Adverse Event|0|||
157150047|NCT03554005|567294860|FG003|Overall Study|Adverse Event|0|||
157150048|NCT03554005|567294861|FG004|Overall Study|Adverse Event|0|||
157150049|NCT03554005|567294862|FG005|Overall Study|Adverse Event|3|||
157223739|NCT01446913|567565762|FG002|Overall Study|Lost to Follow-up|3|||
157223740|NCT02521948|567565763|FG000|Overall Study|Adverse Event|2|||
157223741|NCT02521948|567565763|FG000|Overall Study|Death|4|||
157223742|NCT02521948|567565763|FG000|Overall Study|Lost to Follow-up|1|||
157223743|NCT02521948|567565763|FG000|Overall Study|Did not attend one or both follow-ups|6|||
157223744|NCT00423800|567565764|FG000|Overall Study|Protocol Violation|0|||
157223745|NCT00423800|567565765|FG001|Overall Study|Protocol Violation|1|||
157223746|NCT02292238|567565766|FG000|Overall Study|Protocol Violation|1|||
157223747|NCT02292238|567565767|FG001|Overall Study|Protocol Violation|2|||
157223748|NCT02292238|567565766|FG000|Overall Study|Withdrawal by Subject|2|||
156816622|NCT03835481|566077553|FG000|Double-blind Period|Protocol Violation|0|||
156816623|NCT03835481|566077554|FG001|Double-blind Period|Protocol Violation|2|||
156816624|NCT03835481|566077555|FG002|Double-blind Period|Protocol Violation|0|||
156816625|NCT03835481|566077556|FG003|Double-blind Period|Protocol Violation|1|||
156816626|NCT03835481|566077557|FG004|Double-blind Period|Protocol Violation|0|||
156816627|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
156816628|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
156816629|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
156816630|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
156816631|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
156816632|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
156816633|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
156816634|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
156816635|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
157150050|NCT03554005|567294857|FG000|Overall Study|Physician Decision|0|||
157150051|NCT03554005|567294858|FG001|Overall Study|Physician Decision|0|||
157150052|NCT03554005|567294859|FG002|Overall Study|Physician Decision|0|||
157150053|NCT03554005|567294860|FG003|Overall Study|Physician Decision|0|||
157150054|NCT03554005|567294861|FG004|Overall Study|Physician Decision|1|||
157150055|NCT03554005|567294862|FG005|Overall Study|Physician Decision|0|||
157150056|NCT03554005|567294857|FG000|Overall Study|Other|0|||
157150057|NCT03554005|567294858|FG001|Overall Study|Other|0|||
157150058|NCT03554005|567294859|FG002|Overall Study|Other|0|||
157150059|NCT03554005|567294860|FG003|Overall Study|Other|0|||
157150060|NCT03554005|567294861|FG004|Overall Study|Other|0|||
157150061|NCT03554005|567294862|FG005|Overall Study|Other|1|||
157150062|NCT00631488|567294866|FG000|Overall Study|Adverse Event|1|||
157150063|NCT00631488|567294867|FG001|Overall Study|Adverse Event|0|||
157150064|NCT00631488|567294868|FG002|Overall Study|Adverse Event|0|||
157150065|NCT00631488|567294866|FG000|Overall Study|Lost to Follow-up|2|||
157150066|NCT00631488|567294867|FG001|Overall Study|Lost to Follow-up|2|||
157150067|NCT00631488|567294868|FG002|Overall Study|Lost to Follow-up|0|||
157150068|NCT00631488|567294866|FG000|Overall Study|Physician Decision|1|||
157150069|NCT00631488|567294867|FG001|Overall Study|Physician Decision|0|||
157150070|NCT00631488|567294868|FG002|Overall Study|Physician Decision|1|||
157150071|NCT00631488|567294866|FG000|Overall Study|Protocol Violation|0|||
157150072|NCT00631488|567294867|FG001|Overall Study|Protocol Violation|0|||
157150073|NCT00631488|567294868|FG002|Overall Study|Protocol Violation|1|||
157150074|NCT02855411|567294869|FG000|Overall Study|Study terminated by sponsor|21|||
157150075|NCT02855411|567294869|FG000|Overall Study|Does not meet entrance criteria|14|||
157150076|NCT02639182|567294870|FG000|Overall Study|Disease Progression|50|||
157150077|NCT02639182|567294871|FG001|Overall Study|Disease Progression|49|||
157150078|NCT02639182|567294870|FG000|Overall Study|Adverse Event|7|||
157150079|NCT02639182|567294871|FG001|Overall Study|Adverse Event|5|||
157150080|NCT02639182|567294870|FG000|Overall Study|Physician Decision|3|||
157150081|NCT02639182|567294871|FG001|Overall Study|Physician Decision|3|||
157150082|NCT02639182|567294870|FG000|Overall Study|Withdrew Consent|5|||
157150083|NCT02639182|567294871|FG001|Overall Study|Withdrew Consent|4|||
157150084|NCT02639182|567294870|FG000|Overall Study|Lost to Follow-up|0|||
157150085|NCT02639182|567294871|FG001|Overall Study|Lost to Follow-up|1|||
157150086|NCT02639182|567294870|FG000|Overall Study|Study Closure|1|||
157150087|NCT02639182|567294871|FG001|Overall Study|Study Closure|2|||
157150088|NCT02639182|567294870|FG000|Overall Study|Sponsor Ended Study|0|||
157150089|NCT02639182|567294871|FG001|Overall Study|Sponsor Ended Study|1|||
157150090|NCT02639182|567294870|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
157150091|NCT02639182|567294871|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
157150092|NCT00907881|567294872|FG000|Overall Study|Lost to Follow-up|59|||
157150093|NCT00907881|567294872|FG000|Overall Study|Noncompliance|5|||
157150094|NCT00907881|567294872|FG000|Overall Study|Withdrawal by Subject|5|||
157150095|NCT00907881|567294872|FG000|Overall Study|Protocol Violation|1|||
157150096|NCT00907881|567294872|FG000|Overall Study|Missing discontinuation information|15|||
157150097|NCT02546856|567294875|FG000|4 Months Evaluation|Death|2|||
157150098|NCT02546856|567294876|FG001|4 Months Evaluation|Death|3|||
157150099|NCT02546856|567294875|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
157150100|NCT02546856|567294876|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
157150101|NCT02546856|567294875|FG000|4 Months Evaluation|Lost to Follow-up|3|||
157150102|NCT02546856|567294876|FG001|4 Months Evaluation|Lost to Follow-up|3|||
157150103|NCT02546856|567294875|FG000|4 Months Evaluation|Physician Decision|3|||
157150104|NCT02546856|567294876|FG001|4 Months Evaluation|Physician Decision|0|||
157150105|NCT02546856|567294875|FG000|4 Months Evaluation|Working or living abroad|5|||
157150106|NCT02546856|567294876|FG001|4 Months Evaluation|Working or living abroad|1|||
157150107|NCT02546856|567294875|FG000|4 Months Evaluation|reasons not due to titration|4|||
157150108|NCT02546856|567294876|FG001|4 Months Evaluation|reasons not due to titration|1|||
157150109|NCT02546856|567294875|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
157223749|NCT02292238|567565767|FG001|Overall Study|Withdrawal by Subject|1|||
157223750|NCT02292238|567565766|FG000|Overall Study|Lost to Follow-up|1|||
157223751|NCT02292238|567565767|FG001|Overall Study|Lost to Follow-up|0|||
157223752|NCT02292238|567565766|FG000|Overall Study|Physician Decision|0|||
157223753|NCT02292238|567565767|FG001|Overall Study|Physician Decision|1|||
157223754|NCT04000009|567565768|FG000|Overall Study|Adverse Event|13|||
157223755|NCT04000009|567565768|FG000|Overall Study|Lack of Efficacy|7|||
157223756|NCT04000009|567565768|FG000|Overall Study|Lost to Follow-up|8|||
157223757|NCT04000009|567565768|FG000|Overall Study|Noncompliance with study drug|4|||
157223758|NCT04000009|567565768|FG000|Overall Study|Physician Decision|1|||
157223759|NCT04000009|567565768|FG000|Overall Study|Use of prohibited medication|3|||
157223760|NCT04000009|567565768|FG000|Overall Study|Pregnancy|1|||
157223761|NCT04000009|567565768|FG000|Overall Study|Withdrawal by Subject|22|||
157223762|NCT04000009|567565768|FG000|Overall Study|Study terminated by sponsor|98|||
157223763|NCT04000009|567565768|FG000|Overall Study|Not further specified|8|||
157223764|NCT01754259|567565771|FG000|Overall Study|Withdrawal by Subject|2|||
157223765|NCT01754259|567565772|FG001|Overall Study|Withdrawal by Subject|4|||
157223766|NCT01754259|567565771|FG000|Overall Study|Adverse Event|3|||
156884284|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
156884285|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
156884286|NCT04740905|566334063|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
156884287|NCT04740905|566334064|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
156884288|NCT01534182|566334068|FG000|Overall Study|Administrative problems|1|||
156884289|NCT01534182|566334069|FG001|Overall Study|Administrative problems|0|||
156884290|NCT01534182|566334068|FG000|Overall Study|Withdrawal by Subject|4|||
156884291|NCT01534182|566334069|FG001|Overall Study|Withdrawal by Subject|7|||
156884292|NCT01534182|566334068|FG000|Overall Study|Adverse Event|7|||
156884293|NCT01534182|566334069|FG001|Overall Study|Adverse Event|3|||
156884294|NCT03077087|566334070|FG000|Overall Study|Physician Decision|2|||
156884295|NCT02412488|566334071|FG000|Overall Study|Lost to Follow-up|10|||
156884296|NCT02412488|566334071|FG000|Overall Study|Withdrawal by Subject|5|||
156884297|NCT02412488|566334071|FG000|Overall Study|Physician Decision|1|||
156884298|NCT02412488|566334071|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
156884299|NCT02412488|566334071|FG000|Overall Study|Reveal LINQ explant|1|||
156884300|NCT01989468|566334072|FG000|Overall Study|Adverse Event|10|||
156884301|NCT01989468|566334073|FG001|Overall Study|Adverse Event|15|||
156884302|NCT01989468|566334074|FG002|Overall Study|Adverse Event|4|||
156884303|NCT01989468|566334075|FG003|Overall Study|Adverse Event|5|||
156884304|NCT01989468|566334076|FG004|Overall Study|Adverse Event|4|||
156884305|NCT01989468|566334072|FG000|Overall Study|Lack of Efficacy|11|||
156884306|NCT01989468|566334073|FG001|Overall Study|Lack of Efficacy|11|||
156884307|NCT01989468|566334074|FG002|Overall Study|Lack of Efficacy|7|||
156884308|NCT01989468|566334075|FG003|Overall Study|Lack of Efficacy|4|||
156884309|NCT01989468|566334076|FG004|Overall Study|Lack of Efficacy|2|||
156884310|NCT01989468|566334072|FG000|Overall Study|Lost to Follow-up|5|||
156884311|NCT01989468|566334073|FG001|Overall Study|Lost to Follow-up|2|||
156884312|NCT01989468|566334074|FG002|Overall Study|Lost to Follow-up|0|||
156884313|NCT01989468|566334075|FG003|Overall Study|Lost to Follow-up|1|||
156884314|NCT01989468|566334076|FG004|Overall Study|Lost to Follow-up|1|||
156884315|NCT01989468|566334072|FG000|Overall Study|Physician Decision|4|||
156884316|NCT01989468|566334073|FG001|Overall Study|Physician Decision|1|||
156884317|NCT01989468|566334074|FG002|Overall Study|Physician Decision|0|||
156884318|NCT01989468|566334075|FG003|Overall Study|Physician Decision|1|||
156884319|NCT01989468|566334076|FG004|Overall Study|Physician Decision|0|||
156884320|NCT01989468|566334072|FG000|Overall Study|Pregnancy|0|||
156884321|NCT01989468|566334073|FG001|Overall Study|Pregnancy|1|||
156884322|NCT01989468|566334074|FG002|Overall Study|Pregnancy|0|||
156884323|NCT01989468|566334075|FG003|Overall Study|Pregnancy|0|||
156884324|NCT01989468|566334076|FG004|Overall Study|Pregnancy|0|||
156884325|NCT01989468|566334072|FG000|Overall Study|Technical Problems|3|||
156884326|NCT01989468|566334073|FG001|Overall Study|Technical Problems|1|||
156884327|NCT01989468|566334074|FG002|Overall Study|Technical Problems|3|||
156884328|NCT01989468|566334075|FG003|Overall Study|Technical Problems|1|||
156884329|NCT01989468|566334076|FG004|Overall Study|Technical Problems|0|||
156884330|NCT01989468|566334072|FG000|Overall Study|Subject Guardian Decision|11|||
156884331|NCT01989468|566334073|FG001|Overall Study|Subject Guardian Decision|6|||
156884332|NCT01989468|566334074|FG002|Overall Study|Subject Guardian Decision|4|||
156884333|NCT01989468|566334075|FG003|Overall Study|Subject Guardian Decision|4|||
156884334|NCT01989468|566334076|FG004|Overall Study|Subject Guardian Decision|1|||
156884335|NCT01989468|566334072|FG000|Overall Study|Death|3|||
156884336|NCT01989468|566334073|FG001|Overall Study|Death|0|||
156884337|NCT01989468|566334074|FG002|Overall Study|Death|1|||
156884338|NCT01989468|566334075|FG003|Overall Study|Death|0|||
156884339|NCT01989468|566334076|FG004|Overall Study|Death|0|||
157223767|NCT01754259|567565772|FG001|Overall Study|Adverse Event|1|||
157223768|NCT01754259|567565771|FG000|Overall Study|Lost to Follow-up|0|||
157223769|NCT01754259|567565772|FG001|Overall Study|Lost to Follow-up|1|||
157223770|NCT00619385|567565773|FG000|Overall Study|Adverse Event|0|||
157223771|NCT00619385|567565774|FG001|Overall Study|Adverse Event|0|||
156816636|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
156816637|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816638|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816639|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
156816640|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
156816641|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
156816642|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
156816643|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
156816644|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
156816645|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
156816646|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
156816647|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816648|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816649|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816650|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
156816651|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
156816652|NCT03835481|566077553|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
156816653|NCT03835481|566077554|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
156816654|NCT03835481|566077555|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
156816655|NCT03835481|566077556|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
156816656|NCT03835481|566077557|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
156816657|NCT00976716|566077564|FG000|Overall Study|Adverse Event|1|||
156816658|NCT04222699|566077565|FG000|Overall Study|Lost to Follow-up|2|||
156816659|NCT00281099|566077566|FG000|Overall Study|Death|46|||
156816660|NCT00281099|566077567|FG001|Overall Study|Death|57|||
156816661|NCT00281099|566077566|FG000|Overall Study|Lost to Follow-up|10|||
156816662|NCT00281099|566077567|FG001|Overall Study|Lost to Follow-up|19|||
156816663|NCT00281099|566077566|FG000|Overall Study|Withdrawal by Subject|65|||
156816664|NCT00281099|566077567|FG001|Overall Study|Withdrawal by Subject|70|||
156816665|NCT00281099|566077566|FG000|Overall Study|Physician Decision|79|||
156816666|NCT00281099|566077567|FG001|Overall Study|Physician Decision|72|||
156816667|NCT00281099|566077566|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
156816668|NCT00281099|566077567|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
156816669|NCT02931838|566077568|FG000|Overall Study|Reason not provided by investigator|1|||
156816670|NCT02931838|566077569|FG001|Overall Study|Reason not provided by investigator|0|||
156816671|NCT02931838|566077570|FG002|Overall Study|Reason not provided by investigator|1|||
156816672|NCT02931838|566077571|FG003|Overall Study|Reason not provided by investigator|0|||
156816673|NCT02931838|566077572|FG004|Overall Study|Reason not provided by investigator|0|||
156816674|NCT02931838|566077573|FG005|Overall Study|Reason not provided by investigator|0|||
156816675|NCT02931838|566077568|FG000|Overall Study|Poor/non-compliance|0|||
156816676|NCT02931838|566077569|FG001|Overall Study|Poor/non-compliance|0|||
156816677|NCT02931838|566077570|FG002|Overall Study|Poor/non-compliance|1|||
156816678|NCT02931838|566077571|FG003|Overall Study|Poor/non-compliance|0|||
156816679|NCT02931838|566077572|FG004|Overall Study|Poor/non-compliance|0|||
156816680|NCT02931838|566077573|FG005|Overall Study|Poor/non-compliance|0|||
156816681|NCT02931838|566077568|FG000|Overall Study|Lack of Efficacy|5|||
156816682|NCT02931838|566077569|FG001|Overall Study|Lack of Efficacy|4|||
156816683|NCT02931838|566077570|FG002|Overall Study|Lack of Efficacy|0|||
156816684|NCT02931838|566077571|FG003|Overall Study|Lack of Efficacy|0|||
156816685|NCT02931838|566077572|FG004|Overall Study|Lack of Efficacy|0|||
156816686|NCT02931838|566077573|FG005|Overall Study|Lack of Efficacy|1|||
156816687|NCT02931838|566077568|FG000|Overall Study|Lost to Follow-up|1|||
156816688|NCT02931838|566077569|FG001|Overall Study|Lost to Follow-up|0|||
156816689|NCT02931838|566077570|FG002|Overall Study|Lost to Follow-up|1|||
156816690|NCT02931838|566077571|FG003|Overall Study|Lost to Follow-up|1|||
156816691|NCT02931838|566077572|FG004|Overall Study|Lost to Follow-up|2|||
156816692|NCT02931838|566077573|FG005|Overall Study|Lost to Follow-up|0|||
156816693|NCT02931838|566077568|FG000|Overall Study|Subject request to discontinue treatment|4|||
156816694|NCT02931838|566077569|FG001|Overall Study|Subject request to discontinue treatment|3|||
157150110|NCT02546856|567294876|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
156816695|NCT02931838|566077570|FG002|Overall Study|Subject request to discontinue treatment|3|||
156816696|NCT02931838|566077571|FG003|Overall Study|Subject request to discontinue treatment|0|||
156816697|NCT02931838|566077572|FG004|Overall Study|Subject request to discontinue treatment|1|||
156816698|NCT02931838|566077573|FG005|Overall Study|Subject request to discontinue treatment|0|||
156816699|NCT02931838|566077568|FG000|Overall Study|Withdrawal by Subject|1|||
156816700|NCT02931838|566077569|FG001|Overall Study|Withdrawal by Subject|2|||
157150111|NCT02546856|567294875|FG000|6 Months Evaluation|Death|1|||
157150112|NCT02546856|567294876|FG001|6 Months Evaluation|Death|1|||
157150113|NCT02546856|567294875|FG000|6 Months Evaluation|Lost to Follow-up|1|||
157150114|NCT02546856|567294876|FG001|6 Months Evaluation|Lost to Follow-up|1|||
157150115|NCT02546856|567294875|FG000|6 Months Evaluation|Working or living abroad|6|||
157150116|NCT02546856|567294876|FG001|6 Months Evaluation|Working or living abroad|4|||
156816701|NCT02931838|566077570|FG002|Overall Study|Withdrawal by Subject|0|||
156816702|NCT02931838|566077571|FG003|Overall Study|Withdrawal by Subject|1|||
156816703|NCT02931838|566077572|FG004|Overall Study|Withdrawal by Subject|0|||
156816704|NCT02931838|566077573|FG005|Overall Study|Withdrawal by Subject|0|||
156816705|NCT02931838|566077568|FG000|Overall Study|Adverse Event|2|||
156816706|NCT02931838|566077569|FG001|Overall Study|Adverse Event|1|||
156816707|NCT02931838|566077570|FG002|Overall Study|Adverse Event|2|||
156816708|NCT02931838|566077571|FG003|Overall Study|Adverse Event|1|||
156816709|NCT02931838|566077572|FG004|Overall Study|Adverse Event|3|||
156816710|NCT02931838|566077573|FG005|Overall Study|Adverse Event|1|||
156816711|NCT00104728|566077574|FG000|Overall Study|screen failures|19|||
156816712|NCT01963767|566077575|FG000|Overall Study|Withdrawal by Subject|4|||
156816713|NCT01963767|566077576|FG001|Overall Study|Withdrawal by Subject|2|||
156816714|NCT01963767|566077575|FG000|Overall Study|Adverse Event|2|||
156816715|NCT01963767|566077576|FG001|Overall Study|Adverse Event|0|||
156816716|NCT02709577|566077577|FG000|Overall Study|non-accommodating anatomy|0|||
156816717|NCT02709577|566077578|FG001|Overall Study|non-accommodating anatomy|1|||
156816718|NCT02709577|566077579|FG002|Overall Study|non-accommodating anatomy|0|||
156816719|NCT02709577|566077580|FG003|Overall Study|non-accommodating anatomy|0|||
156816720|NCT02709577|566077577|FG000|Overall Study|procedural complication|0|||
156816721|NCT02709577|566077578|FG001|Overall Study|procedural complication|1|||
156816722|NCT02709577|566077579|FG002|Overall Study|procedural complication|0|||
156816723|NCT02709577|566077580|FG003|Overall Study|procedural complication|0|||
156816724|NCT02709577|566077577|FG000|Overall Study|Withdrawal by Subject|2|||
156816725|NCT02709577|566077578|FG001|Overall Study|Withdrawal by Subject|3|||
156816726|NCT02709577|566077579|FG002|Overall Study|Withdrawal by Subject|2|||
156816727|NCT02709577|566077580|FG003|Overall Study|Withdrawal by Subject|0|||
156816728|NCT03823287|566077581|FG000|Overall Study|Withdrawal by Subject|25|||
156816729|NCT03823287|566077582|FG001|Overall Study|Withdrawal by Subject|17|||
156816730|NCT03823287|566077581|FG000|Overall Study|Death|13|||
156816731|NCT03823287|566077582|FG001|Overall Study|Death|7|||
156816732|NCT03823287|566077581|FG000|Overall Study|Lost to Follow-up|7|||
156816733|NCT03823287|566077582|FG001|Overall Study|Lost to Follow-up|8|||
156816734|NCT03823287|566077581|FG000|Overall Study|Adverse Event|6|||
156816735|NCT03823287|566077582|FG001|Overall Study|Adverse Event|8|||
156816736|NCT03823287|566077581|FG000|Overall Study|Physician Decision|5|||
156816737|NCT03823287|566077582|FG001|Overall Study|Physician Decision|2|||
156816738|NCT03823287|566077581|FG000|Overall Study|Lack of Efficacy|2|||
156816739|NCT03823287|566077582|FG001|Overall Study|Lack of Efficacy|0|||
156816740|NCT03823287|566077581|FG000|Overall Study|Other|2|||
156816741|NCT03823287|566077582|FG001|Overall Study|Other|4|||
156816742|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Adverse Event|7|||
157022561|NCT01902173|566835252|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
157022562|NCT01902173|566835253|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
157022563|NCT01902173|566835254|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
157022564|NCT01902173|566835255|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
157022565|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
157022566|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
157022567|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
156816743|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Adverse Event|0|||
156816744|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Adverse Event|0|||
156816745|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
156816746|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
156816747|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
156816748|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
156816749|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
156816750|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
156816751|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
156816752|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
156816753|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
156816754|NCT01059864|566077583|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
156816755|NCT01059864|566077584|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
156816756|NCT01059864|566077585|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
156816757|NCT01059864|566077583|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156816758|NCT01059864|566077584|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
156816759|NCT01059864|566077585|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
157022568|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
156816760|NCT01575808|566077586|FG000|Overall Study|Death|2|||
156816761|NCT01575808|566077587|FG001|Overall Study|Death|0|||
156816762|NCT01575808|566077586|FG000|Overall Study|Withdrawal by Subject|1|||
156816763|NCT01575808|566077587|FG001|Overall Study|Withdrawal by Subject|0|||
156816764|NCT03159468|566077588|FG000|Overall Study|Withdrawal by Subject|0|||
156816765|NCT03159468|566077589|FG001|Overall Study|Withdrawal by Subject|0|||
156816766|NCT03159468|566077590|FG002|Overall Study|Withdrawal by Subject|3|||
156816767|NCT03159468|566077591|FG003|Overall Study|Withdrawal by Subject|0|||
156816768|NCT03159468|566077592|FG004|Overall Study|Withdrawal by Subject|0|||
156884340|NCT03554486|566334077|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
156884341|NCT03554486|566334078|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
156884342|NCT03554486|566334079|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
156884343|NCT03554486|566334077|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
156816769|NCT03159468|566077593|FG005|Overall Study|Withdrawal by Subject|0|||
156816770|NCT00875485|566079408|FG000|Challenge Dose Epoch|Pregnancy|1|||
156816771|NCT00875485|566079409|FG001|Challenge Dose Epoch|Pregnancy|0|||
156816772|NCT02908685|566079410|FG000|Part 1 OLE|Withdrawal by Subject|0|||
156816773|NCT02908685|566079411|FG001|Part 1 OLE|Withdrawal by Subject|0|||
156816774|NCT02908685|566079412|FG002|Part 1 OLE|Withdrawal by Subject|0|||
156816775|NCT02908685|566079413|FG003|Part 1 OLE|Withdrawal by Subject|0|||
156816776|NCT02908685|566079414|FG004|Part 1 OLE|Withdrawal by Subject|0|||
156816777|NCT02908685|566079415|FG005|Part 1 OLE|Withdrawal by Subject|0|||
156816778|NCT02908685|566079416|FG006|Part 1 OLE|Withdrawal by Subject|0|||
156816779|NCT02908685|566079417|FG007|Part 1 OLE|Withdrawal by Subject|0|||
156816780|NCT02908685|566079418|FG008|Part 1 OLE|Withdrawal by Subject|0|||
156816781|NCT02908685|566079419|FG009|Part 1 OLE|Withdrawal by Subject|0|||
156816782|NCT02908685|566079420|FG010|Part 1 OLE|Withdrawal by Subject|2|||
156816783|NCT02908685|566079421|FG011|Part 1 OLE|Withdrawal by Subject|1|||
156816784|NCT02908685|566079422|FG012|Part 1 OLE|Withdrawal by Subject|0|||
156816785|NCT02908685|566079423|FG013|Part 1 OLE|Withdrawal by Subject|0|||
156816786|NCT02908685|566079410|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816787|NCT02908685|566079411|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816788|NCT02908685|566079412|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816789|NCT02908685|566079413|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816790|NCT02908685|566079414|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816791|NCT02908685|566079415|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816792|NCT02908685|566079416|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816793|NCT02908685|566079417|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816794|NCT02908685|566079418|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816795|NCT02908685|566079419|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816796|NCT02908685|566079420|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816797|NCT02908685|566079421|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
156816798|NCT02908685|566079422|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
156816799|NCT02908685|566079423|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
156816800|NCT02908685|566079410|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816801|NCT02908685|566079411|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816802|NCT02908685|566079412|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816803|NCT02908685|566079413|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816804|NCT02908685|566079414|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816805|NCT02908685|566079415|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816806|NCT02908685|566079416|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816807|NCT02908685|566079417|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816808|NCT02908685|566079418|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816809|NCT02908685|566079419|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816810|NCT02908685|566079420|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816811|NCT02908685|566079421|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816812|NCT02908685|566079422|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
156816813|NCT02908685|566079423|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
156816814|NCT02908685|566079410|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816815|NCT02908685|566079411|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816816|NCT02908685|566079412|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816817|NCT02908685|566079413|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156884344|NCT03554486|566334078|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
156884345|NCT03554486|566334079|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
156884346|NCT03554486|566334077|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
156884347|NCT03554486|566334078|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
156884348|NCT03554486|566334079|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
157022569|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
157022570|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
157150117|NCT02546856|567294875|FG000|6 Months Evaluation|reasons not due to titration|0|||
157150118|NCT02546856|567294876|FG001|6 Months Evaluation|reasons not due to titration|1|||
156884349|NCT01616693|566334080|FG000|Evaluated for Safety|Physician Decision|1|||
156884350|NCT01616693|566334081|FG001|Evaluated for Safety|Physician Decision|0|||
156884351|NCT01616693|566334082|FG002|Evaluated for Safety|Physician Decision|1|||
156884352|NCT01616693|566334083|FG003|Evaluated for Safety|Physician Decision|0|||
157150119|NCT00130208|567294881|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
156816818|NCT02908685|566079414|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816819|NCT02908685|566079415|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816820|NCT02908685|566079416|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816821|NCT02908685|566079417|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816822|NCT02908685|566079418|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816823|NCT02908685|566079419|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816824|NCT02908685|566079420|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816825|NCT02908685|566079421|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816826|NCT02908685|566079422|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
156816827|NCT02908685|566079423|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
156816828|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Death|0|||
156816829|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Death|0|||
156816830|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Death|0|||
156816831|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Death|0|||
156816832|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Death|0|||
156816833|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Death|0|||
156816834|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Death|0|||
156816835|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Death|0|||
156816836|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Death|0|||
156816837|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Death|0|||
156816838|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Death|0|||
156816839|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Death|0|||
156816840|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Death|1|||
156816841|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Death|0|||
156816842|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
156816843|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
156816844|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
156816845|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
156816846|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
156816847|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
156816848|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
156816849|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
156816850|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
156816851|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
156816852|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
156816853|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
156816854|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
156816855|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
156816856|NCT02908685|566079410|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816857|NCT02908685|566079411|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816858|NCT02908685|566079412|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816859|NCT02908685|566079413|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816860|NCT02908685|566079414|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816861|NCT02908685|566079415|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816862|NCT02908685|566079416|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816863|NCT02908685|566079417|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816864|NCT02908685|566079418|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816865|NCT02908685|566079419|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816866|NCT02908685|566079420|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816867|NCT02908685|566079421|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
156816868|NCT02908685|566079422|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
156816869|NCT02908685|566079423|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
156816870|NCT02954406|566079424|FG000|Overall Study|Adverse Event|0|||
156816871|NCT02954406|566079425|FG001|Overall Study|Adverse Event|1|||
156816872|NCT02954406|566079426|FG002|Overall Study|Adverse Event|0|||
156816873|NCT02954406|566079427|FG003|Overall Study|Adverse Event|0|||
156816874|NCT02954406|566079428|FG004|Overall Study|Adverse Event|1|||
156816875|NCT02954406|566079429|FG005|Overall Study|Adverse Event|0|||
156816876|NCT02954406|566079430|FG006|Overall Study|Adverse Event|0|||
156816877|NCT02954406|566079431|FG007|Overall Study|Adverse Event|0|||
156816878|NCT02954406|566079432|FG008|Overall Study|Adverse Event|1|||
156816879|NCT02954406|566079433|FG009|Overall Study|Adverse Event|1|||
156816880|NCT02954406|566079434|FG010|Overall Study|Adverse Event|0|||
156816881|NCT02954406|566079424|FG000|Overall Study|Progressive Disease|3|||
156816882|NCT02954406|566079425|FG001|Overall Study|Progressive Disease|4|||
156816883|NCT02954406|566079426|FG002|Overall Study|Progressive Disease|3|||
156816884|NCT02954406|566079427|FG003|Overall Study|Progressive Disease|4|||
156816885|NCT02954406|566079428|FG004|Overall Study|Progressive Disease|3|||
156816886|NCT02954406|566079429|FG005|Overall Study|Progressive Disease|3|||
156816887|NCT02954406|566079430|FG006|Overall Study|Progressive Disease|2|||
156816888|NCT02954406|566079431|FG007|Overall Study|Progressive Disease|2|||
156816889|NCT02954406|566079432|FG008|Overall Study|Progressive Disease|1|||
156816890|NCT02954406|566079433|FG009|Overall Study|Progressive Disease|1|||
156816891|NCT02954406|566079434|FG010|Overall Study|Progressive Disease|0|||
156816892|NCT02954406|566079424|FG000|Overall Study|Symptomatic Deterioration|0|||
156816893|NCT02954406|566079425|FG001|Overall Study|Symptomatic Deterioration|1|||
156816894|NCT02954406|566079426|FG002|Overall Study|Symptomatic Deterioration|0|||
156816895|NCT02954406|566079427|FG003|Overall Study|Symptomatic Deterioration|0|||
156816896|NCT02954406|566079428|FG004|Overall Study|Symptomatic Deterioration|0|||
156816897|NCT02954406|566079429|FG005|Overall Study|Symptomatic Deterioration|0|||
156816898|NCT02954406|566079430|FG006|Overall Study|Symptomatic Deterioration|0|||
156816899|NCT02954406|566079431|FG007|Overall Study|Symptomatic Deterioration|0|||
156816900|NCT02954406|566079432|FG008|Overall Study|Symptomatic Deterioration|0|||
156816901|NCT02954406|566079433|FG009|Overall Study|Symptomatic Deterioration|0|||
156816902|NCT02954406|566079434|FG010|Overall Study|Symptomatic Deterioration|0|||
156816903|NCT02954406|566079424|FG000|Overall Study|Death|0|||
156816904|NCT02954406|566079425|FG001|Overall Study|Death|0|||
156816905|NCT02954406|566079426|FG002|Overall Study|Death|0|||
156816906|NCT02954406|566079427|FG003|Overall Study|Death|0|||
156816907|NCT02954406|566079428|FG004|Overall Study|Death|1|||
156816908|NCT02954406|566079429|FG005|Overall Study|Death|0|||
156816909|NCT02954406|566079430|FG006|Overall Study|Death|0|||
156816910|NCT02954406|566079431|FG007|Overall Study|Death|0|||
156816911|NCT02954406|566079432|FG008|Overall Study|Death|1|||
156816912|NCT02954406|566079433|FG009|Overall Study|Death|1|||
156816913|NCT02954406|566079434|FG010|Overall Study|Death|0|||
156816914|NCT02954406|566079424|FG000|Overall Study|Reason Not Specified|0|||
156816915|NCT02954406|566079425|FG001|Overall Study|Reason Not Specified|0|||
156816916|NCT02954406|566079426|FG002|Overall Study|Reason Not Specified|3|||
156816917|NCT02954406|566079427|FG003|Overall Study|Reason Not Specified|2|||
156816918|NCT02954406|566079428|FG004|Overall Study|Reason Not Specified|2|||
156816919|NCT02954406|566079429|FG005|Overall Study|Reason Not Specified|0|||
156816920|NCT02954406|566079430|FG006|Overall Study|Reason Not Specified|1|||
156816921|NCT02954406|566079431|FG007|Overall Study|Reason Not Specified|0|||
156816922|NCT02954406|566079432|FG008|Overall Study|Reason Not Specified|1|||
156816923|NCT02954406|566079433|FG009|Overall Study|Reason Not Specified|0|||
156816924|NCT02954406|566079434|FG010|Overall Study|Reason Not Specified|0|||
156816925|NCT00782171|566079435|FG000|Overall Study|Lost to Follow-up|2|||
156816926|NCT00782171|566079436|FG001|Overall Study|Lost to Follow-up|2|||
156816927|NCT00782171|566079435|FG000|Overall Study|Withdrawal by Subject|2|||
156816928|NCT00782171|566079436|FG001|Overall Study|Withdrawal by Subject|1|||
156816929|NCT00782171|566079435|FG000|Overall Study|complications|3|||
156816930|NCT00782171|566079436|FG001|Overall Study|complications|1|||
156816931|NCT00782171|566079435|FG000|Overall Study|others|7|||
156816932|NCT00782171|566079436|FG001|Overall Study|others|9|||
156816933|NCT00782171|566079435|FG000|Overall Study|not eligible|8|||
156816934|NCT00782171|566079436|FG001|Overall Study|not eligible|6|||
156816935|NCT01691014|566079437|FG000|Overall Study|Premature Termination|1|||
156816936|NCT01691014|566079438|FG001|Overall Study|Premature Termination|6|||
156816937|NCT01691014|566079439|FG002|Overall Study|Premature Termination|0|||
156816938|NCT01691014|566079440|FG003|Overall Study|Premature Termination|3|||
156816939|NCT01691014|566079437|FG000|Overall Study|Other|0|||
156816940|NCT01691014|566079438|FG001|Overall Study|Other|0|||
156816941|NCT01691014|566079439|FG002|Overall Study|Other|2|||
156816942|NCT01691014|566079440|FG003|Overall Study|Other|0|||
156816943|NCT01691014|566079437|FG000|Overall Study|Withdrawal by Subject|0|||
156816944|NCT01691014|566079438|FG001|Overall Study|Withdrawal by Subject|1|||
156816945|NCT01691014|566079439|FG002|Overall Study|Withdrawal by Subject|1|||
156816946|NCT01691014|566079440|FG003|Overall Study|Withdrawal by Subject|1|||
156816947|NCT01691014|566079437|FG000|Overall Study|Adverse Event|0|||
156816948|NCT01691014|566079438|FG001|Overall Study|Adverse Event|5|||
156816949|NCT01691014|566079439|FG002|Overall Study|Adverse Event|1|||
156816950|NCT01691014|566079440|FG003|Overall Study|Adverse Event|1|||
156816951|NCT01691014|566079437|FG000|Overall Study|Lack of Efficacy|2|||
156816952|NCT01691014|566079438|FG001|Overall Study|Lack of Efficacy|3|||
156816953|NCT01691014|566079439|FG002|Overall Study|Lack of Efficacy|7|||
156816954|NCT01691014|566079440|FG003|Overall Study|Lack of Efficacy|0|||
156816955|NCT05897242|566079443|FG000|Overall Study|Lost to Follow-up|6|||
157150120|NCT00130208|567294882|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
157150121|NCT00130208|567294881|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
157150122|NCT00130208|567294882|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
157150123|NCT00130208|567294881|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
156816956|NCT05897242|566079444|FG001|Overall Study|Lost to Follow-up|1|||
156816957|NCT05897242|566079443|FG000|Overall Study|Incomplete|1|||
156816958|NCT05897242|566079444|FG001|Overall Study|Incomplete|0|||
156816959|NCT05897242|566079443|FG000|Overall Study|Withdrawal by Subject|1|||
156816960|NCT05897242|566079444|FG001|Overall Study|Withdrawal by Subject|0|||
156816961|NCT03522246|566079445|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
156816962|NCT03522246|566079446|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
156816963|NCT03522246|566079447|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
156816964|NCT03522246|566079448|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
156816965|NCT03522246|566079449|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
156816966|NCT00814580|566079450|FG000|Overall Study|Adverse Event|6|||
156816967|NCT00814580|566079451|FG001|Overall Study|Adverse Event|15|||
156816968|NCT00814580|566079450|FG000|Overall Study|Lack of Efficacy|18|||
156816969|NCT00814580|566079451|FG001|Overall Study|Lack of Efficacy|25|||
156816970|NCT00814580|566079450|FG000|Overall Study|Protocol Violation|2|||
156816971|NCT00814580|566079451|FG001|Overall Study|Protocol Violation|0|||
156816972|NCT00814580|566079450|FG000|Overall Study|Withdrawal by Subject|2|||
156816973|NCT00814580|566079451|FG001|Overall Study|Withdrawal by Subject|2|||
156816974|NCT00814580|566079450|FG000|Overall Study|Other|1|||
156816975|NCT00814580|566079451|FG001|Overall Study|Other|3|||
156816976|NCT00814580|566079450|FG000|Overall Study|Did Not Take Drug|2|||
156816977|NCT00814580|566079451|FG001|Overall Study|Did Not Take Drug|2|||
156816978|NCT02482428|566079452|FG000|Overall Study|Lost to Follow-up|4|||
156816979|NCT02482428|566079453|FG001|Overall Study|Lost to Follow-up|9|||
156816980|NCT02482428|566079454|FG002|Overall Study|Lost to Follow-up|1|||
156816981|NCT02482428|566079455|FG003|Overall Study|Lost to Follow-up|2|||
156816982|NCT02482428|566079456|FG004|Overall Study|Lost to Follow-up|4|||
156816983|NCT02482428|566079452|FG000|Overall Study|Physician Decision|0|||
156816984|NCT02482428|566079453|FG001|Overall Study|Physician Decision|0|||
156816985|NCT02482428|566079454|FG002|Overall Study|Physician Decision|0|||
156816986|NCT02482428|566079455|FG003|Overall Study|Physician Decision|0|||
156816987|NCT02482428|566079456|FG004|Overall Study|Physician Decision|1|||
156816988|NCT02482428|566079452|FG000|Overall Study|protocol deviation|1|||
156816989|NCT02482428|566079453|FG001|Overall Study|protocol deviation|1|||
156816990|NCT02482428|566079454|FG002|Overall Study|protocol deviation|0|||
156816991|NCT02482428|566079455|FG003|Overall Study|protocol deviation|0|||
156816992|NCT02482428|566079456|FG004|Overall Study|protocol deviation|0|||
156816993|NCT02482428|566079452|FG000|Overall Study|subject/guardian decision|4|||
156816994|NCT02482428|566079453|FG001|Overall Study|subject/guardian decision|2|||
156816995|NCT02482428|566079454|FG002|Overall Study|subject/guardian decision|0|||
156816996|NCT02482428|566079455|FG003|Overall Study|subject/guardian decision|0|||
156816997|NCT02482428|566079456|FG004|Overall Study|subject/guardian decision|2|||
156816998|NCT00809835|566079459|FG000|Overall Study|Lost to Follow-up|7|||
156816999|NCT00809835|566079460|FG001|Overall Study|Lost to Follow-up|6|||
156817000|NCT00809835|566079461|FG002|Overall Study|Lost to Follow-up|10|||
156817001|NCT00809835|566079462|FG003|Overall Study|Lost to Follow-up|2|||
156817002|NCT00809835|566079459|FG000|Overall Study|Withdrawal by Subject|1|||
156817003|NCT00809835|566079460|FG001|Overall Study|Withdrawal by Subject|1|||
156817004|NCT00809835|566079461|FG002|Overall Study|Withdrawal by Subject|1|||
156817005|NCT00809835|566079462|FG003|Overall Study|Withdrawal by Subject|0|||
156817006|NCT02547038|566079463|FG000|Overall Study|Lost to Follow-up|3|||
156817007|NCT02547038|566079464|FG001|Overall Study|Lost to Follow-up|2|||
156817008|NCT00516893|566079465|FG000|Overall Study|Lost to Follow-up|4|||
156817009|NCT00516893|566079465|FG000|Overall Study|Adverse Event|3|||
156817010|NCT00516893|566079465|FG000|Overall Study|Withdrawal by Subject|2|||
156817011|NCT00516893|566079465|FG000|Overall Study|Noncompliance|2|||
156817012|NCT00516893|566079465|FG000|Overall Study|Death|1|||
156817013|NCT00516893|566079465|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
156817014|NCT00516893|566079465|FG000|Overall Study|Relocated|1|||
156817015|NCT00516893|566079465|FG000|Overall Study|Pregnancy|1|||
156817016|NCT00516893|566079465|FG000|Overall Study|Received Medication From Another Study|1|||
156817017|NCT01340625|566079468|FG000|First Intervention|Adverse Event|1|||
156817018|NCT01340625|566079469|FG001|First Intervention|Adverse Event|0|||
156817019|NCT01340625|566079468|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
156817020|NCT01340625|566079469|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
156817021|NCT05160415|566079470|FG000|Overall Study|Withdrawal by Subject|3|||
156817022|NCT01519791|566079471|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
156817023|NCT01519791|566079472|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
156817024|NCT01519791|566079471|FG000|Overall Study|Protocol Violation|6|||
156817025|NCT01519791|566079472|FG001|Overall Study|Protocol Violation|19|||
156817026|NCT01519791|566079471|FG000|Overall Study|Other Reason|87|||
156817027|NCT01519791|566079472|FG001|Overall Study|Other Reason|222|||
156817028|NCT01519791|566079471|FG000|Overall Study|subjects randomized in error|2|||
156817029|NCT01519791|566079472|FG001|Overall Study|subjects randomized in error|0|||
156817030|NCT01519791|566079471|FG000|Overall Study|Lack of Efficacy|16|||
156817031|NCT01519791|566079472|FG001|Overall Study|Lack of Efficacy|20|||
157223772|NCT00619385|567565775|FG002|Overall Study|Adverse Event|3|||
156817032|NCT01519791|566079471|FG000|Overall Study|SAE, non-fatal|6|||
156817033|NCT01519791|566079472|FG001|Overall Study|SAE, non-fatal|22|||
156817034|NCT01519791|566079471|FG000|Overall Study|AE, serious fatal|0|||
156817035|NCT01519791|566079472|FG001|Overall Study|AE, serious fatal|1|||
156817036|NCT01519791|566079471|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
156817037|NCT01519791|566079472|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
156817038|NCT01519791|566079471|FG000|Overall Study|AE, non-serious non-fatal|12|||
156817039|NCT01519791|566079472|FG001|Overall Study|AE, non-serious non-fatal|31|||
156817040|NCT01519791|566079471|FG000|Overall Study|Withdrawal by Subject|15|||
156817041|NCT01519791|566079472|FG001|Overall Study|Withdrawal by Subject|37|||
156817042|NCT01519791|566079471|FG000|Overall Study|Lost to Follow-up|6|||
156817043|NCT01519791|566079472|FG001|Overall Study|Lost to Follow-up|14|||
156817044|NCT00623233|566079473|FG000|Overall Study|Adverse Event|10|||
156817045|NCT00623233|566079473|FG000|Overall Study|Physician Decision|10|||
156817046|NCT00623233|566079473|FG000|Overall Study|Lost to Follow-up|1|||
157022571|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
157022572|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
157022573|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
157022574|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
156817047|NCT00623233|566079473|FG000|Overall Study|Withdrawal by Subject|3|||
156817048|NCT00559845|566079474|FG000|Overall Study|Withdrew Consent|1|||
156817049|NCT00559845|566079474|FG000|Overall Study|Disease Progression|1|||
156817050|NCT00559845|566079474|FG000|Overall Study|Adverse Event|3|||
156817051|NCT00559845|566079474|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
156817052|NCT00559845|566079474|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
156817053|NCT00459875|566079475|FG000|Overall Study|Ineligible participant|1|||
156817054|NCT00459875|566079475|FG000|Overall Study|Adverse Event|2|||
156817055|NCT00576628|566079478|FG000|Overall Study|Adverse Event|11|||
156817056|NCT00576628|566079478|FG000|Overall Study|Death|2|||
156817057|NCT00576628|566079478|FG000|Overall Study|Failure to return|1|||
156817058|NCT00576628|566079478|FG000|Overall Study|Refused Treatment|8|||
156817059|NCT00576628|566079478|FG000|Overall Study|Pregnancy|1|||
156817060|NCT00576628|566079478|FG000|Overall Study|RBC transfusion|1|||
156817061|NCT00576628|566079478|FG000|Overall Study|Progression of Kidney Disease|1|||
156817062|NCT00576628|566079478|FG000|Overall Study|Progression of Renal Failure|1|||
156817063|NCT00576628|566079478|FG000|Overall Study|The patient move into other town|1|||
156817064|NCT00576628|566079478|FG000|Overall Study|Transplantation|1|||
156817065|NCT00576628|566079478|FG000|Overall Study|Dialysis|15|||
156817066|NCT03206970|566079479|FG000|Overall Study|Death|21|||
156817067|NCT03206970|566079479|FG000|Overall Study|Withdrawal by Subject|13|||
156817068|NCT03206970|566079479|FG000|Overall Study|Lost to Follow-up|3|||
156817069|NCT03206970|566079479|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
156817070|NCT02516982|566079486|FG000|Overall Study|Called in to antenatal appointment|32|||
156817071|NCT02516982|566079487|FG001|Overall Study|Called in to antenatal appointment|35|||
156817072|NCT02516982|566079488|FG002|Overall Study|Called in to antenatal appointment|0|||
156817073|NCT02516982|566079489|FG003|Overall Study|Called in to antenatal appointment|0|||
156817074|NCT02516982|566079486|FG000|Overall Study|Withdrawal by Subject|0|||
156817075|NCT02516982|566079487|FG001|Overall Study|Withdrawal by Subject|0|||
156817076|NCT02516982|566079488|FG002|Overall Study|Withdrawal by Subject|1|||
156817077|NCT02516982|566079489|FG003|Overall Study|Withdrawal by Subject|2|||
156817078|NCT02516982|566079486|FG000|Overall Study|Protocol Violation|0|||
156817079|NCT02516982|566079487|FG001|Overall Study|Protocol Violation|0|||
156817080|NCT02516982|566079488|FG002|Overall Study|Protocol Violation|1|||
156817081|NCT02516982|566079489|FG003|Overall Study|Protocol Violation|1|||
156817082|NCT02516982|566079486|FG000|Overall Study|Did not install the app|0|||
156817083|NCT02516982|566079487|FG001|Overall Study|Did not install the app|0|||
156817084|NCT02516982|566079488|FG002|Overall Study|Did not install the app|46|||
156817085|NCT02516982|566079489|FG003|Overall Study|Did not install the app|47|||
156817086|NCT03654040|566079490|FG000|Overall Study|Death|1|||
156817087|NCT03654040|566079491|FG001|Overall Study|Death|0|||
156817088|NCT03654040|566079490|FG000|Overall Study|Withdrawal by Subject|1|||
156817089|NCT03654040|566079491|FG001|Overall Study|Withdrawal by Subject|0|||
156817090|NCT03654040|566079490|FG000|Overall Study|Study terminated by sponsor|8|||
156817091|NCT03654040|566079491|FG001|Overall Study|Study terminated by sponsor|2|||
156817092|NCT03654040|566079490|FG000|Overall Study|Failure to initiate study therapy|2|||
156817093|NCT03654040|566079491|FG001|Overall Study|Failure to initiate study therapy|0|||
156817094|NCT03654040|566079490|FG000|Overall Study|Transplanted at another center|2|||
156817095|NCT03654040|566079491|FG001|Overall Study|Transplanted at another center|0|||
156817096|NCT03654040|566079490|FG000|Overall Study|Failure to meet eligibility criteria|14|||
156817097|NCT03654040|566079491|FG001|Overall Study|Failure to meet eligibility criteria|2|||
156817098|NCT03654040|566079490|FG000|Overall Study|No longer transplant candidate|1|||
156817099|NCT03654040|566079491|FG001|Overall Study|No longer transplant candidate|0|||
157022575|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
157022576|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
157223773|NCT00619385|567565773|FG000|Overall Study|Other|1|||
157223774|NCT00619385|567565774|FG001|Overall Study|Other|2|||
156817100|NCT03654040|566079490|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
156817101|NCT03654040|566079491|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
156817102|NCT03654040|566079490|FG000|Overall Study|Recipient ineligible|0|||
156817103|NCT03654040|566079491|FG001|Overall Study|Recipient ineligible|2|||
156817104|NCT03654040|566079490|FG000|Overall Study|Received deceased liver|0|||
156817105|NCT03654040|566079491|FG001|Overall Study|Received deceased liver|1|||
156817106|NCT01951586|566079496|FG000|Overall Study|Death|61|||
156817107|NCT01951586|566079497|FG001|Overall Study|Death|120|||
156817108|NCT01951586|566079496|FG000|Overall Study|Withdrawal by Subject|8|||
156817109|NCT01951586|566079497|FG001|Overall Study|Withdrawal by Subject|17|||
156817110|NCT01951586|566079496|FG000|Overall Study|Lost to Follow-up|0|||
156817111|NCT01951586|566079497|FG001|Overall Study|Lost to Follow-up|1|||
156817112|NCT01951586|566079496|FG000|Overall Study|Sponsor Decision|9|||
157223775|NCT00619385|567565775|FG002|Overall Study|Other|1|||
157223776|NCT02041702|567565778|FG000|Overall Study|Lost to Follow-up|1|||
156817113|NCT01951586|566079497|FG001|Overall Study|Sponsor Decision|10|||
156817114|NCT03645421|566079500|FG000|Overall Study|Adverse Event|0|||
156817115|NCT03645421|566079501|FG001|Overall Study|Adverse Event|0|||
156817116|NCT03645421|566079502|FG002|Overall Study|Adverse Event|4|||
156817117|NCT03645421|566079503|FG003|Overall Study|Adverse Event|1|||
156817118|NCT03645421|566079500|FG000|Overall Study|Withdrawal by patient|0|||
156817119|NCT03645421|566079501|FG001|Overall Study|Withdrawal by patient|0|||
156817120|NCT03645421|566079502|FG002|Overall Study|Withdrawal by patient|0|||
156817121|NCT03645421|566079503|FG003|Overall Study|Withdrawal by patient|3|||
156817122|NCT03645421|566079500|FG000|Overall Study|Study specific withdrawal criteria|0|||
156817123|NCT03645421|566079501|FG001|Overall Study|Study specific withdrawal criteria|0|||
156817124|NCT03645421|566079502|FG002|Overall Study|Study specific withdrawal criteria|1|||
156817125|NCT03645421|566079503|FG003|Overall Study|Study specific withdrawal criteria|0|||
156817126|NCT02120781|566079504|FG000|Overall Study|Physician Decision|2|||
156817127|NCT02120781|566079505|FG001|Overall Study|Physician Decision|0|||
156817128|NCT02120781|566079504|FG000|Overall Study|Completion not documented|2|||
156817129|NCT02120781|566079505|FG001|Overall Study|Completion not documented|1|||
156817130|NCT03379259|566079506|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
156817131|NCT03379259|566079507|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
156817132|NCT03379259|566079508|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
156817133|NCT03379259|566079509|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
156817134|NCT03379259|566079510|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
156817135|NCT03379259|566079511|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
156817136|NCT03379259|566079506|FG000|Overall Study|Death|0|||
156817137|NCT03379259|566079507|FG001|Overall Study|Death|1|||
156817138|NCT03379259|566079508|FG002|Overall Study|Death|2|||
156817139|NCT03379259|566079509|FG003|Overall Study|Death|1|||
156817140|NCT03379259|566079510|FG004|Overall Study|Death|4|||
156817141|NCT03379259|566079511|FG005|Overall Study|Death|2|||
156817142|NCT03379259|566079506|FG000|Overall Study|Withdrawal by Subject|0|||
156817143|NCT03379259|566079507|FG001|Overall Study|Withdrawal by Subject|0|||
156817144|NCT03379259|566079508|FG002|Overall Study|Withdrawal by Subject|1|||
156817145|NCT03379259|566079509|FG003|Overall Study|Withdrawal by Subject|0|||
156817146|NCT03379259|566079510|FG004|Overall Study|Withdrawal by Subject|2|||
156817147|NCT03379259|566079511|FG005|Overall Study|Withdrawal by Subject|0|||
156817148|NCT03379259|566079506|FG000|Overall Study|Study terminated by sponsor|0|||
156817149|NCT03379259|566079507|FG001|Overall Study|Study terminated by sponsor|0|||
156817150|NCT03379259|566079508|FG002|Overall Study|Study terminated by sponsor|0|||
156817151|NCT03379259|566079509|FG003|Overall Study|Study terminated by sponsor|1|||
156817152|NCT03379259|566079510|FG004|Overall Study|Study terminated by sponsor|1|||
156817153|NCT03379259|566079511|FG005|Overall Study|Study terminated by sponsor|4|||
156817154|NCT03379259|566079506|FG000|Overall Study|Disease progression|0|||
156817155|NCT03379259|566079507|FG001|Overall Study|Disease progression|0|||
156817156|NCT03379259|566079508|FG002|Overall Study|Disease progression|0|||
156817157|NCT03379259|566079509|FG003|Overall Study|Disease progression|1|||
156817158|NCT03379259|566079510|FG004|Overall Study|Disease progression|0|||
156817159|NCT03379259|566079511|FG005|Overall Study|Disease progression|1|||
156817160|NCT03379259|566079506|FG000|Overall Study|Lost to Follow-up|0|||
156817161|NCT03379259|566079507|FG001|Overall Study|Lost to Follow-up|0|||
156817162|NCT03379259|566079508|FG002|Overall Study|Lost to Follow-up|0|||
156817163|NCT03379259|566079509|FG003|Overall Study|Lost to Follow-up|0|||
156817164|NCT03379259|566079510|FG004|Overall Study|Lost to Follow-up|1|||
156817165|NCT03379259|566079511|FG005|Overall Study|Lost to Follow-up|0|||
156817166|NCT03379259|566079506|FG000|Overall Study|Deteriorating condition|0|||
156884353|NCT01616693|566334080|FG000|Received Both Vaccines|Adverse Event|2|||
157022577|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
157022578|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
157022579|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
157022580|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
157022581|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
157022582|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
157223777|NCT02041702|567565779|FG001|Overall Study|Lost to Follow-up|6|||
157223778|NCT02041702|567565778|FG000|Overall Study|Death|4|||
156817167|NCT03379259|566079507|FG001|Overall Study|Deteriorating condition|0|||
156817168|NCT03379259|566079508|FG002|Overall Study|Deteriorating condition|0|||
156817169|NCT03379259|566079509|FG003|Overall Study|Deteriorating condition|0|||
156817170|NCT03379259|566079510|FG004|Overall Study|Deteriorating condition|1|||
156817171|NCT03379259|566079511|FG005|Overall Study|Deteriorating condition|0|||
156817172|NCT03195660|566079512|FG000|Overall Study|The study was terminated|2|||
156817173|NCT00375427|566079513|FG000|Overall Study|Adverse Event|21|||
156817174|NCT00375427|566079514|FG001|Overall Study|Adverse Event|27|||
156817175|NCT00375427|566079513|FG000|Overall Study|Abnormal test procedure result(s)|0|||
156817176|NCT00375427|566079514|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156817177|NCT00375427|566079513|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157223779|NCT02041702|567565779|FG001|Overall Study|Death|0|||
156817178|NCT00375427|566079514|FG001|Overall Study|Abnormal laboratory value(s)|2|||
156817179|NCT00375427|566079513|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
156817180|NCT00375427|566079514|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156817181|NCT00375427|566079513|FG000|Overall Study|Patient no longer requires study drug|3|||
156817182|NCT00375427|566079514|FG001|Overall Study|Patient no longer requires study drug|7|||
156817183|NCT00375427|566079513|FG000|Overall Study|Protocol Violation|10|||
156817184|NCT00375427|566079514|FG001|Overall Study|Protocol Violation|8|||
156817185|NCT00375427|566079513|FG000|Overall Study|Withdrawal by Subject|9|||
156817186|NCT00375427|566079514|FG001|Overall Study|Withdrawal by Subject|13|||
156817187|NCT00375427|566079513|FG000|Overall Study|Lost to Follow-up|1|||
156817188|NCT00375427|566079514|FG001|Overall Study|Lost to Follow-up|1|||
156817189|NCT00375427|566079513|FG000|Overall Study|Administrative reasons|0|||
156817190|NCT00375427|566079514|FG001|Overall Study|Administrative reasons|1|||
156817191|NCT00375427|566079513|FG000|Overall Study|Death|11|||
156817192|NCT00375427|566079514|FG001|Overall Study|Death|10|||
156817193|NCT03286543|566079520|FG000|Consented|Screen failure before randomization|2|||
156817194|NCT03286543|566079521|FG001|Consented|Screen failure before randomization|0|||
156817195|NCT03286543|566079522|FG002|Consented|Screen failure before randomization|0|||
156817196|NCT03286543|566079520|FG000|Consented|Screen failure before enrollment|4|||
156817197|NCT03286543|566079521|FG001|Consented|Screen failure before enrollment|0|||
156817198|NCT03286543|566079522|FG002|Consented|Screen failure before enrollment|0|||
156817199|NCT03286543|566079520|FG000|Consented|TKA cancelled after enrollment|1|||
156817200|NCT03286543|566079521|FG001|Consented|TKA cancelled after enrollment|0|||
156817201|NCT03286543|566079522|FG002|Consented|TKA cancelled after enrollment|0|||
156817202|NCT03286543|566079520|FG000|Consented|Withdrawn from study|12|||
156817203|NCT03286543|566079521|FG001|Consented|Withdrawn from study|0|||
156817204|NCT03286543|566079522|FG002|Consented|Withdrawn from study|0|||
156817205|NCT03286543|566079520|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
156817206|NCT03286543|566079521|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
156817207|NCT03286543|566079522|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
156817208|NCT03286543|566079520|FG000|Study Enrollment|Withdrawn from study|0|||
156817209|NCT03286543|566079521|FG001|Study Enrollment|Withdrawn from study|6|||
156817210|NCT03286543|566079522|FG002|Study Enrollment|Withdrawn from study|6|||
156817211|NCT05332392|566079523|FG000|Overall Study|Did not meet inclusion criteria|25|||
156817212|NCT05332392|566079523|FG000|Overall Study|Principal Investigator's decision|17|||
156817213|NCT05332392|566079523|FG000|Overall Study|Adverse Event|1|||
156817214|NCT05332392|566079523|FG000|Overall Study|Subject's decision|1|||
156817215|NCT01268046|566079524|FG000|Overall Study|Withdrawal by Subject|1|||
156817216|NCT01268046|566079525|FG001|Overall Study|Withdrawal by Subject|0|||
156817217|NCT01268046|566079526|FG002|Overall Study|Withdrawal by Subject|0|||
156817218|NCT01268046|566079527|FG003|Overall Study|Withdrawal by Subject|1|||
156817219|NCT01268046|566079524|FG000|Overall Study|Lost to Follow-up|0|||
156817220|NCT01268046|566079525|FG001|Overall Study|Lost to Follow-up|0|||
156817221|NCT01268046|566079526|FG002|Overall Study|Lost to Follow-up|1|||
156817222|NCT01268046|566079527|FG003|Overall Study|Lost to Follow-up|0|||
156817223|NCT03850093|566079528|FG000|Overall Study|Withdrawal by Subject|1|||
156817224|NCT03850093|566079529|FG001|Overall Study|Withdrawal by Subject|0|||
156817225|NCT03850093|566079530|FG002|Overall Study|Withdrawal by Subject|2|||
156817226|NCT03636893|566079532|FG000|Overall Study|Death|0|||
156817227|NCT03636893|566079533|FG001|Overall Study|Death|1|||
156817228|NCT03636893|566079532|FG000|Overall Study|Protocol Violation|0|||
156817229|NCT03636893|566079533|FG001|Overall Study|Protocol Violation|3|||
156817230|NCT03636893|566079532|FG000|Overall Study|Withdrawal by Subject|1|||
156817231|NCT03636893|566079533|FG001|Overall Study|Withdrawal by Subject|2|||
156817232|NCT03636893|566079532|FG000|Overall Study|Refusal to surgery|4|||
156817233|NCT03636893|566079533|FG001|Overall Study|Refusal to surgery|3|||
156817234|NCT03636893|566079532|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
156817235|NCT03636893|566079533|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
156817236|NCT03636893|566079532|FG000|Overall Study|Adverse Event|1|||
156817237|NCT03636893|566079533|FG001|Overall Study|Adverse Event|1|||
156884354|NCT01616693|566334081|FG001|Received Both Vaccines|Adverse Event|0|||
156884355|NCT01616693|566334082|FG002|Received Both Vaccines|Adverse Event|0|||
156884356|NCT01616693|566334083|FG003|Received Both Vaccines|Adverse Event|0|||
156817238|NCT02314156|566079534|FG000|Overall Study|Adverse Event|1|||
156817239|NCT02314156|566079535|FG001|Overall Study|Adverse Event|0|||
156817240|NCT02314156|566079534|FG000|Overall Study|Withdrawal by Subject|1|||
156817241|NCT02314156|566079535|FG001|Overall Study|Withdrawal by Subject|0|||
156817242|NCT00224120|566079536|FG000|Overall Study|Adverse Event|10|||
156817243|NCT00224120|566079537|FG001|Overall Study|Adverse Event|4|||
156817244|NCT00224120|566079536|FG000|Overall Study|Protocol Violation|1|||
156884357|NCT01616693|566334080|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
156817245|NCT00224120|566079537|FG001|Overall Study|Protocol Violation|0|||
156817246|NCT00224120|566079536|FG000|Overall Study|Withdrawal by Subject|5|||
156817247|NCT00224120|566079537|FG001|Overall Study|Withdrawal by Subject|10|||
156817248|NCT00224120|566079536|FG000|Overall Study|Lack of Efficacy|0|||
156817249|NCT00224120|566079537|FG001|Overall Study|Lack of Efficacy|2|||
156817250|NCT00224120|566079536|FG000|Overall Study|Lost to Follow-up|2|||
156817251|NCT00224120|566079537|FG001|Overall Study|Lost to Follow-up|3|||
156817252|NCT00224120|566079536|FG000|Overall Study|Other|4|||
156817253|NCT00224120|566079537|FG001|Overall Study|Other|5|||
156817254|NCT00104416|566079540|FG000|Double-Blind Phase|Adverse Event|2|||
156817255|NCT00104416|566079541|FG001|Double-Blind Phase|Adverse Event|1|||
156817256|NCT00104416|566079542|FG002|Double-Blind Phase|Adverse Event|0|||
156817257|NCT00104416|566079543|FG003|Double-Blind Phase|Adverse Event|0|||
156817258|NCT00104416|566079544|FG004|Double-Blind Phase|Adverse Event|0|||
156817259|NCT00104416|566079540|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156817260|NCT00104416|566079541|FG001|Double-Blind Phase|Lost to Follow-up|1|||
156817261|NCT00104416|566079542|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156817262|NCT00104416|566079543|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156817263|NCT00104416|566079544|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156817264|NCT00104416|566079540|FG000|Double-Blind Phase|Protocol Violation|0|||
156817265|NCT00104416|566079541|FG001|Double-Blind Phase|Protocol Violation|1|||
156817266|NCT00104416|566079542|FG002|Double-Blind Phase|Protocol Violation|0|||
156817267|NCT00104416|566079543|FG003|Double-Blind Phase|Protocol Violation|0|||
156817268|NCT00104416|566079544|FG004|Double-Blind Phase|Protocol Violation|0|||
156817269|NCT00104416|566079540|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
156817270|NCT00104416|566079541|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
156817271|NCT00104416|566079542|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156817272|NCT00104416|566079543|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156817273|NCT00104416|566079544|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156817274|NCT00104416|566079540|FG000|Double-Blind Phase|Pregnancy|1|||
156817275|NCT00104416|566079541|FG001|Double-Blind Phase|Pregnancy|0|||
156817276|NCT00104416|566079542|FG002|Double-Blind Phase|Pregnancy|0|||
156817277|NCT00104416|566079543|FG003|Double-Blind Phase|Pregnancy|0|||
156817278|NCT00104416|566079544|FG004|Double-Blind Phase|Pregnancy|0|||
156817279|NCT00104416|566079540|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
156817280|NCT00104416|566079541|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
156817281|NCT00104416|566079542|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817282|NCT00104416|566079543|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817283|NCT00104416|566079544|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
156817284|NCT00104416|566079540|FG000|Continuation Phase|Adverse Event|0|||
156817285|NCT00104416|566079541|FG001|Continuation Phase|Adverse Event|0|||
156817286|NCT00104416|566079542|FG002|Continuation Phase|Adverse Event|2|||
156817287|NCT00104416|566079543|FG003|Continuation Phase|Adverse Event|0|||
156817288|NCT00104416|566079544|FG004|Continuation Phase|Adverse Event|2|||
156817289|NCT00104416|566079540|FG000|Continuation Phase|Lost to Follow-up|0|||
156817290|NCT00104416|566079541|FG001|Continuation Phase|Lost to Follow-up|0|||
156817291|NCT00104416|566079542|FG002|Continuation Phase|Lost to Follow-up|1|||
156817292|NCT00104416|566079543|FG003|Continuation Phase|Lost to Follow-up|0|||
156817293|NCT00104416|566079544|FG004|Continuation Phase|Lost to Follow-up|1|||
156817294|NCT00104416|566079540|FG000|Continuation Phase|Withdrawal by Subject|0|||
156817295|NCT00104416|566079541|FG001|Continuation Phase|Withdrawal by Subject|0|||
156817296|NCT00104416|566079542|FG002|Continuation Phase|Withdrawal by Subject|2|||
156817297|NCT00104416|566079543|FG003|Continuation Phase|Withdrawal by Subject|1|||
156817298|NCT00104416|566079544|FG004|Continuation Phase|Withdrawal by Subject|1|||
156817299|NCT00104416|566079540|FG000|Continuation Phase|Pregnancy|0|||
156817300|NCT00104416|566079541|FG001|Continuation Phase|Pregnancy|0|||
156817301|NCT00104416|566079542|FG002|Continuation Phase|Pregnancy|1|||
156817302|NCT00104416|566079543|FG003|Continuation Phase|Pregnancy|1|||
156817303|NCT00104416|566079544|FG004|Continuation Phase|Pregnancy|0|||
156817304|NCT00104416|566079540|FG000|Continuation Phase|Non-compliance|0|||
156817305|NCT00104416|566079541|FG001|Continuation Phase|Non-compliance|0|||
156817306|NCT00104416|566079542|FG002|Continuation Phase|Non-compliance|0|||
156817307|NCT00104416|566079543|FG003|Continuation Phase|Non-compliance|0|||
156817308|NCT00104416|566079544|FG004|Continuation Phase|Non-compliance|1|||
156817309|NCT00438360|566079545|FG000|Overall Study|Adverse Event|6|||
156817310|NCT00438360|566079546|FG001|Overall Study|Adverse Event|1|||
156817311|NCT00438360|566079545|FG000|Overall Study|Lack of Efficacy|42|||
156817312|NCT00438360|566079546|FG001|Overall Study|Lack of Efficacy|27|||
156817313|NCT00438360|566079545|FG000|Overall Study|Other|24|||
156817314|NCT00438360|566079546|FG001|Overall Study|Other|15|||
156817315|NCT00758069|566079549|FG000|Overall Study|Lack of Efficacy|0|||
156817316|NCT00758069|566079550|FG001|Overall Study|Lack of Efficacy|0|||
156817317|NCT00758069|566079551|FG002|Overall Study|Lack of Efficacy|1|||
156817318|NCT00758069|566079549|FG000|Overall Study|Incorrect Study Drug|1|||
156817319|NCT00758069|566079550|FG001|Overall Study|Incorrect Study Drug|0|||
156817320|NCT00758069|566079551|FG002|Overall Study|Incorrect Study Drug|0|||
156817321|NCT04560816|566079552|FG000|Overall Study|Withdrawal by Subject|1|||
156817322|NCT04560816|566079553|FG001|Overall Study|Withdrawal by Subject|1|||
156817323|NCT04560816|566079554|FG002|Overall Study|Withdrawal by Subject|1|||
156817324|NCT04560816|566079555|FG003|Overall Study|Withdrawal by Subject|0|||
156817325|NCT04560816|566079556|FG004|Overall Study|Withdrawal by Subject|3|||
156817326|NCT04560816|566079557|FG005|Overall Study|Withdrawal by Subject|0|||
156817327|NCT04560816|566079552|FG000|Overall Study|Lost to Follow-up|1|||
156817328|NCT04560816|566079553|FG001|Overall Study|Lost to Follow-up|0|||
156817329|NCT04560816|566079554|FG002|Overall Study|Lost to Follow-up|0|||
156817330|NCT04560816|566079555|FG003|Overall Study|Lost to Follow-up|0|||
156817331|NCT04560816|566079556|FG004|Overall Study|Lost to Follow-up|0|||
156817332|NCT04560816|566079557|FG005|Overall Study|Lost to Follow-up|0|||
156817333|NCT04560816|566079552|FG000|Overall Study|Protocol Violation|1|||
156817334|NCT04560816|566079553|FG001|Overall Study|Protocol Violation|0|||
156817335|NCT04560816|566079554|FG002|Overall Study|Protocol Violation|0|||
156817336|NCT04560816|566079555|FG003|Overall Study|Protocol Violation|0|||
156817337|NCT04560816|566079556|FG004|Overall Study|Protocol Violation|0|||
156817338|NCT04560816|566079557|FG005|Overall Study|Protocol Violation|0|||
156817339|NCT02277691|566079558|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
156817340|NCT02277691|566079558|FG000|Overall Study|Voluntary Withdrawal|7|||
156817341|NCT02277691|566079558|FG000|Overall Study|Lack of Efficacy|5|||
156817342|NCT02277691|566079558|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
156817343|NCT02846389|566079561|FG000|Overall Study|Withdrawal by Subject|1|||
156817344|NCT02846389|566079562|FG001|Overall Study|Withdrawal by Subject|1|||
156817345|NCT03818607|566079565|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
156817346|NCT03818607|566079566|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
156817347|NCT03818607|566079565|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
156817348|NCT03818607|566079566|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
156817349|NCT03818607|566079565|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
156817350|NCT03818607|566079566|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
156817351|NCT05286658|566079568|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
156817352|NCT05286658|566079568|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
156817353|NCT01345929|566079569|FG000|Overall Study|Withdrawal by Subject|9|||
156817354|NCT01345929|566079570|FG001|Overall Study|Withdrawal by Subject|8|||
156817355|NCT01345929|566079569|FG000|Overall Study|Lost to Follow-up|9|||
156817356|NCT01345929|566079570|FG001|Overall Study|Lost to Follow-up|9|||
156817357|NCT01345929|566079569|FG000|Overall Study|Adverse Event|0|||
156817358|NCT01345929|566079570|FG001|Overall Study|Adverse Event|1|||
156817359|NCT01345929|566079569|FG000|Overall Study|Didn't meet eligibility criteria|2|||
156817360|NCT01345929|566079570|FG001|Overall Study|Didn't meet eligibility criteria|0|||
156817361|NCT01345929|566079569|FG000|Overall Study|40,000 CFU/ML|1|||
156817362|NCT01345929|566079570|FG001|Overall Study|40,000 CFU/ML|0|||
156817363|NCT01345929|566079569|FG000|Overall Study|Patient withdrawal|0|||
156817364|NCT01345929|566079570|FG001|Overall Study|Patient withdrawal|1|||
156817365|NCT02819297|566079571|FG000|Overall Study|Withdrawal by Subject|25|||
156817366|NCT02819297|566079572|FG001|Overall Study|Withdrawal by Subject|13|||
156817367|NCT02819297|566079571|FG000|Overall Study|Lost to Follow-up|12|||
156817368|NCT02819297|566079572|FG001|Overall Study|Lost to Follow-up|14|||
157022583|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
157022584|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
157022585|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156817369|NCT02819297|566079571|FG000|Overall Study|Adverse Event|12|||
156817370|NCT02819297|566079572|FG001|Overall Study|Adverse Event|10|||
156817371|NCT02819297|566079571|FG000|Overall Study|Physician Decision|5|||
156817372|NCT02819297|566079572|FG001|Overall Study|Physician Decision|5|||
156817373|NCT02819297|566079571|FG000|Overall Study|Lack of Efficacy|5|||
156817374|NCT02819297|566079572|FG001|Overall Study|Lack of Efficacy|8|||
156817375|NCT02819297|566079571|FG000|Overall Study|Protocol Violation|1|||
156817376|NCT02819297|566079572|FG001|Overall Study|Protocol Violation|2|||
156817377|NCT01670279|566079573|FG000|Overall Study|Adverse Event|0|||
156817378|NCT01670279|566079574|FG001|Overall Study|Adverse Event|1|||
156817379|NCT01670279|566079575|FG002|Overall Study|Adverse Event|0|||
156817380|NCT01670279|566079576|FG003|Overall Study|Adverse Event|0|||
157022586|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
157022587|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
156817381|NCT01670279|566079573|FG000|Overall Study|Physician Decision|0|||
157022588|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
157022589|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
157022590|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156817382|NCT01670279|566079574|FG001|Overall Study|Physician Decision|1|||
156817383|NCT01670279|566079575|FG002|Overall Study|Physician Decision|0|||
156817384|NCT01670279|566079576|FG003|Overall Study|Physician Decision|0|||
156817385|NCT01670279|566079573|FG000|Overall Study|Participant met withdrawal criteria|0|||
156817386|NCT01670279|566079574|FG001|Overall Study|Participant met withdrawal criteria|0|||
156817387|NCT01670279|566079575|FG002|Overall Study|Participant met withdrawal criteria|0|||
156817388|NCT01670279|566079576|FG003|Overall Study|Participant met withdrawal criteria|1|||
156817389|NCT01901614|566079579|FG000|Overall Study|Adverse Event|0|||
156817390|NCT01901614|566079580|FG001|Overall Study|Adverse Event|1|||
156817391|NCT01901614|566079579|FG000|Overall Study|Lost to Follow-up|1|||
156817392|NCT01901614|566079580|FG001|Overall Study|Lost to Follow-up|0|||
156817393|NCT01901614|566079579|FG000|Overall Study|Screen Fail|1|||
157022591|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156817394|NCT01901614|566079580|FG001|Overall Study|Screen Fail|0|||
156817395|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817396|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817397|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817398|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
156817399|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817400|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
156817401|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817402|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817403|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817404|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
156817405|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817406|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
156817407|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817408|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
156817409|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817410|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817411|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817412|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
156817413|NCT03629223|566079581|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817414|NCT03629223|566079582|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
156817415|NCT03629223|566079583|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817416|NCT03629223|566079584|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817417|NCT03629223|566079585|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817418|NCT03629223|566079586|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
156817419|NCT03629223|566079581|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
156817420|NCT03629223|566079582|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817421|NCT03629223|566079583|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817422|NCT03629223|566079584|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817423|NCT03629223|566079585|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817424|NCT03629223|566079586|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
156817425|NCT01104545|566079587|FG000|Overall Study|Adverse Event|0|||
156817426|NCT01104545|566079588|FG001|Overall Study|Adverse Event|1|||
156817427|NCT01104545|566079589|FG002|Overall Study|Adverse Event|2|||
156817428|NCT04532294|566079590|FG000|Overall Study|Withdrawal by Subject|0|||
156817429|NCT04532294|566079591|FG001|Overall Study|Withdrawal by Subject|0|||
156817430|NCT04532294|566079592|FG002|Overall Study|Withdrawal by Subject|1|||
156817431|NCT04532294|566079590|FG000|Overall Study|Participants Not Dosed|0|||
156817432|NCT04532294|566079591|FG001|Overall Study|Participants Not Dosed|0|||
156817433|NCT04532294|566079592|FG002|Overall Study|Participants Not Dosed|2|||
156817434|NCT02798315|566079593|FG000|Overall Study|Failure to return|1|||
156817435|NCT00912782|566079595|FG000|Overall Study|Death|2|||
156817436|NCT00912782|566079596|FG001|Overall Study|Death|1|||
156817437|NCT00912782|566079595|FG000|Overall Study|Lost to Follow-up|0|||
156817438|NCT00912782|566079596|FG001|Overall Study|Lost to Follow-up|1|||
156817439|NCT00912782|566079595|FG000|Overall Study|Did not receive vascular access type|1|||
156817440|NCT00912782|566079596|FG001|Overall Study|Did not receive vascular access type|2|||
156817441|NCT00912782|566079595|FG000|Overall Study|Relocated before study completion|0|||
156817442|NCT00912782|566079596|FG001|Overall Study|Relocated before study completion|1|||
156817443|NCT01986231|566081241|FG000|Overall Study|Adverse Event|1|||
156817444|NCT05791565|566081242|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
156817445|NCT05791565|566081243|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
156817446|NCT02300558|566081244|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
156817447|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
156817448|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
156817449|NCT02300558|566081244|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
156817450|NCT02318368|566081245|FG000|Overall Study|Withdrawal by Subject|2|||
156817451|NCT02318368|566081246|FG001|Overall Study|Withdrawal by Subject|0|||
156817452|NCT02318368|566081245|FG000|Overall Study|Study terminated by the sponsor|5|||
156817453|NCT02318368|566081246|FG001|Overall Study|Study terminated by the sponsor|2|||
156817454|NCT02318368|566081245|FG000|Overall Study|Death|0|||
156817455|NCT02318368|566081246|FG001|Overall Study|Death|1|||
156817456|NCT01555073|566081247|FG000|Overall Study|Lost to Follow-up|1|||
156817457|NCT01555073|566081248|FG001|Overall Study|Lost to Follow-up|2|||
156817458|NCT01555073|566081249|FG002|Overall Study|Lost to Follow-up|0|||
156817459|NCT01555073|566081250|FG003|Overall Study|Lost to Follow-up|5|||
156817460|NCT02027311|566081251|FG000|Overall Study|Protocol Violation|3|||
156817461|NCT02027311|566081252|FG001|Overall Study|Protocol Violation|2|||
156817462|NCT03928418|566081253|FG000|Overall Study|Lost to Follow-up|5|||
157022592|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
156817463|NCT03928418|566081254|FG001|Overall Study|Lost to Follow-up|3|||
156817464|NCT03928418|566081255|FG002|Overall Study|Lost to Follow-up|5|||
157223780|NCT02041702|567565778|FG000|Overall Study|Withdrawal by Subject|4|||
157223781|NCT02041702|567565779|FG001|Overall Study|Withdrawal by Subject|3|||
156817465|NCT03928418|566081253|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
156817466|NCT03928418|566081254|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
156817467|NCT03928418|566081255|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
156817468|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
156817469|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
156817470|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
156817471|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
156817472|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Death|58|||
156817473|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Death|65|||
156817474|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Adverse Event|28|||
156817475|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Adverse Event|40|||
156817476|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Disease Progression|22|||
156817477|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Disease Progression|35|||
156817478|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Other|25|||
156817479|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Other|33|||
156817480|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
156817481|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
156817482|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Noncompliance|8|||
156817483|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Noncompliance|8|||
156817484|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
156817485|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
156817486|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
156817487|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
156817488|NCT00286091|566081267|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
156817489|NCT00286091|566081268|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
156817490|NCT00286091|566081267|FG000|Open-label Treatment Phase|Physician Decision|24|||
156817491|NCT00286091|566081268|FG001|Open-label Treatment Phase|Physician Decision|21|||
156817492|NCT00286091|566081267|FG000|Open-label Treatment Phase|Adverse Event|5|||
156817493|NCT00286091|566081268|FG001|Open-label Treatment Phase|Adverse Event|16|||
156817494|NCT00286091|566081267|FG000|Open-label Treatment Phase|Other|11|||
156817495|NCT00286091|566081268|FG001|Open-label Treatment Phase|Other|11|||
156817496|NCT00286091|566081267|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
156817497|NCT00286091|566081268|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
156817498|NCT00286091|566081267|FG000|Open-label Treatment Phase|Death|10|||
156817499|NCT00286091|566081268|FG001|Open-label Treatment Phase|Death|7|||
156817500|NCT00286091|566081267|FG000|Open-label Treatment Phase|Disease Progression|9|||
156817501|NCT00286091|566081268|FG001|Open-label Treatment Phase|Disease Progression|3|||
156817502|NCT00286091|566081267|FG000|Open-label Treatment Phase|Noncompliance|3|||
156817503|NCT00286091|566081268|FG001|Open-label Treatment Phase|Noncompliance|1|||
156817504|NCT00286091|566081267|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
156817505|NCT00286091|566081268|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
156817506|NCT00286091|566081267|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
156817507|NCT00286091|566081268|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
156817508|NCT00286091|566081267|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
156817509|NCT00286091|566081268|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
156817510|NCT03799952|566081269|FG000|Overall Study|Program was too easy, discontinued|1|||
156817511|NCT03799952|566081270|FG001|Overall Study|Program was too easy, discontinued|0|||
156817512|NCT03799952|566081269|FG000|Overall Study|Lost to Follow-up|0|||
156817513|NCT03799952|566081270|FG001|Overall Study|Lost to Follow-up|2|||
156817514|NCT02936869|566081271|FG000|Overall Study|Lost to Follow-up|1|||
156817515|NCT02936869|566081272|FG001|Overall Study|Lost to Follow-up|3|||
156817516|NCT02936869|566081271|FG000|Overall Study|Death|0|||
156817517|NCT02936869|566081272|FG001|Overall Study|Death|1|||
156817518|NCT02936869|566081271|FG000|Overall Study|Legal Case|0|||
156817519|NCT02936869|566081272|FG001|Overall Study|Legal Case|1|||
156817520|NCT02936869|566081271|FG000|Overall Study|Protocol Violation|1|||
156817521|NCT02936869|566081272|FG001|Overall Study|Protocol Violation|0|||
156817522|NCT04004221|566081279|FG000|Overall Study|Death|89|||
156817523|NCT04004221|566081279|FG000|Overall Study|Withdrawal by Subject|5|||
157223782|NCT02041702|567565778|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
156817524|NCT04004221|566081279|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
156817525|NCT04004221|566081279|FG000|Overall Study|Sponsor Decision|9|||
156817526|NCT04004221|566081279|FG000|Overall Study|Participant refused to enter LTE|1|||
156817527|NCT03423238|566081280|FG000|Overall Study|Lost to Follow-up|1|||
156817528|NCT03423238|566081281|FG001|Overall Study|Lost to Follow-up|0|||
156817529|NCT03423238|566081280|FG000|Overall Study|Withdrawal by Subject|1|||
157223783|NCT02041702|567565779|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
156817530|NCT03423238|566081281|FG001|Overall Study|Withdrawal by Subject|0|||
157223784|NCT02041702|567565778|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
156817531|NCT02036580|566081285|FG000|Overall Study|Withdrawal by Subject|0|||
156817532|NCT02036580|566081286|FG001|Overall Study|Withdrawal by Subject|1|||
156817533|NCT02036580|566081287|FG002|Overall Study|Withdrawal by Subject|0|||
156817534|NCT02036580|566081285|FG000|Overall Study|Adverse Event|1|||
156817535|NCT02036580|566081286|FG001|Overall Study|Adverse Event|0|||
156817536|NCT02036580|566081287|FG002|Overall Study|Adverse Event|0|||
156817537|NCT00506454|566081288|FG000|Overall Study|Withdrawal by Subject|1|||
156817538|NCT00506454|566081289|FG001|Overall Study|Withdrawal by Subject|1|||
156817539|NCT00260832|566081290|FG000|Overall Study|Adverse Event|26|||
156817540|NCT00260832|566081291|FG001|Overall Study|Adverse Event|19|||
156817541|NCT00260832|566081290|FG000|Overall Study|Progression|116|||
156817542|NCT00260832|566081291|FG001|Overall Study|Progression|96|||
156817543|NCT00260832|566081290|FG000|Overall Study|Withdrawal by Subject|15|||
156817544|NCT00260832|566081291|FG001|Overall Study|Withdrawal by Subject|17|||
156817545|NCT00260832|566081290|FG000|Overall Study|Physician Decision|15|||
156817546|NCT00260832|566081291|FG001|Overall Study|Physician Decision|9|||
156817547|NCT00260832|566081290|FG000|Overall Study|Death|43|||
156817548|NCT00260832|566081291|FG001|Overall Study|Death|62|||
156817549|NCT00260832|566081290|FG000|Overall Study|Other|10|||
156817550|NCT00260832|566081291|FG001|Overall Study|Other|7|||
156817551|NCT00260832|566081290|FG000|Overall Study|Protocol Violation|3|||
156817552|NCT00260832|566081291|FG001|Overall Study|Protocol Violation|1|||
156817553|NCT00902850|566081292|FG000|Overall Study|Physician Decision|2|||
156817554|NCT00902850|566081293|FG001|Overall Study|Physician Decision|2|||
156817555|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
156817556|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
156817557|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
156817558|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817559|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817560|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817561|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
156817562|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
156817563|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817564|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817565|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817566|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817567|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817568|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
156817569|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
156817570|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
156817571|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
156817572|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817573|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817574|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817575|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
156817576|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
156817577|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
156817578|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817579|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817580|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817581|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817582|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
156817583|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
156817584|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817585|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817586|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817587|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817588|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817589|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
156817590|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817591|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
156817592|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817593|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817594|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817595|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817596|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
156817597|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
157223785|NCT02041702|567565779|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
157223786|NCT00203307|567565780|FG000|First Intervention|Adverse Event|2|||
157223787|NCT00203307|567565781|FG001|First Intervention|Adverse Event|0|||
156817598|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
156817599|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
156817600|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817601|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817602|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817603|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
156817604|NCT03745638|566081294|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
156817605|NCT03745638|566081295|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
156817606|NCT03745638|566081296|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817607|NCT03745638|566081297|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817608|NCT03745638|566081298|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817609|NCT03745638|566081299|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817610|NCT03745638|566081300|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
156817611|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817612|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817613|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817614|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817615|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
156817616|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
156817617|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
156817618|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817619|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817620|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817621|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
156817622|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
156817623|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156817624|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
156817625|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817626|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817627|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
156817628|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
156817629|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
156817630|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
156817631|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
156817632|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817633|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817634|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817635|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817636|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
156817637|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
156817638|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
156817639|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817640|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817641|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817642|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817643|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817644|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
156817645|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
156817646|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817647|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817648|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
156817649|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
156817650|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
156817651|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
156817652|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
156817653|NCT03745638|566081294|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817654|NCT03745638|566081295|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817655|NCT03745638|566081296|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
157022593|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
157022594|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
157022595|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
157022596|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
157022597|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
157150124|NCT00130208|567294882|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
156817656|NCT03745638|566081297|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817657|NCT03745638|566081298|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
156817658|NCT03745638|566081299|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
156817659|NCT03745638|566081300|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
156817660|NCT02993822|566081308|FG000|Overall Study|Lack of Efficacy|1|||
156817661|NCT02993822|566081309|FG001|Overall Study|Lack of Efficacy|1|||
156817662|NCT02993822|566081310|FG002|Overall Study|Lack of Efficacy|0|||
156817663|NCT02993822|566081311|FG003|Overall Study|Lack of Efficacy|0|||
156817664|NCT02993822|566081308|FG000|Overall Study|Protocol Violation|1|||
156817665|NCT02993822|566081309|FG001|Overall Study|Protocol Violation|0|||
157150125|NCT00130208|567294881|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
157223788|NCT03730103|567565782|FG000|Overall Study|Did not meet inclusion criteria|0|||
157223789|NCT03730103|567565783|FG001|Overall Study|Did not meet inclusion criteria|5|||
157223790|NCT01488578|567565784|FG000|Overall Study|Protocol Violation|1836|||
157223791|NCT02308111|567565785|FG000|Overall Study|Adverse Event|31|||
157223792|NCT02308111|567565786|FG001|Overall Study|Adverse Event|19|||
157223793|NCT02308111|567565785|FG000|Overall Study|Death|9|||
157223794|NCT02308111|567565786|FG001|Overall Study|Death|6|||
157223795|NCT02308111|567565785|FG000|Overall Study|Lost to Follow-up|2|||
157223796|NCT02308111|567565786|FG001|Overall Study|Lost to Follow-up|7|||
157223797|NCT02308111|567565785|FG000|Overall Study|Physician Decision|6|||
157223798|NCT02308111|567565786|FG001|Overall Study|Physician Decision|17|||
157223799|NCT02308111|567565785|FG000|Overall Study|Protocol Violation|0|||
157223800|NCT02308111|567565786|FG001|Overall Study|Protocol Violation|1|||
157223801|NCT02308111|567565785|FG000|Overall Study|Withdrawal by Subject|28|||
157223802|NCT02308111|567565786|FG001|Overall Study|Withdrawal by Subject|38|||
157223803|NCT02308111|567565785|FG000|Overall Study|Study Terminated by Sponsor|72|||
157150126|NCT00130208|567294882|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
157223804|NCT02308111|567565786|FG001|Overall Study|Study Terminated by Sponsor|61|||
157223805|NCT02308111|567565785|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
157223806|NCT02308111|567565786|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
157150127|NCT00130208|567294881|FG000|Maintenance Period (26 Weeks)|Other|1|||
157223807|NCT02308111|567565785|FG000|Overall Study|Site Closure|3|||
157223808|NCT02308111|567565786|FG001|Overall Study|Site Closure|3|||
157223809|NCT02308111|567565785|FG000|Overall Study|Non-compliance with Study Drug|3|||
157223810|NCT02308111|567565786|FG001|Overall Study|Non-compliance with Study Drug|1|||
157223811|NCT02308111|567565785|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
157223812|NCT02308111|567565786|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
157223813|NCT02308111|567565785|FG000|Overall Study|Liver Transplant|3|||
157223814|NCT02308111|567565786|FG001|Overall Study|Liver Transplant|3|||
157223815|NCT02308111|567565785|FG000|Overall Study|Liver Transplant Waitlist|2|||
157223816|NCT02308111|567565786|FG001|Overall Study|Liver Transplant Waitlist|2|||
157223817|NCT02308111|567565785|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
157223818|NCT02308111|567565786|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
157223819|NCT00717756|567565787|FG000|Overall Study|Withdrawal by Subject|1|||
157223820|NCT01873859|567565792|FG000|Overall Study|Withdrawal by Subject|0|||
157223821|NCT01873859|567565793|FG001|Overall Study|Withdrawal by Subject|4|||
157223822|NCT01364870|567565794|FG000|Overall Study|Withdrawal by Subject|13|||
157223823|NCT01364870|567565795|FG001|Overall Study|Withdrawal by Subject|24|||
157223824|NCT01364870|567565796|FG002|Overall Study|Withdrawal by Subject|10|||
157223825|NCT01364870|567565794|FG000|Overall Study|Adverse Event|8|||
157223826|NCT01364870|567565795|FG001|Overall Study|Adverse Event|6|||
157223827|NCT01364870|567565796|FG002|Overall Study|Adverse Event|4|||
157223828|NCT01364870|567565794|FG000|Overall Study|Protocol Violation|1|||
157223829|NCT01364870|567565795|FG001|Overall Study|Protocol Violation|0|||
157223830|NCT01364870|567565796|FG002|Overall Study|Protocol Violation|0|||
157223831|NCT03977584|567565797|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
157223832|NCT03977584|567565798|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
157150128|NCT00130208|567294882|FG001|Maintenance Period (26 Weeks)|Other|1|||
157150129|NCT00130208|567294881|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
157223833|NCT03977584|567565799|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
157223834|NCT00745251|567565803|FG000|Overall Study|Adverse Event|1|||
157223835|NCT00745251|567565804|FG001|Overall Study|Adverse Event|2|||
157223836|NCT00745251|567565803|FG000|Overall Study|Withdrawal by Subject|1|||
157223837|NCT00745251|567565804|FG001|Overall Study|Withdrawal by Subject|1|||
157150130|NCT00130208|567294882|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
157223838|NCT03850509|567565805|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
157223839|NCT03850509|567565806|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
157150131|NCT00130208|567294881|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
157223840|NCT02666430|567565807|FG000|Period 1|Lost to Follow-up|1|||
157223841|NCT02666430|567565808|FG001|Period 1|Lost to Follow-up|0|||
157223842|NCT02666430|567565807|FG000|Period 1|Adverse Event|0|||
157223843|NCT02666430|567565808|FG001|Period 1|Adverse Event|1|||
157150132|NCT00130208|567294882|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
157223844|NCT02666430|567565807|FG000|Period 2|Withdrawal by Subject|1|||
157223845|NCT02666430|567565808|FG001|Period 2|Withdrawal by Subject|4|||
157223846|NCT02666430|567565807|FG000|Period 3|Lost to Follow-up|1|||
157150133|NCT00130208|567294881|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
157223847|NCT02666430|567565808|FG001|Period 3|Lost to Follow-up|0|||
157223848|NCT03828461|567565809|FG000|Overall Study|Lost to Follow-up|1|||
157223849|NCT03828461|567565809|FG000|Overall Study|Withdrawal by Subject|3|||
157223850|NCT03095352|567565813|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
157223851|NCT03095352|567565814|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
157223852|NCT01565083|567565815|FG000|Overall Study|Withdrawal by Subject|6|||
157223853|NCT01565083|567565816|FG001|Overall Study|Withdrawal by Subject|4|||
157223854|NCT01565083|567565815|FG000|Overall Study|Lost to Follow-up|2|||
157223855|NCT01565083|567565816|FG001|Overall Study|Lost to Follow-up|7|||
157223856|NCT01565083|567565815|FG000|Overall Study|Death|22|||
157223857|NCT01565083|567565816|FG001|Overall Study|Death|23|||
157223858|NCT01565083|567565815|FG000|Overall Study|Other|3|||
157223859|NCT01565083|567565816|FG001|Overall Study|Other|5|||
157223860|NCT05431686|567565817|FG000|Overall Study|unable to schedule|10|||
157223861|NCT01118728|567565818|FG000|Overall Study|Adverse Event|17|||
157223862|NCT01118728|567565818|FG000|Overall Study|Lack of Efficacy|27|||
157223863|NCT01118728|567565818|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
157223864|NCT01118728|567565818|FG000|Overall Study|Withdrawal by Subject|3|||
157223865|NCT01118728|567565818|FG000|Overall Study|Lost to Follow-up|4|||
157223866|NCT02227862|567566714|FG000|Overall Study|Protocol Violation|7|||
157223867|NCT02227862|567566715|FG001|Overall Study|Protocol Violation|9|||
157223868|NCT02227862|567566714|FG000|Overall Study|Other|0|||
157223869|NCT02227862|567566715|FG001|Overall Study|Other|2|||
157223870|NCT02227862|567566714|FG000|Overall Study|Adverse Event|4|||
157223871|NCT02227862|567566715|FG001|Overall Study|Adverse Event|3|||
157223872|NCT02227862|567566714|FG000|Overall Study|Withdrawal by Subject|7|||
157223873|NCT02227862|567566715|FG001|Overall Study|Withdrawal by Subject|6|||
157223874|NCT02227862|567566714|FG000|Overall Study|Lost to Follow-up|1|||
157223875|NCT02227862|567566715|FG001|Overall Study|Lost to Follow-up|2|||
157223876|NCT00783796|567566716|FG000|Overall Study|Did not receive any stent|4|||
157223877|NCT00783796|567566716|FG000|Overall Study|Received non-XIENCE V stent|1|||
157223878|NCT00783796|567566716|FG000|Overall Study|Received commercial XIENCE V stent|1|||
157223879|NCT01215942|567566720|FG000|Treatment Period|Adverse Event|15|||
157223880|NCT01215942|567566721|FG001|Treatment Period|Adverse Event|26|||
157223881|NCT01215942|567566720|FG000|Treatment Period|Death|2|||
157223882|NCT01215942|567566721|FG001|Treatment Period|Death|4|||
157150134|NCT00130208|567294882|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
157150135|NCT00130208|567294881|FG000|Washout Period (8 Weeks)|Other|1|||
157150136|NCT00130208|567294882|FG001|Washout Period (8 Weeks)|Other|1|||
157150137|NCT04655586|567294885|FG000|Overall Study|Physician Decision|1|||
157150138|NCT04655586|567294886|FG001|Overall Study|Physician Decision|3|||
157150139|NCT04655586|567294887|FG002|Overall Study|Physician Decision|4|||
157150140|NCT04655586|567294885|FG000|Overall Study|Withdrawal by Subject|1|||
157150141|NCT04655586|567294886|FG001|Overall Study|Withdrawal by Subject|3|||
157150142|NCT04655586|567294887|FG002|Overall Study|Withdrawal by Subject|1|||
157150143|NCT00589472|567294894|FG000|Overall Study|Adverse Event|1|||
157150144|NCT01372878|567294895|FG000|Overall Study|Withdrawal by Subject|63|||
157150145|NCT01372878|567294895|FG000|Overall Study|Protocol Violation|17|||
157150146|NCT01372878|567294895|FG000|Overall Study|incomplete study procedure|104|||
157150147|NCT00117338|567294896|FG000|Overall Study|Adverse Event|0|||
157150148|NCT00117338|567294897|FG001|Overall Study|Adverse Event|1|||
157150149|NCT00117338|567294896|FG000|Overall Study|Protocol Violation|3|||
157150150|NCT00117338|567294897|FG001|Overall Study|Protocol Violation|2|||
157150151|NCT00117338|567294896|FG000|Overall Study|Withdrawal by Subject|1|||
157150152|NCT00117338|567294897|FG001|Overall Study|Withdrawal by Subject|0|||
157150153|NCT00117338|567294896|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
157150154|NCT00117338|567294897|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
157150155|NCT00117338|567294896|FG000|Overall Study|Lack of Efficacy|0|||
157150156|NCT00117338|567294897|FG001|Overall Study|Lack of Efficacy|1|||
157150157|NCT01380093|567294898|FG000|Naloxone Challenge Phase|Screen failures|21|||
157150158|NCT01380093|567294899|FG001|Naloxone Challenge Phase|Screen failures|0|||
157150159|NCT01380093|567294900|FG002|Naloxone Challenge Phase|Screen failures|0|||
157150160|NCT01380093|567294901|FG003|Naloxone Challenge Phase|Screen failures|0|||
157150161|NCT01380093|567294902|FG004|Naloxone Challenge Phase|Screen failures|0|||
157150162|NCT01380093|567294903|FG005|Naloxone Challenge Phase|Screen failures|0|||
157150163|NCT01380093|567294904|FG006|Naloxone Challenge Phase|Screen failures|0|||
157150164|NCT01380093|567294905|FG007|Naloxone Challenge Phase|Screen failures|0|||
157150165|NCT01380093|567294906|FG008|Naloxone Challenge Phase|Screen failures|0|||
157150166|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150167|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
157150168|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157022598|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
157022599|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
157022600|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
157150169|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150170|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150171|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150172|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150173|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150174|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
157150175|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150176|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
157150177|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
157150178|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150179|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150180|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150181|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150182|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150183|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
157150184|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150185|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
157150186|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150187|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150188|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150189|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150190|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150191|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150192|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
157150193|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150194|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
157150195|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
157150196|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150197|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150198|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150199|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150200|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150201|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
157150202|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150203|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
157150204|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
157150205|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150206|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150207|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150208|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150209|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150210|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
157150211|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150212|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150213|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
157150214|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150215|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150216|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150217|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150218|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150219|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
157150220|NCT01380093|567294898|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150221|NCT01380093|567294899|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150222|NCT01380093|567294900|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
157150223|NCT01380093|567294901|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150224|NCT01380093|567294902|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150225|NCT01380093|567294903|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150226|NCT01380093|567294904|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150227|NCT01380093|567294905|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157150228|NCT01380093|567294906|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
157223883|NCT01215942|567566720|FG000|Treatment Period|Lack of Efficacy|23|||
157223884|NCT01215942|567566721|FG001|Treatment Period|Lack of Efficacy|62|||
157223885|NCT01215942|567566720|FG000|Treatment Period|Lost to Follow-up|3|||
157223886|NCT01215942|567566721|FG001|Treatment Period|Lost to Follow-up|4|||
157223887|NCT01215942|567566720|FG000|Treatment Period|Withdrawal by Subject|17|||
157223888|NCT01215942|567566721|FG001|Treatment Period|Withdrawal by Subject|40|||
157223889|NCT01215942|567566720|FG000|Treatment Period|Physician Decision|5|||
157223890|NCT01215942|567566721|FG001|Treatment Period|Physician Decision|5|||
157223891|NCT01215942|567566720|FG000|Treatment Period|Protocol Violation|0|||
157223892|NCT01215942|567566721|FG001|Treatment Period|Protocol Violation|1|||
157223893|NCT01215942|567566720|FG000|Treatment Period|Sponsor Decision|349|||
157223894|NCT01215942|567566721|FG001|Treatment Period|Sponsor Decision|530|||
157223895|NCT01215942|567566720|FG000|Post-Treatment Follow-Up Period|Death|0|||
157223896|NCT01215942|567566721|FG001|Post-Treatment Follow-Up Period|Death|1|||
157223897|NCT01215942|567566720|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
157223898|NCT01215942|567566721|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
157223899|NCT01215942|567566720|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
157223900|NCT01215942|567566721|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
157223901|NCT01215942|567566720|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
157223902|NCT01215942|567566721|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
157223903|NCT01215942|567566720|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
157223904|NCT01215942|567566721|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
157223905|NCT03305055|567566722|FG000|Overall Study|Withdrawal by Subject|0|||
157223906|NCT03305055|567566723|FG001|Overall Study|Withdrawal by Subject|1|||
157223907|NCT03305055|567566722|FG000|Overall Study|Adverse Event|1|||
157223908|NCT03305055|567566723|FG001|Overall Study|Adverse Event|1|||
157223909|NCT00113490|567566724|FG000|Overall Study|Withdrawal by Subject|1|||
157223910|NCT00113490|567566725|FG001|Overall Study|Withdrawal by Subject|3|||
157223911|NCT00113490|567566724|FG000|Overall Study|Lost to Follow-up|1|||
157223912|NCT00113490|567566725|FG001|Overall Study|Lost to Follow-up|0|||
157223913|NCT00819247|567566726|FG000|Overall Study|Adverse Event|0|||
157223914|NCT00819247|567566727|FG001|Overall Study|Adverse Event|5|||
157223915|NCT00819247|567566728|FG002|Overall Study|Adverse Event|3|||
157223916|NCT00819247|567566726|FG000|Overall Study|Insufficient testosterone response|5|||
157223917|NCT00819247|567566727|FG001|Overall Study|Insufficient testosterone response|8|||
157223918|NCT00819247|567566728|FG002|Overall Study|Insufficient testosterone response|10|||
157223919|NCT00819247|567566726|FG000|Overall Study|Withdrawal by Subject|1|||
157223920|NCT00819247|567566727|FG001|Overall Study|Withdrawal by Subject|0|||
157223921|NCT00819247|567566728|FG002|Overall Study|Withdrawal by Subject|0|||
157223922|NCT00819247|567566726|FG000|Overall Study|Protocol Violation|1|||
157223923|NCT00819247|567566727|FG001|Overall Study|Protocol Violation|0|||
157223924|NCT00819247|567566728|FG002|Overall Study|Protocol Violation|1|||
157223925|NCT00819247|567566726|FG000|Overall Study|Mistakenly withdrawn|0|||
157223926|NCT00819247|567566727|FG001|Overall Study|Mistakenly withdrawn|1|||
157223927|NCT00819247|567566728|FG002|Overall Study|Mistakenly withdrawn|0|||
157223928|NCT00819247|567566726|FG000|Overall Study|Bad prostate-specific antigen response|3|||
157223929|NCT00819247|567566727|FG001|Overall Study|Bad prostate-specific antigen response|2|||
157223930|NCT00819247|567566728|FG002|Overall Study|Bad prostate-specific antigen response|0|||
157223931|NCT00819247|567566726|FG000|Overall Study|Other|1|||
157223932|NCT00819247|567566727|FG001|Overall Study|Other|0|||
157223933|NCT00819247|567566728|FG002|Overall Study|Other|0|||
157223934|NCT03500484|567566729|FG000|Overall Study|Adverse Event|2|||
157223935|NCT03500484|567566730|FG001|Overall Study|Adverse Event|0|||
157223936|NCT03500484|567566729|FG000|Overall Study|Physician Decision|1|||
157223937|NCT03500484|567566730|FG001|Overall Study|Physician Decision|0|||
157223938|NCT03500484|567566729|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
157223939|NCT03500484|567566730|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
157223940|NCT02795104|567566731|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
157223941|NCT02795104|567566732|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
157223942|NCT02795104|567566733|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
157223943|NCT02795104|567566731|FG000|Overall Study|Withdrawal by Subject|0|||
157223944|NCT02795104|567566732|FG001|Overall Study|Withdrawal by Subject|2|||
157223945|NCT02795104|567566733|FG002|Overall Study|Withdrawal by Subject|0|||
157223946|NCT02795104|567566731|FG000|Overall Study|Lost to Follow-up|0|||
157223947|NCT02795104|567566732|FG001|Overall Study|Lost to Follow-up|0|||
157223948|NCT02795104|567566733|FG002|Overall Study|Lost to Follow-up|1|||
157223949|NCT00948675|567566734|FG000|Overall Study|Lost to Follow-up|1|||
157223950|NCT00948675|567566735|FG001|Overall Study|Lost to Follow-up|0|||
157223951|NCT01654380|567566739|FG000|Part B, Period 1|Physician Decision|0|||
157223952|NCT01654380|567566740|FG001|Part B, Period 1|Physician Decision|0|||
157223953|NCT01654380|567566741|FG002|Part B, Period 1|Physician Decision|1|||
157223954|NCT01654380|567566742|FG003|Part B, Period 1|Physician Decision|0|||
157223955|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
157223956|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
157150229|NCT01380093|567294898|FG000|Treatment Phase: Second Intervention|Other|0|||
157150230|NCT01380093|567294899|FG001|Treatment Phase: Second Intervention|Other|0|||
157150231|NCT01380093|567294900|FG002|Treatment Phase: Second Intervention|Other|0|||
157150232|NCT01380093|567294901|FG003|Treatment Phase: Second Intervention|Other|1|||
157150233|NCT01380093|567294902|FG004|Treatment Phase: Second Intervention|Other|0|||
157150234|NCT01380093|567294903|FG005|Treatment Phase: Second Intervention|Other|0|||
157150235|NCT01380093|567294904|FG006|Treatment Phase: Second Intervention|Other|0|||
157150236|NCT01380093|567294905|FG007|Treatment Phase: Second Intervention|Other|0|||
157150237|NCT01380093|567294906|FG008|Treatment Phase: Second Intervention|Other|0|||
157150238|NCT01380093|567294898|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
157150239|NCT01380093|567294899|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
157150240|NCT01380093|567294900|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
157150241|NCT01380093|567294901|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
157150242|NCT01380093|567294902|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
157150243|NCT01380093|567294903|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
157150244|NCT01380093|567294904|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
157150245|NCT01380093|567294905|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
157150246|NCT01380093|567294906|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
157150247|NCT01380093|567294898|FG000|Treatment Phase: Third Intervention|Other|0|||
157150248|NCT01380093|567294899|FG001|Treatment Phase: Third Intervention|Other|0|||
157150249|NCT01380093|567294900|FG002|Treatment Phase: Third Intervention|Other|0|||
157150250|NCT01380093|567294901|FG003|Treatment Phase: Third Intervention|Other|0|||
157150251|NCT01380093|567294902|FG004|Treatment Phase: Third Intervention|Other|0|||
157150252|NCT01380093|567294903|FG005|Treatment Phase: Third Intervention|Other|0|||
157150253|NCT01380093|567294904|FG006|Treatment Phase: Third Intervention|Other|0|||
157150254|NCT01380093|567294905|FG007|Treatment Phase: Third Intervention|Other|0|||
157150255|NCT01380093|567294906|FG008|Treatment Phase: Third Intervention|Other|1|||
157150256|NCT00546351|567294907|FG000|Overall Study|Adverse Event|76|||
157150257|NCT00546351|567294907|FG000|Overall Study|Lack of Efficacy|15|||
157150258|NCT00546351|567294907|FG000|Overall Study|Withdrawal by Subject|109|||
157150259|NCT00546351|567294907|FG000|Overall Study|Lost to Follow-up|9|||
157150260|NCT00546351|567294907|FG000|Overall Study|Protocol Deviation|1|||
157150261|NCT00546351|567294907|FG000|Overall Study|Unsatisfactory compliance|9|||
157150262|NCT00546351|567294907|FG000|Overall Study|Other reasons for premature termination|17|||
157150263|NCT04734873|567294908|FG000|Overall Study|Lost to Follow-up|1|||
157150264|NCT04734873|567294909|FG001|Overall Study|Lost to Follow-up|3|||
157150265|NCT04734873|567294910|FG002|Overall Study|Lost to Follow-up|2|||
157150266|NCT04734873|567294908|FG000|Overall Study|Randomized but not dosed|1|||
157150267|NCT04734873|567294909|FG001|Overall Study|Randomized but not dosed|0|||
157150268|NCT04734873|567294910|FG002|Overall Study|Randomized but not dosed|1|||
157150269|NCT02616029|567294912|FG000|Overall Study|Adverse Event|1|||
157150270|NCT02616029|567294913|FG001|Overall Study|Adverse Event|0|||
157150271|NCT02616029|567294912|FG000|Overall Study|Death|0|||
157150272|NCT02616029|567294913|FG001|Overall Study|Death|1|||
157150273|NCT02616029|567294912|FG000|Overall Study|Protocol Violation|1|||
157150274|NCT02616029|567294913|FG001|Overall Study|Protocol Violation|0|||
157150275|NCT02616029|567294912|FG000|Overall Study|Withdrew Consent|1|||
157150276|NCT02616029|567294913|FG001|Overall Study|Withdrew Consent|0|||
157150277|NCT02616029|567294912|FG000|Overall Study|Enrolled and Never Treated|1|||
157150278|NCT02616029|567294913|FG001|Overall Study|Enrolled and Never Treated|1|||
157150279|NCT00609609|567294914|FG000|Overall Study|Withdrawal by Subject|2|||
157150280|NCT00609609|567294915|FG001|Overall Study|Withdrawal by Subject|0|||
157150281|NCT00609609|567294914|FG000|Overall Study|Progression|4|||
157150282|NCT00609609|567294915|FG001|Overall Study|Progression|2|||
157150283|NCT03988751|567294916|FG000|Overall Study|Withdrawal by Subject|1|||
157150284|NCT03988751|567294917|FG001|Overall Study|Withdrawal by Subject|0|||
157150285|NCT03988751|567294916|FG000|Overall Study|Protocol Violation|0|||
157150286|NCT03988751|567294917|FG001|Overall Study|Protocol Violation|1|||
157150287|NCT00844883|567294918|FG000|Overall Study|Bridged to liver transplant|3|||
157150288|NCT00844883|567294918|FG000|Overall Study|Bridged to resection|1|||
157150289|NCT03065530|567294923|FG000|Overall Study|Lack of Efficacy|1|||
157150290|NCT03065530|567294924|FG001|Overall Study|Lack of Efficacy|1|||
157150291|NCT03065530|567294925|FG002|Overall Study|Lack of Efficacy|0|||
157150292|NCT03065530|567294926|FG003|Overall Study|Lack of Efficacy|1|||
157150293|NCT03065530|567294923|FG000|Overall Study|Protocol Violation|1|||
157150294|NCT03065530|567294924|FG001|Overall Study|Protocol Violation|0|||
157150295|NCT03065530|567294925|FG002|Overall Study|Protocol Violation|1|||
157150296|NCT03065530|567294926|FG003|Overall Study|Protocol Violation|1|||
157150297|NCT00479466|567294929|FG000|Overall Study|Adverse Event|5|||
157150298|NCT00479466|567294930|FG001|Overall Study|Adverse Event|1|||
157150299|NCT00479466|567294931|FG002|Overall Study|Adverse Event|0|||
157150300|NCT00479466|567294932|FG003|Overall Study|Adverse Event|1|||
157150301|NCT00479466|567294933|FG004|Overall Study|Adverse Event|2|||
157223957|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223958|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223959|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223960|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
157223961|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
157223962|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223963|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223964|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223965|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223966|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223967|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223968|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
157223969|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223970|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223971|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223972|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223973|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223974|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
157223975|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
157150302|NCT00479466|567294934|FG005|Overall Study|Adverse Event|0|||
157150303|NCT00479466|567294929|FG000|Overall Study|Hyperglycemia|0|||
157150304|NCT00479466|567294930|FG001|Overall Study|Hyperglycemia|0|||
157150305|NCT00479466|567294931|FG002|Overall Study|Hyperglycemia|0|||
157150306|NCT00479466|567294932|FG003|Overall Study|Hyperglycemia|0|||
157150307|NCT00479466|567294933|FG004|Overall Study|Hyperglycemia|0|||
157223976|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223977|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223978|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223979|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223980|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223981|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223982|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
157223983|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
157223984|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223985|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223986|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223987|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223988|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223989|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
157223990|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223991|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223992|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223993|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223994|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223995|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223996|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
157223997|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157223998|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157223999|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224000|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224001|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224002|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
157224003|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
157224004|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224005|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224006|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224007|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224008|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224009|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224010|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
157224011|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224012|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224013|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224014|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157150308|NCT00479466|567294934|FG005|Overall Study|Hyperglycemia|1|||
157224015|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157150309|NCT00479466|567294929|FG000|Overall Study|Lack of Efficacy|2|||
157150310|NCT00479466|567294930|FG001|Overall Study|Lack of Efficacy|0|||
157224016|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224017|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
157224018|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224019|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224020|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224021|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224022|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224023|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224024|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
157224025|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
157224026|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
157224027|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
157224028|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224029|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224030|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
157224031|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
157224032|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224033|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224034|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224035|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224036|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224037|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224038|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
157224039|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224040|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
157224041|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224042|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224043|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224044|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
157224045|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224046|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224047|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224048|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224049|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224050|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224051|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224052|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
157224053|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
157224054|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224055|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224056|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224057|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224058|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
157224059|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224060|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224061|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224062|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224063|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224064|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224065|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224066|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
157224067|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224068|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224069|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224070|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
157224071|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
157224072|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224073|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224074|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
157224075|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
157224076|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224077|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224078|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224079|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157022601|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
157224080|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
157224081|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157150311|NCT00479466|567294931|FG002|Overall Study|Lack of Efficacy|1|||
157150312|NCT00479466|567294932|FG003|Overall Study|Lack of Efficacy|0|||
157150313|NCT00479466|567294933|FG004|Overall Study|Lack of Efficacy|0|||
157150314|NCT00479466|567294934|FG005|Overall Study|Lack of Efficacy|0|||
157224082|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224083|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224084|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224085|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224086|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224087|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224088|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
157224089|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
157224090|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224091|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224092|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224093|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224094|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
157224095|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224096|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224097|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224098|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224099|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224100|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224101|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224102|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224103|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
157224104|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224105|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224106|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224107|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224108|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
157224109|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224110|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224111|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224112|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
157224113|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224114|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224115|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224116|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224117|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224118|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224119|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224120|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224121|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224122|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
157224123|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224124|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224125|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224126|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224127|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224128|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224129|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224130|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
157224131|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
157224132|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224133|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224134|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224135|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224136|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
157224137|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157150315|NCT00479466|567294929|FG000|Overall Study|Lost to Follow-up|0|||
157150316|NCT00479466|567294930|FG001|Overall Study|Lost to Follow-up|1|||
157150317|NCT00479466|567294931|FG002|Overall Study|Lost to Follow-up|1|||
157150318|NCT00479466|567294932|FG003|Overall Study|Lost to Follow-up|0|||
157150319|NCT00479466|567294933|FG004|Overall Study|Lost to Follow-up|2|||
157150320|NCT00479466|567294934|FG005|Overall Study|Lost to Follow-up|2|||
157150321|NCT00479466|567294929|FG000|Overall Study|Physician Decision|2|||
157150322|NCT00479466|567294930|FG001|Overall Study|Physician Decision|1|||
157150323|NCT00479466|567294931|FG002|Overall Study|Physician Decision|1|||
157150324|NCT00479466|567294932|FG003|Overall Study|Physician Decision|0|||
157150325|NCT00479466|567294933|FG004|Overall Study|Physician Decision|0|||
157150326|NCT00479466|567294934|FG005|Overall Study|Physician Decision|0|||
157150327|NCT00479466|567294929|FG000|Overall Study|Pregnancy|0|||
157150328|NCT00479466|567294930|FG001|Overall Study|Pregnancy|0|||
157150329|NCT00479466|567294931|FG002|Overall Study|Pregnancy|0|||
157150330|NCT00479466|567294932|FG003|Overall Study|Pregnancy|0|||
157150331|NCT00479466|567294933|FG004|Overall Study|Pregnancy|1|||
157150332|NCT00479466|567294934|FG005|Overall Study|Pregnancy|0|||
157150333|NCT00479466|567294929|FG000|Overall Study|Protocol Violation|1|||
157150334|NCT00479466|567294930|FG001|Overall Study|Protocol Violation|0|||
157150335|NCT00479466|567294931|FG002|Overall Study|Protocol Violation|0|||
157150336|NCT00479466|567294932|FG003|Overall Study|Protocol Violation|0|||
157150337|NCT00479466|567294933|FG004|Overall Study|Protocol Violation|0|||
157150338|NCT00479466|567294934|FG005|Overall Study|Protocol Violation|0|||
157150339|NCT00479466|567294929|FG000|Overall Study|Withdrawal by Subject|3|||
157150340|NCT00479466|567294930|FG001|Overall Study|Withdrawal by Subject|5|||
157150341|NCT00479466|567294931|FG002|Overall Study|Withdrawal by Subject|0|||
157150342|NCT00479466|567294932|FG003|Overall Study|Withdrawal by Subject|2|||
157150343|NCT00479466|567294933|FG004|Overall Study|Withdrawal by Subject|3|||
157150344|NCT00479466|567294934|FG005|Overall Study|Withdrawal by Subject|1|||
157150345|NCT02927171|567294935|FG000|Overall Study|Lost to Follow-up|0|||
157150346|NCT02927171|567294936|FG001|Overall Study|Lost to Follow-up|1|||
157150347|NCT04530825|567294941|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
157150348|NCT04530825|567294942|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
157150349|NCT04530825|567294943|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
157150350|NCT04530825|567294944|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
157150351|NCT04530825|567294941|FG000|Overall Study|Did not complete follow-up|3|||
157150352|NCT04530825|567294942|FG001|Overall Study|Did not complete follow-up|0|||
157150353|NCT04530825|567294943|FG002|Overall Study|Did not complete follow-up|0|||
157150354|NCT04530825|567294944|FG003|Overall Study|Did not complete follow-up|0|||
157150355|NCT04101422|567294946|FG000|Overall Study|Ineligible|1|||
157150356|NCT04101422|567294947|FG001|Overall Study|Ineligible|0|||
157150357|NCT04101422|567294948|FG002|Overall Study|Ineligible|9|||
157150358|NCT04101422|567294949|FG003|Overall Study|Ineligible|0|||
157150359|NCT04101422|567294946|FG000|Overall Study|Withdrawal by Subject|0|||
157150360|NCT04101422|567294947|FG001|Overall Study|Withdrawal by Subject|0|||
157150361|NCT04101422|567294948|FG002|Overall Study|Withdrawal by Subject|1|||
157150362|NCT04101422|567294949|FG003|Overall Study|Withdrawal by Subject|0|||
157150363|NCT04101422|567294946|FG000|Overall Study|Not attending to the stimuli|0|||
157150364|NCT04101422|567294947|FG001|Overall Study|Not attending to the stimuli|0|||
157150365|NCT04101422|567294948|FG002|Overall Study|Not attending to the stimuli|4|||
157150366|NCT04101422|567294949|FG003|Overall Study|Not attending to the stimuli|0|||
157150367|NCT04101422|567294946|FG000|Overall Study|Did not download app|0|||
157150368|NCT04101422|567294947|FG001|Overall Study|Did not download app|0|||
157150369|NCT04101422|567294948|FG002|Overall Study|Did not download app|0|||
157150370|NCT04101422|567294949|FG003|Overall Study|Did not download app|17|||
157150371|NCT04101422|567294946|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
157150372|NCT04101422|567294947|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
157150373|NCT04101422|567294948|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
157150374|NCT04101422|567294949|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
157150375|NCT00850499|567294950|FG000|Overall Study|Adverse Event|3|||
157150376|NCT00850499|567294951|FG001|Overall Study|Adverse Event|1|||
157150377|NCT00850499|567294950|FG000|Overall Study|Lack of Efficacy|0|||
157150378|NCT00850499|567294951|FG001|Overall Study|Lack of Efficacy|1|||
157150379|NCT00552305|567294952|FG000|Overall Study|Adverse Event|43|||
157150380|NCT00552305|567294952|FG000|Overall Study|Lack of Efficacy|120|||
157150381|NCT00552305|567294952|FG000|Overall Study|Lost to Follow-up|4|||
157150382|NCT00552305|567294952|FG000|Overall Study|Protocol Violation|3|||
157150383|NCT00552305|567294952|FG000|Overall Study|Withdrawal by Subject|44|||
157150384|NCT00552305|567294952|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
157150385|NCT00552305|567294952|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
157150386|NCT00552305|567294952|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
157150387|NCT00552305|567294952|FG000|Overall Study|Unsatisfactory compliance|11|||
157150388|NCT00552305|567294952|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
157150389|NCT00552305|567294952|FG000|Overall Study|AE/Other: prohibited drug required|1|||
157150390|NCT00552305|567294952|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
157150391|NCT00552305|567294952|FG000|Overall Study|Other: Site closed|4|||
157224138|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224139|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224140|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224141|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224142|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
156817666|NCT02993822|566081310|FG002|Overall Study|Protocol Violation|0|||
157150392|NCT00552305|567294952|FG000|Overall Study|Other: Personal problems|1|||
157150393|NCT00552305|567294952|FG000|Overall Study|Other: Unable to attend visits|1|||
157150394|NCT00552305|567294952|FG000|Overall Study|Other: Subject underwent surgery|4|||
157150395|NCT00552305|567294952|FG000|Overall Study|Other: Subject became pregnant|1|||
157150396|NCT00552305|567294952|FG000|Overall Study|Other: Health problems, not drug related|1|||
157150397|NCT00552305|567294952|FG000|Overall Study|Other: Subject moved from area|2|||
157150398|NCT00552305|567294952|FG000|Overall Study|Other: Subject incarcerated|1|||
157150399|NCT00552305|567294952|FG000|Overall Study|Other: Subject went to rehab|1|||
157150400|NCT00718861|567294953|FG000|Overall Study|Withdrawal by Subject|15|||
157150401|NCT00718861|567294954|FG001|Overall Study|Withdrawal by Subject|10|||
157150402|NCT00718861|567294953|FG000|Overall Study|Adverse Event|2|||
157150403|NCT00718861|567294954|FG001|Overall Study|Adverse Event|1|||
157150404|NCT00718861|567294953|FG000|Overall Study|Lost to Follow-up|2|||
157150405|NCT00718861|567294954|FG001|Overall Study|Lost to Follow-up|1|||
157150406|NCT00718861|567294953|FG000|Overall Study|Administrative Problems|1|||
157150407|NCT00718861|567294954|FG001|Overall Study|Administrative Problems|1|||
157150408|NCT00718861|567294953|FG000|Overall Study|Death|1|||
157150409|NCT00718861|567294954|FG001|Overall Study|Death|5|||
157150410|NCT01703819|567294955|FG000|Overall Study|Adverse Event|0|||
157150411|NCT01703819|567294956|FG001|Overall Study|Adverse Event|1|||
157150412|NCT01703819|567294955|FG000|Overall Study|Withdrawal by Subject|0|||
157150413|NCT01703819|567294956|FG001|Overall Study|Withdrawal by Subject|1|||
157150414|NCT04230486|567294963|FG000|Overall Study|Screen Failure|1|||
157150415|NCT01302041|567294964|FG000|Overall Study|Death|5|||
157150416|NCT01302041|567294964|FG000|Overall Study|Withdrawal by Subject|4|||
157150417|NCT01302041|567294964|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
157150418|NCT01302041|567294964|FG000|Overall Study|Other-Miscellaneous Reason|2|||
157150419|NCT02234583|567294969|FG000|Overall Study|Adverse Event|172|||
157150420|NCT02234583|567294970|FG001|Overall Study|Adverse Event|156|||
157150421|NCT02234583|567294969|FG000|Overall Study|Withdrawal by Subject|109|||
157150422|NCT02234583|567294970|FG001|Overall Study|Withdrawal by Subject|157|||
157150423|NCT02234583|567294969|FG000|Overall Study|Lost to Follow-up|0|||
157150424|NCT02234583|567294970|FG001|Overall Study|Lost to Follow-up|1|||
157150425|NCT02234583|567294969|FG000|Overall Study|Lack of Efficacy|58|||
157150426|NCT02234583|567294970|FG001|Overall Study|Lack of Efficacy|103|||
157150427|NCT02234583|567294969|FG000|Overall Study|Protocol Violation|35|||
157150428|NCT02234583|567294970|FG001|Overall Study|Protocol Violation|42|||
157150429|NCT02234583|567294969|FG000|Overall Study|Other|39|||
157150430|NCT02234583|567294970|FG001|Overall Study|Other|97|||
157150431|NCT01849250|567294971|FG000|Overall Study|Withdrawal by Subject|1|||
157150432|NCT01849250|567294972|FG001|Overall Study|Withdrawal by Subject|0|||
157150433|NCT01849250|567294971|FG000|Overall Study|Not Evaluable|5|||
157150434|NCT01849250|567294972|FG001|Overall Study|Not Evaluable|3|||
157150435|NCT01849250|567294971|FG000|Overall Study|Screen Failure|1|||
157150436|NCT01849250|567294972|FG001|Overall Study|Screen Failure|0|||
157150437|NCT04504032|567294975|FG000|Overall Study|Adverse Event|1|||
157150438|NCT04504032|567294976|FG001|Overall Study|Adverse Event|2|||
157150439|NCT04504032|567294975|FG000|Overall Study|Lost to Follow-up|6|||
157150440|NCT04504032|567294976|FG001|Overall Study|Lost to Follow-up|9|||
157150441|NCT04504032|567294975|FG000|Overall Study|Protocol Violation|2|||
157150442|NCT04504032|567294976|FG001|Overall Study|Protocol Violation|0|||
157150443|NCT04504032|567294975|FG000|Overall Study|Study terminated by sponsor|1|||
157150444|NCT04504032|567294976|FG001|Overall Study|Study terminated by sponsor|2|||
157150445|NCT04504032|567294975|FG000|Overall Study|Withdrawal by Subject|9|||
157150446|NCT04504032|567294976|FG001|Overall Study|Withdrawal by Subject|11|||
157150447|NCT04504032|567294975|FG000|Overall Study|Disease progression prior to dosing|15|||
157150448|NCT04504032|567294976|FG001|Overall Study|Disease progression prior to dosing|3|||
157150449|NCT04504032|567294975|FG000|Overall Study|Drug supply issues|1|||
157150450|NCT04504032|567294976|FG001|Overall Study|Drug supply issues|1|||
157150451|NCT04504032|567294975|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
157150452|NCT04504032|567294976|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
157150453|NCT00771030|567294977|FG000|Overall Study|Adverse Event|0|||
157150454|NCT00771030|567294978|FG001|Overall Study|Adverse Event|1|||
157150455|NCT00771030|567294979|FG002|Overall Study|Adverse Event|0|||
157150456|NCT00771030|567294980|FG003|Overall Study|Adverse Event|0|||
157150457|NCT00771030|567294981|FG004|Overall Study|Adverse Event|0|||
157150458|NCT00771030|567294982|FG005|Overall Study|Adverse Event|0|||
157150459|NCT00771030|567294983|FG006|Overall Study|Adverse Event|0|||
157150460|NCT01839188|567294984|FG000|Overall Study|Withdrawal by Subject|1|||
157224143|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224144|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
157224145|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224146|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224147|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224148|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224149|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224150|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
157224151|NCT04033445|567566744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224152|NCT04033445|567566745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224153|NCT04033445|567566746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224154|NCT04033445|567566747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224155|NCT04033445|567566748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224156|NCT04033445|567566749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224157|NCT04033445|567566750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224158|NCT04033445|567566751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
157224159|NCT04033445|567566752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224160|NCT04033445|567566753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224161|NCT04033445|567566754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224162|NCT04033445|567566755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224163|NCT04033445|567566756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224164|NCT04033445|567566757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
157224165|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224166|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224167|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224168|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224169|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224170|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224171|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224172|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224173|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
157224174|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
157224175|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
157224176|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
157224177|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
157224178|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
157224179|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224180|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224181|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224182|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224183|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224184|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224185|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224186|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224187|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
157224188|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
157224189|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
157224190|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
157224191|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
157224192|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
157224193|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224194|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224195|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224196|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224197|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224198|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224199|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224200|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224201|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224202|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224203|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
157224204|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
157224205|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
157224206|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
157022602|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
157022603|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
157022604|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
157022605|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
157022606|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
157022607|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
157022608|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
157022609|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
157022610|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
157022611|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
157022612|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
157022613|NCT01902173|566835250|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
157022614|NCT01902173|566835251|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
157022615|NCT01902173|566835252|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
157022616|NCT01902173|566835253|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
157022617|NCT01902173|566835254|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
157022618|NCT01902173|566835255|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
157022619|NCT05364671|566835260|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
157022620|NCT05364671|566835261|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
157150461|NCT04983901|567294985|FG000|Overall Study|Death|1|||
157022621|NCT05364671|566835260|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
157022622|NCT05364671|566835261|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
157150462|NCT04983901|567294986|FG001|Overall Study|Death|4|||
157150463|NCT04983901|567294985|FG000|Overall Study|Lost to Follow-up|3|||
157150464|NCT04983901|567294986|FG001|Overall Study|Lost to Follow-up|0|||
157150465|NCT04983901|567294985|FG000|Overall Study|Protocol Violation|1|||
157150466|NCT04983901|567294986|FG001|Overall Study|Protocol Violation|0|||
157150467|NCT04983901|567294985|FG000|Overall Study|Withdrawal by Subject|1|||
157150468|NCT04983901|567294986|FG001|Overall Study|Withdrawal by Subject|2|||
157150469|NCT01174784|567294987|FG000|Overall Study|Screen fails|4|||
157150470|NCT04156646|567294988|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
157150471|NCT04156646|567294989|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
157150472|NCT03825042|567296510|FG000|Overall Study|Adverse Event|1|||
157150473|NCT03825042|567296511|FG001|Overall Study|Adverse Event|0|||
157150474|NCT03825042|567296510|FG000|Overall Study|Withdrawal by Subject|1|||
157150475|NCT03825042|567296511|FG001|Overall Study|Withdrawal by Subject|0|||
157150476|NCT01158534|567296513|FG000|Overall Study|Withdrawal by Subject|1|||
157150477|NCT01158534|567296513|FG000|Overall Study|Death|1|||
157150478|NCT01158534|567296513|FG000|Overall Study|Other|1|||
157150479|NCT04003155|567296514|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
157150480|NCT04003155|567296515|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
157150481|NCT04003155|567296516|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
157150482|NCT04003155|567296517|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
157150483|NCT04003155|567296518|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
157150484|NCT04003155|567296514|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
157150485|NCT04003155|567296515|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
157150486|NCT04003155|567296516|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
157150487|NCT04003155|567296517|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
157150488|NCT04003155|567296518|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
157150489|NCT04003155|567296514|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
157150490|NCT04003155|567296515|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
157150491|NCT04003155|567296516|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
157150492|NCT04003155|567296517|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
157150493|NCT04003155|567296518|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
157150494|NCT04003155|567296514|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
157150495|NCT04003155|567296515|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
157150496|NCT04003155|567296516|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
157150497|NCT04003155|567296517|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
157150498|NCT04003155|567296518|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
157150499|NCT04003155|567296514|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
157150500|NCT04003155|567296515|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
157150501|NCT04003155|567296516|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
157150502|NCT04003155|567296517|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
157150503|NCT04003155|567296518|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
157150504|NCT04003155|567296514|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
157150505|NCT04003155|567296515|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
157150506|NCT04003155|567296516|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
157150507|NCT04003155|567296517|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
157150508|NCT04003155|567296518|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
156884358|NCT01616693|566334081|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
157022623|NCT05364671|566835260|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
157224207|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224208|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224209|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224210|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224211|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224212|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224213|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224214|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224215|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224216|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
157224217|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
157224218|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
157224219|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
157224220|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
157224221|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224222|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224223|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224224|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224225|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224226|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224227|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224228|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224229|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
157224230|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
157224231|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
157224232|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
157224233|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
157224234|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
157224235|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224236|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224237|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224238|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224239|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224240|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224241|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224242|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224243|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224244|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224245|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224246|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224247|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
157224248|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
157224249|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224250|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224251|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224252|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224253|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224254|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224255|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
157022624|NCT05364671|566835261|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
157022625|NCT05364671|566835260|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
157091484|NCT00825825|567089108|FG000|Third Medication Period (14 Days)|poor data quality|0|||
157091485|NCT00825825|567089109|FG001|Third Medication Period (14 Days)|poor data quality|1|||
157091486|NCT00825825|567089110|FG002|Third Medication Period (14 Days)|poor data quality|0|||
157091487|NCT00825825|567089111|FG003|Third Medication Period (14 Days)|poor data quality|0|||
157091488|NCT00825825|567089112|FG004|Third Medication Period (14 Days)|poor data quality|0|||
157091489|NCT00825825|567089113|FG005|Third Medication Period (14 Days)|poor data quality|0|||
157091490|NCT01815138|567089114|FG000|Overall Study|Withdrawal by Subject|0|||
157091491|NCT01815138|567089115|FG001|Overall Study|Withdrawal by Subject|1|||
157091492|NCT01815138|567089114|FG000|Overall Study|Physician Decision|8|||
157091493|NCT01815138|567089115|FG001|Overall Study|Physician Decision|5|||
157224256|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224257|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
157224258|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
157224259|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
157224260|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
157224261|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
157224262|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
157224263|NCT04033445|567566744|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224264|NCT04033445|567566745|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224265|NCT04033445|567566746|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224266|NCT04033445|567566747|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224267|NCT04033445|567566748|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224268|NCT04033445|567566749|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224269|NCT04033445|567566750|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224270|NCT04033445|567566751|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224271|NCT04033445|567566752|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224272|NCT04033445|567566753|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
157224273|NCT04033445|567566754|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224274|NCT04033445|567566755|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
157224275|NCT04033445|567566756|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
157224276|NCT04033445|567566757|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
157224277|NCT02978326|567566761|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
157224278|NCT02978326|567566762|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
157224279|NCT02978326|567566763|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
157224280|NCT02978326|567566761|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
157224281|NCT02978326|567566762|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
157224282|NCT02978326|567566763|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
157224283|NCT02978326|567566761|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
157224284|NCT02978326|567566762|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
157224285|NCT02978326|567566763|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
157224286|NCT02978326|567566761|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
157224287|NCT02978326|567566762|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
157224288|NCT02978326|567566763|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
157224289|NCT02549495|567566766|FG000|Overall Study|Death|2|||
157224290|NCT02549495|567566766|FG000|Overall Study|Withdrawal by Subject|5|||
157224291|NCT02549495|567566766|FG000|Overall Study|Physician Decision|22|||
157224292|NCT02549495|567566766|FG000|Overall Study|Lost to Follow-up|6|||
157224293|NCT02549495|567566766|FG000|Overall Study|Protocol Violation|6|||
157224294|NCT02365597|567566767|FG000|Overall Study|Lost to Follow-up|0|||
157224295|NCT02365597|567566768|FG001|Overall Study|Lost to Follow-up|1|||
157224296|NCT02365597|567566769|FG002|Overall Study|Lost to Follow-up|0|||
157224297|NCT02365597|567566770|FG003|Overall Study|Lost to Follow-up|1|||
157224298|NCT02365597|567566767|FG000|Overall Study|Withdrawal by Subject|1|||
157224299|NCT02365597|567566768|FG001|Overall Study|Withdrawal by Subject|8|||
157224300|NCT02365597|567566769|FG002|Overall Study|Withdrawal by Subject|5|||
157224301|NCT02365597|567566770|FG003|Overall Study|Withdrawal by Subject|1|||
157224302|NCT02365597|567566767|FG000|Overall Study|Sponsor's decision|1|||
157224303|NCT02365597|567566768|FG001|Overall Study|Sponsor's decision|3|||
157224304|NCT02365597|567566769|FG002|Overall Study|Sponsor's decision|13|||
157224305|NCT02365597|567566770|FG003|Overall Study|Sponsor's decision|0|||
157224306|NCT02365597|567566767|FG000|Overall Study|Other|0|||
157224307|NCT02365597|567566768|FG001|Overall Study|Other|4|||
157224308|NCT02365597|567566769|FG002|Overall Study|Other|0|||
157224309|NCT02365597|567566770|FG003|Overall Study|Other|0|||
157224310|NCT02365597|567566767|FG000|Overall Study|Enrolled but not treated|0|||
157224311|NCT02365597|567566768|FG001|Overall Study|Enrolled but not treated|1|||
157224312|NCT02365597|567566769|FG002|Overall Study|Enrolled but not treated|1|||
157224313|NCT02365597|567566770|FG003|Overall Study|Enrolled but not treated|0|||
157224314|NCT02365597|567566767|FG000|Overall Study|Ongoing|0|||
157224315|NCT02365597|567566768|FG001|Overall Study|Ongoing|0|||
157224316|NCT02365597|567566769|FG002|Overall Study|Ongoing|0|||
157224317|NCT02365597|567566770|FG003|Overall Study|Ongoing|17|||
157224318|NCT00601354|567566771|FG000|Overall Study|Lost to Follow-up|4|||
157224319|NCT00601354|567566772|FG001|Overall Study|Lost to Follow-up|5|||
157224320|NCT03462719|567566773|FG000|Overall Study|Withdrawal by Subject|4|||
157224321|NCT03462719|567566774|FG001|Overall Study|Withdrawal by Subject|3|||
157224322|NCT03462719|567566773|FG000|Overall Study|Ongoing|87|||
157224323|NCT03462719|567566774|FG001|Overall Study|Ongoing|72|||
157224324|NCT02829918|567566775|FG000|Overall Study|Death|2|||
157224325|NCT02829918|567566775|FG000|Overall Study|Withdrawal by Subject|4|||
157224326|NCT02829918|567566775|FG000|Overall Study|Adverse Event|1|||
157224327|NCT02829918|567566775|FG000|Overall Study|Progression|1|||
157224328|NCT02257736|567566776|FG000|Overall Study|Progressive disease|365|||
157224329|NCT02257736|567566777|FG001|Overall Study|Progressive disease|327|||
157224330|NCT02257736|567566776|FG000|Overall Study|Adverse Event|45|||
157224331|NCT02257736|567566777|FG001|Overall Study|Adverse Event|56|||
157224332|NCT02257736|567566776|FG000|Overall Study|Withdrawal by Subject|21|||
157224333|NCT02257736|567566777|FG001|Overall Study|Withdrawal by Subject|38|||
157224334|NCT02257736|567566776|FG000|Overall Study|Death|11|||
157224335|NCT02257736|567566777|FG001|Overall Study|Death|6|||
157224336|NCT02257736|567566776|FG000|Overall Study|Physician Decision|5|||
157224337|NCT02257736|567566777|FG001|Overall Study|Physician Decision|9|||
157224338|NCT02257736|567566776|FG000|Overall Study|Non-Compliance with study drug|1|||
157224339|NCT02257736|567566777|FG001|Overall Study|Non-Compliance with study drug|2|||
157224340|NCT02257736|567566776|FG000|Overall Study|Protocol Violation|1|||
157224341|NCT02257736|567566777|FG001|Overall Study|Protocol Violation|0|||
157224342|NCT02257736|567566776|FG000|Overall Study|Other|1|||
157224343|NCT02257736|567566777|FG001|Overall Study|Other|7|||
157224344|NCT02257736|567566776|FG000|Overall Study|Randomized, not treated|1|||
157224345|NCT02257736|567566777|FG001|Overall Study|Randomized, not treated|2|||
157224346|NCT02779855|567566780|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
157224347|NCT02779855|567566781|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
157224348|NCT02779855|567566782|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
157224349|NCT05328375|567567948|FG000|Overall Study|Withdrawal by Subject|0|||
157224350|NCT05328375|567567949|FG001|Overall Study|Withdrawal by Subject|1|||
157224351|NCT05514119|567567954|FG000|Overall Study|Ineligible due to disease progression|1|||
157224352|NCT02178709|567567955|FG000|Overall Study|Adverse Event|5|||
157224353|NCT02178709|567567955|FG000|Overall Study|Death|2|||
157224354|NCT02178709|567567955|FG000|Overall Study|Withdrawal by Subject|2|||
157224355|NCT02178709|567567955|FG000|Overall Study|Physician Decision|2|||
157224356|NCT02178709|567567955|FG000|Overall Study|Disease Progression|5|||
157224357|NCT02946385|567567956|FG000|Overall Study|Lost to Follow-up|0|||
157224358|NCT02946385|567567957|FG001|Overall Study|Lost to Follow-up|0|||
157224359|NCT02946385|567567958|FG002|Overall Study|Lost to Follow-up|3|||
157224360|NCT02946385|567567959|FG003|Overall Study|Lost to Follow-up|0|||
157224361|NCT02946385|567567960|FG004|Overall Study|Lost to Follow-up|2|||
157224362|NCT02946385|567567961|FG005|Overall Study|Lost to Follow-up|1|||
157224363|NCT04849988|567567964|FG000|Overall Study|Lack of Efficacy|3|||
157224364|NCT04849988|567567965|FG001|Overall Study|Lack of Efficacy|4|||
157224365|NCT04849988|567567966|FG002|Overall Study|Lack of Efficacy|1|||
157224366|NCT04849988|567567967|FG003|Overall Study|Lack of Efficacy|4|||
157224367|NCT04849988|567567964|FG000|Overall Study|Other reasons|1|||
157224368|NCT04849988|567567965|FG001|Overall Study|Other reasons|2|||
157224369|NCT04849988|567567966|FG002|Overall Study|Other reasons|2|||
157224370|NCT04849988|567567967|FG003|Overall Study|Other reasons|1|||
157224371|NCT01027143|567567974|FG000|Overall Study|Lost to Follow-up|9|||
157224372|NCT01027143|567567975|FG001|Overall Study|Lost to Follow-up|4|||
156817667|NCT02993822|566081311|FG003|Overall Study|Protocol Violation|0|||
156817668|NCT02993822|566081308|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
156817669|NCT02993822|566081309|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
156817670|NCT02993822|566081310|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
156817671|NCT02993822|566081311|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
156817672|NCT02993822|566081308|FG000|Overall Study|Adverse Event|3|||
156817673|NCT02993822|566081309|FG001|Overall Study|Adverse Event|1|||
156817674|NCT02993822|566081310|FG002|Overall Study|Adverse Event|7|||
156817675|NCT02993822|566081311|FG003|Overall Study|Adverse Event|0|||
156817676|NCT02993822|566081308|FG000|Overall Study|Withdrawal by Subject|4|||
156817677|NCT02993822|566081309|FG001|Overall Study|Withdrawal by Subject|2|||
156817678|NCT02993822|566081310|FG002|Overall Study|Withdrawal by Subject|2|||
156817679|NCT02993822|566081311|FG003|Overall Study|Withdrawal by Subject|3|||
156817680|NCT02993822|566081308|FG000|Overall Study|Lost to Follow-up|1|||
156817681|NCT02993822|566081309|FG001|Overall Study|Lost to Follow-up|0|||
156817682|NCT02993822|566081310|FG002|Overall Study|Lost to Follow-up|1|||
156817683|NCT02993822|566081311|FG003|Overall Study|Lost to Follow-up|0|||
156817684|NCT01221753|566081315|FG000|Overall Study|Adverse Event|1|||
156817685|NCT01939977|566081316|FG000|Overall Study|Adverse Event|4|||
156817686|NCT01939977|566081317|FG001|Overall Study|Adverse Event|3|||
156817687|NCT01939977|566081316|FG000|Overall Study|Lack of Efficacy|3|||
156817688|NCT01939977|566081317|FG001|Overall Study|Lack of Efficacy|0|||
156817689|NCT01939977|566081316|FG000|Overall Study|Physician Decision|1|||
156817690|NCT01939977|566081317|FG001|Overall Study|Physician Decision|1|||
157224373|NCT02228382|567567978|FG000|Overall Study|Death|5|||
157224374|NCT02228382|567567979|FG001|Overall Study|Death|7|||
157224375|NCT02228382|567567980|FG002|Overall Study|Death|5|||
157224376|NCT02228382|567567981|FG003|Overall Study|Death|0|||
157224377|NCT02228382|567567982|FG004|Overall Study|Death|2|||
157224378|NCT02228382|567567978|FG000|Overall Study|Participant refused further follow-up|0|||
157224379|NCT02228382|567567979|FG001|Overall Study|Participant refused further follow-up|0|||
157224380|NCT02228382|567567980|FG002|Overall Study|Participant refused further follow-up|1|||
157224381|NCT02228382|567567981|FG003|Overall Study|Participant refused further follow-up|0|||
157224382|NCT02228382|567567982|FG004|Overall Study|Participant refused further follow-up|0|||
157224383|NCT02228382|567567978|FG000|Overall Study|Study terminated by sponsor|3|||
156817691|NCT01939977|566081316|FG000|Overall Study|Withdrawal by Subject|0|||
156817692|NCT01939977|566081317|FG001|Overall Study|Withdrawal by Subject|2|||
156817693|NCT01939977|566081316|FG000|Overall Study|Did not meet inclusion criteria|1|||
156817694|NCT01939977|566081317|FG001|Overall Study|Did not meet inclusion criteria|0|||
156817695|NCT01939977|566081316|FG000|Overall Study|Did not receive study medication|0|||
156817696|NCT01939977|566081317|FG001|Overall Study|Did not receive study medication|1|||
156817697|NCT03213938|566081320|FG000|Overall Study|Lost to Follow-up|4|||
156817698|NCT03213938|566081321|FG001|Overall Study|Lost to Follow-up|3|||
156817699|NCT03213938|566081320|FG000|Overall Study|Lack of Efficacy|1|||
156817700|NCT03213938|566081321|FG001|Overall Study|Lack of Efficacy|0|||
156817701|NCT03213938|566081320|FG000|Overall Study|Decline to participate|5|||
156817702|NCT03213938|566081321|FG001|Overall Study|Decline to participate|4|||
156817703|NCT03213938|566081320|FG000|Overall Study|Without reason|4|||
156817704|NCT03213938|566081321|FG001|Overall Study|Without reason|5|||
156817705|NCT01917929|566081322|FG000|Overall Study|Death|8|||
156817706|NCT01917929|566081322|FG000|Overall Study|Lost to Follow-up|19|||
156817707|NCT01917929|566081322|FG000|Overall Study|Withdrawal by Subject|33|||
156817708|NCT01917929|566081322|FG000|Overall Study|Adverse Event|6|||
156817709|NCT01917929|566081322|FG000|Overall Study|Investigative Site Terminated|35|||
156817710|NCT01917929|566081322|FG000|Overall Study|Censored because study device not implanted|6|||
156817711|NCT01917929|566081322|FG000|Overall Study|Censored because surgery not performed|3|||
156817712|NCT01917929|566081322|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
156817713|NCT01917929|566081322|FG000|Overall Study|Sponsor terminated study|175|||
156817714|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
156817715|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
156817716|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
156817717|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
156817718|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
156817719|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
156817720|NCT01854775|566081323|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
156817721|NCT01854775|566081324|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
156817722|NCT01854775|566081325|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
156817723|NCT01854775|566081323|FG000|Extension Phase|Pregnancy|3|||
156817724|NCT01854775|566081324|FG001|Extension Phase|Pregnancy|0|||
156817725|NCT01854775|566081325|FG002|Extension Phase|Pregnancy|0|||
156817726|NCT01854775|566081323|FG000|Extension Phase|Investigator's Discretion|1|||
156817727|NCT01854775|566081324|FG001|Extension Phase|Investigator's Discretion|0|||
156817728|NCT01854775|566081325|FG002|Extension Phase|Investigator's Discretion|0|||
156817729|NCT01854775|566081323|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
156817730|NCT01854775|566081324|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
156817731|NCT01854775|566081325|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
156817732|NCT01854775|566081323|FG000|Extension Phase|Lost to Follow-up|2|||
156817733|NCT01854775|566081324|FG001|Extension Phase|Lost to Follow-up|0|||
156817734|NCT01854775|566081325|FG002|Extension Phase|Lost to Follow-up|0|||
156817735|NCT01854775|566081323|FG000|Extension Phase|Still on Study|32|||
156817736|NCT01854775|566081324|FG001|Extension Phase|Still on Study|47|||
156817737|NCT01854775|566081325|FG002|Extension Phase|Still on Study|18|||
156817738|NCT00984594|566081332|FG000|Overall Study|Lost to Follow-up|1|||
156817739|NCT00984594|566081333|FG001|Overall Study|Lost to Follow-up|0|||
156817740|NCT00984594|566081332|FG000|Overall Study|Withdrawal by Subject|0|||
156817741|NCT00984594|566081333|FG001|Overall Study|Withdrawal by Subject|1|||
156817742|NCT00851890|566081334|FG000|Overall Study|Lost to Follow-up|0|||
156817743|NCT00851890|566081335|FG001|Overall Study|Lost to Follow-up|1|||
156817744|NCT00851890|566081336|FG002|Overall Study|Lost to Follow-up|0|||
156817745|NCT00851890|566081337|FG003|Overall Study|Lost to Follow-up|1|||
156817746|NCT03135431|566081338|FG000|Overall Study|Study Surgeon not available|2|||
156817747|NCT03135431|566081339|FG001|Overall Study|Study Surgeon not available|0|||
156817748|NCT01063062|566081340|FG000|Overall Study|Patient withdrew consent|0|||
156817749|NCT01063062|566081341|FG001|Overall Study|Patient withdrew consent|1|||
156817750|NCT01063062|566081340|FG000|Overall Study|Adverse Event|2|||
156817751|NCT01063062|566081341|FG001|Overall Study|Adverse Event|4|||
156817752|NCT01063062|566081340|FG000|Overall Study|Protocol Violation|5|||
156817753|NCT01063062|566081341|FG001|Overall Study|Protocol Violation|4|||
156817754|NCT01063062|566081340|FG000|Overall Study|Investigator's request|1|||
156817755|NCT01063062|566081341|FG001|Overall Study|Investigator's request|0|||
156817756|NCT01063062|566081340|FG000|Overall Study|Lost to Follow-up|0|||
156817757|NCT01063062|566081341|FG001|Overall Study|Lost to Follow-up|2|||
156817758|NCT01063062|566081340|FG000|Overall Study|Miscellaneous reason|0|||
156817759|NCT01063062|566081341|FG001|Overall Study|Miscellaneous reason|1|||
156817760|NCT02015481|566081342|FG000|Overall Study|Death|1|||
156817761|NCT02597452|566081344|FG000|Overall Study|testing incomplete|30|||
157150509|NCT04003155|567296514|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
156817762|NCT03122145|566081347|FG000|Overall Study|Concurrent respiratory disease|3|||
156817763|NCT03122145|566081348|FG001|Overall Study|Concurrent respiratory disease|0|||
156817764|NCT02016716|566081353|FG000|Overall Study|Withdrawal by Subject|5|||
157150510|NCT04003155|567296515|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
157150511|NCT04003155|567296516|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
157150512|NCT04003155|567296517|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
157150513|NCT04003155|567296518|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
156817765|NCT02016716|566081354|FG001|Overall Study|Withdrawal by Subject|5|||
156817766|NCT02016716|566081355|FG002|Overall Study|Withdrawal by Subject|5|||
156817767|NCT02016716|566081353|FG000|Overall Study|Protocol-specified Criteria|0|||
156817768|NCT02016716|566081354|FG001|Overall Study|Protocol-specified Criteria|1|||
156817769|NCT02016716|566081355|FG002|Overall Study|Protocol-specified Criteria|0|||
156817770|NCT02016716|566081353|FG000|Overall Study|Lost to Follow-up|1|||
156817771|NCT02016716|566081354|FG001|Overall Study|Lost to Follow-up|2|||
156817772|NCT02016716|566081355|FG002|Overall Study|Lost to Follow-up|1|||
156817773|NCT00079391|566081356|FG000|Overall Study|Withdrawal by Subject|1|||
156817774|NCT01659996|566081357|FG000|Overall Study|Protocol Violation|3|||
156817775|NCT01659996|566081358|FG001|Overall Study|Protocol Violation|3|||
156817776|NCT01659996|566081359|FG002|Overall Study|Protocol Violation|3|||
156817777|NCT01659996|566081357|FG000|Overall Study|Lost to Follow-up|1|||
156817778|NCT01659996|566081358|FG001|Overall Study|Lost to Follow-up|3|||
156817779|NCT01659996|566081359|FG002|Overall Study|Lost to Follow-up|2|||
156817780|NCT01659996|566081357|FG000|Overall Study|Adverse Event|0|||
156817781|NCT01659996|566081358|FG001|Overall Study|Adverse Event|0|||
156817782|NCT01659996|566081359|FG002|Overall Study|Adverse Event|1|||
156817783|NCT01659996|566081357|FG000|Overall Study|Withdrawal by Subject|4|||
156817784|NCT01659996|566081358|FG001|Overall Study|Withdrawal by Subject|1|||
156817785|NCT01659996|566081359|FG002|Overall Study|Withdrawal by Subject|5|||
156817786|NCT03206918|566081360|FG000|Overall Study|Death|11|||
156817787|NCT03206918|566081360|FG000|Overall Study|Withdrawal by Subject|5|||
156817788|NCT03206918|566081360|FG000|Overall Study|Study terminated by sponsor|12|||
156817789|NCT03206918|566081360|FG000|Overall Study|Lost to Follow-up|3|||
156817790|NCT03206918|566081360|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
156817791|NCT02701764|566081361|FG000|Overall Study|Lost to Follow-up|0|||
157224384|NCT02228382|567567979|FG001|Overall Study|Study terminated by sponsor|5|||
157224385|NCT02228382|567567980|FG002|Overall Study|Study terminated by sponsor|7|||
157224386|NCT02228382|567567981|FG003|Overall Study|Study terminated by sponsor|0|||
157224387|NCT02228382|567567982|FG004|Overall Study|Study terminated by sponsor|0|||
157224388|NCT02228382|567567978|FG000|Overall Study|Lost to Follow-up|0|||
157224389|NCT02228382|567567979|FG001|Overall Study|Lost to Follow-up|0|||
157224390|NCT02228382|567567980|FG002|Overall Study|Lost to Follow-up|3|||
156817792|NCT02701764|566081362|FG001|Overall Study|Lost to Follow-up|1|||
156817793|NCT03108521|566081367|FG000|Overall Study|Lost to Follow-up|3|||
156817794|NCT03108521|566081368|FG001|Overall Study|Lost to Follow-up|0|||
156817795|NCT03108521|566081367|FG000|Overall Study|Lack of Efficacy|2|||
156817796|NCT03108521|566081368|FG001|Overall Study|Lack of Efficacy|0|||
156817797|NCT03108521|566081367|FG000|Overall Study|Physician Decision|4|||
156817798|NCT03108521|566081368|FG001|Overall Study|Physician Decision|0|||
156817799|NCT03108521|566081367|FG000|Overall Study|Adverse Event|3|||
156817800|NCT03108521|566081368|FG001|Overall Study|Adverse Event|0|||
156817801|NCT06899737|566081374|FG000|Overall Study|Lost to Follow-up|19|||
156817802|NCT06899737|566081375|FG001|Overall Study|Lost to Follow-up|7|||
156817803|NCT03281629|566081377|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
156817804|NCT03281629|566081378|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
156817805|NCT03281629|566081377|FG000|Overall Study|Death|0|||
156817806|NCT03281629|566081378|FG001|Overall Study|Death|1|||
156817807|NCT03281629|566081377|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
156817808|NCT03281629|566081378|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
156817809|NCT01170273|566081383|FG000|Overall Study|Lost to Follow-up|6|||
156817810|NCT01170273|566081384|FG001|Overall Study|Lost to Follow-up|8|||
156817811|NCT01170273|566081383|FG000|Overall Study|Protocol Violation|1|||
156817812|NCT01170273|566081384|FG001|Overall Study|Protocol Violation|0|||
157150514|NCT04003155|567296514|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
157150515|NCT04003155|567296515|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
157150516|NCT04003155|567296516|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
157224391|NCT02228382|567567981|FG003|Overall Study|Lost to Follow-up|1|||
157224392|NCT02228382|567567982|FG004|Overall Study|Lost to Follow-up|0|||
157150517|NCT04003155|567296517|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
156817813|NCT01170273|566081383|FG000|Overall Study|Death|1|||
156817814|NCT01170273|566081384|FG001|Overall Study|Death|0|||
156817815|NCT01170273|566081383|FG000|Overall Study|Adverse Event|0|||
156817816|NCT01170273|566081384|FG001|Overall Study|Adverse Event|1|||
156817817|NCT00334737|566081385|FG000|Hospital Phase|Death|1|||
156817818|NCT00334737|566081386|FG001|Hospital Phase|Death|2|||
156817819|NCT00334737|566081387|FG002|Hospital Phase|Death|3|||
156817820|NCT00334737|566081385|FG000|Hospital Phase|Withdrawal by Subject|0|||
157224393|NCT02228382|567567978|FG000|Overall Study|Withdrawal by Subject|0|||
157224394|NCT02228382|567567979|FG001|Overall Study|Withdrawal by Subject|3|||
156817821|NCT00334737|566081386|FG001|Hospital Phase|Withdrawal by Subject|0|||
156817822|NCT00334737|566081387|FG002|Hospital Phase|Withdrawal by Subject|1|||
156817823|NCT00334737|566081385|FG000|Hospital Phase|Did not receive study drug|1|||
156817824|NCT00334737|566081386|FG001|Hospital Phase|Did not receive study drug|0|||
156817825|NCT00334737|566081387|FG002|Hospital Phase|Did not receive study drug|0|||
156817826|NCT00334737|566081385|FG000|Follow up Phase|Lost to Follow-up|5|||
156817827|NCT00334737|566081386|FG001|Follow up Phase|Lost to Follow-up|3|||
156817828|NCT00334737|566081387|FG002|Follow up Phase|Lost to Follow-up|6|||
156817829|NCT02316353|566081388|FG000|Overall Study|Pregnancy|1|||
156817830|NCT02316353|566081389|FG001|Overall Study|Pregnancy|3|||
156817831|NCT02316353|566081388|FG000|Overall Study|Adverse Event|1|||
156817832|NCT02316353|566081389|FG001|Overall Study|Adverse Event|3|||
156817833|NCT02316353|566081388|FG000|Overall Study|Withdrawal by Subject|6|||
156817834|NCT02316353|566081389|FG001|Overall Study|Withdrawal by Subject|2|||
156817835|NCT00375674|566081390|FG000|Overall Study|Other|26|||
156817836|NCT00375674|566081391|FG001|Overall Study|Other|18|||
156817837|NCT00375674|566081390|FG000|Overall Study|Death|67|||
156817838|NCT00375674|566081391|FG001|Overall Study|Death|76|||
156817839|NCT00375674|566081390|FG000|Overall Study|Participants refused further follow-up|31|||
156817840|NCT00375674|566081391|FG001|Overall Study|Participants refused further follow-up|30|||
156817841|NCT00375674|566081390|FG000|Overall Study|Lost to Follow-up|17|||
156817842|NCT00375674|566081391|FG001|Overall Study|Lost to Follow-up|15|||
156817843|NCT00375674|566081390|FG000|Overall Study|Enrolled but not treated|3|||
156817844|NCT00375674|566081391|FG001|Overall Study|Enrolled but not treated|2|||
156817845|NCT01271010|566083190|FG000|Overall Study|Reason not specified|11|||
156817846|NCT01271010|566083190|FG000|Overall Study|Start of new CLL therapy|1|||
156817847|NCT01271010|566083190|FG000|Overall Study|Protocol Violation|1|||
156817848|NCT01271010|566083190|FG000|Overall Study|Death|2|||
156817849|NCT01271010|566083190|FG000|Overall Study|Progression and relapse of disease|1|||
156817850|NCT01271010|566083190|FG000|Overall Study|Withdrawal by Subject|18|||
156817851|NCT01271010|566083190|FG000|Overall Study|Disease progression|27|||
156817852|NCT01631747|566083191|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
156817853|NCT01631747|566083192|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
156817854|NCT01631747|566083191|FG000|Live Birth|Pregnancy Termination|1|||
156817855|NCT01631747|566083192|FG001|Live Birth|Pregnancy Termination|0|||
156817856|NCT01631747|566083191|FG000|Live Birth|MIscarriage|2|||
156817857|NCT01631747|566083192|FG001|Live Birth|MIscarriage|0|||
156817858|NCT01631747|566083191|FG000|Live Birth|Stillbirth|1|||
156817859|NCT01631747|566083192|FG001|Live Birth|Stillbirth|1|||
156817860|NCT01631747|566083191|FG000|One Year Infant Outcomes|Patient Refused|13|||
156817861|NCT01631747|566083192|FG001|One Year Infant Outcomes|Patient Refused|9|||
156817862|NCT01456195|566083193|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156817863|NCT01456195|566083194|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
156817864|NCT01456195|566083195|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156884359|NCT01616693|566334082|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
156884360|NCT01616693|566334083|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
156884361|NCT01616693|566334080|FG000|Received Both Vaccines|Lost to Follow-up|4|||
156884362|NCT01616693|566334081|FG001|Received Both Vaccines|Lost to Follow-up|3|||
156884363|NCT01616693|566334082|FG002|Received Both Vaccines|Lost to Follow-up|4|||
156817865|NCT01456195|566083193|FG000|Overall Study|Lost to Follow-up|3|||
156817866|NCT01456195|566083194|FG001|Overall Study|Lost to Follow-up|1|||
156817867|NCT01456195|566083195|FG002|Overall Study|Lost to Follow-up|3|||
156817868|NCT01456195|566083193|FG000|Overall Study|Voluntary Withdrawal|5|||
156817869|NCT01456195|566083194|FG001|Overall Study|Voluntary Withdrawal|3|||
156817870|NCT01456195|566083195|FG002|Overall Study|Voluntary Withdrawal|7|||
156817871|NCT01456195|566083193|FG000|Overall Study|Lack of Efficacy|0|||
156817872|NCT01456195|566083194|FG001|Overall Study|Lack of Efficacy|1|||
156817873|NCT01456195|566083195|FG002|Overall Study|Lack of Efficacy|0|||
156817874|NCT01456195|566083193|FG000|Overall Study|Other Reasons|2|||
156884364|NCT01616693|566334083|FG003|Received Both Vaccines|Lost to Follow-up|4|||
156817875|NCT01456195|566083194|FG001|Overall Study|Other Reasons|1|||
156817876|NCT01456195|566083195|FG002|Overall Study|Other Reasons|3|||
156817877|NCT02109432|566083196|FG000|Overall Study|Withdrawal by Subject|1|||
156817878|NCT03372551|566083203|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
156817879|NCT03372551|566083204|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
156817880|NCT04683029|566083213|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
156817881|NCT04683029|566083214|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817882|NCT04683029|566083215|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817883|NCT04683029|566083216|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
156817884|NCT04683029|566083213|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156817885|NCT04683029|566083214|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156884365|NCT01616693|566334080|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
156817886|NCT04683029|566083215|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
156817887|NCT04683029|566083216|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
156817888|NCT04683029|566083213|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156817889|NCT04683029|566083214|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156884366|NCT01616693|566334081|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
156884367|NCT01616693|566334082|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
156884368|NCT01616693|566334083|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
156884369|NCT02925338|566334087|FG000|Overall Study|Death|0|||
156884370|NCT02925338|566334088|FG001|Overall Study|Death|2|||
156884371|NCT02925338|566334089|FG002|Overall Study|Death|1|||
156884372|NCT02925338|566334090|FG003|Overall Study|Death|0|||
156884373|NCT02925338|566334091|FG004|Overall Study|Death|0|||
156884374|NCT02925338|566334087|FG000|Overall Study|Lost to Follow-up|30|||
156884375|NCT02925338|566334088|FG001|Overall Study|Lost to Follow-up|10|||
156884376|NCT02925338|566334089|FG002|Overall Study|Lost to Follow-up|1|||
157150518|NCT04003155|567296518|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
157150519|NCT04003155|567296514|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
157150520|NCT04003155|567296515|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
157150521|NCT04003155|567296516|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
157150522|NCT04003155|567296517|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
157150523|NCT04003155|567296518|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
157150524|NCT04275310|567296529|FG000|Overall Study|Non-randomized due to running out of funding|4|||
157150525|NCT04275310|567296530|FG001|Overall Study|Non-randomized due to running out of funding|0|||
157150526|NCT02345161|567296531|FG000|Overall Study|Withdrawal by Subject|25|||
157150527|NCT02345161|567296532|FG001|Overall Study|Withdrawal by Subject|33|||
157150528|NCT02345161|567296531|FG000|Overall Study|Adverse Event|16|||
157150529|NCT02345161|567296532|FG001|Overall Study|Adverse Event|19|||
157150530|NCT02345161|567296531|FG000|Overall Study|Physician Decision|4|||
156817890|NCT04683029|566083215|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
156817891|NCT04683029|566083216|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
156817892|NCT04299308|566083217|FG000|Overall Study|Withdrawal by Subject|1|||
156817893|NCT04299308|566083218|FG001|Overall Study|Withdrawal by Subject|0|||
156817894|NCT04299308|566083217|FG000|Overall Study|issue with PET image (1)|1|||
156817895|NCT04299308|566083218|FG001|Overall Study|issue with PET image (1)|0|||
156817896|NCT02920528|566083221|FG000|Overall Study|Incomplete Data|1|||
156817897|NCT02920528|566083222|FG001|Overall Study|Incomplete Data|1|||
156817898|NCT02920528|566083223|FG002|Overall Study|Incomplete Data|1|||
156817899|NCT02920528|566083221|FG000|Overall Study|Adverse Event|0|||
156817900|NCT02920528|566083222|FG001|Overall Study|Adverse Event|0|||
156817901|NCT02920528|566083223|FG002|Overall Study|Adverse Event|3|||
156817902|NCT02920528|566083221|FG000|Overall Study|Did not meet inclusion criteria|2|||
156817903|NCT02920528|566083222|FG001|Overall Study|Did not meet inclusion criteria|0|||
156817904|NCT02920528|566083223|FG002|Overall Study|Did not meet inclusion criteria|1|||
156817905|NCT00066703|566083224|FG000|Overall Study|Adverse Event|80|||
156817906|NCT00066703|566083225|FG001|Overall Study|Adverse Event|111|||
156817907|NCT00066703|566083224|FG000|Overall Study|Death|3|||
156817908|NCT00066703|566083225|FG001|Overall Study|Death|0|||
156817909|NCT00066703|566083224|FG000|Overall Study|Lack of Efficacy|114|||
156817910|NCT00066703|566083225|FG001|Overall Study|Lack of Efficacy|69|||
156817911|NCT00066703|566083224|FG000|Overall Study|Lost to Follow-up|31|||
156817912|NCT00066703|566083225|FG001|Overall Study|Lost to Follow-up|28|||
156817913|NCT00066703|566083224|FG000|Overall Study|Withdrawal by Subject|38|||
156817914|NCT00066703|566083225|FG001|Overall Study|Withdrawal by Subject|63|||
156817915|NCT00066703|566083224|FG000|Overall Study|Treatment ongoing|346|||
156817916|NCT00066703|566083225|FG001|Overall Study|Treatment ongoing|311|||
156817917|NCT05924165|566083228|FG000|Overall Study|Physician Decision|2|||
156817918|NCT05924165|566083229|FG001|Overall Study|Physician Decision|3|||
156817919|NCT01681186|566083230|FG000|Washout Period From Second Intervention|Adverse Event|0|||
156817920|NCT01681186|566083231|FG001|Washout Period From Second Intervention|Adverse Event|0|||
156817921|NCT01681186|566083232|FG002|Washout Period From Second Intervention|Adverse Event|0|||
156817922|NCT01681186|566083233|FG003|Washout Period From Second Intervention|Adverse Event|0|||
156817923|NCT01681186|566083234|FG004|Washout Period From Second Intervention|Adverse Event|0|||
156817924|NCT01681186|566083235|FG005|Washout Period From Second Intervention|Adverse Event|0|||
156817925|NCT01681186|566083236|FG006|Washout Period From Second Intervention|Adverse Event|1|||
157150531|NCT02345161|567296532|FG001|Overall Study|Physician Decision|4|||
157150532|NCT02345161|567296531|FG000|Overall Study|Lost to Follow-up|0|||
156817926|NCT01681186|566083237|FG007|Washout Period From Second Intervention|Adverse Event|0|||
156817927|NCT01681186|566083230|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
156817928|NCT01681186|566083231|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
156817929|NCT01681186|566083232|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
156817930|NCT01681186|566083233|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
156884377|NCT02925338|566334090|FG003|Overall Study|Lost to Follow-up|16|||
156884378|NCT02925338|566334091|FG004|Overall Study|Lost to Follow-up|3|||
156884379|NCT02925338|566334087|FG000|Overall Study|Withdrawal by Subject|3|||
157150533|NCT02345161|567296532|FG001|Overall Study|Lost to Follow-up|1|||
157150534|NCT03268746|567296534|FG000|Overall Study|Withdrawal by Subject|1|||
156884380|NCT02925338|566334088|FG001|Overall Study|Withdrawal by Subject|0|||
157150535|NCT02345434|567296542|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
156817931|NCT01681186|566083234|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
156817932|NCT01681186|566083235|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
156817933|NCT01681186|566083236|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
156817934|NCT01681186|566083237|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
156817935|NCT01681186|566083230|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817936|NCT01681186|566083231|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817937|NCT01681186|566083232|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817938|NCT01681186|566083233|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817939|NCT01681186|566083234|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817940|NCT01681186|566083235|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817941|NCT01681186|566083236|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
157150536|NCT02345434|567296543|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
156817942|NCT01681186|566083237|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
156817943|NCT01681186|566083230|FG000|Fourth Intervention|Protocol Violation|0|||
156817944|NCT01681186|566083231|FG001|Fourth Intervention|Protocol Violation|0|||
156817945|NCT01681186|566083232|FG002|Fourth Intervention|Protocol Violation|0|||
156817946|NCT01681186|566083233|FG003|Fourth Intervention|Protocol Violation|0|||
156817947|NCT01681186|566083234|FG004|Fourth Intervention|Protocol Violation|0|||
156817948|NCT01681186|566083235|FG005|Fourth Intervention|Protocol Violation|0|||
156817949|NCT01681186|566083236|FG006|Fourth Intervention|Protocol Violation|0|||
156817950|NCT01681186|566083237|FG007|Fourth Intervention|Protocol Violation|1|||
156817951|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Adverse Event|1|||
156817952|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Adverse Event|0|||
156817953|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
156817954|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
156817955|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
156817956|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
156817957|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
156817958|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
156817959|NCT00301262|566083244|FG000|Double Blind Phase (DB)|Other|1|||
156817960|NCT00301262|566083245|FG001|Double Blind Phase (DB)|Other|4|||
156817961|NCT00301262|566083244|FG000|Open Label Phase (OL)|Adverse Event|1|||
156817962|NCT00301262|566083245|FG001|Open Label Phase (OL)|Adverse Event|0|||
156817963|NCT00301262|566083244|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
156817964|NCT00301262|566083245|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
156817965|NCT00301262|566083244|FG000|Open Label Phase (OL)|Other|2|||
156817966|NCT00301262|566083245|FG001|Open Label Phase (OL)|Other|0|||
156817967|NCT03530995|566083249|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
156817968|NCT03530995|566083250|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
156817969|NCT03530995|566083249|FG000|Part 1 Period 3|Protocol Violation|1|||
156817970|NCT03530995|566083250|FG001|Part 1 Period 3|Protocol Violation|0|||
156817971|NCT03530995|566083249|FG000|Part 1 Period 4|Physician Decision|1|||
156817972|NCT03530995|566083250|FG001|Part 1 Period 4|Physician Decision|0|||
156817973|NCT03530995|566083249|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
156817974|NCT03530995|566083250|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
156817975|NCT04308239|566083256|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
156817976|NCT04308239|566083257|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
156817977|NCT04308239|566083256|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
156817978|NCT04308239|566083257|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
156817979|NCT04308239|566083256|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
156817980|NCT04308239|566083257|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
156817981|NCT04308239|566083256|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
156817982|NCT04308239|566083257|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
156817983|NCT01443364|566083258|FG000|Overall Study|Lack of Efficacy|14|||
156817984|NCT01443364|566083258|FG000|Overall Study|Lost to Follow-up|3|||
156817985|NCT01443364|566083258|FG000|Overall Study|Withdrawal by Subject|5|||
156817986|NCT01443364|566083258|FG000|Overall Study|Other Reason|4|||
156817987|NCT01443364|566083258|FG000|Overall Study|SAE, non-fatal|6|||
156817988|NCT01443364|566083258|FG000|Overall Study|AE, non-serious non-fatal|8|||
156817989|NCT01443364|566083258|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156817990|NCT04848220|566083263|FG000|Overall Study|Unable to proceed to study procedure|0|||
156817991|NCT04848220|566083264|FG001|Overall Study|Unable to proceed to study procedure|1|||
156817992|NCT04848220|566083265|FG002|Overall Study|Unable to proceed to study procedure|0|||
156817993|NCT04848220|566083263|FG000|Overall Study|Fractional flow not significant|0|||
156817994|NCT04848220|566083264|FG001|Overall Study|Fractional flow not significant|1|||
156817995|NCT04848220|566083265|FG002|Overall Study|Fractional flow not significant|0|||
156817996|NCT02150057|566083271|FG000|Overall Study|Lost to Follow-up|6|||
156817997|NCT02150057|566083272|FG001|Overall Study|Lost to Follow-up|4|||
156817998|NCT01558115|566083273|FG000|Overall Study|Withdrawal by Subject|3|||
156817999|NCT01558115|566083273|FG000|Overall Study|Study closed due to poor enrollment|4|||
157150537|NCT02805907|567296549|FG000|Overall Study|Lost to Follow-up|3|||
157150538|NCT02805907|567296550|FG001|Overall Study|Lost to Follow-up|3|||
157150539|NCT01671488|567296572|FG000|Overall Study|Withdrawal by Subject|1|||
157150540|NCT01022853|567296573|FG000|Overall Study|Progressive disease|2|||
157150541|NCT01022853|567296574|FG001|Overall Study|Progressive disease|3|||
157150542|NCT01022853|567296575|FG002|Overall Study|Progressive disease|11|||
157150543|NCT01022853|567296576|FG003|Overall Study|Progressive disease|7|||
157150544|NCT01022853|567296577|FG004|Overall Study|Progressive disease|1|||
157150545|NCT01022853|567296573|FG000|Overall Study|Dose-limiting toxicity|0|||
157150546|NCT01022853|567296574|FG001|Overall Study|Dose-limiting toxicity|0|||
157150547|NCT01022853|567296575|FG002|Overall Study|Dose-limiting toxicity|0|||
157150548|NCT01022853|567296576|FG003|Overall Study|Dose-limiting toxicity|0|||
157150549|NCT01022853|567296577|FG004|Overall Study|Dose-limiting toxicity|1|||
157150550|NCT01022853|567296573|FG000|Overall Study|Withdrawal by Subject|0|||
157150551|NCT01022853|567296574|FG001|Overall Study|Withdrawal by Subject|1|||
157150552|NCT01022853|567296575|FG002|Overall Study|Withdrawal by Subject|1|||
157150553|NCT01022853|567296576|FG003|Overall Study|Withdrawal by Subject|1|||
157150554|NCT01022853|567296577|FG004|Overall Study|Withdrawal by Subject|0|||
157150555|NCT01022853|567296573|FG000|Overall Study|Other not stated above|1|||
156818000|NCT01696994|566083274|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
156818001|NCT01696994|566083275|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
156818002|NCT01696994|566083274|FG000|Overall Study|Died Before Randomization|1|||
156818003|NCT01696994|566083275|FG001|Overall Study|Died Before Randomization|2|||
156818004|NCT01696994|566083274|FG000|Overall Study|Died Before ASU (Control)|73|||
156818005|NCT01696994|566083275|FG001|Overall Study|Died Before ASU (Control)|0|||
156818006|NCT01696994|566083274|FG000|Overall Study|No Ovaries at Baseline|4807|||
156818007|NCT01696994|566083275|FG001|Overall Study|No Ovaries at Baseline|4851|||
156818008|NCT01696994|566083274|FG000|Overall Study|Refused ASU (Control)|311|||
156818009|NCT01696994|566083275|FG001|Overall Study|Refused ASU (Control)|0|||
156818010|NCT01696994|566083274|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
156818011|NCT01696994|566083275|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
156818012|NCT02388165|566083276|FG000|Overall Study|Study terminated by sponsor|5|||
156818013|NCT02388165|566083277|FG001|Overall Study|Study terminated by sponsor|5|||
156818014|NCT02388165|566083276|FG000|Overall Study|Other|11|||
156818015|NCT02388165|566083277|FG001|Overall Study|Other|13|||
156818016|NCT02388165|566083276|FG000|Overall Study|No longer meet eligibility criteria|40|||
156818017|NCT02388165|566083277|FG001|Overall Study|No longer meet eligibility criteria|43|||
156818018|NCT02388165|566083276|FG000|Overall Study|Withdrawal of consent|31|||
156818019|NCT02388165|566083277|FG001|Overall Study|Withdrawal of consent|32|||
156818020|NCT02388165|566083276|FG000|Overall Study|Lost to Follow-up|19|||
156818021|NCT02388165|566083277|FG001|Overall Study|Lost to Follow-up|20|||
156818022|NCT02388165|566083276|FG000|Overall Study|Death|13|||
156818023|NCT02388165|566083277|FG001|Overall Study|Death|10|||
156818024|NCT02388165|566083276|FG000|Overall Study|Adverse Event|3|||
156818025|NCT02388165|566083277|FG001|Overall Study|Adverse Event|5|||
156818026|NCT02388165|566083276|FG000|Overall Study|Did not meet entrance criteria|5|||
156818027|NCT02388165|566083277|FG001|Overall Study|Did not meet entrance criteria|2|||
156818028|NCT01406938|566083278|FG000|Induction Period|Subject/guardian decision|6|||
156818029|NCT01406938|566083279|FG001|Induction Period|Subject/guardian decision|8|||
156818030|NCT01406938|566083280|FG002|Induction Period|Subject/guardian decision|0|||
156818031|NCT01406938|566083281|FG003|Induction Period|Subject/guardian decision|0|||
156818032|NCT01406938|566083282|FG004|Induction Period|Subject/guardian decision|0|||
156818033|NCT01406938|566083283|FG005|Induction Period|Subject/guardian decision|0|||
156818034|NCT01406938|566083278|FG000|Induction Period|Protocol deviation|1|||
156818035|NCT01406938|566083279|FG001|Induction Period|Protocol deviation|0|||
156818036|NCT01406938|566083280|FG002|Induction Period|Protocol deviation|0|||
156818037|NCT01406938|566083281|FG003|Induction Period|Protocol deviation|0|||
156818038|NCT01406938|566083282|FG004|Induction Period|Protocol deviation|0|||
156818039|NCT01406938|566083283|FG005|Induction Period|Protocol deviation|0|||
156818040|NCT01406938|566083278|FG000|Induction Period|Adverse Event|8|||
156818041|NCT01406938|566083279|FG001|Induction Period|Adverse Event|9|||
156818042|NCT01406938|566083280|FG002|Induction Period|Adverse Event|0|||
156818043|NCT01406938|566083281|FG003|Induction Period|Adverse Event|0|||
156818044|NCT01406938|566083282|FG004|Induction Period|Adverse Event|0|||
156818045|NCT01406938|566083283|FG005|Induction Period|Adverse Event|0|||
156818046|NCT01406938|566083278|FG000|Induction Period|Lack of Efficacy|1|||
156818047|NCT01406938|566083279|FG001|Induction Period|Lack of Efficacy|0|||
156818048|NCT01406938|566083280|FG002|Induction Period|Lack of Efficacy|0|||
156818049|NCT01406938|566083281|FG003|Induction Period|Lack of Efficacy|0|||
157150556|NCT01022853|567296574|FG001|Overall Study|Other not stated above|0|||
157150557|NCT01022853|567296575|FG002|Overall Study|Other not stated above|1|||
157150558|NCT01022853|567296576|FG003|Overall Study|Other not stated above|0|||
157150559|NCT01022853|567296577|FG004|Overall Study|Other not stated above|0|||
156818050|NCT01406938|566083282|FG004|Induction Period|Lack of Efficacy|0|||
156818051|NCT01406938|566083283|FG005|Induction Period|Lack of Efficacy|0|||
156818052|NCT01406938|566083278|FG000|Induction Period|Lost to Follow-up|2|||
156818053|NCT01406938|566083279|FG001|Induction Period|Lost to Follow-up|3|||
156818054|NCT01406938|566083280|FG002|Induction Period|Lost to Follow-up|0|||
156818055|NCT01406938|566083281|FG003|Induction Period|Lost to Follow-up|0|||
156818056|NCT01406938|566083282|FG004|Induction Period|Lost to Follow-up|0|||
156818057|NCT01406938|566083283|FG005|Induction Period|Lost to Follow-up|0|||
156818058|NCT01406938|566083278|FG000|Maintenance Period|Adverse Event|0|||
156818059|NCT01406938|566083279|FG001|Maintenance Period|Adverse Event|0|||
156818060|NCT01406938|566083280|FG002|Maintenance Period|Adverse Event|2|||
156818061|NCT01406938|566083281|FG003|Maintenance Period|Adverse Event|8|||
156818062|NCT01406938|566083282|FG004|Maintenance Period|Adverse Event|4|||
156818063|NCT01406938|566083283|FG005|Maintenance Period|Adverse Event|2|||
156818064|NCT01406938|566083278|FG000|Maintenance Period|Death|0|||
156818065|NCT01406938|566083279|FG001|Maintenance Period|Death|0|||
156818066|NCT01406938|566083280|FG002|Maintenance Period|Death|0|||
156818067|NCT01406938|566083281|FG003|Maintenance Period|Death|0|||
156818068|NCT01406938|566083282|FG004|Maintenance Period|Death|1|||
156818069|NCT01406938|566083283|FG005|Maintenance Period|Death|0|||
156818070|NCT01406938|566083278|FG000|Maintenance Period|Subject/guardian decision|0|||
156818071|NCT01406938|566083279|FG001|Maintenance Period|Subject/guardian decision|0|||
156818072|NCT01406938|566083280|FG002|Maintenance Period|Subject/guardian decision|11|||
156818073|NCT01406938|566083281|FG003|Maintenance Period|Subject/guardian decision|7|||
156818074|NCT01406938|566083282|FG004|Maintenance Period|Subject/guardian decision|10|||
156818075|NCT01406938|566083283|FG005|Maintenance Period|Subject/guardian decision|7|||
156818076|NCT01406938|566083278|FG000|Maintenance Period|Protocol Violation|0|||
156818077|NCT01406938|566083279|FG001|Maintenance Period|Protocol Violation|0|||
156818078|NCT01406938|566083280|FG002|Maintenance Period|Protocol Violation|2|||
156818079|NCT01406938|566083281|FG003|Maintenance Period|Protocol Violation|2|||
156818080|NCT01406938|566083282|FG004|Maintenance Period|Protocol Violation|2|||
156818081|NCT01406938|566083283|FG005|Maintenance Period|Protocol Violation|2|||
156818082|NCT01406938|566083278|FG000|Maintenance Period|Pregnancy|0|||
156818083|NCT01406938|566083279|FG001|Maintenance Period|Pregnancy|0|||
156818084|NCT01406938|566083280|FG002|Maintenance Period|Pregnancy|0|||
156818085|NCT01406938|566083281|FG003|Maintenance Period|Pregnancy|0|||
156818086|NCT01406938|566083282|FG004|Maintenance Period|Pregnancy|1|||
156818087|NCT01406938|566083283|FG005|Maintenance Period|Pregnancy|0|||
156818088|NCT01406938|566083278|FG000|Maintenance Period|Lost to Follow-up|0|||
156818089|NCT01406938|566083279|FG001|Maintenance Period|Lost to Follow-up|0|||
156818090|NCT01406938|566083280|FG002|Maintenance Period|Lost to Follow-up|0|||
156818091|NCT01406938|566083281|FG003|Maintenance Period|Lost to Follow-up|0|||
156818092|NCT01406938|566083282|FG004|Maintenance Period|Lost to Follow-up|4|||
156818093|NCT01406938|566083283|FG005|Maintenance Period|Lost to Follow-up|0|||
156818094|NCT01406938|566083278|FG000|Maintenance Period|Lack of Efficacy|0|||
156818095|NCT01406938|566083279|FG001|Maintenance Period|Lack of Efficacy|0|||
156818096|NCT01406938|566083280|FG002|Maintenance Period|Lack of Efficacy|2|||
156818097|NCT01406938|566083281|FG003|Maintenance Period|Lack of Efficacy|1|||
157150560|NCT02416908|567296578|FG000|Dose Escalation Phase|Adverse Event|0|||
157150561|NCT02416908|567296579|FG001|Dose Escalation Phase|Adverse Event|0|||
157150562|NCT02416908|567296580|FG002|Dose Escalation Phase|Adverse Event|3|||
157150563|NCT02416908|567296581|FG003|Dose Escalation Phase|Adverse Event|0|||
157150564|NCT02416908|567296578|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
157150565|NCT02416908|567296579|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
157150566|NCT02416908|567296580|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
157150567|NCT02416908|567296581|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
157150568|NCT00532883|567296582|FG000|Overall Study|Adverse Event|1|||
157150569|NCT00532883|567296583|FG001|Overall Study|Adverse Event|0|||
156818098|NCT01406938|566083282|FG004|Maintenance Period|Lack of Efficacy|3|||
156818099|NCT01406938|566083283|FG005|Maintenance Period|Lack of Efficacy|5|||
156818100|NCT01406938|566083278|FG000|Follow up|Lack of Efficacy|3|||
156818101|NCT01406938|566083279|FG001|Follow up|Lack of Efficacy|2|||
156818102|NCT01406938|566083280|FG002|Follow up|Lack of Efficacy|1|||
156818103|NCT01406938|566083281|FG003|Follow up|Lack of Efficacy|0|||
156884381|NCT02925338|566334089|FG002|Overall Study|Withdrawal by Subject|3|||
156884382|NCT02925338|566334090|FG003|Overall Study|Withdrawal by Subject|2|||
156884383|NCT02925338|566334091|FG004|Overall Study|Withdrawal by Subject|2|||
156884384|NCT02925338|566334087|FG000|Overall Study|Missing|38|||
157150570|NCT00532883|567296584|FG002|Overall Study|Adverse Event|0|||
157150571|NCT00532883|567296585|FG003|Overall Study|Adverse Event|1|||
156818104|NCT01406938|566083282|FG004|Follow up|Lack of Efficacy|0|||
156818105|NCT01406938|566083283|FG005|Follow up|Lack of Efficacy|0|||
156818106|NCT01406938|566083278|FG000|Follow up|Patient/guardian decision|4|||
156818107|NCT01406938|566083279|FG001|Follow up|Patient/guardian decision|2|||
156818108|NCT01406938|566083280|FG002|Follow up|Patient/guardian decision|4|||
156818109|NCT01406938|566083281|FG003|Follow up|Patient/guardian decision|2|||
156884385|NCT02925338|566334088|FG001|Overall Study|Missing|27|||
156884386|NCT02925338|566334089|FG002|Overall Study|Missing|0|||
157150572|NCT00532883|567296582|FG000|Overall Study|Lost to Follow-up|1|||
157150573|NCT00532883|567296583|FG001|Overall Study|Lost to Follow-up|1|||
157150574|NCT00532883|567296584|FG002|Overall Study|Lost to Follow-up|1|||
156818110|NCT01406938|566083282|FG004|Follow up|Patient/guardian decision|4|||
156818111|NCT01406938|566083283|FG005|Follow up|Patient/guardian decision|1|||
156818112|NCT01406938|566083278|FG000|Follow up|Protocol Violation|0|||
156818113|NCT01406938|566083279|FG001|Follow up|Protocol Violation|0|||
156818114|NCT01406938|566083280|FG002|Follow up|Protocol Violation|1|||
156818115|NCT01406938|566083281|FG003|Follow up|Protocol Violation|0|||
156818116|NCT01406938|566083282|FG004|Follow up|Protocol Violation|0|||
156818117|NCT01406938|566083283|FG005|Follow up|Protocol Violation|0|||
156818118|NCT01406938|566083278|FG000|Follow up|Physician Decision|0|||
156818119|NCT01406938|566083279|FG001|Follow up|Physician Decision|0|||
156818120|NCT01406938|566083280|FG002|Follow up|Physician Decision|2|||
156818121|NCT01406938|566083281|FG003|Follow up|Physician Decision|0|||
156818122|NCT01406938|566083282|FG004|Follow up|Physician Decision|3|||
156818123|NCT01406938|566083283|FG005|Follow up|Physician Decision|1|||
156818124|NCT01406938|566083278|FG000|Follow up|Lost to Follow-up|1|||
156818125|NCT01406938|566083279|FG001|Follow up|Lost to Follow-up|1|||
156818126|NCT01406938|566083280|FG002|Follow up|Lost to Follow-up|0|||
156818127|NCT01406938|566083281|FG003|Follow up|Lost to Follow-up|1|||
156818128|NCT01406938|566083282|FG004|Follow up|Lost to Follow-up|2|||
156818129|NCT01406938|566083283|FG005|Follow up|Lost to Follow-up|1|||
156818130|NCT02249091|566083284|FG000|Overall Study|Lack of Efficacy|8|||
156818131|NCT02249091|566083285|FG001|Overall Study|Lack of Efficacy|3|||
156818132|NCT02249091|566083284|FG000|Overall Study|Physician Decision|4|||
156818133|NCT02249091|566083285|FG001|Overall Study|Physician Decision|1|||
156818134|NCT02249091|566083284|FG000|Overall Study|Withdrawal by Subject|2|||
156818135|NCT02249091|566083285|FG001|Overall Study|Withdrawal by Subject|2|||
156818136|NCT02249091|566083284|FG000|Overall Study|Death|3|||
156818137|NCT02249091|566083285|FG001|Overall Study|Death|4|||
156818138|NCT02249091|566083284|FG000|Overall Study|Adverse Event|1|||
157224395|NCT02228382|567567980|FG002|Overall Study|Withdrawal by Subject|2|||
156818139|NCT02249091|566083285|FG001|Overall Study|Adverse Event|0|||
156818140|NCT02249091|566083284|FG000|Overall Study|Stable disease with following SCT|0|||
156818141|NCT02249091|566083285|FG001|Overall Study|Stable disease with following SCT|1|||
156818142|NCT02249091|566083284|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
156818143|NCT02249091|566083285|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
156818144|NCT02249091|566083284|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
156818145|NCT02249091|566083285|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
156818146|NCT02249091|566083284|FG000|Overall Study|Refractory AML|1|||
156818147|NCT02249091|566083285|FG001|Overall Study|Refractory AML|1|||
156818148|NCT02684617|566083286|FG000|Overall Study|Adverse Event|1|||
156818149|NCT02684617|566083287|FG001|Overall Study|Adverse Event|0|||
156818150|NCT02684617|566083288|FG002|Overall Study|Adverse Event|1|||
156818151|NCT02684617|566083286|FG000|Overall Study|Death|8|||
156818152|NCT02684617|566083287|FG001|Overall Study|Death|16|||
156818153|NCT02684617|566083288|FG002|Overall Study|Death|28|||
156818154|NCT02684617|566083286|FG000|Overall Study|Withdrawal by Subject|2|||
156818155|NCT02684617|566083287|FG001|Overall Study|Withdrawal by Subject|0|||
156818156|NCT02684617|566083288|FG002|Overall Study|Withdrawal by Subject|4|||
156818157|NCT02684617|566083286|FG000|Overall Study|Screen Failure|1|||
156818158|NCT02684617|566083287|FG001|Overall Study|Screen Failure|0|||
156818159|NCT02684617|566083288|FG002|Overall Study|Screen Failure|2|||
156818160|NCT02684617|566083286|FG000|Overall Study|Study Terminated by Sponsor|6|||
156818161|NCT02684617|566083287|FG001|Overall Study|Study Terminated by Sponsor|1|||
156818162|NCT02684617|566083288|FG002|Overall Study|Study Terminated by Sponsor|5|||
156818163|NCT02141399|566083289|FG000|Overall Study|Adverse Event|158|||
156818164|NCT02141399|566083289|FG000|Overall Study|Lack of Efficacy|62|||
157224396|NCT02228382|567567981|FG003|Overall Study|Withdrawal by Subject|1|||
157224397|NCT02228382|567567982|FG004|Overall Study|Withdrawal by Subject|0|||
157224398|NCT02228382|567567978|FG000|Overall Study|Other|2|||
156818165|NCT02141399|566083289|FG000|Overall Study|Lost to Follow-up|151|||
156818166|NCT02141399|566083289|FG000|Overall Study|Non-compliance with study drug|18|||
156818167|NCT02141399|566083289|FG000|Overall Study|Other|45|||
156818168|NCT02141399|566083289|FG000|Overall Study|Physician Decision|17|||
156818169|NCT02141399|566083289|FG000|Overall Study|Pregnancy|3|||
156818170|NCT02141399|566083289|FG000|Overall Study|Protocol Violation|38|||
156818171|NCT02141399|566083289|FG000|Overall Study|Withdrawal by Subject|238|||
156818172|NCT02141399|566083289|FG000|Overall Study|Failure to meet eligibility criteria|14|||
156818173|NCT05730335|566083290|FG000|Overall Study|Lost to Follow-up|8|||
156818174|NCT05730335|566083290|FG000|Overall Study|Withdrawal by Subject|6|||
156818175|NCT00765037|566083291|FG000|Overall Study|Lost to Follow-up|5|||
156818176|NCT00765037|566083291|FG000|Overall Study|Adverse Event|1|||
156818177|NCT00615719|566083292|FG000|Overall Study|Physician Decision|5|||
156818178|NCT01471028|566083293|FG000|VTI-208|Adverse Event|39|||
157224399|NCT02228382|567567979|FG001|Overall Study|Other|3|||
156818179|NCT01471028|566083294|FG001|VTI-208|Adverse Event|41|||
156818180|NCT01471028|566083293|FG000|VTI-208|Withdrawal by Subject|0|||
156818181|NCT01471028|566083294|FG001|VTI-208|Withdrawal by Subject|2|||
156818182|NCT01471028|566083293|FG000|VTI-208|Lost to Follow-up|1|||
157224400|NCT02228382|567567980|FG002|Overall Study|Other|3|||
156818183|NCT01471028|566083294|FG001|VTI-208|Lost to Follow-up|1|||
156818184|NCT01471028|566083293|FG000|VTI-208E|Death|7|||
156818185|NCT01471028|566083294|FG001|VTI-208E|Death|10|||
156818186|NCT01471028|566083293|FG000|VTI-208E|Withdrawal by Subject|1|||
156818187|NCT01471028|566083294|FG001|VTI-208E|Withdrawal by Subject|0|||
156818188|NCT01471028|566083293|FG000|VTI-208E|Lost to Follow-up|0|||
157224401|NCT02228382|567567981|FG003|Overall Study|Other|0|||
157224402|NCT02228382|567567982|FG004|Overall Study|Other|0|||
157224403|NCT02396381|567567984|FG000|Overall Study|Adverse Event|3|||
157224404|NCT02396381|567567985|FG001|Overall Study|Adverse Event|2|||
157224405|NCT02396381|567567984|FG000|Overall Study|Withdrawal by Subject|33|||
157224406|NCT02396381|567567985|FG001|Overall Study|Withdrawal by Subject|24|||
157224407|NCT02396381|567567984|FG000|Overall Study|Lost to Follow-up|49|||
157224408|NCT02396381|567567985|FG001|Overall Study|Lost to Follow-up|31|||
157224409|NCT02396381|567567984|FG000|Overall Study|Protocol Violation|1|||
157224410|NCT02396381|567567985|FG001|Overall Study|Protocol Violation|0|||
157224411|NCT02396381|567567984|FG000|Overall Study|Site terminated by sponsor|7|||
156818189|NCT01471028|566083294|FG001|VTI-208E|Lost to Follow-up|2|||
156818190|NCT00935493|566083295|FG000|Overall Study|Lost to Follow-up|1|||
156818191|NCT00935493|566083296|FG001|Overall Study|Lost to Follow-up|1|||
156818192|NCT00935493|566083297|FG002|Overall Study|Lost to Follow-up|1|||
156818193|NCT00935493|566083295|FG000|Overall Study|Treatment Discontinued|0|||
156818194|NCT00935493|566083296|FG001|Overall Study|Treatment Discontinued|1|||
156818195|NCT00935493|566083297|FG002|Overall Study|Treatment Discontinued|0|||
156818196|NCT02091362|566083307|FG000|Period 1|Protocol Violation|1|||
156818197|NCT02091362|566083308|FG001|Period 1|Protocol Violation|0|||
156818198|NCT02091362|566083307|FG000|Period 1|Withdrawal by Subject|2|||
156818199|NCT02091362|566083308|FG001|Period 1|Withdrawal by Subject|3|||
156818200|NCT02091362|566083307|FG000|Period 1|Lost to Follow-up|0|||
156818201|NCT02091362|566083308|FG001|Period 1|Lost to Follow-up|1|||
156818202|NCT02091362|566083307|FG000|Period 1|Adverse Event|2|||
156818203|NCT02091362|566083308|FG001|Period 1|Adverse Event|0|||
156818204|NCT02091362|566083307|FG000|Wash-out|Lost to Follow-up|1|||
156818205|NCT02091362|566083308|FG001|Wash-out|Lost to Follow-up|1|||
156818206|NCT02091362|566083307|FG000|Wash-out|Withdrawal by Subject|0|||
156818207|NCT02091362|566083308|FG001|Wash-out|Withdrawal by Subject|2|||
156818208|NCT02091362|566083307|FG000|Period 2|Adverse Event|1|||
156818209|NCT02091362|566083308|FG001|Period 2|Adverse Event|0|||
156818210|NCT02091362|566083307|FG000|Period 2|Lost to Follow-up|0|||
156818211|NCT02091362|566083308|FG001|Period 2|Lost to Follow-up|1|||
156818212|NCT02091362|566083307|FG000|Period 2|Withdrawal by Subject|1|||
156818213|NCT02091362|566083308|FG001|Period 2|Withdrawal by Subject|1|||
156818214|NCT00690430|566083309|FG000|Core Phase|Abnormal Laboratory value|0|||
156818215|NCT00690430|566083310|FG001|Core Phase|Abnormal Laboratory value|1|||
156818216|NCT00690430|566083311|FG002|Core Phase|Abnormal Laboratory value|0|||
156818217|NCT00690430|566083309|FG000|Core Phase|Adverse Event|5|||
156818218|NCT00690430|566083310|FG001|Core Phase|Adverse Event|1|||
157150575|NCT00532883|567296585|FG003|Overall Study|Lost to Follow-up|0|||
157150576|NCT00532883|567296582|FG000|Overall Study|Withdrawal by Subject|0|||
157150577|NCT00532883|567296583|FG001|Overall Study|Withdrawal by Subject|1|||
157150578|NCT00532883|567296584|FG002|Overall Study|Withdrawal by Subject|1|||
157150579|NCT00532883|567296585|FG003|Overall Study|Withdrawal by Subject|0|||
157150580|NCT00532883|567296582|FG000|Overall Study|Subject was Nonadherent|0|||
157150581|NCT00532883|567296583|FG001|Overall Study|Subject was Nonadherent|1|||
157150582|NCT00532883|567296584|FG002|Overall Study|Subject was Nonadherent|1|||
157150583|NCT00532883|567296585|FG003|Overall Study|Subject was Nonadherent|0|||
157150584|NCT00532883|567296582|FG000|Overall Study|Early Study Termination|4|||
156818219|NCT00690430|566083311|FG002|Core Phase|Adverse Event|0|||
156818220|NCT00690430|566083309|FG000|Core Phase|Death|0|||
156818221|NCT00690430|566083310|FG001|Core Phase|Death|2|||
157224412|NCT02396381|567567985|FG001|Overall Study|Site terminated by sponsor|8|||
156818222|NCT00690430|566083311|FG002|Core Phase|Death|0|||
157150585|NCT00532883|567296583|FG001|Overall Study|Early Study Termination|4|||
157150586|NCT00532883|567296584|FG002|Overall Study|Early Study Termination|1|||
157150587|NCT00532883|567296585|FG003|Overall Study|Early Study Termination|4|||
157150588|NCT01214434|567296588|FG000|Overall Study|Withdrawal by Subject|1|||
157150589|NCT01214434|567296589|FG001|Overall Study|Withdrawal by Subject|0|||
157224413|NCT02396381|567567984|FG000|Overall Study|Physician Decision|5|||
156818223|NCT00690430|566083309|FG000|Core Phase|Protocol Violation|1|||
156818224|NCT00690430|566083310|FG001|Core Phase|Protocol Violation|0|||
156818225|NCT00690430|566083311|FG002|Core Phase|Protocol Violation|0|||
156818226|NCT00690430|566083309|FG000|Core Phase|Withdrawal by Subject|3|||
156818227|NCT00690430|566083310|FG001|Core Phase|Withdrawal by Subject|3|||
156818228|NCT00690430|566083311|FG002|Core Phase|Withdrawal by Subject|0|||
156818229|NCT00690430|566083309|FG000|Core Phase|Subject no longer requires study drug|1|||
156818230|NCT00690430|566083310|FG001|Core Phase|Subject no longer requires study drug|0|||
156818231|NCT00690430|566083311|FG002|Core Phase|Subject no longer requires study drug|0|||
156818232|NCT00690430|566083309|FG000|Core Phase|Lack of Efficacy|8|||
156818233|NCT00690430|566083310|FG001|Core Phase|Lack of Efficacy|10|||
157224414|NCT02396381|567567985|FG001|Overall Study|Physician Decision|5|||
157022626|NCT05364671|566835261|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
157150590|NCT01214434|567296588|FG000|Overall Study|Lost to Follow-up|2|||
157150591|NCT01214434|567296589|FG001|Overall Study|Lost to Follow-up|2|||
157150592|NCT01214434|567296588|FG000|Overall Study|Site error|1|||
157150593|NCT01214434|567296589|FG001|Overall Study|Site error|0|||
157150594|NCT03799718|567296590|FG000|Overall Study|Adverse Event|2|||
156818234|NCT00690430|566083311|FG002|Core Phase|Lack of Efficacy|0|||
156818235|NCT00690430|566083309|FG000|Core Phase|Administrative Problems|0|||
156818236|NCT00690430|566083310|FG001|Core Phase|Administrative Problems|1|||
156818237|NCT00690430|566083311|FG002|Core Phase|Administrative Problems|0|||
156818238|NCT00690430|566083309|FG000|Core Phase|Early Termination|0|||
156818239|NCT00690430|566083310|FG001|Core Phase|Early Termination|5|||
156818240|NCT00690430|566083311|FG002|Core Phase|Early Termination|0|||
156818241|NCT00690430|566083309|FG000|Extension Phase|Lack of Efficacy|3|||
156818242|NCT00690430|566083310|FG001|Extension Phase|Lack of Efficacy|1|||
156818243|NCT00690430|566083311|FG002|Extension Phase|Lack of Efficacy|4|||
156818244|NCT00690430|566083309|FG000|Extension Phase|Abnormal Lab Values|1|||
156818245|NCT00690430|566083310|FG001|Extension Phase|Abnormal Lab Values|0|||
156818246|NCT00690430|566083311|FG002|Extension Phase|Abnormal Lab Values|0|||
156818247|NCT00690430|566083309|FG000|Extension Phase|Abnormal test procedure results|1|||
156818248|NCT00690430|566083310|FG001|Extension Phase|Abnormal test procedure results|0|||
156818249|NCT00690430|566083311|FG002|Extension Phase|Abnormal test procedure results|0|||
156818250|NCT00690430|566083309|FG000|Extension Phase|Administrative Problems|0|||
156818251|NCT00690430|566083310|FG001|Extension Phase|Administrative Problems|1|||
156818252|NCT00690430|566083311|FG002|Extension Phase|Administrative Problems|1|||
156818253|NCT00690430|566083309|FG000|Extension Phase|Adverse Event|2|||
156818254|NCT00690430|566083310|FG001|Extension Phase|Adverse Event|1|||
156818255|NCT00690430|566083311|FG002|Extension Phase|Adverse Event|2|||
156818256|NCT00690430|566083309|FG000|Extension Phase|Death|1|||
156818257|NCT00690430|566083310|FG001|Extension Phase|Death|1|||
156818258|NCT00690430|566083311|FG002|Extension Phase|Death|1|||
156818259|NCT00690430|566083309|FG000|Extension Phase|Withdrawal by Subject|0|||
156818260|NCT00690430|566083310|FG001|Extension Phase|Withdrawal by Subject|0|||
156818261|NCT00690430|566083311|FG002|Extension Phase|Withdrawal by Subject|2|||
156818262|NCT00690430|566083309|FG000|Extension Phase|Early Termination|10|||
156818263|NCT00690430|566083310|FG001|Extension Phase|Early Termination|1|||
156818264|NCT00690430|566083311|FG002|Extension Phase|Early Termination|3|||
156818265|NCT02565147|566083312|FG000|Overall Study|Withdrawal by Subject|5|||
156818266|NCT02565147|566083313|FG001|Overall Study|Withdrawal by Subject|1|||
156818267|NCT02565147|566083312|FG000|Overall Study|Lost to Follow-up|0|||
156818268|NCT02565147|566083313|FG001|Overall Study|Lost to Follow-up|1|||
156818269|NCT02565147|566083312|FG000|Overall Study|Death|1|||
156818270|NCT02565147|566083313|FG001|Overall Study|Death|1|||
156818271|NCT03098433|566083317|FG000|Overall Study|Withdrawal by Subject|10|||
156818272|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156818273|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156818274|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156818275|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Adverse Event|1|||
156818276|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Adverse Event|0|||
156818277|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Adverse Event|0|||
156818278|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Adverse Event|0|||
156818279|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818280|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818281|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818282|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818283|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
156818284|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818285|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
156818286|NCT04470050|566083318|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
156818287|NCT04470050|566083319|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
156818288|NCT04470050|566083320|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
156818289|NCT04470050|566083321|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156818290|NCT04470050|566083322|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
156884387|NCT02925338|566334090|FG003|Overall Study|Missing|3|||
157150595|NCT02075255|567296592|FG000|Overall Study|Study specific withdrawal criteria|0|||
156818291|NCT04470050|566083323|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
156818292|NCT04470050|566083324|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
156818293|NCT03640507|566083325|FG000|Overall Study|Withdrawal by Subject|0|||
156818294|NCT03640507|566083326|FG001|Overall Study|Withdrawal by Subject|0|||
156818295|NCT03640507|566083327|FG002|Overall Study|Withdrawal by Subject|1|||
157022627|NCT05364671|566835260|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
157150596|NCT02075255|567296593|FG001|Overall Study|Study specific withdrawal criteria|1|||
156818296|NCT01270880|566083328|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
156884388|NCT02925338|566334091|FG004|Overall Study|Missing|2|||
157022628|NCT05364671|566835261|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
157022629|NCT04015167|566835262|FG000|Overall Study|Lost to Follow-up|40|||
157022630|NCT04015167|566835262|FG000|Overall Study|Adverse Event|5|||
157150597|NCT02075255|567296594|FG002|Overall Study|Study specific withdrawal criteria|1|||
157150598|NCT02075255|567296592|FG000|Overall Study|Withdrawal by Subject|4|||
157150599|NCT02075255|567296593|FG001|Overall Study|Withdrawal by Subject|1|||
156818297|NCT00395486|566083333|FG000|Overall Study|Adverse Event|1|||
156818298|NCT00395486|566083334|FG001|Overall Study|Adverse Event|2|||
156818299|NCT00395486|566083333|FG000|Overall Study|Withdrawal by Subject|5|||
156818300|NCT00395486|566083334|FG001|Overall Study|Withdrawal by Subject|2|||
156818301|NCT00395486|566083333|FG000|Overall Study|Lost to Follow-up|0|||
156818302|NCT00395486|566083334|FG001|Overall Study|Lost to Follow-up|1|||
156818303|NCT02443116|566083337|FG000|Part 1|Adverse Event|2|||
156818304|NCT02443116|566083338|FG001|Part 1|Adverse Event|3|||
156818305|NCT02443116|566083339|FG002|Part 1|Adverse Event|0|||
156818306|NCT02443116|566083340|FG003|Part 1|Adverse Event|0|||
156818307|NCT02443116|566083341|FG004|Part 1|Adverse Event|0|||
156818308|NCT02443116|566083342|FG005|Part 1|Adverse Event|0|||
156818309|NCT02443116|566083343|FG006|Part 1|Adverse Event|0|||
156818310|NCT02443116|566083344|FG007|Part 1|Adverse Event|0|||
156818311|NCT02443116|566083345|FG008|Part 1|Adverse Event|0|||
156818312|NCT02443116|566083337|FG000|Part 1|Withdrew informed consent|0|||
156818313|NCT02443116|566083338|FG001|Part 1|Withdrew informed consent|1|||
156818314|NCT02443116|566083339|FG002|Part 1|Withdrew informed consent|0|||
156818315|NCT02443116|566083340|FG003|Part 1|Withdrew informed consent|0|||
156818316|NCT02443116|566083341|FG004|Part 1|Withdrew informed consent|0|||
156818317|NCT02443116|566083342|FG005|Part 1|Withdrew informed consent|0|||
156818318|NCT02443116|566083343|FG006|Part 1|Withdrew informed consent|0|||
156818319|NCT02443116|566083344|FG007|Part 1|Withdrew informed consent|0|||
156818320|NCT02443116|566083345|FG008|Part 1|Withdrew informed consent|0|||
156818321|NCT02443116|566083337|FG000|Part 1|Lost to Follow-up|0|||
156818322|NCT02443116|566083338|FG001|Part 1|Lost to Follow-up|0|||
156818323|NCT02443116|566083339|FG002|Part 1|Lost to Follow-up|2|||
156818324|NCT02443116|566083340|FG003|Part 1|Lost to Follow-up|0|||
156818325|NCT02443116|566083341|FG004|Part 1|Lost to Follow-up|0|||
156818326|NCT02443116|566083342|FG005|Part 1|Lost to Follow-up|0|||
156818327|NCT02443116|566083343|FG006|Part 1|Lost to Follow-up|0|||
156818328|NCT02443116|566083344|FG007|Part 1|Lost to Follow-up|0|||
156818329|NCT02443116|566083345|FG008|Part 1|Lost to Follow-up|0|||
156818330|NCT02443116|566083337|FG000|Part 1|Participant moved out of state|0|||
156818331|NCT02443116|566083338|FG001|Part 1|Participant moved out of state|0|||
156818332|NCT02443116|566083339|FG002|Part 1|Participant moved out of state|1|||
156818333|NCT02443116|566083340|FG003|Part 1|Participant moved out of state|0|||
156818334|NCT02443116|566083341|FG004|Part 1|Participant moved out of state|0|||
156818335|NCT02443116|566083342|FG005|Part 1|Participant moved out of state|0|||
156818336|NCT02443116|566083343|FG006|Part 1|Participant moved out of state|0|||
157022631|NCT04015167|566835262|FG000|Overall Study|Withdrawal by Subject|2|||
157022632|NCT04015167|566835262|FG000|Overall Study|Subject went to jail|1|||
157022633|NCT03536754|566835263|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
156818337|NCT02443116|566083344|FG007|Part 1|Participant moved out of state|0|||
156818338|NCT02443116|566083345|FG008|Part 1|Participant moved out of state|0|||
156818339|NCT02443116|566083337|FG000|Part 1|Participant enrolled in another clinical trial|0|||
156818340|NCT02443116|566083338|FG001|Part 1|Participant enrolled in another clinical trial|0|||
156818341|NCT02443116|566083339|FG002|Part 1|Participant enrolled in another clinical trial|1|||
156818342|NCT02443116|566083340|FG003|Part 1|Participant enrolled in another clinical trial|0|||
156818343|NCT02443116|566083341|FG004|Part 1|Participant enrolled in another clinical trial|0|||
156818344|NCT02443116|566083342|FG005|Part 1|Participant enrolled in another clinical trial|0|||
157022634|NCT03536754|566835264|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
157150600|NCT02075255|567296594|FG002|Overall Study|Withdrawal by Subject|0|||
156818345|NCT02443116|566083343|FG006|Part 1|Participant enrolled in another clinical trial|0|||
156818346|NCT02443116|566083344|FG007|Part 1|Participant enrolled in another clinical trial|0|||
156818347|NCT02443116|566083345|FG008|Part 1|Participant enrolled in another clinical trial|0|||
156818348|NCT02443116|566083337|FG000|Part 2|Adverse Event|0|||
156818349|NCT02443116|566083338|FG001|Part 2|Adverse Event|0|||
156818350|NCT02443116|566083339|FG002|Part 2|Adverse Event|0|||
156818351|NCT02443116|566083340|FG003|Part 2|Adverse Event|0|||
156818352|NCT02443116|566083341|FG004|Part 2|Adverse Event|1|||
156818353|NCT02443116|566083342|FG005|Part 2|Adverse Event|1|||
156818354|NCT02443116|566083343|FG006|Part 2|Adverse Event|2|||
156818355|NCT02443116|566083344|FG007|Part 2|Adverse Event|0|||
156818356|NCT02443116|566083345|FG008|Part 2|Adverse Event|0|||
156818357|NCT02443116|566083337|FG000|Part 2|Withdrew informed consent|0|||
156818358|NCT02443116|566083338|FG001|Part 2|Withdrew informed consent|0|||
156818359|NCT02443116|566083339|FG002|Part 2|Withdrew informed consent|0|||
156818360|NCT02443116|566083340|FG003|Part 2|Withdrew informed consent|0|||
156818361|NCT02443116|566083341|FG004|Part 2|Withdrew informed consent|0|||
156818362|NCT02443116|566083342|FG005|Part 2|Withdrew informed consent|1|||
156818363|NCT02443116|566083343|FG006|Part 2|Withdrew informed consent|1|||
156818364|NCT02443116|566083344|FG007|Part 2|Withdrew informed consent|0|||
156818365|NCT02443116|566083345|FG008|Part 2|Withdrew informed consent|0|||
156818366|NCT02443116|566083337|FG000|Part 2|Inability to comply with protocol|0|||
156818367|NCT02443116|566083338|FG001|Part 2|Inability to comply with protocol|0|||
156818368|NCT02443116|566083339|FG002|Part 2|Inability to comply with protocol|0|||
156818369|NCT02443116|566083340|FG003|Part 2|Inability to comply with protocol|1|||
156818370|NCT02443116|566083341|FG004|Part 2|Inability to comply with protocol|0|||
156818371|NCT02443116|566083342|FG005|Part 2|Inability to comply with protocol|0|||
156818372|NCT02443116|566083343|FG006|Part 2|Inability to comply with protocol|0|||
156818373|NCT02443116|566083344|FG007|Part 2|Inability to comply with protocol|0|||
156818374|NCT02443116|566083345|FG008|Part 2|Inability to comply with protocol|0|||
156818375|NCT02443116|566083337|FG000|Part 2|Lost to Follow-up|0|||
156818376|NCT02443116|566083338|FG001|Part 2|Lost to Follow-up|0|||
156818377|NCT02443116|566083339|FG002|Part 2|Lost to Follow-up|0|||
156818378|NCT02443116|566083340|FG003|Part 2|Lost to Follow-up|1|||
156818379|NCT02443116|566083341|FG004|Part 2|Lost to Follow-up|0|||
156818380|NCT02443116|566083342|FG005|Part 2|Lost to Follow-up|0|||
156818381|NCT02443116|566083343|FG006|Part 2|Lost to Follow-up|0|||
156818382|NCT02443116|566083344|FG007|Part 2|Lost to Follow-up|0|||
156818383|NCT02443116|566083345|FG008|Part 2|Lost to Follow-up|0|||
156818384|NCT02443116|566083337|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818385|NCT02443116|566083338|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818386|NCT02443116|566083339|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818387|NCT02443116|566083340|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818388|NCT02443116|566083341|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818389|NCT02443116|566083342|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
156818390|NCT02443116|566083343|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156884389|NCT02925338|566334087|FG000|Overall Study|Participant's Decision|11|||
156818391|NCT02443116|566083344|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818392|NCT02443116|566083345|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
156818393|NCT02443116|566083337|FG000|Part 3|Adverse Event|0|||
156818394|NCT02443116|566083338|FG001|Part 3|Adverse Event|0|||
156818395|NCT02443116|566083339|FG002|Part 3|Adverse Event|0|||
156818396|NCT02443116|566083340|FG003|Part 3|Adverse Event|0|||
156818397|NCT02443116|566083341|FG004|Part 3|Adverse Event|0|||
156818398|NCT02443116|566083342|FG005|Part 3|Adverse Event|0|||
156818399|NCT02443116|566083343|FG006|Part 3|Adverse Event|0|||
156818400|NCT02443116|566083344|FG007|Part 3|Adverse Event|0|||
156818401|NCT02443116|566083345|FG008|Part 3|Adverse Event|1|||
156818402|NCT02443116|566083337|FG000|Part 3|Withdrew informed consent|0|||
156818403|NCT02443116|566083338|FG001|Part 3|Withdrew informed consent|0|||
156818404|NCT02443116|566083339|FG002|Part 3|Withdrew informed consent|0|||
156818405|NCT02443116|566083340|FG003|Part 3|Withdrew informed consent|0|||
156818406|NCT02443116|566083341|FG004|Part 3|Withdrew informed consent|0|||
156818407|NCT02443116|566083342|FG005|Part 3|Withdrew informed consent|0|||
156818408|NCT02443116|566083343|FG006|Part 3|Withdrew informed consent|0|||
156818409|NCT02443116|566083344|FG007|Part 3|Withdrew informed consent|3|||
156818410|NCT02443116|566083345|FG008|Part 3|Withdrew informed consent|2|||
156818411|NCT02443116|566083337|FG000|Part 3|Lost to Follow-up|0|||
156818412|NCT02443116|566083338|FG001|Part 3|Lost to Follow-up|0|||
156818413|NCT02443116|566083339|FG002|Part 3|Lost to Follow-up|0|||
156818414|NCT02443116|566083340|FG003|Part 3|Lost to Follow-up|0|||
156818415|NCT02443116|566083341|FG004|Part 3|Lost to Follow-up|0|||
156818416|NCT02443116|566083342|FG005|Part 3|Lost to Follow-up|0|||
156818417|NCT02443116|566083343|FG006|Part 3|Lost to Follow-up|0|||
156818418|NCT02443116|566083344|FG007|Part 3|Lost to Follow-up|1|||
156818419|NCT02443116|566083345|FG008|Part 3|Lost to Follow-up|2|||
156818420|NCT04295759|566083346|FG000|Overall Study|Lack of Efficacy|9|||
156818421|NCT04295759|566083346|FG000|Overall Study|Death|1|||
156818422|NCT04295759|566083346|FG000|Overall Study|Withdrawal by Subject|2|||
156818423|NCT04295759|566083346|FG000|Overall Study|Deemed ineligible|1|||
156818424|NCT01696981|566083347|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
156818425|NCT01696981|566083348|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
156818426|NCT01696981|566083347|FG000|Overall Study|Died Before Randomization|3|||
156884390|NCT02925338|566334088|FG001|Overall Study|Participant's Decision|7|||
156884391|NCT02925338|566334089|FG002|Overall Study|Participant's Decision|3|||
156884392|NCT02925338|566334090|FG003|Overall Study|Participant's Decision|8|||
156818427|NCT01696981|566083348|FG001|Overall Study|Died Before Randomization|8|||
156818428|NCT01696981|566083347|FG000|Overall Study|Died Before ASU (Control)|278|||
156818429|NCT01696981|566083348|FG001|Overall Study|Died Before ASU (Control)|0|||
156818430|NCT01696981|566083347|FG000|Overall Study|Refused ASU (Control)|920|||
156818431|NCT01696981|566083348|FG001|Overall Study|Refused ASU (Control)|0|||
157022635|NCT03536754|566835265|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
156818432|NCT01696981|566083347|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
156818433|NCT01696981|566083348|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
156884393|NCT02925338|566334091|FG004|Overall Study|Participant's Decision|1|||
156818434|NCT00465972|566083351|FG000|Overall Study|Withdrawal by Subject|2|||
156818435|NCT00465972|566083352|FG001|Overall Study|Withdrawal by Subject|1|||
156818436|NCT02097719|566083353|FG000|Overall Study|Subject Withdrew Consent|1|||
156818437|NCT02097719|566083354|FG001|Overall Study|Subject Withdrew Consent|0|||
156818438|NCT02097719|566083353|FG000|Overall Study|Lost to Follow-up|0|||
156818439|NCT02097719|566083354|FG001|Overall Study|Lost to Follow-up|1|||
156818440|NCT02097719|566083353|FG000|Overall Study|Adverse Event|2|||
156818441|NCT02097719|566083354|FG001|Overall Study|Adverse Event|0|||
156818442|NCT03292640|566083355|FG000|Overall Study|Withdrawal by Subject|17|||
156818443|NCT03292640|566083356|FG001|Overall Study|Withdrawal by Subject|16|||
156818444|NCT03292640|566083355|FG000|Overall Study|Adverse Event|20|||
156818445|NCT03292640|566083356|FG001|Overall Study|Adverse Event|2|||
156818446|NCT03292640|566083355|FG000|Overall Study|Lost to Follow-up|24|||
156818447|NCT03292640|566083356|FG001|Overall Study|Lost to Follow-up|24|||
156818448|NCT01108731|566083358|FG000|Overall Study|Withdrawal by Subject|1|||
156818449|NCT01108731|566083359|FG001|Overall Study|Withdrawal by Subject|1|||
156818450|NCT01108731|566083358|FG000|Overall Study|Adverse Event|3|||
156818451|NCT01108731|566083359|FG001|Overall Study|Adverse Event|3|||
156818452|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
156818453|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
156818454|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
156818455|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
156818456|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
156818457|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
156818458|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
156818459|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
156818460|NCT03479541|566083363|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
156818461|NCT03479541|566083364|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
156818462|NCT03479541|566083365|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
156818463|NCT03479541|566083366|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
156818464|NCT03479541|566083363|FG000|Home Monitoring|Lost to Follow-up|0|||
156818465|NCT03479541|566083364|FG001|Home Monitoring|Lost to Follow-up|0|||
156818466|NCT03479541|566083365|FG002|Home Monitoring|Lost to Follow-up|8|||
156818467|NCT03479541|566083366|FG003|Home Monitoring|Lost to Follow-up|12|||
156818468|NCT03479541|566083363|FG000|Home Monitoring|Withdrawal by Subject|0|||
156818469|NCT03479541|566083364|FG001|Home Monitoring|Withdrawal by Subject|0|||
156818470|NCT03479541|566083365|FG002|Home Monitoring|Withdrawal by Subject|17|||
156818471|NCT03479541|566083366|FG003|Home Monitoring|Withdrawal by Subject|30|||
156818472|NCT03479541|566083363|FG000|Home Monitoring|Early Termination - PI Decision|0|||
156818473|NCT03479541|566083364|FG001|Home Monitoring|Early Termination - PI Decision|0|||
156818474|NCT03479541|566083365|FG002|Home Monitoring|Early Termination - PI Decision|4|||
156818475|NCT03479541|566083366|FG003|Home Monitoring|Early Termination - PI Decision|6|||
156818476|NCT03110029|566083367|FG000|Overall Study|Withdrawal by Subject|1|||
156818477|NCT03110029|566083368|FG001|Overall Study|Withdrawal by Subject|1|||
156818478|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
156818479|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
156818480|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
156818481|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
156818482|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
156818483|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
156818484|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
156818485|NCT01673854|566083370|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
156818486|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
156818487|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
156818488|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
156818489|NCT01673854|566083370|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
156818490|NCT00489424|566085320|FG000|Overall Study|Adverse Event|3|||
156818491|NCT00489424|566085321|FG001|Overall Study|Adverse Event|3|||
156818492|NCT00489424|566085322|FG002|Overall Study|Adverse Event|4|||
157022636|NCT03536754|566835266|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
157022637|NCT03536754|566835267|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
156818493|NCT00489424|566085320|FG000|Overall Study|Lack of Efficacy|1|||
156818494|NCT00489424|566085321|FG001|Overall Study|Lack of Efficacy|0|||
156818495|NCT00489424|566085322|FG002|Overall Study|Lack of Efficacy|0|||
156818496|NCT00489424|566085320|FG000|Overall Study|Administrative problems|0|||
156818497|NCT00489424|566085321|FG001|Overall Study|Administrative problems|2|||
156884394|NCT02925338|566334087|FG000|Overall Study|Treatment Discontinuation|144|||
156884395|NCT02925338|566334088|FG001|Overall Study|Treatment Discontinuation|65|||
156818498|NCT00489424|566085322|FG002|Overall Study|Administrative problems|1|||
156818499|NCT01436656|566085323|FG000|Dose Escalation|Death|1|||
156818500|NCT01436656|566085324|FG001|Dose Escalation|Death|3|||
156818501|NCT01436656|566085325|FG002|Dose Escalation|Death|1|||
156818502|NCT01436656|566085326|FG003|Dose Escalation|Death|0|||
156818503|NCT01436656|566085327|FG004|Dose Escalation|Death|2|||
156818504|NCT01436656|566085328|FG005|Dose Escalation|Death|1|||
156818505|NCT01436656|566085329|FG006|Dose Escalation|Death|1|||
156818506|NCT01436656|566085330|FG007|Dose Escalation|Death|1|||
156818507|NCT01436656|566085331|FG008|Dose Escalation|Death|1|||
156818508|NCT01436656|566085332|FG009|Dose Escalation|Death|0|||
156818509|NCT01436656|566085333|FG010|Dose Escalation|Death|0|||
156818510|NCT01436656|566085334|FG011|Dose Escalation|Death|0|||
156818511|NCT01436656|566085335|FG012|Dose Escalation|Death|0|||
156818512|NCT01436656|566085336|FG013|Dose Escalation|Death|0|||
156818513|NCT01436656|566085337|FG014|Dose Escalation|Death|0|||
156818514|NCT01436656|566085338|FG015|Dose Escalation|Death|0|||
156818515|NCT01436656|566085339|FG016|Dose Escalation|Death|0|||
156818516|NCT01436656|566085340|FG017|Dose Escalation|Death|0|||
156818517|NCT01436656|566085323|FG000|Dose Escalation|Protocol Violation|0|||
156818518|NCT01436656|566085324|FG001|Dose Escalation|Protocol Violation|0|||
156818519|NCT01436656|566085325|FG002|Dose Escalation|Protocol Violation|0|||
156818520|NCT01436656|566085326|FG003|Dose Escalation|Protocol Violation|0|||
156818521|NCT01436656|566085327|FG004|Dose Escalation|Protocol Violation|0|||
156818522|NCT01436656|566085328|FG005|Dose Escalation|Protocol Violation|1|||
156818523|NCT01436656|566085329|FG006|Dose Escalation|Protocol Violation|0|||
156818524|NCT01436656|566085330|FG007|Dose Escalation|Protocol Violation|0|||
156818525|NCT01436656|566085331|FG008|Dose Escalation|Protocol Violation|0|||
156818526|NCT01436656|566085332|FG009|Dose Escalation|Protocol Violation|0|||
156818527|NCT01436656|566085333|FG010|Dose Escalation|Protocol Violation|0|||
156818528|NCT01436656|566085334|FG011|Dose Escalation|Protocol Violation|0|||
156818529|NCT01436656|566085335|FG012|Dose Escalation|Protocol Violation|0|||
156818530|NCT01436656|566085336|FG013|Dose Escalation|Protocol Violation|0|||
156818531|NCT01436656|566085337|FG014|Dose Escalation|Protocol Violation|0|||
156818532|NCT01436656|566085338|FG015|Dose Escalation|Protocol Violation|0|||
156818533|NCT01436656|566085339|FG016|Dose Escalation|Protocol Violation|0|||
156818534|NCT01436656|566085340|FG017|Dose Escalation|Protocol Violation|0|||
156818535|NCT01436656|566085323|FG000|Dose Escalation|Withdrawal by Subject|0|||
156818536|NCT01436656|566085324|FG001|Dose Escalation|Withdrawal by Subject|0|||
156818537|NCT01436656|566085325|FG002|Dose Escalation|Withdrawal by Subject|0|||
156818538|NCT01436656|566085326|FG003|Dose Escalation|Withdrawal by Subject|0|||
156818539|NCT01436656|566085327|FG004|Dose Escalation|Withdrawal by Subject|1|||
156818540|NCT01436656|566085328|FG005|Dose Escalation|Withdrawal by Subject|0|||
156818541|NCT01436656|566085329|FG006|Dose Escalation|Withdrawal by Subject|0|||
156818542|NCT01436656|566085330|FG007|Dose Escalation|Withdrawal by Subject|2|||
156818543|NCT01436656|566085331|FG008|Dose Escalation|Withdrawal by Subject|0|||
156818544|NCT01436656|566085332|FG009|Dose Escalation|Withdrawal by Subject|1|||
156818545|NCT01436656|566085333|FG010|Dose Escalation|Withdrawal by Subject|1|||
156818546|NCT01436656|566085334|FG011|Dose Escalation|Withdrawal by Subject|0|||
156818547|NCT01436656|566085335|FG012|Dose Escalation|Withdrawal by Subject|0|||
156818548|NCT01436656|566085336|FG013|Dose Escalation|Withdrawal by Subject|0|||
156818549|NCT01436656|566085337|FG014|Dose Escalation|Withdrawal by Subject|0|||
156818550|NCT01436656|566085338|FG015|Dose Escalation|Withdrawal by Subject|0|||
156818551|NCT01436656|566085339|FG016|Dose Escalation|Withdrawal by Subject|0|||
156818552|NCT01436656|566085340|FG017|Dose Escalation|Withdrawal by Subject|0|||
156818553|NCT01436656|566085323|FG000|Dose Escalation|Administrative problems|0|||
156818554|NCT01436656|566085324|FG001|Dose Escalation|Administrative problems|1|||
156818555|NCT01436656|566085325|FG002|Dose Escalation|Administrative problems|0|||
156818556|NCT01436656|566085326|FG003|Dose Escalation|Administrative problems|0|||
156818557|NCT01436656|566085327|FG004|Dose Escalation|Administrative problems|0|||
156818558|NCT01436656|566085328|FG005|Dose Escalation|Administrative problems|0|||
156818559|NCT01436656|566085329|FG006|Dose Escalation|Administrative problems|0|||
156818560|NCT01436656|566085330|FG007|Dose Escalation|Administrative problems|0|||
156818561|NCT01436656|566085331|FG008|Dose Escalation|Administrative problems|0|||
157150601|NCT02075255|567296592|FG000|Overall Study|Lost to Follow-up|0|||
157150602|NCT02075255|567296593|FG001|Overall Study|Lost to Follow-up|0|||
157150603|NCT02075255|567296594|FG002|Overall Study|Lost to Follow-up|1|||
157150604|NCT02075255|567296592|FG000|Overall Study|Adverse Event|0|||
156818562|NCT01436656|566085332|FG009|Dose Escalation|Administrative problems|0|||
156818563|NCT01436656|566085333|FG010|Dose Escalation|Administrative problems|0|||
156818564|NCT01436656|566085334|FG011|Dose Escalation|Administrative problems|0|||
156818565|NCT01436656|566085335|FG012|Dose Escalation|Administrative problems|0|||
156818566|NCT01436656|566085336|FG013|Dose Escalation|Administrative problems|0|||
157150605|NCT02075255|567296593|FG001|Overall Study|Adverse Event|0|||
156818567|NCT01436656|566085337|FG014|Dose Escalation|Administrative problems|0|||
156818568|NCT01436656|566085338|FG015|Dose Escalation|Administrative problems|0|||
156818569|NCT01436656|566085339|FG016|Dose Escalation|Administrative problems|0|||
156818570|NCT01436656|566085340|FG017|Dose Escalation|Administrative problems|0|||
156818571|NCT01436656|566085323|FG000|Dose Escalation|Lost to Follow-up|1|||
156818572|NCT01436656|566085324|FG001|Dose Escalation|Lost to Follow-up|0|||
156818573|NCT01436656|566085325|FG002|Dose Escalation|Lost to Follow-up|0|||
156818574|NCT01436656|566085326|FG003|Dose Escalation|Lost to Follow-up|0|||
157150606|NCT02075255|567296594|FG002|Overall Study|Adverse Event|1|||
156818575|NCT01436656|566085327|FG004|Dose Escalation|Lost to Follow-up|1|||
156818576|NCT01436656|566085328|FG005|Dose Escalation|Lost to Follow-up|0|||
156818577|NCT01436656|566085329|FG006|Dose Escalation|Lost to Follow-up|0|||
156818578|NCT01436656|566085330|FG007|Dose Escalation|Lost to Follow-up|0|||
156818579|NCT01436656|566085331|FG008|Dose Escalation|Lost to Follow-up|0|||
156818580|NCT01436656|566085332|FG009|Dose Escalation|Lost to Follow-up|0|||
156818581|NCT01436656|566085333|FG010|Dose Escalation|Lost to Follow-up|0|||
156818582|NCT01436656|566085334|FG011|Dose Escalation|Lost to Follow-up|0|||
156818583|NCT01436656|566085335|FG012|Dose Escalation|Lost to Follow-up|0|||
156818584|NCT01436656|566085336|FG013|Dose Escalation|Lost to Follow-up|0|||
156818585|NCT01436656|566085337|FG014|Dose Escalation|Lost to Follow-up|0|||
156818586|NCT01436656|566085338|FG015|Dose Escalation|Lost to Follow-up|0|||
156818587|NCT01436656|566085339|FG016|Dose Escalation|Lost to Follow-up|0|||
156818588|NCT01436656|566085340|FG017|Dose Escalation|Lost to Follow-up|0|||
156818589|NCT01436656|566085323|FG000|Dose Escalation|New anti-cancer therapy|1|||
156818590|NCT01436656|566085324|FG001|Dose Escalation|New anti-cancer therapy|0|||
156818591|NCT01436656|566085325|FG002|Dose Escalation|New anti-cancer therapy|0|||
156818592|NCT01436656|566085326|FG003|Dose Escalation|New anti-cancer therapy|0|||
156818593|NCT01436656|566085327|FG004|Dose Escalation|New anti-cancer therapy|0|||
156818594|NCT01436656|566085328|FG005|Dose Escalation|New anti-cancer therapy|0|||
156818595|NCT01436656|566085329|FG006|Dose Escalation|New anti-cancer therapy|0|||
156818596|NCT01436656|566085330|FG007|Dose Escalation|New anti-cancer therapy|0|||
156818597|NCT01436656|566085331|FG008|Dose Escalation|New anti-cancer therapy|1|||
156818598|NCT01436656|566085332|FG009|Dose Escalation|New anti-cancer therapy|1|||
156818599|NCT01436656|566085333|FG010|Dose Escalation|New anti-cancer therapy|0|||
156818600|NCT01436656|566085334|FG011|Dose Escalation|New anti-cancer therapy|0|||
156818601|NCT01436656|566085335|FG012|Dose Escalation|New anti-cancer therapy|0|||
156818602|NCT01436656|566085336|FG013|Dose Escalation|New anti-cancer therapy|0|||
156818603|NCT01436656|566085337|FG014|Dose Escalation|New anti-cancer therapy|0|||
156818604|NCT01436656|566085338|FG015|Dose Escalation|New anti-cancer therapy|0|||
156818605|NCT01436656|566085339|FG016|Dose Escalation|New anti-cancer therapy|0|||
156818606|NCT01436656|566085340|FG017|Dose Escalation|New anti-cancer therapy|0|||
156818607|NCT01436656|566085323|FG000|Dose Expansion|Adverse Event|0|||
156818608|NCT01436656|566085324|FG001|Dose Expansion|Adverse Event|0|||
156818609|NCT01436656|566085325|FG002|Dose Expansion|Adverse Event|0|||
156818610|NCT01436656|566085326|FG003|Dose Expansion|Adverse Event|0|||
156818611|NCT01436656|566085327|FG004|Dose Expansion|Adverse Event|0|||
156818612|NCT01436656|566085328|FG005|Dose Expansion|Adverse Event|0|||
156818613|NCT01436656|566085329|FG006|Dose Expansion|Adverse Event|0|||
156818614|NCT01436656|566085330|FG007|Dose Expansion|Adverse Event|0|||
156818615|NCT01436656|566085331|FG008|Dose Expansion|Adverse Event|0|||
156818616|NCT01436656|566085332|FG009|Dose Expansion|Adverse Event|0|||
156818617|NCT01436656|566085333|FG010|Dose Expansion|Adverse Event|0|||
156818618|NCT01436656|566085334|FG011|Dose Expansion|Adverse Event|1|||
156818619|NCT01436656|566085335|FG012|Dose Expansion|Adverse Event|0|||
156818620|NCT01436656|566085336|FG013|Dose Expansion|Adverse Event|0|||
156818621|NCT01436656|566085337|FG014|Dose Expansion|Adverse Event|0|||
156818622|NCT01436656|566085338|FG015|Dose Expansion|Adverse Event|0|||
156818623|NCT01436656|566085339|FG016|Dose Expansion|Adverse Event|0|||
156818624|NCT01436656|566085340|FG017|Dose Expansion|Adverse Event|0|||
156818625|NCT01436656|566085323|FG000|Dose Expansion|Withdrawal by Subject|0|||
156818626|NCT01436656|566085324|FG001|Dose Expansion|Withdrawal by Subject|0|||
156818627|NCT01436656|566085325|FG002|Dose Expansion|Withdrawal by Subject|0|||
156818628|NCT01436656|566085326|FG003|Dose Expansion|Withdrawal by Subject|0|||
156818629|NCT01436656|566085327|FG004|Dose Expansion|Withdrawal by Subject|0|||
156818630|NCT01436656|566085328|FG005|Dose Expansion|Withdrawal by Subject|0|||
157150607|NCT02075255|567296592|FG000|Overall Study|Death|0|||
157150608|NCT02075255|567296593|FG001|Overall Study|Death|2|||
157150609|NCT02075255|567296594|FG002|Overall Study|Death|0|||
156818631|NCT01436656|566085329|FG006|Dose Expansion|Withdrawal by Subject|0|||
156818632|NCT01436656|566085330|FG007|Dose Expansion|Withdrawal by Subject|0|||
156818633|NCT01436656|566085331|FG008|Dose Expansion|Withdrawal by Subject|0|||
156818634|NCT01436656|566085332|FG009|Dose Expansion|Withdrawal by Subject|0|||
157150610|NCT03792750|567296595|FG000|Overall Study|Death|3|||
156818635|NCT01436656|566085333|FG010|Dose Expansion|Withdrawal by Subject|0|||
156818636|NCT01436656|566085334|FG011|Dose Expansion|Withdrawal by Subject|1|||
156818637|NCT01436656|566085335|FG012|Dose Expansion|Withdrawal by Subject|3|||
156818638|NCT01436656|566085336|FG013|Dose Expansion|Withdrawal by Subject|1|||
156818639|NCT01436656|566085337|FG014|Dose Expansion|Withdrawal by Subject|2|||
156818640|NCT01436656|566085338|FG015|Dose Expansion|Withdrawal by Subject|0|||
156818641|NCT01436656|566085339|FG016|Dose Expansion|Withdrawal by Subject|1|||
157022638|NCT03536754|566835263|FG000|Open Label Extension|Other|0|||
156818642|NCT01436656|566085340|FG017|Dose Expansion|Withdrawal by Subject|1|||
156818643|NCT01436656|566085323|FG000|Dose Expansion|Death|0|||
157022639|NCT03536754|566835264|FG001|Open Label Extension|Other|0|||
157150611|NCT01651052|567296596|FG000|Overall Study|Death|21|||
157022640|NCT03536754|566835265|FG002|Open Label Extension|Other|0|||
157150612|NCT01651052|567296596|FG000|Overall Study|Explant|1|||
157022641|NCT03536754|566835266|FG003|Open Label Extension|Other|0|||
157022642|NCT03536754|566835267|FG004|Open Label Extension|Other|1|||
157022643|NCT03382652|566835270|FG000|Overall Study|Lost to Follow-up|6|||
157022644|NCT03382652|566835270|FG000|Overall Study|Death|4|||
157022645|NCT03382652|566835270|FG000|Overall Study|Revision|5|||
157022646|NCT03382652|566835270|FG000|Overall Study|Patient withdrew|3|||
157022647|NCT03382652|566835270|FG000|Overall Study|Other reasons|21|||
157022648|NCT04810650|566835272|FG000|Overall Study|Disenrolled in error|0|||
157022649|NCT04810650|566835273|FG001|Overall Study|Disenrolled in error|0|||
157022650|NCT04810650|566835274|FG002|Overall Study|Disenrolled in error|0|||
157022651|NCT04810650|566835275|FG003|Overall Study|Disenrolled in error|0|||
157022652|NCT04810650|566835276|FG004|Overall Study|Disenrolled in error|0|||
157022653|NCT04810650|566835277|FG005|Overall Study|Disenrolled in error|0|||
157022654|NCT04810650|566835278|FG006|Overall Study|Disenrolled in error|0|||
157022655|NCT04810650|566835279|FG007|Overall Study|Disenrolled in error|0|||
157022656|NCT04810650|566835280|FG008|Overall Study|Disenrolled in error|1|||
157022657|NCT04810650|566835281|FG009|Overall Study|Disenrolled in error|0|||
157022658|NCT04810650|566835282|FG010|Overall Study|Disenrolled in error|0|||
157022659|NCT04810650|566835283|FG011|Overall Study|Disenrolled in error|0|||
157022660|NCT04810650|566835284|FG012|Overall Study|Disenrolled in error|0|||
157022661|NCT04810650|566835285|FG013|Overall Study|Disenrolled in error|0|||
157022662|NCT04810650|566835272|FG000|Overall Study|Death|0|||
157022663|NCT04810650|566835273|FG001|Overall Study|Death|0|||
157022664|NCT04810650|566835274|FG002|Overall Study|Death|0|||
157022665|NCT04810650|566835275|FG003|Overall Study|Death|0|||
157022666|NCT04810650|566835276|FG004|Overall Study|Death|0|||
156818644|NCT01436656|566085324|FG001|Dose Expansion|Death|0|||
156818645|NCT01436656|566085325|FG002|Dose Expansion|Death|0|||
156818646|NCT01436656|566085326|FG003|Dose Expansion|Death|0|||
156818647|NCT01436656|566085327|FG004|Dose Expansion|Death|0|||
156818648|NCT01436656|566085328|FG005|Dose Expansion|Death|0|||
156818649|NCT01436656|566085329|FG006|Dose Expansion|Death|0|||
156818650|NCT01436656|566085330|FG007|Dose Expansion|Death|0|||
156818651|NCT01436656|566085331|FG008|Dose Expansion|Death|0|||
156818652|NCT01436656|566085332|FG009|Dose Expansion|Death|0|||
156818653|NCT01436656|566085333|FG010|Dose Expansion|Death|0|||
156818654|NCT01436656|566085334|FG011|Dose Expansion|Death|0|||
156818655|NCT01436656|566085335|FG012|Dose Expansion|Death|1|||
156818656|NCT01436656|566085336|FG013|Dose Expansion|Death|0|||
156818657|NCT01436656|566085337|FG014|Dose Expansion|Death|3|||
156818658|NCT01436656|566085338|FG015|Dose Expansion|Death|0|||
156818659|NCT01436656|566085339|FG016|Dose Expansion|Death|3|||
156818660|NCT01436656|566085340|FG017|Dose Expansion|Death|3|||
156818661|NCT01436656|566085323|FG000|Dose Expansion|Lost to Follow-up|0|||
156818662|NCT01436656|566085324|FG001|Dose Expansion|Lost to Follow-up|0|||
156818663|NCT01436656|566085325|FG002|Dose Expansion|Lost to Follow-up|0|||
156818664|NCT01436656|566085326|FG003|Dose Expansion|Lost to Follow-up|0|||
156818665|NCT01436656|566085327|FG004|Dose Expansion|Lost to Follow-up|0|||
156818666|NCT01436656|566085328|FG005|Dose Expansion|Lost to Follow-up|0|||
156818667|NCT01436656|566085329|FG006|Dose Expansion|Lost to Follow-up|0|||
156818668|NCT01436656|566085330|FG007|Dose Expansion|Lost to Follow-up|0|||
157022667|NCT04810650|566835277|FG005|Overall Study|Death|0|||
157022668|NCT04810650|566835278|FG006|Overall Study|Death|2|||
157022669|NCT04810650|566835279|FG007|Overall Study|Death|2|||
157022670|NCT04810650|566835280|FG008|Overall Study|Death|0|||
157022671|NCT04810650|566835281|FG009|Overall Study|Death|1|||
157022672|NCT04810650|566835282|FG010|Overall Study|Death|0|||
157022673|NCT04810650|566835283|FG011|Overall Study|Death|0|||
157022674|NCT04810650|566835284|FG012|Overall Study|Death|2|||
157022675|NCT04810650|566835285|FG013|Overall Study|Death|1|||
157022676|NCT04810650|566835272|FG000|Overall Study|Moved/transferred care|0|||
156818669|NCT01436656|566085331|FG008|Dose Expansion|Lost to Follow-up|0|||
156818670|NCT01436656|566085332|FG009|Dose Expansion|Lost to Follow-up|0|||
156818671|NCT01436656|566085333|FG010|Dose Expansion|Lost to Follow-up|0|||
156818672|NCT01436656|566085334|FG011|Dose Expansion|Lost to Follow-up|0|||
156818673|NCT01436656|566085335|FG012|Dose Expansion|Lost to Follow-up|0|||
156818674|NCT01436656|566085336|FG013|Dose Expansion|Lost to Follow-up|0|||
156818675|NCT01436656|566085337|FG014|Dose Expansion|Lost to Follow-up|0|||
156818676|NCT01436656|566085338|FG015|Dose Expansion|Lost to Follow-up|0|||
156818677|NCT01436656|566085339|FG016|Dose Expansion|Lost to Follow-up|0|||
156818678|NCT01436656|566085340|FG017|Dose Expansion|Lost to Follow-up|3|||
156818679|NCT01436656|566085323|FG000|Dose Expansion|Disease progression|0|||
157022677|NCT04810650|566835273|FG001|Overall Study|Moved/transferred care|0|||
157022678|NCT04810650|566835274|FG002|Overall Study|Moved/transferred care|0|||
157022679|NCT04810650|566835275|FG003|Overall Study|Moved/transferred care|0|||
157022680|NCT04810650|566835276|FG004|Overall Study|Moved/transferred care|0|||
157022681|NCT04810650|566835277|FG005|Overall Study|Moved/transferred care|0|||
157022682|NCT04810650|566835278|FG006|Overall Study|Moved/transferred care|0|||
157022683|NCT04810650|566835279|FG007|Overall Study|Moved/transferred care|1|||
157022684|NCT04810650|566835280|FG008|Overall Study|Moved/transferred care|12|||
157022685|NCT04810650|566835281|FG009|Overall Study|Moved/transferred care|10|||
157022686|NCT04810650|566835282|FG010|Overall Study|Moved/transferred care|0|||
157150613|NCT01651052|567296596|FG000|Overall Study|Withdrawal by Subject|1|||
157150614|NCT01651052|567296596|FG000|Overall Study|Lost to Follow-up|3|||
157150615|NCT03503773|567296597|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
157150616|NCT03503773|567296598|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
157150617|NCT03503773|567296597|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
157150618|NCT03503773|567296598|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
156818680|NCT01436656|566085324|FG001|Dose Expansion|Disease progression|0|||
156818681|NCT01436656|566085325|FG002|Dose Expansion|Disease progression|0|||
156818682|NCT01436656|566085326|FG003|Dose Expansion|Disease progression|0|||
156818683|NCT01436656|566085327|FG004|Dose Expansion|Disease progression|0|||
156818684|NCT01436656|566085328|FG005|Dose Expansion|Disease progression|0|||
156818685|NCT01436656|566085329|FG006|Dose Expansion|Disease progression|0|||
156818686|NCT01436656|566085330|FG007|Dose Expansion|Disease progression|0|||
156818687|NCT01436656|566085331|FG008|Dose Expansion|Disease progression|0|||
156818688|NCT01436656|566085332|FG009|Dose Expansion|Disease progression|0|||
156818689|NCT01436656|566085333|FG010|Dose Expansion|Disease progression|0|||
156818690|NCT01436656|566085334|FG011|Dose Expansion|Disease progression|3|||
156818691|NCT01436656|566085335|FG012|Dose Expansion|Disease progression|1|||
156818692|NCT01436656|566085336|FG013|Dose Expansion|Disease progression|0|||
156818693|NCT01436656|566085337|FG014|Dose Expansion|Disease progression|1|||
156818694|NCT01436656|566085338|FG015|Dose Expansion|Disease progression|0|||
156818695|NCT01436656|566085339|FG016|Dose Expansion|Disease progression|0|||
156818696|NCT01436656|566085340|FG017|Dose Expansion|Disease progression|1|||
156818697|NCT01436656|566085323|FG000|Dose Expansion|New cancer therapy|0|||
156818698|NCT01436656|566085324|FG001|Dose Expansion|New cancer therapy|0|||
156818699|NCT01436656|566085325|FG002|Dose Expansion|New cancer therapy|0|||
156818700|NCT01436656|566085326|FG003|Dose Expansion|New cancer therapy|0|||
156818701|NCT01436656|566085327|FG004|Dose Expansion|New cancer therapy|0|||
156818702|NCT01436656|566085328|FG005|Dose Expansion|New cancer therapy|0|||
156818703|NCT01436656|566085329|FG006|Dose Expansion|New cancer therapy|0|||
156818704|NCT01436656|566085330|FG007|Dose Expansion|New cancer therapy|0|||
156818705|NCT01436656|566085331|FG008|Dose Expansion|New cancer therapy|0|||
156818706|NCT01436656|566085332|FG009|Dose Expansion|New cancer therapy|0|||
156818707|NCT01436656|566085333|FG010|Dose Expansion|New cancer therapy|0|||
156818708|NCT01436656|566085334|FG011|Dose Expansion|New cancer therapy|1|||
156818709|NCT01436656|566085335|FG012|Dose Expansion|New cancer therapy|1|||
156818710|NCT01436656|566085336|FG013|Dose Expansion|New cancer therapy|0|||
156818711|NCT01436656|566085337|FG014|Dose Expansion|New cancer therapy|2|||
156818712|NCT01436656|566085338|FG015|Dose Expansion|New cancer therapy|0|||
156818713|NCT01436656|566085339|FG016|Dose Expansion|New cancer therapy|0|||
156818714|NCT01436656|566085340|FG017|Dose Expansion|New cancer therapy|0|||
156818715|NCT00705250|566085343|FG000|Overall Study|Withdrawal by Subject|1|||
156818716|NCT00705250|566085343|FG000|Overall Study|Patient died in car accident|1|||
156818717|NCT00880269|566085344|FG000|Overall Study|Protocol Violation|1|||
156818718|NCT00880269|566085345|FG001|Overall Study|Protocol Violation|0|||
156818719|NCT00880269|566085344|FG000|Overall Study|Disease Progression|13|||
156818720|NCT00880269|566085345|FG001|Overall Study|Disease Progression|11|||
156818721|NCT00880269|566085344|FG000|Overall Study|New Cancer Therapy|1|||
156818722|NCT00880269|566085345|FG001|Overall Study|New Cancer Therapy|0|||
156818723|NCT00880269|566085344|FG000|Overall Study|Death|4|||
156818724|NCT00880269|566085345|FG001|Overall Study|Death|2|||
156818725|NCT00880269|566085344|FG000|Overall Study|Lost to Follow-up|0|||
156818726|NCT00880269|566085345|FG001|Overall Study|Lost to Follow-up|1|||
156818727|NCT00880269|566085344|FG000|Overall Study|Withdrawal by Subject|3|||
156818728|NCT00880269|566085345|FG001|Overall Study|Withdrawal by Subject|4|||
156818729|NCT00880269|566085344|FG000|Overall Study|Adverse Event|10|||
156818730|NCT00880269|566085345|FG001|Overall Study|Adverse Event|9|||
156818731|NCT00962741|566085350|FG000|Overall Study|Failed to return|3|||
157150619|NCT03503773|567296597|FG000|Overall Study|Not completing the primary ABPM|3|||
156818732|NCT00962741|566085350|FG000|Overall Study|Lost to Follow-up|2|||
156818733|NCT00962741|566085350|FG000|Overall Study|Withdrawal by Subject|1|||
156818734|NCT00962741|566085350|FG000|Overall Study|Lack of Efficacy|1|||
156818735|NCT00962741|566085350|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
156818736|NCT00316225|566085351|FG000|Overall Study|Adverse Event|2|||
156818737|NCT00316225|566085351|FG000|Overall Study|Physician Decision|3|||
156818738|NCT00316225|566085351|FG000|Overall Study|Progressive Disease|15|||
156818739|NCT00316225|566085351|FG000|Overall Study|Withdrawal by Subject|3|||
156818740|NCT00316225|566085351|FG000|Overall Study|Death|2|||
156818741|NCT01814878|566085353|FG000|Overall Study|Adverse Event|16|||
156818742|NCT01814878|566085354|FG001|Overall Study|Adverse Event|5|||
157150620|NCT03503773|567296598|FG001|Overall Study|Not completing the primary ABPM|1|||
156818743|NCT01814878|566085353|FG000|Overall Study|Withdrawal by Subject|20|||
156818744|NCT01814878|566085354|FG001|Overall Study|Withdrawal by Subject|16|||
156818745|NCT01814878|566085353|FG000|Overall Study|Protocol Violation|5|||
156818746|NCT01814878|566085354|FG001|Overall Study|Protocol Violation|5|||
156818747|NCT01814878|566085353|FG000|Overall Study|Physician Decision|3|||
156818748|NCT01814878|566085354|FG001|Overall Study|Physician Decision|1|||
156818749|NCT01814878|566085353|FG000|Overall Study|Screening failure (drop-out)|0|||
157150621|NCT03503773|567296597|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
157150622|NCT03503773|567296598|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
157150623|NCT00425438|567296602|FG000|Overall Study|Termination by Sponsor|25|||
157150624|NCT00425438|567296603|FG001|Overall Study|Termination by Sponsor|27|||
157150625|NCT02902809|567296606|FG000|Overall Study|Discontinuation of asthma program|28|||
157150626|NCT00532259|567296607|FG000|Overall Study|Withdrawal by Subject|2|||
157150627|NCT00532259|567296607|FG000|Overall Study|Adverse Event|1|||
156818750|NCT01814878|566085354|FG001|Overall Study|Screening failure (drop-out)|3|||
156818751|NCT01814878|566085353|FG000|Overall Study|Other|2|||
156818752|NCT01814878|566085354|FG001|Overall Study|Other|0|||
156818753|NCT01545934|566085355|FG000|Overall Study|Withdrawal by Subject|4|||
156818754|NCT01545934|566085356|FG001|Overall Study|Withdrawal by Subject|3|||
156818755|NCT01545934|566085355|FG000|Overall Study|Lost to Follow-up|1|||
156818756|NCT01545934|566085356|FG001|Overall Study|Lost to Follow-up|0|||
156818757|NCT03654404|566085357|FG000|Overall Study|Death|1|||
156818758|NCT03654404|566085357|FG000|Overall Study|Lost to Follow-up|2|||
156818759|NCT03654404|566085357|FG000|Overall Study|Withdrawal by Subject|5|||
156818760|NCT02003638|566085364|FG000|Overall Study|Withdrawal by Subject|1|||
156818761|NCT02003638|566085365|FG001|Overall Study|Withdrawal by Subject|0|||
156818762|NCT00654745|566085368|FG000|Overall Study|Adverse Event|12|||
156818763|NCT00654745|566085368|FG000|Overall Study|Lost to Follow-up|7|||
156818764|NCT00654745|566085368|FG000|Overall Study|Protocol Violation|11|||
156818765|NCT00654745|566085368|FG000|Overall Study|Withdrawal by Subject|10|||
156818766|NCT00654745|566085368|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
156818767|NCT04551963|566085369|FG000|Overall Study|Physician Decision|1|||
156818768|NCT04551963|566085370|FG001|Overall Study|Physician Decision|1|||
156818769|NCT04551963|566085369|FG000|Overall Study|Death|1|||
156818770|NCT04551963|566085370|FG001|Overall Study|Death|0|||
156818771|NCT02974855|566085371|FG000|Overall Study|Adverse Event|0|||
156818772|NCT02974855|566085372|FG001|Overall Study|Adverse Event|1|||
156818773|NCT02974855|566085373|FG002|Overall Study|Adverse Event|0|||
156818774|NCT02974855|566085374|FG003|Overall Study|Adverse Event|1|||
156818775|NCT01474772|566085375|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
156818776|NCT01474772|566085376|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
156818777|NCT01474772|566085375|FG000|Period 1|AE not Related to Study Drug|1|||
157022687|NCT04810650|566835283|FG011|Overall Study|Moved/transferred care|0|||
156818778|NCT01474772|566085376|FG001|Period 1|AE not Related to Study Drug|0|||
156818779|NCT01474772|566085375|FG000|Period 1|Withdrawal by Subject|3|||
156818780|NCT01474772|566085376|FG001|Period 1|Withdrawal by Subject|1|||
156818781|NCT01474772|566085375|FG000|Period 1|Lost to Follow-up|1|||
156818782|NCT01474772|566085376|FG001|Period 1|Lost to Follow-up|0|||
156818783|NCT01474772|566085375|FG000|Period 1|Reason not Specified|1|||
156818784|NCT01474772|566085376|FG001|Period 1|Reason not Specified|1|||
156818785|NCT01474772|566085375|FG000|Washout|AE not Related to Study Drug|2|||
156818786|NCT01474772|566085376|FG001|Washout|AE not Related to Study Drug|0|||
156818787|NCT01474772|566085375|FG000|Washout|Withdrawal by Subject|1|||
156818788|NCT01474772|566085376|FG001|Washout|Withdrawal by Subject|0|||
156818789|NCT01474772|566085375|FG000|Washout|Lost to Follow-up|0|||
156818790|NCT01474772|566085376|FG001|Washout|Lost to Follow-up|1|||
156818791|NCT01474772|566085375|FG000|Washout|Reason not Specified|0|||
156818792|NCT01474772|566085376|FG001|Washout|Reason not Specified|1|||
156818793|NCT01474772|566085375|FG000|Period 2|Death|0|||
156818794|NCT01474772|566085376|FG001|Period 2|Death|1|||
156818795|NCT01474772|566085375|FG000|Period 2|AE Related to Study Drug|0|||
156818796|NCT01474772|566085376|FG001|Period 2|AE Related to Study Drug|1|||
156818797|NCT01474772|566085375|FG000|Period 2|AE not Related to Study Drug|4|||
156818798|NCT01474772|566085376|FG001|Period 2|AE not Related to Study Drug|1|||
156818799|NCT01474772|566085375|FG000|Period 2|Lack of Efficacy|1|||
156818800|NCT01474772|566085376|FG001|Period 2|Lack of Efficacy|0|||
156818801|NCT01474772|566085375|FG000|Period 2|Withdrawal by Subject|3|||
156818802|NCT01474772|566085376|FG001|Period 2|Withdrawal by Subject|4|||
156818803|NCT01474772|566085375|FG000|Period 2|Lost to Follow-up|1|||
156818804|NCT01474772|566085376|FG001|Period 2|Lost to Follow-up|1|||
156818805|NCT01474772|566085375|FG000|Period 2|Reason not Specified|0|||
157150628|NCT00532259|567296607|FG000|Overall Study|Death|1|||
157150629|NCT00532259|567296607|FG000|Overall Study|Lack of Efficacy|21|||
157150630|NCT00532259|567296607|FG000|Overall Study|Lost to Follow-up|3|||
157150631|NCT00532259|567296607|FG000|Overall Study|Physician Decision|3|||
156818806|NCT01474772|566085376|FG001|Period 2|Reason not Specified|2|||
156818807|NCT01474772|566085375|FG000|Follow-up|AE not Related to Study Drug|0|||
156818808|NCT01474772|566085376|FG001|Follow-up|AE not Related to Study Drug|1|||
156818809|NCT00748618|566085377|FG000|Overall Study|Adverse Event|1|||
156818810|NCT00748618|566085378|FG001|Overall Study|Adverse Event|0|||
156818811|NCT00466947|566085379|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
156818812|NCT00466947|566085380|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
156818813|NCT00466947|566085379|FG000|Study End Analysis Period|Adverse Event|35|||
156818814|NCT00466947|566085380|FG001|Study End Analysis Period|Adverse Event|43|||
156818815|NCT00466947|566085379|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
156818816|NCT00466947|566085380|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
156818817|NCT00466947|566085379|FG000|Study End Analysis Period|Physician Decision|29|||
156818818|NCT00466947|566085380|FG001|Study End Analysis Period|Physician Decision|29|||
156818819|NCT00466947|566085379|FG000|Study End Analysis Period|Protocol Violation|9|||
156818820|NCT00466947|566085380|FG001|Study End Analysis Period|Protocol Violation|17|||
156818821|NCT00466947|566085379|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
156818822|NCT00466947|566085380|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
156818823|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
156818824|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
156818825|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
156818826|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
156818827|NCT00466947|566085379|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
156818828|NCT00466947|566085380|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
156818829|NCT00878254|566085381|FG000|Overall Study|Physician Decision|1|||
156818830|NCT00878254|566085381|FG000|Overall Study|Death|1|||
156818831|NCT00878254|566085381|FG000|Overall Study|Withdrawal by Subject|1|||
156818832|NCT01977729|566085385|FG000|Overall Study|Study terminated|1|||
156818833|NCT00759876|566085388|FG000|Overall Study|Sponsor terminated study early|36|||
156818834|NCT01450696|566085390|FG000|Overall Study|Never Treated|1|||
156818835|NCT01450696|566085391|FG001|Overall Study|Never Treated|1|||
156818836|NCT01450696|566085390|FG000|Overall Study|Death|77|||
156818837|NCT01450696|566085391|FG001|Overall Study|Death|84|||
156818838|NCT01450696|566085390|FG000|Overall Study|Lost to Follow-up|3|||
156818839|NCT01450696|566085391|FG001|Overall Study|Lost to Follow-up|3|||
156818840|NCT01450696|566085390|FG000|Overall Study|Non-Compliance|1|||
156818841|NCT01450696|566085391|FG001|Overall Study|Non-Compliance|0|||
156818842|NCT01450696|566085390|FG000|Overall Study|Withdrawal by Subject|13|||
156818843|NCT01450696|566085391|FG001|Overall Study|Withdrawal by Subject|2|||
156818844|NCT01450696|566085390|FG000|Overall Study|Study Terminated by Sponsor|53|||
156818845|NCT01450696|566085391|FG001|Overall Study|Study Terminated by Sponsor|58|||
156818846|NCT02321319|566085393|FG000|Overall Study|Product discontinued|5|||
156818847|NCT02570152|566085396|FG000|Overall Study|Protocol Violation|2|||
156818848|NCT02570152|566085396|FG000|Overall Study|Migrated/moved from study area|13|||
156818849|NCT00853242|566085397|FG000|Overall Study|Adverse Event|0|||
156818850|NCT00853242|566085398|FG001|Overall Study|Adverse Event|1|||
156818851|NCT00853242|566085399|FG002|Overall Study|Adverse Event|1|||
156818852|NCT00853242|566085400|FG003|Overall Study|Adverse Event|0|||
156818853|NCT00853242|566085401|FG004|Overall Study|Adverse Event|3|||
156818854|NCT00853242|566085402|FG005|Overall Study|Adverse Event|1|||
156818855|NCT00853242|566085403|FG006|Overall Study|Adverse Event|1|||
156818856|NCT00853242|566085397|FG000|Overall Study|Noncompliant|0|||
156818857|NCT00853242|566085398|FG001|Overall Study|Noncompliant|0|||
156818858|NCT00853242|566085399|FG002|Overall Study|Noncompliant|0|||
156818859|NCT00853242|566085400|FG003|Overall Study|Noncompliant|0|||
156818860|NCT00853242|566085401|FG004|Overall Study|Noncompliant|1|||
156818861|NCT00853242|566085402|FG005|Overall Study|Noncompliant|0|||
156818862|NCT00853242|566085403|FG006|Overall Study|Noncompliant|0|||
156818863|NCT00853242|566085397|FG000|Overall Study|Withdrawal by Subject|1|||
156818864|NCT00853242|566085398|FG001|Overall Study|Withdrawal by Subject|2|||
156818865|NCT00853242|566085399|FG002|Overall Study|Withdrawal by Subject|0|||
156818866|NCT00853242|566085400|FG003|Overall Study|Withdrawal by Subject|4|||
156818867|NCT00853242|566085401|FG004|Overall Study|Withdrawal by Subject|0|||
156818868|NCT00853242|566085402|FG005|Overall Study|Withdrawal by Subject|0|||
156818869|NCT00853242|566085403|FG006|Overall Study|Withdrawal by Subject|2|||
156818870|NCT00853242|566085397|FG000|Overall Study|Other|2|||
156818871|NCT00853242|566085398|FG001|Overall Study|Other|0|||
156818872|NCT00853242|566085399|FG002|Overall Study|Other|2|||
156818873|NCT00853242|566085400|FG003|Overall Study|Other|0|||
156818874|NCT00853242|566085401|FG004|Overall Study|Other|0|||
156884396|NCT02925338|566334089|FG002|Overall Study|Treatment Discontinuation|56|||
157022688|NCT04810650|566835284|FG012|Overall Study|Moved/transferred care|0|||
157022689|NCT04810650|566835285|FG013|Overall Study|Moved/transferred care|0|||
156884397|NCT02925338|566334090|FG003|Overall Study|Treatment Discontinuation|131|||
156818875|NCT00853242|566085402|FG005|Overall Study|Other|1|||
156818876|NCT00853242|566085403|FG006|Overall Study|Other|2|||
156818877|NCT03497975|566085404|FG000|Overall Study|Withdrew Consent|34|||
156818878|NCT03497975|566085405|FG001|Overall Study|Withdrew Consent|35|||
156818879|NCT03497975|566085404|FG000|Overall Study|Lost to Follow-up|7|||
156818880|NCT03497975|566085405|FG001|Overall Study|Lost to Follow-up|7|||
156818881|NCT03497975|566085404|FG000|Overall Study|Physician Decision|4|||
156818882|NCT03497975|566085405|FG001|Overall Study|Physician Decision|5|||
156818883|NCT03497975|566085404|FG000|Overall Study|Discontinued|42|||
156818884|NCT03497975|566085405|FG001|Overall Study|Discontinued|39|||
156818885|NCT03497975|566085404|FG000|Overall Study|Reason Not Specified|15|||
156818886|NCT03497975|566085405|FG001|Overall Study|Reason Not Specified|14|||
156884398|NCT02925338|566334091|FG004|Overall Study|Treatment Discontinuation|22|||
156818887|NCT00606034|566085412|FG000|Overall Study|incarceration|1|||
156818888|NCT02516098|566085414|FG000|Period 1|Protocol Violation|1|||
156818889|NCT02516098|566085415|FG001|Period 1|Protocol Violation|0|||
156818890|NCT02516098|566085414|FG000|Washout After Period 1|Adverse Event|0|||
156818891|NCT02516098|566085415|FG001|Washout After Period 1|Adverse Event|1|||
156818892|NCT02516098|566085414|FG000|Period 2|Withdrawal by Subject|0|||
156818893|NCT02516098|566085415|FG001|Period 2|Withdrawal by Subject|1|||
156818894|NCT01355679|566085417|FG000|Overall Study|benign tumor types found at biopsy|2|||
156818895|NCT00964002|566085419|FG000|Overall Study|Protocol Violation|8|||
156818896|NCT02466425|566085422|FG000|Overall Study|Adverse Event|3|||
156818897|NCT02466425|566085423|FG001|Overall Study|Adverse Event|11|||
156818898|NCT02466425|566085422|FG000|Overall Study|Lack of Efficacy|4|||
156818899|NCT02466425|566085423|FG001|Overall Study|Lack of Efficacy|1|||
156818900|NCT02466425|566085422|FG000|Overall Study|Lost to Follow-up|3|||
156818901|NCT02466425|566085423|FG001|Overall Study|Lost to Follow-up|0|||
156818902|NCT02466425|566085422|FG000|Overall Study|Protocol Violation|1|||
156818903|NCT02466425|566085423|FG001|Overall Study|Protocol Violation|0|||
156818904|NCT02466425|566085422|FG000|Overall Study|Withdrawal by Subject|0|||
156818905|NCT02466425|566085423|FG001|Overall Study|Withdrawal by Subject|1|||
156818906|NCT02466425|566085422|FG000|Overall Study|Other|1|||
156818907|NCT02466425|566085423|FG001|Overall Study|Other|3|||
156818908|NCT02466425|566085422|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
156818909|NCT02466425|566085423|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156818910|NCT00582712|566085426|FG000|Overall Study|Adverse Event|1|||
156818911|NCT00582712|566085426|FG000|Overall Study|Lack of Efficacy|1|||
156818912|NCT00582712|566085426|FG000|Overall Study|Withdrawal by Subject|1|||
156818913|NCT00582712|566085426|FG000|Overall Study|Complicating disease requiring treatment|1|||
156818914|NCT05141175|566085433|FG000|Overall Study|Withdrawal by Subject|1|||
156818915|NCT01813058|566085440|FG000|Overall Study|Withdrawal by Subject|5|||
156818916|NCT01813058|566085441|FG001|Overall Study|Withdrawal by Subject|4|||
156818917|NCT03585764|566085442|FG000|Overall Study|Death|3|||
156818918|NCT03585764|566085443|FG001|Overall Study|Death|2|||
156818919|NCT03585764|566085444|FG002|Overall Study|Death|3|||
156818920|NCT03585764|566085445|FG003|Overall Study|Death|0|||
156818921|NCT03585764|566085442|FG000|Overall Study|Lost to Follow-up|0|||
156818922|NCT03585764|566085443|FG001|Overall Study|Lost to Follow-up|1|||
156818923|NCT03585764|566085444|FG002|Overall Study|Lost to Follow-up|0|||
156818924|NCT03585764|566085445|FG003|Overall Study|Lost to Follow-up|0|||
156818925|NCT03585764|566085442|FG000|Overall Study|Physician Decision|0|||
156818926|NCT03585764|566085443|FG001|Overall Study|Physician Decision|0|||
156818927|NCT03585764|566085444|FG002|Overall Study|Physician Decision|2|||
156818928|NCT03585764|566085445|FG003|Overall Study|Physician Decision|0|||
156818929|NCT01581021|566085447|FG000|Overall Study|Lost to Follow-up|4|||
156818930|NCT01581021|566085448|FG001|Overall Study|Lost to Follow-up|6|||
156818931|NCT01581021|566085447|FG000|Overall Study|More than 2 hooks in thoracic|3|||
156818932|NCT01581021|566085448|FG001|Overall Study|More than 2 hooks in thoracic|0|||
156818933|NCT01581021|566085447|FG000|Overall Study|Neuromuscular|2|||
156818934|NCT01581021|566085448|FG001|Overall Study|Neuromuscular|1|||
156818935|NCT01581021|566085447|FG000|Overall Study|Not Randomized|1|||
156818936|NCT01581021|566085448|FG001|Overall Study|Not Randomized|2|||
156818937|NCT01581021|566085447|FG000|Overall Study|Lenke 6 Classification|0|||
156818938|NCT01581021|566085448|FG001|Overall Study|Lenke 6 Classification|1|||
156818939|NCT01581021|566085447|FG000|Overall Study|Lack of Efficacy|0|||
156818940|NCT01581021|566085448|FG001|Overall Study|Lack of Efficacy|1|||
156818941|NCT03604172|566085449|FG000|Overall Study|Lost to Follow-up|1|||
156818942|NCT03604172|566085450|FG001|Overall Study|Lost to Follow-up|2|||
156818943|NCT02676895|566085451|FG000|Overall Study|Administrative reason|1|||
156818944|NCT02676895|566085452|FG001|Overall Study|Administrative reason|0|||
156818945|NCT02676895|566085453|FG002|Overall Study|Administrative reason|0|||
156818946|NCT02676895|566085451|FG000|Overall Study|Protocol Violation|1|||
156818947|NCT02676895|566085452|FG001|Overall Study|Protocol Violation|0|||
157022690|NCT04810650|566835272|FG000|Overall Study|Lost to Follow-up|15|||
156818948|NCT02676895|566085453|FG002|Overall Study|Protocol Violation|0|||
156818949|NCT02676895|566085451|FG000|Overall Study|Adverse Event|0|||
156818950|NCT02676895|566085452|FG001|Overall Study|Adverse Event|3|||
156818951|NCT02676895|566085453|FG002|Overall Study|Adverse Event|1|||
156818952|NCT02676895|566085451|FG000|Overall Study|Lost to Follow-up|0|||
156818953|NCT02676895|566085452|FG001|Overall Study|Lost to Follow-up|0|||
156818954|NCT02676895|566085453|FG002|Overall Study|Lost to Follow-up|1|||
156818955|NCT02676895|566085451|FG000|Overall Study|Withdrawal by Subject|0|||
156818956|NCT02676895|566085452|FG001|Overall Study|Withdrawal by Subject|0|||
156818957|NCT02676895|566085453|FG002|Overall Study|Withdrawal by Subject|1|||
156818958|NCT00054327|566085454|FG000|Overall Study|Engraftment failure|1|||
156818959|NCT00054327|566085455|FG001|Overall Study|Engraftment failure|0|||
156818960|NCT00054327|566085456|FG002|Overall Study|Engraftment failure|0|||
156818961|NCT00054327|566085457|FG003|Overall Study|Engraftment failure|0|||
156818962|NCT00054327|566085458|FG004|Overall Study|Engraftment failure|0|||
156818963|NCT00054327|566085459|FG005|Overall Study|Engraftment failure|0|||
156818964|NCT03028129|566085465|FG000|Overall Study|Adverse Event|13|||
156818965|NCT03028129|566085466|FG001|Overall Study|Adverse Event|2|||
156818966|NCT03028129|566085465|FG000|Overall Study|Lost to Follow-up|50|||
156818967|NCT03028129|566085466|FG001|Overall Study|Lost to Follow-up|38|||
156818968|NCT03028129|566085465|FG000|Overall Study|Physician Decision|0|||
156818969|NCT03028129|566085466|FG001|Overall Study|Physician Decision|1|||
156818970|NCT03028129|566085465|FG000|Overall Study|Protocol Violation|1|||
156818971|NCT03028129|566085466|FG001|Overall Study|Protocol Violation|1|||
156818972|NCT03028129|566085465|FG000|Overall Study|Withdrawal by Subject|62|||
156818973|NCT03028129|566085466|FG001|Overall Study|Withdrawal by Subject|45|||
156818974|NCT00923351|566085467|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
156818975|NCT00923351|566085468|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
156818976|NCT00923351|566085469|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
156818977|NCT00182078|566085470|FG000|Overall Study|Withdrawal by Subject|1|||
156818978|NCT00182078|566085471|FG001|Overall Study|Withdrawal by Subject|0|||
156818979|NCT01076205|566085472|FG000|Overall Study|Adverse Drug Reaction|299|||
156818980|NCT01076205|566085472|FG000|Overall Study|Lack of Effectiveness|1423|||
156818981|NCT01076205|566085472|FG000|Overall Study|Other Reason|1075|||
156818982|NCT01076205|566085472|FG000|Overall Study|Unknown Reason|71|||
156818983|NCT01076205|566085472|FG000|Overall Study|Lost to Follow-up|3151|||
156818984|NCT00361231|566085473|FG000|Overall Study|Physician Decision|3|||
156818985|NCT00361231|566085473|FG000|Overall Study|Symptomatic deterioration|5|||
156818986|NCT00361231|566085473|FG000|Overall Study|Radiographic disease progression|16|||
156818987|NCT00361231|566085473|FG000|Overall Study|Withdrawal by Subject|4|||
156818988|NCT00361231|566085473|FG000|Overall Study|Adverse Event|6|||
156818989|NCT01208961|566085474|FG000|High-Fat Period III|Protocol Violation|1|||
156818990|NCT01208961|566085475|FG001|High-Fat Period III|Protocol Violation|0|||
156818991|NCT03403361|566085476|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
156818992|NCT03596047|566087480|FG000|Overall Study|Withdrawal by Subject|7|||
156818993|NCT03596047|566087481|FG001|Overall Study|Withdrawal by Subject|4|||
156818994|NCT03596047|566087480|FG000|Overall Study|Lost to Follow-up|0|||
156818995|NCT03596047|566087481|FG001|Overall Study|Lost to Follow-up|2|||
156818996|NCT01696968|566087482|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
156818997|NCT01696968|566087483|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
156818998|NCT01696968|566087482|FG000|Overall Study|Died Before Randomization|3|||
156818999|NCT01696968|566087483|FG001|Overall Study|Died Before Randomization|8|||
156819000|NCT01696968|566087482|FG000|Overall Study|Died Before ASU (Control)|278|||
156819001|NCT01696968|566087483|FG001|Overall Study|Died Before ASU (Control)|0|||
156819002|NCT01696968|566087482|FG000|Overall Study|Refused ASU (Control)|920|||
156819003|NCT01696968|566087483|FG001|Overall Study|Refused ASU (Control)|0|||
156819004|NCT01696968|566087482|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
156819005|NCT01696968|566087483|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
156819006|NCT03727646|566087484|FG000|Overall Study|Adverse Event|1|||
156819007|NCT03727646|566087485|FG001|Overall Study|Adverse Event|0|||
156819008|NCT04753658|566087486|FG000|Overall Study|Progressive disease|7|||
156819009|NCT04753658|566087486|FG000|Overall Study|Other|7|||
156819010|NCT04753658|566087486|FG000|Overall Study|Adverse Event|1|||
156819011|NCT02582814|566087493|FG000|Overall Study|Study-specific withdrawal criteria|1|||
156819012|NCT02582814|566087494|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156819013|NCT02582814|566087493|FG000|Overall Study|Withdrawal by Subject|4|||
157022691|NCT04810650|566835273|FG001|Overall Study|Lost to Follow-up|12|||
157022692|NCT04810650|566835274|FG002|Overall Study|Lost to Follow-up|7|||
157022693|NCT04810650|566835275|FG003|Overall Study|Lost to Follow-up|9|||
157022694|NCT04810650|566835276|FG004|Overall Study|Lost to Follow-up|10|||
156819014|NCT02582814|566087494|FG001|Overall Study|Withdrawal by Subject|3|||
156819015|NCT02582814|566087493|FG000|Overall Study|Adverse Event|4|||
156819016|NCT02582814|566087494|FG001|Overall Study|Adverse Event|4|||
157022695|NCT04810650|566835277|FG005|Overall Study|Lost to Follow-up|6|||
157022696|NCT04810650|566835278|FG006|Overall Study|Lost to Follow-up|0|||
157022697|NCT04810650|566835279|FG007|Overall Study|Lost to Follow-up|0|||
157022698|NCT04810650|566835280|FG008|Overall Study|Lost to Follow-up|0|||
157022699|NCT04810650|566835281|FG009|Overall Study|Lost to Follow-up|0|||
157022700|NCT04810650|566835282|FG010|Overall Study|Lost to Follow-up|1|||
157022701|NCT04810650|566835283|FG011|Overall Study|Lost to Follow-up|0|||
157022702|NCT04810650|566835284|FG012|Overall Study|Lost to Follow-up|3|||
157224415|NCT02396381|567567984|FG000|Overall Study|Pregnancy|2|||
157224416|NCT02396381|567567985|FG001|Overall Study|Pregnancy|0|||
157224417|NCT02396381|567567984|FG000|Overall Study|Non-compliance with study procedures|1|||
157224418|NCT02396381|567567985|FG001|Overall Study|Non-compliance with study procedures|0|||
157224419|NCT02396381|567567984|FG000|Overall Study|Moved out of town/state|1|||
156819017|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
156819018|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
156819019|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
156819020|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
156819021|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
156819022|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
157022703|NCT04810650|566835285|FG013|Overall Study|Lost to Follow-up|9|||
157150632|NCT00532259|567296607|FG000|Overall Study|Protocol Violation|1|||
157150633|NCT02795767|567296608|FG000|Overall Study|Received Commercial Emicizumab|1|||
157150634|NCT02795767|567296609|FG001|Overall Study|Received Commercial Emicizumab|0|||
157150635|NCT02795767|567296610|FG002|Overall Study|Received Commercial Emicizumab|0|||
157150636|NCT04983940|567296611|FG000|Overall Study|Lost to Follow-up|14|||
157150637|NCT04983940|567296611|FG000|Overall Study|Lack of Efficacy|2|||
157150638|NCT01478347|567296617|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
157150639|NCT01478347|567296617|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
157224420|NCT02396381|567567985|FG001|Overall Study|Moved out of town/state|3|||
157224421|NCT02396381|567567984|FG000|Overall Study|Could not complete visit|1|||
157224422|NCT02396381|567567985|FG001|Overall Study|Could not complete visit|0|||
157224423|NCT02396381|567567984|FG000|Overall Study|Possible conflict of interest|1|||
157224424|NCT02396381|567567985|FG001|Overall Study|Possible conflict of interest|0|||
156819023|NCT00306293|566087495|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
156819024|NCT00306293|566087496|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
156819025|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
156819026|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
156819027|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
156819028|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
156819029|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
156819030|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
156819031|NCT00306293|566087495|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
156819032|NCT00306293|566087496|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
156819033|NCT00176488|566087497|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
156819034|NCT02650804|566087498|FG000|Overall Study|Adverse Event|3|||
156819035|NCT02650804|566087499|FG001|Overall Study|Adverse Event|2|||
156819036|NCT02650804|566087498|FG000|Overall Study|Death|1|||
156819037|NCT02650804|566087499|FG001|Overall Study|Death|2|||
156819038|NCT02650804|566087498|FG000|Overall Study|Progressive Disease|7|||
156819039|NCT02650804|566087499|FG001|Overall Study|Progressive Disease|10|||
156819040|NCT02650804|566087498|FG000|Overall Study|Physician Decision|0|||
156819041|NCT02650804|566087499|FG001|Overall Study|Physician Decision|2|||
156819042|NCT02650804|566087498|FG000|Overall Study|Withdrawal by Subject|1|||
156819043|NCT02650804|566087499|FG001|Overall Study|Withdrawal by Subject|4|||
156819044|NCT02650804|566087498|FG000|Overall Study|Symptomatic deterioration|5|||
156819045|NCT02650804|566087499|FG001|Overall Study|Symptomatic deterioration|7|||
156819046|NCT02650804|566087498|FG000|Overall Study|Protocol Violation|0|||
156819047|NCT02650804|566087499|FG001|Overall Study|Protocol Violation|1|||
156819048|NCT02557100|566087511|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
156819049|NCT02557100|566087512|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
156819050|NCT02557100|566087513|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
156819051|NCT02557100|566087511|FG000|Single Blind Treatment Period|Death|0|||
156819052|NCT02557100|566087512|FG001|Single Blind Treatment Period|Death|1|||
156819053|NCT02557100|566087513|FG002|Single Blind Treatment Period|Death|0|||
156819054|NCT02557100|566087511|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
156819055|NCT02557100|566087512|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
156819056|NCT02557100|566087513|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
156819057|NCT02557100|566087511|FG000|Single Blind Treatment Period|Adverse Event|0|||
156819058|NCT02557100|566087512|FG001|Single Blind Treatment Period|Adverse Event|1|||
156819059|NCT02557100|566087513|FG002|Single Blind Treatment Period|Adverse Event|0|||
156819060|NCT02557100|566087511|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
156819061|NCT02557100|566087512|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
156819062|NCT02557100|566087513|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
156819063|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Other Reasons|0|||
156819064|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Other Reasons|0|||
156819065|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Other Reasons|1|||
156819066|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
156819067|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
156819068|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
157150640|NCT01478347|567296617|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
157224425|NCT02396381|567567984|FG000|Overall Study|Randomization/Screening Error|3|||
156819069|NCT02557100|566087511|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
156819070|NCT02557100|566087512|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
156819071|NCT02557100|566087513|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
156819072|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
156819073|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
157022704|NCT04810650|566835272|FG000|Overall Study|Participant declined|0|||
156819074|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
157150641|NCT01645930|567296618|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
157150642|NCT01645930|567296618|FG000|Overall Study|Progressive Disease|12|||
157150643|NCT01645930|567296618|FG000|Overall Study|Adverse Event|4|||
156819075|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
157150644|NCT01645930|567296618|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
157150645|NCT01645930|567296618|FG000|Overall Study|Withdrawal by Participant|2|||
157150646|NCT01645930|567296618|FG000|Overall Study|Reason not Defined|1|||
157150647|NCT01748760|567296619|FG000|Overall Study|Withdrawal by Subject|1|||
157150648|NCT01748760|567296620|FG001|Overall Study|Withdrawal by Subject|1|||
157150649|NCT01748760|567296619|FG000|Overall Study|Lost to Follow-up|5|||
157150650|NCT01748760|567296620|FG001|Overall Study|Lost to Follow-up|1|||
157150651|NCT03245814|567296621|FG000|Overall Study|Lost to Follow-up|5|||
157150652|NCT03245814|567296622|FG001|Overall Study|Lost to Follow-up|8|||
157150653|NCT03245814|567296621|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
157150654|NCT03245814|567296622|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
157150655|NCT02263365|567296627|FG000|Overall Study|Physician Decision|22|||
157150656|NCT02263365|567296628|FG001|Overall Study|Physician Decision|18|||
157150657|NCT01879618|567296629|FG000|Overall Study|Does not meet entrance criteria|1|||
156819076|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
156819077|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
156819078|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
156819079|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
156819080|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
156819081|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
156819082|NCT00510718|566087516|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
156819083|NCT00510718|566087517|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
156819084|NCT04644276|566087518|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
156819085|NCT04644276|566087519|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
156819086|NCT04644276|566087520|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
156819087|NCT01576146|566087521|FG000|Extension Period 1|Adverse Event|2|||
156819088|NCT01576146|566087521|FG000|Extension Period 1|Death|2|||
156819089|NCT01576146|566087521|FG000|Extension Period 1|Physician Decision|2|||
156819090|NCT01576146|566087521|FG000|Extension Period 1|Withdrawal by Subject|1|||
156819091|NCT01576146|566087521|FG000|Extension Period 1|Lost to Follow-up|1|||
156819092|NCT01576146|566087521|FG000|Extension Period 1|Parathyroidectomy|1|||
156819093|NCT01576146|566087521|FG000|Extension Period 1|Renal Transplant|1|||
156819094|NCT01576146|566087521|FG000|Extension Period 2|Sponsor Decision|13|||
156819095|NCT01576146|566087521|FG000|Extension Period 2|Death|1|||
156819096|NCT01576146|566087521|FG000|Extension Period 2|Adverse Event|1|||
156819097|NCT01576146|566087521|FG000|Extension Period 2|Renal Transplant|1|||
156819098|NCT01576146|566087521|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
156819099|NCT01811485|566087523|FG000|Overall Study|Adverse Event|1|||
156819100|NCT01811485|566087524|FG001|Overall Study|Adverse Event|3|||
156819101|NCT01811485|566087525|FG002|Overall Study|Adverse Event|2|||
156819102|NCT01811485|566087523|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156819103|NCT01811485|566087524|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156819104|NCT01811485|566087525|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
156819105|NCT01811485|566087523|FG000|Overall Study|Administrative problems|1|||
156819106|NCT01811485|566087524|FG001|Overall Study|Administrative problems|0|||
156819107|NCT01811485|566087525|FG002|Overall Study|Administrative problems|0|||
156819108|NCT01811485|566087523|FG000|Overall Study|Protocol Deviation|0|||
156819109|NCT01811485|566087524|FG001|Overall Study|Protocol Deviation|1|||
156819110|NCT01811485|566087525|FG002|Overall Study|Protocol Deviation|0|||
156819111|NCT03299881|566087526|FG000|Overall Study|Study Termination|17|||
156819112|NCT03299881|566087527|FG001|Overall Study|Study Termination|13|||
156819113|NCT00633074|566087528|FG000|Overall Study|Adverse Event|1|||
156819114|NCT00633074|566087529|FG001|Overall Study|Adverse Event|0|||
156819115|NCT01995526|566087530|FG000|Overall Study|Physician Decision|1|||
156819116|NCT03367403|566087534|FG000|Overall Study|Adverse Event|20|||
156819117|NCT03367403|566087535|FG001|Overall Study|Adverse Event|6|||
156819118|NCT03367403|566087536|FG002|Overall Study|Adverse Event|2|||
156819119|NCT03367403|566087534|FG000|Overall Study|Withdrawal by Subject|12|||
156819120|NCT03367403|566087535|FG001|Overall Study|Withdrawal by Subject|13|||
156819121|NCT03367403|566087536|FG002|Overall Study|Withdrawal by Subject|1|||
157150658|NCT01879618|567296629|FG000|Overall Study|Withdrawal by Subject|1|||
157150659|NCT01879618|567296629|FG000|Overall Study|Surgery;changed schedule; not available|8|||
157150660|NCT01879618|567296629|FG000|Overall Study|Protocol Violation|6|||
157150661|NCT01879618|567296629|FG000|Overall Study|Adverse Event|5|||
157150662|NCT01004146|567296634|FG000|Overall Study|Withdrawal by Subject|4|||
156819122|NCT03367403|566087534|FG000|Overall Study|Death|1|||
156819123|NCT03367403|566087535|FG001|Overall Study|Death|2|||
157150663|NCT01004146|567296635|FG001|Overall Study|Withdrawal by Subject|5|||
157150664|NCT01001494|567296642|FG000|Overall Study|Adverse Event|8|||
156819124|NCT03367403|566087536|FG002|Overall Study|Death|0|||
156819125|NCT03367403|566087534|FG000|Overall Study|Physician Decision|0|||
156819126|NCT03367403|566087535|FG001|Overall Study|Physician Decision|1|||
156819127|NCT03367403|566087536|FG002|Overall Study|Physician Decision|0|||
156819128|NCT03367403|566087534|FG000|Overall Study|Protocol Violation|1|||
156819129|NCT03367403|566087535|FG001|Overall Study|Protocol Violation|1|||
156819130|NCT03367403|566087536|FG002|Overall Study|Protocol Violation|0|||
156819131|NCT03367403|566087534|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156819132|NCT03367403|566087535|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
156819133|NCT03367403|566087536|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
156819134|NCT03367403|566087534|FG000|Overall Study|COVID-19|3|||
156819135|NCT03367403|566087535|FG001|Overall Study|COVID-19|6|||
156819136|NCT03367403|566087536|FG002|Overall Study|COVID-19|0|||
156819137|NCT03367403|566087534|FG000|Overall Study|Abuse of Alcohol Intake|0|||
156819138|NCT03367403|566087535|FG001|Overall Study|Abuse of Alcohol Intake|1|||
156819139|NCT03367403|566087536|FG002|Overall Study|Abuse of Alcohol Intake|0|||
156819140|NCT03367403|566087534|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
156819141|NCT03367403|566087535|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
156819142|NCT03367403|566087536|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
156819143|NCT00194077|566087537|FG000|Overall Study|Lack of Efficacy|22|||
156819144|NCT00194077|566087538|FG001|Overall Study|Lack of Efficacy|29|||
156819145|NCT00194077|566087537|FG000|Overall Study|Study nonadherence|1|||
156819146|NCT00194077|566087538|FG001|Overall Study|Study nonadherence|0|||
156819147|NCT00194077|566087537|FG000|Overall Study|Withdrawal by Subject|1|||
156819148|NCT00194077|566087538|FG001|Overall Study|Withdrawal by Subject|1|||
156819149|NCT03470194|566087539|FG000|Overall Study|Lost to Follow-up|11|||
156819150|NCT03470194|566087540|FG001|Overall Study|Lost to Follow-up|17|||
156819151|NCT01822899|566087541|FG000|Overall Study|Adverse Event|6|||
156819152|NCT01822899|566087542|FG001|Overall Study|Adverse Event|5|||
156819153|NCT01822899|566087541|FG000|Overall Study|Lack of Efficacy|6|||
156819154|NCT01822899|566087542|FG001|Overall Study|Lack of Efficacy|3|||
156819155|NCT01822899|566087541|FG000|Overall Study|Protocol Violation|6|||
156819156|NCT01822899|566087542|FG001|Overall Study|Protocol Violation|3|||
156819157|NCT01822899|566087541|FG000|Overall Study|Lost to Follow-up|1|||
156819158|NCT01822899|566087542|FG001|Overall Study|Lost to Follow-up|0|||
156819159|NCT01822899|566087541|FG000|Overall Study|Withdrawal by Subject|5|||
156819160|NCT01822899|566087542|FG001|Overall Study|Withdrawal by Subject|7|||
156819161|NCT01734395|566087546|FG000|Overall Study|Other|65|||
156819162|NCT01734395|566087546|FG000|Overall Study|Lost to Follow-up|287|||
156819163|NCT01734395|566087546|FG000|Overall Study|Lack of Efficacy|5|||
156819164|NCT01734395|566087546|FG000|Overall Study|Adverse Event|40|||
156819165|NCT01734395|566087546|FG000|Overall Study|Withdrawal by Subject|10|||
156819166|NCT01734395|566087546|FG000|Overall Study|Missing the reasons for not completed|3|||
156819167|NCT01092780|566087547|FG000|Washout Period 1|Adverse Event|0|||
156819168|NCT01092780|566087548|FG001|Washout Period 1|Adverse Event|1|||
156819169|NCT01092780|566087549|FG002|Washout Period 1|Adverse Event|0|||
157150665|NCT01001494|567296643|FG001|Overall Study|Adverse Event|4|||
156819170|NCT01092780|566087550|FG003|Washout Period 1|Adverse Event|0|||
156819171|NCT01092780|566087547|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
156819172|NCT01092780|566087548|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
156819173|NCT01092780|566087549|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
156819174|NCT01092780|566087550|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
157150666|NCT01001494|567296644|FG002|Overall Study|Adverse Event|6|||
157150667|NCT01001494|567296642|FG000|Overall Study|Protocol Violation|0|||
157150668|NCT01001494|567296643|FG001|Overall Study|Protocol Violation|1|||
157150669|NCT01001494|567296644|FG002|Overall Study|Protocol Violation|1|||
157150670|NCT01001494|567296642|FG000|Overall Study|Lost to Follow-up|2|||
157150671|NCT01001494|567296643|FG001|Overall Study|Lost to Follow-up|0|||
157150672|NCT01001494|567296644|FG002|Overall Study|Lost to Follow-up|1|||
157150673|NCT01001494|567296642|FG000|Overall Study|Withdrawal by Subject|9|||
157150674|NCT01001494|567296643|FG001|Overall Study|Withdrawal by Subject|7|||
157150675|NCT01001494|567296644|FG002|Overall Study|Withdrawal by Subject|17|||
157150676|NCT01001494|567296642|FG000|Overall Study|COPD exacerbation|3|||
157150677|NCT01001494|567296643|FG001|Overall Study|COPD exacerbation|4|||
157150678|NCT01001494|567296644|FG002|Overall Study|COPD exacerbation|5|||
157150679|NCT01001494|567296642|FG000|Overall Study|Lack of Efficacy|2|||
157150680|NCT01001494|567296643|FG001|Overall Study|Lack of Efficacy|0|||
157150681|NCT01001494|567296644|FG002|Overall Study|Lack of Efficacy|8|||
156819175|NCT01092780|566087547|FG000|Washout Period 2|Adverse Event|0|||
156819176|NCT01092780|566087548|FG001|Washout Period 2|Adverse Event|1|||
156819177|NCT01092780|566087549|FG002|Washout Period 2|Adverse Event|1|||
156819178|NCT01092780|566087550|FG003|Washout Period 2|Adverse Event|0|||
156819179|NCT04026009|566087551|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156819180|NCT04026009|566087552|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156819181|NCT04026009|566087553|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156819182|NCT04026009|566087554|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156819183|NCT04026009|566087555|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156819184|NCT04026009|566087551|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
157150682|NCT01001494|567296642|FG000|Overall Study|Other|0|||
157150683|NCT01001494|567296643|FG001|Overall Study|Other|1|||
157150684|NCT01001494|567296644|FG002|Overall Study|Other|3|||
157150685|NCT04267562|567298070|FG000|Assessed for Eligibility|Screen Failure|64|||
157150686|NCT04267562|567298070|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
156819185|NCT04026009|566087552|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819186|NCT04026009|566087553|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819187|NCT04026009|566087554|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
156819188|NCT04026009|566087555|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
156819189|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
156819190|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
156819191|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
156819192|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
156819193|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156819194|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
156819195|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
156819196|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
156819197|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
156819198|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
156819199|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
156819200|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
156819201|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
156819202|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
156819203|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
156819204|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
156819205|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
156819206|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819207|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819208|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819209|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819210|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819211|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819212|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819213|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819214|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819215|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819216|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819217|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819218|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
156819219|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
156819220|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
156819221|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
156819222|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
156819223|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
156819224|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
156819225|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
156819226|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
156819227|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
156819228|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
156819229|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
156819230|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
156819231|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
156819232|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
156819233|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
156819234|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
156819235|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
156819236|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
156819237|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
156819238|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
156819239|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
156884399|NCT04255394|566334094|FG000|Overall Study|Death|35|||
157150687|NCT04267562|567298070|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
157150688|NCT04267562|567298070|FG000|Assessed for Eligibility|Site closure|6|||
157150689|NCT04267562|567298070|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
157150690|NCT04267562|567298070|FG000|Assessed for Eligibility|Physician Decision|1|||
157150691|NCT04267562|567298070|FG000|Month 24|Elective hysterectomy|1|||
156819240|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
156819241|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
156819242|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
156819243|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
156819244|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
156819245|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
156819246|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
156819247|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
157150692|NCT04267562|567298070|FG000|Month 24|Lost to Follow-up|1|||
157150693|NCT04267562|567298070|FG000|Month 36|Elective hysterectomy|2|||
157150694|NCT04267562|567298070|FG000|Month 36|Lost to Follow-up|3|||
157150695|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
157150696|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
157150697|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
157150698|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
157150699|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
157150700|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
157150701|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
157150702|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
157150703|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
157150704|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
157150705|NCT00710034|567298073|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
157150706|NCT00710034|567298074|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
157150707|NCT00710034|567298073|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
157150708|NCT00710034|567298074|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
157150709|NCT00710034|567298073|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
157150710|NCT00710034|567298074|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
157150711|NCT00710034|567298073|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
157150712|NCT00710034|567298074|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
157150713|NCT00710034|567298073|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
157150714|NCT00710034|567298074|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
157150715|NCT00710034|567298073|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
157150716|NCT00710034|567298074|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
157150717|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
156819248|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
156819249|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
156819250|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
156819251|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
156819252|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
156819253|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819254|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819255|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819256|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819257|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819258|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819259|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819260|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819261|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819262|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819263|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156819264|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
156819265|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
156819266|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
156819267|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
156819268|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819269|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819270|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819271|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819272|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819273|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819274|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819275|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819276|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819277|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819278|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
156819279|NCT03831191|566087557|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819280|NCT03831191|566087558|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819281|NCT03831191|566087559|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
157150718|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
157150719|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
156819282|NCT03831191|566087560|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
156819283|NCT03831191|566087561|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819284|NCT03831191|566087562|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819285|NCT03831191|566087563|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819286|NCT03831191|566087564|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
157150720|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
157150721|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Death|8|||
156819287|NCT03831191|566087565|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819288|NCT03831191|566087566|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819289|NCT03831191|566087567|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819290|NCT03831191|566087568|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819291|NCT03831191|566087569|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819292|NCT03831191|566087570|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819293|NCT03831191|566087571|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
156819294|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819295|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819296|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819297|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
156819298|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819299|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
156819300|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
156819301|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819302|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
156819303|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819304|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
156819305|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
156819306|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819307|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
156819308|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
156819309|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819310|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819311|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819312|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819313|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
157150722|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Death|3|||
157150723|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
157150724|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
157150725|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
157150726|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
157150727|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
157150728|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
157150729|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
157150730|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
157150731|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
157150732|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
157150733|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
157150734|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
157150735|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
157150736|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
157150737|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
157150738|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
157150739|NCT00494871|567298075|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
157150740|NCT00494871|567298076|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
157150741|NCT00494871|567298075|FG000|Follow-up (FU) Period|Adverse Event|1|||
157150742|NCT00494871|567298076|FG001|Follow-up (FU) Period|Adverse Event|1|||
157150743|NCT00494871|567298075|FG000|Follow-up (FU) Period|Death|13|||
157150744|NCT00494871|567298076|FG001|Follow-up (FU) Period|Death|12|||
157150745|NCT00494871|567298075|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
156819314|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819315|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819316|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819317|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819318|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819319|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819320|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819321|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819322|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156819323|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
156819324|NCT03831191|566087557|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819325|NCT03831191|566087558|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819326|NCT03831191|566087559|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
157150746|NCT00494871|567298076|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
157150747|NCT00494871|567298075|FG000|Follow-up (FU) Period|Physician Decision|0|||
156819327|NCT03831191|566087560|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819328|NCT03831191|566087561|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819329|NCT03831191|566087562|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819330|NCT03831191|566087563|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819331|NCT03831191|566087564|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819332|NCT03831191|566087565|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819333|NCT03831191|566087566|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819334|NCT03831191|566087567|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819335|NCT03831191|566087568|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819336|NCT03831191|566087569|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819337|NCT03831191|566087570|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156819338|NCT03831191|566087571|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
156819339|NCT00695955|566087572|FG000|Cohort 1|Adverse Event|26|||
156819340|NCT00695955|566087572|FG000|Cohort 1|Protocol Violation|2|||
156819341|NCT00695955|566087572|FG000|Cohort 1|Lost to Follow-up|30|||
156819342|NCT00695955|566087572|FG000|Cohort 1|Withdrawal by Subject|25|||
156819343|NCT00695955|566087572|FG000|Cohort 1|Lack of Efficacy|3|||
156819344|NCT00695955|566087572|FG000|Cohort 1|Other|16|||
156819345|NCT00695955|566087572|FG000|Cohort 2|Adverse Event|24|||
156819346|NCT00695955|566087572|FG000|Cohort 2|Protocol Violation|5|||
156819347|NCT00695955|566087572|FG000|Cohort 2|Lost to Follow-up|38|||
156819348|NCT00695955|566087572|FG000|Cohort 2|Withdrawal by Subject|28|||
156819349|NCT00695955|566087572|FG000|Cohort 2|Lack of Efficacy|4|||
156819350|NCT00695955|566087572|FG000|Cohort 2|Other|5|||
156819351|NCT02957747|566087575|FG000|Overall Study|Withdrawal by Subject|0|||
156819352|NCT02957747|566087576|FG001|Overall Study|Withdrawal by Subject|3|||
156819353|NCT02957747|566087575|FG000|Overall Study|Lost to Follow-up|10|||
156819354|NCT02957747|566087576|FG001|Overall Study|Lost to Follow-up|5|||
156819355|NCT01177553|566087577|FG000|Overall Study|babies not yet 6 months of age|1|||
156819356|NCT01177553|566087578|FG001|Overall Study|babies not yet 6 months of age|0|||
156819357|NCT00610857|566087580|FG000|Overall Study|Not evaluable for response|2|||
156819358|NCT00888329|566087581|FG000|Overall Study|Physician Decision|6|||
156819359|NCT00888329|566087582|FG001|Overall Study|Physician Decision|9|||
156819360|NCT00002540|566087583|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
156819361|NCT00002540|566087584|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
156819362|NCT00002540|566087583|FG000|Overall Study|Died Before Randomization|2|||
156819363|NCT00002540|566087584|FG001|Overall Study|Died Before Randomization|6|||
156819364|NCT00002540|566087583|FG000|Overall Study|Died Before ASU (Control)|202|||
156819365|NCT00002540|566087584|FG001|Overall Study|Died Before ASU (Control)|0|||
156819366|NCT00002540|566087583|FG000|Overall Study|Refused ASU (Control)|597|||
156819367|NCT00002540|566087584|FG001|Overall Study|Refused ASU (Control)|0|||
156819368|NCT00002540|566087583|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
156819369|NCT00002540|566087584|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
156819370|NCT04826094|566087585|FG000|Overall Study|Lost to Follow-up|2|||
156819371|NCT04826094|566087586|FG001|Overall Study|Lost to Follow-up|1|||
156819372|NCT04826094|566087587|FG002|Overall Study|Lost to Follow-up|0|||
156819373|NCT04826094|566087588|FG003|Overall Study|Lost to Follow-up|0|||
156819374|NCT04826094|566087589|FG004|Overall Study|Lost to Follow-up|1|||
156819375|NCT04826094|566087590|FG005|Overall Study|Lost to Follow-up|3|||
156819376|NCT04826094|566087591|FG006|Overall Study|Lost to Follow-up|1|||
156819377|NCT04826094|566087592|FG007|Overall Study|Lost to Follow-up|1|||
156819378|NCT04826094|566087585|FG000|Overall Study|Participant withdrew consent|1|||
156819379|NCT04826094|566087586|FG001|Overall Study|Participant withdrew consent|0|||
156819380|NCT04826094|566087587|FG002|Overall Study|Participant withdrew consent|0|||
156819381|NCT04826094|566087588|FG003|Overall Study|Participant withdrew consent|1|||
156819382|NCT04826094|566087589|FG004|Overall Study|Participant withdrew consent|1|||
156819383|NCT04826094|566087590|FG005|Overall Study|Participant withdrew consent|1|||
156819384|NCT04826094|566087591|FG006|Overall Study|Participant withdrew consent|0|||
156819385|NCT04826094|566087592|FG007|Overall Study|Participant withdrew consent|1|||
156819386|NCT04826094|566087585|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
156819387|NCT04826094|566087586|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
156819388|NCT04826094|566087587|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
156819389|NCT04826094|566087588|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
156819390|NCT04826094|566087589|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
156819391|NCT04826094|566087590|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
156819392|NCT04826094|566087591|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
156819393|NCT04826094|566087592|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
156819394|NCT04826094|566087585|FG000|Overall Study|Withdrawn by Investigator|0|||
156819395|NCT04826094|566087586|FG001|Overall Study|Withdrawn by Investigator|0|||
156819396|NCT04826094|566087587|FG002|Overall Study|Withdrawn by Investigator|0|||
156819397|NCT04826094|566087588|FG003|Overall Study|Withdrawn by Investigator|0|||
156819398|NCT04826094|566087589|FG004|Overall Study|Withdrawn by Investigator|0|||
156819399|NCT04826094|566087590|FG005|Overall Study|Withdrawn by Investigator|1|||
156819400|NCT04826094|566087591|FG006|Overall Study|Withdrawn by Investigator|0|||
156819401|NCT04826094|566087592|FG007|Overall Study|Withdrawn by Investigator|1|||
156819402|NCT04826094|566087585|FG000|Overall Study|Other: Moved from area|1|||
156819403|NCT04826094|566087586|FG001|Overall Study|Other: Moved from area|1|||
156819404|NCT04826094|566087587|FG002|Overall Study|Other: Moved from area|1|||
156819405|NCT04826094|566087588|FG003|Overall Study|Other: Moved from area|0|||
156819406|NCT04826094|566087589|FG004|Overall Study|Other: Moved from area|0|||
156819407|NCT04826094|566087590|FG005|Overall Study|Other: Moved from area|0|||
156819408|NCT04826094|566087591|FG006|Overall Study|Other: Moved from area|0|||
156819409|NCT04826094|566087592|FG007|Overall Study|Other: Moved from area|0|||
156819410|NCT04826094|566087585|FG000|Overall Study|Other: Declined|0|||
156819411|NCT04826094|566087586|FG001|Overall Study|Other: Declined|0|||
156819412|NCT04826094|566087587|FG002|Overall Study|Other: Declined|0|||
156819413|NCT04826094|566087588|FG003|Overall Study|Other: Declined|0|||
156819414|NCT04826094|566087589|FG004|Overall Study|Other: Declined|1|||
156819415|NCT04826094|566087590|FG005|Overall Study|Other: Declined|0|||
156819416|NCT04826094|566087591|FG006|Overall Study|Other: Declined|0|||
156819417|NCT04826094|566087592|FG007|Overall Study|Other: Declined|0|||
156819418|NCT04826094|566087585|FG000|Overall Study|Other: Vaccine not administered|0|||
156819419|NCT04826094|566087586|FG001|Overall Study|Other: Vaccine not administered|0|||
156819420|NCT04826094|566087587|FG002|Overall Study|Other: Vaccine not administered|1|||
156819421|NCT04826094|566087588|FG003|Overall Study|Other: Vaccine not administered|0|||
156819422|NCT04826094|566087589|FG004|Overall Study|Other: Vaccine not administered|0|||
156819423|NCT04826094|566087590|FG005|Overall Study|Other: Vaccine not administered|1|||
156819424|NCT04826094|566087591|FG006|Overall Study|Other: Vaccine not administered|1|||
156819425|NCT04826094|566087592|FG007|Overall Study|Other: Vaccine not administered|3|||
156819426|NCT02151903|566087594|FG000|Overall Study|Withdrawal by Subject|1|||
156819427|NCT02151903|566087595|FG001|Overall Study|Withdrawal by Subject|0|||
156819428|NCT02151903|566087594|FG000|Overall Study|Progressive disease|2|||
156819429|NCT02151903|566087595|FG001|Overall Study|Progressive disease|1|||
156819430|NCT00778375|566087601|FG000|Overall Study|Ineligible|3|||
156819431|NCT01421303|566087602|FG000|Overall Study|Lost to Follow-up|13|||
156819432|NCT01421303|566087602|FG000|Overall Study|Non compliance with study procedure|1|||
156819433|NCT01421303|566087602|FG000|Overall Study|Other|7|||
156819434|NCT01421303|566087602|FG000|Overall Study|Withdrawal by Subject|1|||
156819435|NCT06003777|566087603|FG000|Period 1|Adverse Event|0|||
156819436|NCT06003777|566087604|FG001|Period 1|Adverse Event|0|||
156819437|NCT06003777|566087605|FG002|Period 1|Adverse Event|1|||
156819438|NCT06003777|566087606|FG003|Period 1|Adverse Event|0|||
156819439|NCT06003777|566087607|FG004|Period 1|Adverse Event|0|||
156819440|NCT06003777|566087608|FG005|Period 1|Adverse Event|0|||
156819441|NCT06003777|566087609|FG006|Period 1|Adverse Event|0|||
156819442|NCT06003777|566087610|FG007|Period 1|Adverse Event|0|||
156819443|NCT06003777|566087611|FG008|Period 1|Adverse Event|0|||
156819444|NCT06003777|566087612|FG009|Period 1|Adverse Event|0|||
156819445|NCT06003777|566087613|FG010|Period 1|Adverse Event|0|||
156819446|NCT06003777|566087614|FG011|Period 1|Adverse Event|0|||
156819447|NCT06003777|566087603|FG000|Period 1|Withdrawal by Subject|0|||
156819448|NCT06003777|566087604|FG001|Period 1|Withdrawal by Subject|0|||
156819449|NCT06003777|566087605|FG002|Period 1|Withdrawal by Subject|0|||
156819450|NCT06003777|566087606|FG003|Period 1|Withdrawal by Subject|0|||
156819451|NCT06003777|566087607|FG004|Period 1|Withdrawal by Subject|1|||
156819452|NCT06003777|566087608|FG005|Period 1|Withdrawal by Subject|0|||
156819453|NCT06003777|566087609|FG006|Period 1|Withdrawal by Subject|0|||
156884400|NCT04255394|566334095|FG001|Overall Study|Death|25|||
156884401|NCT04255394|566334094|FG000|Overall Study|Device removed|2|||
156884402|NCT04255394|566334095|FG001|Overall Study|Device removed|10|||
156884403|NCT04255394|566334094|FG000|Overall Study|Withdrawal by Subject|9|||
156884404|NCT04255394|566334095|FG001|Overall Study|Withdrawal by Subject|8|||
156884405|NCT04255394|566334094|FG000|Overall Study|Screen Failure/Not treated|12|||
156884406|NCT04255394|566334095|FG001|Overall Study|Screen Failure/Not treated|8|||
156884407|NCT04255394|566334094|FG000|Overall Study|Lost to Follow-up|123|||
156884408|NCT04255394|566334095|FG001|Overall Study|Lost to Follow-up|265|||
157022705|NCT04810650|566835273|FG001|Overall Study|Participant declined|0|||
157224426|NCT02396381|567567985|FG001|Overall Study|Randomization/Screening Error|1|||
156819454|NCT06003777|566087610|FG007|Period 1|Withdrawal by Subject|0|||
156819455|NCT06003777|566087611|FG008|Period 1|Withdrawal by Subject|0|||
156819456|NCT06003777|566087612|FG009|Period 1|Withdrawal by Subject|0|||
156819457|NCT06003777|566087613|FG010|Period 1|Withdrawal by Subject|0|||
156819458|NCT06003777|566087614|FG011|Period 1|Withdrawal by Subject|0|||
156819459|NCT06003777|566087603|FG000|Period 2|Withdrawal by Subject|0|||
156884409|NCT04255394|566334094|FG000|Overall Study|Adverse Event|1|||
156819460|NCT06003777|566087604|FG001|Period 2|Withdrawal by Subject|0|||
156819461|NCT06003777|566087605|FG002|Period 2|Withdrawal by Subject|0|||
156819462|NCT06003777|566087606|FG003|Period 2|Withdrawal by Subject|0|||
156819463|NCT06003777|566087607|FG004|Period 2|Withdrawal by Subject|0|||
156819464|NCT06003777|566087608|FG005|Period 2|Withdrawal by Subject|0|||
156819465|NCT06003777|566087609|FG006|Period 2|Withdrawal by Subject|0|||
156819466|NCT06003777|566087610|FG007|Period 2|Withdrawal by Subject|0|||
156884410|NCT04255394|566334095|FG001|Overall Study|Adverse Event|3|||
156884411|NCT01525225|566334101|FG000|Enrollment|No longer met study criteria|1|||
156884412|NCT01525225|566334101|FG000|Enrollment|Other|1|||
156884413|NCT00363545|566334102|FG000|Overall Study|Serious Adverse Event|0|||
156884414|NCT00363545|566334103|FG001|Overall Study|Serious Adverse Event|1|||
156884415|NCT00363545|566334102|FG000|Overall Study|Withdrawal by Subject|12|||
156884416|NCT00363545|566334103|FG001|Overall Study|Withdrawal by Subject|15|||
156884417|NCT00363545|566334102|FG000|Overall Study|Migrated/moved from study area|3|||
156884418|NCT00363545|566334103|FG001|Overall Study|Migrated/moved from study area|6|||
156819467|NCT06003777|566087611|FG008|Period 2|Withdrawal by Subject|1|||
156819468|NCT06003777|566087612|FG009|Period 2|Withdrawal by Subject|0|||
156819469|NCT06003777|566087613|FG010|Period 2|Withdrawal by Subject|0|||
156819470|NCT06003777|566087614|FG011|Period 2|Withdrawal by Subject|0|||
156819471|NCT06003777|566087603|FG000|Period 3|Adverse Event|0|||
156819472|NCT06003777|566087604|FG001|Period 3|Adverse Event|0|||
156819473|NCT06003777|566087605|FG002|Period 3|Adverse Event|0|||
156819474|NCT06003777|566087606|FG003|Period 3|Adverse Event|0|||
156819475|NCT06003777|566087607|FG004|Period 3|Adverse Event|0|||
156819476|NCT06003777|566087608|FG005|Period 3|Adverse Event|0|||
156819477|NCT06003777|566087609|FG006|Period 3|Adverse Event|1|||
156819478|NCT06003777|566087610|FG007|Period 3|Adverse Event|0|||
156819479|NCT06003777|566087611|FG008|Period 3|Adverse Event|0|||
156819480|NCT06003777|566087612|FG009|Period 3|Adverse Event|0|||
156819481|NCT06003777|566087613|FG010|Period 3|Adverse Event|0|||
156819482|NCT06003777|566087614|FG011|Period 3|Adverse Event|0|||
157150748|NCT00494871|567298076|FG001|Follow-up (FU) Period|Physician Decision|1|||
157150749|NCT00494871|567298075|FG000|Follow-up (FU) Period|Protocol Violation|1|||
157150750|NCT00494871|567298076|FG001|Follow-up (FU) Period|Protocol Violation|0|||
157150751|NCT00494871|567298075|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
157150752|NCT00494871|567298076|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
157150753|NCT00494871|567298075|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
157150754|NCT00494871|567298076|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
157150755|NCT03238248|567298077|FG000|Overall Study|Death|5|||
157150756|NCT03238248|567298077|FG000|Overall Study|Withdrawal by Subject|7|||
157150757|NCT03238248|567298077|FG000|Overall Study|Participant proceeding to transplant|10|||
157150758|NCT03238248|567298077|FG000|Overall Study|Lack of Efficacy|4|||
157150759|NCT03238248|567298077|FG000|Overall Study|Physician Decision|3|||
157150760|NCT03238248|567298077|FG000|Overall Study|Transitioning to another study|1|||
157150761|NCT03238248|567298077|FG000|Overall Study|No longer benefiting|1|||
157150762|NCT03238248|567298077|FG000|Overall Study|Other complicating disease|1|||
157150763|NCT03238248|567298077|FG000|Overall Study|Adverse Event|5|||
157150764|NCT03238248|567298077|FG000|Overall Study|Disease progression|26|||
156819483|NCT06003777|566087603|FG000|Period 4|No longer met eligibility criteria|0|||
156819484|NCT06003777|566087604|FG001|Period 4|No longer met eligibility criteria|0|||
156819485|NCT06003777|566087605|FG002|Period 4|No longer met eligibility criteria|1|||
156819486|NCT06003777|566087606|FG003|Period 4|No longer met eligibility criteria|0|||
156819487|NCT06003777|566087607|FG004|Period 4|No longer met eligibility criteria|0|||
156819488|NCT06003777|566087608|FG005|Period 4|No longer met eligibility criteria|0|||
156819489|NCT06003777|566087609|FG006|Period 4|No longer met eligibility criteria|0|||
156819490|NCT06003777|566087610|FG007|Period 4|No longer met eligibility criteria|0|||
156819491|NCT06003777|566087611|FG008|Period 4|No longer met eligibility criteria|0|||
156819492|NCT06003777|566087612|FG009|Period 4|No longer met eligibility criteria|0|||
156819493|NCT06003777|566087613|FG010|Period 4|No longer met eligibility criteria|0|||
156819494|NCT06003777|566087614|FG011|Period 4|No longer met eligibility criteria|0|||
156819495|NCT06003777|566087603|FG000|Period 4|Withdrawal by Subject|0|||
156819496|NCT06003777|566087604|FG001|Period 4|Withdrawal by Subject|1|||
156819497|NCT06003777|566087605|FG002|Period 4|Withdrawal by Subject|0|||
156884419|NCT00363545|566334102|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
156884420|NCT00363545|566334103|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
156884421|NCT00363545|566334102|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
157150765|NCT03238248|567298077|FG000|Overall Study|N/A participant is still on treatment|1|||
157150766|NCT03238248|567298077|FG000|Overall Study|Decline in condition|1|||
156819498|NCT06003777|566087606|FG003|Period 4|Withdrawal by Subject|0|||
156819499|NCT06003777|566087607|FG004|Period 4|Withdrawal by Subject|0|||
156819500|NCT06003777|566087608|FG005|Period 4|Withdrawal by Subject|0|||
156819501|NCT06003777|566087609|FG006|Period 4|Withdrawal by Subject|0|||
156819502|NCT06003777|566087610|FG007|Period 4|Withdrawal by Subject|0|||
156819503|NCT06003777|566087611|FG008|Period 4|Withdrawal by Subject|0|||
156819504|NCT06003777|566087612|FG009|Period 4|Withdrawal by Subject|0|||
156819505|NCT06003777|566087613|FG010|Period 4|Withdrawal by Subject|0|||
156884422|NCT00363545|566334103|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
156884423|NCT00363545|566334102|FG000|Overall Study|Others|1|||
156819506|NCT06003777|566087614|FG011|Period 4|Withdrawal by Subject|0|||
156819507|NCT05319600|566087615|FG000|Overall Study|Withdrawal by Subject|1|||
156819508|NCT05319600|566087616|FG001|Overall Study|Withdrawal by Subject|0|||
156819509|NCT05319600|566087615|FG000|Overall Study|Lost to Follow-up|0|||
156819510|NCT05319600|566087616|FG001|Overall Study|Lost to Follow-up|4|||
156819511|NCT01732510|566087617|FG000|Overall Study|Adverse Event|0|||
156884424|NCT00363545|566334103|FG001|Overall Study|Others|0|||
156819512|NCT01732510|566087618|FG001|Overall Study|Adverse Event|1|||
156819513|NCT01732510|566087619|FG002|Overall Study|Adverse Event|1|||
156819514|NCT01732510|566087620|FG003|Overall Study|Adverse Event|0|||
156819515|NCT01732510|566087621|FG004|Overall Study|Adverse Event|0|||
156819516|NCT01732510|566087622|FG005|Overall Study|Adverse Event|0|||
156819517|NCT01732510|566087623|FG006|Overall Study|Adverse Event|1|||
156819518|NCT01732510|566087617|FG000|Overall Study|Protocol Violation|0|||
156819519|NCT01732510|566087618|FG001|Overall Study|Protocol Violation|0|||
156819520|NCT01732510|566087619|FG002|Overall Study|Protocol Violation|0|||
156819521|NCT01732510|566087620|FG003|Overall Study|Protocol Violation|1|||
156819522|NCT01732510|566087621|FG004|Overall Study|Protocol Violation|0|||
156819523|NCT01732510|566087622|FG005|Overall Study|Protocol Violation|0|||
156819524|NCT01732510|566087623|FG006|Overall Study|Protocol Violation|0|||
156819525|NCT01732510|566087617|FG000|Overall Study|Withdrawal by Subject|1|||
156819526|NCT01732510|566087618|FG001|Overall Study|Withdrawal by Subject|3|||
156819527|NCT01732510|566087619|FG002|Overall Study|Withdrawal by Subject|2|||
156819528|NCT01732510|566087620|FG003|Overall Study|Withdrawal by Subject|1|||
156819529|NCT01732510|566087621|FG004|Overall Study|Withdrawal by Subject|5|||
156819530|NCT01732510|566087622|FG005|Overall Study|Withdrawal by Subject|0|||
156819531|NCT01732510|566087623|FG006|Overall Study|Withdrawal by Subject|1|||
156819532|NCT01732510|566087617|FG000|Overall Study|Lost to Follow-up|0|||
156819533|NCT01732510|566087618|FG001|Overall Study|Lost to Follow-up|0|||
156819534|NCT01732510|566087619|FG002|Overall Study|Lost to Follow-up|1|||
156819535|NCT01732510|566087620|FG003|Overall Study|Lost to Follow-up|1|||
156819536|NCT01732510|566087621|FG004|Overall Study|Lost to Follow-up|0|||
156819537|NCT01732510|566087622|FG005|Overall Study|Lost to Follow-up|1|||
156819538|NCT01732510|566087623|FG006|Overall Study|Lost to Follow-up|0|||
156819539|NCT01732510|566087617|FG000|Overall Study|Physician Decision|0|||
156819540|NCT01732510|566087618|FG001|Overall Study|Physician Decision|1|||
156819541|NCT01732510|566087619|FG002|Overall Study|Physician Decision|0|||
156819542|NCT01732510|566087620|FG003|Overall Study|Physician Decision|0|||
156819543|NCT01732510|566087621|FG004|Overall Study|Physician Decision|0|||
156819544|NCT01732510|566087622|FG005|Overall Study|Physician Decision|0|||
156819545|NCT01732510|566087623|FG006|Overall Study|Physician Decision|0|||
156819546|NCT01732510|566087617|FG000|Overall Study|Pregnancy|0|||
156819547|NCT01732510|566087618|FG001|Overall Study|Pregnancy|0|||
156819548|NCT01732510|566087619|FG002|Overall Study|Pregnancy|0|||
156819549|NCT01732510|566087620|FG003|Overall Study|Pregnancy|1|||
156819550|NCT01732510|566087621|FG004|Overall Study|Pregnancy|0|||
156819551|NCT01732510|566087622|FG005|Overall Study|Pregnancy|0|||
156819552|NCT01732510|566087623|FG006|Overall Study|Pregnancy|0|||
156819553|NCT01732510|566087617|FG000|Overall Study|Study Terminated By Sponsor|0|||
156819554|NCT01732510|566087618|FG001|Overall Study|Study Terminated By Sponsor|0|||
156819555|NCT01732510|566087619|FG002|Overall Study|Study Terminated By Sponsor|0|||
156819556|NCT01732510|566087620|FG003|Overall Study|Study Terminated By Sponsor|1|||
156819557|NCT01732510|566087621|FG004|Overall Study|Study Terminated By Sponsor|0|||
156819558|NCT01732510|566087622|FG005|Overall Study|Study Terminated By Sponsor|12|||
156819559|NCT01732510|566087623|FG006|Overall Study|Study Terminated By Sponsor|6|||
156819560|NCT01262560|566087624|FG000|Overall Study|Protocol Violation|0|||
156819561|NCT01262560|566087625|FG001|Overall Study|Protocol Violation|1|||
156819562|NCT01262560|566087626|FG002|Overall Study|Protocol Violation|2|||
156819563|NCT00350870|566087631|FG000|Overall Study|Withdrawal by Subject|21|||
156819564|NCT00350870|566087632|FG001|Overall Study|Withdrawal by Subject|17|||
156819565|NCT00350870|566087633|FG002|Overall Study|Withdrawal by Subject|15|||
156819566|NCT00350870|566087634|FG003|Overall Study|Withdrawal by Subject|14|||
156819567|NCT00350870|566087631|FG000|Overall Study|Physician Decision|1|||
156819568|NCT00350870|566087632|FG001|Overall Study|Physician Decision|0|||
156819569|NCT00350870|566087633|FG002|Overall Study|Physician Decision|1|||
156819570|NCT00350870|566087634|FG003|Overall Study|Physician Decision|1|||
156819571|NCT01932372|566087635|FG000|Overall Study|Not meeting eligibility criteria|33|||
156884425|NCT01182844|566334104|FG000|Overall Study|Withdrawal by Subject|0|||
156884426|NCT01182844|566334105|FG001|Overall Study|Withdrawal by Subject|2|||
157150767|NCT03238248|567298077|FG000|Overall Study|Alternative therapy|2|||
156819572|NCT01932372|566087636|FG001|Overall Study|Not meeting eligibility criteria|179|||
156819573|NCT03594747|566087641|FG000|Overall Study|Death|78|||
156884427|NCT00576420|566336238|FG000|Overall Study|Death|0|||
156819574|NCT03594747|566087642|FG001|Overall Study|Death|86|||
156819575|NCT03594747|566087643|FG002|Overall Study|Death|87|||
156819576|NCT03594747|566087641|FG000|Overall Study|Withdrawal by Subject|5|||
156819577|NCT03594747|566087642|FG001|Overall Study|Withdrawal by Subject|2|||
156819578|NCT03594747|566087643|FG002|Overall Study|Withdrawal by Subject|11|||
156819579|NCT03594747|566087641|FG000|Overall Study|Lost to Follow-up|4|||
156819580|NCT03594747|566087642|FG001|Overall Study|Lost to Follow-up|1|||
156819581|NCT03594747|566087643|FG002|Overall Study|Lost to Follow-up|1|||
156819582|NCT03594747|566087641|FG000|Overall Study|Physician Decision|0|||
156819583|NCT03594747|566087642|FG001|Overall Study|Physician Decision|1|||
156819584|NCT03594747|566087643|FG002|Overall Study|Physician Decision|0|||
156819585|NCT03594747|566087641|FG000|Overall Study|Sponsor decision|23|||
156819586|NCT03594747|566087642|FG001|Overall Study|Sponsor decision|17|||
156884428|NCT00576420|566336239|FG001|Overall Study|Death|0|||
156819587|NCT03594747|566087643|FG002|Overall Study|Sponsor decision|16|||
156819588|NCT03594747|566087641|FG000|Overall Study|Did not meet inclusion criteria|0|||
156819589|NCT03594747|566087642|FG001|Overall Study|Did not meet inclusion criteria|0|||
156819590|NCT03594747|566087643|FG002|Overall Study|Did not meet inclusion criteria|1|||
156819591|NCT03594747|566087641|FG000|Overall Study|Transfer to long term extension study|10|||
156819592|NCT03594747|566087642|FG001|Overall Study|Transfer to long term extension study|12|||
156819593|NCT03594747|566087643|FG002|Overall Study|Transfer to long term extension study|5|||
156819594|NCT04382586|566087644|FG000|Overall Study|Death|3|||
156819595|NCT04382586|566087645|FG001|Overall Study|Death|4|||
156819596|NCT04382586|566087644|FG000|Overall Study|Lost to Follow-up|11|||
156819597|NCT04382586|566087645|FG001|Overall Study|Lost to Follow-up|8|||
156819598|NCT04382586|566087644|FG000|Overall Study|Withdrawal by Subject|3|||
156819599|NCT04382586|566087645|FG001|Overall Study|Withdrawal by Subject|1|||
156819600|NCT04382586|566087644|FG000|Overall Study|Physician Decision|0|||
156819601|NCT04382586|566087645|FG001|Overall Study|Physician Decision|3|||
156819602|NCT02265536|566087653|FG000|Overall Study|Adverse Event|1|||
156819603|NCT02265536|566087654|FG001|Overall Study|Adverse Event|0|||
156819604|NCT02265536|566087655|FG002|Overall Study|Adverse Event|0|||
156819605|NCT02265536|566087656|FG003|Overall Study|Adverse Event|0|||
156819606|NCT02265536|566087657|FG004|Overall Study|Adverse Event|1|||
156819607|NCT02265536|566087658|FG005|Overall Study|Adverse Event|0|||
156819608|NCT02265536|566087653|FG000|Overall Study|Physician Decision|0|||
156819609|NCT02265536|566087654|FG001|Overall Study|Physician Decision|0|||
156819610|NCT02265536|566087655|FG002|Overall Study|Physician Decision|0|||
156819611|NCT02265536|566087656|FG003|Overall Study|Physician Decision|0|||
156819612|NCT02265536|566087657|FG004|Overall Study|Physician Decision|2|||
156819613|NCT02265536|566087658|FG005|Overall Study|Physician Decision|0|||
156819614|NCT02265536|566087653|FG000|Overall Study|Withdrawal by Subject|0|||
156819615|NCT02265536|566087654|FG001|Overall Study|Withdrawal by Subject|3|||
156819616|NCT02265536|566087655|FG002|Overall Study|Withdrawal by Subject|0|||
156819617|NCT02265536|566087656|FG003|Overall Study|Withdrawal by Subject|0|||
156819618|NCT02265536|566087657|FG004|Overall Study|Withdrawal by Subject|0|||
156819619|NCT02265536|566087658|FG005|Overall Study|Withdrawal by Subject|0|||
156819620|NCT00349349|566087659|FG000|Overall Study|Adverse Event|5|||
156819621|NCT00349349|566087660|FG001|Overall Study|Adverse Event|6|||
156819622|NCT00349349|566087661|FG002|Overall Study|Adverse Event|2|||
156819623|NCT00349349|566087659|FG000|Overall Study|Withdrawal by Subject|5|||
156819624|NCT00349349|566087660|FG001|Overall Study|Withdrawal by Subject|2|||
156819625|NCT00349349|566087661|FG002|Overall Study|Withdrawal by Subject|1|||
156819626|NCT00349349|566087659|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
156819627|NCT00349349|566087660|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
156819628|NCT00349349|566087661|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
156819629|NCT00349349|566087659|FG000|Overall Study|Death|13|||
156819630|NCT00349349|566087660|FG001|Overall Study|Death|10|||
156819631|NCT00349349|566087661|FG002|Overall Study|Death|1|||
156819632|NCT00349349|566087659|FG000|Overall Study|Other Treatment Selected|2|||
156819633|NCT00349349|566087660|FG001|Overall Study|Other Treatment Selected|0|||
156819634|NCT00349349|566087661|FG002|Overall Study|Other Treatment Selected|0|||
156819635|NCT00349349|566087659|FG000|Overall Study|Participant Reduced General Condition|0|||
156819636|NCT00349349|566087660|FG001|Overall Study|Participant Reduced General Condition|1|||
156819637|NCT00349349|566087661|FG002|Overall Study|Participant Reduced General Condition|0|||
156819638|NCT00349349|566087659|FG000|Overall Study|Physician Decision|1|||
156819639|NCT00349349|566087660|FG001|Overall Study|Physician Decision|2|||
156819640|NCT00349349|566087661|FG002|Overall Study|Physician Decision|1|||
156819641|NCT00349349|566087659|FG000|Overall Study|No Response|0|||
156819642|NCT00349349|566087660|FG001|Overall Study|No Response|3|||
156819643|NCT00349349|566087661|FG002|Overall Study|No Response|0|||
156819644|NCT00349349|566087659|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
156819645|NCT00349349|566087660|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
156819646|NCT00349349|566087661|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
156819647|NCT02095873|566087662|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156819648|NCT02095873|566087663|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156819649|NCT02095873|566087662|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
157150768|NCT02241512|567298084|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
156819650|NCT02095873|566087663|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
156819651|NCT02095873|566087662|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
156819652|NCT02095873|566087663|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
156819653|NCT03763656|566087668|FG000|Overall Study|Physician Decision|1|||
156819654|NCT03763656|566087668|FG000|Overall Study|Protocol Violation|1|||
156819655|NCT03763656|566087668|FG000|Overall Study|Withdrawal by Subject|7|||
156819656|NCT00107900|566087672|FG000|Overall Study|Adverse Event|3|||
156819657|NCT00107900|566087673|FG001|Overall Study|Adverse Event|2|||
156819658|NCT00107900|566087674|FG002|Overall Study|Adverse Event|10|||
156819659|NCT00107900|566087675|FG003|Overall Study|Adverse Event|3|||
156819660|NCT00107900|566087676|FG004|Overall Study|Adverse Event|5|||
156819661|NCT00107900|566087677|FG005|Overall Study|Adverse Event|3|||
156819662|NCT00107900|566087672|FG000|Overall Study|Death|0|||
156819663|NCT00107900|566087673|FG001|Overall Study|Death|0|||
156819664|NCT00107900|566087674|FG002|Overall Study|Death|0|||
156819665|NCT00107900|566087675|FG003|Overall Study|Death|0|||
156819666|NCT00107900|566087676|FG004|Overall Study|Death|1|||
156819667|NCT00107900|566087677|FG005|Overall Study|Death|0|||
156819668|NCT00107900|566087672|FG000|Overall Study|Lost to Follow-up|4|||
156819669|NCT00107900|566087673|FG001|Overall Study|Lost to Follow-up|1|||
156819670|NCT00107900|566087674|FG002|Overall Study|Lost to Follow-up|3|||
156819671|NCT00107900|566087675|FG003|Overall Study|Lost to Follow-up|2|||
156819672|NCT00107900|566087676|FG004|Overall Study|Lost to Follow-up|5|||
156819673|NCT00107900|566087677|FG005|Overall Study|Lost to Follow-up|5|||
156819674|NCT00107900|566087672|FG000|Overall Study|Protocol Violation|1|||
156819675|NCT00107900|566087673|FG001|Overall Study|Protocol Violation|0|||
156819676|NCT00107900|566087674|FG002|Overall Study|Protocol Violation|5|||
156819677|NCT00107900|566087675|FG003|Overall Study|Protocol Violation|5|||
156819678|NCT00107900|566087676|FG004|Overall Study|Protocol Violation|7|||
156819679|NCT00107900|566087677|FG005|Overall Study|Protocol Violation|0|||
156819680|NCT00107900|566087672|FG000|Overall Study|Withdrawal by Subject|1|||
156819681|NCT00107900|566087673|FG001|Overall Study|Withdrawal by Subject|0|||
156819682|NCT00107900|566087674|FG002|Overall Study|Withdrawal by Subject|5|||
156819683|NCT00107900|566087675|FG003|Overall Study|Withdrawal by Subject|0|||
156819684|NCT00107900|566087676|FG004|Overall Study|Withdrawal by Subject|1|||
156819685|NCT00107900|566087677|FG005|Overall Study|Withdrawal by Subject|1|||
156819686|NCT00107900|566087672|FG000|Overall Study|Administrative Reasons|1|||
156819687|NCT00107900|566087673|FG001|Overall Study|Administrative Reasons|0|||
156819688|NCT00107900|566087674|FG002|Overall Study|Administrative Reasons|2|||
156819689|NCT00107900|566087675|FG003|Overall Study|Administrative Reasons|2|||
156819690|NCT00107900|566087676|FG004|Overall Study|Administrative Reasons|2|||
156819691|NCT00107900|566087677|FG005|Overall Study|Administrative Reasons|0|||
156819692|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
156819693|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
156819694|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
156819695|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
156819696|NCT00197145|566089739|FG000|Period 1: Randomized Treatment Phase|Other|2|||
156819697|NCT00197145|566089740|FG001|Period 1: Randomized Treatment Phase|Other|2|||
156819698|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
156819699|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
156819700|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
156819701|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
156819702|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
156819703|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
156819704|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
156819705|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
156819706|NCT00197145|566089739|FG000|Period 2 : Open Label Phase|Other|1|||
156819707|NCT00197145|566089740|FG001|Period 2 : Open Label Phase|Other|0|||
156819708|NCT02242435|566089741|FG000|Overall Study|Lost to Follow-up|3|||
156819709|NCT02242435|566089742|FG001|Overall Study|Lost to Follow-up|4|||
156819710|NCT02242435|566089741|FG000|Overall Study|Adverse Event|3|||
156819711|NCT02242435|566089742|FG001|Overall Study|Adverse Event|2|||
156819712|NCT02242435|566089741|FG000|Overall Study|Withdrawal by Subject|13|||
156819713|NCT02242435|566089742|FG001|Overall Study|Withdrawal by Subject|8|||
156819714|NCT02242435|566089741|FG000|Overall Study|Death|0|||
156819715|NCT02242435|566089742|FG001|Overall Study|Death|1|||
156819716|NCT02242435|566089741|FG000|Overall Study|Protocol Violation|1|||
156819717|NCT02242435|566089742|FG001|Overall Study|Protocol Violation|0|||
156819718|NCT02242435|566089741|FG000|Overall Study|Physician Decision|0|||
156819719|NCT02242435|566089742|FG001|Overall Study|Physician Decision|1|||
156819720|NCT01089413|566089744|FG000|Overall Study|Lost to Follow-up|1|||
156819721|NCT01089413|566089744|FG000|Overall Study|Progressive Disease|93|||
156819722|NCT01089413|566089744|FG000|Overall Study|Participant Withdrew Consent|1|||
156819723|NCT01089413|566089744|FG000|Overall Study|Unacceptable Toxicity|12|||
156819724|NCT01089413|566089744|FG000|Overall Study|Death|10|||
156884429|NCT00576420|566336240|FG002|Overall Study|Death|1|||
156884430|NCT02616146|566336241|FG000|Overall Study|Adverse Event|64|||
156884431|NCT02616146|566336242|FG001|Overall Study|Adverse Event|24|||
156819725|NCT01089413|566089744|FG000|Overall Study|Metastasectomy|13|||
156819726|NCT01089413|566089744|FG000|Overall Study|Other|71|||
156819727|NCT02513485|566089745|FG000|Overall Study|Adverse Event|1|||
156819728|NCT02513485|566089746|FG001|Overall Study|Adverse Event|0|||
156819729|NCT00394251|566089754|FG000|Overall Study|Adverse Event|7|||
156819730|NCT00394251|566089755|FG001|Overall Study|Adverse Event|5|||
156819731|NCT00394251|566089754|FG000|Overall Study|Unacceptable Toxicity|20|||
156819732|NCT00394251|566089755|FG001|Overall Study|Unacceptable Toxicity|18|||
156819733|NCT00394251|566089754|FG000|Overall Study|Physician Decision|1|||
156884432|NCT02616146|566336241|FG000|Overall Study|Lost to Follow-up|23|||
156884433|NCT02616146|566336242|FG001|Overall Study|Lost to Follow-up|13|||
156819734|NCT00394251|566089755|FG001|Overall Study|Physician Decision|1|||
156819735|NCT00394251|566089754|FG000|Overall Study|Protocol Violation|0|||
156819736|NCT00394251|566089755|FG001|Overall Study|Protocol Violation|1|||
156819737|NCT00394251|566089754|FG000|Overall Study|Withdrawal by Subject|7|||
156819738|NCT00394251|566089755|FG001|Overall Study|Withdrawal by Subject|11|||
156819739|NCT00394251|566089754|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
156819740|NCT00394251|566089755|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
156819741|NCT01667224|566089758|FG000|Overall Study|Withdrawal by Subject|3|||
156819742|NCT01667224|566089759|FG001|Overall Study|Withdrawal by Subject|1|||
156819743|NCT01667224|566089758|FG000|Overall Study|Protocol Violation|1|||
156819744|NCT01667224|566089759|FG001|Overall Study|Protocol Violation|1|||
156819745|NCT03350035|566089760|FG000|Overall Study|Lack of Efficacy|2|||
156819746|NCT03350035|566089761|FG001|Overall Study|Lack of Efficacy|0|||
156819747|NCT03350035|566089762|FG002|Overall Study|Lack of Efficacy|0|||
156819748|NCT03350035|566089760|FG000|Overall Study|Subject discharged to hospice|0|||
156819749|NCT03350035|566089761|FG001|Overall Study|Subject discharged to hospice|0|||
156819750|NCT03350035|566089762|FG002|Overall Study|Subject discharged to hospice|1|||
156819751|NCT01610557|566089763|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819752|NCT01610557|566089764|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
156819753|NCT01610557|566089765|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819754|NCT01610557|566089766|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819755|NCT01610557|566089767|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
156819756|NCT01610557|566089763|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819757|NCT01610557|566089764|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819758|NCT01610557|566089765|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819759|NCT01610557|566089766|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
156819760|NCT01610557|566089767|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
156819761|NCT01200407|566089768|FG000|Overall Study|Lost to Follow-up|56|||
156819762|NCT01200407|566089768|FG000|Overall Study|Adverse Event|3|||
156819763|NCT01200407|566089768|FG000|Overall Study|Withdrawal by Subject|4|||
156819764|NCT01200407|566089768|FG000|Overall Study|Other|19|||
156819765|NCT00365105|566089769|FG000|Overall Study|Protocol Violation|5|||
156819766|NCT00365105|566089770|FG001|Overall Study|Protocol Violation|8|||
156819767|NCT06004895|566089771|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
156819768|NCT06004895|566089771|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
156819769|NCT02752633|566089772|FG000|Overall Study|Withdrawal by Subject|1|||
156819770|NCT01843673|566089773|FG000|Overall Study|Lack of Efficacy|2|||
156819771|NCT01843673|566089773|FG000|Overall Study|Withdrawal by Subject|4|||
156819772|NCT00425698|566089774|FG000|Overall Study|Adverse Event|3|||
156819773|NCT00425698|566089775|FG001|Overall Study|Adverse Event|1|||
156819774|NCT00425698|566089774|FG000|Overall Study|Withdrawal by Subject|0|||
156819775|NCT00425698|566089775|FG001|Overall Study|Withdrawal by Subject|1|||
156819776|NCT03275246|566089776|FG000|Overall Study|Protocol Violation|5|||
156819777|NCT03275246|566089776|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
156819778|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
156819779|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
156819780|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
156819781|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
156819782|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
156819783|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
156819784|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
156819785|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
156819786|NCT00433966|566089779|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
156819787|NCT00433966|566089780|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
156819788|NCT00433966|566089781|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
156819789|NCT00433966|566089782|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
156819790|NCT00433966|566089779|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
156819791|NCT00433966|566089780|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
156819792|NCT00433966|566089781|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
156819793|NCT00433966|566089782|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
156819794|NCT00433966|566089779|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
156819795|NCT00433966|566089780|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
156819796|NCT00433966|566089781|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
156819797|NCT00433966|566089782|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
156819798|NCT05059301|566089783|FG000|Overall Study|Adverse Event|0|||
156819799|NCT05059301|566089784|FG001|Overall Study|Adverse Event|2|||
156819800|NCT05059301|566089785|FG002|Overall Study|Adverse Event|2|||
157022706|NCT04810650|566835274|FG002|Overall Study|Participant declined|0|||
157022707|NCT04810650|566835275|FG003|Overall Study|Participant declined|0|||
156819801|NCT05059301|566089783|FG000|Overall Study|Lost to Follow-up|2|||
156819802|NCT05059301|566089784|FG001|Overall Study|Lost to Follow-up|3|||
156819803|NCT05059301|566089785|FG002|Overall Study|Lost to Follow-up|3|||
156819804|NCT04952597|566089787|FG000|Overall Study|Death|12|||
156819805|NCT04952597|566089788|FG001|Overall Study|Death|13|||
156819806|NCT04952597|566089789|FG002|Overall Study|Death|14|||
156819807|NCT04952597|566089787|FG000|Overall Study|Withdrawal by Subject|1|||
156819808|NCT04952597|566089788|FG001|Overall Study|Withdrawal by Subject|0|||
156819809|NCT04952597|566089789|FG002|Overall Study|Withdrawal by Subject|3|||
156819810|NCT04952597|566089787|FG000|Overall Study|Lost to Follow-up|0|||
156819811|NCT04952597|566089788|FG001|Overall Study|Lost to Follow-up|1|||
156819812|NCT04952597|566089789|FG002|Overall Study|Lost to Follow-up|1|||
156819813|NCT01296711|566089790|FG000|Overall Study|Adverse Event|3|||
156819814|NCT01296711|566089791|FG001|Overall Study|Adverse Event|1|||
156819815|NCT01296711|566089792|FG002|Overall Study|Adverse Event|4|||
156819816|NCT01296711|566089793|FG003|Overall Study|Adverse Event|3|||
156819817|NCT01296711|566089794|FG004|Overall Study|Adverse Event|1|||
156819818|NCT01296711|566089795|FG005|Overall Study|Adverse Event|6|||
156819819|NCT01296711|566089796|FG006|Overall Study|Adverse Event|11|||
156819820|NCT01296711|566089797|FG007|Overall Study|Adverse Event|3|||
156819821|NCT01296711|566089790|FG000|Overall Study|Lack of Efficacy|1|||
156819822|NCT01296711|566089791|FG001|Overall Study|Lack of Efficacy|4|||
156819823|NCT01296711|566089792|FG002|Overall Study|Lack of Efficacy|1|||
156819824|NCT01296711|566089793|FG003|Overall Study|Lack of Efficacy|1|||
156819825|NCT01296711|566089794|FG004|Overall Study|Lack of Efficacy|1|||
156819826|NCT01296711|566089795|FG005|Overall Study|Lack of Efficacy|0|||
156819827|NCT01296711|566089796|FG006|Overall Study|Lack of Efficacy|2|||
156819828|NCT01296711|566089797|FG007|Overall Study|Lack of Efficacy|3|||
156819829|NCT01296711|566089790|FG000|Overall Study|Lost to Follow-up|0|||
156819830|NCT01296711|566089791|FG001|Overall Study|Lost to Follow-up|0|||
156819831|NCT01296711|566089792|FG002|Overall Study|Lost to Follow-up|1|||
156819832|NCT01296711|566089793|FG003|Overall Study|Lost to Follow-up|1|||
156819833|NCT01296711|566089794|FG004|Overall Study|Lost to Follow-up|2|||
156819834|NCT01296711|566089795|FG005|Overall Study|Lost to Follow-up|0|||
156819835|NCT01296711|566089796|FG006|Overall Study|Lost to Follow-up|4|||
156819836|NCT01296711|566089797|FG007|Overall Study|Lost to Follow-up|2|||
156819837|NCT01296711|566089790|FG000|Overall Study|Protocol Violation|0|||
156819838|NCT01296711|566089791|FG001|Overall Study|Protocol Violation|0|||
156819839|NCT01296711|566089792|FG002|Overall Study|Protocol Violation|0|||
156819840|NCT01296711|566089793|FG003|Overall Study|Protocol Violation|1|||
156819841|NCT01296711|566089794|FG004|Overall Study|Protocol Violation|1|||
156819842|NCT01296711|566089795|FG005|Overall Study|Protocol Violation|0|||
156819843|NCT01296711|566089796|FG006|Overall Study|Protocol Violation|0|||
156819844|NCT01296711|566089797|FG007|Overall Study|Protocol Violation|0|||
156819845|NCT01296711|566089790|FG000|Overall Study|Withdrawal by Subject|4|||
156819846|NCT01296711|566089791|FG001|Overall Study|Withdrawal by Subject|2|||
156819847|NCT01296711|566089792|FG002|Overall Study|Withdrawal by Subject|2|||
156819848|NCT01296711|566089793|FG003|Overall Study|Withdrawal by Subject|1|||
156819849|NCT01296711|566089794|FG004|Overall Study|Withdrawal by Subject|1|||
156819850|NCT01296711|566089795|FG005|Overall Study|Withdrawal by Subject|1|||
156819851|NCT01296711|566089796|FG006|Overall Study|Withdrawal by Subject|2|||
156819852|NCT01296711|566089797|FG007|Overall Study|Withdrawal by Subject|1|||
156819853|NCT01296711|566089790|FG000|Overall Study|Study termination|8|||
156819854|NCT01296711|566089791|FG001|Overall Study|Study termination|1|||
156819855|NCT01296711|566089792|FG002|Overall Study|Study termination|5|||
157150769|NCT02241512|567298085|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
156819856|NCT01296711|566089793|FG003|Overall Study|Study termination|4|||
157150770|NCT02385123|567298091|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
156819857|NCT01296711|566089794|FG004|Overall Study|Study termination|4|||
156819858|NCT01296711|566089795|FG005|Overall Study|Study termination|4|||
156819859|NCT01296711|566089796|FG006|Overall Study|Study termination|8|||
156819860|NCT01296711|566089797|FG007|Overall Study|Study termination|10|||
156819861|NCT01296711|566089790|FG000|Overall Study|Continued elevated liver enzymes|0|||
156884434|NCT02616146|566336241|FG000|Overall Study|Non-compliance with study protocol|2|||
156884435|NCT02616146|566336242|FG001|Overall Study|Non-compliance with study protocol|0|||
156819862|NCT01296711|566089791|FG001|Overall Study|Continued elevated liver enzymes|0|||
156819863|NCT01296711|566089792|FG002|Overall Study|Continued elevated liver enzymes|0|||
156819864|NCT01296711|566089793|FG003|Overall Study|Continued elevated liver enzymes|1|||
156819865|NCT01296711|566089794|FG004|Overall Study|Continued elevated liver enzymes|0|||
156819866|NCT01296711|566089795|FG005|Overall Study|Continued elevated liver enzymes|0|||
156819867|NCT01296711|566089796|FG006|Overall Study|Continued elevated liver enzymes|0|||
156819868|NCT01296711|566089797|FG007|Overall Study|Continued elevated liver enzymes|0|||
156819869|NCT01296711|566089790|FG000|Overall Study|Methotrexate discontinued|0|||
156884436|NCT02616146|566336241|FG000|Overall Study|Non-compliance with study drug|4|||
156819870|NCT01296711|566089791|FG001|Overall Study|Methotrexate discontinued|0|||
156819871|NCT01296711|566089792|FG002|Overall Study|Methotrexate discontinued|0|||
156819872|NCT01296711|566089793|FG003|Overall Study|Methotrexate discontinued|1|||
157224427|NCT00275002|567567986|FG000|Overall Study|Death|1|||
156819873|NCT01296711|566089794|FG004|Overall Study|Methotrexate discontinued|0|||
156819874|NCT01296711|566089795|FG005|Overall Study|Methotrexate discontinued|0|||
156819875|NCT01296711|566089796|FG006|Overall Study|Methotrexate discontinued|0|||
156819876|NCT01296711|566089797|FG007|Overall Study|Methotrexate discontinued|0|||
156819877|NCT01296711|566089790|FG000|Overall Study|Investigator discretion|0|||
156819878|NCT01296711|566089791|FG001|Overall Study|Investigator discretion|0|||
156819879|NCT01296711|566089792|FG002|Overall Study|Investigator discretion|0|||
156819880|NCT01296711|566089793|FG003|Overall Study|Investigator discretion|0|||
156819881|NCT01296711|566089794|FG004|Overall Study|Investigator discretion|0|||
156819882|NCT01296711|566089795|FG005|Overall Study|Investigator discretion|0|||
156819883|NCT01296711|566089796|FG006|Overall Study|Investigator discretion|1|||
156819884|NCT01296711|566089797|FG007|Overall Study|Investigator discretion|0|||
156819885|NCT01296711|566089790|FG000|Overall Study|Other|0|||
156819886|NCT01296711|566089791|FG001|Overall Study|Other|0|||
156819887|NCT01296711|566089792|FG002|Overall Study|Other|0|||
156819888|NCT01296711|566089793|FG003|Overall Study|Other|0|||
156819889|NCT01296711|566089794|FG004|Overall Study|Other|0|||
156819890|NCT01296711|566089795|FG005|Overall Study|Other|0|||
156819891|NCT01296711|566089796|FG006|Overall Study|Other|1|||
156819892|NCT01296711|566089797|FG007|Overall Study|Other|0|||
156819893|NCT01296711|566089790|FG000|Overall Study|Required restricted steroid injections|0|||
156819894|NCT01296711|566089791|FG001|Overall Study|Required restricted steroid injections|0|||
156819895|NCT01296711|566089792|FG002|Overall Study|Required restricted steroid injections|0|||
156819896|NCT01296711|566089793|FG003|Overall Study|Required restricted steroid injections|0|||
156819897|NCT01296711|566089794|FG004|Overall Study|Required restricted steroid injections|0|||
156819898|NCT01296711|566089795|FG005|Overall Study|Required restricted steroid injections|0|||
156819899|NCT01296711|566089796|FG006|Overall Study|Required restricted steroid injections|1|||
156819900|NCT01296711|566089797|FG007|Overall Study|Required restricted steroid injections|0|||
156819901|NCT01296711|566089790|FG000|Overall Study|Ongoing missed appointments|0|||
156819902|NCT01296711|566089791|FG001|Overall Study|Ongoing missed appointments|0|||
156819903|NCT01296711|566089792|FG002|Overall Study|Ongoing missed appointments|0|||
156819904|NCT01296711|566089793|FG003|Overall Study|Ongoing missed appointments|0|||
156819905|NCT01296711|566089794|FG004|Overall Study|Ongoing missed appointments|0|||
156819906|NCT01296711|566089795|FG005|Overall Study|Ongoing missed appointments|0|||
156819907|NCT01296711|566089796|FG006|Overall Study|Ongoing missed appointments|1|||
156819908|NCT01296711|566089797|FG007|Overall Study|Ongoing missed appointments|0|||
156819909|NCT01296711|566089790|FG000|Overall Study|Failure to comply with visits|0|||
156819910|NCT01296711|566089791|FG001|Overall Study|Failure to comply with visits|0|||
156819911|NCT01296711|566089792|FG002|Overall Study|Failure to comply with visits|0|||
156819912|NCT01296711|566089793|FG003|Overall Study|Failure to comply with visits|0|||
156819913|NCT01296711|566089794|FG004|Overall Study|Failure to comply with visits|0|||
156819914|NCT01296711|566089795|FG005|Overall Study|Failure to comply with visits|0|||
156819915|NCT01296711|566089796|FG006|Overall Study|Failure to comply with visits|0|||
156819916|NCT01296711|566089797|FG007|Overall Study|Failure to comply with visits|1|||
156819917|NCT01296711|566089790|FG000|Overall Study|Patient decision due to transport|0|||
156819918|NCT01296711|566089791|FG001|Overall Study|Patient decision due to transport|0|||
156819919|NCT01296711|566089792|FG002|Overall Study|Patient decision due to transport|0|||
156819920|NCT01296711|566089793|FG003|Overall Study|Patient decision due to transport|0|||
156819921|NCT01296711|566089794|FG004|Overall Study|Patient decision due to transport|0|||
156819922|NCT01296711|566089795|FG005|Overall Study|Patient decision due to transport|0|||
156819923|NCT01296711|566089796|FG006|Overall Study|Patient decision due to transport|0|||
156819924|NCT01296711|566089797|FG007|Overall Study|Patient decision due to transport|1|||
156819925|NCT00923975|566089803|FG000|Overall Study|Did not meet inclusion criteria|1|||
156819926|NCT01328535|566089804|FG000|Overall Study|Ineligible|1|||
156819927|NCT01005316|566089807|FG000|Overall Study|Adverse Event|0|||
156819928|NCT01005316|566089808|FG001|Overall Study|Adverse Event|0|||
156819929|NCT01005316|566089809|FG002|Overall Study|Adverse Event|0|||
156819930|NCT01005316|566089810|FG003|Overall Study|Adverse Event|1|||
156819931|NCT01005316|566089807|FG000|Overall Study|Death|20|||
156819932|NCT01005316|566089808|FG001|Overall Study|Death|5|||
156819933|NCT01005316|566089809|FG002|Overall Study|Death|1|||
156819934|NCT01005316|566089810|FG003|Overall Study|Death|15|||
156819935|NCT01005316|566089807|FG000|Overall Study|Study Termination|5|||
156884437|NCT02616146|566336242|FG001|Overall Study|Non-compliance with study drug|2|||
156884438|NCT02616146|566336241|FG000|Overall Study|Pregnancy|2|||
156819936|NCT01005316|566089808|FG001|Overall Study|Study Termination|63|||
156819937|NCT01005316|566089809|FG002|Overall Study|Study Termination|9|||
156819938|NCT01005316|566089810|FG003|Overall Study|Study Termination|85|||
156819939|NCT01005316|566089807|FG000|Overall Study|Lost to Follow-up|1|||
156819940|NCT01005316|566089808|FG001|Overall Study|Lost to Follow-up|3|||
156819941|NCT01005316|566089809|FG002|Overall Study|Lost to Follow-up|0|||
156819942|NCT01005316|566089810|FG003|Overall Study|Lost to Follow-up|2|||
156819943|NCT01005316|566089807|FG000|Overall Study|Physician Decision|6|||
156819944|NCT01005316|566089808|FG001|Overall Study|Physician Decision|0|||
156884439|NCT02616146|566336242|FG001|Overall Study|Pregnancy|2|||
156819945|NCT01005316|566089809|FG002|Overall Study|Physician Decision|0|||
156819946|NCT01005316|566089810|FG003|Overall Study|Physician Decision|0|||
156819947|NCT01005316|566089807|FG000|Overall Study|Sponsor Decision|6|||
156819948|NCT01005316|566089808|FG001|Overall Study|Sponsor Decision|3|||
156819949|NCT01005316|566089809|FG002|Overall Study|Sponsor Decision|0|||
156819950|NCT01005316|566089810|FG003|Overall Study|Sponsor Decision|0|||
156819951|NCT01005316|566089807|FG000|Overall Study|Withdrawal by Subject|1|||
156819952|NCT01005316|566089808|FG001|Overall Study|Withdrawal by Subject|1|||
156819953|NCT01005316|566089809|FG002|Overall Study|Withdrawal by Subject|0|||
156819954|NCT01005316|566089810|FG003|Overall Study|Withdrawal by Subject|2|||
156819955|NCT01005316|566089807|FG000|Overall Study|Consented to Another Study|2|||
156819956|NCT01005316|566089808|FG001|Overall Study|Consented to Another Study|0|||
156819957|NCT01005316|566089809|FG002|Overall Study|Consented to Another Study|0|||
156819958|NCT01005316|566089810|FG003|Overall Study|Consented to Another Study|0|||
156819959|NCT01005316|566089807|FG000|Overall Study|Delisted|8|||
156819960|NCT01005316|566089808|FG001|Overall Study|Delisted|0|||
156819961|NCT01005316|566089809|FG002|Overall Study|Delisted|0|||
156819962|NCT01005316|566089810|FG003|Overall Study|Delisted|0|||
156819963|NCT01005316|566089807|FG000|Overall Study|Transferred Care|1|||
156819964|NCT01005316|566089808|FG001|Overall Study|Transferred Care|0|||
156819965|NCT01005316|566089809|FG002|Overall Study|Transferred Care|1|||
156819966|NCT01005316|566089810|FG003|Overall Study|Transferred Care|3|||
156819967|NCT01005316|566089807|FG000|Overall Study|Retransplanted|0|||
156819968|NCT01005316|566089808|FG001|Overall Study|Retransplanted|1|||
156819969|NCT01005316|566089809|FG002|Overall Study|Retransplanted|0|||
156819970|NCT01005316|566089810|FG003|Overall Study|Retransplanted|0|||
156819971|NCT00632827|566089811|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
156819972|NCT00632827|566089811|FG000|Overall Study|Death|2|||
156819973|NCT00632827|566089811|FG000|Overall Study|Adverse Event|5|||
156819974|NCT00632827|566089811|FG000|Overall Study|Lost to Follow-up|1|||
156819975|NCT01035463|566089812|FG000|Overall Study|Adverse Event|0|||
156819976|NCT01035463|566089813|FG001|Overall Study|Adverse Event|0|||
156819977|NCT01035463|566089814|FG002|Overall Study|Adverse Event|4|||
156819978|NCT01035463|566089815|FG003|Overall Study|Adverse Event|1|||
156819979|NCT01035463|566089816|FG004|Overall Study|Adverse Event|5|||
156819980|NCT01035463|566089817|FG005|Overall Study|Adverse Event|7|||
156819981|NCT01035463|566089812|FG000|Overall Study|Withdrawal by Subject|0|||
156819982|NCT01035463|566089813|FG001|Overall Study|Withdrawal by Subject|2|||
156819983|NCT01035463|566089814|FG002|Overall Study|Withdrawal by Subject|1|||
156819984|NCT01035463|566089815|FG003|Overall Study|Withdrawal by Subject|0|||
156819985|NCT01035463|566089816|FG004|Overall Study|Withdrawal by Subject|1|||
156819986|NCT01035463|566089817|FG005|Overall Study|Withdrawal by Subject|4|||
156819987|NCT01035463|566089812|FG000|Overall Study|Disease progression|0|||
156819988|NCT01035463|566089813|FG001|Overall Study|Disease progression|0|||
156819989|NCT01035463|566089814|FG002|Overall Study|Disease progression|0|||
156819990|NCT01035463|566089815|FG003|Overall Study|Disease progression|0|||
156819991|NCT01035463|566089816|FG004|Overall Study|Disease progression|0|||
156819992|NCT01035463|566089817|FG005|Overall Study|Disease progression|3|||
156819993|NCT01035463|566089812|FG000|Overall Study|Other Malignancy|0|||
156819994|NCT01035463|566089813|FG001|Overall Study|Other Malignancy|0|||
156819995|NCT01035463|566089814|FG002|Overall Study|Other Malignancy|0|||
156819996|NCT01035463|566089815|FG003|Overall Study|Other Malignancy|0|||
156819997|NCT01035463|566089816|FG004|Overall Study|Other Malignancy|0|||
156819998|NCT01035463|566089817|FG005|Overall Study|Other Malignancy|2|||
156819999|NCT01035463|566089812|FG000|Overall Study|Other|0|||
156820000|NCT01035463|566089813|FG001|Overall Study|Other|0|||
156820001|NCT01035463|566089814|FG002|Overall Study|Other|0|||
156820002|NCT01035463|566089815|FG003|Overall Study|Other|1|||
156820003|NCT01035463|566089816|FG004|Overall Study|Other|0|||
156820004|NCT01035463|566089817|FG005|Overall Study|Other|2|||
156884440|NCT02616146|566336241|FG000|Overall Study|Pregnancy wish|3|||
156884441|NCT02616146|566336242|FG001|Overall Study|Pregnancy wish|0|||
156884442|NCT02616146|566336241|FG000|Overall Study|Protocol Violation|6|||
156884443|NCT02616146|566336242|FG001|Overall Study|Protocol Violation|3|||
156884444|NCT02616146|566336241|FG000|Overall Study|Study terminated by sponsor|1372|||
156820005|NCT01257230|566089820|FG000|Overall Study|Not Treated|0|||
156820006|NCT01257230|566089821|FG001|Overall Study|Not Treated|0|||
156820007|NCT01257230|566089822|FG002|Overall Study|Not Treated|1|||
156820008|NCT01257230|566089820|FG000|Overall Study|Adverse Event|2|||
156820009|NCT01257230|566089821|FG001|Overall Study|Adverse Event|0|||
156820010|NCT01257230|566089822|FG002|Overall Study|Adverse Event|0|||
156820011|NCT01257230|566089820|FG000|Overall Study|Lack of Efficacy|0|||
156820012|NCT01257230|566089821|FG001|Overall Study|Lack of Efficacy|1|||
156820013|NCT01257230|566089822|FG002|Overall Study|Lack of Efficacy|0|||
156820014|NCT01257230|566089820|FG000|Overall Study|Protocol Violation|3|||
156820015|NCT01257230|566089821|FG001|Overall Study|Protocol Violation|0|||
156820016|NCT01257230|566089822|FG002|Overall Study|Protocol Violation|1|||
156820017|NCT01257230|566089820|FG000|Overall Study|Withdrawal by Subject|0|||
156820018|NCT01257230|566089821|FG001|Overall Study|Withdrawal by Subject|4|||
156884445|NCT02616146|566336242|FG001|Overall Study|Study terminated by sponsor|432|||
156884446|NCT02616146|566336241|FG000|Overall Study|Participant moved|4|||
156820019|NCT01257230|566089822|FG002|Overall Study|Withdrawal by Subject|1|||
156820020|NCT01257230|566089820|FG000|Overall Study|Other reason not defined above|1|||
156820021|NCT01257230|566089821|FG001|Overall Study|Other reason not defined above|5|||
156820022|NCT01257230|566089822|FG002|Overall Study|Other reason not defined above|3|||
156820023|NCT01205061|566089830|FG000|Overall Study|Adverse Event|4|||
156820024|NCT01205061|566089830|FG000|Overall Study|Withdrawal by Subject|11|||
156820025|NCT01205061|566089830|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
156820026|NCT01205061|566089830|FG000|Overall Study|Lost to Follow-up|9|||
156820027|NCT01205061|566089830|FG000|Overall Study|Other|1|||
156820028|NCT01988662|566089835|FG000|Overall Study|Subject/guardian decision|1|||
156820029|NCT01988662|566089836|FG001|Overall Study|Subject/guardian decision|1|||
156820030|NCT01988662|566089835|FG000|Overall Study|Adverse Event|3|||
156820031|NCT01988662|566089836|FG001|Overall Study|Adverse Event|1|||
156820032|NCT03748706|566089837|FG000|Overall Study|Lost to Follow-up|1|||
156820033|NCT03655054|566089845|FG000|Overall Study|Lost to Follow-up|1|||
156820034|NCT01626118|566089846|FG000|Overall Study|Lack of Efficacy|1|||
156820035|NCT01626118|566089847|FG001|Overall Study|Lack of Efficacy|0|||
156820036|NCT01626118|566089848|FG002|Overall Study|Lack of Efficacy|1|||
156820037|NCT01626118|566089849|FG003|Overall Study|Lack of Efficacy|3|||
156820038|NCT01626118|566089846|FG000|Overall Study|Lost to Follow-up|1|||
156820039|NCT01626118|566089847|FG001|Overall Study|Lost to Follow-up|0|||
156820040|NCT01626118|566089848|FG002|Overall Study|Lost to Follow-up|0|||
156820041|NCT01626118|566089849|FG003|Overall Study|Lost to Follow-up|0|||
156820042|NCT01626118|566089846|FG000|Overall Study|Adverse Event|0|||
156820043|NCT01626118|566089847|FG001|Overall Study|Adverse Event|1|||
156820044|NCT01626118|566089848|FG002|Overall Study|Adverse Event|1|||
156820045|NCT01626118|566089849|FG003|Overall Study|Adverse Event|0|||
156820046|NCT01626118|566089846|FG000|Overall Study|Investigator Decision|0|||
156820047|NCT01626118|566089847|FG001|Overall Study|Investigator Decision|1|||
156820048|NCT01626118|566089848|FG002|Overall Study|Investigator Decision|0|||
156820049|NCT01626118|566089849|FG003|Overall Study|Investigator Decision|0|||
156820050|NCT03931382|566089850|FG000|Overall Study|Equipment malfunction|2|||
156820051|NCT03931382|566089851|FG001|Overall Study|Equipment malfunction|0|||
156820052|NCT03931382|566089852|FG002|Overall Study|Equipment malfunction|2|||
156820053|NCT03931382|566089850|FG000|Overall Study|Withdrawal by Subject|0|||
156820054|NCT03931382|566089851|FG001|Overall Study|Withdrawal by Subject|1|||
156820055|NCT03931382|566089852|FG002|Overall Study|Withdrawal by Subject|0|||
156820056|NCT01864148|566089853|FG000|Overall Study|Other|2|||
156820057|NCT01864148|566089854|FG001|Overall Study|Other|1|||
156820058|NCT01864148|566089855|FG002|Overall Study|Other|1|||
156820059|NCT01864148|566089856|FG003|Overall Study|Other|3|||
156820060|NCT01864148|566089857|FG004|Overall Study|Other|1|||
156820061|NCT01864148|566089853|FG000|Overall Study|Death|0|||
156820062|NCT01864148|566089854|FG001|Overall Study|Death|0|||
156820063|NCT01864148|566089855|FG002|Overall Study|Death|0|||
156820064|NCT01864148|566089856|FG003|Overall Study|Death|1|||
156820065|NCT01864148|566089857|FG004|Overall Study|Death|0|||
156820066|NCT01864148|566089853|FG000|Overall Study|Investigator Decision|5|||
156820067|NCT01864148|566089854|FG001|Overall Study|Investigator Decision|0|||
156820068|NCT01864148|566089855|FG002|Overall Study|Investigator Decision|0|||
156820069|NCT01864148|566089856|FG003|Overall Study|Investigator Decision|4|||
156820070|NCT01864148|566089857|FG004|Overall Study|Investigator Decision|6|||
156820071|NCT01864148|566089853|FG000|Overall Study|Withdrawal by Subject|9|||
156820072|NCT01864148|566089854|FG001|Overall Study|Withdrawal by Subject|2|||
156820073|NCT01864148|566089855|FG002|Overall Study|Withdrawal by Subject|6|||
156820074|NCT01864148|566089856|FG003|Overall Study|Withdrawal by Subject|8|||
156820075|NCT01864148|566089857|FG004|Overall Study|Withdrawal by Subject|8|||
156820076|NCT01864148|566089853|FG000|Overall Study|Lost to Follow-up|0|||
156820077|NCT01864148|566089854|FG001|Overall Study|Lost to Follow-up|0|||
156820078|NCT01864148|566089855|FG002|Overall Study|Lost to Follow-up|0|||
156820079|NCT01864148|566089856|FG003|Overall Study|Lost to Follow-up|2|||
156820080|NCT01864148|566089857|FG004|Overall Study|Lost to Follow-up|1|||
156820081|NCT01864148|566089853|FG000|Overall Study|Adverse Event|4|||
156820082|NCT01864148|566089854|FG001|Overall Study|Adverse Event|2|||
156820083|NCT01864148|566089855|FG002|Overall Study|Adverse Event|4|||
156820084|NCT01864148|566089856|FG003|Overall Study|Adverse Event|7|||
156820085|NCT01864148|566089857|FG004|Overall Study|Adverse Event|7|||
156820086|NCT01864148|566089853|FG000|Overall Study|Not Dosed|0|||
157150771|NCT04498910|567298092|FG000|Overall Study|Lost to Follow-up|0|||
156820087|NCT01864148|566089854|FG001|Overall Study|Not Dosed|0|||
156820088|NCT01864148|566089855|FG002|Overall Study|Not Dosed|0|||
156820089|NCT01864148|566089856|FG003|Overall Study|Not Dosed|1|||
156820090|NCT01864148|566089857|FG004|Overall Study|Not Dosed|0|||
156820091|NCT01500252|566089858|FG000|Overall Study|Death|4|||
156820092|NCT01500252|566089859|FG001|Overall Study|Death|2|||
156820093|NCT01500252|566089858|FG000|Overall Study|Lost to Follow-up|5|||
156820094|NCT01500252|566089859|FG001|Overall Study|Lost to Follow-up|4|||
156820095|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
156820096|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
156884447|NCT02616146|566336242|FG001|Overall Study|Participant moved|3|||
156820097|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
156820098|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
156820099|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
156820100|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
156820101|NCT03490292|566089860|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
156820102|NCT03490292|566089861|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
156820103|NCT03490292|566089860|FG000|1 Year Follow Up Post Last Dose|Death|1|||
156820104|NCT03490292|566089861|FG001|1 Year Follow Up Post Last Dose|Death|1|||
156820105|NCT01106651|566089862|FG000|Overall Study|Adverse Event|17|||
156820106|NCT01106651|566089863|FG001|Overall Study|Adverse Event|9|||
156820107|NCT01106651|566089864|FG002|Overall Study|Adverse Event|23|||
156820108|NCT01106651|566089862|FG000|Overall Study|Lost to Follow-up|8|||
156820109|NCT01106651|566089863|FG001|Overall Study|Lost to Follow-up|2|||
156820110|NCT01106651|566089864|FG002|Overall Study|Lost to Follow-up|6|||
156820111|NCT01106651|566089862|FG000|Overall Study|Physician Decision|4|||
156820112|NCT01106651|566089863|FG001|Overall Study|Physician Decision|3|||
156820113|NCT01106651|566089864|FG002|Overall Study|Physician Decision|1|||
156820114|NCT01106651|566089862|FG000|Overall Study|Protocol Violation|1|||
156820115|NCT01106651|566089863|FG001|Overall Study|Protocol Violation|2|||
156820116|NCT01106651|566089864|FG002|Overall Study|Protocol Violation|1|||
156820117|NCT01106651|566089862|FG000|Overall Study|Withdrawal by Subject|14|||
156820118|NCT01106651|566089863|FG001|Overall Study|Withdrawal by Subject|7|||
156820119|NCT01106651|566089864|FG002|Overall Study|Withdrawal by Subject|4|||
156820120|NCT01106651|566089862|FG000|Overall Study|Noncompliance with study drug|1|||
156820121|NCT01106651|566089863|FG001|Overall Study|Noncompliance with study drug|0|||
156820122|NCT01106651|566089864|FG002|Overall Study|Noncompliance with study drug|2|||
156820123|NCT01106651|566089862|FG000|Overall Study|Other|34|||
156820124|NCT01106651|566089863|FG001|Overall Study|Other|31|||
156820125|NCT01106651|566089864|FG002|Overall Study|Other|21|||
156820126|NCT01106651|566089862|FG000|Overall Study|Death|0|||
156820127|NCT01106651|566089863|FG001|Overall Study|Death|3|||
156820128|NCT01106651|566089864|FG002|Overall Study|Death|0|||
156820129|NCT00904670|566089865|FG000|Open Label Phase|Withdrawal by Subject|2|||
156820130|NCT00904670|566089866|FG001|Open Label Phase|Withdrawal by Subject|0|||
156820131|NCT00904670|566089865|FG000|Open Label Phase|Adverse Event|2|||
156820132|NCT00904670|566089866|FG001|Open Label Phase|Adverse Event|0|||
156820133|NCT00904670|566089865|FG000|Open Label Phase|Lack of Efficacy|1|||
156820134|NCT00904670|566089866|FG001|Open Label Phase|Lack of Efficacy|0|||
156820135|NCT00904670|566089865|FG000|Open Label Phase|Lost to Follow-up|1|||
156820136|NCT00904670|566089866|FG001|Open Label Phase|Lost to Follow-up|0|||
156820137|NCT02120300|566089871|FG000|Overall Study|Enrolled but Never Treated|2|||
156820138|NCT02120300|566089872|FG001|Overall Study|Enrolled but Never Treated|0|||
156820139|NCT02120300|566089873|FG002|Overall Study|Enrolled but Never Treated|0|||
156820140|NCT02120300|566089874|FG003|Overall Study|Enrolled but Never Treated|0|||
156820141|NCT02120300|566089871|FG000|Overall Study|Lack of Efficacy|0|||
156820142|NCT02120300|566089872|FG001|Overall Study|Lack of Efficacy|0|||
156820143|NCT02120300|566089873|FG002|Overall Study|Lack of Efficacy|0|||
156820144|NCT02120300|566089874|FG003|Overall Study|Lack of Efficacy|1|||
156820145|NCT02120300|566089871|FG000|Overall Study|Lost to Follow-up|1|||
156820146|NCT02120300|566089872|FG001|Overall Study|Lost to Follow-up|0|||
156820147|NCT02120300|566089873|FG002|Overall Study|Lost to Follow-up|0|||
156820148|NCT02120300|566089874|FG003|Overall Study|Lost to Follow-up|0|||
156820149|NCT01721486|566089883|FG000|Overall Study|Protocol Violation|1|||
156820150|NCT01721486|566089884|FG001|Overall Study|Protocol Violation|0|||
156820151|NCT01721486|566089883|FG000|Overall Study|Physician Decision|0|||
156820152|NCT01721486|566089884|FG001|Overall Study|Physician Decision|1|||
156820153|NCT00889603|566089885|FG000|Overall Study|Adverse Event|7|||
156820154|NCT00889603|566089885|FG000|Overall Study|Death|3|||
156820155|NCT00889603|566089885|FG000|Overall Study|Lost to Follow-up|19|||
156820156|NCT00889603|566089885|FG000|Overall Study|No longer willing to participant in stud|4|||
156820157|NCT00889603|566089885|FG000|Overall Study|Other|4|||
156820158|NCT03525600|566089888|FG000|Overall Study|Adverse Event|9|||
156820159|NCT03525600|566089889|FG001|Overall Study|Adverse Event|6|||
156820160|NCT03525600|566089890|FG002|Overall Study|Adverse Event|5|||
157150772|NCT04498910|567298093|FG001|Overall Study|Lost to Follow-up|1|||
156820161|NCT03525600|566089891|FG003|Overall Study|Adverse Event|3|||
156820162|NCT03525600|566089888|FG000|Overall Study|Lost to Follow-up|2|||
156820163|NCT03525600|566089889|FG001|Overall Study|Lost to Follow-up|4|||
156820164|NCT03525600|566089890|FG002|Overall Study|Lost to Follow-up|4|||
156820165|NCT03525600|566089891|FG003|Overall Study|Lost to Follow-up|0|||
156884448|NCT02616146|566336241|FG000|Overall Study|Withdrawal by Subject|30|||
156820166|NCT03525600|566089888|FG000|Overall Study|Physician Decision|1|||
156884449|NCT02616146|566336242|FG001|Overall Study|Withdrawal by Subject|24|||
156820167|NCT03525600|566089889|FG001|Overall Study|Physician Decision|0|||
156820168|NCT03525600|566089890|FG002|Overall Study|Physician Decision|2|||
156820169|NCT03525600|566089891|FG003|Overall Study|Physician Decision|0|||
156820170|NCT03525600|566089888|FG000|Overall Study|Consent withdrawal|36|||
156884450|NCT02616146|566336241|FG000|Overall Study|Physician Decision|2|||
156820171|NCT03525600|566089889|FG001|Overall Study|Consent withdrawal|20|||
156820172|NCT03525600|566089890|FG002|Overall Study|Consent withdrawal|6|||
156820173|NCT03525600|566089891|FG003|Overall Study|Consent withdrawal|13|||
156820174|NCT03525600|566089888|FG000|Overall Study|Death|7|||
156820175|NCT03525600|566089889|FG001|Overall Study|Death|6|||
156820176|NCT03525600|566089890|FG002|Overall Study|Death|4|||
156820177|NCT03525600|566089891|FG003|Overall Study|Death|3|||
156820178|NCT03525600|566089888|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
156820179|NCT03525600|566089889|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
156820180|NCT03525600|566089890|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
156820181|NCT03525600|566089891|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
156820182|NCT03525600|566089888|FG000|Overall Study|Other|0|||
156820183|NCT03525600|566089889|FG001|Overall Study|Other|1|||
156820184|NCT03525600|566089890|FG002|Overall Study|Other|0|||
156820185|NCT03525600|566089891|FG003|Overall Study|Other|0|||
156820186|NCT00613327|566089892|FG000|Overall Study|Adverse Event|38|||
156820187|NCT00613327|566089892|FG000|Overall Study|Lost to Follow-up|8|||
156820188|NCT00613327|566089892|FG000|Overall Study|Withdrawal by Subject|6|||
156820189|NCT00613327|566089892|FG000|Overall Study|Protocol Violation|2|||
156820190|NCT00613327|566089892|FG000|Overall Study|Other|47|||
156820191|NCT01814397|566089893|FG000|Overall Study|Adverse Event|7|||
156820192|NCT01814397|566089893|FG000|Overall Study|Withdrawal by Subject|7|||
156820193|NCT00313144|566089894|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
156820194|NCT00313144|566089894|FG000|Overall Study|Death|7|||
156820195|NCT00313144|566089894|FG000|Overall Study|Lost to Follow-up|5|||
156820196|NCT00313144|566089894|FG000|Overall Study|Withdrawal by Subject|4|||
156820197|NCT00313144|566089894|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
156820198|NCT00313144|566089894|FG000|Overall Study|Physician Decision|4|||
156820199|NCT00313144|566089894|FG000|Overall Study|Adverse event - transient|5|||
156820200|NCT00313144|566089894|FG000|Overall Study|Liver transplant|1|||
156820201|NCT00313144|566089894|FG000|Overall Study|Insurance (homecare provider) change|1|||
156820202|NCT00313144|566089894|FG000|Overall Study|Change to different product|1|||
156820203|NCT00313144|566089894|FG000|Overall Study|Due to termination of the study|66|||
156820204|NCT04154293|566089897|FG000|Overall Study|Withdrawal by Subject|2|||
156820205|NCT04154293|566089898|FG001|Overall Study|Withdrawal by Subject|3|||
156820206|NCT04154293|566089899|FG002|Overall Study|Withdrawal by Subject|1|||
156820207|NCT04154293|566089897|FG000|Overall Study|Physician Decision|0|||
156820208|NCT04154293|566089898|FG001|Overall Study|Physician Decision|0|||
156820209|NCT04154293|566089899|FG002|Overall Study|Physician Decision|1|||
156820210|NCT04731298|566089900|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
156820211|NCT04731298|566089901|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
156820212|NCT02487654|566089910|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
156820213|NCT02487654|566089911|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
156820214|NCT02487654|566089910|FG000|Overall Study|Withdrawal by Subject|3|||
156820215|NCT02487654|566089911|FG001|Overall Study|Withdrawal by Subject|7|||
156820216|NCT04238481|566089912|FG000|Overall Study|Miscellaneous|0|||
156820217|NCT04238481|566089913|FG001|Overall Study|Miscellaneous|1|||
156820218|NCT04238481|566089914|FG002|Overall Study|Miscellaneous|0|||
156820219|NCT04238481|566089915|FG003|Overall Study|Miscellaneous|0|||
156820220|NCT02152371|566089916|FG000|Overall Study|Adverse Event|6|||
156820221|NCT02152371|566089917|FG001|Overall Study|Adverse Event|2|||
156820222|NCT02152371|566089916|FG000|Overall Study|Withdrawal by Subject|3|||
156820223|NCT02152371|566089917|FG001|Overall Study|Withdrawal by Subject|7|||
156820224|NCT02152371|566089916|FG000|Overall Study|Protocol Violation|2|||
156820225|NCT02152371|566089917|FG001|Overall Study|Protocol Violation|3|||
156820226|NCT02152371|566089916|FG000|Overall Study|Lost to Follow-up|1|||
156820227|NCT02152371|566089917|FG001|Overall Study|Lost to Follow-up|0|||
156820228|NCT02152371|566089916|FG000|Overall Study|Lack of Efficacy|0|||
156820229|NCT02152371|566089917|FG001|Overall Study|Lack of Efficacy|1|||
156820230|NCT02152371|566089916|FG000|Overall Study|Physician Decision|0|||
156820231|NCT02152371|566089917|FG001|Overall Study|Physician Decision|2|||
156820232|NCT02152371|566089916|FG000|Overall Study|Reason Not Given|0|||
156820233|NCT02152371|566089917|FG001|Overall Study|Reason Not Given|1|||
156820234|NCT00349921|566089918|FG000|First Spinal Injection|Physician Decision|1|||
156820235|NCT00349921|566089919|FG001|First Spinal Injection|Physician Decision|0|||
156820236|NCT00349921|566089920|FG002|First Spinal Injection|Physician Decision|0|||
156820237|NCT00349921|566089921|FG003|First Spinal Injection|Physician Decision|0|||
156820238|NCT00349921|566089918|FG000|First Spinal Injection|Adverse Event|0|||
156820239|NCT00349921|566089919|FG001|First Spinal Injection|Adverse Event|0|||
156820240|NCT00349921|566089920|FG002|First Spinal Injection|Adverse Event|1|||
156820241|NCT00349921|566089921|FG003|First Spinal Injection|Adverse Event|0|||
156820242|NCT05285644|566089922|FG000|Overall Study|Adverse Event|3|||
157224428|NCT00275002|567567987|FG001|Overall Study|Death|0|||
156820243|NCT05285644|566089923|FG001|Overall Study|Adverse Event|3|||
156820244|NCT05285644|566089922|FG000|Overall Study|Withdrawal of Consent|2|||
156820245|NCT05285644|566089923|FG001|Overall Study|Withdrawal of Consent|5|||
157224429|NCT00275002|567567986|FG000|Overall Study|Disease progression|21|||
156820246|NCT05285644|566089922|FG000|Overall Study|Noncompliance|0|||
156820247|NCT05285644|566089923|FG001|Overall Study|Noncompliance|4|||
156820248|NCT05285644|566089922|FG000|Overall Study|Lost to Follow-up|4|||
156820249|NCT05285644|566089923|FG001|Overall Study|Lost to Follow-up|6|||
156820250|NCT05285644|566089922|FG000|Overall Study|Disallowed Concurrent Medication|1|||
156820251|NCT05285644|566089923|FG001|Overall Study|Disallowed Concurrent Medication|1|||
156820252|NCT05285644|566089922|FG000|Overall Study|Investigator Decision|2|||
156820253|NCT05285644|566089923|FG001|Overall Study|Investigator Decision|0|||
156820254|NCT05285644|566089922|FG000|Overall Study|Protocol Deviation|1|||
156820255|NCT05285644|566089923|FG001|Overall Study|Protocol Deviation|0|||
156820256|NCT05285644|566089922|FG000|Overall Study|As specified in the Clinical Study Report|7|||
156820257|NCT05285644|566089923|FG001|Overall Study|As specified in the Clinical Study Report|3|||
156820258|NCT02470585|566089929|FG000|Overall Study|Death|224|||
156820259|NCT02470585|566089930|FG001|Overall Study|Death|227|||
156820260|NCT02470585|566089931|FG002|Overall Study|Death|199|||
156820261|NCT02470585|566089929|FG000|Overall Study|Withdrew consent|21|||
156820262|NCT02470585|566089930|FG001|Overall Study|Withdrew consent|22|||
156820263|NCT02470585|566089931|FG002|Overall Study|Withdrew consent|31|||
156820264|NCT02470585|566089929|FG000|Overall Study|Lost to Follow-up|8|||
156820265|NCT02470585|566089930|FG001|Overall Study|Lost to Follow-up|15|||
156820266|NCT02470585|566089931|FG002|Overall Study|Lost to Follow-up|13|||
156820267|NCT02470585|566089929|FG000|Overall Study|Sponsor discontinued study|117|||
156820268|NCT02470585|566089930|FG001|Overall Study|Sponsor discontinued study|110|||
156820269|NCT02470585|566089931|FG002|Overall Study|Sponsor discontinued study|122|||
156820270|NCT02470585|566089929|FG000|Overall Study|Other, not specified|5|||
156820271|NCT02470585|566089930|FG001|Overall Study|Other, not specified|7|||
156820272|NCT02470585|566089931|FG002|Overall Study|Other, not specified|14|||
156820273|NCT02470585|566089929|FG000|Overall Study|Missing due to site non-compliance|0|||
156820274|NCT02470585|566089930|FG001|Overall Study|Missing due to site non-compliance|2|||
156820275|NCT02470585|566089931|FG002|Overall Study|Missing due to site non-compliance|3|||
156820276|NCT03028415|566089932|FG000|Overall Study|Lost to Follow-up|6|||
156820277|NCT03028415|566089933|FG001|Overall Study|Lost to Follow-up|3|||
156820278|NCT03028415|566089932|FG000|Overall Study|Withdrawal by Subject|1|||
156820279|NCT03028415|566089933|FG001|Overall Study|Withdrawal by Subject|0|||
156820280|NCT03028415|566089932|FG000|Overall Study|Discontinued due to COVID-19|1|||
156820281|NCT03028415|566089933|FG001|Overall Study|Discontinued due to COVID-19|0|||
156820282|NCT02907216|566089934|FG000|Overall Study|No benefit to be obtained by continuing|0|||
156820283|NCT02907216|566089935|FG001|Overall Study|No benefit to be obtained by continuing|1|||
156820284|NCT02907216|566089934|FG000|Overall Study|Withdrawal by Subject|1|||
156820285|NCT02907216|566089935|FG001|Overall Study|Withdrawal by Subject|0|||
156820286|NCT02640625|566092477|FG000|Overall Study|Adverse Event|1|||
156820287|NCT02370537|566092478|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
156820288|NCT02370537|566092479|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
156820289|NCT02370537|566092480|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
156820290|NCT02370537|566092478|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
156820291|NCT02370537|566092479|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
156820292|NCT02370537|566092480|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
156820293|NCT02370537|566092478|FG000|Part B|Not randomised to receive treatment|1|||
156820294|NCT02370537|566092479|FG001|Part B|Not randomised to receive treatment|2|||
156820295|NCT02370537|566092480|FG002|Part B|Not randomised to receive treatment|259|||
156820296|NCT02370537|566092478|FG000|Part B|Withdrawal by Subject|0|||
156820297|NCT02370537|566092479|FG001|Part B|Withdrawal by Subject|1|||
156820298|NCT02370537|566092480|FG002|Part B|Withdrawal by Subject|0|||
156820299|NCT03100539|566092485|FG000|Overall Study|Lost to Follow-up|60|||
156820300|NCT03100539|566092486|FG001|Overall Study|Lost to Follow-up|54|||
156820301|NCT03100539|566092487|FG002|Overall Study|Lost to Follow-up|17|||
156820302|NCT03100539|566092485|FG000|Overall Study|Uncollected|8|||
156820303|NCT03100539|566092486|FG001|Overall Study|Uncollected|8|||
156820304|NCT03100539|566092487|FG002|Overall Study|Uncollected|0|||
156820305|NCT03100539|566092485|FG000|Overall Study|Ally Health|0|||
156820306|NCT03100539|566092486|FG001|Overall Study|Ally Health|0|||
156820307|NCT03100539|566092487|FG002|Overall Study|Ally Health|3|||
156820308|NCT03100539|566092485|FG000|Overall Study|Disinterest|0|||
156820309|NCT03100539|566092486|FG001|Overall Study|Disinterest|0|||
156884451|NCT02616146|566336242|FG001|Overall Study|Physician Decision|1|||
156820310|NCT03100539|566092487|FG002|Overall Study|Disinterest|22|||
156820311|NCT03100539|566092485|FG000|Overall Study|Veteran Health|0|||
156820312|NCT03100539|566092486|FG001|Overall Study|Veteran Health|0|||
156820313|NCT03100539|566092487|FG002|Overall Study|Veteran Health|8|||
156820314|NCT03100539|566092485|FG000|Overall Study|Moved|0|||
156820315|NCT03100539|566092486|FG001|Overall Study|Moved|0|||
156820316|NCT03100539|566092487|FG002|Overall Study|Moved|1|||
156820317|NCT03100539|566092485|FG000|Overall Study|Scheduling Conflicts|0|||
156820318|NCT03100539|566092486|FG001|Overall Study|Scheduling Conflicts|0|||
156820319|NCT03100539|566092487|FG002|Overall Study|Scheduling Conflicts|12|||
156820320|NCT05659719|566092491|FG000|Overall Study|At sponsor's request|0|||
156820321|NCT05659719|566092492|FG001|Overall Study|At sponsor's request|0|||
156820322|NCT05659719|566092493|FG002|Overall Study|At sponsor's request|0|||
156820323|NCT05659719|566092494|FG003|Overall Study|At sponsor's request|95|||
156820324|NCT05659719|566092491|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820325|NCT05659719|566092492|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820326|NCT05659719|566092493|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
156820327|NCT05659719|566092494|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
156820328|NCT05659719|566092491|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
156820329|NCT05659719|566092492|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
156820330|NCT05659719|566092493|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
156820331|NCT05659719|566092494|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
156820332|NCT05659719|566092491|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820333|NCT05659719|566092492|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820334|NCT05659719|566092493|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
156820335|NCT05659719|566092494|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
156820336|NCT05659719|566092491|FG000|Overall Study|Lost to Follow-up|0|||
156820337|NCT05659719|566092492|FG001|Overall Study|Lost to Follow-up|0|||
156820338|NCT05659719|566092493|FG002|Overall Study|Lost to Follow-up|0|||
156820339|NCT05659719|566092494|FG003|Overall Study|Lost to Follow-up|2|||
156820340|NCT05659719|566092491|FG000|Overall Study|Moved to another observational study|0|||
156820341|NCT05659719|566092492|FG001|Overall Study|Moved to another observational study|0|||
156820342|NCT05659719|566092493|FG002|Overall Study|Moved to another observational study|0|||
156820343|NCT05659719|566092494|FG003|Overall Study|Moved to another observational study|1|||
156820344|NCT05659719|566092491|FG000|Overall Study|The child was enrolled in an interventional study|0|||
156820345|NCT05659719|566092492|FG001|Overall Study|The child was enrolled in an interventional study|0|||
156820346|NCT05659719|566092493|FG002|Overall Study|The child was enrolled in an interventional study|0|||
156820347|NCT05659719|566092494|FG003|Overall Study|The child was enrolled in an interventional study|55|||
156820348|NCT05659719|566092491|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820349|NCT05659719|566092492|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820350|NCT05659719|566092493|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
156820351|NCT05659719|566092494|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
156820352|NCT05659719|566092491|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820353|NCT05659719|566092492|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820354|NCT05659719|566092493|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
156820355|NCT05659719|566092494|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
156820356|NCT02290691|566092495|FG000|Overall Study|Noncompliance|0|||
156820357|NCT02290691|566092496|FG001|Overall Study|Noncompliance|1|||
156820358|NCT02290691|566092495|FG000|Overall Study|Withdrawal by Subject|1|||
156820359|NCT02290691|566092496|FG001|Overall Study|Withdrawal by Subject|1|||
156820360|NCT02290691|566092495|FG000|Overall Study|Lost to Follow-up|7|||
156820361|NCT02290691|566092496|FG001|Overall Study|Lost to Follow-up|7|||
156820362|NCT00185380|566092500|FG000|Overall Study|Adverse Event|41|||
156820363|NCT00185380|566092501|FG001|Overall Study|Adverse Event|43|||
156820364|NCT00185380|566092502|FG002|Overall Study|Adverse Event|48|||
156820365|NCT00185380|566092500|FG000|Overall Study|Lost to Follow-up|0|||
156820366|NCT00185380|566092501|FG001|Overall Study|Lost to Follow-up|4|||
156820367|NCT00185380|566092502|FG002|Overall Study|Lost to Follow-up|3|||
156820368|NCT00185380|566092500|FG000|Overall Study|Pregnancy|1|||
156820369|NCT00185380|566092501|FG001|Overall Study|Pregnancy|4|||
156820370|NCT00185380|566092502|FG002|Overall Study|Pregnancy|0|||
156820371|NCT00185380|566092500|FG000|Overall Study|Protocol Violation|2|||
156820372|NCT00185380|566092501|FG001|Overall Study|Protocol Violation|2|||
156820373|NCT00185380|566092502|FG002|Overall Study|Protocol Violation|1|||
156820374|NCT00185380|566092500|FG000|Overall Study|Withdrawal by Subject|1|||
156820375|NCT00185380|566092501|FG001|Overall Study|Withdrawal by Subject|2|||
156820376|NCT00185380|566092502|FG002|Overall Study|Withdrawal by Subject|0|||
156820377|NCT00185380|566092500|FG000|Overall Study|Failed insertion|1|||
156820378|NCT00185380|566092501|FG001|Overall Study|Failed insertion|1|||
156820379|NCT00185380|566092502|FG002|Overall Study|Failed insertion|2|||
156820380|NCT00185380|566092500|FG000|Overall Study|Planned pregnancy|9|||
156820381|NCT00185380|566092501|FG001|Overall Study|Planned pregnancy|12|||
156820382|NCT00185380|566092502|FG002|Overall Study|Planned pregnancy|12|||
156820383|NCT00185380|566092500|FG000|Overall Study|No need for contraception|3|||
156820384|NCT00185380|566092501|FG001|Overall Study|No need for contraception|3|||
156884452|NCT01221272|566336243|FG000|Period 1|Adverse Event|2|||
156884453|NCT01221272|566336244|FG001|Period 1|Adverse Event|0|||
157224430|NCT00275002|567567987|FG001|Overall Study|Disease progression|15|||
157224431|NCT00275002|567567986|FG000|Overall Study|Adverse Event|0|||
156820385|NCT00185380|566092502|FG002|Overall Study|No need for contraception|3|||
156820386|NCT00185380|566092500|FG000|Overall Study|Could not attend visits|2|||
156820387|NCT00185380|566092501|FG001|Overall Study|Could not attend visits|0|||
156820388|NCT00185380|566092502|FG002|Overall Study|Could not attend visits|4|||
156820389|NCT00185380|566092500|FG000|Overall Study|personal reason|6|||
156820390|NCT00185380|566092501|FG001|Overall Study|personal reason|1|||
156820391|NCT00185380|566092502|FG002|Overall Study|personal reason|1|||
156820392|NCT00978380|566092503|FG000|Overall Study|Protocol Violation|2|||
156820393|NCT00978380|566092503|FG000|Overall Study|Withdrawal criteria|9|||
156820394|NCT00978380|566092503|FG000|Overall Study|Unclassified|8|||
156820395|NCT02199314|566092504|FG000|Overall Study|Withdrawal by Subject|6|||
156820396|NCT02199314|566092504|FG000|Overall Study|Physician Decision|10|||
156820397|NCT01110330|566092509|FG000|Overall Study|Adverse Event|0|||
156820398|NCT01110330|566092510|FG001|Overall Study|Adverse Event|4|||
156820399|NCT01110330|566092511|FG002|Overall Study|Adverse Event|3|||
156820400|NCT01110330|566092509|FG000|Overall Study|Lack of Efficacy|3|||
156820401|NCT01110330|566092510|FG001|Overall Study|Lack of Efficacy|1|||
156820402|NCT01110330|566092511|FG002|Overall Study|Lack of Efficacy|1|||
156820403|NCT01110330|566092509|FG000|Overall Study|Lost to Follow-up|9|||
156820404|NCT01110330|566092510|FG001|Overall Study|Lost to Follow-up|10|||
156820405|NCT01110330|566092511|FG002|Overall Study|Lost to Follow-up|15|||
156820406|NCT01110330|566092509|FG000|Overall Study|Physician Decision|0|||
156820407|NCT01110330|566092510|FG001|Overall Study|Physician Decision|1|||
156820408|NCT01110330|566092511|FG002|Overall Study|Physician Decision|0|||
156820409|NCT01110330|566092509|FG000|Overall Study|Protocol Violation|2|||
156820410|NCT01110330|566092510|FG001|Overall Study|Protocol Violation|0|||
156820411|NCT01110330|566092511|FG002|Overall Study|Protocol Violation|4|||
156820412|NCT01110330|566092509|FG000|Overall Study|Withdrawal by Subject|0|||
156820413|NCT01110330|566092510|FG001|Overall Study|Withdrawal by Subject|6|||
156820414|NCT01110330|566092511|FG002|Overall Study|Withdrawal by Subject|2|||
156820415|NCT01110330|566092509|FG000|Overall Study|Other|1|||
156820416|NCT01110330|566092510|FG001|Overall Study|Other|1|||
156820417|NCT01110330|566092511|FG002|Overall Study|Other|1|||
156820418|NCT03215758|566092523|FG000|Overall Study|Technical Problems|1|||
156820419|NCT03215758|566092524|FG001|Overall Study|Technical Problems|0|||
156820420|NCT03215758|566092523|FG000|Overall Study|Protocol deviation|0|||
156820421|NCT03215758|566092524|FG001|Overall Study|Protocol deviation|1|||
156820422|NCT03215758|566092523|FG000|Overall Study|Physician Decision|0|||
156820423|NCT03215758|566092524|FG001|Overall Study|Physician Decision|1|||
156820424|NCT03215758|566092523|FG000|Overall Study|Death|0|||
156820425|NCT03215758|566092524|FG001|Overall Study|Death|1|||
156820426|NCT03215758|566092523|FG000|Overall Study|Adverse Event|1|||
156820427|NCT03215758|566092524|FG001|Overall Study|Adverse Event|2|||
156820428|NCT03215758|566092523|FG000|Overall Study|Subject/Guardian Decision|3|||
156820429|NCT03215758|566092524|FG001|Overall Study|Subject/Guardian Decision|3|||
156820430|NCT04115748|566092525|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
156820431|NCT04115748|566092526|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
156820432|NCT04115748|566092527|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
156820433|NCT04115748|566092528|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
156820434|NCT04115748|566092529|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820435|NCT04115748|566092530|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820436|NCT04115748|566092531|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820437|NCT04115748|566092532|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820438|NCT04115748|566092533|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820439|NCT04115748|566092534|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
156820440|NCT04115748|566092525|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820441|NCT04115748|566092526|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820442|NCT04115748|566092527|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820443|NCT04115748|566092528|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
156820444|NCT04115748|566092529|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820445|NCT04115748|566092530|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820446|NCT04115748|566092531|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820447|NCT04115748|566092532|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820448|NCT04115748|566092533|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820449|NCT04115748|566092534|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
156820450|NCT04115748|566092525|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820451|NCT04115748|566092526|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820452|NCT04115748|566092527|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820453|NCT04115748|566092528|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
156820454|NCT04115748|566092529|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
156820455|NCT04115748|566092530|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
156820456|NCT04115748|566092531|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820457|NCT04115748|566092532|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820458|NCT04115748|566092533|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
156820459|NCT04115748|566092534|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
156820460|NCT04115748|566092525|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820461|NCT04115748|566092526|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820462|NCT04115748|566092527|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820463|NCT04115748|566092528|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820464|NCT04115748|566092529|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820465|NCT04115748|566092530|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820466|NCT04115748|566092531|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820467|NCT04115748|566092532|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820468|NCT04115748|566092533|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
156820469|NCT04115748|566092534|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
156820470|NCT00713349|566092535|FG000|Overall Study|Protocol Violation|1|||
156820471|NCT01289353|566092536|FG000|Overall Study|Lost to Follow-up|2|||
156820472|NCT01549886|566092537|FG000|Overall Study|Sponsor's decision|2|||
156820473|NCT01549886|566092538|FG001|Overall Study|Sponsor's decision|3|||
156820474|NCT01126268|566092543|FG000|Overall Study|Adverse Event|1|||
156820475|NCT03425006|566092544|FG000|Overall Study|Withdrawal by Subject|1|||
156820476|NCT03425006|566092544|FG000|Overall Study|Physician Decision|1|||
156820477|NCT03425006|566092544|FG000|Overall Study|Death|1|||
156820478|NCT03070171|566092552|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
156820479|NCT03070171|566092553|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
156820480|NCT03070171|566092552|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
156820481|NCT03070171|566092553|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
156820482|NCT03768089|566092554|FG000|Part A|Lost to Follow-up|0|||
156820483|NCT03768089|566092555|FG001|Part A|Lost to Follow-up|0|||
156820484|NCT03768089|566092556|FG002|Part A|Lost to Follow-up|0|||
156820485|NCT03768089|566092557|FG003|Part A|Lost to Follow-up|0|||
156820486|NCT03768089|566092558|FG004|Part A|Lost to Follow-up|1|||
156820487|NCT03768089|566092559|FG005|Part A|Lost to Follow-up|0|||
156820488|NCT03768089|566092560|FG006|Part A|Lost to Follow-up|0|||
156820489|NCT03768089|566092561|FG007|Part A|Lost to Follow-up|0|||
156820490|NCT03768089|566092562|FG008|Part A|Lost to Follow-up|0|||
156820491|NCT03768089|566092563|FG009|Part A|Lost to Follow-up|0|||
156820492|NCT03768089|566092564|FG010|Part A|Lost to Follow-up|0|||
156820493|NCT03768089|566092565|FG011|Part A|Lost to Follow-up|0|||
156820494|NCT03768089|566092566|FG012|Part A|Lost to Follow-up|0|||
156820495|NCT03768089|566092567|FG013|Part A|Lost to Follow-up|0|||
156820496|NCT03768089|566092568|FG014|Part A|Lost to Follow-up|0|||
156820497|NCT03768089|566092569|FG015|Part A|Lost to Follow-up|0|||
156820498|NCT03768089|566092570|FG016|Part A|Lost to Follow-up|0|||
156820499|NCT03768089|566092571|FG017|Part A|Lost to Follow-up|0|||
156820500|NCT03768089|566092554|FG000|Part C|Randomized, Never Dosed|0|||
156820501|NCT03768089|566092555|FG001|Part C|Randomized, Never Dosed|0|||
156820502|NCT03768089|566092556|FG002|Part C|Randomized, Never Dosed|0|||
156820503|NCT03768089|566092557|FG003|Part C|Randomized, Never Dosed|0|||
156820504|NCT03768089|566092558|FG004|Part C|Randomized, Never Dosed|0|||
156820505|NCT03768089|566092559|FG005|Part C|Randomized, Never Dosed|0|||
156820506|NCT03768089|566092560|FG006|Part C|Randomized, Never Dosed|0|||
156820507|NCT03768089|566092561|FG007|Part C|Randomized, Never Dosed|0|||
156820508|NCT03768089|566092562|FG008|Part C|Randomized, Never Dosed|0|||
156820509|NCT03768089|566092563|FG009|Part C|Randomized, Never Dosed|0|||
156820510|NCT03768089|566092564|FG010|Part C|Randomized, Never Dosed|0|||
156820511|NCT03768089|566092565|FG011|Part C|Randomized, Never Dosed|0|||
156820512|NCT03768089|566092566|FG012|Part C|Randomized, Never Dosed|0|||
156820513|NCT03768089|566092567|FG013|Part C|Randomized, Never Dosed|0|||
156820514|NCT03768089|566092568|FG014|Part C|Randomized, Never Dosed|1|||
156820515|NCT03768089|566092569|FG015|Part C|Randomized, Never Dosed|0|||
156820516|NCT03768089|566092570|FG016|Part C|Randomized, Never Dosed|0|||
156820517|NCT03768089|566092571|FG017|Part C|Randomized, Never Dosed|0|||
156820518|NCT00344318|566092572|FG000|Overall Study|Adverse Event|0|||
156820519|NCT00344318|566092573|FG001|Overall Study|Adverse Event|3|||
156820520|NCT00344318|566092574|FG002|Overall Study|Adverse Event|0|||
156820521|NCT00344318|566092575|FG003|Overall Study|Adverse Event|1|||
156820522|NCT00344318|566092572|FG000|Overall Study|Withdrawal by Subject|2|||
156820523|NCT00344318|566092573|FG001|Overall Study|Withdrawal by Subject|2|||
156820524|NCT00344318|566092574|FG002|Overall Study|Withdrawal by Subject|0|||
156820525|NCT00344318|566092575|FG003|Overall Study|Withdrawal by Subject|2|||
156820526|NCT00344318|566092572|FG000|Overall Study|Lost to Follow-up|2|||
156820527|NCT00344318|566092573|FG001|Overall Study|Lost to Follow-up|0|||
156820528|NCT00344318|566092574|FG002|Overall Study|Lost to Follow-up|1|||
156820529|NCT00344318|566092575|FG003|Overall Study|Lost to Follow-up|0|||
156820530|NCT00700882|566092578|FG000|Overall Study|Never received treatment|6|||
156820531|NCT00700882|566092578|FG000|Overall Study|Ineligible|2|||
156820532|NCT00700882|566092578|FG000|Overall Study|No KIT mutation|51|||
156820533|NCT01606176|566092579|FG000|Overall Study|Adverse Event|2|||
156820534|NCT01606176|566092580|FG001|Overall Study|Adverse Event|3|||
156820535|NCT01606176|566092579|FG000|Overall Study|Disease progression|1|||
156820536|NCT01606176|566092580|FG001|Overall Study|Disease progression|0|||
156820537|NCT01606176|566092579|FG000|Overall Study|Withdrawal by Subject|1|||
156884454|NCT01221272|566336243|FG000|Period 1|Consent Withdrawal|0|||
156820538|NCT01606176|566092580|FG001|Overall Study|Withdrawal by Subject|0|||
156820539|NCT00673231|566092581|FG000|Overall Study|Withdrawal by Subject|14|||
156820540|NCT00673231|566092582|FG001|Overall Study|Withdrawal by Subject|10|||
156820541|NCT00673231|566092583|FG002|Overall Study|Withdrawal by Subject|8|||
156820542|NCT00673231|566092584|FG003|Overall Study|Withdrawal by Subject|6|||
156820543|NCT00673231|566092581|FG000|Overall Study|Adverse Event|6|||
156820544|NCT00673231|566092582|FG001|Overall Study|Adverse Event|5|||
156820545|NCT00673231|566092583|FG002|Overall Study|Adverse Event|9|||
156820546|NCT00673231|566092584|FG003|Overall Study|Adverse Event|6|||
156820547|NCT00673231|566092581|FG000|Overall Study|Lost to Follow-up|1|||
156820548|NCT00673231|566092582|FG001|Overall Study|Lost to Follow-up|2|||
156820549|NCT00673231|566092583|FG002|Overall Study|Lost to Follow-up|1|||
156820550|NCT00673231|566092584|FG003|Overall Study|Lost to Follow-up|2|||
156820551|NCT00673231|566092581|FG000|Overall Study|Death|0|||
156820552|NCT00673231|566092582|FG001|Overall Study|Death|0|||
156820553|NCT00673231|566092583|FG002|Overall Study|Death|1|||
156820554|NCT00673231|566092584|FG003|Overall Study|Death|0|||
156820555|NCT00673231|566092581|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
156820556|NCT00673231|566092582|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
156820557|NCT00673231|566092583|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
156820558|NCT00673231|566092584|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
156820559|NCT02952313|566092585|FG000|Primary Endpoint|Lost to Follow-up|4|||
156820560|NCT02952313|566092585|FG000|Primary Endpoint|Withdrawal by Subject|1|||
156820561|NCT02952313|566092585|FG000|Primary Endpoint|Lack of Efficacy|1|||
156820562|NCT02952313|566092585|FG000|Primary Endpoint|Missed visit|1|||
156820563|NCT02952313|566092585|FG000|Long-term Follow-up|Lost to Follow-up|12|||
156820564|NCT02952313|566092585|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
156820565|NCT02952313|566092585|FG000|Long-term Follow-up|Lack of Efficacy|6|||
156820566|NCT02952313|566092585|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
156820567|NCT02952313|566092585|FG000|Long-term Follow-up|Physician Decision|1|||
156820568|NCT02952313|566092585|FG000|Long-term Follow-up|Death|1|||
156820569|NCT00792740|566092588|FG000|Overall Study|Disease Worsening|3|||
156820570|NCT00792740|566092589|FG001|Overall Study|Disease Worsening|2|||
156820571|NCT00792740|566092588|FG000|Overall Study|Personal Reason|1|||
156820572|NCT00792740|566092589|FG001|Overall Study|Personal Reason|0|||
156820573|NCT00792740|566092588|FG000|Overall Study|Adverse Event|1|||
156820574|NCT00792740|566092589|FG001|Overall Study|Adverse Event|3|||
156820575|NCT00792740|566092588|FG000|Overall Study|Patient's withdrawal of consent|0|||
156820576|NCT00792740|566092589|FG001|Overall Study|Patient's withdrawal of consent|1|||
156820577|NCT00792740|566092588|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
156820578|NCT00792740|566092589|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
156820579|NCT00792740|566092588|FG000|Overall Study|Other reasons|0|||
156820580|NCT00792740|566092589|FG001|Overall Study|Other reasons|1|||
156820581|NCT02485639|566092592|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
156820582|NCT02485639|566092592|FG000|Overall Study|Early termination|4|||
156820583|NCT02485639|566092592|FG000|Overall Study|Withdrawal by Subject|4|||
156820584|NCT02791516|566092593|FG000|Overall Study|Withdrawal by Subject|1|||
156820585|NCT02791516|566092594|FG001|Overall Study|Withdrawal by Subject|1|||
156820586|NCT02524275|566092595|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
156820587|NCT01439971|566092596|FG000|Overall Study|Required number in cohort dosed|0|||
156820588|NCT01439971|566092597|FG001|Overall Study|Required number in cohort dosed|1|||
156820589|NCT01439971|566092598|FG002|Overall Study|Required number in cohort dosed|2|||
156820590|NCT01439971|566092599|FG003|Overall Study|Required number in cohort dosed|0|||
156820591|NCT01439971|566092600|FG004|Overall Study|Required number in cohort dosed|1|||
156820592|NCT02628600|566092601|FG000|Overall Study|Death|2|||
156820593|NCT02628600|566092602|FG001|Overall Study|Death|1|||
156820594|NCT02628600|566092601|FG000|Overall Study|Adverse Event|3|||
156820595|NCT02628600|566092602|FG001|Overall Study|Adverse Event|20|||
156820596|NCT02628600|566092601|FG000|Overall Study|Protocol Violation|0|||
156820597|NCT02628600|566092602|FG001|Overall Study|Protocol Violation|1|||
156820598|NCT02628600|566092601|FG000|Overall Study|Lack of Efficacy|2|||
156820599|NCT02628600|566092602|FG001|Overall Study|Lack of Efficacy|0|||
156820600|NCT02628600|566092601|FG000|Overall Study|Withdrawal by Subject|13|||
156820601|NCT02628600|566092602|FG001|Overall Study|Withdrawal by Subject|8|||
156820602|NCT02628600|566092601|FG000|Overall Study|Lost to Follow-up|1|||
156820603|NCT02628600|566092602|FG001|Overall Study|Lost to Follow-up|0|||
156820604|NCT02628600|566092601|FG000|Overall Study|Physician Decision|2|||
156820605|NCT02628600|566092602|FG001|Overall Study|Physician Decision|2|||
156820606|NCT02628600|566092601|FG000|Overall Study|Other not specified|1|||
156820607|NCT02628600|566092602|FG001|Overall Study|Other not specified|0|||
156820608|NCT00583752|566092604|FG000|Overall Study|Lost to Follow-up|5|||
156820609|NCT00583752|566092605|FG001|Overall Study|Lost to Follow-up|5|||
156820610|NCT04091581|566092609|FG000|Overall Study|Lost to Follow-up|0|||
156820611|NCT04091581|566092610|FG001|Overall Study|Lost to Follow-up|1|||
156820612|NCT03724981|566094841|FG000|First Device|Protocol Violation|1|||
156820613|NCT03724981|566094842|FG001|First Device|Protocol Violation|1|||
156820614|NCT00511433|566094844|FG000|Overall Study|Adverse Event|5|||
156820615|NCT00511433|566094845|FG001|Overall Study|Adverse Event|0|||
156820616|NCT00511433|566094844|FG000|Overall Study|Other Reason|1|||
156820617|NCT00511433|566094845|FG001|Overall Study|Other Reason|1|||
156820618|NCT00790868|566094846|FG000|Overall Study|Withdrawal by Subject|4|||
156820619|NCT00790868|566094847|FG001|Overall Study|Withdrawal by Subject|5|||
156820620|NCT00790868|566094846|FG000|Overall Study|Lost to Follow-up|2|||
156820621|NCT00790868|566094847|FG001|Overall Study|Lost to Follow-up|12|||
156820622|NCT01380535|566094848|FG000|Overall Study|Adverse Event|3|||
156820623|NCT01380535|566094849|FG001|Overall Study|Adverse Event|3|||
156820624|NCT01380535|566094848|FG000|Overall Study|Death|3|||
156820625|NCT01380535|566094849|FG001|Overall Study|Death|0|||
156820626|NCT01380535|566094848|FG000|Overall Study|Study site closed|0|||
156820627|NCT01380535|566094849|FG001|Overall Study|Study site closed|5|||
156820628|NCT01380535|566094848|FG000|Overall Study|Withdrawal by Subject|1|||
156820629|NCT01380535|566094849|FG001|Overall Study|Withdrawal by Subject|2|||
156820630|NCT01380535|566094848|FG000|Overall Study|Protocol Violation|0|||
156820631|NCT01380535|566094849|FG001|Overall Study|Protocol Violation|2|||
156820632|NCT01380535|566094848|FG000|Overall Study|Lack of Efficacy|0|||
156820633|NCT01380535|566094849|FG001|Overall Study|Lack of Efficacy|3|||
156820634|NCT01579565|566094850|FG000|Randomized|Adverse Event|1|||
156820635|NCT01579565|566094851|FG001|Randomized|Adverse Event|3|||
156820636|NCT01579565|566094850|FG000|Randomized|Withdrawal by Subject|3|||
156820637|NCT01579565|566094851|FG001|Randomized|Withdrawal by Subject|0|||
156820638|NCT01579565|566094850|FG000|Randomized|inadequate preoperative pupil dilation|0|||
156820639|NCT01579565|566094851|FG001|Randomized|inadequate preoperative pupil dilation|1|||
156820640|NCT01579565|566094850|FG000|Randomized|prohibited preoperative eating|1|||
156820641|NCT01579565|566094851|FG001|Randomized|prohibited preoperative eating|0|||
156820642|NCT01579565|566094850|FG000|Randomized|prohibited preoperative medication|0|||
156820643|NCT01579565|566094851|FG001|Randomized|prohibited preoperative medication|1|||
156820644|NCT01579565|566094850|FG000|Treated|Physician Decision|0|||
156820645|NCT01579565|566094851|FG001|Treated|Physician Decision|1|||
156820646|NCT01579565|566094850|FG000|Treated|Lost to Follow-up|2|||
156820647|NCT01579565|566094851|FG001|Treated|Lost to Follow-up|1|||
156820648|NCT01579565|566094850|FG000|Treated|declined to return for final visit|0|||
156820649|NCT01579565|566094851|FG001|Treated|declined to return for final visit|1|||
156820650|NCT02013206|566094852|FG000|Overall Study|Progressive disease (PD)|14|||
156820651|NCT02013206|566094853|FG001|Overall Study|Progressive disease (PD)|17|||
156820652|NCT02013206|566094852|FG000|Overall Study|Symptomatic deterioration|3|||
156820653|NCT02013206|566094853|FG001|Overall Study|Symptomatic deterioration|1|||
156820654|NCT02013206|566094852|FG000|Overall Study|Adverse Event|1|||
156820655|NCT02013206|566094853|FG001|Overall Study|Adverse Event|0|||
156820656|NCT02013206|566094852|FG000|Overall Study|Patient refusal|2|||
156820657|NCT02013206|566094853|FG001|Overall Study|Patient refusal|0|||
156820658|NCT02013206|566094852|FG000|Overall Study|Patient non-compliance|1|||
156820659|NCT02013206|566094853|FG001|Overall Study|Patient non-compliance|0|||
156820660|NCT02013206|566094852|FG000|Overall Study|Death|1|||
156820661|NCT02013206|566094853|FG001|Overall Study|Death|2|||
156820662|NCT02013206|566094852|FG000|Overall Study|Other reasons off treatment|5|||
156820663|NCT02013206|566094853|FG001|Overall Study|Other reasons off treatment|2|||
156820664|NCT02867813|566094854|FG000|Overall Study|Withdrawal by Subject|57|||
156820665|NCT02867813|566094855|FG001|Overall Study|Withdrawal by Subject|56|||
156820666|NCT02867813|566094854|FG000|Overall Study|Decision by Sponsor|7|||
156820667|NCT02867813|566094855|FG001|Overall Study|Decision by Sponsor|7|||
156820668|NCT02867813|566094854|FG000|Overall Study|Lost to Follow-up|91|||
156820669|NCT02867813|566094855|FG001|Overall Study|Lost to Follow-up|78|||
156820670|NCT02867813|566094854|FG000|Overall Study|Missing|2|||
156820671|NCT02867813|566094855|FG001|Overall Study|Missing|1|||
156820672|NCT02867813|566094854|FG000|Overall Study|Death|294|||
156820673|NCT02867813|566094855|FG001|Overall Study|Death|268|||
156820674|NCT02791191|566094861|FG000|Overall Study|Adverse Event|2|||
157022708|NCT04810650|566835276|FG004|Overall Study|Participant declined|0|||
157022709|NCT04810650|566835277|FG005|Overall Study|Participant declined|0|||
156820675|NCT02791191|566094862|FG001|Overall Study|Adverse Event|4|||
156820676|NCT02791191|566094863|FG002|Overall Study|Adverse Event|5|||
156820677|NCT02791191|566094861|FG000|Overall Study|Lack of Efficacy|0|||
156820678|NCT02791191|566094862|FG001|Overall Study|Lack of Efficacy|1|||
156820679|NCT02791191|566094863|FG002|Overall Study|Lack of Efficacy|0|||
156820680|NCT02791191|566094861|FG000|Overall Study|Study Drug Non-Compliance|0|||
156820681|NCT02791191|566094862|FG001|Overall Study|Study Drug Non-Compliance|2|||
156820682|NCT02791191|566094863|FG002|Overall Study|Study Drug Non-Compliance|0|||
156820683|NCT02791191|566094861|FG000|Overall Study|Site Closed by Sponsor|1|||
156820684|NCT02791191|566094862|FG001|Overall Study|Site Closed by Sponsor|1|||
156820685|NCT02791191|566094863|FG002|Overall Study|Site Closed by Sponsor|3|||
156820686|NCT02791191|566094861|FG000|Overall Study|Progressive Disease|1|||
156820687|NCT02791191|566094862|FG001|Overall Study|Progressive Disease|0|||
156820688|NCT02791191|566094863|FG002|Overall Study|Progressive Disease|0|||
156820689|NCT02791191|566094861|FG000|Overall Study|Study Terminated by Sponsor|29|||
157150773|NCT04498910|567298092|FG000|Overall Study|Withdrawal by Subject|2|||
156820690|NCT02791191|566094862|FG001|Overall Study|Study Terminated by Sponsor|101|||
156820691|NCT02791191|566094863|FG002|Overall Study|Study Terminated by Sponsor|109|||
156820692|NCT02791191|566094861|FG000|Overall Study|Withdrawal by Subject|3|||
156820693|NCT02791191|566094862|FG001|Overall Study|Withdrawal by Subject|1|||
156820694|NCT02791191|566094863|FG002|Overall Study|Withdrawal by Subject|3|||
156820695|NCT02791191|566094861|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
156820696|NCT02791191|566094862|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
156820697|NCT02791191|566094863|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
156820698|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820699|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820700|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820701|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820702|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820703|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820704|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
156820705|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
156820706|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820707|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820708|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820709|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
156820710|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
156820711|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
156820712|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820713|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
156820714|NCT01448824|566094864|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820715|NCT01448824|566094865|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820716|NCT01448824|566094866|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820717|NCT01448824|566094867|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820718|NCT01448824|566094868|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820719|NCT01448824|566094869|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
156820720|NCT01448824|566094870|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820721|NCT01448824|566094871|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
156820722|NCT01448824|566094864|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
156820723|NCT01448824|566094865|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
156820724|NCT01448824|566094866|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
156820725|NCT01448824|566094867|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
156820726|NCT01448824|566094868|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
156820727|NCT01448824|566094869|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
156820728|NCT01448824|566094870|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
156820729|NCT01448824|566094871|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
156820730|NCT01448824|566094864|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820731|NCT01448824|566094865|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820732|NCT01448824|566094866|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820733|NCT01448824|566094867|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820734|NCT01448824|566094868|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820735|NCT01448824|566094869|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820736|NCT01448824|566094870|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
156820737|NCT01448824|566094871|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
156820738|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820739|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820740|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820741|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820742|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820743|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820744|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
156820745|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
156820746|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820747|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820748|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820749|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820750|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820751|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
156820752|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
157022710|NCT04810650|566835278|FG006|Overall Study|Participant declined|0|||
156820753|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
157150774|NCT04498910|567298093|FG001|Overall Study|Withdrawal by Subject|1|||
156820754|NCT01448824|566094864|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820755|NCT01448824|566094865|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820756|NCT01448824|566094866|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820757|NCT01448824|566094867|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820758|NCT01448824|566094868|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820759|NCT01448824|566094869|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820760|NCT01448824|566094870|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
156820761|NCT01448824|566094871|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
156820762|NCT01952665|566094872|FG000|Overall Study|Physician Decision|3|||
156820763|NCT01952665|566094873|FG001|Overall Study|Physician Decision|2|||
156820764|NCT01952665|566094872|FG000|Overall Study|Lost to Follow-up|1|||
156820765|NCT01952665|566094873|FG001|Overall Study|Lost to Follow-up|2|||
156820766|NCT01952665|566094872|FG000|Overall Study|Adverse Event|2|||
156820767|NCT01952665|566094873|FG001|Overall Study|Adverse Event|1|||
156820768|NCT01952665|566094872|FG000|Overall Study|Protocol Violation|0|||
156820769|NCT01952665|566094873|FG001|Overall Study|Protocol Violation|1|||
156820770|NCT01537081|566094877|FG000|Overall Study|Adverse Event|5|||
156820771|NCT01537081|566094878|FG001|Overall Study|Adverse Event|2|||
156820772|NCT01537081|566094879|FG002|Overall Study|Adverse Event|2|||
156820773|NCT01537081|566094877|FG000|Overall Study|Lack of Efficacy|2|||
156820774|NCT01537081|566094878|FG001|Overall Study|Lack of Efficacy|1|||
156820775|NCT01537081|566094879|FG002|Overall Study|Lack of Efficacy|0|||
156820776|NCT01537081|566094877|FG000|Overall Study|Lost to Follow-up|17|||
156820777|NCT01537081|566094878|FG001|Overall Study|Lost to Follow-up|15|||
156820778|NCT01537081|566094879|FG002|Overall Study|Lost to Follow-up|9|||
156820779|NCT01537081|566094877|FG000|Overall Study|Protocol Violation|3|||
156820780|NCT01537081|566094878|FG001|Overall Study|Protocol Violation|2|||
156820781|NCT01537081|566094879|FG002|Overall Study|Protocol Violation|2|||
156820782|NCT01537081|566094877|FG000|Overall Study|Withdrawal by Subject|6|||
156820783|NCT01537081|566094878|FG001|Overall Study|Withdrawal by Subject|11|||
156820784|NCT01537081|566094879|FG002|Overall Study|Withdrawal by Subject|3|||
156820785|NCT01537081|566094877|FG000|Overall Study|Physician Decision|5|||
156820786|NCT01537081|566094878|FG001|Overall Study|Physician Decision|6|||
156820787|NCT01537081|566094879|FG002|Overall Study|Physician Decision|0|||
156820788|NCT01537081|566094877|FG000|Overall Study|Sponsor decision|0|||
156820789|NCT01537081|566094878|FG001|Overall Study|Sponsor decision|1|||
156820790|NCT01537081|566094879|FG002|Overall Study|Sponsor decision|0|||
156820791|NCT01537081|566094877|FG000|Overall Study|Assigned but never dosed|1|||
156820792|NCT01537081|566094878|FG001|Overall Study|Assigned but never dosed|0|||
156820793|NCT01537081|566094879|FG002|Overall Study|Assigned but never dosed|0|||
156820794|NCT01463111|566094882|FG000|Overall Study|Withdrawal by Subject|2|||
156820795|NCT01463111|566094882|FG000|Overall Study|Lost to Follow-up|5|||
156820796|NCT01463111|566094882|FG000|Overall Study|Physician Decision|2|||
156820797|NCT02578680|566094885|FG000|Overall Study|Death|329|||
156820798|NCT02578680|566094886|FG001|Overall Study|Death|181|||
156820799|NCT02578680|566094885|FG000|Overall Study|Lost to Follow-up|3|||
156820800|NCT02578680|566094886|FG001|Overall Study|Lost to Follow-up|1|||
156820801|NCT02578680|566094885|FG000|Overall Study|Physician Decision|0|||
156820802|NCT02578680|566094886|FG001|Overall Study|Physician Decision|1|||
156820803|NCT02578680|566094885|FG000|Overall Study|Protocol Violation|1|||
156820804|NCT02578680|566094886|FG001|Overall Study|Protocol Violation|1|||
156820805|NCT02578680|566094885|FG000|Overall Study|Sponsor Decision|64|||
156820806|NCT02578680|566094886|FG001|Overall Study|Sponsor Decision|13|||
156820807|NCT02578680|566094885|FG000|Overall Study|Withdrawal by Subject|13|||
156820808|NCT02578680|566094886|FG001|Overall Study|Withdrawal by Subject|9|||
156820809|NCT00882583|566094887|FG000|Overall Study|Physician Decision|1|||
156820810|NCT00882583|566094888|FG001|Overall Study|Physician Decision|0|||
156820811|NCT00882583|566094887|FG000|Overall Study|Adverse Event|0|||
156820812|NCT00882583|566094888|FG001|Overall Study|Adverse Event|1|||
156820813|NCT02596958|566094897|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
156820814|NCT02596958|566094897|FG000|Overall Study|Cancer Progression|441|||
156820815|NCT02596958|566094897|FG000|Overall Study|Death From Cancer|112|||
156820816|NCT02596958|566094897|FG000|Overall Study|Death From Other Cause|33|||
156820817|NCT02596958|566094897|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
156820818|NCT02596958|566094897|FG000|Overall Study|Administrative Reasons/Other|231|||
156820819|NCT02596958|566094897|FG000|Overall Study|Lost to Follow-up|33|||
156820820|NCT02596958|566094897|FG000|Overall Study|Missing|32|||
156820821|NCT02596958|566094897|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
156820822|NCT01559259|566094898|FG000|Overall Study|Withdrawal by Subject|0|||
156820823|NCT01559259|566094899|FG001|Overall Study|Withdrawal by Subject|0|||
156820824|NCT01559259|566094900|FG002|Overall Study|Withdrawal by Subject|0|||
156820825|NCT01559259|566094901|FG003|Overall Study|Withdrawal by Subject|1|||
156820826|NCT01559259|566094902|FG004|Overall Study|Withdrawal by Subject|0|||
156820827|NCT01559259|566094898|FG000|Overall Study|Adverse Event|0|||
156820828|NCT01559259|566094899|FG001|Overall Study|Adverse Event|1|||
156820829|NCT01559259|566094900|FG002|Overall Study|Adverse Event|1|||
156820830|NCT01559259|566094901|FG003|Overall Study|Adverse Event|0|||
156820831|NCT01559259|566094902|FG004|Overall Study|Adverse Event|0|||
156820832|NCT01995669|566094903|FG000|Overall Study|Progression|2|||
156820833|NCT01995669|566094904|FG001|Overall Study|Progression|1|||
156820834|NCT01995669|566094905|FG002|Overall Study|Progression|1|||
156820835|NCT01995669|566094906|FG003|Overall Study|Progression|13|||
156820836|NCT01995669|566094903|FG000|Overall Study|Adverse Event|0|||
156820837|NCT01995669|566094904|FG001|Overall Study|Adverse Event|0|||
156820838|NCT01995669|566094905|FG002|Overall Study|Adverse Event|0|||
156820839|NCT01995669|566094906|FG003|Overall Study|Adverse Event|3|||
156820840|NCT01995669|566094903|FG000|Overall Study|Death|0|||
156820841|NCT01995669|566094904|FG001|Overall Study|Death|0|||
156820842|NCT01995669|566094905|FG002|Overall Study|Death|0|||
156820843|NCT01995669|566094906|FG003|Overall Study|Death|6|||
156820844|NCT01995669|566094903|FG000|Overall Study|Withdrawal by Subject|0|||
156820845|NCT01995669|566094904|FG001|Overall Study|Withdrawal by Subject|0|||
156820846|NCT01995669|566094905|FG002|Overall Study|Withdrawal by Subject|0|||
156820847|NCT01995669|566094906|FG003|Overall Study|Withdrawal by Subject|6|||
156820848|NCT01995669|566094903|FG000|Overall Study|Insurance Expired|0|||
156820849|NCT01995669|566094904|FG001|Overall Study|Insurance Expired|0|||
156820850|NCT01995669|566094905|FG002|Overall Study|Insurance Expired|0|||
156820851|NCT01995669|566094906|FG003|Overall Study|Insurance Expired|1|||
156820852|NCT05425732|566094907|FG000|Overall Study|Death|4|||
156820853|NCT05425732|566094908|FG001|Overall Study|Death|2|||
156820854|NCT05425732|566094909|FG002|Overall Study|Death|0|||
156820855|NCT05425732|566094910|FG003|Overall Study|Death|0|||
156820856|NCT05425732|566094907|FG000|Overall Study|Lost to Follow-up|10|||
156820857|NCT05425732|566094908|FG001|Overall Study|Lost to Follow-up|15|||
156820858|NCT05425732|566094909|FG002|Overall Study|Lost to Follow-up|5|||
156820859|NCT05425732|566094910|FG003|Overall Study|Lost to Follow-up|3|||
156820860|NCT05425732|566094907|FG000|Overall Study|Physician Decision|0|||
156820861|NCT05425732|566094908|FG001|Overall Study|Physician Decision|2|||
156820862|NCT05425732|566094909|FG002|Overall Study|Physician Decision|0|||
156820863|NCT05425732|566094910|FG003|Overall Study|Physician Decision|0|||
156820864|NCT05425732|566094907|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156820865|NCT05425732|566094908|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156820866|NCT05425732|566094909|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156820867|NCT05425732|566094910|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156820868|NCT05425732|566094907|FG000|Overall Study|Withdrawal by Subject|4|||
156820869|NCT05425732|566094908|FG001|Overall Study|Withdrawal by Subject|8|||
156820870|NCT05425732|566094909|FG002|Overall Study|Withdrawal by Subject|1|||
156820871|NCT05425732|566094910|FG003|Overall Study|Withdrawal by Subject|1|||
156820872|NCT05425732|566094907|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
156820873|NCT05425732|566094908|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820874|NCT05425732|566094909|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820875|NCT05425732|566094910|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
156820876|NCT00218634|566094912|FG000|Overall Study|Lost to Follow-up|8|||
156820877|NCT00218634|566094913|FG001|Overall Study|Lost to Follow-up|15|||
156820878|NCT00734604|566094914|FG000|Overall Study|Adverse Event|0|||
156820879|NCT00734604|566094915|FG001|Overall Study|Adverse Event|2|||
156820880|NCT00734604|566094916|FG002|Overall Study|Adverse Event|0|||
156820881|NCT00734604|566094917|FG003|Overall Study|Adverse Event|2|||
156820882|NCT00734604|566094918|FG004|Overall Study|Adverse Event|1|||
156820883|NCT00734604|566094919|FG005|Overall Study|Adverse Event|1|||
156820884|NCT00734604|566094914|FG000|Overall Study|Serious Adverse Event|1|||
156820885|NCT00734604|566094915|FG001|Overall Study|Serious Adverse Event|0|||
156820886|NCT00734604|566094916|FG002|Overall Study|Serious Adverse Event|1|||
156820887|NCT00734604|566094917|FG003|Overall Study|Serious Adverse Event|2|||
156820888|NCT00734604|566094918|FG004|Overall Study|Serious Adverse Event|0|||
156820889|NCT00734604|566094919|FG005|Overall Study|Serious Adverse Event|1|||
156820890|NCT00734604|566094914|FG000|Overall Study|Lost to Follow-up|1|||
156820891|NCT00734604|566094915|FG001|Overall Study|Lost to Follow-up|2|||
156820892|NCT00734604|566094916|FG002|Overall Study|Lost to Follow-up|2|||
156820893|NCT00734604|566094917|FG003|Overall Study|Lost to Follow-up|4|||
156820894|NCT00734604|566094918|FG004|Overall Study|Lost to Follow-up|2|||
156820895|NCT00734604|566094919|FG005|Overall Study|Lost to Follow-up|3|||
156820896|NCT00734604|566094914|FG000|Overall Study|Physician Decision|0|||
156820897|NCT00734604|566094915|FG001|Overall Study|Physician Decision|1|||
156820898|NCT00734604|566094916|FG002|Overall Study|Physician Decision|1|||
156820899|NCT00734604|566094917|FG003|Overall Study|Physician Decision|0|||
156820900|NCT00734604|566094918|FG004|Overall Study|Physician Decision|0|||
156820901|NCT00734604|566094919|FG005|Overall Study|Physician Decision|0|||
156820902|NCT00734604|566094914|FG000|Overall Study|Protocol Violation|0|||
156820903|NCT00734604|566094915|FG001|Overall Study|Protocol Violation|2|||
156820904|NCT00734604|566094916|FG002|Overall Study|Protocol Violation|0|||
156820905|NCT00734604|566094917|FG003|Overall Study|Protocol Violation|0|||
156820906|NCT00734604|566094918|FG004|Overall Study|Protocol Violation|1|||
156820907|NCT00734604|566094919|FG005|Overall Study|Protocol Violation|0|||
156820908|NCT00734604|566094914|FG000|Overall Study|Sponsor Decision|1|||
156820909|NCT00734604|566094915|FG001|Overall Study|Sponsor Decision|2|||
156820910|NCT00734604|566094916|FG002|Overall Study|Sponsor Decision|1|||
156820911|NCT00734604|566094917|FG003|Overall Study|Sponsor Decision|0|||
156820912|NCT00734604|566094918|FG004|Overall Study|Sponsor Decision|2|||
156820913|NCT00734604|566094919|FG005|Overall Study|Sponsor Decision|0|||
156820914|NCT00734604|566094914|FG000|Overall Study|Withdrawal by Subject|0|||
156820915|NCT00734604|566094915|FG001|Overall Study|Withdrawal by Subject|2|||
156820916|NCT00734604|566094916|FG002|Overall Study|Withdrawal by Subject|0|||
156820917|NCT00734604|566094917|FG003|Overall Study|Withdrawal by Subject|1|||
156820918|NCT00734604|566094918|FG004|Overall Study|Withdrawal by Subject|2|||
156820919|NCT00734604|566094919|FG005|Overall Study|Withdrawal by Subject|1|||
156820920|NCT00734604|566094914|FG000|Overall Study|Lack of Efficacy|0|||
156820921|NCT00734604|566094915|FG001|Overall Study|Lack of Efficacy|1|||
156820922|NCT00734604|566094916|FG002|Overall Study|Lack of Efficacy|1|||
156820923|NCT00734604|566094917|FG003|Overall Study|Lack of Efficacy|0|||
156820924|NCT00734604|566094918|FG004|Overall Study|Lack of Efficacy|0|||
156820925|NCT00734604|566094919|FG005|Overall Study|Lack of Efficacy|0|||
156820926|NCT00327015|566094922|FG000|Overall Study|Lack of Efficacy|18|||
156820927|NCT00327015|566094923|FG001|Overall Study|Lack of Efficacy|18|||
156820928|NCT00327015|566094924|FG002|Overall Study|Lack of Efficacy|35|||
156820929|NCT00327015|566094925|FG003|Overall Study|Lack of Efficacy|29|||
156820930|NCT00327015|566094922|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
156820931|NCT00327015|566094923|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
156820932|NCT00327015|566094924|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
156820933|NCT00327015|566094925|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
156820934|NCT00327015|566094922|FG000|Overall Study|Lost to Follow-up|22|||
156820935|NCT00327015|566094923|FG001|Overall Study|Lost to Follow-up|23|||
156820936|NCT00327015|566094924|FG002|Overall Study|Lost to Follow-up|29|||
156820937|NCT00327015|566094925|FG003|Overall Study|Lost to Follow-up|22|||
156820938|NCT00327015|566094922|FG000|Overall Study|Adverse Event|14|||
156820939|NCT00327015|566094923|FG001|Overall Study|Adverse Event|10|||
156820940|NCT00327015|566094924|FG002|Overall Study|Adverse Event|14|||
156820941|NCT00327015|566094925|FG003|Overall Study|Adverse Event|14|||
156820942|NCT00327015|566094922|FG000|Overall Study|Subject no longer meets study criteria|4|||
156820943|NCT00327015|566094923|FG001|Overall Study|Subject no longer meets study criteria|2|||
156820944|NCT00327015|566094924|FG002|Overall Study|Subject no longer meets study criteria|8|||
156820945|NCT00327015|566094925|FG003|Overall Study|Subject no longer meets study criteria|7|||
156820946|NCT00327015|566094922|FG000|Overall Study|Poor/Noncompliance|11|||
156820947|NCT00327015|566094923|FG001|Overall Study|Poor/Noncompliance|8|||
156820948|NCT00327015|566094924|FG002|Overall Study|Poor/Noncompliance|4|||
156820949|NCT00327015|566094925|FG003|Overall Study|Poor/Noncompliance|5|||
156820950|NCT00327015|566094922|FG000|Overall Study|Physician Decision|0|||
156820951|NCT00327015|566094923|FG001|Overall Study|Physician Decision|1|||
156820952|NCT00327015|566094924|FG002|Overall Study|Physician Decision|3|||
156820953|NCT00327015|566094925|FG003|Overall Study|Physician Decision|2|||
156820954|NCT00327015|566094922|FG000|Overall Study|Death|1|||
156820955|NCT00327015|566094923|FG001|Overall Study|Death|2|||
156820956|NCT00327015|566094924|FG002|Overall Study|Death|2|||
156820957|NCT00327015|566094925|FG003|Overall Study|Death|3|||
156820958|NCT00327015|566094922|FG000|Overall Study|Pregnancy|0|||
156820959|NCT00327015|566094923|FG001|Overall Study|Pregnancy|2|||
156820960|NCT00327015|566094924|FG002|Overall Study|Pregnancy|1|||
156820961|NCT00327015|566094925|FG003|Overall Study|Pregnancy|1|||
156820962|NCT00327015|566094922|FG000|Overall Study|Administrative Reason by Sponsor|1|||
156820963|NCT00327015|566094923|FG001|Overall Study|Administrative Reason by Sponsor|2|||
156820964|NCT00327015|566094924|FG002|Overall Study|Administrative Reason by Sponsor|2|||
156820965|NCT00327015|566094925|FG003|Overall Study|Administrative Reason by Sponsor|1|||
156820966|NCT03764631|566094930|FG000|Overall Study|Personal Reasons|3|||
156820967|NCT03764631|566094931|FG001|Overall Study|Personal Reasons|2|||
156820968|NCT03764631|566094930|FG000|Overall Study|Switching Therapy|3|||
156820969|NCT03764631|566094931|FG001|Overall Study|Switching Therapy|3|||
156820970|NCT03764631|566094930|FG000|Overall Study|Adverse Event|0|||
156820971|NCT03764631|566094931|FG001|Overall Study|Adverse Event|1|||
156820972|NCT03764631|566094930|FG000|Overall Study|Lost to Follow-up|33|||
156884455|NCT01221272|566336244|FG001|Period 1|Consent Withdrawal|1|||
156820973|NCT03764631|566094931|FG001|Overall Study|Lost to Follow-up|41|||
156820974|NCT03764631|566094930|FG000|Overall Study|No data as study site was closed|2|||
156820975|NCT03764631|566094931|FG001|Overall Study|No data as study site was closed|6|||
156820976|NCT04569136|566094932|FG000|Overall Study|Lost to Follow-up|2|||
156820977|NCT04569136|566094933|FG001|Overall Study|Lost to Follow-up|0|||
156820978|NCT04569136|566094934|FG002|Overall Study|Lost to Follow-up|1|||
156820979|NCT00129701|566094940|FG000|Overall Study|Withdrawal by Subject|33|||
156820980|NCT03576066|566094941|FG000|Overall Study|Noncompliance with study drug|0|||
156820981|NCT03576066|566094942|FG001|Overall Study|Noncompliance with study drug|1|||
156820982|NCT01466660|566094943|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
156820983|NCT01466660|566094944|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
156820984|NCT01466660|566094943|FG000|Overall Study|Worsening of underlying cancer disease|5|||
156820985|NCT01466660|566094944|FG001|Overall Study|Worsening of underlying cancer disease|2|||
156820986|NCT01466660|566094943|FG000|Overall Study|Other adverse event|19|||
156820987|NCT01466660|566094944|FG001|Overall Study|Other adverse event|18|||
156820988|NCT01466660|566094943|FG000|Overall Study|Protocol Violation|2|||
156820989|NCT01466660|566094944|FG001|Overall Study|Protocol Violation|1|||
156820990|NCT01466660|566094943|FG000|Overall Study|Refused continuation of trial medication|4|||
156820991|NCT01466660|566094944|FG001|Overall Study|Refused continuation of trial medication|3|||
156820992|NCT01466660|566094943|FG000|Overall Study|Other reason not defined above|10|||
156820993|NCT01466660|566094944|FG001|Overall Study|Other reason not defined above|8|||
156820994|NCT00712725|566094950|FG000|Overall Study|Adverse Event|1|||
156820995|NCT00712725|566094951|FG001|Overall Study|Adverse Event|0|||
156820996|NCT00712725|566094952|FG002|Overall Study|Adverse Event|0|||
156820997|NCT00712725|566094953|FG003|Overall Study|Adverse Event|1|||
156820998|NCT00712725|566094954|FG004|Overall Study|Adverse Event|0|||
156820999|NCT00712725|566094955|FG005|Overall Study|Adverse Event|0|||
156821000|NCT00712725|566094956|FG006|Overall Study|Adverse Event|0|||
156821001|NCT00712725|566094957|FG007|Overall Study|Adverse Event|0|||
156821002|NCT00712725|566094950|FG000|Overall Study|Lost to Follow-up|3|||
156821003|NCT00712725|566094951|FG001|Overall Study|Lost to Follow-up|2|||
156821004|NCT00712725|566094952|FG002|Overall Study|Lost to Follow-up|1|||
156821005|NCT00712725|566094953|FG003|Overall Study|Lost to Follow-up|1|||
156821006|NCT00712725|566094954|FG004|Overall Study|Lost to Follow-up|2|||
157022711|NCT04810650|566835279|FG007|Overall Study|Participant declined|0|||
157022712|NCT04810650|566835280|FG008|Overall Study|Participant declined|0|||
157022713|NCT04810650|566835281|FG009|Overall Study|Participant declined|0|||
157022714|NCT04810650|566835282|FG010|Overall Study|Participant declined|2|||
157022715|NCT04810650|566835283|FG011|Overall Study|Participant declined|0|||
157022716|NCT04810650|566835284|FG012|Overall Study|Participant declined|0|||
157022717|NCT04810650|566835285|FG013|Overall Study|Participant declined|0|||
157022718|NCT05794243|566835286|FG000|Overall Study|Withdrawal by Subject|1|||
157022719|NCT05794243|566835287|FG001|Overall Study|Withdrawal by Subject|0|||
157022720|NCT05794243|566835288|FG002|Overall Study|Withdrawal by Subject|1|||
157022721|NCT05794243|566835286|FG000|Overall Study|Physician Decision|0|||
157022722|NCT05794243|566835287|FG001|Overall Study|Physician Decision|3|||
157022723|NCT05794243|566835288|FG002|Overall Study|Physician Decision|1|||
157022724|NCT02761057|566835292|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
157022725|NCT02761057|566835293|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
157022726|NCT02761057|566835294|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
157022727|NCT02761057|566835295|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
157022728|NCT02761057|566835292|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
157022729|NCT02761057|566835293|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
157022730|NCT02761057|566835294|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
157022731|NCT02761057|566835295|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
157022732|NCT02761057|566835292|FG000|Overall Study|Currently On Study Treatment|0|||
157022733|NCT02761057|566835293|FG001|Overall Study|Currently On Study Treatment|3|||
157022734|NCT02761057|566835294|FG002|Overall Study|Currently On Study Treatment|0|||
157022735|NCT02761057|566835295|FG003|Overall Study|Currently On Study Treatment|0|||
157022736|NCT02761057|566835292|FG000|Overall Study|Adverse Event|11|||
157022737|NCT02761057|566835293|FG001|Overall Study|Adverse Event|9|||
156821007|NCT00712725|566094955|FG005|Overall Study|Lost to Follow-up|2|||
156821008|NCT00712725|566094956|FG006|Overall Study|Lost to Follow-up|3|||
156821009|NCT00712725|566094957|FG007|Overall Study|Lost to Follow-up|1|||
156821010|NCT00712725|566094950|FG000|Overall Study|Physician Decision|2|||
156821011|NCT00712725|566094951|FG001|Overall Study|Physician Decision|0|||
156821012|NCT00712725|566094952|FG002|Overall Study|Physician Decision|0|||
156821013|NCT00712725|566094953|FG003|Overall Study|Physician Decision|0|||
156821014|NCT00712725|566094954|FG004|Overall Study|Physician Decision|1|||
156821015|NCT00712725|566094955|FG005|Overall Study|Physician Decision|0|||
156821016|NCT00712725|566094956|FG006|Overall Study|Physician Decision|2|||
156821017|NCT00712725|566094957|FG007|Overall Study|Physician Decision|0|||
157022738|NCT02761057|566835294|FG002|Overall Study|Adverse Event|5|||
157022739|NCT02761057|566835295|FG003|Overall Study|Adverse Event|3|||
157022740|NCT02761057|566835292|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
157022741|NCT02761057|566835293|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
157022742|NCT02761057|566835294|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
157022743|NCT02761057|566835295|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
157022744|NCT02761057|566835292|FG000|Overall Study|Progression/Relapse|29|||
157022745|NCT02761057|566835293|FG001|Overall Study|Progression/Relapse|27|||
157150775|NCT04498910|567298092|FG000|Overall Study|Adverse Event|1|||
157150776|NCT04498910|567298093|FG001|Overall Study|Adverse Event|0|||
156821018|NCT00712725|566094950|FG000|Overall Study|Pregnancy|0|||
156821019|NCT00712725|566094951|FG001|Overall Study|Pregnancy|1|||
156821020|NCT00712725|566094952|FG002|Overall Study|Pregnancy|0|||
156821021|NCT00712725|566094953|FG003|Overall Study|Pregnancy|0|||
157022746|NCT02761057|566835294|FG002|Overall Study|Progression/Relapse|20|||
157022747|NCT02761057|566835295|FG003|Overall Study|Progression/Relapse|23|||
157022748|NCT02761057|566835292|FG000|Overall Study|Death|2|||
156821022|NCT00712725|566094954|FG004|Overall Study|Pregnancy|1|||
156821023|NCT00712725|566094955|FG005|Overall Study|Pregnancy|0|||
156821024|NCT00712725|566094956|FG006|Overall Study|Pregnancy|2|||
156821025|NCT00712725|566094957|FG007|Overall Study|Pregnancy|0|||
156821026|NCT00712725|566094950|FG000|Overall Study|Protocol Violation|2|||
156821027|NCT00712725|566094951|FG001|Overall Study|Protocol Violation|0|||
156821028|NCT00712725|566094952|FG002|Overall Study|Protocol Violation|1|||
156821029|NCT00712725|566094953|FG003|Overall Study|Protocol Violation|3|||
156821030|NCT00712725|566094954|FG004|Overall Study|Protocol Violation|2|||
156821031|NCT00712725|566094955|FG005|Overall Study|Protocol Violation|0|||
156821032|NCT00712725|566094956|FG006|Overall Study|Protocol Violation|1|||
156821033|NCT00712725|566094957|FG007|Overall Study|Protocol Violation|1|||
156821034|NCT00712725|566094950|FG000|Overall Study|Withdrawal by Subject|2|||
156821035|NCT00712725|566094951|FG001|Overall Study|Withdrawal by Subject|1|||
156821036|NCT00712725|566094952|FG002|Overall Study|Withdrawal by Subject|1|||
156821037|NCT00712725|566094953|FG003|Overall Study|Withdrawal by Subject|2|||
156821038|NCT00712725|566094954|FG004|Overall Study|Withdrawal by Subject|1|||
156821039|NCT00712725|566094955|FG005|Overall Study|Withdrawal by Subject|1|||
156821040|NCT00712725|566094956|FG006|Overall Study|Withdrawal by Subject|1|||
156821041|NCT00712725|566094957|FG007|Overall Study|Withdrawal by Subject|2|||
156821042|NCT00712725|566094950|FG000|Overall Study|Lack of Qualifying Event|16|||
156821043|NCT00712725|566094951|FG001|Overall Study|Lack of Qualifying Event|2|||
156821044|NCT00712725|566094952|FG002|Overall Study|Lack of Qualifying Event|6|||
156821045|NCT00712725|566094953|FG003|Overall Study|Lack of Qualifying Event|8|||
156821046|NCT00712725|566094954|FG004|Overall Study|Lack of Qualifying Event|11|||
156821047|NCT00712725|566094955|FG005|Overall Study|Lack of Qualifying Event|13|||
156821048|NCT00712725|566094956|FG006|Overall Study|Lack of Qualifying Event|11|||
156821049|NCT00712725|566094957|FG007|Overall Study|Lack of Qualifying Event|6|||
156821050|NCT00712725|566094950|FG000|Overall Study|Protocol Specified Criteria|3|||
156821051|NCT00712725|566094951|FG001|Overall Study|Protocol Specified Criteria|0|||
156821052|NCT00712725|566094952|FG002|Overall Study|Protocol Specified Criteria|1|||
156821053|NCT00712725|566094953|FG003|Overall Study|Protocol Specified Criteria|2|||
156821054|NCT00712725|566094954|FG004|Overall Study|Protocol Specified Criteria|1|||
156821055|NCT00712725|566094955|FG005|Overall Study|Protocol Specified Criteria|0|||
156821056|NCT00712725|566094956|FG006|Overall Study|Protocol Specified Criteria|2|||
156821057|NCT00712725|566094957|FG007|Overall Study|Protocol Specified Criteria|1|||
156821058|NCT01901289|566094958|FG000|Overall Study|Death|32|||
156821059|NCT01901289|566094958|FG000|Overall Study|Lost to Follow-up|16|||
156821060|NCT01901289|566094958|FG000|Overall Study|Withdrawal by Subject|35|||
156821061|NCT01901289|566094958|FG000|Overall Study|Other type of endpoint met|2|||
156821062|NCT01832493|566094966|FG000|Overall Study|Physician Decision|2|||
156821063|NCT01832493|566094966|FG000|Overall Study|Protocol Violation|4|||
156821064|NCT01832493|566094966|FG000|Overall Study|Unable to place LV lead|2|||
156821065|NCT00290771|566094975|FG000|Overall Study|Disease progression|95|||
156821066|NCT00290771|566094976|FG001|Overall Study|Disease progression|73|||
156821067|NCT00290771|566094975|FG000|Overall Study|Death|11|||
156821068|NCT00290771|566094976|FG001|Overall Study|Death|10|||
156821069|NCT00290771|566094975|FG000|Overall Study|Adverse Event|12|||
156821070|NCT00290771|566094976|FG001|Overall Study|Adverse Event|6|||
156821071|NCT00290771|566094975|FG000|Overall Study|Withdrawal by Subject|5|||
156821072|NCT00290771|566094976|FG001|Overall Study|Withdrawal by Subject|6|||
156821073|NCT00290771|566094975|FG000|Overall Study|Administrative problems|2|||
156821074|NCT00290771|566094976|FG001|Overall Study|Administrative problems|1|||
156821075|NCT00290771|566094975|FG000|Overall Study|Protocol Violation|2|||
156821076|NCT00290771|566094976|FG001|Overall Study|Protocol Violation|0|||
156821077|NCT00290771|566094975|FG000|Overall Study|Lost to Follow-up|0|||
156821078|NCT00290771|566094976|FG001|Overall Study|Lost to Follow-up|1|||
156821079|NCT03703817|566094978|FG000|Overall Study|Not meeting eligibility criteria|7|||
156821080|NCT03703817|566094979|FG001|Overall Study|Not meeting eligibility criteria|4|||
156821081|NCT05129449|566094980|FG000|Overall Study|Protocol Violation|1|||
156821082|NCT02247011|566094981|FG000|Overall Study|Poor quality of radiological results|125|||
156821083|NCT01818258|566094983|FG000|Overall Study|Death|3|||
156821084|NCT01818258|566094984|FG001|Overall Study|Death|0|||
156821085|NCT01818258|566094983|FG000|Overall Study|Withdrawal by Subject|0|||
156821086|NCT01818258|566094984|FG001|Overall Study|Withdrawal by Subject|1|||
156821087|NCT01818258|566094983|FG000|Overall Study|Lost to Follow-up|0|||
157022749|NCT02761057|566835293|FG001|Overall Study|Death|2|||
156821088|NCT01818258|566094984|FG001|Overall Study|Lost to Follow-up|1|||
156821089|NCT01818258|566094983|FG000|Overall Study|Unable to Travel to Clinic|0|||
156821090|NCT01818258|566094984|FG001|Overall Study|Unable to Travel to Clinic|1|||
156821091|NCT02839720|566094987|FG000|Overall Study|Adverse Event|2|||
156821092|NCT02839720|566094987|FG000|Overall Study|Non-compliance|2|||
156821093|NCT02839720|566094987|FG000|Overall Study|Intercurrent Illness|1|||
156821094|NCT02839720|566094987|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
156821095|NCT05145322|566094988|FG000|Overall Study|Lost to Follow-up|4|||
156821096|NCT05145322|566094989|FG001|Overall Study|Lost to Follow-up|5|||
156821097|NCT06359028|566094990|FG000|Overall Study|Adverse Event|1|||
156821098|NCT06359028|566094991|FG001|Overall Study|Adverse Event|0|||
156821099|NCT06359028|566094990|FG000|Overall Study|Withdrawal by Subject|1|||
156821100|NCT06359028|566094991|FG001|Overall Study|Withdrawal by Subject|0|||
156821101|NCT02241733|566094994|FG000|Overall Study|Lost to Follow-up|9|||
156821102|NCT02241733|566094995|FG001|Overall Study|Lost to Follow-up|4|||
156821103|NCT02241733|566094994|FG000|Overall Study|Physician Decision|6|||
156821104|NCT02241733|566094995|FG001|Overall Study|Physician Decision|2|||
156821105|NCT02241733|566094994|FG000|Overall Study|Withdrawal by Subject|0|||
156821106|NCT02241733|566094995|FG001|Overall Study|Withdrawal by Subject|2|||
156821107|NCT02241733|566094994|FG000|Overall Study|Death|0|||
156821108|NCT02241733|566094995|FG001|Overall Study|Death|2|||
156821109|NCT04283994|566094996|FG000|Overall Study|Death|11|||
156821110|NCT04283994|566094997|FG001|Overall Study|Death|20|||
156821111|NCT04283994|566094998|FG002|Overall Study|Death|11|||
157150777|NCT01070303|567298094|FG000|Overall Study|Adverse Event|39|||
157150778|NCT01070303|567298094|FG000|Overall Study|Withdrawal by Subject|20|||
157150779|NCT01070303|567298094|FG000|Overall Study|Lost to Follow-up|9|||
157150780|NCT01070303|567298094|FG000|Overall Study|Protocol Violation|0|||
157150781|NCT01070303|567298094|FG000|Overall Study|Lack of Efficacy|2|||
156821112|NCT04283994|566094999|FG003|Overall Study|Death|0|||
156821113|NCT04283994|566095000|FG004|Overall Study|Death|0|||
156821114|NCT04283994|566095001|FG005|Overall Study|Death|0|||
156821115|NCT04283994|566095002|FG006|Overall Study|Death|0|||
156821116|NCT04283994|566094996|FG000|Overall Study|Withdrawal by Subject|16|||
156821117|NCT04283994|566094997|FG001|Overall Study|Withdrawal by Subject|4|||
156821118|NCT04283994|566094998|FG002|Overall Study|Withdrawal by Subject|6|||
156821119|NCT04283994|566094999|FG003|Overall Study|Withdrawal by Subject|1|||
156821120|NCT04283994|566095000|FG004|Overall Study|Withdrawal by Subject|0|||
156821121|NCT04283994|566095001|FG005|Overall Study|Withdrawal by Subject|1|||
156821122|NCT04283994|566095002|FG006|Overall Study|Withdrawal by Subject|0|||
156821123|NCT01700959|566095003|FG000|Overall Study|Adverse Event|0|||
156821124|NCT01700959|566095004|FG001|Overall Study|Adverse Event|1|||
156821125|NCT01700959|566095005|FG002|Overall Study|Adverse Event|1|||
156821126|NCT01700959|566095006|FG003|Overall Study|Adverse Event|2|||
156821127|NCT01700959|566095007|FG004|Overall Study|Adverse Event|0|||
156821128|NCT01700959|566095008|FG005|Overall Study|Adverse Event|2|||
156821129|NCT01700959|566095003|FG000|Overall Study|Withdrawal by Subject|15|||
156821130|NCT01700959|566095004|FG001|Overall Study|Withdrawal by Subject|9|||
156821131|NCT01700959|566095005|FG002|Overall Study|Withdrawal by Subject|12|||
156821132|NCT01700959|566095006|FG003|Overall Study|Withdrawal by Subject|11|||
156821133|NCT01700959|566095007|FG004|Overall Study|Withdrawal by Subject|8|||
156821134|NCT01700959|566095008|FG005|Overall Study|Withdrawal by Subject|12|||
156821135|NCT01700959|566095003|FG000|Overall Study|Ineligible|2|||
156821136|NCT01700959|566095004|FG001|Overall Study|Ineligible|1|||
156821137|NCT01700959|566095005|FG002|Overall Study|Ineligible|2|||
156821138|NCT01700959|566095006|FG003|Overall Study|Ineligible|0|||
156821139|NCT01700959|566095007|FG004|Overall Study|Ineligible|0|||
156821140|NCT01700959|566095008|FG005|Overall Study|Ineligible|1|||
156821141|NCT01700959|566095003|FG000|Overall Study|Noncompliant|9|||
156821142|NCT01700959|566095004|FG001|Overall Study|Noncompliant|9|||
156821143|NCT01700959|566095005|FG002|Overall Study|Noncompliant|17|||
156821144|NCT01700959|566095006|FG003|Overall Study|Noncompliant|18|||
156821145|NCT01700959|566095007|FG004|Overall Study|Noncompliant|15|||
156821146|NCT01700959|566095008|FG005|Overall Study|Noncompliant|9|||
156821147|NCT01700959|566095003|FG000|Overall Study|Side effects|1|||
156821148|NCT01700959|566095004|FG001|Overall Study|Side effects|4|||
156821149|NCT01700959|566095005|FG002|Overall Study|Side effects|8|||
156821150|NCT01700959|566095006|FG003|Overall Study|Side effects|4|||
156821151|NCT01700959|566095007|FG004|Overall Study|Side effects|4|||
156821152|NCT01700959|566095008|FG005|Overall Study|Side effects|1|||
156821153|NCT00830375|566095009|FG000|Overall Study|Lost to Follow-up|1|||
156821154|NCT02589665|566097143|FG000|Induction Period|Did not receive drug|0|||
156821155|NCT02589665|566097144|FG001|Induction Period|Did not receive drug|0|||
157150782|NCT01070303|567298094|FG000|Overall Study|Administrative Reason|1|||
157150783|NCT01070303|567298094|FG000|Overall Study|Other|18|||
156821156|NCT02589665|566097145|FG002|Induction Period|Did not receive drug|0|||
156884456|NCT01221272|566336243|FG000|Period 1|Significant Dosing Noncompliance|0|||
156821157|NCT02589665|566097146|FG003|Induction Period|Did not receive drug|1|||
156821158|NCT02589665|566097147|FG004|Induction Period|Did not receive drug|0|||
156884457|NCT01221272|566336244|FG001|Period 1|Significant Dosing Noncompliance|1|||
157150784|NCT02064439|567298097|FG000|Overall Study|Adverse Event|51|||
157150785|NCT02064439|567298098|FG001|Overall Study|Adverse Event|47|||
157150786|NCT02064439|567298099|FG002|Overall Study|Adverse Event|46|||
156821159|NCT02589665|566097148|FG005|Induction Period|Did not receive drug|0|||
156821160|NCT02589665|566097149|FG006|Induction Period|Did not receive drug|0|||
156821161|NCT02589665|566097150|FG007|Induction Period|Did not receive drug|0|||
156821162|NCT02589665|566097151|FG008|Induction Period|Did not receive drug|0|||
156821163|NCT02589665|566097152|FG009|Induction Period|Did not receive drug|0|||
156821164|NCT02589665|566097143|FG000|Induction Period|Adverse Event|3|||
156821165|NCT02589665|566097144|FG001|Induction Period|Adverse Event|0|||
156821166|NCT02589665|566097145|FG002|Induction Period|Adverse Event|2|||
156821167|NCT02589665|566097146|FG003|Induction Period|Adverse Event|2|||
156821168|NCT02589665|566097147|FG004|Induction Period|Adverse Event|0|||
156821169|NCT02589665|566097148|FG005|Induction Period|Adverse Event|0|||
156821170|NCT02589665|566097149|FG006|Induction Period|Adverse Event|0|||
156821171|NCT02589665|566097150|FG007|Induction Period|Adverse Event|0|||
156821172|NCT02589665|566097151|FG008|Induction Period|Adverse Event|0|||
156821173|NCT02589665|566097152|FG009|Induction Period|Adverse Event|0|||
156821174|NCT02589665|566097143|FG000|Induction Period|Withdrawal by Subject|0|||
156821175|NCT02589665|566097144|FG001|Induction Period|Withdrawal by Subject|1|||
156821176|NCT02589665|566097145|FG002|Induction Period|Withdrawal by Subject|0|||
156821177|NCT02589665|566097146|FG003|Induction Period|Withdrawal by Subject|1|||
156821178|NCT02589665|566097147|FG004|Induction Period|Withdrawal by Subject|0|||
156821179|NCT02589665|566097148|FG005|Induction Period|Withdrawal by Subject|0|||
156821180|NCT02589665|566097149|FG006|Induction Period|Withdrawal by Subject|0|||
156821181|NCT02589665|566097150|FG007|Induction Period|Withdrawal by Subject|0|||
156821182|NCT02589665|566097151|FG008|Induction Period|Withdrawal by Subject|0|||
156821183|NCT02589665|566097152|FG009|Induction Period|Withdrawal by Subject|0|||
156821184|NCT02589665|566097143|FG000|Induction Period|Protocol Violation|0|||
156821185|NCT02589665|566097144|FG001|Induction Period|Protocol Violation|1|||
156821186|NCT02589665|566097145|FG002|Induction Period|Protocol Violation|0|||
156821187|NCT02589665|566097146|FG003|Induction Period|Protocol Violation|0|||
156821188|NCT02589665|566097147|FG004|Induction Period|Protocol Violation|0|||
156821189|NCT02589665|566097148|FG005|Induction Period|Protocol Violation|0|||
156821190|NCT02589665|566097149|FG006|Induction Period|Protocol Violation|0|||
156821191|NCT02589665|566097150|FG007|Induction Period|Protocol Violation|0|||
157150787|NCT02064439|567298097|FG000|Overall Study|Death|0|||
157150788|NCT02064439|567298098|FG001|Overall Study|Death|2|||
157150789|NCT02064439|567298099|FG002|Overall Study|Death|3|||
156821192|NCT02589665|566097151|FG008|Induction Period|Protocol Violation|0|||
156821193|NCT02589665|566097152|FG009|Induction Period|Protocol Violation|0|||
156821194|NCT02589665|566097143|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821195|NCT02589665|566097144|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821196|NCT02589665|566097145|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821197|NCT02589665|566097146|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821198|NCT02589665|566097147|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
156821199|NCT02589665|566097148|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
156821200|NCT02589665|566097149|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
156821201|NCT02589665|566097150|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821202|NCT02589665|566097151|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821203|NCT02589665|566097152|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821204|NCT02589665|566097143|FG000|Maintenance Period|Withdrawal by Subject|0|||
156821205|NCT02589665|566097144|FG001|Maintenance Period|Withdrawal by Subject|0|||
156821206|NCT02589665|566097145|FG002|Maintenance Period|Withdrawal by Subject|0|||
156821207|NCT02589665|566097146|FG003|Maintenance Period|Withdrawal by Subject|0|||
156821208|NCT02589665|566097147|FG004|Maintenance Period|Withdrawal by Subject|4|||
156821209|NCT02589665|566097148|FG005|Maintenance Period|Withdrawal by Subject|2|||
156821210|NCT02589665|566097149|FG006|Maintenance Period|Withdrawal by Subject|4|||
156821211|NCT02589665|566097150|FG007|Maintenance Period|Withdrawal by Subject|0|||
156821212|NCT02589665|566097151|FG008|Maintenance Period|Withdrawal by Subject|0|||
156821213|NCT02589665|566097152|FG009|Maintenance Period|Withdrawal by Subject|0|||
156821214|NCT02589665|566097143|FG000|Maintenance Period|Lack of Efficacy|0|||
156821215|NCT02589665|566097144|FG001|Maintenance Period|Lack of Efficacy|0|||
156821216|NCT02589665|566097145|FG002|Maintenance Period|Lack of Efficacy|0|||
156821217|NCT02589665|566097146|FG003|Maintenance Period|Lack of Efficacy|0|||
156821218|NCT02589665|566097147|FG004|Maintenance Period|Lack of Efficacy|2|||
156821219|NCT02589665|566097148|FG005|Maintenance Period|Lack of Efficacy|1|||
156821220|NCT02589665|566097149|FG006|Maintenance Period|Lack of Efficacy|0|||
156821221|NCT02589665|566097150|FG007|Maintenance Period|Lack of Efficacy|0|||
156821222|NCT02589665|566097151|FG008|Maintenance Period|Lack of Efficacy|0|||
156821223|NCT02589665|566097152|FG009|Maintenance Period|Lack of Efficacy|0|||
157150790|NCT02064439|567298097|FG000|Overall Study|Withdrawal by Subject|29|||
157150791|NCT02064439|567298098|FG001|Overall Study|Withdrawal by Subject|18|||
156821224|NCT02589665|566097143|FG000|Maintenance Period|Adverse Event|0|||
156821225|NCT02589665|566097144|FG001|Maintenance Period|Adverse Event|0|||
156821226|NCT02589665|566097145|FG002|Maintenance Period|Adverse Event|0|||
156821227|NCT02589665|566097146|FG003|Maintenance Period|Adverse Event|0|||
156821228|NCT02589665|566097147|FG004|Maintenance Period|Adverse Event|0|||
156821229|NCT02589665|566097148|FG005|Maintenance Period|Adverse Event|0|||
156821230|NCT02589665|566097149|FG006|Maintenance Period|Adverse Event|2|||
156821231|NCT02589665|566097150|FG007|Maintenance Period|Adverse Event|0|||
156821232|NCT02589665|566097151|FG008|Maintenance Period|Adverse Event|0|||
156821233|NCT02589665|566097152|FG009|Maintenance Period|Adverse Event|0|||
157150792|NCT02064439|567298099|FG002|Overall Study|Withdrawal by Subject|26|||
157150793|NCT02064439|567298097|FG000|Overall Study|Protocol Violation|3|||
157150794|NCT02064439|567298098|FG001|Overall Study|Protocol Violation|5|||
156821234|NCT02589665|566097143|FG000|Maintenance Period|Lost to Follow-up|0|||
156821235|NCT02589665|566097144|FG001|Maintenance Period|Lost to Follow-up|0|||
156821236|NCT02589665|566097145|FG002|Maintenance Period|Lost to Follow-up|0|||
156821237|NCT02589665|566097146|FG003|Maintenance Period|Lost to Follow-up|0|||
156821238|NCT02589665|566097147|FG004|Maintenance Period|Lost to Follow-up|0|||
156821239|NCT02589665|566097148|FG005|Maintenance Period|Lost to Follow-up|1|||
156821240|NCT02589665|566097149|FG006|Maintenance Period|Lost to Follow-up|0|||
156821241|NCT02589665|566097150|FG007|Maintenance Period|Lost to Follow-up|0|||
156821242|NCT02589665|566097151|FG008|Maintenance Period|Lost to Follow-up|0|||
156821243|NCT02589665|566097152|FG009|Maintenance Period|Lost to Follow-up|0|||
156821244|NCT02589665|566097143|FG000|Maintenance Period|Physician Decision|0|||
156821245|NCT02589665|566097144|FG001|Maintenance Period|Physician Decision|0|||
156821246|NCT02589665|566097145|FG002|Maintenance Period|Physician Decision|0|||
156821247|NCT02589665|566097146|FG003|Maintenance Period|Physician Decision|0|||
156821248|NCT02589665|566097147|FG004|Maintenance Period|Physician Decision|0|||
156821249|NCT02589665|566097148|FG005|Maintenance Period|Physician Decision|1|||
156821250|NCT02589665|566097149|FG006|Maintenance Period|Physician Decision|0|||
156821251|NCT02589665|566097150|FG007|Maintenance Period|Physician Decision|0|||
156821252|NCT02589665|566097151|FG008|Maintenance Period|Physician Decision|0|||
156821253|NCT02589665|566097152|FG009|Maintenance Period|Physician Decision|0|||
156821254|NCT02589665|566097143|FG000|Maintenance Period|Reason Not Collected|0|||
156821255|NCT02589665|566097144|FG001|Maintenance Period|Reason Not Collected|0|||
156821256|NCT02589665|566097145|FG002|Maintenance Period|Reason Not Collected|0|||
156821257|NCT02589665|566097146|FG003|Maintenance Period|Reason Not Collected|0|||
156821258|NCT02589665|566097147|FG004|Maintenance Period|Reason Not Collected|0|||
156821259|NCT02589665|566097148|FG005|Maintenance Period|Reason Not Collected|1|||
156821260|NCT02589665|566097149|FG006|Maintenance Period|Reason Not Collected|1|||
156821261|NCT02589665|566097150|FG007|Maintenance Period|Reason Not Collected|0|||
156821262|NCT02589665|566097151|FG008|Maintenance Period|Reason Not Collected|0|||
156821263|NCT02589665|566097152|FG009|Maintenance Period|Reason Not Collected|0|||
156821264|NCT02589665|566097143|FG000|Induction Extension Period|Adverse Event|0|||
156821265|NCT02589665|566097144|FG001|Induction Extension Period|Adverse Event|0|||
156821266|NCT02589665|566097145|FG002|Induction Extension Period|Adverse Event|0|||
156821267|NCT02589665|566097146|FG003|Induction Extension Period|Adverse Event|0|||
156821268|NCT02589665|566097147|FG004|Induction Extension Period|Adverse Event|0|||
156821269|NCT02589665|566097148|FG005|Induction Extension Period|Adverse Event|0|||
156821270|NCT02589665|566097149|FG006|Induction Extension Period|Adverse Event|0|||
156821271|NCT02589665|566097150|FG007|Induction Extension Period|Adverse Event|0|||
156821272|NCT02589665|566097151|FG008|Induction Extension Period|Adverse Event|4|||
156821273|NCT02589665|566097152|FG009|Induction Extension Period|Adverse Event|0|||
156821274|NCT02589665|566097143|FG000|Induction Extension Period|Lack of Efficacy|0|||
156821275|NCT02589665|566097144|FG001|Induction Extension Period|Lack of Efficacy|0|||
156821276|NCT02589665|566097145|FG002|Induction Extension Period|Lack of Efficacy|0|||
156821277|NCT02589665|566097146|FG003|Induction Extension Period|Lack of Efficacy|0|||
156821278|NCT02589665|566097147|FG004|Induction Extension Period|Lack of Efficacy|0|||
156821279|NCT02589665|566097148|FG005|Induction Extension Period|Lack of Efficacy|0|||
156821280|NCT02589665|566097149|FG006|Induction Extension Period|Lack of Efficacy|0|||
156821281|NCT02589665|566097150|FG007|Induction Extension Period|Lack of Efficacy|0|||
156821282|NCT02589665|566097151|FG008|Induction Extension Period|Lack of Efficacy|3|||
156821283|NCT02589665|566097152|FG009|Induction Extension Period|Lack of Efficacy|0|||
156821284|NCT02589665|566097143|FG000|Induction Extension Period|Withdrawal by Subject|0|||
156821285|NCT02589665|566097144|FG001|Induction Extension Period|Withdrawal by Subject|0|||
156821286|NCT02589665|566097145|FG002|Induction Extension Period|Withdrawal by Subject|0|||
156821287|NCT02589665|566097146|FG003|Induction Extension Period|Withdrawal by Subject|0|||
156821288|NCT02589665|566097147|FG004|Induction Extension Period|Withdrawal by Subject|0|||
156821289|NCT02589665|566097148|FG005|Induction Extension Period|Withdrawal by Subject|0|||
156821290|NCT02589665|566097149|FG006|Induction Extension Period|Withdrawal by Subject|0|||
156821291|NCT02589665|566097150|FG007|Induction Extension Period|Withdrawal by Subject|2|||
156821292|NCT02589665|566097151|FG008|Induction Extension Period|Withdrawal by Subject|3|||
156821293|NCT02589665|566097152|FG009|Induction Extension Period|Withdrawal by Subject|0|||
156821294|NCT02589665|566097143|FG000|Induction Extension Period|Physician Decision|0|||
156821295|NCT02589665|566097144|FG001|Induction Extension Period|Physician Decision|0|||
156821296|NCT02589665|566097145|FG002|Induction Extension Period|Physician Decision|0|||
156821297|NCT02589665|566097146|FG003|Induction Extension Period|Physician Decision|0|||
156821298|NCT02589665|566097147|FG004|Induction Extension Period|Physician Decision|0|||
156821299|NCT02589665|566097148|FG005|Induction Extension Period|Physician Decision|0|||
156821300|NCT02589665|566097149|FG006|Induction Extension Period|Physician Decision|0|||
156821301|NCT02589665|566097150|FG007|Induction Extension Period|Physician Decision|0|||
156821302|NCT02589665|566097151|FG008|Induction Extension Period|Physician Decision|1|||
156821303|NCT02589665|566097152|FG009|Induction Extension Period|Physician Decision|0|||
156821304|NCT02589665|566097143|FG000|Induction Extension Period|Reason Not Collected|0|||
156821305|NCT02589665|566097144|FG001|Induction Extension Period|Reason Not Collected|0|||
156821306|NCT02589665|566097145|FG002|Induction Extension Period|Reason Not Collected|0|||
156821307|NCT02589665|566097146|FG003|Induction Extension Period|Reason Not Collected|0|||
156821308|NCT02589665|566097147|FG004|Induction Extension Period|Reason Not Collected|0|||
156821309|NCT02589665|566097148|FG005|Induction Extension Period|Reason Not Collected|0|||
156821310|NCT02589665|566097149|FG006|Induction Extension Period|Reason Not Collected|0|||
156821311|NCT02589665|566097150|FG007|Induction Extension Period|Reason Not Collected|0|||
156821312|NCT02589665|566097151|FG008|Induction Extension Period|Reason Not Collected|1|||
156821313|NCT02589665|566097152|FG009|Induction Extension Period|Reason Not Collected|0|||
156821314|NCT02589665|566097143|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821315|NCT02589665|566097144|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821316|NCT02589665|566097145|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821317|NCT02589665|566097146|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821318|NCT02589665|566097147|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821319|NCT02589665|566097148|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821320|NCT02589665|566097149|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821321|NCT02589665|566097150|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821322|NCT02589665|566097151|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
156821323|NCT02589665|566097152|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
156821324|NCT02589665|566097143|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
156821325|NCT02589665|566097144|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
156821326|NCT02589665|566097145|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
156821327|NCT02589665|566097146|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
156821328|NCT02589665|566097147|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
156821329|NCT02589665|566097148|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
156821330|NCT02589665|566097149|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
156821331|NCT02589665|566097150|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
156821332|NCT02589665|566097151|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
156821333|NCT02589665|566097152|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
156821334|NCT02589665|566097143|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
156821335|NCT02589665|566097144|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
156821336|NCT02589665|566097145|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
156821337|NCT02589665|566097146|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
156821338|NCT02589665|566097147|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
156821339|NCT02589665|566097148|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
156821340|NCT02589665|566097149|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
156821341|NCT02589665|566097150|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
156821342|NCT02589665|566097151|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
156821343|NCT02589665|566097152|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
156821344|NCT02589665|566097143|FG000|Maintenance Extension Period|Adverse Event|0|||
156821345|NCT02589665|566097144|FG001|Maintenance Extension Period|Adverse Event|0|||
156821346|NCT02589665|566097145|FG002|Maintenance Extension Period|Adverse Event|0|||
156821347|NCT02589665|566097146|FG003|Maintenance Extension Period|Adverse Event|0|||
156821348|NCT02589665|566097147|FG004|Maintenance Extension Period|Adverse Event|0|||
156821349|NCT02589665|566097148|FG005|Maintenance Extension Period|Adverse Event|0|||
156821350|NCT02589665|566097149|FG006|Maintenance Extension Period|Adverse Event|0|||
156821351|NCT02589665|566097150|FG007|Maintenance Extension Period|Adverse Event|0|||
156821352|NCT02589665|566097151|FG008|Maintenance Extension Period|Adverse Event|0|||
156821353|NCT02589665|566097152|FG009|Maintenance Extension Period|Adverse Event|2|||
156821354|NCT02589665|566097143|FG000|Maintenance Extension Period|Non-responder|0|||
156821355|NCT02589665|566097144|FG001|Maintenance Extension Period|Non-responder|0|||
156821356|NCT02589665|566097145|FG002|Maintenance Extension Period|Non-responder|0|||
156821357|NCT02589665|566097146|FG003|Maintenance Extension Period|Non-responder|0|||
156821358|NCT02589665|566097147|FG004|Maintenance Extension Period|Non-responder|0|||
156821359|NCT02589665|566097148|FG005|Maintenance Extension Period|Non-responder|0|||
156821360|NCT02589665|566097149|FG006|Maintenance Extension Period|Non-responder|0|||
156821361|NCT02589665|566097150|FG007|Maintenance Extension Period|Non-responder|0|||
156821362|NCT02589665|566097151|FG008|Maintenance Extension Period|Non-responder|0|||
156821363|NCT02589665|566097152|FG009|Maintenance Extension Period|Non-responder|1|||
156821364|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Adverse Event|76|||
156821365|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Adverse Event|0|||
156821366|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Adverse Event|0|||
156821367|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Death|3|||
156821368|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Death|0|||
156821369|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Death|0|||
156821370|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
156821371|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
156821372|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
156821373|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Physician Decision|9|||
157224432|NCT00275002|567567987|FG001|Overall Study|Adverse Event|1|||
156821374|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Physician Decision|0|||
156821375|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Physician Decision|0|||
156821376|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
156821377|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
156821378|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
156821379|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Disease progression|45|||
156821380|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Disease progression|0|||
156821381|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Disease progression|0|||
156821382|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
156821383|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
156821384|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
156821385|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
156821386|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
156821387|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
156821388|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
156821389|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
156821390|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
156821391|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
156821392|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
156821393|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
156821394|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
156821395|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
156821396|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
156821397|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
156821398|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
156821399|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
156821400|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
156821401|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
156821402|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
156821403|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
156821404|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
156821405|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
156821406|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
156821407|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
156821408|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
156821409|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Promotor request|1|||
156821410|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Promotor request|0|||
156821411|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Promotor request|0|||
156821412|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
156821413|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
156821414|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
156821415|NCT01461928|566097155|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
156821416|NCT01461928|566097156|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
156821417|NCT01461928|566097157|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
156821418|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Death|3|||
156821419|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Death|0|||
156821420|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Death|0|||
156821421|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
156821422|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
156821423|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
156821424|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
156821425|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
156821426|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
156821427|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Diseases progression|91|||
156821428|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Diseases progression|0|||
156821429|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Diseases progression|0|||
156821430|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Adverse Event|70|||
156821431|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Adverse Event|0|||
156821432|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Adverse Event|0|||
156821433|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Physician Decision|9|||
156821434|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Physician Decision|0|||
156821435|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Physician Decision|0|||
156884458|NCT01221272|566336243|FG000|Period 2|Adverse Event|0|||
156821436|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
156884459|NCT01221272|566336244|FG001|Period 2|Adverse Event|2|||
156884460|NCT01340872|566336245|FG000|Double-blind Phase|Adverse Event|6|||
156884461|NCT01340872|566336246|FG001|Double-blind Phase|Adverse Event|4|||
156821437|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
156821438|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
156821439|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
156821440|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
156821441|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
156821442|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
156821443|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
156821444|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
156821445|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Not compliant|1|||
156821446|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Not compliant|0|||
156821447|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Not compliant|0|||
156821448|NCT01461928|566097155|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
156821449|NCT01461928|566097156|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
156821450|NCT01461928|566097157|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
156821451|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Adverse Event|0|||
156821452|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Adverse Event|2|||
156821453|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Adverse Event|0|||
156821454|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Death|0|||
156821455|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Death|10|||
156821456|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Death|8|||
156821457|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Physician Decision|0|||
156821458|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Physician Decision|0|||
156821459|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Physician Decision|4|||
156821460|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
156821461|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
156821462|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
156821463|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Moved to another town|0|||
156821464|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Moved to another town|1|||
156821465|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Moved to another town|0|||
156821466|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Disease progression|0|||
156821467|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Disease progression|0|||
156821468|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Disease progression|3|||
156821469|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
156821470|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
156821471|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
156821472|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
156821473|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
156821474|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
156821475|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
156821476|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
156821477|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
156821478|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
156821479|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
156821480|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
156821481|NCT01461928|566097155|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
156821482|NCT01461928|566097156|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
156821483|NCT01461928|566097157|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
156821484|NCT01159171|566097158|FG000|Overall Study|Adverse Event|11|||
156821485|NCT01159171|566097158|FG000|Overall Study|Progression of Disease|28|||
156821486|NCT01159171|566097158|FG000|Overall Study|Protocol Violation|1|||
156821487|NCT01159171|566097158|FG000|Overall Study|Need for Surgery|5|||
156821488|NCT01159171|566097158|FG000|Overall Study|Medical Decision|4|||
156821489|NCT01159171|566097158|FG000|Overall Study|Death|1|||
156821490|NCT01892436|566097159|FG000|Overall Study|Withdrawal by Subject|8|||
156821491|NCT01892436|566097160|FG001|Overall Study|Withdrawal by Subject|15|||
156821492|NCT01892436|566097161|FG002|Overall Study|Withdrawal by Subject|4|||
156821493|NCT01892436|566097162|FG003|Overall Study|Withdrawal by Subject|4|||
156821494|NCT01892436|566097159|FG000|Overall Study|Death|1|||
156821495|NCT01892436|566097160|FG001|Overall Study|Death|1|||
156821496|NCT01892436|566097161|FG002|Overall Study|Death|0|||
156821497|NCT01892436|566097162|FG003|Overall Study|Death|0|||
156821498|NCT01892436|566097159|FG000|Overall Study|Physician Decision|2|||
157224433|NCT02918162|567567989|FG000|Overall Study|Withdrawal by Subject|1|||
156821499|NCT01892436|566097160|FG001|Overall Study|Physician Decision|1|||
156821500|NCT01892436|566097161|FG002|Overall Study|Physician Decision|0|||
156821501|NCT01892436|566097162|FG003|Overall Study|Physician Decision|1|||
156821502|NCT01892436|566097159|FG000|Overall Study|Pregnancy|0|||
156821503|NCT01892436|566097160|FG001|Overall Study|Pregnancy|2|||
156821504|NCT01892436|566097161|FG002|Overall Study|Pregnancy|1|||
156821505|NCT01892436|566097162|FG003|Overall Study|Pregnancy|0|||
156821506|NCT01892436|566097159|FG000|Overall Study|Technical problems|2|||
156821507|NCT01892436|566097160|FG001|Overall Study|Technical problems|1|||
156821508|NCT01892436|566097161|FG002|Overall Study|Technical problems|1|||
156821509|NCT01892436|566097162|FG003|Overall Study|Technical problems|1|||
156821510|NCT01892436|566097159|FG000|Overall Study|Lack of Efficacy|1|||
156821511|NCT01892436|566097160|FG001|Overall Study|Lack of Efficacy|2|||
156821512|NCT01892436|566097161|FG002|Overall Study|Lack of Efficacy|2|||
156821513|NCT01892436|566097162|FG003|Overall Study|Lack of Efficacy|2|||
156821514|NCT01892436|566097159|FG000|Overall Study|Lost to Follow-up|1|||
156821515|NCT01892436|566097160|FG001|Overall Study|Lost to Follow-up|1|||
156821516|NCT01892436|566097161|FG002|Overall Study|Lost to Follow-up|1|||
156821517|NCT01892436|566097162|FG003|Overall Study|Lost to Follow-up|3|||
156821518|NCT01892436|566097159|FG000|Overall Study|non-compliance with treatment|1|||
156821519|NCT01892436|566097160|FG001|Overall Study|non-compliance with treatment|0|||
156821520|NCT01892436|566097161|FG002|Overall Study|non-compliance with treatment|0|||
156821521|NCT01892436|566097162|FG003|Overall Study|non-compliance with treatment|0|||
156821522|NCT01892436|566097159|FG000|Overall Study|Adverse Event|7|||
156821523|NCT01892436|566097160|FG001|Overall Study|Adverse Event|6|||
156821524|NCT01892436|566097161|FG002|Overall Study|Adverse Event|2|||
156821525|NCT01892436|566097162|FG003|Overall Study|Adverse Event|3|||
156821526|NCT02923830|566097166|FG000|Overall Study|Physician Decision|13|||
156821527|NCT02923830|566097167|FG001|Overall Study|Physician Decision|15|||
156821528|NCT00837265|566097168|FG000|Pilot Phase|Withdrawal by Subject|0|||
156821529|NCT00837265|566097169|FG001|Pilot Phase|Withdrawal by Subject|2|||
156821530|NCT00837265|566097170|FG002|Pilot Phase|Withdrawal by Subject|3|||
156821531|NCT00837265|566097171|FG003|Pilot Phase|Withdrawal by Subject|2|||
156821532|NCT00837265|566097172|FG004|Pilot Phase|Withdrawal by Subject|0|||
156821533|NCT00837265|566097173|FG005|Pilot Phase|Withdrawal by Subject|0|||
156821534|NCT00837265|566097174|FG006|Pilot Phase|Withdrawal by Subject|0|||
156821535|NCT00837265|566097168|FG000|Pilot Phase|Decision of the investigator|2|||
156821536|NCT00837265|566097169|FG001|Pilot Phase|Decision of the investigator|1|||
156821537|NCT00837265|566097170|FG002|Pilot Phase|Decision of the investigator|0|||
156821538|NCT00837265|566097171|FG003|Pilot Phase|Decision of the investigator|0|||
156821539|NCT00837265|566097172|FG004|Pilot Phase|Decision of the investigator|0|||
156821540|NCT00837265|566097173|FG005|Pilot Phase|Decision of the investigator|0|||
156821541|NCT00837265|566097174|FG006|Pilot Phase|Decision of the investigator|0|||
156821542|NCT00837265|566097168|FG000|Pilot Phase|Adverse Event|1|||
156821543|NCT00837265|566097169|FG001|Pilot Phase|Adverse Event|0|||
156821544|NCT00837265|566097170|FG002|Pilot Phase|Adverse Event|0|||
156821545|NCT00837265|566097171|FG003|Pilot Phase|Adverse Event|0|||
156821546|NCT00837265|566097172|FG004|Pilot Phase|Adverse Event|0|||
156821547|NCT00837265|566097173|FG005|Pilot Phase|Adverse Event|0|||
156821548|NCT00837265|566097174|FG006|Pilot Phase|Adverse Event|0|||
156821549|NCT00837265|566097168|FG000|Pilot Phase|Disease progression|0|||
156821550|NCT00837265|566097169|FG001|Pilot Phase|Disease progression|0|||
156821551|NCT00837265|566097170|FG002|Pilot Phase|Disease progression|0|||
156821552|NCT00837265|566097171|FG003|Pilot Phase|Disease progression|1|||
156821553|NCT00837265|566097172|FG004|Pilot Phase|Disease progression|0|||
156821554|NCT00837265|566097173|FG005|Pilot Phase|Disease progression|0|||
156821555|NCT00837265|566097174|FG006|Pilot Phase|Disease progression|0|||
156821556|NCT00837265|566097168|FG000|Pilot Phase|Participant left the city|0|||
156821557|NCT00837265|566097169|FG001|Pilot Phase|Participant left the city|0|||
156821558|NCT00837265|566097170|FG002|Pilot Phase|Participant left the city|0|||
156821559|NCT00837265|566097171|FG003|Pilot Phase|Participant left the city|1|||
156821560|NCT00837265|566097172|FG004|Pilot Phase|Participant left the city|0|||
156821561|NCT00837265|566097173|FG005|Pilot Phase|Participant left the city|0|||
156821562|NCT00837265|566097174|FG006|Pilot Phase|Participant left the city|0|||
156821563|NCT00837265|566097168|FG000|Main Phase|Withdrawal by Subject|0|||
156821564|NCT00837265|566097169|FG001|Main Phase|Withdrawal by Subject|0|||
156821565|NCT00837265|566097170|FG002|Main Phase|Withdrawal by Subject|0|||
156821566|NCT00837265|566097171|FG003|Main Phase|Withdrawal by Subject|0|||
156821567|NCT00837265|566097172|FG004|Main Phase|Withdrawal by Subject|4|||
156821568|NCT00837265|566097173|FG005|Main Phase|Withdrawal by Subject|2|||
157022750|NCT02761057|566835294|FG002|Overall Study|Death|1|||
156821569|NCT00837265|566097174|FG006|Main Phase|Withdrawal by Subject|1|||
156821570|NCT00837265|566097168|FG000|Main Phase|Decision of the investigator|0|||
156821571|NCT00837265|566097169|FG001|Main Phase|Decision of the investigator|0|||
156821572|NCT00837265|566097170|FG002|Main Phase|Decision of the investigator|0|||
156821573|NCT00837265|566097171|FG003|Main Phase|Decision of the investigator|0|||
156821574|NCT00837265|566097172|FG004|Main Phase|Decision of the investigator|0|||
156821575|NCT00837265|566097173|FG005|Main Phase|Decision of the investigator|2|||
157022751|NCT02761057|566835295|FG003|Overall Study|Death|1|||
156821576|NCT00837265|566097174|FG006|Main Phase|Decision of the investigator|1|||
156821577|NCT00837265|566097168|FG000|Main Phase|Adverse Event|0|||
156821578|NCT00837265|566097169|FG001|Main Phase|Adverse Event|0|||
157022752|NCT02761057|566835292|FG000|Overall Study|Other - Not Protocol Specified|2|||
156821579|NCT00837265|566097170|FG002|Main Phase|Adverse Event|0|||
156821580|NCT00837265|566097171|FG003|Main Phase|Adverse Event|0|||
156821581|NCT00837265|566097172|FG004|Main Phase|Adverse Event|0|||
156821582|NCT00837265|566097173|FG005|Main Phase|Adverse Event|1|||
156821583|NCT00837265|566097174|FG006|Main Phase|Adverse Event|0|||
156821584|NCT00837265|566097168|FG000|Main Phase|Death|0|||
156821585|NCT00837265|566097169|FG001|Main Phase|Death|0|||
156821586|NCT00837265|566097170|FG002|Main Phase|Death|0|||
156821587|NCT00837265|566097171|FG003|Main Phase|Death|0|||
156821588|NCT00837265|566097172|FG004|Main Phase|Death|2|||
156821589|NCT00837265|566097173|FG005|Main Phase|Death|0|||
156821590|NCT00837265|566097174|FG006|Main Phase|Death|1|||
156821591|NCT00837265|566097168|FG000|Main Phase|Lost to Follow-up|0|||
156821592|NCT00837265|566097169|FG001|Main Phase|Lost to Follow-up|0|||
156821593|NCT00837265|566097170|FG002|Main Phase|Lost to Follow-up|0|||
156821594|NCT00837265|566097171|FG003|Main Phase|Lost to Follow-up|0|||
156821595|NCT00837265|566097172|FG004|Main Phase|Lost to Follow-up|1|||
156821596|NCT00837265|566097173|FG005|Main Phase|Lost to Follow-up|0|||
156821597|NCT00837265|566097174|FG006|Main Phase|Lost to Follow-up|0|||
156821598|NCT00837265|566097168|FG000|Main Phase|Principal investigator resignation|0|||
156821599|NCT00837265|566097169|FG001|Main Phase|Principal investigator resignation|0|||
156821600|NCT00837265|566097170|FG002|Main Phase|Principal investigator resignation|0|||
156821601|NCT00837265|566097171|FG003|Main Phase|Principal investigator resignation|0|||
156821602|NCT00837265|566097172|FG004|Main Phase|Principal investigator resignation|2|||
156821603|NCT00837265|566097173|FG005|Main Phase|Principal investigator resignation|0|||
156821604|NCT00837265|566097174|FG006|Main Phase|Principal investigator resignation|0|||
156821605|NCT00837265|566097168|FG000|Main Phase|Participant's personal reason|0|||
156821606|NCT00837265|566097169|FG001|Main Phase|Participant's personal reason|0|||
156821607|NCT00837265|566097170|FG002|Main Phase|Participant's personal reason|0|||
156821608|NCT00837265|566097171|FG003|Main Phase|Participant's personal reason|0|||
156821609|NCT00837265|566097172|FG004|Main Phase|Participant's personal reason|1|||
156821610|NCT00837265|566097173|FG005|Main Phase|Participant's personal reason|0|||
156821611|NCT00837265|566097174|FG006|Main Phase|Participant's personal reason|0|||
156821612|NCT01751906|566097182|FG000|Overall Study|Lost to Follow-up|151|||
156821613|NCT01751906|566097183|FG001|Overall Study|Lost to Follow-up|68|||
156821614|NCT01751906|566097182|FG000|Overall Study|Withdrawal by Subject|22|||
156821615|NCT01751906|566097183|FG001|Overall Study|Withdrawal by Subject|18|||
156821616|NCT01751906|566097182|FG000|Overall Study|Physician Decision|5|||
156821617|NCT01751906|566097183|FG001|Overall Study|Physician Decision|2|||
156821618|NCT01751906|566097182|FG000|Overall Study|Death|84|||
156821619|NCT01751906|566097183|FG001|Overall Study|Death|43|||
156821620|NCT01751906|566097182|FG000|Overall Study|Denied on premises for follow-up by law|1|||
156821621|NCT01751906|566097183|FG001|Overall Study|Denied on premises for follow-up by law|0|||
156821622|NCT00733291|566097184|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
156821623|NCT00733291|566097185|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821624|NCT00733291|566097186|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821625|NCT00733291|566097187|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
156821626|NCT02759107|566097188|FG000|Overall Study|Adverse Event|0|||
156821627|NCT02759107|566097189|FG001|Overall Study|Adverse Event|0|||
156821628|NCT02759107|566097190|FG002|Overall Study|Adverse Event|0|||
157022753|NCT02761057|566835293|FG001|Overall Study|Other - Not Protocol Specified|1|||
157224434|NCT02918162|567567989|FG000|Overall Study|Omental Disease|1|||
157224435|NCT00395226|567567990|FG000|Overall Study|Adverse Event|4|||
157224436|NCT00395226|567567991|FG001|Overall Study|Adverse Event|3|||
157224437|NCT00395226|567567990|FG000|Overall Study|Withdrawal by Subject|0|||
157224438|NCT00395226|567567991|FG001|Overall Study|Withdrawal by Subject|1|||
157224439|NCT00395226|567567990|FG000|Overall Study|Lost to Follow-up|0|||
157224440|NCT00395226|567567991|FG001|Overall Study|Lost to Follow-up|1|||
157224441|NCT02655237|567567994|FG000|Overall Study|Adverse Event|10|||
157224442|NCT02655237|567567995|FG001|Overall Study|Adverse Event|7|||
157224443|NCT02655237|567567994|FG000|Overall Study|Protocol Deviation|2|||
157224444|NCT02655237|567567995|FG001|Overall Study|Protocol Deviation|0|||
157224445|NCT02655237|567567994|FG000|Overall Study|Withdrawal by Participant|1|||
157224446|NCT02655237|567567995|FG001|Overall Study|Withdrawal by Participant|2|||
157224447|NCT02655237|567567994|FG000|Overall Study|Lack of Efficacy|0|||
156821629|NCT02759107|566097191|FG003|Overall Study|Adverse Event|0|||
156821630|NCT02759107|566097192|FG004|Overall Study|Adverse Event|0|||
156821631|NCT02759107|566097193|FG005|Overall Study|Adverse Event|0|||
156821632|NCT02759107|566097194|FG006|Overall Study|Adverse Event|0|||
156821633|NCT02759107|566097195|FG007|Overall Study|Adverse Event|0|||
156821634|NCT02759107|566097196|FG008|Overall Study|Adverse Event|0|||
157022754|NCT02761057|566835294|FG002|Overall Study|Other - Not Protocol Specified|2|||
156821635|NCT02759107|566097197|FG009|Overall Study|Adverse Event|0|||
156821636|NCT02759107|566097198|FG010|Overall Study|Adverse Event|0|||
156821637|NCT02759107|566097199|FG011|Overall Study|Adverse Event|0|||
156821638|NCT02759107|566097200|FG012|Overall Study|Adverse Event|2|||
156821639|NCT02759107|566097201|FG013|Overall Study|Adverse Event|0|||
157022755|NCT02761057|566835295|FG003|Overall Study|Other - Not Protocol Specified|0|||
157224448|NCT02655237|567567995|FG001|Overall Study|Lack of Efficacy|1|||
157224449|NCT02655237|567567994|FG000|Overall Study|Recovery Leading to Surgery|2|||
157224450|NCT02655237|567567995|FG001|Overall Study|Recovery Leading to Surgery|1|||
157224451|NCT02655237|567567994|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
156821640|NCT02759107|566097202|FG014|Overall Study|Adverse Event|0|||
156821641|NCT02759107|566097203|FG015|Overall Study|Adverse Event|1|||
156821642|NCT02759107|566097204|FG016|Overall Study|Adverse Event|0|||
156821643|NCT02759107|566097205|FG017|Overall Study|Adverse Event|2|||
156821644|NCT02759107|566097188|FG000|Overall Study|Scheduling Conflict|0|||
156821645|NCT02759107|566097189|FG001|Overall Study|Scheduling Conflict|0|||
156821646|NCT02759107|566097190|FG002|Overall Study|Scheduling Conflict|0|||
156821647|NCT02759107|566097191|FG003|Overall Study|Scheduling Conflict|0|||
156821648|NCT02759107|566097192|FG004|Overall Study|Scheduling Conflict|0|||
156821649|NCT02759107|566097193|FG005|Overall Study|Scheduling Conflict|0|||
156821650|NCT02759107|566097194|FG006|Overall Study|Scheduling Conflict|0|||
156821651|NCT02759107|566097195|FG007|Overall Study|Scheduling Conflict|0|||
156821652|NCT02759107|566097196|FG008|Overall Study|Scheduling Conflict|0|||
156821653|NCT02759107|566097197|FG009|Overall Study|Scheduling Conflict|1|||
156821654|NCT02759107|566097198|FG010|Overall Study|Scheduling Conflict|0|||
156821655|NCT02759107|566097199|FG011|Overall Study|Scheduling Conflict|0|||
156821656|NCT02759107|566097200|FG012|Overall Study|Scheduling Conflict|0|||
156821657|NCT02759107|566097201|FG013|Overall Study|Scheduling Conflict|0|||
156821658|NCT02759107|566097202|FG014|Overall Study|Scheduling Conflict|0|||
156821659|NCT02759107|566097203|FG015|Overall Study|Scheduling Conflict|0|||
156821660|NCT02759107|566097204|FG016|Overall Study|Scheduling Conflict|0|||
156821661|NCT02759107|566097205|FG017|Overall Study|Scheduling Conflict|0|||
156821662|NCT00420004|566097213|FG000|Overall Study|Adverse Event|4|||
156821663|NCT00420004|566097214|FG001|Overall Study|Adverse Event|1|||
156821664|NCT00420004|566097215|FG002|Overall Study|Adverse Event|1|||
156821665|NCT00420004|566097213|FG000|Overall Study|Lack of Efficacy|5|||
156821666|NCT00420004|566097214|FG001|Overall Study|Lack of Efficacy|4|||
156821667|NCT00420004|566097215|FG002|Overall Study|Lack of Efficacy|1|||
156821668|NCT00420004|566097213|FG000|Overall Study|Lost to Follow-up|31|||
156821669|NCT00420004|566097214|FG001|Overall Study|Lost to Follow-up|12|||
156821670|NCT00420004|566097215|FG002|Overall Study|Lost to Follow-up|10|||
156821671|NCT00420004|566097213|FG000|Overall Study|Entry Criteria Not Met|0|||
156821672|NCT00420004|566097214|FG001|Overall Study|Entry Criteria Not Met|1|||
156821673|NCT00420004|566097215|FG002|Overall Study|Entry Criteria Not Met|0|||
156821674|NCT00420004|566097213|FG000|Overall Study|Physician Decision|14|||
156821675|NCT00420004|566097214|FG001|Overall Study|Physician Decision|4|||
156821676|NCT00420004|566097215|FG002|Overall Study|Physician Decision|2|||
156821677|NCT00420004|566097213|FG000|Overall Study|Protocol Violation|5|||
156821678|NCT00420004|566097214|FG001|Overall Study|Protocol Violation|4|||
156821679|NCT00420004|566097215|FG002|Overall Study|Protocol Violation|3|||
156821680|NCT00420004|566097213|FG000|Overall Study|Withdrawal by Subject|67|||
156821681|NCT00420004|566097214|FG001|Overall Study|Withdrawal by Subject|42|||
156821682|NCT00420004|566097215|FG002|Overall Study|Withdrawal by Subject|14|||
156821683|NCT00420004|566097213|FG000|Overall Study|Sponsor Decision|3|||
156821684|NCT00420004|566097214|FG001|Overall Study|Sponsor Decision|3|||
156821685|NCT00420004|566097215|FG002|Overall Study|Sponsor Decision|1|||
156821686|NCT00470093|566097217|FG000|Overall Study|Adverse Event|2|||
156821687|NCT00664560|566097218|FG000|Overall Study|Adverse Event|19|||
156821688|NCT00664560|566097219|FG001|Overall Study|Adverse Event|16|||
156821689|NCT00664560|566097220|FG002|Overall Study|Adverse Event|7|||
156821690|NCT00664560|566097218|FG000|Overall Study|Withdrawal by Subject|9|||
156821691|NCT00664560|566097219|FG001|Overall Study|Withdrawal by Subject|13|||
156821692|NCT00664560|566097220|FG002|Overall Study|Withdrawal by Subject|7|||
156821693|NCT00664560|566097218|FG000|Overall Study|Lost to Follow-up|0|||
156821694|NCT00664560|566097219|FG001|Overall Study|Lost to Follow-up|2|||
156821695|NCT00664560|566097220|FG002|Overall Study|Lost to Follow-up|0|||
156821696|NCT00664560|566097218|FG000|Overall Study|Other|11|||
156821697|NCT00664560|566097219|FG001|Overall Study|Other|4|||
156821698|NCT00664560|566097220|FG002|Overall Study|Other|5|||
157022756|NCT05093829|566835297|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
157022757|NCT05093829|566835298|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
157022758|NCT05093829|566835299|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
157022759|NCT05093829|566835300|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
156821699|NCT00473668|566097223|FG000|Overall Study|Withdrawal by Subject|0|||
156821700|NCT00473668|566097224|FG001|Overall Study|Withdrawal by Subject|2|||
156821701|NCT00473668|566097225|FG002|Overall Study|Withdrawal by Subject|0|||
156821702|NCT00473668|566097223|FG000|Overall Study|Migrated/moved from study area|3|||
156821703|NCT00473668|566097224|FG001|Overall Study|Migrated/moved from study area|2|||
156821704|NCT00473668|566097225|FG002|Overall Study|Migrated/moved from study area|0|||
156821705|NCT00473668|566097223|FG000|Overall Study|Lost to Follow-up|0|||
156821706|NCT00473668|566097224|FG001|Overall Study|Lost to Follow-up|4|||
156821707|NCT00473668|566097225|FG002|Overall Study|Lost to Follow-up|6|||
156821708|NCT00473668|566097223|FG000|Overall Study|Other|2|||
156821709|NCT00473668|566097224|FG001|Overall Study|Other|3|||
156821710|NCT00473668|566097225|FG002|Overall Study|Other|4|||
156821711|NCT02039219|566097226|FG000|Treatment|Withdrawal by Subject|1|||
156821712|NCT02039219|566097227|FG001|Treatment|Withdrawal by Subject|0|||
156821713|NCT02039219|566097226|FG000|Treatment|Adverse Event|0|||
156821714|NCT02039219|566097227|FG001|Treatment|Adverse Event|1|||
156821715|NCT02039219|566097226|FG000|Treatment|Physician Decision|1|||
156821716|NCT02039219|566097227|FG001|Treatment|Physician Decision|0|||
156821717|NCT02039219|566097226|FG000|Treatment|Lost to Follow-up|0|||
156821718|NCT02039219|566097227|FG001|Treatment|Lost to Follow-up|1|||
156821719|NCT02039219|566097226|FG000|Treatment|Protocol Violation|1|||
156821720|NCT02039219|566097227|FG001|Treatment|Protocol Violation|0|||
156821721|NCT02039219|566097226|FG000|Treatment|Death|1|||
156821722|NCT02039219|566097227|FG001|Treatment|Death|0|||
156821723|NCT02039219|566097226|FG000|Follow up|Adverse Event|0|||
156821724|NCT02039219|566097227|FG001|Follow up|Adverse Event|1|||
156821725|NCT02226562|566097228|FG000|Overall Study|Lost to Follow-up|0|||
156821726|NCT02226562|566097229|FG001|Overall Study|Lost to Follow-up|1|||
156821727|NCT00006164|566097235|FG000|Overall Study|Withdrew or lost to follow-up|70|||
156821728|NCT00006164|566097236|FG001|Overall Study|Withdrew or lost to follow-up|81|||
156821729|NCT02750345|566097237|FG000|Intervention 1|Adverse Event|0|||
156821730|NCT02750345|566097238|FG001|Intervention 1|Adverse Event|0|||
156821731|NCT02750345|566097239|FG002|Intervention 1|Adverse Event|0|||
156821732|NCT02750345|566097240|FG003|Intervention 1|Adverse Event|0|||
156821733|NCT02750345|566097241|FG004|Intervention 1|Adverse Event|1|||
156821734|NCT02750345|566097242|FG005|Intervention 1|Adverse Event|0|||
156821735|NCT00223808|566097243|FG000|Overall Study|<5 hrs therapy before discharge|3|||
156821736|NCT00223808|566097244|FG001|Overall Study|<5 hrs therapy before discharge|5|||
156821737|NCT00223808|566097245|FG002|Overall Study|<5 hrs therapy before discharge|5|||
156821738|NCT00191724|566097248|FG000|Overall Study|Adverse Event|0|||
156821739|NCT00191724|566097249|FG001|Overall Study|Adverse Event|0|||
156821740|NCT00191724|566097250|FG002|Overall Study|Adverse Event|1|||
156821741|NCT00191724|566097251|FG003|Overall Study|Adverse Event|0|||
156821742|NCT00191724|566097252|FG004|Overall Study|Adverse Event|0|||
156821743|NCT00191724|566097248|FG000|Overall Study|Lost to Follow-up|1|||
156821744|NCT00191724|566097249|FG001|Overall Study|Lost to Follow-up|1|||
156821745|NCT00191724|566097250|FG002|Overall Study|Lost to Follow-up|0|||
156821746|NCT00191724|566097251|FG003|Overall Study|Lost to Follow-up|2|||
156821747|NCT00191724|566097252|FG004|Overall Study|Lost to Follow-up|3|||
156821748|NCT00191724|566097248|FG000|Overall Study|Withdrawal by Subject|0|||
156821749|NCT00191724|566097249|FG001|Overall Study|Withdrawal by Subject|0|||
156821750|NCT00191724|566097250|FG002|Overall Study|Withdrawal by Subject|0|||
156821751|NCT00191724|566097251|FG003|Overall Study|Withdrawal by Subject|1|||
156821752|NCT00191724|566097252|FG004|Overall Study|Withdrawal by Subject|0|||
156821753|NCT00608023|566097253|FG000|Overall Study|Withdrawal by Subject|8|||
156821754|NCT00608023|566097254|FG001|Overall Study|Withdrawal by Subject|10|||
156821755|NCT00608023|566097255|FG002|Overall Study|Withdrawal by Subject|7|||
156821756|NCT00608023|566097253|FG000|Overall Study|Adverse Event|1|||
156821757|NCT00608023|566097254|FG001|Overall Study|Adverse Event|4|||
156821758|NCT00608023|566097255|FG002|Overall Study|Adverse Event|5|||
156821759|NCT00608023|566097253|FG000|Overall Study|Lost to Follow-up|2|||
156821760|NCT00608023|566097254|FG001|Overall Study|Lost to Follow-up|2|||
156821761|NCT00608023|566097255|FG002|Overall Study|Lost to Follow-up|1|||
156821762|NCT00608023|566097253|FG000|Overall Study|Protocol Violation|1|||
156821763|NCT00608023|566097254|FG001|Overall Study|Protocol Violation|3|||
156821764|NCT00608023|566097255|FG002|Overall Study|Protocol Violation|1|||
156821765|NCT00608023|566097253|FG000|Overall Study|Unknown reason|0|||
156821766|NCT00608023|566097254|FG001|Overall Study|Unknown reason|3|||
156821767|NCT00608023|566097255|FG002|Overall Study|Unknown reason|0|||
156821768|NCT01231321|566097258|FG000|Overall Study|Adverse Event|3|||
156821769|NCT01231321|566097258|FG000|Overall Study|Lack of Efficacy|2|||
156821770|NCT00489736|566097259|FG000|Overall Study|Lack of Efficacy|53|||
156821771|NCT00489736|566097260|FG001|Overall Study|Lack of Efficacy|14|||
156821772|NCT00489736|566097259|FG000|Overall Study|Adverse Event|32|||
156821773|NCT00489736|566097260|FG001|Overall Study|Adverse Event|45|||
156821774|NCT00489736|566097259|FG000|Overall Study|Poor compliance|6|||
156821775|NCT00489736|566097260|FG001|Overall Study|Poor compliance|2|||
156821776|NCT00489736|566097259|FG000|Overall Study|Not coded/ Not pre-specified|5|||
156821777|NCT00489736|566097260|FG001|Overall Study|Not coded/ Not pre-specified|8|||
156821778|NCT04021524|566097261|FG000|Overall Study|Change in surgical intervention|0|||
156821779|NCT04021524|566097262|FG001|Overall Study|Change in surgical intervention|1|||
156821780|NCT06422364|566097263|FG000|Overall Study|Withdrawn due to study closure|0|||
156821781|NCT06422364|566097264|FG001|Overall Study|Withdrawn due to study closure|2|||
157022760|NCT05093829|566835301|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
157022761|NCT04806594|566836849|FG000|Overall Study|Withdrawal by Subject|2|||
156821782|NCT05260073|566097266|FG000|Overall Study|Physician Decision|1|||
156821783|NCT05260073|566097266|FG000|Overall Study|Withdrawal by Subject|6|||
156821784|NCT05260073|566097266|FG000|Overall Study|Lost to Follow-up|14|||
156821785|NCT03458910|566097267|FG000|Overall Study|Withdrawal by Subject|7|||
156821786|NCT03458910|566097268|FG001|Overall Study|Withdrawal by Subject|8|||
156821787|NCT03458910|566097269|FG002|Overall Study|Withdrawal by Subject|6|||
156821788|NCT03458910|566097270|FG003|Overall Study|Withdrawal by Subject|4|||
156821789|NCT03458910|566097267|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
156884462|NCT01340872|566336247|FG002|Double-blind Phase|Adverse Event|0|||
156821790|NCT03458910|566097268|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
156821791|NCT03458910|566097269|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
156821792|NCT03458910|566097270|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
156821793|NCT05275010|566097271|FG000|Overall Study|Reason Not Specified|4|||
156821794|NCT05275010|566097272|FG001|Overall Study|Reason Not Specified|1|||
156821795|NCT05275010|566097271|FG000|Overall Study|Withdrawal by Subject|1|||
156821796|NCT05275010|566097272|FG001|Overall Study|Withdrawal by Subject|0|||
156821797|NCT05275010|566097271|FG000|Overall Study|Lost to Follow-up|0|||
156821798|NCT05275010|566097272|FG001|Overall Study|Lost to Follow-up|1|||
156821799|NCT00244933|566097291|FG000|Overall Study|Not response evaluable|2|||
156821800|NCT00656058|566097297|FG000|Overall Study|Withdrawal by Subject|2|||
156821801|NCT00656058|566097297|FG000|Overall Study|Withdrawal by Subject|4|||
156821802|NCT00616018|566097300|FG000|Overall Study|Protocol Violation|3|||
156821803|NCT03718884|566097301|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
156821804|NCT03718884|566097302|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
156821805|NCT03718884|566097301|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
156821806|NCT03718884|566097302|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
156821807|NCT02099344|566097303|FG000|Overall Study|Physician Decision|1|||
156821808|NCT02099344|566097304|FG001|Overall Study|Physician Decision|0|||
156821809|NCT00404755|566097305|FG000|Phase I (Bupropion)|Adverse Event|3|||
156821810|NCT00404755|566097305|FG000|Phase I (Bupropion)|Other|1|||
156821811|NCT00404755|566097305|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
156821812|NCT04700540|566097306|FG000|Overall Study|Withdrawal by Subject|12|||
156821813|NCT04700540|566097307|FG001|Overall Study|Withdrawal by Subject|8|||
156821814|NCT04700540|566097306|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
156821815|NCT04700540|566097307|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
156821816|NCT03194568|566097308|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
156821817|NCT05248997|566097311|FG000|Overall Study|Lost to Follow-up|1|||
156821818|NCT05248997|566097312|FG001|Overall Study|Lost to Follow-up|1|||
156821819|NCT05248997|566097311|FG000|Overall Study|Randomized but not treated|32|||
156821820|NCT05248997|566097312|FG001|Overall Study|Randomized but not treated|25|||
156821821|NCT03515551|566097313|FG000|Overall Study|Death|4|||
156821822|NCT03515551|566097314|FG001|Overall Study|Death|1|||
156821823|NCT03515551|566097315|FG002|Overall Study|Death|2|||
156821824|NCT03515551|566097316|FG003|Overall Study|Death|2|||
156821825|NCT03515551|566097317|FG004|Overall Study|Death|2|||
156821826|NCT03515551|566097318|FG005|Overall Study|Death|4|||
156821827|NCT03515551|566097319|FG006|Overall Study|Death|1|||
156821828|NCT03515551|566097313|FG000|Overall Study|Lost to Follow-up|0|||
156821829|NCT03515551|566097314|FG001|Overall Study|Lost to Follow-up|0|||
156821830|NCT03515551|566097315|FG002|Overall Study|Lost to Follow-up|1|||
156821831|NCT03515551|566097316|FG003|Overall Study|Lost to Follow-up|0|||
156821832|NCT03515551|566097317|FG004|Overall Study|Lost to Follow-up|0|||
156821833|NCT03515551|566097318|FG005|Overall Study|Lost to Follow-up|0|||
156821834|NCT03515551|566097319|FG006|Overall Study|Lost to Follow-up|0|||
156821835|NCT03515551|566097313|FG000|Overall Study|Withdrawal by Subject|0|||
156821836|NCT03515551|566097314|FG001|Overall Study|Withdrawal by Subject|1|||
156821837|NCT03515551|566097315|FG002|Overall Study|Withdrawal by Subject|0|||
156821838|NCT03515551|566097316|FG003|Overall Study|Withdrawal by Subject|0|||
156821839|NCT03515551|566097317|FG004|Overall Study|Withdrawal by Subject|0|||
156821840|NCT03515551|566097318|FG005|Overall Study|Withdrawal by Subject|0|||
156821841|NCT03515551|566097319|FG006|Overall Study|Withdrawal by Subject|1|||
156821842|NCT03515551|566097313|FG000|Overall Study|Study ended by sponsor|0|||
156821843|NCT03515551|566097314|FG001|Overall Study|Study ended by sponsor|0|||
156821844|NCT03515551|566097315|FG002|Overall Study|Study ended by sponsor|2|||
156821845|NCT03515551|566097316|FG003|Overall Study|Study ended by sponsor|1|||
156821846|NCT03515551|566097317|FG004|Overall Study|Study ended by sponsor|3|||
156821847|NCT03515551|566097318|FG005|Overall Study|Study ended by sponsor|0|||
156821848|NCT03515551|566097319|FG006|Overall Study|Study ended by sponsor|3|||
156821849|NCT03515551|566097313|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821850|NCT03515551|566097314|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
156821851|NCT03515551|566097315|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821852|NCT03515551|566097316|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821853|NCT03515551|566097317|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
157150795|NCT02064439|567298099|FG002|Overall Study|Protocol Violation|3|||
157150796|NCT02064439|567298097|FG000|Overall Study|Lost to Follow-up|1|||
157150797|NCT02064439|567298098|FG001|Overall Study|Lost to Follow-up|3|||
157150798|NCT02064439|567298099|FG002|Overall Study|Lost to Follow-up|4|||
157150799|NCT02064439|567298097|FG000|Overall Study|Non-compliance with study medication|21|||
156821854|NCT03515551|566097318|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156821855|NCT03515551|566097319|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
156884463|NCT01340872|566336248|FG003|Double-blind Phase|Adverse Event|0|||
157150800|NCT02064439|567298098|FG001|Overall Study|Non-compliance with study medication|19|||
157150801|NCT02064439|567298099|FG002|Overall Study|Non-compliance with study medication|23|||
156821856|NCT00920387|566097320|FG000|Stage 1|Adverse Event|1|||
156821857|NCT00920387|566097321|FG001|Stage 1|Adverse Event|0|||
156821858|NCT00920387|566097322|FG002|Stage 1|Adverse Event|0|||
156821859|NCT04470908|566097323|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
156821860|NCT02602275|566097334|FG000|Day 1|Physician Decision|0|||
156821861|NCT02602275|566097335|FG001|Day 1|Physician Decision|1|||
156821862|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
156821863|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
156821864|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
156821865|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
156821866|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
156821867|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
156821868|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
156821869|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
156821870|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
156821871|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
156821872|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
156821873|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
156821874|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
156821875|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
156821876|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
156821877|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
156821878|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821879|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821880|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
156821881|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
156821882|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
156821883|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821884|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821885|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
156821886|NCT01866111|566097338|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
156821887|NCT01866111|566097339|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
156821888|NCT01866111|566097340|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
156821889|NCT01866111|566097341|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
156821890|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
156821891|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
156821892|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
156821893|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
156821894|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
156821895|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
156821896|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
156821897|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
156821898|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
156821899|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
156821900|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
156821901|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
156821902|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
156821903|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
156821904|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
156821905|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
156821906|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Death|1|||
156821907|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Death|1|||
156821908|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Death|3|||
156821909|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Death|2|||
156821910|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
156821911|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
156821912|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
156821913|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
156821914|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
156821915|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
157150802|NCT02064439|567298097|FG000|Overall Study|Physician Decision|0|||
157150803|NCT02064439|567298098|FG001|Overall Study|Physician Decision|1|||
157150804|NCT02064439|567298099|FG002|Overall Study|Physician Decision|1|||
156821916|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
156821917|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
156821918|NCT01866111|566097338|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156821919|NCT01866111|566097339|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156821920|NCT01866111|566097340|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
156821921|NCT01866111|566097341|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
156821922|NCT04113018|566097344|FG000|Overall Study|Death|2|||
156821923|NCT04113018|566097344|FG000|Overall Study|Lost to Follow-up|1|||
156821924|NCT04113018|566097344|FG000|Overall Study|Still On Study (on study treatment)|24|||
156821925|NCT04113018|566097344|FG000|Overall Study|Still On Study (in follow up)|12|||
156821926|NCT03802630|566097345|FG000|Overall Study|Study terminated by sponsor|130|||
156821927|NCT03802630|566097346|FG001|Overall Study|Study terminated by sponsor|134|||
156821928|NCT03802630|566097345|FG000|Overall Study|Subject decision|16|||
156821929|NCT03802630|566097346|FG001|Overall Study|Subject decision|9|||
156821930|NCT03802630|566097345|FG000|Overall Study|Adverse Event|3|||
156821931|NCT03802630|566097346|FG001|Overall Study|Adverse Event|1|||
156821932|NCT03802630|566097345|FG000|Overall Study|Lost to Follow-up|2|||
156821933|NCT03802630|566097346|FG001|Overall Study|Lost to Follow-up|2|||
156821934|NCT03802630|566097345|FG000|Overall Study|Physician Decision|2|||
156821935|NCT03802630|566097346|FG001|Overall Study|Physician Decision|0|||
156821936|NCT03802630|566097345|FG000|Overall Study|Death|0|||
156821937|NCT03802630|566097346|FG001|Overall Study|Death|2|||
156821938|NCT00157196|566097347|FG000|Overall Study|Ongoing at data cut-off|9|||
156821939|NCT05005013|566097348|FG000|Overall Study|Withdrawal by Subject|5|||
156821940|NCT05005013|566097349|FG001|Overall Study|Withdrawal by Subject|1|||
156821941|NCT05005013|566097348|FG000|Overall Study|Lost to Follow-up|3|||
156821942|NCT05005013|566097349|FG001|Overall Study|Lost to Follow-up|1|||
156821943|NCT05005013|566097348|FG000|Overall Study|Ineligibility|1|||
156821944|NCT05005013|566097349|FG001|Overall Study|Ineligibility|1|||
156821945|NCT06099223|566097350|FG000|Overall Study|Preoperative surveys missed|0|||
156821946|NCT06099223|566097351|FG001|Overall Study|Preoperative surveys missed|1|||
156821947|NCT01252186|566097352|FG000|Overall Study|Adverse Event|9|||
156821948|NCT01252186|566097353|FG001|Overall Study|Adverse Event|6|||
156821949|NCT01252186|566097354|FG002|Overall Study|Adverse Event|8|||
156821950|NCT01252186|566097352|FG000|Overall Study|Withdrawal by Subject|2|||
156821951|NCT01252186|566097353|FG001|Overall Study|Withdrawal by Subject|5|||
156821952|NCT01252186|566097354|FG002|Overall Study|Withdrawal by Subject|2|||
156821953|NCT01252186|566097352|FG000|Overall Study|Physician Decision|0|||
156821954|NCT01252186|566097353|FG001|Overall Study|Physician Decision|0|||
156821955|NCT01252186|566097354|FG002|Overall Study|Physician Decision|1|||
156821956|NCT01252186|566097352|FG000|Overall Study|Non-compliance|0|||
156821957|NCT01252186|566097353|FG001|Overall Study|Non-compliance|3|||
156821958|NCT01252186|566097354|FG002|Overall Study|Non-compliance|4|||
156821959|NCT01252186|566097352|FG000|Overall Study|Protocol Violation|0|||
156821960|NCT01252186|566097353|FG001|Overall Study|Protocol Violation|0|||
156821961|NCT01252186|566097354|FG002|Overall Study|Protocol Violation|1|||
156821962|NCT01252186|566097352|FG000|Overall Study|Pregnancy|2|||
156821963|NCT01252186|566097353|FG001|Overall Study|Pregnancy|2|||
156821964|NCT01252186|566097354|FG002|Overall Study|Pregnancy|0|||
156821965|NCT01252186|566097352|FG000|Overall Study|Sponsor Request|2|||
156821966|NCT01252186|566097353|FG001|Overall Study|Sponsor Request|1|||
156821967|NCT01252186|566097354|FG002|Overall Study|Sponsor Request|0|||
156821968|NCT01252186|566097352|FG000|Overall Study|Lost to Follow-up|10|||
156821969|NCT01252186|566097353|FG001|Overall Study|Lost to Follow-up|10|||
157091494|NCT02649946|567089121|FG000|Overall Study|Withdrawal by Subject|1|||
156821970|NCT01252186|566097354|FG002|Overall Study|Lost to Follow-up|11|||
156821971|NCT01252186|566097352|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
156821972|NCT01252186|566097353|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
156821973|NCT01252186|566097354|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
156821974|NCT01221623|566097360|FG000|Overall Study|Withdrawal by Subject|19|||
156821975|NCT01221623|566097361|FG001|Overall Study|Withdrawal by Subject|8|||
156821976|NCT01221623|566097360|FG000|Overall Study|Lost to Follow-up|7|||
157091495|NCT02649946|567089122|FG001|Overall Study|Withdrawal by Subject|1|||
157091496|NCT02649946|567089121|FG000|Overall Study|Death|7|||
157091497|NCT02649946|567089122|FG001|Overall Study|Death|9|||
157091498|NCT02649946|567089121|FG000|Overall Study|Physician Decision|1|||
157091499|NCT02649946|567089122|FG001|Overall Study|Physician Decision|0|||
157091500|NCT02649946|567089121|FG000|Overall Study|Lost to Follow-up|2|||
157091501|NCT02649946|567089122|FG001|Overall Study|Lost to Follow-up|1|||
157091502|NCT02649946|567089121|FG000|Overall Study|Erroneously enrolled|1|||
157091503|NCT02649946|567089122|FG001|Overall Study|Erroneously enrolled|0|||
157091504|NCT02649946|567089121|FG000|Overall Study|Missed 6-month follow-up visit|0|||
157091505|NCT02649946|567089122|FG001|Overall Study|Missed 6-month follow-up visit|4|||
157091506|NCT00950950|567089123|FG000|Overall Study|Adverse Event|1|||
157091507|NCT00950950|567089124|FG001|Overall Study|Adverse Event|0|||
157091508|NCT00950950|567089123|FG000|Overall Study|Withdrawal by Subject|0|||
157091509|NCT00950950|567089124|FG001|Overall Study|Withdrawal by Subject|1|||
157091510|NCT01047293|567089125|FG000|Overall Study|DLT criteria not fulfilled|1|||
157091511|NCT01047293|567089126|FG001|Overall Study|DLT criteria not fulfilled|1|||
157091512|NCT01047293|567089127|FG002|Overall Study|DLT criteria not fulfilled|0|||
156821977|NCT01221623|566097361|FG001|Overall Study|Lost to Follow-up|1|||
156821978|NCT01221623|566097360|FG000|Overall Study|Adverse Event|6|||
156821979|NCT01221623|566097361|FG001|Overall Study|Adverse Event|3|||
156821980|NCT01221623|566097360|FG000|Overall Study|Death|1|||
156821981|NCT01221623|566097361|FG001|Overall Study|Death|0|||
156821982|NCT01221623|566097360|FG000|Overall Study|Other|5|||
156821983|NCT01221623|566097361|FG001|Overall Study|Other|2|||
156821984|NCT00661726|566097362|FG000|Overall Study|Adverse Event|1|||
156821985|NCT02147197|566097363|FG000|Overall Study|Adverse Event|1|||
156821986|NCT02147197|566097364|FG001|Overall Study|Adverse Event|0|||
156821987|NCT02147197|566097365|FG002|Overall Study|Adverse Event|0|||
156821988|NCT02147197|566097363|FG000|Overall Study|Withdrawal of Consent|4|||
156821989|NCT02147197|566097364|FG001|Overall Study|Withdrawal of Consent|3|||
156821990|NCT02147197|566097365|FG002|Overall Study|Withdrawal of Consent|2|||
156821991|NCT02147197|566097363|FG000|Overall Study|Lost to Follow-up|2|||
156821992|NCT02147197|566097364|FG001|Overall Study|Lost to Follow-up|3|||
156821993|NCT02147197|566097365|FG002|Overall Study|Lost to Follow-up|1|||
156821994|NCT02147197|566097363|FG000|Overall Study|Protocol Violation|1|||
156821995|NCT02147197|566097364|FG001|Overall Study|Protocol Violation|0|||
156821996|NCT02147197|566097365|FG002|Overall Study|Protocol Violation|3|||
156821997|NCT02147197|566097363|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156821998|NCT02147197|566097364|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156821999|NCT02147197|566097365|FG002|Overall Study|Other Miscellaneous Reasons|3|||
156822000|NCT03315793|566097366|FG000|Overall Study|Adverse Event|4|||
156822001|NCT03315793|566097367|FG001|Overall Study|Adverse Event|2|||
156822002|NCT03315793|566097366|FG000|Overall Study|Protocol Deviation|1|||
156822003|NCT03315793|566097367|FG001|Overall Study|Protocol Deviation|0|||
156822004|NCT03315793|566097366|FG000|Overall Study|Difficult for regular visit|0|||
156822005|NCT03315793|566097367|FG001|Overall Study|Difficult for regular visit|1|||
156822006|NCT01331837|566097368|FG000|Overall Study|Death|30|||
156822007|NCT01331837|566097369|FG001|Overall Study|Death|34|||
156822008|NCT01331837|566097368|FG000|Overall Study|Lost to Follow-up|3|||
156822009|NCT01331837|566097369|FG001|Overall Study|Lost to Follow-up|1|||
156822010|NCT01331837|566097368|FG000|Overall Study|Info not recorded|10|||
156822011|NCT01331837|566097369|FG001|Overall Study|Info not recorded|16|||
156822012|NCT01331837|566097368|FG000|Overall Study|Withdrawal by Subject|13|||
156822013|NCT01331837|566097369|FG001|Overall Study|Withdrawal by Subject|16|||
156822014|NCT01740089|566098780|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
156822015|NCT01740089|566098781|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
156822016|NCT01740089|566098782|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
156822017|NCT01740089|566098780|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
156822018|NCT01740089|566098781|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
156822019|NCT01740089|566098782|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
156822020|NCT01740089|566098780|FG000|After 12 Weeks|Lack of Efficacy|3|||
156822021|NCT01740089|566098781|FG001|After 12 Weeks|Lack of Efficacy|1|||
156822022|NCT01740089|566098782|FG002|After 12 Weeks|Lack of Efficacy|4|||
157150805|NCT02064439|567298097|FG000|Overall Study|Logistical difficulties|6|||
157150806|NCT02064439|567298098|FG001|Overall Study|Logistical difficulties|5|||
157150807|NCT02064439|567298099|FG002|Overall Study|Logistical difficulties|2|||
156822023|NCT01740089|566098780|FG000|After 12 Weeks|Adverse Event|2|||
156822024|NCT01740089|566098781|FG001|After 12 Weeks|Adverse Event|0|||
156822025|NCT01740089|566098782|FG002|After 12 Weeks|Adverse Event|5|||
156822026|NCT01740089|566098780|FG000|After 12 Weeks|Protocol Violation|1|||
156822027|NCT01740089|566098781|FG001|After 12 Weeks|Protocol Violation|1|||
156822028|NCT01740089|566098782|FG002|After 12 Weeks|Protocol Violation|1|||
156884464|NCT01340872|566336245|FG000|Double-blind Phase|Withdrawal by Subject|3|||
156884465|NCT01340872|566336246|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156884466|NCT01340872|566336247|FG002|Double-blind Phase|Withdrawal by Subject|0|||
157022762|NCT04806594|566836849|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
157150808|NCT02064439|567298097|FG000|Overall Study|Efficacy outcome reached|18|||
157022763|NCT05215314|566836850|FG000|Overall Study|Lost to Follow-up|2|||
156822029|NCT01740089|566098780|FG000|After 12 Weeks|Withdrawal by Subject|1|||
157150809|NCT02064439|567298098|FG001|Overall Study|Efficacy outcome reached|16|||
156822030|NCT01740089|566098781|FG001|After 12 Weeks|Withdrawal by Subject|1|||
156822031|NCT01740089|566098782|FG002|After 12 Weeks|Withdrawal by Subject|1|||
156822032|NCT02526524|566098789|FG000|Overall Study|Withdrawal by Subject|3|||
156822033|NCT02526524|566098790|FG001|Overall Study|Withdrawal by Subject|3|||
156822034|NCT02526524|566098791|FG002|Overall Study|Withdrawal by Subject|6|||
156822035|NCT02526524|566098792|FG003|Overall Study|Withdrawal by Subject|1|||
156822036|NCT02526524|566098793|FG004|Overall Study|Withdrawal by Subject|9|||
156822037|NCT02526524|566098794|FG005|Overall Study|Withdrawal by Subject|5|||
156822038|NCT02526524|566098789|FG000|Overall Study|Adverse Event|3|||
156822039|NCT02526524|566098790|FG001|Overall Study|Adverse Event|2|||
156822040|NCT02526524|566098791|FG002|Overall Study|Adverse Event|4|||
156822041|NCT02526524|566098792|FG003|Overall Study|Adverse Event|2|||
156822042|NCT02526524|566098793|FG004|Overall Study|Adverse Event|6|||
156884467|NCT01340872|566336248|FG003|Double-blind Phase|Withdrawal by Subject|0|||
157150810|NCT02064439|567298099|FG002|Overall Study|Efficacy outcome reached|57|||
156822043|NCT02526524|566098794|FG005|Overall Study|Adverse Event|8|||
156822044|NCT02526524|566098789|FG000|Overall Study|Lost to Follow-up|2|||
156822045|NCT02526524|566098790|FG001|Overall Study|Lost to Follow-up|3|||
156822046|NCT02526524|566098791|FG002|Overall Study|Lost to Follow-up|8|||
156822047|NCT02526524|566098792|FG003|Overall Study|Lost to Follow-up|1|||
156822048|NCT02526524|566098793|FG004|Overall Study|Lost to Follow-up|2|||
156822049|NCT02526524|566098794|FG005|Overall Study|Lost to Follow-up|5|||
156822050|NCT02526524|566098789|FG000|Overall Study|Protocol Violation|3|||
156822051|NCT02526524|566098790|FG001|Overall Study|Protocol Violation|1|||
156822052|NCT02526524|566098791|FG002|Overall Study|Protocol Violation|5|||
156822053|NCT02526524|566098792|FG003|Overall Study|Protocol Violation|3|||
156822054|NCT02526524|566098793|FG004|Overall Study|Protocol Violation|4|||
156822055|NCT02526524|566098794|FG005|Overall Study|Protocol Violation|3|||
156822056|NCT02526524|566098789|FG000|Overall Study|Loss of Glucose Control|0|||
156822057|NCT02526524|566098790|FG001|Overall Study|Loss of Glucose Control|0|||
156822058|NCT02526524|566098791|FG002|Overall Study|Loss of Glucose Control|3|||
156822059|NCT02526524|566098792|FG003|Overall Study|Loss of Glucose Control|0|||
156822060|NCT02526524|566098793|FG004|Overall Study|Loss of Glucose Control|2|||
156822061|NCT02526524|566098794|FG005|Overall Study|Loss of Glucose Control|0|||
156822062|NCT02526524|566098789|FG000|Overall Study|Physician Decision|0|||
156822063|NCT02526524|566098790|FG001|Overall Study|Physician Decision|0|||
156822064|NCT02526524|566098791|FG002|Overall Study|Physician Decision|0|||
156822065|NCT02526524|566098792|FG003|Overall Study|Physician Decision|0|||
156822066|NCT02526524|566098793|FG004|Overall Study|Physician Decision|1|||
156822067|NCT02526524|566098794|FG005|Overall Study|Physician Decision|0|||
156822068|NCT02526524|566098789|FG000|Overall Study|Sponsor Decision|1|||
156822069|NCT02526524|566098790|FG001|Overall Study|Sponsor Decision|0|||
156822070|NCT02526524|566098791|FG002|Overall Study|Sponsor Decision|0|||
156822071|NCT02526524|566098792|FG003|Overall Study|Sponsor Decision|0|||
156822072|NCT02526524|566098793|FG004|Overall Study|Sponsor Decision|0|||
156822073|NCT02526524|566098794|FG005|Overall Study|Sponsor Decision|0|||
156822074|NCT00591149|566098798|FG000|Overall Study|Adverse Event|4|||
156822075|NCT00591149|566098798|FG000|Overall Study|Withdrawal by Subject|1|||
156822076|NCT00539513|566098799|FG000|Overall Study|Withdrawal by Subject|2|||
156822077|NCT00539513|566098800|FG001|Overall Study|Withdrawal by Subject|1|||
156822078|NCT00539513|566098799|FG000|Overall Study|Lost to Follow-up|0|||
156822079|NCT00539513|566098800|FG001|Overall Study|Lost to Follow-up|1|||
156822080|NCT03002818|566098801|FG000|Overall Study|Decision of the investigator|1|||
156822081|NCT01328041|566098802|FG000|Overall Study|Adverse Event|7|||
156822082|NCT01328041|566098802|FG000|Overall Study|Lack of Efficacy|27|||
156822083|NCT01328041|566098802|FG000|Overall Study|Protocol Violation|7|||
156822084|NCT01328041|566098802|FG000|Overall Study|Lost to Follow-up|7|||
156822085|NCT01328041|566098802|FG000|Overall Study|Physician Decision|2|||
156822086|NCT01328041|566098802|FG000|Overall Study|Withdrawal by Subject|7|||
156822087|NCT00711113|566098806|FG000|Overall Study|Lost to Follow-up|9|||
156822088|NCT00711113|566098806|FG000|Overall Study|Implant lost|2|||
156822089|NCT02456636|566098807|FG000|Overall Study|Death|0|||
156822090|NCT02456636|566098808|FG001|Overall Study|Death|3|||
157150811|NCT02064439|567298097|FG000|Overall Study|Safety outcome reached|12|||
157150812|NCT02064439|567298098|FG001|Overall Study|Safety outcome reached|20|||
157150813|NCT02064439|567298099|FG002|Overall Study|Safety outcome reached|10|||
157150814|NCT02064439|567298097|FG000|Overall Study|Other|2|||
156822091|NCT02456636|566098809|FG002|Overall Study|Death|0|||
156822092|NCT02456636|566098807|FG000|Overall Study|Pregnancy|1|||
156822093|NCT02456636|566098808|FG001|Overall Study|Pregnancy|3|||
156822094|NCT02456636|566098809|FG002|Overall Study|Pregnancy|5|||
156822095|NCT02456636|566098807|FG000|Overall Study|Physician Decision|4|||
156822096|NCT02456636|566098808|FG001|Overall Study|Physician Decision|5|||
156822097|NCT02456636|566098809|FG002|Overall Study|Physician Decision|4|||
156822098|NCT02456636|566098807|FG000|Overall Study|Withdrawal by Subject|13|||
156822099|NCT02456636|566098808|FG001|Overall Study|Withdrawal by Subject|14|||
157150815|NCT02064439|567298098|FG001|Overall Study|Other|2|||
157150816|NCT02064439|567298099|FG002|Overall Study|Other|7|||
156822100|NCT02456636|566098809|FG002|Overall Study|Withdrawal by Subject|16|||
156822101|NCT02456636|566098807|FG000|Overall Study|Lost to Follow-up|50|||
156822102|NCT02456636|566098808|FG001|Overall Study|Lost to Follow-up|44|||
156822103|NCT02456636|566098809|FG002|Overall Study|Lost to Follow-up|50|||
156822104|NCT01606787|566098811|FG000|Overall Study|Withdrawal by Subject|4|||
157150817|NCT02433288|567298100|FG000|Overall Study|Severe non-compliance to protocol|13|||
156822105|NCT01606787|566098812|FG001|Overall Study|Withdrawal by Subject|5|||
156822106|NCT01606787|566098811|FG000|Overall Study|Surgery canceled|0|||
157022764|NCT05215314|566836851|FG001|Overall Study|Lost to Follow-up|2|||
156822107|NCT01606787|566098812|FG001|Overall Study|Surgery canceled|2|||
156822108|NCT04484649|566098816|FG000|Overall Study|Lost to Follow-up|2|||
156822109|NCT04484649|566098817|FG001|Overall Study|Lost to Follow-up|1|||
156822110|NCT04484649|566098816|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
156822111|NCT04484649|566098817|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
157022765|NCT05215314|566836850|FG000|Overall Study|Withdrawal by Subject|2|||
157150818|NCT02433288|567298101|FG001|Overall Study|Severe non-compliance to protocol|7|||
156822112|NCT01463696|566098818|FG000|Overall Study|Adverse Event|0|||
156822113|NCT01463696|566098819|FG001|Overall Study|Adverse Event|1|||
156822114|NCT01463696|566098820|FG002|Overall Study|Adverse Event|0|||
156822115|NCT01463696|566098821|FG003|Overall Study|Adverse Event|2|||
156822116|NCT01463696|566098822|FG004|Overall Study|Adverse Event|0|||
156822117|NCT01463696|566098823|FG005|Overall Study|Adverse Event|1|||
156822118|NCT01463696|566098824|FG006|Overall Study|Adverse Event|3|||
156822119|NCT01463696|566098825|FG007|Overall Study|Adverse Event|2|||
156822120|NCT01463696|566098818|FG000|Overall Study|Lost to Follow-up|0|||
156822121|NCT01463696|566098819|FG001|Overall Study|Lost to Follow-up|0|||
156822122|NCT01463696|566098820|FG002|Overall Study|Lost to Follow-up|1|||
156822123|NCT01463696|566098821|FG003|Overall Study|Lost to Follow-up|0|||
156822124|NCT01463696|566098822|FG004|Overall Study|Lost to Follow-up|0|||
156822125|NCT01463696|566098823|FG005|Overall Study|Lost to Follow-up|0|||
156822126|NCT01463696|566098824|FG006|Overall Study|Lost to Follow-up|0|||
156822127|NCT01463696|566098825|FG007|Overall Study|Lost to Follow-up|0|||
156822128|NCT01463696|566098818|FG000|Overall Study|Progressive Disease|0|||
156822129|NCT01463696|566098819|FG001|Overall Study|Progressive Disease|1|||
156822130|NCT01463696|566098820|FG002|Overall Study|Progressive Disease|0|||
156822131|NCT01463696|566098821|FG003|Overall Study|Progressive Disease|1|||
156822132|NCT01463696|566098822|FG004|Overall Study|Progressive Disease|0|||
156822133|NCT01463696|566098823|FG005|Overall Study|Progressive Disease|1|||
156822134|NCT01463696|566098824|FG006|Overall Study|Progressive Disease|4|||
156822135|NCT01463696|566098825|FG007|Overall Study|Progressive Disease|2|||
156822136|NCT01463696|566098818|FG000|Overall Study|Withdrawal by Subject|0|||
156822137|NCT01463696|566098819|FG001|Overall Study|Withdrawal by Subject|0|||
156822138|NCT01463696|566098820|FG002|Overall Study|Withdrawal by Subject|0|||
156822139|NCT01463696|566098821|FG003|Overall Study|Withdrawal by Subject|1|||
156822140|NCT01463696|566098822|FG004|Overall Study|Withdrawal by Subject|1|||
156822141|NCT01463696|566098823|FG005|Overall Study|Withdrawal by Subject|1|||
156822142|NCT01463696|566098824|FG006|Overall Study|Withdrawal by Subject|2|||
156822143|NCT01463696|566098825|FG007|Overall Study|Withdrawal by Subject|0|||
156822144|NCT01463696|566098818|FG000|Overall Study|Not Treated|0|||
156822145|NCT01463696|566098819|FG001|Overall Study|Not Treated|0|||
156822146|NCT01463696|566098820|FG002|Overall Study|Not Treated|0|||
156822147|NCT01463696|566098821|FG003|Overall Study|Not Treated|0|||
156822148|NCT01463696|566098822|FG004|Overall Study|Not Treated|0|||
156822149|NCT01463696|566098823|FG005|Overall Study|Not Treated|0|||
156822150|NCT01463696|566098824|FG006|Overall Study|Not Treated|1|||
156822151|NCT01463696|566098825|FG007|Overall Study|Not Treated|0|||
156822152|NCT00967694|566098828|FG000|Overall Study|Withdrawal by Subject|6|||
156822153|NCT00152477|566098834|FG000|Chemotherapy Period|Adverse Event|9|||
156822154|NCT00152477|566098835|FG001|Chemotherapy Period|Adverse Event|4|||
156822155|NCT00152477|566098836|FG002|Chemotherapy Period|Adverse Event|5|||
156822156|NCT00152477|566098834|FG000|Chemotherapy Period|Death|1|||
156822157|NCT00152477|566098835|FG001|Chemotherapy Period|Death|3|||
156822158|NCT00152477|566098836|FG002|Chemotherapy Period|Death|3|||
156822159|NCT00152477|566098834|FG000|Chemotherapy Period|Lack of Efficacy|4|||
156822160|NCT00152477|566098835|FG001|Chemotherapy Period|Lack of Efficacy|5|||
156822161|NCT00152477|566098836|FG002|Chemotherapy Period|Lack of Efficacy|6|||
156884468|NCT01340872|566336245|FG000|Double-blind Phase|Lost to Follow-up|0|||
156884469|NCT01340872|566336246|FG001|Double-blind Phase|Lost to Follow-up|1|||
156884470|NCT01340872|566336247|FG002|Double-blind Phase|Lost to Follow-up|0|||
156884471|NCT01340872|566336248|FG003|Double-blind Phase|Lost to Follow-up|0|||
156884472|NCT01340872|566336245|FG000|Double-blind Phase|Protocol Violation|0|||
156884473|NCT01340872|566336246|FG001|Double-blind Phase|Protocol Violation|1|||
156884474|NCT01340872|566336247|FG002|Double-blind Phase|Protocol Violation|0|||
156884475|NCT01340872|566336248|FG003|Double-blind Phase|Protocol Violation|0|||
156884476|NCT01340872|566336245|FG000|Open-label Phase|Physician Decision|0|||
156884477|NCT01340872|566336246|FG001|Open-label Phase|Physician Decision|0|||
156884478|NCT01340872|566336247|FG002|Open-label Phase|Physician Decision|2|||
157022766|NCT05215314|566836851|FG001|Overall Study|Withdrawal by Subject|0|||
156822162|NCT00152477|566098834|FG000|Chemotherapy Period|Lost to Follow-up|1|||
156822163|NCT00152477|566098835|FG001|Chemotherapy Period|Lost to Follow-up|0|||
156822164|NCT00152477|566098836|FG002|Chemotherapy Period|Lost to Follow-up|1|||
156822165|NCT00152477|566098834|FG000|Chemotherapy Period|Protocol Violation|1|||
156822166|NCT00152477|566098835|FG001|Chemotherapy Period|Protocol Violation|1|||
156822167|NCT00152477|566098836|FG002|Chemotherapy Period|Protocol Violation|0|||
156822168|NCT00152477|566098834|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
156822169|NCT00152477|566098835|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
156822170|NCT00152477|566098836|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
156822171|NCT00152477|566098834|FG000|Chemotherapy Period|Progression of Disease|6|||
156822172|NCT00152477|566098835|FG001|Chemotherapy Period|Progression of Disease|8|||
156822173|NCT00152477|566098836|FG002|Chemotherapy Period|Progression of Disease|4|||
156822174|NCT00152477|566098834|FG000|Chemotherapy Period|Investigator decision|0|||
156884479|NCT01340872|566336248|FG003|Open-label Phase|Physician Decision|1|||
156884480|NCT01340872|566336245|FG000|Open-label Phase|Pregnancy|0|||
156884481|NCT01340872|566336246|FG001|Open-label Phase|Pregnancy|0|||
156822175|NCT00152477|566098835|FG001|Chemotherapy Period|Investigator decision|0|||
156822176|NCT00152477|566098836|FG002|Chemotherapy Period|Investigator decision|1|||
156822177|NCT00152477|566098834|FG000|Chemotherapy Period|Patient condition worsened|1|||
156822178|NCT00152477|566098835|FG001|Chemotherapy Period|Patient condition worsened|0|||
156822179|NCT00152477|566098836|FG002|Chemotherapy Period|Patient condition worsened|0|||
156822180|NCT00152477|566098834|FG000|Monotherapy Period|Adverse Event|1|||
156822181|NCT00152477|566098835|FG001|Monotherapy Period|Adverse Event|0|||
156822182|NCT00152477|566098836|FG002|Monotherapy Period|Adverse Event|5|||
156822183|NCT00152477|566098834|FG000|Monotherapy Period|Death|2|||
156822184|NCT00152477|566098835|FG001|Monotherapy Period|Death|0|||
156822185|NCT00152477|566098836|FG002|Monotherapy Period|Death|1|||
156822186|NCT00152477|566098834|FG000|Monotherapy Period|Lack of Efficacy|7|||
156822187|NCT00152477|566098835|FG001|Monotherapy Period|Lack of Efficacy|16|||
156822188|NCT00152477|566098836|FG002|Monotherapy Period|Lack of Efficacy|10|||
156822189|NCT00152477|566098834|FG000|Monotherapy Period|Protocol Violation|0|||
156822190|NCT00152477|566098835|FG001|Monotherapy Period|Protocol Violation|1|||
156822191|NCT00152477|566098836|FG002|Monotherapy Period|Protocol Violation|0|||
156822192|NCT00152477|566098834|FG000|Monotherapy Period|Withdrawal by Subject|0|||
156822193|NCT00152477|566098835|FG001|Monotherapy Period|Withdrawal by Subject|0|||
156822194|NCT00152477|566098836|FG002|Monotherapy Period|Withdrawal by Subject|4|||
156822195|NCT00152477|566098834|FG000|Monotherapy Period|Progression of Disease|5|||
156822196|NCT00152477|566098835|FG001|Monotherapy Period|Progression of Disease|11|||
156822197|NCT00152477|566098836|FG002|Monotherapy Period|Progression of Disease|12|||
156822198|NCT00152477|566098834|FG000|Monotherapy Period|Patient decision|0|||
156822199|NCT00152477|566098835|FG001|Monotherapy Period|Patient decision|1|||
156822200|NCT00152477|566098836|FG002|Monotherapy Period|Patient decision|1|||
156822201|NCT00152477|566098834|FG000|Monotherapy Period|Study personel decision|0|||
156822202|NCT00152477|566098835|FG001|Monotherapy Period|Study personel decision|0|||
156822203|NCT00152477|566098836|FG002|Monotherapy Period|Study personel decision|1|||
156822204|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
156822205|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
156822206|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
156822207|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
156822208|NCT02301546|566098837|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
156822209|NCT02301546|566098838|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
156822210|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
156822211|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
156822212|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
156822213|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
156822214|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
156822215|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
156822216|NCT02301546|566098837|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
156822217|NCT02301546|566098838|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
156822218|NCT03905265|566098840|FG000|Overall Study|Withdrawal by Subject|1|||
156822219|NCT03905265|566098841|FG001|Overall Study|Withdrawal by Subject|1|||
156822220|NCT03905265|566098842|FG002|Overall Study|Withdrawal by Subject|0|||
156822221|NCT03905265|566098843|FG003|Overall Study|Withdrawal by Subject|0|||
156822222|NCT01801436|566098846|FG000|Overall Study|Withdrawal by Subject|3|||
156822223|NCT01801436|566098846|FG000|Overall Study|Adverse Event|2|||
156822224|NCT01801436|566098846|FG000|Overall Study|Progressive disease|4|||
156822225|NCT02447250|566098849|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
157150819|NCT02433288|567298100|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
156822226|NCT02447250|566098849|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
156822227|NCT02447250|566098849|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
156822228|NCT03632993|566098850|FG000|Overall Study|Withdrawal by Subject|1|||
156822229|NCT03632993|566098851|FG001|Overall Study|Withdrawal by Subject|0|||
156822230|NCT03632993|566098852|FG002|Overall Study|Withdrawal by Subject|0|||
156822231|NCT03632993|566098853|FG003|Overall Study|Withdrawal by Subject|0|||
156822232|NCT03632993|566098854|FG004|Overall Study|Withdrawal by Subject|0|||
156822233|NCT03632993|566098855|FG005|Overall Study|Withdrawal by Subject|0|||
156822234|NCT03632993|566098856|FG006|Overall Study|Withdrawal by Subject|0|||
156822235|NCT03632993|566098857|FG007|Overall Study|Withdrawal by Subject|0|||
156822236|NCT03632993|566098858|FG008|Overall Study|Withdrawal by Subject|0|||
156822237|NCT03632993|566098859|FG009|Overall Study|Withdrawal by Subject|1|||
157150820|NCT02433288|567298101|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
156822238|NCT03632993|566098850|FG000|Overall Study|Protocol Non-compliance|0|||
156822239|NCT03632993|566098851|FG001|Overall Study|Protocol Non-compliance|1|||
157150821|NCT02433288|567298100|FG000|Overall Study|Withdrawal by Subject|101|||
156822240|NCT03632993|566098852|FG002|Overall Study|Protocol Non-compliance|0|||
156822241|NCT03632993|566098853|FG003|Overall Study|Protocol Non-compliance|0|||
156822242|NCT03632993|566098854|FG004|Overall Study|Protocol Non-compliance|0|||
156822243|NCT03632993|566098855|FG005|Overall Study|Protocol Non-compliance|0|||
156822244|NCT03632993|566098856|FG006|Overall Study|Protocol Non-compliance|0|||
156822245|NCT03632993|566098857|FG007|Overall Study|Protocol Non-compliance|0|||
156822246|NCT03632993|566098858|FG008|Overall Study|Protocol Non-compliance|0|||
156822247|NCT03632993|566098859|FG009|Overall Study|Protocol Non-compliance|0|||
156822248|NCT03632993|566098850|FG000|Overall Study|Lost to Follow-up|0|||
156822249|NCT03632993|566098851|FG001|Overall Study|Lost to Follow-up|0|||
156822250|NCT03632993|566098852|FG002|Overall Study|Lost to Follow-up|0|||
156822251|NCT03632993|566098853|FG003|Overall Study|Lost to Follow-up|0|||
156822252|NCT03632993|566098854|FG004|Overall Study|Lost to Follow-up|0|||
156822253|NCT03632993|566098855|FG005|Overall Study|Lost to Follow-up|1|||
156822254|NCT03632993|566098856|FG006|Overall Study|Lost to Follow-up|0|||
156822255|NCT03632993|566098857|FG007|Overall Study|Lost to Follow-up|1|||
156822256|NCT03632993|566098858|FG008|Overall Study|Lost to Follow-up|0|||
156822257|NCT03632993|566098859|FG009|Overall Study|Lost to Follow-up|0|||
156822258|NCT03632993|566098850|FG000|Overall Study|Adverse Event|0|||
156822259|NCT03632993|566098851|FG001|Overall Study|Adverse Event|0|||
156822260|NCT03632993|566098852|FG002|Overall Study|Adverse Event|0|||
156822261|NCT03632993|566098853|FG003|Overall Study|Adverse Event|0|||
156822262|NCT03632993|566098854|FG004|Overall Study|Adverse Event|0|||
156822263|NCT03632993|566098855|FG005|Overall Study|Adverse Event|1|||
156822264|NCT03632993|566098856|FG006|Overall Study|Adverse Event|0|||
156822265|NCT03632993|566098857|FG007|Overall Study|Adverse Event|1|||
156822266|NCT03632993|566098858|FG008|Overall Study|Adverse Event|0|||
156822267|NCT03632993|566098859|FG009|Overall Study|Adverse Event|0|||
156822268|NCT02743949|566098860|FG000|Overall Study|Adverse Event|0|||
156822269|NCT02743949|566098861|FG001|Overall Study|Adverse Event|0|||
156822270|NCT02743949|566098862|FG002|Overall Study|Adverse Event|2|||
156822271|NCT02743949|566098860|FG000|Overall Study|Significant Protocol Deviation|2|||
156822272|NCT02743949|566098861|FG001|Overall Study|Significant Protocol Deviation|0|||
156822273|NCT02743949|566098862|FG002|Overall Study|Significant Protocol Deviation|1|||
156822274|NCT02743949|566098860|FG000|Overall Study|Voluntary Withdrawal|2|||
156822275|NCT02743949|566098861|FG001|Overall Study|Voluntary Withdrawal|1|||
156822276|NCT02743949|566098862|FG002|Overall Study|Voluntary Withdrawal|0|||
156822277|NCT01921218|566098863|FG000|Overall Study|Death|2|||
156822278|NCT01921218|566098864|FG001|Overall Study|Death|1|||
156822279|NCT01921218|566098863|FG000|Overall Study|Withdrawal by Subject|0|||
156822280|NCT01921218|566098864|FG001|Overall Study|Withdrawal by Subject|2|||
156822281|NCT01921218|566098863|FG000|Overall Study|Kidney transplant|1|||
156822282|NCT01921218|566098864|FG001|Overall Study|Kidney transplant|1|||
156822283|NCT03389555|566098865|FG000|Overall Study|Protocol Violation|1|||
156822284|NCT03389555|566098866|FG001|Overall Study|Protocol Violation|3|||
156822285|NCT03389555|566098865|FG000|Overall Study|Death|1|||
156822286|NCT03389555|566098866|FG001|Overall Study|Death|0|||
156822287|NCT01885208|566098867|FG000|Overall Study|Unclassified|32|||
156822288|NCT01885208|566098868|FG001|Overall Study|Unclassified|38|||
156822289|NCT00960011|566098869|FG000|Overall Study|Death|5|||
156822290|NCT00960011|566098870|FG001|Overall Study|Death|0|||
156822291|NCT00960011|566098869|FG000|Overall Study|Lost to Follow-up|6|||
156822292|NCT00960011|566098870|FG001|Overall Study|Lost to Follow-up|2|||
156822293|NCT04417218|566098871|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
156822294|NCT04417218|566098872|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
156822295|NCT00873041|566098873|FG000|Core Study|Adverse Event|2|||
156822296|NCT00873041|566098874|FG001|Core Study|Adverse Event|3|||
156822297|NCT00873041|566098875|FG002|Core Study|Adverse Event|1|||
156822298|NCT00873041|566098873|FG000|Core Study|Withdrawal by Subject|1|||
156822299|NCT00873041|566098874|FG001|Core Study|Withdrawal by Subject|2|||
156822300|NCT00873041|566098875|FG002|Core Study|Withdrawal by Subject|2|||
156822301|NCT00873041|566098873|FG000|Core Study|Lost to Follow-up|3|||
156822302|NCT00873041|566098874|FG001|Core Study|Lost to Follow-up|1|||
156822303|NCT00873041|566098875|FG002|Core Study|Lost to Follow-up|0|||
156822304|NCT00873041|566098873|FG000|Core Study|Abnormal laboratory value|0|||
156822305|NCT00873041|566098874|FG001|Core Study|Abnormal laboratory value|0|||
156822306|NCT00873041|566098875|FG002|Core Study|Abnormal laboratory value|1|||
156822307|NCT00873041|566098873|FG000|Core Study|Protocol deviation|1|||
156822308|NCT00873041|566098874|FG001|Core Study|Protocol deviation|0|||
156884482|NCT01340872|566336247|FG002|Open-label Phase|Pregnancy|1|||
156822309|NCT00873041|566098875|FG002|Core Study|Protocol deviation|1|||
156822310|NCT00873041|566098873|FG000|Extension Study|Adverse Event|1|||
156822311|NCT00873041|566098874|FG001|Extension Study|Adverse Event|0|||
156822312|NCT00873041|566098875|FG002|Extension Study|Adverse Event|1|||
156822313|NCT00873041|566098873|FG000|Extension Study|Administrative reasons|0|||
156822314|NCT00873041|566098874|FG001|Extension Study|Administrative reasons|0|||
156822315|NCT00873041|566098875|FG002|Extension Study|Administrative reasons|1|||
156822316|NCT02449889|566098878|FG000|Overall Study|Adverse Event|1|||
156822317|NCT02449889|566098879|FG001|Overall Study|Adverse Event|2|||
156822318|NCT02449889|566098880|FG002|Overall Study|Adverse Event|0|||
156822319|NCT02449889|566098878|FG000|Overall Study|Protocol Violation|0|||
156822320|NCT02449889|566098879|FG001|Overall Study|Protocol Violation|4|||
156822321|NCT02449889|566098880|FG002|Overall Study|Protocol Violation|1|||
156822322|NCT00313313|566098881|FG000|Overall Study|Lack of Efficacy|14|||
156884483|NCT01340872|566336248|FG003|Open-label Phase|Pregnancy|0|||
156822323|NCT00313313|566098882|FG001|Overall Study|Lack of Efficacy|9|||
156822324|NCT00313313|566098883|FG002|Overall Study|Lack of Efficacy|20|||
156822325|NCT00313313|566098881|FG000|Overall Study|Withdrawal of consent by subject|18|||
156822326|NCT00313313|566098882|FG001|Overall Study|Withdrawal of consent by subject|17|||
156822327|NCT00313313|566098883|FG002|Overall Study|Withdrawal of consent by subject|31|||
156822328|NCT00313313|566098881|FG000|Overall Study|Lost to Follow-up|10|||
156822329|NCT00313313|566098882|FG001|Overall Study|Lost to Follow-up|7|||
156822330|NCT00313313|566098883|FG002|Overall Study|Lost to Follow-up|9|||
156822331|NCT00313313|566098881|FG000|Overall Study|Adverse Event|15|||
156822332|NCT00313313|566098882|FG001|Overall Study|Adverse Event|16|||
156822333|NCT00313313|566098883|FG002|Overall Study|Adverse Event|12|||
156822334|NCT00313313|566098881|FG000|Overall Study|Physician Decision|2|||
156822335|NCT00313313|566098882|FG001|Overall Study|Physician Decision|6|||
156822336|NCT00313313|566098883|FG002|Overall Study|Physician Decision|4|||
156822337|NCT00313313|566098881|FG000|Overall Study|Poor/Noncompliance|3|||
156822338|NCT00313313|566098882|FG001|Overall Study|Poor/Noncompliance|6|||
156822339|NCT00313313|566098883|FG002|Overall Study|Poor/Noncompliance|2|||
156822340|NCT00313313|566098881|FG000|Overall Study|Pregnancy|1|||
156822341|NCT00313313|566098882|FG001|Overall Study|Pregnancy|2|||
156822342|NCT00313313|566098883|FG002|Overall Study|Pregnancy|0|||
156822343|NCT00313313|566098881|FG000|Overall Study|Death|0|||
156822344|NCT00313313|566098882|FG001|Overall Study|Death|0|||
156822345|NCT00313313|566098883|FG002|Overall Study|Death|2|||
156822346|NCT00313313|566098881|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156822347|NCT00313313|566098882|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
156822348|NCT00313313|566098883|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
156822349|NCT00758264|566098884|FG000|Active Phase|Withdrawal by Subject|0|||
156822350|NCT00758264|566098885|FG001|Active Phase|Withdrawal by Subject|0|||
156822351|NCT00758264|566098886|FG002|Active Phase|Withdrawal by Subject|1|||
156822352|NCT00758264|566098884|FG000|Active Phase|Lost to Follow-up|1|||
156822353|NCT00758264|566098885|FG001|Active Phase|Lost to Follow-up|0|||
156822354|NCT00758264|566098886|FG002|Active Phase|Lost to Follow-up|0|||
156822355|NCT00758264|566098884|FG000|Active Phase|Other|0|||
156822356|NCT00758264|566098885|FG001|Active Phase|Other|0|||
156822357|NCT00758264|566098886|FG002|Active Phase|Other|4|||
156822358|NCT04154605|566098892|FG000|Overall Study|Procedure Canceled|1|||
156822359|NCT04154605|566098893|FG001|Overall Study|Procedure Canceled|1|||
156822360|NCT04154605|566098892|FG000|Overall Study|Missed follow up|1|||
156822361|NCT04154605|566098893|FG001|Overall Study|Missed follow up|1|||
156822362|NCT04154605|566098892|FG000|Overall Study|Withdrawal by Subject|1|||
156822363|NCT04154605|566098893|FG001|Overall Study|Withdrawal by Subject|0|||
156822364|NCT00675441|566098894|FG000|Overall Study|Withdrawal by Subject|2|||
156822365|NCT00675441|566098894|FG000|Overall Study|Death|1|||
156822366|NCT01923363|566098895|FG000|Overall Study|Protocol Violation|1|||
156822367|NCT02901054|566098900|FG000|Overall Study|Physician Decision|1|||
156822368|NCT02901054|566098900|FG000|Overall Study|Withdrawal by Subject|3|||
156822369|NCT05593913|566098904|FG000|Overall Study|Insufficient image quality|39|||
156822370|NCT01453205|566098905|FG000|Overall Study|Lost to Follow-up|3|||
156822371|NCT01453205|566098906|FG001|Overall Study|Lost to Follow-up|0|||
156822372|NCT01453205|566098907|FG002|Overall Study|Lost to Follow-up|1|||
156822373|NCT01453205|566098905|FG000|Overall Study|Withdrawal by Subject|8|||
156822374|NCT01453205|566098906|FG001|Overall Study|Withdrawal by Subject|3|||
156822375|NCT01453205|566098907|FG002|Overall Study|Withdrawal by Subject|0|||
156822376|NCT01453205|566098905|FG000|Overall Study|Death|24|||
156822377|NCT01453205|566098906|FG001|Overall Study|Death|22|||
156822378|NCT01453205|566098907|FG002|Overall Study|Death|18|||
156822379|NCT01453205|566098905|FG000|Overall Study|Other|45|||
156822380|NCT01453205|566098906|FG001|Overall Study|Other|27|||
156822381|NCT01453205|566098907|FG002|Overall Study|Other|35|||
156822382|NCT01666119|566098908|FG000|Overall Study|Adverse Event|6|||
156822383|NCT01666119|566098908|FG000|Overall Study|Withdrawal by Subject|16|||
156822384|NCT01666119|566098908|FG000|Overall Study|Lost to Follow-up|7|||
156822385|NCT01666119|566098908|FG000|Overall Study|non compliance with study medication, pa|18|||
156822386|NCT01666119|566098908|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
156822387|NCT03255967|566098913|FG000|Overall Study|Adverse Event|26|||
156822388|NCT03255967|566098914|FG001|Overall Study|Adverse Event|30|||
156884484|NCT01340872|566336245|FG000|Open-label Phase|Adverse Event|0|||
156822389|NCT03255967|566098913|FG000|Overall Study|Withdrawal by Subject|6|||
156822390|NCT03255967|566098914|FG001|Overall Study|Withdrawal by Subject|6|||
156822391|NCT03255967|566098913|FG000|Overall Study|Schedule conflict|6|||
156822392|NCT03255967|566098914|FG001|Overall Study|Schedule conflict|4|||
156822393|NCT03255967|566098913|FG000|Overall Study|POA did not sign consent form|2|||
156822394|NCT03255967|566098914|FG001|Overall Study|POA did not sign consent form|0|||
156822395|NCT02438384|566098917|FG000|Overall Study|Lost to Follow-up|8|||
156822396|NCT02438384|566098918|FG001|Overall Study|Lost to Follow-up|6|||
156822397|NCT02438384|566098919|FG002|Overall Study|Lost to Follow-up|4|||
156822398|NCT01795495|566098921|FG000|Overall Study|Protocol Violation|1|||
156822399|NCT01795495|566098922|FG001|Overall Study|Protocol Violation|0|||
156822400|NCT01795495|566098923|FG002|Overall Study|Protocol Violation|1|||
156822401|NCT01795495|566098921|FG000|Overall Study|Physician Decision|0|||
156822402|NCT01795495|566098922|FG001|Overall Study|Physician Decision|0|||
156822403|NCT01795495|566098923|FG002|Overall Study|Physician Decision|1|||
156822404|NCT04027049|566098924|FG000|Overall Study|Withdrawn by family|1|||
156822405|NCT04027049|566098925|FG001|Overall Study|Withdrawn by family|0|||
156822406|NCT04027049|566098924|FG000|Overall Study|Participant safety|1|||
156822407|NCT04027049|566098925|FG001|Overall Study|Participant safety|0|||
156822408|NCT02650128|566098926|FG000|Overall Study|Death|2|||
156822409|NCT01681069|566100131|FG000|Overall Study|Withdrawal by Subject|4|||
156822410|NCT01681069|566100132|FG001|Overall Study|Withdrawal by Subject|5|||
156822411|NCT01681069|566100131|FG000|Overall Study|Protocol Violation|1|||
156822412|NCT01681069|566100132|FG001|Overall Study|Protocol Violation|1|||
156822413|NCT01681069|566100131|FG000|Overall Study|Adverse Event|0|||
156822414|NCT01681069|566100132|FG001|Overall Study|Adverse Event|1|||
156822415|NCT03883165|566100134|FG000|Overall Study|Withdrawal by Subject|4|||
156822416|NCT03883165|566100135|FG001|Overall Study|Withdrawal by Subject|3|||
156822417|NCT00245050|566100136|FG000|Overall Study|Adverse Event|3|||
156822418|NCT00245050|566100137|FG001|Overall Study|Adverse Event|2|||
156822419|NCT00730041|566100138|FG000|Overall Study|Lost to Follow-up|0|||
156822420|NCT00730041|566100139|FG001|Overall Study|Lost to Follow-up|2|||
156822421|NCT05526781|566100142|FG000|Overall Study|Lost to Follow-up|1|||
156822422|NCT04085458|566100143|FG000|Overall Study|Other|1|||
156822423|NCT04085458|566100143|FG000|Overall Study|Withdrawal by Subject|2|||
156822424|NCT04085458|566100143|FG000|Overall Study|Adverse Event|2|||
156822425|NCT00920218|566100144|FG000|Overall Study|Serious Adverse Event|2|||
156822426|NCT00920218|566100145|FG001|Overall Study|Serious Adverse Event|0|||
156822427|NCT00920218|566100146|FG002|Overall Study|Serious Adverse Event|2|||
156822428|NCT00920218|566100147|FG003|Overall Study|Serious Adverse Event|1|||
156822429|NCT00920218|566100144|FG000|Overall Study|Withdrawal by Subject|0|||
156822430|NCT00920218|566100145|FG001|Overall Study|Withdrawal by Subject|3|||
156822431|NCT00920218|566100146|FG002|Overall Study|Withdrawal by Subject|2|||
156822432|NCT00920218|566100147|FG003|Overall Study|Withdrawal by Subject|0|||
156822433|NCT00920218|566100144|FG000|Overall Study|Migrated/moved from study area|0|||
156822434|NCT00920218|566100145|FG001|Overall Study|Migrated/moved from study area|0|||
156822435|NCT00920218|566100146|FG002|Overall Study|Migrated/moved from study area|1|||
156822436|NCT00920218|566100147|FG003|Overall Study|Migrated/moved from study area|0|||
156822437|NCT00920218|566100144|FG000|Overall Study|Lost to Follow-up|0|||
156822438|NCT00920218|566100145|FG001|Overall Study|Lost to Follow-up|1|||
156822439|NCT00920218|566100146|FG002|Overall Study|Lost to Follow-up|0|||
156822440|NCT00920218|566100147|FG003|Overall Study|Lost to Follow-up|3|||
156822441|NCT00920218|566100144|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
156822442|NCT00920218|566100145|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
156822443|NCT00920218|566100146|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
156822444|NCT00920218|566100147|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
156822445|NCT00920218|566100144|FG000|Overall Study|Other|0|||
156822446|NCT00920218|566100145|FG001|Overall Study|Other|0|||
156822447|NCT00920218|566100146|FG002|Overall Study|Other|1|||
156822448|NCT00920218|566100147|FG003|Overall Study|Other|0|||
156822449|NCT01973387|566100151|FG000|Overall Study|Adverse Event|14|||
156822450|NCT01973387|566100152|FG001|Overall Study|Adverse Event|4|||
156822451|NCT01973387|566100151|FG000|Overall Study|Withdrawal by Subject|7|||
156822452|NCT01973387|566100152|FG001|Overall Study|Withdrawal by Subject|4|||
156822453|NCT01973387|566100151|FG000|Overall Study|Study terminated by sponsor|63|||
156822454|NCT01973387|566100152|FG001|Overall Study|Study terminated by sponsor|0|||
156822455|NCT01973387|566100151|FG000|Overall Study|Progressive disease or relapse|16|||
156822456|NCT01973387|566100152|FG001|Overall Study|Progressive disease or relapse|5|||
156822457|NCT01973387|566100151|FG000|Overall Study|Death|4|||
156822458|NCT01973387|566100152|FG001|Overall Study|Death|3|||
156822459|NCT01973387|566100151|FG000|Overall Study|Randomized, not treated|2|||
156822460|NCT01973387|566100152|FG001|Overall Study|Randomized, not treated|2|||
156822461|NCT00368836|566100154|FG000|Phase II|Screen Failure|1|||
156822462|NCT00368836|566100154|FG000|Phase II|Withdrawal by Subject|1|||
156822463|NCT00368836|566100154|FG000|Phase II|unable to collect blood and/or breath|17|||
157150822|NCT02433288|567298101|FG001|Overall Study|Withdrawal by Subject|99|||
157150823|NCT02433288|567298100|FG000|Overall Study|Lost to Follow-up|2|||
156822464|NCT00368836|566100154|FG000|Phase II|Protocol Violation|2|||
156822465|NCT01082874|566100155|FG000|Overall Study|Lost to Follow-up|10|||
156822466|NCT01082874|566100156|FG001|Overall Study|Lost to Follow-up|10|||
156822467|NCT01082874|566100157|FG002|Overall Study|Lost to Follow-up|6|||
156822468|NCT01082874|566100158|FG003|Overall Study|Lost to Follow-up|10|||
156822469|NCT01082874|566100155|FG000|Overall Study|Withdrawal by Subject|1|||
156822470|NCT01082874|566100156|FG001|Overall Study|Withdrawal by Subject|2|||
156822471|NCT01082874|566100157|FG002|Overall Study|Withdrawal by Subject|5|||
156822472|NCT01082874|566100158|FG003|Overall Study|Withdrawal by Subject|3|||
156822473|NCT01345591|566100163|FG000|Overall Study|Lost to Follow-up|1|||
156822474|NCT00090142|566100164|FG000|Treatment Period I|Lost to Follow-up|1|||
156822475|NCT00090142|566100165|FG001|Treatment Period I|Lost to Follow-up|2|||
157150824|NCT02433288|567298101|FG001|Overall Study|Lost to Follow-up|14|||
156822476|NCT00090142|566100164|FG000|Treatment Period I|Protocol Violation|2|||
156822477|NCT00090142|566100165|FG001|Treatment Period I|Protocol Violation|0|||
156822478|NCT00090142|566100164|FG000|Treatment Period I|Withdrawal by Subject|2|||
156822479|NCT00090142|566100165|FG001|Treatment Period I|Withdrawal by Subject|0|||
156822480|NCT00090142|566100164|FG000|Treatment Period I|Other|0|||
156822481|NCT00090142|566100165|FG001|Treatment Period I|Other|1|||
156822482|NCT00090142|566100164|FG000|Treatment Period II|Other|1|||
156822483|NCT00090142|566100165|FG001|Treatment Period II|Other|0|||
156822484|NCT02442310|566100166|FG000|Overall Study|Adverse Event|2|||
156822485|NCT02442310|566100166|FG000|Overall Study|Withdrawal by Subject|1|||
156822486|NCT01126437|566100167|FG000|Overall Study|Not treated|11|||
156822487|NCT01126437|566100168|FG001|Overall Study|Not treated|18|||
156822488|NCT01126437|566100169|FG002|Overall Study|Not treated|19|||
156822489|NCT01126437|566100167|FG000|Overall Study|Sites with data irregularities/fraud|6|||
156822490|NCT01126437|566100168|FG001|Overall Study|Sites with data irregularities/fraud|6|||
156822491|NCT01126437|566100169|FG002|Overall Study|Sites with data irregularities/fraud|7|||
156822492|NCT01126437|566100167|FG000|Overall Study|Adverse Event|602|||
156822493|NCT01126437|566100168|FG001|Overall Study|Adverse Event|606|||
156822494|NCT01126437|566100169|FG002|Overall Study|Adverse Event|635|||
156822495|NCT01126437|566100167|FG000|Overall Study|Lack of Efficacy|65|||
156822496|NCT01126437|566100168|FG001|Overall Study|Lack of Efficacy|60|||
157150825|NCT02433288|567298100|FG000|Overall Study|Death|0|||
157150826|NCT02433288|567298101|FG001|Overall Study|Death|3|||
157150827|NCT00858702|567298104|FG000|Overall Study|Lack of Efficacy|1|||
157150828|NCT00858702|567298105|FG001|Overall Study|Lack of Efficacy|0|||
156822497|NCT01126437|566100169|FG002|Overall Study|Lack of Efficacy|59|||
156822498|NCT01126437|566100167|FG000|Overall Study|Protocol Violation|64|||
156822499|NCT01126437|566100168|FG001|Overall Study|Protocol Violation|66|||
156822500|NCT01126437|566100169|FG002|Overall Study|Protocol Violation|41|||
156822501|NCT01126437|566100167|FG000|Overall Study|Lost to Follow-up|52|||
156822502|NCT01126437|566100168|FG001|Overall Study|Lost to Follow-up|63|||
156822503|NCT01126437|566100169|FG002|Overall Study|Lost to Follow-up|55|||
156822504|NCT01126437|566100167|FG000|Overall Study|Withdrawal by Subject|331|||
156822505|NCT01126437|566100168|FG001|Overall Study|Withdrawal by Subject|335|||
156822506|NCT01126437|566100169|FG002|Overall Study|Withdrawal by Subject|319|||
156822507|NCT01126437|566100167|FG000|Overall Study|Other reason not specified|210|||
156822508|NCT01126437|566100168|FG001|Overall Study|Other reason not specified|176|||
156822509|NCT01126437|566100169|FG002|Overall Study|Other reason not specified|178|||
156822510|NCT00006046|566100181|FG000|Overall Study|Adverse Event|3|||
156822511|NCT00006046|566100182|FG001|Overall Study|Adverse Event|0|||
156822512|NCT00006046|566100183|FG002|Overall Study|Adverse Event|0|||
156822513|NCT00006046|566100184|FG003|Overall Study|Adverse Event|0|||
156822514|NCT00006046|566100185|FG004|Overall Study|Adverse Event|0|||
156822515|NCT00006046|566100181|FG000|Overall Study|Disease Progression|2|||
156822516|NCT00006046|566100182|FG001|Overall Study|Disease Progression|0|||
156822517|NCT00006046|566100183|FG002|Overall Study|Disease Progression|0|||
156822518|NCT00006046|566100184|FG003|Overall Study|Disease Progression|0|||
156822519|NCT00006046|566100185|FG004|Overall Study|Disease Progression|0|||
156822520|NCT03272828|566100186|FG000|Overall Study|Lost to Follow-up|7|||
156822521|NCT03272828|566100187|FG001|Overall Study|Lost to Follow-up|7|||
156822522|NCT03272828|566100186|FG000|Overall Study|Withdrawal by Subject|2|||
156822523|NCT03272828|566100187|FG001|Overall Study|Withdrawal by Subject|0|||
156822524|NCT03272828|566100186|FG000|Overall Study|Deceased|1|||
156822525|NCT03272828|566100187|FG001|Overall Study|Deceased|1|||
156822526|NCT03272828|566100186|FG000|Overall Study|Failed implant|1|||
156822527|NCT03272828|566100187|FG001|Overall Study|Failed implant|2|||
156822528|NCT03176472|566100188|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
156822529|NCT03176472|566100189|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
156822530|NCT03176472|566100188|FG000|Double Blind Treatment Period|Adverse Event|0|||
156884485|NCT01340872|566336246|FG001|Open-label Phase|Adverse Event|0|||
157150829|NCT00858702|567298104|FG000|Overall Study|Protocol Violation|1|||
156822531|NCT03176472|566100189|FG001|Double Blind Treatment Period|Adverse Event|5|||
156822532|NCT03176472|566100188|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
156822533|NCT03176472|566100189|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156822534|NCT03176472|566100188|FG000|Double Blind Treatment Period|Physician Decision|0|||
156822535|NCT03176472|566100189|FG001|Double Blind Treatment Period|Physician Decision|1|||
156822536|NCT03176472|566100188|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156822537|NCT03176472|566100189|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156822538|NCT03176472|566100188|FG000|Double Blind Treatment Period|Not Provided|1|||
156822539|NCT03176472|566100189|FG001|Double Blind Treatment Period|Not Provided|0|||
156822540|NCT03176472|566100188|FG000|Open Label Extension|Withdrawal by Subject|3|||
156822541|NCT03176472|566100189|FG001|Open Label Extension|Withdrawal by Subject|4|||
156822542|NCT03176472|566100188|FG000|Open Label Extension|Adverse Event|2|||
156822543|NCT03176472|566100189|FG001|Open Label Extension|Adverse Event|4|||
156822544|NCT03176472|566100188|FG000|Open Label Extension|Lost to Follow-up|1|||
156822545|NCT03176472|566100189|FG001|Open Label Extension|Lost to Follow-up|2|||
157150830|NCT00858702|567298105|FG001|Overall Study|Protocol Violation|1|||
157150831|NCT00858702|567298104|FG000|Overall Study|Other|2|||
156822546|NCT03176472|566100188|FG000|Open Label Extension|Protocol Violation|0|||
156822547|NCT03176472|566100189|FG001|Open Label Extension|Protocol Violation|1|||
156822548|NCT03176472|566100188|FG000|Open Label Extension|Not Provided|2|||
156822549|NCT03176472|566100189|FG001|Open Label Extension|Not Provided|1|||
156822550|NCT00596154|566100190|FG000|Overall Study|Not Evaluable|2|||
156822551|NCT01846663|566100195|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
156822552|NCT01846663|566100196|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
156822553|NCT01846663|566100195|FG000|Overall Study|Withdrawal by Subject|1|||
156822554|NCT01846663|566100196|FG001|Overall Study|Withdrawal by Subject|0|||
156822555|NCT01846663|566100195|FG000|Overall Study|Adverse Event|1|||
156822556|NCT01846663|566100196|FG001|Overall Study|Adverse Event|2|||
156822557|NCT03888235|566100207|FG000|Overall Study|Lost to Follow-up|1|||
156822558|NCT03888235|566100208|FG001|Overall Study|Lost to Follow-up|1|||
156822559|NCT03888235|566100209|FG002|Overall Study|Lost to Follow-up|0|||
156822560|NCT01054560|566100216|FG000|Overall Study|Death|10|||
156822561|NCT01054560|566100217|FG001|Overall Study|Death|21|||
156822562|NCT01054560|566100216|FG000|Overall Study|Lost to Follow-up|2|||
156822563|NCT01054560|566100217|FG001|Overall Study|Lost to Follow-up|5|||
156822564|NCT01054560|566100216|FG000|Overall Study|Withdrawal by Subject|0|||
156822565|NCT01054560|566100217|FG001|Overall Study|Withdrawal by Subject|2|||
156822566|NCT01054560|566100216|FG000|Overall Study|Physician Decision|1|||
156822567|NCT01054560|566100217|FG001|Overall Study|Physician Decision|0|||
156822568|NCT02135029|566100224|FG000|Overall Study|Adverse Event|2|||
156822569|NCT02135029|566100225|FG001|Overall Study|Adverse Event|2|||
156822570|NCT02135029|566100226|FG002|Overall Study|Adverse Event|2|||
156822571|NCT02135029|566100224|FG000|Overall Study|Lost to Follow-up|0|||
156822572|NCT02135029|566100225|FG001|Overall Study|Lost to Follow-up|1|||
156822573|NCT02135029|566100226|FG002|Overall Study|Lost to Follow-up|0|||
156822574|NCT02135029|566100224|FG000|Overall Study|Withdrawal by Subject|2|||
156822575|NCT02135029|566100225|FG001|Overall Study|Withdrawal by Subject|0|||
156822576|NCT02135029|566100226|FG002|Overall Study|Withdrawal by Subject|1|||
156822577|NCT02135029|566100224|FG000|Overall Study|Other|0|||
156822578|NCT02135029|566100225|FG001|Overall Study|Other|1|||
156822579|NCT02135029|566100226|FG002|Overall Study|Other|0|||
156822580|NCT02135029|566100224|FG000|Overall Study|Death|0|||
156822581|NCT02135029|566100225|FG001|Overall Study|Death|1|||
156822582|NCT02135029|566100226|FG002|Overall Study|Death|0|||
156822583|NCT03466099|566100229|FG000|Overall Study|Adverse Event|1|||
156822584|NCT03466099|566100230|FG001|Overall Study|Adverse Event|1|||
156822585|NCT03466099|566100231|FG002|Overall Study|Adverse Event|1|||
156822586|NCT03466099|566100229|FG000|Overall Study|Withdrawal by Subject|2|||
156822587|NCT03466099|566100230|FG001|Overall Study|Withdrawal by Subject|3|||
156822588|NCT03466099|566100231|FG002|Overall Study|Withdrawal by Subject|1|||
156822589|NCT03466099|566100229|FG000|Overall Study|Use of rescue medication|8|||
156822590|NCT03466099|566100230|FG001|Overall Study|Use of rescue medication|9|||
156822591|NCT03466099|566100231|FG002|Overall Study|Use of rescue medication|13|||
156822592|NCT03466099|566100229|FG000|Overall Study|Rescued without meeting criteria|4|||
156822593|NCT03466099|566100230|FG001|Overall Study|Rescued without meeting criteria|1|||
156822594|NCT03466099|566100231|FG002|Overall Study|Rescued without meeting criteria|1|||
156822595|NCT03466099|566100229|FG000|Overall Study|Subject compliance|2|||
156822596|NCT03466099|566100230|FG001|Overall Study|Subject compliance|0|||
156822597|NCT03466099|566100231|FG002|Overall Study|Subject compliance|0|||
156822598|NCT03466099|566100229|FG000|Overall Study|Worsening disease|0|||
156822599|NCT03466099|566100230|FG001|Overall Study|Worsening disease|0|||
156822600|NCT03466099|566100231|FG002|Overall Study|Worsening disease|1|||
156822601|NCT02210689|566100234|FG000|Overall Study|Withdrawal by Subject|7|||
156822602|NCT02210689|566100235|FG001|Overall Study|Withdrawal by Subject|4|||
156822603|NCT02210689|566100236|FG002|Overall Study|Withdrawal by Subject|2|||
156884486|NCT01340872|566336247|FG002|Open-label Phase|Adverse Event|8|||
156822604|NCT02210689|566100234|FG000|Overall Study|Adverse Event|0|||
156822605|NCT02210689|566100235|FG001|Overall Study|Adverse Event|1|||
156822606|NCT02210689|566100236|FG002|Overall Study|Adverse Event|0|||
156822607|NCT02210689|566100234|FG000|Overall Study|Protocol Violation|1|||
156822608|NCT02210689|566100235|FG001|Overall Study|Protocol Violation|0|||
156884487|NCT01340872|566336248|FG003|Open-label Phase|Adverse Event|4|||
156884488|NCT01340872|566336245|FG000|Open-label Phase|Withdrawal by Subject|0|||
156884489|NCT01340872|566336246|FG001|Open-label Phase|Withdrawal by Subject|0|||
156822609|NCT02210689|566100236|FG002|Overall Study|Protocol Violation|0|||
156822610|NCT02210689|566100234|FG000|Overall Study|Lost to Follow-up|11|||
156822611|NCT02210689|566100235|FG001|Overall Study|Lost to Follow-up|9|||
156822612|NCT02210689|566100236|FG002|Overall Study|Lost to Follow-up|5|||
156822613|NCT02210689|566100234|FG000|Overall Study|Pregnancy|0|||
156822614|NCT02210689|566100235|FG001|Overall Study|Pregnancy|1|||
156822615|NCT02210689|566100236|FG002|Overall Study|Pregnancy|0|||
156822616|NCT02210689|566100234|FG000|Overall Study|Lack of Efficacy|0|||
156822617|NCT02210689|566100235|FG001|Overall Study|Lack of Efficacy|1|||
156822618|NCT02210689|566100236|FG002|Overall Study|Lack of Efficacy|5|||
156822619|NCT02210689|566100234|FG000|Overall Study|Prohibited medication|2|||
156822620|NCT02210689|566100235|FG001|Overall Study|Prohibited medication|8|||
157022767|NCT05215314|566836850|FG000|Overall Study|Physician Decision|1|||
156822621|NCT02210689|566100236|FG002|Overall Study|Prohibited medication|1|||
156822622|NCT02210689|566100234|FG000|Overall Study|Negative Nugent score at baseline|6|||
156822623|NCT02210689|566100235|FG001|Overall Study|Negative Nugent score at baseline|2|||
156822624|NCT02210689|566100236|FG002|Overall Study|Negative Nugent score at baseline|2|||
156822625|NCT02210689|566100234|FG000|Overall Study|Other|25|||
156822626|NCT02210689|566100235|FG001|Overall Study|Other|21|||
156822627|NCT02210689|566100236|FG002|Overall Study|Other|8|||
156822628|NCT00075946|566100237|FG000|Overall Study|Path ineligible: undetermined histology|0|||
156822629|NCT00075946|566100238|FG001|Overall Study|Path ineligible: undetermined histology|0|||
156822630|NCT00075946|566100239|FG002|Overall Study|Path ineligible: undetermined histology|0|||
156884490|NCT01340872|566336247|FG002|Open-label Phase|Withdrawal by Subject|1|||
156884491|NCT01340872|566336248|FG003|Open-label Phase|Withdrawal by Subject|6|||
156884492|NCT01340872|566336245|FG000|Open-label Phase|Worsening of IBD|0|||
156884493|NCT01340872|566336246|FG001|Open-label Phase|Worsening of IBD|0|||
156884494|NCT01340872|566336247|FG002|Open-label Phase|Worsening of IBD|1|||
156884495|NCT01340872|566336248|FG003|Open-label Phase|Worsening of IBD|0|||
156884496|NCT03039621|566336253|FG000|Overall Study|Violation of inclusion criteria|3|||
156884497|NCT03039621|566336254|FG001|Overall Study|Violation of inclusion criteria|2|||
156884498|NCT03039621|566336253|FG000|Overall Study|Non-compliance with protocol requirement|4|||
156884499|NCT03039621|566336254|FG001|Overall Study|Non-compliance with protocol requirement|5|||
156884500|NCT03039621|566336253|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
156884501|NCT03039621|566336254|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
156884502|NCT03039621|566336253|FG000|Overall Study|Violation of non-inclusion criteria|1|||
156884503|NCT03039621|566336254|FG001|Overall Study|Violation of non-inclusion criteria|2|||
156884504|NCT03254108|566336255|FG000|Overall Study|Adverse Event|0|||
156884505|NCT03254108|566336256|FG001|Overall Study|Adverse Event|2|||
156884506|NCT03254108|566336257|FG002|Overall Study|Adverse Event|0|||
156884507|NCT03254108|566336258|FG003|Overall Study|Adverse Event|1|||
156884508|NCT03254108|566336259|FG004|Overall Study|Adverse Event|1|||
156884509|NCT03254108|566336255|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156884510|NCT03254108|566336256|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156884511|NCT03254108|566336257|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156884512|NCT03254108|566336258|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
156884513|NCT03254108|566336259|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
156884514|NCT00362180|566336260|FG000|Treated Period|Withdrawal by Subject|1|||
156884515|NCT00362180|566336261|FG001|Treated Period|Withdrawal by Subject|0|||
156884516|NCT00362180|566336262|FG002|Treated Period|Withdrawal by Subject|0|||
156884517|NCT00362180|566336263|FG003|Treated Period|Withdrawal by Subject|0|||
156884518|NCT00362180|566336264|FG004|Treated Period|Withdrawal by Subject|0|||
156884519|NCT00362180|566336265|FG005|Treated Period|Withdrawal by Subject|0|||
156884520|NCT00362180|566336266|FG006|Treated Period|Withdrawal by Subject|0|||
156884521|NCT00362180|566336267|FG007|Treated Period|Withdrawal by Subject|0|||
156884522|NCT00362180|566336268|FG008|Treated Period|Withdrawal by Subject|0|||
156884523|NCT00362180|566336260|FG000|Treated Period|Adverse Event|0|||
156884524|NCT00362180|566336261|FG001|Treated Period|Adverse Event|0|||
156884525|NCT00362180|566336262|FG002|Treated Period|Adverse Event|0|||
156884526|NCT00362180|566336263|FG003|Treated Period|Adverse Event|0|||
156884527|NCT00362180|566336264|FG004|Treated Period|Adverse Event|0|||
156884528|NCT00362180|566336265|FG005|Treated Period|Adverse Event|1|||
156884529|NCT00362180|566336266|FG006|Treated Period|Adverse Event|0|||
156884530|NCT00362180|566336267|FG007|Treated Period|Adverse Event|1|||
156884531|NCT00362180|566336268|FG008|Treated Period|Adverse Event|0|||
156884532|NCT02600871|566336271|FG000|Overall Study|Lost to Follow-up|13|||
156884533|NCT02600871|566336272|FG001|Overall Study|Lost to Follow-up|10|||
156884534|NCT01246466|566336276|FG000|Overall Study|Death|1|||
156884535|NCT01246466|566336276|FG000|Overall Study|Withdrawal by Subject|1|||
156884536|NCT01142089|566336277|FG000|Overall Study|Physician Decision|1|||
156884537|NCT01142089|566336278|FG001|Overall Study|Physician Decision|0|||
157150832|NCT00858702|567298105|FG001|Overall Study|Other|1|||
157150833|NCT00858702|567298104|FG000|Overall Study|Withdrawal by Subject|1|||
157150834|NCT00858702|567298105|FG001|Overall Study|Withdrawal by Subject|0|||
157150835|NCT00367640|567298106|FG000|Overall Study|Adverse Event|3|||
157150836|NCT00367640|567298107|FG001|Overall Study|Adverse Event|6|||
156884538|NCT01142089|566336277|FG000|Overall Study|Withdrawal by Subject|1|||
156884539|NCT01142089|566336278|FG001|Overall Study|Withdrawal by Subject|2|||
156884540|NCT01142089|566336277|FG000|Overall Study|Use of prohibited medications|0|||
156884541|NCT01142089|566336278|FG001|Overall Study|Use of prohibited medications|1|||
156884542|NCT01142089|566336277|FG000|Overall Study|Noncompliance with study procedures|2|||
156884543|NCT01142089|566336278|FG001|Overall Study|Noncompliance with study procedures|1|||
156884544|NCT01142089|566336277|FG000|Overall Study|Patient required rescue medication|8|||
156884545|NCT01142089|566336278|FG001|Overall Study|Patient required rescue medication|17|||
156884546|NCT02907892|566336283|FG000|Overall Study|Lost to Follow-up|27|||
156822631|NCT00075946|566100240|FG003|Overall Study|Path ineligible: undetermined histology|0|||
156822632|NCT00075946|566100241|FG004|Overall Study|Path ineligible: undetermined histology|6|||
157224452|NCT02655237|567567995|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
157224453|NCT02655237|567567994|FG000|Overall Study|Randomized but Not Treated|1|||
157224454|NCT02655237|567567995|FG001|Overall Study|Randomized but Not Treated|0|||
156822633|NCT00075946|566100237|FG000|Overall Study|Did not achieve response after induction|0|||
156822634|NCT00075946|566100238|FG001|Overall Study|Did not achieve response after induction|0|||
156822635|NCT00075946|566100239|FG002|Overall Study|Did not achieve response after induction|0|||
156822636|NCT00075946|566100240|FG003|Overall Study|Did not achieve response after induction|0|||
156822637|NCT00075946|566100241|FG004|Overall Study|Did not achieve response after induction|182|||
156822638|NCT00075946|566100237|FG000|Overall Study|Incorrectly randomized (no response)|5|||
156822639|NCT00075946|566100238|FG001|Overall Study|Incorrectly randomized (no response)|5|||
156822640|NCT00075946|566100239|FG002|Overall Study|Incorrectly randomized (no response)|5|||
156822641|NCT00075946|566100240|FG003|Overall Study|Incorrectly randomized (no response)|1|||
156822642|NCT00075946|566100241|FG004|Overall Study|Incorrectly randomized (no response)|0|||
156822643|NCT00075946|566100237|FG000|Overall Study|Adverse Event|2|||
156822644|NCT00075946|566100238|FG001|Overall Study|Adverse Event|10|||
156822645|NCT00075946|566100239|FG002|Overall Study|Adverse Event|0|||
156822646|NCT00075946|566100240|FG003|Overall Study|Adverse Event|2|||
156822647|NCT00075946|566100241|FG004|Overall Study|Adverse Event|0|||
156822648|NCT00075946|566100237|FG000|Overall Study|Death|0|||
156822649|NCT00075946|566100238|FG001|Overall Study|Death|1|||
156822650|NCT00075946|566100239|FG002|Overall Study|Death|0|||
156822651|NCT00075946|566100240|FG003|Overall Study|Death|0|||
156822652|NCT00075946|566100241|FG004|Overall Study|Death|0|||
156822653|NCT00075946|566100237|FG000|Overall Study|Withdrawal by Subject|23|||
156822654|NCT00075946|566100238|FG001|Overall Study|Withdrawal by Subject|58|||
156822655|NCT00075946|566100239|FG002|Overall Study|Withdrawal by Subject|4|||
156822656|NCT00075946|566100240|FG003|Overall Study|Withdrawal by Subject|9|||
156822657|NCT00075946|566100241|FG004|Overall Study|Withdrawal by Subject|0|||
156822658|NCT00075946|566100237|FG000|Overall Study|Alternative therapy|16|||
156822659|NCT00075946|566100238|FG001|Overall Study|Alternative therapy|2|||
156822660|NCT00075946|566100239|FG002|Overall Study|Alternative therapy|5|||
156822661|NCT00075946|566100240|FG003|Overall Study|Alternative therapy|0|||
156822662|NCT00075946|566100241|FG004|Overall Study|Alternative therapy|0|||
156822663|NCT00075946|566100237|FG000|Overall Study|Other complicating disease|7|||
156822664|NCT00075946|566100238|FG001|Overall Study|Other complicating disease|13|||
156822665|NCT00075946|566100239|FG002|Overall Study|Other complicating disease|1|||
156822666|NCT00075946|566100240|FG003|Overall Study|Other complicating disease|4|||
156822667|NCT00075946|566100241|FG004|Overall Study|Other complicating disease|0|||
156822668|NCT00075946|566100237|FG000|Overall Study|No response to retreatment|23|||
156822669|NCT00075946|566100238|FG001|Overall Study|No response to retreatment|0|||
156822670|NCT00075946|566100239|FG002|Overall Study|No response to retreatment|2|||
156822671|NCT00075946|566100240|FG003|Overall Study|No response to retreatment|0|||
156822672|NCT00075946|566100241|FG004|Overall Study|No response to retreatment|0|||
156822673|NCT00075946|566100237|FG000|Overall Study|Time to progression less than 6 months|15|||
156822674|NCT00075946|566100238|FG001|Overall Study|Time to progression less than 6 months|30|||
156822675|NCT00075946|566100239|FG002|Overall Study|Time to progression less than 6 months|8|||
156822676|NCT00075946|566100240|FG003|Overall Study|Time to progression less than 6 months|3|||
156822677|NCT00075946|566100241|FG004|Overall Study|Time to progression less than 6 months|0|||
156822678|NCT00075946|566100237|FG000|Overall Study|Other|57|||
156822679|NCT00075946|566100238|FG001|Overall Study|Other|32|||
156822680|NCT00075946|566100239|FG002|Overall Study|Other|3|||
156822681|NCT00075946|566100240|FG003|Overall Study|Other|11|||
156822682|NCT00075946|566100241|FG004|Overall Study|Other|0|||
156822683|NCT00866047|566100242|FG000|Treatment Period|Progressive disease|13|||
156822684|NCT00866047|566100242|FG000|Treatment Period|Adverse Event|16|||
156822685|NCT00866047|566100242|FG000|Treatment Period|Physician Decision|14|||
156822686|NCT00866047|566100242|FG000|Treatment Period|Withdrawal by Subject|5|||
156822687|NCT00866047|566100242|FG000|Follow-up Period|Lost to Follow-up|5|||
156822688|NCT05427539|566100243|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156822689|NCT05427539|566100244|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
156822690|NCT05427539|566100243|FG000|Period 1|Withdrawal by Subject|1|||
156822691|NCT05427539|566100244|FG001|Period 1|Withdrawal by Subject|0|||
156884547|NCT02907892|566336284|FG001|Overall Study|Lost to Follow-up|40|||
157224455|NCT03679741|567567996|FG000|Period 1|No longer meet eligibility criteria|1|||
157224456|NCT03679741|567567997|FG001|Period 1|No longer meet eligibility criteria|0|||
156822692|NCT00223977|566100245|FG000|Overall Study|Adverse Event|7|||
156822693|NCT00223977|566100246|FG001|Overall Study|Adverse Event|10|||
156822694|NCT00223977|566100247|FG002|Overall Study|Adverse Event|0|||
156822695|NCT00223977|566100245|FG000|Overall Study|Protocol Violation|0|||
156822696|NCT00223977|566100246|FG001|Overall Study|Protocol Violation|0|||
156822697|NCT00223977|566100247|FG002|Overall Study|Protocol Violation|1|||
156822698|NCT00223977|566100245|FG000|Overall Study|Withdrawal by Subject|1|||
156822699|NCT00223977|566100246|FG001|Overall Study|Withdrawal by Subject|1|||
156822700|NCT00223977|566100247|FG002|Overall Study|Withdrawal by Subject|2|||
156822701|NCT00223977|566100245|FG000|Overall Study|Other|1|||
156822702|NCT00223977|566100246|FG001|Overall Study|Other|0|||
156822703|NCT00223977|566100247|FG002|Overall Study|Other|0|||
156822704|NCT00778258|566100251|FG000|Overall Study|Adverse Event|1|||
156822705|NCT00778258|566100252|FG001|Overall Study|Adverse Event|0|||
156822706|NCT00778258|566100253|FG002|Overall Study|Adverse Event|0|||
156822707|NCT00778258|566100254|FG003|Overall Study|Adverse Event|0|||
156822708|NCT00778258|566100255|FG004|Overall Study|Adverse Event|0|||
156822709|NCT00778258|566100256|FG005|Overall Study|Adverse Event|1|||
156822710|NCT00778258|566100257|FG006|Overall Study|Adverse Event|0|||
156822711|NCT00778258|566100258|FG007|Overall Study|Adverse Event|0|||
156822712|NCT00778258|566100259|FG008|Overall Study|Adverse Event|0|||
156822713|NCT00778258|566100251|FG000|Overall Study|Lost to Follow-up|0|||
156822714|NCT00778258|566100252|FG001|Overall Study|Lost to Follow-up|0|||
156822715|NCT00778258|566100253|FG002|Overall Study|Lost to Follow-up|2|||
156822716|NCT00778258|566100254|FG003|Overall Study|Lost to Follow-up|0|||
156822717|NCT00778258|566100255|FG004|Overall Study|Lost to Follow-up|0|||
156822718|NCT00778258|566100256|FG005|Overall Study|Lost to Follow-up|3|||
156822719|NCT00778258|566100257|FG006|Overall Study|Lost to Follow-up|2|||
156822720|NCT00778258|566100258|FG007|Overall Study|Lost to Follow-up|2|||
156822721|NCT00778258|566100259|FG008|Overall Study|Lost to Follow-up|0|||
156822722|NCT00778258|566100251|FG000|Overall Study|Withdrawal by Subject|6|||
156822723|NCT00778258|566100252|FG001|Overall Study|Withdrawal by Subject|2|||
156822724|NCT00778258|566100253|FG002|Overall Study|Withdrawal by Subject|8|||
156822725|NCT00778258|566100254|FG003|Overall Study|Withdrawal by Subject|2|||
157150837|NCT00367640|567298108|FG002|Overall Study|Adverse Event|8|||
156822726|NCT00778258|566100255|FG004|Overall Study|Withdrawal by Subject|0|||
156822727|NCT00778258|566100256|FG005|Overall Study|Withdrawal by Subject|6|||
156822728|NCT00778258|566100257|FG006|Overall Study|Withdrawal by Subject|12|||
156822729|NCT00778258|566100258|FG007|Overall Study|Withdrawal by Subject|12|||
156822730|NCT00778258|566100259|FG008|Overall Study|Withdrawal by Subject|4|||
156822731|NCT00778258|566100251|FG000|Overall Study|New Contraindication|0|||
156822732|NCT00778258|566100252|FG001|Overall Study|New Contraindication|0|||
156822733|NCT00778258|566100253|FG002|Overall Study|New Contraindication|0|||
156822734|NCT00778258|566100254|FG003|Overall Study|New Contraindication|0|||
156822735|NCT00778258|566100255|FG004|Overall Study|New Contraindication|0|||
156822736|NCT00778258|566100256|FG005|Overall Study|New Contraindication|0|||
156822737|NCT00778258|566100257|FG006|Overall Study|New Contraindication|0|||
156822738|NCT00778258|566100258|FG007|Overall Study|New Contraindication|1|||
156822739|NCT00778258|566100259|FG008|Overall Study|New Contraindication|0|||
156822740|NCT00778258|566100251|FG000|Overall Study|Non-compliance|0|||
156822741|NCT00778258|566100252|FG001|Overall Study|Non-compliance|0|||
156822742|NCT00778258|566100253|FG002|Overall Study|Non-compliance|0|||
156822743|NCT00778258|566100254|FG003|Overall Study|Non-compliance|1|||
156822744|NCT00778258|566100255|FG004|Overall Study|Non-compliance|0|||
156822745|NCT00778258|566100256|FG005|Overall Study|Non-compliance|0|||
156822746|NCT00778258|566100257|FG006|Overall Study|Non-compliance|0|||
156822747|NCT00778258|566100258|FG007|Overall Study|Non-compliance|0|||
156822748|NCT00778258|566100259|FG008|Overall Study|Non-compliance|0|||
156822749|NCT00778258|566100251|FG000|Overall Study|Other|0|||
156822750|NCT00778258|566100252|FG001|Overall Study|Other|0|||
156822751|NCT00778258|566100253|FG002|Overall Study|Other|0|||
156822752|NCT00778258|566100254|FG003|Overall Study|Other|0|||
156822753|NCT00778258|566100255|FG004|Overall Study|Other|0|||
156822754|NCT00778258|566100256|FG005|Overall Study|Other|0|||
156822755|NCT00778258|566100257|FG006|Overall Study|Other|1|||
156822756|NCT00778258|566100258|FG007|Overall Study|Other|0|||
156884548|NCT01974765|566336285|FG000|Overall Study|Withdrawal by Subject|1|||
156884549|NCT01974765|566336285|FG000|Overall Study|Death|1|||
156884550|NCT01974765|566336285|FG000|Overall Study|Adverse Event|2|||
157150838|NCT00367640|567298109|FG003|Overall Study|Adverse Event|0|||
157150839|NCT00367640|567298106|FG000|Overall Study|Withdrawal by Subject|8|||
157150840|NCT00367640|567298107|FG001|Overall Study|Withdrawal by Subject|11|||
157150841|NCT00367640|567298108|FG002|Overall Study|Withdrawal by Subject|8|||
157150842|NCT00367640|567298109|FG003|Overall Study|Withdrawal by Subject|6|||
157224457|NCT03679741|567567996|FG000|Period 1|Lost to Follow-up|0|||
156822757|NCT00778258|566100259|FG008|Overall Study|Other|0|||
156822758|NCT00780143|566100260|FG000|Overall Study|Progressive disease|1|||
156822759|NCT00780143|566100260|FG000|Overall Study|Toxicity|1|||
156822760|NCT00780143|566100260|FG000|Overall Study|Adverse Event|1|||
156822761|NCT02644096|566100263|FG000|Overall Study|Withdrawal by Subject|28|||
156822762|NCT02644096|566100264|FG001|Overall Study|Withdrawal by Subject|25|||
156822763|NCT02461290|566100265|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
156822764|NCT02461290|566100265|FG000|Overall Study|Lost to Follow-up|3|||
156822765|NCT00322452|566100266|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156822766|NCT00322452|566100267|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156822767|NCT00322452|566100266|FG000|Overall Study|Lost to Follow-up|5|||
156822768|NCT00322452|566100267|FG001|Overall Study|Lost to Follow-up|2|||
156822769|NCT00322452|566100266|FG000|Overall Study|Withdrawal by Subject|19|||
156822770|NCT00322452|566100267|FG001|Overall Study|Withdrawal by Subject|46|||
156822771|NCT00322452|566100266|FG000|Overall Study|Death|223|||
156822772|NCT00322452|566100267|FG001|Overall Study|Death|227|||
157150843|NCT00367640|567298106|FG000|Overall Study|Any other reason not above-mentioned|7|||
156822773|NCT00526656|566100268|FG000|Overall Study|Death|1|||
156822774|NCT00526656|566100268|FG000|Overall Study|Refused surgery|1|||
156822775|NCT03285958|566102603|FG000|Overall Study|Lost to Follow-up|1|||
156822776|NCT03285958|566102604|FG001|Overall Study|Lost to Follow-up|1|||
156822777|NCT03285958|566102603|FG000|Overall Study|Withdrawal by Subject|1|||
156822778|NCT03285958|566102604|FG001|Overall Study|Withdrawal by Subject|0|||
157150844|NCT00367640|567298107|FG001|Overall Study|Any other reason not above-mentioned|5|||
157150845|NCT00367640|567298108|FG002|Overall Study|Any other reason not above-mentioned|3|||
157150846|NCT00367640|567298109|FG003|Overall Study|Any other reason not above-mentioned|4|||
157150847|NCT02417233|567298110|FG000|Overall Study|Death|4|||
157150848|NCT02417233|567298111|FG001|Overall Study|Death|10|||
157150849|NCT02417233|567298112|FG002|Overall Study|Death|14|||
157150850|NCT02417233|567298110|FG000|Overall Study|Lost to Follow-up|27|||
157150851|NCT02417233|567298111|FG001|Overall Study|Lost to Follow-up|39|||
157150852|NCT02417233|567298112|FG002|Overall Study|Lost to Follow-up|34|||
157150853|NCT02417233|567298110|FG000|Overall Study|Protocol Violation|2|||
157150854|NCT02417233|567298111|FG001|Overall Study|Protocol Violation|0|||
157150855|NCT02417233|567298112|FG002|Overall Study|Protocol Violation|2|||
157150856|NCT02417233|567298110|FG000|Overall Study|Withdrawal by Subject|2|||
157150857|NCT02417233|567298111|FG001|Overall Study|Withdrawal by Subject|1|||
157150858|NCT02417233|567298112|FG002|Overall Study|Withdrawal by Subject|8|||
157150859|NCT02417233|567298110|FG000|Overall Study|Relocation out of study area|1|||
157150860|NCT02417233|567298111|FG001|Overall Study|Relocation out of study area|0|||
157150861|NCT02417233|567298112|FG002|Overall Study|Relocation out of study area|1|||
157150862|NCT02417233|567298110|FG000|Overall Study|Mentally unstable|0|||
157150863|NCT02417233|567298111|FG001|Overall Study|Mentally unstable|1|||
157150864|NCT02417233|567298112|FG002|Overall Study|Mentally unstable|0|||
157150865|NCT01063751|567298114|FG000|Overall Study|Censored from analyses|42|||
157150866|NCT01063751|567298114|FG000|Overall Study|Withdrawal by Subject|34|||
157150867|NCT01063751|567298114|FG000|Overall Study|Lost to Follow-up|30|||
157150868|NCT01063751|567298114|FG000|Overall Study|Death|13|||
157150869|NCT01063751|567298114|FG000|Overall Study|Sponsored Terminated Study|60|||
157150870|NCT01063751|567298114|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
157150871|NCT01063751|567298114|FG000|Overall Study|Investigator site closed|10|||
157150872|NCT01063751|567298114|FG000|Overall Study|Revision|6|||
157150873|NCT01063751|567298114|FG000|Overall Study|Physician Decision|4|||
157150874|NCT01188798|567298115|FG000|Overall Study|Death|0|||
157150875|NCT01188798|567298116|FG001|Overall Study|Death|1|||
157150876|NCT01188798|567298115|FG000|Overall Study|Required additional transplant|1|||
157150877|NCT01188798|567298116|FG001|Overall Study|Required additional transplant|1|||
157150878|NCT01188798|567298115|FG000|Overall Study|Protocol closure|1|||
157150879|NCT01188798|567298116|FG001|Overall Study|Protocol closure|1|||
157150880|NCT03964415|567298121|FG000|Overall Study|Sponsor's decision|1563|||
157150881|NCT03964415|567298122|FG001|Overall Study|Sponsor's decision|1528|||
157150882|NCT03964415|567298121|FG000|Overall Study|Lost to Follow-up|139|||
157150883|NCT03964415|567298122|FG001|Overall Study|Lost to Follow-up|146|||
157150884|NCT03964415|567298121|FG000|Overall Study|Withdrawal by Subject|68|||
156822779|NCT03285958|566102603|FG000|Overall Study|Not able to attend required orientation|3|||
156822780|NCT03285958|566102604|FG001|Overall Study|Not able to attend required orientation|0|||
156884551|NCT01489111|566336286|FG000|Overall Study|Withdrawal criterion|1|||
156884552|NCT01757691|566336291|FG000|Overall Study|Administrative problems|2|||
156884553|NCT01757691|566336292|FG001|Overall Study|Administrative problems|0|||
156884554|NCT00003472|566336293|FG000|Overall Study|Not evaluable|3|||
156884555|NCT01012219|566336294|FG000|Period 1|Withdrawal by Subject|1|||
156884556|NCT01012219|566336294|FG000|Period 2|Withdrawal by Subject|1|||
156884557|NCT00874939|566336295|FG000|Overall Study|Study terminated|4|||
156884558|NCT01909791|566336296|FG000|Overall Study|Death|9|||
156884559|NCT01909791|566336297|FG001|Overall Study|Death|8|||
156884560|NCT01909791|566336298|FG002|Overall Study|Death|4|||
156884561|NCT01909791|566336296|FG000|Overall Study|Withdrawal by Subject|5|||
156884562|NCT01909791|566336297|FG001|Overall Study|Withdrawal by Subject|9|||
157022768|NCT05215314|566836851|FG001|Overall Study|Physician Decision|0|||
157022769|NCT03366649|566836854|FG000|Overall Study|Failed preoperative screening|4|||
157022770|NCT03366649|566836855|FG001|Overall Study|Failed preoperative screening|0|||
157150885|NCT03964415|567298122|FG001|Overall Study|Withdrawal by Subject|72|||
157150886|NCT03964415|567298121|FG000|Overall Study|Physician Decision|34|||
157150887|NCT03964415|567298122|FG001|Overall Study|Physician Decision|48|||
157224458|NCT03679741|567567997|FG001|Period 1|Lost to Follow-up|1|||
157150888|NCT03964415|567298121|FG000|Overall Study|Adverse Event|3|||
157224459|NCT03679741|567567996|FG000|Period 1|Adverse Event|1|||
156822781|NCT03116828|566102605|FG000|Overall Study|Adverse Event|1|||
156822782|NCT03116828|566102606|FG001|Overall Study|Adverse Event|10|||
156822783|NCT03116828|566102605|FG000|Overall Study|Withdrawal by Subject|4|||
156884563|NCT01909791|566336298|FG002|Overall Study|Withdrawal by Subject|13|||
156884564|NCT01909791|566336296|FG000|Overall Study|Lost to Follow-up|5|||
156884565|NCT01909791|566336297|FG001|Overall Study|Lost to Follow-up|11|||
156884566|NCT01909791|566336298|FG002|Overall Study|Lost to Follow-up|10|||
156884567|NCT01909791|566336296|FG000|Overall Study|Missed Visit|2|||
156884568|NCT01909791|566336297|FG001|Overall Study|Missed Visit|0|||
156884569|NCT01909791|566336298|FG002|Overall Study|Missed Visit|1|||
156884570|NCT00910624|566336302|FG000|Treatment Phase|Adverse Event|2|||
156884571|NCT00910624|566336303|FG001|Treatment Phase|Adverse Event|6|||
156884572|NCT00910624|566336304|FG002|Treatment Phase|Adverse Event|6|||
156884573|NCT00910624|566336305|FG003|Treatment Phase|Adverse Event|0|||
156884574|NCT00910624|566336302|FG000|Treatment Phase|Treatment Failure|23|||
156884575|NCT00910624|566336303|FG001|Treatment Phase|Treatment Failure|10|||
156884576|NCT00910624|566336304|FG002|Treatment Phase|Treatment Failure|0|||
156884577|NCT00910624|566336305|FG003|Treatment Phase|Treatment Failure|0|||
156884578|NCT00910624|566336302|FG000|Treatment Phase|Lost to Follow-up|0|||
156884579|NCT00910624|566336303|FG001|Treatment Phase|Lost to Follow-up|0|||
157150889|NCT03964415|567298122|FG001|Overall Study|Adverse Event|0|||
157150890|NCT03964415|567298121|FG000|Overall Study|Death|4|||
157150891|NCT03964415|567298122|FG001|Overall Study|Death|6|||
157150892|NCT03964415|567298121|FG000|Overall Study|Protocol Violation|1|||
157150893|NCT03964415|567298122|FG001|Overall Study|Protocol Violation|4|||
157150894|NCT03964415|567298121|FG000|Overall Study|Other|35|||
157150895|NCT03964415|567298122|FG001|Overall Study|Other|38|||
157150896|NCT03964415|567298121|FG000|Overall Study|Randomized but not treated|6|||
157150897|NCT03964415|567298122|FG001|Overall Study|Randomized but not treated|7|||
156822784|NCT03116828|566102606|FG001|Overall Study|Withdrawal by Subject|8|||
156822785|NCT03116828|566102605|FG000|Overall Study|OTHER|3|||
156822786|NCT03116828|566102606|FG001|Overall Study|OTHER|3|||
156822787|NCT00983515|566102609|FG000|Ritonavir Alone|liver panel out of range|6|||
156822788|NCT00983515|566102609|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
156822789|NCT05243745|566102610|FG000|Overall Study|Withdrawal by Subject|0|||
156822790|NCT05243745|566102611|FG001|Overall Study|Withdrawal by Subject|0|||
156822791|NCT05243745|566102612|FG002|Overall Study|Withdrawal by Subject|0|||
156822792|NCT05243745|566102613|FG003|Overall Study|Withdrawal by Subject|1|||
156822793|NCT05243745|566102610|FG000|Overall Study|Unable to Attend Visit 6|0|||
156822794|NCT05243745|566102611|FG001|Overall Study|Unable to Attend Visit 6|0|||
156822795|NCT05243745|566102612|FG002|Overall Study|Unable to Attend Visit 6|1|||
156822796|NCT05243745|566102613|FG003|Overall Study|Unable to Attend Visit 6|0|||
156822797|NCT02998203|566102614|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
156822798|NCT02998203|566102615|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
156822799|NCT02998203|566102614|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
156822800|NCT02998203|566102615|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
156822801|NCT04187144|566102628|FG000|Overall Study|Lost to Follow-up|12|||
156822802|NCT04187144|566102629|FG001|Overall Study|Lost to Follow-up|11|||
156822803|NCT04187144|566102628|FG000|Overall Study|Withdrawal by Subject|20|||
156822804|NCT04187144|566102629|FG001|Overall Study|Withdrawal by Subject|18|||
156822805|NCT04187144|566102628|FG000|Overall Study|Adverse Event|19|||
156822806|NCT04187144|566102629|FG001|Overall Study|Adverse Event|4|||
156822807|NCT04187144|566102628|FG000|Overall Study|Physician Decision|5|||
156822808|NCT04187144|566102629|FG001|Overall Study|Physician Decision|3|||
156822809|NCT04187144|566102628|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
156822810|NCT04187144|566102629|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
156822811|NCT04187144|566102628|FG000|Overall Study|Protocol Deviation|1|||
156822812|NCT04187144|566102629|FG001|Overall Study|Protocol Deviation|4|||
156822813|NCT03842969|566102630|FG000|Overall Study|Participant declined follow-up visit|0|||
156884580|NCT00910624|566336304|FG002|Treatment Phase|Lost to Follow-up|1|||
156884581|NCT00910624|566336305|FG003|Treatment Phase|Lost to Follow-up|0|||
156884582|NCT00910624|566336302|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
156884583|NCT00910624|566336303|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
156884584|NCT00910624|566336304|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
156884585|NCT00910624|566336305|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
156884586|NCT00910624|566336302|FG000|Treatment Phase|Withdrawal by Subject|2|||
157150898|NCT03662334|567298123|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
157150899|NCT03662334|567298124|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
157150900|NCT01097330|567298129|FG000|Overall Study|Study terminated early|7|||
157150901|NCT01097330|567298130|FG001|Overall Study|Study terminated early|5|||
157150902|NCT00510692|567298131|FG000|Overall Study|Adverse Event|1|||
157150903|NCT00510692|567298132|FG001|Overall Study|Adverse Event|3|||
157150904|NCT00510692|567298131|FG000|Overall Study|Withdrawal by Subject|1|||
156884587|NCT00910624|566336303|FG001|Treatment Phase|Withdrawal by Subject|1|||
157150905|NCT00510692|567298132|FG001|Overall Study|Withdrawal by Subject|0|||
157150906|NCT00945191|567298133|FG000|Overall Study|Did not achieve a complete response|18|||
157224460|NCT03679741|567567997|FG001|Period 1|Adverse Event|1|||
156822814|NCT03842969|566102631|FG001|Overall Study|Participant declined follow-up visit|1|||
156822815|NCT03842969|566102632|FG002|Overall Study|Participant declined follow-up visit|0|||
156822816|NCT03842969|566102630|FG000|Overall Study|Sponsor's decision|12|||
156822817|NCT03842969|566102631|FG001|Overall Study|Sponsor's decision|99|||
156822818|NCT03842969|566102632|FG002|Overall Study|Sponsor's decision|61|||
156822819|NCT03842969|566102630|FG000|Overall Study|Pregnancy|0|||
156822820|NCT03842969|566102631|FG001|Overall Study|Pregnancy|0|||
156822821|NCT03842969|566102632|FG002|Overall Study|Pregnancy|1|||
156822822|NCT03842969|566102630|FG000|Overall Study|Death|1|||
156822823|NCT03842969|566102631|FG001|Overall Study|Death|0|||
156822824|NCT03842969|566102632|FG002|Overall Study|Death|1|||
156822825|NCT03842969|566102630|FG000|Overall Study|Withdrawal by Subject|3|||
156822826|NCT03842969|566102631|FG001|Overall Study|Withdrawal by Subject|30|||
156822827|NCT03842969|566102632|FG002|Overall Study|Withdrawal by Subject|18|||
156822828|NCT03842969|566102630|FG000|Overall Study|Protocol Violation|1|||
156822829|NCT03842969|566102631|FG001|Overall Study|Protocol Violation|1|||
156822830|NCT03842969|566102632|FG002|Overall Study|Protocol Violation|0|||
156822831|NCT03842969|566102630|FG000|Overall Study|Physician Decision|0|||
156822832|NCT03842969|566102631|FG001|Overall Study|Physician Decision|3|||
156822833|NCT03842969|566102632|FG002|Overall Study|Physician Decision|0|||
156822834|NCT03842969|566102630|FG000|Overall Study|Lost to Follow-up|0|||
156822835|NCT03842969|566102631|FG001|Overall Study|Lost to Follow-up|2|||
156822836|NCT03842969|566102632|FG002|Overall Study|Lost to Follow-up|0|||
156822837|NCT03842969|566102630|FG000|Overall Study|Adverse Event|0|||
156822838|NCT03842969|566102631|FG001|Overall Study|Adverse Event|2|||
156822839|NCT03842969|566102632|FG002|Overall Study|Adverse Event|0|||
156822840|NCT01044745|566102633|FG000|Overall Study|Ineiligible|2|||
156822841|NCT05312632|566102636|FG000|Overall Study|Adverse Event|12|||
156822842|NCT05312632|566102636|FG000|Overall Study|Withdrawal by Subject|10|||
156822843|NCT05312632|566102636|FG000|Overall Study|Lack of Efficacy|4|||
156822844|NCT05312632|566102636|FG000|Overall Study|Non-compliance with study procedures|9|||
156822845|NCT05312632|566102636|FG000|Overall Study|Other|4|||
156822846|NCT02379221|566102637|FG000|Overall Study|Lost to Follow-up|1|||
156822847|NCT02019108|566102638|FG000|Overall Study|Lost to Follow-up|5|||
156822848|NCT02019108|566102639|FG001|Overall Study|Lost to Follow-up|7|||
156822849|NCT00519376|566102646|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822850|NCT00519376|566102647|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822851|NCT00519376|566102648|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822852|NCT00519376|566102649|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822853|NCT00519376|566102650|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822854|NCT00519376|566102651|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822855|NCT00519376|566102652|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822856|NCT00519376|566102653|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822857|NCT00519376|566102654|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822858|NCT00519376|566102655|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822859|NCT00519376|566102656|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156884588|NCT00910624|566336304|FG002|Treatment Phase|Withdrawal by Subject|0|||
156884589|NCT00910624|566336305|FG003|Treatment Phase|Withdrawal by Subject|0|||
157150907|NCT00945191|567298133|FG000|Overall Study|Participant relocated to another state|1|||
157150908|NCT00945191|567298133|FG000|Overall Study|Disease progression|3|||
157150909|NCT00945191|567298133|FG000|Overall Study|Serious adverse event or adverse event|1|||
157150910|NCT00945191|567298133|FG000|Overall Study|Investigator's discretion|1|||
157150911|NCT02116972|567298134|FG000|Overall Study|Adverse Event|4|||
157150912|NCT02116972|567298135|FG001|Overall Study|Adverse Event|4|||
157150913|NCT02116972|567298136|FG002|Overall Study|Adverse Event|1|||
157150914|NCT02116972|567298134|FG000|Overall Study|Withdrawal by Subject|1|||
157150915|NCT02116972|567298135|FG001|Overall Study|Withdrawal by Subject|1|||
156822860|NCT00519376|566102657|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156884590|NCT00910624|566336302|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
156884591|NCT00910624|566336303|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
156884592|NCT00910624|566336304|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
156884593|NCT00910624|566336305|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
156884594|NCT00910624|566336302|FG000|Follow-Up Phase|Adverse Event|0|||
156884595|NCT00910624|566336303|FG001|Follow-Up Phase|Adverse Event|0|||
156884596|NCT00910624|566336304|FG002|Follow-Up Phase|Adverse Event|1|||
156884597|NCT00910624|566336305|FG003|Follow-Up Phase|Adverse Event|0|||
156884598|NCT00910624|566336302|FG000|Follow-Up Phase|Lost to Follow-up|3|||
156884599|NCT00910624|566336303|FG001|Follow-Up Phase|Lost to Follow-up|1|||
156884600|NCT00910624|566336304|FG002|Follow-Up Phase|Lost to Follow-up|2|||
156884601|NCT00910624|566336305|FG003|Follow-Up Phase|Lost to Follow-up|0|||
156884602|NCT00910624|566336302|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
156884603|NCT00910624|566336303|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
156822861|NCT00519376|566102658|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
156822862|NCT00519376|566102659|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822863|NCT00519376|566102660|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822864|NCT00519376|566102661|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
156822865|NCT00519376|566102646|FG000|Treatment Period 4|Lost to Follow-up|0|||
156822866|NCT00519376|566102647|FG001|Treatment Period 4|Lost to Follow-up|0|||
156822867|NCT00519376|566102648|FG002|Treatment Period 4|Lost to Follow-up|1|||
157150916|NCT02116972|567298136|FG002|Overall Study|Withdrawal by Subject|5|||
156822868|NCT00519376|566102649|FG003|Treatment Period 4|Lost to Follow-up|0|||
156822869|NCT00519376|566102650|FG004|Treatment Period 4|Lost to Follow-up|0|||
156822870|NCT00519376|566102651|FG005|Treatment Period 4|Lost to Follow-up|0|||
156822871|NCT00519376|566102652|FG006|Treatment Period 4|Lost to Follow-up|0|||
156822872|NCT00519376|566102653|FG007|Treatment Period 4|Lost to Follow-up|0|||
156822873|NCT00519376|566102654|FG008|Treatment Period 4|Lost to Follow-up|0|||
156822874|NCT00519376|566102655|FG009|Treatment Period 4|Lost to Follow-up|0|||
156822875|NCT00519376|566102656|FG010|Treatment Period 4|Lost to Follow-up|0|||
156822876|NCT00519376|566102657|FG011|Treatment Period 4|Lost to Follow-up|0|||
156822877|NCT00519376|566102658|FG012|Treatment Period 4|Lost to Follow-up|0|||
156822878|NCT00519376|566102659|FG013|Treatment Period 4|Lost to Follow-up|0|||
156822879|NCT00519376|566102660|FG014|Treatment Period 4|Lost to Follow-up|0|||
156822880|NCT00519376|566102661|FG015|Treatment Period 4|Lost to Follow-up|0|||
156822881|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822882|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
156822883|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822884|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822885|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
156822886|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822887|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
156822888|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822889|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822890|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
156822891|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822892|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
156822893|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822894|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822895|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
156822896|NCT02688088|566102662|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822897|NCT02688088|566102663|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
156822898|NCT02688088|566102664|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822899|NCT02688088|566102665|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822900|NCT02688088|566102666|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
156822901|NCT02688088|566102662|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822902|NCT02688088|566102663|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822903|NCT02688088|566102664|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
156822904|NCT02688088|566102665|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822905|NCT02688088|566102666|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
156822906|NCT02688088|566102662|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822907|NCT02688088|566102663|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822908|NCT02688088|566102664|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
156822909|NCT02688088|566102665|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822910|NCT02688088|566102666|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
156822911|NCT02688088|566102662|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822912|NCT02688088|566102663|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822913|NCT02688088|566102664|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822914|NCT02688088|566102665|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
156822915|NCT02688088|566102666|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
156822916|NCT02688088|566102662|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822917|NCT02688088|566102663|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822918|NCT02688088|566102664|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822919|NCT02688088|566102665|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
156822920|NCT02688088|566102666|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
156822921|NCT02688088|566102662|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822922|NCT02688088|566102663|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822923|NCT02688088|566102664|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822924|NCT02688088|566102665|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
156822925|NCT02688088|566102666|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
156822926|NCT03812185|566102674|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
156822927|NCT01694121|566102686|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
156822928|NCT01694121|566102687|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
156822929|NCT02928029|566102688|FG000|Overall Study|Withdrawal by Subject|0|||
156822930|NCT02928029|566102689|FG001|Overall Study|Withdrawal by Subject|1|||
156822931|NCT02928029|566102688|FG000|Overall Study|Radiological progression|1|||
156822932|NCT02928029|566102689|FG001|Overall Study|Radiological progression|0|||
156822933|NCT02928029|566102688|FG000|Overall Study|Clinical progression|1|||
156822934|NCT02928029|566102689|FG001|Overall Study|Clinical progression|2|||
156822935|NCT02928029|566102688|FG000|Overall Study|AE not related to clinical progression|1|||
156822936|NCT02928029|566102689|FG001|Overall Study|AE not related to clinical progression|1|||
156822937|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
156822938|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
156822939|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
156822940|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
156822941|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
156822942|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
156822943|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
156822944|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
156822945|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
156822946|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
156822947|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
156822948|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
156822949|NCT04376684|566102699|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
156822950|NCT04376684|566102700|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
156822951|NCT04376684|566102701|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
156822952|NCT04376684|566102702|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
156822953|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
156822954|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
156822955|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
156822956|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
156822957|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
156822958|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
156822959|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
156822960|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
156822961|NCT04376684|566102699|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
156822962|NCT04376684|566102700|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
156822963|NCT04376684|566102701|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
156822964|NCT04376684|566102702|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
156822965|NCT02979093|566102717|FG000|First Scan Session|Scanning data problems|1|||
156822966|NCT02979093|566102718|FG001|First Scan Session|Scanning data problems|2|||
156822967|NCT02979093|566102719|FG002|First Scan Session|Scanning data problems|2|||
156822968|NCT02979093|566102720|FG003|First Scan Session|Scanning data problems|0|||
156822969|NCT02979093|566102717|FG000|Second Scan Session|Scanning data problems|3|||
156822970|NCT02979093|566102718|FG001|Second Scan Session|Scanning data problems|0|||
156822971|NCT02979093|566102719|FG002|Second Scan Session|Scanning data problems|1|||
156822972|NCT02979093|566102720|FG003|Second Scan Session|Scanning data problems|3|||
156822973|NCT06107803|566102721|FG000|Overall Study|Adverse Event|1|||
156822974|NCT06107803|566102721|FG000|Overall Study|Withdrawal by Subject|2|||
156822975|NCT06107803|566102721|FG000|Overall Study|Protocol Violation|1|||
156822976|NCT03099174|566102722|FG000|Overall Study|Withdrawal by Subject|0|||
156822977|NCT03099174|566102723|FG001|Overall Study|Withdrawal by Subject|0|||
156822978|NCT03099174|566102724|FG002|Overall Study|Withdrawal by Subject|1|||
156822979|NCT03099174|566102725|FG003|Overall Study|Withdrawal by Subject|0|||
156822980|NCT03099174|566102726|FG004|Overall Study|Withdrawal by Subject|2|||
156822981|NCT03099174|566102727|FG005|Overall Study|Withdrawal by Subject|2|||
156822982|NCT03099174|566102728|FG006|Overall Study|Withdrawal by Subject|1|||
156822983|NCT03099174|566102729|FG007|Overall Study|Withdrawal by Subject|4|||
156822984|NCT03099174|566102722|FG000|Overall Study|Adverse Event|0|||
156822985|NCT03099174|566102723|FG001|Overall Study|Adverse Event|1|||
156822986|NCT03099174|566102724|FG002|Overall Study|Adverse Event|1|||
156822987|NCT03099174|566102725|FG003|Overall Study|Adverse Event|2|||
156822988|NCT03099174|566102726|FG004|Overall Study|Adverse Event|5|||
156822989|NCT03099174|566102727|FG005|Overall Study|Adverse Event|3|||
156822990|NCT03099174|566102728|FG006|Overall Study|Adverse Event|6|||
156822991|NCT03099174|566102729|FG007|Overall Study|Adverse Event|4|||
156822992|NCT03099174|566102722|FG000|Overall Study|Other than listed|6|||
156822993|NCT03099174|566102723|FG001|Overall Study|Other than listed|6|||
156822994|NCT03099174|566102724|FG002|Overall Study|Other than listed|5|||
156822995|NCT03099174|566102725|FG003|Overall Study|Other than listed|6|||
156822996|NCT03099174|566102726|FG004|Overall Study|Other than listed|19|||
156822997|NCT03099174|566102727|FG005|Overall Study|Other than listed|10|||
156822998|NCT03099174|566102728|FG006|Overall Study|Other than listed|26|||
156822999|NCT03099174|566102729|FG007|Overall Study|Other than listed|23|||
156823000|NCT04730635|566102730|FG000|Overall Study|Lost to Follow-up|1|||
156823001|NCT04730635|566102731|FG001|Overall Study|Lost to Follow-up|0|||
156823002|NCT04730635|566102730|FG000|Overall Study|Withdrawal by Subject|0|||
156823003|NCT04730635|566102731|FG001|Overall Study|Withdrawal by Subject|1|||
156823004|NCT03070223|566102732|FG000|Overall Study|Lost to Follow-up|34|||
157150917|NCT02116972|567298134|FG000|Overall Study|Protocol Violation|1|||
156823005|NCT03070223|566102733|FG001|Overall Study|Lost to Follow-up|27|||
156823006|NCT03070223|566102732|FG000|Overall Study|Withdrawal by Subject|12|||
156823007|NCT03070223|566102733|FG001|Overall Study|Withdrawal by Subject|22|||
156823008|NCT03070223|566102732|FG000|Overall Study|Protocol Violation|0|||
156823009|NCT03070223|566102733|FG001|Overall Study|Protocol Violation|1|||
156884604|NCT00910624|566336304|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
156884605|NCT00910624|566336305|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
156884606|NCT00910624|566336302|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
156884607|NCT00910624|566336303|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
156884608|NCT00910624|566336304|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
156884609|NCT00910624|566336305|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
156884610|NCT00910624|566336302|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
156884611|NCT00910624|566336303|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
156884612|NCT00910624|566336304|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
157224461|NCT03679741|567567996|FG000|Period 1|Withdrawal by Subject|0|||
156823010|NCT04934800|566102734|FG000|Overall Study|Other|1|||
156823011|NCT04934800|566102734|FG000|Overall Study|Withdrawal by Subject|5|||
156823012|NCT04934800|566102734|FG000|Overall Study|Lack of Efficacy|1|||
156823013|NCT04934800|566102734|FG000|Overall Study|Adverse Event|9|||
156823014|NCT04934800|566102734|FG000|Overall Study|Lost to Follow-up|5|||
156823015|NCT04934800|566102734|FG000|Overall Study|Enrolled but not treated|1|||
156823016|NCT00516906|566102735|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
156823017|NCT00516906|566102736|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
156823018|NCT05596734|566102737|FG000|Substudy A|Withdrawal by Subject|1|||
156823019|NCT05596734|566102738|FG001|Substudy A|Withdrawal by Subject|0|||
156823020|NCT05596734|566102739|FG002|Substudy A|Withdrawal by Subject|0|||
156823021|NCT05596734|566102740|FG003|Substudy A|Withdrawal by Subject|0|||
156823022|NCT05596734|566102741|FG004|Substudy A|Withdrawal by Subject|0|||
156823023|NCT05596734|566102742|FG005|Substudy A|Withdrawal by Subject|0|||
156823024|NCT05596734|566102743|FG006|Substudy A|Withdrawal by Subject|1|||
156823025|NCT05596734|566102744|FG007|Substudy A|Withdrawal by Subject|0|||
156823026|NCT05596734|566102745|FG008|Substudy A|Withdrawal by Subject|0|||
156823027|NCT05596734|566102746|FG009|Substudy A|Withdrawal by Subject|0|||
156823028|NCT05596734|566102747|FG010|Substudy A|Withdrawal by Subject|0|||
156823029|NCT05596734|566102748|FG011|Substudy A|Withdrawal by Subject|0|||
156823030|NCT05596734|566102749|FG012|Substudy A|Withdrawal by Subject|0|||
156823031|NCT05596734|566102750|FG013|Substudy A|Withdrawal by Subject|0|||
156823032|NCT05596734|566102751|FG014|Substudy A|Withdrawal by Subject|0|||
156823033|NCT05596734|566102752|FG015|Substudy A|Withdrawal by Subject|0|||
156823034|NCT05596734|566102753|FG016|Substudy A|Withdrawal by Subject|0|||
156823035|NCT05596734|566102754|FG017|Substudy A|Withdrawal by Subject|0|||
156823036|NCT05596734|566102755|FG018|Substudy A|Withdrawal by Subject|0|||
156823037|NCT05596734|566102756|FG019|Substudy A|Withdrawal by Subject|0|||
156823038|NCT05596734|566102757|FG020|Substudy A|Withdrawal by Subject|0|||
156823039|NCT05596734|566102758|FG021|Substudy A|Withdrawal by Subject|0|||
156823040|NCT05596734|566102759|FG022|Substudy A|Withdrawal by Subject|0|||
156823041|NCT05596734|566102760|FG023|Substudy A|Withdrawal by Subject|0|||
156823042|NCT05596734|566102737|FG000|Substudy A|Lost to Follow-up|1|||
156823043|NCT05596734|566102738|FG001|Substudy A|Lost to Follow-up|0|||
156823044|NCT05596734|566102739|FG002|Substudy A|Lost to Follow-up|1|||
156823045|NCT05596734|566102740|FG003|Substudy A|Lost to Follow-up|0|||
156823046|NCT05596734|566102741|FG004|Substudy A|Lost to Follow-up|0|||
156823047|NCT05596734|566102742|FG005|Substudy A|Lost to Follow-up|0|||
156823048|NCT05596734|566102743|FG006|Substudy A|Lost to Follow-up|0|||
156823049|NCT05596734|566102744|FG007|Substudy A|Lost to Follow-up|0|||
156823050|NCT05596734|566102745|FG008|Substudy A|Lost to Follow-up|0|||
156823051|NCT05596734|566102746|FG009|Substudy A|Lost to Follow-up|0|||
156823052|NCT05596734|566102747|FG010|Substudy A|Lost to Follow-up|0|||
156823053|NCT05596734|566102748|FG011|Substudy A|Lost to Follow-up|0|||
156823054|NCT05596734|566102749|FG012|Substudy A|Lost to Follow-up|0|||
156823055|NCT05596734|566102750|FG013|Substudy A|Lost to Follow-up|0|||
156823056|NCT05596734|566102751|FG014|Substudy A|Lost to Follow-up|0|||
156823057|NCT05596734|566102752|FG015|Substudy A|Lost to Follow-up|0|||
156823058|NCT05596734|566102753|FG016|Substudy A|Lost to Follow-up|0|||
156884613|NCT00910624|566336305|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
156823059|NCT05596734|566102754|FG017|Substudy A|Lost to Follow-up|0|||
156823060|NCT05596734|566102755|FG018|Substudy A|Lost to Follow-up|0|||
156823061|NCT05596734|566102756|FG019|Substudy A|Lost to Follow-up|0|||
156823062|NCT05596734|566102757|FG020|Substudy A|Lost to Follow-up|0|||
156823063|NCT05596734|566102758|FG021|Substudy A|Lost to Follow-up|0|||
157224462|NCT03679741|567567997|FG001|Period 1|Withdrawal by Subject|1|||
156823064|NCT05596734|566102759|FG022|Substudy A|Lost to Follow-up|0|||
156884614|NCT00910624|566336302|FG000|Follow-Up Phase|Administrative|0|||
157224463|NCT03679741|567567996|FG000|Period 2|Adverse Event|2|||
156823065|NCT05596734|566102760|FG023|Substudy A|Lost to Follow-up|0|||
156823066|NCT05596734|566102737|FG000|Substudy B|Withdrawal by Subject|0|||
156823067|NCT05596734|566102738|FG001|Substudy B|Withdrawal by Subject|0|||
156884615|NCT00910624|566336303|FG001|Follow-Up Phase|Administrative|1|||
157022771|NCT03366649|566836856|FG002|Overall Study|Failed preoperative screening|0|||
157224464|NCT03679741|567567997|FG001|Period 2|Adverse Event|1|||
156823068|NCT05596734|566102739|FG002|Substudy B|Withdrawal by Subject|0|||
156823069|NCT05596734|566102740|FG003|Substudy B|Withdrawal by Subject|0|||
156823070|NCT05596734|566102741|FG004|Substudy B|Withdrawal by Subject|0|||
156823071|NCT05596734|566102742|FG005|Substudy B|Withdrawal by Subject|0|||
156823072|NCT05596734|566102743|FG006|Substudy B|Withdrawal by Subject|0|||
156823073|NCT05596734|566102744|FG007|Substudy B|Withdrawal by Subject|0|||
156823074|NCT05596734|566102745|FG008|Substudy B|Withdrawal by Subject|0|||
156823075|NCT05596734|566102746|FG009|Substudy B|Withdrawal by Subject|0|||
156823076|NCT05596734|566102747|FG010|Substudy B|Withdrawal by Subject|0|||
156823077|NCT05596734|566102748|FG011|Substudy B|Withdrawal by Subject|0|||
156823078|NCT05596734|566102749|FG012|Substudy B|Withdrawal by Subject|1|||
156823079|NCT05596734|566102750|FG013|Substudy B|Withdrawal by Subject|0|||
156823080|NCT05596734|566102751|FG014|Substudy B|Withdrawal by Subject|1|||
156823081|NCT05596734|566102752|FG015|Substudy B|Withdrawal by Subject|2|||
156823082|NCT05596734|566102753|FG016|Substudy B|Withdrawal by Subject|2|||
156823083|NCT05596734|566102754|FG017|Substudy B|Withdrawal by Subject|1|||
156823084|NCT05596734|566102755|FG018|Substudy B|Withdrawal by Subject|2|||
156823085|NCT05596734|566102756|FG019|Substudy B|Withdrawal by Subject|0|||
156823086|NCT05596734|566102757|FG020|Substudy B|Withdrawal by Subject|0|||
156823087|NCT05596734|566102758|FG021|Substudy B|Withdrawal by Subject|0|||
156823088|NCT05596734|566102759|FG022|Substudy B|Withdrawal by Subject|0|||
156823089|NCT05596734|566102760|FG023|Substudy B|Withdrawal by Subject|1|||
156823090|NCT05596734|566102737|FG000|Substudy B|Physician Decision|0|||
156823091|NCT05596734|566102738|FG001|Substudy B|Physician Decision|0|||
156823092|NCT05596734|566102739|FG002|Substudy B|Physician Decision|0|||
156823093|NCT05596734|566102740|FG003|Substudy B|Physician Decision|0|||
156823094|NCT05596734|566102741|FG004|Substudy B|Physician Decision|0|||
156823095|NCT05596734|566102742|FG005|Substudy B|Physician Decision|0|||
156823096|NCT05596734|566102743|FG006|Substudy B|Physician Decision|0|||
156823097|NCT05596734|566102744|FG007|Substudy B|Physician Decision|0|||
156823098|NCT05596734|566102745|FG008|Substudy B|Physician Decision|0|||
156823099|NCT05596734|566102746|FG009|Substudy B|Physician Decision|0|||
156823100|NCT05596734|566102747|FG010|Substudy B|Physician Decision|0|||
156823101|NCT05596734|566102748|FG011|Substudy B|Physician Decision|0|||
156823102|NCT05596734|566102749|FG012|Substudy B|Physician Decision|0|||
156823103|NCT05596734|566102750|FG013|Substudy B|Physician Decision|0|||
156823104|NCT05596734|566102751|FG014|Substudy B|Physician Decision|0|||
156823105|NCT05596734|566102752|FG015|Substudy B|Physician Decision|1|||
156823106|NCT05596734|566102753|FG016|Substudy B|Physician Decision|0|||
156823107|NCT05596734|566102754|FG017|Substudy B|Physician Decision|0|||
156823108|NCT05596734|566102755|FG018|Substudy B|Physician Decision|0|||
156823109|NCT05596734|566102756|FG019|Substudy B|Physician Decision|0|||
156823110|NCT05596734|566102757|FG020|Substudy B|Physician Decision|0|||
156823111|NCT05596734|566102758|FG021|Substudy B|Physician Decision|0|||
156823112|NCT05596734|566102759|FG022|Substudy B|Physician Decision|0|||
156823113|NCT05596734|566102760|FG023|Substudy B|Physician Decision|0|||
156823114|NCT05596734|566102737|FG000|Substudy B|Lost to Follow-up|0|||
156823115|NCT05596734|566102738|FG001|Substudy B|Lost to Follow-up|0|||
156823116|NCT05596734|566102739|FG002|Substudy B|Lost to Follow-up|0|||
156823117|NCT05596734|566102740|FG003|Substudy B|Lost to Follow-up|0|||
156823118|NCT05596734|566102741|FG004|Substudy B|Lost to Follow-up|0|||
156823119|NCT05596734|566102742|FG005|Substudy B|Lost to Follow-up|0|||
156823120|NCT05596734|566102743|FG006|Substudy B|Lost to Follow-up|0|||
156823121|NCT05596734|566102744|FG007|Substudy B|Lost to Follow-up|0|||
156823122|NCT05596734|566102745|FG008|Substudy B|Lost to Follow-up|0|||
156823123|NCT05596734|566102746|FG009|Substudy B|Lost to Follow-up|0|||
156884616|NCT00910624|566336304|FG002|Follow-Up Phase|Administrative|1|||
156884617|NCT00910624|566336305|FG003|Follow-Up Phase|Administrative|0|||
156884618|NCT04585009|566336306|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
156884619|NCT04585009|566336307|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884620|NCT04585009|566336308|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884621|NCT04585009|566336309|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884622|NCT04585009|566336310|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884623|NCT04585009|566336311|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884624|NCT04585009|566336312|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884625|NCT04585009|566336313|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884626|NCT04585009|566336314|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
157150918|NCT02116972|567298135|FG001|Overall Study|Protocol Violation|0|||
157150919|NCT02116972|567298136|FG002|Overall Study|Protocol Violation|1|||
156823124|NCT05596734|566102747|FG010|Substudy B|Lost to Follow-up|0|||
156823125|NCT05596734|566102748|FG011|Substudy B|Lost to Follow-up|0|||
156823126|NCT05596734|566102749|FG012|Substudy B|Lost to Follow-up|1|||
156823127|NCT05596734|566102750|FG013|Substudy B|Lost to Follow-up|0|||
156823128|NCT05596734|566102751|FG014|Substudy B|Lost to Follow-up|1|||
156823129|NCT05596734|566102752|FG015|Substudy B|Lost to Follow-up|1|||
156823130|NCT05596734|566102753|FG016|Substudy B|Lost to Follow-up|0|||
156823131|NCT05596734|566102754|FG017|Substudy B|Lost to Follow-up|0|||
157150920|NCT02116972|567298134|FG000|Overall Study|Lost to Follow-up|4|||
156823132|NCT05596734|566102755|FG018|Substudy B|Lost to Follow-up|0|||
157150921|NCT02116972|567298135|FG001|Overall Study|Lost to Follow-up|3|||
156823133|NCT05596734|566102756|FG019|Substudy B|Lost to Follow-up|0|||
156823134|NCT05596734|566102757|FG020|Substudy B|Lost to Follow-up|0|||
156823135|NCT05596734|566102758|FG021|Substudy B|Lost to Follow-up|0|||
156823136|NCT05596734|566102759|FG022|Substudy B|Lost to Follow-up|0|||
156823137|NCT05596734|566102760|FG023|Substudy B|Lost to Follow-up|0|||
156823138|NCT01974206|566102761|FG000|Overall Study|Did Not Take Study Drug|0|||
156823139|NCT01974206|566102762|FG001|Overall Study|Did Not Take Study Drug|1|||
156823140|NCT01974206|566102761|FG000|Overall Study|Physician Decision|1|||
156823141|NCT01974206|566102762|FG001|Overall Study|Physician Decision|0|||
156823142|NCT01974206|566102761|FG000|Overall Study|Withdrawal by Subject|3|||
156823143|NCT01974206|566102762|FG001|Overall Study|Withdrawal by Subject|0|||
156823144|NCT01974206|566102761|FG000|Overall Study|Lost to Follow-up|1|||
156823145|NCT01974206|566102762|FG001|Overall Study|Lost to Follow-up|0|||
156823146|NCT01974206|566102761|FG000|Overall Study|Death|1|||
156823147|NCT01974206|566102762|FG001|Overall Study|Death|0|||
156823148|NCT02059499|566102766|FG000|Upto Week 20|Lost to Follow-up|2|||
156823149|NCT02059499|566102767|FG001|Upto Week 20|Lost to Follow-up|6|||
156823150|NCT02059499|566102768|FG002|Upto Week 20|Lost to Follow-up|0|||
156823151|NCT02059499|566102766|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
156823152|NCT02059499|566102767|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
156823153|NCT02059499|566102768|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
156823154|NCT02059499|566102766|FG000|Upto Week 20|Withdrawal by Subject|1|||
156823155|NCT02059499|566102767|FG001|Upto Week 20|Withdrawal by Subject|1|||
156823156|NCT02059499|566102768|FG002|Upto Week 20|Withdrawal by Subject|0|||
156823157|NCT02059499|566102766|FG000|Upto Week 20|No treatment per protocol criteria|0|||
156823158|NCT02059499|566102767|FG001|Upto Week 20|No treatment per protocol criteria|0|||
156823159|NCT02059499|566102768|FG002|Upto Week 20|No treatment per protocol criteria|5|||
156823160|NCT02059499|566102766|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
156823161|NCT02059499|566102767|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
156823162|NCT02059499|566102768|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
156823163|NCT02059499|566102766|FG000|Post-week 20|Lost to Follow-up|0|||
156823164|NCT02059499|566102767|FG001|Post-week 20|Lost to Follow-up|2|||
156823165|NCT02059499|566102768|FG002|Post-week 20|Lost to Follow-up|0|||
156823166|NCT02059499|566102766|FG000|Post-week 20|Withdrawal by Subject|0|||
156823167|NCT02059499|566102767|FG001|Post-week 20|Withdrawal by Subject|1|||
156823168|NCT02059499|566102768|FG002|Post-week 20|Withdrawal by Subject|0|||
156823169|NCT02059499|566102766|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
156823170|NCT02059499|566102767|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
156823171|NCT02059499|566102768|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
156823172|NCT04210245|566102769|FG000|Overall Study|Adverse Event|0|||
156823173|NCT04210245|566102770|FG001|Overall Study|Adverse Event|3|||
156823174|NCT04210245|566102771|FG002|Overall Study|Adverse Event|6|||
156823175|NCT04210245|566102772|FG003|Overall Study|Adverse Event|0|||
156823176|NCT04210245|566102769|FG000|Overall Study|Withdrawal by Subject|0|||
156823177|NCT04210245|566102770|FG001|Overall Study|Withdrawal by Subject|1|||
156823178|NCT04210245|566102771|FG002|Overall Study|Withdrawal by Subject|4|||
156823179|NCT04210245|566102772|FG003|Overall Study|Withdrawal by Subject|4|||
156823180|NCT04210245|566102769|FG000|Overall Study|Lost to Follow-up|0|||
156823181|NCT04210245|566102770|FG001|Overall Study|Lost to Follow-up|1|||
156823182|NCT04210245|566102771|FG002|Overall Study|Lost to Follow-up|1|||
156823183|NCT04210245|566102772|FG003|Overall Study|Lost to Follow-up|1|||
156823184|NCT04210245|566102769|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823185|NCT04210245|566102770|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823186|NCT04210245|566102771|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
156823187|NCT04210245|566102772|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
156823188|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
156823189|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823190|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823191|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823192|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823193|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
156823194|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
156823195|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
156823196|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823197|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823198|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823199|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
156823200|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
156884627|NCT04585009|566336315|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156823201|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
156823202|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156884628|NCT04585009|566336316|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156823203|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823204|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823205|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
156823206|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
156823207|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
156823208|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823209|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823210|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823211|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
156823212|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
156823213|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
156823214|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823215|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823216|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823217|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
156823218|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
156823219|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823220|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823221|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823222|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823223|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
156823224|NCT03989349|566102775|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
156823225|NCT03989349|566102776|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
156823226|NCT03989349|566102777|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823227|NCT03989349|566102778|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823228|NCT03989349|566102779|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823229|NCT03989349|566102780|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
156823230|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156823231|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
156823232|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
156823233|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
156823234|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156823235|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
156823236|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156823237|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
156823238|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156823239|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
156823240|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
156823241|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
156823242|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156823243|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
156823244|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
156823245|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
156823246|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
156823247|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
156823248|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823249|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823250|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
156823251|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823252|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
156823253|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
156823254|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823255|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823256|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823257|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823258|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
156823259|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
156823260|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
156823261|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
156823262|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
156823263|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
157022772|NCT03366649|566836854|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
156823264|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
156823265|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
156823266|NCT03989349|566102775|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823267|NCT03989349|566102776|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823268|NCT03989349|566102777|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823269|NCT03989349|566102778|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
156823270|NCT03989349|566102779|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823271|NCT03989349|566102780|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
156823272|NCT02684058|566102783|FG000|Treatment Period|Progressive disease|4|||
156823273|NCT02684058|566102784|FG001|Treatment Period|Progressive disease|10|||
156823274|NCT02684058|566102785|FG002|Treatment Period|Progressive disease|19|||
156823275|NCT02684058|566102783|FG000|Treatment Period|Adverse Event|3|||
156823276|NCT02684058|566102784|FG001|Treatment Period|Adverse Event|8|||
156823277|NCT02684058|566102785|FG002|Treatment Period|Adverse Event|1|||
156823278|NCT02684058|566102783|FG000|Treatment Period|Physician Decision|5|||
156823279|NCT02684058|566102784|FG001|Treatment Period|Physician Decision|1|||
156823280|NCT02684058|566102785|FG002|Treatment Period|Physician Decision|2|||
156823281|NCT02684058|566102783|FG000|Treatment Period|New therapy for study indication|1|||
156823282|NCT02684058|566102784|FG001|Treatment Period|New therapy for study indication|0|||
156823283|NCT02684058|566102785|FG002|Treatment Period|New therapy for study indication|0|||
156823284|NCT02684058|566102783|FG000|Treatment Period|Protocol deviation|0|||
156823285|NCT02684058|566102784|FG001|Treatment Period|Protocol deviation|1|||
156823286|NCT02684058|566102785|FG002|Treatment Period|Protocol deviation|0|||
156823287|NCT02684058|566102783|FG000|Treatment Period|Subject/guardian decision|4|||
156823288|NCT02684058|566102784|FG001|Treatment Period|Subject/guardian decision|3|||
156823289|NCT02684058|566102785|FG002|Treatment Period|Subject/guardian decision|0|||
156823290|NCT02684058|566102783|FG000|Treatment Period|Death|0|||
156823291|NCT02684058|566102784|FG001|Treatment Period|Death|0|||
156823292|NCT02684058|566102785|FG002|Treatment Period|Death|2|||
156823293|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156823294|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156823295|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156823296|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
156823297|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156823298|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
156823299|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156823300|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156823301|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156823302|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156823303|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|Death|0|||
156823304|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|Death|3|||
156823305|NCT02684058|566102783|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
156823306|NCT02684058|566102784|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
156823307|NCT02684058|566102785|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
156823308|NCT02684058|566102783|FG000|Post-treatment Survival Follow-up|Death|0|||
156823309|NCT02684058|566102784|FG001|Post-treatment Survival Follow-up|Death|0|||
156823310|NCT02684058|566102785|FG002|Post-treatment Survival Follow-up|Death|7|||
156823311|NCT02684058|566102783|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
156823312|NCT02684058|566102784|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
156823313|NCT02684058|566102785|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
156823314|NCT02684058|566102783|FG000|Crossover Treatment Period|Progressive disease|0|||
156823315|NCT02684058|566102784|FG001|Crossover Treatment Period|Progressive disease|1|||
156823316|NCT02684058|566102785|FG002|Crossover Treatment Period|Progressive disease|0|||
156823317|NCT03219034|566102786|FG000|Overall Study|Lost to Follow-up|9|||
156823318|NCT03219034|566102787|FG001|Overall Study|Lost to Follow-up|13|||
156823319|NCT03219034|566102786|FG000|Overall Study|Additional dental work needed|1|||
156823320|NCT03219034|566102787|FG001|Overall Study|Additional dental work needed|0|||
156823321|NCT03219034|566102786|FG000|Overall Study|UPPP Surgery|1|||
156823322|NCT03219034|566102787|FG001|Overall Study|UPPP Surgery|0|||
156823323|NCT03219034|566102786|FG000|Overall Study|Dental sensitivity|0|||
156884629|NCT04585009|566336317|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
156884630|NCT04585009|566336306|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
156884631|NCT04585009|566336307|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
157150922|NCT02116972|567298136|FG002|Overall Study|Lost to Follow-up|1|||
156823324|NCT03219034|566102787|FG001|Overall Study|Dental sensitivity|1|||
156823325|NCT03219034|566102786|FG000|Overall Study|Death in family|0|||
156823326|NCT03219034|566102787|FG001|Overall Study|Death in family|1|||
156823327|NCT01802580|566102788|FG000|Overall Study|Physician Decision|1|||
156823328|NCT01802580|566102789|FG001|Overall Study|Physician Decision|0|||
157150923|NCT02116972|567298134|FG000|Overall Study|Lack of Efficacy|6|||
156823329|NCT01802580|566102788|FG000|Overall Study|Protocol Violation|2|||
156823330|NCT01802580|566102789|FG001|Overall Study|Protocol Violation|0|||
156823331|NCT01802580|566102788|FG000|Overall Study|Withdrawal by Subject|5|||
156823332|NCT01802580|566102789|FG001|Overall Study|Withdrawal by Subject|6|||
156823333|NCT01802580|566102788|FG000|Overall Study|Other|1|||
156823334|NCT01802580|566102789|FG001|Overall Study|Other|3|||
156823335|NCT01802580|566102788|FG000|Overall Study|Lack of Efficacy|0|||
156823336|NCT01802580|566102789|FG001|Overall Study|Lack of Efficacy|2|||
156823337|NCT01327053|566102792|FG000|Overall Study|Adverse Event|23|||
156823338|NCT01327053|566102793|FG001|Overall Study|Adverse Event|57|||
156823339|NCT01327053|566102792|FG000|Overall Study|Patient/guardian decision|11|||
156823340|NCT01327053|566102793|FG001|Overall Study|Patient/guardian decision|35|||
156823341|NCT01327053|566102792|FG000|Overall Study|Physician Decision|10|||
156823342|NCT01327053|566102793|FG001|Overall Study|Physician Decision|14|||
156823343|NCT01327053|566102792|FG000|Overall Study|Death|1|||
156823344|NCT01327053|566102793|FG001|Overall Study|Death|5|||
156823345|NCT01327053|566102792|FG000|Overall Study|Lost to Follow-up|2|||
156823346|NCT01327053|566102793|FG001|Overall Study|Lost to Follow-up|4|||
156823347|NCT01327053|566102792|FG000|Overall Study|Non-compliance with study treatment|0|||
156823348|NCT01327053|566102793|FG001|Overall Study|Non-compliance with study treatment|5|||
156823349|NCT01327053|566102792|FG000|Overall Study|Study terminated by Sponsor|1|||
156823350|NCT01327053|566102793|FG001|Overall Study|Study terminated by Sponsor|3|||
156823351|NCT01327053|566102792|FG000|Overall Study|Progressive disease|31|||
156823352|NCT01327053|566102793|FG001|Overall Study|Progressive disease|26|||
156823353|NCT01327053|566102792|FG000|Overall Study|Protocol Violation|0|||
156823354|NCT01327053|566102793|FG001|Overall Study|Protocol Violation|1|||
156823355|NCT01327053|566102792|FG000|Overall Study|Untreated|0|||
156823356|NCT01327053|566102793|FG001|Overall Study|Untreated|1|||
156823357|NCT00721578|566102799|FG000|Overall Study|Death|1|||
156823358|NCT00721578|566102800|FG001|Overall Study|Death|1|||
156823359|NCT00721578|566102799|FG000|Overall Study|Withdrawal by Subject|1|||
156823360|NCT00721578|566102800|FG001|Overall Study|Withdrawal by Subject|1|||
156823361|NCT04621240|566102801|FG000|Overall Study|Withdrawal by Subject|36|||
156823362|NCT00211757|566102804|FG000|Overall Study|Withdrawal by Subject|1|||
156823363|NCT00211757|566102805|FG001|Overall Study|Withdrawal by Subject|1|||
156884632|NCT04585009|566336308|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884633|NCT04585009|566336309|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884634|NCT04585009|566336310|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884635|NCT04585009|566336311|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884636|NCT04585009|566336312|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884637|NCT04585009|566336313|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884638|NCT04585009|566336314|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884639|NCT04585009|566336315|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884640|NCT04585009|566336316|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884641|NCT04585009|566336317|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
156884642|NCT04585009|566336306|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884643|NCT04585009|566336307|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884644|NCT04585009|566336308|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884645|NCT04585009|566336309|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884646|NCT04585009|566336310|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884647|NCT04585009|566336311|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884648|NCT04585009|566336312|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884649|NCT04585009|566336313|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
157150924|NCT02116972|567298135|FG001|Overall Study|Lack of Efficacy|6|||
157150925|NCT02116972|567298136|FG002|Overall Study|Lack of Efficacy|5|||
157150926|NCT02116972|567298134|FG000|Overall Study|scheduling conflicts and relocation|3|||
156823364|NCT00211757|566102804|FG000|Overall Study|Lack of Efficacy|0|||
156823365|NCT00211757|566102805|FG001|Overall Study|Lack of Efficacy|1|||
156823366|NCT01457014|566102808|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
156823367|NCT01457014|566102809|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823368|NCT01457014|566102810|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823369|NCT01457014|566102811|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
156823370|NCT01457014|566102808|FG000|First Night|Withdrawal by Subject|3|||
157150927|NCT02116972|567298135|FG001|Overall Study|scheduling conflicts and relocation|3|||
157150928|NCT02116972|567298136|FG002|Overall Study|scheduling conflicts and relocation|6|||
157150929|NCT00784784|567298137|FG000|Overall Study|Withdrawal by Subject|2|||
156823371|NCT01457014|566102809|FG001|First Night|Withdrawal by Subject|0|||
156823372|NCT01457014|566102810|FG002|First Night|Withdrawal by Subject|0|||
157150930|NCT00784784|567298138|FG001|Overall Study|Withdrawal by Subject|2|||
157150931|NCT00872898|567298141|FG000|Part Two - Double Blind|Adverse Event|4|||
157150932|NCT00872898|567298142|FG001|Part Two - Double Blind|Adverse Event|3|||
156823373|NCT01457014|566102811|FG003|First Night|Withdrawal by Subject|0|||
156823374|NCT03319953|566102812|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
156823375|NCT03319953|566102813|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823376|NCT03319953|566102814|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823377|NCT03319953|566102815|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
156823378|NCT03319953|566102812|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
156823379|NCT03319953|566102813|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
156823380|NCT03319953|566102814|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
156823381|NCT03319953|566102815|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
156823382|NCT02264665|566104627|FG000|Overall Study|Other|0|||
156823383|NCT02264665|566104628|FG001|Overall Study|Other|0|||
156823384|NCT02264665|566104629|FG002|Overall Study|Other|3|||
156823385|NCT02264665|566104630|FG003|Overall Study|Other|0|||
156823386|NCT02264665|566104631|FG004|Overall Study|Other|0|||
156823387|NCT02264665|566104632|FG005|Overall Study|Other|0|||
156823388|NCT02264665|566104633|FG006|Overall Study|Other|0|||
156823389|NCT02264665|566104627|FG000|Overall Study|Death|9|||
156823390|NCT02264665|566104628|FG001|Overall Study|Death|8|||
156823391|NCT02264665|566104629|FG002|Overall Study|Death|13|||
156823392|NCT02264665|566104630|FG003|Overall Study|Death|5|||
156823393|NCT02264665|566104631|FG004|Overall Study|Death|0|||
156823394|NCT02264665|566104632|FG005|Overall Study|Death|0|||
156823395|NCT02264665|566104633|FG006|Overall Study|Death|1|||
156823396|NCT02264665|566104627|FG000|Overall Study|Lost to Follow-up|1|||
156823397|NCT02264665|566104628|FG001|Overall Study|Lost to Follow-up|0|||
156823398|NCT02264665|566104629|FG002|Overall Study|Lost to Follow-up|2|||
156823399|NCT02264665|566104630|FG003|Overall Study|Lost to Follow-up|1|||
156823400|NCT02264665|566104631|FG004|Overall Study|Lost to Follow-up|0|||
156823401|NCT02264665|566104632|FG005|Overall Study|Lost to Follow-up|0|||
156823402|NCT02264665|566104633|FG006|Overall Study|Lost to Follow-up|0|||
156823403|NCT02264665|566104627|FG000|Overall Study|Participant decision|0|||
156823404|NCT02264665|566104628|FG001|Overall Study|Participant decision|0|||
156823405|NCT02264665|566104629|FG002|Overall Study|Participant decision|0|||
156823406|NCT02264665|566104630|FG003|Overall Study|Participant decision|1|||
156823407|NCT02264665|566104631|FG004|Overall Study|Participant decision|0|||
156823408|NCT02264665|566104632|FG005|Overall Study|Participant decision|0|||
156823409|NCT02264665|566104633|FG006|Overall Study|Participant decision|0|||
156823410|NCT02264665|566104627|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
156823411|NCT02264665|566104628|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823412|NCT02264665|566104629|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823413|NCT02264665|566104630|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823414|NCT02264665|566104631|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823415|NCT02264665|566104632|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
156823416|NCT02264665|566104633|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
156823417|NCT02264665|566104627|FG000|Overall Study|Data Missing|0|||
156823418|NCT02264665|566104628|FG001|Overall Study|Data Missing|0|||
156823419|NCT02264665|566104629|FG002|Overall Study|Data Missing|1|||
156823420|NCT02264665|566104630|FG003|Overall Study|Data Missing|0|||
156823421|NCT02264665|566104631|FG004|Overall Study|Data Missing|0|||
156823422|NCT02264665|566104632|FG005|Overall Study|Data Missing|0|||
156823423|NCT02264665|566104633|FG006|Overall Study|Data Missing|0|||
156823424|NCT00789581|566104634|FG000|AC Therapy|Adverse Event|2|||
157150933|NCT00872898|567298141|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
157150934|NCT00872898|567298142|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
157150935|NCT00872898|567298141|FG000|Part Two - Double Blind|Protocol Violation|1|||
157150936|NCT00872898|567298142|FG001|Part Two - Double Blind|Protocol Violation|0|||
157150937|NCT00872898|567298141|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
157150938|NCT00872898|567298142|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
157150939|NCT00872898|567298141|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
157150940|NCT00872898|567298142|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
157150941|NCT00872898|567298141|FG000|Part Two - Double Blind|Other reasons|2|||
157150942|NCT00872898|567298142|FG001|Part Two - Double Blind|Other reasons|0|||
157150943|NCT00863928|567298144|FG000|Overall Study|Protocol Violation|26|||
157150944|NCT00863928|567298145|FG001|Overall Study|Protocol Violation|0|||
157150945|NCT00863928|567298144|FG000|Overall Study|Withdrawal by Subject|3|||
157150946|NCT00863928|567298145|FG001|Overall Study|Withdrawal by Subject|0|||
157224465|NCT03679741|567567996|FG000|Period 2|Withdrawal by Subject|1|||
157224466|NCT03679741|567567997|FG001|Period 2|Withdrawal by Subject|1|||
156823425|NCT00789581|566104635|FG001|AC Therapy|Adverse Event|3|||
156823426|NCT00789581|566104634|FG000|AC Therapy|Withdrawal by Subject|4|||
156823427|NCT00789581|566104635|FG001|AC Therapy|Withdrawal by Subject|7|||
157150947|NCT00863928|567298144|FG000|Overall Study|surgery cancellation|4|||
157150948|NCT00863928|567298145|FG001|Overall Study|surgery cancellation|0|||
157150949|NCT00863928|567298144|FG000|Overall Study|medication allergy|3|||
156823428|NCT00789581|566104634|FG000|AC Therapy|Disease recurrence|3|||
156823429|NCT00789581|566104635|FG001|AC Therapy|Disease recurrence|1|||
156823430|NCT00789581|566104634|FG000|AC Therapy|Intercurrent Illness|1|||
156823431|NCT00789581|566104635|FG001|AC Therapy|Intercurrent Illness|0|||
156823432|NCT00789581|566104634|FG000|AC Therapy|Never Treated|1|||
156823433|NCT00789581|566104635|FG001|AC Therapy|Never Treated|4|||
156823434|NCT00789581|566104634|FG000|AC Therapy|Other|0|||
156823435|NCT00789581|566104635|FG001|AC Therapy|Other|2|||
156823436|NCT00789581|566104634|FG000|Adjuvant Therapy|Never treated|2|||
156823437|NCT00789581|566104635|FG001|Adjuvant Therapy|Never treated|2|||
156823438|NCT00789581|566104634|FG000|Adjuvant Therapy|Adverse Event|20|||
156823439|NCT00789581|566104635|FG001|Adjuvant Therapy|Adverse Event|44|||
156823440|NCT00789581|566104634|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
156823441|NCT00789581|566104635|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
156823442|NCT00789581|566104634|FG000|Adjuvant Therapy|Disease recurrence|2|||
156823443|NCT00789581|566104635|FG001|Adjuvant Therapy|Disease recurrence|1|||
156823444|NCT00789581|566104634|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
156823445|NCT00789581|566104635|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
156823446|NCT00789581|566104634|FG000|Adjuvant Therapy|Protocol Violation|1|||
156823447|NCT00789581|566104635|FG001|Adjuvant Therapy|Protocol Violation|1|||
156823448|NCT00789581|566104634|FG000|Adjuvant Therapy|Other|0|||
156823449|NCT00789581|566104635|FG001|Adjuvant Therapy|Other|1|||
156823450|NCT03392883|566104636|FG000|Overall Study|Lost to Follow-up|122|||
156823451|NCT03392883|566104637|FG001|Overall Study|Lost to Follow-up|13|||
156823452|NCT03392883|566104638|FG002|Overall Study|Lost to Follow-up|9|||
156823453|NCT03392883|566104636|FG000|Overall Study|Death|4|||
156823454|NCT03392883|566104637|FG001|Overall Study|Death|0|||
156823455|NCT03392883|566104638|FG002|Overall Study|Death|0|||
156823456|NCT03392883|566104636|FG000|Overall Study|Lack of Efficacy|29|||
156823457|NCT03392883|566104637|FG001|Overall Study|Lack of Efficacy|0|||
156823458|NCT03392883|566104638|FG002|Overall Study|Lack of Efficacy|0|||
156823459|NCT03392883|566104636|FG000|Overall Study|Withdrawal by Subject|180|||
156823460|NCT03392883|566104637|FG001|Overall Study|Withdrawal by Subject|0|||
156823461|NCT03392883|566104638|FG002|Overall Study|Withdrawal by Subject|0|||
156823462|NCT03392883|566104636|FG000|Overall Study|Adverse Event|1|||
156823463|NCT03392883|566104637|FG001|Overall Study|Adverse Event|0|||
156823464|NCT03392883|566104638|FG002|Overall Study|Adverse Event|0|||
156823465|NCT00908115|566104643|FG000|Overall Study|Other|14|||
156823466|NCT01498575|566104646|FG000|Overall Sample|Withdrawal by Subject|60|||
156823467|NCT01498575|566104647|FG001|Overall Sample|Withdrawal by Subject|14|||
156823468|NCT01498575|566104646|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
156823469|NCT01498575|566104647|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
156823470|NCT01498575|566104646|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
157150950|NCT00863928|567298145|FG001|Overall Study|medication allergy|0|||
157150951|NCT02795156|567298147|FG000|Overall Study|Progressive Disease|22|||
157150952|NCT02795156|567298148|FG001|Overall Study|Progressive Disease|7|||
157150953|NCT02795156|567298149|FG002|Overall Study|Progressive Disease|34|||
157150954|NCT02795156|567298150|FG003|Overall Study|Progressive Disease|7|||
157150955|NCT02795156|567298147|FG000|Overall Study|Adverse Event|13|||
157150956|NCT02795156|567298148|FG001|Overall Study|Adverse Event|2|||
157150957|NCT02795156|567298149|FG002|Overall Study|Adverse Event|3|||
157150958|NCT02795156|567298150|FG003|Overall Study|Adverse Event|2|||
157150959|NCT02795156|567298147|FG000|Overall Study|Death|1|||
157150960|NCT02795156|567298148|FG001|Overall Study|Death|1|||
157150961|NCT02795156|567298149|FG002|Overall Study|Death|1|||
157150962|NCT02795156|567298150|FG003|Overall Study|Death|0|||
157150963|NCT02795156|567298147|FG000|Overall Study|Physician Decision|1|||
157150964|NCT02795156|567298148|FG001|Overall Study|Physician Decision|0|||
157150965|NCT02795156|567298149|FG002|Overall Study|Physician Decision|1|||
157150966|NCT02795156|567298150|FG003|Overall Study|Physician Decision|0|||
157150967|NCT02795156|567298147|FG000|Overall Study|Withdrawal by Subject|2|||
157150968|NCT02795156|567298148|FG001|Overall Study|Withdrawal by Subject|0|||
157150969|NCT02795156|567298149|FG002|Overall Study|Withdrawal by Subject|3|||
157150970|NCT02795156|567298150|FG003|Overall Study|Withdrawal by Subject|0|||
156823471|NCT01498575|566104647|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
156823472|NCT00847665|566104649|FG000|Overall Study|Withdrawal by Subject|1|||
157150971|NCT00734929|567298154|FG000|Overall Study|Lost to Follow-up|1|||
157150972|NCT00734929|567298155|FG001|Overall Study|Lost to Follow-up|2|||
157150973|NCT00734929|567298154|FG000|Overall Study|No intervention/ screen fail|5|||
157150974|NCT00734929|567298155|FG001|Overall Study|No intervention/ screen fail|3|||
157150975|NCT02961764|567298159|FG000|Overall Study|Protocol Violation|0|||
157150976|NCT02961764|567298160|FG001|Overall Study|Protocol Violation|1|||
156823473|NCT00847665|566104650|FG001|Overall Study|Withdrawal by Subject|0|||
156823474|NCT00585546|566104657|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
156823475|NCT00585546|566104657|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
156823476|NCT02851797|566104658|FG000|Overall Study|Withdrawal by Subject|4|||
156823477|NCT02851797|566104659|FG001|Overall Study|Withdrawal by Subject|2|||
156823478|NCT02851797|566104658|FG000|Overall Study|Adverse Event|3|||
157150977|NCT02961764|567298159|FG000|Overall Study|Death|2|||
157150978|NCT02961764|567298160|FG001|Overall Study|Death|0|||
157150979|NCT02961764|567298159|FG000|Overall Study|Lost to Follow-up|35|||
157150980|NCT02961764|567298160|FG001|Overall Study|Lost to Follow-up|24|||
157150981|NCT02961764|567298159|FG000|Overall Study|Withdrawal by Subject|2|||
157150982|NCT02961764|567298160|FG001|Overall Study|Withdrawal by Subject|0|||
156823479|NCT02851797|566104659|FG001|Overall Study|Adverse Event|0|||
156823480|NCT03077438|566104660|FG000|Overall Study|Protocol Violation|3|||
156823481|NCT03077438|566104661|FG001|Overall Study|Protocol Violation|5|||
156823482|NCT03077438|566104660|FG000|Overall Study|Withdrawal by Subject|3|||
156823483|NCT03077438|566104661|FG001|Overall Study|Withdrawal by Subject|6|||
156823484|NCT03077438|566104660|FG000|Overall Study|Lost to Follow-up|6|||
156823485|NCT03077438|566104661|FG001|Overall Study|Lost to Follow-up|3|||
156823486|NCT00813865|566104662|FG000|Overall Study|Failure to Respond|3|||
156823487|NCT00813865|566104662|FG000|Overall Study|Lost to Follow-up|3|||
156823488|NCT00813865|566104662|FG000|Overall Study|Withdrawal by Subject|1|||
156823489|NCT04295681|566104672|FG000|Overall Study|Eligibility error|1|||
156823490|NCT04295681|566104673|FG001|Overall Study|Eligibility error|3|||
156823491|NCT00939029|566104674|FG000|Overall Study|Withdrawal by Subject|3|||
156823492|NCT00939029|566104675|FG001|Overall Study|Withdrawal by Subject|7|||
156823493|NCT00939029|566104674|FG000|Overall Study|Lost to Follow-up|3|||
156823494|NCT00939029|566104675|FG001|Overall Study|Lost to Follow-up|4|||
156823495|NCT00939029|566104674|FG000|Overall Study|Adverse Event|0|||
156823496|NCT00939029|566104675|FG001|Overall Study|Adverse Event|1|||
156823497|NCT04686084|566104677|FG000|Overall Study|Lost to Follow-up|1|||
156823498|NCT01535599|566104678|FG000|Overall Study|Adverse Event|6|||
156823499|NCT01535599|566104679|FG001|Overall Study|Adverse Event|15|||
156823500|NCT01535599|566104678|FG000|Overall Study|Lost to Follow-up|3|||
156823501|NCT01535599|566104679|FG001|Overall Study|Lost to Follow-up|4|||
156823502|NCT01535599|566104678|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
156823503|NCT01535599|566104679|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
156823504|NCT01535599|566104678|FG000|Overall Study|Treatment Failure|33|||
156823505|NCT01535599|566104679|FG001|Overall Study|Treatment Failure|66|||
156823506|NCT01535599|566104678|FG000|Overall Study|BL Culture + for Group A Strep|0|||
156823507|NCT01535599|566104679|FG001|Overall Study|BL Culture + for Group A Strep|1|||
156823508|NCT01535599|566104678|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
156823509|NCT01535599|566104679|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
156823510|NCT01535599|566104678|FG000|Overall Study|Randomized in Error|2|||
156823511|NCT01535599|566104679|FG001|Overall Study|Randomized in Error|4|||
156823512|NCT01535599|566104678|FG000|Overall Study|Did not use product|1|||
156823513|NCT01535599|566104679|FG001|Overall Study|Did not use product|0|||
156823514|NCT01535599|566104678|FG000|Overall Study|Other|1|||
156823515|NCT01535599|566104679|FG001|Overall Study|Other|0|||
156823516|NCT01535599|566104678|FG000|Overall Study|Stopped medication|0|||
156823517|NCT01535599|566104679|FG001|Overall Study|Stopped medication|1|||
156823518|NCT01535599|566104678|FG000|Overall Study|Noncompliance|0|||
156823519|NCT01535599|566104679|FG001|Overall Study|Noncompliance|1|||
156823520|NCT03172325|566104683|FG000|Overall Study|Adverse Event|2|||
156823521|NCT03172325|566104684|FG001|Overall Study|Adverse Event|3|||
156823522|NCT03172325|566104683|FG000|Overall Study|Positive PPD|1|||
156823523|NCT03172325|566104684|FG001|Overall Study|Positive PPD|0|||
156823524|NCT03172325|566104683|FG000|Overall Study|Poor Compliance|1|||
156823525|NCT03172325|566104684|FG001|Overall Study|Poor Compliance|1|||
156823526|NCT03622112|566104700|FG000|Overall Study|Withdrawal by Subject|6|||
156823527|NCT03622112|566104701|FG001|Overall Study|Withdrawal by Subject|2|||
156823528|NCT03622112|566104702|FG002|Overall Study|Withdrawal by Subject|4|||
156823529|NCT03622112|566104703|FG003|Overall Study|Withdrawal by Subject|2|||
156823530|NCT03622112|566104704|FG004|Overall Study|Withdrawal by Subject|1|||
156823531|NCT03622112|566104705|FG005|Overall Study|Withdrawal by Subject|2|||
156823532|NCT03622112|566104706|FG006|Overall Study|Withdrawal by Subject|2|||
156823533|NCT03622112|566104700|FG000|Overall Study|Death|0|||
156823534|NCT03622112|566104701|FG001|Overall Study|Death|0|||
157022773|NCT03366649|566836855|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
157150983|NCT01903434|567298168|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
157150984|NCT01903434|567298169|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
157150985|NCT01903434|567298168|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
157150986|NCT01903434|567298169|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
157150987|NCT01507246|567298170|FG000|Overall Study|Required different surgical procedures|2|||
157150988|NCT01507246|567298171|FG001|Overall Study|Required different surgical procedures|1|||
156823535|NCT03622112|566104702|FG002|Overall Study|Death|0|||
157150989|NCT03103750|567298172|FG000|Overall Study|Adverse Event|1|||
156823536|NCT03622112|566104703|FG003|Overall Study|Death|1|||
156823537|NCT03622112|566104704|FG004|Overall Study|Death|0|||
156823538|NCT03622112|566104705|FG005|Overall Study|Death|0|||
156823539|NCT03622112|566104706|FG006|Overall Study|Death|0|||
156823540|NCT03622112|566104700|FG000|Overall Study|Lost to Follow-up|1|||
156823541|NCT03622112|566104701|FG001|Overall Study|Lost to Follow-up|1|||
156823542|NCT03622112|566104702|FG002|Overall Study|Lost to Follow-up|0|||
156823543|NCT03622112|566104703|FG003|Overall Study|Lost to Follow-up|0|||
156823544|NCT03622112|566104704|FG004|Overall Study|Lost to Follow-up|0|||
156823545|NCT03622112|566104705|FG005|Overall Study|Lost to Follow-up|0|||
156823546|NCT03622112|566104706|FG006|Overall Study|Lost to Follow-up|0|||
157150990|NCT03103750|567298173|FG001|Overall Study|Adverse Event|0|||
157150991|NCT03103750|567298172|FG000|Overall Study|Lost to Follow-up|1|||
156823547|NCT03622112|566104700|FG000|Overall Study|Study-specific withdrawal criteria|10|||
156823548|NCT03622112|566104701|FG001|Overall Study|Study-specific withdrawal criteria|8|||
156823549|NCT03622112|566104702|FG002|Overall Study|Study-specific withdrawal criteria|7|||
156823550|NCT03622112|566104703|FG003|Overall Study|Study-specific withdrawal criteria|6|||
156823551|NCT03622112|566104704|FG004|Overall Study|Study-specific withdrawal criteria|4|||
156823552|NCT03622112|566104705|FG005|Overall Study|Study-specific withdrawal criteria|18|||
156823553|NCT03622112|566104706|FG006|Overall Study|Study-specific withdrawal criteria|4|||
156823554|NCT03622112|566104700|FG000|Overall Study|Protocol Violation|2|||
156823555|NCT03622112|566104701|FG001|Overall Study|Protocol Violation|0|||
156823556|NCT03622112|566104702|FG002|Overall Study|Protocol Violation|1|||
156823557|NCT03622112|566104703|FG003|Overall Study|Protocol Violation|1|||
156823558|NCT03622112|566104704|FG004|Overall Study|Protocol Violation|0|||
156823559|NCT03622112|566104705|FG005|Overall Study|Protocol Violation|0|||
156823560|NCT03622112|566104706|FG006|Overall Study|Protocol Violation|0|||
156823561|NCT03622112|566104700|FG000|Overall Study|Adverse Event|6|||
156823562|NCT03622112|566104701|FG001|Overall Study|Adverse Event|8|||
156823563|NCT03622112|566104702|FG002|Overall Study|Adverse Event|4|||
156823564|NCT03622112|566104703|FG003|Overall Study|Adverse Event|11|||
156823565|NCT03622112|566104704|FG004|Overall Study|Adverse Event|4|||
156823566|NCT03622112|566104705|FG005|Overall Study|Adverse Event|20|||
156823567|NCT03622112|566104706|FG006|Overall Study|Adverse Event|2|||
156823568|NCT03622112|566104700|FG000|Overall Study|Reason not specified|0|||
156823569|NCT03622112|566104701|FG001|Overall Study|Reason not specified|1|||
156823570|NCT03622112|566104702|FG002|Overall Study|Reason not specified|0|||
156823571|NCT03622112|566104703|FG003|Overall Study|Reason not specified|1|||
156823572|NCT03622112|566104704|FG004|Overall Study|Reason not specified|1|||
156823573|NCT03622112|566104705|FG005|Overall Study|Reason not specified|2|||
156823574|NCT03622112|566104706|FG006|Overall Study|Reason not specified|1|||
156823575|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
156823576|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
156823577|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
156823578|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
157091513|NCT01047293|567089128|FG003|Overall Study|DLT criteria not fulfilled|0|||
156823579|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
156823580|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
156823581|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
156823582|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
156823583|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
156823584|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
156823585|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Other|1|||
156823586|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Other|1|||
156823587|NCT02075047|566104710|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
156823588|NCT02075047|566104711|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
156823589|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
156823590|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
156823591|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
156823592|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
156823593|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
156823594|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
156823595|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
156823596|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
156823597|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
156823598|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
156823599|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Other|1|||
156823600|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Other|2|||
156823601|NCT02075047|566104710|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
156823602|NCT02075047|566104711|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
156823603|NCT03305419|566104712|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823604|NCT03305419|566104713|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
156823605|NCT03305419|566104714|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823606|NCT03305419|566104715|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823607|NCT03305419|566104716|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823608|NCT03305419|566104717|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823609|NCT03305419|566104718|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
157091514|NCT00757783|567089129|FG000|Overall Study|Adverse Event|0|||
157091515|NCT00757783|567089130|FG001|Overall Study|Adverse Event|2|||
157091516|NCT00757783|567089129|FG000|Overall Study|Lost to Follow-up|1|||
157091517|NCT00757783|567089130|FG001|Overall Study|Lost to Follow-up|1|||
157091518|NCT00757783|567089129|FG000|Overall Study|Protocol Violation|1|||
157091519|NCT00757783|567089130|FG001|Overall Study|Protocol Violation|0|||
157091520|NCT00757783|567089129|FG000|Overall Study|Withdrawal by Subject|2|||
157091521|NCT00757783|567089130|FG001|Overall Study|Withdrawal by Subject|1|||
157091522|NCT00757783|567089129|FG000|Overall Study|Other|1|||
156823610|NCT03305419|566104719|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
156823611|NCT03305419|566104712|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
156823612|NCT03305419|566104713|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823613|NCT03305419|566104714|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823614|NCT03305419|566104715|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823615|NCT03305419|566104716|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823616|NCT03305419|566104717|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823617|NCT03305419|566104718|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823618|NCT03305419|566104719|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
156823619|NCT03305419|566104712|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
156823620|NCT03305419|566104713|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823621|NCT03305419|566104714|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823622|NCT03305419|566104715|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823623|NCT03305419|566104716|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823624|NCT03305419|566104717|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823625|NCT03305419|566104718|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823626|NCT03305419|566104719|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
156823627|NCT03305419|566104712|FG000|Part B (14 Days)|Adverse Event|0|||
156823628|NCT03305419|566104713|FG001|Part B (14 Days)|Adverse Event|0|||
156823629|NCT03305419|566104714|FG002|Part B (14 Days)|Adverse Event|0|||
156823630|NCT03305419|566104715|FG003|Part B (14 Days)|Adverse Event|0|||
156823631|NCT03305419|566104716|FG004|Part B (14 Days)|Adverse Event|1|||
156823632|NCT03305419|566104717|FG005|Part B (14 Days)|Adverse Event|2|||
156823633|NCT03305419|566104718|FG006|Part B (14 Days)|Adverse Event|4|||
156823634|NCT03305419|566104719|FG007|Part B (14 Days)|Adverse Event|0|||
156823635|NCT03305419|566104712|FG000|Part B (14 Days)|Physician Decision|0|||
156823636|NCT03305419|566104713|FG001|Part B (14 Days)|Physician Decision|0|||
156823637|NCT03305419|566104714|FG002|Part B (14 Days)|Physician Decision|0|||
156823638|NCT03305419|566104715|FG003|Part B (14 Days)|Physician Decision|0|||
156823639|NCT03305419|566104716|FG004|Part B (14 Days)|Physician Decision|2|||
156823640|NCT03305419|566104717|FG005|Part B (14 Days)|Physician Decision|8|||
156823641|NCT03305419|566104718|FG006|Part B (14 Days)|Physician Decision|1|||
156823642|NCT03305419|566104719|FG007|Part B (14 Days)|Physician Decision|0|||
156823643|NCT01155466|566104720|FG000|Overall Study|Adverse Event|13|||
156823644|NCT01155466|566104721|FG001|Overall Study|Adverse Event|15|||
156823645|NCT01155466|566104722|FG002|Overall Study|Adverse Event|6|||
156823646|NCT01155466|566104723|FG003|Overall Study|Adverse Event|17|||
156823647|NCT01155466|566104724|FG004|Overall Study|Adverse Event|18|||
156823648|NCT01155466|566104720|FG000|Overall Study|Lost to Follow-up|0|||
156823649|NCT01155466|566104721|FG001|Overall Study|Lost to Follow-up|0|||
156823650|NCT01155466|566104722|FG002|Overall Study|Lost to Follow-up|0|||
156823651|NCT01155466|566104723|FG003|Overall Study|Lost to Follow-up|0|||
156823652|NCT01155466|566104724|FG004|Overall Study|Lost to Follow-up|2|||
156823653|NCT01155466|566104720|FG000|Overall Study|Withdrawal by Subject|7|||
157150992|NCT03103750|567298173|FG001|Overall Study|Lost to Follow-up|0|||
157150993|NCT03103750|567298172|FG000|Overall Study|PET Equipment Related|2|||
157150994|NCT03103750|567298173|FG001|Overall Study|PET Equipment Related|2|||
157150995|NCT01663740|567298175|FG000|Overall Study|Lost to Follow-up|1|||
157150996|NCT01663740|567298176|FG001|Overall Study|Lost to Follow-up|4|||
157150997|NCT01663740|567298175|FG000|Overall Study|Other|9|||
157150998|NCT01663740|567298176|FG001|Overall Study|Other|2|||
157150999|NCT01663740|567298175|FG000|Overall Study|Inclusion/Exclusion not met|1|||
157151000|NCT01663740|567298176|FG001|Overall Study|Inclusion/Exclusion not met|0|||
157151001|NCT01663740|567298175|FG000|Overall Study|Death|0|||
157151002|NCT01663740|567298176|FG001|Overall Study|Death|1|||
157151003|NCT01663740|567298175|FG000|Overall Study|Withdrawal by Subject|2|||
157151004|NCT01663740|567298176|FG001|Overall Study|Withdrawal by Subject|1|||
157151005|NCT01663740|567298175|FG000|Overall Study|No end of study status|3|||
157151006|NCT01663740|567298176|FG001|Overall Study|No end of study status|0|||
157151007|NCT00404768|567298179|FG000|Part A and B|Withdrawn due to labor progression|1|||
157151008|NCT00404768|567298180|FG001|Part A and B|Withdrawn due to labor progression|0|||
157151009|NCT00404768|567298181|FG002|Part A and B|Withdrawn due to labor progression|0|||
157151010|NCT00404768|567298182|FG003|Part A and B|Withdrawn due to labor progression|0|||
156823654|NCT01155466|566104721|FG001|Overall Study|Withdrawal by Subject|5|||
156823655|NCT01155466|566104722|FG002|Overall Study|Withdrawal by Subject|9|||
156823656|NCT01155466|566104723|FG003|Overall Study|Withdrawal by Subject|4|||
156823657|NCT01155466|566104724|FG004|Overall Study|Withdrawal by Subject|4|||
156823658|NCT01155466|566104720|FG000|Overall Study|Protocol Violation|0|||
156823659|NCT01155466|566104721|FG001|Overall Study|Protocol Violation|0|||
156823660|NCT01155466|566104722|FG002|Overall Study|Protocol Violation|2|||
157151011|NCT00404768|567298179|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
157151012|NCT00404768|567298180|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
157151013|NCT00404768|567298181|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
157151014|NCT00404768|567298182|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
156823661|NCT01155466|566104723|FG003|Overall Study|Protocol Violation|0|||
156823662|NCT01155466|566104724|FG004|Overall Study|Protocol Violation|1|||
156823663|NCT01155466|566104720|FG000|Overall Study|Administrative|0|||
156823664|NCT01155466|566104721|FG001|Overall Study|Administrative|3|||
156823665|NCT01155466|566104722|FG002|Overall Study|Administrative|0|||
156823666|NCT01155466|566104723|FG003|Overall Study|Administrative|0|||
156823667|NCT01155466|566104724|FG004|Overall Study|Administrative|0|||
156823668|NCT01155466|566104720|FG000|Overall Study|Randomized not treated|2|||
156823669|NCT01155466|566104721|FG001|Overall Study|Randomized not treated|2|||
156823670|NCT01155466|566104722|FG002|Overall Study|Randomized not treated|3|||
156823671|NCT01155466|566104723|FG003|Overall Study|Randomized not treated|0|||
156823672|NCT01155466|566104724|FG004|Overall Study|Randomized not treated|2|||
156823673|NCT01229254|566104731|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
156823674|NCT01229254|566104732|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
156823675|NCT01229254|566104733|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
156823676|NCT01229254|566104731|FG000|Overall Study|Adverse Event|4|||
156823677|NCT01229254|566104732|FG001|Overall Study|Adverse Event|5|||
156823678|NCT01229254|566104733|FG002|Overall Study|Adverse Event|3|||
156823679|NCT01229254|566104731|FG000|Overall Study|Lost to Follow-up|3|||
156823680|NCT01229254|566104732|FG001|Overall Study|Lost to Follow-up|0|||
156823681|NCT01229254|566104733|FG002|Overall Study|Lost to Follow-up|1|||
156823682|NCT01229254|566104731|FG000|Overall Study|Physician Decision|0|||
156823683|NCT01229254|566104732|FG001|Overall Study|Physician Decision|3|||
156823684|NCT01229254|566104733|FG002|Overall Study|Physician Decision|0|||
156823685|NCT01229254|566104731|FG000|Overall Study|Protocol Violation|4|||
156823686|NCT01229254|566104732|FG001|Overall Study|Protocol Violation|6|||
156823687|NCT01229254|566104733|FG002|Overall Study|Protocol Violation|5|||
156823688|NCT01229254|566104731|FG000|Overall Study|Withdrawal by Subject|1|||
156823689|NCT01229254|566104732|FG001|Overall Study|Withdrawal by Subject|0|||
156823690|NCT01229254|566104733|FG002|Overall Study|Withdrawal by Subject|1|||
156823691|NCT01229254|566104731|FG000|Overall Study|Non-compliance with Study Drug|0|||
156884650|NCT04585009|566336314|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884651|NCT04585009|566336315|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884652|NCT04585009|566336316|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884653|NCT04585009|566336317|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
156884654|NCT04585009|566336306|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884655|NCT04585009|566336307|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884656|NCT04585009|566336308|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884657|NCT04585009|566336309|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884658|NCT04585009|566336310|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
156884659|NCT04585009|566336311|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884660|NCT04585009|566336312|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884661|NCT04585009|566336313|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884662|NCT04585009|566336314|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884663|NCT04585009|566336315|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884664|NCT04585009|566336316|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884665|NCT04585009|566336317|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
156884666|NCT04585009|566336306|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884667|NCT04585009|566336307|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884668|NCT04585009|566336308|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884669|NCT04585009|566336309|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884670|NCT04585009|566336310|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884671|NCT04585009|566336311|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884672|NCT04585009|566336312|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884673|NCT04585009|566336313|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884674|NCT04585009|566336314|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884675|NCT04585009|566336315|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
156884676|NCT04585009|566336316|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
157151015|NCT00404768|567298179|FG000|Part C|Adverse Event|0|||
157151016|NCT00404768|567298180|FG001|Part C|Adverse Event|0|||
156884677|NCT04585009|566336317|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
156884678|NCT04585009|566336306|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
157151017|NCT00404768|567298181|FG002|Part C|Adverse Event|0|||
157151018|NCT00404768|567298182|FG003|Part C|Adverse Event|3|||
156823692|NCT01229254|566104732|FG001|Overall Study|Non-compliance with Study Drug|1|||
156823693|NCT01229254|566104733|FG002|Overall Study|Non-compliance with Study Drug|1|||
156823694|NCT02231892|566104734|FG000|Overall Study|Lost to Follow-up|1|||
157151019|NCT00404768|567298179|FG000|Part C|Lost to Follow-up|0|||
156823695|NCT02231892|566104735|FG001|Overall Study|Lost to Follow-up|0|||
156823696|NCT02231892|566104736|FG002|Overall Study|Lost to Follow-up|3|||
156823697|NCT02231892|566104734|FG000|Overall Study|Withdrawal by Subject|4|||
156823698|NCT02231892|566104735|FG001|Overall Study|Withdrawal by Subject|3|||
157151020|NCT00404768|567298180|FG001|Part C|Lost to Follow-up|0|||
157151021|NCT00404768|567298181|FG002|Part C|Lost to Follow-up|3|||
156823699|NCT02231892|566104736|FG002|Overall Study|Withdrawal by Subject|15|||
156823700|NCT02231892|566104734|FG000|Overall Study|Physician Decision|0|||
156823701|NCT02231892|566104735|FG001|Overall Study|Physician Decision|2|||
156823702|NCT02231892|566104736|FG002|Overall Study|Physician Decision|4|||
156823703|NCT02231892|566104734|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
156823704|NCT02231892|566104735|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
156823705|NCT02231892|566104736|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
156823706|NCT02231892|566104734|FG000|Overall Study|Participant motor threshold was >83%|0|||
156823707|NCT02231892|566104735|FG001|Overall Study|Participant motor threshold was >83%|0|||
156823708|NCT02231892|566104736|FG002|Overall Study|Participant motor threshold was >83%|9|||
156823709|NCT02231892|566104734|FG000|Overall Study|Could not find motor threshold|2|||
156823710|NCT02231892|566104735|FG001|Overall Study|Could not find motor threshold|0|||
156823711|NCT02231892|566104736|FG002|Overall Study|Could not find motor threshold|1|||
156823712|NCT02231892|566104734|FG000|Overall Study|Could not find reliable motor hotspot|0|||
156823713|NCT02231892|566104735|FG001|Overall Study|Could not find reliable motor hotspot|0|||
156823714|NCT02231892|566104736|FG002|Overall Study|Could not find reliable motor hotspot|1|||
156823715|NCT03832322|566104737|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
156823716|NCT03832322|566104738|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
156823717|NCT00744978|566104749|FG000|Period 1|Lost to Follow-up|1|||
156823718|NCT00744978|566104750|FG001|Period 1|Lost to Follow-up|0|||
156823719|NCT00744978|566104749|FG000|Period 1|Withdrawal by Subject|0|||
156823720|NCT00744978|566104750|FG001|Period 1|Withdrawal by Subject|2|||
156823721|NCT00744978|566104749|FG000|Period 1|Other|0|||
156823722|NCT00744978|566104750|FG001|Period 1|Other|2|||
156823723|NCT00744978|566104749|FG000|Period 1|Adverse Event|4|||
156823724|NCT00744978|566104750|FG001|Period 1|Adverse Event|0|||
156823725|NCT00744978|566104749|FG000|Period 1|Randomized but not Treated|1|||
156823726|NCT00744978|566104750|FG001|Period 1|Randomized but not Treated|1|||
156823727|NCT00744978|566104749|FG000|Period 2|Adverse Event|0|||
156823728|NCT00744978|566104750|FG001|Period 2|Adverse Event|1|||
156823729|NCT03773133|566104751|FG000|Overall Study|Screen Failure|8|||
156823730|NCT00515294|566104752|FG000|Overall Study|Lost to Follow-up|3|||
156823731|NCT00515294|566104753|FG001|Overall Study|Lost to Follow-up|2|||
156823732|NCT00515294|566104754|FG002|Overall Study|Lost to Follow-up|3|||
156823733|NCT00515294|566104755|FG003|Overall Study|Lost to Follow-up|1|||
156823734|NCT00515294|566104752|FG000|Overall Study|Driver simulator problems|1|||
156823735|NCT00515294|566104753|FG001|Overall Study|Driver simulator problems|1|||
156823736|NCT00515294|566104754|FG002|Overall Study|Driver simulator problems|1|||
156823737|NCT00515294|566104755|FG003|Overall Study|Driver simulator problems|3|||
156823738|NCT00515294|566104752|FG000|Overall Study|Caffeine amount inaccurate|5|||
156823739|NCT00515294|566104753|FG001|Overall Study|Caffeine amount inaccurate|0|||
156823740|NCT00515294|566104754|FG002|Overall Study|Caffeine amount inaccurate|7|||
156823741|NCT00515294|566104755|FG003|Overall Study|Caffeine amount inaccurate|0|||
156823742|NCT02778555|566104758|FG000|Overall Study|Withdrawal by Subject|55|||
156823743|NCT02778555|566104759|FG001|Overall Study|Withdrawal by Subject|32|||
156823744|NCT02778555|566104760|FG002|Overall Study|Withdrawal by Subject|107|||
156823745|NCT00107315|566104761|FG000|Overall Study|Disease Progression|9|||
156823746|NCT00107315|566104761|FG000|Overall Study|Adverse Event|4|||
156823747|NCT00107315|566104761|FG000|Overall Study|Withdrawal by Subject|2|||
156823748|NCT03276026|566104773|FG000|Overall Study|Protocol Violation|1|||
156823749|NCT03276026|566104774|FG001|Overall Study|Protocol Violation|0|||
156823750|NCT03650803|566104776|FG000|Overall Study|Lost to Follow-up|6|||
156823751|NCT01534260|566104777|FG000|Overall Study|Adverse Event|1|||
156823752|NCT01534260|566104778|FG001|Overall Study|Adverse Event|8|||
156823753|NCT01534260|566104777|FG000|Overall Study|Death|2|||
156823754|NCT01534260|566104778|FG001|Overall Study|Death|0|||
156823755|NCT01534260|566104777|FG000|Overall Study|Lack of Efficacy|1|||
156823756|NCT01534260|566104778|FG001|Overall Study|Lack of Efficacy|1|||
156823757|NCT01534260|566104777|FG000|Overall Study|Withdrawal by Subject|1|||
156823758|NCT01534260|566104778|FG001|Overall Study|Withdrawal by Subject|3|||
156823759|NCT01534260|566104777|FG000|Overall Study|Disease Progression|8|||
156823760|NCT01534260|566104778|FG001|Overall Study|Disease Progression|6|||
156823761|NCT01534260|566104777|FG000|Overall Study|Physician Decision|3|||
156823762|NCT01534260|566104778|FG001|Overall Study|Physician Decision|1|||
156823763|NCT01534260|566104777|FG000|Overall Study|No treatment, per protocol|0|||
156823764|NCT01534260|566104778|FG001|Overall Study|No treatment, per protocol|1|||
156823765|NCT02359045|566104779|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
156823766|NCT02359045|566104780|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156823767|NCT02359045|566104779|FG000|Overall Study|Lost to Follow-up|1|||
156823768|NCT02359045|566104780|FG001|Overall Study|Lost to Follow-up|1|||
156823769|NCT02359045|566104779|FG000|Overall Study|Adverse Event|0|||
156823770|NCT02359045|566104780|FG001|Overall Study|Adverse Event|1|||
156823771|NCT00367744|566104786|FG000|Overall Study|Lost to Follow-up|4|||
156823772|NCT00367744|566104787|FG001|Overall Study|Lost to Follow-up|5|||
157151022|NCT00404768|567298182|FG003|Part C|Lost to Follow-up|1|||
156823773|NCT00503581|566104790|FG000|Overall Study|Study closed|3|||
156823774|NCT00503581|566104791|FG001|Overall Study|Study closed|4|||
156823775|NCT00503581|566104792|FG002|Overall Study|Study closed|2|||
156823776|NCT01301066|566104794|FG000|Overall Study|Lost to Follow-up|5|||
156823777|NCT01301066|566104795|FG001|Overall Study|Lost to Follow-up|11|||
156823778|NCT01301066|566104794|FG000|Overall Study|Protocol Violation|8|||
156823779|NCT01301066|566104795|FG001|Overall Study|Protocol Violation|7|||
156823780|NCT01301066|566104794|FG000|Overall Study|Withdrawal by Subject|4|||
156823781|NCT01301066|566104795|FG001|Overall Study|Withdrawal by Subject|9|||
156823782|NCT01301066|566104794|FG000|Overall Study|Adverse Event|6|||
156823783|NCT01301066|566104795|FG001|Overall Study|Adverse Event|6|||
156823784|NCT01301066|566104794|FG000|Overall Study|Sponsor Decision|2|||
156823785|NCT01301066|566104795|FG001|Overall Study|Sponsor Decision|1|||
156823786|NCT01301066|566104794|FG000|Overall Study|Physician Decision|0|||
156823787|NCT01301066|566104795|FG001|Overall Study|Physician Decision|1|||
156823788|NCT01301066|566104794|FG000|Overall Study|Other|2|||
156823789|NCT01301066|566104795|FG001|Overall Study|Other|0|||
156823790|NCT02118766|566104800|FG000|Overall Study|Adverse Event|7|||
156823791|NCT02118766|566104801|FG001|Overall Study|Adverse Event|2|||
156823792|NCT02118766|566104800|FG000|Overall Study|Withdrawal by Subject|3|||
156823793|NCT02118766|566104801|FG001|Overall Study|Withdrawal by Subject|6|||
156823794|NCT02118766|566104800|FG000|Overall Study|Lost to Follow-up|5|||
156823795|NCT02118766|566104801|FG001|Overall Study|Lost to Follow-up|4|||
156823796|NCT02118766|566104800|FG000|Overall Study|Withdrawal by parent/guardian|12|||
156823797|NCT02118766|566104801|FG001|Overall Study|Withdrawal by parent/guardian|18|||
156823798|NCT02118766|566104800|FG000|Overall Study|Other|3|||
156823799|NCT02118766|566104801|FG001|Overall Study|Other|1|||
156823800|NCT02248649|566104804|FG000|Overall Study|Death|7|||
156823801|NCT02248649|566104805|FG001|Overall Study|Death|11|||
156823802|NCT02248649|566104804|FG000|Overall Study|Lost to Follow-up|14|||
156823803|NCT02248649|566104805|FG001|Overall Study|Lost to Follow-up|10|||
156823804|NCT02438683|566104806|FG000|Overall Study|Adverse Event|1|||
156823805|NCT02438683|566104807|FG001|Overall Study|Adverse Event|0|||
156823806|NCT02438683|566104808|FG002|Overall Study|Adverse Event|0|||
156884679|NCT04585009|566336307|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884680|NCT04585009|566336308|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884681|NCT04585009|566336309|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884682|NCT04585009|566336310|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884683|NCT04585009|566336311|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884684|NCT04585009|566336312|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884685|NCT04585009|566336313|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884686|NCT04585009|566336314|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884687|NCT04585009|566336315|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
156884688|NCT04585009|566336316|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
157151023|NCT00404768|567298179|FG000|Part C|Withdrawal by Subject|0|||
157151024|NCT00404768|567298180|FG001|Part C|Withdrawal by Subject|0|||
157151025|NCT00404768|567298181|FG002|Part C|Withdrawal by Subject|2|||
156823807|NCT02438683|566104809|FG003|Overall Study|Adverse Event|0|||
156823808|NCT02438683|566104810|FG004|Overall Study|Adverse Event|0|||
156823809|NCT02438683|566104811|FG005|Overall Study|Adverse Event|0|||
156823810|NCT02226198|566107180|FG000|Lead-in Phase|Protocol Violation|1|||
156823811|NCT02226198|566107181|FG001|Lead-in Phase|Protocol Violation|0|||
156823812|NCT02226198|566107182|FG002|Lead-in Phase|Protocol Violation|0|||
156823813|NCT02226198|566107180|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
156823814|NCT02226198|566107181|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
156823815|NCT02226198|566107182|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
156884689|NCT04585009|566336317|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
156884690|NCT01104376|566336318|FG000|Overall Study|Withdrawal by Subject|15|||
156884691|NCT01104376|566336318|FG000|Overall Study|Consented but excluded after labs|13|||
156884692|NCT01002820|566336326|FG000|Overall Study|Adverse Event|1|||
156884693|NCT01002820|566336326|FG000|Overall Study|Withdrawal by Subject|2|||
157151026|NCT00404768|567298182|FG003|Part C|Withdrawal by Subject|1|||
156884694|NCT01002820|566336326|FG000|Overall Study|Lack of Efficacy|1|||
156884695|NCT01673347|566336327|FG000|Overall Study|failure of allograft|7|||
156884696|NCT00895011|566336333|FG000|Overall Study|Withdrawal by Subject|14|||
156884697|NCT00895011|566336334|FG001|Overall Study|Withdrawal by Subject|7|||
156823816|NCT01440517|566107186|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
156823817|NCT01288612|566107187|FG000|Overall Study|Unable to contact|11|||
156823818|NCT01288612|566107188|FG001|Overall Study|Unable to contact|16|||
156823819|NCT01288612|566107189|FG002|Overall Study|Unable to contact|20|||
156823820|NCT01288612|566107187|FG000|Overall Study|Declined|78|||
156884698|NCT00895011|566336335|FG002|Overall Study|Withdrawal by Subject|2|||
156823821|NCT01288612|566107188|FG001|Overall Study|Declined|63|||
156884699|NCT00895011|566336333|FG000|Overall Study|Lost to Follow-up|5|||
157151027|NCT00404768|567298179|FG000|Part C|Early withdrawal from study medication|0|||
157151028|NCT00404768|567298180|FG001|Part C|Early withdrawal from study medication|0|||
157151029|NCT00404768|567298181|FG002|Part C|Early withdrawal from study medication|1|||
156823822|NCT01288612|566107189|FG002|Overall Study|Declined|62|||
156823823|NCT01288612|566107187|FG000|Overall Study|Unable to intubate|0|||
156823824|NCT01288612|566107188|FG001|Overall Study|Unable to intubate|3|||
156823825|NCT01288612|566107189|FG002|Overall Study|Unable to intubate|0|||
156823826|NCT00871923|566107190|FG000|Overall Study|Death|1|||
156823827|NCT00871923|566107190|FG000|Overall Study|Withdrawal by Subject|1|||
156823828|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
156823829|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
156823830|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
156823831|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
156823832|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
156823833|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
156823834|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
156823835|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
156823836|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
156823837|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
156823838|NCT01263015|566107195|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
156823839|NCT01263015|566107196|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
156823840|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
156823841|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
156823842|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
156823843|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
156823844|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
156823845|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
156823846|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
156823847|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
156823848|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
156823849|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
156823850|NCT01263015|566107195|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
156823851|NCT01263015|566107196|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
156823852|NCT05599451|566107197|FG000|Overall Study|Not randomized|11|||
156823853|NCT05599451|566107198|FG001|Overall Study|Not randomized|0|||
156823854|NCT05599451|566107199|FG002|Overall Study|Not randomized|0|||
156823855|NCT05599451|566107200|FG003|Overall Study|Not randomized|0|||
156823856|NCT05599451|566107201|FG004|Overall Study|Not randomized|0|||
156823857|NCT05599451|566107197|FG000|Overall Study|Physician Decision|0|||
156823858|NCT05599451|566107198|FG001|Overall Study|Physician Decision|0|||
156823859|NCT05599451|566107199|FG002|Overall Study|Physician Decision|0|||
156823860|NCT05599451|566107200|FG003|Overall Study|Physician Decision|1|||
156823861|NCT05599451|566107201|FG004|Overall Study|Physician Decision|0|||
156823862|NCT02723006|566107202|FG000|Overall Study|Withdrawal by Subject|0|||
156823863|NCT02723006|566107203|FG001|Overall Study|Withdrawal by Subject|1|||
156823864|NCT02723006|566107204|FG002|Overall Study|Withdrawal by Subject|1|||
156823865|NCT02723006|566107202|FG000|Overall Study|Study Terminated by Sponsor|1|||
156823866|NCT02723006|566107203|FG001|Overall Study|Study Terminated by Sponsor|6|||
156823867|NCT02723006|566107204|FG002|Overall Study|Study Terminated by Sponsor|6|||
156823868|NCT00303446|566107205|FG000|Overall Study|Withdrawal by Subject|2|||
156823869|NCT00303446|566107206|FG001|Overall Study|Withdrawal by Subject|2|||
156823870|NCT00303446|566107205|FG000|Overall Study|Death|0|||
156823871|NCT00303446|566107206|FG001|Overall Study|Death|1|||
156823872|NCT00303446|566107205|FG000|Overall Study|Physician Decision|0|||
156823873|NCT00303446|566107206|FG001|Overall Study|Physician Decision|1|||
156823874|NCT01468207|566107207|FG000|Treatment Period 1|Adverse Event|1|||
156823875|NCT01468207|566107208|FG001|Treatment Period 1|Adverse Event|0|||
156823876|NCT01468207|566107209|FG002|Treatment Period 1|Adverse Event|0|||
156823877|NCT01468207|566107210|FG003|Treatment Period 1|Adverse Event|0|||
156823878|NCT01468207|566107211|FG004|Treatment Period 1|Adverse Event|0|||
156823879|NCT01468207|566107212|FG005|Treatment Period 1|Adverse Event|0|||
157151030|NCT00404768|567298182|FG003|Part C|Early withdrawal from study medication|0|||
157151031|NCT00404768|567298179|FG000|Part C|Participant did not respond to therapy|0|||
157151032|NCT00404768|567298180|FG001|Part C|Participant did not respond to therapy|0|||
157151033|NCT00404768|567298181|FG002|Part C|Participant did not respond to therapy|1|||
157151034|NCT00404768|567298182|FG003|Part C|Participant did not respond to therapy|1|||
156823880|NCT01468207|566107207|FG000|Treatment Period 1|Protocol Violation|1|||
156823881|NCT01468207|566107208|FG001|Treatment Period 1|Protocol Violation|1|||
156823882|NCT01468207|566107209|FG002|Treatment Period 1|Protocol Violation|0|||
156823883|NCT01468207|566107210|FG003|Treatment Period 1|Protocol Violation|0|||
156823884|NCT01468207|566107211|FG004|Treatment Period 1|Protocol Violation|0|||
156823885|NCT01468207|566107212|FG005|Treatment Period 1|Protocol Violation|0|||
156823886|NCT01468207|566107207|FG000|Treatment Period 1|Withdrawal by Subject|5|||
156823887|NCT01468207|566107208|FG001|Treatment Period 1|Withdrawal by Subject|4|||
157022774|NCT03366649|566836856|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
157151035|NCT00404768|567298179|FG000|Part C|Physician withdrew the study medication|0|||
156823888|NCT01468207|566107209|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156823889|NCT01468207|566107210|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156823890|NCT01468207|566107211|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156823891|NCT01468207|566107212|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156823892|NCT01468207|566107207|FG000|Treatment Period 1|Lost to Follow-up|2|||
156823893|NCT01468207|566107208|FG001|Treatment Period 1|Lost to Follow-up|1|||
156823894|NCT01468207|566107209|FG002|Treatment Period 1|Lost to Follow-up|0|||
156823895|NCT01468207|566107210|FG003|Treatment Period 1|Lost to Follow-up|0|||
156823896|NCT01468207|566107211|FG004|Treatment Period 1|Lost to Follow-up|0|||
156823897|NCT01468207|566107212|FG005|Treatment Period 1|Lost to Follow-up|0|||
156823898|NCT01468207|566107207|FG000|Treatment Period 1|Other|0|||
156823899|NCT01468207|566107208|FG001|Treatment Period 1|Other|2|||
156823900|NCT01468207|566107209|FG002|Treatment Period 1|Other|0|||
156823901|NCT01468207|566107210|FG003|Treatment Period 1|Other|0|||
156823902|NCT01468207|566107211|FG004|Treatment Period 1|Other|0|||
156823903|NCT01468207|566107212|FG005|Treatment Period 1|Other|0|||
156823904|NCT01468207|566107207|FG000|Treatment Period 2|Adverse Event|0|||
156823905|NCT01468207|566107208|FG001|Treatment Period 2|Adverse Event|0|||
156823906|NCT01468207|566107209|FG002|Treatment Period 2|Adverse Event|6|||
156823907|NCT01468207|566107210|FG003|Treatment Period 2|Adverse Event|1|||
156823908|NCT01468207|566107211|FG004|Treatment Period 2|Adverse Event|2|||
156823909|NCT01468207|566107212|FG005|Treatment Period 2|Adverse Event|1|||
156823910|NCT01468207|566107207|FG000|Treatment Period 2|Lack of Efficacy|0|||
156823911|NCT01468207|566107208|FG001|Treatment Period 2|Lack of Efficacy|0|||
156823912|NCT01468207|566107209|FG002|Treatment Period 2|Lack of Efficacy|1|||
156823913|NCT01468207|566107210|FG003|Treatment Period 2|Lack of Efficacy|1|||
156823914|NCT01468207|566107211|FG004|Treatment Period 2|Lack of Efficacy|0|||
156823915|NCT01468207|566107212|FG005|Treatment Period 2|Lack of Efficacy|2|||
156823916|NCT01468207|566107207|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156823917|NCT01468207|566107208|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156823918|NCT01468207|566107209|FG002|Treatment Period 2|Withdrawal by Subject|5|||
156823919|NCT01468207|566107210|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156823920|NCT01468207|566107211|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156823921|NCT01468207|566107212|FG005|Treatment Period 2|Withdrawal by Subject|2|||
156823922|NCT01468207|566107207|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
156823923|NCT01468207|566107208|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
156823924|NCT01468207|566107209|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
156823925|NCT01468207|566107210|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
156823926|NCT01468207|566107211|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
156823927|NCT01468207|566107212|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
156823928|NCT01468207|566107207|FG000|Treatment Period 2|Lost to Follow-up|0|||
156823929|NCT01468207|566107208|FG001|Treatment Period 2|Lost to Follow-up|0|||
156823930|NCT01468207|566107209|FG002|Treatment Period 2|Lost to Follow-up|5|||
156823931|NCT01468207|566107210|FG003|Treatment Period 2|Lost to Follow-up|1|||
156823932|NCT01468207|566107211|FG004|Treatment Period 2|Lost to Follow-up|0|||
156823933|NCT01468207|566107212|FG005|Treatment Period 2|Lost to Follow-up|0|||
156823934|NCT01468207|566107207|FG000|Treatment Period 2|Other|0|||
156823935|NCT01468207|566107208|FG001|Treatment Period 2|Other|0|||
156823936|NCT01468207|566107209|FG002|Treatment Period 2|Other|5|||
156823937|NCT01468207|566107210|FG003|Treatment Period 2|Other|1|||
156823938|NCT01468207|566107211|FG004|Treatment Period 2|Other|1|||
156823939|NCT01468207|566107212|FG005|Treatment Period 2|Other|2|||
156823940|NCT00413894|566107213|FG000|Overall Study|Withdrawal by Subject|10|||
156823941|NCT00413894|566107213|FG000|Overall Study|Administrative Reasons|1|||
156823942|NCT00413894|566107213|FG000|Overall Study|Hb <10 grams/deciliter|12|||
156823943|NCT00413894|566107213|FG000|Overall Study|Adverse Event|28|||
156823944|NCT00413894|566107213|FG000|Overall Study|Protocol Violation|11|||
156823945|NCT00413894|566107213|FG000|Overall Study|Other|18|||
156823946|NCT04225676|566107214|FG000|Overall Study|Physician Decision|1|||
156823947|NCT04225676|566107214|FG000|Overall Study|Lack of Efficacy|1|||
156823948|NCT04225676|566107214|FG000|Overall Study|Study terminated by sponsor|3|||
156823949|NCT05289271|566107217|FG000|Overall Study|Mistakenly allocated, untreated|1|||
156823950|NCT05289271|566107218|FG001|Overall Study|Mistakenly allocated, untreated|0|||
156823951|NCT03356977|566107219|FG000|Overall Study|Lost to Follow-up|3|||
156823952|NCT03356977|566107219|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156823953|NCT01728077|566107225|FG000|Overall Study|Lack of Efficacy|3|||
156823954|NCT01728077|566107226|FG001|Overall Study|Lack of Efficacy|1|||
156823955|NCT01728077|566107225|FG000|Overall Study|Lost to Follow-up|1|||
156823956|NCT01728077|566107226|FG001|Overall Study|Lost to Follow-up|0|||
156823957|NCT01728077|566107225|FG000|Overall Study|Subject choice|2|||
156823958|NCT01728077|566107226|FG001|Overall Study|Subject choice|3|||
156823959|NCT01728077|566107225|FG000|Overall Study|Death|0|||
156823960|NCT01728077|566107226|FG001|Overall Study|Death|1|||
156823961|NCT01728077|566107225|FG000|Overall Study|Patient moving|1|||
156823962|NCT01728077|566107226|FG001|Overall Study|Patient moving|0|||
156823963|NCT01728077|566107225|FG000|Overall Study|Non compliance|1|||
156823964|NCT01728077|566107226|FG001|Overall Study|Non compliance|0|||
156823965|NCT00378599|566107229|FG000|Overall Study|Adverse Event|38|||
156823966|NCT00378599|566107229|FG000|Overall Study|Protocol Violation|2|||
156823967|NCT00378599|566107229|FG000|Overall Study|Treatment failure|7|||
156823968|NCT00378599|566107229|FG000|Overall Study|Withdrawal by Subject|5|||
156823969|NCT03224507|566107231|FG000|Overall Study|Death|3|||
156823970|NCT03224507|566107232|FG001|Overall Study|Death|0|||
156823971|NCT03224507|566107231|FG000|Overall Study|Lack of Efficacy|6|||
156823972|NCT03224507|566107232|FG001|Overall Study|Lack of Efficacy|0|||
156823973|NCT03224507|566107231|FG000|Overall Study|Withdrawal by Subject|6|||
156823974|NCT03224507|566107232|FG001|Overall Study|Withdrawal by Subject|0|||
156823975|NCT01032291|566107233|FG000|Safety Lead-in|Adverse Event|1|||
156823976|NCT01032291|566107234|FG001|Safety Lead-in|Adverse Event|0|||
156823977|NCT01032291|566107235|FG002|Safety Lead-in|Adverse Event|0|||
156823978|NCT01032291|566107233|FG000|Safety Lead-in|Death|1|||
156823979|NCT01032291|566107234|FG001|Safety Lead-in|Death|0|||
156823980|NCT01032291|566107235|FG002|Safety Lead-in|Death|0|||
156823981|NCT01032291|566107233|FG000|Proof of Concept|Adverse Event|0|||
156823982|NCT01032291|566107234|FG001|Proof of Concept|Adverse Event|5|||
156823983|NCT01032291|566107235|FG002|Proof of Concept|Adverse Event|1|||
156823984|NCT01032291|566107233|FG000|Proof of Concept|Death|0|||
156823985|NCT01032291|566107234|FG001|Proof of Concept|Death|1|||
156823986|NCT01032291|566107235|FG002|Proof of Concept|Death|2|||
156823987|NCT01032291|566107233|FG000|Proof of Concept|Lack of Efficacy|0|||
156823988|NCT01032291|566107234|FG001|Proof of Concept|Lack of Efficacy|1|||
156823989|NCT01032291|566107235|FG002|Proof of Concept|Lack of Efficacy|0|||
156823990|NCT01032291|566107233|FG000|Proof of Concept|Never Received Study Drug|0|||
156823991|NCT01032291|566107234|FG001|Proof of Concept|Never Received Study Drug|1|||
156823992|NCT01032291|566107235|FG002|Proof of Concept|Never Received Study Drug|0|||
156823993|NCT00642369|566107236|FG000|Overall Study|Adverse Event|2|||
156823994|NCT00642369|566107237|FG001|Overall Study|Adverse Event|3|||
156823995|NCT00642369|566107236|FG000|Overall Study|Withdrawal by Subject|1|||
156823996|NCT00642369|566107237|FG001|Overall Study|Withdrawal by Subject|0|||
156823997|NCT00642369|566107236|FG000|Overall Study|misdiagnosis|0|||
156823998|NCT00642369|566107237|FG001|Overall Study|misdiagnosis|1|||
156823999|NCT00642369|566107236|FG000|Overall Study|Lack of Efficacy|2|||
156824000|NCT00642369|566107237|FG001|Overall Study|Lack of Efficacy|2|||
156824001|NCT04035564|566107238|FG000|Overall Study|Protocol Violation|1|||
156824002|NCT04035564|566107239|FG001|Overall Study|Protocol Violation|2|||
156824003|NCT04035564|566107238|FG000|Overall Study|No laboratory available|2|||
156824004|NCT04035564|566107239|FG001|Overall Study|No laboratory available|2|||
156824005|NCT04035564|566107238|FG000|Overall Study|Guardian declined consent|1|||
156824006|NCT04035564|566107239|FG001|Overall Study|Guardian declined consent|2|||
156824007|NCT00624585|566107244|FG000|Overall Study|Death|3|||
156824008|NCT00624585|566107244|FG000|Overall Study|Disease Progression|6|||
156824009|NCT00624585|566107244|FG000|Overall Study|Adverse Event|3|||
156824010|NCT04154345|566107248|FG000|Overall Study|Covid-19 pandemic|4|||
156824011|NCT00676520|566107250|FG000|Overall Study|Withdrawal by Subject|163|||
156824012|NCT00676520|566107250|FG000|Overall Study|Lost to Follow-up|162|||
156824013|NCT00676520|566107250|FG000|Overall Study|Death|159|||
156824014|NCT00676520|566107250|FG000|Overall Study|Physician Decision|20|||
156824015|NCT00676520|566107250|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
156824016|NCT00676520|566107250|FG000|Overall Study|Other Reason|18|||
156824017|NCT01425359|566107251|FG000|Overall Study|Randomized but Not Treated|2|||
156824018|NCT01425359|566107252|FG001|Overall Study|Randomized but Not Treated|3|||
156824019|NCT01425359|566107251|FG000|Overall Study|Adverse Event|9|||
156824020|NCT01425359|566107252|FG001|Overall Study|Adverse Event|8|||
156824021|NCT01425359|566107251|FG000|Overall Study|Revascularization|0|||
156824022|NCT01425359|566107252|FG001|Overall Study|Revascularization|1|||
156824023|NCT01425359|566107251|FG000|Overall Study|Death|0|||
156824024|NCT01425359|566107252|FG001|Overall Study|Death|1|||
156824025|NCT01425359|566107251|FG000|Overall Study|Unsatisfactory Response|1|||
156824026|NCT01425359|566107252|FG001|Overall Study|Unsatisfactory Response|0|||
157151036|NCT00404768|567298180|FG001|Part C|Physician withdrew the study medication|0|||
157151037|NCT00404768|567298181|FG002|Part C|Physician withdrew the study medication|1|||
157151038|NCT00404768|567298182|FG003|Part C|Physician withdrew the study medication|0|||
157151039|NCT00404768|567298179|FG000|Part C|Participant delivered baby|0|||
156824027|NCT01425359|566107251|FG000|Overall Study|Protocol Violation|1|||
156824028|NCT01425359|566107252|FG001|Overall Study|Protocol Violation|2|||
156824029|NCT01425359|566107251|FG000|Overall Study|Subject Withdrew Consent|1|||
156824030|NCT01425359|566107252|FG001|Overall Study|Subject Withdrew Consent|2|||
156824031|NCT01425359|566107251|FG000|Overall Study|Investigator's Discretion|2|||
156824032|NCT01425359|566107252|FG001|Overall Study|Investigator's Discretion|0|||
156824033|NCT01425359|566107251|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
156824034|NCT01425359|566107252|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
156824035|NCT04043234|566107257|FG000|Overall Study|Lost to Follow-up|1|||
156824036|NCT04043234|566107257|FG000|Overall Study|Withdrawal by Subject|1|||
156824037|NCT01165320|566107258|FG000|Overall Study|Clinical adverse experience|2|||
156824038|NCT01165320|566107259|FG001|Overall Study|Clinical adverse experience|1|||
157151040|NCT00404768|567298180|FG001|Part C|Participant delivered baby|0|||
157022775|NCT02120456|566836858|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022776|NCT02120456|566836859|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022777|NCT02120456|566836860|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022778|NCT02120456|566836861|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022779|NCT02120456|566836862|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022780|NCT02120456|566836863|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022781|NCT02120456|566836864|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
157022782|NCT02120456|566836865|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022783|NCT02120456|566836866|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
157022784|NCT02120456|566836858|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022785|NCT02120456|566836859|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022786|NCT02120456|566836860|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022787|NCT02120456|566836861|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022788|NCT02120456|566836862|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022789|NCT02120456|566836863|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022790|NCT02120456|566836864|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
157022791|NCT02120456|566836865|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022792|NCT02120456|566836866|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
157022793|NCT02120456|566836858|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022794|NCT02120456|566836859|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157151041|NCT00404768|567298181|FG002|Part C|Participant delivered baby|0|||
157151042|NCT00404768|567298182|FG003|Part C|Participant delivered baby|1|||
157151043|NCT00404768|567298179|FG000|Part C|Unsatisfactory uterine response to IP|0|||
157022795|NCT02120456|566836860|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022796|NCT02120456|566836861|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022797|NCT02120456|566836862|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022798|NCT02120456|566836863|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022799|NCT02120456|566836864|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022800|NCT02120456|566836865|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
157022801|NCT02120456|566836866|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
157022802|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Physician Decision|1|||
157151044|NCT00404768|567298180|FG001|Part C|Unsatisfactory uterine response to IP|0|||
156824039|NCT01165320|566107260|FG002|Overall Study|Clinical adverse experience|0|||
156824040|NCT01165320|566107258|FG000|Overall Study|Laboratory adverse experience|1|||
156824041|NCT01165320|566107259|FG001|Overall Study|Laboratory adverse experience|0|||
156824042|NCT01165320|566107260|FG002|Overall Study|Laboratory adverse experience|0|||
156824043|NCT01165320|566107258|FG000|Overall Study|Lack of Efficacy|0|||
156824044|NCT01165320|566107259|FG001|Overall Study|Lack of Efficacy|2|||
156824045|NCT01165320|566107260|FG002|Overall Study|Lack of Efficacy|0|||
156824046|NCT01165320|566107258|FG000|Overall Study|Reason unknown|0|||
156824047|NCT01165320|566107259|FG001|Overall Study|Reason unknown|1|||
156824048|NCT01165320|566107260|FG002|Overall Study|Reason unknown|0|||
156824049|NCT02186652|566107265|FG000|Overall Study|Lost to Follow-up|2|||
156824050|NCT02186652|566107266|FG001|Overall Study|Lost to Follow-up|0|||
156824051|NCT03770728|566107271|FG000|Overall Study|Adverse Event|1|||
156824052|NCT03770728|566107272|FG001|Overall Study|Adverse Event|0|||
156824053|NCT03770728|566107273|FG002|Overall Study|Adverse Event|1|||
156824054|NCT03770728|566107274|FG003|Overall Study|Adverse Event|0|||
156824055|NCT03770728|566107271|FG000|Overall Study|Poor compliance to protocol|0|||
156824056|NCT03770728|566107272|FG001|Overall Study|Poor compliance to protocol|0|||
156824057|NCT03770728|566107273|FG002|Overall Study|Poor compliance to protocol|1|||
156824058|NCT03770728|566107274|FG003|Overall Study|Poor compliance to protocol|0|||
156824059|NCT03770728|566107271|FG000|Overall Study|Withdrawal by Subject|13|||
156824060|NCT03770728|566107272|FG001|Overall Study|Withdrawal by Subject|8|||
156824061|NCT03770728|566107273|FG002|Overall Study|Withdrawal by Subject|9|||
157151045|NCT00404768|567298181|FG002|Part C|Unsatisfactory uterine response to IP|0|||
156824062|NCT03770728|566107274|FG003|Overall Study|Withdrawal by Subject|13|||
156824063|NCT03770728|566107271|FG000|Overall Study|Other than specified|24|||
157022803|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Physician Decision|0|||
157022804|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
157022805|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
157022806|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
156824064|NCT03770728|566107272|FG001|Overall Study|Other than specified|23|||
157022807|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
156824065|NCT03770728|566107273|FG002|Overall Study|Other than specified|21|||
156824066|NCT03770728|566107274|FG003|Overall Study|Other than specified|22|||
156824067|NCT00503776|566107275|FG000|Overall Study|Withdrawal by Subject|1|||
157022808|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Pregnancy|0|||
157022809|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Pregnancy|2|||
156824068|NCT00503776|566107276|FG001|Overall Study|Withdrawal by Subject|0|||
156824069|NCT00503776|566107277|FG002|Overall Study|Withdrawal by Subject|1|||
157151046|NCT00404768|567298182|FG003|Part C|Unsatisfactory uterine response to IP|1|||
157224467|NCT04652453|567568002|FG000|Overall Study|Death|8|||
156824070|NCT00503776|566107278|FG003|Overall Study|Withdrawal by Subject|1|||
156824071|NCT00503776|566107275|FG000|Overall Study|Physician Decision|0|||
156824072|NCT00503776|566107276|FG001|Overall Study|Physician Decision|0|||
156824073|NCT00503776|566107277|FG002|Overall Study|Physician Decision|1|||
156824074|NCT00503776|566107278|FG003|Overall Study|Physician Decision|1|||
156824075|NCT02379988|566107279|FG000|Overall Study|Not eligible|1|||
156824076|NCT02509039|566107282|FG000|Overall Study|Adverse Event|0|||
156824077|NCT02509039|566107283|FG001|Overall Study|Adverse Event|1|||
156824078|NCT02509039|566107284|FG002|Overall Study|Adverse Event|1|||
156824079|NCT02509039|566107285|FG003|Overall Study|Adverse Event|1|||
156824080|NCT02509039|566107282|FG000|Overall Study|Withdrawal by Subject|0|||
156824081|NCT02509039|566107283|FG001|Overall Study|Withdrawal by Subject|0|||
156824082|NCT02509039|566107284|FG002|Overall Study|Withdrawal by Subject|1|||
156824083|NCT02509039|566107285|FG003|Overall Study|Withdrawal by Subject|0|||
156824084|NCT02509039|566107282|FG000|Overall Study|Progressive disease|2|||
156824085|NCT02509039|566107283|FG001|Overall Study|Progressive disease|2|||
156824086|NCT02509039|566107284|FG002|Overall Study|Progressive disease|1|||
156824087|NCT02509039|566107285|FG003|Overall Study|Progressive disease|5|||
156824088|NCT02509039|566107282|FG000|Overall Study|Study terminated by Sponsor|1|||
156824089|NCT02509039|566107283|FG001|Overall Study|Study terminated by Sponsor|0|||
156824090|NCT02509039|566107284|FG002|Overall Study|Study terminated by Sponsor|0|||
156824091|NCT02509039|566107285|FG003|Overall Study|Study terminated by Sponsor|0|||
156824092|NCT03943550|566107288|FG000|Overall Study|Adverse Event|0|||
156824093|NCT03943550|566107289|FG001|Overall Study|Adverse Event|0|||
156824094|NCT03943550|566107290|FG002|Overall Study|Adverse Event|1|||
156824095|NCT03943550|566107288|FG000|Overall Study|Lost to Follow-up|0|||
156824096|NCT03943550|566107289|FG001|Overall Study|Lost to Follow-up|0|||
156824097|NCT03943550|566107290|FG002|Overall Study|Lost to Follow-up|1|||
156824098|NCT03943550|566107288|FG000|Overall Study|Progressive Disease|0|||
156824099|NCT03943550|566107289|FG001|Overall Study|Progressive Disease|0|||
156824100|NCT03943550|566107290|FG002|Overall Study|Progressive Disease|2|||
156824101|NCT03943550|566107288|FG000|Overall Study|Participant Moved Out of the Country|0|||
156824102|NCT03943550|566107289|FG001|Overall Study|Participant Moved Out of the Country|1|||
156824103|NCT03943550|566107290|FG002|Overall Study|Participant Moved Out of the Country|0|||
156824104|NCT03359785|566107291|FG000|Overall Study|Protocol Violation|0|||
156824105|NCT03359785|566107292|FG001|Overall Study|Protocol Violation|1|||
156824106|NCT03359785|566107293|FG002|Overall Study|Protocol Violation|0|||
156824107|NCT03359785|566107294|FG003|Overall Study|Protocol Violation|0|||
156824108|NCT03359785|566107291|FG000|Overall Study|Early study termination due to study pause|0|||
156824109|NCT03359785|566107292|FG001|Overall Study|Early study termination due to study pause|0|||
156824110|NCT03359785|566107293|FG002|Overall Study|Early study termination due to study pause|2|||
156824111|NCT03359785|566107294|FG003|Overall Study|Early study termination due to study pause|0|||
156824112|NCT03359785|566107291|FG000|Overall Study|Withdrawal by Subject|2|||
156824113|NCT03359785|566107292|FG001|Overall Study|Withdrawal by Subject|2|||
156824114|NCT03359785|566107293|FG002|Overall Study|Withdrawal by Subject|0|||
156824115|NCT03359785|566107294|FG003|Overall Study|Withdrawal by Subject|0|||
156824116|NCT04659174|566107296|FG000|Overall Study|Sponsor decision to discontinue study|0|||
156824117|NCT04659174|566107297|FG001|Overall Study|Sponsor decision to discontinue study|2|||
156824118|NCT04659174|566107296|FG000|Overall Study|Lost to Follow-up|9|||
156824119|NCT04659174|566107297|FG001|Overall Study|Lost to Follow-up|11|||
156824120|NCT04659174|566107296|FG000|Overall Study|Adverse Event|8|||
156824121|NCT04659174|566107297|FG001|Overall Study|Adverse Event|5|||
156824122|NCT04659174|566107296|FG000|Overall Study|Withdrawal by Subject|17|||
156824123|NCT04659174|566107297|FG001|Overall Study|Withdrawal by Subject|33|||
156824124|NCT04659174|566107296|FG000|Overall Study|Progressive disease|0|||
156824125|NCT04659174|566107297|FG001|Overall Study|Progressive disease|2|||
156824126|NCT04659174|566107296|FG000|Overall Study|Other reasons|0|||
156824127|NCT04659174|566107297|FG001|Overall Study|Other reasons|2|||
156884700|NCT00895011|566336334|FG001|Overall Study|Lost to Follow-up|4|||
156884701|NCT00895011|566336335|FG002|Overall Study|Lost to Follow-up|1|||
157091523|NCT00757783|567089130|FG001|Overall Study|Other|2|||
156824128|NCT04659174|566107296|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
156824129|NCT04659174|566107297|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
156824130|NCT04659174|566107296|FG000|Overall Study|Alcohol or illegal drug use|0|||
156824131|NCT04659174|566107297|FG001|Overall Study|Alcohol or illegal drug use|3|||
156824132|NCT04659174|566107296|FG000|Overall Study|Violation of entry criteria|1|||
156824133|NCT04659174|566107297|FG001|Overall Study|Violation of entry criteria|0|||
156824134|NCT04659174|566107296|FG000|Overall Study|Death|0|||
156824135|NCT04659174|566107297|FG001|Overall Study|Death|1|||
156824136|NCT01202188|566107303|FG000|Overall Study|Protocol deviation|14|||
156824137|NCT01202188|566107304|FG001|Overall Study|Protocol deviation|8|||
156824138|NCT01202188|566107305|FG002|Overall Study|Protocol deviation|12|||
156884702|NCT00895011|566336333|FG000|Overall Study|Protocol Violation|3|||
157091524|NCT02372136|567089131|FG000|Overall Study|Death|3|||
157091525|NCT02372136|567089132|FG001|Overall Study|Death|1|||
157091526|NCT03265938|567089133|FG000|Overall Study|Withdrawal by Subject|1|||
156824139|NCT01202188|566107306|FG003|Overall Study|Protocol deviation|10|||
156824140|NCT01202188|566107307|FG004|Overall Study|Protocol deviation|11|||
156824141|NCT01202188|566107303|FG000|Overall Study|Subject withdrew consent|12|||
156824142|NCT01202188|566107304|FG001|Overall Study|Subject withdrew consent|13|||
156824143|NCT01202188|566107305|FG002|Overall Study|Subject withdrew consent|22|||
156824144|NCT01202188|566107306|FG003|Overall Study|Subject withdrew consent|11|||
156824145|NCT01202188|566107307|FG004|Overall Study|Subject withdrew consent|13|||
156824146|NCT01202188|566107303|FG000|Overall Study|Adverse Event|5|||
156824147|NCT01202188|566107304|FG001|Overall Study|Adverse Event|23|||
156824148|NCT01202188|566107305|FG002|Overall Study|Adverse Event|13|||
157224468|NCT04652453|567568003|FG001|Overall Study|Death|2|||
157224469|NCT04652453|567568004|FG002|Overall Study|Death|0|||
157224470|NCT04652453|567568002|FG000|Overall Study|Hospice|5|||
157224471|NCT04652453|567568003|FG001|Overall Study|Hospice|5|||
157224472|NCT04652453|567568004|FG002|Overall Study|Hospice|0|||
157224473|NCT04652453|567568002|FG000|Overall Study|Withdrawal by Subject|2|||
157224474|NCT04652453|567568003|FG001|Overall Study|Withdrawal by Subject|0|||
157224475|NCT04652453|567568004|FG002|Overall Study|Withdrawal by Subject|0|||
157224476|NCT04543136|567568005|FG000|Overall Study|Withdrawal by Subject|0|||
157224477|NCT04543136|567568006|FG001|Overall Study|Withdrawal by Subject|1|||
157224478|NCT04543136|567568007|FG002|Overall Study|Withdrawal by Subject|0|||
156824149|NCT01202188|566107306|FG003|Overall Study|Adverse Event|10|||
156824150|NCT01202188|566107307|FG004|Overall Study|Adverse Event|10|||
156824151|NCT01202188|566107303|FG000|Overall Study|Administrative problems|3|||
156824152|NCT01202188|566107304|FG001|Overall Study|Administrative problems|2|||
156824153|NCT01202188|566107305|FG002|Overall Study|Administrative problems|1|||
156824154|NCT01202188|566107306|FG003|Overall Study|Administrative problems|1|||
156824155|NCT01202188|566107307|FG004|Overall Study|Administrative problems|2|||
156824156|NCT01202188|566107303|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156824157|NCT01202188|566107304|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156824158|NCT01202188|566107305|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156824159|NCT01202188|566107306|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
156824160|NCT01202188|566107307|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
156824161|NCT01202188|566107303|FG000|Overall Study|Lost to Follow-up|1|||
156824162|NCT01202188|566107304|FG001|Overall Study|Lost to Follow-up|1|||
156824163|NCT01202188|566107305|FG002|Overall Study|Lost to Follow-up|0|||
156824164|NCT01202188|566107306|FG003|Overall Study|Lost to Follow-up|4|||
156824165|NCT01202188|566107307|FG004|Overall Study|Lost to Follow-up|1|||
156824166|NCT01202188|566107303|FG000|Overall Study|Death|1|||
156824167|NCT01202188|566107304|FG001|Overall Study|Death|1|||
156824168|NCT01202188|566107305|FG002|Overall Study|Death|1|||
156824169|NCT01202188|566107306|FG003|Overall Study|Death|1|||
156824170|NCT01202188|566107307|FG004|Overall Study|Death|0|||
156824171|NCT01202188|566107303|FG000|Overall Study|Abnormal test procedure result (s)|0|||
156824172|NCT01202188|566107304|FG001|Overall Study|Abnormal test procedure result (s)|0|||
156824173|NCT01202188|566107305|FG002|Overall Study|Abnormal test procedure result (s)|2|||
156824174|NCT01202188|566107306|FG003|Overall Study|Abnormal test procedure result (s)|0|||
156824175|NCT01202188|566107307|FG004|Overall Study|Abnormal test procedure result (s)|0|||
156824176|NCT05032690|566107308|FG000|Period 1|Adverse Event|0|||
156824177|NCT05032690|566107309|FG001|Period 1|Adverse Event|1|||
156824178|NCT05032690|566107310|FG002|Period 1|Adverse Event|0|||
156824179|NCT05032690|566107311|FG003|Period 1|Adverse Event|0|||
156824180|NCT05032690|566107308|FG000|Period 1|Withdrawal by Subject|1|||
156824181|NCT05032690|566107309|FG001|Period 1|Withdrawal by Subject|0|||
156824182|NCT05032690|566107310|FG002|Period 1|Withdrawal by Subject|0|||
156824183|NCT05032690|566107311|FG003|Period 1|Withdrawal by Subject|0|||
156824184|NCT05032690|566107308|FG000|Period 1|No longer meets eligibility criteria|0|||
156824185|NCT05032690|566107309|FG001|Period 1|No longer meets eligibility criteria|1|||
157224479|NCT04543136|567568008|FG003|Overall Study|Withdrawal by Subject|1|||
157224480|NCT04543136|567568009|FG004|Overall Study|Withdrawal by Subject|0|||
157224481|NCT04543136|567568010|FG005|Overall Study|Withdrawal by Subject|0|||
156824186|NCT05032690|566107310|FG002|Period 1|No longer meets eligibility criteria|0|||
156824187|NCT05032690|566107311|FG003|Period 1|No longer meets eligibility criteria|0|||
156824188|NCT05032690|566107308|FG000|Period 2|Adverse Event|1|||
156824189|NCT05032690|566107309|FG001|Period 2|Adverse Event|0|||
156824190|NCT05032690|566107310|FG002|Period 2|Adverse Event|0|||
156824191|NCT05032690|566107311|FG003|Period 2|Adverse Event|0|||
156824192|NCT05032690|566107308|FG000|Period 2|Withdrawal by Subject|0|||
156824193|NCT05032690|566107309|FG001|Period 2|Withdrawal by Subject|1|||
156824194|NCT05032690|566107310|FG002|Period 2|Withdrawal by Subject|0|||
157224482|NCT06331156|567568016|FG000|Overall Study|Adverse Event|1|||
157224483|NCT06331156|567568017|FG001|Overall Study|Adverse Event|0|||
157224484|NCT06331156|567568016|FG000|Overall Study|Lost to Follow-up|1|||
156824195|NCT05032690|566107311|FG003|Period 2|Withdrawal by Subject|0|||
156824196|NCT05032690|566107308|FG000|Period 2|No longer meets eligibility criteria|0|||
156824197|NCT05032690|566107309|FG001|Period 2|No longer meets eligibility criteria|1|||
156824198|NCT05032690|566107310|FG002|Period 2|No longer meets eligibility criteria|0|||
156884703|NCT00895011|566336334|FG001|Overall Study|Protocol Violation|1|||
156824199|NCT05032690|566107311|FG003|Period 2|No longer meets eligibility criteria|0|||
156824200|NCT05032690|566107308|FG000|Period 3|Adverse Event|0|||
156824201|NCT05032690|566107309|FG001|Period 3|Adverse Event|1|||
156824202|NCT05032690|566107310|FG002|Period 3|Adverse Event|0|||
156824203|NCT05032690|566107311|FG003|Period 3|Adverse Event|0|||
156824204|NCT00487942|566107312|FG000|Overall Study|Adverse Event|1|||
156824205|NCT00487942|566107313|FG001|Overall Study|Adverse Event|1|||
156824206|NCT00487942|566107314|FG002|Overall Study|Adverse Event|1|||
156824207|NCT00487942|566107315|FG003|Overall Study|Adverse Event|1|||
156824208|NCT00487942|566107312|FG000|Overall Study|Lost to Follow-up|1|||
156824209|NCT00487942|566107313|FG001|Overall Study|Lost to Follow-up|0|||
156824210|NCT00487942|566107314|FG002|Overall Study|Lost to Follow-up|0|||
156824211|NCT00487942|566107315|FG003|Overall Study|Lost to Follow-up|1|||
156824212|NCT00487942|566107312|FG000|Overall Study|Protocol Violation|1|||
156824213|NCT00487942|566107313|FG001|Overall Study|Protocol Violation|1|||
156824214|NCT00487942|566107314|FG002|Overall Study|Protocol Violation|0|||
156824215|NCT00487942|566107315|FG003|Overall Study|Protocol Violation|0|||
156824216|NCT00487942|566107312|FG000|Overall Study|Withdrawal by Subject|0|||
156824217|NCT00487942|566107313|FG001|Overall Study|Withdrawal by Subject|1|||
156824218|NCT00487942|566107314|FG002|Overall Study|Withdrawal by Subject|2|||
156824219|NCT00487942|566107315|FG003|Overall Study|Withdrawal by Subject|0|||
156824220|NCT05151445|566107316|FG000|Overall Study|Withdrawal by Subject|3|||
156824221|NCT02298179|566107320|FG000|Overall Study|Lost to Follow-up|0|||
156824222|NCT02298179|566107321|FG001|Overall Study|Lost to Follow-up|0|||
156824223|NCT02298179|566107322|FG002|Overall Study|Lost to Follow-up|1|||
156824224|NCT02298179|566107323|FG003|Overall Study|Lost to Follow-up|0|||
156824225|NCT02298179|566107324|FG004|Overall Study|Lost to Follow-up|0|||
156824226|NCT02298179|566107325|FG005|Overall Study|Lost to Follow-up|0|||
156824227|NCT02298179|566107326|FG006|Overall Study|Lost to Follow-up|0|||
156824228|NCT02298179|566107327|FG007|Overall Study|Lost to Follow-up|1|||
156824229|NCT02298179|566107328|FG008|Overall Study|Lost to Follow-up|0|||
156824230|NCT02298179|566107329|FG009|Overall Study|Lost to Follow-up|0|||
156824231|NCT02298179|566107330|FG010|Overall Study|Lost to Follow-up|0|||
156824232|NCT02298179|566107331|FG011|Overall Study|Lost to Follow-up|0|||
156824233|NCT00082368|566107334|FG000|Overall Study|Not treated-pt had poor IV access|1|||
156824234|NCT03559517|566107335|FG000|Overall Study|Withdrawal by Subject|1|||
156824235|NCT03559517|566107336|FG001|Overall Study|Withdrawal by Subject|0|||
156824236|NCT03559517|566107337|FG002|Overall Study|Withdrawal by Subject|0|||
156824237|NCT01846299|566107338|FG000|Overall Study|Physician Decision|4|||
156824238|NCT01846299|566107339|FG001|Overall Study|Physician Decision|2|||
156824239|NCT01846299|566107338|FG000|Overall Study|Protocol deviation|1|||
156824240|NCT01846299|566107339|FG001|Overall Study|Protocol deviation|0|||
156824241|NCT01846299|566107338|FG000|Overall Study|Death|1|||
156824242|NCT01846299|566107339|FG001|Overall Study|Death|2|||
156824243|NCT01846299|566107338|FG000|Overall Study|Lost to Follow-up|3|||
156824244|NCT01846299|566107339|FG001|Overall Study|Lost to Follow-up|0|||
156824245|NCT01846299|566107338|FG000|Overall Study|Withdrawal by Subject|1|||
156824246|NCT01846299|566107339|FG001|Overall Study|Withdrawal by Subject|6|||
156824247|NCT01846299|566107338|FG000|Overall Study|Adverse Event|2|||
156824248|NCT01846299|566107339|FG001|Overall Study|Adverse Event|0|||
156824249|NCT01330628|566107340|FG000|Overall Study|Death|2|||
156824250|NCT01330628|566107341|FG001|Overall Study|Death|3|||
156824251|NCT01330628|566107340|FG000|Overall Study|Lost to Follow-up|5|||
156824252|NCT01330628|566107341|FG001|Overall Study|Lost to Follow-up|6|||
156824253|NCT01330628|566107340|FG000|Overall Study|Adverse Event|44|||
156824254|NCT01330628|566107341|FG001|Overall Study|Adverse Event|25|||
156824255|NCT01330628|566107340|FG000|Overall Study|Withdrawn|18|||
156824256|NCT01330628|566107341|FG001|Overall Study|Withdrawn|6|||
156824257|NCT01330628|566107340|FG000|Overall Study|Didn't receive study treatment|1|||
156824258|NCT01330628|566107341|FG001|Overall Study|Didn't receive study treatment|0|||
156824259|NCT02825420|566107349|FG000|Overall Study|Death|30|||
156824260|NCT02825420|566107350|FG001|Overall Study|Death|12|||
156824261|NCT02825420|566107349|FG000|Overall Study|Progressive disease|6|||
156824262|NCT02825420|566107350|FG001|Overall Study|Progressive disease|1|||
157151047|NCT00404768|567298179|FG000|Part C|Active labor|0|||
156824263|NCT02825420|566107349|FG000|Overall Study|Lost to Follow-up|2|||
156824264|NCT02825420|566107350|FG001|Overall Study|Lost to Follow-up|2|||
156824265|NCT02825420|566107349|FG000|Overall Study|Withdrawal by Subject|1|||
156824266|NCT02825420|566107350|FG001|Overall Study|Withdrawal by Subject|1|||
156824267|NCT02825420|566107349|FG000|Overall Study|Protocol amendment not signed|1|||
156824268|NCT02825420|566107350|FG001|Overall Study|Protocol amendment not signed|1|||
156824269|NCT02825420|566107349|FG000|Overall Study|Physician Decision|1|||
156824270|NCT02825420|566107350|FG001|Overall Study|Physician Decision|0|||
157151048|NCT00404768|567298180|FG001|Part C|Active labor|0|||
156824271|NCT02825420|566107349|FG000|Overall Study|Did not receive PLD|2|||
156824272|NCT02825420|566107350|FG001|Overall Study|Did not receive PLD|0|||
156824273|NCT00496483|566109126|FG000|Overall Study|Not dosed|9|||
156824274|NCT00496483|566109126|FG000|Overall Study|Adverse Event|2|||
156824275|NCT00496483|566109126|FG000|Overall Study|Lack of Efficacy|1|||
156824276|NCT04258995|566109128|FG000|Overall Study|Lost to Follow-up|1|||
157151049|NCT00404768|567298181|FG002|Part C|Active labor|0|||
156824277|NCT04258995|566109129|FG001|Overall Study|Lost to Follow-up|1|||
156824278|NCT01962987|566109132|FG000|Overall Study|Adverse Event|4|||
156824279|NCT01962987|566109133|FG001|Overall Study|Adverse Event|4|||
156824280|NCT01962987|566109134|FG002|Overall Study|Adverse Event|0|||
156824281|NCT01962987|566109132|FG000|Overall Study|Lost to Follow-up|0|||
156824282|NCT01962987|566109133|FG001|Overall Study|Lost to Follow-up|0|||
156824283|NCT01962987|566109134|FG002|Overall Study|Lost to Follow-up|1|||
156824284|NCT01962987|566109132|FG000|Overall Study|Non compliance with dosing requirements|4|||
156824285|NCT01962987|566109133|FG001|Overall Study|Non compliance with dosing requirements|2|||
156824286|NCT01962987|566109134|FG002|Overall Study|Non compliance with dosing requirements|0|||
156824287|NCT01962987|566109132|FG000|Overall Study|Miscellaneous|1|||
156824288|NCT01962987|566109133|FG001|Overall Study|Miscellaneous|9|||
156824289|NCT01962987|566109134|FG002|Overall Study|Miscellaneous|2|||
156824290|NCT01962987|566109132|FG000|Overall Study|Restricted medication|5|||
156824291|NCT01962987|566109133|FG001|Overall Study|Restricted medication|1|||
156824292|NCT01962987|566109134|FG002|Overall Study|Restricted medication|1|||
156824293|NCT01962987|566109132|FG000|Overall Study|Serious Adverse Event|1|||
156824294|NCT01962987|566109133|FG001|Overall Study|Serious Adverse Event|0|||
156824295|NCT01962987|566109134|FG002|Overall Study|Serious Adverse Event|0|||
156824296|NCT01962987|566109132|FG000|Overall Study|Withdrawal by Subject|11|||
156824297|NCT01962987|566109133|FG001|Overall Study|Withdrawal by Subject|10|||
156824298|NCT01962987|566109134|FG002|Overall Study|Withdrawal by Subject|6|||
156824299|NCT01962987|566109132|FG000|Overall Study|Randomized in Error|4|||
156824300|NCT01962987|566109133|FG001|Overall Study|Randomized in Error|2|||
156824301|NCT01962987|566109134|FG002|Overall Study|Randomized in Error|2|||
156824302|NCT01967823|566109135|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
156824303|NCT00316693|566109136|FG000|Overall Study|Adverse Event|6|||
156824304|NCT00316693|566109137|FG001|Overall Study|Adverse Event|1|||
156824305|NCT00316693|566109136|FG000|Overall Study|Protocol Violation|1|||
156824306|NCT00316693|566109137|FG001|Overall Study|Protocol Violation|0|||
156824307|NCT00316693|566109136|FG000|Overall Study|Withdrawal by Subject|6|||
156824308|NCT00316693|566109137|FG001|Overall Study|Withdrawal by Subject|6|||
156824309|NCT00316693|566109136|FG000|Overall Study|Lost to Follow-up|26|||
156824310|NCT00316693|566109137|FG001|Overall Study|Lost to Follow-up|34|||
156824311|NCT00316693|566109136|FG000|Overall Study|Other|38|||
156824312|NCT00316693|566109137|FG001|Overall Study|Other|44|||
156824313|NCT03245736|566109144|FG000|Overall Study|Adverse Event|1|||
156824314|NCT03245736|566109144|FG000|Overall Study|Progressive Disease|4|||
156824315|NCT01942161|566109145|FG000|Overall Study|Adverse Event|1|||
156824316|NCT01942161|566109146|FG001|Overall Study|Adverse Event|2|||
156824317|NCT01942161|566109147|FG002|Overall Study|Adverse Event|5|||
156824318|NCT01942161|566109145|FG000|Overall Study|Physician Decision|3|||
156824319|NCT01942161|566109146|FG001|Overall Study|Physician Decision|1|||
156824320|NCT01942161|566109147|FG002|Overall Study|Physician Decision|0|||
156824321|NCT01942161|566109145|FG000|Overall Study|Protocol Violation|1|||
156824322|NCT01942161|566109146|FG001|Overall Study|Protocol Violation|0|||
156824323|NCT01942161|566109147|FG002|Overall Study|Protocol Violation|0|||
156824324|NCT01942161|566109145|FG000|Overall Study|Withdrawal by Subject|3|||
156824325|NCT01942161|566109146|FG001|Overall Study|Withdrawal by Subject|3|||
156824326|NCT01942161|566109147|FG002|Overall Study|Withdrawal by Subject|1|||
156824327|NCT01257568|566109151|FG000|Overall Study|Lost to Follow-up|2|||
156824328|NCT01257568|566109151|FG000|Overall Study|Withdrawal by Subject|6|||
156824329|NCT01257568|566109151|FG000|Overall Study|Terminated|1|||
156824330|NCT01257568|566109151|FG000|Overall Study|Component Revision|24|||
156824331|NCT00132691|566109153|FG000|Overall Study|Lost to Follow-up|5|||
156824332|NCT00132691|566109154|FG001|Overall Study|Lost to Follow-up|8|||
156824333|NCT00132691|566109153|FG000|Overall Study|Missed 2-year visit|4|||
156824334|NCT00132691|566109154|FG001|Overall Study|Missed 2-year visit|4|||
156824335|NCT00132691|566109153|FG000|Overall Study|Death|2|||
156824336|NCT00132691|566109154|FG001|Overall Study|Death|0|||
156824337|NCT01739933|566109161|FG000|Overall Study|Death|89|||
156824338|NCT01739933|566109162|FG001|Overall Study|Death|86|||
156824339|NCT01739933|566109161|FG000|Overall Study|Withdrawal by Subject|10|||
156884704|NCT00895011|566336335|FG002|Overall Study|Protocol Violation|3|||
157022810|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
157022811|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
157022812|NCT01785719|566836867|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
157091527|NCT03265938|567089133|FG000|Overall Study|Physician Decision|1|||
156824340|NCT01739933|566109162|FG001|Overall Study|Withdrawal by Subject|8|||
156824341|NCT01739933|566109161|FG000|Overall Study|Lost to Follow-up|3|||
156824342|NCT01739933|566109162|FG001|Overall Study|Lost to Follow-up|10|||
156824343|NCT01739933|566109161|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
156824344|NCT01739933|566109162|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
156824345|NCT00416715|566109163|FG000|Overall Study|Not evaluable for joint aches|7|||
156824346|NCT00416715|566109163|FG000|Overall Study|Vitamin D levels not evaluable|8|||
156824347|NCT01007435|566109175|FG000|Overall Study|Adverse Event|16|||
156824348|NCT01007435|566109176|FG001|Overall Study|Adverse Event|25|||
156824349|NCT01007435|566109177|FG002|Overall Study|Adverse Event|47|||
156824350|NCT01007435|566109178|FG003|Overall Study|Adverse Event|31|||
156824351|NCT01007435|566109175|FG000|Overall Study|Death|2|||
157224485|NCT06331156|567568017|FG001|Overall Study|Lost to Follow-up|0|||
156824352|NCT01007435|566109176|FG001|Overall Study|Death|4|||
156824353|NCT01007435|566109177|FG002|Overall Study|Death|2|||
156824354|NCT01007435|566109178|FG003|Overall Study|Death|1|||
156824355|NCT01007435|566109175|FG000|Overall Study|Insufficient Therapeutic Response|21|||
156824356|NCT01007435|566109176|FG001|Overall Study|Insufficient Therapeutic Response|7|||
156824357|NCT01007435|566109177|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156824358|NCT01007435|566109178|FG003|Overall Study|Insufficient Therapeutic Response|9|||
156824359|NCT01007435|566109175|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
156824360|NCT01007435|566109176|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
156824361|NCT01007435|566109177|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
156824362|NCT01007435|566109178|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
156824363|NCT01007435|566109175|FG000|Overall Study|Other Protocol Violation|2|||
156824364|NCT01007435|566109176|FG001|Overall Study|Other Protocol Violation|0|||
156824365|NCT01007435|566109177|FG002|Overall Study|Other Protocol Violation|1|||
156824366|NCT01007435|566109178|FG003|Overall Study|Other Protocol Violation|0|||
156824367|NCT01007435|566109175|FG000|Overall Study|Refused Treatment|13|||
156824368|NCT01007435|566109176|FG001|Overall Study|Refused Treatment|13|||
156824369|NCT01007435|566109177|FG002|Overall Study|Refused Treatment|5|||
156824370|NCT01007435|566109178|FG003|Overall Study|Refused Treatment|8|||
156824371|NCT01007435|566109175|FG000|Overall Study|Failure to Return|5|||
156824372|NCT01007435|566109176|FG001|Overall Study|Failure to Return|4|||
156824373|NCT01007435|566109177|FG002|Overall Study|Failure to Return|3|||
156824374|NCT01007435|566109178|FG003|Overall Study|Failure to Return|6|||
156824375|NCT01007435|566109175|FG000|Overall Study|Reason not Specified|1|||
156824376|NCT01007435|566109176|FG001|Overall Study|Reason not Specified|1|||
156824377|NCT01007435|566109177|FG002|Overall Study|Reason not Specified|2|||
156824378|NCT01007435|566109178|FG003|Overall Study|Reason not Specified|1|||
156824379|NCT02576535|566109179|FG000|Overall Study|Withdrawal by Subject|2|||
156824380|NCT00347438|566109180|FG000|Overall Study|Withdrawal by Subject|1|||
156824381|NCT00347438|566109180|FG000|Overall Study|Physician Decision|1|||
156824382|NCT02545517|566109181|FG000|Overall Study|Death|2|||
156824383|NCT02545517|566109182|FG001|Overall Study|Death|2|||
156824384|NCT02545517|566109183|FG002|Overall Study|Death|1|||
156824385|NCT02545517|566109181|FG000|Overall Study|Lost to Follow-up|14|||
156824386|NCT02545517|566109182|FG001|Overall Study|Lost to Follow-up|13|||
156824387|NCT02545517|566109183|FG002|Overall Study|Lost to Follow-up|17|||
156824388|NCT02545517|566109181|FG000|Overall Study|Protocol Violation|0|||
156824389|NCT02545517|566109182|FG001|Overall Study|Protocol Violation|1|||
156824390|NCT02545517|566109183|FG002|Overall Study|Protocol Violation|1|||
156824391|NCT02545517|566109181|FG000|Overall Study|Withdrawal by Subject|5|||
156824392|NCT02545517|566109182|FG001|Overall Study|Withdrawal by Subject|8|||
156824393|NCT02545517|566109183|FG002|Overall Study|Withdrawal by Subject|9|||
156824394|NCT02545517|566109181|FG000|Overall Study|Administrative reason|5|||
156824395|NCT02545517|566109182|FG001|Overall Study|Administrative reason|6|||
156824396|NCT02545517|566109183|FG002|Overall Study|Administrative reason|10|||
156824397|NCT02545517|566109181|FG000|Overall Study|Other|2|||
156824398|NCT02545517|566109182|FG001|Overall Study|Other|4|||
156824399|NCT02545517|566109183|FG002|Overall Study|Other|3|||
156824400|NCT01529515|566109184|FG000|TRANSITION PHASE|Adverse Event|16|||
156824401|NCT01529515|566109185|FG001|TRANSITION PHASE|Adverse Event|0|||
156824402|NCT01529515|566109186|FG002|TRANSITION PHASE|Adverse Event|0|||
156824403|NCT01529515|566109187|FG003|TRANSITION PHASE|Adverse Event|0|||
156824404|NCT01529515|566109184|FG000|TRANSITION PHASE|Death|1|||
156824405|NCT01529515|566109185|FG001|TRANSITION PHASE|Death|0|||
156824406|NCT01529515|566109186|FG002|TRANSITION PHASE|Death|0|||
156824407|NCT01529515|566109187|FG003|TRANSITION PHASE|Death|0|||
156824408|NCT01529515|566109184|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
156824409|NCT01529515|566109185|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
156824410|NCT01529515|566109186|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
156824411|NCT01529515|566109187|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
156824412|NCT01529515|566109184|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
157224486|NCT06331156|567568016|FG000|Overall Study|Migrated / Moved from the study area|4|||
157224487|NCT06331156|567568017|FG001|Overall Study|Migrated / Moved from the study area|3|||
157224488|NCT06331156|567568016|FG000|Overall Study|Other|7|||
157224489|NCT06331156|567568017|FG001|Overall Study|Other|0|||
156824413|NCT01529515|566109185|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
156824414|NCT01529515|566109186|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
156824415|NCT01529515|566109187|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
156824416|NCT01529515|566109184|FG000|TRANSITION PHASE|Protocol Violation|4|||
156824417|NCT01529515|566109185|FG001|TRANSITION PHASE|Protocol Violation|0|||
156824418|NCT01529515|566109186|FG002|TRANSITION PHASE|Protocol Violation|0|||
156824419|NCT01529515|566109187|FG003|TRANSITION PHASE|Protocol Violation|0|||
156824420|NCT01529515|566109184|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
156824421|NCT01529515|566109185|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
157224490|NCT06331156|567568016|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
156824422|NCT01529515|566109186|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
156824423|NCT01529515|566109187|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
156824424|NCT01529515|566109184|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
156824425|NCT01529515|566109185|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824426|NCT01529515|566109186|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824427|NCT01529515|566109187|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
156824428|NCT01529515|566109184|FG000|TRANSITION PHASE|Other|9|||
156824429|NCT01529515|566109185|FG001|TRANSITION PHASE|Other|0|||
156824430|NCT01529515|566109186|FG002|TRANSITION PHASE|Other|0|||
156824431|NCT01529515|566109187|FG003|TRANSITION PHASE|Other|0|||
156824432|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Adverse Event|0|||
156824433|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Adverse Event|10|||
156824434|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Adverse Event|0|||
156824435|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Adverse Event|0|||
156824436|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824437|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
156824438|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824439|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
156824440|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824441|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
156824442|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824443|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
156824444|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
156824445|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
156824446|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
156824447|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
156824448|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824449|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
156824450|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824451|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
156824452|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824453|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
156824454|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824455|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
156824456|NCT01529515|566109184|FG000|MAINTENANCE PHASE|Other|0|||
156824457|NCT01529515|566109185|FG001|MAINTENANCE PHASE|Other|10|||
156824458|NCT01529515|566109186|FG002|MAINTENANCE PHASE|Other|0|||
156824459|NCT01529515|566109187|FG003|MAINTENANCE PHASE|Other|0|||
156824460|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
156824461|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
156824462|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
156824463|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
156824464|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
156824465|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
156824466|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
156824467|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
156824468|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
156824469|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
156824470|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
156824471|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
156824472|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
156824473|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
156824474|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
156824475|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
156824476|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824477|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824478|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
156824479|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
156824480|NCT01529515|566109184|FG000|DOUBLE BLIND PHASE|Other|0|||
156824481|NCT01529515|566109185|FG001|DOUBLE BLIND PHASE|Other|0|||
156824482|NCT01529515|566109186|FG002|DOUBLE BLIND PHASE|Other|9|||
156824483|NCT01529515|566109187|FG003|DOUBLE BLIND PHASE|Other|2|||
156824484|NCT03334851|566109189|FG000|Overall Study|Other|0|||
156824485|NCT03334851|566109190|FG001|Overall Study|Other|0|||
156824486|NCT03334851|566109191|FG002|Overall Study|Other|0|||
156824487|NCT03334851|566109192|FG003|Overall Study|Other|0|||
156824488|NCT03334851|566109193|FG004|Overall Study|Other|0|||
156824489|NCT03334851|566109194|FG005|Overall Study|Other|0|||
156824490|NCT03334851|566109195|FG006|Overall Study|Other|0|||
156824491|NCT03334851|566109196|FG007|Overall Study|Other|1|||
156824492|NCT03334851|566109197|FG008|Overall Study|Other|0|||
156824493|NCT03334851|566109198|FG009|Overall Study|Other|0|||
156824494|NCT03334851|566109199|FG010|Overall Study|Other|0|||
156824495|NCT03334851|566109200|FG011|Overall Study|Other|0|||
156824496|NCT03334851|566109201|FG012|Overall Study|Other|0|||
156824497|NCT03334851|566109189|FG000|Overall Study|Adverse Event|0|||
156824498|NCT03334851|566109190|FG001|Overall Study|Adverse Event|0|||
156824499|NCT03334851|566109191|FG002|Overall Study|Adverse Event|0|||
156824500|NCT03334851|566109192|FG003|Overall Study|Adverse Event|0|||
156824501|NCT03334851|566109193|FG004|Overall Study|Adverse Event|0|||
156824502|NCT03334851|566109194|FG005|Overall Study|Adverse Event|0|||
156824503|NCT03334851|566109195|FG006|Overall Study|Adverse Event|0|||
156824504|NCT03334851|566109196|FG007|Overall Study|Adverse Event|1|||
156824505|NCT03334851|566109197|FG008|Overall Study|Adverse Event|0|||
156824506|NCT03334851|566109198|FG009|Overall Study|Adverse Event|0|||
156824507|NCT03334851|566109199|FG010|Overall Study|Adverse Event|0|||
156824508|NCT03334851|566109200|FG011|Overall Study|Adverse Event|0|||
156824509|NCT03334851|566109201|FG012|Overall Study|Adverse Event|0|||
156824510|NCT03334851|566109189|FG000|Overall Study|Withdrawal by Subject|0|||
156824511|NCT03334851|566109190|FG001|Overall Study|Withdrawal by Subject|0|||
156824512|NCT03334851|566109191|FG002|Overall Study|Withdrawal by Subject|0|||
156824513|NCT03334851|566109192|FG003|Overall Study|Withdrawal by Subject|0|||
156824514|NCT03334851|566109193|FG004|Overall Study|Withdrawal by Subject|0|||
156824515|NCT03334851|566109194|FG005|Overall Study|Withdrawal by Subject|0|||
156824516|NCT03334851|566109195|FG006|Overall Study|Withdrawal by Subject|0|||
156824517|NCT03334851|566109196|FG007|Overall Study|Withdrawal by Subject|0|||
156824518|NCT03334851|566109197|FG008|Overall Study|Withdrawal by Subject|0|||
156824519|NCT03334851|566109198|FG009|Overall Study|Withdrawal by Subject|0|||
156824520|NCT03334851|566109199|FG010|Overall Study|Withdrawal by Subject|1|||
156824521|NCT03334851|566109200|FG011|Overall Study|Withdrawal by Subject|0|||
156824522|NCT03334851|566109201|FG012|Overall Study|Withdrawal by Subject|1|||
156824523|NCT03334851|566109189|FG000|Overall Study|Lost to Follow-up|0|||
156824524|NCT03334851|566109190|FG001|Overall Study|Lost to Follow-up|0|||
156824525|NCT03334851|566109191|FG002|Overall Study|Lost to Follow-up|0|||
156824526|NCT03334851|566109192|FG003|Overall Study|Lost to Follow-up|0|||
156824527|NCT03334851|566109193|FG004|Overall Study|Lost to Follow-up|0|||
156824528|NCT03334851|566109194|FG005|Overall Study|Lost to Follow-up|0|||
156824529|NCT03334851|566109195|FG006|Overall Study|Lost to Follow-up|0|||
156824530|NCT03334851|566109196|FG007|Overall Study|Lost to Follow-up|0|||
156824531|NCT03334851|566109197|FG008|Overall Study|Lost to Follow-up|0|||
156824532|NCT03334851|566109198|FG009|Overall Study|Lost to Follow-up|0|||
156824533|NCT03334851|566109199|FG010|Overall Study|Lost to Follow-up|2|||
156824534|NCT03334851|566109200|FG011|Overall Study|Lost to Follow-up|1|||
156824535|NCT03334851|566109201|FG012|Overall Study|Lost to Follow-up|0|||
156824536|NCT03327220|566109202|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
156824537|NCT03327220|566109203|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
156824538|NCT03327220|566109202|FG000|Overall Study|Investigator Decision|2|||
156824539|NCT03327220|566109203|FG001|Overall Study|Investigator Decision|0|||
156824540|NCT03327220|566109202|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
156824541|NCT03327220|566109203|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
156824542|NCT03327220|566109202|FG000|Overall Study|Fungal infection|1|||
156824543|NCT03327220|566109203|FG001|Overall Study|Fungal infection|0|||
156824544|NCT03327220|566109202|FG000|Overall Study|Discharged to Rehabilitation|0|||
156824545|NCT03327220|566109203|FG001|Overall Study|Discharged to Rehabilitation|1|||
156824546|NCT03327220|566109202|FG000|Overall Study|Missing|1|||
156824547|NCT03327220|566109203|FG001|Overall Study|Missing|0|||
156824548|NCT00523705|566109204|FG000|Overall Study|No time for study.|0|||
156824549|NCT00523705|566109205|FG001|Overall Study|No time for study.|1|||
156824550|NCT00693017|566109206|FG000|Overall Study|Sponsor Decision|2|||
156824551|NCT00693017|566109207|FG001|Overall Study|Sponsor Decision|1|||
156824552|NCT00693017|566109206|FG000|Overall Study|Death|0|||
156824553|NCT00693017|566109207|FG001|Overall Study|Death|1|||
156824554|NCT01691885|566109209|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
156824555|NCT01691885|566109210|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
156824556|NCT01691885|566109209|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
156824557|NCT01691885|566109210|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
156824558|NCT00688324|566109212|FG000|Overall Study|Withdrawal by Subject|2|||
156824559|NCT00688324|566109212|FG000|Overall Study|Physician Decision|5|||
156824560|NCT00688324|566109212|FG000|Overall Study|Lost to Follow-up|1|||
156824561|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Physician Decision|1|||
156824562|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Physician Decision|0|||
156824563|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Physician Decision|0|||
156824564|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
156824565|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
156824566|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
156824567|NCT00385944|566109216|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
156824568|NCT00385944|566109217|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
157151050|NCT00404768|567298182|FG003|Part C|Active labor|1|||
157151051|NCT00404768|567298179|FG000|Part C|Lack of Efficacy|0|||
157151052|NCT00404768|567298180|FG001|Part C|Lack of Efficacy|0|||
157151053|NCT00404768|567298181|FG002|Part C|Lack of Efficacy|0|||
156824569|NCT00385944|566109218|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
156824570|NCT00385944|566109216|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
156824571|NCT00385944|566109217|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
157151054|NCT00404768|567298182|FG003|Part C|Lack of Efficacy|2|||
156824572|NCT00385944|566109218|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
156824573|NCT00590824|566109219|FG000|Overall Study|Disease could not be resected|0|||
156824574|NCT00590824|566109220|FG001|Overall Study|Disease could not be resected|2|||
156824575|NCT00590824|566109221|FG002|Overall Study|Disease could not be resected|1|||
156824576|NCT00590824|566109222|FG003|Overall Study|Disease could not be resected|0|||
156824577|NCT00590824|566109219|FG000|Overall Study|Adverse Event|0|||
156824578|NCT00590824|566109220|FG001|Overall Study|Adverse Event|0|||
156824579|NCT00590824|566109221|FG002|Overall Study|Adverse Event|0|||
156824580|NCT00590824|566109222|FG003|Overall Study|Adverse Event|1|||
156824581|NCT01778049|566109224|FG000|Open Label Treatment Period|Adverse Event|5|||
156824582|NCT01778049|566109225|FG001|Open Label Treatment Period|Adverse Event|15|||
156824583|NCT01778049|566109226|FG002|Open Label Treatment Period|Adverse Event|0|||
156824584|NCT01778049|566109227|FG003|Open Label Treatment Period|Adverse Event|0|||
156824585|NCT01778049|566109228|FG004|Open Label Treatment Period|Adverse Event|0|||
156824586|NCT01778049|566109229|FG005|Open Label Treatment Period|Adverse Event|0|||
156824587|NCT01778049|566109224|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
156824588|NCT01778049|566109225|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
156824589|NCT01778049|566109226|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
156824590|NCT01778049|566109227|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
156824591|NCT01778049|566109228|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
156824592|NCT01778049|566109229|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
156824593|NCT01778049|566109224|FG000|Open Label Treatment Period|Protocol Violation|5|||
156824594|NCT01778049|566109225|FG001|Open Label Treatment Period|Protocol Violation|5|||
156824595|NCT01778049|566109226|FG002|Open Label Treatment Period|Protocol Violation|0|||
156824596|NCT01778049|566109227|FG003|Open Label Treatment Period|Protocol Violation|0|||
156824597|NCT01778049|566109228|FG004|Open Label Treatment Period|Protocol Violation|0|||
156824598|NCT01778049|566109229|FG005|Open Label Treatment Period|Protocol Violation|0|||
156824599|NCT01778049|566109224|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
156824600|NCT01778049|566109225|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
156824601|NCT01778049|566109226|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
156824602|NCT01778049|566109227|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
156824603|NCT01778049|566109228|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
156824604|NCT01778049|566109229|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
156824605|NCT01778049|566109224|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
156824606|NCT01778049|566109225|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
156824607|NCT01778049|566109226|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
156824608|NCT01778049|566109227|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
156824609|NCT01778049|566109228|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
156824610|NCT01778049|566109229|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
156824611|NCT01778049|566109224|FG000|Open Label Treatment Period|Not treated|2|||
156824612|NCT01778049|566109225|FG001|Open Label Treatment Period|Not treated|1|||
156824613|NCT01778049|566109226|FG002|Open Label Treatment Period|Not treated|0|||
156824614|NCT01778049|566109227|FG003|Open Label Treatment Period|Not treated|0|||
156824615|NCT01778049|566109228|FG004|Open Label Treatment Period|Not treated|0|||
156824616|NCT01778049|566109229|FG005|Open Label Treatment Period|Not treated|0|||
156824617|NCT01778049|566109224|FG000|Open Label Treatment Period|Other reason not defined above|77|||
156824618|NCT01778049|566109225|FG001|Open Label Treatment Period|Other reason not defined above|94|||
156824619|NCT01778049|566109226|FG002|Open Label Treatment Period|Other reason not defined above|0|||
156824620|NCT01778049|566109227|FG003|Open Label Treatment Period|Other reason not defined above|0|||
156824621|NCT01778049|566109228|FG004|Open Label Treatment Period|Other reason not defined above|0|||
156824622|NCT01778049|566109229|FG005|Open Label Treatment Period|Other reason not defined above|0|||
156824623|NCT01778049|566109224|FG000|Double Blind Treatment Period|Adverse Event|0|||
156824624|NCT01778049|566109225|FG001|Double Blind Treatment Period|Adverse Event|0|||
156824625|NCT01778049|566109226|FG002|Double Blind Treatment Period|Adverse Event|4|||
156824626|NCT01778049|566109227|FG003|Double Blind Treatment Period|Adverse Event|5|||
156824627|NCT01778049|566109228|FG004|Double Blind Treatment Period|Adverse Event|3|||
156824628|NCT01778049|566109229|FG005|Double Blind Treatment Period|Adverse Event|2|||
156824629|NCT01778049|566109224|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
156824630|NCT01778049|566109225|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156884705|NCT00895011|566336333|FG000|Overall Study|Adverse Event|1|||
157151055|NCT00404768|567298179|FG000|Part C|Treatment failure|0|||
157151056|NCT00404768|567298180|FG001|Part C|Treatment failure|0|||
157151057|NCT00404768|567298181|FG002|Part C|Treatment failure|0|||
157151058|NCT00404768|567298182|FG003|Part C|Treatment failure|1|||
156824631|NCT01778049|566109226|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156824632|NCT01778049|566109227|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156824633|NCT01778049|566109228|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
156824634|NCT01778049|566109229|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
156824635|NCT01778049|566109224|FG000|Double Blind Treatment Period|Protocol Violation|0|||
156824636|NCT01778049|566109225|FG001|Double Blind Treatment Period|Protocol Violation|0|||
157151059|NCT00404768|567298179|FG000|Part C|Investigator discretion|0|||
157151060|NCT00404768|567298180|FG001|Part C|Investigator discretion|0|||
156884706|NCT00895011|566336334|FG001|Overall Study|Adverse Event|2|||
156884707|NCT00895011|566336335|FG002|Overall Study|Adverse Event|2|||
156884708|NCT00895011|566336333|FG000|Overall Study|schedule conflict|1|||
156884709|NCT00895011|566336334|FG001|Overall Study|schedule conflict|0|||
156884710|NCT00895011|566336335|FG002|Overall Study|schedule conflict|0|||
156884711|NCT02661178|566336343|FG000|Part 1|Protocol Violation|1|||
156884712|NCT02661178|566336344|FG001|Part 1|Protocol Violation|0|||
156884713|NCT02661178|566336345|FG002|Part 1|Protocol Violation|0|||
156884714|NCT02661178|566336346|FG003|Part 1|Protocol Violation|0|||
156884715|NCT02661178|566336347|FG004|Part 1|Protocol Violation|0|||
156884716|NCT02661178|566336348|FG005|Part 1|Protocol Violation|0|||
156884717|NCT02661178|566336349|FG006|Part 1|Protocol Violation|0|||
156884718|NCT02661178|566336350|FG007|Part 1|Protocol Violation|0|||
156884719|NCT02661178|566336351|FG008|Part 1|Protocol Violation|0|||
156884720|NCT02661178|566336352|FG009|Part 1|Protocol Violation|0|||
156884721|NCT02661178|566336353|FG010|Part 1|Protocol Violation|0|||
156884722|NCT02661178|566336354|FG011|Part 1|Protocol Violation|0|||
156884723|NCT02661178|566336355|FG012|Part 1|Protocol Violation|0|||
157022813|NCT01785719|566836868|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
156824637|NCT01778049|566109226|FG002|Double Blind Treatment Period|Protocol Violation|2|||
156824638|NCT01778049|566109227|FG003|Double Blind Treatment Period|Protocol Violation|0|||
156824639|NCT01778049|566109228|FG004|Double Blind Treatment Period|Protocol Violation|0|||
156824640|NCT01778049|566109229|FG005|Double Blind Treatment Period|Protocol Violation|0|||
156824641|NCT01778049|566109224|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156824642|NCT01778049|566109225|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156824643|NCT01778049|566109226|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
156824644|NCT01778049|566109227|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
156824645|NCT01778049|566109228|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
156824646|NCT01778049|566109229|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
156824647|NCT01778049|566109224|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824648|NCT01778049|566109225|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824649|NCT01778049|566109226|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
156824650|NCT01778049|566109227|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
156824651|NCT01778049|566109228|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
156824652|NCT01778049|566109229|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
156824653|NCT01778049|566109224|FG000|Double Blind Treatment Period|Not treated|0|||
156824654|NCT01778049|566109225|FG001|Double Blind Treatment Period|Not treated|0|||
156824655|NCT01778049|566109226|FG002|Double Blind Treatment Period|Not treated|0|||
156824656|NCT01778049|566109227|FG003|Double Blind Treatment Period|Not treated|2|||
156824657|NCT01778049|566109228|FG004|Double Blind Treatment Period|Not treated|2|||
156824658|NCT01778049|566109229|FG005|Double Blind Treatment Period|Not treated|0|||
156824659|NCT01778049|566109224|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
156824660|NCT01778049|566109225|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
156824661|NCT01778049|566109226|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
156824662|NCT01778049|566109227|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
156824663|NCT01778049|566109228|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
156824664|NCT01778049|566109229|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
156824665|NCT01895543|566109232|FG000|Overall Study|Withdrawal by Subject|43|||
156824666|NCT01895543|566109232|FG000|Overall Study|Lost to Follow-up|25|||
156824667|NCT01895543|566109232|FG000|Overall Study|Adverse Event|28|||
156824668|NCT01895543|566109232|FG000|Overall Study|Subject's substantial non-compliance|6|||
156824669|NCT01895543|566109232|FG000|Overall Study|Protocol Violation|1|||
156824670|NCT01895543|566109232|FG000|Overall Study|Physician Decision|2|||
156824671|NCT01895543|566109232|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
156824672|NCT04262882|566109233|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
156824673|NCT04262882|566109234|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
156824674|NCT04262882|566109233|FG000|Overall Study|Lost to Follow-up|1|||
156824675|NCT04262882|566109234|FG001|Overall Study|Lost to Follow-up|0|||
156824676|NCT00443053|566109236|FG000|Overall Study|Adverse Event|2|||
156824677|NCT00443053|566109237|FG001|Overall Study|Adverse Event|1|||
156824678|NCT00443053|566109236|FG000|Overall Study|Withdrawal by Subject|9|||
156824679|NCT00443053|566109237|FG001|Overall Study|Withdrawal by Subject|18|||
156884724|NCT02661178|566336356|FG013|Part 1|Protocol Violation|0|||
156884725|NCT02661178|566336357|FG014|Part 1|Protocol Violation|0|||
156824680|NCT00443053|566109236|FG000|Overall Study|Lost to Follow-up|4|||
156824681|NCT00443053|566109237|FG001|Overall Study|Lost to Follow-up|5|||
156824682|NCT00443053|566109236|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
156884726|NCT05338671|566336358|FG000|Overall Study|Lost to Follow-up|2|||
156884727|NCT05338671|566336359|FG001|Overall Study|Lost to Follow-up|2|||
156884728|NCT05338671|566336358|FG000|Overall Study|Root canal completed in a single visit|1|||
156884729|NCT05338671|566336359|FG001|Overall Study|Root canal completed in a single visit|0|||
156884730|NCT03859973|566336360|FG000|Overall Study|Other reason than listed|3|||
156884731|NCT03859973|566336361|FG001|Overall Study|Other reason than listed|2|||
156824683|NCT00443053|566109237|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156824684|NCT00443053|566109236|FG000|Overall Study|Noncompliance|2|||
156824685|NCT00443053|566109237|FG001|Overall Study|Noncompliance|1|||
156824686|NCT00443053|566109236|FG000|Overall Study|Other|3|||
156824687|NCT00443053|566109237|FG001|Overall Study|Other|4|||
156824688|NCT00443053|566109236|FG000|Overall Study|Physician Decision|0|||
156824689|NCT00443053|566109237|FG001|Overall Study|Physician Decision|4|||
156824690|NCT00541866|566109238|FG000|Overall Study|Adverse Event|3|||
156824691|NCT00541866|566109239|FG001|Overall Study|Adverse Event|0|||
156824692|NCT00541866|566109240|FG002|Overall Study|Adverse Event|0|||
156824693|NCT00541866|566109241|FG003|Overall Study|Adverse Event|0|||
156824694|NCT00541866|566109242|FG004|Overall Study|Adverse Event|0|||
156824695|NCT00541866|566109238|FG000|Overall Study|Death|1|||
156824696|NCT00541866|566109239|FG001|Overall Study|Death|0|||
156824697|NCT00541866|566109240|FG002|Overall Study|Death|0|||
156824698|NCT00541866|566109241|FG003|Overall Study|Death|0|||
156824699|NCT00541866|566109242|FG004|Overall Study|Death|0|||
156824700|NCT00541866|566109238|FG000|Overall Study|Lack of Efficacy|19|||
156824701|NCT00541866|566109239|FG001|Overall Study|Lack of Efficacy|15|||
156824702|NCT00541866|566109240|FG002|Overall Study|Lack of Efficacy|10|||
156824703|NCT00541866|566109241|FG003|Overall Study|Lack of Efficacy|12|||
156824704|NCT00541866|566109242|FG004|Overall Study|Lack of Efficacy|14|||
156824705|NCT00541866|566109238|FG000|Overall Study|Not Reported or Other|11|||
156824706|NCT00541866|566109239|FG001|Overall Study|Not Reported or Other|3|||
156824707|NCT00541866|566109240|FG002|Overall Study|Not Reported or Other|3|||
156824708|NCT00541866|566109241|FG003|Overall Study|Not Reported or Other|3|||
156824709|NCT00541866|566109242|FG004|Overall Study|Not Reported or Other|1|||
156824710|NCT00541866|566109238|FG000|Overall Study|Physician Decision|0|||
156824711|NCT00541866|566109239|FG001|Overall Study|Physician Decision|0|||
156824712|NCT00541866|566109240|FG002|Overall Study|Physician Decision|2|||
156824713|NCT00541866|566109241|FG003|Overall Study|Physician Decision|1|||
156824714|NCT00541866|566109242|FG004|Overall Study|Physician Decision|0|||
156824715|NCT00522418|566109243|FG000|Overall Study|Local IRB Consent Violation|5|||
156824716|NCT00522418|566109244|FG001|Overall Study|Local IRB Consent Violation|5|||
156824717|NCT00522418|566109243|FG000|Overall Study|Early Study Termination|46|||
156824718|NCT00522418|566109244|FG001|Overall Study|Early Study Termination|47|||
156824719|NCT00522418|566109243|FG000|Overall Study|Noncompliance|2|||
156824720|NCT00522418|566109244|FG001|Overall Study|Noncompliance|2|||
156824721|NCT00522418|566109243|FG000|Overall Study|Reason Not Specified|3|||
156824722|NCT00522418|566109244|FG001|Overall Study|Reason Not Specified|1|||
156824723|NCT00522418|566109243|FG000|Overall Study|Consent Withdraw|1|||
156824724|NCT00522418|566109244|FG001|Overall Study|Consent Withdraw|2|||
156824725|NCT00522418|566109243|FG000|Overall Study|Lack of Efficacy|0|||
156824726|NCT00522418|566109244|FG001|Overall Study|Lack of Efficacy|1|||
156824727|NCT00578877|566109245|FG000|Overall Study|Lost to Follow-up|8|||
156824728|NCT00578877|566109246|FG001|Overall Study|Lost to Follow-up|10|||
156824729|NCT00578877|566109245|FG000|Overall Study|early discontinue|61|||
156824730|NCT00578877|566109246|FG001|Overall Study|early discontinue|101|||
156824731|NCT00578877|566109245|FG000|Overall Study|did not provide follow-up data|12|||
156824732|NCT00578877|566109246|FG001|Overall Study|did not provide follow-up data|17|||
156824733|NCT02256384|566109252|FG000|Overall Study|Withdrawal by Subject|12|||
156824734|NCT02256384|566109252|FG000|Overall Study|Equipment not capturing data|2|||
156824735|NCT02136680|566109253|FG000|Overall Study|No Longer Interested|1|||
156824736|NCT02136680|566109254|FG001|Overall Study|No Longer Interested|1|||
156824737|NCT02136680|566109253|FG000|Overall Study|No longer receiving care at clinic|3|||
156824738|NCT02136680|566109254|FG001|Overall Study|No longer receiving care at clinic|5|||
157151061|NCT00404768|567298181|FG002|Part C|Investigator discretion|0|||
157151062|NCT00404768|567298182|FG003|Part C|Investigator discretion|1|||
157151063|NCT00404768|567298179|FG000|Part C|Researcher suspended study medication|0|||
157151064|NCT00404768|567298180|FG001|Part C|Researcher suspended study medication|0|||
157151065|NCT00404768|567298181|FG002|Part C|Researcher suspended study medication|0|||
156824739|NCT02136680|566109253|FG000|Overall Study|Moved away|5|||
156824740|NCT02136680|566109254|FG001|Overall Study|Moved away|4|||
156824741|NCT02136680|566109253|FG000|Overall Study|Unable to schedule|17|||
156824742|NCT02136680|566109254|FG001|Overall Study|Unable to schedule|16|||
156824743|NCT02136680|566109253|FG000|Overall Study|Study ended before interview due|6|||
156824744|NCT02136680|566109254|FG001|Overall Study|Study ended before interview due|3|||
156824745|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
156824746|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
156824747|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
157151066|NCT00404768|567298182|FG003|Part C|Researcher suspended study medication|1|||
157151067|NCT03575468|567298183|FG000|Overall Study|Withdrawal by Subject|3|||
157151068|NCT03575468|567298184|FG001|Overall Study|Withdrawal by Subject|0|||
156824748|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
156824749|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
156824750|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
156824751|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
156824752|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
156824753|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
156824754|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
156824755|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
156824756|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
156824757|NCT01632241|566109255|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
156824758|NCT01632241|566109256|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
156824759|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
156824760|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
156824761|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
156824762|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
156824763|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
156824764|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
156824765|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
156824766|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
156824767|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
156824768|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
156824769|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
156824770|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
156824771|NCT01632241|566109255|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
156824772|NCT01632241|566109256|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
156824773|NCT01638013|566109257|FG000|Overall Study|Adverse Event|36|||
156824774|NCT01638013|566109258|FG001|Overall Study|Adverse Event|29|||
156824775|NCT01638013|566109259|FG002|Overall Study|Adverse Event|48|||
156824776|NCT01638013|566109257|FG000|Overall Study|Lack of Efficacy|39|||
156824777|NCT01638013|566109258|FG001|Overall Study|Lack of Efficacy|11|||
156824778|NCT01638013|566109259|FG002|Overall Study|Lack of Efficacy|14|||
156824779|NCT01638013|566109257|FG000|Overall Study|Protocol Violation|10|||
156824780|NCT01638013|566109258|FG001|Overall Study|Protocol Violation|7|||
156824781|NCT01638013|566109259|FG002|Overall Study|Protocol Violation|11|||
156824782|NCT01638013|566109257|FG000|Overall Study|Met discontinuation criteria|4|||
156824783|NCT01638013|566109258|FG001|Overall Study|Met discontinuation criteria|0|||
156824784|NCT01638013|566109259|FG002|Overall Study|Met discontinuation criteria|7|||
156824785|NCT01638013|566109257|FG000|Overall Study|Subject Lost to Follow up|1|||
156824786|NCT01638013|566109258|FG001|Overall Study|Subject Lost to Follow up|0|||
156824787|NCT01638013|566109259|FG002|Overall Study|Subject Lost to Follow up|1|||
156824788|NCT01638013|566109257|FG000|Overall Study|Miscellaneous|25|||
156824789|NCT01638013|566109258|FG001|Overall Study|Miscellaneous|19|||
156824790|NCT01638013|566109259|FG002|Overall Study|Miscellaneous|23|||
156824791|NCT01638013|566109257|FG000|Overall Study|Withdrawal of Consent|16|||
156824792|NCT01638013|566109258|FG001|Overall Study|Withdrawal of Consent|12|||
156824793|NCT01638013|566109259|FG002|Overall Study|Withdrawal of Consent|16|||
156824794|NCT01638013|566109257|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
156824795|NCT01638013|566109258|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
156824796|NCT01638013|566109259|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
156824797|NCT01145352|566111012|FG000|Overall Study|Found to have been registered twice|6|||
156824798|NCT01145352|566111012|FG000|Overall Study|Treated before marketing approval|4|||
156824799|NCT01145352|566111012|FG000|Overall Study|Syringe formulation was used|1|||
156824800|NCT03095027|566111013|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
156824801|NCT03095027|566111014|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
156824802|NCT02982018|566111015|FG000|Overall Study|Incorrect Lens Dispensed|1|||
156824803|NCT02982018|566111016|FG001|Overall Study|Incorrect Lens Dispensed|0|||
156824804|NCT02982018|566111015|FG000|Overall Study|Protocol Violation|1|||
156824805|NCT02982018|566111016|FG001|Overall Study|Protocol Violation|1|||
156824806|NCT02982018|566111015|FG000|Overall Study|Adverse Event|1|||
156824807|NCT02982018|566111016|FG001|Overall Study|Adverse Event|1|||
156824808|NCT02982018|566111015|FG000|Overall Study|Lens Discomfort|2|||
156824809|NCT02982018|566111016|FG001|Overall Study|Lens Discomfort|0|||
156824810|NCT02982018|566111015|FG000|Overall Study|Withdrawal by Subject|0|||
156824811|NCT02982018|566111016|FG001|Overall Study|Withdrawal by Subject|1|||
156824812|NCT02251717|566111018|FG000|Overall Study|Adverse Event|0|||
156824813|NCT02251717|566111019|FG001|Overall Study|Adverse Event|1|||
156884732|NCT03859973|566336360|FG000|Overall Study|COVID-19 related, not due to AE|3|||
156884733|NCT03859973|566336361|FG001|Overall Study|COVID-19 related, not due to AE|4|||
156824814|NCT02251717|566111018|FG000|Overall Study|Withdrew Consent|1|||
156824815|NCT02251717|566111019|FG001|Overall Study|Withdrew Consent|0|||
156824816|NCT04098367|566111020|FG000|Overall Study|Adverse Event|0|||
156824817|NCT04098367|566111021|FG001|Overall Study|Adverse Event|0|||
156824818|NCT04098367|566111022|FG002|Overall Study|Adverse Event|1|||
156884734|NCT03859973|566336360|FG000|Overall Study|Withdrawal by Subject|8|||
156884735|NCT03859973|566336361|FG001|Overall Study|Withdrawal by Subject|9|||
156824819|NCT04098367|566111020|FG000|Overall Study|Lost to Follow-up|1|||
156884736|NCT03859973|566336360|FG000|Overall Study|Lost to Follow-up|2|||
156884737|NCT03859973|566336361|FG001|Overall Study|Lost to Follow-up|3|||
156824820|NCT04098367|566111021|FG001|Overall Study|Lost to Follow-up|5|||
156824821|NCT04098367|566111022|FG002|Overall Study|Lost to Follow-up|2|||
156824822|NCT04098367|566111020|FG000|Overall Study|Withdrawal by Subject|0|||
156824823|NCT04098367|566111021|FG001|Overall Study|Withdrawal by Subject|0|||
156824824|NCT04098367|566111022|FG002|Overall Study|Withdrawal by Subject|1|||
156824825|NCT04098367|566111020|FG000|Overall Study|Sick . Could not attend visit|1|||
156824826|NCT04098367|566111021|FG001|Overall Study|Sick . Could not attend visit|0|||
156824827|NCT04098367|566111022|FG002|Overall Study|Sick . Could not attend visit|0|||
156824828|NCT00322023|566111023|FG000|Overall Study|various|0|||
156824829|NCT00322023|566111024|FG001|Overall Study|various|2|||
156824830|NCT00322023|566111025|FG002|Overall Study|various|6|||
156824831|NCT03920293|566111026|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
156824832|NCT03920293|566111027|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
156824833|NCT03920293|566111026|FG000|Randomized-Controlled Period|Physician Decision|1|||
156824834|NCT03920293|566111027|FG001|Randomized-Controlled Period|Physician Decision|2|||
156824835|NCT03920293|566111026|FG000|Randomized-Controlled Period|Adverse Event|0|||
156824836|NCT03920293|566111027|FG001|Randomized-Controlled Period|Adverse Event|2|||
156824837|NCT03920293|566111026|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
156824838|NCT03920293|566111027|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
156824839|NCT03920293|566111026|FG000|Randomized-Controlled Period|Death|2|||
156824840|NCT03920293|566111027|FG001|Randomized-Controlled Period|Death|0|||
156824841|NCT03920293|566111026|FG000|Randomized-Controlled Period|Protocol Violation|1|||
156824842|NCT03920293|566111027|FG001|Randomized-Controlled Period|Protocol Violation|0|||
156824843|NCT03920293|566111026|FG000|Randomized-Controlled Period|Noncompliance|1|||
156824844|NCT03920293|566111027|FG001|Randomized-Controlled Period|Noncompliance|0|||
156824845|NCT03920293|566111026|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
156824846|NCT03920293|566111027|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
156824847|NCT03920293|566111026|FG000|Open- Label Extension Period|Death|3|||
156824848|NCT03920293|566111027|FG001|Open- Label Extension Period|Death|3|||
156824849|NCT03920293|566111026|FG000|Open- Label Extension Period|Physician Decision|5|||
156824850|NCT03920293|566111027|FG001|Open- Label Extension Period|Physician Decision|3|||
156824851|NCT03920293|566111026|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
156824852|NCT03920293|566111027|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
156824853|NCT01972308|566111028|FG000|Overall Study|Withdrawal by Subject|0|||
156824854|NCT01972308|566111029|FG001|Overall Study|Withdrawal by Subject|1|||
156824855|NCT01972308|566111028|FG000|Overall Study|Lost to Follow-up|4|||
156824856|NCT01972308|566111029|FG001|Overall Study|Lost to Follow-up|6|||
156824857|NCT01972308|566111028|FG000|Overall Study|Death|4|||
156824858|NCT01972308|566111029|FG001|Overall Study|Death|1|||
156824859|NCT01562314|566111030|FG000|Overall Study|Adverse Event|10|||
156824860|NCT01562314|566111031|FG001|Overall Study|Adverse Event|5|||
156824861|NCT01562314|566111030|FG000|Overall Study|Met Withdrawal Criteria|3|||
156824862|NCT01562314|566111031|FG001|Overall Study|Met Withdrawal Criteria|2|||
156824863|NCT01562314|566111030|FG000|Overall Study|Withdrawal by Subject|0|||
156824864|NCT01562314|566111031|FG001|Overall Study|Withdrawal by Subject|1|||
156824865|NCT01190475|566111034|FG000|Overall Study|Withdrawal by Subject|0|||
156824866|NCT01190475|566111035|FG001|Overall Study|Withdrawal by Subject|0|||
156824867|NCT01190475|566111036|FG002|Overall Study|Withdrawal by Subject|1|||
156824868|NCT00543803|566111037|FG000|Overall Study|Adverse Event|14|||
157151069|NCT03575468|567298183|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
157151070|NCT03575468|567298184|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
157151071|NCT03575468|567298183|FG000|Overall Study|Lost to Follow-up|13|||
157151072|NCT03575468|567298184|FG001|Overall Study|Lost to Follow-up|17|||
157151073|NCT01522651|567298187|FG000|Overall Study|Adverse Event|3|||
156824869|NCT00543803|566111037|FG000|Overall Study|Lack of Efficacy|22|||
156824870|NCT00543803|566111037|FG000|Overall Study|Lost to Follow-up|20|||
156824871|NCT00543803|566111037|FG000|Overall Study|Other|86|||
156824872|NCT00996281|566111038|FG000|Overall Study|Adverse Event|75|||
156824873|NCT00996281|566111039|FG001|Overall Study|Adverse Event|37|||
156824874|NCT00996281|566111038|FG000|Overall Study|Major Protocol Deviation|6|||
156884738|NCT03859973|566336360|FG000|Overall Study|Protocol Violation|1|||
157151074|NCT01522651|567298188|FG001|Overall Study|Adverse Event|4|||
157151075|NCT01522651|567298189|FG002|Overall Study|Adverse Event|4|||
157151076|NCT01522651|567298190|FG003|Overall Study|Adverse Event|5|||
156824875|NCT00996281|566111039|FG001|Overall Study|Major Protocol Deviation|7|||
156824876|NCT00996281|566111038|FG000|Overall Study|Lost to Follow-up|14|||
156824877|NCT00996281|566111039|FG001|Overall Study|Lost to Follow-up|16|||
156824878|NCT00996281|566111038|FG000|Overall Study|Withdrawal by Subject|31|||
156824879|NCT00996281|566111039|FG001|Overall Study|Withdrawal by Subject|20|||
156824880|NCT00996281|566111038|FG000|Overall Study|Lack of Efficacy|0|||
156824881|NCT00996281|566111039|FG001|Overall Study|Lack of Efficacy|2|||
156824882|NCT00996281|566111038|FG000|Overall Study|Other|5|||
156824883|NCT00996281|566111039|FG001|Overall Study|Other|7|||
156824884|NCT03505788|566111042|FG000|Overall Study|Lost to Follow-up|2|||
156824885|NCT03505788|566111043|FG001|Overall Study|Lost to Follow-up|1|||
156824886|NCT03505788|566111042|FG000|Overall Study|Withdrawal by Subject|1|||
156824887|NCT03505788|566111043|FG001|Overall Study|Withdrawal by Subject|3|||
156824888|NCT03505788|566111042|FG000|Overall Study|Physician Decision|0|||
156824889|NCT03505788|566111043|FG001|Overall Study|Physician Decision|1|||
156824890|NCT03575065|566111044|FG000|Overall Study|Death|31|||
156824891|NCT03575065|566111045|FG001|Overall Study|Death|12|||
156824892|NCT03575065|566111044|FG000|Overall Study|Sponsor's Decision|28|||
156824893|NCT03575065|566111045|FG001|Overall Study|Sponsor's Decision|13|||
156824894|NCT03575065|566111044|FG000|Overall Study|Withdrawal by Subject|2|||
156824895|NCT03575065|566111045|FG001|Overall Study|Withdrawal by Subject|1|||
156824896|NCT03575065|566111044|FG000|Overall Study|Lost to Follow-up|1|||
156824897|NCT03575065|566111045|FG001|Overall Study|Lost to Follow-up|0|||
156824898|NCT02323126|566111050|FG000|Overall Study|Patient / guardian decision|0|||
156824899|NCT02323126|566111051|FG001|Overall Study|Patient / guardian decision|1|||
156824900|NCT02323126|566111052|FG002|Overall Study|Patient / guardian decision|2|||
156824901|NCT02323126|566111050|FG000|Overall Study|Progressive disease|14|||
156824902|NCT02323126|566111051|FG001|Overall Study|Progressive disease|8|||
156824903|NCT02323126|566111052|FG002|Overall Study|Progressive disease|14|||
156824904|NCT02323126|566111050|FG000|Overall Study|Physician Decision|0|||
156824905|NCT02323126|566111051|FG001|Overall Study|Physician Decision|1|||
156824906|NCT02323126|566111052|FG002|Overall Study|Physician Decision|3|||
156824907|NCT02323126|566111050|FG000|Overall Study|Death|1|||
156824908|NCT02323126|566111051|FG001|Overall Study|Death|1|||
156824909|NCT02323126|566111052|FG002|Overall Study|Death|4|||
156824910|NCT02323126|566111050|FG000|Overall Study|Adverse Event|3|||
156824911|NCT02323126|566111051|FG001|Overall Study|Adverse Event|5|||
156824912|NCT02323126|566111052|FG002|Overall Study|Adverse Event|7|||
156824913|NCT00396136|566111053|FG000|Overall Study|Death|43|||
156824914|NCT00396136|566111053|FG000|Overall Study|Withdrawal by Subject|59|||
156824915|NCT00396136|566111053|FG000|Overall Study|Lost to Follow-up|15|||
156824916|NCT00396136|566111053|FG000|Overall Study|Study device explanted|8|||
156824917|NCT01779856|566111054|FG000|Overall Study|Withdrawal by Subject|15|||
156824918|NCT01779856|566111054|FG000|Overall Study|Death|3|||
156824919|NCT01779856|566111054|FG000|Overall Study|Physician Decision|1|||
156824920|NCT01779856|566111054|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
156824921|NCT01779856|566111054|FG000|Overall Study|Delays in scheduling implant|1|||
156824922|NCT01779856|566111054|FG000|Overall Study|Subject ineligible for Implant|2|||
156824923|NCT03960580|566111058|FG000|Overall Study|Adverse Event|2|||
156824924|NCT03960580|566111059|FG001|Overall Study|Adverse Event|1|||
156824925|NCT03960580|566111060|FG002|Overall Study|Adverse Event|1|||
156824926|NCT03960580|566111058|FG000|Overall Study|Lost to Follow-up|1|||
156824927|NCT03960580|566111059|FG001|Overall Study|Lost to Follow-up|0|||
156824928|NCT03960580|566111060|FG002|Overall Study|Lost to Follow-up|0|||
156824929|NCT03960580|566111058|FG000|Overall Study|Lack of Efficacy|2|||
156824930|NCT03960580|566111059|FG001|Overall Study|Lack of Efficacy|1|||
156824931|NCT03960580|566111060|FG002|Overall Study|Lack of Efficacy|0|||
156824932|NCT03960580|566111058|FG000|Overall Study|Protocol Violation|0|||
156824933|NCT03960580|566111059|FG001|Overall Study|Protocol Violation|0|||
156824934|NCT03960580|566111060|FG002|Overall Study|Protocol Violation|1|||
156824935|NCT03960580|566111058|FG000|Overall Study|Withdrawal by Subject|1|||
156824936|NCT03960580|566111059|FG001|Overall Study|Withdrawal by Subject|1|||
156824937|NCT03960580|566111060|FG002|Overall Study|Withdrawal by Subject|1|||
156824938|NCT03960580|566111058|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
156824939|NCT03960580|566111059|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
156824940|NCT03960580|566111060|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
156824941|NCT01703208|566111063|FG000|Overall Study|Death|61|||
156824942|NCT01703208|566111064|FG001|Overall Study|Death|48|||
156824943|NCT01703208|566111063|FG000|Overall Study|Lack of Efficacy|1|||
156824944|NCT01703208|566111064|FG001|Overall Study|Lack of Efficacy|2|||
156824945|NCT01703208|566111063|FG000|Overall Study|Lost to Follow-up|68|||
156824946|NCT01703208|566111064|FG001|Overall Study|Lost to Follow-up|62|||
156824947|NCT01703208|566111063|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156824948|NCT01703208|566111064|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156824949|NCT01703208|566111063|FG000|Overall Study|Excluded Medication|1|||
156824950|NCT01703208|566111064|FG001|Overall Study|Excluded Medication|2|||
156824951|NCT01703208|566111063|FG000|Overall Study|Site Discontinued Study Participation|23|||
156824952|NCT01703208|566111064|FG001|Overall Study|Site Discontinued Study Participation|27|||
156824953|NCT01703208|566111063|FG000|Overall Study|Physician Decision|11|||
156824954|NCT01703208|566111064|FG001|Overall Study|Physician Decision|13|||
156824955|NCT01703208|566111063|FG000|Overall Study|Progressive disease|2|||
156824956|NCT01703208|566111064|FG001|Overall Study|Progressive disease|2|||
156824957|NCT01703208|566111063|FG000|Overall Study|Protocol Violation|1|||
156824958|NCT01703208|566111064|FG001|Overall Study|Protocol Violation|1|||
156824959|NCT01703208|566111063|FG000|Overall Study|Study Terminated by Sponsor|1710|||
156824960|NCT01703208|566111064|FG001|Overall Study|Study Terminated by Sponsor|1716|||
156824961|NCT01703208|566111063|FG000|Overall Study|Withdrawal by Subject|205|||
156824962|NCT01703208|566111064|FG001|Overall Study|Withdrawal by Subject|209|||
156824963|NCT01703208|566111063|FG000|Overall Study|Adverse Event|14|||
156824964|NCT01703208|566111064|FG001|Overall Study|Adverse Event|19|||
156824965|NCT01703208|566111063|FG000|Overall Study|Technical Problems|0|||
156824966|NCT01703208|566111064|FG001|Overall Study|Technical Problems|1|||
156824967|NCT01703208|566111063|FG000|Overall Study|Protocol Deviation|2|||
156824968|NCT01703208|566111064|FG001|Overall Study|Protocol Deviation|0|||
156824969|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
156824970|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
156824971|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
156824972|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
156824973|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
156824974|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
156824975|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
156824976|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
156824977|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
156824978|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
156824979|NCT01639339|566111065|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
156824980|NCT01639339|566111066|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
156824981|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
156824982|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
156824983|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
156824984|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
156824985|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
156824986|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
156824987|NCT01639339|566111065|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
156824988|NCT01639339|566111066|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
156824989|NCT00252694|566111067|FG000|Overall Study|Withdrawal by Subject|83|||
156824990|NCT00252694|566111068|FG001|Overall Study|Withdrawal by Subject|91|||
156824991|NCT00252694|566111067|FG000|Overall Study|Death|36|||
156824992|NCT00252694|566111068|FG001|Overall Study|Death|34|||
156824993|NCT00252694|566111067|FG000|Overall Study|Mostly Lost to Follow Up|8|||
156824994|NCT00252694|566111068|FG001|Overall Study|Mostly Lost to Follow Up|13|||
156824995|NCT00252694|566111067|FG000|Overall Study|Patient Moving|17|||
156824996|NCT00252694|566111068|FG001|Overall Study|Patient Moving|16|||
156824997|NCT02649218|566111069|FG000|Overall Study|Adverse Event|8|||
156824998|NCT02649218|566111069|FG000|Overall Study|Lack of Efficacy|8|||
156824999|NCT02649218|566111069|FG000|Overall Study|Pregnancy|3|||
156825000|NCT02649218|566111069|FG000|Overall Study|Protocol Violation|3|||
156825001|NCT02649218|566111069|FG000|Overall Study|Physician Decision|1|||
156825002|NCT02649218|566111069|FG000|Overall Study|Withdrawal by Subject|2|||
156825003|NCT04003207|566111075|FG000|Overall Study|Protocol Violation|1|||
156825004|NCT03894969|566111077|FG000|Overall Study|Adverse Event|0|||
156825005|NCT03894969|566111078|FG001|Overall Study|Adverse Event|2|||
156825006|NCT03894969|566111079|FG002|Overall Study|Adverse Event|0|||
156825007|NCT03894969|566111080|FG003|Overall Study|Adverse Event|1|||
156825008|NCT03894969|566111081|FG004|Overall Study|Adverse Event|2|||
156825009|NCT03894969|566111077|FG000|Overall Study|Lost to Follow-up|3|||
156825010|NCT03894969|566111078|FG001|Overall Study|Lost to Follow-up|1|||
156825011|NCT03894969|566111079|FG002|Overall Study|Lost to Follow-up|1|||
156825012|NCT03894969|566111080|FG003|Overall Study|Lost to Follow-up|0|||
156825013|NCT03894969|566111081|FG004|Overall Study|Lost to Follow-up|0|||
156825014|NCT03894969|566111077|FG000|Overall Study|Withdrawal by Subject|2|||
157022814|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
157022815|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
156825015|NCT03894969|566111078|FG001|Overall Study|Withdrawal by Subject|1|||
156825016|NCT03894969|566111079|FG002|Overall Study|Withdrawal by Subject|3|||
156825017|NCT03894969|566111080|FG003|Overall Study|Withdrawal by Subject|4|||
156825018|NCT03894969|566111081|FG004|Overall Study|Withdrawal by Subject|8|||
156825019|NCT03894969|566111077|FG000|Overall Study|Other|0|||
157022816|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
156825020|NCT03894969|566111078|FG001|Overall Study|Other|0|||
156825021|NCT03894969|566111079|FG002|Overall Study|Other|0|||
156825022|NCT03894969|566111080|FG003|Overall Study|Other|0|||
156825023|NCT03894969|566111081|FG004|Overall Study|Other|3|||
156825024|NCT03894969|566111077|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825025|NCT03894969|566111078|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825026|NCT03894969|566111079|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
156825027|NCT03894969|566111080|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
156825028|NCT03894969|566111081|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
156825029|NCT03894969|566111077|FG000|Overall Study|Solicited Adverse Event|0|||
156825030|NCT03894969|566111078|FG001|Overall Study|Solicited Adverse Event|1|||
156825031|NCT03894969|566111079|FG002|Overall Study|Solicited Adverse Event|0|||
156825032|NCT03894969|566111080|FG003|Overall Study|Solicited Adverse Event|0|||
156825033|NCT03894969|566111081|FG004|Overall Study|Solicited Adverse Event|0|||
156825034|NCT00468676|566111082|FG000|Overall Study|Lost to Follow-up|14|||
156825035|NCT00468676|566111083|FG001|Overall Study|Lost to Follow-up|11|||
156825036|NCT00468676|566111082|FG000|Overall Study|Death|2|||
156825037|NCT00468676|566111083|FG001|Overall Study|Death|1|||
156825038|NCT02378298|566111086|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
156825039|NCT02378298|566111087|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
156825040|NCT02378298|566111088|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
156825041|NCT02378298|566111086|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
156825042|NCT02378298|566111087|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
156825043|NCT02378298|566111088|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
156825044|NCT02378298|566111086|FG000|Surveillance (19-68 Weeks)|Death|1|||
156825045|NCT02378298|566111087|FG001|Surveillance (19-68 Weeks)|Death|0|||
156825046|NCT02378298|566111088|FG002|Surveillance (19-68 Weeks)|Death|0|||
156825047|NCT04173260|566111089|FG000|Overall Study|Early termination|4|||
156825048|NCT02308163|566111092|FG000|Overall Study|Not fulfill eligible criteria|1|||
156825049|NCT02308163|566111093|FG001|Overall Study|Not fulfill eligible criteria|2|||
156825050|NCT02308163|566111094|FG002|Overall Study|Not fulfill eligible criteria|0|||
156825051|NCT02308163|566111095|FG003|Overall Study|Not fulfill eligible criteria|1|||
156825052|NCT02308163|566111096|FG004|Overall Study|Not fulfill eligible criteria|1|||
156825053|NCT02308163|566111092|FG000|Overall Study|Adverse Event|9|||
156825054|NCT02308163|566111093|FG001|Overall Study|Adverse Event|5|||
156825055|NCT02308163|566111094|FG002|Overall Study|Adverse Event|2|||
156825056|NCT02308163|566111095|FG003|Overall Study|Adverse Event|2|||
156825057|NCT02308163|566111096|FG004|Overall Study|Adverse Event|11|||
156825058|NCT02308163|566111092|FG000|Overall Study|Lack of Efficacy|11|||
156825059|NCT02308163|566111093|FG001|Overall Study|Lack of Efficacy|3|||
156825060|NCT02308163|566111094|FG002|Overall Study|Lack of Efficacy|8|||
156825061|NCT02308163|566111095|FG003|Overall Study|Lack of Efficacy|4|||
156825062|NCT02308163|566111096|FG004|Overall Study|Lack of Efficacy|6|||
156825063|NCT02308163|566111092|FG000|Overall Study|Withdrawal of consent|2|||
156825064|NCT02308163|566111093|FG001|Overall Study|Withdrawal of consent|3|||
156825065|NCT02308163|566111094|FG002|Overall Study|Withdrawal of consent|0|||
156825066|NCT02308163|566111095|FG003|Overall Study|Withdrawal of consent|2|||
156825067|NCT02308163|566111096|FG004|Overall Study|Withdrawal of consent|6|||
156825068|NCT02308163|566111092|FG000|Overall Study|Protocol Violation|3|||
156825069|NCT02308163|566111093|FG001|Overall Study|Protocol Violation|3|||
156825070|NCT02308163|566111094|FG002|Overall Study|Protocol Violation|3|||
156825071|NCT02308163|566111095|FG003|Overall Study|Protocol Violation|2|||
156825072|NCT02308163|566111096|FG004|Overall Study|Protocol Violation|5|||
156825073|NCT02308163|566111092|FG000|Overall Study|Lab data met discontinuation criteria|3|||
156825074|NCT02308163|566111093|FG001|Overall Study|Lab data met discontinuation criteria|0|||
156825075|NCT02308163|566111094|FG002|Overall Study|Lab data met discontinuation criteria|0|||
156825076|NCT02308163|566111095|FG003|Overall Study|Lab data met discontinuation criteria|2|||
156825077|NCT02308163|566111096|FG004|Overall Study|Lab data met discontinuation criteria|0|||
156825078|NCT02308163|566111092|FG000|Overall Study|Miscellaneous|2|||
156825079|NCT02308163|566111093|FG001|Overall Study|Miscellaneous|2|||
156825080|NCT02308163|566111094|FG002|Overall Study|Miscellaneous|1|||
156825081|NCT02308163|566111095|FG003|Overall Study|Miscellaneous|0|||
156825082|NCT02308163|566111096|FG004|Overall Study|Miscellaneous|5|||
156825083|NCT03761394|566111107|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825084|NCT03761394|566111108|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
156825085|NCT03761394|566111109|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825086|NCT03761394|566111110|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
156825087|NCT03761394|566111107|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
156825088|NCT03761394|566111108|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
156825089|NCT03761394|566111109|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
156825090|NCT03761394|566111110|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
156825091|NCT03761394|566111107|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825092|NCT03761394|566111108|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825093|NCT03761394|566111109|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
156825094|NCT03761394|566111110|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
156825095|NCT03761394|566111107|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825096|NCT03761394|566111108|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825097|NCT03761394|566111109|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
156825098|NCT03761394|566111110|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
156825099|NCT01939002|566111116|FG000|Overall Study|Adverse Event|13|||
156825100|NCT01939002|566111117|FG001|Overall Study|Adverse Event|13|||
156825101|NCT01939002|566111116|FG000|Overall Study|Withdrawal by Subject|5|||
156825102|NCT01939002|566111117|FG001|Overall Study|Withdrawal by Subject|3|||
157022817|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
156884739|NCT03859973|566336361|FG001|Overall Study|Protocol Violation|3|||
156884740|NCT03859973|566336360|FG000|Overall Study|Adverse Event|3|||
156884741|NCT03859973|566336361|FG001|Overall Study|Adverse Event|5|||
156884742|NCT02855541|566336364|FG000|Overall Study|Change in health status|2|||
156884743|NCT02855541|566336364|FG000|Overall Study|Withdrawal by Subject|2|||
156884744|NCT03085914|566336365|FG000|Overall Study|Death|6|||
156884745|NCT03085914|566336366|FG001|Overall Study|Death|6|||
156884746|NCT03085914|566336367|FG002|Overall Study|Death|4|||
156825103|NCT01939002|566111116|FG000|Overall Study|Other|1|||
156825104|NCT01939002|566111117|FG001|Overall Study|Other|2|||
156825105|NCT02910401|566111120|FG000|Overall Study|Study closure Study closure|0|||
156825106|NCT02910401|566111121|FG001|Overall Study|Study closure Study closure|0|||
156825107|NCT02910401|566111122|FG002|Overall Study|Study closure Study closure|2|||
156825108|NCT02910401|566111120|FG000|Overall Study|Physician Decision|1|||
156825109|NCT02910401|566111121|FG001|Overall Study|Physician Decision|0|||
156825110|NCT02910401|566111122|FG002|Overall Study|Physician Decision|0|||
156825111|NCT00098748|566111124|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
156825112|NCT00098748|566111125|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
156825113|NCT00098748|566111126|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
156825114|NCT00098748|566111124|FG000|Received Study Treatment|Death|2|||
156825115|NCT00098748|566111125|FG001|Received Study Treatment|Death|1|||
156825116|NCT00098748|566111126|FG002|Received Study Treatment|Death|2|||
156825117|NCT00098748|566111124|FG000|Received Study Treatment|Adverse Event|1|||
156825118|NCT00098748|566111125|FG001|Received Study Treatment|Adverse Event|2|||
156825119|NCT00098748|566111126|FG002|Received Study Treatment|Adverse Event|5|||
156825120|NCT00098748|566111124|FG000|Received Study Treatment|Lack of Efficacy|40|||
156825121|NCT00098748|566111125|FG001|Received Study Treatment|Lack of Efficacy|27|||
156825122|NCT00098748|566111126|FG002|Received Study Treatment|Lack of Efficacy|27|||
156825123|NCT00098748|566111124|FG000|Received Study Treatment|Other|2|||
156825124|NCT00098748|566111125|FG001|Received Study Treatment|Other|2|||
156825125|NCT00098748|566111126|FG002|Received Study Treatment|Other|6|||
156825126|NCT00098748|566111124|FG000|Received Study Treatment|Subject defaulted|3|||
156825127|NCT00098748|566111125|FG001|Received Study Treatment|Subject defaulted|4|||
156825128|NCT00098748|566111126|FG002|Received Study Treatment|Subject defaulted|4|||
156825129|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
156825130|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
156825131|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
156825132|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
156825133|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
156825134|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
156825135|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
156825136|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
156825137|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
156825138|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
156825139|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
156825140|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
156825141|NCT00098748|566111124|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
156825142|NCT00098748|566111125|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
156825143|NCT00098748|566111126|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
156825144|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
156825145|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
156825146|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Death|0|||
156825147|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Death|0|||
156825148|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156825149|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156825150|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
156825151|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
156825152|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
156825153|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
156825154|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
156825155|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
156825156|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
156825157|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
156825158|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
156884747|NCT03085914|566336368|FG003|Overall Study|Death|1|||
156825159|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
156825160|NCT00433160|566111129|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
156884748|NCT03085914|566336369|FG004|Overall Study|Death|5|||
156884749|NCT03085914|566336370|FG005|Overall Study|Death|2|||
156884750|NCT03085914|566336371|FG006|Overall Study|Death|2|||
156884751|NCT03085914|566336365|FG000|Overall Study|Withdrawal by Subject|1|||
157224491|NCT06331156|567568017|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
156825161|NCT00433160|566111130|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
156825162|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
156825163|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
156825164|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
156825165|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
156825166|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
156825167|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
156825168|NCT00433160|566111129|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
156825169|NCT00433160|566111130|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
156825170|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
156825171|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
156825172|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
156825173|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
156825174|NCT00433160|566111129|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
156825175|NCT00433160|566111130|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
156825176|NCT01774253|566111131|FG000|Overall Study|Lack of Efficacy|4|||
156825177|NCT01774253|566111131|FG000|Overall Study|Physician Decision|2|||
156825178|NCT01774253|566111131|FG000|Overall Study|Withdrawal by Subject|2|||
156825179|NCT01774253|566111131|FG000|Overall Study|Death|1|||
156825180|NCT02240368|566111132|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
156825181|NCT02240368|566111133|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
156825182|NCT02240368|566111134|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
156825183|NCT02240368|566111132|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
156825184|NCT02240368|566111133|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
156825185|NCT02240368|566111134|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
156825186|NCT00871117|566111143|FG000|Overall Study|Lost to Follow-up|5|||
156825187|NCT00871117|566111144|FG001|Overall Study|Lost to Follow-up|6|||
156825188|NCT00871117|566111143|FG000|Overall Study|Other|0|||
156825189|NCT00871117|566111144|FG001|Overall Study|Other|4|||
156825190|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
156825191|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825192|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825193|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
156825194|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
156825195|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
156825196|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
156825197|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
156825198|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
156825199|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
156825200|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
156825201|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
156825202|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
156825203|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
156825204|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
156825205|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
156825206|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825207|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
157151077|NCT01522651|567298191|FG004|Overall Study|Adverse Event|4|||
157151078|NCT01522651|567298187|FG000|Overall Study|Cardioversion|1|||
157151079|NCT01522651|567298188|FG001|Overall Study|Cardioversion|0|||
157151080|NCT01522651|567298189|FG002|Overall Study|Cardioversion|0|||
156825208|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825209|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
156825210|NCT03222973|566111145|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
156825211|NCT03222973|566111146|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
156825212|NCT03222973|566111147|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
156825213|NCT03222973|566111148|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
156825214|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
156825215|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
156825216|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
156825217|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
157022818|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
156825218|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
156825219|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
156825220|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
157151081|NCT01522651|567298190|FG003|Overall Study|Cardioversion|0|||
157151082|NCT01522651|567298191|FG004|Overall Study|Cardioversion|0|||
157151083|NCT01522651|567298187|FG000|Overall Study|Device Malfunction|0|||
156825221|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
156825222|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
156825223|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
156825224|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
156825225|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
156825226|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
156825227|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
156825228|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
156825229|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
156825230|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
156825231|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
156825232|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
156825233|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
156825234|NCT03222973|566111145|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825235|NCT03222973|566111146|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825236|NCT03222973|566111147|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
156825237|NCT03222973|566111148|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
156825238|NCT02080481|566111149|FG000|Overall Study|Never received a block.|1|||
156825239|NCT02080481|566111150|FG001|Overall Study|Never received a block.|0|||
156825240|NCT00642174|566113186|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
156825241|NCT00642174|566113187|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
156825242|NCT00896363|566113188|FG000|Overall Study|Adverse Event|3|||
156825243|NCT00896363|566113189|FG001|Overall Study|Adverse Event|4|||
156825244|NCT00896363|566113190|FG002|Overall Study|Adverse Event|2|||
156825245|NCT00896363|566113188|FG000|Overall Study|Lack of Efficacy|0|||
156825246|NCT00896363|566113189|FG001|Overall Study|Lack of Efficacy|2|||
156825247|NCT00896363|566113190|FG002|Overall Study|Lack of Efficacy|1|||
156825248|NCT00896363|566113188|FG000|Overall Study|Withdrawal by Subject|3|||
156825249|NCT00896363|566113189|FG001|Overall Study|Withdrawal by Subject|5|||
156825250|NCT00896363|566113190|FG002|Overall Study|Withdrawal by Subject|5|||
156825251|NCT01730339|566113191|FG000|Overall Study|Withdrawal by Subject|3|||
156825252|NCT01730339|566113192|FG001|Overall Study|Withdrawal by Subject|2|||
156825253|NCT01730339|566113191|FG000|Overall Study|Lost to Follow-up|1|||
156825254|NCT01730339|566113192|FG001|Overall Study|Lost to Follow-up|1|||
156825255|NCT01730339|566113191|FG000|Overall Study|Un-specified|1|||
156825256|NCT01730339|566113192|FG001|Overall Study|Un-specified|0|||
156825257|NCT00521599|566113194|FG000|Overall Study|Adverse Event|5|||
156825258|NCT00521599|566113195|FG001|Overall Study|Adverse Event|7|||
156825259|NCT00521599|566113196|FG002|Overall Study|Adverse Event|6|||
156825260|NCT00521599|566113194|FG000|Overall Study|Treatment Failure|8|||
156825261|NCT00521599|566113195|FG001|Overall Study|Treatment Failure|9|||
156825262|NCT00521599|566113196|FG002|Overall Study|Treatment Failure|22|||
156825263|NCT00521599|566113194|FG000|Overall Study|Lost to Follow-up|2|||
156825264|NCT00521599|566113195|FG001|Overall Study|Lost to Follow-up|1|||
156825265|NCT00521599|566113196|FG002|Overall Study|Lost to Follow-up|2|||
156825266|NCT00521599|566113194|FG000|Overall Study|Withdrawal by Subject|3|||
156825267|NCT00521599|566113195|FG001|Overall Study|Withdrawal by Subject|5|||
156825268|NCT00521599|566113196|FG002|Overall Study|Withdrawal by Subject|1|||
156825269|NCT00521599|566113194|FG000|Overall Study|Withdrawal by subject treatment related|3|||
156825270|NCT00521599|566113195|FG001|Overall Study|Withdrawal by subject treatment related|1|||
156825271|NCT00521599|566113196|FG002|Overall Study|Withdrawal by subject treatment related|2|||
156825272|NCT00521599|566113194|FG000|Overall Study|Protocol Violation|2|||
156825273|NCT00521599|566113195|FG001|Overall Study|Protocol Violation|4|||
156825274|NCT00521599|566113196|FG002|Overall Study|Protocol Violation|2|||
156825275|NCT00521599|566113194|FG000|Overall Study|Did not meet protocol eligibility|2|||
156825276|NCT00521599|566113195|FG001|Overall Study|Did not meet protocol eligibility|2|||
156825277|NCT00521599|566113196|FG002|Overall Study|Did not meet protocol eligibility|1|||
156825278|NCT00791479|566113197|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825279|NCT00791479|566113198|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825280|NCT00791479|566113199|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825281|NCT00791479|566113200|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825282|NCT00791479|566113201|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
156825283|NCT00791479|566113202|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
156825284|NCT00791479|566113197|FG000|Overall Study|Adverse Event|0|||
156825285|NCT00791479|566113198|FG001|Overall Study|Adverse Event|1|||
156825286|NCT00791479|566113199|FG002|Overall Study|Adverse Event|0|||
156825287|NCT00791479|566113200|FG003|Overall Study|Adverse Event|2|||
156825288|NCT00791479|566113201|FG004|Overall Study|Adverse Event|0|||
156825289|NCT00791479|566113202|FG005|Overall Study|Adverse Event|1|||
156825290|NCT00791479|566113197|FG000|Overall Study|Lost to Follow-up|0|||
156825291|NCT00791479|566113198|FG001|Overall Study|Lost to Follow-up|1|||
156825292|NCT00791479|566113199|FG002|Overall Study|Lost to Follow-up|0|||
156825293|NCT00791479|566113200|FG003|Overall Study|Lost to Follow-up|0|||
156825294|NCT00791479|566113201|FG004|Overall Study|Lost to Follow-up|0|||
156825295|NCT00791479|566113202|FG005|Overall Study|Lost to Follow-up|1|||
156825296|NCT00791479|566113197|FG000|Overall Study|Protocol Violation|2|||
156825297|NCT00791479|566113198|FG001|Overall Study|Protocol Violation|1|||
156825298|NCT00791479|566113199|FG002|Overall Study|Protocol Violation|0|||
156825299|NCT00791479|566113200|FG003|Overall Study|Protocol Violation|1|||
156825300|NCT00791479|566113201|FG004|Overall Study|Protocol Violation|0|||
156825301|NCT00791479|566113202|FG005|Overall Study|Protocol Violation|0|||
156825302|NCT00791479|566113197|FG000|Overall Study|Withdrawal by Subject|0|||
156825303|NCT00791479|566113198|FG001|Overall Study|Withdrawal by Subject|0|||
156825304|NCT00791479|566113199|FG002|Overall Study|Withdrawal by Subject|0|||
156825305|NCT00791479|566113200|FG003|Overall Study|Withdrawal by Subject|1|||
156825306|NCT00791479|566113201|FG004|Overall Study|Withdrawal by Subject|0|||
156825307|NCT00791479|566113202|FG005|Overall Study|Withdrawal by Subject|1|||
156825308|NCT00496197|566113203|FG000|Overall Study|Discontinued study due to death|43|||
156825309|NCT00496197|566113203|FG000|Overall Study|Adverse Event|13|||
156825310|NCT00496197|566113203|FG000|Overall Study|Does not meet entrance criteria|5|||
156825311|NCT00496197|566113203|FG000|Overall Study|Insufficient clinical response|3|||
156825312|NCT00496197|566113203|FG000|Overall Study|Insufficient bacteriological response|10|||
156825313|NCT00496197|566113203|FG000|Overall Study|Lost to Follow-up|11|||
156825314|NCT00496197|566113203|FG000|Overall Study|Withdrawal by Subject|11|||
156825315|NCT00496197|566113203|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
156825316|NCT00496197|566113203|FG000|Overall Study|Other|14|||
156825317|NCT00496197|566113203|FG000|Overall Study|Protocol Violation|8|||
156825318|NCT00149994|566113204|FG000|Overall Study|Administrative problems:|1|||
156825319|NCT00149994|566113205|FG001|Overall Study|Administrative problems:|0|||
156825320|NCT00149994|566113204|FG000|Overall Study|Protocol Violation|0|||
156825321|NCT00149994|566113205|FG001|Overall Study|Protocol Violation|1|||
156825322|NCT01610713|566113206|FG000|Overall Study|Adverse Event|3|||
156825323|NCT01610713|566113207|FG001|Overall Study|Adverse Event|0|||
156825324|NCT01610713|566113206|FG000|Overall Study|Lack of Efficacy|1|||
156825325|NCT01610713|566113207|FG001|Overall Study|Lack of Efficacy|0|||
156825326|NCT01610713|566113206|FG000|Overall Study|low mood and poor motivation|1|||
156825327|NCT01610713|566113207|FG001|Overall Study|low mood and poor motivation|0|||
156825328|NCT01610713|566113206|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
156825329|NCT01610713|566113207|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
156825330|NCT01610713|566113206|FG000|Overall Study|Lost to Follow-up|0|||
156825331|NCT01610713|566113207|FG001|Overall Study|Lost to Follow-up|1|||
156825332|NCT01774097|566113213|FG000|Overall Study|Withdrawal by Subject|1|||
156825333|NCT01774097|566113214|FG001|Overall Study|Withdrawal by Subject|1|||
156825334|NCT01774097|566113213|FG000|Overall Study|Adverse Event|1|||
156825335|NCT01774097|566113214|FG001|Overall Study|Adverse Event|1|||
156825336|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
156825337|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
156825338|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825339|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
156825340|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
156825341|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825342|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
156825343|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825344|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825345|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825346|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
156825347|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
156825348|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825349|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825350|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825351|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825352|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825353|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
156825354|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825355|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825356|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825357|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825358|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
157151084|NCT01522651|567298188|FG001|Overall Study|Device Malfunction|1|||
157151085|NCT01522651|567298189|FG002|Overall Study|Device Malfunction|0|||
156825359|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825360|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
156825361|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825362|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825363|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825364|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825365|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825366|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
157151086|NCT01522651|567298190|FG003|Overall Study|Device Malfunction|0|||
157151087|NCT01522651|567298191|FG004|Overall Study|Device Malfunction|0|||
157151088|NCT01522651|567298187|FG000|Overall Study|Investigator's Discretion|0|||
157224492|NCT04799158|567568019|FG000|Run-In Period|Adverse Event|6|||
156825367|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825368|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825369|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825370|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825371|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
156825372|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825373|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825374|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
156825375|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825376|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825377|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825378|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
157151089|NCT01522651|567298188|FG001|Overall Study|Investigator's Discretion|1|||
157151090|NCT01522651|567298189|FG002|Overall Study|Investigator's Discretion|0|||
156825379|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825380|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825381|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825382|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825383|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825384|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825385|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825386|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825387|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825388|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825389|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
156825390|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825391|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825392|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
156825393|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825394|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825395|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825396|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825397|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825398|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825399|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825400|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825401|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825402|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825403|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825404|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825405|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825406|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825407|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
156825408|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825409|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825410|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825411|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825412|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825413|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825414|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825415|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825416|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825417|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825418|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
156863432|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156863433|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
157151091|NCT01522651|567298190|FG003|Overall Study|Investigator's Discretion|0|||
157151092|NCT01522651|567298191|FG004|Overall Study|Investigator's Discretion|0|||
157151093|NCT01522651|567298187|FG000|Overall Study|Protocol Violation|3|||
157151094|NCT01522651|567298188|FG001|Overall Study|Protocol Violation|0|||
157151095|NCT01522651|567298189|FG002|Overall Study|Protocol Violation|0|||
157151096|NCT01522651|567298190|FG003|Overall Study|Protocol Violation|0|||
156825419|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825420|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825421|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825422|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825423|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825424|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825425|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
156825426|NCT03447314|566113215|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825427|NCT03447314|566113216|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825428|NCT03447314|566113217|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825429|NCT03447314|566113218|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
156825430|NCT03447314|566113219|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825431|NCT03447314|566113220|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
156825432|NCT03447314|566113221|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825433|NCT03447314|566113222|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825434|NCT03447314|566113223|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825435|NCT03447314|566113224|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825436|NCT03447314|566113225|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825437|NCT03447314|566113226|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
157022819|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
157022820|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
157022821|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
157022822|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
157022823|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
157022824|NCT01785719|566836867|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
157022825|NCT01785719|566836868|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
157022826|NCT01785719|566836867|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
157022827|NCT01785719|566836868|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
157022828|NCT01785719|566836867|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
157022829|NCT01785719|566836868|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
157022830|NCT01785719|566836867|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
157022831|NCT01785719|566836868|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
157022832|NCT03443323|566836869|FG000|Overall Study|Lost to Follow-up|2|||
157022833|NCT03443323|566836870|FG001|Overall Study|Lost to Follow-up|2|||
157022834|NCT03443323|566836869|FG000|Overall Study|PI withdrawal|1|||
157022835|NCT03443323|566836870|FG001|Overall Study|PI withdrawal|0|||
157022836|NCT04887129|566836875|FG000|Overall Study|Lost to Follow-up|0|||
157022837|NCT04887129|566836876|FG001|Overall Study|Lost to Follow-up|24|||
157022838|NCT04887129|566836875|FG000|Overall Study|Withdrawal by Subject|9|||
157022839|NCT04887129|566836876|FG001|Overall Study|Withdrawal by Subject|57|||
157022840|NCT04887129|566836875|FG000|Overall Study|Other|2|||
157022841|NCT04887129|566836876|FG001|Overall Study|Other|9|||
157022842|NCT02921230|566836880|FG000|Overall Study|Withdrawal by Subject|20|||
157022843|NCT02921230|566836881|FG001|Overall Study|Withdrawal by Subject|8|||
157022844|NCT02921230|566836880|FG000|Overall Study|Death|12|||
157022845|NCT02921230|566836881|FG001|Overall Study|Death|3|||
157022846|NCT02921230|566836880|FG000|Overall Study|Protocol Violation|17|||
157022847|NCT02921230|566836881|FG001|Overall Study|Protocol Violation|6|||
157022848|NCT02921230|566836880|FG000|Overall Study|Early completion|5|||
157022849|NCT02921230|566836881|FG001|Overall Study|Early completion|1|||
157022850|NCT02921230|566836880|FG000|Overall Study|Pending data entry|1|||
157022851|NCT02921230|566836881|FG001|Overall Study|Pending data entry|0|||
157022852|NCT04274764|566836882|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
157022853|NCT04274764|566836883|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
157022854|NCT04142788|566836887|FG000|Overall Study|Trial terminated prematurely|2|||
157022855|NCT04142788|566836888|FG001|Overall Study|Trial terminated prematurely|2|||
157022856|NCT03396926|566836892|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
157022857|NCT03396926|566836893|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
157022858|NCT04727554|566836895|FG000|Overall Study|Lost to Follow-up|0|||
157022859|NCT04727554|566836896|FG001|Overall Study|Lost to Follow-up|1|||
157022860|NCT04727554|566836895|FG000|Overall Study|Death|2|||
157022861|NCT04727554|566836896|FG001|Overall Study|Death|6|||
157022862|NCT04727554|566836895|FG000|Overall Study|Withdrawal by Subject|1|||
157022863|NCT04727554|566836896|FG001|Overall Study|Withdrawal by Subject|0|||
157022864|NCT05028634|566836898|FG000|Overall Study|Withdrawal by Subject|0|||
157224493|NCT04799158|567568020|FG001|Run-In Period|Adverse Event|0|||
156825438|NCT03447314|566113227|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825439|NCT03447314|566113228|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825440|NCT03447314|566113229|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825441|NCT03447314|566113230|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825442|NCT03447314|566113231|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825443|NCT03447314|566113232|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
156825444|NCT01920568|566113233|FG000|Overall Study|Adverse Event|27|||
156825445|NCT01920568|566113234|FG001|Overall Study|Adverse Event|8|||
156825446|NCT01920568|566113233|FG000|Overall Study|Protocol Violation|5|||
156825447|NCT01920568|566113234|FG001|Overall Study|Protocol Violation|3|||
156825448|NCT01920568|566113233|FG000|Overall Study|Lost to Follow-up|2|||
156825449|NCT01920568|566113234|FG001|Overall Study|Lost to Follow-up|2|||
156825450|NCT01920568|566113233|FG000|Overall Study|Physician Decision|13|||
156825451|NCT01920568|566113234|FG001|Overall Study|Physician Decision|4|||
156825452|NCT01920568|566113233|FG000|Overall Study|Withdrawal by Subject|79|||
156825453|NCT01920568|566113234|FG001|Overall Study|Withdrawal by Subject|55|||
156825454|NCT01920568|566113233|FG000|Overall Study|Death due to disease progression|25|||
156825455|NCT01920568|566113234|FG001|Overall Study|Death due to disease progression|12|||
156825456|NCT04049266|566113237|FG000|Overall Study|Adverse Event|16|||
156825457|NCT04049266|566113238|FG001|Overall Study|Adverse Event|9|||
156825458|NCT04049266|566113237|FG000|Overall Study|Non-compliance with study drug|0|||
156825459|NCT04049266|566113238|FG001|Overall Study|Non-compliance with study drug|3|||
156825460|NCT04049266|566113237|FG000|Overall Study|Withdrawal by Subject|6|||
156825461|NCT04049266|566113238|FG001|Overall Study|Withdrawal by Subject|10|||
156825462|NCT04049266|566113237|FG000|Overall Study|Lost to Follow-up|2|||
156825463|NCT04049266|566113238|FG001|Overall Study|Lost to Follow-up|2|||
156825464|NCT04049266|566113237|FG000|Overall Study|Progressive disease|11|||
156825465|NCT04049266|566113238|FG001|Overall Study|Progressive disease|2|||
156825466|NCT04049266|566113237|FG000|Overall Study|Physician Decision|1|||
156825467|NCT04049266|566113238|FG001|Overall Study|Physician Decision|0|||
156825468|NCT04049266|566113237|FG000|Overall Study|Patient moved out of state|1|||
156825469|NCT04049266|566113238|FG001|Overall Study|Patient moved out of state|0|||
156825470|NCT03664674|566113242|FG000|Overall Study|Adverse Event|1|||
156825471|NCT03664674|566113243|FG001|Overall Study|Adverse Event|1|||
156825472|NCT03664674|566113242|FG000|Overall Study|Physician Decision|0|||
156825473|NCT03664674|566113243|FG001|Overall Study|Physician Decision|1|||
156825474|NCT03664674|566113242|FG000|Overall Study|Withdrawal by Subject|2|||
156825475|NCT03664674|566113243|FG001|Overall Study|Withdrawal by Subject|0|||
156825476|NCT01342965|566113245|FG000|Overall Study|Death|58|||
156825477|NCT01342965|566113246|FG001|Overall Study|Death|57|||
156825478|NCT01342965|566113245|FG000|Overall Study|Lost to Follow-up|5|||
156825479|NCT01342965|566113246|FG001|Overall Study|Lost to Follow-up|3|||
156825480|NCT01342965|566113245|FG000|Overall Study|Other Reasons- Unspecified|44|||
156825481|NCT01342965|566113246|FG001|Overall Study|Other Reasons- Unspecified|38|||
156825482|NCT01342965|566113245|FG000|Overall Study|Withdrawal by Subject|2|||
156825483|NCT01342965|566113246|FG001|Overall Study|Withdrawal by Subject|9|||
156825484|NCT00856206|566113249|FG000|Overall Study|Protocol Violation|6|||
156825485|NCT00856206|566113250|FG001|Overall Study|Protocol Violation|18|||
156825486|NCT00856206|566113249|FG000|Overall Study|Adverse Event|10|||
156825487|NCT00856206|566113250|FG001|Overall Study|Adverse Event|46|||
156825488|NCT00856206|566113249|FG000|Overall Study|Lack of Efficacy|1|||
156825489|NCT00856206|566113250|FG001|Overall Study|Lack of Efficacy|2|||
156825490|NCT00856206|566113249|FG000|Overall Study|Withdrawal by Subject|15|||
156825491|NCT00856206|566113250|FG001|Overall Study|Withdrawal by Subject|36|||
156825492|NCT00856206|566113249|FG000|Overall Study|Lost to Follow-up|13|||
156825493|NCT00856206|566113250|FG001|Overall Study|Lost to Follow-up|39|||
156825494|NCT00856206|566113249|FG000|Overall Study|Death|2|||
156825495|NCT00856206|566113250|FG001|Overall Study|Death|2|||
156825496|NCT00856206|566113249|FG000|Overall Study|Decision by the Sponsor|4|||
156825497|NCT00856206|566113250|FG001|Overall Study|Decision by the Sponsor|8|||
157224494|NCT04799158|567568021|FG002|Run-In Period|Adverse Event|0|||
156825498|NCT00856206|566113249|FG000|Overall Study|Other than specified above|3|||
156825499|NCT00856206|566113250|FG001|Overall Study|Other than specified above|10|||
156825500|NCT01170598|566113254|FG000|Overall Study|Withdrawal by Subject|1|||
156825501|NCT01170598|566113254|FG000|Overall Study|Death|3|||
156825502|NCT01170598|566113254|FG000|Overall Study|Lost to Follow-up|1|||
156825503|NCT01170598|566113254|FG000|Overall Study|Refused|1|||
156825504|NCT04584346|566113257|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
157224495|NCT04799158|567568022|FG003|Run-In Period|Adverse Event|0|||
157224496|NCT04799158|567568023|FG004|Run-In Period|Adverse Event|0|||
156825505|NCT04584346|566113258|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
156825506|NCT01271712|566113259|FG000|Double Blind Treatment|Death|2|||
156825507|NCT01271712|566113260|FG001|Double Blind Treatment|Death|0|||
156825508|NCT01271712|566113259|FG000|Double Blind Treatment|Lack of Efficacy|1|||
156825509|NCT01271712|566113260|FG001|Double Blind Treatment|Lack of Efficacy|0|||
157224497|NCT04799158|567568019|FG000|Run-In Period|Lost to Follow-up|4|||
156825510|NCT01271712|566113259|FG000|Double Blind Treatment|Adverse Event|9|||
156825511|NCT01271712|566113260|FG001|Double Blind Treatment|Adverse Event|4|||
156825512|NCT01271712|566113259|FG000|Double Blind Treatment|Progressive disease|23|||
156825513|NCT01271712|566113260|FG001|Double Blind Treatment|Progressive disease|3|||
156825514|NCT01271712|566113259|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
156825515|NCT01271712|566113260|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
156825516|NCT01271712|566113259|FG000|Double Blind Treatment|Non compliance with study drug|2|||
156825517|NCT01271712|566113260|FG001|Double Blind Treatment|Non compliance with study drug|0|||
156825518|NCT01271712|566113259|FG000|Double Blind Treatment|receive no study drug|1|||
156825519|NCT01271712|566113260|FG001|Double Blind Treatment|receive no study drug|0|||
156825520|NCT01271712|566113259|FG000|Open Label Treatment|Death|6|||
156825521|NCT01271712|566113260|FG001|Open Label Treatment|Death|5|||
156825522|NCT01271712|566113259|FG000|Open Label Treatment|Withdrawal by Subject|6|||
156825523|NCT01271712|566113260|FG001|Open Label Treatment|Withdrawal by Subject|11|||
156825524|NCT01271712|566113259|FG000|Open Label Treatment|Physician Decision|2|||
156825525|NCT01271712|566113260|FG001|Open Label Treatment|Physician Decision|0|||
156825526|NCT01271712|566113259|FG000|Open Label Treatment|Adverse Event|14|||
156825527|NCT01271712|566113260|FG001|Open Label Treatment|Adverse Event|8|||
156825528|NCT01271712|566113259|FG000|Open Label Treatment|Progressive disease|59|||
156825529|NCT01271712|566113260|FG001|Open Label Treatment|Progressive disease|32|||
156825530|NCT01271712|566113259|FG000|Open Label Treatment|transferred to rollover study|1|||
156825531|NCT01271712|566113260|FG001|Open Label Treatment|transferred to rollover study|0|||
156825532|NCT01271712|566113259|FG000|Open Label Treatment|Non-compliance with study drug|1|||
156825533|NCT01271712|566113260|FG001|Open Label Treatment|Non-compliance with study drug|0|||
156825534|NCT01271712|566113259|FG000|Open Label Treatment|Protocol Violation|0|||
156825535|NCT01271712|566113260|FG001|Open Label Treatment|Protocol Violation|1|||
156825536|NCT01271712|566113259|FG000|Open Label Treatment|Switching to other therapy|2|||
156825537|NCT01271712|566113260|FG001|Open Label Treatment|Switching to other therapy|1|||
156825538|NCT01271712|566113259|FG000|Safety Follow-up|Death|11|||
156825539|NCT01271712|566113260|FG001|Safety Follow-up|Death|7|||
156825540|NCT01271712|566113259|FG000|Safety Follow-up|Withdrawal by Subject|4|||
156825541|NCT01271712|566113260|FG001|Safety Follow-up|Withdrawal by Subject|2|||
156825542|NCT01271712|566113259|FG000|Safety Follow-up|Protocol Violation|1|||
156825543|NCT01271712|566113260|FG001|Safety Follow-up|Protocol Violation|1|||
156825544|NCT01271712|566113259|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
156825545|NCT01271712|566113260|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
156825546|NCT01271712|566113259|FG000|Safety Follow-up|No follow-up|1|||
156825547|NCT01271712|566113260|FG001|Safety Follow-up|No follow-up|1|||
156825548|NCT01271712|566113259|FG000|Safety Follow-up|Progressive disease|1|||
156825549|NCT01271712|566113260|FG001|Safety Follow-up|Progressive disease|0|||
156825550|NCT01271712|566113259|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
156825551|NCT01271712|566113260|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
156825552|NCT00096226|566113263|FG000|Overall Study|Ineligible|2|||
156825553|NCT00096226|566113263|FG000|Overall Study|Protocol treatment not started|1|||
156825554|NCT02780856|566113264|FG000|Overall Study|Lost to Follow-up|1|||
156825555|NCT03941964|566113271|FG000|Overall Study|Adverse Event|1|||
156825556|NCT03941964|566113272|FG001|Overall Study|Adverse Event|8|||
156825557|NCT03941964|566113271|FG000|Overall Study|Progressive disease|7|||
156825558|NCT03941964|566113272|FG001|Overall Study|Progressive disease|3|||
156825559|NCT03941964|566113271|FG000|Overall Study|Lack of Efficacy|0|||
156825560|NCT03941964|566113272|FG001|Overall Study|Lack of Efficacy|1|||
156825561|NCT03941964|566113271|FG000|Overall Study|Death|3|||
156825562|NCT03941964|566113272|FG001|Overall Study|Death|1|||
156825563|NCT03941964|566113271|FG000|Overall Study|Withdrew consent|1|||
157022865|NCT05028634|566836899|FG001|Overall Study|Withdrawal by Subject|1|||
157022866|NCT05076708|566836900|FG000|Overall Study|Withdrawal by Subject|4|||
157151097|NCT01522651|567298191|FG004|Overall Study|Protocol Violation|0|||
157151098|NCT01522651|567298187|FG000|Overall Study|Reason Not Specified|0|||
157151099|NCT01522651|567298188|FG001|Overall Study|Reason Not Specified|0|||
157151100|NCT01522651|567298189|FG002|Overall Study|Reason Not Specified|0|||
157151101|NCT01522651|567298190|FG003|Overall Study|Reason Not Specified|1|||
157151102|NCT01522651|567298191|FG004|Overall Study|Reason Not Specified|0|||
157151103|NCT01522651|567298187|FG000|Overall Study|Participant Non-Compliance|1|||
157151104|NCT01522651|567298188|FG001|Overall Study|Participant Non-Compliance|0|||
157151105|NCT01522651|567298189|FG002|Overall Study|Participant Non-Compliance|0|||
157022867|NCT05076708|566836900|FG000|Overall Study|Lost to study during switch phase|8|||
157151106|NCT01522651|567298190|FG003|Overall Study|Participant Non-Compliance|0|||
157151107|NCT01522651|567298191|FG004|Overall Study|Participant Non-Compliance|0|||
156825564|NCT03941964|566113272|FG001|Overall Study|Withdrew consent|3|||
156825565|NCT03941964|566113271|FG000|Overall Study|Physician Decision|9|||
156825566|NCT03941964|566113272|FG001|Overall Study|Physician Decision|2|||
156825567|NCT03941964|566113271|FG000|Overall Study|Other, not specified|2|||
156825568|NCT03941964|566113272|FG001|Overall Study|Other, not specified|1|||
156825569|NCT03006458|566113273|FG000|First Intervention|Unsatisfied Vision|0|||
156825570|NCT03006458|566113274|FG001|First Intervention|Unsatisfied Vision|3|||
156825571|NCT00118846|566113276|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
156825572|NCT00118846|566113277|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
156825573|NCT00118846|566113276|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
156825574|NCT00118846|566113277|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
156825575|NCT00118846|566113276|FG000|Overall Study|Physician Decision|1|||
156825576|NCT00118846|566113277|FG001|Overall Study|Physician Decision|0|||
156825577|NCT00118846|566113276|FG000|Overall Study|Medical condition|2|||
156825578|NCT00118846|566113277|FG001|Overall Study|Medical condition|2|||
156825579|NCT00118846|566113276|FG000|Overall Study|Lost to Follow-up|0|||
156825580|NCT00118846|566113277|FG001|Overall Study|Lost to Follow-up|2|||
156825581|NCT00118846|566113276|FG000|Overall Study|Personal reason|4|||
156825582|NCT00118846|566113277|FG001|Overall Study|Personal reason|5|||
156825583|NCT01468233|566113278|FG000|Treatment Period 1|Adverse Event|5|||
156825584|NCT01468233|566113279|FG001|Treatment Period 1|Adverse Event|3|||
156825585|NCT01468233|566113280|FG002|Treatment Period 1|Adverse Event|0|||
156825586|NCT01468233|566113281|FG003|Treatment Period 1|Adverse Event|0|||
156825587|NCT01468233|566113282|FG004|Treatment Period 1|Adverse Event|0|||
156825588|NCT01468233|566113283|FG005|Treatment Period 1|Adverse Event|0|||
156825589|NCT01468233|566113278|FG000|Treatment Period 1|Withdrawal by Subject|3|||
156825590|NCT01468233|566113279|FG001|Treatment Period 1|Withdrawal by Subject|4|||
156825591|NCT01468233|566113280|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156825592|NCT01468233|566113281|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156825593|NCT01468233|566113282|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156825594|NCT01468233|566113283|FG005|Treatment Period 1|Withdrawal by Subject|0|||
156825595|NCT01468233|566113278|FG000|Treatment Period 1|Lost to Follow-up|3|||
156825596|NCT01468233|566113279|FG001|Treatment Period 1|Lost to Follow-up|0|||
156825597|NCT01468233|566113280|FG002|Treatment Period 1|Lost to Follow-up|0|||
156825598|NCT01468233|566113281|FG003|Treatment Period 1|Lost to Follow-up|0|||
156825599|NCT01468233|566113282|FG004|Treatment Period 1|Lost to Follow-up|0|||
156825600|NCT01468233|566113283|FG005|Treatment Period 1|Lost to Follow-up|0|||
156825601|NCT01468233|566113278|FG000|Treatment Period 1|Other|1|||
156825602|NCT01468233|566113279|FG001|Treatment Period 1|Other|1|||
156825603|NCT01468233|566113280|FG002|Treatment Period 1|Other|0|||
156825604|NCT01468233|566113281|FG003|Treatment Period 1|Other|0|||
156825605|NCT01468233|566113282|FG004|Treatment Period 1|Other|0|||
156825606|NCT01468233|566113283|FG005|Treatment Period 1|Other|0|||
156825607|NCT01468233|566113278|FG000|Treatment Period 2|Adverse Event|0|||
156825608|NCT01468233|566113279|FG001|Treatment Period 2|Adverse Event|0|||
156825609|NCT01468233|566113280|FG002|Treatment Period 2|Adverse Event|3|||
156825610|NCT01468233|566113281|FG003|Treatment Period 2|Adverse Event|0|||
156825611|NCT01468233|566113282|FG004|Treatment Period 2|Adverse Event|2|||
156825612|NCT01468233|566113283|FG005|Treatment Period 2|Adverse Event|1|||
156825613|NCT01468233|566113278|FG000|Treatment Period 2|Lack of Efficacy|0|||
156825614|NCT01468233|566113279|FG001|Treatment Period 2|Lack of Efficacy|0|||
156825615|NCT01468233|566113280|FG002|Treatment Period 2|Lack of Efficacy|9|||
156825616|NCT01468233|566113281|FG003|Treatment Period 2|Lack of Efficacy|2|||
156825617|NCT01468233|566113282|FG004|Treatment Period 2|Lack of Efficacy|0|||
156825618|NCT01468233|566113283|FG005|Treatment Period 2|Lack of Efficacy|1|||
156825619|NCT01468233|566113278|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156825620|NCT01468233|566113279|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156825621|NCT01468233|566113280|FG002|Treatment Period 2|Withdrawal by Subject|9|||
156825622|NCT01468233|566113281|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156825623|NCT01468233|566113282|FG004|Treatment Period 2|Withdrawal by Subject|1|||
156825624|NCT01468233|566113283|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156825625|NCT01468233|566113278|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
156825626|NCT01468233|566113279|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
157022868|NCT05590403|566836901|FG000|Overall Study|Lost to Follow-up|13|||
157151108|NCT01522651|567298187|FG000|Overall Study|Withdrew Consent|1|||
157151109|NCT01522651|567298188|FG001|Overall Study|Withdrew Consent|1|||
157151110|NCT01522651|567298189|FG002|Overall Study|Withdrew Consent|0|||
157151111|NCT01522651|567298190|FG003|Overall Study|Withdrew Consent|1|||
157151112|NCT01522651|567298191|FG004|Overall Study|Withdrew Consent|1|||
156825627|NCT01468233|566113280|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
156825628|NCT01468233|566113281|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
156825629|NCT01468233|566113282|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
157022869|NCT05590403|566836902|FG001|Overall Study|Lost to Follow-up|1|||
157151113|NCT01522651|567298187|FG000|Overall Study|Randomized but Never Treated|0|||
157151114|NCT01522651|567298188|FG001|Overall Study|Randomized but Never Treated|1|||
157151115|NCT01522651|567298189|FG002|Overall Study|Randomized but Never Treated|0|||
156825630|NCT01468233|566113283|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
156825631|NCT01468233|566113278|FG000|Treatment Period 2|Lost to Follow-up|0|||
156825632|NCT01468233|566113279|FG001|Treatment Period 2|Lost to Follow-up|0|||
156825633|NCT01468233|566113280|FG002|Treatment Period 2|Lost to Follow-up|3|||
156825634|NCT01468233|566113281|FG003|Treatment Period 2|Lost to Follow-up|0|||
156825635|NCT01468233|566113282|FG004|Treatment Period 2|Lost to Follow-up|2|||
156825636|NCT01468233|566113283|FG005|Treatment Period 2|Lost to Follow-up|0|||
156825637|NCT01468233|566113278|FG000|Treatment Period 2|Other|0|||
156825638|NCT01468233|566113279|FG001|Treatment Period 2|Other|0|||
156825639|NCT01468233|566113280|FG002|Treatment Period 2|Other|3|||
156825640|NCT01468233|566113281|FG003|Treatment Period 2|Other|0|||
156825641|NCT01468233|566113282|FG004|Treatment Period 2|Other|1|||
156825642|NCT01468233|566113283|FG005|Treatment Period 2|Other|0|||
156825643|NCT01574157|566113284|FG000|Overall Study|Withdrawal by Subject|4|||
156825644|NCT01574157|566113285|FG001|Overall Study|Withdrawal by Subject|5|||
156825645|NCT01574157|566113284|FG000|Overall Study|Lost to Follow-up|0|||
156825646|NCT01574157|566113285|FG001|Overall Study|Lost to Follow-up|3|||
156825647|NCT02437409|566113295|FG000|Overall Study|Withdrawal by Subject|3|||
156825648|NCT02437409|566113295|FG000|Overall Study|Screening failure|12|||
156825649|NCT01944098|566113296|FG000|Overall Study|Physician Decision|1|||
156825650|NCT01944098|566113297|FG001|Overall Study|Physician Decision|0|||
156825651|NCT04669262|566113307|FG000|Overall Study|Withdrawal by Subject|0|||
156825652|NCT04669262|566113308|FG001|Overall Study|Withdrawal by Subject|0|||
156825653|NCT04669262|566113309|FG002|Overall Study|Withdrawal by Subject|0|||
156825654|NCT04669262|566113310|FG003|Overall Study|Withdrawal by Subject|1|||
156825655|NCT04669262|566113307|FG000|Overall Study|Randomized but Not Treated|0|||
156825656|NCT04669262|566113308|FG001|Overall Study|Randomized but Not Treated|1|||
156825657|NCT04669262|566113309|FG002|Overall Study|Randomized but Not Treated|0|||
156825658|NCT04669262|566113310|FG003|Overall Study|Randomized but Not Treated|0|||
156825659|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
156825660|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
156825661|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
156825662|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
156825663|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
156825664|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
156825665|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
156825666|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
156825667|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
156825668|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
156825669|NCT03549871|566113315|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
156825670|NCT03549871|566113316|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
156825671|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
156825672|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
156825673|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
156825674|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
156825675|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
156825676|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
156825677|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
156825678|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
156825679|NCT03549871|566113315|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
156825680|NCT03549871|566113316|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
156825681|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
156825682|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
156825683|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
156825684|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
156825685|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
156825686|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
156825687|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
156825688|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
156825689|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
156825690|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
156825691|NCT00737568|566113317|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
156825692|NCT00737568|566113318|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
156825693|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
156825694|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
156825695|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
156825696|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
156825697|NCT00737568|566113317|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
156825698|NCT00737568|566113318|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
156825699|NCT01133626|566113319|FG000|Overall Study|Adverse Event|0|||
156825700|NCT01133626|566113320|FG001|Overall Study|Adverse Event|1|||
156825701|NCT01133626|566113321|FG002|Overall Study|Adverse Event|0|||
156825702|NCT01133626|566113319|FG000|Overall Study|Withdrawal by Subject|1|||
156825703|NCT01133626|566113320|FG001|Overall Study|Withdrawal by Subject|2|||
156825704|NCT01133626|566113321|FG002|Overall Study|Withdrawal by Subject|2|||
157151116|NCT01522651|567298190|FG003|Overall Study|Randomized but Never Treated|1|||
157151117|NCT01522651|567298191|FG004|Overall Study|Randomized but Never Treated|1|||
157151118|NCT02658656|567298192|FG000|Screening|Failed eligibility criteria|0|||
157151119|NCT02658656|567298193|FG001|Screening|Failed eligibility criteria|0|||
156825705|NCT01133626|566113319|FG000|Overall Study|Other|0|||
156884752|NCT03085914|566336366|FG001|Overall Study|Withdrawal by Subject|1|||
156884753|NCT03085914|566336367|FG002|Overall Study|Withdrawal by Subject|2|||
156884754|NCT03085914|566336368|FG003|Overall Study|Withdrawal by Subject|2|||
156884755|NCT03085914|566336369|FG004|Overall Study|Withdrawal by Subject|2|||
156884756|NCT03085914|566336370|FG005|Overall Study|Withdrawal by Subject|0|||
156884757|NCT03085914|566336371|FG006|Overall Study|Withdrawal by Subject|1|||
156884758|NCT03085914|566336365|FG000|Overall Study|Lost to Follow-up|0|||
156884759|NCT03085914|566336366|FG001|Overall Study|Lost to Follow-up|0|||
156884760|NCT03085914|566336367|FG002|Overall Study|Lost to Follow-up|1|||
156884761|NCT03085914|566336368|FG003|Overall Study|Lost to Follow-up|0|||
156884762|NCT03085914|566336369|FG004|Overall Study|Lost to Follow-up|0|||
156884763|NCT03085914|566336370|FG005|Overall Study|Lost to Follow-up|1|||
156884764|NCT03085914|566336371|FG006|Overall Study|Lost to Follow-up|1|||
156884765|NCT03085914|566336365|FG000|Overall Study|Reason was not specified,|2|||
156884766|NCT03085914|566336366|FG001|Overall Study|Reason was not specified,|2|||
156884767|NCT03085914|566336367|FG002|Overall Study|Reason was not specified,|2|||
156884768|NCT03085914|566336368|FG003|Overall Study|Reason was not specified,|3|||
156884769|NCT03085914|566336369|FG004|Overall Study|Reason was not specified,|3|||
156884770|NCT03085914|566336370|FG005|Overall Study|Reason was not specified,|3|||
156884771|NCT03085914|566336371|FG006|Overall Study|Reason was not specified,|6|||
156884772|NCT03085914|566336365|FG000|Overall Study|Progressive Disease|0|||
156884773|NCT03085914|566336366|FG001|Overall Study|Progressive Disease|0|||
156884774|NCT03085914|566336367|FG002|Overall Study|Progressive Disease|2|||
156884775|NCT03085914|566336368|FG003|Overall Study|Progressive Disease|2|||
156884776|NCT03085914|566336369|FG004|Overall Study|Progressive Disease|1|||
156884777|NCT03085914|566336370|FG005|Overall Study|Progressive Disease|1|||
156884778|NCT03085914|566336371|FG006|Overall Study|Progressive Disease|1|||
156884779|NCT03085914|566336365|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156884780|NCT03085914|566336366|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156884781|NCT03085914|566336367|FG002|Overall Study|Study Terminated by the Sponsor|0|||
156825706|NCT01133626|566113320|FG001|Overall Study|Other|2|||
156825707|NCT01133626|566113321|FG002|Overall Study|Other|0|||
156825708|NCT00855933|566113322|FG000|Overall Study|Withdrawal by Subject|0|||
156825709|NCT00855933|566113323|FG001|Overall Study|Withdrawal by Subject|1|||
156825710|NCT00951080|566113324|FG000|Overall Study|Adverse Event|3|||
156825711|NCT00951080|566113325|FG001|Overall Study|Adverse Event|3|||
156825712|NCT00951080|566113324|FG000|Overall Study|Lost to Follow-up|0|||
156825713|NCT00951080|566113325|FG001|Overall Study|Lost to Follow-up|1|||
156825714|NCT00951080|566113324|FG000|Overall Study|Physician Decision|4|||
156825715|NCT00951080|566113325|FG001|Overall Study|Physician Decision|1|||
156825716|NCT00951080|566113324|FG000|Overall Study|Other|19|||
156825717|NCT00951080|566113325|FG001|Overall Study|Other|22|||
156825718|NCT05463744|566113326|FG000|Treatment Period|Withdrawal by Subject|19|||
156825719|NCT05463744|566113327|FG001|Treatment Period|Withdrawal by Subject|16|||
156825720|NCT05463744|566113326|FG000|Treatment Period|Adverse Event|4|||
156825721|NCT05463744|566113327|FG001|Treatment Period|Adverse Event|4|||
156825722|NCT05463744|566113326|FG000|Treatment Period|Pregnancy|0|||
156825723|NCT05463744|566113327|FG001|Treatment Period|Pregnancy|3|||
156825724|NCT05463744|566113326|FG000|Treatment Period|Lost to Follow-up|1|||
156825725|NCT05463744|566113327|FG001|Treatment Period|Lost to Follow-up|3|||
156825726|NCT05463744|566113326|FG000|Treatment Period|Inadvertent enrollment|2|||
156825727|NCT05463744|566113327|FG001|Treatment Period|Inadvertent enrollment|1|||
156825728|NCT05463744|566113326|FG000|Treatment Period|Death|0|||
156825729|NCT05463744|566113327|FG001|Treatment Period|Death|1|||
156825730|NCT05463744|566113326|FG000|Treatment Period|Non-compliance with Study Drug|1|||
156825731|NCT05463744|566113327|FG001|Treatment Period|Non-compliance with Study Drug|0|||
156825732|NCT05463744|566113326|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
156884782|NCT03085914|566336368|FG003|Overall Study|Study Terminated by the Sponsor|1|||
157151120|NCT02658656|567298194|FG002|Screening|Failed eligibility criteria|263|||
156825733|NCT05463744|566113327|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
156825734|NCT05463744|566113326|FG000|Treatment Period|Physician Decision|0|||
156825735|NCT05463744|566113327|FG001|Treatment Period|Physician Decision|1|||
156825736|NCT05463744|566113326|FG000|Follow-Up Period|Withdrawal by Subject|3|||
156825737|NCT05463744|566113327|FG001|Follow-Up Period|Withdrawal by Subject|1|||
156825738|NCT05463744|566113326|FG000|Follow-Up Period|Lost to Follow-up|1|||
156884783|NCT03085914|566336369|FG004|Overall Study|Study Terminated by the Sponsor|2|||
156884784|NCT03085914|566336370|FG005|Overall Study|Study Terminated by the Sponsor|1|||
156884785|NCT03085914|566336371|FG006|Overall Study|Study Terminated by the Sponsor|0|||
156884786|NCT01242813|566336372|FG000|Overall Study|Lost to Follow-up|2|||
156825739|NCT05463744|566113327|FG001|Follow-Up Period|Lost to Follow-up|1|||
157022870|NCT05590403|566836903|FG002|Overall Study|Lost to Follow-up|7|||
157022871|NCT05590403|566836904|FG003|Overall Study|Lost to Follow-up|3|||
156825740|NCT01960998|566113328|FG000|Overall Study|Lost to Follow-up|3|||
156825741|NCT01960998|566113329|FG001|Overall Study|Lost to Follow-up|7|||
156825742|NCT01960998|566113328|FG000|Overall Study|Death|0|||
156825743|NCT01960998|566113329|FG001|Overall Study|Death|1|||
156825744|NCT01960998|566113328|FG000|Overall Study|Withdrawal by Subject|8|||
156825745|NCT01960998|566113329|FG001|Overall Study|Withdrawal by Subject|2|||
156825746|NCT01960998|566113328|FG000|Overall Study|lost computer access|0|||
156825747|NCT01960998|566113329|FG001|Overall Study|lost computer access|1|||
156825748|NCT02439450|566113337|FG000|Overall Study|Adverse Event|4|||
156825749|NCT02439450|566113338|FG001|Overall Study|Adverse Event|1|||
156825750|NCT02439450|566113339|FG002|Overall Study|Adverse Event|0|||
156825751|NCT02439450|566113340|FG003|Overall Study|Adverse Event|0|||
156825752|NCT02439450|566113337|FG000|Overall Study|Withdrawal by Subject|1|||
156825753|NCT02439450|566113338|FG001|Overall Study|Withdrawal by Subject|2|||
156825754|NCT02439450|566113339|FG002|Overall Study|Withdrawal by Subject|0|||
156825755|NCT02439450|566113340|FG003|Overall Study|Withdrawal by Subject|0|||
156825756|NCT02439450|566113337|FG000|Overall Study|Death|3|||
156825757|NCT02439450|566113338|FG001|Overall Study|Death|0|||
156825758|NCT02439450|566113339|FG002|Overall Study|Death|0|||
156884787|NCT01445548|566336374|FG000|Overall Study|Adverse Event|1|||
156884788|NCT00701662|566336376|FG000|Overall Study|Lack of Efficacy|1|||
156825759|NCT02439450|566113340|FG003|Overall Study|Death|1|||
156825760|NCT02439450|566113337|FG000|Overall Study|Progressive Disease|18|||
156825761|NCT02439450|566113338|FG001|Overall Study|Progressive Disease|41|||
156825762|NCT02439450|566113339|FG002|Overall Study|Progressive Disease|2|||
156825763|NCT02439450|566113340|FG003|Overall Study|Progressive Disease|3|||
156825764|NCT04508751|566113345|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
156825765|NCT04508751|566113346|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
156825766|NCT04508751|566113347|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
156825767|NCT03551665|566113350|FG000|Overall Study|Lost to Follow-up|11|||
156825768|NCT03551665|566113351|FG001|Overall Study|Lost to Follow-up|2|||
156825769|NCT00445939|566114316|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
156825770|NCT00445939|566114317|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
156825771|NCT00445939|566114318|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
156825772|NCT00445939|566114319|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
156825773|NCT00445939|566114316|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
156825774|NCT00445939|566114317|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
156825775|NCT00445939|566114318|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
156825776|NCT00445939|566114319|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
156825777|NCT00919867|566114320|FG000|First Intervention|Withdrawal by Subject|0|||
156825778|NCT00919867|566114321|FG001|First Intervention|Withdrawal by Subject|0|||
156825779|NCT00919867|566114322|FG002|First Intervention|Withdrawal by Subject|1|||
156825780|NCT00919867|566114323|FG003|First Intervention|Withdrawal by Subject|0|||
156825781|NCT00919867|566114324|FG004|First Intervention|Withdrawal by Subject|0|||
156825782|NCT00919867|566114325|FG005|First Intervention|Withdrawal by Subject|0|||
156825783|NCT00919867|566114320|FG000|First Intervention|Physician Decision|0|||
156825784|NCT00919867|566114321|FG001|First Intervention|Physician Decision|0|||
156825785|NCT00919867|566114322|FG002|First Intervention|Physician Decision|0|||
156825786|NCT00919867|566114323|FG003|First Intervention|Physician Decision|0|||
156825787|NCT00919867|566114324|FG004|First Intervention|Physician Decision|0|||
156825788|NCT00919867|566114325|FG005|First Intervention|Physician Decision|1|||
156825789|NCT03555981|566114334|FG000|Overall Study|Lost to Follow-up|0|||
156825790|NCT03555981|566114335|FG001|Overall Study|Lost to Follow-up|2|||
156825791|NCT00354107|566114338|FG000|Overall Study|Adverse Event|2|||
156825792|NCT00354107|566114338|FG000|Overall Study|Physician Decision|2|||
156825793|NCT00354107|566114338|FG000|Overall Study|Withdrawal by Subject|1|||
156825794|NCT03361189|566114344|FG000|Overall Study|Received heart transplant|1|||
156884789|NCT03560518|566336377|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
156884790|NCT03560518|566336378|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
156884791|NCT03560518|566336379|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
156884792|NCT03560518|566336377|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
156884793|NCT03560518|566336378|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
156884794|NCT03560518|566336379|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
156884795|NCT03560518|566336377|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156884796|NCT03560518|566336378|FG001|Double Blind Treatment Period|Protocol Violation|2|||
156825795|NCT03361189|566114345|FG001|Overall Study|Received heart transplant|0|||
156825796|NCT03361189|566114344|FG000|Overall Study|Pacemake replacement|0|||
156825797|NCT03361189|566114345|FG001|Overall Study|Pacemake replacement|1|||
156825798|NCT03344549|566114346|FG000|Overall Study|Withdrawal by Subject|3|||
156825799|NCT03344549|566114347|FG001|Overall Study|Withdrawal by Subject|2|||
156825800|NCT03344549|566114346|FG000|Overall Study|Dialysis|2|||
156825801|NCT03344549|566114347|FG001|Overall Study|Dialysis|0|||
156825802|NCT03344549|566114346|FG000|Overall Study|Cancer|1|||
156884797|NCT03560518|566336379|FG002|Double Blind Treatment Period|Protocol Violation|0|||
156825803|NCT03344549|566114347|FG001|Overall Study|Cancer|0|||
156825804|NCT03344549|566114346|FG000|Overall Study|Lack of electronic device|1|||
156884798|NCT03560518|566336377|FG000|Double Blind Treatment Period|Pregnancy|0|||
156884799|NCT03560518|566336378|FG001|Double Blind Treatment Period|Pregnancy|2|||
156884800|NCT03560518|566336379|FG002|Double Blind Treatment Period|Pregnancy|0|||
156884801|NCT03560518|566336377|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
156884802|NCT03560518|566336378|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
156825805|NCT03344549|566114347|FG001|Overall Study|Lack of electronic device|0|||
156825806|NCT03344549|566114346|FG000|Overall Study|Transportation difficulty|0|||
156825807|NCT03344549|566114347|FG001|Overall Study|Transportation difficulty|13|||
156825808|NCT03333252|566114348|FG000|Overall Study|Adverse Event|10|||
156825809|NCT03333252|566114349|FG001|Overall Study|Adverse Event|6|||
156825810|NCT03333252|566114350|FG002|Overall Study|Adverse Event|5|||
156825811|NCT03333252|566114351|FG003|Overall Study|Adverse Event|2|||
156825812|NCT03333252|566114348|FG000|Overall Study|Death|1|||
156825813|NCT03333252|566114349|FG001|Overall Study|Death|3|||
156825814|NCT03333252|566114350|FG002|Overall Study|Death|0|||
156825815|NCT03333252|566114351|FG003|Overall Study|Death|0|||
156825816|NCT03333252|566114348|FG000|Overall Study|Lack of Efficacy|8|||
156825817|NCT03333252|566114349|FG001|Overall Study|Lack of Efficacy|4|||
156825818|NCT03333252|566114350|FG002|Overall Study|Lack of Efficacy|0|||
156825819|NCT03333252|566114351|FG003|Overall Study|Lack of Efficacy|7|||
156825820|NCT03333252|566114348|FG000|Overall Study|Lost to Follow-up|0|||
156825821|NCT03333252|566114349|FG001|Overall Study|Lost to Follow-up|5|||
156825822|NCT03333252|566114350|FG002|Overall Study|Lost to Follow-up|9|||
156825823|NCT03333252|566114351|FG003|Overall Study|Lost to Follow-up|3|||
156825824|NCT03333252|566114348|FG000|Overall Study|Withdrawal by Subject|14|||
156825825|NCT03333252|566114349|FG001|Overall Study|Withdrawal by Subject|24|||
156825826|NCT03333252|566114350|FG002|Overall Study|Withdrawal by Subject|11|||
156825827|NCT03333252|566114351|FG003|Overall Study|Withdrawal by Subject|17|||
156825828|NCT01685801|566114357|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825829|NCT01685801|566114358|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825830|NCT01685801|566114359|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
156825831|NCT01685801|566114360|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
156825832|NCT01685801|566114357|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
156825833|NCT01685801|566114358|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
156825834|NCT01685801|566114359|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
156825835|NCT01685801|566114360|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
156825836|NCT00113399|566114361|FG000|Overall Study|Death|1|||
156825837|NCT00113399|566114362|FG001|Overall Study|Death|1|||
156825838|NCT00113399|566114361|FG000|Overall Study|Withdrawal by Subject|1|||
156825839|NCT00113399|566114362|FG001|Overall Study|Withdrawal by Subject|2|||
156825840|NCT00113399|566114361|FG000|Overall Study|Complete Response|0|||
156825841|NCT00113399|566114362|FG001|Overall Study|Complete Response|1|||
156825842|NCT00113399|566114361|FG000|Overall Study|Other|0|||
156825843|NCT00113399|566114362|FG001|Overall Study|Other|1|||
156825844|NCT00666588|566114363|FG000|Overall Study|ineligible|2|||
156825845|NCT00666588|566114364|FG001|Overall Study|ineligible|0|||
156825846|NCT00666588|566114365|FG002|Overall Study|ineligible|0|||
156825847|NCT00666588|566114366|FG003|Overall Study|ineligible|2|||
156825848|NCT00666588|566114363|FG000|Overall Study|inevaluable|2|||
156825849|NCT00666588|566114364|FG001|Overall Study|inevaluable|0|||
156825850|NCT00666588|566114365|FG002|Overall Study|inevaluable|0|||
156825851|NCT00666588|566114366|FG003|Overall Study|inevaluable|0|||
156825852|NCT02781792|566114370|FG000|Overall Study|Adverse Event|1|||
156825853|NCT02781792|566114371|FG001|Overall Study|Adverse Event|2|||
156825854|NCT02781792|566114370|FG000|Overall Study|Withdrawal by Subject|3|||
156825855|NCT02781792|566114371|FG001|Overall Study|Withdrawal by Subject|1|||
156825856|NCT02781792|566114370|FG000|Overall Study|Lack of Efficacy|1|||
156825857|NCT02781792|566114371|FG001|Overall Study|Lack of Efficacy|1|||
156825858|NCT02781792|566114370|FG000|Overall Study|Hospice|0|||
156825859|NCT02781792|566114371|FG001|Overall Study|Hospice|1|||
156825860|NCT04600076|566114372|FG000|Overall Study|Lost to Follow-up|3|||
156825861|NCT00457821|566114373|FG000|Part 2|Withdrawal by Subject|0|||
156825862|NCT00457821|566114374|FG001|Part 2|Withdrawal by Subject|0|||
156825863|NCT00457821|566114375|FG002|Part 2|Withdrawal by Subject|0|||
156825864|NCT00457821|566114376|FG003|Part 2|Withdrawal by Subject|0|||
156825865|NCT00457821|566114377|FG004|Part 2|Withdrawal by Subject|0|||
156825866|NCT00457821|566114378|FG005|Part 2|Withdrawal by Subject|0|||
156825867|NCT00457821|566114379|FG006|Part 2|Withdrawal by Subject|0|||
156825868|NCT00457821|566114380|FG007|Part 2|Withdrawal by Subject|1|||
156825869|NCT00790647|566114383|FG000|Overall Study|Adverse Event|1|||
156825870|NCT00027378|566114384|FG000|Overall Study|Physician Decision|0|||
156825871|NCT00027378|566114385|FG001|Overall Study|Physician Decision|3|||
156825872|NCT02851407|566114390|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156825873|NCT02851407|566114391|FG001|Overall Study|Withdrawal by parent/guardian|7|||
156825874|NCT02851407|566114390|FG000|Overall Study|Protocol deviation|0|||
156825875|NCT02851407|566114391|FG001|Overall Study|Protocol deviation|1|||
156825876|NCT02851407|566114390|FG000|Overall Study|Transferred to another hospital to continue|1|||
156825877|NCT02851407|566114391|FG001|Overall Study|Transferred to another hospital to continue|0|||
156825878|NCT02851407|566114390|FG000|Overall Study|Other Death|30|||
156825879|NCT02851407|566114391|FG001|Overall Study|Other Death|20|||
156825880|NCT02851407|566114390|FG000|Overall Study|Adverse event, serious fatal|6|||
156825881|NCT02851407|566114391|FG001|Overall Study|Adverse event, serious fatal|8|||
156825882|NCT02851407|566114390|FG000|Overall Study|Consent withdrawn by participant|5|||
156825883|NCT02851407|566114391|FG001|Overall Study|Consent withdrawn by participant|3|||
156825884|NCT02851407|566114390|FG000|Overall Study|Screen failure|2|||
156825885|NCT02851407|566114391|FG001|Overall Study|Screen failure|1|||
156825886|NCT02851407|566114390|FG000|Overall Study|Disease relapse|9|||
156825887|NCT02851407|566114391|FG001|Overall Study|Disease relapse|6|||
156825888|NCT02851407|566114390|FG000|Overall Study|Physician Decision|7|||
156825889|NCT02851407|566114391|FG001|Overall Study|Physician Decision|6|||
156825890|NCT02851407|566114390|FG000|Overall Study|Transferred to hospital closer to home|0|||
156825891|NCT02851407|566114391|FG001|Overall Study|Transferred to hospital closer to home|1|||
156825892|NCT02851407|566114390|FG000|Overall Study|Enrolled in an investigational study|0|||
156825893|NCT02851407|566114391|FG001|Overall Study|Enrolled in an investigational study|1|||
156825894|NCT02851407|566114390|FG000|Overall Study|Early recovery|1|||
156825895|NCT02851407|566114391|FG001|Overall Study|Early recovery|0|||
156825896|NCT02851407|566114390|FG000|Overall Study|Adverse event, non-fatal|7|||
156825897|NCT02851407|566114391|FG001|Overall Study|Adverse event, non-fatal|5|||
156825898|NCT02851407|566114390|FG000|Overall Study|Lost to Follow-up|0|||
156825899|NCT02851407|566114391|FG001|Overall Study|Lost to Follow-up|2|||
156825900|NCT01713283|566114395|FG000|Overall Study|Lack of Efficacy|10|||
156825901|NCT01713283|566114396|FG001|Overall Study|Lack of Efficacy|2|||
156825902|NCT01713283|566114395|FG000|Overall Study|Lost to Follow-up|1|||
156825903|NCT01713283|566114396|FG001|Overall Study|Lost to Follow-up|1|||
156825904|NCT02585830|566114397|FG000|Overall Study|Withdrawal by Subject|3|||
156825905|NCT00835640|566114398|FG000|Second Intervention|Protocol Violation|1|||
156825906|NCT00835640|566114399|FG001|Second Intervention|Protocol Violation|0|||
156825907|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
156825908|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
156825909|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Death|1|||
156825910|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Death|0|||
156825911|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
156825912|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
156825913|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
156825914|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
156825915|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
156825916|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
156825917|NCT00350272|566114400|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
156825918|NCT00350272|566114401|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
156825919|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
156825920|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
156825921|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
156825922|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
156825923|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
156825924|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
156825925|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
156825926|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
156825927|NCT00350272|566114400|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
156825928|NCT00350272|566114401|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
156825929|NCT00068250|566114402|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
156825930|NCT00068250|566114403|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
156825931|NCT00068250|566114404|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
156825932|NCT00068250|566114405|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
156825933|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Death|5|||
156825934|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Death|0|||
156825935|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Death|0|||
156825936|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
156825937|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
156825938|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
156825939|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
156825940|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
156825941|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
156825942|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
156825943|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
156825944|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
156825945|NCT01357161|566114406|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
156825946|NCT01357161|566114407|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
156884803|NCT03560518|566336379|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
156825947|NCT01357161|566114408|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
156825948|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
156825949|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
156825950|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
156825951|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
156825952|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
156825953|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
156825954|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
156825955|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
156825956|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
156825957|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
156825958|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
156825959|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
156825960|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
156825961|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
156825962|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
156825963|NCT01357161|566114406|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
156825964|NCT01357161|566114407|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
156825965|NCT01357161|566114408|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
156825966|NCT00235391|566114409|FG000|Overall Study|Adverse Event|4|||
156825967|NCT00235391|566114410|FG001|Overall Study|Adverse Event|5|||
156825968|NCT00235391|566114411|FG002|Overall Study|Adverse Event|10|||
156825969|NCT00235391|566114412|FG003|Overall Study|Adverse Event|72|||
156825970|NCT00235391|566114413|FG004|Overall Study|Adverse Event|5|||
156825971|NCT00235391|566114414|FG005|Overall Study|Adverse Event|2|||
156825972|NCT00235391|566114409|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156825973|NCT00235391|566114410|FG001|Overall Study|Abnormal laboratory value(s)|5|||
156825974|NCT00235391|566114411|FG002|Overall Study|Abnormal laboratory value(s)|4|||
156825975|NCT00235391|566114412|FG003|Overall Study|Abnormal laboratory value(s)|27|||
156825976|NCT00235391|566114413|FG004|Overall Study|Abnormal laboratory value(s)|1|||
156825977|NCT00235391|566114414|FG005|Overall Study|Abnormal laboratory value(s)|2|||
156825978|NCT00235391|566114409|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156825979|NCT00235391|566114410|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156825980|NCT00235391|566114411|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156825981|NCT00235391|566114412|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
156825982|NCT00235391|566114413|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
156825983|NCT00235391|566114414|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
156825984|NCT00235391|566114409|FG000|Overall Study|Condition no longer requires treatment|3|||
156825985|NCT00235391|566114410|FG001|Overall Study|Condition no longer requires treatment|0|||
156825986|NCT00235391|566114411|FG002|Overall Study|Condition no longer requires treatment|0|||
156825987|NCT00235391|566114412|FG003|Overall Study|Condition no longer requires treatment|11|||
156825988|NCT00235391|566114413|FG004|Overall Study|Condition no longer requires treatment|1|||
156825989|NCT00235391|566114414|FG005|Overall Study|Condition no longer requires treatment|0|||
156825990|NCT00235391|566114409|FG000|Overall Study|Protocol deviation|0|||
156825991|NCT00235391|566114410|FG001|Overall Study|Protocol deviation|0|||
156825992|NCT00235391|566114411|FG002|Overall Study|Protocol deviation|1|||
156825993|NCT00235391|566114412|FG003|Overall Study|Protocol deviation|11|||
156825994|NCT00235391|566114413|FG004|Overall Study|Protocol deviation|0|||
156825995|NCT00235391|566114414|FG005|Overall Study|Protocol deviation|0|||
156825996|NCT00235391|566114409|FG000|Overall Study|Withdrawal by Subject|2|||
156825997|NCT00235391|566114410|FG001|Overall Study|Withdrawal by Subject|3|||
156825998|NCT00235391|566114411|FG002|Overall Study|Withdrawal by Subject|3|||
157224498|NCT04799158|567568020|FG001|Run-In Period|Lost to Follow-up|0|||
156825999|NCT00235391|566114412|FG003|Overall Study|Withdrawal by Subject|61|||
156826000|NCT00235391|566114413|FG004|Overall Study|Withdrawal by Subject|5|||
156826001|NCT00235391|566114414|FG005|Overall Study|Withdrawal by Subject|0|||
156826002|NCT00235391|566114409|FG000|Overall Study|Lost to Follow-up|0|||
156826003|NCT00235391|566114410|FG001|Overall Study|Lost to Follow-up|3|||
156826004|NCT00235391|566114411|FG002|Overall Study|Lost to Follow-up|3|||
156826005|NCT00235391|566114412|FG003|Overall Study|Lost to Follow-up|16|||
156826006|NCT00235391|566114413|FG004|Overall Study|Lost to Follow-up|0|||
156826007|NCT00235391|566114414|FG005|Overall Study|Lost to Follow-up|0|||
156826008|NCT00235391|566114409|FG000|Overall Study|Administrative problems|0|||
156826009|NCT00235391|566114410|FG001|Overall Study|Administrative problems|0|||
156826010|NCT00235391|566114411|FG002|Overall Study|Administrative problems|0|||
156826011|NCT00235391|566114412|FG003|Overall Study|Administrative problems|1|||
156826012|NCT00235391|566114413|FG004|Overall Study|Administrative problems|0|||
156826013|NCT00235391|566114414|FG005|Overall Study|Administrative problems|0|||
156826014|NCT00235391|566114409|FG000|Overall Study|Death|0|||
156826015|NCT00235391|566114410|FG001|Overall Study|Death|0|||
156826016|NCT00235391|566114411|FG002|Overall Study|Death|1|||
156826017|NCT00235391|566114412|FG003|Overall Study|Death|4|||
156826018|NCT00235391|566114413|FG004|Overall Study|Death|0|||
156826019|NCT00235391|566114414|FG005|Overall Study|Death|0|||
156826020|NCT01824823|566114415|FG000|Overall Study|Lack of Efficacy|1|||
156826021|NCT01824823|566114416|FG001|Overall Study|Lack of Efficacy|1|||
156826022|NCT01824823|566114415|FG000|Overall Study|Off-treatment reason not submitted|1|||
156884804|NCT03560518|566336377|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
156884805|NCT03560518|566336378|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
156884806|NCT03560518|566336379|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
156884807|NCT03560518|566336377|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
156884808|NCT03560518|566336378|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
156884809|NCT03560518|566336379|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
156884810|NCT03560518|566336377|FG000|Double Blind Treatment Period|Adverse Event|0|||
156884811|NCT03560518|566336378|FG001|Double Blind Treatment Period|Adverse Event|3|||
156884812|NCT03560518|566336379|FG002|Double Blind Treatment Period|Adverse Event|1|||
156884813|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
156826023|NCT01824823|566114416|FG001|Overall Study|Off-treatment reason not submitted|0|||
156826024|NCT03349645|566114417|FG000|Overall Study|Sponsor Terminated Study|75|||
156826025|NCT03349645|566114417|FG000|Overall Study|Withdrawal by Subject|4|||
156826026|NCT03349645|566114417|FG000|Overall Study|Protocol Violation|1|||
156826027|NCT03349645|566114417|FG000|Overall Study|Other|2|||
156826028|NCT01080768|566114427|FG000|Overall Study|Protocol Deviation|2|||
156826029|NCT01080768|566114428|FG001|Overall Study|Protocol Deviation|1|||
156826030|NCT03510468|566114429|FG000|Overall Study|Lost to Follow-up|1|||
156826031|NCT03510468|566114429|FG000|Overall Study|Adverse Event|5|||
156826032|NCT03510468|566114429|FG000|Overall Study|Physician Decision|1|||
156826033|NCT03510468|566114429|FG000|Overall Study|non-compliant with treatment|2|||
156826034|NCT03510468|566114429|FG000|Overall Study|Missed visit|1|||
156826035|NCT03730961|566114431|FG000|Overall Study|Adverse Event|0|||
156826036|NCT03730961|566114432|FG001|Overall Study|Adverse Event|1|||
156826037|NCT00840060|566116082|FG000|Overall Study|Withdrawal by Subject|1|||
156826038|NCT00840060|566116083|FG001|Overall Study|Withdrawal by Subject|0|||
156826039|NCT00840060|566116082|FG000|Overall Study|Change in emotional/behavioral status|0|||
156826040|NCT00840060|566116083|FG001|Overall Study|Change in emotional/behavioral status|1|||
156826041|NCT00428220|566116084|FG000|Overall Study|Participant died|8|||
156826042|NCT00428220|566116084|FG000|Overall Study|Global deterioration of health status|7|||
156826043|NCT00428220|566116084|FG000|Overall Study|Lost to Follow-up|4|||
156826044|NCT00428220|566116084|FG000|Overall Study|Objective progression or relapse|123|||
156826045|NCT00428220|566116084|FG000|Overall Study|Participant refused continued treatment|7|||
156826046|NCT00428220|566116084|FG000|Overall Study|Adverse Event|51|||
156826047|NCT00428220|566116084|FG000|Overall Study|Other|23|||
156826048|NCT00509093|566116085|FG000|Overall Study|Adverse Event|10|||
156826049|NCT00509093|566116085|FG000|Overall Study|Disease Progression|9|||
156826050|NCT00509093|566116085|FG000|Overall Study|Transformed into MDS|1|||
156826051|NCT00509093|566116085|FG000|Overall Study|Withdrawal by Subject|3|||
156826052|NCT00509093|566116085|FG000|Overall Study|Physician Decision|1|||
156826053|NCT01103063|566116086|FG000|Overall Study|Adverse Event|3|||
156826054|NCT01103063|566116087|FG001|Overall Study|Adverse Event|1|||
156826055|NCT01103063|566116086|FG000|Overall Study|Lost to Follow-up|68|||
156826056|NCT01103063|566116087|FG001|Overall Study|Lost to Follow-up|51|||
156826057|NCT01103063|566116086|FG000|Overall Study|Withdrawal by Subject|60|||
156826058|NCT01103063|566116087|FG001|Overall Study|Withdrawal by Subject|15|||
156826059|NCT01103063|566116086|FG000|Overall Study|Other|16|||
156826060|NCT01103063|566116087|FG001|Overall Study|Other|11|||
156826061|NCT01103063|566116086|FG000|Overall Study|Protocol Violation|1|||
156826062|NCT01103063|566116087|FG001|Overall Study|Protocol Violation|0|||
156826063|NCT01103063|566116086|FG000|Overall Study|Study terminated by Sponsor|326|||
156826064|NCT01103063|566116087|FG001|Overall Study|Study terminated by Sponsor|342|||
156826065|NCT01103063|566116086|FG000|Overall Study|Death|3|||
156826066|NCT01103063|566116087|FG001|Overall Study|Death|1|||
156826067|NCT04143217|566116094|FG000|Overall Study|Withdrawal by Subject|42|||
156826068|NCT04143217|566116094|FG000|Overall Study|Adverse Event|29|||
156826069|NCT04143217|566116094|FG000|Overall Study|Lost to Follow-up|29|||
156826070|NCT04143217|566116094|FG000|Overall Study|Lack of Efficacy|15|||
156826071|NCT04143217|566116094|FG000|Overall Study|Physician Decision|1|||
156826072|NCT04143217|566116094|FG000|Overall Study|Non-Compliance With Study Drug|6|||
156884814|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Adverse Event|9|||
156884815|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Death|4|||
157151121|NCT02658656|567298192|FG000|Randomization|Withdrawal by Subject|8|||
156826073|NCT04143217|566116094|FG000|Overall Study|Other, Multiple Categories|11|||
156826074|NCT02210832|566116097|FG000|Overall Study|Pregnancy termination .|3|||
156826075|NCT02210832|566116098|FG001|Overall Study|Pregnancy termination .|4|||
156826076|NCT02210832|566116099|FG002|Overall Study|Pregnancy termination .|1|||
156826077|NCT02210832|566116097|FG000|Overall Study|Lost to Follow-up|26|||
156826078|NCT02210832|566116098|FG001|Overall Study|Lost to Follow-up|32|||
156826079|NCT02210832|566116099|FG002|Overall Study|Lost to Follow-up|17|||
156826080|NCT00798317|566116107|FG000|Overall Study|Physician Decision|0|||
157151122|NCT02658656|567298193|FG001|Randomization|Withdrawal by Subject|7|||
157151123|NCT02658656|567298194|FG002|Randomization|Withdrawal by Subject|0|||
157151124|NCT02658656|567298192|FG000|Randomization|Lost to Follow-up|1|||
157151125|NCT02658656|567298193|FG001|Randomization|Lost to Follow-up|3|||
157151126|NCT02658656|567298194|FG002|Randomization|Lost to Follow-up|0|||
156826081|NCT00798317|566116108|FG001|Overall Study|Physician Decision|1|||
156826082|NCT00798317|566116107|FG000|Overall Study|Withdrawal by Subject|5|||
156826083|NCT00798317|566116108|FG001|Overall Study|Withdrawal by Subject|4|||
156826084|NCT00798317|566116107|FG000|Overall Study|Lost to Follow-up|2|||
156826085|NCT00798317|566116108|FG001|Overall Study|Lost to Follow-up|2|||
156826086|NCT00798317|566116107|FG000|Overall Study|Adverse Event|2|||
156826087|NCT00798317|566116108|FG001|Overall Study|Adverse Event|0|||
156826088|NCT00798317|566116107|FG000|Overall Study|Death|1|||
156826089|NCT00798317|566116108|FG001|Overall Study|Death|0|||
156826090|NCT03405935|566116111|FG000|Overall Study|Adverse Event|3|||
156826091|NCT03405935|566116111|FG000|Overall Study|Death|2|||
156826092|NCT03405935|566116111|FG000|Overall Study|Withdrawal by Subject|1|||
156826093|NCT03405935|566116111|FG000|Overall Study|Lost to Follow-up|2|||
156826094|NCT04979897|566116112|FG000|Overall Study|Death|1|||
156826095|NCT04979897|566116113|FG001|Overall Study|Death|8|||
156826096|NCT04979897|566116112|FG000|Overall Study|Lost to Follow-up|111|||
156826097|NCT04979897|566116113|FG001|Overall Study|Lost to Follow-up|56|||
156826098|NCT04979897|566116112|FG000|Overall Study|Withdrawal by Subject|7|||
156826099|NCT04979897|566116113|FG001|Overall Study|Withdrawal by Subject|2|||
156826100|NCT03136497|566116120|FG000|Overall Study|Screen Failure|1|||
156826101|NCT03136497|566116121|FG001|Overall Study|Screen Failure|0|||
156826102|NCT03136497|566116122|FG002|Overall Study|Screen Failure|0|||
156826103|NCT00934947|566116123|FG000|Overall Study|Adverse Event|0|||
156826104|NCT00934947|566116124|FG001|Overall Study|Adverse Event|2|||
156826105|NCT00557310|566116125|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
156826106|NCT00557310|566116125|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
156826107|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
156826108|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
156826109|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
156826110|NCT00557310|566116125|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
156826111|NCT00683917|566116135|FG000|Overall Study|Study prematurely terminated|10|||
156826112|NCT02174523|566116136|FG000|Overall Study|Withdrawal by Subject|1|||
156826113|NCT02174523|566116137|FG001|Overall Study|Withdrawal by Subject|0|||
156826114|NCT00794365|566116138|FG000|Overall Study|Lost to Follow-up|38|||
156826115|NCT00794365|566116138|FG000|Overall Study|Other|17|||
156826116|NCT00794365|566116138|FG000|Overall Study|Poor Compliance|11|||
156826117|NCT00794365|566116138|FG000|Overall Study|Adverse Event|10|||
156826118|NCT00794365|566116138|FG000|Overall Study|Lack of Efficacy|3|||
156826119|NCT03538444|566116152|FG000|Overall Study|opioid withdrawal|1|||
156826120|NCT03538444|566116153|FG001|Overall Study|opioid withdrawal|0|||
156826121|NCT03022097|566116154|FG000|Overall Study|Adverse Event|3|||
156826122|NCT03022097|566116155|FG001|Overall Study|Adverse Event|4|||
156826123|NCT03022097|566116156|FG002|Overall Study|Adverse Event|1|||
156826124|NCT03022097|566116157|FG003|Overall Study|Adverse Event|3|||
156826125|NCT03022097|566116154|FG000|Overall Study|Progressive Disease|2|||
156826126|NCT03022097|566116155|FG001|Overall Study|Progressive Disease|0|||
156826127|NCT03022097|566116156|FG002|Overall Study|Progressive Disease|5|||
156826128|NCT03022097|566116157|FG003|Overall Study|Progressive Disease|2|||
156826129|NCT03022097|566116154|FG000|Overall Study|Lack of Efficacy|0|||
156826130|NCT03022097|566116155|FG001|Overall Study|Lack of Efficacy|0|||
157022872|NCT05590403|566836905|FG004|Overall Study|Lost to Follow-up|4|||
156826131|NCT03022097|566116156|FG002|Overall Study|Lack of Efficacy|3|||
156826132|NCT03022097|566116157|FG003|Overall Study|Lack of Efficacy|3|||
157022873|NCT05590403|566836901|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
157022874|NCT05590403|566836902|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
156826133|NCT03022097|566116154|FG000|Overall Study|Protocol Violation|1|||
156826134|NCT03022097|566116155|FG001|Overall Study|Protocol Violation|0|||
156826135|NCT03022097|566116156|FG002|Overall Study|Protocol Violation|1|||
156826136|NCT03022097|566116157|FG003|Overall Study|Protocol Violation|0|||
156826137|NCT03022097|566116154|FG000|Overall Study|Withdrawal by Subject|11|||
156826138|NCT03022097|566116155|FG001|Overall Study|Withdrawal by Subject|13|||
156826139|NCT03022097|566116156|FG002|Overall Study|Withdrawal by Subject|15|||
156826140|NCT03022097|566116157|FG003|Overall Study|Withdrawal by Subject|21|||
156826141|NCT03022097|566116154|FG000|Overall Study|Lost to Follow-up|0|||
156826142|NCT03022097|566116155|FG001|Overall Study|Lost to Follow-up|0|||
156826143|NCT03022097|566116156|FG002|Overall Study|Lost to Follow-up|1|||
156826144|NCT03022097|566116157|FG003|Overall Study|Lost to Follow-up|1|||
156826145|NCT03022097|566116154|FG000|Overall Study|Other|4|||
156826146|NCT03022097|566116155|FG001|Overall Study|Other|1|||
157022875|NCT05590403|566836903|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
157022876|NCT05590403|566836904|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
156826147|NCT03022097|566116156|FG002|Overall Study|Other|6|||
156826148|NCT03022097|566116157|FG003|Overall Study|Other|4|||
156826149|NCT03022097|566116154|FG000|Overall Study|Due to COVID-19 pandemic|0|||
156826150|NCT03022097|566116155|FG001|Overall Study|Due to COVID-19 pandemic|1|||
156826151|NCT03022097|566116156|FG002|Overall Study|Due to COVID-19 pandemic|0|||
156826152|NCT03022097|566116157|FG003|Overall Study|Due to COVID-19 pandemic|0|||
156826153|NCT01451931|566116158|FG000|Overall Study|Lost to Follow-up|17|||
156826154|NCT01451931|566116159|FG001|Overall Study|Lost to Follow-up|36|||
156826155|NCT01451931|566116160|FG002|Overall Study|Lost to Follow-up|21|||
156826156|NCT01451931|566116158|FG000|Overall Study|Withdrawal by Subject|16|||
156826157|NCT01451931|566116159|FG001|Overall Study|Withdrawal by Subject|22|||
156826158|NCT01451931|566116160|FG002|Overall Study|Withdrawal by Subject|22|||
156826159|NCT04422561|566116167|FG000|Overall Study|Lost to Follow-up|25|||
156826160|NCT04422561|566116168|FG001|Overall Study|Lost to Follow-up|11|||
156826161|NCT03640052|566116169|FG000|Overall Study|Lost to Follow-up|0|||
157022877|NCT05590403|566836905|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
157022878|NCT05590403|566836901|FG000|Overall Study|Other|2|||
157022879|NCT05590403|566836902|FG001|Overall Study|Other|0|||
157022880|NCT05590403|566836903|FG002|Overall Study|Other|2|||
156826162|NCT03640052|566116170|FG001|Overall Study|Lost to Follow-up|1|||
156826163|NCT03640052|566116171|FG002|Overall Study|Lost to Follow-up|0|||
156826164|NCT03640052|566116172|FG003|Overall Study|Lost to Follow-up|0|||
156826165|NCT03640052|566116173|FG004|Overall Study|Lost to Follow-up|0|||
156826166|NCT04239222|566116174|FG000|Baseline|Withdrawal by Subject|0|||
156826167|NCT04239222|566116175|FG001|Baseline|Withdrawal by Subject|0|||
156826168|NCT04239222|566116176|FG002|Baseline|Withdrawal by Subject|1|||
156826169|NCT04239222|566116177|FG003|Baseline|Withdrawal by Subject|1|||
156826170|NCT04239222|566116174|FG000|First Foot Assignment|Withdrawal by Subject|0|||
157022881|NCT05590403|566836904|FG003|Overall Study|Other|2|||
157022882|NCT05590403|566836905|FG004|Overall Study|Other|0|||
157022883|NCT05590403|566836901|FG000|Overall Study|Migrated / moved from the study area|1|||
157022884|NCT05590403|566836902|FG001|Overall Study|Migrated / moved from the study area|1|||
157022885|NCT05590403|566836903|FG002|Overall Study|Migrated / moved from the study area|0|||
157022886|NCT05590403|566836904|FG003|Overall Study|Migrated / moved from the study area|3|||
157022887|NCT05590403|566836905|FG004|Overall Study|Migrated / moved from the study area|1|||
157022888|NCT05590403|566836901|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
157022889|NCT05590403|566836902|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
157022890|NCT05590403|566836903|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
157022891|NCT05590403|566836904|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
157022892|NCT05590403|566836905|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
157022893|NCT04717492|566836906|FG000|Overall Study|Withdrawal by Subject|2|||
157022894|NCT04717492|566836907|FG001|Overall Study|Withdrawal by Subject|13|||
157022895|NCT04717492|566836906|FG000|Overall Study|Lost to Follow-up|2|||
157022896|NCT04717492|566836907|FG001|Overall Study|Lost to Follow-up|9|||
157022897|NCT03936322|566836910|FG000|Overall Study|Lost to Follow-up|1|||
157022898|NCT03936322|566836910|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
157022899|NCT02919683|566836912|FG000|Post-Surgery Follow-Up|Death|2|||
157022900|NCT02919683|566836913|FG001|Post-Surgery Follow-Up|Death|2|||
157022901|NCT02919683|566836912|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
157022902|NCT02919683|566836913|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
157022903|NCT01160211|566836914|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
157022904|NCT01160211|566836915|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
157022905|NCT01160211|566836916|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
157022906|NCT01160211|566836914|FG000|Overall Study|Lost to Follow-up|4|||
157022907|NCT01160211|566836915|FG001|Overall Study|Lost to Follow-up|8|||
156826171|NCT04239222|566116175|FG001|First Foot Assignment|Withdrawal by Subject|0|||
156826172|NCT04239222|566116176|FG002|First Foot Assignment|Withdrawal by Subject|1|||
156826173|NCT04239222|566116177|FG003|First Foot Assignment|Withdrawal by Subject|0|||
156826174|NCT04239222|566116174|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826175|NCT04239222|566116175|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826176|NCT04239222|566116176|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
156826177|NCT04239222|566116177|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
156826178|NCT02685748|566116183|FG000|Overall Study|Withdrawal by Subject|3|||
156826179|NCT02685748|566116184|FG001|Overall Study|Withdrawal by Subject|2|||
156826180|NCT05479097|566116185|FG000|Overall Study|Withdrawal by Subject|2|||
157022908|NCT01160211|566836916|FG002|Overall Study|Lost to Follow-up|4|||
156826181|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
157022909|NCT01160211|566836914|FG000|Overall Study|Physician Decision|1|||
157022910|NCT01160211|566836915|FG001|Overall Study|Physician Decision|0|||
157022911|NCT01160211|566836916|FG002|Overall Study|Physician Decision|0|||
157022912|NCT01160211|566836914|FG000|Overall Study|Withdrawal by Subject|4|||
157022913|NCT01160211|566836915|FG001|Overall Study|Withdrawal by Subject|2|||
157022914|NCT01160211|566836916|FG002|Overall Study|Withdrawal by Subject|2|||
157022915|NCT01160211|566836914|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
157022916|NCT01160211|566836915|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
157091528|NCT03265938|567089133|FG000|Overall Study|friable mass|6|||
156826182|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
156826183|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
156826184|NCT00230282|566116186|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
156826185|NCT01369680|566116188|FG000|Overall Study|Lost to Follow-up|0|||
157091529|NCT01588496|567089134|FG000|Overall Study|Withdrawal by Subject|0|||
157091530|NCT01588496|567089135|FG001|Overall Study|Withdrawal by Subject|1|||
156826186|NCT01369680|566116189|FG001|Overall Study|Lost to Follow-up|0|||
156826187|NCT01369680|566116190|FG002|Overall Study|Lost to Follow-up|1|||
156826188|NCT01369680|566116191|FG003|Overall Study|Lost to Follow-up|2|||
156826189|NCT01904149|566116193|FG000|Overall Study|Adverse Event|3|||
156826190|NCT01904149|566116194|FG001|Overall Study|Adverse Event|4|||
156826191|NCT01904149|566116195|FG002|Overall Study|Adverse Event|0|||
156826192|NCT01904149|566116196|FG003|Overall Study|Adverse Event|1|||
156826193|NCT01904149|566116197|FG004|Overall Study|Adverse Event|1|||
156826194|NCT01904149|566116198|FG005|Overall Study|Adverse Event|2|||
156826195|NCT01904149|566116193|FG000|Overall Study|Lack of Efficacy|0|||
156826196|NCT01904149|566116194|FG001|Overall Study|Lack of Efficacy|3|||
156826197|NCT01904149|566116195|FG002|Overall Study|Lack of Efficacy|1|||
156826198|NCT01904149|566116196|FG003|Overall Study|Lack of Efficacy|3|||
156826199|NCT01904149|566116197|FG004|Overall Study|Lack of Efficacy|3|||
156826200|NCT01904149|566116198|FG005|Overall Study|Lack of Efficacy|1|||
156826201|NCT01904149|566116193|FG000|Overall Study|Withdrawal by Subject|1|||
156826202|NCT01904149|566116194|FG001|Overall Study|Withdrawal by Subject|3|||
156826203|NCT01904149|566116195|FG002|Overall Study|Withdrawal by Subject|1|||
156826204|NCT01904149|566116196|FG003|Overall Study|Withdrawal by Subject|0|||
156826205|NCT01904149|566116197|FG004|Overall Study|Withdrawal by Subject|1|||
156826206|NCT01904149|566116198|FG005|Overall Study|Withdrawal by Subject|0|||
156826207|NCT01904149|566116193|FG000|Overall Study|Protocol Violation|0|||
156826208|NCT01904149|566116194|FG001|Overall Study|Protocol Violation|1|||
156826209|NCT01904149|566116195|FG002|Overall Study|Protocol Violation|0|||
156826210|NCT01904149|566116196|FG003|Overall Study|Protocol Violation|0|||
156826211|NCT01904149|566116197|FG004|Overall Study|Protocol Violation|0|||
156826212|NCT01904149|566116198|FG005|Overall Study|Protocol Violation|0|||
156826213|NCT01904149|566116193|FG000|Overall Study|non compliance with study drug|1|||
156826214|NCT01904149|566116194|FG001|Overall Study|non compliance with study drug|0|||
156826215|NCT01904149|566116195|FG002|Overall Study|non compliance with study drug|0|||
156826216|NCT01904149|566116196|FG003|Overall Study|non compliance with study drug|0|||
156826217|NCT01904149|566116197|FG004|Overall Study|non compliance with study drug|0|||
156826218|NCT01904149|566116198|FG005|Overall Study|non compliance with study drug|0|||
156826219|NCT02927925|566116201|FG000|Overall Study|Death|16|||
156826220|NCT02927925|566116201|FG000|Overall Study|Physician Decision|1|||
156826221|NCT02927925|566116201|FG000|Overall Study|Withdrawal by Subject|11|||
156826222|NCT02927925|566116201|FG000|Overall Study|Other|3|||
156826223|NCT02927925|566116201|FG000|Overall Study|Disease progression at clinical cutoff|1|||
156826224|NCT00580034|566116203|FG000|Overall Study|Toxicity|10|||
156826225|NCT00580034|566116204|FG001|Overall Study|Toxicity|0|||
156826226|NCT00772369|566116206|FG000|Overall Study|Did not return record release form|1|||
156826227|NCT03372460|566116207|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
156826228|NCT03372460|566116208|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
156826229|NCT02499900|566116209|FG000|Core Study Period|Other|1|||
156826230|NCT02499900|566116210|FG001|Core Study Period|Other|4|||
156826231|NCT02499900|566116209|FG000|Core Study Period|Lost to Follow-up|1|||
156826232|NCT02499900|566116210|FG001|Core Study Period|Lost to Follow-up|2|||
156826233|NCT02499900|566116209|FG000|Core Study Period|Per sponsor request|0|||
156826234|NCT02499900|566116210|FG001|Core Study Period|Per sponsor request|1|||
156826235|NCT02499900|566116209|FG000|Core Study Period|Pregnancy|1|||
156826236|NCT02499900|566116210|FG001|Core Study Period|Pregnancy|0|||
156826237|NCT02499900|566116209|FG000|Core Study Period|Protocol Violation|3|||
156826238|NCT02499900|566116210|FG001|Core Study Period|Protocol Violation|0|||
156826239|NCT02499900|566116209|FG000|Core Study Period|Withdrawal by Subject|11|||
156826240|NCT02499900|566116210|FG001|Core Study Period|Withdrawal by Subject|10|||
156826241|NCT02499900|566116209|FG000|Core Study Period|Adverse Event|18|||
156826242|NCT02499900|566116210|FG001|Core Study Period|Adverse Event|14|||
156826243|NCT02499900|566116209|FG000|Core Study Period|Death|0|||
156826244|NCT02499900|566116210|FG001|Core Study Period|Death|1|||
156826245|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
156826246|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
156826247|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
156826248|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
156826249|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
156826250|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
156884816|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
156884817|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
156826251|NCT02499900|566116209|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
156826252|NCT02499900|566116210|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
156826253|NCT02499900|566116209|FG000|Extension Study Period|Adverse Event|2|||
156884818|NCT00159822|566336380|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
156826254|NCT02499900|566116210|FG001|Extension Study Period|Adverse Event|4|||
156826255|NCT02499900|566116209|FG000|Extension Study Period|Withdrawal by Subject|5|||
156826256|NCT02499900|566116210|FG001|Extension Study Period|Withdrawal by Subject|2|||
156884819|NCT00159822|566336380|FG000|Post-treatment Follow-up Period|Death|1|||
156884820|NCT00159822|566336380|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
156826257|NCT02499900|566116209|FG000|Extension Study Period|Physician Decision|2|||
156826258|NCT02499900|566116210|FG001|Extension Study Period|Physician Decision|5|||
156826259|NCT02499900|566116209|FG000|Extension Study Period|Pregnancy|1|||
156826260|NCT02499900|566116210|FG001|Extension Study Period|Pregnancy|2|||
156826261|NCT02499900|566116209|FG000|Extension Study Period|Lost to Follow-up|2|||
156826262|NCT02499900|566116210|FG001|Extension Study Period|Lost to Follow-up|5|||
156826263|NCT02499900|566116209|FG000|Extension Study Period|Other|0|||
156826264|NCT02499900|566116210|FG001|Extension Study Period|Other|2|||
156826265|NCT00916058|566116211|FG000|Phase 1|Screen Failure|0|||
156826266|NCT00916058|566116212|FG001|Phase 1|Screen Failure|0|||
156826267|NCT00916058|566116213|FG002|Phase 1|Screen Failure|0|||
156826268|NCT00916058|566116214|FG003|Phase 1|Screen Failure|0|||
156826269|NCT00916058|566116215|FG004|Phase 1|Screen Failure|0|||
156826270|NCT00916058|566116216|FG005|Phase 1|Screen Failure|1|||
156826271|NCT00916058|566116217|FG006|Phase 1|Screen Failure|0|||
156826272|NCT00916058|566116211|FG000|Phase 2|Screen Failure|0|||
156826273|NCT00916058|566116212|FG001|Phase 2|Screen Failure|0|||
156826274|NCT00916058|566116213|FG002|Phase 2|Screen Failure|0|||
156826275|NCT00916058|566116214|FG003|Phase 2|Screen Failure|0|||
156826276|NCT00916058|566116215|FG004|Phase 2|Screen Failure|0|||
156826277|NCT00916058|566116216|FG005|Phase 2|Screen Failure|0|||
156826278|NCT00916058|566116217|FG006|Phase 2|Screen Failure|3|||
156826279|NCT02752958|566116218|FG000|Overall Study|Adverse Event|3|||
156826280|NCT02752958|566116218|FG000|Overall Study|Lost to Follow-up|1|||
156826281|NCT02752958|566116218|FG000|Overall Study|Protocol Violation|1|||
156826282|NCT02752958|566116218|FG000|Overall Study|Withdrawal by Subject|2|||
156826283|NCT02752958|566116218|FG000|Overall Study|Other (Reason not specified)|2|||
156826284|NCT02836873|566116221|FG000|Overall Study|Protocol Violation|0|||
156826285|NCT02836873|566116222|FG001|Overall Study|Protocol Violation|1|||
156826286|NCT02836873|566116221|FG000|Overall Study|Adverse Event|1|||
156826287|NCT02836873|566116222|FG001|Overall Study|Adverse Event|4|||
156826288|NCT02836873|566116221|FG000|Overall Study|Withdrawal by Subject|2|||
156826289|NCT02836873|566116222|FG001|Overall Study|Withdrawal by Subject|2|||
156826290|NCT02836873|566116221|FG000|Overall Study|Lost to Follow-up|1|||
156826291|NCT02836873|566116222|FG001|Overall Study|Lost to Follow-up|3|||
156826292|NCT02836873|566116221|FG000|Overall Study|Physician Decision|0|||
156826293|NCT02836873|566116222|FG001|Overall Study|Physician Decision|1|||
156826294|NCT02836873|566116221|FG000|Overall Study|Other|1|||
156826295|NCT02836873|566116222|FG001|Overall Study|Other|0|||
156826296|NCT00853125|566116229|FG000|Overall Study|Study participant's donor was CMV +|1|||
156826297|NCT01646645|566116232|FG000|Overall Study|No Treated|1|||
156826298|NCT01646645|566116232|FG000|Overall Study|Inevaluable Donor|29|||
156826299|NCT00884039|566116233|FG000|Overall Study|Withdrawal by Subject|0|||
156826300|NCT00884039|566116234|FG001|Overall Study|Withdrawal by Subject|1|||
156826301|NCT00884039|566116233|FG000|Overall Study|Lack of Efficacy|2|||
156826302|NCT00884039|566116234|FG001|Overall Study|Lack of Efficacy|0|||
156826303|NCT00717522|566116235|FG000|Overall Study|Disease Progression|5|||
156826304|NCT00717522|566116235|FG000|Overall Study|Adverse Event|1|||
156826305|NCT00717522|566116235|FG000|Overall Study|Death|1|||
156826306|NCT01799239|566116236|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
156826307|NCT01799239|566116237|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
156826308|NCT01799239|566116236|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
156826309|NCT01799239|566116237|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
156826310|NCT01799239|566116236|FG000|Period 1 (7 Days)|Protocol Violation|0|||
156826311|NCT01799239|566116237|FG001|Period 1 (7 Days)|Protocol Violation|1|||
156826312|NCT01799239|566116236|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
156826313|NCT01799239|566116237|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
156826314|NCT01799239|566116236|FG000|Period 2 (7 Days)|Protocol Violation|1|||
156826315|NCT01799239|566116237|FG001|Period 2 (7 Days)|Protocol Violation|0|||
156826316|NCT01300819|566116241|FG000|Overall Study|Adverse Event|9|||
156826317|NCT01300819|566116242|FG001|Overall Study|Adverse Event|27|||
156826318|NCT01300819|566116241|FG000|Overall Study|Lack of Efficacy|2|||
156884821|NCT00159822|566336380|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
156884822|NCT00275821|566336382|FG000|Overall Study|Adverse Event|4|||
156884823|NCT00275821|566336383|FG001|Overall Study|Adverse Event|12|||
156826319|NCT01300819|566116242|FG001|Overall Study|Lack of Efficacy|1|||
156826320|NCT01300819|566116241|FG000|Overall Study|Withdrawal by Subject|10|||
156826321|NCT01300819|566116242|FG001|Overall Study|Withdrawal by Subject|12|||
156826322|NCT01300819|566116241|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
156826323|NCT01300819|566116242|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
156826324|NCT01300819|566116241|FG000|Overall Study|Refusal to down titrate study drug|0|||
156826325|NCT01300819|566116242|FG001|Overall Study|Refusal to down titrate study drug|1|||
156826326|NCT01300819|566116241|FG000|Overall Study|Administrative reason|0|||
156826327|NCT01300819|566116242|FG001|Overall Study|Administrative reason|1|||
156826328|NCT01300819|566116241|FG000|Overall Study|Safety follow up not done by mistake|0|||
156826329|NCT01300819|566116242|FG001|Overall Study|Safety follow up not done by mistake|1|||
156826330|NCT01300819|566116241|FG000|Overall Study|Follow up call was not done|1|||
156884824|NCT00275821|566336384|FG002|Overall Study|Adverse Event|5|||
156826331|NCT01300819|566116242|FG001|Overall Study|Follow up call was not done|0|||
156826332|NCT01444027|566116243|FG000|Overall Study|Withdrawal by Subject|4|||
156826333|NCT01444027|566116244|FG001|Overall Study|Withdrawal by Subject|10|||
156826334|NCT01444027|566116245|FG002|Overall Study|Withdrawal by Subject|24|||
156826335|NCT01444027|566116243|FG000|Overall Study|Lost to Follow-up|26|||
156826336|NCT01444027|566116244|FG001|Overall Study|Lost to Follow-up|20|||
156826337|NCT01444027|566116245|FG002|Overall Study|Lost to Follow-up|14|||
156826338|NCT03966885|566117904|FG000|Overall Study|Death|1|||
156826339|NCT03966885|566117905|FG001|Overall Study|Death|0|||
156826340|NCT03966885|566117904|FG000|Overall Study|Lost to Follow-up|1|||
156826341|NCT03966885|566117905|FG001|Overall Study|Lost to Follow-up|2|||
156826342|NCT03966885|566117904|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
156826343|NCT03966885|566117905|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
156826344|NCT03966885|566117904|FG000|Overall Study|Moved from study area.|0|||
156826345|NCT03966885|566117905|FG001|Overall Study|Moved from study area.|2|||
156826346|NCT01514240|566117906|FG000|Overall Study|Adverse Event|4|||
156826347|NCT01514240|566117907|FG001|Overall Study|Adverse Event|4|||
156826348|NCT01514240|566117906|FG000|Overall Study|Subject Decision|2|||
156826349|NCT01514240|566117907|FG001|Overall Study|Subject Decision|7|||
156826350|NCT05013424|566117908|FG000|Overall Study|Lost to Follow-up|1|||
156826351|NCT05013424|566117909|FG001|Overall Study|Lost to Follow-up|1|||
156826352|NCT05013424|566117910|FG002|Overall Study|Lost to Follow-up|1|||
156826353|NCT05013424|566117908|FG000|Overall Study|Withdrawal by Subject|0|||
156826354|NCT05013424|566117909|FG001|Overall Study|Withdrawal by Subject|1|||
156826355|NCT05013424|566117910|FG002|Overall Study|Withdrawal by Subject|0|||
156826356|NCT04411420|566117911|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
156826357|NCT04411420|566117912|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
156826358|NCT04411420|566117911|FG000|Survey Subset|Lost to Follow-up|134|||
156826359|NCT04411420|566117912|FG001|Survey Subset|Lost to Follow-up|120|||
156826360|NCT00549900|566117913|FG000|Overall Study|Adverse Event|1|||
156826361|NCT03899064|566117917|FG000|Overall Study|Lost to Follow-up|1|||
156826362|NCT03899064|566117917|FG000|Overall Study|Protocol Violation|2|||
156826363|NCT03899064|566117917|FG000|Overall Study|Withdrawal by Subject|2|||
156826364|NCT03899064|566117917|FG000|Overall Study|Other|2|||
156826365|NCT03283098|566117918|FG000|Overall Study|Withdrawal by Subject|0|||
156826366|NCT03283098|566117919|FG001|Overall Study|Withdrawal by Subject|1|||
156826367|NCT01278407|566117922|FG000|Confirmatory Phase|Adverse Event|5|||
156826368|NCT01278407|566117923|FG001|Confirmatory Phase|Adverse Event|10|||
156826369|NCT01278407|566117924|FG002|Confirmatory Phase|Adverse Event|1|||
156826370|NCT01278407|566117925|FG003|Confirmatory Phase|Adverse Event|0|||
156826371|NCT01278407|566117926|FG004|Confirmatory Phase|Adverse Event|0|||
156826372|NCT01278407|566117922|FG000|Confirmatory Phase|Participant's Choice|3|||
156826373|NCT01278407|566117923|FG001|Confirmatory Phase|Participant's Choice|5|||
156826374|NCT01278407|566117924|FG002|Confirmatory Phase|Participant's Choice|3|||
156826375|NCT01278407|566117925|FG003|Confirmatory Phase|Participant's Choice|0|||
156826376|NCT01278407|566117926|FG004|Confirmatory Phase|Participant's Choice|0|||
156826377|NCT01278407|566117922|FG000|Confirmatory Phase|Other|1|||
156826378|NCT01278407|566117923|FG001|Confirmatory Phase|Other|1|||
156826379|NCT01278407|566117924|FG002|Confirmatory Phase|Other|2|||
156826380|NCT01278407|566117925|FG003|Confirmatory Phase|Other|0|||
156826381|NCT01278407|566117926|FG004|Confirmatory Phase|Other|0|||
156826382|NCT01278407|566117922|FG000|Extension Phase|Adverse Event|0|||
156826383|NCT01278407|566117923|FG001|Extension Phase|Adverse Event|0|||
156826384|NCT01278407|566117924|FG002|Extension Phase|Adverse Event|0|||
156826385|NCT01278407|566117925|FG003|Extension Phase|Adverse Event|7|||
156826386|NCT01278407|566117926|FG004|Extension Phase|Adverse Event|16|||
156826387|NCT01278407|566117922|FG000|Extension Phase|Participant's Choice|0|||
156826388|NCT01278407|566117923|FG001|Extension Phase|Participant's Choice|0|||
156826389|NCT01278407|566117924|FG002|Extension Phase|Participant's Choice|0|||
156826390|NCT01278407|566117925|FG003|Extension Phase|Participant's Choice|4|||
156826391|NCT01278407|566117926|FG004|Extension Phase|Participant's Choice|11|||
156826392|NCT01278407|566117922|FG000|Extension Phase|Other|0|||
156826393|NCT01278407|566117923|FG001|Extension Phase|Other|0|||
156826394|NCT01278407|566117924|FG002|Extension Phase|Other|0|||
156826395|NCT01278407|566117925|FG003|Extension Phase|Other|1|||
156826396|NCT01278407|566117926|FG004|Extension Phase|Other|3|||
156826397|NCT02534935|566117927|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
156826398|NCT02534935|566117928|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
156826399|NCT02534935|566117929|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
156826400|NCT02534935|566117927|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
156826401|NCT02534935|566117928|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
156826402|NCT02534935|566117929|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
156826403|NCT02534935|566117927|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
156826404|NCT02534935|566117928|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
156826405|NCT02534935|566117929|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
156826406|NCT02534935|566117927|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
156826407|NCT02534935|566117928|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
156826408|NCT02534935|566117929|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
156826409|NCT02534935|566117927|FG000|Stage 1: 24 Months|Adverse Event|0|||
156826410|NCT02534935|566117928|FG001|Stage 1: 24 Months|Adverse Event|2|||
156826411|NCT02534935|566117929|FG002|Stage 1: 24 Months|Adverse Event|0|||
156826412|NCT02534935|566117927|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
156826413|NCT02534935|566117928|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
156826414|NCT02534935|566117929|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
156826415|NCT02534935|566117927|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
156826416|NCT02534935|566117928|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
156826417|NCT02534935|566117929|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
156826418|NCT01069861|566117930|FG000|Overall Study|Death|1|||
156826419|NCT01069861|566117930|FG000|Overall Study|Adverse Event|1|||
156826420|NCT01069861|566117930|FG000|Overall Study|Did not meet entrance criteria|1|||
156826421|NCT01596335|566117931|FG000|Overall Study|exacerbation of primary disease|5|||
156826422|NCT01596335|566117932|FG001|Overall Study|exacerbation of primary disease|9|||
156826423|NCT01460719|566117933|FG000|Overall Study|Adverse Event|1|||
156826424|NCT01460719|566117933|FG000|Overall Study|Withdrawal by Subject|1|||
156826425|NCT03350256|566117934|FG000|Overall Study|Inclusion/exclusion violation|4|||
156826426|NCT03350256|566117934|FG000|Overall Study|Recommended for other therapies|2|||
156826427|NCT03350256|566117934|FG000|Overall Study|Protocol Violation|3|||
156826428|NCT03350256|566117934|FG000|Overall Study|Non compliance|2|||
156826429|NCT03350256|566117934|FG000|Overall Study|Denial by insurance|1|||
156826430|NCT03350256|566117934|FG000|Overall Study|Adverse Event|2|||
156826431|NCT03350256|566117934|FG000|Overall Study|Trial failure|12|||
156826432|NCT03350256|566117934|FG000|Overall Study|Did not proceed to permanent implant|3|||
156826433|NCT03350256|566117934|FG000|Overall Study|Withdrawal by Subject|3|||
156826434|NCT03350256|566117934|FG000|Overall Study|Subject moving out of state|1|||
156826435|NCT03350256|566117934|FG000|Overall Study|Lost to Follow-up|1|||
156826436|NCT03350256|566117934|FG000|Overall Study|Lack of Efficacy|2|||
156826437|NCT02680041|566117935|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
156826438|NCT02680041|566117935|FG000|Overall Study|Lost to Follow-up|2|||
156826439|NCT04431713|566117938|FG000|Overall Study|Withdrawal by Subject|2|||
156826440|NCT04431713|566117939|FG001|Overall Study|Withdrawal by Subject|0|||
156826441|NCT04431713|566117938|FG000|Overall Study|Death|2|||
156826442|NCT04431713|566117939|FG001|Overall Study|Death|2|||
156826443|NCT01344538|566117940|FG000|Overall Study|Adverse Event|1|||
156826444|NCT01344538|566117941|FG001|Overall Study|Adverse Event|1|||
156826445|NCT01344538|566117940|FG000|Overall Study|Lost to Follow-up|1|||
156826446|NCT01344538|566117941|FG001|Overall Study|Lost to Follow-up|0|||
156826447|NCT01655381|566117944|FG000|Overall Study|Investigator Decision|1|||
156826448|NCT01655381|566117944|FG000|Overall Study|Moved to Another City|1|||
156826449|NCT01655381|566117944|FG000|Overall Study|Insufficient Treatment Response|1|||
156826450|NCT02324205|566117945|FG000|Overall Study|Withdrawal by Subject|37|||
156826451|NCT04195438|566117949|FG000|Overall Study|Withdrawal by Subject|1|||
156826452|NCT00613925|566117954|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
156826453|NCT00613925|566117955|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
156826454|NCT00543296|566117956|FG000|Overall Study|Physician Decision|7|||
156826455|NCT02891681|566117961|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
156826456|NCT02891681|566117962|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
156826457|NCT02891681|566117963|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
156826458|NCT02891681|566117961|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
156826459|NCT02891681|566117962|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
156826460|NCT02891681|566117963|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
156826461|NCT02891681|566117961|FG000|Overall Study|Taken off study after first imaging appointment|1|||
156826462|NCT02891681|566117962|FG001|Overall Study|Taken off study after first imaging appointment|0|||
156826463|NCT02891681|566117963|FG002|Overall Study|Taken off study after first imaging appointment|0|||
156826464|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
156826465|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
156826466|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
156826467|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
156826468|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
156826469|NCT01224821|566117964|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
156826470|NCT01224821|566117964|FG000|Long-Term Follow-Up|Death|2|||
157151127|NCT02658656|567298192|FG000|Randomization|Adverse Event|4|||
157151128|NCT02658656|567298193|FG001|Randomization|Adverse Event|0|||
157151129|NCT02658656|567298194|FG002|Randomization|Adverse Event|0|||
157151130|NCT02658656|567298192|FG000|Randomization|Administrative Termination|3|||
157151131|NCT02658656|567298193|FG001|Randomization|Administrative Termination|1|||
157151132|NCT02658656|567298194|FG002|Randomization|Administrative Termination|0|||
157151133|NCT02658656|567298192|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
157151134|NCT02658656|567298193|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
156826471|NCT01224821|566117964|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
156826472|NCT00623545|566117965|FG000|Overall Study|Adverse Event|6|||
156826473|NCT00623545|566117965|FG000|Overall Study|Withdrawal by Subject|4|||
156826474|NCT04126564|566117966|FG000|Overall Study|Withdrawal by Subject|0|||
156826475|NCT04126564|566117967|FG001|Overall Study|Withdrawal by Subject|2|||
156826476|NCT04126564|566117966|FG000|Overall Study|Lost to Follow-up|0|||
156826477|NCT04126564|566117967|FG001|Overall Study|Lost to Follow-up|1|||
156826478|NCT00937404|566117968|FG000|Overall Study|Protocol Violation|1|||
156826479|NCT00937404|566117968|FG000|Overall Study|Withdrawal by Subject|1|||
156826480|NCT03541187|566117976|FG000|Overall Study|Lost to Follow-up|2|||
156826481|NCT03541187|566117977|FG001|Overall Study|Lost to Follow-up|6|||
156826482|NCT03541187|566117976|FG000|Overall Study|Pregnancy|0|||
156826483|NCT03541187|566117977|FG001|Overall Study|Pregnancy|1|||
156826484|NCT03541187|566117976|FG000|Overall Study|Withdrawal by Subject|6|||
156826485|NCT03541187|566117977|FG001|Overall Study|Withdrawal by Subject|2|||
156826486|NCT03541187|566117976|FG000|Overall Study|Moved out of town|1|||
156826487|NCT03541187|566117977|FG001|Overall Study|Moved out of town|0|||
156826488|NCT03541187|566117976|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
156826489|NCT03541187|566117977|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
156826490|NCT03541187|566117976|FG000|Overall Study|Did not meet randomization criteria|1|||
156826491|NCT03541187|566117977|FG001|Overall Study|Did not meet randomization criteria|1|||
156826492|NCT03541187|566117976|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
156826493|NCT03541187|566117977|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
156826494|NCT03541187|566117976|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
156826495|NCT03541187|566117977|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
156826496|NCT00812006|566117981|FG000|Overall Study|Lost to Follow-up|0|||
156826497|NCT00812006|566117982|FG001|Overall Study|Lost to Follow-up|0|||
156826498|NCT00812006|566117983|FG002|Overall Study|Lost to Follow-up|2|||
156826499|NCT00812006|566117981|FG000|Overall Study|Physician Decision|0|||
156826500|NCT00812006|566117982|FG001|Overall Study|Physician Decision|0|||
156826501|NCT00812006|566117983|FG002|Overall Study|Physician Decision|1|||
156826502|NCT00812006|566117981|FG000|Overall Study|Withdrawal by Subject|2|||
156826503|NCT00812006|566117982|FG001|Overall Study|Withdrawal by Subject|1|||
156826504|NCT00812006|566117983|FG002|Overall Study|Withdrawal by Subject|1|||
156826505|NCT00812006|566117981|FG000|Overall Study|Lack of Qualifying Event|4|||
156826506|NCT00812006|566117982|FG001|Overall Study|Lack of Qualifying Event|2|||
156826507|NCT00812006|566117983|FG002|Overall Study|Lack of Qualifying Event|2|||
156826508|NCT01571284|566117985|FG000|Overall Study|Participant's decision|84|||
156826509|NCT01571284|566117985|FG000|Overall Study|Lost to Follow-up|3|||
156826510|NCT01571284|566117985|FG000|Overall Study|Enrolled but not treated|2|||
156826511|NCT01571284|566117985|FG000|Overall Study|Other than specified above|80|||
156826512|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Death|1|||
156826513|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Death|1|||
156826514|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Death|0|||
156826515|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Death|0|||
156826516|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Death|1|||
156826517|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Death|0|||
156826518|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Death|0|||
156826519|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Death|0|||
156826520|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Death|0|||
156826521|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Death|0|||
156826522|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
156826523|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
156826524|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
156826525|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826526|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
156826527|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826528|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826529|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826530|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826531|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
156826532|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826533|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826534|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826535|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826536|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
156884825|NCT00275821|566336382|FG000|Overall Study|Administrative problems|3|||
157151135|NCT02658656|567298194|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
157151136|NCT02658656|567298192|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
157151137|NCT02658656|567298193|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
156826537|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826538|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826539|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826540|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826541|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
156826542|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
156884826|NCT00275821|566336383|FG001|Overall Study|Administrative problems|4|||
156884827|NCT00275821|566336384|FG002|Overall Study|Administrative problems|4|||
156884828|NCT00275821|566336382|FG000|Overall Study|Withdrawal by Subject|0|||
156884829|NCT00275821|566336383|FG001|Overall Study|Withdrawal by Subject|2|||
156884830|NCT00275821|566336384|FG002|Overall Study|Withdrawal by Subject|1|||
156826543|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826544|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826545|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826546|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826547|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826548|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826549|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826550|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826551|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
156826552|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
156826553|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826554|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826555|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
156826556|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
156826557|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826558|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826559|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826560|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826561|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
156826562|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
156826563|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826564|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826565|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
156826566|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826567|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826568|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826569|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826570|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826571|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
156826572|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
156826573|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826574|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826575|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
156826576|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
156826577|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826578|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826579|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826580|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826581|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
156826582|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
156826583|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156826584|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156826585|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826586|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
156826587|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826588|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826589|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826590|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826591|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826592|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
156826593|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156884831|NCT00275821|566336382|FG000|Overall Study|Lost to Follow-up|0|||
156884832|NCT00275821|566336383|FG001|Overall Study|Lost to Follow-up|1|||
156884833|NCT00275821|566336384|FG002|Overall Study|Lost to Follow-up|1|||
156884834|NCT00275821|566336382|FG000|Overall Study|Death|0|||
156884835|NCT00275821|566336383|FG001|Overall Study|Death|2|||
156884836|NCT00275821|566336384|FG002|Overall Study|Death|1|||
156826594|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826595|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
156826596|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
156826597|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826598|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826599|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826600|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826601|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
156826602|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826603|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826604|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826605|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826606|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826607|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826608|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826609|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826610|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826611|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826612|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826613|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826614|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826615|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826616|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826617|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826618|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826619|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826620|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826621|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826622|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
156826623|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
156826624|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
156826625|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
156826626|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
156826627|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826628|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826629|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826630|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826631|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
156826632|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826633|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826634|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826635|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
156826636|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
156826637|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826638|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826639|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826640|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826641|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826642|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826643|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
157151138|NCT02658656|567298194|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
157151139|NCT02658656|567298192|FG000|Randomization|Not eligible for Randomization|1|||
157151140|NCT02658656|567298193|FG001|Randomization|Not eligible for Randomization|0|||
156826644|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826645|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826646|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826647|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826648|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826649|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826650|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826651|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826652|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826653|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826654|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826655|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826656|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
156826657|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826658|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826659|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826660|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826661|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
156826662|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826663|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826664|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826665|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826666|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
156826667|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826668|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826669|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826670|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826671|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826672|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826673|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
156826674|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826675|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826676|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
156826677|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826678|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826679|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826680|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826681|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
156826682|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
156826683|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826684|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826685|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826686|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
156826687|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826688|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826689|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826690|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826691|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
156826692|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
156826693|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826694|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
156826695|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826696|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
156826697|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826698|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826699|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826700|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156884837|NCT00275821|566336382|FG000|Overall Study|Lack of Efficacy|2|||
156826701|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
156826702|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Other|5|||
156826703|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Other|1|||
156826704|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Other|0|||
156826705|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Other|3|||
156826706|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Other|0|||
156826707|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Other|0|||
156826708|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Other|0|||
156826709|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Other|0|||
156826710|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Other|0|||
156826711|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Other|0|||
156826712|NCT03352557|566117986|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826713|NCT03352557|566117987|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826714|NCT03352557|566117988|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826715|NCT03352557|566117989|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826716|NCT03352557|566117990|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
156826717|NCT03352557|566117991|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826718|NCT03352557|566117992|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826719|NCT03352557|566117993|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826720|NCT03352557|566117994|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826721|NCT03352557|566117995|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
156826722|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Death|0|||
156826723|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Death|0|||
156826724|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Death|0|||
156826725|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Death|0|||
156826726|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Death|0|||
156826727|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Death|1|||
156826728|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Death|0|||
156826729|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Death|1|||
156826730|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Death|1|||
156826731|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Death|1|||
156826732|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826733|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826734|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826735|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826736|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826737|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
156826738|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826739|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826740|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826741|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
156826742|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826743|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826744|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826745|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826746|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826747|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826748|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826749|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826750|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
156826751|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
156826752|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826753|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826754|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826755|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826756|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
156826757|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
156826758|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
156826759|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
156826760|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
156826761|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
156826762|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826763|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826764|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826765|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826766|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826767|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
156884838|NCT00275821|566336383|FG001|Overall Study|Lack of Efficacy|1|||
156826768|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
156826769|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
156826770|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
156826771|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
156826772|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826773|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826774|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826775|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826776|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826777|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826778|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826779|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826780|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
156826781|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
156826782|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826783|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826784|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826785|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826786|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826787|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826788|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
156826789|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826790|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
156826791|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
156826792|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826793|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826794|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826795|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826796|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826797|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826798|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826799|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
156826800|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
156826801|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
156826802|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826803|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826804|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826805|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826806|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826807|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826808|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826809|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
156826810|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826811|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
156826812|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826813|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826814|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826815|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826816|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826817|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826818|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826819|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
156826820|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156826821|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
156884839|NCT00275821|566336384|FG002|Overall Study|Lack of Efficacy|0|||
156884840|NCT00275821|566336382|FG000|Overall Study|Protocol Violation|5|||
156884841|NCT00275821|566336383|FG001|Overall Study|Protocol Violation|1|||
156884842|NCT00275821|566336384|FG002|Overall Study|Protocol Violation|0|||
156826822|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826823|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826824|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826825|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826826|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826827|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826828|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826829|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
156826830|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
156826831|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
156826832|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826833|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826834|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826835|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156884843|NCT01215916|566336385|FG000|Overall Study|Progressive Disease|0|||
156826836|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826837|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
156826838|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826839|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826840|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
156826841|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
156826842|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826843|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826844|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826845|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826846|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826847|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826848|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826849|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826850|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
156826851|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
156826852|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826853|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826854|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826855|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826856|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826857|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826858|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826859|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
156826860|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
156826861|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
156826862|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826863|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826864|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826865|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826866|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826867|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826868|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826869|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
156826870|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
156826871|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
156826872|NCT03352557|566117986|FG000|LTE Period: Week 80 to Week 173|Other|0|||
156826873|NCT03352557|566117987|FG001|LTE Period: Week 80 to Week 173|Other|0|||
156826874|NCT03352557|566117988|FG002|LTE Period: Week 80 to Week 173|Other|0|||
156826875|NCT03352557|566117989|FG003|LTE Period: Week 80 to Week 173|Other|0|||
156826876|NCT03352557|566117990|FG004|LTE Period: Week 80 to Week 173|Other|0|||
156884844|NCT01215916|566336386|FG001|Overall Study|Progressive Disease|2|||
157151141|NCT02658656|567298194|FG002|Randomization|Not eligible for Randomization|0|||
157151142|NCT02658656|567298192|FG000|Randomization|Protocol Violation|1|||
157151143|NCT02658656|567298193|FG001|Randomization|Protocol Violation|0|||
157151144|NCT02658656|567298194|FG002|Randomization|Protocol Violation|0|||
156826877|NCT03352557|566117991|FG005|LTE Period: Week 80 to Week 173|Other|0|||
156826878|NCT03352557|566117992|FG006|LTE Period: Week 80 to Week 173|Other|0|||
156826879|NCT03352557|566117993|FG007|LTE Period: Week 80 to Week 173|Other|1|||
156826880|NCT03352557|566117994|FG008|LTE Period: Week 80 to Week 173|Other|0|||
156826881|NCT03352557|566117995|FG009|LTE Period: Week 80 to Week 173|Other|0|||
156826882|NCT03242772|566117996|FG000|Overall Study|Lost to Follow-up|2|||
156826883|NCT03242772|566117997|FG001|Overall Study|Lost to Follow-up|0|||
156826884|NCT03242772|566117996|FG000|Overall Study|Physician Decision|0|||
156826885|NCT03242772|566117997|FG001|Overall Study|Physician Decision|1|||
156826886|NCT03242772|566117996|FG000|Overall Study|Withdrawal by Subject|1|||
156826887|NCT03242772|566117997|FG001|Overall Study|Withdrawal by Subject|0|||
156826888|NCT03385265|566118000|FG000|Overall Study|Withdrawal by Subject|5|||
156826889|NCT03385265|566118001|FG001|Overall Study|Withdrawal by Subject|2|||
156826890|NCT03385265|566118002|FG002|Overall Study|Withdrawal by Subject|5|||
156826891|NCT03385265|566118003|FG003|Overall Study|Withdrawal by Subject|2|||
156826892|NCT01170065|566118024|FG000|Overall Study|Adverse Event|17|||
156826893|NCT01170065|566118025|FG001|Overall Study|Adverse Event|50|||
156826894|NCT01170065|566118026|FG002|Overall Study|Adverse Event|10|||
156826895|NCT01170065|566118024|FG000|Overall Study|Lost to Follow-up|1|||
156826896|NCT01170065|566118025|FG001|Overall Study|Lost to Follow-up|4|||
156826897|NCT01170065|566118026|FG002|Overall Study|Lost to Follow-up|1|||
156826898|NCT01170065|566118024|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
156826899|NCT01170065|566118025|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
156826900|NCT01170065|566118026|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
156826901|NCT01170065|566118024|FG000|Overall Study|Reason other than specified|3|||
156826902|NCT01170065|566118025|FG001|Overall Study|Reason other than specified|8|||
156826903|NCT01170065|566118026|FG002|Overall Study|Reason other than specified|3|||
156826904|NCT01170065|566118024|FG000|Overall Study|Ongoing after planned observation time|5|||
156884845|NCT01215916|566336387|FG002|Overall Study|Progressive Disease|1|||
156826905|NCT01170065|566118025|FG001|Overall Study|Ongoing after planned observation time|26|||
156826906|NCT01170065|566118026|FG002|Overall Study|Ongoing after planned observation time|10|||
156826907|NCT02434354|566118027|FG000|Overall Study|screen fail|3|||
156826908|NCT01071200|566118028|FG000|Overall Study|Lack of ovarian response|1|||
156826909|NCT01071200|566118029|FG001|Overall Study|Lack of ovarian response|1|||
156826910|NCT01071200|566118028|FG000|Overall Study|No fertilization|4|||
156826911|NCT01071200|566118029|FG001|Overall Study|No fertilization|0|||
156826912|NCT01071200|566118028|FG000|Overall Study|No oocytes retrieved|1|||
156826913|NCT01071200|566118029|FG001|Overall Study|No oocytes retrieved|1|||
156826914|NCT01071200|566118028|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
156826915|NCT01071200|566118029|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
156826916|NCT01071200|566118028|FG000|Overall Study|No viable embryos|0|||
156826917|NCT01071200|566118029|FG001|Overall Study|No viable embryos|1|||
156826918|NCT01920893|566118032|FG000|Overall Study|Adverse Event|5|||
156826919|NCT01920893|566118033|FG001|Overall Study|Adverse Event|2|||
156826920|NCT01920893|566118032|FG000|Overall Study|Lack of Efficacy|2|||
156826921|NCT01920893|566118033|FG001|Overall Study|Lack of Efficacy|0|||
156826922|NCT03440918|566118042|FG000|Overall Study|Protocol Violation|0|||
156826923|NCT03440918|566118043|FG001|Overall Study|Protocol Violation|16|||
156826924|NCT01767493|566118055|FG000|Overall Study|screen failures|3|||
156826925|NCT00724854|566118058|FG000|Overall Study|Lack of Efficacy|187|||
156826926|NCT00724854|566118059|FG001|Overall Study|Lack of Efficacy|13|||
156826927|NCT00724854|566118058|FG000|Overall Study|Lost to Follow-up|87|||
156884846|NCT01215916|566336388|FG003|Overall Study|Progressive Disease|2|||
156884847|NCT01215916|566336389|FG004|Overall Study|Progressive Disease|5|||
156884848|NCT01215916|566336390|FG005|Overall Study|Progressive Disease|4|||
156884849|NCT01215916|566336391|FG006|Overall Study|Progressive Disease|5|||
157151145|NCT01118143|567298195|FG000|Overall Study|Withdrawal by Subject|2|||
156826928|NCT00724854|566118059|FG001|Overall Study|Lost to Follow-up|10|||
156826929|NCT00724854|566118058|FG000|Overall Study|Adverse Event|62|||
156826930|NCT00724854|566118059|FG001|Overall Study|Adverse Event|4|||
156826931|NCT00724854|566118058|FG000|Overall Study|Other|42|||
156826932|NCT00724854|566118059|FG001|Overall Study|Other|3|||
156826933|NCT00724854|566118058|FG000|Overall Study|Death|11|||
156826934|NCT00724854|566118059|FG001|Overall Study|Death|0|||
156826935|NCT00724854|566118058|FG000|Overall Study|Change of treatment|7|||
156826936|NCT00724854|566118059|FG001|Overall Study|Change of treatment|0|||
156826937|NCT00724854|566118058|FG000|Overall Study|Withdrawal by Subject|5|||
156826938|NCT00724854|566118059|FG001|Overall Study|Withdrawal by Subject|0|||
156826939|NCT00724854|566118058|FG000|Overall Study|Adverse event + lack of efficacy|2|||
156826940|NCT00724854|566118059|FG001|Overall Study|Adverse event + lack of efficacy|1|||
156826941|NCT01095653|566118060|FG000|Overall Study|Lack of Efficacy|3|||
156826942|NCT01095653|566118061|FG001|Overall Study|Lack of Efficacy|0|||
156826943|NCT01095653|566118062|FG002|Overall Study|Lack of Efficacy|0|||
156826944|NCT01095653|566118060|FG000|Overall Study|Adverse Event|1|||
156826945|NCT01095653|566118061|FG001|Overall Study|Adverse Event|4|||
156826946|NCT01095653|566118062|FG002|Overall Study|Adverse Event|4|||
156826947|NCT01095653|566118060|FG000|Overall Study|Lost to Follow-up|1|||
156884850|NCT01215916|566336392|FG007|Overall Study|Progressive Disease|3|||
156826948|NCT01095653|566118061|FG001|Overall Study|Lost to Follow-up|0|||
156826949|NCT01095653|566118062|FG002|Overall Study|Lost to Follow-up|4|||
156826950|NCT01095653|566118060|FG000|Overall Study|Withdrawal by Subject|4|||
156826951|NCT01095653|566118061|FG001|Overall Study|Withdrawal by Subject|5|||
156826952|NCT01095653|566118062|FG002|Overall Study|Withdrawal by Subject|3|||
156826953|NCT01095653|566118060|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
156826954|NCT01095653|566118061|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
156826955|NCT01095653|566118062|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
156826956|NCT01819129|566118063|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
156826957|NCT01819129|566118064|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
156826958|NCT01819129|566118063|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
156826959|NCT01819129|566118064|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
156826960|NCT01819129|566118063|FG000|Overall Study|Other, Subject moved out of the country|0|||
156826961|NCT01819129|566118064|FG001|Overall Study|Other, Subject moved out of the country|1|||
156826962|NCT01819129|566118063|FG000|Overall Study|Withdrawal by Subject|15|||
156884851|NCT01215916|566336393|FG008|Overall Study|Progressive Disease|1|||
156884852|NCT01215916|566336385|FG000|Overall Study|Adverse Event|1|||
156884853|NCT01215916|566336386|FG001|Overall Study|Adverse Event|1|||
156826963|NCT01819129|566118064|FG001|Overall Study|Withdrawal by Subject|15|||
156826964|NCT01819129|566118063|FG000|Overall Study|Lost to Follow-up|5|||
156826965|NCT01819129|566118064|FG001|Overall Study|Lost to Follow-up|2|||
156826966|NCT01819129|566118063|FG000|Overall Study|Lack of Efficacy|0|||
156826967|NCT01819129|566118064|FG001|Overall Study|Lack of Efficacy|1|||
156826968|NCT01819129|566118063|FG000|Overall Study|Adverse Event|1|||
156826969|NCT01819129|566118064|FG001|Overall Study|Adverse Event|4|||
156826970|NCT01819129|566118063|FG000|Overall Study|Death|1|||
156826971|NCT01819129|566118064|FG001|Overall Study|Death|1|||
156826972|NCT01819129|566118063|FG000|Overall Study|Withdrawal Criteria|20|||
156826973|NCT01819129|566118064|FG001|Overall Study|Withdrawal Criteria|15|||
156826974|NCT00054691|566118065|FG000|Overall Study|Unmeasurable Disease|2|||
156826975|NCT00054691|566118065|FG000|Overall Study|Noncompliant|1|||
156826976|NCT02914548|566118070|FG000|Overall Study|Adverse Event|15|||
156826977|NCT02914548|566118071|FG001|Overall Study|Adverse Event|7|||
156826978|NCT02914548|566118072|FG002|Overall Study|Adverse Event|15|||
156826979|NCT02914548|566118070|FG000|Overall Study|Physician Decision|2|||
156826980|NCT02914548|566118071|FG001|Overall Study|Physician Decision|2|||
156826981|NCT02914548|566118072|FG002|Overall Study|Physician Decision|0|||
156826982|NCT02914548|566118070|FG000|Overall Study|Protocol Violation|1|||
156826983|NCT02914548|566118071|FG001|Overall Study|Protocol Violation|0|||
156826984|NCT02914548|566118072|FG002|Overall Study|Protocol Violation|0|||
156826985|NCT02914548|566118070|FG000|Overall Study|Withdrawal by Subject|3|||
156826986|NCT02914548|566118071|FG001|Overall Study|Withdrawal by Subject|4|||
156826987|NCT02914548|566118072|FG002|Overall Study|Withdrawal by Subject|4|||
156826988|NCT02914548|566118070|FG000|Overall Study|>40% of body surface area|0|||
156826989|NCT02914548|566118071|FG001|Overall Study|>40% of body surface area|1|||
156826990|NCT02914548|566118072|FG002|Overall Study|>40% of body surface area|1|||
156826991|NCT03746600|566118073|FG000|Overall Study|Withdrawal by Subject|3|||
156826992|NCT03746600|566118074|FG001|Overall Study|Withdrawal by Subject|3|||
156826993|NCT03746600|566118073|FG000|Overall Study|dismissed from study|1|||
156826994|NCT03746600|566118074|FG001|Overall Study|dismissed from study|0|||
156826995|NCT03746600|566118073|FG000|Overall Study|Lost to Follow-up|1|||
156826996|NCT03746600|566118074|FG001|Overall Study|Lost to Follow-up|0|||
156826997|NCT01371643|566118080|FG000|Overall Study|Withdrawal by Subject|3|||
156826998|NCT01371643|566118081|FG001|Overall Study|Withdrawal by Subject|0|||
156826999|NCT02374814|566118082|FG000|Overall Study|Lost to Follow-up|1|||
156827000|NCT02374814|566118083|FG001|Overall Study|Lost to Follow-up|1|||
156827001|NCT02374814|566118084|FG002|Overall Study|Lost to Follow-up|0|||
156884854|NCT01215916|566336387|FG002|Overall Study|Adverse Event|0|||
156884855|NCT01215916|566336388|FG003|Overall Study|Adverse Event|1|||
156827002|NCT02374814|566118085|FG003|Overall Study|Lost to Follow-up|1|||
156827003|NCT02374814|566118086|FG004|Overall Study|Lost to Follow-up|0|||
156827004|NCT02374814|566118087|FG005|Overall Study|Lost to Follow-up|0|||
156827005|NCT02374814|566118082|FG000|Overall Study|Withdrawal by Subject|0|||
156827006|NCT02374814|566118083|FG001|Overall Study|Withdrawal by Subject|0|||
156827007|NCT02374814|566118084|FG002|Overall Study|Withdrawal by Subject|1|||
156827008|NCT02374814|566118085|FG003|Overall Study|Withdrawal by Subject|1|||
156827009|NCT02374814|566118086|FG004|Overall Study|Withdrawal by Subject|0|||
156827010|NCT02374814|566118087|FG005|Overall Study|Withdrawal by Subject|0|||
156827011|NCT04209114|566118088|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
156827012|NCT04209114|566118089|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
156827013|NCT04209114|566118090|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
156827014|NCT04209114|566118088|FG000|Pre-Treatment Phase|Other reasons|0|||
156827015|NCT04209114|566118089|FG001|Pre-Treatment Phase|Other reasons|0|||
156827016|NCT04209114|566118090|FG002|Pre-Treatment Phase|Other reasons|1|||
156827017|NCT04209114|566118088|FG000|Pre-Treatment Phase|Death|0|||
156827018|NCT04209114|566118089|FG001|Pre-Treatment Phase|Death|0|||
156827019|NCT04209114|566118090|FG002|Pre-Treatment Phase|Death|1|||
156827020|NCT04209114|566118088|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
156827021|NCT04209114|566118089|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
156827022|NCT04209114|566118090|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
156827023|NCT04209114|566118088|FG000|Treatment Phase|Other reasons|5|||
156827024|NCT04209114|566118089|FG001|Treatment Phase|Other reasons|3|||
156827025|NCT04209114|566118090|FG002|Treatment Phase|Other reasons|0|||
156827026|NCT04209114|566118088|FG000|Treatment Phase|Lost to Follow-up|1|||
156827027|NCT04209114|566118089|FG001|Treatment Phase|Lost to Follow-up|0|||
156827028|NCT04209114|566118090|FG002|Treatment Phase|Lost to Follow-up|0|||
156827029|NCT04209114|566118088|FG000|Treatment Phase|Participant withdrew consent|1|||
156827030|NCT04209114|566118089|FG001|Treatment Phase|Participant withdrew consent|0|||
156827031|NCT04209114|566118090|FG002|Treatment Phase|Participant withdrew consent|0|||
156827032|NCT04209114|566118088|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
156827033|NCT04209114|566118089|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
156827034|NCT04209114|566118090|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
156827035|NCT04209114|566118088|FG000|Treatment Phase|Death|4|||
156827036|NCT04209114|566118089|FG001|Treatment Phase|Death|1|||
156827037|NCT04209114|566118090|FG002|Treatment Phase|Death|0|||
156827038|NCT04209114|566118088|FG000|Treatment Phase|Study drug toxicity|4|||
156827039|NCT04209114|566118089|FG001|Treatment Phase|Study drug toxicity|6|||
156827040|NCT04209114|566118090|FG002|Treatment Phase|Study drug toxicity|0|||
156827041|NCT04209114|566118088|FG000|Treatment Phase|Disease progression|6|||
156827042|NCT04209114|566118089|FG001|Treatment Phase|Disease progression|9|||
156827043|NCT04209114|566118090|FG002|Treatment Phase|Disease progression|0|||
156827044|NCT03187834|566120998|FG000|Overall Study|Lost to Follow-up|0|||
156827045|NCT03187834|566120999|FG001|Overall Study|Lost to Follow-up|1|||
156827046|NCT03187834|566121000|FG002|Overall Study|Lost to Follow-up|2|||
156827047|NCT03187834|566121001|FG003|Overall Study|Lost to Follow-up|2|||
156827048|NCT03187834|566120998|FG000|Overall Study|Had invalid anthropometric measurements|5|||
156827049|NCT03187834|566120999|FG001|Overall Study|Had invalid anthropometric measurements|3|||
156827050|NCT03187834|566121000|FG002|Overall Study|Had invalid anthropometric measurements|4|||
156827051|NCT03187834|566121001|FG003|Overall Study|Had invalid anthropometric measurements|2|||
156827052|NCT00471887|566121007|FG000|Overall Study|Adverse Event|9|||
156827053|NCT01930890|566121008|FG000|Overall Study|Study Termination|14|||
156827054|NCT01930890|566121009|FG001|Overall Study|Study Termination|28|||
156827055|NCT01930890|566121010|FG002|Overall Study|Study Termination|13|||
156827056|NCT01930890|566121011|FG003|Overall Study|Study Termination|25|||
156827057|NCT01930890|566121008|FG000|Overall Study|Death|0|||
156827058|NCT01930890|566121009|FG001|Overall Study|Death|0|||
156827059|NCT01930890|566121010|FG002|Overall Study|Death|0|||
156827060|NCT01930890|566121011|FG003|Overall Study|Death|1|||
156827061|NCT01930890|566121008|FG000|Overall Study|Investigator Decision|0|||
156827062|NCT01930890|566121009|FG001|Overall Study|Investigator Decision|1|||
156827063|NCT01930890|566121010|FG002|Overall Study|Investigator Decision|0|||
156827064|NCT01930890|566121011|FG003|Overall Study|Investigator Decision|0|||
156827065|NCT01930890|566121008|FG000|Overall Study|Consent Withdrawn|0|||
156827066|NCT01930890|566121009|FG001|Overall Study|Consent Withdrawn|3|||
156827067|NCT01930890|566121010|FG002|Overall Study|Consent Withdrawn|0|||
156827068|NCT01930890|566121011|FG003|Overall Study|Consent Withdrawn|1|||
156827069|NCT01930890|566121008|FG000|Overall Study|Adverse Event|0|||
156827070|NCT01930890|566121009|FG001|Overall Study|Adverse Event|1|||
156827071|NCT01930890|566121010|FG002|Overall Study|Adverse Event|0|||
156827072|NCT01930890|566121011|FG003|Overall Study|Adverse Event|0|||
156827073|NCT03710876|566121012|FG000|Overall Study|Death|0|||
156827074|NCT03710876|566121013|FG001|Overall Study|Death|2|||
156827075|NCT03710876|566121012|FG000|Overall Study|Withdrawal by Subject|0|||
156827076|NCT03710876|566121013|FG001|Overall Study|Withdrawal by Subject|2|||
156827077|NCT01176565|566121021|FG000|Overall Study|Lost to Follow-up|12|||
156827078|NCT01176565|566121022|FG001|Overall Study|Lost to Follow-up|16|||
156827079|NCT01176565|566121021|FG000|Overall Study|Withdrawal by Subject|7|||
156827080|NCT01176565|566121022|FG001|Overall Study|Withdrawal by Subject|1|||
156827081|NCT01176565|566121021|FG000|Overall Study|Not Analyzed (any other reason)|1|||
156827082|NCT01176565|566121022|FG001|Overall Study|Not Analyzed (any other reason)|2|||
156827083|NCT03602885|566121024|FG000|Overall Study|Lost to Follow-up|3|||
156827084|NCT03602885|566121025|FG001|Overall Study|Lost to Follow-up|0|||
156827085|NCT02754141|566121026|FG000|Overall Study|Disease progression|11|||
156827086|NCT02754141|566121027|FG001|Overall Study|Disease progression|7|||
156827087|NCT02754141|566121028|FG002|Overall Study|Disease progression|8|||
156827088|NCT02754141|566121029|FG003|Overall Study|Disease progression|5|||
156827089|NCT02754141|566121030|FG004|Overall Study|Disease progression|7|||
156827090|NCT02754141|566121031|FG005|Overall Study|Disease progression|7|||
156827091|NCT02754141|566121032|FG006|Overall Study|Disease progression|7|||
156827092|NCT02754141|566121033|FG007|Overall Study|Disease progression|6|||
156827093|NCT02754141|566121034|FG008|Overall Study|Disease progression|11|||
156827094|NCT02754141|566121035|FG009|Overall Study|Disease progression|16|||
156827095|NCT02754141|566121036|FG010|Overall Study|Disease progression|18|||
156827096|NCT02754141|566121037|FG011|Overall Study|Disease progression|13|||
156827097|NCT02754141|566121038|FG012|Overall Study|Disease progression|10|||
156827098|NCT02754141|566121039|FG013|Overall Study|Disease progression|12|||
156827099|NCT02754141|566121040|FG014|Overall Study|Disease progression|12|||
156827100|NCT02754141|566121041|FG015|Overall Study|Disease progression|14|||
156827101|NCT02754141|566121042|FG016|Overall Study|Disease progression|0|||
156827102|NCT02754141|566121043|FG017|Overall Study|Disease progression|1|||
156827103|NCT02754141|566121026|FG000|Overall Study|Study drug toxicity|1|||
156827104|NCT02754141|566121027|FG001|Overall Study|Study drug toxicity|1|||
156827105|NCT02754141|566121028|FG002|Overall Study|Study drug toxicity|0|||
156827106|NCT02754141|566121029|FG003|Overall Study|Study drug toxicity|0|||
156827107|NCT02754141|566121030|FG004|Overall Study|Study drug toxicity|0|||
156827108|NCT02754141|566121031|FG005|Overall Study|Study drug toxicity|0|||
156827109|NCT02754141|566121032|FG006|Overall Study|Study drug toxicity|0|||
156827110|NCT02754141|566121033|FG007|Overall Study|Study drug toxicity|0|||
156827111|NCT02754141|566121034|FG008|Overall Study|Study drug toxicity|0|||
156827112|NCT02754141|566121035|FG009|Overall Study|Study drug toxicity|0|||
156827113|NCT02754141|566121036|FG010|Overall Study|Study drug toxicity|2|||
156827114|NCT02754141|566121037|FG011|Overall Study|Study drug toxicity|1|||
156827115|NCT02754141|566121038|FG012|Overall Study|Study drug toxicity|1|||
156827116|NCT02754141|566121039|FG013|Overall Study|Study drug toxicity|0|||
156827117|NCT02754141|566121040|FG014|Overall Study|Study drug toxicity|0|||
156827118|NCT02754141|566121041|FG015|Overall Study|Study drug toxicity|0|||
156827119|NCT02754141|566121042|FG016|Overall Study|Study drug toxicity|0|||
156827120|NCT02754141|566121043|FG017|Overall Study|Study drug toxicity|0|||
156827121|NCT02754141|566121026|FG000|Overall Study|AE unrelated to study drug|1|||
156827122|NCT02754141|566121027|FG001|Overall Study|AE unrelated to study drug|1|||
156827123|NCT02754141|566121028|FG002|Overall Study|AE unrelated to study drug|0|||
156827124|NCT02754141|566121029|FG003|Overall Study|AE unrelated to study drug|1|||
156827125|NCT02754141|566121030|FG004|Overall Study|AE unrelated to study drug|3|||
156827126|NCT02754141|566121031|FG005|Overall Study|AE unrelated to study drug|2|||
156827127|NCT02754141|566121032|FG006|Overall Study|AE unrelated to study drug|1|||
156827128|NCT02754141|566121033|FG007|Overall Study|AE unrelated to study drug|0|||
156827129|NCT02754141|566121034|FG008|Overall Study|AE unrelated to study drug|0|||
156827130|NCT02754141|566121035|FG009|Overall Study|AE unrelated to study drug|0|||
156827131|NCT02754141|566121036|FG010|Overall Study|AE unrelated to study drug|0|||
156827132|NCT02754141|566121037|FG011|Overall Study|AE unrelated to study drug|0|||
156827133|NCT02754141|566121038|FG012|Overall Study|AE unrelated to study drug|0|||
156827134|NCT02754141|566121039|FG013|Overall Study|AE unrelated to study drug|0|||
156827135|NCT02754141|566121040|FG014|Overall Study|AE unrelated to study drug|0|||
156827136|NCT02754141|566121041|FG015|Overall Study|AE unrelated to study drug|0|||
156827137|NCT02754141|566121042|FG016|Overall Study|AE unrelated to study drug|0|||
156827138|NCT02754141|566121043|FG017|Overall Study|AE unrelated to study drug|0|||
156827139|NCT02754141|566121026|FG000|Overall Study|Request to discontinue|0|||
156827140|NCT02754141|566121027|FG001|Overall Study|Request to discontinue|0|||
156827141|NCT02754141|566121028|FG002|Overall Study|Request to discontinue|0|||
156827142|NCT02754141|566121029|FG003|Overall Study|Request to discontinue|0|||
156827143|NCT02754141|566121030|FG004|Overall Study|Request to discontinue|0|||
156827144|NCT02754141|566121031|FG005|Overall Study|Request to discontinue|0|||
156827145|NCT02754141|566121032|FG006|Overall Study|Request to discontinue|0|||
156827146|NCT02754141|566121033|FG007|Overall Study|Request to discontinue|0|||
156827147|NCT02754141|566121034|FG008|Overall Study|Request to discontinue|1|||
156827148|NCT02754141|566121035|FG009|Overall Study|Request to discontinue|0|||
156827149|NCT02754141|566121036|FG010|Overall Study|Request to discontinue|0|||
156827150|NCT02754141|566121037|FG011|Overall Study|Request to discontinue|0|||
157151146|NCT01118143|567298196|FG001|Overall Study|Withdrawal by Subject|5|||
157151147|NCT02112448|567298197|FG000|Overall Study|lab values precluding use of ketorolac|2|||
156827151|NCT02754141|566121038|FG012|Overall Study|Request to discontinue|0|||
156827152|NCT02754141|566121039|FG013|Overall Study|Request to discontinue|1|||
156827153|NCT02754141|566121040|FG014|Overall Study|Request to discontinue|1|||
156827154|NCT02754141|566121041|FG015|Overall Study|Request to discontinue|0|||
156827155|NCT02754141|566121042|FG016|Overall Study|Request to discontinue|0|||
157151148|NCT02112448|567298198|FG001|Overall Study|lab values precluding use of ketorolac|2|||
157151149|NCT02112448|567298197|FG000|Overall Study|Protocol Violation|1|||
156827156|NCT02754141|566121043|FG017|Overall Study|Request to discontinue|0|||
156827157|NCT02754141|566121026|FG000|Overall Study|Withdrew consent|0|||
156827158|NCT02754141|566121027|FG001|Overall Study|Withdrew consent|0|||
156827159|NCT02754141|566121028|FG002|Overall Study|Withdrew consent|0|||
156827160|NCT02754141|566121029|FG003|Overall Study|Withdrew consent|0|||
156827161|NCT02754141|566121030|FG004|Overall Study|Withdrew consent|0|||
156827162|NCT02754141|566121031|FG005|Overall Study|Withdrew consent|0|||
156827163|NCT02754141|566121032|FG006|Overall Study|Withdrew consent|0|||
157151150|NCT02112448|567298198|FG001|Overall Study|Protocol Violation|2|||
156827164|NCT02754141|566121033|FG007|Overall Study|Withdrew consent|0|||
156827165|NCT02754141|566121034|FG008|Overall Study|Withdrew consent|0|||
156827166|NCT02754141|566121035|FG009|Overall Study|Withdrew consent|1|||
156827167|NCT02754141|566121036|FG010|Overall Study|Withdrew consent|0|||
156827168|NCT02754141|566121037|FG011|Overall Study|Withdrew consent|0|||
156827169|NCT02754141|566121038|FG012|Overall Study|Withdrew consent|0|||
156827170|NCT02754141|566121039|FG013|Overall Study|Withdrew consent|0|||
156827171|NCT02754141|566121040|FG014|Overall Study|Withdrew consent|0|||
156827172|NCT02754141|566121041|FG015|Overall Study|Withdrew consent|0|||
156827173|NCT02754141|566121042|FG016|Overall Study|Withdrew consent|0|||
156827174|NCT02754141|566121043|FG017|Overall Study|Withdrew consent|0|||
156827175|NCT02754141|566121026|FG000|Overall Study|Maximum clinical benefit|0|||
156827176|NCT02754141|566121027|FG001|Overall Study|Maximum clinical benefit|0|||
156827177|NCT02754141|566121028|FG002|Overall Study|Maximum clinical benefit|0|||
156827178|NCT02754141|566121029|FG003|Overall Study|Maximum clinical benefit|1|||
156827179|NCT02754141|566121030|FG004|Overall Study|Maximum clinical benefit|0|||
156827180|NCT02754141|566121031|FG005|Overall Study|Maximum clinical benefit|0|||
156827181|NCT02754141|566121032|FG006|Overall Study|Maximum clinical benefit|0|||
156827182|NCT02754141|566121033|FG007|Overall Study|Maximum clinical benefit|0|||
156827183|NCT02754141|566121034|FG008|Overall Study|Maximum clinical benefit|0|||
156827184|NCT02754141|566121035|FG009|Overall Study|Maximum clinical benefit|0|||
156827185|NCT02754141|566121036|FG010|Overall Study|Maximum clinical benefit|0|||
156827186|NCT02754141|566121037|FG011|Overall Study|Maximum clinical benefit|0|||
156827187|NCT02754141|566121038|FG012|Overall Study|Maximum clinical benefit|0|||
156827188|NCT02754141|566121039|FG013|Overall Study|Maximum clinical benefit|0|||
156827189|NCT02754141|566121040|FG014|Overall Study|Maximum clinical benefit|0|||
156827190|NCT02754141|566121041|FG015|Overall Study|Maximum clinical benefit|0|||
156827191|NCT02754141|566121042|FG016|Overall Study|Maximum clinical benefit|0|||
156827192|NCT02754141|566121043|FG017|Overall Study|Maximum clinical benefit|0|||
156827193|NCT02754141|566121026|FG000|Overall Study|No longer meets study criteria|0|||
156827194|NCT02754141|566121027|FG001|Overall Study|No longer meets study criteria|0|||
156827195|NCT02754141|566121028|FG002|Overall Study|No longer meets study criteria|0|||
156827196|NCT02754141|566121029|FG003|Overall Study|No longer meets study criteria|1|||
156827197|NCT02754141|566121030|FG004|Overall Study|No longer meets study criteria|0|||
156827198|NCT02754141|566121031|FG005|Overall Study|No longer meets study criteria|0|||
156827199|NCT02754141|566121032|FG006|Overall Study|No longer meets study criteria|0|||
156827200|NCT02754141|566121033|FG007|Overall Study|No longer meets study criteria|0|||
156827201|NCT02754141|566121034|FG008|Overall Study|No longer meets study criteria|0|||
156827202|NCT02754141|566121035|FG009|Overall Study|No longer meets study criteria|0|||
156827203|NCT02754141|566121036|FG010|Overall Study|No longer meets study criteria|0|||
156827204|NCT02754141|566121037|FG011|Overall Study|No longer meets study criteria|0|||
156827205|NCT02754141|566121038|FG012|Overall Study|No longer meets study criteria|0|||
156827206|NCT02754141|566121039|FG013|Overall Study|No longer meets study criteria|0|||
156827207|NCT02754141|566121040|FG014|Overall Study|No longer meets study criteria|0|||
156827208|NCT02754141|566121041|FG015|Overall Study|No longer meets study criteria|0|||
156827209|NCT02754141|566121042|FG016|Overall Study|No longer meets study criteria|0|||
156827210|NCT02754141|566121043|FG017|Overall Study|No longer meets study criteria|0|||
156827211|NCT02754141|566121026|FG000|Overall Study|Other reasons|0|||
156827212|NCT02754141|566121027|FG001|Overall Study|Other reasons|0|||
156827213|NCT02754141|566121028|FG002|Overall Study|Other reasons|0|||
156827214|NCT02754141|566121029|FG003|Overall Study|Other reasons|0|||
156827215|NCT02754141|566121030|FG004|Overall Study|Other reasons|0|||
156827216|NCT02754141|566121031|FG005|Overall Study|Other reasons|0|||
156827217|NCT02754141|566121032|FG006|Overall Study|Other reasons|0|||
156827218|NCT02754141|566121033|FG007|Overall Study|Other reasons|1|||
156827219|NCT02754141|566121034|FG008|Overall Study|Other reasons|0|||
156827220|NCT02754141|566121035|FG009|Overall Study|Other reasons|0|||
156827221|NCT02754141|566121036|FG010|Overall Study|Other reasons|0|||
156827222|NCT02754141|566121037|FG011|Overall Study|Other reasons|0|||
156827223|NCT02754141|566121038|FG012|Overall Study|Other reasons|2|||
156827224|NCT02754141|566121039|FG013|Overall Study|Other reasons|0|||
156827225|NCT02754141|566121040|FG014|Overall Study|Other reasons|0|||
156827226|NCT02754141|566121041|FG015|Overall Study|Other reasons|0|||
156827227|NCT02754141|566121042|FG016|Overall Study|Other reasons|0|||
156827228|NCT02754141|566121043|FG017|Overall Study|Other reasons|0|||
156827229|NCT02754141|566121026|FG000|Overall Study|Completed treatment as per protocol|0|||
156827230|NCT02754141|566121027|FG001|Overall Study|Completed treatment as per protocol|1|||
156827231|NCT02754141|566121028|FG002|Overall Study|Completed treatment as per protocol|0|||
156827232|NCT02754141|566121029|FG003|Overall Study|Completed treatment as per protocol|0|||
156827233|NCT02754141|566121030|FG004|Overall Study|Completed treatment as per protocol|0|||
156827234|NCT02754141|566121031|FG005|Overall Study|Completed treatment as per protocol|0|||
156827235|NCT02754141|566121032|FG006|Overall Study|Completed treatment as per protocol|0|||
156827236|NCT02754141|566121033|FG007|Overall Study|Completed treatment as per protocol|0|||
156827237|NCT02754141|566121034|FG008|Overall Study|Completed treatment as per protocol|0|||
156827238|NCT02754141|566121035|FG009|Overall Study|Completed treatment as per protocol|0|||
156827239|NCT02754141|566121036|FG010|Overall Study|Completed treatment as per protocol|0|||
156827240|NCT02754141|566121037|FG011|Overall Study|Completed treatment as per protocol|0|||
156827241|NCT02754141|566121038|FG012|Overall Study|Completed treatment as per protocol|1|||
156827242|NCT02754141|566121039|FG013|Overall Study|Completed treatment as per protocol|0|||
156827243|NCT02754141|566121040|FG014|Overall Study|Completed treatment as per protocol|0|||
156827244|NCT02754141|566121041|FG015|Overall Study|Completed treatment as per protocol|0|||
156827245|NCT02754141|566121042|FG016|Overall Study|Completed treatment as per protocol|0|||
156827246|NCT02754141|566121043|FG017|Overall Study|Completed treatment as per protocol|0|||
156827247|NCT02754141|566121026|FG000|Overall Study|Not completing monotherapy|0|||
156827248|NCT02754141|566121027|FG001|Overall Study|Not completing monotherapy|0|||
156827249|NCT02754141|566121028|FG002|Overall Study|Not completing monotherapy|0|||
156827250|NCT02754141|566121029|FG003|Overall Study|Not completing monotherapy|0|||
156827251|NCT02754141|566121030|FG004|Overall Study|Not completing monotherapy|0|||
156827252|NCT02754141|566121031|FG005|Overall Study|Not completing monotherapy|0|||
156827253|NCT02754141|566121032|FG006|Overall Study|Not completing monotherapy|0|||
157022917|NCT01160211|566836916|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
157022918|NCT02734290|566836917|FG000|Overall Study|Adverse Event|1|||
157022919|NCT02734290|566836918|FG001|Overall Study|Adverse Event|0|||
157022920|NCT02734290|566836917|FG000|Overall Study|Death|1|||
157022921|NCT02734290|566836918|FG001|Overall Study|Death|0|||
157022922|NCT04676022|566836923|FG000|Overall Study|Screen Failure/|1|||
157022923|NCT04676022|566836924|FG001|Overall Study|Screen Failure/|1|||
157022924|NCT04676022|566836925|FG002|Overall Study|Screen Failure/|85|||
157022925|NCT04676022|566836923|FG000|Overall Study|Lost to Follow-up|1|||
157022926|NCT04676022|566836924|FG001|Overall Study|Lost to Follow-up|1|||
157022927|NCT04676022|566836925|FG002|Overall Study|Lost to Follow-up|0|||
157022928|NCT04676022|566836923|FG000|Overall Study|Adverse Event|2|||
157224499|NCT04799158|567568021|FG002|Run-In Period|Lost to Follow-up|0|||
157224500|NCT04799158|567568022|FG003|Run-In Period|Lost to Follow-up|0|||
156884856|NCT01215916|566336389|FG004|Overall Study|Adverse Event|0|||
156884857|NCT01215916|566336390|FG005|Overall Study|Adverse Event|0|||
156827254|NCT02754141|566121033|FG007|Overall Study|Not completing monotherapy|0|||
156827255|NCT02754141|566121034|FG008|Overall Study|Not completing monotherapy|0|||
156827256|NCT02754141|566121035|FG009|Overall Study|Not completing monotherapy|0|||
156827257|NCT02754141|566121036|FG010|Overall Study|Not completing monotherapy|0|||
156827258|NCT02754141|566121037|FG011|Overall Study|Not completing monotherapy|0|||
156827259|NCT02754141|566121038|FG012|Overall Study|Not completing monotherapy|0|||
156827260|NCT02754141|566121039|FG013|Overall Study|Not completing monotherapy|1|||
156827261|NCT02754141|566121040|FG014|Overall Study|Not completing monotherapy|0|||
156827262|NCT02754141|566121041|FG015|Overall Study|Not completing monotherapy|0|||
156827263|NCT02754141|566121042|FG016|Overall Study|Not completing monotherapy|0|||
156827264|NCT02754141|566121043|FG017|Overall Study|Not completing monotherapy|0|||
156827265|NCT01187446|566121047|FG000|Overall Study|Patient started non-protocol therapy|0|||
156827266|NCT01187446|566121048|FG001|Overall Study|Patient started non-protocol therapy|1|||
156827267|NCT00823212|566121049|FG000|Overall Study|Death|8|||
156827268|NCT00823212|566121050|FG001|Overall Study|Death|10|||
156827269|NCT00823212|566121049|FG000|Overall Study|Withdrawal by Subject|6|||
156827270|NCT00823212|566121050|FG001|Overall Study|Withdrawal by Subject|1|||
156827271|NCT00823212|566121049|FG000|Overall Study|Incarcerated|0|||
156827272|NCT00823212|566121050|FG001|Overall Study|Incarcerated|1|||
156827273|NCT00823212|566121049|FG000|Overall Study|Missed 12-month visit|21|||
156827274|NCT00823212|566121050|FG001|Overall Study|Missed 12-month visit|21|||
156827275|NCT02285114|566121052|FG000|Main Phase|Investigator's Discretion|0|||
156827276|NCT02285114|566121053|FG001|Main Phase|Investigator's Discretion|2|||
156827277|NCT02285114|566121054|FG002|Main Phase|Investigator's Discretion|0|||
156827278|NCT02285114|566121055|FG003|Main Phase|Investigator's Discretion|0|||
156827279|NCT02285114|566121056|FG004|Main Phase|Investigator's Discretion|0|||
156827280|NCT02285114|566121057|FG005|Main Phase|Investigator's Discretion|0|||
156827281|NCT02285114|566121052|FG000|Main Phase|Enrolled but Never Treated|1|||
156827282|NCT02285114|566121053|FG001|Main Phase|Enrolled but Never Treated|0|||
156884858|NCT01215916|566336391|FG006|Overall Study|Adverse Event|3|||
156884859|NCT01215916|566336392|FG007|Overall Study|Adverse Event|0|||
156827283|NCT02285114|566121054|FG002|Main Phase|Enrolled but Never Treated|0|||
156827284|NCT02285114|566121055|FG003|Main Phase|Enrolled but Never Treated|0|||
156827285|NCT02285114|566121056|FG004|Main Phase|Enrolled but Never Treated|0|||
156884860|NCT01215916|566336393|FG008|Overall Study|Adverse Event|0|||
156884861|NCT01215916|566336385|FG000|Overall Study|Withdrawal by Subject|0|||
157022929|NCT04676022|566836924|FG001|Overall Study|Adverse Event|0|||
157224501|NCT04799158|567568023|FG004|Run-In Period|Lost to Follow-up|0|||
157022930|NCT04676022|566836925|FG002|Overall Study|Adverse Event|1|||
156827286|NCT02285114|566121057|FG005|Main Phase|Enrolled but Never Treated|0|||
156827287|NCT02285114|566121052|FG000|Main Phase|Withdrew Consent|0|||
156884862|NCT01215916|566336386|FG001|Overall Study|Withdrawal by Subject|1|||
156884863|NCT01215916|566336387|FG002|Overall Study|Withdrawal by Subject|1|||
156884864|NCT01215916|566336388|FG003|Overall Study|Withdrawal by Subject|2|||
156884865|NCT01215916|566336389|FG004|Overall Study|Withdrawal by Subject|0|||
157022931|NCT04676022|566836923|FG000|Overall Study|Physician Decision|2|||
157022932|NCT04676022|566836924|FG001|Overall Study|Physician Decision|0|||
156827288|NCT02285114|566121053|FG001|Main Phase|Withdrew Consent|0|||
156827289|NCT02285114|566121054|FG002|Main Phase|Withdrew Consent|1|||
156827290|NCT02285114|566121055|FG003|Main Phase|Withdrew Consent|0|||
156827291|NCT02285114|566121056|FG004|Main Phase|Withdrew Consent|0|||
157022933|NCT04676022|566836925|FG002|Overall Study|Physician Decision|1|||
156884866|NCT01215916|566336390|FG005|Overall Study|Withdrawal by Subject|0|||
156827292|NCT02285114|566121057|FG005|Main Phase|Withdrew Consent|0|||
156827293|NCT02285114|566121052|FG000|Extension Phase|Investigator's Discretion|0|||
156827294|NCT02285114|566121053|FG001|Extension Phase|Investigator's Discretion|0|||
156827295|NCT02285114|566121054|FG002|Extension Phase|Investigator's Discretion|0|||
156827296|NCT02285114|566121055|FG003|Extension Phase|Investigator's Discretion|14|||
156827297|NCT02285114|566121056|FG004|Extension Phase|Investigator's Discretion|1|||
156827298|NCT02285114|566121057|FG005|Extension Phase|Investigator's Discretion|0|||
156827299|NCT02285114|566121052|FG000|Extension Phase|Lost to Follow-up|0|||
156827300|NCT02285114|566121053|FG001|Extension Phase|Lost to Follow-up|0|||
156827301|NCT02285114|566121054|FG002|Extension Phase|Lost to Follow-up|0|||
156827302|NCT02285114|566121055|FG003|Extension Phase|Lost to Follow-up|1|||
156827303|NCT02285114|566121056|FG004|Extension Phase|Lost to Follow-up|1|||
156827304|NCT02285114|566121057|FG005|Extension Phase|Lost to Follow-up|0|||
156827305|NCT02285114|566121052|FG000|Extension Phase|Non-compliance with Study Drug|0|||
156827306|NCT02285114|566121053|FG001|Extension Phase|Non-compliance with Study Drug|0|||
156827307|NCT02285114|566121054|FG002|Extension Phase|Non-compliance with Study Drug|0|||
156827308|NCT02285114|566121055|FG003|Extension Phase|Non-compliance with Study Drug|2|||
156827309|NCT02285114|566121056|FG004|Extension Phase|Non-compliance with Study Drug|0|||
156827310|NCT02285114|566121057|FG005|Extension Phase|Non-compliance with Study Drug|0|||
156827311|NCT02285114|566121052|FG000|Extension Phase|Pregnancy|0|||
156827312|NCT02285114|566121053|FG001|Extension Phase|Pregnancy|0|||
156827313|NCT02285114|566121054|FG002|Extension Phase|Pregnancy|0|||
156827314|NCT02285114|566121055|FG003|Extension Phase|Pregnancy|1|||
156827315|NCT02285114|566121056|FG004|Extension Phase|Pregnancy|0|||
156827316|NCT02285114|566121057|FG005|Extension Phase|Pregnancy|0|||
156827317|NCT00320255|566121058|FG000|Overall Study|Lack of Efficacy|1|||
156827318|NCT00320255|566121059|FG001|Overall Study|Lack of Efficacy|0|||
156827319|NCT00320255|566121060|FG002|Overall Study|Lack of Efficacy|0|||
156827320|NCT00320255|566121061|FG003|Overall Study|Lack of Efficacy|0|||
156827321|NCT00320255|566121062|FG004|Overall Study|Lack of Efficacy|0|||
156827322|NCT00320255|566121063|FG005|Overall Study|Lack of Efficacy|0|||
156827323|NCT00320255|566121058|FG000|Overall Study|Adverse Event|5|||
156827324|NCT00320255|566121059|FG001|Overall Study|Adverse Event|2|||
156827325|NCT00320255|566121060|FG002|Overall Study|Adverse Event|3|||
156827326|NCT00320255|566121061|FG003|Overall Study|Adverse Event|2|||
156827327|NCT00320255|566121062|FG004|Overall Study|Adverse Event|0|||
156827328|NCT00320255|566121063|FG005|Overall Study|Adverse Event|0|||
156827329|NCT00320255|566121058|FG000|Overall Study|Withdrawal by Subject|1|||
156827330|NCT00320255|566121059|FG001|Overall Study|Withdrawal by Subject|2|||
156827331|NCT00320255|566121060|FG002|Overall Study|Withdrawal by Subject|2|||
156827332|NCT00320255|566121061|FG003|Overall Study|Withdrawal by Subject|4|||
156827333|NCT00320255|566121062|FG004|Overall Study|Withdrawal by Subject|0|||
156827334|NCT00320255|566121063|FG005|Overall Study|Withdrawal by Subject|0|||
156827335|NCT00320255|566121058|FG000|Overall Study|Poor compliance/noncompliance|1|||
156827336|NCT00320255|566121059|FG001|Overall Study|Poor compliance/noncompliance|1|||
156827337|NCT00320255|566121060|FG002|Overall Study|Poor compliance/noncompliance|0|||
156827338|NCT00320255|566121061|FG003|Overall Study|Poor compliance/noncompliance|1|||
156827339|NCT00320255|566121062|FG004|Overall Study|Poor compliance/noncompliance|0|||
156884867|NCT01215916|566336391|FG006|Overall Study|Withdrawal by Subject|1|||
156884868|NCT01215916|566336392|FG007|Overall Study|Withdrawal by Subject|0|||
156884869|NCT01215916|566336393|FG008|Overall Study|Withdrawal by Subject|0|||
156827340|NCT00320255|566121063|FG005|Overall Study|Poor compliance/noncompliance|0|||
156827341|NCT00320255|566121058|FG000|Overall Study|No longer meets study criteria|0|||
156827342|NCT00320255|566121059|FG001|Overall Study|No longer meets study criteria|0|||
156827343|NCT00320255|566121060|FG002|Overall Study|No longer meets study criteria|0|||
156827344|NCT00320255|566121061|FG003|Overall Study|No longer meets study criteria|1|||
156827345|NCT00320255|566121062|FG004|Overall Study|No longer meets study criteria|0|||
156827346|NCT00320255|566121063|FG005|Overall Study|No longer meets study criteria|0|||
156827347|NCT00320255|566121058|FG000|Overall Study|Other|3|||
156827348|NCT00320255|566121059|FG001|Overall Study|Other|2|||
156884870|NCT01215916|566336385|FG000|Overall Study|Death|0|||
156827349|NCT00320255|566121060|FG002|Overall Study|Other|1|||
156827350|NCT00320255|566121061|FG003|Overall Study|Other|0|||
156827351|NCT00320255|566121062|FG004|Overall Study|Other|0|||
156827352|NCT00320255|566121063|FG005|Overall Study|Other|0|||
156827353|NCT01156389|566121064|FG000|Overall Study|Elevated liver enzymes|4|||
156827354|NCT01156389|566121065|FG001|Overall Study|Elevated liver enzymes|0|||
156827355|NCT01156389|566121064|FG000|Overall Study|Vomiting|0|||
156827356|NCT01156389|566121065|FG001|Overall Study|Vomiting|1|||
156827357|NCT02351349|566121066|FG000|Overall Study|Withdrawal by Subject|2|||
156827358|NCT02351349|566121067|FG001|Overall Study|Withdrawal by Subject|3|||
156827359|NCT00350623|566121068|FG000|Overall Study|Lost to Follow-up|8|||
156827360|NCT00350623|566121069|FG001|Overall Study|Lost to Follow-up|3|||
156827361|NCT00350623|566121070|FG002|Overall Study|Lost to Follow-up|4|||
156827362|NCT00350623|566121068|FG000|Overall Study|Withdrawal by Subject|0|||
156884871|NCT01215916|566336386|FG001|Overall Study|Death|1|||
156827363|NCT00350623|566121069|FG001|Overall Study|Withdrawal by Subject|1|||
156827364|NCT00350623|566121070|FG002|Overall Study|Withdrawal by Subject|1|||
156827365|NCT00350623|566121068|FG000|Overall Study|patient traveling outside the country|0|||
156827366|NCT00350623|566121069|FG001|Overall Study|patient traveling outside the country|0|||
156827367|NCT00350623|566121070|FG002|Overall Study|patient traveling outside the country|1|||
156827368|NCT00090233|566121078|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
156827369|NCT00090233|566121079|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
156827370|NCT00090233|566121078|FG000|Overall Study|Adverse Event|214|||
156827371|NCT00090233|566121079|FG001|Overall Study|Adverse Event|198|||
156827372|NCT00090233|566121078|FG000|Overall Study|Lost to Follow-up|68|||
156827373|NCT00090233|566121079|FG001|Overall Study|Lost to Follow-up|95|||
156827374|NCT00090233|566121078|FG000|Overall Study|Protocol Violation|960|||
156827375|NCT00090233|566121079|FG001|Overall Study|Protocol Violation|1022|||
156827376|NCT00090233|566121078|FG000|Overall Study|Withdrawal by Subject|182|||
156827377|NCT00090233|566121079|FG001|Overall Study|Withdrawal by Subject|211|||
156827378|NCT00090233|566121078|FG000|Overall Study|Moved|203|||
156827379|NCT00090233|566121079|FG001|Overall Study|Moved|189|||
156827380|NCT00090233|566121078|FG000|Overall Study|Other|1211|||
156827381|NCT00090233|566121079|FG001|Overall Study|Other|1160|||
156827382|NCT00090233|566121078|FG000|Overall Study|Data not available at data cut-off point|1552|||
156827383|NCT00090233|566121079|FG001|Overall Study|Data not available at data cut-off point|1563|||
156827384|NCT04863248|566121080|FG000|Overall Study|Sponsor Terminated|4|||
156827385|NCT04863248|566121081|FG001|Overall Study|Sponsor Terminated|1|||
156827386|NCT04863248|566121080|FG000|Overall Study|Death|0|||
156827387|NCT04863248|566121081|FG001|Overall Study|Death|1|||
156827388|NCT04863248|566121080|FG000|Overall Study|Withdrawal by Subject|0|||
156827389|NCT04863248|566121081|FG001|Overall Study|Withdrawal by Subject|1|||
156827390|NCT02536300|566121082|FG000|Overall Study|Investigator's Discretion|17|||
156827391|NCT02536300|566121083|FG001|Overall Study|Investigator's Discretion|11|||
156827392|NCT02536300|566121084|FG002|Overall Study|Investigator's Discretion|2|||
156827393|NCT02536300|566121082|FG000|Overall Study|Progressive Disease|11|||
156827394|NCT02536300|566121083|FG001|Overall Study|Progressive Disease|7|||
156827395|NCT02536300|566121084|FG002|Overall Study|Progressive Disease|6|||
156827396|NCT02536300|566121082|FG000|Overall Study|Study Terminated by Sponsor|6|||
156827397|NCT02536300|566121083|FG001|Overall Study|Study Terminated by Sponsor|4|||
156827398|NCT02536300|566121084|FG002|Overall Study|Study Terminated by Sponsor|7|||
156827399|NCT02536300|566121082|FG000|Overall Study|Death|7|||
156827400|NCT02536300|566121083|FG001|Overall Study|Death|0|||
156827401|NCT02536300|566121084|FG002|Overall Study|Death|5|||
156827402|NCT02536300|566121082|FG000|Overall Study|Withdrew Consent|4|||
156827403|NCT02536300|566121083|FG001|Overall Study|Withdrew Consent|2|||
156827404|NCT02536300|566121084|FG002|Overall Study|Withdrew Consent|0|||
156827405|NCT02536300|566121082|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
156827406|NCT02536300|566121083|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
156827407|NCT02536300|566121084|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
157022934|NCT04676022|566836923|FG000|Overall Study|Withdrawal by Subject|3|||
157022935|NCT04676022|566836924|FG001|Overall Study|Withdrawal by Subject|1|||
156827408|NCT02536300|566121082|FG000|Overall Study|Enrolled but Never Treated|0|||
156827409|NCT02536300|566121083|FG001|Overall Study|Enrolled but Never Treated|0|||
156827410|NCT02536300|566121084|FG002|Overall Study|Enrolled but Never Treated|1|||
156827411|NCT02536300|566121082|FG000|Overall Study|Non-compliance With Study Drug|1|||
156827412|NCT02536300|566121083|FG001|Overall Study|Non-compliance With Study Drug|0|||
156827413|NCT02536300|566121084|FG002|Overall Study|Non-compliance With Study Drug|0|||
156827414|NCT02536300|566121082|FG000|Overall Study|Protocol Violation|0|||
156827415|NCT02536300|566121083|FG001|Overall Study|Protocol Violation|1|||
156827416|NCT02536300|566121084|FG002|Overall Study|Protocol Violation|0|||
156827417|NCT01779869|566121085|FG000|Overall Study|Physician Decision|2|||
156827418|NCT01691105|566121095|FG000|1 Month Follow-up|Lost to Follow-up|41|||
156827419|NCT01691105|566121096|FG001|1 Month Follow-up|Lost to Follow-up|38|||
156827420|NCT01691105|566121095|FG000|1 Month Follow-up|Death|2|||
156827421|NCT01691105|566121096|FG001|1 Month Follow-up|Death|3|||
156827422|NCT01691105|566121095|FG000|6 Month Follow-up|Lost to Follow-up|39|||
156827423|NCT01691105|566121096|FG001|6 Month Follow-up|Lost to Follow-up|58|||
156827424|NCT01691105|566121095|FG000|6 Month Follow-up|Death|13|||
157022936|NCT04676022|566836925|FG002|Overall Study|Withdrawal by Subject|6|||
156827425|NCT01691105|566121096|FG001|6 Month Follow-up|Death|13|||
156827426|NCT01691105|566121095|FG000|12 Month Follow-up|Lost to Follow-up|50|||
156827427|NCT01691105|566121096|FG001|12 Month Follow-up|Lost to Follow-up|71|||
156827428|NCT01691105|566121095|FG000|12 Month Follow-up|Death|22|||
157022937|NCT04676022|566836923|FG000|Overall Study|Will not move forward with permanent implant|6|||
157151151|NCT02112448|567298197|FG000|Overall Study|Physician Decision|4|||
157151152|NCT02112448|567298198|FG001|Overall Study|Physician Decision|6|||
156827429|NCT01691105|566121096|FG001|12 Month Follow-up|Death|30|||
156827430|NCT01691105|566121095|FG000|12 Month Biochemical Verification|Death|22|||
156827431|NCT01691105|566121096|FG001|12 Month Biochemical Verification|Death|30|||
156884872|NCT01215916|566336387|FG002|Overall Study|Death|0|||
156827432|NCT01691105|566121095|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
156827433|NCT01691105|566121096|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
156827434|NCT01691105|566121095|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
156827435|NCT01691105|566121096|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
156827436|NCT00957944|566121097|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
156827437|NCT00957944|566121098|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
156827438|NCT01482169|566121100|FG000|Overall Study|Physician Decision|2|||
156827439|NCT00445848|566121103|FG000|Overall Study|Adverse Event|14|||
156827440|NCT00445848|566121103|FG000|Overall Study|Withdrawal by Subject|4|||
156827441|NCT00445848|566121103|FG000|Overall Study|Progression|62|||
156827442|NCT00445848|566121103|FG000|Overall Study|Other-Not protocol specified|5|||
156827443|NCT02701777|566121104|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
156827444|NCT02701777|566121105|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
156827445|NCT02701777|566121106|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
156827446|NCT02701777|566121107|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
156827447|NCT02701777|566121104|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
156827448|NCT02701777|566121105|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
156827449|NCT02701777|566121106|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
156827450|NCT02701777|566121107|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
156827451|NCT01560637|566121110|FG000|Overall Study|Adverse Event|63|||
156827452|NCT01560637|566121110|FG000|Overall Study|Death|69|||
156827453|NCT01560637|566121110|FG000|Overall Study|Lost to Follow-up|8|||
156827454|NCT01560637|566121110|FG000|Overall Study|Protocol Violation|8|||
156827455|NCT01560637|566121110|FG000|Overall Study|Withdrawal by Subject|24|||
156827456|NCT01560637|566121110|FG000|Overall Study|Progressive Disease|20|||
156827457|NCT01560637|566121110|FG000|Overall Study|Other Reason Not Specified|6|||
156827458|NCT01089023|566121111|FG000|Overall Study|Lost to Follow-up|3|||
156827459|NCT01089023|566121111|FG000|Overall Study|Adverse Event|1|||
156827460|NCT01089023|566121111|FG000|Overall Study|Withdrawal by Subject|1|||
156827461|NCT01089023|566121111|FG000|Overall Study|Protocol Violation|1|||
156827462|NCT01089023|566121111|FG000|Overall Study|Lack of Efficacy|1|||
156827463|NCT03220581|566121112|FG000|Overall Study|Withdrawal by Subject|0|||
156827464|NCT03220581|566121113|FG001|Overall Study|Withdrawal by Subject|1|||
156827465|NCT03220581|566121112|FG000|Overall Study|Lost to Follow-up|3|||
156827466|NCT03220581|566121113|FG001|Overall Study|Lost to Follow-up|6|||
156827467|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
156827468|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
156827469|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
156827470|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
156827471|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
156827472|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
156827473|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
156827474|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
156827475|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827476|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827477|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
156827478|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
156827479|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Adverse Event|1|||
156827480|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Adverse Event|0|||
156827481|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Adverse Event|2|||
156827482|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Adverse Event|0|||
156827483|NCT01185964|566121115|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
156827484|NCT01185964|566121116|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
156827485|NCT01185964|566121117|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
156827486|NCT01185964|566121118|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
156827487|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827488|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827489|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
156827490|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
156827491|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827492|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827493|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
156827494|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
156827495|NCT01185964|566121115|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827496|NCT01185964|566121116|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827497|NCT01185964|566121117|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
156827498|NCT01185964|566121118|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
157151153|NCT02112448|567298197|FG000|Overall Study|required heparin so could not use ketoro|1|||
157151154|NCT02112448|567298198|FG001|Overall Study|required heparin so could not use ketoro|0|||
157151155|NCT05270694|567299600|FG000|Overall Study|Death|1|||
156827499|NCT04465877|566121119|FG000|Overall Study|Noncompliant with study requirements|0|||
156827500|NCT04465877|566121120|FG001|Overall Study|Noncompliant with study requirements|0|||
156827501|NCT04465877|566121121|FG002|Overall Study|Noncompliant with study requirements|1|||
156827502|NCT04465877|566121122|FG003|Overall Study|Noncompliant with study requirements|0|||
156827503|NCT02323204|566121123|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
156827504|NCT02323204|566121124|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
156827505|NCT02323204|566121125|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
156827506|NCT02323204|566121126|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
156827507|NCT02323204|566121123|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
156827508|NCT02323204|566121124|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
156827509|NCT02323204|566121125|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
156827510|NCT02323204|566121126|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
156827511|NCT02323204|566121123|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
156827512|NCT02323204|566121124|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
156827513|NCT02323204|566121125|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
156827514|NCT02323204|566121126|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
156827515|NCT02323204|566121123|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
156827516|NCT02323204|566121124|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
156827517|NCT02323204|566121125|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
156827518|NCT02323204|566121126|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
156827519|NCT02323204|566121123|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
156827520|NCT02323204|566121124|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
156827521|NCT02323204|566121125|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
156827522|NCT02323204|566121126|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
156827523|NCT02323204|566121123|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
156827524|NCT02323204|566121124|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
156827525|NCT02323204|566121125|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
156827526|NCT02323204|566121126|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
156827527|NCT02323204|566121123|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827528|NCT02323204|566121124|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
156827529|NCT02323204|566121125|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827530|NCT02323204|566121126|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
156827531|NCT02323204|566121123|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
156827532|NCT02323204|566121124|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
156827533|NCT02323204|566121125|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
156827534|NCT02323204|566121126|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
156827535|NCT02323204|566121123|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156884873|NCT01215916|566336388|FG003|Overall Study|Death|0|||
156884874|NCT01215916|566336389|FG004|Overall Study|Death|1|||
156827536|NCT02323204|566121124|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
156827537|NCT02323204|566121125|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
156827538|NCT02323204|566121126|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
156827539|NCT03576755|566121127|FG000|Overall Study|Withdrawal by Subject|1|||
156827540|NCT03576755|566121128|FG001|Overall Study|Withdrawal by Subject|0|||
156827541|NCT03576755|566121129|FG002|Overall Study|Withdrawal by Subject|0|||
156827542|NCT03576755|566121130|FG003|Overall Study|Withdrawal by Subject|0|||
156884875|NCT01215916|566336390|FG005|Overall Study|Death|0|||
156884876|NCT01215916|566336391|FG006|Overall Study|Death|0|||
156884877|NCT01215916|566336392|FG007|Overall Study|Death|0|||
156884878|NCT01215916|566336393|FG008|Overall Study|Death|1|||
156884879|NCT01215916|566336385|FG000|Overall Study|Physician Decision|0|||
156827543|NCT04962230|566121131|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
156827544|NCT04962230|566121131|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
156827545|NCT01396265|566121132|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
156884880|NCT01215916|566336386|FG001|Overall Study|Physician Decision|0|||
156884881|NCT01215916|566336387|FG002|Overall Study|Physician Decision|1|||
156827546|NCT03444766|566121133|FG000|Overall Study|Other Reasons|2|||
156827547|NCT03444766|566121133|FG000|Overall Study|Participant Withdrew Consent|5|||
156827548|NCT03444766|566121133|FG000|Overall Study|Lost to Follow-up|2|||
156827549|NCT03444766|566121133|FG000|Overall Study|Death|2|||
156827550|NCT03444766|566121133|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
156827551|NCT03444766|566121133|FG000|Overall Study|Disease Progression|49|||
156827552|NCT04346108|566121134|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
156827553|NCT04346108|566121135|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
156884882|NCT01215916|566336388|FG003|Overall Study|Physician Decision|1|||
156884883|NCT01215916|566336389|FG004|Overall Study|Physician Decision|0|||
156884884|NCT01215916|566336390|FG005|Overall Study|Physician Decision|0|||
156884885|NCT01215916|566336391|FG006|Overall Study|Physician Decision|0|||
156884886|NCT01215916|566336392|FG007|Overall Study|Physician Decision|0|||
156884887|NCT01215916|566336393|FG008|Overall Study|Physician Decision|0|||
156827554|NCT04346108|566121136|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
156827555|NCT04346108|566121134|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
156827556|NCT04346108|566121135|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
156827557|NCT04346108|566121136|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
156827558|NCT01598753|566121137|FG000|Overall Study|Adverse Event|1|||
156827559|NCT01598753|566121138|FG001|Overall Study|Adverse Event|9|||
156827560|NCT01598753|566121139|FG002|Overall Study|Adverse Event|1|||
156827561|NCT01598753|566121140|FG003|Overall Study|Adverse Event|7|||
156827562|NCT01598753|566121137|FG000|Overall Study|Lost to Follow-up|4|||
156827563|NCT01598753|566121138|FG001|Overall Study|Lost to Follow-up|3|||
156827564|NCT01598753|566121139|FG002|Overall Study|Lost to Follow-up|7|||
156827565|NCT01598753|566121140|FG003|Overall Study|Lost to Follow-up|5|||
156827566|NCT01598753|566121137|FG000|Overall Study|Physician Decision|0|||
156827567|NCT01598753|566121138|FG001|Overall Study|Physician Decision|1|||
156827568|NCT01598753|566121139|FG002|Overall Study|Physician Decision|0|||
156827569|NCT01598753|566121140|FG003|Overall Study|Physician Decision|2|||
156827570|NCT01598753|566121137|FG000|Overall Study|Withdrawal by Subject|7|||
156827571|NCT01598753|566121138|FG001|Overall Study|Withdrawal by Subject|2|||
156827572|NCT01598753|566121139|FG002|Overall Study|Withdrawal by Subject|0|||
156827573|NCT01598753|566121140|FG003|Overall Study|Withdrawal by Subject|1|||
156827574|NCT02275117|566121141|FG000|Overall Study|Adverse Event|0|||
156827575|NCT02275117|566121142|FG001|Overall Study|Adverse Event|0|||
156827576|NCT02275117|566121143|FG002|Overall Study|Adverse Event|0|||
156827577|NCT02275117|566121144|FG003|Overall Study|Adverse Event|0|||
156827578|NCT02275117|566121145|FG004|Overall Study|Adverse Event|1|||
156827579|NCT02275117|566121141|FG000|Overall Study|Lack of Efficacy|6|||
156827580|NCT02275117|566121142|FG001|Overall Study|Lack of Efficacy|7|||
156827581|NCT02275117|566121143|FG002|Overall Study|Lack of Efficacy|5|||
156827582|NCT02275117|566121144|FG003|Overall Study|Lack of Efficacy|2|||
156827583|NCT02275117|566121145|FG004|Overall Study|Lack of Efficacy|10|||
156827584|NCT02275117|566121141|FG000|Overall Study|Lost to Follow-up|11|||
156827585|NCT02275117|566121142|FG001|Overall Study|Lost to Follow-up|16|||
156827586|NCT02275117|566121143|FG002|Overall Study|Lost to Follow-up|15|||
156827587|NCT02275117|566121144|FG003|Overall Study|Lost to Follow-up|16|||
156827588|NCT02275117|566121145|FG004|Overall Study|Lost to Follow-up|8|||
156827589|NCT02275117|566121141|FG000|Overall Study|Physician Decision|0|||
156827590|NCT02275117|566121142|FG001|Overall Study|Physician Decision|1|||
156827591|NCT02275117|566121143|FG002|Overall Study|Physician Decision|1|||
156827592|NCT02275117|566121144|FG003|Overall Study|Physician Decision|0|||
156827593|NCT02275117|566121145|FG004|Overall Study|Physician Decision|1|||
156827594|NCT02275117|566121141|FG000|Overall Study|Protocol Violation|1|||
156827595|NCT02275117|566121142|FG001|Overall Study|Protocol Violation|0|||
156827596|NCT02275117|566121143|FG002|Overall Study|Protocol Violation|1|||
156827597|NCT02275117|566121144|FG003|Overall Study|Protocol Violation|1|||
156827598|NCT02275117|566121145|FG004|Overall Study|Protocol Violation|0|||
156827599|NCT02275117|566121141|FG000|Overall Study|Withdrawal by Subject|6|||
156827600|NCT02275117|566121142|FG001|Overall Study|Withdrawal by Subject|4|||
156827601|NCT02275117|566121143|FG002|Overall Study|Withdrawal by Subject|7|||
156827602|NCT02275117|566121144|FG003|Overall Study|Withdrawal by Subject|3|||
156884888|NCT00958438|566336397|FG000|Overall Study|Protocol Violation|3|||
156884889|NCT00958438|566336398|FG001|Overall Study|Protocol Violation|2|||
156884890|NCT00958438|566336399|FG002|Overall Study|Protocol Violation|2|||
156884891|NCT00958438|566336397|FG000|Overall Study|Withdrawal by Subject|4|||
156884892|NCT00958438|566336398|FG001|Overall Study|Withdrawal by Subject|2|||
156827603|NCT02275117|566121145|FG004|Overall Study|Withdrawal by Subject|3|||
156827604|NCT02275117|566121141|FG000|Overall Study|Terminated by Sponsor|4|||
156827605|NCT02275117|566121142|FG001|Overall Study|Terminated by Sponsor|4|||
156827606|NCT02275117|566121143|FG002|Overall Study|Terminated by Sponsor|4|||
156827607|NCT02275117|566121144|FG003|Overall Study|Terminated by Sponsor|6|||
156827608|NCT02275117|566121145|FG004|Overall Study|Terminated by Sponsor|4|||
156827609|NCT02275117|566121141|FG000|Overall Study|Worsening of Study Indication|0|||
156827610|NCT02275117|566121142|FG001|Overall Study|Worsening of Study Indication|1|||
156827611|NCT02275117|566121143|FG002|Overall Study|Worsening of Study Indication|2|||
156827612|NCT02275117|566121144|FG003|Overall Study|Worsening of Study Indication|0|||
156827613|NCT02275117|566121145|FG004|Overall Study|Worsening of Study Indication|0|||
156827614|NCT02275117|566121141|FG000|Overall Study|Study Burden|5|||
156827615|NCT02275117|566121142|FG001|Overall Study|Study Burden|4|||
156827616|NCT02275117|566121143|FG002|Overall Study|Study Burden|7|||
156827617|NCT02275117|566121144|FG003|Overall Study|Study Burden|5|||
156827618|NCT02275117|566121145|FG004|Overall Study|Study Burden|7|||
156827619|NCT02275117|566121141|FG000|Overall Study|Other|1|||
156827620|NCT02275117|566121142|FG001|Overall Study|Other|0|||
156827621|NCT02275117|566121143|FG002|Overall Study|Other|0|||
156827622|NCT02275117|566121144|FG003|Overall Study|Other|0|||
156827623|NCT02275117|566121145|FG004|Overall Study|Other|2|||
156827624|NCT01081301|566121148|FG000|Overall Study|Bereaved|3|||
156827625|NCT01081301|566121148|FG000|Overall Study|Too busy|5|||
156827626|NCT01081301|566121148|FG000|Overall Study|Patient too ill|2|||
156827627|NCT01081301|566121148|FG000|Overall Study|Lost to Follow-up|4|||
156827628|NCT02014480|566121149|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827629|NCT02014480|566121150|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827630|NCT02014480|566121151|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156827631|NCT02014480|566121152|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827632|NCT02014480|566121153|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827633|NCT02014480|566121154|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156827634|NCT02014480|566121149|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827635|NCT02014480|566121150|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156827636|NCT02014480|566121151|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827637|NCT02014480|566121152|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
156827638|NCT02014480|566121153|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156827639|NCT02014480|566121154|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156827640|NCT02014480|566121149|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827641|NCT02014480|566121150|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827642|NCT02014480|566121151|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
156827643|NCT02014480|566121152|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827644|NCT02014480|566121153|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827645|NCT02014480|566121154|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
156827646|NCT02014480|566121149|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827647|NCT02014480|566121150|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827648|NCT02014480|566121151|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
156827649|NCT02014480|566121152|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
156827650|NCT02014480|566121153|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156827651|NCT02014480|566121154|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
156827652|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827653|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
156827654|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827655|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827656|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827657|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
156827658|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827659|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827660|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
156827661|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827662|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
156827663|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
156827664|NCT02014480|566121149|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827665|NCT02014480|566121150|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827666|NCT02014480|566121151|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827667|NCT02014480|566121152|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827668|NCT02014480|566121153|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156827669|NCT02014480|566121154|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156827670|NCT01338610|566121155|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
156827671|NCT01338610|566121156|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
156827672|NCT01338610|566121157|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
156827673|NCT01338610|566121155|FG000|Overall Study|Protocol Violation|1|||
156827674|NCT01338610|566121156|FG001|Overall Study|Protocol Violation|0|||
156827675|NCT01338610|566121157|FG002|Overall Study|Protocol Violation|1|||
156827676|NCT01338610|566121155|FG000|Overall Study|Adverse Event|3|||
156827677|NCT01338610|566121156|FG001|Overall Study|Adverse Event|0|||
156827678|NCT01338610|566121157|FG002|Overall Study|Adverse Event|0|||
156884893|NCT00958438|566336399|FG002|Overall Study|Withdrawal by Subject|1|||
156884894|NCT00958438|566336397|FG000|Overall Study|Adverse Event|0|||
156884895|NCT00958438|566336398|FG001|Overall Study|Adverse Event|3|||
156884896|NCT00958438|566336399|FG002|Overall Study|Adverse Event|0|||
156884897|NCT00958438|566336397|FG000|Overall Study|Physician Decision|1|||
156884898|NCT00958438|566336398|FG001|Overall Study|Physician Decision|0|||
156827679|NCT01865812|566121158|FG000|Primary Treatment Phase|Adverse Event|2|||
156827680|NCT01865812|566121159|FG001|Primary Treatment Phase|Adverse Event|0|||
156827681|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
156827682|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
156827683|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Pruritus|0|||
156827684|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Pruritus|3|||
156827685|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
156827686|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
156827687|NCT01865812|566121158|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
156827688|NCT01865812|566121159|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
156827689|NCT02046226|566121160|FG000|Overall Study|Lost to Follow-up|7|||
156884899|NCT00958438|566336399|FG002|Overall Study|Physician Decision|1|||
156884900|NCT00958438|566336397|FG000|Overall Study|Other than specified above|2|||
156827690|NCT00171925|566121164|FG000|Overall Study|Adverse Event|10|||
156827691|NCT00171925|566121165|FG001|Overall Study|Adverse Event|6|||
156827692|NCT00171925|566121164|FG000|Overall Study|Protocol Violation|1|||
156827693|NCT00171925|566121165|FG001|Overall Study|Protocol Violation|1|||
156827694|NCT00171925|566121164|FG000|Overall Study|Withdrawal by Subject|6|||
156827695|NCT00171925|566121165|FG001|Overall Study|Withdrawal by Subject|9|||
156827696|NCT00171925|566121164|FG000|Overall Study|Lost to Follow-up|2|||
156827697|NCT00171925|566121165|FG001|Overall Study|Lost to Follow-up|2|||
156827698|NCT00171925|566121164|FG000|Overall Study|Administrative problems|10|||
156827699|NCT00171925|566121165|FG001|Overall Study|Administrative problems|11|||
156827700|NCT00171925|566121164|FG000|Overall Study|Death|1|||
156827701|NCT00171925|566121165|FG001|Overall Study|Death|2|||
156827702|NCT02692040|566121166|FG000|Overall Study|Protocol Violation|0|||
156827703|NCT02692040|566121167|FG001|Overall Study|Protocol Violation|0|||
156827704|NCT02692040|566121168|FG002|Overall Study|Protocol Violation|0|||
156827705|NCT02692040|566121169|FG003|Overall Study|Protocol Violation|0|||
156827706|NCT02692040|566121170|FG004|Overall Study|Protocol Violation|0|||
156827707|NCT02692040|566121171|FG005|Overall Study|Protocol Violation|0|||
156827708|NCT02692040|566121172|FG006|Overall Study|Protocol Violation|0|||
156827709|NCT02692040|566121173|FG007|Overall Study|Protocol Violation|0|||
156827710|NCT02692040|566121174|FG008|Overall Study|Protocol Violation|0|||
156827711|NCT02692040|566121175|FG009|Overall Study|Protocol Violation|0|||
156827712|NCT02692040|566121176|FG010|Overall Study|Protocol Violation|0|||
156827713|NCT02692040|566121177|FG011|Overall Study|Protocol Violation|0|||
156827714|NCT02692040|566121178|FG012|Overall Study|Protocol Violation|1|||
156827715|NCT02692040|566121179|FG013|Overall Study|Protocol Violation|0|||
156827716|NCT02692040|566121180|FG014|Overall Study|Protocol Violation|0|||
156827717|NCT02692040|566121181|FG015|Overall Study|Protocol Violation|0|||
156827718|NCT02692040|566121182|FG016|Overall Study|Protocol Violation|0|||
156827719|NCT02692040|566121166|FG000|Overall Study|Adverse Event|0|||
156827720|NCT02692040|566121167|FG001|Overall Study|Adverse Event|0|||
156827721|NCT02692040|566121168|FG002|Overall Study|Adverse Event|0|||
156827722|NCT02692040|566121169|FG003|Overall Study|Adverse Event|0|||
156827723|NCT02692040|566121170|FG004|Overall Study|Adverse Event|0|||
156827724|NCT02692040|566121171|FG005|Overall Study|Adverse Event|0|||
156827725|NCT02692040|566121172|FG006|Overall Study|Adverse Event|0|||
156827726|NCT02692040|566121173|FG007|Overall Study|Adverse Event|0|||
156827727|NCT02692040|566121174|FG008|Overall Study|Adverse Event|0|||
156827728|NCT02692040|566121175|FG009|Overall Study|Adverse Event|0|||
156827729|NCT02692040|566121176|FG010|Overall Study|Adverse Event|0|||
156827730|NCT02692040|566121177|FG011|Overall Study|Adverse Event|0|||
156827731|NCT02692040|566121178|FG012|Overall Study|Adverse Event|0|||
156827732|NCT02692040|566121179|FG013|Overall Study|Adverse Event|3|||
156827733|NCT02692040|566121180|FG014|Overall Study|Adverse Event|1|||
156827734|NCT02692040|566121181|FG015|Overall Study|Adverse Event|1|||
156827735|NCT02692040|566121182|FG016|Overall Study|Adverse Event|0|||
156827736|NCT03023826|566121188|FG000|Period 1|Withdrawal by Subject|0|||
156827737|NCT03023826|566121189|FG001|Period 1|Withdrawal by Subject|0|||
156827738|NCT03023826|566121190|FG002|Period 1|Withdrawal by Subject|0|||
156827739|NCT03023826|566121191|FG003|Period 1|Withdrawal by Subject|0|||
156827740|NCT03023826|566121192|FG004|Period 1|Withdrawal by Subject|1|||
156884901|NCT00958438|566336398|FG001|Overall Study|Other than specified above|3|||
156827741|NCT03023826|566121193|FG005|Period 1|Withdrawal by Subject|0|||
156827742|NCT02142283|566121197|FG000|Overall Study|Death|20|||
156827743|NCT02142283|566121198|FG001|Overall Study|Death|18|||
156827744|NCT02142283|566121197|FG000|Overall Study|Withdrawal by Subject|1|||
156827745|NCT02142283|566121198|FG001|Overall Study|Withdrawal by Subject|3|||
156884902|NCT00958438|566336399|FG002|Overall Study|Other than specified above|2|||
157151156|NCT05270694|567299600|FG000|Overall Study|Medical issues impacted ability to participate|2|||
156827746|NCT00747344|566121199|FG000|Controlled Period|Adverse Event|3|||
156827747|NCT00747344|566121200|FG001|Controlled Period|Adverse Event|0|||
156827748|NCT00747344|566121201|FG002|Controlled Period|Adverse Event|0|||
156827749|NCT00747344|566121202|FG003|Controlled Period|Adverse Event|0|||
156827750|NCT00747344|566121199|FG000|Controlled Period|Lack of Efficacy|2|||
156827751|NCT00747344|566121200|FG001|Controlled Period|Lack of Efficacy|1|||
156827752|NCT00747344|566121201|FG002|Controlled Period|Lack of Efficacy|0|||
156884903|NCT02788279|566336400|FG000|Overall Study|Death|62|||
157151157|NCT05270694|567299600|FG000|Overall Study|Lost to Follow-up|3|||
156827753|NCT00747344|566121202|FG003|Controlled Period|Lack of Efficacy|0|||
156827754|NCT00747344|566121199|FG000|Controlled Period|Other|0|||
156827755|NCT00747344|566121200|FG001|Controlled Period|Other|3|||
156827756|NCT00747344|566121201|FG002|Controlled Period|Other|0|||
156827757|NCT00747344|566121202|FG003|Controlled Period|Other|0|||
156827758|NCT00747344|566121199|FG000|After Controlled Period|Adverse Event|0|||
156827759|NCT00747344|566121200|FG001|After Controlled Period|Adverse Event|0|||
156827760|NCT00747344|566121201|FG002|After Controlled Period|Adverse Event|0|||
156827761|NCT00747344|566121202|FG003|After Controlled Period|Adverse Event|1|||
156827762|NCT01484834|566121203|FG000|Overall Study|Lost to Follow-up|5|||
156827763|NCT01484834|566121204|FG001|Overall Study|Lost to Follow-up|8|||
156827764|NCT01484834|566121205|FG002|Overall Study|Lost to Follow-up|1|||
156827765|NCT01484834|566121206|FG003|Overall Study|Lost to Follow-up|4|||
156827766|NCT02460783|566121207|FG000|Overall Study|Withdrawal by Subject|1|||
156827767|NCT02460783|566121208|FG001|Overall Study|Withdrawal by Subject|3|||
156827768|NCT02460783|566121207|FG000|Overall Study|Lost to Follow-up|1|||
156827769|NCT02460783|566121208|FG001|Overall Study|Lost to Follow-up|1|||
156827770|NCT02182440|566121213|FG000|Overall Study|Adverse Event|0|||
156827771|NCT02182440|566121214|FG001|Overall Study|Adverse Event|1|||
156827772|NCT02182440|566121215|FG002|Overall Study|Adverse Event|0|||
156827773|NCT02182440|566121216|FG003|Overall Study|Adverse Event|0|||
156827774|NCT02182440|566121213|FG000|Overall Study|Death|31|||
156827775|NCT02182440|566121214|FG001|Overall Study|Death|8|||
156827776|NCT02182440|566121215|FG002|Overall Study|Death|5|||
156827777|NCT02182440|566121216|FG003|Overall Study|Death|16|||
156827778|NCT02182440|566121213|FG000|Overall Study|Protocol Violation|0|||
156827779|NCT02182440|566121214|FG001|Overall Study|Protocol Violation|1|||
156827780|NCT02182440|566121215|FG002|Overall Study|Protocol Violation|0|||
156827781|NCT02182440|566121216|FG003|Overall Study|Protocol Violation|0|||
156827782|NCT02182440|566121213|FG000|Overall Study|Physician Decision|1|||
156827783|NCT02182440|566121214|FG001|Overall Study|Physician Decision|0|||
156827784|NCT02182440|566121215|FG002|Overall Study|Physician Decision|0|||
156827785|NCT02182440|566121216|FG003|Overall Study|Physician Decision|0|||
156827786|NCT02182440|566121213|FG000|Overall Study|Withdrawal by Subject|1|||
156827787|NCT02182440|566121214|FG001|Overall Study|Withdrawal by Subject|1|||
156827788|NCT02182440|566121215|FG002|Overall Study|Withdrawal by Subject|3|||
156827789|NCT02182440|566121216|FG003|Overall Study|Withdrawal by Subject|4|||
156827790|NCT02182440|566121213|FG000|Overall Study|different, e.g adm other hospital|12|||
156827791|NCT02182440|566121214|FG001|Overall Study|different, e.g adm other hospital|3|||
156827792|NCT02182440|566121215|FG002|Overall Study|different, e.g adm other hospital|3|||
156827793|NCT02182440|566121216|FG003|Overall Study|different, e.g adm other hospital|10|||
156827794|NCT00072293|566121219|FG000|Overall Study|Lost to Follow-up|1|||
156827795|NCT00072293|566121220|FG001|Overall Study|Lost to Follow-up|1|||
156827796|NCT00072293|566121219|FG000|Overall Study|Withdrawal by Subject|0|||
156827797|NCT00072293|566121220|FG001|Overall Study|Withdrawal by Subject|1|||
156827798|NCT03754582|566121221|FG000|Treatment Phase|Adverse Event|0|||
156827799|NCT03754582|566121222|FG001|Treatment Phase|Adverse Event|1|||
156827800|NCT03754582|566121223|FG002|Treatment Phase|Adverse Event|0|||
156827801|NCT03754582|566121221|FG000|Follow-up Phase|Other|0|||
156827802|NCT03754582|566121222|FG001|Follow-up Phase|Other|0|||
156827803|NCT03754582|566121223|FG002|Follow-up Phase|Other|1|||
156827804|NCT01561755|566121224|FG000|Overall Study|Lost to Follow-up|0|||
156827805|NCT01561755|566121225|FG001|Overall Study|Lost to Follow-up|1|||
156827806|NCT02826421|566121228|FG000|Overall Study|Adverse Event|1|||
156827807|NCT02826421|566121229|FG001|Overall Study|Adverse Event|0|||
156827808|NCT02826421|566121230|FG002|Overall Study|Adverse Event|0|||
156827809|NCT02826421|566121231|FG003|Overall Study|Adverse Event|1|||
156827810|NCT02826421|566121228|FG000|Overall Study|Withdrawal by Subject|1|||
156827811|NCT02826421|566121229|FG001|Overall Study|Withdrawal by Subject|3|||
156827812|NCT02826421|566121230|FG002|Overall Study|Withdrawal by Subject|1|||
156827813|NCT02826421|566121231|FG003|Overall Study|Withdrawal by Subject|1|||
156827814|NCT02826421|566121228|FG000|Overall Study|Reason not given|1|||
156827815|NCT02826421|566121229|FG001|Overall Study|Reason not given|0|||
156827816|NCT02826421|566121230|FG002|Overall Study|Reason not given|1|||
156827817|NCT02826421|566121231|FG003|Overall Study|Reason not given|0|||
156827818|NCT02210221|566121234|FG000|Overall Study|Lack of Efficacy|7|||
156827819|NCT02210221|566121234|FG000|Overall Study|Withdrawal by Subject|43|||
156827820|NCT00405964|566121237|FG000|Overall Study|Treatment Failure|17|||
156827821|NCT00405964|566121238|FG001|Overall Study|Treatment Failure|45|||
156827822|NCT00405964|566121237|FG000|Overall Study|Adverse Event|7|||
156827823|NCT00405964|566121238|FG001|Overall Study|Adverse Event|16|||
156827824|NCT00405964|566121237|FG000|Overall Study|Lost to Follow-up|5|||
156827825|NCT00405964|566121238|FG001|Overall Study|Lost to Follow-up|5|||
156827826|NCT00405964|566121237|FG000|Overall Study|Withdrawal by Subject|19|||
156827827|NCT00405964|566121238|FG001|Overall Study|Withdrawal by Subject|23|||
156827828|NCT00405964|566121237|FG000|Overall Study|Protocol Violation|11|||
156827829|NCT00405964|566121238|FG001|Overall Study|Protocol Violation|6|||
156827830|NCT02981407|566121239|FG000|Overall Study|Withdrawal by Subject|2|||
156827831|NCT02981407|566121240|FG001|Overall Study|Withdrawal by Subject|0|||
157151158|NCT05270694|567299600|FG000|Overall Study|Withdrawal by Subject|3|||
157151159|NCT00128206|567299610|FG000|Overall Study|Lost to Follow-up|137|||
157151160|NCT00128206|567299611|FG001|Overall Study|Lost to Follow-up|118|||
156827832|NCT02818036|566121246|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
156827833|NCT02818036|566121247|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
156827834|NCT02818036|566121246|FG000|Overall Study|Withdrawal by Subject|1|||
156827835|NCT02818036|566121247|FG001|Overall Study|Withdrawal by Subject|0|||
156827836|NCT01319721|566121250|FG000|Overall Study|Lost to Follow-up|1|||
156827837|NCT01319721|566121251|FG001|Overall Study|Lost to Follow-up|6|||
156827838|NCT03515941|566121254|FG000|Overall Study|Adverse Event|1|||
157151161|NCT00128206|567299610|FG000|Overall Study|Adverse Event|0|||
157151162|NCT00128206|567299611|FG001|Overall Study|Adverse Event|2|||
156827839|NCT03515941|566121255|FG001|Overall Study|Adverse Event|0|||
156827840|NCT00468845|566121256|FG000|Overall Study|Adverse Event|9|||
156827841|NCT00468845|566121257|FG001|Overall Study|Adverse Event|14|||
156827842|NCT00468845|566121258|FG002|Overall Study|Adverse Event|11|||
156827843|NCT00468845|566121256|FG000|Overall Study|Lost to Follow-up|2|||
156827844|NCT00468845|566121257|FG001|Overall Study|Lost to Follow-up|1|||
156827845|NCT00468845|566121258|FG002|Overall Study|Lost to Follow-up|2|||
156827846|NCT00468845|566121256|FG000|Overall Study|Other|4|||
156827847|NCT00468845|566121257|FG001|Overall Study|Other|9|||
156827848|NCT00468845|566121258|FG002|Overall Study|Other|5|||
156827849|NCT00468845|566121256|FG000|Overall Study|No longer willing to participate|5|||
156827850|NCT00468845|566121257|FG001|Overall Study|No longer willing to participate|6|||
156827851|NCT00468845|566121258|FG002|Overall Study|No longer willing to participate|10|||
156827852|NCT00468845|566121256|FG000|Overall Study|Randomized, not treated|1|||
156827853|NCT00468845|566121257|FG001|Overall Study|Randomized, not treated|4|||
156827854|NCT00468845|566121258|FG002|Overall Study|Randomized, not treated|2|||
156827855|NCT04030247|566122904|FG000|Overall Study|Withdrawal by Subject|4|||
156827856|NCT04030247|566122904|FG000|Overall Study|Lost to Follow-up|13|||
156827857|NCT05320393|566122905|FG000|Overall Study|Withdrawal by Subject|1|||
156827858|NCT05320393|566122906|FG001|Overall Study|Withdrawal by Subject|0|||
156827859|NCT05320393|566122907|FG002|Overall Study|Withdrawal by Subject|2|||
156827860|NCT05320393|566122905|FG000|Overall Study|Lost to Follow-up|1|||
156827861|NCT05320393|566122906|FG001|Overall Study|Lost to Follow-up|2|||
156827862|NCT05320393|566122907|FG002|Overall Study|Lost to Follow-up|1|||
156827863|NCT05320393|566122905|FG000|Overall Study|Moved; too much driving|0|||
156827864|NCT05320393|566122906|FG001|Overall Study|Moved; too much driving|0|||
156827865|NCT05320393|566122907|FG002|Overall Study|Moved; too much driving|2|||
156827866|NCT05320393|566122905|FG000|Overall Study|Did not receive treatment|0|||
156827867|NCT05320393|566122906|FG001|Overall Study|Did not receive treatment|0|||
156827868|NCT05320393|566122907|FG002|Overall Study|Did not receive treatment|1|||
156827869|NCT03559699|566122908|FG000|Overall Study|Withdrawal by Subject|6|||
156827870|NCT03559699|566122908|FG000|Overall Study|Lost to Follow-up|1|||
156827871|NCT00031460|566122909|FG000|Overall Study|Lost to Follow-up|0|||
156827872|NCT00031460|566122910|FG001|Overall Study|Lost to Follow-up|1|||
156827873|NCT00031460|566122909|FG000|Overall Study|Withdrawal by Subject|1|||
156827874|NCT00031460|566122910|FG001|Overall Study|Withdrawal by Subject|1|||
156827875|NCT00031460|566122909|FG000|Overall Study|Non-Compliant|1|||
156827876|NCT00031460|566122910|FG001|Overall Study|Non-Compliant|1|||
156827877|NCT00031460|566122909|FG000|Overall Study|Death|0|||
156827878|NCT00031460|566122910|FG001|Overall Study|Death|1|||
156827879|NCT00031460|566122909|FG000|Overall Study|Reactivation of Disease|5|||
156827880|NCT00031460|566122910|FG001|Overall Study|Reactivation of Disease|9|||
156827881|NCT00031460|566122909|FG000|Overall Study|Disruption of blinded drug supply|2|||
156827882|NCT00031460|566122910|FG001|Overall Study|Disruption of blinded drug supply|0|||
156827883|NCT00031460|566122909|FG000|Overall Study|Confirmed unevaluable|0|||
156827884|NCT00031460|566122910|FG001|Overall Study|Confirmed unevaluable|1|||
156827885|NCT02838901|566122916|FG000|Overall Study|Withdrawal by Subject|1|||
156827886|NCT02838901|566122917|FG001|Overall Study|Withdrawal by Subject|1|||
156827887|NCT02838901|566122916|FG000|Overall Study|Lost to Follow-up|1|||
156827888|NCT02838901|566122917|FG001|Overall Study|Lost to Follow-up|1|||
156827889|NCT01007123|566122918|FG000|Overall Study|Adverse Event|3|||
156827890|NCT01007123|566122919|FG001|Overall Study|Adverse Event|4|||
156827891|NCT01007123|566122920|FG002|Overall Study|Adverse Event|7|||
156827892|NCT01007123|566122921|FG003|Overall Study|Adverse Event|1|||
156827893|NCT01007123|566122918|FG000|Overall Study|Lack of Efficacy|1|||
156827894|NCT01007123|566122919|FG001|Overall Study|Lack of Efficacy|0|||
156827895|NCT01007123|566122920|FG002|Overall Study|Lack of Efficacy|1|||
156827896|NCT01007123|566122921|FG003|Overall Study|Lack of Efficacy|4|||
156827897|NCT01007123|566122918|FG000|Overall Study|Protocol Violation|1|||
156827898|NCT01007123|566122919|FG001|Overall Study|Protocol Violation|1|||
156827899|NCT01007123|566122920|FG002|Overall Study|Protocol Violation|2|||
156827900|NCT01007123|566122921|FG003|Overall Study|Protocol Violation|1|||
156827901|NCT01007123|566122918|FG000|Overall Study|Withdrawal by Subject|1|||
156827902|NCT01007123|566122919|FG001|Overall Study|Withdrawal by Subject|0|||
156827903|NCT01007123|566122920|FG002|Overall Study|Withdrawal by Subject|1|||
156827904|NCT01007123|566122921|FG003|Overall Study|Withdrawal by Subject|0|||
156827905|NCT01007123|566122918|FG000|Overall Study|Lost to Follow-up|0|||
156827906|NCT01007123|566122919|FG001|Overall Study|Lost to Follow-up|1|||
156827907|NCT01007123|566122920|FG002|Overall Study|Lost to Follow-up|0|||
156827908|NCT01007123|566122921|FG003|Overall Study|Lost to Follow-up|0|||
156827909|NCT01777542|566122924|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
156827910|NCT01777542|566122925|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
157151163|NCT03032068|567299620|FG000|Overall Study|Adverse Event|1|||
156827911|NCT05605691|566122928|FG000|Overall Study|Lost to Follow-up|1|||
156827912|NCT02279719|566122929|FG000|Overall Study|Patients randomized but never treated|0|||
156827913|NCT02279719|566122930|FG001|Overall Study|Patients randomized but never treated|0|||
156827914|NCT02279719|566122931|FG002|Overall Study|Patients randomized but never treated|0|||
156884904|NCT02788279|566336401|FG001|Overall Study|Death|136|||
156827915|NCT02279719|566122932|FG003|Overall Study|Patients randomized but never treated|0|||
156827916|NCT02279719|566122933|FG004|Overall Study|Patients randomized but never treated|3|||
156827917|NCT02279719|566122934|FG005|Overall Study|Patients randomized but never treated|0|||
156827918|NCT02279719|566122935|FG006|Overall Study|Patients randomized but never treated|3|||
156827919|NCT04706273|566122936|FG000|Overall Study|Withdrawal by Subject|27|||
156827920|NCT04706273|566122936|FG000|Overall Study|Physician Decision|1|||
156827921|NCT04706273|566122936|FG000|Overall Study|Lost to Follow-up|42|||
156827922|NCT04706273|566122936|FG000|Overall Study|Death|85|||
156827923|NCT04706273|566122936|FG000|Overall Study|Amputation that removes study device|2|||
156827924|NCT04706273|566122936|FG000|Overall Study|Surgical bypass|3|||
156827925|NCT04706273|566122936|FG000|Overall Study|Changing hospital|23|||
156827926|NCT04706273|566122936|FG000|Overall Study|Unable to attend hospital|2|||
156827927|NCT00869050|566122939|FG000|Overall Study|Screen Failure|3|||
156827928|NCT03199053|566122942|FG000|ST Period|Withdrawal by Subject|2|||
156827929|NCT03199053|566122943|FG001|ST Period|Withdrawal by Subject|4|||
156827930|NCT03199053|566122944|FG002|ST Period|Withdrawal by Subject|6|||
156827931|NCT03199053|566122942|FG000|ST Period|Withdrawal by parent/guardian|1|||
156827932|NCT03199053|566122943|FG001|ST Period|Withdrawal by parent/guardian|1|||
156827933|NCT03199053|566122944|FG002|ST Period|Withdrawal by parent/guardian|1|||
156827934|NCT03199053|566122942|FG000|ST Period|Lost to Follow-up|2|||
156827935|NCT03199053|566122943|FG001|ST Period|Lost to Follow-up|0|||
156827936|NCT03199053|566122944|FG002|ST Period|Lost to Follow-up|1|||
156827937|NCT03199053|566122942|FG000|LT Period|Withdrawal by Subject|1|||
156827938|NCT03199053|566122943|FG001|LT Period|Withdrawal by Subject|3|||
156827939|NCT03199053|566122944|FG002|LT Period|Withdrawal by Subject|3|||
156827940|NCT03199053|566122942|FG000|LT Period|Withdrawal by parent/guardian|0|||
156827941|NCT03199053|566122943|FG001|LT Period|Withdrawal by parent/guardian|0|||
156827942|NCT03199053|566122944|FG002|LT Period|Withdrawal by parent/guardian|1|||
156827943|NCT03199053|566122942|FG000|LT Period|Lost to Follow-up|0|||
156827944|NCT03199053|566122943|FG001|LT Period|Lost to Follow-up|1|||
156827945|NCT03199053|566122944|FG002|LT Period|Lost to Follow-up|1|||
156827946|NCT03199053|566122942|FG000|LT Period|Miscellaneous|0|||
156827947|NCT03199053|566122943|FG001|LT Period|Miscellaneous|0|||
156827948|NCT03199053|566122944|FG002|LT Period|Miscellaneous|2|||
156827949|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
156827950|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
156827951|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
156827952|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
156827953|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
156827954|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
156827955|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
156827956|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
156827957|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
156827958|NCT03199053|566122942|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
156827959|NCT03199053|566122943|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
156827960|NCT03199053|566122944|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
156827961|NCT00759356|566122945|FG000|Overall Study|Adverse Event|0|||
156827962|NCT00759356|566122946|FG001|Overall Study|Adverse Event|1|||
156827963|NCT00759356|566122945|FG000|Overall Study|Withdrawal by Subject|0|||
156827964|NCT00759356|566122946|FG001|Overall Study|Withdrawal by Subject|2|||
156827965|NCT00759356|566122945|FG000|Overall Study|Subject was unable to return|1|||
156827966|NCT00759356|566122946|FG001|Overall Study|Subject was unable to return|0|||
156827967|NCT03298984|566122951|FG000|Overall Study|Physician Decision|1|||
156827968|NCT03298984|566122952|FG001|Overall Study|Physician Decision|0|||
156827969|NCT03298984|566122953|FG002|Overall Study|Physician Decision|0|||
156827970|NCT03298984|566122954|FG003|Overall Study|Physician Decision|6|||
156827971|NCT03298984|566122951|FG000|Overall Study|Lack of Efficacy|0|||
156827972|NCT03298984|566122952|FG001|Overall Study|Lack of Efficacy|1|||
156827973|NCT03298984|566122953|FG002|Overall Study|Lack of Efficacy|1|||
156827974|NCT03298984|566122954|FG003|Overall Study|Lack of Efficacy|4|||
156827975|NCT03298984|566122951|FG000|Overall Study|Relapsed disease (following remission)|0|||
156827976|NCT03298984|566122952|FG001|Overall Study|Relapsed disease (following remission)|0|||
156827977|NCT03298984|566122953|FG002|Overall Study|Relapsed disease (following remission)|1|||
156827978|NCT03298984|566122954|FG003|Overall Study|Relapsed disease (following remission)|1|||
156827979|NCT03298984|566122951|FG000|Overall Study|Adverse Event|0|||
156827980|NCT03298984|566122952|FG001|Overall Study|Adverse Event|0|||
156827981|NCT03298984|566122953|FG002|Overall Study|Adverse Event|0|||
156827982|NCT03298984|566122954|FG003|Overall Study|Adverse Event|1|||
156827983|NCT03298984|566122951|FG000|Overall Study|Death|0|||
156827984|NCT03298984|566122952|FG001|Overall Study|Death|0|||
156827985|NCT03298984|566122953|FG002|Overall Study|Death|0|||
156827986|NCT03298984|566122954|FG003|Overall Study|Death|2|||
156827987|NCT03298984|566122951|FG000|Overall Study|Insurance Company Decision|0|||
156827988|NCT03298984|566122952|FG001|Overall Study|Insurance Company Decision|0|||
156827989|NCT03298984|566122953|FG002|Overall Study|Insurance Company Decision|0|||
156827990|NCT03298984|566122954|FG003|Overall Study|Insurance Company Decision|1|||
156827991|NCT02509052|566122962|FG000|Overall Study|Non compliance|0|||
156827992|NCT02509052|566122963|FG001|Overall Study|Non compliance|0|||
156827993|NCT02509052|566122964|FG002|Overall Study|Non compliance|1|||
156827994|NCT00585221|566122965|FG000|Overall Study|Protocol Violation|8|||
156827995|NCT01323270|566122966|FG000|Overall Study|Withdrawal by Subject|19|||
156827996|NCT01323270|566122967|FG001|Overall Study|Withdrawal by Subject|10|||
156827997|NCT01323270|566122966|FG000|Overall Study|Protocol Violation|9|||
156827998|NCT01323270|566122967|FG001|Overall Study|Protocol Violation|7|||
156827999|NCT01323270|566122966|FG000|Overall Study|Lost to Follow-up|4|||
156828000|NCT01323270|566122967|FG001|Overall Study|Lost to Follow-up|6|||
156828001|NCT01323270|566122966|FG000|Overall Study|Adverse Event|8|||
156828002|NCT01323270|566122967|FG001|Overall Study|Adverse Event|0|||
156828003|NCT01323270|566122966|FG000|Overall Study|Other|0|||
156828004|NCT01323270|566122967|FG001|Overall Study|Other|3|||
156828005|NCT01323270|566122966|FG000|Overall Study|Physician Decision|0|||
156828006|NCT01323270|566122967|FG001|Overall Study|Physician Decision|2|||
156828007|NCT01323270|566122966|FG000|Overall Study|Not eligible|1|||
156828008|NCT01323270|566122967|FG001|Overall Study|Not eligible|1|||
156828009|NCT01323270|566122966|FG000|Overall Study|Death|1|||
156828010|NCT01323270|566122967|FG001|Overall Study|Death|0|||
156828011|NCT01323270|566122966|FG000|Overall Study|Randomized, but not vaccinated|1|||
156828012|NCT01323270|566122967|FG001|Overall Study|Randomized, but not vaccinated|0|||
156828013|NCT00075725|566122974|FG000|Overall Study|Adverse Event|6|||
156828014|NCT00075725|566122975|FG001|Overall Study|Adverse Event|6|||
156828015|NCT00075725|566122976|FG002|Overall Study|Adverse Event|20|||
156828016|NCT00075725|566122977|FG003|Overall Study|Adverse Event|8|||
156828017|NCT00075725|566122978|FG004|Overall Study|Adverse Event|4|||
156828018|NCT00075725|566122979|FG005|Overall Study|Adverse Event|38|||
156828019|NCT00075725|566122980|FG006|Overall Study|Adverse Event|3|||
156828020|NCT00075725|566122981|FG007|Overall Study|Adverse Event|51|||
156828021|NCT00075725|566122982|FG008|Overall Study|Adverse Event|15|||
156828022|NCT00075725|566122983|FG009|Overall Study|Adverse Event|4|||
156828023|NCT00075725|566122984|FG010|Overall Study|Adverse Event|2|||
156828024|NCT00075725|566122985|FG011|Overall Study|Adverse Event|2|||
156828025|NCT00075725|566122974|FG000|Overall Study|Death|3|||
156828026|NCT00075725|566122975|FG001|Overall Study|Death|5|||
156828027|NCT00075725|566122976|FG002|Overall Study|Death|10|||
156828028|NCT00075725|566122977|FG003|Overall Study|Death|2|||
156828029|NCT00075725|566122978|FG004|Overall Study|Death|3|||
156828030|NCT00075725|566122979|FG005|Overall Study|Death|25|||
156828031|NCT00075725|566122980|FG006|Overall Study|Death|4|||
156828032|NCT00075725|566122981|FG007|Overall Study|Death|22|||
156828033|NCT00075725|566122982|FG008|Overall Study|Death|14|||
156828034|NCT00075725|566122983|FG009|Overall Study|Death|4|||
156828035|NCT00075725|566122984|FG010|Overall Study|Death|3|||
156828036|NCT00075725|566122985|FG011|Overall Study|Death|0|||
156828037|NCT00075725|566122974|FG000|Overall Study|Lost to Follow-up|1|||
156828038|NCT00075725|566122975|FG001|Overall Study|Lost to Follow-up|1|||
156828039|NCT00075725|566122976|FG002|Overall Study|Lost to Follow-up|4|||
157022938|NCT04676022|566836924|FG001|Overall Study|Will not move forward with permanent implant|0|||
156828040|NCT00075725|566122977|FG003|Overall Study|Lost to Follow-up|1|||
156828041|NCT00075725|566122978|FG004|Overall Study|Lost to Follow-up|0|||
156828042|NCT00075725|566122979|FG005|Overall Study|Lost to Follow-up|13|||
156828043|NCT00075725|566122980|FG006|Overall Study|Lost to Follow-up|2|||
156828044|NCT00075725|566122981|FG007|Overall Study|Lost to Follow-up|4|||
156828045|NCT00075725|566122982|FG008|Overall Study|Lost to Follow-up|1|||
156828046|NCT00075725|566122983|FG009|Overall Study|Lost to Follow-up|0|||
156828047|NCT00075725|566122984|FG010|Overall Study|Lost to Follow-up|0|||
156828048|NCT00075725|566122985|FG011|Overall Study|Lost to Follow-up|0|||
156828049|NCT00075725|566122974|FG000|Overall Study|Physician Decision|2|||
156828050|NCT00075725|566122975|FG001|Overall Study|Physician Decision|6|||
156828051|NCT00075725|566122976|FG002|Overall Study|Physician Decision|5|||
156828052|NCT00075725|566122977|FG003|Overall Study|Physician Decision|8|||
156828053|NCT00075725|566122978|FG004|Overall Study|Physician Decision|4|||
156828054|NCT00075725|566122979|FG005|Overall Study|Physician Decision|19|||
156828055|NCT00075725|566122980|FG006|Overall Study|Physician Decision|3|||
156828056|NCT00075725|566122981|FG007|Overall Study|Physician Decision|17|||
156828057|NCT00075725|566122982|FG008|Overall Study|Physician Decision|5|||
156828058|NCT00075725|566122983|FG009|Overall Study|Physician Decision|0|||
156828059|NCT00075725|566122984|FG010|Overall Study|Physician Decision|1|||
156828060|NCT00075725|566122985|FG011|Overall Study|Physician Decision|0|||
156884905|NCT02788279|566336402|FG002|Overall Study|Death|72|||
157151164|NCT01597622|567299621|FG000|Overall Study|Adverse Event|7|||
156828061|NCT00075725|566122974|FG000|Overall Study|Pregnancy|0|||
156828062|NCT00075725|566122975|FG001|Overall Study|Pregnancy|0|||
156828063|NCT00075725|566122976|FG002|Overall Study|Pregnancy|0|||
156828064|NCT00075725|566122977|FG003|Overall Study|Pregnancy|0|||
156828065|NCT00075725|566122978|FG004|Overall Study|Pregnancy|0|||
156828066|NCT00075725|566122979|FG005|Overall Study|Pregnancy|1|||
156828067|NCT00075725|566122980|FG006|Overall Study|Pregnancy|0|||
156828068|NCT00075725|566122981|FG007|Overall Study|Pregnancy|1|||
156828069|NCT00075725|566122982|FG008|Overall Study|Pregnancy|0|||
156828070|NCT00075725|566122983|FG009|Overall Study|Pregnancy|0|||
156828071|NCT00075725|566122984|FG010|Overall Study|Pregnancy|0|||
156828072|NCT00075725|566122985|FG011|Overall Study|Pregnancy|0|||
156828073|NCT00075725|566122974|FG000|Overall Study|Protocol Violation|1|||
156828074|NCT00075725|566122975|FG001|Overall Study|Protocol Violation|1|||
156828075|NCT00075725|566122976|FG002|Overall Study|Protocol Violation|0|||
156828076|NCT00075725|566122977|FG003|Overall Study|Protocol Violation|3|||
156828077|NCT00075725|566122978|FG004|Overall Study|Protocol Violation|3|||
156828078|NCT00075725|566122979|FG005|Overall Study|Protocol Violation|2|||
156828079|NCT00075725|566122980|FG006|Overall Study|Protocol Violation|1|||
156828080|NCT00075725|566122981|FG007|Overall Study|Protocol Violation|2|||
156828081|NCT00075725|566122982|FG008|Overall Study|Protocol Violation|3|||
156828082|NCT00075725|566122983|FG009|Overall Study|Protocol Violation|0|||
156828083|NCT00075725|566122984|FG010|Overall Study|Protocol Violation|0|||
156828084|NCT00075725|566122985|FG011|Overall Study|Protocol Violation|1|||
156828085|NCT00075725|566122974|FG000|Overall Study|Withdrawal by Subject|12|||
156828086|NCT00075725|566122975|FG001|Overall Study|Withdrawal by Subject|3|||
156828087|NCT00075725|566122976|FG002|Overall Study|Withdrawal by Subject|6|||
156828088|NCT00075725|566122977|FG003|Overall Study|Withdrawal by Subject|10|||
156828089|NCT00075725|566122978|FG004|Overall Study|Withdrawal by Subject|6|||
156828090|NCT00075725|566122979|FG005|Overall Study|Withdrawal by Subject|27|||
156828091|NCT00075725|566122980|FG006|Overall Study|Withdrawal by Subject|7|||
156828092|NCT00075725|566122981|FG007|Overall Study|Withdrawal by Subject|31|||
156828093|NCT00075725|566122982|FG008|Overall Study|Withdrawal by Subject|10|||
156828094|NCT00075725|566122983|FG009|Overall Study|Withdrawal by Subject|2|||
156828095|NCT00075725|566122984|FG010|Overall Study|Withdrawal by Subject|0|||
156828096|NCT00075725|566122985|FG011|Overall Study|Withdrawal by Subject|0|||
156828097|NCT00075725|566122974|FG000|Overall Study|Disease Progression, all other reasons|17|||
156828098|NCT00075725|566122975|FG001|Overall Study|Disease Progression, all other reasons|5|||
156828099|NCT00075725|566122976|FG002|Overall Study|Disease Progression, all other reasons|33|||
156828100|NCT00075725|566122977|FG003|Overall Study|Disease Progression, all other reasons|6|||
156828101|NCT00075725|566122978|FG004|Overall Study|Disease Progression, all other reasons|21|||
156828102|NCT00075725|566122979|FG005|Overall Study|Disease Progression, all other reasons|59|||
156828103|NCT00075725|566122980|FG006|Overall Study|Disease Progression, all other reasons|20|||
156828104|NCT00075725|566122981|FG007|Overall Study|Disease Progression, all other reasons|46|||
156828105|NCT00075725|566122982|FG008|Overall Study|Disease Progression, all other reasons|21|||
156828106|NCT00075725|566122983|FG009|Overall Study|Disease Progression, all other reasons|4|||
156828107|NCT00075725|566122984|FG010|Overall Study|Disease Progression, all other reasons|0|||
156828108|NCT00075725|566122985|FG011|Overall Study|Disease Progression, all other reasons|5|||
156828109|NCT00075725|566122974|FG000|Overall Study|Patient off treatment|0|||
156828110|NCT00075725|566122975|FG001|Overall Study|Patient off treatment|0|||
156828111|NCT00075725|566122976|FG002|Overall Study|Patient off treatment|1|||
156828112|NCT00075725|566122977|FG003|Overall Study|Patient off treatment|2|||
156828113|NCT00075725|566122978|FG004|Overall Study|Patient off treatment|1|||
156828114|NCT00075725|566122979|FG005|Overall Study|Patient off treatment|0|||
156828115|NCT00075725|566122980|FG006|Overall Study|Patient off treatment|0|||
156828116|NCT00075725|566122981|FG007|Overall Study|Patient off treatment|2|||
156828117|NCT00075725|566122982|FG008|Overall Study|Patient off treatment|1|||
156828118|NCT00075725|566122983|FG009|Overall Study|Patient off treatment|0|||
156828119|NCT00075725|566122984|FG010|Overall Study|Patient off treatment|0|||
156828120|NCT00075725|566122985|FG011|Overall Study|Patient off treatment|0|||
156828121|NCT00075725|566122974|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
156828122|NCT00075725|566122975|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
156828123|NCT00075725|566122976|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
156828124|NCT00075725|566122977|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
156828125|NCT00075725|566122978|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
156828126|NCT00075725|566122979|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
156828127|NCT00075725|566122980|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
156828128|NCT00075725|566122981|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
156828129|NCT00075725|566122982|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
156828130|NCT00075725|566122983|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
156828131|NCT00075725|566122984|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
156828132|NCT00075725|566122985|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
156828133|NCT00075725|566122974|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
156828134|NCT00075725|566122975|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
156828135|NCT00075725|566122976|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
156828136|NCT00075725|566122977|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
156828137|NCT00075725|566122978|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
157151165|NCT01597622|567299621|FG000|Overall Study|Lack of Efficacy|3|||
157151166|NCT01597622|567299621|FG000|Overall Study|Protocol Violation|1|||
157151167|NCT01597622|567299621|FG000|Overall Study|Lost to Follow-up|1|||
157151168|NCT01597622|567299621|FG000|Overall Study|Investigator Discretion|5|||
157151169|NCT01597622|567299621|FG000|Overall Study|Withdrawal by Subject|20|||
157151170|NCT01597622|567299621|FG000|Overall Study|Death|1|||
156828138|NCT00075725|566122979|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
156828139|NCT00075725|566122980|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
156828140|NCT00075725|566122981|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
156828141|NCT00075725|566122982|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
156828142|NCT00075725|566122983|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
156828143|NCT00075725|566122984|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
156828144|NCT00075725|566122985|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
156828145|NCT00075725|566122974|FG000|Overall Study|Pt non compliant with therapy|2|||
156828146|NCT00075725|566122975|FG001|Overall Study|Pt non compliant with therapy|1|||
156828147|NCT00075725|566122976|FG002|Overall Study|Pt non compliant with therapy|1|||
156828148|NCT00075725|566122977|FG003|Overall Study|Pt non compliant with therapy|0|||
156828149|NCT00075725|566122978|FG004|Overall Study|Pt non compliant with therapy|2|||
156828150|NCT00075725|566122979|FG005|Overall Study|Pt non compliant with therapy|14|||
156828151|NCT00075725|566122980|FG006|Overall Study|Pt non compliant with therapy|2|||
156828152|NCT00075725|566122981|FG007|Overall Study|Pt non compliant with therapy|5|||
156828153|NCT00075725|566122982|FG008|Overall Study|Pt non compliant with therapy|3|||
156828154|NCT00075725|566122983|FG009|Overall Study|Pt non compliant with therapy|0|||
156828155|NCT00075725|566122984|FG010|Overall Study|Pt non compliant with therapy|0|||
156828156|NCT00075725|566122985|FG011|Overall Study|Pt non compliant with therapy|0|||
156828157|NCT00075725|566122974|FG000|Overall Study|Pt age out of range for treatment|0|||
156828158|NCT00075725|566122975|FG001|Overall Study|Pt age out of range for treatment|1|||
156828159|NCT00075725|566122976|FG002|Overall Study|Pt age out of range for treatment|0|||
156828160|NCT00075725|566122977|FG003|Overall Study|Pt age out of range for treatment|0|||
156828161|NCT00075725|566122978|FG004|Overall Study|Pt age out of range for treatment|0|||
156828162|NCT00075725|566122979|FG005|Overall Study|Pt age out of range for treatment|1|||
156828163|NCT00075725|566122980|FG006|Overall Study|Pt age out of range for treatment|0|||
156828164|NCT00075725|566122981|FG007|Overall Study|Pt age out of range for treatment|1|||
156828165|NCT00075725|566122982|FG008|Overall Study|Pt age out of range for treatment|0|||
156828166|NCT00075725|566122983|FG009|Overall Study|Pt age out of range for treatment|0|||
156828167|NCT00075725|566122984|FG010|Overall Study|Pt age out of range for treatment|0|||
156828168|NCT00075725|566122985|FG011|Overall Study|Pt age out of range for treatment|0|||
156828169|NCT00075725|566122974|FG000|Overall Study|Insurance issues|0|||
156828170|NCT00075725|566122975|FG001|Overall Study|Insurance issues|1|||
156828171|NCT00075725|566122976|FG002|Overall Study|Insurance issues|0|||
156828172|NCT00075725|566122977|FG003|Overall Study|Insurance issues|1|||
156828173|NCT00075725|566122978|FG004|Overall Study|Insurance issues|1|||
156828174|NCT00075725|566122979|FG005|Overall Study|Insurance issues|1|||
156828175|NCT00075725|566122980|FG006|Overall Study|Insurance issues|0|||
156828176|NCT00075725|566122981|FG007|Overall Study|Insurance issues|1|||
156828177|NCT00075725|566122982|FG008|Overall Study|Insurance issues|0|||
156828178|NCT00075725|566122983|FG009|Overall Study|Insurance issues|0|||
156828179|NCT00075725|566122984|FG010|Overall Study|Insurance issues|0|||
156828180|NCT00075725|566122985|FG011|Overall Study|Insurance issues|0|||
156828181|NCT00075725|566122974|FG000|Overall Study|MRD positive after extended ind|0|||
156828182|NCT00075725|566122975|FG001|Overall Study|MRD positive after extended ind|1|||
156828183|NCT00075725|566122976|FG002|Overall Study|MRD positive after extended ind|1|||
156828184|NCT00075725|566122977|FG003|Overall Study|MRD positive after extended ind|0|||
156828185|NCT00075725|566122978|FG004|Overall Study|MRD positive after extended ind|1|||
156828186|NCT00075725|566122979|FG005|Overall Study|MRD positive after extended ind|2|||
156828187|NCT00075725|566122980|FG006|Overall Study|MRD positive after extended ind|0|||
156828188|NCT00075725|566122981|FG007|Overall Study|MRD positive after extended ind|1|||
156828189|NCT00075725|566122982|FG008|Overall Study|MRD positive after extended ind|0|||
156828190|NCT00075725|566122983|FG009|Overall Study|MRD positive after extended ind|0|||
156828191|NCT00075725|566122984|FG010|Overall Study|MRD positive after extended ind|0|||
156828192|NCT00075725|566122985|FG011|Overall Study|MRD positive after extended ind|0|||
156828193|NCT00075725|566122974|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
156828194|NCT00075725|566122975|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
156828195|NCT00075725|566122976|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
156828196|NCT00075725|566122977|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
156828197|NCT00075725|566122978|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
156884906|NCT02788279|566336400|FG000|Overall Study|Withdrawal by Subject|10|||
156884907|NCT02788279|566336401|FG001|Overall Study|Withdrawal by Subject|15|||
156884908|NCT02788279|566336402|FG002|Overall Study|Withdrawal by Subject|5|||
157151171|NCT00408421|567299622|FG000|Treatment Initial Randomization|Adverse Event|5|||
156828198|NCT00075725|566122979|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
156828199|NCT00075725|566122980|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
156828200|NCT00075725|566122981|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
156828201|NCT00075725|566122982|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
156828202|NCT00075725|566122983|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
156884909|NCT02788279|566336400|FG000|Overall Study|Lost to Follow-up|0|||
156884910|NCT02788279|566336401|FG001|Overall Study|Lost to Follow-up|3|||
156828203|NCT00075725|566122984|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
156828204|NCT00075725|566122985|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
156828205|NCT00075725|566122974|FG000|Overall Study|Inevaluable|1|||
156828206|NCT00075725|566122975|FG001|Overall Study|Inevaluable|1|||
156828207|NCT00075725|566122976|FG002|Overall Study|Inevaluable|4|||
156828208|NCT00075725|566122977|FG003|Overall Study|Inevaluable|2|||
156828209|NCT00075725|566122978|FG004|Overall Study|Inevaluable|2|||
156828210|NCT00075725|566122979|FG005|Overall Study|Inevaluable|9|||
156828211|NCT00075725|566122980|FG006|Overall Study|Inevaluable|1|||
156828212|NCT00075725|566122981|FG007|Overall Study|Inevaluable|11|||
156828213|NCT00075725|566122982|FG008|Overall Study|Inevaluable|2|||
156828214|NCT00075725|566122983|FG009|Overall Study|Inevaluable|0|||
156828215|NCT00075725|566122984|FG010|Overall Study|Inevaluable|1|||
156828216|NCT00075725|566122985|FG011|Overall Study|Inevaluable|0|||
156828217|NCT00075725|566122974|FG000|Overall Study|Other|4|||
156828218|NCT00075725|566122975|FG001|Overall Study|Other|2|||
156828219|NCT00075725|566122976|FG002|Overall Study|Other|1|||
156828220|NCT00075725|566122977|FG003|Overall Study|Other|1|||
156828221|NCT00075725|566122978|FG004|Overall Study|Other|1|||
156828222|NCT00075725|566122979|FG005|Overall Study|Other|4|||
156828223|NCT00075725|566122980|FG006|Overall Study|Other|2|||
156828224|NCT00075725|566122981|FG007|Overall Study|Other|9|||
156828225|NCT00075725|566122982|FG008|Overall Study|Other|2|||
156828226|NCT00075725|566122983|FG009|Overall Study|Other|1|||
156828227|NCT00075725|566122984|FG010|Overall Study|Other|0|||
156828228|NCT00075725|566122985|FG011|Overall Study|Other|3|||
156828229|NCT00075725|566122974|FG000|Overall Study|Pt trying to find a BM donor|0|||
156828230|NCT00075725|566122975|FG001|Overall Study|Pt trying to find a BM donor|1|||
156828231|NCT00075725|566122976|FG002|Overall Study|Pt trying to find a BM donor|0|||
156828232|NCT00075725|566122977|FG003|Overall Study|Pt trying to find a BM donor|0|||
156828233|NCT00075725|566122978|FG004|Overall Study|Pt trying to find a BM donor|0|||
156828234|NCT00075725|566122979|FG005|Overall Study|Pt trying to find a BM donor|0|||
156828235|NCT00075725|566122980|FG006|Overall Study|Pt trying to find a BM donor|0|||
156828236|NCT00075725|566122981|FG007|Overall Study|Pt trying to find a BM donor|0|||
156828237|NCT00075725|566122982|FG008|Overall Study|Pt trying to find a BM donor|0|||
156828238|NCT00075725|566122983|FG009|Overall Study|Pt trying to find a BM donor|0|||
156828239|NCT00075725|566122984|FG010|Overall Study|Pt trying to find a BM donor|0|||
156828240|NCT00075725|566122985|FG011|Overall Study|Pt trying to find a BM donor|0|||
156828241|NCT00075725|566122974|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
156828242|NCT00075725|566122975|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
156828243|NCT00075725|566122976|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
156828244|NCT00075725|566122977|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
156828245|NCT00075725|566122978|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
156828246|NCT00075725|566122979|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
156828247|NCT00075725|566122980|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
156828248|NCT00075725|566122981|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
156828249|NCT00075725|566122982|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
156828250|NCT00075725|566122983|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
156828251|NCT00075725|566122984|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
156828252|NCT00075725|566122985|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
156828253|NCT00075725|566122974|FG000|Overall Study|Unsuccessful institutional transfer|0|||
156828254|NCT00075725|566122975|FG001|Overall Study|Unsuccessful institutional transfer|0|||
156828255|NCT00075725|566122976|FG002|Overall Study|Unsuccessful institutional transfer|2|||
156828256|NCT00075725|566122977|FG003|Overall Study|Unsuccessful institutional transfer|0|||
156828257|NCT00075725|566122978|FG004|Overall Study|Unsuccessful institutional transfer|0|||
156828258|NCT00075725|566122979|FG005|Overall Study|Unsuccessful institutional transfer|0|||
156828259|NCT00075725|566122980|FG006|Overall Study|Unsuccessful institutional transfer|0|||
156828260|NCT00075725|566122981|FG007|Overall Study|Unsuccessful institutional transfer|0|||
156828261|NCT00075725|566122982|FG008|Overall Study|Unsuccessful institutional transfer|0|||
157022939|NCT04676022|566836925|FG002|Overall Study|Will not move forward with permanent implant|0|||
156828262|NCT00075725|566122983|FG009|Overall Study|Unsuccessful institutional transfer|1|||
156828263|NCT00075725|566122984|FG010|Overall Study|Unsuccessful institutional transfer|0|||
156828264|NCT00075725|566122985|FG011|Overall Study|Unsuccessful institutional transfer|0|||
156828265|NCT00075725|566122974|FG000|Overall Study|specimen(s) not submitted|0|||
156828266|NCT00075725|566122975|FG001|Overall Study|specimen(s) not submitted|0|||
156828267|NCT00075725|566122976|FG002|Overall Study|specimen(s) not submitted|2|||
156828268|NCT00075725|566122977|FG003|Overall Study|specimen(s) not submitted|0|||
156828269|NCT00075725|566122978|FG004|Overall Study|specimen(s) not submitted|0|||
156828270|NCT00075725|566122979|FG005|Overall Study|specimen(s) not submitted|0|||
156828271|NCT00075725|566122980|FG006|Overall Study|specimen(s) not submitted|0|||
156828272|NCT00075725|566122981|FG007|Overall Study|specimen(s) not submitted|0|||
156828273|NCT00075725|566122982|FG008|Overall Study|specimen(s) not submitted|0|||
156828274|NCT00075725|566122983|FG009|Overall Study|specimen(s) not submitted|0|||
156828275|NCT00075725|566122984|FG010|Overall Study|specimen(s) not submitted|0|||
156828276|NCT00075725|566122985|FG011|Overall Study|specimen(s) not submitted|0|||
156828277|NCT00075725|566122974|FG000|Overall Study|Pt went to transplant|0|||
156828278|NCT00075725|566122975|FG001|Overall Study|Pt went to transplant|0|||
156828279|NCT00075725|566122976|FG002|Overall Study|Pt went to transplant|0|||
156828280|NCT00075725|566122977|FG003|Overall Study|Pt went to transplant|1|||
156828281|NCT00075725|566122978|FG004|Overall Study|Pt went to transplant|0|||
156828282|NCT00075725|566122979|FG005|Overall Study|Pt went to transplant|1|||
156828283|NCT00075725|566122980|FG006|Overall Study|Pt went to transplant|0|||
156828284|NCT00075725|566122981|FG007|Overall Study|Pt went to transplant|0|||
156828285|NCT00075725|566122982|FG008|Overall Study|Pt went to transplant|0|||
156828286|NCT00075725|566122983|FG009|Overall Study|Pt went to transplant|0|||
156828287|NCT00075725|566122984|FG010|Overall Study|Pt went to transplant|0|||
156828288|NCT00075725|566122985|FG011|Overall Study|Pt went to transplant|0|||
156828289|NCT00075725|566122974|FG000|Overall Study|Pt received additional steroids|0|||
156828290|NCT00075725|566122975|FG001|Overall Study|Pt received additional steroids|0|||
156828291|NCT00075725|566122976|FG002|Overall Study|Pt received additional steroids|0|||
156828292|NCT00075725|566122977|FG003|Overall Study|Pt received additional steroids|1|||
156828293|NCT00075725|566122978|FG004|Overall Study|Pt received additional steroids|0|||
156828294|NCT00075725|566122979|FG005|Overall Study|Pt received additional steroids|0|||
156828295|NCT00075725|566122980|FG006|Overall Study|Pt received additional steroids|0|||
156828296|NCT00075725|566122981|FG007|Overall Study|Pt received additional steroids|0|||
156828297|NCT00075725|566122982|FG008|Overall Study|Pt received additional steroids|0|||
156828298|NCT00075725|566122983|FG009|Overall Study|Pt received additional steroids|0|||
156828299|NCT00075725|566122984|FG010|Overall Study|Pt received additional steroids|0|||
156828300|NCT00075725|566122985|FG011|Overall Study|Pt received additional steroids|0|||
156828301|NCT00075725|566122974|FG000|Overall Study|Pt relocated|0|||
156828302|NCT00075725|566122975|FG001|Overall Study|Pt relocated|0|||
156828303|NCT00075725|566122976|FG002|Overall Study|Pt relocated|0|||
156828304|NCT00075725|566122977|FG003|Overall Study|Pt relocated|2|||
156828305|NCT00075725|566122978|FG004|Overall Study|Pt relocated|0|||
156828306|NCT00075725|566122979|FG005|Overall Study|Pt relocated|1|||
156828307|NCT00075725|566122980|FG006|Overall Study|Pt relocated|1|||
156828308|NCT00075725|566122981|FG007|Overall Study|Pt relocated|2|||
156828309|NCT00075725|566122982|FG008|Overall Study|Pt relocated|1|||
156828310|NCT00075725|566122983|FG009|Overall Study|Pt relocated|0|||
156828311|NCT00075725|566122984|FG010|Overall Study|Pt relocated|0|||
156828312|NCT00075725|566122985|FG011|Overall Study|Pt relocated|0|||
156828313|NCT00075725|566122974|FG000|Overall Study|Institution Terminated|0|||
156828314|NCT00075725|566122975|FG001|Overall Study|Institution Terminated|0|||
156828315|NCT00075725|566122976|FG002|Overall Study|Institution Terminated|0|||
156828316|NCT00075725|566122977|FG003|Overall Study|Institution Terminated|0|||
156828317|NCT00075725|566122978|FG004|Overall Study|Institution Terminated|1|||
156828318|NCT00075725|566122979|FG005|Overall Study|Institution Terminated|0|||
156828319|NCT00075725|566122980|FG006|Overall Study|Institution Terminated|0|||
156828320|NCT00075725|566122981|FG007|Overall Study|Institution Terminated|3|||
156828321|NCT00075725|566122982|FG008|Overall Study|Institution Terminated|0|||
156828322|NCT00075725|566122983|FG009|Overall Study|Institution Terminated|0|||
156828323|NCT00075725|566122984|FG010|Overall Study|Institution Terminated|0|||
156828324|NCT00075725|566122985|FG011|Overall Study|Institution Terminated|0|||
156828325|NCT00075725|566122974|FG000|Overall Study|Study Closure|1|||
156828326|NCT00075725|566122975|FG001|Overall Study|Study Closure|0|||
156828327|NCT00075725|566122976|FG002|Overall Study|Study Closure|0|||
156828328|NCT00075725|566122977|FG003|Overall Study|Study Closure|0|||
156828329|NCT00075725|566122978|FG004|Overall Study|Study Closure|1|||
156828330|NCT00075725|566122979|FG005|Overall Study|Study Closure|3|||
156828331|NCT00075725|566122980|FG006|Overall Study|Study Closure|0|||
156828332|NCT00075725|566122981|FG007|Overall Study|Study Closure|1|||
156828333|NCT00075725|566122982|FG008|Overall Study|Study Closure|0|||
156828334|NCT00075725|566122983|FG009|Overall Study|Study Closure|0|||
156828335|NCT00075725|566122984|FG010|Overall Study|Study Closure|0|||
156828336|NCT00075725|566122985|FG011|Overall Study|Study Closure|0|||
156828337|NCT00075725|566122974|FG000|Overall Study|Other complications|0|||
156828338|NCT00075725|566122975|FG001|Overall Study|Other complications|0|||
156828339|NCT00075725|566122976|FG002|Overall Study|Other complications|0|||
156828340|NCT00075725|566122977|FG003|Overall Study|Other complications|0|||
156828341|NCT00075725|566122978|FG004|Overall Study|Other complications|0|||
156828342|NCT00075725|566122979|FG005|Overall Study|Other complications|1|||
156828343|NCT00075725|566122980|FG006|Overall Study|Other complications|0|||
156828344|NCT00075725|566122981|FG007|Overall Study|Other complications|0|||
156828345|NCT00075725|566122982|FG008|Overall Study|Other complications|0|||
156828346|NCT00075725|566122983|FG009|Overall Study|Other complications|0|||
156828347|NCT00075725|566122984|FG010|Overall Study|Other complications|0|||
156828348|NCT00075725|566122985|FG011|Overall Study|Other complications|0|||
156828349|NCT00075725|566122974|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
156828350|NCT00075725|566122975|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
156828351|NCT00075725|566122976|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
156884911|NCT02788279|566336402|FG002|Overall Study|Lost to Follow-up|2|||
156884912|NCT02788279|566336400|FG000|Overall Study|Sponsor decision|18|||
156884913|NCT02788279|566336401|FG001|Overall Study|Sponsor decision|29|||
156884914|NCT02788279|566336402|FG002|Overall Study|Sponsor decision|11|||
156884915|NCT02683746|566336404|FG000|Overall Study|Adverse Event|3|||
156884916|NCT02683746|566336405|FG001|Overall Study|Adverse Event|2|||
156884917|NCT02683746|566336404|FG000|Overall Study|Lost to Follow-up|5|||
156884918|NCT02683746|566336405|FG001|Overall Study|Lost to Follow-up|6|||
156884919|NCT02683746|566336404|FG000|Overall Study|Withdrawal by Subject|6|||
156884920|NCT02683746|566336405|FG001|Overall Study|Withdrawal by Subject|5|||
156828352|NCT00075725|566122977|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
157151172|NCT00408421|567299623|FG001|Treatment Initial Randomization|Adverse Event|9|||
156828353|NCT00075725|566122978|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
156828354|NCT00075725|566122979|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
156828355|NCT00075725|566122980|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
156828356|NCT00075725|566122981|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
156828357|NCT00075725|566122982|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
156828358|NCT00075725|566122983|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
156828359|NCT00075725|566122984|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
156828360|NCT00075725|566122985|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
156828361|NCT00075725|566122974|FG000|Overall Study|Pt incarcerated|0|||
156828362|NCT00075725|566122975|FG001|Overall Study|Pt incarcerated|0|||
156828363|NCT00075725|566122976|FG002|Overall Study|Pt incarcerated|0|||
156828364|NCT00075725|566122977|FG003|Overall Study|Pt incarcerated|0|||
156828365|NCT00075725|566122978|FG004|Overall Study|Pt incarcerated|0|||
156828366|NCT00075725|566122979|FG005|Overall Study|Pt incarcerated|0|||
156828367|NCT00075725|566122980|FG006|Overall Study|Pt incarcerated|0|||
156828368|NCT00075725|566122981|FG007|Overall Study|Pt incarcerated|1|||
156828369|NCT00075725|566122982|FG008|Overall Study|Pt incarcerated|0|||
156828370|NCT00075725|566122983|FG009|Overall Study|Pt incarcerated|0|||
156828371|NCT00075725|566122984|FG010|Overall Study|Pt incarcerated|0|||
156828372|NCT00075725|566122985|FG011|Overall Study|Pt incarcerated|0|||
156828373|NCT04677660|566122986|FG000|Overall Study|Lost to Follow-up|0|||
156828374|NCT04677660|566122987|FG001|Overall Study|Lost to Follow-up|2|||
156828375|NCT04677660|566122986|FG000|Overall Study|Withdrawal by Subject|0|||
156828376|NCT04677660|566122987|FG001|Overall Study|Withdrawal by Subject|1|||
156828377|NCT04677660|566122986|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
156828378|NCT04677660|566122987|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
156828379|NCT02446418|566122991|FG000|Overall Study|Adverse Event|4|||
156828380|NCT02446418|566122992|FG001|Overall Study|Adverse Event|8|||
156828381|NCT02446418|566122991|FG000|Overall Study|Physician Decision|5|||
156828382|NCT02446418|566122992|FG001|Overall Study|Physician Decision|1|||
156828383|NCT02446418|566122991|FG000|Overall Study|Withdrawal by Subject|3|||
156828384|NCT02446418|566122992|FG001|Overall Study|Withdrawal by Subject|3|||
156828385|NCT02446418|566122991|FG000|Overall Study|Lost to Follow-up|2|||
156828386|NCT02446418|566122992|FG001|Overall Study|Lost to Follow-up|2|||
156828387|NCT02446418|566122991|FG000|Overall Study|Protocol Violation|1|||
156828388|NCT02446418|566122992|FG001|Overall Study|Protocol Violation|2|||
156828389|NCT02446418|566122991|FG000|Overall Study|Lack of Efficacy|2|||
156828390|NCT02446418|566122992|FG001|Overall Study|Lack of Efficacy|0|||
156828391|NCT02446418|566122991|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
156884921|NCT02683746|566336404|FG000|Overall Study|Physician Decision|2|||
156884922|NCT02683746|566336405|FG001|Overall Study|Physician Decision|1|||
156884923|NCT04987944|566336410|FG000|Overall Study|Adverse Event|0|||
157151173|NCT00408421|567299624|FG002|Treatment Initial Randomization|Adverse Event|0|||
157151174|NCT00408421|567299622|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
157151175|NCT00408421|567299623|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
157151176|NCT00408421|567299624|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
157151177|NCT00408421|567299622|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
157151178|NCT00408421|567299623|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
157224502|NCT04799158|567568019|FG000|Run-In Period|Significant Protocol Deviation|1|||
157224503|NCT04799158|567568020|FG001|Run-In Period|Significant Protocol Deviation|0|||
156828392|NCT02446418|566122992|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
156828393|NCT03421743|566122995|FG000|Overall Study|Lack of Efficacy|1|||
156828394|NCT03421743|566122996|FG001|Overall Study|Lack of Efficacy|0|||
156828395|NCT03421743|566122995|FG000|Overall Study|Adverse Event|2|||
156828396|NCT03421743|566122996|FG001|Overall Study|Adverse Event|1|||
156828397|NCT03421743|566122995|FG000|Overall Study|Withdrawal by Subject|0|||
156828398|NCT03421743|566122996|FG001|Overall Study|Withdrawal by Subject|1|||
156828399|NCT00435162|566122997|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
156828400|NCT00435162|566122998|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
156828401|NCT00435162|566122999|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
156884924|NCT04987944|566336411|FG001|Overall Study|Adverse Event|1|||
156884925|NCT04987944|566336410|FG000|Overall Study|Withdrawal by Subject|0|||
156884926|NCT04987944|566336411|FG001|Overall Study|Withdrawal by Subject|1|||
156884927|NCT03222492|566336418|FG000|Overall Study|Withdrawal by Subject|0|||
157151179|NCT00408421|567299624|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
156828402|NCT00435162|566123000|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
156828403|NCT00435162|566123001|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
156828404|NCT00435162|566123002|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
156828405|NCT00694096|566123003|FG000|Overall Study|Withdrawal by Subject|5|||
156828406|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
156828407|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
156828408|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
156828409|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
156828410|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
156828411|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
156828412|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
156828413|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
156828414|NCT00977938|566123008|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
156828415|NCT00977938|566123009|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
156828416|NCT00977938|566123010|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
156828417|NCT00977938|566123011|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
156828418|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
156828419|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
156828420|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
156828421|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
156828422|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
156828423|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
156828424|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
156828425|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
156828426|NCT00977938|566123008|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
156828427|NCT00977938|566123009|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
156828428|NCT00977938|566123010|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
156828429|NCT00977938|566123011|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
156828430|NCT01605227|566123020|FG000|Overall Study|Did not receive study treatment|2|||
156828431|NCT01605227|566123021|FG001|Overall Study|Did not receive study treatment|3|||
156828432|NCT01605227|566123020|FG000|Overall Study|Adverse Event|228|||
156828433|NCT01605227|566123021|FG001|Overall Study|Adverse Event|42|||
156828434|NCT01605227|566123020|FG000|Overall Study|Progressive Disease|132|||
156828435|NCT01605227|566123021|FG001|Overall Study|Progressive Disease|128|||
156828436|NCT01605227|566123020|FG000|Overall Study|Clinical Deterioration|227|||
156828437|NCT01605227|566123021|FG001|Overall Study|Clinical Deterioration|133|||
156828438|NCT01605227|566123020|FG000|Overall Study|Lost to Follow-up|1|||
156828439|NCT01605227|566123021|FG001|Overall Study|Lost to Follow-up|0|||
156828440|NCT01605227|566123020|FG000|Overall Study|Protocol Violation|1|||
156828441|NCT01605227|566123021|FG001|Overall Study|Protocol Violation|0|||
156828442|NCT01605227|566123020|FG000|Overall Study|Physician Decision|9|||
156828443|NCT01605227|566123021|FG001|Overall Study|Physician Decision|7|||
156828444|NCT01605227|566123020|FG000|Overall Study|Withdrawal by Subject|18|||
156828445|NCT01605227|566123021|FG001|Overall Study|Withdrawal by Subject|14|||
156828446|NCT01605227|566123020|FG000|Overall Study|Sponsor Decision|2|||
156828447|NCT01605227|566123021|FG001|Overall Study|Sponsor Decision|0|||
156828448|NCT01605227|566123020|FG000|Overall Study|Started New Therapy|1|||
156828449|NCT01605227|566123021|FG001|Overall Study|Started New Therapy|0|||
156828450|NCT01605227|566123020|FG000|Overall Study|Subject Decision|0|||
156828451|NCT01605227|566123021|FG001|Overall Study|Subject Decision|1|||
156828452|NCT01605227|566123020|FG000|Overall Study|Dose Held >6 weeks|0|||
156828453|NCT01605227|566123021|FG001|Overall Study|Dose Held >6 weeks|1|||
156828454|NCT01166958|566123022|FG000|Overall Study|Withdrawal by Subject|1|||
156828455|NCT01166958|566123023|FG001|Overall Study|Withdrawal by Subject|0|||
156828456|NCT02680574|566123024|FG000|Overall Study|Death|137|||
156828457|NCT02680574|566123025|FG001|Overall Study|Death|137|||
156828458|NCT02680574|566123024|FG000|Overall Study|Withdrawal by Subject|17|||
156828459|NCT02680574|566123025|FG001|Overall Study|Withdrawal by Subject|9|||
156828460|NCT02680574|566123024|FG000|Overall Study|Lost to Follow-up|4|||
156828461|NCT02680574|566123025|FG001|Overall Study|Lost to Follow-up|6|||
156828462|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
156828463|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
156828464|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
156828465|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
156828466|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
156828467|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
156828468|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
156828469|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
156828470|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
156828471|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
156828472|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
156828473|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
156828474|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
156828475|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
156828476|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
156828477|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
156828478|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
156828479|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
156828480|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
156828481|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
156828482|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
156828483|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
156828484|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
156828485|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
156828486|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
156828487|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
156828488|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
156828489|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
156828490|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
156828491|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
156828492|NCT01286987|566123026|FG000|Part 1: Dose Escalation|Physician Decision|0|||
156828493|NCT01286987|566123027|FG001|Part 1: Dose Escalation|Physician Decision|0|||
156828494|NCT01286987|566123028|FG002|Part 1: Dose Escalation|Physician Decision|0|||
156828495|NCT01286987|566123029|FG003|Part 1: Dose Escalation|Physician Decision|0|||
156828496|NCT01286987|566123030|FG004|Part 1: Dose Escalation|Physician Decision|1|||
156828497|NCT01286987|566123031|FG005|Part 1: Dose Escalation|Physician Decision|0|||
156828498|NCT01286987|566123032|FG006|Part 1: Dose Escalation|Physician Decision|0|||
157224504|NCT04799158|567568021|FG002|Run-In Period|Significant Protocol Deviation|0|||
157224505|NCT04799158|567568022|FG003|Run-In Period|Significant Protocol Deviation|0|||
157224506|NCT04799158|567568023|FG004|Run-In Period|Significant Protocol Deviation|0|||
157224507|NCT04799158|567568019|FG000|Run-In Period|Withdrawal by Subject|11|||
156828499|NCT01286987|566123033|FG007|Part 1: Dose Escalation|Physician Decision|0|||
156828500|NCT01286987|566123034|FG008|Part 1: Dose Escalation|Physician Decision|0|||
156828501|NCT01286987|566123035|FG009|Part 1: Dose Escalation|Physician Decision|0|||
156828502|NCT01286987|566123036|FG010|Part 1: Dose Escalation|Physician Decision|0|||
156828503|NCT01286987|566123037|FG011|Part 1: Dose Escalation|Physician Decision|0|||
156828504|NCT01286987|566123038|FG012|Part 1: Dose Escalation|Physician Decision|0|||
156828505|NCT01286987|566123039|FG013|Part 1: Dose Escalation|Physician Decision|0|||
156828506|NCT01286987|566123040|FG014|Part 1: Dose Escalation|Physician Decision|0|||
156828507|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Death|0|||
156828508|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Death|0|||
156828509|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Death|0|||
156828510|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Death|0|||
156828511|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Death|0|||
156828512|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Death|0|||
156828513|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Death|0|||
157022940|NCT04676022|566836923|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
157022941|NCT04676022|566836924|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
157022942|NCT04676022|566836925|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
157022943|NCT02274662|566836943|FG000|Overall Study|Death|1|||
157022944|NCT02274662|566836943|FG000|Overall Study|Lost to Follow-up|3|||
157022945|NCT03134196|566836954|FG000|Overall Study|Death|2|||
157022946|NCT03134196|566836955|FG001|Overall Study|Death|1|||
157022947|NCT03134196|566836954|FG000|Overall Study|Lost to Follow-up|13|||
156828514|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Death|0|||
157022948|NCT03134196|566836955|FG001|Overall Study|Lost to Follow-up|15|||
157022949|NCT03134196|566836954|FG000|Overall Study|Physician Decision|0|||
157022950|NCT03134196|566836955|FG001|Overall Study|Physician Decision|1|||
157224508|NCT04799158|567568020|FG001|Run-In Period|Withdrawal by Subject|0|||
156828515|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Death|0|||
156828516|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Death|0|||
157224509|NCT04799158|567568021|FG002|Run-In Period|Withdrawal by Subject|0|||
157224510|NCT04799158|567568022|FG003|Run-In Period|Withdrawal by Subject|0|||
157224511|NCT04799158|567568023|FG004|Run-In Period|Withdrawal by Subject|0|||
157224512|NCT04799158|567568019|FG000|Run-In Period|Miscellaneous|3|||
157224513|NCT04799158|567568020|FG001|Run-In Period|Miscellaneous|0|||
157224514|NCT04799158|567568021|FG002|Run-In Period|Miscellaneous|0|||
157224515|NCT04799158|567568022|FG003|Run-In Period|Miscellaneous|0|||
157224516|NCT04799158|567568023|FG004|Run-In Period|Miscellaneous|0|||
157224517|NCT04799158|567568019|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
156828517|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Death|0|||
156828518|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Death|0|||
156884928|NCT03222492|566336419|FG001|Overall Study|Withdrawal by Subject|0|||
157224518|NCT04799158|567568020|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156884929|NCT03222492|566336420|FG002|Overall Study|Withdrawal by Subject|1|||
157022951|NCT03134196|566836954|FG000|Overall Study|Withdrawal by Subject|19|||
157022952|NCT03134196|566836955|FG001|Overall Study|Withdrawal by Subject|12|||
157022953|NCT03134196|566836954|FG000|Overall Study|Site Unable to Contact Participant|2|||
157022954|NCT03134196|566836955|FG001|Overall Study|Site Unable to Contact Participant|0|||
157022955|NCT03134196|566836954|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
157022956|NCT03134196|566836955|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
157022957|NCT03134196|566836954|FG000|Overall Study|Scheduling Conflict|1|||
157022958|NCT03134196|566836955|FG001|Overall Study|Scheduling Conflict|0|||
157022959|NCT04683744|566836960|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
157022960|NCT04683744|566836961|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
157022961|NCT04683744|566836962|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
156828519|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Death|1|||
156828520|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Death|1|||
156828521|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Death|0|||
156828522|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Physician Decision|0|||
156828523|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Physician Decision|0|||
156828524|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Physician Decision|0|||
156828525|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Physician Decision|0|||
156828526|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Physician Decision|0|||
156828527|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Physician Decision|0|||
156828528|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Physician Decision|0|||
156828529|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Physician Decision|0|||
156828530|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Physician Decision|0|||
156828531|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Physician Decision|0|||
156828532|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Physician Decision|1|||
156828533|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Physician Decision|1|||
156828534|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Physician Decision|0|||
156828535|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Physician Decision|1|||
156828536|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Physician Decision|0|||
156828537|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Other|0|||
156828538|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Other|0|||
156828539|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Other|0|||
156828540|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Other|0|||
156828541|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Other|0|||
156828542|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Other|0|||
156828543|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Other|0|||
156828544|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Other|0|||
156828545|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Other|0|||
156828546|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Other|0|||
156828547|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Other|0|||
156828548|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Other|0|||
156828549|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Other|0|||
156828550|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Other|1|||
156828551|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Other|0|||
156828552|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
156828553|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
156828554|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
156828555|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
156828556|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
156828557|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
156828558|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
156828559|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
156828560|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
156828561|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
156828562|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
156828563|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
156828564|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
156828565|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
156828566|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
156828567|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
156828568|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
156828569|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
156828570|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
156828571|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
156828572|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
157022962|NCT04592549|566836965|FG000|Overall Study|Withdrawal by Subject|0|||
157022963|NCT04592549|566836966|FG001|Overall Study|Withdrawal by Subject|1|||
156828573|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
156828574|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
156828575|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
156828576|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
156828577|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
156828578|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
156884930|NCT03222492|566336421|FG003|Overall Study|Withdrawal by Subject|0|||
156884931|NCT03222492|566336418|FG000|Overall Study|COVID-19 related|0|||
156884932|NCT03222492|566336419|FG001|Overall Study|COVID-19 related|0|||
156884933|NCT03222492|566336420|FG002|Overall Study|COVID-19 related|1|||
156884934|NCT03222492|566336421|FG003|Overall Study|COVID-19 related|0|||
156828579|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
156828580|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
156828581|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
156828582|NCT01286987|566123026|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828583|NCT01286987|566123027|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828584|NCT01286987|566123028|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828585|NCT01286987|566123029|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828586|NCT01286987|566123030|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156884935|NCT00674154|566336422|FG000|Overall Study|Withdrawal by Subject|3|||
156828587|NCT01286987|566123031|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828588|NCT01286987|566123032|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828589|NCT01286987|566123033|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828590|NCT01286987|566123034|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828591|NCT01286987|566123035|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828592|NCT01286987|566123036|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
156828593|NCT01286987|566123037|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828594|NCT01286987|566123038|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828595|NCT01286987|566123039|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828596|NCT01286987|566123040|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
156828597|NCT00624819|566123041|FG000|Follow-up Period: Year 4|Parents decision|0|||
156828598|NCT00624819|566123042|FG001|Follow-up Period: Year 4|Parents decision|0|||
156828599|NCT00624819|566123043|FG002|Follow-up Period: Year 4|Parents decision|1|||
156828600|NCT00624819|566123044|FG003|Follow-up Period: Year 4|Parents decision|0|||
156828601|NCT00624819|566123041|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
156828602|NCT00624819|566123042|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
156828603|NCT00624819|566123043|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
156828604|NCT00624819|566123044|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
156828605|NCT02847858|566123045|FG000|Overall Study|Lost to Follow-up|401|||
156828606|NCT02847858|566123046|FG001|Overall Study|Lost to Follow-up|269|||
156828607|NCT00681564|566123047|FG000|Overall Study|Lost to Follow-up|6|||
156828608|NCT00681564|566123048|FG001|Overall Study|Lost to Follow-up|6|||
156828609|NCT00681564|566123047|FG000|Overall Study|Withdrawal by Subject|0|||
156828610|NCT00681564|566123048|FG001|Overall Study|Withdrawal by Subject|1|||
156828611|NCT00681564|566123047|FG000|Overall Study|Death|0|||
156828612|NCT00681564|566123048|FG001|Overall Study|Death|1|||
156828613|NCT03093974|566123051|FG000|Overall Study|Withdrawal by Subject|32|||
156828614|NCT03093974|566123052|FG001|Overall Study|Withdrawal by Subject|27|||
156828615|NCT03093974|566123051|FG000|Overall Study|Adverse Event|17|||
156828616|NCT03093974|566123052|FG001|Overall Study|Adverse Event|24|||
156828617|NCT03093974|566123051|FG000|Overall Study|Death|0|||
156828618|NCT03093974|566123052|FG001|Overall Study|Death|1|||
156828619|NCT03093974|566123051|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156828620|NCT03093974|566123052|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156828621|NCT03093974|566123051|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
156828622|NCT03093974|566123052|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
156828623|NCT03093974|566123051|FG000|Overall Study|Lost to Follow-up|0|||
156828624|NCT03093974|566123052|FG001|Overall Study|Lost to Follow-up|1|||
156828625|NCT03093974|566123051|FG000|Overall Study|Other|1|||
156828626|NCT03093974|566123052|FG001|Overall Study|Other|2|||
156828627|NCT02387164|566123053|FG000|Overall Study|Lost to Follow-up|2|||
156828628|NCT02387164|566123054|FG001|Overall Study|Lost to Follow-up|0|||
156828629|NCT02387164|566123053|FG000|Overall Study|Diagnosed|1|||
156828630|NCT02387164|566123054|FG001|Overall Study|Diagnosed|2|||
156884936|NCT00674154|566336423|FG001|Overall Study|Withdrawal by Subject|1|||
156884937|NCT00674154|566336422|FG000|Overall Study|Did not want parathyroidectomy|0|||
156884938|NCT00674154|566336423|FG001|Overall Study|Did not want parathyroidectomy|2|||
156884939|NCT00816023|566336424|FG000|Overall Study|Lost to Follow-up|1|||
157022964|NCT04592549|566836967|FG002|Overall Study|Withdrawal by Subject|0|||
156828631|NCT01253265|566123058|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
156828632|NCT01253265|566123059|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828633|NCT01253265|566123060|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828634|NCT01253265|566123061|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828635|NCT01253265|566123062|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
156828636|NCT01253265|566123058|FG000|Overall Study|Withdrawal by Subject|0|||
156828637|NCT01253265|566123059|FG001|Overall Study|Withdrawal by Subject|0|||
156828638|NCT01253265|566123060|FG002|Overall Study|Withdrawal by Subject|0|||
156828639|NCT01253265|566123061|FG003|Overall Study|Withdrawal by Subject|0|||
156884940|NCT00816023|566336425|FG001|Overall Study|Lost to Follow-up|1|||
157022965|NCT04592549|566836968|FG003|Overall Study|Withdrawal by Subject|1|||
156828640|NCT01253265|566123062|FG004|Overall Study|Withdrawal by Subject|1|||
156828641|NCT00541099|566123064|FG000|Overall Study|Ineligible|3|||
156828642|NCT01416441|566123067|FG000|Overall Study|Lost to Follow-up|5|||
156828643|NCT01416441|566123067|FG000|Overall Study|Adverse Event|6|||
156828644|NCT01416441|566123067|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
156828645|NCT01416441|566123067|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
156828646|NCT01416441|566123067|FG000|Overall Study|Investigator Withdrew Subject|2|||
156828647|NCT01416441|566123067|FG000|Overall Study|Subject Withdrew Consent|12|||
156828648|NCT01416441|566123067|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
156828649|NCT00526110|566123068|FG000|Overall Study|Adverse Event|2|||
156828650|NCT00526110|566123069|FG001|Overall Study|Adverse Event|9|||
156828651|NCT00526110|566123068|FG000|Overall Study|Disease Progression|0|||
156828652|NCT00526110|566123069|FG001|Overall Study|Disease Progression|19|||
156828653|NCT00526110|566123068|FG000|Overall Study|Maximal Response|0|||
156828654|NCT00526110|566123069|FG001|Overall Study|Maximal Response|6|||
156828655|NCT00526110|566123068|FG000|Overall Study|Withdrawal by Subject|0|||
156828656|NCT00526110|566123069|FG001|Overall Study|Withdrawal by Subject|2|||
156828657|NCT00526110|566123068|FG000|Overall Study|Poor Tolerance|0|||
156828658|NCT00526110|566123069|FG001|Overall Study|Poor Tolerance|5|||
156828659|NCT01309269|566124993|FG000|Overall Study|Adverse Event|56|||
156828660|NCT01309269|566124993|FG000|Overall Study|Withdrawal by Subject|25|||
156828661|NCT01309269|566124993|FG000|Overall Study|Lack of Acceptance|15|||
156828662|NCT01309269|566124993|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
156828663|NCT01309269|566124993|FG000|Overall Study|Kidney Transplant|25|||
156828664|NCT01309269|566124993|FG000|Overall Study|Administrative Problems|141|||
156828665|NCT01309269|566124993|FG000|Overall Study|Other|256|||
156828666|NCT01309269|566124993|FG000|Overall Study|Other|1|||
156828667|NCT01309269|566124993|FG000|Overall Study|Study Completion Data Not Recorded|95|||
156828668|NCT01309269|566124993|FG000|Overall Study|Enrolled but not Treated|107|||
156828669|NCT03383783|566124996|FG000|Overall Study|Withdrawal by Subject|2|||
156828670|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
156884941|NCT00816023|566336426|FG002|Overall Study|Lost to Follow-up|0|||
156884942|NCT00816023|566336427|FG003|Overall Study|Lost to Follow-up|0|||
156884943|NCT00816023|566336424|FG000|Overall Study|Withdrawal by Subject|1|||
156884944|NCT00816023|566336425|FG001|Overall Study|Withdrawal by Subject|0|||
156828671|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
156828672|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
156828673|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
156828674|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
156828675|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
156828676|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
156828677|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
156828678|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
156828679|NCT02119156|566125002|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
156828680|NCT02119156|566125003|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
156828681|NCT02119156|566125004|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
156828682|NCT02119156|566125002|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
156828683|NCT02119156|566125003|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
156828684|NCT02119156|566125004|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
156828685|NCT01030874|566125006|FG000|Overall Study|Withdrawal by Subject|1|||
156828686|NCT01030874|566125007|FG001|Overall Study|Withdrawal by Subject|0|||
156828687|NCT01030874|566125006|FG000|Overall Study|Discharged in first 2 weeks|17|||
156828688|NCT01030874|566125007|FG001|Overall Study|Discharged in first 2 weeks|16|||
156828689|NCT03263923|566125012|FG000|Overall Study|Withdrawal by Subject|10|||
156828690|NCT03263923|566125013|FG001|Overall Study|Withdrawal by Subject|8|||
156828691|NCT03263923|566125012|FG000|Overall Study|Lost to Follow-up|15|||
156828692|NCT03263923|566125013|FG001|Overall Study|Lost to Follow-up|13|||
156828693|NCT02229214|566125018|FG000|Overall Study|Adverse Event|2|||
156884945|NCT00816023|566336426|FG002|Overall Study|Withdrawal by Subject|0|||
156828694|NCT02229214|566125019|FG001|Overall Study|Adverse Event|0|||
156828695|NCT02229214|566125018|FG000|Overall Study|Withdrawal by Subject|4|||
156828696|NCT02229214|566125019|FG001|Overall Study|Withdrawal by Subject|0|||
156828697|NCT00246025|566125020|FG000|Overall Study|Adverse Event|7|||
156828698|NCT00246025|566125021|FG001|Overall Study|Adverse Event|9|||
156828699|NCT00246025|566125022|FG002|Overall Study|Adverse Event|9|||
156828700|NCT00246025|566125023|FG003|Overall Study|Adverse Event|10|||
156828701|NCT00246025|566125020|FG000|Overall Study|Withdrawal by Subject|3|||
156884946|NCT00816023|566336427|FG003|Overall Study|Withdrawal by Subject|0|||
156884947|NCT00816023|566336424|FG000|Overall Study|Physician Decision|0|||
156884948|NCT00816023|566336425|FG001|Overall Study|Physician Decision|0|||
156828702|NCT00246025|566125021|FG001|Overall Study|Withdrawal by Subject|0|||
156828703|NCT00246025|566125022|FG002|Overall Study|Withdrawal by Subject|1|||
156828704|NCT00246025|566125023|FG003|Overall Study|Withdrawal by Subject|2|||
156828705|NCT00246025|566125020|FG000|Overall Study|unsuitable medical history was found|0|||
156828706|NCT00246025|566125021|FG001|Overall Study|unsuitable medical history was found|0|||
156828707|NCT00246025|566125022|FG002|Overall Study|unsuitable medical history was found|0|||
156828708|NCT00246025|566125023|FG003|Overall Study|unsuitable medical history was found|1|||
156828709|NCT03054350|566125026|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
156828710|NCT03054350|566125027|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
156828711|NCT03054350|566125028|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
156828712|NCT03054350|566125029|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
156828713|NCT03054350|566125030|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
156828714|NCT03054350|566125031|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
156828715|NCT03054350|566125026|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828716|NCT03054350|566125027|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828717|NCT03054350|566125028|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
156828718|NCT03054350|566125029|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828719|NCT03054350|566125030|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828720|NCT03054350|566125031|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
156828721|NCT03054350|566125026|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
156828722|NCT03054350|566125027|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828723|NCT03054350|566125028|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828724|NCT03054350|566125029|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
156828725|NCT03054350|566125030|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828726|NCT03054350|566125031|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
156828727|NCT03054350|566125026|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828728|NCT03054350|566125027|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828729|NCT03054350|566125028|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
156828730|NCT03054350|566125029|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828731|NCT03054350|566125030|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828732|NCT03054350|566125031|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
156828733|NCT00931723|566125032|FG000|Overall Study|Withdrawal by Subject|11|||
156828734|NCT00931723|566125033|FG001|Overall Study|Withdrawal by Subject|13|||
156828735|NCT00931723|566125032|FG000|Overall Study|Adverse Event|6|||
156828736|NCT00931723|566125033|FG001|Overall Study|Adverse Event|13|||
156828737|NCT00931723|566125032|FG000|Overall Study|Lithium found in blood|0|||
156828738|NCT00931723|566125033|FG001|Overall Study|Lithium found in blood|1|||
156828739|NCT00931723|566125032|FG000|Overall Study|Condition under investigation worsened|1|||
156828740|NCT00931723|566125033|FG001|Overall Study|Condition under investigation worsened|2|||
156828741|NCT00931723|566125032|FG000|Overall Study|Lost to Follow-up|1|||
156828742|NCT00931723|566125033|FG001|Overall Study|Lost to Follow-up|2|||
156828743|NCT00931723|566125032|FG000|Overall Study|Study-specific discontinuation criteria|1|||
156828744|NCT00931723|566125033|FG001|Overall Study|Study-specific discontinuation criteria|1|||
156828745|NCT00931723|566125032|FG000|Overall Study|Severe non-compliance to protocol|2|||
156828746|NCT00931723|566125033|FG001|Overall Study|Severe non-compliance to protocol|0|||
156828747|NCT00931723|566125032|FG000|Overall Study|Safety reasons|0|||
156828748|NCT00931723|566125033|FG001|Overall Study|Safety reasons|1|||
156828749|NCT00931723|566125032|FG000|Overall Study|Took prohibited concomitant medication|0|||
156828750|NCT00931723|566125033|FG001|Overall Study|Took prohibited concomitant medication|1|||
156828751|NCT00931723|566125032|FG000|Overall Study|Lack or insufficient theraputic response|2|||
156828752|NCT00931723|566125033|FG001|Overall Study|Lack or insufficient theraputic response|5|||
156828753|NCT00931723|566125032|FG000|Overall Study|Sponsor decision|1|||
156828754|NCT00931723|566125033|FG001|Overall Study|Sponsor decision|0|||
156828755|NCT00931723|566125032|FG000|Overall Study|Late hospital discharge|1|||
156828756|NCT00931723|566125033|FG001|Overall Study|Late hospital discharge|0|||
156828757|NCT01643850|566125034|FG000|Overall Study|Withdrawal by Subject|0|||
156828758|NCT01643850|566125035|FG001|Overall Study|Withdrawal by Subject|0|||
156828759|NCT01643850|566125036|FG002|Overall Study|Withdrawal by Subject|0|||
156828760|NCT01643850|566125037|FG003|Overall Study|Withdrawal by Subject|0|||
156828761|NCT01643850|566125038|FG004|Overall Study|Withdrawal by Subject|1|||
156828762|NCT01643850|566125039|FG005|Overall Study|Withdrawal by Subject|0|||
156828763|NCT01643850|566125040|FG006|Overall Study|Withdrawal by Subject|0|||
156828764|NCT01643850|566125041|FG007|Overall Study|Withdrawal by Subject|0|||
156828765|NCT01643850|566125042|FG008|Overall Study|Withdrawal by Subject|0|||
156828766|NCT01643850|566125034|FG000|Overall Study|Lost to Follow-up|0|||
156828767|NCT01643850|566125035|FG001|Overall Study|Lost to Follow-up|0|||
156828768|NCT01643850|566125036|FG002|Overall Study|Lost to Follow-up|0|||
156828769|NCT01643850|566125037|FG003|Overall Study|Lost to Follow-up|0|||
156828770|NCT01643850|566125038|FG004|Overall Study|Lost to Follow-up|0|||
156828771|NCT01643850|566125039|FG005|Overall Study|Lost to Follow-up|0|||
156828772|NCT01643850|566125040|FG006|Overall Study|Lost to Follow-up|1|||
156828773|NCT01643850|566125041|FG007|Overall Study|Lost to Follow-up|0|||
156828774|NCT01643850|566125042|FG008|Overall Study|Lost to Follow-up|1|||
156828775|NCT01643850|566125034|FG000|Overall Study|Adverse Event|0|||
156828776|NCT01643850|566125035|FG001|Overall Study|Adverse Event|0|||
156828777|NCT01643850|566125036|FG002|Overall Study|Adverse Event|0|||
156828778|NCT01643850|566125037|FG003|Overall Study|Adverse Event|0|||
156828779|NCT01643850|566125038|FG004|Overall Study|Adverse Event|1|||
156828780|NCT01643850|566125039|FG005|Overall Study|Adverse Event|0|||
156828781|NCT01643850|566125040|FG006|Overall Study|Adverse Event|0|||
156828782|NCT01643850|566125041|FG007|Overall Study|Adverse Event|0|||
156828783|NCT01643850|566125042|FG008|Overall Study|Adverse Event|0|||
156828784|NCT01643850|566125034|FG000|Overall Study|Administrative Problems|0|||
156828785|NCT01643850|566125035|FG001|Overall Study|Administrative Problems|0|||
156828786|NCT01643850|566125036|FG002|Overall Study|Administrative Problems|1|||
156828787|NCT01643850|566125037|FG003|Overall Study|Administrative Problems|0|||
156828788|NCT01643850|566125038|FG004|Overall Study|Administrative Problems|1|||
156828789|NCT01643850|566125039|FG005|Overall Study|Administrative Problems|0|||
156828790|NCT01643850|566125040|FG006|Overall Study|Administrative Problems|0|||
156828791|NCT01643850|566125041|FG007|Overall Study|Administrative Problems|0|||
156828792|NCT01643850|566125042|FG008|Overall Study|Administrative Problems|0|||
156828793|NCT03305081|566125049|FG000|Overall Study|Lost to Follow-up|10|||
156828794|NCT03305081|566125050|FG001|Overall Study|Lost to Follow-up|15|||
156828795|NCT05426031|566125055|FG000|Overall Study|Circulatory Arrest|3|||
156828796|NCT05426031|566125056|FG001|Overall Study|Circulatory Arrest|2|||
156828797|NCT04065074|566125057|FG000|Overall Study|Adverse Event|1|||
156828798|NCT04065074|566125057|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
156828799|NCT00241631|566125058|FG000|Run in (2 Weeks)|Physician Decision|3|||
156828800|NCT00241631|566125059|FG001|Run in (2 Weeks)|Physician Decision|3|||
156828801|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|sore throat|1|||
156828802|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|sore throat|0|||
156828803|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
156828804|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
156828805|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
156828806|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
156828807|NCT00241631|566125058|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
156828808|NCT00241631|566125059|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
156828809|NCT01218100|566125060|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828810|NCT01218100|566125061|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828811|NCT01218100|566125062|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
156828812|NCT01218100|566125063|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
156828813|NCT01218100|566125060|FG000|Overall Study|Adverse Event|4|||
156828814|NCT01218100|566125061|FG001|Overall Study|Adverse Event|6|||
156828815|NCT01218100|566125062|FG002|Overall Study|Adverse Event|6|||
156828816|NCT01218100|566125063|FG003|Overall Study|Adverse Event|7|||
156828817|NCT01218100|566125060|FG000|Overall Study|Lack of Efficacy|9|||
156828818|NCT01218100|566125061|FG001|Overall Study|Lack of Efficacy|6|||
156828819|NCT01218100|566125062|FG002|Overall Study|Lack of Efficacy|5|||
156828820|NCT01218100|566125063|FG003|Overall Study|Lack of Efficacy|12|||
156828821|NCT01218100|566125060|FG000|Overall Study|Protocol Violation|0|||
156828822|NCT01218100|566125061|FG001|Overall Study|Protocol Violation|0|||
156828823|NCT01218100|566125062|FG002|Overall Study|Protocol Violation|1|||
156828824|NCT01218100|566125063|FG003|Overall Study|Protocol Violation|1|||
156828825|NCT01218100|566125060|FG000|Overall Study|Withdrawal by Subject|5|||
156828826|NCT01218100|566125061|FG001|Overall Study|Withdrawal by Subject|2|||
156828827|NCT01218100|566125062|FG002|Overall Study|Withdrawal by Subject|6|||
156884949|NCT00816023|566336426|FG002|Overall Study|Physician Decision|1|||
157022966|NCT04592549|566836969|FG004|Overall Study|Withdrawal by Subject|1|||
157022967|NCT04592549|566836970|FG005|Overall Study|Withdrawal by Subject|0|||
156828828|NCT01218100|566125063|FG003|Overall Study|Withdrawal by Subject|7|||
156828829|NCT01218100|566125060|FG000|Overall Study|Lost to Follow-up|3|||
156828830|NCT01218100|566125061|FG001|Overall Study|Lost to Follow-up|8|||
156828831|NCT01218100|566125062|FG002|Overall Study|Lost to Follow-up|2|||
156828832|NCT01218100|566125063|FG003|Overall Study|Lost to Follow-up|1|||
156828833|NCT01218100|566125060|FG000|Overall Study|Other Reason|2|||
156828834|NCT01218100|566125061|FG001|Overall Study|Other Reason|2|||
156828835|NCT01218100|566125062|FG002|Overall Study|Other Reason|6|||
156828836|NCT01218100|566125063|FG003|Overall Study|Other Reason|4|||
156828837|NCT02437305|566125064|FG000|Overall Study|Lost to Follow-up|18|||
156828838|NCT02437305|566125065|FG001|Overall Study|Lost to Follow-up|12|||
156828839|NCT03883113|566125067|FG000|Overall Study|Physician Decision|4|||
157022968|NCT04592549|566836965|FG000|Overall Study|Lost to Follow-up|2|||
156828840|NCT03883113|566125068|FG001|Overall Study|Physician Decision|2|||
156828841|NCT03883113|566125067|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
156828842|NCT03883113|566125068|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
156828843|NCT03883113|566125067|FG000|Overall Study|Pregnancy|1|||
156828844|NCT03883113|566125068|FG001|Overall Study|Pregnancy|0|||
157022969|NCT04592549|566836966|FG001|Overall Study|Lost to Follow-up|0|||
157022970|NCT04592549|566836967|FG002|Overall Study|Lost to Follow-up|0|||
156828845|NCT03883113|566125067|FG000|Overall Study|Adverse Event|0|||
156828846|NCT03883113|566125068|FG001|Overall Study|Adverse Event|1|||
157022971|NCT04592549|566836968|FG003|Overall Study|Lost to Follow-up|1|||
157022972|NCT04592549|566836969|FG004|Overall Study|Lost to Follow-up|1|||
157022973|NCT04592549|566836970|FG005|Overall Study|Lost to Follow-up|1|||
157022974|NCT05603143|566836971|FG000|Overall Study|Withdrew consent|6|||
157022975|NCT05603143|566836972|FG001|Overall Study|Withdrew consent|2|||
157022976|NCT05603143|566836971|FG000|Overall Study|Randomized but never treated|0|||
157022977|NCT05603143|566836972|FG001|Overall Study|Randomized but never treated|3|||
157022978|NCT05603143|566836971|FG000|Overall Study|Adverse Event|2|||
157022979|NCT05603143|566836972|FG001|Overall Study|Adverse Event|0|||
157022980|NCT05603143|566836971|FG000|Overall Study|Death|0|||
157022981|NCT05603143|566836972|FG001|Overall Study|Death|1|||
157022982|NCT05603143|566836971|FG000|Overall Study|Investigator's discretion|1|||
157022983|NCT05603143|566836972|FG001|Overall Study|Investigator's discretion|0|||
156828847|NCT03883113|566125067|FG000|Overall Study|Withdrawal by Subject|1|||
156828848|NCT03883113|566125068|FG001|Overall Study|Withdrawal by Subject|2|||
156828849|NCT03883113|566125067|FG000|Overall Study|Lost to Follow-up|1|||
156828850|NCT03883113|566125068|FG001|Overall Study|Lost to Follow-up|0|||
156828851|NCT02141490|566125073|FG000|Overall Study|Screening failures|4|||
156828852|NCT02141490|566125074|FG001|Overall Study|Screening failures|0|||
156828853|NCT02141490|566125075|FG002|Overall Study|Screening failures|0|||
156828854|NCT01009346|566125076|FG000|Overall Study|Adverse Event|4|||
156828855|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
156828856|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
156828857|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
156828858|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
156828859|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
156828860|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
156828861|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
156828862|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
156828863|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
157022984|NCT05603143|566836971|FG000|Overall Study|Lost to Follow-up|0|||
156828864|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
156828865|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
156828866|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
156828867|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
156828868|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
156828869|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
156828870|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
156828871|NCT03906656|566125077|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
156828872|NCT03906656|566125078|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
156828873|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
156828874|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
156828875|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
156828876|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
156828877|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
156828878|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
156828879|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
156828880|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
156828881|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
156828882|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
156828883|NCT03906656|566125077|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
156828884|NCT03906656|566125078|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
156828885|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
156828886|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
156828887|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
156828888|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
156828889|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Death|2|||
156828890|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Death|0|||
156828891|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
156828892|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
156828893|NCT03906656|566125077|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
156828894|NCT03906656|566125078|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
156828895|NCT00033540|566125079|FG000|Overall Study|Adverse Event|14|||
156828896|NCT00033540|566125079|FG000|Overall Study|Death|1|||
156828897|NCT00033540|566125079|FG000|Overall Study|Progression|26|||
156828898|NCT00033540|566125079|FG000|Overall Study|Withdrawal by Subject|6|||
157022985|NCT05603143|566836972|FG001|Overall Study|Lost to Follow-up|1|||
157022986|NCT05603143|566836971|FG000|Overall Study|Protocol Violation|0|||
157022987|NCT05603143|566836972|FG001|Overall Study|Protocol Violation|1|||
157151180|NCT00408421|567299622|FG000|Treatment Initial Randomization|Physician Decision|1|||
156828899|NCT00033540|566125079|FG000|Overall Study|Other|5|||
156828900|NCT00033540|566125079|FG000|Overall Study|Ineligible|3|||
157022988|NCT05609760|566836977|FG000|Overall Study|Lost to Follow-up|0|||
157022989|NCT05609760|566836978|FG001|Overall Study|Lost to Follow-up|1|||
157022990|NCT05609760|566836977|FG000|Overall Study|Withdrawal by Subject|1|||
157022991|NCT05609760|566836978|FG001|Overall Study|Withdrawal by Subject|0|||
157022992|NCT03396588|566836979|FG000|Overall Study|Physician Decision|2|||
157022993|NCT03396588|566836980|FG001|Overall Study|Physician Decision|3|||
157022994|NCT05179395|566836981|FG000|Overall Study|Lack of Efficacy|1|||
157022995|NCT00812461|566836983|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
157022996|NCT00812461|566836984|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
157022997|NCT00812461|566836983|FG000|All Treated Patients|Adverse Event|8|||
157022998|NCT00812461|566836984|FG001|All Treated Patients|Adverse Event|15|||
157022999|NCT00812461|566836983|FG000|All Treated Patients|Lack of Efficacy|13|||
157023000|NCT00812461|566836984|FG001|All Treated Patients|Lack of Efficacy|7|||
157023001|NCT00812461|566836983|FG000|All Treated Patients|Non-compliance|6|||
157023002|NCT00812461|566836984|FG001|All Treated Patients|Non-compliance|9|||
157023003|NCT00812461|566836983|FG000|All Treated Patients|Protocol Violation|36|||
157023004|NCT00812461|566836984|FG001|All Treated Patients|Protocol Violation|27|||
157023005|NCT00812461|566836983|FG000|All Treated Patients|Withdrawal by Subject|45|||
157023006|NCT00812461|566836984|FG001|All Treated Patients|Withdrawal by Subject|54|||
157023007|NCT00812461|566836983|FG000|All Treated Patients|Lost to Follow-up|11|||
157023008|NCT00812461|566836984|FG001|All Treated Patients|Lost to Follow-up|14|||
157023009|NCT00812461|566836983|FG000|All Treated Patients|Other Reason|13|||
157023010|NCT00812461|566836984|FG001|All Treated Patients|Other Reason|21|||
157023011|NCT02727699|566838698|FG000|Overall Study|Adverse Event|2|||
157023012|NCT02727699|566838699|FG001|Overall Study|Adverse Event|0|||
157023013|NCT02727699|566838698|FG000|Overall Study|Withdrawal by Subject|5|||
157023014|NCT02727699|566838699|FG001|Overall Study|Withdrawal by Subject|3|||
157023015|NCT02727699|566838698|FG000|Overall Study|Protocol Violation|0|||
157023016|NCT02727699|566838699|FG001|Overall Study|Protocol Violation|1|||
157023017|NCT02727699|566838698|FG000|Overall Study|Physician Decision|0|||
157023018|NCT02727699|566838699|FG001|Overall Study|Physician Decision|1|||
157023019|NCT02727699|566838698|FG000|Overall Study|Lost to Follow-up|1|||
157023020|NCT02727699|566838699|FG001|Overall Study|Lost to Follow-up|0|||
157023021|NCT02727699|566838698|FG000|Overall Study|Sponsor Decision|1|||
157023022|NCT02727699|566838699|FG001|Overall Study|Sponsor Decision|0|||
157023023|NCT04318548|566838704|FG000|Overall Study|Adverse Event|0|||
157023024|NCT04318548|566838705|FG001|Overall Study|Adverse Event|0|||
157023025|NCT04318548|566838706|FG002|Overall Study|Adverse Event|1|||
157023026|NCT04318548|566838704|FG000|Overall Study|Lost to Follow-up|6|||
157023027|NCT04318548|566838705|FG001|Overall Study|Lost to Follow-up|13|||
157023028|NCT04318548|566838706|FG002|Overall Study|Lost to Follow-up|9|||
157023029|NCT04318548|566838704|FG000|Overall Study|Protocol Violation|1|||
157023030|NCT04318548|566838705|FG001|Overall Study|Protocol Violation|0|||
157023031|NCT04318548|566838706|FG002|Overall Study|Protocol Violation|2|||
157023032|NCT04318548|566838704|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
157023033|NCT04318548|566838705|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
157023034|NCT04318548|566838706|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
157023035|NCT04318548|566838704|FG000|Overall Study|Migrated / moved from the study area|0|||
157023036|NCT04318548|566838705|FG001|Overall Study|Migrated / moved from the study area|0|||
157023037|NCT04318548|566838706|FG002|Overall Study|Migrated / moved from the study area|1|||
157023038|NCT04318548|566838704|FG000|Overall Study|Other|1|||
157023039|NCT04318548|566838705|FG001|Overall Study|Other|2|||
157023040|NCT04318548|566838706|FG002|Overall Study|Other|3|||
157023041|NCT05192200|566838710|FG000|Treatment Period|Other|1|||
157023042|NCT05192200|566838710|FG000|Treatment Period|Lack of Efficacy|1|||
157023043|NCT05192200|566838710|FG000|Treatment Period|Withdrawal by Subject|1|||
157023044|NCT05192200|566838710|FG000|Follow-up|Withdrawal by Subject|1|||
157023045|NCT03445988|566838711|FG000|Overall Study|Lost to Follow-up|14|||
157023046|NCT03445988|566838712|FG001|Overall Study|Lost to Follow-up|26|||
157023047|NCT03445988|566838713|FG002|Overall Study|Lost to Follow-up|27|||
157151181|NCT00408421|567299623|FG001|Treatment Initial Randomization|Physician Decision|0|||
157151182|NCT00408421|567299624|FG002|Treatment Initial Randomization|Physician Decision|0|||
157151183|NCT00408421|567299622|FG000|Treatment Initial Randomization|Protocol Violation|0|||
157151184|NCT00408421|567299623|FG001|Treatment Initial Randomization|Protocol Violation|1|||
157023048|NCT03445988|566838714|FG003|Overall Study|Lost to Follow-up|66|||
157023049|NCT03445988|566838711|FG000|Overall Study|Withdrawal by Subject|7|||
157023050|NCT03445988|566838712|FG001|Overall Study|Withdrawal by Subject|4|||
157023051|NCT03445988|566838713|FG002|Overall Study|Withdrawal by Subject|3|||
157023052|NCT03445988|566838714|FG003|Overall Study|Withdrawal by Subject|5|||
157023053|NCT03445988|566838711|FG000|Overall Study|Death (unrelated to study)|5|||
157023054|NCT03445988|566838712|FG001|Overall Study|Death (unrelated to study)|1|||
157023055|NCT03445988|566838713|FG002|Overall Study|Death (unrelated to study)|2|||
157023056|NCT03445988|566838714|FG003|Overall Study|Death (unrelated to study)|4|||
157023057|NCT03611621|566838740|FG000|Overall Study|Graft loss|3|||
157023058|NCT03611621|566838740|FG000|Overall Study|Death|3|||
157151185|NCT00408421|567299624|FG002|Treatment Initial Randomization|Protocol Violation|0|||
156828901|NCT00033540|566125079|FG000|Overall Study|Never received treatment|2|||
156828902|NCT01036529|566125080|FG000|Overall Study|Adverse Event|0|||
156828903|NCT01036529|566125081|FG001|Overall Study|Adverse Event|1|||
156828904|NCT01036529|566125080|FG000|Overall Study|Lost to Follow-up|0|||
156828905|NCT01036529|566125081|FG001|Overall Study|Lost to Follow-up|1|||
156828906|NCT01036529|566125080|FG000|Overall Study|Physician Decision|1|||
156828907|NCT01036529|566125081|FG001|Overall Study|Physician Decision|0|||
156828908|NCT01036529|566125080|FG000|Overall Study|Withdrawal by Subject|1|||
156828909|NCT01036529|566125081|FG001|Overall Study|Withdrawal by Subject|1|||
156828910|NCT01036529|566125080|FG000|Overall Study|Sponsor study termination|11|||
156828911|NCT01036529|566125081|FG001|Overall Study|Sponsor study termination|12|||
156828912|NCT00066469|566125093|FG000|Overall Study|Death|3|||
156828913|NCT00066469|566125093|FG000|Overall Study|Lack of Efficacy|9|||
156828914|NCT00066469|566125093|FG000|Overall Study|Lost to Follow-up|1|||
156828915|NCT00066469|566125093|FG000|Overall Study|Physician Decision|1|||
156828916|NCT00066469|566125093|FG000|Overall Study|Withdrawal by Subject|1|||
156828917|NCT00066469|566125093|FG000|Overall Study|ineligible|1|||
156828918|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Death|8|||
156828919|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Death|8|||
156828920|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Death|0|||
156828921|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Death|0|||
156828922|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
156828923|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828924|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828925|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
156828926|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828927|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
156828928|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828929|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
156828930|NCT03271047|566125094|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
156828931|NCT03271047|566125095|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
156828932|NCT03271047|566125096|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
156828933|NCT03271047|566125097|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
156828934|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Other|0|||
156828935|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Other|0|||
156828936|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Other|0|||
156828937|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Other|1|||
156828938|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Death|0|||
156828939|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Death|0|||
156828940|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Death|20|||
156828941|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Death|21|||
156828942|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
156828943|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
156828944|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
156828945|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
156828946|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828947|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828948|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
156828949|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
156828950|NCT03271047|566125094|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828951|NCT03271047|566125095|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828952|NCT03271047|566125096|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
156828953|NCT03271047|566125097|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
156828954|NCT00711802|566125098|FG000|Overall Study|Not treated (no further detail)|2|||
156828955|NCT00711802|566125099|FG001|Overall Study|Not treated (no further detail)|1|||
156828956|NCT00711802|566125100|FG002|Overall Study|Not treated (no further detail)|2|||
157023059|NCT03611621|566838740|FG000|Overall Study|Lost to Follow-up|1|||
156828957|NCT00711802|566125101|FG003|Overall Study|Not treated (no further detail)|0|||
156828958|NCT00711802|566125102|FG004|Overall Study|Not treated (no further detail)|2|||
156828959|NCT00711802|566125103|FG005|Overall Study|Not treated (no further detail)|0|||
156828960|NCT00711802|566125104|FG006|Overall Study|Not treated (no further detail)|0|||
156828961|NCT00711802|566125105|FG007|Overall Study|Not treated (no further detail)|0|||
156828962|NCT00711802|566125098|FG000|Overall Study|Adverse Event|0|||
156828963|NCT00711802|566125099|FG001|Overall Study|Adverse Event|0|||
156828964|NCT00711802|566125100|FG002|Overall Study|Adverse Event|0|||
156828965|NCT00711802|566125101|FG003|Overall Study|Adverse Event|0|||
156828966|NCT00711802|566125102|FG004|Overall Study|Adverse Event|1|||
157023060|NCT04764448|566838745|FG000|Overall Study|Study terminated by sponsor|2|||
156828967|NCT00711802|566125103|FG005|Overall Study|Adverse Event|1|||
156828968|NCT00711802|566125104|FG006|Overall Study|Adverse Event|0|||
157023061|NCT04764448|566838746|FG001|Overall Study|Study terminated by sponsor|2|||
157224519|NCT04799158|567568021|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
157224520|NCT04799158|567568022|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
156884950|NCT00816023|566336427|FG003|Overall Study|Physician Decision|0|||
156884951|NCT00816023|566336424|FG000|Overall Study|assessments complete prior to window|1|||
156884952|NCT00816023|566336425|FG001|Overall Study|assessments complete prior to window|1|||
156828969|NCT00711802|566125105|FG007|Overall Study|Adverse Event|0|||
156828970|NCT00711802|566125098|FG000|Overall Study|Microbiological failure|0|||
156828971|NCT00711802|566125099|FG001|Overall Study|Microbiological failure|1|||
156828972|NCT00711802|566125100|FG002|Overall Study|Microbiological failure|0|||
156828973|NCT00711802|566125101|FG003|Overall Study|Microbiological failure|0|||
156828974|NCT00711802|566125102|FG004|Overall Study|Microbiological failure|0|||
156828975|NCT00711802|566125103|FG005|Overall Study|Microbiological failure|1|||
156828976|NCT00711802|566125104|FG006|Overall Study|Microbiological failure|0|||
156828977|NCT00711802|566125105|FG007|Overall Study|Microbiological failure|0|||
156828978|NCT00711802|566125098|FG000|Overall Study|Protocol Violation|0|||
156828979|NCT00711802|566125099|FG001|Overall Study|Protocol Violation|0|||
156828980|NCT00711802|566125100|FG002|Overall Study|Protocol Violation|0|||
156828981|NCT00711802|566125101|FG003|Overall Study|Protocol Violation|1|||
156828982|NCT00711802|566125102|FG004|Overall Study|Protocol Violation|0|||
156828983|NCT00711802|566125103|FG005|Overall Study|Protocol Violation|0|||
156828984|NCT00711802|566125104|FG006|Overall Study|Protocol Violation|0|||
156828985|NCT00711802|566125105|FG007|Overall Study|Protocol Violation|0|||
156828986|NCT00711802|566125098|FG000|Overall Study|Physician Decision|0|||
156828987|NCT00711802|566125099|FG001|Overall Study|Physician Decision|2|||
156828988|NCT00711802|566125100|FG002|Overall Study|Physician Decision|0|||
156828989|NCT00711802|566125101|FG003|Overall Study|Physician Decision|0|||
156828990|NCT00711802|566125102|FG004|Overall Study|Physician Decision|0|||
156828991|NCT00711802|566125103|FG005|Overall Study|Physician Decision|0|||
156828992|NCT00711802|566125104|FG006|Overall Study|Physician Decision|0|||
156828993|NCT00711802|566125105|FG007|Overall Study|Physician Decision|0|||
156828994|NCT00711802|566125098|FG000|Overall Study|Withdrawal by Subject|0|||
156828995|NCT00711802|566125099|FG001|Overall Study|Withdrawal by Subject|1|||
156828996|NCT00711802|566125100|FG002|Overall Study|Withdrawal by Subject|0|||
156828997|NCT00711802|566125101|FG003|Overall Study|Withdrawal by Subject|1|||
156828998|NCT00711802|566125102|FG004|Overall Study|Withdrawal by Subject|0|||
156828999|NCT00711802|566125103|FG005|Overall Study|Withdrawal by Subject|0|||
156829000|NCT00711802|566125104|FG006|Overall Study|Withdrawal by Subject|0|||
156829001|NCT00711802|566125105|FG007|Overall Study|Withdrawal by Subject|0|||
156829002|NCT00711802|566125098|FG000|Overall Study|Lost to Follow-up|0|||
156829003|NCT00711802|566125099|FG001|Overall Study|Lost to Follow-up|0|||
156829004|NCT00711802|566125100|FG002|Overall Study|Lost to Follow-up|3|||
156829005|NCT00711802|566125101|FG003|Overall Study|Lost to Follow-up|1|||
156829006|NCT00711802|566125102|FG004|Overall Study|Lost to Follow-up|10|||
156884953|NCT00816023|566336426|FG002|Overall Study|assessments complete prior to window|2|||
157224521|NCT04799158|567568023|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
157224522|NCT04799158|567568019|FG000|On-Demand Treatment Period|Adverse Event|0|||
157224523|NCT04799158|567568020|FG001|On-Demand Treatment Period|Adverse Event|1|||
157224524|NCT04799158|567568021|FG002|On-Demand Treatment Period|Adverse Event|0|||
157224525|NCT04799158|567568022|FG003|On-Demand Treatment Period|Adverse Event|0|||
157224526|NCT04799158|567568023|FG004|On-Demand Treatment Period|Adverse Event|1|||
157224527|NCT04799158|567568019|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
157224528|NCT04799158|567568020|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
157224529|NCT04799158|567568021|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
157224530|NCT04799158|567568022|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
157224531|NCT04799158|567568023|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
157224532|NCT04799158|567568019|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
157224533|NCT04799158|567568020|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
157224534|NCT04799158|567568021|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
157224535|NCT04799158|567568022|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
157224536|NCT04799158|567568023|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
157224537|NCT04799158|567568019|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
157224538|NCT04799158|567568020|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
156829007|NCT00711802|566125103|FG005|Overall Study|Lost to Follow-up|6|||
156884954|NCT00816023|566336427|FG003|Overall Study|assessments complete prior to window|1|||
156884955|NCT00816023|566336424|FG000|Overall Study|Randomized Not Treated|6|||
157224539|NCT04799158|567568021|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
157224540|NCT04799158|567568022|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
156884956|NCT00816023|566336425|FG001|Overall Study|Randomized Not Treated|4|||
156884957|NCT00816023|566336426|FG002|Overall Study|Randomized Not Treated|6|||
156884958|NCT00816023|566336427|FG003|Overall Study|Randomized Not Treated|11|||
157224541|NCT04799158|567568023|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
157224542|NCT04799158|567568019|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
156829008|NCT00711802|566125104|FG006|Overall Study|Lost to Follow-up|4|||
156829009|NCT00711802|566125105|FG007|Overall Study|Lost to Follow-up|2|||
156829010|NCT00711802|566125098|FG000|Overall Study|Reason not reported|0|||
156829011|NCT00711802|566125099|FG001|Overall Study|Reason not reported|1|||
156829012|NCT00711802|566125100|FG002|Overall Study|Reason not reported|1|||
156829013|NCT00711802|566125101|FG003|Overall Study|Reason not reported|0|||
156829014|NCT00711802|566125102|FG004|Overall Study|Reason not reported|1|||
156829015|NCT00711802|566125103|FG005|Overall Study|Reason not reported|0|||
156829016|NCT00711802|566125104|FG006|Overall Study|Reason not reported|1|||
156829017|NCT00711802|566125105|FG007|Overall Study|Reason not reported|0|||
156829018|NCT03283150|566125107|FG000|Overall Study|Withdrawal by Subject|6|||
156829019|NCT03283150|566125108|FG001|Overall Study|Withdrawal by Subject|0|||
156829020|NCT03283150|566125109|FG002|Overall Study|Withdrawal by Subject|0|||
156829021|NCT05291936|566125110|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
156829022|NCT05291936|566125111|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
156829023|NCT05291936|566125110|FG000|Period 1|Withdrew Consent during study|1|||
156829024|NCT05291936|566125111|FG001|Period 1|Withdrew Consent during study|0|||
156829025|NCT05291936|566125110|FG000|Period 2|Adverse Event|0|||
156829026|NCT05291936|566125111|FG001|Period 2|Adverse Event|1|||
156829027|NCT05291936|566125110|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156829028|NCT05291936|566125111|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156829029|NCT02410824|566125112|FG000|First Intervention (One Week)|Headache|0|||
156829030|NCT02410824|566125113|FG001|First Intervention (One Week)|Headache|1|||
156829031|NCT02084238|566125114|FG000|Overall Study|Lost to Follow-up|2|||
156829032|NCT00392808|566125115|FG000|Overall Study|Lost to Follow-up|3|||
156829033|NCT00392808|566125116|FG001|Overall Study|Lost to Follow-up|2|||
156829034|NCT00392808|566125117|FG002|Overall Study|Lost to Follow-up|1|||
156829035|NCT00392808|566125118|FG003|Overall Study|Lost to Follow-up|2|||
156829036|NCT00392808|566125115|FG000|Overall Study|Unable to withdraw blood|3|||
156829037|NCT00392808|566125116|FG001|Overall Study|Unable to withdraw blood|1|||
156829038|NCT00392808|566125117|FG002|Overall Study|Unable to withdraw blood|1|||
156829039|NCT00392808|566125118|FG003|Overall Study|Unable to withdraw blood|2|||
156829040|NCT00391391|566125119|FG000|Overall Study|Adverse Event|0|||
156829041|NCT00391391|566125120|FG001|Overall Study|Adverse Event|0|||
156829042|NCT00391391|566125121|FG002|Overall Study|Adverse Event|0|||
156829043|NCT00391391|566125122|FG003|Overall Study|Adverse Event|1|||
156829044|NCT00391391|566125119|FG000|Overall Study|Lost to Follow-up|1|||
156829045|NCT00391391|566125120|FG001|Overall Study|Lost to Follow-up|3|||
156829046|NCT00391391|566125121|FG002|Overall Study|Lost to Follow-up|7|||
156829047|NCT00391391|566125122|FG003|Overall Study|Lost to Follow-up|4|||
156829048|NCT00391391|566125119|FG000|Overall Study|Protocol Violation|2|||
156829049|NCT00391391|566125120|FG001|Overall Study|Protocol Violation|3|||
156829050|NCT00391391|566125121|FG002|Overall Study|Protocol Violation|6|||
156829051|NCT00391391|566125122|FG003|Overall Study|Protocol Violation|7|||
156829052|NCT00391391|566125119|FG000|Overall Study|Withdrawal by Subject|6|||
156829053|NCT00391391|566125120|FG001|Overall Study|Withdrawal by Subject|4|||
156829054|NCT00391391|566125121|FG002|Overall Study|Withdrawal by Subject|10|||
156829055|NCT00391391|566125122|FG003|Overall Study|Withdrawal by Subject|7|||
156884959|NCT01960907|566336430|FG000|Overall Study|Death|4|||
156884960|NCT01960907|566336431|FG001|Overall Study|Death|3|||
156884961|NCT01960907|566336430|FG000|Overall Study|Withdrawal by Subject|32|||
156884962|NCT01960907|566336431|FG001|Overall Study|Withdrawal by Subject|42|||
156884963|NCT03612856|566336436|FG000|Pre-dose Period|Physician Decision|0|||
156884964|NCT03612856|566336437|FG001|Pre-dose Period|Physician Decision|1|||
156884965|NCT03612856|566336438|FG002|Pre-dose Period|Physician Decision|1|||
156884966|NCT03612856|566336436|FG000|Pre-dose Period|Withdrawal by Subject|0|||
156884967|NCT03612856|566336437|FG001|Pre-dose Period|Withdrawal by Subject|1|||
156884968|NCT03612856|566336438|FG002|Pre-dose Period|Withdrawal by Subject|0|||
156884969|NCT01181986|566336439|FG000|Phase 1|Lost to Follow-up|0|||
156884970|NCT01181986|566336440|FG001|Phase 1|Lost to Follow-up|1|||
156884971|NCT01181986|566336441|FG002|Phase 1|Lost to Follow-up|1|||
156884972|NCT01181986|566336439|FG000|Phase 1|Adverse Event|0|||
156884973|NCT01181986|566336440|FG001|Phase 1|Adverse Event|0|||
156884974|NCT01181986|566336441|FG002|Phase 1|Adverse Event|1|||
156884975|NCT01181986|566336439|FG000|Phase 1|Protocol Violation|1|||
156884976|NCT01181986|566336440|FG001|Phase 1|Protocol Violation|0|||
156884977|NCT01181986|566336441|FG002|Phase 1|Protocol Violation|0|||
156884978|NCT01181986|566336439|FG000|Phase 2|Adverse Event|0|||
156884979|NCT01181986|566336440|FG001|Phase 2|Adverse Event|3|||
156884980|NCT01181986|566336441|FG002|Phase 2|Adverse Event|0|||
156829056|NCT02436408|566125123|FG000|Overall Study|Death|1|||
156884981|NCT01181986|566336439|FG000|Phase 2|Medical condition|0|||
156884982|NCT01181986|566336440|FG001|Phase 2|Medical condition|1|||
156884983|NCT01181986|566336441|FG002|Phase 2|Medical condition|0|||
156884984|NCT00831493|566336443|FG000|Overall Study|Intractable nausea and vomiting|1|||
156829057|NCT02649855|566125124|FG000|Overall Study|Refused further treatment|2|||
156829058|NCT02649855|566125125|FG001|Overall Study|Refused further treatment|1|||
156829059|NCT02649855|566125126|FG002|Overall Study|Refused further treatment|1|||
156829060|NCT02649855|566125124|FG000|Overall Study|Withdrew consent|0|||
156829061|NCT02649855|566125125|FG001|Overall Study|Withdrew consent|1|||
156829062|NCT02649855|566125126|FG002|Overall Study|Withdrew consent|0|||
156884985|NCT02656680|566338189|FG000|Overall Study|Lost to Follow-up|0|||
156884986|NCT02656680|566338190|FG001|Overall Study|Lost to Follow-up|1|||
156884987|NCT02656680|566338191|FG002|Overall Study|Lost to Follow-up|7|||
156829063|NCT02649855|566125124|FG000|Overall Study|Switched to alternative treatment|0|||
156829064|NCT02649855|566125125|FG001|Overall Study|Switched to alternative treatment|1|||
156829065|NCT02649855|566125126|FG002|Overall Study|Switched to alternative treatment|1|||
156829066|NCT02649855|566125124|FG000|Overall Study|Principal investigator discretion|0|||
156829067|NCT02649855|566125125|FG001|Overall Study|Principal investigator discretion|1|||
156829068|NCT02649855|566125126|FG002|Overall Study|Principal investigator discretion|1|||
156829069|NCT02649855|566125124|FG000|Overall Study|No treatment, per protocol|1|||
157151186|NCT00408421|567299622|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
157151187|NCT00408421|567299623|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
157151188|NCT00408421|567299624|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
157151189|NCT00408421|567299622|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
157151190|NCT00408421|567299623|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
157151191|NCT00408421|567299624|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
157151192|NCT00408421|567299622|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
157151193|NCT00408421|567299623|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
157151194|NCT00408421|567299624|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
157151195|NCT00408421|567299622|FG000|Treatment Re-Randomization|Adverse Event|2|||
157151196|NCT00408421|567299623|FG001|Treatment Re-Randomization|Adverse Event|2|||
157151197|NCT00408421|567299624|FG002|Treatment Re-Randomization|Adverse Event|4|||
156829070|NCT02649855|566125125|FG001|Overall Study|No treatment, per protocol|0|||
156829071|NCT02649855|566125126|FG002|Overall Study|No treatment, per protocol|0|||
156829072|NCT02649855|566125124|FG000|Overall Study|Initiate new treatment|1|||
156829073|NCT02649855|566125125|FG001|Overall Study|Initiate new treatment|0|||
156829074|NCT02649855|566125126|FG002|Overall Study|Initiate new treatment|0|||
156829075|NCT01038713|566125127|FG000|Overall Study|Patient to hospice|1|||
156829076|NCT01038713|566125128|FG001|Overall Study|Patient to hospice|1|||
156829077|NCT01038713|566125129|FG002|Overall Study|Patient to hospice|1|||
156829078|NCT01038713|566125127|FG000|Overall Study|Lost to Follow-up|3|||
156829079|NCT01038713|566125128|FG001|Overall Study|Lost to Follow-up|0|||
156829080|NCT01038713|566125129|FG002|Overall Study|Lost to Follow-up|0|||
156829081|NCT01038713|566125127|FG000|Overall Study|Neuroendocrine Tumor|0|||
156829082|NCT01038713|566125128|FG001|Overall Study|Neuroendocrine Tumor|1|||
156829083|NCT01038713|566125129|FG002|Overall Study|Neuroendocrine Tumor|0|||
156829084|NCT01038713|566125127|FG000|Overall Study|died from PEP|0|||
156829085|NCT01038713|566125128|FG001|Overall Study|died from PEP|1|||
156829086|NCT01038713|566125129|FG002|Overall Study|died from PEP|0|||
156829087|NCT01038713|566125127|FG000|Overall Study|Autoimmune Pancreatitis|1|||
156829088|NCT01038713|566125128|FG001|Overall Study|Autoimmune Pancreatitis|0|||
156829089|NCT01038713|566125129|FG002|Overall Study|Autoimmune Pancreatitis|0|||
156829090|NCT03777917|566125130|FG000|Overall Study|Withdrawal by Subject|1|||
156829091|NCT03777917|566125131|FG001|Overall Study|Withdrawal by Subject|0|||
157151198|NCT00408421|567299622|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
156829092|NCT03777917|566125130|FG000|Overall Study|Physician Decision|1|||
156829093|NCT03777917|566125131|FG001|Overall Study|Physician Decision|0|||
156829094|NCT03777917|566125130|FG000|Overall Study|Lost to Follow-up|6|||
156829095|NCT03777917|566125131|FG001|Overall Study|Lost to Follow-up|2|||
156829096|NCT03777917|566125130|FG000|Overall Study|Other|1|||
156829097|NCT03777917|566125131|FG001|Overall Study|Other|0|||
157151199|NCT00408421|567299623|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
157151200|NCT00408421|567299624|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
157151201|NCT00408421|567299622|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
156829098|NCT01154283|566125132|FG000|0-6 Weeks|Withdrawal by Subject|7|||
156829099|NCT01154283|566125133|FG001|0-6 Weeks|Withdrawal by Subject|2|||
156884988|NCT00002931|566338194|FG000|Overall Study|rapidly progressing disease during|2|||
156884989|NCT04531462|566338195|FG000|Overall Study|Withdrawal by Subject|3|||
156884990|NCT04531462|566338196|FG001|Overall Study|Withdrawal by Subject|1|||
156884991|NCT04531462|566338195|FG000|Overall Study|Adverse Event|3|||
156884992|NCT04531462|566338196|FG001|Overall Study|Adverse Event|3|||
156884993|NCT00348933|566338199|FG000|Overall Study|Withdrawal by Subject|10|||
156884994|NCT00348933|566338199|FG000|Overall Study|Lost to Follow-up|6|||
156884995|NCT00348933|566338199|FG000|Overall Study|Protocol Violation|2|||
156884996|NCT00348933|566338199|FG000|Overall Study|Adverse Event|7|||
156884997|NCT01727700|566338200|FG000|Overall Study|Adverse Event|0|||
156884998|NCT01727700|566338201|FG001|Overall Study|Adverse Event|7|||
156884999|NCT01727700|566338202|FG002|Overall Study|Adverse Event|1|||
156885000|NCT01727700|566338200|FG000|Overall Study|Particpant withdrew consent|0|||
156885001|NCT01727700|566338201|FG001|Overall Study|Particpant withdrew consent|3|||
156885002|NCT01727700|566338202|FG002|Overall Study|Particpant withdrew consent|1|||
157151202|NCT00408421|567299623|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
156829100|NCT01154283|566125132|FG000|0-6 Weeks|Death|0|||
156885003|NCT01727700|566338200|FG000|Overall Study|Protocol Violation|2|||
156885004|NCT01727700|566338201|FG001|Overall Study|Protocol Violation|0|||
156829101|NCT01154283|566125133|FG001|0-6 Weeks|Death|1|||
156829102|NCT01154283|566125132|FG000|7-12 Weeks|Death|1|||
156829103|NCT01154283|566125133|FG001|7-12 Weeks|Death|0|||
156885005|NCT01727700|566338202|FG002|Overall Study|Protocol Violation|0|||
156829104|NCT01154283|566125132|FG000|7-12 Weeks|Withdrawal by Subject|0|||
156829105|NCT01154283|566125133|FG001|7-12 Weeks|Withdrawal by Subject|1|||
156829106|NCT00320372|566125134|FG000|Overall Study|Physician Decision|4|||
156829107|NCT00320372|566125135|FG001|Overall Study|Physician Decision|7|||
156829108|NCT00320372|566125134|FG000|Overall Study|Death|7|||
156829109|NCT00320372|566125135|FG001|Overall Study|Death|8|||
156829110|NCT00320372|566125134|FG000|Overall Study|Withdrawal by Subject|55|||
156829111|NCT00320372|566125135|FG001|Overall Study|Withdrawal by Subject|37|||
156829112|NCT00320372|566125134|FG000|Overall Study|Non-Compliance|40|||
156829113|NCT00320372|566125135|FG001|Overall Study|Non-Compliance|39|||
156829114|NCT00320372|566125134|FG000|Overall Study|Did not Meet (I/E)|3|||
156829115|NCT00320372|566125135|FG001|Overall Study|Did not Meet (I/E)|1|||
156829116|NCT00320372|566125134|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
156829117|NCT00320372|566125135|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
156829118|NCT04063787|566125136|FG000|Overall Study|Inadequate Doppler data|4|||
156829119|NCT04063787|566125136|FG000|Overall Study|Lost to Follow-up|2|||
156885006|NCT01444092|566338205|FG000|Overall Study|Adverse Event|8|||
156885007|NCT01444092|566338205|FG000|Overall Study|Protocol Violation|1|||
156885008|NCT01444092|566338205|FG000|Overall Study|Withdrawal by Subject|1|||
156885009|NCT01444092|566338205|FG000|Overall Study|Other Eligibility criteria|7|||
156885010|NCT01328366|566338206|FG000|Overall Study|Death|1|||
156885011|NCT01328366|566338206|FG000|Overall Study|Withdrawal by Subject|2|||
156885012|NCT01328366|566338206|FG000|Overall Study|Lost to Follow-up|7|||
156885013|NCT00603590|566338207|FG000|Overall Study|Did not attend study clinic|39|||
156885014|NCT00603590|566338208|FG001|Overall Study|Did not attend study clinic|30|||
156885015|NCT00603590|566338207|FG000|Overall Study|Refused blood test|5|||
156885016|NCT00603590|566338208|FG001|Overall Study|Refused blood test|1|||
156885017|NCT00603590|566338207|FG000|Overall Study|Patient discontinued study drug|22|||
156885018|NCT00603590|566338208|FG001|Overall Study|Patient discontinued study drug|15|||
156885019|NCT00603590|566338207|FG000|Overall Study|Adverse Event|2|||
156885020|NCT00603590|566338208|FG001|Overall Study|Adverse Event|0|||
156885021|NCT00603590|566338207|FG000|Overall Study|Lost to Follow-up|8|||
156885022|NCT00603590|566338208|FG001|Overall Study|Lost to Follow-up|4|||
156885023|NCT00603590|566338207|FG000|Overall Study|Cardiovascular event|0|||
156885024|NCT00603590|566338208|FG001|Overall Study|Cardiovascular event|1|||
156885025|NCT03005873|566338209|FG000|Overall Study|Prohibited medication use post radnomization|1|||
156885026|NCT03005873|566338210|FG001|Overall Study|Prohibited medication use post radnomization|1|||
156885027|NCT03005873|566338211|FG002|Overall Study|Prohibited medication use post radnomization|1|||
156885028|NCT03005873|566338209|FG000|Overall Study|Withdrew consent|0|||
156885029|NCT03005873|566338210|FG001|Overall Study|Withdrew consent|1|||
156885030|NCT03005873|566338211|FG002|Overall Study|Withdrew consent|2|||
156885031|NCT03005873|566338209|FG000|Overall Study|Lost to Follow-up|0|||
156885032|NCT03005873|566338210|FG001|Overall Study|Lost to Follow-up|1|||
156885033|NCT03005873|566338211|FG002|Overall Study|Lost to Follow-up|0|||
156885034|NCT03005873|566338209|FG000|Overall Study|Ineligible post randomization|0|||
156885035|NCT03005873|566338210|FG001|Overall Study|Ineligible post randomization|0|||
156885036|NCT03005873|566338211|FG002|Overall Study|Ineligible post randomization|1|||
156885037|NCT03699475|566338212|FG000|Overall Study|Death|1|||
156885038|NCT01713933|566338215|FG000|Overall Study|Lost to Follow-up|2|||
156885039|NCT01713933|566338215|FG000|Overall Study|Withdrawal by Subject|3|||
156885040|NCT01713933|566338215|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
156885041|NCT00528970|566338216|FG000|Overall Study|Adverse Event|6|||
156885042|NCT00528970|566338217|FG001|Overall Study|Adverse Event|8|||
156885043|NCT00528970|566338218|FG002|Overall Study|Adverse Event|5|||
156885044|NCT00528970|566338216|FG000|Overall Study|Lost to Follow-up|0|||
156885045|NCT00528970|566338217|FG001|Overall Study|Lost to Follow-up|0|||
156885046|NCT00528970|566338218|FG002|Overall Study|Lost to Follow-up|1|||
156885047|NCT00528970|566338216|FG000|Overall Study|Other than specified|2|||
156885048|NCT00528970|566338217|FG001|Overall Study|Other than specified|3|||
156885049|NCT00528970|566338218|FG002|Overall Study|Other than specified|3|||
156885050|NCT00528970|566338216|FG000|Overall Study|Protocol Violation|2|||
156885051|NCT00528970|566338217|FG001|Overall Study|Protocol Violation|1|||
156829120|NCT04063787|566125136|FG000|Overall Study|Death|3|||
156829121|NCT01853072|566125137|FG000|Overall Study|Adverse event prior to treatment|0|||
156829122|NCT01853072|566125138|FG001|Overall Study|Adverse event prior to treatment|1|||
156829123|NCT01853072|566125137|FG000|Overall Study|Adverse Event|0|||
156829124|NCT01853072|566125138|FG001|Overall Study|Adverse Event|3|||
156885052|NCT00528970|566338218|FG002|Overall Study|Protocol Violation|4|||
156885053|NCT00528970|566338216|FG000|Overall Study|Lack of Efficacy|0|||
156885054|NCT00528970|566338217|FG001|Overall Study|Lack of Efficacy|0|||
156885055|NCT00528970|566338218|FG002|Overall Study|Lack of Efficacy|1|||
156885056|NCT00528970|566338216|FG000|Overall Study|Withdrawal by Subject|4|||
156885057|NCT00528970|566338217|FG001|Overall Study|Withdrawal by Subject|3|||
156829125|NCT01853072|566125137|FG000|Overall Study|Death|1|||
156829126|NCT01853072|566125138|FG001|Overall Study|Death|4|||
156829127|NCT01853072|566125137|FG000|Overall Study|Lost to Follow-up|0|||
156885058|NCT00528970|566338218|FG002|Overall Study|Withdrawal by Subject|5|||
157023062|NCT04764448|566838747|FG002|Overall Study|Study terminated by sponsor|5|||
157023063|NCT04764448|566838745|FG000|Overall Study|Withdrawal by Subject|3|||
157023064|NCT04764448|566838746|FG001|Overall Study|Withdrawal by Subject|3|||
157023065|NCT04764448|566838747|FG002|Overall Study|Withdrawal by Subject|1|||
157023066|NCT01084876|566838748|FG000|Main Study Treatment Period|Adverse Event|12|||
157023067|NCT01084876|566838749|FG001|Main Study Treatment Period|Adverse Event|7|||
157023068|NCT01084876|566838748|FG000|Main Study Treatment Period|Disease Progression|41|||
157023069|NCT01084876|566838749|FG001|Main Study Treatment Period|Disease Progression|24|||
157023070|NCT01084876|566838748|FG000|Main Study Treatment Period|Physician Decision|2|||
157023071|NCT01084876|566838749|FG001|Main Study Treatment Period|Physician Decision|0|||
157023072|NCT01084876|566838748|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
157023073|NCT01084876|566838749|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
157023074|NCT01084876|566838748|FG000|Main Study Treatment Period|Other Reason|0|||
157023075|NCT01084876|566838749|FG001|Main Study Treatment Period|Other Reason|1|||
157023076|NCT01084876|566838748|FG000|Main Study Treatment Period|Other|0|||
157023077|NCT01084876|566838749|FG001|Main Study Treatment Period|Other|1|||
157023078|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
157023079|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
157023080|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
157023081|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
157023082|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
157023083|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
157023084|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
157023085|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
157023086|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
157023087|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
157023088|NCT01084876|566838748|FG000|Treatment Period Beyond Cycle 8|Other|6|||
157023089|NCT01084876|566838749|FG001|Treatment Period Beyond Cycle 8|Other|9|||
157023090|NCT05653427|566838750|FG000|Overall Study|Study Terminated by Sponsor|13|||
157023091|NCT03891667|566838756|FG000|Overall Study|Physician Decision|1|||
157023092|NCT03891667|566838757|FG001|Overall Study|Physician Decision|1|||
157023093|NCT03891667|566838756|FG000|Overall Study|COVID related pause|1|||
157023094|NCT03891667|566838757|FG001|Overall Study|COVID related pause|0|||
157023095|NCT03891667|566838756|FG000|Overall Study|Withdrawal by Subject|0|||
157023096|NCT03891667|566838757|FG001|Overall Study|Withdrawal by Subject|1|||
157023097|NCT03891667|566838756|FG000|Overall Study|Adverse Event|0|||
157023098|NCT03891667|566838757|FG001|Overall Study|Adverse Event|1|||
157023099|NCT04256941|566838758|FG000|Overall Study|Withdrawal by Subject|0|||
157023100|NCT04256941|566838759|FG001|Overall Study|Withdrawal by Subject|1|||
157023101|NCT04256941|566838758|FG000|Overall Study|Death|1|||
157023102|NCT04256941|566838759|FG001|Overall Study|Death|0|||
157023103|NCT04256941|566838758|FG000|Overall Study|Disease Progession|0|||
157023104|NCT04256941|566838759|FG001|Overall Study|Disease Progession|2|||
157023105|NCT05659537|566838766|FG000|Overall Study|Adverse Event|5|||
157023106|NCT05659537|566838766|FG000|Overall Study|Lost to Follow-up|4|||
157023107|NCT05659537|566838766|FG000|Overall Study|Withdrawal by Subject|13|||
157023108|NCT05659537|566838766|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
157023109|NCT05659537|566838766|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
157023110|NCT05659537|566838766|FG000|Overall Study|Participant was suffering from anaemia|1|||
157023111|NCT04971395|566838767|FG000|Overall Study|Withdrawal by Subject|0|||
157023112|NCT04971395|566838768|FG001|Overall Study|Withdrawal by Subject|1|||
157023113|NCT04971395|566838769|FG002|Overall Study|Withdrawal by Subject|0|||
157023114|NCT00506519|566838775|FG000|Overall Study|Death|4|||
157023115|NCT00506519|566838776|FG001|Overall Study|Death|6|||
157023116|NCT00506519|566838777|FG002|Overall Study|Death|0|||
157023117|NCT00506519|566838775|FG000|Overall Study|Adverse Event|1|||
157023118|NCT00506519|566838776|FG001|Overall Study|Adverse Event|0|||
157023119|NCT00506519|566838777|FG002|Overall Study|Adverse Event|0|||
157023120|NCT02975882|566838778|FG000|Overall Study|Adverse Event|1|||
157151203|NCT00408421|567299624|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
156829128|NCT01853072|566125138|FG001|Overall Study|Lost to Follow-up|3|||
156829129|NCT01853072|566125137|FG000|Overall Study|Non-compliance with study drug|0|||
156829130|NCT01853072|566125138|FG001|Overall Study|Non-compliance with study drug|1|||
156829131|NCT01853072|566125137|FG000|Overall Study|Physician Decision|1|||
157023121|NCT02975882|566838779|FG001|Overall Study|Adverse Event|2|||
157023122|NCT02975882|566838780|FG002|Overall Study|Adverse Event|1|||
157023123|NCT02975882|566838781|FG003|Overall Study|Adverse Event|1|||
157023124|NCT02975882|566838778|FG000|Overall Study|Death|0|||
157023125|NCT02975882|566838779|FG001|Overall Study|Death|1|||
157023126|NCT02975882|566838780|FG002|Overall Study|Death|0|||
157023127|NCT02975882|566838781|FG003|Overall Study|Death|0|||
157023128|NCT02975882|566838778|FG000|Overall Study|Lack of Efficacy|3|||
157023129|NCT02975882|566838779|FG001|Overall Study|Lack of Efficacy|7|||
157023130|NCT02975882|566838780|FG002|Overall Study|Lack of Efficacy|4|||
157151204|NCT00408421|567299622|FG000|Treatment Re-Randomization|Physician Decision|1|||
157023131|NCT02975882|566838781|FG003|Overall Study|Lack of Efficacy|3|||
156829132|NCT01853072|566125138|FG001|Overall Study|Physician Decision|1|||
156829133|NCT01853072|566125137|FG000|Overall Study|Withdrawal by Subject|1|||
156829134|NCT01853072|566125138|FG001|Overall Study|Withdrawal by Subject|2|||
156829135|NCT01853072|566125137|FG000|Overall Study|Reason not specified|9|||
156829136|NCT01853072|566125138|FG001|Overall Study|Reason not specified|6|||
156829137|NCT00930969|566125139|FG000|Overall Study|Death|5|||
156829138|NCT00930969|566125139|FG000|Overall Study|Lost to Follow-up|1|||
156829139|NCT00930969|566125139|FG000|Overall Study|Physician Decision|13|||
156829140|NCT00930969|566125139|FG000|Overall Study|Withdrawal by Subject|19|||
156829141|NCT01287221|566125140|FG000|Overall Study|Lack of Perceived Benefit|1|||
156829142|NCT01287221|566125141|FG001|Overall Study|Lack of Perceived Benefit|1|||
156829143|NCT01287221|566125140|FG000|Overall Study|Adverse Event|3|||
156829144|NCT01287221|566125141|FG001|Overall Study|Adverse Event|3|||
156829145|NCT01287221|566125140|FG000|Overall Study|Withdrawal by Subject|0|||
156829146|NCT01287221|566125141|FG001|Overall Study|Withdrawal by Subject|1|||
156829147|NCT00657150|566125142|FG000|Overall Study|Adverse Event|19|||
156829148|NCT00657150|566125143|FG001|Overall Study|Adverse Event|10|||
156829149|NCT00657150|566125142|FG000|Overall Study|Non-compliant with protocol|5|||
156829150|NCT00657150|566125143|FG001|Overall Study|Non-compliant with protocol|9|||
156829151|NCT00657150|566125142|FG000|Overall Study|Lost to Follow-up|2|||
156829152|NCT00657150|566125143|FG001|Overall Study|Lost to Follow-up|0|||
156829153|NCT00657150|566125142|FG000|Overall Study|Withdrawal by Subject|51|||
156829154|NCT00657150|566125143|FG001|Overall Study|Withdrawal by Subject|36|||
156829155|NCT00657150|566125142|FG000|Overall Study|Other|38|||
156829156|NCT00657150|566125143|FG001|Overall Study|Other|38|||
156829157|NCT00657150|566125142|FG000|Treatment|Adverse Event|60|||
156829158|NCT00657150|566125143|FG001|Treatment|Adverse Event|53|||
156829159|NCT00657150|566125142|FG000|Treatment|Non-compliant with protocol|10|||
156829160|NCT00657150|566125143|FG001|Treatment|Non-compliant with protocol|9|||
156829161|NCT00657150|566125142|FG000|Treatment|Lost to Follow-up|1|||
156829162|NCT00657150|566125143|FG001|Treatment|Lost to Follow-up|0|||
156829163|NCT00657150|566125142|FG000|Treatment|Withdrawal by Subject|23|||
156829164|NCT00657150|566125143|FG001|Treatment|Withdrawal by Subject|20|||
156829165|NCT00657150|566125142|FG000|Treatment|Other|13|||
156829166|NCT00657150|566125143|FG001|Treatment|Other|15|||
156829167|NCT02653495|566125158|FG000|Overall Study|Lost to Follow-up|2|||
156829168|NCT02653495|566125159|FG001|Overall Study|Lost to Follow-up|0|||
156829169|NCT02653495|566125158|FG000|Overall Study|Screening Failure|10|||
156829170|NCT02653495|566125159|FG001|Overall Study|Screening Failure|0|||
156829171|NCT00461305|566125160|FG000|Treatment|Adverse Event|26|||
156829172|NCT00461305|566125161|FG001|Treatment|Adverse Event|3|||
156829173|NCT00461305|566125160|FG000|Treatment|Lost to Follow-up|4|||
156829174|NCT00461305|566125161|FG001|Treatment|Lost to Follow-up|2|||
156829175|NCT00461305|566125160|FG000|Treatment|Protocol Violation|13|||
156829176|NCT00461305|566125161|FG001|Treatment|Protocol Violation|2|||
156829177|NCT00461305|566125160|FG000|Treatment|Withdrawal by Subject|48|||
156829178|NCT00461305|566125161|FG001|Treatment|Withdrawal by Subject|2|||
156829179|NCT00461305|566125160|FG000|Treatment|Never dispensed|5|||
156829180|NCT00461305|566125161|FG001|Treatment|Never dispensed|0|||
156829181|NCT00461305|566125160|FG000|Treatment|Study drug not taken|1|||
156829182|NCT00461305|566125161|FG001|Treatment|Study drug not taken|0|||
156829183|NCT00461305|566125160|FG000|Treatment|Partially missing diary|2|||
156829184|NCT00461305|566125161|FG001|Treatment|Partially missing diary|0|||
156829185|NCT00461305|566125160|FG000|Treatment|Other (missing drug etc)|2|||
156829186|NCT00461305|566125161|FG001|Treatment|Other (missing drug etc)|0|||
156829187|NCT00461305|566125160|FG000|Continued Treatment|Adverse Event|26|||
156829188|NCT00461305|566125161|FG001|Continued Treatment|Adverse Event|0|||
156829189|NCT00461305|566125160|FG000|Continued Treatment|Lost to Follow-up|4|||
156829190|NCT00461305|566125161|FG001|Continued Treatment|Lost to Follow-up|0|||
156829191|NCT00461305|566125160|FG000|Continued Treatment|Protocol Violation|13|||
156829192|NCT00461305|566125161|FG001|Continued Treatment|Protocol Violation|0|||
156829193|NCT00461305|566125160|FG000|Continued Treatment|Withdrawal by Subject|48|||
156885059|NCT00528970|566338216|FG000|Overall Study|Randomized but not treated|0|||
156829194|NCT00461305|566125161|FG001|Continued Treatment|Withdrawal by Subject|0|||
156829195|NCT00461305|566125160|FG000|Continued Treatment|Partially missing diary|2|||
156829196|NCT00461305|566125161|FG001|Continued Treatment|Partially missing diary|0|||
156829197|NCT00461305|566125160|FG000|Continued Treatment|Other (missing drug etc)|2|||
156829198|NCT00461305|566125161|FG001|Continued Treatment|Other (missing drug etc)|0|||
156829199|NCT01896271|566125163|FG000|Overall Study|Physician Decision|10|||
156829200|NCT01294462|566125164|FG000|Overall Study|Lost to Follow-up|1|||
156829201|NCT01294462|566125165|FG001|Overall Study|Lost to Follow-up|0|||
156829202|NCT01294462|566125164|FG000|Overall Study|Withdrawal by Subject|65|||
156885060|NCT00528970|566338217|FG001|Overall Study|Randomized but not treated|0|||
156829203|NCT01294462|566125165|FG001|Overall Study|Withdrawal by Subject|63|||
156829204|NCT02743780|566125166|FG000|Part 3 (7 Days)|Adverse Event|0|||
156829205|NCT02743780|566125167|FG001|Part 3 (7 Days)|Adverse Event|0|||
156829206|NCT02743780|566125168|FG002|Part 3 (7 Days)|Adverse Event|1|||
156829207|NCT02743780|566125169|FG003|Part 3 (7 Days)|Adverse Event|0|||
156829208|NCT02743780|566125170|FG004|Part 3 (7 Days)|Adverse Event|0|||
156829209|NCT01460407|566125176|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
156829210|NCT01460407|566125177|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
156829211|NCT01400243|566125178|FG000|Overall Study|Protocol Violation|8|||
156829212|NCT01400243|566125179|FG001|Overall Study|Protocol Violation|11|||
156829213|NCT00953680|566125180|FG000|Period 1|Withdrawal by Subject|0|||
156829214|NCT00953680|566125181|FG001|Period 1|Withdrawal by Subject|1|||
156829215|NCT01703117|566127072|FG000|Overall Study|Adverse Event|4|||
156829216|NCT01703117|566127073|FG001|Overall Study|Adverse Event|3|||
156829217|NCT01703117|566127072|FG000|Overall Study|Withdrawal by Subject|0|||
156829218|NCT01703117|566127073|FG001|Overall Study|Withdrawal by Subject|1|||
156829219|NCT00440310|566127075|FG000|Overall Study|Lost to Follow-up|4|||
156829220|NCT00440310|566127076|FG001|Overall Study|Lost to Follow-up|5|||
156829221|NCT00440310|566127075|FG000|Overall Study|Protocol Violation|0|||
156829222|NCT00440310|566127076|FG001|Overall Study|Protocol Violation|1|||
156829223|NCT00440310|566127075|FG000|Overall Study|Withdrawal by Subject|15|||
156829224|NCT00440310|566127076|FG001|Overall Study|Withdrawal by Subject|14|||
156829225|NCT00440310|566127075|FG000|Overall Study|No Reply at EOS|7|||
156829226|NCT00440310|566127076|FG001|Overall Study|No Reply at EOS|7|||
156829227|NCT00440310|566127075|FG000|Overall Study|Other|1|||
156829228|NCT00440310|566127076|FG001|Overall Study|Other|0|||
156829229|NCT00440310|566127075|FG000|Overall Study|Status Unknown|1|||
156829230|NCT00440310|566127076|FG001|Overall Study|Status Unknown|3|||
156829231|NCT02469415|566127077|FG000|Overall Study|Withdrawal by Subject|1|||
156829232|NCT02469415|566127077|FG000|Overall Study|Investigational agent placed on hold|2|||
156829233|NCT00330928|566127085|FG000|Overall Study|Lost to Follow-up|6|||
156829234|NCT00330928|566127085|FG000|Overall Study|Physician Decision|9|||
156829235|NCT00330928|566127085|FG000|Overall Study|Death|1|||
156829236|NCT00330928|566127085|FG000|Overall Study|IVUS could not be performed.|1|||
156829237|NCT03028480|566127088|FG000|Overall Study|No revisit after the first prescription date|2|||
156829238|NCT03028480|566127088|FG000|Overall Study|Did not use the drug|1|||
156829239|NCT03028480|566127088|FG000|Overall Study|Violation of the enrollment deadline|10|||
156829240|NCT03028480|566127088|FG000|Overall Study|Case report forms were not collected|21|||
156829241|NCT02403635|566127091|FG000|Overall Study|Not eligible|9|||
156829242|NCT03554772|566127094|FG000|Overall Study|Lost to Follow-up|0|||
156829243|NCT03554772|566127095|FG001|Overall Study|Lost to Follow-up|0|||
156829244|NCT03554772|566127096|FG002|Overall Study|Lost to Follow-up|0|||
156829245|NCT03554772|566127097|FG003|Overall Study|Lost to Follow-up|2|||
156829246|NCT03362931|566127099|FG000|Overall Study|Adverse Event|1|||
156829247|NCT03362931|566127099|FG000|Overall Study|Death|2|||
156885061|NCT00528970|566338218|FG002|Overall Study|Randomized but not treated|1|||
156885062|NCT02882152|566338219|FG000|Overall Study|Lost to Follow-up|1|||
156885063|NCT02882152|566338220|FG001|Overall Study|Lost to Follow-up|0|||
156885064|NCT01009840|566338223|FG000|Overall Study|Lost to Follow-up|1|||
156885065|NCT01009840|566338223|FG000|Overall Study|Adverse Event|4|||
156885066|NCT01009840|566338223|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
156885067|NCT01009840|566338223|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
156885068|NCT01009840|566338223|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
156885069|NCT00797966|566338228|FG000|Phase A|Lost to Follow-up|0|||
156885070|NCT00797966|566338229|FG001|Phase A|Lost to Follow-up|0|||
156885071|NCT00797966|566338230|FG002|Phase A|Lost to Follow-up|0|||
156885072|NCT00797966|566338231|FG003|Phase A|Lost to Follow-up|0|||
156885073|NCT00797966|566338232|FG004|Phase A|Lost to Follow-up|33|||
156885074|NCT00797966|566338233|FG005|Phase A|Lost to Follow-up|0|||
156885075|NCT00797966|566338228|FG000|Phase A|Adverse Event|0|||
156885076|NCT00797966|566338229|FG001|Phase A|Adverse Event|0|||
156885077|NCT00797966|566338230|FG002|Phase A|Adverse Event|0|||
156885078|NCT00797966|566338231|FG003|Phase A|Adverse Event|0|||
156885079|NCT00797966|566338232|FG004|Phase A|Adverse Event|46|||
156885080|NCT00797966|566338233|FG005|Phase A|Adverse Event|0|||
156885081|NCT00797966|566338228|FG000|Phase A|Met withdrawal criteria|0|||
157151205|NCT00408421|567299623|FG001|Treatment Re-Randomization|Physician Decision|3|||
156829248|NCT01998893|566127100|FG000|Overall Study|Adverse Event|2|||
156829249|NCT01998893|566127100|FG000|Overall Study|Death|1|||
156829250|NCT01998893|566127100|FG000|Overall Study|Lost to Follow-up|8|||
156829251|NCT01998893|566127100|FG000|Overall Study|Physician Decision|2|||
156829252|NCT01998893|566127100|FG000|Overall Study|Protocol Violation|2|||
156829253|NCT01998893|566127100|FG000|Overall Study|Withdrawal by Subject|1|||
156829254|NCT01998893|566127100|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
156829255|NCT03276052|566127101|FG000|Overall Study|Withdrawal by Subject|5|||
156829256|NCT03276052|566127101|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
156885082|NCT00797966|566338229|FG001|Phase A|Met withdrawal criteria|0|||
156885083|NCT00797966|566338230|FG002|Phase A|Met withdrawal criteria|0|||
157023132|NCT02975882|566838778|FG000|Overall Study|Physician Decision|0|||
156885084|NCT00797966|566338231|FG003|Phase A|Met withdrawal criteria|0|||
157023133|NCT02975882|566838779|FG001|Overall Study|Physician Decision|2|||
157151206|NCT00408421|567299624|FG002|Treatment Re-Randomization|Physician Decision|0|||
156829257|NCT05136898|566127106|FG000|Overall Study|Adverse Event|2|||
156829258|NCT01133405|566127107|FG000|Period 1|Withdrawal by Subject|0|||
156885085|NCT00797966|566338232|FG004|Phase A|Met withdrawal criteria|4|||
156829259|NCT01133405|566127108|FG001|Period 1|Withdrawal by Subject|1|||
156829260|NCT01133405|566127109|FG002|Period 1|Withdrawal by Subject|0|||
156829261|NCT01133405|566127110|FG003|Period 1|Withdrawal by Subject|1|||
156829262|NCT01133405|566127111|FG004|Period 1|Withdrawal by Subject|0|||
156829263|NCT01133405|566127112|FG005|Period 1|Withdrawal by Subject|1|||
156829264|NCT01133405|566127113|FG006|Period 1|Withdrawal by Subject|0|||
156829265|NCT01133405|566127114|FG007|Period 1|Withdrawal by Subject|0|||
156829266|NCT01133405|566127115|FG008|Period 1|Withdrawal by Subject|0|||
156829267|NCT01133405|566127116|FG009|Period 1|Withdrawal by Subject|0|||
156829268|NCT01133405|566127107|FG000|Period 1|Physician Decision|0|||
156829269|NCT01133405|566127108|FG001|Period 1|Physician Decision|0|||
156829270|NCT01133405|566127109|FG002|Period 1|Physician Decision|0|||
156829271|NCT01133405|566127110|FG003|Period 1|Physician Decision|1|||
156829272|NCT01133405|566127111|FG004|Period 1|Physician Decision|0|||
156829273|NCT01133405|566127112|FG005|Period 1|Physician Decision|0|||
156829274|NCT01133405|566127113|FG006|Period 1|Physician Decision|0|||
156829275|NCT01133405|566127114|FG007|Period 1|Physician Decision|0|||
156829276|NCT01133405|566127115|FG008|Period 1|Physician Decision|0|||
156829277|NCT01133405|566127116|FG009|Period 1|Physician Decision|0|||
156829278|NCT01133405|566127107|FG000|Period 1|Discontinued after randomization|1|||
156829279|NCT01133405|566127108|FG001|Period 1|Discontinued after randomization|0|||
156829280|NCT01133405|566127109|FG002|Period 1|Discontinued after randomization|0|||
156829281|NCT01133405|566127110|FG003|Period 1|Discontinued after randomization|0|||
156829282|NCT01133405|566127111|FG004|Period 1|Discontinued after randomization|0|||
156829283|NCT01133405|566127112|FG005|Period 1|Discontinued after randomization|0|||
156829284|NCT01133405|566127113|FG006|Period 1|Discontinued after randomization|1|||
156829285|NCT01133405|566127114|FG007|Period 1|Discontinued after randomization|0|||
156829286|NCT01133405|566127115|FG008|Period 1|Discontinued after randomization|0|||
156829287|NCT01133405|566127116|FG009|Period 1|Discontinued after randomization|0|||
156829288|NCT01133405|566127107|FG000|Period 1|Received drug only in period 2|0|||
156829289|NCT01133405|566127108|FG001|Period 1|Received drug only in period 2|1|||
156829290|NCT01133405|566127109|FG002|Period 1|Received drug only in period 2|0|||
156829291|NCT01133405|566127110|FG003|Period 1|Received drug only in period 2|2|||
156829292|NCT01133405|566127111|FG004|Period 1|Received drug only in period 2|0|||
156829293|NCT01133405|566127112|FG005|Period 1|Received drug only in period 2|1|||
156829294|NCT01133405|566127113|FG006|Period 1|Received drug only in period 2|0|||
156829295|NCT01133405|566127114|FG007|Period 1|Received drug only in period 2|0|||
156829296|NCT01133405|566127115|FG008|Period 1|Received drug only in period 2|0|||
156829297|NCT01133405|566127116|FG009|Period 1|Received drug only in period 2|0|||
156829298|NCT01133405|566127107|FG000|Period 1|Received drug only in period 3|0|||
156829299|NCT01133405|566127108|FG001|Period 1|Received drug only in period 3|1|||
156829300|NCT01133405|566127109|FG002|Period 1|Received drug only in period 3|1|||
156829301|NCT01133405|566127110|FG003|Period 1|Received drug only in period 3|0|||
156829302|NCT01133405|566127111|FG004|Period 1|Received drug only in period 3|0|||
156829303|NCT01133405|566127112|FG005|Period 1|Received drug only in period 3|0|||
156829304|NCT01133405|566127113|FG006|Period 1|Received drug only in period 3|0|||
156829305|NCT01133405|566127114|FG007|Period 1|Received drug only in period 3|0|||
156829306|NCT01133405|566127115|FG008|Period 1|Received drug only in period 3|0|||
156829307|NCT01133405|566127116|FG009|Period 1|Received drug only in period 3|0|||
156829308|NCT01133405|566127107|FG000|Period 2|Adverse Event|0|||
156829309|NCT01133405|566127108|FG001|Period 2|Adverse Event|0|||
156829310|NCT01133405|566127109|FG002|Period 2|Adverse Event|1|||
156829311|NCT01133405|566127110|FG003|Period 2|Adverse Event|0|||
156829312|NCT01133405|566127111|FG004|Period 2|Adverse Event|0|||
156829313|NCT01133405|566127112|FG005|Period 2|Adverse Event|0|||
156829314|NCT01133405|566127113|FG006|Period 2|Adverse Event|0|||
156829315|NCT01133405|566127114|FG007|Period 2|Adverse Event|0|||
156829316|NCT01133405|566127115|FG008|Period 2|Adverse Event|0|||
156829317|NCT01133405|566127116|FG009|Period 2|Adverse Event|0|||
156829318|NCT01133405|566127107|FG000|Period 2|Withdrawal by Subject|0|||
156829319|NCT01133405|566127108|FG001|Period 2|Withdrawal by Subject|0|||
156829320|NCT01133405|566127109|FG002|Period 2|Withdrawal by Subject|0|||
156829321|NCT01133405|566127110|FG003|Period 2|Withdrawal by Subject|1|||
156829322|NCT01133405|566127111|FG004|Period 2|Withdrawal by Subject|0|||
156829323|NCT01133405|566127112|FG005|Period 2|Withdrawal by Subject|1|||
156829324|NCT01133405|566127113|FG006|Period 2|Withdrawal by Subject|0|||
156829325|NCT01133405|566127114|FG007|Period 2|Withdrawal by Subject|0|||
156829326|NCT01133405|566127115|FG008|Period 2|Withdrawal by Subject|0|||
156829327|NCT01133405|566127116|FG009|Period 2|Withdrawal by Subject|0|||
156829328|NCT01133405|566127107|FG000|Period 2|Entry Criteria Not Met|0|||
156829329|NCT01133405|566127108|FG001|Period 2|Entry Criteria Not Met|1|||
156829330|NCT01133405|566127109|FG002|Period 2|Entry Criteria Not Met|0|||
156829331|NCT01133405|566127110|FG003|Period 2|Entry Criteria Not Met|0|||
156829332|NCT01133405|566127111|FG004|Period 2|Entry Criteria Not Met|0|||
156829333|NCT01133405|566127112|FG005|Period 2|Entry Criteria Not Met|0|||
156829334|NCT01133405|566127113|FG006|Period 2|Entry Criteria Not Met|0|||
156829335|NCT01133405|566127114|FG007|Period 2|Entry Criteria Not Met|0|||
156829336|NCT01133405|566127115|FG008|Period 2|Entry Criteria Not Met|0|||
156829337|NCT01133405|566127116|FG009|Period 2|Entry Criteria Not Met|0|||
156829338|NCT01133405|566127107|FG000|Period 2|Physician Decision|0|||
156829339|NCT01133405|566127108|FG001|Period 2|Physician Decision|0|||
156829340|NCT01133405|566127109|FG002|Period 2|Physician Decision|0|||
156829341|NCT01133405|566127110|FG003|Period 2|Physician Decision|0|||
156829342|NCT01133405|566127111|FG004|Period 2|Physician Decision|0|||
156829343|NCT01133405|566127112|FG005|Period 2|Physician Decision|1|||
156829344|NCT01133405|566127113|FG006|Period 2|Physician Decision|0|||
156829345|NCT01133405|566127114|FG007|Period 2|Physician Decision|0|||
156829346|NCT01133405|566127115|FG008|Period 2|Physician Decision|0|||
156829347|NCT01133405|566127116|FG009|Period 2|Physician Decision|0|||
156829348|NCT03300024|566127119|FG000|Overall Study|Physician Decision|4|||
156829349|NCT03300024|566127120|FG001|Overall Study|Physician Decision|6|||
156829350|NCT01238835|566127121|FG000|Overall Study|Death|124|||
156829351|NCT01238835|566127121|FG000|Overall Study|Withdrawal by Subject|9|||
156829352|NCT01238835|566127121|FG000|Overall Study|Lost to Follow-up|1|||
156829353|NCT01238835|566127121|FG000|Overall Study|Site early discontinuation|2|||
156829354|NCT00554619|566127122|FG000|Overall Study|Adverse Event|1|||
156829355|NCT00554619|566127122|FG000|Overall Study|Physician Decision|1|||
156829356|NCT00554619|566127122|FG000|Overall Study|Liver Function Test Abnormality|1|||
156829357|NCT00907803|566127126|FG000|Overall Study|Withdrawal of consent - long commute|1|||
156829358|NCT00907803|566127127|FG001|Overall Study|Withdrawal of consent - long commute|0|||
156829359|NCT00907803|566127128|FG002|Overall Study|Withdrawal of consent - long commute|0|||
156829360|NCT00907803|566127126|FG000|Overall Study|Adverse Event|2|||
156829361|NCT00907803|566127127|FG001|Overall Study|Adverse Event|0|||
156829362|NCT00907803|566127128|FG002|Overall Study|Adverse Event|0|||
156829363|NCT00907803|566127126|FG000|Overall Study|Withdrawal by Subject|0|||
156829364|NCT00907803|566127127|FG001|Overall Study|Withdrawal by Subject|1|||
156829365|NCT00907803|566127128|FG002|Overall Study|Withdrawal by Subject|0|||
156829366|NCT00907803|566127126|FG000|Overall Study|Lost to Follow-up|0|||
156829367|NCT00907803|566127127|FG001|Overall Study|Lost to Follow-up|1|||
156829368|NCT00907803|566127128|FG002|Overall Study|Lost to Follow-up|0|||
156829369|NCT00907803|566127126|FG000|Overall Study|Protocol Violation|0|||
156829370|NCT00907803|566127127|FG001|Overall Study|Protocol Violation|1|||
156829371|NCT00907803|566127128|FG002|Overall Study|Protocol Violation|0|||
156829372|NCT01118520|566127133|FG000|Overall Study|AAA repair|9|||
156829373|NCT01118520|566127134|FG001|Overall Study|AAA repair|7|||
156829374|NCT01118520|566127135|FG002|Overall Study|AAA repair|9|||
156829375|NCT01118520|566127133|FG000|Overall Study|Adverse Event|3|||
156829376|NCT01118520|566127134|FG001|Overall Study|Adverse Event|3|||
156829377|NCT01118520|566127135|FG002|Overall Study|Adverse Event|3|||
156829378|NCT01118520|566127133|FG000|Overall Study|Withdrawal by Subject|8|||
156829379|NCT01118520|566127134|FG001|Overall Study|Withdrawal by Subject|13|||
156829380|NCT01118520|566127135|FG002|Overall Study|Withdrawal by Subject|8|||
156829381|NCT03958656|566127136|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829382|NCT03958656|566127137|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
156829383|NCT03958656|566127138|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829384|NCT03958656|566127139|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
156829385|NCT03958656|566127136|FG000|Overall Study|No longer meets eligibility criteria|0|||
156829386|NCT03958656|566127137|FG001|Overall Study|No longer meets eligibility criteria|0|||
156829387|NCT03958656|566127138|FG002|Overall Study|No longer meets eligibility criteria|1|||
156829388|NCT03958656|566127139|FG003|Overall Study|No longer meets eligibility criteria|0|||
156829389|NCT03958656|566127136|FG000|Overall Study|Started anti-cancer treatment|0|||
156829390|NCT03958656|566127137|FG001|Overall Study|Started anti-cancer treatment|0|||
156829391|NCT03958656|566127138|FG002|Overall Study|Started anti-cancer treatment|1|||
156829392|NCT03958656|566127139|FG003|Overall Study|Started anti-cancer treatment|0|||
156829393|NCT03158012|566127140|FG000|Overall Study|Withdrawal by Subject|0|||
156829394|NCT03158012|566127141|FG001|Overall Study|Withdrawal by Subject|1|||
156829395|NCT01852825|566127142|FG000|Overall Study|Withdrawal by Subject|2|||
156829396|NCT01852825|566127143|FG001|Overall Study|Withdrawal by Subject|0|||
156829397|NCT01852825|566127144|FG002|Overall Study|Withdrawal by Subject|0|||
156829398|NCT02214225|566127151|FG000|Overall Study|Lost to Follow-up|46|||
156829399|NCT02214225|566127152|FG001|Overall Study|Lost to Follow-up|18|||
156829400|NCT02214225|566127153|FG002|Overall Study|Lost to Follow-up|18|||
156829401|NCT02214225|566127151|FG000|Overall Study|Withdrawal by Subject|2|||
156829402|NCT02214225|566127152|FG001|Overall Study|Withdrawal by Subject|0|||
156829403|NCT02214225|566127153|FG002|Overall Study|Withdrawal by Subject|2|||
156829404|NCT02214225|566127151|FG000|Overall Study|Death|5|||
156829405|NCT02214225|566127152|FG001|Overall Study|Death|0|||
156829406|NCT02214225|566127153|FG002|Overall Study|Death|1|||
156829407|NCT02214225|566127151|FG000|Overall Study|randomized in error, not vaccinated|2|||
156829408|NCT02214225|566127152|FG001|Overall Study|randomized in error, not vaccinated|1|||
156829409|NCT02214225|566127153|FG002|Overall Study|randomized in error, not vaccinated|1|||
156829410|NCT03987932|566127154|FG000|Overall Study|Lost to Follow-up|2|||
156829411|NCT03987932|566127155|FG001|Overall Study|Lost to Follow-up|1|||
156829412|NCT03987932|566127156|FG002|Overall Study|Lost to Follow-up|1|||
156829413|NCT03987932|566127154|FG000|Overall Study|Non-study related elective surgery|0|||
156829414|NCT03987932|566127155|FG001|Overall Study|Non-study related elective surgery|0|||
156829415|NCT03987932|566127156|FG002|Overall Study|Non-study related elective surgery|1|||
156829416|NCT01669421|566127159|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
156829417|NCT01669421|566127159|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
156829418|NCT02961790|566127161|FG000|Overall Study|Canceled|4|||
156829419|NCT02961790|566127162|FG001|Overall Study|Canceled|5|||
156829420|NCT02961790|566127163|FG002|Overall Study|Canceled|1|||
156829421|NCT02961790|566127164|FG003|Overall Study|Canceled|4|||
156829422|NCT02961790|566127161|FG000|Overall Study|without baseline data|4|||
156829423|NCT02961790|566127162|FG001|Overall Study|without baseline data|0|||
156829424|NCT02961790|566127163|FG002|Overall Study|without baseline data|1|||
156829425|NCT02961790|566127164|FG003|Overall Study|without baseline data|0|||
156829426|NCT02961790|566127161|FG000|Overall Study|without post baseline data|7|||
156829427|NCT02961790|566127162|FG001|Overall Study|without post baseline data|6|||
156829428|NCT02961790|566127163|FG002|Overall Study|without post baseline data|4|||
156829429|NCT02961790|566127164|FG003|Overall Study|without post baseline data|1|||
156829430|NCT02078102|566127167|FG000|Overall Study|Adverse Event|1|||
156829431|NCT02078102|566127168|FG001|Overall Study|Adverse Event|0|||
156829432|NCT02078102|566127167|FG000|Overall Study|Withdrawal by Subject|1|||
156829433|NCT02078102|566127168|FG001|Overall Study|Withdrawal by Subject|0|||
156829434|NCT02078102|566127167|FG000|Overall Study|Physician Decision|0|||
156829435|NCT02078102|566127168|FG001|Overall Study|Physician Decision|1|||
156829436|NCT02185014|566127171|FG000|Overall Study|Adverse Event|18|||
156829437|NCT02185014|566127171|FG000|Overall Study|Withdrew Consent|8|||
156829438|NCT02185014|566127171|FG000|Overall Study|Lost to Follow-up|4|||
156829439|NCT02185014|566127171|FG000|Overall Study|Lack of Efficacy|14|||
156829440|NCT02185014|566127171|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
156829441|NCT02185014|566127171|FG000|Overall Study|Subject Noncompliance|1|||
156829442|NCT02185014|566127171|FG000|Overall Study|Other|4|||
156829443|NCT01813721|566127175|FG000|Overall Study|Ineligibility determined|63|||
156829444|NCT01813721|566127175|FG000|Overall Study|Withdrawal by Subject|1|||
156829445|NCT02370641|566127176|FG000|Overall Study|dropped study|4|||
156829446|NCT02370641|566127177|FG001|Overall Study|dropped study|2|||
156829447|NCT02133664|566127180|FG000|Overall Study|Lost to Follow-up|2|||
156829448|NCT02133664|566127181|FG001|Overall Study|Lost to Follow-up|1|||
156829449|NCT02133664|566127180|FG000|Overall Study|Adverse Event|3|||
156829450|NCT02133664|566127181|FG001|Overall Study|Adverse Event|6|||
156829451|NCT02120365|566127184|FG000|Overall Study|Withdrawal by Subject|0|||
156829452|NCT02120365|566127185|FG001|Overall Study|Withdrawal by Subject|0|||
156829453|NCT02120365|566127186|FG002|Overall Study|Withdrawal by Subject|2|||
156829454|NCT02120365|566127187|FG003|Overall Study|Withdrawal by Subject|4|||
156829455|NCT02120365|566127188|FG004|Overall Study|Withdrawal by Subject|0|||
156829456|NCT02120365|566127189|FG005|Overall Study|Withdrawal by Subject|2|||
156829457|NCT00343915|566127191|FG000|Primary Study|Withdrawal by Subject|1|||
156829458|NCT00343915|566127192|FG001|Primary Study|Withdrawal by Subject|0|||
156829459|NCT00343915|566127191|FG000|Primary Study|Lost to Follow-up|2|||
156829460|NCT00343915|566127192|FG001|Primary Study|Lost to Follow-up|3|||
156829461|NCT00343915|566127191|FG000|Primary Study|Other|1|||
156829462|NCT00343915|566127192|FG001|Primary Study|Other|0|||
156829463|NCT01719003|566127193|FG000|Overall Study|Non compliant with protocol|1|||
156829464|NCT01719003|566127194|FG001|Overall Study|Non compliant with protocol|1|||
156829465|NCT01719003|566127195|FG002|Overall Study|Non compliant with protocol|0|||
156885086|NCT00797966|566338233|FG005|Phase A|Met withdrawal criteria|0|||
156885087|NCT00797966|566338228|FG000|Phase A|Physician Decision|0|||
156885088|NCT00797966|566338229|FG001|Phase A|Physician Decision|0|||
156829466|NCT01719003|566127196|FG003|Overall Study|Non compliant with protocol|1|||
156829467|NCT01719003|566127197|FG004|Overall Study|Non compliant with protocol|2|||
156829468|NCT01719003|566127198|FG005|Overall Study|Non compliant with protocol|1|||
156829469|NCT01719003|566127199|FG006|Overall Study|Non compliant with protocol|2|||
156829470|NCT01719003|566127200|FG007|Overall Study|Non compliant with protocol|3|||
156829471|NCT01719003|566127201|FG008|Overall Study|Non compliant with protocol|0|||
156829472|NCT01719003|566127193|FG000|Overall Study|Adverse Event|6|||
156829473|NCT01719003|566127194|FG001|Overall Study|Adverse Event|5|||
156829474|NCT01719003|566127195|FG002|Overall Study|Adverse Event|4|||
156829475|NCT01719003|566127196|FG003|Overall Study|Adverse Event|3|||
156829476|NCT01719003|566127197|FG004|Overall Study|Adverse Event|4|||
156829477|NCT01719003|566127198|FG005|Overall Study|Adverse Event|3|||
156829478|NCT01719003|566127199|FG006|Overall Study|Adverse Event|6|||
156829479|NCT01719003|566127200|FG007|Overall Study|Adverse Event|5|||
156829480|NCT01719003|566127201|FG008|Overall Study|Adverse Event|0|||
156829481|NCT01719003|566127193|FG000|Overall Study|Lost to Follow-up|0|||
156829482|NCT01719003|566127194|FG001|Overall Study|Lost to Follow-up|6|||
156829483|NCT01719003|566127195|FG002|Overall Study|Lost to Follow-up|7|||
156829484|NCT01719003|566127196|FG003|Overall Study|Lost to Follow-up|2|||
156829485|NCT01719003|566127197|FG004|Overall Study|Lost to Follow-up|3|||
156829486|NCT01719003|566127198|FG005|Overall Study|Lost to Follow-up|4|||
156829487|NCT01719003|566127199|FG006|Overall Study|Lost to Follow-up|3|||
156829488|NCT01719003|566127200|FG007|Overall Study|Lost to Follow-up|2|||
156829489|NCT01719003|566127201|FG008|Overall Study|Lost to Follow-up|2|||
156829490|NCT01719003|566127193|FG000|Overall Study|Refusal to continue, not due to AE|2|||
156829491|NCT01719003|566127194|FG001|Overall Study|Refusal to continue, not due to AE|5|||
156829492|NCT01719003|566127195|FG002|Overall Study|Refusal to continue, not due to AE|4|||
156829493|NCT01719003|566127196|FG003|Overall Study|Refusal to continue, not due to AE|4|||
156829494|NCT01719003|566127197|FG004|Overall Study|Refusal to continue, not due to AE|4|||
156829495|NCT01719003|566127198|FG005|Overall Study|Refusal to continue, not due to AE|3|||
156829496|NCT01719003|566127199|FG006|Overall Study|Refusal to continue, not due to AE|8|||
156829497|NCT01719003|566127200|FG007|Overall Study|Refusal to continue, not due to AE|7|||
156829498|NCT01719003|566127201|FG008|Overall Study|Refusal to continue, not due to AE|1|||
156829499|NCT01719003|566127193|FG000|Overall Study|Reason other than those specified|0|||
156829500|NCT01719003|566127194|FG001|Overall Study|Reason other than those specified|0|||
156829501|NCT01719003|566127195|FG002|Overall Study|Reason other than those specified|2|||
156829502|NCT01719003|566127196|FG003|Overall Study|Reason other than those specified|3|||
156829503|NCT01719003|566127197|FG004|Overall Study|Reason other than those specified|4|||
156829504|NCT01719003|566127198|FG005|Overall Study|Reason other than those specified|1|||
156829505|NCT01719003|566127199|FG006|Overall Study|Reason other than those specified|0|||
156829506|NCT01719003|566127200|FG007|Overall Study|Reason other than those specified|3|||
156829507|NCT01719003|566127201|FG008|Overall Study|Reason other than those specified|1|||
156829508|NCT01719003|566127193|FG000|Overall Study|Lack of Efficacy|0|||
156829509|NCT01719003|566127194|FG001|Overall Study|Lack of Efficacy|0|||
156829510|NCT01719003|566127195|FG002|Overall Study|Lack of Efficacy|0|||
156829511|NCT01719003|566127196|FG003|Overall Study|Lack of Efficacy|0|||
156829512|NCT01719003|566127197|FG004|Overall Study|Lack of Efficacy|0|||
156829513|NCT01719003|566127198|FG005|Overall Study|Lack of Efficacy|0|||
156829514|NCT01719003|566127199|FG006|Overall Study|Lack of Efficacy|1|||
156829515|NCT01719003|566127200|FG007|Overall Study|Lack of Efficacy|0|||
156829516|NCT01719003|566127201|FG008|Overall Study|Lack of Efficacy|0|||
156829517|NCT00882908|566127203|FG000|Overall Study|Adverse Event|0|||
156829518|NCT00882908|566127204|FG001|Overall Study|Adverse Event|0|||
156829519|NCT00882908|566127205|FG002|Overall Study|Adverse Event|1|||
156829520|NCT00882908|566127206|FG003|Overall Study|Adverse Event|0|||
156829521|NCT00882908|566127207|FG004|Overall Study|Adverse Event|1|||
156829522|NCT00882908|566127203|FG000|Overall Study|Lost to Follow-up|3|||
156829523|NCT00882908|566127204|FG001|Overall Study|Lost to Follow-up|5|||
156829524|NCT00882908|566127205|FG002|Overall Study|Lost to Follow-up|3|||
156829525|NCT00882908|566127206|FG003|Overall Study|Lost to Follow-up|1|||
156829526|NCT00882908|566127207|FG004|Overall Study|Lost to Follow-up|2|||
156829527|NCT00882908|566127203|FG000|Overall Study|Protocol Violation|0|||
156829528|NCT00882908|566127204|FG001|Overall Study|Protocol Violation|1|||
156829529|NCT00882908|566127205|FG002|Overall Study|Protocol Violation|0|||
156829530|NCT00882908|566127206|FG003|Overall Study|Protocol Violation|0|||
156829531|NCT00882908|566127207|FG004|Overall Study|Protocol Violation|0|||
156829532|NCT00882908|566127203|FG000|Overall Study|Withdrawal by Subject|0|||
156829533|NCT00882908|566127204|FG001|Overall Study|Withdrawal by Subject|0|||
156829534|NCT00882908|566127205|FG002|Overall Study|Withdrawal by Subject|3|||
156829535|NCT00882908|566127206|FG003|Overall Study|Withdrawal by Subject|5|||
156829536|NCT00882908|566127207|FG004|Overall Study|Withdrawal by Subject|2|||
156829537|NCT00882908|566127203|FG000|Overall Study|Subject reached a virologic endpoint|0|||
156829538|NCT00882908|566127204|FG001|Overall Study|Subject reached a virologic endpoint|0|||
156829539|NCT00882908|566127205|FG002|Overall Study|Subject reached a virologic endpoint|0|||
156829540|NCT00882908|566127206|FG003|Overall Study|Subject reached a virologic endpoint|0|||
156829541|NCT00882908|566127207|FG004|Overall Study|Subject reached a virologic endpoint|1|||
156829542|NCT00882908|566127203|FG000|Overall Study|Study terminated in error|0|||
156829543|NCT00882908|566127204|FG001|Overall Study|Study terminated in error|0|||
156829544|NCT00882908|566127205|FG002|Overall Study|Study terminated in error|0|||
156829545|NCT00882908|566127206|FG003|Overall Study|Study terminated in error|1|||
156829546|NCT00882908|566127207|FG004|Overall Study|Study terminated in error|0|||
156829547|NCT00581828|566127208|FG000|Overall Study|Protocol Violation|1|||
156829548|NCT02370095|566127209|FG000|Overall Study|Withdrawal by Subject|0|||
156829549|NCT02370095|566127210|FG001|Overall Study|Withdrawal by Subject|1|||
156829550|NCT00700102|566127211|FG000|Overall Study|Died|394|||
156829551|NCT00700102|566127212|FG001|Overall Study|Died|385|||
156829552|NCT00700102|566127211|FG000|Overall Study|Lost to Follow-up|8|||
156829553|NCT00700102|566127212|FG001|Overall Study|Lost to Follow-up|10|||
156829554|NCT02525939|566127213|FG000|Overall Study|Lost to Follow-up|27|||
156829555|NCT02525939|566127214|FG001|Overall Study|Lost to Follow-up|24|||
156829556|NCT02525939|566127213|FG000|Overall Study|Physician Decision|0|||
156829557|NCT02525939|566127214|FG001|Overall Study|Physician Decision|1|||
156829558|NCT02525939|566127213|FG000|Overall Study|Withdrawal by Subject|24|||
156829559|NCT02525939|566127214|FG001|Overall Study|Withdrawal by Subject|39|||
156829560|NCT02525939|566127213|FG000|Overall Study|Death|180|||
156829561|NCT02525939|566127214|FG001|Overall Study|Death|179|||
156829562|NCT01667562|566127215|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
156829563|NCT01667562|566127216|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
156829564|NCT01667562|566127215|FG000|Erlotinib Phase|Lost to Follow-up|0|||
156829565|NCT01667562|566127216|FG001|Erlotinib Phase|Lost to Follow-up|1|||
156829566|NCT01667562|566127215|FG000|Erlotinib Phase|Adverse Event|0|||
156829567|NCT01667562|566127216|FG001|Erlotinib Phase|Adverse Event|1|||
156829568|NCT01667562|566127215|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
156829569|NCT01667562|566127216|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
156829570|NCT01028716|566127217|FG000|Overall Study|Physician Decision|1|||
156829571|NCT02130986|566127218|FG000|Overall Study|Withdrawal by Subject|4|||
156829572|NCT02130986|566127219|FG001|Overall Study|Withdrawal by Subject|4|||
156829573|NCT02130986|566127218|FG000|Overall Study|Lost to Follow-up|151|||
156829574|NCT02130986|566127219|FG001|Overall Study|Lost to Follow-up|160|||
156829575|NCT01129882|566127220|FG000|Overall Study|Adverse Event|39|||
156829576|NCT01129882|566127220|FG000|Overall Study|Death|6|||
156829577|NCT01129882|566127220|FG000|Overall Study|Lack of Efficacy|5|||
156829578|NCT01129882|566127220|FG000|Overall Study|Lost to Follow-up|13|||
156829579|NCT01129882|566127220|FG000|Overall Study|Physician Decision|27|||
156829580|NCT01129882|566127220|FG000|Overall Study|Protocol Deviation|3|||
156829581|NCT01129882|566127220|FG000|Overall Study|Withdrawal Criteria Met|19|||
156829582|NCT01129882|566127220|FG000|Overall Study|Trial Termination by Sponsor|6|||
156829583|NCT01129882|566127220|FG000|Overall Study|Withdrawal by Subject|160|||
156829584|NCT02305849|566127221|FG000|Overall Study|Adverse Event|10|||
156829585|NCT02305849|566127222|FG001|Overall Study|Adverse Event|12|||
156829586|NCT02305849|566127223|FG002|Overall Study|Adverse Event|7|||
156829587|NCT02305849|566127224|FG003|Overall Study|Adverse Event|3|||
156829588|NCT02305849|566127221|FG000|Overall Study|Lack of Efficacy|10|||
156829589|NCT02305849|566127222|FG001|Overall Study|Lack of Efficacy|6|||
156829590|NCT02305849|566127223|FG002|Overall Study|Lack of Efficacy|3|||
156829591|NCT02305849|566127224|FG003|Overall Study|Lack of Efficacy|9|||
156829592|NCT02305849|566127221|FG000|Overall Study|Withdrawal by Subject|2|||
156829593|NCT02305849|566127222|FG001|Overall Study|Withdrawal by Subject|2|||
156829594|NCT02305849|566127223|FG002|Overall Study|Withdrawal by Subject|1|||
156829595|NCT02305849|566127224|FG003|Overall Study|Withdrawal by Subject|4|||
156829596|NCT02305849|566127221|FG000|Overall Study|Lost to Follow-up|0|||
156829597|NCT02305849|566127222|FG001|Overall Study|Lost to Follow-up|2|||
156829598|NCT02305849|566127223|FG002|Overall Study|Lost to Follow-up|0|||
156829599|NCT02305849|566127224|FG003|Overall Study|Lost to Follow-up|0|||
156829600|NCT02305849|566127221|FG000|Overall Study|Protocol Violation|3|||
156829601|NCT02305849|566127222|FG001|Overall Study|Protocol Violation|2|||
156829602|NCT02305849|566127223|FG002|Overall Study|Protocol Violation|1|||
156829603|NCT02305849|566127224|FG003|Overall Study|Protocol Violation|1|||
156829604|NCT02305849|566127221|FG000|Overall Study|Lab data met discontinuation criteria|0|||
156829605|NCT02305849|566127222|FG001|Overall Study|Lab data met discontinuation criteria|1|||
156829606|NCT02305849|566127223|FG002|Overall Study|Lab data met discontinuation criteria|2|||
156829607|NCT02305849|566127224|FG003|Overall Study|Lab data met discontinuation criteria|1|||
156829608|NCT02305849|566127221|FG000|Overall Study|Miscellaneous|1|||
156829609|NCT02305849|566127222|FG001|Overall Study|Miscellaneous|2|||
156829610|NCT02305849|566127223|FG002|Overall Study|Miscellaneous|4|||
156829611|NCT02305849|566127224|FG003|Overall Study|Miscellaneous|1|||
156829612|NCT02305849|566127221|FG000|Overall Study|Not fulfill eligibility criteria|1|||
156829613|NCT02305849|566127222|FG001|Overall Study|Not fulfill eligibility criteria|1|||
157023134|NCT02975882|566838780|FG002|Overall Study|Physician Decision|4|||
157023135|NCT02975882|566838781|FG003|Overall Study|Physician Decision|2|||
156829614|NCT02305849|566127223|FG002|Overall Study|Not fulfill eligibility criteria|0|||
156829615|NCT02305849|566127224|FG003|Overall Study|Not fulfill eligibility criteria|0|||
156829616|NCT00355342|566127225|FG000|Overall Study|Adverse Event|13|||
156829617|NCT00355342|566127226|FG001|Overall Study|Adverse Event|15|||
156829618|NCT00355342|566127225|FG000|Overall Study|Lost to Follow-up|4|||
156829619|NCT00355342|566127226|FG001|Overall Study|Lost to Follow-up|2|||
157023136|NCT02975882|566838778|FG000|Overall Study|Ineligible|0|||
156829620|NCT00355342|566127225|FG000|Overall Study|Withdrawal by Subject|14|||
156829621|NCT00355342|566127226|FG001|Overall Study|Withdrawal by Subject|11|||
156829622|NCT00355342|566127225|FG000|Overall Study|Sponsor terminated study|2|||
156829623|NCT00355342|566127226|FG001|Overall Study|Sponsor terminated study|2|||
156829624|NCT00355342|566127225|FG000|Overall Study|Overcompliant-PI discretion|1|||
156829625|NCT00355342|566127226|FG001|Overall Study|Overcompliant-PI discretion|0|||
156829626|NCT00355342|566127225|FG000|Overall Study|Use of prohibited medication|1|||
156829627|NCT00355342|566127226|FG001|Overall Study|Use of prohibited medication|0|||
156829628|NCT00355342|566127225|FG000|Overall Study|COPD exacerbation|1|||
156829629|NCT00355342|566127226|FG001|Overall Study|COPD exacerbation|1|||
156829630|NCT00355342|566127225|FG000|Overall Study|Dispensed wrong study drug kit|1|||
156829631|NCT00355342|566127226|FG001|Overall Study|Dispensed wrong study drug kit|0|||
156829632|NCT00355342|566127225|FG000|Overall Study|Non-compliance with Dexa scans|1|||
156829633|NCT00355342|566127226|FG001|Overall Study|Non-compliance with Dexa scans|0|||
156829634|NCT00355342|566127225|FG000|Overall Study|Withdrawal by participant and physician|1|||
156829635|NCT00355342|566127226|FG001|Overall Study|Withdrawal by participant and physician|0|||
156829636|NCT00355342|566127225|FG000|Overall Study|Participant relocated|0|||
156829637|NCT00355342|566127226|FG001|Overall Study|Participant relocated|1|||
156829638|NCT00355342|566127225|FG000|Overall Study|Participant discontinued study drug|0|||
157023137|NCT02975882|566838779|FG001|Overall Study|Ineligible|1|||
156829639|NCT00355342|566127226|FG001|Overall Study|Participant discontinued study drug|1|||
156829640|NCT00355342|566127225|FG000|Overall Study|Study management|0|||
156829641|NCT00355342|566127226|FG001|Overall Study|Study management|1|||
156829642|NCT00355342|566127225|FG000|Overall Study|Protocol Violation|0|||
156829643|NCT00355342|566127226|FG001|Overall Study|Protocol Violation|1|||
156829644|NCT00355342|566127225|FG000|Overall Study|Use of protocol excluded medication|0|||
156829645|NCT00355342|566127226|FG001|Overall Study|Use of protocol excluded medication|1|||
156829646|NCT00536874|566127227|FG000|Overall Study|Adverse Event|1|||
156829647|NCT00536874|566127227|FG000|Overall Study|Death|2|||
156829648|NCT00536874|566127227|FG000|Overall Study|Withdrawal by Subject|1|||
156829649|NCT00762996|566127228|FG000|Period One|Protocol Violation|0|||
156829650|NCT00762996|566127229|FG001|Period One|Protocol Violation|0|||
156829651|NCT00762996|566127230|FG002|Period One|Protocol Violation|1|||
156829652|NCT00762996|566127231|FG003|Period One|Protocol Violation|0|||
156829653|NCT00762996|566127228|FG000|Period One|ineligible|0|||
156829654|NCT00762996|566127229|FG001|Period One|ineligible|0|||
156829655|NCT00762996|566127230|FG002|Period One|ineligible|1|||
156829656|NCT00762996|566127231|FG003|Period One|ineligible|1|||
156829657|NCT00762996|566127228|FG000|Period One|Adverse Event|0|||
156829658|NCT00762996|566127229|FG001|Period One|Adverse Event|0|||
156829659|NCT00762996|566127230|FG002|Period One|Adverse Event|1|||
156829660|NCT00762996|566127231|FG003|Period One|Adverse Event|0|||
156829661|NCT00762996|566127228|FG000|Period One|Withdrawal by Subject|0|||
156829662|NCT00762996|566127229|FG001|Period One|Withdrawal by Subject|0|||
156829663|NCT00762996|566127230|FG002|Period One|Withdrawal by Subject|1|||
156829664|NCT00762996|566127231|FG003|Period One|Withdrawal by Subject|0|||
156829665|NCT00434759|566127237|FG000|Overall Study|Lack of Efficacy|5|||
156829666|NCT00434759|566127238|FG001|Overall Study|Lack of Efficacy|4|||
156829667|NCT00434759|566127237|FG000|Overall Study|Withdrawal by Subject|17|||
156829668|NCT00434759|566127238|FG001|Overall Study|Withdrawal by Subject|1|||
156829669|NCT00434759|566127237|FG000|Overall Study|family affairs|2|||
156829670|NCT00434759|566127238|FG001|Overall Study|family affairs|0|||
156829671|NCT02966795|566127241|FG000|Overall Study|Patient Left the Country|0|||
156829672|NCT02966795|566127242|FG001|Overall Study|Patient Left the Country|1|||
156829673|NCT02279498|566127247|FG000|Overall Study|Adverse Event|3|||
156829674|NCT02279498|566127248|FG001|Overall Study|Adverse Event|0|||
156829675|NCT02279498|566127247|FG000|Overall Study|Lack of Efficacy|4|||
156829676|NCT02279498|566127248|FG001|Overall Study|Lack of Efficacy|0|||
156829677|NCT02279498|566127247|FG000|Overall Study|Lost to Follow-up|0|||
156829678|NCT02279498|566127248|FG001|Overall Study|Lost to Follow-up|1|||
156829679|NCT02279498|566127247|FG000|Overall Study|Withdrawal by Subject|9|||
156829680|NCT02279498|566127248|FG001|Overall Study|Withdrawal by Subject|2|||
156829681|NCT02279498|566127247|FG000|Overall Study|Undefined|2|||
156829682|NCT02279498|566127248|FG001|Overall Study|Undefined|1|||
156829683|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
156829684|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
156829685|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
156829686|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
156829687|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
156829688|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
156829689|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
156829690|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
156885089|NCT00797966|566338230|FG002|Phase A|Physician Decision|0|||
156885090|NCT00797966|566338231|FG003|Phase A|Physician Decision|0|||
156885091|NCT00797966|566338232|FG004|Phase A|Physician Decision|13|||
156829691|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
156829692|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
156829693|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
156829694|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
156829695|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
156829696|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
156829697|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
156829698|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
156829699|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
156829700|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
156829701|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
156829702|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
156829703|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
156829704|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
156829705|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
156829706|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
156829707|NCT00624780|566127249|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
156829708|NCT00624780|566127250|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
157151207|NCT00408421|567299622|FG000|Treatment Re-Randomization|Protocol Violation|1|||
156829709|NCT00624780|566127251|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
156829710|NCT00624780|566127252|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
156829711|NCT00624780|566127253|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
156829712|NCT00624780|566127254|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
156829713|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
156829714|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
156829715|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
156829716|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
156829717|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
156829718|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
156829719|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829720|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
156829721|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829722|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
156829723|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
156829724|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
156829725|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829726|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
156829727|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829728|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
156829729|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829730|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
156829731|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
156829732|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
156829733|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
156829734|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
156829735|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
156829736|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
156829737|NCT00624780|566127249|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
156829738|NCT00624780|566127250|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
156829739|NCT00624780|566127251|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
156829740|NCT00624780|566127252|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
156829741|NCT00624780|566127253|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
156829742|NCT00624780|566127254|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
156829743|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829744|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
156829745|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
156829746|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829747|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
156829748|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
156829749|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
156829750|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829751|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829752|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829753|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829754|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
156829755|NCT00624780|566127249|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829756|NCT00624780|566127250|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829757|NCT00624780|566127251|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
156829758|NCT00624780|566127252|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829759|NCT00624780|566127253|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829760|NCT00624780|566127254|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
156829761|NCT00624780|566127249|FG000|Follow-up (Week 26)|Death|0|||
156829762|NCT00624780|566127250|FG001|Follow-up (Week 26)|Death|0|||
156829763|NCT00624780|566127251|FG002|Follow-up (Week 26)|Death|1|||
156829764|NCT00624780|566127252|FG003|Follow-up (Week 26)|Death|0|||
156829765|NCT00624780|566127253|FG004|Follow-up (Week 26)|Death|0|||
156829766|NCT00624780|566127254|FG005|Follow-up (Week 26)|Death|0|||
156829767|NCT00624780|566127249|FG000|Follow-up (Week 26)|Adverse Event|0|||
156829768|NCT00624780|566127250|FG001|Follow-up (Week 26)|Adverse Event|0|||
156829769|NCT00624780|566127251|FG002|Follow-up (Week 26)|Adverse Event|0|||
156829770|NCT00624780|566127252|FG003|Follow-up (Week 26)|Adverse Event|0|||
156829771|NCT00624780|566127253|FG004|Follow-up (Week 26)|Adverse Event|1|||
156829772|NCT00624780|566127254|FG005|Follow-up (Week 26)|Adverse Event|0|||
156829773|NCT00624780|566127249|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
157151208|NCT00408421|567299623|FG001|Treatment Re-Randomization|Protocol Violation|1|||
156829774|NCT00624780|566127250|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
156829775|NCT00624780|566127251|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
157151209|NCT00408421|567299624|FG002|Treatment Re-Randomization|Protocol Violation|0|||
157151210|NCT00408421|567299622|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
157151211|NCT00408421|567299623|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
157023138|NCT02975882|566838780|FG002|Overall Study|Ineligible|0|||
157023139|NCT02975882|566838781|FG003|Overall Study|Ineligible|0|||
156829776|NCT00624780|566127252|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
156829777|NCT00624780|566127253|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
156829778|NCT00624780|566127254|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
156829779|NCT00624780|566127249|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
156829780|NCT00624780|566127250|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829781|NCT00624780|566127251|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829782|NCT00624780|566127252|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829783|NCT00624780|566127253|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829784|NCT00624780|566127254|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
156829785|NCT00624780|566127249|FG000|Follow-up (Week 26)|Other|1|||
156829786|NCT00624780|566127250|FG001|Follow-up (Week 26)|Other|1|||
156829787|NCT00624780|566127251|FG002|Follow-up (Week 26)|Other|0|||
156829788|NCT00624780|566127252|FG003|Follow-up (Week 26)|Other|0|||
156829789|NCT00624780|566127253|FG004|Follow-up (Week 26)|Other|0|||
156829790|NCT00624780|566127254|FG005|Follow-up (Week 26)|Other|0|||
156829791|NCT04068519|566127255|FG000|Dose Verification|Death|15|||
156829792|NCT04068519|566127255|FG000|Dose Verification|Withdrawal by Subject|1|||
156829793|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Death|35|||
156829794|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
156829795|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
156829796|NCT04068519|566127255|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
156829797|NCT04068519|566127255|FG000|Indication Expansion|Death|152|||
156829798|NCT04068519|566127255|FG000|Indication Expansion|Withdrawal by Subject|10|||
156829799|NCT04068519|566127255|FG000|Indication Expansion|Lost to Follow-up|7|||
156829800|NCT03762616|566127256|FG000|Overall Study|Protocol Violation|2|||
156829801|NCT02032407|566129627|FG000|Overall Study|Lost to Follow-up|2|||
156829802|NCT02032407|566129627|FG000|Overall Study|Pregnancy|1|||
156829803|NCT02032407|566129627|FG000|Overall Study|Other Miscellaneous Reasons|2|||
156829804|NCT03131596|566129628|FG000|Overall Study|Protocol Violation|3|||
156829805|NCT03131596|566129629|FG001|Overall Study|Protocol Violation|3|||
156829806|NCT03131596|566129628|FG000|Overall Study|Lost to Follow-up|3|||
156829807|NCT03131596|566129629|FG001|Overall Study|Lost to Follow-up|0|||
156829808|NCT02091284|566129632|FG000|Overall Study|Withdrawal by Subject|2|||
156829809|NCT02091284|566129633|FG001|Overall Study|Withdrawal by Subject|1|||
156829810|NCT02091284|566129632|FG000|Overall Study|unreliable data|1|||
156829811|NCT02091284|566129633|FG001|Overall Study|unreliable data|0|||
156829812|NCT04524455|566129640|FG000|Overall Study|Death|3|||
156829813|NCT04524455|566129641|FG001|Overall Study|Death|3|||
156829814|NCT04524455|566129640|FG000|Overall Study|Decision by Sponsor|0|||
156829815|NCT04524455|566129641|FG001|Overall Study|Decision by Sponsor|2|||
156829816|NCT04524455|566129640|FG000|Overall Study|Withdrawal of Consent From Study|1|||
156829817|NCT04524455|566129641|FG001|Overall Study|Withdrawal of Consent From Study|0|||
156829818|NCT04524455|566129640|FG000|Overall Study|Lost to Follow-up|0|||
156829819|NCT04524455|566129641|FG001|Overall Study|Lost to Follow-up|1|||
156829820|NCT01688739|566129642|FG000|Overall Study|Administrative Decision|1|||
156829821|NCT01688739|566129643|FG001|Overall Study|Administrative Decision|0|||
156829822|NCT01688739|566129644|FG002|Overall Study|Administrative Decision|0|||
156829823|NCT01688739|566129645|FG003|Overall Study|Administrative Decision|0|||
156829824|NCT01688739|566129646|FG004|Overall Study|Administrative Decision|0|||
156829825|NCT01688739|566129647|FG005|Overall Study|Administrative Decision|0|||
156885092|NCT00797966|566338233|FG005|Phase A|Physician Decision|0|||
157023140|NCT03829410|566838782|FG000|Overall Study|Adverse Event|1|||
157023141|NCT03829410|566838783|FG001|Overall Study|Adverse Event|0|||
157023142|NCT03829410|566838784|FG002|Overall Study|Adverse Event|1|||
157023143|NCT03829410|566838785|FG003|Overall Study|Adverse Event|4|||
157023144|NCT03829410|566838782|FG000|Overall Study|Physician Decision|0|||
157023145|NCT03829410|566838783|FG001|Overall Study|Physician Decision|0|||
157023146|NCT03829410|566838784|FG002|Overall Study|Physician Decision|0|||
157224543|NCT04799158|567568020|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
157224544|NCT04799158|567568021|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
156829826|NCT01688739|566129648|FG006|Overall Study|Administrative Decision|0|||
156829827|NCT01688739|566129649|FG007|Overall Study|Administrative Decision|0|||
156829828|NCT01688739|566129650|FG008|Overall Study|Administrative Decision|0|||
156829829|NCT01688739|566129651|FG009|Overall Study|Administrative Decision|0|||
156829830|NCT00490776|566129652|FG000|Overall Study|Withdrawal by Subject|1|||
156829831|NCT00490776|566129652|FG000|Overall Study|Administrative Problems|1|||
156829832|NCT00490776|566129652|FG000|Overall Study|Death|1|||
156829833|NCT00490776|566129652|FG000|Overall Study|New Cancer Therapy|1|||
156829834|NCT00490776|566129652|FG000|Overall Study|Disease Progression|5|||
156829835|NCT01340937|566129653|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
156829836|NCT01340937|566129654|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
157023147|NCT03829410|566838785|FG003|Overall Study|Physician Decision|2|||
157023148|NCT03829410|566838782|FG000|Overall Study|Disease Progressing|3|||
157023149|NCT03829410|566838783|FG001|Overall Study|Disease Progressing|4|||
157023150|NCT03829410|566838784|FG002|Overall Study|Disease Progressing|2|||
156829837|NCT01340937|566129655|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
156829838|NCT01340937|566129656|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
156829839|NCT01340937|566129653|FG000|Period 1: Infant Series|Adverse Event|0|||
156829840|NCT01340937|566129654|FG001|Period 1: Infant Series|Adverse Event|1|||
156829841|NCT01340937|566129655|FG002|Period 1: Infant Series|Adverse Event|4|||
156829842|NCT01340937|566129656|FG003|Period 1: Infant Series|Adverse Event|0|||
156829843|NCT01340937|566129653|FG000|Period 1: Infant Series|Death|2|||
156829844|NCT01340937|566129654|FG001|Period 1: Infant Series|Death|0|||
156829845|NCT01340937|566129655|FG002|Period 1: Infant Series|Death|2|||
156829846|NCT01340937|566129656|FG003|Period 1: Infant Series|Death|0|||
156829847|NCT01340937|566129653|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
156829848|NCT01340937|566129654|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
156829849|NCT01340937|566129655|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
156829850|NCT01340937|566129656|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
156829851|NCT01340937|566129653|FG000|Period 1: Infant Series|Physician Decision|2|||
156829852|NCT01340937|566129654|FG001|Period 1: Infant Series|Physician Decision|3|||
156829853|NCT01340937|566129655|FG002|Period 1: Infant Series|Physician Decision|1|||
156829854|NCT01340937|566129656|FG003|Period 1: Infant Series|Physician Decision|0|||
156829855|NCT01340937|566129653|FG000|Period 1: Infant Series|Protocol Violation|1|||
156829856|NCT01340937|566129654|FG001|Period 1: Infant Series|Protocol Violation|4|||
156829857|NCT01340937|566129655|FG002|Period 1: Infant Series|Protocol Violation|4|||
156829858|NCT01340937|566129656|FG003|Period 1: Infant Series|Protocol Violation|3|||
156829859|NCT01340937|566129653|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
156829860|NCT01340937|566129654|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
156829861|NCT01340937|566129655|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
156829862|NCT01340937|566129656|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
156829863|NCT01340937|566129653|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
156829864|NCT01340937|566129654|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
156829865|NCT01340937|566129655|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
156829866|NCT01340937|566129656|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
156829867|NCT01340937|566129653|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
156829868|NCT01340937|566129654|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
156829869|NCT01340937|566129655|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
156829870|NCT01340937|566129656|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
156829871|NCT01340937|566129653|FG000|Period 2: Interim Period|Adverse Event|1|||
156829872|NCT01340937|566129654|FG001|Period 2: Interim Period|Adverse Event|0|||
156829873|NCT01340937|566129655|FG002|Period 2: Interim Period|Adverse Event|1|||
156829874|NCT01340937|566129656|FG003|Period 2: Interim Period|Adverse Event|0|||
156829875|NCT01340937|566129653|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
156829876|NCT01340937|566129654|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
156829877|NCT01340937|566129655|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
156829878|NCT01340937|566129656|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
156829879|NCT01340937|566129653|FG000|Period 2: Interim Period|Physician Decision|0|||
156829880|NCT01340937|566129654|FG001|Period 2: Interim Period|Physician Decision|1|||
156829881|NCT01340937|566129655|FG002|Period 2: Interim Period|Physician Decision|1|||
156829882|NCT01340937|566129656|FG003|Period 2: Interim Period|Physician Decision|0|||
156829883|NCT01340937|566129653|FG000|Period 2: Interim Period|Protocol Violation|5|||
156829884|NCT01340937|566129654|FG001|Period 2: Interim Period|Protocol Violation|3|||
156829885|NCT01340937|566129655|FG002|Period 2: Interim Period|Protocol Violation|6|||
156829886|NCT01340937|566129656|FG003|Period 2: Interim Period|Protocol Violation|3|||
156829887|NCT01340937|566129653|FG000|Period 2: Interim Period|Technical problems|4|||
156829888|NCT01340937|566129654|FG001|Period 2: Interim Period|Technical problems|4|||
156829889|NCT01340937|566129655|FG002|Period 2: Interim Period|Technical problems|6|||
156829890|NCT01340937|566129656|FG003|Period 2: Interim Period|Technical problems|3|||
156829891|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
156829892|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
156829893|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
156829894|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
156829895|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
156829896|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
156829897|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
156829898|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
156829899|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829900|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829901|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
156829902|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
156829903|NCT01340937|566129653|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
156829904|NCT01340937|566129654|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
156829905|NCT01340937|566129655|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
156829906|NCT01340937|566129656|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
156829907|NCT02317809|566129657|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
156885093|NCT00797966|566338228|FG000|Phase A|Withdrawal by Subject|0|||
156829908|NCT02317809|566129658|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
156829909|NCT02317809|566129657|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
156829910|NCT02317809|566129658|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
156829911|NCT02233738|566129659|FG000|Overall Study|Lost to Follow-up|5|||
156829912|NCT02233738|566129660|FG001|Overall Study|Lost to Follow-up|12|||
156829913|NCT02233738|566129659|FG000|Overall Study|Death|0|||
156829914|NCT02233738|566129660|FG001|Overall Study|Death|1|||
156829915|NCT02233738|566129659|FG000|Overall Study|Withdrawal by Subject|0|||
156829916|NCT02233738|566129660|FG001|Overall Study|Withdrawal by Subject|1|||
156829917|NCT02233738|566129659|FG000|Overall Study|Did not return after Baseline|3|||
156829918|NCT02233738|566129660|FG001|Overall Study|Did not return after Baseline|2|||
156829919|NCT00096174|566129661|FG000|Overall Study|Lack of Efficacy|9|||
156829920|NCT00096174|566129661|FG000|Overall Study|Adverse Event|15|||
156829921|NCT00096174|566129661|FG000|Overall Study|Death|6|||
156829922|NCT00096174|566129661|FG000|Overall Study|Withdrawal by Subject|15|||
156829923|NCT00096174|566129661|FG000|Overall Study|Not started protocol therapy|3|||
156829924|NCT00096174|566129661|FG000|Overall Study|Ineligible|6|||
156829925|NCT00096174|566129661|FG000|Overall Study|other reason|8|||
156829926|NCT00294645|566129664|FG000|Overall Study|Death|10|||
156829927|NCT00294645|566129665|FG001|Overall Study|Death|18|||
156829928|NCT00294645|566129664|FG000|Overall Study|Lost to Follow-up|1|||
156829929|NCT00294645|566129665|FG001|Overall Study|Lost to Follow-up|10|||
156829930|NCT00294645|566129664|FG000|Overall Study|Withdrawal by Subject|18|||
156829931|NCT00294645|566129665|FG001|Overall Study|Withdrawal by Subject|34|||
156829932|NCT00294645|566129664|FG000|Overall Study|Physician Decision|15|||
156829933|NCT00294645|566129665|FG001|Overall Study|Physician Decision|20|||
156829934|NCT00294645|566129664|FG000|Overall Study|Other|4|||
156829935|NCT00294645|566129665|FG001|Overall Study|Other|10|||
156829936|NCT02098369|566129668|FG000|Overall Study|Withdrawal by Subject|1|||
156829937|NCT02098369|566129669|FG001|Overall Study|Withdrawal by Subject|5|||
156829938|NCT02098369|566129670|FG002|Overall Study|Withdrawal by Subject|0|||
156829939|NCT02098369|566129668|FG000|Overall Study|Lost to Follow-up|5|||
156829940|NCT02098369|566129669|FG001|Overall Study|Lost to Follow-up|1|||
156829941|NCT02098369|566129670|FG002|Overall Study|Lost to Follow-up|3|||
156829942|NCT02098369|566129668|FG000|Overall Study|Death|1|||
156829943|NCT02098369|566129669|FG001|Overall Study|Death|1|||
156829944|NCT02098369|566129670|FG002|Overall Study|Death|1|||
156829945|NCT02098369|566129668|FG000|Overall Study|Other|0|||
156829946|NCT02098369|566129669|FG001|Overall Study|Other|2|||
156829947|NCT02098369|566129670|FG002|Overall Study|Other|1|||
156829948|NCT03784846|566129671|FG000|Pre-COVID Study|Lost to Follow-up|3|||
156829949|NCT03784846|566129672|FG001|Pre-COVID Study|Lost to Follow-up|3|||
156829950|NCT03784846|566129673|FG002|Pre-COVID Study|Lost to Follow-up|2|||
156829951|NCT03784846|566129671|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
156829952|NCT03784846|566129672|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
156829953|NCT03784846|566129673|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
156829954|NCT03784846|566129671|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
156829955|NCT03784846|566129672|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
156829956|NCT03784846|566129673|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
156829957|NCT03784846|566129671|FG000|Post-COVID Study|Lost to Follow-up|3|||
156829958|NCT03784846|566129672|FG001|Post-COVID Study|Lost to Follow-up|5|||
156829959|NCT03784846|566129673|FG002|Post-COVID Study|Lost to Follow-up|1|||
156829960|NCT03784846|566129671|FG000|Post-COVID Study|Withdrawal by Subject|1|||
156829961|NCT03784846|566129672|FG001|Post-COVID Study|Withdrawal by Subject|2|||
156829962|NCT03784846|566129673|FG002|Post-COVID Study|Withdrawal by Subject|0|||
156829963|NCT00867087|566129674|FG000|Overall Study|Other|1|||
156829964|NCT00867087|566129674|FG000|Overall Study|Withdrawal by Subject|4|||
156829965|NCT00867087|566129674|FG000|Overall Study|Death|37|||
156829966|NCT00570037|566129675|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
156829967|NCT00570037|566129676|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
156829968|NCT00089986|566129677|FG000|Overall Study|Adverse Event|6|||
156829969|NCT00089986|566129678|FG001|Overall Study|Adverse Event|9|||
156829970|NCT00089986|566129679|FG002|Overall Study|Adverse Event|6|||
156829971|NCT00089986|566129677|FG000|Overall Study|Lost to Follow-up|3|||
156829972|NCT00089986|566129678|FG001|Overall Study|Lost to Follow-up|1|||
156829973|NCT00089986|566129679|FG002|Overall Study|Lost to Follow-up|1|||
157023151|NCT03829410|566838785|FG003|Overall Study|Disease Progressing|31|||
156829974|NCT00089986|566129677|FG000|Overall Study|Protocol Violation|0|||
156829975|NCT00089986|566129678|FG001|Overall Study|Protocol Violation|1|||
156829976|NCT00089986|566129679|FG002|Overall Study|Protocol Violation|0|||
156829977|NCT00089986|566129677|FG000|Overall Study|Patient transferred to another hospital|2|||
156829978|NCT00089986|566129678|FG001|Overall Study|Patient transferred to another hospital|1|||
156829979|NCT00089986|566129679|FG002|Overall Study|Patient transferred to another hospital|0|||
156829980|NCT00089986|566129677|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
156829981|NCT00089986|566129678|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
156829982|NCT00089986|566129679|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
156829983|NCT00089986|566129677|FG000|Overall Study|Hemohlobin stopping rule|0|||
157224545|NCT04799158|567568022|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
156829984|NCT00089986|566129678|FG001|Overall Study|Hemohlobin stopping rule|1|||
156829985|NCT00089986|566129679|FG002|Overall Study|Hemohlobin stopping rule|0|||
156829986|NCT00089986|566129677|FG000|Overall Study|Investigator decision to withdrew|0|||
156829987|NCT00089986|566129678|FG001|Overall Study|Investigator decision to withdrew|1|||
156829988|NCT00089986|566129679|FG002|Overall Study|Investigator decision to withdrew|0|||
156829989|NCT00089986|566129677|FG000|Overall Study|Enrollment in another study|0|||
156829990|NCT00089986|566129678|FG001|Overall Study|Enrollment in another study|1|||
156829991|NCT00089986|566129679|FG002|Overall Study|Enrollment in another study|0|||
156829992|NCT00089986|566129677|FG000|Overall Study|Family decision|0|||
156829993|NCT00089986|566129678|FG001|Overall Study|Family decision|1|||
156829994|NCT00089986|566129679|FG002|Overall Study|Family decision|0|||
156829995|NCT00089986|566129677|FG000|Overall Study|Do not resuscitate (DNR)|0|||
156829996|NCT00089986|566129678|FG001|Overall Study|Do not resuscitate (DNR)|0|||
156829997|NCT00089986|566129679|FG002|Overall Study|Do not resuscitate (DNR)|1|||
156829998|NCT00089986|566129677|FG000|Overall Study|Withdrawal by Subject|3|||
156829999|NCT00089986|566129678|FG001|Overall Study|Withdrawal by Subject|6|||
156830000|NCT00089986|566129679|FG002|Overall Study|Withdrawal by Subject|2|||
156830001|NCT03946124|566129680|FG000|Overall Study|Withdrawal by Subject|19|||
156830002|NCT02334683|566129682|FG000|First 12 Week Period|Lost to Follow-up|1|||
156830003|NCT02334683|566129683|FG001|First 12 Week Period|Lost to Follow-up|0|||
156830004|NCT02334683|566129682|FG000|Second 12 Week Period|Adverse Event|0|||
156830005|NCT02334683|566129683|FG001|Second 12 Week Period|Adverse Event|1|||
156830006|NCT01062841|566129684|FG000|Overall Study|Indwelling Device Removed|41|||
156830007|NCT01062841|566129685|FG001|Overall Study|Indwelling Device Removed|48|||
156830008|NCT01062841|566129684|FG000|Overall Study|Death|3|||
156830009|NCT01062841|566129685|FG001|Overall Study|Death|5|||
156830010|NCT01062841|566129684|FG000|Overall Study|Withdrawal by Subject|2|||
156830011|NCT01062841|566129685|FG001|Overall Study|Withdrawal by Subject|0|||
156830012|NCT01062841|566129684|FG000|Overall Study|Withdrawal by Study|3|||
156830013|NCT01062841|566129685|FG001|Overall Study|Withdrawal by Study|0|||
156830014|NCT02046174|566129686|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
156830015|NCT02046174|566129687|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
156830016|NCT00413920|566129691|FG000|Overall Study|Adverse Event|9|||
156830017|NCT00413920|566129692|FG001|Overall Study|Adverse Event|11|||
156830018|NCT00413920|566129691|FG000|Overall Study|Lack of Efficacy|11|||
156830019|NCT00413920|566129692|FG001|Overall Study|Lack of Efficacy|9|||
156830020|NCT00413920|566129691|FG000|Overall Study|Death|3|||
156830021|NCT00413920|566129692|FG001|Overall Study|Death|5|||
156830022|NCT00413920|566129691|FG000|Overall Study|Graft Loss|5|||
156830023|NCT00413920|566129692|FG001|Overall Study|Graft Loss|3|||
156830024|NCT03831880|566129693|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
156830025|NCT03831880|566129694|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
156830026|NCT03831880|566129693|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
156830027|NCT03831880|566129694|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
156830028|NCT01891344|566129695|FG000|Overall Study|Ongoing|6|||
156830029|NCT01891344|566129696|FG001|Overall Study|Ongoing|2|||
156830030|NCT01891344|566129697|FG002|Overall Study|Ongoing|0|||
156830031|NCT01891344|566129698|FG003|Overall Study|Ongoing|1|||
156830032|NCT01891344|566129699|FG004|Overall Study|Ongoing|4|||
156830033|NCT01891344|566129700|FG005|Overall Study|Ongoing|1|||
156830034|NCT01891344|566129701|FG006|Overall Study|Ongoing|0|||
156830035|NCT01891344|566129702|FG007|Overall Study|Ongoing|0|||
156830036|NCT02969590|566129706|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
156830037|NCT02969590|566129707|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
156885094|NCT00797966|566338229|FG001|Phase A|Withdrawal by Subject|0|||
156885095|NCT00797966|566338230|FG002|Phase A|Withdrawal by Subject|0|||
156885096|NCT00797966|566338231|FG003|Phase A|Withdrawal by Subject|0|||
157224546|NCT04799158|567568023|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
157224547|NCT04799158|567568019|FG000|On-Demand Treatment Period|Miscellaneous|0|||
157224548|NCT04799158|567568020|FG001|On-Demand Treatment Period|Miscellaneous|0|||
156830038|NCT02969590|566129708|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
156830039|NCT01414205|566129709|FG000|Overall Study|Death|5|||
156830040|NCT01414205|566129710|FG001|Overall Study|Death|1|||
156830041|NCT01414205|566129709|FG000|Overall Study|Lost to Follow-up|1|||
156830042|NCT01414205|566129710|FG001|Overall Study|Lost to Follow-up|4|||
156830043|NCT01414205|566129709|FG000|Overall Study|Physician Decision|0|||
156830044|NCT01414205|566129710|FG001|Overall Study|Physician Decision|1|||
156830045|NCT01414205|566129709|FG000|Overall Study|Randomized but not Treated|1|||
156885097|NCT00797966|566338232|FG004|Phase A|Withdrawal by Subject|33|||
156830046|NCT01414205|566129710|FG001|Overall Study|Randomized but not Treated|1|||
156830047|NCT01166373|566129711|FG000|Overall Study|Lost to Follow-up|3|||
156830048|NCT01166373|566129712|FG001|Overall Study|Lost to Follow-up|2|||
156830049|NCT01166373|566129713|FG002|Overall Study|Lost to Follow-up|2|||
156830050|NCT01166373|566129714|FG003|Overall Study|Lost to Follow-up|2|||
156830051|NCT01166373|566129711|FG000|Overall Study|Withdrawal by Subject|1|||
156830052|NCT01166373|566129712|FG001|Overall Study|Withdrawal by Subject|2|||
157224549|NCT04799158|567568021|FG002|On-Demand Treatment Period|Miscellaneous|0|||
156830053|NCT01166373|566129713|FG002|Overall Study|Withdrawal by Subject|2|||
156830054|NCT01166373|566129714|FG003|Overall Study|Withdrawal by Subject|3|||
156830055|NCT01166373|566129711|FG000|Overall Study|Physician Decision|1|||
156830056|NCT01166373|566129712|FG001|Overall Study|Physician Decision|0|||
157023152|NCT03829410|566838782|FG000|Overall Study|Miscellaneous|2|||
157023153|NCT03829410|566838783|FG001|Overall Study|Miscellaneous|4|||
157023154|NCT03829410|566838784|FG002|Overall Study|Miscellaneous|3|||
157023155|NCT03829410|566838785|FG003|Overall Study|Miscellaneous|10|||
157023156|NCT03158129|566838786|FG000|Overall Study|Adverse Event|0|||
157023157|NCT03158129|566838787|FG001|Overall Study|Adverse Event|1|||
157023158|NCT03158129|566838788|FG002|Overall Study|Adverse Event|0|||
157023159|NCT03158129|566838789|FG003|Overall Study|Adverse Event|0|||
157023160|NCT03158129|566838786|FG000|Overall Study|Death|0|||
157023161|NCT03158129|566838787|FG001|Overall Study|Death|0|||
157023162|NCT03158129|566838788|FG002|Overall Study|Death|0|||
157023163|NCT03158129|566838789|FG003|Overall Study|Death|1|||
157023164|NCT03158129|566838786|FG000|Overall Study|High surgical risk|1|||
157023165|NCT03158129|566838787|FG001|Overall Study|High surgical risk|1|||
157023166|NCT03158129|566838788|FG002|Overall Study|High surgical risk|0|||
157023167|NCT03158129|566838789|FG003|Overall Study|High surgical risk|0|||
157023168|NCT03158129|566838786|FG000|Overall Study|Progression|1|||
157023169|NCT03158129|566838787|FG001|Overall Study|Progression|1|||
157023170|NCT03158129|566838788|FG002|Overall Study|Progression|0|||
157023171|NCT03158129|566838789|FG003|Overall Study|Progression|0|||
157023172|NCT03158129|566838786|FG000|Overall Study|Lack of resectability|0|||
157023173|NCT03158129|566838787|FG001|Overall Study|Lack of resectability|1|||
157023174|NCT03158129|566838788|FG002|Overall Study|Lack of resectability|0|||
157023175|NCT03158129|566838789|FG003|Overall Study|Lack of resectability|0|||
157023176|NCT03158129|566838786|FG000|Overall Study|Declined surgery|0|||
157023177|NCT03158129|566838787|FG001|Overall Study|Declined surgery|1|||
157023178|NCT03158129|566838788|FG002|Overall Study|Declined surgery|0|||
157023179|NCT03158129|566838789|FG003|Overall Study|Declined surgery|0|||
157023180|NCT03158129|566838786|FG000|Overall Study|No longer surgical candidate|0|||
157023181|NCT03158129|566838787|FG001|Overall Study|No longer surgical candidate|0|||
157023182|NCT03158129|566838788|FG002|Overall Study|No longer surgical candidate|0|||
157023183|NCT03158129|566838789|FG003|Overall Study|No longer surgical candidate|1|||
157023184|NCT02105766|566838794|FG000|Overall Study|Physician Decision|1|||
157023185|NCT02105766|566838795|FG001|Overall Study|Physician Decision|1|||
157023186|NCT02105766|566838796|FG002|Overall Study|Physician Decision|0|||
157023187|NCT02105766|566838794|FG000|Overall Study|Lost to Follow-up|2|||
157023188|NCT02105766|566838795|FG001|Overall Study|Lost to Follow-up|0|||
157023189|NCT02105766|566838796|FG002|Overall Study|Lost to Follow-up|0|||
157023190|NCT02105766|566838794|FG000|Overall Study|Death|1|||
157023191|NCT02105766|566838795|FG001|Overall Study|Death|1|||
157023192|NCT02105766|566838796|FG002|Overall Study|Death|0|||
157023193|NCT03867500|566838797|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
157023194|NCT06205407|566838798|FG000|Period 2|Withdrawal by Subject|0|||
157023195|NCT06205407|566838799|FG001|Period 2|Withdrawal by Subject|1|||
157023196|NCT06205407|566838798|FG000|Period 2|Adverse Event|2|||
157023197|NCT06205407|566838799|FG001|Period 2|Adverse Event|1|||
157023198|NCT06491433|566838800|FG000|Overall Study|Protocol Violation|51|||
157023199|NCT06491433|566838800|FG000|Overall Study|consent withdrawal|2|||
157023200|NCT06491433|566838800|FG000|Overall Study|screen failure|1|||
157023201|NCT05409183|566838802|FG000|Complete Study|Adverse Event|1|||
157023202|NCT05409183|566838803|FG001|Complete Study|Adverse Event|2|||
157023203|NCT05409183|566838802|FG000|Complete Study|Withdrawal by Subject|3|||
157023204|NCT05409183|566838803|FG001|Complete Study|Withdrawal by Subject|0|||
157023205|NCT04806451|566838804|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
157023206|NCT04806451|566838805|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
157023207|NCT04806451|566838804|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
157023208|NCT04806451|566838805|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
157023209|NCT04806451|566838804|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
157023210|NCT04806451|566838805|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
157023211|NCT02936752|566838806|FG000|Overall Study|Death|2|||
157023212|NCT02936752|566838807|FG001|Overall Study|Death|1|||
157023213|NCT02936752|566838806|FG000|Overall Study|Physician Decision|4|||
157023214|NCT02936752|566838807|FG001|Overall Study|Physician Decision|0|||
157023215|NCT02936752|566838806|FG000|Overall Study|Withdrawal by Subject|0|||
157023216|NCT02936752|566838807|FG001|Overall Study|Withdrawal by Subject|2|||
157023217|NCT05292365|566838814|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
157023218|NCT05292365|566838815|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
156830057|NCT01166373|566129713|FG002|Overall Study|Physician Decision|0|||
157023219|NCT05292365|566838816|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
157023220|NCT05292365|566838817|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
157023221|NCT05282173|566838818|FG000|Overall Study|Missed|3|||
157023222|NCT05282173|566838819|FG001|Overall Study|Missed|2|||
157023223|NCT05282173|566838820|FG002|Overall Study|Missed|4|||
157023224|NCT02023866|566838831|FG000|Overall Study|Non-compliance|2|||
157023225|NCT02023866|566838831|FG000|Overall Study|Adverse Event|3|||
157023226|NCT02023866|566838831|FG000|Overall Study|Withdrawal by Subject|1|||
157023227|NCT01798498|566838839|FG000|Overall Study|Lost to Follow-up|1|||
157023228|NCT04625283|566838849|FG000|Overall Study|post randomization exclusion|28|||
157023229|NCT04625283|566838850|FG001|Overall Study|post randomization exclusion|20|||
157023230|NCT01824394|566838851|FG000|Overall Study|Early Termination|1|||
157023231|NCT01824394|566838852|FG001|Overall Study|Early Termination|1|||
157023232|NCT01824394|566838853|FG002|Overall Study|Early Termination|3|||
157023233|NCT01824394|566838851|FG000|Overall Study|Withdrawn due to Study Termination|91|||
157023234|NCT01824394|566838852|FG001|Overall Study|Withdrawn due to Study Termination|83|||
157023235|NCT01824394|566838853|FG002|Overall Study|Withdrawn due to Study Termination|41|||
157023236|NCT01824394|566838851|FG000|Overall Study|Lost to Follow-up|0|||
157023237|NCT01824394|566838852|FG001|Overall Study|Lost to Follow-up|9|||
157023238|NCT01824394|566838853|FG002|Overall Study|Lost to Follow-up|3|||
157023239|NCT01824394|566838851|FG000|Overall Study|Death|3|||
157023240|NCT01824394|566838852|FG001|Overall Study|Death|2|||
157023241|NCT01824394|566838853|FG002|Overall Study|Death|4|||
157023242|NCT01824394|566838851|FG000|Overall Study|Discontinued Subjects|1|||
157023243|NCT01824394|566838852|FG001|Overall Study|Discontinued Subjects|1|||
157023244|NCT01824394|566838853|FG002|Overall Study|Discontinued Subjects|2|||
157023245|NCT01824394|566838851|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
157023246|NCT01824394|566838852|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
157023247|NCT01824394|566838853|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
157023248|NCT04938492|566838856|FG000|Overall Study|Lost to Follow-up|17|||
157023249|NCT04938492|566838857|FG001|Overall Study|Lost to Follow-up|18|||
156830058|NCT01166373|566129714|FG003|Overall Study|Physician Decision|0|||
156830059|NCT02498067|566129715|FG000|Overall Study|Lost to Follow-up|22|||
156830060|NCT02498067|566129715|FG000|Overall Study|Did not meet inclusion criteria|11|||
156830061|NCT01874275|566129716|FG000|Overall Study|Lost to Follow-up|1|||
156830062|NCT01874275|566129717|FG001|Overall Study|Lost to Follow-up|0|||
156830063|NCT02813668|566129723|FG000|Overall Study|Death|4|||
156830064|NCT02813668|566129723|FG000|Overall Study|Lost to Follow-up|509|||
156830065|NCT02813668|566129723|FG000|Overall Study|Withdrawal by Subject|148|||
156830066|NCT02813668|566129723|FG000|Overall Study|No longer at worksite|85|||
156830067|NCT02813668|566129723|FG000|Overall Study|Medical reasons not related to the study|4|||
156830068|NCT02594098|566129728|FG000|Overall Study|Lack of Efficacy|17|||
156830069|NCT02594098|566129729|FG001|Overall Study|Lack of Efficacy|6|||
156830070|NCT02594098|566129728|FG000|Overall Study|Withdrawal by Subject|1|||
156830071|NCT02594098|566129729|FG001|Overall Study|Withdrawal by Subject|3|||
156830072|NCT02594098|566129728|FG000|Overall Study|Terminated participation|6|||
156830073|NCT02594098|566129729|FG001|Overall Study|Terminated participation|2|||
156830074|NCT02594098|566129728|FG000|Overall Study|Seek alternative treatment|2|||
156830075|NCT02594098|566129729|FG001|Overall Study|Seek alternative treatment|1|||
156830076|NCT02594098|566129728|FG000|Overall Study|Other|0|||
156830077|NCT02594098|566129729|FG001|Overall Study|Other|1|||
156830078|NCT00495521|566129730|FG000|Overall Study|Physician Decision|0|||
156830079|NCT00495521|566129731|FG001|Overall Study|Physician Decision|1|||
156830080|NCT02782325|566129732|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
156830081|NCT02782325|566129733|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
156830082|NCT02782325|566129734|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
156830083|NCT02782325|566129732|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
156830084|NCT02782325|566129733|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
156830085|NCT02782325|566129734|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
156830086|NCT00042432|566129735|FG000|Overall Study|Adverse Event|4|||
156830087|NCT00042432|566129736|FG001|Overall Study|Adverse Event|1|||
157023250|NCT05084508|566838858|FG000|Overall Study|Lost to Follow-up|6|||
157023251|NCT05084508|566838859|FG001|Overall Study|Lost to Follow-up|3|||
157023252|NCT05084508|566838860|FG002|Overall Study|Lost to Follow-up|7|||
157023253|NCT05084508|566838861|FG003|Overall Study|Lost to Follow-up|3|||
157023254|NCT05084508|566838858|FG000|Overall Study|Withdrawal by Subject|0|||
157023255|NCT05084508|566838859|FG001|Overall Study|Withdrawal by Subject|2|||
156830088|NCT00042432|566129735|FG000|Overall Study|Withdrawal by Subject|1|||
156830089|NCT00042432|566129736|FG001|Overall Study|Withdrawal by Subject|3|||
156830090|NCT00042432|566129735|FG000|Overall Study|Death|0|||
156830091|NCT00042432|566129736|FG001|Overall Study|Death|2|||
156830092|NCT00042432|566129735|FG000|Overall Study|Ineligibility determined|1|||
156830093|NCT00042432|566129736|FG001|Overall Study|Ineligibility determined|0|||
156830094|NCT00042432|566129735|FG000|Overall Study|Initiation of maintenance dialysis|1|||
156830095|NCT00042432|566129736|FG001|Overall Study|Initiation of maintenance dialysis|1|||
156830096|NCT00042432|566129735|FG000|Overall Study|Other|2|||
156830097|NCT00042432|566129736|FG001|Overall Study|Other|0|||
156830098|NCT01527383|566129737|FG000|Overall Study|Adverse Event|5|||
157023256|NCT05084508|566838860|FG002|Overall Study|Withdrawal by Subject|3|||
157023257|NCT05084508|566838861|FG003|Overall Study|Withdrawal by Subject|1|||
157023258|NCT05084508|566838858|FG000|Overall Study|Other|0|||
157023259|NCT05084508|566838859|FG001|Overall Study|Other|0|||
156885098|NCT00797966|566338233|FG005|Phase A|Withdrawal by Subject|0|||
156830099|NCT01527383|566129738|FG001|Overall Study|Adverse Event|0|||
156830100|NCT01527383|566129737|FG000|Overall Study|Lost to Follow-up|3|||
156830101|NCT01527383|566129738|FG001|Overall Study|Lost to Follow-up|0|||
156830102|NCT01527383|566129737|FG000|Overall Study|Physician Decision|2|||
156830103|NCT01527383|566129738|FG001|Overall Study|Physician Decision|0|||
156830104|NCT01527383|566129737|FG000|Overall Study|Pregnancy|1|||
156830105|NCT01527383|566129738|FG001|Overall Study|Pregnancy|0|||
156830106|NCT01527383|566129737|FG000|Overall Study|Protocol Violation|1|||
156830107|NCT01527383|566129738|FG001|Overall Study|Protocol Violation|0|||
156830108|NCT01527383|566129737|FG000|Overall Study|Screen failure|1|||
156830109|NCT01527383|566129738|FG001|Overall Study|Screen failure|0|||
156830110|NCT01527383|566129737|FG000|Overall Study|Participant moved|0|||
156830111|NCT01527383|566129738|FG001|Overall Study|Participant moved|1|||
156830112|NCT01527383|566129737|FG000|Overall Study|Withdrawal by Subject|2|||
156830113|NCT01527383|566129738|FG001|Overall Study|Withdrawal by Subject|3|||
156830114|NCT00432744|566129739|FG000|Months 0-6|Withdrawal by Subject|4|||
156830115|NCT00432744|566129740|FG001|Months 0-6|Withdrawal by Subject|4|||
156830116|NCT00432744|566129739|FG000|Months 0-6|Too disabled to score|1|||
156830117|NCT00432744|566129740|FG001|Months 0-6|Too disabled to score|0|||
156830118|NCT00432744|566129739|FG000|Months 7 - 12|Withdrawal by Subject|1|||
156830119|NCT00432744|566129740|FG001|Months 7 - 12|Withdrawal by Subject|0|||
156830120|NCT00432744|566129739|FG000|Months 7 - 12|Too disabled to score|0|||
156830121|NCT00432744|566129740|FG001|Months 7 - 12|Too disabled to score|1|||
156830122|NCT02761694|566129745|FG000|Overall Study|Lack of Efficacy|0|||
156830123|NCT02761694|566129746|FG001|Overall Study|Lack of Efficacy|0|||
156830124|NCT02761694|566129747|FG002|Overall Study|Lack of Efficacy|0|||
156830125|NCT02761694|566129748|FG003|Overall Study|Lack of Efficacy|0|||
156830126|NCT02761694|566129749|FG004|Overall Study|Lack of Efficacy|0|||
156830127|NCT02761694|566129750|FG005|Overall Study|Lack of Efficacy|0|||
156830128|NCT02761694|566129751|FG006|Overall Study|Lack of Efficacy|6|||
156830129|NCT02761694|566129752|FG007|Overall Study|Lack of Efficacy|0|||
156830130|NCT02761694|566129753|FG008|Overall Study|Lack of Efficacy|0|||
156830131|NCT02761694|566129754|FG009|Overall Study|Lack of Efficacy|1|||
156830132|NCT02761694|566129755|FG010|Overall Study|Lack of Efficacy|1|||
156830133|NCT02761694|566129756|FG011|Overall Study|Lack of Efficacy|4|||
156830134|NCT02761694|566129745|FG000|Overall Study|Death|0|||
156830135|NCT02761694|566129746|FG001|Overall Study|Death|0|||
156830136|NCT02761694|566129747|FG002|Overall Study|Death|0|||
156830137|NCT02761694|566129748|FG003|Overall Study|Death|0|||
156830138|NCT02761694|566129749|FG004|Overall Study|Death|0|||
156830139|NCT02761694|566129750|FG005|Overall Study|Death|0|||
156830140|NCT02761694|566129751|FG006|Overall Study|Death|2|||
156830141|NCT02761694|566129752|FG007|Overall Study|Death|0|||
156830142|NCT02761694|566129753|FG008|Overall Study|Death|2|||
156830143|NCT02761694|566129754|FG009|Overall Study|Death|2|||
156830144|NCT02761694|566129755|FG010|Overall Study|Death|1|||
156830145|NCT02761694|566129756|FG011|Overall Study|Death|0|||
156830146|NCT02761694|566129745|FG000|Overall Study|Physician Decision|0|||
156830147|NCT02761694|566129746|FG001|Overall Study|Physician Decision|0|||
156830148|NCT02761694|566129747|FG002|Overall Study|Physician Decision|0|||
156830149|NCT02761694|566129748|FG003|Overall Study|Physician Decision|0|||
156830150|NCT02761694|566129749|FG004|Overall Study|Physician Decision|0|||
156830151|NCT02761694|566129750|FG005|Overall Study|Physician Decision|0|||
156885099|NCT00797966|566338228|FG000|Phase A|Protocol deviation|0|||
156885100|NCT00797966|566338229|FG001|Phase A|Protocol deviation|0|||
156885101|NCT00797966|566338230|FG002|Phase A|Protocol deviation|0|||
157224550|NCT04799158|567568022|FG003|On-Demand Treatment Period|Miscellaneous|0|||
156830152|NCT02761694|566129751|FG006|Overall Study|Physician Decision|1|||
156830153|NCT02761694|566129752|FG007|Overall Study|Physician Decision|0|||
156830154|NCT02761694|566129753|FG008|Overall Study|Physician Decision|0|||
156830155|NCT02761694|566129754|FG009|Overall Study|Physician Decision|0|||
156830156|NCT02761694|566129755|FG010|Overall Study|Physician Decision|0|||
156830157|NCT02761694|566129756|FG011|Overall Study|Physician Decision|0|||
156830158|NCT02761694|566129745|FG000|Overall Study|Withdrawal by Subject|0|||
156830159|NCT02761694|566129746|FG001|Overall Study|Withdrawal by Subject|0|||
156830160|NCT02761694|566129747|FG002|Overall Study|Withdrawal by Subject|0|||
156830161|NCT02761694|566129748|FG003|Overall Study|Withdrawal by Subject|1|||
156830162|NCT02761694|566129749|FG004|Overall Study|Withdrawal by Subject|0|||
156830163|NCT02761694|566129750|FG005|Overall Study|Withdrawal by Subject|0|||
156830164|NCT02761694|566129751|FG006|Overall Study|Withdrawal by Subject|4|||
156830165|NCT02761694|566129752|FG007|Overall Study|Withdrawal by Subject|0|||
156885102|NCT00797966|566338231|FG003|Phase A|Protocol deviation|0|||
156885103|NCT00797966|566338232|FG004|Phase A|Protocol deviation|56|||
156830166|NCT02761694|566129753|FG008|Overall Study|Withdrawal by Subject|2|||
156830167|NCT02761694|566129754|FG009|Overall Study|Withdrawal by Subject|1|||
156830168|NCT02761694|566129755|FG010|Overall Study|Withdrawal by Subject|0|||
156830169|NCT02761694|566129756|FG011|Overall Study|Withdrawal by Subject|0|||
156830170|NCT02761694|566129745|FG000|Overall Study|Lost to Follow-up|0|||
156830171|NCT02761694|566129746|FG001|Overall Study|Lost to Follow-up|0|||
156830172|NCT02761694|566129747|FG002|Overall Study|Lost to Follow-up|0|||
156885104|NCT00797966|566338233|FG005|Phase A|Protocol deviation|0|||
156885105|NCT00797966|566338228|FG000|Phase B|Lost to Follow-up|0|||
156885106|NCT00797966|566338229|FG001|Phase B|Lost to Follow-up|1|||
156885107|NCT00797966|566338230|FG002|Phase B|Lost to Follow-up|3|||
156885108|NCT00797966|566338231|FG003|Phase B|Lost to Follow-up|0|||
157151212|NCT00408421|567299624|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
157151213|NCT03132805|567299627|FG000|Overall Study|Lost to Follow-up|142|||
157151214|NCT03132805|567299628|FG001|Overall Study|Lost to Follow-up|141|||
157151215|NCT03132805|567299629|FG002|Overall Study|Lost to Follow-up|113|||
157151216|NCT03009539|567299630|FG000|Overall Study|Lost to Follow-up|132|||
157151217|NCT03009539|567299631|FG001|Overall Study|Lost to Follow-up|113|||
157151218|NCT03009539|567299632|FG002|Overall Study|Lost to Follow-up|132|||
157151219|NCT03009539|567299633|FG003|Overall Study|Lost to Follow-up|113|||
157151220|NCT01115569|567299636|FG000|Conversion/Titration Phase|Adverse Event|59|||
157151221|NCT01115569|567299637|FG001|Conversion/Titration Phase|Adverse Event|0|||
157151222|NCT01115569|567299636|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
157151223|NCT01115569|567299637|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
157151224|NCT01115569|567299636|FG000|Conversion/Titration Phase|Physician Decision|5|||
157151225|NCT01115569|567299637|FG001|Conversion/Titration Phase|Physician Decision|0|||
157151226|NCT01115569|567299636|FG000|Conversion/Titration Phase|Protocol Violation|68|||
157151227|NCT01115569|567299637|FG001|Conversion/Titration Phase|Protocol Violation|0|||
157151228|NCT01115569|567299636|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
157151229|NCT01115569|567299637|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
157151230|NCT01115569|567299636|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
157151231|NCT01115569|567299637|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
157151232|NCT01115569|567299636|FG000|Maintenance Phase|Adverse Event|0|||
157151233|NCT01115569|567299637|FG001|Maintenance Phase|Adverse Event|43|||
157151234|NCT01115569|567299636|FG000|Maintenance Phase|Lost to Follow-up|0|||
156830173|NCT02761694|566129748|FG003|Overall Study|Lost to Follow-up|0|||
156830174|NCT02761694|566129749|FG004|Overall Study|Lost to Follow-up|0|||
156830175|NCT02761694|566129750|FG005|Overall Study|Lost to Follow-up|0|||
156830176|NCT02761694|566129751|FG006|Overall Study|Lost to Follow-up|1|||
156830177|NCT02761694|566129752|FG007|Overall Study|Lost to Follow-up|0|||
156830178|NCT02761694|566129753|FG008|Overall Study|Lost to Follow-up|0|||
156830179|NCT02761694|566129754|FG009|Overall Study|Lost to Follow-up|0|||
156830180|NCT02761694|566129755|FG010|Overall Study|Lost to Follow-up|0|||
156830181|NCT02761694|566129756|FG011|Overall Study|Lost to Follow-up|1|||
156830182|NCT02761694|566129745|FG000|Overall Study|Adverse Event|0|||
156830183|NCT02761694|566129746|FG001|Overall Study|Adverse Event|0|||
156830184|NCT02761694|566129747|FG002|Overall Study|Adverse Event|0|||
156830185|NCT02761694|566129748|FG003|Overall Study|Adverse Event|0|||
156830186|NCT02761694|566129749|FG004|Overall Study|Adverse Event|0|||
156830187|NCT02761694|566129750|FG005|Overall Study|Adverse Event|0|||
156830188|NCT02761694|566129751|FG006|Overall Study|Adverse Event|1|||
156830189|NCT02761694|566129752|FG007|Overall Study|Adverse Event|0|||
156830190|NCT02761694|566129753|FG008|Overall Study|Adverse Event|1|||
156830191|NCT02761694|566129754|FG009|Overall Study|Adverse Event|0|||
156830192|NCT02761694|566129755|FG010|Overall Study|Adverse Event|0|||
156830193|NCT02761694|566129756|FG011|Overall Study|Adverse Event|1|||
157151235|NCT01115569|567299637|FG001|Maintenance Phase|Lost to Follow-up|8|||
157151236|NCT01115569|567299636|FG000|Maintenance Phase|Physician Decision|0|||
157151237|NCT01115569|567299637|FG001|Maintenance Phase|Physician Decision|3|||
157151238|NCT01115569|567299636|FG000|Maintenance Phase|Protocol Violation|0|||
157151239|NCT01115569|567299637|FG001|Maintenance Phase|Protocol Violation|9|||
157151240|NCT01115569|567299636|FG000|Maintenance Phase|Withdrawal by Subject|0|||
157151241|NCT01115569|567299637|FG001|Maintenance Phase|Withdrawal by Subject|27|||
157151242|NCT01115569|567299636|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
157151243|NCT01115569|567299637|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
156885109|NCT00797966|566338232|FG004|Phase B|Lost to Follow-up|0|||
156885110|NCT00797966|566338233|FG005|Phase B|Lost to Follow-up|0|||
157151244|NCT01115569|567299636|FG000|Maintenance Phase|Administrative|0|||
157151245|NCT01115569|567299637|FG001|Maintenance Phase|Administrative|1|||
157151246|NCT03242928|567299639|FG000|Overall Study|Adverse Event|2|||
157224551|NCT04799158|567568023|FG004|On-Demand Treatment Period|Miscellaneous|1|||
156830194|NCT02761694|566129745|FG000|Overall Study|Other|4|||
156830195|NCT02761694|566129746|FG001|Overall Study|Other|4|||
156830196|NCT02761694|566129747|FG002|Overall Study|Other|1|||
156830197|NCT02761694|566129748|FG003|Overall Study|Other|2|||
156830198|NCT02761694|566129749|FG004|Overall Study|Other|3|||
156885111|NCT00797966|566338228|FG000|Phase B|Adverse Event|2|||
156885112|NCT00797966|566338229|FG001|Phase B|Adverse Event|1|||
157151247|NCT03242928|567299640|FG001|Overall Study|Adverse Event|1|||
157151248|NCT03242928|567299639|FG000|Overall Study|Lost to Follow-up|2|||
157151249|NCT03242928|567299640|FG001|Overall Study|Lost to Follow-up|0|||
157151250|NCT03242928|567299639|FG000|Overall Study|Physician Decision|0|||
157151251|NCT03242928|567299640|FG001|Overall Study|Physician Decision|1|||
156830199|NCT02761694|566129750|FG005|Overall Study|Other|3|||
156830200|NCT02761694|566129751|FG006|Overall Study|Other|18|||
156830201|NCT02761694|566129752|FG007|Overall Study|Other|8|||
156830202|NCT02761694|566129753|FG008|Overall Study|Other|0|||
156830203|NCT02761694|566129754|FG009|Overall Study|Other|1|||
156830204|NCT02761694|566129755|FG010|Overall Study|Other|1|||
156830205|NCT02761694|566129756|FG011|Overall Study|Other|0|||
156830206|NCT00787930|566129764|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
156830207|NCT02395055|566129765|FG000|Overall Study|Withdrawal by Subject|7|||
156830208|NCT02395055|566129766|FG001|Overall Study|Withdrawal by Subject|3|||
156830209|NCT02513823|566129767|FG000|Overall Study|Lost to Follow-up|4|||
156830210|NCT02513823|566129767|FG000|Overall Study|Physician Decision|1|||
156830211|NCT00394901|566129768|FG000|Baseline Phase|Protocol Violation|0|||
156830212|NCT00394901|566129769|FG001|Baseline Phase|Protocol Violation|0|||
156830213|NCT00394901|566129770|FG002|Baseline Phase|Protocol Violation|1|||
156830214|NCT00394901|566129771|FG003|Baseline Phase|Protocol Violation|0|||
156830215|NCT00394901|566129768|FG000|Double-blind Phase|Adverse Event|5|||
156830216|NCT00394901|566129769|FG001|Double-blind Phase|Adverse Event|7|||
156830217|NCT00394901|566129770|FG002|Double-blind Phase|Adverse Event|16|||
156830218|NCT00394901|566129771|FG003|Double-blind Phase|Adverse Event|20|||
156830219|NCT00394901|566129768|FG000|Double-blind Phase|Lack of Efficacy|6|||
156830220|NCT00394901|566129769|FG001|Double-blind Phase|Lack of Efficacy|4|||
156830221|NCT00394901|566129770|FG002|Double-blind Phase|Lack of Efficacy|1|||
156830222|NCT00394901|566129771|FG003|Double-blind Phase|Lack of Efficacy|3|||
156830223|NCT00394901|566129768|FG000|Double-blind Phase|Withdrawal by Subject|2|||
156830224|NCT00394901|566129769|FG001|Double-blind Phase|Withdrawal by Subject|0|||
156830225|NCT00394901|566129770|FG002|Double-blind Phase|Withdrawal by Subject|0|||
156830226|NCT00394901|566129771|FG003|Double-blind Phase|Withdrawal by Subject|0|||
156830227|NCT00394901|566129768|FG000|Double-blind Phase|Lost to Follow-up|0|||
156830228|NCT00394901|566129769|FG001|Double-blind Phase|Lost to Follow-up|0|||
156830229|NCT00394901|566129770|FG002|Double-blind Phase|Lost to Follow-up|0|||
156830230|NCT00394901|566129771|FG003|Double-blind Phase|Lost to Follow-up|1|||
156830231|NCT00394901|566129768|FG000|Double-blind Phase|Protocol Violation|0|||
156830232|NCT00394901|566129769|FG001|Double-blind Phase|Protocol Violation|0|||
156830233|NCT00394901|566129770|FG002|Double-blind Phase|Protocol Violation|0|||
156830234|NCT00394901|566129771|FG003|Double-blind Phase|Protocol Violation|1|||
156830235|NCT00394901|566129768|FG000|Double-blind Phase|Death|1|||
156830236|NCT00394901|566129769|FG001|Double-blind Phase|Death|0|||
156830237|NCT00394901|566129770|FG002|Double-blind Phase|Death|0|||
156830238|NCT00394901|566129771|FG003|Double-blind Phase|Death|0|||
156830239|NCT00394901|566129768|FG000|Double-blind Phase|Subject's Personal Reason|1|||
156830240|NCT00394901|566129769|FG001|Double-blind Phase|Subject's Personal Reason|0|||
156830241|NCT00394901|566129770|FG002|Double-blind Phase|Subject's Personal Reason|0|||
156830242|NCT00394901|566129771|FG003|Double-blind Phase|Subject's Personal Reason|1|||
156830243|NCT00394901|566129768|FG000|Double-blind Phase|Lack of Compliance|0|||
156830244|NCT00394901|566129769|FG001|Double-blind Phase|Lack of Compliance|3|||
156830245|NCT00394901|566129770|FG002|Double-blind Phase|Lack of Compliance|0|||
156830246|NCT00394901|566129771|FG003|Double-blind Phase|Lack of Compliance|0|||
156830247|NCT00394901|566129768|FG000|Double-blind Phase|Entry into another study was found|0|||
156830248|NCT00394901|566129769|FG001|Double-blind Phase|Entry into another study was found|0|||
156830249|NCT00394901|566129770|FG002|Double-blind Phase|Entry into another study was found|1|||
156830250|NCT00394901|566129771|FG003|Double-blind Phase|Entry into another study was found|0|||
156830251|NCT00394901|566129768|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
156830252|NCT00394901|566129769|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
156830253|NCT00394901|566129770|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
156830254|NCT00394901|566129771|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
156830255|NCT03002623|566129774|FG000|Overall Study|Lost to Follow-up|1|||
156830256|NCT03002623|566129775|FG001|Overall Study|Lost to Follow-up|0|||
156885113|NCT00797966|566338230|FG002|Phase B|Adverse Event|3|||
157151252|NCT03242928|567299639|FG000|Overall Study|Withdrawal by Subject|5|||
157151253|NCT03242928|567299640|FG001|Overall Study|Withdrawal by Subject|3|||
157151254|NCT00960440|567299641|FG000|Overall Study|Death|0|||
157151255|NCT00960440|567299642|FG001|Overall Study|Death|0|||
157151256|NCT00960440|567299643|FG002|Overall Study|Death|0|||
156830257|NCT03002623|566129774|FG000|Overall Study|Physician Decision|1|||
156830258|NCT03002623|566129775|FG001|Overall Study|Physician Decision|1|||
156830259|NCT04342689|566129779|FG000|Overall Study|Withdrawal by Subject|32|||
156830260|NCT04342689|566129780|FG001|Overall Study|Withdrawal by Subject|33|||
156830261|NCT04342689|566129779|FG000|Overall Study|Lost to Follow-up|10|||
156830262|NCT04342689|566129780|FG001|Overall Study|Lost to Follow-up|12|||
156830263|NCT00844805|566129781|FG000|Treatment Phase|Adverse Event|5|||
156830264|NCT00844805|566129782|FG001|Treatment Phase|Adverse Event|1|||
156830265|NCT00844805|566129783|FG002|Treatment Phase|Adverse Event|0|||
156830266|NCT00844805|566129784|FG003|Treatment Phase|Adverse Event|0|||
156830267|NCT00844805|566129781|FG000|Treatment Phase|Withdrawal by Subject|3|||
157151257|NCT00960440|567299644|FG003|Overall Study|Death|1|||
157151258|NCT00960440|567299641|FG000|Overall Study|Adverse Event|12|||
156830268|NCT00844805|566129782|FG001|Treatment Phase|Withdrawal by Subject|4|||
156830269|NCT00844805|566129783|FG002|Treatment Phase|Withdrawal by Subject|0|||
156830270|NCT00844805|566129784|FG003|Treatment Phase|Withdrawal by Subject|0|||
156830271|NCT00844805|566129781|FG000|Treatment Phase|Noncompliance With Protocol|1|||
156830272|NCT00844805|566129782|FG001|Treatment Phase|Noncompliance With Protocol|0|||
156830273|NCT00844805|566129783|FG002|Treatment Phase|Noncompliance With Protocol|0|||
156830274|NCT00844805|566129784|FG003|Treatment Phase|Noncompliance With Protocol|0|||
156830275|NCT00844805|566129781|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
156830276|NCT00844805|566129782|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
156830277|NCT00844805|566129783|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
156830278|NCT00844805|566129784|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
156830279|NCT00844805|566129781|FG000|Follow-Up Phase|Adverse Event|0|||
156830280|NCT00844805|566129782|FG001|Follow-Up Phase|Adverse Event|0|||
156830281|NCT00844805|566129783|FG002|Follow-Up Phase|Adverse Event|1|||
156830282|NCT00844805|566129784|FG003|Follow-Up Phase|Adverse Event|0|||
156830283|NCT00844805|566129781|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
156830284|NCT00844805|566129782|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
156830285|NCT00844805|566129783|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
156830286|NCT00844805|566129784|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
156830287|NCT00844805|566129781|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
156830288|NCT00844805|566129782|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
156830289|NCT00844805|566129783|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
156830290|NCT00844805|566129784|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
156830291|NCT00844805|566129781|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
156830292|NCT00844805|566129782|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
156830293|NCT00844805|566129783|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
156830294|NCT00844805|566129784|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
156830295|NCT00844805|566129781|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830296|NCT00844805|566129782|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830297|NCT00844805|566129783|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
156830298|NCT00844805|566129784|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
156830299|NCT00475865|566129785|FG000|Overall Study|Adverse Event|0|||
156830300|NCT00475865|566129786|FG001|Overall Study|Adverse Event|3|||
156830301|NCT00475865|566129787|FG002|Overall Study|Adverse Event|4|||
156830302|NCT00475865|566129785|FG000|Overall Study|Lack of Efficacy|1|||
156830303|NCT00475865|566129786|FG001|Overall Study|Lack of Efficacy|0|||
156830304|NCT00475865|566129787|FG002|Overall Study|Lack of Efficacy|0|||
156830305|NCT00475865|566129785|FG000|Overall Study|Progressive disease|0|||
156830306|NCT00475865|566129786|FG001|Overall Study|Progressive disease|1|||
156830307|NCT00475865|566129787|FG002|Overall Study|Progressive disease|2|||
156830308|NCT00475865|566129785|FG000|Overall Study|Participant did not wish to continue|1|||
156830309|NCT00475865|566129786|FG001|Overall Study|Participant did not wish to continue|0|||
156830310|NCT00475865|566129787|FG002|Overall Study|Participant did not wish to continue|0|||
156830311|NCT00475865|566129785|FG000|Overall Study|Other than above|0|||
156830312|NCT00475865|566129786|FG001|Overall Study|Other than above|1|||
156830313|NCT00475865|566129787|FG002|Overall Study|Other than above|0|||
156830314|NCT04316741|566129788|FG000|Baseline Enrollment|Lost to Follow-up|1|||
156830315|NCT04316741|566129789|FG001|Baseline Enrollment|Lost to Follow-up|1|||
156830316|NCT04316741|566129788|FG000|Immediate Post-Test|Lost to Follow-up|5|||
156830317|NCT04316741|566129789|FG001|Immediate Post-Test|Lost to Follow-up|1|||
156830318|NCT04316741|566129788|FG000|1-month Post-test|Lost to Follow-up|7|||
156830319|NCT04316741|566129789|FG001|1-month Post-test|Lost to Follow-up|2|||
156830320|NCT04316741|566129788|FG000|3-month Follow-up|Lost to Follow-up|10|||
156830321|NCT04316741|566129789|FG001|3-month Follow-up|Lost to Follow-up|2|||
156830322|NCT02278614|566129793|FG000|Overall Study|Withdrawal by Subject|3|||
156830323|NCT02278614|566129794|FG001|Overall Study|Withdrawal by Subject|5|||
156830324|NCT02278614|566129793|FG000|Overall Study|Adverse Event|1|||
157151259|NCT00960440|567299642|FG001|Overall Study|Adverse Event|12|||
157151260|NCT00960440|567299643|FG002|Overall Study|Adverse Event|4|||
157151261|NCT00960440|567299644|FG003|Overall Study|Adverse Event|4|||
157151262|NCT00960440|567299641|FG000|Overall Study|Lack of Efficacy|2|||
157151263|NCT00960440|567299642|FG001|Overall Study|Lack of Efficacy|5|||
157151264|NCT00960440|567299643|FG002|Overall Study|Lack of Efficacy|3|||
156830325|NCT02278614|566129794|FG001|Overall Study|Adverse Event|0|||
156830326|NCT02278614|566129793|FG000|Overall Study|left eye was not eligible|1|||
157151265|NCT00960440|567299644|FG003|Overall Study|Lack of Efficacy|8|||
157151266|NCT00960440|567299641|FG000|Overall Study|Protocol Violation|2|||
157151267|NCT00960440|567299642|FG001|Overall Study|Protocol Violation|8|||
156830327|NCT02278614|566129794|FG001|Overall Study|left eye was not eligible|0|||
156830328|NCT00737711|566129795|FG000|Overall Study|Adverse Event|2|||
156830329|NCT00737711|566129795|FG000|Overall Study|Death|8|||
156830330|NCT00737711|566129795|FG000|Overall Study|Failure to return|4|||
156830331|NCT00737711|566129795|FG000|Overall Study|Protocol Violation|1|||
156830332|NCT00737711|566129795|FG000|Overall Study|Withdrawal by Subject|5|||
156830333|NCT00737711|566129795|FG000|Overall Study|Blood transfusion|6|||
157151268|NCT00960440|567299643|FG002|Overall Study|Protocol Violation|3|||
157151269|NCT00960440|567299644|FG003|Overall Study|Protocol Violation|4|||
156830334|NCT00737711|566129795|FG000|Overall Study|Other|5|||
156830335|NCT03081858|566132210|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
156830336|NCT03081858|566132211|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830337|NCT03081858|566132212|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830338|NCT03081858|566132213|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
156830339|NCT03959982|566132216|FG000|Overall Study|Withdrawal by Subject|1|||
156830340|NCT03959982|566132217|FG001|Overall Study|Withdrawal by Subject|0|||
156830341|NCT03959982|566132216|FG000|Overall Study|Physician Decision|2|||
156830342|NCT03959982|566132217|FG001|Overall Study|Physician Decision|0|||
156830343|NCT03959982|566132216|FG000|Overall Study|Lost to Follow-up|1|||
156830344|NCT03959982|566132217|FG001|Overall Study|Lost to Follow-up|0|||
156830345|NCT00758589|566132218|FG000|Overall Study|Adverse Event|3|||
156830346|NCT00758589|566132219|FG001|Overall Study|Adverse Event|2|||
156830347|NCT00758589|566132220|FG002|Overall Study|Adverse Event|5|||
156830348|NCT00758589|566132221|FG003|Overall Study|Adverse Event|4|||
156830349|NCT00758589|566132218|FG000|Overall Study|Withdrawal by Subject|0|||
156830350|NCT00758589|566132219|FG001|Overall Study|Withdrawal by Subject|1|||
156830351|NCT00758589|566132220|FG002|Overall Study|Withdrawal by Subject|1|||
156830352|NCT00758589|566132221|FG003|Overall Study|Withdrawal by Subject|1|||
156830353|NCT00758589|566132218|FG000|Overall Study|Palm stopped to work|0|||
156830354|NCT00758589|566132219|FG001|Overall Study|Palm stopped to work|0|||
156830355|NCT00758589|566132220|FG002|Overall Study|Palm stopped to work|0|||
156830356|NCT00758589|566132221|FG003|Overall Study|Palm stopped to work|1|||
156830357|NCT02191605|566132222|FG000|Overall Study|Lost to Follow-up|9|||
156830358|NCT02191605|566132223|FG001|Overall Study|Lost to Follow-up|4|||
156830359|NCT02191605|566132224|FG002|Overall Study|Lost to Follow-up|7|||
156830360|NCT02191605|566132225|FG003|Overall Study|Lost to Follow-up|3|||
156830361|NCT02191605|566132226|FG004|Overall Study|Lost to Follow-up|4|||
156830362|NCT03647267|566132231|FG000|Overall Study|Lost to Follow-up|1|||
156830363|NCT03647267|566132232|FG001|Overall Study|Lost to Follow-up|0|||
156830364|NCT05079477|566132233|FG000|Overall Study|Lost to Follow-up|2|||
156830365|NCT05079477|566132234|FG001|Overall Study|Lost to Follow-up|0|||
156830366|NCT05079477|566132233|FG000|Overall Study|Withdrawal by Subject|1|||
156830367|NCT05079477|566132234|FG001|Overall Study|Withdrawal by Subject|0|||
156830368|NCT05079477|566132233|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
156830369|NCT05079477|566132234|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
156830370|NCT05079477|566132233|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
156830371|NCT05079477|566132234|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
156885114|NCT00797966|566338231|FG003|Phase B|Adverse Event|1|||
156885115|NCT00797966|566338232|FG004|Phase B|Adverse Event|0|||
156885116|NCT00797966|566338233|FG005|Phase B|Adverse Event|0|||
156885117|NCT00797966|566338228|FG000|Phase B|Met Withdrawal Criteria|3|||
156885118|NCT00797966|566338229|FG001|Phase B|Met Withdrawal Criteria|3|||
156885119|NCT00797966|566338230|FG002|Phase B|Met Withdrawal Criteria|6|||
156885120|NCT00797966|566338231|FG003|Phase B|Met Withdrawal Criteria|1|||
156885121|NCT00797966|566338232|FG004|Phase B|Met Withdrawal Criteria|0|||
156885122|NCT00797966|566338233|FG005|Phase B|Met Withdrawal Criteria|0|||
156885123|NCT00797966|566338228|FG000|Phase B|Physician Decision|1|||
156885124|NCT00797966|566338229|FG001|Phase B|Physician Decision|0|||
156885125|NCT00797966|566338230|FG002|Phase B|Physician Decision|3|||
156885126|NCT00797966|566338231|FG003|Phase B|Physician Decision|1|||
156885127|NCT00797966|566338232|FG004|Phase B|Physician Decision|0|||
156885128|NCT00797966|566338233|FG005|Phase B|Physician Decision|0|||
156885129|NCT00797966|566338228|FG000|Phase B|Withdrawal by Subject|1|||
156830372|NCT00734071|566132237|FG000|Overall Study|Adverse Event|4|||
156830373|NCT00734071|566132238|FG001|Overall Study|Adverse Event|3|||
156830374|NCT00734071|566132237|FG000|Overall Study|Lack of Efficacy|3|||
156830375|NCT00734071|566132238|FG001|Overall Study|Lack of Efficacy|1|||
156830376|NCT00734071|566132237|FG000|Overall Study|Noncompliance|2|||
156830377|NCT00734071|566132238|FG001|Overall Study|Noncompliance|2|||
156830378|NCT00734071|566132237|FG000|Overall Study|Protocol Deviations|3|||
156830379|NCT00734071|566132238|FG001|Overall Study|Protocol Deviations|4|||
156885130|NCT00797966|566338229|FG001|Phase B|Withdrawal by Subject|4|||
156885131|NCT00797966|566338230|FG002|Phase B|Withdrawal by Subject|3|||
156885132|NCT00797966|566338231|FG003|Phase B|Withdrawal by Subject|3|||
156830380|NCT00734071|566132237|FG000|Overall Study|Voluntary Withdrawal|9|||
156830381|NCT00734071|566132238|FG001|Overall Study|Voluntary Withdrawal|7|||
156830382|NCT00734071|566132237|FG000|Overall Study|Lost to Follow-up|16|||
156830383|NCT00734071|566132238|FG001|Overall Study|Lost to Follow-up|8|||
156830384|NCT00734071|566132237|FG000|Overall Study|Other|1|||
156830385|NCT00734071|566132238|FG001|Overall Study|Other|2|||
156830386|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
156885133|NCT00797966|566338232|FG004|Phase B|Withdrawal by Subject|0|||
156885134|NCT00797966|566338233|FG005|Phase B|Withdrawal by Subject|0|||
156885135|NCT00797966|566338228|FG000|Phase B|Protocol Deviation|4|||
156885136|NCT00797966|566338229|FG001|Phase B|Protocol Deviation|8|||
156885137|NCT00797966|566338230|FG002|Phase B|Protocol Deviation|2|||
156885138|NCT00797966|566338231|FG003|Phase B|Protocol Deviation|6|||
156830387|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
156830388|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
156830389|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
156830390|NCT03654885|566132239|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
156830391|NCT03654885|566132240|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
156830392|NCT03654885|566132239|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
156830393|NCT03654885|566132240|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
156830394|NCT03654885|566132239|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
156830395|NCT03654885|566132240|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
156830396|NCT03654885|566132239|FG000|Overall Study|Adverse Event in Study Eye|3|||
156830397|NCT03654885|566132240|FG001|Overall Study|Adverse Event in Study Eye|0|||
156830398|NCT03654885|566132239|FG000|Overall Study|Consent Withdrawn|1|||
156830399|NCT03654885|566132240|FG001|Overall Study|Consent Withdrawn|0|||
156830400|NCT03654885|566132239|FG000|Overall Study|Death|3|||
156830401|NCT03654885|566132240|FG001|Overall Study|Death|1|||
156830402|NCT03654885|566132239|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
156830403|NCT03654885|566132240|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
156830404|NCT03654885|566132239|FG000|Overall Study|Lost to Follow-up|3|||
156830405|NCT03654885|566132240|FG001|Overall Study|Lost to Follow-up|3|||
156830406|NCT05275582|566132241|FG000|Overall Study|Lost to Follow-up|1|||
156830407|NCT05275582|566132242|FG001|Overall Study|Lost to Follow-up|0|||
156830408|NCT05275582|566132241|FG000|Overall Study|Withdrawal by Subject|0|||
156830409|NCT05275582|566132242|FG001|Overall Study|Withdrawal by Subject|2|||
156830410|NCT05275582|566132241|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
156830411|NCT05275582|566132242|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
156830412|NCT05275582|566132241|FG000|Overall Study|Death|1|||
156830413|NCT05275582|566132242|FG001|Overall Study|Death|0|||
156830414|NCT05275582|566132241|FG000|Overall Study|Protocol Violation|1|||
156830415|NCT05275582|566132242|FG001|Overall Study|Protocol Violation|0|||
156830416|NCT00240110|566132246|FG000|Overall Study|Lost to Follow-up|6|||
156830417|NCT00240110|566132247|FG001|Overall Study|Lost to Follow-up|7|||
156830418|NCT00583791|566132248|FG000|Overall Study|Other|67|||
156830419|NCT00583791|566132248|FG000|Overall Study|Death|6|||
156830420|NCT00203021|566132251|FG000|Overall Study|Death|4|||
156830421|NCT00203021|566132252|FG001|Overall Study|Death|1|||
156830422|NCT00203021|566132251|FG000|Overall Study|Adverse Event|10|||
156830423|NCT00203021|566132252|FG001|Overall Study|Adverse Event|5|||
156830424|NCT00203021|566132251|FG000|Overall Study|Withdrawal by Subject|45|||
156830425|NCT00203021|566132252|FG001|Overall Study|Withdrawal by Subject|48|||
156830426|NCT00203021|566132251|FG000|Overall Study|Lost to Follow-up|9|||
156830427|NCT00203021|566132252|FG001|Overall Study|Lost to Follow-up|7|||
156830428|NCT00203021|566132251|FG000|Overall Study|Other than specified|11|||
156830429|NCT00203021|566132252|FG001|Overall Study|Other than specified|16|||
156830430|NCT02080260|566132254|FG000|Overall Study|Death|18|||
156830431|NCT02080260|566132254|FG000|Overall Study|Withdrawal by Subject|1|||
156830432|NCT05438602|566132259|FG000|Treatment (15 Days)|Adverse Event|2|||
156830433|NCT05438602|566132260|FG001|Treatment (15 Days)|Adverse Event|1|||
156830434|NCT05438602|566132261|FG002|Treatment (15 Days)|Adverse Event|3|||
156830435|NCT05438602|566132259|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
156830436|NCT05438602|566132260|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
156830437|NCT05438602|566132261|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
156830438|NCT05438602|566132259|FG000|Treatment (15 Days)|Other|0|||
156830439|NCT05438602|566132260|FG001|Treatment (15 Days)|Other|0|||
156830440|NCT05438602|566132261|FG002|Treatment (15 Days)|Other|1|||
156830441|NCT05438602|566132259|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
156830442|NCT05438602|566132260|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
156830443|NCT05438602|566132261|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
156830444|NCT05438602|566132259|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
156830445|NCT05438602|566132260|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
156830446|NCT05438602|566132261|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
156830447|NCT05438602|566132259|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
156830448|NCT05438602|566132260|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
156830449|NCT05438602|566132261|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
156830450|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
156830451|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
156830452|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
156830453|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
156830454|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
156830455|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
156885139|NCT00797966|566338232|FG004|Phase B|Protocol Deviation|0|||
156885140|NCT00797966|566338233|FG005|Phase B|Protocol Deviation|0|||
156830456|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
156830457|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
156830458|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
156830459|NCT05438602|566132259|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
156830460|NCT05438602|566132260|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
156830461|NCT05438602|566132261|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
156830462|NCT03204890|566132262|FG000|Overall Study|Withdrawal by Subject|1|||
156830463|NCT02853435|566132263|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830464|NCT02853435|566132264|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830465|NCT02853435|566132265|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830466|NCT02853435|566132266|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830467|NCT02853435|566132267|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
156830468|NCT02853435|566132268|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
156830469|NCT03747120|566132271|FG000|Overall Study|treatment related toxicity|3|||
156830470|NCT03747120|566132272|FG001|Overall Study|treatment related toxicity|0|||
156830471|NCT03747120|566132273|FG002|Overall Study|treatment related toxicity|0|||
156830472|NCT03747120|566132271|FG000|Overall Study|Withdrawal by Subject|0|||
156830473|NCT03747120|566132272|FG001|Overall Study|Withdrawal by Subject|1|||
156830474|NCT03747120|566132273|FG002|Overall Study|Withdrawal by Subject|2|||
156830475|NCT01657760|566132287|FG000|Overall Study|Withdrawal by Subject|0|||
156830476|NCT01657760|566132288|FG001|Overall Study|Withdrawal by Subject|0|||
156830477|NCT01657760|566132289|FG002|Overall Study|Withdrawal by Subject|0|||
156830478|NCT01657760|566132290|FG003|Overall Study|Withdrawal by Subject|1|||
156830479|NCT01657760|566132287|FG000|Overall Study|Physician Decision|1|||
156830480|NCT01657760|566132288|FG001|Overall Study|Physician Decision|1|||
156830481|NCT01657760|566132289|FG002|Overall Study|Physician Decision|1|||
156830482|NCT01657760|566132290|FG003|Overall Study|Physician Decision|2|||
156830483|NCT02435680|566132304|FG000|Overall Study|Physician Decision|3|||
156830484|NCT02435680|566132305|FG001|Overall Study|Physician Decision|0|||
156830485|NCT02435680|566132306|FG002|Overall Study|Physician Decision|0|||
156830486|NCT02435680|566132304|FG000|Overall Study|subject / guardian decision|0|||
156830487|NCT02435680|566132305|FG001|Overall Study|subject / guardian decision|3|||
156830488|NCT02435680|566132306|FG002|Overall Study|subject / guardian decision|2|||
156830489|NCT02435680|566132304|FG000|Overall Study|Adverse Event|8|||
156830490|NCT02435680|566132305|FG001|Overall Study|Adverse Event|3|||
156830491|NCT02435680|566132306|FG002|Overall Study|Adverse Event|2|||
156830492|NCT02435680|566132304|FG000|Overall Study|progressive disease|10|||
156830493|NCT02435680|566132305|FG001|Overall Study|progressive disease|7|||
156830494|NCT02435680|566132306|FG002|Overall Study|progressive disease|11|||
156830495|NCT02435680|566132304|FG000|Overall Study|not treated|0|||
156830496|NCT02435680|566132305|FG001|Overall Study|not treated|0|||
156830497|NCT02435680|566132306|FG002|Overall Study|not treated|1|||
156830498|NCT00953524|566132307|FG000|Overall Study|Adverse Event|2|||
156830499|NCT00953524|566132308|FG001|Overall Study|Adverse Event|0|||
156830500|NCT00953524|566132309|FG002|Overall Study|Adverse Event|1|||
156830501|NCT00953524|566132310|FG003|Overall Study|Adverse Event|2|||
156830502|NCT00953524|566132307|FG000|Overall Study|Protocol Violation|18|||
156830503|NCT00953524|566132308|FG001|Overall Study|Protocol Violation|10|||
156830504|NCT00953524|566132309|FG002|Overall Study|Protocol Violation|11|||
156830505|NCT00953524|566132310|FG003|Overall Study|Protocol Violation|6|||
156830506|NCT00953524|566132307|FG000|Overall Study|Lost to Follow-up|0|||
156830507|NCT00953524|566132308|FG001|Overall Study|Lost to Follow-up|1|||
156830508|NCT00953524|566132309|FG002|Overall Study|Lost to Follow-up|1|||
156830509|NCT00953524|566132310|FG003|Overall Study|Lost to Follow-up|0|||
156830510|NCT00953524|566132307|FG000|Overall Study|Withdrawal by Subject|2|||
156830511|NCT00953524|566132308|FG001|Overall Study|Withdrawal by Subject|4|||
156830512|NCT00953524|566132309|FG002|Overall Study|Withdrawal by Subject|1|||
156830513|NCT00953524|566132310|FG003|Overall Study|Withdrawal by Subject|0|||
156830514|NCT01994863|566132312|FG000|Period 1|Adverse Event|4|||
156830515|NCT01994863|566132313|FG001|Period 1|Adverse Event|0|||
156830516|NCT01994863|566132312|FG000|Period 1|Withdrawal by Subject|1|||
156830517|NCT01994863|566132313|FG001|Period 1|Withdrawal by Subject|0|||
156830518|NCT01994863|566132312|FG000|Period 1|Trial stopped by sponsor|1|||
156830519|NCT01994863|566132313|FG001|Period 1|Trial stopped by sponsor|3|||
156830520|NCT01994863|566132312|FG000|Period 1|Lack of Efficacy|1|||
156885141|NCT00797966|566338228|FG000|Phase B|Lack of Efficacy|0|||
156885142|NCT00797966|566338229|FG001|Phase B|Lack of Efficacy|1|||
156885143|NCT00797966|566338230|FG002|Phase B|Lack of Efficacy|1|||
156830521|NCT01994863|566132313|FG001|Period 1|Lack of Efficacy|0|||
156830522|NCT01994863|566132312|FG000|Period 2|Adverse Event|0|||
156830523|NCT01994863|566132313|FG001|Period 2|Adverse Event|1|||
156885144|NCT00797966|566338231|FG003|Phase B|Lack of Efficacy|4|||
156830524|NCT01994863|566132312|FG000|Period 2|Lack of Efficacy|0|||
156830525|NCT01994863|566132313|FG001|Period 2|Lack of Efficacy|2|||
156830526|NCT01994863|566132312|FG000|Period 2|Withdrawal by Subject|1|||
156830527|NCT01994863|566132313|FG001|Period 2|Withdrawal by Subject|1|||
156830528|NCT04612842|566132314|FG000|Overall Study|Lost to Follow-up|20|||
156830529|NCT04612842|566132315|FG001|Overall Study|Lost to Follow-up|11|||
157151270|NCT00960440|567299641|FG000|Overall Study|Withdrawal by Subject|9|||
156830530|NCT04612842|566132314|FG000|Overall Study|Withdrawal by Subject|26|||
156830531|NCT04612842|566132315|FG001|Overall Study|Withdrawal by Subject|15|||
156830532|NCT04612842|566132314|FG000|Overall Study|Death|2|||
156830533|NCT04612842|566132315|FG001|Overall Study|Death|2|||
156830534|NCT02419131|566132316|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
156830535|NCT02419131|566132317|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
156830536|NCT02419131|566132318|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
156830537|NCT02419131|566132316|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
156830538|NCT02419131|566132317|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
156830539|NCT02419131|566132318|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
156830540|NCT03060512|566132319|FG000|Overall Study|Adverse Event|4|||
156830541|NCT03060512|566132320|FG001|Overall Study|Adverse Event|6|||
156830542|NCT03060512|566132319|FG000|Overall Study|Lost to Follow-up|1|||
156830543|NCT03060512|566132320|FG001|Overall Study|Lost to Follow-up|1|||
156830544|NCT03060512|566132319|FG000|Overall Study|Withdrawal by Subject|1|||
156830545|NCT03060512|566132320|FG001|Overall Study|Withdrawal by Subject|0|||
156830546|NCT03060512|566132319|FG000|Overall Study|Non-compliance with study medication|1|||
156830547|NCT03060512|566132320|FG001|Overall Study|Non-compliance with study medication|2|||
156830548|NCT01765426|566132321|FG000|Overall Study|Lost to Follow-up|0|||
156830549|NCT01765426|566132322|FG001|Overall Study|Lost to Follow-up|1|||
156830550|NCT01765426|566132323|FG002|Overall Study|Lost to Follow-up|0|||
156830551|NCT01765426|566132324|FG003|Overall Study|Lost to Follow-up|0|||
156830552|NCT03351114|566132325|FG000|Overall Study|Withdrawal by Subject|1|||
156830553|NCT01665430|566132329|FG000|Overall Study|Adverse Event|1|||
156830554|NCT01665430|566132329|FG000|Overall Study|Withdrawal by Subject|6|||
156830555|NCT01665430|566132329|FG000|Overall Study|Other Unspecified|2|||
156885145|NCT00797966|566338232|FG004|Phase B|Lack of Efficacy|0|||
156885146|NCT00797966|566338233|FG005|Phase B|Lack of Efficacy|0|||
156885147|NCT00797966|566338228|FG000|Phase A+|Lost to Follow-up|0|||
156885148|NCT00797966|566338229|FG001|Phase A+|Lost to Follow-up|0|||
156885149|NCT00797966|566338230|FG002|Phase A+|Lost to Follow-up|0|||
156885150|NCT00797966|566338231|FG003|Phase A+|Lost to Follow-up|0|||
156885151|NCT00797966|566338232|FG004|Phase A+|Lost to Follow-up|0|||
156885152|NCT00797966|566338233|FG005|Phase A+|Lost to Follow-up|9|||
156885153|NCT00797966|566338228|FG000|Phase A+|Met withdrawal criteria|0|||
156885154|NCT00797966|566338229|FG001|Phase A+|Met withdrawal criteria|0|||
156885155|NCT00797966|566338230|FG002|Phase A+|Met withdrawal criteria|0|||
156885156|NCT00797966|566338231|FG003|Phase A+|Met withdrawal criteria|0|||
156885157|NCT00797966|566338232|FG004|Phase A+|Met withdrawal criteria|0|||
156885158|NCT00797966|566338233|FG005|Phase A+|Met withdrawal criteria|5|||
156885159|NCT00797966|566338228|FG000|Phase A+|Withdrawal by Subject|0|||
156885160|NCT00797966|566338229|FG001|Phase A+|Withdrawal by Subject|0|||
156885161|NCT00797966|566338230|FG002|Phase A+|Withdrawal by Subject|0|||
156885162|NCT00797966|566338231|FG003|Phase A+|Withdrawal by Subject|0|||
156885163|NCT00797966|566338232|FG004|Phase A+|Withdrawal by Subject|0|||
156885164|NCT00797966|566338233|FG005|Phase A+|Withdrawal by Subject|6|||
156885165|NCT00797966|566338228|FG000|Phase A+|Adverse Event|0|||
156885166|NCT00797966|566338229|FG001|Phase A+|Adverse Event|0|||
156885167|NCT00797966|566338230|FG002|Phase A+|Adverse Event|0|||
156885168|NCT00797966|566338231|FG003|Phase A+|Adverse Event|0|||
156885169|NCT00797966|566338232|FG004|Phase A+|Adverse Event|0|||
156885170|NCT00797966|566338233|FG005|Phase A+|Adverse Event|4|||
156885171|NCT00797966|566338228|FG000|Phase A+|Protocol deviation|0|||
156885172|NCT00797966|566338229|FG001|Phase A+|Protocol deviation|0|||
156885173|NCT00797966|566338230|FG002|Phase A+|Protocol deviation|0|||
156885174|NCT00797966|566338231|FG003|Phase A+|Protocol deviation|0|||
156885175|NCT00797966|566338232|FG004|Phase A+|Protocol deviation|0|||
156885176|NCT00797966|566338233|FG005|Phase A+|Protocol deviation|4|||
156885177|NCT01430754|566338234|FG000|Run-In Phase|Circadian Period Ineligible|24|||
156885178|NCT01430754|566338235|FG001|Run-In Phase|Circadian Period Ineligible|0|||
157151271|NCT00960440|567299642|FG001|Overall Study|Withdrawal by Subject|5|||
157151272|NCT00960440|567299643|FG002|Overall Study|Withdrawal by Subject|2|||
157151273|NCT00960440|567299644|FG003|Overall Study|Withdrawal by Subject|1|||
156830556|NCT02310230|566132330|FG000|Overall Study|Physician Decision|1|||
156885179|NCT01430754|566338234|FG000|Run-In Phase|Protocol Violation|6|||
157151274|NCT00960440|567299641|FG000|Overall Study|Other|1|||
157151275|NCT00960440|567299642|FG001|Overall Study|Other|1|||
156885180|NCT01430754|566338235|FG001|Run-In Phase|Protocol Violation|0|||
156885181|NCT01430754|566338234|FG000|Run-In Phase|Adverse Event|2|||
157151276|NCT00960440|567299643|FG002|Overall Study|Other|1|||
156830557|NCT02310230|566132331|FG001|Overall Study|Physician Decision|3|||
156830558|NCT02310230|566132330|FG000|Overall Study|monitor baseline taken after induction|2|||
156830559|NCT02310230|566132331|FG001|Overall Study|monitor baseline taken after induction|7|||
156885182|NCT01430754|566338235|FG001|Run-In Phase|Adverse Event|0|||
156885183|NCT01430754|566338234|FG000|Run-In Phase|Other|2|||
156885184|NCT01430754|566338235|FG001|Run-In Phase|Other|0|||
156885185|NCT01430754|566338234|FG000|Run-In Phase|Withdrawal by Subject|2|||
156830560|NCT02310230|566132330|FG000|Overall Study|Poor signal quality|5|||
156830561|NCT02310230|566132331|FG001|Overall Study|Poor signal quality|8|||
156830562|NCT02310230|566132330|FG000|Overall Study|Case cancelled|1|||
156830563|NCT02310230|566132331|FG001|Overall Study|Case cancelled|0|||
156830564|NCT00989235|566132332|FG000|Overall Study|Death|0|||
156830565|NCT00989235|566132333|FG001|Overall Study|Death|1|||
156830566|NCT00989235|566132332|FG000|Overall Study|Adverse Event|0|||
156830567|NCT00989235|566132333|FG001|Overall Study|Adverse Event|1|||
156830568|NCT00989235|566132332|FG000|Overall Study|Lack of Efficacy|1|||
156830569|NCT00989235|566132333|FG001|Overall Study|Lack of Efficacy|0|||
156830570|NCT00989235|566132332|FG000|Overall Study|Withdrawal of Consent|1|||
156830571|NCT00989235|566132333|FG001|Overall Study|Withdrawal of Consent|1|||
156830572|NCT00989235|566132332|FG000|Overall Study|Desire to Become Pregnant|1|||
156830573|NCT00989235|566132333|FG001|Overall Study|Desire to Become Pregnant|0|||
156830574|NCT00989235|566132332|FG000|Overall Study|Randomized by Mistake|0|||
156830575|NCT00989235|566132333|FG001|Overall Study|Randomized by Mistake|2|||
156830576|NCT00989235|566132332|FG000|Overall Study|Lost to Follow-up|0|||
156830577|NCT00989235|566132333|FG001|Overall Study|Lost to Follow-up|1|||
156830578|NCT03249935|566132334|FG000|Overall Study|Discharged from facility early|36|||
156830579|NCT03249935|566132334|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
156830580|NCT03249935|566132334|FG000|Overall Study|Protocol Violation|5|||
156830581|NCT04662073|566132335|FG000|Overall Study|Withdrawal by Subject|1|||
156830582|NCT04662073|566132336|FG001|Overall Study|Withdrawal by Subject|0|||
156830583|NCT01135914|566132337|FG000|Overall Study|Withdrawal by Subject|1|||
156830584|NCT01135914|566132338|FG001|Overall Study|Withdrawal by Subject|3|||
156830585|NCT01135914|566132339|FG002|Overall Study|Withdrawal by Subject|6|||
156830586|NCT01135914|566132337|FG000|Overall Study|Lost to Follow-up|1|||
156830587|NCT01135914|566132338|FG001|Overall Study|Lost to Follow-up|0|||
156830588|NCT01135914|566132339|FG002|Overall Study|Lost to Follow-up|1|||
156830589|NCT01135914|566132337|FG000|Overall Study|Protocol Violation|0|||
156830590|NCT01135914|566132338|FG001|Overall Study|Protocol Violation|0|||
156830591|NCT01135914|566132339|FG002|Overall Study|Protocol Violation|3|||
156830592|NCT01135914|566132337|FG000|Overall Study|Lack of Efficacy|2|||
156830593|NCT01135914|566132338|FG001|Overall Study|Lack of Efficacy|1|||
156830594|NCT01135914|566132339|FG002|Overall Study|Lack of Efficacy|10|||
156830595|NCT01135914|566132337|FG000|Overall Study|Adverse Event|0|||
156830596|NCT01135914|566132338|FG001|Overall Study|Adverse Event|1|||
156830597|NCT01135914|566132339|FG002|Overall Study|Adverse Event|2|||
156830598|NCT00598078|566132340|FG000|Period 2 (Day 2)|Adverse Event|1|||
156830599|NCT00598078|566132341|FG001|Period 2 (Day 2)|Adverse Event|0|||
156830600|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
156830601|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
156830602|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
156830603|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
156830604|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
156830605|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
156830606|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
156830607|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
156830608|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
156830609|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
156830610|NCT00900146|566132342|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
156830611|NCT00900146|566132343|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830612|NCT00900146|566132344|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830613|NCT00900146|566132345|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830614|NCT00900146|566132346|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
156830615|NCT00900146|566132342|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
156830616|NCT00900146|566132343|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
156830617|NCT00900146|566132344|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
156830618|NCT00900146|566132345|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
157151277|NCT00960440|567299644|FG003|Overall Study|Other|0|||
156830619|NCT00900146|566132346|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
156830620|NCT00900146|566132342|FG000|Intermediate: Period III|Lost to Follow-up|2|||
156830621|NCT00900146|566132343|FG001|Intermediate: Period III|Lost to Follow-up|0|||
156830622|NCT00900146|566132344|FG002|Intermediate: Period III|Lost to Follow-up|0|||
156830623|NCT00900146|566132345|FG003|Intermediate: Period III|Lost to Follow-up|0|||
156830624|NCT00900146|566132346|FG004|Intermediate: Period III|Lost to Follow-up|1|||
156830625|NCT00900146|566132342|FG000|Intermediate: Period III|Administrative problems|85|||
156830626|NCT00900146|566132343|FG001|Intermediate: Period III|Administrative problems|92|||
156830627|NCT00900146|566132344|FG002|Intermediate: Period III|Administrative problems|84|||
156830628|NCT00900146|566132345|FG003|Intermediate: Period III|Administrative problems|90|||
156830629|NCT00900146|566132346|FG004|Intermediate: Period III|Administrative problems|163|||
156830630|NCT01635764|566132347|FG000|Overall Study|Adverse Event|46|||
157151278|NCT03504774|567299648|FG000|Overall Study|Adverse Event|2|||
157151279|NCT03504774|567299649|FG001|Overall Study|Adverse Event|0|||
157023260|NCT05084508|566838860|FG002|Overall Study|Other|0|||
157023261|NCT05084508|566838861|FG003|Overall Study|Other|1|||
157023262|NCT04137289|566838862|FG000|Overall Study|Death|0|||
157023263|NCT04137289|566838863|FG001|Overall Study|Death|0|||
157023264|NCT04137289|566838864|FG002|Overall Study|Death|0|||
157023265|NCT04137289|566838865|FG003|Overall Study|Death|0|||
157023266|NCT04137289|566838866|FG004|Overall Study|Death|0|||
157023267|NCT04137289|566838867|FG005|Overall Study|Death|0|||
157023268|NCT04137289|566838868|FG006|Overall Study|Death|1|||
156830631|NCT01635764|566132347|FG000|Overall Study|Lack of Efficacy|76|||
156830632|NCT01635764|566132347|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
156830633|NCT01635764|566132347|FG000|Overall Study|Protocol Deviation|1|||
156830634|NCT01635764|566132347|FG000|Overall Study|Withdrew Consent|67|||
156830635|NCT01635764|566132347|FG000|Overall Study|Lost to Follow-up|53|||
156830636|NCT01635764|566132347|FG000|Overall Study|Other|28|||
156830637|NCT05590000|566132348|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
156830638|NCT00693472|566132349|FG000|Part 1|Adverse Event|1|||
156830639|NCT00693472|566132350|FG001|Part 1|Adverse Event|1|||
156830640|NCT00693472|566132351|FG002|Part 1|Adverse Event|0|||
156830641|NCT00693472|566132352|FG003|Part 1|Adverse Event|0|||
156830642|NCT00693472|566132349|FG000|Part 1|Lost to Follow-up|0|||
156830643|NCT00693472|566132350|FG001|Part 1|Lost to Follow-up|1|||
156830644|NCT00693472|566132351|FG002|Part 1|Lost to Follow-up|0|||
156830645|NCT00693472|566132352|FG003|Part 1|Lost to Follow-up|0|||
156830646|NCT00693472|566132349|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
156830647|NCT00693472|566132350|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
156830648|NCT00693472|566132351|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
156830649|NCT00693472|566132352|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
156830650|NCT00693472|566132349|FG000|Part 2|Adverse Event|0|||
156830651|NCT00693472|566132350|FG001|Part 2|Adverse Event|0|||
156830652|NCT00693472|566132351|FG002|Part 2|Adverse Event|1|||
156830653|NCT00693472|566132352|FG003|Part 2|Adverse Event|0|||
156830654|NCT00693472|566132349|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
156830655|NCT00693472|566132350|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
156830656|NCT00693472|566132351|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
156830657|NCT00693472|566132352|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
156830658|NCT02075632|566132356|FG000|Overall Study|Adverse Event|1|||
156830659|NCT02075632|566132357|FG001|Overall Study|Adverse Event|1|||
156830660|NCT02075632|566132356|FG000|Overall Study|Lost to Follow-up|0|||
156830661|NCT02075632|566132357|FG001|Overall Study|Lost to Follow-up|3|||
156830662|NCT02075632|566132356|FG000|Overall Study|Withdrawal by Subject|0|||
156830663|NCT02075632|566132357|FG001|Overall Study|Withdrawal by Subject|1|||
156830664|NCT00740714|566132360|FG000|Overall Study|Withdrawal by Subject|17|||
156830665|NCT00740714|566132361|FG001|Overall Study|Withdrawal by Subject|19|||
156830666|NCT00740714|566132362|FG002|Overall Study|Withdrawal by Subject|29|||
156830667|NCT04070326|566132365|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
156830668|NCT04070326|566132366|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
156830669|NCT01367704|566132370|FG000|Overall Study|Lost to Follow-up|47|||
156830670|NCT01367704|566132371|FG001|Overall Study|Lost to Follow-up|161|||
156830671|NCT02193087|566132373|FG000|Overall Study|Adverse Event|2|||
156830672|NCT02193087|566132374|FG001|Overall Study|Adverse Event|0|||
157023269|NCT04137289|566838869|FG007|Overall Study|Death|0|||
157023270|NCT04137289|566838870|FG008|Overall Study|Death|0|||
157023271|NCT04137289|566838862|FG000|Overall Study|Clinical disease progression|0|||
157023272|NCT04137289|566838863|FG001|Overall Study|Clinical disease progression|0|||
156830673|NCT02193087|566132375|FG002|Overall Study|Adverse Event|0|||
156830674|NCT02193087|566132376|FG003|Overall Study|Adverse Event|11|||
156830675|NCT02193087|566132373|FG000|Overall Study|Lost to Follow-up|14|||
156830676|NCT02193087|566132374|FG001|Overall Study|Lost to Follow-up|6|||
156830677|NCT02193087|566132375|FG002|Overall Study|Lost to Follow-up|4|||
156830678|NCT02193087|566132376|FG003|Overall Study|Lost to Follow-up|37|||
156830679|NCT02193087|566132373|FG000|Overall Study|Protocol Violation|2|||
156830680|NCT02193087|566132374|FG001|Overall Study|Protocol Violation|0|||
156830681|NCT02193087|566132375|FG002|Overall Study|Protocol Violation|1|||
156830682|NCT02193087|566132376|FG003|Overall Study|Protocol Violation|2|||
156830683|NCT02193087|566132373|FG000|Overall Study|Withdrawal by Subject|10|||
156830684|NCT02193087|566132374|FG001|Overall Study|Withdrawal by Subject|3|||
156830685|NCT02193087|566132375|FG002|Overall Study|Withdrawal by Subject|1|||
156830686|NCT02193087|566132376|FG003|Overall Study|Withdrawal by Subject|19|||
156830687|NCT02193087|566132373|FG000|Overall Study|Other Reason Not Specified|7|||
156830688|NCT02193087|566132374|FG001|Overall Study|Other Reason Not Specified|2|||
157023273|NCT04137289|566838864|FG002|Overall Study|Clinical disease progression|0|||
156830689|NCT02193087|566132375|FG002|Overall Study|Other Reason Not Specified|1|||
157023274|NCT04137289|566838865|FG003|Overall Study|Clinical disease progression|4|||
156830690|NCT02193087|566132376|FG003|Overall Study|Other Reason Not Specified|9|||
156830691|NCT02193087|566132373|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
157023275|NCT04137289|566838866|FG004|Overall Study|Clinical disease progression|4|||
157023276|NCT04137289|566838867|FG005|Overall Study|Clinical disease progression|2|||
156830692|NCT02193087|566132374|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
156830693|NCT02193087|566132375|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
156830694|NCT02193087|566132376|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
156830695|NCT04096820|566132377|FG000|Overall Study|Did not return for intervention|2|||
156830696|NCT04096820|566132377|FG000|Overall Study|Death|1|||
156830697|NCT02726880|566132378|FG000|Overall Study|Withdrawal by Subject|2|||
156830698|NCT02726880|566132379|FG001|Overall Study|Withdrawal by Subject|0|||
156830699|NCT02726880|566132378|FG000|Overall Study|Lost to Follow-up|1|||
156830700|NCT02726880|566132379|FG001|Overall Study|Lost to Follow-up|3|||
156830701|NCT01510145|566132380|FG000|Overall Study|Adverse Event|6|||
156830702|NCT01510145|566132380|FG000|Overall Study|Lost to Follow-up|5|||
156830703|NCT01510145|566132380|FG000|Overall Study|Withdrawal by Subject|6|||
156830704|NCT01510145|566132380|FG000|Overall Study|Relative reported subject withdrew|1|||
156830705|NCT00787202|566132381|FG000|Overall Study|Adverse Event|3|||
156830706|NCT00787202|566132382|FG001|Overall Study|Adverse Event|2|||
156830707|NCT00787202|566132383|FG002|Overall Study|Adverse Event|0|||
156830708|NCT00787202|566132384|FG003|Overall Study|Adverse Event|0|||
156830709|NCT00787202|566132385|FG004|Overall Study|Adverse Event|2|||
156830710|NCT00787202|566132381|FG000|Overall Study|Lack of Efficacy|5|||
156830711|NCT00787202|566132382|FG001|Overall Study|Lack of Efficacy|6|||
156830712|NCT00787202|566132383|FG002|Overall Study|Lack of Efficacy|5|||
156830713|NCT00787202|566132384|FG003|Overall Study|Lack of Efficacy|2|||
156830714|NCT00787202|566132385|FG004|Overall Study|Lack of Efficacy|1|||
156830715|NCT00787202|566132381|FG000|Overall Study|Lost to Follow-up|1|||
156830716|NCT00787202|566132382|FG001|Overall Study|Lost to Follow-up|0|||
156830717|NCT00787202|566132383|FG002|Overall Study|Lost to Follow-up|0|||
156830718|NCT00787202|566132384|FG003|Overall Study|Lost to Follow-up|0|||
156830719|NCT00787202|566132385|FG004|Overall Study|Lost to Follow-up|0|||
156830720|NCT00787202|566132381|FG000|Overall Study|Withdrawal by Subject|2|||
156830721|NCT00787202|566132382|FG001|Overall Study|Withdrawal by Subject|2|||
156830722|NCT00787202|566132383|FG002|Overall Study|Withdrawal by Subject|2|||
156830723|NCT00787202|566132384|FG003|Overall Study|Withdrawal by Subject|0|||
156830724|NCT00787202|566132385|FG004|Overall Study|Withdrawal by Subject|0|||
156830725|NCT00787202|566132381|FG000|Overall Study|Protocol Violation|2|||
156830726|NCT00787202|566132382|FG001|Overall Study|Protocol Violation|1|||
156830727|NCT00787202|566132383|FG002|Overall Study|Protocol Violation|0|||
156830728|NCT00787202|566132384|FG003|Overall Study|Protocol Violation|0|||
156830729|NCT00787202|566132385|FG004|Overall Study|Protocol Violation|1|||
156830730|NCT00787202|566132381|FG000|Overall Study|Randomized, not treated|1|||
156830731|NCT00787202|566132382|FG001|Overall Study|Randomized, not treated|0|||
156830732|NCT00787202|566132383|FG002|Overall Study|Randomized, not treated|0|||
156830733|NCT00787202|566132384|FG003|Overall Study|Randomized, not treated|0|||
156830734|NCT00787202|566132385|FG004|Overall Study|Randomized, not treated|0|||
156830735|NCT02153346|566132386|FG000|Overall Study|Lost to Follow-up|11|||
156830736|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830737|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830738|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830739|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830740|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830741|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830742|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830743|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830744|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
157023277|NCT04137289|566838868|FG006|Overall Study|Clinical disease progression|5|||
157023278|NCT04137289|566838869|FG007|Overall Study|Clinical disease progression|1|||
157023279|NCT04137289|566838870|FG008|Overall Study|Clinical disease progression|0|||
157023280|NCT04137289|566838862|FG000|Overall Study|Lost to Follow-up|0|||
156830745|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
156830746|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830747|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
156830748|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830749|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830750|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
156830751|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830752|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830753|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830754|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830755|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830756|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830757|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
157023281|NCT04137289|566838863|FG001|Overall Study|Lost to Follow-up|0|||
156830758|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830759|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
156830760|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830761|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830762|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
156830763|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830764|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830765|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830766|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830767|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830768|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
157023282|NCT04137289|566838864|FG002|Overall Study|Lost to Follow-up|0|||
157023283|NCT04137289|566838865|FG003|Overall Study|Lost to Follow-up|1|||
157023284|NCT04137289|566838866|FG004|Overall Study|Lost to Follow-up|0|||
157023285|NCT04137289|566838867|FG005|Overall Study|Lost to Follow-up|0|||
157023286|NCT04137289|566838868|FG006|Overall Study|Lost to Follow-up|0|||
157023287|NCT04137289|566838869|FG007|Overall Study|Lost to Follow-up|0|||
157023288|NCT04137289|566838870|FG008|Overall Study|Lost to Follow-up|0|||
156830769|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830770|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830771|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
156830772|NCT00969761|566132387|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830773|NCT00969761|566132388|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830774|NCT00969761|566132389|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830775|NCT00969761|566132390|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830776|NCT00969761|566132391|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830777|NCT00969761|566132392|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830778|NCT00969761|566132393|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
157023289|NCT04137289|566838862|FG000|Overall Study|Adverse Event|0|||
157023290|NCT04137289|566838863|FG001|Overall Study|Adverse Event|0|||
157023291|NCT04137289|566838864|FG002|Overall Study|Adverse Event|1|||
157023292|NCT04137289|566838865|FG003|Overall Study|Adverse Event|0|||
157023293|NCT04137289|566838866|FG004|Overall Study|Adverse Event|0|||
157023294|NCT04137289|566838867|FG005|Overall Study|Adverse Event|1|||
157023295|NCT04137289|566838868|FG006|Overall Study|Adverse Event|0|||
157023296|NCT04137289|566838869|FG007|Overall Study|Adverse Event|0|||
157023297|NCT04137289|566838870|FG008|Overall Study|Adverse Event|0|||
157023298|NCT04137289|566838862|FG000|Overall Study|Lack of clinical benefit|0|||
157023299|NCT04137289|566838863|FG001|Overall Study|Lack of clinical benefit|0|||
157023300|NCT04137289|566838864|FG002|Overall Study|Lack of clinical benefit|0|||
157023301|NCT04137289|566838865|FG003|Overall Study|Lack of clinical benefit|0|||
157023302|NCT04137289|566838866|FG004|Overall Study|Lack of clinical benefit|0|||
157023303|NCT04137289|566838867|FG005|Overall Study|Lack of clinical benefit|0|||
157023304|NCT04137289|566838868|FG006|Overall Study|Lack of clinical benefit|0|||
157023305|NCT04137289|566838869|FG007|Overall Study|Lack of clinical benefit|0|||
157023306|NCT04137289|566838870|FG008|Overall Study|Lack of clinical benefit|1|||
157023307|NCT04137289|566838862|FG000|Overall Study|Objective disease progression|1|||
157023308|NCT04137289|566838863|FG001|Overall Study|Objective disease progression|1|||
157023309|NCT04137289|566838864|FG002|Overall Study|Objective disease progression|6|||
157023310|NCT04137289|566838865|FG003|Overall Study|Objective disease progression|18|||
157023311|NCT04137289|566838866|FG004|Overall Study|Objective disease progression|12|||
157023312|NCT04137289|566838867|FG005|Overall Study|Objective disease progression|20|||
157023313|NCT04137289|566838868|FG006|Overall Study|Objective disease progression|18|||
157023314|NCT04137289|566838869|FG007|Overall Study|Objective disease progression|7|||
157023315|NCT04137289|566838870|FG008|Overall Study|Objective disease progression|6|||
157023316|NCT03931174|566838875|FG000|Providers|Staff left organization|26|||
157023317|NCT03931174|566838876|FG001|Providers|Staff left organization|25|||
157023318|NCT03931174|566838875|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
157224552|NCT00936975|567568024|FG000|Overall Study|Withdrawal by Subject|1|||
157224553|NCT00936975|567568024|FG000|Overall Study|Disease progression|3|||
156830779|NCT00969761|566132394|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830780|NCT00969761|566132395|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
156830781|NCT00969761|566132396|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
157023319|NCT03931174|566838876|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
157023320|NCT03931174|566838875|FG000|Providers|Lost to Follow-up|4|||
157023321|NCT03931174|566838876|FG001|Providers|Lost to Follow-up|4|||
157023322|NCT03931174|566838875|FG000|Patients|Post-consent screening failure|1|||
157023323|NCT03931174|566838876|FG001|Patients|Post-consent screening failure|1|||
157224554|NCT00936975|567568024|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
157023324|NCT03931174|566838875|FG000|Patients|Death|1|||
156830782|NCT00969761|566132397|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830783|NCT00969761|566132398|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
156830784|NCT00969761|566132387|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830785|NCT00969761|566132388|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830786|NCT00969761|566132389|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
156830787|NCT00969761|566132390|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830788|NCT00969761|566132391|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830789|NCT00969761|566132392|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830790|NCT00969761|566132393|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830791|NCT00969761|566132394|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
156830792|NCT00969761|566132395|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
156830793|NCT00969761|566132396|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
156830794|NCT00969761|566132397|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830795|NCT00969761|566132398|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
156830796|NCT00969761|566132387|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830797|NCT00969761|566132388|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830798|NCT00969761|566132389|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830799|NCT00969761|566132390|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
156830800|NCT00969761|566132391|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
156830801|NCT00969761|566132392|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830802|NCT00969761|566132393|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830803|NCT00969761|566132394|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830804|NCT00969761|566132395|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
156830805|NCT00969761|566132396|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830806|NCT00969761|566132397|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830807|NCT00969761|566132398|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
156830808|NCT00664326|566133844|FG000|Overall Study|Adverse Event|14|||
156830809|NCT00664326|566133844|FG000|Overall Study|Noncompliance with study medication|3|||
156830810|NCT00664326|566133844|FG000|Overall Study|Withdrawal by Subject|1|||
156830811|NCT00664326|566133844|FG000|Overall Study|Physician Decision|1|||
156830812|NCT00664326|566133844|FG000|Overall Study|Other Reasons|3|||
156830813|NCT00664326|566133844|FG000|Overall Study|Death|2|||
156830814|NCT00664326|566133844|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
156830815|NCT00262847|566133845|FG000|Overall Study|Disease Progression|309|||
156830816|NCT00262847|566133846|FG001|Overall Study|Disease Progression|274|||
156830817|NCT00262847|566133847|FG002|Overall Study|Disease Progression|195|||
156830818|NCT00262847|566133845|FG000|Overall Study|Patient Refusal|41|||
156830819|NCT00262847|566133846|FG001|Overall Study|Patient Refusal|52|||
156830820|NCT00262847|566133847|FG002|Overall Study|Patient Refusal|47|||
156830821|NCT00262847|566133845|FG000|Overall Study|Adverse Event|74|||
156830822|NCT00262847|566133846|FG001|Overall Study|Adverse Event|88|||
156830823|NCT00262847|566133847|FG002|Overall Study|Adverse Event|108|||
156830824|NCT00262847|566133845|FG000|Overall Study|Death|8|||
156830825|NCT00262847|566133846|FG001|Overall Study|Death|8|||
156830826|NCT00262847|566133847|FG002|Overall Study|Death|11|||
156830827|NCT00262847|566133845|FG000|Overall Study|Concomitant disease|3|||
156830828|NCT00262847|566133846|FG001|Overall Study|Concomitant disease|2|||
156830829|NCT00262847|566133847|FG002|Overall Study|Concomitant disease|4|||
156830830|NCT00262847|566133845|FG000|Overall Study|Other Reasons|79|||
156830831|NCT00262847|566133846|FG001|Overall Study|Other Reasons|88|||
156830832|NCT00262847|566133847|FG002|Overall Study|Other Reasons|27|||
156830833|NCT00262847|566133845|FG000|Overall Study|Did not receive study treatment|4|||
156830834|NCT00262847|566133846|FG001|Overall Study|Did not receive study treatment|1|||
156830835|NCT00262847|566133847|FG002|Overall Study|Did not receive study treatment|4|||
156830836|NCT00387647|566133848|FG000|Overall Study|Death|18|||
156830837|NCT02943915|566133849|FG000|Overall Study|Withdrawal by Subject|2|||
156830838|NCT02943915|566133850|FG001|Overall Study|Withdrawal by Subject|1|||
156830839|NCT02943915|566133851|FG002|Overall Study|Withdrawal by Subject|0|||
156830840|NCT02943915|566133852|FG003|Overall Study|Withdrawal by Subject|0|||
156830841|NCT02943915|566133849|FG000|Overall Study|Lost to Follow-up|3|||
156830842|NCT02943915|566133850|FG001|Overall Study|Lost to Follow-up|1|||
156830843|NCT02943915|566133851|FG002|Overall Study|Lost to Follow-up|0|||
156830844|NCT02943915|566133852|FG003|Overall Study|Lost to Follow-up|0|||
156830845|NCT02943915|566133849|FG000|Overall Study|excluded|0|||
156830846|NCT02943915|566133850|FG001|Overall Study|excluded|1|||
156830847|NCT02943915|566133851|FG002|Overall Study|excluded|0|||
156830848|NCT02943915|566133852|FG003|Overall Study|excluded|0|||
156830849|NCT03769311|566133853|FG000|Overall Study|Withdrawal by Subject|1|||
156830850|NCT03627065|566133854|FG000|Overall Study|Study Terminated by sponsor|1|||
156830851|NCT03627065|566133854|FG000|Overall Study|Withdrawal by Subject|2|||
156830852|NCT01266317|566133855|FG000|Overall Study|Withdrawal by Subject|2|||
156830853|NCT00098722|566133858|FG000|Double Blind Phase|Adverse Event|7|||
156830854|NCT00098722|566133859|FG001|Double Blind Phase|Adverse Event|7|||
156830855|NCT00098722|566133860|FG002|Double Blind Phase|Adverse Event|3|||
157023325|NCT03931174|566838876|FG001|Patients|Death|1|||
157023326|NCT03931174|566838875|FG000|Patients|Lost to Follow-up|60|||
157023327|NCT03931174|566838876|FG001|Patients|Lost to Follow-up|89|||
157023328|NCT05386030|566838877|FG000|Overall Study|Death|1|||
157023329|NCT05386030|566838878|FG001|Overall Study|Death|0|||
157023330|NCT05386030|566838877|FG000|Overall Study|Physician Decision|2|||
157023331|NCT05386030|566838878|FG001|Overall Study|Physician Decision|1|||
157023332|NCT05386030|566838877|FG000|Overall Study|Lost to Follow-up|19|||
157023333|NCT05386030|566838878|FG001|Overall Study|Lost to Follow-up|7|||
157023334|NCT05386030|566838877|FG000|Overall Study|Withdrawal by Subject|20|||
157023335|NCT05386030|566838878|FG001|Overall Study|Withdrawal by Subject|10|||
157023336|NCT05386030|566838877|FG000|Overall Study|Eligibility criteria violation|1|||
157023337|NCT05386030|566838878|FG001|Overall Study|Eligibility criteria violation|1|||
157023338|NCT05386030|566838877|FG000|Overall Study|Personal Reasons|1|||
157023339|NCT05386030|566838878|FG001|Overall Study|Personal Reasons|0|||
157023340|NCT03213691|566838881|FG000|Overall Study|Adverse Event|2|||
157023341|NCT03213691|566838881|FG000|Overall Study|Death|3|||
157023342|NCT03213691|566838881|FG000|Overall Study|Physician Decision|1|||
157023343|NCT03213691|566838881|FG000|Overall Study|Progressive Disease|14|||
157023344|NCT03213691|566838881|FG000|Overall Study|Ineligible|1|||
157023345|NCT05302596|566838884|FG000|Overall Study|Withdrawal by Subject|1|||
157023346|NCT05302596|566838885|FG001|Overall Study|Withdrawal by Subject|1|||
157023347|NCT04977947|566841016|FG000|Overall Study|Lost to Follow-up|1|||
157023348|NCT04977947|566841017|FG001|Overall Study|Lost to Follow-up|1|||
157023349|NCT04029688|566841018|FG000|Overall Study|Death|8|||
157023350|NCT04029688|566841019|FG001|Overall Study|Death|3|||
157023351|NCT04029688|566841020|FG002|Overall Study|Death|6|||
157023352|NCT04029688|566841021|FG003|Overall Study|Death|2|||
157023353|NCT04029688|566841022|FG004|Overall Study|Death|5|||
157023354|NCT04029688|566841023|FG005|Overall Study|Death|0|||
157023355|NCT04029688|566841024|FG006|Overall Study|Death|2|||
157023356|NCT04029688|566841025|FG007|Overall Study|Death|3|||
157023357|NCT04029688|566841018|FG000|Overall Study|Study Terminated by Sponsor|0|||
157023358|NCT04029688|566841019|FG001|Overall Study|Study Terminated by Sponsor|0|||
157023359|NCT04029688|566841020|FG002|Overall Study|Study Terminated by Sponsor|0|||
157151280|NCT03504774|567299648|FG000|Overall Study|Lost to Follow-up|0|||
157151281|NCT03504774|567299649|FG001|Overall Study|Lost to Follow-up|1|||
157151282|NCT03504774|567299648|FG000|Overall Study|Protocol Violation|11|||
157151283|NCT03504774|567299649|FG001|Overall Study|Protocol Violation|3|||
157151284|NCT03504774|567299648|FG000|Overall Study|failed wk 52 DBPCFC|1|||
157151285|NCT03504774|567299649|FG001|Overall Study|failed wk 52 DBPCFC|0|||
157151286|NCT00625365|567299650|FG000|Overall Study|Withdrawal by Subject|1|||
157151287|NCT00625365|567299650|FG000|Overall Study|No IV access|5|||
156830856|NCT00098722|566133861|FG003|Double Blind Phase|Adverse Event|0|||
156830857|NCT00098722|566133862|FG004|Double Blind Phase|Adverse Event|0|||
156830858|NCT00098722|566133863|FG005|Double Blind Phase|Adverse Event|0|||
156830859|NCT00098722|566133864|FG006|Double Blind Phase|Adverse Event|0|||
156830860|NCT00098722|566133858|FG000|Double Blind Phase|Death|2|||
156830861|NCT00098722|566133859|FG001|Double Blind Phase|Death|5|||
156830862|NCT00098722|566133860|FG002|Double Blind Phase|Death|0|||
156830863|NCT00098722|566133861|FG003|Double Blind Phase|Death|0|||
156830864|NCT00098722|566133862|FG004|Double Blind Phase|Death|0|||
156830865|NCT00098722|566133863|FG005|Double Blind Phase|Death|0|||
156830866|NCT00098722|566133864|FG006|Double Blind Phase|Death|0|||
156830867|NCT00098722|566133858|FG000|Double Blind Phase|Lack of Efficacy|21|||
156830868|NCT00098722|566133859|FG001|Double Blind Phase|Lack of Efficacy|23|||
156830869|NCT00098722|566133860|FG002|Double Blind Phase|Lack of Efficacy|15|||
156830870|NCT00098722|566133861|FG003|Double Blind Phase|Lack of Efficacy|0|||
156830871|NCT00098722|566133862|FG004|Double Blind Phase|Lack of Efficacy|0|||
156830872|NCT00098722|566133863|FG005|Double Blind Phase|Lack of Efficacy|0|||
157151288|NCT00625365|567299650|FG000|Overall Study|VSD|1|||
157151289|NCT01781429|567299651|FG000|Overall Study|Death|0|||
157151290|NCT01781429|567299652|FG001|Overall Study|Death|0|||
156830873|NCT00098722|566133864|FG006|Double Blind Phase|Lack of Efficacy|0|||
156830874|NCT00098722|566133858|FG000|Double Blind Phase|Participant defaulted|16|||
156830875|NCT00098722|566133859|FG001|Double Blind Phase|Participant defaulted|11|||
157023360|NCT04029688|566841021|FG003|Overall Study|Study Terminated by Sponsor|0|||
157023361|NCT04029688|566841022|FG004|Overall Study|Study Terminated by Sponsor|1|||
157151291|NCT01781429|567299653|FG002|Overall Study|Death|0|||
157151292|NCT01781429|567299654|FG003|Overall Study|Death|0|||
157151293|NCT01781429|567299655|FG004|Overall Study|Death|0|||
157151294|NCT01781429|567299656|FG005|Overall Study|Death|0|||
156830876|NCT00098722|566133860|FG002|Double Blind Phase|Participant defaulted|9|||
156830877|NCT00098722|566133861|FG003|Double Blind Phase|Participant defaulted|0|||
156830878|NCT00098722|566133862|FG004|Double Blind Phase|Participant defaulted|0|||
157023362|NCT04029688|566841023|FG005|Overall Study|Study Terminated by Sponsor|3|||
157023363|NCT04029688|566841024|FG006|Overall Study|Study Terminated by Sponsor|1|||
157023364|NCT04029688|566841025|FG007|Overall Study|Study Terminated by Sponsor|3|||
157023365|NCT04029688|566841018|FG000|Overall Study|Withdrawal by Subject|0|||
157023366|NCT04029688|566841019|FG001|Overall Study|Withdrawal by Subject|0|||
157151295|NCT01781429|567299657|FG006|Overall Study|Death|0|||
157224555|NCT00679783|567568032|FG000|Overall Study|Adverse Event|0|||
156830879|NCT00098722|566133863|FG005|Double Blind Phase|Participant defaulted|0|||
156830880|NCT00098722|566133864|FG006|Double Blind Phase|Participant defaulted|0|||
156830881|NCT00098722|566133858|FG000|Double Blind Phase|Pregnancy|1|||
156830882|NCT00098722|566133859|FG001|Double Blind Phase|Pregnancy|0|||
156830883|NCT00098722|566133860|FG002|Double Blind Phase|Pregnancy|0|||
156830884|NCT00098722|566133861|FG003|Double Blind Phase|Pregnancy|0|||
156830885|NCT00098722|566133862|FG004|Double Blind Phase|Pregnancy|0|||
156830886|NCT00098722|566133863|FG005|Double Blind Phase|Pregnancy|0|||
156830887|NCT00098722|566133864|FG006|Double Blind Phase|Pregnancy|0|||
156830888|NCT00098722|566133858|FG000|Double Blind Phase|Randomized, not treated|4|||
156830889|NCT00098722|566133859|FG001|Double Blind Phase|Randomized, not treated|3|||
156830890|NCT00098722|566133860|FG002|Double Blind Phase|Randomized, not treated|3|||
156830891|NCT00098722|566133861|FG003|Double Blind Phase|Randomized, not treated|0|||
156830892|NCT00098722|566133862|FG004|Double Blind Phase|Randomized, not treated|0|||
156830893|NCT00098722|566133863|FG005|Double Blind Phase|Randomized, not treated|0|||
156830894|NCT00098722|566133864|FG006|Double Blind Phase|Randomized, not treated|0|||
156830895|NCT00098722|566133858|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
156830896|NCT00098722|566133859|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
156830897|NCT00098722|566133860|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
156830898|NCT00098722|566133861|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
156830899|NCT00098722|566133862|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
156830900|NCT00098722|566133863|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
156830901|NCT00098722|566133864|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
156830902|NCT00098722|566133858|FG000|Double Blind Phase|Other|7|||
156830903|NCT00098722|566133859|FG001|Double Blind Phase|Other|8|||
156830904|NCT00098722|566133860|FG002|Double Blind Phase|Other|7|||
156830905|NCT00098722|566133861|FG003|Double Blind Phase|Other|0|||
156830906|NCT00098722|566133862|FG004|Double Blind Phase|Other|0|||
156830907|NCT00098722|566133863|FG005|Double Blind Phase|Other|0|||
156830908|NCT00098722|566133864|FG006|Double Blind Phase|Other|0|||
156830909|NCT00098722|566133858|FG000|Open Label Phase|Adverse Event|0|||
156830910|NCT00098722|566133859|FG001|Open Label Phase|Adverse Event|0|||
156830911|NCT00098722|566133860|FG002|Open Label Phase|Adverse Event|0|||
156830912|NCT00098722|566133861|FG003|Open Label Phase|Adverse Event|5|||
156830913|NCT00098722|566133862|FG004|Open Label Phase|Adverse Event|0|||
156830914|NCT00098722|566133863|FG005|Open Label Phase|Adverse Event|0|||
156830915|NCT00098722|566133864|FG006|Open Label Phase|Adverse Event|0|||
156830916|NCT00098722|566133858|FG000|Open Label Phase|Death|0|||
156830917|NCT00098722|566133859|FG001|Open Label Phase|Death|0|||
156830918|NCT00098722|566133860|FG002|Open Label Phase|Death|0|||
156830919|NCT00098722|566133861|FG003|Open Label Phase|Death|2|||
156830920|NCT00098722|566133862|FG004|Open Label Phase|Death|0|||
156830921|NCT00098722|566133863|FG005|Open Label Phase|Death|0|||
156830922|NCT00098722|566133864|FG006|Open Label Phase|Death|0|||
156830923|NCT00098722|566133858|FG000|Open Label Phase|Lack of Efficacy|0|||
156830924|NCT00098722|566133859|FG001|Open Label Phase|Lack of Efficacy|0|||
156830925|NCT00098722|566133860|FG002|Open Label Phase|Lack of Efficacy|0|||
156830926|NCT00098722|566133861|FG003|Open Label Phase|Lack of Efficacy|8|||
156830927|NCT00098722|566133862|FG004|Open Label Phase|Lack of Efficacy|0|||
156830928|NCT00098722|566133863|FG005|Open Label Phase|Lack of Efficacy|0|||
156830929|NCT00098722|566133864|FG006|Open Label Phase|Lack of Efficacy|0|||
157224556|NCT00679783|567568033|FG001|Overall Study|Adverse Event|0|||
156830930|NCT00098722|566133858|FG000|Open Label Phase|Pregnancy|0|||
157224557|NCT00679783|567568034|FG002|Overall Study|Adverse Event|0|||
157224558|NCT00679783|567568035|FG003|Overall Study|Adverse Event|3|||
157224559|NCT00679783|567568036|FG004|Overall Study|Adverse Event|0|||
156830931|NCT00098722|566133859|FG001|Open Label Phase|Pregnancy|0|||
156830932|NCT00098722|566133860|FG002|Open Label Phase|Pregnancy|0|||
156830933|NCT00098722|566133861|FG003|Open Label Phase|Pregnancy|1|||
156830934|NCT00098722|566133862|FG004|Open Label Phase|Pregnancy|0|||
156830935|NCT00098722|566133863|FG005|Open Label Phase|Pregnancy|0|||
156830936|NCT00098722|566133864|FG006|Open Label Phase|Pregnancy|0|||
156830937|NCT00098722|566133858|FG000|Open Label Phase|Participant defaulted|0|||
156830938|NCT00098722|566133859|FG001|Open Label Phase|Participant defaulted|0|||
156830939|NCT00098722|566133860|FG002|Open Label Phase|Participant defaulted|0|||
156830940|NCT00098722|566133861|FG003|Open Label Phase|Participant defaulted|18|||
156830941|NCT00098722|566133862|FG004|Open Label Phase|Participant defaulted|0|||
156830942|NCT00098722|566133863|FG005|Open Label Phase|Participant defaulted|0|||
156830943|NCT00098722|566133864|FG006|Open Label Phase|Participant defaulted|0|||
156830944|NCT00098722|566133858|FG000|Open Label Phase|Ongoing at cut-off date|0|||
156830945|NCT00098722|566133859|FG001|Open Label Phase|Ongoing at cut-off date|0|||
156830946|NCT00098722|566133860|FG002|Open Label Phase|Ongoing at cut-off date|0|||
156830947|NCT00098722|566133861|FG003|Open Label Phase|Ongoing at cut-off date|220|||
156830948|NCT00098722|566133862|FG004|Open Label Phase|Ongoing at cut-off date|50|||
156830949|NCT00098722|566133863|FG005|Open Label Phase|Ongoing at cut-off date|0|||
156830950|NCT00098722|566133864|FG006|Open Label Phase|Ongoing at cut-off date|0|||
157224560|NCT00679783|567568037|FG005|Overall Study|Adverse Event|0|||
157224561|NCT00679783|567568038|FG006|Overall Study|Adverse Event|1|||
156830951|NCT00098722|566133858|FG000|Open Label Phase|Other|0|||
156830952|NCT00098722|566133859|FG001|Open Label Phase|Other|0|||
156830953|NCT00098722|566133860|FG002|Open Label Phase|Other|0|||
156830954|NCT00098722|566133861|FG003|Open Label Phase|Other|18|||
157023367|NCT04029688|566841020|FG002|Overall Study|Withdrawal by Subject|0|||
157023368|NCT04029688|566841021|FG003|Overall Study|Withdrawal by Subject|1|||
157023369|NCT04029688|566841022|FG004|Overall Study|Withdrawal by Subject|0|||
156830955|NCT00098722|566133862|FG004|Open Label Phase|Other|0|||
156830956|NCT00098722|566133863|FG005|Open Label Phase|Other|0|||
156830957|NCT00098722|566133864|FG006|Open Label Phase|Other|0|||
156830958|NCT00098722|566133858|FG000|Observation Phase|Death|0|||
156830959|NCT00098722|566133859|FG001|Observation Phase|Death|0|||
156830960|NCT00098722|566133860|FG002|Observation Phase|Death|0|||
156830961|NCT00098722|566133861|FG003|Observation Phase|Death|0|||
156830962|NCT00098722|566133862|FG004|Observation Phase|Death|0|||
156830963|NCT00098722|566133863|FG005|Observation Phase|Death|5|||
156830964|NCT00098722|566133864|FG006|Observation Phase|Death|3|||
156830965|NCT00098722|566133858|FG000|Observation Phase|Lack of Efficacy|0|||
156830966|NCT00098722|566133859|FG001|Observation Phase|Lack of Efficacy|0|||
156830967|NCT00098722|566133860|FG002|Observation Phase|Lack of Efficacy|0|||
156830968|NCT00098722|566133861|FG003|Observation Phase|Lack of Efficacy|0|||
156830969|NCT00098722|566133862|FG004|Observation Phase|Lack of Efficacy|0|||
156830970|NCT00098722|566133863|FG005|Observation Phase|Lack of Efficacy|2|||
156830971|NCT00098722|566133864|FG006|Observation Phase|Lack of Efficacy|0|||
156830972|NCT00098722|566133858|FG000|Observation Phase|Participant defaulted|0|||
156830973|NCT00098722|566133859|FG001|Observation Phase|Participant defaulted|0|||
156830974|NCT00098722|566133860|FG002|Observation Phase|Participant defaulted|0|||
156830975|NCT00098722|566133861|FG003|Observation Phase|Participant defaulted|0|||
156830976|NCT00098722|566133862|FG004|Observation Phase|Participant defaulted|0|||
156830977|NCT00098722|566133863|FG005|Observation Phase|Participant defaulted|17|||
156830978|NCT00098722|566133864|FG006|Observation Phase|Participant defaulted|4|||
156830979|NCT00098722|566133858|FG000|Observation Phase|Other|0|||
156830980|NCT00098722|566133859|FG001|Observation Phase|Other|0|||
156830981|NCT00098722|566133860|FG002|Observation Phase|Other|0|||
156830982|NCT00098722|566133861|FG003|Observation Phase|Other|0|||
156830983|NCT00098722|566133862|FG004|Observation Phase|Other|0|||
156830984|NCT00098722|566133863|FG005|Observation Phase|Other|21|||
156830985|NCT00098722|566133864|FG006|Observation Phase|Other|10|||
156830986|NCT01610596|566133867|FG000|Overall Study|Lost to Follow-up|0|||
156830987|NCT01610596|566133868|FG001|Overall Study|Lost to Follow-up|1|||
156830988|NCT00799591|566133871|FG000|Overall Study|De-escalation of doses|20|||
156830989|NCT00799591|566133871|FG000|Overall Study|Death|14|||
156830990|NCT00799591|566133871|FG000|Overall Study|Technical failure|12|||
156830991|NCT00799591|566133871|FG000|Overall Study|Resistant germ|11|||
156830992|NCT00799591|566133871|FG000|Overall Study|New infection|4|||
156830993|NCT00799591|566133871|FG000|Overall Study|Resistance germ and technical failure|2|||
156830994|NCT00799591|566133871|FG000|Overall Study|Persistance of fever undetermined origin|1|||
156830995|NCT00799591|566133871|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
156830996|NCT00799591|566133871|FG000|Overall Study|Infectious origin not probable|1|||
156830997|NCT04599166|566133872|FG000|Overall Study|Technological failure connecting to study app|80|||
156830998|NCT01974752|566133873|FG000|Overall Study|Death|33|||
156830999|NCT01974752|566133874|FG001|Overall Study|Death|11|||
156831000|NCT01974752|566133873|FG000|Overall Study|Lost to Follow-up|2|||
156831001|NCT01974752|566133874|FG001|Overall Study|Lost to Follow-up|0|||
156831002|NCT01974752|566133873|FG000|Overall Study|Withdrawal by Subject|2|||
156831003|NCT01974752|566133874|FG001|Overall Study|Withdrawal by Subject|3|||
156831004|NCT01974752|566133873|FG000|Overall Study|Other Eligibility Criteria|0|||
156831005|NCT01974752|566133874|FG001|Overall Study|Other Eligibility Criteria|1|||
156831006|NCT02088073|566133879|FG000|Acute Phase|Withdrawal by Subject|5|||
156831007|NCT02088073|566133880|FG001|Acute Phase|Withdrawal by Subject|0|||
156831008|NCT02088073|566133881|FG002|Acute Phase|Withdrawal by Subject|0|||
156831009|NCT02088073|566133882|FG003|Acute Phase|Withdrawal by Subject|0|||
156831010|NCT02088073|566133883|FG004|Acute Phase|Withdrawal by Subject|0|||
156831011|NCT02088073|566133879|FG000|Acute Phase|Hyperkalemia|2|||
156831012|NCT02088073|566133880|FG001|Acute Phase|Hyperkalemia|0|||
156831013|NCT02088073|566133881|FG002|Acute Phase|Hyperkalemia|0|||
156831014|NCT02088073|566133882|FG003|Acute Phase|Hyperkalemia|0|||
156831015|NCT02088073|566133883|FG004|Acute Phase|Hyperkalemia|0|||
156831016|NCT02088073|566133879|FG000|Maintanance Phase|Withdrawal by Subject|0|||
156831017|NCT02088073|566133880|FG001|Maintanance Phase|Withdrawal by Subject|2|||
156831018|NCT02088073|566133881|FG002|Maintanance Phase|Withdrawal by Subject|0|||
156831019|NCT02088073|566133882|FG003|Maintanance Phase|Withdrawal by Subject|0|||
156831020|NCT02088073|566133883|FG004|Maintanance Phase|Withdrawal by Subject|0|||
156831021|NCT02088073|566133879|FG000|Maintanance Phase|Adverse Event|0|||
156831022|NCT02088073|566133880|FG001|Maintanance Phase|Adverse Event|0|||
156831023|NCT02088073|566133881|FG002|Maintanance Phase|Adverse Event|3|||
156831024|NCT02088073|566133882|FG003|Maintanance Phase|Adverse Event|0|||
156831025|NCT02088073|566133883|FG004|Maintanance Phase|Adverse Event|1|||
156831026|NCT02088073|566133879|FG000|Maintanance Phase|Physician Decision|0|||
156831027|NCT02088073|566133880|FG001|Maintanance Phase|Physician Decision|0|||
157151296|NCT01781429|567299658|FG007|Overall Study|Death|0|||
157151297|NCT01781429|567299659|FG008|Overall Study|Death|0|||
157151298|NCT01781429|567299660|FG009|Overall Study|Death|1|||
157151299|NCT01781429|567299661|FG010|Overall Study|Death|0|||
157151300|NCT01781429|567299662|FG011|Overall Study|Death|0|||
157151301|NCT01781429|567299663|FG012|Overall Study|Death|1|||
156831028|NCT02088073|566133881|FG002|Maintanance Phase|Physician Decision|0|||
156831029|NCT02088073|566133882|FG003|Maintanance Phase|Physician Decision|0|||
156831030|NCT02088073|566133883|FG004|Maintanance Phase|Physician Decision|1|||
156831031|NCT02088073|566133879|FG000|Maintanance Phase|Sponsor's decision|0|||
156831032|NCT02088073|566133880|FG001|Maintanance Phase|Sponsor's decision|2|||
156831033|NCT02088073|566133881|FG002|Maintanance Phase|Sponsor's decision|0|||
156831034|NCT02088073|566133882|FG003|Maintanance Phase|Sponsor's decision|2|||
156831035|NCT02088073|566133883|FG004|Maintanance Phase|Sponsor's decision|1|||
156831036|NCT02088073|566133879|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
156831037|NCT02088073|566133880|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
156831038|NCT02088073|566133881|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
156831039|NCT02088073|566133882|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
156831040|NCT02088073|566133883|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
156831041|NCT02088073|566133879|FG000|Maintanance Phase|Miscellaneous|0|||
156831042|NCT02088073|566133880|FG001|Maintanance Phase|Miscellaneous|2|||
156831043|NCT02088073|566133881|FG002|Maintanance Phase|Miscellaneous|1|||
156831044|NCT02088073|566133882|FG003|Maintanance Phase|Miscellaneous|2|||
156831045|NCT02088073|566133883|FG004|Maintanance Phase|Miscellaneous|1|||
156831046|NCT02088073|566133879|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831047|NCT02088073|566133880|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831048|NCT02088073|566133881|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
156831049|NCT02088073|566133882|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
156831050|NCT02088073|566133883|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
156831051|NCT02088073|566133879|FG000|Maintanance Phase|Subject compliance|0|||
156831052|NCT02088073|566133880|FG001|Maintanance Phase|Subject compliance|1|||
156831053|NCT02088073|566133881|FG002|Maintanance Phase|Subject compliance|0|||
156831054|NCT02088073|566133882|FG003|Maintanance Phase|Subject compliance|0|||
156831055|NCT02088073|566133883|FG004|Maintanance Phase|Subject compliance|0|||
156831056|NCT02118597|566133889|FG000|Overall Study|Sponsor terminated the study|14|||
156831057|NCT02118597|566133889|FG000|Overall Study|Serious Adverse Event|1|||
156831058|NCT02118597|566133889|FG000|Overall Study|Investigator's decision|1|||
156831059|NCT02788201|566133890|FG000|Overall Study|Death|1|||
156831060|NCT02788201|566133891|FG001|Overall Study|Death|1|||
156831061|NCT02788201|566133892|FG002|Overall Study|Death|1|||
156831062|NCT02788201|566133893|FG003|Overall Study|Death|1|||
156831063|NCT02788201|566133894|FG004|Overall Study|Death|0|||
156885186|NCT01430754|566338235|FG001|Run-In Phase|Withdrawal by Subject|0|||
156885187|NCT01430754|566338234|FG000|Run-In Phase|Lost to Follow-up|1|||
156885188|NCT01430754|566338235|FG001|Run-In Phase|Lost to Follow-up|0|||
156885189|NCT04618770|566338236|FG000|Overall Study|Censored from Analysis|12|||
156885190|NCT04618770|566338236|FG000|Overall Study|Early Termination|25|||
156885191|NCT03874429|566338237|FG000|Overall Study|Adverse Event|2|||
156885192|NCT03874429|566338238|FG001|Overall Study|Adverse Event|2|||
156885193|NCT03874429|566338237|FG000|Overall Study|Lack of Efficacy|0|||
156885194|NCT03874429|566338238|FG001|Overall Study|Lack of Efficacy|1|||
156885195|NCT03874429|566338237|FG000|Overall Study|Covid-19 pandemic|4|||
156885196|NCT03874429|566338238|FG001|Overall Study|Covid-19 pandemic|2|||
156885197|NCT02353143|566338239|FG000|Overall Study|Withdrawal by Subject|1|||
156885198|NCT02353143|566338240|FG001|Overall Study|Withdrawal by Subject|0|||
156885199|NCT02353143|566338241|FG002|Overall Study|Withdrawal by Subject|0|||
156885200|NCT02353143|566338242|FG003|Overall Study|Withdrawal by Subject|0|||
156885201|NCT02353143|566338243|FG004|Overall Study|Withdrawal by Subject|1|||
156885202|NCT02353143|566338244|FG005|Overall Study|Withdrawal by Subject|0|||
156885203|NCT02353143|566338245|FG006|Overall Study|Withdrawal by Subject|0|||
156885204|NCT02353143|566338246|FG007|Overall Study|Withdrawal by Subject|1|||
157151302|NCT01781429|567299664|FG013|Overall Study|Death|0|||
157151303|NCT01781429|567299665|FG014|Overall Study|Death|1|||
156831064|NCT02788201|566133895|FG005|Overall Study|Death|1|||
156831065|NCT02788201|566133890|FG000|Overall Study|Ineligible|0|||
156831066|NCT02788201|566133891|FG001|Overall Study|Ineligible|0|||
156831067|NCT02788201|566133892|FG002|Overall Study|Ineligible|0|||
156831068|NCT02788201|566133893|FG003|Overall Study|Ineligible|0|||
156831069|NCT02788201|566133894|FG004|Overall Study|Ineligible|0|||
156831070|NCT02788201|566133895|FG005|Overall Study|Ineligible|1|||
156831071|NCT02788201|566133890|FG000|Overall Study|Withdrawal by Subject|0|||
156831072|NCT02788201|566133891|FG001|Overall Study|Withdrawal by Subject|0|||
156831073|NCT02788201|566133892|FG002|Overall Study|Withdrawal by Subject|0|||
156885205|NCT02353143|566338247|FG008|Overall Study|Withdrawal by Subject|1|||
156885206|NCT02353143|566338239|FG000|Overall Study|Lack of Efficacy|2|||
156885207|NCT02353143|566338240|FG001|Overall Study|Lack of Efficacy|1|||
156885208|NCT02353143|566338241|FG002|Overall Study|Lack of Efficacy|2|||
157151304|NCT01781429|567299666|FG015|Overall Study|Death|0|||
157151305|NCT01781429|567299651|FG000|Overall Study|Withdrawal by Subject|0|||
156831074|NCT02788201|566133893|FG003|Overall Study|Withdrawal by Subject|0|||
156831075|NCT02788201|566133894|FG004|Overall Study|Withdrawal by Subject|0|||
156831076|NCT02788201|566133895|FG005|Overall Study|Withdrawal by Subject|1|||
156831077|NCT00186537|566133896|FG000|Overall Study|Withdrawal by Subject|4|||
156831078|NCT00186537|566133897|FG001|Overall Study|Withdrawal by Subject|0|||
156831079|NCT00186537|566133898|FG002|Overall Study|Withdrawal by Subject|3|||
156831080|NCT00186537|566133896|FG000|Overall Study|ALT > 1.5 x ULN|3|||
156831081|NCT00186537|566133897|FG001|Overall Study|ALT > 1.5 x ULN|0|||
156831082|NCT00186537|566133898|FG002|Overall Study|ALT > 1.5 x ULN|0|||
156831083|NCT02590562|566133905|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
156831084|NCT01457950|566133906|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
156831085|NCT01457950|566133907|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831086|NCT01457950|566133908|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831087|NCT01457950|566133909|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
156831088|NCT01457950|566133906|FG000|Double-Blind Phase|Protocol Violation|2|||
156831089|NCT01457950|566133907|FG001|Double-Blind Phase|Protocol Violation|1|||
156831090|NCT01457950|566133908|FG002|Double-Blind Phase|Protocol Violation|0|||
156831091|NCT01457950|566133909|FG003|Double-Blind Phase|Protocol Violation|0|||
156831092|NCT01457950|566133906|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
156831093|NCT01457950|566133907|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
156831094|NCT01457950|566133908|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156831095|NCT01457950|566133909|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
157023370|NCT04029688|566841023|FG005|Overall Study|Withdrawal by Subject|0|||
157023371|NCT04029688|566841024|FG006|Overall Study|Withdrawal by Subject|0|||
156831096|NCT01457950|566133906|FG000|Open-Label Phase|Adverse Event|0|||
156831097|NCT01457950|566133907|FG001|Open-Label Phase|Adverse Event|0|||
156831098|NCT01457950|566133908|FG002|Open-Label Phase|Adverse Event|0|||
156831099|NCT01457950|566133909|FG003|Open-Label Phase|Adverse Event|1|||
156831100|NCT01457950|566133906|FG000|Open-Label Phase|Protocol Violation|0|||
156831101|NCT01457950|566133907|FG001|Open-Label Phase|Protocol Violation|0|||
156831102|NCT01457950|566133908|FG002|Open-Label Phase|Protocol Violation|0|||
156831103|NCT01457950|566133909|FG003|Open-Label Phase|Protocol Violation|1|||
156831104|NCT01457950|566133906|FG000|Open-Label Phase|Withdrawal by Subject|0|||
156831105|NCT01457950|566133907|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156831106|NCT01457950|566133908|FG002|Open-Label Phase|Withdrawal by Subject|2|||
156831107|NCT01457950|566133909|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156831108|NCT03684304|566133910|FG000|Overall Study|Lost to Follow-up|19|||
156831109|NCT03684304|566133911|FG001|Overall Study|Lost to Follow-up|17|||
156831110|NCT01510184|566133912|FG000|Overall Study|Sponsor discretion|28|||
156831111|NCT01510184|566133913|FG001|Overall Study|Sponsor discretion|28|||
156831112|NCT01510184|566133912|FG000|Overall Study|Death|1|||
156831113|NCT01510184|566133913|FG001|Overall Study|Death|2|||
156831114|NCT01510184|566133912|FG000|Overall Study|Withdrawal by Subject|1|||
156831115|NCT01510184|566133913|FG001|Overall Study|Withdrawal by Subject|4|||
156831116|NCT01510184|566133912|FG000|Overall Study|Other|0|||
156831117|NCT01510184|566133913|FG001|Overall Study|Other|1|||
156831118|NCT01143051|566133914|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
156831119|NCT01143051|566133915|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
156831120|NCT01143051|566133916|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
156831121|NCT01143051|566133917|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
156831122|NCT01143051|566133918|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
156831123|NCT01143051|566133919|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
156831124|NCT01143051|566133914|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
156831125|NCT01143051|566133915|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
156831126|NCT01143051|566133916|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
156831127|NCT01143051|566133917|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
156831128|NCT01143051|566133918|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
157023372|NCT04029688|566841025|FG007|Overall Study|Withdrawal by Subject|0|||
157023373|NCT05875142|566841026|FG000|Overall Study|Lost to Follow-up|0|||
157023374|NCT05875142|566841027|FG001|Overall Study|Lost to Follow-up|1|||
157023375|NCT05875142|566841028|FG002|Overall Study|Lost to Follow-up|1|||
157023376|NCT03436290|566841029|FG000|Overall Study|Post-randomization Exclusion|1|||
156831129|NCT01143051|566133919|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
156831130|NCT02677844|566133921|FG000|Period 3|Withdrawal by Subject|0|||
156831131|NCT02677844|566133922|FG001|Period 3|Withdrawal by Subject|0|||
156831132|NCT02677844|566133923|FG002|Period 3|Withdrawal by Subject|0|||
156831133|NCT02677844|566133924|FG003|Period 3|Withdrawal by Subject|1|||
156831134|NCT02677844|566133925|FG004|Period 3|Withdrawal by Subject|0|||
157023377|NCT03436290|566841030|FG001|Overall Study|Post-randomization Exclusion|0|||
157023378|NCT03436290|566841029|FG000|Overall Study|Death|6|||
157023379|NCT03436290|566841030|FG001|Overall Study|Death|0|||
156831135|NCT02677844|566133926|FG005|Period 3|Withdrawal by Subject|0|||
156831136|NCT02677844|566133927|FG006|Period 3|Withdrawal by Subject|0|||
156831137|NCT00765882|566133928|FG000|Overall Study|Adverse Event|10|||
156831138|NCT00765882|566133929|FG001|Overall Study|Adverse Event|21|||
156831139|NCT00765882|566133930|FG002|Overall Study|Adverse Event|20|||
156831140|NCT00765882|566133928|FG000|Overall Study|Lack of Efficacy|4|||
156831141|NCT00765882|566133929|FG001|Overall Study|Lack of Efficacy|0|||
156831142|NCT00765882|566133930|FG002|Overall Study|Lack of Efficacy|1|||
156831143|NCT00765882|566133928|FG000|Overall Study|Protocol Violation|4|||
156831144|NCT00765882|566133929|FG001|Overall Study|Protocol Violation|3|||
156831145|NCT00765882|566133930|FG002|Overall Study|Protocol Violation|1|||
156831146|NCT00765882|566133928|FG000|Overall Study|Withdrawal by Subject|2|||
156831147|NCT00765882|566133929|FG001|Overall Study|Withdrawal by Subject|6|||
156831148|NCT00765882|566133930|FG002|Overall Study|Withdrawal by Subject|6|||
156831149|NCT00765882|566133928|FG000|Overall Study|Lost to Follow-up|1|||
156831150|NCT00765882|566133929|FG001|Overall Study|Lost to Follow-up|9|||
156831151|NCT00765882|566133930|FG002|Overall Study|Lost to Follow-up|6|||
156831152|NCT00765882|566133928|FG000|Overall Study|Other Reason|3|||
156831153|NCT00765882|566133929|FG001|Overall Study|Other Reason|1|||
156831154|NCT00765882|566133930|FG002|Overall Study|Other Reason|2|||
156831155|NCT02231762|566133933|FG000|Combination Phase|Adverse Event|10|||
156831156|NCT02231762|566133934|FG001|Combination Phase|Adverse Event|0|||
156831157|NCT02231762|566133935|FG002|Combination Phase|Adverse Event|0|||
156831158|NCT02231762|566133936|FG003|Combination Phase|Adverse Event|0|||
156831159|NCT02231762|566133933|FG000|Combination Phase|Withdrawal by Subject|2|||
156831160|NCT02231762|566133934|FG001|Combination Phase|Withdrawal by Subject|0|||
156831161|NCT02231762|566133935|FG002|Combination Phase|Withdrawal by Subject|0|||
156831162|NCT02231762|566133936|FG003|Combination Phase|Withdrawal by Subject|0|||
156831163|NCT02231762|566133933|FG000|Combination Phase|Disease Progression|6|||
156831164|NCT02231762|566133934|FG001|Combination Phase|Disease Progression|0|||
156831165|NCT02231762|566133935|FG002|Combination Phase|Disease Progression|0|||
156831166|NCT02231762|566133936|FG003|Combination Phase|Disease Progression|0|||
156831167|NCT02231762|566133933|FG000|Combination Phase|Did not meet inclusion criteria|1|||
156831168|NCT02231762|566133934|FG001|Combination Phase|Did not meet inclusion criteria|0|||
156831169|NCT02231762|566133935|FG002|Combination Phase|Did not meet inclusion criteria|0|||
156831170|NCT02231762|566133936|FG003|Combination Phase|Did not meet inclusion criteria|0|||
156831171|NCT02231762|566133933|FG000|Combination Phase|Protocol Violation|1|||
156831172|NCT02231762|566133934|FG001|Combination Phase|Protocol Violation|0|||
156831173|NCT02231762|566133935|FG002|Combination Phase|Protocol Violation|0|||
156831174|NCT02231762|566133936|FG003|Combination Phase|Protocol Violation|0|||
156831175|NCT02231762|566133933|FG000|Maintenance Phase|Disease progression|0|||
156831176|NCT02231762|566133934|FG001|Maintenance Phase|Disease progression|3|||
156831177|NCT02231762|566133935|FG002|Maintenance Phase|Disease progression|4|||
156831178|NCT02231762|566133936|FG003|Maintenance Phase|Disease progression|3|||
156831179|NCT02231762|566133933|FG000|Maintenance Phase|Adverse Event|0|||
156831180|NCT02231762|566133934|FG001|Maintenance Phase|Adverse Event|0|||
156831181|NCT02231762|566133935|FG002|Maintenance Phase|Adverse Event|1|||
156831182|NCT02231762|566133936|FG003|Maintenance Phase|Adverse Event|2|||
156831183|NCT03593681|566133941|FG000|Overall Study|Inadequate sample collected|12|||
156831184|NCT03593681|566133941|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
156831185|NCT03593681|566133941|FG000|Overall Study|Protocol Violation|3|||
156831186|NCT03593681|566133941|FG000|Overall Study|Withdrawal by Subject|3|||
156831187|NCT03593681|566133941|FG000|Overall Study|Procedure not attempted|3|||
156831188|NCT03593681|566133941|FG000|Overall Study|Adverse Event|2|||
156831189|NCT03593681|566133941|FG000|Overall Study|Physician Decision|1|||
156831190|NCT00545532|566133944|FG000|Overall Study|Withdrawal by Subject|1|||
156831191|NCT00545532|566133945|FG001|Overall Study|Withdrawal by Subject|3|||
156831192|NCT00545532|566133944|FG000|Overall Study|Lost to Follow-up|5|||
156831193|NCT00545532|566133945|FG001|Overall Study|Lost to Follow-up|6|||
156831194|NCT00545532|566133944|FG000|Overall Study|Death|0|||
156831195|NCT00545532|566133945|FG001|Overall Study|Death|1|||
156831196|NCT01149486|566133946|FG000|First Intervention|Adverse Event|0|||
156831197|NCT01149486|566133947|FG001|First Intervention|Adverse Event|1|||
156831198|NCT03630302|566133948|FG000|Surgery|hardware issue prevented LFP recordings|1|||
156831199|NCT03630302|566133948|FG000|3 Month Visit|Adverse Event|2|||
156831200|NCT03630302|566133948|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
156831201|NCT01866423|566133952|FG000|Overall Study|Lack of Efficacy|3|||
156831202|NCT01866423|566133952|FG000|Overall Study|Sponsor Decision|1|||
156885209|NCT02353143|566338242|FG003|Overall Study|Lack of Efficacy|4|||
157224562|NCT00679783|567568032|FG000|Overall Study|Lack of Efficacy|0|||
156831203|NCT01479595|566133955|FG000|Overall Study|Protocol deviation|0|||
156831204|NCT01479595|566133956|FG001|Overall Study|Protocol deviation|1|||
156831205|NCT01479595|566133955|FG000|Overall Study|Adverse Event|2|||
156831206|NCT01479595|566133956|FG001|Overall Study|Adverse Event|1|||
156831207|NCT03366103|566133957|FG000|Overall Study|Disease Progression|3|||
156831208|NCT03366103|566133958|FG001|Overall Study|Disease Progression|1|||
156831209|NCT03366103|566133959|FG002|Overall Study|Disease Progression|0|||
156885210|NCT02353143|566338243|FG004|Overall Study|Lack of Efficacy|13|||
156885211|NCT02353143|566338244|FG005|Overall Study|Lack of Efficacy|2|||
156885212|NCT02353143|566338245|FG006|Overall Study|Lack of Efficacy|2|||
156831210|NCT03366103|566133957|FG000|Overall Study|Adverse Event|0|||
156831211|NCT03366103|566133958|FG001|Overall Study|Adverse Event|1|||
156831212|NCT03366103|566133959|FG002|Overall Study|Adverse Event|0|||
156885213|NCT02353143|566338246|FG007|Overall Study|Lack of Efficacy|2|||
157224563|NCT00679783|567568033|FG001|Overall Study|Lack of Efficacy|1|||
157224564|NCT00679783|567568034|FG002|Overall Study|Lack of Efficacy|0|||
157224565|NCT00679783|567568035|FG003|Overall Study|Lack of Efficacy|2|||
157224566|NCT00679783|567568036|FG004|Overall Study|Lack of Efficacy|0|||
157224567|NCT00679783|567568037|FG005|Overall Study|Lack of Efficacy|0|||
157224568|NCT00679783|567568038|FG006|Overall Study|Lack of Efficacy|0|||
156831213|NCT01344629|566133964|FG000|Crossover Period 2|Withdrawal by Subject|0|||
156831214|NCT01344629|566133965|FG001|Crossover Period 2|Withdrawal by Subject|1|||
156831215|NCT01174004|566133974|FG000|Overall Study|Adverse Event|2|||
156831216|NCT01174004|566133975|FG001|Overall Study|Adverse Event|10|||
156831217|NCT01174004|566133974|FG000|Overall Study|Withdrawal by Subject|2|||
156831218|NCT01174004|566133975|FG001|Overall Study|Withdrawal by Subject|3|||
156831219|NCT01174004|566133974|FG000|Overall Study|At Discretion of Sponsor|2|||
156831220|NCT01174004|566133975|FG001|Overall Study|At Discretion of Sponsor|2|||
156831221|NCT01174004|566133974|FG000|Overall Study|Protocol Violation|0|||
156831222|NCT01174004|566133975|FG001|Overall Study|Protocol Violation|1|||
156831223|NCT01174004|566133974|FG000|Overall Study|Physician Decision|1|||
156831224|NCT01174004|566133975|FG001|Overall Study|Physician Decision|0|||
156831225|NCT00933244|566133976|FG000|Overall Study|Withdrawal by Subject|5|||
156831226|NCT00933244|566133977|FG001|Overall Study|Withdrawal by Subject|1|||
156831227|NCT00933244|566133978|FG002|Overall Study|Withdrawal by Subject|3|||
156831228|NCT00746733|566133984|FG000|Second Intervention|Adverse Event|1|||
156831229|NCT00746733|566133985|FG001|Second Intervention|Adverse Event|0|||
156831230|NCT00746733|566133984|FG000|Third Intervention|Withdrawal by Subject|1|||
156831231|NCT00746733|566133985|FG001|Third Intervention|Withdrawal by Subject|1|||
156831232|NCT00849875|566133986|FG000|Overall Study|Death|28|||
156831233|NCT00849875|566133986|FG000|Overall Study|Ongoing (unknown completion status)|11|||
156831234|NCT00849875|566133986|FG000|Overall Study|Others|6|||
156831235|NCT00849875|566133986|FG000|Overall Study|Lost to Follow-up|2|||
156831236|NCT00528996|566135758|FG000|Overall Study|Other reasons than listing|6|||
156831237|NCT00528996|566135759|FG001|Overall Study|Other reasons than listing|7|||
156831238|NCT00528996|566135760|FG002|Overall Study|Other reasons than listing|14|||
156831239|NCT00528996|566135761|FG003|Overall Study|Other reasons than listing|11|||
156831240|NCT00528996|566135762|FG004|Overall Study|Other reasons than listing|5|||
156831241|NCT00528996|566135758|FG000|Overall Study|Refused continue medication|16|||
156831242|NCT00528996|566135759|FG001|Overall Study|Refused continue medication|0|||
156831243|NCT00528996|566135760|FG002|Overall Study|Refused continue medication|3|||
156831244|NCT00528996|566135761|FG003|Overall Study|Refused continue medication|3|||
156831245|NCT00528996|566135762|FG004|Overall Study|Refused continue medication|6|||
156831246|NCT00528996|566135758|FG000|Overall Study|Lost to Follow-up|2|||
156831247|NCT00528996|566135759|FG001|Overall Study|Lost to Follow-up|0|||
156831248|NCT00528996|566135760|FG002|Overall Study|Lost to Follow-up|4|||
156831249|NCT00528996|566135761|FG003|Overall Study|Lost to Follow-up|1|||
156831250|NCT00528996|566135762|FG004|Overall Study|Lost to Follow-up|3|||
156831251|NCT00528996|566135758|FG000|Overall Study|Protocol Violation|1|||
156831252|NCT00528996|566135759|FG001|Overall Study|Protocol Violation|2|||
156831253|NCT00528996|566135760|FG002|Overall Study|Protocol Violation|3|||
156831254|NCT00528996|566135761|FG003|Overall Study|Protocol Violation|3|||
156831255|NCT00528996|566135762|FG004|Overall Study|Protocol Violation|2|||
156831256|NCT00528996|566135758|FG000|Overall Study|Lack of Efficacy|7|||
156831257|NCT00528996|566135759|FG001|Overall Study|Lack of Efficacy|2|||
156831258|NCT00528996|566135760|FG002|Overall Study|Lack of Efficacy|1|||
156831259|NCT00528996|566135761|FG003|Overall Study|Lack of Efficacy|3|||
156831260|NCT00528996|566135762|FG004|Overall Study|Lack of Efficacy|3|||
156831261|NCT00528996|566135758|FG000|Overall Study|Adverse Event|32|||
156831262|NCT00528996|566135759|FG001|Overall Study|Adverse Event|13|||
156831263|NCT00528996|566135760|FG002|Overall Study|Adverse Event|18|||
156831264|NCT00528996|566135761|FG003|Overall Study|Adverse Event|29|||
156831265|NCT00528996|566135762|FG004|Overall Study|Adverse Event|18|||
156831266|NCT00996801|566135763|FG000|Overall Study|Adverse Event|6|||
156831267|NCT00996801|566135764|FG001|Overall Study|Adverse Event|4|||
156831268|NCT00996801|566135765|FG002|Overall Study|Adverse Event|12|||
156831269|NCT00996801|566135766|FG003|Overall Study|Adverse Event|17|||
156831270|NCT00996801|566135767|FG004|Overall Study|Adverse Event|31|||
156831271|NCT00996801|566135768|FG005|Overall Study|Adverse Event|3|||
156831272|NCT00996801|566135763|FG000|Overall Study|Lack of Efficacy|3|||
157224569|NCT00679783|567568032|FG000|Overall Study|Withdrawal by Subject|0|||
157224570|NCT00679783|567568033|FG001|Overall Study|Withdrawal by Subject|0|||
157224571|NCT00679783|567568034|FG002|Overall Study|Withdrawal by Subject|1|||
157224572|NCT00679783|567568035|FG003|Overall Study|Withdrawal by Subject|1|||
157224573|NCT00679783|567568036|FG004|Overall Study|Withdrawal by Subject|0|||
156831273|NCT00996801|566135764|FG001|Overall Study|Lack of Efficacy|0|||
156831274|NCT00996801|566135765|FG002|Overall Study|Lack of Efficacy|1|||
156831275|NCT00996801|566135766|FG003|Overall Study|Lack of Efficacy|3|||
156831276|NCT00996801|566135767|FG004|Overall Study|Lack of Efficacy|0|||
156831277|NCT00996801|566135768|FG005|Overall Study|Lack of Efficacy|1|||
156831278|NCT00996801|566135763|FG000|Overall Study|Lost to Follow-up|0|||
156831279|NCT00996801|566135764|FG001|Overall Study|Lost to Follow-up|0|||
156831280|NCT00996801|566135765|FG002|Overall Study|Lost to Follow-up|0|||
156831281|NCT00996801|566135766|FG003|Overall Study|Lost to Follow-up|3|||
156831282|NCT00996801|566135767|FG004|Overall Study|Lost to Follow-up|3|||
156831283|NCT00996801|566135768|FG005|Overall Study|Lost to Follow-up|2|||
156831284|NCT00996801|566135763|FG000|Overall Study|Physician Decision|0|||
156831285|NCT00996801|566135764|FG001|Overall Study|Physician Decision|0|||
156831286|NCT00996801|566135765|FG002|Overall Study|Physician Decision|0|||
156831287|NCT00996801|566135766|FG003|Overall Study|Physician Decision|1|||
156831288|NCT00996801|566135767|FG004|Overall Study|Physician Decision|0|||
156831289|NCT00996801|566135768|FG005|Overall Study|Physician Decision|0|||
156831290|NCT00996801|566135763|FG000|Overall Study|Progressive Disease|0|||
156831291|NCT00996801|566135764|FG001|Overall Study|Progressive Disease|1|||
156831292|NCT00996801|566135765|FG002|Overall Study|Progressive Disease|0|||
156831293|NCT00996801|566135766|FG003|Overall Study|Progressive Disease|0|||
156831294|NCT00996801|566135767|FG004|Overall Study|Progressive Disease|0|||
156831295|NCT00996801|566135768|FG005|Overall Study|Progressive Disease|0|||
156831296|NCT00996801|566135763|FG000|Overall Study|Protocol Violation|3|||
156831297|NCT00996801|566135764|FG001|Overall Study|Protocol Violation|4|||
156831298|NCT00996801|566135765|FG002|Overall Study|Protocol Violation|1|||
156831299|NCT00996801|566135766|FG003|Overall Study|Protocol Violation|2|||
156831300|NCT00996801|566135767|FG004|Overall Study|Protocol Violation|3|||
156831301|NCT00996801|566135768|FG005|Overall Study|Protocol Violation|4|||
156831302|NCT00996801|566135763|FG000|Overall Study|Study Terminated by Sponsor|0|||
156831303|NCT00996801|566135764|FG001|Overall Study|Study Terminated by Sponsor|1|||
156831304|NCT00996801|566135765|FG002|Overall Study|Study Terminated by Sponsor|0|||
156831305|NCT00996801|566135766|FG003|Overall Study|Study Terminated by Sponsor|0|||
156831306|NCT00996801|566135767|FG004|Overall Study|Study Terminated by Sponsor|46|||
156831307|NCT00996801|566135768|FG005|Overall Study|Study Terminated by Sponsor|0|||
156831308|NCT00996801|566135763|FG000|Overall Study|Withdrawal by Subject|8|||
156831309|NCT00996801|566135764|FG001|Overall Study|Withdrawal by Subject|6|||
156831310|NCT00996801|566135765|FG002|Overall Study|Withdrawal by Subject|9|||
156831311|NCT00996801|566135766|FG003|Overall Study|Withdrawal by Subject|5|||
156831312|NCT00996801|566135767|FG004|Overall Study|Withdrawal by Subject|5|||
156831313|NCT00996801|566135768|FG005|Overall Study|Withdrawal by Subject|9|||
156831314|NCT00289198|566135769|FG000|Overall Study|Adverse Event|0|||
156831315|NCT00289198|566135770|FG001|Overall Study|Adverse Event|2|||
156831316|NCT00289198|566135769|FG000|Overall Study|Protocol Violation|2|||
156831317|NCT00289198|566135770|FG001|Overall Study|Protocol Violation|1|||
156831318|NCT00289198|566135769|FG000|Overall Study|Withdrawal by Subject|4|||
156831319|NCT00289198|566135770|FG001|Overall Study|Withdrawal by Subject|1|||
156831320|NCT00289198|566135769|FG000|Overall Study|Lack of Efficacy|2|||
156831321|NCT00289198|566135770|FG001|Overall Study|Lack of Efficacy|0|||
156831322|NCT00289198|566135769|FG000|Overall Study|Other: Low compliance|0|||
156831323|NCT00289198|566135770|FG001|Overall Study|Other: Low compliance|1|||
156831324|NCT00289198|566135769|FG000|Overall Study|Other: Physician's decision|0|||
156831325|NCT00289198|566135770|FG001|Overall Study|Other: Physician's decision|1|||
156831326|NCT00289198|566135769|FG000|Overall Study|Other: Unable to attend on schedule|2|||
156831327|NCT00289198|566135770|FG001|Overall Study|Other: Unable to attend on schedule|1|||
156831328|NCT00289198|566135769|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
156831329|NCT00289198|566135770|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
156831330|NCT00289198|566135769|FG000|Overall Study|Other: Impossible to come on visit|0|||
156831331|NCT00289198|566135770|FG001|Overall Study|Other: Impossible to come on visit|1|||
156831332|NCT03369431|566135778|FG000|Overall Study|Lost to Follow-up|1|||
156831333|NCT03369431|566135779|FG001|Overall Study|Lost to Follow-up|3|||
156831334|NCT03369431|566135778|FG000|Overall Study|Withdrawal by Subject|2|||
156831335|NCT03369431|566135779|FG001|Overall Study|Withdrawal by Subject|3|||
156831336|NCT03369431|566135778|FG000|Overall Study|Protocol Violation|1|||
156831337|NCT03369431|566135779|FG001|Overall Study|Protocol Violation|1|||
156831338|NCT01062061|566135780|FG000|Overall Study|Enrolled more than once|2|||
156831339|NCT01062061|566135780|FG000|Overall Study|Investigated before study start|13|||
156831340|NCT01062061|566135780|FG000|Overall Study|Outside chief indications|10|||
156831341|NCT01062061|566135780|FG000|Overall Study|Failed to meet inclusion criteria|2|||
156831342|NCT00004445|566135781|FG000|Overall Study|Physician Decision|2|||
156831343|NCT00004445|566135781|FG000|Overall Study|Withdrawal by Subject|1|||
156831344|NCT00076336|566135782|FG000|Overall Study|Death|13|||
156831345|NCT00076336|566135783|FG001|Overall Study|Death|17|||
156831346|NCT00076336|566135782|FG000|Overall Study|Adverse Event|4|||
156831347|NCT00076336|566135783|FG001|Overall Study|Adverse Event|4|||
156831348|NCT00076336|566135782|FG000|Overall Study|Lost to Follow-up|4|||
156831349|NCT00076336|566135783|FG001|Overall Study|Lost to Follow-up|4|||
156831350|NCT00076336|566135782|FG000|Overall Study|Non-Compliance|2|||
156831351|NCT00076336|566135783|FG001|Overall Study|Non-Compliance|0|||
156831352|NCT00076336|566135782|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
156831353|NCT00076336|566135783|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
156831354|NCT00076336|566135782|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
156831355|NCT00076336|566135783|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
156831356|NCT00076336|566135782|FG000|Overall Study|Liver Transplantation|3|||
156831357|NCT00076336|566135783|FG001|Overall Study|Liver Transplantation|3|||
156831358|NCT00076336|566135782|FG000|Overall Study|Virologic Breakthrough|14|||
156831359|NCT00076336|566135783|FG001|Overall Study|Virologic Breakthrough|16|||
156831360|NCT00076336|566135782|FG000|Overall Study|Treatment failure|4|||
156831361|NCT00076336|566135783|FG001|Overall Study|Treatment failure|5|||
156831362|NCT00524589|566135784|FG000|Overall Study|Withdrawal by Subject|2|||
156831363|NCT00524589|566135784|FG000|Overall Study|Disease Progression|16|||
156831364|NCT02753127|566135788|FG000|Overall Study|Lost to Follow-up|13|||
156831365|NCT02753127|566135789|FG001|Overall Study|Lost to Follow-up|11|||
156831366|NCT02753127|566135788|FG000|Overall Study|Withdrawal by Subject|37|||
156831367|NCT02753127|566135789|FG001|Overall Study|Withdrawal by Subject|47|||
156831368|NCT02753127|566135788|FG000|Overall Study|Other|3|||
156831369|NCT02753127|566135789|FG001|Overall Study|Other|8|||
156831370|NCT02753127|566135788|FG000|Overall Study|Hospice|0|||
156831371|NCT02753127|566135789|FG001|Overall Study|Hospice|2|||
156831372|NCT00046930|566135792|FG000|Overall Study|Ineligible|12|||
156831373|NCT00046930|566135793|FG001|Overall Study|Ineligible|4|||
156831374|NCT00940485|566135799|FG000|Overall Study|HBeAb positive at Baseline|3|||
156831375|NCT00940485|566135800|FG001|Overall Study|HBeAb positive at Baseline|2|||
156831376|NCT00940485|566135799|FG000|Overall Study|Lost to Follow-up|2|||
156831377|NCT00940485|566135800|FG001|Overall Study|Lost to Follow-up|3|||
156831378|NCT00940485|566135799|FG000|Overall Study|Adverse Event|8|||
156831379|NCT00940485|566135800|FG001|Overall Study|Adverse Event|0|||
156831380|NCT00940485|566135799|FG000|Overall Study|Withdrawal by Subject|1|||
156831381|NCT00940485|566135800|FG001|Overall Study|Withdrawal by Subject|1|||
156831382|NCT00940485|566135799|FG000|Overall Study|Others|1|||
156831383|NCT00940485|566135800|FG001|Overall Study|Others|1|||
156831384|NCT01113580|566135801|FG000|Overall Study|Protocol Violation|1|||
156831385|NCT01113580|566135802|FG001|Overall Study|Protocol Violation|0|||
156831386|NCT02936284|566135803|FG000|Overall Study|Withdrawal by Subject|3|||
156831387|NCT02936284|566135804|FG001|Overall Study|Withdrawal by Subject|1|||
156831388|NCT02936284|566135803|FG000|Overall Study|Lost to Follow-up|7|||
156831389|NCT02936284|566135804|FG001|Overall Study|Lost to Follow-up|8|||
156831390|NCT01519674|566135809|FG000|Overall Study|Adverse Event|3|||
156831391|NCT01519674|566135810|FG001|Overall Study|Adverse Event|3|||
156831392|NCT01519674|566135811|FG002|Overall Study|Adverse Event|0|||
156831393|NCT01519674|566135809|FG000|Overall Study|Lack of Efficacy|1|||
156831394|NCT01519674|566135810|FG001|Overall Study|Lack of Efficacy|1|||
156831395|NCT01519674|566135811|FG002|Overall Study|Lack of Efficacy|1|||
156831396|NCT01519674|566135809|FG000|Overall Study|Protocol Violation|0|||
156831397|NCT01519674|566135810|FG001|Overall Study|Protocol Violation|3|||
156831398|NCT01519674|566135811|FG002|Overall Study|Protocol Violation|1|||
156831399|NCT01519674|566135809|FG000|Overall Study|Withdrawal Criteria|7|||
156831400|NCT01519674|566135810|FG001|Overall Study|Withdrawal Criteria|2|||
156831401|NCT01519674|566135811|FG002|Overall Study|Withdrawal Criteria|7|||
156831402|NCT01519674|566135809|FG000|Overall Study|Unsclassified|10|||
156831403|NCT01519674|566135810|FG001|Overall Study|Unsclassified|4|||
156831404|NCT01519674|566135811|FG002|Overall Study|Unsclassified|3|||
156831405|NCT01146288|566135814|FG000|First Intervention(1 Day)|Adverse Event|0|||
156831406|NCT01146288|566135815|FG001|First Intervention(1 Day)|Adverse Event|1|||
156831407|NCT03458702|566135816|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
156831408|NCT03458702|566135817|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
156831409|NCT03458702|566135816|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
156831410|NCT03458702|566135817|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
156831411|NCT01697462|566135818|FG000|Overall Study|Disease Progression|1|||
156831412|NCT01697462|566135818|FG000|Overall Study|Adverse Event|6|||
156831413|NCT01697462|566135818|FG000|Overall Study|Lost to Follow-up|21|||
156831414|NCT01697462|566135818|FG000|Overall Study|Withdrawal by Subject|12|||
156831415|NCT01697462|566135818|FG000|Overall Study|Investigator Decision|21|||
156831416|NCT01697462|566135818|FG000|Overall Study|Death|1|||
156831417|NCT01697462|566135818|FG000|Overall Study|Other|10|||
156831418|NCT01697462|566135818|FG000|Overall Study|Missing|5|||
156831419|NCT03532932|566135819|FG000|Overall Study|Protocol Deviation|33|||
156831420|NCT03532932|566135820|FG001|Overall Study|Protocol Deviation|31|||
156831421|NCT03532932|566135819|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
156831422|NCT03532932|566135820|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
156831423|NCT03532932|566135819|FG000|Overall Study|Withdrawal by Subject|2|||
156831424|NCT03532932|566135820|FG001|Overall Study|Withdrawal by Subject|0|||
156831425|NCT03532932|566135819|FG000|Overall Study|Lost to Follow-up|15|||
156831426|NCT03532932|566135820|FG001|Overall Study|Lost to Follow-up|9|||
156831427|NCT03532932|566135819|FG000|Overall Study|Adverse Event|4|||
156831428|NCT03532932|566135820|FG001|Overall Study|Adverse Event|3|||
156831429|NCT03532932|566135819|FG000|Overall Study|Death|0|||
156831430|NCT03532932|566135820|FG001|Overall Study|Death|2|||
156831431|NCT03532932|566135819|FG000|Overall Study|Other|11|||
156831432|NCT03532932|566135820|FG001|Overall Study|Other|16|||
156831433|NCT02255565|566135822|FG000|Overall Study|Withdrawal by Subject|0|||
156831434|NCT02255565|566135823|FG001|Overall Study|Withdrawal by Subject|1|||
156831435|NCT02255565|566135824|FG002|Overall Study|Withdrawal by Subject|0|||
156831436|NCT02699450|566135825|FG000|Overall Study|Death|2|||
156831437|NCT02699450|566135826|FG001|Overall Study|Death|1|||
156831438|NCT02699450|566135827|FG002|Overall Study|Death|2|||
156831439|NCT02699450|566135825|FG000|Overall Study|Met Criteria for Study Exit|0|||
156831440|NCT02699450|566135826|FG001|Overall Study|Met Criteria for Study Exit|0|||
156831441|NCT02699450|566135827|FG002|Overall Study|Met Criteria for Study Exit|1|||
156831442|NCT02699450|566135825|FG000|Overall Study|Protocol Violation|4|||
156831443|NCT02699450|566135826|FG001|Overall Study|Protocol Violation|3|||
156831444|NCT02699450|566135827|FG002|Overall Study|Protocol Violation|5|||
156831445|NCT02699450|566135825|FG000|Overall Study|Lost to Follow-up|3|||
156831446|NCT02699450|566135826|FG001|Overall Study|Lost to Follow-up|0|||
156831447|NCT02699450|566135827|FG002|Overall Study|Lost to Follow-up|5|||
156831448|NCT02699450|566135825|FG000|Overall Study|Physician Decision|2|||
156831449|NCT02699450|566135826|FG001|Overall Study|Physician Decision|0|||
156831450|NCT02699450|566135827|FG002|Overall Study|Physician Decision|0|||
156831451|NCT02699450|566135825|FG000|Overall Study|Withdrawal by Subject|3|||
156831452|NCT02699450|566135826|FG001|Overall Study|Withdrawal by Subject|1|||
156831453|NCT02699450|566135827|FG002|Overall Study|Withdrawal by Subject|2|||
156831454|NCT02699450|566135825|FG000|Overall Study|Adverse Event|1|||
156831455|NCT02699450|566135826|FG001|Overall Study|Adverse Event|0|||
156831456|NCT02699450|566135827|FG002|Overall Study|Adverse Event|0|||
156831457|NCT00810901|566135828|FG000|Overall Study|Lost to Follow-up|88|||
156831458|NCT00810901|566135829|FG001|Overall Study|Lost to Follow-up|58|||
156831459|NCT00931801|566135830|FG000|Overall Study|Adverse Event|0|||
156831460|NCT00931801|566135831|FG001|Overall Study|Adverse Event|0|||
156831461|NCT00931801|566135832|FG002|Overall Study|Adverse Event|1|||
156831462|NCT00931801|566135830|FG000|Overall Study|Lost to Follow-up|0|||
156831463|NCT00931801|566135831|FG001|Overall Study|Lost to Follow-up|1|||
156831464|NCT00931801|566135832|FG002|Overall Study|Lost to Follow-up|0|||
156831465|NCT00931801|566135830|FG000|Overall Study|Withdrawal by Subject|1|||
156831466|NCT00931801|566135831|FG001|Overall Study|Withdrawal by Subject|0|||
156831467|NCT00931801|566135832|FG002|Overall Study|Withdrawal by Subject|0|||
156831468|NCT00931801|566135830|FG000|Overall Study|Confirmed Virologic Failure|0|||
156831469|NCT00931801|566135831|FG001|Overall Study|Confirmed Virologic Failure|0|||
156831470|NCT00931801|566135832|FG002|Overall Study|Confirmed Virologic Failure|3|||
156831471|NCT01133275|566135833|FG000|Overall Study|Withdrawal by Subject|1|||
156831472|NCT01133275|566135833|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
156831473|NCT02689076|566135834|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
156831474|NCT02689076|566135835|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
156831475|NCT02689076|566135836|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
156831476|NCT02689076|566135834|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
156831477|NCT02689076|566135835|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
156831478|NCT02689076|566135836|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
156831479|NCT02689076|566135834|FG000|Overall Study|Did not have an HIE match|2|||
156831480|NCT02689076|566135835|FG001|Overall Study|Did not have an HIE match|0|||
156831481|NCT02689076|566135836|FG002|Overall Study|Did not have an HIE match|0|||
156831482|NCT02689076|566135834|FG000|Overall Study|Death during non-VA encounter|2|||
156831483|NCT02689076|566135835|FG001|Overall Study|Death during non-VA encounter|5|||
156831484|NCT02689076|566135836|FG002|Overall Study|Death during non-VA encounter|0|||
156831485|NCT02689076|566135834|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
156831486|NCT02689076|566135835|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
156831487|NCT02689076|566135836|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
156831488|NCT02689076|566135834|FG000|Overall Study|Participant no longer active in VA system|1|||
156831489|NCT02689076|566135835|FG001|Overall Study|Participant no longer active in VA system|0|||
156831490|NCT02689076|566135836|FG002|Overall Study|Participant no longer active in VA system|0|||
156831491|NCT02689076|566135834|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
156831492|NCT02689076|566135835|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
156831493|NCT02689076|566135836|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
156831494|NCT02266875|566135837|FG000|Overall Study|Withdrawal by Subject|9|||
156831495|NCT02266875|566135838|FG001|Overall Study|Withdrawal by Subject|0|||
156831496|NCT02266875|566135837|FG000|Overall Study|Lost to Follow-up|2|||
156831497|NCT02266875|566135838|FG001|Overall Study|Lost to Follow-up|0|||
156831498|NCT01143896|566135839|FG000|Overall Study|Did not complete Baseline Interview|5|||
156831499|NCT01143896|566135840|FG001|Overall Study|Did not complete Baseline Interview|4|||
156831500|NCT01143896|566135839|FG000|Overall Study|Lost to Follow-up|18|||
156831501|NCT01143896|566135840|FG001|Overall Study|Lost to Follow-up|13|||
156831502|NCT01143896|566135839|FG000|Overall Study|Withdrawal by Subject|13|||
156831503|NCT01143896|566135840|FG001|Overall Study|Withdrawal by Subject|5|||
156831504|NCT01143896|566135839|FG000|Overall Study|Death|6|||
156831505|NCT01143896|566135840|FG001|Overall Study|Death|3|||
156831506|NCT01318070|566135841|FG000|Overall Study|Adverse Event|1|||
156831507|NCT01318070|566135842|FG001|Overall Study|Adverse Event|1|||
156831508|NCT01318070|566135843|FG002|Overall Study|Adverse Event|5|||
157151306|NCT01781429|567299652|FG001|Overall Study|Withdrawal by Subject|0|||
157151307|NCT01781429|567299653|FG002|Overall Study|Withdrawal by Subject|0|||
156831509|NCT01318070|566135841|FG000|Overall Study|Withdrawal by Subject|0|||
156831510|NCT01318070|566135842|FG001|Overall Study|Withdrawal by Subject|1|||
156831511|NCT01318070|566135843|FG002|Overall Study|Withdrawal by Subject|1|||
157151308|NCT01781429|567299654|FG003|Overall Study|Withdrawal by Subject|0|||
157151309|NCT01781429|567299655|FG004|Overall Study|Withdrawal by Subject|0|||
157151310|NCT01781429|567299656|FG005|Overall Study|Withdrawal by Subject|0|||
157151311|NCT01781429|567299657|FG006|Overall Study|Withdrawal by Subject|0|||
157151312|NCT01781429|567299658|FG007|Overall Study|Withdrawal by Subject|0|||
157151313|NCT01781429|567299659|FG008|Overall Study|Withdrawal by Subject|1|||
157151314|NCT01781429|567299660|FG009|Overall Study|Withdrawal by Subject|3|||
157151315|NCT01781429|567299661|FG010|Overall Study|Withdrawal by Subject|1|||
157151316|NCT01781429|567299662|FG011|Overall Study|Withdrawal by Subject|1|||
157151317|NCT01781429|567299663|FG012|Overall Study|Withdrawal by Subject|5|||
157151318|NCT01781429|567299664|FG013|Overall Study|Withdrawal by Subject|2|||
157151319|NCT01781429|567299665|FG014|Overall Study|Withdrawal by Subject|3|||
157151320|NCT01781429|567299666|FG015|Overall Study|Withdrawal by Subject|0|||
157151321|NCT01781429|567299651|FG000|Overall Study|Disease Progression|1|||
157151322|NCT01781429|567299652|FG001|Overall Study|Disease Progression|0|||
157151323|NCT01781429|567299653|FG002|Overall Study|Disease Progression|1|||
157151324|NCT01781429|567299654|FG003|Overall Study|Disease Progression|1|||
157151325|NCT01781429|567299655|FG004|Overall Study|Disease Progression|1|||
157151326|NCT01781429|567299656|FG005|Overall Study|Disease Progression|4|||
157151327|NCT01781429|567299657|FG006|Overall Study|Disease Progression|7|||
157151328|NCT01781429|567299658|FG007|Overall Study|Disease Progression|4|||
157151329|NCT01781429|567299659|FG008|Overall Study|Disease Progression|6|||
157151330|NCT01781429|567299660|FG009|Overall Study|Disease Progression|15|||
157151331|NCT01781429|567299661|FG010|Overall Study|Disease Progression|15|||
157151332|NCT01781429|567299662|FG011|Overall Study|Disease Progression|15|||
157151333|NCT01781429|567299663|FG012|Overall Study|Disease Progression|15|||
157151334|NCT01781429|567299664|FG013|Overall Study|Disease Progression|4|||
157151335|NCT01781429|567299665|FG014|Overall Study|Disease Progression|11|||
157151336|NCT01781429|567299666|FG015|Overall Study|Disease Progression|0|||
157151337|NCT01781429|567299651|FG000|Overall Study|Unacceptable Toxicity|0|||
156831512|NCT01318070|566135841|FG000|Overall Study|Lack of Efficacy|0|||
156831513|NCT01318070|566135842|FG001|Overall Study|Lack of Efficacy|0|||
156831514|NCT01318070|566135843|FG002|Overall Study|Lack of Efficacy|1|||
156831515|NCT01318070|566135841|FG000|Overall Study|Principal Investigator Discretion|1|||
156831516|NCT01318070|566135842|FG001|Overall Study|Principal Investigator Discretion|0|||
156831517|NCT01318070|566135843|FG002|Overall Study|Principal Investigator Discretion|0|||
156831518|NCT01816906|566135848|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
156831519|NCT01816906|566135849|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
156831520|NCT01816906|566135848|FG000|Six Months|Lost to Follow-up|14|||
156831521|NCT01816906|566135849|FG001|Six Months|Lost to Follow-up|16|||
157023380|NCT03436290|566841029|FG000|Overall Study|Withdrawal by Subject|4|||
157023381|NCT03436290|566841030|FG001|Overall Study|Withdrawal by Subject|0|||
157023382|NCT03436290|566841029|FG000|Overall Study|Protocol Violation|30|||
157023383|NCT03436290|566841030|FG001|Overall Study|Protocol Violation|0|||
157023384|NCT02677298|566841031|FG000|Double Blind Phase|Adverse Event|2|||
156831522|NCT01816906|566135848|FG000|12 Months|Adverse Event|2|||
156831523|NCT01816906|566135849|FG001|12 Months|Adverse Event|2|||
156831524|NCT01816906|566135848|FG000|12 Months|Death|0|||
156831525|NCT01816906|566135849|FG001|12 Months|Death|2|||
156831526|NCT01816906|566135848|FG000|12 Months|Lost to Follow-up|2|||
156831527|NCT01816906|566135849|FG001|12 Months|Lost to Follow-up|1|||
156831528|NCT04375397|566135850|FG000|Overall Study|Death|1|||
156831529|NCT04375397|566135851|FG001|Overall Study|Death|1|||
156831530|NCT04375397|566135850|FG000|Overall Study|Withdrew consent|2|||
156831531|NCT04375397|566135851|FG001|Overall Study|Withdrew consent|0|||
156831532|NCT04375397|566135850|FG000|Overall Study|Lost to Follow-up|6|||
156831533|NCT04375397|566135851|FG001|Overall Study|Lost to Follow-up|4|||
156831534|NCT04375397|566135850|FG000|Overall Study|Other, not specified|0|||
157023385|NCT02677298|566841032|FG001|Double Blind Phase|Adverse Event|1|||
157151338|NCT01781429|567299652|FG001|Overall Study|Unacceptable Toxicity|0|||
157151339|NCT01781429|567299653|FG002|Overall Study|Unacceptable Toxicity|0|||
157023386|NCT02677298|566841033|FG002|Double Blind Phase|Adverse Event|0|||
157151340|NCT01781429|567299654|FG003|Overall Study|Unacceptable Toxicity|0|||
157151341|NCT01781429|567299655|FG004|Overall Study|Unacceptable Toxicity|0|||
157023387|NCT02677298|566841031|FG000|Double Blind Phase|Physician Decision|5|||
157151342|NCT01781429|567299656|FG005|Overall Study|Unacceptable Toxicity|0|||
156831535|NCT04375397|566135851|FG001|Overall Study|Other, not specified|1|||
157151343|NCT01781429|567299657|FG006|Overall Study|Unacceptable Toxicity|0|||
157151344|NCT01781429|567299658|FG007|Overall Study|Unacceptable Toxicity|0|||
157151345|NCT01781429|567299659|FG008|Overall Study|Unacceptable Toxicity|0|||
157151346|NCT01781429|567299660|FG009|Overall Study|Unacceptable Toxicity|0|||
156831536|NCT00086502|566135852|FG000|Overall Study|Adverse Event|11|||
157151347|NCT01781429|567299661|FG010|Overall Study|Unacceptable Toxicity|0|||
157151348|NCT01781429|567299662|FG011|Overall Study|Unacceptable Toxicity|2|||
157151349|NCT01781429|567299663|FG012|Overall Study|Unacceptable Toxicity|0|||
157151350|NCT01781429|567299664|FG013|Overall Study|Unacceptable Toxicity|0|||
157151351|NCT01781429|567299665|FG014|Overall Study|Unacceptable Toxicity|0|||
157151352|NCT01781429|567299666|FG015|Overall Study|Unacceptable Toxicity|0|||
157151353|NCT01781429|567299651|FG000|Overall Study|Patient Condition Changed|0|||
157151354|NCT01781429|567299652|FG001|Overall Study|Patient Condition Changed|0|||
157151355|NCT01781429|567299653|FG002|Overall Study|Patient Condition Changed|0|||
157151356|NCT01781429|567299654|FG003|Overall Study|Patient Condition Changed|0|||
157151357|NCT01781429|567299655|FG004|Overall Study|Patient Condition Changed|0|||
157151358|NCT01781429|567299656|FG005|Overall Study|Patient Condition Changed|0|||
157151359|NCT01781429|567299657|FG006|Overall Study|Patient Condition Changed|0|||
157151360|NCT01781429|567299658|FG007|Overall Study|Patient Condition Changed|0|||
156831537|NCT00086502|566135853|FG001|Overall Study|Adverse Event|2|||
156831538|NCT00086502|566135852|FG000|Overall Study|Lack of Efficacy|0|||
156831539|NCT00086502|566135853|FG001|Overall Study|Lack of Efficacy|2|||
156831540|NCT00086502|566135852|FG000|Overall Study|Lost to Follow-up|3|||
156831541|NCT00086502|566135853|FG001|Overall Study|Lost to Follow-up|1|||
156831542|NCT00086502|566135852|FG000|Overall Study|Physician Decision|1|||
156831543|NCT00086502|566135853|FG001|Overall Study|Physician Decision|1|||
156831544|NCT00086502|566135852|FG000|Overall Study|Pregnancy|0|||
156831545|NCT00086502|566135853|FG001|Overall Study|Pregnancy|1|||
156831546|NCT00086502|566135852|FG000|Overall Study|Protocol Violation|3|||
156831547|NCT00086502|566135853|FG001|Overall Study|Protocol Violation|3|||
156831548|NCT00086502|566135852|FG000|Overall Study|Withdrawal by Subject|5|||
156831549|NCT00086502|566135853|FG001|Overall Study|Withdrawal by Subject|6|||
156831550|NCT00086502|566135852|FG000|Overall Study|Patient Moved|1|||
156831551|NCT00086502|566135853|FG001|Overall Study|Patient Moved|1|||
156831552|NCT00086502|566135852|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
156831553|NCT00086502|566135853|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
156831554|NCT00086502|566135852|FG000|Overall Study|Patient Accidentally Unblinded|1|||
156831555|NCT00086502|566135853|FG001|Overall Study|Patient Accidentally Unblinded|0|||
156831556|NCT03618628|566135858|FG000|Overall Study|Death|1|||
156831557|NCT03618628|566135858|FG000|Overall Study|Lost to Follow-up|1|||
156831558|NCT00612508|566135859|FG000|Overall Study|Withdrawal by Subject|3|||
156831559|NCT00612508|566135860|FG001|Overall Study|Withdrawal by Subject|4|||
156831560|NCT01442064|566135861|FG000|Overall Study|Adverse Event|2|||
156831561|NCT01442064|566135862|FG001|Overall Study|Adverse Event|2|||
156831562|NCT01442064|566135863|FG002|Overall Study|Adverse Event|2|||
156831563|NCT01442064|566135864|FG003|Overall Study|Adverse Event|1|||
156831564|NCT01442064|566135865|FG004|Overall Study|Adverse Event|2|||
156831565|NCT01442064|566135866|FG005|Overall Study|Adverse Event|0|||
156831566|NCT01442064|566135861|FG000|Overall Study|Death|0|||
156831567|NCT01442064|566135862|FG001|Overall Study|Death|1|||
156831568|NCT01442064|566135863|FG002|Overall Study|Death|3|||
156831569|NCT01442064|566135864|FG003|Overall Study|Death|3|||
156831570|NCT01442064|566135865|FG004|Overall Study|Death|1|||
157151361|NCT01781429|567299659|FG008|Overall Study|Patient Condition Changed|0|||
157151362|NCT01781429|567299660|FG009|Overall Study|Patient Condition Changed|4|||
157151363|NCT01781429|567299661|FG010|Overall Study|Patient Condition Changed|0|||
157151364|NCT01781429|567299662|FG011|Overall Study|Patient Condition Changed|1|||
157151365|NCT01781429|567299663|FG012|Overall Study|Patient Condition Changed|0|||
157151366|NCT01781429|567299664|FG013|Overall Study|Patient Condition Changed|1|||
156831571|NCT01442064|566135866|FG005|Overall Study|Death|3|||
156831572|NCT01442064|566135861|FG000|Overall Study|Lost to Follow-up|5|||
156831573|NCT01442064|566135862|FG001|Overall Study|Lost to Follow-up|5|||
156831574|NCT01442064|566135863|FG002|Overall Study|Lost to Follow-up|1|||
156831575|NCT01442064|566135864|FG003|Overall Study|Lost to Follow-up|1|||
156831576|NCT01442064|566135865|FG004|Overall Study|Lost to Follow-up|3|||
156831577|NCT01442064|566135866|FG005|Overall Study|Lost to Follow-up|3|||
156831578|NCT01442064|566135861|FG000|Overall Study|Physician Decision|1|||
156831579|NCT01442064|566135862|FG001|Overall Study|Physician Decision|1|||
156831580|NCT01442064|566135863|FG002|Overall Study|Physician Decision|2|||
156831581|NCT01442064|566135864|FG003|Overall Study|Physician Decision|3|||
156831582|NCT01442064|566135865|FG004|Overall Study|Physician Decision|3|||
156831583|NCT01442064|566135866|FG005|Overall Study|Physician Decision|1|||
156831584|NCT01442064|566135861|FG000|Overall Study|Withdrawal by Subject|6|||
156831585|NCT01442064|566135862|FG001|Overall Study|Withdrawal by Subject|3|||
156831586|NCT01442064|566135863|FG002|Overall Study|Withdrawal by Subject|2|||
156831587|NCT01442064|566135864|FG003|Overall Study|Withdrawal by Subject|2|||
156831588|NCT01442064|566135865|FG004|Overall Study|Withdrawal by Subject|2|||
156831589|NCT01442064|566135866|FG005|Overall Study|Withdrawal by Subject|1|||
156831590|NCT01442064|566135861|FG000|Overall Study|Sponsor decision|82|||
156831591|NCT01442064|566135862|FG001|Overall Study|Sponsor decision|88|||
156831592|NCT01442064|566135863|FG002|Overall Study|Sponsor decision|92|||
156831593|NCT01442064|566135864|FG003|Overall Study|Sponsor decision|88|||
156831594|NCT01442064|566135865|FG004|Overall Study|Sponsor decision|95|||
156831595|NCT01442064|566135866|FG005|Overall Study|Sponsor decision|87|||
156831596|NCT01442064|566135861|FG000|Overall Study|Subject non-compliance|0|||
156831597|NCT01442064|566135862|FG001|Overall Study|Subject non-compliance|0|||
156831598|NCT01442064|566135863|FG002|Overall Study|Subject non-compliance|0|||
156831599|NCT01442064|566135864|FG003|Overall Study|Subject non-compliance|0|||
156831600|NCT01442064|566135865|FG004|Overall Study|Subject non-compliance|0|||
156831601|NCT01442064|566135866|FG005|Overall Study|Subject non-compliance|2|||
156831602|NCT01442064|566135861|FG000|Overall Study|Condition mandated other intervention|1|||
156831603|NCT01442064|566135862|FG001|Overall Study|Condition mandated other intervention|1|||
156831604|NCT01442064|566135863|FG002|Overall Study|Condition mandated other intervention|2|||
156831605|NCT01442064|566135864|FG003|Overall Study|Condition mandated other intervention|0|||
156831606|NCT01442064|566135865|FG004|Overall Study|Condition mandated other intervention|0|||
156831607|NCT01442064|566135866|FG005|Overall Study|Condition mandated other intervention|2|||
156831608|NCT04941807|566135867|FG000|Overall Study|Lost to Follow-up|1|||
156831609|NCT04941807|566135868|FG001|Overall Study|Lost to Follow-up|1|||
156831610|NCT03553498|566135869|FG000|Overall Study|Missing primary outcome|1|||
156831611|NCT03553498|566135870|FG001|Overall Study|Missing primary outcome|2|||
156831612|NCT02741570|566135871|FG000|Pre-Treatment Period|Other reasons|0|||
156831613|NCT02741570|566135872|FG001|Pre-Treatment Period|Other reasons|3|||
156831614|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
156831615|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
156831616|NCT02741570|566135871|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
156831617|NCT02741570|566135872|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
156831618|NCT02741570|566135871|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
156831619|NCT02741570|566135872|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
156831620|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
156831621|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
156831622|NCT02741570|566135871|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
156831623|NCT02741570|566135872|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
156831624|NCT02741570|566135871|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
156831625|NCT02741570|566135872|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
156831626|NCT02741570|566135871|FG000|Pre-Treatment Period|Death|0|||
156831627|NCT02741570|566135872|FG001|Pre-Treatment Period|Death|1|||
156831628|NCT02741570|566135871|FG000|Pre-Treatment Period|Disease progression|0|||
156831629|NCT02741570|566135872|FG001|Pre-Treatment Period|Disease progression|1|||
156831630|NCT02741570|566135871|FG000|Treatment Period|Other reasons|47|||
156831631|NCT02741570|566135872|FG001|Treatment Period|Other reasons|12|||
156831632|NCT02741570|566135871|FG000|Treatment Period|Poor/non-compliance|0|||
156831633|NCT02741570|566135872|FG001|Treatment Period|Poor/non-compliance|2|||
156831634|NCT02741570|566135871|FG000|Treatment Period|Maximum clinical benefit|4|||
156831635|NCT02741570|566135872|FG001|Treatment Period|Maximum clinical benefit|6|||
156831636|NCT02741570|566135871|FG000|Treatment Period|Lost to Follow-up|1|||
156831637|NCT02741570|566135872|FG001|Treatment Period|Lost to Follow-up|3|||
156831638|NCT02741570|566135871|FG000|Treatment Period|Participant withdrew consent|9|||
156831639|NCT02741570|566135872|FG001|Treatment Period|Participant withdrew consent|13|||
156831640|NCT02741570|566135871|FG000|Treatment Period|Participant request to discontinue treatment|8|||
156831641|NCT02741570|566135872|FG001|Treatment Period|Participant request to discontinue treatment|23|||
156831642|NCT02741570|566135871|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
156831643|NCT02741570|566135872|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
156831644|NCT02741570|566135871|FG000|Treatment Period|Death|9|||
156831645|NCT02741570|566135872|FG001|Treatment Period|Death|7|||
156831646|NCT02741570|566135871|FG000|Treatment Period|Study drug toxicity|55|||
156831647|NCT02741570|566135872|FG001|Treatment Period|Study drug toxicity|47|||
156831648|NCT02741570|566135871|FG000|Treatment Period|Disease progression|294|||
156831649|NCT02741570|566135872|FG001|Treatment Period|Disease progression|301|||
157151367|NCT01781429|567299665|FG014|Overall Study|Patient Condition Changed|0|||
157151368|NCT01781429|567299666|FG015|Overall Study|Patient Condition Changed|0|||
157151369|NCT01781429|567299651|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
157151370|NCT01781429|567299652|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
157151371|NCT01781429|567299653|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
157151372|NCT01781429|567299654|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
157151373|NCT01781429|567299655|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
157151374|NCT01781429|567299656|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
157151375|NCT01781429|567299657|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
157151376|NCT01781429|567299658|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
157151377|NCT01781429|567299659|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
157151378|NCT01781429|567299660|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
156831650|NCT02741570|566135871|FG000|Treatment Period|Administrative reason by sponsor|0|||
156831651|NCT02741570|566135872|FG001|Treatment Period|Administrative reason by sponsor|1|||
156831652|NCT01360398|566135873|FG000|Overall Study|Withdrawal by Subject|14|||
156831653|NCT01360398|566135873|FG000|Overall Study|Other|7|||
156831654|NCT01360398|566135873|FG000|Overall Study|Migrated/moved from study area|1|||
156885214|NCT02353143|566338247|FG008|Overall Study|Lack of Efficacy|1|||
157023388|NCT02677298|566841032|FG001|Double Blind Phase|Physician Decision|0|||
157023389|NCT02677298|566841033|FG002|Double Blind Phase|Physician Decision|0|||
157023390|NCT02677298|566841031|FG000|Double Blind Phase|Lost to Follow-up|11|||
157023391|NCT02677298|566841032|FG001|Double Blind Phase|Lost to Follow-up|7|||
157023392|NCT02677298|566841033|FG002|Double Blind Phase|Lost to Follow-up|0|||
157023393|NCT02677298|566841031|FG000|Double Blind Phase|Withdrawal by Subject|11|||
157023394|NCT02677298|566841032|FG001|Double Blind Phase|Withdrawal by Subject|8|||
157023395|NCT02677298|566841033|FG002|Double Blind Phase|Withdrawal by Subject|0|||
156831655|NCT00846040|566135874|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
156831656|NCT00846040|566135875|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
156831657|NCT00846040|566135876|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
156831658|NCT00846040|566135874|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
156831659|NCT00846040|566135875|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
156831660|NCT00846040|566135876|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
156831661|NCT03158272|566135880|FG000|Overall Study|Disease progression|3|||
156831662|NCT03158272|566135881|FG001|Overall Study|Disease progression|3|||
156831663|NCT03158272|566135882|FG002|Overall Study|Disease progression|4|||
156831664|NCT03158272|566135883|FG003|Overall Study|Disease progression|6|||
156831665|NCT03158272|566135880|FG000|Overall Study|Death|0|||
156831666|NCT03158272|566135881|FG001|Overall Study|Death|0|||
156831667|NCT03158272|566135882|FG002|Overall Study|Death|1|||
156831668|NCT03158272|566135883|FG003|Overall Study|Death|0|||
156831669|NCT03158272|566135880|FG000|Overall Study|Other reasons|0|||
156831670|NCT03158272|566135881|FG001|Overall Study|Other reasons|0|||
156831671|NCT03158272|566135882|FG002|Overall Study|Other reasons|1|||
156831672|NCT03158272|566135883|FG003|Overall Study|Other reasons|0|||
156831673|NCT03158272|566135880|FG000|Overall Study|Adverse event unrelated to the drug|0|||
156831674|NCT03158272|566135881|FG001|Overall Study|Adverse event unrelated to the drug|1|||
156831675|NCT03158272|566135882|FG002|Overall Study|Adverse event unrelated to the drug|0|||
156831676|NCT03158272|566135883|FG003|Overall Study|Adverse event unrelated to the drug|0|||
156831677|NCT01822535|566135884|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
156831678|NCT01822535|566135885|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
156831679|NCT01822535|566135884|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
156831680|NCT01822535|566135885|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
156831681|NCT01822535|566135884|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
156831682|NCT01822535|566135885|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
156831683|NCT01048866|566135890|FG000|Overall Study|Adverse Event|1|||
156831684|NCT01048866|566135891|FG001|Overall Study|Adverse Event|0|||
156831685|NCT01048866|566135890|FG000|Overall Study|Protocol Violation|1|||
156831686|NCT01048866|566135891|FG001|Overall Study|Protocol Violation|0|||
156831687|NCT01048866|566135890|FG000|Overall Study|Physician Decision|1|||
156831688|NCT01048866|566135891|FG001|Overall Study|Physician Decision|0|||
156831689|NCT01048866|566135890|FG000|Overall Study|Withdrawal by Subject|0|||
156831690|NCT01048866|566135891|FG001|Overall Study|Withdrawal by Subject|2|||
156831691|NCT01048866|566135890|FG000|Overall Study|Lost to Follow-up|0|||
156831692|NCT01048866|566135891|FG001|Overall Study|Lost to Follow-up|2|||
156831693|NCT01048866|566135890|FG000|Overall Study|Other|1|||
156831694|NCT01048866|566135891|FG001|Overall Study|Other|1|||
156831695|NCT03582813|566135892|FG000|Overall Study|Lost to Follow-up|18|||
156831696|NCT03582813|566135893|FG001|Overall Study|Lost to Follow-up|21|||
156831697|NCT03582813|566135892|FG000|Overall Study|Withdrawal by Subject|1|||
156831698|NCT03582813|566135893|FG001|Overall Study|Withdrawal by Subject|0|||
156831699|NCT01591863|566135898|FG000|Overall Study|Adverse Event|3|||
156831700|NCT01591863|566135898|FG000|Overall Study|Withdrawal by Subject|1|||
156831701|NCT01591863|566135898|FG000|Overall Study|recurrence|9|||
156831702|NCT01591863|566135898|FG000|Overall Study|Lack of Efficacy|1|||
156831703|NCT00160654|566135899|FG000|Overall Study|Adverse Event|14|||
156831704|NCT00160654|566135899|FG000|Overall Study|Lack of Efficacy|4|||
156831705|NCT00160654|566135899|FG000|Overall Study|Lost to Follow-up|2|||
156831706|NCT00160654|566135899|FG000|Overall Study|Intake of expired drug|7|||
156831707|NCT00160654|566135899|FG000|Overall Study|Psychological trauma|1|||
156831708|NCT00160654|566135899|FG000|Overall Study|Sponsor decision|1|||
157023396|NCT02677298|566841031|FG000|Double Blind Phase|No study drug available at site|0|||
157023397|NCT02677298|566841032|FG001|Double Blind Phase|No study drug available at site|1|||
157023398|NCT02677298|566841033|FG002|Double Blind Phase|No study drug available at site|0|||
157151379|NCT01781429|567299661|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
157151380|NCT01781429|567299662|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
156831709|NCT00160654|566135899|FG000|Overall Study|Patient met exclusion criteria|1|||
156831710|NCT00160654|566135899|FG000|Overall Study|Patient decision|1|||
156831711|NCT00160654|566135899|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
156831712|NCT00160654|566135899|FG000|Overall Study|Met exclusion criteria|1|||
156831713|NCT02366767|566135902|FG000|Overall Study|left for home after 1 day at camp|1|||
156831714|NCT02366767|566135903|FG001|Overall Study|left for home after 1 day at camp|0|||
156831715|NCT02242981|566135904|FG000|Overall Study|Withdrawal by Subject|1|||
157023399|NCT02677298|566841031|FG000|Open Label Phase|Adverse Event|0|||
156831716|NCT03474081|566135909|FG000|Overall Study|Adverse Event|6|||
156831717|NCT03474081|566135910|FG001|Overall Study|Adverse Event|3|||
156831718|NCT03474081|566135909|FG000|Overall Study|Lost to Follow-up|2|||
156831719|NCT03474081|566135910|FG001|Overall Study|Lost to Follow-up|1|||
156831720|NCT03474081|566135909|FG000|Overall Study|Physician Decision|3|||
156831721|NCT03474081|566135910|FG001|Overall Study|Physician Decision|2|||
156831722|NCT03474081|566135909|FG000|Overall Study|Withdrawal by Subject|5|||
156831723|NCT03474081|566135910|FG001|Overall Study|Withdrawal by Subject|7|||
156831724|NCT03474081|566135909|FG000|Overall Study|Investigator site closed|1|||
156831725|NCT03474081|566135910|FG001|Overall Study|Investigator site closed|0|||
156831726|NCT02558400|566135913|FG000|Overall Study|Adverse Event|47|||
156831727|NCT02558400|566135914|FG001|Overall Study|Adverse Event|53|||
156831728|NCT02558400|566135915|FG002|Overall Study|Adverse Event|4|||
156831729|NCT02558400|566135913|FG000|Overall Study|Withdrawal by Subject|13|||
156831730|NCT02558400|566135914|FG001|Overall Study|Withdrawal by Subject|9|||
156831731|NCT02558400|566135915|FG002|Overall Study|Withdrawal by Subject|8|||
156831732|NCT02558400|566135913|FG000|Overall Study|Non-Compliant|0|||
156831733|NCT02558400|566135914|FG001|Overall Study|Non-Compliant|1|||
156831734|NCT02558400|566135915|FG002|Overall Study|Non-Compliant|3|||
156831735|NCT02558400|566135913|FG000|Overall Study|Lost to Follow-up|5|||
156831736|NCT02558400|566135914|FG001|Overall Study|Lost to Follow-up|5|||
156831737|NCT02558400|566135915|FG002|Overall Study|Lost to Follow-up|4|||
156831738|NCT02558400|566135913|FG000|Overall Study|Lack of Efficacy|0|||
156831739|NCT02558400|566135914|FG001|Overall Study|Lack of Efficacy|13|||
156831740|NCT02558400|566135915|FG002|Overall Study|Lack of Efficacy|1|||
156831741|NCT02558400|566135913|FG000|Overall Study|Disallowed Concurrent Medication|6|||
156831742|NCT02558400|566135914|FG001|Overall Study|Disallowed Concurrent Medication|7|||
156831743|NCT02558400|566135915|FG002|Overall Study|Disallowed Concurrent Medication|5|||
156831744|NCT02558400|566135913|FG000|Overall Study|Physician Decision|2|||
156831745|NCT02558400|566135914|FG001|Overall Study|Physician Decision|2|||
156831746|NCT02558400|566135915|FG002|Overall Study|Physician Decision|0|||
156831747|NCT02558400|566135913|FG000|Overall Study|Protocol Violation|6|||
156831748|NCT02558400|566135914|FG001|Overall Study|Protocol Violation|3|||
156831749|NCT02558400|566135915|FG002|Overall Study|Protocol Violation|8|||
156831750|NCT02558400|566135913|FG000|Overall Study|Death|0|||
156831751|NCT02558400|566135914|FG001|Overall Study|Death|1|||
156831752|NCT02558400|566135915|FG002|Overall Study|Death|0|||
156831753|NCT02558400|566135913|FG000|Overall Study|Ineligible for the study|0|||
156831754|NCT02558400|566135914|FG001|Overall Study|Ineligible for the study|2|||
156831755|NCT02558400|566135915|FG002|Overall Study|Ineligible for the study|0|||
156831756|NCT02230683|566135919|FG000|Overall Study|Adverse Event|1|||
156831757|NCT00456599|566135921|FG000|Overall Study|Non-compliance|1|||
156831758|NCT00456599|566135921|FG000|Overall Study|Withdrawal by Subject|2|||
156831759|NCT02198235|566135922|FG000|Overall Study|Lost to Follow-up|3|||
156831760|NCT02198235|566135923|FG001|Overall Study|Lost to Follow-up|2|||
156831761|NCT02198235|566135924|FG002|Overall Study|Lost to Follow-up|2|||
156831762|NCT00260065|566135925|FG000|Overall Study|Progressive Disease|22|||
156831763|NCT00260065|566135925|FG000|Overall Study|Adverse Event|17|||
156831764|NCT00260065|566135925|FG000|Overall Study|Death|13|||
156831765|NCT00260065|566135925|FG000|Overall Study|Withdrawal by Subject|13|||
156831766|NCT00260065|566135925|FG000|Overall Study|Physician Decision|19|||
156831767|NCT00260065|566135925|FG000|Overall Study|Not otherwise specified|8|||
156831768|NCT00260065|566135925|FG000|Overall Study|Medication Noncompliance|1|||
156831769|NCT04573881|566135927|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
156831770|NCT01304329|566137505|FG000|Third Intervention (3 Days)|Adverse Event|0|||
156831771|NCT01304329|566137506|FG001|Third Intervention (3 Days)|Adverse Event|1|||
156831772|NCT01304329|566137507|FG002|Third Intervention (3 Days)|Adverse Event|0|||
156831773|NCT01304329|566137508|FG003|Third Intervention (3 Days)|Adverse Event|0|||
156831774|NCT01304329|566137509|FG004|Third Intervention (3 Days)|Adverse Event|0|||
156831775|NCT01304329|566137510|FG005|Third Intervention (3 Days)|Adverse Event|0|||
156831776|NCT05545644|566137512|FG000|Overall Study|Lost to Follow-up|4|||
156831777|NCT05545644|566137513|FG001|Overall Study|Lost to Follow-up|3|||
156831778|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156831779|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156831780|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
156831781|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
156831782|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831783|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831784|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
156831785|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
156831786|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831787|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831788|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
156831789|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
156831790|NCT00610441|566137514|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831791|NCT00610441|566137515|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
157151381|NCT01781429|567299663|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
156831792|NCT00610441|566137516|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831793|NCT00610441|566137517|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
156831794|NCT00610441|566137514|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831795|NCT00610441|566137515|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831796|NCT00610441|566137516|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
156831797|NCT00610441|566137517|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
156831798|NCT00610441|566137514|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156831799|NCT00610441|566137515|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
156831800|NCT00610441|566137516|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
156831801|NCT00610441|566137517|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
157151382|NCT01781429|567299664|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
157151383|NCT01781429|567299665|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
157151384|NCT01781429|567299666|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
157151385|NCT01781429|567299651|FG000|Overall Study|Enrolled, but not treated|0|||
156831802|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
157151386|NCT01781429|567299652|FG001|Overall Study|Enrolled, but not treated|0|||
157151387|NCT01781429|567299653|FG002|Overall Study|Enrolled, but not treated|0|||
157151388|NCT01781429|567299654|FG003|Overall Study|Enrolled, but not treated|0|||
157151389|NCT01781429|567299655|FG004|Overall Study|Enrolled, but not treated|0|||
157151390|NCT01781429|567299656|FG005|Overall Study|Enrolled, but not treated|0|||
157151391|NCT01781429|567299657|FG006|Overall Study|Enrolled, but not treated|0|||
157151392|NCT01781429|567299658|FG007|Overall Study|Enrolled, but not treated|0|||
157151393|NCT01781429|567299659|FG008|Overall Study|Enrolled, but not treated|0|||
157151394|NCT01781429|567299660|FG009|Overall Study|Enrolled, but not treated|0|||
157151395|NCT01781429|567299661|FG010|Overall Study|Enrolled, but not treated|1|||
157151396|NCT01781429|567299662|FG011|Overall Study|Enrolled, but not treated|0|||
157151397|NCT01781429|567299663|FG012|Overall Study|Enrolled, but not treated|0|||
157151398|NCT01781429|567299664|FG013|Overall Study|Enrolled, but not treated|0|||
157151399|NCT01781429|567299665|FG014|Overall Study|Enrolled, but not treated|0|||
157151400|NCT01781429|567299666|FG015|Overall Study|Enrolled, but not treated|0|||
157151401|NCT01703286|567299668|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
157151402|NCT01703286|567299669|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
157151403|NCT01703286|567299670|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
157151404|NCT01703286|567299671|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
157151405|NCT01703286|567299672|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
157151406|NCT01703286|567299673|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
157151407|NCT01703286|567299668|FG000|Period 2 Including Washout|Adverse Event|0|||
157151408|NCT01703286|567299669|FG001|Period 2 Including Washout|Adverse Event|0|||
157151409|NCT01703286|567299670|FG002|Period 2 Including Washout|Adverse Event|0|||
157151410|NCT01703286|567299671|FG003|Period 2 Including Washout|Adverse Event|1|||
157151411|NCT01703286|567299672|FG004|Period 2 Including Washout|Adverse Event|0|||
157151412|NCT01703286|567299673|FG005|Period 2 Including Washout|Adverse Event|0|||
157151413|NCT00931892|567299674|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
157151414|NCT00931892|567299675|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
157151415|NCT02207530|567299678|FG000|Overall Study|Worsening condition under investigation|78|||
157151416|NCT02207530|567299678|FG000|Overall Study|Patient decision to stop study treatment|5|||
157151417|NCT02207530|567299678|FG000|Overall Study|Adverse Event|8|||
157151418|NCT00859898|567299681|FG000|Overall Study|Lack of Efficacy|0|||
156831803|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
156831804|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
156831805|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
156831806|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831807|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831808|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
156831809|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
156831810|NCT00610441|566137514|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
156831811|NCT00610441|566137515|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831812|NCT00610441|566137516|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831813|NCT00610441|566137517|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
156831814|NCT01945775|566137527|FG000|Overall Study|Death|214|||
156831815|NCT01945775|566137528|FG001|Overall Study|Death|98|||
156831816|NCT01945775|566137527|FG000|Overall Study|Lost to Follow-up|12|||
157151419|NCT00859898|567299682|FG001|Overall Study|Lack of Efficacy|1|||
157151420|NCT00859898|567299683|FG002|Overall Study|Lack of Efficacy|1|||
157151421|NCT00859898|567299681|FG000|Overall Study|Adverse Event|4|||
157151422|NCT00859898|567299682|FG001|Overall Study|Adverse Event|9|||
157151423|NCT00859898|567299683|FG002|Overall Study|Adverse Event|8|||
157151424|NCT00859898|567299681|FG000|Overall Study|Withdrawal by Subject|11|||
157151425|NCT00859898|567299682|FG001|Overall Study|Withdrawal by Subject|8|||
157224574|NCT00679783|567568037|FG005|Overall Study|Withdrawal by Subject|0|||
156831817|NCT01945775|566137528|FG001|Overall Study|Lost to Follow-up|7|||
156831818|NCT01945775|566137527|FG000|Overall Study|Withdrawal by Subject|11|||
156831819|NCT01945775|566137528|FG001|Overall Study|Withdrawal by Subject|21|||
156831820|NCT01945775|566137527|FG000|Overall Study|Other|50|||
156831821|NCT01945775|566137528|FG001|Overall Study|Other|18|||
156831822|NCT02876328|566137529|FG000|Overall Study|Death|2|||
156831823|NCT02876328|566137530|FG001|Overall Study|Death|1|||
156831824|NCT02876328|566137531|FG002|Overall Study|Death|3|||
156831825|NCT02876328|566137532|FG003|Overall Study|Death|0|||
156831826|NCT02876328|566137533|FG004|Overall Study|Death|0|||
156831827|NCT02876328|566137534|FG005|Overall Study|Death|0|||
156831828|NCT02876328|566137535|FG006|Overall Study|Death|1|||
156831829|NCT02876328|566137536|FG007|Overall Study|Death|3|||
156831830|NCT02876328|566137537|FG008|Overall Study|Death|0|||
156831831|NCT02876328|566137538|FG009|Overall Study|Death|1|||
156831832|NCT02876328|566137539|FG010|Overall Study|Death|1|||
156831833|NCT02876328|566137540|FG011|Overall Study|Death|0|||
156831834|NCT02876328|566137541|FG012|Overall Study|Death|0|||
156831835|NCT02876328|566137542|FG013|Overall Study|Death|0|||
156831836|NCT02876328|566137543|FG014|Overall Study|Death|0|||
156831837|NCT02876328|566137544|FG015|Overall Study|Death|0|||
156831838|NCT02876328|566137545|FG016|Overall Study|Death|1|||
156831839|NCT02876328|566137546|FG017|Overall Study|Death|1|||
156831840|NCT02876328|566137547|FG018|Overall Study|Death|0|||
156831841|NCT02876328|566137548|FG019|Overall Study|Death|0|||
156831842|NCT02876328|566137549|FG020|Overall Study|Death|0|||
156831843|NCT02876328|566137550|FG021|Overall Study|Death|1|||
156831844|NCT02876328|566137551|FG022|Overall Study|Death|0|||
156831845|NCT02876328|566137552|FG023|Overall Study|Death|0|||
156831846|NCT02876328|566137529|FG000|Overall Study|Withdrawal by Subject|0|||
156831847|NCT02876328|566137530|FG001|Overall Study|Withdrawal by Subject|2|||
156831848|NCT02876328|566137531|FG002|Overall Study|Withdrawal by Subject|3|||
156831849|NCT02876328|566137532|FG003|Overall Study|Withdrawal by Subject|3|||
156831850|NCT02876328|566137533|FG004|Overall Study|Withdrawal by Subject|0|||
156831851|NCT02876328|566137534|FG005|Overall Study|Withdrawal by Subject|1|||
156831852|NCT02876328|566137535|FG006|Overall Study|Withdrawal by Subject|0|||
156831853|NCT02876328|566137536|FG007|Overall Study|Withdrawal by Subject|1|||
156831854|NCT02876328|566137537|FG008|Overall Study|Withdrawal by Subject|1|||
156831855|NCT02876328|566137538|FG009|Overall Study|Withdrawal by Subject|2|||
156831856|NCT02876328|566137539|FG010|Overall Study|Withdrawal by Subject|0|||
156831857|NCT02876328|566137540|FG011|Overall Study|Withdrawal by Subject|0|||
156831858|NCT02876328|566137541|FG012|Overall Study|Withdrawal by Subject|0|||
156831859|NCT02876328|566137542|FG013|Overall Study|Withdrawal by Subject|0|||
156831860|NCT02876328|566137543|FG014|Overall Study|Withdrawal by Subject|0|||
156831861|NCT02876328|566137544|FG015|Overall Study|Withdrawal by Subject|0|||
156831862|NCT02876328|566137545|FG016|Overall Study|Withdrawal by Subject|1|||
156831863|NCT02876328|566137546|FG017|Overall Study|Withdrawal by Subject|3|||
156831864|NCT02876328|566137547|FG018|Overall Study|Withdrawal by Subject|0|||
156831865|NCT02876328|566137548|FG019|Overall Study|Withdrawal by Subject|0|||
156831866|NCT02876328|566137549|FG020|Overall Study|Withdrawal by Subject|1|||
156831867|NCT02876328|566137550|FG021|Overall Study|Withdrawal by Subject|0|||
156831868|NCT02876328|566137551|FG022|Overall Study|Withdrawal by Subject|0|||
156831869|NCT02876328|566137552|FG023|Overall Study|Withdrawal by Subject|0|||
156831870|NCT02876328|566137529|FG000|Overall Study|Missed 12 Month Visit|15|||
156831871|NCT02876328|566137530|FG001|Overall Study|Missed 12 Month Visit|10|||
156831872|NCT02876328|566137531|FG002|Overall Study|Missed 12 Month Visit|11|||
156831873|NCT02876328|566137532|FG003|Overall Study|Missed 12 Month Visit|6|||
156831874|NCT02876328|566137533|FG004|Overall Study|Missed 12 Month Visit|10|||
156831875|NCT02876328|566137534|FG005|Overall Study|Missed 12 Month Visit|14|||
156831876|NCT02876328|566137535|FG006|Overall Study|Missed 12 Month Visit|3|||
156831877|NCT02876328|566137536|FG007|Overall Study|Missed 12 Month Visit|8|||
156831878|NCT02876328|566137537|FG008|Overall Study|Missed 12 Month Visit|9|||
156831879|NCT02876328|566137538|FG009|Overall Study|Missed 12 Month Visit|5|||
156831880|NCT02876328|566137539|FG010|Overall Study|Missed 12 Month Visit|4|||
156831881|NCT02876328|566137540|FG011|Overall Study|Missed 12 Month Visit|1|||
156831882|NCT02876328|566137541|FG012|Overall Study|Missed 12 Month Visit|5|||
156831883|NCT02876328|566137542|FG013|Overall Study|Missed 12 Month Visit|4|||
156831884|NCT02876328|566137543|FG014|Overall Study|Missed 12 Month Visit|4|||
156831885|NCT02876328|566137544|FG015|Overall Study|Missed 12 Month Visit|4|||
157151426|NCT00859898|567299683|FG002|Overall Study|Withdrawal by Subject|11|||
156831886|NCT02876328|566137545|FG016|Overall Study|Missed 12 Month Visit|3|||
156831887|NCT02876328|566137546|FG017|Overall Study|Missed 12 Month Visit|6|||
156831888|NCT02876328|566137547|FG018|Overall Study|Missed 12 Month Visit|2|||
156831889|NCT02876328|566137548|FG019|Overall Study|Missed 12 Month Visit|2|||
156831890|NCT02876328|566137549|FG020|Overall Study|Missed 12 Month Visit|11|||
156831891|NCT02876328|566137550|FG021|Overall Study|Missed 12 Month Visit|7|||
156831892|NCT02876328|566137551|FG022|Overall Study|Missed 12 Month Visit|1|||
156831893|NCT02876328|566137552|FG023|Overall Study|Missed 12 Month Visit|0|||
156831894|NCT01287195|566137553|FG000|Overall Study|Withdrawal by Subject|2|||
156831895|NCT00334282|566137561|FG000|Overall Study|Lost to Follow-up|11|||
156831896|NCT00334282|566137562|FG001|Overall Study|Lost to Follow-up|5|||
156831897|NCT00334282|566137561|FG000|Overall Study|Withdrawal by Subject|17|||
156831898|NCT00334282|566137562|FG001|Overall Study|Withdrawal by Subject|3|||
156831899|NCT00334282|566137561|FG000|Overall Study|Death|194|||
156831900|NCT00334282|566137562|FG001|Overall Study|Death|100|||
156831901|NCT01420627|566137563|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
156831902|NCT00837876|566137564|FG000|Overall Study|Death|2|||
156831903|NCT00837876|566137564|FG000|Overall Study|Adverse Event|7|||
156831904|NCT00837876|566137564|FG000|Overall Study|Physician Decision|1|||
156831905|NCT00837876|566137564|FG000|Overall Study|Withdrawal by Subject|3|||
156831906|NCT00837876|566137564|FG000|Overall Study|disease progression|24|||
156831907|NCT00276094|566137567|FG000|Overall Study|Adverse Event|15|||
156831908|NCT00276094|566137568|FG001|Overall Study|Adverse Event|13|||
156831909|NCT00276094|566137569|FG002|Overall Study|Adverse Event|11|||
156831910|NCT00276094|566137567|FG000|Overall Study|Withdrawal by Subject|14|||
156831911|NCT00276094|566137568|FG001|Overall Study|Withdrawal by Subject|14|||
156831912|NCT00276094|566137569|FG002|Overall Study|Withdrawal by Subject|12|||
156831913|NCT00276094|566137567|FG000|Overall Study|Protocol Violation|16|||
156831914|NCT00276094|566137568|FG001|Overall Study|Protocol Violation|7|||
156831915|NCT00276094|566137569|FG002|Overall Study|Protocol Violation|10|||
156831916|NCT00276094|566137567|FG000|Overall Study|Lost to Follow-up|8|||
156831917|NCT00276094|566137568|FG001|Overall Study|Lost to Follow-up|6|||
156831918|NCT00276094|566137569|FG002|Overall Study|Lost to Follow-up|4|||
156831919|NCT00276094|566137567|FG000|Overall Study|Other-Subject moved out of country|1|||
156831920|NCT00276094|566137568|FG001|Overall Study|Other-Subject moved out of country|0|||
156831921|NCT00276094|566137569|FG002|Overall Study|Other-Subject moved out of country|0|||
156831922|NCT00276094|566137567|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
156831923|NCT00276094|566137568|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
156831924|NCT00276094|566137569|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
156831925|NCT00276094|566137567|FG000|Overall Study|Other-Lack of efficacy|1|||
156831926|NCT00276094|566137568|FG001|Overall Study|Other-Lack of efficacy|0|||
156831927|NCT00276094|566137569|FG002|Overall Study|Other-Lack of efficacy|0|||
156831928|NCT00276094|566137567|FG000|Overall Study|Other-Refused follow-up visit|1|||
156831929|NCT00276094|566137568|FG001|Overall Study|Other-Refused follow-up visit|0|||
156831930|NCT00276094|566137569|FG002|Overall Study|Other-Refused follow-up visit|0|||
156831931|NCT00276094|566137567|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
156831932|NCT00276094|566137568|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
156831933|NCT00276094|566137569|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
156831934|NCT00276094|566137567|FG000|Overall Study|Other-Relocation|0|||
156831935|NCT00276094|566137568|FG001|Overall Study|Other-Relocation|1|||
156831936|NCT00276094|566137569|FG002|Overall Study|Other-Relocation|0|||
156831937|NCT00276094|566137567|FG000|Overall Study|Other-Study medication lost|0|||
156831938|NCT00276094|566137568|FG001|Overall Study|Other-Study medication lost|0|||
156831939|NCT00276094|566137569|FG002|Overall Study|Other-Study medication lost|1|||
156831940|NCT02759315|566137576|FG000|Overall Study|Adverse Event|0|||
156831941|NCT02759315|566137577|FG001|Overall Study|Adverse Event|0|||
156831942|NCT02759315|566137578|FG002|Overall Study|Adverse Event|0|||
156831943|NCT02759315|566137579|FG003|Overall Study|Adverse Event|1|||
156831944|NCT02759315|566137580|FG004|Overall Study|Adverse Event|0|||
156831945|NCT02759315|566137576|FG000|Overall Study|Death|0|||
156831946|NCT02759315|566137577|FG001|Overall Study|Death|0|||
156831947|NCT02759315|566137578|FG002|Overall Study|Death|1|||
156831948|NCT02759315|566137579|FG003|Overall Study|Death|0|||
156831949|NCT02759315|566137580|FG004|Overall Study|Death|0|||
156831950|NCT02759315|566137576|FG000|Overall Study|Lost to Follow-up|2|||
156831951|NCT02759315|566137577|FG001|Overall Study|Lost to Follow-up|0|||
156831952|NCT02759315|566137578|FG002|Overall Study|Lost to Follow-up|4|||
156831953|NCT02759315|566137579|FG003|Overall Study|Lost to Follow-up|0|||
156831954|NCT02759315|566137580|FG004|Overall Study|Lost to Follow-up|0|||
156831955|NCT02759315|566137576|FG000|Overall Study|Protocol Violation|0|||
156831956|NCT02759315|566137577|FG001|Overall Study|Protocol Violation|1|||
156831957|NCT02759315|566137578|FG002|Overall Study|Protocol Violation|0|||
156831958|NCT02759315|566137579|FG003|Overall Study|Protocol Violation|0|||
156831959|NCT02759315|566137580|FG004|Overall Study|Protocol Violation|0|||
156831960|NCT02759315|566137576|FG000|Overall Study|Study terminated prior to completion|2|||
156831961|NCT02759315|566137577|FG001|Overall Study|Study terminated prior to completion|0|||
156831962|NCT02759315|566137578|FG002|Overall Study|Study terminated prior to completion|5|||
156831963|NCT02759315|566137579|FG003|Overall Study|Study terminated prior to completion|0|||
156831964|NCT02759315|566137580|FG004|Overall Study|Study terminated prior to completion|1|||
156831965|NCT01996592|566137581|FG000|Overall Study|no response to text/no diary entry|32|||
156831966|NCT01996592|566137581|FG000|Overall Study|change in surgical date|4|||
157151427|NCT00859898|567299681|FG000|Overall Study|Death|0|||
157151428|NCT00859898|567299682|FG001|Overall Study|Death|0|||
157151429|NCT00859898|567299683|FG002|Overall Study|Death|1|||
157151430|NCT00859898|567299681|FG000|Overall Study|Lost to Follow-up|10|||
156831967|NCT01996592|566137581|FG000|Overall Study|Withdrawal by Subject|5|||
156831968|NCT01996592|566137581|FG000|Overall Study|change in mode of delivery|4|||
157151431|NCT00859898|567299682|FG001|Overall Study|Lost to Follow-up|11|||
156831969|NCT01406015|566137582|FG000|Overall Study|Withdrawal by Subject|3|||
156831970|NCT01406015|566137583|FG001|Overall Study|Withdrawal by Subject|3|||
156831971|NCT00787137|566137584|FG000|Overall Study|Study Termination|0|||
156831972|NCT00787137|566137585|FG001|Overall Study|Study Termination|0|||
156831973|NCT00787137|566137586|FG002|Overall Study|Study Termination|1|||
156831974|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
156831975|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
156831976|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
156831977|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
156831978|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
156831979|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
156831980|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156831981|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156831982|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
156831983|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
156831984|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
156831985|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
156831986|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
156831987|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
156831988|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
156831989|NCT00554099|566137590|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156831990|NCT00554099|566137591|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156831991|NCT00554099|566137592|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156831992|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
156831993|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
156831994|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
156831995|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
156831996|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
156831997|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
156831998|NCT00554099|566137590|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
156831999|NCT00554099|566137591|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
156832000|NCT00554099|566137592|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
156832001|NCT03464422|566137593|FG000|Overall Study|Lost to Follow-up|2|||
156832002|NCT03464422|566137593|FG000|Overall Study|Withdrawal by Subject|2|||
156832003|NCT01628367|566137597|FG000|Overall Study|Adverse Event|1|||
156832004|NCT01628367|566137598|FG001|Overall Study|Adverse Event|0|||
156832005|NCT04957758|566137601|FG000|Overall Study|Adverse Event|1|||
156832006|NCT04957758|566137602|FG001|Overall Study|Adverse Event|0|||
156832007|NCT04957758|566137601|FG000|Overall Study|Lost to Follow-up|0|||
156832008|NCT04957758|566137602|FG001|Overall Study|Lost to Follow-up|2|||
156832009|NCT04957758|566137601|FG000|Overall Study|Withdrawal by Subject|4|||
156832010|NCT04957758|566137602|FG001|Overall Study|Withdrawal by Subject|2|||
156832011|NCT04957758|566137601|FG000|Overall Study|Protocol Violation|0|||
156832012|NCT04957758|566137602|FG001|Overall Study|Protocol Violation|1|||
156832013|NCT03353922|566137603|FG000|Overall Study|Withdrawal by Subject|1|||
156832014|NCT03353922|566137604|FG001|Overall Study|Withdrawal by Subject|0|||
156832015|NCT03353922|566137605|FG002|Overall Study|Withdrawal by Subject|1|||
156832016|NCT03353922|566137606|FG003|Overall Study|Withdrawal by Subject|1|||
156832017|NCT03353922|566137607|FG004|Overall Study|Withdrawal by Subject|0|||
156832018|NCT03353922|566137608|FG005|Overall Study|Withdrawal by Subject|0|||
156832019|NCT03353922|566137603|FG000|Overall Study|Adverse Event|0|||
156832020|NCT03353922|566137604|FG001|Overall Study|Adverse Event|1|||
156832021|NCT03353922|566137605|FG002|Overall Study|Adverse Event|0|||
156832022|NCT03353922|566137606|FG003|Overall Study|Adverse Event|0|||
156832023|NCT03353922|566137607|FG004|Overall Study|Adverse Event|0|||
156832024|NCT03353922|566137608|FG005|Overall Study|Adverse Event|0|||
156832025|NCT03688555|566137609|FG000|Treatment Period|Adverse Event|0|||
157151432|NCT00859898|567299683|FG002|Overall Study|Lost to Follow-up|5|||
156832026|NCT03688555|566137610|FG001|Treatment Period|Adverse Event|0|||
156832027|NCT03688555|566137611|FG002|Treatment Period|Adverse Event|1|||
156832028|NCT00886119|566137614|FG000|Period 1|Did not meet inclusion criteria|1|||
156832029|NCT00886119|566137615|FG001|Period 1|Did not meet inclusion criteria|0|||
156832030|NCT00357656|566137616|FG000|Overall Study|Other, No surgery performed|0|||
156832031|NCT00357656|566137617|FG001|Overall Study|Other, No surgery performed|3|||
156832032|NCT02256267|566137618|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
156832033|NCT02256267|566137618|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
156832034|NCT01685983|566137619|FG000|Overall Study|Adverse Event|7|||
157151433|NCT00859898|567299681|FG000|Overall Study|poor/non-compliance|2|||
157151434|NCT00859898|567299682|FG001|Overall Study|poor/non-compliance|0|||
157151435|NCT00859898|567299683|FG002|Overall Study|poor/non-compliance|0|||
156832035|NCT01685983|566137619|FG000|Overall Study|Death|1|||
156832036|NCT01685983|566137619|FG000|Overall Study|Withdrawal by Subject|19|||
156832037|NCT01685983|566137619|FG000|Overall Study|Protocol Violation|2|||
156832038|NCT01685983|566137619|FG000|Overall Study|Physician Decision|13|||
156832039|NCT01685983|566137619|FG000|Overall Study|Other|7|||
156832040|NCT01685983|566137619|FG000|Overall Study|Progressive Disease|32|||
156832041|NCT01685983|566137619|FG000|Overall Study|Noncompliance with Study Drug|1|||
156832042|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
156832043|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
156832044|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
156832045|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
156832046|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
156832047|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
156832048|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
156832049|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
156832050|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
156832051|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
156832052|NCT01352741|566137626|FG000|Open-label Tapentadol Titration Period|Other|4|||
156832053|NCT01352741|566137627|FG001|Open-label Tapentadol Titration Period|Other|0|||
156832054|NCT01352741|566137626|FG000|Double-blind Comparative Period|Protocol Violation|2|||
156832055|NCT01352741|566137627|FG001|Double-blind Comparative Period|Protocol Violation|0|||
156832056|NCT01352741|566137626|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
156832057|NCT01352741|566137627|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
156832058|NCT01352741|566137626|FG000|Double-blind Comparative Period|Adverse Event|16|||
156832059|NCT01352741|566137627|FG001|Double-blind Comparative Period|Adverse Event|17|||
156832060|NCT01352741|566137626|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
156832061|NCT01352741|566137627|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
156832062|NCT01352741|566137626|FG000|Double-blind Comparative Period|Death|0|||
156832063|NCT01352741|566137627|FG001|Double-blind Comparative Period|Death|1|||
156832064|NCT01352741|566137626|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
157023400|NCT02677298|566841032|FG001|Open Label Phase|Adverse Event|0|||
157023401|NCT02677298|566841033|FG002|Open Label Phase|Adverse Event|4|||
157023402|NCT02677298|566841031|FG000|Open Label Phase|Physician Decision|0|||
157023403|NCT02677298|566841032|FG001|Open Label Phase|Physician Decision|0|||
157023404|NCT02677298|566841033|FG002|Open Label Phase|Physician Decision|1|||
157023405|NCT02677298|566841031|FG000|Open Label Phase|Lost to Follow-up|0|||
157023406|NCT02677298|566841032|FG001|Open Label Phase|Lost to Follow-up|0|||
157023407|NCT02677298|566841033|FG002|Open Label Phase|Lost to Follow-up|17|||
157023408|NCT02677298|566841031|FG000|Open Label Phase|Withdrawal by Subject|0|||
157023409|NCT02677298|566841032|FG001|Open Label Phase|Withdrawal by Subject|0|||
157023410|NCT02677298|566841033|FG002|Open Label Phase|Withdrawal by Subject|38|||
157023411|NCT03812679|566841035|FG000|Overall Study|Adverse Event|2|||
157023412|NCT03812679|566841035|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
157023413|NCT03812679|566841035|FG000|Overall Study|Renal transplant|1|||
157023414|NCT03812679|566841035|FG000|Overall Study|Withdrawal by Subject|1|||
157023415|NCT03812679|566841035|FG000|Overall Study|Termination of study|2|||
157023416|NCT03812679|566841035|FG000|Overall Study|Water device replacement|1|||
157023417|NCT03953508|566841036|FG000|Baseline|Lost to Follow-up|3|||
157023418|NCT03953508|566841037|FG001|Baseline|Lost to Follow-up|2|||
157023419|NCT03953508|566841036|FG000|6-month Follow-up|Lost to Follow-up|62|||
157023420|NCT03953508|566841037|FG001|6-month Follow-up|Lost to Follow-up|70|||
157151436|NCT00859898|567299681|FG000|Overall Study|No longer meets criteria|0|||
157151437|NCT00859898|567299682|FG001|Overall Study|No longer meets criteria|1|||
156832065|NCT01352741|566137627|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
156832066|NCT01352741|566137626|FG000|Double-blind Comparative Period|Other|1|||
156832067|NCT01352741|566137627|FG001|Double-blind Comparative Period|Other|2|||
156832068|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
156832069|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
156832070|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
156832071|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
157023421|NCT03771417|566841038|FG000|Overall Study|Withdrawal by Subject|1|||
157023422|NCT03771417|566841039|FG001|Overall Study|Withdrawal by Subject|0|||
157023423|NCT03771417|566841040|FG002|Overall Study|Withdrawal by Subject|0|||
157023424|NCT03771417|566841038|FG000|Overall Study|Covid-19 Shutdown|0|||
157023425|NCT03771417|566841039|FG001|Overall Study|Covid-19 Shutdown|1|||
157023426|NCT03771417|566841040|FG002|Overall Study|Covid-19 Shutdown|0|||
157023427|NCT04456517|566841041|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
157023428|NCT04456517|566841042|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
157151438|NCT00859898|567299683|FG002|Overall Study|No longer meets criteria|0|||
157151439|NCT00859898|567299681|FG000|Overall Study|non-specified|1|||
157023429|NCT02100813|566841043|FG000|Overall Study|Adverse Event|0|||
157023430|NCT02100813|566841044|FG001|Overall Study|Adverse Event|0|||
157023431|NCT02100813|566841045|FG002|Overall Study|Adverse Event|0|||
157023432|NCT02100813|566841046|FG003|Overall Study|Adverse Event|0|||
157023433|NCT02100813|566841047|FG004|Overall Study|Adverse Event|0|||
157151440|NCT00859898|567299682|FG001|Overall Study|non-specified|1|||
157151441|NCT00859898|567299683|FG002|Overall Study|non-specified|1|||
157151442|NCT03215264|567299685|FG000|Dose Level 2|Adverse Event|0|||
157151443|NCT03215264|567299686|FG001|Dose Level 2|Adverse Event|1|||
157151444|NCT03215264|567299687|FG002|Dose Level 2|Adverse Event|0|||
157151445|NCT03215264|567299685|FG000|Dose Level 3|Withdrawal by Subject|0|||
157151446|NCT03215264|567299686|FG001|Dose Level 3|Withdrawal by Subject|0|||
157151447|NCT03215264|567299687|FG002|Dose Level 3|Withdrawal by Subject|1|||
157151448|NCT02145156|567299688|FG000|Overall Study|No match to vaccination records|60|||
157151449|NCT02145156|567299689|FG001|Overall Study|No match to vaccination records|52|||
157151450|NCT02145156|567299690|FG002|Overall Study|No match to vaccination records|41|||
157151451|NCT03408873|567299692|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
157151452|NCT03408873|567299692|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
157151453|NCT03408873|567299692|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
156832072|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
156832073|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
156832074|NCT01352741|566137626|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
156832075|NCT01352741|566137627|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
156832076|NCT00259298|566137628|FG000|Overall Study|Withdrawal by Subject|1|||
156832077|NCT00259298|566137628|FG000|Overall Study|Physician Decision|2|||
156832078|NCT00645528|566137631|FG000|Overall Study|Did not show up for Visit 2|7|||
156832079|NCT03077698|566137633|FG000|Progestin Monotherapy|Stable Disease|8|||
156832080|NCT03077698|566137634|FG001|Progestin Monotherapy|Stable Disease|0|||
156832081|NCT03077698|566137633|FG000|Progestin Monotherapy|Adverse Event|1|||
156832082|NCT03077698|566137634|FG001|Progestin Monotherapy|Adverse Event|0|||
156832083|NCT03077698|566137633|FG000|Progestin Monotherapy|Death|1|||
156832084|NCT03077698|566137634|FG001|Progestin Monotherapy|Death|0|||
156832085|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
156832086|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
156832087|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
156832088|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
156832089|NCT03077698|566137633|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
156832090|NCT03077698|566137634|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
156832091|NCT03077698|566137633|FG000|Safety Follow Up|Withdrawal by Subject|2|||
156832092|NCT03077698|566137634|FG001|Safety Follow Up|Withdrawal by Subject|1|||
156832093|NCT03077698|566137633|FG000|Safety Follow Up|Transfer of care to hospice|1|||
156832094|NCT03077698|566137634|FG001|Safety Follow Up|Transfer of care to hospice|0|||
156832095|NCT01886690|566137635|FG000|Overall Study|Protocol Violation|0|||
156832096|NCT01886690|566137636|FG001|Overall Study|Protocol Violation|1|||
156832097|NCT01886690|566137635|FG000|Overall Study|Personal Reasons|0|||
156832098|NCT01886690|566137636|FG001|Overall Study|Personal Reasons|1|||
156832099|NCT01011933|566137637|FG000|Overall Study|Wrong cell type|1|||
156832100|NCT01011933|566137637|FG000|Overall Study|Improper pre-protocol Rx|1|||
156832101|NCT01011933|566137637|FG000|Overall Study|Inadequate pathology|1|||
156832102|NCT01011933|566137637|FG000|Overall Study|Never treated|1|||
156832103|NCT03461406|566137638|FG000|Overall Study|Death|1|||
156832104|NCT03461406|566137639|FG001|Overall Study|Death|2|||
156832105|NCT03461406|566137638|FG000|Overall Study|Consent Withdrawn by Participant|0|||
156832106|NCT03461406|566137639|FG001|Overall Study|Consent Withdrawn by Participant|1|||
157023434|NCT02100813|566841048|FG005|Overall Study|Adverse Event|0|||
157023435|NCT02100813|566841049|FG006|Overall Study|Adverse Event|0|||
157151454|NCT03408873|567299692|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
157151455|NCT03408873|567299692|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
157151456|NCT03408873|567299692|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
157151457|NCT01469013|567299694|FG000|Part A (Treatment Period)|Adverse Event|1|||
157151458|NCT01469013|567299695|FG001|Part A (Treatment Period)|Adverse Event|0|||
157151459|NCT01469013|567299696|FG002|Part A (Treatment Period)|Adverse Event|0|||
157151460|NCT01469013|567299697|FG003|Part A (Treatment Period)|Adverse Event|0|||
157151461|NCT01469013|567299698|FG004|Part A (Treatment Period)|Adverse Event|1|||
157151462|NCT01469013|567299699|FG005|Part A (Treatment Period)|Adverse Event|0|||
156832107|NCT03461406|566137638|FG000|Overall Study|Screen Failure|3|||
156832108|NCT03461406|566137639|FG001|Overall Study|Screen Failure|1|||
156832109|NCT03461406|566137638|FG000|Overall Study|Reason not Specified|1|||
156832110|NCT03461406|566137639|FG001|Overall Study|Reason not Specified|3|||
156832111|NCT03461406|566137638|FG000|Overall Study|Lost to Follow-up|3|||
156832112|NCT03461406|566137639|FG001|Overall Study|Lost to Follow-up|0|||
156832113|NCT01439074|566137640|FG000|Overall Study|Lost to Follow-up|3|||
156832114|NCT01439074|566137641|FG001|Overall Study|Lost to Follow-up|4|||
156832115|NCT01439074|566137640|FG000|Overall Study|Subject shedding|1|||
157151463|NCT01469013|567299700|FG006|Part A (Treatment Period)|Adverse Event|0|||
157151464|NCT01469013|567299701|FG007|Part A (Treatment Period)|Adverse Event|0|||
157151465|NCT01469013|567299702|FG008|Part A (Treatment Period)|Adverse Event|0|||
157151466|NCT01469013|567299703|FG009|Part A (Treatment Period)|Adverse Event|0|||
156832116|NCT01439074|566137641|FG001|Overall Study|Subject shedding|0|||
156832117|NCT01439074|566137640|FG000|Overall Study|Withdrawal by Subject|1|||
156832118|NCT01439074|566137641|FG001|Overall Study|Withdrawal by Subject|5|||
156832119|NCT01439074|566137640|FG000|Overall Study|Other|4|||
156832120|NCT01439074|566137641|FG001|Overall Study|Other|4|||
156832121|NCT01140568|566137642|FG000|Overall Study|disease progression|31|||
156885215|NCT02353143|566338239|FG000|Overall Study|reason not specified|1|||
156885216|NCT02353143|566338240|FG001|Overall Study|reason not specified|2|||
156885217|NCT02353143|566338241|FG002|Overall Study|reason not specified|0|||
156885218|NCT02353143|566338242|FG003|Overall Study|reason not specified|0|||
156885219|NCT02353143|566338243|FG004|Overall Study|reason not specified|6|||
156885220|NCT02353143|566338244|FG005|Overall Study|reason not specified|1|||
156885221|NCT02353143|566338245|FG006|Overall Study|reason not specified|0|||
156885222|NCT02353143|566338246|FG007|Overall Study|reason not specified|3|||
156885223|NCT02353143|566338247|FG008|Overall Study|reason not specified|1|||
156885224|NCT02353143|566338239|FG000|Overall Study|Physician Decision|0|||
156885225|NCT02353143|566338240|FG001|Overall Study|Physician Decision|4|||
156885226|NCT02353143|566338241|FG002|Overall Study|Physician Decision|2|||
156885227|NCT02353143|566338242|FG003|Overall Study|Physician Decision|3|||
156885228|NCT02353143|566338243|FG004|Overall Study|Physician Decision|4|||
156885229|NCT02353143|566338244|FG005|Overall Study|Physician Decision|0|||
156885230|NCT02353143|566338245|FG006|Overall Study|Physician Decision|1|||
156885231|NCT02353143|566338246|FG007|Overall Study|Physician Decision|2|||
156885232|NCT02353143|566338247|FG008|Overall Study|Physician Decision|0|||
156885233|NCT02353143|566338239|FG000|Overall Study|Adverse Event|0|||
156885234|NCT02353143|566338240|FG001|Overall Study|Adverse Event|0|||
156885235|NCT02353143|566338241|FG002|Overall Study|Adverse Event|1|||
156885236|NCT02353143|566338242|FG003|Overall Study|Adverse Event|0|||
156885237|NCT02353143|566338243|FG004|Overall Study|Adverse Event|1|||
156885238|NCT02353143|566338244|FG005|Overall Study|Adverse Event|1|||
156885239|NCT02353143|566338245|FG006|Overall Study|Adverse Event|0|||
156885240|NCT02353143|566338246|FG007|Overall Study|Adverse Event|0|||
156885241|NCT02353143|566338247|FG008|Overall Study|Adverse Event|0|||
156885242|NCT02353143|566338239|FG000|Overall Study|patient receiving other treatment for AML|0|||
156885243|NCT02353143|566338240|FG001|Overall Study|patient receiving other treatment for AML|0|||
156885244|NCT02353143|566338241|FG002|Overall Study|patient receiving other treatment for AML|1|||
156885245|NCT02353143|566338242|FG003|Overall Study|patient receiving other treatment for AML|0|||
156885246|NCT02353143|566338243|FG004|Overall Study|patient receiving other treatment for AML|0|||
156885247|NCT02353143|566338244|FG005|Overall Study|patient receiving other treatment for AML|0|||
156885248|NCT02353143|566338245|FG006|Overall Study|patient receiving other treatment for AML|0|||
156885249|NCT02353143|566338246|FG007|Overall Study|patient receiving other treatment for AML|0|||
156885250|NCT02353143|566338247|FG008|Overall Study|patient receiving other treatment for AML|0|||
156885251|NCT02353143|566338239|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156885252|NCT02353143|566338240|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
157023436|NCT02100813|566841050|FG007|Overall Study|Adverse Event|1|||
157023437|NCT01186367|566841051|FG000|Overall Study|Lost to Follow-up|7|||
157023438|NCT01186367|566841052|FG001|Overall Study|Lost to Follow-up|4|||
157023439|NCT01186367|566841053|FG002|Overall Study|Lost to Follow-up|7|||
157023440|NCT01186367|566841051|FG000|Overall Study|Did not receive study treatment|0|||
157023441|NCT01186367|566841052|FG001|Overall Study|Did not receive study treatment|1|||
157023442|NCT01186367|566841053|FG002|Overall Study|Did not receive study treatment|0|||
157023443|NCT02577835|566841055|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
157023444|NCT04749615|566841056|FG000|Overall Study|Lost to Follow-up|6|||
156832122|NCT01140568|566137642|FG000|Overall Study|Withdrawal by Subject|1|||
156832123|NCT01140568|566137642|FG000|Overall Study|Screen Fail|4|||
156832124|NCT01969500|566137643|FG000|Overall Study|Death|0|||
156832125|NCT01969500|566137644|FG001|Overall Study|Death|1|||
156832126|NCT01969500|566137643|FG000|Overall Study|extended hospitalization|1|||
156832127|NCT01969500|566137644|FG001|Overall Study|extended hospitalization|1|||
156832128|NCT00815191|566137645|FG000|Overall Study|Protocol Violation|1|||
156832129|NCT00815191|566137646|FG001|Overall Study|Protocol Violation|1|||
156832130|NCT02463032|566137650|FG000|Overall Study|Lack of Efficacy|61|||
156832131|NCT02463032|566137651|FG001|Overall Study|Lack of Efficacy|50|||
156832132|NCT02463032|566137650|FG000|Overall Study|Death|8|||
156832133|NCT02463032|566137651|FG001|Overall Study|Death|8|||
156832134|NCT02463032|566137650|FG000|Overall Study|Adverse Event|2|||
157151467|NCT01469013|567299704|FG010|Part A (Treatment Period)|Adverse Event|0|||
157151468|NCT01469013|567299705|FG011|Part A (Treatment Period)|Adverse Event|0|||
156832135|NCT02463032|566137651|FG001|Overall Study|Adverse Event|6|||
156832136|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
156832137|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
156885253|NCT02353143|566338241|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156885254|NCT02353143|566338242|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
156885255|NCT02353143|566338243|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
156885256|NCT02353143|566338244|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
156885257|NCT02353143|566338245|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156832138|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
156832139|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
156832140|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
156832141|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
156832142|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
156832143|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
156832144|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
156832145|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
156832146|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
156832147|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
156832148|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
156832149|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
156832150|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
156832151|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
156832152|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
156832153|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
156832154|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
156832155|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
156832156|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
156832157|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
156832158|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
156832159|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
156832160|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
156832161|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
156832162|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
156832163|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
156832164|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
156832165|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
156832166|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
156832167|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
156832168|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
156832169|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
156832170|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
156832171|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
156832172|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
156832173|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
156832174|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
156832175|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
156832176|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
156832177|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
156832178|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
156832179|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
156832180|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
156832181|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
156832182|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
156832183|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
157224575|NCT00679783|567568038|FG006|Overall Study|Withdrawal by Subject|0|||
157224576|NCT00679783|567568032|FG000|Overall Study|Not Captured|0|||
157224577|NCT00679783|567568033|FG001|Overall Study|Not Captured|0|||
157224578|NCT00679783|567568034|FG002|Overall Study|Not Captured|0|||
157224579|NCT00679783|567568035|FG003|Overall Study|Not Captured|5|||
157224580|NCT00679783|567568036|FG004|Overall Study|Not Captured|0|||
157224581|NCT00679783|567568037|FG005|Overall Study|Not Captured|0|||
157224582|NCT00679783|567568038|FG006|Overall Study|Not Captured|0|||
157224583|NCT00679783|567568032|FG000|Overall Study|Ongoing at data cut-off|2|||
157224584|NCT00679783|567568033|FG001|Overall Study|Ongoing at data cut-off|2|||
156885258|NCT02353143|566338246|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156885259|NCT02353143|566338247|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
157224585|NCT00679783|567568034|FG002|Overall Study|Ongoing at data cut-off|0|||
157224586|NCT00679783|567568035|FG003|Overall Study|Ongoing at data cut-off|9|||
157224587|NCT00679783|567568036|FG004|Overall Study|Ongoing at data cut-off|1|||
157224588|NCT00679783|567568037|FG005|Overall Study|Ongoing at data cut-off|0|||
157224589|NCT00679783|567568038|FG006|Overall Study|Ongoing at data cut-off|0|||
157224590|NCT01485536|567568041|FG000|Overall Study|Withdrawal by Subject|3|||
157224591|NCT01485536|567568041|FG000|Overall Study|Adverse Event|1|||
156832184|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
156832185|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
156832186|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
156832187|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
156832188|NCT02008357|566137653|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
156832189|NCT02008357|566137654|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
156832190|NCT02008357|566137653|FG000|Open-label Extension Period|Adverse Event|8|||
156832191|NCT02008357|566137654|FG001|Open-label Extension Period|Adverse Event|7|||
156832192|NCT02008357|566137653|FG000|Open-label Extension Period|Death|7|||
156832193|NCT02008357|566137654|FG001|Open-label Extension Period|Death|4|||
156832194|NCT02008357|566137653|FG000|Open-label Extension Period|Lack of Efficacy|9|||
156832195|NCT02008357|566137654|FG001|Open-label Extension Period|Lack of Efficacy|5|||
156832196|NCT02008357|566137653|FG000|Open-label Extension Period|Lost to Follow-up|2|||
156832197|NCT02008357|566137654|FG001|Open-label Extension Period|Lost to Follow-up|2|||
156832198|NCT02008357|566137653|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
156832199|NCT02008357|566137654|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
156832200|NCT02008357|566137653|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
156832201|NCT02008357|566137654|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
156832202|NCT02008357|566137653|FG000|Open-label Extension Period|Safety Risk|2|||
156832203|NCT02008357|566137654|FG001|Open-label Extension Period|Safety Risk|1|||
156832204|NCT02008357|566137653|FG000|Open-label Extension Period|Non-Compliance|0|||
156832205|NCT02008357|566137654|FG001|Open-label Extension Period|Non-Compliance|1|||
156832206|NCT02008357|566137653|FG000|Open-label Extension Period|Investigator Recommendation|0|||
156832207|NCT02008357|566137654|FG001|Open-label Extension Period|Investigator Recommendation|1|||
156832208|NCT02008357|566137653|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
156832209|NCT02008357|566137654|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
156832210|NCT02008357|566137653|FG000|Open-label Extension Period|Coordinating Center Request|2|||
156832211|NCT02008357|566137654|FG001|Open-label Extension Period|Coordinating Center Request|4|||
156832212|NCT02008357|566137653|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
156832213|NCT02008357|566137654|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
156832214|NCT02008357|566137653|FG000|Open-label Extension Period|Study Ended|20|||
156832215|NCT02008357|566137654|FG001|Open-label Extension Period|Study Ended|25|||
156832216|NCT02008357|566137653|FG000|Open-label Extension Period|Personal Reasons|0|||
156832217|NCT02008357|566137654|FG001|Open-label Extension Period|Personal Reasons|1|||
156832218|NCT02008357|566137653|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
156832219|NCT02008357|566137654|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
156832220|NCT02008357|566137653|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
156832221|NCT02008357|566137654|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
156832222|NCT02008357|566137653|FG000|Open-label Extension Period|Other|2|||
156832223|NCT02008357|566137654|FG001|Open-label Extension Period|Other|0|||
156832224|NCT02312219|566137656|FG000|Overall Study|Withdrawal by Subject|1|||
156832225|NCT02312219|566137657|FG001|Overall Study|Withdrawal by Subject|2|||
156832226|NCT02312219|566137656|FG000|Overall Study|could not schedule imaging in time|0|||
156832227|NCT02312219|566137657|FG001|Overall Study|could not schedule imaging in time|2|||
156832228|NCT02312219|566137656|FG000|Overall Study|Other|0|||
156832229|NCT02312219|566137657|FG001|Overall Study|Other|1|||
156832230|NCT02312219|566137656|FG000|Overall Study|Not randomized. Ineligible|0|||
156832231|NCT02312219|566137657|FG001|Overall Study|Not randomized. Ineligible|1|||
156832232|NCT01269385|566137658|FG000|Overall Study|Adverse Event|1|||
156832233|NCT01269385|566137659|FG001|Overall Study|Adverse Event|1|||
156832234|NCT01269385|566137660|FG002|Overall Study|Adverse Event|0|||
156832235|NCT01269385|566137661|FG003|Overall Study|Adverse Event|0|||
156832236|NCT01100567|566137663|FG000|Overall Study|Withdrawal by Subject|5|||
156832237|NCT01100567|566137664|FG001|Overall Study|Withdrawal by Subject|8|||
156832238|NCT01100567|566137663|FG000|Overall Study|Early Hospital Discharge|6|||
156832239|NCT01100567|566137664|FG001|Overall Study|Early Hospital Discharge|4|||
156832240|NCT01100567|566137663|FG000|Overall Study|Lost to Follow-up|1|||
156885260|NCT04905498|566338250|FG000|Overall Study|Lost to Follow-up|0|||
156885261|NCT04905498|566338251|FG001|Overall Study|Lost to Follow-up|2|||
156885262|NCT04905498|566338250|FG000|Overall Study|COVID lockdown|1|||
156832241|NCT01100567|566137664|FG001|Overall Study|Lost to Follow-up|2|||
156832242|NCT01100567|566137663|FG000|Overall Study|Physician Decision|0|||
156832243|NCT01100567|566137664|FG001|Overall Study|Physician Decision|1|||
156832244|NCT01100567|566137663|FG000|Overall Study|Deemed ineligible after consent|0|||
156832245|NCT01100567|566137664|FG001|Overall Study|Deemed ineligible after consent|1|||
156832246|NCT01498185|566137665|FG000|Overall Study|Adverse Event|0|||
156832247|NCT01498185|566137666|FG001|Overall Study|Adverse Event|0|||
156832248|NCT01498185|566137667|FG002|Overall Study|Adverse Event|0|||
156832249|NCT01498185|566137668|FG003|Overall Study|Adverse Event|1|||
156832250|NCT01498185|566137669|FG004|Overall Study|Adverse Event|0|||
156832251|NCT01498185|566137665|FG000|Overall Study|Withdrawal by Subject|1|||
156832252|NCT01498185|566137666|FG001|Overall Study|Withdrawal by Subject|1|||
156832253|NCT01498185|566137667|FG002|Overall Study|Withdrawal by Subject|0|||
156832254|NCT01498185|566137668|FG003|Overall Study|Withdrawal by Subject|2|||
156832255|NCT01498185|566137669|FG004|Overall Study|Withdrawal by Subject|1|||
156832256|NCT01498185|566137665|FG000|Overall Study|No longer met criteria, etc|0|||
156832257|NCT01498185|566137666|FG001|Overall Study|No longer met criteria, etc|0|||
156832258|NCT01498185|566137667|FG002|Overall Study|No longer met criteria, etc|0|||
156832259|NCT01498185|566137668|FG003|Overall Study|No longer met criteria, etc|0|||
156832260|NCT01498185|566137669|FG004|Overall Study|No longer met criteria, etc|2|||
156832261|NCT00946322|566137670|FG000|Pre-treatment|participant failure to follow up|1|||
156832262|NCT00946322|566137670|FG000|Post-treatment|participant failure to follow up|2|||
156832263|NCT01453946|566137671|FG000|Overall Study|Did not receive drug for the taper phase|1|||
156832264|NCT01453946|566137671|FG000|Overall Study|Protocol Violation|2|||
156832265|NCT01453946|566137671|FG000|Overall Study|Lack of Efficacy|3|||
156832266|NCT01453946|566137671|FG000|Overall Study|Adverse Event|3|||
156832267|NCT01710527|566137672|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
156832268|NCT01710527|566137673|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
156885263|NCT04905498|566338251|FG001|Overall Study|COVID lockdown|0|||
156885264|NCT02946931|566338254|FG000|Overall Study|Did not require collection of CRFs|588|||
156885265|NCT02946931|566338254|FG000|Overall Study|Other than listed|37|||
156885266|NCT02946931|566338254|FG000|Overall Study|Discharge from hospital|118|||
156885267|NCT02946931|566338254|FG000|Overall Study|Adverse Event|81|||
156885268|NCT02946931|566338254|FG000|Overall Study|CRFs not valid|1|||
156885269|NCT02946931|566338254|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
156885270|NCT03339297|566338255|FG000|Overall Study|Relapse of Hematologic Disease|1|||
156885271|NCT03339297|566338256|FG001|Overall Study|Relapse of Hematologic Disease|0|||
156885272|NCT03339297|566338255|FG000|Overall Study|Death|10|||
156885273|NCT03339297|566338256|FG001|Overall Study|Death|7|||
156885274|NCT03339297|566338255|FG000|Overall Study|Hepatic Candidosis|1|||
156885275|NCT03339297|566338256|FG001|Overall Study|Hepatic Candidosis|0|||
156885276|NCT03339297|566338255|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
156885277|NCT03339297|566338256|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
156885278|NCT03339297|566338255|FG000|Overall Study|Consent Withdrawn by Participant|3|||
156885279|NCT03339297|566338256|FG001|Overall Study|Consent Withdrawn by Participant|3|||
156885280|NCT03339297|566338255|FG000|Overall Study|Disease Relapse|2|||
156885281|NCT03339297|566338256|FG001|Overall Study|Disease Relapse|0|||
156885282|NCT03339297|566338255|FG000|Overall Study|Physician Decision|1|||
156885283|NCT03339297|566338256|FG001|Overall Study|Physician Decision|1|||
156885284|NCT03339297|566338255|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
156885285|NCT03339297|566338256|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
156885286|NCT03339297|566338255|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
156885287|NCT03339297|566338256|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
156885288|NCT03339297|566338255|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
156885289|NCT03339297|566338256|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
156885290|NCT03339297|566338255|FG000|Overall Study|Adverse Event, Non-fatal|1|||
156885291|NCT03339297|566338256|FG001|Overall Study|Adverse Event, Non-fatal|0|||
156885292|NCT03339297|566338255|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
156885293|NCT03339297|566338256|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
156885294|NCT03339297|566338255|FG000|Overall Study|Patient Was Not Eligible|1|||
156885295|NCT03339297|566338256|FG001|Overall Study|Patient Was Not Eligible|0|||
156885296|NCT01566214|566338263|FG000|Overall Study|Lost to Follow-up|3|||
156885297|NCT01566214|566338264|FG001|Overall Study|Lost to Follow-up|0|||
156885298|NCT03051620|566338265|FG000|Overall Study|Lost to Follow-up|6|||
156885299|NCT03051620|566338265|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
156885300|NCT00393510|566338266|FG000|Overall Study|Physician Decision|3|||
156885301|NCT00393510|566338267|FG001|Overall Study|Physician Decision|9|||
157151469|NCT01469013|567299706|FG012|Part A (Treatment Period)|Adverse Event|0|||
156832269|NCT01688921|566137675|FG000|Overall Study|Lost to Follow-up|7|||
156832270|NCT01688921|566137676|FG001|Overall Study|Lost to Follow-up|13|||
156885302|NCT00770146|566338270|FG000|Treatment Period|Withdrawal by Subject|6|||
156885303|NCT00770146|566338271|FG001|Treatment Period|Withdrawal by Subject|13|||
156885304|NCT00770146|566338270|FG000|Treatment Period|Adverse Event|2|||
156885305|NCT00770146|566338271|FG001|Treatment Period|Adverse Event|26|||
156885306|NCT00770146|566338270|FG000|Treatment Period|Other|1|||
156885307|NCT00770146|566338271|FG001|Treatment Period|Other|5|||
156832271|NCT01688921|566137675|FG000|Overall Study|Physician Decision|6|||
156885308|NCT00770146|566338270|FG000|Treatment Period|Protocol non-compliance|0|||
156885309|NCT00770146|566338271|FG001|Treatment Period|Protocol non-compliance|1|||
156885310|NCT00770146|566338270|FG000|Follow-up Period|Withdrawal by Subject|7|||
156885311|NCT00770146|566338271|FG001|Follow-up Period|Withdrawal by Subject|13|||
157023445|NCT04749615|566841057|FG001|Overall Study|Lost to Follow-up|10|||
156832272|NCT01688921|566137676|FG001|Overall Study|Physician Decision|1|||
157023446|NCT03611491|566841058|FG000|Overall Study|Lost to Follow-up|1|||
156832273|NCT01688921|566137675|FG000|Overall Study|Protocol Violation|0|||
156832274|NCT01688921|566137676|FG001|Overall Study|Protocol Violation|1|||
156832275|NCT01688921|566137675|FG000|Overall Study|informed consent|3|||
156832276|NCT01688921|566137676|FG001|Overall Study|informed consent|0|||
156832277|NCT03697993|566137679|FG000|Overall Study|Became Ineligible after Enrollment|1|||
156832278|NCT03697993|566137680|FG001|Overall Study|Became Ineligible after Enrollment|3|||
156832279|NCT03697993|566137679|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
156832280|NCT03697993|566137680|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
156832281|NCT03697993|566137679|FG000|Overall Study|Lost to Follow-up|3|||
156832282|NCT03697993|566137680|FG001|Overall Study|Lost to Follow-up|0|||
156832283|NCT03697993|566137679|FG000|Overall Study|Physician Decision|4|||
156832284|NCT03697993|566137680|FG001|Overall Study|Physician Decision|0|||
156832285|NCT03697993|566137679|FG000|Overall Study|Initial Urine Culture Negative|0|||
156832286|NCT03697993|566137680|FG001|Overall Study|Initial Urine Culture Negative|1|||
156832287|NCT04384107|566137681|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
156832288|NCT04384107|566137682|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156832289|NCT04384107|566137681|FG000|Overall Study|Lost to Follow-up|1|||
156832290|NCT04384107|566137682|FG001|Overall Study|Lost to Follow-up|0|||
156832291|NCT02739321|566137683|FG000|Overall Study|Lack of Efficacy|1|||
156832292|NCT02739321|566137684|FG001|Overall Study|Lack of Efficacy|1|||
156832293|NCT02739321|566137683|FG000|Overall Study|Lost to Follow-up|1|||
156832294|NCT02739321|566137684|FG001|Overall Study|Lost to Follow-up|1|||
156832295|NCT02739321|566137683|FG000|Overall Study|Withdrawal by Subject|1|||
156832296|NCT02739321|566137684|FG001|Overall Study|Withdrawal by Subject|2|||
156832297|NCT01999218|566137688|FG000|Overall Study|Hyperglycemia|18|||
156832298|NCT01999218|566137689|FG001|Overall Study|Hyperglycemia|17|||
156832299|NCT01999218|566137690|FG002|Overall Study|Hyperglycemia|17|||
156832300|NCT01999218|566137688|FG000|Overall Study|Lack of Efficacy|1|||
156832301|NCT01999218|566137689|FG001|Overall Study|Lack of Efficacy|0|||
156832302|NCT01999218|566137690|FG002|Overall Study|Lack of Efficacy|1|||
156832303|NCT01999218|566137688|FG000|Overall Study|Lost to Follow-up|22|||
156832304|NCT01999218|566137689|FG001|Overall Study|Lost to Follow-up|17|||
156832305|NCT01999218|566137690|FG002|Overall Study|Lost to Follow-up|18|||
156832306|NCT01999218|566137688|FG000|Overall Study|Non-Compliance With Study Drug|6|||
156832307|NCT01999218|566137689|FG001|Overall Study|Non-Compliance With Study Drug|4|||
156832308|NCT01999218|566137690|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156832309|NCT01999218|566137688|FG000|Overall Study|Physician Decision|1|||
156832310|NCT01999218|566137689|FG001|Overall Study|Physician Decision|4|||
156832311|NCT01999218|566137690|FG002|Overall Study|Physician Decision|6|||
156832312|NCT01999218|566137688|FG000|Overall Study|Protocol Violation|4|||
156832313|NCT01999218|566137689|FG001|Overall Study|Protocol Violation|5|||
156832314|NCT01999218|566137690|FG002|Overall Study|Protocol Violation|4|||
156832315|NCT01999218|566137688|FG000|Overall Study|Screen failure|0|||
156832316|NCT01999218|566137689|FG001|Overall Study|Screen failure|1|||
156832317|NCT01999218|566137690|FG002|Overall Study|Screen failure|0|||
156832318|NCT01999218|566137688|FG000|Overall Study|Study Terminated By Sponsor|7|||
156832319|NCT01999218|566137689|FG001|Overall Study|Study Terminated By Sponsor|5|||
156832320|NCT01999218|566137690|FG002|Overall Study|Study Terminated By Sponsor|12|||
156832321|NCT01999218|566137688|FG000|Overall Study|Participant moves|2|||
156832322|NCT01999218|566137689|FG001|Overall Study|Participant moves|5|||
156832323|NCT01999218|566137690|FG002|Overall Study|Participant moves|3|||
156832324|NCT01999218|566137688|FG000|Overall Study|Withdrawal by Subject|28|||
156832325|NCT01999218|566137689|FG001|Overall Study|Withdrawal by Subject|29|||
156832326|NCT01999218|566137690|FG002|Overall Study|Withdrawal by Subject|34|||
156832327|NCT01999218|566137688|FG000|Overall Study|Creatinine/eGFR|0|||
156832328|NCT01999218|566137689|FG001|Overall Study|Creatinine/eGFR|0|||
156832329|NCT01999218|566137690|FG002|Overall Study|Creatinine/eGFR|1|||
156832330|NCT01999218|566137688|FG000|Overall Study|Death|7|||
156832331|NCT01999218|566137689|FG001|Overall Study|Death|1|||
156832332|NCT01999218|566137690|FG002|Overall Study|Death|2|||
156832333|NCT01999218|566137688|FG000|Overall Study|Excluded Medication|1|||
156832334|NCT01999218|566137689|FG001|Overall Study|Excluded Medication|1|||
156832335|NCT01999218|566137690|FG002|Overall Study|Excluded Medication|2|||
156832336|NCT01999218|566137688|FG000|Overall Study|Adverse Event|9|||
156832337|NCT01999218|566137689|FG001|Overall Study|Adverse Event|7|||
156832338|NCT01999218|566137690|FG002|Overall Study|Adverse Event|7|||
156832339|NCT01999218|566137688|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
156832340|NCT01999218|566137689|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
156832341|NCT01999218|566137690|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
156832342|NCT00546260|566137693|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
156832343|NCT00546260|566137694|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
156832344|NCT03780959|566137695|FG000|Part 1|Adverse Event|1|||
156832345|NCT03780959|566137696|FG001|Part 1|Adverse Event|0|||
156832346|NCT03780959|566137697|FG002|Part 1|Adverse Event|0|||
156832347|NCT03780959|566137695|FG000|Part 1|Withdrawal by Subject|1|||
156832348|NCT03780959|566137696|FG001|Part 1|Withdrawal by Subject|0|||
156832349|NCT03780959|566137697|FG002|Part 1|Withdrawal by Subject|0|||
156832350|NCT03780959|566137695|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
157151470|NCT01469013|567299694|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151471|NCT01469013|567299695|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151472|NCT01469013|567299696|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
157151473|NCT01469013|567299697|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151474|NCT01469013|567299698|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151475|NCT01469013|567299699|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151476|NCT01469013|567299700|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151477|NCT01469013|567299701|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151478|NCT01469013|567299702|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151479|NCT01469013|567299703|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151480|NCT01469013|567299704|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151481|NCT01469013|567299705|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151482|NCT01469013|567299706|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
157151483|NCT01469013|567299694|FG000|Part B (Extension Period)|Adverse Event|0|||
157151484|NCT01469013|567299695|FG001|Part B (Extension Period)|Adverse Event|0|||
157151485|NCT01469013|567299696|FG002|Part B (Extension Period)|Adverse Event|0|||
157151486|NCT01469013|567299697|FG003|Part B (Extension Period)|Adverse Event|0|||
157151487|NCT01469013|567299698|FG004|Part B (Extension Period)|Adverse Event|0|||
157151488|NCT01469013|567299699|FG005|Part B (Extension Period)|Adverse Event|2|||
157151489|NCT01469013|567299700|FG006|Part B (Extension Period)|Adverse Event|5|||
157151490|NCT01469013|567299701|FG007|Part B (Extension Period)|Adverse Event|5|||
157151491|NCT01469013|567299702|FG008|Part B (Extension Period)|Adverse Event|3|||
157151492|NCT01469013|567299703|FG009|Part B (Extension Period)|Adverse Event|3|||
157151493|NCT01469013|567299704|FG010|Part B (Extension Period)|Adverse Event|1|||
157151494|NCT01469013|567299705|FG011|Part B (Extension Period)|Adverse Event|6|||
157151495|NCT01469013|567299706|FG012|Part B (Extension Period)|Adverse Event|3|||
156832351|NCT03780959|566137696|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
156832352|NCT03780959|566137697|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
156832353|NCT03780959|566137695|FG000|Part 1|Response Status|2|||
156832354|NCT03780959|566137696|FG001|Part 1|Response Status|0|||
156832355|NCT03780959|566137697|FG002|Part 1|Response Status|0|||
157151496|NCT01469013|567299694|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
157151497|NCT01469013|567299695|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
157151498|NCT01469013|567299696|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
157151499|NCT01469013|567299697|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
157151500|NCT01469013|567299698|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
157151501|NCT01469013|567299699|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
157151502|NCT01469013|567299700|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
157151503|NCT01469013|567299701|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
157151504|NCT01469013|567299702|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
157151505|NCT01469013|567299703|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
157151506|NCT01469013|567299704|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
157151507|NCT01469013|567299705|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
157151508|NCT01469013|567299706|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
157151509|NCT05232097|567299707|FG000|Overall Study|Physician Decision|1|||
157151510|NCT01327339|567299710|FG000|Overall Study|Protocol Violation|8|||
157151511|NCT01172288|567299711|FG000|Overall Study|Adverse Event|1|||
157151512|NCT01172288|567299712|FG001|Overall Study|Adverse Event|0|||
156832356|NCT03780959|566137695|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
157151513|NCT01172288|567299711|FG000|Overall Study|Protocol Violation|0|||
157151514|NCT01172288|567299712|FG001|Overall Study|Protocol Violation|1|||
157151515|NCT00871858|567299713|FG000|Overall Study|Protocol Violation|3|||
157151516|NCT00871858|567299714|FG001|Overall Study|Protocol Violation|4|||
157224592|NCT02626949|567568042|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
157224593|NCT02626949|567568043|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
157224594|NCT02626949|567568042|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
157224595|NCT02626949|567568043|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
156832357|NCT03780959|566137696|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
156832358|NCT03780959|566137697|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
156832359|NCT03780959|566137695|FG000|Part 2|Response Status|0|||
156832360|NCT03780959|566137696|FG001|Part 2|Response Status|18|||
156832361|NCT03780959|566137697|FG002|Part 2|Response Status|6|||
156832362|NCT03172130|566139834|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
156832363|NCT03172130|566139835|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
157151517|NCT00871858|567299713|FG000|Overall Study|Adverse Event|1|||
157151518|NCT00871858|567299714|FG001|Overall Study|Adverse Event|1|||
157151519|NCT00871858|567299713|FG000|Overall Study|Withdrawal by Subject|1|||
157151520|NCT00871858|567299714|FG001|Overall Study|Withdrawal by Subject|1|||
157151521|NCT00871858|567299713|FG000|Overall Study|Lost to Follow-up|0|||
157151522|NCT00871858|567299714|FG001|Overall Study|Lost to Follow-up|1|||
157224596|NCT02626949|567568042|FG000|Enrolled|Lost to Follow-up|7|||
157224597|NCT02626949|567568043|FG001|Enrolled|Lost to Follow-up|6|||
156832364|NCT02559414|566139838|FG000|Overall Study|Lost to Follow-up|0|||
156832365|NCT02559414|566139839|FG001|Overall Study|Lost to Follow-up|1|||
156832366|NCT02559414|566139840|FG002|Overall Study|Lost to Follow-up|0|||
156832367|NCT02559414|566139838|FG000|Overall Study|Withdrawal by Subject|1|||
156832368|NCT02559414|566139839|FG001|Overall Study|Withdrawal by Subject|0|||
156832369|NCT02559414|566139840|FG002|Overall Study|Withdrawal by Subject|1|||
156832370|NCT02559414|566139838|FG000|Overall Study|Other|0|||
156832371|NCT02559414|566139839|FG001|Overall Study|Other|1|||
156832372|NCT02559414|566139840|FG002|Overall Study|Other|1|||
156832373|NCT02046070|566139843|FG000|Overall Study|Progressive Disease|18|||
156832374|NCT02046070|566139844|FG001|Overall Study|Progressive Disease|11|||
156832375|NCT02046070|566139845|FG002|Overall Study|Progressive Disease|40|||
156832376|NCT02046070|566139843|FG000|Overall Study|Adverse Event|8|||
156832377|NCT02046070|566139844|FG001|Overall Study|Adverse Event|10|||
156832378|NCT02046070|566139845|FG002|Overall Study|Adverse Event|17|||
156832379|NCT02046070|566139843|FG000|Overall Study|Withdrawal by Subject|1|||
156832380|NCT02046070|566139844|FG001|Overall Study|Withdrawal by Subject|2|||
156832381|NCT02046070|566139845|FG002|Overall Study|Withdrawal by Subject|6|||
156832382|NCT02046070|566139843|FG000|Overall Study|Study Terminated by Sponsor|1|||
156832383|NCT02046070|566139844|FG001|Overall Study|Study Terminated by Sponsor|1|||
156832384|NCT02046070|566139845|FG002|Overall Study|Study Terminated by Sponsor|1|||
156832385|NCT02046070|566139843|FG000|Overall Study|Reason not Specified|4|||
156832386|NCT02046070|566139844|FG001|Overall Study|Reason not Specified|4|||
156832387|NCT02046070|566139845|FG002|Overall Study|Reason not Specified|6|||
156832388|NCT04619004|566139846|FG000|Overall Study|Death|114|||
156832389|NCT04619004|566139847|FG001|Overall Study|Death|28|||
156832390|NCT04619004|566139846|FG000|Overall Study|Lost to Follow-up|1|||
156832391|NCT04619004|566139847|FG001|Overall Study|Lost to Follow-up|1|||
156832392|NCT04619004|566139846|FG000|Overall Study|Withdrawal by Subject|24|||
156832393|NCT04619004|566139847|FG001|Overall Study|Withdrawal by Subject|7|||
156832394|NCT04619004|566139846|FG000|Overall Study|Other - Not specified|0|||
156832395|NCT04619004|566139847|FG001|Overall Study|Other - Not specified|1|||
156832396|NCT03007745|566139849|FG000|Overall Study|Sleep test negative for OSA|53|||
156832397|NCT03007745|566139850|FG001|Overall Study|Sleep test negative for OSA|49|||
156832398|NCT03007745|566139849|FG000|Overall Study|Physician Decision|6|||
156832399|NCT03007745|566139850|FG001|Overall Study|Physician Decision|9|||
156832400|NCT03007745|566139849|FG000|Overall Study|Withdrawal by Subject|38|||
156832401|NCT03007745|566139850|FG001|Overall Study|Withdrawal by Subject|16|||
156832402|NCT03007745|566139849|FG000|Overall Study|Lost to Follow-up|19|||
156832403|NCT03007745|566139850|FG001|Overall Study|Lost to Follow-up|25|||
156832404|NCT03007745|566139849|FG000|Overall Study|Unable to login to website|17|||
156832405|NCT03007745|566139850|FG001|Overall Study|Unable to login to website|4|||
156832406|NCT04912895|566139851|FG000|Overall Study|Unable to provide specimen|2|||
156832407|NCT04912895|566139852|FG001|Overall Study|Unable to provide specimen|0|||
156832408|NCT04912895|566139853|FG002|Overall Study|Unable to provide specimen|0|||
156832409|NCT01145053|566139858|FG000|Overall Study|Adverse Event|22|||
156832410|NCT01145053|566139858|FG000|Overall Study|Lost to Follow-up|28|||
156832411|NCT01145053|566139858|FG000|Overall Study|Withdrawal by Subject|25|||
156832412|NCT01145053|566139858|FG000|Overall Study|Other|18|||
156832413|NCT00293709|566139859|FG000|Overall Study|Other|47|||
156832414|NCT02785458|566139860|FG000|1 Month|Withdrawal by Subject|2|||
156832415|NCT02785458|566139861|FG001|1 Month|Withdrawal by Subject|1|||
156832416|NCT02785458|566139860|FG000|1 Month|Lost to Follow-up|38|||
156832417|NCT02785458|566139861|FG001|1 Month|Lost to Follow-up|31|||
156832418|NCT02785458|566139860|FG000|1 Month|Deemed Ineligible|1|||
156832419|NCT02785458|566139861|FG001|1 Month|Deemed Ineligible|0|||
156832420|NCT02785458|566139860|FG000|1 Month|Completed Evaluation by Baseline|42|||
156832421|NCT02785458|566139861|FG001|1 Month|Completed Evaluation by Baseline|39|||
156832422|NCT02785458|566139860|FG000|1 Month|Partial Interview|0|||
156832423|NCT02785458|566139861|FG001|1 Month|Partial Interview|4|||
156832424|NCT02785458|566139860|FG000|3 Months|Withdrawal by Subject|3|||
156832425|NCT02785458|566139861|FG001|3 Months|Withdrawal by Subject|1|||
156832426|NCT02785458|566139860|FG000|3 Months|Lost to Follow-up|25|||
156832427|NCT02785458|566139861|FG001|3 Months|Lost to Follow-up|21|||
156832428|NCT02785458|566139860|FG000|3 Months|Completed Evaluation at 1 Month|100|||
156832429|NCT02785458|566139861|FG001|3 Months|Completed Evaluation at 1 Month|89|||
156832430|NCT01146652|566139862|FG000|Overall Study|Adverse Event|506|||
156832431|NCT01146652|566139863|FG001|Overall Study|Adverse Event|15|||
156832432|NCT01146652|566139862|FG000|Overall Study|Lack of Efficacy|91|||
156832433|NCT01146652|566139863|FG001|Overall Study|Lack of Efficacy|7|||
157151523|NCT00700752|567299720|FG000|First Intervention|Withdrawal by Subject|0|||
157151524|NCT00700752|567299721|FG001|First Intervention|Withdrawal by Subject|2|||
157151525|NCT01302769|567299722|FG000|Overall Study|Lost to Follow-up|1|||
157151526|NCT01302769|567299723|FG001|Overall Study|Lost to Follow-up|1|||
156832434|NCT01146652|566139862|FG000|Overall Study|Poor compliance to protocol|38|||
156832435|NCT01146652|566139863|FG001|Overall Study|Poor compliance to protocol|1|||
156832436|NCT01146652|566139862|FG000|Overall Study|Other unspecified reasons|314|||
156832437|NCT01146652|566139863|FG001|Overall Study|Other unspecified reasons|22|||
156832438|NCT01146652|566139862|FG000|Overall Study|Enrolled but not treated|2|||
156832439|NCT01146652|566139863|FG001|Overall Study|Enrolled but not treated|0|||
157151527|NCT01734993|567299727|FG000|Overall Study|Adverse Event|1|||
156832440|NCT00520013|566139864|FG000|Overall Study|Withdrawal by Subject|0|||
156832441|NCT00520013|566139865|FG001|Overall Study|Withdrawal by Subject|0|||
157151528|NCT01734993|567299727|FG000|Overall Study|Lack of Efficacy|1|||
157151529|NCT01426386|567299728|FG000|Overall Study|Adverse Event|0|||
157151530|NCT01426386|567299729|FG001|Overall Study|Adverse Event|1|||
156832442|NCT00520013|566139866|FG002|Overall Study|Withdrawal by Subject|1|||
156832443|NCT00520013|566139864|FG000|Overall Study|Adverse Event|2|||
156832444|NCT00520013|566139865|FG001|Overall Study|Adverse Event|10|||
156832445|NCT00520013|566139866|FG002|Overall Study|Adverse Event|7|||
156832446|NCT00520013|566139864|FG000|Overall Study|Progressive Disease|7|||
156832447|NCT00520013|566139865|FG001|Overall Study|Progressive Disease|3|||
156832448|NCT00520013|566139866|FG002|Overall Study|Progressive Disease|0|||
156832449|NCT00520013|566139864|FG000|Overall Study|Clinical Progression|3|||
156832450|NCT00520013|566139865|FG001|Overall Study|Clinical Progression|1|||
156832451|NCT00520013|566139866|FG002|Overall Study|Clinical Progression|0|||
156832452|NCT00520013|566139864|FG000|Overall Study|Death|0|||
156832453|NCT00520013|566139865|FG001|Overall Study|Death|1|||
156832454|NCT00520013|566139866|FG002|Overall Study|Death|0|||
156832455|NCT00520013|566139864|FG000|Overall Study|Physician Decision|0|||
156832456|NCT00520013|566139865|FG001|Overall Study|Physician Decision|0|||
156832457|NCT00520013|566139866|FG002|Overall Study|Physician Decision|3|||
156832458|NCT02981524|566139867|FG000|Overall Study|Progressive Disease|14|||
156832459|NCT02981524|566139867|FG000|Overall Study|Death (unrelated)|1|||
156832460|NCT02981524|566139867|FG000|Overall Study|Treatment Related Toxicity|1|||
156832461|NCT02981524|566139867|FG000|Overall Study|Withdrawal by Subject|1|||
156832462|NCT00159913|566139871|FG000|Overall Study|Adverse Event|1|||
156832463|NCT00159913|566139872|FG001|Overall Study|Adverse Event|0|||
156832464|NCT00159913|566139873|FG002|Overall Study|Adverse Event|1|||
156832465|NCT00159913|566139874|FG003|Overall Study|Adverse Event|0|||
156832466|NCT00159913|566139871|FG000|Overall Study|Withdrawal by Subject|0|||
156832467|NCT00159913|566139872|FG001|Overall Study|Withdrawal by Subject|0|||
156832468|NCT00159913|566139873|FG002|Overall Study|Withdrawal by Subject|0|||
156832469|NCT00159913|566139874|FG003|Overall Study|Withdrawal by Subject|1|||
156832470|NCT00159913|566139871|FG000|Overall Study|Lost to Follow-up|0|||
156832471|NCT00159913|566139872|FG001|Overall Study|Lost to Follow-up|0|||
156832472|NCT00159913|566139873|FG002|Overall Study|Lost to Follow-up|0|||
156832473|NCT00159913|566139874|FG003|Overall Study|Lost to Follow-up|1|||
156832474|NCT00159913|566139871|FG000|Overall Study|Protocol Violation|1|||
156832475|NCT00159913|566139872|FG001|Overall Study|Protocol Violation|0|||
156832476|NCT00159913|566139873|FG002|Overall Study|Protocol Violation|1|||
156832477|NCT00159913|566139874|FG003|Overall Study|Protocol Violation|0|||
156832478|NCT03294135|566139875|FG000|Overall Study|Serious Adverse Event|1|||
156832479|NCT03294135|566139876|FG001|Overall Study|Serious Adverse Event|0|||
156832480|NCT03294135|566139877|FG002|Overall Study|Serious Adverse Event|0|||
156832481|NCT03294135|566139875|FG000|Overall Study|Lost to Follow-up|1|||
156832482|NCT03294135|566139876|FG001|Overall Study|Lost to Follow-up|0|||
156832483|NCT03294135|566139877|FG002|Overall Study|Lost to Follow-up|1|||
156832484|NCT03294135|566139875|FG000|Overall Study|Withdrawal by Subject|0|||
156832485|NCT03294135|566139876|FG001|Overall Study|Withdrawal by Subject|0|||
156832486|NCT03294135|566139877|FG002|Overall Study|Withdrawal by Subject|1|||
156832487|NCT03294135|566139875|FG000|Overall Study|Other|2|||
156832488|NCT03294135|566139876|FG001|Overall Study|Other|0|||
156832489|NCT03294135|566139877|FG002|Overall Study|Other|0|||
156832490|NCT02763254|566139878|FG000|Overall Study|Adverse Event|1|||
156832491|NCT00824005|566139879|FG000|Overall Study|Death|0|||
156832492|NCT00824005|566139880|FG001|Overall Study|Death|1|||
156832493|NCT00824005|566139879|FG000|Overall Study|Lost to Follow-up|0|||
156832494|NCT00824005|566139880|FG001|Overall Study|Lost to Follow-up|1|||
156832495|NCT00431951|566139881|FG000|Overall Study|Inability to follow study procedures|1|||
156832496|NCT00431951|566139882|FG001|Overall Study|Inability to follow study procedures|0|||
156832497|NCT00431951|566139883|FG002|Overall Study|Inability to follow study procedures|1|||
156832498|NCT00431951|566139884|FG003|Overall Study|Inability to follow study procedures|2|||
156832499|NCT00431951|566139881|FG000|Overall Study|Lost to Follow-up|0|||
157151531|NCT01426386|567299730|FG002|Overall Study|Adverse Event|0|||
157151532|NCT01426386|567299731|FG003|Overall Study|Adverse Event|0|||
156832500|NCT00431951|566139882|FG001|Overall Study|Lost to Follow-up|1|||
156832501|NCT00431951|566139883|FG002|Overall Study|Lost to Follow-up|0|||
156832502|NCT00431951|566139884|FG003|Overall Study|Lost to Follow-up|0|||
156832503|NCT00431951|566139881|FG000|Overall Study|Withdrawal by Subject|0|||
156832504|NCT00431951|566139882|FG001|Overall Study|Withdrawal by Subject|1|||
156832505|NCT00431951|566139883|FG002|Overall Study|Withdrawal by Subject|0|||
156832506|NCT00431951|566139884|FG003|Overall Study|Withdrawal by Subject|0|||
156832507|NCT00431951|566139881|FG000|Overall Study|Adverse Event|0|||
156832508|NCT00431951|566139882|FG001|Overall Study|Adverse Event|0|||
156832509|NCT00431951|566139883|FG002|Overall Study|Adverse Event|1|||
157151533|NCT01426386|567299732|FG004|Overall Study|Adverse Event|0|||
156832510|NCT00431951|566139884|FG003|Overall Study|Adverse Event|0|||
156832511|NCT00168103|566139885|FG000|Overall Study|Withdrawal by Subject|1|||
157151534|NCT01426386|567299733|FG005|Overall Study|Adverse Event|0|||
156832512|NCT00168103|566139886|FG001|Overall Study|Withdrawal by Subject|2|||
156832513|NCT00168103|566139887|FG002|Overall Study|Withdrawal by Subject|1|||
156832514|NCT00168103|566139888|FG003|Overall Study|Withdrawal by Subject|0|||
156832515|NCT00168103|566139885|FG000|Overall Study|Lost to Follow-up|1|||
156832516|NCT00168103|566139886|FG001|Overall Study|Lost to Follow-up|3|||
156832517|NCT00168103|566139887|FG002|Overall Study|Lost to Follow-up|0|||
156832518|NCT00168103|566139888|FG003|Overall Study|Lost to Follow-up|0|||
156832519|NCT02956850|566139890|FG000|Overall Study|Withdrawal by Subject|0|||
156832520|NCT02956850|566139891|FG001|Overall Study|Withdrawal by Subject|0|||
156832521|NCT02956850|566139892|FG002|Overall Study|Withdrawal by Subject|0|||
156832522|NCT02956850|566139893|FG003|Overall Study|Withdrawal by Subject|0|||
156832523|NCT02956850|566139894|FG004|Overall Study|Withdrawal by Subject|0|||
156832524|NCT02956850|566139895|FG005|Overall Study|Withdrawal by Subject|0|||
156832525|NCT02956850|566139896|FG006|Overall Study|Withdrawal by Subject|0|||
156832526|NCT02956850|566139897|FG007|Overall Study|Withdrawal by Subject|0|||
156832527|NCT02956850|566139898|FG008|Overall Study|Withdrawal by Subject|0|||
156832528|NCT02956850|566139899|FG009|Overall Study|Withdrawal by Subject|0|||
156832529|NCT02956850|566139900|FG010|Overall Study|Withdrawal by Subject|0|||
156832530|NCT02956850|566139901|FG011|Overall Study|Withdrawal by Subject|0|||
156832531|NCT02956850|566139902|FG012|Overall Study|Withdrawal by Subject|0|||
156832532|NCT02956850|566139903|FG013|Overall Study|Withdrawal by Subject|0|||
156832533|NCT02956850|566139904|FG014|Overall Study|Withdrawal by Subject|0|||
156832534|NCT02956850|566139905|FG015|Overall Study|Withdrawal by Subject|0|||
156832535|NCT02956850|566139906|FG016|Overall Study|Withdrawal by Subject|0|||
156832536|NCT02956850|566139907|FG017|Overall Study|Withdrawal by Subject|1|||
156832537|NCT01920152|566139908|FG000|Overall Study|Withdrawal by Subject|1|||
156832538|NCT01920152|566139909|FG001|Overall Study|Withdrawal by Subject|2|||
156832539|NCT03412604|566139910|FG000|Overall Study|Withdrawal by Subject|1|||
156832540|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Adverse Event|0|||
156832541|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Adverse Event|1|||
156832542|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Adverse Event|0|||
156832543|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Adverse Event|0|||
156832544|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Adverse Event|0|||
157023447|NCT05119023|566841060|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
157091531|NCT01588496|567089136|FG002|Overall Study|Withdrawal by Subject|0|||
156832545|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Adverse Event|0|||
156832546|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
156832547|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832548|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832549|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832550|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832551|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
156832552|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
156832553|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
156832554|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
156832555|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
156832556|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
156832557|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
156832558|NCT00993499|566139911|FG000|Run-in Period (8 Days)|Progressive disease|0|||
156832559|NCT00993499|566139912|FG001|Run-in Period (8 Days)|Progressive disease|1|||
156832560|NCT00993499|566139913|FG002|Run-in Period (8 Days)|Progressive disease|1|||
156832561|NCT00993499|566139914|FG003|Run-in Period (8 Days)|Progressive disease|0|||
156832562|NCT00993499|566139915|FG004|Run-in Period (8 Days)|Progressive disease|0|||
156832563|NCT00993499|566139916|FG005|Run-in Period (8 Days)|Progressive disease|0|||
156832564|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
156832565|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
156832566|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832567|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832568|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832569|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
156832570|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
156832571|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
156832572|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832573|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832574|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832575|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
156832576|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832577|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832578|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
157091532|NCT03143166|567089137|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
156832579|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
156832580|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832581|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
156832582|NCT00993499|566139911|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832583|NCT00993499|566139912|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832584|NCT00993499|566139913|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
156832585|NCT00993499|566139914|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832586|NCT00993499|566139915|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832587|NCT00993499|566139916|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
156832588|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832589|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
156832590|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832591|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832592|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832593|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
156832594|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
156832595|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
156832596|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
156832597|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
156832598|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
156832599|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
156832600|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|DLT|1|||
156832601|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|DLT|0|||
156832602|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|DLT|2|||
156832603|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|DLT|1|||
156832604|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|DLT|0|||
156832605|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|DLT|0|||
156832606|NCT00993499|566139911|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
156832607|NCT00993499|566139912|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
156832608|NCT00993499|566139913|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
156832609|NCT00993499|566139914|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
156832610|NCT00993499|566139915|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
156832611|NCT00993499|566139916|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
156832612|NCT02068118|566139917|FG000|18-month Comparative Study Period|Death|90|||
156832613|NCT02068118|566139918|FG001|18-month Comparative Study Period|Death|97|||
156832614|NCT02068118|566139917|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
156832615|NCT02068118|566139918|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
156832616|NCT02068118|566139917|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
156832617|NCT02068118|566139918|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
156832618|NCT02068118|566139917|FG000|18-month Comparative Study Period|Heart transplant|9|||
157023448|NCT05119023|566841060|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
156832619|NCT02068118|566139918|FG001|18-month Comparative Study Period|Heart transplant|15|||
156832620|NCT02068118|566139917|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
156832621|NCT02068118|566139918|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
156832622|NCT02068118|566139917|FG000|18-month Comparative Study Period|Hemiplegia|0|||
156832623|NCT02068118|566139918|FG001|18-month Comparative Study Period|Hemiplegia|1|||
156832624|NCT02068118|566139917|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
156832625|NCT02068118|566139918|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
156832626|NCT02068118|566139917|FG000|18-month Comparative Study Period|Move|0|||
156832627|NCT02068118|566139918|FG001|18-month Comparative Study Period|Move|1|||
156832628|NCT02068118|566139917|FG000|18-month Comparative Study Period|Hearing loss|0|||
156832629|NCT02068118|566139918|FG001|18-month Comparative Study Period|Hearing loss|1|||
156832630|NCT02068118|566139917|FG000|Extension Period|Death|0|||
156832631|NCT02068118|566139918|FG001|Extension Period|Death|2|||
156832632|NCT02068118|566139917|FG000|Extension Period|Withdrawal by Subject|1|||
156832633|NCT02068118|566139918|FG001|Extension Period|Withdrawal by Subject|0|||
156832634|NCT02068118|566139917|FG000|Extension Period|Heart transplant|1|||
156832635|NCT02068118|566139918|FG001|Extension Period|Heart transplant|0|||
156832636|NCT02068118|566139917|FG000|Extension Period|Wrong device use|0|||
156832637|NCT02068118|566139918|FG001|Extension Period|Wrong device use|1|||
156832638|NCT00453973|566139919|FG000|Overall Study|Adverse Event|4|||
156832639|NCT00453973|566139920|FG001|Overall Study|Adverse Event|9|||
156832640|NCT00453973|566139919|FG000|Overall Study|Withdrawal by Subject|7|||
156832641|NCT00453973|566139920|FG001|Overall Study|Withdrawal by Subject|6|||
156832642|NCT00453973|566139919|FG000|Overall Study|PI Decision|0|||
156832643|NCT00453973|566139920|FG001|Overall Study|PI Decision|2|||
156832644|NCT00453973|566139919|FG000|Overall Study|Relocation|1|||
156832645|NCT00453973|566139920|FG001|Overall Study|Relocation|0|||
156832646|NCT00453973|566139919|FG000|Overall Study|Renal transplant|1|||
156832647|NCT00453973|566139920|FG001|Overall Study|Renal transplant|1|||
156832648|NCT00453973|566139919|FG000|Overall Study|Site closed by sponsor|3|||
156832649|NCT00453973|566139920|FG001|Overall Study|Site closed by sponsor|0|||
156832650|NCT00453973|566139919|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
156832651|NCT00453973|566139920|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
156832652|NCT00707746|566139921|FG000|Treatment Period|Adverse Event|2|||
156832653|NCT00707746|566139922|FG001|Treatment Period|Adverse Event|4|||
156832654|NCT00707746|566139921|FG000|Treatment Period|Ineligibility|0|||
156832655|NCT00707746|566139922|FG001|Treatment Period|Ineligibility|1|||
156832656|NCT01219933|566139930|FG000|Overall Study|Adverse Event|8|||
156832657|NCT01219933|566139930|FG000|Overall Study|No LDA reached|5|||
156832658|NCT01219933|566139930|FG000|Overall Study|No LDA maintained|7|||
156832659|NCT01219933|566139930|FG000|Overall Study|Lost to Follow-up|3|||
156832660|NCT01219933|566139930|FG000|Overall Study|GC free|1|||
156832661|NCT01219933|566139930|FG000|Overall Study|Withdrawal by Subject|5|||
156832662|NCT01219933|566139930|FG000|Overall Study|Protocol Violation|8|||
156832663|NCT01219933|566139930|FG000|Overall Study|Lack of Efficacy|1|||
156832664|NCT01902888|566139931|FG000|Overall Study|Study Terminated|3|||
156832665|NCT02226549|566139932|FG000|Overall Study|Randomized but Never Treated|1|||
156832666|NCT02226549|566139933|FG001|Overall Study|Randomized but Never Treated|0|||
156832667|NCT02226549|566139932|FG000|Overall Study|Lost to Follow-up|0|||
156832668|NCT02226549|566139933|FG001|Overall Study|Lost to Follow-up|1|||
156832669|NCT02713529|566139934|FG000|Overall Study|Withdrawal by Subject|3|||
156832670|NCT02713529|566139935|FG001|Overall Study|Withdrawal by Subject|1|||
156832671|NCT02713529|566139936|FG002|Overall Study|Withdrawal by Subject|4|||
156832672|NCT02713529|566139937|FG003|Overall Study|Withdrawal by Subject|2|||
156832673|NCT02713529|566139938|FG004|Overall Study|Withdrawal by Subject|0|||
156832674|NCT02713529|566139939|FG005|Overall Study|Withdrawal by Subject|1|||
156832675|NCT02713529|566139940|FG006|Overall Study|Withdrawal by Subject|1|||
156832676|NCT02713529|566139934|FG000|Overall Study|Lost to Follow-up|1|||
156832677|NCT02713529|566139935|FG001|Overall Study|Lost to Follow-up|0|||
156832678|NCT02713529|566139936|FG002|Overall Study|Lost to Follow-up|1|||
156832679|NCT02713529|566139937|FG003|Overall Study|Lost to Follow-up|0|||
156832680|NCT02713529|566139938|FG004|Overall Study|Lost to Follow-up|0|||
156832681|NCT02713529|566139939|FG005|Overall Study|Lost to Follow-up|0|||
156832682|NCT02713529|566139940|FG006|Overall Study|Lost to Follow-up|0|||
156832683|NCT02713529|566139934|FG000|Overall Study|Death|3|||
156832684|NCT02713529|566139935|FG001|Overall Study|Death|3|||
156832685|NCT02713529|566139936|FG002|Overall Study|Death|26|||
156832686|NCT02713529|566139937|FG003|Overall Study|Death|27|||
156832687|NCT02713529|566139938|FG004|Overall Study|Death|3|||
156832688|NCT02713529|566139939|FG005|Overall Study|Death|13|||
156832689|NCT02713529|566139940|FG006|Overall Study|Death|3|||
156832690|NCT03352453|566139943|FG000|Overall Study|Miscellaneous Reasons|1|||
156832691|NCT03352453|566139944|FG001|Overall Study|Miscellaneous Reasons|2|||
156832692|NCT03352453|566139943|FG000|Overall Study|Lack of Efficacy|1|||
156832693|NCT03352453|566139944|FG001|Overall Study|Lack of Efficacy|0|||
156832694|NCT03352453|566139943|FG000|Overall Study|Withdrawal by Subject|8|||
156832695|NCT03352453|566139944|FG001|Overall Study|Withdrawal by Subject|14|||
156832696|NCT03352453|566139943|FG000|Overall Study|Study Terminated by Sponsor|2|||
156832697|NCT03352453|566139944|FG001|Overall Study|Study Terminated by Sponsor|1|||
156832698|NCT03352453|566139943|FG000|Overall Study|Protocol Deviation|1|||
156832699|NCT03352453|566139944|FG001|Overall Study|Protocol Deviation|0|||
156832700|NCT03352453|566139943|FG000|Overall Study|Lost to Follow-up|7|||
156832701|NCT03352453|566139944|FG001|Overall Study|Lost to Follow-up|6|||
156832702|NCT03352453|566139943|FG000|Overall Study|Adverse Event|2|||
156832703|NCT03352453|566139944|FG001|Overall Study|Adverse Event|9|||
156832704|NCT02827500|566139945|FG000|Overall Study|Death|7|||
156832705|NCT02827500|566139946|FG001|Overall Study|Death|3|||
156832706|NCT02827500|566139945|FG000|Overall Study|Lost to Follow-up|1|||
156832707|NCT02827500|566139946|FG001|Overall Study|Lost to Follow-up|1|||
156832708|NCT02827500|566139945|FG000|Overall Study|Withdrawal by Subject|3|||
156832709|NCT02827500|566139946|FG001|Overall Study|Withdrawal by Subject|1|||
156832710|NCT02827500|566139945|FG000|Overall Study|Missing primary endpoint data|3|||
156832711|NCT02827500|566139946|FG001|Overall Study|Missing primary endpoint data|1|||
156832712|NCT02827500|566139945|FG000|Overall Study|Other|5|||
156832713|NCT02827500|566139946|FG001|Overall Study|Other|1|||
156832714|NCT01241760|566139949|FG000|Overall Study|Adverse Event|1|||
156832715|NCT01241760|566139950|FG001|Overall Study|Adverse Event|0|||
156832716|NCT01241760|566139949|FG000|Overall Study|Lost to Follow-up|18|||
156832717|NCT01241760|566139950|FG001|Overall Study|Lost to Follow-up|22|||
156832718|NCT01241760|566139949|FG000|Overall Study|Withdrawal by Subject|13|||
156832719|NCT01241760|566139950|FG001|Overall Study|Withdrawal by Subject|13|||
156832720|NCT01241760|566139949|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
156832721|NCT01241760|566139950|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
156832722|NCT01241760|566139949|FG000|Overall Study|Other|1|||
156832723|NCT01241760|566139950|FG001|Overall Study|Other|1|||
156832724|NCT00514020|566139951|FG000|Overall Study|Adverse Event|6|||
156832725|NCT00514020|566139951|FG000|Overall Study|Withdrawal by Subject|3|||
156832726|NCT00514020|566139951|FG000|Overall Study|Physician Decision|1|||
156832727|NCT00514020|566139951|FG000|Overall Study|disease progression|9|||
156832728|NCT00514020|566139951|FG000|Overall Study|other complicating disease|2|||
156832729|NCT00514020|566139951|FG000|Overall Study|patient went to radiation treatment|1|||
156832730|NCT00514020|566139951|FG000|Overall Study|"patients moved to the no tx group"|6|||
156832731|NCT01636713|566139956|FG000|Overall Study|Adverse Event|16|||
156832732|NCT01636713|566139957|FG001|Overall Study|Adverse Event|16|||
156832733|NCT01636713|566139958|FG002|Overall Study|Adverse Event|7|||
156832734|NCT01636713|566139956|FG000|Overall Study|Lack of Efficacy|6|||
156832735|NCT01636713|566139957|FG001|Overall Study|Lack of Efficacy|6|||
156832736|NCT01636713|566139958|FG002|Overall Study|Lack of Efficacy|2|||
156832737|NCT01636713|566139956|FG000|Overall Study|Protocol Violation|3|||
156832738|NCT01636713|566139957|FG001|Overall Study|Protocol Violation|0|||
156832739|NCT01636713|566139958|FG002|Overall Study|Protocol Violation|1|||
156832740|NCT01636713|566139956|FG000|Overall Study|Lost to Follow-up|0|||
156832741|NCT01636713|566139957|FG001|Overall Study|Lost to Follow-up|0|||
156832742|NCT01636713|566139958|FG002|Overall Study|Lost to Follow-up|1|||
156832743|NCT01636713|566139956|FG000|Overall Study|Withdrawal by Subject|5|||
156832744|NCT01636713|566139957|FG001|Overall Study|Withdrawal by Subject|4|||
156832745|NCT01636713|566139958|FG002|Overall Study|Withdrawal by Subject|8|||
156832746|NCT01636713|566139956|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156832747|NCT01636713|566139957|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
156832748|NCT01636713|566139958|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156832749|NCT00276614|566139966|FG000|Overall Study|Progression of disease under study|3|||
156832750|NCT02525094|566139970|FG000|Overall Study|Lost to Follow-up|2|||
156832751|NCT02525094|566139971|FG001|Overall Study|Lost to Follow-up|1|||
156832752|NCT02525094|566139970|FG000|Overall Study|Withdrawal by Subject|5|||
156832753|NCT02525094|566139971|FG001|Overall Study|Withdrawal by Subject|6|||
156832754|NCT02525094|566139970|FG000|Overall Study|Not Treated|1|||
156832755|NCT02525094|566139971|FG001|Overall Study|Not Treated|1|||
156832756|NCT01490294|566139972|FG000|Overall Study|Prematurely discontinuation|4|||
156832757|NCT01490294|566139973|FG001|Overall Study|Prematurely discontinuation|0|||
156832758|NCT01490294|566139974|FG002|Overall Study|Prematurely discontinuation|1|||
156832759|NCT01490294|566139975|FG003|Overall Study|Prematurely discontinuation|1|||
156832760|NCT01490294|566139972|FG000|Overall Study|Adverse Event|1|||
156832761|NCT01490294|566139973|FG001|Overall Study|Adverse Event|0|||
156832762|NCT01490294|566139974|FG002|Overall Study|Adverse Event|0|||
156832763|NCT01490294|566139975|FG003|Overall Study|Adverse Event|0|||
156832764|NCT01751776|566139978|FG000|Overall Study|Adverse Event|0|||
156832765|NCT01751776|566139979|FG001|Overall Study|Adverse Event|0|||
156832766|NCT01751776|566139980|FG002|Overall Study|Adverse Event|0|||
156832767|NCT01751776|566139981|FG003|Overall Study|Adverse Event|0|||
156832768|NCT01751776|566139982|FG004|Overall Study|Adverse Event|0|||
156832769|NCT01751776|566139983|FG005|Overall Study|Adverse Event|0|||
156832770|NCT01751776|566139984|FG006|Overall Study|Adverse Event|4|||
156832771|NCT01751776|566139985|FG007|Overall Study|Adverse Event|2|||
156832772|NCT01751776|566139978|FG000|Overall Study|Consent withdrawn|0|||
156832773|NCT01751776|566139979|FG001|Overall Study|Consent withdrawn|0|||
156832774|NCT01751776|566139980|FG002|Overall Study|Consent withdrawn|0|||
156832775|NCT01751776|566139981|FG003|Overall Study|Consent withdrawn|0|||
156832776|NCT01751776|566139982|FG004|Overall Study|Consent withdrawn|0|||
156832777|NCT01751776|566139983|FG005|Overall Study|Consent withdrawn|0|||
156832778|NCT01751776|566139984|FG006|Overall Study|Consent withdrawn|0|||
156832779|NCT01751776|566139985|FG007|Overall Study|Consent withdrawn|1|||
156832780|NCT01751776|566139978|FG000|Overall Study|Other reason not specified above|0|||
156832781|NCT01751776|566139979|FG001|Overall Study|Other reason not specified above|0|||
156832782|NCT01751776|566139980|FG002|Overall Study|Other reason not specified above|0|||
156832783|NCT01751776|566139981|FG003|Overall Study|Other reason not specified above|0|||
156832784|NCT01751776|566139982|FG004|Overall Study|Other reason not specified above|0|||
156832785|NCT01751776|566139983|FG005|Overall Study|Other reason not specified above|0|||
156832786|NCT01751776|566139984|FG006|Overall Study|Other reason not specified above|0|||
156832787|NCT01751776|566139985|FG007|Overall Study|Other reason not specified above|1|||
156832788|NCT00831701|566139988|FG000|Overall Study|Withdrawal by Subject|2|||
156832789|NCT00831701|566139989|FG001|Overall Study|Withdrawal by Subject|0|||
156832790|NCT00831701|566139988|FG000|Overall Study|Stone expulsion before first medication|2|||
156832791|NCT00831701|566139989|FG001|Overall Study|Stone expulsion before first medication|2|||
157151535|NCT01426386|567299728|FG000|Overall Study|Did not attend scheduled visit|1|||
156832792|NCT00831701|566139988|FG000|Overall Study|Lost to Follow-up|1|||
156832793|NCT00831701|566139989|FG001|Overall Study|Lost to Follow-up|3|||
156832794|NCT02117349|566139990|FG000|Overall Study|Withdrawal by Subject|1|||
156832795|NCT02117349|566139991|FG001|Overall Study|Withdrawal by Subject|0|||
156832796|NCT02117349|566139990|FG000|Overall Study|Lost to Follow-up|1|||
156832797|NCT02117349|566139991|FG001|Overall Study|Lost to Follow-up|1|||
156832798|NCT02117349|566139990|FG000|Overall Study|Death|1|||
157151536|NCT01426386|567299729|FG001|Overall Study|Did not attend scheduled visit|4|||
156832799|NCT02117349|566139991|FG001|Overall Study|Death|0|||
156832800|NCT02535416|566139992|FG000|Overall Study|Family bereavement overseas|1|||
156832801|NCT02535416|566139993|FG001|Overall Study|Family bereavement overseas|0|||
156832802|NCT02535416|566139994|FG002|Overall Study|Family bereavement overseas|0|||
156832803|NCT02535416|566139995|FG003|Overall Study|Family bereavement overseas|0|||
156832804|NCT02535416|566139996|FG004|Overall Study|Family bereavement overseas|0|||
156832805|NCT02535416|566139997|FG005|Overall Study|Family bereavement overseas|0|||
156832806|NCT02535416|566139998|FG006|Overall Study|Family bereavement overseas|0|||
156832807|NCT02535416|566139999|FG007|Overall Study|Family bereavement overseas|0|||
156832808|NCT02535416|566140000|FG008|Overall Study|Family bereavement overseas|0|||
156832809|NCT01977690|566140003|FG000|Overall Study|Withdrawal by Subject|0|||
156832810|NCT01977690|566140004|FG001|Overall Study|Withdrawal by Subject|4|||
156832811|NCT01711866|566140009|FG000|Overall Study|Noncompliant|3|||
156832812|NCT01711866|566140009|FG000|Overall Study|Withdrawal by Subject|3|||
156832813|NCT01711866|566140009|FG000|Overall Study|Adverse Event|2|||
156832814|NCT00459537|566140010|FG000|Overall Study|Adverse Event|1|||
156832815|NCT00459537|566140011|FG001|Overall Study|Adverse Event|6|||
156832816|NCT00459537|566140010|FG000|Overall Study|Lack of Efficacy|10|||
156832817|NCT00459537|566140011|FG001|Overall Study|Lack of Efficacy|11|||
156832818|NCT00459537|566140010|FG000|Overall Study|Withdrawal by Subject|20|||
156832819|NCT00459537|566140011|FG001|Overall Study|Withdrawal by Subject|26|||
156832820|NCT00459537|566140010|FG000|Overall Study|Lost to Follow-up|27|||
156832821|NCT00459537|566140011|FG001|Overall Study|Lost to Follow-up|30|||
156832822|NCT00459537|566140010|FG000|Overall Study|Administrative problems|3|||
156832823|NCT00459537|566140011|FG001|Overall Study|Administrative problems|0|||
156832824|NCT00459537|566140010|FG000|Overall Study|Protocol Violation|4|||
156832825|NCT00459537|566140011|FG001|Overall Study|Protocol Violation|3|||
156832826|NCT00459537|566140010|FG000|Overall Study|Missing|1|||
156832827|NCT00459537|566140011|FG001|Overall Study|Missing|0|||
156832828|NCT01831817|566140012|FG000|Overall Study|Lost to Follow-up|1|||
156832829|NCT01831817|566140013|FG001|Overall Study|Lost to Follow-up|0|||
156832830|NCT01831817|566140014|FG002|Overall Study|Lost to Follow-up|0|||
156832831|NCT01831817|566140015|FG003|Overall Study|Lost to Follow-up|0|||
156832832|NCT01831817|566140012|FG000|Overall Study|Withdrawl of Consent|3|||
156832833|NCT01831817|566140013|FG001|Overall Study|Withdrawl of Consent|0|||
156832834|NCT01831817|566140014|FG002|Overall Study|Withdrawl of Consent|0|||
156832835|NCT01831817|566140015|FG003|Overall Study|Withdrawl of Consent|0|||
156832836|NCT03159104|566140016|FG000|Overall Study|Violation of inclusion criteria|1|||
156832837|NCT03159104|566140017|FG001|Overall Study|Violation of inclusion criteria|2|||
156832838|NCT00958217|566140018|FG000|Overall Study|Death|2|||
156832839|NCT00958217|566140019|FG001|Overall Study|Death|1|||
156832840|NCT00958217|566140018|FG000|Overall Study|Withdrawal by Subject|4|||
156832841|NCT00958217|566140019|FG001|Overall Study|Withdrawal by Subject|3|||
156832842|NCT00958217|566140018|FG000|Overall Study|Lost to Follow-up|17|||
156832843|NCT00958217|566140019|FG001|Overall Study|Lost to Follow-up|19|||
156832844|NCT00958217|566140018|FG000|Overall Study|Moved out of area|1|||
156832845|NCT00958217|566140019|FG001|Overall Study|Moved out of area|1|||
156832846|NCT00958217|566140018|FG000|Overall Study|Inpatient hospitalization|0|||
156832847|NCT00958217|566140019|FG001|Overall Study|Inpatient hospitalization|1|||
156832848|NCT02440789|566140022|FG000|Overall Study|Withdrawal by Subject|3|||
156832849|NCT02440789|566140022|FG000|Overall Study|Not willing to adhere to reqs|1|||
156832850|NCT01825941|566141430|FG000|Overall Study|Lost to Follow-up|4|||
156832851|NCT01825941|566141431|FG001|Overall Study|Lost to Follow-up|1|||
156832852|NCT02831933|566141432|FG000|Overall Study|Physician Decision|11|||
156885312|NCT00770146|566338270|FG000|Follow-up Period|Adverse Event|0|||
156885313|NCT00770146|566338271|FG001|Follow-up Period|Adverse Event|2|||
156885314|NCT00770146|566338270|FG000|Follow-up Period|Other|4|||
156885315|NCT00770146|566338271|FG001|Follow-up Period|Other|5|||
156885316|NCT04620798|566338272|FG000|Overall Study|Lost to Follow-up|126|||
156832853|NCT05065190|566141433|FG000|Overall Study|Other than listed|2|||
156832854|NCT05065190|566141434|FG001|Overall Study|Other than listed|12|||
156832855|NCT05065190|566141433|FG000|Overall Study|Lack of Efficacy|4|||
156885317|NCT04620798|566338273|FG001|Overall Study|Lost to Follow-up|138|||
157023449|NCT05119023|566841060|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
157224598|NCT02626949|567568042|FG000|Enrolled|Withdrawal by Subject|3|||
156832856|NCT05065190|566141434|FG001|Overall Study|Lack of Efficacy|0|||
156832857|NCT05065190|566141433|FG000|Overall Study|Adverse Event|1|||
156832858|NCT05065190|566141434|FG001|Overall Study|Adverse Event|10|||
156832859|NCT03938324|566141442|FG000|Overall Study|Lost to Follow-up|42|||
156832860|NCT03938324|566141443|FG001|Overall Study|Lost to Follow-up|21|||
156832861|NCT03938324|566141442|FG000|Overall Study|Withdrawal by Subject|6|||
156832862|NCT03938324|566141443|FG001|Overall Study|Withdrawal by Subject|1|||
156832863|NCT02769962|566141444|FG000|Overall Study|Physician Decision|0|||
156832864|NCT02769962|566141445|FG001|Overall Study|Physician Decision|0|||
156832865|NCT02769962|566141446|FG002|Overall Study|Physician Decision|0|||
156832866|NCT02769962|566141447|FG003|Overall Study|Physician Decision|0|||
156832867|NCT02769962|566141448|FG004|Overall Study|Physician Decision|0|||
156885318|NCT02486627|566338277|FG000|Overall Study|Death|1|||
156885319|NCT02486627|566338278|FG001|Overall Study|Death|0|||
156885320|NCT02486627|566338277|FG000|Overall Study|Other Unspecified|0|||
157224599|NCT02626949|567568043|FG001|Enrolled|Withdrawal by Subject|2|||
156832868|NCT02769962|566141449|FG005|Overall Study|Physician Decision|1|||
156832869|NCT02769962|566141450|FG006|Overall Study|Physician Decision|0|||
156832870|NCT02769962|566141451|FG007|Overall Study|Physician Decision|1|||
157224600|NCT00673790|567568044|FG000|Overall Study|Adverse Event|23|||
157224601|NCT00673790|567568045|FG001|Overall Study|Adverse Event|14|||
157224602|NCT00673790|567568046|FG002|Overall Study|Adverse Event|2|||
157224603|NCT00673790|567568044|FG000|Overall Study|Lack of Efficacy|2|||
157224604|NCT00673790|567568045|FG001|Overall Study|Lack of Efficacy|2|||
157224605|NCT00673790|567568046|FG002|Overall Study|Lack of Efficacy|2|||
157224606|NCT00673790|567568044|FG000|Overall Study|Protocol Violation|6|||
157224607|NCT00673790|567568045|FG001|Overall Study|Protocol Violation|9|||
157224608|NCT00673790|567568046|FG002|Overall Study|Protocol Violation|1|||
157224609|NCT00673790|567568044|FG000|Overall Study|Withdrawal by Subject|7|||
157224610|NCT00673790|567568045|FG001|Overall Study|Withdrawal by Subject|4|||
157224611|NCT00673790|567568046|FG002|Overall Study|Withdrawal by Subject|1|||
157224612|NCT00673790|567568044|FG000|Overall Study|Lost to Follow-up|6|||
156832871|NCT02769962|566141444|FG000|Overall Study|Refused further treatment|0|||
156832872|NCT02769962|566141445|FG001|Overall Study|Refused further treatment|0|||
156832873|NCT02769962|566141446|FG002|Overall Study|Refused further treatment|0|||
156832874|NCT02769962|566141447|FG003|Overall Study|Refused further treatment|0|||
156832875|NCT02769962|566141448|FG004|Overall Study|Refused further treatment|0|||
156832876|NCT02769962|566141449|FG005|Overall Study|Refused further treatment|1|||
156832877|NCT02769962|566141450|FG006|Overall Study|Refused further treatment|1|||
156832878|NCT02769962|566141451|FG007|Overall Study|Refused further treatment|0|||
156832879|NCT05565937|566141452|FG000|Overall Study|Adverse Event|0|||
156832880|NCT05565937|566141453|FG001|Overall Study|Adverse Event|1|||
156832881|NCT05565937|566141452|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
156832882|NCT05565937|566141453|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
156832883|NCT05565937|566141452|FG000|Overall Study|Lost to Follow-up|2|||
156832884|NCT05565937|566141453|FG001|Overall Study|Lost to Follow-up|0|||
156832885|NCT05565937|566141452|FG000|Overall Study|Pregnancy|0|||
156832886|NCT05565937|566141453|FG001|Overall Study|Pregnancy|2|||
156832887|NCT05565937|566141452|FG000|Overall Study|Anisometropia|0|||
156832888|NCT05565937|566141453|FG001|Overall Study|Anisometropia|1|||
156885321|NCT02486627|566338278|FG001|Overall Study|Other Unspecified|2|||
156885322|NCT02486627|566338277|FG000|Overall Study|Consent Withdrawn by Participant|4|||
156885323|NCT02486627|566338278|FG001|Overall Study|Consent Withdrawn by Participant|3|||
156885324|NCT02486627|566338277|FG000|Overall Study|Significant Participant Noncompliance|1|||
156885325|NCT02486627|566338278|FG001|Overall Study|Significant Participant Noncompliance|1|||
156885326|NCT02486627|566338277|FG000|Overall Study|Lost to Follow-up|1|||
156885327|NCT02486627|566338278|FG001|Overall Study|Lost to Follow-up|3|||
157023450|NCT03194217|566841061|FG000|Overall Study|Adverse Event|0|||
157023451|NCT03194217|566841062|FG001|Overall Study|Adverse Event|2|||
157023452|NCT03194217|566841063|FG002|Overall Study|Adverse Event|3|||
157023453|NCT03194217|566841064|FG003|Overall Study|Adverse Event|3|||
157023454|NCT03194217|566841061|FG000|Overall Study|Failure to meet randomisation criteria|0|||
157023455|NCT03194217|566841062|FG001|Overall Study|Failure to meet randomisation criteria|0|||
157151537|NCT01426386|567299730|FG002|Overall Study|Did not attend scheduled visit|0|||
157151538|NCT01426386|567299731|FG003|Overall Study|Did not attend scheduled visit|0|||
157151539|NCT01426386|567299732|FG004|Overall Study|Did not attend scheduled visit|2|||
157151540|NCT01426386|567299733|FG005|Overall Study|Did not attend scheduled visit|1|||
157151541|NCT01426386|567299728|FG000|Overall Study|Poor response|2|||
157151542|NCT01426386|567299729|FG001|Overall Study|Poor response|1|||
157151543|NCT01426386|567299730|FG002|Overall Study|Poor response|2|||
157151544|NCT01426386|567299731|FG003|Overall Study|Poor response|0|||
157151545|NCT01426386|567299732|FG004|Overall Study|Poor response|1|||
157151546|NCT01426386|567299733|FG005|Overall Study|Poor response|0|||
157224613|NCT00673790|567568045|FG001|Overall Study|Lost to Follow-up|6|||
157224614|NCT00673790|567568046|FG002|Overall Study|Lost to Follow-up|5|||
157224615|NCT00673790|567568044|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
157224616|NCT00673790|567568045|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
157224617|NCT00673790|567568046|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
157224618|NCT00673790|567568044|FG000|Overall Study|Poor compliance|1|||
157224619|NCT00673790|567568045|FG001|Overall Study|Poor compliance|0|||
157224620|NCT00673790|567568046|FG002|Overall Study|Poor compliance|0|||
157224621|NCT00673790|567568044|FG000|Overall Study|Participated in two Nebivolol studies|0|||
157224622|NCT00673790|567568045|FG001|Overall Study|Participated in two Nebivolol studies|0|||
156832889|NCT04544683|566141454|FG000|Overall Study|Lost to Follow-up|2|||
156832890|NCT04544683|566141454|FG000|Overall Study|Underwent cervical spine surgery|6|||
156832891|NCT00151372|566141455|FG000|Overall Study|Death|12|||
156832892|NCT00151372|566141456|FG001|Overall Study|Death|11|||
156832893|NCT00151372|566141455|FG000|Overall Study|Lost to Follow-up|5|||
156885328|NCT02112045|566338281|FG000|Overall Study|Withdrawal by Subject|1|||
156885329|NCT02112045|566338282|FG001|Overall Study|Withdrawal by Subject|0|||
156885330|NCT01073462|566338283|FG000|Overall Study|Death|14|||
157151547|NCT01426386|567299728|FG000|Overall Study|Personal reasons|0|||
157151548|NCT01426386|567299729|FG001|Overall Study|Personal reasons|0|||
157151549|NCT01426386|567299730|FG002|Overall Study|Personal reasons|0|||
157151550|NCT01426386|567299731|FG003|Overall Study|Personal reasons|0|||
157151551|NCT01426386|567299732|FG004|Overall Study|Personal reasons|1|||
157151552|NCT01426386|567299733|FG005|Overall Study|Personal reasons|0|||
157151553|NCT01797432|567299738|FG000|Overall Study|Lost to Follow-up|1|||
157151554|NCT01797432|567299738|FG000|Overall Study|Adverse Event|1|||
157151555|NCT01797432|567299738|FG000|Overall Study|Withdrawal by Subject|1|||
157151556|NCT01797432|567299738|FG000|Overall Study|lived too far from study site|1|||
157151557|NCT02792777|567299739|FG000|Overall Study|Withdrawal by Subject|2|||
157151558|NCT02792777|567299740|FG001|Overall Study|Withdrawal by Subject|0|||
157151559|NCT02792777|567299739|FG000|Overall Study|Recording malfunction|2|||
157151560|NCT02792777|567299740|FG001|Overall Study|Recording malfunction|0|||
157151561|NCT02792777|567299739|FG000|Overall Study|Later determined to be ineligible|2|||
157151562|NCT02792777|567299740|FG001|Overall Study|Later determined to be ineligible|0|||
157151563|NCT02792777|567299739|FG000|Overall Study|Participant interviewed twice|1|||
157151564|NCT02792777|567299740|FG001|Overall Study|Participant interviewed twice|0|||
157151565|NCT00638846|567299741|FG000|Overall Study|Adverse Event|0|||
157151566|NCT00638846|567299742|FG001|Overall Study|Adverse Event|1|||
157151567|NCT00638846|567299741|FG000|Overall Study|Lost to Follow-up|3|||
157151568|NCT00638846|567299742|FG001|Overall Study|Lost to Follow-up|2|||
156832894|NCT00151372|566141456|FG001|Overall Study|Lost to Follow-up|5|||
156832895|NCT00151372|566141455|FG000|Overall Study|Too sick medically to continue|5|||
156832896|NCT00151372|566141456|FG001|Overall Study|Too sick medically to continue|6|||
156832897|NCT00151372|566141455|FG000|Overall Study|Withdrawal by Subject|7|||
156832898|NCT00151372|566141456|FG001|Overall Study|Withdrawal by Subject|7|||
156832899|NCT01266590|566141457|FG000|Overall Study|Adverse Event|3|||
156832900|NCT01266590|566141457|FG000|Overall Study|Lost to Follow-up|1|||
156832901|NCT01266590|566141457|FG000|Overall Study|Withdrawal by Subject|1|||
157151569|NCT00638846|567299741|FG000|Overall Study|lens issue|1|||
157151570|NCT00638846|567299742|FG001|Overall Study|lens issue|3|||
157151571|NCT03176966|567299746|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
157151572|NCT03176966|567299747|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
157151573|NCT03176966|567299746|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
157151574|NCT03176966|567299747|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
157151575|NCT03176966|567299746|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
157151576|NCT03176966|567299747|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
157151577|NCT03176966|567299746|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
157151578|NCT03176966|567299747|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
157151579|NCT03176966|567299746|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
157151580|NCT03176966|567299747|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
157151581|NCT03176966|567299746|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
157151582|NCT03176966|567299747|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
157151583|NCT03176966|567299746|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
157151584|NCT03176966|567299747|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
156832902|NCT01266590|566141457|FG000|Overall Study|Physician Decision|1|||
156832903|NCT04732949|566141460|FG000|Overall Study|Withdrawal by Subject|23|||
156832904|NCT04732949|566141461|FG001|Overall Study|Withdrawal by Subject|27|||
156885331|NCT01073462|566338283|FG000|Overall Study|Kidney transplant|10|||
156885332|NCT01073462|566338283|FG000|Overall Study|Low parathyroid hormone levels|8|||
156885333|NCT01073462|566338283|FG000|Overall Study|Serious adverse event|2|||
156885334|NCT01073462|566338283|FG000|Overall Study|Lost to Follow-up|7|||
156885335|NCT00247611|566338288|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
156885336|NCT00247611|566338289|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
156885337|NCT00247611|566338288|FG000|Baselined|Completed baseline only|9|||
156885338|NCT00247611|566338289|FG001|Baselined|Completed baseline only|8|||
156885339|NCT05395091|566338290|FG000|Baseline to Month 12|Adverse Event|7|||
156885340|NCT05395091|566338291|FG001|Baseline to Month 12|Adverse Event|2|||
156885341|NCT05395091|566338292|FG002|Baseline to Month 12|Adverse Event|0|||
156885342|NCT05395091|566338290|FG000|Baseline to Month 12|Death|3|||
156885343|NCT05395091|566338291|FG001|Baseline to Month 12|Death|1|||
156885344|NCT05395091|566338292|FG002|Baseline to Month 12|Death|0|||
156885345|NCT05395091|566338290|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
156885346|NCT05395091|566338291|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
156885347|NCT05395091|566338292|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
156885348|NCT05395091|566338290|FG000|Baseline to Month 12|Protocol Violation|2|||
157151585|NCT00633139|567299755|FG000|Overall Study|Non compliance|0|||
157151586|NCT00633139|567299756|FG001|Overall Study|Non compliance|0|||
157151587|NCT00633139|567299757|FG002|Overall Study|Non compliance|1|||
157151588|NCT00633139|567299755|FG000|Overall Study|Withdrawal by Subject|0|||
156832905|NCT04732949|566141460|FG000|Overall Study|Protocol Violation|0|||
156885349|NCT05395091|566338291|FG001|Baseline to Month 12|Protocol Violation|3|||
157151589|NCT00633139|567299756|FG001|Overall Study|Withdrawal by Subject|1|||
157151590|NCT00633139|567299757|FG002|Overall Study|Withdrawal by Subject|0|||
156832906|NCT04732949|566141461|FG001|Overall Study|Protocol Violation|1|||
156832907|NCT04732949|566141460|FG000|Overall Study|Non-compliance|0|||
156832908|NCT04732949|566141461|FG001|Overall Study|Non-compliance|2|||
156832909|NCT04732949|566141460|FG000|Overall Study|Physician Decision|2|||
156832910|NCT04732949|566141461|FG001|Overall Study|Physician Decision|1|||
156832911|NCT04732949|566141460|FG000|Overall Study|Serious adverse event (Fatal)|16|||
156832912|NCT04732949|566141461|FG001|Overall Study|Serious adverse event (Fatal)|18|||
156832913|NCT04732949|566141460|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
156832914|NCT04732949|566141461|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
156832915|NCT04732949|566141460|FG000|Overall Study|Non-serious adverse event|1|||
156832916|NCT04732949|566141461|FG001|Overall Study|Non-serious adverse event|3|||
156832917|NCT04732949|566141460|FG000|Overall Study|Lost to Follow-up|26|||
156832918|NCT04732949|566141461|FG001|Overall Study|Lost to Follow-up|27|||
156832919|NCT04732949|566141460|FG000|Overall Study|Other|6|||
156832920|NCT04732949|566141461|FG001|Overall Study|Other|3|||
156832921|NCT05160766|566141462|FG000|Overall Study|Adverse Event|0|||
156832922|NCT05160766|566141463|FG001|Overall Study|Adverse Event|1|||
156832923|NCT05160766|566141464|FG002|Overall Study|Adverse Event|0|||
156832924|NCT05160766|566141465|FG003|Overall Study|Adverse Event|0|||
156832925|NCT05160766|566141462|FG000|Overall Study|COVID-19 infection|0|||
156832926|NCT05160766|566141463|FG001|Overall Study|COVID-19 infection|1|||
156832927|NCT05160766|566141464|FG002|Overall Study|COVID-19 infection|0|||
156832928|NCT05160766|566141465|FG003|Overall Study|COVID-19 infection|0|||
156832929|NCT05160766|566141462|FG000|Overall Study|travel time|1|||
156832930|NCT05160766|566141463|FG001|Overall Study|travel time|0|||
156832931|NCT05160766|566141464|FG002|Overall Study|travel time|0|||
156832932|NCT05160766|566141465|FG003|Overall Study|travel time|1|||
156832933|NCT05160766|566141462|FG000|Overall Study|Withdrawal by Subject|3|||
156832934|NCT05160766|566141463|FG001|Overall Study|Withdrawal by Subject|5|||
156832935|NCT05160766|566141464|FG002|Overall Study|Withdrawal by Subject|4|||
156832936|NCT05160766|566141465|FG003|Overall Study|Withdrawal by Subject|2|||
156832937|NCT05160766|566141462|FG000|Overall Study|Death|0|||
156832938|NCT05160766|566141463|FG001|Overall Study|Death|0|||
156832939|NCT05160766|566141464|FG002|Overall Study|Death|2|||
157151591|NCT02160977|567299758|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
157151592|NCT02160977|567299759|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
157151593|NCT02160977|567299758|FG000|Three Months After Surgery|Lost to Follow-up|0|||
157151594|NCT02160977|567299759|FG001|Three Months After Surgery|Lost to Follow-up|2|||
157151595|NCT02160977|567299758|FG000|Six Months After Surgery|Lost to Follow-up|2|||
157151596|NCT02160977|567299759|FG001|Six Months After Surgery|Lost to Follow-up|1|||
157151597|NCT02269319|567299760|FG000|Overall Study|Lost to Follow-up|4|||
157151598|NCT02269319|567299761|FG001|Overall Study|Lost to Follow-up|3|||
157151599|NCT02269319|567299760|FG000|Overall Study|Adverse Event|0|||
157151600|NCT02269319|567299761|FG001|Overall Study|Adverse Event|1|||
157151601|NCT02269319|567299760|FG000|Overall Study|Instructions not followed|1|||
157151602|NCT02269319|567299761|FG001|Overall Study|Instructions not followed|0|||
157151603|NCT03625986|567301411|FG000|Randomization Period|Lost to Follow-up|7|||
157151604|NCT03625986|567301412|FG001|Randomization Period|Lost to Follow-up|12|||
157151605|NCT03625986|567301411|FG000|Randomization Period|Withdrawal by Subject|10|||
157151606|NCT03625986|567301412|FG001|Randomization Period|Withdrawal by Subject|6|||
157151607|NCT01850563|567301413|FG000|Overall Study|Not eligible|3|||
157151608|NCT01850563|567301414|FG001|Overall Study|Not eligible|0|||
157151609|NCT04359823|567301415|FG000|Overall Study|Lost to Follow-up|0|||
157151610|NCT04359823|567301416|FG001|Overall Study|Lost to Follow-up|1|||
157151611|NCT04359823|567301415|FG000|Overall Study|Withdrawal by Subject|0|||
157151612|NCT04359823|567301416|FG001|Overall Study|Withdrawal by Subject|1|||
157151613|NCT03151148|567301419|FG000|Overall Study|Lost to Follow-up|1|||
157151614|NCT03151148|567301420|FG001|Overall Study|Lost to Follow-up|0|||
157151615|NCT03151148|567301419|FG000|Overall Study|Withdrawal by Subject|1|||
157151616|NCT03151148|567301420|FG001|Overall Study|Withdrawal by Subject|0|||
157151617|NCT04543955|567301421|FG000|Overall Study|Company cancelled study|1|||
156832940|NCT05160766|566141465|FG003|Overall Study|Death|5|||
156832941|NCT05160766|566141462|FG000|Overall Study|Lost to Follow-up|0|||
157151618|NCT04543955|567301422|FG001|Overall Study|Company cancelled study|0|||
157151619|NCT03918642|567301423|FG000|Overall Study|Lost to Follow-up|12|||
157151620|NCT03918642|567301424|FG001|Overall Study|Lost to Follow-up|10|||
156832942|NCT05160766|566141463|FG001|Overall Study|Lost to Follow-up|0|||
156832943|NCT05160766|566141464|FG002|Overall Study|Lost to Follow-up|1|||
156832944|NCT05160766|566141465|FG003|Overall Study|Lost to Follow-up|2|||
157151621|NCT06094296|567301427|FG000|Overall Study|Progressive Disease|1|||
157151622|NCT06094296|567301428|FG001|Overall Study|Progressive Disease|0|||
157151623|NCT06094296|567301429|FG002|Overall Study|Progressive Disease|0|||
157151624|NCT06094296|567301430|FG003|Overall Study|Progressive Disease|0|||
157151625|NCT00986258|567301431|FG000|Observation Period|Not eligible to be dosed|11|||
156832945|NCT05160766|566141462|FG000|Overall Study|No show|0|||
156832946|NCT05160766|566141463|FG001|Overall Study|No show|0|||
156832947|NCT05160766|566141464|FG002|Overall Study|No show|1|||
156832948|NCT05160766|566141465|FG003|Overall Study|No show|1|||
156832949|NCT05160766|566141462|FG000|Overall Study|Physician Decision|0|||
156832950|NCT05160766|566141463|FG001|Overall Study|Physician Decision|0|||
157151626|NCT00986258|567301431|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
157151627|NCT00986258|567301431|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
157151628|NCT00986258|567301431|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
157151629|NCT00986258|567301431|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
157151630|NCT00986258|567301431|FG000|Titration and Optimal Dose Period|Other|1|||
157151631|NCT00986258|567301431|FG000|Maintenance Period|Adverse Event|5|||
157151632|NCT00986258|567301431|FG000|Maintenance Period|Lack of Efficacy|2|||
157151633|NCT00986258|567301431|FG000|Maintenance Period|Withdrawal by Subject|2|||
157151634|NCT03332667|567301432|FG000|Overall Study|Adverse Event|0|||
157151635|NCT03332667|567301433|FG001|Overall Study|Adverse Event|0|||
157151636|NCT03332667|567301434|FG002|Overall Study|Adverse Event|2|||
157151637|NCT03332667|567301435|FG003|Overall Study|Adverse Event|1|||
157151638|NCT03332667|567301432|FG000|Overall Study|Withdrawal by Subject|2|||
157151639|NCT03332667|567301433|FG001|Overall Study|Withdrawal by Subject|1|||
157151640|NCT03332667|567301434|FG002|Overall Study|Withdrawal by Subject|5|||
157151641|NCT03332667|567301435|FG003|Overall Study|Withdrawal by Subject|1|||
157151642|NCT03332667|567301432|FG000|Overall Study|Disease Progression or Relapse|2|||
157151643|NCT03332667|567301433|FG001|Overall Study|Disease Progression or Relapse|1|||
157151644|NCT03332667|567301434|FG002|Overall Study|Disease Progression or Relapse|3|||
157151645|NCT03332667|567301435|FG003|Overall Study|Disease Progression or Relapse|0|||
157151646|NCT03332667|567301432|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
157151647|NCT03332667|567301433|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
157151648|NCT03332667|567301434|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
157151649|NCT03332667|567301435|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
157151650|NCT03332667|567301432|FG000|Overall Study|No Treatment Received|0|||
157151651|NCT03332667|567301433|FG001|Overall Study|No Treatment Received|0|||
157151652|NCT03332667|567301434|FG002|Overall Study|No Treatment Received|1|||
157151653|NCT03332667|567301435|FG003|Overall Study|No Treatment Received|0|||
157151654|NCT01035606|567301436|FG000|Overall Study|change in health, job demands,family|3|||
157151655|NCT01035606|567301437|FG001|Overall Study|change in health, job demands,family|3|||
157151656|NCT01035606|567301438|FG002|Overall Study|change in health, job demands,family|4|||
157151657|NCT01809262|567301439|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151658|NCT01809262|567301440|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151659|NCT01809262|567301441|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151660|NCT01809262|567301442|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151661|NCT01809262|567301443|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
156832951|NCT05160766|566141464|FG002|Overall Study|Physician Decision|0|||
156832952|NCT05160766|566141465|FG003|Overall Study|Physician Decision|1|||
156832953|NCT05160766|566141462|FG000|Overall Study|Protocol Violation|0|||
156832954|NCT05160766|566141463|FG001|Overall Study|Protocol Violation|0|||
156832955|NCT05160766|566141464|FG002|Overall Study|Protocol Violation|1|||
156832956|NCT05160766|566141465|FG003|Overall Study|Protocol Violation|0|||
156832957|NCT04284813|566141472|FG000|Overall Study|Withdrawal by Subject|1|||
156832958|NCT03106415|566141473|FG000|Phase 1|Withdrawal by Subject|1|||
156832959|NCT03106415|566141474|FG001|Phase 1|Withdrawal by Subject|0|||
156832960|NCT03106415|566141475|FG002|Phase 1|Withdrawal by Subject|0|||
156832961|NCT03106415|566141473|FG000|Phase 1|Adverse Event|1|||
156832962|NCT03106415|566141474|FG001|Phase 1|Adverse Event|1|||
156832963|NCT03106415|566141475|FG002|Phase 1|Adverse Event|0|||
156832964|NCT03106415|566141473|FG000|Phase 1|Protocol Violation|0|||
156832965|NCT03106415|566141474|FG001|Phase 1|Protocol Violation|1|||
156832966|NCT03106415|566141475|FG002|Phase 1|Protocol Violation|0|||
156832967|NCT01804582|566141476|FG000|Overall Study|Lost to Follow-up|47|||
156832968|NCT01804582|566141477|FG001|Overall Study|Lost to Follow-up|56|||
156832969|NCT01804582|566141476|FG000|Overall Study|Physician Decision|2|||
156832970|NCT01804582|566141477|FG001|Overall Study|Physician Decision|0|||
156832971|NCT00708734|566141480|FG000|Overall Study|scheduling conflict|2|||
156832972|NCT00708734|566141480|FG000|Overall Study|moved|1|||
156832973|NCT00708734|566141480|FG000|Overall Study|leg injury|1|||
156832974|NCT00708734|566141480|FG000|Overall Study|knee replacement|1|||
156832975|NCT00708734|566141480|FG000|Overall Study|vertigo|1|||
156832976|NCT00708734|566141480|FG000|Overall Study|leg fracture|1|||
156832977|NCT02634606|566141481|FG000|Overall Study|unable to obtain the drug at start|13|||
156832978|NCT00685373|566141487|FG000|Overall Study|Adverse Event|3|||
156832979|NCT00685373|566141487|FG000|Overall Study|Withdrawal by Subject|5|||
157151662|NCT01809262|567301444|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151663|NCT01809262|567301445|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151664|NCT01809262|567301446|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151665|NCT01809262|567301447|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
157151666|NCT01809262|567301448|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
156832980|NCT00685373|566141487|FG000|Overall Study|Lack of Efficacy|3|||
156832981|NCT00685373|566141487|FG000|Overall Study|Condition no longer requires study drug|1|||
156832982|NCT00685373|566141487|FG000|Overall Study|Lost to Follow-up|2|||
156832983|NCT00685373|566141487|FG000|Overall Study|Protocol Violation|1|||
156832984|NCT02758301|566141488|FG000|Overall Study|Death|12|||
156885350|NCT05395091|566338292|FG002|Baseline to Month 12|Protocol Violation|0|||
156885351|NCT05395091|566338290|FG000|Baseline to Month 12|Physician Decision|1|||
156885352|NCT05395091|566338291|FG001|Baseline to Month 12|Physician Decision|0|||
156885353|NCT05395091|566338292|FG002|Baseline to Month 12|Physician Decision|0|||
156885354|NCT05395091|566338290|FG000|Month 12 to Month 18|Death|1|||
156885355|NCT05395091|566338291|FG001|Month 12 to Month 18|Death|0|||
156885356|NCT05395091|566338292|FG002|Month 12 to Month 18|Death|0|||
156885357|NCT05395091|566338290|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
156885358|NCT05395091|566338291|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
156885359|NCT05395091|566338292|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
156885360|NCT05395091|566338290|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
156885361|NCT05395091|566338291|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
156885362|NCT05395091|566338292|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
156885363|NCT05395091|566338290|FG000|Month 12 to Month 18|Other reasons|0|||
156885364|NCT05395091|566338291|FG001|Month 12 to Month 18|Other reasons|0|||
156885365|NCT05395091|566338292|FG002|Month 12 to Month 18|Other reasons|1|||
156885366|NCT01509053|566338294|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
156885367|NCT01509053|566338294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
156885368|NCT01509053|566338294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
156885369|NCT01509053|566338294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
156885370|NCT01509053|566338294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
156885371|NCT01509053|566338294|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
156885372|NCT01915303|566338299|FG000|Core Phase|Adverse Event|7|||
156885373|NCT01915303|566338299|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
156885374|NCT01915303|566338299|FG000|Core Phase|Death|2|||
156885375|NCT01915303|566338299|FG000|Core Phase|Protocol Violation|2|||
156885376|NCT01915303|566338299|FG000|Core Phase|Abnormal lab value|1|||
156885377|NCT01915303|566338299|FG000|Core Phase|Withdrawal by Subject|1|||
156885378|NCT01915303|566338299|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
156885379|NCT01915303|566338299|FG000|Extension Phase|Withdrawal by Subject|4|||
156885380|NCT01915303|566338299|FG000|Extension Phase|Adverse Event|3|||
157151667|NCT01809262|567301439|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151668|NCT01809262|567301440|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
157151669|NCT01809262|567301441|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151670|NCT01809262|567301442|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151671|NCT01809262|567301443|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151672|NCT01809262|567301444|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151673|NCT01809262|567301445|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151674|NCT01809262|567301446|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151675|NCT01809262|567301447|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151676|NCT01809262|567301448|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
157151677|NCT01505491|567301449|FG000|Overall Study|Other reason not listed|1|||
157151678|NCT01505491|567301450|FG001|Overall Study|Other reason not listed|0|||
157151679|NCT01505491|567301451|FG002|Overall Study|Other reason not listed|0|||
157151680|NCT01505491|567301449|FG000|Overall Study|Withdrawal by Subject|1|||
157151681|NCT01505491|567301450|FG001|Overall Study|Withdrawal by Subject|1|||
157151682|NCT01505491|567301451|FG002|Overall Study|Withdrawal by Subject|4|||
157151683|NCT01505491|567301449|FG000|Overall Study|Lost to Follow-up|0|||
157151684|NCT01505491|567301450|FG001|Overall Study|Lost to Follow-up|0|||
157151685|NCT01505491|567301451|FG002|Overall Study|Lost to Follow-up|1|||
157151686|NCT03350750|567301454|FG000|Overall Study|Death|1|||
157151687|NCT03350750|567301455|FG001|Overall Study|Death|1|||
157151688|NCT01740440|567301458|FG000|Overall Study|Lost to Follow-up|3|||
157151689|NCT01264965|567301461|FG000|Overall Study|Withdrawal by Subject|10|||
157151690|NCT00406315|567301463|FG000|Overall Study|Death|1|||
157151691|NCT00406315|567301463|FG000|Overall Study|Adverse Event|39|||
157151692|NCT00406315|567301463|FG000|Overall Study|Laboratory Abnormality|4|||
157151693|NCT00406315|567301463|FG000|Overall Study|Lack of Efficacy|13|||
157151694|NCT00406315|567301463|FG000|Overall Study|Other|33|||
157151695|NCT00406315|567301463|FG000|Overall Study|Lost to Follow-up|21|||
157151696|NCT00406315|567301463|FG000|Overall Study|Withdrawal by Subject|30|||
157151697|NCT01797783|567301466|FG000|Overall Study|Adverse Event|1|||
157151698|NCT01797783|567301467|FG001|Overall Study|Adverse Event|1|||
157151699|NCT01797783|567301466|FG000|Overall Study|Withdrawal by Subject|1|||
157151700|NCT01797783|567301467|FG001|Overall Study|Withdrawal by Subject|0|||
157151701|NCT02202031|567301469|FG000|Overall Study|Lost to Follow-up|1|||
157151702|NCT02202031|567301470|FG001|Overall Study|Lost to Follow-up|0|||
157151703|NCT02202031|567301469|FG000|Overall Study|Too Busy|1|||
157151704|NCT02202031|567301470|FG001|Overall Study|Too Busy|3|||
156885381|NCT01915303|566338299|FG000|Extension Phase|Death|1|||
156885382|NCT01915303|566338299|FG000|Extension Phase|Protocol Violation|1|||
156885383|NCT02509117|566338301|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885384|NCT02509117|566338302|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
156885385|NCT02509117|566338303|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
157151705|NCT02202031|567301469|FG000|Overall Study|Illness/Medical Reason|0|||
157151706|NCT02202031|567301470|FG001|Overall Study|Illness/Medical Reason|2|||
157151707|NCT02202031|567301469|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
157151708|NCT02202031|567301470|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
157151709|NCT02184143|567301471|FG000|Overall Study|Withdrawal by Subject|4|||
157151710|NCT02184143|567301472|FG001|Overall Study|Withdrawal by Subject|4|||
157151711|NCT02184143|567301471|FG000|Overall Study|Lost to Follow-up|5|||
157151712|NCT02184143|567301472|FG001|Overall Study|Lost to Follow-up|3|||
157151713|NCT02184143|567301471|FG000|Overall Study|Death|1|||
157151714|NCT02184143|567301472|FG001|Overall Study|Death|0|||
157151715|NCT00321984|567301474|FG000|Overall Study|Adverse Event|9|||
157151716|NCT00321984|567301475|FG001|Overall Study|Adverse Event|6|||
157151717|NCT00321984|567301476|FG002|Overall Study|Adverse Event|8|||
157151718|NCT00321984|567301474|FG000|Overall Study|Protocol Violation|0|||
157151719|NCT00321984|567301475|FG001|Overall Study|Protocol Violation|1|||
157151720|NCT00321984|567301476|FG002|Overall Study|Protocol Violation|1|||
157151721|NCT00321984|567301474|FG000|Overall Study|Lost to Follow-up|2|||
157151722|NCT00321984|567301475|FG001|Overall Study|Lost to Follow-up|4|||
157151723|NCT00321984|567301476|FG002|Overall Study|Lost to Follow-up|2|||
157151724|NCT00321984|567301474|FG000|Overall Study|Withdrawal by Subject|8|||
157151725|NCT00321984|567301475|FG001|Overall Study|Withdrawal by Subject|6|||
157151726|NCT00321984|567301476|FG002|Overall Study|Withdrawal by Subject|5|||
157151727|NCT00321984|567301474|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
157151728|NCT00321984|567301475|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
157151729|NCT00321984|567301476|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
157151730|NCT00321984|567301474|FG000|Overall Study|Lack of Efficacy|3|||
157151731|NCT00321984|567301475|FG001|Overall Study|Lack of Efficacy|1|||
157151732|NCT00321984|567301476|FG002|Overall Study|Lack of Efficacy|3|||
157151733|NCT00321984|567301474|FG000|Overall Study|Noncompliant|0|||
157151734|NCT00321984|567301475|FG001|Overall Study|Noncompliant|0|||
157151735|NCT00321984|567301476|FG002|Overall Study|Noncompliant|2|||
157151736|NCT00321984|567301474|FG000|Overall Study|Pregnancy|0|||
157151737|NCT00321984|567301475|FG001|Overall Study|Pregnancy|1|||
157151738|NCT00321984|567301476|FG002|Overall Study|Pregnancy|0|||
157151739|NCT00321984|567301474|FG000|Overall Study|Per Subject Request|1|||
157151740|NCT00321984|567301475|FG001|Overall Study|Per Subject Request|0|||
157151741|NCT00321984|567301476|FG002|Overall Study|Per Subject Request|0|||
157224623|NCT00673790|567568046|FG002|Overall Study|Participated in two Nebivolol studies|1|||
156832985|NCT02758301|566141489|FG001|Overall Study|Death|0|||
156885386|NCT02509117|566338304|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885387|NCT02509117|566338305|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885388|NCT02509117|566338306|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885389|NCT02509117|566338307|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885390|NCT02509117|566338308|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885391|NCT02509117|566338309|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885392|NCT02509117|566338310|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
156885393|NCT02509117|566338301|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885394|NCT02509117|566338302|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885395|NCT02509117|566338303|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
157023456|NCT03194217|566841063|FG002|Overall Study|Failure to meet randomisation criteria|0|||
157151742|NCT00321984|567301474|FG000|Overall Study|Per Investigator Request|1|||
157151743|NCT00321984|567301475|FG001|Overall Study|Per Investigator Request|0|||
157151744|NCT00321984|567301476|FG002|Overall Study|Per Investigator Request|0|||
157151745|NCT00321984|567301474|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
156832986|NCT02758301|566141488|FG000|Overall Study|Physician Decision|10|||
156832987|NCT02758301|566141489|FG001|Overall Study|Physician Decision|1|||
156832988|NCT02758301|566141488|FG000|Overall Study|Withdrawal by Subject|5|||
156832989|NCT02758301|566141489|FG001|Overall Study|Withdrawal by Subject|6|||
156832990|NCT02758301|566141488|FG000|Overall Study|Lost to Follow-up|7|||
156832991|NCT02758301|566141489|FG001|Overall Study|Lost to Follow-up|0|||
156832992|NCT02758301|566141488|FG000|Overall Study|Protocol Violation|0|||
156832993|NCT02758301|566141489|FG001|Overall Study|Protocol Violation|1|||
156832994|NCT00582738|566141490|FG000|Overall Study|Administrative Problems|7|||
156832995|NCT00582738|566141491|FG001|Overall Study|Administrative Problems|8|||
156832996|NCT00582738|566141490|FG000|Overall Study|Adverse Event|0|||
156832997|NCT00582738|566141491|FG001|Overall Study|Adverse Event|5|||
157151746|NCT00321984|567301475|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
157151747|NCT00321984|567301476|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
157151748|NCT02214186|567301479|FG000|Overall Study|Lost to Follow-up|1|||
157151749|NCT02214186|567301480|FG001|Overall Study|Lost to Follow-up|1|||
157151750|NCT02214186|567301479|FG000|Overall Study|Protocol Violation|1|||
156832998|NCT00582738|566141490|FG000|Overall Study|Graft Lost|0|||
156832999|NCT00582738|566141491|FG001|Overall Study|Graft Lost|1|||
156833000|NCT00582738|566141490|FG000|Overall Study|Other|1|||
157151751|NCT02214186|567301480|FG001|Overall Study|Protocol Violation|1|||
157151752|NCT01525849|567301481|FG000|Overall Study|Lost to Follow-up|3|||
156833001|NCT00582738|566141491|FG001|Overall Study|Other|0|||
156833002|NCT00582738|566141490|FG000|Overall Study|Protocol Violation|1|||
156833003|NCT00582738|566141491|FG001|Overall Study|Protocol Violation|1|||
156833004|NCT00582738|566141490|FG000|Overall Study|Withdrawal by Subject|0|||
156833005|NCT00582738|566141491|FG001|Overall Study|Withdrawal by Subject|3|||
156833006|NCT01167907|566141494|FG000|Overall Study|Protocol Violation|1|||
156833007|NCT01167907|566141495|FG001|Overall Study|Protocol Violation|0|||
156833008|NCT01167907|566141494|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
156833009|NCT01167907|566141495|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
156833010|NCT01873729|566141498|FG000|Overall Study|Withdrawal by Subject|1|||
156833011|NCT01741532|566141499|FG000|Overall Study|Adverse Event|4|||
156833012|NCT01741532|566141500|FG001|Overall Study|Adverse Event|0|||
156833013|NCT01741532|566141499|FG000|Overall Study|Withdrawal by Subject|1|||
156833014|NCT01741532|566141500|FG001|Overall Study|Withdrawal by Subject|1|||
156885396|NCT02509117|566338304|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885397|NCT02509117|566338305|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885398|NCT02509117|566338306|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885399|NCT02509117|566338307|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885400|NCT02509117|566338308|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885401|NCT02509117|566338309|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
156885402|NCT02509117|566338310|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
156885403|NCT02509117|566338301|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885404|NCT02509117|566338302|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885405|NCT02509117|566338303|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885406|NCT02509117|566338304|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885407|NCT02509117|566338305|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885408|NCT02509117|566338306|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885409|NCT02509117|566338307|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885410|NCT02509117|566338308|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885411|NCT02509117|566338309|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
156885412|NCT02509117|566338310|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
156885413|NCT00832624|566338311|FG000|Overall Study|Study Terminated|10|||
156885414|NCT00548184|566338314|FG000|Overall Study|Adverse Event|3|||
156885415|NCT00548184|566338314|FG000|Overall Study|took other drug|1|||
156885416|NCT00548184|566338314|FG000|Overall Study|Found Her2 negative|1|||
157151753|NCT01525849|567301482|FG001|Overall Study|Lost to Follow-up|2|||
157151754|NCT01525849|567301481|FG000|Overall Study|Withdrawal by Subject|1|||
157151755|NCT01525849|567301482|FG001|Overall Study|Withdrawal by Subject|9|||
157151756|NCT01525849|567301481|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
157151757|NCT01525849|567301482|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
157151758|NCT01525849|567301481|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
157151759|NCT01525849|567301482|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
157151760|NCT01024465|567301487|FG000|Overall Study|Adverse Event|2|||
157151761|NCT01024465|567301487|FG000|Overall Study|Physician Decision|1|||
157151762|NCT03078608|567301490|FG000|Overall Study|Death|1|||
157151763|NCT03078608|567301491|FG001|Overall Study|Death|2|||
157151764|NCT03078608|567301492|FG002|Overall Study|Death|0|||
157151765|NCT03078608|567301493|FG003|Overall Study|Death|0|||
157151766|NCT03078608|567301490|FG000|Overall Study|Withdrawal by Subject|8|||
157151767|NCT03078608|567301491|FG001|Overall Study|Withdrawal by Subject|1|||
157151768|NCT03078608|567301492|FG002|Overall Study|Withdrawal by Subject|0|||
157151769|NCT03078608|567301493|FG003|Overall Study|Withdrawal by Subject|0|||
157151770|NCT03078608|567301490|FG000|Overall Study|Lost to Follow-up|5|||
157151771|NCT03078608|567301491|FG001|Overall Study|Lost to Follow-up|8|||
157151772|NCT03078608|567301492|FG002|Overall Study|Lost to Follow-up|4|||
157151773|NCT03078608|567301493|FG003|Overall Study|Lost to Follow-up|1|||
157151774|NCT00723840|567301494|FG000|Overall Study|Lost to Follow-up|2|||
157151775|NCT00723840|567301494|FG000|Overall Study|Failure to return|18|||
157151776|NCT00723840|567301494|FG000|Overall Study|Withdrawal by Subject|55|||
157151777|NCT00723840|567301494|FG000|Overall Study|Serious Adverse Events|3|||
157151778|NCT00723840|567301494|FG000|Overall Study|Other Medical Event|2|||
157151779|NCT00723840|567301494|FG000|Overall Study|Unspecified reason|2|||
157151780|NCT03303339|567301495|FG000|Overall Study|Death|2|||
157151781|NCT03303339|567301496|FG001|Overall Study|Death|2|||
157151782|NCT03303339|567301497|FG002|Overall Study|Death|2|||
157151783|NCT03303339|567301498|FG003|Overall Study|Death|1|||
157151784|NCT03303339|567301499|FG004|Overall Study|Death|4|||
157151785|NCT03303339|567301500|FG005|Overall Study|Death|2|||
156833015|NCT01741532|566141499|FG000|Overall Study|Protocol Violation|0|||
156833016|NCT01741532|566141500|FG001|Overall Study|Protocol Violation|1|||
156833017|NCT01741532|566141499|FG000|Overall Study|Worsening of the disease|3|||
156833018|NCT01741532|566141500|FG001|Overall Study|Worsening of the disease|1|||
157151786|NCT03303339|567301501|FG006|Overall Study|Death|2|||
157151787|NCT03303339|567301502|FG007|Overall Study|Death|2|||
156833019|NCT01741532|566141499|FG000|Overall Study|Sponsor decision|1|||
156833020|NCT01741532|566141500|FG001|Overall Study|Sponsor decision|0|||
156833021|NCT01741532|566141499|FG000|Overall Study|Medical event|1|||
156833022|NCT01741532|566141500|FG001|Overall Study|Medical event|0|||
156833023|NCT01066780|566141501|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
156833024|NCT01066780|566141502|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
156833025|NCT00613080|566141503|FG000|Overall Study|Ineligible / no protocol treatment|11|||
156833026|NCT03099148|566141504|FG000|Wash-out|scheduling conflict|0|||
156885417|NCT00280748|566338318|FG000|Overall Study|Decline in performance|3|||
156885418|NCT00280748|566338318|FG000|Overall Study|Extra-cranial disease progression|1|||
156885419|NCT01433250|566338319|FG000|Overall Study|Protocol Violation|0|||
156885420|NCT01433250|566338320|FG001|Overall Study|Protocol Violation|1|||
156885421|NCT01433250|566338319|FG000|Overall Study|Withdrawal by Subject|3|||
156885422|NCT01433250|566338320|FG001|Overall Study|Withdrawal by Subject|2|||
156885423|NCT03148691|566338321|FG000|Overall Study|Protocol Violation|1|||
157151788|NCT03303339|567301503|FG008|Overall Study|Death|3|||
157151789|NCT03303339|567301504|FG009|Overall Study|Death|3|||
157151790|NCT03303339|567301505|FG010|Overall Study|Death|4|||
157151791|NCT03303339|567301506|FG011|Overall Study|Death|24|||
157151792|NCT03303339|567301495|FG000|Overall Study|Study Terminated by Sponsor|0|||
157151793|NCT03303339|567301496|FG001|Overall Study|Study Terminated by Sponsor|0|||
157151794|NCT03303339|567301497|FG002|Overall Study|Study Terminated by Sponsor|0|||
157151795|NCT03303339|567301498|FG003|Overall Study|Study Terminated by Sponsor|0|||
157151796|NCT03303339|567301499|FG004|Overall Study|Study Terminated by Sponsor|0|||
157151797|NCT03303339|567301500|FG005|Overall Study|Study Terminated by Sponsor|0|||
157151798|NCT03303339|567301501|FG006|Overall Study|Study Terminated by Sponsor|0|||
157151799|NCT03303339|567301502|FG007|Overall Study|Study Terminated by Sponsor|0|||
157151800|NCT03303339|567301503|FG008|Overall Study|Study Terminated by Sponsor|1|||
157151801|NCT03303339|567301504|FG009|Overall Study|Study Terminated by Sponsor|0|||
157151802|NCT03303339|567301505|FG010|Overall Study|Study Terminated by Sponsor|1|||
157151803|NCT03303339|567301506|FG011|Overall Study|Study Terminated by Sponsor|1|||
157151804|NCT03303339|567301495|FG000|Overall Study|Withdrawal by Subject|1|||
157151805|NCT03303339|567301496|FG001|Overall Study|Withdrawal by Subject|0|||
157151806|NCT03303339|567301497|FG002|Overall Study|Withdrawal by Subject|0|||
157151807|NCT03303339|567301498|FG003|Overall Study|Withdrawal by Subject|0|||
157151808|NCT03303339|567301499|FG004|Overall Study|Withdrawal by Subject|0|||
157151809|NCT03303339|567301500|FG005|Overall Study|Withdrawal by Subject|1|||
157151810|NCT03303339|567301501|FG006|Overall Study|Withdrawal by Subject|1|||
157151811|NCT03303339|567301502|FG007|Overall Study|Withdrawal by Subject|0|||
157151812|NCT03303339|567301503|FG008|Overall Study|Withdrawal by Subject|0|||
157151813|NCT03303339|567301504|FG009|Overall Study|Withdrawal by Subject|0|||
157151814|NCT03303339|567301505|FG010|Overall Study|Withdrawal by Subject|0|||
157151815|NCT03303339|567301506|FG011|Overall Study|Withdrawal by Subject|2|||
157151816|NCT03303339|567301495|FG000|Overall Study|Physician Decision|0|||
156833027|NCT03099148|566141505|FG001|Wash-out|scheduling conflict|1|||
156833028|NCT03099148|566141506|FG002|Wash-out|scheduling conflict|0|||
156833029|NCT03099148|566141507|FG003|Wash-out|scheduling conflict|0|||
156833030|NCT03099148|566141504|FG000|Wash-out|Adverse Event|0|||
156833031|NCT03099148|566141505|FG001|Wash-out|Adverse Event|1|||
156833032|NCT03099148|566141506|FG002|Wash-out|Adverse Event|0|||
156833033|NCT03099148|566141507|FG003|Wash-out|Adverse Event|0|||
156833034|NCT02124772|566141509|FG000|Overall Study|Lack of Efficacy|2|||
156833035|NCT02124772|566141510|FG001|Overall Study|Lack of Efficacy|0|||
156833036|NCT02124772|566141511|FG002|Overall Study|Lack of Efficacy|0|||
156833037|NCT02124772|566141512|FG003|Overall Study|Lack of Efficacy|1|||
156885424|NCT03148691|566338322|FG001|Overall Study|Protocol Violation|2|||
156885425|NCT03148691|566338323|FG002|Overall Study|Protocol Violation|7|||
156885426|NCT03148691|566338321|FG000|Overall Study|Lost to Follow-up|0|||
156885427|NCT03148691|566338322|FG001|Overall Study|Lost to Follow-up|0|||
156885428|NCT03148691|566338323|FG002|Overall Study|Lost to Follow-up|1|||
156885429|NCT03148691|566338321|FG000|Overall Study|Other|1|||
156885430|NCT03148691|566338322|FG001|Overall Study|Other|0|||
156885431|NCT03148691|566338323|FG002|Overall Study|Other|0|||
156885432|NCT03148691|566338321|FG000|Overall Study|Withdrawal by Subject|1|||
156885433|NCT03148691|566338322|FG001|Overall Study|Withdrawal by Subject|0|||
157151817|NCT03303339|567301496|FG001|Overall Study|Physician Decision|0|||
157151818|NCT03303339|567301497|FG002|Overall Study|Physician Decision|0|||
157151819|NCT03303339|567301498|FG003|Overall Study|Physician Decision|0|||
157151820|NCT03303339|567301499|FG004|Overall Study|Physician Decision|1|||
156833038|NCT02124772|566141513|FG004|Overall Study|Lack of Efficacy|2|||
156833039|NCT02124772|566141514|FG005|Overall Study|Lack of Efficacy|3|||
156833040|NCT02124772|566141515|FG006|Overall Study|Lack of Efficacy|0|||
156833041|NCT02124772|566141516|FG007|Overall Study|Lack of Efficacy|2|||
156833042|NCT02124772|566141517|FG008|Overall Study|Lack of Efficacy|0|||
156885434|NCT03148691|566338323|FG002|Overall Study|Withdrawal by Subject|0|||
156885435|NCT01375075|566338328|FG000|Overall Study|Adverse Event|0|||
156885436|NCT01375075|566338329|FG001|Overall Study|Adverse Event|0|||
157151821|NCT03303339|567301500|FG005|Overall Study|Physician Decision|0|||
157151822|NCT03303339|567301501|FG006|Overall Study|Physician Decision|0|||
156833043|NCT02124772|566141518|FG009|Overall Study|Lack of Efficacy|1|||
156833044|NCT02124772|566141519|FG010|Overall Study|Lack of Efficacy|0|||
156833045|NCT02124772|566141520|FG011|Overall Study|Lack of Efficacy|0|||
156833046|NCT02124772|566141521|FG012|Overall Study|Lack of Efficacy|1|||
156833047|NCT02124772|566141509|FG000|Overall Study|Adverse Event|1|||
156833048|NCT02124772|566141510|FG001|Overall Study|Adverse Event|4|||
156833049|NCT02124772|566141511|FG002|Overall Study|Adverse Event|1|||
156833050|NCT02124772|566141512|FG003|Overall Study|Adverse Event|5|||
156833051|NCT02124772|566141513|FG004|Overall Study|Adverse Event|2|||
156833052|NCT02124772|566141514|FG005|Overall Study|Adverse Event|1|||
156833053|NCT02124772|566141515|FG006|Overall Study|Adverse Event|1|||
156833054|NCT02124772|566141516|FG007|Overall Study|Adverse Event|5|||
156833055|NCT02124772|566141517|FG008|Overall Study|Adverse Event|0|||
156833056|NCT02124772|566141518|FG009|Overall Study|Adverse Event|3|||
156833057|NCT02124772|566141519|FG010|Overall Study|Adverse Event|1|||
156833058|NCT02124772|566141520|FG011|Overall Study|Adverse Event|3|||
156833059|NCT02124772|566141521|FG012|Overall Study|Adverse Event|1|||
156833060|NCT02124772|566141509|FG000|Overall Study|Withdrawal consent|0|||
156833061|NCT02124772|566141510|FG001|Overall Study|Withdrawal consent|1|||
156833062|NCT02124772|566141511|FG002|Overall Study|Withdrawal consent|1|||
156833063|NCT02124772|566141512|FG003|Overall Study|Withdrawal consent|1|||
156833064|NCT02124772|566141513|FG004|Overall Study|Withdrawal consent|0|||
156833065|NCT02124772|566141514|FG005|Overall Study|Withdrawal consent|1|||
156833066|NCT02124772|566141515|FG006|Overall Study|Withdrawal consent|1|||
156833067|NCT02124772|566141516|FG007|Overall Study|Withdrawal consent|0|||
156833068|NCT02124772|566141517|FG008|Overall Study|Withdrawal consent|0|||
156833069|NCT02124772|566141518|FG009|Overall Study|Withdrawal consent|1|||
156833070|NCT02124772|566141519|FG010|Overall Study|Withdrawal consent|0|||
156833071|NCT02124772|566141520|FG011|Overall Study|Withdrawal consent|1|||
156833072|NCT02124772|566141521|FG012|Overall Study|Withdrawal consent|0|||
156833073|NCT02124772|566141509|FG000|Overall Study|Investigator discretion|0|||
156833074|NCT02124772|566141510|FG001|Overall Study|Investigator discretion|2|||
156833075|NCT02124772|566141511|FG002|Overall Study|Investigator discretion|2|||
156833076|NCT02124772|566141512|FG003|Overall Study|Investigator discretion|1|||
156833077|NCT02124772|566141513|FG004|Overall Study|Investigator discretion|1|||
156833078|NCT02124772|566141514|FG005|Overall Study|Investigator discretion|0|||
156833079|NCT02124772|566141515|FG006|Overall Study|Investigator discretion|1|||
156833080|NCT02124772|566141516|FG007|Overall Study|Investigator discretion|0|||
156833081|NCT02124772|566141517|FG008|Overall Study|Investigator discretion|0|||
156833082|NCT02124772|566141518|FG009|Overall Study|Investigator discretion|1|||
156833083|NCT02124772|566141519|FG010|Overall Study|Investigator discretion|0|||
156833084|NCT02124772|566141520|FG011|Overall Study|Investigator discretion|1|||
156833085|NCT02124772|566141521|FG012|Overall Study|Investigator discretion|0|||
156833086|NCT02124772|566141509|FG000|Overall Study|Progressive disease|0|||
156833087|NCT02124772|566141510|FG001|Overall Study|Progressive disease|0|||
156833088|NCT02124772|566141511|FG002|Overall Study|Progressive disease|0|||
156833089|NCT02124772|566141512|FG003|Overall Study|Progressive disease|0|||
156833090|NCT02124772|566141513|FG004|Overall Study|Progressive disease|0|||
156833091|NCT02124772|566141514|FG005|Overall Study|Progressive disease|0|||
156833092|NCT02124772|566141515|FG006|Overall Study|Progressive disease|1|||
156833093|NCT02124772|566141516|FG007|Overall Study|Progressive disease|1|||
156833094|NCT02124772|566141517|FG008|Overall Study|Progressive disease|0|||
156833095|NCT02124772|566141518|FG009|Overall Study|Progressive disease|0|||
156833096|NCT02124772|566141519|FG010|Overall Study|Progressive disease|0|||
156833097|NCT02124772|566141520|FG011|Overall Study|Progressive disease|0|||
156833098|NCT02124772|566141521|FG012|Overall Study|Progressive disease|0|||
156833099|NCT02124772|566141509|FG000|Overall Study|Other|0|||
156833100|NCT02124772|566141510|FG001|Overall Study|Other|7|||
156833101|NCT02124772|566141511|FG002|Overall Study|Other|2|||
156833102|NCT02124772|566141512|FG003|Overall Study|Other|5|||
156833103|NCT02124772|566141513|FG004|Overall Study|Other|4|||
156833104|NCT02124772|566141514|FG005|Overall Study|Other|3|||
156885437|NCT01375075|566338330|FG002|Overall Study|Adverse Event|3|||
156885438|NCT01375075|566338331|FG003|Overall Study|Adverse Event|1|||
156833105|NCT02124772|566141515|FG006|Overall Study|Other|4|||
156833106|NCT02124772|566141516|FG007|Overall Study|Other|1|||
156833107|NCT02124772|566141517|FG008|Overall Study|Other|1|||
156885439|NCT01375075|566338332|FG004|Overall Study|Adverse Event|0|||
156833108|NCT02124772|566141518|FG009|Overall Study|Other|1|||
156833109|NCT02124772|566141519|FG010|Overall Study|Other|1|||
156833110|NCT02124772|566141520|FG011|Overall Study|Other|1|||
156833111|NCT02124772|566141521|FG012|Overall Study|Other|0|||
156833112|NCT01827332|566141522|FG000|Overall Study|Lost to Follow-up|2|||
156833113|NCT01827332|566141523|FG001|Overall Study|Lost to Follow-up|1|||
156833114|NCT02725593|566141524|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
156833115|NCT02725593|566141525|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
156833116|NCT02725593|566141524|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
156833117|NCT02725593|566141525|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
156833118|NCT02725593|566141524|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
156885440|NCT01375075|566338333|FG005|Overall Study|Adverse Event|1|||
156885441|NCT01375075|566338328|FG000|Overall Study|Entry Criterion Not Met|1|||
156885442|NCT01375075|566338329|FG001|Overall Study|Entry Criterion Not Met|0|||
156885443|NCT01375075|566338330|FG002|Overall Study|Entry Criterion Not Met|0|||
156885444|NCT01375075|566338331|FG003|Overall Study|Entry Criterion Not Met|0|||
156885445|NCT01375075|566338332|FG004|Overall Study|Entry Criterion Not Met|0|||
156885446|NCT01375075|566338333|FG005|Overall Study|Entry Criterion Not Met|1|||
156885447|NCT01375075|566338328|FG000|Overall Study|Withdrawal by Subject|0|||
156885448|NCT01375075|566338329|FG001|Overall Study|Withdrawal by Subject|1|||
156885449|NCT01375075|566338330|FG002|Overall Study|Withdrawal by Subject|0|||
156885450|NCT01375075|566338331|FG003|Overall Study|Withdrawal by Subject|0|||
156885451|NCT01375075|566338332|FG004|Overall Study|Withdrawal by Subject|0|||
156885452|NCT01375075|566338333|FG005|Overall Study|Withdrawal by Subject|1|||
157023457|NCT03194217|566841064|FG003|Overall Study|Failure to meet randomisation criteria|1|||
157023458|NCT03194217|566841061|FG000|Overall Study|Other|0|||
156885453|NCT01576159|566338334|FG000|Overall Study|Withdrawal by Subject|0|||
156885454|NCT01576159|566338335|FG001|Overall Study|Withdrawal by Subject|1|||
156885455|NCT01576159|566338336|FG002|Overall Study|Withdrawal by Subject|0|||
156885456|NCT01576159|566338337|FG003|Overall Study|Withdrawal by Subject|0|||
156885457|NCT01576159|566338334|FG000|Overall Study|Physician Decision|0|||
156885458|NCT01576159|566338335|FG001|Overall Study|Physician Decision|0|||
156885459|NCT01576159|566338336|FG002|Overall Study|Physician Decision|1|||
156885460|NCT01576159|566338337|FG003|Overall Study|Physician Decision|0|||
156885461|NCT01576159|566338334|FG000|Overall Study|Lost to Follow-up|0|||
156885462|NCT01576159|566338335|FG001|Overall Study|Lost to Follow-up|0|||
156885463|NCT01576159|566338336|FG002|Overall Study|Lost to Follow-up|0|||
156885464|NCT01576159|566338337|FG003|Overall Study|Lost to Follow-up|1|||
157151823|NCT03303339|567301502|FG007|Overall Study|Physician Decision|0|||
157151824|NCT03303339|567301503|FG008|Overall Study|Physician Decision|0|||
157151825|NCT03303339|567301504|FG009|Overall Study|Physician Decision|0|||
157151826|NCT03303339|567301505|FG010|Overall Study|Physician Decision|0|||
157151827|NCT03303339|567301506|FG011|Overall Study|Physician Decision|0|||
157151828|NCT03303339|567301495|FG000|Overall Study|Safety/Non-compliance|0|||
157151829|NCT03303339|567301496|FG001|Overall Study|Safety/Non-compliance|0|||
157151830|NCT03303339|567301497|FG002|Overall Study|Safety/Non-compliance|0|||
157151831|NCT03303339|567301498|FG003|Overall Study|Safety/Non-compliance|0|||
157151832|NCT03303339|567301499|FG004|Overall Study|Safety/Non-compliance|0|||
157151833|NCT03303339|567301500|FG005|Overall Study|Safety/Non-compliance|0|||
157151834|NCT03303339|567301501|FG006|Overall Study|Safety/Non-compliance|0|||
157151835|NCT03303339|567301502|FG007|Overall Study|Safety/Non-compliance|0|||
157151836|NCT03303339|567301503|FG008|Overall Study|Safety/Non-compliance|0|||
157151837|NCT03303339|567301504|FG009|Overall Study|Safety/Non-compliance|0|||
157151838|NCT03303339|567301505|FG010|Overall Study|Safety/Non-compliance|0|||
157151839|NCT03303339|567301506|FG011|Overall Study|Safety/Non-compliance|1|||
157151840|NCT03694522|567301507|FG000|Overall Study|Withdrawal by Subject|8|||
157151841|NCT03694522|567301508|FG001|Overall Study|Withdrawal by Subject|10|||
157151842|NCT03694522|567301507|FG000|Overall Study|Physician Decision|53|||
157151843|NCT03694522|567301508|FG001|Overall Study|Physician Decision|54|||
157151844|NCT03694522|567301507|FG000|Overall Study|Other|1|||
157151845|NCT03694522|567301508|FG001|Overall Study|Other|1|||
157151846|NCT03694522|567301507|FG000|Overall Study|Lost to Follow-up|0|||
157151847|NCT03694522|567301508|FG001|Overall Study|Lost to Follow-up|1|||
157151848|NCT02760407|567301509|FG000|Overall Study|Death|2|||
157151849|NCT02760407|567301510|FG001|Overall Study|Death|3|||
157151850|NCT02760407|567301511|FG002|Overall Study|Death|1|||
156885465|NCT01576159|566338334|FG000|Overall Study|Protocol Violation|1|||
156885466|NCT01576159|566338335|FG001|Overall Study|Protocol Violation|0|||
157023459|NCT03194217|566841062|FG001|Overall Study|Other|1|||
157023460|NCT03194217|566841063|FG002|Overall Study|Other|1|||
157023461|NCT03194217|566841064|FG003|Overall Study|Other|0|||
157023462|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
157023463|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
157023464|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
157023465|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
157023466|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
157023467|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
157151851|NCT02760407|567301512|FG003|Overall Study|Death|1|||
157151852|NCT02760407|567301509|FG000|Overall Study|Lost to Follow-up|1|||
157151853|NCT02760407|567301510|FG001|Overall Study|Lost to Follow-up|7|||
157151854|NCT02760407|567301511|FG002|Overall Study|Lost to Follow-up|4|||
157151855|NCT02760407|567301512|FG003|Overall Study|Lost to Follow-up|6|||
156885467|NCT01576159|566338336|FG002|Overall Study|Protocol Violation|0|||
157151856|NCT02760407|567301509|FG000|Overall Study|Withdrawal by Subject|25|||
156885468|NCT01576159|566338337|FG003|Overall Study|Protocol Violation|0|||
156885469|NCT00311584|566338338|FG000|Overall Study|Death|1|||
156885470|NCT00311584|566338339|FG001|Overall Study|Death|0|||
156885471|NCT00311584|566338338|FG000|Overall Study|Lack of Efficacy|12|||
156885472|NCT00311584|566338339|FG001|Overall Study|Lack of Efficacy|15|||
156833119|NCT02725593|566141525|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
156833120|NCT02725593|566141524|FG000|Long Term Extension|Withdrawal by Subject|1|||
156833121|NCT02725593|566141525|FG001|Long Term Extension|Withdrawal by Subject|3|||
156833122|NCT01522404|566141526|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
156833123|NCT01522404|566141527|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
156833124|NCT01522404|566141526|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
156833125|NCT01522404|566141527|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
156833126|NCT01522404|566141526|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
156833127|NCT01522404|566141527|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
156885473|NCT00311584|566338338|FG000|Overall Study|Physician Decision|4|||
156885474|NCT00311584|566338339|FG001|Overall Study|Physician Decision|5|||
156885475|NCT00311584|566338338|FG000|Overall Study|Withdrawal by Subject|1|||
156885476|NCT00311584|566338339|FG001|Overall Study|Withdrawal by Subject|1|||
156885477|NCT00311584|566338338|FG000|Overall Study|ineligible|2|||
156885478|NCT00311584|566338339|FG001|Overall Study|ineligible|2|||
156885479|NCT01454778|566338340|FG000|Overall Study|Lost to Follow-up|2|||
156885480|NCT01454778|566338340|FG000|Overall Study|Death|1|||
156885481|NCT01227629|566338342|FG000|Overall Study|Adverse Event|2|||
156885482|NCT01227629|566338343|FG001|Overall Study|Adverse Event|2|||
156885483|NCT01227629|566338344|FG002|Overall Study|Adverse Event|1|||
156885484|NCT01227629|566338345|FG003|Overall Study|Adverse Event|6|||
156885485|NCT01227629|566338346|FG004|Overall Study|Adverse Event|1|||
156885486|NCT01227629|566338347|FG005|Overall Study|Adverse Event|1|||
156885487|NCT01227629|566338348|FG006|Overall Study|Adverse Event|6|||
156885488|NCT01227629|566338349|FG007|Overall Study|Adverse Event|6|||
156885489|NCT01227629|566338350|FG008|Overall Study|Adverse Event|4|||
156885490|NCT01227629|566338351|FG009|Overall Study|Adverse Event|0|||
156885491|NCT01227629|566338342|FG000|Overall Study|Protocol Violation|0|||
156885492|NCT01227629|566338343|FG001|Overall Study|Protocol Violation|0|||
156885493|NCT01227629|566338344|FG002|Overall Study|Protocol Violation|0|||
156885494|NCT01227629|566338345|FG003|Overall Study|Protocol Violation|1|||
156885495|NCT01227629|566338346|FG004|Overall Study|Protocol Violation|0|||
156885496|NCT01227629|566338347|FG005|Overall Study|Protocol Violation|0|||
156885497|NCT01227629|566338348|FG006|Overall Study|Protocol Violation|0|||
156885498|NCT01227629|566338349|FG007|Overall Study|Protocol Violation|0|||
156885499|NCT01227629|566338350|FG008|Overall Study|Protocol Violation|0|||
156885500|NCT01227629|566338351|FG009|Overall Study|Protocol Violation|0|||
156885501|NCT01227629|566338342|FG000|Overall Study|Lost to Follow-up|0|||
156885502|NCT01227629|566338343|FG001|Overall Study|Lost to Follow-up|0|||
156885503|NCT01227629|566338344|FG002|Overall Study|Lost to Follow-up|0|||
156885504|NCT01227629|566338345|FG003|Overall Study|Lost to Follow-up|0|||
156885505|NCT01227629|566338346|FG004|Overall Study|Lost to Follow-up|1|||
156885506|NCT01227629|566338347|FG005|Overall Study|Lost to Follow-up|0|||
156885507|NCT01227629|566338348|FG006|Overall Study|Lost to Follow-up|0|||
156885508|NCT01227629|566338349|FG007|Overall Study|Lost to Follow-up|0|||
156885509|NCT01227629|566338350|FG008|Overall Study|Lost to Follow-up|0|||
156885510|NCT01227629|566338351|FG009|Overall Study|Lost to Follow-up|0|||
156885511|NCT01227629|566338342|FG000|Overall Study|Withdrawal by Subject|0|||
156885512|NCT01227629|566338343|FG001|Overall Study|Withdrawal by Subject|0|||
156885513|NCT01227629|566338344|FG002|Overall Study|Withdrawal by Subject|0|||
156885514|NCT01227629|566338345|FG003|Overall Study|Withdrawal by Subject|0|||
156885515|NCT01227629|566338346|FG004|Overall Study|Withdrawal by Subject|0|||
156885516|NCT01227629|566338347|FG005|Overall Study|Withdrawal by Subject|0|||
156885517|NCT01227629|566338348|FG006|Overall Study|Withdrawal by Subject|2|||
156885518|NCT01227629|566338349|FG007|Overall Study|Withdrawal by Subject|0|||
156885519|NCT01227629|566338350|FG008|Overall Study|Withdrawal by Subject|0|||
156885520|NCT01227629|566338351|FG009|Overall Study|Withdrawal by Subject|1|||
156885521|NCT01227629|566338342|FG000|Overall Study|Other|0|||
156885522|NCT01227629|566338343|FG001|Overall Study|Other|0|||
156885523|NCT01227629|566338344|FG002|Overall Study|Other|0|||
156885524|NCT01227629|566338345|FG003|Overall Study|Other|1|||
157151857|NCT02760407|567301510|FG001|Overall Study|Withdrawal by Subject|31|||
156885525|NCT01227629|566338346|FG004|Overall Study|Other|0|||
156885526|NCT01227629|566338347|FG005|Overall Study|Other|0|||
156885527|NCT01227629|566338348|FG006|Overall Study|Other|0|||
156885528|NCT01227629|566338349|FG007|Overall Study|Other|0|||
157151858|NCT02760407|567301511|FG002|Overall Study|Withdrawal by Subject|37|||
156885529|NCT01227629|566338350|FG008|Overall Study|Other|2|||
156885530|NCT01227629|566338351|FG009|Overall Study|Other|1|||
156885531|NCT01011478|566340026|FG000|Overall Study|No follow up data|12|||
156885532|NCT01011478|566340027|FG001|Overall Study|No follow up data|7|||
156885533|NCT04461600|566340028|FG000|Overall Study|Death|6|||
156885534|NCT04461600|566340029|FG001|Overall Study|Death|5|||
156885535|NCT04461600|566340028|FG000|Overall Study|Withdrawal by Subject|0|||
156885536|NCT04461600|566340029|FG001|Overall Study|Withdrawal by Subject|1|||
156885537|NCT02278471|566340033|FG000|Overall Study|Lost to Follow-up|6|||
156885538|NCT02278471|566340034|FG001|Overall Study|Lost to Follow-up|15|||
156885539|NCT02278471|566340033|FG000|Overall Study|Death|2|||
156885540|NCT02278471|566340034|FG001|Overall Study|Death|2|||
156885541|NCT02278471|566340033|FG000|Overall Study|Withdrawal by Subject|0|||
156833128|NCT02698371|566141528|FG000|All Participants Flow|Lost to Follow-up|3|||
156833129|NCT02698371|566141528|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
156833130|NCT02698371|566141528|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
156833131|NCT02698371|566141528|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
156833132|NCT02698371|566141528|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
156833133|NCT02698371|566141528|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
156833134|NCT02698371|566141528|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
156833135|NCT01440881|566141534|FG000|Overall Study|Death|0|||
156833136|NCT01440881|566141535|FG001|Overall Study|Death|1|||
156833137|NCT02644356|566141538|FG000|Overall Study|Withdrawal by Subject|2|||
156833138|NCT02210091|566141539|FG000|Overall Study|Physician Decision|0|||
156833139|NCT02210091|566141540|FG001|Overall Study|Physician Decision|1|||
156833140|NCT02210091|566141539|FG000|Overall Study|Withdrawal by Sponsor|0|||
156833141|NCT02210091|566141540|FG001|Overall Study|Withdrawal by Sponsor|1|||
156833142|NCT02290938|566141541|FG000|Overall Study|Lost to Follow-up|14|||
156833143|NCT02290938|566141542|FG001|Overall Study|Lost to Follow-up|43|||
156833144|NCT00897390|566141543|FG000|Overall Study|Adverse Event|2|||
156833145|NCT00897390|566141543|FG000|Overall Study|No Longer Met Study Criteria|1|||
156833146|NCT00897390|566141543|FG000|Overall Study|Personal Reasons|1|||
157151859|NCT02760407|567301512|FG003|Overall Study|Withdrawal by Subject|25|||
157151860|NCT02760407|567301509|FG000|Overall Study|Violation of Eligibility criteria|0|||
157151861|NCT02760407|567301510|FG001|Overall Study|Violation of Eligibility criteria|0|||
157151862|NCT02760407|567301511|FG002|Overall Study|Violation of Eligibility criteria|1|||
157151863|NCT02760407|567301512|FG003|Overall Study|Violation of Eligibility criteria|1|||
157151864|NCT02760407|567301509|FG000|Overall Study|Personal reasons|0|||
157151865|NCT02760407|567301510|FG001|Overall Study|Personal reasons|0|||
157151866|NCT02760407|567301511|FG002|Overall Study|Personal reasons|0|||
157151867|NCT02760407|567301512|FG003|Overall Study|Personal reasons|1|||
157151868|NCT02760407|567301509|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
157151869|NCT02760407|567301510|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
157151870|NCT02760407|567301511|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
157151871|NCT02760407|567301512|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
157151872|NCT02760407|567301509|FG000|Overall Study|Use of prohibited Medication|0|||
157151873|NCT02760407|567301510|FG001|Overall Study|Use of prohibited Medication|0|||
157151874|NCT02760407|567301511|FG002|Overall Study|Use of prohibited Medication|1|||
157151875|NCT02760407|567301512|FG003|Overall Study|Use of prohibited Medication|0|||
157151876|NCT02760407|567301509|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
157151877|NCT02760407|567301510|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
157151878|NCT02760407|567301511|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
157151879|NCT02760407|567301512|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
157151880|NCT02760407|567301509|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
157151881|NCT02760407|567301510|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
157151882|NCT02760407|567301511|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
157151883|NCT02760407|567301512|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
157151884|NCT02760407|567301509|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
157151885|NCT02760407|567301510|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
157151886|NCT02760407|567301511|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
157151887|NCT02760407|567301512|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
157151888|NCT02760407|567301509|FG000|Overall Study|Inadequately Enrolled|0|||
157151889|NCT02760407|567301510|FG001|Overall Study|Inadequately Enrolled|0|||
157151890|NCT02760407|567301511|FG002|Overall Study|Inadequately Enrolled|0|||
157151891|NCT02760407|567301512|FG003|Overall Study|Inadequately Enrolled|1|||
157151892|NCT02760407|567301509|FG000|Overall Study|Withdrawal By PI's Decision|0|||
157151893|NCT02760407|567301510|FG001|Overall Study|Withdrawal By PI's Decision|1|||
157151894|NCT02760407|567301511|FG002|Overall Study|Withdrawal By PI's Decision|0|||
157151895|NCT02760407|567301512|FG003|Overall Study|Withdrawal By PI's Decision|0|||
157151896|NCT02760407|567301509|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
157151897|NCT02760407|567301510|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
157151898|NCT02760407|567301511|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
157151899|NCT02760407|567301512|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
156833147|NCT00897390|566141543|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
156833148|NCT01023672|566143115|FG000|Overall Study|Worsening disease|2|||
156833149|NCT01023672|566143115|FG000|Overall Study|Death|1|||
156833150|NCT01282294|566143116|FG000|Overall Study|Lost to Follow-up|14|||
156833151|NCT01282294|566143116|FG000|Overall Study|Screening failure|1|||
156833152|NCT01282294|566143116|FG000|Overall Study|Adverse Event|1|||
157224624|NCT00673790|567568044|FG000|Overall Study|Unconfirmed pregnancy|0|||
157224625|NCT00673790|567568045|FG001|Overall Study|Unconfirmed pregnancy|1|||
157224626|NCT00673790|567568046|FG002|Overall Study|Unconfirmed pregnancy|0|||
157224627|NCT00673790|567568044|FG000|Overall Study|Randomization criteria not met|0|||
157224628|NCT00673790|567568045|FG001|Overall Study|Randomization criteria not met|1|||
157224629|NCT00673790|567568046|FG002|Overall Study|Randomization criteria not met|0|||
157224630|NCT00306384|567568047|FG000|Overall Study|Adverse Event|103|||
156885542|NCT02278471|566340034|FG001|Overall Study|Withdrawal by Subject|3|||
156885543|NCT01437995|566340037|FG000|Overall Study|Lost to Follow-up|11|||
156885544|NCT01437995|566340038|FG001|Overall Study|Lost to Follow-up|18|||
156885545|NCT01437995|566340039|FG002|Overall Study|Lost to Follow-up|20|||
156885546|NCT04456673|566340040|FG000|Overall Study|Adverse Event|7|||
156885547|NCT04456673|566340041|FG001|Overall Study|Adverse Event|14|||
156885548|NCT04456673|566340040|FG000|Overall Study|Poor compliance to protocol|1|||
156885549|NCT04456673|566340041|FG001|Overall Study|Poor compliance to protocol|0|||
156885550|NCT04456673|566340040|FG000|Overall Study|Withdrawal by Subject|31|||
156885551|NCT04456673|566340041|FG001|Overall Study|Withdrawal by Subject|23|||
156885552|NCT04456673|566340040|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
156885553|NCT04456673|566340041|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
157151900|NCT02760407|567301509|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
157151901|NCT02760407|567301510|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
157151902|NCT02760407|567301511|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
157151903|NCT02760407|567301512|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
157151904|NCT02760407|567301509|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
157151905|NCT02760407|567301510|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
157151906|NCT02760407|567301511|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
157151907|NCT02760407|567301512|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
157151908|NCT02760407|567301509|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
157151909|NCT02760407|567301510|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
157151910|NCT02760407|567301511|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
157151911|NCT02760407|567301512|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
157151912|NCT02760407|567301509|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
157151913|NCT02760407|567301510|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
157151914|NCT02760407|567301511|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
157151915|NCT02760407|567301512|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
157151916|NCT02760407|567301509|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
157151917|NCT02760407|567301510|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
157151918|NCT02760407|567301511|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
157151919|NCT02760407|567301512|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
157151920|NCT02760407|567301509|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
157151921|NCT02760407|567301510|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
157151922|NCT02760407|567301511|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
157151923|NCT02760407|567301512|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
157151924|NCT02760407|567301509|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
157151925|NCT02760407|567301510|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
157151926|NCT02760407|567301511|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
157151927|NCT02760407|567301512|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
157151928|NCT02760407|567301509|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
157151929|NCT02760407|567301510|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
157151930|NCT02760407|567301511|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
157151931|NCT02760407|567301512|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
157224631|NCT00306384|567568048|FG001|Overall Study|Adverse Event|87|||
157224632|NCT00306384|567568049|FG002|Overall Study|Adverse Event|40|||
157224633|NCT00306384|567568047|FG000|Overall Study|Major protocol deviation|43|||
156885554|NCT04391049|566340042|FG000|Overall Study|Protocol Violation|1|||
156885555|NCT03337490|566340043|FG000|Overall Study|Withdrawal by Subject|1|||
156885556|NCT03337490|566340044|FG001|Overall Study|Withdrawal by Subject|0|||
156885557|NCT03337490|566340045|FG002|Overall Study|Withdrawal by Subject|0|||
157023468|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
157023469|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157224634|NCT00306384|567568048|FG001|Overall Study|Major protocol deviation|51|||
156885558|NCT03337490|566340043|FG000|Overall Study|Lack of Efficacy|10|||
156885559|NCT03337490|566340044|FG001|Overall Study|Lack of Efficacy|12|||
156885560|NCT03337490|566340045|FG002|Overall Study|Lack of Efficacy|35|||
156833153|NCT01282294|566143116|FG000|Overall Study|Patient non-compliance|2|||
156833154|NCT01282294|566143116|FG000|Overall Study|Physician Decision|1|||
156833155|NCT02408523|566143117|FG000|Overall Study|Adverse Event|4|||
156833156|NCT02408523|566143118|FG001|Overall Study|Adverse Event|10|||
156833157|NCT02408523|566143117|FG000|Overall Study|Lack of Efficacy|0|||
156833158|NCT02408523|566143118|FG001|Overall Study|Lack of Efficacy|1|||
156833159|NCT02408523|566143117|FG000|Overall Study|Protocol Violation|1|||
156833160|NCT02408523|566143118|FG001|Overall Study|Protocol Violation|2|||
156833161|NCT02408523|566143117|FG000|Overall Study|Lost to Follow-up|2|||
156833162|NCT02408523|566143118|FG001|Overall Study|Lost to Follow-up|3|||
156833163|NCT02408523|566143117|FG000|Overall Study|Withdrawal by Subject|3|||
156833164|NCT02408523|566143118|FG001|Overall Study|Withdrawal by Subject|1|||
156833165|NCT02408523|566143117|FG000|Overall Study|Sponsor request|1|||
156833166|NCT02408523|566143118|FG001|Overall Study|Sponsor request|0|||
156833167|NCT02408523|566143117|FG000|Overall Study|Did not satisfy extension conditions|0|||
156833168|NCT02408523|566143118|FG001|Overall Study|Did not satisfy extension conditions|1|||
156833169|NCT02905006|566143119|FG000|Overall Study|Adverse Event|1|||
156833170|NCT02905006|566143120|FG001|Overall Study|Adverse Event|1|||
156833171|NCT02905006|566143121|FG002|Overall Study|Adverse Event|1|||
156833172|NCT02905006|566143122|FG003|Overall Study|Adverse Event|1|||
156833173|NCT02905006|566143123|FG004|Overall Study|Adverse Event|0|||
156833174|NCT02905006|566143124|FG005|Overall Study|Adverse Event|1|||
156833175|NCT02905006|566143119|FG000|Overall Study|Lack of Efficacy|1|||
156833176|NCT02905006|566143120|FG001|Overall Study|Lack of Efficacy|0|||
156833177|NCT02905006|566143121|FG002|Overall Study|Lack of Efficacy|0|||
156833178|NCT02905006|566143122|FG003|Overall Study|Lack of Efficacy|0|||
156833179|NCT02905006|566143123|FG004|Overall Study|Lack of Efficacy|0|||
156833180|NCT02905006|566143124|FG005|Overall Study|Lack of Efficacy|0|||
156833181|NCT02905006|566143119|FG000|Overall Study|Protocol Violation|2|||
156833182|NCT02905006|566143120|FG001|Overall Study|Protocol Violation|0|||
156833183|NCT02905006|566143121|FG002|Overall Study|Protocol Violation|0|||
156833184|NCT02905006|566143122|FG003|Overall Study|Protocol Violation|0|||
156833185|NCT02905006|566143123|FG004|Overall Study|Protocol Violation|0|||
156833186|NCT02905006|566143124|FG005|Overall Study|Protocol Violation|0|||
156833187|NCT02905006|566143119|FG000|Overall Study|Lost to Follow-up|0|||
156833188|NCT02905006|566143120|FG001|Overall Study|Lost to Follow-up|0|||
156833189|NCT02905006|566143121|FG002|Overall Study|Lost to Follow-up|0|||
156833190|NCT02905006|566143122|FG003|Overall Study|Lost to Follow-up|1|||
156833191|NCT02905006|566143123|FG004|Overall Study|Lost to Follow-up|1|||
156833192|NCT02905006|566143124|FG005|Overall Study|Lost to Follow-up|0|||
156833193|NCT02905006|566143119|FG000|Overall Study|Withdrawal by Subject|0|||
156833194|NCT02905006|566143120|FG001|Overall Study|Withdrawal by Subject|0|||
156833195|NCT02905006|566143121|FG002|Overall Study|Withdrawal by Subject|1|||
156833196|NCT02905006|566143122|FG003|Overall Study|Withdrawal by Subject|1|||
156833197|NCT02905006|566143123|FG004|Overall Study|Withdrawal by Subject|0|||
156833198|NCT02905006|566143124|FG005|Overall Study|Withdrawal by Subject|1|||
156833199|NCT02905006|566143119|FG000|Overall Study|Screening exclusion criteria met|1|||
156833200|NCT02905006|566143120|FG001|Overall Study|Screening exclusion criteria met|0|||
156833201|NCT02905006|566143121|FG002|Overall Study|Screening exclusion criteria met|0|||
156833202|NCT02905006|566143122|FG003|Overall Study|Screening exclusion criteria met|0|||
156833203|NCT02905006|566143123|FG004|Overall Study|Screening exclusion criteria met|0|||
156833204|NCT02905006|566143124|FG005|Overall Study|Screening exclusion criteria met|0|||
156833205|NCT02905006|566143119|FG000|Overall Study|Lab withdrawal criterion met|0|||
156833206|NCT02905006|566143120|FG001|Overall Study|Lab withdrawal criterion met|1|||
156833207|NCT02905006|566143121|FG002|Overall Study|Lab withdrawal criterion met|2|||
156833208|NCT02905006|566143122|FG003|Overall Study|Lab withdrawal criterion met|2|||
156833209|NCT02905006|566143123|FG004|Overall Study|Lab withdrawal criterion met|2|||
156833210|NCT02905006|566143124|FG005|Overall Study|Lab withdrawal criterion met|1|||
156833211|NCT02905006|566143119|FG000|Overall Study|Positive for Tuberculosis|0|||
156833212|NCT02905006|566143120|FG001|Overall Study|Positive for Tuberculosis|1|||
156833213|NCT02905006|566143121|FG002|Overall Study|Positive for Tuberculosis|0|||
156833214|NCT02905006|566143122|FG003|Overall Study|Positive for Tuberculosis|0|||
156833215|NCT02905006|566143123|FG004|Overall Study|Positive for Tuberculosis|0|||
156833216|NCT02905006|566143124|FG005|Overall Study|Positive for Tuberculosis|0|||
156833217|NCT02905006|566143119|FG000|Overall Study|Subject positive for Hep B|0|||
156833218|NCT02905006|566143120|FG001|Overall Study|Subject positive for Hep B|0|||
156833219|NCT02905006|566143121|FG002|Overall Study|Subject positive for Hep B|1|||
156833220|NCT02905006|566143122|FG003|Overall Study|Subject positive for Hep B|0|||
156833221|NCT02905006|566143123|FG004|Overall Study|Subject positive for Hep B|0|||
156833222|NCT02905006|566143124|FG005|Overall Study|Subject positive for Hep B|0|||
156833223|NCT02905006|566143119|FG000|Overall Study|Patient moved abroad|0|||
156833224|NCT02905006|566143120|FG001|Overall Study|Patient moved abroad|0|||
156833225|NCT02905006|566143121|FG002|Overall Study|Patient moved abroad|0|||
156833226|NCT02905006|566143122|FG003|Overall Study|Patient moved abroad|1|||
156833227|NCT02905006|566143123|FG004|Overall Study|Patient moved abroad|0|||
156833228|NCT02905006|566143124|FG005|Overall Study|Patient moved abroad|0|||
156885561|NCT03337490|566340043|FG000|Overall Study|Physician Decision|0|||
156833229|NCT02905006|566143119|FG000|Overall Study|Patient randomized by mistake|0|||
156833230|NCT02905006|566143120|FG001|Overall Study|Patient randomized by mistake|0|||
156833231|NCT02905006|566143121|FG002|Overall Study|Patient randomized by mistake|0|||
156833232|NCT02905006|566143122|FG003|Overall Study|Patient randomized by mistake|0|||
156833233|NCT02905006|566143123|FG004|Overall Study|Patient randomized by mistake|0|||
156833234|NCT02905006|566143124|FG005|Overall Study|Patient randomized by mistake|1|||
156833235|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
156833236|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
156833237|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
156833238|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
156833239|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
156833240|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
156833241|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
156833242|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
156833243|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
156833244|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833245|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833246|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
156833247|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
156833248|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
156833249|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
156833250|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
156833251|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
156833252|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833253|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833254|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
156833255|NCT05149313|566143130|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
156833256|NCT05149313|566143131|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
156833257|NCT05149313|566143132|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
156833258|NCT05149313|566143133|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
156833259|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
157224635|NCT00306384|567568049|FG002|Overall Study|Major protocol deviation|18|||
157224636|NCT00306384|567568047|FG000|Overall Study|Lost to Follow-up|57|||
156833260|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
156833261|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
156833262|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
156833263|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156833264|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
156833265|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
156833266|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
156833267|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156833268|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
156833269|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
156833270|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
156833271|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833272|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833273|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
156833274|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
156833275|NCT05149313|566143130|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833276|NCT05149313|566143131|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833277|NCT05149313|566143132|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
156833278|NCT05149313|566143133|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
156833279|NCT02212678|566143134|FG000|Overall Study|Adverse Event|1|||
156833280|NCT06250738|566143135|FG000|Overall Study|Lost to Follow-up|1|||
156833281|NCT04030962|566143138|FG000|Stage 2|Adverse Event|0|||
156833282|NCT04030962|566143139|FG001|Stage 2|Adverse Event|0|||
156833283|NCT04030962|566143140|FG002|Stage 2|Adverse Event|0|||
156833284|NCT04030962|566143141|FG003|Stage 2|Adverse Event|0|||
156833285|NCT04030962|566143142|FG004|Stage 2|Adverse Event|0|||
156833286|NCT04030962|566143143|FG005|Stage 2|Adverse Event|0|||
156833287|NCT04030962|566143144|FG006|Stage 2|Adverse Event|0|||
156833288|NCT04030962|566143145|FG007|Stage 2|Adverse Event|0|||
156833289|NCT04030962|566143146|FG008|Stage 2|Adverse Event|1|||
156885562|NCT03337490|566340044|FG001|Overall Study|Physician Decision|1|||
156885563|NCT03337490|566340045|FG002|Overall Study|Physician Decision|0|||
156885564|NCT03337490|566340043|FG000|Overall Study|Lost to Follow-up|0|||
157224637|NCT00306384|567568048|FG001|Overall Study|Lost to Follow-up|41|||
157224638|NCT00306384|567568049|FG002|Overall Study|Lost to Follow-up|35|||
157224639|NCT00306384|567568047|FG000|Overall Study|Voluntary withdrawal|199|||
156833290|NCT04030962|566143147|FG009|Stage 2|Adverse Event|0|||
156833291|NCT04030962|566143148|FG010|Stage 2|Adverse Event|1|||
156833292|NCT04030962|566143149|FG011|Stage 2|Adverse Event|1|||
156833293|NCT04030962|566143150|FG012|Stage 2|Adverse Event|1|||
156833294|NCT04030962|566143138|FG000|Stage 2|Withdrawal by Subject|0|||
156833295|NCT04030962|566143139|FG001|Stage 2|Withdrawal by Subject|0|||
156833296|NCT04030962|566143140|FG002|Stage 2|Withdrawal by Subject|0|||
156833297|NCT04030962|566143141|FG003|Stage 2|Withdrawal by Subject|0|||
156833298|NCT04030962|566143142|FG004|Stage 2|Withdrawal by Subject|0|||
156833299|NCT04030962|566143143|FG005|Stage 2|Withdrawal by Subject|0|||
156833300|NCT04030962|566143144|FG006|Stage 2|Withdrawal by Subject|0|||
156833301|NCT04030962|566143145|FG007|Stage 2|Withdrawal by Subject|0|||
156833302|NCT04030962|566143146|FG008|Stage 2|Withdrawal by Subject|1|||
156833303|NCT04030962|566143147|FG009|Stage 2|Withdrawal by Subject|0|||
156833304|NCT04030962|566143148|FG010|Stage 2|Withdrawal by Subject|0|||
156833305|NCT04030962|566143149|FG011|Stage 2|Withdrawal by Subject|2|||
156833306|NCT04030962|566143150|FG012|Stage 2|Withdrawal by Subject|1|||
156885565|NCT03337490|566340044|FG001|Overall Study|Lost to Follow-up|1|||
156885566|NCT03337490|566340045|FG002|Overall Study|Lost to Follow-up|0|||
156885567|NCT01689532|566340046|FG000|Overall Study|Adverse Event|9|||
156885568|NCT01689532|566340047|FG001|Overall Study|Adverse Event|5|||
156885569|NCT01689532|566340046|FG000|Overall Study|Lack of Efficacy|2|||
156885570|NCT01689532|566340047|FG001|Overall Study|Lack of Efficacy|2|||
156885571|NCT01689532|566340046|FG000|Overall Study|Withdrawal by Subject|1|||
156885572|NCT01689532|566340047|FG001|Overall Study|Withdrawal by Subject|2|||
156885573|NCT01689532|566340046|FG000|Overall Study|Physician Decision|2|||
157023470|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
157023471|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157023472|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157023473|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157023474|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157023475|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
157023476|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
157023477|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
157023478|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
157023479|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
157023480|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
157023481|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
157023482|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
157023483|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
157023484|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023485|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023486|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023487|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023488|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023489|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
157023490|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023491|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
157023492|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023493|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023494|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023495|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023496|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
157023497|NCT02962895|566841065|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023498|NCT02962895|566841066|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023499|NCT02962895|566841067|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023500|NCT02962895|566841068|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
157023501|NCT02962895|566841069|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023502|NCT02962895|566841070|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023503|NCT02962895|566841071|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
157023504|NCT02962895|566841065|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
156833307|NCT04030962|566143138|FG000|Stage 2|Lost to Follow-up|0|||
156833308|NCT04030962|566143139|FG001|Stage 2|Lost to Follow-up|0|||
156833309|NCT04030962|566143140|FG002|Stage 2|Lost to Follow-up|0|||
156833310|NCT04030962|566143141|FG003|Stage 2|Lost to Follow-up|0|||
156833311|NCT04030962|566143142|FG004|Stage 2|Lost to Follow-up|0|||
156833312|NCT04030962|566143143|FG005|Stage 2|Lost to Follow-up|0|||
156885574|NCT01689532|566340047|FG001|Overall Study|Physician Decision|0|||
156885575|NCT01363349|566340048|FG000|Overall Study|Adverse Event|6|||
156833313|NCT04030962|566143144|FG006|Stage 2|Lost to Follow-up|0|||
156833314|NCT04030962|566143145|FG007|Stage 2|Lost to Follow-up|0|||
156833315|NCT04030962|566143146|FG008|Stage 2|Lost to Follow-up|1|||
156833316|NCT04030962|566143147|FG009|Stage 2|Lost to Follow-up|0|||
156833317|NCT04030962|566143148|FG010|Stage 2|Lost to Follow-up|0|||
156833318|NCT04030962|566143149|FG011|Stage 2|Lost to Follow-up|0|||
156833319|NCT04030962|566143150|FG012|Stage 2|Lost to Follow-up|0|||
156833320|NCT04030962|566143138|FG000|Stage 2|Technical Problems|0|||
156833321|NCT04030962|566143139|FG001|Stage 2|Technical Problems|0|||
156833322|NCT04030962|566143140|FG002|Stage 2|Technical Problems|0|||
156833323|NCT04030962|566143141|FG003|Stage 2|Technical Problems|0|||
156833324|NCT04030962|566143142|FG004|Stage 2|Technical Problems|0|||
156833325|NCT04030962|566143143|FG005|Stage 2|Technical Problems|0|||
156833326|NCT04030962|566143144|FG006|Stage 2|Technical Problems|0|||
156833327|NCT04030962|566143145|FG007|Stage 2|Technical Problems|0|||
156833328|NCT04030962|566143146|FG008|Stage 2|Technical Problems|0|||
156833329|NCT04030962|566143147|FG009|Stage 2|Technical Problems|0|||
156833330|NCT04030962|566143148|FG010|Stage 2|Technical Problems|0|||
156833331|NCT04030962|566143149|FG011|Stage 2|Technical Problems|1|||
156833332|NCT04030962|566143150|FG012|Stage 2|Technical Problems|0|||
156833333|NCT05601102|566143151|FG000|Overall Study|Death|1|||
156833334|NCT05601102|566143152|FG001|Overall Study|Death|2|||
156833335|NCT05601102|566143151|FG000|Overall Study|Withdrawal by Subject|1|||
156833336|NCT05601102|566143152|FG001|Overall Study|Withdrawal by Subject|1|||
156833337|NCT05601102|566143151|FG000|Overall Study|Lost to Follow-up|0|||
156833338|NCT05601102|566143152|FG001|Overall Study|Lost to Follow-up|2|||
156833339|NCT05288166|566143158|FG000|Overall Study|Adverse Event|1|||
156833340|NCT05288166|566143159|FG001|Overall Study|Adverse Event|0|||
156833341|NCT05288166|566143158|FG000|Overall Study|Lost to Follow-up|2|||
156833342|NCT05288166|566143159|FG001|Overall Study|Lost to Follow-up|0|||
156833343|NCT05288166|566143158|FG000|Overall Study|Physician Decision|0|||
156833344|NCT05288166|566143159|FG001|Overall Study|Physician Decision|2|||
156833345|NCT05288166|566143158|FG000|Overall Study|Screen Failure|1|||
156833346|NCT05288166|566143159|FG001|Overall Study|Screen Failure|1|||
156833347|NCT05288166|566143158|FG000|Overall Study|Withdrawal by Subject|4|||
156833348|NCT05288166|566143159|FG001|Overall Study|Withdrawal by Subject|2|||
156833349|NCT05288166|566143158|FG000|Overall Study|On Study Treatment|408|||
156833350|NCT05288166|566143159|FG001|Overall Study|On Study Treatment|418|||
156833351|NCT01114360|566143160|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
156833352|NCT01114360|566143161|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
156833353|NCT03344172|566143164|FG000|Overall Study|Received <1 dose of treatment|1|||
156833354|NCT03344172|566143165|FG001|Overall Study|Received <1 dose of treatment|0|||
156833355|NCT00385723|566143167|FG000|Overall Study|Lost to Follow-up|1|||
156833356|NCT00385723|566143168|FG001|Overall Study|Lost to Follow-up|1|||
156833357|NCT00385723|566143169|FG002|Overall Study|Lost to Follow-up|0|||
156833358|NCT00385723|566143167|FG000|Overall Study|Withdrawal by Subject|1|||
156833359|NCT00385723|566143168|FG001|Overall Study|Withdrawal by Subject|0|||
156833360|NCT00385723|566143169|FG002|Overall Study|Withdrawal by Subject|2|||
156833361|NCT01390779|566143170|FG000|Overall Study|Physician Decision|1|||
156833362|NCT03455829|566143171|FG000|Overall Study|Death|2|||
156833363|NCT03455829|566143172|FG001|Overall Study|Death|3|||
156833364|NCT03455829|566143173|FG002|Overall Study|Death|2|||
156833365|NCT03455829|566143174|FG003|Overall Study|Death|4|||
156833366|NCT03455829|566143175|FG004|Overall Study|Death|2|||
156833367|NCT03455829|566143171|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
156833368|NCT03455829|566143172|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
156833369|NCT03455829|566143173|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
156833370|NCT03455829|566143174|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
156833371|NCT03455829|566143175|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
156833372|NCT03455829|566143171|FG000|Overall Study|Disease progression|0|||
156833373|NCT03455829|566143172|FG001|Overall Study|Disease progression|0|||
156833374|NCT03455829|566143173|FG002|Overall Study|Disease progression|0|||
156833375|NCT03455829|566143174|FG003|Overall Study|Disease progression|1|||
156833376|NCT03455829|566143175|FG004|Overall Study|Disease progression|1|||
156833377|NCT03689712|566143187|FG000|Overall Study|Adverse Event|1|||
156833378|NCT03689712|566143188|FG001|Overall Study|Adverse Event|0|||
156833379|NCT03689712|566143187|FG000|Overall Study|Death|20|||
156833380|NCT03689712|566143188|FG001|Overall Study|Death|10|||
156833381|NCT03689712|566143187|FG000|Overall Study|Lost to Follow-up|6|||
156833382|NCT03689712|566143188|FG001|Overall Study|Lost to Follow-up|6|||
156833383|NCT03689712|566143187|FG000|Overall Study|Other|1|||
156833384|NCT03689712|566143188|FG001|Overall Study|Other|0|||
156833385|NCT03689712|566143187|FG000|Overall Study|Patient Non-Compliance|0|||
156833386|NCT03689712|566143188|FG001|Overall Study|Patient Non-Compliance|1|||
156833387|NCT03689712|566143187|FG000|Overall Study|Withdrawal by Subject|20|||
156833388|NCT03689712|566143188|FG001|Overall Study|Withdrawal by Subject|4|||
156833389|NCT03689712|566143187|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
156833390|NCT03689712|566143188|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
156833391|NCT03689712|566143187|FG000|Overall Study|Randomized but not Treated|13|||
156833392|NCT03689712|566143188|FG001|Overall Study|Randomized but not Treated|7|||
156833393|NCT03689712|566143187|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
156833394|NCT03689712|566143188|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
156833395|NCT00689793|566143189|FG000|Overall Study|Lost to Follow-up|4|||
156833396|NCT00689793|566143190|FG001|Overall Study|Lost to Follow-up|5|||
156833397|NCT00413010|566143196|FG000|Overall Study|Adverse Event|8|||
156833398|NCT00413010|566143197|FG001|Overall Study|Adverse Event|4|||
156833399|NCT00413010|566143196|FG000|Overall Study|Laboratory abnormality|0|||
157151932|NCT02522377|567301513|FG000|Overall Study|Withdrawal by Subject|1|||
157151933|NCT02522377|567301514|FG001|Overall Study|Withdrawal by Subject|0|||
157151934|NCT02522377|567301513|FG000|Overall Study|Remission Achieved|3|||
157151935|NCT02522377|567301514|FG001|Overall Study|Remission Achieved|0|||
157151936|NCT01158950|567301515|FG000|1st Intervention (1 Day)|Physician Decision|1|||
157151937|NCT01158950|567301516|FG001|1st Intervention (1 Day)|Physician Decision|2|||
157151938|NCT02137772|567301519|FG000|Overall Study|Adverse Event|6|||
157151939|NCT02137772|567301520|FG001|Overall Study|Adverse Event|3|||
157151940|NCT02137772|567301519|FG000|Overall Study|Death|71|||
157151941|NCT02137772|567301520|FG001|Overall Study|Death|44|||
157151942|NCT02137772|567301519|FG000|Overall Study|Lost to Follow-up|8|||
157151943|NCT02137772|567301520|FG001|Overall Study|Lost to Follow-up|4|||
157151944|NCT02137772|567301519|FG000|Overall Study|Physician Decision|15|||
157151945|NCT02137772|567301520|FG001|Overall Study|Physician Decision|5|||
157151946|NCT02137772|567301519|FG000|Overall Study|Withdrawal by Subject|28|||
157151947|NCT02137772|567301520|FG001|Overall Study|Withdrawal by Subject|17|||
157151948|NCT02137772|567301519|FG000|Overall Study|Non-compliance with study drug|1|||
157151949|NCT02137772|567301520|FG001|Overall Study|Non-compliance with study drug|0|||
157151950|NCT02137772|567301519|FG000|Overall Study|Not treated|3|||
157151951|NCT02137772|567301520|FG001|Overall Study|Not treated|2|||
157151952|NCT01844700|567301521|FG000|Overall Study|Lack of Efficacy|1|||
157151953|NCT01844700|567301522|FG001|Overall Study|Lack of Efficacy|0|||
157151954|NCT01844700|567301521|FG000|Overall Study|refused medication switch|1|||
157151955|NCT01844700|567301522|FG001|Overall Study|refused medication switch|0|||
157151956|NCT01844700|567301521|FG000|Overall Study|Withdrawal by Subject|1|||
157151957|NCT01844700|567301522|FG001|Overall Study|Withdrawal by Subject|0|||
157151958|NCT01844700|567301521|FG000|Overall Study|stopped taking meds|0|||
157151959|NCT01844700|567301522|FG001|Overall Study|stopped taking meds|1|||
157151960|NCT03290300|567301523|FG000|Overall Study|Lost to Follow-up|3|||
157151961|NCT00864227|567301524|FG000|Overall Study|Withdrawal by Subject|1|||
157151962|NCT00864227|567301524|FG000|Overall Study|Disease Relapse/Progression|3|||
157151963|NCT02124798|567301525|FG000|Overall Study|Adverse Event|3|||
157151964|NCT02124798|567301525|FG000|Overall Study|Lost to Follow-up|1|||
157151965|NCT02746679|567301533|FG000|Overall Study|Lost to Follow-up|4|||
157151966|NCT02746679|567301534|FG001|Overall Study|Lost to Follow-up|6|||
157151967|NCT00487279|567301535|FG000|Overall Study|Death|1|||
157151968|NCT00487279|567301536|FG001|Overall Study|Death|0|||
157151969|NCT00487279|567301535|FG000|Overall Study|Withdrawal by Subject|0|||
157151970|NCT00487279|567301536|FG001|Overall Study|Withdrawal by Subject|2|||
157151971|NCT00501852|567301537|FG000|Overall Study|Adverse Event|3|||
157151972|NCT00501852|567301537|FG000|Overall Study|Withdrawal by Subject|2|||
157151973|NCT01416610|567301540|FG000|Overall Study|Adverse Event|4|||
157151974|NCT01416610|567301540|FG000|Overall Study|Adverse Event -Patient decision|3|||
157151975|NCT01416610|567301540|FG000|Overall Study|Lack of Efficacy|4|||
157151976|NCT01416610|567301540|FG000|Overall Study|No reason given|5|||
157151977|NCT01416610|567301540|FG000|Overall Study|Withdrawal by Subject|13|||
157151978|NCT01416610|567301540|FG000|Overall Study|Lost to Follow-up|7|||
157151979|NCT01416610|567301540|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
157151980|NCT01171521|567301541|FG000|Overall Study|Lost to Follow-up|5|||
157151981|NCT01171521|567301541|FG000|Overall Study|screen failure|1|||
157151982|NCT00492921|567301543|FG000|Overall Study|Death|1|||
156833400|NCT00413010|566143197|FG001|Overall Study|Laboratory abnormality|2|||
156833401|NCT00413010|566143196|FG000|Overall Study|Lack of Efficacy|0|||
156833402|NCT00413010|566143197|FG001|Overall Study|Lack of Efficacy|3|||
157151983|NCT00492921|567301544|FG001|Overall Study|Death|0|||
157151984|NCT00492921|567301545|FG002|Overall Study|Death|1|||
157151985|NCT01520922|567301546|FG000|Treatment Phase|Physician Decision|2|||
157151986|NCT01520922|567301547|FG001|Treatment Phase|Physician Decision|1|||
157151987|NCT01520922|567301546|FG000|Treatment Phase|Progression|0|||
157151988|NCT01520922|567301547|FG001|Treatment Phase|Progression|2|||
157151989|NCT01520922|567301546|FG000|Treatment Phase|Adverse Event|3|||
157151990|NCT01520922|567301547|FG001|Treatment Phase|Adverse Event|5|||
157151991|NCT01520922|567301546|FG000|Follow up|Lost to Follow-up|0|||
157151992|NCT01520922|567301547|FG001|Follow up|Lost to Follow-up|1|||
157151993|NCT01520922|567301546|FG000|Survival Follow-up|Withdrawal by Subject|1|||
157151994|NCT01520922|567301547|FG001|Survival Follow-up|Withdrawal by Subject|0|||
156833403|NCT00413010|566143196|FG000|Overall Study|Lost to Follow-up|3|||
157151995|NCT01696877|567301550|FG000|Overall Study|Adverse Event|0|||
157151996|NCT01696877|567301551|FG001|Overall Study|Adverse Event|1|||
157151997|NCT01422304|567301554|FG000|Overall Study|Adverse Event|0|||
157151998|NCT01422304|567301555|FG001|Overall Study|Adverse Event|1|||
157151999|NCT01422304|567301554|FG000|Overall Study|Lost to Follow-up|14|||
157152000|NCT01422304|567301555|FG001|Overall Study|Lost to Follow-up|20|||
157152001|NCT01422304|567301554|FG000|Overall Study|Never Entered Follow-up|2|||
157152002|NCT01422304|567301555|FG001|Overall Study|Never Entered Follow-up|1|||
157152003|NCT01422304|567301554|FG000|Overall Study|Protocol Violation|1|||
157152004|NCT01422304|567301555|FG001|Overall Study|Protocol Violation|0|||
157152005|NCT01422304|567301554|FG000|Overall Study|Withdrawal by Subject|4|||
157152006|NCT01422304|567301555|FG001|Overall Study|Withdrawal by Subject|2|||
157152007|NCT01422304|567301554|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
157152008|NCT01422304|567301555|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
157152009|NCT01422304|567301554|FG000|Overall Study|Not Treated|3|||
157152010|NCT01422304|567301555|FG001|Overall Study|Not Treated|11|||
157152011|NCT00469014|567301558|FG000|Initial Phase Randomization|Disease Progression|0|||
157152012|NCT00469014|567301559|FG001|Initial Phase Randomization|Disease Progression|1|||
157152013|NCT00469014|567301560|FG002|Initial Phase Randomization|Disease Progression|1|||
157152014|NCT00469014|567301561|FG003|Initial Phase Randomization|Disease Progression|0|||
157152015|NCT00469014|567301558|FG000|Initial Phase Randomization|No Response|1|||
157152016|NCT00469014|567301559|FG001|Initial Phase Randomization|No Response|0|||
157152017|NCT00469014|567301560|FG002|Initial Phase Randomization|No Response|0|||
157152018|NCT00469014|567301561|FG003|Initial Phase Randomization|No Response|1|||
157152019|NCT00469014|567301558|FG000|Adaptive Randomization|Not Evaluable|1|||
157152020|NCT00469014|567301559|FG001|Adaptive Randomization|Not Evaluable|0|||
157152021|NCT00469014|567301560|FG002|Adaptive Randomization|Not Evaluable|0|||
157152022|NCT00469014|567301561|FG003|Adaptive Randomization|Not Evaluable|1|||
157152023|NCT00469014|567301558|FG000|Adaptive Randomization|No Response|0|||
157152024|NCT00469014|567301559|FG001|Adaptive Randomization|No Response|1|||
157152025|NCT00469014|567301560|FG002|Adaptive Randomization|No Response|0|||
157152026|NCT00469014|567301561|FG003|Adaptive Randomization|No Response|0|||
157152027|NCT00469014|567301558|FG000|Adaptive Randomization|Death|0|||
157152028|NCT00469014|567301559|FG001|Adaptive Randomization|Death|0|||
157152029|NCT00469014|567301560|FG002|Adaptive Randomization|Death|1|||
157152030|NCT00469014|567301561|FG003|Adaptive Randomization|Death|0|||
157152031|NCT03461289|567301563|FG000|Overall Study|Death|1|||
156833404|NCT00413010|566143197|FG001|Overall Study|Lost to Follow-up|0|||
156833405|NCT00413010|566143196|FG000|Overall Study|Withdrawal by Subject|7|||
156833406|NCT00413010|566143197|FG001|Overall Study|Withdrawal by Subject|2|||
156833407|NCT00413010|566143196|FG000|Overall Study|Due to termination of the study|54|||
156833408|NCT00413010|566143197|FG001|Overall Study|Due to termination of the study|52|||
156833409|NCT00875056|566143198|FG000|Overall Study|Adverse Event|6|||
156833410|NCT00875056|566143199|FG001|Overall Study|Adverse Event|1|||
156833411|NCT00875056|566143200|FG002|Overall Study|Adverse Event|2|||
156833412|NCT00875056|566143198|FG000|Overall Study|Progressive Disease|14|||
156833413|NCT00875056|566143199|FG001|Overall Study|Progressive Disease|8|||
156833414|NCT00875056|566143200|FG002|Overall Study|Progressive Disease|3|||
156833415|NCT00875056|566143198|FG000|Overall Study|Withdrawal by Subject|3|||
156833416|NCT00875056|566143199|FG001|Overall Study|Withdrawal by Subject|0|||
156833417|NCT00875056|566143200|FG002|Overall Study|Withdrawal by Subject|1|||
156833418|NCT01842581|566143205|FG000|Overall Study|Adverse Event|6|||
156833419|NCT01842581|566143206|FG001|Overall Study|Adverse Event|4|||
156833420|NCT01842581|566143205|FG000|Overall Study|HE breakthrough|26|||
156833421|NCT01842581|566143206|FG001|Overall Study|HE breakthrough|13|||
156833422|NCT01842581|566143205|FG000|Overall Study|Liver transplant|2|||
156833423|NCT01842581|566143206|FG001|Overall Study|Liver transplant|0|||
156833424|NCT01842581|566143205|FG000|Overall Study|Lost to Follow-up|2|||
156833425|NCT01842581|566143206|FG001|Overall Study|Lost to Follow-up|5|||
156833426|NCT01842581|566143205|FG000|Overall Study|Withdrawal by Subject|5|||
156833427|NCT01842581|566143206|FG001|Overall Study|Withdrawal by Subject|7|||
156885576|NCT01363349|566340049|FG001|Overall Study|Adverse Event|7|||
156833428|NCT01842581|566143205|FG000|Overall Study|Other than specified|3|||
156833429|NCT01842581|566143206|FG001|Overall Study|Other than specified|1|||
156885577|NCT01363349|566340048|FG000|Overall Study|Lack of Efficacy|3|||
156833430|NCT05432167|566143207|FG000|Overall Study|Adverse Event|0|||
156833431|NCT05432167|566143208|FG001|Overall Study|Adverse Event|2|||
156833432|NCT05432167|566143209|FG002|Overall Study|Adverse Event|1|||
156885578|NCT01363349|566340049|FG001|Overall Study|Lack of Efficacy|10|||
157152032|NCT03241173|567301566|FG000|Overall Study|Death|3|||
157152033|NCT03241173|567301567|FG001|Overall Study|Death|2|||
156833433|NCT05432167|566143207|FG000|Overall Study|Lost to Follow-up|3|||
156885579|NCT01363349|566340048|FG000|Overall Study|Non compliance/Protocol deviations|2|||
157152034|NCT03241173|567301568|FG002|Overall Study|Death|4|||
157152035|NCT03241173|567301569|FG003|Overall Study|Death|4|||
157152036|NCT03241173|567301570|FG004|Overall Study|Death|2|||
157152037|NCT03241173|567301571|FG005|Overall Study|Death|2|||
157152038|NCT03241173|567301572|FG006|Overall Study|Death|3|||
157152039|NCT03241173|567301573|FG007|Overall Study|Death|1|||
157152040|NCT03241173|567301574|FG008|Overall Study|Death|0|||
156833434|NCT05432167|566143208|FG001|Overall Study|Lost to Follow-up|3|||
156833435|NCT05432167|566143209|FG002|Overall Study|Lost to Follow-up|2|||
156833436|NCT05432167|566143207|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
156833437|NCT05432167|566143208|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
156833438|NCT05432167|566143209|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156833439|NCT05432167|566143207|FG000|Overall Study|Physician Decision|1|||
156833440|NCT05432167|566143208|FG001|Overall Study|Physician Decision|0|||
156833441|NCT05432167|566143209|FG002|Overall Study|Physician Decision|0|||
156833442|NCT05432167|566143207|FG000|Overall Study|Withdrawal by Subject|7|||
156833443|NCT05432167|566143208|FG001|Overall Study|Withdrawal by Subject|4|||
156833444|NCT05432167|566143209|FG002|Overall Study|Withdrawal by Subject|11|||
156833445|NCT05432167|566143207|FG000|Overall Study|Other|0|||
156833446|NCT05432167|566143208|FG001|Overall Study|Other|0|||
156833447|NCT05432167|566143209|FG002|Overall Study|Other|1|||
156833448|NCT01995552|566143210|FG000|Overall Study|Protocol Violation|1|||
156833449|NCT01995552|566143210|FG000|Overall Study|Lack of Efficacy|15|||
156833450|NCT01995552|566143210|FG000|Overall Study|Death|1|||
156833451|NCT00283868|566143213|FG000|Overall Study|Lost to Follow-up|7|||
156833452|NCT00283868|566143214|FG001|Overall Study|Lost to Follow-up|8|||
156833453|NCT00353873|566143215|FG000|Overall Study|Protocol Violation|1|||
156833454|NCT00353873|566143216|FG001|Overall Study|Protocol Violation|2|||
156833455|NCT00353873|566143215|FG000|Overall Study|Exacerbation|1|||
156833456|NCT00353873|566143216|FG001|Overall Study|Exacerbation|0|||
156833457|NCT00353873|566143215|FG000|Overall Study|Adverse Event|1|||
156833458|NCT00353873|566143216|FG001|Overall Study|Adverse Event|0|||
156833459|NCT00353873|566143215|FG000|Overall Study|Physician Decision|2|||
156833460|NCT00353873|566143216|FG001|Overall Study|Physician Decision|0|||
156833461|NCT00353873|566143215|FG000|Overall Study|Withdrawal by Subject|1|||
156833462|NCT00353873|566143216|FG001|Overall Study|Withdrawal by Subject|1|||
156833463|NCT03743064|566143218|FG000|Overall Study|Adverse Event|7|||
156833464|NCT03743064|566143219|FG001|Overall Study|Adverse Event|9|||
156833465|NCT03743064|566143218|FG000|Overall Study|Death|25|||
156833466|NCT03743064|566143219|FG001|Overall Study|Death|28|||
156833467|NCT03743064|566143218|FG000|Overall Study|Lost to Follow-up|3|||
156833468|NCT03743064|566143219|FG001|Overall Study|Lost to Follow-up|6|||
156833469|NCT03743064|566143218|FG000|Overall Study|Withdrawal by Subject|28|||
156833470|NCT03743064|566143219|FG001|Overall Study|Withdrawal by Subject|25|||
156833471|NCT03743064|566143218|FG000|Overall Study|Physician Decision|2|||
156833472|NCT03743064|566143219|FG001|Overall Study|Physician Decision|4|||
156833473|NCT03743064|566143218|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
156833474|NCT03743064|566143219|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
156833475|NCT00870194|566143220|FG000|Overall Study|Adverse Event|10|||
156885580|NCT01363349|566340049|FG001|Overall Study|Non compliance/Protocol deviations|2|||
156885581|NCT01363349|566340048|FG000|Overall Study|Withdrawal by Subject|14|||
156885582|NCT01363349|566340049|FG001|Overall Study|Withdrawal by Subject|6|||
156885583|NCT01363349|566340048|FG000|Overall Study|Lost to Follow-up|5|||
157091533|NCT05924945|567089138|FG000|Overall Study|Withdrawal by Subject|3|||
156833476|NCT00870194|566143221|FG001|Overall Study|Adverse Event|5|||
156833477|NCT00870194|566143220|FG000|Overall Study|Lack of Efficacy|0|||
156833478|NCT00870194|566143221|FG001|Overall Study|Lack of Efficacy|1|||
156833479|NCT00870194|566143220|FG000|Overall Study|Lost to Follow-up|2|||
156833480|NCT00870194|566143221|FG001|Overall Study|Lost to Follow-up|0|||
156833481|NCT00870194|566143220|FG000|Overall Study|Physician Decision|3|||
156833482|NCT00870194|566143221|FG001|Overall Study|Physician Decision|1|||
156833483|NCT00870194|566143220|FG000|Overall Study|Protocol Violation|3|||
156833484|NCT00870194|566143221|FG001|Overall Study|Protocol Violation|3|||
156833485|NCT00870194|566143220|FG000|Overall Study|Entry Criteria Not Met|1|||
156833486|NCT00870194|566143221|FG001|Overall Study|Entry Criteria Not Met|2|||
156885584|NCT01363349|566340049|FG001|Overall Study|Lost to Follow-up|6|||
157091534|NCT05924945|567089139|FG001|Overall Study|Withdrawal by Subject|4|||
157091535|NCT02471833|567089140|FG000|Overall Study|Lost to Follow-up|1|||
157091536|NCT02471833|567089141|FG001|Overall Study|Lost to Follow-up|0|||
157091537|NCT02471833|567089142|FG002|Overall Study|Lost to Follow-up|0|||
157091538|NCT02471833|567089140|FG000|Overall Study|Withdrawal by Subject|2|||
157091539|NCT02471833|567089141|FG001|Overall Study|Withdrawal by Subject|1|||
157091540|NCT02471833|567089142|FG002|Overall Study|Withdrawal by Subject|5|||
157091541|NCT02673515|567089156|FG000|Overall Study|Lack of motivation|2|||
157091542|NCT02673515|567089157|FG001|Overall Study|Lack of motivation|1|||
157091543|NCT03683823|567089162|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
157091544|NCT03683823|567089163|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
157091545|NCT03683823|567089162|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
157091546|NCT03683823|567089163|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
157091547|NCT03683823|567089162|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
157091548|NCT03683823|567089163|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
157091549|NCT00994682|567089164|FG000|Double Bilnd|Withdrawal by Subject|5|||
157091550|NCT00994682|567089165|FG001|Double Bilnd|Withdrawal by Subject|6|||
157091551|NCT00994682|567089164|FG000|Double Bilnd|Lost to Follow-up|3|||
156833487|NCT00870194|566143220|FG000|Overall Study|Subject Decision|7|||
156833488|NCT00870194|566143221|FG001|Overall Study|Subject Decision|2|||
156833489|NCT02573246|566143223|FG000|Overall Study|Lost to Follow-up|2|||
156833490|NCT02573246|566143224|FG001|Overall Study|Lost to Follow-up|0|||
156833491|NCT02573246|566143225|FG002|Overall Study|Lost to Follow-up|0|||
156833492|NCT02573246|566143226|FG003|Overall Study|Lost to Follow-up|0|||
156833493|NCT02573246|566143227|FG004|Overall Study|Lost to Follow-up|1|||
156833494|NCT02573246|566143223|FG000|Overall Study|Withdrawal by Subject|0|||
156833495|NCT02573246|566143224|FG001|Overall Study|Withdrawal by Subject|0|||
156833496|NCT02573246|566143225|FG002|Overall Study|Withdrawal by Subject|0|||
157224640|NCT00306384|567568048|FG001|Overall Study|Voluntary withdrawal|187|||
157224641|NCT00306384|567568049|FG002|Overall Study|Voluntary withdrawal|91|||
156833497|NCT02573246|566143226|FG003|Overall Study|Withdrawal by Subject|0|||
157023505|NCT02962895|566841066|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
157023506|NCT02962895|566841067|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
157023507|NCT02962895|566841068|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
157023508|NCT02962895|566841069|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
157023509|NCT02962895|566841070|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
157023510|NCT02962895|566841071|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
157023511|NCT02962895|566841065|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
157023512|NCT02962895|566841066|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
157023513|NCT02962895|566841067|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
157023514|NCT02962895|566841068|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
157023515|NCT02962895|566841069|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
157023516|NCT02962895|566841070|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
157023517|NCT02962895|566841071|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
157023518|NCT02962895|566841065|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023519|NCT02962895|566841066|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023520|NCT02962895|566841067|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023521|NCT02962895|566841068|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023522|NCT02962895|566841069|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023523|NCT02962895|566841070|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
157023524|NCT02962895|566841071|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
157023525|NCT02962895|566841065|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023526|NCT02962895|566841066|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
157023527|NCT02962895|566841067|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023528|NCT02962895|566841068|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023529|NCT02962895|566841069|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023530|NCT02962895|566841070|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023531|NCT02962895|566841071|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
157023532|NCT02962895|566841065|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023533|NCT02962895|566841066|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023534|NCT02962895|566841067|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023535|NCT02962895|566841068|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023536|NCT02962895|566841069|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
157023537|NCT02962895|566841070|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023538|NCT02962895|566841071|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
157023539|NCT02962895|566841065|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023540|NCT02962895|566841066|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023541|NCT02962895|566841067|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023542|NCT02962895|566841068|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023543|NCT02962895|566841069|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
157023544|NCT02962895|566841070|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023545|NCT02962895|566841071|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
157023546|NCT02962895|566841065|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
157023547|NCT02962895|566841066|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
157023548|NCT02962895|566841067|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
157023549|NCT02962895|566841068|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
157023550|NCT02962895|566841069|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
157023551|NCT02962895|566841070|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
157023552|NCT02962895|566841071|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
157023553|NCT02962895|566841065|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
157023554|NCT02962895|566841066|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
157023555|NCT02962895|566841067|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
157023556|NCT02962895|566841068|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
157224642|NCT00306384|567568047|FG000|Overall Study|Study termination|1|||
157224643|NCT00306384|567568048|FG001|Overall Study|Study termination|0|||
156833498|NCT02573246|566143227|FG004|Overall Study|Withdrawal by Subject|1|||
156833499|NCT02573246|566143223|FG000|Overall Study|Physician Decision|1|||
157152041|NCT03241173|567301575|FG009|Overall Study|Death|5|||
157152042|NCT03241173|567301576|FG010|Overall Study|Death|4|||
157152043|NCT03241173|567301577|FG011|Overall Study|Death|3|||
157152044|NCT03241173|567301578|FG012|Overall Study|Death|0|||
157152045|NCT03241173|567301579|FG013|Overall Study|Death|0|||
157152046|NCT03241173|567301580|FG014|Overall Study|Death|0|||
157152047|NCT03241173|567301566|FG000|Overall Study|Withdrawal by Subject|0|||
157152048|NCT03241173|567301567|FG001|Overall Study|Withdrawal by Subject|0|||
157152049|NCT03241173|567301568|FG002|Overall Study|Withdrawal by Subject|1|||
157152050|NCT03241173|567301569|FG003|Overall Study|Withdrawal by Subject|0|||
157152051|NCT03241173|567301570|FG004|Overall Study|Withdrawal by Subject|0|||
157152052|NCT03241173|567301571|FG005|Overall Study|Withdrawal by Subject|1|||
157152053|NCT03241173|567301572|FG006|Overall Study|Withdrawal by Subject|0|||
157152054|NCT03241173|567301573|FG007|Overall Study|Withdrawal by Subject|0|||
157152055|NCT03241173|567301574|FG008|Overall Study|Withdrawal by Subject|0|||
157152056|NCT03241173|567301575|FG009|Overall Study|Withdrawal by Subject|0|||
157152057|NCT03241173|567301576|FG010|Overall Study|Withdrawal by Subject|0|||
157152058|NCT03241173|567301577|FG011|Overall Study|Withdrawal by Subject|0|||
157152059|NCT03241173|567301578|FG012|Overall Study|Withdrawal by Subject|0|||
157152060|NCT03241173|567301579|FG013|Overall Study|Withdrawal by Subject|0|||
157152061|NCT03241173|567301580|FG014|Overall Study|Withdrawal by Subject|0|||
157152062|NCT03241173|567301566|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
157152063|NCT03241173|567301567|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
157152064|NCT03241173|567301568|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152065|NCT03241173|567301569|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
157152066|NCT03241173|567301570|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
157152067|NCT03241173|567301571|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
157152068|NCT03241173|567301572|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
157152069|NCT03241173|567301573|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
157152070|NCT03241173|567301574|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152071|NCT03241173|567301575|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152072|NCT03241173|567301576|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
157152073|NCT03241173|567301577|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
157152074|NCT03241173|567301578|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152075|NCT03241173|567301579|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152076|NCT03241173|567301580|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
157152077|NCT03241173|567301566|FG000|Overall Study|Lost to Follow-up|0|||
157152078|NCT03241173|567301567|FG001|Overall Study|Lost to Follow-up|0|||
157152079|NCT03241173|567301568|FG002|Overall Study|Lost to Follow-up|0|||
157152080|NCT03241173|567301569|FG003|Overall Study|Lost to Follow-up|0|||
157152081|NCT03241173|567301570|FG004|Overall Study|Lost to Follow-up|1|||
157152082|NCT03241173|567301571|FG005|Overall Study|Lost to Follow-up|0|||
157152083|NCT03241173|567301572|FG006|Overall Study|Lost to Follow-up|0|||
157152084|NCT03241173|567301573|FG007|Overall Study|Lost to Follow-up|0|||
157152085|NCT03241173|567301574|FG008|Overall Study|Lost to Follow-up|0|||
157152086|NCT03241173|567301575|FG009|Overall Study|Lost to Follow-up|1|||
157152087|NCT03241173|567301576|FG010|Overall Study|Lost to Follow-up|0|||
157152088|NCT03241173|567301577|FG011|Overall Study|Lost to Follow-up|0|||
157152089|NCT03241173|567301578|FG012|Overall Study|Lost to Follow-up|0|||
157152090|NCT03241173|567301579|FG013|Overall Study|Lost to Follow-up|0|||
157152091|NCT03241173|567301580|FG014|Overall Study|Lost to Follow-up|0|||
157152092|NCT00564629|567301581|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
157152093|NCT00564629|567301582|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
157152094|NCT03648996|567301583|FG000|Overall Study|Withdrawal by Subject|0|||
157152095|NCT03648996|567301584|FG001|Overall Study|Withdrawal by Subject|2|||
157152096|NCT03648996|567301585|FG002|Overall Study|Withdrawal by Subject|2|||
157152097|NCT03648996|567301583|FG000|Overall Study|Physician Decision|2|||
157152098|NCT03648996|567301584|FG001|Overall Study|Physician Decision|0|||
156833500|NCT02573246|566143224|FG001|Overall Study|Physician Decision|1|||
156833501|NCT02573246|566143225|FG002|Overall Study|Physician Decision|3|||
156833502|NCT02573246|566143226|FG003|Overall Study|Physician Decision|2|||
156833503|NCT02573246|566143227|FG004|Overall Study|Physician Decision|2|||
156833504|NCT03149003|566143228|FG000|Overall Study|Randomized but not treated|0|||
157152099|NCT03648996|567301585|FG002|Overall Study|Physician Decision|0|||
157152100|NCT01519427|567301587|FG000|Overall Study|disease progression|2|||
157152101|NCT00365976|567301592|FG000|Overall Study|Withdrawal by Subject|1|||
157152102|NCT00365976|567301593|FG001|Overall Study|Withdrawal by Subject|5|||
157152103|NCT01780389|567301594|FG000|Overall Study|Adverse Event|1|||
157152104|NCT01614769|567303365|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
157152105|NCT01614769|567303366|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
156833505|NCT03149003|566143229|FG001|Overall Study|Randomized but not treated|1|||
156833506|NCT03149003|566143230|FG002|Overall Study|Randomized but not treated|18|||
156833507|NCT01443130|566143231|FG000|Overall Study|Lost to Follow-up|44|||
157023557|NCT02962895|566841069|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
157023558|NCT02962895|566841070|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
157023559|NCT02962895|566841071|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
157023560|NCT05894577|566841072|FG000|Overall Study|No receipt of study drug|14|||
157023561|NCT05894577|566841073|FG001|Overall Study|No receipt of study drug|13|||
157023562|NCT05894577|566841072|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
157023563|NCT05894577|566841073|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
157023564|NCT05894577|566841072|FG000|Overall Study|Screen Fail|2|||
157023565|NCT05894577|566841073|FG001|Overall Study|Screen Fail|0|||
156833508|NCT01443130|566143232|FG001|Overall Study|Lost to Follow-up|42|||
156833509|NCT01443130|566143233|FG002|Overall Study|Lost to Follow-up|50|||
156833510|NCT01443130|566143234|FG003|Overall Study|Lost to Follow-up|23|||
156833511|NCT01443130|566143235|FG004|Overall Study|Lost to Follow-up|25|||
156833512|NCT01443130|566143236|FG005|Overall Study|Lost to Follow-up|21|||
156833513|NCT01443130|566143231|FG000|Overall Study|Death|0|||
156833514|NCT01443130|566143232|FG001|Overall Study|Death|1|||
156833515|NCT01443130|566143233|FG002|Overall Study|Death|0|||
156833516|NCT01443130|566143234|FG003|Overall Study|Death|7|||
156833517|NCT01443130|566143235|FG004|Overall Study|Death|10|||
156833518|NCT01443130|566143236|FG005|Overall Study|Death|8|||
156833519|NCT01443130|566143231|FG000|Overall Study|Adverse Event|2|||
157023566|NCT05894577|566841072|FG000|Overall Study|Study drug recall|86|||
157023567|NCT05894577|566841073|FG001|Overall Study|Study drug recall|63|||
157023568|NCT04064164|566841074|FG000|Overall Study|Withdrawal by Subject|8|||
157023569|NCT04064164|566841075|FG001|Overall Study|Withdrawal by Subject|8|||
157023570|NCT04295798|566841085|FG000|Overall Study|Lost to Follow-up|1|||
157023571|NCT03524118|566841086|FG000|Overall Study|Lost to Follow-up|0|||
157023572|NCT03524118|566841087|FG001|Overall Study|Lost to Follow-up|0|||
157023573|NCT03524118|566841088|FG002|Overall Study|Lost to Follow-up|0|||
157023574|NCT03524118|566841089|FG003|Overall Study|Lost to Follow-up|0|||
157023575|NCT03524118|566841090|FG004|Overall Study|Lost to Follow-up|1|||
157023576|NCT03524118|566841091|FG005|Overall Study|Lost to Follow-up|0|||
157023577|NCT03524118|566841086|FG000|Overall Study|Other|0|||
157023578|NCT03524118|566841087|FG001|Overall Study|Other|1|||
157023579|NCT03524118|566841088|FG002|Overall Study|Other|0|||
157023580|NCT03524118|566841089|FG003|Overall Study|Other|0|||
157023581|NCT03524118|566841090|FG004|Overall Study|Other|1|||
157023582|NCT03524118|566841091|FG005|Overall Study|Other|1|||
157023583|NCT03524118|566841086|FG000|Overall Study|Physician Decision|0|||
157023584|NCT03524118|566841087|FG001|Overall Study|Physician Decision|0|||
157023585|NCT03524118|566841088|FG002|Overall Study|Physician Decision|0|||
157023586|NCT03524118|566841089|FG003|Overall Study|Physician Decision|0|||
157023587|NCT03524118|566841090|FG004|Overall Study|Physician Decision|1|||
157023588|NCT03524118|566841091|FG005|Overall Study|Physician Decision|0|||
157023589|NCT03524118|566841086|FG000|Overall Study|Protocol Violation|0|||
157023590|NCT03524118|566841087|FG001|Overall Study|Protocol Violation|0|||
157023591|NCT03524118|566841088|FG002|Overall Study|Protocol Violation|1|||
157023592|NCT03524118|566841089|FG003|Overall Study|Protocol Violation|0|||
157023593|NCT03524118|566841090|FG004|Overall Study|Protocol Violation|1|||
157023594|NCT03524118|566841091|FG005|Overall Study|Protocol Violation|0|||
157152106|NCT01614769|567303367|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
157152107|NCT01614769|567303368|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
156833520|NCT01443130|566143232|FG001|Overall Study|Adverse Event|1|||
156833521|NCT01443130|566143233|FG002|Overall Study|Adverse Event|1|||
156833522|NCT01443130|566143234|FG003|Overall Study|Adverse Event|0|||
156833523|NCT01443130|566143235|FG004|Overall Study|Adverse Event|0|||
156833524|NCT01443130|566143236|FG005|Overall Study|Adverse Event|0|||
156833525|NCT01443130|566143231|FG000|Overall Study|Protocol Violation|2|||
156833526|NCT01443130|566143232|FG001|Overall Study|Protocol Violation|1|||
156833527|NCT01443130|566143233|FG002|Overall Study|Protocol Violation|3|||
156833528|NCT01443130|566143234|FG003|Overall Study|Protocol Violation|2|||
156833529|NCT01443130|566143235|FG004|Overall Study|Protocol Violation|2|||
156833530|NCT01443130|566143236|FG005|Overall Study|Protocol Violation|3|||
156833531|NCT01443130|566143231|FG000|Overall Study|Withdrawal by Subject|15|||
156833532|NCT01443130|566143232|FG001|Overall Study|Withdrawal by Subject|14|||
156833533|NCT01443130|566143233|FG002|Overall Study|Withdrawal by Subject|12|||
157023595|NCT03524118|566841086|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157023596|NCT03524118|566841087|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
157023597|NCT03524118|566841088|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157023598|NCT03524118|566841089|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
157023599|NCT03524118|566841090|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
157152108|NCT01614769|567303369|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
156833534|NCT01443130|566143234|FG003|Overall Study|Withdrawal by Subject|7|||
156833535|NCT01443130|566143235|FG004|Overall Study|Withdrawal by Subject|7|||
156833536|NCT01443130|566143236|FG005|Overall Study|Withdrawal by Subject|2|||
156833537|NCT01443130|566143231|FG000|Overall Study|Death of Subject's Infant|5|||
156885585|NCT01363349|566340048|FG000|Overall Study|Not reported|36|||
156885586|NCT01363349|566340049|FG001|Overall Study|Not reported|37|||
156885587|NCT01363349|566340048|FG000|Overall Study|missing|1|||
156885588|NCT01363349|566340049|FG001|Overall Study|missing|2|||
156885589|NCT01958489|566340050|FG000|Period 2|Adverse Event|0|||
156885590|NCT01958489|566340051|FG001|Period 2|Adverse Event|1|||
157152109|NCT01614769|567303370|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
157152110|NCT01614769|567303365|FG000|Period 1|Protocol Violation|0|||
157152111|NCT01614769|567303366|FG001|Period 1|Protocol Violation|0|||
157152112|NCT01614769|567303367|FG002|Period 1|Protocol Violation|0|||
157152113|NCT01614769|567303368|FG003|Period 1|Protocol Violation|1|||
157152114|NCT01614769|567303369|FG004|Period 1|Protocol Violation|0|||
157152115|NCT01614769|567303370|FG005|Period 1|Protocol Violation|0|||
157152116|NCT01614769|567303365|FG000|Period 1|Withdrawal by Subject|1|||
157152117|NCT01614769|567303366|FG001|Period 1|Withdrawal by Subject|0|||
157152118|NCT01614769|567303367|FG002|Period 1|Withdrawal by Subject|0|||
157152119|NCT01614769|567303368|FG003|Period 1|Withdrawal by Subject|0|||
157152120|NCT01614769|567303369|FG004|Period 1|Withdrawal by Subject|0|||
157152121|NCT01614769|567303370|FG005|Period 1|Withdrawal by Subject|0|||
157152122|NCT01614769|567303365|FG000|Period 3|Withdrawal by Subject|0|||
157152123|NCT01614769|567303366|FG001|Period 3|Withdrawal by Subject|0|||
157152124|NCT01614769|567303367|FG002|Period 3|Withdrawal by Subject|1|||
157152125|NCT01614769|567303368|FG003|Period 3|Withdrawal by Subject|0|||
157152126|NCT01614769|567303369|FG004|Period 3|Withdrawal by Subject|0|||
156833538|NCT01443130|566143232|FG001|Overall Study|Death of Subject's Infant|10|||
156833539|NCT01443130|566143233|FG002|Overall Study|Death of Subject's Infant|11|||
156833540|NCT01443130|566143234|FG003|Overall Study|Death of Subject's Infant|0|||
156833541|NCT01443130|566143235|FG004|Overall Study|Death of Subject's Infant|0|||
156833542|NCT01443130|566143236|FG005|Overall Study|Death of Subject's Infant|0|||
156833543|NCT00364533|566143237|FG000|Overall Study|Adverse Event|8|||
156833544|NCT00364533|566143238|FG001|Overall Study|Adverse Event|7|||
156833545|NCT00364533|566143239|FG002|Overall Study|Adverse Event|15|||
156833546|NCT00364533|566143240|FG003|Overall Study|Adverse Event|5|||
156833547|NCT00364533|566143241|FG004|Overall Study|Adverse Event|2|||
156833548|NCT00364533|566143237|FG000|Overall Study|Withdrawal by Subject|4|||
156833549|NCT00364533|566143238|FG001|Overall Study|Withdrawal by Subject|8|||
156833550|NCT00364533|566143239|FG002|Overall Study|Withdrawal by Subject|6|||
156833551|NCT00364533|566143240|FG003|Overall Study|Withdrawal by Subject|6|||
156833552|NCT00364533|566143241|FG004|Overall Study|Withdrawal by Subject|6|||
156833553|NCT00364533|566143237|FG000|Overall Study|Lack of Efficacy|22|||
156833554|NCT00364533|566143238|FG001|Overall Study|Lack of Efficacy|22|||
156833555|NCT00364533|566143239|FG002|Overall Study|Lack of Efficacy|21|||
156833556|NCT00364533|566143240|FG003|Overall Study|Lack of Efficacy|17|||
156833557|NCT00364533|566143241|FG004|Overall Study|Lack of Efficacy|42|||
156833558|NCT00364533|566143237|FG000|Overall Study|Subject discharged from hospital|4|||
156833559|NCT00364533|566143238|FG001|Overall Study|Subject discharged from hospital|1|||
156833560|NCT00364533|566143239|FG002|Overall Study|Subject discharged from hospital|2|||
156833561|NCT00364533|566143240|FG003|Overall Study|Subject discharged from hospital|3|||
156833562|NCT00364533|566143241|FG004|Overall Study|Subject discharged from hospital|1|||
156833563|NCT00364533|566143237|FG000|Overall Study|Variations in drug compliance|2|||
156833564|NCT00364533|566143238|FG001|Overall Study|Variations in drug compliance|1|||
156833565|NCT00364533|566143239|FG002|Overall Study|Variations in drug compliance|1|||
156833566|NCT00364533|566143240|FG003|Overall Study|Variations in drug compliance|0|||
156833567|NCT00364533|566143241|FG004|Overall Study|Variations in drug compliance|0|||
156833568|NCT00364533|566143237|FG000|Overall Study|Non-compliance|1|||
156833569|NCT00364533|566143238|FG001|Overall Study|Non-compliance|0|||
156833570|NCT00364533|566143239|FG002|Overall Study|Non-compliance|0|||
156833571|NCT00364533|566143240|FG003|Overall Study|Non-compliance|0|||
156833572|NCT00364533|566143241|FG004|Overall Study|Non-compliance|0|||
156833573|NCT00364533|566143237|FG000|Overall Study|Protocol Violation|1|||
156833574|NCT00364533|566143238|FG001|Overall Study|Protocol Violation|1|||
156833575|NCT00364533|566143239|FG002|Overall Study|Protocol Violation|0|||
156833576|NCT00364533|566143240|FG003|Overall Study|Protocol Violation|0|||
156833577|NCT00364533|566143241|FG004|Overall Study|Protocol Violation|0|||
156833578|NCT02639338|566143250|FG000|Overall Study|Lost to Follow-up|2|||
156833579|NCT02639338|566143251|FG001|Overall Study|Lost to Follow-up|2|||
156833580|NCT02639338|566143250|FG000|Overall Study|Withdrew Consent|1|||
156833581|NCT02639338|566143251|FG001|Overall Study|Withdrew Consent|2|||
156833582|NCT02639338|566143250|FG000|Overall Study|Death|1|||
156833583|NCT02639338|566143251|FG001|Overall Study|Death|0|||
156833584|NCT02639338|566143250|FG000|Overall Study|Randomized but Not Treated|0|||
156833585|NCT02639338|566143251|FG001|Overall Study|Randomized but Not Treated|1|||
156833586|NCT00493636|566143252|FG000|Overall Study|Withdrawal by Subject|1|||
156833587|NCT00493636|566143253|FG001|Overall Study|Withdrawal by Subject|0|||
156833588|NCT00493636|566143252|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
157152127|NCT01614769|567303370|FG005|Period 3|Withdrawal by Subject|0|||
157152128|NCT02115815|567303371|FG000|Overall Study|Withdrawal by Subject|2|||
156885591|NCT00917644|566340052|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
157152129|NCT02115815|567303372|FG001|Overall Study|Withdrawal by Subject|0|||
156833589|NCT00493636|566143253|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
156833590|NCT00493636|566143252|FG000|Overall Study|Mis-randomization|1|||
156833591|NCT00493636|566143253|FG001|Overall Study|Mis-randomization|1|||
156833592|NCT02900170|566143255|FG000|Overall Study|Lost to Follow-up|8|||
156833593|NCT02012686|566143260|FG000|Overall Study|muscle contraction|0|||
156833594|NCT02012686|566143261|FG001|Overall Study|muscle contraction|1|||
156833595|NCT02012686|566143260|FG000|Overall Study|electrocardiography monitoring noise|0|||
156833596|NCT02012686|566143261|FG001|Overall Study|electrocardiography monitoring noise|1|||
156833597|NCT01703065|566143264|FG000|Overall Study|Lack of Efficacy|1|||
156833598|NCT01703065|566143265|FG001|Overall Study|Lack of Efficacy|0|||
156833599|NCT02635347|566143266|FG000|Overall Study|Failed screening|20|||
156833600|NCT02635347|566143267|FG001|Overall Study|Failed screening|7|||
156833601|NCT03759041|566143272|FG000|Overall Study|Withdrawal by Subject|4|||
156833602|NCT03759041|566143273|FG001|Overall Study|Withdrawal by Subject|10|||
156833603|NCT03759041|566143274|FG002|Overall Study|Withdrawal by Subject|10|||
156833604|NCT03759041|566143272|FG000|Overall Study|Adverse Event|1|||
156833605|NCT03759041|566143273|FG001|Overall Study|Adverse Event|3|||
156833606|NCT03759041|566143274|FG002|Overall Study|Adverse Event|4|||
156833607|NCT03759041|566143272|FG000|Overall Study|Lack of Efficacy|0|||
156885592|NCT00917644|566340053|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
156885593|NCT00917644|566340052|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
156885594|NCT00917644|566340053|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
156885595|NCT00917644|566340052|FG000|Period 2: Second Intervention|family emergency|1|||
156885596|NCT00917644|566340053|FG001|Period 2: Second Intervention|family emergency|0|||
156885597|NCT01101308|566340054|FG000|Period 1|Adverse Event|2|||
156885598|NCT01101308|566340055|FG001|Period 1|Adverse Event|1|||
156885599|NCT01101308|566340054|FG000|Period 1|Positive for cotinine|1|||
156885600|NCT01101308|566340055|FG001|Period 1|Positive for cotinine|0|||
156885601|NCT02282345|566340060|FG000|Overall Study|Progression|0|||
156885602|NCT02282345|566340061|FG001|Overall Study|Progression|1|||
156885603|NCT00711516|566340062|FG000|Overall Study|Adverse Event|1|||
156885604|NCT00711516|566340063|FG001|Overall Study|Adverse Event|1|||
156885605|NCT00711516|566340062|FG000|Overall Study|Withdrawal by Subject|0|||
156885606|NCT00711516|566340063|FG001|Overall Study|Withdrawal by Subject|1|||
156885607|NCT00711516|566340062|FG000|Overall Study|Protocol Violation|0|||
156885608|NCT00711516|566340063|FG001|Overall Study|Protocol Violation|1|||
156885609|NCT04575597|566340064|FG000|Overall Study|Death|0|||
157152130|NCT02115815|567303373|FG002|Overall Study|Withdrawal by Subject|0|||
157152131|NCT02115815|567303374|FG003|Overall Study|Withdrawal by Subject|0|||
157152132|NCT02115815|567303375|FG004|Overall Study|Withdrawal by Subject|0|||
157152133|NCT02115815|567303376|FG005|Overall Study|Withdrawal by Subject|0|||
157152134|NCT02115815|567303377|FG006|Overall Study|Withdrawal by Subject|0|||
157152135|NCT02115815|567303371|FG000|Overall Study|Not enough drug to dose participant|0|||
157152136|NCT02115815|567303372|FG001|Overall Study|Not enough drug to dose participant|0|||
157152137|NCT02115815|567303373|FG002|Overall Study|Not enough drug to dose participant|0|||
157152138|NCT02115815|567303374|FG003|Overall Study|Not enough drug to dose participant|0|||
157152139|NCT02115815|567303375|FG004|Overall Study|Not enough drug to dose participant|0|||
157152140|NCT02115815|567303376|FG005|Overall Study|Not enough drug to dose participant|1|||
157152141|NCT02115815|567303377|FG006|Overall Study|Not enough drug to dose participant|0|||
157152142|NCT02115815|567303371|FG000|Overall Study|Missed appointment, randomized in error|0|||
157152143|NCT02115815|567303372|FG001|Overall Study|Missed appointment, randomized in error|0|||
157152144|NCT02115815|567303373|FG002|Overall Study|Missed appointment, randomized in error|0|||
157152145|NCT02115815|567303374|FG003|Overall Study|Missed appointment, randomized in error|0|||
157152146|NCT02115815|567303375|FG004|Overall Study|Missed appointment, randomized in error|0|||
157152147|NCT02115815|567303376|FG005|Overall Study|Missed appointment, randomized in error|1|||
157152148|NCT02115815|567303377|FG006|Overall Study|Missed appointment, randomized in error|0|||
157152149|NCT01228071|567303378|FG000|Overall Study|Protocol Violation|1|||
157152150|NCT01228071|567303378|FG000|Overall Study|Withdrawal by Subject|1|||
157152151|NCT01989546|567303379|FG000|Overall Study|Clinical Progression|1|||
157152152|NCT01989546|567303379|FG000|Overall Study|Disease progression on study|8|||
156885610|NCT04575597|566340065|FG001|Overall Study|Death|0|||
156885611|NCT04575597|566340066|FG002|Overall Study|Death|0|||
157152153|NCT02819310|567303382|FG000|Overall Study|Withdrawal by Subject|37|||
157023600|NCT03524118|566841091|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
157152154|NCT02819310|567303382|FG000|Overall Study|Lost to Follow-up|16|||
157152155|NCT02819310|567303382|FG000|Overall Study|Adverse Event|13|||
157152156|NCT02819310|567303382|FG000|Overall Study|Lack of Efficacy|5|||
157152157|NCT02819310|567303382|FG000|Overall Study|Physician Decision|8|||
157152158|NCT02819310|567303382|FG000|Overall Study|Protocol Violation|30|||
156833608|NCT03759041|566143273|FG001|Overall Study|Lack of Efficacy|0|||
156833609|NCT03759041|566143274|FG002|Overall Study|Lack of Efficacy|1|||
156833610|NCT03759041|566143272|FG000|Overall Study|Study Terminated by Sponsor|15|||
156885612|NCT04575597|566340067|FG003|Overall Study|Death|1|||
156885613|NCT04575597|566340068|FG004|Overall Study|Death|3|||
156885614|NCT04575597|566340069|FG005|Overall Study|Death|14|||
156885615|NCT04575597|566340064|FG000|Overall Study|Lost to Follow-up|2|||
156833611|NCT03759041|566143273|FG001|Overall Study|Study Terminated by Sponsor|16|||
156833612|NCT03759041|566143274|FG002|Overall Study|Study Terminated by Sponsor|10|||
156833613|NCT03759041|566143272|FG000|Overall Study|Other reason for discontinuation|0|||
157152159|NCT01793051|567303387|FG000|Overall Study|Withdrawal by Subject|6|||
157152160|NCT01793051|567303388|FG001|Overall Study|Withdrawal by Subject|4|||
157152161|NCT01793051|567303387|FG000|Overall Study|Adverse Event|0|||
157152162|NCT01793051|567303388|FG001|Overall Study|Adverse Event|2|||
156833614|NCT03759041|566143273|FG001|Overall Study|Other reason for discontinuation|2|||
156833615|NCT03759041|566143274|FG002|Overall Study|Other reason for discontinuation|1|||
156833616|NCT03759041|566143272|FG000|Overall Study|Lost to Follow-up|7|||
156833617|NCT03759041|566143273|FG001|Overall Study|Lost to Follow-up|2|||
156833618|NCT03759041|566143274|FG002|Overall Study|Lost to Follow-up|2|||
156833619|NCT03759041|566143272|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
156833620|NCT03759041|566143273|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
156833621|NCT03759041|566143274|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
156833622|NCT02449018|566143275|FG000|Overall Study|Abnormal laboratory value|0|||
156833623|NCT02449018|566143276|FG001|Overall Study|Abnormal laboratory value|1|||
156833624|NCT02449018|566143275|FG000|Overall Study|Administrative problems|1|||
156833625|NCT02449018|566143276|FG001|Overall Study|Administrative problems|0|||
156833626|NCT02449018|566143275|FG000|Overall Study|Adverse Event|5|||
156833627|NCT02449018|566143276|FG001|Overall Study|Adverse Event|1|||
156833628|NCT02449018|566143275|FG000|Overall Study|Protocol deviation|4|||
156833629|NCT02449018|566143276|FG001|Overall Study|Protocol deviation|0|||
156833630|NCT02449018|566143275|FG000|Overall Study|Patient decision|2|||
156833631|NCT02449018|566143276|FG001|Overall Study|Patient decision|0|||
156833632|NCT00525824|566143281|FG000|Overall Study|Adverse Event|7|||
156833633|NCT00525824|566143282|FG001|Overall Study|Adverse Event|11|||
156833634|NCT00525824|566143283|FG002|Overall Study|Adverse Event|6|||
156833635|NCT00525824|566143284|FG003|Overall Study|Adverse Event|7|||
156833636|NCT00525824|566143281|FG000|Overall Study|Withdrawal by Subject|5|||
156833637|NCT00525824|566143282|FG001|Overall Study|Withdrawal by Subject|9|||
156833638|NCT00525824|566143283|FG002|Overall Study|Withdrawal by Subject|3|||
156833639|NCT00525824|566143284|FG003|Overall Study|Withdrawal by Subject|4|||
156833640|NCT00525824|566143281|FG000|Overall Study|Lost to Follow-up|4|||
156833641|NCT00525824|566143282|FG001|Overall Study|Lost to Follow-up|2|||
156833642|NCT00525824|566143283|FG002|Overall Study|Lost to Follow-up|4|||
156833643|NCT00525824|566143284|FG003|Overall Study|Lost to Follow-up|0|||
156833644|NCT00525824|566143281|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
156833645|NCT00525824|566143282|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
156833646|NCT00525824|566143283|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
156833647|NCT00525824|566143284|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
156833648|NCT00525824|566143281|FG000|Overall Study|Severe non-compliance|0|||
156833649|NCT00525824|566143282|FG001|Overall Study|Severe non-compliance|1|||
156833650|NCT00525824|566143283|FG002|Overall Study|Severe non-compliance|1|||
156833651|NCT00525824|566143284|FG003|Overall Study|Severe non-compliance|1|||
156833652|NCT00525824|566143281|FG000|Overall Study|Safety reasons|1|||
156833653|NCT00525824|566143282|FG001|Overall Study|Safety reasons|0|||
156833654|NCT00525824|566143283|FG002|Overall Study|Safety reasons|1|||
156833655|NCT00525824|566143284|FG003|Overall Study|Safety reasons|0|||
156833656|NCT00525824|566143281|FG000|Overall Study|Other|1|||
156833657|NCT00525824|566143282|FG001|Overall Study|Other|3|||
156833658|NCT00525824|566143283|FG002|Overall Study|Other|3|||
156833659|NCT00525824|566143284|FG003|Overall Study|Other|1|||
156833660|NCT05011513|566144358|FG000|Overall Study|Death|0|||
156833661|NCT05011513|566144359|FG001|Overall Study|Death|1|||
156833662|NCT05011513|566144358|FG000|Overall Study|Lost to Follow-up|4|||
157152163|NCT01793051|567303387|FG000|Overall Study|Too ill to continue|1|||
156833663|NCT05011513|566144359|FG001|Overall Study|Lost to Follow-up|0|||
156833664|NCT05011513|566144358|FG000|Overall Study|Withdrawal by Subject|18|||
156833665|NCT05011513|566144359|FG001|Overall Study|Withdrawal by Subject|17|||
156833666|NCT05011513|566144358|FG000|Overall Study|Other|4|||
156833667|NCT05011513|566144359|FG001|Overall Study|Other|2|||
156833668|NCT03495102|566144360|FG000|Overall Study|Adverse Event|5|||
156833669|NCT03495102|566144361|FG001|Overall Study|Adverse Event|7|||
156833670|NCT03495102|566144362|FG002|Overall Study|Adverse Event|10|||
156833671|NCT03495102|566144360|FG000|Overall Study|Death|3|||
156833672|NCT03495102|566144361|FG001|Overall Study|Death|4|||
156833673|NCT03495102|566144362|FG002|Overall Study|Death|4|||
156833674|NCT03495102|566144360|FG000|Overall Study|Lost to Follow-up|15|||
157152164|NCT01793051|567303388|FG001|Overall Study|Too ill to continue|0|||
157152165|NCT01793051|567303387|FG000|Overall Study|Switched chemo|1|||
157152166|NCT01793051|567303388|FG001|Overall Study|Switched chemo|1|||
156833675|NCT03495102|566144361|FG001|Overall Study|Lost to Follow-up|16|||
156833676|NCT03495102|566144362|FG002|Overall Study|Lost to Follow-up|17|||
156833677|NCT03495102|566144360|FG000|Overall Study|Physician Decision|2|||
156833678|NCT03495102|566144361|FG001|Overall Study|Physician Decision|0|||
156833679|NCT03495102|566144362|FG002|Overall Study|Physician Decision|2|||
156833680|NCT03495102|566144360|FG000|Overall Study|Withdrawal by Subject|25|||
157152167|NCT01793051|567303387|FG000|Overall Study|Lack of compliance|1|||
157152168|NCT01793051|567303388|FG001|Overall Study|Lack of compliance|0|||
157152169|NCT01793051|567303387|FG000|Overall Study|Requested to be removed from the study|1|||
157152170|NCT01793051|567303388|FG001|Overall Study|Requested to be removed from the study|1|||
157152171|NCT00059215|567303391|FG000|Overall Study|Adverse Event|5|||
157152172|NCT00059215|567303392|FG001|Overall Study|Adverse Event|5|||
157152173|NCT00059215|567303393|FG002|Overall Study|Adverse Event|9|||
157152174|NCT00059215|567303394|FG003|Overall Study|Adverse Event|9|||
157152175|NCT00059215|567303391|FG000|Overall Study|Death|0|||
157152176|NCT00059215|567303392|FG001|Overall Study|Death|0|||
157152177|NCT00059215|567303393|FG002|Overall Study|Death|3|||
157152178|NCT00059215|567303394|FG003|Overall Study|Death|0|||
157152179|NCT00059215|567303391|FG000|Overall Study|Lost to Follow-up|1|||
157152180|NCT00059215|567303392|FG001|Overall Study|Lost to Follow-up|2|||
157152181|NCT00059215|567303393|FG002|Overall Study|Lost to Follow-up|0|||
157152182|NCT00059215|567303394|FG003|Overall Study|Lost to Follow-up|0|||
157152183|NCT00059215|567303391|FG000|Overall Study|Withdrawal by Subject|4|||
157152184|NCT00059215|567303392|FG001|Overall Study|Withdrawal by Subject|4|||
157152185|NCT00059215|567303393|FG002|Overall Study|Withdrawal by Subject|1|||
157152186|NCT00059215|567303394|FG003|Overall Study|Withdrawal by Subject|3|||
157152187|NCT00059215|567303391|FG000|Overall Study|Protocol Violation|1|||
157152188|NCT00059215|567303392|FG001|Overall Study|Protocol Violation|0|||
157152189|NCT00059215|567303393|FG002|Overall Study|Protocol Violation|1|||
157152190|NCT00059215|567303394|FG003|Overall Study|Protocol Violation|0|||
157152191|NCT00059215|567303391|FG000|Overall Study|Protocol entry criteria not met|1|||
157152192|NCT00059215|567303392|FG001|Overall Study|Protocol entry criteria not met|1|||
157152193|NCT00059215|567303393|FG002|Overall Study|Protocol entry criteria not met|0|||
156833681|NCT03495102|566144361|FG001|Overall Study|Withdrawal by Subject|36|||
156833682|NCT03495102|566144362|FG002|Overall Study|Withdrawal by Subject|18|||
156833683|NCT03495102|566144360|FG000|Overall Study|Protocol Violation|1|||
156833684|NCT03495102|566144361|FG001|Overall Study|Protocol Violation|1|||
156833685|NCT03495102|566144362|FG002|Overall Study|Protocol Violation|0|||
156833686|NCT03495102|566144360|FG000|Overall Study|Site Closure|3|||
156833687|NCT03495102|566144361|FG001|Overall Study|Site Closure|1|||
156833688|NCT03495102|566144362|FG002|Overall Study|Site Closure|2|||
156833689|NCT03495102|566144360|FG000|Overall Study|Non-compliance|1|||
156833690|NCT03495102|566144361|FG001|Overall Study|Non-compliance|0|||
156833691|NCT03495102|566144362|FG002|Overall Study|Non-compliance|0|||
156833692|NCT03495102|566144360|FG000|Overall Study|Participant Duplicated at Another Site|0|||
156833693|NCT03495102|566144361|FG001|Overall Study|Participant Duplicated at Another Site|0|||
156833694|NCT03495102|566144362|FG002|Overall Study|Participant Duplicated at Another Site|1|||
156833695|NCT03495102|566144360|FG000|Overall Study|Primary Care Physician Recommendation|0|||
156833696|NCT03495102|566144361|FG001|Overall Study|Primary Care Physician Recommendation|1|||
156833697|NCT03495102|566144362|FG002|Overall Study|Primary Care Physician Recommendation|0|||
156833698|NCT03495102|566144360|FG000|Overall Study|Relocated to Another Country|0|||
156833699|NCT03495102|566144361|FG001|Overall Study|Relocated to Another Country|1|||
156833700|NCT03495102|566144362|FG002|Overall Study|Relocated to Another Country|0|||
156833701|NCT03495102|566144360|FG000|Overall Study|Participant was in Rehabilitation|1|||
156833702|NCT03495102|566144361|FG001|Overall Study|Participant was in Rehabilitation|0|||
156833703|NCT03495102|566144362|FG002|Overall Study|Participant was in Rehabilitation|0|||
156833704|NCT01161537|566144365|FG000|Part B|Withdrawal by Subject|2|||
156833705|NCT00358436|566144368|FG000|Overall Study|Adverse Event|29|||
156833706|NCT00358436|566144369|FG001|Overall Study|Adverse Event|13|||
156833707|NCT00358436|566144368|FG000|Overall Study|Lack of Efficacy|34|||
156833708|NCT00358436|566144369|FG001|Overall Study|Lack of Efficacy|36|||
156833709|NCT00358436|566144368|FG000|Overall Study|Lost to Follow-up|11|||
156833710|NCT00358436|566144369|FG001|Overall Study|Lost to Follow-up|6|||
156833711|NCT00358436|566144368|FG000|Overall Study|Protocol Violation|8|||
156833712|NCT00358436|566144369|FG001|Overall Study|Protocol Violation|3|||
156833713|NCT00358436|566144368|FG000|Overall Study|Withdrawal by Subject|40|||
156833714|NCT00358436|566144369|FG001|Overall Study|Withdrawal by Subject|17|||
156833715|NCT00358436|566144368|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
156833716|NCT00358436|566144369|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
156833717|NCT00358436|566144368|FG000|Overall Study|COPD exacerbation|22|||
156833718|NCT00358436|566144369|FG001|Overall Study|COPD exacerbation|10|||
156833719|NCT00358436|566144368|FG000|Overall Study|Other|6|||
157152194|NCT00059215|567303394|FG003|Overall Study|Protocol entry criteria not met|2|||
157152195|NCT00059215|567303391|FG000|Overall Study|Physician Decision|1|||
157152196|NCT00059215|567303392|FG001|Overall Study|Physician Decision|2|||
157152197|NCT00059215|567303393|FG002|Overall Study|Physician Decision|1|||
157152198|NCT00059215|567303394|FG003|Overall Study|Physician Decision|1|||
157152199|NCT04439838|567303396|FG000|Overall Study|Withdrawal by Subject|0|||
157152200|NCT04439838|567303397|FG001|Overall Study|Withdrawal by Subject|0|||
156833720|NCT00358436|566144369|FG001|Overall Study|Other|1|||
156833721|NCT01286077|566144372|FG000|Overall Study|Adverse Event|2|||
156833722|NCT01286077|566144373|FG001|Overall Study|Adverse Event|0|||
156833723|NCT01286077|566144372|FG000|Overall Study|Death|1|||
156833724|NCT01286077|566144373|FG001|Overall Study|Death|0|||
156833725|NCT01286077|566144372|FG000|Overall Study|Protocol Violation|1|||
156833726|NCT01286077|566144373|FG001|Overall Study|Protocol Violation|1|||
156833727|NCT01286077|566144372|FG000|Overall Study|Withdrawal by Subject|0|||
156833728|NCT01286077|566144373|FG001|Overall Study|Withdrawal by Subject|2|||
156833729|NCT01286077|566144372|FG000|Overall Study|Intercurrent illness|1|||
156833730|NCT01286077|566144373|FG001|Overall Study|Intercurrent illness|0|||
156833731|NCT01286077|566144372|FG000|Overall Study|Non-compliance|1|||
156833732|NCT01286077|566144373|FG001|Overall Study|Non-compliance|0|||
156833733|NCT01286077|566144372|FG000|Overall Study|The subject starts with alternative MMY|0|||
156833734|NCT01286077|566144373|FG001|Overall Study|The subject starts with alternative MMY|3|||
156833735|NCT01286077|566144372|FG000|Overall Study|Patient's decision to stop treatment|3|||
156833736|NCT01286077|566144373|FG001|Overall Study|Patient's decision to stop treatment|0|||
156833737|NCT01286077|566144372|FG000|Overall Study|Progression of disease|0|||
156833738|NCT01286077|566144373|FG001|Overall Study|Progression of disease|1|||
156833739|NCT01286077|566144372|FG000|Overall Study|refill medication not received in time|1|||
156833740|NCT01286077|566144373|FG001|Overall Study|refill medication not received in time|0|||
156833741|NCT02654236|566144374|FG000|Overall Study|Withdrawal by Subject|0|||
156833742|NCT02654236|566144375|FG001|Overall Study|Withdrawal by Subject|0|||
156833743|NCT02654236|566144376|FG002|Overall Study|Withdrawal by Subject|2|||
156833744|NCT01549873|566144377|FG000|Overall Study|Physician Decision|0|||
156833745|NCT01549873|566144378|FG001|Overall Study|Physician Decision|1|||
156833746|NCT00701805|566144379|FG000|Overall Study|Withdrawal by Subject|3|||
156833747|NCT00701805|566144380|FG001|Overall Study|Withdrawal by Subject|1|||
156833748|NCT00701805|566144381|FG002|Overall Study|Withdrawal by Subject|4|||
156833749|NCT00701805|566144382|FG003|Overall Study|Withdrawal by Subject|3|||
156833750|NCT00701805|566144379|FG000|Overall Study|Adverse Event|0|||
156833751|NCT00701805|566144380|FG001|Overall Study|Adverse Event|1|||
156833752|NCT00701805|566144381|FG002|Overall Study|Adverse Event|1|||
156833753|NCT00701805|566144382|FG003|Overall Study|Adverse Event|0|||
156833754|NCT00701805|566144379|FG000|Overall Study|Missed 7 consecutive doses|0|||
156833755|NCT00701805|566144380|FG001|Overall Study|Missed 7 consecutive doses|1|||
156833756|NCT00701805|566144381|FG002|Overall Study|Missed 7 consecutive doses|0|||
156833757|NCT00701805|566144382|FG003|Overall Study|Missed 7 consecutive doses|0|||
156833758|NCT00701805|566144379|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
156833759|NCT00701805|566144380|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
156833760|NCT00701805|566144381|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
156833761|NCT00701805|566144382|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
156833762|NCT00701805|566144379|FG000|Overall Study|Physician decision, change of therapy|0|||
156833763|NCT00701805|566144380|FG001|Overall Study|Physician decision, change of therapy|0|||
156885616|NCT04575597|566340065|FG001|Overall Study|Lost to Follow-up|1|||
156885617|NCT04575597|566340066|FG002|Overall Study|Lost to Follow-up|1|||
156885618|NCT04575597|566340067|FG003|Overall Study|Lost to Follow-up|2|||
156885619|NCT04575597|566340068|FG004|Overall Study|Lost to Follow-up|10|||
156885620|NCT04575597|566340069|FG005|Overall Study|Lost to Follow-up|8|||
156885621|NCT04575597|566340064|FG000|Overall Study|Withdrawal by Subject|2|||
156885622|NCT04575597|566340065|FG001|Overall Study|Withdrawal by Subject|2|||
156885623|NCT04575597|566340066|FG002|Overall Study|Withdrawal by Subject|4|||
156885624|NCT04575597|566340067|FG003|Overall Study|Withdrawal by Subject|2|||
156885625|NCT04575597|566340068|FG004|Overall Study|Withdrawal by Subject|25|||
156885626|NCT04575597|566340069|FG005|Overall Study|Withdrawal by Subject|28|||
156885627|NCT04575597|566340064|FG000|Overall Study|Not Recorded|0|||
156885628|NCT04575597|566340065|FG001|Overall Study|Not Recorded|0|||
156885629|NCT04575597|566340066|FG002|Overall Study|Not Recorded|0|||
156885630|NCT04575597|566340067|FG003|Overall Study|Not Recorded|0|||
156885631|NCT04575597|566340068|FG004|Overall Study|Not Recorded|0|||
156885632|NCT04575597|566340069|FG005|Overall Study|Not Recorded|2|||
156885633|NCT04575597|566340064|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156885634|NCT04575597|566340065|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156885635|NCT04575597|566340066|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156885636|NCT04575597|566340067|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156885637|NCT04575597|566340068|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
156885638|NCT04575597|566340069|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
156885639|NCT02095132|566340077|FG000|Overall Study|Adverse Event|0|||
156885640|NCT02095132|566340078|FG001|Overall Study|Adverse Event|0|||
156885641|NCT02095132|566340079|FG002|Overall Study|Adverse Event|0|||
156885642|NCT02095132|566340080|FG003|Overall Study|Adverse Event|0|||
156885643|NCT02095132|566340081|FG004|Overall Study|Adverse Event|1|||
156833764|NCT00701805|566144381|FG002|Overall Study|Physician decision, change of therapy|0|||
156833765|NCT00701805|566144382|FG003|Overall Study|Physician decision, change of therapy|1|||
156885644|NCT02095132|566340082|FG005|Overall Study|Adverse Event|0|||
156885645|NCT02095132|566340083|FG006|Overall Study|Adverse Event|1|||
156885646|NCT02095132|566340084|FG007|Overall Study|Adverse Event|0|||
156885647|NCT02095132|566340085|FG008|Overall Study|Adverse Event|0|||
156885648|NCT02095132|566340077|FG000|Overall Study|Death|0|||
156833766|NCT00701805|566144379|FG000|Overall Study|Difficult to travel to dialysis site|0|||
156833767|NCT00701805|566144380|FG001|Overall Study|Difficult to travel to dialysis site|0|||
156833768|NCT00701805|566144381|FG002|Overall Study|Difficult to travel to dialysis site|1|||
156833769|NCT00701805|566144382|FG003|Overall Study|Difficult to travel to dialysis site|0|||
156833770|NCT00701805|566144379|FG000|Overall Study|Resumption criteria were not met|0|||
156833771|NCT00701805|566144380|FG001|Overall Study|Resumption criteria were not met|1|||
156833772|NCT00701805|566144381|FG002|Overall Study|Resumption criteria were not met|0|||
156833773|NCT00701805|566144382|FG003|Overall Study|Resumption criteria were not met|0|||
156833774|NCT04435600|566144388|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833775|NCT04435600|566144389|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833776|NCT04435600|566144390|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
156833777|NCT04435600|566144391|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833778|NCT04435600|566144392|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833779|NCT04435600|566144393|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833780|NCT04435600|566144394|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833781|NCT04435600|566144395|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833782|NCT04435600|566144396|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833783|NCT04435600|566144397|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
156833784|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833785|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833786|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833787|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833788|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833789|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833790|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833791|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833792|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
156833793|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
156833794|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833795|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833796|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833797|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833798|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833799|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833800|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833801|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833802|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
156833803|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
156885649|NCT02095132|566340078|FG001|Overall Study|Death|0|||
156885650|NCT02095132|566340079|FG002|Overall Study|Death|0|||
156885651|NCT02095132|566340080|FG003|Overall Study|Death|0|||
156885652|NCT02095132|566340081|FG004|Overall Study|Death|0|||
156885653|NCT02095132|566340082|FG005|Overall Study|Death|0|||
156885654|NCT02095132|566340083|FG006|Overall Study|Death|1|||
156885655|NCT02095132|566340084|FG007|Overall Study|Death|0|||
156885656|NCT02095132|566340085|FG008|Overall Study|Death|0|||
156885657|NCT02095132|566340077|FG000|Overall Study|Lack of Efficacy|3|||
156885658|NCT02095132|566340078|FG001|Overall Study|Lack of Efficacy|5|||
156885659|NCT02095132|566340079|FG002|Overall Study|Lack of Efficacy|2|||
156885660|NCT02095132|566340080|FG003|Overall Study|Lack of Efficacy|8|||
156885661|NCT02095132|566340081|FG004|Overall Study|Lack of Efficacy|3|||
156885662|NCT02095132|566340082|FG005|Overall Study|Lack of Efficacy|6|||
156885663|NCT02095132|566340083|FG006|Overall Study|Lack of Efficacy|10|||
156885664|NCT02095132|566340084|FG007|Overall Study|Lack of Efficacy|9|||
156885665|NCT02095132|566340085|FG008|Overall Study|Lack of Efficacy|8|||
156885666|NCT02095132|566340077|FG000|Overall Study|Physician Decision|1|||
156885667|NCT02095132|566340078|FG001|Overall Study|Physician Decision|0|||
156885668|NCT02095132|566340079|FG002|Overall Study|Physician Decision|0|||
156885669|NCT02095132|566340080|FG003|Overall Study|Physician Decision|0|||
156885670|NCT02095132|566340081|FG004|Overall Study|Physician Decision|0|||
157152201|NCT04439838|567303398|FG002|Overall Study|Withdrawal by Subject|0|||
157152202|NCT04439838|567303399|FG003|Overall Study|Withdrawal by Subject|0|||
157152203|NCT04439838|567303400|FG004|Overall Study|Withdrawal by Subject|0|||
157152204|NCT04439838|567303401|FG005|Overall Study|Withdrawal by Subject|0|||
157152205|NCT04439838|567303402|FG006|Overall Study|Withdrawal by Subject|0|||
157152206|NCT04439838|567303403|FG007|Overall Study|Withdrawal by Subject|0|||
157152207|NCT04439838|567303404|FG008|Overall Study|Withdrawal by Subject|1|||
157152208|NCT04494633|567303409|FG000|Overall Study|Lost to Follow-up|5|||
157152209|NCT04494633|567303410|FG001|Overall Study|Lost to Follow-up|3|||
157152210|NCT04494633|567303409|FG000|Overall Study|Protocol Violation|1|||
156885671|NCT02095132|566340082|FG005|Overall Study|Physician Decision|0|||
156885672|NCT02095132|566340083|FG006|Overall Study|Physician Decision|1|||
156885673|NCT02095132|566340084|FG007|Overall Study|Physician Decision|0|||
156833804|NCT04435600|566144388|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833805|NCT04435600|566144389|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833806|NCT04435600|566144390|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833807|NCT04435600|566144391|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833808|NCT04435600|566144392|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833809|NCT04435600|566144393|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833810|NCT04435600|566144394|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833811|NCT04435600|566144395|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833812|NCT04435600|566144396|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
156833813|NCT04435600|566144397|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
156833814|NCT02797184|566144398|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
156833815|NCT02797184|566144399|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
156833816|NCT00673881|566144411|FG000|Overall Study|Withdrawal by Subject|1|||
156833817|NCT03968159|566144414|FG000|Overall Study|Adverse Event|4|||
157023601|NCT04316871|566841094|FG000|Overall Study|Protocol Violation|2|||
156833818|NCT03968159|566144415|FG001|Overall Study|Adverse Event|4|||
156885674|NCT02095132|566340085|FG008|Overall Study|Physician Decision|2|||
156885675|NCT02095132|566340077|FG000|Overall Study|Withdrawal by Subject|0|||
156885676|NCT02095132|566340078|FG001|Overall Study|Withdrawal by Subject|0|||
156885677|NCT02095132|566340079|FG002|Overall Study|Withdrawal by Subject|2|||
156885678|NCT02095132|566340080|FG003|Overall Study|Withdrawal by Subject|2|||
156885679|NCT02095132|566340081|FG004|Overall Study|Withdrawal by Subject|3|||
156885680|NCT02095132|566340082|FG005|Overall Study|Withdrawal by Subject|0|||
156885681|NCT02095132|566340083|FG006|Overall Study|Withdrawal by Subject|5|||
156885682|NCT02095132|566340084|FG007|Overall Study|Withdrawal by Subject|0|||
156885683|NCT02095132|566340085|FG008|Overall Study|Withdrawal by Subject|0|||
156885684|NCT01029405|566340086|FG000|Overall Study|Withdrawal by Subject|0|||
156885685|NCT01029405|566340087|FG001|Overall Study|Withdrawal by Subject|1|||
156885686|NCT01029405|566340088|FG002|Overall Study|Withdrawal by Subject|2|||
156885687|NCT01029405|566340089|FG003|Overall Study|Withdrawal by Subject|0|||
156885688|NCT01029405|566340086|FG000|Overall Study|Protocol Violation|0|||
156885689|NCT01029405|566340087|FG001|Overall Study|Protocol Violation|0|||
156885690|NCT01029405|566340088|FG002|Overall Study|Protocol Violation|0|||
156885691|NCT01029405|566340089|FG003|Overall Study|Protocol Violation|1|||
156885692|NCT01029405|566340086|FG000|Overall Study|Adverse Event|0|||
156885693|NCT01029405|566340087|FG001|Overall Study|Adverse Event|0|||
156885694|NCT01029405|566340088|FG002|Overall Study|Adverse Event|1|||
156885695|NCT01029405|566340089|FG003|Overall Study|Adverse Event|1|||
156885696|NCT01029405|566340086|FG000|Overall Study|Lost to Follow-up|2|||
156885697|NCT01029405|566340087|FG001|Overall Study|Lost to Follow-up|1|||
156885698|NCT01029405|566340088|FG002|Overall Study|Lost to Follow-up|1|||
156885699|NCT01029405|566340089|FG003|Overall Study|Lost to Follow-up|2|||
156885700|NCT01029405|566340086|FG000|Overall Study|Other|0|||
156885701|NCT01029405|566340087|FG001|Overall Study|Other|1|||
156885702|NCT01029405|566340088|FG002|Overall Study|Other|0|||
156885703|NCT01029405|566340089|FG003|Overall Study|Other|1|||
156885704|NCT00409175|566340090|FG000|Overall Study|Adverse Event|4|||
156885705|NCT00409175|566340091|FG001|Overall Study|Adverse Event|3|||
156885706|NCT00409175|566340090|FG000|Overall Study|Withdrawal by Subject|1|||
156885707|NCT00409175|566340091|FG001|Overall Study|Withdrawal by Subject|2|||
156885708|NCT00409175|566340090|FG000|Overall Study|Negative genotype|0|||
156885709|NCT00409175|566340091|FG001|Overall Study|Negative genotype|1|||
156885710|NCT00409175|566340090|FG000|Overall Study|Liver transplantation|13|||
156885711|NCT00409175|566340091|FG001|Overall Study|Liver transplantation|13|||
156885712|NCT02108262|566340096|FG000|Overall Study|Non-compliance|0|||
156885713|NCT02108262|566340097|FG001|Overall Study|Non-compliance|2|||
156885714|NCT02108262|566340098|FG002|Overall Study|Non-compliance|1|||
156885715|NCT02108262|566340099|FG003|Overall Study|Non-compliance|1|||
156885716|NCT02108262|566340096|FG000|Overall Study|Randomized by error/screen failure|0|||
156885717|NCT02108262|566340097|FG001|Overall Study|Randomized by error/screen failure|0|||
156885718|NCT02108262|566340098|FG002|Overall Study|Randomized by error/screen failure|1|||
157152211|NCT04494633|567303410|FG001|Overall Study|Protocol Violation|1|||
157152212|NCT01254604|567303413|FG000|Overall Study|Lost to Follow-up|1|||
156885719|NCT02108262|566340099|FG003|Overall Study|Randomized by error/screen failure|0|||
156885720|NCT02108262|566340096|FG000|Overall Study|Distance to center|0|||
156885721|NCT02108262|566340097|FG001|Overall Study|Distance to center|1|||
156885722|NCT02108262|566340098|FG002|Overall Study|Distance to center|1|||
156885723|NCT02108262|566340099|FG003|Overall Study|Distance to center|0|||
156885724|NCT02108262|566340096|FG000|Overall Study|Adverse Event|0|||
156885725|NCT02108262|566340097|FG001|Overall Study|Adverse Event|11|||
156885726|NCT02108262|566340098|FG002|Overall Study|Adverse Event|6|||
156885727|NCT02108262|566340099|FG003|Overall Study|Adverse Event|12|||
156885728|NCT02108262|566340096|FG000|Overall Study|Death|0|||
156885729|NCT02108262|566340097|FG001|Overall Study|Death|2|||
156885730|NCT02108262|566340098|FG002|Overall Study|Death|2|||
156885731|NCT02108262|566340099|FG003|Overall Study|Death|1|||
157152213|NCT01254604|567303414|FG001|Overall Study|Lost to Follow-up|1|||
156833819|NCT03968159|566144414|FG000|Overall Study|Lost to Follow-up|1|||
156833820|NCT03968159|566144415|FG001|Overall Study|Lost to Follow-up|1|||
156833821|NCT03968159|566144414|FG000|Overall Study|Use of prohibited medication|0|||
156833822|NCT03968159|566144415|FG001|Overall Study|Use of prohibited medication|1|||
156833823|NCT03968159|566144414|FG000|Overall Study|Protocol Violation|2|||
156833824|NCT03968159|566144415|FG001|Overall Study|Protocol Violation|2|||
156833825|NCT03968159|566144414|FG000|Overall Study|Withdrawal by Subject|4|||
156833826|NCT03968159|566144415|FG001|Overall Study|Withdrawal by Subject|6|||
156833827|NCT03968159|566144414|FG000|Overall Study|Lack of Efficacy|0|||
156833828|NCT03968159|566144415|FG001|Overall Study|Lack of Efficacy|1|||
156833829|NCT03968159|566144414|FG000|Overall Study|Not further specified|2|||
156833830|NCT03968159|566144415|FG001|Overall Study|Not further specified|0|||
156833831|NCT01299571|566144418|FG000|Overall Study|Protocol Violation|107|||
156833832|NCT02258529|566144419|FG000|Overall Study|Study Terminated by Sponsor|9|||
156833833|NCT02258529|566144419|FG000|Overall Study|Adverse Event|1|||
156833834|NCT00443781|566144420|FG000|Overall Study|Lost to Follow-up|10|||
156833835|NCT00443781|566144420|FG000|Overall Study|Physician Decision|2|||
156833836|NCT00443781|566144420|FG000|Overall Study|Protocol Violation|1|||
156833837|NCT00443781|566144420|FG000|Overall Study|Withdrawal by Subject|6|||
156833838|NCT00443781|566144420|FG000|Overall Study|Unable to comply with study follow up|2|||
156833839|NCT00443781|566144420|FG000|Overall Study|Investigator terminated participation|1|||
156833840|NCT00443781|566144420|FG000|Overall Study|Insurance not covered|2|||
156833841|NCT00443781|566144420|FG000|Overall Study|PD/FAD not done|1|||
156833842|NCT00430937|566144421|FG000|Overall Study|Adverse Event|3|||
156833843|NCT00430937|566144422|FG001|Overall Study|Adverse Event|8|||
156833844|NCT00430937|566144421|FG000|Overall Study|Death|0|||
156833845|NCT00430937|566144422|FG001|Overall Study|Death|1|||
156833846|NCT00430937|566144421|FG000|Overall Study|Lost to Follow-up|6|||
156833847|NCT00430937|566144422|FG001|Overall Study|Lost to Follow-up|6|||
156833848|NCT00430937|566144421|FG000|Overall Study|Withdrawal by Subject|5|||
156833849|NCT00430937|566144422|FG001|Overall Study|Withdrawal by Subject|2|||
156833850|NCT00430937|566144421|FG000|Overall Study|Protocol Violation|3|||
156833851|NCT00430937|566144422|FG001|Overall Study|Protocol Violation|2|||
156833852|NCT00430937|566144421|FG000|Overall Study|Lack of Efficacy|6|||
156833853|NCT00430937|566144422|FG001|Overall Study|Lack of Efficacy|5|||
156833854|NCT00430937|566144421|FG000|Overall Study|Inappropriate enrollment|2|||
156833855|NCT00430937|566144422|FG001|Overall Study|Inappropriate enrollment|1|||
156833856|NCT00430937|566144421|FG000|Overall Study|Administrative reasons|1|||
156833857|NCT00430937|566144422|FG001|Overall Study|Administrative reasons|0|||
156833858|NCT00430937|566144421|FG000|Overall Study|Protocol discontinuation criteria met|1|||
156833859|NCT00430937|566144422|FG001|Overall Study|Protocol discontinuation criteria met|2|||
156833860|NCT00430937|566144421|FG000|Overall Study|Unable to classify|0|||
156833861|NCT00430937|566144422|FG001|Overall Study|Unable to classify|1|||
156833862|NCT01515475|566144426|FG000|Overall Study|Lost to Follow-up|20|||
156833863|NCT01515475|566144427|FG001|Overall Study|Lost to Follow-up|15|||
156833864|NCT01515475|566144428|FG002|Overall Study|Lost to Follow-up|12|||
156833865|NCT01515475|566144429|FG003|Overall Study|Lost to Follow-up|12|||
156833866|NCT02066129|566144430|FG000|Overall Study|Lost to Follow-up|13|||
156833867|NCT02066129|566144431|FG001|Overall Study|Lost to Follow-up|12|||
156833868|NCT02066129|566144430|FG000|Overall Study|Withdrawal by Subject|7|||
156833869|NCT02066129|566144431|FG001|Overall Study|Withdrawal by Subject|10|||
156833870|NCT02066129|566144430|FG000|Overall Study|Lack of Efficacy|8|||
156833871|NCT02066129|566144431|FG001|Overall Study|Lack of Efficacy|10|||
156833872|NCT02066129|566144430|FG000|Overall Study|Physician Decision|1|||
156833873|NCT02066129|566144431|FG001|Overall Study|Physician Decision|1|||
156833874|NCT02642965|566144432|FG000|Overall Study|Lack of Efficacy|4|||
156833875|NCT02642965|566144432|FG000|Overall Study|Physician Decision|9|||
156833876|NCT01814670|566144438|FG000|Overall Study|Protocol Violation|12|||
156833877|NCT00973102|566144439|FG000|Overall Study|Protocol Violation|1|||
156833878|NCT00973102|566144440|FG001|Overall Study|Protocol Violation|0|||
156833879|NCT00973102|566144439|FG000|Overall Study|Prisoner|0|||
156833880|NCT00973102|566144440|FG001|Overall Study|Prisoner|1|||
156833881|NCT02360293|566144441|FG000|Overall Study|Lost to Follow-up|73|||
156833882|NCT02360293|566144442|FG001|Overall Study|Lost to Follow-up|95|||
156833883|NCT02360293|566144441|FG000|Overall Study|Withdrawal by Subject|2|||
156833884|NCT02360293|566144442|FG001|Overall Study|Withdrawal by Subject|1|||
156833885|NCT02360293|566144441|FG000|Overall Study|Excluded|1|||
156833886|NCT02360293|566144442|FG001|Overall Study|Excluded|0|||
156833887|NCT00966719|566144443|FG000|Overall Study|Lost to Follow-up|6|||
156833888|NCT00966719|566144444|FG001|Overall Study|Lost to Follow-up|11|||
156833889|NCT03242018|566144445|FG000|Overall Study|Adverse Event|7|||
156833890|NCT03242018|566144446|FG001|Overall Study|Adverse Event|7|||
156833891|NCT03242018|566144447|FG002|Overall Study|Adverse Event|6|||
156833892|NCT03242018|566144445|FG000|Overall Study|Lost to Follow-up|2|||
156833893|NCT03242018|566144446|FG001|Overall Study|Lost to Follow-up|2|||
156833894|NCT03242018|566144447|FG002|Overall Study|Lost to Follow-up|2|||
156833895|NCT03242018|566144445|FG000|Overall Study|At the Participant's Own Request|5|||
156833896|NCT03242018|566144446|FG001|Overall Study|At the Participant's Own Request|1|||
156833897|NCT03242018|566144447|FG002|Overall Study|At the Participant's Own Request|4|||
156833898|NCT03242018|566144445|FG000|Overall Study|Reason Not Specified|3|||
156833899|NCT03242018|566144446|FG001|Overall Study|Reason Not Specified|4|||
156833900|NCT03242018|566144447|FG002|Overall Study|Reason Not Specified|1|||
156833901|NCT03242018|566144445|FG000|Overall Study|Study Terminated by Sponsor|1|||
156833902|NCT03242018|566144446|FG001|Overall Study|Study Terminated by Sponsor|0|||
156833903|NCT03242018|566144447|FG002|Overall Study|Study Terminated by Sponsor|1|||
156833904|NCT00687609|566144449|FG000|Overall Study|Physician Decision|1|||
156833905|NCT00687609|566144449|FG000|Overall Study|Withdrawal by Subject|2|||
156833906|NCT00160199|566144450|FG000|Overall Study|Adverse Event|5|||
156833907|NCT00160199|566144451|FG001|Overall Study|Adverse Event|14|||
156833908|NCT00160199|566144450|FG000|Overall Study|Lack of Efficacy|0|||
156833909|NCT00160199|566144451|FG001|Overall Study|Lack of Efficacy|1|||
156833910|NCT00160199|566144450|FG000|Overall Study|Lost to Follow-up|7|||
156833911|NCT00160199|566144451|FG001|Overall Study|Lost to Follow-up|7|||
156833912|NCT00160199|566144450|FG000|Overall Study|Withdrawal by Subject|4|||
156833913|NCT00160199|566144451|FG001|Overall Study|Withdrawal by Subject|6|||
156833914|NCT00160199|566144450|FG000|Overall Study|Administrative|0|||
156833915|NCT00160199|566144451|FG001|Overall Study|Administrative|1|||
156833916|NCT00160199|566144450|FG000|Overall Study|Protocol Violation|8|||
156833917|NCT00160199|566144451|FG001|Overall Study|Protocol Violation|8|||
156833918|NCT03089944|566144452|FG000|Overall Study|Lost to Follow-up|8|||
156833919|NCT03089944|566144452|FG000|Overall Study|Withdrew Consent|2|||
156833920|NCT03089944|566144452|FG000|Overall Study|Adverse Event|1|||
156833921|NCT03089944|566144452|FG000|Overall Study|Other|1|||
156833922|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
156833923|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
156833924|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
156833925|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
156833926|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
156833927|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
156833928|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
156833929|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
156833930|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
156833931|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
156833932|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
156833933|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
156833934|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
156833935|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833936|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833937|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
156833938|NCT03689244|566144453|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
156833939|NCT03689244|566144454|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
156833940|NCT03689244|566144455|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
156833941|NCT03689244|566144456|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
156833942|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833943|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833944|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
156833945|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
156833946|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156833947|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156833948|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
156833949|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
156885732|NCT02108262|566340096|FG000|Overall Study|Lost to Follow-up|0|||
156885733|NCT02108262|566340097|FG001|Overall Study|Lost to Follow-up|0|||
156885734|NCT02108262|566340098|FG002|Overall Study|Lost to Follow-up|1|||
156885735|NCT02108262|566340099|FG003|Overall Study|Lost to Follow-up|0|||
156885736|NCT02108262|566340096|FG000|Overall Study|Physician Decision|0|||
156833950|NCT03689244|566144453|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
156885737|NCT02108262|566340097|FG001|Overall Study|Physician Decision|0|||
156885738|NCT02108262|566340098|FG002|Overall Study|Physician Decision|2|||
156833951|NCT03689244|566144454|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
156833952|NCT03689244|566144455|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
156885739|NCT02108262|566340099|FG003|Overall Study|Physician Decision|0|||
156885740|NCT02108262|566340096|FG000|Overall Study|Withdrawal by Subject|0|||
156885741|NCT02108262|566340097|FG001|Overall Study|Withdrawal by Subject|7|||
156885742|NCT02108262|566340098|FG002|Overall Study|Withdrawal by Subject|3|||
156885743|NCT02108262|566340099|FG003|Overall Study|Withdrawal by Subject|4|||
156833953|NCT03689244|566144456|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
156833954|NCT02308488|566144459|FG000|Overall Study|Withdrawal by Subject|2|||
156833955|NCT01541917|566144460|FG000|Overall Study|Lost to Follow-up|2|||
156885744|NCT02108262|566340096|FG000|Overall Study|Due to key hepatic values|0|||
156885745|NCT02108262|566340097|FG001|Overall Study|Due to key hepatic values|1|||
156833956|NCT01541917|566144461|FG001|Overall Study|Lost to Follow-up|2|||
156833957|NCT01541917|566144460|FG000|Overall Study|Withdrawal by Subject|13|||
156833958|NCT01541917|566144461|FG001|Overall Study|Withdrawal by Subject|7|||
156833959|NCT01739803|566144462|FG000|Overall Study|Lost to Follow-up|9|||
156833960|NCT01739803|566144463|FG001|Overall Study|Lost to Follow-up|6|||
156833961|NCT01565564|566144470|FG000|Overall Study|Lost to Follow-up|5|||
156833962|NCT01565564|566144471|FG001|Overall Study|Lost to Follow-up|1|||
156833963|NCT00969436|566144473|FG000|Overall Study|Protocol Violation|1|||
156833964|NCT00969436|566144474|FG001|Overall Study|Protocol Violation|3|||
156833965|NCT00969436|566144475|FG002|Overall Study|Protocol Violation|0|||
156833966|NCT00969436|566144473|FG000|Overall Study|Migrated/moved from study area|12|||
156833967|NCT00969436|566144474|FG001|Overall Study|Migrated/moved from study area|10|||
156833968|NCT00969436|566144475|FG002|Overall Study|Migrated/moved from study area|2|||
156833969|NCT00969436|566144473|FG000|Overall Study|Father - serious health problem|0|||
156833970|NCT00969436|566144474|FG001|Overall Study|Father - serious health problem|0|||
156833971|NCT00969436|566144475|FG002|Overall Study|Father - serious health problem|1|||
156833972|NCT00969436|566144473|FG000|Overall Study|Parents personal problem|0|||
156833973|NCT00969436|566144474|FG001|Overall Study|Parents personal problem|0|||
156833974|NCT00969436|566144475|FG002|Overall Study|Parents personal problem|1|||
156833975|NCT00969436|566144473|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
156833976|NCT00969436|566144474|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
156885746|NCT02108262|566340098|FG002|Overall Study|Due to key hepatic values|0|||
156885747|NCT02108262|566340099|FG003|Overall Study|Due to key hepatic values|0|||
156885748|NCT02108262|566340096|FG000|Overall Study|Unable to contact patient|0|||
156885749|NCT02108262|566340097|FG001|Overall Study|Unable to contact patient|3|||
156885750|NCT02108262|566340098|FG002|Overall Study|Unable to contact patient|1|||
156885751|NCT02108262|566340099|FG003|Overall Study|Unable to contact patient|2|||
156885752|NCT02108262|566340096|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
156885753|NCT02108262|566340097|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
156885754|NCT02108262|566340098|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
156885755|NCT02108262|566340099|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
156885756|NCT02108262|566340096|FG000|Overall Study|Patient did not want another infusion|0|||
156885757|NCT02108262|566340097|FG001|Overall Study|Patient did not want another infusion|3|||
156885758|NCT02108262|566340098|FG002|Overall Study|Patient did not want another infusion|3|||
156885759|NCT02108262|566340099|FG003|Overall Study|Patient did not want another infusion|2|||
156885760|NCT02108262|566340096|FG000|Overall Study|Vacation|0|||
156885761|NCT02108262|566340097|FG001|Overall Study|Vacation|1|||
156885762|NCT02108262|566340098|FG002|Overall Study|Vacation|0|||
156885763|NCT02108262|566340099|FG003|Overall Study|Vacation|0|||
156885764|NCT02108262|566340096|FG000|Overall Study|Patient decision|0|||
156885765|NCT02108262|566340097|FG001|Overall Study|Patient decision|7|||
156885766|NCT02108262|566340098|FG002|Overall Study|Patient decision|9|||
156885767|NCT02108262|566340099|FG003|Overall Study|Patient decision|14|||
156885768|NCT02108262|566340096|FG000|Overall Study|Missed IV due to pharmacy error|0|||
156885769|NCT02108262|566340097|FG001|Overall Study|Missed IV due to pharmacy error|0|||
156885770|NCT02108262|566340098|FG002|Overall Study|Missed IV due to pharmacy error|1|||
156885771|NCT02108262|566340099|FG003|Overall Study|Missed IV due to pharmacy error|0|||
156885772|NCT01119937|566340103|FG000|Overall Study|Adverse Event|11|||
156885773|NCT01119937|566340104|FG001|Overall Study|Adverse Event|5|||
156885774|NCT01119937|566340103|FG000|Overall Study|Protocol deviation|3|||
156885775|NCT01119937|566340104|FG001|Overall Study|Protocol deviation|1|||
156885776|NCT01119937|566340103|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
156885777|NCT01119937|566340104|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156885778|NCT01119937|566340103|FG000|Overall Study|Withdrawal by Subject|2|||
156885779|NCT01119937|566340104|FG001|Overall Study|Withdrawal by Subject|1|||
156885780|NCT03316911|566340105|FG000|Overall Study|Lost to Follow-up|33|||
156885781|NCT03316911|566340106|FG001|Overall Study|Lost to Follow-up|29|||
156885782|NCT01270802|566340107|FG000|Overall Study|Withdrawal by Subject|1|||
156885783|NCT01270802|566340108|FG001|Overall Study|Withdrawal by Subject|0|||
156885784|NCT01270802|566340107|FG000|Overall Study|Adverse Event|1|||
156885785|NCT01270802|566340108|FG001|Overall Study|Adverse Event|0|||
156885786|NCT01270802|566340107|FG000|Overall Study|Lost to Follow-up|0|||
156885787|NCT01270802|566340108|FG001|Overall Study|Lost to Follow-up|1|||
156885788|NCT01525901|566340111|FG000|Period 2: 12 Weeks|Adverse Event|0|||
156885789|NCT01525901|566340112|FG001|Period 2: 12 Weeks|Adverse Event|1|||
156885790|NCT01525901|566340113|FG002|Period 2: 12 Weeks|Adverse Event|0|||
156885791|NCT01525901|566340114|FG003|Period 2: 12 Weeks|Adverse Event|0|||
156885792|NCT04449029|566340115|FG000|Overall Study|Adverse Event|0|||
156833977|NCT00969436|566144475|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
156833978|NCT00969436|566144473|FG000|Overall Study|Withdrawal by Subject|3|||
156833979|NCT00969436|566144474|FG001|Overall Study|Withdrawal by Subject|0|||
156885793|NCT04449029|566340116|FG001|Overall Study|Adverse Event|1|||
156885794|NCT04449029|566340117|FG002|Overall Study|Adverse Event|1|||
156885795|NCT04449029|566340118|FG003|Overall Study|Adverse Event|0|||
156885796|NCT04449029|566340119|FG004|Overall Study|Adverse Event|1|||
156885797|NCT04449029|566340120|FG005|Overall Study|Adverse Event|0|||
156833980|NCT00969436|566144475|FG002|Overall Study|Withdrawal by Subject|2|||
156833981|NCT00969436|566144473|FG000|Overall Study|Lost to Follow-up|8|||
156833982|NCT00969436|566144474|FG001|Overall Study|Lost to Follow-up|8|||
156833983|NCT00969436|566144475|FG002|Overall Study|Lost to Follow-up|5|||
156833984|NCT02544373|566144478|FG000|Overall Study|Lost to Follow-up|5|||
156833985|NCT02544373|566144479|FG001|Overall Study|Lost to Follow-up|3|||
156833986|NCT02544373|566144478|FG000|Overall Study|Withdrawal by Subject|8|||
156833987|NCT02544373|566144479|FG001|Overall Study|Withdrawal by Subject|2|||
156833988|NCT03667690|566145602|FG000|Overall Study|Adverse Event|0|||
156833989|NCT03667690|566145603|FG001|Overall Study|Adverse Event|3|||
156833990|NCT03667690|566145602|FG000|Overall Study|Death|22|||
156833991|NCT03667690|566145603|FG001|Overall Study|Death|21|||
156833992|NCT03667690|566145602|FG000|Overall Study|Lost to Follow-up|4|||
156833993|NCT03667690|566145603|FG001|Overall Study|Lost to Follow-up|5|||
156833994|NCT03667690|566145602|FG000|Overall Study|Withdrawal by Subject|7|||
156833995|NCT03667690|566145603|FG001|Overall Study|Withdrawal by Subject|8|||
156833996|NCT03667690|566145602|FG000|Overall Study|Subject could not return for additional investigational product|1|||
156833997|NCT03667690|566145603|FG001|Overall Study|Subject could not return for additional investigational product|0|||
156833998|NCT03667690|566145602|FG000|Overall Study|Subject discharged to hospice care|2|||
156833999|NCT03667690|566145603|FG001|Overall Study|Subject discharged to hospice care|0|||
156834000|NCT03667690|566145602|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
156834001|NCT03667690|566145603|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
156834002|NCT03667690|566145602|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
156834003|NCT03667690|566145603|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
156834004|NCT03667690|566145602|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
156834005|NCT03667690|566145603|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
156834006|NCT03667690|566145602|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
156834007|NCT03667690|566145603|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
156834008|NCT03667690|566145602|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
156834009|NCT03667690|566145603|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
156834010|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
156834011|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
156834012|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
156834013|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
156834014|NCT01350115|566145607|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
156834015|NCT01350115|566145608|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
156834016|NCT04327024|566145609|FG000|Overall Study|Death|1|||
156834017|NCT04327024|566145610|FG001|Overall Study|Death|2|||
156834018|NCT04327024|566145611|FG002|Overall Study|Death|1|||
156834019|NCT04327024|566145609|FG000|Overall Study|Non-compliance with study drug|0|||
156834020|NCT04327024|566145610|FG001|Overall Study|Non-compliance with study drug|1|||
156834021|NCT04327024|566145611|FG002|Overall Study|Non-compliance with study drug|0|||
156834022|NCT04327024|566145609|FG000|Overall Study|Withdrawal by Subject|1|||
156834023|NCT04327024|566145610|FG001|Overall Study|Withdrawal by Subject|1|||
156834024|NCT04327024|566145611|FG002|Overall Study|Withdrawal by Subject|2|||
156834025|NCT00837759|566145615|FG000|Overall Study|Protocol Violation|3|||
156834026|NCT00837759|566145615|FG000|Overall Study|Lost to Follow-up|1|||
156834027|NCT01597635|566145616|FG000|Part A|Adverse Event|3|||
156834028|NCT01597635|566145617|FG001|Part A|Adverse Event|0|||
156834029|NCT01597635|566145618|FG002|Part A|Adverse Event|0|||
156834030|NCT01597635|566145616|FG000|Part B|Adverse Event|0|||
156834031|NCT01597635|566145617|FG001|Part B|Adverse Event|0|||
156834032|NCT01597635|566145618|FG002|Part B|Adverse Event|1|||
156834033|NCT01597635|566145616|FG000|Part B|Protocol Violation|0|||
156834034|NCT01597635|566145617|FG001|Part B|Protocol Violation|1|||
156834035|NCT01597635|566145618|FG002|Part B|Protocol Violation|0|||
156834036|NCT01597635|566145616|FG000|Part B|Protocol-defined stopping criteria|0|||
156834037|NCT01597635|566145617|FG001|Part B|Protocol-defined stopping criteria|4|||
156834038|NCT01597635|566145618|FG002|Part B|Protocol-defined stopping criteria|3|||
156834039|NCT01597635|566145616|FG000|Part B|Withdrawal by Subject|0|||
156834040|NCT01597635|566145617|FG001|Part B|Withdrawal by Subject|1|||
156834041|NCT01597635|566145618|FG002|Part B|Withdrawal by Subject|0|||
156834042|NCT01073930|566145619|FG000|Overall Study|Withdrawal by Subject|3|||
156834043|NCT01073930|566145620|FG001|Overall Study|Withdrawal by Subject|2|||
156834044|NCT01073930|566145619|FG000|Overall Study|Lost to Follow-up|0|||
156834045|NCT01073930|566145620|FG001|Overall Study|Lost to Follow-up|1|||
156834046|NCT01073930|566145619|FG000|Overall Study|Adverse Event|0|||
156834047|NCT01073930|566145620|FG001|Overall Study|Adverse Event|1|||
156834048|NCT01073930|566145619|FG000|Overall Study|Noncompliance with study drug|0|||
156834049|NCT01073930|566145620|FG001|Overall Study|Noncompliance with study drug|1|||
156834050|NCT01073930|566145619|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
157224644|NCT00306384|567568049|FG002|Overall Study|Study termination|1|||
157224645|NCT00306384|567568047|FG000|Overall Study|Pregnancy|3|||
157224646|NCT00306384|567568048|FG001|Overall Study|Pregnancy|1|||
157224647|NCT00306384|567568049|FG002|Overall Study|Pregnancy|1|||
157224648|NCT00306384|567568047|FG000|Overall Study|Lack of Efficacy|26|||
157224649|NCT00306384|567568048|FG001|Overall Study|Lack of Efficacy|40|||
157224650|NCT00306384|567568049|FG002|Overall Study|Lack of Efficacy|38|||
157224651|NCT00306384|567568047|FG000|Overall Study|Investigator discretion|28|||
157224652|NCT00306384|567568048|FG001|Overall Study|Investigator discretion|31|||
157224653|NCT00306384|567568049|FG002|Overall Study|Investigator discretion|21|||
157224654|NCT00306384|567568047|FG000|Overall Study|Other|80|||
157224655|NCT00306384|567568048|FG001|Overall Study|Other|70|||
157224656|NCT00306384|567568049|FG002|Overall Study|Other|32|||
157224657|NCT00306384|567568047|FG000|Overall Study|Site closure|2|||
157224658|NCT00306384|567568048|FG001|Overall Study|Site closure|0|||
157224659|NCT00306384|567568049|FG002|Overall Study|Site closure|0|||
157224660|NCT00601484|567568050|FG000|Overall Study|Adverse Event|0|||
157224661|NCT00601484|567568051|FG001|Overall Study|Adverse Event|1|||
157224662|NCT00601484|567568050|FG000|Overall Study|Lost to Follow-up|4|||
157224663|NCT00601484|567568051|FG001|Overall Study|Lost to Follow-up|3|||
157224664|NCT00601484|567568050|FG000|Overall Study|Lack of Efficacy|0|||
156834051|NCT01073930|566145620|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
156834052|NCT01192568|566145621|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
156834053|NCT01192568|566145622|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
156834054|NCT01192568|566145623|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
156834055|NCT01192568|566145624|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
156834056|NCT01192568|566145621|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
156834057|NCT01192568|566145622|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
156834058|NCT01192568|566145623|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
156834059|NCT01192568|566145624|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
156834060|NCT02783170|566145629|FG000|Overall Study|Randomized but not Vaccinated|1|||
156834061|NCT02783170|566145630|FG001|Overall Study|Randomized but not Vaccinated|0|||
156834062|NCT00541346|566145631|FG000|Follow-up|Adverse Event|1|||
156834063|NCT02008773|566145632|FG000|Overall Study|Adverse Event|3|||
156834064|NCT02008773|566145633|FG001|Overall Study|Adverse Event|3|||
156834065|NCT02008773|566145634|FG002|Overall Study|Adverse Event|1|||
156834066|NCT02008773|566145635|FG003|Overall Study|Adverse Event|2|||
156834067|NCT02008773|566145632|FG000|Overall Study|Medication Non-compliance|2|||
156834068|NCT02008773|566145633|FG001|Overall Study|Medication Non-compliance|1|||
156834069|NCT02008773|566145634|FG002|Overall Study|Medication Non-compliance|3|||
156834070|NCT02008773|566145635|FG003|Overall Study|Medication Non-compliance|2|||
156834071|NCT02008773|566145632|FG000|Overall Study|Withdrawal by Subject|8|||
156834072|NCT02008773|566145633|FG001|Overall Study|Withdrawal by Subject|4|||
156834073|NCT02008773|566145634|FG002|Overall Study|Withdrawal by Subject|7|||
156834074|NCT02008773|566145635|FG003|Overall Study|Withdrawal by Subject|6|||
156834075|NCT02008773|566145632|FG000|Overall Study|Lost to Follow-up|0|||
156834076|NCT02008773|566145633|FG001|Overall Study|Lost to Follow-up|1|||
156834077|NCT02008773|566145634|FG002|Overall Study|Lost to Follow-up|3|||
156834078|NCT02008773|566145635|FG003|Overall Study|Lost to Follow-up|2|||
156834079|NCT04938037|566145636|FG000|Overall Study|Lost to Follow-up|4|||
156834080|NCT04938037|566145637|FG001|Overall Study|Lost to Follow-up|3|||
156834081|NCT03320330|566145640|FG000|Overall Study|Lack of Efficacy|5|||
156834082|NCT03320330|566145641|FG001|Overall Study|Lack of Efficacy|5|||
156834083|NCT03320330|566145642|FG002|Overall Study|Lack of Efficacy|14|||
156834084|NCT03320330|566145640|FG000|Overall Study|Physician Decision|1|||
156885798|NCT04449029|566340121|FG006|Overall Study|Adverse Event|1|||
156885799|NCT04449029|566340122|FG007|Overall Study|Adverse Event|0|||
156885800|NCT04449029|566340115|FG000|Overall Study|Lost to Follow-up|0|||
156885801|NCT04449029|566340116|FG001|Overall Study|Lost to Follow-up|1|||
156885802|NCT04449029|566340117|FG002|Overall Study|Lost to Follow-up|0|||
156885803|NCT04449029|566340118|FG003|Overall Study|Lost to Follow-up|0|||
156885804|NCT04449029|566340119|FG004|Overall Study|Lost to Follow-up|0|||
157224665|NCT00601484|567568051|FG001|Overall Study|Lack of Efficacy|2|||
157224666|NCT00601484|567568050|FG000|Overall Study|Withdrawal by Subject|1|||
157224667|NCT00601484|567568051|FG001|Overall Study|Withdrawal by Subject|1|||
157224668|NCT00601484|567568050|FG000|Overall Study|Randomized, but not treated|0|||
156834085|NCT03320330|566145641|FG001|Overall Study|Physician Decision|0|||
156834086|NCT03320330|566145642|FG002|Overall Study|Physician Decision|0|||
156834087|NCT03323736|566145643|FG000|Overall Study|Screen Failure|14|||
156834088|NCT03323736|566145644|FG001|Overall Study|Screen Failure|9|||
156834089|NCT03323736|566145645|FG002|Overall Study|Screen Failure|1|||
156885805|NCT04449029|566340120|FG005|Overall Study|Lost to Follow-up|0|||
156885806|NCT04449029|566340121|FG006|Overall Study|Lost to Follow-up|0|||
157224669|NCT00601484|567568051|FG001|Overall Study|Randomized, but not treated|1|||
157224670|NCT03504852|567568057|FG000|Overall Study|Withdrawal of informed consent|2|||
157224671|NCT03504852|567568058|FG001|Overall Study|Withdrawal of informed consent|1|||
157224672|NCT03504852|567568059|FG002|Overall Study|Withdrawal of informed consent|0|||
157224673|NCT03504852|567568057|FG000|Overall Study|Withdrawal by Subject|5|||
157224674|NCT03504852|567568058|FG001|Overall Study|Withdrawal by Subject|5|||
156834090|NCT03323736|566145643|FG000|Overall Study|Withdrawal Before Treatment|3|||
156834091|NCT03323736|566145644|FG001|Overall Study|Withdrawal Before Treatment|1|||
156834092|NCT03323736|566145645|FG002|Overall Study|Withdrawal Before Treatment|1|||
156834093|NCT03323736|566145643|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
156834094|NCT03323736|566145644|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
156834095|NCT03323736|566145645|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
156834096|NCT01806064|566145647|FG000|Overall Study|Randomized Not Enrolled|0|||
156834097|NCT01806064|566145648|FG001|Overall Study|Randomized Not Enrolled|0|||
156834098|NCT01806064|566145649|FG002|Overall Study|Randomized Not Enrolled|0|||
156834099|NCT01806064|566145650|FG003|Overall Study|Randomized Not Enrolled|1|||
156834100|NCT01806064|566145651|FG004|Overall Study|Randomized Not Enrolled|2|||
156834101|NCT05063539|566145657|FG000|Overall Study|Adverse Event|1|||
156834102|NCT05063539|566145658|FG001|Overall Study|Adverse Event|2|||
156834103|NCT05063539|566145659|FG002|Overall Study|Adverse Event|1|||
156834104|NCT05063539|566145657|FG000|Overall Study|Death|0|||
156834105|NCT05063539|566145658|FG001|Overall Study|Death|1|||
156834106|NCT05063539|566145659|FG002|Overall Study|Death|1|||
156834107|NCT05063539|566145657|FG000|Overall Study|Lost to Follow-up|0|||
156834108|NCT05063539|566145658|FG001|Overall Study|Lost to Follow-up|1|||
156834109|NCT05063539|566145659|FG002|Overall Study|Lost to Follow-up|0|||
156834110|NCT05063539|566145657|FG000|Overall Study|Physician Decision|4|||
156834111|NCT05063539|566145658|FG001|Overall Study|Physician Decision|3|||
156834112|NCT05063539|566145659|FG002|Overall Study|Physician Decision|1|||
156834113|NCT05063539|566145657|FG000|Overall Study|Progressive Disease|0|||
156834114|NCT05063539|566145658|FG001|Overall Study|Progressive Disease|2|||
156834115|NCT05063539|566145659|FG002|Overall Study|Progressive Disease|0|||
156834116|NCT05063539|566145657|FG000|Overall Study|Withdrawal by Subject|17|||
156834117|NCT05063539|566145658|FG001|Overall Study|Withdrawal by Subject|26|||
156834118|NCT05063539|566145659|FG002|Overall Study|Withdrawal by Subject|14|||
156834119|NCT05063539|566145657|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156834120|NCT05063539|566145658|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156834121|NCT05063539|566145659|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
156834122|NCT05063539|566145657|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
156834123|NCT05063539|566145658|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
156834124|NCT05063539|566145659|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
156834125|NCT05063539|566145657|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
156834126|NCT05063539|566145658|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
156834127|NCT05063539|566145659|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
156834128|NCT05063539|566145657|FG000|Overall Study|Discontinued due to Common Close Design|0|||
156834129|NCT05063539|566145658|FG001|Overall Study|Discontinued due to Common Close Design|1|||
156834130|NCT05063539|566145659|FG002|Overall Study|Discontinued due to Common Close Design|0|||
156834131|NCT05063539|566145657|FG000|Overall Study|Participant not co-operative|0|||
156834132|NCT05063539|566145658|FG001|Overall Study|Participant not co-operative|1|||
156834133|NCT05063539|566145659|FG002|Overall Study|Participant not co-operative|0|||
156834134|NCT05063539|566145657|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
156834135|NCT05063539|566145658|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
156834136|NCT05063539|566145659|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
156834137|NCT05063539|566145657|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
156834138|NCT05063539|566145658|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
156834139|NCT05063539|566145659|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
156834140|NCT04256512|566145660|FG000|Overall Study|Withdrawal by Subject|1|||
156834141|NCT02804750|566145666|FG000|Period 1|Adverse Event|0|||
156834142|NCT02804750|566145667|FG001|Period 1|Adverse Event|2|||
156834143|NCT02804750|566145666|FG000|Period 1|Withdrawal by Subject|0|||
156834144|NCT02804750|566145667|FG001|Period 1|Withdrawal by Subject|1|||
156834145|NCT02804750|566145666|FG000|Period 2|Adverse Event|1|||
156834146|NCT02804750|566145667|FG001|Period 2|Adverse Event|0|||
156834147|NCT02804750|566145666|FG000|Period 3|Adverse Event|0|||
156834148|NCT02804750|566145667|FG001|Period 3|Adverse Event|2|||
156834149|NCT02804750|566145666|FG000|Period 4|Adverse Event|0|||
156834150|NCT02804750|566145667|FG001|Period 4|Adverse Event|5|||
156885807|NCT04449029|566340122|FG007|Overall Study|Lost to Follow-up|0|||
156885808|NCT04449029|566340115|FG000|Overall Study|Protocol Violation|0|||
156885809|NCT04449029|566340116|FG001|Overall Study|Protocol Violation|1|||
156885810|NCT04449029|566340117|FG002|Overall Study|Protocol Violation|0|||
156885811|NCT04449029|566340118|FG003|Overall Study|Protocol Violation|0|||
156885812|NCT04449029|566340119|FG004|Overall Study|Protocol Violation|0|||
156885813|NCT04449029|566340120|FG005|Overall Study|Protocol Violation|0|||
156834151|NCT04692077|566145671|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
156834152|NCT01751139|566145676|FG000|Overall Study|Other|135|||
156834153|NCT01751139|566145676|FG000|Overall Study|Sponsor study termination|1609|||
156834154|NCT01751139|566145676|FG000|Overall Study|Lost to Follow-up|240|||
156834155|NCT01751139|566145676|FG000|Overall Study|Withdrawal by Subject|251|||
156834156|NCT01751139|566145676|FG000|Overall Study|Adverse Event|1|||
156834157|NCT01751139|566145676|FG000|Overall Study|Death|31|||
156834158|NCT03199391|566145677|FG000|Overall Study|Death|1|||
156834159|NCT03199391|566145677|FG000|Overall Study|Lost to Follow-up|3|||
156834160|NCT03199391|566145677|FG000|Overall Study|Adverse Event|2|||
156834161|NCT03199391|566145677|FG000|Overall Study|Withdrawal by Subject|10|||
156834162|NCT01867086|566145678|FG000|Overall Study|Disease Progression|1|||
156834163|NCT03826342|566145679|FG000|Overall Study|Withdrawal by Subject|8|||
156834164|NCT03826342|566145680|FG001|Overall Study|Withdrawal by Subject|1|||
156834165|NCT03826342|566145679|FG000|Overall Study|Lost to Follow-up|7|||
156834166|NCT03826342|566145680|FG001|Overall Study|Lost to Follow-up|7|||
156834167|NCT03826342|566145679|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
156834168|NCT03826342|566145680|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
156834169|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Death|1|||
156834170|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Death|0|||
156834171|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Death|0|||
156834172|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Death|0|||
156834173|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
156834174|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
156834175|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
156834176|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
156834177|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
156834178|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
156834179|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
156834180|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
156834181|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
156834182|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
156834183|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
156834184|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
156834185|NCT04271475|566145685|FG000|DB Period: Day 1 up to EODBT|Other|8|||
156834186|NCT04271475|566145686|FG001|DB Period: Day 1 up to EODBT|Other|5|||
156834187|NCT04271475|566145687|FG002|DB Period: Day 1 up to EODBT|Other|0|||
156834188|NCT04271475|566145688|FG003|DB Period: Day 1 up to EODBT|Other|0|||
156834189|NCT04271475|566145685|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
156834190|NCT04271475|566145686|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
156834191|NCT04271475|566145687|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
156834192|NCT04271475|566145688|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
156834193|NCT04271475|566145685|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834194|NCT04271475|566145686|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834195|NCT04271475|566145687|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
156834196|NCT04271475|566145688|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
156834197|NCT02337634|566145689|FG000|Overall Study|Protocol Violation|3|||
156834198|NCT02337634|566145690|FG001|Overall Study|Protocol Violation|1|||
156834199|NCT02337634|566145689|FG000|Overall Study|Lost to Follow-up|1|||
156834200|NCT02337634|566145690|FG001|Overall Study|Lost to Follow-up|0|||
156834201|NCT02428205|566145694|FG000|Overall Study|Lack of Efficacy|1|||
156834202|NCT02428205|566145695|FG001|Overall Study|Lack of Efficacy|0|||
156834203|NCT02428205|566145694|FG000|Overall Study|Lost to Follow-up|1|||
156834204|NCT02428205|566145695|FG001|Overall Study|Lost to Follow-up|1|||
156834205|NCT02428205|566145694|FG000|Overall Study|Worse behavior|0|||
156834206|NCT02428205|566145695|FG001|Overall Study|Worse behavior|1|||
156834207|NCT01818284|566145696|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
156834208|NCT01818284|566145697|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
156834209|NCT01818284|566145696|FG000|Overall Study|Death|0|||
156834210|NCT01818284|566145697|FG001|Overall Study|Death|2|||
156834211|NCT02888743|566145698|FG000|Overall Study|Withdrawal by Subject|1|||
156834212|NCT02888743|566145699|FG001|Overall Study|Withdrawal by Subject|2|||
156834213|NCT02888743|566145700|FG002|Overall Study|Withdrawal by Subject|2|||
156834214|NCT02888743|566145701|FG003|Overall Study|Withdrawal by Subject|0|||
156834215|NCT02888743|566145702|FG004|Overall Study|Withdrawal by Subject|1|||
156834216|NCT02888743|566145698|FG000|Overall Study|Disease progression before treatment|2|||
156834217|NCT02888743|566145699|FG001|Overall Study|Disease progression before treatment|0|||
156834218|NCT02888743|566145700|FG002|Overall Study|Disease progression before treatment|2|||
156834219|NCT02888743|566145701|FG003|Overall Study|Disease progression before treatment|0|||
156834220|NCT02888743|566145702|FG004|Overall Study|Disease progression before treatment|0|||
156834221|NCT02888743|566145698|FG000|Overall Study|Patient ineligible|1|||
156834222|NCT02888743|566145699|FG001|Overall Study|Patient ineligible|2|||
156834223|NCT02888743|566145700|FG002|Overall Study|Patient ineligible|0|||
156834224|NCT02888743|566145701|FG003|Overall Study|Patient ineligible|0|||
156834225|NCT02888743|566145702|FG004|Overall Study|Patient ineligible|0|||
156834226|NCT00527319|566145703|FG000|Overall Study|Withdrawal by Subject|5|||
156834227|NCT00527319|566145704|FG001|Overall Study|Withdrawal by Subject|0|||
156834228|NCT00527319|566145705|FG002|Overall Study|Withdrawal by Subject|1|||
156834229|NCT00527319|566145703|FG000|Overall Study|Lost to Follow-up|1|||
156834230|NCT00527319|566145704|FG001|Overall Study|Lost to Follow-up|0|||
156834231|NCT00527319|566145705|FG002|Overall Study|Lost to Follow-up|0|||
156834232|NCT00527319|566145703|FG000|Overall Study|Death|0|||
156834233|NCT00527319|566145704|FG001|Overall Study|Death|3|||
156834234|NCT00527319|566145705|FG002|Overall Study|Death|1|||
156834235|NCT00527319|566145703|FG000|Overall Study|Intercurrent Medical Illness|0|||
156834236|NCT00527319|566145704|FG001|Overall Study|Intercurrent Medical Illness|1|||
156834237|NCT00527319|566145705|FG002|Overall Study|Intercurrent Medical Illness|3|||
156834238|NCT00527319|566145703|FG000|Overall Study|Adverse Event|0|||
156834239|NCT00527319|566145704|FG001|Overall Study|Adverse Event|0|||
156834240|NCT00527319|566145705|FG002|Overall Study|Adverse Event|1|||
156834241|NCT01300351|566145710|FG000|Overall Study|Did not receive treatment|2|||
156834242|NCT01300351|566145711|FG001|Overall Study|Did not receive treatment|0|||
156834243|NCT01300351|566145710|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
156834244|NCT01300351|566145711|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
156834245|NCT01300351|566145710|FG000|Overall Study|Lost to Follow-up|0|||
156834246|NCT01300351|566145711|FG001|Overall Study|Lost to Follow-up|1|||
156834247|NCT01300351|566145710|FG000|Overall Study|Adverse Event|0|||
156834248|NCT01300351|566145711|FG001|Overall Study|Adverse Event|4|||
156834249|NCT01300351|566145710|FG000|Overall Study|Withdrawal by Subject|7|||
156834250|NCT01300351|566145711|FG001|Overall Study|Withdrawal by Subject|10|||
156834251|NCT05824936|566145714|FG000|Overall Study|Lost to Follow-up|1|||
156834252|NCT00096018|566145715|FG000|Overall Study|Became Ineligible (not treated)|0|||
156834253|NCT00096018|566145716|FG001|Overall Study|Became Ineligible (not treated)|3|||
156834254|NCT00096018|566145715|FG000|Overall Study|Miscellaneous (not treated)|0|||
156834255|NCT00096018|566145716|FG001|Overall Study|Miscellaneous (not treated)|2|||
156834256|NCT00096018|566145715|FG000|Overall Study|Adverse Event|0|||
156834257|NCT00096018|566145716|FG001|Overall Study|Adverse Event|5|||
156834258|NCT00096018|566145715|FG000|Overall Study|Death|0|||
156834259|NCT00096018|566145716|FG001|Overall Study|Death|1|||
156834260|NCT00096018|566145715|FG000|Overall Study|Withdrawal by Subject|0|||
156834261|NCT00096018|566145716|FG001|Overall Study|Withdrawal by Subject|2|||
156834262|NCT00096018|566145715|FG000|Overall Study|Miscellaneous|2|||
156834263|NCT00096018|566145716|FG001|Overall Study|Miscellaneous|1|||
156834264|NCT03779503|566145717|FG000|First Intervention|Adverse Event|0|||
156834265|NCT03779503|566145718|FG001|First Intervention|Adverse Event|1|||
156834266|NCT03779503|566145717|FG000|First Intervention|Withdrawal by Subject|1|||
156834267|NCT03779503|566145718|FG001|First Intervention|Withdrawal by Subject|0|||
156834268|NCT00864851|566145719|FG000|Overall Study|Withdrawal by Subject|0|||
156834269|NCT00864851|566145720|FG001|Overall Study|Withdrawal by Subject|1|||
156834270|NCT00864851|566145721|FG002|Overall Study|Withdrawal by Subject|0|||
156834271|NCT00864851|566145719|FG000|Overall Study|Physician Decision|1|||
156834272|NCT00864851|566145720|FG001|Overall Study|Physician Decision|0|||
156834273|NCT00864851|566145721|FG002|Overall Study|Physician Decision|0|||
156834274|NCT00864851|566145719|FG000|Overall Study|Death|1|||
156834275|NCT00864851|566145720|FG001|Overall Study|Death|0|||
156834276|NCT00864851|566145721|FG002|Overall Study|Death|0|||
156834277|NCT00864851|566145719|FG000|Overall Study|Patient uncooperative|1|||
156834278|NCT00864851|566145720|FG001|Overall Study|Patient uncooperative|0|||
156834279|NCT00864851|566145721|FG002|Overall Study|Patient uncooperative|0|||
156834280|NCT02066415|566145722|FG000|Overall Study|Decision by Sponsor|5|||
156834281|NCT02066415|566145723|FG001|Overall Study|Decision by Sponsor|4|||
156834282|NCT02066415|566145724|FG002|Overall Study|Decision by Sponsor|2|||
156834283|NCT02066415|566145722|FG000|Overall Study|Withdrawal by Subject|9|||
156834284|NCT02066415|566145723|FG001|Overall Study|Withdrawal by Subject|1|||
156834285|NCT02066415|566145724|FG002|Overall Study|Withdrawal by Subject|4|||
156834286|NCT02066415|566145722|FG000|Overall Study|Lost to Follow-up|7|||
156834287|NCT02066415|566145723|FG001|Overall Study|Lost to Follow-up|2|||
156834288|NCT02066415|566145724|FG002|Overall Study|Lost to Follow-up|2|||
156834289|NCT02006069|566145726|FG000|Overall Study|MPP other programming|239|||
156834290|NCT02006069|566145727|FG001|Overall Study|MPP other programming|0|||
156834291|NCT02006069|566145726|FG000|Overall Study|RV only pacing|0|||
156834292|NCT02006069|566145727|FG001|Overall Study|RV only pacing|3|||
156834293|NCT02276547|566145730|FG000|Overall Study|Death|2|||
156834294|NCT02276547|566145730|FG000|Overall Study|Explant|2|||
156834295|NCT01439126|566145731|FG000|Overall Study|Adverse Event|2|||
156834296|NCT01439126|566145732|FG001|Overall Study|Adverse Event|0|||
156834297|NCT01439126|566145731|FG000|Overall Study|Withdrawal by Subject|5|||
156834298|NCT01439126|566145732|FG001|Overall Study|Withdrawal by Subject|21|||
156834299|NCT01439126|566145731|FG000|Overall Study|Protocol Violation|6|||
156834300|NCT01439126|566145732|FG001|Overall Study|Protocol Violation|4|||
156834301|NCT01439126|566145731|FG000|Overall Study|Lost to Follow-up|6|||
156834302|NCT01439126|566145732|FG001|Overall Study|Lost to Follow-up|3|||
156834303|NCT01439126|566145731|FG000|Overall Study|Other-Use of prohibited treatment|0|||
156834304|NCT01439126|566145732|FG001|Overall Study|Other-Use of prohibited treatment|2|||
156834305|NCT01439126|566145731|FG000|Overall Study|Other-Miscellaneous|12|||
156885814|NCT04449029|566340121|FG006|Overall Study|Protocol Violation|0|||
156885815|NCT04449029|566340122|FG007|Overall Study|Protocol Violation|0|||
156885816|NCT04449029|566340115|FG000|Overall Study|Physician Decision|0|||
157152214|NCT01254604|567303413|FG000|Overall Study|Protocol Violation|2|||
157152215|NCT01254604|567303414|FG001|Overall Study|Protocol Violation|2|||
157152216|NCT01254604|567303413|FG000|Overall Study|Withdrawal by Subject|2|||
157152217|NCT01254604|567303414|FG001|Overall Study|Withdrawal by Subject|4|||
157152218|NCT01254604|567303413|FG000|Overall Study|Adverse Event|3|||
157152219|NCT01254604|567303414|FG001|Overall Study|Adverse Event|2|||
156834306|NCT01439126|566145732|FG001|Overall Study|Other-Miscellaneous|12|||
156834307|NCT01216683|566147122|FG000|Induction|Never started treatment|0|||
156834308|NCT01216683|566147123|FG001|Induction|Never started treatment|6|||
156834309|NCT01216683|566147124|FG002|Induction|Never started treatment|3|||
156834310|NCT01216683|566147122|FG000|Induction|Lack of Efficacy|4|||
156834311|NCT01216683|566147123|FG001|Induction|Lack of Efficacy|3|||
156834312|NCT01216683|566147124|FG002|Induction|Lack of Efficacy|7|||
156834313|NCT01216683|566147122|FG000|Induction|Adverse Event|0|||
156834314|NCT01216683|566147123|FG001|Induction|Adverse Event|5|||
156834315|NCT01216683|566147124|FG002|Induction|Adverse Event|5|||
156834316|NCT01216683|566147122|FG000|Induction|Death|0|||
156834317|NCT01216683|566147123|FG001|Induction|Death|0|||
156834318|NCT01216683|566147124|FG002|Induction|Death|2|||
156834319|NCT01216683|566147122|FG000|Induction|Withdrawal by Subject|0|||
156834320|NCT01216683|566147123|FG001|Induction|Withdrawal by Subject|4|||
156834321|NCT01216683|566147124|FG002|Induction|Withdrawal by Subject|2|||
156834322|NCT01216683|566147122|FG000|Induction|Other disease|0|||
156834323|NCT01216683|566147123|FG001|Induction|Other disease|1|||
156834324|NCT01216683|566147124|FG002|Induction|Other disease|2|||
156834325|NCT01216683|566147122|FG000|Continuation|Lack of Efficacy|3|||
156834326|NCT01216683|566147123|FG001|Continuation|Lack of Efficacy|2|||
156834327|NCT01216683|566147124|FG002|Continuation|Lack of Efficacy|7|||
156834328|NCT01216683|566147122|FG000|Continuation|Adverse Event|5|||
156834329|NCT01216683|566147123|FG001|Continuation|Adverse Event|3|||
156834330|NCT01216683|566147124|FG002|Continuation|Adverse Event|16|||
156834331|NCT01216683|566147122|FG000|Continuation|Death|1|||
156834332|NCT01216683|566147123|FG001|Continuation|Death|0|||
156834333|NCT01216683|566147124|FG002|Continuation|Death|2|||
156834334|NCT01216683|566147122|FG000|Continuation|Withdrawal by Subject|4|||
156834335|NCT01216683|566147123|FG001|Continuation|Withdrawal by Subject|5|||
156834336|NCT01216683|566147124|FG002|Continuation|Withdrawal by Subject|9|||
156834337|NCT01216683|566147122|FG000|Continuation|Other diseases|0|||
156834338|NCT01216683|566147123|FG001|Continuation|Other diseases|2|||
156834339|NCT01216683|566147124|FG002|Continuation|Other diseases|1|||
156834340|NCT01216683|566147122|FG000|Continuation|Physician Decision|1|||
156834341|NCT01216683|566147123|FG001|Continuation|Physician Decision|0|||
156834342|NCT01216683|566147124|FG002|Continuation|Physician Decision|1|||
156834343|NCT01216683|566147122|FG000|Continuation|Non-compliance|1|||
156834344|NCT01216683|566147123|FG001|Continuation|Non-compliance|0|||
156834345|NCT01216683|566147124|FG002|Continuation|Non-compliance|1|||
156834346|NCT01216683|566147122|FG000|Continuation|Insurance change|0|||
156834347|NCT01216683|566147123|FG001|Continuation|Insurance change|1|||
156834348|NCT01216683|566147124|FG002|Continuation|Insurance change|0|||
156834349|NCT01216683|566147122|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
156834350|NCT01216683|566147123|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
156834351|NCT01216683|566147124|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
156834352|NCT01216683|566147122|FG000|Continuation|Not reported|0|||
156885817|NCT04449029|566340116|FG001|Overall Study|Physician Decision|0|||
157152220|NCT03074162|567303415|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
157152221|NCT03074162|567303416|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
157152222|NCT03074162|567303417|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
157152223|NCT03074162|567303418|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
157152224|NCT03074162|567303419|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
157152225|NCT03074162|567303420|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
157152226|NCT03074162|567303415|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
157152227|NCT03074162|567303416|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
156834353|NCT01216683|566147123|FG001|Continuation|Not reported|0|||
156834354|NCT01216683|566147124|FG002|Continuation|Not reported|1|||
156834355|NCT01216683|566147122|FG000|Continuation|Never started treatment|0|||
156834356|NCT01216683|566147123|FG001|Continuation|Never started treatment|1|||
156834357|NCT01216683|566147124|FG002|Continuation|Never started treatment|5|||
156834358|NCT01949090|566147130|FG000|Overall Study|Serious Adverse Event|0|||
156834359|NCT01949090|566147131|FG001|Overall Study|Serious Adverse Event|1|||
156834360|NCT01949090|566147132|FG002|Overall Study|Serious Adverse Event|2|||
156834361|NCT01949090|566147133|FG003|Overall Study|Serious Adverse Event|0|||
156834362|NCT01949090|566147134|FG004|Overall Study|Serious Adverse Event|1|||
156834363|NCT01949090|566147130|FG000|Overall Study|Withdrawal by Subject|2|||
156834364|NCT01949090|566147131|FG001|Overall Study|Withdrawal by Subject|0|||
156834365|NCT01949090|566147132|FG002|Overall Study|Withdrawal by Subject|0|||
156834366|NCT01949090|566147133|FG003|Overall Study|Withdrawal by Subject|0|||
156834367|NCT01949090|566147134|FG004|Overall Study|Withdrawal by Subject|1|||
156834368|NCT01949090|566147130|FG000|Overall Study|Protocol non-compliance|0|||
156834369|NCT01949090|566147131|FG001|Overall Study|Protocol non-compliance|0|||
156834370|NCT01949090|566147132|FG002|Overall Study|Protocol non-compliance|0|||
156834371|NCT01949090|566147133|FG003|Overall Study|Protocol non-compliance|0|||
156834372|NCT01949090|566147134|FG004|Overall Study|Protocol non-compliance|1|||
156834373|NCT01949090|566147130|FG000|Overall Study|Lost to Follow-up|2|||
156834374|NCT01949090|566147131|FG001|Overall Study|Lost to Follow-up|1|||
156834375|NCT01949090|566147132|FG002|Overall Study|Lost to Follow-up|0|||
156834376|NCT01949090|566147133|FG003|Overall Study|Lost to Follow-up|1|||
156834377|NCT01949090|566147134|FG004|Overall Study|Lost to Follow-up|1|||
156834378|NCT01533922|566147135|FG000|Overall Study|Adverse Event|5|||
156834379|NCT01533922|566147136|FG001|Overall Study|Adverse Event|8|||
156834380|NCT01533922|566147137|FG002|Overall Study|Adverse Event|6|||
156834381|NCT01533922|566147138|FG003|Overall Study|Adverse Event|3|||
156834382|NCT01533922|566147139|FG004|Overall Study|Adverse Event|4|||
156834383|NCT01533922|566147135|FG000|Overall Study|Lack of Efficacy|0|||
156834384|NCT01533922|566147136|FG001|Overall Study|Lack of Efficacy|0|||
156834385|NCT01533922|566147137|FG002|Overall Study|Lack of Efficacy|1|||
156834386|NCT01533922|566147138|FG003|Overall Study|Lack of Efficacy|0|||
156834387|NCT01533922|566147139|FG004|Overall Study|Lack of Efficacy|0|||
156885818|NCT04449029|566340117|FG002|Overall Study|Physician Decision|0|||
156885819|NCT04449029|566340118|FG003|Overall Study|Physician Decision|0|||
156885820|NCT04449029|566340119|FG004|Overall Study|Physician Decision|0|||
156885821|NCT04449029|566340120|FG005|Overall Study|Physician Decision|1|||
156885822|NCT04449029|566340121|FG006|Overall Study|Physician Decision|0|||
156885823|NCT04449029|566340122|FG007|Overall Study|Physician Decision|0|||
156834388|NCT01533922|566147135|FG000|Overall Study|Protocol Violation|0|||
156834389|NCT01533922|566147136|FG001|Overall Study|Protocol Violation|3|||
156885824|NCT04449029|566340115|FG000|Overall Study|Withdrawal by Subject|3|||
156885825|NCT04449029|566340116|FG001|Overall Study|Withdrawal by Subject|0|||
156885826|NCT04449029|566340117|FG002|Overall Study|Withdrawal by Subject|1|||
156885827|NCT04449029|566340118|FG003|Overall Study|Withdrawal by Subject|1|||
156885828|NCT04449029|566340119|FG004|Overall Study|Withdrawal by Subject|5|||
156885829|NCT04449029|566340120|FG005|Overall Study|Withdrawal by Subject|1|||
157152228|NCT03074162|567303417|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
157152229|NCT03074162|567303418|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
157152230|NCT03074162|567303419|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
157152231|NCT03074162|567303420|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
157152232|NCT03074162|567303415|FG000|Period 3|Withdrawal by Subject|1|||
157152233|NCT03074162|567303416|FG001|Period 3|Withdrawal by Subject|0|||
157152234|NCT03074162|567303417|FG002|Period 3|Withdrawal by Subject|0|||
157152235|NCT03074162|567303418|FG003|Period 3|Withdrawal by Subject|0|||
157152236|NCT03074162|567303419|FG004|Period 3|Withdrawal by Subject|1|||
157152237|NCT03074162|567303420|FG005|Period 3|Withdrawal by Subject|0|||
156885830|NCT04449029|566340121|FG006|Overall Study|Withdrawal by Subject|4|||
156885831|NCT04449029|566340122|FG007|Overall Study|Withdrawal by Subject|0|||
156885832|NCT00321646|566340129|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
156885833|NCT00321646|566340129|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
156885834|NCT00321646|566340129|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
156885835|NCT00392379|566340135|FG000|Overall Study|Withdrawal by Subject|17|||
156885836|NCT00392379|566340136|FG001|Overall Study|Withdrawal by Subject|28|||
156885837|NCT00392379|566340135|FG000|Overall Study|Lost to Follow-up|4|||
156885838|NCT00392379|566340136|FG001|Overall Study|Lost to Follow-up|9|||
156885839|NCT00392379|566340135|FG000|Overall Study|Adverse Event|1|||
157152238|NCT01958671|567303421|FG000|Overall Study|Adverse Event|1|||
156885840|NCT00392379|566340136|FG001|Overall Study|Adverse Event|1|||
156885841|NCT01700387|566340142|FG000|Overall Study|Withdrawal by Subject|1|||
156885842|NCT01700387|566340143|FG001|Overall Study|Withdrawal by Subject|2|||
156885843|NCT01700387|566340142|FG000|Overall Study|Adverse Event|1|||
156885844|NCT01700387|566340143|FG001|Overall Study|Adverse Event|1|||
157152239|NCT01958671|567303422|FG001|Overall Study|Adverse Event|1|||
157152240|NCT01958671|567303423|FG002|Overall Study|Adverse Event|5|||
157152241|NCT01958671|567303421|FG000|Overall Study|Death|1|||
156834390|NCT01533922|566147137|FG002|Overall Study|Protocol Violation|0|||
156834391|NCT01533922|566147138|FG003|Overall Study|Protocol Violation|0|||
156834392|NCT01533922|566147139|FG004|Overall Study|Protocol Violation|1|||
156834393|NCT01533922|566147135|FG000|Overall Study|Withdrawal by Subject|3|||
156834394|NCT01533922|566147136|FG001|Overall Study|Withdrawal by Subject|1|||
157152242|NCT01958671|567303422|FG001|Overall Study|Death|0|||
157152243|NCT01958671|567303423|FG002|Overall Study|Death|0|||
156834395|NCT01533922|566147137|FG002|Overall Study|Withdrawal by Subject|2|||
156834396|NCT01533922|566147138|FG003|Overall Study|Withdrawal by Subject|2|||
156834397|NCT01533922|566147139|FG004|Overall Study|Withdrawal by Subject|1|||
156834398|NCT01533922|566147135|FG000|Overall Study|Other reason not defined above|2|||
156834399|NCT01533922|566147136|FG001|Overall Study|Other reason not defined above|0|||
156834400|NCT01533922|566147137|FG002|Overall Study|Other reason not defined above|1|||
156834401|NCT01533922|566147138|FG003|Overall Study|Other reason not defined above|0|||
156834402|NCT01533922|566147139|FG004|Overall Study|Other reason not defined above|0|||
156834403|NCT03242252|566147141|FG000|Overall Study|At the Participant's own Request|18|||
156834404|NCT03242252|566147142|FG001|Overall Study|At the Participant's own Request|10|||
156834405|NCT03242252|566147143|FG002|Overall Study|At the Participant's own Request|15|||
156834406|NCT03242252|566147141|FG000|Overall Study|Adverse Event|8|||
156834407|NCT03242252|566147142|FG001|Overall Study|Adverse Event|6|||
156834408|NCT03242252|566147143|FG002|Overall Study|Adverse Event|9|||
156834409|NCT03242252|566147141|FG000|Overall Study|Poor Compliance to Protocol|0|||
156834410|NCT03242252|566147142|FG001|Overall Study|Poor Compliance to Protocol|2|||
156834411|NCT03242252|566147143|FG002|Overall Study|Poor Compliance to Protocol|3|||
156834412|NCT03242252|566147141|FG000|Overall Study|Study Terminated by Sponsor|1|||
156834413|NCT03242252|566147142|FG001|Overall Study|Study Terminated by Sponsor|0|||
156834414|NCT03242252|566147143|FG002|Overall Study|Study Terminated by Sponsor|0|||
156834415|NCT03242252|566147141|FG000|Overall Study|Reason not Specified|4|||
156834416|NCT03242252|566147142|FG001|Overall Study|Reason not Specified|4|||
156834417|NCT03242252|566147143|FG002|Overall Study|Reason not Specified|1|||
156834418|NCT03242252|566147141|FG000|Overall Study|Lost to Follow-up|5|||
156834419|NCT03242252|566147142|FG001|Overall Study|Lost to Follow-up|1|||
156834420|NCT03242252|566147143|FG002|Overall Study|Lost to Follow-up|4|||
156834421|NCT01267175|566147146|FG000|Overall Study|Withdrawal by Subject|1|||
156834422|NCT01267175|566147146|FG000|Overall Study|Lost to Follow-up|1|||
156834423|NCT00895661|566147147|FG000|Overall Study|Death|1|||
156834424|NCT00895661|566147147|FG000|Overall Study|reason unknown|2|||
156834425|NCT02989805|566147150|FG000|Overall Study|invalid consent|6|||
156834426|NCT02989805|566147151|FG001|Overall Study|invalid consent|4|||
156834427|NCT00286221|566147152|FG000|Overall Study|Protocol Violation|2|||
156834428|NCT00286221|566147153|FG001|Overall Study|Protocol Violation|1|||
156834429|NCT00286221|566147154|FG002|Overall Study|Protocol Violation|6|||
156834430|NCT00286221|566147155|FG003|Overall Study|Protocol Violation|4|||
156834431|NCT00286221|566147152|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
156834432|NCT00286221|566147153|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
156834433|NCT00286221|566147154|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
156834434|NCT00286221|566147155|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
156834435|NCT00286221|566147152|FG000|Overall Study|Inability to trigger PCA|2|||
156834436|NCT00286221|566147153|FG001|Overall Study|Inability to trigger PCA|0|||
156834437|NCT00286221|566147154|FG002|Overall Study|Inability to trigger PCA|0|||
156834438|NCT00286221|566147155|FG003|Overall Study|Inability to trigger PCA|0|||
156834439|NCT00286221|566147152|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
156834440|NCT00286221|566147153|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
156834441|NCT00286221|566147154|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
156834442|NCT00286221|566147155|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
156834443|NCT02771626|566147157|FG000|Overall Study|Adverse Event|1|||
156834444|NCT02771626|566147158|FG001|Overall Study|Adverse Event|5|||
156834445|NCT02771626|566147159|FG002|Overall Study|Adverse Event|3|||
156834446|NCT02771626|566147160|FG003|Overall Study|Adverse Event|0|||
156834447|NCT02771626|566147161|FG004|Overall Study|Adverse Event|1|||
156834448|NCT02771626|566147162|FG005|Overall Study|Adverse Event|1|||
156834449|NCT02771626|566147157|FG000|Overall Study|Radiologic Disease Progression|6|||
156834450|NCT02771626|566147158|FG001|Overall Study|Radiologic Disease Progression|13|||
156834451|NCT02771626|566147159|FG002|Overall Study|Radiologic Disease Progression|10|||
156834452|NCT02771626|566147160|FG003|Overall Study|Radiologic Disease Progression|7|||
156834453|NCT02771626|566147161|FG004|Overall Study|Radiologic Disease Progression|28|||
156834454|NCT02771626|566147162|FG005|Overall Study|Radiologic Disease Progression|15|||
156834455|NCT02771626|566147157|FG000|Overall Study|Symptomatic Deterioration|0|||
156834456|NCT02771626|566147158|FG001|Overall Study|Symptomatic Deterioration|4|||
156834457|NCT02771626|566147159|FG002|Overall Study|Symptomatic Deterioration|2|||
156834458|NCT02771626|566147160|FG003|Overall Study|Symptomatic Deterioration|0|||
156834459|NCT02771626|566147161|FG004|Overall Study|Symptomatic Deterioration|5|||
156834460|NCT02771626|566147162|FG005|Overall Study|Symptomatic Deterioration|2|||
156834461|NCT02771626|566147157|FG000|Overall Study|Participant Request|0|||
156834462|NCT02771626|566147158|FG001|Overall Study|Participant Request|1|||
156834463|NCT02771626|566147159|FG002|Overall Study|Participant Request|0|||
156834464|NCT02771626|566147160|FG003|Overall Study|Participant Request|2|||
156834465|NCT02771626|566147161|FG004|Overall Study|Participant Request|0|||
156834466|NCT02771626|566147162|FG005|Overall Study|Participant Request|1|||
156834467|NCT02771626|566147157|FG000|Overall Study|Investigator Decision|0|||
156834468|NCT02771626|566147158|FG001|Overall Study|Investigator Decision|1|||
156834469|NCT02771626|566147159|FG002|Overall Study|Investigator Decision|0|||
156834470|NCT02771626|566147160|FG003|Overall Study|Investigator Decision|0|||
156834471|NCT02771626|566147161|FG004|Overall Study|Investigator Decision|1|||
156834472|NCT02771626|566147162|FG005|Overall Study|Investigator Decision|0|||
156834473|NCT02771626|566147157|FG000|Overall Study|Study Termination by Sponsor|0|||
156834474|NCT02771626|566147158|FG001|Overall Study|Study Termination by Sponsor|2|||
156834475|NCT02771626|566147159|FG002|Overall Study|Study Termination by Sponsor|1|||
156834476|NCT02771626|566147160|FG003|Overall Study|Study Termination by Sponsor|0|||
156834477|NCT02771626|566147161|FG004|Overall Study|Study Termination by Sponsor|1|||
156834478|NCT02771626|566147162|FG005|Overall Study|Study Termination by Sponsor|0|||
156834479|NCT02771626|566147157|FG000|Overall Study|Informed Consent Withdrawn|0|||
156834480|NCT02771626|566147158|FG001|Overall Study|Informed Consent Withdrawn|0|||
156834481|NCT02771626|566147159|FG002|Overall Study|Informed Consent Withdrawn|1|||
156834482|NCT02771626|566147160|FG003|Overall Study|Informed Consent Withdrawn|0|||
156834483|NCT02771626|566147161|FG004|Overall Study|Informed Consent Withdrawn|1|||
156834484|NCT02771626|566147162|FG005|Overall Study|Informed Consent Withdrawn|1|||
156834485|NCT02771626|566147157|FG000|Overall Study|Other, Not Specified|1|||
156834486|NCT02771626|566147158|FG001|Overall Study|Other, Not Specified|0|||
156834487|NCT02771626|566147159|FG002|Overall Study|Other, Not Specified|0|||
156834488|NCT02771626|566147160|FG003|Overall Study|Other, Not Specified|0|||
156834489|NCT02771626|566147161|FG004|Overall Study|Other, Not Specified|0|||
156834490|NCT02771626|566147162|FG005|Overall Study|Other, Not Specified|1|||
156834491|NCT02553538|566147163|FG000|Overall Study|Could Not Reach by Telephone|133|||
156834492|NCT02553538|566147164|FG001|Overall Study|Could Not Reach by Telephone|0|||
156834493|NCT02553538|566147163|FG000|Overall Study|Died or Left Network|54|||
156834494|NCT02553538|566147164|FG001|Overall Study|Died or Left Network|56|||
156834495|NCT02690649|566147165|FG000|Overall Study|Withdrawal by Subject|1|||
156834496|NCT02690649|566147166|FG001|Overall Study|Withdrawal by Subject|1|||
156834497|NCT02690649|566147165|FG000|Overall Study|Protocol Violation|0|||
156834498|NCT02690649|566147166|FG001|Overall Study|Protocol Violation|3|||
156834499|NCT00106691|566147167|FG000|Overall Study|Adverse Event|60|||
156834500|NCT00106691|566147168|FG001|Overall Study|Adverse Event|64|||
156834501|NCT00106691|566147167|FG000|Overall Study|Lost to Follow-up|23|||
156834502|NCT00106691|566147168|FG001|Overall Study|Lost to Follow-up|18|||
156834503|NCT00106691|566147167|FG000|Overall Study|Physician Decision|18|||
156834504|NCT00106691|566147168|FG001|Overall Study|Physician Decision|21|||
156885845|NCT01700387|566340142|FG000|Overall Study|Lost to Follow-up|2|||
156885846|NCT01700387|566340143|FG001|Overall Study|Lost to Follow-up|1|||
156885847|NCT02730793|566340146|FG000|Overall Study|Physician Decision|0|||
156885848|NCT02730793|566340147|FG001|Overall Study|Physician Decision|1|||
156885849|NCT02730793|566340146|FG000|Overall Study|Withdrawal by Subject|0|||
156885850|NCT02730793|566340147|FG001|Overall Study|Withdrawal by Subject|1|||
156885851|NCT02365233|566340148|FG000|Overall Study|IRB withheld the data|1|||
156885852|NCT02365233|566340149|FG001|Overall Study|IRB withheld the data|2|||
156885853|NCT02365233|566340150|FG002|Overall Study|IRB withheld the data|2|||
156885854|NCT00934843|566340151|FG000|Overall Study|Protocol Violation|0|||
156885855|NCT00934843|566340152|FG001|Overall Study|Protocol Violation|1|||
156885856|NCT00160667|566340153|FG000|Overall Study|Adverse Event|3|||
156885857|NCT00160667|566340154|FG001|Overall Study|Adverse Event|1|||
156885858|NCT00160667|566340155|FG002|Overall Study|Adverse Event|4|||
156885859|NCT00160667|566340153|FG000|Overall Study|Withdrawal by Subject|2|||
156885860|NCT00160667|566340154|FG001|Overall Study|Withdrawal by Subject|0|||
156885861|NCT00160667|566340155|FG002|Overall Study|Withdrawal by Subject|1|||
156885862|NCT00160667|566340153|FG000|Overall Study|Lack of Efficacy|0|||
156885863|NCT00160667|566340154|FG001|Overall Study|Lack of Efficacy|1|||
156885864|NCT00160667|566340155|FG002|Overall Study|Lack of Efficacy|0|||
156885865|NCT00160667|566340153|FG000|Overall Study|Protocol Violation|0|||
156885866|NCT00160667|566340154|FG001|Overall Study|Protocol Violation|1|||
156885867|NCT00160667|566340155|FG002|Overall Study|Protocol Violation|0|||
156885868|NCT00160667|566340153|FG000|Overall Study|Patient decision|0|||
156885869|NCT00160667|566340154|FG001|Overall Study|Patient decision|0|||
156885870|NCT00160667|566340155|FG002|Overall Study|Patient decision|1|||
156885871|NCT00995566|566340161|FG000|Overall Study|Adverse Event|2|||
156885872|NCT00995566|566340161|FG000|Overall Study|Early study termination|52|||
156885873|NCT00384111|566340166|FG000|Overall Study|Disease Progression|3|||
156885874|NCT00384111|566340166|FG000|Overall Study|Adverse Event|1|||
156885875|NCT00384111|566340166|FG000|Overall Study|Investigator Decision|3|||
156885876|NCT00384111|566340166|FG000|Overall Study|Study Terminated by the Sponsor|19|||
156885877|NCT02055365|566342341|FG000|Overall Study|Prematurely Withdrawn|1|||
156885878|NCT01258998|566342344|FG000|Overall Study|Ineligible|1|||
156885879|NCT01143389|566342345|FG000|Overall Study|Lost to Follow-up|26|||
156885880|NCT01143389|566342346|FG001|Overall Study|Lost to Follow-up|25|||
156885881|NCT04966910|566342347|FG000|Baseline|Participant did not complete measure|0|||
156885882|NCT04966910|566342348|FG001|Baseline|Participant did not complete measure|0|||
156834505|NCT00106691|566147167|FG000|Overall Study|Protocol Violation|13|||
156834506|NCT00106691|566147168|FG001|Overall Study|Protocol Violation|18|||
156834507|NCT00106691|566147167|FG000|Overall Study|Withdrawal by Subject|75|||
156834508|NCT00106691|566147168|FG001|Overall Study|Withdrawal by Subject|70|||
156834509|NCT00106691|566147167|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
156834510|NCT00106691|566147168|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
156885883|NCT04966910|566342349|FG002|Baseline|Participant did not complete measure|1|||
156885884|NCT04966910|566342350|FG003|Baseline|Participant did not complete measure|0|||
156834511|NCT00106691|566147167|FG000|Overall Study|QTc>480|3|||
156885885|NCT04966910|566342347|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
156834512|NCT00106691|566147168|FG001|Overall Study|QTc>480|1|||
156834513|NCT00106691|566147167|FG000|Overall Study|mililtary deployment|2|||
156834514|NCT00106691|566147168|FG001|Overall Study|mililtary deployment|0|||
156834515|NCT00106691|566147167|FG000|Overall Study|Study Site Closing/PI Moved|1|||
156834516|NCT00106691|566147168|FG001|Overall Study|Study Site Closing/PI Moved|2|||
156834517|NCT00106691|566147167|FG000|Overall Study|Cardiologist recommendation|1|||
156834518|NCT00106691|566147168|FG001|Overall Study|Cardiologist recommendation|0|||
156834519|NCT00106691|566147167|FG000|Overall Study|Pt. moved to another state|1|||
156834520|NCT00106691|566147168|FG001|Overall Study|Pt. moved to another state|0|||
156834521|NCT00106691|566147167|FG000|Overall Study|Taking exclusionary avodart|1|||
156834522|NCT00106691|566147168|FG001|Overall Study|Taking exclusionary avodart|0|||
156834523|NCT00106691|566147167|FG000|Overall Study|Not able to discontinue plavix|0|||
156834524|NCT00106691|566147168|FG001|Overall Study|Not able to discontinue plavix|1|||
156834525|NCT01754194|566147169|FG000|Overall Study|Lost to Follow-up|39|||
156834526|NCT01754194|566147170|FG001|Overall Study|Lost to Follow-up|14|||
156834527|NCT01754194|566147169|FG000|Overall Study|Withdrawal by Subject|4|||
156834528|NCT01754194|566147170|FG001|Overall Study|Withdrawal by Subject|5|||
156834529|NCT01754194|566147169|FG000|Overall Study|Other|9|||
156834530|NCT01754194|566147170|FG001|Overall Study|Other|8|||
156834531|NCT00530920|566147171|FG000|Overall Study|Randomized but not treated|0|||
156834532|NCT00530920|566147172|FG001|Overall Study|Randomized but not treated|2|||
156834533|NCT00530920|566147173|FG002|Overall Study|Randomized but not treated|0|||
156834534|NCT00530920|566147171|FG000|Overall Study|Adverse Event|0|||
156834535|NCT00530920|566147172|FG001|Overall Study|Adverse Event|0|||
156834536|NCT00530920|566147173|FG002|Overall Study|Adverse Event|3|||
156834537|NCT00530920|566147171|FG000|Overall Study|Withdrawal by Subject|0|||
156834538|NCT00530920|566147172|FG001|Overall Study|Withdrawal by Subject|0|||
156834539|NCT00530920|566147173|FG002|Overall Study|Withdrawal by Subject|1|||
156834540|NCT00907296|566147174|FG000|Overall Study|Ineligibility Determined|1|||
156834541|NCT00907296|566147175|FG001|Overall Study|Ineligibility Determined|0|||
156834542|NCT00907296|566147176|FG002|Overall Study|Ineligibility Determined|0|||
156834543|NCT00907296|566147177|FG003|Overall Study|Ineligibility Determined|1|||
156834544|NCT00907296|566147178|FG004|Overall Study|Ineligibility Determined|0|||
156834545|NCT00907296|566147179|FG005|Overall Study|Ineligibility Determined|0|||
156834546|NCT00907296|566147180|FG006|Overall Study|Ineligibility Determined|0|||
156834547|NCT00907296|566147181|FG007|Overall Study|Ineligibility Determined|1|||
157152244|NCT01958671|567303421|FG000|Overall Study|Excluded medication|0|||
157152245|NCT01958671|567303422|FG001|Overall Study|Excluded medication|0|||
157152246|NCT01958671|567303423|FG002|Overall Study|Excluded medication|1|||
157152247|NCT01958671|567303421|FG000|Overall Study|Hyperglycemia|0|||
157152248|NCT01958671|567303422|FG001|Overall Study|Hyperglycemia|0|||
157152249|NCT01958671|567303423|FG002|Overall Study|Hyperglycemia|2|||
157152250|NCT01958671|567303421|FG000|Overall Study|Lost to Follow-up|7|||
157152251|NCT01958671|567303422|FG001|Overall Study|Lost to Follow-up|11|||
157152252|NCT01958671|567303423|FG002|Overall Study|Lost to Follow-up|7|||
157152253|NCT01958671|567303421|FG000|Overall Study|Non-compliance with study drug|1|||
157152254|NCT01958671|567303422|FG001|Overall Study|Non-compliance with study drug|1|||
157152255|NCT01958671|567303423|FG002|Overall Study|Non-compliance with study drug|1|||
156834548|NCT00907296|566147182|FG008|Overall Study|Ineligibility Determined|0|||
156834549|NCT00907296|566147183|FG009|Overall Study|Ineligibility Determined|0|||
156834550|NCT00907296|566147174|FG000|Overall Study|Protocol Deviation|0|||
156834551|NCT00907296|566147175|FG001|Overall Study|Protocol Deviation|1|||
156834552|NCT00907296|566147176|FG002|Overall Study|Protocol Deviation|0|||
156834553|NCT00907296|566147177|FG003|Overall Study|Protocol Deviation|0|||
156834554|NCT00907296|566147178|FG004|Overall Study|Protocol Deviation|0|||
156834555|NCT00907296|566147179|FG005|Overall Study|Protocol Deviation|0|||
156834556|NCT00907296|566147180|FG006|Overall Study|Protocol Deviation|0|||
156834557|NCT00907296|566147181|FG007|Overall Study|Protocol Deviation|0|||
156834558|NCT00907296|566147182|FG008|Overall Study|Protocol Deviation|0|||
156834559|NCT00907296|566147183|FG009|Overall Study|Protocol Deviation|0|||
156834560|NCT00907296|566147174|FG000|Overall Study|Noncompliance|1|||
156834561|NCT00907296|566147175|FG001|Overall Study|Noncompliance|1|||
156834562|NCT00907296|566147176|FG002|Overall Study|Noncompliance|1|||
156834563|NCT00907296|566147177|FG003|Overall Study|Noncompliance|0|||
156834564|NCT00907296|566147178|FG004|Overall Study|Noncompliance|0|||
156834565|NCT00907296|566147179|FG005|Overall Study|Noncompliance|1|||
156834566|NCT00907296|566147180|FG006|Overall Study|Noncompliance|0|||
156834567|NCT00907296|566147181|FG007|Overall Study|Noncompliance|2|||
156834568|NCT00907296|566147182|FG008|Overall Study|Noncompliance|0|||
156834569|NCT00907296|566147183|FG009|Overall Study|Noncompliance|0|||
156834570|NCT00907296|566147174|FG000|Overall Study|Adverse Event|2|||
156834571|NCT00907296|566147175|FG001|Overall Study|Adverse Event|0|||
156834572|NCT00907296|566147176|FG002|Overall Study|Adverse Event|0|||
156834573|NCT00907296|566147177|FG003|Overall Study|Adverse Event|0|||
156834574|NCT00907296|566147178|FG004|Overall Study|Adverse Event|0|||
157152256|NCT01958671|567303421|FG000|Overall Study|Pregnancy|0|||
157152257|NCT01958671|567303422|FG001|Overall Study|Pregnancy|0|||
157152258|NCT01958671|567303423|FG002|Overall Study|Pregnancy|1|||
157152259|NCT01958671|567303421|FG000|Overall Study|Protocol Violation|0|||
157152260|NCT01958671|567303422|FG001|Overall Study|Protocol Violation|1|||
157152261|NCT01958671|567303423|FG002|Overall Study|Protocol Violation|0|||
157152262|NCT01958671|567303421|FG000|Overall Study|Study site terminated by sponsor|1|||
156834575|NCT00907296|566147179|FG005|Overall Study|Adverse Event|0|||
156834576|NCT00907296|566147180|FG006|Overall Study|Adverse Event|1|||
156834577|NCT00907296|566147181|FG007|Overall Study|Adverse Event|0|||
156834578|NCT00907296|566147182|FG008|Overall Study|Adverse Event|0|||
156834579|NCT00907296|566147183|FG009|Overall Study|Adverse Event|1|||
156834580|NCT00907296|566147174|FG000|Overall Study|Withdrawal by Subject|7|||
156834581|NCT00907296|566147175|FG001|Overall Study|Withdrawal by Subject|2|||
156834582|NCT00907296|566147176|FG002|Overall Study|Withdrawal by Subject|1|||
156834583|NCT00907296|566147177|FG003|Overall Study|Withdrawal by Subject|1|||
156834584|NCT00907296|566147178|FG004|Overall Study|Withdrawal by Subject|1|||
156834585|NCT00907296|566147179|FG005|Overall Study|Withdrawal by Subject|5|||
156834586|NCT00907296|566147180|FG006|Overall Study|Withdrawal by Subject|3|||
156834587|NCT00907296|566147181|FG007|Overall Study|Withdrawal by Subject|2|||
156834588|NCT00907296|566147182|FG008|Overall Study|Withdrawal by Subject|4|||
156834589|NCT00907296|566147183|FG009|Overall Study|Withdrawal by Subject|2|||
156834590|NCT00907296|566147174|FG000|Overall Study|Lost to Follow-up|9|||
156834591|NCT00907296|566147175|FG001|Overall Study|Lost to Follow-up|1|||
156834592|NCT00907296|566147176|FG002|Overall Study|Lost to Follow-up|0|||
156834593|NCT00907296|566147177|FG003|Overall Study|Lost to Follow-up|2|||
156834594|NCT00907296|566147178|FG004|Overall Study|Lost to Follow-up|0|||
156834595|NCT00907296|566147179|FG005|Overall Study|Lost to Follow-up|3|||
156834596|NCT00907296|566147180|FG006|Overall Study|Lost to Follow-up|2|||
156834597|NCT00907296|566147181|FG007|Overall Study|Lost to Follow-up|2|||
156834598|NCT00907296|566147182|FG008|Overall Study|Lost to Follow-up|0|||
156834599|NCT00907296|566147183|FG009|Overall Study|Lost to Follow-up|4|||
156834600|NCT02392403|566147185|FG000|Overall Study|Adverse Event|1|||
156834601|NCT02392403|566147185|FG000|Overall Study|Death|1|||
156834602|NCT02392403|566147185|FG000|Overall Study|Withdrawal by Subject|1|||
156834603|NCT02776033|566147190|FG000|Overall Study|Withdrawal by Subject|0|||
156834604|NCT02776033|566147191|FG001|Overall Study|Withdrawal by Subject|0|||
156834605|NCT02776033|566147192|FG002|Overall Study|Withdrawal by Subject|2|||
156834606|NCT02776033|566147190|FG000|Overall Study|Physician Decision|2|||
156834607|NCT02776033|566147191|FG001|Overall Study|Physician Decision|0|||
156834608|NCT02776033|566147192|FG002|Overall Study|Physician Decision|0|||
156834609|NCT02776033|566147190|FG000|Overall Study|Lost to Follow-up|1|||
156834610|NCT02776033|566147191|FG001|Overall Study|Lost to Follow-up|0|||
156834611|NCT02776033|566147192|FG002|Overall Study|Lost to Follow-up|0|||
156834612|NCT02776033|566147190|FG000|Overall Study|Adverse Event|1|||
156834613|NCT02776033|566147191|FG001|Overall Study|Adverse Event|2|||
156834614|NCT02776033|566147192|FG002|Overall Study|Adverse Event|0|||
156834615|NCT02616393|566147196|FG000|Overall Study|Death|5|||
156834616|NCT02616393|566147197|FG001|Overall Study|Death|12|||
156834617|NCT02616393|566147198|FG002|Overall Study|Death|1|||
156834618|NCT02616393|566147196|FG000|Overall Study|Termination by Sponsor|4|||
156834619|NCT02616393|566147197|FG001|Overall Study|Termination by Sponsor|5|||
156834620|NCT02616393|566147198|FG002|Overall Study|Termination by Sponsor|2|||
156834621|NCT02616393|566147196|FG000|Overall Study|Other|3|||
156834622|NCT02616393|566147197|FG001|Overall Study|Other|0|||
156834623|NCT02616393|566147198|FG002|Overall Study|Other|0|||
156834624|NCT02616393|566147196|FG000|Overall Study|Withdrawal by Subject|1|||
156834625|NCT02616393|566147197|FG001|Overall Study|Withdrawal by Subject|1|||
156834626|NCT02616393|566147198|FG002|Overall Study|Withdrawal by Subject|0|||
156834627|NCT02616393|566147196|FG000|Overall Study|Lost to Follow-up|0|||
156834628|NCT02616393|566147197|FG001|Overall Study|Lost to Follow-up|2|||
156834629|NCT02616393|566147198|FG002|Overall Study|Lost to Follow-up|0|||
156834630|NCT02445573|566147202|FG000|Overall Study|Withdrawal by Subject|1|||
156834631|NCT02445573|566147203|FG001|Overall Study|Withdrawal by Subject|1|||
157152263|NCT01958671|567303422|FG001|Overall Study|Study site terminated by sponsor|0|||
157152264|NCT01958671|567303423|FG002|Overall Study|Study site terminated by sponsor|1|||
156834632|NCT02445573|566147202|FG000|Overall Study|Lost to Follow-up|0|||
156834633|NCT02445573|566147203|FG001|Overall Study|Lost to Follow-up|1|||
156834634|NCT04047420|566147204|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
156834635|NCT04047420|566147204|FG000|Washout Period|Refused Participation|2|||
156834636|NCT03757130|566147205|FG000|Overall Study|Lost to Follow-up|0|||
157152265|NCT01958671|567303421|FG000|Overall Study|Participant moved|0|||
156834637|NCT03757130|566147206|FG001|Overall Study|Lost to Follow-up|0|||
156834638|NCT03757130|566147207|FG002|Overall Study|Lost to Follow-up|0|||
156834639|NCT03757130|566147208|FG003|Overall Study|Lost to Follow-up|1|||
157152266|NCT01958671|567303422|FG001|Overall Study|Participant moved|0|||
156834640|NCT03757130|566147209|FG004|Overall Study|Lost to Follow-up|0|||
156834641|NCT03757130|566147210|FG005|Overall Study|Lost to Follow-up|0|||
156834642|NCT03757130|566147211|FG006|Overall Study|Lost to Follow-up|0|||
157152267|NCT01958671|567303423|FG002|Overall Study|Participant moved|1|||
156834643|NCT03757130|566147212|FG007|Overall Study|Lost to Follow-up|1|||
156834644|NCT03757130|566147205|FG000|Overall Study|Withdrawal by Subject|0|||
156834645|NCT03757130|566147206|FG001|Overall Study|Withdrawal by Subject|0|||
156834646|NCT03757130|566147207|FG002|Overall Study|Withdrawal by Subject|0|||
156834647|NCT03757130|566147208|FG003|Overall Study|Withdrawal by Subject|0|||
156885886|NCT04966910|566342348|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
156885887|NCT04966910|566342349|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
156885888|NCT04966910|566342350|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
156885889|NCT04966910|566342347|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
156885890|NCT04966910|566342348|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
156885891|NCT04966910|566342349|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
156885892|NCT04966910|566342350|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
156885893|NCT04966910|566342347|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
156885894|NCT04966910|566342348|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
156885895|NCT04966910|566342349|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
156885896|NCT04966910|566342350|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
156885897|NCT03224598|566342353|FG000|Overall Study|Lost to Follow-up|0|||
156885898|NCT03224598|566342354|FG001|Overall Study|Lost to Follow-up|2|||
156885899|NCT03224598|566342355|FG002|Overall Study|Lost to Follow-up|0|||
156885900|NCT03224598|566342353|FG000|Overall Study|Other|0|||
156885901|NCT03224598|566342354|FG001|Overall Study|Other|1|||
156885902|NCT03224598|566342355|FG002|Overall Study|Other|0|||
156885903|NCT00504582|566342365|FG000|Overall Study|Lost to Follow-up|1|||
156885904|NCT00504582|566342366|FG001|Overall Study|Lost to Follow-up|0|||
156885905|NCT00504582|566342367|FG002|Overall Study|Lost to Follow-up|0|||
156885906|NCT01264081|566342368|FG000|Participants Screened|Screening failures|30|||
156885907|NCT01264081|566342368|FG000|Started Treatment|Withdrawal by Subject|1|||
156885908|NCT01264081|566342368|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
156885909|NCT02716896|566342369|FG000|Overall Study|Physician Decision|0|||
156885910|NCT02716896|566342370|FG001|Overall Study|Physician Decision|1|||
156885911|NCT02054481|566342376|FG000|Overall Study|Adverse Event|1|||
156885912|NCT02054481|566342377|FG001|Overall Study|Adverse Event|1|||
156885913|NCT02054481|566342378|FG002|Overall Study|Adverse Event|0|||
156834648|NCT03757130|566147209|FG004|Overall Study|Withdrawal by Subject|0|||
156834649|NCT03757130|566147210|FG005|Overall Study|Withdrawal by Subject|0|||
156834650|NCT03757130|566147211|FG006|Overall Study|Withdrawal by Subject|1|||
156834651|NCT03757130|566147212|FG007|Overall Study|Withdrawal by Subject|0|||
156834652|NCT01639755|566147213|FG000|Overall Study|Study Ongoing|15|||
156834653|NCT01639755|566147213|FG000|Overall Study|Patient had device explantation|4|||
156834654|NCT02391961|566147215|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
156834655|NCT02391961|566147216|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
156834656|NCT02391961|566147215|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156834657|NCT02391961|566147216|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
156834658|NCT02391961|566147215|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156834659|NCT02391961|566147216|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156834660|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
156834661|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
156834662|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
156834663|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
156834664|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
156834665|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
156834666|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
156834667|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
156834668|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
156834669|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
156834670|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
156834671|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
156834672|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
156834673|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
156834674|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
156834675|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
156834676|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
156834677|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
156885914|NCT02054481|566342379|FG003|Overall Study|Adverse Event|1|||
156885915|NCT02054481|566342376|FG000|Overall Study|Lost to Follow-up|1|||
156885916|NCT02054481|566342377|FG001|Overall Study|Lost to Follow-up|0|||
156834678|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
156834679|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
156885917|NCT02054481|566342378|FG002|Overall Study|Lost to Follow-up|0|||
156885918|NCT02054481|566342379|FG003|Overall Study|Lost to Follow-up|0|||
156885919|NCT02054481|566342376|FG000|Overall Study|Other reason|2|||
156885920|NCT02054481|566342377|FG001|Overall Study|Other reason|1|||
156885921|NCT02054481|566342378|FG002|Overall Study|Other reason|2|||
156885922|NCT02054481|566342379|FG003|Overall Study|Other reason|0|||
156885923|NCT02320903|566342380|FG000|Overall Study|Withdrawal by Subject|0|||
156834680|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
156834681|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
156834682|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
156834683|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
156834684|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
156834685|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834686|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834687|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
156834688|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
156834689|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
156834690|NCT00121641|566147217|FG000|24-week Short-term Treatment Period|Other Reason|1|||
156834691|NCT00121641|566147218|FG001|24-week Short-term Treatment Period|Other Reason|0|||
156834692|NCT00121641|566147219|FG002|24-week Short-term Treatment Period|Other Reason|0|||
156834693|NCT00121641|566147220|FG003|24-week Short-term Treatment Period|Other Reason|0|||
156834694|NCT00121641|566147221|FG004|24-week Short-term Treatment Period|Other Reason|0|||
156834695|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
156834696|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
156834697|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
156834698|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
156834699|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
156834700|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
156834701|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
156834702|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
156834703|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
156834704|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
156834705|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
156834706|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
156834707|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
156834708|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
156834709|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
156834710|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
156834711|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
156834712|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
156834713|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
156834714|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
156834715|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
156834716|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
156834717|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
156834718|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
156834719|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
156834720|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
156834721|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
156834722|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
156834723|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
156834724|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
156834725|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
156834726|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
156834727|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
156834728|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
156834729|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
156834730|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
156834731|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
156834732|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
156834733|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
156834734|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
156834735|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Death|0|||
156834736|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Death|0|||
156834737|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Death|0|||
156834738|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Death|1|||
156834739|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Death|0|||
156834740|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Missing|0|||
157152268|NCT01958671|567303421|FG000|Overall Study|Withdrawal by Subject|8|||
157152269|NCT01958671|567303422|FG001|Overall Study|Withdrawal by Subject|10|||
157152270|NCT01958671|567303423|FG002|Overall Study|Withdrawal by Subject|13|||
157152271|NCT02948777|567303424|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
157152272|NCT03952468|567303431|FG000|Overall Study|Death|0|||
157152273|NCT03952468|567303432|FG001|Overall Study|Death|1|||
157152274|NCT03952468|567303431|FG000|Overall Study|Adverse Event|0|||
157152275|NCT03952468|567303432|FG001|Overall Study|Adverse Event|1|||
157152276|NCT03952468|567303431|FG000|Overall Study|Physician Decision|1|||
156834741|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Missing|0|||
156834742|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Missing|1|||
156834743|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Missing|0|||
156834744|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Missing|0|||
156834745|NCT00121641|566147217|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
156834746|NCT00121641|566147218|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
156834747|NCT00121641|566147219|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
156834748|NCT00121641|566147220|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
156834749|NCT00121641|566147221|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
156834750|NCT03263780|566147222|FG000|Overall Study|Withdrawal by Subject|3|||
156834751|NCT03263780|566147222|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
156834752|NCT03995355|566147225|FG000|Overall Study|Adverse Event|1|||
156834753|NCT03995355|566147226|FG001|Overall Study|Adverse Event|0|||
156834754|NCT03995355|566147225|FG000|Overall Study|Withdrawal by Subject|1|||
156834755|NCT03995355|566147226|FG001|Overall Study|Withdrawal by Subject|0|||
156834756|NCT03995355|566147225|FG000|Overall Study|Scheduling Issues|0|||
156834757|NCT03995355|566147226|FG001|Overall Study|Scheduling Issues|1|||
156834758|NCT00249613|566147227|FG000|12 Month Follow-up|Death|1|||
156834759|NCT00249613|566147228|FG001|12 Month Follow-up|Death|1|||
156834760|NCT00249613|566147227|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
156834761|NCT00249613|566147228|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
156834762|NCT00249613|566147227|FG000|12 Month Follow-up|Lost to Follow-up|10|||
156834763|NCT00249613|566147228|FG001|12 Month Follow-up|Lost to Follow-up|8|||
156834764|NCT00094107|566147229|FG000|Overall Study|Lack of Efficacy|23|||
156834765|NCT00094107|566147229|FG000|Overall Study|Death|5|||
156834766|NCT00094107|566147229|FG000|Overall Study|Adverse Event|3|||
156834767|NCT00094107|566147229|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
156834768|NCT00806442|566147254|FG000|Overall Study|Lost to Follow-up|3|||
156834769|NCT00806442|566147255|FG001|Overall Study|Lost to Follow-up|2|||
156834770|NCT00806442|566147254|FG000|Overall Study|Withdrawal by Subject|1|||
156834771|NCT00806442|566147255|FG001|Overall Study|Withdrawal by Subject|5|||
156834772|NCT01455220|566147258|FG000|Overall Study|screen fail|30|||
156834773|NCT00267150|566147259|FG000|Overall Study|Adverse Event|1|||
156834774|NCT00424190|566147261|FG000|Overall Study|Withdrew consent|3|||
156834775|NCT00424190|566147262|FG001|Overall Study|Withdrew consent|4|||
156834776|NCT00424190|566147261|FG000|Overall Study|Death|3|||
156834777|NCT00424190|566147262|FG001|Overall Study|Death|0|||
156834778|NCT00424190|566147261|FG000|Overall Study|Noncompliance|1|||
156834779|NCT00424190|566147262|FG001|Overall Study|Noncompliance|2|||
156834780|NCT00424190|566147261|FG000|Overall Study|Request of sponsor or investigator|0|||
156834781|NCT00424190|566147262|FG001|Overall Study|Request of sponsor or investigator|2|||
156834782|NCT00424190|566147261|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
156834783|NCT00424190|566147262|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
156834784|NCT00424190|566147261|FG000|Overall Study|Other|15|||
156834785|NCT00424190|566147262|FG001|Overall Study|Other|21|||
156834786|NCT00351273|566147263|FG000|Overall Study|Lost to Follow-up|1|||
156834787|NCT00351273|566147264|FG001|Overall Study|Lost to Follow-up|2|||
156834788|NCT00351273|566147265|FG002|Overall Study|Lost to Follow-up|5|||
156834789|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
156834790|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
156834791|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
156834792|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
156834793|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
156885924|NCT02320903|566342381|FG001|Overall Study|Withdrawal by Subject|9|||
156885925|NCT02320903|566342382|FG002|Overall Study|Withdrawal by Subject|9|||
157152277|NCT03952468|567303432|FG001|Overall Study|Physician Decision|0|||
157152278|NCT03952468|567303431|FG000|Overall Study|Lost to Follow-up|3|||
156834794|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
156834795|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
156834796|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
156834797|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
156834798|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834799|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834800|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
156834801|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
157023602|NCT04316871|566841095|FG001|Overall Study|Protocol Violation|2|||
156885926|NCT02320903|566342380|FG000|Overall Study|Exited therapy; no longer eligible|8|||
157152279|NCT03952468|567303432|FG001|Overall Study|Lost to Follow-up|4|||
157152280|NCT03952468|567303431|FG000|Overall Study|Withdrawal by Subject|2|||
156834802|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
156834803|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
156834804|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
156834805|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
156834806|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
156834807|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
156834808|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
156834809|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
156834810|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
156834811|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
156834812|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
156834813|NCT01672866|566147266|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
156834814|NCT01672866|566147267|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
156834815|NCT01672866|566147268|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
156834816|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
156834817|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
156834818|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
156834819|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
156834820|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
156834821|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
156834822|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
156834823|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
156834824|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
156834825|NCT01672866|566147266|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
156834826|NCT01672866|566147267|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
156834827|NCT01672866|566147268|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
156834828|NCT00619489|566147271|FG000|Overall Study|Adverse Event|0|||
156834829|NCT00619489|566147272|FG001|Overall Study|Adverse Event|7|||
156834830|NCT00619489|566147271|FG000|Overall Study|Withdrawal by Subject|1|||
156834831|NCT00619489|566147272|FG001|Overall Study|Withdrawal by Subject|1|||
156834832|NCT00619489|566147271|FG000|Overall Study|Lack of Efficacy|0|||
156834833|NCT00619489|566147272|FG001|Overall Study|Lack of Efficacy|11|||
156834834|NCT00619489|566147271|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
156834835|NCT00619489|566147272|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
156834836|NCT01638559|566147276|FG000|Overall Study|Lost to Follow-up|1|||
156834837|NCT01638559|566147276|FG000|Overall Study|Withdrawal by Subject|1|||
156834838|NCT01638559|566147276|FG000|Overall Study|Subject declined to travel for biopsy|1|||
156834839|NCT02593825|566149229|FG000|Intervention|Lost to Follow-up|10|||
156834840|NCT02593825|566149230|FG001|Intervention|Lost to Follow-up|12|||
156834841|NCT06359080|566149231|FG000|Overall Study|Withdrawal by Subject|3|||
156834842|NCT00511134|566149232|FG000|Overall Study|Withdrawal by Subject|0|||
156834843|NCT00511134|566149233|FG001|Overall Study|Withdrawal by Subject|2|||
156834844|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
156834845|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834846|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834847|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
156834848|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
156834849|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834850|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834851|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
156834852|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
156834853|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834854|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834855|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
156834856|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
156834857|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834858|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834859|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
156834860|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
156834861|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
156834862|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
156885927|NCT02320903|566342381|FG001|Overall Study|Exited therapy; no longer eligible|2|||
156834863|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
156834864|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
156834865|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156834866|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156834867|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
156885928|NCT02320903|566342382|FG002|Overall Study|Exited therapy; no longer eligible|2|||
156834868|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
156834869|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834870|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834871|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
156834872|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
156834873|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834874|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834875|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
156834876|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
156834877|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834878|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834879|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
156834880|NCT02198794|566149234|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
156834881|NCT02198794|566149235|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834882|NCT02198794|566149236|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834883|NCT02198794|566149237|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
156834884|NCT02198794|566149234|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
156834885|NCT02198794|566149235|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
156834886|NCT02198794|566149236|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
156834887|NCT02198794|566149237|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
156834888|NCT02198794|566149234|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
156834889|NCT02198794|566149235|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
156834890|NCT02198794|566149236|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
156834891|NCT02198794|566149237|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
156834892|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834893|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834894|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
156834895|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
156834896|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834897|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834898|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
156834899|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
156834900|NCT02198794|566149234|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834901|NCT02198794|566149235|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834902|NCT02198794|566149236|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
156834903|NCT02198794|566149237|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
156834904|NCT00477152|566149238|FG000|Overall Study|Parent withdrew consent|2|||
156834905|NCT00477152|566149238|FG000|Overall Study|Adverse Event|1|||
156834906|NCT01918332|566149239|FG000|Overall Study|Adverse Event|0|||
156834907|NCT01918332|566149240|FG001|Overall Study|Adverse Event|0|||
156834908|NCT01918332|566149241|FG002|Overall Study|Adverse Event|0|||
156834909|NCT01918332|566149242|FG003|Overall Study|Adverse Event|1|||
156834910|NCT01918332|566149239|FG000|Overall Study|Withdrawal by Subject|2|||
156834911|NCT01918332|566149240|FG001|Overall Study|Withdrawal by Subject|3|||
156834912|NCT01918332|566149241|FG002|Overall Study|Withdrawal by Subject|2|||
156834913|NCT01918332|566149242|FG003|Overall Study|Withdrawal by Subject|3|||
156834914|NCT01918332|566149239|FG000|Overall Study|Protocol Violation|6|||
156834915|NCT01918332|566149240|FG001|Overall Study|Protocol Violation|2|||
156834916|NCT01918332|566149241|FG002|Overall Study|Protocol Violation|6|||
156834917|NCT01918332|566149242|FG003|Overall Study|Protocol Violation|3|||
156834918|NCT01918332|566149239|FG000|Overall Study|lipid result by central lab did not meet|0|||
156834919|NCT01918332|566149240|FG001|Overall Study|lipid result by central lab did not meet|0|||
157152281|NCT03952468|567303432|FG001|Overall Study|Withdrawal by Subject|1|||
157152282|NCT04964063|567303433|FG000|Overall Study|Adverse Event|4|||
156834920|NCT01918332|566149241|FG002|Overall Study|lipid result by central lab did not meet|1|||
156834921|NCT01918332|566149242|FG003|Overall Study|lipid result by central lab did not meet|0|||
156834922|NCT00483041|566149245|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
156834923|NCT00483041|566149246|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
156834924|NCT02648217|566149249|FG000|Overall Study|Adverse Event|0|||
156834925|NCT02648217|566149250|FG001|Overall Study|Adverse Event|1|||
157152283|NCT04964063|567303433|FG000|Overall Study|Lost to Follow-up|47|||
157152284|NCT04964063|567303433|FG000|Overall Study|Withdrawal by Subject|5|||
157152285|NCT04964063|567303433|FG000|Overall Study|Baseline Tasks Expired|41|||
157152286|NCT04964063|567303433|FG000|Overall Study|Participant withdrawn in error|1|||
157152287|NCT01702363|567303436|FG000|Overall Study|Adverse Event|14|||
156834926|NCT02648217|566149249|FG000|Overall Study|Lost to Follow-up|1|||
156834927|NCT02648217|566149250|FG001|Overall Study|Lost to Follow-up|1|||
156834928|NCT02648217|566149249|FG000|Overall Study|Withdrawal by Subject|4|||
156834929|NCT02648217|566149250|FG001|Overall Study|Withdrawal by Subject|3|||
156834930|NCT02648217|566149249|FG000|Overall Study|Unclassified|5|||
156834931|NCT02648217|566149250|FG001|Overall Study|Unclassified|0|||
157152288|NCT01702363|567303436|FG000|Overall Study|Lack of Efficacy|4|||
156834932|NCT00316888|566149253|FG000|Overall Study|Adverse Event|4|||
156834933|NCT00316888|566149254|FG001|Overall Study|Adverse Event|5|||
156834934|NCT00316888|566149253|FG000|Overall Study|Withdrawal by Subject|2|||
156834935|NCT00316888|566149254|FG001|Overall Study|Withdrawal by Subject|2|||
156834936|NCT00316888|566149253|FG000|Overall Study|Not start protocol therapy|0|||
156834937|NCT00316888|566149254|FG001|Overall Study|Not start protocol therapy|1|||
156834938|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
156834939|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
156834940|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
156834941|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
156834942|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
156834943|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
156834944|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
156834945|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
156834946|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
156834947|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
156834948|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
156834949|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
156834950|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
156834951|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
156834952|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
156834953|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
156834954|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
156834955|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
156834956|NCT01302054|566149255|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
156834957|NCT01302054|566149256|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
156834958|NCT01302054|566149257|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
156834959|NCT01302054|566149255|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
156834960|NCT01302054|566149256|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
156834961|NCT01302054|566149257|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
156834962|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
156834963|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
156834964|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
156834965|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
156834966|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
156834967|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156834968|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
156834969|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
156834970|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
156834971|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
156834972|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
156834973|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
156834974|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
156834975|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
156834976|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
156834977|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
156834978|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
156834979|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
156834980|NCT01302054|566149255|FG000|Double-Blind Treatment Phase|Other|0|||
156834981|NCT01302054|566149256|FG001|Double-Blind Treatment Phase|Other|4|||
156834982|NCT01302054|566149257|FG002|Double-Blind Treatment Phase|Other|9|||
156834983|NCT02713867|566149258|FG000|Randomization|Other Reason|2|||
156834984|NCT02713867|566149259|FG001|Randomization|Other Reason|1|||
156834985|NCT02713867|566149258|FG000|Randomization|Participant Withdrew consent|0|||
156834986|NCT02713867|566149259|FG001|Randomization|Participant Withdrew consent|2|||
156834987|NCT02713867|566149258|FG000|Treatment Period|Other Reasons|22|||
156834988|NCT02713867|566149259|FG001|Treatment Period|Other Reasons|28|||
156834989|NCT02713867|566149258|FG000|Treatment Period|Administrative reason by sponsor|21|||
156834990|NCT02713867|566149259|FG001|Treatment Period|Administrative reason by sponsor|16|||
156834991|NCT02713867|566149258|FG000|Treatment Period|No longer meets study criteria|2|||
156834992|NCT02713867|566149259|FG001|Treatment Period|No longer meets study criteria|1|||
156834993|NCT02713867|566149258|FG000|Treatment Period|Poor/Non Compliance|1|||
156834994|NCT02713867|566149259|FG001|Treatment Period|Poor/Non Compliance|0|||
156834995|NCT02713867|566149258|FG000|Treatment Period|Maximum Clinical Benefit|5|||
156834996|NCT02713867|566149259|FG001|Treatment Period|Maximum Clinical Benefit|6|||
156834997|NCT02713867|566149258|FG000|Treatment Period|Withdrew consent|3|||
156834998|NCT02713867|566149259|FG001|Treatment Period|Withdrew consent|6|||
156834999|NCT02713867|566149258|FG000|Treatment Period|Requested to Discontinue|8|||
156835000|NCT02713867|566149259|FG001|Treatment Period|Requested to Discontinue|8|||
156885929|NCT02320903|566342380|FG000|Overall Study|Lost to Follow-up|0|||
157152289|NCT01702363|567303436|FG000|Overall Study|Withdrawal by Subject|2|||
157152290|NCT01312428|567303437|FG000|Overall Study|Study Termination|3|||
157152291|NCT01312428|567303438|FG001|Overall Study|Study Termination|4|||
156835001|NCT02713867|566149258|FG000|Treatment Period|AE unrelated to Study Drug|11|||
156835002|NCT02713867|566149259|FG001|Treatment Period|AE unrelated to Study Drug|10|||
156835003|NCT02713867|566149258|FG000|Treatment Period|Death|7|||
156835004|NCT02713867|566149259|FG001|Treatment Period|Death|3|||
156835005|NCT02713867|566149258|FG000|Treatment Period|Study Drug Toxicity|16|||
156835006|NCT02713867|566149259|FG001|Treatment Period|Study Drug Toxicity|19|||
156835007|NCT02713867|566149258|FG000|Treatment Period|Disease Progression|82|||
156835008|NCT02713867|566149259|FG001|Treatment Period|Disease Progression|83|||
156835009|NCT00857948|566149260|FG000|Overall Study|Withdrawal by Subject|2|||
156835010|NCT00857948|566149261|FG001|Overall Study|Withdrawal by Subject|0|||
156835011|NCT00857948|566149262|FG002|Overall Study|Withdrawal by Subject|0|||
156835012|NCT00857948|566149263|FG003|Overall Study|Withdrawal by Subject|0|||
156835013|NCT00857948|566149260|FG000|Overall Study|Protocol Violation|1|||
156835014|NCT00857948|566149261|FG001|Overall Study|Protocol Violation|0|||
156835015|NCT00857948|566149262|FG002|Overall Study|Protocol Violation|1|||
156835016|NCT00857948|566149263|FG003|Overall Study|Protocol Violation|0|||
156835017|NCT02715726|566149264|FG000|Overall Study|Adverse Event|2|||
156835018|NCT02715726|566149265|FG001|Overall Study|Adverse Event|6|||
156835019|NCT02715726|566149264|FG000|Overall Study|Protocol Violation|1|||
156835020|NCT02715726|566149265|FG001|Overall Study|Protocol Violation|0|||
156835021|NCT02715726|566149264|FG000|Overall Study|Death|2|||
156835022|NCT02715726|566149265|FG001|Overall Study|Death|1|||
156835023|NCT02715726|566149264|FG000|Overall Study|Participant moved|1|||
156835024|NCT02715726|566149265|FG001|Overall Study|Participant moved|3|||
156835025|NCT02715726|566149264|FG000|Overall Study|Other than specified above|11|||
156835026|NCT02715726|566149265|FG001|Overall Study|Other than specified above|15|||
156835027|NCT02715726|566149264|FG000|Overall Study|Randomized but not treated|1|||
156835028|NCT02715726|566149265|FG001|Overall Study|Randomized but not treated|2|||
156835029|NCT03230292|566149268|FG000|Overall Study|Adverse Event|1|||
156835030|NCT03230292|566149268|FG000|Overall Study|Protocol Violation|1|||
156835031|NCT03230292|566149268|FG000|Overall Study|Lost to Follow-up|1|||
156835032|NCT03230292|566149268|FG000|Overall Study|Withdrawal by Subject|3|||
156835033|NCT02855944|566149269|FG000|Period 1: Treatment|Ongoing|14|||
156835034|NCT02855944|566149270|FG001|Period 1: Treatment|Ongoing|0|||
156835035|NCT02855944|566149269|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
156835036|NCT02855944|566149270|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
156835037|NCT02855944|566149269|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
156835038|NCT02855944|566149270|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
156835039|NCT03262116|566149274|FG000|Overall Study|Physician Decision|0|||
156835040|NCT03262116|566149275|FG001|Overall Study|Physician Decision|2|||
156835041|NCT03262116|566149276|FG002|Overall Study|Physician Decision|1|||
156835042|NCT03262116|566149277|FG003|Overall Study|Physician Decision|1|||
156835043|NCT03262116|566149278|FG004|Overall Study|Physician Decision|1|||
156835044|NCT03262116|566149279|FG005|Overall Study|Physician Decision|2|||
156835045|NCT02365285|566149280|FG000|Overall Study|Physician Decision|0|||
156835046|NCT02365285|566149281|FG001|Overall Study|Physician Decision|1|||
156835047|NCT02365285|566149282|FG002|Overall Study|Physician Decision|1|||
156835048|NCT02365285|566149283|FG003|Overall Study|Physician Decision|0|||
156835049|NCT02365285|566149280|FG000|Overall Study|Adverse Event|0|||
156835050|NCT02365285|566149281|FG001|Overall Study|Adverse Event|0|||
156835051|NCT02365285|566149282|FG002|Overall Study|Adverse Event|0|||
156835052|NCT02365285|566149283|FG003|Overall Study|Adverse Event|2|||
156835053|NCT02608450|566149289|FG000|Overall Study|Lost to Follow-up|39|||
156835054|NCT02608450|566149290|FG001|Overall Study|Lost to Follow-up|32|||
156835055|NCT02608450|566149289|FG000|Overall Study|Withdrawal by Subject|21|||
156835056|NCT02608450|566149290|FG001|Overall Study|Withdrawal by Subject|15|||
156835057|NCT02608450|566149289|FG000|Overall Study|Adverse Event|3|||
156835058|NCT02608450|566149290|FG001|Overall Study|Adverse Event|6|||
156835059|NCT02608450|566149289|FG000|Overall Study|Withdrawal by parent|2|||
156835060|NCT02608450|566149290|FG001|Overall Study|Withdrawal by parent|3|||
156835061|NCT02608450|566149289|FG000|Overall Study|Lack of Efficacy|0|||
156835062|NCT02608450|566149290|FG001|Overall Study|Lack of Efficacy|3|||
156835063|NCT02608450|566149289|FG000|Overall Study|Noncompliance with study drug|0|||
156835064|NCT02608450|566149290|FG001|Overall Study|Noncompliance with study drug|2|||
156835065|NCT02608450|566149289|FG000|Overall Study|Physician Decision|0|||
156835066|NCT02608450|566149290|FG001|Overall Study|Physician Decision|1|||
156835067|NCT02608450|566149289|FG000|Overall Study|Pregnancy|0|||
156835068|NCT02608450|566149290|FG001|Overall Study|Pregnancy|1|||
156835069|NCT02608450|566149289|FG000|Overall Study|Progressive disease|1|||
156835070|NCT02608450|566149290|FG001|Overall Study|Progressive disease|0|||
156835071|NCT02608450|566149289|FG000|Overall Study|Multiple reasons|0|||
156835072|NCT02608450|566149290|FG001|Overall Study|Multiple reasons|2|||
156835073|NCT00635089|566149292|FG000|Overall Study|Adverse Event|7|||
156835074|NCT00635089|566149292|FG000|Overall Study|Lack of Efficacy|28|||
156835075|NCT00635089|566149292|FG000|Overall Study|Protocol Deviation|4|||
156835076|NCT00635089|566149292|FG000|Overall Study|Lost to Follow-up|8|||
156835077|NCT00635089|566149292|FG000|Overall Study|Other|31|||
156835078|NCT01617447|566149293|FG000|Overall Study|Adverse Event|0|||
156835079|NCT01617447|566149294|FG001|Overall Study|Adverse Event|1|||
156835080|NCT01617447|566149293|FG000|Overall Study|Physician Decision|0|||
156835081|NCT01617447|566149294|FG001|Overall Study|Physician Decision|2|||
156835082|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
156835083|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
156835084|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
156835085|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
156835086|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
156835087|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
156835088|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
156835089|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
156835090|NCT02636946|566149296|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
156835091|NCT02636946|566149297|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
156835092|NCT02636946|566149296|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
156835093|NCT02636946|566149297|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
156835094|NCT01283542|566149298|FG000|Main Phase|Acute or progressive vision loss|1|||
156835095|NCT01283542|566149298|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
156835096|NCT01283542|566149298|FG000|Main Phase|abnormal laboratory values|5|||
156835097|NCT01283542|566149298|FG000|Extension Phase|Physician Decision|1|||
156835098|NCT01283542|566149298|FG000|Extension Phase|Adverse Event|1|||
156835099|NCT01283542|566149298|FG000|Extension Phase|Administrative problems|1|||
156835100|NCT05059977|566149299|FG000|Overall Study|Withdrawal by Subject|0|||
156835101|NCT05059977|566149300|FG001|Overall Study|Withdrawal by Subject|0|||
156835102|NCT05059977|566149301|FG002|Overall Study|Withdrawal by Subject|1|||
156835103|NCT00576472|566149302|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835104|NCT00576472|566149303|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835105|NCT00576472|566149304|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835106|NCT00576472|566149305|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
156835107|NCT00576472|566149306|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835108|NCT00576472|566149307|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835109|NCT00576472|566149308|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835110|NCT00576472|566149309|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835111|NCT00576472|566149310|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835112|NCT00576472|566149311|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835113|NCT00576472|566149312|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835114|NCT00576472|566149313|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835115|NCT00576472|566149314|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835116|NCT00576472|566149315|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835117|NCT00576472|566149316|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
156835118|NCT00576472|566149302|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
156835119|NCT00576472|566149303|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
156835120|NCT00576472|566149304|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
156835121|NCT00576472|566149305|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
156835122|NCT00576472|566149306|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
156835123|NCT00576472|566149307|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
156835124|NCT00576472|566149308|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
156835125|NCT00576472|566149309|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
156835126|NCT00576472|566149310|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
156835127|NCT00576472|566149311|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
156835128|NCT00576472|566149312|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
156835129|NCT00576472|566149313|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
156835130|NCT00576472|566149314|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
156835131|NCT00576472|566149315|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
156835132|NCT00576472|566149316|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
156835133|NCT00576472|566149302|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835134|NCT00576472|566149303|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835135|NCT00576472|566149304|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835136|NCT00576472|566149305|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
156835137|NCT00576472|566149306|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835138|NCT00576472|566149307|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835139|NCT00576472|566149308|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835140|NCT00576472|566149309|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835141|NCT00576472|566149310|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835142|NCT00576472|566149311|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835143|NCT00576472|566149312|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835144|NCT00576472|566149313|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835145|NCT00576472|566149314|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835146|NCT00576472|566149315|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835147|NCT00576472|566149316|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
156835148|NCT00576472|566149302|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
156835149|NCT00576472|566149303|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
156835150|NCT00576472|566149304|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
156835151|NCT00576472|566149305|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
156835152|NCT00576472|566149306|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
156835153|NCT00576472|566149307|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
156835154|NCT00576472|566149308|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
156835155|NCT00576472|566149309|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
156835156|NCT00576472|566149310|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
156835157|NCT00576472|566149311|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
156835158|NCT00576472|566149312|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
156835159|NCT00576472|566149313|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
156835160|NCT00576472|566149314|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
156835161|NCT00576472|566149315|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
156835162|NCT00576472|566149316|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
156835163|NCT00576472|566149302|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835164|NCT00576472|566149303|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835165|NCT00576472|566149304|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835166|NCT00576472|566149305|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
157152292|NCT00431847|567303444|FG000|Overall Study|completion of less than two study visits|6|||
157152293|NCT00431847|567303445|FG001|Overall Study|completion of less than two study visits|3|||
156835167|NCT00576472|566149306|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835168|NCT00576472|566149307|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835169|NCT00576472|566149308|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835170|NCT00576472|566149309|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835171|NCT00576472|566149310|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835172|NCT00576472|566149311|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835173|NCT00576472|566149312|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835174|NCT00576472|566149313|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835175|NCT00576472|566149314|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835176|NCT00576472|566149315|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835177|NCT00576472|566149316|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
156835178|NCT00576472|566149302|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
156885930|NCT02320903|566342381|FG001|Overall Study|Lost to Follow-up|5|||
156885931|NCT02320903|566342382|FG002|Overall Study|Lost to Follow-up|5|||
156885932|NCT03811093|566342399|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
156885933|NCT03811093|566342400|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
156885934|NCT03811093|566342399|FG000|Overall Study|Unable to measure body fat percentage|2|||
156885935|NCT03811093|566342400|FG001|Overall Study|Unable to measure body fat percentage|0|||
156885936|NCT01095094|566342402|FG000|Overall Study|Withdrawal by Subject|1|||
156885937|NCT01095094|566342402|FG000|Overall Study|Death|1|||
156885938|NCT01095094|566342402|FG000|Overall Study|Physician Decision|1|||
156885939|NCT00464490|566342403|FG000|Overall Study|Physician Decision|11|||
156885940|NCT00464490|566342404|FG001|Overall Study|Physician Decision|11|||
156885941|NCT03188042|566342407|FG000|Overall Study|Withdrawal by Subject|1|||
156885942|NCT03188042|566342408|FG001|Overall Study|Withdrawal by Subject|1|||
156885943|NCT00137839|566342415|FG000|Overall Study|Adverse Event|7|||
156885944|NCT00137839|566342415|FG000|Overall Study|Physician Decision|7|||
156885945|NCT00137839|566342415|FG000|Overall Study|Death|8|||
156885946|NCT00137839|566342415|FG000|Overall Study|Disease Progression|60|||
156885947|NCT00137839|566342415|FG000|Overall Study|Not Start Treatment|1|||
156885948|NCT00137839|566342415|FG000|Overall Study|Prolonged Treatment Delay|1|||
156885949|NCT02446743|566342420|FG000|Overall Study|Withdrawal by Subject|1|||
156885950|NCT02446743|566342421|FG001|Overall Study|Withdrawal by Subject|1|||
156885951|NCT02446743|566342420|FG000|Overall Study|Lost to Follow-up|1|||
156885952|NCT02446743|566342421|FG001|Overall Study|Lost to Follow-up|0|||
156885953|NCT02446743|566342420|FG000|Overall Study|Adverse Event|1|||
156885954|NCT02446743|566342421|FG001|Overall Study|Adverse Event|1|||
156885955|NCT02446743|566342420|FG000|Overall Study|Other|2|||
156885956|NCT02446743|566342421|FG001|Overall Study|Other|3|||
156885957|NCT03086967|566342422|FG000|Overall Study|Screen Failure|2|||
156885958|NCT03086967|566342423|FG001|Overall Study|Screen Failure|2|||
156885959|NCT01475071|566342425|FG000|Overall Study|Physician Decision|1|||
156885960|NCT01475071|566342425|FG000|Overall Study|Withdrawal by Subject|6|||
157152294|NCT00431847|567303446|FG002|Overall Study|completion of less than two study visits|4|||
157152295|NCT00431847|567303447|FG003|Overall Study|completion of less than two study visits|14|||
156885961|NCT01475071|566342425|FG000|Overall Study|Lost to Follow-up|1|||
156885962|NCT01752036|566342426|FG000|Overall Study|Death|2|||
156885963|NCT02230527|566342427|FG000|Overall Study|Withdrawal by Subject|1|||
156835179|NCT00576472|566149303|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835180|NCT00576472|566149304|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
156885964|NCT02230527|566342428|FG001|Overall Study|Withdrawal by Subject|1|||
156885965|NCT02230527|566342427|FG000|Overall Study|Death|1|||
156835181|NCT00576472|566149305|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835182|NCT00576472|566149306|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835183|NCT00576472|566149307|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835184|NCT00576472|566149308|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
156835185|NCT00576472|566149309|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835186|NCT00576472|566149310|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835187|NCT00576472|566149311|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835188|NCT00576472|566149312|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835189|NCT00576472|566149313|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835190|NCT00576472|566149314|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835191|NCT00576472|566149315|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835192|NCT00576472|566149316|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
156835193|NCT00576472|566149302|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
156835194|NCT00576472|566149303|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
156835195|NCT00576472|566149304|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
156835196|NCT00576472|566149305|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
156835197|NCT00576472|566149306|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
156835198|NCT00576472|566149307|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
157023603|NCT04316871|566841096|FG002|Overall Study|Protocol Violation|2|||
157023604|NCT04316871|566841097|FG003|Overall Study|Protocol Violation|2|||
156835199|NCT00576472|566149308|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
156835200|NCT00576472|566149309|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
156835201|NCT00576472|566149310|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
156835202|NCT00576472|566149311|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
156835203|NCT00576472|566149312|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
156835204|NCT00576472|566149313|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
156835205|NCT00576472|566149314|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
156835206|NCT00576472|566149315|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
156835207|NCT00576472|566149316|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
156835208|NCT00576472|566149302|FG000|MPH Cross Over Phase|Physician Decision|0|||
156835209|NCT00576472|566149303|FG001|MPH Cross Over Phase|Physician Decision|0|||
156835210|NCT00576472|566149304|FG002|MPH Cross Over Phase|Physician Decision|0|||
156835211|NCT00576472|566149305|FG003|MPH Cross Over Phase|Physician Decision|0|||
156835212|NCT00576472|566149306|FG004|MPH Cross Over Phase|Physician Decision|0|||
156835213|NCT00576472|566149307|FG005|MPH Cross Over Phase|Physician Decision|0|||
156835214|NCT00576472|566149308|FG006|MPH Cross Over Phase|Physician Decision|4|||
156835215|NCT00576472|566149309|FG007|MPH Cross Over Phase|Physician Decision|0|||
156835216|NCT00576472|566149310|FG008|MPH Cross Over Phase|Physician Decision|0|||
156835217|NCT00576472|566149311|FG009|MPH Cross Over Phase|Physician Decision|0|||
156835218|NCT00576472|566149312|FG010|MPH Cross Over Phase|Physician Decision|0|||
156835219|NCT00576472|566149313|FG011|MPH Cross Over Phase|Physician Decision|0|||
156835220|NCT00576472|566149314|FG012|MPH Cross Over Phase|Physician Decision|0|||
156835221|NCT00576472|566149315|FG013|MPH Cross Over Phase|Physician Decision|0|||
156835222|NCT00576472|566149316|FG014|MPH Cross Over Phase|Physician Decision|0|||
156835223|NCT00576472|566149302|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835224|NCT00576472|566149303|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835225|NCT00576472|566149304|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835226|NCT00576472|566149305|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835227|NCT00576472|566149306|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835228|NCT00576472|566149307|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835229|NCT00576472|566149308|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835230|NCT00576472|566149309|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835231|NCT00576472|566149310|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
156835232|NCT00576472|566149311|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835233|NCT00576472|566149312|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
156835234|NCT00576472|566149313|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
156835235|NCT00576472|566149314|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835236|NCT00576472|566149315|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835237|NCT00576472|566149316|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
156835238|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835239|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835240|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
157023605|NCT04650269|566841098|FG000|Overall Study|Death|3|||
157023606|NCT04650269|566841098|FG000|Overall Study|Lost to Follow-up|6|||
157023607|NCT01437709|566841099|FG000|Overall Study|Adverse Event|0|||
156835241|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835242|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835243|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835244|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835245|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835246|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835247|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835248|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835249|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835250|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835251|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
156835252|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
156835253|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
156835254|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
156835255|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
156835256|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
156835257|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
156835258|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
156835259|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
156835260|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
156835261|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
156835262|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
156835263|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
156835264|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
156835265|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
156835266|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
156835267|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
156835268|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
156835269|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
156835270|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
156835271|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
156835272|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
156835273|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
156835274|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
156835275|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
156835276|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
156835277|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
156835278|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
156835279|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
156835280|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
156835281|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
156835282|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
156835283|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Side effects|0|||
156835284|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Side effects|0|||
156835285|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Side effects|0|||
156835286|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Side effects|0|||
156835287|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Side effects|0|||
156835288|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Side effects|0|||
156835289|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Side effects|0|||
156835290|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Side effects|0|||
156835291|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Side effects|0|||
156835292|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Side effects|0|||
156835293|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Side effects|0|||
156835294|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Side effects|0|||
156835295|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Side effects|0|||
156835296|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Side effects|0|||
156835297|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Side effects|8|||
156835298|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835299|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835300|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835301|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835302|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835303|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835304|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835305|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835306|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835307|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835308|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835309|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835310|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835311|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
156835312|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
156835313|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
156835314|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
156885966|NCT02230527|566342428|FG001|Overall Study|Death|0|||
156835315|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
156835316|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
156835317|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
156835318|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
156835319|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
156835320|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
156835321|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
156835322|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
156835323|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
156835324|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
156835325|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
156835326|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
156835327|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
156835328|NCT00576472|566149302|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835329|NCT00576472|566149303|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835330|NCT00576472|566149304|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835331|NCT00576472|566149305|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835332|NCT00576472|566149306|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835333|NCT00576472|566149307|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835334|NCT00576472|566149308|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835335|NCT00576472|566149309|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835336|NCT00576472|566149310|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835337|NCT00576472|566149311|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835338|NCT00576472|566149312|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835339|NCT00576472|566149313|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835340|NCT00576472|566149314|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835341|NCT00576472|566149315|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
156835342|NCT00576472|566149316|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
156835343|NCT04405245|566149317|FG000|Overall Study|Adverse Event|0|||
156835344|NCT04405245|566149318|FG001|Overall Study|Adverse Event|1|||
156835345|NCT04405245|566149319|FG002|Overall Study|Adverse Event|0|||
156835346|NCT03443427|566149321|FG000|Overall Study|Adverse Event|2|||
156835347|NCT03443427|566149322|FG001|Overall Study|Adverse Event|3|||
156835348|NCT03443427|566149321|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
156835349|NCT03443427|566149322|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
156835350|NCT03443427|566149321|FG000|Overall Study|Other|4|||
156835351|NCT03443427|566149322|FG001|Overall Study|Other|6|||
156835352|NCT02576860|566149325|FG000|Overall Study|Adverse Event|6|||
156835353|NCT02576860|566149326|FG001|Overall Study|Adverse Event|6|||
156835354|NCT02576860|566149325|FG000|Overall Study|Lost to Follow-up|5|||
156835355|NCT02576860|566149326|FG001|Overall Study|Lost to Follow-up|7|||
156835356|NCT02576860|566149325|FG000|Overall Study|Physician Decision|0|||
156835357|NCT02576860|566149326|FG001|Overall Study|Physician Decision|1|||
156835358|NCT02576860|566149325|FG000|Overall Study|Protocol Violation|0|||
156835359|NCT02576860|566149326|FG001|Overall Study|Protocol Violation|2|||
156835360|NCT02576860|566149325|FG000|Overall Study|Withdrawal by Subject|13|||
156835361|NCT02576860|566149326|FG001|Overall Study|Withdrawal by Subject|8|||
156835362|NCT02576860|566149325|FG000|Overall Study|Disallowed medication|1|||
156835363|NCT02576860|566149326|FG001|Overall Study|Disallowed medication|0|||
156835364|NCT00780273|566149327|FG000|Overall Study|Death|1|||
156835365|NCT00780273|566149327|FG000|Overall Study|Lost to Follow-up|1|||
156835366|NCT00477269|566149328|FG000|Core Study|Adverse Event|6|||
156835367|NCT00477269|566149329|FG001|Core Study|Adverse Event|4|||
156835368|NCT00477269|566149330|FG002|Core Study|Adverse Event|0|||
156835369|NCT00477269|566149328|FG000|Core Study|Death|3|||
156835370|NCT00477269|566149329|FG001|Core Study|Death|3|||
156835371|NCT00477269|566149330|FG002|Core Study|Death|0|||
156835372|NCT00477269|566149328|FG000|Core Study|Withdrawn Consent|0|||
156835373|NCT00477269|566149329|FG001|Core Study|Withdrawn Consent|1|||
156835374|NCT00477269|566149330|FG002|Core Study|Withdrawn Consent|0|||
156835375|NCT00477269|566149328|FG000|Open Label Extension|Adverse Event|0|||
156835376|NCT00477269|566149329|FG001|Open Label Extension|Adverse Event|0|||
156835377|NCT00477269|566149330|FG002|Open Label Extension|Adverse Event|4|||
156835378|NCT00477269|566149328|FG000|Open Label Extension|Abnormal laboratory values|0|||
156835379|NCT00477269|566149329|FG001|Open Label Extension|Abnormal laboratory values|0|||
156835380|NCT00477269|566149330|FG002|Open Label Extension|Abnormal laboratory values|1|||
156835381|NCT00477269|566149328|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
156835382|NCT00477269|566149329|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
156835383|NCT00477269|566149330|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
156835384|NCT00477269|566149328|FG000|Open Label Extension|Adminiatrative problems|0|||
156835385|NCT00477269|566149329|FG001|Open Label Extension|Adminiatrative problems|0|||
156835386|NCT00477269|566149330|FG002|Open Label Extension|Adminiatrative problems|2|||
156835387|NCT00477269|566149328|FG000|Open Label Extension|Death|0|||
156835388|NCT00477269|566149329|FG001|Open Label Extension|Death|0|||
156885967|NCT02230527|566342427|FG000|Overall Study|Lost to Follow-up|2|||
156835389|NCT00477269|566149330|FG002|Open Label Extension|Death|4|||
156835390|NCT01792518|566149333|FG000|Overall Study|Adverse Event|3|||
156835391|NCT01792518|566149334|FG001|Overall Study|Adverse Event|4|||
156835392|NCT01792518|566149333|FG000|Overall Study|Protocol Violation|0|||
156835393|NCT01792518|566149334|FG001|Overall Study|Protocol Violation|1|||
156835394|NCT01792518|566149333|FG000|Overall Study|Lost to Follow-up|3|||
156835395|NCT01792518|566149334|FG001|Overall Study|Lost to Follow-up|1|||
156835396|NCT01792518|566149333|FG000|Overall Study|Withdrawal by Subject|2|||
156835397|NCT01792518|566149334|FG001|Overall Study|Withdrawal by Subject|0|||
156835398|NCT01792518|566149333|FG000|Overall Study|Other Reason|0|||
156835399|NCT01792518|566149334|FG001|Overall Study|Other Reason|1|||
156835400|NCT01504204|566149337|FG000|Overall Study|Lost to Follow-up|1|||
156835401|NCT01504204|566149338|FG001|Overall Study|Lost to Follow-up|1|||
156835402|NCT00654004|566149347|FG000|Overall Study|Lost to Follow-up|1|||
156835403|NCT00654004|566149348|FG001|Overall Study|Lost to Follow-up|0|||
156835404|NCT01571453|566149351|FG000|Overall Study|Adverse Event|14|||
156835405|NCT01571453|566149352|FG001|Overall Study|Adverse Event|32|||
156835406|NCT01571453|566149351|FG000|Overall Study|Lack of Efficacy|8|||
156835407|NCT01571453|566149352|FG001|Overall Study|Lack of Efficacy|3|||
156835408|NCT01571453|566149351|FG000|Overall Study|Non-compliance|2|||
156835409|NCT01571453|566149352|FG001|Overall Study|Non-compliance|4|||
156835410|NCT01571453|566149351|FG000|Overall Study|Protocol Violation|1|||
156835411|NCT01571453|566149352|FG001|Overall Study|Protocol Violation|5|||
156835412|NCT01571453|566149351|FG000|Overall Study|Withdrawal of consent|5|||
156835413|NCT01571453|566149352|FG001|Overall Study|Withdrawal of consent|13|||
156835414|NCT01571453|566149351|FG000|Overall Study|Lost to Follow-up|4|||
156835415|NCT01571453|566149352|FG001|Overall Study|Lost to Follow-up|2|||
156835416|NCT01571453|566149351|FG000|Overall Study|Administrative or other reason(s)|4|||
156835417|NCT01571453|566149352|FG001|Overall Study|Administrative or other reason(s)|3|||
156835418|NCT00444067|566149356|FG000|Overall Study|Lost to Follow-up|0|||
156835419|NCT00444067|566149357|FG001|Overall Study|Lost to Follow-up|1|||
156835420|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835421|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
156835422|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835423|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835424|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835425|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835426|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835427|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835428|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835429|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835430|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835431|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835432|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835433|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835434|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835435|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835436|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835437|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835438|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
156835439|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835440|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835441|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835442|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
156835443|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835444|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
156835445|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835446|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
156835447|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835448|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835449|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835450|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835451|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835452|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835453|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835454|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835455|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835456|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156885968|NCT02230527|566342428|FG001|Overall Study|Lost to Follow-up|1|||
156835457|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
156835458|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835459|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835460|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
156835461|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835462|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
156835463|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835464|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
156835465|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
156835466|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835467|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835468|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835469|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835470|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835471|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835472|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835473|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835474|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835475|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835476|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
156835477|NCT02528357|566149358|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835478|NCT02528357|566149359|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835479|NCT02528357|566149360|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835480|NCT02528357|566149361|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835481|NCT02528357|566149362|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835482|NCT02528357|566149363|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835483|NCT02528357|566149364|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835484|NCT02528357|566149365|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835485|NCT02528357|566149366|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156885969|NCT02230527|566342427|FG000|Overall Study|Other|1|||
156885970|NCT02230527|566342428|FG001|Overall Study|Other|0|||
156885971|NCT05027971|566342439|FG000|Overall Study|Physician Decision|7|||
156885972|NCT05027971|566342440|FG001|Overall Study|Physician Decision|3|||
156885973|NCT05027971|566342439|FG000|Overall Study|Lost to Follow-up|1|||
156885974|NCT05027971|566342440|FG001|Overall Study|Lost to Follow-up|1|||
156885975|NCT05027971|566342439|FG000|Overall Study|Withdrawal by Subject|0|||
156885976|NCT05027971|566342440|FG001|Overall Study|Withdrawal by Subject|2|||
156885977|NCT05027971|566342439|FG000|Overall Study|Non-study fiber used.|0|||
156885978|NCT05027971|566342440|FG001|Overall Study|Non-study fiber used.|1|||
156885979|NCT05027971|566342439|FG000|Overall Study|Protocol Violation|0|||
156885980|NCT05027971|566342440|FG001|Overall Study|Protocol Violation|2|||
156885981|NCT02025556|566342441|FG000|Overall Study|Adverse Event|0|||
156885982|NCT02025556|566342442|FG001|Overall Study|Adverse Event|4|||
156885983|NCT02025556|566342443|FG002|Overall Study|Adverse Event|2|||
156885984|NCT02025556|566342441|FG000|Overall Study|Lack of Efficacy|2|||
156885985|NCT02025556|566342442|FG001|Overall Study|Lack of Efficacy|1|||
156885986|NCT02025556|566342443|FG002|Overall Study|Lack of Efficacy|0|||
156885987|NCT02025556|566342441|FG000|Overall Study|Protocol Violation|2|||
156885988|NCT02025556|566342442|FG001|Overall Study|Protocol Violation|1|||
156885989|NCT02025556|566342443|FG002|Overall Study|Protocol Violation|0|||
156885990|NCT02025556|566342441|FG000|Overall Study|Withdrawal by Subject|0|||
156885991|NCT02025556|566342442|FG001|Overall Study|Withdrawal by Subject|3|||
156885992|NCT02025556|566342443|FG002|Overall Study|Withdrawal by Subject|6|||
156885993|NCT02025556|566342441|FG000|Overall Study|Lost to Follow-up|2|||
156885994|NCT02025556|566342442|FG001|Overall Study|Lost to Follow-up|4|||
156885995|NCT02025556|566342443|FG002|Overall Study|Lost to Follow-up|0|||
156885996|NCT02025556|566342441|FG000|Overall Study|Reason not reported|0|||
156885997|NCT02025556|566342442|FG001|Overall Study|Reason not reported|0|||
156885998|NCT02025556|566342443|FG002|Overall Study|Reason not reported|1|||
156885999|NCT00627445|566342445|FG000|Overall Study|Adverse Event|3|||
156886000|NCT00627445|566342446|FG001|Overall Study|Adverse Event|3|||
156886001|NCT00627445|566342445|FG000|Overall Study|Lack of Efficacy|0|||
156886002|NCT00627445|566342446|FG001|Overall Study|Lack of Efficacy|1|||
156886003|NCT00627445|566342445|FG000|Overall Study|Other|6|||
156886004|NCT00627445|566342446|FG001|Overall Study|Other|8|||
156886005|NCT01238588|566342448|FG000|Overall Study|Withdrawal by Subject|1|||
156886006|NCT01238588|566342448|FG000|Overall Study|Physician Decision|2|||
156886007|NCT00796991|566342452|FG000|Overall Study|Adverse Event|0|||
156886008|NCT00796991|566342453|FG001|Overall Study|Adverse Event|0|||
156835486|NCT02528357|566149367|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835487|NCT02528357|566149368|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835488|NCT02528357|566149369|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835489|NCT02528357|566149370|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835490|NCT02528357|566149371|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835491|NCT02528357|566149372|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835492|NCT02528357|566149373|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835493|NCT02528357|566149374|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835494|NCT02528357|566149375|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835495|NCT02528357|566149376|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835496|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835497|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835498|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835499|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
157152296|NCT00431847|567303448|FG004|Overall Study|completion of less than two study visits|0|||
156835500|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835501|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835502|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835503|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835504|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835505|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835506|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835507|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835508|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835509|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
156835510|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
156835511|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835512|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835513|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835514|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
156835515|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835516|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835517|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835518|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156886009|NCT00796991|566342454|FG002|Overall Study|Adverse Event|1|||
156886010|NCT00796991|566342452|FG000|Overall Study|Death|2|||
156886011|NCT00796991|566342453|FG001|Overall Study|Death|0|||
156886012|NCT00796991|566342454|FG002|Overall Study|Death|0|||
156886013|NCT00796991|566342452|FG000|Overall Study|Disease Progression|10|||
156886014|NCT00796991|566342453|FG001|Overall Study|Disease Progression|9|||
156886015|NCT00796991|566342454|FG002|Overall Study|Disease Progression|7|||
156886016|NCT00796991|566342452|FG000|Overall Study|Study Drug Toxicity|3|||
156886017|NCT00796991|566342453|FG001|Overall Study|Study Drug Toxicity|3|||
156886018|NCT00796991|566342454|FG002|Overall Study|Study Drug Toxicity|5|||
156886019|NCT00796991|566342452|FG000|Overall Study|Withdrawal by Subject|0|||
156886020|NCT00796991|566342453|FG001|Overall Study|Withdrawal by Subject|0|||
156886021|NCT00796991|566342454|FG002|Overall Study|Withdrawal by Subject|1|||
156886022|NCT00834080|566342457|FG000|Overall Study|Adverse Event|7|||
156886023|NCT00834080|566342457|FG000|Overall Study|Lost to Follow-up|7|||
156886024|NCT00834080|566342457|FG000|Overall Study|Withdrawal by Subject|5|||
156886025|NCT00834080|566342457|FG000|Overall Study|Other - Pregnancy|1|||
156886026|NCT00834080|566342457|FG000|Overall Study|Other - False positive tests of the UDS|1|||
156886027|NCT00834080|566342457|FG000|Overall Study|Physician Decision|1|||
156886028|NCT00834080|566342457|FG000|Overall Study|Subject Relocated|1|||
156886029|NCT04345367|566342459|FG000|Overall Study|Other|3|||
156886030|NCT04345367|566342460|FG001|Overall Study|Other|4|||
156886031|NCT04345367|566342459|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
157152297|NCT00431847|567303444|FG000|Overall Study|Protocol Violation|0|||
157152298|NCT00431847|567303445|FG001|Overall Study|Protocol Violation|0|||
156886032|NCT04345367|566342460|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
156886033|NCT04345367|566342459|FG000|Overall Study|Withdrawal by Subject|11|||
156886034|NCT04345367|566342460|FG001|Overall Study|Withdrawal by Subject|11|||
156886035|NCT04345367|566342459|FG000|Overall Study|Protocol Violation|4|||
157152299|NCT00431847|567303446|FG002|Overall Study|Protocol Violation|0|||
157152300|NCT00431847|567303447|FG003|Overall Study|Protocol Violation|0|||
156886036|NCT04345367|566342460|FG001|Overall Study|Protocol Violation|3|||
156835519|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835520|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835521|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835522|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835523|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835524|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835525|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835526|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835527|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835528|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
156835529|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835530|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835531|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835532|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835533|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
156835534|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835535|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835536|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835537|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835538|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835539|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835540|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835541|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835542|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835543|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835544|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
156835545|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835546|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
156835547|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
156835548|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
156835549|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835550|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835551|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835552|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
156835553|NCT02528357|566149358|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835554|NCT02528357|566149359|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835555|NCT02528357|566149360|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835556|NCT02528357|566149361|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835557|NCT02528357|566149362|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156886037|NCT04345367|566342459|FG000|Overall Study|Lost to Follow-up|2|||
156886038|NCT04345367|566342460|FG001|Overall Study|Lost to Follow-up|4|||
156886039|NCT04345367|566342459|FG000|Overall Study|Lack of Efficacy|2|||
156886040|NCT04345367|566342460|FG001|Overall Study|Lack of Efficacy|0|||
156886041|NCT04345367|566342459|FG000|Overall Study|Death|2|||
156886042|NCT04345367|566342460|FG001|Overall Study|Death|0|||
156886043|NCT04345367|566342459|FG000|Overall Study|Adverse Event|10|||
156886044|NCT04345367|566342460|FG001|Overall Study|Adverse Event|9|||
156886045|NCT00796523|566342461|FG000|Overall Study|Lost to Follow-up|9|||
156886046|NCT00796523|566342462|FG001|Overall Study|Lost to Follow-up|7|||
156886047|NCT02431260|566342463|FG000|Overall Study|Subject Decision|0|||
156886048|NCT02431260|566342464|FG001|Overall Study|Subject Decision|1|||
156886049|NCT02431260|566342465|FG002|Overall Study|Subject Decision|1|||
156886050|NCT02431260|566342466|FG003|Overall Study|Subject Decision|0|||
156886051|NCT02431260|566342467|FG004|Overall Study|Subject Decision|0|||
156886052|NCT02431260|566342468|FG005|Overall Study|Subject Decision|0|||
156886053|NCT02431260|566342469|FG006|Overall Study|Subject Decision|0|||
156886054|NCT02431260|566342470|FG007|Overall Study|Subject Decision|0|||
156886055|NCT02431260|566342471|FG008|Overall Study|Subject Decision|1|||
156886056|NCT02431260|566342472|FG009|Overall Study|Subject Decision|1|||
156886057|NCT02431260|566342473|FG010|Overall Study|Subject Decision|0|||
156886058|NCT02431260|566342474|FG011|Overall Study|Subject Decision|1|||
156886059|NCT02431260|566342475|FG012|Overall Study|Subject Decision|0|||
156886060|NCT02431260|566342476|FG013|Overall Study|Subject Decision|0|||
156886061|NCT02431260|566342463|FG000|Overall Study|Death|4|||
156886062|NCT02431260|566342464|FG001|Overall Study|Death|4|||
156886063|NCT02431260|566342465|FG002|Overall Study|Death|3|||
156886064|NCT02431260|566342466|FG003|Overall Study|Death|4|||
156886065|NCT02431260|566342467|FG004|Overall Study|Death|2|||
157152301|NCT00431847|567303448|FG004|Overall Study|Protocol Violation|1|||
157152302|NCT00339183|567303451|FG000|Overall Study|Adverse Event|5|||
157152303|NCT00339183|567303452|FG001|Overall Study|Adverse Event|3|||
157152304|NCT00339183|567303451|FG000|Overall Study|Withdrawal by Subject|16|||
157152305|NCT00339183|567303452|FG001|Overall Study|Withdrawal by Subject|19|||
157152306|NCT00339183|567303451|FG000|Overall Study|Physician Decision|2|||
157152307|NCT00339183|567303452|FG001|Overall Study|Physician Decision|4|||
157152308|NCT00339183|567303451|FG000|Overall Study|Lost to Follow-up|17|||
157152309|NCT00339183|567303452|FG001|Overall Study|Lost to Follow-up|17|||
157152310|NCT00339183|567303451|FG000|Overall Study|Protocol-specified criteria|12|||
157152311|NCT00339183|567303452|FG001|Overall Study|Protocol-specified criteria|8|||
157152312|NCT00339183|567303451|FG000|Overall Study|Missing reason|3|||
157152313|NCT00339183|567303452|FG001|Overall Study|Missing reason|1|||
157152314|NCT00339183|567303451|FG000|Overall Study|Other|46|||
157152315|NCT00339183|567303452|FG001|Overall Study|Other|40|||
157152316|NCT00339183|567303451|FG000|Overall Study|Ongoing|20|||
157152317|NCT00339183|567303452|FG001|Overall Study|Ongoing|13|||
157152318|NCT00793819|567303453|FG000|Overall Study|Adverse Event|8|||
157152319|NCT00793819|567303454|FG001|Overall Study|Adverse Event|4|||
157152320|NCT00793819|567303453|FG000|Overall Study|Lack of Efficacy|1|||
157152321|NCT00793819|567303454|FG001|Overall Study|Lack of Efficacy|1|||
157152322|NCT00793819|567303453|FG000|Overall Study|Withdrawal by Subject|4|||
157152323|NCT00793819|567303454|FG001|Overall Study|Withdrawal by Subject|3|||
157152324|NCT00793819|567303453|FG000|Overall Study|Lost to Follow-up|1|||
157152325|NCT00793819|567303454|FG001|Overall Study|Lost to Follow-up|1|||
157152326|NCT00002663|567303455|FG000|Overall Study|Death|4|||
157152327|NCT00002663|567303456|FG001|Overall Study|Death|1|||
157152328|NCT00002663|567303457|FG002|Overall Study|Death|1|||
157152329|NCT00002663|567303458|FG003|Overall Study|Death|0|||
157152330|NCT00002663|567303459|FG004|Overall Study|Death|0|||
157152331|NCT00002663|567303460|FG005|Overall Study|Death|13|||
157152332|NCT00002663|567303461|FG006|Overall Study|Death|0|||
157152333|NCT00002663|567303462|FG007|Overall Study|Death|1|||
157152334|NCT00002663|567303463|FG008|Overall Study|Death|1|||
157152335|NCT00002663|567303464|FG009|Overall Study|Death|1|||
157152336|NCT00002663|567303455|FG000|Overall Study|Lost to Follow-up|3|||
157152337|NCT00002663|567303456|FG001|Overall Study|Lost to Follow-up|0|||
157152338|NCT00002663|567303457|FG002|Overall Study|Lost to Follow-up|0|||
157152339|NCT00002663|567303458|FG003|Overall Study|Lost to Follow-up|1|||
157152340|NCT00002663|567303459|FG004|Overall Study|Lost to Follow-up|0|||
157152341|NCT00002663|567303460|FG005|Overall Study|Lost to Follow-up|1|||
156835558|NCT02528357|566149363|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835559|NCT02528357|566149364|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835560|NCT02528357|566149365|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835561|NCT02528357|566149366|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835562|NCT02528357|566149367|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835563|NCT02528357|566149368|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835564|NCT02528357|566149369|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
156835565|NCT02528357|566149370|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
156835566|NCT02528357|566149371|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835567|NCT02528357|566149372|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835568|NCT02528357|566149373|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835569|NCT02528357|566149374|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835570|NCT02528357|566149375|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156863434|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
156863435|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157152342|NCT00002663|567303461|FG006|Overall Study|Lost to Follow-up|0|||
157152343|NCT00002663|567303462|FG007|Overall Study|Lost to Follow-up|0|||
157152344|NCT00002663|567303463|FG008|Overall Study|Lost to Follow-up|0|||
157152345|NCT00002663|567303464|FG009|Overall Study|Lost to Follow-up|0|||
157152346|NCT00002663|567303455|FG000|Overall Study|Other|0|||
157152347|NCT00002663|567303456|FG001|Overall Study|Other|1|||
157152348|NCT00002663|567303457|FG002|Overall Study|Other|0|||
157152349|NCT00002663|567303458|FG003|Overall Study|Other|0|||
157152350|NCT00002663|567303459|FG004|Overall Study|Other|0|||
157152351|NCT00002663|567303460|FG005|Overall Study|Other|1|||
157152352|NCT00002663|567303461|FG006|Overall Study|Other|1|||
157152353|NCT00002663|567303462|FG007|Overall Study|Other|0|||
157152354|NCT00002663|567303463|FG008|Overall Study|Other|0|||
157152355|NCT00002663|567303464|FG009|Overall Study|Other|0|||
157152356|NCT00002663|567303455|FG000|Overall Study|Physician Decision|0|||
157152357|NCT00002663|567303456|FG001|Overall Study|Physician Decision|0|||
157152358|NCT00002663|567303457|FG002|Overall Study|Physician Decision|0|||
157152359|NCT00002663|567303458|FG003|Overall Study|Physician Decision|0|||
156835571|NCT02528357|566149376|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835572|NCT02528357|566149358|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
157152360|NCT00002663|567303459|FG004|Overall Study|Physician Decision|1|||
157152361|NCT00002663|567303460|FG005|Overall Study|Physician Decision|0|||
157152362|NCT00002663|567303461|FG006|Overall Study|Physician Decision|0|||
156835573|NCT02528357|566149359|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835574|NCT02528357|566149360|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835575|NCT02528357|566149361|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835576|NCT02528357|566149362|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835577|NCT02528357|566149363|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835578|NCT02528357|566149364|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835579|NCT02528357|566149365|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835580|NCT02528357|566149366|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835581|NCT02528357|566149367|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835582|NCT02528357|566149368|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835583|NCT02528357|566149369|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835584|NCT02528357|566149370|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835585|NCT02528357|566149371|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835586|NCT02528357|566149372|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835587|NCT02528357|566149373|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835588|NCT02528357|566149374|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
156835589|NCT02528357|566149375|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835590|NCT02528357|566149376|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
156835591|NCT02528357|566149358|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835592|NCT02528357|566149359|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835593|NCT02528357|566149360|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835594|NCT02528357|566149361|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835595|NCT02528357|566149362|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835596|NCT02528357|566149363|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
157152363|NCT00002663|567303462|FG007|Overall Study|Physician Decision|0|||
157152364|NCT00002663|567303463|FG008|Overall Study|Physician Decision|1|||
157152365|NCT00002663|567303464|FG009|Overall Study|Physician Decision|1|||
157152366|NCT00002663|567303455|FG000|Overall Study|Adverse Event|0|||
157152367|NCT00002663|567303456|FG001|Overall Study|Adverse Event|0|||
156835597|NCT02528357|566149364|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835598|NCT02528357|566149365|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835599|NCT02528357|566149366|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835600|NCT02528357|566149367|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835601|NCT02528357|566149368|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835602|NCT02528357|566149369|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835603|NCT02528357|566149370|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835604|NCT02528357|566149371|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835605|NCT02528357|566149372|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835606|NCT02528357|566149373|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
156835607|NCT02528357|566149374|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
156835608|NCT02528357|566149375|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
156835609|NCT02528357|566149376|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
156835610|NCT03869333|566149387|FG000|Overall Study|Lost to Follow-up|1|||
156835611|NCT03869333|566149388|FG001|Overall Study|Lost to Follow-up|0|||
156835612|NCT03869333|566149389|FG002|Overall Study|Lost to Follow-up|0|||
156835613|NCT03869333|566149390|FG003|Overall Study|Lost to Follow-up|0|||
156835614|NCT03869333|566149387|FG000|Overall Study|Pregnancy|1|||
156886066|NCT02431260|566342468|FG005|Overall Study|Death|2|||
157152368|NCT00002663|567303457|FG002|Overall Study|Adverse Event|0|||
157152369|NCT00002663|567303458|FG003|Overall Study|Adverse Event|1|||
157152370|NCT00002663|567303459|FG004|Overall Study|Adverse Event|0|||
157152371|NCT00002663|567303460|FG005|Overall Study|Adverse Event|0|||
157152372|NCT00002663|567303461|FG006|Overall Study|Adverse Event|0|||
157152373|NCT00002663|567303462|FG007|Overall Study|Adverse Event|1|||
157152374|NCT00002663|567303463|FG008|Overall Study|Adverse Event|0|||
157152375|NCT00002663|567303464|FG009|Overall Study|Adverse Event|0|||
157152376|NCT00446446|567303468|FG000|Overall Study|Death|10|||
156835615|NCT03869333|566149388|FG001|Overall Study|Pregnancy|0|||
156835616|NCT03869333|566149389|FG002|Overall Study|Pregnancy|0|||
156835617|NCT03869333|566149390|FG003|Overall Study|Pregnancy|0|||
156835618|NCT03869333|566149387|FG000|Overall Study|Physician Decision|0|||
156835619|NCT03869333|566149388|FG001|Overall Study|Physician Decision|1|||
156835620|NCT03869333|566149389|FG002|Overall Study|Physician Decision|0|||
156835621|NCT03869333|566149390|FG003|Overall Study|Physician Decision|0|||
156835622|NCT01927055|566149391|FG000|Open-label|Adverse Event|6|||
156835623|NCT01927055|566149392|FG001|Open-label|Adverse Event|0|||
156835624|NCT01927055|566149393|FG002|Open-label|Adverse Event|0|||
156835625|NCT01927055|566149391|FG000|Open-label|Withdrawal by Subject|1|||
156835626|NCT01927055|566149392|FG001|Open-label|Withdrawal by Subject|0|||
156835627|NCT01927055|566149393|FG002|Open-label|Withdrawal by Subject|0|||
156835628|NCT01927055|566149391|FG000|Open-label|Study Stopped|4|||
156835629|NCT01927055|566149392|FG001|Open-label|Study Stopped|0|||
156835630|NCT01927055|566149393|FG002|Open-label|Study Stopped|0|||
156835631|NCT01927055|566149391|FG000|Open-label|Supine Hypertension|4|||
156835632|NCT01927055|566149392|FG001|Open-label|Supine Hypertension|0|||
156835633|NCT01927055|566149393|FG002|Open-label|Supine Hypertension|0|||
156835634|NCT01927055|566149391|FG000|Open-label|Difficulty attending study visits|1|||
156835635|NCT01927055|566149392|FG001|Open-label|Difficulty attending study visits|0|||
156835636|NCT01927055|566149393|FG002|Open-label|Difficulty attending study visits|0|||
156835637|NCT01927055|566149391|FG000|Double-Blind|Adverse Event|0|||
156835638|NCT01927055|566149392|FG001|Double-Blind|Adverse Event|1|||
156835639|NCT01927055|566149393|FG002|Double-Blind|Adverse Event|1|||
156835640|NCT01927055|566149391|FG000|Double-Blind|Protocol Violation|0|||
156835641|NCT01927055|566149392|FG001|Double-Blind|Protocol Violation|0|||
156835642|NCT01927055|566149393|FG002|Double-Blind|Protocol Violation|1|||
156835643|NCT01927055|566149391|FG000|Double-Blind|Withdrawal by Subject|0|||
156835644|NCT01927055|566149392|FG001|Double-Blind|Withdrawal by Subject|2|||
156835645|NCT01927055|566149393|FG002|Double-Blind|Withdrawal by Subject|3|||
156835646|NCT01927055|566149391|FG000|Double-Blind|Study Stopped|0|||
156835647|NCT01927055|566149392|FG001|Double-Blind|Study Stopped|7|||
156835648|NCT01927055|566149393|FG002|Double-Blind|Study Stopped|7|||
156835649|NCT01927055|566149391|FG000|Double-Blind|Supine Hypertension|0|||
156835650|NCT01927055|566149392|FG001|Double-Blind|Supine Hypertension|0|||
156835651|NCT01927055|566149393|FG002|Double-Blind|Supine Hypertension|1|||
156835652|NCT01927055|566149391|FG000|Double-Blind|Extended Vacation|0|||
156835653|NCT01927055|566149392|FG001|Double-Blind|Extended Vacation|1|||
156835654|NCT01927055|566149393|FG002|Double-Blind|Extended Vacation|0|||
156835655|NCT01378429|566149395|FG000|Overall Study|Noncompliance with study drug|1|||
156835656|NCT01378429|566149396|FG001|Overall Study|Noncompliance with study drug|0|||
156835657|NCT02241187|566149397|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
156835658|NCT02966015|566149398|FG000|Inclusion Visit|did not answer questionnaire|8|||
156835659|NCT02966015|566149399|FG001|Inclusion Visit|did not answer questionnaire|3|||
156835660|NCT02356887|566149400|FG000|Overall Study|poor compliance|2|||
156835661|NCT00199888|566149401|FG000|Overall Study|Lost to Follow-up|1|||
156835662|NCT04208087|566149402|FG000|Overall Study|Adverse Event|1|||
156835663|NCT04208087|566149403|FG001|Overall Study|Adverse Event|0|||
156835664|NCT04208087|566149404|FG002|Overall Study|Adverse Event|0|||
156835665|NCT04208087|566149405|FG003|Overall Study|Adverse Event|0|||
156835666|NCT04208087|566149406|FG004|Overall Study|Adverse Event|0|||
156835667|NCT04208087|566149402|FG000|Overall Study|Withdrawal by Subject|0|||
156835668|NCT04208087|566149403|FG001|Overall Study|Withdrawal by Subject|0|||
156835669|NCT04208087|566149404|FG002|Overall Study|Withdrawal by Subject|1|||
156835670|NCT04208087|566149405|FG003|Overall Study|Withdrawal by Subject|0|||
156835671|NCT04208087|566149406|FG004|Overall Study|Withdrawal by Subject|0|||
157023608|NCT01437709|566841100|FG001|Overall Study|Adverse Event|1|||
157023609|NCT01437709|566841101|FG002|Overall Study|Adverse Event|0|||
157023610|NCT01437709|566841099|FG000|Overall Study|Pt trasnferred care|0|||
157023611|NCT01437709|566841100|FG001|Overall Study|Pt trasnferred care|1|||
157023612|NCT01437709|566841101|FG002|Overall Study|Pt trasnferred care|0|||
156835672|NCT04208087|566149402|FG000|Overall Study|Other|0|||
156886067|NCT02431260|566342469|FG006|Overall Study|Death|3|||
157023613|NCT04091750|566841102|FG000|Overall Study|Adverse Event|4|||
156835673|NCT04208087|566149403|FG001|Overall Study|Other|0|||
156835674|NCT04208087|566149404|FG002|Overall Study|Other|0|||
156835675|NCT04208087|566149405|FG003|Overall Study|Other|0|||
157023614|NCT04091750|566841102|FG000|Overall Study|Withdrawal by Subject|1|||
157023615|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
157091552|NCT00994682|567089165|FG001|Double Bilnd|Lost to Follow-up|3|||
156835676|NCT04208087|566149406|FG004|Overall Study|Other|1|||
156835677|NCT01198509|566149407|FG000|Overall Study|Withdrawal by Subject|1|||
156835678|NCT01198509|566149408|FG001|Overall Study|Withdrawal by Subject|0|||
156835679|NCT01198509|566149409|FG002|Overall Study|Withdrawal by Subject|0|||
156835680|NCT01198509|566149410|FG003|Overall Study|Withdrawal by Subject|0|||
156835681|NCT01198509|566149411|FG004|Overall Study|Withdrawal by Subject|0|||
156835682|NCT01198509|566149412|FG005|Overall Study|Withdrawal by Subject|0|||
156835683|NCT00330668|566149413|FG000|BID Dosing Period|Adverse Event|1|||
156835684|NCT00330668|566149413|FG000|BID Dosing Period|Lost to Follow-up|7|||
156835685|NCT00330668|566149413|FG000|BID Dosing Period|Non-Compliance|5|||
156835686|NCT00330668|566149413|FG000|BID Dosing Period|Withdrawal by Subject|19|||
156835687|NCT00330668|566149413|FG000|BID Dosing Period|Sponsor's decision|1|||
156835688|NCT00330668|566149413|FG000|BID Dosing Period|Other|3|||
156835689|NCT00330668|566149413|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
156835690|NCT00330668|566149413|FG000|QD Dosing Period|Other|1|||
156835691|NCT00330668|566149413|FG000|QD Dosing Period|Withdrawal by Subject|1|||
156835692|NCT00330668|566149413|FG000|QD Dosing Period|Lost to Follow-up|2|||
156835693|NCT02621073|566149419|FG000|Overall Study|Lost to Follow-up|0|||
156835694|NCT02621073|566149420|FG001|Overall Study|Lost to Follow-up|1|||
156835695|NCT02621073|566149419|FG000|Overall Study|Physician Decision|3|||
156835696|NCT02621073|566149420|FG001|Overall Study|Physician Decision|2|||
156835697|NCT01012323|566149422|FG000|Overall Study|Investigator Judgment|1|||
156835698|NCT00495755|566149423|FG000|Overall Study|Adverse Event|3|||
156835699|NCT02920957|566149424|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
156835700|NCT02920957|566149425|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
156835701|NCT02920957|566149424|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
156835702|NCT02920957|566149425|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
156835703|NCT02920957|566149424|FG000|First Intervention : 1 Month|Adverse Event|1|||
156835704|NCT02920957|566149425|FG001|First Intervention : 1 Month|Adverse Event|0|||
156835705|NCT02920957|566149424|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
156835706|NCT02920957|566149425|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
156835707|NCT01789606|566149426|FG000|Overall Study|Participant not Purchased the Product|0|||
156835708|NCT01789606|566149427|FG001|Overall Study|Participant not Purchased the Product|20|||
156835709|NCT01789606|566149426|FG000|Overall Study|Withdrawal by Subject|0|||
156835710|NCT01789606|566149427|FG001|Overall Study|Withdrawal by Subject|1|||
156835711|NCT01789606|566149426|FG000|Overall Study|Ineligible|6|||
156835712|NCT01789606|566149427|FG001|Overall Study|Ineligible|2|||
156835713|NCT01789606|566149426|FG000|Overall Study|Administrative Reasons|17|||
156835714|NCT01789606|566149427|FG001|Overall Study|Administrative Reasons|6|||
156835715|NCT01789606|566149426|FG000|Overall Study|No Study Medication Taken|0|||
156835716|NCT01789606|566149427|FG001|Overall Study|No Study Medication Taken|1|||
156835717|NCT01789606|566149426|FG000|Overall Study|Protocol Violation|0|||
156835718|NCT01789606|566149427|FG001|Overall Study|Protocol Violation|55|||
156835719|NCT01789606|566149426|FG000|Overall Study|Adverse Event|0|||
156835720|NCT01789606|566149427|FG001|Overall Study|Adverse Event|3|||
156835721|NCT01789606|566149426|FG000|Overall Study|Lost to Follow-up|0|||
156835722|NCT01789606|566149427|FG001|Overall Study|Lost to Follow-up|14|||
156835723|NCT01789606|566149426|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
156835724|NCT01789606|566149427|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
156835725|NCT03180307|566149428|FG000|Overall Study|Lost to Follow-up|2|||
156835726|NCT03180307|566149429|FG001|Overall Study|Lost to Follow-up|0|||
156835727|NCT03180307|566149428|FG000|Overall Study|Death|1|||
156835728|NCT03180307|566149429|FG001|Overall Study|Death|0|||
156835729|NCT03180307|566149428|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
156835730|NCT03180307|566149429|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
156835731|NCT01563172|566149432|FG000|Overall Study|Adverse Event|5|||
156835732|NCT01563172|566149432|FG000|Overall Study|Lost to Follow-up|2|||
156835733|NCT01563172|566149432|FG000|Overall Study|Other (Protocol deviation)|5|||
156835734|NCT01563172|566149432|FG000|Overall Study|Other (Not specified)|1|||
156863411|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
156863412|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
156863413|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
156863414|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156863415|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
156863416|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
156863417|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156863418|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156863419|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
156863420|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156863421|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
156863422|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863423|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
156863424|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863425|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
156863426|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
156863427|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
156863428|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156863429|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
156886068|NCT02431260|566342470|FG007|Overall Study|Death|1|||
156886069|NCT02431260|566342471|FG008|Overall Study|Death|6|||
156835735|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835736|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835737|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835738|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
156835739|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835740|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835741|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
156835742|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835743|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835744|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835745|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
156835746|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835747|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835748|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
156835749|NCT03268941|566151464|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
156835750|NCT03268941|566151465|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835751|NCT03268941|566151466|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835752|NCT03268941|566151467|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835753|NCT03268941|566151468|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835754|NCT03268941|566151469|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835755|NCT03268941|566151470|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
156835756|NCT03268941|566151464|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
156835757|NCT03268941|566151465|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
156835758|NCT03268941|566151466|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
156835759|NCT03268941|566151467|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
156835760|NCT03268941|566151468|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
156835761|NCT03268941|566151469|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
156835762|NCT03268941|566151470|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
156835763|NCT03268941|566151464|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835764|NCT03268941|566151465|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835765|NCT03268941|566151466|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835766|NCT03268941|566151467|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835767|NCT03268941|566151468|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835768|NCT03268941|566151469|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
156835769|NCT03268941|566151470|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
156835770|NCT02720692|566151475|FG000|Overall Study|Withdrawal by Subject|3|||
156835771|NCT02720692|566151476|FG001|Overall Study|Withdrawal by Subject|0|||
156835772|NCT02720692|566151475|FG000|Overall Study|Physician Decision|1|||
156835773|NCT02720692|566151476|FG001|Overall Study|Physician Decision|0|||
156835774|NCT02720692|566151475|FG000|Overall Study|Lost to Follow-up|8|||
156835775|NCT02720692|566151476|FG001|Overall Study|Lost to Follow-up|3|||
156835776|NCT02720692|566151475|FG000|Overall Study|Subject unable to return for visit|1|||
156835777|NCT02720692|566151476|FG001|Overall Study|Subject unable to return for visit|0|||
156835778|NCT03878758|566151477|FG000|Overall Study|Withdrawal by Subject|1|||
156835779|NCT03878758|566151477|FG000|Overall Study|Protocol defined|2|||
156835780|NCT03878758|566151477|FG000|Overall Study|Improper consent documentation|1|||
156835781|NCT01769196|566151478|FG000|Overall Study|Adverse Event|24|||
156835782|NCT01769196|566151479|FG001|Overall Study|Adverse Event|20|||
156835783|NCT01769196|566151478|FG000|Overall Study|Death|21|||
156835784|NCT01769196|566151479|FG001|Overall Study|Death|26|||
156835785|NCT01769196|566151478|FG000|Overall Study|Investigator Discretion|7|||
156835786|NCT01769196|566151479|FG001|Overall Study|Investigator Discretion|3|||
156835787|NCT01769196|566151478|FG000|Overall Study|Lack of Efficacy|3|||
156835788|NCT01769196|566151479|FG001|Overall Study|Lack of Efficacy|2|||
156835789|NCT01769196|566151478|FG000|Overall Study|Progressive disease|11|||
156835790|NCT01769196|566151479|FG001|Overall Study|Progressive disease|6|||
156835791|NCT01769196|566151478|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
157152377|NCT00446446|567303468|FG000|Overall Study|Withdrawal by Subject|6|||
157152378|NCT00446446|567303468|FG000|Overall Study|Other|4|||
157152379|NCT00446446|567303468|FG000|Overall Study|Disease Progession|2|||
157152380|NCT00446446|567303468|FG000|Overall Study|Adverse Event|1|||
157152381|NCT00446446|567303468|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
157152382|NCT02142894|567303469|FG000|Overall Study|Protocol Violation|8|||
157152383|NCT00611130|567303475|FG000|Overall Study|Lost to Follow-up|25|||
156835792|NCT01769196|566151479|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
157152384|NCT00611130|567303476|FG001|Overall Study|Lost to Follow-up|29|||
157224675|NCT03504852|567568059|FG002|Overall Study|Withdrawal by Subject|1|||
156835793|NCT01769196|566151478|FG000|Overall Study|Protocol Violation|0|||
156835794|NCT01769196|566151479|FG001|Overall Study|Protocol Violation|3|||
156835795|NCT01769196|566151478|FG000|Overall Study|Study terminated by sponsor|160|||
156835796|NCT01769196|566151479|FG001|Overall Study|Study terminated by sponsor|161|||
156835797|NCT01769196|566151478|FG000|Overall Study|Participant never dosed with study drug|1|||
156835798|NCT01769196|566151479|FG001|Overall Study|Participant never dosed with study drug|0|||
157152385|NCT00611130|567303475|FG000|Overall Study|Protocol noncompliance|7|||
156835799|NCT01769196|566151478|FG000|Overall Study|Withdrew consent|36|||
156835800|NCT01769196|566151479|FG001|Overall Study|Withdrew consent|40|||
156835801|NCT00765063|566151480|FG000|Overall Study|Lack of Efficacy|5|||
156835802|NCT00765063|566151480|FG000|Overall Study|Withdrawal by Subject|1|||
156835803|NCT00765063|566151480|FG000|Overall Study|Other|16|||
156835804|NCT00765063|566151480|FG000|Overall Study|Protocol Violation|6|||
156835805|NCT00765063|566151480|FG000|Overall Study|Adverse Event|4|||
156835806|NCT03614325|566151481|FG000|Overall Study|Withdrawal by Subject|0|||
156835807|NCT03614325|566151482|FG001|Overall Study|Withdrawal by Subject|2|||
156835808|NCT03614325|566151481|FG000|Overall Study|Surgery Cancelled|2|||
156835809|NCT03614325|566151482|FG001|Overall Study|Surgery Cancelled|1|||
156835810|NCT03614325|566151481|FG000|Overall Study|Lost to Follow-up|2|||
156835811|NCT03614325|566151482|FG001|Overall Study|Lost to Follow-up|1|||
156835812|NCT03614325|566151481|FG000|Overall Study|Surgery never scheduled|1|||
156835813|NCT03614325|566151482|FG001|Overall Study|Surgery never scheduled|0|||
156835814|NCT00652951|566151489|FG000|Booster Phase|Adverse event, non-fatal|0|||
156835815|NCT00652951|566151490|FG001|Booster Phase|Adverse event, non-fatal|1|||
156835816|NCT00652951|566151491|FG002|Booster Phase|Adverse event, non-fatal|0|||
156835817|NCT00652951|566151489|FG000|Booster Phase|Other|1|||
156835818|NCT00652951|566151490|FG001|Booster Phase|Other|0|||
156835819|NCT00652951|566151491|FG002|Booster Phase|Other|0|||
156835820|NCT01022424|566151492|FG000|Overall Study|Adverse Event|1|||
156835821|NCT01022424|566151492|FG000|Overall Study|Physician Decision|1|||
156835822|NCT01022424|566151492|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
156835823|NCT01206582|566151493|FG000|Overall Study|Withdrew prior to study|1|||
156835824|NCT01206582|566151494|FG001|Overall Study|Withdrew prior to study|0|||
156835825|NCT01206582|566151493|FG000|Overall Study|Discontinued intervention before week 8|1|||
156835826|NCT01206582|566151494|FG001|Overall Study|Discontinued intervention before week 8|2|||
156835827|NCT02522325|566151495|FG000|Overall Study|Adverse Event|0|||
156835828|NCT02522325|566151496|FG001|Overall Study|Adverse Event|1|||
156835829|NCT02100969|566151499|FG000|Overall Study|Did not pass screening phase|1|||
157023616|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
157023617|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
157023618|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
157023619|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
157023620|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
157023621|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
157023622|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
157023623|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
157023624|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
157023625|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
157023626|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
157023627|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
157023628|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
157023629|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
157023630|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
157023631|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
157023632|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
157023633|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
157023634|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
157023635|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
156835850|NCT01629953|566151502|FG000|Overall Study|Death|3|||
156835851|NCT01629953|566151503|FG001|Overall Study|Death|1|||
156835852|NCT01629953|566151502|FG000|Overall Study|Lost to Follow-up|10|||
156835853|NCT01629953|566151503|FG001|Overall Study|Lost to Follow-up|14|||
156835854|NCT00720343|566151504|FG000|Overall Study|Lost to Follow-up|1|||
156835855|NCT00720343|566151505|FG001|Overall Study|Lost to Follow-up|0|||
156835856|NCT00720343|566151504|FG000|Overall Study|Protocol Violation|0|||
156835857|NCT00720343|566151505|FG001|Overall Study|Protocol Violation|2|||
156835858|NCT03459365|566151508|FG000|Overall Study|Withdrawal by Subject|6|||
156835859|NCT03459365|566151508|FG000|Overall Study|Protocol Violation|8|||
156835860|NCT00707954|566151509|FG000|Overall Study|Physician Decision|0|||
156835861|NCT00707954|566151510|FG001|Overall Study|Physician Decision|0|||
156835862|NCT00707954|566151511|FG002|Overall Study|Physician Decision|0|||
156835863|NCT00707954|566151512|FG003|Overall Study|Physician Decision|0|||
156835864|NCT00707954|566151513|FG004|Overall Study|Physician Decision|1|||
156835865|NCT00344500|566151515|FG000|Overall Study|Adverse Event|6|||
156835866|NCT00344500|566151516|FG001|Overall Study|Adverse Event|2|||
156835867|NCT00344500|566151517|FG002|Overall Study|Adverse Event|0|||
156835868|NCT00344500|566151515|FG000|Overall Study|Lost to Follow-up|5|||
156835869|NCT00344500|566151516|FG001|Overall Study|Lost to Follow-up|13|||
156835870|NCT00344500|566151517|FG002|Overall Study|Lost to Follow-up|1|||
156835871|NCT00344500|566151515|FG000|Overall Study|Withdrawal by Subject|7|||
156835872|NCT00344500|566151516|FG001|Overall Study|Withdrawal by Subject|10|||
156835873|NCT00344500|566151517|FG002|Overall Study|Withdrawal by Subject|0|||
156835874|NCT00344500|566151515|FG000|Overall Study|Protocol Violation|4|||
157091553|NCT00994682|567089164|FG000|Double Bilnd|Adverse Event|1|||
156835875|NCT00344500|566151516|FG001|Overall Study|Protocol Violation|7|||
156835876|NCT00344500|566151517|FG002|Overall Study|Protocol Violation|1|||
156835877|NCT00344500|566151515|FG000|Overall Study|Not Noted|1|||
156835878|NCT00344500|566151516|FG001|Overall Study|Not Noted|3|||
156835879|NCT00344500|566151517|FG002|Overall Study|Not Noted|0|||
156835880|NCT00599755|566151518|FG000|Overall Study|Adverse Event|11|||
156835881|NCT00599755|566151518|FG000|Overall Study|Withdrawal by Subject|2|||
156835882|NCT00599755|566151518|FG000|Overall Study|Progression of Disease|3|||
156835883|NCT00599755|566151518|FG000|Overall Study|Other Reason|2|||
156835884|NCT00599755|566151518|FG000|Overall Study|No data available|1|||
156835885|NCT04037254|566151519|FG000|Overall Study|Protocol Violation|1|||
156835886|NCT04037254|566151520|FG001|Overall Study|Protocol Violation|0|||
156835887|NCT04037254|566151521|FG002|Overall Study|Protocol Violation|0|||
156835888|NCT04037254|566151522|FG003|Overall Study|Protocol Violation|0|||
156835889|NCT04037254|566151523|FG004|Overall Study|Protocol Violation|0|||
156835890|NCT04037254|566151519|FG000|Overall Study|Withdrawal by Subject|0|||
156835891|NCT04037254|566151520|FG001|Overall Study|Withdrawal by Subject|0|||
156835892|NCT04037254|566151521|FG002|Overall Study|Withdrawal by Subject|1|||
156835893|NCT04037254|566151522|FG003|Overall Study|Withdrawal by Subject|0|||
156835894|NCT04037254|566151523|FG004|Overall Study|Withdrawal by Subject|0|||
156835895|NCT04037254|566151519|FG000|Overall Study|Delayed or incomplete treatment|0|||
156835896|NCT04037254|566151520|FG001|Overall Study|Delayed or incomplete treatment|2|||
156835897|NCT04037254|566151521|FG002|Overall Study|Delayed or incomplete treatment|1|||
156835898|NCT04037254|566151522|FG003|Overall Study|Delayed or incomplete treatment|0|||
156835899|NCT04037254|566151523|FG004|Overall Study|Delayed or incomplete treatment|0|||
156835900|NCT01306656|566151524|FG000|Overall Study|Lost to Follow-up|1|||
156835901|NCT01306656|566151525|FG001|Overall Study|Lost to Follow-up|0|||
156835902|NCT02504580|566151529|FG000|Overall Study|Other|1|||
156835903|NCT02504580|566151530|FG001|Overall Study|Other|0|||
156835904|NCT02504580|566151531|FG002|Overall Study|Other|0|||
156835905|NCT02504580|566151532|FG003|Overall Study|Other|2|||
156835906|NCT02504580|566151533|FG004|Overall Study|Other|1|||
156835907|NCT02504580|566151534|FG005|Overall Study|Other|1|||
156835908|NCT02504580|566151535|FG006|Overall Study|Other|1|||
156835909|NCT02504580|566151536|FG007|Overall Study|Other|2|||
156835910|NCT02504580|566151537|FG008|Overall Study|Other|0|||
156835911|NCT02504580|566151538|FG009|Overall Study|Other|0|||
156835912|NCT02504580|566151539|FG010|Overall Study|Other|0|||
156835913|NCT02504580|566151540|FG011|Overall Study|Other|2|||
156835914|NCT02504580|566151529|FG000|Overall Study|Subject refusal to continue|0|||
156835915|NCT02504580|566151530|FG001|Overall Study|Subject refusal to continue|1|||
156835916|NCT02504580|566151531|FG002|Overall Study|Subject refusal to continue|0|||
156835917|NCT02504580|566151532|FG003|Overall Study|Subject refusal to continue|0|||
156835918|NCT02504580|566151533|FG004|Overall Study|Subject refusal to continue|0|||
156835919|NCT02504580|566151534|FG005|Overall Study|Subject refusal to continue|0|||
156835920|NCT02504580|566151535|FG006|Overall Study|Subject refusal to continue|0|||
156835921|NCT02504580|566151536|FG007|Overall Study|Subject refusal to continue|0|||
156835922|NCT02504580|566151537|FG008|Overall Study|Subject refusal to continue|0|||
156835923|NCT02504580|566151538|FG009|Overall Study|Subject refusal to continue|0|||
156835924|NCT02504580|566151539|FG010|Overall Study|Subject refusal to continue|0|||
156835925|NCT02504580|566151540|FG011|Overall Study|Subject refusal to continue|0|||
156835926|NCT04736628|566151543|FG000|Overall Study|Not treated|0|||
156835927|NCT04736628|566151544|FG001|Overall Study|Not treated|0|||
156835928|NCT04736628|566151545|FG002|Overall Study|Not treated|0|||
156886070|NCT02431260|566342472|FG009|Overall Study|Death|6|||
157152386|NCT00611130|567303476|FG001|Overall Study|Protocol noncompliance|6|||
157152387|NCT00611130|567303475|FG000|Overall Study|Withdrawal by Subject|6|||
157152388|NCT00611130|567303476|FG001|Overall Study|Withdrawal by Subject|5|||
157152389|NCT00611130|567303475|FG000|Overall Study|Other|5|||
157152390|NCT00611130|567303476|FG001|Overall Study|Other|4|||
157152391|NCT00611130|567303475|FG000|Overall Study|Incarceration|3|||
156835929|NCT04736628|566151546|FG003|Overall Study|Not treated|2|||
156835930|NCT04736628|566151543|FG000|Overall Study|Other reason than listed|1|||
156835931|NCT04736628|566151544|FG001|Overall Study|Other reason than listed|2|||
156886071|NCT02431260|566342473|FG010|Overall Study|Death|3|||
157152392|NCT00611130|567303476|FG001|Overall Study|Incarceration|2|||
157152393|NCT00611130|567303475|FG000|Overall Study|Administrative|1|||
156835932|NCT04736628|566151545|FG002|Overall Study|Other reason than listed|2|||
156835933|NCT04736628|566151546|FG003|Overall Study|Other reason than listed|3|||
156835934|NCT04736628|566151543|FG000|Overall Study|Protocol deviation|0|||
156835935|NCT04736628|566151544|FG001|Overall Study|Protocol deviation|0|||
156835936|NCT04736628|566151545|FG002|Overall Study|Protocol deviation|0|||
156835937|NCT04736628|566151546|FG003|Overall Study|Protocol deviation|1|||
156835938|NCT04736628|566151543|FG000|Overall Study|Burden of study procedures|1|||
156835939|NCT04736628|566151544|FG001|Overall Study|Burden of study procedures|0|||
156835940|NCT04736628|566151545|FG002|Overall Study|Burden of study procedures|0|||
157152394|NCT00611130|567303476|FG001|Overall Study|Administrative|1|||
156835941|NCT04736628|566151546|FG003|Overall Study|Burden of study procedures|1|||
156835942|NCT04736628|566151543|FG000|Overall Study|Change of residence|0|||
156886072|NCT02431260|566342474|FG011|Overall Study|Death|2|||
156835943|NCT04736628|566151544|FG001|Overall Study|Change of residence|1|||
156835944|NCT04736628|566151545|FG002|Overall Study|Change of residence|0|||
156835945|NCT04736628|566151546|FG003|Overall Study|Change of residence|0|||
156835946|NCT04736628|566151543|FG000|Overall Study|Perceived lack of efficacy|1|||
156835947|NCT04736628|566151544|FG001|Overall Study|Perceived lack of efficacy|0|||
156835948|NCT04736628|566151545|FG002|Overall Study|Perceived lack of efficacy|0|||
156835949|NCT04736628|566151546|FG003|Overall Study|Perceived lack of efficacy|1|||
156835950|NCT04736628|566151543|FG000|Overall Study|Adverse Event|3|||
156835951|NCT04736628|566151544|FG001|Overall Study|Adverse Event|2|||
156835952|NCT04736628|566151545|FG002|Overall Study|Adverse Event|4|||
156835953|NCT04736628|566151546|FG003|Overall Study|Adverse Event|3|||
156835954|NCT00680368|566151547|FG000|Overall Study|not supervised, not eligible|15|||
156835955|NCT04094584|566151549|FG000|Overall Study|No interest in study|88|||
156835956|NCT04094584|566151549|FG000|Overall Study|Unwilling to undergo screening tests|36|||
156835957|NCT04094584|566151549|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
156835958|NCT04094584|566151549|FG000|Overall Study|Opioid use|7|||
156835959|NCT04094584|566151549|FG000|Overall Study|Need for major surgery in study period|4|||
156835960|NCT04094584|566151549|FG000|Overall Study|eligible but declined enrollment|4|||
156835961|NCT04094584|566151549|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
156835962|NCT04094584|566151549|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
156835963|NCT04094584|566151549|FG000|Overall Study|Lost to Follow-up|3|||
156835964|NCT04094584|566151549|FG000|Overall Study|Withdrawal by Subject|2|||
156835965|NCT00652899|566151553|FG000|Overall Study|Death|1|||
156835966|NCT00652899|566151553|FG000|Overall Study|Treating physician decision|1|||
156835967|NCT04135859|566151554|FG000|Overall Study|Withdrawal by Subject|1|||
156835968|NCT04135859|566151555|FG001|Overall Study|Withdrawal by Subject|0|||
156835969|NCT04135859|566151554|FG000|Overall Study|Withdrawal due to screening failure|1|||
156835970|NCT04135859|566151555|FG001|Overall Study|Withdrawal due to screening failure|2|||
156835971|NCT04135859|566151554|FG000|Overall Study|Did not complete stress test|3|||
156835972|NCT04135859|566151555|FG001|Overall Study|Did not complete stress test|3|||
156835973|NCT04135859|566151554|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
156835974|NCT04135859|566151555|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
156835975|NCT01600053|566151556|FG000|Overall Study|Adverse Event|2|||
156835976|NCT01600053|566151556|FG000|Overall Study|trial will not meet the interim endpoint|9|||
156835977|NCT01565941|566151557|FG000|Overall Study|Withdrawn by parent/guardian|3|||
156835978|NCT01565941|566151558|FG001|Overall Study|Withdrawn by parent/guardian|2|||
156835979|NCT01565941|566151557|FG000|Overall Study|Randomized; did not receive intevention|8|||
156835980|NCT01565941|566151558|FG001|Overall Study|Randomized; did not receive intevention|2|||
156835981|NCT03629912|566151564|FG000|Overall Study|Lost to Follow-up|19|||
156835982|NCT03629912|566151565|FG001|Overall Study|Lost to Follow-up|7|||
156835983|NCT03629912|566151566|FG002|Overall Study|Lost to Follow-up|5|||
156835984|NCT03629912|566151567|FG003|Overall Study|Lost to Follow-up|1|||
156835985|NCT03629912|566151564|FG000|Overall Study|Withdrawal by Subject|6|||
156835986|NCT03629912|566151565|FG001|Overall Study|Withdrawal by Subject|0|||
156835987|NCT03629912|566151566|FG002|Overall Study|Withdrawal by Subject|1|||
156835988|NCT03629912|566151567|FG003|Overall Study|Withdrawal by Subject|2|||
156835989|NCT03629912|566151564|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
156835990|NCT03629912|566151565|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
156835991|NCT03629912|566151566|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
156835992|NCT03629912|566151567|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
156835993|NCT03629912|566151564|FG000|Overall Study|Death|1|||
156835994|NCT03629912|566151565|FG001|Overall Study|Death|0|||
156835995|NCT03629912|566151566|FG002|Overall Study|Death|0|||
156835996|NCT03629912|566151567|FG003|Overall Study|Death|0|||
156835997|NCT02049138|566151573|FG000|Overall Study|Adverse Event|46|||
156835998|NCT02049138|566151574|FG001|Overall Study|Adverse Event|25|||
156835999|NCT02049138|566151575|FG002|Overall Study|Adverse Event|1|||
156836000|NCT02049138|566151573|FG000|Overall Study|Withdrawal by Subject|57|||
156836001|NCT02049138|566151574|FG001|Overall Study|Withdrawal by Subject|21|||
156836002|NCT02049138|566151575|FG002|Overall Study|Withdrawal by Subject|5|||
156836003|NCT02049138|566151573|FG000|Overall Study|Lost to Follow-up|18|||
156836004|NCT02049138|566151574|FG001|Overall Study|Lost to Follow-up|5|||
156836005|NCT02049138|566151575|FG002|Overall Study|Lost to Follow-up|1|||
157023636|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
157023637|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
156836006|NCT02049138|566151573|FG000|Overall Study|Lack of Efficacy|10|||
156836007|NCT02049138|566151574|FG001|Overall Study|Lack of Efficacy|26|||
156836008|NCT02049138|566151575|FG002|Overall Study|Lack of Efficacy|1|||
156836009|NCT02049138|566151573|FG000|Overall Study|Non-Compliance|15|||
156836010|NCT02049138|566151574|FG001|Overall Study|Non-Compliance|6|||
156836011|NCT02049138|566151575|FG002|Overall Study|Non-Compliance|0|||
156886073|NCT02431260|566342475|FG012|Overall Study|Death|5|||
157091554|NCT00994682|567089165|FG001|Double Bilnd|Adverse Event|0|||
157224676|NCT03504852|567568057|FG000|Overall Study|Lost to Follow-up|4|||
156836012|NCT02049138|566151573|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
156836013|NCT02049138|566151574|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
156836014|NCT02049138|566151575|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
156836015|NCT02049138|566151573|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
156836016|NCT02049138|566151574|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156836017|NCT02049138|566151575|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
156836018|NCT02049138|566151573|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156836019|NCT02049138|566151574|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
156836020|NCT02049138|566151575|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156836021|NCT02049138|566151573|FG000|Overall Study|Other|15|||
156836022|NCT02049138|566151574|FG001|Overall Study|Other|13|||
156836023|NCT02049138|566151575|FG002|Overall Study|Other|0|||
156836024|NCT02049138|566151573|FG000|Overall Study|Missing|0|||
156836025|NCT02049138|566151574|FG001|Overall Study|Missing|1|||
156836026|NCT02049138|566151575|FG002|Overall Study|Missing|0|||
156836027|NCT05086510|566151576|FG000|Overall Study|Lost to Follow-up|0|||
156836028|NCT05086510|566151577|FG001|Overall Study|Lost to Follow-up|2|||
156836029|NCT05086510|566151576|FG000|Overall Study|Death|0|||
156836030|NCT05086510|566151577|FG001|Overall Study|Death|2|||
156836031|NCT00521222|566151578|FG000|Overall Study|Lost to Follow-up|0|||
156836032|NCT00521222|566151579|FG001|Overall Study|Lost to Follow-up|0|||
156836033|NCT00521222|566151580|FG002|Overall Study|Lost to Follow-up|1|||
156836034|NCT00521222|566151581|FG003|Overall Study|Lost to Follow-up|1|||
156836035|NCT00521222|566151578|FG000|Overall Study|Withdrawal by Subject|0|||
156836036|NCT00521222|566151579|FG001|Overall Study|Withdrawal by Subject|0|||
156836037|NCT00521222|566151580|FG002|Overall Study|Withdrawal by Subject|2|||
156836038|NCT00521222|566151581|FG003|Overall Study|Withdrawal by Subject|0|||
156836039|NCT00521222|566151578|FG000|Overall Study|Physician Decision|0|||
156836040|NCT00521222|566151579|FG001|Overall Study|Physician Decision|1|||
156836041|NCT00521222|566151580|FG002|Overall Study|Physician Decision|0|||
156836042|NCT00521222|566151581|FG003|Overall Study|Physician Decision|1|||
156836043|NCT02598128|566151584|FG000|Period A: Days -7 to -1|Adverse Event|1|||
156836044|NCT02598128|566151585|FG001|Period A: Days -7 to -1|Adverse Event|0|||
156836045|NCT02598128|566151586|FG002|Period A: Days -7 to -1|Adverse Event|0|||
156836046|NCT02598128|566151587|FG003|Period A: Days -7 to -1|Adverse Event|0|||
156836047|NCT01064687|566151588|FG000|Overall Study|Adverse Event|9|||
156836048|NCT01064687|566151589|FG001|Overall Study|Adverse Event|4|||
156836049|NCT01064687|566151590|FG002|Overall Study|Adverse Event|10|||
156836050|NCT01064687|566151591|FG003|Overall Study|Adverse Event|3|||
156836051|NCT01064687|566151588|FG000|Overall Study|Death|1|||
156836052|NCT01064687|566151589|FG001|Overall Study|Death|1|||
156836053|NCT01064687|566151590|FG002|Overall Study|Death|0|||
156836054|NCT01064687|566151591|FG003|Overall Study|Death|0|||
157224677|NCT03504852|567568058|FG001|Overall Study|Lost to Follow-up|1|||
156836055|NCT01064687|566151588|FG000|Overall Study|Entry Criteria Not Met|3|||
156836056|NCT01064687|566151589|FG001|Overall Study|Entry Criteria Not Met|0|||
156836057|NCT01064687|566151590|FG002|Overall Study|Entry Criteria Not Met|0|||
156836058|NCT01064687|566151591|FG003|Overall Study|Entry Criteria Not Met|0|||
156836059|NCT01064687|566151588|FG000|Overall Study|Lack of Efficacy|1|||
156836060|NCT01064687|566151589|FG001|Overall Study|Lack of Efficacy|0|||
156836061|NCT01064687|566151590|FG002|Overall Study|Lack of Efficacy|2|||
156836062|NCT01064687|566151591|FG003|Overall Study|Lack of Efficacy|3|||
156836063|NCT01064687|566151588|FG000|Overall Study|Lost to Follow-up|7|||
156836064|NCT01064687|566151589|FG001|Overall Study|Lost to Follow-up|10|||
156836065|NCT01064687|566151590|FG002|Overall Study|Lost to Follow-up|13|||
156836066|NCT01064687|566151591|FG003|Overall Study|Lost to Follow-up|5|||
156836067|NCT01064687|566151588|FG000|Overall Study|Physician Decision|2|||
156836068|NCT01064687|566151589|FG001|Overall Study|Physician Decision|2|||
156836069|NCT01064687|566151590|FG002|Overall Study|Physician Decision|0|||
156836070|NCT01064687|566151591|FG003|Overall Study|Physician Decision|0|||
156836071|NCT01064687|566151588|FG000|Overall Study|Protocol Violation|1|||
156836072|NCT01064687|566151589|FG001|Overall Study|Protocol Violation|1|||
156836073|NCT01064687|566151590|FG002|Overall Study|Protocol Violation|0|||
156836074|NCT01064687|566151591|FG003|Overall Study|Protocol Violation|1|||
156836075|NCT01064687|566151588|FG000|Overall Study|Sponsor Decision|0|||
156836076|NCT01064687|566151589|FG001|Overall Study|Sponsor Decision|0|||
156836077|NCT01064687|566151590|FG002|Overall Study|Sponsor Decision|3|||
156836078|NCT01064687|566151591|FG003|Overall Study|Sponsor Decision|0|||
156836079|NCT01064687|566151588|FG000|Overall Study|Withdrawal by Subject|9|||
156836080|NCT01064687|566151589|FG001|Overall Study|Withdrawal by Subject|7|||
156836081|NCT01064687|566151590|FG002|Overall Study|Withdrawal by Subject|12|||
156836082|NCT01064687|566151591|FG003|Overall Study|Withdrawal by Subject|5|||
156836083|NCT01064687|566151588|FG000|Overall Study|Treatment Noncompliance|1|||
156836084|NCT01064687|566151589|FG001|Overall Study|Treatment Noncompliance|1|||
156836085|NCT01064687|566151590|FG002|Overall Study|Treatment Noncompliance|1|||
156836086|NCT01064687|566151591|FG003|Overall Study|Treatment Noncompliance|0|||
156836087|NCT05219669|566151594|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836088|NCT05219669|566151595|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836089|NCT05219669|566151596|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
156836090|NCT05219669|566151597|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836091|NCT05219669|566151598|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836092|NCT05219669|566151599|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
156836093|NCT03134183|566151601|FG000|Overall Study|Withdrawal by Subject|1|||
156836094|NCT03134183|566151602|FG001|Overall Study|Withdrawal by Subject|1|||
156836095|NCT02177838|566151603|FG000|Overall Study|Withdrawal by Subject|1|||
156836096|NCT02177838|566151603|FG000|Overall Study|Physician Decision|1|||
156836097|NCT02177838|566151603|FG000|Overall Study|Death|1|||
156836098|NCT02404649|566151604|FG000|Overall Study|Adverse Event|1|||
156836099|NCT02404649|566151605|FG001|Overall Study|Adverse Event|2|||
156836100|NCT01595581|566151615|FG000|Overall Study|Withdrawal by Subject|1|||
156836101|NCT01595581|566151616|FG001|Overall Study|Withdrawal by Subject|0|||
156836102|NCT01969721|566151619|FG000|Overall Study|Adverse Event|3|||
156836103|NCT01969721|566151620|FG001|Overall Study|Adverse Event|8|||
156836104|NCT01969721|566151621|FG002|Overall Study|Adverse Event|3|||
156836105|NCT01969721|566151622|FG003|Overall Study|Adverse Event|2|||
156836106|NCT01969721|566151619|FG000|Overall Study|Lack of Efficacy|0|||
156836107|NCT01969721|566151620|FG001|Overall Study|Lack of Efficacy|0|||
156836108|NCT01969721|566151621|FG002|Overall Study|Lack of Efficacy|1|||
156836109|NCT01969721|566151622|FG003|Overall Study|Lack of Efficacy|0|||
156836110|NCT01969721|566151619|FG000|Overall Study|Non compliant with protocol|1|||
156836111|NCT01969721|566151620|FG001|Overall Study|Non compliant with protocol|1|||
156836112|NCT01969721|566151621|FG002|Overall Study|Non compliant with protocol|0|||
156836113|NCT01969721|566151622|FG003|Overall Study|Non compliant with protocol|2|||
156836114|NCT01969721|566151619|FG000|Overall Study|Other not defined above|0|||
156836115|NCT01969721|566151620|FG001|Overall Study|Other not defined above|2|||
156836116|NCT01969721|566151621|FG002|Overall Study|Other not defined above|0|||
157152395|NCT00611130|567303475|FG000|Overall Study|Adverse Event|1|||
157152396|NCT00611130|567303476|FG001|Overall Study|Adverse Event|0|||
157152397|NCT00611130|567303475|FG000|Overall Study|Death|1|||
157152398|NCT00611130|567303476|FG001|Overall Study|Death|0|||
156836117|NCT01969721|566151622|FG003|Overall Study|Other not defined above|0|||
156836118|NCT01969721|566151619|FG000|Overall Study|Discontinued during washout periods.|0|||
156836119|NCT01969721|566151620|FG001|Overall Study|Discontinued during washout periods.|1|||
156836120|NCT01969721|566151621|FG002|Overall Study|Discontinued during washout periods.|1|||
156836121|NCT01969721|566151622|FG003|Overall Study|Discontinued during washout periods.|2|||
156836122|NCT02273960|566151623|FG000|Short Term Period|Lost to Follow-up|1|||
156836123|NCT02273960|566151624|FG001|Short Term Period|Lost to Follow-up|0|||
156836124|NCT02273960|566151625|FG002|Short Term Period|Lost to Follow-up|0|||
156836125|NCT02273960|566151626|FG003|Short Term Period|Lost to Follow-up|0|||
156836126|NCT02273960|566151623|FG000|Short Term Period|Lack of Efficacy|0|||
156836127|NCT02273960|566151624|FG001|Short Term Period|Lack of Efficacy|0|||
156836128|NCT02273960|566151625|FG002|Short Term Period|Lack of Efficacy|0|||
156836129|NCT02273960|566151626|FG003|Short Term Period|Lack of Efficacy|1|||
156836130|NCT02273960|566151623|FG000|Short Term Period|ST complete, not entering LTE|4|||
156836131|NCT02273960|566151624|FG001|Short Term Period|ST complete, not entering LTE|6|||
156836132|NCT02273960|566151625|FG002|Short Term Period|ST complete, not entering LTE|4|||
156836133|NCT02273960|566151626|FG003|Short Term Period|ST complete, not entering LTE|5|||
156836134|NCT02273960|566151623|FG000|Long Term Extension|Death|0|||
156836135|NCT02273960|566151624|FG001|Long Term Extension|Death|0|||
156836136|NCT02273960|566151625|FG002|Long Term Extension|Death|0|||
156836137|NCT02273960|566151626|FG003|Long Term Extension|Death|1|||
156836138|NCT01105377|566151632|FG000|Overall Study|Withdrawal by Subject|0|||
156836139|NCT01105377|566151633|FG001|Overall Study|Withdrawal by Subject|1|||
156836140|NCT00483002|566151635|FG000|Overall Study|Adverse Event|68|||
156836141|NCT00483002|566151635|FG000|Overall Study|Lack of Efficacy|555|||
156836142|NCT00483002|566151635|FG000|Overall Study|Lost to Follow-up|962|||
156836143|NCT00483002|566151635|FG000|Overall Study|Other|2|||
156836144|NCT00483002|566151635|FG000|Overall Study|Other|967|||
156836145|NCT02014584|566151636|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
157152399|NCT01137435|567303485|FG000|Overall Study|Lost to Follow-up|24|||
157152400|NCT01137435|567303485|FG000|Overall Study|Off label usage|4|||
157152401|NCT00652093|567303486|FG000|Overall Study|Withdrawal by Subject|0|||
156836146|NCT02014584|566151637|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
156836147|NCT02014584|566151638|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836148|NCT02014584|566151639|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
157152402|NCT00652093|567303487|FG001|Overall Study|Withdrawal by Subject|0|||
157152403|NCT00652093|567303488|FG002|Overall Study|Withdrawal by Subject|1|||
157152404|NCT00652093|567303489|FG003|Overall Study|Withdrawal by Subject|0|||
156836149|NCT02014584|566151640|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836150|NCT02014584|566151641|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
156836151|NCT02014584|566151636|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
156836152|NCT02014584|566151637|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
156836153|NCT02014584|566151638|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
157152405|NCT00652093|567303490|FG004|Overall Study|Withdrawal by Subject|1|||
157152406|NCT00652093|567303491|FG005|Overall Study|Withdrawal by Subject|0|||
157152407|NCT00652093|567303486|FG000|Overall Study|Physician Decision|0|||
157152408|NCT00652093|567303487|FG001|Overall Study|Physician Decision|0|||
157152409|NCT00652093|567303488|FG002|Overall Study|Physician Decision|0|||
157152410|NCT00652093|567303489|FG003|Overall Study|Physician Decision|0|||
157152411|NCT00652093|567303490|FG004|Overall Study|Physician Decision|1|||
157152412|NCT00652093|567303491|FG005|Overall Study|Physician Decision|0|||
157152413|NCT00866294|567303494|FG000|Overall Study|Adverse Event|12|||
157152414|NCT00866294|567303495|FG001|Overall Study|Adverse Event|13|||
156836154|NCT02014584|566151639|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836155|NCT02014584|566151640|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836156|NCT02014584|566151641|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
156836157|NCT02014584|566151636|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836158|NCT02014584|566151637|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836159|NCT02014584|566151638|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
156836160|NCT02014584|566151639|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836161|NCT02014584|566151640|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836162|NCT02014584|566151641|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
156836163|NCT02014584|566151636|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836164|NCT02014584|566151637|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836165|NCT02014584|566151638|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
156836166|NCT02014584|566151639|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
156836167|NCT02014584|566151640|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836168|NCT02014584|566151641|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
156836169|NCT02014584|566151636|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836170|NCT02014584|566151637|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836171|NCT02014584|566151638|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836172|NCT02014584|566151639|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836173|NCT02014584|566151640|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
156836174|NCT02014584|566151641|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
156836175|NCT02651220|566151642|FG000|Overall Study|Adverse Event|1|||
156836176|NCT02651220|566151643|FG001|Overall Study|Adverse Event|5|||
156836177|NCT02651220|566151644|FG002|Overall Study|Adverse Event|1|||
156836178|NCT02651220|566151642|FG000|Overall Study|Lost to Follow-up|8|||
156836179|NCT02651220|566151643|FG001|Overall Study|Lost to Follow-up|14|||
156836180|NCT02651220|566151644|FG002|Overall Study|Lost to Follow-up|14|||
156836181|NCT02651220|566151642|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156836182|NCT02651220|566151643|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156836183|NCT02651220|566151644|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156836184|NCT02651220|566151642|FG000|Overall Study|Pregnancy|1|||
156836185|NCT02651220|566151643|FG001|Overall Study|Pregnancy|0|||
156836186|NCT02651220|566151644|FG002|Overall Study|Pregnancy|1|||
156836187|NCT02651220|566151642|FG000|Overall Study|Protocol Violation|0|||
156836188|NCT02651220|566151643|FG001|Overall Study|Protocol Violation|0|||
156836189|NCT02651220|566151644|FG002|Overall Study|Protocol Violation|1|||
156836190|NCT02651220|566151642|FG000|Overall Study|Withdrawal by Subject|5|||
156836191|NCT02651220|566151643|FG001|Overall Study|Withdrawal by Subject|6|||
156836192|NCT02651220|566151644|FG002|Overall Study|Withdrawal by Subject|8|||
156836193|NCT02651220|566151642|FG000|Overall Study|Miscellaneous|4|||
156836194|NCT02651220|566151643|FG001|Overall Study|Miscellaneous|1|||
156836195|NCT02651220|566151644|FG002|Overall Study|Miscellaneous|2|||
156836196|NCT02651220|566151642|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156836197|NCT02651220|566151643|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156836198|NCT02651220|566151644|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
156836199|NCT00447122|566151645|FG000|Overall Study|worsening medical condition -came off|0|||
156836200|NCT00447122|566151646|FG001|Overall Study|worsening medical condition -came off|1|||
156836201|NCT00447122|566151647|FG002|Overall Study|worsening medical condition -came off|0|||
156836202|NCT00447122|566151648|FG003|Overall Study|worsening medical condition -came off|0|||
156836203|NCT01439373|566151653|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
156836204|NCT01439373|566151654|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
156836205|NCT01439373|566151653|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
156836206|NCT01439373|566151654|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
156836207|NCT04046250|566151657|FG000|Overall Study|Death|0|||
156836208|NCT04046250|566151658|FG001|Overall Study|Death|1|||
156836209|NCT04046250|566151657|FG000|Overall Study|Withdrawal by Subject|3|||
157152415|NCT00866294|567303496|FG002|Overall Study|Adverse Event|9|||
157152416|NCT00866294|567303494|FG000|Overall Study|Lack of Efficacy|7|||
157152417|NCT00866294|567303495|FG001|Overall Study|Lack of Efficacy|1|||
157152418|NCT00866294|567303496|FG002|Overall Study|Lack of Efficacy|0|||
157152419|NCT00866294|567303494|FG000|Overall Study|Protocol Violation|2|||
156836210|NCT04046250|566151658|FG001|Overall Study|Withdrawal by Subject|3|||
157152420|NCT00866294|567303495|FG001|Overall Study|Protocol Violation|0|||
157152421|NCT00866294|567303496|FG002|Overall Study|Protocol Violation|0|||
157152422|NCT00866294|567303494|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
157152423|NCT00866294|567303495|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157152424|NCT00866294|567303496|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157152425|NCT00866294|567303494|FG000|Overall Study|Lost to Follow-up|1|||
157152426|NCT00866294|567303495|FG001|Overall Study|Lost to Follow-up|3|||
157152427|NCT00866294|567303496|FG002|Overall Study|Lost to Follow-up|0|||
157152428|NCT00866294|567303494|FG000|Overall Study|Physician Decision|6|||
157152429|NCT00866294|567303495|FG001|Overall Study|Physician Decision|2|||
157152430|NCT00866294|567303496|FG002|Overall Study|Physician Decision|1|||
157152431|NCT00515463|567303497|FG000|Overall Study|Physician Decision|4|||
157152432|NCT00515463|567303498|FG001|Overall Study|Physician Decision|2|||
157152433|NCT00515463|567303497|FG000|Overall Study|Adverse Event|1|||
157152434|NCT00515463|567303498|FG001|Overall Study|Adverse Event|2|||
157152435|NCT00515463|567303497|FG000|Overall Study|Withdrawal by Subject|3|||
157152436|NCT00515463|567303498|FG001|Overall Study|Withdrawal by Subject|4|||
157152437|NCT00515463|567303497|FG000|Overall Study|Lost to Follow-up|6|||
157152438|NCT00515463|567303498|FG001|Overall Study|Lost to Follow-up|5|||
157152439|NCT00515463|567303497|FG000|Overall Study|Other|0|||
157152440|NCT00515463|567303498|FG001|Overall Study|Other|1|||
157152441|NCT00916721|567303499|FG000|Overall Study|Lost to Follow-up|0|||
157152442|NCT00916721|567303500|FG001|Overall Study|Lost to Follow-up|1|||
157152443|NCT00916721|567303499|FG000|Overall Study|Adverse Event|6|||
157152444|NCT00916721|567303500|FG001|Overall Study|Adverse Event|3|||
157152445|NCT00916721|567303499|FG000|Overall Study|Withdrawal by Subject|2|||
157152446|NCT00916721|567303500|FG001|Overall Study|Withdrawal by Subject|2|||
157152447|NCT00916721|567303499|FG000|Overall Study|Protocol Violation|2|||
157152448|NCT00916721|567303500|FG001|Overall Study|Protocol Violation|4|||
157152449|NCT01469052|567303503|FG000|Overall Study|Adverse Event|2|||
157152450|NCT01469052|567303504|FG001|Overall Study|Adverse Event|3|||
157152451|NCT01469052|567303505|FG002|Overall Study|Adverse Event|0|||
157152452|NCT01469052|567303506|FG003|Overall Study|Adverse Event|2|||
157152453|NCT01469052|567303507|FG004|Overall Study|Adverse Event|0|||
157152454|NCT01469052|567303508|FG005|Overall Study|Adverse Event|1|||
157152455|NCT01469052|567303503|FG000|Overall Study|Progressive disease|3|||
157152456|NCT01469052|567303504|FG001|Overall Study|Progressive disease|0|||
157152457|NCT01469052|567303505|FG002|Overall Study|Progressive disease|5|||
157152458|NCT01469052|567303506|FG003|Overall Study|Progressive disease|3|||
157152459|NCT01469052|567303507|FG004|Overall Study|Progressive disease|7|||
157152460|NCT01469052|567303508|FG005|Overall Study|Progressive disease|2|||
157152461|NCT01469052|567303503|FG000|Overall Study|Lack of Efficacy|0|||
157152462|NCT01469052|567303504|FG001|Overall Study|Lack of Efficacy|0|||
157152463|NCT01469052|567303505|FG002|Overall Study|Lack of Efficacy|0|||
157152464|NCT01469052|567303506|FG003|Overall Study|Lack of Efficacy|0|||
157152465|NCT01469052|567303507|FG004|Overall Study|Lack of Efficacy|0|||
157152466|NCT01469052|567303508|FG005|Overall Study|Lack of Efficacy|2|||
157152467|NCT01469052|567303503|FG000|Overall Study|Moved to rollover protocol|1|||
157152468|NCT01469052|567303504|FG001|Overall Study|Moved to rollover protocol|0|||
157152469|NCT01469052|567303505|FG002|Overall Study|Moved to rollover protocol|1|||
157152470|NCT01469052|567303506|FG003|Overall Study|Moved to rollover protocol|0|||
157152471|NCT01469052|567303507|FG004|Overall Study|Moved to rollover protocol|0|||
157152472|NCT01469052|567303508|FG005|Overall Study|Moved to rollover protocol|1|||
157152473|NCT01469052|567303503|FG000|Overall Study|Other|0|||
157152474|NCT01469052|567303504|FG001|Overall Study|Other|1|||
157152475|NCT01469052|567303505|FG002|Overall Study|Other|0|||
157152476|NCT01469052|567303506|FG003|Overall Study|Other|0|||
157152477|NCT01469052|567303507|FG004|Overall Study|Other|1|||
157152478|NCT01469052|567303508|FG005|Overall Study|Other|0|||
157152479|NCT02749370|567303510|FG000|Overall Study|Withdrawal by Subject|11|||
157152480|NCT02749370|567303510|FG000|Overall Study|Lost to Follow-up|3|||
157152481|NCT03894904|567303514|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
157152482|NCT03894904|567303515|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
157152483|NCT03894904|567303514|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
157152484|NCT03894904|567303515|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
157152485|NCT00651118|567303518|FG000|Overall Study|Adverse Event|4|||
157152486|NCT00651118|567303519|FG001|Overall Study|Adverse Event|0|||
157152487|NCT00651118|567303520|FG002|Overall Study|Adverse Event|1|||
157152488|NCT00651118|567303521|FG003|Overall Study|Adverse Event|1|||
157152489|NCT00651118|567303518|FG000|Overall Study|Protocol Violation|2|||
157152490|NCT00651118|567303519|FG001|Overall Study|Protocol Violation|2|||
157152491|NCT00651118|567303520|FG002|Overall Study|Protocol Violation|6|||
157152492|NCT00651118|567303521|FG003|Overall Study|Protocol Violation|2|||
157152493|NCT00651118|567303518|FG000|Overall Study|Lost to Follow-up|2|||
157152494|NCT00651118|567303519|FG001|Overall Study|Lost to Follow-up|0|||
157152495|NCT00651118|567303520|FG002|Overall Study|Lost to Follow-up|1|||
157152496|NCT00651118|567303521|FG003|Overall Study|Lost to Follow-up|2|||
157152497|NCT00651118|567303518|FG000|Overall Study|administrative|1|||
157152498|NCT00651118|567303519|FG001|Overall Study|administrative|4|||
157152499|NCT00651118|567303520|FG002|Overall Study|administrative|2|||
157023638|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
157023639|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
157023640|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
157023641|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
157023642|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
157023643|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
157023644|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
157023645|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
157023646|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
157023647|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
157023648|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
157023649|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
157023650|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
157023651|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
157023652|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
157023653|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
157023654|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
157023655|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
157023656|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
157023657|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
157023658|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
157023659|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
157152500|NCT00651118|567303521|FG003|Overall Study|administrative|1|||
157152501|NCT00651118|567303518|FG000|Overall Study|Withdrawal by Subject|0|||
156836211|NCT03834220|566151663|FG000|Overall Study|Adverse Event|1|||
156836212|NCT03834220|566151664|FG001|Overall Study|Adverse Event|0|||
156836213|NCT03834220|566151665|FG002|Overall Study|Adverse Event|0|||
156836214|NCT03834220|566151663|FG000|Overall Study|Death|8|||
156836215|NCT03834220|566151664|FG001|Overall Study|Death|1|||
156836216|NCT03834220|566151665|FG002|Overall Study|Death|17|||
156836217|NCT03834220|566151663|FG000|Overall Study|Reason not Specified|9|||
156836218|NCT03834220|566151664|FG001|Overall Study|Reason not Specified|0|||
156836219|NCT03834220|566151665|FG002|Overall Study|Reason not Specified|6|||
156836220|NCT03834220|566151663|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
156836221|NCT03834220|566151664|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
156836222|NCT03834220|566151665|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
156836223|NCT03834220|566151663|FG000|Overall Study|Withdrawal of Consent|2|||
156836224|NCT03834220|566151664|FG001|Overall Study|Withdrawal of Consent|2|||
156836225|NCT03834220|566151665|FG002|Overall Study|Withdrawal of Consent|2|||
156836226|NCT02593318|566151668|FG000|Overall Study|Withdrawal by Subject|1|||
156836227|NCT02593318|566151669|FG001|Overall Study|Withdrawal by Subject|1|||
156836228|NCT03684694|566151671|FG000|Phase 1|Withdrawal by Subject|1|||
156836229|NCT03684694|566151672|FG001|Phase 1|Withdrawal by Subject|0|||
156836230|NCT03684694|566151673|FG002|Phase 1|Withdrawal by Subject|0|||
156836231|NCT03684694|566151674|FG003|Phase 1|Withdrawal by Subject|0|||
156836232|NCT03684694|566151675|FG004|Phase 1|Withdrawal by Subject|0|||
156836233|NCT03684694|566151676|FG005|Phase 1|Withdrawal by Subject|0|||
156836234|NCT03684694|566151671|FG000|Phase 1|Investigator/Sponsor Decision|12|||
156836235|NCT03684694|566151672|FG001|Phase 1|Investigator/Sponsor Decision|2|||
156836236|NCT03684694|566151673|FG002|Phase 1|Investigator/Sponsor Decision|1|||
156836237|NCT03684694|566151674|FG003|Phase 1|Investigator/Sponsor Decision|0|||
156836238|NCT03684694|566151675|FG004|Phase 1|Investigator/Sponsor Decision|0|||
156886074|NCT02431260|566342476|FG013|Overall Study|Death|1|||
156886075|NCT02431260|566342463|FG000|Overall Study|Lost to Follow-up|0|||
156886076|NCT02431260|566342464|FG001|Overall Study|Lost to Follow-up|0|||
156886077|NCT02431260|566342465|FG002|Overall Study|Lost to Follow-up|0|||
156886078|NCT02431260|566342466|FG003|Overall Study|Lost to Follow-up|0|||
156886079|NCT02431260|566342467|FG004|Overall Study|Lost to Follow-up|0|||
156886080|NCT02431260|566342468|FG005|Overall Study|Lost to Follow-up|1|||
156886081|NCT02431260|566342469|FG006|Overall Study|Lost to Follow-up|0|||
156886082|NCT02431260|566342470|FG007|Overall Study|Lost to Follow-up|0|||
157023660|NCT01369355|566841104|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
157152502|NCT00651118|567303519|FG001|Overall Study|Withdrawal by Subject|1|||
156836239|NCT03684694|566151676|FG005|Phase 1|Investigator/Sponsor Decision|0|||
156886083|NCT02431260|566342471|FG008|Overall Study|Lost to Follow-up|0|||
157152503|NCT00651118|567303520|FG002|Overall Study|Withdrawal by Subject|1|||
157152504|NCT00651118|567303521|FG003|Overall Study|Withdrawal by Subject|1|||
157224678|NCT03504852|567568059|FG002|Overall Study|Lost to Follow-up|0|||
156836240|NCT03684694|566151671|FG000|Phase 1|Death|24|||
156836241|NCT03684694|566151672|FG001|Phase 1|Death|0|||
156836242|NCT03684694|566151673|FG002|Phase 1|Death|3|||
156836243|NCT03684694|566151674|FG003|Phase 1|Death|0|||
156836244|NCT03684694|566151675|FG004|Phase 1|Death|0|||
156836245|NCT03684694|566151676|FG005|Phase 1|Death|0|||
156886084|NCT02431260|566342472|FG009|Overall Study|Lost to Follow-up|0|||
156886085|NCT02431260|566342473|FG010|Overall Study|Lost to Follow-up|0|||
156836246|NCT03684694|566151671|FG000|Phase 1|Lost to Follow-up|0|||
156836247|NCT03684694|566151672|FG001|Phase 1|Lost to Follow-up|0|||
156836248|NCT03684694|566151673|FG002|Phase 1|Lost to Follow-up|1|||
156836249|NCT03684694|566151674|FG003|Phase 1|Lost to Follow-up|0|||
156836250|NCT03684694|566151675|FG004|Phase 1|Lost to Follow-up|0|||
156836251|NCT03684694|566151676|FG005|Phase 1|Lost to Follow-up|0|||
156836252|NCT03684694|566151671|FG000|Phase 1|Miscellaneous|0|||
156886086|NCT02431260|566342474|FG011|Overall Study|Lost to Follow-up|0|||
156886087|NCT02431260|566342475|FG012|Overall Study|Lost to Follow-up|0|||
156886088|NCT02431260|566342476|FG013|Overall Study|Lost to Follow-up|0|||
156886089|NCT02431260|566342463|FG000|Overall Study|Study Terminated by the Sponsor|0|||
156886090|NCT02431260|566342464|FG001|Overall Study|Study Terminated by the Sponsor|0|||
156886091|NCT02431260|566342465|FG002|Overall Study|Study Terminated by the Sponsor|2|||
156886092|NCT02431260|566342466|FG003|Overall Study|Study Terminated by the Sponsor|1|||
156886093|NCT02431260|566342467|FG004|Overall Study|Study Terminated by the Sponsor|1|||
156886094|NCT02431260|566342468|FG005|Overall Study|Study Terminated by the Sponsor|0|||
156886095|NCT02431260|566342469|FG006|Overall Study|Study Terminated by the Sponsor|1|||
156886096|NCT02431260|566342470|FG007|Overall Study|Study Terminated by the Sponsor|2|||
156886097|NCT02431260|566342471|FG008|Overall Study|Study Terminated by the Sponsor|1|||
156886098|NCT02431260|566342472|FG009|Overall Study|Study Terminated by the Sponsor|1|||
156886099|NCT02431260|566342473|FG010|Overall Study|Study Terminated by the Sponsor|1|||
156886100|NCT02431260|566342474|FG011|Overall Study|Study Terminated by the Sponsor|0|||
156886101|NCT02431260|566342475|FG012|Overall Study|Study Terminated by the Sponsor|4|||
156886102|NCT02431260|566342476|FG013|Overall Study|Study Terminated by the Sponsor|0|||
156886103|NCT02431260|566342463|FG000|Overall Study|Physician Decision|0|||
156886104|NCT02431260|566342464|FG001|Overall Study|Physician Decision|0|||
156886105|NCT02431260|566342465|FG002|Overall Study|Physician Decision|0|||
156886106|NCT02431260|566342466|FG003|Overall Study|Physician Decision|0|||
156886107|NCT02431260|566342467|FG004|Overall Study|Physician Decision|0|||
156886108|NCT02431260|566342468|FG005|Overall Study|Physician Decision|1|||
156886109|NCT02431260|566342469|FG006|Overall Study|Physician Decision|0|||
156886110|NCT02431260|566342470|FG007|Overall Study|Physician Decision|0|||
156886111|NCT02431260|566342471|FG008|Overall Study|Physician Decision|0|||
156886112|NCT02431260|566342472|FG009|Overall Study|Physician Decision|0|||
156886113|NCT02431260|566342473|FG010|Overall Study|Physician Decision|0|||
156886114|NCT02431260|566342474|FG011|Overall Study|Physician Decision|0|||
156836253|NCT03684694|566151672|FG001|Phase 1|Miscellaneous|1|||
156836254|NCT03684694|566151673|FG002|Phase 1|Miscellaneous|0|||
156836255|NCT03684694|566151674|FG003|Phase 1|Miscellaneous|0|||
156836256|NCT03684694|566151675|FG004|Phase 1|Miscellaneous|0|||
156836257|NCT03684694|566151676|FG005|Phase 1|Miscellaneous|0|||
156886115|NCT02431260|566342475|FG012|Overall Study|Physician Decision|0|||
156886116|NCT02431260|566342476|FG013|Overall Study|Physician Decision|0|||
156886117|NCT02431260|566342463|FG000|Overall Study|Other Unspecified|0|||
156886118|NCT02431260|566342464|FG001|Overall Study|Other Unspecified|0|||
156886119|NCT02431260|566342465|FG002|Overall Study|Other Unspecified|0|||
156886120|NCT02431260|566342466|FG003|Overall Study|Other Unspecified|0|||
156886121|NCT02431260|566342467|FG004|Overall Study|Other Unspecified|0|||
156886122|NCT02431260|566342468|FG005|Overall Study|Other Unspecified|0|||
156886123|NCT02431260|566342469|FG006|Overall Study|Other Unspecified|0|||
156886124|NCT02431260|566342470|FG007|Overall Study|Other Unspecified|0|||
156886125|NCT02431260|566342471|FG008|Overall Study|Other Unspecified|0|||
156886126|NCT02431260|566342472|FG009|Overall Study|Other Unspecified|0|||
156886127|NCT02431260|566342473|FG010|Overall Study|Other Unspecified|0|||
156886128|NCT02431260|566342474|FG011|Overall Study|Other Unspecified|1|||
156886129|NCT02431260|566342475|FG012|Overall Study|Other Unspecified|1|||
156886130|NCT02431260|566342476|FG013|Overall Study|Other Unspecified|0|||
156886131|NCT00439738|566342478|FG000|Overall Study|Withdrawal by Subject|16|||
156886132|NCT00439738|566342479|FG001|Overall Study|Withdrawal by Subject|13|||
156886133|NCT00439738|566342478|FG000|Overall Study|Adverse Event|6|||
156886134|NCT00439738|566342479|FG001|Overall Study|Adverse Event|4|||
156886135|NCT00439738|566342478|FG000|Overall Study|Lost to Follow-up|5|||
156886136|NCT00439738|566342479|FG001|Overall Study|Lost to Follow-up|6|||
156836258|NCT03684694|566151671|FG000|Phase 2|Withdrawal by Subject|0|||
156886137|NCT00439738|566342478|FG000|Overall Study|Protocol Violation|6|||
156886138|NCT00439738|566342479|FG001|Overall Study|Protocol Violation|3|||
156886139|NCT00439738|566342478|FG000|Overall Study|Lack of Efficacy|2|||
156886140|NCT00439738|566342479|FG001|Overall Study|Lack of Efficacy|2|||
156886141|NCT00439738|566342478|FG000|Overall Study|Abnormal Lab Values|1|||
156886142|NCT00439738|566342479|FG001|Overall Study|Abnormal Lab Values|0|||
156886143|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
156886144|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
156836259|NCT03684694|566151672|FG001|Phase 2|Withdrawal by Subject|0|||
156836260|NCT03684694|566151673|FG002|Phase 2|Withdrawal by Subject|0|||
156836261|NCT03684694|566151674|FG003|Phase 2|Withdrawal by Subject|0|||
156886145|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
156886146|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
156886147|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
156836262|NCT03684694|566151675|FG004|Phase 2|Withdrawal by Subject|0|||
156836263|NCT03684694|566151676|FG005|Phase 2|Withdrawal by Subject|1|||
156836264|NCT03684694|566151671|FG000|Phase 2|Investigator/Sponsor Decision|0|||
156836265|NCT03684694|566151672|FG001|Phase 2|Investigator/Sponsor Decision|0|||
156836266|NCT03684694|566151673|FG002|Phase 2|Investigator/Sponsor Decision|0|||
156836267|NCT03684694|566151674|FG003|Phase 2|Investigator/Sponsor Decision|17|||
156836268|NCT03684694|566151675|FG004|Phase 2|Investigator/Sponsor Decision|16|||
156836269|NCT03684694|566151676|FG005|Phase 2|Investigator/Sponsor Decision|6|||
156836270|NCT03684694|566151671|FG000|Phase 2|Death|0|||
156836271|NCT03684694|566151672|FG001|Phase 2|Death|0|||
156836272|NCT03684694|566151673|FG002|Phase 2|Death|0|||
156836273|NCT03684694|566151674|FG003|Phase 2|Death|28|||
156836274|NCT03684694|566151675|FG004|Phase 2|Death|14|||
156836275|NCT03684694|566151676|FG005|Phase 2|Death|3|||
156836276|NCT03684694|566151671|FG000|Phase 2|Lost to Follow-up|0|||
156836277|NCT03684694|566151672|FG001|Phase 2|Lost to Follow-up|0|||
156836278|NCT03684694|566151673|FG002|Phase 2|Lost to Follow-up|0|||
156836279|NCT03684694|566151674|FG003|Phase 2|Lost to Follow-up|1|||
156836280|NCT03684694|566151675|FG004|Phase 2|Lost to Follow-up|0|||
156836281|NCT03684694|566151676|FG005|Phase 2|Lost to Follow-up|0|||
156836282|NCT03684694|566151671|FG000|Phase 2|Miscellaneous|0|||
156836283|NCT03684694|566151672|FG001|Phase 2|Miscellaneous|0|||
156836284|NCT03684694|566151673|FG002|Phase 2|Miscellaneous|0|||
156836285|NCT03684694|566151674|FG003|Phase 2|Miscellaneous|3|||
157152505|NCT03117049|567303522|FG000|Overall Study|Continued the follow-up period|109|||
157152506|NCT03117049|567303523|FG001|Overall Study|Continued the follow-up period|129|||
157152507|NCT03117049|567303522|FG000|Overall Study|Died|82|||
157152508|NCT03117049|567303523|FG001|Overall Study|Died|93|||
157152509|NCT03117049|567303522|FG000|Overall Study|Consent withdrawal|7|||
157152510|NCT03117049|567303523|FG001|Overall Study|Consent withdrawal|6|||
157152511|NCT03117049|567303522|FG000|Overall Study|Missing contact|3|||
157152512|NCT03117049|567303523|FG001|Overall Study|Missing contact|3|||
157152513|NCT00839098|567303524|FG000|Overall Study|Withdrawal by Subject|2|||
157152514|NCT00839098|567303525|FG001|Overall Study|Withdrawal by Subject|1|||
157152515|NCT00839098|567303526|FG002|Overall Study|Withdrawal by Subject|7|||
157152516|NCT02190435|567303527|FG000|Overall Study|First 12 patients were lead-ins|12|||
157152517|NCT02190435|567303528|FG001|Overall Study|First 12 patients were lead-ins|0|||
157152518|NCT02190435|567303527|FG000|Overall Study|3 consented screen fails|3|||
157152519|NCT02190435|567303528|FG001|Overall Study|3 consented screen fails|0|||
157152520|NCT02399475|567303537|FG000|Overall Study|Physician Decision|1|||
157152521|NCT02399475|567303538|FG001|Overall Study|Physician Decision|0|||
157152522|NCT00935220|567303539|FG000|Overall Study|Adverse Event|1|||
157152523|NCT00935220|567303539|FG000|Overall Study|Other reason (not specified)|1|||
157152524|NCT01000064|567303540|FG000|Overall Study|Withdrawal by Subject|1|||
157152525|NCT01000064|567303541|FG001|Overall Study|Withdrawal by Subject|1|||
157152526|NCT00798967|567303542|FG000|Overall Study|Adverse Event|2|||
157152527|NCT00798967|567303543|FG001|Overall Study|Adverse Event|3|||
157152528|NCT00798967|567303542|FG000|Overall Study|Withdrawal by Subject|0|||
157152529|NCT00798967|567303543|FG001|Overall Study|Withdrawal by Subject|1|||
157152530|NCT00798967|567303542|FG000|Overall Study|Physician Decision|1|||
156836286|NCT03684694|566151675|FG004|Phase 2|Miscellaneous|0|||
156836287|NCT03684694|566151676|FG005|Phase 2|Miscellaneous|0|||
156836288|NCT02100475|566153739|FG000|Overall Study|Unclassified|1|||
156836289|NCT02100475|566153740|FG001|Overall Study|Unclassified|2|||
156836290|NCT02100475|566153739|FG000|Overall Study|Withdrawal criteria|1|||
156836291|NCT02100475|566153740|FG001|Overall Study|Withdrawal criteria|0|||
156836292|NCT01673620|566153743|FG000|Overall Study|Adverse Event|1|||
156836293|NCT01673620|566153744|FG001|Overall Study|Adverse Event|0|||
156836294|NCT00528801|566153745|FG000|Overall Study|Withdrawal by Subject|1|||
156836295|NCT00528801|566153746|FG001|Overall Study|Withdrawal by Subject|1|||
156836296|NCT00528801|566153745|FG000|Overall Study|Protocol Violation|11|||
156836297|NCT00528801|566153746|FG001|Overall Study|Protocol Violation|5|||
156836298|NCT00528801|566153745|FG000|Overall Study|Lost to Follow-up|15|||
156836299|NCT00528801|566153746|FG001|Overall Study|Lost to Follow-up|4|||
156836300|NCT00528801|566153745|FG000|Overall Study|Administrative Reasons|0|||
156836301|NCT00528801|566153746|FG001|Overall Study|Administrative Reasons|1|||
157152531|NCT00798967|567303543|FG001|Overall Study|Physician Decision|0|||
157152532|NCT00798967|567303542|FG000|Overall Study|Randomized in error by site|1|||
157152533|NCT00798967|567303543|FG001|Overall Study|Randomized in error by site|0|||
157152534|NCT01415440|567303544|FG000|Overall Study|Lost to Follow-up|0|||
157152535|NCT01415440|567303545|FG001|Overall Study|Lost to Follow-up|1|||
156836302|NCT01939366|566153751|FG000|Overall Study|Adverse Event|8|||
156836303|NCT01939366|566153752|FG001|Overall Study|Adverse Event|17|||
156836304|NCT01939366|566153753|FG002|Overall Study|Adverse Event|30|||
156836305|NCT01939366|566153754|FG003|Overall Study|Adverse Event|8|||
156836306|NCT01939366|566153755|FG004|Overall Study|Adverse Event|5|||
156836307|NCT01939366|566153751|FG000|Overall Study|Lack of Efficacy|2|||
156836308|NCT01939366|566153752|FG001|Overall Study|Lack of Efficacy|1|||
156836309|NCT01939366|566153753|FG002|Overall Study|Lack of Efficacy|1|||
156836310|NCT01939366|566153754|FG003|Overall Study|Lack of Efficacy|1|||
156836311|NCT01939366|566153755|FG004|Overall Study|Lack of Efficacy|3|||
156836312|NCT01939366|566153751|FG000|Overall Study|Lost to Follow-up|1|||
156836313|NCT01939366|566153752|FG001|Overall Study|Lost to Follow-up|1|||
156836314|NCT01939366|566153753|FG002|Overall Study|Lost to Follow-up|0|||
156836315|NCT01939366|566153754|FG003|Overall Study|Lost to Follow-up|0|||
156836316|NCT01939366|566153755|FG004|Overall Study|Lost to Follow-up|0|||
156836317|NCT01939366|566153751|FG000|Overall Study|Withdrawal by Subject|1|||
156836318|NCT01939366|566153752|FG001|Overall Study|Withdrawal by Subject|0|||
156836319|NCT01939366|566153753|FG002|Overall Study|Withdrawal by Subject|2|||
156836320|NCT01939366|566153754|FG003|Overall Study|Withdrawal by Subject|2|||
156836321|NCT01939366|566153755|FG004|Overall Study|Withdrawal by Subject|3|||
156836322|NCT01939366|566153751|FG000|Overall Study|Inclusion criteria not met|0|||
156836323|NCT01939366|566153752|FG001|Overall Study|Inclusion criteria not met|1|||
156836324|NCT01939366|566153753|FG002|Overall Study|Inclusion criteria not met|1|||
156836325|NCT01939366|566153754|FG003|Overall Study|Inclusion criteria not met|0|||
156836326|NCT01939366|566153755|FG004|Overall Study|Inclusion criteria not met|1|||
156836327|NCT01939366|566153751|FG000|Overall Study|Other|0|||
156836328|NCT01939366|566153752|FG001|Overall Study|Other|0|||
156836329|NCT01939366|566153753|FG002|Overall Study|Other|2|||
156836330|NCT01939366|566153754|FG003|Overall Study|Other|2|||
156836331|NCT01939366|566153755|FG004|Overall Study|Other|1|||
156836332|NCT01939366|566153751|FG000|Overall Study|Protocol Violation|0|||
156836333|NCT01939366|566153752|FG001|Overall Study|Protocol Violation|0|||
156836334|NCT01939366|566153753|FG002|Overall Study|Protocol Violation|0|||
156836335|NCT01939366|566153754|FG003|Overall Study|Protocol Violation|1|||
156836336|NCT01939366|566153755|FG004|Overall Study|Protocol Violation|0|||
156836337|NCT01939366|566153751|FG000|Overall Study|Sponsor decision|0|||
156836338|NCT01939366|566153752|FG001|Overall Study|Sponsor decision|0|||
156836339|NCT01939366|566153753|FG002|Overall Study|Sponsor decision|0|||
156836340|NCT01939366|566153754|FG003|Overall Study|Sponsor decision|0|||
156836341|NCT01939366|566153755|FG004|Overall Study|Sponsor decision|2|||
156836342|NCT01939366|566153751|FG000|Overall Study|GCP non-compliance at site|2|||
156836343|NCT01939366|566153752|FG001|Overall Study|GCP non-compliance at site|3|||
156836344|NCT01939366|566153753|FG002|Overall Study|GCP non-compliance at site|2|||
156836345|NCT01939366|566153754|FG003|Overall Study|GCP non-compliance at site|3|||
156836346|NCT01939366|566153755|FG004|Overall Study|GCP non-compliance at site|3|||
156836347|NCT02252965|566153756|FG000|Overall Study|Adverse Event|9|||
156836348|NCT02252965|566153757|FG001|Overall Study|Adverse Event|14|||
156836349|NCT02252965|566153756|FG000|Overall Study|Lost to Follow-up|16|||
156836350|NCT02252965|566153757|FG001|Overall Study|Lost to Follow-up|8|||
156836351|NCT02252965|566153756|FG000|Overall Study|Protocol Violation|4|||
156836352|NCT02252965|566153757|FG001|Overall Study|Protocol Violation|5|||
156836353|NCT02252965|566153756|FG000|Overall Study|Lack of Efficacy|0|||
156836354|NCT02252965|566153757|FG001|Overall Study|Lack of Efficacy|2|||
156836355|NCT02252965|566153756|FG000|Overall Study|Withdrawal by Subject|7|||
156836356|NCT02252965|566153757|FG001|Overall Study|Withdrawal by Subject|9|||
156836357|NCT02252965|566153756|FG000|Overall Study|Other|4|||
156836358|NCT02252965|566153757|FG001|Overall Study|Other|5|||
156836359|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
156836360|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
156836361|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
156836362|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
156836363|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
156836364|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
156836365|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
156836366|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
156836367|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
156836368|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
156836369|NCT02429791|566153765|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
156836370|NCT02429791|566153766|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
156836371|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
156836372|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
156836373|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
156836374|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
156836375|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
156836376|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
156836377|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
156836378|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
156836379|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156836380|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
156836381|NCT02429791|566153765|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
156836382|NCT02429791|566153766|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
156836383|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
156836384|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
156836385|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
157023661|NCT01369355|566841105|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
157023662|NCT01369355|566841106|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
157023663|NCT01369355|566841107|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
157023664|NCT01369355|566841108|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
157023665|NCT01369355|566841109|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
157023666|NCT01369355|566841110|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
157023667|NCT01369355|566841111|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
156836386|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
157023668|NCT01369355|566841112|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
157023669|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
157023670|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
157023671|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
157023672|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
156836387|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
156836388|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
156836389|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
156836390|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
156836391|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
156836392|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
156836393|NCT02429791|566153765|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
156836394|NCT02429791|566153766|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
156836395|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
156836396|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
156836397|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
156836398|NCT02615691|566153767|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
156836399|NCT04201093|566153768|FG000|Overall Study|Adverse Event|6|||
156836400|NCT04201093|566153769|FG001|Overall Study|Adverse Event|29|||
156836401|NCT04201093|566153770|FG002|Overall Study|Adverse Event|35|||
157023673|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
157023674|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
157023675|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
157023676|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
157023677|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
157023678|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Death|0|||
157023679|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Death|0|||
157023680|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Death|0|||
157023681|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Death|0|||
157023682|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Death|0|||
157023683|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Death|0|||
157023684|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Death|0|||
157023685|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Death|1|||
157023686|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Death|3|||
157023687|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156886148|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
156886149|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
156886150|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
156886151|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
157023688|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
156836402|NCT04201093|566153768|FG000|Overall Study|Death|2|||
156836403|NCT04201093|566153769|FG001|Overall Study|Death|1|||
156836404|NCT04201093|566153770|FG002|Overall Study|Death|0|||
156836405|NCT04201093|566153768|FG000|Overall Study|Lack of Efficacy|5|||
156836406|NCT04201093|566153769|FG001|Overall Study|Lack of Efficacy|1|||
156836407|NCT04201093|566153770|FG002|Overall Study|Lack of Efficacy|2|||
156836408|NCT04201093|566153768|FG000|Overall Study|Lost to Follow-up|0|||
156836409|NCT04201093|566153769|FG001|Overall Study|Lost to Follow-up|0|||
156836410|NCT04201093|566153770|FG002|Overall Study|Lost to Follow-up|1|||
156836411|NCT04201093|566153768|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
156836412|NCT04201093|566153769|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
156836413|NCT04201093|566153770|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
156836414|NCT04201093|566153768|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156836415|NCT04201093|566153769|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
156836416|NCT04201093|566153770|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
157023689|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
157023690|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
157023691|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
157023692|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
157023693|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
157023694|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
157152536|NCT01415440|567303546|FG002|Overall Study|Lost to Follow-up|2|||
157152537|NCT01415440|567303544|FG000|Overall Study|Physician Decision|3|||
156836417|NCT04201093|566153768|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
156836418|NCT04201093|566153769|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
156836419|NCT04201093|566153770|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
156836420|NCT04201093|566153768|FG000|Overall Study|Physician Decision|1|||
156836421|NCT04201093|566153769|FG001|Overall Study|Physician Decision|0|||
156836422|NCT04201093|566153770|FG002|Overall Study|Physician Decision|0|||
156836423|NCT04201093|566153768|FG000|Overall Study|Protocol Deviation|1|||
156836424|NCT04201093|566153769|FG001|Overall Study|Protocol Deviation|0|||
156836425|NCT04201093|566153770|FG002|Overall Study|Protocol Deviation|0|||
156836426|NCT04201093|566153768|FG000|Overall Study|Site Terminated by Sponsor|5|||
156836427|NCT04201093|566153769|FG001|Overall Study|Site Terminated by Sponsor|3|||
156836428|NCT04201093|566153770|FG002|Overall Study|Site Terminated by Sponsor|1|||
156836429|NCT04201093|566153768|FG000|Overall Study|Withdrawal by Subject|7|||
156836430|NCT04201093|566153769|FG001|Overall Study|Withdrawal by Subject|8|||
156836431|NCT04201093|566153770|FG002|Overall Study|Withdrawal by Subject|15|||
156836432|NCT04201093|566153768|FG000|Overall Study|Other|0|||
156836433|NCT04201093|566153769|FG001|Overall Study|Other|1|||
156836434|NCT04201093|566153770|FG002|Overall Study|Other|2|||
156836435|NCT01276223|566153771|FG000|Overall Study|Adverse Event|7|||
156836436|NCT01276223|566153772|FG001|Overall Study|Adverse Event|4|||
156836437|NCT01276223|566153773|FG002|Overall Study|Adverse Event|1|||
156836438|NCT01276223|566153771|FG000|Overall Study|Lost to Follow-up|0|||
156836439|NCT01276223|566153772|FG001|Overall Study|Lost to Follow-up|0|||
156836440|NCT01276223|566153773|FG002|Overall Study|Lost to Follow-up|1|||
156836441|NCT01276223|566153771|FG000|Overall Study|Other|0|||
156836442|NCT01276223|566153772|FG001|Overall Study|Other|0|||
156836443|NCT01276223|566153773|FG002|Overall Study|Other|1|||
156836444|NCT01276223|566153771|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
156836445|NCT01276223|566153772|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
156836446|NCT01276223|566153773|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
156836447|NCT01276223|566153771|FG000|Overall Study|Protocol Violation|1|||
156836448|NCT01276223|566153772|FG001|Overall Study|Protocol Violation|0|||
156836449|NCT01276223|566153773|FG002|Overall Study|Protocol Violation|0|||
156836450|NCT04279613|566153774|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836451|NCT04279613|566153775|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836452|NCT04279613|566153776|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836453|NCT04279613|566153777|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
156836454|NCT04279613|566153778|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
156836455|NCT04279613|566153774|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836456|NCT04279613|566153775|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
156836457|NCT04279613|566153776|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836458|NCT04279613|566153777|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836459|NCT04279613|566153778|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
156836460|NCT04279613|566153774|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836461|NCT04279613|566153775|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836462|NCT04279613|566153776|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
156836463|NCT04279613|566153777|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836464|NCT04279613|566153778|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
156836465|NCT04279613|566153774|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836466|NCT04279613|566153775|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836467|NCT04279613|566153776|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836468|NCT04279613|566153777|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
156836469|NCT04279613|566153778|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
156836470|NCT04279613|566153774|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836471|NCT04279613|566153775|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836472|NCT04279613|566153776|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836473|NCT04279613|566153777|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
156836474|NCT04279613|566153778|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
156836475|NCT02478164|566153779|FG000|Overall Study|Lack of Efficacy|13|||
156836476|NCT02478164|566153779|FG000|Overall Study|Adverse Event|1|||
156836477|NCT02478164|566153779|FG000|Overall Study|Withdrawal by Subject|1|||
156836478|NCT04051827|566153780|FG000|Overall Study|Death|1|||
156836479|NCT04051827|566153780|FG000|Overall Study|Withdrawal by Subject|4|||
156836480|NCT04051827|566153780|FG000|Overall Study|Progressive disease|16|||
156836481|NCT04051827|566153780|FG000|Overall Study|Physician Decision|1|||
156836482|NCT04051827|566153780|FG000|Overall Study|Other|4|||
156836483|NCT05779007|566153781|FG000|Overall Study|not meeting eligibility criteria|3517|||
156836484|NCT05779007|566153782|FG001|Overall Study|not meeting eligibility criteria|2009|||
156836485|NCT01424566|566153783|FG000|Single-blind Treatment|Adverse Event|71|||
156836486|NCT01424566|566153784|FG001|Single-blind Treatment|Adverse Event|0|||
156836487|NCT01424566|566153785|FG002|Single-blind Treatment|Adverse Event|0|||
156836488|NCT01424566|566153783|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
156836489|NCT01424566|566153784|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
156836490|NCT01424566|566153785|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
156836491|NCT01424566|566153783|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
157152538|NCT01415440|567303545|FG001|Overall Study|Physician Decision|0|||
156836492|NCT01424566|566153784|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
156836493|NCT01424566|566153785|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
156836494|NCT01424566|566153783|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
156836495|NCT01424566|566153784|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
156836496|NCT01424566|566153785|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
156836497|NCT01424566|566153783|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
156836498|NCT01424566|566153784|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
156836499|NCT01424566|566153785|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
156836500|NCT01424566|566153783|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
156836501|NCT01424566|566153784|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
156836502|NCT01424566|566153785|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
156836503|NCT01424566|566153783|FG000|Double-blind Treatment|Adverse Event|0|||
156836504|NCT01424566|566153784|FG001|Double-blind Treatment|Adverse Event|21|||
156836505|NCT01424566|566153785|FG002|Double-blind Treatment|Adverse Event|13|||
156836506|NCT01424566|566153783|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
156836507|NCT01424566|566153784|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
156836508|NCT01424566|566153785|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
156836509|NCT01424566|566153783|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
156836510|NCT01424566|566153784|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
156836511|NCT01424566|566153785|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
156836512|NCT01424566|566153783|FG000|Double-blind Treatment|Lack of Efficacy|0|||
156836513|NCT01424566|566153784|FG001|Double-blind Treatment|Lack of Efficacy|1|||
156836514|NCT01424566|566153785|FG002|Double-blind Treatment|Lack of Efficacy|1|||
156836515|NCT01116427|566153790|FG000|Core Phase|Adverse Event|0|||
156836516|NCT01116427|566153791|FG001|Core Phase|Adverse Event|1|||
156836517|NCT01116427|566153790|FG000|Core Phase|Lost to Follow-up|1|||
156836518|NCT01116427|566153791|FG001|Core Phase|Lost to Follow-up|0|||
156836519|NCT01116427|566153790|FG000|Core Phase|Withdrawal by Subject|3|||
156836520|NCT01116427|566153791|FG001|Core Phase|Withdrawal by Subject|0|||
156836521|NCT01116427|566153790|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
156836522|NCT01116427|566153791|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
156836523|NCT01116427|566153790|FG000|Extension Phase|Adverse Event|1|||
156836524|NCT01116427|566153791|FG001|Extension Phase|Adverse Event|1|||
156836525|NCT01116427|566153790|FG000|Extension Phase|Lost to Follow-up|2|||
156836526|NCT01116427|566153791|FG001|Extension Phase|Lost to Follow-up|0|||
156836527|NCT01116427|566153790|FG000|Extension Phase|Withdrawal by Subject|5|||
156836528|NCT01116427|566153791|FG001|Extension Phase|Withdrawal by Subject|1|||
156836529|NCT01116427|566153790|FG000|Extension Phase|Not using appropriate birth control|1|||
156836530|NCT01116427|566153791|FG001|Extension Phase|Not using appropriate birth control|0|||
156836531|NCT00791557|566153792|FG000|Overall Study|Adverse Event|1|||
156836532|NCT01079936|566153793|FG000|Phase I: MTD|First Remission Status|2|||
156836533|NCT01079936|566153794|FG001|Phase I: MTD|First Remission Status|0|||
156836534|NCT01079936|566153795|FG002|Phase I: MTD|First Remission Status|0|||
156836535|NCT01079936|566153796|FG003|Phase I: MTD|First Remission Status|0|||
156836536|NCT01079936|566153797|FG004|Phase I: MTD|First Remission Status|0|||
156836537|NCT01079936|566153793|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
156836538|NCT01079936|566153794|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
156836539|NCT01079936|566153795|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
156836540|NCT01079936|566153796|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
156836541|NCT01079936|566153797|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
156836542|NCT01079936|566153793|FG000|Phase II|Adverse Event|0|||
156836543|NCT01079936|566153794|FG001|Phase II|Adverse Event|0|||
156836544|NCT01079936|566153795|FG002|Phase II|Adverse Event|1|||
156836545|NCT01079936|566153796|FG003|Phase II|Adverse Event|0|||
156836546|NCT01079936|566153797|FG004|Phase II|Adverse Event|0|||
156836547|NCT01079936|566153793|FG000|Phase II|Insurance Issue|0|||
156836548|NCT01079936|566153794|FG001|Phase II|Insurance Issue|0|||
156836549|NCT01079936|566153795|FG002|Phase II|Insurance Issue|0|||
156836550|NCT01079936|566153796|FG003|Phase II|Insurance Issue|0|||
156886152|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
156886153|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
156886154|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
156886155|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
157152539|NCT01415440|567303546|FG002|Overall Study|Physician Decision|0|||
156836551|NCT01079936|566153797|FG004|Phase II|Insurance Issue|1|||
156836552|NCT02322190|566153798|FG000|Overall Study|Death on study|1|||
156836553|NCT02322190|566153799|FG001|Overall Study|Death on study|0|||
156836554|NCT03344640|566153800|FG000|Overall Study|Adverse Event|1|||
156836555|NCT03344640|566153801|FG001|Overall Study|Adverse Event|0|||
156836556|NCT03344640|566153800|FG000|Overall Study|Physician Decision|1|||
156836557|NCT03344640|566153801|FG001|Overall Study|Physician Decision|1|||
156836558|NCT03344640|566153800|FG000|Overall Study|Withdrawal by Subject|1|||
157152540|NCT01415440|567303544|FG000|Overall Study|Withdrawal by Subject|1|||
156836559|NCT03344640|566153801|FG001|Overall Study|Withdrawal by Subject|2|||
156836560|NCT03344640|566153800|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
156836561|NCT03344640|566153801|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
156836562|NCT00657371|566153802|FG000|Overall Study|Poor bowel preparation|15|||
156836563|NCT00657371|566153802|FG000|Overall Study|Unable to intubate the cecum|5|||
156836564|NCT00657371|566153802|FG000|Overall Study|Protocol Violation|2|||
156836565|NCT00657371|566153802|FG000|Overall Study|Device- related reasons|13|||
156836566|NCT00657371|566153802|FG000|Overall Study|Pre-existing medical condition|4|||
156836567|NCT00129961|566153812|FG000|Overall Study|Adverse Event|1|||
156836568|NCT00129961|566153813|FG001|Overall Study|Adverse Event|0|||
156836569|NCT00129961|566153812|FG000|Overall Study|Death|1|||
156836570|NCT00129961|566153813|FG001|Overall Study|Death|1|||
156836571|NCT00129961|566153812|FG000|Overall Study|Withdrawal by Sponsor|14|||
156836572|NCT00129961|566153813|FG001|Overall Study|Withdrawal by Sponsor|20|||
156836573|NCT00129961|566153812|FG000|Overall Study|Physician Decision|1|||
156836574|NCT00129961|566153813|FG001|Overall Study|Physician Decision|0|||
156836575|NCT00129961|566153812|FG000|Overall Study|Withdrawal by Subject|2|||
156836576|NCT00129961|566153813|FG001|Overall Study|Withdrawal by Subject|1|||
156836577|NCT00129961|566153812|FG000|Overall Study|Missing Record|0|||
156836578|NCT00129961|566153813|FG001|Overall Study|Missing Record|1|||
156836579|NCT01985360|566153814|FG000|Overall Study|Withdrawal by Subject|4|||
156836580|NCT01985360|566153815|FG001|Overall Study|Withdrawal by Subject|0|||
156836581|NCT01985360|566153814|FG000|Overall Study|Lost to Follow-up|5|||
156836582|NCT01985360|566153815|FG001|Overall Study|Lost to Follow-up|3|||
156836583|NCT03691779|566153820|FG000|Part B (24 Weeks)|Adverse Event|0|||
156836584|NCT03691779|566153821|FG001|Part B (24 Weeks)|Adverse Event|1|||
156836585|NCT03691779|566153820|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
156836586|NCT03691779|566153821|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
156836587|NCT04881747|566153822|FG000|Period 2 Washout|Adverse Event|1|||
156836588|NCT04881747|566153823|FG001|Period 2 Washout|Adverse Event|0|||
156836589|NCT04881747|566153824|FG002|Period 2 Washout|Adverse Event|0|||
156836590|NCT04881747|566153825|FG003|Period 2 Washout|Adverse Event|0|||
156836591|NCT04881747|566153826|FG004|Period 2 Washout|Adverse Event|1|||
156836592|NCT04881747|566153827|FG005|Period 2 Washout|Adverse Event|0|||
156836593|NCT04881747|566153822|FG000|Period 2 Washout|Withdrawal by Subject|1|||
156836594|NCT04881747|566153823|FG001|Period 2 Washout|Withdrawal by Subject|0|||
156836595|NCT04881747|566153824|FG002|Period 2 Washout|Withdrawal by Subject|0|||
156836596|NCT04881747|566153825|FG003|Period 2 Washout|Withdrawal by Subject|1|||
156836597|NCT04881747|566153826|FG004|Period 2 Washout|Withdrawal by Subject|0|||
156836598|NCT04881747|566153827|FG005|Period 2 Washout|Withdrawal by Subject|0|||
156836599|NCT00162266|566153837|FG000|Double-Blind Period|Adverse Event|5|||
156836600|NCT00162266|566153838|FG001|Double-Blind Period|Adverse Event|9|||
156836601|NCT00162266|566153839|FG002|Double-Blind Period|Adverse Event|11|||
156836602|NCT00162266|566153840|FG003|Double-Blind Period|Adverse Event|0|||
156836603|NCT00162266|566153837|FG000|Double-Blind Period|Death|0|||
156836604|NCT00162266|566153838|FG001|Double-Blind Period|Death|1|||
156836605|NCT00162266|566153839|FG002|Double-Blind Period|Death|0|||
157152541|NCT01415440|567303545|FG001|Overall Study|Withdrawal by Subject|0|||
156836606|NCT00162266|566153840|FG003|Double-Blind Period|Death|0|||
156836607|NCT00162266|566153837|FG000|Double-Blind Period|Lost to Follow-up|1|||
156836608|NCT00162266|566153838|FG001|Double-Blind Period|Lost to Follow-up|2|||
156836609|NCT00162266|566153839|FG002|Double-Blind Period|Lost to Follow-up|0|||
156836610|NCT00162266|566153840|FG003|Double-Blind Period|Lost to Follow-up|0|||
156836611|NCT00162266|566153837|FG000|Double-Blind Period|Other Reason|1|||
156836612|NCT00162266|566153838|FG001|Double-Blind Period|Other Reason|0|||
156836613|NCT00162266|566153839|FG002|Double-Blind Period|Other Reason|1|||
156836614|NCT00162266|566153840|FG003|Double-Blind Period|Other Reason|0|||
156836615|NCT00162266|566153837|FG000|Double-Blind Period|Lack of Efficacy|13|||
156886156|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
156886157|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
157152542|NCT01415440|567303546|FG002|Overall Study|Withdrawal by Subject|0|||
157152543|NCT00336492|567303549|FG000|Overall Study|Adverse Event|4|||
157152544|NCT00336492|567303550|FG001|Overall Study|Adverse Event|3|||
156836616|NCT00162266|566153838|FG001|Double-Blind Period|Lack of Efficacy|17|||
156836617|NCT00162266|566153839|FG002|Double-Blind Period|Lack of Efficacy|30|||
156836618|NCT00162266|566153840|FG003|Double-Blind Period|Lack of Efficacy|0|||
156836619|NCT00162266|566153837|FG000|Double-Blind Period|Withdrawal by Subject|5|||
156836620|NCT00162266|566153838|FG001|Double-Blind Period|Withdrawal by Subject|2|||
156836621|NCT00162266|566153839|FG002|Double-Blind Period|Withdrawal by Subject|6|||
156836622|NCT00162266|566153840|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156836623|NCT00162266|566153837|FG000|Open-Label Period|Death|0|||
156836624|NCT00162266|566153838|FG001|Open-Label Period|Death|0|||
156836625|NCT00162266|566153839|FG002|Open-Label Period|Death|0|||
156836626|NCT00162266|566153840|FG003|Open-Label Period|Death|7|||
156836627|NCT00162266|566153837|FG000|Open-Label Period|Adverse Event|0|||
156836628|NCT00162266|566153838|FG001|Open-Label Period|Adverse Event|0|||
156836629|NCT00162266|566153839|FG002|Open-Label Period|Adverse Event|0|||
156836630|NCT00162266|566153840|FG003|Open-Label Period|Adverse Event|46|||
156836631|NCT00162266|566153837|FG000|Open-Label Period|Lack of Efficacy|0|||
156836632|NCT00162266|566153838|FG001|Open-Label Period|Lack of Efficacy|0|||
156836633|NCT00162266|566153839|FG002|Open-Label Period|Lack of Efficacy|0|||
156836634|NCT00162266|566153840|FG003|Open-Label Period|Lack of Efficacy|26|||
156836635|NCT00162266|566153837|FG000|Open-Label Period|Lost to Follow-up|0|||
156836636|NCT00162266|566153838|FG001|Open-Label Period|Lost to Follow-up|0|||
156836637|NCT00162266|566153839|FG002|Open-Label Period|Lost to Follow-up|0|||
156836638|NCT00162266|566153840|FG003|Open-Label Period|Lost to Follow-up|3|||
156836639|NCT00162266|566153837|FG000|Open-Label Period|Withdrawal by Subject|0|||
156836640|NCT00162266|566153838|FG001|Open-Label Period|Withdrawal by Subject|0|||
156836641|NCT00162266|566153839|FG002|Open-Label Period|Withdrawal by Subject|0|||
156836642|NCT00162266|566153840|FG003|Open-Label Period|Withdrawal by Subject|31|||
156836643|NCT00162266|566153837|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
156836644|NCT00162266|566153838|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
156836645|NCT00162266|566153839|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
156836646|NCT00162266|566153840|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
156836647|NCT00162266|566153837|FG000|Open-Label Period|Other Reasons|0|||
156836648|NCT00162266|566153838|FG001|Open-Label Period|Other Reasons|0|||
156836649|NCT00162266|566153839|FG002|Open-Label Period|Other Reasons|0|||
156836650|NCT00162266|566153840|FG003|Open-Label Period|Other Reasons|15|||
156836651|NCT02299076|566153841|FG000|Overall Study|Fraudulent Entries|20|||
156836652|NCT02299076|566153842|FG001|Overall Study|Fraudulent Entries|14|||
156836653|NCT01839656|566153843|FG000|Overall Study|Withdrawal by Subject|1|||
156836654|NCT01839656|566153844|FG001|Overall Study|Withdrawal by Subject|1|||
156836655|NCT01839656|566153843|FG000|Overall Study|Adverse event, serious fatal|1|||
156836656|NCT01839656|566153844|FG001|Overall Study|Adverse event, serious fatal|4|||
156836657|NCT01839656|566153843|FG000|Overall Study|Early study closure|0|||
156836658|NCT01839656|566153844|FG001|Overall Study|Early study closure|11|||
156836659|NCT01839656|566153843|FG000|Overall Study|Adverse Event|1|||
156836660|NCT01839656|566153844|FG001|Overall Study|Adverse Event|0|||
156836661|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
156836662|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
156836663|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
156836664|NCT00499746|566153845|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
156836665|NCT00558272|566153848|FG000|Overall Study|Adverse Event|10|||
156836666|NCT00558272|566153849|FG001|Overall Study|Adverse Event|0|||
156836667|NCT00558272|566153848|FG000|Overall Study|Death|1|||
156836668|NCT00558272|566153849|FG001|Overall Study|Death|0|||
156836669|NCT00558272|566153848|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
156836670|NCT00558272|566153849|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
156836671|NCT00558272|566153848|FG000|Overall Study|AZ study team decision|0|||
156836672|NCT00558272|566153849|FG001|Overall Study|AZ study team decision|1|||
156836673|NCT00558272|566153848|FG000|Overall Study|Incorrectly enrolled|1|||
156836674|NCT00558272|566153849|FG001|Overall Study|Incorrectly enrolled|0|||
156836675|NCT00558272|566153848|FG000|Overall Study|Withdrawal by Subject|0|||
156836676|NCT00558272|566153849|FG001|Overall Study|Withdrawal by Subject|1|||
156836677|NCT04311463|566153850|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
156836678|NCT04311463|566153851|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
156836679|NCT04311463|566153850|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
156836680|NCT04311463|566153851|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
156836681|NCT04311463|566153850|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
156836682|NCT04311463|566153851|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
156836683|NCT00737633|566153858|FG000|Overall Study|Study terminated by sponsor|44|||
156836684|NCT00737633|566153859|FG001|Overall Study|Study terminated by sponsor|55|||
156836685|NCT00737633|566153858|FG000|Overall Study|Lost to Follow-up|0|||
156836686|NCT00737633|566153859|FG001|Overall Study|Lost to Follow-up|1|||
156836687|NCT00737633|566153858|FG000|Overall Study|protocol non-compliance|0|||
156836688|NCT00737633|566153859|FG001|Overall Study|protocol non-compliance|1|||
156836689|NCT02745535|566153860|FG000|Overall Study|Death|1|||
156836690|NCT02745535|566153860|FG000|Overall Study|Adverse Event|3|||
156836691|NCT02745535|566153860|FG000|Overall Study|Lost to Follow-up|2|||
156836692|NCT00377364|566153865|FG000|Overall Study|Lost to Follow-up|1|||
156836693|NCT00377364|566153866|FG001|Overall Study|Lost to Follow-up|0|||
156836694|NCT00377364|566153865|FG000|Overall Study|Withdrawal by Subject|1|||
156836695|NCT00377364|566153866|FG001|Overall Study|Withdrawal by Subject|0|||
156836696|NCT01291277|566153867|FG000|Overall Study|Death|2|||
156836697|NCT01291277|566153868|FG001|Overall Study|Death|2|||
156836698|NCT01291277|566153867|FG000|Overall Study|Lost to Follow-up|3|||
156836699|NCT01291277|566153868|FG001|Overall Study|Lost to Follow-up|1|||
156836700|NCT02963701|566153875|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
156836701|NCT02963701|566153876|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
156836702|NCT03480009|566153877|FG000|Overall Study|Lost to Follow-up|4|||
156836703|NCT03480009|566153878|FG001|Overall Study|Lost to Follow-up|5|||
156836704|NCT03480009|566153879|FG002|Overall Study|Lost to Follow-up|4|||
156836705|NCT03480009|566153880|FG003|Overall Study|Lost to Follow-up|0|||
156836706|NCT00637572|566153883|FG000|Overall Study|Adverse Event|1|||
157152545|NCT00336492|567303551|FG002|Overall Study|Adverse Event|6|||
156836707|NCT00637572|566153884|FG001|Overall Study|Adverse Event|2|||
156836708|NCT00637572|566153883|FG000|Overall Study|Death|0|||
156836709|NCT00637572|566153884|FG001|Overall Study|Death|1|||
156836710|NCT00637572|566153883|FG000|Overall Study|Lost to Follow-up|0|||
156836711|NCT00637572|566153884|FG001|Overall Study|Lost to Follow-up|1|||
156836712|NCT00637572|566153883|FG000|Overall Study|Physician Decision|1|||
156836713|NCT00637572|566153884|FG001|Overall Study|Physician Decision|1|||
156836714|NCT00637572|566153883|FG000|Overall Study|Withdrawal by Subject|0|||
156836715|NCT00637572|566153884|FG001|Overall Study|Withdrawal by Subject|2|||
156836716|NCT00637572|566153883|FG000|Overall Study|Illicit Drug Use|1|||
156836717|NCT00637572|566153884|FG001|Overall Study|Illicit Drug Use|0|||
156836718|NCT01345682|566153885|FG000|Overall Study|Progressive disease per RECIST|226|||
156836719|NCT01345682|566153886|FG001|Overall Study|Progressive disease per RECIST|93|||
156836720|NCT01345682|566153885|FG000|Overall Study|Worsening of underlying cancer disease|23|||
156836721|NCT01345682|566153886|FG001|Overall Study|Worsening of underlying cancer disease|12|||
156836722|NCT01345682|566153885|FG000|Overall Study|Adverse Event|51|||
156836723|NCT01345682|566153886|FG001|Overall Study|Adverse Event|41|||
156836724|NCT01345682|566153885|FG000|Overall Study|Non-compliance with protocol|0|||
156836725|NCT01345682|566153886|FG001|Overall Study|Non-compliance with protocol|1|||
156836726|NCT01345682|566153885|FG000|Overall Study|Lost to Follow-up|0|||
156836727|NCT01345682|566153886|FG001|Overall Study|Lost to Follow-up|1|||
156836728|NCT01345682|566153885|FG000|Overall Study|Refused to continue trial medication|16|||
156836729|NCT01345682|566153886|FG001|Overall Study|Refused to continue trial medication|9|||
156836730|NCT01345682|566153885|FG000|Overall Study|Not treated|2|||
156836731|NCT01345682|566153886|FG001|Overall Study|Not treated|1|||
156836732|NCT01345682|566153885|FG000|Overall Study|Reason other than those specified above|4|||
156836733|NCT01345682|566153886|FG001|Overall Study|Reason other than those specified above|3|||
156836734|NCT00896649|566153887|FG000|Overall Study|Physician Decision|1|||
156836735|NCT00896649|566153887|FG000|Overall Study|Pregnancy|1|||
156836736|NCT00896649|566153887|FG000|Overall Study|missing documentation|1|||
156836737|NCT00896649|566153887|FG000|Overall Study|technical difficulties|2|||
156836738|NCT01075984|566153888|FG000|Treatment Phase|Adverse Event|0|||
156836739|NCT01075984|566153889|FG001|Treatment Phase|Adverse Event|1|||
156836740|NCT01075984|566153890|FG002|Treatment Phase|Adverse Event|3|||
156836741|NCT01075984|566153891|FG003|Treatment Phase|Adverse Event|7|||
156836742|NCT01075984|566153892|FG004|Treatment Phase|Adverse Event|35|||
156836743|NCT01075984|566153888|FG000|Treatment Phase|Protocol Violation|0|||
156836744|NCT01075984|566153889|FG001|Treatment Phase|Protocol Violation|0|||
156836745|NCT01075984|566153890|FG002|Treatment Phase|Protocol Violation|1|||
156836746|NCT01075984|566153891|FG003|Treatment Phase|Protocol Violation|0|||
156836747|NCT01075984|566153892|FG004|Treatment Phase|Protocol Violation|3|||
156836748|NCT01075984|566153888|FG000|Treatment Phase|Withdrawal by Subject|0|||
156836749|NCT01075984|566153889|FG001|Treatment Phase|Withdrawal by Subject|0|||
156836750|NCT01075984|566153890|FG002|Treatment Phase|Withdrawal by Subject|2|||
156836751|NCT01075984|566153891|FG003|Treatment Phase|Withdrawal by Subject|0|||
156836752|NCT01075984|566153892|FG004|Treatment Phase|Withdrawal by Subject|15|||
156836753|NCT01075984|566153888|FG000|Treatment Phase|Treatment Failure|0|||
156836754|NCT01075984|566153889|FG001|Treatment Phase|Treatment Failure|0|||
156836755|NCT01075984|566153890|FG002|Treatment Phase|Treatment Failure|1|||
156836756|NCT01075984|566153891|FG003|Treatment Phase|Treatment Failure|0|||
156836757|NCT01075984|566153892|FG004|Treatment Phase|Treatment Failure|5|||
156836758|NCT01075984|566153888|FG000|Treatment Phase|Progression of disease|0|||
156836759|NCT01075984|566153889|FG001|Treatment Phase|Progression of disease|0|||
156836760|NCT01075984|566153890|FG002|Treatment Phase|Progression of disease|0|||
156836761|NCT01075984|566153891|FG003|Treatment Phase|Progression of disease|0|||
156836762|NCT01075984|566153892|FG004|Treatment Phase|Progression of disease|2|||
156836763|NCT01075984|566153888|FG000|Follow-up Phase|Protocol Violation|0|||
156836764|NCT01075984|566153889|FG001|Follow-up Phase|Protocol Violation|0|||
156836765|NCT01075984|566153890|FG002|Follow-up Phase|Protocol Violation|1|||
156836766|NCT01075984|566153891|FG003|Follow-up Phase|Protocol Violation|0|||
156836767|NCT01075984|566153892|FG004|Follow-up Phase|Protocol Violation|3|||
156836768|NCT01075984|566153888|FG000|Follow-up Phase|Adverse Event|0|||
156836769|NCT01075984|566153889|FG001|Follow-up Phase|Adverse Event|0|||
156836770|NCT01075984|566153890|FG002|Follow-up Phase|Adverse Event|0|||
156836771|NCT01075984|566153891|FG003|Follow-up Phase|Adverse Event|2|||
156836772|NCT01075984|566153892|FG004|Follow-up Phase|Adverse Event|27|||
156836773|NCT01075984|566153888|FG000|Follow-up Phase|Administrative|0|||
156836774|NCT01075984|566153889|FG001|Follow-up Phase|Administrative|0|||
157152546|NCT00336492|567303549|FG000|Overall Study|Lack of Efficacy|6|||
156836775|NCT01075984|566153890|FG002|Follow-up Phase|Administrative|0|||
156836776|NCT01075984|566153891|FG003|Follow-up Phase|Administrative|0|||
156836777|NCT01075984|566153892|FG004|Follow-up Phase|Administrative|1|||
156836778|NCT01075984|566153888|FG000|Follow-up Phase|Withdrawal by Subject|0|||
157152547|NCT00336492|567303550|FG001|Overall Study|Lack of Efficacy|1|||
156836779|NCT01075984|566153889|FG001|Follow-up Phase|Withdrawal by Subject|0|||
156836780|NCT01075984|566153890|FG002|Follow-up Phase|Withdrawal by Subject|0|||
156836781|NCT01075984|566153891|FG003|Follow-up Phase|Withdrawal by Subject|0|||
156836782|NCT01075984|566153892|FG004|Follow-up Phase|Withdrawal by Subject|10|||
156836783|NCT01075984|566153888|FG000|Follow-up Phase|Progression of disease|0|||
156836784|NCT01075984|566153889|FG001|Follow-up Phase|Progression of disease|0|||
156836785|NCT01075984|566153890|FG002|Follow-up Phase|Progression of disease|0|||
156836786|NCT01075984|566153891|FG003|Follow-up Phase|Progression of disease|0|||
156836787|NCT01075984|566153892|FG004|Follow-up Phase|Progression of disease|2|||
156836788|NCT01075984|566153888|FG000|Follow-up Phase|Treatment failure|0|||
156836789|NCT01075984|566153889|FG001|Follow-up Phase|Treatment failure|0|||
156836790|NCT01075984|566153890|FG002|Follow-up Phase|Treatment failure|0|||
156836791|NCT01075984|566153891|FG003|Follow-up Phase|Treatment failure|0|||
156836792|NCT01075984|566153892|FG004|Follow-up Phase|Treatment failure|4|||
156836793|NCT03652675|566153893|FG000|Overall Study|Lost to Follow-up|4|||
156836794|NCT03652675|566153894|FG001|Overall Study|Lost to Follow-up|4|||
156836795|NCT03101085|566153896|FG000|Overall Study|Lost to Follow-up|0|||
156836796|NCT03101085|566153897|FG001|Overall Study|Lost to Follow-up|1|||
156836797|NCT02986854|566153898|FG000|Overall Study|Withdrawal by Subject|0|||
156836798|NCT02986854|566153899|FG001|Overall Study|Withdrawal by Subject|1|||
156836799|NCT02986854|566153900|FG002|Overall Study|Withdrawal by Subject|1|||
156836800|NCT02986854|566153898|FG000|Overall Study|Lost to Follow-up|3|||
156836801|NCT02986854|566153899|FG001|Overall Study|Lost to Follow-up|11|||
156836802|NCT02986854|566153900|FG002|Overall Study|Lost to Follow-up|2|||
156836803|NCT03442296|566153908|FG000|3 Month Follow-up|Death|3|||
156836804|NCT03442296|566153909|FG001|3 Month Follow-up|Death|1|||
156836805|NCT03442296|566153908|FG000|3 Month Follow-up|Lost to Follow-up|1|||
156836806|NCT03442296|566153909|FG001|3 Month Follow-up|Lost to Follow-up|1|||
156836807|NCT03442296|566153908|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
156836808|NCT03442296|566153909|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
156836809|NCT03442296|566153908|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
156836810|NCT03442296|566153909|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
156836811|NCT03442296|566153908|FG000|12 Month Follow-up|Incomplete measurement|1|||
156836812|NCT03442296|566153909|FG001|12 Month Follow-up|Incomplete measurement|1|||
156836813|NCT02409342|566153910|FG000|Overall Study|Death|211|||
156836814|NCT02409342|566153911|FG001|Overall Study|Death|201|||
156836815|NCT02409342|566153910|FG000|Overall Study|Withdrawal by Subject|24|||
156836816|NCT02409342|566153911|FG001|Overall Study|Withdrawal by Subject|17|||
156836817|NCT02409342|566153910|FG000|Overall Study|Study Terminated By Sponsor|48|||
156836818|NCT02409342|566153911|FG001|Overall Study|Study Terminated By Sponsor|59|||
156836819|NCT02409342|566153910|FG000|Overall Study|Lost to Follow-up|3|||
156836820|NCT02409342|566153911|FG001|Overall Study|Lost to Follow-up|5|||
156836821|NCT02409342|566153910|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
156836822|NCT02409342|566153911|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
156836823|NCT02409342|566153910|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
156836824|NCT02409342|566153911|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
156836825|NCT02409342|566153910|FG000|Overall Study|Sponsor Decision|1|||
156836826|NCT02409342|566153911|FG001|Overall Study|Sponsor Decision|0|||
156836827|NCT00279812|566153912|FG000|Overall Study|Protocol Violation|1|||
156836828|NCT00279812|566153913|FG001|Overall Study|Protocol Violation|1|||
156836829|NCT00279812|566153914|FG002|Overall Study|Protocol Violation|0|||
156836830|NCT00279812|566153915|FG003|Overall Study|Protocol Violation|0|||
156836831|NCT00279812|566153916|FG004|Overall Study|Protocol Violation|1|||
156836832|NCT00279812|566153917|FG005|Overall Study|Protocol Violation|0|||
156836833|NCT00279812|566153912|FG000|Overall Study|Withdrawal by Subject|0|||
156836834|NCT00279812|566153913|FG001|Overall Study|Withdrawal by Subject|4|||
156836835|NCT00279812|566153914|FG002|Overall Study|Withdrawal by Subject|2|||
156836836|NCT00279812|566153915|FG003|Overall Study|Withdrawal by Subject|0|||
156836837|NCT00279812|566153916|FG004|Overall Study|Withdrawal by Subject|0|||
156836838|NCT00279812|566153917|FG005|Overall Study|Withdrawal by Subject|0|||
156836839|NCT00279812|566153912|FG000|Overall Study|Adverse Event|0|||
156836840|NCT00279812|566153913|FG001|Overall Study|Adverse Event|1|||
156836841|NCT00279812|566153914|FG002|Overall Study|Adverse Event|1|||
156836842|NCT00279812|566153915|FG003|Overall Study|Adverse Event|0|||
156836843|NCT00279812|566153916|FG004|Overall Study|Adverse Event|2|||
156836844|NCT00279812|566153917|FG005|Overall Study|Adverse Event|1|||
156836845|NCT01274429|566153918|FG000|Overall Study|Study closed do to lack of funding|5|||
156836846|NCT04576897|566153923|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
156836847|NCT00527332|566153924|FG000|Overall Study|Protocol Violation|4|||
156836848|NCT00527332|566153925|FG001|Overall Study|Protocol Violation|8|||
156836849|NCT00527332|566153924|FG000|Overall Study|Withdrew consent|5|||
156836850|NCT00527332|566153925|FG001|Overall Study|Withdrew consent|1|||
156836851|NCT00372697|566155567|FG000|Overall Study|Protocol Violation|1|||
156836852|NCT00372697|566155568|FG001|Overall Study|Protocol Violation|1|||
156836853|NCT03221842|566155569|FG000|Period 1 (Open-label)|Adverse Event|4|||
156836854|NCT03221842|566155570|FG001|Period 1 (Open-label)|Adverse Event|0|||
156836855|NCT03221842|566155569|FG000|Period 1 (Open-label)|Physician Decision|2|||
156836856|NCT03221842|566155570|FG001|Period 1 (Open-label)|Physician Decision|0|||
156836857|NCT03221842|566155569|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
156886158|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
156886159|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
156886160|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
156886161|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
156886162|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
156886163|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
156886164|NCT01227824|566342482|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
157023695|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
156836858|NCT03221842|566155570|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
156836859|NCT03221842|566155569|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
156836860|NCT03221842|566155570|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
156836861|NCT03221842|566155569|FG000|Period 1 (Open-label)|Other|2|||
156836862|NCT03221842|566155570|FG001|Period 1 (Open-label)|Other|0|||
156836863|NCT03221842|566155569|FG000|Period 2 (Randomized, Blinded)|Death|0|||
156836864|NCT03221842|566155570|FG001|Period 2 (Randomized, Blinded)|Death|1|||
156836865|NCT03221842|566155569|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
156836866|NCT03221842|566155570|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
156836867|NCT00448747|566155571|FG000|Overall Study|collapsed veins|1|||
156836868|NCT00448747|566155572|FG001|Overall Study|collapsed veins|0|||
156836869|NCT00387725|566155573|FG000|Overall Study|Adverse Event|0|||
156836870|NCT00387725|566155574|FG001|Overall Study|Adverse Event|0|||
156836871|NCT00387725|566155575|FG002|Overall Study|Adverse Event|0|||
156836872|NCT00387725|566155576|FG003|Overall Study|Adverse Event|1|||
156836873|NCT00387725|566155573|FG000|Overall Study|Protocol Violation|0|||
156836874|NCT00387725|566155574|FG001|Overall Study|Protocol Violation|1|||
156836875|NCT00387725|566155575|FG002|Overall Study|Protocol Violation|0|||
156836876|NCT00387725|566155576|FG003|Overall Study|Protocol Violation|0|||
156836877|NCT00387725|566155573|FG000|Overall Study|Withdrawal by Subject|1|||
156836878|NCT00387725|566155574|FG001|Overall Study|Withdrawal by Subject|0|||
156836879|NCT00387725|566155575|FG002|Overall Study|Withdrawal by Subject|1|||
156836880|NCT00387725|566155576|FG003|Overall Study|Withdrawal by Subject|0|||
156836881|NCT00387725|566155573|FG000|Overall Study|Parent/legal guardian request|0|||
156836882|NCT00387725|566155574|FG001|Overall Study|Parent/legal guardian request|0|||
157023696|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023697|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023698|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023699|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023700|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023701|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023702|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
157023703|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
157023704|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
157023705|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023706|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023707|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023708|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023709|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023710|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
157023711|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
157023712|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
157023713|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
157023714|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023715|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023716|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023717|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023718|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023719|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
157023720|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
157023721|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
157023722|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
157023723|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156836883|NCT00387725|566155575|FG002|Overall Study|Parent/legal guardian request|1|||
156836884|NCT00387725|566155576|FG003|Overall Study|Parent/legal guardian request|1|||
156836885|NCT00568126|566155577|FG000|Overall Study|Adverse Event|3|||
156836886|NCT00568126|566155578|FG001|Overall Study|Adverse Event|0|||
156836887|NCT00568126|566155577|FG000|Overall Study|Withdrawal by Subject|2|||
156836888|NCT00568126|566155578|FG001|Overall Study|Withdrawal by Subject|3|||
156836889|NCT00568126|566155577|FG000|Overall Study|Lost to Follow-up|4|||
156836890|NCT00568126|566155578|FG001|Overall Study|Lost to Follow-up|3|||
156836891|NCT00568126|566155577|FG000|Overall Study|Lack of Efficacy|0|||
156836892|NCT00568126|566155578|FG001|Overall Study|Lack of Efficacy|1|||
156836893|NCT00568126|566155577|FG000|Overall Study|Physician Decision|2|||
156836894|NCT00568126|566155578|FG001|Overall Study|Physician Decision|2|||
156836895|NCT00527982|566155580|FG000|Overall Study|Physician Decision|1|||
156836896|NCT00527982|566155581|FG001|Overall Study|Physician Decision|0|||
156836897|NCT00007020|566155582|FG000|Overall Study|Death|16|||
156836898|NCT00007020|566155582|FG000|Overall Study|Lost to Follow-up|13|||
156836899|NCT00007020|566155582|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
156836900|NCT00007020|566155582|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
156836901|NCT00007020|566155582|FG000|Overall Study|Pt cared for by outside physician|4|||
156836902|NCT00007020|566155582|FG000|Overall Study|No evidence of treatment|6|||
156836903|NCT00881504|566155583|FG000|Overall Study|Withdrawal by Subject|1|||
156836904|NCT02017522|566155584|FG000|Overall Study|Withdrawal by Subject|1|||
156836905|NCT02596230|566155585|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
156836906|NCT02596230|566155586|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
156836907|NCT02596230|566155587|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
156836908|NCT02596230|566155588|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
156836909|NCT02596230|566155589|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
156836910|NCT02596230|566155585|FG000|Objective 2, One Year|Lost to Follow-up|0|||
156836911|NCT02596230|566155586|FG001|Objective 2, One Year|Lost to Follow-up|41|||
156836912|NCT02596230|566155587|FG002|Objective 2, One Year|Lost to Follow-up|41|||
156836913|NCT02596230|566155588|FG003|Objective 2, One Year|Lost to Follow-up|32|||
156836914|NCT02596230|566155589|FG004|Objective 2, One Year|Lost to Follow-up|46|||
156836915|NCT02596230|566155585|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
156836916|NCT02596230|566155586|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
156836917|NCT02596230|566155587|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
156836918|NCT02596230|566155588|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
156836919|NCT02596230|566155589|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
156836920|NCT02596230|566155585|FG000|Objective 2, One Year|Adverse drug reaction|0|||
156836921|NCT02596230|566155586|FG001|Objective 2, One Year|Adverse drug reaction|1|||
156836922|NCT02596230|566155587|FG002|Objective 2, One Year|Adverse drug reaction|0|||
156836923|NCT02596230|566155588|FG003|Objective 2, One Year|Adverse drug reaction|0|||
156836924|NCT02596230|566155589|FG004|Objective 2, One Year|Adverse drug reaction|0|||
156836925|NCT02596230|566155585|FG000|Objective 2, One Year|Death|0|||
156836926|NCT02596230|566155586|FG001|Objective 2, One Year|Death|12|||
156836927|NCT02596230|566155587|FG002|Objective 2, One Year|Death|41|||
156836928|NCT02596230|566155588|FG003|Objective 2, One Year|Death|21|||
156836929|NCT02596230|566155589|FG004|Objective 2, One Year|Death|30|||
156836930|NCT02596230|566155585|FG000|Objective 2, One Year|Other|0|||
156836931|NCT02596230|566155586|FG001|Objective 2, One Year|Other|3|||
156836932|NCT02596230|566155587|FG002|Objective 2, One Year|Other|2|||
156836933|NCT02596230|566155588|FG003|Objective 2, One Year|Other|0|||
156836934|NCT02596230|566155589|FG004|Objective 2, One Year|Other|0|||
156836935|NCT00771615|566155590|FG000|Overall Study|Withdrawal by Subject|0|||
156836936|NCT00771615|566155591|FG001|Overall Study|Withdrawal by Subject|1|||
156836937|NCT00771615|566155592|FG002|Overall Study|Withdrawal by Subject|0|||
156836938|NCT00771615|566155593|FG003|Overall Study|Withdrawal by Subject|0|||
156836939|NCT00771615|566155594|FG004|Overall Study|Withdrawal by Subject|0|||
156836940|NCT00771615|566155595|FG005|Overall Study|Withdrawal by Subject|0|||
156836941|NCT00771615|566155596|FG006|Overall Study|Withdrawal by Subject|0|||
156836942|NCT00771615|566155597|FG007|Overall Study|Withdrawal by Subject|1|||
156836943|NCT00771615|566155598|FG008|Overall Study|Withdrawal by Subject|0|||
156836944|NCT00771615|566155590|FG000|Overall Study|Lost to Follow-up|1|||
156836945|NCT00771615|566155591|FG001|Overall Study|Lost to Follow-up|1|||
156836946|NCT00771615|566155592|FG002|Overall Study|Lost to Follow-up|1|||
156836947|NCT00771615|566155593|FG003|Overall Study|Lost to Follow-up|1|||
156836948|NCT00771615|566155594|FG004|Overall Study|Lost to Follow-up|0|||
156836949|NCT00771615|566155595|FG005|Overall Study|Lost to Follow-up|1|||
156836950|NCT00771615|566155596|FG006|Overall Study|Lost to Follow-up|1|||
156836951|NCT00771615|566155597|FG007|Overall Study|Lost to Follow-up|0|||
156836952|NCT00771615|566155598|FG008|Overall Study|Lost to Follow-up|0|||
156836953|NCT02704689|566155600|FG000|Overall Study|Physician Decision|1|||
156836954|NCT02704689|566155600|FG000|Overall Study|Study device not implanted|2|||
156836955|NCT00802893|566155601|FG000|Overall Study|study terminated|3|||
157023724|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156836956|NCT00320424|566155602|FG000|Overall Study|Adverse Event|3|||
156836957|NCT00320424|566155602|FG000|Overall Study|Other|3|||
156836958|NCT03270891|566155604|FG000|Overall Study|Lost to Follow-up|3|||
156836959|NCT03270891|566155605|FG001|Overall Study|Lost to Follow-up|6|||
156836960|NCT03270891|566155606|FG002|Overall Study|Lost to Follow-up|0|||
156836961|NCT03270891|566155604|FG000|Overall Study|Withdrawal by Subject|1|||
156836962|NCT03270891|566155605|FG001|Overall Study|Withdrawal by Subject|0|||
156836963|NCT03270891|566155606|FG002|Overall Study|Withdrawal by Subject|0|||
156836964|NCT03270891|566155604|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
157152548|NCT00336492|567303551|FG002|Overall Study|Lack of Efficacy|4|||
156836965|NCT03270891|566155605|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
156836966|NCT03270891|566155606|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
156836967|NCT02540668|566155607|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
156836968|NCT02540668|566155608|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
156836969|NCT00849108|566155609|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
156836970|NCT00849108|566155610|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
156836971|NCT00849108|566155609|FG000|Cohort 2 Efficacy|Adverse Event|0|||
156836972|NCT00849108|566155610|FG001|Cohort 2 Efficacy|Adverse Event|1|||
156836973|NCT00849108|566155609|FG000|Cohort 2 Efficacy|Other|0|||
156836974|NCT00849108|566155610|FG001|Cohort 2 Efficacy|Other|9|||
156836975|NCT02708485|566155613|FG000|Overall Study|Withdrawal by Subject|3|||
156836976|NCT02708485|566155614|FG001|Overall Study|Withdrawal by Subject|2|||
156836977|NCT00231413|566155615|FG000|Overall Study|Non-serious AE|0|||
156836978|NCT00231413|566155616|FG001|Overall Study|Non-serious AE|0|||
156836979|NCT00231413|566155617|FG002|Overall Study|Non-serious AE|1|||
156836980|NCT00231413|566155618|FG003|Overall Study|Non-serious AE|0|||
156836981|NCT00231413|566155619|FG004|Overall Study|Non-serious AE|0|||
156836982|NCT00231413|566155620|FG005|Overall Study|Non-serious AE|0|||
156836983|NCT00231413|566155621|FG006|Overall Study|Non-serious AE|1|||
156836984|NCT00231413|566155615|FG000|Overall Study|Withdrawal by Subject|3|||
156836985|NCT00231413|566155616|FG001|Overall Study|Withdrawal by Subject|1|||
156836986|NCT00231413|566155617|FG002|Overall Study|Withdrawal by Subject|4|||
156836987|NCT00231413|566155618|FG003|Overall Study|Withdrawal by Subject|2|||
156836988|NCT00231413|566155619|FG004|Overall Study|Withdrawal by Subject|2|||
156836989|NCT00231413|566155620|FG005|Overall Study|Withdrawal by Subject|0|||
156836990|NCT00231413|566155621|FG006|Overall Study|Withdrawal by Subject|3|||
156836991|NCT00231413|566155615|FG000|Overall Study|Migrated/moved from study area|0|||
156836992|NCT00231413|566155616|FG001|Overall Study|Migrated/moved from study area|0|||
156836993|NCT00231413|566155617|FG002|Overall Study|Migrated/moved from study area|1|||
156836994|NCT00231413|566155618|FG003|Overall Study|Migrated/moved from study area|0|||
156836995|NCT00231413|566155619|FG004|Overall Study|Migrated/moved from study area|0|||
156836996|NCT00231413|566155620|FG005|Overall Study|Migrated/moved from study area|1|||
156836997|NCT00231413|566155621|FG006|Overall Study|Migrated/moved from study area|0|||
156836998|NCT00231413|566155615|FG000|Overall Study|Lost to Follow-up|4|||
156836999|NCT00231413|566155616|FG001|Overall Study|Lost to Follow-up|4|||
156837000|NCT00231413|566155617|FG002|Overall Study|Lost to Follow-up|1|||
156837001|NCT00231413|566155618|FG003|Overall Study|Lost to Follow-up|1|||
156837002|NCT00231413|566155619|FG004|Overall Study|Lost to Follow-up|1|||
156837003|NCT00231413|566155620|FG005|Overall Study|Lost to Follow-up|4|||
156837004|NCT00231413|566155621|FG006|Overall Study|Lost to Follow-up|0|||
156837005|NCT00231413|566155615|FG000|Overall Study|Pregnancy|1|||
156837006|NCT00231413|566155616|FG001|Overall Study|Pregnancy|0|||
156837007|NCT00231413|566155617|FG002|Overall Study|Pregnancy|0|||
156837008|NCT00231413|566155618|FG003|Overall Study|Pregnancy|0|||
156837009|NCT00231413|566155619|FG004|Overall Study|Pregnancy|0|||
156837010|NCT00231413|566155620|FG005|Overall Study|Pregnancy|0|||
156837011|NCT00231413|566155621|FG006|Overall Study|Pregnancy|0|||
156837012|NCT01100528|566155625|FG000|Overall Study|Death|1|||
156837013|NCT01100528|566155625|FG000|Overall Study|Withdrawal by Subject|2|||
156837014|NCT01659255|566155626|FG000|Overall Study|Adverse Event|0|||
156837015|NCT01659255|566155627|FG001|Overall Study|Adverse Event|0|||
156837016|NCT01659255|566155628|FG002|Overall Study|Adverse Event|0|||
156837017|NCT01659255|566155629|FG003|Overall Study|Adverse Event|0|||
156837018|NCT01659255|566155630|FG004|Overall Study|Adverse Event|0|||
156837019|NCT01659255|566155631|FG005|Overall Study|Adverse Event|1|||
156837020|NCT01659255|566155632|FG006|Overall Study|Adverse Event|1|||
156837021|NCT01659255|566155633|FG007|Overall Study|Adverse Event|0|||
156837022|NCT01659255|566155634|FG008|Overall Study|Adverse Event|0|||
156837023|NCT01659255|566155635|FG009|Overall Study|Adverse Event|1|||
156837024|NCT01659255|566155636|FG010|Overall Study|Adverse Event|0|||
156837025|NCT01659255|566155637|FG011|Overall Study|Adverse Event|1|||
156837026|NCT01659255|566155638|FG012|Overall Study|Adverse Event|0|||
156837027|NCT01659255|566155639|FG013|Overall Study|Adverse Event|2|||
156837028|NCT01659255|566155640|FG014|Overall Study|Adverse Event|0|||
156837029|NCT01659255|566155641|FG015|Overall Study|Adverse Event|1|||
156837030|NCT01659255|566155642|FG016|Overall Study|Adverse Event|0|||
156837031|NCT01659255|566155626|FG000|Overall Study|Death|0|||
156837032|NCT01659255|566155627|FG001|Overall Study|Death|1|||
157023725|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
156837033|NCT01659255|566155628|FG002|Overall Study|Death|0|||
156837034|NCT01659255|566155629|FG003|Overall Study|Death|0|||
156837035|NCT01659255|566155630|FG004|Overall Study|Death|0|||
156837036|NCT01659255|566155631|FG005|Overall Study|Death|0|||
156837037|NCT01659255|566155632|FG006|Overall Study|Death|0|||
156837038|NCT01659255|566155633|FG007|Overall Study|Death|1|||
156837039|NCT01659255|566155634|FG008|Overall Study|Death|1|||
156837040|NCT01659255|566155635|FG009|Overall Study|Death|0|||
156837041|NCT01659255|566155636|FG010|Overall Study|Death|0|||
157152549|NCT00336492|567303549|FG000|Overall Study|Other|5|||
157152550|NCT00336492|567303550|FG001|Overall Study|Other|0|||
157152551|NCT00336492|567303551|FG002|Overall Study|Other|1|||
157152552|NCT01781026|567303554|FG000|Overall Study|Lack of Efficacy|2|||
157152553|NCT03090737|567303555|FG000|Overall Study|Other reasons|1|||
157152554|NCT03090737|567303555|FG000|Overall Study|Completed treatment as per protocol|17|||
157152555|NCT03090737|567303555|FG000|Overall Study|Maximum clinical benefit|2|||
157152556|NCT03090737|567303555|FG000|Overall Study|Adverse event unrelated to study drug|7|||
157152557|NCT03090737|567303555|FG000|Overall Study|Study drug toxicity|4|||
157152558|NCT03090737|567303555|FG000|Overall Study|Disease progression|98|||
157152559|NCT00227877|567303556|FG000|Pre-visit Assessment|Technical difficulties|7|||
157152560|NCT00227877|567303557|FG001|Pre-visit Assessment|Technical difficulties|3|||
157152561|NCT00227877|567303558|FG002|Pre-visit Assessment|Technical difficulties|0|||
157152562|NCT00227877|567303559|FG003|Pre-visit Assessment|Technical difficulties|0|||
157152563|NCT00227877|567303556|FG000|Post-visit Checklist|Lost to Follow-up|24|||
157152564|NCT00227877|567303557|FG001|Post-visit Checklist|Lost to Follow-up|13|||
157152565|NCT00227877|567303558|FG002|Post-visit Checklist|Lost to Follow-up|1|||
156837042|NCT01659255|566155637|FG011|Overall Study|Death|0|||
156837043|NCT01659255|566155638|FG012|Overall Study|Death|1|||
156837044|NCT01659255|566155639|FG013|Overall Study|Death|1|||
156837045|NCT01659255|566155640|FG014|Overall Study|Death|2|||
156837046|NCT01659255|566155641|FG015|Overall Study|Death|1|||
156837047|NCT01659255|566155642|FG016|Overall Study|Death|0|||
156837048|NCT01659255|566155626|FG000|Overall Study|Progressive Disease|2|||
156837049|NCT01659255|566155627|FG001|Overall Study|Progressive Disease|0|||
156837050|NCT01659255|566155628|FG002|Overall Study|Progressive Disease|0|||
156837051|NCT01659255|566155629|FG003|Overall Study|Progressive Disease|0|||
156837052|NCT01659255|566155630|FG004|Overall Study|Progressive Disease|0|||
156837053|NCT01659255|566155631|FG005|Overall Study|Progressive Disease|0|||
156837054|NCT01659255|566155632|FG006|Overall Study|Progressive Disease|0|||
156837055|NCT01659255|566155633|FG007|Overall Study|Progressive Disease|1|||
156837056|NCT01659255|566155634|FG008|Overall Study|Progressive Disease|0|||
156837057|NCT01659255|566155635|FG009|Overall Study|Progressive Disease|2|||
156837058|NCT01659255|566155636|FG010|Overall Study|Progressive Disease|2|||
156837059|NCT01659255|566155637|FG011|Overall Study|Progressive Disease|3|||
156837060|NCT01659255|566155638|FG012|Overall Study|Progressive Disease|5|||
156837061|NCT01659255|566155639|FG013|Overall Study|Progressive Disease|13|||
156837062|NCT01659255|566155640|FG014|Overall Study|Progressive Disease|6|||
156837063|NCT01659255|566155641|FG015|Overall Study|Progressive Disease|2|||
156837064|NCT01659255|566155642|FG016|Overall Study|Progressive Disease|3|||
156837065|NCT01659255|566155626|FG000|Overall Study|Withdrew Consent|0|||
156837066|NCT01659255|566155627|FG001|Overall Study|Withdrew Consent|0|||
156837067|NCT01659255|566155628|FG002|Overall Study|Withdrew Consent|0|||
156837068|NCT01659255|566155629|FG003|Overall Study|Withdrew Consent|0|||
156837069|NCT01659255|566155630|FG004|Overall Study|Withdrew Consent|0|||
156837070|NCT01659255|566155631|FG005|Overall Study|Withdrew Consent|0|||
156837071|NCT01659255|566155632|FG006|Overall Study|Withdrew Consent|0|||
156837072|NCT01659255|566155633|FG007|Overall Study|Withdrew Consent|0|||
156837073|NCT01659255|566155634|FG008|Overall Study|Withdrew Consent|0|||
156837074|NCT01659255|566155635|FG009|Overall Study|Withdrew Consent|0|||
156837075|NCT01659255|566155636|FG010|Overall Study|Withdrew Consent|1|||
156837076|NCT01659255|566155637|FG011|Overall Study|Withdrew Consent|0|||
156837077|NCT01659255|566155638|FG012|Overall Study|Withdrew Consent|0|||
156837078|NCT01659255|566155639|FG013|Overall Study|Withdrew Consent|1|||
156837079|NCT01659255|566155640|FG014|Overall Study|Withdrew Consent|0|||
156837080|NCT01659255|566155641|FG015|Overall Study|Withdrew Consent|0|||
156837081|NCT01659255|566155642|FG016|Overall Study|Withdrew Consent|0|||
156837082|NCT01659255|566155626|FG000|Overall Study|Investigator Decision|0|||
156837083|NCT01659255|566155627|FG001|Overall Study|Investigator Decision|0|||
156837084|NCT01659255|566155628|FG002|Overall Study|Investigator Decision|0|||
156837085|NCT01659255|566155629|FG003|Overall Study|Investigator Decision|0|||
156837086|NCT01659255|566155630|FG004|Overall Study|Investigator Decision|0|||
156837087|NCT01659255|566155631|FG005|Overall Study|Investigator Decision|0|||
156837088|NCT01659255|566155632|FG006|Overall Study|Investigator Decision|0|||
156837089|NCT01659255|566155633|FG007|Overall Study|Investigator Decision|0|||
156837090|NCT01659255|566155634|FG008|Overall Study|Investigator Decision|0|||
156837091|NCT01659255|566155635|FG009|Overall Study|Investigator Decision|0|||
156837092|NCT01659255|566155636|FG010|Overall Study|Investigator Decision|0|||
157152566|NCT00227877|567303559|FG003|Post-visit Checklist|Lost to Follow-up|0|||
157152567|NCT00227877|567303556|FG000|3-months Follow-up|Completed late|135|||
157152568|NCT00227877|567303557|FG001|3-months Follow-up|Completed late|128|||
157152569|NCT00227877|567303558|FG002|3-months Follow-up|Completed late|34|||
157152570|NCT00227877|567303559|FG003|3-months Follow-up|Completed late|8|||
156837093|NCT01659255|566155637|FG011|Overall Study|Investigator Decision|0|||
156837094|NCT01659255|566155638|FG012|Overall Study|Investigator Decision|1|||
156837095|NCT01659255|566155639|FG013|Overall Study|Investigator Decision|1|||
156837096|NCT01659255|566155640|FG014|Overall Study|Investigator Decision|0|||
156837097|NCT01659255|566155641|FG015|Overall Study|Investigator Decision|0|||
156837098|NCT01659255|566155642|FG016|Overall Study|Investigator Decision|0|||
156886165|NCT01227824|566342483|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
156886166|NCT01227824|566342484|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
156886167|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
156886168|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
156886169|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
156886170|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
156886171|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
156886172|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
156886173|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
157152571|NCT00227877|567303556|FG000|3-months Follow-up|Lost to Follow-up|178|||
157152572|NCT00227877|567303557|FG001|3-months Follow-up|Lost to Follow-up|139|||
157152573|NCT00227877|567303558|FG002|3-months Follow-up|Lost to Follow-up|18|||
156837099|NCT01659255|566155626|FG000|Overall Study|Sponsor's Decision|0|||
156837100|NCT01659255|566155627|FG001|Overall Study|Sponsor's Decision|0|||
156837101|NCT01659255|566155628|FG002|Overall Study|Sponsor's Decision|0|||
156837102|NCT01659255|566155629|FG003|Overall Study|Sponsor's Decision|0|||
156837103|NCT01659255|566155630|FG004|Overall Study|Sponsor's Decision|0|||
156837104|NCT01659255|566155631|FG005|Overall Study|Sponsor's Decision|0|||
156837105|NCT01659255|566155632|FG006|Overall Study|Sponsor's Decision|1|||
156837106|NCT01659255|566155633|FG007|Overall Study|Sponsor's Decision|0|||
156837107|NCT01659255|566155634|FG008|Overall Study|Sponsor's Decision|0|||
156837108|NCT01659255|566155635|FG009|Overall Study|Sponsor's Decision|0|||
156837109|NCT01659255|566155636|FG010|Overall Study|Sponsor's Decision|0|||
156837110|NCT01659255|566155637|FG011|Overall Study|Sponsor's Decision|0|||
156837111|NCT01659255|566155638|FG012|Overall Study|Sponsor's Decision|0|||
156837112|NCT01659255|566155639|FG013|Overall Study|Sponsor's Decision|0|||
156837113|NCT01659255|566155640|FG014|Overall Study|Sponsor's Decision|0|||
156837114|NCT01659255|566155641|FG015|Overall Study|Sponsor's Decision|0|||
156837115|NCT01659255|566155642|FG016|Overall Study|Sponsor's Decision|0|||
156837116|NCT01659255|566155626|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837117|NCT01659255|566155627|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837118|NCT01659255|566155628|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837119|NCT01659255|566155629|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837120|NCT01659255|566155630|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837121|NCT01659255|566155631|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837122|NCT01659255|566155632|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837123|NCT01659255|566155633|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837124|NCT01659255|566155634|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837125|NCT01659255|566155635|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837126|NCT01659255|566155636|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837127|NCT01659255|566155637|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837128|NCT01659255|566155638|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837129|NCT01659255|566155639|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837130|NCT01659255|566155640|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837131|NCT01659255|566155641|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
156837132|NCT01659255|566155642|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
156837133|NCT01659255|566155626|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
156837134|NCT01659255|566155627|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
156837135|NCT01659255|566155628|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
156837136|NCT01659255|566155629|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
156837137|NCT01659255|566155630|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
156837138|NCT01659255|566155631|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
156837139|NCT01659255|566155632|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
156837140|NCT01659255|566155633|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
156837141|NCT01659255|566155634|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
157152574|NCT00227877|567303559|FG003|3-months Follow-up|Lost to Follow-up|13|||
157152575|NCT00227877|567303556|FG000|12-months Follow-up|Completed late|78|||
156837142|NCT01659255|566155635|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
156837143|NCT01659255|566155636|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
157152576|NCT00227877|567303557|FG001|12-months Follow-up|Completed late|74|||
157152577|NCT00227877|567303558|FG002|12-months Follow-up|Completed late|1|||
156886174|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
156837144|NCT01659255|566155637|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
156837145|NCT01659255|566155638|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
156837146|NCT01659255|566155639|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
156837147|NCT01659255|566155640|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
156837148|NCT01659255|566155641|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
156886175|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
157152578|NCT00227877|567303559|FG003|12-months Follow-up|Completed late|0|||
156837149|NCT01659255|566155642|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
156837150|NCT02211313|566155643|FG000|Overall Study|Treatment Failure|5|||
156837151|NCT02211313|566155644|FG001|Overall Study|Treatment Failure|2|||
156837152|NCT02211313|566155643|FG000|Overall Study|No Follow up Questionnaires|1|||
156837153|NCT02211313|566155644|FG001|Overall Study|No Follow up Questionnaires|1|||
156837154|NCT01423916|566155645|FG000|Overall Study|Adverse Event|5|||
156837155|NCT01423916|566155646|FG001|Overall Study|Adverse Event|9|||
156837156|NCT01423916|566155647|FG002|Overall Study|Adverse Event|2|||
156837157|NCT01423916|566155645|FG000|Overall Study|Met Withdrawal Criteria|1|||
156837158|NCT01423916|566155646|FG001|Overall Study|Met Withdrawal Criteria|1|||
156837159|NCT01423916|566155647|FG002|Overall Study|Met Withdrawal Criteria|1|||
156837160|NCT01423916|566155645|FG000|Overall Study|Physician Decision|1|||
156837161|NCT01423916|566155646|FG001|Overall Study|Physician Decision|0|||
156837162|NCT01423916|566155647|FG002|Overall Study|Physician Decision|1|||
156837163|NCT01423916|566155645|FG000|Overall Study|Withdrawal by Subject|3|||
156837164|NCT01423916|566155646|FG001|Overall Study|Withdrawal by Subject|10|||
156837165|NCT01423916|566155647|FG002|Overall Study|Withdrawal by Subject|3|||
156837166|NCT01423916|566155645|FG000|Overall Study|Protocol Deviation|1|||
156837167|NCT01423916|566155646|FG001|Overall Study|Protocol Deviation|0|||
156837168|NCT01423916|566155647|FG002|Overall Study|Protocol Deviation|0|||
156837169|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
156837170|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
156837171|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
156837172|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
156837173|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
156837174|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
156837175|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
156837176|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
156837177|NCT03316950|566155648|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
156837178|NCT03316950|566155649|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
156837179|NCT03316950|566155650|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
156837180|NCT03316950|566155651|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
156837181|NCT02809053|566155655|FG000|Overall Study|Death|0|||
156837182|NCT02809053|566155656|FG001|Overall Study|Death|1|||
156837183|NCT02809053|566155655|FG000|Overall Study|Lost to Follow-up|3|||
156837184|NCT02809053|566155656|FG001|Overall Study|Lost to Follow-up|1|||
156837185|NCT02809053|566155655|FG000|Overall Study|Withdrawal by Subject|2|||
156837186|NCT02809053|566155656|FG001|Overall Study|Withdrawal by Subject|3|||
156837187|NCT02809053|566155655|FG000|Overall Study|Disease Progression|2|||
156837188|NCT02809053|566155656|FG001|Overall Study|Disease Progression|1|||
156837189|NCT00551291|566155660|FG000|Overall Study|Physician Decision|1|||
156837190|NCT01943552|566155662|FG000|Overall Study|Adverse Event|3|||
156837191|NCT01943552|566155663|FG001|Overall Study|Adverse Event|2|||
156837192|NCT01943552|566155662|FG000|Overall Study|Withdrawal by Subject|6|||
156837193|NCT01943552|566155663|FG001|Overall Study|Withdrawal by Subject|6|||
156837194|NCT01943552|566155662|FG000|Overall Study|Other Reasons|16|||
156837195|NCT01943552|566155663|FG001|Overall Study|Other Reasons|17|||
156837196|NCT01177969|566155664|FG000|Overall Study|Protocol Violation|2|||
156837197|NCT01177969|566155665|FG001|Overall Study|Protocol Violation|1|||
156837198|NCT01177969|566155664|FG000|Overall Study|Withdrawal by Subject|1|||
156837199|NCT01177969|566155665|FG001|Overall Study|Withdrawal by Subject|2|||
156837200|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837201|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837202|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837203|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837204|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
156837205|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837206|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
156837207|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837208|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
156837209|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837210|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
157152579|NCT00227877|567303556|FG000|12-months Follow-up|Lost to Follow-up|232|||
156837211|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
156837212|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837213|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837214|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837215|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837216|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
156837217|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837218|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837219|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
157152580|NCT00227877|567303557|FG001|12-months Follow-up|Lost to Follow-up|189|||
157152581|NCT00227877|567303558|FG002|12-months Follow-up|Lost to Follow-up|30|||
157152582|NCT00227877|567303559|FG003|12-months Follow-up|Lost to Follow-up|26|||
157152583|NCT03141307|567303560|FG000|In-Hospital|Withdrawal by Subject|0|||
157152584|NCT03141307|567303561|FG001|In-Hospital|Withdrawal by Subject|2|||
157152585|NCT03141307|567303560|FG000|In-Hospital|Protocol Violation|4|||
157152586|NCT03141307|567303561|FG001|In-Hospital|Protocol Violation|0|||
157152587|NCT03141307|567303560|FG000|Follow-Up|Lost to Follow-up|97|||
157152588|NCT03141307|567303561|FG001|Follow-Up|Lost to Follow-up|54|||
156837220|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
156837221|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837222|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837223|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
156837224|NCT00908037|566155667|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837225|NCT00908037|566155668|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837226|NCT00908037|566155669|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837227|NCT00908037|566155670|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
156837228|NCT00908037|566155671|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837229|NCT00908037|566155672|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837230|NCT00908037|566155673|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
156837231|NCT00908037|566155674|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837232|NCT00908037|566155675|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837233|NCT00908037|566155676|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837234|NCT00908037|566155677|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837235|NCT00908037|566155678|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
156837236|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837237|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837238|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837239|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837240|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837241|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837242|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837243|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837244|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837245|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837246|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
156837247|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
156837248|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837249|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837250|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837251|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837252|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837253|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156886176|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
156886177|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
156886178|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
156886179|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
156886180|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
156886181|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
156886182|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
156886183|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
156886184|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
156886185|NCT01227824|566342482|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
157152589|NCT03596177|567303564|FG000|Single Blind Period|Withdrawal by Subject|1|||
157152590|NCT03596177|567303565|FG001|Single Blind Period|Withdrawal by Subject|1|||
157152591|NCT03596177|567303564|FG000|Single Blind Period|Other|1|||
157152592|NCT03596177|567303565|FG001|Single Blind Period|Other|0|||
156837254|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837255|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837256|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837257|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
156837258|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
156837259|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
156837260|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
157152593|NCT03596177|567303564|FG000|Double Blind Period|Withdrawal by Subject|0|||
157152594|NCT03596177|567303565|FG001|Double Blind Period|Withdrawal by Subject|1|||
157152595|NCT03596177|567303564|FG000|Double Blind Period|Other|0|||
156837261|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837262|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837263|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837264|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837265|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837266|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837267|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837268|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837269|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
156837270|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837271|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
156837272|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837273|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837274|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837275|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837276|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837277|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837278|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837279|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837280|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837281|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837282|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
156837283|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
156837284|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837285|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837286|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837287|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837288|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837289|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837290|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837291|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837292|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837293|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
156837294|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837295|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
156837296|NCT00908037|566155667|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837297|NCT00908037|566155668|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837298|NCT00908037|566155669|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837299|NCT00908037|566155670|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837300|NCT00908037|566155671|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837301|NCT00908037|566155672|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837302|NCT00908037|566155673|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837303|NCT00908037|566155674|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837304|NCT00908037|566155675|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837305|NCT00908037|566155676|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837306|NCT00908037|566155677|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
156837307|NCT00908037|566155678|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
156837308|NCT01475162|566155679|FG000|Overall Study|Physician Decision|1|||
156837309|NCT01475162|566155679|FG000|Overall Study|Death|10|||
156837310|NCT01475162|566155679|FG000|Overall Study|Study closed for safety|3|||
156837311|NCT02565810|566155680|FG000|Overall Study|Withdrawal by Subject|1|||
156837312|NCT01147900|566155681|FG000|At Year 10|Lost to Follow-up|0|||
156837313|NCT01147900|566155682|FG001|At Year 10|Lost to Follow-up|1|||
156837314|NCT01147900|566155683|FG002|At Year 10|Lost to Follow-up|0|||
156837315|NCT02358044|566155684|FG000|Overall Study|Adverse Event|0|||
156837316|NCT02358044|566155685|FG001|Overall Study|Adverse Event|1|||
156837317|NCT02358044|566155684|FG000|Overall Study|Lost to Follow-up|2|||
156837318|NCT02358044|566155685|FG001|Overall Study|Lost to Follow-up|1|||
156837319|NCT02358044|566155684|FG000|Overall Study|Physician Decision|0|||
156837320|NCT02358044|566155685|FG001|Overall Study|Physician Decision|1|||
156837321|NCT02358044|566155684|FG000|Overall Study|Withdrawal by Subject|0|||
156837322|NCT02358044|566155685|FG001|Overall Study|Withdrawal by Subject|4|||
156837323|NCT00903331|566155688|FG000|Overall Study|Death|4|||
156837324|NCT00903331|566155689|FG001|Overall Study|Death|8|||
157152596|NCT03596177|567303565|FG001|Double Blind Period|Other|4|||
157152597|NCT03596177|567303564|FG000|Double Blind Period|Death during safety follow-up|0|||
157152598|NCT03596177|567303565|FG001|Double Blind Period|Death during safety follow-up|1|||
157152599|NCT02522481|567303568|FG000|Overall Study|discontinued|1|||
157152600|NCT02522481|567303568|FG000|Overall Study|Not dosed|2|||
157152601|NCT03123939|567303569|FG000|Overall Study|Lack of Efficacy|6|||
157152602|NCT03123939|567303569|FG000|Overall Study|Death|5|||
157152603|NCT03123939|567303569|FG000|Overall Study|Physician Decision|2|||
157152604|NCT03123939|567303569|FG000|Overall Study|Subject/guardian decision|2|||
157152605|NCT03123939|567303569|FG000|Overall Study|Lost to Follow-up|1|||
157152606|NCT03123939|567303569|FG000|Overall Study|New therapy for study indication|1|||
157152607|NCT03123939|567303569|FG000|Overall Study|Protocol deviation|1|||
157152608|NCT03123939|567303569|FG000|Overall Study|Progressive disease|18|||
157152609|NCT03123939|567303569|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
157152610|NCT03123939|567303569|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
157152611|NCT02078713|567305547|FG000|Overall Study|Lost to Follow-up|49|||
157152612|NCT02078713|567305548|FG001|Overall Study|Lost to Follow-up|55|||
157152613|NCT02078713|567305549|FG002|Overall Study|Lost to Follow-up|0|||
157152614|NCT02078713|567305550|FG003|Overall Study|Lost to Follow-up|0|||
157152615|NCT02078713|567305547|FG000|Overall Study|Pregnant at baseline|3|||
157152616|NCT02078713|567305548|FG001|Overall Study|Pregnant at baseline|5|||
157152617|NCT02078713|567305549|FG002|Overall Study|Pregnant at baseline|0|||
157152618|NCT02078713|567305550|FG003|Overall Study|Pregnant at baseline|0|||
157152619|NCT02078713|567305547|FG000|Overall Study|Enrolled twice|0|||
157152620|NCT02078713|567305548|FG001|Overall Study|Enrolled twice|1|||
157152621|NCT02078713|567305549|FG002|Overall Study|Enrolled twice|0|||
157152622|NCT02078713|567305550|FG003|Overall Study|Enrolled twice|0|||
157152623|NCT02778867|567305563|FG000|Phase 1|Withdrawal by Subject|2|||
157152624|NCT02778867|567305564|FG001|Phase 1|Withdrawal by Subject|3|||
157152625|NCT02778867|567305565|FG002|Phase 1|Withdrawal by Subject|0|||
157152626|NCT02778867|567305566|FG003|Phase 1|Withdrawal by Subject|0|||
157152627|NCT02778867|567305563|FG000|Phase 2|Withdrawal by Subject|0|||
157152628|NCT02778867|567305564|FG001|Phase 2|Withdrawal by Subject|0|||
157152629|NCT02778867|567305565|FG002|Phase 2|Withdrawal by Subject|1|||
157152630|NCT02778867|567305566|FG003|Phase 2|Withdrawal by Subject|0|||
157152631|NCT02778867|567305563|FG000|Phase 2|Physician Decision|0|||
157152632|NCT02778867|567305564|FG001|Phase 2|Physician Decision|0|||
157152633|NCT02778867|567305565|FG002|Phase 2|Physician Decision|0|||
157152634|NCT02778867|567305566|FG003|Phase 2|Physician Decision|1|||
157152635|NCT02778867|567305563|FG000|Phase 2|Adverse Event|0|||
157152636|NCT02778867|567305564|FG001|Phase 2|Adverse Event|0|||
157152637|NCT02778867|567305565|FG002|Phase 2|Adverse Event|0|||
157152638|NCT02778867|567305566|FG003|Phase 2|Adverse Event|1|||
157152639|NCT02311478|567305567|FG000|Overall Study|Withdrawal by Subject|1|||
157152640|NCT02311478|567305567|FG000|Overall Study|Lost to Follow-up|5|||
157152641|NCT02311478|567305567|FG000|Overall Study|Failed IUD Insertion|1|||
157152642|NCT03276936|567305568|FG000|Overall Study|Adverse Event|4|||
157152643|NCT03276936|567305569|FG001|Overall Study|Adverse Event|2|||
157152644|NCT03276936|567305568|FG000|Overall Study|Lost to Follow-up|16|||
157152645|NCT03276936|567305569|FG001|Overall Study|Lost to Follow-up|13|||
157152646|NCT03276936|567305568|FG000|Overall Study|Withdrawal by Subject|30|||
157152647|NCT03276936|567305569|FG001|Overall Study|Withdrawal by Subject|20|||
157152648|NCT03276936|567305568|FG000|Overall Study|Not mentioned|6|||
157152649|NCT03276936|567305569|FG001|Overall Study|Not mentioned|3|||
157152650|NCT00943319|567305570|FG000|Overall Study|Death|1|||
157152651|NCT02043301|567305571|FG000|Overall Study|Discontinued|0|||
157152652|NCT02043301|567305572|FG001|Overall Study|Discontinued|1|||
157152653|NCT02043301|567305573|FG002|Overall Study|Discontinued|0|||
157152654|NCT02653976|567305574|FG000|Overall Study|Withdrawal by Subject|5|||
157152655|NCT02653976|567305574|FG000|Overall Study|Death|4|||
157152656|NCT03703375|567305575|FG000|Randomization Period|Withdrawal by Subject|0|||
157152657|NCT03703375|567305576|FG001|Randomization Period|Withdrawal by Subject|0|||
157152658|NCT03703375|567305577|FG002|Randomization Period|Withdrawal by Subject|0|||
157152659|NCT03703375|567305578|FG003|Randomization Period|Withdrawal by Subject|1|||
157152660|NCT03703375|567305575|FG000|Randomization Period|Completed safety run-in treatment|7|||
157152661|NCT03703375|567305576|FG001|Randomization Period|Completed safety run-in treatment|0|||
157152662|NCT03703375|567305577|FG002|Randomization Period|Completed safety run-in treatment|0|||
157152663|NCT03703375|567305578|FG003|Randomization Period|Completed safety run-in treatment|0|||
157152664|NCT03703375|567305575|FG000|Treatment Period|Other Reasons|0|||
157152665|NCT03703375|567305576|FG001|Treatment Period|Other Reasons|1|||
157152666|NCT03703375|567305577|FG002|Treatment Period|Other Reasons|0|||
157152667|NCT03703375|567305578|FG003|Treatment Period|Other Reasons|3|||
157152668|NCT03703375|567305575|FG000|Treatment Period|Consent Withdrawal|0|||
157152669|NCT03703375|567305576|FG001|Treatment Period|Consent Withdrawal|0|||
157152670|NCT03703375|567305577|FG002|Treatment Period|Consent Withdrawal|0|||
157152671|NCT03703375|567305578|FG003|Treatment Period|Consent Withdrawal|1|||
157152672|NCT03703375|567305575|FG000|Treatment Period|Death|1|||
157152673|NCT03703375|567305576|FG001|Treatment Period|Death|0|||
156837325|NCT00903331|566155688|FG000|Overall Study|Withdrawal of consent|1|||
156837326|NCT00903331|566155689|FG001|Overall Study|Withdrawal of consent|8|||
156837327|NCT00903331|566155688|FG000|Overall Study|Lung transplant|0|||
156837328|NCT00903331|566155689|FG001|Overall Study|Lung transplant|2|||
156837329|NCT04109976|566155693|FG000|Overall Study|Withdrawal by Subject|1|||
156837330|NCT04109976|566155694|FG001|Overall Study|Withdrawal by Subject|0|||
156837331|NCT00257660|566155695|FG000|Overall Study|Lack of Efficacy|5|||
156837332|NCT00257660|566155696|FG001|Overall Study|Lack of Efficacy|23|||
156837333|NCT00257660|566155695|FG000|Overall Study|Withdrawal by Subject|2|||
156837334|NCT00257660|566155696|FG001|Overall Study|Withdrawal by Subject|0|||
156837335|NCT00257660|566155695|FG000|Overall Study|Lost to Follow-up|1|||
156837336|NCT00257660|566155696|FG001|Overall Study|Lost to Follow-up|0|||
156837337|NCT00257660|566155695|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
156837338|NCT00257660|566155696|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
156837339|NCT00257660|566155695|FG000|Overall Study|No longer wanted to do blood draws|1|||
156837340|NCT00257660|566155696|FG001|Overall Study|No longer wanted to do blood draws|0|||
156837341|NCT00491608|566155697|FG000|Overall Study|Death|2|||
156837342|NCT00491608|566155697|FG000|Overall Study|Withdrawal by Subject|1|||
156837343|NCT00025155|566155700|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
156837344|NCT00025155|566155700|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
156837345|NCT00552760|566155703|FG000|Overall Study|Adverse Event|3|||
156837346|NCT00552760|566155704|FG001|Overall Study|Adverse Event|5|||
156837347|NCT00552760|566155703|FG000|Overall Study|Relapsed- Depressed Event|10|||
156837348|NCT00552760|566155704|FG001|Overall Study|Relapsed- Depressed Event|16|||
156837349|NCT00552760|566155703|FG000|Overall Study|Relapse- Manic Event|3|||
156837350|NCT00552760|566155704|FG001|Overall Study|Relapse- Manic Event|3|||
156837351|NCT00552760|566155703|FG000|Overall Study|Relapsed- Mixed Event|3|||
156837352|NCT00552760|566155704|FG001|Overall Study|Relapsed- Mixed Event|5|||
156837353|NCT00552760|566155703|FG000|Overall Study|Protocol Violation|0|||
156837354|NCT00552760|566155704|FG001|Overall Study|Protocol Violation|1|||
156837355|NCT00552760|566155703|FG000|Overall Study|Lost to Follow-up|1|||
156837356|NCT00552760|566155704|FG001|Overall Study|Lost to Follow-up|1|||
156837357|NCT00552760|566155703|FG000|Overall Study|Non-compliance|1|||
156837358|NCT00552760|566155704|FG001|Overall Study|Non-compliance|1|||
156837359|NCT00552760|566155703|FG000|Overall Study|Medical Condition|1|||
156837360|NCT00552760|566155704|FG001|Overall Study|Medical Condition|1|||
156837361|NCT00552760|566155703|FG000|Overall Study|Withdrawal by Subject|3|||
156886186|NCT01227824|566342483|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
156886187|NCT01227824|566342484|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
156886188|NCT00781885|566342485|FG000|Overall Study|Physician Decision|1|||
156837362|NCT00552760|566155704|FG001|Overall Study|Withdrawal by Subject|0|||
156837363|NCT00552760|566155703|FG000|Overall Study|Medication Change|1|||
156837364|NCT00552760|566155704|FG001|Overall Study|Medication Change|0|||
156886189|NCT02576145|566342486|FG000|Overall Study|Adverse Event|1|||
156886190|NCT02576145|566342487|FG001|Overall Study|Adverse Event|0|||
156886191|NCT02576145|566342486|FG000|Overall Study|Withdrawal by Subject|1|||
156886192|NCT02576145|566342487|FG001|Overall Study|Withdrawal by Subject|0|||
157152674|NCT03703375|567305577|FG002|Treatment Period|Death|1|||
157152675|NCT03703375|567305578|FG003|Treatment Period|Death|2|||
157152676|NCT03703375|567305575|FG000|Treatment Period|Toxicity of Study Treatment|2|||
157152677|NCT03703375|567305576|FG001|Treatment Period|Toxicity of Study Treatment|0|||
157152678|NCT03703375|567305577|FG002|Treatment Period|Toxicity of Study Treatment|4|||
157152679|NCT03703375|567305578|FG003|Treatment Period|Toxicity of Study Treatment|1|||
157152680|NCT03703375|567305575|FG000|Treatment Period|Progression|32|||
157152681|NCT03703375|567305576|FG001|Treatment Period|Progression|1|||
157152682|NCT03703375|567305577|FG002|Treatment Period|Progression|7|||
157152683|NCT03703375|567305578|FG003|Treatment Period|Progression|11|||
157152684|NCT03703375|567305575|FG000|Treatment Period|Completed treatment|7|||
157152685|NCT03703375|567305576|FG001|Treatment Period|Completed treatment|2|||
157152686|NCT03703375|567305577|FG002|Treatment Period|Completed treatment|0|||
157152687|NCT03703375|567305578|FG003|Treatment Period|Completed treatment|0|||
157152688|NCT01675011|567305579|FG000|Overall Study|Trial terminated by Sponsor|3|||
157152689|NCT01675011|567305580|FG001|Overall Study|Trial terminated by Sponsor|1|||
157152690|NCT00366548|567305581|FG000|Infant Series|Adverse Event|1|||
157152691|NCT00366548|567305582|FG001|Infant Series|Adverse Event|3|||
157152692|NCT00366548|567305581|FG000|Infant Series|Protocol Violation|0|||
156837365|NCT03426631|566155707|FG000|Overall Study|Lost to Follow-up|0|||
156837366|NCT03426631|566155708|FG001|Overall Study|Lost to Follow-up|1|||
156837367|NCT00343382|566155711|FG000|Overall Study|Adverse Event|2|||
156837368|NCT00343382|566155712|FG001|Overall Study|Adverse Event|10|||
156886193|NCT02576145|566342486|FG000|Overall Study|Acute rejection|1|||
156886194|NCT02576145|566342487|FG001|Overall Study|Acute rejection|0|||
156837369|NCT00343382|566155713|FG002|Overall Study|Adverse Event|7|||
156837370|NCT00343382|566155711|FG000|Overall Study|Withdrawal by Subject|1|||
156837371|NCT00343382|566155712|FG001|Overall Study|Withdrawal by Subject|2|||
156886195|NCT02576145|566342486|FG000|Overall Study|Tetanus Titers Decreased|0|||
157152693|NCT00366548|567305582|FG001|Infant Series|Protocol Violation|1|||
157152694|NCT00366548|567305581|FG000|Infant Series|Withdrawal by Subject|3|||
157152695|NCT00366548|567305582|FG001|Infant Series|Withdrawal by Subject|1|||
157152696|NCT00366548|567305581|FG000|After Infant Series|Withdrawal by Subject|3|||
157152697|NCT00366548|567305582|FG001|After Infant Series|Withdrawal by Subject|1|||
157152698|NCT00366548|567305581|FG000|After Infant Series|Adverse Event|2|||
157152699|NCT00366548|567305582|FG001|After Infant Series|Adverse Event|0|||
157152700|NCT00366548|567305581|FG000|After Infant Series|Lost to Follow-up|1|||
157152701|NCT00366548|567305582|FG001|After Infant Series|Lost to Follow-up|0|||
156837372|NCT00343382|566155713|FG002|Overall Study|Withdrawal by Subject|6|||
156837373|NCT00343382|566155711|FG000|Overall Study|Other Reason Not Specified|1|||
156837374|NCT00343382|566155712|FG001|Overall Study|Other Reason Not Specified|2|||
156837375|NCT00343382|566155713|FG002|Overall Study|Other Reason Not Specified|4|||
156837376|NCT02337725|566155718|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
156837377|NCT02337725|566155719|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
156837378|NCT02337725|566155718|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
156837379|NCT02337725|566155719|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
156837380|NCT02337725|566155718|FG000|Overall Study|Major Protocol Deviation|0|||
156837381|NCT02337725|566155719|FG001|Overall Study|Major Protocol Deviation|1|||
156837382|NCT02337725|566155718|FG000|Overall Study|Voluntary Withdrawal|14|||
156837383|NCT02337725|566155719|FG001|Overall Study|Voluntary Withdrawal|3|||
156837384|NCT02337725|566155718|FG000|Overall Study|Lack of Efficacy|4|||
156837385|NCT02337725|566155719|FG001|Overall Study|Lack of Efficacy|0|||
156837386|NCT00710385|566155724|FG000|Overall Study|Did not qualify|1|||
156837387|NCT00710385|566155724|FG000|Overall Study|Withdrawal by Subject|1|||
156837388|NCT00710385|566155724|FG000|Overall Study|Undisclosed back pain|1|||
156837389|NCT00710385|566155724|FG000|Overall Study|Physician Decision|1|||
156837390|NCT00710385|566155724|FG000|Overall Study|Undisclosed excessive methadone use|1|||
156837391|NCT01264770|566155725|FG000|Overall Study|Not reported|0|||
156837392|NCT01264770|566155726|FG001|Overall Study|Not reported|0|||
156837393|NCT01264770|566155727|FG002|Overall Study|Not reported|1|||
156837394|NCT01264770|566155728|FG003|Overall Study|Not reported|0|||
156837395|NCT01264770|566155729|FG004|Overall Study|Not reported|0|||
156837396|NCT01264770|566155730|FG005|Overall Study|Not reported|0|||
156837397|NCT01264770|566155725|FG000|Overall Study|e.g., change in circumstances|8|||
156837398|NCT01264770|566155726|FG001|Overall Study|e.g., change in circumstances|3|||
156837399|NCT01264770|566155727|FG002|Overall Study|e.g., change in circumstances|3|||
156837400|NCT01264770|566155728|FG003|Overall Study|e.g., change in circumstances|3|||
156837401|NCT01264770|566155729|FG004|Overall Study|e.g., change in circumstances|4|||
156837402|NCT01264770|566155730|FG005|Overall Study|e.g., change in circumstances|4|||
156837403|NCT01264770|566155725|FG000|Overall Study|Severe non-compliance to protocol|0|||
156837404|NCT01264770|566155726|FG001|Overall Study|Severe non-compliance to protocol|0|||
156837405|NCT01264770|566155727|FG002|Overall Study|Severe non-compliance to protocol|1|||
156837406|NCT01264770|566155728|FG003|Overall Study|Severe non-compliance to protocol|1|||
156837407|NCT01264770|566155729|FG004|Overall Study|Severe non-compliance to protocol|0|||
156837408|NCT01264770|566155730|FG005|Overall Study|Severe non-compliance to protocol|0|||
156837409|NCT01264770|566155725|FG000|Overall Study|Lack of therapeutic response|1|||
156837410|NCT01264770|566155726|FG001|Overall Study|Lack of therapeutic response|0|||
156837411|NCT01264770|566155727|FG002|Overall Study|Lack of therapeutic response|2|||
156837412|NCT01264770|566155728|FG003|Overall Study|Lack of therapeutic response|1|||
156837413|NCT01264770|566155729|FG004|Overall Study|Lack of therapeutic response|1|||
156837414|NCT01264770|566155730|FG005|Overall Study|Lack of therapeutic response|0|||
156837415|NCT01264770|566155725|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
156837416|NCT01264770|566155726|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
156837417|NCT01264770|566155727|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
156837418|NCT01264770|566155728|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
156837419|NCT01264770|566155729|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
156837420|NCT01264770|566155730|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
156837421|NCT01264770|566155725|FG000|Overall Study|Lost to Follow-up|0|||
156837422|NCT01264770|566155726|FG001|Overall Study|Lost to Follow-up|0|||
156837423|NCT01264770|566155727|FG002|Overall Study|Lost to Follow-up|1|||
157152702|NCT02849990|567305583|FG000|Overall Study|Adverse Event|1|||
157152703|NCT02849990|567305583|FG000|Overall Study|Withdrawal by Subject|1|||
157152704|NCT01252134|567305584|FG000|Period 1, 8 Hours|Personal Reasons|0|||
157152705|NCT01252134|567305585|FG001|Period 1, 8 Hours|Personal Reasons|1|||
156837424|NCT01264770|566155728|FG003|Overall Study|Lost to Follow-up|1|||
156837425|NCT01264770|566155729|FG004|Overall Study|Lost to Follow-up|0|||
156837426|NCT01264770|566155730|FG005|Overall Study|Lost to Follow-up|0|||
156837427|NCT01264770|566155725|FG000|Overall Study|Adverse Event|7|||
156837428|NCT01264770|566155726|FG001|Overall Study|Adverse Event|7|||
156837429|NCT01264770|566155727|FG002|Overall Study|Adverse Event|8|||
156837430|NCT01264770|566155728|FG003|Overall Study|Adverse Event|0|||
156837431|NCT01264770|566155729|FG004|Overall Study|Adverse Event|2|||
156837432|NCT01264770|566155730|FG005|Overall Study|Adverse Event|1|||
156837433|NCT03109184|566157913|FG000|Overall Study|Lost to Follow-up|6|||
157023726|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
157023727|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
157023728|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
157023729|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
157023730|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
157023731|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
157023732|NCT01369355|566841104|FG000|Long-term Extension (Week 44-272)|Other|0|||
157023733|NCT01369355|566841105|FG001|Long-term Extension (Week 44-272)|Other|0|||
157023734|NCT01369355|566841106|FG002|Long-term Extension (Week 44-272)|Other|0|||
157023735|NCT01369355|566841107|FG003|Long-term Extension (Week 44-272)|Other|0|||
157023736|NCT01369355|566841108|FG004|Long-term Extension (Week 44-272)|Other|0|||
157023737|NCT01369355|566841109|FG005|Long-term Extension (Week 44-272)|Other|0|||
157023738|NCT01369355|566841110|FG006|Long-term Extension (Week 44-272)|Other|110|||
157023739|NCT01369355|566841111|FG007|Long-term Extension (Week 44-272)|Other|9|||
157023740|NCT01369355|566841112|FG008|Long-term Extension (Week 44-272)|Other|17|||
157023741|NCT02319759|566841113|FG000|Week 0 - 16|Lack of Efficacy|1|||
157023742|NCT02319759|566841114|FG001|Week 0 - 16|Lack of Efficacy|0|||
157023743|NCT02319759|566841115|FG002|Week 0 - 16|Lack of Efficacy|0|||
157023744|NCT02319759|566841116|FG003|Week 0 - 16|Lack of Efficacy|0|||
157023745|NCT02319759|566841117|FG004|Week 0 - 16|Lack of Efficacy|0|||
157023746|NCT02319759|566841113|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
157023747|NCT02319759|566841114|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
157023748|NCT02319759|566841115|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
157023749|NCT02319759|566841116|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
157023750|NCT02319759|566841117|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
157023751|NCT02319759|566841113|FG000|Week 16 - 24|Lack of Efficacy|1|||
157023752|NCT02319759|566841114|FG001|Week 16 - 24|Lack of Efficacy|0|||
157023753|NCT02319759|566841115|FG002|Week 16 - 24|Lack of Efficacy|1|||
157023754|NCT02319759|566841116|FG003|Week 16 - 24|Lack of Efficacy|0|||
157023755|NCT02319759|566841117|FG004|Week 16 - 24|Lack of Efficacy|0|||
157023756|NCT02319759|566841113|FG000|Week 16 - 24|Lost to Follow-up|1|||
157023757|NCT02319759|566841114|FG001|Week 16 - 24|Lost to Follow-up|0|||
157023758|NCT02319759|566841115|FG002|Week 16 - 24|Lost to Follow-up|0|||
157023759|NCT02319759|566841116|FG003|Week 16 - 24|Lost to Follow-up|0|||
157023760|NCT02319759|566841117|FG004|Week 16 - 24|Lost to Follow-up|0|||
157023761|NCT02319759|566841113|FG000|Week 16 - 24|Withdrawal by Subject|0|||
157023762|NCT02319759|566841114|FG001|Week 16 - 24|Withdrawal by Subject|0|||
157023763|NCT02319759|566841115|FG002|Week 16 - 24|Withdrawal by Subject|2|||
157023764|NCT02319759|566841116|FG003|Week 16 - 24|Withdrawal by Subject|0|||
157023765|NCT02319759|566841117|FG004|Week 16 - 24|Withdrawal by Subject|0|||
157023766|NCT02319759|566841113|FG000|Week 24 - 56|Adverse Event|0|||
157023767|NCT02319759|566841114|FG001|Week 24 - 56|Adverse Event|0|||
157023768|NCT02319759|566841115|FG002|Week 24 - 56|Adverse Event|2|||
157023769|NCT02319759|566841116|FG003|Week 24 - 56|Adverse Event|0|||
157023770|NCT02319759|566841117|FG004|Week 24 - 56|Adverse Event|0|||
157023771|NCT02319759|566841113|FG000|Week 24 - 56|Lack of Efficacy|0|||
157023772|NCT02319759|566841114|FG001|Week 24 - 56|Lack of Efficacy|0|||
157023773|NCT02319759|566841115|FG002|Week 24 - 56|Lack of Efficacy|0|||
157023774|NCT02319759|566841116|FG003|Week 24 - 56|Lack of Efficacy|2|||
157023775|NCT02319759|566841117|FG004|Week 24 - 56|Lack of Efficacy|1|||
157023776|NCT02319759|566841113|FG000|Week 24 - 56|Withdrawal by Subject|0|||
157023777|NCT02319759|566841114|FG001|Week 24 - 56|Withdrawal by Subject|1|||
157023778|NCT02319759|566841115|FG002|Week 24 - 56|Withdrawal by Subject|0|||
157023779|NCT02319759|566841116|FG003|Week 24 - 56|Withdrawal by Subject|0|||
157023780|NCT02319759|566841117|FG004|Week 24 - 56|Withdrawal by Subject|0|||
157023781|NCT02319759|566841113|FG000|Week 24 - 56|Lost to Follow-up|0|||
157023782|NCT02319759|566841114|FG001|Week 24 - 56|Lost to Follow-up|0|||
157023783|NCT02319759|566841115|FG002|Week 24 - 56|Lost to Follow-up|0|||
157023784|NCT02319759|566841116|FG003|Week 24 - 56|Lost to Follow-up|0|||
157023785|NCT02319759|566841117|FG004|Week 24 - 56|Lost to Follow-up|1|||
156837434|NCT03109184|566157914|FG001|Overall Study|Lost to Follow-up|6|||
157023786|NCT01959425|566841118|FG000|Overall Study|Withdrawal by Subject|5|||
157023787|NCT01959425|566841119|FG001|Overall Study|Withdrawal by Subject|4|||
157023788|NCT01959425|566841118|FG000|Overall Study|Lost to Follow-up|1|||
157023789|NCT01959425|566841119|FG001|Overall Study|Lost to Follow-up|0|||
157023790|NCT01959425|566841118|FG000|Overall Study|Discontinued Subjects|6|||
157023791|NCT01959425|566841119|FG001|Overall Study|Discontinued Subjects|4|||
157023792|NCT02262728|566841120|FG000|Follow-up Phase (3 Years)|Death|0|||
157023793|NCT02262728|566841121|FG001|Follow-up Phase (3 Years)|Death|1|||
157023794|NCT02262728|566841120|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
157023795|NCT02262728|566841121|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
157023796|NCT02262728|566841120|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
157023797|NCT02262728|566841121|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
156837435|NCT03109184|566157913|FG000|Overall Study|Withdrawal by Subject|1|||
157023798|NCT02619838|566841122|FG000|Overall Study|Lost to Follow-up|9|||
157023799|NCT02619838|566841122|FG000|Overall Study|Withdrawal by Subject|15|||
156837436|NCT03109184|566157914|FG001|Overall Study|Withdrawal by Subject|1|||
156837437|NCT02503501|566157915|FG000|Overall Study|Physician Decision|1|||
156837438|NCT02503501|566157916|FG001|Overall Study|Physician Decision|0|||
156837439|NCT02503501|566157915|FG000|Overall Study|Protocol Violation|0|||
156837440|NCT02503501|566157916|FG001|Overall Study|Protocol Violation|1|||
156837441|NCT02503501|566157915|FG000|Overall Study|Withdrawal by Subject|0|||
156837442|NCT02503501|566157916|FG001|Overall Study|Withdrawal by Subject|2|||
156837443|NCT01740401|566157917|FG000|Overall Study|Progression of disease|6|||
156837444|NCT01740401|566157917|FG000|Overall Study|Adverse Event|2|||
156837445|NCT01740401|566157917|FG000|Overall Study|Did not reach primary endpoint|2|||
156886196|NCT02576145|566342487|FG001|Overall Study|Tetanus Titers Decreased|1|||
156886197|NCT01755026|566342488|FG000|Overall Study|Adverse Event|1|||
156886198|NCT01755026|566342489|FG001|Overall Study|Adverse Event|0|||
156886199|NCT01755026|566342488|FG000|Overall Study|Withdrawal by Subject|1|||
156886200|NCT01755026|566342489|FG001|Overall Study|Withdrawal by Subject|1|||
156886201|NCT00545129|566342490|FG000|Overall Study|Lack of Efficacy|2|||
156886202|NCT00545129|566342491|FG001|Overall Study|Lack of Efficacy|5|||
156886203|NCT00545129|566342490|FG000|Overall Study|Death|2|||
156886204|NCT00545129|566342491|FG001|Overall Study|Death|1|||
156886205|NCT00545129|566342490|FG000|Overall Study|Adverse Event|1|||
156886206|NCT00545129|566342491|FG001|Overall Study|Adverse Event|1|||
156886207|NCT00545129|566342490|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
156886208|NCT00545129|566342491|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
156886209|NCT00545129|566342490|FG000|Overall Study|Other|3|||
156886210|NCT00545129|566342491|FG001|Overall Study|Other|3|||
156886211|NCT00821509|566342492|FG000|Overall Study|Withdrawal by Subject|12|||
156886212|NCT00821509|566342493|FG001|Overall Study|Withdrawal by Subject|11|||
156886213|NCT00821509|566342494|FG002|Overall Study|Withdrawal by Subject|34|||
156886214|NCT00807573|566342496|FG000|Overall Study|Withdrawal by Subject|1|||
156886215|NCT00807573|566342496|FG000|Overall Study|Adverse Event|1|||
156886216|NCT01551420|566342497|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
156886217|NCT01551420|566342498|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
156886218|NCT01551420|566342497|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
156886219|NCT01551420|566342498|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
156886220|NCT01551420|566342497|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
156886221|NCT01551420|566342498|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
156886222|NCT01551420|566342497|FG000|Screened for Part B Eligibility|Declined participation|8|||
156886223|NCT01551420|566342498|FG001|Screened for Part B Eligibility|Declined participation|1|||
156886224|NCT01551420|566342497|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
156886225|NCT01551420|566342498|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
156886226|NCT01551420|566342497|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
156886227|NCT01551420|566342498|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
156886228|NCT01551420|566342497|FG000|Home Use (Part B)|Withdrawal by staff|0|||
156886229|NCT01551420|566342498|FG001|Home Use (Part B)|Withdrawal by staff|1|||
156886230|NCT00169442|566342499|FG000|Overall Study|Withdrawal by Subject|0|||
156886231|NCT00169442|566342500|FG001|Overall Study|Withdrawal by Subject|0|||
156886232|NCT00169442|566342501|FG002|Overall Study|Withdrawal by Subject|1|||
156886233|NCT00169442|566342502|FG003|Overall Study|Withdrawal by Subject|0|||
156886234|NCT00169442|566342503|FG004|Overall Study|Withdrawal by Subject|0|||
156886235|NCT00169442|566342504|FG005|Overall Study|Withdrawal by Subject|0|||
156886236|NCT00169442|566342499|FG000|Overall Study|Migrated/moved from study area|0|||
156886237|NCT00169442|566342500|FG001|Overall Study|Migrated/moved from study area|0|||
156886238|NCT00169442|566342501|FG002|Overall Study|Migrated/moved from study area|0|||
156886239|NCT00169442|566342502|FG003|Overall Study|Migrated/moved from study area|0|||
156886240|NCT00169442|566342503|FG004|Overall Study|Migrated/moved from study area|0|||
156886241|NCT00169442|566342504|FG005|Overall Study|Migrated/moved from study area|2|||
156886242|NCT00169442|566342499|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156886243|NCT00169442|566342500|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156886244|NCT00169442|566342501|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156886245|NCT00169442|566342502|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
157023800|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
156837446|NCT02806960|566157918|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837447|NCT02806960|566157919|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156886246|NCT00169442|566342503|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
157023801|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
156837448|NCT02806960|566157920|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837449|NCT02806960|566157921|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
156837450|NCT00321464|566157922|FG000|Overall Study|Death|169|||
156837451|NCT00321464|566157923|FG001|Overall Study|Death|174|||
156886247|NCT00169442|566342504|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
156886248|NCT00169442|566342499|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156886249|NCT00169442|566342500|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
157023802|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
157152706|NCT01252134|567305586|FG002|Period 1, 8 Hours|Personal Reasons|1|||
157152707|NCT01252134|567305587|FG003|Period 1, 8 Hours|Personal Reasons|0|||
156837452|NCT00321464|566157922|FG000|Overall Study|Disease progression|124|||
156837453|NCT00321464|566157923|FG001|Overall Study|Disease progression|124|||
156837454|NCT00321464|566157922|FG000|Overall Study|Withdrawal by Subject|117|||
156837455|NCT00321464|566157923|FG001|Overall Study|Withdrawal by Subject|118|||
156837456|NCT00321464|566157922|FG000|Overall Study|Participant request|57|||
156837457|NCT00321464|566157923|FG001|Overall Study|Participant request|61|||
156837458|NCT00321464|566157922|FG000|Overall Study|Adverse Event|43|||
156837459|NCT00321464|566157923|FG001|Overall Study|Adverse Event|28|||
156837460|NCT00321464|566157922|FG000|Overall Study|Physician Decision|15|||
156886250|NCT00169442|566342501|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156886251|NCT00169442|566342502|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156886252|NCT00169442|566342503|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156886253|NCT00169442|566342504|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
156886254|NCT01426789|566342505|FG000|Part 1|Protocol deviation|0|||
156886255|NCT01426789|566342506|FG001|Part 1|Protocol deviation|1|||
156886256|NCT01426789|566342507|FG002|Part 1|Protocol deviation|0|||
156886257|NCT01426789|566342508|FG003|Part 1|Protocol deviation|0|||
156886258|NCT01426789|566342509|FG004|Part 1|Protocol deviation|0|||
156886259|NCT01426789|566342510|FG005|Part 1|Protocol deviation|0|||
156886260|NCT01426789|566342505|FG000|Part 1|Lost to Follow-up|1|||
156886261|NCT01426789|566342506|FG001|Part 1|Lost to Follow-up|2|||
156886262|NCT01426789|566342507|FG002|Part 1|Lost to Follow-up|0|||
156886263|NCT01426789|566342508|FG003|Part 1|Lost to Follow-up|0|||
156886264|NCT01426789|566342509|FG004|Part 1|Lost to Follow-up|0|||
156886265|NCT01426789|566342510|FG005|Part 1|Lost to Follow-up|0|||
156886266|NCT01426789|566342505|FG000|Part 1|Lack of Efficacy|2|||
157152708|NCT01252134|567305588|FG004|Period 1, 8 Hours|Personal Reasons|0|||
157152709|NCT01252134|567305589|FG005|Period 1, 8 Hours|Personal Reasons|0|||
157152710|NCT02678741|567305591|FG000|Overall Study|Death|4|||
157152711|NCT02678741|567305591|FG000|Overall Study|Withdrawal by Subject|1|||
157152712|NCT02678741|567305591|FG000|Overall Study|ineligible|3|||
157152713|NCT02678741|567305591|FG000|Overall Study|Not RECIST Measurable|2|||
157152714|NCT02678741|567305591|FG000|Overall Study|Lack of Efficacy|10|||
157152715|NCT01795898|567305592|FG000|Overall Study|Adverse Event|27|||
157152716|NCT01795898|567305592|FG000|Overall Study|Lost to Follow-up|20|||
157152717|NCT01795898|567305592|FG000|Overall Study|Withdrawal of consent|6|||
157152718|NCT01795898|567305592|FG000|Overall Study|Diagnosed with metastasis|1|||
157152719|NCT01795898|567305592|FG000|Overall Study|No pain|1|||
157152720|NCT01795898|567305592|FG000|Overall Study|Death|1|||
157152721|NCT01795898|567305592|FG000|Overall Study|Withdrew consent & had adverse events|3|||
157152722|NCT01795898|567305592|FG000|Overall Study|Physician Decision|1|||
157152723|NCT02421120|567305603|FG000|Overall Study|Adverse Event|1|||
157152724|NCT00372190|567305604|FG000|Overall Study|Lost to Follow-up|3|||
157152725|NCT00372190|567305605|FG001|Overall Study|Lost to Follow-up|1|||
157152726|NCT00623467|567305606|FG000|Overall Study|Lost to Follow-up|1|||
157152727|NCT00623467|567305606|FG000|Overall Study|Protocol Violation|4|||
157152728|NCT00623467|567305606|FG000|Overall Study|Withdrawal by Subject|2|||
157152729|NCT00273858|567305620|FG000|Overall Study|Not completed 24 month observation time|334|||
157152730|NCT00273858|567305620|FG000|Overall Study|Lost to Follow-up|101|||
157152731|NCT00273858|567305620|FG000|Overall Study|Withdrawal by Subject|21|||
157152732|NCT00273858|567305620|FG000|Overall Study|Adverse Event|81|||
157152733|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
157152734|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
157152735|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
157152736|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
156837461|NCT00321464|566157923|FG001|Overall Study|Physician Decision|14|||
156886267|NCT01426789|566342506|FG001|Part 1|Lack of Efficacy|1|||
156837462|NCT00321464|566157922|FG000|Overall Study|Noncompliance|4|||
156837463|NCT00321464|566157923|FG001|Overall Study|Noncompliance|10|||
156886268|NCT01426789|566342507|FG002|Part 1|Lack of Efficacy|0|||
156886269|NCT01426789|566342508|FG003|Part 1|Lack of Efficacy|0|||
156886270|NCT01426789|566342509|FG004|Part 1|Lack of Efficacy|0|||
156886271|NCT01426789|566342510|FG005|Part 1|Lack of Efficacy|0|||
156886272|NCT01426789|566342505|FG000|Part 1|Adverse Event|3|||
157152737|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
157152738|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
156837464|NCT00321464|566157922|FG000|Overall Study|Lost to Follow-up|7|||
156837465|NCT00321464|566157923|FG001|Overall Study|Lost to Follow-up|8|||
156837466|NCT00321464|566157922|FG000|Overall Study|Protocol deviation|0|||
156886273|NCT01426789|566342506|FG001|Part 1|Adverse Event|0|||
156886274|NCT01426789|566342507|FG002|Part 1|Adverse Event|0|||
156886275|NCT01426789|566342508|FG003|Part 1|Adverse Event|0|||
156886276|NCT01426789|566342509|FG004|Part 1|Adverse Event|0|||
156886277|NCT01426789|566342510|FG005|Part 1|Adverse Event|0|||
156886278|NCT01426789|566342505|FG000|Part 2|Protocol deviation|0|||
156886279|NCT01426789|566342506|FG001|Part 2|Protocol deviation|0|||
157152739|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
157152740|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
156837467|NCT00321464|566157923|FG001|Overall Study|Protocol deviation|2|||
156837468|NCT00321464|566157922|FG000|Overall Study|Ineligibility determined|2|||
156837469|NCT00321464|566157923|FG001|Overall Study|Ineligibility determined|1|||
156837470|NCT00321464|566157922|FG000|Overall Study|Other|21|||
156837471|NCT00321464|566157923|FG001|Overall Study|Other|18|||
156837472|NCT01209078|566157924|FG000|Overall Study|Adverse Event|5|||
156837473|NCT01209078|566157925|FG001|Overall Study|Adverse Event|0|||
156837474|NCT01209078|566157924|FG000|Overall Study|Lost to Follow-up|4|||
156837475|NCT01209078|566157925|FG001|Overall Study|Lost to Follow-up|0|||
156837476|NCT01209078|566157924|FG000|Overall Study|Physician Decision|5|||
156837477|NCT01209078|566157925|FG001|Overall Study|Physician Decision|2|||
156837478|NCT01209078|566157924|FG000|Overall Study|Withdrawal by Subject|2|||
156837479|NCT01209078|566157925|FG001|Overall Study|Withdrawal by Subject|1|||
156837480|NCT02207491|566157928|FG000|Overall Study|Adverse Event|20|||
156837481|NCT02207491|566157929|FG001|Overall Study|Adverse Event|4|||
156837482|NCT02207491|566157928|FG000|Overall Study|Withdrawal by Subject|3|||
156837483|NCT02207491|566157929|FG001|Overall Study|Withdrawal by Subject|2|||
156837484|NCT02207491|566157928|FG000|Overall Study|Non-compliant|0|||
156837485|NCT02207491|566157929|FG001|Overall Study|Non-compliant|1|||
156837486|NCT02207491|566157928|FG000|Overall Study|Lost to Follow-up|0|||
156837487|NCT02207491|566157929|FG001|Overall Study|Lost to Follow-up|1|||
156837488|NCT02207491|566157928|FG000|Overall Study|Lack of Efficacy|3|||
156837489|NCT02207491|566157929|FG001|Overall Study|Lack of Efficacy|0|||
156837490|NCT02207491|566157928|FG000|Overall Study|Physician Decision|2|||
156837491|NCT02207491|566157929|FG001|Overall Study|Physician Decision|0|||
156837492|NCT02207491|566157928|FG000|Overall Study|Protocol Violation|3|||
156837493|NCT02207491|566157929|FG001|Overall Study|Protocol Violation|5|||
156837494|NCT00126776|566157930|FG000|Overall Study|follow up complete on all patients|0|||
156837495|NCT00126776|566157931|FG001|Overall Study|follow up complete on all patients|0|||
156837496|NCT05856227|566157943|FG000|Overall Study|Adverse Event|0|||
156837497|NCT05856227|566157944|FG001|Overall Study|Adverse Event|1|||
156837498|NCT05856227|566157943|FG000|Overall Study|Due to Investigator absence|1|||
156837499|NCT05856227|566157944|FG001|Overall Study|Due to Investigator absence|0|||
156837500|NCT05856227|566157943|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
156837501|NCT05856227|566157944|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
156837502|NCT05011058|566157945|FG000|Overall Study|Sponsor Decision|2|||
156837503|NCT05011058|566157946|FG001|Overall Study|Sponsor Decision|0|||
156837504|NCT05011058|566157947|FG002|Overall Study|Sponsor Decision|14|||
156837505|NCT05011058|566157948|FG003|Overall Study|Sponsor Decision|0|||
156837506|NCT05011058|566157949|FG004|Overall Study|Sponsor Decision|0|||
156837507|NCT05011058|566157950|FG005|Overall Study|Sponsor Decision|1|||
156837508|NCT05011058|566157951|FG006|Overall Study|Sponsor Decision|0|||
156837509|NCT05011058|566157952|FG007|Overall Study|Sponsor Decision|5|||
156837510|NCT01272869|566157953|FG000|Period 2 (14 Days)|Adverse Event|1|||
156837511|NCT01272869|566157954|FG001|Period 2 (14 Days)|Adverse Event|0|||
156837512|NCT01571232|566157955|FG000|Overall Study|Lost to Follow-up|0|||
156837513|NCT01571232|566157956|FG001|Overall Study|Lost to Follow-up|1|||
156837514|NCT01571232|566157955|FG000|Overall Study|Withdrawal by Subject|1|||
156837515|NCT01571232|566157956|FG001|Overall Study|Withdrawal by Subject|0|||
156837516|NCT02455076|566157957|FG000|Inpatient|Withdrawal by Subject|1|||
156837517|NCT02455076|566157958|FG001|Inpatient|Withdrawal by Subject|0|||
156837518|NCT02455076|566157959|FG002|Inpatient|Withdrawal by Subject|0|||
156837519|NCT02455076|566157960|FG003|Inpatient|Withdrawal by Subject|0|||
156837520|NCT02455076|566157961|FG004|Inpatient|Withdrawal by Subject|0|||
156837521|NCT02455076|566157957|FG000|Inpatient|Discharged <24 h after admission|0|||
156837522|NCT02455076|566157958|FG001|Inpatient|Discharged <24 h after admission|1|||
156837523|NCT02455076|566157959|FG002|Inpatient|Discharged <24 h after admission|0|||
156837524|NCT02455076|566157960|FG003|Inpatient|Discharged <24 h after admission|0|||
156837525|NCT02455076|566157961|FG004|Inpatient|Discharged <24 h after admission|0|||
156837526|NCT02455076|566157957|FG000|Inpatient|Adverse Event|3|||
156837527|NCT02455076|566157958|FG001|Inpatient|Adverse Event|0|||
156837528|NCT02455076|566157959|FG002|Inpatient|Adverse Event|0|||
156837529|NCT02455076|566157960|FG003|Inpatient|Adverse Event|0|||
156837530|NCT02455076|566157961|FG004|Inpatient|Adverse Event|0|||
156837531|NCT02455076|566157957|FG000|Outpatient|Adverse Event|0|||
156837532|NCT02455076|566157958|FG001|Outpatient|Adverse Event|0|||
156837533|NCT02455076|566157959|FG002|Outpatient|Adverse Event|0|||
156837534|NCT02455076|566157960|FG003|Outpatient|Adverse Event|5|||
156837535|NCT02455076|566157961|FG004|Outpatient|Adverse Event|0|||
156837536|NCT02455076|566157957|FG000|Outpatient|Lost to Follow-up|0|||
156837537|NCT02455076|566157958|FG001|Outpatient|Lost to Follow-up|0|||
156837538|NCT02455076|566157959|FG002|Outpatient|Lost to Follow-up|0|||
156837539|NCT02455076|566157960|FG003|Outpatient|Lost to Follow-up|1|||
156837540|NCT02455076|566157961|FG004|Outpatient|Lost to Follow-up|12|||
156837541|NCT03908476|566157962|FG000|Overall Study|Death|3|||
156837542|NCT03908476|566157963|FG001|Overall Study|Death|0|||
156837543|NCT03908476|566157962|FG000|Overall Study|Lost to Follow-up|3|||
156837544|NCT03908476|566157963|FG001|Overall Study|Lost to Follow-up|1|||
156837545|NCT03908476|566157962|FG000|Overall Study|Withdrawal by Subject|7|||
157152741|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
157152742|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
157152743|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
157152744|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
156837546|NCT03908476|566157963|FG001|Overall Study|Withdrawal by Subject|1|||
156837547|NCT03908476|566157962|FG000|Overall Study|Physician Decision|2|||
156837548|NCT03908476|566157963|FG001|Overall Study|Physician Decision|0|||
156837549|NCT03908476|566157962|FG000|Overall Study|System Explanted and not Replaced|4|||
156837550|NCT03908476|566157963|FG001|Overall Study|System Explanted and not Replaced|0|||
156837551|NCT03908476|566157962|FG000|Overall Study|Intrathecal Pump|1|||
156837552|NCT03908476|566157963|FG001|Overall Study|Intrathecal Pump|0|||
156837553|NCT03908476|566157962|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
156837554|NCT03908476|566157963|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
156837555|NCT05194267|566157964|FG000|Overall Study|Withdrawal by Subject|2|||
156837556|NCT02868229|566157965|FG000|Overall Study|Adverse Event|1|||
156837557|NCT02868229|566157966|FG001|Overall Study|Adverse Event|0|||
156837558|NCT02868229|566157967|FG002|Overall Study|Adverse Event|0|||
156837559|NCT02868229|566157968|FG003|Overall Study|Adverse Event|1|||
156837560|NCT02868229|566157965|FG000|Overall Study|Death|0|||
156837561|NCT02868229|566157966|FG001|Overall Study|Death|0|||
156837562|NCT02868229|566157967|FG002|Overall Study|Death|1|||
156837563|NCT02868229|566157968|FG003|Overall Study|Death|1|||
156837564|NCT02868229|566157965|FG000|Overall Study|Missed dose|0|||
156837565|NCT02868229|566157966|FG001|Overall Study|Missed dose|0|||
156837566|NCT02868229|566157967|FG002|Overall Study|Missed dose|0|||
156837567|NCT02868229|566157968|FG003|Overall Study|Missed dose|3|||
156837568|NCT06151288|566157969|FG000|Overall Study|Lost to Follow-up|4|||
156837569|NCT06151288|566157970|FG001|Overall Study|Lost to Follow-up|2|||
156837570|NCT06151288|566157971|FG002|Overall Study|Lost to Follow-up|4|||
156837571|NCT06151288|566157972|FG003|Overall Study|Lost to Follow-up|3|||
156837572|NCT06151288|566157969|FG000|Overall Study|Withdrawal by Subject|4|||
156837573|NCT06151288|566157970|FG001|Overall Study|Withdrawal by Subject|5|||
156837574|NCT06151288|566157971|FG002|Overall Study|Withdrawal by Subject|1|||
156837575|NCT06151288|566157972|FG003|Overall Study|Withdrawal by Subject|1|||
156837576|NCT03194438|566157979|FG000|Overall Study|Withdrawal by Subject|2|||
156837577|NCT02717130|566157980|FG000|Overall Study|Withdrawal by Subject|1|||
156837578|NCT02717130|566157980|FG000|Overall Study|Adverse Event|1|||
156837579|NCT02717130|566157980|FG000|Overall Study|Physician Decision|1|||
156837580|NCT02717130|566157980|FG000|Overall Study|Study Closure|4|||
156837581|NCT00548717|566157981|FG000|Overall Study|Death|5|||
156837582|NCT00548717|566157982|FG001|Overall Study|Death|2|||
156837583|NCT00548717|566157981|FG000|Overall Study|Relapse|3|||
156837584|NCT00548717|566157982|FG001|Overall Study|Relapse|0|||
156837585|NCT00548717|566157981|FG000|Overall Study|Alternative treatment for GVHD|1|||
156837586|NCT00548717|566157982|FG001|Overall Study|Alternative treatment for GVHD|0|||
156837587|NCT02712424|566157983|FG000|Overall Study|Lost to Follow-up|34|||
156837588|NCT02712424|566157984|FG001|Overall Study|Lost to Follow-up|32|||
156837589|NCT02723175|566157985|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
156837590|NCT02723175|566157986|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
156837591|NCT02723175|566157985|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
156837592|NCT02723175|566157986|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
156837593|NCT03022981|566157987|FG000|Overall Study|Adverse Event|0|||
156837594|NCT03022981|566157988|FG001|Overall Study|Adverse Event|1|||
156837595|NCT03022981|566157989|FG002|Overall Study|Adverse Event|0|||
156837596|NCT03022981|566157987|FG000|Overall Study|Investigator's Discretion|0|||
156837597|NCT03022981|566157988|FG001|Overall Study|Investigator's Discretion|1|||
156837598|NCT03022981|566157989|FG002|Overall Study|Investigator's Discretion|2|||
156837599|NCT03022981|566157987|FG000|Overall Study|Lost to Follow-up|6|||
156837600|NCT03022981|566157988|FG001|Overall Study|Lost to Follow-up|2|||
156837601|NCT03022981|566157989|FG002|Overall Study|Lost to Follow-up|1|||
156837602|NCT03022981|566157987|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156837603|NCT03022981|566157988|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156837604|NCT03022981|566157989|FG002|Overall Study|Non-Compliance With Study Drug|2|||
157023803|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
156837605|NCT03022981|566157987|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
156837606|NCT03022981|566157988|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
156837607|NCT03022981|566157989|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
156837608|NCT03615066|566157991|FG000|Main Study|Withdrew Consent|0|||
156837609|NCT03615066|566157992|FG001|Main Study|Withdrew Consent|1|||
156837610|NCT03615066|566157993|FG002|Main Study|Withdrew Consent|1|||
156837611|NCT03615066|566157991|FG000|Main Study|Lost to Follow-up|0|||
156837612|NCT03615066|566157992|FG001|Main Study|Lost to Follow-up|0|||
156837613|NCT03615066|566157993|FG002|Main Study|Lost to Follow-up|1|||
156837614|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
157023804|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
156837615|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
156886280|NCT01426789|566342507|FG002|Part 2|Protocol deviation|1|||
156837616|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
156837617|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
156837618|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
156837619|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
156837620|NCT03615066|566157991|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
156837621|NCT03615066|566157992|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
156837622|NCT03615066|566157993|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
156837623|NCT00924404|566157994|FG000|Overall Study|Lost to Follow-up|6|||
156837624|NCT00924404|566157995|FG001|Overall Study|Lost to Follow-up|4|||
156837625|NCT03831945|566157996|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
156837626|NCT03831945|566157997|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
156837627|NCT03831945|566157996|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
156837628|NCT03831945|566157997|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
156837629|NCT03831945|566157996|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
156837630|NCT03831945|566157997|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
156837631|NCT02437084|566157998|FG000|Overall Study|Withdrawal by Subject|2|||
156837632|NCT02437084|566157998|FG000|Overall Study|Physician Decision|1|||
156837633|NCT00587847|566157999|FG000|Overall Study|Lack of Efficacy|5|||
156837634|NCT00587847|566157999|FG000|Overall Study|Adverse Event|2|||
156837635|NCT02613169|566158000|FG000|Overall Study|Withdrawal by Subject|4|||
156837636|NCT02613169|566158001|FG001|Overall Study|Withdrawal by Subject|1|||
156837637|NCT02613169|566158000|FG000|Overall Study|Lost to Follow-up|0|||
156837638|NCT02613169|566158001|FG001|Overall Study|Lost to Follow-up|5|||
156837639|NCT02613169|566158000|FG000|Overall Study|HIV|0|||
156837640|NCT02613169|566158001|FG001|Overall Study|HIV|2|||
156837641|NCT02613169|566158000|FG000|Overall Study|No TB infection endpoint|14|||
156837642|NCT02613169|566158001|FG001|Overall Study|No TB infection endpoint|9|||
156837643|NCT04032080|566158002|FG000|Overall Study|Death|6|||
156837644|NCT00884832|566158003|FG000|Overall Study|Withdrawal by Subject|0|||
156837645|NCT00884832|566158004|FG001|Overall Study|Withdrawal by Subject|1|||
156837646|NCT01600092|566158012|FG000|Overall Study|Adverse Event|2|||
156837647|NCT01600092|566158013|FG001|Overall Study|Adverse Event|0|||
156837648|NCT01600092|566158012|FG000|Overall Study|Lost to Follow-up|4|||
156837649|NCT01600092|566158013|FG001|Overall Study|Lost to Follow-up|6|||
156837650|NCT01600092|566158012|FG000|Overall Study|Withdrawal by parent/guardian|8|||
156837651|NCT01600092|566158013|FG001|Overall Study|Withdrawal by parent/guardian|6|||
156837652|NCT01600092|566158012|FG000|Overall Study|Physician Decision|1|||
156837653|NCT01600092|566158013|FG001|Overall Study|Physician Decision|1|||
156837654|NCT01600092|566158012|FG000|Overall Study|Randomized but not vaccinated|3|||
156837655|NCT01600092|566158013|FG001|Overall Study|Randomized but not vaccinated|3|||
156837656|NCT02976103|566158014|FG000|Overall Study|Withdrawal by Subject|1|||
156837657|NCT02976103|566158015|FG001|Overall Study|Withdrawal by Subject|0|||
156837658|NCT02976103|566158014|FG000|Overall Study|Lost to Follow-up|12|||
156837659|NCT02976103|566158015|FG001|Overall Study|Lost to Follow-up|8|||
156837660|NCT00079677|566158016|FG000|Overall Study|Adverse Event|5|||
156837661|NCT00079677|566158017|FG001|Overall Study|Adverse Event|6|||
156837662|NCT00079677|566158016|FG000|Overall Study|Lack of Efficacy|1|||
156837663|NCT00079677|566158017|FG001|Overall Study|Lack of Efficacy|0|||
156837664|NCT00079677|566158016|FG000|Overall Study|Lost to Follow-up|2|||
156837665|NCT00079677|566158017|FG001|Overall Study|Lost to Follow-up|2|||
156837666|NCT00079677|566158016|FG000|Overall Study|Physician Decision|3|||
156837667|NCT00079677|566158017|FG001|Overall Study|Physician Decision|0|||
156837668|NCT00079677|566158016|FG000|Overall Study|Protocol Violation|2|||
156886281|NCT01426789|566342508|FG003|Part 2|Protocol deviation|0|||
156886282|NCT01426789|566342509|FG004|Part 2|Protocol deviation|0|||
156886283|NCT01426789|566342510|FG005|Part 2|Protocol deviation|0|||
156886284|NCT01426789|566342505|FG000|Part 2|Death|0|||
156886285|NCT01426789|566342506|FG001|Part 2|Death|0|||
156886286|NCT01426789|566342507|FG002|Part 2|Death|1|||
156886287|NCT01426789|566342508|FG003|Part 2|Death|0|||
156886288|NCT01426789|566342509|FG004|Part 2|Death|1|||
156837669|NCT00079677|566158017|FG001|Overall Study|Protocol Violation|3|||
156837670|NCT00079677|566158016|FG000|Overall Study|Withdrawal by Subject|5|||
156837671|NCT00079677|566158017|FG001|Overall Study|Withdrawal by Subject|3|||
156837672|NCT00079677|566158016|FG000|Overall Study|Miscellaneous|2|||
156886289|NCT01426789|566342510|FG005|Part 2|Death|0|||
156837673|NCT00079677|566158017|FG001|Overall Study|Miscellaneous|0|||
156837674|NCT01300455|566158018|FG000|Washout|Withdrawal by Subject|1|||
156837675|NCT01300455|566158019|FG001|Washout|Withdrawal by Subject|0|||
156837676|NCT00084487|566158020|FG000|Overall Study|Death|1|||
156837677|NCT00845065|566158028|FG000|Overall Study|Adverse Event|3|||
156886290|NCT01426789|566342505|FG000|Part 2|Administrative problems|0|||
156886291|NCT01426789|566342506|FG001|Part 2|Administrative problems|0|||
156886292|NCT01426789|566342507|FG002|Part 2|Administrative problems|2|||
157152745|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
157152746|NCT02232516|567305621|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
157152747|NCT02232516|567305621|FG000|Survival Follow-up|Death|15|||
157152748|NCT02232516|567305621|FG000|Survival Follow-up|Withdrawal by Subject|3|||
157152749|NCT02232516|567305621|FG000|Survival Follow-up|Lost to Follow-up|1|||
157152750|NCT02232516|567305621|FG000|Survival Follow-up|Still in follow-up|5|||
157152751|NCT01070550|567305622|FG000|Overall Study|Adverse Event|43|||
157152752|NCT01070550|567305623|FG001|Overall Study|Adverse Event|1|||
157152753|NCT01070550|567305624|FG002|Overall Study|Adverse Event|3|||
157152754|NCT01070550|567305625|FG003|Overall Study|Adverse Event|0|||
157152755|NCT01070550|567305626|FG004|Overall Study|Adverse Event|0|||
156837678|NCT00845065|566158029|FG001|Overall Study|Adverse Event|23|||
157152756|NCT01070550|567305627|FG005|Overall Study|Adverse Event|0|||
157152757|NCT01070550|567305622|FG000|Overall Study|Death|20|||
157152758|NCT01070550|567305623|FG001|Overall Study|Death|4|||
157152759|NCT01070550|567305624|FG002|Overall Study|Death|3|||
157152760|NCT01070550|567305625|FG003|Overall Study|Death|0|||
157152761|NCT01070550|567305626|FG004|Overall Study|Death|0|||
157152762|NCT01070550|567305627|FG005|Overall Study|Death|0|||
157152763|NCT01070550|567305622|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
157152764|NCT01070550|567305623|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
157152765|NCT01070550|567305624|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
157152766|NCT01070550|567305625|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
157152767|NCT01070550|567305626|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
157152768|NCT01070550|567305627|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
157152769|NCT01070550|567305622|FG000|Overall Study|Early termination|3|||
157152770|NCT01070550|567305623|FG001|Overall Study|Early termination|0|||
157152771|NCT01070550|567305624|FG002|Overall Study|Early termination|0|||
157152772|NCT01070550|567305625|FG003|Overall Study|Early termination|0|||
157152773|NCT01070550|567305626|FG004|Overall Study|Early termination|0|||
157152774|NCT01070550|567305627|FG005|Overall Study|Early termination|0|||
157152775|NCT01070550|567305622|FG000|Overall Study|Failed to return|450|||
157152776|NCT01070550|567305623|FG001|Overall Study|Failed to return|33|||
157152777|NCT01070550|567305624|FG002|Overall Study|Failed to return|144|||
157152778|NCT01070550|567305625|FG003|Overall Study|Failed to return|40|||
157152779|NCT01070550|567305626|FG004|Overall Study|Failed to return|1|||
157152780|NCT01070550|567305627|FG005|Overall Study|Failed to return|2|||
157152781|NCT01070550|567305622|FG000|Overall Study|Incomplete treatment|2|||
157152782|NCT01070550|567305623|FG001|Overall Study|Incomplete treatment|0|||
157152783|NCT01070550|567305624|FG002|Overall Study|Incomplete treatment|0|||
157152784|NCT01070550|567305625|FG003|Overall Study|Incomplete treatment|0|||
157152785|NCT01070550|567305626|FG004|Overall Study|Incomplete treatment|0|||
157152786|NCT01070550|567305627|FG005|Overall Study|Incomplete treatment|0|||
157152787|NCT01070550|567305622|FG000|Overall Study|Lab test not done|22|||
157152788|NCT01070550|567305623|FG001|Overall Study|Lab test not done|3|||
157152789|NCT01070550|567305624|FG002|Overall Study|Lab test not done|4|||
156837679|NCT00845065|566158028|FG000|Overall Study|Lack of Efficacy|43|||
156837680|NCT00845065|566158029|FG001|Overall Study|Lack of Efficacy|21|||
156837681|NCT00845065|566158028|FG000|Overall Study|Non-Medical Reasons|1|||
156837682|NCT00845065|566158029|FG001|Overall Study|Non-Medical Reasons|11|||
156837683|NCT02228096|566158033|FG000|Overall Study|Study terminated by Sponsor|24|||
156837684|NCT02228096|566158033|FG000|Overall Study|Lack of Efficacy|18|||
156837685|NCT02228096|566158033|FG000|Overall Study|Death|12|||
156837686|NCT02228096|566158033|FG000|Overall Study|Physician Decision|3|||
156837687|NCT02228096|566158033|FG000|Overall Study|Subject/guardian decision|2|||
156837688|NCT02228096|566158033|FG000|Overall Study|New therapy for study indication|1|||
156837689|NCT02228096|566158033|FG000|Overall Study|Enrolled, not infused|11|||
156837690|NCT02265796|566158034|FG000|Overall Study|Death|1|||
156886293|NCT01426789|566342508|FG003|Part 2|Administrative problems|0|||
156886294|NCT01426789|566342509|FG004|Part 2|Administrative problems|1|||
156886295|NCT01426789|566342510|FG005|Part 2|Administrative problems|0|||
156886296|NCT01426789|566342505|FG000|Part 2|Lost to Follow-up|0|||
156886297|NCT01426789|566342506|FG001|Part 2|Lost to Follow-up|0|||
156886298|NCT01426789|566342507|FG002|Part 2|Lost to Follow-up|4|||
156886299|NCT01426789|566342508|FG003|Part 2|Lost to Follow-up|0|||
156886300|NCT01426789|566342509|FG004|Part 2|Lost to Follow-up|1|||
157152790|NCT01070550|567305625|FG003|Overall Study|Lab test not done|1|||
157152791|NCT01070550|567305626|FG004|Overall Study|Lab test not done|0|||
157152792|NCT01070550|567305627|FG005|Overall Study|Lab test not done|1|||
157152793|NCT01070550|567305622|FG000|Overall Study|Lack of Efficacy|65|||
157152794|NCT01070550|567305623|FG001|Overall Study|Lack of Efficacy|1|||
157152795|NCT01070550|567305624|FG002|Overall Study|Lack of Efficacy|5|||
157152796|NCT01070550|567305625|FG003|Overall Study|Lack of Efficacy|5|||
156837691|NCT02265796|566158035|FG001|Overall Study|Death|0|||
156837692|NCT02265796|566158034|FG000|Overall Study|started on excluded medication|1|||
156837693|NCT02265796|566158035|FG001|Overall Study|started on excluded medication|0|||
157152797|NCT01070550|567305626|FG004|Overall Study|Lack of Efficacy|0|||
156837694|NCT02265796|566158034|FG000|Overall Study|Withdrawal by Subject|1|||
156886301|NCT01426789|566342510|FG005|Part 2|Lost to Follow-up|0|||
156886302|NCT01426789|566342505|FG000|Part 2|Withdrawal by Subject|0|||
156837695|NCT02265796|566158035|FG001|Overall Study|Withdrawal by Subject|1|||
156837696|NCT00952614|566158038|FG000|Overall Study|Death|3|||
156837697|NCT00952614|566158038|FG000|Overall Study|Lost to Follow-up|3|||
156837698|NCT00952614|566158038|FG000|Overall Study|other reason|1|||
156837699|NCT01624090|566158043|FG000|Overall Study|DLT, taken off therapy|0|||
156837700|NCT01624090|566158044|FG001|Overall Study|DLT, taken off therapy|1|||
156837701|NCT01624090|566158045|FG002|Overall Study|DLT, taken off therapy|0|||
156837702|NCT01624090|566158046|FG003|Overall Study|DLT, taken off therapy|0|||
156837703|NCT01624090|566158043|FG000|Overall Study|Withdrew prior to treatment|0|||
156837704|NCT01624090|566158044|FG001|Overall Study|Withdrew prior to treatment|1|||
156837705|NCT01624090|566158045|FG002|Overall Study|Withdrew prior to treatment|0|||
156837706|NCT01624090|566158046|FG003|Overall Study|Withdrew prior to treatment|0|||
156837707|NCT01624090|566158043|FG000|Overall Study|Died on study|0|||
156837708|NCT01624090|566158044|FG001|Overall Study|Died on study|0|||
157152798|NCT01070550|567305627|FG005|Overall Study|Lack of Efficacy|1|||
157152799|NCT01070550|567305622|FG000|Overall Study|Miscellaneous|12|||
157152800|NCT01070550|567305623|FG001|Overall Study|Miscellaneous|2|||
157152801|NCT01070550|567305624|FG002|Overall Study|Miscellaneous|3|||
157152802|NCT01070550|567305625|FG003|Overall Study|Miscellaneous|1|||
157152803|NCT01070550|567305626|FG004|Overall Study|Miscellaneous|0|||
157152804|NCT01070550|567305627|FG005|Overall Study|Miscellaneous|0|||
157152805|NCT01070550|567305622|FG000|Overall Study|New treatment started|3|||
157152806|NCT01070550|567305623|FG001|Overall Study|New treatment started|1|||
157152807|NCT01070550|567305624|FG002|Overall Study|New treatment started|0|||
157152808|NCT01070550|567305625|FG003|Overall Study|New treatment started|2|||
157152809|NCT01070550|567305626|FG004|Overall Study|New treatment started|0|||
157152810|NCT01070550|567305627|FG005|Overall Study|New treatment started|0|||
157152811|NCT01070550|567305622|FG000|Overall Study|Non-responders|493|||
157152812|NCT01070550|567305623|FG001|Overall Study|Non-responders|4|||
157152813|NCT01070550|567305624|FG002|Overall Study|Non-responders|21|||
157152814|NCT01070550|567305625|FG003|Overall Study|Non-responders|20|||
157152815|NCT01070550|567305626|FG004|Overall Study|Non-responders|0|||
157152816|NCT01070550|567305627|FG005|Overall Study|Non-responders|2|||
157152817|NCT01070550|567305622|FG000|Overall Study|Not categorized|33|||
157152818|NCT01070550|567305623|FG001|Overall Study|Not categorized|2|||
157152819|NCT01070550|567305624|FG002|Overall Study|Not categorized|6|||
157152820|NCT01070550|567305625|FG003|Overall Study|Not categorized|1|||
157152821|NCT01070550|567305626|FG004|Overall Study|Not categorized|0|||
157152822|NCT01070550|567305627|FG005|Overall Study|Not categorized|1|||
157152823|NCT01070550|567305622|FG000|Overall Study|Protocol Violation|15|||
157152824|NCT01070550|567305623|FG001|Overall Study|Protocol Violation|1|||
157152825|NCT01070550|567305624|FG002|Overall Study|Protocol Violation|1|||
157152826|NCT01070550|567305625|FG003|Overall Study|Protocol Violation|1|||
157152827|NCT01070550|567305626|FG004|Overall Study|Protocol Violation|0|||
157152828|NCT01070550|567305627|FG005|Overall Study|Protocol Violation|0|||
157152829|NCT01070550|567305622|FG000|Overall Study|Relapse|44|||
157152830|NCT01070550|567305623|FG001|Overall Study|Relapse|5|||
157152831|NCT01070550|567305624|FG002|Overall Study|Relapse|14|||
157152832|NCT01070550|567305625|FG003|Overall Study|Relapse|4|||
157152833|NCT01070550|567305626|FG004|Overall Study|Relapse|0|||
157152834|NCT01070550|567305627|FG005|Overall Study|Relapse|0|||
157152835|NCT01070550|567305622|FG000|Overall Study|Result not available|3|||
157152836|NCT01070550|567305623|FG001|Overall Study|Result not available|1|||
156837709|NCT01624090|566158045|FG002|Overall Study|Died on study|2|||
156837710|NCT01624090|566158046|FG003|Overall Study|Died on study|0|||
156837711|NCT01624090|566158043|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
156837712|NCT01624090|566158044|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
156837713|NCT01624090|566158045|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
156837714|NCT01624090|566158046|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
156837715|NCT01624090|566158043|FG000|Overall Study|Dose escalated|0|||
156886303|NCT01426789|566342506|FG001|Part 2|Withdrawal by Subject|0|||
156886304|NCT01426789|566342507|FG002|Part 2|Withdrawal by Subject|0|||
156886305|NCT01426789|566342508|FG003|Part 2|Withdrawal by Subject|1|||
157152837|NCT01070550|567305624|FG002|Overall Study|Result not available|3|||
156837716|NCT01624090|566158044|FG001|Overall Study|Dose escalated|0|||
156837717|NCT01624090|566158045|FG002|Overall Study|Dose escalated|3|||
156837718|NCT01624090|566158046|FG003|Overall Study|Dose escalated|0|||
156837719|NCT01403116|566158047|FG000|Overall Study|Adverse Event|7|||
156837720|NCT01403116|566158048|FG001|Overall Study|Adverse Event|4|||
156837721|NCT01403116|566158047|FG000|Overall Study|Lost to Follow-up|7|||
156837722|NCT01403116|566158048|FG001|Overall Study|Lost to Follow-up|5|||
156837723|NCT01403116|566158047|FG000|Overall Study|Withdrawal by Subject|12|||
156837724|NCT01403116|566158048|FG001|Overall Study|Withdrawal by Subject|15|||
156837725|NCT01403116|566158047|FG000|Overall Study|Non-compliance of study drug|3|||
156837726|NCT01403116|566158048|FG001|Overall Study|Non-compliance of study drug|0|||
156886306|NCT01426789|566342509|FG004|Part 2|Withdrawal by Subject|2|||
157152838|NCT01070550|567305625|FG003|Overall Study|Result not available|0|||
157152839|NCT01070550|567305626|FG004|Overall Study|Result not available|0|||
157152840|NCT01070550|567305627|FG005|Overall Study|Result not available|0|||
157023805|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
157023806|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
157023807|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
157023808|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
157023809|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
157023810|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
157023811|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
157023812|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
157023813|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
157023814|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
157023815|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
157023816|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
157023817|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
157023818|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
157023819|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
157023820|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
157023821|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
157023822|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
156837727|NCT01403116|566158047|FG000|Overall Study|Protocol Violation|0|||
156837728|NCT01403116|566158048|FG001|Overall Study|Protocol Violation|1|||
156837729|NCT01403116|566158047|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
156837730|NCT01403116|566158048|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
156837731|NCT01403116|566158047|FG000|Overall Study|Hct >54%|2|||
156837732|NCT01403116|566158048|FG001|Overall Study|Hct >54%|0|||
156837733|NCT01403116|566158047|FG000|Overall Study|unable to keep appointments|0|||
156837734|NCT01403116|566158048|FG001|Overall Study|unable to keep appointments|2|||
156837735|NCT01895309|566158049|FG000|Overall Study|Adverse Event|13|||
156837736|NCT01895309|566158050|FG001|Overall Study|Adverse Event|17|||
156837737|NCT01895309|566158049|FG000|Overall Study|Protocol Violation|1|||
156837738|NCT01895309|566158050|FG001|Overall Study|Protocol Violation|0|||
157023823|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
157023824|NCT01715285|566841123|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
156837739|NCT01895309|566158049|FG000|Overall Study|Lack of Efficacy|1|||
156837740|NCT01895309|566158050|FG001|Overall Study|Lack of Efficacy|3|||
156837741|NCT01895309|566158049|FG000|Overall Study|Lost to Follow-up|1|||
156837742|NCT01895309|566158050|FG001|Overall Study|Lost to Follow-up|3|||
156837743|NCT01895309|566158049|FG000|Overall Study|Physician Decision|15|||
157023825|NCT01715285|566841124|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
157023826|NCT01715285|566841125|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
157023827|NCT01715285|566841123|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
157023828|NCT01715285|566841124|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
157023829|NCT01715285|566841125|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
157023830|NCT01715285|566841123|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
157023831|NCT01715285|566841124|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
157023832|NCT01715285|566841125|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
157023833|NCT01715285|566841123|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
157023834|NCT01715285|566841124|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
157023835|NCT01715285|566841125|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
157023836|NCT01715285|566841123|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
157023837|NCT01715285|566841124|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
157023838|NCT01715285|566841125|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
157023839|NCT01715285|566841123|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
157023840|NCT01715285|566841124|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
157023841|NCT01715285|566841125|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
157023842|NCT05020249|566841126|FG000|Overall Study|Protocol Violation|1|||
157023843|NCT05020249|566841127|FG001|Overall Study|Protocol Violation|0|||
157023844|NCT04971681|566841133|FG000|Followup|Lost to Follow-up|1|||
157023845|NCT04971681|566841134|FG001|Followup|Lost to Follow-up|0|||
157023846|NCT00686335|566841135|FG000|Run-in Period|Adverse Event|1|||
157023847|NCT00686335|566841135|FG000|Run-in Period|asthma exacerbation|1|||
157023848|NCT00686335|566841135|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
157023849|NCT04376502|566841138|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
157023850|NCT04632992|566841139|FG000|Overall Study|Adverse Event|0|||
157023851|NCT04632992|566841140|FG001|Overall Study|Adverse Event|0|||
157023852|NCT04632992|566841141|FG002|Overall Study|Adverse Event|0|||
157152841|NCT01070550|567305622|FG000|Overall Study|Screen failure|1|||
157152842|NCT01070550|567305623|FG001|Overall Study|Screen failure|0|||
156837744|NCT01895309|566158050|FG001|Overall Study|Physician Decision|10|||
156837745|NCT01895309|566158049|FG000|Overall Study|Withdrawal by Subject|9|||
156837746|NCT01895309|566158050|FG001|Overall Study|Withdrawal by Subject|18|||
156837747|NCT00042666|566158051|FG000|Overall Study|Adverse Event|2|||
156837748|NCT00042666|566158051|FG000|Overall Study|Death|4|||
156837749|NCT00042666|566158051|FG000|Overall Study|Protocol Violation|1|||
156837750|NCT00042666|566158051|FG000|Overall Study|Participant/Physician Perception|1|||
156837751|NCT00042666|566158051|FG000|Overall Study|Progressive Disease|41|||
156837752|NCT00042666|566158051|FG000|Overall Study|Other|1|||
156837753|NCT00042666|566158051|FG000|Overall Study|Other|4|||
156837754|NCT01555125|566158054|FG000|Induction Period|Lost to Follow-up|0|||
156837755|NCT01555125|566158055|FG001|Induction Period|Lost to Follow-up|2|||
156837756|NCT01555125|566158056|FG002|Induction Period|Lost to Follow-up|0|||
156837757|NCT01555125|566158057|FG003|Induction Period|Lost to Follow-up|0|||
156837758|NCT01555125|566158058|FG004|Induction Period|Lost to Follow-up|0|||
156837759|NCT01555125|566158054|FG000|Induction Period|Adverse Event|0|||
156837760|NCT01555125|566158055|FG001|Induction Period|Adverse Event|1|||
157152843|NCT01070550|567305624|FG002|Overall Study|Screen failure|0|||
157152844|NCT01070550|567305625|FG003|Overall Study|Screen failure|0|||
157152845|NCT01070550|567305626|FG004|Overall Study|Screen failure|0|||
157152846|NCT01070550|567305627|FG005|Overall Study|Screen failure|0|||
157152847|NCT01070550|567305622|FG000|Overall Study|Sponsor decision|1|||
157152848|NCT01070550|567305623|FG001|Overall Study|Sponsor decision|0|||
157152849|NCT01070550|567305624|FG002|Overall Study|Sponsor decision|0|||
157152850|NCT01070550|567305625|FG003|Overall Study|Sponsor decision|0|||
157152851|NCT01070550|567305626|FG004|Overall Study|Sponsor decision|0|||
157152852|NCT01070550|567305627|FG005|Overall Study|Sponsor decision|0|||
157152853|NCT01070550|567305622|FG000|Overall Study|Treatment duration shortened|1|||
157152854|NCT01070550|567305623|FG001|Overall Study|Treatment duration shortened|0|||
156837761|NCT01555125|566158056|FG002|Induction Period|Adverse Event|0|||
156837762|NCT01555125|566158057|FG003|Induction Period|Adverse Event|0|||
156837763|NCT01555125|566158058|FG004|Induction Period|Adverse Event|1|||
156837764|NCT01555125|566158054|FG000|Induction Period|Subject / guardian decision|0|||
156837765|NCT01555125|566158055|FG001|Induction Period|Subject / guardian decision|0|||
156837766|NCT01555125|566158056|FG002|Induction Period|Subject / guardian decision|0|||
156837767|NCT01555125|566158057|FG003|Induction Period|Subject / guardian decision|0|||
156837768|NCT01555125|566158058|FG004|Induction Period|Subject / guardian decision|2|||
156837769|NCT01555125|566158054|FG000|Induction Period|Death|1|||
156837770|NCT01555125|566158055|FG001|Induction Period|Death|0|||
156837771|NCT01555125|566158056|FG002|Induction Period|Death|0|||
156837772|NCT01555125|566158057|FG003|Induction Period|Death|0|||
156837773|NCT01555125|566158058|FG004|Induction Period|Death|0|||
156837774|NCT01555125|566158054|FG000|Maintenance Period|Adverse Event|1|||
156837775|NCT01555125|566158055|FG001|Maintenance Period|Adverse Event|1|||
156837776|NCT01555125|566158056|FG002|Maintenance Period|Adverse Event|0|||
156837777|NCT01555125|566158057|FG003|Maintenance Period|Adverse Event|0|||
156837778|NCT01555125|566158058|FG004|Maintenance Period|Adverse Event|0|||
156837779|NCT01555125|566158054|FG000|Maintenance Period|Subject / guardian decision|1|||
156837780|NCT01555125|566158055|FG001|Maintenance Period|Subject / guardian decision|2|||
156837781|NCT01555125|566158056|FG002|Maintenance Period|Subject / guardian decision|0|||
156837782|NCT01555125|566158057|FG003|Maintenance Period|Subject / guardian decision|0|||
156837783|NCT01555125|566158058|FG004|Maintenance Period|Subject / guardian decision|0|||
156837784|NCT01555125|566158054|FG000|Maintenance Period|Lost to Follow-up|2|||
156837785|NCT01555125|566158055|FG001|Maintenance Period|Lost to Follow-up|0|||
156837786|NCT01555125|566158056|FG002|Maintenance Period|Lost to Follow-up|0|||
156837787|NCT01555125|566158057|FG003|Maintenance Period|Lost to Follow-up|1|||
156837788|NCT01555125|566158058|FG004|Maintenance Period|Lost to Follow-up|0|||
156837789|NCT01555125|566158054|FG000|Maintenance Period|Lack of Efficacy|6|||
156837790|NCT01555125|566158055|FG001|Maintenance Period|Lack of Efficacy|1|||
156837791|NCT01555125|566158056|FG002|Maintenance Period|Lack of Efficacy|3|||
156837792|NCT01555125|566158057|FG003|Maintenance Period|Lack of Efficacy|0|||
156837793|NCT01555125|566158058|FG004|Maintenance Period|Lack of Efficacy|0|||
156837794|NCT01555125|566158054|FG000|Maintenance Period|Physician Decision|0|||
156837795|NCT01555125|566158055|FG001|Maintenance Period|Physician Decision|0|||
156837796|NCT01555125|566158056|FG002|Maintenance Period|Physician Decision|1|||
157023853|NCT04632992|566841142|FG003|Overall Study|Adverse Event|0|||
157152855|NCT01070550|567305624|FG002|Overall Study|Treatment duration shortened|0|||
156837797|NCT01555125|566158057|FG003|Maintenance Period|Physician Decision|0|||
156837798|NCT01555125|566158058|FG004|Maintenance Period|Physician Decision|0|||
156837799|NCT01555125|566158054|FG000|Maintenance Period|Death|0|||
156837800|NCT01555125|566158055|FG001|Maintenance Period|Death|0|||
156837801|NCT01555125|566158056|FG002|Maintenance Period|Death|0|||
156837802|NCT01555125|566158057|FG003|Maintenance Period|Death|1|||
156837803|NCT01555125|566158058|FG004|Maintenance Period|Death|0|||
156837804|NCT01555125|566158054|FG000|Extension|Adverse Event|1|||
156837805|NCT01555125|566158055|FG001|Extension|Adverse Event|2|||
156837806|NCT01555125|566158056|FG002|Extension|Adverse Event|1|||
156837807|NCT01555125|566158057|FG003|Extension|Adverse Event|1|||
157152856|NCT01070550|567305625|FG003|Overall Study|Treatment duration shortened|0|||
157152857|NCT01070550|567305626|FG004|Overall Study|Treatment duration shortened|0|||
156837808|NCT01555125|566158058|FG004|Extension|Adverse Event|0|||
156837809|NCT01555125|566158054|FG000|Extension|Protocol deviation|1|||
156837810|NCT01555125|566158055|FG001|Extension|Protocol deviation|0|||
157152858|NCT01070550|567305627|FG005|Overall Study|Treatment duration shortened|0|||
157152859|NCT01070550|567305622|FG000|Overall Study|Treatment interrupted|7|||
157152860|NCT01070550|567305623|FG001|Overall Study|Treatment interrupted|0|||
157152861|NCT01070550|567305624|FG002|Overall Study|Treatment interrupted|1|||
157152862|NCT01070550|567305625|FG003|Overall Study|Treatment interrupted|1|||
157152863|NCT01070550|567305626|FG004|Overall Study|Treatment interrupted|0|||
157152864|NCT01070550|567305627|FG005|Overall Study|Treatment interrupted|0|||
157152865|NCT01070550|567305622|FG000|Overall Study|Treatment not started|14|||
157152866|NCT01070550|567305623|FG001|Overall Study|Treatment not started|2|||
157152867|NCT01070550|567305624|FG002|Overall Study|Treatment not started|4|||
157152868|NCT01070550|567305625|FG003|Overall Study|Treatment not started|0|||
157152869|NCT01070550|567305626|FG004|Overall Study|Treatment not started|0|||
157152870|NCT01070550|567305627|FG005|Overall Study|Treatment not started|0|||
157152871|NCT01070550|567305622|FG000|Overall Study|Treatment restarted|0|||
157152872|NCT01070550|567305623|FG001|Overall Study|Treatment restarted|1|||
157152873|NCT01070550|567305624|FG002|Overall Study|Treatment restarted|0|||
157152874|NCT01070550|567305625|FG003|Overall Study|Treatment restarted|0|||
157152875|NCT01070550|567305626|FG004|Overall Study|Treatment restarted|0|||
157152876|NCT01070550|567305627|FG005|Overall Study|Treatment restarted|0|||
157152877|NCT01070550|567305622|FG000|Overall Study|Treatment stopped|3|||
157152878|NCT01070550|567305623|FG001|Overall Study|Treatment stopped|0|||
157152879|NCT01070550|567305624|FG002|Overall Study|Treatment stopped|0|||
157152880|NCT01070550|567305625|FG003|Overall Study|Treatment stopped|0|||
157152881|NCT01070550|567305626|FG004|Overall Study|Treatment stopped|0|||
157152882|NCT01070550|567305627|FG005|Overall Study|Treatment stopped|0|||
157152883|NCT01070550|567305622|FG000|Overall Study|Treatment unavailable|1|||
157152884|NCT01070550|567305623|FG001|Overall Study|Treatment unavailable|0|||
157152885|NCT01070550|567305624|FG002|Overall Study|Treatment unavailable|0|||
157152886|NCT01070550|567305625|FG003|Overall Study|Treatment unavailable|0|||
157152887|NCT01070550|567305626|FG004|Overall Study|Treatment unavailable|0|||
157152888|NCT01070550|567305627|FG005|Overall Study|Treatment unavailable|0|||
157152889|NCT01070550|567305622|FG000|Overall Study|Treatment was stopped early|7|||
157152890|NCT01070550|567305623|FG001|Overall Study|Treatment was stopped early|0|||
157152891|NCT01070550|567305624|FG002|Overall Study|Treatment was stopped early|0|||
157152892|NCT01070550|567305625|FG003|Overall Study|Treatment was stopped early|0|||
157152893|NCT01070550|567305626|FG004|Overall Study|Treatment was stopped early|0|||
157152894|NCT01070550|567305627|FG005|Overall Study|Treatment was stopped early|0|||
157152895|NCT01070550|567305622|FG000|Overall Study|Other|5|||
157152896|NCT01070550|567305623|FG001|Overall Study|Other|0|||
157152897|NCT01070550|567305624|FG002|Overall Study|Other|0|||
157152898|NCT01070550|567305625|FG003|Overall Study|Other|1|||
157152899|NCT01070550|567305626|FG004|Overall Study|Other|0|||
157152900|NCT01070550|567305627|FG005|Overall Study|Other|0|||
157152901|NCT01070550|567305622|FG000|Overall Study|Withdrawal by Subject|35|||
157152902|NCT01070550|567305623|FG001|Overall Study|Withdrawal by Subject|0|||
157152903|NCT01070550|567305624|FG002|Overall Study|Withdrawal by Subject|3|||
157152904|NCT01070550|567305625|FG003|Overall Study|Withdrawal by Subject|0|||
157152905|NCT01070550|567305626|FG004|Overall Study|Withdrawal by Subject|0|||
157152906|NCT01070550|567305627|FG005|Overall Study|Withdrawal by Subject|0|||
157152907|NCT01849848|567305629|FG000|Overall Study|Physician Decision|1|||
157152908|NCT01849848|567305629|FG000|Overall Study|Progression of the primary disease|3|||
157152909|NCT03649321|567305630|FG000|Overall Study|Withdrawal by Subject|1|||
157152910|NCT03649321|567305631|FG001|Overall Study|Withdrawal by Subject|0|||
157152911|NCT03649321|567305630|FG000|Overall Study|Death|1|||
157152912|NCT03649321|567305631|FG001|Overall Study|Death|0|||
157152913|NCT05100199|567305632|FG000|Overall Study|Lost to Follow-up|5|||
156837811|NCT01555125|566158056|FG002|Extension|Protocol deviation|0|||
156837812|NCT01555125|566158057|FG003|Extension|Protocol deviation|0|||
156837813|NCT01555125|566158058|FG004|Extension|Protocol deviation|0|||
156837814|NCT01555125|566158054|FG000|Extension|Lack of Efficacy|7|||
157152914|NCT05100199|567305633|FG001|Overall Study|Lost to Follow-up|8|||
157152915|NCT05100199|567305634|FG002|Overall Study|Lost to Follow-up|3|||
157152916|NCT05100199|567305635|FG003|Overall Study|Lost to Follow-up|6|||
157152917|NCT05100199|567305632|FG000|Overall Study|Withdrawal by Subject|3|||
157152918|NCT05100199|567305633|FG001|Overall Study|Withdrawal by Subject|3|||
157152919|NCT05100199|567305634|FG002|Overall Study|Withdrawal by Subject|9|||
157152920|NCT05100199|567305635|FG003|Overall Study|Withdrawal by Subject|7|||
157152921|NCT05100199|567305632|FG000|Overall Study|Other|0|||
157152922|NCT05100199|567305633|FG001|Overall Study|Other|0|||
156837815|NCT01555125|566158055|FG001|Extension|Lack of Efficacy|6|||
156837816|NCT01555125|566158056|FG002|Extension|Lack of Efficacy|3|||
157152923|NCT05100199|567305634|FG002|Overall Study|Other|1|||
157152924|NCT05100199|567305635|FG003|Overall Study|Other|1|||
157152925|NCT02853331|567305636|FG000|Overall Study|Death|59|||
157152926|NCT02853331|567305637|FG001|Overall Study|Death|95|||
157152927|NCT02853331|567305636|FG000|Overall Study|Withdrawal by Subject|5|||
156837817|NCT01555125|566158057|FG003|Extension|Lack of Efficacy|0|||
157152928|NCT02853331|567305637|FG001|Overall Study|Withdrawal by Subject|9|||
157152929|NCT02853331|567305636|FG000|Overall Study|Ongoing in study|368|||
156837818|NCT01555125|566158058|FG004|Extension|Lack of Efficacy|0|||
156837819|NCT01555125|566158054|FG000|Extension|Lost to Follow-up|2|||
156837820|NCT01555125|566158055|FG001|Extension|Lost to Follow-up|1|||
156837821|NCT01555125|566158056|FG002|Extension|Lost to Follow-up|2|||
156837822|NCT01555125|566158057|FG003|Extension|Lost to Follow-up|0|||
156837823|NCT01555125|566158058|FG004|Extension|Lost to Follow-up|0|||
156837824|NCT01555125|566158054|FG000|Extension|Study terminated by sponsor|32|||
156837825|NCT01555125|566158055|FG001|Extension|Study terminated by sponsor|33|||
156837826|NCT01555125|566158056|FG002|Extension|Study terminated by sponsor|16|||
156837827|NCT01555125|566158057|FG003|Extension|Study terminated by sponsor|20|||
156837828|NCT01555125|566158058|FG004|Extension|Study terminated by sponsor|0|||
156837829|NCT01555125|566158054|FG000|Extension|Subject/guardian decision|1|||
156837830|NCT01555125|566158055|FG001|Extension|Subject/guardian decision|9|||
156837831|NCT01555125|566158056|FG002|Extension|Subject/guardian decision|1|||
156837832|NCT01555125|566158057|FG003|Extension|Subject/guardian decision|0|||
156837833|NCT01555125|566158058|FG004|Extension|Subject/guardian decision|0|||
156837834|NCT01555125|566158054|FG000|Extension|Technical Problems|1|||
156837835|NCT01555125|566158055|FG001|Extension|Technical Problems|0|||
156837836|NCT01555125|566158056|FG002|Extension|Technical Problems|0|||
156837837|NCT01555125|566158057|FG003|Extension|Technical Problems|1|||
156837838|NCT01555125|566158058|FG004|Extension|Technical Problems|0|||
156837839|NCT01555125|566158054|FG000|Follow-Up Period|Lost to Follow-up|1|||
156837840|NCT01555125|566158055|FG001|Follow-Up Period|Lost to Follow-up|0|||
156837841|NCT01555125|566158056|FG002|Follow-Up Period|Lost to Follow-up|0|||
156837842|NCT01555125|566158057|FG003|Follow-Up Period|Lost to Follow-up|0|||
156837843|NCT01555125|566158058|FG004|Follow-Up Period|Lost to Follow-up|0|||
156837844|NCT01555125|566158054|FG000|Follow-Up Period|Subject / guardian decision|3|||
156837845|NCT01555125|566158055|FG001|Follow-Up Period|Subject / guardian decision|1|||
156837846|NCT01555125|566158056|FG002|Follow-Up Period|Subject / guardian decision|1|||
156837847|NCT01555125|566158057|FG003|Follow-Up Period|Subject / guardian decision|1|||
156837848|NCT01555125|566158058|FG004|Follow-Up Period|Subject / guardian decision|0|||
156837849|NCT04268745|566158059|FG000|Overall Study|Lost to Follow-up|2|||
156837850|NCT04268745|566158060|FG001|Overall Study|Lost to Follow-up|3|||
156837851|NCT04268745|566158059|FG000|Overall Study|Withdrawal by Subject|4|||
156837852|NCT04268745|566158060|FG001|Overall Study|Withdrawal by Subject|2|||
156837853|NCT04268745|566158059|FG000|Overall Study|Death in the family|1|||
156837854|NCT04268745|566158060|FG001|Overall Study|Death in the family|0|||
156837855|NCT05327361|566158064|FG000|Overall Study|Lost to Follow-up|4|||
156837856|NCT00626405|566158065|FG000|Overall Study|Deemed Ineligible|1|||
156837857|NCT00626405|566158066|FG001|Overall Study|Deemed Ineligible|0|||
156837858|NCT00626405|566158065|FG000|Overall Study|Withdrawal by Subject|0|||
156837859|NCT00626405|566158066|FG001|Overall Study|Withdrawal by Subject|1|||
156837860|NCT01174173|566158067|FG000|Overall Study|drug-drug interaction|1|||
156837861|NCT01041287|566159460|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
156837862|NCT01041287|566159461|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
156837863|NCT01041287|566159460|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
156837864|NCT01041287|566159461|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
156837865|NCT00785980|566159462|FG000|7 Day Washout Period|Protocol Violation|3|||
156837866|NCT01815840|566159463|FG000|Overall Study|Missing|1|||
156837867|NCT01815840|566159464|FG001|Overall Study|Missing|0|||
156837868|NCT01815840|566159463|FG000|Overall Study|Withdrew Consent|31|||
156837869|NCT01815840|566159464|FG001|Overall Study|Withdrew Consent|30|||
156837870|NCT01815840|566159463|FG000|Overall Study|Administrative/Other|1|||
156837871|NCT01815840|566159464|FG001|Overall Study|Administrative/Other|3|||
156837872|NCT01815840|566159463|FG000|Overall Study|Adverse Event|10|||
156837873|NCT01815840|566159464|FG001|Overall Study|Adverse Event|16|||
156837874|NCT01815840|566159463|FG000|Overall Study|Death|2|||
156837875|NCT01815840|566159464|FG001|Overall Study|Death|2|||
156837876|NCT01815840|566159463|FG000|Overall Study|Disease progression|3|||
156837877|NCT01815840|566159464|FG001|Overall Study|Disease progression|2|||
156837878|NCT01815840|566159463|FG000|Overall Study|Investigators Decision|2|||
156837879|NCT01815840|566159464|FG001|Overall Study|Investigators Decision|3|||
156837880|NCT01815840|566159463|FG000|Overall Study|Lost to Follow-up|3|||
156837881|NCT01815840|566159464|FG001|Overall Study|Lost to Follow-up|6|||
156837882|NCT01815840|566159463|FG000|Overall Study|Refused Treatment|5|||
156837883|NCT01815840|566159464|FG001|Overall Study|Refused Treatment|1|||
156837884|NCT01815840|566159463|FG000|Overall Study|Sponsor Termination Treatment|1|||
156837885|NCT01815840|566159464|FG001|Overall Study|Sponsor Termination Treatment|0|||
156837886|NCT01286740|566159470|FG000|Overall Study|Enrolled but not treated|1|||
156837887|NCT01286740|566159470|FG000|Overall Study|Protocol Violation|1|||
156837888|NCT01646203|566159471|FG000|Overall Study|Adverse Event|2|||
156886307|NCT01426789|566342510|FG005|Part 2|Withdrawal by Subject|0|||
157023854|NCT04632992|566841143|FG004|Overall Study|Adverse Event|0|||
156837889|NCT01646203|566159472|FG001|Overall Study|Adverse Event|0|||
156837890|NCT01646203|566159473|FG002|Overall Study|Adverse Event|1|||
156837891|NCT01646203|566159471|FG000|Overall Study|Withdrawal by Subject|0|||
156837892|NCT01646203|566159472|FG001|Overall Study|Withdrawal by Subject|1|||
156886308|NCT01426789|566342505|FG000|Part 2|Lack of Efficacy|0|||
157152930|NCT02853331|567305637|FG001|Overall Study|Ongoing in study|325|||
157152931|NCT01455428|567305638|FG000|Overall Study|Protocol Violation|2|||
157152932|NCT01455428|567305639|FG001|Overall Study|Protocol Violation|1|||
157152933|NCT01455428|567305638|FG000|Overall Study|Adverse Event|6|||
157152934|NCT01455428|567305639|FG001|Overall Study|Adverse Event|2|||
157152935|NCT01455428|567305638|FG000|Overall Study|Lost to Follow-up|1|||
157152936|NCT01455428|567305639|FG001|Overall Study|Lost to Follow-up|1|||
157152937|NCT01455428|567305638|FG000|Overall Study|Withdrawal by Subject|2|||
157152938|NCT01455428|567305639|FG001|Overall Study|Withdrawal by Subject|5|||
157152939|NCT01455428|567305638|FG000|Overall Study|Did not meet entrance criteria|0|||
157152940|NCT01455428|567305639|FG001|Overall Study|Did not meet entrance criteria|2|||
157152941|NCT01455428|567305638|FG000|Overall Study|Insufficient clinical response|0|||
157152942|NCT01455428|567305639|FG001|Overall Study|Insufficient clinical response|2|||
157152943|NCT01455428|567305638|FG000|Overall Study|Did not receive treatment|1|||
157152944|NCT01455428|567305639|FG001|Overall Study|Did not receive treatment|1|||
157152945|NCT01455428|567305638|FG000|Overall Study|Other|2|||
157152946|NCT01455428|567305639|FG001|Overall Study|Other|4|||
157152947|NCT02062151|567305643|FG000|Overall Study|screen failure|1|||
157152948|NCT00257192|567305644|FG000|Overall Study|Adverse Event|21|||
157152949|NCT00257192|567305645|FG001|Overall Study|Adverse Event|10|||
157152950|NCT00257192|567305644|FG000|Overall Study|Laboratory abnormality|1|||
157152951|NCT00257192|567305645|FG001|Overall Study|Laboratory abnormality|1|||
157152952|NCT00257192|567305644|FG000|Overall Study|Lost to Follow-up|3|||
157152953|NCT00257192|567305645|FG001|Overall Study|Lost to Follow-up|3|||
157152954|NCT00257192|567305644|FG000|Overall Study|Insufficient clinical response|18|||
157152955|NCT00257192|567305645|FG001|Overall Study|Insufficient clinical response|18|||
157152956|NCT00257192|567305644|FG000|Overall Study|Withdrawal by Subject|14|||
157152957|NCT00257192|567305645|FG001|Overall Study|Withdrawal by Subject|2|||
157152958|NCT00257192|567305644|FG000|Overall Study|Randomized but not treated|0|||
157152959|NCT00257192|567305645|FG001|Overall Study|Randomized but not treated|1|||
157152960|NCT00257192|567305644|FG000|Overall Study|Study terminated by sponsor|1|||
157152961|NCT00257192|567305645|FG001|Overall Study|Study terminated by sponsor|0|||
157152962|NCT00257192|567305644|FG000|Overall Study|Miscellaneous|0|||
157152963|NCT00257192|567305645|FG001|Overall Study|Miscellaneous|4|||
157152964|NCT00751101|567305648|FG000|Overall Study|Withdrawal by Subject|1|||
157152965|NCT00751101|567305649|FG001|Overall Study|Withdrawal by Subject|0|||
157152966|NCT00751101|567305648|FG000|Overall Study|No HFS / Never Started Patch/|0|||
156837893|NCT01646203|566159473|FG002|Overall Study|Withdrawal by Subject|0|||
156837894|NCT01646203|566159471|FG000|Overall Study|Physician's Decision|0|||
156837895|NCT01646203|566159472|FG001|Overall Study|Physician's Decision|1|||
156837896|NCT01646203|566159473|FG002|Overall Study|Physician's Decision|0|||
156837897|NCT04676867|566159474|FG000|Overall Study|Screen failure|0|||
156837898|NCT04676867|566159475|FG001|Overall Study|Screen failure|0|||
156837899|NCT04676867|566159476|FG002|Overall Study|Screen failure|6|||
156837900|NCT04676867|566159477|FG003|Overall Study|Screen failure|2|||
156837901|NCT04676867|566159474|FG000|Overall Study|Death|0|||
156837902|NCT04676867|566159475|FG001|Overall Study|Death|0|||
156837903|NCT04676867|566159476|FG002|Overall Study|Death|1|||
156837904|NCT04676867|566159477|FG003|Overall Study|Death|0|||
156837905|NCT04676867|566159474|FG000|Overall Study|Withdrawal by Subject|2|||
156837906|NCT04676867|566159475|FG001|Overall Study|Withdrawal by Subject|2|||
156837907|NCT04676867|566159476|FG002|Overall Study|Withdrawal by Subject|4|||
156837908|NCT04676867|566159477|FG003|Overall Study|Withdrawal by Subject|4|||
156837909|NCT04676867|566159474|FG000|Overall Study|Lost to Follow-up|1|||
156837910|NCT04676867|566159475|FG001|Overall Study|Lost to Follow-up|0|||
156837911|NCT04676867|566159476|FG002|Overall Study|Lost to Follow-up|0|||
156837912|NCT04676867|566159477|FG003|Overall Study|Lost to Follow-up|0|||
156837913|NCT02294734|566159481|FG000|Overall Study|Adverse Event|5|||
156837914|NCT02294734|566159482|FG001|Overall Study|Adverse Event|5|||
156837915|NCT02294734|566159481|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
156837916|NCT02294734|566159482|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
157152967|NCT00751101|567305649|FG001|Overall Study|No HFS / Never Started Patch/|4|||
157152968|NCT00751101|567305648|FG000|Overall Study|Never began capecitabine|1|||
157152969|NCT00751101|567305649|FG001|Overall Study|Never began capecitabine|0|||
156837917|NCT02294734|566159481|FG000|Overall Study|Lost to Follow-up|2|||
156886309|NCT01426789|566342506|FG001|Part 2|Lack of Efficacy|0|||
156886310|NCT01426789|566342507|FG002|Part 2|Lack of Efficacy|5|||
156886311|NCT01426789|566342508|FG003|Part 2|Lack of Efficacy|0|||
157152970|NCT00751101|567305648|FG000|Overall Study|Physician Decision|0|||
157152971|NCT00751101|567305649|FG001|Overall Study|Physician Decision|1|||
157152972|NCT01905397|567305650|FG000|Overall Study|Death|0|||
157152973|NCT01905397|567305651|FG001|Overall Study|Death|1|||
157152974|NCT01905397|567305650|FG000|Overall Study|Withdrawal by Subject|2|||
156837918|NCT02294734|566159482|FG001|Overall Study|Lost to Follow-up|0|||
156837919|NCT02294734|566159481|FG000|Overall Study|Physician Decision|2|||
156837920|NCT02294734|566159482|FG001|Overall Study|Physician Decision|1|||
156837921|NCT02294734|566159481|FG000|Overall Study|Withdrawal by Subject|4|||
156886312|NCT01426789|566342509|FG004|Part 2|Lack of Efficacy|2|||
157152975|NCT01905397|567305651|FG001|Overall Study|Withdrawal by Subject|0|||
157152976|NCT01905397|567305650|FG000|Overall Study|Surgery canceled/aborted|9|||
157152977|NCT01905397|567305651|FG001|Overall Study|Surgery canceled/aborted|5|||
157152978|NCT01905397|567305650|FG000|Overall Study|Incision < 7 cm|2|||
157152979|NCT01905397|567305651|FG001|Overall Study|Incision < 7 cm|0|||
157152980|NCT01905397|567305650|FG000|Overall Study|Wrong treatment|1|||
157152981|NCT01905397|567305651|FG001|Overall Study|Wrong treatment|1|||
157152982|NCT01905397|567305650|FG000|Overall Study|Device not applied|3|||
157152983|NCT01905397|567305651|FG001|Overall Study|Device not applied|0|||
157152984|NCT01905397|567305650|FG000|Overall Study|Dressing not applied in operating room|1|||
157152985|NCT01905397|567305651|FG001|Overall Study|Dressing not applied in operating room|0|||
157152986|NCT01905397|567305650|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
156837922|NCT02294734|566159482|FG001|Overall Study|Withdrawal by Subject|2|||
156837923|NCT02335424|566159483|FG000|Overall Study|Withdrawal by Subject|19|||
156837924|NCT02335424|566159483|FG000|Overall Study|Adverse Event|25|||
156837925|NCT02335424|566159483|FG000|Overall Study|Death|273|||
156837926|NCT02335424|566159483|FG000|Overall Study|Lost to Follow-up|3|||
156837927|NCT02335424|566159483|FG000|Overall Study|Physician Decision|13|||
156837928|NCT02335424|566159483|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
156837929|NCT02335424|566159483|FG000|Overall Study|Protocol Violation|1|||
156837930|NCT02335424|566159483|FG000|Overall Study|Screen failure|1|||
156837931|NCT03157583|566159484|FG000|Overall Study|Other (did not meet study criteria)|1|||
156837932|NCT01141478|566159485|FG000|Overall Study|Withdrawal by Subject|1|||
156837933|NCT01141478|566159486|FG001|Overall Study|Withdrawal by Subject|1|||
156837934|NCT00290498|566159491|FG000|Overall Study|Death|2|||
156837935|NCT00290498|566159492|FG001|Overall Study|Death|0|||
156837936|NCT00290498|566159491|FG000|Overall Study|Physician Decision|1|||
156837937|NCT00290498|566159492|FG001|Overall Study|Physician Decision|0|||
156837938|NCT00290498|566159491|FG000|Overall Study|Withdrawal by Subject|1|||
156837939|NCT00290498|566159492|FG001|Overall Study|Withdrawal by Subject|0|||
156837940|NCT00290498|566159491|FG000|Overall Study|Ineligible|3|||
156837941|NCT00290498|566159492|FG001|Overall Study|Ineligible|0|||
156837942|NCT00290498|566159491|FG000|Overall Study|Non-Compliance|1|||
156837943|NCT00290498|566159492|FG001|Overall Study|Non-Compliance|0|||
156837944|NCT03847909|566159495|FG000|Overall Study|Withdrawal by Subject|1|||
156837945|NCT03847909|566159496|FG001|Overall Study|Withdrawal by Subject|1|||
156837946|NCT00490022|566159497|FG000|Overall Study|Adverse Event|0|||
156837947|NCT00490022|566159498|FG001|Overall Study|Adverse Event|2|||
156837948|NCT00490022|566159497|FG000|Overall Study|Withdrawal by Subject|1|||
156837949|NCT00490022|566159498|FG001|Overall Study|Withdrawal by Subject|0|||
156837950|NCT00490022|566159497|FG000|Overall Study|Subject failed to disclose concommitant|0|||
156837951|NCT00490022|566159498|FG001|Overall Study|Subject failed to disclose concommitant|1|||
156837952|NCT04268173|566159499|FG000|Overall Study|Lost to Follow-up|75|||
156837953|NCT04268173|566159500|FG001|Overall Study|Lost to Follow-up|108|||
156837954|NCT00869401|566159501|FG000|Overall Study|Withdrawal by Subject|0|||
156837955|NCT00869401|566159502|FG001|Overall Study|Withdrawal by Subject|0|||
156837956|NCT00869401|566159503|FG002|Overall Study|Withdrawal by Subject|0|||
156837957|NCT00869401|566159504|FG003|Overall Study|Withdrawal by Subject|5|||
156837958|NCT00869401|566159505|FG004|Overall Study|Withdrawal by Subject|3|||
156837959|NCT00545103|566159506|FG000|Overall Study|Lack of Efficacy|48|||
156837960|NCT00545103|566159507|FG001|Overall Study|Lack of Efficacy|45|||
156837961|NCT00545103|566159508|FG002|Overall Study|Lack of Efficacy|31|||
156837962|NCT00545103|566159509|FG003|Overall Study|Lack of Efficacy|27|||
156837963|NCT00545103|566159506|FG000|Overall Study|Withdrawal by Subject|6|||
156886313|NCT01426789|566342510|FG005|Part 2|Lack of Efficacy|0|||
156886314|NCT01426789|566342505|FG000|Part 2|Adverse Event|0|||
156886315|NCT01426789|566342506|FG001|Part 2|Adverse Event|0|||
156886316|NCT01426789|566342507|FG002|Part 2|Adverse Event|2|||
156886317|NCT01426789|566342508|FG003|Part 2|Adverse Event|0|||
156886318|NCT01426789|566342509|FG004|Part 2|Adverse Event|1|||
156886319|NCT01426789|566342510|FG005|Part 2|Adverse Event|0|||
156886320|NCT04054947|566342511|FG000|Overall Study|Withdrawal by Subject|1|||
156886321|NCT04054947|566342512|FG001|Overall Study|Withdrawal by Subject|0|||
157152987|NCT01905397|567305651|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
157152988|NCT01921270|567305655|FG000|Overall Study|Withdrawal by Subject|1|||
157152989|NCT00844428|567305656|FG000|Screening Period|Screen Failure|3|||
157152990|NCT00844428|567305656|FG000|Extension Treatment Period|Death|1|||
157152991|NCT00844428|567305656|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
156837964|NCT00545103|566159507|FG001|Overall Study|Withdrawal by Subject|10|||
156837965|NCT00545103|566159508|FG002|Overall Study|Withdrawal by Subject|18|||
156837966|NCT00545103|566159509|FG003|Overall Study|Withdrawal by Subject|22|||
156837967|NCT00545103|566159506|FG000|Overall Study|Adverse Event|11|||
156837968|NCT00545103|566159507|FG001|Overall Study|Adverse Event|12|||
157023855|NCT04632992|566841144|FG005|Overall Study|Adverse Event|0|||
156837969|NCT00545103|566159508|FG002|Overall Study|Adverse Event|17|||
156837970|NCT00545103|566159509|FG003|Overall Study|Adverse Event|10|||
156886322|NCT04054947|566342511|FG000|Overall Study|Lost to Follow-up|2|||
156886323|NCT04054947|566342512|FG001|Overall Study|Lost to Follow-up|5|||
156886324|NCT04463069|566342515|FG000|Overall Study|Withdrawal by Subject|2|||
156886325|NCT04463069|566342516|FG001|Overall Study|Withdrawal by Subject|10|||
156886326|NCT04463069|566342515|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
156886327|NCT04463069|566342516|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
156886328|NCT03073733|566342523|FG000|Overall Study|Lost to Follow-up|1|||
156886329|NCT03073733|566342524|FG001|Overall Study|Lost to Follow-up|0|||
156886330|NCT03073733|566342525|FG002|Overall Study|Lost to Follow-up|0|||
156886331|NCT03073733|566342523|FG000|Overall Study|Physician Decision|0|||
156886332|NCT03073733|566342524|FG001|Overall Study|Physician Decision|1|||
156886333|NCT03073733|566342525|FG002|Overall Study|Physician Decision|0|||
156886334|NCT03073733|566342523|FG000|Overall Study|Withdrawal by Subject|0|||
156886335|NCT03073733|566342524|FG001|Overall Study|Withdrawal by Subject|0|||
156886336|NCT03073733|566342525|FG002|Overall Study|Withdrawal by Subject|1|||
156886337|NCT00835731|566342526|FG000|Overall Study|Withdrawal by Subject|1|||
156886338|NCT00835731|566342527|FG001|Overall Study|Withdrawal by Subject|0|||
156886339|NCT00835731|566342526|FG000|Overall Study|Physician Decision|1|||
156886340|NCT00835731|566342527|FG001|Overall Study|Physician Decision|1|||
156886341|NCT00348881|566342528|FG000|Overall Study|Lost to Follow-up|12|||
156886342|NCT00348881|566342529|FG001|Overall Study|Lost to Follow-up|6|||
156886343|NCT00348881|566342528|FG000|Overall Study|Withdrawal by Subject|3|||
156886344|NCT00348881|566342529|FG001|Overall Study|Withdrawal by Subject|4|||
156886345|NCT00348881|566342528|FG000|Overall Study|Adverse Event|2|||
156886346|NCT00348881|566342529|FG001|Overall Study|Adverse Event|0|||
156886347|NCT00348881|566342528|FG000|Overall Study|Serious Adverse Event|0|||
156886348|NCT00348881|566342529|FG001|Overall Study|Serious Adverse Event|2|||
156886349|NCT00129311|566342530|FG000|Overall Study|Withdrawal by Subject|12|||
156886350|NCT00129311|566342531|FG001|Overall Study|Withdrawal by Subject|19|||
156837971|NCT00545103|566159506|FG000|Overall Study|Lost to Follow-up|4|||
156837972|NCT00545103|566159507|FG001|Overall Study|Lost to Follow-up|6|||
156837973|NCT00545103|566159508|FG002|Overall Study|Lost to Follow-up|3|||
156837974|NCT00545103|566159509|FG003|Overall Study|Lost to Follow-up|4|||
156837975|NCT00545103|566159506|FG000|Overall Study|Protocol Violation|1|||
156837976|NCT00545103|566159507|FG001|Overall Study|Protocol Violation|2|||
156837977|NCT00545103|566159508|FG002|Overall Study|Protocol Violation|3|||
156837978|NCT00545103|566159509|FG003|Overall Study|Protocol Violation|0|||
156837979|NCT00545103|566159506|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
156837980|NCT00545103|566159507|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
156837981|NCT00545103|566159508|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
156886351|NCT00336583|566343937|FG000|Overall Study|Lost to Follow-up|1|||
156886352|NCT00336583|566343937|FG000|Overall Study|Death|1|||
156886353|NCT03603509|566343939|FG000|Overall Study|Lost to Follow-up|3|||
156886354|NCT03603509|566343940|FG001|Overall Study|Lost to Follow-up|4|||
156886355|NCT02276027|566343943|FG000|Overall Study|Death|1|||
157152992|NCT00455858|567305657|FG000|Overall Study|Lost to Follow-up|2|||
157152993|NCT00455858|567305657|FG000|Overall Study|Protocol Violation|1|||
157152994|NCT00455858|567305657|FG000|Overall Study|Lack of Efficacy|1|||
157152995|NCT00455858|567305657|FG000|Overall Study|Well controlled FPG without insulin|1|||
157152996|NCT00455858|567305657|FG000|Overall Study|Withdrawal|1|||
157152997|NCT02092389|567305658|FG000|Overall Study|Adverse Event|1|||
157152998|NCT02092389|567305658|FG000|Overall Study|Other|5|||
157152999|NCT01242020|567305659|FG000|Overall Study|Withdrawal by Subject|2|||
157153000|NCT01242020|567305660|FG001|Overall Study|Withdrawal by Subject|0|||
157153001|NCT01242020|567305659|FG000|Overall Study|Failed screening|1|||
157153002|NCT01242020|567305660|FG001|Overall Study|Failed screening|0|||
157153003|NCT02680847|567305661|FG000|Overall Study|Other|2|||
157153004|NCT02680847|567305662|FG001|Overall Study|Other|0|||
157153005|NCT02680847|567305663|FG002|Overall Study|Other|0|||
157153006|NCT02680847|567305661|FG000|Overall Study|No longer met eligibility criteria|2|||
157153007|NCT02680847|567305662|FG001|Overall Study|No longer met eligibility criteria|2|||
157153008|NCT02680847|567305663|FG002|Overall Study|No longer met eligibility criteria|0|||
157153009|NCT02680847|567305661|FG000|Overall Study|Unwilling to participate in study|1|||
157153010|NCT02680847|567305662|FG001|Overall Study|Unwilling to participate in study|1|||
157153011|NCT02680847|567305663|FG002|Overall Study|Unwilling to participate in study|0|||
157153012|NCT02680847|567305661|FG000|Overall Study|Lack of Efficacy|0|||
156837982|NCT00545103|566159509|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
156837983|NCT00545103|566159506|FG000|Overall Study|Difficult to open package|0|||
156837984|NCT00545103|566159507|FG001|Overall Study|Difficult to open package|0|||
156837985|NCT00545103|566159508|FG002|Overall Study|Difficult to open package|0|||
156886356|NCT02276027|566343944|FG001|Overall Study|Death|0|||
156886357|NCT02276027|566343945|FG002|Overall Study|Death|0|||
156886358|NCT02276027|566343946|FG003|Overall Study|Death|2|||
156886359|NCT02276027|566343943|FG000|Overall Study|Physician Decision|0|||
156886360|NCT02276027|566343944|FG001|Overall Study|Physician Decision|0|||
156886361|NCT02276027|566343945|FG002|Overall Study|Physician Decision|0|||
156886362|NCT02276027|566343946|FG003|Overall Study|Physician Decision|1|||
157153013|NCT02680847|567305662|FG001|Overall Study|Lack of Efficacy|0|||
157153014|NCT02680847|567305663|FG002|Overall Study|Lack of Efficacy|2|||
156837986|NCT00545103|566159509|FG003|Overall Study|Difficult to open package|1|||
156837987|NCT00545103|566159506|FG000|Overall Study|Investigational product not taken|1|||
156837988|NCT00545103|566159507|FG001|Overall Study|Investigational product not taken|0|||
156837989|NCT00545103|566159508|FG002|Overall Study|Investigational product not taken|0|||
156837990|NCT00545103|566159509|FG003|Overall Study|Investigational product not taken|1|||
156837991|NCT00545103|566159506|FG000|Overall Study|Wish to start a family|0|||
156837992|NCT00545103|566159507|FG001|Overall Study|Wish to start a family|0|||
156837993|NCT00545103|566159508|FG002|Overall Study|Wish to start a family|0|||
156837994|NCT00545103|566159509|FG003|Overall Study|Wish to start a family|1|||
156837995|NCT00545103|566159506|FG000|Overall Study|Diverticulitis crisis|0|||
156837996|NCT00545103|566159507|FG001|Overall Study|Diverticulitis crisis|0|||
156837997|NCT00545103|566159508|FG002|Overall Study|Diverticulitis crisis|0|||
156837998|NCT00545103|566159509|FG003|Overall Study|Diverticulitis crisis|1|||
156837999|NCT00545103|566159506|FG000|Overall Study|Personal reasons|1|||
156838000|NCT00545103|566159507|FG001|Overall Study|Personal reasons|0|||
156838001|NCT00545103|566159508|FG002|Overall Study|Personal reasons|0|||
156838002|NCT00545103|566159509|FG003|Overall Study|Personal reasons|0|||
156838003|NCT00545103|566159506|FG000|Overall Study|Subject's decision|1|||
156838004|NCT00545103|566159507|FG001|Overall Study|Subject's decision|0|||
156838005|NCT00545103|566159508|FG002|Overall Study|Subject's decision|0|||
156838006|NCT00545103|566159509|FG003|Overall Study|Subject's decision|0|||
156838007|NCT00545103|566159506|FG000|Overall Study|Noncompliance|0|||
156838008|NCT00545103|566159507|FG001|Overall Study|Noncompliance|1|||
156838009|NCT00545103|566159508|FG002|Overall Study|Noncompliance|0|||
156838010|NCT00545103|566159509|FG003|Overall Study|Noncompliance|0|||
156838011|NCT00545103|566159506|FG000|Overall Study|Investigator decision|0|||
156838012|NCT00545103|566159507|FG001|Overall Study|Investigator decision|0|||
156838013|NCT00545103|566159508|FG002|Overall Study|Investigator decision|1|||
156838014|NCT00545103|566159509|FG003|Overall Study|Investigator decision|0|||
156838015|NCT00545103|566159506|FG000|Overall Study|Subject moved|0|||
156838016|NCT00545103|566159507|FG001|Overall Study|Subject moved|1|||
156838017|NCT00545103|566159508|FG002|Overall Study|Subject moved|0|||
156838018|NCT00545103|566159509|FG003|Overall Study|Subject moved|0|||
156838019|NCT00545103|566159506|FG000|Overall Study|Use of prohibited medication|0|||
156838020|NCT00545103|566159507|FG001|Overall Study|Use of prohibited medication|0|||
156838021|NCT00545103|566159508|FG002|Overall Study|Use of prohibited medication|1|||
156838022|NCT00545103|566159509|FG003|Overall Study|Use of prohibited medication|0|||
156838023|NCT00545103|566159506|FG000|Overall Study|Does not want to take study drug anymore|1|||
156838024|NCT00545103|566159507|FG001|Overall Study|Does not want to take study drug anymore|0|||
156838025|NCT00545103|566159508|FG002|Overall Study|Does not want to take study drug anymore|1|||
156838026|NCT00545103|566159509|FG003|Overall Study|Does not want to take study drug anymore|0|||
156838027|NCT00545103|566159506|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838028|NCT00545103|566159507|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838029|NCT00545103|566159508|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
156838030|NCT00545103|566159509|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
156838031|NCT00545103|566159506|FG000|Overall Study|Death|0|||
156838032|NCT00545103|566159507|FG001|Overall Study|Death|1|||
156838033|NCT00545103|566159508|FG002|Overall Study|Death|0|||
156838034|NCT00545103|566159509|FG003|Overall Study|Death|0|||
156838035|NCT01953913|566159510|FG000|Overall Study|Disease Progression|349|||
156838036|NCT01953913|566159510|FG000|Overall Study|Worsening of underlying cancer|22|||
156838037|NCT01953913|566159510|FG000|Overall Study|Adverse Event|20|||
156838038|NCT01953913|566159510|FG000|Overall Study|Protocol Violation|6|||
156838039|NCT01953913|566159510|FG000|Overall Study|Lost to Follow-up|4|||
156838040|NCT01953913|566159510|FG000|Overall Study|Withdrawal by Subject|32|||
156838041|NCT01953913|566159510|FG000|Overall Study|Other than listed|108|||
156838042|NCT01953913|566159510|FG000|Overall Study|Not Treated|1|||
156838043|NCT05026853|566159511|FG000|Overall Study|Cancelled appointment|1|||
156838044|NCT05026853|566159512|FG001|Overall Study|Cancelled appointment|0|||
156838045|NCT05026853|566159511|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
156838046|NCT05026853|566159512|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
156838047|NCT05026853|566159511|FG000|Overall Study|Did not complete 12-week survey|16|||
156838048|NCT05026853|566159512|FG001|Overall Study|Did not complete 12-week survey|16|||
156838049|NCT01732913|566159513|FG000|Overall Study|Study Terminated by Sponsor|105|||
156838050|NCT01732913|566159514|FG001|Overall Study|Study Terminated by Sponsor|55|||
156838051|NCT01732913|566159513|FG000|Overall Study|Withdrawal by Subject|27|||
156838052|NCT01732913|566159514|FG001|Overall Study|Withdrawal by Subject|4|||
156838053|NCT01732913|566159513|FG000|Overall Study|Physician Decision|14|||
156838054|NCT01732913|566159514|FG001|Overall Study|Physician Decision|7|||
156838055|NCT01732913|566159513|FG000|Overall Study|Other|7|||
156838056|NCT01732913|566159514|FG001|Overall Study|Other|1|||
156838057|NCT01732913|566159513|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
156838058|NCT01732913|566159514|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
156838059|NCT01353911|566159515|FG000|Overall Study|Lost to Follow-up|2|||
156838060|NCT01353911|566159516|FG001|Overall Study|Lost to Follow-up|6|||
157153015|NCT02680847|567305661|FG000|Overall Study|Adverse Event|0|||
157153016|NCT02680847|567305662|FG001|Overall Study|Adverse Event|0|||
156838061|NCT01353911|566159517|FG002|Overall Study|Lost to Follow-up|4|||
156838062|NCT01353911|566159518|FG003|Overall Study|Lost to Follow-up|0|||
156838063|NCT01353911|566159519|FG004|Overall Study|Lost to Follow-up|4|||
156838064|NCT01353911|566159520|FG005|Overall Study|Lost to Follow-up|4|||
156838065|NCT01353911|566159521|FG006|Overall Study|Lost to Follow-up|3|||
156838066|NCT01353911|566159522|FG007|Overall Study|Lost to Follow-up|6|||
156838067|NCT01353911|566159515|FG000|Overall Study|Withdrawal by Subject|2|||
156838068|NCT01353911|566159516|FG001|Overall Study|Withdrawal by Subject|3|||
156838069|NCT01353911|566159517|FG002|Overall Study|Withdrawal by Subject|4|||
156838070|NCT01353911|566159518|FG003|Overall Study|Withdrawal by Subject|2|||
156838071|NCT01353911|566159519|FG004|Overall Study|Withdrawal by Subject|2|||
156838072|NCT01353911|566159520|FG005|Overall Study|Withdrawal by Subject|3|||
156838073|NCT01353911|566159521|FG006|Overall Study|Withdrawal by Subject|3|||
156838074|NCT01353911|566159522|FG007|Overall Study|Withdrawal by Subject|9|||
156838075|NCT01353911|566159515|FG000|Overall Study|Status Not Recorded|4|||
156838076|NCT01353911|566159516|FG001|Overall Study|Status Not Recorded|0|||
156838077|NCT01353911|566159517|FG002|Overall Study|Status Not Recorded|1|||
156838078|NCT01353911|566159518|FG003|Overall Study|Status Not Recorded|0|||
156838079|NCT01353911|566159519|FG004|Overall Study|Status Not Recorded|0|||
156838080|NCT01353911|566159520|FG005|Overall Study|Status Not Recorded|0|||
156838081|NCT01353911|566159521|FG006|Overall Study|Status Not Recorded|0|||
156838082|NCT01353911|566159522|FG007|Overall Study|Status Not Recorded|0|||
156838083|NCT03233438|566159523|FG000|Overall Study|Lost to Follow-up|4|||
156838084|NCT03233438|566159524|FG001|Overall Study|Lost to Follow-up|9|||
156838085|NCT03233438|566159523|FG000|Overall Study|Withdrawal by Subject|2|||
156838086|NCT03233438|566159524|FG001|Overall Study|Withdrawal by Subject|1|||
156838087|NCT03233438|566159523|FG000|Overall Study|No recording of dalbavancin|0|||
156838088|NCT03233438|566159524|FG001|Overall Study|No recording of dalbavancin|1|||
156838089|NCT02925741|566159526|FG000|Overall Study|Withdrawal by Subject|11|||
156838090|NCT02925741|566159527|FG001|Overall Study|Withdrawal by Subject|0|||
156838091|NCT00413374|566159530|FG000|Overall Study|Ineligible due to screening criteria.|3|||
156838092|NCT00413374|566159531|FG001|Overall Study|Ineligible due to screening criteria.|0|||
156838093|NCT00413374|566159530|FG000|Overall Study|Adverse Event|1|||
156838094|NCT00413374|566159531|FG001|Overall Study|Adverse Event|0|||
156838095|NCT00413374|566159530|FG000|Overall Study|Lost to Follow-up|1|||
156838096|NCT00413374|566159531|FG001|Overall Study|Lost to Follow-up|0|||
156838097|NCT00413374|566159530|FG000|Overall Study|Surgery|1|||
156838098|NCT00413374|566159531|FG001|Overall Study|Surgery|0|||
156838099|NCT00295932|566159534|FG000|Overall Study|Not Treated|0|||
156838100|NCT00295932|566159535|FG001|Overall Study|Not Treated|0|||
156838101|NCT00295932|566159536|FG002|Overall Study|Not Treated|0|||
156838102|NCT00295932|566159537|FG003|Overall Study|Not Treated|0|||
156838103|NCT00295932|566159538|FG004|Overall Study|Not Treated|0|||
156838104|NCT00295932|566159539|FG005|Overall Study|Not Treated|0|||
156838105|NCT00295932|566159540|FG006|Overall Study|Not Treated|0|||
156838106|NCT00295932|566159541|FG007|Overall Study|Not Treated|0|||
156838107|NCT00295932|566159542|FG008|Overall Study|Not Treated|0|||
156838108|NCT00295932|566159543|FG009|Overall Study|Not Treated|0|||
156838109|NCT00295932|566159544|FG010|Overall Study|Not Treated|1|||
156838110|NCT00500760|566159546|FG000|Overall Study|Death|32|||
156886363|NCT02276027|566343943|FG000|Overall Study|Progressive disease|1|||
156886364|NCT02276027|566343944|FG001|Overall Study|Progressive disease|13|||
156886365|NCT02276027|566343945|FG002|Overall Study|Progressive disease|12|||
156886366|NCT02276027|566343946|FG003|Overall Study|Progressive disease|14|||
156886367|NCT02276027|566343943|FG000|Overall Study|Subject/guardian decision|0|||
156886368|NCT02276027|566343944|FG001|Overall Study|Subject/guardian decision|1|||
156886369|NCT02276027|566343945|FG002|Overall Study|Subject/guardian decision|0|||
156886370|NCT02276027|566343946|FG003|Overall Study|Subject/guardian decision|3|||
156886371|NCT02276027|566343943|FG000|Overall Study|Adverse Event|0|||
156886372|NCT02276027|566343944|FG001|Overall Study|Adverse Event|2|||
156886373|NCT02276027|566343945|FG002|Overall Study|Adverse Event|8|||
156886374|NCT02276027|566343946|FG003|Overall Study|Adverse Event|2|||
156886375|NCT02446171|566343948|FG000|Overall Study|Withdrawal by Subject|0|||
156838111|NCT00500760|566159547|FG001|Overall Study|Death|15|||
156838112|NCT00500760|566159546|FG000|Overall Study|Withdrawal by Subject|5|||
156838113|NCT00500760|566159547|FG001|Overall Study|Withdrawal by Subject|7|||
156838114|NCT00500760|566159546|FG000|Overall Study|Administrative decision|2|||
156838115|NCT00500760|566159547|FG001|Overall Study|Administrative decision|0|||
156838116|NCT00500760|566159546|FG000|Overall Study|Lost to Follow-up|3|||
156886376|NCT02446171|566343949|FG001|Overall Study|Withdrawal by Subject|0|||
156886377|NCT02446171|566343950|FG002|Overall Study|Withdrawal by Subject|2|||
156886378|NCT02446171|566343951|FG003|Overall Study|Withdrawal by Subject|0|||
157153017|NCT02680847|567305663|FG002|Overall Study|Adverse Event|1|||
156838117|NCT00500760|566159547|FG001|Overall Study|Lost to Follow-up|0|||
156838118|NCT00500760|566159546|FG000|Overall Study|Other|1|||
156838119|NCT00500760|566159547|FG001|Overall Study|Other|2|||
156838120|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
156838121|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
156838122|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
156838123|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
156838124|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
156838125|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
156838126|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838127|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838128|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838129|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838130|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
156838131|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
156838132|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
156838133|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
156838134|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838135|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
156838136|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
156838137|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838138|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838139|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838140|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838141|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
156838142|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838143|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
156838144|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838145|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838146|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
156838147|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
156838148|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838149|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838150|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838151|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838152|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
156838153|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
156838154|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
156838155|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
156838156|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838157|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
156838158|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
156838159|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838160|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838161|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838162|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838163|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
156838164|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838165|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156886379|NCT03328182|566343952|FG000|Overall Study|Withdrawal by Subject|1|||
156886380|NCT03328182|566343952|FG000|Overall Study|Protocol Violation|2|||
156886381|NCT03328182|566343952|FG000|Overall Study|No Product Evaluated|1|||
156886382|NCT00003830|566343954|FG000|Overall Study|No follow up data|3|||
156886383|NCT00003830|566343955|FG001|Overall Study|No follow up data|0|||
156886384|NCT00003830|566343954|FG000|Overall Study|Sentinel node positive patients|829|||
156886385|NCT00003830|566343955|FG001|Overall Study|Sentinel node positive patients|793|||
156886386|NCT00883688|566343956|FG000|Overall Study|Ineligible|2|||
156886387|NCT03860935|566343957|FG000|Overall Study|Withdrawal of Consent|15|||
156886388|NCT03860935|566343958|FG001|Overall Study|Withdrawal of Consent|6|||
156886389|NCT03860935|566343957|FG000|Overall Study|Death|75|||
156886390|NCT03860935|566343958|FG001|Overall Study|Death|51|||
156886391|NCT03739242|566343962|FG000|Overall Study|Withdrawal by Subject|1|||
156886392|NCT03739242|566343963|FG001|Overall Study|Withdrawal by Subject|1|||
156886393|NCT03739242|566343962|FG000|Overall Study|Protocol Violation|0|||
156886394|NCT03739242|566343963|FG001|Overall Study|Protocol Violation|1|||
157023856|NCT04632992|566841145|FG006|Overall Study|Adverse Event|0|||
157023857|NCT04632992|566841146|FG007|Overall Study|Adverse Event|0|||
156886395|NCT01122394|566343964|FG000|Overall Study|Withdrawal by Subject|1|||
156886396|NCT01122394|566343965|FG001|Overall Study|Withdrawal by Subject|1|||
156886397|NCT01122394|566343964|FG000|Overall Study|Lost to Follow-up|2|||
156886398|NCT01122394|566343965|FG001|Overall Study|Lost to Follow-up|2|||
156886399|NCT01122394|566343964|FG000|Overall Study|Adverse Event|0|||
156838166|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
156886400|NCT01122394|566343965|FG001|Overall Study|Adverse Event|1|||
156886401|NCT00039871|566343966|FG000|Overall Study|Adverse Event|165|||
156838167|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838168|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838169|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
156838170|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838171|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838172|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838173|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838174|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
156838175|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
156838176|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838177|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838178|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838179|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838180|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838181|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838182|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
157153018|NCT00399802|567305669|FG000|Overall Study|Adverse Event|0|||
157153019|NCT00399802|567305670|FG001|Overall Study|Adverse Event|2|||
157153020|NCT00399802|567305669|FG000|Overall Study|Participant discontinued by mistake|0|||
157153021|NCT00399802|567305670|FG001|Overall Study|Participant discontinued by mistake|1|||
157153022|NCT04172831|567305673|FG000|Overall Study|Adverse Event|21|||
157153023|NCT04172831|567305674|FG001|Overall Study|Adverse Event|9|||
157153024|NCT04172831|567305673|FG000|Overall Study|Lack of Efficacy|2|||
157153025|NCT04172831|567305674|FG001|Overall Study|Lack of Efficacy|8|||
157153026|NCT04172831|567305673|FG000|Overall Study|Physician Decision|0|||
157153027|NCT04172831|567305674|FG001|Overall Study|Physician Decision|1|||
157153028|NCT04172831|567305673|FG000|Overall Study|Withdrawal by Subject|12|||
157153029|NCT04172831|567305674|FG001|Overall Study|Withdrawal by Subject|11|||
157153030|NCT04172831|567305673|FG000|Overall Study|Lost to Follow-up|4|||
157153031|NCT04172831|567305674|FG001|Overall Study|Lost to Follow-up|9|||
157153032|NCT04172831|567305673|FG000|Overall Study|COVID-19 related crisis|3|||
157153033|NCT04172831|567305674|FG001|Overall Study|COVID-19 related crisis|3|||
157153034|NCT04172831|567305673|FG000|Overall Study|Subject non-compliance|1|||
157153035|NCT04172831|567305674|FG001|Overall Study|Subject non-compliance|1|||
157153036|NCT04172831|567305673|FG000|Overall Study|Family emergency|1|||
157153037|NCT04172831|567305674|FG001|Overall Study|Family emergency|0|||
157153038|NCT01899144|567305676|FG000|Treatment Period 2|Other|1|||
157153039|NCT01899144|567305676|FG000|Treatment Period 3|Other|2|||
157153040|NCT01899144|567305676|FG000|Treatment Period 5|Other|1|||
157153041|NCT02021812|567305677|FG000|Overall Study|Death|8|||
157153042|NCT02021812|567305677|FG000|Overall Study|Withdrawal by Subject|3|||
157153043|NCT02021812|567305677|FG000|Overall Study|Lost to Follow-up|2|||
157153044|NCT02021812|567305677|FG000|Overall Study|Refuse to return, COVD 19|2|||
157153045|NCT02119104|567305679|FG000|Overall Study|Protocol Violation|16|||
157153046|NCT01651260|567305680|FG000|Overall Study|unable to apply product|3|||
157153047|NCT00081289|567305683|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
157153048|NCT00081289|567305684|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
157153049|NCT00081289|567305683|FG000|Overall Study|Ineligible / no protocol treatment|3|||
157153050|NCT00081289|567305684|FG001|Overall Study|Ineligible / no protocol treatment|4|||
157153051|NCT01952015|567305687|FG000|Induction|Protocol Violation|1|||
157153052|NCT01952015|567305687|FG000|Maintenance|Adverse Event|2|||
157153053|NCT01952015|567305687|FG000|Treatment Period 3|Physician Decision|9|||
157153054|NCT02239094|567305688|FG000|Overall Study|Withdrawal by Subject|1|||
157153055|NCT02239094|567305688|FG000|Overall Study|Remitted before started|1|||
157153056|NCT02508701|567305691|FG000|Overall Study|Lost to Follow-up|9|||
157153057|NCT02508701|567305692|FG001|Overall Study|Lost to Follow-up|5|||
157153058|NCT02508701|567305693|FG002|Overall Study|Lost to Follow-up|5|||
157153059|NCT02508701|567305694|FG003|Overall Study|Lost to Follow-up|3|||
157153060|NCT00530712|567305699|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
157153061|NCT00530712|567305699|FG000|30 Day Follow-up Visit|Missed Visit|5|||
157153062|NCT00530712|567305699|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
157153063|NCT00530712|567305699|FG000|6 Month Follow-up Visit|Missed Visit|3|||
157153064|NCT00530712|567305699|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
157153065|NCT00530712|567305699|FG000|6 Month Follow-up Visit|Death|2|||
157153066|NCT00530712|567305699|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
157153067|NCT00530712|567305699|FG000|12 Month Follow-up Visit|Missed Visit|3|||
157153068|NCT00530712|567305699|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
157153069|NCT00530712|567305699|FG000|12 Month Follow-up Visit|Death|9|||
157153070|NCT03242759|567305702|FG000|Overall Study|Adverse Event|5|||
157153071|NCT03242759|567305703|FG001|Overall Study|Adverse Event|1|||
157153072|NCT03242759|567305702|FG000|Overall Study|Withdrawal by Subject|4|||
157153073|NCT03242759|567305703|FG001|Overall Study|Withdrawal by Subject|3|||
156838183|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
157153074|NCT03242759|567305702|FG000|Overall Study|Lost to Follow-up|3|||
157153075|NCT03242759|567305703|FG001|Overall Study|Lost to Follow-up|1|||
157153076|NCT03242759|567305702|FG000|Overall Study|Administrative problems|1|||
157153077|NCT03242759|567305703|FG001|Overall Study|Administrative problems|1|||
157153078|NCT03242759|567305702|FG000|Overall Study|Death|22|||
157153079|NCT03242759|567305703|FG001|Overall Study|Death|0|||
157153080|NCT03242759|567305702|FG000|Overall Study|Change visit schedule|0|||
157153081|NCT03242759|567305703|FG001|Overall Study|Change visit schedule|1|||
157153082|NCT02260193|567305704|FG000|Overall Study|Lack of Efficacy|0|||
157153083|NCT02260193|567305705|FG001|Overall Study|Lack of Efficacy|1|||
157153084|NCT02260193|567305706|FG002|Overall Study|Lack of Efficacy|6|||
157153085|NCT02260193|567305704|FG000|Overall Study|Adverse Event|3|||
157153086|NCT02260193|567305705|FG001|Overall Study|Adverse Event|4|||
157153087|NCT02260193|567305706|FG002|Overall Study|Adverse Event|1|||
157153088|NCT02260193|567305704|FG000|Overall Study|Protocol Violation|0|||
157153089|NCT02260193|567305705|FG001|Overall Study|Protocol Violation|4|||
157153090|NCT02260193|567305706|FG002|Overall Study|Protocol Violation|0|||
157153091|NCT02260193|567305704|FG000|Overall Study|Withdrawal by Subject|3|||
157153092|NCT02260193|567305705|FG001|Overall Study|Withdrawal by Subject|0|||
157153093|NCT02260193|567305706|FG002|Overall Study|Withdrawal by Subject|2|||
157153094|NCT02260193|567305704|FG000|Overall Study|Kidney Transplantation|0|||
157153095|NCT02260193|567305705|FG001|Overall Study|Kidney Transplantation|0|||
157153096|NCT02260193|567305706|FG002|Overall Study|Kidney Transplantation|1|||
157153097|NCT01095250|567305707|FG000|Overall Study|administrative reasons|8|||
157153098|NCT01095250|567305708|FG001|Overall Study|administrative reasons|10|||
157153099|NCT01095250|567305709|FG002|Overall Study|administrative reasons|7|||
157153100|NCT01095250|567305710|FG003|Overall Study|administrative reasons|5|||
157153101|NCT01095250|567305707|FG000|Overall Study|Withdrawal by Subject|0|||
157153102|NCT01095250|567305708|FG001|Overall Study|Withdrawal by Subject|0|||
157153103|NCT01095250|567305709|FG002|Overall Study|Withdrawal by Subject|1|||
157153104|NCT01095250|567305710|FG003|Overall Study|Withdrawal by Subject|0|||
157153105|NCT02518620|567305711|FG000|Overall Study|Adverse Event|23|||
157153106|NCT02518620|567305712|FG001|Overall Study|Adverse Event|11|||
157153107|NCT02518620|567305711|FG000|Overall Study|Lack of Efficacy|2|||
157153108|NCT02518620|567305712|FG001|Overall Study|Lack of Efficacy|0|||
157153109|NCT02518620|567305711|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157153110|NCT02518620|567305712|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157153111|NCT02518620|567305711|FG000|Overall Study|Physician Decision|1|||
157153112|NCT02518620|567305712|FG001|Overall Study|Physician Decision|1|||
157153113|NCT02518620|567305711|FG000|Overall Study|Sponsor's Decision|0|||
157153114|NCT02518620|567305712|FG001|Overall Study|Sponsor's Decision|3|||
157153115|NCT02518620|567305711|FG000|Overall Study|Lost to Follow-up|1|||
157153116|NCT02518620|567305712|FG001|Overall Study|Lost to Follow-up|1|||
157153117|NCT02518620|567305711|FG000|Overall Study|Withdrawal by Subject|17|||
157153118|NCT02518620|567305712|FG001|Overall Study|Withdrawal by Subject|9|||
157153119|NCT02518620|567305711|FG000|Overall Study|Death|1|||
157153120|NCT02518620|567305712|FG001|Overall Study|Death|0|||
157153121|NCT02518620|567305711|FG000|Overall Study|Pregnancy Wish|3|||
157153122|NCT02518620|567305712|FG001|Overall Study|Pregnancy Wish|0|||
157153123|NCT02518620|567305711|FG000|Overall Study|Pregnancy|1|||
157153124|NCT02518620|567305712|FG001|Overall Study|Pregnancy|0|||
157153125|NCT02518620|567305711|FG000|Overall Study|Relocation|2|||
157153126|NCT02518620|567305712|FG001|Overall Study|Relocation|1|||
157153127|NCT04400318|567307419|FG000|Overall Study|Adverse Event|1|||
157153128|NCT04400318|567307420|FG001|Overall Study|Adverse Event|0|||
157153129|NCT04400318|567307419|FG000|Overall Study|Withdrawal by Subject|1|||
157153130|NCT04400318|567307420|FG001|Overall Study|Withdrawal by Subject|1|||
157153131|NCT04400318|567307419|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
156838184|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838185|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
156838186|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838187|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838188|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
156838189|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838190|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838191|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838192|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838193|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
157153132|NCT04400318|567307420|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
156886402|NCT00039871|566343966|FG000|Overall Study|Lost to Follow-up|18|||
157153133|NCT00165646|567307421|FG000|Overall Study|Adverse Event|1|||
157153134|NCT00165646|567307422|FG001|Overall Study|Adverse Event|1|||
157153135|NCT00165646|567307423|FG002|Overall Study|Adverse Event|1|||
157153136|NCT00165646|567307421|FG000|Overall Study|Lack of Efficacy|1|||
157153137|NCT00165646|567307422|FG001|Overall Study|Lack of Efficacy|2|||
157153138|NCT00165646|567307423|FG002|Overall Study|Lack of Efficacy|0|||
157153139|NCT00165646|567307421|FG000|Overall Study|Withdrawal by Subject|0|||
157153140|NCT00165646|567307422|FG001|Overall Study|Withdrawal by Subject|2|||
156838194|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838195|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838196|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
156838197|NCT02914561|566159548|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
156838198|NCT02914561|566159549|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838199|NCT02914561|566159550|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838200|NCT02914561|566159551|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838201|NCT02914561|566159552|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838202|NCT02914561|566159553|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
156838203|NCT02914561|566159554|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838204|NCT02914561|566159555|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838205|NCT02914561|566159556|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838206|NCT02914561|566159557|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
157153141|NCT00165646|567307423|FG002|Overall Study|Withdrawal by Subject|1|||
157153142|NCT00165646|567307421|FG000|Overall Study|Physician Decision|2|||
157153143|NCT00165646|567307422|FG001|Overall Study|Physician Decision|0|||
157153144|NCT00165646|567307423|FG002|Overall Study|Physician Decision|2|||
157153145|NCT00165646|567307421|FG000|Overall Study|Protocol Violation|1|||
156838207|NCT02914561|566159558|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
156838208|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838209|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838210|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838211|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838212|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838213|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
156838214|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
156838215|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
156838216|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
156838217|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
156838218|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
156838219|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838220|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838221|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838222|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838223|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838224|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
156838225|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
156838226|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
156838227|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
156838228|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
156838229|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
156838230|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838231|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838232|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838233|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838234|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838235|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
156838236|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
156838237|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
156838238|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
156838239|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
156838240|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
156838241|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838242|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838243|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838244|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838245|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838246|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838247|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
156838248|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
157153146|NCT00165646|567307422|FG001|Overall Study|Protocol Violation|0|||
157153147|NCT00165646|567307423|FG002|Overall Study|Protocol Violation|0|||
157153148|NCT01790438|567307424|FG000|Overall Study|Adverse Event|3|||
157153149|NCT01790438|567307425|FG001|Overall Study|Adverse Event|2|||
157153150|NCT01790438|567307424|FG000|Overall Study|Death|4|||
157153151|NCT01790438|567307425|FG001|Overall Study|Death|0|||
157153152|NCT01790438|567307424|FG000|Overall Study|Lost to Follow-up|5|||
157153153|NCT01790438|567307425|FG001|Overall Study|Lost to Follow-up|2|||
157153154|NCT01790438|567307424|FG000|Overall Study|Withdrawal by Subject|13|||
157153155|NCT01790438|567307425|FG001|Overall Study|Withdrawal by Subject|2|||
157153156|NCT01790438|567307424|FG000|Overall Study|Physician Decision|3|||
157153157|NCT01790438|567307425|FG001|Overall Study|Physician Decision|1|||
157153158|NCT01790438|567307424|FG000|Overall Study|Sponsor Decision|0|||
157153159|NCT01790438|567307425|FG001|Overall Study|Sponsor Decision|3|||
157153160|NCT01790438|567307424|FG000|Overall Study|Protocol Required Discontinuation|7|||
157153161|NCT01790438|567307425|FG001|Overall Study|Protocol Required Discontinuation|1|||
157153162|NCT02433210|567307428|FG000|Overall Study|Physician Decision|1|||
157153163|NCT02433210|567307429|FG001|Overall Study|Physician Decision|0|||
157153164|NCT02433210|567307430|FG002|Overall Study|Physician Decision|0|||
157153165|NCT01931462|567307431|FG000|Overall Study|Withdrawal by Subject|1|||
157153166|NCT04907539|567307432|FG000|Overall Study|Consent withdrawn|1|||
157153167|NCT04907539|567307433|FG001|Overall Study|Consent withdrawn|0|||
157153168|NCT04907539|567307432|FG000|Overall Study|Death|14|||
157153169|NCT04907539|567307433|FG001|Overall Study|Death|3|||
157153170|NCT01701583|567307434|FG000|Overall Study|Withdrawal by Subject|2|||
157153171|NCT01701583|567307435|FG001|Overall Study|Withdrawal by Subject|0|||
157153172|NCT05070429|567307436|FG000|Overall Study|Death|0|||
157153173|NCT05070429|567307437|FG001|Overall Study|Death|4|||
157153174|NCT05070429|567307436|FG000|Overall Study|Withdrawal by Subject|2|||
157153175|NCT05070429|567307437|FG001|Overall Study|Withdrawal by Subject|1|||
157153176|NCT05070429|567307436|FG000|Overall Study|Other|15|||
157153177|NCT05070429|567307437|FG001|Overall Study|Other|5|||
156838249|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
156838250|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
156838251|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
156838252|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
157023858|NCT04632992|566841147|FG008|Overall Study|Adverse Event|0|||
157023859|NCT04632992|566841148|FG009|Overall Study|Adverse Event|0|||
157023860|NCT04632992|566841149|FG010|Overall Study|Adverse Event|0|||
157023861|NCT04632992|566841150|FG011|Overall Study|Adverse Event|0|||
157023862|NCT04632992|566841151|FG012|Overall Study|Adverse Event|1|||
157023863|NCT04632992|566841152|FG013|Overall Study|Adverse Event|0|||
157023864|NCT04632992|566841139|FG000|Overall Study|Death|17|||
157023865|NCT04632992|566841140|FG001|Overall Study|Death|1|||
157023866|NCT04632992|566841141|FG002|Overall Study|Death|14|||
156838253|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838254|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838255|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838256|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838257|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838258|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
156838259|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
156838260|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
156838261|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
157023867|NCT04632992|566841142|FG003|Overall Study|Death|14|||
157023868|NCT04632992|566841143|FG004|Overall Study|Death|13|||
157023869|NCT04632992|566841144|FG005|Overall Study|Death|6|||
157153178|NCT03041116|567307438|FG000|Double-blind|Death|0|||
157153179|NCT03041116|567307439|FG001|Double-blind|Death|2|||
157153180|NCT03041116|567307438|FG000|Double-blind|Withdrawal by Subject|0|||
157153181|NCT03041116|567307439|FG001|Double-blind|Withdrawal by Subject|4|||
157153182|NCT03041116|567307438|FG000|Open-label|Death|1|||
157153183|NCT03041116|567307439|FG001|Open-label|Death|0|||
157153184|NCT03041116|567307438|FG000|Open-label|Termination of the study by Sponsor|39|||
157153185|NCT03041116|567307439|FG001|Open-label|Termination of the study by Sponsor|37|||
156838262|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
156838263|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838264|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838265|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838266|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838267|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
157023870|NCT04632992|566841145|FG006|Overall Study|Death|7|||
157023871|NCT04632992|566841146|FG007|Overall Study|Death|12|||
157023872|NCT04632992|566841147|FG008|Overall Study|Death|15|||
157153186|NCT03041116|567307438|FG000|Open-label|Withdrawal by Subject|1|||
157153187|NCT03041116|567307439|FG001|Open-label|Withdrawal by Subject|0|||
157153188|NCT01798134|567307440|FG000|Overall Study|Lost to Follow-up|1|||
157153189|NCT01798134|567307440|FG000|Overall Study|Withdrawal by Subject|3|||
157153190|NCT01798134|567307440|FG000|Overall Study|Death|2|||
157153191|NCT01798134|567307440|FG000|Overall Study|Adverse Event|3|||
157023873|NCT04632992|566841148|FG009|Overall Study|Death|20|||
157153192|NCT01798134|567307440|FG000|Overall Study|Physician Decision|3|||
157153193|NCT01798134|567307440|FG000|Overall Study|Liver transplant/surgery|4|||
157153194|NCT02436577|567307441|FG000|Overall Study|Protocol Deviation|0|||
156838268|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838269|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
156838270|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838271|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
156838272|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838273|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
156838274|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838275|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838276|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838277|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838278|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838279|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838280|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838281|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838282|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
156838283|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838284|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
156838285|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838286|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838287|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838288|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838289|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838290|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838291|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
156838292|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838293|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838294|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838295|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
156838296|NCT02914561|566159548|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838297|NCT02914561|566159549|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838298|NCT02914561|566159550|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838299|NCT02914561|566159551|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838300|NCT02914561|566159552|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838301|NCT02914561|566159553|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838302|NCT02914561|566159554|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838303|NCT02914561|566159555|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
156838304|NCT02914561|566159556|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838305|NCT02914561|566159557|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838306|NCT02914561|566159558|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
156838307|NCT03332160|566159559|FG000|Overall Study|Withdrawal by Subject|1|||
156838308|NCT03332160|566159560|FG001|Overall Study|Withdrawal by Subject|1|||
156838309|NCT03332160|566159559|FG000|Overall Study|Adverse Event|0|||
156838310|NCT03332160|566159560|FG001|Overall Study|Adverse Event|1|||
157153195|NCT02436577|567307442|FG001|Overall Study|Protocol Deviation|1|||
157153196|NCT02436577|567307443|FG002|Overall Study|Protocol Deviation|0|||
156838311|NCT03332160|566159559|FG000|Overall Study|Developed Exclusion Criteria|0|||
156838312|NCT03332160|566159560|FG001|Overall Study|Developed Exclusion Criteria|1|||
156838313|NCT03332160|566159559|FG000|Overall Study|Non-adherence to treatment|0|||
156838314|NCT03332160|566159560|FG001|Overall Study|Non-adherence to treatment|2|||
156838315|NCT01561963|566159561|FG000|Overall Study|Adverse Event|1|||
156838316|NCT04598269|566159562|FG000|Overall Study|Adverse Event|0|||
156838317|NCT04598269|566159563|FG001|Overall Study|Adverse Event|3|||
156838318|NCT04598269|566159562|FG000|Overall Study|Withdrawal by Subject|1|||
156838319|NCT04598269|566159563|FG001|Overall Study|Withdrawal by Subject|4|||
156838320|NCT04598269|566159562|FG000|Overall Study|Lost to Follow-up|1|||
156838321|NCT04598269|566159563|FG001|Overall Study|Lost to Follow-up|0|||
156838322|NCT04598269|566159562|FG000|Overall Study|Not Treated|2|||
156838323|NCT04598269|566159563|FG001|Overall Study|Not Treated|0|||
156838324|NCT03040986|566159572|FG000|Overall Study|Hospice|1|||
156838325|NCT03040986|566159573|FG001|Overall Study|Hospice|0|||
156838326|NCT03040986|566159572|FG000|Overall Study|Adverse Event|2|||
156838327|NCT03040986|566159573|FG001|Overall Study|Adverse Event|1|||
156838328|NCT03040986|566159572|FG000|Overall Study|Disease progression on study|3|||
156838329|NCT03040986|566159573|FG001|Overall Study|Disease progression on study|1|||
156838330|NCT02383433|566159574|FG000|Overall Study|Disease progression|2|||
156886403|NCT00039871|566343966|FG000|Overall Study|Protocol Violation|24|||
156886404|NCT00039871|566343966|FG000|Overall Study|Withdrawal by Subject|97|||
157153197|NCT02436577|567307444|FG003|Overall Study|Protocol Deviation|0|||
157153198|NCT02436577|567307445|FG004|Overall Study|Protocol Deviation|0|||
156838331|NCT02477553|566159575|FG000|Overall Study|Screening up-to-date|12|||
156838332|NCT02477553|566159576|FG001|Overall Study|Screening up-to-date|13|||
156838333|NCT02477553|566159575|FG000|Overall Study|No MD visit|1|||
156838334|NCT02477553|566159576|FG001|Overall Study|No MD visit|1|||
156838335|NCT02477553|566159575|FG000|Overall Study|Workup consistent w/CRC|1|||
156838336|NCT02477553|566159576|FG001|Overall Study|Workup consistent w/CRC|1|||
156838337|NCT02477553|566159575|FG000|Overall Study|Technical issues with intervention|2|||
156838338|NCT02477553|566159576|FG001|Overall Study|Technical issues with intervention|0|||
156838339|NCT02477553|566159575|FG000|Overall Study|Elevated risk for CRC|2|||
156838340|NCT02477553|566159576|FG001|Overall Study|Elevated risk for CRC|2|||
156838341|NCT02477553|566159575|FG000|Overall Study|MD advised against screening|1|||
156838342|NCT02477553|566159576|FG001|Overall Study|MD advised against screening|3|||
156838343|NCT02477553|566159575|FG000|Overall Study|patient deceased|1|||
156838344|NCT02477553|566159576|FG001|Overall Study|patient deceased|0|||
156838345|NCT04023682|566159581|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
156838346|NCT00695864|566159589|FG000|Placebo|Withdrawal by Subject|1|||
156838347|NCT00695864|566159589|FG000|Placebo|Physician Decision|4|||
156838348|NCT00772109|566159593|FG000|Overall Study|Serious adverse event|1|||
156838349|NCT00772109|566159594|FG001|Overall Study|Serious adverse event|0|||
156838350|NCT00772109|566159595|FG002|Overall Study|Serious adverse event|1|||
156838351|NCT00772109|566159596|FG003|Overall Study|Serious adverse event|0|||
156838352|NCT00772109|566159593|FG000|Overall Study|Protocol Violation|5|||
156838353|NCT00772109|566159594|FG001|Overall Study|Protocol Violation|8|||
156838354|NCT00772109|566159595|FG002|Overall Study|Protocol Violation|7|||
156838355|NCT00772109|566159596|FG003|Overall Study|Protocol Violation|6|||
156838356|NCT00772109|566159593|FG000|Overall Study|Lost to Follow-up|7|||
156838357|NCT00772109|566159594|FG001|Overall Study|Lost to Follow-up|3|||
156838358|NCT00772109|566159595|FG002|Overall Study|Lost to Follow-up|5|||
156838359|NCT00772109|566159596|FG003|Overall Study|Lost to Follow-up|9|||
156838360|NCT00772109|566159593|FG000|Overall Study|Withdrawal by Subject|8|||
156838361|NCT00772109|566159594|FG001|Overall Study|Withdrawal by Subject|8|||
156838362|NCT00772109|566159595|FG002|Overall Study|Withdrawal by Subject|6|||
156838363|NCT00772109|566159596|FG003|Overall Study|Withdrawal by Subject|16|||
156838364|NCT00752726|566159597|FG000|Overall Study|Lost to Follow-up|2|||
156838365|NCT00752726|566159598|FG001|Overall Study|Lost to Follow-up|1|||
156838366|NCT00752726|566159597|FG000|Overall Study|Adverse Event|3|||
156838367|NCT00752726|566159598|FG001|Overall Study|Adverse Event|0|||
156838368|NCT00752726|566159597|FG000|Overall Study|Withdrawal by Subject|5|||
156838369|NCT00752726|566159598|FG001|Overall Study|Withdrawal by Subject|10|||
156838370|NCT00752726|566159597|FG000|Overall Study|Other Reason|1|||
156838371|NCT00752726|566159598|FG001|Overall Study|Other Reason|2|||
156838372|NCT04232215|566159599|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156838373|NCT04232215|566159600|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156838374|NCT00410605|566159601|FG000|Overall Study|Adverse Event|12|||
156838375|NCT00410605|566159601|FG000|Overall Study|Physician Decision|3|||
156838376|NCT00410605|566159601|FG000|Overall Study|Withdrawal by Subject|5|||
156838377|NCT00410605|566159601|FG000|Overall Study|Started Non-Protocol Therapy|3|||
156838378|NCT00410605|566159601|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
156838379|NCT00410605|566159601|FG000|Overall Study|Transferred to another Institution|1|||
156838380|NCT01887353|566159604|FG000|Overall Study|Study stopped early|4|||
156838381|NCT01887353|566159605|FG001|Overall Study|Study stopped early|3|||
156838382|NCT02039856|566159606|FG000|Overall Study|Death|5|||
156838383|NCT02039856|566159607|FG001|Overall Study|Death|3|||
156838384|NCT02039856|566159606|FG000|Overall Study|Partial survey completion|61|||
156838385|NCT02039856|566159607|FG001|Overall Study|Partial survey completion|26|||
156838386|NCT02039856|566159606|FG000|Overall Study|Lost to Follow-up|388|||
156838387|NCT02039856|566159607|FG001|Overall Study|Lost to Follow-up|206|||
156838388|NCT02039856|566159606|FG000|Overall Study|Withdrawal by Subject|1573|||
156838389|NCT02039856|566159607|FG001|Overall Study|Withdrawal by Subject|618|||
156838390|NCT02666105|566159608|FG000|Overall Study|Death|1|||
156838391|NCT00602420|566161469|FG000|Overall Study|Death|1|||
156886405|NCT00039871|566343966|FG000|Overall Study|Did not meet eligibility criteria|11|||
156886406|NCT00039871|566343966|FG000|Overall Study|Administrative|1|||
156886407|NCT00039871|566343966|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
156838392|NCT00602420|566161470|FG001|Overall Study|Death|4|||
156838393|NCT00602420|566161469|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
156838394|NCT00602420|566161470|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
156838395|NCT00602420|566161469|FG000|Overall Study|Withdrawal by Subject|18|||
156838396|NCT00602420|566161470|FG001|Overall Study|Withdrawal by Subject|17|||
156838397|NCT00602420|566161469|FG000|Overall Study|Adverse Event|1|||
156838398|NCT00602420|566161470|FG001|Overall Study|Adverse Event|0|||
156838399|NCT00649428|566161479|FG000|Overall Study|Adverse Event|2|||
156838400|NCT00649428|566161480|FG001|Overall Study|Adverse Event|2|||
156838401|NCT00649428|566161479|FG000|Overall Study|Withdrawal by Subject|6|||
156838402|NCT00649428|566161480|FG001|Overall Study|Withdrawal by Subject|6|||
156838403|NCT00649428|566161479|FG000|Overall Study|Lost to Follow-up|1|||
156838404|NCT00649428|566161480|FG001|Overall Study|Lost to Follow-up|3|||
156838405|NCT00649428|566161479|FG000|Overall Study|Insufficient manufacturing yield|5|||
156838406|NCT00649428|566161480|FG001|Overall Study|Insufficient manufacturing yield|1|||
156838407|NCT00649428|566161479|FG000|Overall Study|Protocol Violation|6|||
156838408|NCT00649428|566161480|FG001|Overall Study|Protocol Violation|2|||
156838409|NCT00649428|566161479|FG000|Overall Study|Physician Decision|0|||
156838410|NCT00649428|566161480|FG001|Overall Study|Physician Decision|1|||
156838411|NCT02315560|566161481|FG000|Overall Study|noncompliance by subjects|3|||
156838412|NCT02008227|566161482|FG000|Overall Study|Lost to Follow-up|7|||
156838413|NCT02008227|566161483|FG001|Overall Study|Lost to Follow-up|9|||
156838414|NCT02008227|566161482|FG000|Overall Study|Death|494|||
156838415|NCT02008227|566161483|FG001|Overall Study|Death|485|||
156838416|NCT02008227|566161482|FG000|Overall Study|Withdrawal by Subject|67|||
156838417|NCT02008227|566161483|FG001|Overall Study|Withdrawal by Subject|36|||
156838418|NCT02008227|566161482|FG000|Overall Study|Study Terminated By Sponsor|44|||
156838419|NCT02008227|566161483|FG001|Overall Study|Study Terminated By Sponsor|83|||
156838420|NCT04599465|566161484|FG000|Overall Study|Physician Decision|1|||
156838421|NCT04599465|566161484|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
156838422|NCT00742417|566161485|FG000|Randomized|Withdrawal by legal representative|0|||
156838423|NCT00742417|566161486|FG001|Randomized|Withdrawal by legal representative|1|||
156838424|NCT00742417|566161485|FG000|Randomized|Withdrawal by Subject|1|||
156838425|NCT00742417|566161486|FG001|Randomized|Withdrawal by Subject|0|||
156838426|NCT00742417|566161485|FG000|Randomized|Physician Decision|1|||
156838427|NCT00742417|566161486|FG001|Randomized|Physician Decision|0|||
156838428|NCT00742417|566161485|FG000|Intensive Period|Withdrawal by Subject|1|||
156838429|NCT00742417|566161486|FG001|Intensive Period|Withdrawal by Subject|1|||
156838430|NCT00742417|566161485|FG000|Intensive Period|Adverse Event|2|||
156838431|NCT00742417|566161486|FG001|Intensive Period|Adverse Event|0|||
156838432|NCT00965575|566161491|FG000|Overall Study|subject unwillingness to swallow study c|1|||
156838433|NCT00965575|566161492|FG001|Overall Study|subject unwillingness to swallow study c|0|||
156838434|NCT00306527|566161495|FG000|Overall Study|Lost to Follow-up|3|||
156838435|NCT00306527|566161496|FG001|Overall Study|Lost to Follow-up|4|||
156838436|NCT00306527|566161497|FG002|Overall Study|Lost to Follow-up|3|||
156838437|NCT00306527|566161498|FG003|Overall Study|Lost to Follow-up|0|||
156838438|NCT00306527|566161495|FG000|Overall Study|Withdrawal by Subject|2|||
156838439|NCT00306527|566161496|FG001|Overall Study|Withdrawal by Subject|3|||
156886408|NCT00039871|566343966|FG000|Overall Study|Never entered follow-up|7|||
156886409|NCT03361176|566343967|FG000|Overall Study|Lost to Follow-up|1|||
156886410|NCT03361176|566343968|FG001|Overall Study|Lost to Follow-up|2|||
156886411|NCT03361176|566343967|FG000|Overall Study|Adverse Event|0|||
156886412|NCT03361176|566343968|FG001|Overall Study|Adverse Event|2|||
156886413|NCT03361176|566343967|FG000|Overall Study|Withdrawal by Subject|0|||
156886414|NCT03361176|566343968|FG001|Overall Study|Withdrawal by Subject|1|||
156886415|NCT02478398|566343969|FG000|Overall Study|Adverse Event|20|||
156886416|NCT02478398|566343970|FG001|Overall Study|Adverse Event|5|||
156886417|NCT02478398|566343969|FG000|Overall Study|Lost to Follow-up|5|||
157023874|NCT04632992|566841149|FG010|Overall Study|Death|8|||
157023875|NCT04632992|566841150|FG011|Overall Study|Death|2|||
157153199|NCT02436577|567307446|FG005|Overall Study|Protocol Deviation|0|||
157153200|NCT00615290|567307447|FG000|Overall Study|Adverse Event|2|||
156838440|NCT00306527|566161497|FG002|Overall Study|Withdrawal by Subject|0|||
156838441|NCT00306527|566161498|FG003|Overall Study|Withdrawal by Subject|3|||
156886418|NCT02478398|566343970|FG001|Overall Study|Lost to Follow-up|4|||
157023876|NCT04632992|566841151|FG012|Overall Study|Death|10|||
157023877|NCT04632992|566841152|FG013|Overall Study|Death|1|||
157023878|NCT04632992|566841139|FG000|Overall Study|Lost to Follow-up|1|||
157023879|NCT04632992|566841140|FG001|Overall Study|Lost to Follow-up|0|||
157023880|NCT04632992|566841141|FG002|Overall Study|Lost to Follow-up|1|||
157023881|NCT04632992|566841142|FG003|Overall Study|Lost to Follow-up|0|||
157023882|NCT04632992|566841143|FG004|Overall Study|Lost to Follow-up|2|||
157023883|NCT04632992|566841144|FG005|Overall Study|Lost to Follow-up|0|||
157023884|NCT04632992|566841145|FG006|Overall Study|Lost to Follow-up|1|||
157023885|NCT04632992|566841146|FG007|Overall Study|Lost to Follow-up|1|||
157023886|NCT04632992|566841147|FG008|Overall Study|Lost to Follow-up|1|||
157153201|NCT00615290|567307447|FG000|Overall Study|Lost to Follow-up|3|||
156838442|NCT00306527|566161495|FG000|Overall Study|Adverse Event|0|||
156838443|NCT00306527|566161496|FG001|Overall Study|Adverse Event|0|||
156838444|NCT00306527|566161497|FG002|Overall Study|Adverse Event|1|||
156838445|NCT00306527|566161498|FG003|Overall Study|Adverse Event|1|||
156838446|NCT00306527|566161495|FG000|Overall Study|Death|1|||
156838447|NCT00306527|566161496|FG001|Overall Study|Death|0|||
156886419|NCT02478398|566343969|FG000|Overall Study|Non-Compliance With Study Drug|5|||
156886420|NCT02478398|566343970|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157023887|NCT04632992|566841148|FG009|Overall Study|Lost to Follow-up|1|||
157023888|NCT04632992|566841149|FG010|Overall Study|Lost to Follow-up|2|||
157023889|NCT04632992|566841150|FG011|Overall Study|Lost to Follow-up|0|||
157023890|NCT04632992|566841151|FG012|Overall Study|Lost to Follow-up|0|||
157023891|NCT04632992|566841152|FG013|Overall Study|Lost to Follow-up|0|||
157023892|NCT04632992|566841139|FG000|Overall Study|Reason not Specified|2|||
157023893|NCT04632992|566841140|FG001|Overall Study|Reason not Specified|0|||
156838448|NCT00306527|566161497|FG002|Overall Study|Death|1|||
156838449|NCT00306527|566161498|FG003|Overall Study|Death|2|||
156838450|NCT02702180|566161499|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
156838451|NCT02702180|566161500|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
157023894|NCT04632992|566841141|FG002|Overall Study|Reason not Specified|1|||
157023895|NCT04632992|566841142|FG003|Overall Study|Reason not Specified|1|||
157023896|NCT04632992|566841143|FG004|Overall Study|Reason not Specified|0|||
157023897|NCT04632992|566841144|FG005|Overall Study|Reason not Specified|0|||
157023898|NCT04632992|566841145|FG006|Overall Study|Reason not Specified|0|||
157023899|NCT04632992|566841146|FG007|Overall Study|Reason not Specified|0|||
157023900|NCT04632992|566841147|FG008|Overall Study|Reason not Specified|0|||
157023901|NCT04632992|566841148|FG009|Overall Study|Reason not Specified|0|||
157023902|NCT04632992|566841149|FG010|Overall Study|Reason not Specified|1|||
157023903|NCT04632992|566841150|FG011|Overall Study|Reason not Specified|0|||
157023904|NCT04632992|566841151|FG012|Overall Study|Reason not Specified|0|||
157023905|NCT04632992|566841152|FG013|Overall Study|Reason not Specified|0|||
157023906|NCT04632992|566841139|FG000|Overall Study|Physician Decision|0|||
157023907|NCT04632992|566841140|FG001|Overall Study|Physician Decision|0|||
157023908|NCT04632992|566841141|FG002|Overall Study|Physician Decision|0|||
157023909|NCT04632992|566841142|FG003|Overall Study|Physician Decision|2|||
157023910|NCT04632992|566841143|FG004|Overall Study|Physician Decision|1|||
157023911|NCT04632992|566841144|FG005|Overall Study|Physician Decision|0|||
157023912|NCT04632992|566841145|FG006|Overall Study|Physician Decision|0|||
157023913|NCT04632992|566841146|FG007|Overall Study|Physician Decision|0|||
157023914|NCT04632992|566841147|FG008|Overall Study|Physician Decision|0|||
157023915|NCT04632992|566841148|FG009|Overall Study|Physician Decision|0|||
157023916|NCT04632992|566841149|FG010|Overall Study|Physician Decision|0|||
157023917|NCT04632992|566841150|FG011|Overall Study|Physician Decision|0|||
157023918|NCT04632992|566841151|FG012|Overall Study|Physician Decision|3|||
157023919|NCT04632992|566841152|FG013|Overall Study|Physician Decision|0|||
157023920|NCT04632992|566841139|FG000|Overall Study|Progressive Disease|0|||
157023921|NCT04632992|566841140|FG001|Overall Study|Progressive Disease|0|||
157023922|NCT04632992|566841141|FG002|Overall Study|Progressive Disease|0|||
157023923|NCT04632992|566841142|FG003|Overall Study|Progressive Disease|0|||
157023924|NCT04632992|566841143|FG004|Overall Study|Progressive Disease|1|||
157023925|NCT04632992|566841144|FG005|Overall Study|Progressive Disease|0|||
157023926|NCT04632992|566841145|FG006|Overall Study|Progressive Disease|0|||
157023927|NCT04632992|566841146|FG007|Overall Study|Progressive Disease|0|||
157023928|NCT04632992|566841147|FG008|Overall Study|Progressive Disease|0|||
157023929|NCT04632992|566841148|FG009|Overall Study|Progressive Disease|1|||
157023930|NCT04632992|566841149|FG010|Overall Study|Progressive Disease|1|||
157153202|NCT00615290|567307447|FG000|Overall Study|Withdrawal by Subject|1|||
157153203|NCT00615290|567307447|FG000|Overall Study|Other|2|||
157153204|NCT02531373|567307450|FG000|Overall Study|Lack of Efficacy|0|||
157153205|NCT02531373|567307451|FG001|Overall Study|Lack of Efficacy|0|||
157153206|NCT02531373|567307452|FG002|Overall Study|Lack of Efficacy|0|||
157153207|NCT02531373|567307453|FG003|Overall Study|Lack of Efficacy|0|||
157153208|NCT02531373|567307454|FG004|Overall Study|Lack of Efficacy|3|||
157153209|NCT02531373|567307455|FG005|Overall Study|Lack of Efficacy|2|||
157153210|NCT02531373|567307456|FG006|Overall Study|Lack of Efficacy|4|||
157153211|NCT02531373|567307457|FG007|Overall Study|Lack of Efficacy|8|||
157153212|NCT02531373|567307458|FG008|Overall Study|Lack of Efficacy|5|||
157153213|NCT02531373|567307450|FG000|Overall Study|Lost to Follow-up|0|||
157153214|NCT02531373|567307451|FG001|Overall Study|Lost to Follow-up|0|||
157153215|NCT02531373|567307452|FG002|Overall Study|Lost to Follow-up|0|||
157153216|NCT02531373|567307453|FG003|Overall Study|Lost to Follow-up|0|||
157153217|NCT02531373|567307454|FG004|Overall Study|Lost to Follow-up|0|||
157153218|NCT02531373|567307455|FG005|Overall Study|Lost to Follow-up|2|||
157153219|NCT02531373|567307456|FG006|Overall Study|Lost to Follow-up|2|||
157153220|NCT02531373|567307457|FG007|Overall Study|Lost to Follow-up|0|||
157153221|NCT02531373|567307458|FG008|Overall Study|Lost to Follow-up|0|||
156838452|NCT02702180|566161501|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
156838453|NCT02702180|566161499|FG000|Double-blind Treatment Period|Adverse Event|0|||
157023931|NCT04632992|566841150|FG011|Overall Study|Progressive Disease|0|||
157023932|NCT04632992|566841151|FG012|Overall Study|Progressive Disease|2|||
157023933|NCT04632992|566841152|FG013|Overall Study|Progressive Disease|0|||
157023934|NCT04632992|566841139|FG000|Overall Study|Withdrawal by Subject|4|||
157023935|NCT04632992|566841140|FG001|Overall Study|Withdrawal by Subject|1|||
157153222|NCT02531373|567307450|FG000|Overall Study|Physician Decision|0|||
156838454|NCT02702180|566161500|FG001|Double-blind Treatment Period|Adverse Event|0|||
156838455|NCT02702180|566161501|FG002|Double-blind Treatment Period|Adverse Event|1|||
157023936|NCT04632992|566841141|FG002|Overall Study|Withdrawal by Subject|5|||
157023937|NCT04632992|566841142|FG003|Overall Study|Withdrawal by Subject|4|||
157023938|NCT04632992|566841143|FG004|Overall Study|Withdrawal by Subject|3|||
157023939|NCT04632992|566841144|FG005|Overall Study|Withdrawal by Subject|3|||
157023940|NCT04632992|566841145|FG006|Overall Study|Withdrawal by Subject|0|||
157023941|NCT04632992|566841146|FG007|Overall Study|Withdrawal by Subject|5|||
157153223|NCT02531373|567307451|FG001|Overall Study|Physician Decision|0|||
157153224|NCT02531373|567307452|FG002|Overall Study|Physician Decision|0|||
157153225|NCT02531373|567307453|FG003|Overall Study|Physician Decision|0|||
157153226|NCT02531373|567307454|FG004|Overall Study|Physician Decision|2|||
157153227|NCT02531373|567307455|FG005|Overall Study|Physician Decision|1|||
157153228|NCT02531373|567307456|FG006|Overall Study|Physician Decision|0|||
157153229|NCT02531373|567307457|FG007|Overall Study|Physician Decision|0|||
157153230|NCT02531373|567307458|FG008|Overall Study|Physician Decision|0|||
157153231|NCT02531373|567307450|FG000|Overall Study|Protocol Violation|0|||
157153232|NCT02531373|567307451|FG001|Overall Study|Protocol Violation|0|||
157153233|NCT02531373|567307452|FG002|Overall Study|Protocol Violation|0|||
157153234|NCT02531373|567307453|FG003|Overall Study|Protocol Violation|0|||
157153235|NCT02531373|567307454|FG004|Overall Study|Protocol Violation|0|||
157153236|NCT02531373|567307455|FG005|Overall Study|Protocol Violation|1|||
157153237|NCT02531373|567307456|FG006|Overall Study|Protocol Violation|1|||
157153238|NCT02531373|567307457|FG007|Overall Study|Protocol Violation|0|||
157153239|NCT02531373|567307458|FG008|Overall Study|Protocol Violation|1|||
156886421|NCT02478398|566343969|FG000|Overall Study|Protocol Violation|3|||
156886422|NCT02478398|566343970|FG001|Overall Study|Protocol Violation|1|||
156886423|NCT02478398|566343969|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
156886424|NCT02478398|566343970|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156886425|NCT02478398|566343969|FG000|Overall Study|Withdrawal By Participant|10|||
156886426|NCT02478398|566343970|FG001|Overall Study|Withdrawal By Participant|4|||
157153240|NCT02531373|567307450|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157153241|NCT02531373|567307451|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157153242|NCT02531373|567307452|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157153243|NCT02531373|567307453|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
157153244|NCT02531373|567307454|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
157153245|NCT02531373|567307455|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
157153246|NCT02531373|567307456|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
157153247|NCT02531373|567307457|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
156886427|NCT01205581|566343974|FG000|Overall Study|Withdrawal by Subject|1|||
156886428|NCT01205581|566343975|FG001|Overall Study|Withdrawal by Subject|0|||
156886429|NCT01205581|566343976|FG002|Overall Study|Withdrawal by Subject|0|||
156886430|NCT01205581|566343977|FG003|Overall Study|Withdrawal by Subject|0|||
156886431|NCT01205581|566343978|FG004|Overall Study|Withdrawal by Subject|0|||
156886432|NCT01205581|566343979|FG005|Overall Study|Withdrawal by Subject|0|||
156886433|NCT02160002|566343980|FG000|Overall Study|Withdrawal by Subject|2|||
156886434|NCT02160002|566343981|FG001|Overall Study|Withdrawal by Subject|1|||
156886435|NCT00704522|566343982|FG000|Overall Study|Lack of Efficacy|65|||
156886436|NCT00704522|566343983|FG001|Overall Study|Lack of Efficacy|17|||
156886437|NCT00704522|566343982|FG000|Overall Study|Failure to appear again at hospital|56|||
156886438|NCT00704522|566343983|FG001|Overall Study|Failure to appear again at hospital|10|||
156886439|NCT00704522|566343982|FG000|Overall Study|Withdrawal by Subject|17|||
156886440|NCT00704522|566343983|FG001|Overall Study|Withdrawal by Subject|8|||
156886441|NCT00704522|566343982|FG000|Overall Study|Adverse Event|9|||
156886442|NCT00704522|566343983|FG001|Overall Study|Adverse Event|1|||
156886443|NCT00704522|566343982|FG000|Overall Study|Undefined causes|9|||
156886444|NCT00704522|566343983|FG001|Overall Study|Undefined causes|7|||
156886445|NCT00704522|566343982|FG000|Overall Study|No information on therapy end|27|||
156886446|NCT00704522|566343983|FG001|Overall Study|No information on therapy end|2|||
156886447|NCT04896229|566343985|FG000|Overall Study|Lost to Follow-up|113|||
156886448|NCT04896229|566343986|FG001|Overall Study|Lost to Follow-up|113|||
156886449|NCT04395001|566343987|FG000|Overall Study|Lost to Follow-up|8|||
156886450|NCT04395001|566343988|FG001|Overall Study|Lost to Follow-up|9|||
156886451|NCT04395001|566343989|FG002|Overall Study|Lost to Follow-up|5|||
156886452|NCT04395001|566343987|FG000|Overall Study|Withdrawal by Subject|3|||
156886453|NCT04395001|566343988|FG001|Overall Study|Withdrawal by Subject|1|||
156886454|NCT04395001|566343989|FG002|Overall Study|Withdrawal by Subject|3|||
156886455|NCT04395001|566343987|FG000|Overall Study|missed appointment|7|||
156886456|NCT04395001|566343988|FG001|Overall Study|missed appointment|4|||
156886457|NCT04395001|566343989|FG002|Overall Study|missed appointment|1|||
157153248|NCT02531373|567307458|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
157153249|NCT02531373|567307450|FG000|Overall Study|Withdrawal by Subject|0|||
156886458|NCT04418661|566343990|FG000|Overall Study|Adverse Event|0|||
156886459|NCT04418661|566343991|FG001|Overall Study|Adverse Event|1|||
156886460|NCT04418661|566343992|FG002|Overall Study|Adverse Event|5|||
157153250|NCT02531373|567307451|FG001|Overall Study|Withdrawal by Subject|0|||
157153251|NCT02531373|567307452|FG002|Overall Study|Withdrawal by Subject|0|||
157153252|NCT02531373|567307453|FG003|Overall Study|Withdrawal by Subject|0|||
156886461|NCT04418661|566343993|FG003|Overall Study|Adverse Event|3|||
156886462|NCT04418661|566343994|FG004|Overall Study|Adverse Event|0|||
156886463|NCT04418661|566343995|FG005|Overall Study|Adverse Event|2|||
156886464|NCT04418661|566343990|FG000|Overall Study|Progressive disease|4|||
156886465|NCT04418661|566343991|FG001|Overall Study|Progressive disease|11|||
156886466|NCT04418661|566343992|FG002|Overall Study|Progressive disease|6|||
156886467|NCT04418661|566343993|FG003|Overall Study|Progressive disease|11|||
156886468|NCT04418661|566343994|FG004|Overall Study|Progressive disease|1|||
157153253|NCT02531373|567307454|FG004|Overall Study|Withdrawal by Subject|3|||
156886469|NCT04418661|566343995|FG005|Overall Study|Progressive disease|12|||
156886470|NCT04418661|566343990|FG000|Overall Study|Withdrawal by Subject|0|||
156886471|NCT04418661|566343991|FG001|Overall Study|Withdrawal by Subject|1|||
156886472|NCT04418661|566343992|FG002|Overall Study|Withdrawal by Subject|0|||
156886473|NCT04418661|566343993|FG003|Overall Study|Withdrawal by Subject|1|||
156886474|NCT04418661|566343994|FG004|Overall Study|Withdrawal by Subject|0|||
156886475|NCT04418661|566343995|FG005|Overall Study|Withdrawal by Subject|0|||
156886476|NCT04418661|566343990|FG000|Overall Study|Other|0|||
156886477|NCT04418661|566343991|FG001|Overall Study|Other|0|||
156886478|NCT04418661|566343992|FG002|Overall Study|Other|1|||
156886479|NCT04418661|566343993|FG003|Overall Study|Other|3|||
156886480|NCT04418661|566343994|FG004|Overall Study|Other|0|||
156886481|NCT04418661|566343995|FG005|Overall Study|Other|1|||
156886482|NCT00045942|566343997|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
156886483|NCT00045942|566343998|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886484|NCT00045942|566343999|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886485|NCT00045942|566344000|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886486|NCT00045942|566344001|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886487|NCT00045942|566344002|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886488|NCT00045942|566344003|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886489|NCT00045942|566344004|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886490|NCT00045942|566344005|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
156886491|NCT00045942|566343997|FG000|PKC412A2104 (Core)|Adverse Event|5|||
156886492|NCT00045942|566343998|FG001|PKC412A2104 (Core)|Adverse Event|0|||
156886493|NCT00045942|566343999|FG002|PKC412A2104 (Core)|Adverse Event|0|||
156886494|NCT00045942|566344000|FG003|PKC412A2104 (Core)|Adverse Event|0|||
156886495|NCT00045942|566344001|FG004|PKC412A2104 (Core)|Adverse Event|0|||
156886496|NCT00045942|566344002|FG005|PKC412A2104 (Core)|Adverse Event|0|||
156886497|NCT00045942|566344003|FG006|PKC412A2104 (Core)|Adverse Event|0|||
156886498|NCT00045942|566344004|FG007|PKC412A2104 (Core)|Adverse Event|0|||
156886499|NCT00045942|566344005|FG008|PKC412A2104 (Core)|Adverse Event|0|||
156886500|NCT00045942|566343997|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
156886501|NCT00045942|566343998|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
157153254|NCT02531373|567307455|FG005|Overall Study|Withdrawal by Subject|0|||
157153255|NCT02531373|567307456|FG006|Overall Study|Withdrawal by Subject|0|||
157153256|NCT02531373|567307457|FG007|Overall Study|Withdrawal by Subject|0|||
157153257|NCT02531373|567307458|FG008|Overall Study|Withdrawal by Subject|0|||
157153258|NCT01623531|567307459|FG000|Overall Study|Death|1|||
157153259|NCT01623531|567307460|FG001|Overall Study|Death|0|||
157153260|NCT01623531|567307459|FG000|Overall Study|Protocol Violation|2|||
157153261|NCT01623531|567307460|FG001|Overall Study|Protocol Violation|1|||
157153262|NCT01623531|567307459|FG000|Overall Study|Missing data at primary outcome time poi|1|||
157153263|NCT01623531|567307460|FG001|Overall Study|Missing data at primary outcome time poi|1|||
157153264|NCT02834403|567307465|FG000|Overall Study|Physician Decision|2|||
157153265|NCT02834403|567307466|FG001|Overall Study|Physician Decision|1|||
157153266|NCT02834403|567307467|FG002|Overall Study|Physician Decision|2|||
157153267|NCT02834403|567307468|FG003|Overall Study|Physician Decision|1|||
157153268|NCT02834403|567307469|FG004|Overall Study|Physician Decision|1|||
157153269|NCT02834403|567307470|FG005|Overall Study|Physician Decision|2|||
157153270|NCT02834403|567307471|FG006|Overall Study|Physician Decision|12|||
157153271|NCT02834403|567307465|FG000|Overall Study|Adverse Event|0|||
157153272|NCT02834403|567307466|FG001|Overall Study|Adverse Event|0|||
157153273|NCT02834403|567307467|FG002|Overall Study|Adverse Event|0|||
157153274|NCT02834403|567307468|FG003|Overall Study|Adverse Event|0|||
157153275|NCT02834403|567307469|FG004|Overall Study|Adverse Event|1|||
157153276|NCT02834403|567307470|FG005|Overall Study|Adverse Event|1|||
157153277|NCT02834403|567307471|FG006|Overall Study|Adverse Event|3|||
156886502|NCT00045942|566343999|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886503|NCT00045942|566344000|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886504|NCT00045942|566344001|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886505|NCT00045942|566344002|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886506|NCT00045942|566344003|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886507|NCT00045942|566344004|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886508|NCT00045942|566344005|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
156886509|NCT00045942|566343997|FG000|PKC412A2104 (Core)|Death|1|||
156886510|NCT00045942|566343998|FG001|PKC412A2104 (Core)|Death|0|||
156886511|NCT00045942|566343999|FG002|PKC412A2104 (Core)|Death|0|||
156886512|NCT00045942|566344000|FG003|PKC412A2104 (Core)|Death|0|||
156886513|NCT00045942|566344001|FG004|PKC412A2104 (Core)|Death|0|||
156886514|NCT00045942|566344002|FG005|PKC412A2104 (Core)|Death|0|||
156886515|NCT00045942|566344003|FG006|PKC412A2104 (Core)|Death|0|||
156886516|NCT00045942|566344004|FG007|PKC412A2104 (Core)|Death|0|||
156886517|NCT00045942|566344005|FG008|PKC412A2104 (Core)|Death|0|||
156886518|NCT00045942|566343997|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
156886519|NCT00045942|566343998|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
156886520|NCT00045942|566343999|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
157153278|NCT02834403|567307465|FG000|Overall Study|Withdrawal by Subject|0|||
157153279|NCT02834403|567307466|FG001|Overall Study|Withdrawal by Subject|1|||
157153280|NCT02834403|567307467|FG002|Overall Study|Withdrawal by Subject|0|||
156838456|NCT02702180|566161499|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
156838457|NCT02702180|566161500|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
156838458|NCT02702180|566161501|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
156838459|NCT02702180|566161499|FG000|Double-blind Treatment Period|Protocol Violation|0|||
156838460|NCT02702180|566161500|FG001|Double-blind Treatment Period|Protocol Violation|0|||
156838461|NCT02702180|566161501|FG002|Double-blind Treatment Period|Protocol Violation|2|||
156838462|NCT02702180|566161499|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
156838463|NCT02702180|566161500|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
156838464|NCT02702180|566161501|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
156838465|NCT02702180|566161499|FG000|Open-label Treatment Period|Withdrawn in error|0|||
157153281|NCT02834403|567307468|FG003|Overall Study|Withdrawal by Subject|0|||
157153282|NCT02834403|567307469|FG004|Overall Study|Withdrawal by Subject|1|||
157153283|NCT02834403|567307470|FG005|Overall Study|Withdrawal by Subject|0|||
157153284|NCT02834403|567307471|FG006|Overall Study|Withdrawal by Subject|0|||
157153285|NCT02834403|567307465|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
157153286|NCT02834403|567307466|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
157153287|NCT02834403|567307467|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
157153288|NCT02834403|567307468|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
157153289|NCT02834403|567307469|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
157153290|NCT02834403|567307470|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
157153291|NCT02834403|567307471|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
157153292|NCT04705597|567307472|FG000|Overall Study|Death|16|||
157153293|NCT04705597|567307473|FG001|Overall Study|Death|9|||
157153294|NCT04705597|567307472|FG000|Overall Study|Lost to Follow-up|1|||
157153295|NCT04705597|567307473|FG001|Overall Study|Lost to Follow-up|0|||
156838466|NCT02702180|566161500|FG001|Open-label Treatment Period|Withdrawn in error|0|||
156838467|NCT02702180|566161501|FG002|Open-label Treatment Period|Withdrawn in error|1|||
156838468|NCT02352753|566161502|FG000|6-Month Dosing Period|Decision by sponsor|2|||
156838469|NCT02352753|566161502|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
156838470|NCT02352753|566161502|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
156838471|NCT02352753|566161502|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
156838472|NCT02352753|566161502|FG000|3-Month Dosing Period|Decision by sponsor|14|||
156838473|NCT02352753|566161502|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
156838474|NCT00539305|566161503|FG000|Overall Study|Adverse Event|1|||
156838475|NCT00539305|566161504|FG001|Overall Study|Adverse Event|0|||
157153296|NCT04705597|567307472|FG000|Overall Study|Withdrawal by Subject|1|||
157153297|NCT04705597|567307473|FG001|Overall Study|Withdrawal by Subject|2|||
157153298|NCT00390780|567307474|FG000|Overall Study|Not completed|10|||
157153299|NCT00390780|567307475|FG001|Overall Study|Not completed|4|||
157153300|NCT00390780|567307474|FG000|Overall Study|Protocol Violation|6|||
157153301|NCT00390780|567307475|FG001|Overall Study|Protocol Violation|4|||
157153302|NCT00390780|567307474|FG000|Overall Study|Lost to Follow-up|3|||
157153303|NCT00390780|567307475|FG001|Overall Study|Lost to Follow-up|6|||
157153304|NCT00390780|567307474|FG000|Overall Study|Adverse Event|2|||
157153305|NCT00390780|567307475|FG001|Overall Study|Adverse Event|3|||
157153306|NCT00390780|567307474|FG000|Overall Study|Death|1|||
157153307|NCT00390780|567307475|FG001|Overall Study|Death|3|||
157153308|NCT00390780|567307474|FG000|Overall Study|Withdrawal by Subject|1|||
157153309|NCT00390780|567307475|FG001|Overall Study|Withdrawal by Subject|2|||
157153310|NCT00390780|567307474|FG000|Overall Study|Inclusion criteria not satisfied|0|||
157153311|NCT00390780|567307475|FG001|Overall Study|Inclusion criteria not satisfied|2|||
157153312|NCT00390780|567307474|FG000|Overall Study|Lost to follow up and other reasons|0|||
157153313|NCT00390780|567307475|FG001|Overall Study|Lost to follow up and other reasons|1|||
157153314|NCT00390780|567307474|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
157153315|NCT00390780|567307475|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
157153316|NCT00390780|567307474|FG000|Overall Study|SAE, death|0|||
157153317|NCT00390780|567307475|FG001|Overall Study|SAE, death|1|||
157153318|NCT01585961|567307476|FG000|Overall Study|Death|6|||
157153319|NCT01585961|567307476|FG000|Overall Study|Physician Decision|1|||
157153320|NCT01585961|567307476|FG000|Overall Study|Decision to use non-study catheter|1|||
157153321|NCT01585961|567307476|FG000|Overall Study|Withdrawal by Subject|1|||
157153322|NCT01585961|567307476|FG000|Overall Study|Lost to Follow-up|23|||
157153323|NCT01585961|567307476|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
157153324|NCT01258348|567307477|FG000|Overall Study|Adverse Event|1|||
157153325|NCT01258348|567307478|FG001|Overall Study|Adverse Event|1|||
156838476|NCT00539305|566161503|FG000|Overall Study|Substance Use|0|||
156838477|NCT00539305|566161504|FG001|Overall Study|Substance Use|1|||
156838478|NCT00539305|566161503|FG000|Overall Study|Withdrawal by Subject|0|||
156838479|NCT00539305|566161504|FG001|Overall Study|Withdrawal by Subject|1|||
156838480|NCT00679172|566161508|FG000|Overall Study|Non-compliance|1|||
156838481|NCT00679172|566161509|FG001|Overall Study|Non-compliance|1|||
157153326|NCT01258348|567307479|FG002|Overall Study|Adverse Event|3|||
157153327|NCT01258348|567307480|FG003|Overall Study|Adverse Event|2|||
157153328|NCT01258348|567307481|FG004|Overall Study|Adverse Event|4|||
156838482|NCT00679172|566161510|FG002|Overall Study|Non-compliance|0|||
156838483|NCT00679172|566161511|FG003|Overall Study|Non-compliance|1|||
156838484|NCT00679172|566161512|FG004|Overall Study|Non-compliance|0|||
156838485|NCT00679172|566161508|FG000|Overall Study|Other not specified|0|||
156838486|NCT00679172|566161509|FG001|Overall Study|Other not specified|0|||
156838487|NCT00679172|566161510|FG002|Overall Study|Other not specified|1|||
156838488|NCT00679172|566161511|FG003|Overall Study|Other not specified|0|||
156838489|NCT00679172|566161512|FG004|Overall Study|Other not specified|0|||
156838490|NCT00417963|566161513|FG000|Overall Study|Lost to Follow-up|3|||
156838491|NCT00417963|566161513|FG000|Overall Study|Withdrawal by Subject|18|||
156838492|NCT00417963|566161513|FG000|Overall Study|Death|17|||
156838493|NCT00417963|566161513|FG000|Overall Study|Study device could not be deployed|3|||
156838494|NCT00704288|566161516|FG000|Overall Treatment Period|Adverse Event|11|||
156838495|NCT00704288|566161517|FG001|Overall Treatment Period|Adverse Event|8|||
156838496|NCT00704288|566161518|FG002|Overall Treatment Period|Adverse Event|22|||
156838497|NCT00704288|566161516|FG000|Overall Treatment Period|Death|0|||
156838498|NCT00704288|566161517|FG001|Overall Treatment Period|Death|0|||
156838499|NCT00704288|566161518|FG002|Overall Treatment Period|Death|1|||
156838500|NCT00704288|566161516|FG000|Overall Treatment Period|Physician Decision|0|||
156838501|NCT00704288|566161517|FG001|Overall Treatment Period|Physician Decision|2|||
156838502|NCT00704288|566161518|FG002|Overall Treatment Period|Physician Decision|0|||
156838503|NCT00704288|566161516|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
156838504|NCT00704288|566161517|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
156838505|NCT00704288|566161518|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
156838506|NCT00704288|566161516|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
156838507|NCT00704288|566161517|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
156838508|NCT00704288|566161518|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
156838509|NCT00704288|566161516|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
156838510|NCT00704288|566161517|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
156838511|NCT00704288|566161518|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
156838512|NCT00704288|566161516|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
156838513|NCT00704288|566161517|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
156838514|NCT00704288|566161518|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
156838515|NCT00704288|566161516|FG000|Overall Treatment Period|Roll-over to another study|1|||
156838516|NCT00704288|566161517|FG001|Overall Treatment Period|Roll-over to another study|0|||
156838517|NCT00704288|566161518|FG002|Overall Treatment Period|Roll-over to another study|4|||
156838518|NCT00704288|566161516|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
156838519|NCT00704288|566161517|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
156838520|NCT00704288|566161518|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
156838521|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Death|41|||
156838522|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Death|50|||
156838523|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Death|93|||
156838524|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
156838525|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
156838526|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
156838527|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
156838528|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
156838529|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
156838530|NCT00704288|566161516|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
156838531|NCT00704288|566161517|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
156838532|NCT00704288|566161518|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
156838533|NCT01055314|566161519|FG000|Overall Study|Adverse Event|7|||
156838534|NCT01055314|566161520|FG001|Overall Study|Adverse Event|4|||
156838535|NCT01055314|566161519|FG000|Overall Study|Death|2|||
156838536|NCT01055314|566161520|FG001|Overall Study|Death|1|||
156838537|NCT01055314|566161519|FG000|Overall Study|Lack of Efficacy|11|||
157023942|NCT04632992|566841147|FG008|Overall Study|Withdrawal by Subject|0|||
156838538|NCT01055314|566161520|FG001|Overall Study|Lack of Efficacy|19|||
156838539|NCT01055314|566161519|FG000|Overall Study|Physician Decision|10|||
156838540|NCT01055314|566161520|FG001|Overall Study|Physician Decision|5|||
156838541|NCT01055314|566161519|FG000|Overall Study|Withdrawal by Subject|1|||
157023943|NCT04632992|566841148|FG009|Overall Study|Withdrawal by Subject|2|||
157023944|NCT04632992|566841149|FG010|Overall Study|Withdrawal by Subject|8|||
157023945|NCT04632992|566841150|FG011|Overall Study|Withdrawal by Subject|0|||
157023946|NCT04632992|566841151|FG012|Overall Study|Withdrawal by Subject|1|||
156838542|NCT01055314|566161520|FG001|Overall Study|Withdrawal by Subject|0|||
156838543|NCT01055314|566161519|FG000|Overall Study|Ineligible|3|||
156838544|NCT01055314|566161520|FG001|Overall Study|Ineligible|5|||
156838545|NCT01055314|566161519|FG000|Overall Study|Refusal of further protocol therapy|10|||
156838546|NCT01055314|566161520|FG001|Overall Study|Refusal of further protocol therapy|4|||
156838547|NCT01055314|566161519|FG000|Overall Study|No treatment|1|||
156838548|NCT01055314|566161520|FG001|Overall Study|No treatment|0|||
156838549|NCT00434642|566161521|FG000|Blinded Treatment Phase|Adverse Event|12|||
156838550|NCT00434642|566161522|FG001|Blinded Treatment Phase|Adverse Event|58|||
156838551|NCT00434642|566161521|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
156838552|NCT00434642|566161522|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
156838553|NCT00434642|566161521|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
157153329|NCT01258348|567307477|FG000|Overall Study|Progressive Disease|0|||
157153330|NCT01258348|567307478|FG001|Overall Study|Progressive Disease|3|||
157153331|NCT01258348|567307479|FG002|Overall Study|Progressive Disease|0|||
157153332|NCT01258348|567307480|FG003|Overall Study|Progressive Disease|2|||
157153333|NCT01258348|567307481|FG004|Overall Study|Progressive Disease|2|||
157153334|NCT01258348|567307477|FG000|Overall Study|Physician Decision|0|||
157153335|NCT01258348|567307478|FG001|Overall Study|Physician Decision|0|||
157153336|NCT01258348|567307479|FG002|Overall Study|Physician Decision|0|||
157153337|NCT01258348|567307480|FG003|Overall Study|Physician Decision|2|||
157153338|NCT01258348|567307481|FG004|Overall Study|Physician Decision|0|||
157153339|NCT01258348|567307477|FG000|Overall Study|Withdrawal by Subject|0|||
157153340|NCT01258348|567307478|FG001|Overall Study|Withdrawal by Subject|1|||
157153341|NCT01258348|567307479|FG002|Overall Study|Withdrawal by Subject|0|||
157153342|NCT01258348|567307480|FG003|Overall Study|Withdrawal by Subject|0|||
157153343|NCT01258348|567307481|FG004|Overall Study|Withdrawal by Subject|0|||
157153344|NCT00305006|567307482|FG000|Overall Study|Withdrawal by Subject|1|||
157153345|NCT00305006|567307483|FG001|Overall Study|Withdrawal by Subject|0|||
157153346|NCT00305006|567307482|FG000|Overall Study|Failure to complete pretest|0|||
157153347|NCT00305006|567307483|FG001|Overall Study|Failure to complete pretest|1|||
157153348|NCT02606045|567307484|FG000|Overall Study|Study closed before treament could begin|1|||
157153349|NCT02606045|567307485|FG001|Overall Study|Study closed before treament could begin|2|||
157153350|NCT01996319|567307486|FG000|Overall Study|Protocol Violation|1|||
157153351|NCT01996319|567307487|FG001|Overall Study|Protocol Violation|0|||
157153352|NCT01996319|567307486|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
157153353|NCT01996319|567307487|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
157153354|NCT01996319|567307486|FG000|Overall Study|Adverse Event|2|||
157153355|NCT01996319|567307487|FG001|Overall Study|Adverse Event|2|||
157153356|NCT01671085|567307489|FG000|Overall Study|Withdrawal by Subject|1|||
157153357|NCT01671085|567307490|FG001|Overall Study|Withdrawal by Subject|0|||
157153358|NCT00637273|567307491|FG000|Overall Study|Adverse Event|11|||
157153359|NCT00637273|567307492|FG001|Overall Study|Adverse Event|5|||
157153360|NCT00637273|567307493|FG002|Overall Study|Adverse Event|7|||
157153361|NCT00637273|567307491|FG000|Overall Study|Lost to Follow-up|8|||
157153362|NCT00637273|567307492|FG001|Overall Study|Lost to Follow-up|9|||
157153363|NCT00637273|567307493|FG002|Overall Study|Lost to Follow-up|13|||
157153364|NCT00637273|567307491|FG000|Overall Study|Protocol Violation|2|||
157153365|NCT00637273|567307492|FG001|Overall Study|Protocol Violation|4|||
157153366|NCT00637273|567307493|FG002|Overall Study|Protocol Violation|1|||
157153367|NCT00637273|567307491|FG000|Overall Study|Withdrawal of Consent|18|||
157153368|NCT00637273|567307492|FG001|Overall Study|Withdrawal of Consent|6|||
157153369|NCT00637273|567307493|FG002|Overall Study|Withdrawal of Consent|18|||
157153370|NCT00637273|567307491|FG000|Overall Study|Investigator Decision|1|||
157153371|NCT00637273|567307492|FG001|Overall Study|Investigator Decision|3|||
157153372|NCT00637273|567307493|FG002|Overall Study|Investigator Decision|1|||
157153373|NCT00637273|567307491|FG000|Overall Study|Administrative|2|||
157153374|NCT00637273|567307492|FG001|Overall Study|Administrative|0|||
157153375|NCT00637273|567307493|FG002|Overall Study|Administrative|0|||
157153376|NCT00637273|567307491|FG000|Overall Study|Loss of Glucose Control|1|||
157153377|NCT00637273|567307492|FG001|Overall Study|Loss of Glucose Control|1|||
157153378|NCT00637273|567307493|FG002|Overall Study|Loss of Glucose Control|1|||
157153379|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
157153380|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
157153381|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
157153382|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
156838554|NCT00434642|566161522|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
157153383|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
157153384|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
157153385|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
157153386|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
157153387|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
157153388|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
157153389|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
157153390|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
157153391|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
157224679|NCT03504852|567568057|FG000|Overall Study|New therapy for study indication|1|||
156838555|NCT00434642|566161521|FG000|Blinded Treatment Phase|Physician Decision|19|||
157153392|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
156838556|NCT00434642|566161522|FG001|Blinded Treatment Phase|Physician Decision|27|||
156838557|NCT00434642|566161521|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
156838558|NCT00434642|566161522|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
156838559|NCT00434642|566161521|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
156838560|NCT00434642|566161522|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
156838561|NCT00434642|566161521|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
156838562|NCT00434642|566161522|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
156838563|NCT00434642|566161521|FG000|Open-label Treatment Phase|Adverse Event|0|||
156838564|NCT00434642|566161522|FG001|Open-label Treatment Phase|Adverse Event|5|||
156838565|NCT00434642|566161521|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
156838566|NCT00434642|566161522|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
156838567|NCT02241343|566161525|FG000|Overall Study|Adverse Event|1|||
156838568|NCT04680975|566161526|FG000|Overall Study|Adverse Event|3|||
156838569|NCT04680975|566161526|FG000|Overall Study|Death|1|||
156838570|NCT04680975|566161526|FG000|Overall Study|Progressive Disease|1|||
156838571|NCT04680975|566161526|FG000|Overall Study|Withdrawal by Subject|1|||
156838572|NCT00753454|566161527|FG000|Overall Study|Adverse Event|4|||
156838573|NCT00753454|566161527|FG000|Overall Study|Lack of Efficacy|1|||
156838574|NCT00753454|566161527|FG000|Overall Study|Lost to Follow-up|3|||
156838575|NCT00753454|566161527|FG000|Overall Study|Withdrawal by Subject|5|||
156838576|NCT00753454|566161527|FG000|Overall Study|Investigator Decision|1|||
156838577|NCT03927144|566161528|FG000|Core Phase|Adverse Event|9|||
157153393|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
156838578|NCT03927144|566161529|FG001|Core Phase|Adverse Event|5|||
156838579|NCT03927144|566161528|FG000|Core Phase|Lost to Follow-up|3|||
156838580|NCT03927144|566161529|FG001|Core Phase|Lost to Follow-up|2|||
156838581|NCT03927144|566161528|FG000|Core Phase|New Therapy for Study Indication|0|||
156838582|NCT03927144|566161529|FG001|Core Phase|New Therapy for Study Indication|1|||
156838583|NCT03927144|566161528|FG000|Core Phase|No Longer Clinically Benefiting|4|||
156838584|NCT03927144|566161529|FG001|Core Phase|No Longer Clinically Benefiting|4|||
156838585|NCT03927144|566161528|FG000|Core Phase|Physician Decision|2|||
157153394|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
156838586|NCT03927144|566161529|FG001|Core Phase|Physician Decision|8|||
156838587|NCT03927144|566161528|FG000|Core Phase|Protocol Violation|2|||
156838588|NCT03927144|566161529|FG001|Core Phase|Protocol Violation|2|||
156838589|NCT03927144|566161528|FG000|Core Phase|Withdrawal by Subject|16|||
156838590|NCT03927144|566161529|FG001|Core Phase|Withdrawal by Subject|40|||
156838591|NCT03927144|566161528|FG000|Extension Phase|Adverse Event|2|||
156838592|NCT03927144|566161529|FG001|Extension Phase|Adverse Event|1|||
157153395|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
157153396|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
157153397|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
157153398|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
157153399|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
157153400|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Other|0|||
157153401|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Other|1|||
157153402|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Other|0|||
157153403|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Other|0|||
157153404|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Other|0|||
157153405|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Other|0|||
157153406|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Other|0|||
157153407|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
157153408|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
157153409|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
157153410|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
157153411|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
157153412|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
157153413|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
157153414|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
157153415|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
156838593|NCT03927144|566161528|FG000|Extension Phase|No longer clinically benefiting|4|||
156838594|NCT03927144|566161529|FG001|Extension Phase|No longer clinically benefiting|5|||
156838595|NCT03927144|566161528|FG000|Extension Phase|Pregnancy|1|||
156838596|NCT03927144|566161529|FG001|Extension Phase|Pregnancy|0|||
156838597|NCT03927144|566161528|FG000|Extension Phase|Protocol Violation|0|||
157153416|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
157153417|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
157153418|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
156838598|NCT03927144|566161529|FG001|Extension Phase|Protocol Violation|1|||
156838599|NCT03927144|566161528|FG000|Extension Phase|Withdrawal by Subject|8|||
156838600|NCT03927144|566161529|FG001|Extension Phase|Withdrawal by Subject|3|||
156838601|NCT03909152|566161530|FG000|Overall Study|Adverse Event|14|||
156838602|NCT03909152|566161531|FG001|Overall Study|Adverse Event|5|||
156838603|NCT03909152|566161532|FG002|Overall Study|Adverse Event|1|||
156838604|NCT03909152|566161533|FG003|Overall Study|Adverse Event|14|||
156838605|NCT02702414|566161538|FG000|Overall Study|Death|96|||
156838606|NCT02702414|566161539|FG001|Overall Study|Death|42|||
156838607|NCT02702414|566161538|FG000|Overall Study|Lost to Follow-up|0|||
156838608|NCT02702414|566161539|FG001|Overall Study|Lost to Follow-up|1|||
156838609|NCT02702414|566161538|FG000|Overall Study|Withdrawal by Subject|0|||
156838610|NCT02702414|566161539|FG001|Overall Study|Withdrawal by Subject|1|||
156838611|NCT02702414|566161538|FG000|Overall Study|Protocol Violation|1|||
156838612|NCT02702414|566161539|FG001|Overall Study|Protocol Violation|0|||
156838613|NCT02702414|566161538|FG000|Overall Study|Sponsor Decision|8|||
156838614|NCT02702414|566161539|FG001|Overall Study|Sponsor Decision|7|||
156838615|NCT04541628|566161540|FG000|Overall Study|Study Terminated|1|||
156838616|NCT04541628|566161541|FG001|Overall Study|Study Terminated|1|||
156838617|NCT04541628|566161542|FG002|Overall Study|Study Terminated|1|||
156838618|NCT02271945|566161546|FG000|Overall Study|Death|3|||
156838619|NCT02271945|566161547|FG001|Overall Study|Death|3|||
156838620|NCT02271945|566161546|FG000|Overall Study|Withdrawal by Subject|1|||
156838621|NCT02271945|566161547|FG001|Overall Study|Withdrawal by Subject|1|||
156838622|NCT02271945|566161546|FG000|Overall Study|Other|1|||
156838623|NCT02271945|566161547|FG001|Overall Study|Other|1|||
156838624|NCT04099511|566161549|FG000|Overall Study|Lost to Follow-up|2|||
156838625|NCT04099511|566161550|FG001|Overall Study|Lost to Follow-up|2|||
156838626|NCT04099511|566161549|FG000|Overall Study|Withdrawal by Subject|8|||
156838627|NCT04099511|566161550|FG001|Overall Study|Withdrawal by Subject|4|||
156838628|NCT04369950|566161551|FG000|Overall Study|Protocol Violation|2|||
156838629|NCT04369950|566161552|FG001|Overall Study|Protocol Violation|2|||
157153419|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
157153420|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
157153421|NCT00365716|567307494|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
157153422|NCT00365716|567307495|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
157153423|NCT00365716|567307496|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
157153424|NCT00365716|567307497|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
157153425|NCT00365716|567307498|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
157153426|NCT00365716|567307499|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
157153427|NCT00365716|567307500|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
157153428|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
157153429|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
157153430|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
157153431|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
157153432|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
157153433|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
157153434|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
157153435|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
157153436|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
157153437|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
157153438|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
157153439|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
157153440|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
157153441|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
157153442|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
157153443|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
157153444|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
157153445|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
157153446|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
157153447|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
157153448|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
157153449|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
157153450|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156838630|NCT02473367|566161553|FG000|Wait 1|Withdrawal by Subject|1|||
156838631|NCT02473367|566161553|FG000|Period 4|Lost to Follow-up|1|||
157153451|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
156838632|NCT04816721|566161554|FG000|Overall Study|Withdrawal by Subject|0|||
156838633|NCT04816721|566161555|FG001|Overall Study|Withdrawal by Subject|2|||
156838634|NCT04816721|566161556|FG002|Overall Study|Withdrawal by Subject|0|||
157153452|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
157153453|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
157224680|NCT03504852|567568058|FG001|Overall Study|New therapy for study indication|0|||
156838635|NCT04816721|566161557|FG003|Overall Study|Withdrawal by Subject|1|||
156838636|NCT04816721|566161558|FG004|Overall Study|Withdrawal by Subject|1|||
156838637|NCT04816721|566161559|FG005|Overall Study|Withdrawal by Subject|0|||
156838638|NCT04816721|566161560|FG006|Overall Study|Withdrawal by Subject|0|||
156838639|NCT04816721|566161561|FG007|Overall Study|Withdrawal by Subject|0|||
156838640|NCT04816721|566161554|FG000|Overall Study|Miscellaneous|0|||
157153454|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
157153455|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
157153456|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
157153457|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
157153458|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
157153459|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
157153460|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
157153461|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
157153462|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
157153463|NCT00365716|567307494|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
157153464|NCT00365716|567307495|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
157153465|NCT00365716|567307496|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
157153466|NCT00365716|567307497|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
157153467|NCT00365716|567307498|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
157153468|NCT00365716|567307499|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
157153469|NCT00365716|567307500|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
157153470|NCT00365716|567307494|FG000|Extension 1|Lost to Follow-up|0|||
157153471|NCT00365716|567307495|FG001|Extension 1|Lost to Follow-up|0|||
157153472|NCT00365716|567307496|FG002|Extension 1|Lost to Follow-up|0|||
157153473|NCT00365716|567307497|FG003|Extension 1|Lost to Follow-up|0|||
157153474|NCT00365716|567307498|FG004|Extension 1|Lost to Follow-up|0|||
157153475|NCT00365716|567307499|FG005|Extension 1|Lost to Follow-up|1|||
157153476|NCT00365716|567307500|FG006|Extension 1|Lost to Follow-up|0|||
157153477|NCT00365716|567307494|FG000|Extension 1|Other|0|||
157153478|NCT00365716|567307495|FG001|Extension 1|Other|0|||
157153479|NCT00365716|567307496|FG002|Extension 1|Other|0|||
157153480|NCT00365716|567307497|FG003|Extension 1|Other|0|||
157153481|NCT00365716|567307498|FG004|Extension 1|Other|0|||
157153482|NCT00365716|567307499|FG005|Extension 1|Other|9|||
157153483|NCT00365716|567307500|FG006|Extension 1|Other|0|||
157153484|NCT00365716|567307494|FG000|Extension 1|Moved|0|||
157153485|NCT00365716|567307495|FG001|Extension 1|Moved|0|||
157153486|NCT00365716|567307496|FG002|Extension 1|Moved|0|||
157153487|NCT00365716|567307497|FG003|Extension 1|Moved|0|||
157153488|NCT00365716|567307498|FG004|Extension 1|Moved|0|||
157153489|NCT00365716|567307499|FG005|Extension 1|Moved|4|||
157153490|NCT00365716|567307500|FG006|Extension 1|Moved|0|||
157153491|NCT00365716|567307494|FG000|Extension 1|Withdrawal by Subject|0|||
157153492|NCT00365716|567307495|FG001|Extension 1|Withdrawal by Subject|0|||
157153493|NCT00365716|567307496|FG002|Extension 1|Withdrawal by Subject|0|||
157153494|NCT00365716|567307497|FG003|Extension 1|Withdrawal by Subject|0|||
157153495|NCT00365716|567307498|FG004|Extension 1|Withdrawal by Subject|0|||
157153496|NCT00365716|567307499|FG005|Extension 1|Withdrawal by Subject|3|||
157153497|NCT00365716|567307500|FG006|Extension 1|Withdrawal by Subject|0|||
157153498|NCT00365716|567307494|FG000|Extension 1|Pregnancy|0|||
157153499|NCT00365716|567307495|FG001|Extension 1|Pregnancy|0|||
157153500|NCT00365716|567307496|FG002|Extension 1|Pregnancy|0|||
157153501|NCT00365716|567307497|FG003|Extension 1|Pregnancy|0|||
157153502|NCT00365716|567307498|FG004|Extension 1|Pregnancy|0|||
157153503|NCT00365716|567307499|FG005|Extension 1|Pregnancy|4|||
157153504|NCT00365716|567307500|FG006|Extension 1|Pregnancy|0|||
157153505|NCT00365716|567307494|FG000|Extension 1|Protocol Violation|0|||
157153506|NCT00365716|567307495|FG001|Extension 1|Protocol Violation|0|||
157153507|NCT00365716|567307496|FG002|Extension 1|Protocol Violation|0|||
157153508|NCT00365716|567307497|FG003|Extension 1|Protocol Violation|0|||
157153509|NCT00365716|567307498|FG004|Extension 1|Protocol Violation|0|||
157153510|NCT00365716|567307499|FG005|Extension 1|Protocol Violation|1|||
157153511|NCT00365716|567307500|FG006|Extension 1|Protocol Violation|0|||
157153512|NCT00365716|567307494|FG000|Extension 2|Lost to Follow-up|0|||
157153513|NCT00365716|567307495|FG001|Extension 2|Lost to Follow-up|0|||
157153514|NCT00365716|567307496|FG002|Extension 2|Lost to Follow-up|0|||
157153515|NCT00365716|567307497|FG003|Extension 2|Lost to Follow-up|0|||
157153516|NCT00365716|567307498|FG004|Extension 2|Lost to Follow-up|0|||
157153517|NCT00365716|567307499|FG005|Extension 2|Lost to Follow-up|0|||
157153518|NCT00365716|567307500|FG006|Extension 2|Lost to Follow-up|2|||
157153519|NCT00365716|567307494|FG000|Extension 2|Other|0|||
157153520|NCT00365716|567307495|FG001|Extension 2|Other|0|||
157153521|NCT00365716|567307496|FG002|Extension 2|Other|0|||
157153522|NCT00365716|567307497|FG003|Extension 2|Other|0|||
157153523|NCT00365716|567307498|FG004|Extension 2|Other|0|||
157153524|NCT00365716|567307499|FG005|Extension 2|Other|0|||
157153525|NCT00365716|567307500|FG006|Extension 2|Other|3|||
156886521|NCT00045942|566344000|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
156886522|NCT00045942|566344001|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
157153526|NCT00365716|567307494|FG000|Extension 2|Withdrawal by Subject|0|||
157153527|NCT00365716|567307495|FG001|Extension 2|Withdrawal by Subject|0|||
157153528|NCT00365716|567307496|FG002|Extension 2|Withdrawal by Subject|0|||
157153529|NCT00365716|567307497|FG003|Extension 2|Withdrawal by Subject|0|||
157153530|NCT00365716|567307498|FG004|Extension 2|Withdrawal by Subject|0|||
157153531|NCT00365716|567307499|FG005|Extension 2|Withdrawal by Subject|0|||
156838641|NCT04816721|566161555|FG001|Overall Study|Miscellaneous|0|||
156838642|NCT04816721|566161556|FG002|Overall Study|Miscellaneous|0|||
156838643|NCT04816721|566161557|FG003|Overall Study|Miscellaneous|0|||
156838644|NCT04816721|566161558|FG004|Overall Study|Miscellaneous|0|||
156838645|NCT04816721|566161559|FG005|Overall Study|Miscellaneous|1|||
156838646|NCT04816721|566161560|FG006|Overall Study|Miscellaneous|0|||
156838647|NCT04816721|566161561|FG007|Overall Study|Miscellaneous|0|||
156838648|NCT04816721|566161554|FG000|Overall Study|Lost to Follow-up|0|||
156838649|NCT04816721|566161555|FG001|Overall Study|Lost to Follow-up|0|||
156838650|NCT04816721|566161556|FG002|Overall Study|Lost to Follow-up|0|||
156838651|NCT04816721|566161557|FG003|Overall Study|Lost to Follow-up|1|||
156838652|NCT04816721|566161558|FG004|Overall Study|Lost to Follow-up|0|||
156838653|NCT04816721|566161559|FG005|Overall Study|Lost to Follow-up|0|||
156838654|NCT04816721|566161560|FG006|Overall Study|Lost to Follow-up|0|||
156838655|NCT04816721|566161561|FG007|Overall Study|Lost to Follow-up|0|||
156838656|NCT00975143|566161566|FG000|Overall Study|Adverse Event|19|||
156838657|NCT00975143|566161567|FG001|Overall Study|Adverse Event|15|||
156838658|NCT00975143|566161566|FG000|Overall Study|Withdrawal by Subject|15|||
156838659|NCT00975143|566161567|FG001|Overall Study|Withdrawal by Subject|15|||
156838660|NCT00975143|566161566|FG000|Overall Study|Lost to Follow-up|20|||
156838661|NCT00975143|566161567|FG001|Overall Study|Lost to Follow-up|16|||
156838662|NCT00975143|566161566|FG000|Overall Study|Non-compliance|5|||
156838663|NCT00975143|566161567|FG001|Overall Study|Non-compliance|8|||
156838664|NCT00975143|566161566|FG000|Overall Study|Physician Decision|1|||
156838665|NCT00975143|566161567|FG001|Overall Study|Physician Decision|2|||
156838666|NCT00975143|566161566|FG000|Overall Study|Details not available|10|||
156838667|NCT00975143|566161567|FG001|Overall Study|Details not available|4|||
156838668|NCT02345330|566161569|FG000|Overall Study|Death|1|||
156838669|NCT02345330|566161569|FG000|Overall Study|Progressive Disease|2|||
156838670|NCT00494507|566161572|FG000|Double-Blind Phase|Adverse Event|2|||
156838671|NCT00494507|566161573|FG001|Double-Blind Phase|Adverse Event|0|||
156838672|NCT00494507|566161574|FG002|Double-Blind Phase|Adverse Event|1|||
156838673|NCT00494507|566161575|FG003|Double-Blind Phase|Adverse Event|0|||
156838674|NCT00494507|566161572|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
156838675|NCT00494507|566161573|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
156838676|NCT00494507|566161574|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156838677|NCT00494507|566161575|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156838678|NCT00494507|566161572|FG000|Double-Blind Phase|Subject Non-compliance|0|||
156838679|NCT00494507|566161573|FG001|Double-Blind Phase|Subject Non-compliance|0|||
156838680|NCT00494507|566161574|FG002|Double-Blind Phase|Subject Non-compliance|1|||
156838681|NCT00494507|566161575|FG003|Double-Blind Phase|Subject Non-compliance|0|||
156838682|NCT00494507|566161572|FG000|Double-Blind Phase|Negative DNA test|0|||
156838683|NCT00494507|566161573|FG001|Double-Blind Phase|Negative DNA test|0|||
156838684|NCT00494507|566161574|FG002|Double-Blind Phase|Negative DNA test|0|||
156838685|NCT00494507|566161575|FG003|Double-Blind Phase|Negative DNA test|1|||
156838686|NCT00494507|566161572|FG000|Open-Label Phase|Adverse Event|0|||
156838687|NCT00494507|566161573|FG001|Open-Label Phase|Adverse Event|1|||
156838688|NCT00494507|566161574|FG002|Open-Label Phase|Adverse Event|5|||
156838689|NCT00494507|566161575|FG003|Open-Label Phase|Adverse Event|3|||
156838690|NCT00494507|566161572|FG000|Open-Label Phase|Worsening Disease|0|||
156838691|NCT00494507|566161573|FG001|Open-Label Phase|Worsening Disease|0|||
156838692|NCT00494507|566161574|FG002|Open-Label Phase|Worsening Disease|0|||
156838693|NCT00494507|566161575|FG003|Open-Label Phase|Worsening Disease|2|||
156838694|NCT00454181|566161576|FG000|Overall Study|Adverse Event|1|||
156838695|NCT00454181|566161577|FG001|Overall Study|Adverse Event|1|||
156838696|NCT00454181|566161576|FG000|Overall Study|Lost to Follow-up|11|||
156838697|NCT00454181|566161577|FG001|Overall Study|Lost to Follow-up|1|||
156838698|NCT00454181|566161576|FG000|Overall Study|Protocol Violation|1|||
156838699|NCT00454181|566161577|FG001|Overall Study|Protocol Violation|1|||
156838700|NCT00454181|566161576|FG000|Overall Study|Withdrawal by Subject|2|||
156838701|NCT00454181|566161577|FG001|Overall Study|Withdrawal by Subject|0|||
156838702|NCT03729245|566161578|FG000|Overall Study|Lost to Follow-up|5|||
156838703|NCT03729245|566161579|FG001|Overall Study|Lost to Follow-up|6|||
156838704|NCT03729245|566161578|FG000|Overall Study|Withdrawal by Subject|16|||
156838705|NCT03729245|566161579|FG001|Overall Study|Withdrawal by Subject|19|||
156838706|NCT03729245|566161578|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
156838707|NCT03729245|566161579|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
156838708|NCT02096263|566161580|FG000|Overall Study|Adverse Event|1|||
156838709|NCT02096263|566161581|FG001|Overall Study|Adverse Event|0|||
156838710|NCT02096263|566161582|FG002|Overall Study|Adverse Event|1|||
156838711|NCT02096263|566161580|FG000|Overall Study|Lost to Follow-up|14|||
156838712|NCT02096263|566161581|FG001|Overall Study|Lost to Follow-up|18|||
156838713|NCT02096263|566161582|FG002|Overall Study|Lost to Follow-up|15|||
156838714|NCT02096263|566161580|FG000|Overall Study|Other|7|||
156838715|NCT02096263|566161581|FG001|Overall Study|Other|9|||
156838716|NCT02096263|566161582|FG002|Overall Study|Other|6|||
156838717|NCT02096263|566161580|FG000|Overall Study|Sponsor study termination|0|||
156838718|NCT02096263|566161581|FG001|Overall Study|Sponsor study termination|0|||
156838719|NCT02096263|566161582|FG002|Overall Study|Sponsor study termination|1|||
156838720|NCT02096263|566161580|FG000|Overall Study|Protocol Violation|7|||
156838721|NCT02096263|566161581|FG001|Overall Study|Protocol Violation|2|||
156838722|NCT02096263|566161582|FG002|Overall Study|Protocol Violation|8|||
156838723|NCT02096263|566161580|FG000|Overall Study|Withdrawal by Subject|5|||
156838724|NCT02096263|566161581|FG001|Overall Study|Withdrawal by Subject|7|||
156838725|NCT02096263|566161582|FG002|Overall Study|Withdrawal by Subject|8|||
156838726|NCT03178669|566161583|FG000|Overall Study|Adverse Event|4|||
156838727|NCT03178669|566161584|FG001|Overall Study|Adverse Event|1|||
156838728|NCT03178669|566161585|FG002|Overall Study|Adverse Event|4|||
156838729|NCT03178669|566161586|FG003|Overall Study|Adverse Event|2|||
156838730|NCT03178669|566161587|FG004|Overall Study|Adverse Event|2|||
156838731|NCT03178669|566161583|FG000|Overall Study|Lack of Efficacy|0|||
156838732|NCT03178669|566161584|FG001|Overall Study|Lack of Efficacy|0|||
156838733|NCT03178669|566161585|FG002|Overall Study|Lack of Efficacy|2|||
156838734|NCT03178669|566161586|FG003|Overall Study|Lack of Efficacy|0|||
156838735|NCT03178669|566161587|FG004|Overall Study|Lack of Efficacy|1|||
157153532|NCT00365716|567307500|FG006|Extension 2|Withdrawal by Subject|5|||
157153533|NCT01120093|567307510|FG000|Treatment Period 1|Adverse Event|0|||
157153534|NCT01120093|567307511|FG001|Treatment Period 1|Adverse Event|0|||
157153535|NCT01120093|567307512|FG002|Treatment Period 1|Adverse Event|1|||
157153536|NCT01120093|567307513|FG003|Treatment Period 1|Adverse Event|0|||
157153537|NCT01120093|567307514|FG004|Treatment Period 1|Adverse Event|1|||
157153538|NCT01120093|567307510|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157153539|NCT01120093|567307511|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157153540|NCT01120093|567307512|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157153541|NCT01120093|567307513|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157153542|NCT01120093|567307514|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157153543|NCT01120093|567307510|FG000|Treatment Period 2|Adverse Event|0|||
157153544|NCT01120093|567307511|FG001|Treatment Period 2|Adverse Event|0|||
157153545|NCT01120093|567307512|FG002|Treatment Period 2|Adverse Event|0|||
157153546|NCT01120093|567307513|FG003|Treatment Period 2|Adverse Event|1|||
157153547|NCT01120093|567307514|FG004|Treatment Period 2|Adverse Event|0|||
157153548|NCT01120093|567307510|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157153549|NCT01120093|567307511|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157153550|NCT01120093|567307512|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157153551|NCT01120093|567307513|FG003|Treatment Period 2|Withdrawal by Subject|0|||
157153552|NCT01120093|567307514|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157153553|NCT01120093|567307510|FG000|Treatment Period 3|Lack of Efficacy|0|||
157153554|NCT01120093|567307511|FG001|Treatment Period 3|Lack of Efficacy|0|||
157153555|NCT01120093|567307512|FG002|Treatment Period 3|Lack of Efficacy|0|||
157153556|NCT01120093|567307513|FG003|Treatment Period 3|Lack of Efficacy|1|||
157153557|NCT01120093|567307514|FG004|Treatment Period 3|Lack of Efficacy|0|||
157153558|NCT01120093|567307510|FG000|Treatment Period 3|Adverse Event|0|||
157153559|NCT01120093|567307511|FG001|Treatment Period 3|Adverse Event|0|||
157153560|NCT01120093|567307512|FG002|Treatment Period 3|Adverse Event|0|||
157153561|NCT01120093|567307513|FG003|Treatment Period 3|Adverse Event|0|||
157153562|NCT01120093|567307514|FG004|Treatment Period 3|Adverse Event|1|||
157153563|NCT01120093|567307510|FG000|Treatment Period 3|Withdrawal by Subject|0|||
157153564|NCT01120093|567307511|FG001|Treatment Period 3|Withdrawal by Subject|0|||
157153565|NCT01120093|567307512|FG002|Treatment Period 3|Withdrawal by Subject|1|||
157153566|NCT01120093|567307513|FG003|Treatment Period 3|Withdrawal by Subject|0|||
157153567|NCT01120093|567307514|FG004|Treatment Period 3|Withdrawal by Subject|0|||
157153568|NCT01120093|567307510|FG000|Treatment Period 4|Adverse Event|1|||
157153569|NCT01120093|567307511|FG001|Treatment Period 4|Adverse Event|0|||
157153570|NCT01120093|567307512|FG002|Treatment Period 4|Adverse Event|0|||
157153571|NCT01120093|567307513|FG003|Treatment Period 4|Adverse Event|0|||
157153572|NCT01120093|567307514|FG004|Treatment Period 4|Adverse Event|0|||
157153573|NCT01120093|567307510|FG000|Treatment Period 5|Adverse Event|0|||
157153574|NCT01120093|567307511|FG001|Treatment Period 5|Adverse Event|1|||
157153575|NCT01120093|567307512|FG002|Treatment Period 5|Adverse Event|0|||
157153576|NCT01120093|567307513|FG003|Treatment Period 5|Adverse Event|1|||
157153577|NCT01120093|567307514|FG004|Treatment Period 5|Adverse Event|0|||
157153578|NCT00525148|567307517|FG000|Overall Study|Other Adverse Event|3|||
157153579|NCT00525148|567307518|FG001|Overall Study|Other Adverse Event|5|||
157153580|NCT00525148|567307519|FG002|Overall Study|Other Adverse Event|1|||
157153581|NCT00525148|567307520|FG003|Overall Study|Other Adverse Event|8|||
157153582|NCT00525148|567307517|FG000|Overall Study|Progressive disease|18|||
157153583|NCT00525148|567307518|FG001|Overall Study|Progressive disease|30|||
157153584|NCT00525148|567307519|FG002|Overall Study|Progressive disease|6|||
156838736|NCT03178669|566161583|FG000|Overall Study|Physician Decision|0|||
156838737|NCT03178669|566161584|FG001|Overall Study|Physician Decision|0|||
157153585|NCT00525148|567307520|FG003|Overall Study|Progressive disease|49|||
156838738|NCT03178669|566161585|FG002|Overall Study|Physician Decision|0|||
156838739|NCT03178669|566161586|FG003|Overall Study|Physician Decision|0|||
156838740|NCT03178669|566161587|FG004|Overall Study|Physician Decision|1|||
157153586|NCT00525148|567307517|FG000|Overall Study|Refused continuation of study medication|0|||
157153587|NCT00525148|567307518|FG001|Overall Study|Refused continuation of study medication|2|||
157153588|NCT00525148|567307519|FG002|Overall Study|Refused continuation of study medication|0|||
156886523|NCT00045942|566344002|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
156886524|NCT00045942|566344003|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
156886525|NCT00045942|566344004|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
156886526|NCT00045942|566344005|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
156886527|NCT00045942|566343997|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
156886528|NCT00045942|566343998|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
156886529|NCT00045942|566343999|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
156886530|NCT00045942|566344000|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
156886531|NCT00045942|566344001|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
156886532|NCT00045942|566344002|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
156886533|NCT00045942|566344003|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
156886534|NCT00045942|566344004|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
156886535|NCT00045942|566344005|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
156886536|NCT00045942|566343997|FG000|PKC412A2104E1|Lack of Efficacy|0|||
156886537|NCT00045942|566343998|FG001|PKC412A2104E1|Lack of Efficacy|11|||
156886538|NCT00045942|566343999|FG002|PKC412A2104E1|Lack of Efficacy|11|||
157153589|NCT00525148|567307520|FG003|Overall Study|Refused continuation of study medication|1|||
157153590|NCT00525148|567307517|FG000|Overall Study|Other than stated|2|||
157153591|NCT00525148|567307518|FG001|Overall Study|Other than stated|1|||
157153592|NCT00525148|567307519|FG002|Overall Study|Other than stated|0|||
157153593|NCT00525148|567307520|FG003|Overall Study|Other than stated|3|||
157153594|NCT00570739|567307521|FG000|Overall Study|Adverse Event|8|||
157153595|NCT00570739|567307522|FG001|Overall Study|Adverse Event|6|||
157153596|NCT00570739|567307523|FG002|Overall Study|Adverse Event|2|||
157153597|NCT00570739|567307524|FG003|Overall Study|Adverse Event|2|||
157153598|NCT00570739|567307521|FG000|Overall Study|Lost to Follow-up|4|||
157153599|NCT00570739|567307522|FG001|Overall Study|Lost to Follow-up|5|||
157153600|NCT00570739|567307523|FG002|Overall Study|Lost to Follow-up|4|||
157153601|NCT00570739|567307524|FG003|Overall Study|Lost to Follow-up|1|||
157153602|NCT00570739|567307521|FG000|Overall Study|Physician Decision|1|||
157153603|NCT00570739|567307522|FG001|Overall Study|Physician Decision|1|||
157153604|NCT00570739|567307523|FG002|Overall Study|Physician Decision|0|||
157153605|NCT00570739|567307524|FG003|Overall Study|Physician Decision|0|||
157153606|NCT00570739|567307521|FG000|Overall Study|Withdrawal by Subject|7|||
157153607|NCT00570739|567307522|FG001|Overall Study|Withdrawal by Subject|7|||
157153608|NCT00570739|567307523|FG002|Overall Study|Withdrawal by Subject|3|||
157153609|NCT00570739|567307524|FG003|Overall Study|Withdrawal by Subject|5|||
157153610|NCT00570739|567307521|FG000|Overall Study|Required restricted medication|0|||
157153611|NCT00570739|567307522|FG001|Overall Study|Required restricted medication|0|||
157153612|NCT00570739|567307523|FG002|Overall Study|Required restricted medication|1|||
157153613|NCT00570739|567307524|FG003|Overall Study|Required restricted medication|0|||
157153614|NCT00570739|567307521|FG000|Overall Study|Met discontinuation criteria|1|||
157153615|NCT00570739|567307522|FG001|Overall Study|Met discontinuation criteria|0|||
157153616|NCT00570739|567307523|FG002|Overall Study|Met discontinuation criteria|1|||
157153617|NCT00570739|567307524|FG003|Overall Study|Met discontinuation criteria|1|||
157153618|NCT00570739|567307521|FG000|Overall Study|Other|0|||
157153619|NCT00570739|567307522|FG001|Overall Study|Other|2|||
157153620|NCT00570739|567307523|FG002|Overall Study|Other|5|||
157153621|NCT00570739|567307524|FG003|Overall Study|Other|3|||
157153622|NCT00789477|567307528|FG000|Overall Study|Withdrawal by Subject|2|||
157153623|NCT00789477|567307529|FG001|Overall Study|Withdrawal by Subject|1|||
157153624|NCT00789477|567307530|FG002|Overall Study|Withdrawal by Subject|3|||
157153625|NCT00789477|567307531|FG003|Overall Study|Withdrawal by Subject|2|||
157153626|NCT00789477|567307532|FG004|Overall Study|Withdrawal by Subject|3|||
157153627|NCT00789477|567307528|FG000|Overall Study|Protocol Violation|1|||
157153628|NCT00789477|567307529|FG001|Overall Study|Protocol Violation|0|||
157153629|NCT00789477|567307530|FG002|Overall Study|Protocol Violation|0|||
157153630|NCT00789477|567307531|FG003|Overall Study|Protocol Violation|1|||
157153631|NCT00789477|567307532|FG004|Overall Study|Protocol Violation|0|||
157153632|NCT00789477|567307528|FG000|Overall Study|Adverse Event|3|||
157153633|NCT00789477|567307529|FG001|Overall Study|Adverse Event|3|||
157153634|NCT00789477|567307530|FG002|Overall Study|Adverse Event|1|||
157224681|NCT03504852|567568059|FG002|Overall Study|New therapy for study indication|0|||
157224682|NCT03504852|567568057|FG000|Overall Study|Lack of Efficacy|1|||
157224683|NCT03504852|567568058|FG001|Overall Study|Lack of Efficacy|2|||
157153635|NCT00789477|567307531|FG003|Overall Study|Adverse Event|0|||
157153636|NCT00789477|567307532|FG004|Overall Study|Adverse Event|0|||
157153637|NCT00789477|567307528|FG000|Overall Study|Death|1|||
157224684|NCT03504852|567568059|FG002|Overall Study|Lack of Efficacy|0|||
157153638|NCT00789477|567307529|FG001|Overall Study|Death|1|||
157224685|NCT03504852|567568057|FG000|Overall Study|Death|0|||
156886539|NCT00045942|566344000|FG003|PKC412A2104E1|Lack of Efficacy|23|||
157153639|NCT00789477|567307530|FG002|Overall Study|Death|2|||
157224686|NCT03504852|567568058|FG001|Overall Study|Death|1|||
157153640|NCT00789477|567307531|FG003|Overall Study|Death|2|||
157153641|NCT00789477|567307532|FG004|Overall Study|Death|0|||
157153642|NCT00789477|567307528|FG000|Overall Study|Lost to Follow-up|0|||
156886540|NCT00045942|566344001|FG004|PKC412A2104E1|Lack of Efficacy|17|||
156886541|NCT00045942|566344002|FG005|PKC412A2104E1|Lack of Efficacy|0|||
156886542|NCT00045942|566344003|FG006|PKC412A2104E1|Lack of Efficacy|0|||
156886543|NCT00045942|566344004|FG007|PKC412A2104E1|Lack of Efficacy|0|||
156886544|NCT00045942|566344005|FG008|PKC412A2104E1|Lack of Efficacy|0|||
156886545|NCT00045942|566343997|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
156886546|NCT00045942|566343998|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
156886547|NCT00045942|566343999|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
156886548|NCT00045942|566344000|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
156886549|NCT00045942|566344001|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
156886550|NCT00045942|566344002|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
156886551|NCT00045942|566344003|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
156886552|NCT00045942|566344004|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
156886553|NCT00045942|566344005|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
156886554|NCT00045942|566343997|FG000|PKC412A2104E1|Adverse Event|0|||
156886555|NCT00045942|566343998|FG001|PKC412A2104E1|Adverse Event|1|||
156886556|NCT00045942|566343999|FG002|PKC412A2104E1|Adverse Event|1|||
156886557|NCT00045942|566344000|FG003|PKC412A2104E1|Adverse Event|3|||
156886558|NCT00045942|566344001|FG004|PKC412A2104E1|Adverse Event|6|||
156886559|NCT00045942|566344002|FG005|PKC412A2104E1|Adverse Event|0|||
156886560|NCT00045942|566344003|FG006|PKC412A2104E1|Adverse Event|0|||
156886561|NCT00045942|566344004|FG007|PKC412A2104E1|Adverse Event|0|||
156886562|NCT00045942|566344005|FG008|PKC412A2104E1|Adverse Event|0|||
156886563|NCT00045942|566343997|FG000|PKC412A2104E1|Death|0|||
156886564|NCT00045942|566343998|FG001|PKC412A2104E1|Death|4|||
156886565|NCT00045942|566343999|FG002|PKC412A2104E1|Death|1|||
156886566|NCT00045942|566344000|FG003|PKC412A2104E1|Death|1|||
156886567|NCT00045942|566344001|FG004|PKC412A2104E1|Death|1|||
156886568|NCT00045942|566344002|FG005|PKC412A2104E1|Death|0|||
156886569|NCT00045942|566344003|FG006|PKC412A2104E1|Death|0|||
156886570|NCT00045942|566344004|FG007|PKC412A2104E1|Death|0|||
156886571|NCT00045942|566344005|FG008|PKC412A2104E1|Death|0|||
156886572|NCT00045942|566343997|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886573|NCT00045942|566343998|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886574|NCT00045942|566343999|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
156886575|NCT00045942|566344000|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
156886576|NCT00045942|566344001|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886577|NCT00045942|566344002|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886578|NCT00045942|566344003|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886579|NCT00045942|566344004|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886580|NCT00045942|566344005|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
156886581|NCT00045942|566343997|FG000|PKC412A2104E2|Lost to Follow-up|0|||
156886582|NCT00045942|566343998|FG001|PKC412A2104E2|Lost to Follow-up|0|||
156886583|NCT00045942|566343999|FG002|PKC412A2104E2|Lost to Follow-up|0|||
156886584|NCT00045942|566344000|FG003|PKC412A2104E2|Lost to Follow-up|0|||
156886585|NCT00045942|566344001|FG004|PKC412A2104E2|Lost to Follow-up|0|||
156886586|NCT00045942|566344002|FG005|PKC412A2104E2|Lost to Follow-up|0|||
156886587|NCT00045942|566344003|FG006|PKC412A2104E2|Lost to Follow-up|0|||
156886588|NCT00045942|566344004|FG007|PKC412A2104E2|Lost to Follow-up|3|||
156886589|NCT00045942|566344005|FG008|PKC412A2104E2|Lost to Follow-up|0|||
156886590|NCT00045942|566343997|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
156886591|NCT00045942|566343998|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
156886592|NCT00045942|566343999|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
156886593|NCT00045942|566344000|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
156886594|NCT00045942|566344001|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
157023947|NCT04632992|566841152|FG013|Overall Study|Withdrawal by Subject|1|||
157023948|NCT02677805|566841153|FG000|Double Blind Phase|Lost to Follow-up|8|||
157023949|NCT02677805|566841154|FG001|Double Blind Phase|Lost to Follow-up|3|||
157023950|NCT02677805|566841155|FG002|Double Blind Phase|Lost to Follow-up|0|||
157023951|NCT02677805|566841153|FG000|Double Blind Phase|Withdrawal by Subject|5|||
157023952|NCT02677805|566841154|FG001|Double Blind Phase|Withdrawal by Subject|2|||
157023953|NCT02677805|566841155|FG002|Double Blind Phase|Withdrawal by Subject|0|||
157023954|NCT02677805|566841153|FG000|Open Label Phase|Lost to Follow-up|0|||
157023955|NCT02677805|566841154|FG001|Open Label Phase|Lost to Follow-up|0|||
157023956|NCT02677805|566841155|FG002|Open Label Phase|Lost to Follow-up|10|||
157023957|NCT02677805|566841153|FG000|Open Label Phase|Withdrawal by Subject|0|||
157023958|NCT02677805|566841154|FG001|Open Label Phase|Withdrawal by Subject|0|||
157023959|NCT02677805|566841155|FG002|Open Label Phase|Withdrawal by Subject|6|||
157023960|NCT04111536|566841156|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
157023961|NCT04111536|566841157|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
157023962|NCT04111536|566841156|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
156886595|NCT00045942|566344002|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
156886596|NCT00045942|566344003|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
156886597|NCT00045942|566344004|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
156886598|NCT00045942|566344005|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
156886599|NCT00045942|566343997|FG000|PKC412A2104E2|Lack of Efficacy|0|||
156886600|NCT00045942|566343998|FG001|PKC412A2104E2|Lack of Efficacy|0|||
156886601|NCT00045942|566343999|FG002|PKC412A2104E2|Lack of Efficacy|0|||
157153643|NCT00789477|567307529|FG001|Overall Study|Lost to Follow-up|1|||
157153644|NCT00789477|567307530|FG002|Overall Study|Lost to Follow-up|4|||
157153645|NCT00789477|567307531|FG003|Overall Study|Lost to Follow-up|2|||
157153646|NCT00789477|567307532|FG004|Overall Study|Lost to Follow-up|4|||
157153647|NCT00789477|567307528|FG000|Overall Study|Lack of Efficacy|2|||
157153648|NCT00789477|567307529|FG001|Overall Study|Lack of Efficacy|0|||
157153649|NCT00789477|567307530|FG002|Overall Study|Lack of Efficacy|0|||
157153650|NCT00789477|567307531|FG003|Overall Study|Lack of Efficacy|0|||
157153651|NCT00789477|567307532|FG004|Overall Study|Lack of Efficacy|0|||
157153652|NCT00789477|567307528|FG000|Overall Study|Other|2|||
157153653|NCT00789477|567307529|FG001|Overall Study|Other|0|||
157153654|NCT00789477|567307530|FG002|Overall Study|Other|1|||
157153655|NCT00789477|567307531|FG003|Overall Study|Other|3|||
157153656|NCT00789477|567307532|FG004|Overall Study|Other|0|||
157153657|NCT01927562|567307533|FG000|Overall Study|Lost to Follow-up|30|||
157153658|NCT01927562|567307533|FG000|Overall Study|Withdrawal by Subject|3|||
157153659|NCT01927562|567307533|FG000|Overall Study|Physician Decision|5|||
157153660|NCT01161524|567307534|FG000|Core Study (23 Weeks)|Adverse Event|3|||
157153661|NCT01161524|567307535|FG001|Core Study (23 Weeks)|Adverse Event|0|||
157153662|NCT01161524|567307536|FG002|Core Study (23 Weeks)|Adverse Event|0|||
157153663|NCT01161524|567307534|FG000|Core Study (23 Weeks)|Other|1|||
157153664|NCT01161524|567307535|FG001|Core Study (23 Weeks)|Other|0|||
157153665|NCT01161524|567307536|FG002|Core Study (23 Weeks)|Other|0|||
157153666|NCT01161524|567307534|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
157153667|NCT01161524|567307535|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
157153668|NCT01161524|567307536|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
157153669|NCT01161524|567307534|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
157153670|NCT01161524|567307535|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
157153671|NCT01161524|567307536|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
157153672|NCT01161524|567307534|FG000|Core Study (23 Weeks)|Subject Choice|3|||
157153673|NCT01161524|567307535|FG001|Core Study (23 Weeks)|Subject Choice|2|||
157153674|NCT01161524|567307536|FG002|Core Study (23 Weeks)|Subject Choice|0|||
157153675|NCT01161524|567307534|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
157153676|NCT01161524|567307535|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
157153677|NCT01161524|567307536|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
157153678|NCT01161524|567307534|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
157153679|NCT01161524|567307535|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
157153680|NCT01161524|567307536|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
157153681|NCT01161524|567307534|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
157153682|NCT01161524|567307535|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
157153683|NCT01161524|567307536|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
157153684|NCT01161524|567307534|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
157153685|NCT01161524|567307535|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
157153686|NCT01161524|567307536|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
157153687|NCT01161524|567307534|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
157153688|NCT01161524|567307535|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
157153689|NCT01161524|567307536|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
157153690|NCT00642616|567307537|FG000|Overall Study|Adverse Event|2|||
157153691|NCT00642616|567307538|FG001|Overall Study|Adverse Event|0|||
157153692|NCT00642616|567307539|FG002|Overall Study|Adverse Event|1|||
157153693|NCT00642616|567307540|FG003|Overall Study|Adverse Event|0|||
157153694|NCT00642616|567307537|FG000|Overall Study|Study Terminated by Sponsor|7|||
157153695|NCT00642616|567307538|FG001|Overall Study|Study Terminated by Sponsor|6|||
157153696|NCT00642616|567307539|FG002|Overall Study|Study Terminated by Sponsor|4|||
157153697|NCT00642616|567307540|FG003|Overall Study|Study Terminated by Sponsor|5|||
157153698|NCT00642616|567307537|FG000|Overall Study|Withdrawal by Subject|0|||
157153699|NCT00642616|567307538|FG001|Overall Study|Withdrawal by Subject|1|||
157153700|NCT00642616|567307539|FG002|Overall Study|Withdrawal by Subject|1|||
156838741|NCT03178669|566161583|FG000|Overall Study|Withdrawal by Subject|1|||
156838742|NCT03178669|566161584|FG001|Overall Study|Withdrawal by Subject|0|||
157153701|NCT00642616|567307540|FG003|Overall Study|Withdrawal by Subject|1|||
157153702|NCT00642616|567307537|FG000|Overall Study|Protocol Violation|0|||
157153703|NCT00642616|567307538|FG001|Overall Study|Protocol Violation|0|||
157153704|NCT00642616|567307539|FG002|Overall Study|Protocol Violation|2|||
157153705|NCT00642616|567307540|FG003|Overall Study|Protocol Violation|0|||
157153706|NCT00642616|567307537|FG000|Overall Study|Physician Decision|0|||
156838743|NCT03178669|566161585|FG002|Overall Study|Withdrawal by Subject|1|||
157153707|NCT00642616|567307538|FG001|Overall Study|Physician Decision|0|||
157153708|NCT00642616|567307539|FG002|Overall Study|Physician Decision|1|||
157153709|NCT00642616|567307540|FG003|Overall Study|Physician Decision|1|||
157153710|NCT00542815|567307541|FG000|Overall Study|Adverse Event|19|||
157153711|NCT00542815|567307542|FG001|Overall Study|Adverse Event|6|||
157153712|NCT00542815|567307543|FG002|Overall Study|Adverse Event|9|||
157153713|NCT00542815|567307541|FG000|Overall Study|Death|10|||
156838744|NCT03178669|566161586|FG003|Overall Study|Withdrawal by Subject|1|||
156886602|NCT00045942|566344000|FG003|PKC412A2104E2|Lack of Efficacy|0|||
156886603|NCT00045942|566344001|FG004|PKC412A2104E2|Lack of Efficacy|0|||
156886604|NCT00045942|566344002|FG005|PKC412A2104E2|Lack of Efficacy|3|||
156886605|NCT00045942|566344003|FG006|PKC412A2104E2|Lack of Efficacy|2|||
156886606|NCT00045942|566344004|FG007|PKC412A2104E2|Lack of Efficacy|2|||
156886607|NCT00045942|566344005|FG008|PKC412A2104E2|Lack of Efficacy|6|||
156886608|NCT00045942|566343997|FG000|PKC412A2104E2|Adverse Event|0|||
156886609|NCT00045942|566343998|FG001|PKC412A2104E2|Adverse Event|0|||
156886610|NCT00045942|566343999|FG002|PKC412A2104E2|Adverse Event|0|||
156886611|NCT00045942|566344000|FG003|PKC412A2104E2|Adverse Event|0|||
157153714|NCT00542815|567307542|FG001|Overall Study|Death|7|||
157153715|NCT00542815|567307543|FG002|Overall Study|Death|3|||
157153716|NCT00542815|567307541|FG000|Overall Study|Lack of Efficacy|9|||
157153717|NCT00542815|567307542|FG001|Overall Study|Lack of Efficacy|2|||
157153718|NCT00542815|567307543|FG002|Overall Study|Lack of Efficacy|0|||
157153719|NCT00542815|567307541|FG000|Overall Study|Physician Decision|2|||
157153720|NCT00542815|567307542|FG001|Overall Study|Physician Decision|1|||
157153721|NCT00542815|567307543|FG002|Overall Study|Physician Decision|0|||
157153722|NCT00542815|567307541|FG000|Overall Study|Protocol Violation|1|||
157153723|NCT00542815|567307542|FG001|Overall Study|Protocol Violation|1|||
157153724|NCT00542815|567307543|FG002|Overall Study|Protocol Violation|2|||
157153725|NCT00542815|567307541|FG000|Overall Study|Withdrawal by Subject|41|||
157153726|NCT00542815|567307542|FG001|Overall Study|Withdrawal by Subject|5|||
157153727|NCT00542815|567307543|FG002|Overall Study|Withdrawal by Subject|8|||
157153728|NCT00542815|567307541|FG000|Overall Study|Other reasons|24|||
157153729|NCT00542815|567307542|FG001|Overall Study|Other reasons|10|||
157153730|NCT00542815|567307543|FG002|Overall Study|Other reasons|10|||
157153731|NCT01041573|567307544|FG000|Overall Study|Withdrawal by Subject|2|||
157153732|NCT01041573|567307545|FG001|Overall Study|Withdrawal by Subject|5|||
157153733|NCT01041573|567307546|FG002|Overall Study|Withdrawal by Subject|2|||
157153734|NCT01041573|567307547|FG003|Overall Study|Withdrawal by Subject|0|||
157153735|NCT01041573|567307544|FG000|Overall Study|Death|1|||
157153736|NCT01041573|567307545|FG001|Overall Study|Death|0|||
157153737|NCT01041573|567307546|FG002|Overall Study|Death|0|||
157153738|NCT01041573|567307547|FG003|Overall Study|Death|0|||
157153739|NCT01041573|567307544|FG000|Overall Study|Lost to Follow-up|0|||
157153740|NCT01041573|567307545|FG001|Overall Study|Lost to Follow-up|1|||
157153741|NCT01041573|567307546|FG002|Overall Study|Lost to Follow-up|2|||
157153742|NCT01041573|567307547|FG003|Overall Study|Lost to Follow-up|1|||
157153743|NCT01041573|567307544|FG000|Overall Study|Adverse Event|0|||
157153744|NCT01041573|567307545|FG001|Overall Study|Adverse Event|2|||
157153745|NCT01041573|567307546|FG002|Overall Study|Adverse Event|0|||
157153746|NCT01041573|567307547|FG003|Overall Study|Adverse Event|0|||
157153747|NCT01041573|567307544|FG000|Overall Study|relocation|1|||
157153748|NCT01041573|567307545|FG001|Overall Study|relocation|4|||
157153749|NCT01041573|567307546|FG002|Overall Study|relocation|3|||
157153750|NCT01041573|567307547|FG003|Overall Study|relocation|1|||
157153751|NCT01041573|567307544|FG000|Overall Study|further blood extraction|0|||
157153752|NCT01041573|567307545|FG001|Overall Study|further blood extraction|1|||
157153753|NCT01041573|567307546|FG002|Overall Study|further blood extraction|0|||
157153754|NCT01041573|567307547|FG003|Overall Study|further blood extraction|0|||
157153755|NCT01041573|567307544|FG000|Overall Study|positive to anti-HCV|1|||
157153756|NCT01041573|567307545|FG001|Overall Study|positive to anti-HCV|0|||
157153757|NCT01041573|567307546|FG002|Overall Study|positive to anti-HCV|0|||
157153758|NCT01041573|567307547|FG003|Overall Study|positive to anti-HCV|0|||
157153759|NCT02955186|567307548|FG000|Overall Study|Withdrawal by Subject|6|||
156886612|NCT00045942|566344001|FG004|PKC412A2104E2|Adverse Event|0|||
157153760|NCT02955186|567307549|FG001|Overall Study|Withdrawal by Subject|2|||
157153761|NCT02955186|567307548|FG000|Overall Study|Protocol Violation|1|||
157153762|NCT02955186|567307549|FG001|Overall Study|Protocol Violation|0|||
157153763|NCT01618656|567307551|FG000|Overall Study|Withdrawal by Subject|7|||
157153764|NCT01618656|567307552|FG001|Overall Study|Withdrawal by Subject|3|||
157153765|NCT01618656|567307551|FG000|Overall Study|Physician Decision|1|||
157153766|NCT01618656|567307552|FG001|Overall Study|Physician Decision|1|||
156886613|NCT00045942|566344002|FG005|PKC412A2104E2|Adverse Event|4|||
157153767|NCT01276847|567307553|FG000|Overall Study|Withdrawal by Subject|1|||
157153768|NCT01276847|567307554|FG001|Overall Study|Withdrawal by Subject|0|||
156886614|NCT00045942|566344003|FG006|PKC412A2104E2|Adverse Event|3|||
156886615|NCT00045942|566344004|FG007|PKC412A2104E2|Adverse Event|1|||
156886616|NCT00045942|566344005|FG008|PKC412A2104E2|Adverse Event|0|||
156886617|NCT00045942|566343997|FG000|PKC412A2104E2|Death|0|||
156886618|NCT00045942|566343998|FG001|PKC412A2104E2|Death|0|||
156886619|NCT00045942|566343999|FG002|PKC412A2104E2|Death|0|||
157153769|NCT01276847|567307555|FG002|Overall Study|Withdrawal by Subject|0|||
157153770|NCT02698423|567307559|FG000|Overall Study|Lost to Follow-up|19|||
157153771|NCT02698423|567307560|FG001|Overall Study|Lost to Follow-up|24|||
156886620|NCT00045942|566344000|FG003|PKC412A2104E2|Death|0|||
157153772|NCT00064662|567307564|FG000|Overall Study|Death|1|||
157153773|NCT00064662|567307565|FG001|Overall Study|Death|1|||
157153774|NCT00064662|567307564|FG000|Overall Study|Lost to Follow-up|57|||
157153775|NCT00064662|567307565|FG001|Overall Study|Lost to Follow-up|44|||
156838745|NCT03178669|566161587|FG004|Overall Study|Withdrawal by Subject|0|||
156838746|NCT03178669|566161583|FG000|Overall Study|Lost to Follow-up|0|||
156838747|NCT03178669|566161584|FG001|Overall Study|Lost to Follow-up|0|||
156838748|NCT03178669|566161585|FG002|Overall Study|Lost to Follow-up|0|||
157023963|NCT04111536|566841157|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
157023964|NCT04111536|566841156|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
157023965|NCT04111536|566841157|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
156838749|NCT03178669|566161586|FG003|Overall Study|Lost to Follow-up|1|||
156838750|NCT03178669|566161587|FG004|Overall Study|Lost to Follow-up|0|||
156838751|NCT00694304|566161591|FG000|Overall Study|Adverse Event|42|||
156838752|NCT00694304|566161591|FG000|Overall Study|Lack of Efficacy|35|||
156838753|NCT00694304|566161591|FG000|Overall Study|Non-compliance With Study Product|16|||
156838754|NCT00694304|566161591|FG000|Overall Study|Protocol Violation|6|||
156838755|NCT00694304|566161591|FG000|Overall Study|Withdrawal of Consent|61|||
156838756|NCT00694304|566161591|FG000|Overall Study|Lost to Follow-up|15|||
156838757|NCT00694304|566161591|FG000|Overall Study|Administrative or Other Reasons|32|||
156838758|NCT01459913|566161594|FG000|Overall Study|Adverse Event|0|||
156838759|NCT01459913|566161595|FG001|Overall Study|Adverse Event|0|||
156838760|NCT01459913|566161596|FG002|Overall Study|Adverse Event|0|||
156838761|NCT01459913|566161597|FG003|Overall Study|Adverse Event|3|||
156838762|NCT01459913|566161594|FG000|Overall Study|Withdrawal by Subject|4|||
156838763|NCT01459913|566161595|FG001|Overall Study|Withdrawal by Subject|0|||
156838764|NCT01459913|566161596|FG002|Overall Study|Withdrawal by Subject|0|||
156838765|NCT01459913|566161597|FG003|Overall Study|Withdrawal by Subject|5|||
156838766|NCT01459913|566161594|FG000|Overall Study|Lost to Follow-up|7|||
156838767|NCT01459913|566161595|FG001|Overall Study|Lost to Follow-up|4|||
156838768|NCT01459913|566161596|FG002|Overall Study|Lost to Follow-up|1|||
156838769|NCT01459913|566161597|FG003|Overall Study|Lost to Follow-up|8|||
156838770|NCT01459913|566161594|FG000|Overall Study|Death|0|||
156838771|NCT01459913|566161595|FG001|Overall Study|Death|0|||
156838772|NCT01459913|566161596|FG002|Overall Study|Death|0|||
156838773|NCT01459913|566161597|FG003|Overall Study|Death|1|||
156838774|NCT01459913|566161594|FG000|Overall Study|Non- Compliance|0|||
156838775|NCT01459913|566161595|FG001|Overall Study|Non- Compliance|0|||
156838776|NCT01459913|566161596|FG002|Overall Study|Non- Compliance|0|||
156838777|NCT01459913|566161597|FG003|Overall Study|Non- Compliance|3|||
156838778|NCT01459913|566161594|FG000|Overall Study|Physician Decision|0|||
156838779|NCT01459913|566161595|FG001|Overall Study|Physician Decision|1|||
156838780|NCT01459913|566161596|FG002|Overall Study|Physician Decision|0|||
156838781|NCT01459913|566161597|FG003|Overall Study|Physician Decision|0|||
156838782|NCT01459913|566161594|FG000|Overall Study|Study Terminated by Sponsor|30|||
156838783|NCT01459913|566161595|FG001|Overall Study|Study Terminated by Sponsor|15|||
156838784|NCT01459913|566161596|FG002|Overall Study|Study Terminated by Sponsor|9|||
156838785|NCT01459913|566161597|FG003|Overall Study|Study Terminated by Sponsor|11|||
156838786|NCT01459913|566161594|FG000|Overall Study|Other|0|||
156838787|NCT01459913|566161595|FG001|Overall Study|Other|0|||
156838788|NCT01459913|566161596|FG002|Overall Study|Other|3|||
157023966|NCT04111536|566841156|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
157023967|NCT04111536|566841157|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
157023968|NCT04187833|566841158|FG000|Overall Study|Withdrawal by Subject|1|||
157023969|NCT06037369|566841162|FG000|Overall Study|Lost to Follow-up|0|||
157023970|NCT06037369|566841163|FG001|Overall Study|Lost to Follow-up|1|||
157023971|NCT04209465|566841164|FG000|Overall Study|Adverse Event|0|||
157023972|NCT04209465|566841165|FG001|Overall Study|Adverse Event|0|||
157023973|NCT04209465|566841166|FG002|Overall Study|Adverse Event|0|||
157023974|NCT04209465|566841167|FG003|Overall Study|Adverse Event|0|||
157023975|NCT04209465|566841168|FG004|Overall Study|Adverse Event|0|||
157023976|NCT04209465|566841169|FG005|Overall Study|Adverse Event|1|||
157023977|NCT04209465|566841170|FG006|Overall Study|Adverse Event|0|||
157023978|NCT04209465|566841171|FG007|Overall Study|Adverse Event|0|||
157023979|NCT04209465|566841172|FG008|Overall Study|Adverse Event|1|||
157023980|NCT04209465|566841173|FG009|Overall Study|Adverse Event|0|||
157023981|NCT04209465|566841174|FG010|Overall Study|Adverse Event|2|||
157023982|NCT04209465|566841175|FG011|Overall Study|Adverse Event|1|||
157023983|NCT04209465|566841176|FG012|Overall Study|Adverse Event|1|||
157023984|NCT04209465|566841164|FG000|Overall Study|Death|1|||
157153776|NCT00064662|567307564|FG000|Overall Study|Withdrawal by Subject|14|||
157153777|NCT00064662|567307565|FG001|Overall Study|Withdrawal by Subject|14|||
156838789|NCT01459913|566161597|FG003|Overall Study|Other|1|||
156838790|NCT01459913|566161594|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838791|NCT01459913|566161595|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838792|NCT01459913|566161596|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
156838793|NCT01459913|566161597|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
156838794|NCT00454649|566161600|FG000|Overall Study|Lack of Efficacy|2|||
156838795|NCT00454649|566161601|FG001|Overall Study|Lack of Efficacy|2|||
156838796|NCT00454649|566161602|FG002|Overall Study|Lack of Efficacy|10|||
156838797|NCT00454649|566161603|FG003|Overall Study|Lack of Efficacy|3|||
156838798|NCT00454649|566161604|FG004|Overall Study|Lack of Efficacy|0|||
157023985|NCT04209465|566841165|FG001|Overall Study|Death|0|||
157023986|NCT04209465|566841166|FG002|Overall Study|Death|0|||
157023987|NCT04209465|566841167|FG003|Overall Study|Death|0|||
157023988|NCT04209465|566841168|FG004|Overall Study|Death|2|||
157023989|NCT04209465|566841169|FG005|Overall Study|Death|7|||
157023990|NCT04209465|566841170|FG006|Overall Study|Death|2|||
157023991|NCT04209465|566841171|FG007|Overall Study|Death|2|||
157023992|NCT04209465|566841172|FG008|Overall Study|Death|1|||
157023993|NCT04209465|566841173|FG009|Overall Study|Death|1|||
157023994|NCT04209465|566841174|FG010|Overall Study|Death|1|||
156838799|NCT00454649|566161605|FG005|Overall Study|Lack of Efficacy|4|||
156838800|NCT00454649|566161606|FG006|Overall Study|Lack of Efficacy|5|||
156838801|NCT00454649|566161607|FG007|Overall Study|Lack of Efficacy|13|||
156838802|NCT00454649|566161608|FG008|Overall Study|Lack of Efficacy|10|||
156838803|NCT00454649|566161609|FG009|Overall Study|Lack of Efficacy|2|||
156838804|NCT00454649|566161600|FG000|Overall Study|Adverse Event|0|||
156838805|NCT00454649|566161601|FG001|Overall Study|Adverse Event|1|||
156838806|NCT00454649|566161602|FG002|Overall Study|Adverse Event|3|||
156838807|NCT00454649|566161603|FG003|Overall Study|Adverse Event|0|||
156838808|NCT00454649|566161604|FG004|Overall Study|Adverse Event|1|||
156838809|NCT00454649|566161605|FG005|Overall Study|Adverse Event|2|||
156838810|NCT00454649|566161606|FG006|Overall Study|Adverse Event|3|||
156838811|NCT00454649|566161607|FG007|Overall Study|Adverse Event|4|||
157023995|NCT04209465|566841175|FG011|Overall Study|Death|0|||
157023996|NCT04209465|566841176|FG012|Overall Study|Death|10|||
157023997|NCT04209465|566841164|FG000|Overall Study|Physician Decision|0|||
157023998|NCT04209465|566841165|FG001|Overall Study|Physician Decision|1|||
157023999|NCT04209465|566841166|FG002|Overall Study|Physician Decision|0|||
157024000|NCT04209465|566841167|FG003|Overall Study|Physician Decision|0|||
156838812|NCT00454649|566161608|FG008|Overall Study|Adverse Event|6|||
156838813|NCT00454649|566161609|FG009|Overall Study|Adverse Event|2|||
156838814|NCT00454649|566161600|FG000|Overall Study|Lost to Follow-up|0|||
156838815|NCT00454649|566161601|FG001|Overall Study|Lost to Follow-up|0|||
156838816|NCT00454649|566161602|FG002|Overall Study|Lost to Follow-up|1|||
156838817|NCT00454649|566161603|FG003|Overall Study|Lost to Follow-up|0|||
156838818|NCT00454649|566161604|FG004|Overall Study|Lost to Follow-up|0|||
156838819|NCT00454649|566161605|FG005|Overall Study|Lost to Follow-up|0|||
156838820|NCT00454649|566161606|FG006|Overall Study|Lost to Follow-up|1|||
156838821|NCT00454649|566161607|FG007|Overall Study|Lost to Follow-up|0|||
156838822|NCT00454649|566161608|FG008|Overall Study|Lost to Follow-up|0|||
156838823|NCT00454649|566161609|FG009|Overall Study|Lost to Follow-up|0|||
156838824|NCT00454649|566161600|FG000|Overall Study|Other|1|||
156838825|NCT00454649|566161601|FG001|Overall Study|Other|1|||
156838826|NCT00454649|566161602|FG002|Overall Study|Other|5|||
156838827|NCT00454649|566161603|FG003|Overall Study|Other|3|||
156838828|NCT00454649|566161604|FG004|Overall Study|Other|0|||
156838829|NCT00454649|566161605|FG005|Overall Study|Other|0|||
156838830|NCT00454649|566161606|FG006|Overall Study|Other|0|||
156838831|NCT00454649|566161607|FG007|Overall Study|Other|0|||
156838832|NCT00454649|566161608|FG008|Overall Study|Other|3|||
156838833|NCT00454649|566161609|FG009|Overall Study|Other|1|||
156838834|NCT00454649|566161600|FG000|Overall Study|Withdrawal by Subject|0|||
156838835|NCT00454649|566161601|FG001|Overall Study|Withdrawal by Subject|0|||
156838836|NCT00454649|566161602|FG002|Overall Study|Withdrawal by Subject|0|||
156838837|NCT00454649|566161603|FG003|Overall Study|Withdrawal by Subject|0|||
156838838|NCT00454649|566161604|FG004|Overall Study|Withdrawal by Subject|0|||
156838839|NCT00454649|566161605|FG005|Overall Study|Withdrawal by Subject|1|||
156838840|NCT00454649|566161606|FG006|Overall Study|Withdrawal by Subject|0|||
156838841|NCT00454649|566161607|FG007|Overall Study|Withdrawal by Subject|2|||
156838842|NCT00454649|566161608|FG008|Overall Study|Withdrawal by Subject|1|||
156838843|NCT00454649|566161609|FG009|Overall Study|Withdrawal by Subject|0|||
157024001|NCT04209465|566841168|FG004|Overall Study|Physician Decision|0|||
157024002|NCT04209465|566841169|FG005|Overall Study|Physician Decision|0|||
157024003|NCT04209465|566841170|FG006|Overall Study|Physician Decision|0|||
157024004|NCT04209465|566841171|FG007|Overall Study|Physician Decision|0|||
157024005|NCT04209465|566841172|FG008|Overall Study|Physician Decision|0|||
157024006|NCT04209465|566841173|FG009|Overall Study|Physician Decision|0|||
157024007|NCT04209465|566841174|FG010|Overall Study|Physician Decision|0|||
157024008|NCT04209465|566841175|FG011|Overall Study|Physician Decision|0|||
156838844|NCT02925728|566161610|FG000|Overall Study|Death|3|||
156838845|NCT02925728|566161611|FG001|Overall Study|Death|5|||
156838846|NCT02925728|566161610|FG000|Overall Study|Physician Decision|1|||
156838847|NCT02925728|566161611|FG001|Overall Study|Physician Decision|0|||
156838848|NCT02925728|566161610|FG000|Overall Study|Withdrawal by Subject|1|||
156838849|NCT02925728|566161611|FG001|Overall Study|Withdrawal by Subject|0|||
156838850|NCT02102399|566161612|FG000|Overall Study|Withdrawal by Subject|6|||
156838851|NCT02102399|566161613|FG001|Overall Study|Withdrawal by Subject|4|||
156838852|NCT00086411|566161616|FG000|Overall Study|Lost to Follow-up|11|||
156838853|NCT00086411|566161617|FG001|Overall Study|Lost to Follow-up|11|||
156838854|NCT00086411|566161618|FG002|Overall Study|Lost to Follow-up|13|||
156838855|NCT00086411|566161619|FG003|Overall Study|Lost to Follow-up|12|||
157024009|NCT04209465|566841176|FG012|Overall Study|Physician Decision|0|||
157024010|NCT04209465|566841164|FG000|Overall Study|Progressive Disease|0|||
157153778|NCT00064662|567307564|FG000|Overall Study|Administratively withdrawn|2|||
157153779|NCT00064662|567307565|FG001|Overall Study|Administratively withdrawn|2|||
157153780|NCT00504166|567307570|FG000|Overall Study|Adverse Event|1|||
157153781|NCT00504166|567307571|FG001|Overall Study|Adverse Event|4|||
157153782|NCT00504166|567307570|FG000|Overall Study|Withdrawal by Subject|3|||
157153783|NCT00504166|567307571|FG001|Overall Study|Withdrawal by Subject|6|||
157153784|NCT00504166|567307570|FG000|Overall Study|Physician Decision|1|||
157153785|NCT00504166|567307571|FG001|Overall Study|Physician Decision|1|||
157153786|NCT00504166|567307570|FG000|Overall Study|Lost to Follow-up|1|||
157153787|NCT00504166|567307571|FG001|Overall Study|Lost to Follow-up|3|||
157153788|NCT01096550|567307572|FG000|Overall Study|discontinued site|10|||
157153789|NCT01096550|567307573|FG001|Overall Study|discontinued site|11|||
157153790|NCT01096550|567307572|FG000|Overall Study|non-regular treatment track at clinic|1|||
157153791|NCT01096550|567307573|FG001|Overall Study|non-regular treatment track at clinic|1|||
157153792|NCT01096550|567307572|FG000|Overall Study|clinic readmission|1|||
157153793|NCT01096550|567307573|FG001|Overall Study|clinic readmission|1|||
157153794|NCT01096550|567307572|FG000|Overall Study|Withdrawal by Subject|0|||
157153795|NCT01096550|567307573|FG001|Overall Study|Withdrawal by Subject|1|||
157153796|NCT01096550|567307572|FG000|Overall Study|non-African American participant|13|||
157153797|NCT01096550|567307573|FG001|Overall Study|non-African American participant|6|||
157153798|NCT01096550|567307572|FG000|Overall Study|Lost to Follow-up|12|||
157153799|NCT01096550|567307573|FG001|Overall Study|Lost to Follow-up|9|||
157153800|NCT01345786|567307578|FG000|Overall Study|Adverse Event|0|||
157153801|NCT01345786|567307579|FG001|Overall Study|Adverse Event|1|||
157153802|NCT01345786|567307580|FG002|Overall Study|Adverse Event|3|||
157153803|NCT01345786|567307581|FG003|Overall Study|Adverse Event|1|||
157153804|NCT01345786|567307578|FG000|Overall Study|Subject withdrew consent|2|||
157153805|NCT01345786|567307579|FG001|Overall Study|Subject withdrew consent|2|||
156838856|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838857|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838858|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838859|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838860|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838861|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838862|NCT00718770|566161620|FG000|Overall Study|Lack of Efficacy|1|||
156838863|NCT00718770|566161620|FG000|Overall Study|Adverse Event|1|||
156838864|NCT02540291|566161626|FG000|Overall Study|Death|7|||
156838865|NCT02540291|566161627|FG001|Overall Study|Death|7|||
156838866|NCT02540291|566161628|FG002|Overall Study|Death|5|||
156838867|NCT02540291|566161629|FG003|Overall Study|Death|7|||
156838868|NCT02540291|566161626|FG000|Overall Study|Lost to Follow-up|0|||
156838869|NCT02540291|566161627|FG001|Overall Study|Lost to Follow-up|0|||
156838870|NCT02540291|566161628|FG002|Overall Study|Lost to Follow-up|1|||
156838871|NCT02540291|566161629|FG003|Overall Study|Lost to Follow-up|0|||
156838872|NCT02540291|566161626|FG000|Overall Study|Withdrawal Of Consent|0|||
156838873|NCT02540291|566161627|FG001|Overall Study|Withdrawal Of Consent|1|||
156838874|NCT02540291|566161628|FG002|Overall Study|Withdrawal Of Consent|0|||
156838875|NCT02540291|566161629|FG003|Overall Study|Withdrawal Of Consent|0|||
156838876|NCT02540291|566161626|FG000|Overall Study|Study Terminated By Sponsor|1|||
156838877|NCT02540291|566161627|FG001|Overall Study|Study Terminated By Sponsor|0|||
156838878|NCT02540291|566161628|FG002|Overall Study|Study Terminated By Sponsor|0|||
156838879|NCT02540291|566161629|FG003|Overall Study|Study Terminated By Sponsor|0|||
156838880|NCT02540291|566161626|FG000|Overall Study|Other|0|||
156838881|NCT02540291|566161627|FG001|Overall Study|Other|0|||
156838882|NCT02540291|566161628|FG002|Overall Study|Other|1|||
157153806|NCT01345786|567307580|FG002|Overall Study|Subject withdrew consent|1|||
156838883|NCT02540291|566161629|FG003|Overall Study|Other|0|||
156838884|NCT01879072|566161643|FG000|Overall Study|Withdrawal by Subject|121|||
156838885|NCT01879072|566161643|FG000|Overall Study|Not Transplanted|30|||
156838886|NCT04667104|566161652|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
156838887|NCT04667104|566161653|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
156838888|NCT04667104|566161654|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
156838889|NCT01078168|566161655|FG000|Overall Study|Physician Decision|0|||
156838890|NCT01078168|566161656|FG001|Overall Study|Physician Decision|1|||
156838891|NCT01264419|566161657|FG000|Overall Study|Lost to Follow-up|3|||
156838892|NCT04566601|566163275|FG000|Overall Study|Other than listed|13|||
156838893|NCT04566601|566163276|FG001|Overall Study|Other than listed|4|||
156838894|NCT04566601|566163277|FG002|Overall Study|Other than listed|2|||
156838895|NCT04566601|566163278|FG003|Overall Study|Other than listed|1|||
156838896|NCT04566601|566163279|FG004|Overall Study|Other than listed|4|||
156838897|NCT04566601|566163275|FG000|Overall Study|Protocol deviation|3|||
156886621|NCT00045942|566344001|FG004|PKC412A2104E2|Death|0|||
156838898|NCT04566601|566163276|FG001|Overall Study|Protocol deviation|0|||
156838899|NCT04566601|566163277|FG002|Overall Study|Protocol deviation|1|||
156838900|NCT04566601|566163278|FG003|Overall Study|Protocol deviation|1|||
157153807|NCT01345786|567307581|FG003|Overall Study|Subject withdrew consent|0|||
157153808|NCT01345786|567307578|FG000|Overall Study|Noncompliance with protocol|1|||
157153809|NCT01345786|567307579|FG001|Overall Study|Noncompliance with protocol|0|||
157153810|NCT01345786|567307580|FG002|Overall Study|Noncompliance with protocol|1|||
156838901|NCT04566601|566163279|FG004|Overall Study|Protocol deviation|1|||
156838902|NCT04566601|566163275|FG000|Overall Study|Technical problems|0|||
156838903|NCT04566601|566163276|FG001|Overall Study|Technical problems|0|||
156838904|NCT04566601|566163277|FG002|Overall Study|Technical problems|1|||
156838905|NCT04566601|566163278|FG003|Overall Study|Technical problems|0|||
156838906|NCT04566601|566163279|FG004|Overall Study|Technical problems|0|||
156838907|NCT04566601|566163275|FG000|Overall Study|No reason available|3|||
156838908|NCT04566601|566163276|FG001|Overall Study|No reason available|2|||
156838909|NCT04566601|566163277|FG002|Overall Study|No reason available|7|||
156838910|NCT04566601|566163278|FG003|Overall Study|No reason available|1|||
156838911|NCT04566601|566163279|FG004|Overall Study|No reason available|5|||
156838912|NCT04566601|566163275|FG000|Overall Study|Burden of study procedures|3|||
156838913|NCT04566601|566163276|FG001|Overall Study|Burden of study procedures|0|||
156838914|NCT04566601|566163277|FG002|Overall Study|Burden of study procedures|0|||
156838915|NCT04566601|566163278|FG003|Overall Study|Burden of study procedures|3|||
156838916|NCT04566601|566163279|FG004|Overall Study|Burden of study procedures|1|||
156838917|NCT04566601|566163275|FG000|Overall Study|Change of residence|2|||
156838918|NCT04566601|566163276|FG001|Overall Study|Change of residence|2|||
156838919|NCT04566601|566163277|FG002|Overall Study|Change of residence|0|||
156838920|NCT04566601|566163278|FG003|Overall Study|Change of residence|1|||
156838921|NCT04566601|566163279|FG004|Overall Study|Change of residence|2|||
156838922|NCT04566601|566163275|FG000|Overall Study|Perceived lack of efficacy|2|||
156838923|NCT04566601|566163276|FG001|Overall Study|Perceived lack of efficacy|0|||
156838924|NCT04566601|566163277|FG002|Overall Study|Perceived lack of efficacy|1|||
156838925|NCT04566601|566163278|FG003|Overall Study|Perceived lack of efficacy|1|||
156838926|NCT04566601|566163279|FG004|Overall Study|Perceived lack of efficacy|2|||
156838927|NCT04566601|566163275|FG000|Overall Study|Adverse Event|7|||
156838928|NCT04566601|566163276|FG001|Overall Study|Adverse Event|4|||
156838929|NCT04566601|566163277|FG002|Overall Study|Adverse Event|6|||
156838930|NCT04566601|566163278|FG003|Overall Study|Adverse Event|5|||
156838931|NCT04566601|566163279|FG004|Overall Study|Adverse Event|12|||
156838932|NCT02814175|566163282|FG000|Part 1|Adverse Event|2|||
156838933|NCT02814175|566163283|FG001|Part 1|Adverse Event|3|||
156838934|NCT02814175|566163284|FG002|Part 1|Adverse Event|0|||
156838935|NCT02814175|566163285|FG003|Part 1|Adverse Event|0|||
156838936|NCT02814175|566163286|FG004|Part 1|Adverse Event|0|||
156838937|NCT02814175|566163287|FG005|Part 1|Adverse Event|0|||
156838938|NCT02814175|566163282|FG000|Part 1|Withdrawal Consent|8|||
156838939|NCT02814175|566163283|FG001|Part 1|Withdrawal Consent|1|||
156838940|NCT02814175|566163284|FG002|Part 1|Withdrawal Consent|0|||
156838941|NCT02814175|566163285|FG003|Part 1|Withdrawal Consent|0|||
156838942|NCT02814175|566163286|FG004|Part 1|Withdrawal Consent|0|||
156838943|NCT02814175|566163287|FG005|Part 1|Withdrawal Consent|0|||
156838944|NCT02814175|566163282|FG000|Part 1|Lost to Follow-up|1|||
156838945|NCT02814175|566163283|FG001|Part 1|Lost to Follow-up|0|||
156838946|NCT02814175|566163284|FG002|Part 1|Lost to Follow-up|0|||
156838947|NCT02814175|566163285|FG003|Part 1|Lost to Follow-up|0|||
156838948|NCT02814175|566163286|FG004|Part 1|Lost to Follow-up|0|||
156838949|NCT02814175|566163287|FG005|Part 1|Lost to Follow-up|0|||
156838950|NCT02814175|566163282|FG000|Part 1|Lack of Efficacy|1|||
156838951|NCT02814175|566163283|FG001|Part 1|Lack of Efficacy|2|||
156838952|NCT02814175|566163284|FG002|Part 1|Lack of Efficacy|0|||
156838953|NCT02814175|566163285|FG003|Part 1|Lack of Efficacy|0|||
156838954|NCT02814175|566163286|FG004|Part 1|Lack of Efficacy|0|||
156838955|NCT02814175|566163287|FG005|Part 1|Lack of Efficacy|0|||
156838956|NCT02814175|566163282|FG000|Part 2|Adverse Event|0|||
156838957|NCT02814175|566163283|FG001|Part 2|Adverse Event|0|||
156838958|NCT02814175|566163284|FG002|Part 2|Adverse Event|0|||
156838959|NCT02814175|566163285|FG003|Part 2|Adverse Event|1|||
156838960|NCT02814175|566163286|FG004|Part 2|Adverse Event|1|||
156838961|NCT02814175|566163287|FG005|Part 2|Adverse Event|2|||
156838962|NCT02814175|566163282|FG000|Part 2|Withdrawal Consent|0|||
156838963|NCT02814175|566163283|FG001|Part 2|Withdrawal Consent|0|||
156838964|NCT02814175|566163284|FG002|Part 2|Withdrawal Consent|0|||
156838965|NCT02814175|566163285|FG003|Part 2|Withdrawal Consent|2|||
156838966|NCT02814175|566163286|FG004|Part 2|Withdrawal Consent|1|||
156838967|NCT02814175|566163287|FG005|Part 2|Withdrawal Consent|1|||
156838968|NCT02814175|566163282|FG000|Part 2|Lost to Follow-up|0|||
156838969|NCT02814175|566163283|FG001|Part 2|Lost to Follow-up|0|||
156838970|NCT02814175|566163284|FG002|Part 2|Lost to Follow-up|0|||
156838971|NCT02814175|566163285|FG003|Part 2|Lost to Follow-up|1|||
156838972|NCT02814175|566163286|FG004|Part 2|Lost to Follow-up|0|||
156838973|NCT02814175|566163287|FG005|Part 2|Lost to Follow-up|0|||
156838974|NCT02814175|566163282|FG000|Part 2|Lack of Efficacy|0|||
156838975|NCT02814175|566163283|FG001|Part 2|Lack of Efficacy|0|||
156838976|NCT02814175|566163284|FG002|Part 2|Lack of Efficacy|0|||
156838977|NCT02814175|566163285|FG003|Part 2|Lack of Efficacy|0|||
156838978|NCT02814175|566163286|FG004|Part 2|Lack of Efficacy|0|||
156838979|NCT02814175|566163287|FG005|Part 2|Lack of Efficacy|3|||
156838980|NCT01971008|566163295|FG000|Overall Study|Protocol Violation|2|||
156838981|NCT01971008|566163296|FG001|Overall Study|Protocol Violation|1|||
156838982|NCT00924508|566163297|FG000|Overall Study|Withdrawal by Subject|3|||
156838983|NCT03775512|566163298|FG000|Overall Study|Death|1|||
156838984|NCT03775512|566163299|FG001|Overall Study|Death|1|||
156838985|NCT03775512|566163298|FG000|Overall Study|Withdrawal by Subject|7|||
156838986|NCT03775512|566163299|FG001|Overall Study|Withdrawal by Subject|4|||
156838987|NCT03775512|566163298|FG000|Overall Study|Lost to Follow-up|5|||
156838988|NCT03775512|566163299|FG001|Overall Study|Lost to Follow-up|5|||
156838989|NCT03775512|566163298|FG000|Overall Study|Excluded before Catheter insertion|14|||
156838990|NCT03775512|566163299|FG001|Overall Study|Excluded before Catheter insertion|5|||
156838991|NCT03775512|566163298|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
156886622|NCT00045942|566344002|FG005|PKC412A2104E2|Death|1|||
156886623|NCT00045942|566344003|FG006|PKC412A2104E2|Death|2|||
156886624|NCT00045942|566344004|FG007|PKC412A2104E2|Death|0|||
157153811|NCT01345786|567307581|FG003|Overall Study|Noncompliance with protocol|0|||
157153812|NCT01345786|567307578|FG000|Overall Study|Administrative|3|||
157153813|NCT01345786|567307579|FG001|Overall Study|Administrative|5|||
157153814|NCT01345786|567307580|FG002|Overall Study|Administrative|0|||
157153815|NCT01345786|567307581|FG003|Overall Study|Administrative|0|||
157153816|NCT01345786|567307578|FG000|Overall Study|Lost to Follow-up|0|||
157153817|NCT01345786|567307579|FG001|Overall Study|Lost to Follow-up|0|||
157153818|NCT01345786|567307580|FG002|Overall Study|Lost to Follow-up|0|||
157153819|NCT01345786|567307581|FG003|Overall Study|Lost to Follow-up|2|||
157153820|NCT01963117|567307584|FG000|Overall Study|Death|1|||
157153821|NCT01070784|567307585|FG000|Overall Study|Withdrawal by Subject|6|||
157153822|NCT01070784|567307586|FG001|Overall Study|Withdrawal by Subject|9|||
157153823|NCT01070784|567307585|FG000|Overall Study|Adverse Event|14|||
157153824|NCT01070784|567307586|FG001|Overall Study|Adverse Event|9|||
157153825|NCT01323673|567307587|FG000|Overall Study|Adverse Event|0|||
157153826|NCT01323673|567307588|FG001|Overall Study|Adverse Event|1|||
157153827|NCT01323673|567307587|FG000|Overall Study|Lost to Follow-up|0|||
157153828|NCT01323673|567307588|FG001|Overall Study|Lost to Follow-up|1|||
157153829|NCT01323673|567307587|FG000|Overall Study|Protocol Violation|1|||
157153830|NCT01323673|567307588|FG001|Overall Study|Protocol Violation|0|||
157153831|NCT01323673|567307587|FG000|Overall Study|Withdrawal by Subject|2|||
157153832|NCT01323673|567307588|FG001|Overall Study|Withdrawal by Subject|3|||
157153833|NCT03844633|567307590|FG000|1 Week FU|Lost to Follow-up|0|||
157153834|NCT03844633|567307591|FG001|1 Week FU|Lost to Follow-up|1|||
157153835|NCT03844633|567307592|FG002|1 Week FU|Lost to Follow-up|4|||
157153836|NCT03844633|567307590|FG000|12-month Follow-up|Lost to Follow-up|7|||
157153837|NCT03844633|567307591|FG001|12-month Follow-up|Lost to Follow-up|5|||
157153838|NCT03844633|567307592|FG002|12-month Follow-up|Lost to Follow-up|8|||
157153839|NCT02588248|567307593|FG000|Overall Study|Physician Decision|4|||
157153840|NCT02588248|567307594|FG001|Overall Study|Physician Decision|3|||
157153841|NCT01355068|567307597|FG000|First Intervention Period|Adverse Event|0|||
157153842|NCT01355068|567307598|FG001|First Intervention Period|Adverse Event|1|||
157153843|NCT01355068|567307597|FG000|First Intervention Period|Withdrawal by Subject|0|||
157153844|NCT01355068|567307598|FG001|First Intervention Period|Withdrawal by Subject|1|||
157153845|NCT04229446|567307599|FG000|Overall Study|Death|12|||
157153846|NCT04229446|567307600|FG001|Overall Study|Death|10|||
157153847|NCT04229446|567307599|FG000|Overall Study|Lost to Follow-up|5|||
157153848|NCT04229446|567307600|FG001|Overall Study|Lost to Follow-up|8|||
157153849|NCT04083222|567307602|FG000|Overall Study|Voluntary Withdrawal|0|||
157153850|NCT04083222|567307603|FG001|Overall Study|Voluntary Withdrawal|1|||
157153851|NCT04083222|567307602|FG000|Overall Study|Reason not Specified|0|||
157153852|NCT04083222|567307603|FG001|Overall Study|Reason not Specified|1|||
157153853|NCT01937130|567309472|FG000|Overall Study|Withdrawal by Subject|0|||
157153854|NCT01937130|567309473|FG001|Overall Study|Withdrawal by Subject|0|||
157153855|NCT01937130|567309474|FG002|Overall Study|Withdrawal by Subject|0|||
157153856|NCT01937130|567309475|FG003|Overall Study|Withdrawal by Subject|1|||
157153857|NCT01937130|567309472|FG000|Overall Study|Adverse Event|0|||
156838992|NCT03775512|566163299|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
156838993|NCT03775512|566163298|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
156838994|NCT03775512|566163299|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
156838995|NCT00495625|566163300|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
156838996|NCT01610336|566163301|FG000|Overall Study|Progressive Disease|4|||
157153858|NCT01937130|567309473|FG001|Overall Study|Adverse Event|1|||
157153859|NCT01937130|567309474|FG002|Overall Study|Adverse Event|0|||
157153860|NCT01937130|567309475|FG003|Overall Study|Adverse Event|1|||
157153861|NCT01937130|567309472|FG000|Overall Study|Death|1|||
157153862|NCT01937130|567309473|FG001|Overall Study|Death|1|||
157153863|NCT01937130|567309474|FG002|Overall Study|Death|1|||
156838997|NCT01610336|566163302|FG001|Overall Study|Progressive Disease|6|||
156886625|NCT00045942|566344005|FG008|PKC412A2104E2|Death|0|||
157153864|NCT01937130|567309475|FG003|Overall Study|Death|0|||
157153865|NCT01937130|567309472|FG000|Overall Study|Lost to Follow-up|2|||
157153866|NCT01937130|567309473|FG001|Overall Study|Lost to Follow-up|0|||
157153867|NCT01937130|567309474|FG002|Overall Study|Lost to Follow-up|2|||
157153868|NCT01937130|567309475|FG003|Overall Study|Lost to Follow-up|0|||
156886626|NCT05508074|566344006|FG000|Overall Study|Death|2|||
156886627|NCT05508074|566344007|FG001|Overall Study|Death|5|||
156886628|NCT05508074|566344006|FG000|Overall Study|Withdrawal by Subject|1|||
156886629|NCT05508074|566344007|FG001|Overall Study|Withdrawal by Subject|2|||
156886630|NCT05508074|566344006|FG000|Overall Study|Adverse Event|0|||
156886631|NCT05508074|566344007|FG001|Overall Study|Adverse Event|1|||
156886632|NCT05508074|566344006|FG000|Overall Study|Physician Decision|0|||
156886633|NCT05508074|566344007|FG001|Overall Study|Physician Decision|1|||
156886634|NCT05508074|566344006|FG000|Overall Study|wrongly randomized|0|||
156886635|NCT05508074|566344007|FG001|Overall Study|wrongly randomized|1|||
156886636|NCT05508074|566344006|FG000|Overall Study|non-compliance|0|||
156886637|NCT05508074|566344007|FG001|Overall Study|non-compliance|1|||
156886638|NCT00466687|566344008|FG000|Overall Study|Adverse Event|1|||
156886639|NCT00466687|566344008|FG000|Overall Study|Other complicating illness|3|||
156886640|NCT00466687|566344008|FG000|Overall Study|Withdrawal by Subject|1|||
156886641|NCT00466687|566344008|FG000|Overall Study|Disease progression|29|||
156886642|NCT02395302|566344009|FG000|Overall Study|Screen Failure|3|||
156886643|NCT02395302|566344009|FG000|Overall Study|Run In Failure|7|||
156886644|NCT02395302|566344009|FG000|Overall Study|Withdrawal by Subject|2|||
156886645|NCT02395302|566344009|FG000|Overall Study|Physician Decision|2|||
156886646|NCT00783302|566344010|FG000|Overall Study|Lost to Follow-up|17|||
156886647|NCT00783302|566344010|FG000|Overall Study|Technical Problems|11|||
156886648|NCT00783302|566344010|FG000|Overall Study|Protocol Violation|3|||
156886649|NCT00783302|566344010|FG000|Overall Study|Physician Decision|1|||
156886650|NCT00783302|566344010|FG000|Overall Study|Withdrawal by Subject|3|||
156886651|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
156886652|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
156886653|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
156886654|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
156886655|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
156886656|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
156886657|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
156886658|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
156886659|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
156886660|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
156886661|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
156886662|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
156886663|NCT01087788|566344011|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
156886664|NCT01087788|566344012|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
156886665|NCT01087788|566344013|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
156886666|NCT01087788|566344011|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
156886667|NCT01087788|566344012|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
156886668|NCT01087788|566344013|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
156886669|NCT01087788|566344011|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
156838998|NCT01610336|566163303|FG002|Overall Study|Progressive Disease|6|||
156838999|NCT01610336|566163304|FG003|Overall Study|Progressive Disease|5|||
156839000|NCT01610336|566163305|FG004|Overall Study|Progressive Disease|3|||
156839001|NCT01610336|566163306|FG005|Overall Study|Progressive Disease|10|||
156839002|NCT01610336|566163307|FG006|Overall Study|Progressive Disease|1|||
156839003|NCT01610336|566163308|FG007|Overall Study|Progressive Disease|6|||
156839004|NCT01610336|566163309|FG008|Overall Study|Progressive Disease|6|||
156839005|NCT01610336|566163310|FG009|Overall Study|Progressive Disease|40|||
156839006|NCT01610336|566163311|FG010|Overall Study|Progressive Disease|36|||
156839007|NCT01610336|566163301|FG000|Overall Study|Adverse Event|0|||
156839008|NCT01610336|566163302|FG001|Overall Study|Adverse Event|0|||
156839009|NCT01610336|566163303|FG002|Overall Study|Adverse Event|0|||
156886670|NCT01087788|566344012|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
157024011|NCT04209465|566841165|FG001|Overall Study|Progressive Disease|0|||
156839010|NCT01610336|566163304|FG003|Overall Study|Adverse Event|1|||
156886671|NCT01087788|566344013|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
156886672|NCT01087788|566344011|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
156886673|NCT01087788|566344012|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
157024012|NCT04209465|566841166|FG002|Overall Study|Progressive Disease|1|||
157024013|NCT04209465|566841167|FG003|Overall Study|Progressive Disease|2|||
156839011|NCT01610336|566163305|FG004|Overall Study|Adverse Event|1|||
156839012|NCT01610336|566163306|FG005|Overall Study|Adverse Event|1|||
156839013|NCT01610336|566163307|FG006|Overall Study|Adverse Event|0|||
156886674|NCT01087788|566344013|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
156886675|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
156886676|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
156886677|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
156886678|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
156886679|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
156839014|NCT01610336|566163308|FG007|Overall Study|Adverse Event|0|||
156839015|NCT01610336|566163309|FG008|Overall Study|Adverse Event|2|||
156839016|NCT01610336|566163310|FG009|Overall Study|Adverse Event|8|||
156839017|NCT01610336|566163311|FG010|Overall Study|Adverse Event|6|||
156839018|NCT01610336|566163301|FG000|Overall Study|Subject/Guardian decision|1|||
156839019|NCT01610336|566163302|FG001|Overall Study|Subject/Guardian decision|1|||
156839020|NCT01610336|566163303|FG002|Overall Study|Subject/Guardian decision|0|||
156839021|NCT01610336|566163304|FG003|Overall Study|Subject/Guardian decision|1|||
156839022|NCT01610336|566163305|FG004|Overall Study|Subject/Guardian decision|0|||
156839023|NCT01610336|566163306|FG005|Overall Study|Subject/Guardian decision|0|||
156839024|NCT01610336|566163307|FG006|Overall Study|Subject/Guardian decision|0|||
156839025|NCT01610336|566163308|FG007|Overall Study|Subject/Guardian decision|1|||
156839026|NCT01610336|566163309|FG008|Overall Study|Subject/Guardian decision|0|||
156839027|NCT01610336|566163310|FG009|Overall Study|Subject/Guardian decision|2|||
156839028|NCT01610336|566163311|FG010|Overall Study|Subject/Guardian decision|2|||
156839029|NCT01610336|566163301|FG000|Overall Study|Death|0|||
156839030|NCT01610336|566163302|FG001|Overall Study|Death|0|||
156839031|NCT01610336|566163303|FG002|Overall Study|Death|0|||
156839032|NCT01610336|566163304|FG003|Overall Study|Death|0|||
156839033|NCT01610336|566163305|FG004|Overall Study|Death|0|||
156839034|NCT01610336|566163306|FG005|Overall Study|Death|1|||
156839035|NCT01610336|566163307|FG006|Overall Study|Death|3|||
156839036|NCT01610336|566163308|FG007|Overall Study|Death|0|||
156839037|NCT01610336|566163309|FG008|Overall Study|Death|0|||
156839038|NCT01610336|566163310|FG009|Overall Study|Death|1|||
156839039|NCT01610336|566163311|FG010|Overall Study|Death|2|||
156839040|NCT01610336|566163301|FG000|Overall Study|Non-Compliance with study treatment|0|||
156839041|NCT01610336|566163302|FG001|Overall Study|Non-Compliance with study treatment|0|||
156839042|NCT01610336|566163303|FG002|Overall Study|Non-Compliance with study treatment|0|||
156839043|NCT01610336|566163304|FG003|Overall Study|Non-Compliance with study treatment|0|||
156839044|NCT01610336|566163305|FG004|Overall Study|Non-Compliance with study treatment|0|||
156839045|NCT01610336|566163306|FG005|Overall Study|Non-Compliance with study treatment|0|||
156839046|NCT01610336|566163307|FG006|Overall Study|Non-Compliance with study treatment|0|||
156839047|NCT01610336|566163308|FG007|Overall Study|Non-Compliance with study treatment|0|||
156839048|NCT01610336|566163309|FG008|Overall Study|Non-Compliance with study treatment|0|||
156839049|NCT01610336|566163310|FG009|Overall Study|Non-Compliance with study treatment|1|||
156839050|NCT01610336|566163311|FG010|Overall Study|Non-Compliance with study treatment|0|||
156839051|NCT01610336|566163301|FG000|Overall Study|Physician Decision|0|||
156839052|NCT01610336|566163302|FG001|Overall Study|Physician Decision|0|||
156839053|NCT01610336|566163303|FG002|Overall Study|Physician Decision|0|||
156839054|NCT01610336|566163304|FG003|Overall Study|Physician Decision|0|||
156839055|NCT01610336|566163305|FG004|Overall Study|Physician Decision|0|||
156839056|NCT01610336|566163306|FG005|Overall Study|Physician Decision|0|||
156839057|NCT01610336|566163307|FG006|Overall Study|Physician Decision|1|||
156839058|NCT01610336|566163308|FG007|Overall Study|Physician Decision|0|||
156839059|NCT01610336|566163309|FG008|Overall Study|Physician Decision|0|||
156839060|NCT01610336|566163310|FG009|Overall Study|Physician Decision|0|||
156839061|NCT01610336|566163311|FG010|Overall Study|Physician Decision|0|||
156839062|NCT01610336|566163301|FG000|Overall Study|Protocol Deviation|0|||
156839063|NCT01610336|566163302|FG001|Overall Study|Protocol Deviation|0|||
156839064|NCT01610336|566163303|FG002|Overall Study|Protocol Deviation|0|||
156839065|NCT01610336|566163304|FG003|Overall Study|Protocol Deviation|0|||
156839066|NCT01610336|566163305|FG004|Overall Study|Protocol Deviation|0|||
156839067|NCT01610336|566163306|FG005|Overall Study|Protocol Deviation|0|||
156839068|NCT01610336|566163307|FG006|Overall Study|Protocol Deviation|0|||
156839069|NCT01610336|566163308|FG007|Overall Study|Protocol Deviation|0|||
156839070|NCT01610336|566163309|FG008|Overall Study|Protocol Deviation|0|||
156839071|NCT01610336|566163310|FG009|Overall Study|Protocol Deviation|1|||
156839072|NCT01610336|566163311|FG010|Overall Study|Protocol Deviation|0|||
156839073|NCT01610336|566163301|FG000|Overall Study|Transfer to another trial|0|||
156839074|NCT01610336|566163302|FG001|Overall Study|Transfer to another trial|0|||
156839075|NCT01610336|566163303|FG002|Overall Study|Transfer to another trial|0|||
156839076|NCT01610336|566163304|FG003|Overall Study|Transfer to another trial|0|||
156839077|NCT01610336|566163305|FG004|Overall Study|Transfer to another trial|0|||
156839078|NCT01610336|566163306|FG005|Overall Study|Transfer to another trial|0|||
156839079|NCT01610336|566163307|FG006|Overall Study|Transfer to another trial|0|||
156839080|NCT01610336|566163308|FG007|Overall Study|Transfer to another trial|0|||
156839081|NCT01610336|566163309|FG008|Overall Study|Transfer to another trial|0|||
156839082|NCT01610336|566163310|FG009|Overall Study|Transfer to another trial|0|||
156839083|NCT01610336|566163311|FG010|Overall Study|Transfer to another trial|1|||
156839084|NCT02629822|566163312|FG000|Base Study|Lost to Follow-up|2|||
156886680|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
156886681|NCT01087788|566344011|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
156839085|NCT02629822|566163312|FG000|Base Study|Non-Compliance With Study Drug|1|||
156839086|NCT02629822|566163312|FG000|Extension Study|Adverse Event|1|||
156839087|NCT02629822|566163312|FG000|Extension Study|Lost to Follow-up|1|||
156839088|NCT03679624|566163313|FG000|Overall Study|Adverse Event|1|||
156839089|NCT03679624|566163314|FG001|Overall Study|Adverse Event|0|||
156839090|NCT01912339|566163315|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
156839091|NCT01912339|566163316|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
156839092|NCT01912339|566163317|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
156839093|NCT01912339|566163315|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
156839094|NCT01912339|566163316|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
156839095|NCT01912339|566163317|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
156839096|NCT01912339|566163315|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
156839097|NCT01912339|566163316|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
156839098|NCT01912339|566163317|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
156839099|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
156839100|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
156839101|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
156839102|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
156839103|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
156839104|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
156839105|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
156839106|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
156839107|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
156839108|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
156839109|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
156839110|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
156839111|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
156839112|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
156839113|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
156839114|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
156839115|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
156839116|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
156839117|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
156839118|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
156839119|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
156839120|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
156839121|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
156839122|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
156839123|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
156839124|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
156839125|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
156886682|NCT01087788|566344012|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
156886683|NCT01087788|566344013|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
156886684|NCT01087788|566344011|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
157153869|NCT01937130|567309472|FG000|Overall Study|Physician Decision|0|||
157153870|NCT01937130|567309473|FG001|Overall Study|Physician Decision|1|||
157153871|NCT01937130|567309474|FG002|Overall Study|Physician Decision|0|||
157153872|NCT01937130|567309475|FG003|Overall Study|Physician Decision|0|||
157153873|NCT01937130|567309472|FG000|Overall Study|Patients unable to swallow|0|||
157224687|NCT03504852|567568059|FG002|Overall Study|Death|0|||
157224688|NCT03504852|567568057|FG000|Overall Study|Adverse Event|4|||
157224689|NCT03504852|567568058|FG001|Overall Study|Adverse Event|8|||
156839126|NCT01912339|566163315|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
157153874|NCT01937130|567309473|FG001|Overall Study|Patients unable to swallow|1|||
157153875|NCT01937130|567309474|FG002|Overall Study|Patients unable to swallow|0|||
157153876|NCT01937130|567309475|FG003|Overall Study|Patients unable to swallow|0|||
157153877|NCT01937130|567309472|FG000|Overall Study|Patient lost to FU due to death|2|||
157153878|NCT01937130|567309473|FG001|Overall Study|Patient lost to FU due to death|0|||
157153879|NCT01937130|567309474|FG002|Overall Study|Patient lost to FU due to death|0|||
157153880|NCT01937130|567309475|FG003|Overall Study|Patient lost to FU due to death|0|||
157153881|NCT04191967|567309476|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
157153882|NCT04191967|567309476|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
157153883|NCT01431144|567309477|FG000|Overall Study|Implant mobility and removal|2|||
157153884|NCT01431144|567309478|FG001|Overall Study|Implant mobility and removal|0|||
157153885|NCT00953043|567309484|FG000|Overall Study|Withdrawal by Subject|4|||
157153886|NCT00953043|567309485|FG001|Overall Study|Withdrawal by Subject|0|||
157153887|NCT00953043|567309484|FG000|Overall Study|Physician Decision|0|||
157153888|NCT00953043|567309485|FG001|Overall Study|Physician Decision|2|||
156839127|NCT01912339|566163316|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
156886685|NCT01087788|566344012|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
157224690|NCT03504852|567568059|FG002|Overall Study|Adverse Event|2|||
157224691|NCT03290079|567568060|FG000|Overall Study|Death|2|||
157224692|NCT03390504|567568061|FG000|Overall Study|Lost to Follow-up|2|||
157224693|NCT03390504|567568062|FG001|Overall Study|Lost to Follow-up|4|||
156839128|NCT01912339|566163317|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
156839129|NCT00741013|566163318|FG000|Overall Study|Adverse Event|1|||
156839130|NCT00741013|566163319|FG001|Overall Study|Adverse Event|0|||
156839131|NCT00741013|566163320|FG002|Overall Study|Adverse Event|0|||
156839132|NCT00741013|566163318|FG000|Overall Study|Withdrawal by Subject|0|||
156839133|NCT00741013|566163319|FG001|Overall Study|Withdrawal by Subject|0|||
156839134|NCT00741013|566163320|FG002|Overall Study|Withdrawal by Subject|1|||
156839135|NCT00741013|566163318|FG000|Overall Study|Discovered failed screen after enrolled|0|||
156839136|NCT00741013|566163319|FG001|Overall Study|Discovered failed screen after enrolled|2|||
156839137|NCT00741013|566163320|FG002|Overall Study|Discovered failed screen after enrolled|0|||
156839138|NCT00082407|566163322|FG000|Overall Study|Adverse Event|20|||
156839139|NCT00082407|566163323|FG001|Overall Study|Adverse Event|0|||
156839140|NCT00082407|566163322|FG000|Overall Study|Protocol Violation|14|||
156839141|NCT00082407|566163323|FG001|Overall Study|Protocol Violation|12|||
156839142|NCT00082407|566163322|FG000|Overall Study|Patient Decision|13|||
156839143|NCT00082407|566163323|FG001|Overall Study|Patient Decision|6|||
156839144|NCT00082407|566163322|FG000|Overall Study|Physician Decision|5|||
156839145|NCT00082407|566163323|FG001|Overall Study|Physician Decision|3|||
156839146|NCT00082407|566163322|FG000|Overall Study|Loss of Glucose Control|2|||
156839147|NCT00082407|566163323|FG001|Overall Study|Loss of Glucose Control|2|||
156839148|NCT00082407|566163322|FG000|Overall Study|Death|2|||
156839149|NCT00082407|566163323|FG001|Overall Study|Death|1|||
156839150|NCT00082407|566163322|FG000|Overall Study|Lost to Follow-up|0|||
156839151|NCT00082407|566163323|FG001|Overall Study|Lost to Follow-up|3|||
156839152|NCT03464019|566163324|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
156839153|NCT03464019|566163325|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
156839154|NCT03464019|566163326|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
156839155|NCT03464019|566163324|FG000|NODE-301 Part 1|Ablation|0|||
156839156|NCT03464019|566163325|FG001|NODE-301 Part 1|Ablation|0|||
156839157|NCT03464019|566163326|FG002|NODE-301 Part 1|Ablation|16|||
156839158|NCT03464019|566163324|FG000|NODE-301 Part 1|Test Dose Failure|0|||
156886686|NCT01087788|566344013|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
157153889|NCT02322892|567309487|FG000|Overall Study|Surgery cancelled|1|||
157153890|NCT02322892|567309488|FG001|Overall Study|Surgery cancelled|2|||
157153891|NCT02322892|567309487|FG000|Overall Study|Met exclusion criteria|0|||
157153892|NCT02322892|567309488|FG001|Overall Study|Met exclusion criteria|1|||
157153893|NCT02322892|567309487|FG000|Overall Study|Protocol Violation|1|||
157153894|NCT02322892|567309488|FG001|Overall Study|Protocol Violation|0|||
157153895|NCT00747617|567309489|FG000|Overall Study|Lost to Follow-up|3|||
157153896|NCT00747617|567309490|FG001|Overall Study|Lost to Follow-up|1|||
157153897|NCT03509207|567309491|FG000|Overall Study|Death|2|||
157153898|NCT02125331|567309492|FG000|Overall Study|Protocol Violation|1|||
157153899|NCT02125331|567309493|FG001|Overall Study|Protocol Violation|0|||
157153900|NCT02125331|567309492|FG000|Overall Study|technical problem|2|||
157153901|NCT02125331|567309493|FG001|Overall Study|technical problem|0|||
157153902|NCT02125331|567309492|FG000|Overall Study|screen failure|2|||
157153903|NCT02125331|567309493|FG001|Overall Study|screen failure|0|||
157153904|NCT01432262|567309494|FG000|Overall Study|Withdrawal by Subject|2|||
157153905|NCT01432262|567309495|FG001|Overall Study|Withdrawal by Subject|1|||
157153906|NCT04657016|567309496|FG000|Overall Study|Adverse Event|2|||
157153907|NCT04657016|567309497|FG001|Overall Study|Adverse Event|4|||
157153908|NCT04657016|567309496|FG000|Overall Study|Death|1|||
157153909|NCT04657016|567309497|FG001|Overall Study|Death|1|||
157153910|NCT04657016|567309496|FG000|Overall Study|Lost to Follow-up|24|||
157153911|NCT04657016|567309497|FG001|Overall Study|Lost to Follow-up|12|||
157153912|NCT04657016|567309496|FG000|Overall Study|Physician Decision|1|||
157153913|NCT04657016|567309497|FG001|Overall Study|Physician Decision|2|||
157153914|NCT04657016|567309496|FG000|Overall Study|Pregnancy|2|||
157153915|NCT04657016|567309497|FG001|Overall Study|Pregnancy|2|||
157153916|NCT04657016|567309496|FG000|Overall Study|Protocol Deviation|1|||
157153917|NCT04657016|567309497|FG001|Overall Study|Protocol Deviation|0|||
157153918|NCT04657016|567309496|FG000|Overall Study|Withdrawal by Subject|28|||
157153919|NCT04657016|567309497|FG001|Overall Study|Withdrawal by Subject|14|||
157153920|NCT04657016|567309496|FG000|Overall Study|Other - as reported by the investigator|6|||
156839159|NCT03464019|566163325|FG001|NODE-301 Part 1|Test Dose Failure|0|||
156839160|NCT03464019|566163326|FG002|NODE-301 Part 1|Test Dose Failure|8|||
156839161|NCT03464019|566163324|FG000|NODE-301 Part 1|Adverse Event|0|||
156886687|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
157153921|NCT04657016|567309497|FG001|Overall Study|Other - as reported by the investigator|0|||
157153922|NCT01104558|567309500|FG000|Overall Study|Protocol Violation|6|||
157153923|NCT01104558|567309500|FG000|Overall Study|Missing of primary efficacy assessment|10|||
157224694|NCT03390504|567568063|FG002|Overall Study|Lost to Follow-up|0|||
156839162|NCT03464019|566163325|FG001|NODE-301 Part 1|Adverse Event|0|||
156839163|NCT03464019|566163326|FG002|NODE-301 Part 1|Adverse Event|5|||
156839164|NCT03464019|566163324|FG000|NODE-301 Part 1|Physician Decision|0|||
157153924|NCT01104558|567309500|FG000|Overall Study|Missing of genetic analysis results|1|||
157153925|NCT00696657|567309501|FG000|Overall Study|Protocol Violation|0|||
157153926|NCT00696657|567309502|FG001|Overall Study|Protocol Violation|0|||
156839165|NCT03464019|566163325|FG001|NODE-301 Part 1|Physician Decision|0|||
156839166|NCT03464019|566163326|FG002|NODE-301 Part 1|Physician Decision|4|||
156839167|NCT03464019|566163324|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
156839168|NCT03464019|566163325|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
156839169|NCT03464019|566163326|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
156839170|NCT03464019|566163324|FG000|NODE-301 Part 1|Protocol Violation|0|||
156839171|NCT03464019|566163325|FG001|NODE-301 Part 1|Protocol Violation|0|||
156839172|NCT03464019|566163326|FG002|NODE-301 Part 1|Protocol Violation|2|||
156839173|NCT03464019|566163324|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
156839174|NCT03464019|566163325|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
156839175|NCT03464019|566163326|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
156839176|NCT03464019|566163324|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
156839177|NCT03464019|566163325|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
156839178|NCT03464019|566163326|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
156839179|NCT03464019|566163324|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
156839180|NCT03464019|566163325|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
156839181|NCT03464019|566163326|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
156839182|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
156839183|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
156839184|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
156839185|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
156839186|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
156839187|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
156839188|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
156839189|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
156839190|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
157024014|NCT04209465|566841168|FG004|Overall Study|Progressive Disease|8|||
157024015|NCT04209465|566841169|FG005|Overall Study|Progressive Disease|5|||
157024016|NCT04209465|566841170|FG006|Overall Study|Progressive Disease|3|||
157024017|NCT04209465|566841171|FG007|Overall Study|Progressive Disease|4|||
157024018|NCT04209465|566841172|FG008|Overall Study|Progressive Disease|1|||
157024019|NCT04209465|566841173|FG009|Overall Study|Progressive Disease|3|||
157024020|NCT04209465|566841174|FG010|Overall Study|Progressive Disease|2|||
157024021|NCT04209465|566841175|FG011|Overall Study|Progressive Disease|1|||
157024022|NCT04209465|566841176|FG012|Overall Study|Progressive Disease|0|||
157024023|NCT04209465|566841164|FG000|Overall Study|Withdrawal by Subject|0|||
157024024|NCT04209465|566841165|FG001|Overall Study|Withdrawal by Subject|0|||
157024025|NCT04209465|566841166|FG002|Overall Study|Withdrawal by Subject|0|||
156839191|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
157024026|NCT04209465|566841167|FG003|Overall Study|Withdrawal by Subject|0|||
157024027|NCT04209465|566841168|FG004|Overall Study|Withdrawal by Subject|0|||
157024028|NCT04209465|566841169|FG005|Overall Study|Withdrawal by Subject|1|||
157024029|NCT04209465|566841170|FG006|Overall Study|Withdrawal by Subject|2|||
157024030|NCT04209465|566841171|FG007|Overall Study|Withdrawal by Subject|0|||
157024031|NCT04209465|566841172|FG008|Overall Study|Withdrawal by Subject|1|||
157024032|NCT04209465|566841173|FG009|Overall Study|Withdrawal by Subject|0|||
157024033|NCT04209465|566841174|FG010|Overall Study|Withdrawal by Subject|0|||
157024034|NCT04209465|566841175|FG011|Overall Study|Withdrawal by Subject|2|||
157024035|NCT04209465|566841176|FG012|Overall Study|Withdrawal by Subject|2|||
157024036|NCT04209465|566841164|FG000|Overall Study|Lost to Follow-up|0|||
157024037|NCT04209465|566841165|FG001|Overall Study|Lost to Follow-up|0|||
157024038|NCT04209465|566841166|FG002|Overall Study|Lost to Follow-up|0|||
157024039|NCT04209465|566841167|FG003|Overall Study|Lost to Follow-up|0|||
157024040|NCT04209465|566841168|FG004|Overall Study|Lost to Follow-up|0|||
157024041|NCT04209465|566841169|FG005|Overall Study|Lost to Follow-up|1|||
157024042|NCT04209465|566841170|FG006|Overall Study|Lost to Follow-up|0|||
157024043|NCT04209465|566841171|FG007|Overall Study|Lost to Follow-up|0|||
157024044|NCT04209465|566841172|FG008|Overall Study|Lost to Follow-up|1|||
157024045|NCT04209465|566841173|FG009|Overall Study|Lost to Follow-up|0|||
157024046|NCT04209465|566841174|FG010|Overall Study|Lost to Follow-up|0|||
157024047|NCT04209465|566841175|FG011|Overall Study|Lost to Follow-up|1|||
157153927|NCT00696657|567309503|FG002|Overall Study|Protocol Violation|0|||
157153928|NCT00696657|567309504|FG003|Overall Study|Protocol Violation|0|||
156839192|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
156839193|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
156839194|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
156839195|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
156839196|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
157024048|NCT04209465|566841176|FG012|Overall Study|Lost to Follow-up|0|||
157024049|NCT04209465|566841164|FG000|Overall Study|Started new therapy|0|||
157024050|NCT04209465|566841165|FG001|Overall Study|Started new therapy|0|||
157024051|NCT04209465|566841166|FG002|Overall Study|Started new therapy|0|||
157024052|NCT04209465|566841167|FG003|Overall Study|Started new therapy|0|||
157024053|NCT04209465|566841168|FG004|Overall Study|Started new therapy|0|||
157153929|NCT00696657|567309505|FG004|Overall Study|Protocol Violation|0|||
157153930|NCT00696657|567309506|FG005|Overall Study|Protocol Violation|1|||
157153931|NCT00696657|567309507|FG006|Overall Study|Protocol Violation|0|||
157153932|NCT00696657|567309508|FG007|Overall Study|Protocol Violation|0|||
157153933|NCT00696657|567309509|FG008|Overall Study|Protocol Violation|1|||
157153934|NCT00696657|567309501|FG000|Overall Study|Lack of Efficacy|0|||
157153935|NCT00696657|567309502|FG001|Overall Study|Lack of Efficacy|1|||
157153936|NCT00696657|567309503|FG002|Overall Study|Lack of Efficacy|0|||
157153937|NCT00696657|567309504|FG003|Overall Study|Lack of Efficacy|0|||
157153938|NCT00696657|567309505|FG004|Overall Study|Lack of Efficacy|0|||
157153939|NCT00696657|567309506|FG005|Overall Study|Lack of Efficacy|0|||
157153940|NCT00696657|567309507|FG006|Overall Study|Lack of Efficacy|0|||
157153941|NCT00696657|567309508|FG007|Overall Study|Lack of Efficacy|0|||
157153942|NCT00696657|567309509|FG008|Overall Study|Lack of Efficacy|0|||
157153943|NCT00696657|567309501|FG000|Overall Study|Withdrawal criteria|1|||
157153944|NCT00696657|567309502|FG001|Overall Study|Withdrawal criteria|3|||
157153945|NCT00696657|567309503|FG002|Overall Study|Withdrawal criteria|2|||
156839197|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
156839198|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
156839199|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
156839200|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
156839201|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
157153946|NCT00696657|567309504|FG003|Overall Study|Withdrawal criteria|2|||
157153947|NCT00696657|567309505|FG004|Overall Study|Withdrawal criteria|0|||
157153948|NCT00696657|567309506|FG005|Overall Study|Withdrawal criteria|0|||
157153949|NCT00696657|567309507|FG006|Overall Study|Withdrawal criteria|1|||
157153950|NCT00696657|567309508|FG007|Overall Study|Withdrawal criteria|1|||
157153951|NCT00696657|567309509|FG008|Overall Study|Withdrawal criteria|2|||
157153952|NCT00696657|567309501|FG000|Overall Study|Unclassified|0|||
157153953|NCT00696657|567309502|FG001|Overall Study|Unclassified|1|||
157224695|NCT03390504|567568064|FG003|Overall Study|Lost to Follow-up|1|||
156839202|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
156839203|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
156839204|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
156839205|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
156839206|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
156839207|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
156839208|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
156839209|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
156839210|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
156839211|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
156839212|NCT03464019|566163324|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
156839213|NCT03464019|566163325|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
156839214|NCT03464019|566163326|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
156839215|NCT01754493|566163327|FG000|Overall Study|Adverse Event|1|||
156839216|NCT01754493|566163327|FG000|Overall Study|Lost to Follow-up|3|||
156839217|NCT01754493|566163327|FG000|Overall Study|Withdrawal by Subject|1|||
156886688|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
156886689|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
156886690|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
156886691|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
156886692|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
156886693|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
156886694|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
156886695|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
156839218|NCT01754493|566163327|FG000|Overall Study|Moved out of town|1|||
156839219|NCT01754493|566163327|FG000|Overall Study|Scheduling conflict|1|||
156839220|NCT00767806|566163328|FG000|Overall Study|Adverse Event|30|||
156839221|NCT00767806|566163329|FG001|Overall Study|Adverse Event|11|||
156839222|NCT00767806|566163328|FG000|Overall Study|Withdrawal by Subject|8|||
156839223|NCT00767806|566163329|FG001|Overall Study|Withdrawal by Subject|13|||
156839224|NCT00767806|566163328|FG000|Overall Study|Protocol Violation|6|||
156839225|NCT00767806|566163329|FG001|Overall Study|Protocol Violation|5|||
156839226|NCT00767806|566163328|FG000|Overall Study|Lack of Efficacy|1|||
156886696|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
156839227|NCT00767806|566163329|FG001|Overall Study|Lack of Efficacy|9|||
157153954|NCT00696657|567309503|FG002|Overall Study|Unclassified|3|||
157153955|NCT00696657|567309504|FG003|Overall Study|Unclassified|2|||
157224696|NCT03390504|567568061|FG000|Overall Study|Withdrawal by Subject|3|||
156839228|NCT00767806|566163328|FG000|Overall Study|Physician Decision|4|||
156839229|NCT00767806|566163329|FG001|Overall Study|Physician Decision|3|||
157153956|NCT00696657|567309505|FG004|Overall Study|Unclassified|4|||
157153957|NCT00696657|567309506|FG005|Overall Study|Unclassified|2|||
157153958|NCT00696657|567309507|FG006|Overall Study|Unclassified|0|||
157153959|NCT00696657|567309508|FG007|Overall Study|Unclassified|0|||
157153960|NCT00696657|567309509|FG008|Overall Study|Unclassified|1|||
157153961|NCT00696657|567309501|FG000|Overall Study|Adverse Event|0|||
157153962|NCT00696657|567309502|FG001|Overall Study|Adverse Event|0|||
157153963|NCT00696657|567309503|FG002|Overall Study|Adverse Event|3|||
157153964|NCT00696657|567309504|FG003|Overall Study|Adverse Event|7|||
157153965|NCT00696657|567309505|FG004|Overall Study|Adverse Event|6|||
157153966|NCT00696657|567309506|FG005|Overall Study|Adverse Event|9|||
157153967|NCT00696657|567309507|FG006|Overall Study|Adverse Event|14|||
157153968|NCT00696657|567309508|FG007|Overall Study|Adverse Event|2|||
157153969|NCT00696657|567309509|FG008|Overall Study|Adverse Event|5|||
157153970|NCT00523341|567309513|FG000|Overall Study|Withdrawal by Subject|399|||
157153971|NCT00523341|567309514|FG001|Overall Study|Withdrawal by Subject|427|||
157153972|NCT00523341|567309513|FG000|Overall Study|Other|181|||
157153973|NCT00523341|567309514|FG001|Overall Study|Other|198|||
157153974|NCT00523341|567309513|FG000|Overall Study|Adverse Event|122|||
157153975|NCT00523341|567309514|FG001|Overall Study|Adverse Event|155|||
157153976|NCT00523341|567309513|FG000|Overall Study|Death|101|||
157153977|NCT00523341|567309514|FG001|Overall Study|Death|110|||
157153978|NCT00523341|567309513|FG000|Overall Study|Lost to Follow-up|73|||
157153979|NCT00523341|567309514|FG001|Overall Study|Lost to Follow-up|61|||
157153980|NCT00523341|567309513|FG000|Overall Study|Non-compliance|20|||
157153981|NCT00523341|567309514|FG001|Overall Study|Non-compliance|13|||
157153982|NCT00523341|567309513|FG000|Overall Study|Physician Decision|14|||
157153983|NCT00523341|567309514|FG001|Overall Study|Physician Decision|13|||
157153984|NCT00523341|567309513|FG000|Overall Study|Requirement for Alternative Therapy|4|||
157153985|NCT00523341|567309514|FG001|Overall Study|Requirement for Alternative Therapy|14|||
157153986|NCT00523341|567309513|FG000|Overall Study|Protocol Deviation|6|||
157153987|NCT00523341|567309514|FG001|Overall Study|Protocol Deviation|5|||
157153988|NCT00523341|567309513|FG000|Overall Study|Ineligibility Determined|3|||
157153989|NCT00523341|567309514|FG001|Overall Study|Ineligibility Determined|4|||
157153990|NCT00523341|567309513|FG000|Overall Study|Disease Progression|1|||
157153991|NCT00523341|567309514|FG001|Overall Study|Disease Progression|0|||
157153992|NCT02601001|567309517|FG000|Dosing Period 2|Adverse Event|0|||
157153993|NCT02601001|567309518|FG001|Dosing Period 2|Adverse Event|0|||
157153994|NCT02601001|567309519|FG002|Dosing Period 2|Adverse Event|0|||
156839230|NCT00767806|566163328|FG000|Overall Study|Lost to Follow-up|1|||
156839231|NCT00767806|566163329|FG001|Overall Study|Lost to Follow-up|4|||
156839232|NCT00767806|566163328|FG000|Overall Study|Entry Criteria Not Met|1|||
156839233|NCT00767806|566163329|FG001|Overall Study|Entry Criteria Not Met|1|||
156839234|NCT00767806|566163328|FG000|Overall Study|Sponsor Decision|0|||
156839235|NCT00767806|566163329|FG001|Overall Study|Sponsor Decision|1|||
156839236|NCT02489942|566163330|FG000|Overall Study|Request by patient|602|||
156839237|NCT02489942|566163330|FG000|Overall Study|Improvement/remission|157|||
156839238|NCT02489942|566163330|FG000|Overall Study|No change/Progressive disease|263|||
156839239|NCT02489942|566163330|FG000|Overall Study|Adverse Event|522|||
156839240|NCT02489942|566163330|FG000|Overall Study|Other personal reasons|1218|||
156839241|NCT02489942|566163330|FG000|Overall Study|Lost to Follow-up|456|||
156839242|NCT02489942|566163330|FG000|Overall Study|Not continuously investigated|7|||
156839243|NCT02489942|566163330|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
156839244|NCT02489942|566163330|FG000|Overall Study|Multiple registration|1|||
156839245|NCT02489942|566163330|FG000|Overall Study|No patient visit after entry|100|||
156839246|NCT02489942|566163330|FG000|Overall Study|No treatment with Jardiance|2|||
156839247|NCT02489942|566163330|FG000|Overall Study|Patient received Jardiance before registration|1|||
156839248|NCT02489942|566163330|FG000|Overall Study|No CRF collected|86|||
156839249|NCT00858208|566163331|FG000|Overall Study|Adverse Event|3|||
156839250|NCT00858208|566163331|FG000|Overall Study|Lost to Follow-up|26|||
156839251|NCT00858208|566163331|FG000|Overall Study|Participant refused|40|||
156839252|NCT00858208|566163331|FG000|Overall Study|Other|10|||
156839253|NCT01272635|566163332|FG000|Overall Study|Lost to Follow-up|31|||
156839254|NCT01272635|566163333|FG001|Overall Study|Lost to Follow-up|20|||
156839255|NCT01272635|566163334|FG002|Overall Study|Lost to Follow-up|31|||
156839256|NCT01272635|566163335|FG003|Overall Study|Lost to Follow-up|23|||
156839257|NCT01543776|566163338|FG000|Overall Study|Withdrawal by Subject|2|||
156839258|NCT01543776|566163339|FG001|Overall Study|Withdrawal by Subject|2|||
156839259|NCT00567359|566163340|FG000|Overall Study|Withdrawal by Subject|1|||
157153995|NCT02601001|567309520|FG003|Dosing Period 2|Adverse Event|0|||
157153996|NCT02601001|567309521|FG004|Dosing Period 2|Adverse Event|0|||
157153997|NCT02601001|567309522|FG005|Dosing Period 2|Adverse Event|0|||
157153998|NCT02601001|567309523|FG006|Dosing Period 2|Adverse Event|1|||
156839260|NCT02397057|566163341|FG000|Overall Study|Withdrawal by Subject|6|||
156839261|NCT02397057|566163342|FG001|Overall Study|Withdrawal by Subject|7|||
156839262|NCT02397057|566163341|FG000|Overall Study|Lost to Follow-up|4|||
156839263|NCT02397057|566163342|FG001|Overall Study|Lost to Follow-up|3|||
156839264|NCT02397057|566163341|FG000|Overall Study|Death|1|||
156839265|NCT02397057|566163342|FG001|Overall Study|Death|0|||
156839266|NCT02397057|566163341|FG000|Overall Study|Adverse Event|0|||
156839267|NCT02397057|566163342|FG001|Overall Study|Adverse Event|1|||
157153999|NCT01356602|567309524|FG000|Overall Study|Protocol Deviation|0|||
157154000|NCT01356602|567309525|FG001|Overall Study|Protocol Deviation|1|||
157154001|NCT01356602|567309526|FG002|Overall Study|Protocol Deviation|1|||
157154002|NCT01356602|567309524|FG000|Overall Study|Administrative Problems|1|||
157154003|NCT01356602|567309525|FG001|Overall Study|Administrative Problems|4|||
157154004|NCT01356602|567309526|FG002|Overall Study|Administrative Problems|5|||
157224697|NCT03390504|567568062|FG001|Overall Study|Withdrawal by Subject|15|||
157224698|NCT03390504|567568063|FG002|Overall Study|Withdrawal by Subject|5|||
157224699|NCT03390504|567568064|FG003|Overall Study|Withdrawal by Subject|2|||
157224700|NCT03390504|567568061|FG000|Overall Study|Other|1|||
157224701|NCT03390504|567568062|FG001|Overall Study|Other|2|||
157224702|NCT03390504|567568063|FG002|Overall Study|Other|2|||
157224703|NCT03390504|567568064|FG003|Overall Study|Other|6|||
157224704|NCT00969332|567568065|FG000|Overall Study|Physician Decision|8|||
157224705|NCT00969332|567568065|FG000|Overall Study|Withdrawal by Subject|3|||
157224706|NCT00576199|567568066|FG000|Overall Study|Adverse Event|12|||
157224707|NCT00576199|567568066|FG000|Overall Study|Insufficient Therapeutic Response|14|||
157224708|NCT00576199|567568066|FG000|Overall Study|Refused Treatment|2|||
157224709|NCT00576199|567568066|FG000|Overall Study|Reason Unspecified|2|||
157224710|NCT00663871|567568067|FG000|Overall Study|Lost to Follow-up|5|||
157224711|NCT00663871|567568068|FG001|Overall Study|Lost to Follow-up|5|||
157224712|NCT00663871|567568067|FG000|Overall Study|Withdrawal by Subject|5|||
157224713|NCT00663871|567568068|FG001|Overall Study|Withdrawal by Subject|2|||
157224714|NCT00582309|567568069|FG000|Overall Study|Protocol Violation|0|||
157224715|NCT00582309|567568070|FG001|Overall Study|Protocol Violation|0|||
157224716|NCT00582309|567568071|FG002|Overall Study|Protocol Violation|2|||
157224717|NCT03922477|567568072|FG000|Overall Study|Death|9|||
157154005|NCT01356602|567309524|FG000|Overall Study|Lost to Follow-up|4|||
157154006|NCT01356602|567309525|FG001|Overall Study|Lost to Follow-up|5|||
157154007|NCT01356602|567309526|FG002|Overall Study|Lost to Follow-up|6|||
157154008|NCT01356602|567309524|FG000|Overall Study|Withdrawal by Subject|4|||
157154009|NCT01356602|567309525|FG001|Overall Study|Withdrawal by Subject|3|||
157154010|NCT01356602|567309526|FG002|Overall Study|Withdrawal by Subject|7|||
157154011|NCT01356602|567309524|FG000|Overall Study|Lack of Efficacy|0|||
157154012|NCT01356602|567309525|FG001|Overall Study|Lack of Efficacy|1|||
157154013|NCT01356602|567309526|FG002|Overall Study|Lack of Efficacy|4|||
157154014|NCT01356602|567309524|FG000|Overall Study|Adverse Event|0|||
157154015|NCT01356602|567309525|FG001|Overall Study|Adverse Event|1|||
157154016|NCT01356602|567309526|FG002|Overall Study|Adverse Event|1|||
157154017|NCT03123354|567309527|FG000|Overall Study|Physician Decision|6|||
157154018|NCT01345123|567309528|FG000|Overall Study|participants no longer with health plan|79|||
157154019|NCT01345123|567309529|FG001|Overall Study|participants no longer with health plan|85|||
157154020|NCT01345123|567309530|FG002|Overall Study|participants no longer with health plan|88|||
157154021|NCT03097328|567309531|FG000|Overall Study|Still on Therapy|2|||
157154022|NCT03097328|567309531|FG000|Overall Study|Progressive Disease|29|||
157154023|NCT03097328|567309531|FG000|Overall Study|Adverse Event|4|||
157154024|NCT03097328|567309531|FG000|Overall Study|Withdrawal by Subject|1|||
157154025|NCT03097328|567309531|FG000|Overall Study|Physician Decision|1|||
157154026|NCT03097328|567309531|FG000|Overall Study|Patient Decision|1|||
157154027|NCT03097328|567309531|FG000|Overall Study|Ineligible for Study Drug|1|||
157154028|NCT02023164|567309532|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
157154029|NCT02023164|567309533|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
157154030|NCT03539458|567309535|FG000|Overall Study|Death|1|||
157154031|NCT01984346|567309537|FG000|Overall Study|Physician Decision|4|||
157154032|NCT01984346|567309538|FG001|Overall Study|Physician Decision|2|||
157154033|NCT01984346|567309537|FG000|Overall Study|Withdrawal by Subject|2|||
157154034|NCT01984346|567309538|FG001|Overall Study|Withdrawal by Subject|2|||
157154035|NCT01984346|567309537|FG000|Overall Study|Enrollment Closed|8|||
157154036|NCT01984346|567309538|FG001|Overall Study|Enrollment Closed|1|||
157154037|NCT01984346|567309537|FG000|Overall Study|Insurance Coverage|1|||
157154038|NCT01984346|567309538|FG001|Overall Study|Insurance Coverage|0|||
157154039|NCT01984346|567309537|FG000|Overall Study|Intra-operative Exclusion|2|||
157224718|NCT03922477|567568072|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
157224719|NCT03922477|567568072|FG000|Overall Study|Physician Decision|1|||
157224720|NCT03922477|567568072|FG000|Overall Study|Withdrawal by Subject|2|||
157154040|NCT01984346|567309538|FG001|Overall Study|Intra-operative Exclusion|0|||
157224721|NCT01893905|567569848|FG000|Overall Study|Withdrawal by Subject|1|||
157224722|NCT01893905|567569849|FG001|Overall Study|Withdrawal by Subject|0|||
157224723|NCT01893905|567569848|FG000|Overall Study|Adverse Event|9|||
157154041|NCT04184622|567309539|FG000|Primary Treatment Period|Adverse Event|6|||
157154042|NCT04184622|567309540|FG001|Primary Treatment Period|Adverse Event|4|||
157154043|NCT04184622|567309541|FG002|Primary Treatment Period|Adverse Event|8|||
157154044|NCT04184622|567309542|FG003|Primary Treatment Period|Adverse Event|6|||
157224724|NCT01893905|567569849|FG001|Overall Study|Adverse Event|3|||
157224725|NCT01893905|567569848|FG000|Overall Study|Lack of Efficacy|5|||
157224726|NCT01893905|567569849|FG001|Overall Study|Lack of Efficacy|7|||
156839268|NCT02397057|566163341|FG000|Overall Study|Physician Decision|0|||
157154045|NCT04184622|567309539|FG000|Primary Treatment Period|Death|4|||
157154046|NCT04184622|567309540|FG001|Primary Treatment Period|Death|4|||
157224727|NCT01893905|567569848|FG000|Overall Study|Lost to Follow-up|1|||
157224728|NCT01893905|567569849|FG001|Overall Study|Lost to Follow-up|0|||
157154047|NCT04184622|567309541|FG002|Primary Treatment Period|Death|2|||
157154048|NCT04184622|567309542|FG003|Primary Treatment Period|Death|1|||
157154049|NCT04184622|567309539|FG000|Primary Treatment Period|Lost to Follow-up|41|||
157154050|NCT04184622|567309540|FG001|Primary Treatment Period|Lost to Follow-up|17|||
157154051|NCT04184622|567309541|FG002|Primary Treatment Period|Lost to Follow-up|15|||
157154052|NCT04184622|567309542|FG003|Primary Treatment Period|Lost to Follow-up|13|||
156839269|NCT02397057|566163342|FG001|Overall Study|Physician Decision|1|||
156839270|NCT02397057|566163341|FG000|Overall Study|Subject did not receive study drug|0|||
156839271|NCT02397057|566163342|FG001|Overall Study|Subject did not receive study drug|1|||
156839272|NCT04395690|566163344|FG000|Overall Study|Lost to Follow-up|1|||
156839273|NCT04395690|566163345|FG001|Overall Study|Lost to Follow-up|1|||
157154053|NCT04184622|567309539|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
157154054|NCT04184622|567309540|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
157154055|NCT04184622|567309541|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
157154056|NCT04184622|567309542|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
157154057|NCT04184622|567309539|FG000|Primary Treatment Period|Physician Decision|0|||
157154058|NCT04184622|567309540|FG001|Primary Treatment Period|Physician Decision|0|||
157154059|NCT04184622|567309541|FG002|Primary Treatment Period|Physician Decision|3|||
157154060|NCT04184622|567309542|FG003|Primary Treatment Period|Physician Decision|1|||
157154061|NCT04184622|567309539|FG000|Primary Treatment Period|Pregnancy|4|||
157154062|NCT04184622|567309540|FG001|Primary Treatment Period|Pregnancy|3|||
157154063|NCT04184622|567309541|FG002|Primary Treatment Period|Pregnancy|4|||
157154064|NCT04184622|567309542|FG003|Primary Treatment Period|Pregnancy|1|||
157154065|NCT04184622|567309539|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
157154066|NCT04184622|567309540|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
157154067|NCT04184622|567309541|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
157154068|NCT04184622|567309542|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
157154069|NCT04184622|567309539|FG000|Additional Treatment Period|Adverse Event|1|||
157154070|NCT04184622|567309540|FG001|Additional Treatment Period|Adverse Event|2|||
157154071|NCT04184622|567309541|FG002|Additional Treatment Period|Adverse Event|1|||
157154072|NCT04184622|567309542|FG003|Additional Treatment Period|Adverse Event|0|||
157154073|NCT04184622|567309539|FG000|Additional Treatment Period|Death|0|||
157154074|NCT04184622|567309540|FG001|Additional Treatment Period|Death|0|||
157154075|NCT04184622|567309541|FG002|Additional Treatment Period|Death|1|||
157154076|NCT04184622|567309542|FG003|Additional Treatment Period|Death|1|||
157154077|NCT04184622|567309539|FG000|Additional Treatment Period|Lost to Follow-up|6|||
157154078|NCT04184622|567309540|FG001|Additional Treatment Period|Lost to Follow-up|4|||
157154079|NCT04184622|567309541|FG002|Additional Treatment Period|Lost to Follow-up|8|||
157154080|NCT04184622|567309542|FG003|Additional Treatment Period|Lost to Follow-up|6|||
157154081|NCT04184622|567309539|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
157154082|NCT04184622|567309540|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
157154083|NCT04184622|567309541|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
157154084|NCT04184622|567309542|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
157154085|NCT04184622|567309539|FG000|Additional Treatment Period|Physician Decision|0|||
157154086|NCT04184622|567309540|FG001|Additional Treatment Period|Physician Decision|0|||
157154087|NCT04184622|567309541|FG002|Additional Treatment Period|Physician Decision|1|||
157154088|NCT04184622|567309542|FG003|Additional Treatment Period|Physician Decision|0|||
157154089|NCT04184622|567309539|FG000|Additional Treatment Period|Pregnancy|0|||
157154090|NCT04184622|567309540|FG001|Additional Treatment Period|Pregnancy|0|||
157154091|NCT04184622|567309541|FG002|Additional Treatment Period|Pregnancy|0|||
157154092|NCT04184622|567309542|FG003|Additional Treatment Period|Pregnancy|1|||
157154093|NCT04184622|567309539|FG000|Additional Treatment Period|Protocol deviation|0|||
157154094|NCT04184622|567309540|FG001|Additional Treatment Period|Protocol deviation|0|||
157154095|NCT04184622|567309541|FG002|Additional Treatment Period|Protocol deviation|1|||
157154096|NCT04184622|567309542|FG003|Additional Treatment Period|Protocol deviation|0|||
157154097|NCT04184622|567309539|FG000|Additional Treatment Period|Site closed|1|||
157154098|NCT04184622|567309540|FG001|Additional Treatment Period|Site closed|0|||
157154099|NCT04184622|567309541|FG002|Additional Treatment Period|Site closed|1|||
157154100|NCT04184622|567309542|FG003|Additional Treatment Period|Site closed|0|||
157154101|NCT04184622|567309539|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
157154102|NCT04184622|567309540|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
157154103|NCT04184622|567309541|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
157154104|NCT04184622|567309542|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
157154105|NCT04184622|567309539|FG000|Safety Follow-up Period|Adverse Event|6|||
157154106|NCT04184622|567309540|FG001|Safety Follow-up Period|Adverse Event|8|||
157154107|NCT04184622|567309541|FG002|Safety Follow-up Period|Adverse Event|9|||
157154108|NCT04184622|567309542|FG003|Safety Follow-up Period|Adverse Event|16|||
157154109|NCT04184622|567309539|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
157224729|NCT01893905|567569848|FG000|Overall Study|Protocol Violation|6|||
156839274|NCT01554514|566163351|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
156839275|NCT01554514|566163351|FG000|Overall Study|Physician Decision|1|||
157154110|NCT04184622|567309540|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
156839276|NCT00549770|566163352|FG000|Overall Study|Protocol deviation|1|||
156839277|NCT00549770|566163353|FG001|Overall Study|Protocol deviation|1|||
156839278|NCT00549770|566163354|FG002|Overall Study|Protocol deviation|1|||
156839279|NCT00549770|566163355|FG003|Overall Study|Protocol deviation|2|||
156839280|NCT00549770|566163356|FG004|Overall Study|Protocol deviation|2|||
156839281|NCT00549770|566163357|FG005|Overall Study|Protocol deviation|2|||
156839282|NCT00549770|566163358|FG006|Overall Study|Protocol deviation|1|||
156839283|NCT00549770|566163359|FG007|Overall Study|Protocol deviation|2|||
157024054|NCT04209465|566841169|FG005|Overall Study|Started new therapy|1|||
157154111|NCT04184622|567309541|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
157154112|NCT04184622|567309542|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
157154113|NCT04184622|567309539|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
157154114|NCT04184622|567309540|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
157154115|NCT04184622|567309541|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
157154116|NCT04184622|567309542|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
157154117|NCT04184622|567309539|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
157154118|NCT04184622|567309540|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
157154119|NCT04184622|567309541|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
157154120|NCT04184622|567309542|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
157154121|NCT04184622|567309539|FG000|Safety Follow-up Period|Physician Decision|1|||
157154122|NCT04184622|567309540|FG001|Safety Follow-up Period|Physician Decision|0|||
157154123|NCT04184622|567309541|FG002|Safety Follow-up Period|Physician Decision|0|||
157154124|NCT04184622|567309542|FG003|Safety Follow-up Period|Physician Decision|1|||
157154125|NCT04184622|567309539|FG000|Safety Follow-up Period|Pregnancy|1|||
157154126|NCT04184622|567309540|FG001|Safety Follow-up Period|Pregnancy|3|||
157154127|NCT04184622|567309541|FG002|Safety Follow-up Period|Pregnancy|0|||
157154128|NCT04184622|567309542|FG003|Safety Follow-up Period|Pregnancy|6|||
157154129|NCT04184622|567309539|FG000|Safety Follow-up Period|Protocol deviation|1|||
157154130|NCT04184622|567309540|FG001|Safety Follow-up Period|Protocol deviation|0|||
157154131|NCT04184622|567309541|FG002|Safety Follow-up Period|Protocol deviation|0|||
157154132|NCT04184622|567309542|FG003|Safety Follow-up Period|Protocol deviation|0|||
157154133|NCT04184622|567309539|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
157154134|NCT04184622|567309540|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
157154135|NCT04184622|567309541|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
157154136|NCT04184622|567309542|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
157154137|NCT02795988|567309543|FG000|Phase 1b|Withdrawal by Subject|0|||
157154138|NCT02795988|567309544|FG001|Phase 1b|Withdrawal by Subject|1|||
157154139|NCT02795988|567309545|FG002|Phase 1b|Withdrawal by Subject|0|||
157154140|NCT02795988|567309546|FG003|Phase 1b|Withdrawal by Subject|0|||
157154141|NCT02795988|567309547|FG004|Phase 1b|Withdrawal by Subject|0|||
157154142|NCT02795988|567309548|FG005|Phase 1b|Withdrawal by Subject|0|||
157154143|NCT02795988|567309549|FG006|Phase 1b|Withdrawal by Subject|0|||
157154144|NCT02795988|567309543|FG000|Phase 1b|Death|1|||
157154145|NCT02795988|567309544|FG001|Phase 1b|Death|2|||
157154146|NCT02795988|567309545|FG002|Phase 1b|Death|1|||
157154147|NCT02795988|567309546|FG003|Phase 1b|Death|0|||
157154148|NCT02795988|567309547|FG004|Phase 1b|Death|0|||
157154149|NCT02795988|567309548|FG005|Phase 1b|Death|0|||
157154150|NCT02795988|567309549|FG006|Phase 1b|Death|0|||
157154151|NCT02795988|567309543|FG000|Phase 1b|Physician Decision|0|||
157154152|NCT02795988|567309544|FG001|Phase 1b|Physician Decision|0|||
157154153|NCT02795988|567309545|FG002|Phase 1b|Physician Decision|1|||
157154154|NCT02795988|567309546|FG003|Phase 1b|Physician Decision|0|||
157154155|NCT02795988|567309547|FG004|Phase 1b|Physician Decision|0|||
157154156|NCT02795988|567309548|FG005|Phase 1b|Physician Decision|0|||
157154157|NCT02795988|567309549|FG006|Phase 1b|Physician Decision|0|||
157154158|NCT02795988|567309543|FG000|Phase 1b|Progressive Disease|2|||
157154159|NCT02795988|567309544|FG001|Phase 1b|Progressive Disease|2|||
157154160|NCT02795988|567309545|FG002|Phase 1b|Progressive Disease|0|||
157154161|NCT02795988|567309546|FG003|Phase 1b|Progressive Disease|0|||
157154162|NCT02795988|567309547|FG004|Phase 1b|Progressive Disease|0|||
157154163|NCT02795988|567309548|FG005|Phase 1b|Progressive Disease|0|||
157154164|NCT02795988|567309549|FG006|Phase 1b|Progressive Disease|0|||
157154165|NCT02795988|567309543|FG000|Phase 2|Withdrawal by Subject|0|||
157154166|NCT02795988|567309544|FG001|Phase 2|Withdrawal by Subject|0|||
156839284|NCT00549770|566163352|FG000|Overall Study|Administrative problems|0|||
157024055|NCT04209465|566841170|FG006|Overall Study|Started new therapy|0|||
157154167|NCT02795988|567309545|FG002|Phase 2|Withdrawal by Subject|0|||
156839285|NCT00549770|566163353|FG001|Overall Study|Administrative problems|1|||
156839286|NCT00549770|566163354|FG002|Overall Study|Administrative problems|0|||
156839287|NCT00549770|566163355|FG003|Overall Study|Administrative problems|0|||
157154168|NCT02795988|567309546|FG003|Phase 2|Withdrawal by Subject|1|||
157154169|NCT02795988|567309547|FG004|Phase 2|Withdrawal by Subject|0|||
157154170|NCT02795988|567309548|FG005|Phase 2|Withdrawal by Subject|0|||
157154171|NCT02795988|567309549|FG006|Phase 2|Withdrawal by Subject|0|||
157154172|NCT02795988|567309543|FG000|Phase 2|Death|0|||
157154173|NCT02795988|567309544|FG001|Phase 2|Death|0|||
157024056|NCT04209465|566841171|FG007|Overall Study|Started new therapy|0|||
157024057|NCT04209465|566841172|FG008|Overall Study|Started new therapy|0|||
156839288|NCT00549770|566163356|FG004|Overall Study|Administrative problems|0|||
156839289|NCT00549770|566163357|FG005|Overall Study|Administrative problems|0|||
156839290|NCT00549770|566163358|FG006|Overall Study|Administrative problems|0|||
156839291|NCT00549770|566163359|FG007|Overall Study|Administrative problems|1|||
156839292|NCT00549770|566163352|FG000|Overall Study|Lost to Follow-up|0|||
156839293|NCT00549770|566163353|FG001|Overall Study|Lost to Follow-up|0|||
156839294|NCT00549770|566163354|FG002|Overall Study|Lost to Follow-up|2|||
156839295|NCT00549770|566163355|FG003|Overall Study|Lost to Follow-up|2|||
156839296|NCT00549770|566163356|FG004|Overall Study|Lost to Follow-up|3|||
156839297|NCT00549770|566163357|FG005|Overall Study|Lost to Follow-up|2|||
156839298|NCT00549770|566163358|FG006|Overall Study|Lost to Follow-up|0|||
156839299|NCT00549770|566163359|FG007|Overall Study|Lost to Follow-up|0|||
156839300|NCT00549770|566163352|FG000|Overall Study|Withdrawal by Subject|4|||
156839301|NCT00549770|566163353|FG001|Overall Study|Withdrawal by Subject|6|||
156839302|NCT00549770|566163354|FG002|Overall Study|Withdrawal by Subject|4|||
156839303|NCT00549770|566163355|FG003|Overall Study|Withdrawal by Subject|5|||
156839304|NCT00549770|566163356|FG004|Overall Study|Withdrawal by Subject|6|||
156839305|NCT00549770|566163357|FG005|Overall Study|Withdrawal by Subject|6|||
156839306|NCT00549770|566163358|FG006|Overall Study|Withdrawal by Subject|4|||
157024058|NCT04209465|566841173|FG009|Overall Study|Started new therapy|0|||
157154174|NCT02795988|567309545|FG002|Phase 2|Death|0|||
157154175|NCT02795988|567309546|FG003|Phase 2|Death|17|||
157154176|NCT02795988|567309547|FG004|Phase 2|Death|17|||
157154177|NCT02795988|567309548|FG005|Phase 2|Death|0|||
157154178|NCT02795988|567309549|FG006|Phase 2|Death|0|||
157154179|NCT02795988|567309543|FG000|Phase 2|Other|0|||
157154180|NCT02795988|567309544|FG001|Phase 2|Other|0|||
157154181|NCT02795988|567309545|FG002|Phase 2|Other|0|||
157154182|NCT02795988|567309546|FG003|Phase 2|Other|1|||
157154183|NCT02795988|567309547|FG004|Phase 2|Other|0|||
157154184|NCT02795988|567309548|FG005|Phase 2|Other|0|||
157154185|NCT02795988|567309549|FG006|Phase 2|Other|0|||
157154186|NCT02795988|567309543|FG000|Phase 2 Extension|Death|0|||
157154187|NCT02795988|567309544|FG001|Phase 2 Extension|Death|0|||
157154188|NCT02795988|567309545|FG002|Phase 2 Extension|Death|0|||
157154189|NCT02795988|567309546|FG003|Phase 2 Extension|Death|0|||
157154190|NCT02795988|567309547|FG004|Phase 2 Extension|Death|0|||
157154191|NCT02795988|567309548|FG005|Phase 2 Extension|Death|5|||
157154192|NCT02795988|567309549|FG006|Phase 2 Extension|Death|6|||
157154193|NCT02795988|567309543|FG000|Phase 2 Extension|Other reasons|0|||
157154194|NCT02795988|567309544|FG001|Phase 2 Extension|Other reasons|0|||
157154195|NCT02795988|567309545|FG002|Phase 2 Extension|Other reasons|0|||
156839307|NCT00549770|566163359|FG007|Overall Study|Withdrawal by Subject|9|||
156839308|NCT00549770|566163352|FG000|Overall Study|Lack of Efficacy|1|||
156839309|NCT00549770|566163353|FG001|Overall Study|Lack of Efficacy|0|||
157154196|NCT02795988|567309546|FG003|Phase 2 Extension|Other reasons|0|||
157154197|NCT02795988|567309547|FG004|Phase 2 Extension|Other reasons|0|||
157154198|NCT02795988|567309548|FG005|Phase 2 Extension|Other reasons|2|||
157154199|NCT02795988|567309549|FG006|Phase 2 Extension|Other reasons|1|||
157154200|NCT02341014|567309550|FG000|Overall Study|Adverse Event|0|||
157154201|NCT02341014|567309551|FG001|Overall Study|Adverse Event|1|||
157154202|NCT02341014|567309552|FG002|Overall Study|Adverse Event|0|||
157154203|NCT02341014|567309553|FG003|Overall Study|Adverse Event|0|||
157154204|NCT02341014|567309554|FG004|Overall Study|Adverse Event|2|||
157154205|NCT00726323|567309555|FG000|Overall Study|Withdrawal by Subject|3|||
157154206|NCT00726323|567309556|FG001|Overall Study|Withdrawal by Subject|1|||
157154207|NCT00726323|567309555|FG000|Overall Study|Physician Decision|1|||
157154208|NCT00726323|567309556|FG001|Overall Study|Physician Decision|0|||
157154209|NCT00726323|567309555|FG000|Overall Study|Progressive disease|23|||
157154210|NCT00726323|567309556|FG001|Overall Study|Progressive disease|16|||
157154211|NCT00726323|567309555|FG000|Overall Study|Clinical progression|0|||
157154212|NCT00726323|567309556|FG001|Overall Study|Clinical progression|3|||
156839310|NCT00549770|566163354|FG002|Overall Study|Lack of Efficacy|2|||
156839311|NCT00549770|566163355|FG003|Overall Study|Lack of Efficacy|3|||
157024059|NCT04209465|566841174|FG010|Overall Study|Started new therapy|0|||
157154213|NCT00726323|567309555|FG000|Overall Study|Adverse Event|9|||
157154214|NCT00726323|567309556|FG001|Overall Study|Adverse Event|9|||
157154215|NCT00726323|567309555|FG000|Overall Study|Death|1|||
157154216|NCT00726323|567309556|FG001|Overall Study|Death|0|||
157154217|NCT00726323|567309555|FG000|Overall Study|Participant wished to discontinue|0|||
157154218|NCT00726323|567309556|FG001|Overall Study|Participant wished to discontinue|1|||
156839312|NCT00549770|566163356|FG004|Overall Study|Lack of Efficacy|5|||
156839313|NCT00549770|566163357|FG005|Overall Study|Lack of Efficacy|1|||
156839314|NCT00549770|566163358|FG006|Overall Study|Lack of Efficacy|3|||
157024060|NCT04209465|566841175|FG011|Overall Study|Started new therapy|0|||
157154219|NCT00726323|567309555|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
157154220|NCT00726323|567309556|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
157154221|NCT05058664|567309557|FG000|Overall Study|No follow-up data provided|4|||
157154222|NCT05058664|567309558|FG001|Overall Study|No follow-up data provided|0|||
157154223|NCT05058664|567309559|FG002|Overall Study|No follow-up data provided|2|||
156839315|NCT00549770|566163359|FG007|Overall Study|Lack of Efficacy|8|||
156839316|NCT00549770|566163352|FG000|Overall Study|Abnormal test procedure results|0|||
156839317|NCT00549770|566163353|FG001|Overall Study|Abnormal test procedure results|0|||
156839318|NCT00549770|566163354|FG002|Overall Study|Abnormal test procedure results|0|||
156839319|NCT00549770|566163355|FG003|Overall Study|Abnormal test procedure results|2|||
156839320|NCT00549770|566163356|FG004|Overall Study|Abnormal test procedure results|0|||
156839321|NCT00549770|566163357|FG005|Overall Study|Abnormal test procedure results|1|||
156839322|NCT00549770|566163358|FG006|Overall Study|Abnormal test procedure results|1|||
156839323|NCT00549770|566163359|FG007|Overall Study|Abnormal test procedure results|1|||
156886697|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
156886698|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
156886699|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
156886700|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
157154224|NCT05058664|567309557|FG000|Overall Study|Withdrawal by Subject|0|||
157154225|NCT05058664|567309558|FG001|Overall Study|Withdrawal by Subject|0|||
157154226|NCT05058664|567309559|FG002|Overall Study|Withdrawal by Subject|1|||
157154227|NCT01617681|567309560|FG000|Period 1 Double Blind|Adverse Event|2|||
157154228|NCT01617681|567309561|FG001|Period 1 Double Blind|Adverse Event|0|||
157154229|NCT01617681|567309562|FG002|Period 1 Double Blind|Adverse Event|0|||
157154230|NCT01617681|567309563|FG003|Period 1 Double Blind|Adverse Event|2|||
157154231|NCT01617681|567309564|FG004|Period 1 Double Blind|Adverse Event|0|||
157154232|NCT01617681|567309560|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
157154233|NCT01617681|567309561|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
157154234|NCT01617681|567309562|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
157154235|NCT01617681|567309563|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
157154236|NCT01617681|567309564|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
157154237|NCT01617681|567309560|FG000|Period 2 Open Label|Adverse Event|0|||
157154238|NCT01617681|567309561|FG001|Period 2 Open Label|Adverse Event|0|||
157154239|NCT01617681|567309562|FG002|Period 2 Open Label|Adverse Event|0|||
157154240|NCT01617681|567309563|FG003|Period 2 Open Label|Adverse Event|0|||
157154241|NCT01617681|567309564|FG004|Period 2 Open Label|Adverse Event|3|||
157154242|NCT01617681|567309560|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
157154243|NCT01617681|567309561|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
157154244|NCT01617681|567309562|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
157154245|NCT01617681|567309563|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
157154246|NCT01617681|567309564|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
157154247|NCT00109733|567309572|FG000|Overall Study|Protocol Violation|0|||
157154248|NCT00109733|567309573|FG001|Overall Study|Protocol Violation|1|||
157154249|NCT00109733|567309572|FG000|Overall Study|Stopped taking study drug|1|||
157154250|NCT00109733|567309573|FG001|Overall Study|Stopped taking study drug|1|||
157154251|NCT00109733|567309572|FG000|Overall Study|Non-compliant|0|||
156886701|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
156886702|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
156886703|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
156886704|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
156886705|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
156886706|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
156886707|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
156886708|NCT01087788|566344011|FG000|24-weeks Dose-blind Period|Patient moved|0|||
156886709|NCT01087788|566344012|FG001|24-weeks Dose-blind Period|Patient moved|0|||
156886710|NCT01087788|566344013|FG002|24-weeks Dose-blind Period|Patient moved|1|||
156886711|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
156886712|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
156886713|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
156886714|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
156886715|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
156886716|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
156886717|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
156886718|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
156886719|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
156886720|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
156886721|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
156886722|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
156886723|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
157154252|NCT00109733|567309573|FG001|Overall Study|Non-compliant|1|||
157154253|NCT00109733|567309572|FG000|Overall Study|Could not commit time for study|1|||
157154254|NCT00109733|567309573|FG001|Overall Study|Could not commit time for study|1|||
157154255|NCT02086565|567309582|FG000|Overall Study|Lost to Follow-up|9|||
157154256|NCT02086565|567309583|FG001|Overall Study|Lost to Follow-up|7|||
157154257|NCT02086565|567309582|FG000|Overall Study|Withdrawal by Subject|2|||
156839324|NCT00549770|566163352|FG000|Overall Study|Abnormal laboratory values|0|||
156839325|NCT00549770|566163353|FG001|Overall Study|Abnormal laboratory values|0|||
156839326|NCT00549770|566163354|FG002|Overall Study|Abnormal laboratory values|0|||
156839327|NCT00549770|566163355|FG003|Overall Study|Abnormal laboratory values|0|||
156839328|NCT00549770|566163356|FG004|Overall Study|Abnormal laboratory values|0|||
156839329|NCT00549770|566163357|FG005|Overall Study|Abnormal laboratory values|1|||
156839330|NCT00549770|566163358|FG006|Overall Study|Abnormal laboratory values|0|||
156839331|NCT00549770|566163359|FG007|Overall Study|Abnormal laboratory values|0|||
156839332|NCT00549770|566163352|FG000|Overall Study|Adverse Event|1|||
156839333|NCT00549770|566163353|FG001|Overall Study|Adverse Event|3|||
156839334|NCT00549770|566163354|FG002|Overall Study|Adverse Event|1|||
156839335|NCT00549770|566163355|FG003|Overall Study|Adverse Event|2|||
156839336|NCT00549770|566163356|FG004|Overall Study|Adverse Event|1|||
156839337|NCT00549770|566163357|FG005|Overall Study|Adverse Event|0|||
156839338|NCT00549770|566163358|FG006|Overall Study|Adverse Event|5|||
156839339|NCT00549770|566163359|FG007|Overall Study|Adverse Event|4|||
156839340|NCT00847015|566163360|FG000|Overall Study|Withdrawal by Subject|1|||
156839341|NCT00847015|566163360|FG000|Overall Study|declined any surgery|1|||
156839342|NCT00847015|566163360|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
156839343|NCT01641822|566163361|FG000|Run-in Phase|Noncompliance with study drug|1|||
156839344|NCT01641822|566163362|FG001|Run-in Phase|Noncompliance with study drug|0|||
156839345|NCT01641822|566163363|FG002|Run-in Phase|Noncompliance with study drug|0|||
156839346|NCT01641822|566163361|FG000|Run-in Phase|Adverse Event|3|||
156839347|NCT01641822|566163362|FG001|Run-in Phase|Adverse Event|0|||
156839348|NCT01641822|566163363|FG002|Run-in Phase|Adverse Event|0|||
156839349|NCT01641822|566163361|FG000|Run-in Phase|Withdrew consent|1|||
156839350|NCT01641822|566163362|FG001|Run-in Phase|Withdrew consent|0|||
156839351|NCT01641822|566163363|FG002|Run-in Phase|Withdrew consent|0|||
156839352|NCT01641822|566163361|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
156839353|NCT01641822|566163362|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
156839354|NCT01641822|566163363|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
156839355|NCT01641822|566163361|FG000|Comparative Phase|Noncompliance with study drug|0|||
156839356|NCT01641822|566163362|FG001|Comparative Phase|Noncompliance with study drug|1|||
156839357|NCT01641822|566163363|FG002|Comparative Phase|Noncompliance with study drug|0|||
156839358|NCT01641822|566163361|FG000|Comparative Phase|Investigator's discretion|0|||
156839359|NCT01641822|566163362|FG001|Comparative Phase|Investigator's discretion|0|||
156839360|NCT01641822|566163363|FG002|Comparative Phase|Investigator's discretion|1|||
156839361|NCT01641822|566163361|FG000|Comparative Phase|Pregnancy|0|||
156839362|NCT01641822|566163362|FG001|Comparative Phase|Pregnancy|0|||
156839363|NCT01641822|566163363|FG002|Comparative Phase|Pregnancy|1|||
156839364|NCT01641822|566163361|FG000|Comparative Phase|Adverse event, serious fatal|0|||
157154258|NCT02086565|567309583|FG001|Overall Study|Withdrawal by Subject|1|||
157154259|NCT02086565|567309582|FG000|Overall Study|Death|3|||
157154260|NCT02086565|567309583|FG001|Overall Study|Death|2|||
157154261|NCT02086565|567309582|FG000|Overall Study|withdrawn by research team|2|||
157154262|NCT02086565|567309583|FG001|Overall Study|withdrawn by research team|2|||
157154263|NCT00739297|567309584|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
157154264|NCT00739297|567309585|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
157154265|NCT00739297|567309586|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
157154266|NCT00739297|567309587|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
157154267|NCT00739297|567309588|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
157154268|NCT00739297|567309589|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
157154269|NCT00739297|567309590|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
157154270|NCT00739297|567309584|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
157154271|NCT00739297|567309585|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
157154272|NCT00739297|567309586|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
157154273|NCT00739297|567309587|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
157154274|NCT00739297|567309588|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
157154275|NCT00739297|567309589|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
157154276|NCT00739297|567309590|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
156839365|NCT01641822|566163362|FG001|Comparative Phase|Adverse event, serious fatal|1|||
156839366|NCT01641822|566163363|FG002|Comparative Phase|Adverse event, serious fatal|0|||
156839367|NCT01641822|566163361|FG000|Comparative Phase|Withdrew consent|0|||
156839368|NCT01641822|566163362|FG001|Comparative Phase|Withdrew consent|3|||
156839369|NCT01641822|566163363|FG002|Comparative Phase|Withdrew consent|7|||
156839370|NCT01641822|566163361|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
156839371|NCT01641822|566163362|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
156839372|NCT01641822|566163363|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
156839373|NCT00454584|566163364|FG000|Controlled Period|Adverse Event|5|||
156839374|NCT00454584|566163365|FG001|Controlled Period|Adverse Event|2|||
156839375|NCT00454584|566163366|FG002|Controlled Period|Adverse Event|1|||
156839376|NCT00454584|566163367|FG003|Controlled Period|Adverse Event|0|||
156839377|NCT00454584|566163368|FG004|Controlled Period|Adverse Event|0|||
156839378|NCT00454584|566163369|FG005|Controlled Period|Adverse Event|0|||
157154277|NCT01400971|567309591|FG000|Overall Study|Death|82|||
157154278|NCT01400971|567309591|FG000|Overall Study|Lost to Follow-up|196|||
157154279|NCT01400971|567309591|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
157154280|NCT01400971|567309591|FG000|Overall Study|Physician Decision|57|||
157154281|NCT01400971|567309591|FG000|Overall Study|Withdrawal by Subject|158|||
157154282|NCT01400971|567309591|FG000|Overall Study|Other|422|||
157154283|NCT02375698|567309594|FG000|Overall Study|Withdrawal by Subject|0|||
157154284|NCT02375698|567309595|FG001|Overall Study|Withdrawal by Subject|2|||
157154285|NCT02375698|567309594|FG000|Overall Study|Physician Decision|2|||
157154286|NCT02375698|567309595|FG001|Overall Study|Physician Decision|0|||
157154287|NCT01595646|567309597|FG000|Overall Study|Withdrawal by Subject|1|||
157154288|NCT01595646|567309598|FG001|Overall Study|Withdrawal by Subject|0|||
157154289|NCT01595646|567309599|FG002|Overall Study|Withdrawal by Subject|0|||
157154290|NCT00751881|567309605|FG000|Core Treatment Period|Not treated|1|||
157154291|NCT00751881|567309606|FG001|Core Treatment Period|Not treated|1|||
157154292|NCT00751881|567309607|FG002|Core Treatment Period|Not treated|2|||
156839379|NCT00454584|566163364|FG000|Controlled Period|Lost to Follow-up|1|||
156839380|NCT00454584|566163365|FG001|Controlled Period|Lost to Follow-up|2|||
156839381|NCT00454584|566163366|FG002|Controlled Period|Lost to Follow-up|2|||
156839382|NCT00454584|566163367|FG003|Controlled Period|Lost to Follow-up|0|||
156839383|NCT00454584|566163368|FG004|Controlled Period|Lost to Follow-up|0|||
156839384|NCT00454584|566163369|FG005|Controlled Period|Lost to Follow-up|0|||
156839385|NCT00454584|566163364|FG000|Controlled Period|Other|5|||
156839386|NCT00454584|566163365|FG001|Controlled Period|Other|4|||
156839387|NCT00454584|566163366|FG002|Controlled Period|Other|2|||
156839388|NCT00454584|566163367|FG003|Controlled Period|Other|0|||
156839389|NCT00454584|566163368|FG004|Controlled Period|Other|0|||
156839390|NCT00454584|566163369|FG005|Controlled Period|Other|0|||
156839391|NCT00454584|566163364|FG000|After Controlled Period|Adverse Event|0|||
156839392|NCT00454584|566163365|FG001|After Controlled Period|Adverse Event|0|||
156839393|NCT00454584|566163366|FG002|After Controlled Period|Adverse Event|0|||
156839394|NCT00454584|566163367|FG003|After Controlled Period|Adverse Event|9|||
156839395|NCT00454584|566163368|FG004|After Controlled Period|Adverse Event|3|||
156839396|NCT00454584|566163369|FG005|After Controlled Period|Adverse Event|9|||
156839397|NCT00454584|566163364|FG000|After Controlled Period|Lack of Efficacy|0|||
156839398|NCT00454584|566163365|FG001|After Controlled Period|Lack of Efficacy|0|||
156839399|NCT00454584|566163366|FG002|After Controlled Period|Lack of Efficacy|0|||
156839400|NCT00454584|566163367|FG003|After Controlled Period|Lack of Efficacy|1|||
156839401|NCT00454584|566163368|FG004|After Controlled Period|Lack of Efficacy|0|||
156839402|NCT00454584|566163369|FG005|After Controlled Period|Lack of Efficacy|0|||
156839403|NCT00454584|566163364|FG000|After Controlled Period|Lost to Follow-up|0|||
156839404|NCT00454584|566163365|FG001|After Controlled Period|Lost to Follow-up|0|||
156839405|NCT00454584|566163366|FG002|After Controlled Period|Lost to Follow-up|0|||
156839406|NCT00454584|566163367|FG003|After Controlled Period|Lost to Follow-up|2|||
156839407|NCT00454584|566163368|FG004|After Controlled Period|Lost to Follow-up|4|||
156839408|NCT00454584|566163369|FG005|After Controlled Period|Lost to Follow-up|6|||
156839409|NCT00454584|566163364|FG000|After Controlled Period|Other|0|||
156839410|NCT00454584|566163365|FG001|After Controlled Period|Other|0|||
156839411|NCT00454584|566163366|FG002|After Controlled Period|Other|0|||
156839412|NCT00454584|566163367|FG003|After Controlled Period|Other|1|||
156839413|NCT00454584|566163368|FG004|After Controlled Period|Other|0|||
156839414|NCT00454584|566163369|FG005|After Controlled Period|Other|0|||
156839415|NCT00454584|566163364|FG000|After Controlled Period|Other|0|||
156839416|NCT00454584|566163365|FG001|After Controlled Period|Other|0|||
156839417|NCT00454584|566163366|FG002|After Controlled Period|Other|0|||
156839418|NCT00454584|566163367|FG003|After Controlled Period|Other|13|||
156839419|NCT00454584|566163368|FG004|After Controlled Period|Other|5|||
156839420|NCT00454584|566163369|FG005|After Controlled Period|Other|17|||
156886724|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
157154293|NCT00751881|567309605|FG000|Core Treatment Period|Adverse Event|26|||
157154294|NCT00751881|567309606|FG001|Core Treatment Period|Adverse Event|54|||
157154295|NCT00751881|567309607|FG002|Core Treatment Period|Adverse Event|58|||
157154296|NCT00751881|567309605|FG000|Core Treatment Period|Lack of Efficacy|37|||
157154297|NCT00751881|567309606|FG001|Core Treatment Period|Lack of Efficacy|30|||
156839421|NCT02760810|566163370|FG000|Overall Study|Protocol Violation|1|||
156839422|NCT02421601|566163371|FG000|Overall Study|Adverse Event|4|||
156839423|NCT02421601|566163371|FG000|Overall Study|Lack of Efficacy|5|||
156839424|NCT02421601|566163371|FG000|Overall Study|Physician Decision|1|||
156839425|NCT02421601|566163371|FG000|Overall Study|Withdrawal by Subject|31|||
156839426|NCT02421601|566163371|FG000|Overall Study|Others|41|||
156886725|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
156839427|NCT01581619|566163372|FG000|Overall Study|Withdrawal by Subject|1|||
156839428|NCT01581619|566163372|FG000|Overall Study|Lost to Follow-up|1|||
156839429|NCT02250664|566163375|FG000|Overall Study|Lost to Follow-up|18|||
156886726|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
157154298|NCT00751881|567309607|FG002|Core Treatment Period|Lack of Efficacy|20|||
157154299|NCT00751881|567309605|FG000|Core Treatment Period|Poor compliance to protocol|15|||
157154300|NCT00751881|567309606|FG001|Core Treatment Period|Poor compliance to protocol|3|||
157154301|NCT00751881|567309607|FG002|Core Treatment Period|Poor compliance to protocol|4|||
157154302|NCT00751881|567309605|FG000|Core Treatment Period|Lost to Follow-up|6|||
157154303|NCT00751881|567309606|FG001|Core Treatment Period|Lost to Follow-up|4|||
157154304|NCT00751881|567309607|FG002|Core Treatment Period|Lost to Follow-up|3|||
157154305|NCT00751881|567309605|FG000|Core Treatment Period|Other: protocol deviation|3|||
157154306|NCT00751881|567309606|FG001|Core Treatment Period|Other: protocol deviation|3|||
157154307|NCT00751881|567309607|FG002|Core Treatment Period|Other: protocol deviation|7|||
157154308|NCT00751881|567309605|FG000|Core Treatment Period|Other: wish to parent|5|||
157154309|NCT00751881|567309606|FG001|Core Treatment Period|Other: wish to parent|7|||
157154310|NCT00751881|567309607|FG002|Core Treatment Period|Other: wish to parent|4|||
157154311|NCT00751881|567309605|FG000|Core Treatment Period|Other: personal/family constraints|6|||
157154312|NCT00751881|567309606|FG001|Core Treatment Period|Other: personal/family constraints|7|||
157154313|NCT00751881|567309607|FG002|Core Treatment Period|Other: personal/family constraints|10|||
157154314|NCT00751881|567309605|FG000|Core Treatment Period|Other: MS treatment change|6|||
156839430|NCT02250664|566163376|FG001|Overall Study|Lost to Follow-up|28|||
156839431|NCT02250664|566163377|FG002|Overall Study|Lost to Follow-up|33|||
156839432|NCT02250664|566163375|FG000|Overall Study|Personal Reasons|7|||
156839433|NCT02250664|566163376|FG001|Overall Study|Personal Reasons|8|||
156839434|NCT02250664|566163377|FG002|Overall Study|Personal Reasons|14|||
156839435|NCT02250664|566163375|FG000|Overall Study|Adverse Event|6|||
156839436|NCT02250664|566163376|FG001|Overall Study|Adverse Event|3|||
156839437|NCT02250664|566163377|FG002|Overall Study|Adverse Event|8|||
156839438|NCT02250664|566163375|FG000|Overall Study|Incarcerated|2|||
156839439|NCT02250664|566163376|FG001|Overall Study|Incarcerated|1|||
156839440|NCT02250664|566163377|FG002|Overall Study|Incarcerated|2|||
156839441|NCT02250664|566163375|FG000|Overall Study|Withdrawal by Subject|0|||
156839442|NCT02250664|566163376|FG001|Overall Study|Withdrawal by Subject|1|||
156839443|NCT02250664|566163377|FG002|Overall Study|Withdrawal by Subject|2|||
156839444|NCT02250664|566163375|FG000|Overall Study|Death|0|||
156839445|NCT02250664|566163376|FG001|Overall Study|Death|1|||
156839446|NCT02250664|566163377|FG002|Overall Study|Death|1|||
156839447|NCT02250664|566163375|FG000|Overall Study|Physician Decision|1|||
156839448|NCT02250664|566163376|FG001|Overall Study|Physician Decision|3|||
156839449|NCT02250664|566163377|FG002|Overall Study|Physician Decision|1|||
156839450|NCT02250664|566163375|FG000|Overall Study|Protocol Violation|1|||
156839451|NCT02250664|566163376|FG001|Overall Study|Protocol Violation|0|||
156839452|NCT02250664|566163377|FG002|Overall Study|Protocol Violation|1|||
156839453|NCT02250664|566163375|FG000|Overall Study|Reason unknown|1|||
156839454|NCT02250664|566163376|FG001|Overall Study|Reason unknown|0|||
156839455|NCT02250664|566163377|FG002|Overall Study|Reason unknown|0|||
156839456|NCT01716104|566163379|FG000|Overall Study|Do not meet inclusion criteria|6|||
156839457|NCT01716104|566163380|FG001|Overall Study|Do not meet inclusion criteria|7|||
156839458|NCT00117793|566163381|FG000|Overall Study|Withdrawal by Subject|12|||
156839459|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839460|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
156839461|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839462|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
156839463|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
156839464|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
156839465|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
156839466|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
156839467|NCT01753401|566163388|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839468|NCT01753401|566163389|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
156839469|NCT01753401|566163390|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839470|NCT01753401|566163391|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
156839471|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
156839472|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
156839473|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
156839474|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
156839475|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
156839476|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
156839477|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
157154315|NCT00751881|567309606|FG001|Core Treatment Period|Other: MS treatment change|4|||
157154316|NCT00751881|567309607|FG002|Core Treatment Period|Other: MS treatment change|4|||
157154317|NCT00751881|567309605|FG000|Core Treatment Period|Other: tolerability complaints|2|||
156839478|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
156839479|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
156839480|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
156839481|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
156839482|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
156839483|NCT01753401|566163388|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
156839484|NCT01753401|566163389|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
157024061|NCT04209465|566841176|FG012|Overall Study|Started new therapy|0|||
156839485|NCT01753401|566163390|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
156839486|NCT01753401|566163391|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
157154318|NCT00751881|567309606|FG001|Core Treatment Period|Other: tolerability complaints|0|||
157154319|NCT00751881|567309607|FG002|Core Treatment Period|Other: tolerability complaints|0|||
157154320|NCT00751881|567309605|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
157154321|NCT00751881|567309606|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
157154322|NCT00751881|567309607|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
157154323|NCT00751881|567309605|FG000|Extension Study Period|Adverse Event|18|||
157154324|NCT00751881|567309606|FG001|Extension Study Period|Adverse Event|20|||
157154325|NCT00751881|567309607|FG002|Extension Study Period|Adverse Event|21|||
157154326|NCT00751881|567309605|FG000|Extension Study Period|Lack of Efficacy|14|||
157154327|NCT00751881|567309606|FG001|Extension Study Period|Lack of Efficacy|10|||
157154328|NCT00751881|567309607|FG002|Extension Study Period|Lack of Efficacy|20|||
157154329|NCT00751881|567309605|FG000|Extension Study Period|Lost to Follow-up|4|||
157154330|NCT00751881|567309606|FG001|Extension Study Period|Lost to Follow-up|9|||
157154331|NCT00751881|567309607|FG002|Extension Study Period|Lost to Follow-up|6|||
157154332|NCT00751881|567309605|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
157154333|NCT00751881|567309606|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
157154334|NCT00751881|567309607|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
157154335|NCT00751881|567309605|FG000|Extension Study Period|Other than specified above|26|||
157154336|NCT00751881|567309606|FG001|Extension Study Period|Other than specified above|30|||
157154337|NCT00751881|567309607|FG002|Extension Study Period|Other than specified above|18|||
157154338|NCT04770155|567309608|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154339|NCT04770155|567309609|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154340|NCT04770155|567309610|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154341|NCT04770155|567309611|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154342|NCT04770155|567309612|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154343|NCT04770155|567309613|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154344|NCT04770155|567309614|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154345|NCT04770155|567309615|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
157154346|NCT01632878|567309616|FG000|Screening|Physician Decision|268|||
156839487|NCT00581360|566163392|FG000|Overall Study|Withdrawal by Subject|1|||
156839488|NCT03129360|566163393|FG000|Overall Study|Did not meet entry criteria|0|||
156839489|NCT03129360|566163394|FG001|Overall Study|Did not meet entry criteria|2|||
156839490|NCT03129360|566163395|FG002|Overall Study|Did not meet entry criteria|1|||
156839491|NCT03129360|566163393|FG000|Overall Study|Excluded due to motion in scanner|1|||
156839492|NCT03129360|566163394|FG001|Overall Study|Excluded due to motion in scanner|0|||
156839493|NCT03129360|566163395|FG002|Overall Study|Excluded due to motion in scanner|0|||
156839494|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
156839495|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
156839496|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
156839497|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
156839498|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
156839499|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
156839500|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
156839501|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
156839502|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
156839503|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
156839504|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
156839505|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
156839506|NCT00599638|566163396|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
156839507|NCT00599638|566163397|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
156839508|NCT00599638|566163398|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
157224730|NCT01893905|567569849|FG001|Overall Study|Protocol Violation|1|||
157224731|NCT01893905|567569848|FG000|Overall Study|Lack of adherence to treatment|2|||
156839509|NCT00599638|566163399|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
156839510|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
156839511|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
156839512|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
156839513|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
156839514|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
156839515|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
156839516|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
156839517|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
156839518|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
157154347|NCT01632878|567309616|FG000|Treatment|Lost to Follow-up|41|||
157154348|NCT01632878|567309616|FG000|Treatment|Withdrawal by Subject|36|||
157154349|NCT01632878|567309616|FG000|Treatment|Physician Decision|34|||
157154350|NCT01632878|567309616|FG000|Treatment|missing information|4|||
157154351|NCT01632878|567309616|FG000|Treatment|no information on study completion|43|||
157154352|NCT03634072|567309617|FG000|Overall Study|Early termination of overall study|1|||
157154353|NCT03634072|567309618|FG001|Overall Study|Early termination of overall study|0|||
157154354|NCT01765764|567309619|FG000|Treatment Period|Adverse Event|1|||
157154355|NCT01765764|567309620|FG001|Treatment Period|Adverse Event|2|||
157154356|NCT01765764|567309621|FG002|Treatment Period|Adverse Event|1|||
157154357|NCT01765764|567309619|FG000|Treatment Period|Lost to Follow-up|0|||
157154358|NCT01765764|567309620|FG001|Treatment Period|Lost to Follow-up|3|||
157154359|NCT01765764|567309621|FG002|Treatment Period|Lost to Follow-up|2|||
157154360|NCT01765764|567309619|FG000|Treatment Period|Personal Reasons|1|||
157154361|NCT01765764|567309620|FG001|Treatment Period|Personal Reasons|2|||
157154362|NCT01765764|567309621|FG002|Treatment Period|Personal Reasons|1|||
157154363|NCT01765764|567309619|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
157154364|NCT01765764|567309620|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
157154365|NCT01765764|567309621|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
157154366|NCT01597193|567309624|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
157154367|NCT01597193|567309625|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
157154368|NCT01597193|567309626|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
157154369|NCT01597193|567309627|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
157154370|NCT01597193|567309628|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
157154371|NCT01597193|567309629|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
157154372|NCT01597193|567309630|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
157154373|NCT01597193|567309624|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
157154374|NCT01597193|567309625|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
157154375|NCT01597193|567309626|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
157154376|NCT01597193|567309627|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
157154377|NCT01597193|567309628|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
157154378|NCT01597193|567309629|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
157154379|NCT01597193|567309630|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
157154380|NCT01597193|567309624|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
157154381|NCT01597193|567309625|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
157154382|NCT01597193|567309626|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
157154383|NCT01597193|567309627|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
157154384|NCT01597193|567309628|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
157154385|NCT01597193|567309629|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
157154386|NCT01597193|567309630|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
157154387|NCT01597193|567309624|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154388|NCT01597193|567309625|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154389|NCT01597193|567309626|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154390|NCT01597193|567309627|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154391|NCT01597193|567309628|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154392|NCT01597193|567309629|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
157154393|NCT01597193|567309630|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
157154394|NCT01597193|567309624|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
157154395|NCT01597193|567309625|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
157154396|NCT01597193|567309626|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
157154397|NCT01597193|567309627|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
157154398|NCT01597193|567309628|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
157154399|NCT01597193|567309629|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
157154400|NCT01597193|567309630|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
157154401|NCT03184701|567309632|FG000|Overall Study|Death|3|||
156839519|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
156839520|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
156839521|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
156839522|NCT00599638|566163396|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
156839523|NCT00599638|566163397|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
157154402|NCT03184701|567309632|FG000|Overall Study|Physician Decision|3|||
157154403|NCT03184701|567309632|FG000|Overall Study|Withdrawal by Subject|6|||
157154404|NCT03184701|567309632|FG000|Overall Study|Lost to Follow-up|5|||
157154405|NCT01259297|567309635|FG000|Double Blind Randomized Period|Death|1|||
157154406|NCT01259297|567309636|FG001|Double Blind Randomized Period|Death|1|||
157154407|NCT01259297|567309637|FG002|Double Blind Randomized Period|Death|1|||
157154408|NCT01259297|567309638|FG003|Double Blind Randomized Period|Death|2|||
157154409|NCT01259297|567309639|FG004|Double Blind Randomized Period|Death|1|||
157154410|NCT01259297|567309640|FG005|Double Blind Randomized Period|Death|5|||
157154411|NCT01259297|567309641|FG006|Double Blind Randomized Period|Death|2|||
157154412|NCT01259297|567309642|FG007|Double Blind Randomized Period|Death|1|||
156839524|NCT00599638|566163398|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
157224732|NCT01893905|567569849|FG001|Overall Study|Lack of adherence to treatment|0|||
157224733|NCT01893905|567569848|FG000|Overall Study|Other reason|1|||
157224734|NCT01893905|567569849|FG001|Overall Study|Other reason|3|||
157224735|NCT01768858|567569850|FG000|Overall Study|Lost to Follow-up|9|||
157224736|NCT01768858|567569850|FG000|Overall Study|Lack of Efficacy|8|||
157224737|NCT01768858|567569850|FG000|Overall Study|Serious Adverse Event|1|||
157224738|NCT01768858|567569850|FG000|Overall Study|Participant moved to Germany|1|||
157224739|NCT01768858|567569850|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
157224740|NCT01768858|567569850|FG000|Overall Study|Exanthema|1|||
157224741|NCT01768858|567569850|FG000|Overall Study|Withdrawal by Subject|1|||
157224742|NCT02742090|567569852|FG000|Overall Study|Adverse Event|10|||
157224743|NCT02742090|567569852|FG000|Overall Study|Death|3|||
157224744|NCT02742090|567569852|FG000|Overall Study|Disease Progression|25|||
157224745|NCT02742090|567569852|FG000|Overall Study|Investigator's Decision|1|||
157224746|NCT02742090|567569852|FG000|Overall Study|Lost to Follow-up|1|||
156839525|NCT00599638|566163399|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
156839526|NCT00599638|566163396|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
156839527|NCT00599638|566163397|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839528|NCT00599638|566163398|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839529|NCT00599638|566163399|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
156839530|NCT03006887|566163403|FG000|Overall Study|Adverse Event|1|||
156839531|NCT03836677|566163404|FG000|Period 1|Adverse Event|0|||
156839532|NCT03836677|566163405|FG001|Period 1|Adverse Event|1|||
156839533|NCT03836677|566163404|FG000|Period 2|Severe non-compliance to protocol|1|||
156839534|NCT03836677|566163405|FG001|Period 2|Severe non-compliance to protocol|0|||
156839535|NCT02895945|566163406|FG000|Overall Study|Physician Decision|2|||
156839536|NCT02895945|566163407|FG001|Overall Study|Physician Decision|1|||
156839537|NCT00462748|566163408|FG000|Overall Study|Adverse Event|7|||
156839538|NCT00462748|566163409|FG001|Overall Study|Adverse Event|5|||
156839539|NCT00462748|566163410|FG002|Overall Study|Adverse Event|9|||
156839540|NCT00462748|566163408|FG000|Overall Study|Protocol Violation|0|||
156839541|NCT00462748|566163409|FG001|Overall Study|Protocol Violation|2|||
156839542|NCT00462748|566163410|FG002|Overall Study|Protocol Violation|1|||
156839543|NCT00462748|566163408|FG000|Overall Study|Withdrew consent|3|||
156839544|NCT00462748|566163409|FG001|Overall Study|Withdrew consent|3|||
156839545|NCT00462748|566163410|FG002|Overall Study|Withdrew consent|0|||
156839546|NCT00462748|566163408|FG000|Overall Study|Lost to Follow-up|1|||
156839547|NCT00462748|566163409|FG001|Overall Study|Lost to Follow-up|1|||
156839548|NCT00462748|566163410|FG002|Overall Study|Lost to Follow-up|1|||
156839549|NCT00462748|566163408|FG000|Overall Study|Discontinued after 41 days Rx|1|||
156839550|NCT00462748|566163409|FG001|Overall Study|Discontinued after 41 days Rx|0|||
156839551|NCT00462748|566163410|FG002|Overall Study|Discontinued after 41 days Rx|0|||
156839552|NCT01818492|566163411|FG000|Overall Study|Adverse Event|2|||
156839553|NCT01818492|566163411|FG000|Overall Study|Death|3|||
156839554|NCT01818492|566163411|FG000|Overall Study|Withdrawal by Subject|1|||
156839555|NCT01818492|566163411|FG000|Overall Study|Additional therapy when not allowed PP|4|||
156839556|NCT01729208|566163412|FG000|Baseline|Physician Decision|5|||
156839557|NCT01729208|566163413|FG001|Baseline|Physician Decision|4|||
156839558|NCT01729208|566163412|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
156839559|NCT01729208|566163413|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
156839560|NCT01729208|566163412|FG000|12 Months Follow-up|Lost to Follow-up|3|||
156839561|NCT01729208|566163413|FG001|12 Months Follow-up|Lost to Follow-up|3|||
156839562|NCT01729208|566163412|FG000|24 Months Follow-up|Lost to Follow-up|3|||
156839563|NCT01729208|566163413|FG001|24 Months Follow-up|Lost to Follow-up|0|||
156839564|NCT01729208|566163412|FG000|36 Months Follow-up|Physician Decision|1|||
156839565|NCT01729208|566163413|FG001|36 Months Follow-up|Physician Decision|0|||
156839566|NCT01729208|566163412|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
156839567|NCT01729208|566163413|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
157024062|NCT04209465|566841164|FG000|Overall Study|Study terminated early by sponsor|0|||
157224747|NCT02742090|567569852|FG000|Overall Study|Non-compliance with Study|1|||
156839568|NCT00082381|566163414|FG000|Overall Study|Adverse Event|27|||
156839569|NCT00082381|566163415|FG001|Overall Study|Adverse Event|2|||
156839570|NCT00082381|566163414|FG000|Overall Study|Lost to Follow-up|5|||
156839571|NCT00082381|566163415|FG001|Overall Study|Lost to Follow-up|7|||
156839572|NCT00082381|566163414|FG000|Overall Study|Patient Decision|8|||
156839573|NCT00082381|566163415|FG001|Overall Study|Patient Decision|4|||
157224748|NCT02742090|567569852|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
156839574|NCT00082381|566163414|FG000|Overall Study|Physician Decision|1|||
156839575|NCT00082381|566163415|FG001|Overall Study|Physician Decision|2|||
156839576|NCT00082381|566163414|FG000|Overall Study|Protocol Violation|10|||
156839577|NCT00082381|566163415|FG001|Overall Study|Protocol Violation|11|||
156839578|NCT00082381|566163414|FG000|Overall Study|Loss of Glucose Control|4|||
156839579|NCT00082381|566163415|FG001|Overall Study|Loss of Glucose Control|0|||
156839580|NCT02428413|566163416|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
156839581|NCT02428413|566163417|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
157224749|NCT02742090|567569852|FG000|Overall Study|Withdrawal by Subject|4|||
157224750|NCT02742090|567569852|FG000|Overall Study|Reason Not Specified|1|||
156839582|NCT02428413|566163416|FG000|Overall Study|Protocol Violation|1|||
156839583|NCT02428413|566163417|FG001|Overall Study|Protocol Violation|2|||
156839584|NCT02428413|566163416|FG000|Overall Study|Case Cancelled|2|||
156839585|NCT02428413|566163417|FG001|Overall Study|Case Cancelled|0|||
156839586|NCT02428413|566163416|FG000|Overall Study|Missed Cases|1|||
156839587|NCT02428413|566163417|FG001|Overall Study|Missed Cases|2|||
156839588|NCT02428413|566163416|FG000|Overall Study|Nurse Refusal|1|||
156839589|NCT02428413|566163417|FG001|Overall Study|Nurse Refusal|0|||
156839590|NCT00109577|566163418|FG000|Overall Study|Withdrawal by Subject|3|||
156839591|NCT00109577|566163419|FG001|Overall Study|Withdrawal by Subject|3|||
156839592|NCT04891107|566163420|FG000|Overall Study|Physician Decision|1|||
156839593|NCT04891107|566163420|FG000|Overall Study|Withdrawal by Subject|1|||
156839594|NCT04891107|566163420|FG000|Overall Study|Screen failure after consent|1|||
156839595|NCT00565136|566163421|FG000|Overall Study|Lost to Follow-up|1|||
156839596|NCT00565136|566163421|FG000|Overall Study|Withdrawal by Subject|1|||
156839597|NCT00565136|566163421|FG000|Overall Study|Protocol Violation|1|||
156839598|NCT05096312|566163424|FG000|Overall Study|Lost to Follow-up|2|||
156839599|NCT05096312|566163425|FG001|Overall Study|Lost to Follow-up|4|||
156839600|NCT05096312|566163424|FG000|Overall Study|Adverse Event|1|||
156839601|NCT05096312|566163425|FG001|Overall Study|Adverse Event|0|||
156839602|NCT00576576|566163426|FG000|Overall Study|Lost to Follow-up|6|||
156839603|NCT00576576|566163426|FG000|Overall Study|Protocol Violation|1|||
156839604|NCT03135210|566163427|FG000|Overall Study|Death|0|||
156839605|NCT03135210|566163428|FG001|Overall Study|Death|1|||
156839606|NCT04512976|566165350|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839607|NCT04512976|566165351|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839608|NCT04512976|566165352|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839609|NCT04512976|566165353|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839610|NCT04512976|566165354|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
156839611|NCT04512976|566165355|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
156839612|NCT05249569|566165360|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
156839613|NCT01192412|566165363|FG000|Overall Study|Lost to Follow-up|2|||
156839614|NCT01192412|566165364|FG001|Overall Study|Lost to Follow-up|1|||
156839615|NCT01192412|566165363|FG000|Overall Study|Withdrawal by Subject|2|||
156839616|NCT01192412|566165364|FG001|Overall Study|Withdrawal by Subject|1|||
156839617|NCT00859937|566165365|FG000|Overall Study|Protocol Violation|1|||
156839618|NCT00859937|566165366|FG001|Overall Study|Protocol Violation|0|||
156839619|NCT00615030|566165367|FG000|Period I|Administrative problem|0|||
156839620|NCT00615030|566165368|FG001|Period I|Administrative problem|0|||
156839621|NCT00615030|566165369|FG002|Period I|Administrative problem|0|||
156839622|NCT00615030|566165370|FG003|Period I|Administrative problem|0|||
156839623|NCT00615030|566165371|FG004|Period I|Administrative problem|1|||
156839624|NCT00615030|566165372|FG005|Period I|Administrative problem|0|||
156839625|NCT00615030|566165373|FG006|Period I|Administrative problem|0|||
156839626|NCT00615030|566165374|FG007|Period I|Administrative problem|0|||
156839627|NCT00615030|566165375|FG008|Period I|Administrative problem|0|||
156839628|NCT00615030|566165376|FG009|Period I|Administrative problem|0|||
156839629|NCT00615030|566165377|FG010|Period I|Administrative problem|0|||
157154413|NCT01259297|567309635|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
157154414|NCT01259297|567309636|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
157154415|NCT01259297|567309637|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
157154416|NCT01259297|567309638|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
157154417|NCT01259297|567309639|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
157154418|NCT01259297|567309640|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
157154419|NCT01259297|567309641|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
157154420|NCT01259297|567309642|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
157154421|NCT01259297|567309635|FG000|Double Blind Randomized Period|Other reasons|0|||
156839630|NCT00615030|566165378|FG011|Period I|Administrative problem|0|||
156839631|NCT00615030|566165367|FG000|Period I|Protocol deviation|1|||
156839632|NCT00615030|566165368|FG001|Period I|Protocol deviation|0|||
156839633|NCT00615030|566165369|FG002|Period I|Protocol deviation|0|||
156839634|NCT00615030|566165370|FG003|Period I|Protocol deviation|0|||
156839635|NCT00615030|566165371|FG004|Period I|Protocol deviation|0|||
156839636|NCT00615030|566165372|FG005|Period I|Protocol deviation|0|||
156839637|NCT00615030|566165373|FG006|Period I|Protocol deviation|0|||
156839638|NCT00615030|566165374|FG007|Period I|Protocol deviation|0|||
156839639|NCT00615030|566165375|FG008|Period I|Protocol deviation|0|||
156839640|NCT00615030|566165376|FG009|Period I|Protocol deviation|0|||
156839641|NCT00615030|566165377|FG010|Period I|Protocol deviation|0|||
156839642|NCT00615030|566165378|FG011|Period I|Protocol deviation|0|||
156839643|NCT00615030|566165367|FG000|Period I|Subject withdrew consent|0|||
156839644|NCT00615030|566165368|FG001|Period I|Subject withdrew consent|0|||
156839645|NCT00615030|566165369|FG002|Period I|Subject withdrew consent|0|||
156839646|NCT00615030|566165370|FG003|Period I|Subject withdrew consent|0|||
156839647|NCT00615030|566165371|FG004|Period I|Subject withdrew consent|0|||
157154422|NCT01259297|567309636|FG001|Double Blind Randomized Period|Other reasons|1|||
157154423|NCT01259297|567309637|FG002|Double Blind Randomized Period|Other reasons|0|||
157154424|NCT01259297|567309638|FG003|Double Blind Randomized Period|Other reasons|0|||
157154425|NCT01259297|567309639|FG004|Double Blind Randomized Period|Other reasons|1|||
157154426|NCT01259297|567309640|FG005|Double Blind Randomized Period|Other reasons|2|||
157154427|NCT01259297|567309641|FG006|Double Blind Randomized Period|Other reasons|3|||
157154428|NCT01259297|567309642|FG007|Double Blind Randomized Period|Other reasons|1|||
157154429|NCT00705224|567309643|FG000|Overall Study|Adverse Event|1|||
157154430|NCT00705224|567309643|FG000|Overall Study|Lack of Efficacy|2|||
157154431|NCT00705224|567309643|FG000|Overall Study|Withdrawal by Subject|3|||
157154432|NCT00705224|567309643|FG000|Overall Study|Lost to Follow-up|5|||
157154433|NCT02566525|567309644|FG000|Overall Study|Protocol Violation|3|||
156839648|NCT00615030|566165372|FG005|Period I|Subject withdrew consent|0|||
156839649|NCT00615030|566165373|FG006|Period I|Subject withdrew consent|0|||
156839650|NCT00615030|566165374|FG007|Period I|Subject withdrew consent|0|||
156839651|NCT00615030|566165375|FG008|Period I|Subject withdrew consent|1|||
156839652|NCT00615030|566165376|FG009|Period I|Subject withdrew consent|0|||
156839653|NCT00615030|566165377|FG010|Period I|Subject withdrew consent|1|||
156839654|NCT00615030|566165378|FG011|Period I|Subject withdrew consent|1|||
156839655|NCT00615030|566165367|FG000|Period I|Abnormal laboratory value(s)|0|||
156839656|NCT00615030|566165368|FG001|Period I|Abnormal laboratory value(s)|0|||
156839657|NCT00615030|566165369|FG002|Period I|Abnormal laboratory value(s)|0|||
156839658|NCT00615030|566165370|FG003|Period I|Abnormal laboratory value(s)|0|||
156839659|NCT00615030|566165371|FG004|Period I|Abnormal laboratory value(s)|0|||
156839660|NCT00615030|566165372|FG005|Period I|Abnormal laboratory value(s)|1|||
156839661|NCT00615030|566165373|FG006|Period I|Abnormal laboratory value(s)|0|||
156839662|NCT00615030|566165374|FG007|Period I|Abnormal laboratory value(s)|0|||
156839663|NCT00615030|566165375|FG008|Period I|Abnormal laboratory value(s)|0|||
156839664|NCT00615030|566165376|FG009|Period I|Abnormal laboratory value(s)|0|||
156839665|NCT00615030|566165377|FG010|Period I|Abnormal laboratory value(s)|0|||
156839666|NCT00615030|566165378|FG011|Period I|Abnormal laboratory value(s)|0|||
156839667|NCT00615030|566165367|FG000|Period II|Adverse Event|0|||
156839668|NCT00615030|566165368|FG001|Period II|Adverse Event|0|||
156839669|NCT00615030|566165369|FG002|Period II|Adverse Event|1|||
156839670|NCT00615030|566165370|FG003|Period II|Adverse Event|0|||
156839671|NCT00615030|566165371|FG004|Period II|Adverse Event|0|||
156839672|NCT00615030|566165372|FG005|Period II|Adverse Event|0|||
156839673|NCT00615030|566165373|FG006|Period II|Adverse Event|0|||
156839674|NCT00615030|566165374|FG007|Period II|Adverse Event|0|||
156839675|NCT00615030|566165375|FG008|Period II|Adverse Event|1|||
156839676|NCT00615030|566165376|FG009|Period II|Adverse Event|0|||
157154434|NCT02566525|567309645|FG001|Overall Study|Protocol Violation|5|||
157154435|NCT03141086|567309646|FG000|Overall Study|Study Terminated By Sponsor|1|||
157154436|NCT03141086|567309647|FG001|Overall Study|Study Terminated By Sponsor|1|||
157154437|NCT03141086|567309646|FG000|Overall Study|Withdrawal by Subject|0|||
157154438|NCT03141086|567309647|FG001|Overall Study|Withdrawal by Subject|1|||
157154439|NCT03141086|567309646|FG000|Overall Study|Protocol Violation|0|||
157154440|NCT03141086|567309647|FG001|Overall Study|Protocol Violation|1|||
157154441|NCT03141086|567309646|FG000|Overall Study|Adverse Event|0|||
157154442|NCT03141086|567309647|FG001|Overall Study|Adverse Event|2|||
157154443|NCT02410902|567311259|FG000|Overall Study|Adverse Event|2|||
157154444|NCT02410902|567311260|FG001|Overall Study|Adverse Event|3|||
156839677|NCT00615030|566165377|FG010|Period II|Adverse Event|0|||
156839678|NCT00615030|566165378|FG011|Period II|Adverse Event|0|||
156839679|NCT00615030|566165367|FG000|Period II|Subject withdrew consent|0|||
157024063|NCT04209465|566841165|FG001|Overall Study|Study terminated early by sponsor|0|||
157024064|NCT04209465|566841166|FG002|Overall Study|Study terminated early by sponsor|0|||
157154445|NCT02410902|567311259|FG000|Overall Study|Lost to Follow-up|4|||
157154446|NCT02410902|567311260|FG001|Overall Study|Lost to Follow-up|1|||
156839680|NCT00615030|566165368|FG001|Period II|Subject withdrew consent|0|||
156839681|NCT00615030|566165369|FG002|Period II|Subject withdrew consent|0|||
156839682|NCT00615030|566165370|FG003|Period II|Subject withdrew consent|1|||
156839683|NCT00615030|566165371|FG004|Period II|Subject withdrew consent|0|||
156839684|NCT00615030|566165372|FG005|Period II|Subject withdrew consent|0|||
156839685|NCT00615030|566165373|FG006|Period II|Subject withdrew consent|1|||
156839686|NCT00615030|566165374|FG007|Period II|Subject withdrew consent|0|||
157024065|NCT04209465|566841167|FG003|Overall Study|Study terminated early by sponsor|0|||
156839687|NCT00615030|566165375|FG008|Period II|Subject withdrew consent|0|||
156839688|NCT00615030|566165376|FG009|Period II|Subject withdrew consent|0|||
156839689|NCT00615030|566165377|FG010|Period II|Subject withdrew consent|0|||
156839690|NCT00615030|566165378|FG011|Period II|Subject withdrew consent|0|||
156839691|NCT00615030|566165367|FG000|Period III|Administrative problems|1|||
156839692|NCT00615030|566165368|FG001|Period III|Administrative problems|0|||
157154447|NCT02410902|567311259|FG000|Overall Study|Protocol Violation|1|||
157154448|NCT02410902|567311260|FG001|Overall Study|Protocol Violation|4|||
157154449|NCT02410902|567311259|FG000|Overall Study|Withdrawal by Subject|6|||
157154450|NCT02410902|567311260|FG001|Overall Study|Withdrawal by Subject|8|||
157154451|NCT02410902|567311259|FG000|Overall Study|Non-Compliance|8|||
156839693|NCT00615030|566165369|FG002|Period III|Administrative problems|0|||
156839694|NCT00615030|566165370|FG003|Period III|Administrative problems|1|||
156839695|NCT00615030|566165371|FG004|Period III|Administrative problems|0|||
156839696|NCT00615030|566165372|FG005|Period III|Administrative problems|0|||
156839697|NCT00615030|566165373|FG006|Period III|Administrative problems|0|||
156839698|NCT00615030|566165374|FG007|Period III|Administrative problems|0|||
156839699|NCT00615030|566165375|FG008|Period III|Administrative problems|0|||
156839700|NCT00615030|566165376|FG009|Period III|Administrative problems|0|||
156839701|NCT00615030|566165377|FG010|Period III|Administrative problems|0|||
156839702|NCT00615030|566165378|FG011|Period III|Administrative problems|0|||
156839703|NCT00151476|566165379|FG000|FAP Identified Subjects|Protocol Violation|0|||
156839704|NCT00151476|566165380|FG001|FAP Identified Subjects|Protocol Violation|1|||
156839705|NCT00151476|566165379|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
156839706|NCT00151476|566165380|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
156839707|NCT00151476|566165379|FG000|FAP Analyzed Subjects|Other study participation|0|||
156839708|NCT00151476|566165380|FG001|FAP Analyzed Subjects|Other study participation|1|||
156839709|NCT03446456|566165381|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
156839710|NCT03446456|566165382|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
156839711|NCT03446456|566165381|FG000|Overall Study|Lost to Follow-up|1|||
156839712|NCT03446456|566165382|FG001|Overall Study|Lost to Follow-up|3|||
156839713|NCT03446456|566165381|FG000|Overall Study|Participant failed the toxicology test|1|||
156839714|NCT03446456|566165382|FG001|Overall Study|Participant failed the toxicology test|0|||
156839715|NCT03446456|566165381|FG000|Overall Study|Break down of the experimental equipment|1|||
156839716|NCT03446456|566165382|FG001|Overall Study|Break down of the experimental equipment|0|||
156839717|NCT00308074|566165397|FG000|Overall Study|Withdrawal by Subject|1|||
156839718|NCT03002311|566165398|FG000|Overall Study|Lost to Follow-up|13|||
156839719|NCT03002311|566165399|FG001|Overall Study|Lost to Follow-up|26|||
156839720|NCT03002311|566165398|FG000|Overall Study|Referral provider called to schedule app|3|||
156839721|NCT03002311|566165399|FG001|Overall Study|Referral provider called to schedule app|3|||
156839722|NCT03002311|566165398|FG000|Overall Study|Physician Decision|3|||
156839723|NCT03002311|566165399|FG001|Overall Study|Physician Decision|1|||
156839724|NCT01329939|566165403|FG000|Overall Study|Lost to Follow-up|3|||
156839725|NCT01329939|566165404|FG001|Overall Study|Lost to Follow-up|0|||
156839726|NCT01329939|566165405|FG002|Overall Study|Lost to Follow-up|1|||
156839727|NCT01329939|566165406|FG003|Overall Study|Lost to Follow-up|2|||
156839728|NCT01329939|566165403|FG000|Overall Study|Withdrawal by Subject|0|||
156839729|NCT01329939|566165404|FG001|Overall Study|Withdrawal by Subject|1|||
156839730|NCT01329939|566165405|FG002|Overall Study|Withdrawal by Subject|0|||
156839731|NCT01329939|566165406|FG003|Overall Study|Withdrawal by Subject|0|||
156839732|NCT01329939|566165403|FG000|Overall Study|Adverse Event|0|||
156839733|NCT01329939|566165404|FG001|Overall Study|Adverse Event|0|||
156839734|NCT01329939|566165405|FG002|Overall Study|Adverse Event|0|||
156839735|NCT01329939|566165406|FG003|Overall Study|Adverse Event|3|||
156839736|NCT03722524|566165407|FG000|Overall Study|Protocol Violation|86|||
156839737|NCT03722524|566165407|FG000|Overall Study|Adverse Event|7|||
156839738|NCT03722524|566165407|FG000|Overall Study|Lost to Follow-up|1|||
156839739|NCT03722524|566165407|FG000|Overall Study|Reason is not stated|1|||
156839740|NCT03722524|566165407|FG000|Overall Study|Physician Decision|1|||
156839741|NCT03722524|566165407|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
156839742|NCT00989963|566165409|FG000|Overall Study|Adverse Event|1|||
156839743|NCT00989963|566165410|FG001|Overall Study|Adverse Event|1|||
156886727|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
156886728|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
156886729|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
156886730|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
156886731|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
156886732|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
156886733|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
156886734|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
157024066|NCT04209465|566841168|FG004|Overall Study|Study terminated early by sponsor|0|||
157024067|NCT04209465|566841169|FG005|Overall Study|Study terminated early by sponsor|0|||
157024068|NCT04209465|566841170|FG006|Overall Study|Study terminated early by sponsor|3|||
157154452|NCT02410902|567311260|FG001|Overall Study|Non-Compliance|2|||
157154453|NCT02279524|567311262|FG000|Overall Study|Withdrawal by Subject|3|||
156839744|NCT00989963|566165411|FG002|Overall Study|Adverse Event|1|||
156839745|NCT01240200|566165418|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
156839746|NCT01240200|566165419|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
156839747|NCT01529034|566165422|FG000|Overall Study|Discontinued prior to study treatment|14|||
156839748|NCT01529034|566165422|FG000|Overall Study|Site closure|62|||
156839749|NCT01529034|566165422|FG000|Overall Study|Study termination|29|||
156839750|NCT01529034|566165422|FG000|Overall Study|Withdrawal by Subject|25|||
156839751|NCT01529034|566165422|FG000|Overall Study|No treated SCs within protocol window|13|||
157224751|NCT02192905|567569859|FG000|Overall Study|Lost to Follow-up|1|||
156839752|NCT01529034|566165422|FG000|Overall Study|Noncompliance|8|||
156839753|NCT01529034|566165422|FG000|Overall Study|Caregiver no longer available|7|||
156839754|NCT01529034|566165422|FG000|Overall Study|Adverse Event|4|||
156839755|NCT01529034|566165422|FG000|Overall Study|Protocol Violation|4|||
156839756|NCT01529034|566165422|FG000|Overall Study|Lack of Efficacy|4|||
156839757|NCT01529034|566165422|FG000|Overall Study|Investigator no longer available|2|||
156839758|NCT01529034|566165422|FG000|Overall Study|Study drug not available|2|||
156839759|NCT04588389|566165423|FG000|Overall Study|Issues with anesthesia during surgery|2|||
156839760|NCT04588389|566165424|FG001|Overall Study|Issues with anesthesia during surgery|0|||
156839761|NCT04588389|566165425|FG002|Overall Study|Issues with anesthesia during surgery|0|||
156839762|NCT00719680|566165429|FG000|Overall Study|Adverse Event|1|||
156839763|NCT00719680|566165429|FG000|Overall Study|Lost to Follow-up|1|||
156839764|NCT00719680|566165429|FG000|Overall Study|Withdrawal by Subject|3|||
156839765|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
156839766|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
156839767|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
156839768|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
156839769|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
156839770|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
156839771|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Death|1|||
156839772|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Death|4|||
156839773|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
156839774|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
156839775|NCT00658814|566165430|FG000|Remission Induction Chemotherapy|Not eligible|1|||
156839776|NCT00658814|566165431|FG001|Remission Induction Chemotherapy|Not eligible|2|||
156839777|NCT00658814|566165430|FG000|Consolidation Therapy|Not protocol specified|0|||
156839778|NCT00658814|566165431|FG001|Consolidation Therapy|Not protocol specified|1|||
156839779|NCT00658814|566165430|FG000|Consolidation Therapy|Not eligible|2|||
156839780|NCT00658814|566165431|FG001|Consolidation Therapy|Not eligible|2|||
156839781|NCT00658814|566165430|FG000|Maintenance Therapy|Adverse Event|1|||
156839782|NCT00658814|566165431|FG001|Maintenance Therapy|Adverse Event|1|||
156839783|NCT00658814|566165430|FG000|Maintenance Therapy|Not protocol specified|1|||
156839784|NCT00658814|566165431|FG001|Maintenance Therapy|Not protocol specified|0|||
156839785|NCT00658814|566165430|FG000|Maintenance Therapy|Not eligible|1|||
156839786|NCT00658814|566165431|FG001|Maintenance Therapy|Not eligible|0|||
156839787|NCT02911142|566165432|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
156839788|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
156839789|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
156839790|NCT02911142|566165432|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
156839791|NCT04071158|566165433|FG000|Overall Study|Lost to Follow-up|1|||
156839792|NCT04071158|566165434|FG001|Overall Study|Lost to Follow-up|2|||
156839793|NCT04071158|566165435|FG002|Overall Study|Lost to Follow-up|3|||
156839794|NCT04071158|566165436|FG003|Overall Study|Lost to Follow-up|3|||
156839795|NCT04071158|566165437|FG004|Overall Study|Lost to Follow-up|5|||
156839796|NCT04071158|566165433|FG000|Overall Study|Randomized but not treated|2|||
156839797|NCT04071158|566165434|FG001|Overall Study|Randomized but not treated|2|||
156839798|NCT04071158|566165435|FG002|Overall Study|Randomized but not treated|0|||
156839799|NCT04071158|566165436|FG003|Overall Study|Randomized but not treated|0|||
156839800|NCT04071158|566165437|FG004|Overall Study|Randomized but not treated|0|||
156839801|NCT01178099|566165438|FG000|Overall Study|Physician Decision|0|||
156839802|NCT01178099|566165439|FG001|Overall Study|Physician Decision|1|||
156839803|NCT02678923|566165452|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
156839804|NCT02678923|566165453|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
156839805|NCT02678923|566165452|FG000|Overall Study|Withdrawal by Subject|3|||
156839806|NCT02678923|566165453|FG001|Overall Study|Withdrawal by Subject|2|||
156839807|NCT02678923|566165452|FG000|Overall Study|Lost to Follow-up|1|||
156839808|NCT02678923|566165453|FG001|Overall Study|Lost to Follow-up|0|||
156839809|NCT02678923|566165452|FG000|Overall Study|Did Not Return for Study Visits|1|||
156839810|NCT02678923|566165453|FG001|Overall Study|Did Not Return for Study Visits|0|||
156839811|NCT00455143|566165454|FG000|Overall Study|Physician Decision|1|||
156839812|NCT00455143|566165454|FG000|Overall Study|Withdrawal by Subject|1|||
156839813|NCT00455143|566165454|FG000|Overall Study|Staff was not avail to follow patient|2|||
156839814|NCT00455143|566165454|FG000|Overall Study|No longer met Inclusion Criteria|1|||
156839815|NCT00455143|566165454|FG000|Overall Study|Surgical time, staff not available|1|||
156839816|NCT03266172|566165455|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
156839817|NCT03266172|566165456|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
156839818|NCT03266172|566165457|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
156839819|NCT03266172|566165455|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
156839820|NCT03266172|566165456|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
156839821|NCT03266172|566165457|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
156839822|NCT03266172|566165455|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
157224752|NCT01691859|567569865|FG000|Overall Study|Adverse Event|19|||
156839823|NCT03266172|566165456|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
156839824|NCT03266172|566165457|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
156839825|NCT03266172|566165455|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
156839826|NCT03266172|566165456|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
156839827|NCT03266172|566165457|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
156839828|NCT03266172|566165455|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839829|NCT03266172|566165456|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156886735|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
156886736|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
156886737|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
156886738|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
156886739|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
156886740|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
156886741|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
156886742|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
156886743|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
156886744|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
156886745|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
156886746|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
156886747|NCT01087788|566344011|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
156886748|NCT01087788|566344012|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
156886749|NCT01087788|566344013|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
156886750|NCT01806662|566344017|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
156886751|NCT01806662|566344018|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
156886752|NCT01806662|566344017|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
156886753|NCT01806662|566344018|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
156886754|NCT01806662|566344017|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
156886755|NCT01806662|566344018|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
156886756|NCT01806662|566344017|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
156886757|NCT01806662|566344018|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
156886758|NCT00043550|566344021|FG000|Overall Study|Withdrawal by Subject|22|||
156886759|NCT00043550|566344022|FG001|Overall Study|Withdrawal by Subject|12|||
156886760|NCT00043550|566344023|FG002|Overall Study|Withdrawal by Subject|20|||
156886761|NCT01917656|566344027|FG000|Overall Study|Adverse Event|11|||
156886762|NCT01917656|566344028|FG001|Overall Study|Adverse Event|0|||
156886763|NCT01917656|566344027|FG000|Overall Study|Withdrawal criteria|8|||
156886764|NCT01917656|566344028|FG001|Overall Study|Withdrawal criteria|14|||
156886765|NCT01917656|566344027|FG000|Overall Study|Unclassified|0|||
156886766|NCT01917656|566344028|FG001|Overall Study|Unclassified|3|||
156886767|NCT01917656|566344027|FG000|Overall Study|Withdrawal by Subject|4|||
156886768|NCT01917656|566344028|FG001|Overall Study|Withdrawal by Subject|3|||
156886769|NCT01917656|566344027|FG000|Overall Study|Lost to Follow-up|3|||
156886770|NCT01917656|566344028|FG001|Overall Study|Lost to Follow-up|4|||
156886771|NCT02285062|566344029|FG000|Pre-Treatment Period|Protocol Violation|0|||
156886772|NCT02285062|566344030|FG001|Pre-Treatment Period|Protocol Violation|2|||
156886773|NCT02285062|566344029|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
156886774|NCT02285062|566344030|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
156886775|NCT02015221|566344031|FG000|Overall Study|Withdrawal by Subject|8|||
156839830|NCT03266172|566165457|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
156886776|NCT02015221|566344032|FG001|Overall Study|Withdrawal by Subject|6|||
156886777|NCT02015221|566344031|FG000|Overall Study|Lost to Follow-up|1|||
156886778|NCT02015221|566344032|FG001|Overall Study|Lost to Follow-up|0|||
156886779|NCT01306929|566344033|FG000|Overall Study|Withdrawal by Subject|23|||
156886780|NCT01306929|566344033|FG000|Overall Study|Adverse Event|21|||
156886781|NCT01306929|566344033|FG000|Overall Study|Physician Decision|13|||
156886782|NCT01306929|566344033|FG000|Overall Study|Death|8|||
156886783|NCT01306929|566344033|FG000|Overall Study|Withdrawal by parent/guardian|5|||
156886784|NCT01306929|566344033|FG000|Overall Study|Protocol Violation|3|||
156886785|NCT01306929|566344033|FG000|Overall Study|Non-compliance with study drug|2|||
156886786|NCT01306929|566344033|FG000|Overall Study|Lost to Follow-up|2|||
156886787|NCT01306929|566344033|FG000|Overall Study|Various|17|||
156886788|NCT01894568|566344039|FG000|Overall Study|Adverse Event|2|||
156886789|NCT01894568|566344040|FG001|Overall Study|Adverse Event|3|||
156886790|NCT01894568|566344039|FG000|Overall Study|Protocol required discontinuation|2|||
156886791|NCT01894568|566344040|FG001|Overall Study|Protocol required discontinuation|1|||
156886792|NCT01894568|566344039|FG000|Overall Study|Withdrawal by Subject|5|||
156886793|NCT01894568|566344040|FG001|Overall Study|Withdrawal by Subject|5|||
156886794|NCT01894568|566344039|FG000|Overall Study|Physician Decision|1|||
156886795|NCT01894568|566344040|FG001|Overall Study|Physician Decision|0|||
156886796|NCT01894568|566344039|FG000|Overall Study|Lost to Follow-up|0|||
156886797|NCT01894568|566344040|FG001|Overall Study|Lost to Follow-up|1|||
157024069|NCT04209465|566841171|FG007|Overall Study|Study terminated early by sponsor|0|||
157024070|NCT04209465|566841172|FG008|Overall Study|Study terminated early by sponsor|0|||
157024071|NCT04209465|566841173|FG009|Overall Study|Study terminated early by sponsor|0|||
157024072|NCT04209465|566841174|FG010|Overall Study|Study terminated early by sponsor|0|||
157024073|NCT04209465|566841175|FG011|Overall Study|Study terminated early by sponsor|0|||
157024074|NCT04209465|566841176|FG012|Overall Study|Study terminated early by sponsor|3|||
157024075|NCT04209465|566841164|FG000|Overall Study|Other|0|||
157024076|NCT04209465|566841165|FG001|Overall Study|Other|0|||
157024077|NCT04209465|566841166|FG002|Overall Study|Other|0|||
157024078|NCT04209465|566841167|FG003|Overall Study|Other|0|||
157024079|NCT04209465|566841168|FG004|Overall Study|Other|0|||
157024080|NCT04209465|566841169|FG005|Overall Study|Other|0|||
157024081|NCT04209465|566841170|FG006|Overall Study|Other|0|||
157024082|NCT04209465|566841171|FG007|Overall Study|Other|0|||
157024083|NCT04209465|566841172|FG008|Overall Study|Other|1|||
157024084|NCT04209465|566841173|FG009|Overall Study|Other|0|||
157024085|NCT04209465|566841174|FG010|Overall Study|Other|0|||
157024086|NCT04209465|566841175|FG011|Overall Study|Other|0|||
156839831|NCT03266172|566165455|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839832|NCT03266172|566165456|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
156839833|NCT03266172|566165457|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
156839834|NCT05222555|566165459|FG000|Overall Study|Ongoing|2|||
156839835|NCT05222555|566165460|FG001|Overall Study|Ongoing|18|||
156839836|NCT05222555|566165459|FG000|Overall Study|Adverse Event|1|||
156839837|NCT05222555|566165460|FG001|Overall Study|Adverse Event|1|||
156839838|NCT05222555|566165459|FG000|Overall Study|Death|0|||
156839839|NCT05222555|566165460|FG001|Overall Study|Death|6|||
156839840|NCT05222555|566165459|FG000|Overall Study|Withdrawal by Subject|0|||
156839841|NCT05222555|566165460|FG001|Overall Study|Withdrawal by Subject|11|||
156839842|NCT00300365|566165461|FG000|Overall Study|Lost to Follow-up|1|||
156839843|NCT00300365|566165462|FG001|Overall Study|Lost to Follow-up|0|||
156839844|NCT00300365|566165461|FG000|Overall Study|Physician Decision|2|||
156839845|NCT00300365|566165462|FG001|Overall Study|Physician Decision|0|||
156839846|NCT00300365|566165461|FG000|Overall Study|Withdrawal by Subject|1|||
156839847|NCT00300365|566165462|FG001|Overall Study|Withdrawal by Subject|0|||
156839848|NCT00300365|566165461|FG000|Overall Study|Adverse Event|0|||
156839849|NCT00300365|566165462|FG001|Overall Study|Adverse Event|2|||
156839850|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839851|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839852|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839853|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
156839854|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839855|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
156839856|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
156839857|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839858|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839859|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839860|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839861|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
156839862|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839863|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
156839864|NCT01966445|566165465|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839865|NCT01966445|566165466|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
156839866|NCT01966445|566165467|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
156839867|NCT01966445|566165468|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839868|NCT01966445|566165469|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
156839869|NCT01966445|566165470|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839870|NCT01966445|566165471|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
156839871|NCT01966445|566165465|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839872|NCT01966445|566165466|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839873|NCT01966445|566165467|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839874|NCT01966445|566165468|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839875|NCT01966445|566165469|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
156839876|NCT01966445|566165470|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
157024087|NCT04209465|566841176|FG012|Overall Study|Other|0|||
157024088|NCT05783102|566841177|FG000|Overall Study|Lost to Follow-up|1|||
157024089|NCT05783102|566841177|FG000|Overall Study|Withdrawal by Subject|2|||
156839877|NCT01966445|566165471|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
156839878|NCT01966445|566165465|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839879|NCT01966445|566165466|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839880|NCT01966445|566165467|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839881|NCT01966445|566165468|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
157024090|NCT05647304|566841178|FG000|Overall Study|Withdrawal by Subject|1|||
157024091|NCT05647304|566841179|FG001|Overall Study|Withdrawal by Subject|0|||
157154454|NCT02279524|567311263|FG001|Overall Study|Withdrawal by Subject|6|||
157154455|NCT02279524|567311264|FG002|Overall Study|Withdrawal by Subject|3|||
157154456|NCT02279524|567311262|FG000|Overall Study|Adverse Event|4|||
157154457|NCT02279524|567311263|FG001|Overall Study|Adverse Event|3|||
157154458|NCT02279524|567311264|FG002|Overall Study|Adverse Event|2|||
157154459|NCT02279524|567311262|FG000|Overall Study|Lost to Follow-up|1|||
157154460|NCT02279524|567311263|FG001|Overall Study|Lost to Follow-up|1|||
157154461|NCT02279524|567311264|FG002|Overall Study|Lost to Follow-up|0|||
157154462|NCT02279524|567311262|FG000|Overall Study|Disallowed medication|1|||
157154463|NCT02279524|567311263|FG001|Overall Study|Disallowed medication|1|||
157154464|NCT02279524|567311264|FG002|Overall Study|Disallowed medication|2|||
157154465|NCT02279524|567311262|FG000|Overall Study|Bariatric surgery|1|||
157154466|NCT02279524|567311263|FG001|Overall Study|Bariatric surgery|0|||
157154467|NCT02279524|567311264|FG002|Overall Study|Bariatric surgery|0|||
157154468|NCT01746732|567311265|FG000|Lead-In Period|Withdrawal by Subject|1|||
157154469|NCT01746732|567311266|FG001|Lead-In Period|Withdrawal by Subject|0|||
157154470|NCT01746732|567311267|FG002|Lead-In Period|Withdrawal by Subject|0|||
157154471|NCT01746732|567311265|FG000|Period 1|Physician Decision|0|||
157154472|NCT01746732|567311266|FG001|Period 1|Physician Decision|1|||
157154473|NCT01746732|567311267|FG002|Period 1|Physician Decision|0|||
157154474|NCT01746732|567311265|FG000|Period 2|Withdrawal by Subject|0|||
157154475|NCT01746732|567311266|FG001|Period 2|Withdrawal by Subject|0|||
157154476|NCT01746732|567311267|FG002|Period 2|Withdrawal by Subject|2|||
157154477|NCT01746732|567311265|FG000|Period 2|Adverse Event|0|||
157154478|NCT01746732|567311266|FG001|Period 2|Adverse Event|0|||
157154479|NCT01746732|567311267|FG002|Period 2|Adverse Event|1|||
157154480|NCT01746732|567311265|FG000|Period 2|Lost to Follow-up|0|||
157154481|NCT01746732|567311266|FG001|Period 2|Lost to Follow-up|0|||
157154482|NCT01746732|567311267|FG002|Period 2|Lost to Follow-up|1|||
157154483|NCT02817555|567311268|FG000|Overall Study|Death|1|||
157154484|NCT02817555|567311269|FG001|Overall Study|Death|3|||
157154485|NCT02817555|567311268|FG000|Overall Study|moved away|1|||
157154486|NCT02817555|567311269|FG001|Overall Study|moved away|0|||
157154487|NCT02817555|567311268|FG000|Overall Study|transplant|1|||
157154488|NCT02817555|567311269|FG001|Overall Study|transplant|1|||
157154489|NCT02817555|567311268|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
157154490|NCT02817555|567311269|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
157154491|NCT00137436|567311270|FG000|Overall Study|Adverse Event|13|||
157154492|NCT00137436|567311270|FG000|Overall Study|Death|2|||
157154493|NCT00137436|567311270|FG000|Overall Study|Lack of Efficacy|17|||
157154494|NCT00137436|567311270|FG000|Overall Study|Withdrawal by Subject|6|||
157154495|NCT00137436|567311270|FG000|Overall Study|Other|5|||
157154496|NCT00701727|567311271|FG000|First Treatment Period|Adverse Event|0|||
157154497|NCT00701727|567311272|FG001|First Treatment Period|Adverse Event|0|||
157154498|NCT00701727|567311271|FG000|First Treatment Period|Withdrawal by Subject|1|||
157154499|NCT00701727|567311272|FG001|First Treatment Period|Withdrawal by Subject|0|||
156839882|NCT01966445|566165469|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839883|NCT01966445|566165470|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
156839884|NCT01966445|566165471|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
156839885|NCT01374178|566165472|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
156839886|NCT01374178|566165473|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
156839887|NCT01374178|566165472|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
156839888|NCT01374178|566165473|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
156839889|NCT04856904|566165476|FG000|Overall Study|Physician Decision|1|||
156839890|NCT04856904|566165477|FG001|Overall Study|Physician Decision|1|||
156839891|NCT04856904|566165476|FG000|Overall Study|Withdrawal by Subject|13|||
156839892|NCT04856904|566165477|FG001|Overall Study|Withdrawal by Subject|13|||
156839893|NCT04856904|566165476|FG000|Overall Study|Adverse Event|1|||
156839894|NCT04856904|566165477|FG001|Overall Study|Adverse Event|1|||
157154500|NCT00701727|567311271|FG000|First Treatment Period|sponsor decision|0|||
156839895|NCT04856904|566165476|FG000|Overall Study|Non-compliance with study drug|1|||
157154501|NCT00701727|567311272|FG001|First Treatment Period|sponsor decision|1|||
157154502|NCT00701727|567311271|FG000|First Treatment Period|Lost to Follow-up|0|||
157154503|NCT00701727|567311272|FG001|First Treatment Period|Lost to Follow-up|1|||
156839896|NCT04856904|566165477|FG001|Overall Study|Non-compliance with study drug|1|||
156839897|NCT04856904|566165476|FG000|Overall Study|Lost to Follow-up|4|||
157154504|NCT00701727|567311271|FG000|Second Treatment Period|Withdrawal by Subject|2|||
157154505|NCT00701727|567311272|FG001|Second Treatment Period|Withdrawal by Subject|0|||
157154506|NCT02090114|567311273|FG000|Overall Study|Withdrawal by Subject|3|||
157154507|NCT02090114|567311274|FG001|Overall Study|Withdrawal by Subject|6|||
157154508|NCT02090114|567311275|FG002|Overall Study|Withdrawal by Subject|2|||
157154509|NCT02090114|567311276|FG003|Overall Study|Withdrawal by Subject|1|||
157154510|NCT02090114|567311273|FG000|Overall Study|Physician Decision|5|||
157154511|NCT02090114|567311274|FG001|Overall Study|Physician Decision|0|||
157154512|NCT02090114|567311275|FG002|Overall Study|Physician Decision|1|||
157154513|NCT02090114|567311276|FG003|Overall Study|Physician Decision|1|||
157154514|NCT02090114|567311273|FG000|Overall Study|Adverse Event|1|||
156839898|NCT04856904|566165477|FG001|Overall Study|Lost to Follow-up|4|||
156839899|NCT04856904|566165476|FG000|Overall Study|Withdrawal by Subject|1|||
156839900|NCT04856904|566165477|FG001|Overall Study|Withdrawal by Subject|1|||
156839901|NCT04856904|566165476|FG000|Overall Study|Protocol Violation|1|||
156839902|NCT04856904|566165477|FG001|Overall Study|Protocol Violation|1|||
156839903|NCT01422824|566165478|FG000|Overall Study|Case record form not evaluated|1|||
156839904|NCT01422824|566165478|FG000|Overall Study|Lost to Follow-up|37|||
156839905|NCT00902174|566165479|FG000|Overall Study|Adverse Event|27|||
156839906|NCT00902174|566165480|FG001|Overall Study|Adverse Event|7|||
156839907|NCT00902174|566165479|FG000|Overall Study|Lack of Efficacy|1|||
156839908|NCT00902174|566165480|FG001|Overall Study|Lack of Efficacy|5|||
156839909|NCT00902174|566165479|FG000|Overall Study|Death|2|||
156839910|NCT00902174|566165480|FG001|Overall Study|Death|2|||
156839911|NCT00902174|566165479|FG000|Overall Study|Withdrawal by Subject|2|||
156839912|NCT00902174|566165480|FG001|Overall Study|Withdrawal by Subject|1|||
156839913|NCT00902174|566165479|FG000|Overall Study|Abnormal labs|1|||
156839914|NCT00902174|566165480|FG001|Overall Study|Abnormal labs|1|||
156839915|NCT00902174|566165479|FG000|Overall Study|Protocol Violation|1|||
156839916|NCT00902174|566165480|FG001|Overall Study|Protocol Violation|1|||
156839917|NCT00902174|566165479|FG000|Overall Study|Administration problem|0|||
156839918|NCT00902174|566165480|FG001|Overall Study|Administration problem|1|||
156839919|NCT01375608|566165481|FG000|Overall Study|Withdrawal by Subject|2|||
156839920|NCT03429543|566165482|FG000|Overall Study|Adverse Event|1|||
156839921|NCT03429543|566165483|FG001|Overall Study|Adverse Event|1|||
156839922|NCT03429543|566165484|FG002|Overall Study|Adverse Event|0|||
156839923|NCT03429543|566165485|FG003|Overall Study|Adverse Event|0|||
156839924|NCT03429543|566165486|FG004|Overall Study|Adverse Event|0|||
156839925|NCT03429543|566165487|FG005|Overall Study|Adverse Event|2|||
156839926|NCT03429543|566165488|FG006|Overall Study|Adverse Event|0|||
156839927|NCT03429543|566165482|FG000|Overall Study|Lost to Follow-up|1|||
156839928|NCT03429543|566165483|FG001|Overall Study|Lost to Follow-up|0|||
156839929|NCT03429543|566165484|FG002|Overall Study|Lost to Follow-up|0|||
156839930|NCT03429543|566165485|FG003|Overall Study|Lost to Follow-up|0|||
156839931|NCT03429543|566165486|FG004|Overall Study|Lost to Follow-up|1|||
156839932|NCT03429543|566165487|FG005|Overall Study|Lost to Follow-up|0|||
157154515|NCT02090114|567311274|FG001|Overall Study|Adverse Event|2|||
157154516|NCT02090114|567311275|FG002|Overall Study|Adverse Event|2|||
157154517|NCT02090114|567311276|FG003|Overall Study|Adverse Event|0|||
157154518|NCT02090114|567311273|FG000|Overall Study|Progressive Disease|20|||
157154519|NCT02090114|567311274|FG001|Overall Study|Progressive Disease|21|||
157154520|NCT02090114|567311275|FG002|Overall Study|Progressive Disease|23|||
157154521|NCT02090114|567311276|FG003|Overall Study|Progressive Disease|6|||
157154522|NCT02090114|567311273|FG000|Overall Study|Death|1|||
157154523|NCT02090114|567311274|FG001|Overall Study|Death|0|||
157154524|NCT02090114|567311275|FG002|Overall Study|Death|1|||
157154525|NCT02090114|567311276|FG003|Overall Study|Death|0|||
157154526|NCT00392171|567311277|FG000|Overall Study|Did not meet inclusion criteria|4|||
157154527|NCT00392171|567311277|FG000|Overall Study|Disease progression|101|||
157154528|NCT01605071|567311278|FG000|Overall Study|Withdrawal by Subject|3|||
157154529|NCT01605071|567311279|FG001|Overall Study|Withdrawal by Subject|2|||
157154530|NCT00051558|567311282|FG000|Overall Study|Adverse Event|30|||
157154531|NCT00051558|567311283|FG001|Overall Study|Adverse Event|18|||
157154532|NCT00051558|567311282|FG000|Overall Study|Withdrawal by Subject|29|||
157154533|NCT00051558|567311283|FG001|Overall Study|Withdrawal by Subject|42|||
157154534|NCT00051558|567311282|FG000|Overall Study|Death|9|||
156839933|NCT03429543|566165488|FG006|Overall Study|Lost to Follow-up|0|||
156839934|NCT03429543|566165482|FG000|Overall Study|Withdrawal by Subject|5|||
156839935|NCT03429543|566165483|FG001|Overall Study|Withdrawal by Subject|0|||
156839936|NCT03429543|566165484|FG002|Overall Study|Withdrawal by Subject|1|||
156839937|NCT03429543|566165485|FG003|Overall Study|Withdrawal by Subject|2|||
156839938|NCT03429543|566165486|FG004|Overall Study|Withdrawal by Subject|6|||
156839939|NCT03429543|566165487|FG005|Overall Study|Withdrawal by Subject|3|||
157154535|NCT00051558|567311283|FG001|Overall Study|Death|15|||
156839940|NCT03429543|566165488|FG006|Overall Study|Withdrawal by Subject|1|||
156886798|NCT03720652|566344041|FG000|Overall Study|Withdrawal by Subject|2|||
157024092|NCT04171999|566841180|FG000|Overall Study|deemed ineligible after randomization|2|||
157154536|NCT00051558|567311282|FG000|Overall Study|Lost to Follow-up|4|||
156839941|NCT03429543|566165482|FG000|Overall Study|Other reason than listed|0|||
156839942|NCT03429543|566165483|FG001|Overall Study|Other reason than listed|1|||
156839943|NCT03429543|566165484|FG002|Overall Study|Other reason than listed|0|||
156839944|NCT03429543|566165485|FG003|Overall Study|Other reason than listed|0|||
156839945|NCT03429543|566165486|FG004|Overall Study|Other reason than listed|4|||
157154537|NCT00051558|567311283|FG001|Overall Study|Lost to Follow-up|13|||
157154538|NCT00051558|567311282|FG000|Overall Study|Protocol Violation|3|||
156839946|NCT03429543|566165487|FG005|Overall Study|Other reason than listed|4|||
156839947|NCT03429543|566165488|FG006|Overall Study|Other reason than listed|0|||
156839948|NCT03429543|566165482|FG000|Overall Study|Not treated|0|||
157154539|NCT00051558|567311283|FG001|Overall Study|Protocol Violation|4|||
157154540|NCT00051558|567311282|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
157154541|NCT00051558|567311283|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
157154542|NCT00051558|567311282|FG000|Overall Study|Sponsor Decision|6|||
157154543|NCT00051558|567311283|FG001|Overall Study|Sponsor Decision|1|||
157154544|NCT00051558|567311282|FG000|Overall Study|Other|2|||
157154545|NCT00051558|567311283|FG001|Overall Study|Other|1|||
157154546|NCT00051558|567311282|FG000|Overall Study|Significant Lab Value|2|||
157154547|NCT00051558|567311283|FG001|Overall Study|Significant Lab Value|0|||
157154548|NCT00051558|567311282|FG000|Overall Study|Physician Decision|5|||
157154549|NCT00051558|567311283|FG001|Overall Study|Physician Decision|0|||
157154550|NCT02163993|567311285|FG000|Treatment Period|Adverse Event|0|||
157154551|NCT02163993|567311286|FG001|Treatment Period|Adverse Event|1|||
157154552|NCT02163993|567311287|FG002|Treatment Period|Adverse Event|0|||
157154553|NCT02163993|567311288|FG003|Treatment Period|Adverse Event|0|||
157154554|NCT02163993|567311289|FG004|Treatment Period|Adverse Event|1|||
157154555|NCT02163993|567311285|FG000|Treatment Period|Lost to Follow-up|2|||
157154556|NCT02163993|567311286|FG001|Treatment Period|Lost to Follow-up|3|||
157154557|NCT02163993|567311287|FG002|Treatment Period|Lost to Follow-up|1|||
157154558|NCT02163993|567311288|FG003|Treatment Period|Lost to Follow-up|3|||
157154559|NCT02163993|567311289|FG004|Treatment Period|Lost to Follow-up|1|||
157154560|NCT02163993|567311285|FG000|Treatment Period|Physician Decision|1|||
157154561|NCT02163993|567311286|FG001|Treatment Period|Physician Decision|0|||
157154562|NCT02163993|567311287|FG002|Treatment Period|Physician Decision|0|||
157154563|NCT02163993|567311288|FG003|Treatment Period|Physician Decision|0|||
157154564|NCT02163993|567311289|FG004|Treatment Period|Physician Decision|0|||
157154565|NCT02163993|567311285|FG000|Treatment Period|Protocol Violation|2|||
157154566|NCT02163993|567311286|FG001|Treatment Period|Protocol Violation|1|||
157154567|NCT02163993|567311287|FG002|Treatment Period|Protocol Violation|0|||
157154568|NCT02163993|567311288|FG003|Treatment Period|Protocol Violation|1|||
157154569|NCT02163993|567311289|FG004|Treatment Period|Protocol Violation|2|||
157154570|NCT02163993|567311285|FG000|Treatment Period|Withdrawal by Subject|6|||
156839949|NCT03429543|566165483|FG001|Overall Study|Not treated|0|||
156839950|NCT03429543|566165484|FG002|Overall Study|Not treated|0|||
156839951|NCT03429543|566165485|FG003|Overall Study|Not treated|0|||
156839952|NCT03429543|566165486|FG004|Overall Study|Not treated|1|||
156839953|NCT03429543|566165487|FG005|Overall Study|Not treated|0|||
156839954|NCT03429543|566165488|FG006|Overall Study|Not treated|0|||
156839955|NCT03322423|566165490|FG000|Period 1|Subject no longer eligible|0|||
156839956|NCT03322423|566165491|FG001|Period 1|Subject no longer eligible|1|||
156839957|NCT03322423|566165490|FG000|Period 1|Withdrawal by Subject|0|||
156839958|NCT03322423|566165491|FG001|Period 1|Withdrawal by Subject|1|||
156839959|NCT03322423|566165490|FG000|Period 1|Incorrect Lens Dispensed|1|||
156839960|NCT03322423|566165491|FG001|Period 1|Incorrect Lens Dispensed|0|||
156839961|NCT03322423|566165490|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
156839962|NCT03322423|566165491|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
156839963|NCT03322423|566165490|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
156839964|NCT03322423|566165491|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
156839965|NCT03322423|566165490|FG000|Period 2|Protocol Violation|1|||
156839966|NCT03322423|566165491|FG001|Period 2|Protocol Violation|0|||
156839967|NCT03322423|566165490|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
156839968|NCT03322423|566165491|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
156839969|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
157154571|NCT02163993|567311286|FG001|Treatment Period|Withdrawal by Subject|4|||
157154572|NCT02163993|567311287|FG002|Treatment Period|Withdrawal by Subject|1|||
157154573|NCT02163993|567311288|FG003|Treatment Period|Withdrawal by Subject|4|||
157154574|NCT02163993|567311289|FG004|Treatment Period|Withdrawal by Subject|1|||
157154575|NCT02163993|567311285|FG000|Treatment Period|Not treated|1|||
157154576|NCT02163993|567311286|FG001|Treatment Period|Not treated|0|||
157154577|NCT02163993|567311287|FG002|Treatment Period|Not treated|0|||
157154578|NCT02163993|567311288|FG003|Treatment Period|Not treated|1|||
156839970|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
157154579|NCT02163993|567311289|FG004|Treatment Period|Not treated|2|||
157154580|NCT02163993|567311285|FG000|Post-treatment Period|Adverse Event|0|||
157154581|NCT02163993|567311286|FG001|Post-treatment Period|Adverse Event|0|||
157154582|NCT02163993|567311287|FG002|Post-treatment Period|Adverse Event|1|||
156839971|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
157154583|NCT02163993|567311288|FG003|Post-treatment Period|Adverse Event|0|||
157154584|NCT02163993|567311289|FG004|Post-treatment Period|Adverse Event|0|||
157154585|NCT02163993|567311285|FG000|Post-treatment Period|Lost to Follow-up|2|||
157154586|NCT02163993|567311286|FG001|Post-treatment Period|Lost to Follow-up|2|||
156839972|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
156839973|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
156839974|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
157154587|NCT02163993|567311287|FG002|Post-treatment Period|Lost to Follow-up|3|||
157154588|NCT02163993|567311288|FG003|Post-treatment Period|Lost to Follow-up|1|||
157154589|NCT02163993|567311289|FG004|Post-treatment Period|Lost to Follow-up|0|||
157154590|NCT02163993|567311285|FG000|Post-treatment Period|Protocol Violation|0|||
157154591|NCT02163993|567311286|FG001|Post-treatment Period|Protocol Violation|0|||
156839975|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
156839976|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839977|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839978|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839979|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839980|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
156839981|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
156839982|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
156839983|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839984|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839985|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839986|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156839987|NCT02453555|566165494|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
156839988|NCT02453555|566165495|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
156839989|NCT02453555|566165496|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
156839990|NCT02453555|566165497|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
156839991|NCT02453555|566165498|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
156839992|NCT02453555|566165499|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
156839993|NCT02453555|566165494|FG000|Extension Period|Adverse Event|0|||
156839994|NCT02453555|566165495|FG001|Extension Period|Adverse Event|0|||
156839995|NCT02453555|566165496|FG002|Extension Period|Adverse Event|1|||
156839996|NCT02453555|566165497|FG003|Extension Period|Adverse Event|2|||
156839997|NCT02453555|566165498|FG004|Extension Period|Adverse Event|1|||
156839998|NCT02453555|566165499|FG005|Extension Period|Adverse Event|1|||
156839999|NCT02453555|566165494|FG000|Extension Period|Protocol Violation|0|||
156840000|NCT02453555|566165495|FG001|Extension Period|Protocol Violation|0|||
156840001|NCT02453555|566165496|FG002|Extension Period|Protocol Violation|1|||
156840002|NCT02453555|566165497|FG003|Extension Period|Protocol Violation|0|||
156840003|NCT02453555|566165498|FG004|Extension Period|Protocol Violation|0|||
156840004|NCT02453555|566165499|FG005|Extension Period|Protocol Violation|0|||
156840005|NCT02453555|566165494|FG000|Extension Period|Withdrawal by Subject|0|||
156840006|NCT02453555|566165495|FG001|Extension Period|Withdrawal by Subject|0|||
156840007|NCT02453555|566165496|FG002|Extension Period|Withdrawal by Subject|1|||
156840008|NCT02453555|566165497|FG003|Extension Period|Withdrawal by Subject|0|||
156840009|NCT02453555|566165498|FG004|Extension Period|Withdrawal by Subject|0|||
156840010|NCT02453555|566165499|FG005|Extension Period|Withdrawal by Subject|0|||
156840011|NCT03689855|566165507|FG000|Overall Study|Adverse Event|3|||
156840012|NCT03689855|566165507|FG000|Overall Study|Withdrawal by Subject|1|||
156840013|NCT02409719|566165508|FG000|Overall Study|Lost to Follow-up|3|||
156840014|NCT02409719|566165509|FG001|Overall Study|Lost to Follow-up|3|||
156840015|NCT02879578|566165510|FG000|Overall Study|Adverse Event|1|||
156840016|NCT02879578|566165511|FG001|Overall Study|Adverse Event|2|||
156840017|NCT02879578|566165512|FG002|Overall Study|Adverse Event|14|||
156840018|NCT02879578|566165510|FG000|Overall Study|Protocol Violation|0|||
156840019|NCT02879578|566165511|FG001|Overall Study|Protocol Violation|1|||
156840020|NCT02879578|566165512|FG002|Overall Study|Protocol Violation|1|||
156840021|NCT02879578|566165510|FG000|Overall Study|Withdrawal by Subject|8|||
156840022|NCT02879578|566165511|FG001|Overall Study|Withdrawal by Subject|6|||
156840023|NCT02879578|566165512|FG002|Overall Study|Withdrawal by Subject|9|||
156840024|NCT02879578|566165510|FG000|Overall Study|Lost to Follow-up|1|||
156840025|NCT02879578|566165511|FG001|Overall Study|Lost to Follow-up|0|||
157154592|NCT02163993|567311287|FG002|Post-treatment Period|Protocol Violation|0|||
157154593|NCT02163993|567311288|FG003|Post-treatment Period|Protocol Violation|0|||
157154594|NCT02163993|567311289|FG004|Post-treatment Period|Protocol Violation|1|||
157154595|NCT02163993|567311285|FG000|Post-treatment Period|Withdrawal by Subject|2|||
156840026|NCT02879578|566165512|FG002|Overall Study|Lost to Follow-up|4|||
156840027|NCT02879578|566165510|FG000|Overall Study|Physician Decision|0|||
156840028|NCT02879578|566165511|FG001|Overall Study|Physician Decision|0|||
156840029|NCT02879578|566165512|FG002|Overall Study|Physician Decision|4|||
157154596|NCT02163993|567311286|FG001|Post-treatment Period|Withdrawal by Subject|4|||
157154597|NCT02163993|567311287|FG002|Post-treatment Period|Withdrawal by Subject|0|||
156840030|NCT03517566|566165516|FG000|Overall Study|Adverse Event|5|||
156840031|NCT03517566|566165517|FG001|Overall Study|Adverse Event|2|||
156840032|NCT03517566|566165518|FG002|Overall Study|Adverse Event|2|||
157154598|NCT02163993|567311288|FG003|Post-treatment Period|Withdrawal by Subject|1|||
156840033|NCT03517566|566165519|FG003|Overall Study|Adverse Event|8|||
156840034|NCT03517566|566165520|FG004|Overall Study|Adverse Event|7|||
156840035|NCT03517566|566165516|FG000|Overall Study|Lack of Efficacy|3|||
156840036|NCT03517566|566165517|FG001|Overall Study|Lack of Efficacy|2|||
156840037|NCT03517566|566165518|FG002|Overall Study|Lack of Efficacy|1|||
156840038|NCT03517566|566165519|FG003|Overall Study|Lack of Efficacy|1|||
156840039|NCT03517566|566165520|FG004|Overall Study|Lack of Efficacy|4|||
156840040|NCT03517566|566165516|FG000|Overall Study|Lost to Follow-up|3|||
157154599|NCT02163993|567311289|FG004|Post-treatment Period|Withdrawal by Subject|2|||
156840041|NCT03517566|566165517|FG001|Overall Study|Lost to Follow-up|1|||
156840042|NCT03517566|566165518|FG002|Overall Study|Lost to Follow-up|1|||
156840043|NCT03517566|566165519|FG003|Overall Study|Lost to Follow-up|1|||
156840044|NCT03517566|566165520|FG004|Overall Study|Lost to Follow-up|0|||
156840045|NCT03517566|566165516|FG000|Overall Study|Physician Decision|1|||
156840046|NCT03517566|566165517|FG001|Overall Study|Physician Decision|1|||
156840047|NCT03517566|566165518|FG002|Overall Study|Physician Decision|0|||
156840048|NCT03517566|566165519|FG003|Overall Study|Physician Decision|1|||
156840049|NCT03517566|566165520|FG004|Overall Study|Physician Decision|0|||
156840050|NCT03517566|566165516|FG000|Overall Study|Pregnancy|0|||
156840051|NCT03517566|566165517|FG001|Overall Study|Pregnancy|1|||
156840052|NCT03517566|566165518|FG002|Overall Study|Pregnancy|0|||
156840053|NCT03517566|566165519|FG003|Overall Study|Pregnancy|0|||
156840054|NCT03517566|566165520|FG004|Overall Study|Pregnancy|0|||
156840055|NCT03517566|566165516|FG000|Overall Study|Protocol Deviation|0|||
156840056|NCT03517566|566165517|FG001|Overall Study|Protocol Deviation|1|||
156840057|NCT03517566|566165518|FG002|Overall Study|Protocol Deviation|0|||
156840058|NCT03517566|566165519|FG003|Overall Study|Protocol Deviation|1|||
156840059|NCT03517566|566165520|FG004|Overall Study|Protocol Deviation|1|||
156840060|NCT03517566|566165516|FG000|Overall Study|Study terminated by Sponsor|11|||
156840061|NCT03517566|566165517|FG001|Overall Study|Study terminated by Sponsor|5|||
156840062|NCT03517566|566165518|FG002|Overall Study|Study terminated by Sponsor|6|||
156840063|NCT03517566|566165519|FG003|Overall Study|Study terminated by Sponsor|14|||
156840064|NCT03517566|566165520|FG004|Overall Study|Study terminated by Sponsor|12|||
156840065|NCT03517566|566165516|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
156840066|NCT03517566|566165517|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
156840067|NCT03517566|566165518|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
156840068|NCT03517566|566165519|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
156840069|NCT03517566|566165520|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
156840070|NCT04566692|566165521|FG000|Overall Study|Adverse Event|2|||
156840071|NCT04566692|566165522|FG001|Overall Study|Adverse Event|0|||
156840072|NCT04566692|566165521|FG000|Overall Study|Withdrawal by Subject|1|||
156840073|NCT04566692|566165522|FG001|Overall Study|Withdrawal by Subject|1|||
156840074|NCT00671437|566165523|FG000|Overall Study|Progressive disease before C1 week 8|8|||
156840075|NCT00671437|566165523|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
156840076|NCT00671437|566165523|FG000|Overall Study|Adverse Event|3|||
156840077|NCT00671437|566165523|FG000|Overall Study|Ineligible post-hoc|1|||
156840078|NCT00590577|566165524|FG000|Overall Study|Lack of Efficacy|31|||
156840079|NCT00590577|566165525|FG001|Overall Study|Lack of Efficacy|28|||
156840080|NCT00590577|566165526|FG002|Overall Study|Lack of Efficacy|23|||
156840081|NCT00590577|566165527|FG003|Overall Study|Lack of Efficacy|45|||
156840082|NCT00590577|566165524|FG000|Overall Study|Withdrawal by Subject|23|||
156840083|NCT00590577|566165525|FG001|Overall Study|Withdrawal by Subject|28|||
156840084|NCT00590577|566165526|FG002|Overall Study|Withdrawal by Subject|30|||
156840085|NCT00590577|566165527|FG003|Overall Study|Withdrawal by Subject|26|||
156840086|NCT00590577|566165524|FG000|Overall Study|Adverse Event|10|||
156840087|NCT00590577|566165525|FG001|Overall Study|Adverse Event|10|||
156840088|NCT00590577|566165526|FG002|Overall Study|Adverse Event|13|||
156840089|NCT00590577|566165527|FG003|Overall Study|Adverse Event|11|||
156840090|NCT00590577|566165524|FG000|Overall Study|Lost to Follow-up|12|||
156840091|NCT00590577|566165525|FG001|Overall Study|Lost to Follow-up|6|||
156840092|NCT00590577|566165526|FG002|Overall Study|Lost to Follow-up|6|||
156840093|NCT00590577|566165527|FG003|Overall Study|Lost to Follow-up|9|||
157024093|NCT04171999|566841181|FG001|Overall Study|deemed ineligible after randomization|1|||
157024094|NCT04505904|566841182|FG000|Overall Study|Withdrawal by Subject|1|||
157024095|NCT04505904|566841183|FG001|Overall Study|Withdrawal by Subject|2|||
157024096|NCT04505904|566841184|FG002|Overall Study|Withdrawal by Subject|0|||
156840094|NCT00590577|566165524|FG000|Overall Study|Pregnancy|0|||
156840095|NCT00590577|566165525|FG001|Overall Study|Pregnancy|1|||
156840096|NCT00590577|566165526|FG002|Overall Study|Pregnancy|0|||
156840097|NCT00590577|566165527|FG003|Overall Study|Pregnancy|0|||
156840098|NCT00590577|566165524|FG000|Overall Study|Various reasons|1|||
156840099|NCT00590577|566165525|FG001|Overall Study|Various reasons|3|||
156840100|NCT00590577|566165526|FG002|Overall Study|Various reasons|1|||
156840101|NCT00590577|566165527|FG003|Overall Study|Various reasons|2|||
156840102|NCT04349033|566165529|FG000|Overall Study|Lost to Follow-up|3|||
156840103|NCT04349033|566165530|FG001|Overall Study|Lost to Follow-up|1|||
156840104|NCT04349033|566165531|FG002|Overall Study|Lost to Follow-up|1|||
156840105|NCT01704456|566165532|FG000|Overall Study|Lost to Follow-up|8|||
156840106|NCT01704456|566165533|FG001|Overall Study|Lost to Follow-up|14|||
156840107|NCT04583956|566165534|FG000|Overall Study|Death|9|||
156840108|NCT04583956|566165535|FG001|Overall Study|Death|11|||
156840109|NCT04583956|566165534|FG000|Overall Study|Lost to Follow-up|7|||
157024097|NCT04505904|566841185|FG003|Overall Study|Withdrawal by Subject|0|||
157024098|NCT04505904|566841182|FG000|Overall Study|Physician Decision|1|||
156840110|NCT04583956|566165535|FG001|Overall Study|Lost to Follow-up|9|||
156840111|NCT04583956|566165534|FG000|Overall Study|Protocol Violation|2|||
156840112|NCT04583956|566165535|FG001|Overall Study|Protocol Violation|0|||
156840113|NCT04583956|566165534|FG000|Overall Study|Withdrawal by Subject|0|||
156840114|NCT04583956|566165535|FG001|Overall Study|Withdrawal by Subject|2|||
156840115|NCT04583956|566165534|FG000|Overall Study|Randomized but not dosed|2|||
156840116|NCT04583956|566165535|FG001|Overall Study|Randomized but not dosed|3|||
156840117|NCT04583956|566165534|FG000|Overall Study|Withdrawal of consent before product administration|1|||
156840118|NCT04583956|566165535|FG001|Overall Study|Withdrawal of consent before product administration|0|||
156840119|NCT00915551|566165536|FG000|Overall Study|Withdrawal by Subject|0|||
156840120|NCT00915551|566165537|FG001|Overall Study|Withdrawal by Subject|1|||
156840121|NCT05066165|566167829|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
156840122|NCT05066165|566167830|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
156840123|NCT05066165|566167829|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
156840124|NCT05066165|566167830|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
156840125|NCT03210961|566167831|FG000|Overall Study|Adverse Event|0|||
156840126|NCT03210961|566167832|FG001|Overall Study|Adverse Event|0|||
156840127|NCT03210961|566167833|FG002|Overall Study|Adverse Event|0|||
156840128|NCT03210961|566167834|FG003|Overall Study|Adverse Event|0|||
156840129|NCT03210961|566167835|FG004|Overall Study|Adverse Event|0|||
156840130|NCT03210961|566167836|FG005|Overall Study|Adverse Event|0|||
156840131|NCT03210961|566167837|FG006|Overall Study|Adverse Event|0|||
156840132|NCT03210961|566167838|FG007|Overall Study|Adverse Event|0|||
156840133|NCT03210961|566167839|FG008|Overall Study|Adverse Event|0|||
156840134|NCT03210961|566167840|FG009|Overall Study|Adverse Event|0|||
156840135|NCT03210961|566167841|FG010|Overall Study|Adverse Event|0|||
156840136|NCT03210961|566167842|FG011|Overall Study|Adverse Event|0|||
156840137|NCT03210961|566167843|FG012|Overall Study|Adverse Event|0|||
156840138|NCT03210961|566167844|FG013|Overall Study|Adverse Event|1|||
156840139|NCT03210961|566167845|FG014|Overall Study|Adverse Event|0|||
156840140|NCT03210961|566167831|FG000|Overall Study|Lost to Follow-up|0|||
156840141|NCT03210961|566167832|FG001|Overall Study|Lost to Follow-up|0|||
156840142|NCT03210961|566167833|FG002|Overall Study|Lost to Follow-up|0|||
156840143|NCT03210961|566167834|FG003|Overall Study|Lost to Follow-up|0|||
156840144|NCT03210961|566167835|FG004|Overall Study|Lost to Follow-up|0|||
156840145|NCT03210961|566167836|FG005|Overall Study|Lost to Follow-up|0|||
156840146|NCT03210961|566167837|FG006|Overall Study|Lost to Follow-up|0|||
156840147|NCT03210961|566167838|FG007|Overall Study|Lost to Follow-up|0|||
156840148|NCT03210961|566167839|FG008|Overall Study|Lost to Follow-up|0|||
156840149|NCT03210961|566167840|FG009|Overall Study|Lost to Follow-up|0|||
156840150|NCT03210961|566167841|FG010|Overall Study|Lost to Follow-up|0|||
156840151|NCT03210961|566167842|FG011|Overall Study|Lost to Follow-up|0|||
156840152|NCT03210961|566167843|FG012|Overall Study|Lost to Follow-up|0|||
156840153|NCT03210961|566167844|FG013|Overall Study|Lost to Follow-up|0|||
156840154|NCT03210961|566167845|FG014|Overall Study|Lost to Follow-up|1|||
156840155|NCT03210961|566167831|FG000|Overall Study|Withdrawal by Subject|0|||
156840156|NCT03210961|566167832|FG001|Overall Study|Withdrawal by Subject|0|||
156840157|NCT03210961|566167833|FG002|Overall Study|Withdrawal by Subject|0|||
156840158|NCT03210961|566167834|FG003|Overall Study|Withdrawal by Subject|0|||
156840159|NCT03210961|566167835|FG004|Overall Study|Withdrawal by Subject|0|||
156840160|NCT03210961|566167836|FG005|Overall Study|Withdrawal by Subject|0|||
156840161|NCT03210961|566167837|FG006|Overall Study|Withdrawal by Subject|0|||
156840162|NCT03210961|566167838|FG007|Overall Study|Withdrawal by Subject|0|||
156840163|NCT03210961|566167839|FG008|Overall Study|Withdrawal by Subject|0|||
156840164|NCT03210961|566167840|FG009|Overall Study|Withdrawal by Subject|0|||
156840165|NCT03210961|566167841|FG010|Overall Study|Withdrawal by Subject|0|||
156840166|NCT03210961|566167842|FG011|Overall Study|Withdrawal by Subject|0|||
157154600|NCT00414310|567311292|FG000|Overall Study|Not treated|1|||
157154601|NCT00414310|567311293|FG001|Overall Study|Not treated|0|||
157154602|NCT01808118|567311294|FG000|Period 1|Adverse Event|15|||
157154603|NCT01808118|567311295|FG001|Period 1|Adverse Event|0|||
157154604|NCT01808118|567311296|FG002|Period 1|Adverse Event|0|||
157154605|NCT01808118|567311294|FG000|Period 1|Withdrew consent|24|||
156840167|NCT03210961|566167843|FG012|Overall Study|Withdrawal by Subject|0|||
156840168|NCT03210961|566167844|FG013|Overall Study|Withdrawal by Subject|0|||
156840169|NCT03210961|566167845|FG014|Overall Study|Withdrawal by Subject|1|||
156840170|NCT03210961|566167831|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840171|NCT03210961|566167832|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840172|NCT03210961|566167833|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840173|NCT03210961|566167834|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840174|NCT03210961|566167835|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840175|NCT03210961|566167836|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840176|NCT03210961|566167837|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840177|NCT03210961|566167838|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840178|NCT03210961|566167839|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840179|NCT03210961|566167840|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840180|NCT03210961|566167841|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840181|NCT03210961|566167842|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
157154606|NCT01808118|567311295|FG001|Period 1|Withdrew consent|0|||
156840182|NCT03210961|566167843|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840183|NCT03210961|566167844|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
156840184|NCT03210961|566167845|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
156840185|NCT03210961|566167831|FG000|Overall Study|Other|0|||
156840186|NCT03210961|566167832|FG001|Overall Study|Other|0|||
156840187|NCT03210961|566167833|FG002|Overall Study|Other|0|||
156840188|NCT03210961|566167834|FG003|Overall Study|Other|1|||
156840189|NCT03210961|566167835|FG004|Overall Study|Other|0|||
156840190|NCT03210961|566167836|FG005|Overall Study|Other|0|||
156840191|NCT03210961|566167837|FG006|Overall Study|Other|1|||
156840192|NCT03210961|566167838|FG007|Overall Study|Other|0|||
156840193|NCT03210961|566167839|FG008|Overall Study|Other|0|||
156840194|NCT03210961|566167840|FG009|Overall Study|Other|0|||
156840195|NCT03210961|566167841|FG010|Overall Study|Other|1|||
156840196|NCT03210961|566167842|FG011|Overall Study|Other|0|||
156840197|NCT03210961|566167843|FG012|Overall Study|Other|2|||
156840198|NCT03210961|566167844|FG013|Overall Study|Other|2|||
156840199|NCT03210961|566167845|FG014|Overall Study|Other|0|||
156840200|NCT02467582|566167846|FG000|Allocation|Withdrawal by Subject|1|||
156840201|NCT02467582|566167847|FG001|Allocation|Withdrawal by Subject|0|||
156840202|NCT02467582|566167846|FG000|Follow-up|Death|5|||
156840203|NCT02467582|566167847|FG001|Follow-up|Death|4|||
156840204|NCT02467582|566167846|FG000|Follow-up|Lost to Follow-up|6|||
156840205|NCT02467582|566167847|FG001|Follow-up|Lost to Follow-up|5|||
156840206|NCT01370265|566167848|FG000|First Intervention|Adverse Event|1|||
156840207|NCT01370265|566167849|FG001|First Intervention|Adverse Event|1|||
156840208|NCT03343626|566167850|FG000|Overall Study|Lost to Follow-up|4|||
156840209|NCT03343626|566167851|FG001|Overall Study|Lost to Follow-up|3|||
156840210|NCT03343626|566167852|FG002|Overall Study|Lost to Follow-up|2|||
156840211|NCT03343626|566167853|FG003|Overall Study|Lost to Follow-up|5|||
156840212|NCT03343626|566167854|FG004|Overall Study|Lost to Follow-up|4|||
156840213|NCT03343626|566167855|FG005|Overall Study|Lost to Follow-up|4|||
156840214|NCT03343626|566167856|FG006|Overall Study|Lost to Follow-up|4|||
156840215|NCT03343626|566167857|FG007|Overall Study|Lost to Follow-up|7|||
156840216|NCT03343626|566167850|FG000|Overall Study|Withdrawal of Consent|2|||
156840217|NCT03343626|566167851|FG001|Overall Study|Withdrawal of Consent|1|||
156840218|NCT03343626|566167852|FG002|Overall Study|Withdrawal of Consent|0|||
156840219|NCT03343626|566167853|FG003|Overall Study|Withdrawal of Consent|3|||
156840220|NCT03343626|566167854|FG004|Overall Study|Withdrawal of Consent|3|||
156840221|NCT03343626|566167855|FG005|Overall Study|Withdrawal of Consent|1|||
156840222|NCT03343626|566167856|FG006|Overall Study|Withdrawal of Consent|1|||
156840223|NCT03343626|566167857|FG007|Overall Study|Withdrawal of Consent|2|||
156840224|NCT03343626|566167850|FG000|Overall Study|Reason not Specified|0|||
156840225|NCT03343626|566167851|FG001|Overall Study|Reason not Specified|1|||
156840226|NCT03343626|566167852|FG002|Overall Study|Reason not Specified|0|||
156840227|NCT03343626|566167853|FG003|Overall Study|Reason not Specified|0|||
157154607|NCT01808118|567311296|FG002|Period 1|Withdrew consent|0|||
156840228|NCT03343626|566167854|FG004|Overall Study|Reason not Specified|0|||
156840229|NCT03343626|566167855|FG005|Overall Study|Reason not Specified|0|||
156840230|NCT03343626|566167856|FG006|Overall Study|Reason not Specified|0|||
156840231|NCT03343626|566167857|FG007|Overall Study|Reason not Specified|1|||
156840232|NCT03343626|566167850|FG000|Overall Study|Data Entry Error|0|||
157154608|NCT01808118|567311294|FG000|Period 1|Lost to Follow-up|9|||
157154609|NCT01808118|567311295|FG001|Period 1|Lost to Follow-up|0|||
157154610|NCT01808118|567311296|FG002|Period 1|Lost to Follow-up|0|||
157154611|NCT01808118|567311294|FG000|Period 1|Did not meet criteria for remission|303|||
156840233|NCT03343626|566167851|FG001|Overall Study|Data Entry Error|0|||
156840234|NCT03343626|566167852|FG002|Overall Study|Data Entry Error|0|||
157154612|NCT01808118|567311295|FG001|Period 1|Did not meet criteria for remission|0|||
157154613|NCT01808118|567311296|FG002|Period 1|Did not meet criteria for remission|0|||
157154614|NCT01808118|567311294|FG000|Period 1|Enrolled in error|7|||
156840235|NCT03343626|566167853|FG003|Overall Study|Data Entry Error|0|||
156840236|NCT03343626|566167854|FG004|Overall Study|Data Entry Error|0|||
156840237|NCT03343626|566167855|FG005|Overall Study|Data Entry Error|0|||
156840238|NCT03343626|566167856|FG006|Overall Study|Data Entry Error|0|||
156840239|NCT03343626|566167857|FG007|Overall Study|Data Entry Error|1|||
156840240|NCT00703924|566167858|FG000|Overall Study|Withdrawal by Subject|1|||
156840241|NCT00703924|566167859|FG001|Overall Study|Withdrawal by Subject|1|||
156840242|NCT03592368|566167862|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840243|NCT03592368|566167863|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
156840244|NCT03592368|566167864|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840245|NCT03592368|566167865|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
156840246|NCT03592368|566167862|FG000|Overall Study|Adverse Event|0|||
156840247|NCT03592368|566167863|FG001|Overall Study|Adverse Event|0|||
156840248|NCT03592368|566167864|FG002|Overall Study|Adverse Event|0|||
156840249|NCT03592368|566167865|FG003|Overall Study|Adverse Event|1|||
156840250|NCT03592368|566167862|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
156840251|NCT03592368|566167863|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
156840252|NCT03592368|566167864|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
156840253|NCT03592368|566167865|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
156840254|NCT03831100|566167866|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
156840255|NCT03831100|566167867|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
156840256|NCT01732770|566167879|FG000|Overall Study|Lost to Follow-up|2|||
156840257|NCT01732770|566167880|FG001|Overall Study|Lost to Follow-up|3|||
156840258|NCT01732770|566167879|FG000|Overall Study|Withdrawal by Subject|5|||
156840259|NCT01732770|566167880|FG001|Overall Study|Withdrawal by Subject|3|||
156840260|NCT01732770|566167879|FG000|Overall Study|Decision by Sponsor|2|||
156840261|NCT01732770|566167880|FG001|Overall Study|Decision by Sponsor|2|||
156840262|NCT01732770|566167879|FG000|Overall Study|Death|1|||
156840263|NCT01732770|566167880|FG001|Overall Study|Death|0|||
156840264|NCT03047031|566167884|FG000|Overall Study|Other than listed|1|||
156840265|NCT03047031|566167885|FG001|Overall Study|Other than listed|0|||
156840266|NCT03047031|566167886|FG002|Overall Study|Other than listed|0|||
156840267|NCT03047031|566167884|FG000|Overall Study|Lost to Follow-up|4|||
156840268|NCT03047031|566167885|FG001|Overall Study|Lost to Follow-up|0|||
156840269|NCT03047031|566167886|FG002|Overall Study|Lost to Follow-up|0|||
156840270|NCT03047031|566167884|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
156840271|NCT03047031|566167885|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
156840272|NCT03047031|566167886|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
156840273|NCT03047031|566167884|FG000|Overall Study|Adverse Event|1|||
156840274|NCT03047031|566167885|FG001|Overall Study|Adverse Event|0|||
156840275|NCT03047031|566167886|FG002|Overall Study|Adverse Event|0|||
156840276|NCT03047031|566167884|FG000|Overall Study|Withdrawal by Subject|2|||
156840277|NCT03047031|566167885|FG001|Overall Study|Withdrawal by Subject|0|||
156840278|NCT03047031|566167886|FG002|Overall Study|Withdrawal by Subject|0|||
156840279|NCT03047031|566167884|FG000|Overall Study|Change to other medication|2|||
156840280|NCT03047031|566167885|FG001|Overall Study|Change to other medication|0|||
156840281|NCT03047031|566167886|FG002|Overall Study|Change to other medication|0|||
156840282|NCT03047031|566167884|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
156840283|NCT03047031|566167885|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
156840284|NCT03047031|566167886|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
156840285|NCT01450098|566167894|FG000|Period 3|Protocol Violation|0|||
156840286|NCT01450098|566167895|FG001|Period 3|Protocol Violation|1|||
156840287|NCT01450098|566167894|FG000|Period 3|Withdrawal by Subject|0|||
156840288|NCT01450098|566167895|FG001|Period 3|Withdrawal by Subject|2|||
156840289|NCT03229109|566167906|FG000|Overall Study|Withdrawal by Subject|0|||
156840290|NCT03229109|566167907|FG001|Overall Study|Withdrawal by Subject|0|||
156840291|NCT03229109|566167908|FG002|Overall Study|Withdrawal by Subject|0|||
156840292|NCT03229109|566167909|FG003|Overall Study|Withdrawal by Subject|1|||
156840293|NCT03416127|566167912|FG000|Overall Study|Withdrawal by Subject|0|||
156840294|NCT03416127|566167913|FG001|Overall Study|Withdrawal by Subject|1|||
156840295|NCT03416127|566167914|FG002|Overall Study|Withdrawal by Subject|1|||
156840296|NCT03387020|566167918|FG000|Overall Study|Adverse Event|0|||
156840297|NCT03387020|566167919|FG001|Overall Study|Adverse Event|2|||
156840298|NCT03387020|566167920|FG002|Overall Study|Adverse Event|0|||
156840299|NCT03387020|566167918|FG000|Overall Study|Withdrawal by Subject|2|||
156840300|NCT03387020|566167919|FG001|Overall Study|Withdrawal by Subject|0|||
156840301|NCT03387020|566167920|FG002|Overall Study|Withdrawal by Subject|0|||
156840302|NCT01452919|566167921|FG000|Open-Label Treatment|Adverse Event|5|||
156840303|NCT01452919|566167922|FG001|Open-Label Treatment|Adverse Event|0|||
156840304|NCT01452919|566167923|FG002|Open-Label Treatment|Adverse Event|0|||
156840305|NCT01452919|566167921|FG000|Open-Label Treatment|Lost to Follow-up|4|||
156840306|NCT01452919|566167922|FG001|Open-Label Treatment|Lost to Follow-up|0|||
156840307|NCT01452919|566167923|FG002|Open-Label Treatment|Lost to Follow-up|0|||
156840308|NCT01452919|566167921|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
156840309|NCT01452919|566167922|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
156840310|NCT01452919|566167923|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
156840311|NCT01452919|566167921|FG000|Open-Label Treatment|Protocol Violation|4|||
156840312|NCT01452919|566167922|FG001|Open-Label Treatment|Protocol Violation|0|||
157154615|NCT01808118|567311295|FG001|Period 1|Enrolled in error|0|||
157154616|NCT01808118|567311296|FG002|Period 1|Enrolled in error|0|||
157154617|NCT01808118|567311294|FG000|Period 1|Did not meet inclusion criteria|3|||
156840313|NCT01452919|566167923|FG002|Open-Label Treatment|Protocol Violation|0|||
156840314|NCT01452919|566167921|FG000|Open-Label Treatment|Sponsor Decision|1|||
156840315|NCT01452919|566167922|FG001|Open-Label Treatment|Sponsor Decision|0|||
156840316|NCT01452919|566167923|FG002|Open-Label Treatment|Sponsor Decision|0|||
156840317|NCT01452919|566167921|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
156840318|NCT01452919|566167922|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156840319|NCT01452919|566167923|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
157024099|NCT04505904|566841183|FG001|Overall Study|Physician Decision|0|||
157024100|NCT04505904|566841184|FG002|Overall Study|Physician Decision|0|||
156840320|NCT01452919|566167921|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
156840321|NCT01452919|566167922|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
156840322|NCT01452919|566167923|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
156840323|NCT01452919|566167921|FG000|Randomization Treatment|Adverse Event|0|||
156840324|NCT01452919|566167922|FG001|Randomization Treatment|Adverse Event|0|||
156840325|NCT01452919|566167923|FG002|Randomization Treatment|Adverse Event|2|||
156840326|NCT01452919|566167921|FG000|Randomization Treatment|Sponsor Decision|0|||
156840327|NCT01452919|566167922|FG001|Randomization Treatment|Sponsor Decision|1|||
156840328|NCT01452919|566167923|FG002|Randomization Treatment|Sponsor Decision|0|||
156840329|NCT01452919|566167921|FG000|Randomization Treatment|Withdrawal by Subject|0|||
156840330|NCT01452919|566167922|FG001|Randomization Treatment|Withdrawal by Subject|1|||
156840331|NCT01452919|566167923|FG002|Randomization Treatment|Withdrawal by Subject|0|||
156840332|NCT01452919|566167921|FG000|Randomization Treatment|Subject is moving or has moved|0|||
156840333|NCT01452919|566167922|FG001|Randomization Treatment|Subject is moving or has moved|1|||
156840334|NCT01452919|566167923|FG002|Randomization Treatment|Subject is moving or has moved|0|||
156840335|NCT02421588|566167924|FG000|Overall Study|Non-treatment-related AE|8|||
156840336|NCT02421588|566167925|FG001|Overall Study|Non-treatment-related AE|8|||
156840337|NCT02421588|566167924|FG000|Overall Study|Progressive disease|152|||
156840338|NCT02421588|566167925|FG001|Overall Study|Progressive disease|135|||
156840339|NCT02421588|566167924|FG000|Overall Study|Death|11|||
156840340|NCT02421588|566167925|FG001|Overall Study|Death|3|||
156840341|NCT02421588|566167924|FG000|Overall Study|Physician Decision|8|||
156840342|NCT02421588|566167925|FG001|Overall Study|Physician Decision|17|||
156840343|NCT02421588|566167924|FG000|Overall Study|Other reason not specified|3|||
156840344|NCT02421588|566167925|FG001|Overall Study|Other reason not specified|1|||
156840345|NCT02421588|566167924|FG000|Overall Study|Symptomatic deterioration|13|||
156840346|NCT02421588|566167925|FG001|Overall Study|Symptomatic deterioration|19|||
156840347|NCT02421588|566167924|FG000|Overall Study|Treatment-related AE|10|||
156840348|NCT02421588|566167925|FG001|Overall Study|Treatment-related AE|14|||
156840349|NCT02421588|566167924|FG000|Overall Study|Withdrawal by Subject|14|||
156840350|NCT02421588|566167925|FG001|Overall Study|Withdrawal by Subject|16|||
156840351|NCT02421588|566167924|FG000|Overall Study|Not treated|2|||
156840352|NCT02421588|566167925|FG001|Overall Study|Not treated|8|||
156840353|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
156840354|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
156840355|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
156840356|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
156840357|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
156840358|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
156840359|NCT01359943|566167926|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
156840360|NCT01359943|566167927|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
156840361|NCT01359943|566167928|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
156840362|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
156840363|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
156840364|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
156840365|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
156840366|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
156840367|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
156840368|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
156840369|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
156840370|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
156840371|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840372|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840373|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
156840374|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
156840375|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
156840376|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
156840377|NCT01359943|566167926|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
156840378|NCT01359943|566167927|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
156840379|NCT01359943|566167928|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
156840380|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
156840381|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
156840382|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
156840383|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
156840384|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
156840385|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
156840386|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
156840387|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
157024101|NCT04505904|566841185|FG003|Overall Study|Physician Decision|0|||
156840388|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
156840389|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840390|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840391|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
156840392|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
156840393|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
156840394|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
156840395|NCT01359943|566167926|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
156840396|NCT01359943|566167927|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
156840397|NCT01359943|566167928|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
156840398|NCT02516592|566167929|FG000|Overall Study|Patient withdrew consent|5|||
156840399|NCT02516592|566167930|FG001|Overall Study|Patient withdrew consent|2|||
156840400|NCT02516592|566167929|FG000|Overall Study|Protocol deviation|4|||
156840401|NCT02516592|566167930|FG001|Overall Study|Protocol deviation|4|||
156840402|NCT02516592|566167929|FG000|Overall Study|Lost to Follow-up|2|||
156840403|NCT02516592|566167930|FG001|Overall Study|Lost to Follow-up|3|||
156840404|NCT02516592|566167929|FG000|Overall Study|Patient/guardian decision|2|||
156840405|NCT02516592|566167930|FG001|Overall Study|Patient/guardian decision|1|||
156840406|NCT02516592|566167929|FG000|Overall Study|Adverse Event|1|||
156840407|NCT02516592|566167930|FG001|Overall Study|Adverse Event|2|||
156840408|NCT02516592|566167929|FG000|Overall Study|Abnormal test procedure result|1|||
156840409|NCT02516592|566167930|FG001|Overall Study|Abnormal test procedure result|0|||
156840410|NCT02516592|566167929|FG000|Overall Study|Death|1|||
156840411|NCT02516592|566167930|FG001|Overall Study|Death|1|||
156840412|NCT00098306|566167933|FG000|Double Blind|Randomized, not treated|9|||
156840413|NCT00098306|566167934|FG001|Double Blind|Randomized, not treated|5|||
156840414|NCT00098306|566167935|FG002|Double Blind|Randomized, not treated|2|||
156840415|NCT00098306|566167936|FG003|Double Blind|Randomized, not treated|0|||
156840416|NCT00098306|566167937|FG004|Double Blind|Randomized, not treated|0|||
156840417|NCT00098306|566167938|FG005|Double Blind|Randomized, not treated|0|||
156886799|NCT03720652|566344042|FG001|Overall Study|Withdrawal by Subject|7|||
156886800|NCT03720652|566344041|FG000|Overall Study|Lost to Follow-up|0|||
156886801|NCT03720652|566344042|FG001|Overall Study|Lost to Follow-up|4|||
156886802|NCT03353740|566344046|FG000|Overall Study|Images for these participants not viable|52|||
156886803|NCT03976648|566344049|FG000|Overall Study|Adverse Event|0|||
156886804|NCT03976648|566344050|FG001|Overall Study|Adverse Event|2|||
156886805|NCT03976648|566344049|FG000|Overall Study|Study terminated by sponsor|21|||
156886806|NCT03976648|566344050|FG001|Overall Study|Study terminated by sponsor|8|||
156886807|NCT00881868|566344051|FG000|Overall Study|Adverse Event|0|||
156886808|NCT00881868|566344052|FG001|Overall Study|Adverse Event|1|||
156886809|NCT00881868|566344051|FG000|Overall Study|Lost to Follow-up|2|||
156886810|NCT00881868|566344052|FG001|Overall Study|Lost to Follow-up|1|||
156886811|NCT00881868|566344051|FG000|Overall Study|Physician Decision|4|||
156886812|NCT00881868|566344052|FG001|Overall Study|Physician Decision|0|||
156886813|NCT00881868|566344051|FG000|Overall Study|Protocol Violation|2|||
156886814|NCT00881868|566344052|FG001|Overall Study|Protocol Violation|0|||
156886815|NCT01981551|566344053|FG000|Overall Study|Refused further treatment|8|||
156886816|NCT01981551|566344053|FG000|Overall Study|Adverse Event|1|||
156886817|NCT02880956|566344054|FG000|Overall Study|Adverse Event|3|||
156886818|NCT02880956|566344055|FG001|Overall Study|Adverse Event|6|||
156886819|NCT02880956|566344056|FG002|Overall Study|Adverse Event|5|||
156886820|NCT02880956|566344057|FG003|Overall Study|Adverse Event|4|||
156886821|NCT02880956|566344054|FG000|Overall Study|Withdrawal by Subject|9|||
156886822|NCT02880956|566344055|FG001|Overall Study|Withdrawal by Subject|4|||
156886823|NCT02880956|566344056|FG002|Overall Study|Withdrawal by Subject|6|||
156886824|NCT02880956|566344057|FG003|Overall Study|Withdrawal by Subject|11|||
156886825|NCT02880956|566344054|FG000|Overall Study|Lost to Follow-up|0|||
156886826|NCT02880956|566344055|FG001|Overall Study|Lost to Follow-up|1|||
156886827|NCT02880956|566344056|FG002|Overall Study|Lost to Follow-up|0|||
156886828|NCT02880956|566344057|FG003|Overall Study|Lost to Follow-up|0|||
156886829|NCT02880956|566344054|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156886830|NCT02880956|566344055|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
156886831|NCT02880956|566344056|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156886832|NCT02880956|566344057|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
157024102|NCT04505904|566841182|FG000|Overall Study|Adverse Event|0|||
157024103|NCT04505904|566841183|FG001|Overall Study|Adverse Event|1|||
156840418|NCT00098306|566167939|FG006|Double Blind|Randomized, not treated|0|||
156886833|NCT02880956|566344054|FG000|Overall Study|Other, Not Specified|4|||
157024104|NCT04505904|566841184|FG002|Overall Study|Adverse Event|0|||
156840419|NCT00098306|566167933|FG000|Double Blind|Ongoing at cut-off date|151|||
156840420|NCT00098306|566167934|FG001|Double Blind|Ongoing at cut-off date|166|||
156840421|NCT00098306|566167935|FG002|Double Blind|Ongoing at cut-off date|72|||
156840422|NCT00098306|566167936|FG003|Double Blind|Ongoing at cut-off date|0|||
156886834|NCT02880956|566344055|FG001|Overall Study|Other, Not Specified|2|||
156886835|NCT02880956|566344056|FG002|Overall Study|Other, Not Specified|0|||
156886836|NCT02880956|566344057|FG003|Overall Study|Other, Not Specified|3|||
156886837|NCT02081859|566344058|FG000|Overall Study|No fertilization|2|||
156886838|NCT02081859|566344059|FG001|Overall Study|No fertilization|2|||
156886839|NCT02081859|566344058|FG000|Overall Study|No sperm|1|||
156886840|NCT02081859|566344059|FG001|Overall Study|No sperm|0|||
156886841|NCT02081859|566344058|FG000|Overall Study|Unanticipated freeze all cycle|2|||
156886842|NCT02081859|566344059|FG001|Overall Study|Unanticipated freeze all cycle|6|||
156886843|NCT02081859|566344058|FG000|Overall Study|< 4 embryos|27|||
156886844|NCT02081859|566344059|FG001|Overall Study|< 4 embryos|23|||
156886845|NCT02081859|566344058|FG000|Overall Study|Other reasons|2|||
156886846|NCT02081859|566344059|FG001|Overall Study|Other reasons|0|||
156886847|NCT00773383|566345319|FG000|Overall Study|Adverse Event|4|||
156886848|NCT00773383|566345319|FG000|Overall Study|Death|1|||
156886849|NCT00773383|566345319|FG000|Overall Study|Progression of Disease|23|||
156886850|NCT00773383|566345319|FG000|Overall Study|Other|2|||
156886851|NCT00773383|566345319|FG000|Overall Study|No study dose received|1|||
156886852|NCT05347147|566345322|FG000|Overall Study|Lost to Follow-up|0|||
156886853|NCT05347147|566345323|FG001|Overall Study|Lost to Follow-up|1|||
156886854|NCT05347147|566345322|FG000|Overall Study|Sponsor request|3|||
156886855|NCT05347147|566345323|FG001|Overall Study|Sponsor request|3|||
156886856|NCT05347147|566345322|FG000|Overall Study|Study termination|2|||
156886857|NCT05347147|566345323|FG001|Overall Study|Study termination|1|||
156886858|NCT02984943|566345328|FG000|Overall Study|Withdrawal by Subject|3|||
156886859|NCT02984943|566345328|FG000|Overall Study|Physician Decision|1|||
156886860|NCT02692651|566345329|FG000|Study Treatment|Death|7|||
156886861|NCT02692651|566345330|FG001|Study Treatment|Death|3|||
156886862|NCT02692651|566345329|FG000|Study Treatment|comfort care|1|||
156886863|NCT02692651|566345330|FG001|Study Treatment|comfort care|1|||
156886864|NCT02692651|566345329|FG000|Study Treatment|Protocol violation per treating team preference|8|||
156886865|NCT02692651|566345330|FG001|Study Treatment|Protocol violation per treating team preference|6|||
156886866|NCT02692651|566345329|FG000|Post Study Treatment Follow-up|Death|4|||
156886867|NCT02692651|566345330|FG001|Post Study Treatment Follow-up|Death|4|||
156886868|NCT03490981|566345331|FG000|Overall Study|Lost to Follow-up|1|||
156886869|NCT03490981|566345332|FG001|Overall Study|Lost to Follow-up|2|||
156886870|NCT02480712|566345333|FG000|Overall Study|Enrolled but Never Treated|1|||
156886871|NCT02480712|566345333|FG000|Overall Study|Lost to Follow-up|5|||
156886872|NCT02480712|566345333|FG000|Overall Study|Withdrew Consent|3|||
156886873|NCT02480712|566345333|FG000|Overall Study|Death|1|||
156886874|NCT02480712|566345333|FG000|Overall Study|Lack of Efficacy|1|||
156886875|NCT05463198|566345340|FG000|Overall Study|Withdrawal by Subject|19|||
156886876|NCT05463198|566345340|FG000|Overall Study|Procedure Notes Missing|18|||
156886877|NCT01860846|566345341|FG000|Overall Study|Lost to Follow-up|33|||
156886878|NCT02239120|566345344|FG000|Overall Study|Death|56|||
156886879|NCT02239120|566345345|FG001|Overall Study|Death|58|||
156886880|NCT02239120|566345344|FG000|Overall Study|Lost to Follow-up|19|||
156886881|NCT02239120|566345345|FG001|Overall Study|Lost to Follow-up|14|||
156886882|NCT00046891|566345350|FG000|Overall Study|Cancels|5|||
156886883|NCT00046891|566345351|FG001|Overall Study|Cancels|9|||
156886884|NCT00046891|566345350|FG000|Overall Study|Ineligible|1|||
156886885|NCT00046891|566345351|FG001|Overall Study|Ineligible|1|||
156886886|NCT00046891|566345350|FG000|Overall Study|Withdrawal by Subject|18|||
156886887|NCT00046891|566345351|FG001|Overall Study|Withdrawal by Subject|15|||
156886888|NCT00046891|566345350|FG000|Overall Study|Adverse Event|5|||
156886889|NCT00046891|566345351|FG001|Overall Study|Adverse Event|5|||
156886890|NCT00420641|566345354|FG000|Overall Study|Adverse Event|3|||
156886891|NCT00420641|566345355|FG001|Overall Study|Adverse Event|25|||
156886892|NCT00420641|566345356|FG002|Overall Study|Adverse Event|10|||
156886893|NCT00420641|566345354|FG000|Overall Study|Lost to Follow-up|2|||
156886894|NCT00420641|566345355|FG001|Overall Study|Lost to Follow-up|4|||
156886895|NCT00420641|566345356|FG002|Overall Study|Lost to Follow-up|2|||
156886896|NCT00420641|566345354|FG000|Overall Study|Protocol Violation|8|||
157154618|NCT01808118|567311295|FG001|Period 1|Did not meet inclusion criteria|0|||
157154619|NCT01808118|567311296|FG002|Period 1|Did not meet inclusion criteria|0|||
156886897|NCT00420641|566345355|FG001|Overall Study|Protocol Violation|8|||
156886898|NCT00420641|566345356|FG002|Overall Study|Protocol Violation|7|||
156886899|NCT00420641|566345354|FG000|Overall Study|Withdrawal by Subject|15|||
157154620|NCT01808118|567311294|FG000|Period 1|Non-conformance with inclusion criteria|3|||
156886900|NCT00420641|566345355|FG001|Overall Study|Withdrawal by Subject|21|||
156886901|NCT00420641|566345356|FG002|Overall Study|Withdrawal by Subject|14|||
156886902|NCT00420641|566345354|FG000|Overall Study|Lack of Efficacy|6|||
157154621|NCT01808118|567311295|FG001|Period 1|Non-conformance with inclusion criteria|0|||
156886903|NCT00420641|566345355|FG001|Overall Study|Lack of Efficacy|5|||
156886904|NCT00420641|566345356|FG002|Overall Study|Lack of Efficacy|4|||
156886905|NCT00420641|566345354|FG000|Overall Study|Non-compliance|7|||
156886906|NCT00420641|566345355|FG001|Overall Study|Non-compliance|5|||
156886907|NCT00420641|566345356|FG002|Overall Study|Non-compliance|4|||
156886908|NCT00420641|566345354|FG000|Overall Study|Other|4|||
156886909|NCT00420641|566345355|FG001|Overall Study|Other|4|||
156886910|NCT00420641|566345356|FG002|Overall Study|Other|3|||
156886911|NCT02586506|566345362|FG000|Overall Study|Protocol Violation|6|||
156886912|NCT02586506|566345362|FG000|Overall Study|Lost to Follow-up|1|||
156840423|NCT00098306|566167937|FG004|Double Blind|Ongoing at cut-off date|0|||
156840424|NCT00098306|566167938|FG005|Double Blind|Ongoing at cut-off date|0|||
156840425|NCT00098306|566167939|FG006|Double Blind|Ongoing at cut-off date|0|||
156840426|NCT00098306|566167933|FG000|Double Blind|Adverse Event|11|||
156840427|NCT00098306|566167934|FG001|Double Blind|Adverse Event|10|||
156840428|NCT00098306|566167935|FG002|Double Blind|Adverse Event|6|||
156840429|NCT00098306|566167936|FG003|Double Blind|Adverse Event|0|||
156840430|NCT00098306|566167937|FG004|Double Blind|Adverse Event|0|||
156840431|NCT00098306|566167938|FG005|Double Blind|Adverse Event|0|||
156840432|NCT00098306|566167939|FG006|Double Blind|Adverse Event|0|||
156840433|NCT00098306|566167933|FG000|Double Blind|Lack of Efficacy|43|||
156840434|NCT00098306|566167934|FG001|Double Blind|Lack of Efficacy|34|||
156840435|NCT00098306|566167935|FG002|Double Blind|Lack of Efficacy|17|||
156840436|NCT00098306|566167936|FG003|Double Blind|Lack of Efficacy|0|||
156840437|NCT00098306|566167937|FG004|Double Blind|Lack of Efficacy|0|||
156840438|NCT00098306|566167938|FG005|Double Blind|Lack of Efficacy|0|||
157154622|NCT01808118|567311296|FG002|Period 1|Non-conformance with inclusion criteria|0|||
157154623|NCT01808118|567311294|FG000|Period 1|Investigator decision: site closure|2|||
157154624|NCT01808118|567311295|FG001|Period 1|Investigator decision: site closure|0|||
157154625|NCT01808118|567311296|FG002|Period 1|Investigator decision: site closure|0|||
156840439|NCT00098306|566167939|FG006|Double Blind|Lack of Efficacy|0|||
156840440|NCT00098306|566167933|FG000|Double Blind|Death|1|||
156840441|NCT00098306|566167934|FG001|Double Blind|Death|4|||
156840442|NCT00098306|566167935|FG002|Double Blind|Death|1|||
157154626|NCT01808118|567311294|FG000|Period 1|Non-compliance per sponsor|1|||
157154627|NCT01808118|567311295|FG001|Period 1|Non-compliance per sponsor|0|||
157154628|NCT01808118|567311296|FG002|Period 1|Non-compliance per sponsor|0|||
157154629|NCT01808118|567311294|FG000|Period 1|Lack of Efficacy|1|||
157154630|NCT01808118|567311295|FG001|Period 1|Lack of Efficacy|0|||
157154631|NCT01808118|567311296|FG002|Period 1|Lack of Efficacy|0|||
157154632|NCT01808118|567311294|FG000|Period 2|Adverse Event|0|||
157224753|NCT01691859|567569865|FG000|Overall Study|Lack of Efficacy|11|||
157224754|NCT01691859|567569865|FG000|Overall Study|Protocol Violation|4|||
156840443|NCT00098306|566167936|FG003|Double Blind|Death|0|||
156840444|NCT00098306|566167937|FG004|Double Blind|Death|0|||
156840445|NCT00098306|566167938|FG005|Double Blind|Death|0|||
156840446|NCT00098306|566167939|FG006|Double Blind|Death|0|||
156840447|NCT00098306|566167933|FG000|Double Blind|Participant defaulted|19|||
156840448|NCT00098306|566167934|FG001|Double Blind|Participant defaulted|18|||
156840449|NCT00098306|566167935|FG002|Double Blind|Participant defaulted|11|||
156840450|NCT00098306|566167936|FG003|Double Blind|Participant defaulted|0|||
156840451|NCT00098306|566167937|FG004|Double Blind|Participant defaulted|0|||
156840452|NCT00098306|566167938|FG005|Double Blind|Participant defaulted|0|||
156840453|NCT00098306|566167939|FG006|Double Blind|Participant defaulted|0|||
156840454|NCT00098306|566167933|FG000|Double Blind|Un-specified|7|||
156840455|NCT00098306|566167934|FG001|Double Blind|Un-specified|3|||
156840456|NCT00098306|566167935|FG002|Double Blind|Un-specified|11|||
156840457|NCT00098306|566167936|FG003|Double Blind|Un-specified|0|||
156840458|NCT00098306|566167937|FG004|Double Blind|Un-specified|0|||
156840459|NCT00098306|566167938|FG005|Double Blind|Un-specified|0|||
156840460|NCT00098306|566167939|FG006|Double Blind|Un-specified|0|||
156840461|NCT00098306|566167933|FG000|Open Label|Lack of Efficacy|0|||
156840462|NCT00098306|566167934|FG001|Open Label|Lack of Efficacy|0|||
156840463|NCT00098306|566167935|FG002|Open Label|Lack of Efficacy|0|||
156840464|NCT00098306|566167936|FG003|Open Label|Lack of Efficacy|13|||
156840465|NCT00098306|566167937|FG004|Open Label|Lack of Efficacy|0|||
156840466|NCT00098306|566167938|FG005|Open Label|Lack of Efficacy|0|||
156840467|NCT00098306|566167939|FG006|Open Label|Lack of Efficacy|0|||
156840468|NCT00098306|566167933|FG000|Open Label|Adverse Event|0|||
156840469|NCT00098306|566167934|FG001|Open Label|Adverse Event|0|||
156840470|NCT00098306|566167935|FG002|Open Label|Adverse Event|0|||
156840471|NCT00098306|566167936|FG003|Open Label|Adverse Event|2|||
156840472|NCT00098306|566167937|FG004|Open Label|Adverse Event|0|||
156886913|NCT02586506|566345362|FG000|Overall Study|Other Reason|2|||
157154633|NCT01808118|567311295|FG001|Period 2|Adverse Event|4|||
156840473|NCT00098306|566167938|FG005|Open Label|Adverse Event|0|||
156840474|NCT00098306|566167939|FG006|Open Label|Adverse Event|0|||
156840475|NCT00098306|566167933|FG000|Open Label|Death|0|||
156840476|NCT00098306|566167934|FG001|Open Label|Death|0|||
157154634|NCT01808118|567311296|FG002|Period 2|Adverse Event|0|||
157154635|NCT01808118|567311294|FG000|Period 2|Withdrew consent|0|||
157224755|NCT01691859|567569865|FG000|Overall Study|Product commercially available|221|||
156840477|NCT00098306|566167935|FG002|Open Label|Death|0|||
156840478|NCT00098306|566167936|FG003|Open Label|Death|4|||
156840479|NCT00098306|566167937|FG004|Open Label|Death|0|||
156840480|NCT00098306|566167938|FG005|Open Label|Death|0|||
156840481|NCT00098306|566167939|FG006|Open Label|Death|0|||
156840482|NCT00098306|566167933|FG000|Open Label|Participant defaulted|0|||
156840483|NCT00098306|566167934|FG001|Open Label|Participant defaulted|0|||
156840484|NCT00098306|566167935|FG002|Open Label|Participant defaulted|0|||
156840485|NCT00098306|566167936|FG003|Open Label|Participant defaulted|24|||
156840486|NCT00098306|566167937|FG004|Open Label|Participant defaulted|0|||
156886914|NCT02815280|566345364|FG000|Double-Blind Phase|Adverse Event|1|||
157024105|NCT04505904|566841185|FG003|Overall Study|Adverse Event|0|||
157024106|NCT04277442|566841188|FG000|Overall Study|Death|1|||
157024107|NCT03092518|566841189|FG000|Overall Study|Ineligible|2|||
157024108|NCT02547987|566841190|FG000|Overall Study|Withdrawal by Subject|1|||
157024109|NCT02547987|566841190|FG000|Overall Study|Adverse Event|2|||
157024110|NCT06181760|566841202|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
157024111|NCT06181760|566841203|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
157024112|NCT06181760|566841204|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
157024113|NCT06181760|566841205|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
157024114|NCT03524612|566841207|FG000|Overall Study|Lack of Efficacy|10|||
157024115|NCT03524612|566841207|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
157024116|NCT03524612|566841207|FG000|Overall Study|Adverse Event|10|||
156840487|NCT00098306|566167938|FG005|Open Label|Participant defaulted|0|||
156840488|NCT00098306|566167939|FG006|Open Label|Participant defaulted|0|||
156840489|NCT00098306|566167933|FG000|Open Label|Un-specified|0|||
156840490|NCT00098306|566167934|FG001|Open Label|Un-specified|0|||
156840491|NCT00098306|566167935|FG002|Open Label|Un-specified|0|||
156840492|NCT00098306|566167936|FG003|Open Label|Un-specified|15|||
157024117|NCT03524612|566841207|FG000|Overall Study|Withdrawal by Subject|7|||
157024118|NCT03524612|566841207|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
157024119|NCT03524612|566841207|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
157024120|NCT03524612|566841207|FG000|Overall Study|New therapy for study indication|6|||
157024121|NCT03524612|566841207|FG000|Overall Study|Death|3|||
157024122|NCT03524612|566841207|FG000|Overall Study|Lost to Follow-up|2|||
157024123|NCT03524612|566841207|FG000|Overall Study|Protocol Violation|1|||
157024124|NCT05457647|566841209|FG000|Overall Study|Lost to Follow-up|3|||
157024125|NCT03115476|566841210|FG000|LP0084-1369|Death|1|||
157024126|NCT03115476|566841211|FG001|LP0084-1369|Death|0|||
157024127|NCT03115476|566841212|FG002|LP0084-1369|Death|2|||
157024128|NCT03115476|566841210|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
157024129|NCT03115476|566841211|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
157024130|NCT03115476|566841212|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
157024131|NCT03865498|566841213|FG000|Overall Study|Lack of Efficacy|12|||
157024132|NCT03865498|566841214|FG001|Overall Study|Lack of Efficacy|11|||
157024133|NCT03865498|566841213|FG000|Overall Study|Lost to Follow-up|125|||
157024134|NCT03865498|566841214|FG001|Overall Study|Lost to Follow-up|133|||
157024135|NCT03865498|566841213|FG000|Overall Study|Withdrawal by Subject|2|||
157024136|NCT03865498|566841214|FG001|Overall Study|Withdrawal by Subject|4|||
157024137|NCT01648023|566841215|FG000|Overall Study|Screen Fail Post Randomization|1|||
157024138|NCT01648023|566841216|FG001|Overall Study|Screen Fail Post Randomization|2|||
157154636|NCT01808118|567311295|FG001|Period 2|Withdrew consent|7|||
157154637|NCT01808118|567311296|FG002|Period 2|Withdrew consent|6|||
157154638|NCT01808118|567311294|FG000|Period 2|Lost to Follow-up|0|||
157154639|NCT01808118|567311295|FG001|Period 2|Lost to Follow-up|0|||
156840493|NCT00098306|566167937|FG004|Open Label|Un-specified|0|||
156840494|NCT00098306|566167938|FG005|Open Label|Un-specified|0|||
156840495|NCT00098306|566167939|FG006|Open Label|Un-specified|0|||
156840496|NCT00098306|566167933|FG000|Open Label|Ongoing at cut-off date|0|||
156840497|NCT00098306|566167934|FG001|Open Label|Ongoing at cut-off date|0|||
156840498|NCT00098306|566167935|FG002|Open Label|Ongoing at cut-off date|0|||
156840499|NCT00098306|566167936|FG003|Open Label|Ongoing at cut-off date|269|||
156840500|NCT00098306|566167937|FG004|Open Label|Ongoing at cut-off date|62|||
156840501|NCT00098306|566167938|FG005|Open Label|Ongoing at cut-off date|0|||
156840502|NCT00098306|566167939|FG006|Open Label|Ongoing at cut-off date|0|||
156840503|NCT00098306|566167933|FG000|Observational Phase|Death|0|||
156840504|NCT00098306|566167934|FG001|Observational Phase|Death|0|||
156840505|NCT00098306|566167935|FG002|Observational Phase|Death|0|||
156840506|NCT00098306|566167936|FG003|Observational Phase|Death|0|||
156840507|NCT00098306|566167937|FG004|Observational Phase|Death|0|||
156840508|NCT00098306|566167938|FG005|Observational Phase|Death|5|||
156886915|NCT02815280|566345365|FG001|Double-Blind Phase|Adverse Event|1|||
156886916|NCT02815280|566345364|FG000|Double-Blind Phase|Lost to Follow-up|10|||
157154640|NCT01808118|567311296|FG002|Period 2|Lost to Follow-up|2|||
157154641|NCT01808118|567311294|FG000|Period 2|Investigator no longer conducting trials|0|||
156840509|NCT00098306|566167939|FG006|Observational Phase|Death|4|||
156840510|NCT00098306|566167933|FG000|Observational Phase|Participant defaulted|0|||
156840511|NCT00098306|566167934|FG001|Observational Phase|Participant defaulted|0|||
156840512|NCT00098306|566167935|FG002|Observational Phase|Participant defaulted|0|||
156840513|NCT00098306|566167936|FG003|Observational Phase|Participant defaulted|0|||
156840514|NCT00098306|566167937|FG004|Observational Phase|Participant defaulted|0|||
157024139|NCT05296525|566841220|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
157024140|NCT05296525|566841221|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
157024141|NCT05296525|566841222|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
157024142|NCT05296525|566841223|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
157024143|NCT02547363|566841226|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
157024144|NCT02547363|566841227|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
157024145|NCT02547363|566841226|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
157154642|NCT01808118|567311295|FG001|Period 2|Investigator no longer conducting trials|1|||
157154643|NCT01808118|567311296|FG002|Period 2|Investigator no longer conducting trials|0|||
157154644|NCT01808118|567311294|FG000|Period 2|Switched to other therapy|0|||
157154645|NCT01808118|567311295|FG001|Period 2|Switched to other therapy|1|||
157154646|NCT01808118|567311296|FG002|Period 2|Switched to other therapy|0|||
157154647|NCT01441440|567311305|FG000|Overall Study|Death|1|||
157154648|NCT01441440|567311306|FG001|Overall Study|Death|0|||
157154649|NCT01441440|567311307|FG002|Overall Study|Death|1|||
157154650|NCT01441440|567311305|FG000|Overall Study|Adverse Event|2|||
157154651|NCT01441440|567311306|FG001|Overall Study|Adverse Event|9|||
157154652|NCT01441440|567311307|FG002|Overall Study|Adverse Event|9|||
157154653|NCT01441440|567311305|FG000|Overall Study|Lost to Follow-up|0|||
157154654|NCT01441440|567311306|FG001|Overall Study|Lost to Follow-up|2|||
157154655|NCT01441440|567311307|FG002|Overall Study|Lost to Follow-up|1|||
157154656|NCT01441440|567311305|FG000|Overall Study|Withdrawal by Subject|11|||
157154657|NCT01441440|567311306|FG001|Overall Study|Withdrawal by Subject|9|||
157154658|NCT01441440|567311307|FG002|Overall Study|Withdrawal by Subject|9|||
157154659|NCT01441440|567311305|FG000|Overall Study|Pregnancy|1|||
157154660|NCT01441440|567311306|FG001|Overall Study|Pregnancy|0|||
157154661|NCT01441440|567311307|FG002|Overall Study|Pregnancy|0|||
157154662|NCT01441440|567311305|FG000|Overall Study|Lack of Efficacy|1|||
157154663|NCT01441440|567311306|FG001|Overall Study|Lack of Efficacy|0|||
157154664|NCT01441440|567311307|FG002|Overall Study|Lack of Efficacy|1|||
157154665|NCT01441440|567311305|FG000|Overall Study|Moving|0|||
157154666|NCT01441440|567311306|FG001|Overall Study|Moving|1|||
157154667|NCT01441440|567311307|FG002|Overall Study|Moving|1|||
157154668|NCT01441440|567311305|FG000|Overall Study|Work-related matter|0|||
157154669|NCT01441440|567311306|FG001|Overall Study|Work-related matter|1|||
157154670|NCT01441440|567311307|FG002|Overall Study|Work-related matter|0|||
157154671|NCT01441440|567311305|FG000|Overall Study|Difficllty in keeping the schedule|1|||
157154672|NCT01441440|567311306|FG001|Overall Study|Difficllty in keeping the schedule|1|||
157154673|NCT01441440|567311307|FG002|Overall Study|Difficllty in keeping the schedule|0|||
157154674|NCT01993329|567311308|FG000|Period 2|Adverse Event|0|||
157154675|NCT01993329|567311309|FG001|Period 2|Adverse Event|0|||
157154676|NCT01993329|567311310|FG002|Period 2|Adverse Event|0|||
157154677|NCT01993329|567311311|FG003|Period 2|Adverse Event|0|||
157154678|NCT01993329|567311312|FG004|Period 2|Adverse Event|0|||
157154679|NCT01993329|567311313|FG005|Period 2|Adverse Event|1|||
157154680|NCT01993329|567311308|FG000|Wash-out|Personal reasons|0|||
157154681|NCT01993329|567311309|FG001|Wash-out|Personal reasons|1|||
157154682|NCT01993329|567311310|FG002|Wash-out|Personal reasons|0|||
157154683|NCT01993329|567311311|FG003|Wash-out|Personal reasons|0|||
157154684|NCT01993329|567311312|FG004|Wash-out|Personal reasons|0|||
157154685|NCT01993329|567311313|FG005|Wash-out|Personal reasons|0|||
157154686|NCT00883558|567311314|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
157154687|NCT00883558|567311315|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
157154688|NCT00883558|567311316|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
157154689|NCT00883558|567311314|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
157154690|NCT00883558|567311315|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
157154691|NCT00883558|567311316|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
157154692|NCT00883558|567311314|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
157154693|NCT00883558|567311315|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
157154694|NCT00883558|567311316|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
157154695|NCT00883558|567311314|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
157154696|NCT00883558|567311315|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
157154697|NCT00883558|567311316|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
157154698|NCT00883558|567311314|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
157154699|NCT00883558|567311315|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
157154700|NCT00883558|567311316|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
157154701|NCT03650452|567311317|FG000|Overall Study|Physician Decision|1|||
157154702|NCT03650452|567311318|FG001|Overall Study|Physician Decision|0|||
157224756|NCT01691859|567569865|FG000|Overall Study|Study closed/terminated|50|||
156840515|NCT00098306|566167938|FG005|Observational Phase|Participant defaulted|34|||
157154703|NCT03650452|567311317|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
157154704|NCT03650452|567311318|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
157154705|NCT03650452|567311317|FG000|Overall Study|Adverse Event|3|||
157154706|NCT03650452|567311318|FG001|Overall Study|Adverse Event|4|||
157154707|NCT03650452|567311317|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
157154708|NCT03650452|567311318|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
157154709|NCT02042404|567311322|FG000|Overall Study|Death|1|||
157154710|NCT02042404|567311323|FG001|Overall Study|Death|0|||
157154711|NCT02042404|567311322|FG000|Overall Study|Unrelated Adverse Event|3|||
157154712|NCT02042404|567311323|FG001|Overall Study|Unrelated Adverse Event|0|||
157154713|NCT02042404|567311322|FG000|Overall Study|Inability to meet time requirements|1|||
157154714|NCT02042404|567311323|FG001|Overall Study|Inability to meet time requirements|0|||
157154715|NCT03100942|567311324|FG000|Randomized Treatment Period|Withdrew Consent|4|||
157154716|NCT03100942|567311325|FG001|Randomized Treatment Period|Withdrew Consent|5|||
157154717|NCT03100942|567311326|FG002|Randomized Treatment Period|Withdrew Consent|3|||
157154718|NCT03100942|567311327|FG003|Randomized Treatment Period|Withdrew Consent|3|||
157154719|NCT03100942|567311328|FG004|Randomized Treatment Period|Withdrew Consent|0|||
157154720|NCT03100942|567311329|FG005|Randomized Treatment Period|Withdrew Consent|0|||
157154721|NCT03100942|567311330|FG006|Randomized Treatment Period|Withdrew Consent|0|||
157154722|NCT03100942|567311324|FG000|Randomized Treatment Period|Adverse Event|5|||
157154723|NCT03100942|567311325|FG001|Randomized Treatment Period|Adverse Event|2|||
156840516|NCT00098306|566167939|FG006|Observational Phase|Participant defaulted|18|||
156840517|NCT00098306|566167933|FG000|Observational Phase|Un-specified|0|||
156840518|NCT00098306|566167934|FG001|Observational Phase|Un-specified|0|||
156840519|NCT00098306|566167935|FG002|Observational Phase|Un-specified|0|||
156840520|NCT00098306|566167936|FG003|Observational Phase|Un-specified|0|||
156840521|NCT00098306|566167937|FG004|Observational Phase|Un-specified|0|||
156840522|NCT00098306|566167938|FG005|Observational Phase|Un-specified|7|||
156840523|NCT00098306|566167939|FG006|Observational Phase|Un-specified|4|||
156840524|NCT00619099|566167940|FG000|Overall Study|Progressive Disease|7|||
157154724|NCT03100942|567311326|FG002|Randomized Treatment Period|Adverse Event|1|||
157154725|NCT03100942|567311327|FG003|Randomized Treatment Period|Adverse Event|0|||
157154726|NCT03100942|567311328|FG004|Randomized Treatment Period|Adverse Event|0|||
157154727|NCT03100942|567311329|FG005|Randomized Treatment Period|Adverse Event|0|||
157154728|NCT03100942|567311330|FG006|Randomized Treatment Period|Adverse Event|0|||
157154729|NCT03100942|567311324|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
157154730|NCT03100942|567311325|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
157154731|NCT03100942|567311326|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
157154732|NCT03100942|567311327|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
157154733|NCT03100942|567311328|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
157154734|NCT03100942|567311329|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
157154735|NCT03100942|567311330|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
156840525|NCT00619099|566167941|FG001|Overall Study|Progressive Disease|5|||
156840526|NCT00619099|566167940|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
156840527|NCT00619099|566167941|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
156840528|NCT00619099|566167940|FG000|Overall Study|Adverse Event|4|||
156840529|NCT00619099|566167941|FG001|Overall Study|Adverse Event|3|||
156840530|NCT00619099|566167940|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
156840531|NCT00619099|566167941|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
156840532|NCT00619099|566167940|FG000|Overall Study|Withdrawal by Subject|10|||
156840533|NCT00619099|566167941|FG001|Overall Study|Withdrawal by Subject|2|||
156840534|NCT00619099|566167940|FG000|Overall Study|Physician Decision|9|||
156840535|NCT00619099|566167941|FG001|Overall Study|Physician Decision|6|||
156840536|NCT00885482|566167942|FG000|Overall Study|Pregnancy|1|||
157154736|NCT03100942|567311324|FG000|Randomized Treatment Period|Protocol Violation|0|||
157154737|NCT03100942|567311325|FG001|Randomized Treatment Period|Protocol Violation|1|||
157154738|NCT03100942|567311326|FG002|Randomized Treatment Period|Protocol Violation|1|||
157154739|NCT03100942|567311327|FG003|Randomized Treatment Period|Protocol Violation|1|||
157154740|NCT03100942|567311328|FG004|Randomized Treatment Period|Protocol Violation|0|||
157154741|NCT03100942|567311329|FG005|Randomized Treatment Period|Protocol Violation|0|||
157154742|NCT03100942|567311330|FG006|Randomized Treatment Period|Protocol Violation|0|||
157154743|NCT03100942|567311324|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
157154744|NCT03100942|567311325|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
157154745|NCT03100942|567311326|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
157154746|NCT03100942|567311327|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
157154747|NCT03100942|567311328|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
157154748|NCT03100942|567311329|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
157154749|NCT03100942|567311330|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
156840537|NCT00885482|566167942|FG000|Overall Study|Lack of Efficacy|1|||
156840538|NCT00885482|566167942|FG000|Overall Study|Death|1|||
156886917|NCT02815280|566345365|FG001|Double-Blind Phase|Lost to Follow-up|9|||
156886918|NCT02815280|566345364|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
156886919|NCT02815280|566345365|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
156886920|NCT02815280|566345364|FG000|Double-Blind Phase|Protocol Violation|2|||
156886921|NCT02815280|566345365|FG001|Double-Blind Phase|Protocol Violation|2|||
156886922|NCT02815280|566345364|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
156886923|NCT02815280|566345365|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
157154750|NCT03100942|567311324|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
157154751|NCT03100942|567311325|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
156840539|NCT00885482|566167942|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
156840540|NCT00989781|566167943|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
156840541|NCT00989781|566167944|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
156840542|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
156840543|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
157224757|NCT01691859|567569865|FG000|Overall Study|Lost to Follow-up|5|||
157224758|NCT01691859|567569865|FG000|Overall Study|Physician Decision|6|||
157224759|NCT01691859|567569865|FG000|Overall Study|Withdrawal by Subject|31|||
157224760|NCT00862979|567569868|FG000|Overall Study|Adverse Event|6|||
157224761|NCT00862979|567569869|FG001|Overall Study|Adverse Event|3|||
157224762|NCT00862979|567569868|FG000|Overall Study|Protocol Violation|0|||
157224763|NCT00862979|567569869|FG001|Overall Study|Protocol Violation|1|||
156840544|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
156840545|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
156840546|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
156840547|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
156840548|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
156840549|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
156840550|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
156840551|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
156840552|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
156840553|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
156840554|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
156840555|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
156840556|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
156840557|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
156840558|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
156840559|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
156840560|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
156840561|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
156840562|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
156840563|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
156840564|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
156840565|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
156840566|NCT01532869|566167945|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
156840567|NCT01532869|566167946|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
156840568|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
156840569|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
156840570|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
156840571|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
156840572|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
156840573|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
156840574|NCT01532869|566167945|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
156840575|NCT01532869|566167946|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
156840576|NCT02438813|566167947|FG000|Overall Study|Patient Decision|59|||
156840577|NCT02438813|566167947|FG000|Overall Study|Patient Lost to Follow-Up|137|||
156840578|NCT02438813|566167947|FG000|Overall Study|Study Ended by Sponsor|80|||
156840579|NCT02438813|566167947|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
156840580|NCT00778895|566167948|FG000|Active Phase|Adverse Event|3|||
156840581|NCT00778895|566167949|FG001|Active Phase|Adverse Event|1|||
156840582|NCT00778895|566167950|FG002|Active Phase|Adverse Event|0|||
156840583|NCT00778895|566167948|FG000|Active Phase|Withdrawal by Subject|1|||
156840584|NCT00778895|566167949|FG001|Active Phase|Withdrawal by Subject|4|||
156840585|NCT00778895|566167950|FG002|Active Phase|Withdrawal by Subject|0|||
156840586|NCT00778895|566167948|FG000|Active Phase|Lost to Follow-up|1|||
156840587|NCT00778895|566167949|FG001|Active Phase|Lost to Follow-up|1|||
156840588|NCT00778895|566167950|FG002|Active Phase|Lost to Follow-up|0|||
156840589|NCT00778895|566167948|FG000|Active Phase|Other|2|||
156840590|NCT00778895|566167949|FG001|Active Phase|Other|0|||
156840591|NCT00778895|566167950|FG002|Active Phase|Other|0|||
156840592|NCT00778895|566167948|FG000|ESFU Phase|Adverse Event|2|||
156840593|NCT00778895|566167949|FG001|ESFU Phase|Adverse Event|1|||
156840594|NCT00778895|566167950|FG002|ESFU Phase|Adverse Event|0|||
156840595|NCT00778895|566167948|FG000|ESFU Phase|Withdrawal by Subject|1|||
156840596|NCT00778895|566167949|FG001|ESFU Phase|Withdrawal by Subject|4|||
156840597|NCT00778895|566167950|FG002|ESFU Phase|Withdrawal by Subject|0|||
156840598|NCT00778895|566167948|FG000|ESFU Phase|Lost to Follow-up|6|||
156840599|NCT00778895|566167949|FG001|ESFU Phase|Lost to Follow-up|7|||
156840600|NCT00778895|566167950|FG002|ESFU Phase|Lost to Follow-up|2|||
157224764|NCT00862979|567569868|FG000|Overall Study|Patient withdrew consent|2|||
157224765|NCT00862979|567569869|FG001|Overall Study|Patient withdrew consent|1|||
156840601|NCT00778895|566167948|FG000|ESFU Phase|Other|2|||
156840602|NCT00778895|566167949|FG001|ESFU Phase|Other|0|||
156840603|NCT00778895|566167950|FG002|ESFU Phase|Other|0|||
156840604|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
156886924|NCT02815280|566345364|FG000|Open-Label Phase|Adverse Event|2|||
157224766|NCT00862979|567569868|FG000|Overall Study|Administrative problems|0|||
156886925|NCT02815280|566345365|FG001|Open-Label Phase|Adverse Event|3|||
156886926|NCT02815280|566345364|FG000|Open-Label Phase|Lost to Follow-up|18|||
156886927|NCT02815280|566345365|FG001|Open-Label Phase|Lost to Follow-up|9|||
156886928|NCT02815280|566345364|FG000|Open-Label Phase|Withdrawal by Subject|33|||
156886929|NCT02815280|566345365|FG001|Open-Label Phase|Withdrawal by Subject|18|||
156886930|NCT02815280|566345364|FG000|Open-Label Phase|Protocol Violation|3|||
156886931|NCT02815280|566345365|FG001|Open-Label Phase|Protocol Violation|0|||
157154752|NCT03100942|567311326|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
157154753|NCT03100942|567311327|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
157154754|NCT03100942|567311328|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
157154755|NCT03100942|567311329|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
157154756|NCT03100942|567311330|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
157154757|NCT03100942|567311324|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154758|NCT03100942|567311325|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154759|NCT03100942|567311326|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154760|NCT03100942|567311327|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154761|NCT03100942|567311328|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154762|NCT03100942|567311329|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
157154763|NCT03100942|567311330|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
157154764|NCT01876732|567311335|FG000|Overall Study|MMA was not over 800mg/dL|75|||
157154765|NCT00536731|567311336|FG000|Overall Study|Adverse Event|3|||
157154766|NCT00536731|567311337|FG001|Overall Study|Adverse Event|2|||
157154767|NCT00536731|567311338|FG002|Overall Study|Adverse Event|3|||
157154768|NCT00536731|567311336|FG000|Overall Study|Withdrawal by Subject|0|||
157154769|NCT00536731|567311337|FG001|Overall Study|Withdrawal by Subject|2|||
157154770|NCT00536731|567311338|FG002|Overall Study|Withdrawal by Subject|0|||
157154771|NCT00536731|567311336|FG000|Overall Study|Intake of prohibited conc. medication|0|||
157154772|NCT00536731|567311337|FG001|Overall Study|Intake of prohibited conc. medication|0|||
157154773|NCT00536731|567311338|FG002|Overall Study|Intake of prohibited conc. medication|1|||
157224767|NCT00862979|567569869|FG001|Overall Study|Administrative problems|1|||
156840605|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
156840606|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
156840607|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
156840608|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
156840609|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
156840610|NCT01805037|566167954|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
156840611|NCT01805037|566167955|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
156840612|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
156840613|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
156840614|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
156840615|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
156840616|NCT01805037|566167954|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
156840617|NCT01805037|566167955|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
156840618|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Death|0|||
156840619|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Death|2|||
156840620|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
156840621|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
156840622|NCT01805037|566167954|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
156840623|NCT01805037|566167955|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
156840624|NCT01270256|566167956|FG000|Overall Study|Withdrawal by Subject|1|||
156840625|NCT01270256|566167957|FG001|Overall Study|Withdrawal by Subject|0|||
156840626|NCT01183468|566167958|FG000|Overall Study|Lost to Follow-up|2|||
156840627|NCT01183468|566167959|FG001|Overall Study|Lost to Follow-up|1|||
156840628|NCT01183468|566167960|FG002|Overall Study|Lost to Follow-up|0|||
156840629|NCT01183468|566167961|FG003|Overall Study|Lost to Follow-up|0|||
156840630|NCT01183468|566167958|FG000|Overall Study|Physician Decision|1|||
156840631|NCT01183468|566167959|FG001|Overall Study|Physician Decision|0|||
156840632|NCT01183468|566167960|FG002|Overall Study|Physician Decision|0|||
156840633|NCT01183468|566167961|FG003|Overall Study|Physician Decision|0|||
156840634|NCT01183468|566167958|FG000|Overall Study|Withdrawal by Subject|0|||
156840635|NCT01183468|566167959|FG001|Overall Study|Withdrawal by Subject|1|||
156840636|NCT01183468|566167960|FG002|Overall Study|Withdrawal by Subject|0|||
156840637|NCT01183468|566167961|FG003|Overall Study|Withdrawal by Subject|0|||
156840638|NCT03927404|566167962|FG000|Overall Study|Withdrawal by Subject|1|||
157224768|NCT00862979|567569868|FG000|Overall Study|Death|0|||
156840639|NCT01229449|566167965|FG000|Overall Study|Withdrawal by Subject|0|||
156840640|NCT01229449|566167966|FG001|Overall Study|Withdrawal by Subject|3|||
156840641|NCT01229449|566167967|FG002|Overall Study|Withdrawal by Subject|0|||
156840642|NCT01229449|566167968|FG003|Overall Study|Withdrawal by Subject|1|||
156840643|NCT01229449|566167969|FG004|Overall Study|Withdrawal by Subject|1|||
157154774|NCT00536731|567311336|FG000|Overall Study|Safety reasons|0|||
157154775|NCT00536731|567311337|FG001|Overall Study|Safety reasons|0|||
157224769|NCT00862979|567569869|FG001|Overall Study|Death|1|||
156886932|NCT02815280|566345364|FG000|Open-Label Phase|Administrative|26|||
156886933|NCT02815280|566345365|FG001|Open-Label Phase|Administrative|12|||
156886934|NCT02815280|566345364|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
157154776|NCT00536731|567311338|FG002|Overall Study|Safety reasons|1|||
157154777|NCT00536731|567311336|FG000|Overall Study|Other|1|||
157154778|NCT00536731|567311337|FG001|Overall Study|Other|1|||
157154779|NCT00536731|567311338|FG002|Overall Study|Other|0|||
157154780|NCT00718419|567311339|FG000|Overall Study|Adverse Event|2|||
157154781|NCT00718419|567311340|FG001|Overall Study|Adverse Event|1|||
157154782|NCT00718419|567311339|FG000|Overall Study|Physician Decision|1|||
157154783|NCT00718419|567311340|FG001|Overall Study|Physician Decision|6|||
157154784|NCT00718419|567311339|FG000|Overall Study|Sponsor decision|0|||
157154785|NCT00718419|567311340|FG001|Overall Study|Sponsor decision|1|||
157154786|NCT00718419|567311339|FG000|Overall Study|Withdrawal by Subject|0|||
157154787|NCT00718419|567311340|FG001|Overall Study|Withdrawal by Subject|5|||
157154788|NCT00718419|567311339|FG000|Overall Study|Progressive Disease|7|||
157154789|NCT00718419|567311340|FG001|Overall Study|Progressive Disease|25|||
157154790|NCT00718419|567311339|FG000|Overall Study|Death Due to Progressive Disease|2|||
157154791|NCT00718419|567311340|FG001|Overall Study|Death Due to Progressive Disease|0|||
157154792|NCT00718419|567311339|FG000|Overall Study|Death Due to Study Drug Related|0|||
157154793|NCT00718419|567311340|FG001|Overall Study|Death Due to Study Drug Related|1|||
157154794|NCT00718419|567311339|FG000|Overall Study|Death Due to Adverse Events|1|||
157154795|NCT00718419|567311340|FG001|Overall Study|Death Due to Adverse Events|0|||
157154796|NCT01675531|567311343|FG000|Overall Study|Adverse Event|9|||
157154797|NCT01675531|567311343|FG000|Overall Study|Withdrawal by Subject|7|||
157154798|NCT01675531|567311343|FG000|Overall Study|Lack of Efficacy|1|||
157154799|NCT01675531|567311343|FG000|Overall Study|Protocol Violation|8|||
157154800|NCT01234402|567311347|FG000|Overall Study|Lost to Follow-up|0|||
157154801|NCT01234402|567311348|FG001|Overall Study|Lost to Follow-up|1|||
157154802|NCT01234402|567311349|FG002|Overall Study|Lost to Follow-up|3|||
157154803|NCT01234402|567311347|FG000|Overall Study|Withdrawal by Subject|1|||
157154804|NCT01234402|567311348|FG001|Overall Study|Withdrawal by Subject|3|||
157154805|NCT01234402|567311349|FG002|Overall Study|Withdrawal by Subject|4|||
157154806|NCT01234402|567311347|FG000|Overall Study|Never treated: Death|0|||
157154807|NCT01234402|567311348|FG001|Overall Study|Never treated: Death|0|||
157154808|NCT01234402|567311349|FG002|Overall Study|Never treated: Death|1|||
157154809|NCT01234402|567311347|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
157154810|NCT01234402|567311348|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
157154811|NCT01234402|567311349|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
157154812|NCT01234402|567311347|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
157154813|NCT01234402|567311348|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
157154814|NCT01234402|567311349|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
157154815|NCT02280291|567311351|FG000|Overall Study|Lost to Follow-up|2|||
157154816|NCT02280291|567311352|FG001|Overall Study|Lost to Follow-up|1|||
157154817|NCT02280291|567311353|FG002|Overall Study|Lost to Follow-up|3|||
157154818|NCT02280291|567311354|FG003|Overall Study|Lost to Follow-up|8|||
157154819|NCT02280291|567311351|FG000|Overall Study|Protocol Violation|1|||
157154820|NCT02280291|567311352|FG001|Overall Study|Protocol Violation|0|||
157154821|NCT02280291|567311353|FG002|Overall Study|Protocol Violation|0|||
157154822|NCT02280291|567311354|FG003|Overall Study|Protocol Violation|0|||
157154823|NCT02280291|567311351|FG000|Overall Study|Other|1|||
157154824|NCT02280291|567311352|FG001|Overall Study|Other|1|||
157154825|NCT02280291|567311353|FG002|Overall Study|Other|0|||
157154826|NCT02280291|567311354|FG003|Overall Study|Other|0|||
157154827|NCT00316303|567311356|FG000|Overall Study|Lost to Follow-up|11|||
157154828|NCT00316303|567311357|FG001|Overall Study|Lost to Follow-up|16|||
157154829|NCT01106534|567311358|FG000|Overall Study|Withdrawal by Subject|18|||
157154830|NCT01106534|567311358|FG000|Overall Study|Lost to Follow-up|2|||
157154831|NCT01106534|567311358|FG000|Overall Study|Death|16|||
157154832|NCT01106534|567311358|FG000|Overall Study|Physician Decision|1|||
157154833|NCT03838367|567311359|FG000|Overall Study|Early termination of study|3|||
157154834|NCT03838367|567311360|FG001|Overall Study|Early termination of study|4|||
157154835|NCT03838367|567311361|FG002|Overall Study|Early termination of study|3|||
157154836|NCT03838367|567311362|FG003|Overall Study|Early termination of study|0|||
157224770|NCT02688400|567569871|FG000|Overall Study|Protocol Violation|2|||
157224771|NCT02688400|567569872|FG001|Overall Study|Protocol Violation|5|||
157154837|NCT03015610|567311365|FG000|Overall Study|Lost to Follow-up|1|||
157154838|NCT03015610|567311366|FG001|Overall Study|Lost to Follow-up|5|||
157154839|NCT01603641|567311367|FG000|Overall Study|Did not Receive Treatment|3|||
157224772|NCT02688400|567569871|FG000|Overall Study|Lack of Efficacy|7|||
157154840|NCT01603641|567311367|FG000|Overall Study|Adverse Event|1|||
157154841|NCT01603641|567311367|FG000|Overall Study|Lack of Efficacy|1|||
157154842|NCT01603641|567311367|FG000|Overall Study|Lost to Follow-up|6|||
157154843|NCT01603641|567311367|FG000|Overall Study|Personal Reasons|18|||
157154844|NCT01603641|567311367|FG000|Overall Study|Other Miscellaneous Reasons|6|||
157154845|NCT00114972|567311368|FG000|Overall Study|Withdrawal by Subject|40|||
157154846|NCT00114972|567311369|FG001|Overall Study|Withdrawal by Subject|7|||
156840644|NCT01229449|566167965|FG000|Overall Study|Lost to Follow-up|1|||
156840645|NCT01229449|566167966|FG001|Overall Study|Lost to Follow-up|1|||
156840646|NCT01229449|566167967|FG002|Overall Study|Lost to Follow-up|1|||
156840647|NCT01229449|566167968|FG003|Overall Study|Lost to Follow-up|0|||
156840648|NCT01229449|566167969|FG004|Overall Study|Lost to Follow-up|0|||
156840649|NCT01229449|566167965|FG000|Overall Study|Physician Decision|0|||
156840650|NCT01229449|566167966|FG001|Overall Study|Physician Decision|0|||
156840651|NCT01229449|566167967|FG002|Overall Study|Physician Decision|1|||
156840652|NCT01229449|566167968|FG003|Overall Study|Physician Decision|0|||
156840653|NCT01229449|566167969|FG004|Overall Study|Physician Decision|0|||
156840654|NCT03203291|566167971|FG000|Overall Study|Withdrawal by Subject|1|||
156840655|NCT01300260|566167972|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
156840656|NCT01300260|566167973|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
156840657|NCT01300260|566167972|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
156840658|NCT01300260|566167973|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
156840659|NCT01300260|566167972|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
157154847|NCT00114972|567311368|FG000|Overall Study|Lost to Follow-up|8|||
156840660|NCT01300260|566167973|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
156840661|NCT05098509|566167979|FG000|Overall Study|Withdrawal by Subject|0|||
156840662|NCT05098509|566167980|FG001|Overall Study|Withdrawal by Subject|0|||
156840663|NCT05098509|566167981|FG002|Overall Study|Withdrawal by Subject|1|||
156840664|NCT05098509|566167982|FG003|Overall Study|Withdrawal by Subject|0|||
156840665|NCT05098509|566167979|FG000|Overall Study|Early study termination|1|||
156840666|NCT05098509|566167980|FG001|Overall Study|Early study termination|1|||
156840667|NCT05098509|566167981|FG002|Overall Study|Early study termination|1|||
156840668|NCT05098509|566167982|FG003|Overall Study|Early study termination|0|||
156840669|NCT03157037|566167986|FG000|Overall Study|Death|1|||
156840670|NCT00324233|566167987|FG000|First Period|unable to insert catheter|1|||
156840671|NCT00324233|566167988|FG001|First Period|unable to insert catheter|0|||
156840672|NCT00324233|566167987|FG000|Second Period|unable to insert catheter|1|||
156840673|NCT00324233|566167988|FG001|Second Period|unable to insert catheter|1|||
156840674|NCT00324233|566167987|FG000|Second Period|Protocol Violation|4|||
156840675|NCT00324233|566167988|FG001|Second Period|Protocol Violation|6|||
156840676|NCT01069705|566167993|FG000|Overall Study|Adverse Event|1|||
156840677|NCT01069705|566167993|FG000|Overall Study|Withdrawal by Subject|2|||
156840678|NCT02607228|566167994|FG000|Overall Study|Progressive Disease|4|||
156840679|NCT02607228|566167995|FG001|Overall Study|Progressive Disease|3|||
156840680|NCT02607228|566167996|FG002|Overall Study|Progressive Disease|1|||
156840681|NCT02607228|566167997|FG003|Overall Study|Progressive Disease|5|||
156840682|NCT02607228|566167998|FG004|Overall Study|Progressive Disease|4|||
156840683|NCT02607228|566167999|FG005|Overall Study|Progressive Disease|3|||
156840684|NCT02607228|566168000|FG006|Overall Study|Progressive Disease|1|||
156840685|NCT02607228|566167994|FG000|Overall Study|Adverse Event|1|||
156840686|NCT02607228|566167995|FG001|Overall Study|Adverse Event|0|||
156840687|NCT02607228|566167996|FG002|Overall Study|Adverse Event|1|||
156840688|NCT02607228|566167997|FG003|Overall Study|Adverse Event|0|||
156840689|NCT02607228|566167998|FG004|Overall Study|Adverse Event|1|||
156840690|NCT02607228|566167999|FG005|Overall Study|Adverse Event|1|||
156840691|NCT02607228|566168000|FG006|Overall Study|Adverse Event|1|||
156840692|NCT02607228|566167994|FG000|Overall Study|Investigator's Discretion|0|||
156840693|NCT02607228|566167995|FG001|Overall Study|Investigator's Discretion|0|||
156840694|NCT02607228|566167996|FG002|Overall Study|Investigator's Discretion|1|||
156840695|NCT02607228|566167997|FG003|Overall Study|Investigator's Discretion|0|||
156840696|NCT02607228|566167998|FG004|Overall Study|Investigator's Discretion|0|||
156840697|NCT02607228|566167999|FG005|Overall Study|Investigator's Discretion|1|||
156840698|NCT02607228|566168000|FG006|Overall Study|Investigator's Discretion|0|||
156840699|NCT02607228|566167994|FG000|Overall Study|Withdrew Consent|0|||
156840700|NCT02607228|566167995|FG001|Overall Study|Withdrew Consent|1|||
156840701|NCT02607228|566167996|FG002|Overall Study|Withdrew Consent|0|||
156840702|NCT02607228|566167997|FG003|Overall Study|Withdrew Consent|0|||
156840703|NCT02607228|566167998|FG004|Overall Study|Withdrew Consent|0|||
156840704|NCT02607228|566167999|FG005|Overall Study|Withdrew Consent|1|||
156840705|NCT02607228|566168000|FG006|Overall Study|Withdrew Consent|0|||
156840706|NCT02607228|566167994|FG000|Overall Study|Study Terminated by Sponsor|0|||
156840707|NCT02607228|566167995|FG001|Overall Study|Study Terminated by Sponsor|0|||
156840708|NCT02607228|566167996|FG002|Overall Study|Study Terminated by Sponsor|0|||
156840709|NCT02607228|566167997|FG003|Overall Study|Study Terminated by Sponsor|1|||
156840710|NCT02607228|566167998|FG004|Overall Study|Study Terminated by Sponsor|0|||
156840711|NCT02607228|566167999|FG005|Overall Study|Study Terminated by Sponsor|0|||
156840712|NCT02607228|566168000|FG006|Overall Study|Study Terminated by Sponsor|0|||
156840713|NCT03908970|566168001|FG000|Overall Study|Adverse Event|7|||
156840714|NCT03908970|566168002|FG001|Overall Study|Adverse Event|21|||
156840715|NCT03908970|566168001|FG000|Overall Study|Physician Decision|1|||
156840716|NCT03908970|566168002|FG001|Overall Study|Physician Decision|4|||
156840717|NCT03908970|566168001|FG000|Overall Study|Withdrawal by Subject|9|||
156840718|NCT03908970|566168002|FG001|Overall Study|Withdrawal by Subject|22|||
157154848|NCT00114972|567311369|FG001|Overall Study|Lost to Follow-up|5|||
156840719|NCT04407234|566168003|FG000|Overall Study|Adverse Event|3|||
156840720|NCT04407234|566168004|FG001|Overall Study|Adverse Event|3|||
156840721|NCT00727558|566168010|FG000|Overall Study|Lens issue|0|||
156840722|NCT00727558|566168011|FG001|Overall Study|Lens issue|1|||
156840723|NCT00727558|566168010|FG000|Overall Study|Adverse Event|0|||
156840724|NCT00727558|566168011|FG001|Overall Study|Adverse Event|1|||
156840725|NCT00727558|566168010|FG000|Overall Study|Subject unable to return for follow-up|1|||
156840726|NCT00727558|566168011|FG001|Overall Study|Subject unable to return for follow-up|1|||
156840727|NCT00727558|566168010|FG000|Overall Study|Lost to Follow-up|1|||
156840728|NCT00727558|566168011|FG001|Overall Study|Lost to Follow-up|0|||
156840729|NCT01123707|566168016|FG000|Overall Study|Lost to Follow-up|3|||
157154849|NCT00358917|567311370|FG000|Overall Study|Adverse Event|14|||
157154850|NCT00358917|567311371|FG001|Overall Study|Adverse Event|21|||
157154851|NCT00358917|567311370|FG000|Overall Study|Withdrawal by Subject|5|||
157154852|NCT00358917|567311371|FG001|Overall Study|Withdrawal by Subject|7|||
157154853|NCT00358917|567311370|FG000|Overall Study|Lost to Follow-up|20|||
157154854|NCT00358917|567311371|FG001|Overall Study|Lost to Follow-up|17|||
157154855|NCT00358917|567311370|FG000|Overall Study|Noncompliance|12|||
157154856|NCT00358917|567311371|FG001|Overall Study|Noncompliance|11|||
157154857|NCT00358917|567311370|FG000|Overall Study|Death|2|||
157154858|NCT00358917|567311371|FG001|Overall Study|Death|3|||
157154859|NCT00358917|567311370|FG000|Overall Study|Virologic failure|11|||
157154860|NCT00358917|567311371|FG001|Overall Study|Virologic failure|8|||
157154861|NCT00358917|567311370|FG000|Overall Study|Unable to Continue Participation|2|||
157154862|NCT00358917|567311371|FG001|Overall Study|Unable to Continue Participation|2|||
156840730|NCT01123707|566168017|FG001|Overall Study|Lost to Follow-up|1|||
156840731|NCT01123707|566168018|FG002|Overall Study|Lost to Follow-up|3|||
156840732|NCT01123707|566168019|FG003|Overall Study|Lost to Follow-up|2|||
156840733|NCT01123707|566168016|FG000|Overall Study|Adverse Event|5|||
156840734|NCT01123707|566168017|FG001|Overall Study|Adverse Event|7|||
156840735|NCT01123707|566168018|FG002|Overall Study|Adverse Event|5|||
156840736|NCT01123707|566168019|FG003|Overall Study|Adverse Event|3|||
156840737|NCT01123707|566168016|FG000|Overall Study|Sponsor Discontinued Study|30|||
156840738|NCT01123707|566168017|FG001|Overall Study|Sponsor Discontinued Study|24|||
156840739|NCT01123707|566168018|FG002|Overall Study|Sponsor Discontinued Study|25|||
156840740|NCT01123707|566168019|FG003|Overall Study|Sponsor Discontinued Study|40|||
156840741|NCT01123707|566168016|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
156840742|NCT01123707|566168017|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
156840743|NCT01123707|566168018|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
156840744|NCT01123707|566168019|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
156840745|NCT01123707|566168016|FG000|Overall Study|Investigator Withdrew Participant|0|||
156840746|NCT01123707|566168017|FG001|Overall Study|Investigator Withdrew Participant|1|||
156840747|NCT01123707|566168018|FG002|Overall Study|Investigator Withdrew Participant|1|||
156840748|NCT01123707|566168019|FG003|Overall Study|Investigator Withdrew Participant|1|||
156840749|NCT01123707|566168016|FG000|Overall Study|Subject Withdrew Consent|4|||
156840750|NCT01123707|566168017|FG001|Overall Study|Subject Withdrew Consent|5|||
156840751|NCT01123707|566168018|FG002|Overall Study|Subject Withdrew Consent|1|||
156840752|NCT01123707|566168019|FG003|Overall Study|Subject Withdrew Consent|2|||
156840753|NCT01123707|566168016|FG000|Overall Study|Lack of Efficacy|1|||
156840754|NCT01123707|566168017|FG001|Overall Study|Lack of Efficacy|2|||
156840755|NCT01123707|566168018|FG002|Overall Study|Lack of Efficacy|1|||
156840756|NCT01123707|566168019|FG003|Overall Study|Lack of Efficacy|0|||
156840757|NCT01123707|566168016|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
156840758|NCT01123707|566168017|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
156840759|NCT01123707|566168018|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
156840760|NCT01123707|566168019|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
156840761|NCT00488826|566168024|FG000|Overall Study|Withdrawal by Subject|40|||
156840762|NCT00488826|566168025|FG001|Overall Study|Withdrawal by Subject|35|||
156840763|NCT00488826|566168026|FG002|Overall Study|Withdrawal by Subject|19|||
156840764|NCT00488826|566168024|FG000|Overall Study|Protocol Violation|0|||
156840765|NCT00488826|566168025|FG001|Overall Study|Protocol Violation|0|||
156840766|NCT00488826|566168026|FG002|Overall Study|Protocol Violation|2|||
156840767|NCT00488826|566168024|FG000|Overall Study|Adverse Event|9|||
156840768|NCT00488826|566168025|FG001|Overall Study|Adverse Event|15|||
156840769|NCT00488826|566168026|FG002|Overall Study|Adverse Event|4|||
156840770|NCT00488826|566168024|FG000|Overall Study|Lost to Follow-up|5|||
156840771|NCT00488826|566168025|FG001|Overall Study|Lost to Follow-up|1|||
156840772|NCT00488826|566168026|FG002|Overall Study|Lost to Follow-up|0|||
156840773|NCT00488826|566168024|FG000|Overall Study|Protocol Deviations|2|||
156840774|NCT00488826|566168025|FG001|Overall Study|Protocol Deviations|1|||
156840775|NCT00488826|566168026|FG002|Overall Study|Protocol Deviations|1|||
156840776|NCT02725866|566168027|FG000|Overall Study|Failure to return|6|||
156840777|NCT02725866|566168027|FG000|Overall Study|Withdrew consent|3|||
156840778|NCT02725866|566168027|FG000|Overall Study|Insufficient virological response|1|||
156840779|NCT02725866|566168027|FG000|Overall Study|Other, not specified|4|||
156977435|NCT04534114|566670717|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
157154863|NCT01555463|567311380|FG000|Treatment|Adverse Event|6|||
157024146|NCT02547363|566841227|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
157024147|NCT02547363|566841226|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
157024148|NCT02547363|566841227|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
157024149|NCT02547363|566841226|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
157024150|NCT02547363|566841227|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
157024151|NCT02547363|566841226|FG000|12-month Follow-up|Withdrawal by Subject|4|||
157024152|NCT02547363|566841227|FG001|12-month Follow-up|Withdrawal by Subject|3|||
157024153|NCT02547363|566841226|FG000|12-month Follow-up|Lost to Follow-up|4|||
157024154|NCT02547363|566841227|FG001|12-month Follow-up|Lost to Follow-up|1|||
157024155|NCT02547363|566841226|FG000|12-month Follow-up|Lack of Efficacy|1|||
157024156|NCT02547363|566841227|FG001|12-month Follow-up|Lack of Efficacy|1|||
157024157|NCT02547363|566841226|FG000|12-month Follow-up|Other|1|||
157024158|NCT02547363|566841227|FG001|12-month Follow-up|Other|0|||
157024159|NCT05228457|566841228|FG000|Overall Study|Withdrawal by Subject|1|||
157024160|NCT05228457|566841229|FG001|Overall Study|Withdrawal by Subject|1|||
157024161|NCT03161028|566841232|FG000|Overall Study|Withdrawal by Subject|6|||
157024162|NCT03161028|566841233|FG001|Overall Study|Withdrawal by Subject|4|||
157024163|NCT03161028|566841232|FG000|Overall Study|Adverse Event|5|||
157024164|NCT03161028|566841233|FG001|Overall Study|Adverse Event|1|||
157024165|NCT03161028|566841232|FG000|Overall Study|Study drug side effects|2|||
157024166|NCT03161028|566841233|FG001|Overall Study|Study drug side effects|2|||
157024167|NCT03161028|566841232|FG000|Overall Study|Administrative PD/UP|4|||
157024168|NCT03161028|566841233|FG001|Overall Study|Administrative PD/UP|2|||
157024169|NCT03161028|566841232|FG000|Overall Study|Lost to Follow-up|2|||
157024170|NCT03161028|566841233|FG001|Overall Study|Lost to Follow-up|0|||
157024171|NCT03161028|566841232|FG000|Overall Study|Unable to comply with procedures|1|||
157024172|NCT03161028|566841233|FG001|Overall Study|Unable to comply with procedures|1|||
157024173|NCT00736723|566841236|FG000|Overall Study|Withdrawal by Subject|4|||
157024174|NCT00736723|566841237|FG001|Overall Study|Withdrawal by Subject|3|||
157024175|NCT03492216|566841238|FG000|Overall Study|Death|1|||
157024176|NCT03492216|566841239|FG001|Overall Study|Death|0|||
157024177|NCT03492216|566841240|FG002|Overall Study|Death|4|||
157024178|NCT03492216|566841241|FG003|Overall Study|Death|0|||
157024179|NCT03492216|566841238|FG000|Overall Study|Withdrawal by Subject|5|||
157024180|NCT03492216|566841239|FG001|Overall Study|Withdrawal by Subject|3|||
157024181|NCT03492216|566841240|FG002|Overall Study|Withdrawal by Subject|1|||
157024182|NCT03492216|566841241|FG003|Overall Study|Withdrawal by Subject|1|||
157024183|NCT03492216|566841238|FG000|Overall Study|Lost to Follow-up|9|||
157024184|NCT03492216|566841239|FG001|Overall Study|Lost to Follow-up|2|||
157024185|NCT03492216|566841240|FG002|Overall Study|Lost to Follow-up|7|||
157024186|NCT03492216|566841241|FG003|Overall Study|Lost to Follow-up|8|||
157024187|NCT03492216|566841238|FG000|Overall Study|Moved|5|||
157024188|NCT03492216|566841239|FG001|Overall Study|Moved|3|||
157024189|NCT03492216|566841240|FG002|Overall Study|Moved|3|||
157024190|NCT03492216|566841241|FG003|Overall Study|Moved|5|||
157024191|NCT03492216|566841238|FG000|Overall Study|Too ill|0|||
157024192|NCT03492216|566841239|FG001|Overall Study|Too ill|1|||
157024193|NCT03492216|566841240|FG002|Overall Study|Too ill|0|||
157024194|NCT03492216|566841241|FG003|Overall Study|Too ill|0|||
157024195|NCT03492216|566841238|FG000|Overall Study|Incarcerated|0|||
157024196|NCT03492216|566841239|FG001|Overall Study|Incarcerated|0|||
157024197|NCT03492216|566841240|FG002|Overall Study|Incarcerated|2|||
157024198|NCT03492216|566841241|FG003|Overall Study|Incarcerated|0|||
157024199|NCT04130438|566843152|FG000|Overall Study|Lost to Follow-up|0|||
157024200|NCT04130438|566843153|FG001|Overall Study|Lost to Follow-up|0|||
157154864|NCT01555463|567311381|FG001|Treatment|Adverse Event|12|||
157154865|NCT01555463|567311380|FG000|Treatment|Withdrawal by Subject|24|||
157154866|NCT01555463|567311381|FG001|Treatment|Withdrawal by Subject|36|||
157154867|NCT01555463|567311380|FG000|Treatment|Lost to Follow-up|28|||
157024201|NCT04130438|566843154|FG002|Overall Study|Lost to Follow-up|1|||
157024202|NCT03338933|566843159|FG000|Screening Visit|Lost to Follow-up|1|||
157024203|NCT03338933|566843160|FG001|Screening Visit|Lost to Follow-up|3|||
157024204|NCT03338933|566843161|FG002|Screening Visit|Lost to Follow-up|1|||
157024205|NCT03338933|566843162|FG003|Screening Visit|Lost to Follow-up|4|||
157154868|NCT01555463|567311381|FG001|Treatment|Lost to Follow-up|23|||
157154869|NCT01555463|567311380|FG000|Treatment|Protocol Violation|4|||
157154870|NCT01555463|567311381|FG001|Treatment|Protocol Violation|5|||
157024206|NCT03338933|566843159|FG000|Screening Visit|Screen fail after consent|2|||
157024207|NCT03338933|566843160|FG001|Screening Visit|Screen fail after consent|7|||
157024208|NCT03338933|566843161|FG002|Screening Visit|Screen fail after consent|1|||
157024209|NCT03338933|566843162|FG003|Screening Visit|Screen fail after consent|4|||
157024210|NCT03338933|566843159|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
157024211|NCT03338933|566843160|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
157024212|NCT03338933|566843161|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
157024213|NCT03338933|566843162|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
157024214|NCT03338933|566843159|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
157024215|NCT03338933|566843160|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
156886935|NCT02815280|566345365|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
156886936|NCT01944839|566345367|FG000|Overall Study|Physician Decision|2|||
156886937|NCT01944839|566345368|FG001|Overall Study|Physician Decision|2|||
156886938|NCT01944839|566345367|FG000|Overall Study|Protocol Violation|0|||
156886939|NCT01944839|566345368|FG001|Overall Study|Protocol Violation|1|||
156886940|NCT01944839|566345367|FG000|Overall Study|Adverse Event|10|||
156886941|NCT01944839|566345368|FG001|Overall Study|Adverse Event|5|||
156886942|NCT01944839|566345367|FG000|Overall Study|Withdrawal by Subject|9|||
156886943|NCT01944839|566345368|FG001|Overall Study|Withdrawal by Subject|17|||
156886944|NCT01944839|566345367|FG000|Overall Study|Lost to Follow-up|1|||
156886945|NCT01944839|566345368|FG001|Overall Study|Lost to Follow-up|0|||
156886946|NCT01944839|566345367|FG000|Overall Study|Subject non-compliance|0|||
156886947|NCT01944839|566345368|FG001|Overall Study|Subject non-compliance|3|||
156886948|NCT00171834|566345369|FG000|Overall Study|Adverse Event|2|||
156886949|NCT00171834|566345370|FG001|Overall Study|Adverse Event|1|||
156886950|NCT00171834|566345371|FG002|Overall Study|Adverse Event|3|||
156886951|NCT00171834|566345372|FG003|Overall Study|Adverse Event|2|||
156886952|NCT00171834|566345373|FG004|Overall Study|Adverse Event|2|||
156886953|NCT00171834|566345374|FG005|Overall Study|Adverse Event|15|||
156886954|NCT00171834|566345375|FG006|Overall Study|Adverse Event|1|||
156886955|NCT00171834|566345369|FG000|Overall Study|Withdrawal by Subject|0|||
156886956|NCT00171834|566345370|FG001|Overall Study|Withdrawal by Subject|2|||
156886957|NCT00171834|566345371|FG002|Overall Study|Withdrawal by Subject|0|||
156886958|NCT00171834|566345372|FG003|Overall Study|Withdrawal by Subject|1|||
156886959|NCT00171834|566345373|FG004|Overall Study|Withdrawal by Subject|1|||
156886960|NCT00171834|566345374|FG005|Overall Study|Withdrawal by Subject|1|||
156886961|NCT00171834|566345375|FG006|Overall Study|Withdrawal by Subject|0|||
156886962|NCT00171834|566345369|FG000|Overall Study|Death from study indication|0|||
156886963|NCT00171834|566345370|FG001|Overall Study|Death from study indication|1|||
156886964|NCT00171834|566345371|FG002|Overall Study|Death from study indication|0|||
156886965|NCT00171834|566345372|FG003|Overall Study|Death from study indication|0|||
156886966|NCT00171834|566345373|FG004|Overall Study|Death from study indication|1|||
156886967|NCT00171834|566345374|FG005|Overall Study|Death from study indication|0|||
156886968|NCT00171834|566345375|FG006|Overall Study|Death from study indication|0|||
156886969|NCT00171834|566345369|FG000|Overall Study|Disease Progression|4|||
156886970|NCT00171834|566345370|FG001|Overall Study|Disease Progression|8|||
156886971|NCT00171834|566345371|FG002|Overall Study|Disease Progression|8|||
156886972|NCT00171834|566345372|FG003|Overall Study|Disease Progression|9|||
156886973|NCT00171834|566345373|FG004|Overall Study|Disease Progression|2|||
156886974|NCT00171834|566345374|FG005|Overall Study|Disease Progression|18|||
156886975|NCT00171834|566345375|FG006|Overall Study|Disease Progression|3|||
156886976|NCT00171834|566345369|FG000|Overall Study|Treatment Duration Completed|0|||
156840780|NCT00605345|566168034|FG000|Overall Study|Withdrawal by Subject|1|||
156840781|NCT00605345|566168035|FG001|Overall Study|Withdrawal by Subject|0|||
156840782|NCT00605345|566168034|FG000|Overall Study|Adverse Event|0|||
156840783|NCT00605345|566168035|FG001|Overall Study|Adverse Event|1|||
156840784|NCT00605345|566168034|FG000|Overall Study|Protocol Violation|0|||
156840785|NCT00605345|566168035|FG001|Overall Study|Protocol Violation|2|||
156840786|NCT02577016|566168036|FG000|Overall Study|Adverse Event|2|||
156840787|NCT02577016|566168037|FG001|Overall Study|Adverse Event|1|||
156840788|NCT02577016|566168036|FG000|Overall Study|Physician Decision|0|||
156840789|NCT02577016|566168037|FG001|Overall Study|Physician Decision|1|||
156840790|NCT02126839|566168038|FG000|Overall Study|Adverse Event|0|||
156840791|NCT02126839|566168039|FG001|Overall Study|Adverse Event|1|||
156840792|NCT02126839|566168038|FG000|Overall Study|Withdrawal by Subject|1|||
156840793|NCT02126839|566168039|FG001|Overall Study|Withdrawal by Subject|0|||
156840794|NCT02126839|566168038|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156840795|NCT02126839|566168039|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156840796|NCT02126839|566168038|FG000|Overall Study|Protocol Violation|2|||
156840797|NCT02126839|566168039|FG001|Overall Study|Protocol Violation|3|||
156840798|NCT02126839|566168038|FG000|Overall Study|Sponsor request|0|||
156886977|NCT00171834|566345370|FG001|Overall Study|Treatment Duration Completed|0|||
156886978|NCT00171834|566345371|FG002|Overall Study|Treatment Duration Completed|1|||
156886979|NCT00171834|566345372|FG003|Overall Study|Treatment Duration Completed|0|||
156886980|NCT00171834|566345373|FG004|Overall Study|Treatment Duration Completed|2|||
156840799|NCT02126839|566168039|FG001|Overall Study|Sponsor request|1|||
156840800|NCT02126839|566168038|FG000|Overall Study|Lost to Follow-up|1|||
156840801|NCT02126839|566168039|FG001|Overall Study|Lost to Follow-up|4|||
156840802|NCT02126839|566168038|FG000|Overall Study|Other|5|||
156840803|NCT02126839|566168039|FG001|Overall Study|Other|5|||
156840804|NCT00411632|566168040|FG000|Overall Study|Death|1|||
156840805|NCT01108523|566168041|FG000|Overall Study|Protocol Violation|4|||
156886981|NCT00171834|566345374|FG005|Overall Study|Treatment Duration Completed|1|||
156886982|NCT00171834|566345375|FG006|Overall Study|Treatment Duration Completed|0|||
156886983|NCT01284491|566345378|FG000|Overall Study|Study termination|13|||
156840806|NCT00761527|566168044|FG000|Overall Study|Adverse Event|3|||
156840807|NCT00761527|566168044|FG000|Overall Study|Poor Compliance|8|||
156886984|NCT01978938|566345379|FG000|Overall Study|Lost to Follow-up|12|||
156886985|NCT01978938|566345380|FG001|Overall Study|Lost to Follow-up|6|||
156886986|NCT01978938|566345379|FG000|Overall Study|Withdrawal by Subject|8|||
156886987|NCT01978938|566345380|FG001|Overall Study|Withdrawal by Subject|4|||
156886988|NCT01978938|566345379|FG000|Overall Study|Adverse Event, non-fatal|2|||
156886989|NCT01978938|566345380|FG001|Overall Study|Adverse Event, non-fatal|1|||
156886990|NCT01978938|566345379|FG000|Overall Study|Participant noncompliance|1|||
156886991|NCT01978938|566345380|FG001|Overall Study|Participant noncompliance|1|||
156886992|NCT01978938|566345379|FG000|Overall Study|Did not meet inclusion criteria|0|||
156886993|NCT01978938|566345380|FG001|Overall Study|Did not meet inclusion criteria|1|||
156886994|NCT01978938|566345379|FG000|Overall Study|Previously scheduled procedure|0|||
156886995|NCT01978938|566345380|FG001|Overall Study|Previously scheduled procedure|1|||
156886996|NCT02694757|566345381|FG000|Overall Study|Lack of Efficacy|3|||
156886997|NCT02650921|566345382|FG000|Overall Study|Withdrawal by Subject|4|||
156886998|NCT02650921|566345382|FG000|Overall Study|Lost to Follow-up|2|||
156886999|NCT02650921|566345382|FG000|Overall Study|Adverse Event|1|||
156887000|NCT02650921|566345382|FG000|Overall Study|Due to Medical Condition|1|||
156887001|NCT03709576|566345383|FG000|Overall Study|progression prior to enrollment|1|||
156887002|NCT03041129|566345391|FG000|Overall Study|Withdrawal by Subject|2|||
156887003|NCT03041129|566345392|FG001|Overall Study|Withdrawal by Subject|0|||
156887004|NCT03041129|566345393|FG002|Overall Study|Withdrawal by Subject|0|||
156887005|NCT03041129|566345394|FG003|Overall Study|Withdrawal by Subject|0|||
156887006|NCT00510653|566345397|FG000|Overall Study|Withdrawal by Subject|8|||
156887007|NCT00510653|566345397|FG000|Overall Study|Monetary|3|||
156887008|NCT00483756|566345400|FG000|Overall Study|Death|2|||
156887009|NCT00483756|566345401|FG001|Overall Study|Death|0|||
156887010|NCT00483756|566345402|FG002|Overall Study|Death|1|||
156887011|NCT00483756|566345400|FG000|Overall Study|Adverse Event|19|||
156887012|NCT00483756|566345401|FG001|Overall Study|Adverse Event|38|||
156887013|NCT00483756|566345402|FG002|Overall Study|Adverse Event|40|||
156887014|NCT00483756|566345400|FG000|Overall Study|Lack of Efficacy|1|||
156887015|NCT00483756|566345401|FG001|Overall Study|Lack of Efficacy|0|||
156887016|NCT00483756|566345402|FG002|Overall Study|Lack of Efficacy|0|||
156887017|NCT00483756|566345400|FG000|Overall Study|Lost to Follow-up|3|||
156887018|NCT00483756|566345401|FG001|Overall Study|Lost to Follow-up|1|||
156887019|NCT00483756|566345402|FG002|Overall Study|Lost to Follow-up|0|||
156887020|NCT00483756|566345400|FG000|Overall Study|Withdrawal by Subject|5|||
156887021|NCT00483756|566345401|FG001|Overall Study|Withdrawal by Subject|3|||
156887022|NCT00483756|566345402|FG002|Overall Study|Withdrawal by Subject|4|||
156887023|NCT00483756|566345400|FG000|Overall Study|Other|2|||
156887024|NCT00483756|566345401|FG001|Overall Study|Other|4|||
156887025|NCT00483756|566345402|FG002|Overall Study|Other|3|||
156887026|NCT00483756|566345400|FG000|Overall Study|Randomized, Not Treated|1|||
156887027|NCT00483756|566345401|FG001|Overall Study|Randomized, Not Treated|4|||
156887028|NCT00483756|566345402|FG002|Overall Study|Randomized, Not Treated|4|||
156887029|NCT00710762|566345403|FG000|Overall Study|Progressive disease|27|||
156887030|NCT00710762|566345404|FG001|Overall Study|Progressive disease|30|||
156887031|NCT00710762|566345403|FG000|Overall Study|Adverse Event other disease worsening|2|||
156887032|NCT00710762|566345404|FG001|Overall Study|Adverse Event other disease worsening|1|||
156887033|NCT00710762|566345403|FG000|Overall Study|Other Adverse Event|7|||
156887034|NCT00710762|566345404|FG001|Overall Study|Other Adverse Event|7|||
157154871|NCT01555463|567311380|FG000|Treatment|Other reason|2|||
157154872|NCT01555463|567311381|FG001|Treatment|Other reason|3|||
157154873|NCT01555463|567311380|FG000|Follow up|Adverse Event|2|||
157154874|NCT01555463|567311381|FG001|Follow up|Adverse Event|5|||
157154875|NCT01555463|567311380|FG000|Follow up|Death|0|||
156887035|NCT00710762|566345403|FG000|Overall Study|Lost to Follow-up|1|||
156887036|NCT00710762|566345404|FG001|Overall Study|Lost to Follow-up|0|||
156887037|NCT00710762|566345403|FG000|Overall Study|Reason other than listed above|2|||
157154876|NCT01555463|567311381|FG001|Follow up|Death|1|||
157154877|NCT01555463|567311380|FG000|Follow up|Withdrawal by Subject|22|||
157154878|NCT01555463|567311381|FG001|Follow up|Withdrawal by Subject|22|||
157154879|NCT01555463|567311380|FG000|Follow up|Lost to Follow-up|9|||
156887038|NCT00710762|566345404|FG001|Overall Study|Reason other than listed above|2|||
156887039|NCT00436501|566345405|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
157154880|NCT01555463|567311381|FG001|Follow up|Lost to Follow-up|10|||
156887040|NCT00436501|566345406|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
156887041|NCT00436501|566345405|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
156887042|NCT00436501|566345406|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
156887043|NCT00495040|566345407|FG000|Overall Study|Withdrawal by Subject|3|||
156887044|NCT02282293|566345414|FG000|Overall Study|Lost to Follow-up|2|||
157154881|NCT01555463|567311380|FG000|Follow up|Protocol Violation|2|||
156887045|NCT02282293|566345415|FG001|Overall Study|Lost to Follow-up|2|||
156887046|NCT02282293|566345414|FG000|Overall Study|Unable to comply with study procedures|1|||
156887047|NCT02282293|566345415|FG001|Overall Study|Unable to comply with study procedures|0|||
156887048|NCT02282293|566345414|FG000|Overall Study|Moved out of study area|0|||
156887049|NCT02282293|566345415|FG001|Overall Study|Moved out of study area|1|||
157154882|NCT01555463|567311381|FG001|Follow up|Protocol Violation|4|||
157154883|NCT01555463|567311380|FG000|Follow up|Other reason|3|||
156887050|NCT03011892|566345416|FG000|Double Blind (DB) Period|Adverse Event|0|||
156887051|NCT03011892|566345417|FG001|Double Blind (DB) Period|Adverse Event|1|||
156887052|NCT03011892|566345418|FG002|Double Blind (DB) Period|Adverse Event|1|||
156887053|NCT03011892|566345419|FG003|Double Blind (DB) Period|Adverse Event|0|||
156887054|NCT03011892|566345420|FG004|Double Blind (DB) Period|Adverse Event|0|||
156887055|NCT03011892|566345421|FG005|Double Blind (DB) Period|Adverse Event|0|||
156840808|NCT00761527|566168044|FG000|Overall Study|Lost to Follow-up|9|||
156840809|NCT00761527|566168044|FG000|Overall Study|Unknown reason|2|||
156840810|NCT00687531|566168045|FG000|Overall Study|Did not meet protocol eligibility|104|||
156840811|NCT00687531|566168045|FG000|Overall Study|Adverse Event|5|||
156840812|NCT00687531|566168045|FG000|Overall Study|Lost to Follow-up|26|||
156840813|NCT02353728|566168046|FG000|Overall Study|Subject non-compliance|1|||
156840814|NCT00895310|566168047|FG000|Overall Study|Withdrawal by Subject|1|||
156840815|NCT00659230|566168048|FG000|Overall Study|Lost to Follow-up|2|||
156887056|NCT03011892|566345422|FG006|Double Blind (DB) Period|Adverse Event|0|||
156887057|NCT03011892|566345423|FG007|Double Blind (DB) Period|Adverse Event|0|||
156887058|NCT03011892|566345424|FG008|Double Blind (DB) Period|Adverse Event|0|||
156887059|NCT03011892|566345425|FG009|Double Blind (DB) Period|Adverse Event|0|||
156887060|NCT03011892|566345426|FG010|Double Blind (DB) Period|Adverse Event|0|||
156887061|NCT03011892|566345427|FG011|Double Blind (DB) Period|Adverse Event|0|||
156887062|NCT03011892|566345416|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
156887063|NCT03011892|566345417|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
156887064|NCT03011892|566345418|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
156887065|NCT03011892|566345419|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
156887066|NCT03011892|566345420|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
156887067|NCT03011892|566345421|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
156887068|NCT03011892|566345422|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
156887069|NCT03011892|566345423|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
156887070|NCT03011892|566345424|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
156887071|NCT03011892|566345425|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
156887072|NCT03011892|566345426|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
156887073|NCT03011892|566345427|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
156887074|NCT03011892|566345416|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
156887075|NCT03011892|566345417|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
156887076|NCT03011892|566345418|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
156887077|NCT03011892|566345419|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
156887078|NCT03011892|566345420|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
156887079|NCT03011892|566345421|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
156887080|NCT03011892|566345422|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
156887081|NCT03011892|566345423|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
156887082|NCT03011892|566345424|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
156887083|NCT03011892|566345425|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
156887084|NCT03011892|566345426|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
156887085|NCT03011892|566345427|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
156887086|NCT03011892|566345416|FG000|Double Blind (DB) Period|Other|1|||
156887087|NCT03011892|566345417|FG001|Double Blind (DB) Period|Other|1|||
156887088|NCT03011892|566345418|FG002|Double Blind (DB) Period|Other|1|||
156887089|NCT03011892|566345419|FG003|Double Blind (DB) Period|Other|0|||
156887090|NCT03011892|566345420|FG004|Double Blind (DB) Period|Other|1|||
156887091|NCT03011892|566345421|FG005|Double Blind (DB) Period|Other|0|||
156887092|NCT03011892|566345422|FG006|Double Blind (DB) Period|Other|0|||
156887093|NCT03011892|566345423|FG007|Double Blind (DB) Period|Other|0|||
156887094|NCT03011892|566345424|FG008|Double Blind (DB) Period|Other|0|||
156887095|NCT03011892|566345425|FG009|Double Blind (DB) Period|Other|0|||
156887096|NCT03011892|566345426|FG010|Double Blind (DB) Period|Other|0|||
156887097|NCT03011892|566345427|FG011|Double Blind (DB) Period|Other|0|||
156887098|NCT03011892|566345416|FG000|Double Blind (DB) Period|Physician Decision|1|||
156887099|NCT03011892|566345417|FG001|Double Blind (DB) Period|Physician Decision|0|||
156887100|NCT03011892|566345418|FG002|Double Blind (DB) Period|Physician Decision|1|||
156887101|NCT03011892|566345419|FG003|Double Blind (DB) Period|Physician Decision|0|||
156887102|NCT03011892|566345420|FG004|Double Blind (DB) Period|Physician Decision|0|||
156887103|NCT03011892|566345421|FG005|Double Blind (DB) Period|Physician Decision|0|||
156887104|NCT03011892|566345422|FG006|Double Blind (DB) Period|Physician Decision|0|||
156887105|NCT03011892|566345423|FG007|Double Blind (DB) Period|Physician Decision|0|||
156887106|NCT03011892|566345424|FG008|Double Blind (DB) Period|Physician Decision|0|||
156887107|NCT03011892|566345425|FG009|Double Blind (DB) Period|Physician Decision|0|||
156887108|NCT03011892|566345426|FG010|Double Blind (DB) Period|Physician Decision|0|||
156840816|NCT00659230|566168049|FG001|Overall Study|Lost to Follow-up|5|||
156887109|NCT03011892|566345427|FG011|Double Blind (DB) Period|Physician Decision|0|||
156887110|NCT03011892|566345416|FG000|Double Blind (DB) Period|Pregnancy|0|||
156887111|NCT03011892|566345417|FG001|Double Blind (DB) Period|Pregnancy|0|||
157154884|NCT01555463|567311381|FG001|Follow up|Other reason|3|||
156840817|NCT00659230|566168048|FG000|Overall Study|Lost source documentation|5|||
156840818|NCT00659230|566168049|FG001|Overall Study|Lost source documentation|4|||
156840819|NCT00659230|566168048|FG000|Overall Study|Did not return post-randomization|2|||
156840820|NCT00659230|566168049|FG001|Overall Study|Did not return post-randomization|3|||
156840821|NCT01031979|566169949|FG000|Overall Study|Lost to Follow-up|5|||
156840822|NCT01031979|566169950|FG001|Overall Study|Lost to Follow-up|4|||
156840823|NCT02454478|566169953|FG000|Overall Study|Incomplete DLT Evaluation|1|||
156840824|NCT01959841|566169957|FG000|Overall Study|Adverse Event|1|||
156840825|NCT01959841|566169958|FG001|Overall Study|Adverse Event|3|||
156840826|NCT01959841|566169959|FG002|Overall Study|Adverse Event|2|||
156840827|NCT01959841|566169957|FG000|Overall Study|Lack of Efficacy|5|||
156840828|NCT01959841|566169958|FG001|Overall Study|Lack of Efficacy|0|||
156840829|NCT01959841|566169959|FG002|Overall Study|Lack of Efficacy|0|||
156887112|NCT03011892|566345418|FG002|Double Blind (DB) Period|Pregnancy|0|||
156887113|NCT03011892|566345419|FG003|Double Blind (DB) Period|Pregnancy|0|||
156887114|NCT03011892|566345420|FG004|Double Blind (DB) Period|Pregnancy|1|||
156887115|NCT03011892|566345421|FG005|Double Blind (DB) Period|Pregnancy|0|||
156887116|NCT03011892|566345422|FG006|Double Blind (DB) Period|Pregnancy|0|||
156887117|NCT03011892|566345423|FG007|Double Blind (DB) Period|Pregnancy|0|||
156887118|NCT03011892|566345424|FG008|Double Blind (DB) Period|Pregnancy|0|||
156887119|NCT03011892|566345425|FG009|Double Blind (DB) Period|Pregnancy|0|||
156887120|NCT03011892|566345426|FG010|Double Blind (DB) Period|Pregnancy|0|||
156887121|NCT03011892|566345427|FG011|Double Blind (DB) Period|Pregnancy|0|||
156887122|NCT03011892|566345416|FG000|Double Blind (DB) Period|Protocol Violation|1|||
156887123|NCT03011892|566345417|FG001|Double Blind (DB) Period|Protocol Violation|0|||
156887124|NCT03011892|566345418|FG002|Double Blind (DB) Period|Protocol Violation|0|||
156887125|NCT03011892|566345419|FG003|Double Blind (DB) Period|Protocol Violation|0|||
156887126|NCT03011892|566345420|FG004|Double Blind (DB) Period|Protocol Violation|0|||
156887127|NCT03011892|566345421|FG005|Double Blind (DB) Period|Protocol Violation|0|||
156887128|NCT03011892|566345422|FG006|Double Blind (DB) Period|Protocol Violation|0|||
156887129|NCT03011892|566345423|FG007|Double Blind (DB) Period|Protocol Violation|0|||
156887130|NCT03011892|566345424|FG008|Double Blind (DB) Period|Protocol Violation|0|||
156887131|NCT03011892|566345425|FG009|Double Blind (DB) Period|Protocol Violation|0|||
156887132|NCT03011892|566345426|FG010|Double Blind (DB) Period|Protocol Violation|0|||
156887133|NCT03011892|566345427|FG011|Double Blind (DB) Period|Protocol Violation|0|||
156887134|NCT03011892|566345416|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
156887135|NCT03011892|566345417|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
156887136|NCT03011892|566345418|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
156887137|NCT03011892|566345419|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
156887138|NCT03011892|566345420|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
156887139|NCT03011892|566345421|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
156887140|NCT03011892|566345422|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887141|NCT03011892|566345423|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887142|NCT03011892|566345424|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887143|NCT03011892|566345425|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887144|NCT03011892|566345426|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887145|NCT03011892|566345427|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
156887146|NCT03011892|566345416|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
156887147|NCT03011892|566345417|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
156887148|NCT03011892|566345418|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
156887149|NCT03011892|566345419|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
156887150|NCT03011892|566345420|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
156887151|NCT03011892|566345421|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
156887152|NCT03011892|566345422|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
156887153|NCT03011892|566345423|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
156887154|NCT03011892|566345424|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
156887155|NCT03011892|566345425|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
156887156|NCT03011892|566345426|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
156887157|NCT03011892|566345427|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
156887158|NCT03011892|566345416|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
156887159|NCT03011892|566345417|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
156887160|NCT03011892|566345418|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
156887161|NCT03011892|566345419|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
157024216|NCT03338933|566843161|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
156840830|NCT01959841|566169957|FG000|Overall Study|Lost to Follow-up|1|||
156887162|NCT03011892|566345420|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
156887163|NCT03011892|566345421|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
156887164|NCT03011892|566345422|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
156887165|NCT03011892|566345423|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
156887166|NCT03011892|566345424|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
156887167|NCT03011892|566345425|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
157224773|NCT02688400|567569872|FG001|Overall Study|Lack of Efficacy|7|||
156840831|NCT01959841|566169958|FG001|Overall Study|Lost to Follow-up|1|||
156840832|NCT01959841|566169959|FG002|Overall Study|Lost to Follow-up|0|||
156840833|NCT01959841|566169957|FG000|Overall Study|Physician Decision|0|||
156887168|NCT03011892|566345426|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
156887169|NCT03011892|566345427|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
156887170|NCT03011892|566345416|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
156887171|NCT03011892|566345417|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
156887172|NCT03011892|566345418|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
156887173|NCT03011892|566345419|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
156887174|NCT03011892|566345420|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
156887175|NCT03011892|566345421|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
156887176|NCT03011892|566345422|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
156887177|NCT03011892|566345423|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
156887178|NCT03011892|566345424|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
156887179|NCT03011892|566345425|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
156887180|NCT03011892|566345426|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
156887181|NCT03011892|566345427|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
156887182|NCT03011892|566345416|FG000|Open Label (OL) Period|Reason not specified|0|||
156887183|NCT03011892|566345417|FG001|Open Label (OL) Period|Reason not specified|0|||
156887184|NCT03011892|566345418|FG002|Open Label (OL) Period|Reason not specified|0|||
156887185|NCT03011892|566345419|FG003|Open Label (OL) Period|Reason not specified|0|||
156887186|NCT03011892|566345420|FG004|Open Label (OL) Period|Reason not specified|0|||
156887187|NCT03011892|566345421|FG005|Open Label (OL) Period|Reason not specified|0|||
156887188|NCT03011892|566345422|FG006|Open Label (OL) Period|Reason not specified|0|||
156887189|NCT03011892|566345423|FG007|Open Label (OL) Period|Reason not specified|1|||
156887190|NCT03011892|566345424|FG008|Open Label (OL) Period|Reason not specified|0|||
156887191|NCT03011892|566345425|FG009|Open Label (OL) Period|Reason not specified|0|||
156887192|NCT03011892|566345426|FG010|Open Label (OL) Period|Reason not specified|0|||
156887193|NCT03011892|566345427|FG011|Open Label (OL) Period|Reason not specified|0|||
156887194|NCT02312687|566345438|FG000|Overall Study|Other, Not Specified|1|||
156887195|NCT00906971|566345441|FG000|Overall Study|Withdrawal by Subject|8|||
156887196|NCT00906971|566345442|FG001|Overall Study|Withdrawal by Subject|2|||
156887197|NCT00906971|566345441|FG000|Overall Study|Lost to Follow-up|0|||
156887198|NCT00906971|566345442|FG001|Overall Study|Lost to Follow-up|1|||
156887199|NCT03678870|566345443|FG000|Overall Study|prescribed non- protocol medications|10|||
156887200|NCT03678870|566345444|FG001|Overall Study|prescribed non- protocol medications|6|||
156887201|NCT03678870|566345443|FG000|Overall Study|Lost to Follow-up|3|||
156887202|NCT03678870|566345444|FG001|Overall Study|Lost to Follow-up|2|||
156887203|NCT03104816|566345445|FG000|Overall Study|Lack of Efficacy|0|||
156887204|NCT03104816|566345446|FG001|Overall Study|Lack of Efficacy|2|||
156887205|NCT03104816|566345447|FG002|Overall Study|Lack of Efficacy|0|||
156887206|NCT03104816|566345445|FG000|Overall Study|Protocol Violation|2|||
156887207|NCT03104816|566345446|FG001|Overall Study|Protocol Violation|0|||
156887208|NCT03104816|566345447|FG002|Overall Study|Protocol Violation|2|||
156887209|NCT02232880|566345451|FG000|Overall Study|study stopped prior to randomization|1|||
156887210|NCT01155167|566345452|FG000|Overall Study|Insufficient ultrasound data|2|||
156887211|NCT01155167|566345453|FG001|Overall Study|Insufficient ultrasound data|0|||
156840834|NCT01959841|566169958|FG001|Overall Study|Physician Decision|2|||
156840835|NCT01959841|566169959|FG002|Overall Study|Physician Decision|3|||
156840836|NCT01959841|566169957|FG000|Overall Study|Protocol Violation|16|||
156840837|NCT01959841|566169958|FG001|Overall Study|Protocol Violation|23|||
156840838|NCT01959841|566169959|FG002|Overall Study|Protocol Violation|16|||
156840839|NCT01959841|566169957|FG000|Overall Study|Withdrawal by Subject|7|||
156840840|NCT01959841|566169958|FG001|Overall Study|Withdrawal by Subject|7|||
156840841|NCT01959841|566169959|FG002|Overall Study|Withdrawal by Subject|5|||
156840842|NCT01959841|566169957|FG000|Overall Study|Clinical laboratory value|2|||
156840843|NCT01959841|566169958|FG001|Overall Study|Clinical laboratory value|6|||
156840844|NCT01959841|566169959|FG002|Overall Study|Clinical laboratory value|6|||
156840845|NCT01959841|566169957|FG000|Overall Study|Platelet count below on day1 or 4|11|||
156840846|NCT01959841|566169958|FG001|Overall Study|Platelet count below on day1 or 4|15|||
156887212|NCT01155167|566345452|FG000|Overall Study|Access site changed to femoral artery|1|||
156887213|NCT01155167|566345453|FG001|Overall Study|Access site changed to femoral artery|0|||
156887214|NCT00853970|566345462|FG000|Overall Study|Withdrawal by Subject|2|||
156840847|NCT01959841|566169959|FG002|Overall Study|Platelet count below on day1 or 4|11|||
156840848|NCT00780416|566169960|FG000|Overall Study|Physician Decision|3|||
156887215|NCT00853970|566345463|FG001|Overall Study|Withdrawal by Subject|1|||
156887216|NCT00853970|566345462|FG000|Overall Study|Cancelled surgery|4|||
156840849|NCT00780416|566169961|FG001|Overall Study|Physician Decision|3|||
156840850|NCT00780416|566169960|FG000|Overall Study|Protocol Violation|1|||
156840851|NCT00780416|566169961|FG001|Overall Study|Protocol Violation|0|||
156840852|NCT00780416|566169960|FG000|Overall Study|Withdrawal by Subject|8|||
156887217|NCT00853970|566345463|FG001|Overall Study|Cancelled surgery|2|||
156887218|NCT00992589|566347311|FG000|Open-Label Phase|Adverse Event|4|||
156887219|NCT00992589|566347312|FG001|Open-Label Phase|Adverse Event|0|||
156840853|NCT00780416|566169961|FG001|Overall Study|Withdrawal by Subject|6|||
156840854|NCT00666224|566169964|FG000|Double-Blind|Adverse Event|15|||
156840855|NCT00666224|566169965|FG001|Double-Blind|Adverse Event|5|||
156840856|NCT00666224|566169964|FG000|Double-Blind|Lost to Follow-up|2|||
156840857|NCT00666224|566169965|FG001|Double-Blind|Lost to Follow-up|2|||
156840858|NCT00666224|566169964|FG000|Double-Blind|Withdrawal by Subject|18|||
156840859|NCT00666224|566169965|FG001|Double-Blind|Withdrawal by Subject|14|||
156840860|NCT00666224|566169964|FG000|Double-Blind|Physician Decision|0|||
156840861|NCT00666224|566169965|FG001|Double-Blind|Physician Decision|3|||
156840862|NCT00666224|566169964|FG000|Double-Blind|Sponsor decision|1|||
156840863|NCT00666224|566169965|FG001|Double-Blind|Sponsor decision|0|||
156840864|NCT00666224|566169964|FG000|Double-Blind|Pregnancy|3|||
156840865|NCT00666224|566169965|FG001|Double-Blind|Pregnancy|2|||
156840866|NCT00666224|566169964|FG000|Double-Blind|Noncompliance|1|||
156840867|NCT00666224|566169965|FG001|Double-Blind|Noncompliance|0|||
156840868|NCT00666224|566169964|FG000|Double-Blind|Death|1|||
156840869|NCT00666224|566169965|FG001|Double-Blind|Death|0|||
156840870|NCT00666224|566169964|FG000|Double-Blind|Undefined/Unknown|4|||
156840871|NCT00666224|566169965|FG001|Double-Blind|Undefined/Unknown|1|||
156840872|NCT00666224|566169964|FG000|Open-Label|Adverse Event|8|||
156840873|NCT00666224|566169965|FG001|Open-Label|Adverse Event|43|||
156840874|NCT00666224|566169964|FG000|Open-Label|Lost to Follow-up|4|||
156840875|NCT00666224|566169965|FG001|Open-Label|Lost to Follow-up|5|||
156840876|NCT00666224|566169964|FG000|Open-Label|Withdrawal by Subject|12|||
156840877|NCT00666224|566169965|FG001|Open-Label|Withdrawal by Subject|25|||
156840878|NCT00666224|566169964|FG000|Open-Label|Physician Decision|7|||
156840879|NCT00666224|566169965|FG001|Open-Label|Physician Decision|5|||
156840880|NCT00666224|566169964|FG000|Open-Label|Pregnancy|1|||
156840881|NCT00666224|566169965|FG001|Open-Label|Pregnancy|5|||
156840882|NCT00666224|566169964|FG000|Open-Label|Noncompliance|2|||
156840883|NCT00666224|566169965|FG001|Open-Label|Noncompliance|1|||
156840884|NCT00666224|566169964|FG000|Open-Label|Undefined/Unknown|1|||
156840885|NCT00666224|566169965|FG001|Open-Label|Undefined/Unknown|1|||
156840886|NCT03521141|566169966|FG000|Overall Study|Death|1|||
156840887|NCT03521141|566169967|FG001|Overall Study|Death|0|||
156840888|NCT03521141|566169968|FG002|Overall Study|Death|1|||
156840889|NCT03828617|566169974|FG000|Overall Study|Lost to Follow-up|22|||
156840890|NCT03828617|566169975|FG001|Overall Study|Lost to Follow-up|12|||
156840891|NCT03828617|566169976|FG002|Overall Study|Lost to Follow-up|23|||
156840892|NCT03828617|566169977|FG003|Overall Study|Lost to Follow-up|7|||
156840893|NCT03828617|566169974|FG000|Overall Study|No longer met eligibility criteria|0|||
156840894|NCT03828617|566169975|FG001|Overall Study|No longer met eligibility criteria|1|||
156840895|NCT03828617|566169976|FG002|Overall Study|No longer met eligibility criteria|1|||
156840896|NCT03828617|566169977|FG003|Overall Study|No longer met eligibility criteria|3|||
156840897|NCT03828617|566169974|FG000|Overall Study|Protocol Violation|0|||
156840898|NCT03828617|566169975|FG001|Overall Study|Protocol Violation|2|||
156840899|NCT03828617|566169976|FG002|Overall Study|Protocol Violation|0|||
156840900|NCT03828617|566169977|FG003|Overall Study|Protocol Violation|0|||
156840901|NCT03828617|566169974|FG000|Overall Study|Withdrawal by Subject|2|||
156840902|NCT03828617|566169975|FG001|Overall Study|Withdrawal by Subject|0|||
156840903|NCT03828617|566169976|FG002|Overall Study|Withdrawal by Subject|2|||
156840904|NCT03828617|566169977|FG003|Overall Study|Withdrawal by Subject|0|||
156840905|NCT03354273|566169979|FG000|Overall Study|Adverse Event|5|||
156840906|NCT03354273|566169979|FG000|Overall Study|Screen Failure|21|||
156840907|NCT03354273|566169979|FG000|Overall Study|Withdrawal by Subject|34|||
156840908|NCT03354273|566169979|FG000|Overall Study|Technical Problems|30|||
156840909|NCT03354273|566169979|FG000|Overall Study|Lost to Follow-up|4|||
156840910|NCT03354273|566169979|FG000|Overall Study|Investigator Decision|3|||
156840911|NCT03354273|566169979|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
156840912|NCT03354273|566169979|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
156840913|NCT03354273|566169979|FG000|Overall Study|COVID-19 Restrictions|9|||
156840914|NCT03354273|566169979|FG000|Overall Study|Other|5|||
156840915|NCT04207749|566169982|FG000|Overall Study|Lost to Follow-up|0|||
156840916|NCT04207749|566169983|FG001|Overall Study|Lost to Follow-up|2|||
156840917|NCT04207749|566169982|FG000|Overall Study|Protocol Violation|0|||
156840918|NCT04207749|566169983|FG001|Overall Study|Protocol Violation|1|||
156840919|NCT04207749|566169982|FG000|Overall Study|Withdrawal by Subject|3|||
156840920|NCT04207749|566169983|FG001|Overall Study|Withdrawal by Subject|0|||
156840921|NCT04207749|566169982|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
156840922|NCT04207749|566169983|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
156840923|NCT00655629|566169984|FG000|Overall Study|Adverse Event|4|||
156840924|NCT00655629|566169985|FG001|Overall Study|Adverse Event|1|||
156840925|NCT00655629|566169984|FG000|Overall Study|Lack of Efficacy|2|||
156840926|NCT00655629|566169985|FG001|Overall Study|Lack of Efficacy|12|||
156840927|NCT00655629|566169984|FG000|Overall Study|Lost to Follow-up|4|||
156840928|NCT00655629|566169985|FG001|Overall Study|Lost to Follow-up|3|||
156840929|NCT00655629|566169984|FG000|Overall Study|Protocol Violation|5|||
156840930|NCT00655629|566169985|FG001|Overall Study|Protocol Violation|3|||
156840931|NCT00655629|566169984|FG000|Overall Study|consent withdrawn|6|||
156840932|NCT00655629|566169985|FG001|Overall Study|consent withdrawn|4|||
156840933|NCT00705367|566169986|FG000|Long-term Extension Period|Adverse Event|2|||
156840934|NCT00705367|566169987|FG001|Long-term Extension Period|Adverse Event|0|||
157024217|NCT03338933|566843162|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
157024218|NCT03338933|566843159|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
157024219|NCT03338933|566843160|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
157024220|NCT03338933|566843161|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
157024221|NCT03338933|566843162|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
157024222|NCT04515576|566843163|FG000|Overall Study|Withdrawal by Subject|0|||
157024223|NCT04515576|566843164|FG001|Overall Study|Withdrawal by Subject|0|||
157024224|NCT04515576|566843165|FG002|Overall Study|Withdrawal by Subject|0|||
157024225|NCT04515576|566843166|FG003|Overall Study|Withdrawal by Subject|0|||
157024226|NCT04515576|566843167|FG004|Overall Study|Withdrawal by Subject|0|||
157024227|NCT04515576|566843168|FG005|Overall Study|Withdrawal by Subject|1|||
157024228|NCT02140554|566843175|FG000|Overall Study|Withdrawal of consent|1|||
157024229|NCT02140554|566843176|FG001|Overall Study|Withdrawal of consent|0|||
157024230|NCT02140554|566843177|FG002|Overall Study|Withdrawal of consent|4|||
157024231|NCT02140554|566843175|FG000|Overall Study|Physician Decision|1|||
157024232|NCT02140554|566843176|FG001|Overall Study|Physician Decision|0|||
157024233|NCT02140554|566843177|FG002|Overall Study|Physician Decision|2|||
157024234|NCT02140554|566843175|FG000|Overall Study|Death|0|||
157024235|NCT02140554|566843176|FG001|Overall Study|Death|0|||
157024236|NCT02140554|566843177|FG002|Overall Study|Death|1|||
157024237|NCT02140554|566843175|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
157024238|NCT02140554|566843176|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
157024239|NCT02140554|566843177|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
157024240|NCT04509674|566843179|FG000|Overall Study|Not treated|33|||
157024241|NCT04509674|566843180|FG001|Overall Study|Not treated|26|||
157024242|NCT04509674|566843179|FG000|Overall Study|Protocol Violation|9|||
157024243|NCT04509674|566843180|FG001|Overall Study|Protocol Violation|10|||
157024244|NCT04509674|566843179|FG000|Overall Study|Lost to Follow-up|31|||
157024245|NCT04509674|566843180|FG001|Overall Study|Lost to Follow-up|39|||
157024246|NCT04509674|566843179|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
157024247|NCT04509674|566843180|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
157024248|NCT04509674|566843179|FG000|Overall Study|Adverse event, serious fatal event|11|||
157024249|NCT04509674|566843180|FG001|Overall Study|Adverse event, serious fatal event|4|||
157024250|NCT04509674|566843179|FG000|Overall Study|Adverse event, non-fatal event|107|||
157024251|NCT04509674|566843180|FG001|Overall Study|Adverse event, non-fatal event|118|||
157024252|NCT04509674|566843179|FG000|Overall Study|Other reason than listed|106|||
157024253|NCT04509674|566843180|FG001|Overall Study|Other reason than listed|95|||
157024254|NCT04019873|566843183|FG000|Overall Study|Discontinued from the treatment|1|||
157024255|NCT04019873|566843184|FG001|Overall Study|Discontinued from the treatment|39|||
157024256|NCT04019873|566843185|FG002|Overall Study|Discontinued from the treatment|2|||
157024257|NCT04185298|566843193|FG000|Overall Study|Lost to Follow-up|1|||
157024258|NCT04185298|566843194|FG001|Overall Study|Lost to Follow-up|3|||
157024259|NCT04185298|566843193|FG000|Overall Study|Withdrawal by Subject|0|||
157024260|NCT04185298|566843194|FG001|Overall Study|Withdrawal by Subject|3|||
157024261|NCT03896789|566843195|FG000|Baseline|Lost to Follow-up|1|||
157024262|NCT03896789|566843196|FG001|Baseline|Lost to Follow-up|2|||
157024263|NCT03896789|566843195|FG000|Baseline|Death|3|||
157024264|NCT03896789|566843196|FG001|Baseline|Death|6|||
157024265|NCT03896789|566843195|FG000|Post-Randomization|Lost to Follow-up|12|||
157024266|NCT03896789|566843196|FG001|Post-Randomization|Lost to Follow-up|11|||
157024267|NCT03896789|566843195|FG000|Post-Randomization|Death|12|||
157024268|NCT03896789|566843196|FG001|Post-Randomization|Death|13|||
157024269|NCT01606215|566843197|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
157024270|NCT01606215|566843198|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
157024271|NCT05087992|566843203|FG000|Overall Study|Adverse Event|0|||
157024272|NCT05087992|566843204|FG001|Overall Study|Adverse Event|1|||
157024273|NCT05087992|566843205|FG002|Overall Study|Adverse Event|0|||
157024274|NCT05087992|566843203|FG000|Overall Study|Withdrawal by Subject|2|||
157024275|NCT05087992|566843204|FG001|Overall Study|Withdrawal by Subject|0|||
157024276|NCT05087992|566843205|FG002|Overall Study|Withdrawal by Subject|0|||
157224774|NCT02688400|567569871|FG000|Overall Study|Adverse Event|21|||
157224775|NCT02688400|567569872|FG001|Overall Study|Adverse Event|12|||
157224776|NCT02688400|567569871|FG000|Overall Study|Withdrawal by Subject|15|||
157224777|NCT02688400|567569872|FG001|Overall Study|Withdrawal by Subject|13|||
157024277|NCT05087992|566843203|FG000|Overall Study|clinical disease progression|3|||
157024278|NCT05087992|566843204|FG001|Overall Study|clinical disease progression|1|||
157024279|NCT05087992|566843205|FG002|Overall Study|clinical disease progression|0|||
157024280|NCT05087992|566843203|FG000|Overall Study|objective disease progression|4|||
157024281|NCT05087992|566843204|FG001|Overall Study|objective disease progression|1|||
157024282|NCT05087992|566843205|FG002|Overall Study|objective disease progression|0|||
157024283|NCT01842542|566843206|FG000|Overall Study|Withdrawal by Subject|2|||
157224778|NCT02688400|567569871|FG000|Overall Study|No study medication intake|1|||
156840935|NCT00705367|566169986|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
156840936|NCT00705367|566169987|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
156840937|NCT00705367|566169986|FG000|Long-term Extension Period|Lack of Efficacy|1|||
156840938|NCT00705367|566169987|FG001|Long-term Extension Period|Lack of Efficacy|0|||
156840939|NCT00705367|566169986|FG000|Long-term Extension Period|No longer met study criteria|1|||
156840940|NCT00705367|566169987|FG001|Long-term Extension Period|No longer met study criteria|0|||
156840941|NCT00705367|566169986|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
156840942|NCT00705367|566169987|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
156840943|NCT01835223|566169990|FG000|Overall Study|Adverse Event|1|||
156840944|NCT01835223|566169991|FG001|Overall Study|Adverse Event|0|||
156840945|NCT01835223|566169990|FG000|Overall Study|Withdrawal by Subject|2|||
156840946|NCT01835223|566169991|FG001|Overall Study|Withdrawal by Subject|0|||
156840947|NCT01835223|566169990|FG000|Overall Study|Disease progression|2|||
156840948|NCT01835223|566169991|FG001|Overall Study|Disease progression|1|||
156840949|NCT01835223|566169990|FG000|Overall Study|Became Inelligible|4|||
156840950|NCT01835223|566169991|FG001|Overall Study|Became Inelligible|0|||
156840951|NCT00303485|566169992|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
156840952|NCT00303485|566169993|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
156840953|NCT00303485|566169992|FG000|Overall Study|Failure to return|0|||
156840954|NCT00303485|566169993|FG001|Overall Study|Failure to return|1|||
156840955|NCT00303485|566169992|FG000|Overall Study|Withdrawal by Subject|1|||
156840956|NCT00303485|566169993|FG001|Overall Study|Withdrawal by Subject|0|||
156840957|NCT01959139|566169994|FG000|Phase II|Disease progression|0|||
156840958|NCT01959139|566169995|FG001|Phase II|Disease progression|0|||
156840959|NCT01959139|566169996|FG002|Phase II|Disease progression|26|||
156840960|NCT01959139|566169997|FG003|Phase II|Disease progression|34|||
156840961|NCT01959139|566169994|FG000|Phase II|Adverse Event|0|||
156840962|NCT01959139|566169995|FG001|Phase II|Adverse Event|0|||
156840963|NCT01959139|566169996|FG002|Phase II|Adverse Event|10|||
156840964|NCT01959139|566169997|FG003|Phase II|Adverse Event|11|||
156840965|NCT01959139|566169994|FG000|Phase II|Patient Refusal|0|||
156840966|NCT01959139|566169995|FG001|Phase II|Patient Refusal|0|||
156840967|NCT01959139|566169996|FG002|Phase II|Patient Refusal|5|||
156840968|NCT01959139|566169997|FG003|Phase II|Patient Refusal|4|||
156840969|NCT01959139|566169994|FG000|Phase II|Death|0|||
156840970|NCT01959139|566169995|FG001|Phase II|Death|0|||
156840971|NCT01959139|566169996|FG002|Phase II|Death|3|||
156840972|NCT01959139|566169997|FG003|Phase II|Death|1|||
156840973|NCT01959139|566169994|FG000|Phase II|Other/Unknown|0|||
156840974|NCT01959139|566169995|FG001|Phase II|Other/Unknown|0|||
156840975|NCT01959139|566169996|FG002|Phase II|Other/Unknown|8|||
156840976|NCT01959139|566169997|FG003|Phase II|Other/Unknown|5|||
156840977|NCT01959139|566169994|FG000|Phase II|On treatment|0|||
156840978|NCT01959139|566169995|FG001|Phase II|On treatment|0|||
156840979|NCT01959139|566169996|FG002|Phase II|On treatment|4|||
156840980|NCT01959139|566169997|FG003|Phase II|On treatment|0|||
156840981|NCT01378325|566170003|FG000|Overall Study|Protocol Violation|0|||
156840982|NCT01378325|566170004|FG001|Overall Study|Protocol Violation|1|||
156840983|NCT01559675|566170005|FG000|Overall Study|Protocol Violation|1|||
156840984|NCT01559675|566170006|FG001|Overall Study|Protocol Violation|2|||
156840985|NCT01559675|566170005|FG000|Overall Study|2nd operation on same patient excluded|14|||
156840986|NCT01559675|566170006|FG001|Overall Study|2nd operation on same patient excluded|12|||
156840987|NCT01496469|566170007|FG000|Overall Study|Adverse Event|1|||
156840988|NCT01496469|566170008|FG001|Overall Study|Adverse Event|0|||
156840989|NCT01496469|566170007|FG000|Overall Study|Protocol Violation|2|||
156840990|NCT01496469|566170008|FG001|Overall Study|Protocol Violation|0|||
156840991|NCT01496469|566170007|FG000|Overall Study|Lost to Follow-up|1|||
156840992|NCT01496469|566170008|FG001|Overall Study|Lost to Follow-up|1|||
156840993|NCT01496469|566170007|FG000|Overall Study|Withdrawal by Subject|4|||
156840994|NCT01496469|566170008|FG001|Overall Study|Withdrawal by Subject|4|||
156887220|NCT00992589|566347313|FG002|Open-Label Phase|Adverse Event|0|||
156887221|NCT00992589|566347314|FG003|Open-Label Phase|Adverse Event|0|||
156840995|NCT01496469|566170007|FG000|Overall Study|BP exceeds protocol limits|1|||
156840996|NCT01496469|566170008|FG001|Overall Study|BP exceeds protocol limits|2|||
156840997|NCT01496469|566170007|FG000|Overall Study|Other|1|||
156840998|NCT01496469|566170008|FG001|Overall Study|Other|1|||
156840999|NCT00193180|566170012|FG000|Overall Study|Lack of Efficacy|1|||
156887222|NCT00992589|566347311|FG000|Open-Label Phase|Withdrawal by Subject|20|||
156841000|NCT00193180|566170012|FG000|Overall Study|Adverse Event|8|||
156841001|NCT00193180|566170012|FG000|Overall Study|Protocol Violation|1|||
156841002|NCT02942485|566170013|FG000|Overall Study|Lost to Follow-up|1|||
156841003|NCT02942485|566170014|FG001|Overall Study|Lost to Follow-up|0|||
156841004|NCT04302545|566170021|FG000|Overall Study|Lost to Follow-up|3|||
156841005|NCT04302545|566170022|FG001|Overall Study|Lost to Follow-up|4|||
156841006|NCT01110382|566170024|FG000|Overall Study|Withdrawal by Subject|0|||
156841007|NCT01110382|566170025|FG001|Overall Study|Withdrawal by Subject|1|||
156841008|NCT01110382|566170024|FG000|Overall Study|Protocol Violation|0|||
156841009|NCT01110382|566170025|FG001|Overall Study|Protocol Violation|1|||
156841010|NCT00077649|566170026|FG000|Overall Study|Adverse Event|5|||
156841011|NCT00077649|566170027|FG001|Overall Study|Adverse Event|1|||
156841012|NCT00077649|566170028|FG002|Overall Study|Adverse Event|7|||
156841013|NCT00077649|566170029|FG003|Overall Study|Adverse Event|9|||
156841014|NCT00077649|566170026|FG000|Overall Study|Lack of Efficacy|5|||
156841015|NCT00077649|566170027|FG001|Overall Study|Lack of Efficacy|3|||
156841016|NCT00077649|566170028|FG002|Overall Study|Lack of Efficacy|3|||
156841017|NCT00077649|566170029|FG003|Overall Study|Lack of Efficacy|2|||
156841018|NCT00077649|566170026|FG000|Overall Study|Withdrawal by Subject|0|||
156841019|NCT00077649|566170027|FG001|Overall Study|Withdrawal by Subject|1|||
156841020|NCT00077649|566170028|FG002|Overall Study|Withdrawal by Subject|1|||
156841021|NCT00077649|566170029|FG003|Overall Study|Withdrawal by Subject|2|||
156841022|NCT00077649|566170026|FG000|Overall Study|Lost to Follow-up|2|||
156841023|NCT00077649|566170027|FG001|Overall Study|Lost to Follow-up|2|||
156841024|NCT00077649|566170028|FG002|Overall Study|Lost to Follow-up|3|||
156841025|NCT00077649|566170029|FG003|Overall Study|Lost to Follow-up|2|||
156841026|NCT00077649|566170026|FG000|Overall Study|Abnormality of Laboratory Test|1|||
156841027|NCT00077649|566170027|FG001|Overall Study|Abnormality of Laboratory Test|2|||
156841028|NCT00077649|566170028|FG002|Overall Study|Abnormality of Laboratory Test|1|||
156841029|NCT00077649|566170029|FG003|Overall Study|Abnormality of Laboratory Test|2|||
156841030|NCT00077649|566170026|FG000|Overall Study|Randomized but never dosed|1|||
156841031|NCT00077649|566170027|FG001|Overall Study|Randomized but never dosed|0|||
156841032|NCT00077649|566170028|FG002|Overall Study|Randomized but never dosed|0|||
156841033|NCT00077649|566170029|FG003|Overall Study|Randomized but never dosed|0|||
156841034|NCT00470418|566170030|FG000|Overall Study|Withdrawal by Subject|1|||
156841035|NCT00470418|566170031|FG001|Overall Study|Withdrawal by Subject|0|||
156841036|NCT03688100|566170036|FG000|Overall Study|Lost to Follow-up|21|||
156841037|NCT03688100|566170037|FG001|Overall Study|Lost to Follow-up|15|||
156841038|NCT03688100|566170038|FG002|Overall Study|Lost to Follow-up|15|||
156841039|NCT03688100|566170039|FG003|Overall Study|Lost to Follow-up|18|||
156841040|NCT03688100|566170036|FG000|Overall Study|Withdrawal by Subject|19|||
156841041|NCT03688100|566170037|FG001|Overall Study|Withdrawal by Subject|16|||
156841042|NCT03688100|566170038|FG002|Overall Study|Withdrawal by Subject|0|||
156841043|NCT03688100|566170039|FG003|Overall Study|Withdrawal by Subject|0|||
156841044|NCT03688100|566170036|FG000|Overall Study|Death|36|||
156841045|NCT03688100|566170037|FG001|Overall Study|Death|27|||
156841046|NCT03688100|566170038|FG002|Overall Study|Death|0|||
156841047|NCT03688100|566170039|FG003|Overall Study|Death|0|||
156841048|NCT02479139|566170045|FG000|Overall Study|Lost to Follow-up|2|||
156841049|NCT02479139|566170046|FG001|Overall Study|Lost to Follow-up|4|||
156841050|NCT02479139|566170047|FG002|Overall Study|Lost to Follow-up|4|||
156841051|NCT02479139|566170048|FG003|Overall Study|Lost to Follow-up|2|||
156841052|NCT02479139|566170049|FG004|Overall Study|Lost to Follow-up|3|||
156841053|NCT02479139|566170050|FG005|Overall Study|Lost to Follow-up|5|||
156841054|NCT02479139|566170045|FG000|Overall Study|Withdrew Consent|5|||
156841055|NCT02479139|566170046|FG001|Overall Study|Withdrew Consent|6|||
156841056|NCT02479139|566170047|FG002|Overall Study|Withdrew Consent|1|||
156841057|NCT02479139|566170048|FG003|Overall Study|Withdrew Consent|4|||
156841058|NCT02479139|566170049|FG004|Overall Study|Withdrew Consent|1|||
156841059|NCT02479139|566170050|FG005|Overall Study|Withdrew Consent|1|||
156841060|NCT02479139|566170045|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841061|NCT02479139|566170046|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841062|NCT02479139|566170047|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
156841063|NCT02479139|566170048|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841064|NCT02479139|566170049|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841065|NCT02479139|566170050|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
156841066|NCT02479139|566170045|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156841067|NCT02479139|566170046|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156841068|NCT02479139|566170047|FG002|Overall Study|Other Miscellaneous Reasons|1|||
156841069|NCT02479139|566170048|FG003|Overall Study|Other Miscellaneous Reasons|1|||
156841070|NCT02479139|566170049|FG004|Overall Study|Other Miscellaneous Reasons|1|||
156841071|NCT02479139|566170050|FG005|Overall Study|Other Miscellaneous Reasons|0|||
156841072|NCT00764673|566170051|FG000|Overall Study|Death|1|||
156841073|NCT00764673|566170051|FG000|Overall Study|Lost to Follow-up|3|||
156841074|NCT00764673|566170051|FG000|Overall Study|Withdrawal by Subject|6|||
156887223|NCT00992589|566347312|FG001|Open-Label Phase|Withdrawal by Subject|0|||
156887224|NCT00992589|566347313|FG002|Open-Label Phase|Withdrawal by Subject|0|||
156887225|NCT00992589|566347314|FG003|Open-Label Phase|Withdrawal by Subject|0|||
156841075|NCT00764673|566170051|FG000|Overall Study|Revision of Device|2|||
156841076|NCT01438177|566170052|FG000|Overall Study|Withdrawal by Subject|1|||
156841077|NCT01438177|566170052|FG000|Overall Study|Initiation of new therapy|1|||
156841078|NCT01727336|566170053|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841079|NCT01727336|566170054|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
156841080|NCT01727336|566170055|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
156841081|NCT01727336|566170056|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841082|NCT01727336|566170057|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841083|NCT01727336|566170058|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
156841084|NCT01727336|566170053|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
157024284|NCT01842542|566843206|FG000|Overall Study|Lack of Efficacy|1|||
157024285|NCT01842542|566843206|FG000|Overall Study|Protocol Non-compliance|2|||
157024286|NCT01842542|566843206|FG000|Overall Study|Lost to Follow-up|1|||
156841085|NCT01727336|566170054|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
156841086|NCT01727336|566170055|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
156841087|NCT01727336|566170056|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
156841088|NCT01727336|566170057|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
156841089|NCT01727336|566170058|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
157024287|NCT04473222|566843207|FG000|Overall Study|Lost to Follow-up|13|||
157024288|NCT04473222|566843208|FG001|Overall Study|Lost to Follow-up|13|||
157024289|NCT04473222|566843207|FG000|Overall Study|Withdrawal by Subject|0|||
157024290|NCT04473222|566843208|FG001|Overall Study|Withdrawal by Subject|1|||
157024291|NCT04473222|566843207|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
157024292|NCT04473222|566843208|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
157024293|NCT02919306|566843209|FG000|Overall Study|Withdrawal by Subject|1|||
157024294|NCT02919306|566843210|FG001|Overall Study|Withdrawal by Subject|0|||
157024295|NCT02919306|566843209|FG000|Overall Study|Protocol Violation|1|||
157024296|NCT02919306|566843210|FG001|Overall Study|Protocol Violation|0|||
157024297|NCT04293055|566843211|FG000|Overall Study|Lost to Follow-up|1|||
157024298|NCT04293055|566843212|FG001|Overall Study|Lost to Follow-up|1|||
157024299|NCT04293055|566843211|FG000|Overall Study|Did not trigger randomization|6|||
157024300|NCT04293055|566843212|FG001|Overall Study|Did not trigger randomization|5|||
157024301|NCT05006872|566843223|FG000|Overall Study|Lost to Follow-up|37|||
157024302|NCT05006872|566843224|FG001|Overall Study|Lost to Follow-up|31|||
157024303|NCT05499377|566843230|FG000|Overall Study|Withdrawal by Subject|2|||
157024304|NCT05499377|566843231|FG001|Overall Study|Withdrawal by Subject|0|||
157024305|NCT05499377|566843230|FG000|Overall Study|Physician Decision|1|||
157024306|NCT05499377|566843231|FG001|Overall Study|Physician Decision|0|||
157024307|NCT04149704|566843235|FG000|Three Month Follow-up|Death|2|||
157024308|NCT04149704|566843236|FG001|Three Month Follow-up|Death|0|||
157024309|NCT04149704|566843237|FG002|Three Month Follow-up|Death|0|||
157024310|NCT04149704|566843238|FG003|Three Month Follow-up|Death|0|||
157024311|NCT04149704|566843235|FG000|Three Month Follow-up|Lost to Follow-up|1|||
157024312|NCT04149704|566843236|FG001|Three Month Follow-up|Lost to Follow-up|4|||
157024313|NCT04149704|566843237|FG002|Three Month Follow-up|Lost to Follow-up|5|||
157024314|NCT04149704|566843238|FG003|Three Month Follow-up|Lost to Follow-up|5|||
157024315|NCT04149704|566843235|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
157024316|NCT04149704|566843236|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
157024317|NCT04149704|566843237|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
157024318|NCT04149704|566843238|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
157024319|NCT04149704|566843235|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
157024320|NCT04149704|566843236|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
157024321|NCT04149704|566843237|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
157024322|NCT04149704|566843238|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
157024323|NCT04332926|566843239|FG000|Overall Study|Withdrawal by Subject|6|||
157024324|NCT04332926|566843239|FG000|Overall Study|Physician Decision|6|||
157024325|NCT04652700|566843244|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
157024326|NCT04652700|566843245|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
157024327|NCT04652700|566843244|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
157024328|NCT04652700|566843245|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
157024329|NCT04652700|566843244|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
157024330|NCT04652700|566843245|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
157024331|NCT04652700|566843244|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
157024332|NCT04652700|566843245|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
157024333|NCT04652700|566843244|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
157024334|NCT04652700|566843245|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
157024335|NCT04652700|566843244|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
157024336|NCT04652700|566843245|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
157024337|NCT04652700|566843244|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
157024338|NCT04652700|566843245|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
157024339|NCT04652700|566843244|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
157024340|NCT04652700|566843245|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
156841090|NCT01727336|566170053|FG000|Part 2 Blinded|Death|0|||
156841091|NCT01727336|566170054|FG001|Part 2 Blinded|Death|0|||
157024341|NCT04652700|566843244|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
157024342|NCT04652700|566843245|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
157024343|NCT03097549|566843246|FG000|Overall Study|Withdrawal by Subject|1|||
156841092|NCT01727336|566170055|FG002|Part 2 Blinded|Death|0|||
156841093|NCT01727336|566170056|FG003|Part 2 Blinded|Death|0|||
157154885|NCT01165203|567311382|FG000|Active Phase|Serious Adverse Event|1|||
157154886|NCT01165203|567311383|FG001|Active Phase|Serious Adverse Event|0|||
157154887|NCT01165203|567311382|FG000|Active Phase|Withdrawal by Subject|2|||
156841094|NCT01727336|566170057|FG004|Part 2 Blinded|Death|20|||
156841095|NCT01727336|566170058|FG005|Part 2 Blinded|Death|16|||
156841096|NCT01727336|566170053|FG000|Part 2 Blinded|Lack of Efficacy|0|||
156841097|NCT01727336|566170054|FG001|Part 2 Blinded|Lack of Efficacy|0|||
156841098|NCT01727336|566170055|FG002|Part 2 Blinded|Lack of Efficacy|0|||
156887226|NCT00992589|566347311|FG000|Open-Label Phase|Lost to Follow-up|1|||
156887227|NCT00992589|566347312|FG001|Open-Label Phase|Lost to Follow-up|0|||
156887228|NCT00992589|566347313|FG002|Open-Label Phase|Lost to Follow-up|0|||
156887229|NCT00992589|566347314|FG003|Open-Label Phase|Lost to Follow-up|0|||
156887230|NCT00992589|566347311|FG000|Open-Label Phase|Protocol Violation|3|||
156887231|NCT00992589|566347312|FG001|Open-Label Phase|Protocol Violation|0|||
157224779|NCT02688400|567569872|FG001|Overall Study|No study medication intake|4|||
156887232|NCT00992589|566347313|FG002|Open-Label Phase|Protocol Violation|0|||
157154888|NCT01165203|567311383|FG001|Active Phase|Withdrawal by Subject|1|||
157154889|NCT01165203|567311382|FG000|Active Phase|Migrated/moved from study area|0|||
157154890|NCT01165203|567311383|FG001|Active Phase|Migrated/moved from study area|1|||
157154891|NCT01165203|567311382|FG000|Active Phase|Lost to Follow-up|2|||
157154892|NCT01165203|567311383|FG001|Active Phase|Lost to Follow-up|0|||
157154893|NCT01165203|567311382|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
157154894|NCT01165203|567311383|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
157154895|NCT01165203|567311382|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
157154896|NCT01165203|567311383|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
157154897|NCT01165203|567311382|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
157154898|NCT01165203|567311383|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
157154899|NCT01165203|567311382|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
157224780|NCT02688400|567569871|FG000|Overall Study|Lost to Follow-up|0|||
157224781|NCT02688400|567569872|FG001|Overall Study|Lost to Follow-up|3|||
157224782|NCT00992407|567569873|FG000|Overall Study|Protocol Violation|2|||
157224783|NCT00992407|567569874|FG001|Overall Study|Protocol Violation|1|||
157224784|NCT00992407|567569873|FG000|Overall Study|Lost to Follow-up|3|||
156841099|NCT01727336|566170056|FG003|Part 2 Blinded|Lack of Efficacy|0|||
156841100|NCT01727336|566170057|FG004|Part 2 Blinded|Lack of Efficacy|42|||
156841101|NCT01727336|566170058|FG005|Part 2 Blinded|Lack of Efficacy|44|||
156887233|NCT00992589|566347314|FG003|Open-Label Phase|Protocol Violation|0|||
156887234|NCT00992589|566347311|FG000|Open-Label Phase|Physician Decision|4|||
156887235|NCT00992589|566347312|FG001|Open-Label Phase|Physician Decision|0|||
156887236|NCT00992589|566347313|FG002|Open-Label Phase|Physician Decision|0|||
156887237|NCT00992589|566347314|FG003|Open-Label Phase|Physician Decision|0|||
156887238|NCT00992589|566347311|FG000|Open-Label Phase|Other|45|||
156887239|NCT00992589|566347312|FG001|Open-Label Phase|Other|0|||
156887240|NCT00992589|566347313|FG002|Open-Label Phase|Other|0|||
156887241|NCT00992589|566347314|FG003|Open-Label Phase|Other|0|||
156887242|NCT00992589|566347311|FG000|Double-Blind Phase|Adverse Event|0|||
156887243|NCT00992589|566347312|FG001|Double-Blind Phase|Adverse Event|6|||
156887244|NCT00992589|566347313|FG002|Double-Blind Phase|Adverse Event|2|||
156887245|NCT00992589|566347314|FG003|Double-Blind Phase|Adverse Event|3|||
156887246|NCT00992589|566347311|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156887247|NCT00992589|566347312|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
156887248|NCT00992589|566347313|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
156887249|NCT00992589|566347314|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
156887250|NCT00992589|566347311|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156887251|NCT00992589|566347312|FG001|Double-Blind Phase|Lost to Follow-up|0|||
156887252|NCT00992589|566347313|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156887253|NCT00992589|566347314|FG003|Double-Blind Phase|Lost to Follow-up|2|||
156887254|NCT00992589|566347311|FG000|Double-Blind Phase|Other|0|||
156887255|NCT00992589|566347312|FG001|Double-Blind Phase|Other|1|||
156887256|NCT00992589|566347313|FG002|Double-Blind Phase|Other|6|||
156841102|NCT01727336|566170053|FG000|Part 2 Blinded|Lost to Follow-up|0|||
156887257|NCT00992589|566347314|FG003|Double-Blind Phase|Other|3|||
156887258|NCT02142387|566347315|FG000|Overall Study|<19 years old|49|||
157154900|NCT01165203|567311383|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
157154901|NCT01165203|567311382|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
156841103|NCT01727336|566170054|FG001|Part 2 Blinded|Lost to Follow-up|0|||
156841104|NCT01727336|566170055|FG002|Part 2 Blinded|Lost to Follow-up|0|||
156841105|NCT01727336|566170056|FG003|Part 2 Blinded|Lost to Follow-up|0|||
156841106|NCT01727336|566170057|FG004|Part 2 Blinded|Lost to Follow-up|0|||
156887259|NCT02142387|566347316|FG001|Overall Study|<19 years old|326|||
156887260|NCT02142387|566347315|FG000|Overall Study|non-cardiac etiology|504|||
156887261|NCT02142387|566347316|FG001|Overall Study|non-cardiac etiology|3431|||
156887262|NCT02142387|566347315|FG000|Overall Study|CPR not performed|74|||
156887263|NCT02142387|566347316|FG001|Overall Study|CPR not performed|473|||
156887264|NCT02142387|566347315|FG000|Overall Study|witnessed by paramedic|139|||
156841107|NCT01727336|566170058|FG005|Part 2 Blinded|Lost to Follow-up|1|||
156841108|NCT01727336|566170053|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
156841109|NCT01727336|566170054|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
156841110|NCT01727336|566170055|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
156841111|NCT01727336|566170056|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
156841112|NCT01727336|566170057|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
156841113|NCT01727336|566170058|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
156841114|NCT01727336|566170053|FG000|Part 2 Blinded|use of prohibited medications|0|||
156841115|NCT01727336|566170054|FG001|Part 2 Blinded|use of prohibited medications|0|||
156841116|NCT01727336|566170055|FG002|Part 2 Blinded|use of prohibited medications|0|||
156841117|NCT01727336|566170056|FG003|Part 2 Blinded|use of prohibited medications|0|||
156841118|NCT01727336|566170057|FG004|Part 2 Blinded|use of prohibited medications|1|||
156841119|NCT01727336|566170058|FG005|Part 2 Blinded|use of prohibited medications|3|||
156841120|NCT00084656|566170061|FG000|Overall Study|Other reasons|0|||
156841121|NCT00084656|566170062|FG001|Overall Study|Other reasons|12|||
156841122|NCT00084656|566170063|FG002|Overall Study|Other reasons|11|||
156841123|NCT00084656|566170061|FG000|Overall Study|Withdrawal by Subject|15|||
156841124|NCT00084656|566170062|FG001|Overall Study|Withdrawal by Subject|4|||
156841125|NCT00084656|566170063|FG002|Overall Study|Withdrawal by Subject|4|||
156841126|NCT00084656|566170061|FG000|Overall Study|Disease relapse|0|||
156841127|NCT00084656|566170062|FG001|Overall Study|Disease relapse|9|||
156841128|NCT00084656|566170063|FG002|Overall Study|Disease relapse|10|||
156841129|NCT00084656|566170061|FG000|Overall Study|Disease progression|9|||
156841130|NCT00084656|566170062|FG001|Overall Study|Disease progression|0|||
156841131|NCT00084656|566170063|FG002|Overall Study|Disease progression|0|||
156841132|NCT00084656|566170061|FG000|Overall Study|Lost to Follow-up|1|||
156841133|NCT00084656|566170062|FG001|Overall Study|Lost to Follow-up|0|||
156841134|NCT00084656|566170063|FG002|Overall Study|Lost to Follow-up|1|||
156841135|NCT02772978|566170064|FG000|Overall Study|Withdrawal by Subject|1|||
156841136|NCT02772978|566170065|FG001|Overall Study|Withdrawal by Subject|1|||
156841137|NCT01331291|566170066|FG000|Overall Study|Lack of Efficacy|2|||
156841138|NCT01331291|566170067|FG001|Overall Study|Lack of Efficacy|8|||
156841139|NCT01331291|566170066|FG000|Overall Study|Death|0|||
156841140|NCT01331291|566170067|FG001|Overall Study|Death|1|||
156841141|NCT01026220|566170068|FG000|Induction|Death|1|||
156841142|NCT01026220|566170069|FG001|Induction|Death|0|||
156841143|NCT01026220|566170070|FG002|Induction|Death|0|||
156841144|NCT01026220|566170068|FG000|Induction|Lack of Efficacy|2|||
156841145|NCT01026220|566170069|FG001|Induction|Lack of Efficacy|0|||
156841146|NCT01026220|566170070|FG002|Induction|Lack of Efficacy|0|||
156841147|NCT01026220|566170068|FG000|Induction|Physician Decision|12|||
156841148|NCT01026220|566170069|FG001|Induction|Physician Decision|0|||
156841149|NCT01026220|566170070|FG002|Induction|Physician Decision|0|||
156841150|NCT01026220|566170068|FG000|Induction|Withdrawal by Subject|9|||
156841151|NCT01026220|566170069|FG001|Induction|Withdrawal by Subject|0|||
156841152|NCT01026220|566170070|FG002|Induction|Withdrawal by Subject|0|||
156841153|NCT01026220|566170068|FG000|Induction|Ineligible|1|||
156841154|NCT01026220|566170069|FG001|Induction|Ineligible|0|||
156841155|NCT01026220|566170070|FG002|Induction|Ineligible|0|||
156841156|NCT01026220|566170068|FG000|Consolidation Maintenance|Death|0|||
156841157|NCT01026220|566170069|FG001|Consolidation Maintenance|Death|1|||
156841158|NCT01026220|566170070|FG002|Consolidation Maintenance|Death|0|||
156841159|NCT01026220|566170068|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
156841160|NCT01026220|566170069|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
156841161|NCT01026220|566170070|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
156841162|NCT01026220|566170068|FG000|Consolidation Maintenance|Physician Decision|0|||
156841163|NCT01026220|566170069|FG001|Consolidation Maintenance|Physician Decision|2|||
156841164|NCT01026220|566170070|FG002|Consolidation Maintenance|Physician Decision|7|||
156887265|NCT02142387|566347316|FG001|Overall Study|witnessed by paramedic|917|||
156841165|NCT01026220|566170068|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
156841166|NCT01026220|566170069|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
156841167|NCT01026220|566170070|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
156841168|NCT00409344|566170074|FG000|Overall Study|no enrollment|0|||
156841169|NCT00409344|566170075|FG001|Overall Study|no enrollment|0|||
156841170|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
156841171|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
156841172|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
156841173|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
156841174|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
156841175|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
156887266|NCT02142387|566347315|FG000|Overall Study|incomplete data|1|||
156887267|NCT02142387|566347316|FG001|Overall Study|incomplete data|9|||
156887268|NCT02142387|566347315|FG000|Overall Study|occurred not at home|298|||
156841176|NCT01389323|566170081|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
156841177|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
156841178|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
156841179|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
156841180|NCT01389323|566170081|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
156841181|NCT04033068|566170082|FG000|Overall Study|Withdrawal by Subject|0|||
156841182|NCT04033068|566170083|FG001|Overall Study|Withdrawal by Subject|0|||
156841183|NCT04033068|566170084|FG002|Overall Study|Withdrawal by Subject|1|||
156841184|NCT04033068|566170085|FG003|Overall Study|Withdrawal by Subject|0|||
156841185|NCT04033068|566170082|FG000|Overall Study|Lost to Follow-up|0|||
157024344|NCT03097549|566843247|FG001|Overall Study|Withdrawal by Subject|0|||
157024345|NCT03097549|566843246|FG000|Overall Study|Lost to Follow-up|1|||
157024346|NCT03097549|566843247|FG001|Overall Study|Lost to Follow-up|0|||
157024347|NCT01824537|566843250|FG000|Overall Study|Lost to Follow-up|78|||
157024348|NCT01824537|566843251|FG001|Overall Study|Lost to Follow-up|87|||
157024349|NCT04282148|566843252|FG000|Overall Study|Death|7|||
157024350|NCT04282148|566843252|FG000|Overall Study|Withdrawal by Subject|1|||
157024351|NCT04282148|566843252|FG000|Overall Study|Physician Decision|1|||
157024352|NCT06215521|566843253|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
157024353|NCT06215521|566843254|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
157024354|NCT06215521|566843255|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
157024355|NCT06215521|566843256|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
157024356|NCT06215521|566843257|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
157024357|NCT06215521|566843258|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
157024358|NCT04096040|566843259|FG000|Overall Study|Protocol Violation|12|||
157024359|NCT04096040|566843259|FG000|Overall Study|Non-compliant site|4|||
157024360|NCT04973254|566843260|FG000|Overall Study|Not adherent|0|||
157024361|NCT04973254|566843261|FG001|Overall Study|Not adherent|1|||
157024362|NCT04973254|566843262|FG002|Overall Study|Not adherent|0|||
157024363|NCT04044768|566843263|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
157024364|NCT04044768|566843264|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
157024365|NCT05089019|566843265|FG000|Period 1|Withdrawal by Subject|0|||
157024366|NCT05089019|566843266|FG001|Period 1|Withdrawal by Subject|1|||
157024367|NCT05089019|566843265|FG000|Washout Period|Adverse Event|3|||
157024368|NCT05089019|566843266|FG001|Washout Period|Adverse Event|4|||
157024369|NCT05089019|566843265|FG000|Washout Period|Lost to Follow-up|1|||
157024370|NCT05089019|566843266|FG001|Washout Period|Lost to Follow-up|0|||
157024371|NCT05089019|566843265|FG000|Washout Period|Physician Decision|2|||
157024372|NCT05089019|566843266|FG001|Washout Period|Physician Decision|0|||
157024373|NCT05089019|566843265|FG000|Washout Period|Withdrawal by Subject|6|||
157024374|NCT05089019|566843266|FG001|Washout Period|Withdrawal by Subject|3|||
157024375|NCT05089019|566843265|FG000|Period 2|Adverse Event|4|||
157024376|NCT05089019|566843266|FG001|Period 2|Adverse Event|2|||
157024377|NCT05089019|566843265|FG000|Period 2|Lost to Follow-up|1|||
157024378|NCT05089019|566843266|FG001|Period 2|Lost to Follow-up|0|||
157024379|NCT05089019|566843265|FG000|Period 2|Withdrawal by Subject|0|||
157024380|NCT05089019|566843266|FG001|Period 2|Withdrawal by Subject|1|||
157024381|NCT05170009|566843267|FG000|Overall Study|Physician Decision|0|||
157024382|NCT05170009|566843268|FG001|Overall Study|Physician Decision|1|||
157024383|NCT04925986|566843269|FG000|Overall Study|Death|0|||
157024384|NCT04925986|566843270|FG001|Overall Study|Death|0|||
157024385|NCT04925986|566843271|FG002|Overall Study|Death|2|||
157024386|NCT04925986|566843272|FG003|Overall Study|Death|0|||
157024387|NCT04925986|566843269|FG000|Overall Study|Lack of Efficacy|1|||
157024388|NCT04925986|566843270|FG001|Overall Study|Lack of Efficacy|2|||
157024389|NCT04925986|566843271|FG002|Overall Study|Lack of Efficacy|0|||
157024390|NCT04925986|566843272|FG003|Overall Study|Lack of Efficacy|1|||
157024391|NCT04925986|566843269|FG000|Overall Study|Withdrawal by Subject|0|||
157024392|NCT04925986|566843270|FG001|Overall Study|Withdrawal by Subject|0|||
157224785|NCT00992407|567569874|FG001|Overall Study|Lost to Follow-up|3|||
156841186|NCT04033068|566170083|FG001|Overall Study|Lost to Follow-up|1|||
156841187|NCT04033068|566170084|FG002|Overall Study|Lost to Follow-up|0|||
156841188|NCT04033068|566170085|FG003|Overall Study|Lost to Follow-up|0|||
156841189|NCT04033068|566170082|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841190|NCT04033068|566170083|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841191|NCT04033068|566170084|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
156841192|NCT04033068|566170085|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
156841193|NCT01717326|566170086|FG000|Overall Study|Death|0|||
156841194|NCT01717326|566170087|FG001|Overall Study|Death|0|||
156841195|NCT01717326|566170088|FG002|Overall Study|Death|0|||
156841196|NCT01717326|566170089|FG003|Overall Study|Death|0|||
156841197|NCT01717326|566170090|FG004|Overall Study|Death|0|||
156841198|NCT01717326|566170091|FG005|Overall Study|Death|0|||
156841199|NCT01717326|566170092|FG006|Overall Study|Death|0|||
156841200|NCT01717326|566170093|FG007|Overall Study|Death|0|||
156841201|NCT01717326|566170094|FG008|Overall Study|Death|0|||
156841202|NCT01717326|566170095|FG009|Overall Study|Death|0|||
157024393|NCT04925986|566843271|FG002|Overall Study|Withdrawal by Subject|1|||
157024394|NCT04925986|566843272|FG003|Overall Study|Withdrawal by Subject|2|||
157024395|NCT03808818|566843273|FG000|Overall Study|Death|6|||
157024396|NCT03808818|566843274|FG001|Overall Study|Death|6|||
157024397|NCT03808818|566843273|FG000|Overall Study|Withdrawal by Subject|7|||
156841203|NCT01717326|566170096|FG010|Overall Study|Death|1|||
156841204|NCT01717326|566170097|FG011|Overall Study|Death|0|||
156841205|NCT01717326|566170098|FG012|Overall Study|Death|0|||
156841206|NCT01717326|566170099|FG013|Overall Study|Death|0|||
156841207|NCT01717326|566170100|FG014|Overall Study|Death|0|||
156841208|NCT01717326|566170101|FG015|Overall Study|Death|0|||
156841209|NCT01717326|566170102|FG016|Overall Study|Death|0|||
156841210|NCT01717326|566170103|FG017|Overall Study|Death|0|||
156841211|NCT01717326|566170104|FG018|Overall Study|Death|0|||
156841212|NCT01717326|566170105|FG019|Overall Study|Death|0|||
156841213|NCT01717326|566170086|FG000|Overall Study|Lost to Follow-up|3|||
156841214|NCT01717326|566170087|FG001|Overall Study|Lost to Follow-up|0|||
156841215|NCT01717326|566170088|FG002|Overall Study|Lost to Follow-up|0|||
156841216|NCT01717326|566170089|FG003|Overall Study|Lost to Follow-up|2|||
156841217|NCT01717326|566170090|FG004|Overall Study|Lost to Follow-up|1|||
156841218|NCT01717326|566170091|FG005|Overall Study|Lost to Follow-up|0|||
156841219|NCT01717326|566170092|FG006|Overall Study|Lost to Follow-up|1|||
156841220|NCT01717326|566170093|FG007|Overall Study|Lost to Follow-up|0|||
156841221|NCT01717326|566170094|FG008|Overall Study|Lost to Follow-up|0|||
156841222|NCT01717326|566170095|FG009|Overall Study|Lost to Follow-up|0|||
156841223|NCT01717326|566170096|FG010|Overall Study|Lost to Follow-up|1|||
156841224|NCT01717326|566170097|FG011|Overall Study|Lost to Follow-up|0|||
156841225|NCT01717326|566170098|FG012|Overall Study|Lost to Follow-up|0|||
156841226|NCT01717326|566170099|FG013|Overall Study|Lost to Follow-up|0|||
156841227|NCT01717326|566170100|FG014|Overall Study|Lost to Follow-up|0|||
156841228|NCT01717326|566170101|FG015|Overall Study|Lost to Follow-up|2|||
156841229|NCT01717326|566170102|FG016|Overall Study|Lost to Follow-up|1|||
156841230|NCT01717326|566170103|FG017|Overall Study|Lost to Follow-up|0|||
156841231|NCT01717326|566170104|FG018|Overall Study|Lost to Follow-up|2|||
156841232|NCT01717326|566170105|FG019|Overall Study|Lost to Follow-up|3|||
156841233|NCT01717326|566170086|FG000|Overall Study|Physician Decision|0|||
156887269|NCT02142387|566347316|FG001|Overall Study|occurred not at home|2474|||
156887270|NCT01895361|566347320|FG000|Overall Study|Adverse Event|1|||
156887271|NCT01895361|566347321|FG001|Overall Study|Adverse Event|1|||
156887272|NCT01895361|566347322|FG002|Overall Study|Adverse Event|3|||
156887273|NCT01895361|566347320|FG000|Overall Study|Death|2|||
156887274|NCT01895361|566347321|FG001|Overall Study|Death|1|||
156887275|NCT01895361|566347322|FG002|Overall Study|Death|2|||
156887276|NCT01895361|566347320|FG000|Overall Study|Lost to Follow-up|4|||
156887277|NCT01895361|566347321|FG001|Overall Study|Lost to Follow-up|4|||
156887278|NCT01895361|566347322|FG002|Overall Study|Lost to Follow-up|6|||
156887279|NCT01895361|566347320|FG000|Overall Study|Non-compliance with study|1|||
156887280|NCT01895361|566347321|FG001|Overall Study|Non-compliance with study|3|||
156887281|NCT01895361|566347322|FG002|Overall Study|Non-compliance with study|1|||
156887282|NCT01895361|566347320|FG000|Overall Study|Physician Decision|2|||
156887283|NCT01895361|566347321|FG001|Overall Study|Physician Decision|2|||
156887284|NCT01895361|566347322|FG002|Overall Study|Physician Decision|2|||
156887285|NCT01895361|566347320|FG000|Overall Study|Withdrawal by Subject|7|||
156887286|NCT01895361|566347321|FG001|Overall Study|Withdrawal by Subject|6|||
156887287|NCT01895361|566347322|FG002|Overall Study|Withdrawal by Subject|6|||
156887288|NCT01895361|566347320|FG000|Overall Study|Lack of Efficacy|0|||
156887289|NCT01895361|566347321|FG001|Overall Study|Lack of Efficacy|1|||
156887290|NCT01895361|566347322|FG002|Overall Study|Lack of Efficacy|0|||
156887291|NCT01895361|566347320|FG000|Overall Study|Reasons different from categories above|7|||
156887292|NCT01895361|566347321|FG001|Overall Study|Reasons different from categories above|3|||
156887293|NCT01895361|566347322|FG002|Overall Study|Reasons different from categories above|4|||
156887294|NCT01268579|566347326|FG000|Overall Study|Adverse Event|1|||
156887295|NCT01268579|566347326|FG000|Overall Study|Withdrawal by Subject|2|||
157024398|NCT03808818|566843274|FG001|Overall Study|Withdrawal by Subject|18|||
157024399|NCT03808818|566843273|FG000|Overall Study|Lost to Follow-up|31|||
156887296|NCT01209832|566347327|FG000|Period 1|Sponsor Decision and was not dosed|1|||
156887297|NCT01209832|566347327|FG000|Period 2|Sponsor Decision|1|||
157024400|NCT03808818|566843274|FG001|Overall Study|Lost to Follow-up|33|||
157024401|NCT03858634|566843275|FG000|Overall Study|Withdrawal by Subject|1|||
157154902|NCT01165203|567311383|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
156841234|NCT01717326|566170087|FG001|Overall Study|Physician Decision|0|||
156841235|NCT01717326|566170088|FG002|Overall Study|Physician Decision|0|||
156841236|NCT01717326|566170089|FG003|Overall Study|Physician Decision|0|||
156841237|NCT01717326|566170090|FG004|Overall Study|Physician Decision|0|||
156887298|NCT02158364|566347340|FG000|Overall Study|Case report forms uncollected|10|||
156887299|NCT02158364|566347340|FG000|Overall Study|Protocol Deviation|50|||
156887300|NCT02514473|566347341|FG000|Overall Study|Adverse Event|0|||
156887301|NCT02514473|566347342|FG001|Overall Study|Adverse Event|2|||
156841238|NCT01717326|566170091|FG005|Overall Study|Physician Decision|0|||
156841239|NCT01717326|566170092|FG006|Overall Study|Physician Decision|0|||
156841240|NCT01717326|566170093|FG007|Overall Study|Physician Decision|0|||
156841241|NCT01717326|566170094|FG008|Overall Study|Physician Decision|0|||
156841242|NCT01717326|566170095|FG009|Overall Study|Physician Decision|1|||
156841243|NCT01717326|566170096|FG010|Overall Study|Physician Decision|0|||
156841244|NCT01717326|566170097|FG011|Overall Study|Physician Decision|0|||
157024402|NCT03858634|566843276|FG001|Overall Study|Withdrawal by Subject|0|||
157024403|NCT03858634|566843275|FG000|Overall Study|Adverse Event|1|||
157024404|NCT03858634|566843276|FG001|Overall Study|Adverse Event|0|||
157024405|NCT03858634|566843275|FG000|Overall Study|Lost to Follow-up|0|||
157024406|NCT03858634|566843276|FG001|Overall Study|Lost to Follow-up|1|||
157024407|NCT03858634|566843275|FG000|Overall Study|Other, Not Specified|1|||
157024408|NCT03858634|566843276|FG001|Overall Study|Other, Not Specified|1|||
157024409|NCT05415722|566843277|FG000|Overall Study|Lost to Follow-up|0|||
157024410|NCT05415722|566843278|FG001|Overall Study|Lost to Follow-up|2|||
157024411|NCT05415722|566843279|FG002|Overall Study|Lost to Follow-up|0|||
157024412|NCT05415722|566843280|FG003|Overall Study|Lost to Follow-up|1|||
157024413|NCT05415722|566843281|FG004|Overall Study|Lost to Follow-up|0|||
157024414|NCT05415722|566843282|FG005|Overall Study|Lost to Follow-up|0|||
157024415|NCT05415722|566843283|FG006|Overall Study|Lost to Follow-up|1|||
157024416|NCT05415722|566843277|FG000|Overall Study|Physician Decision|0|||
157024417|NCT05415722|566843278|FG001|Overall Study|Physician Decision|0|||
157024418|NCT05415722|566843279|FG002|Overall Study|Physician Decision|0|||
157024419|NCT05415722|566843280|FG003|Overall Study|Physician Decision|1|||
157024420|NCT05415722|566843281|FG004|Overall Study|Physician Decision|0|||
157024421|NCT05415722|566843282|FG005|Overall Study|Physician Decision|0|||
157024422|NCT05415722|566843283|FG006|Overall Study|Physician Decision|1|||
157024423|NCT05415722|566843277|FG000|Overall Study|Protocol Violation|0|||
157024424|NCT05415722|566843278|FG001|Overall Study|Protocol Violation|0|||
157024425|NCT05415722|566843279|FG002|Overall Study|Protocol Violation|0|||
157024426|NCT05415722|566843280|FG003|Overall Study|Protocol Violation|1|||
157024427|NCT05415722|566843281|FG004|Overall Study|Protocol Violation|0|||
157024428|NCT05415722|566843282|FG005|Overall Study|Protocol Violation|0|||
157024429|NCT05415722|566843283|FG006|Overall Study|Protocol Violation|0|||
157024430|NCT05415722|566843277|FG000|Overall Study|Sponsor Discretion|0|||
157024431|NCT05415722|566843278|FG001|Overall Study|Sponsor Discretion|0|||
157024432|NCT05415722|566843279|FG002|Overall Study|Sponsor Discretion|0|||
157024433|NCT05415722|566843280|FG003|Overall Study|Sponsor Discretion|0|||
157024434|NCT05415722|566843281|FG004|Overall Study|Sponsor Discretion|1|||
157024435|NCT05415722|566843282|FG005|Overall Study|Sponsor Discretion|1|||
157024436|NCT05415722|566843283|FG006|Overall Study|Sponsor Discretion|0|||
157024437|NCT05415722|566843277|FG000|Overall Study|Withdrawal by Subject|0|||
157024438|NCT05415722|566843278|FG001|Overall Study|Withdrawal by Subject|1|||
157024439|NCT05415722|566843279|FG002|Overall Study|Withdrawal by Subject|0|||
157024440|NCT05415722|566843280|FG003|Overall Study|Withdrawal by Subject|1|||
157024441|NCT05415722|566843281|FG004|Overall Study|Withdrawal by Subject|1|||
157024442|NCT05415722|566843282|FG005|Overall Study|Withdrawal by Subject|0|||
157024443|NCT05415722|566843283|FG006|Overall Study|Withdrawal by Subject|1|||
157024444|NCT04537715|566843285|FG000|Overall Study|Death|3|||
157024445|NCT04537715|566843286|FG001|Overall Study|Death|1|||
157024446|NCT04537715|566843285|FG000|Overall Study|Withdrawal by Subject|3|||
157024447|NCT04537715|566843286|FG001|Overall Study|Withdrawal by Subject|1|||
157024448|NCT04537715|566843285|FG000|Overall Study|Other|4|||
157024449|NCT04537715|566843286|FG001|Overall Study|Other|3|||
157024450|NCT04537715|566843285|FG000|Overall Study|Progressive disease|1|||
157024451|NCT04537715|566843286|FG001|Overall Study|Progressive disease|0|||
157024452|NCT03448107|566843287|FG000|Overall Study|Lost to Follow-up|229|||
157024453|NCT03448107|566843288|FG001|Overall Study|Lost to Follow-up|258|||
157024454|NCT04700163|566843289|FG000|Overall Study|Lost to Follow-up|0|||
157024455|NCT04700163|566843290|FG001|Overall Study|Lost to Follow-up|0|||
157024456|NCT04700163|566843291|FG002|Overall Study|Lost to Follow-up|0|||
157024457|NCT04700163|566843292|FG003|Overall Study|Lost to Follow-up|0|||
157154903|NCT02815397|567311387|FG000|Overall Study|Physician Decision|2|||
157154904|NCT00085540|567311388|FG000|Overall Study|Withdrawal by Subject|0|||
157024458|NCT04700163|566843293|FG004|Overall Study|Lost to Follow-up|0|||
157024459|NCT04700163|566843294|FG005|Overall Study|Lost to Follow-up|1|||
157024460|NCT05543629|566843301|FG000|Overall Study|Death|1|||
157024461|NCT05543629|566843302|FG001|Overall Study|Death|0|||
157024462|NCT05543629|566843303|FG002|Overall Study|Death|1|||
157154905|NCT00085540|567311389|FG001|Overall Study|Withdrawal by Subject|1|||
157154906|NCT00085540|567311388|FG000|Overall Study|Protocol Violation|0|||
157024463|NCT05543629|566843304|FG003|Overall Study|Death|0|||
157024464|NCT05543629|566843305|FG004|Overall Study|Death|0|||
157024465|NCT05543629|566843306|FG005|Overall Study|Death|1|||
157024466|NCT05543629|566843307|FG006|Overall Study|Death|2|||
157024467|NCT05543629|566843308|FG007|Overall Study|Death|2|||
157024468|NCT05543629|566843301|FG000|Overall Study|Other Reasons|0|||
157024469|NCT05543629|566843302|FG001|Overall Study|Other Reasons|0|||
157024470|NCT05543629|566843303|FG002|Overall Study|Other Reasons|0|||
157154907|NCT00085540|567311389|FG001|Overall Study|Protocol Violation|1|||
157024471|NCT05543629|566843304|FG003|Overall Study|Other Reasons|0|||
157024472|NCT05543629|566843305|FG004|Overall Study|Other Reasons|1|||
157024473|NCT05543629|566843306|FG005|Overall Study|Other Reasons|0|||
157024474|NCT05543629|566843307|FG006|Overall Study|Other Reasons|0|||
157024475|NCT05543629|566843308|FG007|Overall Study|Other Reasons|0|||
157024476|NCT05543629|566843301|FG000|Overall Study|Physician Decision|0|||
157024477|NCT05543629|566843302|FG001|Overall Study|Physician Decision|0|||
157024478|NCT05543629|566843303|FG002|Overall Study|Physician Decision|3|||
157024479|NCT05543629|566843304|FG003|Overall Study|Physician Decision|0|||
157024480|NCT05543629|566843305|FG004|Overall Study|Physician Decision|0|||
157024481|NCT05543629|566843306|FG005|Overall Study|Physician Decision|0|||
157024482|NCT05543629|566843307|FG006|Overall Study|Physician Decision|1|||
157024483|NCT05543629|566843308|FG007|Overall Study|Physician Decision|0|||
157024484|NCT05543629|566843301|FG000|Overall Study|Study terminated by Sponsor|1|||
157024485|NCT05543629|566843302|FG001|Overall Study|Study terminated by Sponsor|0|||
157024486|NCT05543629|566843303|FG002|Overall Study|Study terminated by Sponsor|0|||
157024487|NCT05543629|566843304|FG003|Overall Study|Study terminated by Sponsor|1|||
157024488|NCT05543629|566843305|FG004|Overall Study|Study terminated by Sponsor|0|||
157024489|NCT05543629|566843306|FG005|Overall Study|Study terminated by Sponsor|4|||
157024490|NCT05543629|566843307|FG006|Overall Study|Study terminated by Sponsor|1|||
157024491|NCT05543629|566843308|FG007|Overall Study|Study terminated by Sponsor|0|||
157024492|NCT05543629|566843301|FG000|Overall Study|Withdrawal by Subject|1|||
157024493|NCT05543629|566843302|FG001|Overall Study|Withdrawal by Subject|1|||
157024494|NCT05543629|566843303|FG002|Overall Study|Withdrawal by Subject|0|||
157024495|NCT05543629|566843304|FG003|Overall Study|Withdrawal by Subject|2|||
157024496|NCT05543629|566843305|FG004|Overall Study|Withdrawal by Subject|1|||
157024497|NCT05543629|566843306|FG005|Overall Study|Withdrawal by Subject|1|||
157024498|NCT05543629|566843307|FG006|Overall Study|Withdrawal by Subject|1|||
157024499|NCT05543629|566843308|FG007|Overall Study|Withdrawal by Subject|1|||
157024500|NCT05543629|566843301|FG000|Overall Study|Not Reported|2|||
157024501|NCT05543629|566843302|FG001|Overall Study|Not Reported|2|||
157024502|NCT05543629|566843303|FG002|Overall Study|Not Reported|0|||
157024503|NCT05543629|566843304|FG003|Overall Study|Not Reported|0|||
157024504|NCT05543629|566843305|FG004|Overall Study|Not Reported|1|||
157024505|NCT05543629|566843306|FG005|Overall Study|Not Reported|1|||
157024506|NCT05543629|566843307|FG006|Overall Study|Not Reported|3|||
157024507|NCT05543629|566843308|FG007|Overall Study|Not Reported|0|||
157024508|NCT04568603|566843309|FG000|Overall Study|Physician Decision|1|||
157024509|NCT01799265|566843312|FG000|Overall Study|Lost to Follow-up|1|||
157024510|NCT01799265|566843313|FG001|Overall Study|Lost to Follow-up|0|||
157024511|NCT01799265|566843312|FG000|Overall Study|Protocol Violation|2|||
157024512|NCT01799265|566843313|FG001|Overall Study|Protocol Violation|1|||
157024513|NCT01799265|566843312|FG000|Overall Study|inadequate sleep study|0|||
157024514|NCT01799265|566843313|FG001|Overall Study|inadequate sleep study|2|||
157024515|NCT03084536|566843317|FG000|Overall Study|Determined to be ineligible|0|||
157024516|NCT03084536|566843318|FG001|Overall Study|Determined to be ineligible|0|||
157024517|NCT03084536|566843319|FG002|Overall Study|Determined to be ineligible|16|||
157024518|NCT03084536|566843317|FG000|Overall Study|Withdrawal by Subject|0|||
157024519|NCT03084536|566843318|FG001|Overall Study|Withdrawal by Subject|0|||
157024520|NCT03084536|566843319|FG002|Overall Study|Withdrawal by Subject|4|||
157024521|NCT03084536|566843317|FG000|Overall Study|Physician Decision|0|||
157024522|NCT03084536|566843318|FG001|Overall Study|Physician Decision|0|||
157024523|NCT03084536|566843319|FG002|Overall Study|Physician Decision|3|||
157024524|NCT03084536|566843317|FG000|Overall Study|Death|0|||
157024525|NCT03084536|566843318|FG001|Overall Study|Death|0|||
157024526|NCT03084536|566843319|FG002|Overall Study|Death|1|||
157024527|NCT03084536|566843317|FG000|Overall Study|Lost to Follow-up|0|||
157024528|NCT03084536|566843318|FG001|Overall Study|Lost to Follow-up|0|||
157024529|NCT03084536|566843319|FG002|Overall Study|Lost to Follow-up|1|||
157024530|NCT03084536|566843317|FG000|Overall Study|Protocol Violation|0|||
157024531|NCT03084536|566843318|FG001|Overall Study|Protocol Violation|0|||
157024532|NCT03084536|566843319|FG002|Overall Study|Protocol Violation|1|||
157024533|NCT03084536|566843317|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
157024534|NCT03084536|566843318|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
157024535|NCT03084536|566843319|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
157024536|NCT05351554|566843329|FG000|Overall Study|Study terminated by sponsor|1|||
157024537|NCT05030233|566843330|FG000|Overall Study|withdrawn for transfer|1|||
157024538|NCT05030233|566843331|FG001|Overall Study|withdrawn for transfer|0|||
157024539|NCT04342494|566845387|FG000|Overall Study|Questionnaire partially completed|1|||
157024540|NCT04342494|566845388|FG001|Overall Study|Questionnaire partially completed|0|||
157024541|NCT04342494|566845389|FG002|Overall Study|Questionnaire partially completed|2|||
156887302|NCT02514473|566347341|FG000|Overall Study|Withdrawal by Subject|2|||
157024542|NCT04342494|566845390|FG003|Overall Study|Questionnaire partially completed|0|||
157024543|NCT04342494|566845391|FG004|Overall Study|Questionnaire partially completed|1|||
157024544|NCT04342494|566845387|FG000|Overall Study|Lost to Follow-up|49|||
157024545|NCT04342494|566845388|FG001|Overall Study|Lost to Follow-up|38|||
157024546|NCT04342494|566845389|FG002|Overall Study|Lost to Follow-up|34|||
157024547|NCT04342494|566845390|FG003|Overall Study|Lost to Follow-up|34|||
157024548|NCT04342494|566845391|FG004|Overall Study|Lost to Follow-up|35|||
157024549|NCT06190691|566845402|FG000|Overall Study|Adverse Event|2|||
157024550|NCT06190691|566845403|FG001|Overall Study|Adverse Event|0|||
157024551|NCT06190691|566845404|FG002|Overall Study|Adverse Event|0|||
157024552|NCT06190691|566845405|FG003|Overall Study|Adverse Event|0|||
156887303|NCT02514473|566347342|FG001|Overall Study|Withdrawal by Subject|1|||
156841245|NCT01717326|566170098|FG012|Overall Study|Physician Decision|0|||
156841246|NCT01717326|566170099|FG013|Overall Study|Physician Decision|0|||
156841247|NCT01717326|566170100|FG014|Overall Study|Physician Decision|0|||
156841248|NCT01717326|566170101|FG015|Overall Study|Physician Decision|0|||
156841249|NCT01717326|566170102|FG016|Overall Study|Physician Decision|0|||
156841250|NCT01717326|566170103|FG017|Overall Study|Physician Decision|0|||
156841251|NCT01717326|566170104|FG018|Overall Study|Physician Decision|0|||
156841252|NCT01717326|566170105|FG019|Overall Study|Physician Decision|0|||
156841253|NCT01717326|566170086|FG000|Overall Study|Protocol Violation|0|||
156841254|NCT01717326|566170087|FG001|Overall Study|Protocol Violation|0|||
156841255|NCT01717326|566170088|FG002|Overall Study|Protocol Violation|0|||
156841256|NCT01717326|566170089|FG003|Overall Study|Protocol Violation|0|||
156841257|NCT01717326|566170090|FG004|Overall Study|Protocol Violation|1|||
156841258|NCT01717326|566170091|FG005|Overall Study|Protocol Violation|0|||
156841259|NCT01717326|566170092|FG006|Overall Study|Protocol Violation|0|||
156887304|NCT02514473|566347341|FG000|Overall Study|Lost to Follow-up|0|||
156887305|NCT02514473|566347342|FG001|Overall Study|Lost to Follow-up|1|||
156887306|NCT02514473|566347341|FG000|Overall Study|Other|1|||
156887307|NCT02514473|566347342|FG001|Overall Study|Other|1|||
156887308|NCT04381988|566347345|FG000|Overall Study|The study was terminated|4|||
156887309|NCT04381988|566347346|FG001|Overall Study|The study was terminated|0|||
156887310|NCT00609362|566347347|FG000|Overall Study|Withdrawal by Subject|2|||
156887311|NCT00609362|566347348|FG001|Overall Study|Withdrawal by Subject|1|||
156887312|NCT00609362|566347347|FG000|Overall Study|Adverse Event|1|||
156887313|NCT00609362|566347348|FG001|Overall Study|Adverse Event|0|||
156887314|NCT05093790|566347349|FG000|Overall Study|Failure to meet continuation criteria|0|||
156887315|NCT05093790|566347350|FG001|Overall Study|Failure to meet continuation criteria|0|||
156887316|NCT05093790|566347351|FG002|Overall Study|Failure to meet continuation criteria|1|||
156887317|NCT05093790|566347352|FG003|Overall Study|Failure to meet continuation criteria|0|||
156887318|NCT05093790|566347349|FG000|Overall Study|Adverse Event|1|||
156887319|NCT05093790|566347350|FG001|Overall Study|Adverse Event|0|||
156887320|NCT05093790|566347351|FG002|Overall Study|Adverse Event|0|||
156887321|NCT05093790|566347352|FG003|Overall Study|Adverse Event|0|||
156887322|NCT01624870|566347353|FG000|Overall Study|Death|19|||
156887323|NCT01624870|566347353|FG000|Overall Study|Withdrawal by Subject|1|||
156887324|NCT01624870|566347353|FG000|Overall Study|CoreValve not implanted|6|||
156887325|NCT01624870|566347353|FG000|Overall Study|Lost to follow up|1|||
156887326|NCT04098224|566347354|FG000|Overall Study|Adverse Event|1|||
156887327|NCT04098224|566347355|FG001|Overall Study|Adverse Event|0|||
156887328|NCT04098224|566347354|FG000|Overall Study|Physician Decision|1|||
156887329|NCT04098224|566347355|FG001|Overall Study|Physician Decision|0|||
156887330|NCT04098224|566347354|FG000|Overall Study|Patient not required enteral feeding|1|||
156887331|NCT04098224|566347355|FG001|Overall Study|Patient not required enteral feeding|0|||
156887332|NCT04098224|566347354|FG000|Overall Study|Patient failure nasogastric tube|1|||
156887333|NCT04098224|566347355|FG001|Overall Study|Patient failure nasogastric tube|0|||
156887334|NCT04098224|566347354|FG000|Overall Study|Patient early extubation|1|||
156887335|NCT04098224|566347355|FG001|Overall Study|Patient early extubation|3|||
156887336|NCT01738477|566347365|FG000|Overall Study|Lost to Follow-up|1|||
156887337|NCT01738477|566347366|FG001|Overall Study|Lost to Follow-up|4|||
156887338|NCT00502203|566347367|FG000|Overall Study|Inevaluable|1|||
156887339|NCT02437110|566347370|FG000|Screening|Lost to Follow-up|3|||
156887340|NCT02437110|566347370|FG000|Screening|Physician Decision|1|||
156887341|NCT02437110|566347370|FG000|ART|Adverse Event|3|||
156887342|NCT02437110|566347370|FG000|ART|Protocol Violation|3|||
156887343|NCT02437110|566347370|FG000|ART|Withdrawal by Subject|4|||
156887344|NCT02437110|566347370|FG000|ART|Lost to follow-up prior to start of intervention|1|||
156887345|NCT02437110|566347370|FG000|ART|Physician decision prior to start of intervention|2|||
156887346|NCT02437110|566347370|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
156841260|NCT01717326|566170093|FG007|Overall Study|Protocol Violation|0|||
156841261|NCT01717326|566170094|FG008|Overall Study|Protocol Violation|0|||
156887347|NCT02437110|566347370|FG000|Post-ART|Lost to Follow-up|3|||
156887348|NCT02437110|566347370|FG000|Post-ART|Protocol Violation|4|||
156887349|NCT02437110|566347370|FG000|Post-ART|Withdrawal by Subject|3|||
156887350|NCT01431638|566347371|FG000|Overall Study|Adverse Event|1|||
156887351|NCT01431638|566347372|FG001|Overall Study|Adverse Event|3|||
156887352|NCT01431638|566347373|FG002|Overall Study|Adverse Event|1|||
156887353|NCT01431638|566347371|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156887354|NCT01431638|566347372|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
156841262|NCT01717326|566170095|FG009|Overall Study|Protocol Violation|0|||
156841263|NCT01717326|566170096|FG010|Overall Study|Protocol Violation|0|||
156841264|NCT01717326|566170097|FG011|Overall Study|Protocol Violation|0|||
156841265|NCT01717326|566170098|FG012|Overall Study|Protocol Violation|0|||
156841266|NCT01717326|566170099|FG013|Overall Study|Protocol Violation|0|||
156887355|NCT01431638|566347373|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156887356|NCT01431638|566347371|FG000|Overall Study|Participants condition no longer requires study drug|0|||
156887357|NCT01431638|566347372|FG001|Overall Study|Participants condition no longer requires study drug|1|||
156887358|NCT01431638|566347373|FG002|Overall Study|Participants condition no longer requires study drug|0|||
157024553|NCT03016754|566845406|FG000|Overall Study|Death|5|||
157224786|NCT00992407|567569873|FG000|Overall Study|Adverse Event|3|||
157224787|NCT00992407|567569874|FG001|Overall Study|Adverse Event|2|||
156841267|NCT01717326|566170100|FG014|Overall Study|Protocol Violation|0|||
156841268|NCT01717326|566170101|FG015|Overall Study|Protocol Violation|0|||
156841269|NCT01717326|566170102|FG016|Overall Study|Protocol Violation|0|||
156841270|NCT01717326|566170103|FG017|Overall Study|Protocol Violation|0|||
156841271|NCT01717326|566170104|FG018|Overall Study|Protocol Violation|0|||
156841272|NCT01717326|566170105|FG019|Overall Study|Protocol Violation|0|||
156841273|NCT01717326|566170086|FG000|Overall Study|Withdrawal by Subject|0|||
156841274|NCT01717326|566170087|FG001|Overall Study|Withdrawal by Subject|1|||
156841275|NCT01717326|566170088|FG002|Overall Study|Withdrawal by Subject|0|||
156841276|NCT01717326|566170089|FG003|Overall Study|Withdrawal by Subject|0|||
156887359|NCT01431638|566347371|FG000|Overall Study|Participant withdrew consent|14|||
156887360|NCT01431638|566347372|FG001|Overall Study|Participant withdrew consent|5|||
156887361|NCT01431638|566347373|FG002|Overall Study|Participant withdrew consent|8|||
156887362|NCT01431638|566347371|FG000|Overall Study|Lost to Follow-up|7|||
156887363|NCT01431638|566347372|FG001|Overall Study|Lost to Follow-up|9|||
156887364|NCT01431638|566347373|FG002|Overall Study|Lost to Follow-up|7|||
156887365|NCT01431638|566347371|FG000|Overall Study|Administrative problems|1|||
156887366|NCT01431638|566347372|FG001|Overall Study|Administrative problems|4|||
156887367|NCT01431638|566347373|FG002|Overall Study|Administrative problems|6|||
156887368|NCT01431638|566347371|FG000|Overall Study|Death|1|||
156887369|NCT01431638|566347372|FG001|Overall Study|Death|0|||
156887370|NCT01431638|566347373|FG002|Overall Study|Death|0|||
156887371|NCT01431638|566347371|FG000|Overall Study|Protocol deviation|1|||
156887372|NCT01431638|566347372|FG001|Overall Study|Protocol deviation|1|||
156887373|NCT01431638|566347373|FG002|Overall Study|Protocol deviation|4|||
156887374|NCT01431638|566347371|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
156887375|NCT01431638|566347372|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
156887376|NCT01431638|566347373|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
156887377|NCT01261780|566347374|FG000|Overall Study|Withdrawal by Subject|1|||
156887378|NCT01261780|566347375|FG001|Overall Study|Withdrawal by Subject|0|||
156887379|NCT01261780|566347374|FG000|Overall Study|Event not related to subject|1|||
156887380|NCT01261780|566347375|FG001|Overall Study|Event not related to subject|2|||
156887381|NCT01239732|566347376|FG000|Overall Study|Termination of study per protocol|667|||
156887382|NCT01239732|566347376|FG000|Overall Study|Death|226|||
156887383|NCT01239732|566347376|FG000|Overall Study|Withdrawal by Subject|87|||
156887384|NCT01239732|566347376|FG000|Overall Study|Adverse Event|6|||
156887385|NCT01239732|566347376|FG000|Overall Study|Protocol Violation|3|||
156887386|NCT01239732|566347376|FG000|Overall Study|Participant non compliance|5|||
156887387|NCT01239732|566347376|FG000|Overall Study|Study termination by sponsor|2|||
156887388|NCT01239732|566347376|FG000|Overall Study|Investigator's decision|4|||
156887389|NCT01239732|566347376|FG000|Overall Study|Treatment failure|2|||
156887390|NCT01239732|566347376|FG000|Overall Study|Other|19|||
156887391|NCT03836001|566347377|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
156887392|NCT03836001|566347378|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
156887393|NCT03836001|566347379|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
156887394|NCT03836001|566347377|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
156887395|NCT03836001|566347378|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
156887396|NCT03836001|566347379|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
156887397|NCT03836001|566347377|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
156887398|NCT03836001|566347378|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
156887399|NCT03836001|566347379|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
156887400|NCT03836001|566347377|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
156887401|NCT03836001|566347378|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
156887402|NCT03836001|566347379|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
156887403|NCT01381562|566347380|FG000|Overall Study|Adverse Event|0|||
156887404|NCT01381562|566347381|FG001|Overall Study|Adverse Event|1|||
156887405|NCT01381562|566347382|FG002|Overall Study|Adverse Event|0|||
156887406|NCT02660138|566347384|FG000|Overall Study|Adverse Event|0|||
156887407|NCT02660138|566347385|FG001|Overall Study|Adverse Event|3|||
156887408|NCT02660138|566347386|FG002|Overall Study|Adverse Event|2|||
156887409|NCT02660138|566347384|FG000|Overall Study|Lack of Efficacy|1|||
156887410|NCT02660138|566347385|FG001|Overall Study|Lack of Efficacy|2|||
156841277|NCT01717326|566170090|FG004|Overall Study|Withdrawal by Subject|0|||
156887411|NCT02660138|566347386|FG002|Overall Study|Lack of Efficacy|1|||
156887412|NCT02660138|566347384|FG000|Overall Study|Withdrawal by Subject|7|||
156841278|NCT01717326|566170091|FG005|Overall Study|Withdrawal by Subject|0|||
156841279|NCT01717326|566170092|FG006|Overall Study|Withdrawal by Subject|0|||
156841280|NCT01717326|566170093|FG007|Overall Study|Withdrawal by Subject|0|||
156887413|NCT02660138|566347385|FG001|Overall Study|Withdrawal by Subject|6|||
156887414|NCT02660138|566347386|FG002|Overall Study|Withdrawal by Subject|6|||
156841281|NCT01717326|566170094|FG008|Overall Study|Withdrawal by Subject|0|||
156841282|NCT01717326|566170095|FG009|Overall Study|Withdrawal by Subject|1|||
156841283|NCT01717326|566170096|FG010|Overall Study|Withdrawal by Subject|0|||
156841284|NCT01717326|566170097|FG011|Overall Study|Withdrawal by Subject|0|||
156841285|NCT01717326|566170098|FG012|Overall Study|Withdrawal by Subject|1|||
156841286|NCT01717326|566170099|FG013|Overall Study|Withdrawal by Subject|0|||
156841287|NCT01717326|566170100|FG014|Overall Study|Withdrawal by Subject|0|||
156841288|NCT01717326|566170101|FG015|Overall Study|Withdrawal by Subject|1|||
156841289|NCT01717326|566170102|FG016|Overall Study|Withdrawal by Subject|0|||
156841290|NCT01717326|566170103|FG017|Overall Study|Withdrawal by Subject|0|||
156841291|NCT01717326|566170104|FG018|Overall Study|Withdrawal by Subject|2|||
156841292|NCT01717326|566170105|FG019|Overall Study|Withdrawal by Subject|3|||
156841293|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Adverse Event|2|||
156841294|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Adverse Event|4|||
156841295|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Adverse Event|4|||
156841296|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
156841297|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
156841298|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
156841299|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
156841300|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
156841301|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
156841302|NCT00428844|566170110|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
156841303|NCT00428844|566170111|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
156841304|NCT00428844|566170112|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
156841305|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
156841306|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
156841307|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
156841308|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
156841309|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
156841310|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
156841311|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
156841312|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
156841313|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
156841314|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
156841315|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
156841316|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
156841317|NCT00428844|566170110|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
156841318|NCT00428844|566170111|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
156841319|NCT00428844|566170112|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
156841320|NCT02292706|566170115|FG000|Overall Study|Lost to Follow-up|20|||
156841321|NCT02292706|566170116|FG001|Overall Study|Lost to Follow-up|44|||
156841322|NCT02292706|566170117|FG002|Overall Study|Lost to Follow-up|24|||
156841323|NCT02292706|566170118|FG003|Overall Study|Lost to Follow-up|61|||
156841324|NCT02292706|566170119|FG004|Overall Study|Lost to Follow-up|21|||
156841325|NCT02292706|566170120|FG005|Overall Study|Lost to Follow-up|52|||
156841326|NCT02292706|566170121|FG006|Overall Study|Lost to Follow-up|25|||
156841327|NCT02292706|566170122|FG007|Overall Study|Lost to Follow-up|0|||
156841328|NCT02292706|566170115|FG000|Overall Study|Withdrew consent|15|||
156841329|NCT02292706|566170116|FG001|Overall Study|Withdrew consent|56|||
156841330|NCT02292706|566170117|FG002|Overall Study|Withdrew consent|43|||
156841331|NCT02292706|566170118|FG003|Overall Study|Withdrew consent|36|||
156841332|NCT02292706|566170119|FG004|Overall Study|Withdrew consent|13|||
156841333|NCT02292706|566170120|FG005|Overall Study|Withdrew consent|51|||
156841334|NCT02292706|566170121|FG006|Overall Study|Withdrew consent|20|||
156841335|NCT02292706|566170122|FG007|Overall Study|Withdrew consent|0|||
156841336|NCT02292706|566170115|FG000|Overall Study|Death|3|||
156841337|NCT02292706|566170116|FG001|Overall Study|Death|11|||
156841338|NCT02292706|566170117|FG002|Overall Study|Death|16|||
156841339|NCT02292706|566170118|FG003|Overall Study|Death|22|||
156841340|NCT02292706|566170119|FG004|Overall Study|Death|8|||
156841341|NCT02292706|566170120|FG005|Overall Study|Death|17|||
156841342|NCT02292706|566170121|FG006|Overall Study|Death|3|||
156841343|NCT02292706|566170122|FG007|Overall Study|Death|0|||
156841344|NCT02292706|566170115|FG000|Overall Study|Study terminated by sponsor|0|||
156841345|NCT02292706|566170116|FG001|Overall Study|Study terminated by sponsor|9|||
156841346|NCT02292706|566170117|FG002|Overall Study|Study terminated by sponsor|4|||
156841347|NCT02292706|566170118|FG003|Overall Study|Study terminated by sponsor|21|||
156841348|NCT02292706|566170119|FG004|Overall Study|Study terminated by sponsor|11|||
156841349|NCT02292706|566170120|FG005|Overall Study|Study terminated by sponsor|13|||
156841350|NCT02292706|566170121|FG006|Overall Study|Study terminated by sponsor|3|||
156841351|NCT02292706|566170122|FG007|Overall Study|Study terminated by sponsor|0|||
156841352|NCT02292706|566170115|FG000|Overall Study|Investigator's discretion|4|||
156841353|NCT02292706|566170116|FG001|Overall Study|Investigator's discretion|9|||
156841354|NCT02292706|566170117|FG002|Overall Study|Investigator's discretion|7|||
156841355|NCT02292706|566170118|FG003|Overall Study|Investigator's discretion|11|||
156841356|NCT02292706|566170119|FG004|Overall Study|Investigator's discretion|4|||
157154908|NCT01605396|567311392|FG000|Overall Study|Adverse Event|5|||
157154909|NCT01605396|567311393|FG001|Overall Study|Adverse Event|3|||
156841357|NCT02292706|566170120|FG005|Overall Study|Investigator's discretion|10|||
156841358|NCT02292706|566170121|FG006|Overall Study|Investigator's discretion|1|||
156841359|NCT02292706|566170122|FG007|Overall Study|Investigator's discretion|0|||
156841360|NCT02292706|566170115|FG000|Overall Study|Liver transplant|1|||
156841361|NCT02292706|566170116|FG001|Overall Study|Liver transplant|1|||
156841362|NCT02292706|566170117|FG002|Overall Study|Liver transplant|11|||
156841363|NCT02292706|566170118|FG003|Overall Study|Liver transplant|16|||
156841364|NCT02292706|566170119|FG004|Overall Study|Liver transplant|5|||
156841365|NCT02292706|566170120|FG005|Overall Study|Liver transplant|6|||
156841366|NCT02292706|566170121|FG006|Overall Study|Liver transplant|5|||
156841367|NCT02292706|566170122|FG007|Overall Study|Liver transplant|0|||
156841368|NCT02292706|566170115|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
156841369|NCT02292706|566170116|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
156841370|NCT02292706|566170117|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
156841371|NCT02292706|566170118|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
156841372|NCT02292706|566170119|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
156841373|NCT02292706|566170120|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
156841374|NCT02292706|566170121|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
156841375|NCT02292706|566170122|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
156841376|NCT02292706|566170115|FG000|Overall Study|Subject terminated by sponsor|1|||
156841377|NCT02292706|566170116|FG001|Overall Study|Subject terminated by sponsor|0|||
156841378|NCT02292706|566170117|FG002|Overall Study|Subject terminated by sponsor|0|||
156841379|NCT02292706|566170118|FG003|Overall Study|Subject terminated by sponsor|2|||
156841380|NCT02292706|566170119|FG004|Overall Study|Subject terminated by sponsor|1|||
156841381|NCT02292706|566170120|FG005|Overall Study|Subject terminated by sponsor|0|||
156841382|NCT02292706|566170121|FG006|Overall Study|Subject terminated by sponsor|0|||
156841383|NCT02292706|566170122|FG007|Overall Study|Subject terminated by sponsor|0|||
156841384|NCT02292706|566170115|FG000|Overall Study|Missing|0|||
156841385|NCT02292706|566170116|FG001|Overall Study|Missing|0|||
156841386|NCT02292706|566170117|FG002|Overall Study|Missing|1|||
156841387|NCT02292706|566170118|FG003|Overall Study|Missing|1|||
156841388|NCT02292706|566170119|FG004|Overall Study|Missing|0|||
156841389|NCT02292706|566170120|FG005|Overall Study|Missing|1|||
156841390|NCT02292706|566170121|FG006|Overall Study|Missing|0|||
156841391|NCT02292706|566170122|FG007|Overall Study|Missing|0|||
156841392|NCT02292706|566170115|FG000|Overall Study|Virologic relapse or reinfection|1|||
156841393|NCT02292706|566170116|FG001|Overall Study|Virologic relapse or reinfection|0|||
157154910|NCT01605396|567311392|FG000|Overall Study|Lost to Follow-up|1|||
157154911|NCT01605396|567311393|FG001|Overall Study|Lost to Follow-up|0|||
157154912|NCT01605396|567311392|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157154913|NCT01605396|567311393|FG001|Overall Study|Non-Compliance With Study Drug|1|||
156841394|NCT02292706|566170117|FG002|Overall Study|Virologic relapse or reinfection|0|||
156841395|NCT02292706|566170118|FG003|Overall Study|Virologic relapse or reinfection|1|||
156841396|NCT02292706|566170119|FG004|Overall Study|Virologic relapse or reinfection|0|||
156841397|NCT02292706|566170120|FG005|Overall Study|Virologic relapse or reinfection|1|||
156841398|NCT02292706|566170121|FG006|Overall Study|Virologic relapse or reinfection|0|||
156841399|NCT02292706|566170122|FG007|Overall Study|Virologic relapse or reinfection|0|||
156841400|NCT01990612|566170125|FG000|Overall Study|Lost to Follow-up|2|||
156841401|NCT01990612|566170126|FG001|Overall Study|Lost to Follow-up|1|||
156841402|NCT01990612|566170125|FG000|Overall Study|Withdrawal by Subject|5|||
156841403|NCT01990612|566170126|FG001|Overall Study|Withdrawal by Subject|2|||
156841404|NCT02188849|566170128|FG000|Overall Study|Lost to Follow-up|3|||
156841405|NCT02188849|566170129|FG001|Overall Study|Lost to Follow-up|8|||
156841406|NCT03208088|566170131|FG000|Period 2|Withdrawal by Subject|0|||
156841407|NCT03208088|566170132|FG001|Period 2|Withdrawal by Subject|0|||
156841408|NCT03208088|566170133|FG002|Period 2|Withdrawal by Subject|0|||
156841409|NCT03208088|566170134|FG003|Period 2|Withdrawal by Subject|0|||
156841410|NCT03208088|566170135|FG004|Period 2|Withdrawal by Subject|0|||
156841411|NCT03208088|566170136|FG005|Period 2|Withdrawal by Subject|0|||
156841412|NCT03208088|566170137|FG006|Period 2|Withdrawal by Subject|0|||
156841413|NCT03208088|566170138|FG007|Period 2|Withdrawal by Subject|0|||
156841414|NCT03208088|566170139|FG008|Period 2|Withdrawal by Subject|1|||
156841415|NCT03208088|566170140|FG009|Period 2|Withdrawal by Subject|0|||
156841416|NCT03208088|566170131|FG000|Period 3|Unsatisfactory Test Article|0|||
156841417|NCT03208088|566170132|FG001|Period 3|Unsatisfactory Test Article|0|||
156841418|NCT03208088|566170133|FG002|Period 3|Unsatisfactory Test Article|0|||
156841419|NCT03208088|566170134|FG003|Period 3|Unsatisfactory Test Article|1|||
157154914|NCT01605396|567311392|FG000|Overall Study|Physician Decision|2|||
156841420|NCT03208088|566170135|FG004|Period 3|Unsatisfactory Test Article|0|||
156841421|NCT03208088|566170136|FG005|Period 3|Unsatisfactory Test Article|0|||
156841422|NCT03208088|566170137|FG006|Period 3|Unsatisfactory Test Article|0|||
156841423|NCT03208088|566170138|FG007|Period 3|Unsatisfactory Test Article|0|||
156841424|NCT03208088|566170139|FG008|Period 3|Unsatisfactory Test Article|0|||
156841425|NCT03208088|566170140|FG009|Period 3|Unsatisfactory Test Article|0|||
156841426|NCT03208088|566170131|FG000|Period 4|Unsatisfactory Test Article|0|||
156841427|NCT03208088|566170132|FG001|Period 4|Unsatisfactory Test Article|0|||
156841428|NCT03208088|566170133|FG002|Period 4|Unsatisfactory Test Article|0|||
156841429|NCT03208088|566170134|FG003|Period 4|Unsatisfactory Test Article|1|||
156841430|NCT03208088|566170135|FG004|Period 4|Unsatisfactory Test Article|0|||
156841431|NCT03208088|566170136|FG005|Period 4|Unsatisfactory Test Article|0|||
156841432|NCT03208088|566170137|FG006|Period 4|Unsatisfactory Test Article|0|||
156841433|NCT03208088|566170138|FG007|Period 4|Unsatisfactory Test Article|0|||
156841434|NCT03208088|566170139|FG008|Period 4|Unsatisfactory Test Article|0|||
156841435|NCT03208088|566170140|FG009|Period 4|Unsatisfactory Test Article|0|||
156841436|NCT00812565|566170143|FG000|Overall Study|Did Not Receive Study Medication|1|||
156841437|NCT00812565|566170144|FG001|Overall Study|Did Not Receive Study Medication|1|||
156841438|NCT00812565|566170145|FG002|Overall Study|Did Not Receive Study Medication|0|||
156841439|NCT00812565|566170146|FG003|Overall Study|Did Not Receive Study Medication|0|||
156841440|NCT00812565|566170147|FG004|Overall Study|Did Not Receive Study Medication|0|||
156841441|NCT00812565|566170148|FG005|Overall Study|Did Not Receive Study Medication|0|||
156841442|NCT00812565|566170149|FG006|Overall Study|Did Not Receive Study Medication|0|||
156841443|NCT00812565|566170150|FG007|Overall Study|Did Not Receive Study Medication|0|||
156841444|NCT00812565|566170143|FG000|Overall Study|Adverse Event|0|||
156841445|NCT00812565|566170144|FG001|Overall Study|Adverse Event|0|||
156841446|NCT00812565|566170145|FG002|Overall Study|Adverse Event|0|||
156841447|NCT00812565|566170146|FG003|Overall Study|Adverse Event|2|||
156841448|NCT00812565|566170147|FG004|Overall Study|Adverse Event|0|||
156841449|NCT00812565|566170148|FG005|Overall Study|Adverse Event|0|||
156841450|NCT00812565|566170149|FG006|Overall Study|Adverse Event|0|||
156841451|NCT00812565|566170150|FG007|Overall Study|Adverse Event|1|||
156841452|NCT00812565|566170143|FG000|Overall Study|Did Not Come to Study Visit|1|||
156841453|NCT00812565|566170144|FG001|Overall Study|Did Not Come to Study Visit|0|||
156841454|NCT00812565|566170145|FG002|Overall Study|Did Not Come to Study Visit|0|||
156841455|NCT00812565|566170146|FG003|Overall Study|Did Not Come to Study Visit|0|||
156841456|NCT00812565|566170147|FG004|Overall Study|Did Not Come to Study Visit|0|||
156887415|NCT02660138|566347384|FG000|Overall Study|Lost to Follow-up|4|||
156887416|NCT02660138|566347385|FG001|Overall Study|Lost to Follow-up|4|||
156887417|NCT02660138|566347386|FG002|Overall Study|Lost to Follow-up|1|||
156887418|NCT02660138|566347384|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
156887419|NCT02660138|566347385|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
156887420|NCT02660138|566347386|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
156887421|NCT02660138|566347384|FG000|Overall Study|Other|1|||
156887422|NCT02660138|566347385|FG001|Overall Study|Other|1|||
156887423|NCT02660138|566347386|FG002|Overall Study|Other|0|||
156887424|NCT02660138|566347384|FG000|Overall Study|Not treated|0|||
156887425|NCT02660138|566347385|FG001|Overall Study|Not treated|1|||
156887426|NCT02660138|566347386|FG002|Overall Study|Not treated|0|||
156887427|NCT00308581|566347387|FG000|Induction Phase|Adverse Event|0|||
156887428|NCT00308581|566347388|FG001|Induction Phase|Adverse Event|0|||
156887429|NCT00308581|566347389|FG002|Induction Phase|Adverse Event|37|||
156887430|NCT00308581|566347387|FG000|Induction Phase|Lack of Efficacy|0|||
156887431|NCT00308581|566347388|FG001|Induction Phase|Lack of Efficacy|0|||
156887432|NCT00308581|566347389|FG002|Induction Phase|Lack of Efficacy|121|||
156887433|NCT00308581|566347387|FG000|Induction Phase|Withdrawal by Subject|0|||
156887434|NCT00308581|566347388|FG001|Induction Phase|Withdrawal by Subject|0|||
156887435|NCT00308581|566347389|FG002|Induction Phase|Withdrawal by Subject|5|||
156887436|NCT00308581|566347387|FG000|Induction Phase|Unknown reason|0|||
156887437|NCT00308581|566347388|FG001|Induction Phase|Unknown reason|0|||
156887438|NCT00308581|566347389|FG002|Induction Phase|Unknown reason|3|||
156887439|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Adverse Event|10|||
156887440|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Adverse Event|17|||
156887441|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Adverse Event|0|||
156887442|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
157024554|NCT03016754|566845407|FG001|Overall Study|Death|4|||
157024555|NCT03016754|566845408|FG002|Overall Study|Death|5|||
157024556|NCT03016754|566845409|FG003|Overall Study|Death|1|||
157024557|NCT03016754|566845406|FG000|Overall Study|Lost to Follow-up|23|||
157024558|NCT03016754|566845407|FG001|Overall Study|Lost to Follow-up|17|||
157024559|NCT03016754|566845408|FG002|Overall Study|Lost to Follow-up|4|||
157024560|NCT03016754|566845409|FG003|Overall Study|Lost to Follow-up|2|||
157024561|NCT03016754|566845406|FG000|Overall Study|Withdrawal by Subject|6|||
157024562|NCT03016754|566845407|FG001|Overall Study|Withdrawal by Subject|6|||
157024563|NCT03016754|566845408|FG002|Overall Study|Withdrawal by Subject|2|||
157024564|NCT03016754|566845409|FG003|Overall Study|Withdrawal by Subject|2|||
157024565|NCT03016754|566845406|FG000|Overall Study|Other/Unknown|2|||
156841457|NCT00812565|566170148|FG005|Overall Study|Did Not Come to Study Visit|0|||
156841458|NCT00812565|566170149|FG006|Overall Study|Did Not Come to Study Visit|0|||
156841459|NCT00812565|566170150|FG007|Overall Study|Did Not Come to Study Visit|0|||
156841460|NCT00812565|566170143|FG000|Overall Study|Withdrawal of Consent|1|||
156841461|NCT00812565|566170144|FG001|Overall Study|Withdrawal of Consent|0|||
157024566|NCT03016754|566845407|FG001|Overall Study|Other/Unknown|4|||
157024567|NCT03016754|566845408|FG002|Overall Study|Other/Unknown|2|||
157024568|NCT03016754|566845409|FG003|Overall Study|Other/Unknown|1|||
157024569|NCT03016754|566845406|FG000|Overall Study|Protocol Violation|0|||
157024570|NCT03016754|566845407|FG001|Overall Study|Protocol Violation|0|||
157024571|NCT03016754|566845408|FG002|Overall Study|Protocol Violation|0|||
157024572|NCT03016754|566845409|FG003|Overall Study|Protocol Violation|4|||
157024573|NCT01098812|566845418|FG000|Overall Study|Death|2|||
157024574|NCT01098812|566845419|FG001|Overall Study|Death|0|||
157024575|NCT01098812|566845420|FG002|Overall Study|Death|1|||
157024576|NCT01098812|566845418|FG000|Overall Study|Lost to Follow-up|0|||
157024577|NCT01098812|566845419|FG001|Overall Study|Lost to Follow-up|1|||
157024578|NCT01098812|566845420|FG002|Overall Study|Lost to Follow-up|0|||
157024579|NCT04908722|566845421|FG000|Overall Study|Protocol deviation|1|||
157154915|NCT01605396|567311393|FG001|Overall Study|Physician Decision|2|||
157154916|NCT01605396|567311392|FG000|Overall Study|Progressive Disease|23|||
156841462|NCT00812565|566170145|FG002|Overall Study|Withdrawal of Consent|0|||
156841463|NCT00812565|566170146|FG003|Overall Study|Withdrawal of Consent|0|||
156841464|NCT00812565|566170147|FG004|Overall Study|Withdrawal of Consent|1|||
156841465|NCT00812565|566170148|FG005|Overall Study|Withdrawal of Consent|0|||
156841466|NCT00812565|566170149|FG006|Overall Study|Withdrawal of Consent|0|||
156841467|NCT00812565|566170150|FG007|Overall Study|Withdrawal of Consent|0|||
156841468|NCT00812565|566170143|FG000|Overall Study|Reason Not Specified|0|||
156841469|NCT00812565|566170144|FG001|Overall Study|Reason Not Specified|0|||
156841470|NCT00812565|566170145|FG002|Overall Study|Reason Not Specified|0|||
156841471|NCT00812565|566170146|FG003|Overall Study|Reason Not Specified|0|||
156841472|NCT00812565|566170147|FG004|Overall Study|Reason Not Specified|0|||
156841473|NCT00812565|566170148|FG005|Overall Study|Reason Not Specified|1|||
156841474|NCT00812565|566170149|FG006|Overall Study|Reason Not Specified|0|||
156841475|NCT00812565|566170150|FG007|Overall Study|Reason Not Specified|0|||
156841476|NCT00422383|566170153|FG000|Overall Study|Adverse Event|5|||
156841477|NCT00422383|566170154|FG001|Overall Study|Adverse Event|3|||
156841478|NCT00422383|566170155|FG002|Overall Study|Adverse Event|1|||
156841479|NCT00422383|566170156|FG003|Overall Study|Adverse Event|1|||
156841480|NCT00422383|566170157|FG004|Overall Study|Adverse Event|0|||
156841481|NCT00422383|566170153|FG000|Overall Study|Lack of Efficacy|4|||
156841482|NCT00422383|566170154|FG001|Overall Study|Lack of Efficacy|4|||
156841483|NCT00422383|566170155|FG002|Overall Study|Lack of Efficacy|2|||
156841484|NCT00422383|566170156|FG003|Overall Study|Lack of Efficacy|1|||
156841485|NCT00422383|566170157|FG004|Overall Study|Lack of Efficacy|1|||
156841486|NCT00422383|566170153|FG000|Overall Study|Lost to Follow-up|0|||
156841487|NCT00422383|566170154|FG001|Overall Study|Lost to Follow-up|1|||
156841488|NCT00422383|566170155|FG002|Overall Study|Lost to Follow-up|0|||
156841489|NCT00422383|566170156|FG003|Overall Study|Lost to Follow-up|0|||
156841490|NCT00422383|566170157|FG004|Overall Study|Lost to Follow-up|1|||
156841491|NCT00422383|566170153|FG000|Overall Study|Protocol Violation|1|||
156841492|NCT00422383|566170154|FG001|Overall Study|Protocol Violation|1|||
156841493|NCT00422383|566170155|FG002|Overall Study|Protocol Violation|1|||
156841494|NCT00422383|566170156|FG003|Overall Study|Protocol Violation|0|||
156841495|NCT00422383|566170157|FG004|Overall Study|Protocol Violation|0|||
156841496|NCT00422383|566170153|FG000|Overall Study|Withdrawal by Subject|5|||
156841497|NCT00422383|566170154|FG001|Overall Study|Withdrawal by Subject|5|||
156841498|NCT00422383|566170155|FG002|Overall Study|Withdrawal by Subject|0|||
156841499|NCT00422383|566170156|FG003|Overall Study|Withdrawal by Subject|0|||
156841500|NCT00422383|566170157|FG004|Overall Study|Withdrawal by Subject|1|||
156841501|NCT00566254|566170158|FG000|Overall Study|Adverse Event|3|||
156841502|NCT00566254|566170159|FG001|Overall Study|Adverse Event|1|||
156841503|NCT00566254|566170158|FG000|Overall Study|Protocol Violation|1|||
156841504|NCT00566254|566170159|FG001|Overall Study|Protocol Violation|3|||
156841505|NCT00566254|566170158|FG000|Overall Study|Withdrawal by Subject|1|||
156841506|NCT00566254|566170159|FG001|Overall Study|Withdrawal by Subject|2|||
157024580|NCT04908722|566845422|FG001|Overall Study|Protocol deviation|0|||
157154917|NCT01605396|567311393|FG001|Overall Study|Progressive Disease|27|||
157154918|NCT01605396|567311392|FG000|Overall Study|Withdrawal by Subject|4|||
157154919|NCT01605396|567311393|FG001|Overall Study|Withdrawal by Subject|2|||
156841507|NCT00566254|566170158|FG000|Overall Study|Lack of Efficacy|5|||
156841508|NCT00566254|566170159|FG001|Overall Study|Lack of Efficacy|6|||
157154920|NCT01605396|567311392|FG000|Overall Study|Transfer Off Study|4|||
157154921|NCT01605396|567311393|FG001|Overall Study|Transfer Off Study|5|||
156841509|NCT00566254|566170158|FG000|Overall Study|Other|0|||
157024581|NCT04908722|566845423|FG002|Overall Study|Protocol deviation|0|||
156841510|NCT00566254|566170159|FG001|Overall Study|Other|2|||
156841511|NCT01793883|566170160|FG000|Overall Study|Withdrawal by Subject|3|||
156841512|NCT01793883|566170161|FG001|Overall Study|Withdrawal by Subject|7|||
156841513|NCT01793883|566170162|FG002|Overall Study|Withdrawal by Subject|3|||
156841514|NCT01793883|566170160|FG000|Overall Study|Subject noncompliance|0|||
156841515|NCT01793883|566170161|FG001|Overall Study|Subject noncompliance|1|||
157024582|NCT04908722|566845424|FG003|Overall Study|Protocol deviation|0|||
157024583|NCT04908722|566845425|FG004|Overall Study|Protocol deviation|0|||
157154922|NCT04598165|567311394|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
157024584|NCT04908722|566845426|FG005|Overall Study|Protocol deviation|1|||
157224788|NCT00992407|567569873|FG000|Overall Study|protocol Violation & Adverse events|2|||
156841516|NCT01793883|566170162|FG002|Overall Study|Subject noncompliance|1|||
156841517|NCT01793883|566170160|FG000|Overall Study|Lost to Follow-up|5|||
156841518|NCT01793883|566170161|FG001|Overall Study|Lost to Follow-up|1|||
156841519|NCT01793883|566170162|FG002|Overall Study|Lost to Follow-up|3|||
156841520|NCT01793883|566170160|FG000|Overall Study|Randomized in error|1|||
156841521|NCT01793883|566170161|FG001|Overall Study|Randomized in error|0|||
156841522|NCT01793883|566170162|FG002|Overall Study|Randomized in error|0|||
156841523|NCT01793883|566170160|FG000|Overall Study|Unable to complete spriometry|1|||
156841524|NCT01793883|566170161|FG001|Overall Study|Unable to complete spriometry|0|||
156841525|NCT01793883|566170162|FG002|Overall Study|Unable to complete spriometry|0|||
156841526|NCT01793883|566170160|FG000|Overall Study|Unable to complete measurements|1|||
156841527|NCT01793883|566170161|FG001|Overall Study|Unable to complete measurements|0|||
156841528|NCT01793883|566170162|FG002|Overall Study|Unable to complete measurements|0|||
156841529|NCT01793883|566170160|FG000|Overall Study|Met exclusion criteria|1|||
156841530|NCT01793883|566170161|FG001|Overall Study|Met exclusion criteria|0|||
156841531|NCT01793883|566170162|FG002|Overall Study|Met exclusion criteria|0|||
156841532|NCT01793883|566170160|FG000|Overall Study|Dosing error|0|||
156841533|NCT01793883|566170161|FG001|Overall Study|Dosing error|1|||
156841534|NCT01793883|566170162|FG002|Overall Study|Dosing error|0|||
156841535|NCT01793883|566170160|FG000|Overall Study|Respiratory distress during spirometry|0|||
156841536|NCT01793883|566170161|FG001|Overall Study|Respiratory distress during spirometry|0|||
156841537|NCT01793883|566170162|FG002|Overall Study|Respiratory distress during spirometry|1|||
156841538|NCT00891228|566172265|FG000|Overall Study|Adverse Event|0|||
156841539|NCT00891228|566172266|FG001|Overall Study|Adverse Event|2|||
156841540|NCT00891228|566172267|FG002|Overall Study|Adverse Event|3|||
156841541|NCT00891228|566172265|FG000|Overall Study|Withdrawal by Subject|2|||
156841542|NCT00891228|566172266|FG001|Overall Study|Withdrawal by Subject|4|||
156841543|NCT00891228|566172267|FG002|Overall Study|Withdrawal by Subject|5|||
156841544|NCT00891228|566172265|FG000|Overall Study|Protocol Violation|3|||
156841545|NCT00891228|566172266|FG001|Overall Study|Protocol Violation|1|||
156841546|NCT00891228|566172267|FG002|Overall Study|Protocol Violation|2|||
156841547|NCT00891228|566172265|FG000|Overall Study|Physician Decision|2|||
156841548|NCT00891228|566172266|FG001|Overall Study|Physician Decision|1|||
156841549|NCT00891228|566172267|FG002|Overall Study|Physician Decision|0|||
156841550|NCT00891228|566172265|FG000|Overall Study|Lost to Follow-up|4|||
156841551|NCT00891228|566172266|FG001|Overall Study|Lost to Follow-up|4|||
156841552|NCT00891228|566172267|FG002|Overall Study|Lost to Follow-up|5|||
156841553|NCT00891228|566172265|FG000|Overall Study|Pregnancy|0|||
156841554|NCT00891228|566172266|FG001|Overall Study|Pregnancy|1|||
156841555|NCT00891228|566172267|FG002|Overall Study|Pregnancy|0|||
156841556|NCT02688985|566172276|FG000|Overall Study|Adverse Event|1|||
156841557|NCT02688985|566172277|FG001|Overall Study|Adverse Event|2|||
156841558|NCT02688985|566172278|FG002|Overall Study|Adverse Event|2|||
156841559|NCT02688985|566172279|FG003|Overall Study|Adverse Event|0|||
156841560|NCT02688985|566172280|FG004|Overall Study|Adverse Event|0|||
156841561|NCT02688985|566172276|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
156841562|NCT02688985|566172277|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
156841563|NCT02688985|566172278|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
156841564|NCT02688985|566172279|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
156841565|NCT02688985|566172280|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
156841566|NCT02688985|566172276|FG000|Overall Study|Death|0|||
156841567|NCT02688985|566172277|FG001|Overall Study|Death|0|||
156841568|NCT02688985|566172278|FG002|Overall Study|Death|0|||
156841569|NCT02688985|566172279|FG003|Overall Study|Death|0|||
156841570|NCT02688985|566172280|FG004|Overall Study|Death|1|||
156841571|NCT02688985|566172276|FG000|Overall Study|Lack of Efficacy|0|||
156841572|NCT02688985|566172277|FG001|Overall Study|Lack of Efficacy|0|||
156841573|NCT02688985|566172278|FG002|Overall Study|Lack of Efficacy|0|||
156841574|NCT02688985|566172279|FG003|Overall Study|Lack of Efficacy|0|||
156841575|NCT02688985|566172280|FG004|Overall Study|Lack of Efficacy|1|||
156841576|NCT02688985|566172276|FG000|Overall Study|Lost to Follow-up|2|||
156841577|NCT02688985|566172277|FG001|Overall Study|Lost to Follow-up|0|||
156841578|NCT02688985|566172278|FG002|Overall Study|Lost to Follow-up|1|||
156841579|NCT02688985|566172279|FG003|Overall Study|Lost to Follow-up|1|||
156841580|NCT02688985|566172280|FG004|Overall Study|Lost to Follow-up|1|||
156841581|NCT02688985|566172276|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156841582|NCT02688985|566172277|FG001|Overall Study|Non-Compliance With Study Drug|3|||
156841583|NCT02688985|566172278|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156841584|NCT02688985|566172279|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156841585|NCT02688985|566172280|FG004|Overall Study|Non-Compliance With Study Drug|1|||
156841586|NCT02688985|566172276|FG000|Overall Study|Other|3|||
156841587|NCT02688985|566172277|FG001|Overall Study|Other|4|||
156841588|NCT02688985|566172278|FG002|Overall Study|Other|1|||
156841589|NCT02688985|566172279|FG003|Overall Study|Other|0|||
156841590|NCT02688985|566172280|FG004|Overall Study|Other|0|||
156887443|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
156887444|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
156887445|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
156887446|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
156887447|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
156887448|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
156887449|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
156887450|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
156887451|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
156887452|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
156887453|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
156887454|NCT00308581|566347387|FG000|Randomized Maintenance Phase|Unknown reason|3|||
156887455|NCT00308581|566347388|FG001|Randomized Maintenance Phase|Unknown reason|0|||
156887456|NCT00308581|566347389|FG002|Randomized Maintenance Phase|Unknown reason|0|||
156887457|NCT00827931|566347395|FG000|Overall Study|Death|3|||
156887458|NCT00827931|566347396|FG001|Overall Study|Death|5|||
156887459|NCT00827931|566347395|FG000|Overall Study|Adverse Event|1|||
156887460|NCT00827931|566347396|FG001|Overall Study|Adverse Event|0|||
156887461|NCT00827931|566347395|FG000|Overall Study|Lost to Follow-up|1|||
156887462|NCT00827931|566347396|FG001|Overall Study|Lost to Follow-up|0|||
156887463|NCT00827931|566347395|FG000|Overall Study|Withdrawal by Subject|0|||
156887464|NCT00827931|566347396|FG001|Overall Study|Withdrawal by Subject|1|||
156887465|NCT00827931|566347395|FG000|Overall Study|Other|1|||
156887466|NCT00827931|566347396|FG001|Overall Study|Other|0|||
156887467|NCT00890045|566347399|FG000|Overall Study|Death|0|||
156887468|NCT00890045|566347400|FG001|Overall Study|Death|1|||
156887469|NCT00890045|566347399|FG000|Overall Study|Did not receive HeRO Graft|0|||
156887470|NCT00890045|566347400|FG001|Overall Study|Did not receive HeRO Graft|2|||
156887471|NCT00890045|566347399|FG000|Overall Study|Lost to Follow-up|5|||
156887472|NCT00890045|566347400|FG001|Overall Study|Lost to Follow-up|7|||
156887473|NCT01947855|566347401|FG000|Overall Study|Withdrawal by Subject|1|||
156887474|NCT01947855|566347402|FG001|Overall Study|Withdrawal by Subject|0|||
156887475|NCT01947855|566347403|FG002|Overall Study|Withdrawal by Subject|0|||
156887476|NCT01700439|566347407|FG000|Overall Study|Lost to Follow-up|47|||
156887477|NCT01700439|566347407|FG000|Overall Study|Withdrawal by Subject|183|||
156887478|NCT01700439|566347407|FG000|Overall Study|Death|186|||
156887479|NCT01892384|566347408|FG000|Overall Study|Withdrawal by Subject|1|||
156887480|NCT01892384|566347409|FG001|Overall Study|Withdrawal by Subject|1|||
156887481|NCT01892384|566347410|FG002|Overall Study|Withdrawal by Subject|0|||
156887482|NCT01892384|566347411|FG003|Overall Study|Withdrawal by Subject|0|||
156887483|NCT00592774|566347412|FG000|Overall Study|Adverse Event|5|||
156887484|NCT00592774|566347413|FG001|Overall Study|Adverse Event|19|||
156887485|NCT00592774|566347414|FG002|Overall Study|Adverse Event|2|||
156887486|NCT00592774|566347415|FG003|Overall Study|Adverse Event|14|||
156887487|NCT00592774|566347416|FG004|Overall Study|Adverse Event|8|||
156887488|NCT00592774|566347412|FG000|Overall Study|Protocol Violation|0|||
156887489|NCT00592774|566347413|FG001|Overall Study|Protocol Violation|1|||
156887490|NCT00592774|566347414|FG002|Overall Study|Protocol Violation|0|||
156887491|NCT00592774|566347415|FG003|Overall Study|Protocol Violation|0|||
156887492|NCT00592774|566347416|FG004|Overall Study|Protocol Violation|1|||
156887493|NCT00592774|566347412|FG000|Overall Study|Withdrawal by Subject|3|||
156887494|NCT00592774|566347413|FG001|Overall Study|Withdrawal by Subject|7|||
156887495|NCT00592774|566347414|FG002|Overall Study|Withdrawal by Subject|0|||
156887496|NCT00592774|566347415|FG003|Overall Study|Withdrawal by Subject|0|||
156887497|NCT00592774|566347416|FG004|Overall Study|Withdrawal by Subject|0|||
156887498|NCT00592774|566347412|FG000|Overall Study|Lack of Efficacy|3|||
156887499|NCT00592774|566347413|FG001|Overall Study|Lack of Efficacy|3|||
156887500|NCT00592774|566347414|FG002|Overall Study|Lack of Efficacy|0|||
156887501|NCT00592774|566347415|FG003|Overall Study|Lack of Efficacy|0|||
156887502|NCT00592774|566347416|FG004|Overall Study|Lack of Efficacy|2|||
156887503|NCT00592774|566347412|FG000|Overall Study|Physician Decision|0|||
156887504|NCT00592774|566347413|FG001|Overall Study|Physician Decision|1|||
156887505|NCT00592774|566347414|FG002|Overall Study|Physician Decision|1|||
156887506|NCT00592774|566347415|FG003|Overall Study|Physician Decision|0|||
156887507|NCT00592774|566347416|FG004|Overall Study|Physician Decision|1|||
156887508|NCT00592774|566347412|FG000|Overall Study|Other|0|||
156887509|NCT00592774|566347413|FG001|Overall Study|Other|1|||
156887510|NCT00592774|566347414|FG002|Overall Study|Other|1|||
156887511|NCT00592774|566347415|FG003|Overall Study|Other|0|||
156887512|NCT00592774|566347416|FG004|Overall Study|Other|2|||
156887513|NCT00621621|566347425|FG000|Overall Study|Subjects were exited at EP study|30|||
156887514|NCT00621621|566347426|FG001|Overall Study|Subjects were exited at EP study|0|||
156887515|NCT01829243|566347427|FG000|First Intervention|Screen Failure|4|||
156887516|NCT01829243|566347428|FG001|First Intervention|Screen Failure|2|||
156887517|NCT00608569|566347429|FG000|Overall Study|Death|4|||
156887518|NCT00608569|566347430|FG001|Overall Study|Death|3|||
156887519|NCT00608569|566347429|FG000|Overall Study|Lost to Follow-up|4|||
156887520|NCT00608569|566347430|FG001|Overall Study|Lost to Follow-up|5|||
156841591|NCT02688985|566172276|FG000|Overall Study|Physician Decision|2|||
156841592|NCT02688985|566172277|FG001|Overall Study|Physician Decision|2|||
156841593|NCT02688985|566172278|FG002|Overall Study|Physician Decision|0|||
156841594|NCT02688985|566172279|FG003|Overall Study|Physician Decision|0|||
156841595|NCT02688985|566172280|FG004|Overall Study|Physician Decision|1|||
156841596|NCT02688985|566172276|FG000|Overall Study|Pregnancy|0|||
156841597|NCT02688985|566172277|FG001|Overall Study|Pregnancy|0|||
156841598|NCT02688985|566172278|FG002|Overall Study|Pregnancy|2|||
156841599|NCT02688985|566172279|FG003|Overall Study|Pregnancy|1|||
156841600|NCT02688985|566172280|FG004|Overall Study|Pregnancy|0|||
156841601|NCT02688985|566172276|FG000|Overall Study|Study Terminated By Sponsor|0|||
156841602|NCT02688985|566172277|FG001|Overall Study|Study Terminated By Sponsor|0|||
156841603|NCT02688985|566172278|FG002|Overall Study|Study Terminated By Sponsor|0|||
156841604|NCT02688985|566172279|FG003|Overall Study|Study Terminated By Sponsor|1|||
156841605|NCT02688985|566172280|FG004|Overall Study|Study Terminated By Sponsor|0|||
156841606|NCT02688985|566172276|FG000|Overall Study|Withdrawal by Subject|2|||
156841607|NCT02688985|566172277|FG001|Overall Study|Withdrawal by Subject|8|||
156841608|NCT02688985|566172278|FG002|Overall Study|Withdrawal by Subject|7|||
156841609|NCT02688985|566172279|FG003|Overall Study|Withdrawal by Subject|1|||
156841610|NCT02688985|566172280|FG004|Overall Study|Withdrawal by Subject|4|||
156841611|NCT00930553|566172283|FG000|Overall Study|Adverse Event|1|||
156841612|NCT00930553|566172283|FG000|Overall Study|Lack of Efficacy|7|||
156841613|NCT00930553|566172283|FG000|Overall Study|Physician Decision|39|||
156841614|NCT00930553|566172283|FG000|Overall Study|Protocol Violation|1|||
156841615|NCT00930553|566172283|FG000|Overall Study|Pregnancy|1|||
156841616|NCT00930553|566172283|FG000|Overall Study|Withdrawal by Subject|88|||
156841617|NCT00930553|566172283|FG000|Overall Study|Lost to Follow-up|25|||
156841618|NCT00930553|566172283|FG000|Overall Study|Death|9|||
156841619|NCT00930553|566172283|FG000|Overall Study|Study terminated by sponsor|24|||
156841620|NCT00930553|566172283|FG000|Overall Study|Other than specified above|28|||
156841621|NCT01964963|566172284|FG000|Overall Study|Case Report Forms Uncollected|888|||
156841622|NCT01964963|566172284|FG000|Overall Study|Protocol Deviation|50|||
156841623|NCT01964963|566172284|FG000|Overall Study|Data Reliability was not Assured|5|||
156841624|NCT01726582|566172285|FG000|Overall Study|Physician Decision|99|||
156841625|NCT01726582|566172285|FG000|Overall Study|Death|85|||
156841626|NCT01235234|566172286|FG000|Overall Study|Adverse Event|2|||
156841627|NCT01235234|566172287|FG001|Overall Study|Adverse Event|2|||
156841628|NCT01235234|566172288|FG002|Overall Study|Adverse Event|1|||
157154923|NCT04598165|567311395|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
156841629|NCT02630472|566172289|FG000|Overall Study|Physician Decision|10|||
156841630|NCT02630472|566172290|FG001|Overall Study|Physician Decision|0|||
156841631|NCT00787189|566172291|FG000|Overall Study|Lost to Follow-up|2|||
156841632|NCT00787189|566172292|FG001|Overall Study|Lost to Follow-up|2|||
156841633|NCT01279616|566172293|FG000|Overall Study|donor could not be located|5|||
156841634|NCT01279616|566172293|FG000|Overall Study|no signs of sickle cell disease|2|||
156841635|NCT00183625|566172294|FG000|Overall Study|Withdrawal by Subject|18|||
156841636|NCT00183625|566172295|FG001|Overall Study|Withdrawal by Subject|18|||
156841637|NCT00183625|566172296|FG002|Overall Study|Withdrawal by Subject|19|||
156841638|NCT00183625|566172297|FG003|Overall Study|Withdrawal by Subject|14|||
156841639|NCT01369641|566172300|FG000|Overall Study|Withdrawal by Subject|1|||
156841640|NCT00842543|566172301|FG000|Overall Study|Withdrawal by Subject|2|||
156841641|NCT00842543|566172302|FG001|Overall Study|Withdrawal by Subject|0|||
156841642|NCT00842543|566172303|FG002|Overall Study|Withdrawal by Subject|3|||
156841643|NCT00842543|566172304|FG003|Overall Study|Withdrawal by Subject|4|||
156841644|NCT01483183|566172313|FG000|Overall Study|Physician Decision|0|||
156841645|NCT01483183|566172314|FG001|Overall Study|Physician Decision|0|||
156841646|NCT01483183|566172315|FG002|Overall Study|Physician Decision|0|||
156841647|NCT01483183|566172316|FG003|Overall Study|Physician Decision|0|||
156841648|NCT01483183|566172317|FG004|Overall Study|Physician Decision|0|||
156841649|NCT01483183|566172318|FG005|Overall Study|Physician Decision|0|||
156841650|NCT01483183|566172319|FG006|Overall Study|Physician Decision|2|||
156841651|NCT01483183|566172320|FG007|Overall Study|Physician Decision|0|||
156841652|NCT01483183|566172321|FG008|Overall Study|Physician Decision|0|||
156841653|NCT01483183|566172322|FG009|Overall Study|Physician Decision|0|||
156841654|NCT01483183|566172313|FG000|Overall Study|Withdrawal by Subject|0|||
156841655|NCT01483183|566172314|FG001|Overall Study|Withdrawal by Subject|0|||
156887521|NCT00608569|566347429|FG000|Overall Study|Withdrawal by Subject|1|||
156887522|NCT00608569|566347430|FG001|Overall Study|Withdrawal by Subject|0|||
156887523|NCT00608569|566347429|FG000|Overall Study|Adverse Event|1|||
156841656|NCT01483183|566172315|FG002|Overall Study|Withdrawal by Subject|0|||
156841657|NCT01483183|566172316|FG003|Overall Study|Withdrawal by Subject|0|||
156841658|NCT01483183|566172317|FG004|Overall Study|Withdrawal by Subject|0|||
156841659|NCT01483183|566172318|FG005|Overall Study|Withdrawal by Subject|0|||
156887524|NCT00608569|566347430|FG001|Overall Study|Adverse Event|0|||
156887525|NCT00608569|566347429|FG000|Overall Study|Unable to adhere with study requirements|0|||
156841660|NCT01483183|566172319|FG006|Overall Study|Withdrawal by Subject|0|||
156841661|NCT01483183|566172320|FG007|Overall Study|Withdrawal by Subject|0|||
156841662|NCT01483183|566172321|FG008|Overall Study|Withdrawal by Subject|0|||
157024585|NCT04908722|566845421|FG000|Overall Study|Lost to Follow-up|33|||
157024586|NCT04908722|566845422|FG001|Overall Study|Lost to Follow-up|33|||
157024587|NCT04908722|566845423|FG002|Overall Study|Lost to Follow-up|36|||
157024588|NCT04908722|566845424|FG003|Overall Study|Lost to Follow-up|30|||
157024589|NCT04908722|566845425|FG004|Overall Study|Lost to Follow-up|32|||
157024590|NCT04908722|566845426|FG005|Overall Study|Lost to Follow-up|34|||
157024591|NCT04908722|566845421|FG000|Overall Study|Physician Decision|1|||
157024592|NCT04908722|566845422|FG001|Overall Study|Physician Decision|1|||
157024593|NCT04908722|566845423|FG002|Overall Study|Physician Decision|1|||
157024594|NCT04908722|566845424|FG003|Overall Study|Physician Decision|2|||
157024595|NCT04908722|566845425|FG004|Overall Study|Physician Decision|0|||
157024596|NCT04908722|566845426|FG005|Overall Study|Physician Decision|0|||
157024597|NCT04908722|566845421|FG000|Overall Study|Death|1|||
157024598|NCT04908722|566845422|FG001|Overall Study|Death|0|||
157024599|NCT04908722|566845423|FG002|Overall Study|Death|0|||
156887526|NCT00608569|566347430|FG001|Overall Study|Unable to adhere with study requirements|1|||
156887527|NCT03985878|566347438|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
156887528|NCT03985878|566347438|FG000|Overall Study|Study Terminated by Sponsor|12|||
156887529|NCT03985878|566347438|FG000|Overall Study|Withdrawal by Subject|1|||
156887530|NCT01089361|566347441|FG000|Overall Study|Death|1|||
156887531|NCT01089361|566347442|FG001|Overall Study|Death|0|||
156841663|NCT01483183|566172322|FG009|Overall Study|Withdrawal by Subject|1|||
156887532|NCT01514370|566347443|FG000|Overall Study|Protocol Violation|2|||
156887533|NCT01514370|566347444|FG001|Overall Study|Protocol Violation|3|||
156887534|NCT01514370|566347443|FG000|Overall Study|Lost to Follow-up|0|||
156887535|NCT01514370|566347444|FG001|Overall Study|Lost to Follow-up|2|||
156887536|NCT01514370|566347443|FG000|Overall Study|Withdrawal by Subject|2|||
156887537|NCT01514370|566347444|FG001|Overall Study|Withdrawal by Subject|1|||
156887538|NCT01514370|566347443|FG000|Overall Study|Adverse Event|1|||
156887539|NCT01514370|566347444|FG001|Overall Study|Adverse Event|3|||
156887540|NCT01514370|566347443|FG000|Overall Study|Other|6|||
156887541|NCT01514370|566347444|FG001|Overall Study|Other|7|||
156887542|NCT01606878|566347445|FG000|Overall Study|Adverse Event|1|||
156887543|NCT01606878|566347446|FG001|Overall Study|Adverse Event|1|||
156887544|NCT01606878|566347447|FG002|Overall Study|Adverse Event|0|||
156887545|NCT01606878|566347448|FG003|Overall Study|Adverse Event|0|||
156887546|NCT01606878|566347449|FG004|Overall Study|Adverse Event|0|||
156887547|NCT01606878|566347450|FG005|Overall Study|Adverse Event|0|||
156887548|NCT01606878|566347451|FG006|Overall Study|Adverse Event|1|||
156887549|NCT01606878|566347452|FG007|Overall Study|Adverse Event|0|||
156887550|NCT01606878|566347453|FG008|Overall Study|Adverse Event|1|||
157024600|NCT04908722|566845424|FG003|Overall Study|Death|0|||
157024601|NCT04908722|566845425|FG004|Overall Study|Death|0|||
157024602|NCT04908722|566845426|FG005|Overall Study|Death|1|||
157024603|NCT04908722|566845421|FG000|Overall Study|Withdrawal by Subject|12|||
157024604|NCT04908722|566845422|FG001|Overall Study|Withdrawal by Subject|8|||
156841664|NCT00239928|566172323|FG000|Overall Study|Lack of Efficacy|1|||
156841665|NCT00239928|566172323|FG000|Overall Study|Adverse Event|4|||
156841666|NCT00239928|566172323|FG000|Overall Study|Not need to continue study|3|||
156841667|NCT00239928|566172323|FG000|Overall Study|Withdrawal by Subject|2|||
156841668|NCT02524158|566172324|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
156841669|NCT02524158|566172325|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
156841670|NCT02524158|566172324|FG000|12-weeks Assessment|Lost to Follow-up|18|||
156841671|NCT02524158|566172325|FG001|12-weeks Assessment|Lost to Follow-up|12|||
156841672|NCT02524158|566172324|FG000|6-month Assessment|Withdrawal by Subject|1|||
156841673|NCT02524158|566172325|FG001|6-month Assessment|Withdrawal by Subject|1|||
156841674|NCT02524158|566172324|FG000|6-month Assessment|Lost to Follow-up|21|||
156841675|NCT02524158|566172325|FG001|6-month Assessment|Lost to Follow-up|20|||
156841676|NCT02718716|566172327|FG000|Overall Study|Lack of Efficacy|1|||
156887551|NCT01606878|566347454|FG009|Overall Study|Adverse Event|3|||
157024605|NCT04908722|566845423|FG002|Overall Study|Withdrawal by Subject|7|||
157024606|NCT04908722|566845424|FG003|Overall Study|Withdrawal by Subject|6|||
157024607|NCT04908722|566845425|FG004|Overall Study|Withdrawal by Subject|12|||
157024608|NCT04908722|566845426|FG005|Overall Study|Withdrawal by Subject|14|||
157024609|NCT04908722|566845421|FG000|Overall Study|Other|3|||
157024610|NCT04908722|566845422|FG001|Overall Study|Other|1|||
157024611|NCT04908722|566845423|FG002|Overall Study|Other|3|||
156841677|NCT02718716|566172328|FG001|Overall Study|Lack of Efficacy|0|||
156887552|NCT01606878|566347455|FG010|Overall Study|Adverse Event|0|||
156887553|NCT01606878|566347445|FG000|Overall Study|Lack of Efficacy|1|||
156887554|NCT01606878|566347446|FG001|Overall Study|Lack of Efficacy|1|||
157024612|NCT04908722|566845424|FG003|Overall Study|Other|2|||
157024613|NCT04908722|566845425|FG004|Overall Study|Other|4|||
157024614|NCT04908722|566845426|FG005|Overall Study|Other|1|||
157024615|NCT04908722|566845421|FG000|Overall Study|Initiated prohibited medication|0|||
156887555|NCT01606878|566347447|FG002|Overall Study|Lack of Efficacy|1|||
157024616|NCT04908722|566845422|FG001|Overall Study|Initiated prohibited medication|0|||
156887556|NCT01606878|566347448|FG003|Overall Study|Lack of Efficacy|2|||
157024617|NCT04908722|566845423|FG002|Overall Study|Initiated prohibited medication|0|||
157024618|NCT04908722|566845424|FG003|Overall Study|Initiated prohibited medication|1|||
156841678|NCT02718716|566172329|FG002|Overall Study|Lack of Efficacy|0|||
156841679|NCT02718716|566172330|FG003|Overall Study|Lack of Efficacy|0|||
156841680|NCT02718716|566172331|FG004|Overall Study|Lack of Efficacy|0|||
156841681|NCT03550404|566172332|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
156841682|NCT03550404|566172333|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
156841683|NCT03550404|566172334|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
156841684|NCT03550404|566172332|FG000|Phase 2|Vacated position|1|||
156841685|NCT03550404|566172333|FG001|Phase 2|Vacated position|0|||
156841686|NCT03550404|566172334|FG002|Phase 2|Vacated position|0|||
156841687|NCT00820222|566172336|FG000|Overall Study|Lost to Follow-up|10|||
156841688|NCT00820222|566172337|FG001|Overall Study|Lost to Follow-up|9|||
156841689|NCT00820222|566172336|FG000|Overall Study|Withdrawal by Subject|19|||
156841690|NCT00820222|566172337|FG001|Overall Study|Withdrawal by Subject|21|||
156841691|NCT00820222|566172336|FG000|Overall Study|Physician Decision|93|||
156841692|NCT00820222|566172337|FG001|Overall Study|Physician Decision|88|||
156841693|NCT00820222|566172336|FG000|Overall Study|Sponsor Terminated Study|43|||
156841694|NCT00820222|566172337|FG001|Overall Study|Sponsor Terminated Study|65|||
157024619|NCT04908722|566845425|FG004|Overall Study|Initiated prohibited medication|0|||
157024620|NCT04908722|566845426|FG005|Overall Study|Initiated prohibited medication|1|||
156841695|NCT00820222|566172336|FG000|Overall Study|Unkown|11|||
156841696|NCT00820222|566172337|FG001|Overall Study|Unkown|7|||
156841697|NCT02690714|566172338|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
156841698|NCT02690714|566172338|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
156841699|NCT00293020|566172339|FG000|Overall Study|Withdrawal by Subject|34|||
156841700|NCT00293020|566172339|FG000|Overall Study|Adverse Event|30|||
156841701|NCT00293020|566172339|FG000|Overall Study|Death|32|||
156841702|NCT00293020|566172339|FG000|Overall Study|Lack of Efficacy|12|||
156841703|NCT00293020|566172339|FG000|Overall Study|Lost to Follow-up|4|||
156841704|NCT00293020|566172339|FG000|Overall Study|Protocol Violation|6|||
156841705|NCT00293020|566172339|FG000|Overall Study|Physician Decision|21|||
156841706|NCT00293020|566172339|FG000|Overall Study|Other Reason|22|||
156841707|NCT00293020|566172339|FG000|Overall Study|No dose taken|1|||
156841708|NCT01147848|566172340|FG000|Run-in Period|Screen Failure|623|||
156841709|NCT01147848|566172341|FG001|Run-in Period|Screen Failure|0|||
156841710|NCT01147848|566172342|FG002|Run-in Period|Screen Failure|0|||
156841711|NCT01147848|566172340|FG000|Run-in Period|Run-in Failure|135|||
156841712|NCT01147848|566172341|FG001|Run-in Period|Run-in Failure|0|||
156841713|NCT01147848|566172342|FG002|Run-in Period|Run-in Failure|0|||
156841714|NCT01147848|566172340|FG000|Randomized Phase|Adverse Event|0|||
156841715|NCT01147848|566172341|FG001|Randomized Phase|Adverse Event|6|||
156841716|NCT01147848|566172342|FG002|Randomized Phase|Adverse Event|8|||
156841717|NCT01147848|566172340|FG000|Randomized Phase|Lack of Efficacy|0|||
156841718|NCT01147848|566172341|FG001|Randomized Phase|Lack of Efficacy|20|||
156841719|NCT01147848|566172342|FG002|Randomized Phase|Lack of Efficacy|11|||
156841720|NCT01147848|566172340|FG000|Randomized Phase|Protocol Violation|0|||
156841721|NCT01147848|566172341|FG001|Randomized Phase|Protocol Violation|7|||
156841722|NCT01147848|566172342|FG002|Randomized Phase|Protocol Violation|10|||
156841723|NCT01147848|566172340|FG000|Randomized Phase|Lost to Follow-up|0|||
156841724|NCT01147848|566172341|FG001|Randomized Phase|Lost to Follow-up|5|||
156841725|NCT01147848|566172342|FG002|Randomized Phase|Lost to Follow-up|7|||
156841726|NCT01147848|566172340|FG000|Randomized Phase|Physician Decision|0|||
156841727|NCT01147848|566172341|FG001|Randomized Phase|Physician Decision|0|||
156841728|NCT01147848|566172342|FG002|Randomized Phase|Physician Decision|1|||
156841729|NCT01147848|566172340|FG000|Randomized Phase|Withdrawal by Subject|0|||
156841730|NCT01147848|566172341|FG001|Randomized Phase|Withdrawal by Subject|7|||
156841731|NCT01147848|566172342|FG002|Randomized Phase|Withdrawal by Subject|9|||
156841732|NCT02540265|566172343|FG000|Overall Study|Lost to Follow-up|0|||
156841733|NCT02540265|566172344|FG001|Overall Study|Lost to Follow-up|0|||
156841734|NCT02540265|566172345|FG002|Overall Study|Lost to Follow-up|1|||
156841735|NCT01972789|566172359|FG000|Overall Study|Adverse Event|11|||
156841736|NCT01972789|566172360|FG001|Overall Study|Adverse Event|4|||
156841737|NCT01972789|566172359|FG000|Overall Study|Subject withdrew consent|14|||
156841738|NCT01972789|566172360|FG001|Overall Study|Subject withdrew consent|12|||
156841739|NCT01972789|566172359|FG000|Overall Study|Lost to Follow-up|4|||
156841740|NCT01972789|566172360|FG001|Overall Study|Lost to Follow-up|7|||
156841741|NCT01972789|566172359|FG000|Overall Study|Death|7|||
156841742|NCT01972789|566172360|FG001|Overall Study|Death|5|||
156841743|NCT01972789|566172359|FG000|Overall Study|Protocol deviation|1|||
156841744|NCT01972789|566172360|FG001|Overall Study|Protocol deviation|0|||
156841745|NCT01972789|566172359|FG000|Overall Study|Physician Decision|3|||
156887557|NCT01606878|566347449|FG004|Overall Study|Lack of Efficacy|1|||
156841746|NCT01972789|566172360|FG001|Overall Study|Physician Decision|2|||
156887558|NCT01606878|566347450|FG005|Overall Study|Lack of Efficacy|2|||
156841747|NCT00666965|566172363|FG000|Overall Study|Adverse Event|0|||
156887559|NCT01606878|566347451|FG006|Overall Study|Lack of Efficacy|1|||
156841748|NCT00666965|566172364|FG001|Overall Study|Adverse Event|2|||
156841749|NCT00666965|566172365|FG002|Overall Study|Adverse Event|1|||
156841750|NCT00666965|566172366|FG003|Overall Study|Adverse Event|9|||
156841751|NCT00666965|566172363|FG000|Overall Study|Lack of Efficacy|1|||
156841752|NCT00666965|566172364|FG001|Overall Study|Lack of Efficacy|1|||
156841753|NCT00666965|566172365|FG002|Overall Study|Lack of Efficacy|0|||
156841754|NCT00666965|566172366|FG003|Overall Study|Lack of Efficacy|0|||
156841755|NCT00666965|566172363|FG000|Overall Study|Protocol Violation|0|||
156841756|NCT00666965|566172364|FG001|Overall Study|Protocol Violation|0|||
156841757|NCT00666965|566172365|FG002|Overall Study|Protocol Violation|0|||
156841758|NCT00666965|566172366|FG003|Overall Study|Protocol Violation|2|||
156841759|NCT00666965|566172363|FG000|Overall Study|Discontinuation criteria|2|||
156841760|NCT00666965|566172364|FG001|Overall Study|Discontinuation criteria|1|||
156841761|NCT00666965|566172365|FG002|Overall Study|Discontinuation criteria|1|||
156841762|NCT00666965|566172366|FG003|Overall Study|Discontinuation criteria|2|||
156841763|NCT00666965|566172363|FG000|Overall Study|Withdrawal by Subject|0|||
156841764|NCT00666965|566172364|FG001|Overall Study|Withdrawal by Subject|0|||
156841765|NCT00666965|566172365|FG002|Overall Study|Withdrawal by Subject|0|||
156841766|NCT00666965|566172366|FG003|Overall Study|Withdrawal by Subject|2|||
156841767|NCT03596450|566172367|FG000|Overall Study|Death|9|||
156841768|NCT03596450|566172368|FG001|Overall Study|Death|9|||
156841769|NCT03596450|566172367|FG000|Overall Study|Protocol Violation|18|||
156841770|NCT03596450|566172368|FG001|Overall Study|Protocol Violation|26|||
156841771|NCT03596450|566172367|FG000|Overall Study|Lost to Follow-up|50|||
156841772|NCT03596450|566172368|FG001|Overall Study|Lost to Follow-up|56|||
156841773|NCT03596450|566172367|FG000|Overall Study|Adverse Event|14|||
156841774|NCT03596450|566172368|FG001|Overall Study|Adverse Event|7|||
156841775|NCT03596450|566172367|FG000|Overall Study|Withdrawal by Subject|38|||
156841776|NCT03596450|566172368|FG001|Overall Study|Withdrawal by Subject|36|||
156841777|NCT03596450|566172367|FG000|Overall Study|Accidentally Randomized|2|||
156841778|NCT03596450|566172368|FG001|Overall Study|Accidentally Randomized|0|||
156841779|NCT03596450|566172367|FG000|Overall Study|Other reasons|48|||
156841780|NCT03596450|566172368|FG001|Overall Study|Other reasons|53|||
156841781|NCT03596450|566172367|FG000|Overall Study|Pregnancy|2|||
156841782|NCT03596450|566172368|FG001|Overall Study|Pregnancy|0|||
156841783|NCT00498355|566172369|FG000|Overall Study|Lost to Follow-up|1|||
156841784|NCT04496453|566172370|FG000|Overall Study|Lost to Follow-up|6|||
156841785|NCT04058886|566172375|FG000|Overall Study|Withdrawal by Subject|4|||
156841786|NCT04058886|566172375|FG000|Overall Study|Inadequate deafness interpreter service|1|||
156841787|NCT03624127|566172378|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
156841788|NCT03624127|566172379|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
156841789|NCT03624127|566172380|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
156841790|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
156841791|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
156841792|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
156841793|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Death|0|||
156841794|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Death|1|||
156841795|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Death|0|||
156841796|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
156841797|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
156841798|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
156841799|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
156841800|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
156841801|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
156841802|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
156841803|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
156841804|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
156841805|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
156841806|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
156841807|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
156841808|NCT03624127|566172378|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
156841809|NCT03624127|566172379|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
156841810|NCT03624127|566172380|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
156841811|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
157154924|NCT04598165|567311394|FG000|Completed 6-week Follow-up|Death|2|||
157154925|NCT04598165|567311395|FG001|Completed 6-week Follow-up|Death|1|||
157154926|NCT04598165|567311394|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
157154927|NCT04598165|567311395|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
157154928|NCT04598165|567311394|FG000|Completed 6-week Follow-up|Ineligible|4|||
156841812|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
156841813|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
156841814|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
156841815|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
156841816|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
156841817|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156841818|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
156841819|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
156887560|NCT01606878|566347452|FG007|Overall Study|Lack of Efficacy|2|||
156887561|NCT01606878|566347453|FG008|Overall Study|Lack of Efficacy|2|||
156887562|NCT01606878|566347454|FG009|Overall Study|Lack of Efficacy|0|||
156887563|NCT01606878|566347455|FG010|Overall Study|Lack of Efficacy|1|||
156887564|NCT01606878|566347445|FG000|Overall Study|Physician Decision|1|||
156841820|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
156841821|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
156887565|NCT01606878|566347446|FG001|Overall Study|Physician Decision|0|||
156887566|NCT01606878|566347447|FG002|Overall Study|Physician Decision|2|||
156887567|NCT01606878|566347448|FG003|Overall Study|Physician Decision|1|||
156887568|NCT01606878|566347449|FG004|Overall Study|Physician Decision|1|||
156887569|NCT01606878|566347450|FG005|Overall Study|Physician Decision|1|||
156887570|NCT01606878|566347451|FG006|Overall Study|Physician Decision|2|||
156841822|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
156841823|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
156841824|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
156841825|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
156841826|NCT03624127|566172378|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
156841827|NCT03624127|566172379|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
156841828|NCT03624127|566172380|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
156841829|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
156841830|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
156841831|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
156841832|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
156841833|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
156841834|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
156841835|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
156841836|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
156841837|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
156841838|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
156841839|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
156841840|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
156841841|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
156841842|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
156841843|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
156841844|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
156841845|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
156841846|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
156841847|NCT03624127|566172378|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
156841848|NCT03624127|566172379|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
156841849|NCT03624127|566172380|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
156841850|NCT04390841|566172381|FG000|Overall Study|Withdrawal by Subject|2|||
156841851|NCT02999633|566172384|FG000|Overall Study|Adverse Event|2|||
156841852|NCT02999633|566172384|FG000|Overall Study|Progressive disease|12|||
156841853|NCT03262441|566172385|FG000|Overall Study|Withdrawal by Subject|1|||
156841854|NCT03238924|566172395|FG000|Overall Study|Withdrawal by Subject|2|||
156841855|NCT03238924|566172396|FG001|Overall Study|Withdrawal by Subject|2|||
156841856|NCT03576716|566172399|FG000|Overall Study|Withdrawal by Subject|0|||
156841857|NCT03576716|566172400|FG001|Overall Study|Withdrawal by Subject|1|||
156841858|NCT00559988|566172401|FG000|Overall Study|Death|147|||
156841859|NCT00559988|566172402|FG001|Overall Study|Death|140|||
156841860|NCT00559988|566172401|FG000|Overall Study|Withdrawal by Subject|152|||
156841861|NCT00559988|566172402|FG001|Overall Study|Withdrawal by Subject|139|||
156841862|NCT00559988|566172401|FG000|Overall Study|Lost to Follow-up|42|||
156887571|NCT01606878|566347452|FG007|Overall Study|Physician Decision|0|||
156887572|NCT01606878|566347453|FG008|Overall Study|Physician Decision|1|||
156887573|NCT01606878|566347454|FG009|Overall Study|Physician Decision|0|||
156887574|NCT01606878|566347455|FG010|Overall Study|Physician Decision|0|||
156887575|NCT01606878|566347445|FG000|Overall Study|Withdrawal by Subject|3|||
156887576|NCT01606878|566347446|FG001|Overall Study|Withdrawal by Subject|2|||
156887577|NCT01606878|566347447|FG002|Overall Study|Withdrawal by Subject|2|||
156887578|NCT01606878|566347448|FG003|Overall Study|Withdrawal by Subject|0|||
156887579|NCT01606878|566347449|FG004|Overall Study|Withdrawal by Subject|1|||
156887580|NCT01606878|566347450|FG005|Overall Study|Withdrawal by Subject|1|||
157024621|NCT04908722|566845421|FG000|Overall Study|Randomized but not vaccinated|3|||
156887581|NCT01606878|566347451|FG006|Overall Study|Withdrawal by Subject|2|||
157024622|NCT04908722|566845422|FG001|Overall Study|Randomized but not vaccinated|1|||
157024623|NCT04908722|566845423|FG002|Overall Study|Randomized but not vaccinated|2|||
156841863|NCT00559988|566172402|FG001|Overall Study|Lost to Follow-up|56|||
156841864|NCT00559988|566172401|FG000|Overall Study|ICD device explanted|10|||
156841865|NCT00559988|566172402|FG001|Overall Study|ICD device explanted|17|||
156841866|NCT02891382|566172403|FG000|Overall Study|Lost to Follow-up|3|||
156841867|NCT02891382|566172404|FG001|Overall Study|Lost to Follow-up|4|||
156841868|NCT02891382|566172405|FG002|Overall Study|Lost to Follow-up|5|||
156841869|NCT02891382|566172406|FG003|Overall Study|Lost to Follow-up|3|||
156841870|NCT02891382|566172407|FG004|Overall Study|Lost to Follow-up|4|||
156841871|NCT02249182|566172408|FG000|Treatment Phase|Lost to Follow-up|4|||
156841872|NCT02249182|566172409|FG001|Treatment Phase|Lost to Follow-up|0|||
156841873|NCT02249182|566172410|FG002|Treatment Phase|Lost to Follow-up|0|||
156841874|NCT02249182|566172411|FG003|Treatment Phase|Lost to Follow-up|0|||
156841875|NCT02249182|566172412|FG004|Treatment Phase|Lost to Follow-up|0|||
156841876|NCT01455194|566172413|FG000|Overall Study|Screen Failure|20|||
156841877|NCT01455194|566172414|FG001|Overall Study|Screen Failure|0|||
156841878|NCT01455194|566172415|FG002|Overall Study|Screen Failure|0|||
156841879|NCT01455194|566172416|FG003|Overall Study|Screen Failure|0|||
156841880|NCT01455194|566172413|FG000|Overall Study|Randomisation Failure|90|||
156841881|NCT01455194|566172414|FG001|Overall Study|Randomisation Failure|0|||
156841882|NCT01455194|566172415|FG002|Overall Study|Randomisation Failure|0|||
156841883|NCT01455194|566172416|FG003|Overall Study|Randomisation Failure|0|||
156841884|NCT01455194|566172413|FG000|Overall Study|Deterioration in asthma|12|||
156841885|NCT01455194|566172414|FG001|Overall Study|Deterioration in asthma|6|||
156841886|NCT01455194|566172415|FG002|Overall Study|Deterioration in asthma|14|||
156841887|NCT01455194|566172416|FG003|Overall Study|Deterioration in asthma|9|||
156841888|NCT01455194|566172413|FG000|Overall Study|Adverse Event|1|||
156841889|NCT01455194|566172414|FG001|Overall Study|Adverse Event|1|||
156841890|NCT01455194|566172415|FG002|Overall Study|Adverse Event|1|||
156841891|NCT01455194|566172416|FG003|Overall Study|Adverse Event|3|||
156841892|NCT01455194|566172413|FG000|Overall Study|Withdrawal by Subject|21|||
156841893|NCT01455194|566172414|FG001|Overall Study|Withdrawal by Subject|16|||
156841894|NCT01455194|566172415|FG002|Overall Study|Withdrawal by Subject|12|||
156841895|NCT01455194|566172416|FG003|Overall Study|Withdrawal by Subject|9|||
156841896|NCT01455194|566172413|FG000|Overall Study|Lost to Follow-up|2|||
156841897|NCT01455194|566172414|FG001|Overall Study|Lost to Follow-up|0|||
156841898|NCT01455194|566172415|FG002|Overall Study|Lost to Follow-up|1|||
156841899|NCT01455194|566172416|FG003|Overall Study|Lost to Follow-up|1|||
156841900|NCT01455194|566172413|FG000|Overall Study|Pregnancy|0|||
156841901|NCT01455194|566172414|FG001|Overall Study|Pregnancy|1|||
156841902|NCT01455194|566172415|FG002|Overall Study|Pregnancy|1|||
156841903|NCT01455194|566172416|FG003|Overall Study|Pregnancy|0|||
156841904|NCT01455194|566172413|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
156841905|NCT01455194|566172414|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
156841906|NCT01455194|566172415|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
156841907|NCT01455194|566172416|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
156841908|NCT01455194|566172413|FG000|Overall Study|Miscellaneous|4|||
156841909|NCT01455194|566172414|FG001|Overall Study|Miscellaneous|5|||
156841910|NCT01455194|566172415|FG002|Overall Study|Miscellaneous|1|||
156841911|NCT01455194|566172416|FG003|Overall Study|Miscellaneous|4|||
156841912|NCT02516228|566172417|FG000|Overall Study|Lost to Follow-up|1|||
156841913|NCT02516228|566172417|FG000|Overall Study|Withdrawal by Subject|1|||
156841914|NCT02516228|566172417|FG000|Overall Study|Physician Decision|1|||
156841915|NCT03916484|566172418|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841916|NCT03916484|566172419|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
156841917|NCT03916484|566172420|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841918|NCT03916484|566172421|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
156841919|NCT03916484|566172418|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
156841920|NCT03916484|566172419|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
156841921|NCT03916484|566172420|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
156841922|NCT03916484|566172421|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
156841923|NCT00504894|566172422|FG000|Overall Study|fMRI technical problems|1|||
156841924|NCT00504894|566172423|FG001|Overall Study|fMRI technical problems|1|||
156841925|NCT00504894|566172424|FG002|Overall Study|fMRI technical problems|0|||
156841926|NCT00504894|566172422|FG000|Overall Study|Withdrawal by Subject|0|||
156841927|NCT00504894|566172423|FG001|Overall Study|Withdrawal by Subject|1|||
156841928|NCT00504894|566172424|FG002|Overall Study|Withdrawal by Subject|0|||
156841929|NCT00504894|566172422|FG000|Overall Study|Infusion technical problems|0|||
156841930|NCT00504894|566172423|FG001|Overall Study|Infusion technical problems|1|||
156841931|NCT00504894|566172424|FG002|Overall Study|Infusion technical problems|0|||
156841932|NCT00504894|566172422|FG000|Overall Study|poor subject data|2|||
156841933|NCT00504894|566172423|FG001|Overall Study|poor subject data|0|||
156841934|NCT00504894|566172424|FG002|Overall Study|poor subject data|0|||
156841935|NCT05090852|566172425|FG000|Overall Study|Physician Decision|5|||
156841936|NCT01196416|566172426|FG000|Overall Study|Withdrawal by Subject|2|||
156841937|NCT00148941|566172427|FG000|Overall Study|Lost to Follow-up|17|||
156841938|NCT00148941|566172428|FG001|Overall Study|Lost to Follow-up|24|||
156841939|NCT00148941|566172429|FG002|Overall Study|Lost to Follow-up|18|||
156841940|NCT00148941|566172430|FG003|Overall Study|Lost to Follow-up|22|||
156841941|NCT00148941|566172427|FG000|Overall Study|Withdrawal by Subject|1|||
156841942|NCT00148941|566172428|FG001|Overall Study|Withdrawal by Subject|0|||
156841943|NCT00148941|566172429|FG002|Overall Study|Withdrawal by Subject|1|||
156841944|NCT00148941|566172430|FG003|Overall Study|Withdrawal by Subject|0|||
156841945|NCT00148941|566172427|FG000|Overall Study|Other|0|||
156841946|NCT00148941|566172428|FG001|Overall Study|Other|0|||
157024624|NCT04908722|566845424|FG003|Overall Study|Randomized but not vaccinated|2|||
157024625|NCT04908722|566845425|FG004|Overall Study|Randomized but not vaccinated|3|||
157024626|NCT04908722|566845426|FG005|Overall Study|Randomized but not vaccinated|4|||
157024627|NCT06424236|566845430|FG000|Overall Study|Adverse Event|0|||
157024628|NCT06424236|566845431|FG001|Overall Study|Adverse Event|1|||
157024629|NCT06424236|566845432|FG002|Overall Study|Adverse Event|0|||
157024630|NCT06424236|566845430|FG000|Overall Study|Withdrawal by Subject|3|||
157024631|NCT06424236|566845431|FG001|Overall Study|Withdrawal by Subject|1|||
157024632|NCT06424236|566845432|FG002|Overall Study|Withdrawal by Subject|2|||
157024633|NCT06424236|566845430|FG000|Overall Study|Physician Decision|0|||
157024634|NCT06424236|566845431|FG001|Overall Study|Physician Decision|1|||
157024635|NCT06424236|566845432|FG002|Overall Study|Physician Decision|0|||
157024636|NCT06424236|566845430|FG000|Overall Study|Study Terminated by Sponsor|11|||
157024637|NCT06424236|566845431|FG001|Overall Study|Study Terminated by Sponsor|20|||
157024638|NCT06424236|566845432|FG002|Overall Study|Study Terminated by Sponsor|16|||
157024639|NCT06424236|566845430|FG000|Overall Study|Lost to Follow-up|0|||
157024640|NCT06424236|566845431|FG001|Overall Study|Lost to Follow-up|1|||
157024641|NCT06424236|566845432|FG002|Overall Study|Lost to Follow-up|0|||
157024642|NCT06424236|566845430|FG000|Overall Study|Disease Progression|0|||
156841947|NCT00148941|566172429|FG002|Overall Study|Other|1|||
156841948|NCT00148941|566172430|FG003|Overall Study|Other|2|||
156841949|NCT02673684|566172431|FG000|Overall Study|Study not completed d/t loss of funding|9|||
156841950|NCT02673684|566172432|FG001|Overall Study|Study not completed d/t loss of funding|8|||
156841951|NCT04356040|566172435|FG000|Overall Study|Death|2|||
156841952|NCT04356040|566172436|FG001|Overall Study|Death|0|||
156841953|NCT04356040|566172435|FG000|Overall Study|Lost to Follow-up|1|||
156841954|NCT04356040|566172436|FG001|Overall Study|Lost to Follow-up|0|||
156841955|NCT04356040|566172435|FG000|Overall Study|Physician Decision|0|||
156841956|NCT04356040|566172436|FG001|Overall Study|Physician Decision|1|||
156841957|NCT04356040|566172435|FG000|Overall Study|Withdrawal by Subject|13|||
156841958|NCT04356040|566172436|FG001|Overall Study|Withdrawal by Subject|1|||
156841959|NCT04356040|566172435|FG000|Overall Study|Enrollment Pause|10|||
156841960|NCT04356040|566172436|FG001|Overall Study|Enrollment Pause|0|||
156841961|NCT04356040|566172435|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
156841962|NCT04356040|566172436|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
156841963|NCT04356040|566172435|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
156841964|NCT04356040|566172436|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
156841965|NCT04356040|566172435|FG000|Overall Study|PI left institution|3|||
156841966|NCT04356040|566172436|FG001|Overall Study|PI left institution|0|||
156841967|NCT01092663|566172437|FG000|Overall Study|Withdrawal by Subject|3|||
156841968|NCT01092663|566172438|FG001|Overall Study|Withdrawal by Subject|2|||
156841969|NCT01092663|566172437|FG000|Overall Study|Glucose >300mg/dL|1|||
156841970|NCT01092663|566172438|FG001|Overall Study|Glucose >300mg/dL|0|||
156841971|NCT01092663|566172437|FG000|Overall Study|High fasting triglyceride|2|||
156841972|NCT01092663|566172438|FG001|Overall Study|High fasting triglyceride|0|||
156841973|NCT01092663|566172437|FG000|Overall Study|Adverse Event|1|||
156841974|NCT01092663|566172438|FG001|Overall Study|Adverse Event|1|||
156841975|NCT01092663|566172437|FG000|Overall Study|Protocol Violation|0|||
156841976|NCT01092663|566172438|FG001|Overall Study|Protocol Violation|1|||
156841977|NCT01008904|566172439|FG000|Overall Study|Lost to Follow-up|1|||
156841978|NCT01008904|566172439|FG000|Overall Study|Adverse Event|2|||
156841979|NCT01008904|566172439|FG000|Overall Study|unexpected unrelated surgery|1|||
156841980|NCT00788710|566172440|FG000|Overall Study|Adverse Event|1|||
156841981|NCT00788710|566172441|FG001|Overall Study|Adverse Event|3|||
156841982|NCT00788710|566172442|FG002|Overall Study|Adverse Event|4|||
156841983|NCT00788710|566172440|FG000|Overall Study|Lack of Efficacy|0|||
156841984|NCT00788710|566172441|FG001|Overall Study|Lack of Efficacy|0|||
156841985|NCT00788710|566172442|FG002|Overall Study|Lack of Efficacy|1|||
156841986|NCT00788710|566172440|FG000|Overall Study|Lost to Follow-up|0|||
156841987|NCT00788710|566172441|FG001|Overall Study|Lost to Follow-up|1|||
156841988|NCT00788710|566172442|FG002|Overall Study|Lost to Follow-up|0|||
156841989|NCT00788710|566172440|FG000|Overall Study|Physician Decision|2|||
156841990|NCT00788710|566172441|FG001|Overall Study|Physician Decision|1|||
156841991|NCT00788710|566172442|FG002|Overall Study|Physician Decision|0|||
156841992|NCT00788710|566172440|FG000|Overall Study|Protocol Violation|0|||
157024643|NCT06424236|566845431|FG001|Overall Study|Disease Progression|1|||
156841993|NCT00788710|566172441|FG001|Overall Study|Protocol Violation|1|||
156841994|NCT00788710|566172442|FG002|Overall Study|Protocol Violation|1|||
157024644|NCT06424236|566845432|FG002|Overall Study|Disease Progression|2|||
157024645|NCT06424236|566845430|FG000|Overall Study|Other|0|||
157024646|NCT06424236|566845431|FG001|Overall Study|Other|0|||
156841995|NCT00788710|566172440|FG000|Overall Study|Withdrawal by Subject|2|||
157024647|NCT06424236|566845432|FG002|Overall Study|Other|1|||
157024648|NCT00227344|566845437|FG000|Overall Study|study terminated early|12|||
156841996|NCT00788710|566172441|FG001|Overall Study|Withdrawal by Subject|2|||
156841997|NCT00788710|566172442|FG002|Overall Study|Withdrawal by Subject|0|||
156841998|NCT00360568|566172444|FG000|Overall Study|Adverse Event|1|||
156841999|NCT00360568|566172445|FG001|Overall Study|Adverse Event|2|||
156842000|NCT00360568|566172444|FG000|Overall Study|Lack of Efficacy|1|||
156842001|NCT00360568|566172445|FG001|Overall Study|Lack of Efficacy|0|||
156842002|NCT00360568|566172444|FG000|Overall Study|Withdrawal by Subject|0|||
156842003|NCT00360568|566172445|FG001|Overall Study|Withdrawal by Subject|3|||
156842004|NCT01008449|566172448|FG000|Overall Study|Lost to Follow-up|29|||
156842005|NCT01008449|566172449|FG001|Overall Study|Lost to Follow-up|19|||
156842006|NCT01220180|566172450|FG000|Overall Study|Lost to Follow-up|76|||
156842007|NCT01220180|566172450|FG000|Overall Study|Other|72|||
156842008|NCT01220180|566172450|FG000|Overall Study|Adverse Event|35|||
156842009|NCT01220180|566172450|FG000|Overall Study|Lack of Efficacy|22|||
156842010|NCT01220180|566172450|FG000|Overall Study|Death|1|||
156842011|NCT01220180|566172450|FG000|Overall Study|Randomized but not treated|1|||
156842012|NCT02262754|566172452|FG000|Overall Study|Adverse Event|3|||
156842013|NCT02262754|566172453|FG001|Overall Study|Adverse Event|4|||
156842014|NCT02262754|566172454|FG002|Overall Study|Adverse Event|0|||
156842015|NCT02262754|566172452|FG000|Overall Study|Lack of Efficacy|2|||
156842016|NCT02262754|566172453|FG001|Overall Study|Lack of Efficacy|0|||
156842017|NCT02262754|566172454|FG002|Overall Study|Lack of Efficacy|1|||
156842018|NCT02262754|566172452|FG000|Overall Study|Lost to Follow-up|0|||
156842019|NCT02262754|566172453|FG001|Overall Study|Lost to Follow-up|0|||
156842020|NCT02262754|566172454|FG002|Overall Study|Lost to Follow-up|1|||
156842021|NCT02262754|566172452|FG000|Overall Study|No longer meets eligibility criteria|0|||
156842022|NCT02262754|566172453|FG001|Overall Study|No longer meets eligibility criteria|1|||
156842023|NCT02262754|566172454|FG002|Overall Study|No longer meets eligibility criteria|0|||
156842024|NCT02262754|566172452|FG000|Overall Study|Study terminated by sponsor|5|||
156842025|NCT02262754|566172453|FG001|Overall Study|Study terminated by sponsor|4|||
156842026|NCT02262754|566172454|FG002|Overall Study|Study terminated by sponsor|4|||
156842027|NCT02262754|566172452|FG000|Overall Study|Protocol Violation|1|||
156842028|NCT02262754|566172453|FG001|Overall Study|Protocol Violation|0|||
156842029|NCT02262754|566172454|FG002|Overall Study|Protocol Violation|0|||
156842030|NCT02262754|566172452|FG000|Overall Study|Withdrawal by Subject|1|||
156842031|NCT02262754|566172453|FG001|Overall Study|Withdrawal by Subject|0|||
156842032|NCT02262754|566172454|FG002|Overall Study|Withdrawal by Subject|1|||
156842033|NCT02262754|566172452|FG000|Overall Study|Other|4|||
156842034|NCT02262754|566172453|FG001|Overall Study|Other|0|||
156842035|NCT02262754|566172454|FG002|Overall Study|Other|2|||
156842036|NCT01299116|566172458|FG000|Overall Study|Lost to Follow-up|65|||
156842037|NCT01299116|566172459|FG001|Overall Study|Lost to Follow-up|9|||
156842038|NCT01299116|566172460|FG002|Overall Study|Lost to Follow-up|11|||
156842039|NCT04079114|566172462|FG000|Overall Study|Study prematuely terminated.|166|||
156842040|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
156842041|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
156842042|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
156842043|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
156842044|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
156842045|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
156842046|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
156842047|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
156842048|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Death|0|||
156842049|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Death|1|||
156842050|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
156842051|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
156842052|NCT03281304|566172466|FG000|Treatment Phase (up to 42 Months)|Other|0|||
156842053|NCT03281304|566172467|FG001|Treatment Phase (up to 42 Months)|Other|2|||
156842054|NCT03281304|566172466|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
156842055|NCT03281304|566172467|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
156842056|NCT01114438|566172468|FG000|Overall Study|Adverse Event|10|||
156887582|NCT01606878|566347452|FG007|Overall Study|Withdrawal by Subject|1|||
156887583|NCT01606878|566347453|FG008|Overall Study|Withdrawal by Subject|2|||
156842057|NCT01114438|566172468|FG000|Overall Study|concomitant medication|1|||
156842058|NCT01114438|566172468|FG000|Overall Study|Physician Decision|1|||
156842059|NCT01114438|566172468|FG000|Overall Study|Withdrawal by Subject|2|||
156842060|NCT02611817|566174177|FG000|Open-label Induction Phase|Reason not Specified|9|||
156842061|NCT02611817|566174178|FG001|Open-label Induction Phase|Reason not Specified|0|||
156842062|NCT02611817|566174179|FG002|Open-label Induction Phase|Reason not Specified|0|||
156842063|NCT02611817|566174177|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
156842064|NCT02611817|566174178|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
156887584|NCT01606878|566347454|FG009|Overall Study|Withdrawal by Subject|0|||
156842065|NCT02611817|566174179|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
156842066|NCT02611817|566174177|FG000|Open-label Induction Phase|Pregnancy|1|||
156842067|NCT02611817|566174178|FG001|Open-label Induction Phase|Pregnancy|0|||
156842068|NCT02611817|566174179|FG002|Open-label Induction Phase|Pregnancy|0|||
156842069|NCT02611817|566174177|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
156842070|NCT02611817|566174178|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
156887585|NCT01606878|566347455|FG010|Overall Study|Withdrawal by Subject|2|||
157154929|NCT04598165|567311395|FG001|Completed 6-week Follow-up|Ineligible|3|||
156842071|NCT02611817|566174179|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
156842072|NCT02611817|566174177|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
156842073|NCT02611817|566174178|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
156842074|NCT02611817|566174179|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
156842075|NCT02611817|566174177|FG000|Open-label Induction Phase|Protocol Violation|5|||
156842076|NCT02611817|566174178|FG001|Open-label Induction Phase|Protocol Violation|0|||
156842077|NCT02611817|566174179|FG002|Open-label Induction Phase|Protocol Violation|0|||
156842078|NCT02611817|566174177|FG000|Open-label Induction Phase|Adverse Event|16|||
156842079|NCT02611817|566174178|FG001|Open-label Induction Phase|Adverse Event|0|||
156842080|NCT02611817|566174179|FG002|Open-label Induction Phase|Adverse Event|0|||
156842081|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
156842082|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
156842083|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
156842084|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
156842085|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
156842086|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
156842087|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
156842088|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
156842089|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
156842090|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
156842091|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
156842092|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
156842093|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
156842094|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
156842095|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
156842096|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
156842097|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
156842098|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
156842099|NCT02611817|566174177|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
156842100|NCT02611817|566174178|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
156842101|NCT02611817|566174179|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
156842102|NCT03077919|566174180|FG000|Overall Study|Lost to Follow-up|4|||
156842103|NCT03077919|566174181|FG001|Overall Study|Lost to Follow-up|1|||
156842104|NCT03738618|566174182|FG000|Overall Study|Protocol deviation|23|||
156842105|NCT03738618|566174183|FG001|Overall Study|Protocol deviation|0|||
156842106|NCT03738618|566174182|FG000|Overall Study|Adverse Event|4|||
156842107|NCT03738618|566174183|FG001|Overall Study|Adverse Event|0|||
156842108|NCT03738618|566174182|FG000|Overall Study|Lost to Follow-up|2|||
156842109|NCT03738618|566174183|FG001|Overall Study|Lost to Follow-up|0|||
156842110|NCT03738618|566174182|FG000|Overall Study|Randomization failure|1|||
156842111|NCT03738618|566174183|FG001|Overall Study|Randomization failure|0|||
156842112|NCT03738618|566174182|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
156842113|NCT03738618|566174183|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
156842114|NCT03738618|566174182|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
156842115|NCT03738618|566174183|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
156842116|NCT00826618|566174184|FG000|Overall Study|Withdrawal by Subject|1|||
156842117|NCT01363661|566174187|FG000|Overall Study|Adverse Event|9|||
156842118|NCT01363661|566174188|FG001|Overall Study|Adverse Event|2|||
156842119|NCT01363661|566174187|FG000|Overall Study|Withdrawal by Subject|1|||
156842120|NCT01363661|566174188|FG001|Overall Study|Withdrawal by Subject|1|||
156842121|NCT01363661|566174187|FG000|Overall Study|Protocol Violation|1|||
156842122|NCT01363661|566174188|FG001|Overall Study|Protocol Violation|0|||
156842123|NCT01363661|566174187|FG000|Overall Study|Lost to Follow-up|3|||
156842124|NCT01363661|566174188|FG001|Overall Study|Lost to Follow-up|1|||
156842125|NCT02219334|566174191|FG000|Overall Study|Withdrawal by Subject|1|||
156842126|NCT02219334|566174192|FG001|Overall Study|Withdrawal by Subject|0|||
156842127|NCT02219334|566174191|FG000|Overall Study|Protocol Violation|7|||
156842128|NCT02219334|566174192|FG001|Overall Study|Protocol Violation|3|||
156842129|NCT03704688|566174201|FG000|Overall Study|Adverse Event|0|||
156842130|NCT03704688|566174202|FG001|Overall Study|Adverse Event|0|||
156842131|NCT03704688|566174203|FG002|Overall Study|Adverse Event|0|||
156842132|NCT03704688|566174204|FG003|Overall Study|Adverse Event|4|||
156842133|NCT03704688|566174205|FG004|Overall Study|Adverse Event|1|||
156842134|NCT03704688|566174206|FG005|Overall Study|Adverse Event|0|||
156842135|NCT03704688|566174201|FG000|Overall Study|Disease Progression|0|||
156842136|NCT03704688|566174202|FG001|Overall Study|Disease Progression|0|||
156842137|NCT03704688|566174203|FG002|Overall Study|Disease Progression|0|||
156842138|NCT03704688|566174204|FG003|Overall Study|Disease Progression|3|||
156842139|NCT03704688|566174205|FG004|Overall Study|Disease Progression|1|||
156842140|NCT03704688|566174206|FG005|Overall Study|Disease Progression|0|||
156842141|NCT03704688|566174201|FG000|Overall Study|Death|0|||
156842142|NCT03704688|566174202|FG001|Overall Study|Death|0|||
156842143|NCT03704688|566174203|FG002|Overall Study|Death|0|||
157154930|NCT04598165|567311394|FG000|Completed 6-week Follow-up|Partner refusal|0|||
156842144|NCT03704688|566174204|FG003|Overall Study|Death|0|||
156842145|NCT03704688|566174205|FG004|Overall Study|Death|3|||
156842146|NCT03704688|566174206|FG005|Overall Study|Death|0|||
156842147|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842148|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842149|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
156842150|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
156842151|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
156842152|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842153|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
156842154|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
156842155|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
156842156|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842157|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842158|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842159|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
156842160|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
156842161|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156842162|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
156842163|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156887586|NCT01007253|566347456|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
156887587|NCT01007253|566347457|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156887588|NCT01007253|566347458|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156887589|NCT01007253|566347459|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
156887590|NCT01159431|566347462|FG000|Overall Study|Adverse Event|1|||
156887591|NCT01159431|566347463|FG001|Overall Study|Adverse Event|2|||
156887592|NCT01159431|566347462|FG000|Overall Study|non-compliance|1|||
156887593|NCT01159431|566347463|FG001|Overall Study|non-compliance|1|||
156887594|NCT01159431|566347462|FG000|Overall Study|Lack of Efficacy|0|||
156887595|NCT01159431|566347463|FG001|Overall Study|Lack of Efficacy|3|||
156887596|NCT00604214|566347465|FG000|Baseline to Day 28|Death|223|||
156887597|NCT00604214|566347466|FG001|Baseline to Day 28|Death|202|||
156887598|NCT00604214|566347465|FG000|Baseline to Day 28|Lost to Follow-up|2|||
156887599|NCT00604214|566347466|FG001|Baseline to Day 28|Lost to Follow-up|4|||
156887600|NCT00604214|566347465|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
156887601|NCT00604214|566347466|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
156887602|NCT00604214|566347465|FG000|Day 29 to Day 90|Death|64|||
156887603|NCT00604214|566347466|FG001|Day 29 to Day 90|Death|67|||
156887604|NCT00604214|566347465|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
156887605|NCT00604214|566347466|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
156887606|NCT00604214|566347465|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
156887607|NCT00604214|566347466|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
156887608|NCT00604214|566347465|FG000|Day 91 to Day 180|Death|19|||
156887609|NCT00604214|566347466|FG001|Day 91 to Day 180|Death|23|||
156887610|NCT00604214|566347465|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
156887611|NCT00604214|566347466|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
156887612|NCT00604214|566347465|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
156887613|NCT00604214|566347466|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
156887614|NCT00534599|566347467|FG000|Overall Study|Adverse Event|25|||
156887615|NCT00534599|566347468|FG001|Overall Study|Adverse Event|4|||
156887616|NCT00534599|566347467|FG000|Overall Study|Incorrect enrollment|2|||
156887617|NCT00534599|566347468|FG001|Overall Study|Incorrect enrollment|1|||
156887618|NCT00534599|566347467|FG000|Overall Study|Mis-randomization|2|||
156887619|NCT00534599|566347468|FG001|Overall Study|Mis-randomization|2|||
156887620|NCT00534599|566347467|FG000|Overall Study|Developed study-specific d/c criteria|5|||
156887621|NCT00534599|566347468|FG001|Overall Study|Developed study-specific d/c criteria|0|||
156887622|NCT00534599|566347467|FG000|Overall Study|Lack of Efficacy|0|||
156887623|NCT00534599|566347468|FG001|Overall Study|Lack of Efficacy|1|||
156887624|NCT00534599|566347467|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
157154931|NCT04598165|567311395|FG001|Completed 6-week Follow-up|Partner refusal|1|||
157154932|NCT04598165|567311394|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
157154933|NCT04598165|567311395|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
156842164|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156842165|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156887625|NCT00534599|566347468|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
156887626|NCT00534599|566347467|FG000|Overall Study|Protocol Violation|1|||
156887627|NCT00534599|566347468|FG001|Overall Study|Protocol Violation|3|||
156887628|NCT00534599|566347467|FG000|Overall Study|Lost to Follow-up|11|||
156887629|NCT00534599|566347468|FG001|Overall Study|Lost to Follow-up|14|||
156887630|NCT00534599|566347467|FG000|Overall Study|Withdrawal by Subject|4|||
156842166|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
156842167|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
156887631|NCT00534599|566347468|FG001|Overall Study|Withdrawal by Subject|6|||
157024649|NCT00227344|566845438|FG001|Overall Study|study terminated early|5|||
157024650|NCT01987895|566845439|FG000|Overall Study|Withdrawal by Subject|12|||
157024651|NCT01987895|566845440|FG001|Overall Study|Withdrawal by Subject|7|||
157024652|NCT01987895|566845439|FG000|Overall Study|Physician Decision|8|||
157024653|NCT01987895|566845440|FG001|Overall Study|Physician Decision|10|||
157024654|NCT01987895|566845439|FG000|Overall Study|Death|7|||
157024655|NCT01987895|566845440|FG001|Overall Study|Death|7|||
157024656|NCT01987895|566845439|FG000|Overall Study|Lost to Follow-up|3|||
157024657|NCT01987895|566845440|FG001|Overall Study|Lost to Follow-up|5|||
157024658|NCT01987895|566845439|FG000|Overall Study|randomized before giving IC|0|||
157024659|NCT01987895|566845440|FG001|Overall Study|randomized before giving IC|1|||
157024660|NCT02979327|566845441|FG000|First Intervention|Protocol Violation|1|||
157024661|NCT02979327|566845442|FG001|First Intervention|Protocol Violation|0|||
157024662|NCT01073566|566845448|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
157024663|NCT01073566|566845449|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
157024664|NCT05780437|566845450|FG000|Overall Study|Withdrawal by Subject|22|||
157024665|NCT05780437|566845451|FG001|Overall Study|Withdrawal by Subject|16|||
157024666|NCT03452579|566845465|FG000|Overall Study|Death|0|||
157024667|NCT03452579|566845466|FG001|Overall Study|Death|1|||
157024668|NCT03452579|566845465|FG000|Overall Study|Withdrawal by Subject|2|||
157024669|NCT03452579|566845466|FG001|Overall Study|Withdrawal by Subject|0|||
157024670|NCT03452579|566845465|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
157024671|NCT03452579|566845466|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
157024672|NCT03452579|566845465|FG000|Overall Study|Physician Decision|1|||
157024673|NCT03452579|566845466|FG001|Overall Study|Physician Decision|1|||
157024674|NCT03452579|566845465|FG000|Overall Study|Adverse Event|1|||
157024675|NCT03452579|566845466|FG001|Overall Study|Adverse Event|4|||
157024676|NCT03474679|566845467|FG000|Overall Study|Death|7|||
157024677|NCT03474679|566845467|FG000|Overall Study|Withdrawal by Subject|1|||
157024678|NCT04858321|566845474|FG000|Overall Study|Withdrawal by Subject|3|||
157024679|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
157024680|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
157024681|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
157024682|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
157024683|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
157024684|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
157024685|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Death|6|||
157024686|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Death|0|||
157024687|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Death|0|||
157024688|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
157024689|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
157024690|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
157024691|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
157024692|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
157024693|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
157024694|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
157024695|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
157024696|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
157024697|NCT01539083|566845475|FG000|Before Randomization (VCD Induction)|Other|5|||
157024698|NCT01539083|566845476|FG001|Before Randomization (VCD Induction)|Other|0|||
157024699|NCT01539083|566845477|FG002|Before Randomization (VCD Induction)|Other|0|||
157024700|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
157024701|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
157024702|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
157024703|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Other|0|||
157024704|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Other|1|||
157024705|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Other|1|||
157024706|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
157024707|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
157024708|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
157024709|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
157024710|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
157024711|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
157024712|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
157024713|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
157024714|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
157024715|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
157024716|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
157024717|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
157024718|NCT01539083|566845475|FG000|After Randomization (TP and VTP)|Death|0|||
157024719|NCT01539083|566845476|FG001|After Randomization (TP and VTP)|Death|6|||
156842168|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
156842169|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842170|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842171|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842172|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
156842173|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842174|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842175|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842176|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842177|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842178|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842179|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
156842180|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842181|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842182|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842183|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842184|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842185|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
156842186|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842187|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842188|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842189|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842190|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842191|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842192|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842193|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842194|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
156842195|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842196|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842197|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842198|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
156842199|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842200|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842201|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842202|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
156842203|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842204|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842205|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842206|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
156842207|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842208|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842209|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842210|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842211|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
156842212|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842213|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842214|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842215|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
156842216|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842217|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842218|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
156842219|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842220|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842221|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842222|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842223|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842224|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
156842225|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842226|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
156842227|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842228|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842229|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842230|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842231|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842232|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
157024720|NCT01539083|566845477|FG002|After Randomization (TP and VTP)|Death|11|||
157024721|NCT02573493|566845480|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
157024722|NCT02573493|566845481|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
157024723|NCT02573493|566845482|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
157024724|NCT02573493|566845483|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
157024725|NCT04350463|566845493|FG000|Overall Study|Other reason|0|||
157024726|NCT04350463|566845494|FG001|Overall Study|Other reason|0|||
157024727|NCT04350463|566845495|FG002|Overall Study|Other reason|0|||
157024728|NCT04350463|566845496|FG003|Overall Study|Other reason|1|||
157024729|NCT04350463|566845493|FG000|Overall Study|Lost to Follow-up|0|||
157024730|NCT04350463|566845494|FG001|Overall Study|Lost to Follow-up|0|||
157024731|NCT04350463|566845495|FG002|Overall Study|Lost to Follow-up|0|||
157024732|NCT04350463|566845496|FG003|Overall Study|Lost to Follow-up|2|||
157024733|NCT04350463|566845493|FG000|Overall Study|Withdrawal by Subject|4|||
157024734|NCT04350463|566845494|FG001|Overall Study|Withdrawal by Subject|0|||
157024735|NCT04350463|566845495|FG002|Overall Study|Withdrawal by Subject|1|||
157024736|NCT04350463|566845496|FG003|Overall Study|Withdrawal by Subject|4|||
157024737|NCT04350463|566845493|FG000|Overall Study|Adverse Event|0|||
157024738|NCT04350463|566845494|FG001|Overall Study|Adverse Event|0|||
157024739|NCT04350463|566845495|FG002|Overall Study|Adverse Event|0|||
157024740|NCT04350463|566845496|FG003|Overall Study|Adverse Event|2|||
157024741|NCT04350463|566845493|FG000|Overall Study|Death|27|||
157024742|NCT04350463|566845494|FG001|Overall Study|Death|2|||
157024743|NCT04350463|566845495|FG002|Overall Study|Death|13|||
157024744|NCT04350463|566845496|FG003|Overall Study|Death|26|||
157024745|NCT02146378|566845497|FG000|Overall Study|No information of administration|2|||
157024746|NCT04629716|566845498|FG000|Overall Study|Lost to Follow-up|7|||
157024747|NCT04629716|566845499|FG001|Overall Study|Lost to Follow-up|3|||
156887632|NCT00534599|566347467|FG000|Overall Study|Other|7|||
156887633|NCT00534599|566347468|FG001|Overall Study|Other|0|||
156887634|NCT03645434|566347473|FG000|Period 1|Adverse Event|0|||
156887635|NCT03645434|566347474|FG001|Period 1|Adverse Event|0|||
156887636|NCT03645434|566347475|FG002|Period 1|Adverse Event|0|||
156887637|NCT03645434|566347476|FG003|Period 1|Adverse Event|1|||
156887638|NCT03645434|566347477|FG004|Period 1|Adverse Event|0|||
156887639|NCT03645434|566347478|FG005|Period 1|Adverse Event|0|||
156887640|NCT03645434|566347473|FG000|Period 1|COPD exacerbation|0|||
156887641|NCT03645434|566347474|FG001|Period 1|COPD exacerbation|0|||
156887642|NCT03645434|566347475|FG002|Period 1|COPD exacerbation|0|||
157024748|NCT04623671|566845500|FG000|Overall Study|Adverse Event|0|||
157024749|NCT04623671|566845501|FG001|Overall Study|Adverse Event|1|||
157024750|NCT04623671|566845500|FG000|Overall Study|Lost to Follow-up|2|||
157024751|NCT04623671|566845501|FG001|Overall Study|Lost to Follow-up|1|||
157024752|NCT04623671|566845500|FG000|Overall Study|Death|5|||
157024753|NCT04623671|566845501|FG001|Overall Study|Death|5|||
157024754|NCT04025554|566845502|FG000|Overall Study|Adverse Event|3|||
157024755|NCT01802788|566845506|FG000|Overall Study|Withdrawal by Subject|102|||
157024756|NCT01802788|566845507|FG001|Overall Study|Withdrawal by Subject|5|||
157024757|NCT01802788|566845506|FG000|Overall Study|Death|382|||
157024758|NCT01802788|566845507|FG001|Overall Study|Death|18|||
157024759|NCT01802788|566845506|FG000|Overall Study|Lost to Follow-up|31|||
157024760|NCT01802788|566845507|FG001|Overall Study|Lost to Follow-up|2|||
157024761|NCT01802788|566845506|FG000|Overall Study|Physician Decision|3|||
157024762|NCT01802788|566845507|FG001|Overall Study|Physician Decision|0|||
157024763|NCT01802788|566845506|FG000|Overall Study|Patient Non-Compliance|1|||
157024764|NCT01802788|566845507|FG001|Overall Study|Patient Non-Compliance|0|||
157024765|NCT01802788|566845506|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
157024766|NCT01802788|566845507|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
157024767|NCT01802788|566845506|FG000|Overall Study|Other Reasons|19|||
157154934|NCT00426751|567311398|FG000|Overall Study|Adverse Event|8|||
157154935|NCT00426751|567311399|FG001|Overall Study|Adverse Event|1|||
157154936|NCT00426751|567311398|FG000|Overall Study|Lost to Follow-up|7|||
157154937|NCT00426751|567311399|FG001|Overall Study|Lost to Follow-up|6|||
157154938|NCT00426751|567311398|FG000|Overall Study|Consent Withdrawn|0|||
157154939|NCT00426751|567311399|FG001|Overall Study|Consent Withdrawn|1|||
157154940|NCT00426751|567311398|FG000|Overall Study|Other Reasons|7|||
157154941|NCT00426751|567311399|FG001|Overall Study|Other Reasons|12|||
157024768|NCT01802788|566845507|FG001|Overall Study|Other Reasons|0|||
157024769|NCT05257486|566845508|FG000|Overall Study|Protocol Violation|3|||
157024770|NCT03848065|566845509|FG000|Overall Study|Death|0|||
157224789|NCT00992407|567569874|FG001|Overall Study|protocol Violation & Adverse events|4|||
157024771|NCT03848065|566845510|FG001|Overall Study|Death|1|||
157024772|NCT03848065|566845511|FG002|Overall Study|Death|0|||
157024773|NCT03848065|566845509|FG000|Overall Study|Lost to Follow-up|0|||
157024774|NCT03848065|566845510|FG001|Overall Study|Lost to Follow-up|0|||
157024775|NCT03848065|566845511|FG002|Overall Study|Lost to Follow-up|1|||
157024776|NCT03848065|566845509|FG000|Overall Study|Physician Decision|0|||
156887643|NCT03645434|566347476|FG003|Period 1|COPD exacerbation|0|||
157024777|NCT03848065|566845510|FG001|Overall Study|Physician Decision|0|||
157154942|NCT00576693|567311400|FG000|Overall Study|Lost to Follow-up|7|||
157154943|NCT00576693|567311401|FG001|Overall Study|Lost to Follow-up|11|||
157024778|NCT03848065|566845511|FG002|Overall Study|Physician Decision|1|||
157024779|NCT04564742|566845512|FG000|Overall Study|Lost to Follow-up|1|||
157024780|NCT04564742|566845513|FG001|Overall Study|Lost to Follow-up|0|||
157024781|NCT04564742|566845512|FG000|Overall Study|Consent Withdrawal|4|||
157024782|NCT04564742|566845513|FG001|Overall Study|Consent Withdrawal|4|||
157024783|NCT05869383|566845517|FG000|Overall Study|Withdrawal by Subject|2|||
157024784|NCT05869383|566845518|FG001|Overall Study|Withdrawal by Subject|0|||
157024785|NCT03270501|566845525|FG000|Overall Study|Screen failure|6|||
157024786|NCT03270501|566845525|FG000|Overall Study|Lost to Follow-up|2|||
157024787|NCT03270501|566845525|FG000|Overall Study|Adverse Event|1|||
157024788|NCT00764751|566845530|FG000|Overall Study|Adverse Event|1|||
157024789|NCT00764751|566845531|FG001|Overall Study|Adverse Event|1|||
157024790|NCT00764751|566845530|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
157024791|NCT00764751|566845531|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
157024792|NCT04065841|566845538|FG000|Overall Study|Adverse Event|4|||
157024793|NCT04065841|566845539|FG001|Overall Study|Adverse Event|2|||
157024794|NCT04065841|566845540|FG002|Overall Study|Adverse Event|10|||
157024795|NCT04065841|566845541|FG003|Overall Study|Adverse Event|1|||
157024796|NCT04065841|566845538|FG000|Overall Study|Lost to Follow-up|1|||
157024797|NCT04065841|566845539|FG001|Overall Study|Lost to Follow-up|2|||
157024798|NCT04065841|566845540|FG002|Overall Study|Lost to Follow-up|2|||
157024799|NCT04065841|566845541|FG003|Overall Study|Lost to Follow-up|2|||
157024800|NCT04065841|566845538|FG000|Overall Study|Physician Decision|1|||
157024801|NCT04065841|566845539|FG001|Overall Study|Physician Decision|0|||
157154944|NCT00576693|567311400|FG000|Overall Study|Withdrawal by Subject|3|||
157154945|NCT00576693|567311401|FG001|Overall Study|Withdrawal by Subject|13|||
157154946|NCT01413178|567311402|FG000|Overall Study|Toxicity|1|||
157154947|NCT01413178|567311403|FG001|Overall Study|Toxicity|0|||
157154948|NCT01413178|567311402|FG000|Overall Study|Ineligible|0|||
157154949|NCT01413178|567311403|FG001|Overall Study|Ineligible|2|||
157154950|NCT03283163|567311404|FG000|Overall Study|Lost to Follow-up|1|||
157154951|NCT03283163|567311404|FG000|Overall Study|other life commitments|6|||
157024802|NCT04065841|566845540|FG002|Overall Study|Physician Decision|0|||
157024803|NCT04065841|566845541|FG003|Overall Study|Physician Decision|0|||
157024804|NCT04065841|566845538|FG000|Overall Study|Protocol Violation|0|||
157024805|NCT04065841|566845539|FG001|Overall Study|Protocol Violation|1|||
157024806|NCT04065841|566845540|FG002|Overall Study|Protocol Violation|0|||
157024807|NCT04065841|566845541|FG003|Overall Study|Protocol Violation|0|||
157024808|NCT04065841|566845538|FG000|Overall Study|Study terminated by Sponsor|22|||
157024809|NCT04065841|566845539|FG001|Overall Study|Study terminated by Sponsor|16|||
157024810|NCT04065841|566845540|FG002|Overall Study|Study terminated by Sponsor|28|||
157024811|NCT04065841|566845541|FG003|Overall Study|Study terminated by Sponsor|17|||
157024812|NCT04065841|566845538|FG000|Overall Study|Withdrawal by Subject|1|||
157024813|NCT04065841|566845539|FG001|Overall Study|Withdrawal by Subject|1|||
157024814|NCT04065841|566845540|FG002|Overall Study|Withdrawal by Subject|2|||
157024815|NCT04065841|566845541|FG003|Overall Study|Withdrawal by Subject|0|||
157024816|NCT01420237|566845542|FG000|Overall Study|Death|13|||
157024817|NCT01420237|566845542|FG000|Overall Study|Withdrawal by Subject|41|||
157024818|NCT01420237|566845542|FG000|Overall Study|Lost to Follow-up|32|||
157024819|NCT01420237|566845542|FG000|Overall Study|Adverse Event|10|||
157024820|NCT01420237|566845542|FG000|Overall Study|Investigative Site Termination|43|||
157024821|NCT01420237|566845542|FG000|Overall Study|Censored because study device not implanted|21|||
157024822|NCT01420237|566845542|FG000|Overall Study|Censored because surgery not performed|2|||
157024823|NCT01420237|566845542|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
157024824|NCT01420237|566845542|FG000|Overall Study|Sponsor terminated study early|127|||
157024825|NCT04074759|566845544|FG000|Overall Study|Withdrawal by Subject|0|||
157024826|NCT04074759|566845545|FG001|Overall Study|Withdrawal by Subject|0|||
157024827|NCT04074759|566845546|FG002|Overall Study|Withdrawal by Subject|0|||
157024828|NCT04074759|566845547|FG003|Overall Study|Withdrawal by Subject|0|||
157024829|NCT04074759|566845548|FG004|Overall Study|Withdrawal by Subject|0|||
157154952|NCT03283163|567311404|FG000|Overall Study|COVID-19 institution wide halting|1|||
157154953|NCT03283163|567311404|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
157224790|NCT00992407|567569873|FG000|Overall Study|Other|2|||
157224791|NCT00992407|567569874|FG001|Overall Study|Other|0|||
157224792|NCT00992407|567569873|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
157024830|NCT04074759|566845549|FG005|Overall Study|Withdrawal by Subject|2|||
157024831|NCT04074759|566845550|FG006|Overall Study|Withdrawal by Subject|0|||
156842233|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
157024832|NCT04074759|566845551|FG007|Overall Study|Withdrawal by Subject|2|||
157024833|NCT04074759|566845552|FG008|Overall Study|Withdrawal by Subject|1|||
157024834|NCT04074759|566845553|FG009|Overall Study|Withdrawal by Subject|2|||
157024835|NCT04074759|566845554|FG010|Overall Study|Withdrawal by Subject|9|||
157224793|NCT00992407|567569874|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
157024836|NCT04074759|566845555|FG011|Overall Study|Withdrawal by Subject|2|||
157024837|NCT04074759|566845556|FG012|Overall Study|Withdrawal by Subject|1|||
157154954|NCT03283163|567311404|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
157024838|NCT04074759|566845557|FG013|Overall Study|Withdrawal by Subject|3|||
157024839|NCT04074759|566845558|FG014|Overall Study|Withdrawal by Subject|2|||
157024840|NCT04074759|566845559|FG015|Overall Study|Withdrawal by Subject|0|||
157024841|NCT04074759|566845560|FG016|Overall Study|Withdrawal by Subject|0|||
157024842|NCT04074759|566845561|FG017|Overall Study|Withdrawal by Subject|3|||
157024843|NCT04074759|566845562|FG018|Overall Study|Withdrawal by Subject|1|||
157024844|NCT04074759|566845544|FG000|Overall Study|Death|1|||
157024845|NCT04074759|566845545|FG001|Overall Study|Death|0|||
157024846|NCT04074759|566845546|FG002|Overall Study|Death|1|||
157024847|NCT04074759|566845547|FG003|Overall Study|Death|1|||
157024848|NCT04074759|566845548|FG004|Overall Study|Death|2|||
157024849|NCT04074759|566845549|FG005|Overall Study|Death|0|||
157024850|NCT04074759|566845550|FG006|Overall Study|Death|1|||
157024851|NCT04074759|566845551|FG007|Overall Study|Death|0|||
157024852|NCT04074759|566845552|FG008|Overall Study|Death|3|||
157024853|NCT04074759|566845553|FG009|Overall Study|Death|2|||
157024854|NCT04074759|566845554|FG010|Overall Study|Death|4|||
157024855|NCT04074759|566845555|FG011|Overall Study|Death|1|||
157024856|NCT04074759|566845556|FG012|Overall Study|Death|0|||
157024857|NCT04074759|566845557|FG013|Overall Study|Death|2|||
157024858|NCT04074759|566845558|FG014|Overall Study|Death|1|||
157024859|NCT04074759|566845559|FG015|Overall Study|Death|0|||
157024860|NCT04074759|566845560|FG016|Overall Study|Death|1|||
157024861|NCT04074759|566845561|FG017|Overall Study|Death|0|||
157024862|NCT04074759|566845562|FG018|Overall Study|Death|1|||
157024863|NCT04074759|566845544|FG000|Overall Study|Lost to Follow-up|0|||
157024864|NCT04074759|566845545|FG001|Overall Study|Lost to Follow-up|0|||
157024865|NCT04074759|566845546|FG002|Overall Study|Lost to Follow-up|0|||
157024866|NCT04074759|566845547|FG003|Overall Study|Lost to Follow-up|0|||
157024867|NCT04074759|566845548|FG004|Overall Study|Lost to Follow-up|0|||
157024868|NCT04074759|566845549|FG005|Overall Study|Lost to Follow-up|0|||
157024869|NCT04074759|566845550|FG006|Overall Study|Lost to Follow-up|0|||
157024870|NCT04074759|566845551|FG007|Overall Study|Lost to Follow-up|0|||
157024871|NCT04074759|566845552|FG008|Overall Study|Lost to Follow-up|0|||
157024872|NCT04074759|566845553|FG009|Overall Study|Lost to Follow-up|0|||
157024873|NCT04074759|566845554|FG010|Overall Study|Lost to Follow-up|1|||
157024874|NCT04074759|566845555|FG011|Overall Study|Lost to Follow-up|0|||
157024875|NCT04074759|566845556|FG012|Overall Study|Lost to Follow-up|0|||
157024876|NCT04074759|566845557|FG013|Overall Study|Lost to Follow-up|0|||
157024877|NCT04074759|566845558|FG014|Overall Study|Lost to Follow-up|0|||
157024878|NCT04074759|566845559|FG015|Overall Study|Lost to Follow-up|0|||
157024879|NCT04074759|566845560|FG016|Overall Study|Lost to Follow-up|1|||
157024880|NCT04074759|566845561|FG017|Overall Study|Lost to Follow-up|0|||
157024881|NCT04074759|566845562|FG018|Overall Study|Lost to Follow-up|1|||
157024882|NCT04074759|566845544|FG000|Overall Study|Other|0|||
157024883|NCT04074759|566845545|FG001|Overall Study|Other|1|||
157024884|NCT04074759|566845546|FG002|Overall Study|Other|1|||
157154955|NCT04238663|567311405|FG000|Overall Study|Lost to Follow-up|0|||
157154956|NCT04238663|567311406|FG001|Overall Study|Lost to Follow-up|1|||
157154957|NCT04238663|567311407|FG002|Overall Study|Lost to Follow-up|0|||
157154958|NCT00337467|567311408|FG000|Overall Study|Adverse Event|3|||
157154959|NCT00337467|567311408|FG000|Overall Study|Subject Withdrew Consent|2|||
157154960|NCT00337467|567311408|FG000|Overall Study|Pregnancy|1|||
157154961|NCT00337467|567311408|FG000|Overall Study|Lost to Follow-up|2|||
157154962|NCT00337467|567311408|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
157154963|NCT00620321|567312811|FG000|Overall Study|Adverse Event|1|||
157154964|NCT00620321|567312812|FG001|Overall Study|Adverse Event|1|||
157154965|NCT00620321|567312811|FG000|Overall Study|Death|1|||
157154966|NCT00620321|567312812|FG001|Overall Study|Death|1|||
157154967|NCT00620321|567312811|FG000|Overall Study|Physician Decision|0|||
156842234|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
157024885|NCT04074759|566845547|FG003|Overall Study|Other|0|||
157024886|NCT04074759|566845548|FG004|Overall Study|Other|2|||
156842235|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
157024887|NCT04074759|566845549|FG005|Overall Study|Other|1|||
157024888|NCT04074759|566845550|FG006|Overall Study|Other|2|||
157024889|NCT04074759|566845551|FG007|Overall Study|Other|1|||
157024890|NCT04074759|566845552|FG008|Overall Study|Other|1|||
157024891|NCT04074759|566845553|FG009|Overall Study|Other|4|||
157024892|NCT04074759|566845554|FG010|Overall Study|Other|4|||
157024893|NCT04074759|566845555|FG011|Overall Study|Other|2|||
156842236|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
157024894|NCT04074759|566845556|FG012|Overall Study|Other|0|||
157024895|NCT04074759|566845557|FG013|Overall Study|Other|0|||
157024896|NCT04074759|566845558|FG014|Overall Study|Other|0|||
157024897|NCT04074759|566845559|FG015|Overall Study|Other|1|||
157024898|NCT04074759|566845560|FG016|Overall Study|Other|0|||
157024899|NCT04074759|566845561|FG017|Overall Study|Other|0|||
157024900|NCT04074759|566845562|FG018|Overall Study|Other|0|||
157024901|NCT04074759|566845544|FG000|Overall Study|Missing end of study status|0|||
157154968|NCT00620321|567312812|FG001|Overall Study|Physician Decision|7|||
157154969|NCT00620321|567312811|FG000|Overall Study|Progressive Disease|5|||
157154970|NCT00620321|567312812|FG001|Overall Study|Progressive Disease|5|||
156842237|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
156842238|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
156842239|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842240|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842241|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842242|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842243|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842244|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842245|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842246|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842247|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842248|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842249|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842250|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
156842251|NCT03100058|566174208|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842252|NCT03100058|566174209|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842253|NCT03100058|566174210|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842254|NCT03100058|566174211|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842255|NCT03100058|566174212|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842256|NCT03100058|566174213|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842257|NCT03100058|566174214|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
156842258|NCT03100058|566174215|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842259|NCT03100058|566174216|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842260|NCT03100058|566174217|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842261|NCT03100058|566174218|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842262|NCT03100058|566174219|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842263|NCT03100058|566174220|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
156842264|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842265|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842266|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842267|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842268|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842269|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842270|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842271|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842272|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842273|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
156842274|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
156842275|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
156842276|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
156842277|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842278|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842279|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842280|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842281|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842282|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842283|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842284|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842285|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842286|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842287|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
156842288|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
156842289|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
156842290|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842291|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842292|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842293|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842294|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842295|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842296|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842297|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842298|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842299|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
156842300|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
156842301|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
156842302|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
156842303|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156887644|NCT03645434|566347477|FG004|Period 1|COPD exacerbation|1|||
156887645|NCT03645434|566347478|FG005|Period 1|COPD exacerbation|0|||
156887646|NCT00167778|566347479|FG000|Overall Study|Withdrawal by Subject|1|||
156887647|NCT02654717|566347480|FG000|Overall Study|Adverse Event|2|||
156887648|NCT02654717|566347481|FG001|Overall Study|Adverse Event|2|||
156887649|NCT02654717|566347480|FG000|Overall Study|Protocol Violation|1|||
156887650|NCT02654717|566347481|FG001|Overall Study|Protocol Violation|2|||
156887651|NCT02654717|566347480|FG000|Overall Study|Withdrawal by Subject|0|||
156887652|NCT02654717|566347481|FG001|Overall Study|Withdrawal by Subject|1|||
156887653|NCT02654717|566347480|FG000|Overall Study|Non-permitted medication|3|||
156887654|NCT02654717|566347481|FG001|Overall Study|Non-permitted medication|0|||
156887655|NCT00960570|566347482|FG000|21 Day Washout Period|Adverse Event|1|||
156887656|NCT00960570|566347482|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
156842304|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842305|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842306|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842307|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842308|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842309|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842310|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842311|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842312|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842313|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
156842314|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842315|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
156842316|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842317|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156887657|NCT00960570|566347482|FG000|1 Day Period Between Dosing|Adverse Event|2|||
156887658|NCT00960570|566347482|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
156887659|NCT01451437|566347483|FG000|Overall Study|Adverse Event|0|||
156887660|NCT01451437|566347484|FG001|Overall Study|Adverse Event|0|||
156887661|NCT01451437|566347485|FG002|Overall Study|Adverse Event|0|||
156887662|NCT01451437|566347486|FG003|Overall Study|Adverse Event|0|||
156887663|NCT01451437|566347487|FG004|Overall Study|Adverse Event|0|||
156887664|NCT01451437|566347488|FG005|Overall Study|Adverse Event|1|||
156887665|NCT01451437|566347489|FG006|Overall Study|Adverse Event|1|||
156887666|NCT01451437|566347490|FG007|Overall Study|Adverse Event|2|||
156887667|NCT01451437|566347491|FG008|Overall Study|Adverse Event|1|||
156887668|NCT01451437|566347483|FG000|Overall Study|Physician Decision|1|||
156887669|NCT01451437|566347484|FG001|Overall Study|Physician Decision|1|||
156887670|NCT01451437|566347485|FG002|Overall Study|Physician Decision|2|||
156887671|NCT01451437|566347486|FG003|Overall Study|Physician Decision|0|||
156887672|NCT01451437|566347487|FG004|Overall Study|Physician Decision|0|||
156887673|NCT01451437|566347488|FG005|Overall Study|Physician Decision|0|||
156887674|NCT01451437|566347489|FG006|Overall Study|Physician Decision|0|||
156887675|NCT01451437|566347490|FG007|Overall Study|Physician Decision|0|||
156887676|NCT01451437|566347491|FG008|Overall Study|Physician Decision|0|||
156887677|NCT01451437|566347483|FG000|Overall Study|Disease Progression|0|||
156887678|NCT01451437|566347484|FG001|Overall Study|Disease Progression|0|||
156887679|NCT01451437|566347485|FG002|Overall Study|Disease Progression|1|||
156887680|NCT01451437|566347486|FG003|Overall Study|Disease Progression|1|||
156887681|NCT01451437|566347487|FG004|Overall Study|Disease Progression|3|||
156887682|NCT01451437|566347488|FG005|Overall Study|Disease Progression|2|||
156887683|NCT01451437|566347489|FG006|Overall Study|Disease Progression|3|||
156887684|NCT01451437|566347490|FG007|Overall Study|Disease Progression|1|||
156887685|NCT01451437|566347491|FG008|Overall Study|Disease Progression|3|||
156887686|NCT01451437|566347483|FG000|Overall Study|Protocol Violation|0|||
156887687|NCT01451437|566347484|FG001|Overall Study|Protocol Violation|0|||
156887688|NCT01451437|566347485|FG002|Overall Study|Protocol Violation|0|||
157154971|NCT00620321|567312811|FG000|Overall Study|Sponsor Decision|0|||
157154972|NCT00620321|567312812|FG001|Overall Study|Sponsor Decision|1|||
156842318|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842319|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842320|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842321|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156887689|NCT01451437|566347486|FG003|Overall Study|Protocol Violation|0|||
156842322|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156887690|NCT01451437|566347487|FG004|Overall Study|Protocol Violation|0|||
156887691|NCT01451437|566347488|FG005|Overall Study|Protocol Violation|0|||
156887692|NCT01451437|566347489|FG006|Overall Study|Protocol Violation|1|||
156887693|NCT01451437|566347490|FG007|Overall Study|Protocol Violation|0|||
156887694|NCT01451437|566347491|FG008|Overall Study|Protocol Violation|0|||
156887695|NCT01451437|566347483|FG000|Overall Study|Withdrawal by Subject|0|||
156887696|NCT01451437|566347484|FG001|Overall Study|Withdrawal by Subject|0|||
156887697|NCT01451437|566347485|FG002|Overall Study|Withdrawal by Subject|0|||
157154973|NCT00620321|567312811|FG000|Overall Study|Withdrawal by Subject|1|||
157154974|NCT00620321|567312812|FG001|Overall Study|Withdrawal by Subject|1|||
156887698|NCT01451437|566347486|FG003|Overall Study|Withdrawal by Subject|0|||
156887699|NCT01451437|566347487|FG004|Overall Study|Withdrawal by Subject|1|||
156887700|NCT01451437|566347488|FG005|Overall Study|Withdrawal by Subject|0|||
156887701|NCT01451437|566347489|FG006|Overall Study|Withdrawal by Subject|1|||
156887702|NCT01451437|566347490|FG007|Overall Study|Withdrawal by Subject|0|||
156887703|NCT01451437|566347491|FG008|Overall Study|Withdrawal by Subject|0|||
156887704|NCT01275339|566349342|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
156887705|NCT01275339|566349343|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
156887706|NCT01275339|566349344|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
156887707|NCT01275339|566349345|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
156887708|NCT01275339|566349342|FG000|Overall Study|Withdrawal by Subject|0|||
156887709|NCT01275339|566349343|FG001|Overall Study|Withdrawal by Subject|0|||
156887710|NCT01275339|566349344|FG002|Overall Study|Withdrawal by Subject|1|||
156887711|NCT01275339|566349345|FG003|Overall Study|Withdrawal by Subject|0|||
156887712|NCT03718299|566349346|FG000|Overall Study|Adverse Event|1|||
156887713|NCT03718299|566349346|FG000|Overall Study|Withdrawal by Subject|6|||
156887714|NCT03718299|566349346|FG000|Overall Study|Physician Decision|2|||
156887715|NCT03718299|566349346|FG000|Overall Study|Lost to Follow-up|1|||
156887716|NCT04389970|566349347|FG000|Overall Study|Lost to Follow-up|1|||
156887717|NCT03123185|566349348|FG000|Overall Study|Withdrawal by Subject|0|||
156887718|NCT03123185|566349349|FG001|Overall Study|Withdrawal by Subject|0|||
156887719|NCT03123185|566349350|FG002|Overall Study|Withdrawal by Subject|0|||
156887720|NCT03123185|566349351|FG003|Overall Study|Withdrawal by Subject|0|||
156887721|NCT03123185|566349352|FG004|Overall Study|Withdrawal by Subject|0|||
156887722|NCT03123185|566349353|FG005|Overall Study|Withdrawal by Subject|0|||
156887723|NCT03123185|566349354|FG006|Overall Study|Withdrawal by Subject|0|||
156887724|NCT03123185|566349355|FG007|Overall Study|Withdrawal by Subject|0|||
156887725|NCT03123185|566349356|FG008|Overall Study|Withdrawal by Subject|0|||
156887726|NCT03123185|566349357|FG009|Overall Study|Withdrawal by Subject|0|||
156887727|NCT03123185|566349358|FG010|Overall Study|Withdrawal by Subject|0|||
156887728|NCT03123185|566349359|FG011|Overall Study|Withdrawal by Subject|0|||
156887729|NCT03123185|566349360|FG012|Overall Study|Withdrawal by Subject|1|||
156887730|NCT03123185|566349361|FG013|Overall Study|Withdrawal by Subject|0|||
156887731|NCT00923364|566349363|FG000|Overall Study|Death|3|||
156887732|NCT00923364|566349364|FG001|Overall Study|Death|0|||
156887733|NCT00923364|566349363|FG000|Overall Study|Did not go to transplant|1|||
156887734|NCT00923364|566349364|FG001|Overall Study|Did not go to transplant|0|||
156887735|NCT00976508|566349366|FG000|Overall Study|Death|7|||
156887736|NCT00976508|566349367|FG001|Overall Study|Death|1|||
156887737|NCT00976508|566349366|FG000|Overall Study|Lost to Follow-up|1|||
156887738|NCT00976508|566349367|FG001|Overall Study|Lost to Follow-up|0|||
156887739|NCT00976508|566349366|FG000|Overall Study|Withdrawal by Subject|1|||
156887740|NCT00976508|566349367|FG001|Overall Study|Withdrawal by Subject|0|||
156887741|NCT00976508|566349366|FG000|Overall Study|Disease Progression|4|||
156887742|NCT00976508|566349367|FG001|Overall Study|Disease Progression|4|||
156887743|NCT00976508|566349366|FG000|Overall Study|Subject Enrolled in Hospice|1|||
156887744|NCT00976508|566349367|FG001|Overall Study|Subject Enrolled in Hospice|0|||
156887745|NCT00976508|566349366|FG000|Overall Study|Terminated by the Sponsor|0|||
156887746|NCT00976508|566349367|FG001|Overall Study|Terminated by the Sponsor|1|||
156887747|NCT04352127|566349368|FG000|Overall Study|Unable to obtain readings|4|||
156887748|NCT04352127|566349369|FG001|Overall Study|Unable to obtain readings|1|||
156887749|NCT03023046|566349370|FG000|Overall Study|Withdrawal by Subject|1|||
156887750|NCT00640835|566349371|FG000|Overall Study|Adverse Event|5|||
156887751|NCT00640835|566349372|FG001|Overall Study|Adverse Event|3|||
156887752|NCT00640835|566349371|FG000|Overall Study|Withdrawal by Subject|12|||
156887753|NCT00640835|566349372|FG001|Overall Study|Withdrawal by Subject|14|||
156887754|NCT00640835|566349371|FG000|Overall Study|Physician Decision|10|||
156887755|NCT00640835|566349372|FG001|Overall Study|Physician Decision|14|||
156887756|NCT00640835|566349371|FG000|Overall Study|Sponsor's Decision|11|||
156887757|NCT00640835|566349372|FG001|Overall Study|Sponsor's Decision|7|||
156887758|NCT00640835|566349371|FG000|Overall Study|Protocol Violation|2|||
156887759|NCT00640835|566349372|FG001|Overall Study|Protocol Violation|2|||
156887760|NCT00640835|566349371|FG000|Overall Study|Lost to Follow-up|17|||
156887761|NCT00640835|566349372|FG001|Overall Study|Lost to Follow-up|13|||
156887762|NCT00640835|566349371|FG000|Overall Study|Other Reason|19|||
156887763|NCT00640835|566349372|FG001|Overall Study|Other Reason|4|||
156887764|NCT00775203|566349373|FG000|Overall Study|Adverse Event|25|||
156887765|NCT00775203|566349374|FG001|Overall Study|Adverse Event|6|||
156887766|NCT00775203|566349373|FG000|Overall Study|Lack of Efficacy|8|||
156887767|NCT00775203|566349374|FG001|Overall Study|Lack of Efficacy|9|||
156887768|NCT00775203|566349373|FG000|Overall Study|Withdrawal by Subject|11|||
156887769|NCT00775203|566349374|FG001|Overall Study|Withdrawal by Subject|9|||
156887770|NCT00775203|566349373|FG000|Overall Study|Lost to Follow-up|11|||
156887771|NCT00775203|566349374|FG001|Overall Study|Lost to Follow-up|15|||
157154975|NCT00912015|567312813|FG000|Overall Study|Lack of Efficacy|1|||
156887772|NCT00775203|566349373|FG000|Overall Study|Administrative reason|2|||
156887773|NCT00775203|566349374|FG001|Overall Study|Administrative reason|0|||
157024902|NCT04074759|566845545|FG001|Overall Study|Missing end of study status|0|||
157024903|NCT04074759|566845546|FG002|Overall Study|Missing end of study status|0|||
157024904|NCT04074759|566845547|FG003|Overall Study|Missing end of study status|0|||
157024905|NCT04074759|566845548|FG004|Overall Study|Missing end of study status|0|||
157024906|NCT04074759|566845549|FG005|Overall Study|Missing end of study status|0|||
157024907|NCT04074759|566845550|FG006|Overall Study|Missing end of study status|0|||
157024908|NCT04074759|566845551|FG007|Overall Study|Missing end of study status|0|||
157024909|NCT04074759|566845552|FG008|Overall Study|Missing end of study status|0|||
157024910|NCT04074759|566845553|FG009|Overall Study|Missing end of study status|0|||
157024911|NCT04074759|566845554|FG010|Overall Study|Missing end of study status|2|||
157024912|NCT04074759|566845555|FG011|Overall Study|Missing end of study status|0|||
157024913|NCT04074759|566845556|FG012|Overall Study|Missing end of study status|0|||
157024914|NCT04074759|566845557|FG013|Overall Study|Missing end of study status|0|||
157024915|NCT04074759|566845558|FG014|Overall Study|Missing end of study status|0|||
157024916|NCT04074759|566845559|FG015|Overall Study|Missing end of study status|0|||
157024917|NCT04074759|566845560|FG016|Overall Study|Missing end of study status|1|||
157024918|NCT04074759|566845561|FG017|Overall Study|Missing end of study status|0|||
157024919|NCT04074759|566845562|FG018|Overall Study|Missing end of study status|0|||
157024920|NCT03631784|566845563|FG000|Overall Study|Participants Ongoing|1|||
157024921|NCT03631784|566845564|FG001|Overall Study|Participants Ongoing|0|||
157024922|NCT03631784|566845563|FG000|Overall Study|Withdrawal by Subject|3|||
157024923|NCT03631784|566845564|FG001|Overall Study|Withdrawal by Subject|3|||
157024924|NCT03631784|566845563|FG000|Overall Study|Sponsor's Decision|36|||
157024925|NCT03631784|566845564|FG001|Overall Study|Sponsor's Decision|52|||
157024926|NCT03631784|566845563|FG000|Overall Study|Lost to Follow-up|1|||
157024927|NCT03631784|566845564|FG001|Overall Study|Lost to Follow-up|0|||
157024928|NCT03631784|566845563|FG000|Overall Study|Death|71|||
157024929|NCT03631784|566845564|FG001|Overall Study|Death|49|||
157024930|NCT05329220|566845565|FG000|Active Trial Period|Adverse Event|0|||
157024931|NCT05329220|566845566|FG001|Active Trial Period|Adverse Event|0|||
157024932|NCT05329220|566845567|FG002|Active Trial Period|Adverse Event|0|||
157024933|NCT05329220|566845568|FG003|Active Trial Period|Adverse Event|0|||
157024934|NCT05329220|566845569|FG004|Active Trial Period|Adverse Event|1|||
157024935|NCT05329220|566845570|FG005|Active Trial Period|Adverse Event|0|||
156842323|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842324|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842325|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
157024936|NCT05329220|566845565|FG000|Active Trial Period|Lost to Follow-up|0|||
157024937|NCT05329220|566845566|FG001|Active Trial Period|Lost to Follow-up|0|||
157024938|NCT05329220|566845567|FG002|Active Trial Period|Lost to Follow-up|0|||
157024939|NCT05329220|566845568|FG003|Active Trial Period|Lost to Follow-up|0|||
157024940|NCT05329220|566845569|FG004|Active Trial Period|Lost to Follow-up|32|||
157024941|NCT05329220|566845570|FG005|Active Trial Period|Lost to Follow-up|28|||
157024942|NCT05329220|566845565|FG000|Active Trial Period|Physician Decision|0|||
157024943|NCT05329220|566845566|FG001|Active Trial Period|Physician Decision|0|||
157024944|NCT05329220|566845567|FG002|Active Trial Period|Physician Decision|0|||
157024945|NCT05329220|566845568|FG003|Active Trial Period|Physician Decision|0|||
157024946|NCT05329220|566845569|FG004|Active Trial Period|Physician Decision|2|||
157024947|NCT05329220|566845570|FG005|Active Trial Period|Physician Decision|0|||
157024948|NCT05329220|566845565|FG000|Active Trial Period|Protocol Violation|0|||
157024949|NCT05329220|566845566|FG001|Active Trial Period|Protocol Violation|0|||
157024950|NCT05329220|566845567|FG002|Active Trial Period|Protocol Violation|0|||
157024951|NCT05329220|566845568|FG003|Active Trial Period|Protocol Violation|0|||
157024952|NCT05329220|566845569|FG004|Active Trial Period|Protocol Violation|1|||
157024953|NCT05329220|566845570|FG005|Active Trial Period|Protocol Violation|3|||
157024954|NCT05329220|566845565|FG000|Active Trial Period|Withdrawal by Subject|0|||
157024955|NCT05329220|566845566|FG001|Active Trial Period|Withdrawal by Subject|0|||
157024956|NCT05329220|566845567|FG002|Active Trial Period|Withdrawal by Subject|0|||
157154976|NCT00912015|567312814|FG001|Overall Study|Lack of Efficacy|0|||
157154977|NCT00912015|567312815|FG002|Overall Study|Lack of Efficacy|0|||
157154978|NCT00912015|567312816|FG003|Overall Study|Lack of Efficacy|0|||
156842326|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
156842327|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
157024957|NCT05329220|566845568|FG003|Active Trial Period|Withdrawal by Subject|1|||
157024958|NCT05329220|566845569|FG004|Active Trial Period|Withdrawal by Subject|12|||
157154979|NCT00912015|567312813|FG000|Overall Study|Withdrawal by Subject|8|||
156842328|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
156842329|NCT03100058|566174208|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842330|NCT03100058|566174209|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
157024959|NCT05329220|566845570|FG005|Active Trial Period|Withdrawal by Subject|13|||
157024960|NCT05329220|566845565|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
157024961|NCT05329220|566845566|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
157024962|NCT05329220|566845567|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156842331|NCT03100058|566174210|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842332|NCT03100058|566174211|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842333|NCT03100058|566174212|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842334|NCT03100058|566174213|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842335|NCT03100058|566174214|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842336|NCT03100058|566174215|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842337|NCT03100058|566174216|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842338|NCT03100058|566174217|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
156842339|NCT03100058|566174218|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842340|NCT03100058|566174219|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842341|NCT03100058|566174220|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
156842342|NCT03671304|566174221|FG000|Overall Study|study terminated|7|||
156842343|NCT00596830|566174226|FG000|Overall Study|Death|258|||
156842344|NCT00596830|566174227|FG001|Overall Study|Death|247|||
156842345|NCT00596830|566174226|FG000|Overall Study|Lost to Follow-up|7|||
156842346|NCT00596830|566174227|FG001|Overall Study|Lost to Follow-up|11|||
156842347|NCT00596830|566174226|FG000|Overall Study|Withdrawal by Subject|22|||
156842348|NCT00596830|566174227|FG001|Overall Study|Withdrawal by Subject|12|||
156842349|NCT00596830|566174226|FG000|Overall Study|Study terminated by sponsor|51|||
156842350|NCT00596830|566174227|FG001|Overall Study|Study terminated by sponsor|62|||
156842351|NCT00596830|566174226|FG000|Overall Study|Follow-up was discontinued|1|||
156842352|NCT00596830|566174227|FG001|Overall Study|Follow-up was discontinued|0|||
156842353|NCT00596830|566174226|FG000|Overall Study|Randomized but not treated|3|||
156842354|NCT00596830|566174227|FG001|Overall Study|Randomized but not treated|7|||
156842355|NCT00887926|566174228|FG000|Overall Study|Withdrawal by Subject|0|||
156842356|NCT00887926|566174229|FG001|Overall Study|Withdrawal by Subject|1|||
156842357|NCT00887926|566174230|FG002|Overall Study|Withdrawal by Subject|0|||
156842358|NCT00887926|566174231|FG003|Overall Study|Withdrawal by Subject|0|||
156842359|NCT02097030|566174232|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
156842360|NCT02097030|566174233|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
156842361|NCT02097030|566174232|FG000|First Intervention (3 Days)|Visual Acuity|0|||
156842362|NCT02097030|566174233|FG001|First Intervention (3 Days)|Visual Acuity|1|||
156842363|NCT04869358|566174234|FG000|Overall Study|Wish to have children.|1|||
156842364|NCT04869358|566174235|FG001|Overall Study|Wish to have children.|0|||
156842365|NCT04869358|566174236|FG002|Overall Study|Wish to have children.|0|||
156842366|NCT04869358|566174237|FG003|Overall Study|Wish to have children.|0|||
156842367|NCT01336023|566174239|FG000|Week 0 to Week 26|Adverse Event|8|||
156842368|NCT01336023|566174240|FG001|Week 0 to Week 26|Adverse Event|10|||
156842369|NCT01336023|566174241|FG002|Week 0 to Week 26|Adverse Event|24|||
156842370|NCT01336023|566174239|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
156842371|NCT01336023|566174240|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
156842372|NCT01336023|566174241|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
156842373|NCT01336023|566174239|FG000|Week 0 to Week 26|Protocol Violation|1|||
156842374|NCT01336023|566174240|FG001|Week 0 to Week 26|Protocol Violation|2|||
156842375|NCT01336023|566174241|FG002|Week 0 to Week 26|Protocol Violation|0|||
156842376|NCT01336023|566174239|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
156842377|NCT01336023|566174240|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
156842378|NCT01336023|566174241|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
156842379|NCT01336023|566174239|FG000|Week 0 to Week 26|Unclassified|5|||
156842380|NCT01336023|566174240|FG001|Week 0 to Week 26|Unclassified|16|||
156842381|NCT01336023|566174241|FG002|Week 0 to Week 26|Unclassified|9|||
156842382|NCT01336023|566174239|FG000|Week 27 to 52|Adverse Event|1|||
156842383|NCT01336023|566174240|FG001|Week 27 to 52|Adverse Event|5|||
156842384|NCT01336023|566174241|FG002|Week 27 to 52|Adverse Event|2|||
157024963|NCT05329220|566845568|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
157024964|NCT05329220|566845569|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
156842385|NCT01336023|566174239|FG000|Week 27 to 52|Protocol Violation|0|||
156842386|NCT01336023|566174240|FG001|Week 27 to 52|Protocol Violation|2|||
156842387|NCT01336023|566174241|FG002|Week 27 to 52|Protocol Violation|1|||
156842388|NCT01336023|566174239|FG000|Week 27 to 52|Withdrawal Criteria|14|||
156842389|NCT01336023|566174240|FG001|Week 27 to 52|Withdrawal Criteria|19|||
156842390|NCT01336023|566174241|FG002|Week 27 to 52|Withdrawal Criteria|16|||
156842391|NCT01336023|566174239|FG000|Week 27 to 52|Unclassified|13|||
156842392|NCT01336023|566174240|FG001|Week 27 to 52|Unclassified|18|||
156842393|NCT01336023|566174241|FG002|Week 27 to 52|Unclassified|9|||
156842394|NCT01894022|566174244|FG000|Overall Study|Death|1|||
156842395|NCT01894022|566174245|FG001|Overall Study|Death|0|||
156842396|NCT01894022|566174244|FG000|Overall Study|Adverse Event, non-fatal|1|||
156842397|NCT01894022|566174245|FG001|Overall Study|Adverse Event, non-fatal|0|||
156842398|NCT01894022|566174244|FG000|Overall Study|Study Closed/terminated|7|||
156842399|NCT01894022|566174245|FG001|Overall Study|Study Closed/terminated|10|||
156842400|NCT00235716|566174248|FG000|Overall Study|Death|26|||
157024965|NCT05329220|566845570|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
157024966|NCT05329220|566845565|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
157024967|NCT05329220|566845566|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
157024968|NCT05329220|566845567|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
157024969|NCT05329220|566845568|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
157024970|NCT05329220|566845569|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
157024971|NCT05329220|566845570|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
156842401|NCT00235716|566174249|FG001|Overall Study|Death|39|||
156842402|NCT00235716|566174250|FG002|Overall Study|Death|32|||
156842403|NCT00235716|566174251|FG003|Overall Study|Death|31|||
157024972|NCT05329220|566845565|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
157024973|NCT05329220|566845566|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
157024974|NCT05329220|566845567|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
157024975|NCT05329220|566845568|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
157024976|NCT05329220|566845569|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
157024977|NCT05329220|566845570|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
157024978|NCT05329220|566845565|FG000|Follow-up Period|Adverse Event|0|||
157024979|NCT05329220|566845566|FG001|Follow-up Period|Adverse Event|0|||
157024980|NCT05329220|566845567|FG002|Follow-up Period|Adverse Event|0|||
157024981|NCT05329220|566845568|FG003|Follow-up Period|Adverse Event|0|||
157024982|NCT05329220|566845569|FG004|Follow-up Period|Adverse Event|2|||
157024983|NCT05329220|566845570|FG005|Follow-up Period|Adverse Event|1|||
157024984|NCT05329220|566845565|FG000|Follow-up Period|Death|0|||
157024985|NCT05329220|566845566|FG001|Follow-up Period|Death|0|||
157024986|NCT05329220|566845567|FG002|Follow-up Period|Death|1|||
157024987|NCT05329220|566845568|FG003|Follow-up Period|Death|1|||
157024988|NCT05329220|566845569|FG004|Follow-up Period|Death|0|||
157024989|NCT05329220|566845570|FG005|Follow-up Period|Death|1|||
157024990|NCT05329220|566845565|FG000|Follow-up Period|Lost to Follow-up|0|||
157024991|NCT05329220|566845566|FG001|Follow-up Period|Lost to Follow-up|1|||
157024992|NCT05329220|566845567|FG002|Follow-up Period|Lost to Follow-up|2|||
157024993|NCT05329220|566845568|FG003|Follow-up Period|Lost to Follow-up|2|||
157024994|NCT05329220|566845569|FG004|Follow-up Period|Lost to Follow-up|113|||
157024995|NCT05329220|566845570|FG005|Follow-up Period|Lost to Follow-up|89|||
157024996|NCT05329220|566845565|FG000|Follow-up Period|Physician Decision|0|||
157024997|NCT05329220|566845566|FG001|Follow-up Period|Physician Decision|0|||
157024998|NCT05329220|566845567|FG002|Follow-up Period|Physician Decision|0|||
157024999|NCT05329220|566845568|FG003|Follow-up Period|Physician Decision|0|||
157025000|NCT05329220|566845569|FG004|Follow-up Period|Physician Decision|2|||
157025001|NCT05329220|566845570|FG005|Follow-up Period|Physician Decision|2|||
157025002|NCT05329220|566845565|FG000|Follow-up Period|Protocol Violation|0|||
157025003|NCT05329220|566845566|FG001|Follow-up Period|Protocol Violation|0|||
157025004|NCT05329220|566845567|FG002|Follow-up Period|Protocol Violation|0|||
157025005|NCT05329220|566845568|FG003|Follow-up Period|Protocol Violation|0|||
157025006|NCT05329220|566845569|FG004|Follow-up Period|Protocol Violation|0|||
157025007|NCT05329220|566845570|FG005|Follow-up Period|Protocol Violation|1|||
157025008|NCT05329220|566845565|FG000|Follow-up Period|Withdrawal by Subject|0|||
157025009|NCT05329220|566845566|FG001|Follow-up Period|Withdrawal by Subject|0|||
157025010|NCT05329220|566845567|FG002|Follow-up Period|Withdrawal by Subject|1|||
157025011|NCT05329220|566845568|FG003|Follow-up Period|Withdrawal by Subject|1|||
157025012|NCT05329220|566845569|FG004|Follow-up Period|Withdrawal by Subject|34|||
157025013|NCT05329220|566845570|FG005|Follow-up Period|Withdrawal by Subject|35|||
157025014|NCT05329220|566845565|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
157025015|NCT05329220|566845566|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
157025016|NCT05329220|566845567|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
157025017|NCT05329220|566845568|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
157025018|NCT05329220|566845569|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
156842404|NCT00235716|566174248|FG000|Overall Study|Withdrawal by Subject|23|||
156842405|NCT00235716|566174249|FG001|Overall Study|Withdrawal by Subject|19|||
156842406|NCT00235716|566174250|FG002|Overall Study|Withdrawal by Subject|17|||
156842407|NCT00235716|566174251|FG003|Overall Study|Withdrawal by Subject|18|||
156842408|NCT00235716|566174248|FG000|Overall Study|Lost to Follow-up|12|||
156842409|NCT00235716|566174249|FG001|Overall Study|Lost to Follow-up|7|||
156842410|NCT00235716|566174250|FG002|Overall Study|Lost to Follow-up|14|||
156842411|NCT00235716|566174251|FG003|Overall Study|Lost to Follow-up|10|||
156842412|NCT00235716|566174248|FG000|Overall Study|Adverse Event|1|||
157025019|NCT05329220|566845570|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
157091555|NCT00994682|567089164|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
157091556|NCT00994682|567089165|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
156842413|NCT00235716|566174249|FG001|Overall Study|Adverse Event|1|||
156842414|NCT00235716|566174250|FG002|Overall Study|Adverse Event|1|||
156842415|NCT00235716|566174251|FG003|Overall Study|Adverse Event|0|||
156842416|NCT00235716|566174248|FG000|Overall Study|Physician Decision|0|||
156842417|NCT00235716|566174249|FG001|Overall Study|Physician Decision|1|||
156842418|NCT00235716|566174250|FG002|Overall Study|Physician Decision|1|||
156842419|NCT00235716|566174251|FG003|Overall Study|Physician Decision|3|||
156842420|NCT01545050|566174252|FG000|Overall Study|Lack of Efficacy|0|||
156842421|NCT01545050|566174253|FG001|Overall Study|Lack of Efficacy|0|||
156842422|NCT01545050|566174254|FG002|Overall Study|Lack of Efficacy|0|||
156842423|NCT01545050|566174255|FG003|Overall Study|Lack of Efficacy|3|||
156842424|NCT01545050|566174256|FG004|Overall Study|Lack of Efficacy|2|||
156842425|NCT01545050|566174252|FG000|Overall Study|Adverse Event|1|||
156842426|NCT01545050|566174253|FG001|Overall Study|Adverse Event|1|||
156842427|NCT01545050|566174254|FG002|Overall Study|Adverse Event|2|||
156842428|NCT01545050|566174255|FG003|Overall Study|Adverse Event|2|||
156842429|NCT01545050|566174256|FG004|Overall Study|Adverse Event|0|||
156842430|NCT01545050|566174252|FG000|Overall Study|Discontinued study treatment|1|||
156842431|NCT01545050|566174253|FG001|Overall Study|Discontinued study treatment|0|||
156842432|NCT01545050|566174254|FG002|Overall Study|Discontinued study treatment|0|||
156842433|NCT01545050|566174255|FG003|Overall Study|Discontinued study treatment|0|||
156842434|NCT01545050|566174256|FG004|Overall Study|Discontinued study treatment|0|||
156842435|NCT01545050|566174252|FG000|Overall Study|Withdrawal by Subject|1|||
156842436|NCT01545050|566174253|FG001|Overall Study|Withdrawal by Subject|0|||
156842437|NCT01545050|566174254|FG002|Overall Study|Withdrawal by Subject|0|||
156842438|NCT01545050|566174255|FG003|Overall Study|Withdrawal by Subject|2|||
156842439|NCT01545050|566174256|FG004|Overall Study|Withdrawal by Subject|1|||
156842440|NCT01545050|566174252|FG000|Overall Study|Participant no longer meets study criteria|0|||
156842441|NCT01545050|566174253|FG001|Overall Study|Participant no longer meets study criteria|2|||
156842442|NCT01545050|566174254|FG002|Overall Study|Participant no longer meets study criteria|0|||
156842443|NCT01545050|566174255|FG003|Overall Study|Participant no longer meets study criteria|0|||
156842444|NCT01545050|566174256|FG004|Overall Study|Participant no longer meets study criteria|1|||
156842445|NCT01545050|566174252|FG000|Overall Study|Administrative reason by sponsor|4|||
156842446|NCT01545050|566174253|FG001|Overall Study|Administrative reason by sponsor|2|||
156842447|NCT01545050|566174254|FG002|Overall Study|Administrative reason by sponsor|3|||
156842448|NCT01545050|566174255|FG003|Overall Study|Administrative reason by sponsor|5|||
156842449|NCT01545050|566174256|FG004|Overall Study|Administrative reason by sponsor|5|||
156842450|NCT03235089|566174257|FG000|Overall Study|Lost to Follow-up|1|||
156842451|NCT03235089|566174258|FG001|Overall Study|Lost to Follow-up|1|||
156842452|NCT03235089|566174257|FG000|Overall Study|Physician Decision|2|||
156842453|NCT03235089|566174258|FG001|Overall Study|Physician Decision|2|||
156842454|NCT01364389|566174259|FG000|Overall Study|Withdrawal by Subject|0|||
156842455|NCT01364389|566174260|FG001|Overall Study|Withdrawal by Subject|1|||
156842456|NCT01364389|566174261|FG002|Overall Study|Withdrawal by Subject|0|||
156842457|NCT01364389|566174259|FG000|Overall Study|Protocol deviation|0|||
156842458|NCT01364389|566174260|FG001|Overall Study|Protocol deviation|0|||
156842459|NCT01364389|566174261|FG002|Overall Study|Protocol deviation|1|||
156842460|NCT01364389|566174259|FG000|Overall Study|Administrative problems|1|||
156842461|NCT01364389|566174260|FG001|Overall Study|Administrative problems|0|||
156842462|NCT01364389|566174261|FG002|Overall Study|Administrative problems|0|||
156842463|NCT01364389|566174259|FG000|Overall Study|Adverse Event|1|||
156842464|NCT01364389|566174260|FG001|Overall Study|Adverse Event|0|||
156842465|NCT01364389|566174261|FG002|Overall Study|Adverse Event|0|||
156842466|NCT01534195|566174262|FG000|Overall Study|Withdrawal by Subject|1|||
156842467|NCT01534195|566174263|FG001|Overall Study|Withdrawal by Subject|1|||
156842468|NCT00629798|566174266|FG000|Overall Study|Not Treated|4|||
156842469|NCT02554981|566174267|FG000|Overall Study|Adverse Event|1|||
156842470|NCT02554981|566174267|FG000|Overall Study|Administrative Reasons|1|||
156842471|NCT02554981|566174267|FG000|Overall Study|Other Miscellaneous Reasons|3|||
156842472|NCT03043651|566174273|FG000|Overall Study|Death|1|||
156842473|NCT03043651|566174273|FG000|Overall Study|Progressive Disease|2|||
156842474|NCT03043651|566174273|FG000|Overall Study|Adverse Event|2|||
156842475|NCT03043651|566174273|FG000|Overall Study|Withdrawal by Subject|4|||
156842476|NCT03043651|566174273|FG000|Overall Study|Study Terminated by Sponsor|39|||
156842477|NCT01630889|566174274|FG000|Overall Study|Death|2|||
156842478|NCT01630889|566174274|FG000|Overall Study|Withdrawal by Subject|1|||
156887774|NCT00775203|566349373|FG000|Overall Study|Noncompliance|4|||
156887775|NCT00775203|566349374|FG001|Overall Study|Noncompliance|2|||
156842479|NCT01630889|566174274|FG000|Overall Study|Other than Specified|2|||
156887776|NCT00775203|566349373|FG000|Overall Study|Protocol Violation|0|||
156887777|NCT00775203|566349374|FG001|Overall Study|Protocol Violation|1|||
156842480|NCT01630889|566174274|FG000|Overall Study|Lost to Follow-up|4|||
156842481|NCT01630889|566174274|FG000|Overall Study|Other|1|||
156842482|NCT02980133|566174275|FG000|Overall Study|Other than specified|1|||
156842483|NCT02980133|566174276|FG001|Overall Study|Other than specified|1|||
156842484|NCT02980133|566174277|FG002|Overall Study|Other than specified|2|||
156842485|NCT02980133|566174278|FG003|Overall Study|Other than specified|2|||
156842486|NCT02980133|566174275|FG000|Overall Study|Lost to Follow-up|0|||
156842487|NCT02980133|566174276|FG001|Overall Study|Lost to Follow-up|0|||
156842488|NCT02980133|566174277|FG002|Overall Study|Lost to Follow-up|1|||
156842489|NCT02980133|566174278|FG003|Overall Study|Lost to Follow-up|3|||
156842490|NCT02980133|566174275|FG000|Overall Study|Protocol Violation|0|||
156842491|NCT02980133|566174276|FG001|Overall Study|Protocol Violation|1|||
156842492|NCT02980133|566174277|FG002|Overall Study|Protocol Violation|0|||
156842493|NCT02980133|566174278|FG003|Overall Study|Protocol Violation|0|||
156842494|NCT02980133|566174275|FG000|Overall Study|Withdrawal by parent/guardian|6|||
156842495|NCT02980133|566174276|FG001|Overall Study|Withdrawal by parent/guardian|3|||
157025020|NCT05329220|566845565|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
157025021|NCT05329220|566845566|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
157025022|NCT05329220|566845567|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
157025023|NCT05329220|566845568|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
157025024|NCT05329220|566845569|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
157025025|NCT05329220|566845570|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
157025026|NCT05329220|566845565|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
157025027|NCT05329220|566845566|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
157025028|NCT05329220|566845567|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
157025029|NCT05329220|566845568|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
157025030|NCT05329220|566845569|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
157025031|NCT05329220|566845570|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
157025032|NCT05329220|566845565|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
157025033|NCT05329220|566845566|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
157025034|NCT05329220|566845567|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
157025035|NCT05329220|566845568|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
157025036|NCT05329220|566845569|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
157025037|NCT05329220|566845570|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
157025038|NCT05329220|566845565|FG000|Follow-up Period|EARLY TERMINATION|0|||
157025039|NCT05329220|566845566|FG001|Follow-up Period|EARLY TERMINATION|0|||
157025040|NCT05329220|566845567|FG002|Follow-up Period|EARLY TERMINATION|0|||
157025041|NCT05329220|566845568|FG003|Follow-up Period|EARLY TERMINATION|0|||
157025042|NCT05329220|566845569|FG004|Follow-up Period|EARLY TERMINATION|0|||
157025043|NCT05329220|566845570|FG005|Follow-up Period|EARLY TERMINATION|1|||
157025044|NCT05329220|566845565|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
157025045|NCT05329220|566845566|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
157025046|NCT05329220|566845567|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
157025047|NCT05329220|566845568|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
157025048|NCT05329220|566845569|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
157025049|NCT05329220|566845570|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
157025050|NCT05329220|566845565|FG000|Follow-up Period|DROPPED|0|||
157025051|NCT05329220|566845566|FG001|Follow-up Period|DROPPED|0|||
157025052|NCT05329220|566845567|FG002|Follow-up Period|DROPPED|0|||
157025053|NCT05329220|566845568|FG003|Follow-up Period|DROPPED|0|||
157025054|NCT05329220|566845569|FG004|Follow-up Period|DROPPED|0|||
157025055|NCT05329220|566845570|FG005|Follow-up Period|DROPPED|1|||
157025056|NCT05329220|566845565|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
157025057|NCT05329220|566845566|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
157025058|NCT05329220|566845567|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
157025059|NCT05329220|566845568|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
157025060|NCT05329220|566845569|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
157025061|NCT05329220|566845570|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
157025062|NCT02465268|566845572|FG000|Overall Study|Withdrawal by Subject|4|||
157025063|NCT02465268|566845573|FG001|Overall Study|Withdrawal by Subject|3|||
157025064|NCT02465268|566845574|FG002|Overall Study|Withdrawal by Subject|1|||
157025065|NCT02465268|566845572|FG000|Overall Study|Not evaluable per protocol criteria|3|||
157025066|NCT02465268|566845573|FG001|Overall Study|Not evaluable per protocol criteria|2|||
157025067|NCT02465268|566845574|FG002|Overall Study|Not evaluable per protocol criteria|1|||
157025068|NCT02465268|566845572|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
156842496|NCT02980133|566174277|FG002|Overall Study|Withdrawal by parent/guardian|3|||
156887778|NCT00775203|566349373|FG000|Overall Study|Entered other study|1|||
157025069|NCT02465268|566845573|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
157025070|NCT02465268|566845574|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
157025071|NCT02465268|566845572|FG000|Overall Study|Study drug did not pass QA/QC|1|||
157025072|NCT02465268|566845573|FG001|Overall Study|Study drug did not pass QA/QC|0|||
157025073|NCT02465268|566845574|FG002|Overall Study|Study drug did not pass QA/QC|0|||
157025074|NCT02465268|566845572|FG000|Overall Study|Adverse Event|0|||
157025075|NCT02465268|566845573|FG001|Overall Study|Adverse Event|1|||
157025076|NCT02465268|566845574|FG002|Overall Study|Adverse Event|0|||
156842497|NCT02980133|566174278|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156887779|NCT00775203|566349374|FG001|Overall Study|Entered other study|0|||
156887780|NCT00775203|566349373|FG000|Overall Study|Physician Decision|0|||
156887781|NCT00775203|566349374|FG001|Overall Study|Physician Decision|1|||
156887782|NCT00635024|566349377|FG000|Overall Study|Adverse Event|1|||
156887783|NCT00713310|566349378|FG000|Overall Study|Adverse Event|5|||
156887784|NCT00713310|566349379|FG001|Overall Study|Adverse Event|2|||
156887785|NCT00713310|566349378|FG000|Overall Study|Lack of Efficacy|0|||
156887786|NCT00713310|566349379|FG001|Overall Study|Lack of Efficacy|2|||
156887787|NCT00713310|566349378|FG000|Overall Study|Withdrawal by Subject|0|||
156887788|NCT00713310|566349379|FG001|Overall Study|Withdrawal by Subject|2|||
156887789|NCT02195687|566349380|FG000|Overall Study|Personal Reasons|1|||
156887790|NCT02195687|566349381|FG001|Overall Study|Personal Reasons|1|||
156887791|NCT02195687|566349380|FG000|Overall Study|Lost to Follow-up|4|||
156887792|NCT02195687|566349381|FG001|Overall Study|Lost to Follow-up|1|||
156887793|NCT00779259|566349382|FG000|Quinine Alone|Adverse Event|2|||
156887794|NCT00686634|566349383|FG000|Overall Study|Protocol Violation|6|||
156887795|NCT04369924|566349386|FG000|Overall Study|Lost to Follow-up|302|||
156887796|NCT04369924|566349387|FG001|Overall Study|Lost to Follow-up|339|||
156887797|NCT01653132|566349388|FG000|First Intervention|Protocol Violation|1|||
156887798|NCT01653132|566349389|FG001|First Intervention|Protocol Violation|0|||
156887799|NCT03312751|566349390|FG000|Overall Study|Death|7|||
156887800|NCT03312751|566349391|FG001|Overall Study|Death|9|||
156887801|NCT03312751|566349390|FG000|Overall Study|Study discontinuation due to other reason|0|||
156887802|NCT03312751|566349391|FG001|Overall Study|Study discontinuation due to other reason|1|||
156887803|NCT00282464|566349392|FG000|Overall Study|Adverse Event|26|||
156887804|NCT00282464|566349393|FG001|Overall Study|Adverse Event|20|||
156887805|NCT00282464|566349392|FG000|Overall Study|Lack of Efficacy|8|||
157025077|NCT02465268|566845572|FG000|Overall Study|Physician Decision|0|||
157025078|NCT02465268|566845573|FG001|Overall Study|Physician Decision|1|||
157025079|NCT02465268|566845574|FG002|Overall Study|Physician Decision|0|||
156887806|NCT00282464|566349393|FG001|Overall Study|Lack of Efficacy|8|||
156887807|NCT00282464|566349392|FG000|Overall Study|Lost to Follow-up|10|||
156887808|NCT00282464|566349393|FG001|Overall Study|Lost to Follow-up|10|||
156887809|NCT00282464|566349392|FG000|Overall Study|Withdrawal by Subject|24|||
156887810|NCT00282464|566349393|FG001|Overall Study|Withdrawal by Subject|10|||
156887811|NCT00282464|566349392|FG000|Overall Study|laboratory abnormality|1|||
156887812|NCT00282464|566349393|FG001|Overall Study|laboratory abnormality|2|||
156887813|NCT00282464|566349392|FG000|Overall Study|Protocol Violation|0|||
156887814|NCT00282464|566349393|FG001|Overall Study|Protocol Violation|7|||
156887815|NCT00282464|566349392|FG000|Overall Study|Patient moved|1|||
156887816|NCT00282464|566349393|FG001|Overall Study|Patient moved|0|||
157025080|NCT03322267|566845576|FG000|Overall Study|Lack of Efficacy|11|||
157025081|NCT03322267|566845576|FG000|Overall Study|Adverse Event|1|||
157025082|NCT03322267|566845576|FG000|Overall Study|Withdrawal by Subject|2|||
157025083|NCT05704543|566845581|FG000|Overall Study|Withdrawal by Subject|1|||
157025084|NCT05704543|566845582|FG001|Overall Study|Withdrawal by Subject|1|||
157025085|NCT05704543|566845583|FG002|Overall Study|Withdrawal by Subject|0|||
157025086|NCT05704543|566845584|FG003|Overall Study|Withdrawal by Subject|2|||
157025087|NCT05704543|566845581|FG000|Overall Study|Lost to Follow-up|1|||
157025088|NCT05704543|566845582|FG001|Overall Study|Lost to Follow-up|2|||
157025089|NCT05704543|566845583|FG002|Overall Study|Lost to Follow-up|0|||
157025090|NCT05704543|566845584|FG003|Overall Study|Lost to Follow-up|0|||
157025091|NCT04830800|566845589|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
157025092|NCT04830800|566845590|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
157025093|NCT04830800|566845591|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
156887817|NCT00282464|566349392|FG000|Overall Study|patient non-compliant|3|||
156887818|NCT00282464|566349393|FG001|Overall Study|patient non-compliant|0|||
156887819|NCT00282464|566349392|FG000|Overall Study|patient no show|0|||
156887820|NCT00282464|566349393|FG001|Overall Study|patient no show|1|||
156887821|NCT00282464|566349392|FG000|Overall Study|patient incarcerated|0|||
156887822|NCT00282464|566349393|FG001|Overall Study|patient incarcerated|1|||
156887823|NCT00282464|566349392|FG000|Overall Study|family crisis|0|||
156887824|NCT00282464|566349393|FG001|Overall Study|family crisis|1|||
156887825|NCT00282464|566349392|FG000|Overall Study|dispensed wrong kit|0|||
156887826|NCT00282464|566349393|FG001|Overall Study|dispensed wrong kit|1|||
156887827|NCT00282464|566349392|FG000|Overall Study|dropped due to missed visits|0|||
157025094|NCT04830800|566845592|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
157025095|NCT04830800|566845593|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
157025096|NCT05192109|566845598|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
157025097|NCT05192109|566845599|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
157025098|NCT05192109|566845600|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156887828|NCT00282464|566349393|FG001|Overall Study|dropped due to missed visits|1|||
156887829|NCT00475423|566349394|FG000|Overall Study|Protocol Violation|5|||
156887830|NCT00475423|566349394|FG000|Overall Study|Adverse Event|4|||
156887831|NCT00475423|566349394|FG000|Overall Study|Withdrawal by Subject|6|||
157154980|NCT00912015|567312814|FG001|Overall Study|Withdrawal by Subject|8|||
157154981|NCT00912015|567312815|FG002|Overall Study|Withdrawal by Subject|3|||
157154982|NCT00912015|567312816|FG003|Overall Study|Withdrawal by Subject|0|||
157154983|NCT00912015|567312813|FG000|Overall Study|Protocol Violation|1|||
157154984|NCT00912015|567312814|FG001|Overall Study|Protocol Violation|0|||
156842498|NCT02980133|566174275|FG000|Overall Study|Withdrawal by Subject|0|||
156842499|NCT02980133|566174276|FG001|Overall Study|Withdrawal by Subject|0|||
156842500|NCT02980133|566174277|FG002|Overall Study|Withdrawal by Subject|1|||
156842501|NCT02980133|566174278|FG003|Overall Study|Withdrawal by Subject|0|||
156842502|NCT02974842|566174279|FG000|Overall Study|Withdrawal by Subject|4|||
156842503|NCT02974842|566174279|FG000|Overall Study|Screen failures|4|||
156842504|NCT01068158|566174289|FG000|Overall Study|Withdrawal by Subject|1|||
156842505|NCT01068158|566174290|FG001|Overall Study|Withdrawal by Subject|2|||
156842506|NCT01068158|566174289|FG000|Overall Study|Lost to Follow-up|7|||
156842507|NCT01068158|566174290|FG001|Overall Study|Lost to Follow-up|0|||
156842508|NCT01068158|566174289|FG000|Overall Study|Protocol Violation|0|||
156842509|NCT01068158|566174290|FG001|Overall Study|Protocol Violation|2|||
156842510|NCT01959243|566174297|FG000|Overall Study|Investigator Decision|3|||
156842511|NCT01959243|566174298|FG001|Overall Study|Investigator Decision|0|||
156842512|NCT01959243|566174297|FG000|Overall Study|Adverse Event|5|||
156842513|NCT01959243|566174298|FG001|Overall Study|Adverse Event|2|||
156842514|NCT01959243|566174297|FG000|Overall Study|Administrative reasons|2|||
157154985|NCT00912015|567312815|FG002|Overall Study|Protocol Violation|0|||
157154986|NCT00912015|567312816|FG003|Overall Study|Protocol Violation|1|||
157154987|NCT00912015|567312813|FG000|Overall Study|Adverse Event|6|||
156842515|NCT01959243|566174298|FG001|Overall Study|Administrative reasons|1|||
156842516|NCT01959243|566174297|FG000|Overall Study|Lost to Follow-up|3|||
156842517|NCT01959243|566174298|FG001|Overall Study|Lost to Follow-up|1|||
156842518|NCT01368081|566174299|FG000|Overall Study|Adverse Event|4|||
156842519|NCT01368081|566174300|FG001|Overall Study|Adverse Event|4|||
156842520|NCT01368081|566174301|FG002|Overall Study|Adverse Event|3|||
156842521|NCT01368081|566174302|FG003|Overall Study|Adverse Event|2|||
156842522|NCT01368081|566174303|FG004|Overall Study|Adverse Event|2|||
156842523|NCT01368081|566174304|FG005|Overall Study|Adverse Event|5|||
156842524|NCT01368081|566174305|FG006|Overall Study|Adverse Event|6|||
156842525|NCT01368081|566174306|FG007|Overall Study|Adverse Event|2|||
156842526|NCT01368081|566174307|FG008|Overall Study|Adverse Event|3|||
156842527|NCT01368081|566174308|FG009|Overall Study|Adverse Event|5|||
156842528|NCT01368081|566174309|FG010|Overall Study|Adverse Event|6|||
156842529|NCT01368081|566174310|FG011|Overall Study|Adverse Event|1|||
156842530|NCT01368081|566174311|FG012|Overall Study|Adverse Event|3|||
156842531|NCT01368081|566174299|FG000|Overall Study|Lack of Efficacy|0|||
156842532|NCT01368081|566174300|FG001|Overall Study|Lack of Efficacy|1|||
156842533|NCT01368081|566174301|FG002|Overall Study|Lack of Efficacy|0|||
156842534|NCT01368081|566174302|FG003|Overall Study|Lack of Efficacy|1|||
156842535|NCT01368081|566174303|FG004|Overall Study|Lack of Efficacy|0|||
156842536|NCT01368081|566174304|FG005|Overall Study|Lack of Efficacy|0|||
156842537|NCT01368081|566174305|FG006|Overall Study|Lack of Efficacy|0|||
156842538|NCT01368081|566174306|FG007|Overall Study|Lack of Efficacy|2|||
156842539|NCT01368081|566174307|FG008|Overall Study|Lack of Efficacy|0|||
156842540|NCT01368081|566174308|FG009|Overall Study|Lack of Efficacy|0|||
156842541|NCT01368081|566174309|FG010|Overall Study|Lack of Efficacy|0|||
156842542|NCT01368081|566174310|FG011|Overall Study|Lack of Efficacy|0|||
156842543|NCT01368081|566174311|FG012|Overall Study|Lack of Efficacy|0|||
156842544|NCT01368081|566174299|FG000|Overall Study|Protocol Violation|0|||
156842545|NCT01368081|566174300|FG001|Overall Study|Protocol Violation|0|||
156842546|NCT01368081|566174301|FG002|Overall Study|Protocol Violation|0|||
156842547|NCT01368081|566174302|FG003|Overall Study|Protocol Violation|0|||
156842548|NCT01368081|566174303|FG004|Overall Study|Protocol Violation|0|||
156842549|NCT01368081|566174304|FG005|Overall Study|Protocol Violation|1|||
156842550|NCT01368081|566174305|FG006|Overall Study|Protocol Violation|0|||
156887832|NCT00475423|566349394|FG000|Overall Study|Lack of Efficacy|8|||
157154988|NCT00912015|567312814|FG001|Overall Study|Adverse Event|0|||
156842551|NCT01368081|566174306|FG007|Overall Study|Protocol Violation|1|||
156887833|NCT00475423|566349394|FG000|Overall Study|Death|1|||
157154989|NCT00912015|567312815|FG002|Overall Study|Adverse Event|0|||
156842552|NCT01368081|566174307|FG008|Overall Study|Protocol Violation|0|||
156842553|NCT01368081|566174308|FG009|Overall Study|Protocol Violation|0|||
156842554|NCT01368081|566174309|FG010|Overall Study|Protocol Violation|0|||
156842555|NCT01368081|566174310|FG011|Overall Study|Protocol Violation|0|||
156842556|NCT01368081|566174311|FG012|Overall Study|Protocol Violation|0|||
156842557|NCT01368081|566174299|FG000|Overall Study|Lost to Follow-up|0|||
156842558|NCT01368081|566174300|FG001|Overall Study|Lost to Follow-up|0|||
156842559|NCT01368081|566174301|FG002|Overall Study|Lost to Follow-up|0|||
156842560|NCT01368081|566174302|FG003|Overall Study|Lost to Follow-up|0|||
156842561|NCT01368081|566174303|FG004|Overall Study|Lost to Follow-up|0|||
156842562|NCT01368081|566174304|FG005|Overall Study|Lost to Follow-up|0|||
156842563|NCT01368081|566174305|FG006|Overall Study|Lost to Follow-up|0|||
156842564|NCT01368081|566174306|FG007|Overall Study|Lost to Follow-up|0|||
156842565|NCT01368081|566174307|FG008|Overall Study|Lost to Follow-up|0|||
156842566|NCT01368081|566174308|FG009|Overall Study|Lost to Follow-up|0|||
156842567|NCT01368081|566174309|FG010|Overall Study|Lost to Follow-up|0|||
156842568|NCT01368081|566174310|FG011|Overall Study|Lost to Follow-up|0|||
156842569|NCT01368081|566174311|FG012|Overall Study|Lost to Follow-up|1|||
156842570|NCT01368081|566174299|FG000|Overall Study|Withdrawal by Subject|4|||
156842571|NCT01368081|566174300|FG001|Overall Study|Withdrawal by Subject|4|||
156842572|NCT01368081|566174301|FG002|Overall Study|Withdrawal by Subject|1|||
156842573|NCT01368081|566174302|FG003|Overall Study|Withdrawal by Subject|1|||
156842574|NCT01368081|566174303|FG004|Overall Study|Withdrawal by Subject|0|||
156842575|NCT01368081|566174304|FG005|Overall Study|Withdrawal by Subject|3|||
156842576|NCT01368081|566174305|FG006|Overall Study|Withdrawal by Subject|4|||
156842577|NCT01368081|566174306|FG007|Overall Study|Withdrawal by Subject|2|||
156842578|NCT01368081|566174307|FG008|Overall Study|Withdrawal by Subject|5|||
156842579|NCT01368081|566174308|FG009|Overall Study|Withdrawal by Subject|4|||
156842580|NCT01368081|566174309|FG010|Overall Study|Withdrawal by Subject|3|||
156842581|NCT01368081|566174310|FG011|Overall Study|Withdrawal by Subject|2|||
156842582|NCT01368081|566174311|FG012|Overall Study|Withdrawal by Subject|0|||
156842583|NCT01368081|566174299|FG000|Overall Study|Other reason not defined above|2|||
157154990|NCT00912015|567312816|FG003|Overall Study|Adverse Event|1|||
156842584|NCT01368081|566174300|FG001|Overall Study|Other reason not defined above|0|||
156842585|NCT01368081|566174301|FG002|Overall Study|Other reason not defined above|0|||
156842586|NCT01368081|566174302|FG003|Overall Study|Other reason not defined above|1|||
156842587|NCT01368081|566174303|FG004|Overall Study|Other reason not defined above|0|||
156842588|NCT01368081|566174304|FG005|Overall Study|Other reason not defined above|1|||
156842589|NCT01368081|566174305|FG006|Overall Study|Other reason not defined above|2|||
156842590|NCT01368081|566174306|FG007|Overall Study|Other reason not defined above|0|||
156842591|NCT01368081|566174307|FG008|Overall Study|Other reason not defined above|0|||
156842592|NCT01368081|566174308|FG009|Overall Study|Other reason not defined above|1|||
156842593|NCT01368081|566174309|FG010|Overall Study|Other reason not defined above|0|||
156842594|NCT01368081|566174310|FG011|Overall Study|Other reason not defined above|0|||
156842595|NCT01368081|566174311|FG012|Overall Study|Other reason not defined above|3|||
156842596|NCT02596945|566174312|FG000|Overall Study|No documentation of study drug dosing|3|||
156842597|NCT02596945|566174312|FG000|Overall Study|Other|32|||
156842598|NCT02596945|566174312|FG000|Overall Study|Change to hemodialysis|15|||
156842599|NCT02596945|566174312|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
156842600|NCT02596945|566174312|FG000|Overall Study|Withdrawal by Subject|1|||
156842601|NCT02596945|566174312|FG000|Overall Study|Missing|1|||
156842602|NCT00238238|566174313|FG000|Overall Study|Withdrawal by Subject|0|||
156842603|NCT00238238|566174314|FG001|Overall Study|Withdrawal by Subject|3|||
156842604|NCT00238238|566174315|FG002|Overall Study|Withdrawal by Subject|0|||
156842605|NCT01007838|566174316|FG000|Overall Study|Withdrawal by Subject|1|||
156842606|NCT01007838|566174317|FG001|Overall Study|Withdrawal by Subject|0|||
156842607|NCT01007838|566174318|FG002|Overall Study|Withdrawal by Subject|0|||
156842608|NCT01007838|566174319|FG003|Overall Study|Withdrawal by Subject|0|||
156842609|NCT01007838|566174316|FG000|Overall Study|Physician Decision|1|||
156842610|NCT01007838|566174317|FG001|Overall Study|Physician Decision|0|||
156842611|NCT01007838|566174318|FG002|Overall Study|Physician Decision|0|||
156842612|NCT01007838|566174319|FG003|Overall Study|Physician Decision|0|||
156842613|NCT01007838|566174316|FG000|Overall Study|Started home haemodialysis|1|||
156842614|NCT01007838|566174317|FG001|Overall Study|Started home haemodialysis|0|||
156842615|NCT01007838|566174318|FG002|Overall Study|Started home haemodialysis|0|||
156842616|NCT01007838|566174319|FG003|Overall Study|Started home haemodialysis|0|||
156842617|NCT02277119|566174323|FG000|Overall Study|Lack of Efficacy|1|||
156842618|NCT02277119|566174324|FG001|Overall Study|Lack of Efficacy|1|||
156842619|NCT02277119|566174325|FG002|Overall Study|Lack of Efficacy|1|||
156842620|NCT02277119|566174323|FG000|Overall Study|Protocol Violation|2|||
156842621|NCT02277119|566174324|FG001|Overall Study|Protocol Violation|3|||
156842622|NCT02277119|566174325|FG002|Overall Study|Protocol Violation|7|||
156842623|NCT01345669|566174326|FG000|Overall Study|Primary tumour recurrence|53|||
156842624|NCT01345669|566174327|FG001|Overall Study|Primary tumour recurrence|32|||
156842625|NCT01345669|566174326|FG000|Overall Study|Second primary tumour|4|||
156842626|NCT01345669|566174327|FG001|Overall Study|Second primary tumour|3|||
156842627|NCT01345669|566174326|FG000|Overall Study|Adverse Event|63|||
156842628|NCT01345669|566174327|FG001|Overall Study|Adverse Event|9|||
156842629|NCT01345669|566174326|FG000|Overall Study|Protocol Violation|3|||
156842630|NCT01345669|566174327|FG001|Overall Study|Protocol Violation|1|||
156842631|NCT01345669|566174326|FG000|Overall Study|Lost to Follow-up|1|||
156842632|NCT01345669|566174327|FG001|Overall Study|Lost to Follow-up|1|||
156842633|NCT01345669|566174326|FG000|Overall Study|Withdrawal by Subject|52|||
156842634|NCT01345669|566174327|FG001|Overall Study|Withdrawal by Subject|13|||
156842635|NCT01345669|566174326|FG000|Overall Study|Other Reasons|111|||
156842636|NCT01345669|566174327|FG001|Overall Study|Other Reasons|60|||
156842637|NCT04699461|566174328|FG000|Overall Study|Withdrawal by Subject|1|||
156842638|NCT04699461|566174329|FG001|Overall Study|Withdrawal by Subject|0|||
156842639|NCT04699461|566174328|FG000|Overall Study|Study termination by sponsor|2|||
156842640|NCT04699461|566174329|FG001|Overall Study|Study termination by sponsor|1|||
156842641|NCT04699461|566174328|FG000|Overall Study|Death|1|||
156842642|NCT04699461|566174329|FG001|Overall Study|Death|0|||
156842643|NCT04699461|566174328|FG000|Overall Study|Radiographic progression|0|||
156842644|NCT04699461|566174329|FG001|Overall Study|Radiographic progression|1|||
156842645|NCT02478255|566174331|FG000|Overall Study|Physician Decision|6|||
156842646|NCT02478255|566174332|FG001|Overall Study|Physician Decision|0|||
156842647|NCT02478255|566174331|FG000|Overall Study|Withdrawal by Subject|2|||
156842648|NCT02478255|566174332|FG001|Overall Study|Withdrawal by Subject|0|||
156842649|NCT03068767|566174338|FG000|Overall Study|Lost to Follow-up|7|||
156842650|NCT03068767|566174339|FG001|Overall Study|Lost to Follow-up|3|||
156842651|NCT03068767|566174338|FG000|Overall Study|Protocol Violation|3|||
156842652|NCT03068767|566174339|FG001|Overall Study|Protocol Violation|0|||
156842653|NCT00061633|566174342|FG000|Overall Study|Adverse Event|1|||
156842654|NCT00061633|566174343|FG001|Overall Study|Adverse Event|2|||
156842655|NCT00061633|566174342|FG000|Overall Study|Withdrawal by Subject|2|||
156842656|NCT00061633|566174343|FG001|Overall Study|Withdrawal by Subject|2|||
156842657|NCT00061633|566174342|FG000|Overall Study|Lost to Follow-up|1|||
156842658|NCT00061633|566174343|FG001|Overall Study|Lost to Follow-up|4|||
156842659|NCT00061633|566174342|FG000|Overall Study|Other|1|||
156842660|NCT00061633|566174343|FG001|Overall Study|Other|1|||
156842661|NCT00061633|566174342|FG000|Overall Study|Never received study treatment|0|||
156842662|NCT00061633|566174343|FG001|Overall Study|Never received study treatment|2|||
156842663|NCT01431963|566174344|FG000|Overall Study|Adverse Event|18|||
156842664|NCT01431963|566174344|FG000|Overall Study|Lack of Efficacy|7|||
156842665|NCT01431963|566174344|FG000|Overall Study|Protocol Violation|1|||
156842666|NCT01431963|566174344|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
156842667|NCT01431963|566174344|FG000|Overall Study|Physician Decision|4|||
156842668|NCT01431963|566174344|FG000|Overall Study|Withdrawal by Subject|3|||
156842669|NCT01487265|566177340|FG000|Overall Study|Adverse Event|8|||
156842670|NCT01487265|566177340|FG000|Overall Study|Withdrawal by Subject|5|||
156842671|NCT01487265|566177340|FG000|Overall Study|Disease Progression|21|||
156842672|NCT01487265|566177340|FG000|Overall Study|Death|2|||
156842673|NCT01487265|566177340|FG000|Overall Study|Still on Treatment|1|||
156842674|NCT03499314|566177341|FG000|Overall Study|Time Commitment|1|||
156842675|NCT03499314|566177342|FG001|Overall Study|Time Commitment|2|||
156842676|NCT03499314|566177341|FG000|Overall Study|Medical issue unrelated to research study|1|||
156842677|NCT03499314|566177342|FG001|Overall Study|Medical issue unrelated to research study|1|||
156842678|NCT01618695|566177343|FG000|Core Phase|Adverse Event|4|||
156842679|NCT01618695|566177344|FG001|Core Phase|Adverse Event|5|||
156842680|NCT01618695|566177345|FG002|Core Phase|Adverse Event|15|||
156842681|NCT01618695|566177346|FG003|Core Phase|Adverse Event|20|||
156842682|NCT01618695|566177343|FG000|Core Phase|Lost to Follow-up|0|||
156842683|NCT01618695|566177344|FG001|Core Phase|Lost to Follow-up|0|||
156842684|NCT01618695|566177345|FG002|Core Phase|Lost to Follow-up|1|||
156842685|NCT01618695|566177346|FG003|Core Phase|Lost to Follow-up|0|||
156842686|NCT01618695|566177343|FG000|Core Phase|Withdrawal by Subject|16|||
156842687|NCT01618695|566177344|FG001|Core Phase|Withdrawal by Subject|11|||
156842688|NCT01618695|566177345|FG002|Core Phase|Withdrawal by Subject|9|||
156842689|NCT01618695|566177346|FG003|Core Phase|Withdrawal by Subject|13|||
156842690|NCT01618695|566177343|FG000|Core Phase|Pregnancy|2|||
156842691|NCT01618695|566177344|FG001|Core Phase|Pregnancy|0|||
156842692|NCT01618695|566177345|FG002|Core Phase|Pregnancy|0|||
156842693|NCT01618695|566177346|FG003|Core Phase|Pregnancy|0|||
156842694|NCT01618695|566177343|FG000|Core Phase|Lack of Efficacy|1|||
156842695|NCT01618695|566177344|FG001|Core Phase|Lack of Efficacy|2|||
156842696|NCT01618695|566177345|FG002|Core Phase|Lack of Efficacy|1|||
156842697|NCT01618695|566177346|FG003|Core Phase|Lack of Efficacy|1|||
156842698|NCT01618695|566177343|FG000|Core Phase|Other than specified|1|||
156842699|NCT01618695|566177344|FG001|Core Phase|Other than specified|2|||
156842700|NCT01618695|566177345|FG002|Core Phase|Other than specified|2|||
156842701|NCT01618695|566177346|FG003|Core Phase|Other than specified|2|||
156842702|NCT01618695|566177343|FG000|Core Phase|Not treated|1|||
156842703|NCT01618695|566177344|FG001|Core Phase|Not treated|0|||
156842704|NCT01618695|566177345|FG002|Core Phase|Not treated|2|||
156842705|NCT01618695|566177346|FG003|Core Phase|Not treated|0|||
156842706|NCT01618695|566177343|FG000|Extension Phase|Lack of Efficacy|17|||
156842707|NCT01618695|566177344|FG001|Extension Phase|Lack of Efficacy|33|||
156842708|NCT01618695|566177345|FG002|Extension Phase|Lack of Efficacy|26|||
156842709|NCT01618695|566177346|FG003|Extension Phase|Lack of Efficacy|24|||
156842710|NCT01618695|566177343|FG000|Extension Phase|Pregnancy|2|||
156842711|NCT01618695|566177344|FG001|Extension Phase|Pregnancy|0|||
156842712|NCT01618695|566177345|FG002|Extension Phase|Pregnancy|1|||
156842713|NCT01618695|566177346|FG003|Extension Phase|Pregnancy|1|||
156842714|NCT01618695|566177343|FG000|Extension Phase|Withdrawal by Subject|43|||
156842715|NCT01618695|566177344|FG001|Extension Phase|Withdrawal by Subject|48|||
156842716|NCT01618695|566177345|FG002|Extension Phase|Withdrawal by Subject|42|||
156842717|NCT01618695|566177346|FG003|Extension Phase|Withdrawal by Subject|33|||
156842718|NCT01618695|566177343|FG000|Extension Phase|Adverse Event|18|||
156842719|NCT01618695|566177344|FG001|Extension Phase|Adverse Event|16|||
156842720|NCT01618695|566177345|FG002|Extension Phase|Adverse Event|9|||
156842721|NCT01618695|566177346|FG003|Extension Phase|Adverse Event|20|||
156842722|NCT01618695|566177343|FG000|Extension Phase|Lost to Follow-up|2|||
156842723|NCT01618695|566177344|FG001|Extension Phase|Lost to Follow-up|1|||
156842724|NCT01618695|566177345|FG002|Extension Phase|Lost to Follow-up|1|||
156842725|NCT01618695|566177346|FG003|Extension Phase|Lost to Follow-up|1|||
156842726|NCT01618695|566177343|FG000|Extension Phase|Other than specified|13|||
156842727|NCT01618695|566177344|FG001|Extension Phase|Other than specified|18|||
156842728|NCT01618695|566177345|FG002|Extension Phase|Other than specified|13|||
156842729|NCT01618695|566177346|FG003|Extension Phase|Other than specified|18|||
156842730|NCT02291419|566177348|FG000|Overall Study|Early study termination|1|||
156842731|NCT02291419|566177349|FG001|Overall Study|Early study termination|5|||
156842732|NCT00931606|566177352|FG000|Overall Study|Death|1|||
156842733|NCT00931606|566177353|FG001|Overall Study|Death|3|||
156842734|NCT00931606|566177354|FG002|Overall Study|Death|2|||
156842735|NCT00931606|566177355|FG003|Overall Study|Death|0|||
156842736|NCT00931606|566177352|FG000|Overall Study|Lost to Follow-up|0|||
156842737|NCT00931606|566177353|FG001|Overall Study|Lost to Follow-up|1|||
156842738|NCT00931606|566177354|FG002|Overall Study|Lost to Follow-up|0|||
156842739|NCT00931606|566177355|FG003|Overall Study|Lost to Follow-up|0|||
156842740|NCT00931606|566177352|FG000|Overall Study|Physician Decision|0|||
156842741|NCT00931606|566177353|FG001|Overall Study|Physician Decision|0|||
156842742|NCT00931606|566177354|FG002|Overall Study|Physician Decision|3|||
156842743|NCT00931606|566177355|FG003|Overall Study|Physician Decision|0|||
156842744|NCT00931606|566177352|FG000|Overall Study|Sponsor Decision|1|||
156842745|NCT00931606|566177353|FG001|Overall Study|Sponsor Decision|4|||
156842746|NCT00931606|566177354|FG002|Overall Study|Sponsor Decision|0|||
156842747|NCT00931606|566177355|FG003|Overall Study|Sponsor Decision|2|||
156842748|NCT00931606|566177352|FG000|Overall Study|Withdrawal by Subject|3|||
156842749|NCT00931606|566177353|FG001|Overall Study|Withdrawal by Subject|1|||
156842750|NCT00931606|566177354|FG002|Overall Study|Withdrawal by Subject|1|||
156842751|NCT00931606|566177355|FG003|Overall Study|Withdrawal by Subject|1|||
156842752|NCT00871338|566177356|FG000|Prior to Booster|Withdrawal by Subject|1|||
156842753|NCT00871338|566177357|FG001|Prior to Booster|Withdrawal by Subject|3|||
156842754|NCT00871338|566177356|FG000|Prior to Booster|Lost to Follow-up|1|||
156842755|NCT00871338|566177357|FG001|Prior to Booster|Lost to Follow-up|0|||
156842756|NCT02391363|566177358|FG000|Overall Study|Lost to Follow-up|5|||
156842757|NCT02391363|566177359|FG001|Overall Study|Lost to Follow-up|5|||
156842758|NCT02391363|566177358|FG000|Overall Study|Withdrawal by Subject|6|||
156842759|NCT02391363|566177359|FG001|Overall Study|Withdrawal by Subject|3|||
156842760|NCT01016600|566177360|FG000|Overall Study|Did not start treatment|1|||
156842761|NCT01016600|566177361|FG001|Overall Study|Did not start treatment|0|||
156842762|NCT01016600|566177362|FG002|Overall Study|Did not start treatment|0|||
156842763|NCT01016600|566177363|FG003|Overall Study|Did not start treatment|0|||
156842764|NCT00872599|566177364|FG000|Second Washout Period|Adverse Event|1|||
156842765|NCT00872599|566177365|FG001|Second Washout Period|Adverse Event|1|||
156842766|NCT01271725|566177368|FG000|Part A|Progressive disease according to RECIST|8|||
156842767|NCT01271725|566177369|FG001|Part A|Progressive disease according to RECIST|0|||
156842768|NCT01271725|566177368|FG000|Part A|Clinical signs/symptoms of progression|2|||
156842769|NCT01271725|566177369|FG001|Part A|Clinical signs/symptoms of progression|0|||
156842770|NCT01271725|566177368|FG000|Part A|Other Adverse Event|8|||
156842771|NCT01271725|566177369|FG001|Part A|Other Adverse Event|0|||
156842772|NCT01271725|566177368|FG000|Part A|Lost to Follow-up|1|||
156842773|NCT01271725|566177369|FG001|Part A|Lost to Follow-up|0|||
156842774|NCT01271725|566177368|FG000|Part A|Withdrawal by Subject|12|||
156842775|NCT01271725|566177369|FG001|Part A|Withdrawal by Subject|0|||
156842776|NCT01271725|566177368|FG000|Part A|Other than specified|3|||
156842777|NCT01271725|566177369|FG001|Part A|Other than specified|0|||
156842778|NCT01271725|566177368|FG000|Part A|Protocol Violation|1|||
156842779|NCT01271725|566177369|FG001|Part A|Protocol Violation|0|||
156842780|NCT01271725|566177368|FG000|Part B|Other than specified|0|||
156842781|NCT01271725|566177369|FG001|Part B|Other than specified|2|||
156842782|NCT01271725|566177368|FG000|Part B|Clinical signs/symptoms of progression|0|||
156842783|NCT01271725|566177369|FG001|Part B|Clinical signs/symptoms of progression|2|||
156842784|NCT01271725|566177368|FG000|Part B|Other Adverse Event|0|||
156842785|NCT01271725|566177369|FG001|Part B|Other Adverse Event|1|||
156842786|NCT01271725|566177368|FG000|Part B|Protocol Violation|0|||
156842787|NCT01271725|566177369|FG001|Part B|Protocol Violation|1|||
156842788|NCT01271725|566177368|FG000|Part B|Withdrawal by Subject|0|||
156842789|NCT01271725|566177369|FG001|Part B|Withdrawal by Subject|6|||
156842790|NCT00801229|566177370|FG000|Signed Consent|Withdrawal by Subject|2|||
156842791|NCT00801229|566177371|FG001|Signed Consent|Withdrawal by Subject|2|||
156842792|NCT00801229|566177370|FG000|Signed Consent|Found Ineligible|1|||
156842793|NCT00801229|566177371|FG001|Signed Consent|Found Ineligible|1|||
156842794|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
156842795|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
156842796|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
156842797|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
156842798|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
156842799|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
156842800|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
156842801|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
156842802|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
156842803|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
156842804|NCT00801229|566177370|FG000|Received Study Drug/Placebo|Adverse Event|1|||
156842805|NCT00801229|566177371|FG001|Received Study Drug/Placebo|Adverse Event|1|||
156842806|NCT03826186|566177372|FG000|Overall Study|Protocol Violation|2|||
156842807|NCT03826186|566177373|FG001|Overall Study|Protocol Violation|0|||
156842808|NCT03826186|566177372|FG000|Overall Study|Withdrawal by Subject|1|||
156842809|NCT03826186|566177373|FG001|Overall Study|Withdrawal by Subject|0|||
156842810|NCT02737475|566177376|FG000|Overall Study|Other reasons|0|||
156842811|NCT02737475|566177377|FG001|Overall Study|Other reasons|0|||
156842812|NCT02737475|566177378|FG002|Overall Study|Other reasons|0|||
156842813|NCT02737475|566177379|FG003|Overall Study|Other reasons|0|||
156842814|NCT02737475|566177380|FG004|Overall Study|Other reasons|1|||
156842815|NCT02737475|566177381|FG005|Overall Study|Other reasons|1|||
156842816|NCT02737475|566177382|FG006|Overall Study|Other reasons|0|||
156842817|NCT02737475|566177383|FG007|Overall Study|Other reasons|0|||
156842818|NCT02737475|566177384|FG008|Overall Study|Other reasons|1|||
156842819|NCT02737475|566177385|FG009|Overall Study|Other reasons|0|||
156842820|NCT02737475|566177386|FG010|Overall Study|Other reasons|1|||
156842821|NCT02737475|566177387|FG011|Overall Study|Other reasons|0|||
156842822|NCT02737475|566177388|FG012|Overall Study|Other reasons|0|||
156842823|NCT02737475|566177389|FG013|Overall Study|Other reasons|0|||
156842824|NCT02737475|566177390|FG014|Overall Study|Other reasons|0|||
156842825|NCT02737475|566177391|FG015|Overall Study|Other reasons|0|||
156842826|NCT02737475|566177392|FG016|Overall Study|Other reasons|0|||
156842827|NCT02737475|566177393|FG017|Overall Study|Other reasons|0|||
156842828|NCT02737475|566177394|FG018|Overall Study|Other reasons|0|||
156842829|NCT02737475|566177395|FG019|Overall Study|Other reasons|0|||
156842830|NCT02737475|566177396|FG020|Overall Study|Other reasons|0|||
156842831|NCT02737475|566177397|FG021|Overall Study|Other reasons|1|||
156842832|NCT02737475|566177398|FG022|Overall Study|Other reasons|0|||
156842833|NCT02737475|566177399|FG023|Overall Study|Other reasons|1|||
156842834|NCT02737475|566177400|FG024|Overall Study|Other reasons|1|||
156842835|NCT02737475|566177401|FG025|Overall Study|Other reasons|1|||
156842836|NCT02737475|566177402|FG026|Overall Study|Other reasons|0|||
156842837|NCT02737475|566177376|FG000|Overall Study|Death|1|||
156842838|NCT02737475|566177377|FG001|Overall Study|Death|0|||
156842839|NCT02737475|566177378|FG002|Overall Study|Death|0|||
156842840|NCT02737475|566177379|FG003|Overall Study|Death|1|||
156842841|NCT02737475|566177380|FG004|Overall Study|Death|0|||
156842842|NCT02737475|566177381|FG005|Overall Study|Death|0|||
156842843|NCT02737475|566177382|FG006|Overall Study|Death|0|||
156842844|NCT02737475|566177383|FG007|Overall Study|Death|2|||
156842845|NCT02737475|566177384|FG008|Overall Study|Death|0|||
156842846|NCT02737475|566177385|FG009|Overall Study|Death|0|||
156842847|NCT02737475|566177386|FG010|Overall Study|Death|0|||
156842848|NCT02737475|566177387|FG011|Overall Study|Death|4|||
156842849|NCT02737475|566177388|FG012|Overall Study|Death|2|||
156887834|NCT00475423|566349394|FG000|Overall Study|Reason not specified|1|||
156887835|NCT00475423|566349394|FG000|Overall Study|Lost to Follow-up|7|||
156887836|NCT01925989|566349395|FG000|Period 1|Sponsor Decision|1|||
156842850|NCT02737475|566177389|FG013|Overall Study|Death|2|||
156842851|NCT02737475|566177390|FG014|Overall Study|Death|0|||
156842852|NCT02737475|566177391|FG015|Overall Study|Death|2|||
156842853|NCT02737475|566177392|FG016|Overall Study|Death|2|||
156842854|NCT02737475|566177393|FG017|Overall Study|Death|2|||
156842855|NCT02737475|566177394|FG018|Overall Study|Death|1|||
156842856|NCT02737475|566177395|FG019|Overall Study|Death|0|||
156842857|NCT02737475|566177396|FG020|Overall Study|Death|0|||
156842858|NCT02737475|566177397|FG021|Overall Study|Death|0|||
156842859|NCT02737475|566177398|FG022|Overall Study|Death|0|||
156842860|NCT02737475|566177399|FG023|Overall Study|Death|0|||
156842861|NCT02737475|566177400|FG024|Overall Study|Death|0|||
156842862|NCT02737475|566177401|FG025|Overall Study|Death|0|||
156842863|NCT02737475|566177402|FG026|Overall Study|Death|0|||
156842864|NCT02737475|566177376|FG000|Overall Study|Participant withdrew consent|0|||
156842865|NCT02737475|566177377|FG001|Overall Study|Participant withdrew consent|0|||
156842866|NCT02737475|566177378|FG002|Overall Study|Participant withdrew consent|0|||
156842867|NCT02737475|566177379|FG003|Overall Study|Participant withdrew consent|0|||
156842868|NCT02737475|566177380|FG004|Overall Study|Participant withdrew consent|0|||
156842869|NCT02737475|566177381|FG005|Overall Study|Participant withdrew consent|2|||
156842870|NCT02737475|566177382|FG006|Overall Study|Participant withdrew consent|0|||
156842871|NCT02737475|566177383|FG007|Overall Study|Participant withdrew consent|0|||
156842872|NCT02737475|566177384|FG008|Overall Study|Participant withdrew consent|0|||
156842873|NCT02737475|566177385|FG009|Overall Study|Participant withdrew consent|0|||
156842874|NCT02737475|566177386|FG010|Overall Study|Participant withdrew consent|0|||
156842875|NCT02737475|566177387|FG011|Overall Study|Participant withdrew consent|0|||
156842876|NCT02737475|566177388|FG012|Overall Study|Participant withdrew consent|0|||
156842877|NCT02737475|566177389|FG013|Overall Study|Participant withdrew consent|0|||
156842878|NCT02737475|566177390|FG014|Overall Study|Participant withdrew consent|1|||
156842879|NCT02737475|566177391|FG015|Overall Study|Participant withdrew consent|0|||
156842880|NCT02737475|566177392|FG016|Overall Study|Participant withdrew consent|0|||
156842881|NCT02737475|566177393|FG017|Overall Study|Participant withdrew consent|2|||
156842882|NCT02737475|566177394|FG018|Overall Study|Participant withdrew consent|1|||
156842883|NCT02737475|566177395|FG019|Overall Study|Participant withdrew consent|0|||
156842884|NCT02737475|566177396|FG020|Overall Study|Participant withdrew consent|2|||
156842885|NCT02737475|566177397|FG021|Overall Study|Participant withdrew consent|0|||
156842886|NCT02737475|566177398|FG022|Overall Study|Participant withdrew consent|0|||
156842887|NCT02737475|566177399|FG023|Overall Study|Participant withdrew consent|0|||
156842888|NCT02737475|566177400|FG024|Overall Study|Participant withdrew consent|0|||
156842889|NCT02737475|566177401|FG025|Overall Study|Participant withdrew consent|0|||
156842890|NCT02737475|566177402|FG026|Overall Study|Participant withdrew consent|0|||
156842891|NCT02737475|566177376|FG000|Overall Study|Lost to Follow-up|0|||
156842892|NCT02737475|566177377|FG001|Overall Study|Lost to Follow-up|0|||
156842893|NCT02737475|566177378|FG002|Overall Study|Lost to Follow-up|0|||
156842894|NCT02737475|566177379|FG003|Overall Study|Lost to Follow-up|0|||
156842895|NCT02737475|566177380|FG004|Overall Study|Lost to Follow-up|0|||
156842896|NCT02737475|566177381|FG005|Overall Study|Lost to Follow-up|0|||
156842897|NCT02737475|566177382|FG006|Overall Study|Lost to Follow-up|0|||
156842898|NCT02737475|566177383|FG007|Overall Study|Lost to Follow-up|0|||
156842899|NCT02737475|566177384|FG008|Overall Study|Lost to Follow-up|0|||
156842900|NCT02737475|566177385|FG009|Overall Study|Lost to Follow-up|0|||
156842901|NCT02737475|566177386|FG010|Overall Study|Lost to Follow-up|0|||
156842902|NCT02737475|566177387|FG011|Overall Study|Lost to Follow-up|0|||
156842903|NCT02737475|566177388|FG012|Overall Study|Lost to Follow-up|0|||
156842904|NCT02737475|566177389|FG013|Overall Study|Lost to Follow-up|0|||
156842905|NCT02737475|566177390|FG014|Overall Study|Lost to Follow-up|0|||
156842906|NCT02737475|566177391|FG015|Overall Study|Lost to Follow-up|1|||
156842907|NCT02737475|566177392|FG016|Overall Study|Lost to Follow-up|0|||
156842908|NCT02737475|566177393|FG017|Overall Study|Lost to Follow-up|0|||
156842909|NCT02737475|566177394|FG018|Overall Study|Lost to Follow-up|0|||
156842910|NCT02737475|566177395|FG019|Overall Study|Lost to Follow-up|0|||
156842911|NCT02737475|566177396|FG020|Overall Study|Lost to Follow-up|0|||
156842912|NCT02737475|566177397|FG021|Overall Study|Lost to Follow-up|0|||
156842913|NCT02737475|566177398|FG022|Overall Study|Lost to Follow-up|0|||
156842914|NCT02737475|566177399|FG023|Overall Study|Lost to Follow-up|0|||
156842915|NCT02737475|566177400|FG024|Overall Study|Lost to Follow-up|0|||
156842916|NCT02737475|566177401|FG025|Overall Study|Lost to Follow-up|0|||
156842917|NCT02737475|566177402|FG026|Overall Study|Lost to Follow-up|0|||
156842918|NCT02737475|566177376|FG000|Overall Study|Disease Progression|0|||
156842919|NCT02737475|566177377|FG001|Overall Study|Disease Progression|0|||
156842920|NCT02737475|566177378|FG002|Overall Study|Disease Progression|0|||
156842921|NCT02737475|566177379|FG003|Overall Study|Disease Progression|0|||
156842922|NCT02737475|566177380|FG004|Overall Study|Disease Progression|0|||
156842923|NCT02737475|566177381|FG005|Overall Study|Disease Progression|0|||
156842924|NCT02737475|566177382|FG006|Overall Study|Disease Progression|0|||
156842925|NCT02737475|566177383|FG007|Overall Study|Disease Progression|0|||
156842926|NCT02737475|566177384|FG008|Overall Study|Disease Progression|0|||
156842927|NCT02737475|566177385|FG009|Overall Study|Disease Progression|0|||
156842928|NCT02737475|566177386|FG010|Overall Study|Disease Progression|0|||
156842929|NCT02737475|566177387|FG011|Overall Study|Disease Progression|0|||
156842930|NCT02737475|566177388|FG012|Overall Study|Disease Progression|0|||
156842931|NCT02737475|566177389|FG013|Overall Study|Disease Progression|0|||
156842932|NCT02737475|566177390|FG014|Overall Study|Disease Progression|0|||
156842933|NCT02737475|566177391|FG015|Overall Study|Disease Progression|0|||
156842934|NCT02737475|566177392|FG016|Overall Study|Disease Progression|0|||
156842935|NCT02737475|566177393|FG017|Overall Study|Disease Progression|0|||
156842936|NCT02737475|566177394|FG018|Overall Study|Disease Progression|0|||
157154991|NCT05137041|567312819|FG000|Overall Study|Lost to Follow-up|1|||
157154992|NCT05137041|567312820|FG001|Overall Study|Lost to Follow-up|1|||
157154993|NCT05137041|567312819|FG000|Overall Study|Withdrawal by Subject|0|||
157154994|NCT05137041|567312820|FG001|Overall Study|Withdrawal by Subject|2|||
157154995|NCT05137041|567312819|FG000|Overall Study|Reason not Specified|0|||
156842937|NCT02737475|566177395|FG019|Overall Study|Disease Progression|0|||
156842938|NCT02737475|566177396|FG020|Overall Study|Disease Progression|0|||
156842939|NCT02737475|566177397|FG021|Overall Study|Disease Progression|0|||
156842940|NCT02737475|566177398|FG022|Overall Study|Disease Progression|0|||
156842941|NCT02737475|566177399|FG023|Overall Study|Disease Progression|0|||
156842942|NCT02737475|566177400|FG024|Overall Study|Disease Progression|0|||
156842943|NCT02737475|566177401|FG025|Overall Study|Disease Progression|0|||
156842944|NCT02737475|566177402|FG026|Overall Study|Disease Progression|1|||
156842945|NCT02950480|566177409|FG000|Overall Study|Withdrawal by Subject|1|||
156842946|NCT02950480|566177410|FG001|Overall Study|Withdrawal by Subject|0|||
156842947|NCT02255461|566177418|FG000|Overall Study|Adverse Event|0|||
156842948|NCT02255461|566177419|FG001|Overall Study|Adverse Event|1|||
156842949|NCT02255461|566177420|FG002|Overall Study|Adverse Event|0|||
156842950|NCT02255461|566177421|FG003|Overall Study|Adverse Event|0|||
156842951|NCT02255461|566177422|FG004|Overall Study|Adverse Event|1|||
156842952|NCT02255461|566177418|FG000|Overall Study|Withdrawal by Subject|0|||
156842953|NCT02255461|566177419|FG001|Overall Study|Withdrawal by Subject|0|||
156842954|NCT02255461|566177420|FG002|Overall Study|Withdrawal by Subject|1|||
156842955|NCT02255461|566177421|FG003|Overall Study|Withdrawal by Subject|0|||
156842956|NCT02255461|566177422|FG004|Overall Study|Withdrawal by Subject|1|||
156842957|NCT02255461|566177418|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
156842958|NCT02255461|566177419|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
156842959|NCT02255461|566177420|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
156842960|NCT02255461|566177421|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
156842961|NCT02255461|566177422|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
156842962|NCT01357551|566177426|FG000|Overall Study|Withdrawal by Subject|6|||
156842963|NCT01357551|566177427|FG001|Overall Study|Withdrawal by Subject|4|||
156842964|NCT01357551|566177426|FG000|Overall Study|Death|0|||
156842965|NCT01357551|566177427|FG001|Overall Study|Death|1|||
156842966|NCT01357551|566177426|FG000|Overall Study|Lost to Follow-up|16|||
156842967|NCT01357551|566177427|FG001|Overall Study|Lost to Follow-up|6|||
156842968|NCT00711971|566177436|FG000|Overall Study|Lost to Follow-up|3|||
156842969|NCT00711971|566177437|FG001|Overall Study|Lost to Follow-up|4|||
156842970|NCT00711971|566177438|FG002|Overall Study|Lost to Follow-up|1|||
156842971|NCT04774926|566177439|FG000|Overall Study|Adverse Event|15|||
156842972|NCT04774926|566177439|FG000|Overall Study|Lost to Follow-up|3|||
156842973|NCT04774926|566177439|FG000|Overall Study|Physician Decision|6|||
156842974|NCT04774926|566177439|FG000|Overall Study|Withdrawal by Subject|3|||
156842975|NCT04774926|566177439|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
156842976|NCT01393639|566177440|FG000|Overall Study|Protocol Violation|0|||
156842977|NCT01393639|566177441|FG001|Overall Study|Protocol Violation|0|||
156842978|NCT01393639|566177442|FG002|Overall Study|Protocol Violation|0|||
156842979|NCT01393639|566177443|FG003|Overall Study|Protocol Violation|1|||
156842980|NCT01393639|566177444|FG004|Overall Study|Protocol Violation|0|||
156842981|NCT01393639|566177445|FG005|Overall Study|Protocol Violation|0|||
156842982|NCT01393639|566177446|FG006|Overall Study|Protocol Violation|0|||
156842983|NCT01393639|566177440|FG000|Overall Study|Other|0|||
156842984|NCT01393639|566177441|FG001|Overall Study|Other|2|||
156842985|NCT01393639|566177442|FG002|Overall Study|Other|0|||
156842986|NCT01393639|566177443|FG003|Overall Study|Other|2|||
156842987|NCT01393639|566177444|FG004|Overall Study|Other|1|||
156842988|NCT01393639|566177445|FG005|Overall Study|Other|0|||
156842989|NCT01393639|566177446|FG006|Overall Study|Other|1|||
156842990|NCT01393639|566177440|FG000|Overall Study|Withdrawal by Subject|1|||
156842991|NCT01393639|566177441|FG001|Overall Study|Withdrawal by Subject|1|||
156842992|NCT01393639|566177442|FG002|Overall Study|Withdrawal by Subject|0|||
156842993|NCT01393639|566177443|FG003|Overall Study|Withdrawal by Subject|0|||
156842994|NCT01393639|566177444|FG004|Overall Study|Withdrawal by Subject|0|||
156842995|NCT01393639|566177445|FG005|Overall Study|Withdrawal by Subject|0|||
156842996|NCT01393639|566177446|FG006|Overall Study|Withdrawal by Subject|1|||
156842997|NCT01393639|566177440|FG000|Overall Study|Medication error without associated AE|0|||
156842998|NCT01393639|566177441|FG001|Overall Study|Medication error without associated AE|0|||
156842999|NCT01393639|566177442|FG002|Overall Study|Medication error without associated AE|0|||
156843000|NCT01393639|566177443|FG003|Overall Study|Medication error without associated AE|0|||
156843001|NCT01393639|566177444|FG004|Overall Study|Medication error without associated AE|0|||
156843002|NCT01393639|566177445|FG005|Overall Study|Medication error without associated AE|0|||
156843003|NCT01393639|566177446|FG006|Overall Study|Medication error without associated AE|1|||
156843004|NCT01393639|566177440|FG000|Overall Study|Lost to Follow-up|0|||
156843005|NCT01393639|566177441|FG001|Overall Study|Lost to Follow-up|1|||
156843006|NCT01393639|566177442|FG002|Overall Study|Lost to Follow-up|0|||
156843007|NCT01393639|566177443|FG003|Overall Study|Lost to Follow-up|0|||
156843008|NCT01393639|566177444|FG004|Overall Study|Lost to Follow-up|0|||
156843009|NCT01393639|566177445|FG005|Overall Study|Lost to Follow-up|0|||
156843010|NCT01393639|566177446|FG006|Overall Study|Lost to Follow-up|1|||
156843011|NCT01393639|566177440|FG000|Overall Study|Lack of Efficacy|0|||
156887837|NCT01925989|566349396|FG001|Period 1|Sponsor Decision|1|||
156887838|NCT01925989|566349397|FG002|Period 1|Sponsor Decision|0|||
156887839|NCT01925989|566349395|FG000|Period 1|Withdrawal by Subject|0|||
156887840|NCT01925989|566349396|FG001|Period 1|Withdrawal by Subject|1|||
156843012|NCT01393639|566177441|FG001|Overall Study|Lack of Efficacy|0|||
156843013|NCT01393639|566177442|FG002|Overall Study|Lack of Efficacy|0|||
156843014|NCT01393639|566177443|FG003|Overall Study|Lack of Efficacy|0|||
156843015|NCT01393639|566177444|FG004|Overall Study|Lack of Efficacy|0|||
156843016|NCT01393639|566177445|FG005|Overall Study|Lack of Efficacy|0|||
156843017|NCT01393639|566177446|FG006|Overall Study|Lack of Efficacy|1|||
156843018|NCT01393639|566177440|FG000|Overall Study|Adverse Event|2|||
156843019|NCT01393639|566177441|FG001|Overall Study|Adverse Event|3|||
156843020|NCT01393639|566177442|FG002|Overall Study|Adverse Event|1|||
156843021|NCT01393639|566177443|FG003|Overall Study|Adverse Event|2|||
156843022|NCT01393639|566177444|FG004|Overall Study|Adverse Event|0|||
156887841|NCT01925989|566349397|FG002|Period 1|Withdrawal by Subject|0|||
156887842|NCT02536404|566349407|FG000|Overall Study|Adverse Event|5|||
156887843|NCT02536404|566349408|FG001|Overall Study|Adverse Event|0|||
156887844|NCT02536404|566349407|FG000|Overall Study|Withdrawal by Subject|4|||
156887845|NCT02536404|566349408|FG001|Overall Study|Withdrawal by Subject|1|||
156887846|NCT02536404|566349407|FG000|Overall Study|Physician Decision|10|||
156887847|NCT02536404|566349408|FG001|Overall Study|Physician Decision|0|||
156887848|NCT02536404|566349407|FG000|Overall Study|Sponsor decision|1|||
156887849|NCT02536404|566349408|FG001|Overall Study|Sponsor decision|0|||
156887850|NCT03915860|566349409|FG000|Overall Study|Adverse Event|3|||
156887851|NCT03915860|566349409|FG000|Overall Study|Withdrawal by Subject|6|||
157025099|NCT05192109|566845601|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
156843023|NCT01393639|566177445|FG005|Overall Study|Adverse Event|2|||
156843024|NCT01393639|566177446|FG006|Overall Study|Adverse Event|3|||
156843025|NCT03626545|566177447|FG000|Overall Study|Progressive disease|3|||
156843026|NCT03626545|566177448|FG001|Overall Study|Progressive disease|82|||
156843027|NCT03626545|566177449|FG002|Overall Study|Progressive disease|85|||
156843028|NCT03626545|566177447|FG000|Overall Study|Adverse Event|3|||
156843029|NCT03626545|566177448|FG001|Overall Study|Adverse Event|13|||
156843030|NCT03626545|566177449|FG002|Overall Study|Adverse Event|10|||
156843031|NCT03626545|566177447|FG000|Overall Study|Physician Decision|1|||
156843032|NCT03626545|566177448|FG001|Overall Study|Physician Decision|18|||
156843033|NCT03626545|566177449|FG002|Overall Study|Physician Decision|14|||
156843034|NCT03626545|566177447|FG000|Overall Study|Subject Decision|0|||
156843035|NCT03626545|566177448|FG001|Overall Study|Subject Decision|5|||
156843036|NCT03626545|566177449|FG002|Overall Study|Subject Decision|5|||
156843037|NCT03626545|566177447|FG000|Overall Study|Death|1|||
156843038|NCT03626545|566177448|FG001|Overall Study|Death|1|||
156843039|NCT03626545|566177449|FG002|Overall Study|Death|1|||
156843040|NCT03626545|566177447|FG000|Overall Study|Protocol Deviation|0|||
156843041|NCT03626545|566177448|FG001|Overall Study|Protocol Deviation|1|||
156843042|NCT03626545|566177449|FG002|Overall Study|Protocol Deviation|1|||
156843043|NCT03626545|566177447|FG000|Overall Study|Guardian Decision|0|||
156843044|NCT03626545|566177448|FG001|Overall Study|Guardian Decision|0|||
156843045|NCT03626545|566177449|FG002|Overall Study|Guardian Decision|1|||
156843046|NCT00793325|566177451|FG000|Overall Study|Protocol Violation|18|||
156843047|NCT00793325|566177451|FG000|Overall Study|Lost to Follow-up|1|||
156843048|NCT01832155|566177454|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
156843049|NCT01832155|566177455|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
156843050|NCT01832155|566177454|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
156843051|NCT01832155|566177455|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
156887852|NCT03915860|566349409|FG000|Overall Study|Lost to Follow-up|2|||
156887853|NCT03915860|566349409|FG000|Overall Study|Other than specified|3|||
156887854|NCT04559529|566349410|FG000|First Intervention (1 Day)|Adverse Event|0|||
156887855|NCT04559529|566349411|FG001|First Intervention (1 Day)|Adverse Event|0|||
157025100|NCT05192109|566845598|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
157025101|NCT05192109|566845599|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
157025102|NCT05192109|566845600|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
157025103|NCT05192109|566845601|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
157025104|NCT03287817|566847882|FG000|Overall Study|Progressive disease|4|||
157025105|NCT03287817|566847883|FG001|Overall Study|Progressive disease|2|||
157025106|NCT03287817|566847884|FG002|Overall Study|Progressive disease|3|||
157025107|NCT03287817|566847885|FG003|Overall Study|Progressive disease|10|||
157025108|NCT03287817|566847886|FG004|Overall Study|Progressive disease|8|||
157025109|NCT03287817|566847882|FG000|Overall Study|Death|0|||
157025110|NCT03287817|566847883|FG001|Overall Study|Death|0|||
157025111|NCT03287817|566847884|FG002|Overall Study|Death|2|||
157154996|NCT05137041|567312820|FG001|Overall Study|Reason not Specified|1|||
157154997|NCT01881620|567312822|FG000|Overall Study|Protocol Violation|4|||
157154998|NCT00879814|567312824|FG000|Overall Study|Adverse Event|0|||
157154999|NCT00879814|567312825|FG001|Overall Study|Adverse Event|1|||
156887856|NCT04559529|566349412|FG002|First Intervention (1 Day)|Adverse Event|0|||
156887857|NCT04559529|566349413|FG003|First Intervention (1 Day)|Adverse Event|1|||
156887858|NCT04559529|566349410|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
156887859|NCT04559529|566349411|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
157025112|NCT03287817|566847885|FG003|Overall Study|Death|3|||
156887860|NCT04559529|566349412|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
157025113|NCT03287817|566847886|FG004|Overall Study|Death|4|||
157025114|NCT03287817|566847882|FG000|Overall Study|Physician Decision|0|||
157155000|NCT00879814|567312826|FG002|Overall Study|Adverse Event|0|||
156843052|NCT00847886|566177456|FG000|Overall Study|Adverse Event|0|||
156843053|NCT00847886|566177457|FG001|Overall Study|Adverse Event|1|||
156843054|NCT00413036|566177458|FG000|Overall Study|Adverse Event|44|||
156843055|NCT00413036|566177458|FG000|Overall Study|Lack of Efficacy|129|||
156843056|NCT00413036|566177458|FG000|Overall Study|Withdrawal by Subject|7|||
156843057|NCT00413036|566177458|FG000|Overall Study|Death|9|||
156843058|NCT00413036|566177458|FG000|Overall Study|Other|26|||
156843059|NCT00413036|566177458|FG000|Overall Study|Missing|2|||
156843060|NCT03250182|566177463|FG000|Overall Study|Withdrawal by Subject|1|||
156843061|NCT03668613|566177467|FG000|Overall Study|Adverse Event|1|||
156843062|NCT03668613|566177468|FG001|Overall Study|Adverse Event|2|||
156843063|NCT03668613|566177467|FG000|Overall Study|Lack of Efficacy|5|||
156843064|NCT03668613|566177468|FG001|Overall Study|Lack of Efficacy|1|||
156843065|NCT03668613|566177467|FG000|Overall Study|Pregnancy|0|||
156843066|NCT03668613|566177468|FG001|Overall Study|Pregnancy|2|||
156843067|NCT03668613|566177467|FG000|Overall Study|Protocol Violation|1|||
156843068|NCT03668613|566177468|FG001|Overall Study|Protocol Violation|0|||
156843069|NCT03668613|566177467|FG000|Overall Study|Physician Decision|1|||
156843070|NCT03668613|566177468|FG001|Overall Study|Physician Decision|0|||
156843071|NCT03668613|566177467|FG000|Overall Study|Withdrawal by Subject|2|||
156843072|NCT03668613|566177468|FG001|Overall Study|Withdrawal by Subject|1|||
156843073|NCT03668613|566177467|FG000|Overall Study|Guardian decision|1|||
156843074|NCT03668613|566177468|FG001|Overall Study|Guardian decision|0|||
156843075|NCT01858740|566177471|FG000|Overall Study|Death|4|||
156843076|NCT03386487|566177472|FG000|Overall Study|Lost to Follow-up|5|||
156843077|NCT03386487|566177473|FG001|Overall Study|Lost to Follow-up|6|||
156843078|NCT03386487|566177472|FG000|Overall Study|Withdrawal by Subject|11|||
156843079|NCT03386487|566177473|FG001|Overall Study|Withdrawal by Subject|7|||
156843080|NCT03386487|566177472|FG000|Overall Study|Physician Decision|11|||
156843081|NCT03386487|566177473|FG001|Overall Study|Physician Decision|8|||
156843082|NCT01068769|566177474|FG000|Overall Study|Ineligible|1|||
156843083|NCT04776317|566177477|FG000|Overall Study|Physician Decision|0|||
156843084|NCT04776317|566177478|FG001|Overall Study|Physician Decision|1|||
156843085|NCT04776317|566177479|FG002|Overall Study|Physician Decision|0|||
156843086|NCT04776317|566177480|FG003|Overall Study|Physician Decision|0|||
156843087|NCT04776317|566177481|FG004|Overall Study|Physician Decision|0|||
156843088|NCT04776317|566177482|FG005|Overall Study|Physician Decision|0|||
156843089|NCT04776317|566177483|FG006|Overall Study|Physician Decision|0|||
156843090|NCT04776317|566177484|FG007|Overall Study|Physician Decision|0|||
156887861|NCT04559529|566349413|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
156887862|NCT04559529|566349410|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
156887863|NCT04559529|566349411|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
156887864|NCT04559529|566349412|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
156887865|NCT04559529|566349413|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
156887866|NCT01009281|566349414|FG000|Overall Study|Administrative problems|7|||
156887867|NCT03901456|566349417|FG000|Overall Study|Withdrawal by Subject|0|||
156887868|NCT03901456|566349418|FG001|Overall Study|Withdrawal by Subject|0|||
156887869|NCT03901456|566349419|FG002|Overall Study|Withdrawal by Subject|1|||
156887870|NCT03901456|566349417|FG000|Overall Study|Lost to Follow-up|0|||
156887871|NCT03901456|566349418|FG001|Overall Study|Lost to Follow-up|1|||
156887872|NCT03901456|566349419|FG002|Overall Study|Lost to Follow-up|0|||
156887873|NCT02217527|566349421|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
156887874|NCT02217527|566349422|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
156887875|NCT02217527|566349421|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
156887876|NCT02217527|566349422|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
156887877|NCT01203852|566349423|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
156887878|NCT01203852|566349423|FG000|Washout 2 Weeks|Physician Decision|46|||
156887879|NCT02582684|566349424|FG000|Overall Study|Unable to contact subject/parent|4|||
157025115|NCT03287817|566847883|FG001|Overall Study|Physician Decision|0|||
157025116|NCT03287817|566847884|FG002|Overall Study|Physician Decision|0|||
157025117|NCT03287817|566847885|FG003|Overall Study|Physician Decision|1|||
157025118|NCT03287817|566847886|FG004|Overall Study|Physician Decision|0|||
157025119|NCT03287817|566847882|FG000|Overall Study|Withdrawal by Subject|0|||
157025120|NCT03287817|566847883|FG001|Overall Study|Withdrawal by Subject|0|||
157025121|NCT03287817|566847884|FG002|Overall Study|Withdrawal by Subject|0|||
157025122|NCT03287817|566847885|FG003|Overall Study|Withdrawal by Subject|0|||
157025123|NCT03287817|566847886|FG004|Overall Study|Withdrawal by Subject|4|||
157025124|NCT05251909|566847891|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
156843091|NCT04776317|566177485|FG008|Overall Study|Physician Decision|0|||
156843092|NCT04776317|566177486|FG009|Overall Study|Physician Decision|0|||
156843093|NCT04776317|566177487|FG010|Overall Study|Physician Decision|0|||
156887880|NCT02582684|566349424|FG000|Overall Study|Subject not able to get to clinic|10|||
156887881|NCT02582684|566349424|FG000|Overall Study|Subject withdrew consent|1|||
156887882|NCT02582684|566349424|FG000|Overall Study|Found to be ineligible after enrollment|2|||
156887883|NCT01878149|566349425|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
157091557|NCT00994682|567089164|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
156843094|NCT04776317|566177488|FG011|Overall Study|Physician Decision|0|||
156843095|NCT04776317|566177489|FG012|Overall Study|Physician Decision|0|||
156843096|NCT04776317|566177490|FG013|Overall Study|Physician Decision|0|||
156843097|NCT04776317|566177491|FG014|Overall Study|Physician Decision|0|||
156843098|NCT04776317|566177477|FG000|Overall Study|Protocol Violation|0|||
156843099|NCT04776317|566177478|FG001|Overall Study|Protocol Violation|0|||
156843100|NCT04776317|566177479|FG002|Overall Study|Protocol Violation|1|||
156843101|NCT04776317|566177480|FG003|Overall Study|Protocol Violation|0|||
157155001|NCT00879814|567312827|FG003|Overall Study|Adverse Event|0|||
156843102|NCT04776317|566177481|FG004|Overall Study|Protocol Violation|0|||
156843103|NCT04776317|566177482|FG005|Overall Study|Protocol Violation|0|||
156843104|NCT04776317|566177483|FG006|Overall Study|Protocol Violation|0|||
156843105|NCT04776317|566177484|FG007|Overall Study|Protocol Violation|0|||
156843106|NCT04776317|566177485|FG008|Overall Study|Protocol Violation|0|||
156843107|NCT04776317|566177486|FG009|Overall Study|Protocol Violation|0|||
156843108|NCT04776317|566177487|FG010|Overall Study|Protocol Violation|0|||
156843109|NCT04776317|566177488|FG011|Overall Study|Protocol Violation|0|||
156843110|NCT04776317|566177489|FG012|Overall Study|Protocol Violation|0|||
156843111|NCT04776317|566177490|FG013|Overall Study|Protocol Violation|0|||
156843112|NCT04776317|566177491|FG014|Overall Study|Protocol Violation|0|||
156843113|NCT04776317|566177477|FG000|Overall Study|Withdrawal by Subject|0|||
156843114|NCT04776317|566177478|FG001|Overall Study|Withdrawal by Subject|0|||
156843115|NCT04776317|566177479|FG002|Overall Study|Withdrawal by Subject|0|||
156843116|NCT04776317|566177480|FG003|Overall Study|Withdrawal by Subject|0|||
156843117|NCT04776317|566177481|FG004|Overall Study|Withdrawal by Subject|1|||
156843118|NCT04776317|566177482|FG005|Overall Study|Withdrawal by Subject|0|||
156843119|NCT04776317|566177483|FG006|Overall Study|Withdrawal by Subject|0|||
156843120|NCT04776317|566177484|FG007|Overall Study|Withdrawal by Subject|0|||
156843121|NCT04776317|566177485|FG008|Overall Study|Withdrawal by Subject|0|||
156843122|NCT04776317|566177486|FG009|Overall Study|Withdrawal by Subject|0|||
156843123|NCT04776317|566177487|FG010|Overall Study|Withdrawal by Subject|0|||
156843124|NCT04776317|566177488|FG011|Overall Study|Withdrawal by Subject|0|||
156843125|NCT04776317|566177489|FG012|Overall Study|Withdrawal by Subject|0|||
156843126|NCT04776317|566177490|FG013|Overall Study|Withdrawal by Subject|0|||
156843127|NCT04776317|566177491|FG014|Overall Study|Withdrawal by Subject|0|||
156843128|NCT01067144|566177492|FG000|Treatment|Did not receive allocated intervention|4|||
156843129|NCT01067144|566177493|FG001|Treatment|Did not receive allocated intervention|7|||
156843130|NCT01067144|566177492|FG000|Follow-up|Lost to Follow-up|22|||
156843131|NCT01067144|566177493|FG001|Follow-up|Lost to Follow-up|12|||
156843132|NCT01067144|566177492|FG000|Follow-up|Censored owing to second surgery|19|||
157155002|NCT00879814|567312824|FG000|Overall Study|Lost to Follow-up|1|||
157155003|NCT00879814|567312825|FG001|Overall Study|Lost to Follow-up|0|||
157155004|NCT00879814|567312826|FG002|Overall Study|Lost to Follow-up|0|||
156843133|NCT01067144|566177493|FG001|Follow-up|Censored owing to second surgery|28|||
156843134|NCT01067144|566177492|FG000|Follow-up|Withdrawal by Subject|18|||
156843135|NCT01067144|566177493|FG001|Follow-up|Withdrawal by Subject|14|||
156843136|NCT01067144|566177492|FG000|Follow-up|Surgery cancelled|0|||
156843137|NCT01067144|566177493|FG001|Follow-up|Surgery cancelled|1|||
156843138|NCT01067144|566177492|FG000|Follow-up|Death|0|||
156843139|NCT01067144|566177493|FG001|Follow-up|Death|1|||
156843140|NCT01843062|566177497|FG000|Overall Study|Protocol Violation|1|||
156843141|NCT01843062|566177498|FG001|Overall Study|Protocol Violation|0|||
156843142|NCT01843062|566177497|FG000|Overall Study|New treatment following progression|2|||
156843143|NCT01843062|566177498|FG001|Overall Study|New treatment following progression|0|||
156843144|NCT01843062|566177497|FG000|Overall Study|Pregnancy|1|||
156843145|NCT01843062|566177498|FG001|Overall Study|Pregnancy|0|||
156843146|NCT01843062|566177497|FG000|Overall Study|Adverse Event|2|||
156843147|NCT01843062|566177498|FG001|Overall Study|Adverse Event|0|||
156843148|NCT01843062|566177497|FG000|Overall Study|Incorrect randomisation|1|||
156843149|NCT01843062|566177498|FG001|Overall Study|Incorrect randomisation|0|||
156843150|NCT01843062|566177497|FG000|Overall Study|Withdrawal by Subject|12|||
156843151|NCT01843062|566177498|FG001|Overall Study|Withdrawal by Subject|3|||
156843152|NCT01843062|566177497|FG000|Overall Study|Death|1|||
156843153|NCT01843062|566177498|FG001|Overall Study|Death|2|||
156843154|NCT01843062|566177497|FG000|Overall Study|Lost to Follow-up|2|||
156843155|NCT01843062|566177498|FG001|Overall Study|Lost to Follow-up|4|||
156843156|NCT00129467|566177510|FG000|Received Intervention|Death|1|||
156843157|NCT00129467|566177511|FG001|Received Intervention|Death|1|||
156843158|NCT00129467|566177510|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
156843159|NCT00129467|566177511|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
156843160|NCT00129467|566177510|FG000|Received Intervention|Delirium|2|||
156843161|NCT00129467|566177511|FG001|Received Intervention|Delirium|0|||
156843162|NCT00129467|566177510|FG000|Received Intervention|Withdrawal by Subject|1|||
156843163|NCT00129467|566177511|FG001|Received Intervention|Withdrawal by Subject|0|||
156843164|NCT00129467|566177510|FG000|Received Intervention|Nausea|1|||
156843165|NCT00129467|566177511|FG001|Received Intervention|Nausea|0|||
156843166|NCT00129467|566177510|FG000|Received Intervention|Intolerance to citalopram|0|||
156843167|NCT00129467|566177511|FG001|Received Intervention|Intolerance to citalopram|1|||
156843168|NCT00129467|566177510|FG000|Received Intervention|Dizzyness, fatigue|0|||
156843169|NCT00129467|566177511|FG001|Received Intervention|Dizzyness, fatigue|1|||
156843170|NCT00129467|566177510|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
156843171|NCT00129467|566177511|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
156843172|NCT00129467|566177510|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
156843173|NCT00129467|566177511|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
156843174|NCT00699335|566177521|FG000|Overall Study|Combination of multiple reasons|176|||
156843175|NCT00699335|566177521|FG000|Overall Study|Missing data|52|||
156843176|NCT01817959|566177522|FG000|Overall Study|Graft loss|1|||
156843177|NCT01817959|566177523|FG001|Overall Study|Graft loss|1|||
156843178|NCT01817959|566177522|FG000|Overall Study|forbidden medication|1|||
156843179|NCT01817959|566177523|FG001|Overall Study|forbidden medication|1|||
156843180|NCT01817959|566177522|FG000|Overall Study|Adverse Event|1|||
156843181|NCT01817959|566177523|FG001|Overall Study|Adverse Event|0|||
156843182|NCT01817959|566177522|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
156843183|NCT01817959|566177523|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
156843184|NCT02301624|566177527|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
156843185|NCT02301624|566177528|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
156843186|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
156843187|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
156843188|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Adverse Event|2|||
156843189|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Adverse Event|5|||
156843190|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Physician Decision|3|||
156843191|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Physician Decision|3|||
156843192|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Death|2|||
156843193|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Death|1|||
156843194|NCT02301624|566177527|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
156843195|NCT02301624|566177528|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
156843196|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Adverse Event|1|||
156843197|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Adverse Event|0|||
156843198|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
156843199|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
156843200|NCT00547521|566177529|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
156843201|NCT00547521|566177530|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
156843202|NCT00547521|566177529|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
156843203|NCT00547521|566177530|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
156843204|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
156843205|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
156843206|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
156843207|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
156843208|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
156843209|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
156843210|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
156843211|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
156843212|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Other|0|||
156843213|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Other|2|||
156843214|NCT00547521|566177529|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
156843215|NCT00547521|566177530|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
156843216|NCT02475278|566179476|FG000|Overall Study|Lost to Follow-up|1|||
156887884|NCT01878149|566349426|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
156887885|NCT06390839|566349431|FG000|Overall Study|Ineligible|2|||
156887886|NCT06390839|566349431|FG000|Overall Study|Never start protocol therapy|3|||
156887887|NCT06390839|566349431|FG000|Overall Study|Adverse Event|1|||
156887888|NCT06390839|566349431|FG000|Overall Study|Alternative therapy|2|||
156887889|NCT06390839|566349431|FG000|Overall Study|Death|3|||
156887890|NCT06390839|566349431|FG000|Overall Study|Disease progression|28|||
156887891|NCT06390839|566349431|FG000|Overall Study|Withdrawal by Subject|2|||
156887892|NCT06390839|566349431|FG000|Overall Study|Complicating disease|1|||
156887893|NCT06390839|566349431|FG000|Overall Study|Noncompliance|1|||
156887894|NCT01587898|566349434|FG000|Overall Study|Adverse Event|1|||
156887895|NCT01587898|566349435|FG001|Overall Study|Adverse Event|1|||
156887896|NCT01587898|566349436|FG002|Overall Study|Adverse Event|0|||
156887897|NCT01587898|566349437|FG003|Overall Study|Adverse Event|0|||
156887898|NCT01587898|566349434|FG000|Overall Study|Protocol Violation|0|||
156887899|NCT01587898|566349435|FG001|Overall Study|Protocol Violation|2|||
156887900|NCT01587898|566349436|FG002|Overall Study|Protocol Violation|1|||
156887901|NCT01587898|566349437|FG003|Overall Study|Protocol Violation|1|||
156887902|NCT01587898|566349434|FG000|Overall Study|Lost to Follow-up|0|||
156887903|NCT01587898|566349435|FG001|Overall Study|Lost to Follow-up|0|||
157025125|NCT05251909|566847892|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
156843217|NCT02475278|566179476|FG000|Overall Study|Reason Not Specified|1|||
156843218|NCT01946152|566179477|FG000|Overall Study|Adverse Event|1|||
156843219|NCT01946152|566179478|FG001|Overall Study|Adverse Event|0|||
156843220|NCT01946152|566179479|FG002|Overall Study|Adverse Event|0|||
156843221|NCT01946152|566179480|FG003|Overall Study|Adverse Event|0|||
156843222|NCT01946152|566179477|FG000|Overall Study|Withdrawal by Subject|0|||
156843223|NCT01946152|566179478|FG001|Overall Study|Withdrawal by Subject|2|||
156887904|NCT01587898|566349436|FG002|Overall Study|Lost to Follow-up|0|||
156887905|NCT01587898|566349437|FG003|Overall Study|Lost to Follow-up|1|||
156887906|NCT01587898|566349434|FG000|Overall Study|Withdrawal by Subject|2|||
156843224|NCT01946152|566179479|FG002|Overall Study|Withdrawal by Subject|0|||
156843225|NCT01946152|566179480|FG003|Overall Study|Withdrawal by Subject|0|||
156843226|NCT01946152|566179477|FG000|Overall Study|Progression|0|||
156843227|NCT01946152|566179478|FG001|Overall Study|Progression|1|||
156843228|NCT01946152|566179479|FG002|Overall Study|Progression|4|||
156843229|NCT01946152|566179480|FG003|Overall Study|Progression|7|||
156843230|NCT01946152|566179477|FG000|Overall Study|Physician Decision|0|||
156843231|NCT01946152|566179478|FG001|Overall Study|Physician Decision|0|||
156843232|NCT01946152|566179479|FG002|Overall Study|Physician Decision|1|||
156843233|NCT01946152|566179480|FG003|Overall Study|Physician Decision|0|||
156843234|NCT01946152|566179477|FG000|Overall Study|Second malignancy|0|||
156843235|NCT01946152|566179478|FG001|Overall Study|Second malignancy|0|||
156843236|NCT01946152|566179479|FG002|Overall Study|Second malignancy|1|||
156843237|NCT01946152|566179480|FG003|Overall Study|Second malignancy|0|||
156843238|NCT01946152|566179477|FG000|Overall Study|Adverse Event|0|||
156843239|NCT01946152|566179478|FG001|Overall Study|Adverse Event|0|||
156843240|NCT01946152|566179479|FG002|Overall Study|Adverse Event|0|||
156843241|NCT01946152|566179480|FG003|Overall Study|Adverse Event|1|||
156843242|NCT03712787|566179481|FG000|Overall Study|Adverse Event|2|||
156843243|NCT03712787|566179482|FG001|Overall Study|Adverse Event|3|||
156843244|NCT03712787|566179483|FG002|Overall Study|Adverse Event|0|||
156843245|NCT03712787|566179484|FG003|Overall Study|Adverse Event|4|||
156843246|NCT03712787|566179481|FG000|Overall Study|Withdrawal by Subject|4|||
156843247|NCT03712787|566179482|FG001|Overall Study|Withdrawal by Subject|14|||
156843248|NCT03712787|566179483|FG002|Overall Study|Withdrawal by Subject|12|||
156843249|NCT03712787|566179484|FG003|Overall Study|Withdrawal by Subject|8|||
156843250|NCT03712787|566179481|FG000|Overall Study|Lost to Follow-up|1|||
156843251|NCT03712787|566179482|FG001|Overall Study|Lost to Follow-up|1|||
156843252|NCT03712787|566179483|FG002|Overall Study|Lost to Follow-up|2|||
156843253|NCT03712787|566179484|FG003|Overall Study|Lost to Follow-up|1|||
156843254|NCT03712787|566179481|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
156843255|NCT03712787|566179482|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
156843256|NCT03712787|566179483|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
156843257|NCT03712787|566179484|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
156843258|NCT03712787|566179481|FG000|Overall Study|COVID-19 Infection|0|||
156843259|NCT03712787|566179482|FG001|Overall Study|COVID-19 Infection|1|||
156843260|NCT03712787|566179483|FG002|Overall Study|COVID-19 Infection|0|||
156843261|NCT03712787|566179484|FG003|Overall Study|COVID-19 Infection|0|||
156843262|NCT03712787|566179481|FG000|Overall Study|Other, Not Specified|79|||
156843263|NCT03712787|566179482|FG001|Overall Study|Other, Not Specified|77|||
156843264|NCT03712787|566179483|FG002|Overall Study|Other, Not Specified|74|||
156843265|NCT03712787|566179484|FG003|Overall Study|Other, Not Specified|78|||
156843266|NCT01865448|566179485|FG000|Overall Study|Adverse Event|1|||
156843267|NCT01865448|566179486|FG001|Overall Study|Adverse Event|1|||
156843268|NCT01865448|566179485|FG000|Overall Study|Pregnancy|0|||
156843269|NCT01865448|566179486|FG001|Overall Study|Pregnancy|1|||
156843270|NCT01865448|566179485|FG000|Overall Study|dropout unrelated to study|1|||
156843271|NCT01865448|566179486|FG001|Overall Study|dropout unrelated to study|1|||
156843272|NCT00799266|566179487|FG000|Overall Study|Adverse Event|0|||
156843273|NCT00799266|566179488|FG001|Overall Study|Adverse Event|1|||
156843274|NCT00799266|566179487|FG000|Overall Study|Subject withdrew consent|3|||
156843275|NCT00799266|566179488|FG001|Overall Study|Subject withdrew consent|0|||
156843276|NCT04794270|566179489|FG000|Period 1|Non Compliance|1|||
156843277|NCT04794270|566179490|FG001|Period 1|Non Compliance|0|||
156843278|NCT04794270|566179489|FG000|Period 1|Adverse Event|1|||
156843279|NCT04794270|566179490|FG001|Period 1|Adverse Event|0|||
156843280|NCT04794270|566179489|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
156843281|NCT04794270|566179490|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
156843282|NCT00265317|566179494|FG000|Lead-In|Objective progression or relapse|6|||
156843283|NCT00265317|566179495|FG001|Lead-In|Objective progression or relapse|11|||
156843284|NCT00265317|566179496|FG002|Lead-In|Objective progression or relapse|0|||
156887907|NCT01587898|566349435|FG001|Overall Study|Withdrawal by Subject|1|||
156887908|NCT01587898|566349436|FG002|Overall Study|Withdrawal by Subject|0|||
156843285|NCT00265317|566179497|FG003|Lead-In|Objective progression or relapse|0|||
156843286|NCT00265317|566179494|FG000|Lead-In|Adverse Event|2|||
156843287|NCT00265317|566179495|FG001|Lead-In|Adverse Event|1|||
156843288|NCT00265317|566179496|FG002|Lead-In|Adverse Event|0|||
156843289|NCT00265317|566179497|FG003|Lead-In|Adverse Event|0|||
156887909|NCT01587898|566349437|FG003|Overall Study|Withdrawal by Subject|0|||
156887910|NCT01587898|566349434|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
156843290|NCT00265317|566179494|FG000|Lead-In|Death|3|||
156843291|NCT00265317|566179495|FG001|Lead-In|Death|5|||
156843292|NCT00265317|566179496|FG002|Lead-In|Death|0|||
156843293|NCT00265317|566179497|FG003|Lead-In|Death|0|||
156843294|NCT00265317|566179494|FG000|Lead-In|Withdrawal/other than adverse event|1|||
156843295|NCT00265317|566179495|FG001|Lead-In|Withdrawal/other than adverse event|0|||
156843296|NCT00265317|566179496|FG002|Lead-In|Withdrawal/other than adverse event|0|||
156843297|NCT00265317|566179497|FG003|Lead-In|Withdrawal/other than adverse event|0|||
156843298|NCT00265317|566179494|FG000|Phase 2|Objective progression or relapse|0|||
156843299|NCT00265317|566179495|FG001|Phase 2|Objective progression or relapse|0|||
156843300|NCT00265317|566179496|FG002|Phase 2|Objective progression or relapse|37|||
156843301|NCT00265317|566179497|FG003|Phase 2|Objective progression or relapse|38|||
156843302|NCT00265317|566179494|FG000|Phase 2|Global deterioration of health status|0|||
156843303|NCT00265317|566179495|FG001|Phase 2|Global deterioration of health status|0|||
156843304|NCT00265317|566179496|FG002|Phase 2|Global deterioration of health status|3|||
156843305|NCT00265317|566179497|FG003|Phase 2|Global deterioration of health status|0|||
156843306|NCT00265317|566179494|FG000|Phase 2|Adverse Event|0|||
156843307|NCT00265317|566179495|FG001|Phase 2|Adverse Event|0|||
156843308|NCT00265317|566179496|FG002|Phase 2|Adverse Event|7|||
156843309|NCT00265317|566179497|FG003|Phase 2|Adverse Event|5|||
156843310|NCT00265317|566179494|FG000|Phase 2|Death|0|||
156843311|NCT00265317|566179495|FG001|Phase 2|Death|0|||
156843312|NCT00265317|566179496|FG002|Phase 2|Death|12|||
156843313|NCT00265317|566179497|FG003|Phase 2|Death|15|||
156843314|NCT00265317|566179494|FG000|Phase 2|Protocol Violation|0|||
156843315|NCT00265317|566179495|FG001|Phase 2|Protocol Violation|0|||
156843316|NCT00265317|566179496|FG002|Phase 2|Protocol Violation|1|||
156843317|NCT00265317|566179497|FG003|Phase 2|Protocol Violation|4|||
156843318|NCT00265317|566179494|FG000|Phase 2|Lost to Follow-up|0|||
156843319|NCT00265317|566179495|FG001|Phase 2|Lost to Follow-up|0|||
156843320|NCT00265317|566179496|FG002|Phase 2|Lost to Follow-up|0|||
156843321|NCT00265317|566179497|FG003|Phase 2|Lost to Follow-up|1|||
156843322|NCT00265317|566179494|FG000|Phase 2|Withdrawal/other than adverse event|0|||
156843323|NCT00265317|566179495|FG001|Phase 2|Withdrawal/other than adverse event|0|||
156843324|NCT00265317|566179496|FG002|Phase 2|Withdrawal/other than adverse event|2|||
156843325|NCT00265317|566179497|FG003|Phase 2|Withdrawal/other than adverse event|1|||
156843326|NCT00265317|566179494|FG000|Phase 2|Study terminated by sponsor|0|||
156843327|NCT00265317|566179495|FG001|Phase 2|Study terminated by sponsor|0|||
156843328|NCT00265317|566179496|FG002|Phase 2|Study terminated by sponsor|1|||
156843329|NCT00265317|566179497|FG003|Phase 2|Study terminated by sponsor|0|||
156843330|NCT00265317|566179494|FG000|Phase 2|Other|0|||
156843331|NCT00265317|566179495|FG001|Phase 2|Other|0|||
156843332|NCT00265317|566179496|FG002|Phase 2|Other|1|||
156843333|NCT00265317|566179497|FG003|Phase 2|Other|1|||
156843334|NCT00732875|566179498|FG000|Overall Study|Adverse Event|16|||
156843335|NCT00732875|566179498|FG000|Overall Study|Withdrawal by Subject|6|||
156843336|NCT00732875|566179498|FG000|Overall Study|Lack of Efficacy|13|||
156843337|NCT02300259|566179499|FG000|Period 1|Adverse Event|0|||
156843338|NCT02300259|566179500|FG001|Period 1|Adverse Event|0|||
156843339|NCT02300259|566179501|FG002|Period 1|Adverse Event|1|||
156843340|NCT02300259|566179499|FG000|Period 1|Withdrawal by Subject|0|||
156843341|NCT02300259|566179500|FG001|Period 1|Withdrawal by Subject|0|||
156843342|NCT02300259|566179501|FG002|Period 1|Withdrawal by Subject|1|||
156843343|NCT02300259|566179499|FG000|Period 2|Adverse Event|1|||
156843344|NCT02300259|566179500|FG001|Period 2|Adverse Event|0|||
156843345|NCT02300259|566179501|FG002|Period 2|Adverse Event|0|||
156843346|NCT02300259|566179499|FG000|Period 2|Withdrawal by Subject|0|||
156843347|NCT02300259|566179500|FG001|Period 2|Withdrawal by Subject|0|||
156843348|NCT02300259|566179501|FG002|Period 2|Withdrawal by Subject|1|||
156843349|NCT02510001|566179502|FG000|Overall Study|Early disease progression|0|||
156843350|NCT02510001|566179503|FG001|Overall Study|Early disease progression|0|||
156843351|NCT02510001|566179504|FG002|Overall Study|Early disease progression|0|||
156843352|NCT02510001|566179505|FG003|Overall Study|Early disease progression|1|||
156843353|NCT02510001|566179506|FG004|Overall Study|Early disease progression|1|||
156843354|NCT02510001|566179507|FG005|Overall Study|Early disease progression|1|||
156843355|NCT02510001|566179508|FG006|Overall Study|Early disease progression|0|||
156843356|NCT02510001|566179509|FG007|Overall Study|Early disease progression|0|||
156843357|NCT02510001|566179502|FG000|Overall Study|Adverse Event|0|||
157155005|NCT00879814|567312827|FG003|Overall Study|Lost to Follow-up|2|||
157155006|NCT00879814|567312824|FG000|Overall Study|Participant Failed to Return|0|||
157155007|NCT00879814|567312825|FG001|Overall Study|Participant Failed to Return|0|||
156843358|NCT02510001|566179503|FG001|Overall Study|Adverse Event|0|||
156843359|NCT02510001|566179504|FG002|Overall Study|Adverse Event|0|||
156843360|NCT02510001|566179505|FG003|Overall Study|Adverse Event|1|||
157025126|NCT04728347|566847896|FG000|Overall Study|Sponsor decision|0|||
156843361|NCT02510001|566179506|FG004|Overall Study|Adverse Event|2|||
156843362|NCT02510001|566179507|FG005|Overall Study|Adverse Event|1|||
156843363|NCT02510001|566179508|FG006|Overall Study|Adverse Event|2|||
156843364|NCT02510001|566179509|FG007|Overall Study|Adverse Event|5|||
156843365|NCT02510001|566179502|FG000|Overall Study|Physician Decision|0|||
156843366|NCT02510001|566179503|FG001|Overall Study|Physician Decision|0|||
157155008|NCT00879814|567312826|FG002|Overall Study|Participant Failed to Return|0|||
156843367|NCT02510001|566179504|FG002|Overall Study|Physician Decision|0|||
156843368|NCT02510001|566179505|FG003|Overall Study|Physician Decision|0|||
156843369|NCT02510001|566179506|FG004|Overall Study|Physician Decision|1|||
156843370|NCT02510001|566179507|FG005|Overall Study|Physician Decision|0|||
156843371|NCT02510001|566179508|FG006|Overall Study|Physician Decision|0|||
156843372|NCT02510001|566179509|FG007|Overall Study|Physician Decision|0|||
156843373|NCT02510001|566179502|FG000|Overall Study|Withdrawal by Subject|0|||
156843374|NCT02510001|566179503|FG001|Overall Study|Withdrawal by Subject|0|||
156843375|NCT02510001|566179504|FG002|Overall Study|Withdrawal by Subject|0|||
156843376|NCT02510001|566179505|FG003|Overall Study|Withdrawal by Subject|0|||
156843377|NCT02510001|566179506|FG004|Overall Study|Withdrawal by Subject|0|||
156843378|NCT02510001|566179507|FG005|Overall Study|Withdrawal by Subject|0|||
156843379|NCT02510001|566179508|FG006|Overall Study|Withdrawal by Subject|0|||
156843380|NCT02510001|566179509|FG007|Overall Study|Withdrawal by Subject|2|||
156843381|NCT01504841|566179511|FG000|Overall Study|Withdrawal by Subject|1|||
156843382|NCT01504841|566179512|FG001|Overall Study|Withdrawal by Subject|1|||
156843383|NCT01504841|566179513|FG002|Overall Study|Withdrawal by Subject|0|||
156843384|NCT03149055|566179518|FG000|Overall Study|Not treated|4|||
156843385|NCT04440813|566179519|FG000|Overall Study|Lost to Follow-up|5|||
156843386|NCT04440813|566179520|FG001|Overall Study|Lost to Follow-up|5|||
156843387|NCT00291018|566179523|FG000|Overall Study|Not Consented or Declined PAS|12|||
156843388|NCT00291018|566179524|FG001|Overall Study|Not Consented or Declined PAS|15|||
156843389|NCT00291018|566179525|FG002|Overall Study|Not Consented or Declined PAS|15|||
156843390|NCT00291018|566179523|FG000|Overall Study|Death|3|||
156843391|NCT00291018|566179524|FG001|Overall Study|Death|3|||
156843392|NCT00291018|566179525|FG002|Overall Study|Death|4|||
156843393|NCT00291018|566179523|FG000|Overall Study|Withdrawal by Subject|2|||
156843394|NCT00291018|566179524|FG001|Overall Study|Withdrawal by Subject|8|||
156843395|NCT00291018|566179525|FG002|Overall Study|Withdrawal by Subject|1|||
156843396|NCT00291018|566179523|FG000|Overall Study|Failures|5|||
156843397|NCT00291018|566179524|FG001|Overall Study|Failures|12|||
156843398|NCT00291018|566179525|FG002|Overall Study|Failures|5|||
156843399|NCT00291018|566179523|FG000|Overall Study|Lost to Follow-up|3|||
156843400|NCT00291018|566179524|FG001|Overall Study|Lost to Follow-up|4|||
156843401|NCT00291018|566179525|FG002|Overall Study|Lost to Follow-up|18|||
156843402|NCT00630344|566179526|FG000|Overall Study|Adverse Event|5|||
156843403|NCT00630344|566179526|FG000|Overall Study|Progressive Disease|19|||
156843404|NCT00630344|566179526|FG000|Overall Study|Physician Decision|9|||
156843405|NCT00630344|566179526|FG000|Overall Study|Withdrawal by Subject|1|||
156843406|NCT00630344|566179526|FG000|Overall Study|Intercurrent Illness|1|||
156843407|NCT00630344|566179526|FG000|Overall Study|Other|1|||
156843408|NCT01440816|566179527|FG000|Overall Study|Disease Progression|0|||
156843409|NCT01440816|566179528|FG001|Overall Study|Disease Progression|9|||
156843410|NCT01440816|566179527|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
156843411|NCT01440816|566179528|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
156843412|NCT02462720|566179529|FG000|Part 2|Withdrawal by Subject|1|||
156843413|NCT02462720|566179530|FG001|Part 2|Withdrawal by Subject|0|||
156843414|NCT02462720|566179529|FG000|Part 2|Protocol Violation|0|||
156843415|NCT02462720|566179530|FG001|Part 2|Protocol Violation|1|||
156843416|NCT01835158|566179534|FG000|Overall Study|Withdrawal by Subject|1|||
156843417|NCT01835158|566179535|FG001|Overall Study|Withdrawal by Subject|6|||
156843418|NCT03078855|566179541|FG000|Overall Study|Lack of Efficacy|62|||
156843419|NCT03078855|566179542|FG001|Overall Study|Lack of Efficacy|31|||
156843420|NCT03078855|566179541|FG000|Overall Study|Death|1|||
156843421|NCT03078855|566179542|FG001|Overall Study|Death|0|||
156843422|NCT03078855|566179541|FG000|Overall Study|Withdrawal by Subject|12|||
156843423|NCT03078855|566179542|FG001|Overall Study|Withdrawal by Subject|6|||
156843424|NCT03078855|566179541|FG000|Overall Study|Physician Decision|3|||
156843425|NCT03078855|566179542|FG001|Overall Study|Physician Decision|2|||
156887911|NCT01587898|566349435|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
156887912|NCT01587898|566349436|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
156887913|NCT01587898|566349437|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
156887914|NCT02720094|566349438|FG000|Overall Study|Ongoing|2210|||
156887915|NCT02720094|566349439|FG001|Overall Study|Ongoing|2203|||
156887916|NCT02720094|566349438|FG000|Overall Study|Scheduled exit visit/end of study|2|||
156887917|NCT02720094|566349439|FG001|Overall Study|Scheduled exit visit/end of study|1|||
156887918|NCT02720094|566349438|FG000|Overall Study|Death|4|||
156887919|NCT02720094|566349439|FG001|Overall Study|Death|7|||
157025127|NCT04728347|566847897|FG001|Overall Study|Sponsor decision|0|||
156843426|NCT03078855|566179541|FG000|Overall Study|Second Malignancy|4|||
156887920|NCT02720094|566349438|FG000|Overall Study|Withdrawal by Subject|55|||
156843427|NCT03078855|566179542|FG001|Overall Study|Second Malignancy|0|||
156887921|NCT02720094|566349439|FG001|Overall Study|Withdrawal by Subject|56|||
157025128|NCT04728347|566847898|FG002|Overall Study|Sponsor decision|1|||
156843428|NCT03078855|566179541|FG000|Overall Study|Ineligible|2|||
156843429|NCT03078855|566179542|FG001|Overall Study|Ineligible|0|||
156887922|NCT02720094|566349438|FG000|Overall Study|Lost to Follow-up|2|||
157025129|NCT04728347|566847899|FG003|Overall Study|Sponsor decision|0|||
156843430|NCT03078855|566179541|FG000|Overall Study|Withdrew before day 1 treatment|2|||
156843431|NCT03078855|566179542|FG001|Overall Study|Withdrew before day 1 treatment|1|||
157025130|NCT03869866|566847902|FG000|Overall Study|Protocol Violation|1|||
156843432|NCT00391027|566179543|FG000|Overall Study|Adverse Event|8|||
156887923|NCT02720094|566349439|FG001|Overall Study|Lost to Follow-up|7|||
156843433|NCT00391027|566179544|FG001|Overall Study|Adverse Event|8|||
156843434|NCT00391027|566179543|FG000|Overall Study|Lack of Efficacy|3|||
156843435|NCT00391027|566179544|FG001|Overall Study|Lack of Efficacy|0|||
156843436|NCT00391027|566179543|FG000|Overall Study|Withdrawal by Subject|10|||
156843437|NCT00391027|566179544|FG001|Overall Study|Withdrawal by Subject|1|||
156843438|NCT00391027|566179543|FG000|Overall Study|Other|4|||
156843439|NCT00391027|566179544|FG001|Overall Study|Other|3|||
156843440|NCT03194646|566179545|FG000|Overall Study|Adverse Event|24|||
156843441|NCT03194646|566179546|FG001|Overall Study|Adverse Event|25|||
156843442|NCT03194646|566179547|FG002|Overall Study|Adverse Event|14|||
156843443|NCT03194646|566179548|FG003|Overall Study|Adverse Event|17|||
156843444|NCT03194646|566179545|FG000|Overall Study|Lack of Efficacy|4|||
156843445|NCT03194646|566179546|FG001|Overall Study|Lack of Efficacy|2|||
156843446|NCT03194646|566179547|FG002|Overall Study|Lack of Efficacy|2|||
156843447|NCT03194646|566179548|FG003|Overall Study|Lack of Efficacy|12|||
156843448|NCT03194646|566179545|FG000|Overall Study|Lost to Follow-up|30|||
156843449|NCT03194646|566179546|FG001|Overall Study|Lost to Follow-up|22|||
156843450|NCT03194646|566179547|FG002|Overall Study|Lost to Follow-up|12|||
156843451|NCT03194646|566179548|FG003|Overall Study|Lost to Follow-up|35|||
156843452|NCT03194646|566179545|FG000|Overall Study|Non-compliance with study drug|4|||
156843453|NCT03194646|566179546|FG001|Overall Study|Non-compliance with study drug|0|||
156843454|NCT03194646|566179547|FG002|Overall Study|Non-compliance with study drug|1|||
156843455|NCT03194646|566179548|FG003|Overall Study|Non-compliance with study drug|1|||
156843456|NCT03194646|566179545|FG000|Overall Study|Other|89|||
156843457|NCT03194646|566179546|FG001|Overall Study|Other|68|||
156843458|NCT03194646|566179547|FG002|Overall Study|Other|34|||
156843459|NCT03194646|566179548|FG003|Overall Study|Other|31|||
156843460|NCT03194646|566179545|FG000|Overall Study|Physician Decision|7|||
156843461|NCT03194646|566179546|FG001|Overall Study|Physician Decision|9|||
156843462|NCT03194646|566179547|FG002|Overall Study|Physician Decision|5|||
156843463|NCT03194646|566179548|FG003|Overall Study|Physician Decision|4|||
156843464|NCT03194646|566179545|FG000|Overall Study|Pregnancy|4|||
156843465|NCT03194646|566179546|FG001|Overall Study|Pregnancy|5|||
156843466|NCT03194646|566179547|FG002|Overall Study|Pregnancy|1|||
156843467|NCT03194646|566179548|FG003|Overall Study|Pregnancy|2|||
156843468|NCT03194646|566179545|FG000|Overall Study|Protocol Violation|4|||
156843469|NCT03194646|566179546|FG001|Overall Study|Protocol Violation|2|||
156843470|NCT03194646|566179547|FG002|Overall Study|Protocol Violation|1|||
156843471|NCT03194646|566179548|FG003|Overall Study|Protocol Violation|1|||
156843472|NCT03194646|566179545|FG000|Overall Study|Site terminated by sponsor|0|||
156843473|NCT03194646|566179546|FG001|Overall Study|Site terminated by sponsor|0|||
156843474|NCT03194646|566179547|FG002|Overall Study|Site terminated by sponsor|2|||
156843475|NCT03194646|566179548|FG003|Overall Study|Site terminated by sponsor|0|||
156843476|NCT03194646|566179545|FG000|Overall Study|Study terminated by sponsor|62|||
156843477|NCT03194646|566179546|FG001|Overall Study|Study terminated by sponsor|61|||
156843478|NCT03194646|566179547|FG002|Overall Study|Study terminated by sponsor|30|||
156843479|NCT03194646|566179548|FG003|Overall Study|Study terminated by sponsor|34|||
156843480|NCT03194646|566179545|FG000|Overall Study|Withdrawal by Subject|75|||
156843481|NCT03194646|566179546|FG001|Overall Study|Withdrawal by Subject|74|||
156843482|NCT03194646|566179547|FG002|Overall Study|Withdrawal by Subject|36|||
156843483|NCT03194646|566179548|FG003|Overall Study|Withdrawal by Subject|131|||
156843484|NCT03194646|566179545|FG000|Overall Study|Missing|1|||
156843485|NCT03194646|566179546|FG001|Overall Study|Missing|0|||
156843486|NCT03194646|566179547|FG002|Overall Study|Missing|1|||
156843487|NCT03194646|566179548|FG003|Overall Study|Missing|12|||
156887924|NCT02720094|566349438|FG000|Overall Study|Physician Decision|1|||
156887925|NCT02720094|566349439|FG001|Overall Study|Physician Decision|3|||
156887926|NCT02720094|566349438|FG000|Overall Study|Inappropriate enrollment|1|||
156887927|NCT02720094|566349439|FG001|Overall Study|Inappropriate enrollment|3|||
156887928|NCT02720094|566349438|FG000|Overall Study|Relocation|1|||
156887929|NCT02720094|566349439|FG001|Overall Study|Relocation|1|||
156887930|NCT03735238|566349442|FG000|Overall Study|Did not want to participate in research|3|||
156887931|NCT03735238|566349442|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
156887932|NCT00899353|566349448|FG000|Overall Study|Adverse Event|2|||
156887933|NCT00899353|566349448|FG000|Overall Study|Lost to Follow-up|1|||
156887934|NCT00899353|566349448|FG000|Overall Study|Withdrawal by Subject|2|||
156887935|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
156843488|NCT04164732|566179550|FG000|Treatment run-in Period|Adverse Event|4|||
156843489|NCT04164732|566179551|FG001|Treatment run-in Period|Adverse Event|0|||
156843490|NCT04164732|566179552|FG002|Treatment run-in Period|Adverse Event|0|||
156843491|NCT04164732|566179550|FG000|Treatment run-in Period|Physician Decision|1|||
156843492|NCT04164732|566179551|FG001|Treatment run-in Period|Physician Decision|0|||
156843493|NCT04164732|566179552|FG002|Treatment run-in Period|Physician Decision|0|||
156887936|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
156887937|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
156843494|NCT04164732|566179550|FG000|Treatment run-in Period|Screen Failure|1|||
156843495|NCT04164732|566179551|FG001|Treatment run-in Period|Screen Failure|0|||
156843496|NCT04164732|566179552|FG002|Treatment run-in Period|Screen Failure|0|||
156843497|NCT04164732|566179550|FG000|Randomized Treatment Period|Adverse Event|0|||
156843498|NCT04164732|566179551|FG001|Randomized Treatment Period|Adverse Event|1|||
156843499|NCT04164732|566179552|FG002|Randomized Treatment Period|Adverse Event|0|||
156843500|NCT04164732|566179550|FG000|Randomized Treatment Period|Protocol Deviation|0|||
156843501|NCT04164732|566179551|FG001|Randomized Treatment Period|Protocol Deviation|1|||
156843502|NCT04164732|566179552|FG002|Randomized Treatment Period|Protocol Deviation|1|||
156843503|NCT04164732|566179550|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
156843504|NCT04164732|566179551|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
157025131|NCT03869866|566847902|FG000|Overall Study|Withdrawal by Subject|3|||
156843505|NCT04164732|566179552|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
156843506|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
156843507|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
156843508|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
156843509|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
156843510|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Death|2|||
156843511|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Death|2|||
156843512|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Death|0|||
156843513|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Death|0|||
156843514|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
156843515|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
156843516|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
156843517|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
156843518|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
156843519|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843520|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843521|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
156843522|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
156843523|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
156843524|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
156843525|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
156843526|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
156843527|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843528|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843529|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
156843530|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843531|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
156843532|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843533|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
156843534|NCT03068754|566179553|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
157025132|NCT06181227|566847903|FG000|Overall Study|Study terminated by sponsor|7|||
157025133|NCT06181227|566847904|FG001|Overall Study|Study terminated by sponsor|9|||
157025134|NCT05543915|566847905|FG000|Overall Study|Lost to Follow-up|0|||
157025135|NCT05543915|566847906|FG001|Overall Study|Lost to Follow-up|1|||
157155009|NCT00879814|567312827|FG003|Overall Study|Participant Failed to Return|1|||
157155010|NCT00879814|567312824|FG000|Overall Study|Withdrawal by Subject|3|||
157155011|NCT00879814|567312825|FG001|Overall Study|Withdrawal by Subject|1|||
157155012|NCT00879814|567312826|FG002|Overall Study|Withdrawal by Subject|1|||
156843535|NCT03068754|566179554|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
156843536|NCT03068754|566179555|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
156843537|NCT03068754|566179556|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
156843538|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
156843539|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
156843540|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
156843541|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
156843542|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Death|0|||
156843543|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Death|0|||
156843544|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Death|0|||
156843545|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Death|1|||
156843546|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
156843547|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
156843548|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
156843549|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
156843550|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843551|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843552|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
156843553|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
156843554|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156843555|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156887938|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
156887939|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
157155013|NCT00879814|567312827|FG003|Overall Study|Withdrawal by Subject|2|||
156887940|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
156887941|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
156887942|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
156887943|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
156887944|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
156887945|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
156887946|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
156887947|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
156887948|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
156843556|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
156843557|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
156843558|NCT03068754|566179553|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
156843559|NCT03068754|566179554|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
156843560|NCT03068754|566179555|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
156843561|NCT03068754|566179556|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
156843562|NCT01009086|566179557|FG000|Overall Study|Lack of Efficacy|16|||
156843563|NCT01009086|566179558|FG001|Overall Study|Lack of Efficacy|15|||
156843564|NCT01009086|566179559|FG002|Overall Study|Lack of Efficacy|9|||
156843565|NCT01009086|566179557|FG000|Overall Study|Lost to Follow-up|4|||
156843566|NCT01009086|566179558|FG001|Overall Study|Lost to Follow-up|5|||
156843567|NCT01009086|566179559|FG002|Overall Study|Lost to Follow-up|3|||
156843568|NCT01009086|566179557|FG000|Overall Study|Adverse Event|12|||
156843569|NCT01009086|566179558|FG001|Overall Study|Adverse Event|11|||
156843570|NCT01009086|566179559|FG002|Overall Study|Adverse Event|8|||
156843571|NCT01009086|566179557|FG000|Overall Study|Withdrawal by Subject|9|||
156843572|NCT01009086|566179558|FG001|Overall Study|Withdrawal by Subject|11|||
156843573|NCT01009086|566179559|FG002|Overall Study|Withdrawal by Subject|13|||
156843574|NCT01009086|566179557|FG000|Overall Study|Other|3|||
156843575|NCT01009086|566179558|FG001|Overall Study|Other|5|||
156843576|NCT01009086|566179559|FG002|Overall Study|Other|1|||
156843577|NCT01361178|566179561|FG000|Overall Study|Death|13|||
156843578|NCT01361178|566179562|FG001|Overall Study|Death|0|||
156843579|NCT00767819|566179563|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
156843580|NCT00767819|566179564|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
156843581|NCT00767819|566179565|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
156843582|NCT00767819|566179563|FG000|Overall Study|Withdrawal by Subject|1|||
156843583|NCT00767819|566179564|FG001|Overall Study|Withdrawal by Subject|1|||
156843584|NCT00767819|566179565|FG002|Overall Study|Withdrawal by Subject|0|||
156843585|NCT00767819|566179563|FG000|Overall Study|Administrative problems|0|||
156843586|NCT00767819|566179564|FG001|Overall Study|Administrative problems|1|||
156843587|NCT00767819|566179565|FG002|Overall Study|Administrative problems|0|||
156843588|NCT00767819|566179563|FG000|Overall Study|Death|2|||
156843589|NCT00767819|566179564|FG001|Overall Study|Death|3|||
156843590|NCT00767819|566179565|FG002|Overall Study|Death|0|||
156843591|NCT00767819|566179563|FG000|Overall Study|Adverse Event|2|||
156843592|NCT00767819|566179564|FG001|Overall Study|Adverse Event|0|||
156843593|NCT00767819|566179565|FG002|Overall Study|Adverse Event|0|||
156843594|NCT00767819|566179563|FG000|Overall Study|Abnormal lab values|1|||
156843595|NCT00767819|566179564|FG001|Overall Study|Abnormal lab values|0|||
157155014|NCT00879814|567312824|FG000|Overall Study|Physician Decision|0|||
157155015|NCT00879814|567312825|FG001|Overall Study|Physician Decision|0|||
157155016|NCT00879814|567312826|FG002|Overall Study|Physician Decision|1|||
157155017|NCT00879814|567312827|FG003|Overall Study|Physician Decision|0|||
157155018|NCT00879814|567312824|FG000|Overall Study|Other|0|||
157155019|NCT00879814|567312825|FG001|Overall Study|Other|0|||
157155020|NCT00879814|567312826|FG002|Overall Study|Other|1|||
157155021|NCT00879814|567312827|FG003|Overall Study|Other|0|||
157155022|NCT00630812|567312828|FG000|Randomisation to First Dose|Adverse Event|1|||
156843596|NCT00767819|566179565|FG002|Overall Study|Abnormal lab values|0|||
156843597|NCT00767819|566179563|FG000|Overall Study|Lost to Follow-up|1|||
156843598|NCT00767819|566179564|FG001|Overall Study|Lost to Follow-up|0|||
156843599|NCT00767819|566179565|FG002|Overall Study|Lost to Follow-up|0|||
156843600|NCT04294147|566179566|FG000|Overall Study|Protocol Violation|2|||
156843601|NCT04294147|566179567|FG001|Overall Study|Protocol Violation|0|||
156843602|NCT03916081|566179572|FG000|Overall Study|Adverse Event|1|||
156887949|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
156887950|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
156887951|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
157155023|NCT00630812|567312829|FG001|Randomisation to First Dose|Adverse Event|1|||
156887952|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
157155024|NCT00630812|567312828|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
157155025|NCT00630812|567312829|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
156843603|NCT03916081|566179573|FG001|Overall Study|Adverse Event|0|||
156843604|NCT03916081|566179574|FG002|Overall Study|Adverse Event|0|||
156843605|NCT03916081|566179572|FG000|Overall Study|Physician Decision|0|||
157155026|NCT00630812|567312828|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
157155027|NCT00630812|567312829|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
157155028|NCT00630812|567312828|FG000|Randomisation to First Dose|Protocol Violation|4|||
157155029|NCT00630812|567312829|FG001|Randomisation to First Dose|Protocol Violation|1|||
157155030|NCT00630812|567312828|FG000|Double Blind Treatment Period|Adverse Event|13|||
157155031|NCT00630812|567312829|FG001|Double Blind Treatment Period|Adverse Event|5|||
157155032|NCT00630812|567312828|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
157155033|NCT00630812|567312829|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
157155034|NCT00630812|567312828|FG000|Double Blind Treatment Period|Physician Decision|2|||
156843606|NCT03916081|566179573|FG001|Overall Study|Physician Decision|0|||
156843607|NCT03916081|566179574|FG002|Overall Study|Physician Decision|1|||
156843608|NCT03916081|566179572|FG000|Overall Study|Lost to Follow-up|0|||
156843609|NCT03916081|566179573|FG001|Overall Study|Lost to Follow-up|1|||
156843610|NCT03916081|566179574|FG002|Overall Study|Lost to Follow-up|0|||
156843611|NCT03916081|566179572|FG000|Overall Study|Withdrawal by Subject|3|||
156843612|NCT03916081|566179573|FG001|Overall Study|Withdrawal by Subject|0|||
156843613|NCT03916081|566179574|FG002|Overall Study|Withdrawal by Subject|1|||
156843614|NCT03916081|566179572|FG000|Overall Study|Worsening of AD|0|||
156843615|NCT03916081|566179573|FG001|Overall Study|Worsening of AD|0|||
156843616|NCT03916081|566179574|FG002|Overall Study|Worsening of AD|1|||
156843617|NCT01371305|566179578|FG000|Overall Study|Adverse Event|0|||
156843618|NCT01371305|566179579|FG001|Overall Study|Adverse Event|0|||
156843619|NCT01371305|566179580|FG002|Overall Study|Adverse Event|0|||
156843620|NCT01371305|566179581|FG003|Overall Study|Adverse Event|2|||
156843621|NCT01371305|566179582|FG004|Overall Study|Adverse Event|1|||
156843622|NCT01371305|566179583|FG005|Overall Study|Adverse Event|0|||
156843623|NCT01371305|566179578|FG000|Overall Study|Study terminated by sponsor|0|||
156843624|NCT01371305|566179579|FG001|Overall Study|Study terminated by sponsor|0|||
156843625|NCT01371305|566179580|FG002|Overall Study|Study terminated by sponsor|0|||
156843626|NCT01371305|566179581|FG003|Overall Study|Study terminated by sponsor|0|||
156843627|NCT01371305|566179582|FG004|Overall Study|Study terminated by sponsor|3|||
156843628|NCT01371305|566179583|FG005|Overall Study|Study terminated by sponsor|1|||
156843629|NCT01371305|566179578|FG000|Overall Study|Subject request|0|||
156843630|NCT01371305|566179579|FG001|Overall Study|Subject request|0|||
156843631|NCT01371305|566179580|FG002|Overall Study|Subject request|0|||
156843632|NCT01371305|566179581|FG003|Overall Study|Subject request|0|||
156843633|NCT01371305|566179582|FG004|Overall Study|Subject request|0|||
156843634|NCT01371305|566179583|FG005|Overall Study|Subject request|1|||
156843635|NCT04038567|566179584|FG000|Overall Study|Lost to Follow-up|6|||
156843636|NCT04038567|566179585|FG001|Overall Study|Lost to Follow-up|4|||
156843637|NCT04038567|566179586|FG002|Overall Study|Lost to Follow-up|5|||
156843638|NCT04038567|566179587|FG003|Overall Study|Lost to Follow-up|4|||
156843639|NCT04038567|566179588|FG004|Overall Study|Lost to Follow-up|6|||
156843640|NCT04038567|566179589|FG005|Overall Study|Lost to Follow-up|4|||
156843641|NCT04038567|566179590|FG006|Overall Study|Lost to Follow-up|4|||
156843642|NCT04038567|566179591|FG007|Overall Study|Lost to Follow-up|1|||
156843643|NCT04038567|566179584|FG000|Overall Study|Withdrawal by Subject|2|||
156843644|NCT04038567|566179585|FG001|Overall Study|Withdrawal by Subject|1|||
156843645|NCT04038567|566179586|FG002|Overall Study|Withdrawal by Subject|1|||
156843646|NCT04038567|566179587|FG003|Overall Study|Withdrawal by Subject|1|||
156843647|NCT04038567|566179588|FG004|Overall Study|Withdrawal by Subject|4|||
156843648|NCT04038567|566179589|FG005|Overall Study|Withdrawal by Subject|1|||
156843649|NCT04038567|566179590|FG006|Overall Study|Withdrawal by Subject|1|||
156843650|NCT04038567|566179591|FG007|Overall Study|Withdrawal by Subject|1|||
156843651|NCT04038567|566179584|FG000|Overall Study|missed survey window|1|||
156843652|NCT04038567|566179585|FG001|Overall Study|missed survey window|2|||
156843653|NCT04038567|566179586|FG002|Overall Study|missed survey window|0|||
156843654|NCT04038567|566179587|FG003|Overall Study|missed survey window|0|||
156843655|NCT04038567|566179588|FG004|Overall Study|missed survey window|1|||
156843656|NCT04038567|566179589|FG005|Overall Study|missed survey window|1|||
156843657|NCT04038567|566179590|FG006|Overall Study|missed survey window|2|||
156843658|NCT04038567|566179591|FG007|Overall Study|missed survey window|2|||
156843659|NCT04038567|566179584|FG000|Overall Study|technical issues|0|||
156843660|NCT04038567|566179585|FG001|Overall Study|technical issues|0|||
156843661|NCT04038567|566179586|FG002|Overall Study|technical issues|0|||
156843662|NCT04038567|566179587|FG003|Overall Study|technical issues|0|||
157155035|NCT00630812|567312829|FG001|Double Blind Treatment Period|Physician Decision|1|||
156843663|NCT04038567|566179588|FG004|Overall Study|technical issues|0|||
156843664|NCT04038567|566179589|FG005|Overall Study|technical issues|0|||
156887953|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
156887954|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
157155036|NCT00630812|567312828|FG000|Double Blind Treatment Period|Protocol Violation|1|||
157155037|NCT00630812|567312829|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156843665|NCT04038567|566179590|FG006|Overall Study|technical issues|1|||
156843666|NCT04038567|566179591|FG007|Overall Study|technical issues|0|||
156843667|NCT04038567|566179584|FG000|Overall Study|Medical issues (i.e., illness)|0|||
156843668|NCT04038567|566179585|FG001|Overall Study|Medical issues (i.e., illness)|1|||
156843669|NCT04038567|566179586|FG002|Overall Study|Medical issues (i.e., illness)|2|||
156843670|NCT04038567|566179587|FG003|Overall Study|Medical issues (i.e., illness)|1|||
156843671|NCT04038567|566179588|FG004|Overall Study|Medical issues (i.e., illness)|1|||
156843672|NCT04038567|566179589|FG005|Overall Study|Medical issues (i.e., illness)|1|||
156843673|NCT04038567|566179590|FG006|Overall Study|Medical issues (i.e., illness)|0|||
156843674|NCT04038567|566179591|FG007|Overall Study|Medical issues (i.e., illness)|0|||
156843675|NCT04038567|566179584|FG000|Overall Study|Death|0|||
156843676|NCT04038567|566179585|FG001|Overall Study|Death|0|||
156843677|NCT04038567|566179586|FG002|Overall Study|Death|0|||
156843678|NCT04038567|566179587|FG003|Overall Study|Death|1|||
156843679|NCT04038567|566179588|FG004|Overall Study|Death|1|||
156843680|NCT04038567|566179589|FG005|Overall Study|Death|0|||
156843681|NCT04038567|566179590|FG006|Overall Study|Death|0|||
156843682|NCT04038567|566179591|FG007|Overall Study|Death|1|||
156843683|NCT02726022|566179592|FG000|Overall Study|Adverse Event|14|||
156843684|NCT02726022|566179592|FG000|Overall Study|Treatment Failure|8|||
156843685|NCT02726022|566179592|FG000|Overall Study|Poor Compliance|13|||
156843686|NCT02726022|566179592|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
156843687|NCT03244826|566179602|FG000|Overall Study|Withdrawal by Subject|2|||
156843688|NCT03244826|566179603|FG001|Overall Study|Withdrawal by Subject|0|||
156843689|NCT03244826|566179602|FG000|Overall Study|Transplant delayed or withdrawn|12|||
156843690|NCT03244826|566179603|FG001|Overall Study|Transplant delayed or withdrawn|10|||
156843691|NCT04356352|566179604|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
156843692|NCT04356352|566179605|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
156843693|NCT04356352|566179606|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
156843694|NCT04356352|566179604|FG000|Overall Study|Protocol Violation|0|||
156843695|NCT04356352|566179605|FG001|Overall Study|Protocol Violation|3|||
156843696|NCT04356352|566179606|FG002|Overall Study|Protocol Violation|1|||
156843697|NCT00416455|566179609|FG000|Overall Study|PET / CT not done|3|||
156843698|NCT00416455|566179610|FG001|Overall Study|PET / CT not done|5|||
156843699|NCT00416455|566179609|FG000|Overall Study|PET / CT poor quality|2|||
156843700|NCT00416455|566179610|FG001|Overall Study|PET / CT poor quality|1|||
156843701|NCT00416455|566179609|FG000|Overall Study|Inadequate pathology|11|||
156843702|NCT00416455|566179610|FG001|Overall Study|Inadequate pathology|2|||
156843703|NCT02456857|566179611|FG000|Overall Study|Disease Progression|4|||
156843704|NCT00781859|566179612|FG000|Overall Study|Adverse Event|2|||
156843705|NCT00781859|566179613|FG001|Overall Study|Adverse Event|2|||
156843706|NCT00781859|566179612|FG000|Overall Study|Withdrawal by Subject|8|||
156843707|NCT00781859|566179613|FG001|Overall Study|Withdrawal by Subject|4|||
156843708|NCT00781859|566179612|FG000|Overall Study|Lost to Follow-up|6|||
156843709|NCT00781859|566179613|FG001|Overall Study|Lost to Follow-up|3|||
156843710|NCT00781859|566179612|FG000|Overall Study|Death|3|||
156843711|NCT00781859|566179613|FG001|Overall Study|Death|0|||
156843712|NCT01983774|566179614|FG000|Overall Study|Lung Transplant|0|||
156843713|NCT01983774|566179615|FG001|Overall Study|Lung Transplant|1|||
156843714|NCT01983774|566179614|FG000|Overall Study|Lost to Follow-up|1|||
156843715|NCT01983774|566179615|FG001|Overall Study|Lost to Follow-up|0|||
156843716|NCT01138501|566179616|FG000|Overall Study|Protocol Violation|2|||
156843717|NCT01138501|566179616|FG000|Overall Study|Withdrawal by Subject|3|||
156843718|NCT01339897|566179617|FG000|Overall Study|Adverse Event|1|||
156843719|NCT01339897|566179618|FG001|Overall Study|Adverse Event|0|||
156843720|NCT01339897|566179619|FG002|Overall Study|Adverse Event|0|||
156843721|NCT01339897|566179620|FG003|Overall Study|Adverse Event|1|||
156843722|NCT00847197|566179622|FG000|Overall Study|Adverse Event|21|||
156843723|NCT00847197|566179623|FG001|Overall Study|Adverse Event|3|||
156843724|NCT00847197|566179622|FG000|Overall Study|Protocol Violation|0|||
156843725|NCT00847197|566179623|FG001|Overall Study|Protocol Violation|1|||
156843726|NCT00847197|566179622|FG000|Overall Study|Withdrawal by Subject|3|||
156843727|NCT00847197|566179623|FG001|Overall Study|Withdrawal by Subject|1|||
156843728|NCT01990859|566179624|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
156843729|NCT01990859|566179624|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
156843730|NCT00622388|566179627|FG000|Overall Study|Disease Progression|47|||
156843731|NCT00622388|566179627|FG000|Overall Study|Adverse Event|6|||
156843732|NCT00622388|566179627|FG000|Overall Study|Protocol Violation|3|||
156843733|NCT00622388|566179627|FG000|Overall Study|Participant Refusal|1|||
156843734|NCT00622388|566179627|FG000|Overall Study|Death|3|||
156843735|NCT00622388|566179627|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
156843736|NCT00622388|566179627|FG000|Overall Study|Took Prohibited Medication|2|||
156843737|NCT00622388|566179627|FG000|Overall Study|Withdrew Consent|1|||
157025136|NCT05835336|566847908|FG000|Overall Study|Withdrawal by Subject|5|||
157025137|NCT05835336|566847908|FG000|Overall Study|Did not complete the personalization process|3|||
156843738|NCT00622388|566179627|FG000|Overall Study|Insurance Expired|1|||
156843739|NCT00348309|566179628|FG000|Overall Study|Adverse Event|56|||
156843740|NCT00348309|566179629|FG001|Overall Study|Adverse Event|28|||
156843741|NCT00348309|566179630|FG002|Overall Study|Adverse Event|63|||
156843742|NCT00348309|566179628|FG000|Overall Study|Lost to Follow-up|6|||
156843743|NCT00348309|566179629|FG001|Overall Study|Lost to Follow-up|7|||
156843744|NCT00348309|566179630|FG002|Overall Study|Lost to Follow-up|4|||
156843745|NCT00348309|566179628|FG000|Overall Study|Protocol Violation|7|||
156843746|NCT00348309|566179629|FG001|Overall Study|Protocol Violation|12|||
156843747|NCT00348309|566179630|FG002|Overall Study|Protocol Violation|7|||
156843748|NCT00348309|566179628|FG000|Overall Study|Withdrawal by Subject|33|||
156843749|NCT00348309|566179629|FG001|Overall Study|Withdrawal by Subject|37|||
156843750|NCT00348309|566179630|FG002|Overall Study|Withdrawal by Subject|40|||
156843751|NCT00348309|566179628|FG000|Overall Study|Non-compliance|8|||
156843752|NCT00348309|566179629|FG001|Overall Study|Non-compliance|6|||
156843753|NCT00348309|566179630|FG002|Overall Study|Non-compliance|8|||
156843754|NCT00348309|566179628|FG000|Overall Study|Death of caregiver|1|||
156843755|NCT00348309|566179629|FG001|Overall Study|Death of caregiver|0|||
156843756|NCT00348309|566179630|FG002|Overall Study|Death of caregiver|1|||
156843757|NCT00348309|566179628|FG000|Overall Study|Lack of insight, dementia|1|||
156843758|NCT00348309|566179629|FG001|Overall Study|Lack of insight, dementia|0|||
156843759|NCT00348309|566179630|FG002|Overall Study|Lack of insight, dementia|0|||
156843760|NCT00348309|566179628|FG000|Overall Study|Wrong bottle allocated|1|||
156843761|NCT00348309|566179629|FG001|Overall Study|Wrong bottle allocated|0|||
156843762|NCT00348309|566179630|FG002|Overall Study|Wrong bottle allocated|0|||
156843763|NCT00348309|566179628|FG000|Overall Study|Caregiver sick|1|||
156843764|NCT00348309|566179629|FG001|Overall Study|Caregiver sick|0|||
156843765|NCT00348309|566179630|FG002|Overall Study|Caregiver sick|0|||
156843766|NCT00348309|566179628|FG000|Overall Study|Use of prohibited medication|5|||
156843767|NCT00348309|566179629|FG001|Overall Study|Use of prohibited medication|2|||
156843768|NCT00348309|566179630|FG002|Overall Study|Use of prohibited medication|2|||
156843769|NCT00348309|566179628|FG000|Overall Study|Caregiver withdrawal|3|||
156843770|NCT00348309|566179629|FG001|Overall Study|Caregiver withdrawal|0|||
156843771|NCT00348309|566179630|FG002|Overall Study|Caregiver withdrawal|7|||
156843772|NCT00348309|566179628|FG000|Overall Study|Unable to complete ET visit|1|||
156843773|NCT00348309|566179629|FG001|Overall Study|Unable to complete ET visit|0|||
156843774|NCT00348309|566179630|FG002|Overall Study|Unable to complete ET visit|0|||
156843775|NCT00348309|566179628|FG000|Overall Study|PI closing medical practice|1|||
156843776|NCT00348309|566179629|FG001|Overall Study|PI closing medical practice|0|||
156843777|NCT00348309|566179630|FG002|Overall Study|PI closing medical practice|0|||
156843778|NCT00348309|566179628|FG000|Overall Study|Principal investigator's decision|1|||
156843779|NCT00348309|566179629|FG001|Overall Study|Principal investigator's decision|0|||
156843780|NCT00348309|566179630|FG002|Overall Study|Principal investigator's decision|0|||
156843781|NCT00348309|566179628|FG000|Overall Study|No disponibility of medication|1|||
156843782|NCT00348309|566179629|FG001|Overall Study|No disponibility of medication|0|||
156843783|NCT00348309|566179630|FG002|Overall Study|No disponibility of medication|0|||
156843784|NCT00348309|566179628|FG000|Overall Study|Worsened neurodegenerative disease|1|||
156843785|NCT00348309|566179629|FG001|Overall Study|Worsened neurodegenerative disease|0|||
156843786|NCT00348309|566179630|FG002|Overall Study|Worsened neurodegenerative disease|0|||
156843787|NCT00348309|566179628|FG000|Overall Study|Cognitive and behaviour worsening|2|||
156843788|NCT00348309|566179629|FG001|Overall Study|Cognitive and behaviour worsening|0|||
156843789|NCT00348309|566179630|FG002|Overall Study|Cognitive and behaviour worsening|0|||
156843790|NCT00348309|566179628|FG000|Overall Study|Worsening of alzheimer|1|||
156843791|NCT00348309|566179629|FG001|Overall Study|Worsening of alzheimer|0|||
156843792|NCT00348309|566179630|FG002|Overall Study|Worsening of alzheimer|1|||
156843793|NCT00348309|566179628|FG000|Overall Study|Did not appear in time for Visit 3|1|||
156843794|NCT00348309|566179629|FG001|Overall Study|Did not appear in time for Visit 3|0|||
156843795|NCT00348309|566179630|FG002|Overall Study|Did not appear in time for Visit 3|0|||
156843796|NCT00348309|566179628|FG000|Overall Study|Participant died|2|||
156843797|NCT00348309|566179629|FG001|Overall Study|Participant died|1|||
156843798|NCT00348309|566179630|FG002|Overall Study|Participant died|1|||
156843799|NCT00348309|566179628|FG000|Overall Study|Decision of sponsor|1|||
156843800|NCT00348309|566179629|FG001|Overall Study|Decision of sponsor|0|||
156843801|NCT00348309|566179630|FG002|Overall Study|Decision of sponsor|0|||
156843802|NCT00348309|566179628|FG000|Overall Study|Ineffectiveness of treatment|0|||
156843803|NCT00348309|566179629|FG001|Overall Study|Ineffectiveness of treatment|1|||
156843804|NCT00348309|566179630|FG002|Overall Study|Ineffectiveness of treatment|0|||
156843805|NCT00348309|566179628|FG000|Overall Study|A foul of exclusion criteria|0|||
156843806|NCT00348309|566179629|FG001|Overall Study|A foul of exclusion criteria|1|||
156843807|NCT00348309|566179630|FG002|Overall Study|A foul of exclusion criteria|0|||
156843808|NCT00348309|566179628|FG000|Overall Study|Participant was hospitalized|0|||
156843809|NCT00348309|566179629|FG001|Overall Study|Participant was hospitalized|1|||
156843810|NCT00348309|566179630|FG002|Overall Study|Participant was hospitalized|0|||
156843811|NCT00348309|566179628|FG000|Overall Study|Sponsor refuseal|0|||
156843812|NCT00348309|566179629|FG001|Overall Study|Sponsor refuseal|1|||
156843813|NCT00348309|566179630|FG002|Overall Study|Sponsor refuseal|1|||
156843814|NCT00348309|566179628|FG000|Overall Study|Forgot often medication|0|||
156843815|NCT00348309|566179629|FG001|Overall Study|Forgot often medication|1|||
156887955|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
156843816|NCT00348309|566179630|FG002|Overall Study|Forgot often medication|0|||
156843817|NCT00348309|566179628|FG000|Overall Study|Medical Monitor decision|0|||
156843818|NCT00348309|566179629|FG001|Overall Study|Medical Monitor decision|0|||
156843819|NCT00348309|566179630|FG002|Overall Study|Medical Monitor decision|1|||
156843820|NCT00348309|566179628|FG000|Overall Study|Increased dose of Aricept|0|||
156843821|NCT00348309|566179629|FG001|Overall Study|Increased dose of Aricept|0|||
156843822|NCT00348309|566179630|FG002|Overall Study|Increased dose of Aricept|1|||
156843823|NCT00348309|566179628|FG000|Overall Study|Site closure|0|||
156843824|NCT00348309|566179629|FG001|Overall Study|Site closure|0|||
156843825|NCT00348309|566179630|FG002|Overall Study|Site closure|1|||
156843826|NCT00348309|566179628|FG000|Overall Study|Adverse event not attended|0|||
156843827|NCT00348309|566179629|FG001|Overall Study|Adverse event not attended|0|||
156843828|NCT00348309|566179630|FG002|Overall Study|Adverse event not attended|1|||
156843829|NCT00348309|566179628|FG000|Overall Study|ECG abnormal|0|||
156843830|NCT00348309|566179629|FG001|Overall Study|ECG abnormal|0|||
156843831|NCT00348309|566179630|FG002|Overall Study|ECG abnormal|2|||
156843832|NCT00348309|566179628|FG000|Overall Study|Cardiologist recommendations|0|||
156843833|NCT00348309|566179629|FG001|Overall Study|Cardiologist recommendations|0|||
156843834|NCT00348309|566179630|FG002|Overall Study|Cardiologist recommendations|1|||
156843835|NCT00348309|566179628|FG000|Overall Study|HCV career|0|||
156843836|NCT00348309|566179629|FG001|Overall Study|HCV career|0|||
156843837|NCT00348309|566179630|FG002|Overall Study|HCV career|1|||
156843838|NCT01894243|566179631|FG000|Overall Study|Adverse Event|0|||
156843839|NCT01894243|566179632|FG001|Overall Study|Adverse Event|1|||
156843840|NCT01894243|566179633|FG002|Overall Study|Adverse Event|2|||
156843841|NCT01894243|566179631|FG000|Overall Study|Death|0|||
156843842|NCT01894243|566179632|FG001|Overall Study|Death|0|||
156843843|NCT01894243|566179633|FG002|Overall Study|Death|3|||
156843844|NCT01894243|566179631|FG000|Overall Study|Lack of Efficacy|3|||
156843845|NCT01894243|566179632|FG001|Overall Study|Lack of Efficacy|3|||
156843846|NCT01894243|566179633|FG002|Overall Study|Lack of Efficacy|1|||
156843847|NCT01894243|566179631|FG000|Overall Study|Condition under investigation worsened|8|||
156843848|NCT01894243|566179632|FG001|Overall Study|Condition under investigation worsened|6|||
156843849|NCT01894243|566179633|FG002|Overall Study|Condition under investigation worsened|2|||
156843850|NCT01894243|566179631|FG000|Overall Study|Subject decision|1|||
156843851|NCT01894243|566179632|FG001|Overall Study|Subject decision|0|||
156843852|NCT01894243|566179633|FG002|Overall Study|Subject decision|0|||
156843853|NCT01894243|566179631|FG000|Overall Study|Other|1|||
156843854|NCT01894243|566179632|FG001|Overall Study|Other|0|||
156843855|NCT01894243|566179633|FG002|Overall Study|Other|0|||
156843856|NCT01743040|566179634|FG000|Overall Study|Death|1|||
156843857|NCT01743040|566179634|FG000|Overall Study|Lost to Follow-up|66|||
156843858|NCT01743040|566179634|FG000|Overall Study|Physician Decision|40|||
156843859|NCT01743040|566179634|FG000|Overall Study|Protocol Violation|1|||
156843860|NCT01743040|566179634|FG000|Overall Study|Withdrawal by Subject|121|||
156843861|NCT01067469|566179635|FG000|Overall Study|Withdrawal by Subject|0|||
156843862|NCT01067469|566179636|FG001|Overall Study|Withdrawal by Subject|1|||
156843863|NCT01067469|566179635|FG000|Overall Study|Disease Progression|0|||
156843864|NCT01067469|566179636|FG001|Overall Study|Disease Progression|1|||
156843865|NCT04006392|566179637|FG000|Overall Study|Lost to Follow-up|0|||
156843866|NCT04006392|566179638|FG001|Overall Study|Lost to Follow-up|1|||
156843867|NCT04378114|566179639|FG000|Overall Study|Withdrawal by Subject|5|||
156843868|NCT01730586|566179644|FG000|Overall Study|Progressive Disease|2|||
156843869|NCT01730586|566179644|FG000|Overall Study|Inadequate Trial|8|||
156843870|NCT01730586|566179644|FG000|Overall Study|Adverse Event|2|||
156887956|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156887957|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
156887958|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156843871|NCT01730586|566179644|FG000|Overall Study|Hospice|1|||
156843872|NCT00660179|566181892|FG000|Overall Study|Death|44|||
156843873|NCT00660179|566181893|FG001|Overall Study|Death|47|||
156887959|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
156887960|NCT00095147|566349452|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
156887961|NCT00095147|566349453|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
157155038|NCT00630812|567312828|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
156843874|NCT00660179|566181894|FG002|Overall Study|Death|34|||
156843875|NCT00660179|566181892|FG000|Overall Study|Withdrawal of consent|4|||
156843876|NCT00660179|566181893|FG001|Overall Study|Withdrawal of consent|6|||
156843877|NCT00660179|566181894|FG002|Overall Study|Withdrawal of consent|4|||
156887962|NCT00095147|566349454|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156887963|NCT00095147|566349455|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156843878|NCT00660179|566181892|FG000|Overall Study|Lost to Follow-up|7|||
156887964|NCT00095147|566349456|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
156843879|NCT00660179|566181893|FG001|Overall Study|Lost to Follow-up|5|||
156843880|NCT00660179|566181894|FG002|Overall Study|Lost to Follow-up|2|||
156843881|NCT00660179|566181892|FG000|Overall Study|Administrative reason|0|||
156843882|NCT00660179|566181893|FG001|Overall Study|Administrative reason|0|||
156843883|NCT00660179|566181894|FG002|Overall Study|Administrative reason|1|||
156843884|NCT00660179|566181892|FG000|Overall Study|Incorrect randomization|1|||
156843885|NCT00660179|566181893|FG001|Overall Study|Incorrect randomization|0|||
156843886|NCT00660179|566181894|FG002|Overall Study|Incorrect randomization|0|||
156843887|NCT00100789|566181898|FG000|Overall Study|Adverse Event|10|||
156843888|NCT00100789|566181898|FG000|Overall Study|Withdrawal by Subject|1|||
156843889|NCT00100789|566181898|FG000|Overall Study|Progression/relapse|42|||
156843890|NCT00100789|566181898|FG000|Overall Study|Death|2|||
156843891|NCT00100789|566181898|FG000|Overall Study|Not protocol specified|5|||
156843892|NCT00100789|566181898|FG000|Overall Study|Ineligible|3|||
156843893|NCT00100789|566181898|FG000|Overall Study|Never received treatment|1|||
156843894|NCT03472950|566181899|FG000|Overall Study|Lost to Follow-up|0|||
156843895|NCT03472950|566181900|FG001|Overall Study|Lost to Follow-up|1|||
156843896|NCT03472950|566181899|FG000|Overall Study|Adverse Event|0|||
156843897|NCT03472950|566181900|FG001|Overall Study|Adverse Event|3|||
156843898|NCT01393821|566181901|FG000|Overall Study|Cancel|1|||
156843899|NCT01393821|566181902|FG001|Overall Study|Cancel|1|||
156843900|NCT01393821|566181901|FG000|Overall Study|not evaluable for primary endpoint|4|||
156843901|NCT01393821|566181902|FG001|Overall Study|not evaluable for primary endpoint|2|||
156843902|NCT00894361|566181909|FG000|Overall Study|deaths and less than 2 years followup|24|||
156843903|NCT00894361|566181910|FG001|Overall Study|deaths and less than 2 years followup|64|||
156843904|NCT00286494|566181915|FG000|Overall Study|Hyperglycemic rescue|12|||
156843905|NCT00286494|566181916|FG001|Overall Study|Hyperglycemic rescue|19|||
156843906|NCT00286494|566181917|FG002|Overall Study|Hyperglycemic rescue|18|||
156843907|NCT00286494|566181915|FG000|Overall Study|Withdrawal by Subject|2|||
156843908|NCT00286494|566181916|FG001|Overall Study|Withdrawal by Subject|10|||
156843909|NCT00286494|566181917|FG002|Overall Study|Withdrawal by Subject|9|||
156843910|NCT00286494|566181915|FG000|Overall Study|Adverse Event|3|||
156843911|NCT00286494|566181916|FG001|Overall Study|Adverse Event|8|||
156843912|NCT00286494|566181917|FG002|Overall Study|Adverse Event|6|||
156843913|NCT00286494|566181915|FG000|Overall Study|Physician Decision|5|||
156843914|NCT00286494|566181916|FG001|Overall Study|Physician Decision|5|||
156843915|NCT00286494|566181917|FG002|Overall Study|Physician Decision|1|||
156843916|NCT00286494|566181915|FG000|Overall Study|Lost to Follow-up|3|||
156843917|NCT00286494|566181916|FG001|Overall Study|Lost to Follow-up|1|||
156843918|NCT00286494|566181917|FG002|Overall Study|Lost to Follow-up|3|||
156843919|NCT00286494|566181915|FG000|Overall Study|Protocol Violation|1|||
156843920|NCT00286494|566181916|FG001|Overall Study|Protocol Violation|1|||
156843921|NCT00286494|566181917|FG002|Overall Study|Protocol Violation|2|||
156843922|NCT04207060|566181918|FG000|Overall Study|Lost to Follow-up|2|||
156843923|NCT04207060|566181919|FG001|Overall Study|Lost to Follow-up|0|||
156887965|NCT00095147|566349452|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
156887966|NCT00095147|566349453|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
156887967|NCT00095147|566349454|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
156887968|NCT00095147|566349455|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
156887969|NCT00095147|566349456|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
156887970|NCT00095147|566349452|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
156887971|NCT00095147|566349453|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
156887972|NCT00095147|566349454|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156887973|NCT00095147|566349455|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156887974|NCT00095147|566349456|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
156887975|NCT00095147|566349452|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
156887976|NCT00095147|566349453|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
156887977|NCT00095147|566349454|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
156887978|NCT00095147|566349455|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
156887979|NCT00095147|566349456|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
156887980|NCT00095147|566349452|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
156887981|NCT00095147|566349453|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
156887982|NCT00095147|566349454|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156887983|NCT00095147|566349455|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156887984|NCT00095147|566349456|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
156887985|NCT00095147|566349452|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
156843924|NCT05438576|566181920|FG000|Overall Study|Death|1|||
156887986|NCT00095147|566349453|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156887987|NCT00095147|566349454|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156887988|NCT00095147|566349455|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
157025138|NCT04489771|566847909|FG000|Overall Study|Death|27|||
156843925|NCT05438576|566181921|FG001|Overall Study|Death|1|||
156843926|NCT05438576|566181920|FG000|Overall Study|Withdrawal by Subject|4|||
156843927|NCT05438576|566181921|FG001|Overall Study|Withdrawal by Subject|2|||
156843928|NCT05438576|566181920|FG000|Overall Study|Not Eligible|2|||
156843929|NCT05438576|566181921|FG001|Overall Study|Not Eligible|1|||
156843930|NCT05438576|566181920|FG000|Overall Study|Did not complete baseline testing|22|||
156843931|NCT05438576|566181921|FG001|Overall Study|Did not complete baseline testing|4|||
156843932|NCT02881762|566181922|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156843933|NCT02881762|566181923|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156843934|NCT00296140|566181924|FG000|Overall Study|Lost to Follow-up|1|||
156843935|NCT00296140|566181925|FG001|Overall Study|Lost to Follow-up|0|||
156843936|NCT00296140|566181924|FG000|Overall Study|Withdrawal by Subject|1|||
156843937|NCT00296140|566181925|FG001|Overall Study|Withdrawal by Subject|0|||
156843938|NCT00296140|566181924|FG000|Overall Study|Discharge to Nursing Home|1|||
156843939|NCT00296140|566181925|FG001|Overall Study|Discharge to Nursing Home|0|||
156843940|NCT00880191|566181932|FG000|Overall Study|Refused further treatment|4|||
156843941|NCT00880191|566181933|FG001|Overall Study|Refused further treatment|1|||
156843942|NCT00880191|566181932|FG000|Overall Study|Adverse Event|8|||
156843943|NCT00880191|566181933|FG001|Overall Study|Adverse Event|6|||
156843944|NCT00880191|566181932|FG000|Overall Study|Hospitalization/efficacy|1|||
156843945|NCT00880191|566181933|FG001|Overall Study|Hospitalization/efficacy|1|||
156843946|NCT00774800|566181935|FG000|Intervention 4|Withdrawal by Subject|1|||
156843947|NCT01919801|566181936|FG000|Overall Study|Withdrawal by Subject|1|||
156843948|NCT01919801|566181937|FG001|Overall Study|Withdrawal by Subject|0|||
156843949|NCT01919801|566181936|FG000|Overall Study|Physician Decision|0|||
156843950|NCT01919801|566181937|FG001|Overall Study|Physician Decision|1|||
156843951|NCT01919801|566181936|FG000|Overall Study|Lost to Follow-up|0|||
156843952|NCT01919801|566181937|FG001|Overall Study|Lost to Follow-up|1|||
156843953|NCT01919801|566181936|FG000|Overall Study|Other|0|||
156843954|NCT01919801|566181937|FG001|Overall Study|Other|1|||
156843955|NCT01677858|566181938|FG000|Overall Study|Adverse Event|0|||
156843956|NCT01677858|566181939|FG001|Overall Study|Adverse Event|0|||
156843957|NCT01677858|566181940|FG002|Overall Study|Adverse Event|2|||
156843958|NCT01677858|566181941|FG003|Overall Study|Adverse Event|3|||
156843959|NCT01677858|566181942|FG004|Overall Study|Adverse Event|13|||
156843960|NCT01677858|566181938|FG000|Overall Study|Death|0|||
156843961|NCT01677858|566181939|FG001|Overall Study|Death|0|||
156843962|NCT01677858|566181940|FG002|Overall Study|Death|0|||
156843963|NCT01677858|566181941|FG003|Overall Study|Death|0|||
156843964|NCT01677858|566181942|FG004|Overall Study|Death|1|||
156843965|NCT01677858|566181938|FG000|Overall Study|Physician Decision|1|||
156843966|NCT01677858|566181939|FG001|Overall Study|Physician Decision|0|||
156843967|NCT01677858|566181940|FG002|Overall Study|Physician Decision|2|||
156843968|NCT01677858|566181941|FG003|Overall Study|Physician Decision|0|||
156843969|NCT01677858|566181942|FG004|Overall Study|Physician Decision|12|||
156843970|NCT01677858|566181938|FG000|Overall Study|Progressive Disease|2|||
156843971|NCT01677858|566181939|FG001|Overall Study|Progressive Disease|1|||
156843972|NCT01677858|566181940|FG002|Overall Study|Progressive Disease|9|||
156843973|NCT01677858|566181941|FG003|Overall Study|Progressive Disease|3|||
156843974|NCT01677858|566181942|FG004|Overall Study|Progressive Disease|43|||
156843975|NCT01677858|566181938|FG000|Overall Study|Withdrawal by Subject|0|||
156843976|NCT01677858|566181939|FG001|Overall Study|Withdrawal by Subject|1|||
156843977|NCT01677858|566181940|FG002|Overall Study|Withdrawal by Subject|1|||
156843978|NCT01677858|566181941|FG003|Overall Study|Withdrawal by Subject|0|||
156843979|NCT01677858|566181942|FG004|Overall Study|Withdrawal by Subject|15|||
156843980|NCT01677858|566181938|FG000|Overall Study|Lost to Follow-up|0|||
156843981|NCT01677858|566181939|FG001|Overall Study|Lost to Follow-up|0|||
156843982|NCT01677858|566181940|FG002|Overall Study|Lost to Follow-up|0|||
156843983|NCT01677858|566181941|FG003|Overall Study|Lost to Follow-up|0|||
156843984|NCT01677858|566181942|FG004|Overall Study|Lost to Follow-up|1|||
156843985|NCT01331109|566181943|FG000|Overall Study|Adverse Event|6|||
156843986|NCT01331109|566181943|FG000|Overall Study|Lack of Efficacy|2|||
156843987|NCT01331109|566181943|FG000|Overall Study|Protocol Violation|3|||
156843988|NCT01331109|566181943|FG000|Overall Study|Withdrawal by Subject|7|||
156843989|NCT01331109|566181943|FG000|Overall Study|Lost to Follow-up|1|||
156843990|NCT01331109|566181943|FG000|Overall Study|Study Terminated by Sponsor|38|||
156843991|NCT00988091|566181944|FG000|Double-blind Period|Withdrawal by Subject|15|||
156843992|NCT00988091|566181945|FG001|Double-blind Period|Withdrawal by Subject|13|||
156843993|NCT00988091|566181944|FG000|Double-blind Period|Lost to Follow-up|12|||
156843994|NCT00988091|566181945|FG001|Double-blind Period|Lost to Follow-up|14|||
156843995|NCT00988091|566181944|FG000|Double-blind Period|Other|8|||
156843996|NCT00988091|566181945|FG001|Double-blind Period|Other|8|||
156843997|NCT00988091|566181944|FG000|Double-blind Period|Adverse Event|6|||
156843998|NCT00988091|566181945|FG001|Double-blind Period|Adverse Event|9|||
156843999|NCT00988091|566181944|FG000|Double-blind Period|Use of exclusionary medication|2|||
156844000|NCT00988091|566181945|FG001|Double-blind Period|Use of exclusionary medication|3|||
156844001|NCT00988091|566181944|FG000|Open-label Period|Adverse Event|4|||
156844002|NCT00988091|566181945|FG001|Open-label Period|Adverse Event|7|||
156844003|NCT00988091|566181944|FG000|Open-label Period|Use of exclusionary medication|1|||
156844004|NCT00988091|566181945|FG001|Open-label Period|Use of exclusionary medication|1|||
156844005|NCT00988091|566181944|FG000|Open-label Period|Protocol Violation|1|||
156844006|NCT00988091|566181945|FG001|Open-label Period|Protocol Violation|1|||
156844007|NCT00988091|566181944|FG000|Open-label Period|Withdrawal by Subject|10|||
156844008|NCT00988091|566181945|FG001|Open-label Period|Withdrawal by Subject|16|||
156844009|NCT00988091|566181944|FG000|Open-label Period|Lost to Follow-up|3|||
156844010|NCT00988091|566181945|FG001|Open-label Period|Lost to Follow-up|5|||
156844011|NCT00988091|566181944|FG000|Open-label Period|Other|2|||
156844012|NCT00988091|566181945|FG001|Open-label Period|Other|3|||
156844013|NCT00773747|566181946|FG000|Overall Study|Lack of Efficacy|112|||
156844014|NCT00773747|566181947|FG001|Overall Study|Lack of Efficacy|144|||
156844015|NCT00773747|566181946|FG000|Overall Study|Physician Decision|26|||
156844016|NCT00773747|566181947|FG001|Overall Study|Physician Decision|18|||
156844017|NCT00773747|566181946|FG000|Overall Study|Lost to Follow-up|0|||
156844018|NCT00773747|566181947|FG001|Overall Study|Lost to Follow-up|1|||
156844019|NCT00773747|566181946|FG000|Overall Study|Protocol Violation|2|||
156844020|NCT00773747|566181947|FG001|Overall Study|Protocol Violation|2|||
156844021|NCT00773747|566181946|FG000|Overall Study|Withdrawal by Subject|89|||
156844022|NCT00773747|566181947|FG001|Overall Study|Withdrawal by Subject|61|||
156844023|NCT00773747|566181946|FG000|Overall Study|Adverse Event|61|||
156844024|NCT00773747|566181947|FG001|Overall Study|Adverse Event|62|||
156844025|NCT00773747|566181946|FG000|Overall Study|Death|5|||
156844026|NCT00773747|566181947|FG001|Overall Study|Death|8|||
156844027|NCT00773747|566181946|FG000|Overall Study|Not Treated|2|||
156844028|NCT00773747|566181947|FG001|Overall Study|Not Treated|0|||
156844029|NCT00994422|566181950|FG000|Overall Study|Lost to Follow-up|7|||
156844030|NCT00994422|566181951|FG001|Overall Study|Lost to Follow-up|1|||
156844031|NCT02669212|566181952|FG000|Overall Study|Lost to Follow-up|1|||
156844032|NCT02669212|566181953|FG001|Overall Study|Lost to Follow-up|0|||
156844033|NCT02669212|566181952|FG000|Overall Study|Medical Condition|3|||
156844034|NCT02669212|566181953|FG001|Overall Study|Medical Condition|4|||
156844035|NCT02669212|566181952|FG000|Overall Study|Withdrawal by Subject|0|||
156844036|NCT02669212|566181953|FG001|Overall Study|Withdrawal by Subject|2|||
156844037|NCT02669212|566181952|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
156844038|NCT02669212|566181953|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
156844039|NCT03549104|566181954|FG000|Overall Study|Withdrawal by Subject|5|||
156844040|NCT03549104|566181955|FG001|Overall Study|Withdrawal by Subject|2|||
156844041|NCT03549104|566181954|FG000|Overall Study|Covid shelter in place|1|||
156844042|NCT03549104|566181955|FG001|Overall Study|Covid shelter in place|2|||
156844043|NCT03422536|566181956|FG000|Randomized|Physician Decision|1|||
156844044|NCT03422536|566181957|FG001|Randomized|Physician Decision|1|||
156844045|NCT03422536|566181956|FG000|Allocation - Received Intervention|Disease progression|19|||
156844046|NCT03422536|566181957|FG001|Allocation - Received Intervention|Disease progression|25|||
156844047|NCT03422536|566181956|FG000|Allocation - Received Intervention|Death|1|||
156844048|NCT03422536|566181957|FG001|Allocation - Received Intervention|Death|3|||
156844049|NCT03422536|566181956|FG000|Allocation - Received Intervention|Adverse Event|1|||
156844050|NCT03422536|566181957|FG001|Allocation - Received Intervention|Adverse Event|0|||
156844051|NCT03422536|566181956|FG000|Allocation - Received Intervention|Physician Decision|1|||
156844052|NCT03422536|566181957|FG001|Allocation - Received Intervention|Physician Decision|1|||
156844053|NCT03422536|566181956|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
156844054|NCT03422536|566181957|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
156844055|NCT03422536|566181956|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
156844056|NCT03422536|566181957|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
156844057|NCT00532298|566181958|FG000|Overall Study|Adverse Event|1|||
156844058|NCT00532298|566181959|FG001|Overall Study|Adverse Event|0|||
156844059|NCT00532298|566181960|FG002|Overall Study|Adverse Event|0|||
156844060|NCT00532298|566181961|FG003|Overall Study|Adverse Event|0|||
156844061|NCT00532298|566181962|FG004|Overall Study|Adverse Event|1|||
156844062|NCT00532298|566181963|FG005|Overall Study|Adverse Event|1|||
156844063|NCT00532298|566181958|FG000|Overall Study|Lost to Follow-up|1|||
157155039|NCT00630812|567312829|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
156844064|NCT00532298|566181959|FG001|Overall Study|Lost to Follow-up|1|||
156844065|NCT00532298|566181960|FG002|Overall Study|Lost to Follow-up|1|||
156844066|NCT00532298|566181961|FG003|Overall Study|Lost to Follow-up|0|||
156844067|NCT00532298|566181962|FG004|Overall Study|Lost to Follow-up|0|||
156844068|NCT00532298|566181963|FG005|Overall Study|Lost to Follow-up|1|||
156844069|NCT00479856|566181964|FG000|Overall Study|Adverse Event|1|||
156844070|NCT00479856|566181964|FG000|Overall Study|Withdrawal by Subject|1|||
156844071|NCT00479856|566181964|FG000|Overall Study|Physician Decision|1|||
156844072|NCT01973998|566181965|FG000|Overall Study|Death|2|||
156844073|NCT01973998|566181966|FG001|Overall Study|Death|2|||
156844074|NCT02141360|566181967|FG000|Overall Study|Withdrawal by Subject|6|||
156844075|NCT02141360|566181968|FG001|Overall Study|Withdrawal by Subject|0|||
157155040|NCT00630812|567312828|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
156844076|NCT02141360|566181969|FG002|Overall Study|Withdrawal by Subject|0|||
156844077|NCT02141360|566181967|FG000|Overall Study|Study Terminated before Visit|1|||
156844078|NCT02141360|566181968|FG001|Overall Study|Study Terminated before Visit|0|||
156844079|NCT02141360|566181969|FG002|Overall Study|Study Terminated before Visit|0|||
156844080|NCT00646399|566181970|FG000|Overall Study|Death|63|||
156844081|NCT00646399|566181971|FG001|Overall Study|Death|53|||
156844082|NCT00646399|566181970|FG000|Overall Study|Withdrawal by Subject|9|||
156844083|NCT00646399|566181971|FG001|Overall Study|Withdrawal by Subject|10|||
156844084|NCT00646399|566181970|FG000|Overall Study|Other Reason|11|||
157025139|NCT04489771|566847910|FG001|Overall Study|Death|25|||
156844085|NCT00646399|566181971|FG001|Overall Study|Other Reason|11|||
156844086|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
156844087|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844088|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844089|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
156844090|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
156844091|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844092|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844093|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
156844094|NCT00395850|566181978|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
156844095|NCT00395850|566181979|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844096|NCT00395850|566181980|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844097|NCT00395850|566181981|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
156844098|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
156844099|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
156844100|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
156844101|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
156844102|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
156844103|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844104|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844105|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
156844106|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
156844107|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844108|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844109|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
156844110|NCT00395850|566181978|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
156844111|NCT00395850|566181979|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844112|NCT00395850|566181980|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844113|NCT00395850|566181981|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
156844114|NCT01424228|566181982|FG000|Overall Study|Withdrawal by Subject|27|||
156844115|NCT01424228|566181983|FG001|Overall Study|Withdrawal by Subject|11|||
156844116|NCT01424228|566181982|FG000|Overall Study|Adverse Event|10|||
156844117|NCT01424228|566181983|FG001|Overall Study|Adverse Event|14|||
156844118|NCT01424228|566181982|FG000|Overall Study|Sponsor's decision|9|||
156844119|NCT01424228|566181983|FG001|Overall Study|Sponsor's decision|12|||
156844120|NCT01424228|566181982|FG000|Overall Study|Lack of Efficacy|5|||
156844121|NCT01424228|566181983|FG001|Overall Study|Lack of Efficacy|7|||
156844122|NCT01424228|566181982|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
156844123|NCT01424228|566181983|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
157025140|NCT04489771|566847909|FG000|Overall Study|Withdrawal by Subject|1|||
157025141|NCT04489771|566847910|FG001|Overall Study|Withdrawal by Subject|0|||
157025142|NCT04489771|566847909|FG000|Overall Study|Participants Ongoing in Study|50|||
157025143|NCT04489771|566847910|FG001|Overall Study|Participants Ongoing in Study|51|||
157025144|NCT06516705|566847912|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
156844124|NCT01424228|566181982|FG000|Overall Study|Non-compliance|2|||
156844125|NCT01424228|566181983|FG001|Overall Study|Non-compliance|0|||
157025145|NCT06516705|566847913|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
156844126|NCT01424228|566181982|FG000|Overall Study|Worsening of symptoms|1|||
156844127|NCT01424228|566181983|FG001|Overall Study|Worsening of symptoms|0|||
156844128|NCT01424228|566181982|FG000|Overall Study|Unplanned journey|0|||
156844129|NCT01424228|566181983|FG001|Overall Study|Unplanned journey|1|||
156844130|NCT00844558|566181986|FG000|Overall Study|Withdrawal by Subject|9|||
156844131|NCT00844558|566181987|FG001|Overall Study|Withdrawal by Subject|2|||
156844132|NCT00844558|566181986|FG000|Overall Study|Death|1|||
156844133|NCT00844558|566181987|FG001|Overall Study|Death|0|||
156844134|NCT00844558|566181986|FG000|Overall Study|Protocol Violation|1|||
156844135|NCT00844558|566181987|FG001|Overall Study|Protocol Violation|1|||
157025146|NCT06516705|566847912|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
156844136|NCT00844558|566181986|FG000|Overall Study|Lost to Follow-up|0|||
156844137|NCT00844558|566181987|FG001|Overall Study|Lost to Follow-up|1|||
157025147|NCT06516705|566847913|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
157025148|NCT06516705|566847912|FG000|T3 ( 3 Month After Education)|covid-19|1|||
157025149|NCT06516705|566847913|FG001|T3 ( 3 Month After Education)|covid-19|2|||
157155041|NCT00630812|567312829|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
157025150|NCT06516705|566847912|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
157155042|NCT00630812|567312828|FG000|Double Blind Treatment Period|Non-compliance|0|||
156844138|NCT00844558|566181986|FG000|Overall Study|Physician Decision|1|||
156844139|NCT00844558|566181987|FG001|Overall Study|Physician Decision|0|||
156844140|NCT00932165|566181988|FG000|Overall Study|Lost to Follow-up|1|||
156844141|NCT00588094|566181989|FG000|Overall Study|Adverse Event|3|||
156844142|NCT00588094|566181989|FG000|Overall Study|Progression of Disease|2|||
156844143|NCT02951429|566181996|FG000|Overall Study|Adverse Event|3|||
156844144|NCT02951429|566181997|FG001|Overall Study|Adverse Event|7|||
156844145|NCT02951429|566181996|FG000|Overall Study|Death|28|||
156844146|NCT02951429|566181997|FG001|Overall Study|Death|36|||
156844147|NCT02951429|566181996|FG000|Overall Study|Lack of Efficacy|0|||
156844148|NCT02951429|566181997|FG001|Overall Study|Lack of Efficacy|1|||
156844149|NCT02951429|566181996|FG000|Overall Study|Lost to Follow-up|0|||
156844150|NCT02951429|566181997|FG001|Overall Study|Lost to Follow-up|1|||
156844151|NCT02951429|566181996|FG000|Overall Study|Lung Transplantation|9|||
156844152|NCT02951429|566181997|FG001|Overall Study|Lung Transplantation|6|||
156844153|NCT02951429|566181996|FG000|Overall Study|Other|1|||
156844154|NCT02951429|566181997|FG001|Overall Study|Other|3|||
156844155|NCT02951429|566181996|FG000|Overall Study|Progressive Disease|1|||
156844156|NCT02951429|566181997|FG001|Overall Study|Progressive Disease|1|||
156844157|NCT02951429|566181996|FG000|Overall Study|Withdrawal by Subject|7|||
156844158|NCT02951429|566181997|FG001|Overall Study|Withdrawal by Subject|11|||
156844159|NCT02951429|566181996|FG000|Overall Study|Participant ongoing in the study|23|||
156844160|NCT02951429|566181997|FG001|Overall Study|Participant ongoing in the study|17|||
156844161|NCT02202538|566182000|FG000|Overall Study|Withdrawal by Subject|5|||
156844162|NCT02202538|566182000|FG000|Overall Study|Did not meet all inclusion criteria|2|||
156844163|NCT02202538|566182000|FG000|Overall Study|Investigator Decision|1|||
156844164|NCT01457846|566182001|FG000|Overall Study|Death before treatment|1|||
156844165|NCT01457846|566182002|FG001|Overall Study|Death before treatment|2|||
156844166|NCT01457846|566182001|FG000|Overall Study|Did not receive treatment|0|||
156844167|NCT01457846|566182002|FG001|Overall Study|Did not receive treatment|1|||
156844168|NCT01457846|566182001|FG000|Overall Study|Death|27|||
156844169|NCT01457846|566182002|FG001|Overall Study|Death|16|||
156844170|NCT01457846|566182001|FG000|Overall Study|Unclassified reason for not completed|11|||
156844171|NCT01457846|566182002|FG001|Overall Study|Unclassified reason for not completed|10|||
156844172|NCT01457846|566182001|FG000|Overall Study|Withdrawal by Subject|1|||
156844173|NCT01457846|566182002|FG001|Overall Study|Withdrawal by Subject|1|||
156844174|NCT01457846|566182001|FG000|Overall Study|Lost to Follow-up|1|||
156844175|NCT01457846|566182002|FG001|Overall Study|Lost to Follow-up|0|||
156844176|NCT01853878|566182003|FG000|Overall Study|Recurrence|2|||
156844177|NCT01853878|566182004|FG001|Overall Study|Recurrence|0|||
156844178|NCT01853878|566182003|FG000|Overall Study|Adverse Event|2|||
156844179|NCT01853878|566182004|FG001|Overall Study|Adverse Event|0|||
156844180|NCT01853878|566182003|FG000|Overall Study|Withdrawal by Subject|3|||
156844181|NCT01853878|566182004|FG001|Overall Study|Withdrawal by Subject|1|||
156844182|NCT01853878|566182003|FG000|Overall Study|Migrated/moved from the study area|1|||
156844183|NCT01853878|566182004|FG001|Overall Study|Migrated/moved from the study area|0|||
156844184|NCT01853878|566182003|FG000|Overall Study|Other|55|||
156844185|NCT01853878|566182004|FG001|Overall Study|Other|43|||
156844186|NCT01846741|566182005|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
156844187|NCT05392803|566182009|FG000|Overall Study|Lost to Follow-up|0|||
156844188|NCT05392803|566182010|FG001|Overall Study|Lost to Follow-up|2|||
156844189|NCT01240135|566182011|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
156844190|NCT01240135|566182012|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
156844191|NCT01240135|566182011|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
156844192|NCT01240135|566182012|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
156844193|NCT01628965|566182013|FG000|Overall Study|Adverse Event|30|||
156844194|NCT01628965|566182013|FG000|Overall Study|Lack of Efficacy|7|||
156844195|NCT01628965|566182013|FG000|Overall Study|Withdrawal by Subject|3|||
156844196|NCT01628965|566182013|FG000|Overall Study|Lost to Follow-up|1|||
156844197|NCT01628965|566182013|FG000|Overall Study|Discontinuation criteria|8|||
156844198|NCT02828020|566182019|FG000|Treatment Period|Adverse Event|3|||
156844199|NCT02828020|566182020|FG001|Treatment Period|Adverse Event|1|||
156844200|NCT02828020|566182021|FG002|Treatment Period|Adverse Event|1|||
156844201|NCT02828020|566182019|FG000|Treatment Period|Withdrawal of Consent|10|||
156844202|NCT02828020|566182020|FG001|Treatment Period|Withdrawal of Consent|14|||
156844203|NCT02828020|566182021|FG002|Treatment Period|Withdrawal of Consent|9|||
156844204|NCT02828020|566182019|FG000|Treatment Period|Lost to Follow-up|21|||
156844205|NCT02828020|566182020|FG001|Treatment Period|Lost to Follow-up|24|||
156844206|NCT02828020|566182021|FG002|Treatment Period|Lost to Follow-up|18|||
156844207|NCT02828020|566182019|FG000|Treatment Period|Lack of Qualifying Event|44|||
156844208|NCT02828020|566182020|FG001|Treatment Period|Lack of Qualifying Event|53|||
156844209|NCT02828020|566182021|FG002|Treatment Period|Lack of Qualifying Event|43|||
156844210|NCT02828020|566182019|FG000|Treatment Period|Pregnancy|0|||
156844211|NCT02828020|566182020|FG001|Treatment Period|Pregnancy|2|||
156844212|NCT02828020|566182021|FG002|Treatment Period|Pregnancy|0|||
156844213|NCT02828020|566182019|FG000|Treatment Period|Protocol Violation|2|||
156844214|NCT02828020|566182020|FG001|Treatment Period|Protocol Violation|4|||
156844215|NCT02828020|566182021|FG002|Treatment Period|Protocol Violation|7|||
156844216|NCT02828020|566182019|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
156844217|NCT02828020|566182020|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
156844218|NCT02828020|566182021|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
156844219|NCT02828020|566182019|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
156844220|NCT02828020|566182020|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
156844221|NCT02828020|566182021|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
156844222|NCT02828020|566182019|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
156844223|NCT02828020|566182020|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
156844224|NCT02828020|566182021|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
156844225|NCT02828020|566182019|FG000|Safety Follow-up Period|Protocol Violation|0|||
156844226|NCT02828020|566182020|FG001|Safety Follow-up Period|Protocol Violation|2|||
156844227|NCT02828020|566182021|FG002|Safety Follow-up Period|Protocol Violation|1|||
156844228|NCT02828020|566182019|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
156844229|NCT02828020|566182020|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156844230|NCT02828020|566182021|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
156844231|NCT03688620|566182022|FG000|Overall Study|Other|0|||
156844232|NCT03688620|566182023|FG001|Overall Study|Other|0|||
156844233|NCT03688620|566182024|FG002|Overall Study|Other|1|||
156844234|NCT03688620|566182022|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
156844235|NCT03688620|566182023|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
156844236|NCT03688620|566182024|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
156844237|NCT03688620|566182022|FG000|Overall Study|Lost to Follow-up|16|||
156844238|NCT03688620|566182023|FG001|Overall Study|Lost to Follow-up|0|||
156844239|NCT03688620|566182024|FG002|Overall Study|Lost to Follow-up|1|||
156844240|NCT03688620|566182022|FG000|Overall Study|Withdrawal by Subject|0|||
156844241|NCT03688620|566182023|FG001|Overall Study|Withdrawal by Subject|0|||
156844242|NCT03688620|566182024|FG002|Overall Study|Withdrawal by Subject|6|||
156844243|NCT01183065|566182025|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
156844244|NCT00330681|566182027|FG000|Overall Study|Adverse Event|3|||
156844245|NCT00330681|566182028|FG001|Overall Study|Adverse Event|6|||
156844246|NCT00330681|566182027|FG000|Overall Study|Protocol Violation|0|||
156844247|NCT00330681|566182028|FG001|Overall Study|Protocol Violation|1|||
156844248|NCT00330681|566182027|FG000|Overall Study|Withdrawal by Subject|5|||
156844249|NCT00330681|566182028|FG001|Overall Study|Withdrawal by Subject|5|||
156844250|NCT00330681|566182027|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
156844251|NCT00330681|566182028|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
156844252|NCT02578186|566182032|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
156844253|NCT02578186|566182033|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
156844254|NCT02578186|566182032|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
156844255|NCT02578186|566182033|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
156844256|NCT03657095|566182034|FG000|Overall Study|Withdrawal by Subject|1|||
156844257|NCT03657095|566182035|FG001|Overall Study|Withdrawal by Subject|1|||
156844258|NCT03657095|566182034|FG000|Overall Study|Adverse Event|0|||
156844259|NCT03657095|566182035|FG001|Overall Study|Adverse Event|3|||
156844260|NCT03657095|566182034|FG000|Overall Study|Study Terminated by Sponsor|58|||
156844261|NCT03657095|566182035|FG001|Overall Study|Study Terminated by Sponsor|49|||
156844262|NCT00828750|566182036|FG000|Overall Study|Lack of Efficacy|3|||
156844263|NCT00828750|566182036|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
156844264|NCT00830180|566182037|FG000|Overall Study|Adverse Event|6|||
156844265|NCT00830180|566182037|FG000|Overall Study|Death|11|||
156844266|NCT00830180|566182037|FG000|Overall Study|Insufficient clinical response|1|||
156844267|NCT00830180|566182037|FG000|Overall Study|Withdrawal by Subject|5|||
156844268|NCT00830180|566182037|FG000|Overall Study|Progressive disease|2|||
156844269|NCT00830180|566182037|FG000|Overall Study|Other - Unspecified|1|||
156844270|NCT01832532|566182038|FG000|Overall Study|Withdrawal by Subject|5|||
156844271|NCT01832532|566182039|FG001|Overall Study|Withdrawal by Subject|2|||
156844272|NCT03824587|566182045|FG000|Run-in Period|Screen Failure|0|||
156844273|NCT03824587|566182046|FG001|Run-in Period|Screen Failure|275|||
156844274|NCT03824587|566182045|FG000|Treatment Period|Adverse Event|4|||
156844275|NCT03824587|566182046|FG001|Treatment Period|Adverse Event|1|||
156844276|NCT03824587|566182045|FG000|Treatment Period|Withdrawal by Subject|0|||
156844277|NCT03824587|566182046|FG001|Treatment Period|Withdrawal by Subject|1|||
156844278|NCT03824587|566182045|FG000|Treatment Period|Kidney Transplant|1|||
156844279|NCT03824587|566182046|FG001|Treatment Period|Kidney Transplant|1|||
157224794|NCT00992407|567569873|FG000|Overall Study|Study medication not administered|17|||
156844280|NCT01300572|566182047|FG000|Overall Study|HAMA + post dosimetry|1|||
156844281|NCT03597061|566182048|FG000|Overall Study|Lost to Follow-up|1|||
156844282|NCT03597061|566182049|FG001|Overall Study|Lost to Follow-up|0|||
156844283|NCT03597061|566182048|FG000|Overall Study|Protocol Violation|0|||
156844284|NCT03597061|566182049|FG001|Overall Study|Protocol Violation|1|||
156844285|NCT05111249|566183389|FG000|Overall Study|Lost to Follow-up|0|||
156844286|NCT05111249|566183390|FG001|Overall Study|Lost to Follow-up|2|||
156844287|NCT05111249|566183389|FG000|Overall Study|Physician Decision|0|||
156844288|NCT05111249|566183390|FG001|Overall Study|Physician Decision|1|||
156844289|NCT05111249|566183389|FG000|Overall Study|Participant decision|1|||
156844290|NCT05111249|566183390|FG001|Overall Study|Participant decision|5|||
156844291|NCT02813889|566183391|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
156844292|NCT02813889|566183392|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
156844293|NCT05128578|566183393|FG000|Overall Study|Withdrawal by Subject|9|||
156844294|NCT05128578|566183393|FG000|Overall Study|Lost to Follow-up|5|||
156844295|NCT01504412|566183404|FG000|Overall Study|Adverse Event|1|||
156844296|NCT01504412|566183405|FG001|Overall Study|Adverse Event|8|||
156844297|NCT01504412|566183406|FG002|Overall Study|Adverse Event|1|||
156844298|NCT01504412|566183407|FG003|Overall Study|Adverse Event|7|||
156844299|NCT01504412|566183408|FG004|Overall Study|Adverse Event|10|||
156844300|NCT01504412|566183404|FG000|Overall Study|Withdrawal by Subject|2|||
156844301|NCT01504412|566183405|FG001|Overall Study|Withdrawal by Subject|1|||
156844302|NCT01504412|566183406|FG002|Overall Study|Withdrawal by Subject|1|||
156844303|NCT01504412|566183407|FG003|Overall Study|Withdrawal by Subject|5|||
156844304|NCT01504412|566183408|FG004|Overall Study|Withdrawal by Subject|1|||
156844305|NCT01504412|566183404|FG000|Overall Study|Other|2|||
156844306|NCT01504412|566183405|FG001|Overall Study|Other|1|||
156844307|NCT01504412|566183406|FG002|Overall Study|Other|1|||
156844308|NCT01504412|566183407|FG003|Overall Study|Other|6|||
156844309|NCT01504412|566183408|FG004|Overall Study|Other|1|||
156844310|NCT01504412|566183404|FG000|Overall Study|Lost to Follow-up|0|||
156844311|NCT01504412|566183405|FG001|Overall Study|Lost to Follow-up|2|||
156844312|NCT01504412|566183406|FG002|Overall Study|Lost to Follow-up|0|||
156844313|NCT01504412|566183407|FG003|Overall Study|Lost to Follow-up|0|||
156844314|NCT01504412|566183408|FG004|Overall Study|Lost to Follow-up|0|||
156844315|NCT01504412|566183404|FG000|Overall Study|Lack of Efficacy|0|||
156844316|NCT01504412|566183405|FG001|Overall Study|Lack of Efficacy|0|||
156844317|NCT01504412|566183406|FG002|Overall Study|Lack of Efficacy|1|||
156844318|NCT01504412|566183407|FG003|Overall Study|Lack of Efficacy|0|||
156844319|NCT01504412|566183408|FG004|Overall Study|Lack of Efficacy|1|||
156844320|NCT01504412|566183404|FG000|Overall Study|Death|0|||
156844321|NCT01504412|566183405|FG001|Overall Study|Death|0|||
156844322|NCT01504412|566183406|FG002|Overall Study|Death|0|||
156844323|NCT01504412|566183407|FG003|Overall Study|Death|1|||
156844324|NCT01504412|566183408|FG004|Overall Study|Death|0|||
156844325|NCT05362058|566183409|FG000|Treatment Period|Adverse Event|3|||
156844326|NCT05362058|566183410|FG001|Treatment Period|Adverse Event|3|||
156844327|NCT05362058|566183409|FG000|Treatment Period|Assigned treatment by mistake|3|||
156844328|NCT05362058|566183410|FG001|Treatment Period|Assigned treatment by mistake|4|||
156844329|NCT05362058|566183409|FG000|Treatment Period|Death|1|||
156844330|NCT05362058|566183410|FG001|Treatment Period|Death|1|||
156844331|NCT05362058|566183409|FG000|Treatment Period|Lost to Follow-up|6|||
156844332|NCT05362058|566183410|FG001|Treatment Period|Lost to Follow-up|3|||
156844333|NCT05362058|566183409|FG000|Treatment Period|Non-compliance with study drug|0|||
156844334|NCT05362058|566183410|FG001|Treatment Period|Non-compliance with study drug|1|||
156844335|NCT05362058|566183409|FG000|Treatment Period|Physician Decision|1|||
156844336|NCT05362058|566183410|FG001|Treatment Period|Physician Decision|0|||
156844337|NCT05362058|566183409|FG000|Treatment Period|Protocol deviation|1|||
156844338|NCT05362058|566183410|FG001|Treatment Period|Protocol deviation|0|||
156844339|NCT05362058|566183409|FG000|Treatment Period|Withdrawal by Subject|10|||
156844340|NCT05362058|566183410|FG001|Treatment Period|Withdrawal by Subject|11|||
156844341|NCT05362058|566183409|FG000|Follow-Up Period|Death|1|||
156844342|NCT05362058|566183410|FG001|Follow-Up Period|Death|0|||
156844343|NCT05362058|566183409|FG000|Follow-Up Period|Lost to Follow-up|2|||
156844344|NCT05362058|566183410|FG001|Follow-Up Period|Lost to Follow-up|1|||
156844345|NCT05362058|566183409|FG000|Follow-Up Period|Protocol deviation|1|||
156844346|NCT05362058|566183410|FG001|Follow-Up Period|Protocol deviation|1|||
156844347|NCT05362058|566183409|FG000|Follow-Up Period|Withdrawal by Subject|0|||
156844348|NCT05362058|566183410|FG001|Follow-Up Period|Withdrawal by Subject|3|||
156844349|NCT00398567|566183411|FG000|Overall Study|Disease Progression|3|||
156844350|NCT00398567|566183412|FG001|Overall Study|Disease Progression|4|||
156844351|NCT00398567|566183413|FG002|Overall Study|Disease Progression|27|||
156887989|NCT00095147|566349456|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
156887990|NCT00095147|566349452|FG000|Long-term Extension Period|Death|0|||
156887991|NCT00095147|566349453|FG001|Long-term Extension Period|Death|0|||
156887992|NCT00095147|566349454|FG002|Long-term Extension Period|Death|0|||
156844352|NCT00398567|566183411|FG000|Overall Study|Withdrawal by Subject|1|||
156844353|NCT00398567|566183412|FG001|Overall Study|Withdrawal by Subject|0|||
156844354|NCT00398567|566183413|FG002|Overall Study|Withdrawal by Subject|4|||
156844355|NCT00398567|566183411|FG000|Overall Study|Adverse Event|0|||
156844356|NCT00398567|566183412|FG001|Overall Study|Adverse Event|0|||
156844357|NCT00398567|566183413|FG002|Overall Study|Adverse Event|2|||
156844358|NCT00398567|566183411|FG000|Overall Study|Protocol Violation|0|||
156844359|NCT00398567|566183412|FG001|Overall Study|Protocol Violation|0|||
156844360|NCT00398567|566183413|FG002|Overall Study|Protocol Violation|1|||
156844361|NCT03437577|566183416|FG000|Pre-Randomization|Withdrawal by Subject|0|||
156844362|NCT03437577|566183417|FG001|Pre-Randomization|Withdrawal by Subject|0|||
156844363|NCT03437577|566183418|FG002|Pre-Randomization|Withdrawal by Subject|10|||
156844364|NCT03437577|566183416|FG000|Post-Randomization|Physician Decision|0|||
156844365|NCT03437577|566183417|FG001|Post-Randomization|Physician Decision|2|||
156844366|NCT03437577|566183418|FG002|Post-Randomization|Physician Decision|0|||
156844367|NCT04273893|566183421|FG000|Overall Study|Withdrawal by Subject|0|||
156844368|NCT04273893|566183422|FG001|Overall Study|Withdrawal by Subject|2|||
156844369|NCT04273893|566183421|FG000|Overall Study|Treatment of Disease Progression|0|||
156844370|NCT04273893|566183422|FG001|Overall Study|Treatment of Disease Progression|2|||
156844371|NCT04273893|566183421|FG000|Overall Study|Death|1|||
156844372|NCT04273893|566183422|FG001|Overall Study|Death|2|||
156844373|NCT04273893|566183421|FG000|Overall Study|Lost to Follow-up|0|||
156844374|NCT04273893|566183422|FG001|Overall Study|Lost to Follow-up|2|||
156844375|NCT04273893|566183421|FG000|Overall Study|Physician Decision|1|||
156844376|NCT04273893|566183422|FG001|Overall Study|Physician Decision|0|||
156844377|NCT01036321|566183427|FG000|Overall Study|Ineligible after randomization|0|||
156844378|NCT01036321|566183428|FG001|Overall Study|Ineligible after randomization|1|||
156844379|NCT01036321|566183427|FG000|Overall Study|Withdrawal by Subject|3|||
156844380|NCT01036321|566183428|FG001|Overall Study|Withdrawal by Subject|2|||
156844381|NCT01036321|566183427|FG000|Overall Study|Adverse Event|2|||
156844382|NCT01036321|566183428|FG001|Overall Study|Adverse Event|1|||
156844383|NCT00381693|566183429|FG000|Overall Study|Death|1|||
156844384|NCT00381693|566183429|FG000|Overall Study|Adverse Event|4|||
156844385|NCT00381693|566183429|FG000|Overall Study|Patient Choice|1|||
156844386|NCT00381693|566183429|FG000|Overall Study|Progression|2|||
156844387|NCT02598297|566183430|FG000|Overall Study|Study terminated by Sponsor|21|||
156844388|NCT02598297|566183431|FG001|Overall Study|Study terminated by Sponsor|23|||
156844389|NCT02598297|566183430|FG000|Overall Study|Adverse Event|1|||
156844390|NCT02598297|566183431|FG001|Overall Study|Adverse Event|1|||
156844391|NCT02598297|566183430|FG000|Overall Study|Physician Decision|1|||
156844392|NCT02598297|566183431|FG001|Overall Study|Physician Decision|0|||
156844393|NCT02598297|566183430|FG000|Overall Study|Subject/guardian decision|1|||
156844394|NCT02598297|566183431|FG001|Overall Study|Subject/guardian decision|0|||
156844395|NCT02598297|566183430|FG000|Overall Study|Followed for survival|1|||
156844396|NCT02598297|566183431|FG001|Overall Study|Followed for survival|0|||
156844397|NCT00887549|566183440|FG000|Induction Therapy|Adverse Event|8|||
156844398|NCT00887549|566183440|FG000|Induction Therapy|Physician Decision|1|||
156844399|NCT00887549|566183440|FG000|Induction Therapy|Progressive Disease|13|||
156844400|NCT00887549|566183440|FG000|Induction Therapy|Death due to Study Disease|4|||
156844401|NCT00887549|566183440|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
156844402|NCT00887549|566183440|FG000|Maintenance Therapy|Adverse Event|16|||
156844403|NCT00887549|566183440|FG000|Maintenance Therapy|Physician Decision|1|||
156844404|NCT00887549|566183440|FG000|Maintenance Therapy|Progressive Disease|25|||
156844405|NCT00887549|566183440|FG000|Maintenance Therapy|Death due to adverse event|1|||
156844406|NCT05173012|566183441|FG000|Overall Study|Adverse Event|2|||
156844407|NCT05173012|566183442|FG001|Overall Study|Adverse Event|3|||
156844408|NCT05173012|566183443|FG002|Overall Study|Adverse Event|4|||
156844409|NCT05173012|566183444|FG003|Overall Study|Adverse Event|13|||
156844410|NCT05173012|566183445|FG004|Overall Study|Adverse Event|0|||
156844411|NCT05173012|566183446|FG005|Overall Study|Adverse Event|0|||
156844412|NCT05173012|566183447|FG006|Overall Study|Adverse Event|2|||
156844413|NCT05173012|566183448|FG007|Overall Study|Adverse Event|4|||
156844414|NCT05173012|566183441|FG000|Overall Study|Lost to Follow-up|0|||
156844415|NCT05173012|566183442|FG001|Overall Study|Lost to Follow-up|0|||
156844416|NCT05173012|566183443|FG002|Overall Study|Lost to Follow-up|0|||
156844417|NCT05173012|566183444|FG003|Overall Study|Lost to Follow-up|1|||
156844418|NCT05173012|566183445|FG004|Overall Study|Lost to Follow-up|0|||
156844419|NCT05173012|566183446|FG005|Overall Study|Lost to Follow-up|0|||
156844420|NCT05173012|566183447|FG006|Overall Study|Lost to Follow-up|0|||
156844421|NCT05173012|566183448|FG007|Overall Study|Lost to Follow-up|0|||
156844422|NCT05173012|566183441|FG000|Overall Study|Withdrawal by Subject|1|||
156844423|NCT05173012|566183442|FG001|Overall Study|Withdrawal by Subject|0|||
156844424|NCT05173012|566183443|FG002|Overall Study|Withdrawal by Subject|1|||
156844425|NCT05173012|566183444|FG003|Overall Study|Withdrawal by Subject|3|||
156844426|NCT05173012|566183445|FG004|Overall Study|Withdrawal by Subject|1|||
156844427|NCT05173012|566183446|FG005|Overall Study|Withdrawal by Subject|0|||
156844428|NCT05173012|566183447|FG006|Overall Study|Withdrawal by Subject|1|||
156844429|NCT05173012|566183448|FG007|Overall Study|Withdrawal by Subject|0|||
157155043|NCT00630812|567312829|FG001|Double Blind Treatment Period|Non-compliance|1|||
157155044|NCT00972478|567312830|FG000|Overall Study|Adverse Event|3|||
156844430|NCT05173012|566183441|FG000|Overall Study|Protocol Deviation|0|||
156844431|NCT05173012|566183442|FG001|Overall Study|Protocol Deviation|0|||
156844432|NCT05173012|566183443|FG002|Overall Study|Protocol Deviation|0|||
156844433|NCT05173012|566183444|FG003|Overall Study|Protocol Deviation|1|||
156844434|NCT05173012|566183445|FG004|Overall Study|Protocol Deviation|0|||
156844435|NCT05173012|566183446|FG005|Overall Study|Protocol Deviation|0|||
156844436|NCT05173012|566183447|FG006|Overall Study|Protocol Deviation|0|||
156844437|NCT05173012|566183448|FG007|Overall Study|Protocol Deviation|0|||
156844438|NCT05173012|566183441|FG000|Overall Study|Other|0|||
156844439|NCT05173012|566183442|FG001|Overall Study|Other|0|||
156844440|NCT05173012|566183443|FG002|Overall Study|Other|0|||
156844441|NCT05173012|566183444|FG003|Overall Study|Other|2|||
156844442|NCT05173012|566183445|FG004|Overall Study|Other|0|||
156844443|NCT05173012|566183446|FG005|Overall Study|Other|0|||
156844444|NCT05173012|566183447|FG006|Overall Study|Other|0|||
156844445|NCT05173012|566183448|FG007|Overall Study|Other|0|||
156844446|NCT02936843|566183449|FG000|Overall Study|Lost to Follow-up|3|||
156844447|NCT02936843|566183450|FG001|Overall Study|Lost to Follow-up|1|||
156844448|NCT02936843|566183449|FG000|Overall Study|Withdrawal by Subject|1|||
156844449|NCT02936843|566183450|FG001|Overall Study|Withdrawal by Subject|1|||
156844450|NCT00517361|566183458|FG000|Overall Study|Death|6|||
156844451|NCT00517361|566183458|FG000|Overall Study|The study was terminated|5|||
156844452|NCT01856582|566183470|FG000|Overall Study|Died prior to Boost infusion|1|||
156844453|NCT04124705|566183471|FG000|Titration Period|Adverse Event|9|||
156844454|NCT04124705|566183472|FG001|Titration Period|Adverse Event|5|||
156844455|NCT04124705|566183471|FG000|Titration Period|Withdrawal by Subject|6|||
156844456|NCT04124705|566183472|FG001|Titration Period|Withdrawal by Subject|3|||
156844457|NCT04124705|566183471|FG000|Titration Period|Lost to Follow-up|0|||
156844458|NCT04124705|566183472|FG001|Titration Period|Lost to Follow-up|1|||
156844459|NCT04124705|566183471|FG000|Titration Period|Death|1|||
156844460|NCT04124705|566183472|FG001|Titration Period|Death|1|||
156844461|NCT04124705|566183471|FG000|Titration Period|Lack of Efficacy|2|||
156844462|NCT04124705|566183472|FG001|Titration Period|Lack of Efficacy|0|||
156844463|NCT04124705|566183471|FG000|Titration Period|Physician Decision|2|||
156844464|NCT04124705|566183472|FG001|Titration Period|Physician Decision|0|||
156844465|NCT04124705|566183471|FG000|Titration Period|Non-compliance with Study Drug|2|||
156844466|NCT04124705|566183472|FG001|Titration Period|Non-compliance with Study Drug|0|||
156844467|NCT04124705|566183471|FG000|Titration Period|Other|4|||
156844468|NCT04124705|566183472|FG001|Titration Period|Other|9|||
156844469|NCT04124705|566183471|FG000|Stabilization Period|Adverse Event|4|||
156844470|NCT04124705|566183472|FG001|Stabilization Period|Adverse Event|2|||
156844471|NCT04124705|566183471|FG000|Stabilization Period|Withdrawal by Subject|1|||
156844472|NCT04124705|566183472|FG001|Stabilization Period|Withdrawal by Subject|1|||
156844473|NCT04124705|566183471|FG000|Stabilization Period|Lost to Follow-up|0|||
156844474|NCT04124705|566183472|FG001|Stabilization Period|Lost to Follow-up|1|||
156844475|NCT04124705|566183471|FG000|Stabilization Period|Lack of Efficacy|4|||
156844476|NCT04124705|566183472|FG001|Stabilization Period|Lack of Efficacy|2|||
156844477|NCT04124705|566183471|FG000|Stabilization Period|Protocol Deviation|0|||
156844478|NCT04124705|566183472|FG001|Stabilization Period|Protocol Deviation|2|||
156844479|NCT04124705|566183471|FG000|Stabilization Period|Other|2|||
156844480|NCT04124705|566183472|FG001|Stabilization Period|Other|2|||
156844481|NCT00661622|566183475|FG000|Overall Study|Protocol Violation|1|||
156844482|NCT00661622|566183476|FG001|Overall Study|Protocol Violation|0|||
156844483|NCT04427072|566183477|FG000|Randomized Treatment Phase|Progressive disease|9|||
156844484|NCT04427072|566183478|FG001|Randomized Treatment Phase|Progressive disease|4|||
156844485|NCT04427072|566183477|FG000|Randomized Treatment Phase|Adverse Event|3|||
156844486|NCT04427072|566183478|FG001|Randomized Treatment Phase|Adverse Event|1|||
156844487|NCT04427072|566183477|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
156844488|NCT04427072|566183478|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
156844489|NCT04427072|566183477|FG000|Randomized Treatment Phase|Death|0|||
156844490|NCT04427072|566183478|FG001|Randomized Treatment Phase|Death|1|||
156887993|NCT00095147|566349455|FG003|Long-term Extension Period|Death|0|||
156887994|NCT00095147|566349456|FG004|Long-term Extension Period|Death|3|||
156887995|NCT00095147|566349452|FG000|Long-term Extension Period|Adverse Event|0|||
156887996|NCT00095147|566349453|FG001|Long-term Extension Period|Adverse Event|0|||
156887997|NCT00095147|566349454|FG002|Long-term Extension Period|Adverse Event|0|||
156887998|NCT00095147|566349455|FG003|Long-term Extension Period|Adverse Event|0|||
156887999|NCT00095147|566349456|FG004|Long-term Extension Period|Adverse Event|11|||
156888000|NCT00095147|566349452|FG000|Long-term Extension Period|Lack of Efficacy|0|||
157025151|NCT06516705|566847913|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
157025152|NCT06516705|566847912|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
157224795|NCT00992407|567569874|FG001|Overall Study|Study medication not administered|13|||
156844491|NCT04427072|566183477|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
156844492|NCT04427072|566183478|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
156844493|NCT04427072|566183477|FG000|Extension Treatment Phase|Progressive disease|0|||
156888001|NCT00095147|566349453|FG001|Long-term Extension Period|Lack of Efficacy|0|||
156888002|NCT00095147|566349454|FG002|Long-term Extension Period|Lack of Efficacy|0|||
156844494|NCT04427072|566183478|FG001|Extension Treatment Phase|Progressive disease|5|||
156844495|NCT05232864|566183479|FG000|Overall Study|Adverse Event|0|||
156844496|NCT05232864|566183480|FG001|Overall Study|Adverse Event|1|||
156844497|NCT05232864|566183479|FG000|Overall Study|Study terminated by sponsor|16|||
156844498|NCT05232864|566183480|FG001|Overall Study|Study terminated by sponsor|14|||
156844499|NCT04765202|566183485|FG000|Overall Study|Lost to Follow-up|1|||
156844500|NCT04765202|566183486|FG001|Overall Study|Lost to Follow-up|1|||
156844501|NCT04765202|566183487|FG002|Overall Study|Lost to Follow-up|2|||
156844502|NCT04765202|566183488|FG003|Overall Study|Lost to Follow-up|2|||
156844503|NCT04765202|566183485|FG000|Overall Study|Physician Decision|0|||
156844504|NCT04765202|566183486|FG001|Overall Study|Physician Decision|0|||
156844505|NCT04765202|566183487|FG002|Overall Study|Physician Decision|1|||
156844506|NCT04765202|566183488|FG003|Overall Study|Physician Decision|1|||
156844507|NCT04929249|566183489|FG000|Overall Study|Adverse Event|2|||
156844508|NCT04929249|566183490|FG001|Overall Study|Adverse Event|1|||
156844509|NCT04929249|566183489|FG000|Overall Study|Death|2|||
156844510|NCT04929249|566183490|FG001|Overall Study|Death|1|||
156844511|NCT04929249|566183489|FG000|Overall Study|Lost to Follow-up|3|||
156844512|NCT04929249|566183490|FG001|Overall Study|Lost to Follow-up|11|||
156844513|NCT04929249|566183489|FG000|Overall Study|Technical problems|0|||
156844514|NCT04929249|566183490|FG001|Overall Study|Technical problems|1|||
156844515|NCT04929249|566183489|FG000|Overall Study|Subject decision|6|||
156844516|NCT04929249|566183490|FG001|Overall Study|Subject decision|8|||
156844517|NCT04929249|566183489|FG000|Overall Study|Withdrew consent|0|||
156844518|NCT04929249|566183490|FG001|Overall Study|Withdrew consent|8|||
156844519|NCT02160145|566183493|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
156844520|NCT02160145|566183494|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
156844521|NCT02160145|566183495|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
156844522|NCT02160145|566183493|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
156844523|NCT02160145|566183494|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
156844524|NCT02160145|566183495|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
156844525|NCT02160145|566183493|FG000|Randomized Double-blind Period|Subject decision|0|||
156844526|NCT02160145|566183494|FG001|Randomized Double-blind Period|Subject decision|21|||
156844527|NCT02160145|566183495|FG002|Randomized Double-blind Period|Subject decision|20|||
156844528|NCT02160145|566183493|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
156844529|NCT02160145|566183494|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
156844530|NCT02160145|566183495|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
156844531|NCT02160145|566183493|FG000|Randomized Double-blind Period|Physician Decision|0|||
156844532|NCT02160145|566183494|FG001|Randomized Double-blind Period|Physician Decision|7|||
156844533|NCT02160145|566183495|FG002|Randomized Double-blind Period|Physician Decision|5|||
156844534|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
156844535|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
156844536|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
156844537|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
156844538|NCT02332291|566183496|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
156844539|NCT02332291|566183497|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
156844540|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
156844541|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
156844542|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
156844543|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
156844544|NCT02332291|566183496|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
156844545|NCT02332291|566183497|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
156844546|NCT02540993|566183502|FG000|Overall Study|Lost to Follow-up|5|||
156844547|NCT02540993|566183503|FG001|Overall Study|Lost to Follow-up|3|||
156844548|NCT02540993|566183502|FG000|Overall Study|Withdrawal by Subject|4|||
156844549|NCT02540993|566183503|FG001|Overall Study|Withdrawal by Subject|6|||
156844550|NCT02540993|566183502|FG000|Overall Study|GCP violations|33|||
156844551|NCT02540993|566183503|FG001|Overall Study|GCP violations|27|||
156844552|NCT00392990|566183506|FG000|Treatment on Study|Adverse Event|3|||
156844553|NCT00392990|566183507|FG001|Treatment on Study|Adverse Event|1|||
156844554|NCT00392990|566183506|FG000|Follow up for 2 Years|Death|4|||
156844555|NCT00392990|566183507|FG001|Follow up for 2 Years|Death|0|||
156844556|NCT00825812|566183508|FG000|Overall Study|Never entered follow up|0|||
156844557|NCT00825812|566183509|FG001|Overall Study|Never entered follow up|0|||
157155045|NCT00972478|567312831|FG001|Overall Study|Adverse Event|16|||
156844558|NCT00825812|566183510|FG002|Overall Study|Never entered follow up|0|||
156844559|NCT00825812|566183511|FG003|Overall Study|Never entered follow up|1|||
156844560|NCT00825812|566183508|FG000|Overall Study|Adverse Event|0|||
156844561|NCT00825812|566183509|FG001|Overall Study|Adverse Event|0|||
156844562|NCT00825812|566183510|FG002|Overall Study|Adverse Event|0|||
156844563|NCT00825812|566183511|FG003|Overall Study|Adverse Event|1|||
156844564|NCT00825812|566183508|FG000|Overall Study|Subject withdrew consent|0|||
157155046|NCT00972478|567312830|FG000|Overall Study|Withdrawal by Subject|1|||
157155047|NCT00972478|567312831|FG001|Overall Study|Withdrawal by Subject|8|||
157155048|NCT00972478|567312830|FG000|Overall Study|Progression/Relapse|0|||
156844565|NCT00825812|566183509|FG001|Overall Study|Subject withdrew consent|0|||
156844566|NCT00825812|566183510|FG002|Overall Study|Subject withdrew consent|3|||
157155049|NCT00972478|567312831|FG001|Overall Study|Progression/Relapse|2|||
156844567|NCT00825812|566183511|FG003|Overall Study|Subject withdrew consent|2|||
156844568|NCT00825812|566183508|FG000|Overall Study|Non-compliance with protocol|0|||
156844569|NCT00825812|566183509|FG001|Overall Study|Non-compliance with protocol|0|||
157155050|NCT00972478|567312830|FG000|Overall Study|Death|0|||
157155051|NCT00972478|567312831|FG001|Overall Study|Death|2|||
156844570|NCT00825812|566183510|FG002|Overall Study|Non-compliance with protocol|0|||
156844571|NCT00825812|566183511|FG003|Overall Study|Non-compliance with protocol|1|||
156844572|NCT00825812|566183508|FG000|Overall Study|Administrative|0|||
156844573|NCT00825812|566183509|FG001|Overall Study|Administrative|1|||
156844574|NCT00825812|566183510|FG002|Overall Study|Administrative|3|||
156844575|NCT00825812|566183511|FG003|Overall Study|Administrative|5|||
156844576|NCT00991406|566183512|FG000|Overall Study|One participant did not respond to FES.|1|||
156844577|NCT02006979|566183513|FG000|Overall Study|Withdrawal by Subject|1|||
156844578|NCT02006979|566183514|FG001|Overall Study|Withdrawal by Subject|1|||
156844579|NCT02006979|566183513|FG000|Overall Study|Protocol Violation|0|||
156844580|NCT02006979|566183514|FG001|Overall Study|Protocol Violation|1|||
156844581|NCT02038075|566183515|FG000|Overall Study|Withdrawal by Subject|3|||
156844582|NCT02038075|566183516|FG001|Overall Study|Withdrawal by Subject|0|||
156844583|NCT03477838|566183517|FG000|Overall Study|Lost to Follow-up|14|||
156844584|NCT02519595|566183519|FG000|Overall Study|Protocol Violation|8|||
156844585|NCT02519595|566183520|FG001|Overall Study|Protocol Violation|22|||
156844586|NCT02519595|566183521|FG002|Overall Study|Protocol Violation|16|||
156844587|NCT00850538|566183524|FG000|Overall Study|unable/unwilling to complete MRI|13|||
156844588|NCT00850538|566183524|FG000|Overall Study|specimen missed due to scheduling error|14|||
156844589|NCT00850538|566183524|FG000|Overall Study|specimen unusable|7|||
156844590|NCT00850538|566183524|FG000|Overall Study|Withdrawal by Subject|3|||
156844591|NCT00850538|566183524|FG000|Overall Study|radiology error|2|||
156844592|NCT00850538|566183524|FG000|Overall Study|Protocol Violation|2|||
156844593|NCT03188510|566183525|FG000|Overall Study|Inappropriate behavior with site staff|0|||
156844594|NCT03188510|566183526|FG001|Overall Study|Inappropriate behavior with site staff|1|||
156844595|NCT03188510|566183527|FG002|Overall Study|Inappropriate behavior with site staff|0|||
156844596|NCT01736618|566183530|FG000|Overall Study|Death|294|||
156844597|NCT01736618|566183530|FG000|Overall Study|Lost to Follow-up|193|||
156844598|NCT01736618|566183530|FG000|Overall Study|Withdrawal by Subject|54|||
156844599|NCT01736618|566183530|FG000|Overall Study|Subject unable to be followed at study location|223|||
156844600|NCT01736618|566183530|FG000|Overall Study|Physician Decision|33|||
156844601|NCT01736618|566183530|FG000|Overall Study|Transplant or removal of target organ|19|||
156844602|NCT01736618|566183530|FG000|Overall Study|Change in indication or condition|78|||
156844603|NCT01736618|566183530|FG000|Overall Study|Study device explant|103|||
156844604|NCT01736618|566183530|FG000|Overall Study|Unable to complete implant|2|||
156844605|NCT04167137|566183532|FG000|Overall Study|Disease progression|1|||
156844606|NCT04167137|566183533|FG001|Overall Study|Disease progression|1|||
156844607|NCT04167137|566183534|FG002|Overall Study|Disease progression|3|||
156844608|NCT04167137|566183535|FG003|Overall Study|Disease progression|3|||
156844609|NCT04167137|566183536|FG004|Overall Study|Disease progression|2|||
156844610|NCT04167137|566183537|FG005|Overall Study|Disease progression|3|||
156844611|NCT04167137|566183538|FG006|Overall Study|Disease progression|2|||
156844612|NCT04167137|566183539|FG007|Overall Study|Disease progression|2|||
156844613|NCT04167137|566183532|FG000|Overall Study|Withdrawal by Subject|1|||
156844614|NCT04167137|566183533|FG001|Overall Study|Withdrawal by Subject|0|||
156844615|NCT04167137|566183534|FG002|Overall Study|Withdrawal by Subject|0|||
156844616|NCT04167137|566183535|FG003|Overall Study|Withdrawal by Subject|1|||
156844617|NCT04167137|566183536|FG004|Overall Study|Withdrawal by Subject|0|||
156844618|NCT04167137|566183537|FG005|Overall Study|Withdrawal by Subject|2|||
156844619|NCT04167137|566183538|FG006|Overall Study|Withdrawal by Subject|1|||
156844620|NCT04167137|566183539|FG007|Overall Study|Withdrawal by Subject|0|||
156844621|NCT04167137|566183532|FG000|Overall Study|Adverse Event|0|||
156844622|NCT04167137|566183533|FG001|Overall Study|Adverse Event|0|||
156844623|NCT04167137|566183534|FG002|Overall Study|Adverse Event|0|||
156844624|NCT04167137|566183535|FG003|Overall Study|Adverse Event|0|||
156844625|NCT04167137|566183536|FG004|Overall Study|Adverse Event|0|||
156844626|NCT04167137|566183537|FG005|Overall Study|Adverse Event|1|||
156844627|NCT04167137|566183538|FG006|Overall Study|Adverse Event|0|||
156844628|NCT04167137|566183539|FG007|Overall Study|Adverse Event|1|||
156844629|NCT04167137|566183532|FG000|Overall Study|Physician Decision|0|||
156888003|NCT00095147|566349455|FG003|Long-term Extension Period|Lack of Efficacy|0|||
156888004|NCT00095147|566349456|FG004|Long-term Extension Period|Lack of Efficacy|9|||
156888005|NCT00095147|566349452|FG000|Long-term Extension Period|Lost to Follow-up|0|||
157025153|NCT06516705|566847913|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
157155052|NCT00972478|567312830|FG000|Overall Study|Not protocol specified|1|||
156844630|NCT04167137|566183533|FG001|Overall Study|Physician Decision|0|||
156844631|NCT04167137|566183534|FG002|Overall Study|Physician Decision|0|||
156844632|NCT04167137|566183535|FG003|Overall Study|Physician Decision|1|||
156844633|NCT04167137|566183536|FG004|Overall Study|Physician Decision|0|||
156844634|NCT04167137|566183537|FG005|Overall Study|Physician Decision|0|||
156844635|NCT04167137|566183538|FG006|Overall Study|Physician Decision|1|||
156844636|NCT04167137|566183539|FG007|Overall Study|Physician Decision|0|||
156844637|NCT04167137|566183532|FG000|Overall Study|Death|0|||
156844638|NCT04167137|566183533|FG001|Overall Study|Death|1|||
156844639|NCT04167137|566183534|FG002|Overall Study|Death|0|||
156844640|NCT04167137|566183535|FG003|Overall Study|Death|0|||
156844641|NCT04167137|566183536|FG004|Overall Study|Death|0|||
156844642|NCT04167137|566183537|FG005|Overall Study|Death|0|||
156844643|NCT04167137|566183538|FG006|Overall Study|Death|0|||
156844644|NCT04167137|566183539|FG007|Overall Study|Death|0|||
156844645|NCT04167137|566183532|FG000|Overall Study|Study terminated by Sponsor|0|||
156844646|NCT04167137|566183533|FG001|Overall Study|Study terminated by Sponsor|0|||
156844647|NCT04167137|566183534|FG002|Overall Study|Study terminated by Sponsor|0|||
156844648|NCT04167137|566183535|FG003|Overall Study|Study terminated by Sponsor|0|||
156844649|NCT04167137|566183536|FG004|Overall Study|Study terminated by Sponsor|0|||
156844650|NCT04167137|566183537|FG005|Overall Study|Study terminated by Sponsor|0|||
156844651|NCT04167137|566183538|FG006|Overall Study|Study terminated by Sponsor|0|||
156844652|NCT04167137|566183539|FG007|Overall Study|Study terminated by Sponsor|1|||
156844653|NCT02461745|566183545|FG000|Overall Study|Lack of Efficacy|9|||
156844654|NCT02461745|566183546|FG001|Overall Study|Lack of Efficacy|1|||
156844655|NCT02461745|566183545|FG000|Overall Study|Lost to Follow-up|2|||
156844656|NCT02461745|566183546|FG001|Overall Study|Lost to Follow-up|2|||
156844657|NCT02461745|566183545|FG000|Overall Study|Withdrawal by Subject|3|||
156844658|NCT02461745|566183546|FG001|Overall Study|Withdrawal by Subject|1|||
156844659|NCT02921087|566183547|FG000|Overall Study|Withdrawal by Subject|0|||
156844660|NCT02921087|566183548|FG001|Overall Study|Withdrawal by Subject|1|||
156844661|NCT00211887|566183549|FG000|Overall Study|Adverse Event|8|||
156844662|NCT00211887|566183550|FG001|Overall Study|Adverse Event|4|||
156844663|NCT00211887|566183551|FG002|Overall Study|Adverse Event|6|||
156844664|NCT00211887|566183549|FG000|Overall Study|Death|1|||
156844665|NCT00211887|566183550|FG001|Overall Study|Death|1|||
156844666|NCT00211887|566183551|FG002|Overall Study|Death|1|||
156844667|NCT00211887|566183549|FG000|Overall Study|Lost to Follow-up|28|||
156844668|NCT00211887|566183550|FG001|Overall Study|Lost to Follow-up|13|||
156844669|NCT00211887|566183551|FG002|Overall Study|Lost to Follow-up|9|||
156844670|NCT00211887|566183549|FG000|Overall Study|Non-medical reason|31|||
156844671|NCT00211887|566183550|FG001|Overall Study|Non-medical reason|14|||
156844672|NCT00211887|566183551|FG002|Overall Study|Non-medical reason|8|||
156844673|NCT00211887|566183549|FG000|Overall Study|Other medical reason|15|||
156844674|NCT00211887|566183550|FG001|Overall Study|Other medical reason|11|||
156844675|NCT00211887|566183551|FG002|Overall Study|Other medical reason|7|||
156844676|NCT00211887|566183549|FG000|Overall Study|Side effects|19|||
156844677|NCT00211887|566183550|FG001|Overall Study|Side effects|13|||
156844678|NCT00211887|566183551|FG002|Overall Study|Side effects|5|||
156844679|NCT03058692|566185390|FG000|Overall Study|Lost to Follow-up|2|||
156844680|NCT03058692|566185391|FG001|Overall Study|Lost to Follow-up|1|||
156844681|NCT03058692|566185390|FG000|Overall Study|Withdrawal by Subject|1|||
156844682|NCT03058692|566185391|FG001|Overall Study|Withdrawal by Subject|1|||
156844683|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
156844684|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
156844685|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
156844686|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
156844687|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
156844688|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
156844689|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
156844690|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
156844691|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
156844692|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
156844693|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
156844694|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
156844695|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
156844696|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
156844697|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
156844698|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
156844699|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
156844700|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
156844701|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
156844702|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
157224796|NCT03738332|567569875|FG000|Overall Study|Withdrawal by Subject|1|||
156844703|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
156844704|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
156844705|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
156844706|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
156844707|NCT03777059|566185392|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
156844708|NCT03777059|566185393|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
156844709|NCT03777059|566185394|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
156844710|NCT03777059|566185395|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
156844711|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
156844712|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
156844713|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
156844714|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
156844715|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
156844716|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
156844717|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
156844718|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
156844719|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
156844720|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
156844721|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
156844722|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
156844723|NCT03777059|566185392|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
156844724|NCT03777059|566185393|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
156844725|NCT03777059|566185394|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
156844726|NCT03777059|566185395|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
156844727|NCT01702025|566185400|FG000|Overall Study|Equipment failure|1|||
156844728|NCT01702025|566185401|FG001|Overall Study|Equipment failure|0|||
156844729|NCT01702025|566185402|FG002|Overall Study|Equipment failure|0|||
156844730|NCT01702025|566185403|FG003|Overall Study|Equipment failure|0|||
156844731|NCT01702025|566185400|FG000|Overall Study|Adverse Event|1|||
156844732|NCT01702025|566185401|FG001|Overall Study|Adverse Event|1|||
156844733|NCT01702025|566185402|FG002|Overall Study|Adverse Event|1|||
156844734|NCT01702025|566185403|FG003|Overall Study|Adverse Event|0|||
156844735|NCT02679755|566185404|FG000|Overall Study|Death|0|||
156844736|NCT02679755|566185405|FG001|Overall Study|Death|3|||
156844737|NCT02679755|566185404|FG000|Overall Study|Global deterioration of health status|1|||
156844738|NCT02679755|566185405|FG001|Overall Study|Global deterioration of health status|8|||
156844739|NCT02679755|566185404|FG000|Overall Study|Lost to Follow-up|1|||
156844740|NCT02679755|566185405|FG001|Overall Study|Lost to Follow-up|0|||
156844741|NCT02679755|566185404|FG000|Overall Study|Objective progression or relapse|24|||
156844742|NCT02679755|566185405|FG001|Overall Study|Objective progression or relapse|83|||
156844743|NCT02679755|566185404|FG000|Overall Study|Not defined|0|||
156844744|NCT02679755|566185405|FG001|Overall Study|Not defined|2|||
156844745|NCT02679755|566185404|FG000|Overall Study|Withdrawal by participant|6|||
156844746|NCT02679755|566185405|FG001|Overall Study|Withdrawal by participant|3|||
156844747|NCT02679755|566185404|FG000|Overall Study|Adverse Event|1|||
156844748|NCT02679755|566185405|FG001|Overall Study|Adverse Event|4|||
156844749|NCT02679755|566185404|FG000|Overall Study|Adverse events not related to study drug|1|||
156844750|NCT02679755|566185405|FG001|Overall Study|Adverse events not related to study drug|2|||
156844751|NCT01061359|566185406|FG000|Overall Study|Death|32|||
156844752|NCT01061359|566185406|FG000|Overall Study|Lost to Follow-up|1072|||
156844753|NCT01061359|566185406|FG000|Overall Study|Relapse|187|||
156844754|NCT01061359|566185406|FG000|Overall Study|Secondary neoplasm|11|||
156844755|NCT02610777|566185407|FG000|Overall Study|Lost to Follow-up|1|||
156844756|NCT02610777|566185408|FG001|Overall Study|Lost to Follow-up|0|||
156844757|NCT02610777|566185407|FG000|Overall Study|Site Terminated by Sponsor|9|||
156844758|NCT02610777|566185408|FG001|Overall Study|Site Terminated by Sponsor|8|||
156844759|NCT02610777|566185407|FG000|Overall Study|Withdrawal by Subject|2|||
156844760|NCT02610777|566185408|FG001|Overall Study|Withdrawal by Subject|2|||
156844761|NCT02610777|566185407|FG000|Overall Study|Reason not Specified|0|||
156844762|NCT02610777|566185408|FG001|Overall Study|Reason not Specified|1|||
156844763|NCT02610777|566185407|FG000|Overall Study|Death|50|||
156844764|NCT02610777|566185408|FG001|Overall Study|Death|47|||
156844765|NCT00411671|566185411|FG000|Overall Study|Adverse Event|15|||
156844766|NCT00411671|566185411|FG000|Overall Study|Death|2|||
156844767|NCT00411671|566185411|FG000|Overall Study|Lost to Follow-up|3|||
156844768|NCT04737278|566185412|FG000|Overall Study|Lost to Follow-up|1|||
156844769|NCT04737278|566185413|FG001|Overall Study|Lost to Follow-up|1|||
156844770|NCT04737278|566185412|FG000|Overall Study|Withdrawal by Subject|1|||
156844771|NCT04737278|566185413|FG001|Overall Study|Withdrawal by Subject|0|||
156844772|NCT04737278|566185412|FG000|Overall Study|Protocol Violation|1|||
156844773|NCT04737278|566185413|FG001|Overall Study|Protocol Violation|1|||
157025154|NCT06516705|566847912|FG000|T4 ( 6 Month After Education)|covid-19|3|||
156844774|NCT04737278|566185412|FG000|Overall Study|failure to complete questionnaire|1|||
156844775|NCT04737278|566185413|FG001|Overall Study|failure to complete questionnaire|1|||
156844776|NCT00546000|566185418|FG000|Overall Study|Adverse Event|1|||
156844777|NCT00546000|566185418|FG000|Overall Study|Lost to Follow-up|1|||
156844778|NCT00546000|566185418|FG000|Overall Study|Baseline HPA Axis Supression|2|||
156844779|NCT03688074|566185423|FG000|Overall Study|Adverse Event|0|||
156844780|NCT03688074|566185424|FG001|Overall Study|Adverse Event|1|||
156844781|NCT03688074|566185423|FG000|Overall Study|Other|1|||
156844782|NCT03688074|566185424|FG001|Overall Study|Other|0|||
156844783|NCT01362608|566185427|FG000|Overall Study|Protocol Violation|0|||
156844784|NCT01362608|566185428|FG001|Overall Study|Protocol Violation|1|||
156844785|NCT01362608|566185427|FG000|Overall Study|Lost to Follow-up|3|||
156844786|NCT01362608|566185428|FG001|Overall Study|Lost to Follow-up|1|||
156844787|NCT01362608|566185427|FG000|Overall Study|Withdrawal by Subject|1|||
156844788|NCT01362608|566185428|FG001|Overall Study|Withdrawal by Subject|2|||
156844789|NCT01362608|566185427|FG000|Overall Study|Lack of Efficacy|0|||
156844790|NCT01362608|566185428|FG001|Overall Study|Lack of Efficacy|2|||
156844791|NCT01362608|566185427|FG000|Overall Study|Adverse Event|0|||
156844792|NCT01362608|566185428|FG001|Overall Study|Adverse Event|2|||
156844793|NCT03056339|566185434|FG000|Overall Study|Failed Requirements|0|||
156844794|NCT03056339|566185435|FG001|Overall Study|Failed Requirements|2|||
156844795|NCT03056339|566185436|FG002|Overall Study|Failed Requirements|7|||
156844796|NCT03056339|566185437|FG003|Overall Study|Failed Requirements|1|||
156844797|NCT01128244|566185442|FG000|Overall Study|Adverse Event|1|||
156844798|NCT01128244|566185442|FG000|Overall Study|Scheduling conflict|2|||
156844799|NCT04171219|566185448|FG000|Overall Study|Adverse Event|1|||
156844800|NCT04171219|566185449|FG001|Overall Study|Adverse Event|0|||
156844801|NCT04171219|566185448|FG000|Overall Study|Death|0|||
156844802|NCT04171219|566185449|FG001|Overall Study|Death|1|||
156844803|NCT04171219|566185448|FG000|Overall Study|Lack of Efficacy|9|||
156844804|NCT04171219|566185449|FG001|Overall Study|Lack of Efficacy|13|||
156844805|NCT04171219|566185448|FG000|Overall Study|Withdrawal by Subject|1|||
156844806|NCT04171219|566185449|FG001|Overall Study|Withdrawal by Subject|2|||
156844807|NCT04171219|566185448|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
156844808|NCT04171219|566185449|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
156844809|NCT04171219|566185448|FG000|Overall Study|Clinical PD/Patient choice|1|||
156844810|NCT04171219|566185449|FG001|Overall Study|Clinical PD/Patient choice|0|||
156844811|NCT04171219|566185448|FG000|Overall Study|Toxicity/ Patient choice|1|||
156844812|NCT04171219|566185449|FG001|Overall Study|Toxicity/ Patient choice|0|||
156844813|NCT04809285|566185454|FG000|Phase 1|Lost to Follow-up|6|||
156844814|NCT04809285|566185454|FG000|Phase 1|Protocol Violation|2|||
156844815|NCT04809285|566185454|FG000|Phase 1|Physician Decision|3|||
156844816|NCT04809285|566185454|FG000|Phase 1|Withdrawal by Subject|29|||
156844817|NCT04809285|566185454|FG000|Phase 2|Protocol Violation|3|||
156844818|NCT04809285|566185454|FG000|Phase 2|Withdrawal by Subject|4|||
156844819|NCT02974257|566185455|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
156844820|NCT02974257|566185456|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
156844821|NCT02974257|566185455|FG000|Overall Study|Clinical indication for thiamine|1|||
156844822|NCT02974257|566185456|FG001|Overall Study|Clinical indication for thiamine|0|||
156844823|NCT02974257|566185455|FG000|Overall Study|Already on thiamine|1|||
156844824|NCT02974257|566185456|FG001|Overall Study|Already on thiamine|0|||
156844825|NCT02974257|566185455|FG000|Overall Study|Extubated prior to study drug|0|||
156844826|NCT02974257|566185456|FG001|Overall Study|Extubated prior to study drug|1|||
156844827|NCT02974257|566185455|FG000|Overall Study|Death|0|||
156844828|NCT02974257|566185456|FG001|Overall Study|Death|1|||
156844829|NCT03526146|566185457|FG000|Overall Study|Lost to Follow-up|5|||
156844830|NCT03526146|566185457|FG000|Overall Study|Withdrawal by Subject|6|||
156844831|NCT03526146|566185457|FG000|Overall Study|class canceled due to COVID-19|4|||
156844832|NCT00699608|566185462|FG000|First Intervention|Withdrawal by Subject|0|||
156844833|NCT00699608|566185463|FG001|First Intervention|Withdrawal by Subject|0|||
156844834|NCT00699608|566185464|FG002|First Intervention|Withdrawal by Subject|1|||
156844835|NCT00699608|566185465|FG003|First Intervention|Withdrawal by Subject|0|||
156844836|NCT00699608|566185466|FG004|First Intervention|Withdrawal by Subject|0|||
156844837|NCT00699608|566185467|FG005|First Intervention|Withdrawal by Subject|0|||
156844838|NCT00699608|566185462|FG000|First Intervention|Protocol Violation|0|||
156888006|NCT00095147|566349453|FG001|Long-term Extension Period|Lost to Follow-up|0|||
156888007|NCT00095147|566349454|FG002|Long-term Extension Period|Lost to Follow-up|0|||
156888008|NCT00095147|566349455|FG003|Long-term Extension Period|Lost to Follow-up|0|||
156888009|NCT00095147|566349456|FG004|Long-term Extension Period|Lost to Follow-up|6|||
156888010|NCT00095147|566349452|FG000|Long-term Extension Period|Withdrawal of consent|0|||
156888011|NCT00095147|566349453|FG001|Long-term Extension Period|Withdrawal of consent|0|||
156888012|NCT00095147|566349454|FG002|Long-term Extension Period|Withdrawal of consent|0|||
156888013|NCT00095147|566349455|FG003|Long-term Extension Period|Withdrawal of consent|0|||
156888014|NCT00095147|566349456|FG004|Long-term Extension Period|Withdrawal of consent|12|||
156888015|NCT00095147|566349452|FG000|Long-term Extension Period|Pregnancy|0|||
156888016|NCT00095147|566349453|FG001|Long-term Extension Period|Pregnancy|0|||
156888017|NCT00095147|566349454|FG002|Long-term Extension Period|Pregnancy|0|||
157224797|NCT01521559|567569876|FG000|Overall Study|Adverse Event|0|||
156844839|NCT00699608|566185463|FG001|First Intervention|Protocol Violation|0|||
156844840|NCT00699608|566185464|FG002|First Intervention|Protocol Violation|0|||
156844841|NCT00699608|566185465|FG003|First Intervention|Protocol Violation|0|||
156844842|NCT00699608|566185466|FG004|First Intervention|Protocol Violation|1|||
156844843|NCT00699608|566185467|FG005|First Intervention|Protocol Violation|0|||
156844844|NCT00699608|566185462|FG000|Second Intervention|Adverse Event|0|||
156844845|NCT00699608|566185463|FG001|Second Intervention|Adverse Event|0|||
156844846|NCT00699608|566185464|FG002|Second Intervention|Adverse Event|1|||
156844847|NCT00699608|566185465|FG003|Second Intervention|Adverse Event|0|||
156844848|NCT00699608|566185466|FG004|Second Intervention|Adverse Event|0|||
156844849|NCT00699608|566185467|FG005|Second Intervention|Adverse Event|0|||
156888018|NCT00095147|566349455|FG003|Long-term Extension Period|Pregnancy|0|||
157155053|NCT00972478|567312831|FG001|Overall Study|Not protocol specified|1|||
156844850|NCT00699608|566185462|FG000|Second Intervention|Withdrawal by Subject|0|||
156844851|NCT00699608|566185463|FG001|Second Intervention|Withdrawal by Subject|0|||
156844852|NCT00699608|566185464|FG002|Second Intervention|Withdrawal by Subject|0|||
156844853|NCT00699608|566185465|FG003|Second Intervention|Withdrawal by Subject|1|||
156844854|NCT00699608|566185466|FG004|Second Intervention|Withdrawal by Subject|0|||
156844855|NCT00699608|566185467|FG005|Second Intervention|Withdrawal by Subject|0|||
156844856|NCT02837029|566185468|FG000|Screening|Failed to meet screening requirements.|7|||
156844857|NCT02837029|566185469|FG001|Screening|Failed to meet screening requirements.|3|||
156844858|NCT02837029|566185470|FG002|Screening|Failed to meet screening requirements.|0|||
156844859|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
156844860|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
156844861|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
156844862|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
156844863|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
156844864|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
156844865|NCT02837029|566185468|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
156844866|NCT02837029|566185469|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
156844867|NCT02837029|566185470|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
156844868|NCT02837029|566185468|FG000|Cycle 2 and Beyond|Adverse Event|1|||
156844869|NCT02837029|566185469|FG001|Cycle 2 and Beyond|Adverse Event|0|||
156844870|NCT02837029|566185470|FG002|Cycle 2 and Beyond|Adverse Event|0|||
156844871|NCT02837029|566185468|FG000|2 Year Follow-up|Death|6|||
156844872|NCT02837029|566185469|FG001|2 Year Follow-up|Death|7|||
156844873|NCT02837029|566185470|FG002|2 Year Follow-up|Death|0|||
156844874|NCT02644343|566185471|FG000|Overall Study|Withdrawal by Subject|1|||
156844875|NCT02206035|566185478|FG000|Overall Study|Physician Decision|10|||
156844876|NCT02206035|566185479|FG001|Overall Study|Physician Decision|0|||
156844877|NCT02206035|566185480|FG002|Overall Study|Physician Decision|175|||
156844878|NCT00377858|566185481|FG000|Overall Study|Withdrawal by Subject|12|||
156844879|NCT00377858|566185482|FG001|Overall Study|Withdrawal by Subject|11|||
156844880|NCT00377858|566185481|FG000|Overall Study|Lost to Follow-up|6|||
156844881|NCT00377858|566185482|FG001|Overall Study|Lost to Follow-up|1|||
156844882|NCT00377858|566185481|FG000|Overall Study|Physician Decision|5|||
156844883|NCT00377858|566185482|FG001|Overall Study|Physician Decision|5|||
156844884|NCT00377858|566185481|FG000|Overall Study|Protocol Violation|3|||
156844885|NCT00377858|566185482|FG001|Overall Study|Protocol Violation|4|||
156844886|NCT00377858|566185481|FG000|Overall Study|Adverse Event|2|||
156844887|NCT00377858|566185482|FG001|Overall Study|Adverse Event|1|||
156844888|NCT00377858|566185481|FG000|Overall Study|Entry Criteria Not Met|2|||
156844889|NCT00377858|566185482|FG001|Overall Study|Entry Criteria Not Met|0|||
156844890|NCT00377858|566185481|FG000|Overall Study|Sponsor Decision|1|||
156844891|NCT00377858|566185482|FG001|Overall Study|Sponsor Decision|2|||
156844892|NCT00377858|566185481|FG000|Overall Study|Death|0|||
156844893|NCT00377858|566185482|FG001|Overall Study|Death|3|||
156844894|NCT03534141|566185483|FG000|Overall Study|Enrolled in other clinical trial|1|||
156844895|NCT03534141|566185484|FG001|Overall Study|Enrolled in other clinical trial|0|||
156844896|NCT03534141|566185483|FG000|Overall Study|Liver transplant aborted after randomization|0|||
156844897|NCT03534141|566185484|FG001|Overall Study|Liver transplant aborted after randomization|2|||
156844898|NCT03534141|566185483|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
156844899|NCT03534141|566185484|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
156844900|NCT01824355|566185485|FG000|Overall Study|Adverse Event|2|||
156844901|NCT01824355|566185485|FG000|Overall Study|unevaluable reference method results per|1|||
156844902|NCT01636986|566185486|FG000|Overall Study|Withdrawal by Subject|0|||
156844903|NCT01636986|566185487|FG001|Overall Study|Withdrawal by Subject|1|||
156844904|NCT01636986|566185486|FG000|Overall Study|Corneal Staining|0|||
156844905|NCT01636986|566185487|FG001|Overall Study|Corneal Staining|1|||
156844906|NCT01620762|566185497|FG000|Overall Study|Protocol Violation|1|||
156844907|NCT01620762|566185498|FG001|Overall Study|Protocol Violation|1|||
156844908|NCT01620762|566185499|FG002|Overall Study|Protocol Violation|1|||
156844909|NCT01620762|566185497|FG000|Overall Study|Adverse Event|9|||
156844910|NCT01620762|566185498|FG001|Overall Study|Adverse Event|5|||
156844911|NCT01620762|566185499|FG002|Overall Study|Adverse Event|2|||
156844912|NCT01620762|566185497|FG000|Overall Study|Withdrawal by Subject|23|||
156844913|NCT01620762|566185498|FG001|Overall Study|Withdrawal by Subject|26|||
156844914|NCT01620762|566185499|FG002|Overall Study|Withdrawal by Subject|27|||
156844915|NCT01620762|566185497|FG000|Overall Study|Lost to Follow-up|11|||
156844916|NCT01620762|566185498|FG001|Overall Study|Lost to Follow-up|17|||
156844917|NCT01620762|566185499|FG002|Overall Study|Lost to Follow-up|10|||
156844918|NCT01620762|566185497|FG000|Overall Study|Protocol deviation|1|||
156844919|NCT01620762|566185498|FG001|Overall Study|Protocol deviation|1|||
156844920|NCT01620762|566185499|FG002|Overall Study|Protocol deviation|6|||
156844921|NCT01620762|566185497|FG000|Overall Study|Subject deterioration|0|||
156844922|NCT01620762|566185498|FG001|Overall Study|Subject deterioration|1|||
156844923|NCT01620762|566185499|FG002|Overall Study|Subject deterioration|1|||
156844924|NCT01620762|566185497|FG000|Overall Study|Non-specified|3|||
156844925|NCT01620762|566185498|FG001|Overall Study|Non-specified|6|||
156844926|NCT01620762|566185499|FG002|Overall Study|Non-specified|5|||
156844927|NCT01620762|566185497|FG000|Overall Study|Use of prohibted therapies|0|||
156844928|NCT01620762|566185498|FG001|Overall Study|Use of prohibted therapies|1|||
156844929|NCT01620762|566185499|FG002|Overall Study|Use of prohibted therapies|1|||
156844930|NCT00705146|566185504|FG000|Overall Study|Lost to Follow-up|1|||
156844931|NCT00705146|566185505|FG001|Overall Study|Lost to Follow-up|1|||
156844932|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
156844933|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844934|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844935|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844936|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844937|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
156844938|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
156844939|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844940|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844941|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844942|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844943|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
156844944|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
156844945|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844946|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844947|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844948|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844949|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
156844950|NCT00095173|566185506|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
156844951|NCT00095173|566185507|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
156844952|NCT00095173|566185508|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
156844953|NCT00095173|566185509|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
156844954|NCT00095173|566185510|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
156844955|NCT00095173|566185511|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
156844956|NCT00095173|566185506|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844957|NCT00095173|566185507|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
156844958|NCT00095173|566185508|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
156844959|NCT00095173|566185509|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844960|NCT00095173|566185510|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844961|NCT00095173|566185511|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
156844962|NCT00095173|566185506|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844963|NCT00095173|566185507|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
156844964|NCT00095173|566185508|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844965|NCT00095173|566185509|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844966|NCT00095173|566185510|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844967|NCT00095173|566185511|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
156844968|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Death|0|||
156844969|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Death|0|||
156844970|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Death|0|||
156844971|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Death|0|||
157224798|NCT01521559|567569877|FG001|Overall Study|Adverse Event|4|||
156844972|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Death|0|||
156844973|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Death|1|||
156844974|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844975|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844976|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
156844977|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
156844978|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
156844979|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
156844980|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844981|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844982|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
156844983|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
156844984|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
156844985|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
156844986|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844987|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844988|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
156844989|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
156844990|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
156844991|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
157224799|NCT01521559|567569876|FG000|Overall Study|Death|1|||
156844992|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844993|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844994|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844995|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
156844996|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
156844997|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
156844998|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156844999|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845000|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845001|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
156845002|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
156845003|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
156845004|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845005|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845006|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845007|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
156845008|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
156845009|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
156845010|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845011|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845012|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
156845013|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
156845014|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
156845015|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
156845016|NCT00095173|566185506|FG000|Open-Label Extension Phase (Period C)|Other|0|||
156845017|NCT00095173|566185507|FG001|Open-Label Extension Phase (Period C)|Other|0|||
156845018|NCT00095173|566185508|FG002|Open-Label Extension Phase (Period C)|Other|0|||
156845019|NCT00095173|566185509|FG003|Open-Label Extension Phase (Period C)|Other|4|||
156845020|NCT00095173|566185510|FG004|Open-Label Extension Phase (Period C)|Other|6|||
156845021|NCT00095173|566185511|FG005|Open-Label Extension Phase (Period C)|Other|8|||
156845022|NCT01620528|566185513|FG000|Treatment Period|Did Not Receive Study Drug|0|||
156845023|NCT01620528|566185514|FG001|Treatment Period|Did Not Receive Study Drug|0|||
156845024|NCT01620528|566185515|FG002|Treatment Period|Did Not Receive Study Drug|1|||
156845025|NCT01620528|566185513|FG000|Treatment Period|Withdrawal by Subject|35|||
156845026|NCT01620528|566185514|FG001|Treatment Period|Withdrawal by Subject|21|||
156845027|NCT01620528|566185515|FG002|Treatment Period|Withdrawal by Subject|16|||
156845028|NCT01620528|566185513|FG000|Treatment Period|Adverse Event|17|||
156845029|NCT01620528|566185514|FG001|Treatment Period|Adverse Event|13|||
156845030|NCT01620528|566185515|FG002|Treatment Period|Adverse Event|21|||
156845031|NCT01620528|566185513|FG000|Treatment Period|Lost to Follow-up|16|||
156845032|NCT01620528|566185514|FG001|Treatment Period|Lost to Follow-up|8|||
156845033|NCT01620528|566185515|FG002|Treatment Period|Lost to Follow-up|14|||
156845034|NCT01620528|566185513|FG000|Treatment Period|Other|9|||
156845035|NCT01620528|566185514|FG001|Treatment Period|Other|5|||
156845036|NCT01620528|566185515|FG002|Treatment Period|Other|7|||
156845037|NCT01620528|566185513|FG000|Treatment Period|Subject Noncompliant|11|||
156845038|NCT01620528|566185514|FG001|Treatment Period|Subject Noncompliant|2|||
156845039|NCT01620528|566185515|FG002|Treatment Period|Subject Noncompliant|2|||
156845040|NCT01620528|566185513|FG000|Treatment Period|Pregnancy|7|||
156845041|NCT01620528|566185514|FG001|Treatment Period|Pregnancy|2|||
156845042|NCT01620528|566185515|FG002|Treatment Period|Pregnancy|2|||
156845043|NCT01620528|566185513|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
156845044|NCT01620528|566185514|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
156845045|NCT01620528|566185515|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
156845046|NCT01620528|566185513|FG000|Treatment Period|Exclusionary Medication Received|0|||
156845047|NCT01620528|566185514|FG001|Treatment Period|Exclusionary Medication Received|1|||
156845048|NCT01620528|566185515|FG002|Treatment Period|Exclusionary Medication Received|0|||
156845049|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
156845050|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
156845051|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
156845052|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156845053|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
157224800|NCT01521559|567569877|FG001|Overall Study|Death|0|||
157224801|NCT01521559|567569876|FG000|Overall Study|Withdrawal by Subject|9|||
156845054|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
156845055|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
156845056|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
156845057|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
157224802|NCT01521559|567569877|FG001|Overall Study|Withdrawal by Subject|11|||
156845058|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
156845059|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
156845060|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
156845061|NCT01620528|566185513|FG000|Post-Treatment Follow-Up Period|Other|6|||
156845062|NCT01620528|566185514|FG001|Post-Treatment Follow-Up Period|Other|4|||
156845063|NCT01620528|566185515|FG002|Post-Treatment Follow-Up Period|Other|2|||
156845064|NCT03997825|566185527|FG000|Overall Study|Death|3|||
156845065|NCT03997825|566185527|FG000|Overall Study|Lost to Follow-up|10|||
156845066|NCT03997825|566185527|FG000|Overall Study|Withdrawal by Subject|3|||
156845067|NCT03997825|566185527|FG000|Overall Study|Refused participation|1|||
157025155|NCT06516705|566847913|FG001|T4 ( 6 Month After Education)|covid-19|2|||
157025156|NCT06516705|566847912|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
157025157|NCT06516705|566847913|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
157025158|NCT04059484|566847915|FG000|Overall Study|Adverse Event|2|||
157025159|NCT04059484|566847916|FG001|Overall Study|Adverse Event|5|||
157025160|NCT04059484|566847915|FG000|Overall Study|Withdrawal by Subject|5|||
156845068|NCT01153698|566185528|FG000|Overall Study|Adverse Event|12|||
156845069|NCT01153698|566185528|FG000|Overall Study|Lost to Follow-up|4|||
156845070|NCT01153698|566185528|FG000|Overall Study|Withdrawal by Subject|2|||
156845071|NCT01153698|566185528|FG000|Overall Study|Switch to other anticoagulants|4|||
156845072|NCT01153698|566185528|FG000|Overall Study|Other|2|||
156845073|NCT01153698|566185528|FG000|Overall Study|Not treated with Pradaxa|5|||
156845074|NCT00465647|566185529|FG000|Overall Study|Administrative|2|||
156845075|NCT00465647|566185530|FG001|Overall Study|Administrative|2|||
156845076|NCT00465647|566185531|FG002|Overall Study|Administrative|3|||
156845077|NCT00465647|566185532|FG003|Overall Study|Administrative|2|||
156845078|NCT00465647|566185529|FG000|Overall Study|Adverse Event|2|||
156845079|NCT00465647|566185530|FG001|Overall Study|Adverse Event|0|||
156845080|NCT00465647|566185531|FG002|Overall Study|Adverse Event|3|||
156845081|NCT00465647|566185532|FG003|Overall Study|Adverse Event|2|||
156845082|NCT00465647|566185529|FG000|Overall Study|Withdrawal by Subject|1|||
156845083|NCT00465647|566185530|FG001|Overall Study|Withdrawal by Subject|2|||
156845084|NCT00465647|566185531|FG002|Overall Study|Withdrawal by Subject|2|||
156845085|NCT00465647|566185532|FG003|Overall Study|Withdrawal by Subject|7|||
156845086|NCT00465647|566185529|FG000|Overall Study|"The other reasons included loss of IV"|8|||
156845087|NCT00465647|566185530|FG001|Overall Study|"The other reasons included loss of IV"|4|||
156845088|NCT00465647|566185531|FG002|Overall Study|"The other reasons included loss of IV"|3|||
156845089|NCT00465647|566185532|FG003|Overall Study|"The other reasons included loss of IV"|2|||
156845090|NCT02220712|566185533|FG000|Overall Study|Adverse Event|1|||
156845091|NCT02220712|566185533|FG000|Overall Study|Withdrawal by Subject|2|||
156845092|NCT02220712|566185533|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
156845093|NCT00760838|566185534|FG000|Overall Study|Adverse Event|1|||
156845094|NCT00760838|566185535|FG001|Overall Study|Adverse Event|1|||
156845095|NCT00760838|566185534|FG000|Overall Study|Lack of Efficacy|1|||
156845096|NCT00760838|566185535|FG001|Overall Study|Lack of Efficacy|0|||
156845097|NCT00760838|566185534|FG000|Overall Study|Lost to Follow-up|2|||
156845098|NCT00760838|566185535|FG001|Overall Study|Lost to Follow-up|0|||
156845099|NCT00760838|566185534|FG000|Overall Study|Withdrawal by Subject|1|||
156845100|NCT00760838|566185535|FG001|Overall Study|Withdrawal by Subject|1|||
156845101|NCT00986362|566185538|FG000|Overall Study|Death|2|||
156845102|NCT00986362|566185539|FG001|Overall Study|Death|0|||
156845103|NCT00986362|566185538|FG000|Overall Study|Lost to Follow-up|0|||
156845104|NCT00986362|566185539|FG001|Overall Study|Lost to Follow-up|1|||
156845105|NCT01748825|566185540|FG000|Dose Escalation|Refused further treatment|2|||
156845106|NCT01748825|566185541|FG001|Dose Escalation|Refused further treatment|2|||
156845107|NCT01748825|566185542|FG002|Dose Escalation|Refused further treatment|0|||
156845108|NCT01748825|566185543|FG003|Dose Escalation|Refused further treatment|0|||
156845109|NCT01748825|566185544|FG004|Dose Escalation|Refused further treatment|1|||
156845110|NCT01748825|566185545|FG005|Dose Escalation|Refused further treatment|2|||
156845111|NCT01748825|566185546|FG006|Dose Escalation|Refused further treatment|0|||
156845112|NCT01748825|566185547|FG007|Dose Escalation|Refused further treatment|0|||
156845113|NCT01748825|566185548|FG008|Dose Escalation|Refused further treatment|0|||
156845114|NCT01748825|566185549|FG009|Dose Escalation|Refused further treatment|0|||
156845115|NCT01748825|566185540|FG000|Dose Escalation|Switched to alternative treatment|0|||
156845116|NCT01748825|566185541|FG001|Dose Escalation|Switched to alternative treatment|0|||
156845117|NCT01748825|566185542|FG002|Dose Escalation|Switched to alternative treatment|0|||
156845118|NCT01748825|566185543|FG003|Dose Escalation|Switched to alternative treatment|1|||
156845119|NCT01748825|566185544|FG004|Dose Escalation|Switched to alternative treatment|0|||
156888019|NCT00095147|566349456|FG004|Long-term Extension Period|Pregnancy|1|||
157025161|NCT04059484|566847916|FG001|Overall Study|Withdrawal by Subject|3|||
156845120|NCT01748825|566185545|FG005|Dose Escalation|Switched to alternative treatment|0|||
156845121|NCT01748825|566185546|FG006|Dose Escalation|Switched to alternative treatment|0|||
156845122|NCT01748825|566185547|FG007|Dose Escalation|Switched to alternative treatment|0|||
156845123|NCT01748825|566185548|FG008|Dose Escalation|Switched to alternative treatment|0|||
157025162|NCT04059484|566847915|FG000|Overall Study|Progressive disease|112|||
156845124|NCT01748825|566185549|FG009|Dose Escalation|Switched to alternative treatment|0|||
156845125|NCT01748825|566185540|FG000|Dose Escalation|Adverse Event|0|||
156845126|NCT01748825|566185541|FG001|Dose Escalation|Adverse Event|0|||
156845127|NCT01748825|566185542|FG002|Dose Escalation|Adverse Event|0|||
156845128|NCT01748825|566185543|FG003|Dose Escalation|Adverse Event|0|||
156845129|NCT01748825|566185544|FG004|Dose Escalation|Adverse Event|0|||
156845130|NCT01748825|566185545|FG005|Dose Escalation|Adverse Event|0|||
156845131|NCT01748825|566185546|FG006|Dose Escalation|Adverse Event|1|||
156845132|NCT01748825|566185547|FG007|Dose Escalation|Adverse Event|0|||
156845133|NCT01748825|566185548|FG008|Dose Escalation|Adverse Event|0|||
156845134|NCT01748825|566185549|FG009|Dose Escalation|Adverse Event|0|||
156845135|NCT01748825|566185540|FG000|Dose Expansion|Refused further treatment|0|||
156845136|NCT01748825|566185541|FG001|Dose Expansion|Refused further treatment|0|||
156845137|NCT01748825|566185542|FG002|Dose Expansion|Refused further treatment|0|||
156845138|NCT01748825|566185543|FG003|Dose Expansion|Refused further treatment|0|||
156845139|NCT01748825|566185544|FG004|Dose Expansion|Refused further treatment|0|||
156845140|NCT01748825|566185545|FG005|Dose Expansion|Refused further treatment|0|||
156845141|NCT01748825|566185546|FG006|Dose Expansion|Refused further treatment|0|||
156845142|NCT01748825|566185547|FG007|Dose Expansion|Refused further treatment|0|||
156845143|NCT01748825|566185548|FG008|Dose Expansion|Refused further treatment|1|||
156845144|NCT01748825|566185549|FG009|Dose Expansion|Refused further treatment|1|||
156845145|NCT01748825|566185540|FG000|Dose Expansion|Switched to alternative treatment|0|||
156845146|NCT01748825|566185541|FG001|Dose Expansion|Switched to alternative treatment|0|||
156845147|NCT01748825|566185542|FG002|Dose Expansion|Switched to alternative treatment|0|||
156845148|NCT01748825|566185543|FG003|Dose Expansion|Switched to alternative treatment|0|||
156845149|NCT01748825|566185544|FG004|Dose Expansion|Switched to alternative treatment|0|||
156845150|NCT01748825|566185545|FG005|Dose Expansion|Switched to alternative treatment|0|||
156845151|NCT01748825|566185546|FG006|Dose Expansion|Switched to alternative treatment|0|||
156845152|NCT01748825|566185547|FG007|Dose Expansion|Switched to alternative treatment|0|||
156845153|NCT01748825|566185548|FG008|Dose Expansion|Switched to alternative treatment|0|||
156845154|NCT01748825|566185549|FG009|Dose Expansion|Switched to alternative treatment|1|||
157025163|NCT04059484|566847916|FG001|Overall Study|Progressive disease|112|||
157025164|NCT04059484|566847915|FG000|Overall Study|Other|8|||
157025165|NCT04059484|566847916|FG001|Overall Study|Other|3|||
156845155|NCT01748825|566185540|FG000|Dose Expansion|Adverse Event|0|||
156845156|NCT01748825|566185541|FG001|Dose Expansion|Adverse Event|0|||
156845157|NCT01748825|566185542|FG002|Dose Expansion|Adverse Event|0|||
156845158|NCT01748825|566185543|FG003|Dose Expansion|Adverse Event|0|||
156845159|NCT01748825|566185544|FG004|Dose Expansion|Adverse Event|0|||
156845160|NCT01748825|566185545|FG005|Dose Expansion|Adverse Event|0|||
156845161|NCT01748825|566185546|FG006|Dose Expansion|Adverse Event|0|||
156845162|NCT01748825|566185547|FG007|Dose Expansion|Adverse Event|0|||
156845163|NCT01748825|566185548|FG008|Dose Expansion|Adverse Event|0|||
156845164|NCT01748825|566185549|FG009|Dose Expansion|Adverse Event|3|||
156845165|NCT01748825|566185540|FG000|Dose Expansion|Physician Decision|0|||
156845166|NCT01748825|566185541|FG001|Dose Expansion|Physician Decision|0|||
156845167|NCT01748825|566185542|FG002|Dose Expansion|Physician Decision|0|||
156845168|NCT01748825|566185543|FG003|Dose Expansion|Physician Decision|0|||
156845169|NCT01748825|566185544|FG004|Dose Expansion|Physician Decision|0|||
156845170|NCT01748825|566185545|FG005|Dose Expansion|Physician Decision|0|||
156845171|NCT01748825|566185546|FG006|Dose Expansion|Physician Decision|0|||
156845172|NCT01748825|566185547|FG007|Dose Expansion|Physician Decision|0|||
157025166|NCT04059484|566847915|FG000|Overall Study|Ongoing|20|||
156845173|NCT01748825|566185548|FG008|Dose Expansion|Physician Decision|1|||
156845174|NCT01748825|566185549|FG009|Dose Expansion|Physician Decision|0|||
156845175|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Adverse Event|33|||
156845176|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
156845177|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
156845178|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
156845179|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Physician Decision|6|||
157025167|NCT04059484|566847916|FG001|Overall Study|Ongoing|20|||
156845180|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
156845181|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
156845182|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
156845183|NCT00965419|566185550|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
156845184|NCT00965419|566185550|FG000|Follow-up Phase|Adverse Event|9|||
156845185|NCT00965419|566185550|FG000|Follow-up Phase|Protocol Violation|4|||
156845186|NCT00965419|566185550|FG000|Follow-up Phase|Withdrawal by Subject|8|||
156845187|NCT00965419|566185550|FG000|Follow-up Phase|Physician Decision|4|||
156845188|NCT00965419|566185550|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
156845189|NCT00965419|566185550|FG000|Follow-up Phase|Lack of Efficacy|28|||
157025168|NCT04292223|566847917|FG000|Overall Study|Adverse Event|1|||
156845190|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
156845191|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
157025169|NCT04292223|566847917|FG000|Overall Study|Lost to Follow-up|1|||
157025170|NCT04292223|566847917|FG000|Overall Study|Noncompliance with study drug|2|||
156845192|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
156845193|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
156845194|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
156845195|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
156845196|NCT01363908|566187593|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
156845197|NCT01363908|566187594|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
156845198|NCT02034877|566187595|FG000|Overall Study|Lost to Follow-up|0|||
156845199|NCT02034877|566187596|FG001|Overall Study|Lost to Follow-up|3|||
156845200|NCT02034877|566187595|FG000|Overall Study|No Longer Willing to Participate|0|||
156845201|NCT02034877|566187596|FG001|Overall Study|No Longer Willing to Participate|3|||
156845202|NCT00536471|566187597|FG000|Overall Study|Lost to Follow-up|48|||
156845203|NCT00536471|566187598|FG001|Overall Study|Lost to Follow-up|23|||
156845204|NCT00536471|566187599|FG002|Overall Study|Lost to Follow-up|48|||
156845205|NCT00536471|566187600|FG003|Overall Study|Lost to Follow-up|22|||
156845206|NCT00536471|566187597|FG000|Overall Study|Adverse Event|32|||
156845207|NCT00536471|566187598|FG001|Overall Study|Adverse Event|16|||
156845208|NCT00536471|566187599|FG002|Overall Study|Adverse Event|28|||
156845209|NCT00536471|566187600|FG003|Overall Study|Adverse Event|13|||
156845210|NCT00536471|566187597|FG000|Overall Study|Withdrawal by Subject|40|||
156845211|NCT00536471|566187598|FG001|Overall Study|Withdrawal by Subject|24|||
156845212|NCT00536471|566187599|FG002|Overall Study|Withdrawal by Subject|43|||
156845213|NCT00536471|566187600|FG003|Overall Study|Withdrawal by Subject|21|||
156845214|NCT00536471|566187597|FG000|Overall Study|Lack of Efficacy|17|||
156845215|NCT00536471|566187598|FG001|Overall Study|Lack of Efficacy|18|||
156845216|NCT00536471|566187599|FG002|Overall Study|Lack of Efficacy|11|||
156845217|NCT00536471|566187600|FG003|Overall Study|Lack of Efficacy|9|||
156845218|NCT00536471|566187597|FG000|Overall Study|Protocol Violation|8|||
156845219|NCT00536471|566187598|FG001|Overall Study|Protocol Violation|1|||
156845220|NCT00536471|566187599|FG002|Overall Study|Protocol Violation|2|||
156845221|NCT00536471|566187600|FG003|Overall Study|Protocol Violation|3|||
156845222|NCT00536471|566187597|FG000|Overall Study|Physician Decision|11|||
156845223|NCT00536471|566187598|FG001|Overall Study|Physician Decision|1|||
156845224|NCT00536471|566187599|FG002|Overall Study|Physician Decision|3|||
156845225|NCT00536471|566187600|FG003|Overall Study|Physician Decision|2|||
156845226|NCT00536471|566187597|FG000|Overall Study|Death|0|||
156845227|NCT00536471|566187598|FG001|Overall Study|Death|0|||
156845228|NCT00536471|566187599|FG002|Overall Study|Death|1|||
156845229|NCT00536471|566187600|FG003|Overall Study|Death|2|||
156845230|NCT00536471|566187597|FG000|Overall Study|Sponsor Decision|0|||
156845231|NCT00536471|566187598|FG001|Overall Study|Sponsor Decision|1|||
156845232|NCT00536471|566187599|FG002|Overall Study|Sponsor Decision|3|||
156845233|NCT00536471|566187600|FG003|Overall Study|Sponsor Decision|2|||
156845234|NCT04878211|566187606|FG000|Overall Study|Lost to Follow-up|0|||
156845235|NCT04878211|566187607|FG001|Overall Study|Lost to Follow-up|0|||
157155054|NCT00972478|567312830|FG000|Overall Study|Ineligible|1|||
157155055|NCT00972478|567312831|FG001|Overall Study|Ineligible|7|||
157155056|NCT00972478|567312830|FG000|Overall Study|Not start protocol treatment|1|||
157155057|NCT00972478|567312831|FG001|Overall Study|Not start protocol treatment|2|||
157155058|NCT02561000|567312832|FG000|Overall Study|Withdrawal by Subject|2|||
157155059|NCT02561000|567312833|FG001|Overall Study|Withdrawal by Subject|3|||
157155060|NCT02561000|567312834|FG002|Overall Study|Withdrawal by Subject|0|||
157155061|NCT02561000|567312832|FG000|Overall Study|Adverse Event|0|||
156845236|NCT04878211|566187608|FG002|Overall Study|Lost to Follow-up|0|||
156845237|NCT04878211|566187609|FG003|Overall Study|Lost to Follow-up|1|||
156845238|NCT04878211|566187610|FG004|Overall Study|Lost to Follow-up|0|||
156845239|NCT04878211|566187611|FG005|Overall Study|Lost to Follow-up|1|||
156845240|NCT04878211|566187606|FG000|Overall Study|Protocol deviation|1|||
156845241|NCT04878211|566187607|FG001|Overall Study|Protocol deviation|0|||
156845242|NCT04878211|566187608|FG002|Overall Study|Protocol deviation|0|||
156845243|NCT04878211|566187609|FG003|Overall Study|Protocol deviation|0|||
156845244|NCT04878211|566187610|FG004|Overall Study|Protocol deviation|0|||
156845245|NCT04878211|566187611|FG005|Overall Study|Protocol deviation|0|||
156845246|NCT04878211|566187606|FG000|Overall Study|Study terminated by sponsor|0|||
156845247|NCT04878211|566187607|FG001|Overall Study|Study terminated by sponsor|0|||
156888020|NCT00095147|566349452|FG000|Long-term Extension Period|No longer meets study criteria|0|||
157155062|NCT02561000|567312833|FG001|Overall Study|Adverse Event|1|||
156845248|NCT04878211|566187608|FG002|Overall Study|Study terminated by sponsor|0|||
156845249|NCT04878211|566187609|FG003|Overall Study|Study terminated by sponsor|0|||
156845250|NCT04878211|566187610|FG004|Overall Study|Study terminated by sponsor|9|||
156845251|NCT04878211|566187611|FG005|Overall Study|Study terminated by sponsor|4|||
157155063|NCT02561000|567312834|FG002|Overall Study|Adverse Event|0|||
157155064|NCT00506077|567312835|FG000|Treatment Period 1|Adverse Event|2|||
156845252|NCT04878211|566187606|FG000|Overall Study|Subject decision|0|||
156845253|NCT04878211|566187607|FG001|Overall Study|Subject decision|0|||
156845254|NCT04878211|566187608|FG002|Overall Study|Subject decision|0|||
156845255|NCT04878211|566187609|FG003|Overall Study|Subject decision|0|||
156845256|NCT04878211|566187610|FG004|Overall Study|Subject decision|1|||
156845257|NCT04878211|566187611|FG005|Overall Study|Subject decision|0|||
157155065|NCT00506077|567312836|FG001|Treatment Period 1|Adverse Event|1|||
157155066|NCT00506077|567312835|FG000|Treatment Period 1|Lost to Follow-up|0|||
157155067|NCT00506077|567312836|FG001|Treatment Period 1|Lost to Follow-up|2|||
157155068|NCT00506077|567312835|FG000|Treatment Period 1|Withdrawal by Subject|2|||
157155069|NCT00506077|567312836|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157155070|NCT00506077|567312835|FG000|Treatment Period 2|Adverse Event|0|||
157155071|NCT00506077|567312836|FG001|Treatment Period 2|Adverse Event|1|||
157155072|NCT00506077|567312835|FG000|Treatment Period 2|Withdrawal by Subject|1|||
157155073|NCT00506077|567312836|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157155074|NCT02918266|567312837|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
157155075|NCT02918266|567312838|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155076|NCT02918266|567312839|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155077|NCT02918266|567312840|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155078|NCT02918266|567312841|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155079|NCT02918266|567312842|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155080|NCT02918266|567312843|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
157155081|NCT02918266|567312844|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156845258|NCT03574779|566187618|FG000|Overall Study|Screening failure|13|||
156845259|NCT03574779|566187619|FG001|Overall Study|Screening failure|83|||
156845260|NCT02783599|566187620|FG000|Overall Study|Progressive disease|23|||
156845261|NCT02783599|566187620|FG000|Overall Study|Surgical Resection|10|||
156845262|NCT02783599|566187620|FG000|Overall Study|Adverse Event|4|||
156845263|NCT02783599|566187620|FG000|Overall Study|Physician Decision|2|||
156845264|NCT02783599|566187620|FG000|Overall Study|Death|1|||
156845265|NCT00856544|566187628|FG000|Overall Study|Randomized but not treated|3|||
156845266|NCT00856544|566187629|FG001|Overall Study|Randomized but not treated|0|||
156845267|NCT00856544|566187630|FG002|Overall Study|Randomized but not treated|0|||
156845268|NCT00856544|566187631|FG003|Overall Study|Randomized but not treated|0|||
156845269|NCT00856544|566187628|FG000|Overall Study|Death|0|||
156845270|NCT00856544|566187629|FG001|Overall Study|Death|2|||
156845271|NCT00856544|566187630|FG002|Overall Study|Death|0|||
156845272|NCT00856544|566187631|FG003|Overall Study|Death|0|||
156845273|NCT00856544|566187628|FG000|Overall Study|Adverse Event|20|||
156845274|NCT00856544|566187629|FG001|Overall Study|Adverse Event|29|||
156845275|NCT00856544|566187630|FG002|Overall Study|Adverse Event|2|||
156845276|NCT00856544|566187631|FG003|Overall Study|Adverse Event|3|||
156845277|NCT00856544|566187628|FG000|Overall Study|Lack of Efficacy|16|||
156845278|NCT00856544|566187629|FG001|Overall Study|Lack of Efficacy|12|||
156845279|NCT00856544|566187630|FG002|Overall Study|Lack of Efficacy|3|||
156845280|NCT00856544|566187631|FG003|Overall Study|Lack of Efficacy|3|||
156845281|NCT00856544|566187628|FG000|Overall Study|Other|9|||
156845282|NCT00856544|566187629|FG001|Overall Study|Other|16|||
156845283|NCT00856544|566187630|FG002|Overall Study|Other|1|||
156845284|NCT00856544|566187631|FG003|Overall Study|Other|6|||
156845285|NCT00856544|566187628|FG000|Overall Study|Lost to Follow-up|1|||
156845286|NCT00856544|566187629|FG001|Overall Study|Lost to Follow-up|2|||
156845287|NCT00856544|566187630|FG002|Overall Study|Lost to Follow-up|2|||
156845288|NCT00856544|566187631|FG003|Overall Study|Lost to Follow-up|0|||
156845289|NCT00856544|566187628|FG000|Overall Study|Withdrawal by Subject|8|||
156845290|NCT00856544|566187629|FG001|Overall Study|Withdrawal by Subject|5|||
156845291|NCT00856544|566187630|FG002|Overall Study|Withdrawal by Subject|0|||
156845292|NCT00856544|566187631|FG003|Overall Study|Withdrawal by Subject|1|||
156845293|NCT01564732|566187632|FG000|Overall Study|Early termination by the study sponsor|6|||
156845294|NCT01564732|566187633|FG001|Overall Study|Early termination by the study sponsor|5|||
156845295|NCT01687101|566187638|FG000|Overall Study|Lost to Follow-up|7|||
156888021|NCT00095147|566349453|FG001|Long-term Extension Period|No longer meets study criteria|0|||
156888022|NCT00095147|566349454|FG002|Long-term Extension Period|No longer meets study criteria|0|||
156888023|NCT00095147|566349455|FG003|Long-term Extension Period|No longer meets study criteria|0|||
156888024|NCT00095147|566349456|FG004|Long-term Extension Period|No longer meets study criteria|1|||
156888025|NCT00095147|566349452|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
156845296|NCT00394706|566187642|FG000|Overall Study|Withdrawal by Subject|2|||
156888026|NCT00095147|566349453|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
156845297|NCT00394706|566187643|FG001|Overall Study|Withdrawal by Subject|0|||
156845298|NCT00394706|566187644|FG002|Overall Study|Withdrawal by Subject|1|||
156845299|NCT00394706|566187645|FG003|Overall Study|Withdrawal by Subject|0|||
156845300|NCT00394706|566187646|FG004|Overall Study|Withdrawal by Subject|0|||
156888027|NCT00095147|566349454|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
156888028|NCT00095147|566349455|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
157155082|NCT02918266|567312845|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
157155083|NCT02918266|567312846|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
157155084|NCT02918266|567312847|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
156845301|NCT00394706|566187647|FG005|Overall Study|Withdrawal by Subject|2|||
156845302|NCT00394706|566187648|FG006|Overall Study|Withdrawal by Subject|1|||
156845303|NCT00394706|566187649|FG007|Overall Study|Withdrawal by Subject|0|||
156845304|NCT00394706|566187642|FG000|Overall Study|Lost to Follow-up|2|||
156845305|NCT00394706|566187643|FG001|Overall Study|Lost to Follow-up|2|||
156845306|NCT00394706|566187644|FG002|Overall Study|Lost to Follow-up|8|||
156845307|NCT00394706|566187645|FG003|Overall Study|Lost to Follow-up|1|||
156845308|NCT00394706|566187646|FG004|Overall Study|Lost to Follow-up|2|||
156845309|NCT00394706|566187647|FG005|Overall Study|Lost to Follow-up|5|||
156845310|NCT00394706|566187648|FG006|Overall Study|Lost to Follow-up|2|||
156845311|NCT00394706|566187649|FG007|Overall Study|Lost to Follow-up|0|||
156845312|NCT02003534|566187654|FG000|Overall Study|Lost to Follow-up|47|||
156845313|NCT03920254|566187655|FG000|Overall Study|Adverse Event|1|||
156845314|NCT03920254|566187656|FG001|Overall Study|Adverse Event|0|||
156845315|NCT03920254|566187657|FG002|Overall Study|Adverse Event|0|||
156845316|NCT03920254|566187655|FG000|Overall Study|Physician Decision|0|||
156845317|NCT03920254|566187656|FG001|Overall Study|Physician Decision|1|||
156845318|NCT03920254|566187657|FG002|Overall Study|Physician Decision|2|||
156845319|NCT03920254|566187655|FG000|Overall Study|Study Terminated By Sponsor|12|||
156845320|NCT03920254|566187656|FG001|Overall Study|Study Terminated By Sponsor|17|||
156845321|NCT03920254|566187657|FG002|Overall Study|Study Terminated By Sponsor|12|||
156845322|NCT03920254|566187655|FG000|Overall Study|Withdrawal by Subject|0|||
156845323|NCT03920254|566187656|FG001|Overall Study|Withdrawal by Subject|0|||
156845324|NCT03920254|566187657|FG002|Overall Study|Withdrawal by Subject|1|||
156845325|NCT03040674|566187658|FG000|Overall Study|Lost to Follow-up|225|||
156845326|NCT03040674|566187658|FG000|Overall Study|Death|23|||
156845327|NCT05274269|566187659|FG000|Overall Study|Adverse Event|0|||
156845328|NCT05274269|566187660|FG001|Overall Study|Adverse Event|3|||
156845329|NCT05274269|566187659|FG000|Overall Study|Death|0|||
156845330|NCT05274269|566187660|FG001|Overall Study|Death|1|||
156845331|NCT05274269|566187659|FG000|Overall Study|Other|0|||
156845332|NCT05274269|566187660|FG001|Overall Study|Other|2|||
156845333|NCT05274269|566187659|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156845334|NCT05274269|566187660|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156845335|NCT01934010|566187661|FG000|Overall Study|Adverse Event|1|||
156845336|NCT01934010|566187662|FG001|Overall Study|Adverse Event|1|||
156845337|NCT01934010|566187663|FG002|Overall Study|Adverse Event|0|||
156845338|NCT01934010|566187661|FG000|Overall Study|Withdrawal by Subject|15|||
156845339|NCT01934010|566187662|FG001|Overall Study|Withdrawal by Subject|6|||
156845340|NCT01934010|566187663|FG002|Overall Study|Withdrawal by Subject|2|||
156845341|NCT01934010|566187661|FG000|Overall Study|Lost to Follow-up|7|||
156845342|NCT01934010|566187662|FG001|Overall Study|Lost to Follow-up|4|||
156845343|NCT01934010|566187663|FG002|Overall Study|Lost to Follow-up|0|||
156845344|NCT04112303|566187664|FG000|Overall Study|Death|1|||
156845345|NCT01685697|566187665|FG000|Overall Study|Protocol Violation|3|||
156888029|NCT00095147|566349456|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
156888030|NCT00095147|566349452|FG000|Long-term Extension Period|Leaving country|0|||
156888031|NCT00095147|566349453|FG001|Long-term Extension Period|Leaving country|0|||
156888032|NCT00095147|566349454|FG002|Long-term Extension Period|Leaving country|0|||
156888033|NCT00095147|566349455|FG003|Long-term Extension Period|Leaving country|0|||
156888034|NCT00095147|566349456|FG004|Long-term Extension Period|Leaving country|1|||
156888035|NCT04604132|566349457|FG000|Overall Study|Adverse Event|2|||
156888036|NCT04604132|566349458|FG001|Overall Study|Adverse Event|0|||
156888037|NCT04604132|566349459|FG002|Overall Study|Adverse Event|0|||
156888038|NCT04604132|566349460|FG003|Overall Study|Adverse Event|1|||
157155085|NCT01293032|567312848|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
157155086|NCT01293032|567312849|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
157155087|NCT01293032|567312850|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
157155088|NCT01293032|567312851|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
157155089|NCT01293032|567312848|FG000|Treatment|Adverse Event|0|||
157155090|NCT01293032|567312849|FG001|Treatment|Adverse Event|0|||
157155091|NCT01293032|567312850|FG002|Treatment|Adverse Event|1|||
157155092|NCT01293032|567312851|FG003|Treatment|Adverse Event|1|||
157155093|NCT01293032|567312848|FG000|Treatment|Withdrawal by Subject|2|||
157155094|NCT01293032|567312849|FG001|Treatment|Withdrawal by Subject|4|||
157155095|NCT01293032|567312850|FG002|Treatment|Withdrawal by Subject|0|||
157155096|NCT01293032|567312851|FG003|Treatment|Withdrawal by Subject|0|||
157224803|NCT01521559|567569876|FG000|Overall Study|Lost to Follow-up|3|||
157025171|NCT04292223|566847917|FG000|Overall Study|Patient moved out of the state|1|||
157025172|NCT04719390|566847918|FG000|Overall Study|Withdrawal by Subject|1|||
156845346|NCT01685697|566187666|FG001|Overall Study|Protocol Violation|3|||
156845347|NCT02703324|566187667|FG000|Period Two|Withdrawal by Subject|0|||
156845348|NCT02703324|566187668|FG001|Period Two|Withdrawal by Subject|0|||
156845349|NCT02703324|566187669|FG002|Period Two|Withdrawal by Subject|1|||
156845350|NCT02703324|566187670|FG003|Period Two|Withdrawal by Subject|0|||
156845351|NCT02703324|566187671|FG004|Period Two|Withdrawal by Subject|0|||
156845352|NCT02703324|566187672|FG005|Period Two|Withdrawal by Subject|0|||
156845353|NCT04303572|566187675|FG000|Overall Study|Study closed due to poor enrollment|1|||
156845354|NCT06312592|566187676|FG000|Overall Study|Lost to Follow-up|29|||
156845355|NCT06312592|566187677|FG001|Overall Study|Lost to Follow-up|13|||
156845356|NCT01948063|566187680|FG000|Overall Study|Boston MCI halted research protocol|0|||
157155097|NCT01293032|567312848|FG000|Treatment|Disease Progression, relapse|0|||
156845357|NCT01948063|566187681|FG001|Overall Study|Boston MCI halted research protocol|1|||
156845358|NCT01948063|566187680|FG000|Overall Study|Discovered an enrollment in other study|0|||
156845359|NCT01948063|566187681|FG001|Overall Study|Discovered an enrollment in other study|1|||
156845360|NCT01948063|566187680|FG000|Overall Study|Blood samples were accidentally thawed|1|||
156845361|NCT01948063|566187681|FG001|Overall Study|Blood samples were accidentally thawed|0|||
156845362|NCT01858766|566187682|FG000|Overall Study|Randomized but Never Treated|0|||
156845363|NCT01858766|566187683|FG001|Overall Study|Randomized but Never Treated|0|||
156845364|NCT01858766|566187684|FG002|Overall Study|Randomized but Never Treated|0|||
156845365|NCT01858766|566187685|FG003|Overall Study|Randomized but Never Treated|0|||
156845366|NCT01858766|566187686|FG004|Overall Study|Randomized but Never Treated|0|||
156845367|NCT01858766|566187687|FG005|Overall Study|Randomized but Never Treated|1|||
156845368|NCT01858766|566187688|FG006|Overall Study|Randomized but Never Treated|0|||
156845369|NCT01858766|566187689|FG007|Overall Study|Randomized but Never Treated|0|||
156845370|NCT01858766|566187690|FG008|Overall Study|Randomized but Never Treated|0|||
156845371|NCT01858766|566187691|FG009|Overall Study|Randomized but Never Treated|0|||
156845372|NCT01858766|566187692|FG010|Overall Study|Randomized but Never Treated|0|||
156845373|NCT01858766|566187693|FG011|Overall Study|Randomized but Never Treated|0|||
156845374|NCT01858766|566187694|FG012|Overall Study|Randomized but Never Treated|0|||
156845375|NCT01858766|566187695|FG013|Overall Study|Randomized but Never Treated|0|||
156845376|NCT01858766|566187696|FG014|Overall Study|Randomized but Never Treated|0|||
156845377|NCT01858766|566187697|FG015|Overall Study|Randomized but Never Treated|0|||
156845378|NCT01858766|566187698|FG016|Overall Study|Randomized but Never Treated|0|||
156845379|NCT01858766|566187699|FG017|Overall Study|Randomized but Never Treated|1|||
156845380|NCT01858766|566187700|FG018|Overall Study|Randomized but Never Treated|0|||
156845381|NCT01858766|566187682|FG000|Overall Study|Death|0|||
156845382|NCT01858766|566187683|FG001|Overall Study|Death|0|||
156845383|NCT01858766|566187684|FG002|Overall Study|Death|1|||
156845384|NCT01858766|566187685|FG003|Overall Study|Death|0|||
156845385|NCT01858766|566187686|FG004|Overall Study|Death|0|||
156845386|NCT01858766|566187687|FG005|Overall Study|Death|0|||
156845387|NCT01858766|566187688|FG006|Overall Study|Death|0|||
156845388|NCT01858766|566187689|FG007|Overall Study|Death|0|||
156845389|NCT01858766|566187690|FG008|Overall Study|Death|0|||
156845390|NCT01858766|566187691|FG009|Overall Study|Death|0|||
156845391|NCT01858766|566187692|FG010|Overall Study|Death|0|||
156845392|NCT01858766|566187693|FG011|Overall Study|Death|0|||
156845393|NCT01858766|566187694|FG012|Overall Study|Death|0|||
156845394|NCT01858766|566187695|FG013|Overall Study|Death|0|||
156845395|NCT01858766|566187696|FG014|Overall Study|Death|0|||
156845396|NCT01858766|566187697|FG015|Overall Study|Death|0|||
156845397|NCT01858766|566187698|FG016|Overall Study|Death|0|||
156845398|NCT01858766|566187699|FG017|Overall Study|Death|0|||
156845399|NCT01858766|566187700|FG018|Overall Study|Death|0|||
156845400|NCT01858766|566187682|FG000|Overall Study|Lack of Efficacy|1|||
156845401|NCT01858766|566187683|FG001|Overall Study|Lack of Efficacy|0|||
156845402|NCT01858766|566187684|FG002|Overall Study|Lack of Efficacy|0|||
156845403|NCT01858766|566187685|FG003|Overall Study|Lack of Efficacy|0|||
156845404|NCT01858766|566187686|FG004|Overall Study|Lack of Efficacy|1|||
156845405|NCT01858766|566187687|FG005|Overall Study|Lack of Efficacy|2|||
156845406|NCT01858766|566187688|FG006|Overall Study|Lack of Efficacy|0|||
156845407|NCT01858766|566187689|FG007|Overall Study|Lack of Efficacy|0|||
156845408|NCT01858766|566187690|FG008|Overall Study|Lack of Efficacy|0|||
156845409|NCT01858766|566187691|FG009|Overall Study|Lack of Efficacy|0|||
156845410|NCT01858766|566187692|FG010|Overall Study|Lack of Efficacy|0|||
156845411|NCT01858766|566187693|FG011|Overall Study|Lack of Efficacy|3|||
156845412|NCT01858766|566187694|FG012|Overall Study|Lack of Efficacy|5|||
156845413|NCT01858766|566187695|FG013|Overall Study|Lack of Efficacy|3|||
157155098|NCT01293032|567312849|FG001|Treatment|Disease Progression, relapse|1|||
157155099|NCT01293032|567312850|FG002|Treatment|Disease Progression, relapse|0|||
157155100|NCT01293032|567312851|FG003|Treatment|Disease Progression, relapse|0|||
157155101|NCT02985450|567312863|FG000|Overall Study|Lost to Follow-up|7|||
157155102|NCT00069576|567312864|FG000|Original Trial|Lost to Follow-up|25|||
156845414|NCT01858766|566187696|FG014|Overall Study|Lack of Efficacy|5|||
156845415|NCT01858766|566187697|FG015|Overall Study|Lack of Efficacy|5|||
156845416|NCT01858766|566187698|FG016|Overall Study|Lack of Efficacy|2|||
156845417|NCT01858766|566187699|FG017|Overall Study|Lack of Efficacy|3|||
156845418|NCT01858766|566187700|FG018|Overall Study|Lack of Efficacy|3|||
156845419|NCT01858766|566187682|FG000|Overall Study|Lost to Follow-up|0|||
156845420|NCT01858766|566187683|FG001|Overall Study|Lost to Follow-up|0|||
156845421|NCT01858766|566187684|FG002|Overall Study|Lost to Follow-up|0|||
156845422|NCT01858766|566187685|FG003|Overall Study|Lost to Follow-up|0|||
156845423|NCT01858766|566187686|FG004|Overall Study|Lost to Follow-up|0|||
156845424|NCT01858766|566187687|FG005|Overall Study|Lost to Follow-up|1|||
156845425|NCT01858766|566187688|FG006|Overall Study|Lost to Follow-up|0|||
156845426|NCT01858766|566187689|FG007|Overall Study|Lost to Follow-up|2|||
156845427|NCT01858766|566187690|FG008|Overall Study|Lost to Follow-up|0|||
156845428|NCT01858766|566187691|FG009|Overall Study|Lost to Follow-up|0|||
156845429|NCT01858766|566187692|FG010|Overall Study|Lost to Follow-up|0|||
156845430|NCT01858766|566187693|FG011|Overall Study|Lost to Follow-up|1|||
157025173|NCT00753545|566847919|FG000|Overall Study|Death|98|||
157025174|NCT00753545|566847920|FG001|Overall Study|Death|112|||
157025175|NCT00753545|566847919|FG000|Overall Study|Lost to Follow-up|2|||
157025176|NCT00753545|566847920|FG001|Overall Study|Lost to Follow-up|3|||
157025177|NCT00753545|566847919|FG000|Overall Study|Protocol Violation|1|||
157025178|NCT00753545|566847920|FG001|Overall Study|Protocol Violation|0|||
157025179|NCT00753545|566847919|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
157025180|NCT00753545|566847920|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
157025181|NCT05453773|566847921|FG000|Overall Study|Withdrawal by Subject|3|||
157025182|NCT05453773|566847921|FG000|Overall Study|Lost to Follow-up|3|||
157025183|NCT05453773|566847921|FG000|Overall Study|Difficult Blood Draw|3|||
157025184|NCT04633122|566847924|FG000|Overall Study|Remained on treatment|19|||
157025185|NCT04633122|566847925|FG001|Overall Study|Remained on treatment|14|||
157025186|NCT04633122|566847924|FG000|Overall Study|Survival follow-up stopped|22|||
157025187|NCT04633122|566847925|FG001|Overall Study|Survival follow-up stopped|25|||
157025188|NCT03839940|566847926|FG000|Overall Study|Withdrawal by Subject|3|||
157025189|NCT03839940|566847927|FG001|Overall Study|Withdrawal by Subject|0|||
157155103|NCT00069576|567312865|FG001|Original Trial|Lost to Follow-up|33|||
156845431|NCT01858766|566187694|FG012|Overall Study|Lost to Follow-up|0|||
156845432|NCT01858766|566187695|FG013|Overall Study|Lost to Follow-up|0|||
156845433|NCT01858766|566187696|FG014|Overall Study|Lost to Follow-up|3|||
156845434|NCT01858766|566187697|FG015|Overall Study|Lost to Follow-up|1|||
156845435|NCT01858766|566187698|FG016|Overall Study|Lost to Follow-up|1|||
156845436|NCT01858766|566187699|FG017|Overall Study|Lost to Follow-up|0|||
156845437|NCT01858766|566187700|FG018|Overall Study|Lost to Follow-up|1|||
156845438|NCT01858766|566187682|FG000|Overall Study|Withdrew Consent|0|||
156845439|NCT01858766|566187683|FG001|Overall Study|Withdrew Consent|0|||
156845440|NCT01858766|566187684|FG002|Overall Study|Withdrew Consent|0|||
156845441|NCT01858766|566187685|FG003|Overall Study|Withdrew Consent|0|||
156845442|NCT01858766|566187686|FG004|Overall Study|Withdrew Consent|0|||
156845443|NCT01858766|566187687|FG005|Overall Study|Withdrew Consent|0|||
156845444|NCT01858766|566187688|FG006|Overall Study|Withdrew Consent|0|||
156845445|NCT01858766|566187689|FG007|Overall Study|Withdrew Consent|0|||
156845446|NCT01858766|566187690|FG008|Overall Study|Withdrew Consent|0|||
156845447|NCT01858766|566187691|FG009|Overall Study|Withdrew Consent|0|||
156845448|NCT01858766|566187692|FG010|Overall Study|Withdrew Consent|0|||
156845449|NCT01858766|566187693|FG011|Overall Study|Withdrew Consent|1|||
156845450|NCT01858766|566187694|FG012|Overall Study|Withdrew Consent|0|||
156845451|NCT01858766|566187695|FG013|Overall Study|Withdrew Consent|0|||
156845452|NCT01858766|566187696|FG014|Overall Study|Withdrew Consent|0|||
156845453|NCT01858766|566187697|FG015|Overall Study|Withdrew Consent|0|||
156845454|NCT01858766|566187698|FG016|Overall Study|Withdrew Consent|0|||
156845455|NCT01858766|566187699|FG017|Overall Study|Withdrew Consent|0|||
156845456|NCT01858766|566187700|FG018|Overall Study|Withdrew Consent|0|||
156845457|NCT03517228|566187701|FG000|Overall Study|Withdrawal by Subject|2|||
156845458|NCT03517228|566187701|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
156845459|NCT03517228|566187701|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
156845460|NCT03517228|566187701|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
156845461|NCT03517228|566187701|FG000|Overall Study|Canceled due to device being updated|1|||
156845462|NCT03517228|566187701|FG000|Overall Study|No V Cares in stock|1|||
156845463|NCT03517228|566187701|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
156845464|NCT01979952|566187711|FG000|Overall Study|Adverse Event|4|||
156845465|NCT01979952|566187712|FG001|Overall Study|Adverse Event|5|||
156845466|NCT01979952|566187711|FG000|Overall Study|Protocol Violation|1|||
156845467|NCT01979952|566187712|FG001|Overall Study|Protocol Violation|0|||
156845468|NCT01979952|566187711|FG000|Overall Study|Withdrawal by Subject|2|||
156845469|NCT01979952|566187712|FG001|Overall Study|Withdrawal by Subject|1|||
156845470|NCT01979952|566187711|FG000|Overall Study|Other than specified above|1|||
156845471|NCT01979952|566187712|FG001|Overall Study|Other than specified above|0|||
157025190|NCT03839940|566847926|FG000|Overall Study|Protocol Violation|0|||
157025191|NCT03839940|566847927|FG001|Overall Study|Protocol Violation|1|||
157025192|NCT03839940|566847926|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
157025193|NCT03839940|566847927|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
157155104|NCT00069576|567312864|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
156845472|NCT03781414|566187713|FG000|Overall Study|Study terminated by sponsor|39|||
157155105|NCT00069576|567312865|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
156888039|NCT04604132|566349461|FG004|Overall Study|Adverse Event|2|||
156888040|NCT04604132|566349457|FG000|Overall Study|Study terminated by sponsor|0|||
156845473|NCT03781414|566187714|FG001|Overall Study|Study terminated by sponsor|34|||
157025194|NCT04799899|566847928|FG000|Overall Study|Lost to Follow-up|2|||
157025195|NCT04799899|566847929|FG001|Overall Study|Lost to Follow-up|4|||
157025196|NCT00470704|566847930|FG000|Overall Study|Withdrawal by Subject|4|||
157025197|NCT00470704|566847931|FG001|Overall Study|Withdrawal by Subject|3|||
157025198|NCT00470704|566847930|FG000|Overall Study|Relapse/Progression|37|||
156845474|NCT03781414|566187715|FG002|Overall Study|Study terminated by sponsor|25|||
156845475|NCT03781414|566187713|FG000|Overall Study|Adverse Event|3|||
156845476|NCT03781414|566187714|FG001|Overall Study|Adverse Event|6|||
156845477|NCT03781414|566187715|FG002|Overall Study|Adverse Event|3|||
156845478|NCT03781414|566187713|FG000|Overall Study|Physician Decision|2|||
156845479|NCT03781414|566187714|FG001|Overall Study|Physician Decision|0|||
156845480|NCT03781414|566187715|FG002|Overall Study|Physician Decision|1|||
156845481|NCT03781414|566187713|FG000|Overall Study|Withdrawal by Subject|2|||
156845482|NCT03781414|566187714|FG001|Overall Study|Withdrawal by Subject|3|||
156845483|NCT03781414|566187715|FG002|Overall Study|Withdrawal by Subject|3|||
156845484|NCT03781414|566187713|FG000|Overall Study|Death|1|||
156845485|NCT03781414|566187714|FG001|Overall Study|Death|4|||
156845486|NCT03781414|566187715|FG002|Overall Study|Death|0|||
156845487|NCT03781414|566187713|FG000|Overall Study|Lost to Follow-up|1|||
156845488|NCT03781414|566187714|FG001|Overall Study|Lost to Follow-up|1|||
156845489|NCT03781414|566187715|FG002|Overall Study|Lost to Follow-up|0|||
156845490|NCT00245037|566187718|FG000|Overall Study|Death|17|||
156845491|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
156845492|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845493|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845494|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845495|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845496|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156845497|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
156845498|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845499|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845500|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845501|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845502|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156845503|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
156845504|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845505|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845506|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845507|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845508|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156845509|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
156845510|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845511|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845512|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845513|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845514|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
156845515|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
156845516|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845517|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845518|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845519|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845520|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
156845521|NCT01053988|566187720|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
156845522|NCT01053988|566187721|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845523|NCT01053988|566187722|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845524|NCT01053988|566187723|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845525|NCT01053988|566187724|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845526|NCT01053988|566187725|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156845527|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
157155106|NCT00905307|567312866|FG000|Overall Study|Switched to Open Label Rescue|7|||
157155107|NCT00905307|567312867|FG001|Overall Study|Switched to Open Label Rescue|17|||
157155108|NCT00905307|567312868|FG002|Overall Study|Switched to Open Label Rescue|11|||
157155109|NCT00905307|567312869|FG003|Overall Study|Switched to Open Label Rescue|11|||
157155110|NCT00905307|567312870|FG004|Overall Study|Switched to Open Label Rescue|4|||
157155111|NCT00905307|567312871|FG005|Overall Study|Switched to Open Label Rescue|15|||
157155112|NCT00905307|567312866|FG000|Overall Study|Lost to Follow-up|0|||
156845528|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
156845529|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
156845530|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
156845531|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
156845532|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
156888041|NCT04604132|566349458|FG001|Overall Study|Study terminated by sponsor|0|||
156888042|NCT04604132|566349459|FG002|Overall Study|Study terminated by sponsor|0|||
156888043|NCT04604132|566349460|FG003|Overall Study|Study terminated by sponsor|0|||
157025199|NCT00470704|566847931|FG001|Overall Study|Relapse/Progression|42|||
157155113|NCT00905307|567312867|FG001|Overall Study|Lost to Follow-up|0|||
157155114|NCT00905307|567312868|FG002|Overall Study|Lost to Follow-up|0|||
157025200|NCT00470704|566847930|FG000|Overall Study|toxicity|0|||
157025201|NCT00470704|566847931|FG001|Overall Study|toxicity|1|||
157025202|NCT02561247|566847932|FG000|Overall Study|Protocol Violation|1|||
157025203|NCT02561247|566847932|FG000|Overall Study|Withdrawal by Subject|1|||
157025204|NCT02561247|566847932|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
157025205|NCT04963270|566847933|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
157025206|NCT04963270|566847934|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
157025207|NCT04963270|566847935|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
157025208|NCT04963270|566847936|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
157025209|NCT04963270|566847933|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
157025210|NCT04963270|566847934|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
157025211|NCT04963270|566847935|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
157025212|NCT04963270|566847936|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
157025213|NCT04963270|566847933|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
157025214|NCT04963270|566847934|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
157025215|NCT04963270|566847935|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
157025216|NCT04963270|566847936|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
157025217|NCT04963270|566847933|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
157025218|NCT04963270|566847934|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
157025219|NCT04963270|566847935|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
157025220|NCT04963270|566847936|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
156845533|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
157025221|NCT04963270|566847933|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
157025222|NCT04963270|566847934|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
157025223|NCT04963270|566847935|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
157025224|NCT04963270|566847936|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
157025225|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
157025226|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
157025227|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
157025228|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
157025229|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
157025230|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
157025231|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
157155115|NCT00905307|567312869|FG003|Overall Study|Lost to Follow-up|0|||
157155116|NCT00905307|567312870|FG004|Overall Study|Lost to Follow-up|1|||
157155117|NCT00905307|567312871|FG005|Overall Study|Lost to Follow-up|1|||
157155118|NCT00905307|567312866|FG000|Overall Study|Adverse Event|3|||
157155119|NCT00905307|567312867|FG001|Overall Study|Adverse Event|4|||
156845534|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156845535|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
156845536|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
156845537|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156845538|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156845539|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
156845540|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
156845541|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
156845542|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
156845543|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
156845544|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
156845545|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
156845546|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
156845547|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156845548|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
156845549|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
156845550|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
156845551|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
156845552|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
156845553|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
156845554|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
157025232|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
157025233|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
157025234|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
157025235|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
157155120|NCT00905307|567312868|FG002|Overall Study|Adverse Event|5|||
157155121|NCT00905307|567312869|FG003|Overall Study|Adverse Event|11|||
157025236|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
157025237|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
157025238|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
157025239|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
157025240|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
156845555|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
156845556|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
156845557|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156845558|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
156845559|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156845560|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156845561|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156845562|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
156845563|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156845564|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845565|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
156845566|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845567|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
156845568|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
156845569|NCT01053988|566187720|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156845570|NCT01053988|566187721|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
156845571|NCT01053988|566187722|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156845572|NCT01053988|566187723|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
156845573|NCT01053988|566187724|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
156845574|NCT01053988|566187725|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
157025241|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
157025242|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
157155122|NCT00905307|567312870|FG004|Overall Study|Adverse Event|3|||
157155123|NCT00905307|567312871|FG005|Overall Study|Adverse Event|5|||
157155124|NCT00905307|567312866|FG000|Overall Study|Withdrawal by Subject|5|||
157155125|NCT00905307|567312867|FG001|Overall Study|Withdrawal by Subject|13|||
157155126|NCT00905307|567312868|FG002|Overall Study|Withdrawal by Subject|15|||
157155127|NCT00905307|567312869|FG003|Overall Study|Withdrawal by Subject|11|||
157155128|NCT00905307|567312870|FG004|Overall Study|Withdrawal by Subject|4|||
157155129|NCT00905307|567312871|FG005|Overall Study|Withdrawal by Subject|13|||
157155130|NCT00905307|567312866|FG000|Overall Study|Protocol Violation|1|||
157155131|NCT00905307|567312867|FG001|Overall Study|Protocol Violation|0|||
157155132|NCT00905307|567312868|FG002|Overall Study|Protocol Violation|1|||
157155133|NCT00905307|567312869|FG003|Overall Study|Protocol Violation|0|||
157155134|NCT00905307|567312870|FG004|Overall Study|Protocol Violation|0|||
157155135|NCT00905307|567312871|FG005|Overall Study|Protocol Violation|0|||
157155136|NCT00905307|567312866|FG000|Overall Study|Lack of Efficacy|6|||
157155137|NCT00905307|567312867|FG001|Overall Study|Lack of Efficacy|3|||
157155138|NCT00905307|567312868|FG002|Overall Study|Lack of Efficacy|5|||
157155139|NCT00905307|567312869|FG003|Overall Study|Lack of Efficacy|4|||
157155140|NCT00905307|567312870|FG004|Overall Study|Lack of Efficacy|4|||
157155141|NCT00905307|567312871|FG005|Overall Study|Lack of Efficacy|8|||
157155142|NCT05590793|567312872|FG000|Overall Study|Withdrawal by Subject|6|||
157155143|NCT05590793|567312872|FG000|Overall Study|Physician Decision|1|||
157155144|NCT04060667|567312873|FG000|Overall Study|Lost to Follow-up|75|||
157155145|NCT04060667|567312874|FG001|Overall Study|Lost to Follow-up|10|||
157155146|NCT04488822|567312875|FG000|Overall Study|Adverse Event|8|||
157155147|NCT04488822|567312875|FG000|Overall Study|Withdrawal by Subject|1|||
157155148|NCT03406104|567312876|FG000|Overall Study|Lost to Follow-up|2|||
157155149|NCT03406104|567312876|FG000|Overall Study|Withdrawal by Subject|2|||
157155150|NCT03406104|567312876|FG000|Overall Study|due to Covid patient did not want to travel|1|||
157155151|NCT03406104|567312876|FG000|Overall Study|Death|2|||
157155152|NCT01757704|567312884|FG000|Overall Study|Protocol Violation|1|||
157155153|NCT01757704|567312885|FG001|Overall Study|Protocol Violation|3|||
157155154|NCT00772967|567312889|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
157155155|NCT00772967|567312890|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
156845575|NCT01922271|566187726|FG000|WASHOUT Period|Withdrawal by Subject|1|||
157025243|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
157025244|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
157025245|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
157155156|NCT00772967|567312891|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
157155157|NCT00772967|567312892|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
157155158|NCT00772967|567312893|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
157155159|NCT00772967|567312894|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
157155160|NCT00772967|567312889|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
157155161|NCT00772967|567312890|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
156845576|NCT01922271|566187727|FG001|WASHOUT Period|Withdrawal by Subject|0|||
156845577|NCT00719355|566187728|FG000|Overall Study|Death|0|||
156845578|NCT00719355|566187729|FG001|Overall Study|Death|1|||
156845579|NCT00719355|566187728|FG000|Overall Study|Medical|14|||
156845580|NCT00719355|566187729|FG001|Overall Study|Medical|5|||
156845581|NCT00719355|566187728|FG000|Overall Study|Compliance|4|||
156845582|NCT00719355|566187729|FG001|Overall Study|Compliance|6|||
156845583|NCT00719355|566187728|FG000|Overall Study|Moved|0|||
156845584|NCT00719355|566187729|FG001|Overall Study|Moved|1|||
156845585|NCT03724890|566187730|FG000|Overall Study|Death|2|||
156845586|NCT03724890|566187731|FG001|Overall Study|Death|6|||
156845587|NCT03724890|566187732|FG002|Overall Study|Death|3|||
156845588|NCT03724890|566187733|FG003|Overall Study|Death|5|||
156845589|NCT03724890|566187734|FG004|Overall Study|Death|2|||
156845590|NCT03724890|566187735|FG005|Overall Study|Death|0|||
156845591|NCT03724890|566187736|FG006|Overall Study|Death|2|||
156845592|NCT03724890|566187737|FG007|Overall Study|Death|3|||
156845593|NCT03724890|566187738|FG008|Overall Study|Death|4|||
156845594|NCT03724890|566187739|FG009|Overall Study|Death|2|||
156845595|NCT03724890|566187740|FG010|Overall Study|Death|2|||
156845596|NCT03724890|566187730|FG000|Overall Study|Lost to Follow-up|0|||
156845597|NCT03724890|566187731|FG001|Overall Study|Lost to Follow-up|3|||
156845598|NCT03724890|566187732|FG002|Overall Study|Lost to Follow-up|0|||
156845599|NCT03724890|566187733|FG003|Overall Study|Lost to Follow-up|1|||
156845600|NCT03724890|566187734|FG004|Overall Study|Lost to Follow-up|2|||
156845601|NCT03724890|566187735|FG005|Overall Study|Lost to Follow-up|2|||
156845602|NCT03724890|566187736|FG006|Overall Study|Lost to Follow-up|1|||
156845603|NCT03724890|566187737|FG007|Overall Study|Lost to Follow-up|0|||
156845604|NCT03724890|566187738|FG008|Overall Study|Lost to Follow-up|2|||
156845605|NCT03724890|566187739|FG009|Overall Study|Lost to Follow-up|0|||
156888044|NCT04604132|566349461|FG004|Overall Study|Study terminated by sponsor|1|||
156888045|NCT04604132|566349457|FG000|Overall Study|Progressive disease: Clinical progression|0|||
156888046|NCT04604132|566349458|FG001|Overall Study|Progressive disease: Clinical progression|0|||
156888047|NCT04604132|566349459|FG002|Overall Study|Progressive disease: Clinical progression|1|||
156888048|NCT04604132|566349460|FG003|Overall Study|Progressive disease: Clinical progression|0|||
156888049|NCT04604132|566349461|FG004|Overall Study|Progressive disease: Clinical progression|0|||
156888050|NCT04604132|566349457|FG000|Overall Study|Progressive disease: Radiological progression|8|||
156888051|NCT04604132|566349458|FG001|Overall Study|Progressive disease: Radiological progression|7|||
156888052|NCT04604132|566349459|FG002|Overall Study|Progressive disease: Radiological progression|10|||
156888053|NCT04604132|566349460|FG003|Overall Study|Progressive disease: Radiological progression|4|||
156888054|NCT04604132|566349461|FG004|Overall Study|Progressive disease: Radiological progression|3|||
156888055|NCT04604132|566349457|FG000|Overall Study|Death|3|||
156888056|NCT04604132|566349458|FG001|Overall Study|Death|1|||
156888057|NCT04604132|566349459|FG002|Overall Study|Death|2|||
156888058|NCT04604132|566349460|FG003|Overall Study|Death|1|||
156888059|NCT04604132|566349461|FG004|Overall Study|Death|0|||
156888060|NCT00952380|566349462|FG000|Overall Study|Other|0|||
156888061|NCT00952380|566349463|FG001|Overall Study|Other|0|||
156888062|NCT00952380|566349464|FG002|Overall Study|Other|0|||
156888063|NCT00952380|566349465|FG003|Overall Study|Other|0|||
156888064|NCT00952380|566349466|FG004|Overall Study|Other|1|||
156888065|NCT00952380|566349462|FG000|Overall Study|Withdrawal by Subject|0|||
156888066|NCT00952380|566349463|FG001|Overall Study|Withdrawal by Subject|0|||
156888067|NCT00952380|566349464|FG002|Overall Study|Withdrawal by Subject|1|||
156888068|NCT00952380|566349465|FG003|Overall Study|Withdrawal by Subject|0|||
156888069|NCT00952380|566349466|FG004|Overall Study|Withdrawal by Subject|2|||
156888070|NCT00952380|566349462|FG000|Overall Study|Adverse Event|0|||
156888071|NCT00952380|566349463|FG001|Overall Study|Adverse Event|1|||
156888072|NCT00952380|566349464|FG002|Overall Study|Adverse Event|0|||
156888073|NCT00952380|566349465|FG003|Overall Study|Adverse Event|0|||
157224804|NCT01521559|567569877|FG001|Overall Study|Lost to Follow-up|1|||
156845606|NCT03724890|566187740|FG010|Overall Study|Lost to Follow-up|0|||
156845607|NCT03724890|566187730|FG000|Overall Study|Withdrawal by Subject|1|||
156888074|NCT00952380|566349466|FG004|Overall Study|Adverse Event|3|||
156888075|NCT00952380|566349462|FG000|Overall Study|Physician Decision|0|||
157025246|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
156845608|NCT03724890|566187731|FG001|Overall Study|Withdrawal by Subject|2|||
156845609|NCT03724890|566187732|FG002|Overall Study|Withdrawal by Subject|1|||
156845610|NCT03724890|566187733|FG003|Overall Study|Withdrawal by Subject|0|||
156888076|NCT00952380|566349463|FG001|Overall Study|Physician Decision|0|||
156888077|NCT00952380|566349464|FG002|Overall Study|Physician Decision|1|||
157025247|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
157224805|NCT01521559|567569876|FG000|Overall Study|Protocol Violation|1|||
156845611|NCT03724890|566187734|FG004|Overall Study|Withdrawal by Subject|0|||
156888078|NCT00952380|566349465|FG003|Overall Study|Physician Decision|2|||
156845612|NCT03724890|566187735|FG005|Overall Study|Withdrawal by Subject|1|||
156845613|NCT03724890|566187736|FG006|Overall Study|Withdrawal by Subject|0|||
156845614|NCT03724890|566187737|FG007|Overall Study|Withdrawal by Subject|0|||
156845615|NCT03724890|566187738|FG008|Overall Study|Withdrawal by Subject|2|||
156845616|NCT03724890|566187739|FG009|Overall Study|Withdrawal by Subject|2|||
156845617|NCT03724890|566187740|FG010|Overall Study|Withdrawal by Subject|1|||
156845618|NCT03724890|566187730|FG000|Overall Study|Other|1|||
156845619|NCT03724890|566187731|FG001|Overall Study|Other|0|||
156845620|NCT03724890|566187732|FG002|Overall Study|Other|0|||
156845621|NCT03724890|566187733|FG003|Overall Study|Other|0|||
156845622|NCT03724890|566187734|FG004|Overall Study|Other|0|||
156845623|NCT03724890|566187735|FG005|Overall Study|Other|0|||
156845624|NCT03724890|566187736|FG006|Overall Study|Other|0|||
156845625|NCT03724890|566187737|FG007|Overall Study|Other|1|||
156845626|NCT03724890|566187738|FG008|Overall Study|Other|1|||
156845627|NCT03724890|566187739|FG009|Overall Study|Other|0|||
156845628|NCT03724890|566187740|FG010|Overall Study|Other|2|||
156845629|NCT03664765|566187742|FG000|Overall Study|Withdrawal by Subject|4|||
156845630|NCT03664765|566187743|FG001|Overall Study|Withdrawal by Subject|1|||
156845631|NCT03664765|566187742|FG000|Overall Study|Lost to Follow-up|0|||
156845632|NCT03664765|566187743|FG001|Overall Study|Lost to Follow-up|1|||
156845633|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
156845634|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
156845635|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
156845636|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
156845637|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
156845638|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
156845639|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
156845640|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
156845641|NCT00383162|566187744|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
156845642|NCT00383162|566187745|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
156845643|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
156845644|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
156845645|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
156845646|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
156845647|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
156845648|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
156845649|NCT00383162|566187744|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
156845650|NCT00383162|566187745|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
156845651|NCT01496846|566187749|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
156845652|NCT01496846|566187750|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
156845653|NCT01496846|566187751|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845654|NCT01496846|566187752|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845655|NCT01496846|566187753|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845656|NCT01496846|566187754|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
156845657|NCT01772576|566187755|FG000|Overall Study|Death|15|||
156845658|NCT01772576|566187755|FG000|Overall Study|Protocol Violation|1|||
156845659|NCT01772576|566187755|FG000|Overall Study|Lost to Follow-up|3|||
156845660|NCT01772576|566187755|FG000|Overall Study|Study device not used|3|||
156845661|NCT01772576|566187755|FG000|Overall Study|Adverse Event|6|||
156845662|NCT01772576|566187755|FG000|Overall Study|Withdrawal by Subject|6|||
156845663|NCT00923845|566187756|FG000|Induction Therapy|Poor performance status|0|||
156845664|NCT00923845|566187757|FG001|Induction Therapy|Poor performance status|2|||
156845665|NCT02873338|566187766|FG000|Overall Study|Adverse Event|0|||
156845666|NCT02873338|566187767|FG001|Overall Study|Adverse Event|2|||
156845667|NCT02873338|566187768|FG002|Overall Study|Adverse Event|1|||
156845668|NCT02873338|566187766|FG000|Overall Study|Death|2|||
156845669|NCT02873338|566187767|FG001|Overall Study|Death|1|||
156845670|NCT02873338|566187768|FG002|Overall Study|Death|1|||
156845671|NCT02873338|566187766|FG000|Overall Study|Withdrawal by Subject|2|||
156845672|NCT02873338|566187767|FG001|Overall Study|Withdrawal by Subject|1|||
156845673|NCT02873338|566187768|FG002|Overall Study|Withdrawal by Subject|3|||
156845674|NCT02873338|566187766|FG000|Overall Study|Lack of Efficacy|0|||
156845675|NCT02873338|566187767|FG001|Overall Study|Lack of Efficacy|2|||
156845676|NCT02873338|566187768|FG002|Overall Study|Lack of Efficacy|0|||
156845677|NCT02873338|566187766|FG000|Overall Study|Other or Missing|14|||
156845678|NCT02873338|566187767|FG001|Overall Study|Other or Missing|15|||
157025248|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
157025249|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
156845679|NCT02873338|566187768|FG002|Overall Study|Other or Missing|13|||
156845680|NCT01620944|566187769|FG000|Overall Study|Early termination of Study|2|||
156845681|NCT01620944|566187770|FG001|Overall Study|Early termination of Study|1|||
156845682|NCT00375518|566187771|FG000|Overall Study|Withdrawal by Subject|2|||
156845683|NCT00375518|566187772|FG001|Overall Study|Withdrawal by Subject|10|||
156845684|NCT00375518|566187771|FG000|Overall Study|Patient Not Treated|6|||
156845685|NCT00375518|566187772|FG001|Overall Study|Patient Not Treated|6|||
156845686|NCT00375518|566187771|FG000|Overall Study|Death|0|||
156845687|NCT00375518|566187772|FG001|Overall Study|Death|1|||
157025250|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
157025251|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
157025252|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
157025253|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
157025254|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
157025255|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
156845688|NCT03170193|566187773|FG000|Overall Study|Withdrawal by Subject|0|||
156845689|NCT03170193|566187774|FG001|Overall Study|Withdrawal by Subject|0|||
156845690|NCT03170193|566187775|FG002|Overall Study|Withdrawal by Subject|0|||
156845691|NCT03170193|566187776|FG003|Overall Study|Withdrawal by Subject|1|||
156845692|NCT03170193|566187777|FG004|Overall Study|Withdrawal by Subject|0|||
156845693|NCT03170193|566187778|FG005|Overall Study|Withdrawal by Subject|0|||
156845694|NCT03170193|566187779|FG006|Overall Study|Withdrawal by Subject|0|||
156845695|NCT03170193|566187773|FG000|Overall Study|Lost to Follow-up|1|||
156845696|NCT03170193|566187774|FG001|Overall Study|Lost to Follow-up|1|||
156845697|NCT03170193|566187775|FG002|Overall Study|Lost to Follow-up|0|||
156845698|NCT03170193|566187776|FG003|Overall Study|Lost to Follow-up|0|||
156845699|NCT03170193|566187777|FG004|Overall Study|Lost to Follow-up|0|||
156845700|NCT03170193|566187778|FG005|Overall Study|Lost to Follow-up|0|||
156845701|NCT03170193|566187779|FG006|Overall Study|Lost to Follow-up|0|||
156845702|NCT03052816|566187784|FG000|Overall Study|Withdrawal by Subject|1|||
156845703|NCT03052816|566187785|FG001|Overall Study|Withdrawal by Subject|0|||
156845704|NCT03052816|566187784|FG000|Overall Study|Desired opioids|2|||
156845705|NCT03052816|566187785|FG001|Overall Study|Desired opioids|0|||
156845706|NCT03755661|566187786|FG000|Overall Study|Lost to Follow-up|1|||
156845707|NCT03755661|566187787|FG001|Overall Study|Lost to Follow-up|0|||
156845708|NCT04000581|566187788|FG000|Overall Study|Withdrawal by Subject|0|||
156845709|NCT04000581|566187789|FG001|Overall Study|Withdrawal by Subject|1|||
156845710|NCT00895453|566187793|FG000|Overall Study|Lost to Follow-up|25|||
156845711|NCT00895453|566187794|FG001|Overall Study|Lost to Follow-up|25|||
156845712|NCT00895453|566187795|FG002|Overall Study|Lost to Follow-up|23|||
156845713|NCT00619307|566187798|FG000|Overall Study|Adverse Event|0|||
156845714|NCT00619307|566187799|FG001|Overall Study|Adverse Event|1|||
156845715|NCT00619307|566187798|FG000|Overall Study|Lost to Follow-up|0|||
156845716|NCT00619307|566187799|FG001|Overall Study|Lost to Follow-up|1|||
156845717|NCT00619307|566187798|FG000|Overall Study|Protocol Violation|3|||
156845718|NCT00619307|566187799|FG001|Overall Study|Protocol Violation|0|||
156845719|NCT00619307|566187798|FG000|Overall Study|Withdrew consent|1|||
156845720|NCT00619307|566187799|FG001|Overall Study|Withdrew consent|0|||
156845721|NCT00619307|566187798|FG000|Overall Study|Severe migraine|0|||
156845722|NCT00619307|566187799|FG001|Overall Study|Severe migraine|1|||
156845723|NCT00619307|566187798|FG000|Overall Study|MS attack plus steroids|0|||
156845724|NCT00619307|566187799|FG001|Overall Study|MS attack plus steroids|1|||
156845725|NCT00118430|566187808|FG000|Overall Study|Withdrawal by Subject|6|||
156845726|NCT00118430|566187809|FG001|Overall Study|Withdrawal by Subject|2|||
156845727|NCT00118430|566187810|FG002|Overall Study|Withdrawal by Subject|0|||
156845728|NCT00118430|566187808|FG000|Overall Study|Lost to Follow-up|15|||
156845729|NCT00118430|566187809|FG001|Overall Study|Lost to Follow-up|22|||
156845730|NCT00118430|566187810|FG002|Overall Study|Lost to Follow-up|28|||
156845731|NCT00534976|566187811|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
156845732|NCT00534976|566187812|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
156845733|NCT00534976|566187811|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
156845734|NCT00534976|566187812|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
156845735|NCT00534976|566187811|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
156845736|NCT00534976|566187812|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
156845737|NCT02147288|566187813|FG000|Overall Study|post-operative hematoma|1|||
156845738|NCT02147288|566187814|FG001|Overall Study|post-operative hematoma|1|||
156845739|NCT02147288|566187815|FG002|Overall Study|post-operative hematoma|0|||
156845740|NCT02147288|566187816|FG003|Overall Study|post-operative hematoma|0|||
156845741|NCT02147288|566187817|FG004|Overall Study|post-operative hematoma|0|||
156845742|NCT02147288|566187818|FG005|Overall Study|post-operative hematoma|0|||
156845743|NCT02147288|566187819|FG006|Overall Study|post-operative hematoma|0|||
156845744|NCT02147288|566187820|FG007|Overall Study|post-operative hematoma|0|||
156845745|NCT02147288|566187821|FG008|Overall Study|post-operative hematoma|0|||
157224806|NCT01521559|567569877|FG001|Overall Study|Protocol Violation|0|||
156845746|NCT02147288|566187822|FG009|Overall Study|post-operative hematoma|0|||
156845747|NCT02147288|566187813|FG000|Overall Study|complications from concurrent hernia rep|0|||
156845748|NCT02147288|566187814|FG001|Overall Study|complications from concurrent hernia rep|1|||
156845749|NCT02147288|566187815|FG002|Overall Study|complications from concurrent hernia rep|0|||
156845750|NCT02147288|566187816|FG003|Overall Study|complications from concurrent hernia rep|0|||
156845751|NCT02147288|566187817|FG004|Overall Study|complications from concurrent hernia rep|0|||
156845752|NCT02147288|566187818|FG005|Overall Study|complications from concurrent hernia rep|0|||
156845753|NCT02147288|566187819|FG006|Overall Study|complications from concurrent hernia rep|0|||
156888079|NCT00952380|566349466|FG004|Overall Study|Physician Decision|0|||
156845754|NCT02147288|566187820|FG007|Overall Study|complications from concurrent hernia rep|0|||
156845755|NCT02147288|566187821|FG008|Overall Study|complications from concurrent hernia rep|0|||
156845756|NCT02147288|566187822|FG009|Overall Study|complications from concurrent hernia rep|0|||
156845757|NCT00861471|566187823|FG000|Overall Study|Withdrawal by Subject|1|||
156845758|NCT00861471|566187823|FG000|Overall Study|Adverse Event|2|||
156845759|NCT00861471|566187823|FG000|Overall Study|Lack of Efficacy|3|||
156845760|NCT00861471|566187823|FG000|Overall Study|treatment for lumbar laminectomy|1|||
156845761|NCT00861471|566187823|FG000|Overall Study|Physician Decision|2|||
156845762|NCT02069392|566187826|FG000|Overall Study|Withdrawal by Subject|4|||
156845763|NCT02069392|566187827|FG001|Overall Study|Withdrawal by Subject|2|||
156845764|NCT00269633|566187828|FG000|Overall Study|Withdrawal by Subject|1|||
156845765|NCT00269633|566187829|FG001|Overall Study|Withdrawal by Subject|0|||
156845766|NCT04412707|566187830|FG000|Cycle 1|Death|0|||
156845767|NCT04412707|566187831|FG001|Cycle 1|Death|3|||
156845768|NCT04412707|566187830|FG000|Cycle 1|Disease progression|1|||
156845769|NCT04412707|566187831|FG001|Cycle 1|Disease progression|2|||
156845770|NCT04412707|566187830|FG000|Cycle 2|Death|0|||
156845771|NCT04412707|566187831|FG001|Cycle 2|Death|1|||
156845772|NCT04412707|566187830|FG000|Cycle 2|Disease progression|3|||
156845773|NCT04412707|566187831|FG001|Cycle 2|Disease progression|0|||
156845774|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
156845775|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
156845776|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
156845777|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
156845778|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
156845779|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
156845780|NCT04412707|566187830|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
156845781|NCT04412707|566187831|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
156845782|NCT00855959|566189834|FG000|Overall Study|Adverse Event|2|||
156845783|NCT00855959|566189834|FG000|Overall Study|Lost to Follow-up|2|||
156845784|NCT00855959|566189834|FG000|Overall Study|Withdrawal by Subject|3|||
156845785|NCT00855959|566189834|FG000|Overall Study|Pregnancy|1|||
156845786|NCT00855959|566189834|FG000|Overall Study|Incorrect enrolment|1|||
156845787|NCT04014062|566189835|FG000|Period I: Dosing|Medical Grounds|4|||
156845788|NCT04014062|566189836|FG001|Period I: Dosing|Medical Grounds|5|||
156845789|NCT04014062|566189835|FG000|Period I: Dosing|Withdrawal by Subject|3|||
156845790|NCT04014062|566189836|FG001|Period I: Dosing|Withdrawal by Subject|1|||
156845791|NCT03038126|566189838|FG000|Overall Study|Death|1|||
156845792|NCT03038126|566189839|FG001|Overall Study|Death|1|||
156845793|NCT03038126|566189838|FG000|Overall Study|Withdrawal by Subject|5|||
156845794|NCT03038126|566189839|FG001|Overall Study|Withdrawal by Subject|0|||
156845795|NCT03038126|566189838|FG000|Overall Study|Lost to Follow-up|0|||
156845796|NCT03038126|566189839|FG001|Overall Study|Lost to Follow-up|1|||
156845797|NCT03038126|566189838|FG000|Overall Study|Long Term Hospitalization|2|||
156845798|NCT03038126|566189839|FG001|Overall Study|Long Term Hospitalization|0|||
156845799|NCT03038126|566189838|FG000|Overall Study|Too Ill to Participate|1|||
156845800|NCT03038126|566189839|FG001|Overall Study|Too Ill to Participate|2|||
156845801|NCT01724866|566189840|FG000|Overall Study|Adverse Event|0|||
156845802|NCT01724866|566189841|FG001|Overall Study|Adverse Event|0|||
156845803|NCT01724866|566189842|FG002|Overall Study|Adverse Event|1|||
156845804|NCT01724866|566189843|FG003|Overall Study|Adverse Event|1|||
156845805|NCT01724866|566189840|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845806|NCT01724866|566189841|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
156845807|NCT01724866|566189842|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845808|NCT01724866|566189843|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
156845809|NCT01724866|566189840|FG000|Overall Study|Investigator's Discretion|0|||
156845810|NCT01724866|566189841|FG001|Overall Study|Investigator's Discretion|1|||
156845811|NCT01724866|566189842|FG002|Overall Study|Investigator's Discretion|1|||
156845812|NCT01724866|566189843|FG003|Overall Study|Investigator's Discretion|0|||
156845813|NCT01724866|566189840|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
156845814|NCT01724866|566189841|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845815|NCT01724866|566189842|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845816|NCT01724866|566189843|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
156845817|NCT01724866|566189840|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
156845818|NCT01724866|566189841|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
157025256|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
157224807|NCT01521559|567569876|FG000|Overall Study|Other|1|||
156845819|NCT01724866|566189842|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
156845820|NCT01724866|566189843|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
156845821|NCT04506502|566189847|FG000|Overall Study|Withdrawal by Subject|1|||
156845822|NCT04506502|566189847|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
156845823|NCT03350815|566189848|FG000|Period 1|Adverse Event|10|||
156845824|NCT03350815|566189849|FG001|Period 1|Adverse Event|0|||
156845825|NCT03350815|566189850|FG002|Period 1|Adverse Event|0|||
156845826|NCT03350815|566189851|FG003|Period 1|Adverse Event|0|||
156845827|NCT03350815|566189848|FG000|Period 1|Technical problems|1|||
156845828|NCT03350815|566189849|FG001|Period 1|Technical problems|0|||
156845829|NCT03350815|566189850|FG002|Period 1|Technical problems|0|||
156845830|NCT03350815|566189851|FG003|Period 1|Technical problems|0|||
156845831|NCT03350815|566189848|FG000|Period 1|Lost to Follow-up|3|||
156845832|NCT03350815|566189849|FG001|Period 1|Lost to Follow-up|0|||
156845833|NCT03350815|566189850|FG002|Period 1|Lost to Follow-up|0|||
156845834|NCT03350815|566189851|FG003|Period 1|Lost to Follow-up|0|||
156845835|NCT03350815|566189848|FG000|Period 1|Physician Decision|1|||
156845836|NCT03350815|566189849|FG001|Period 1|Physician Decision|0|||
156845837|NCT03350815|566189850|FG002|Period 1|Physician Decision|0|||
156845838|NCT03350815|566189851|FG003|Period 1|Physician Decision|0|||
156845839|NCT03350815|566189848|FG000|Period 1|Withdrawal by Subject|8|||
156845840|NCT03350815|566189849|FG001|Period 1|Withdrawal by Subject|0|||
156845841|NCT03350815|566189850|FG002|Period 1|Withdrawal by Subject|0|||
156845842|NCT03350815|566189851|FG003|Period 1|Withdrawal by Subject|0|||
156845843|NCT03350815|566189848|FG000|Period 1|Lack of Efficacy|15|||
156845844|NCT03350815|566189849|FG001|Period 1|Lack of Efficacy|0|||
156845845|NCT03350815|566189850|FG002|Period 1|Lack of Efficacy|0|||
156845846|NCT03350815|566189851|FG003|Period 1|Lack of Efficacy|0|||
156845847|NCT03350815|566189848|FG000|Period 1|Non-compliance with study treatment|2|||
156845848|NCT03350815|566189849|FG001|Period 1|Non-compliance with study treatment|0|||
156845849|NCT03350815|566189850|FG002|Period 1|Non-compliance with study treatment|0|||
156845850|NCT03350815|566189851|FG003|Period 1|Non-compliance with study treatment|0|||
156845851|NCT03350815|566189848|FG000|Period 1|Protocol Violation|3|||
156845852|NCT03350815|566189849|FG001|Period 1|Protocol Violation|0|||
156845853|NCT03350815|566189850|FG002|Period 1|Protocol Violation|0|||
156845854|NCT03350815|566189851|FG003|Period 1|Protocol Violation|0|||
156845855|NCT03350815|566189848|FG000|Period 2|Adverse Event|0|||
156845856|NCT03350815|566189849|FG001|Period 2|Adverse Event|3|||
156845857|NCT03350815|566189850|FG002|Period 2|Adverse Event|5|||
156845858|NCT03350815|566189851|FG003|Period 2|Adverse Event|0|||
156845859|NCT03350815|566189848|FG000|Period 2|Technical problem|0|||
156845860|NCT03350815|566189849|FG001|Period 2|Technical problem|1|||
156845861|NCT03350815|566189850|FG002|Period 2|Technical problem|0|||
156845862|NCT03350815|566189851|FG003|Period 2|Technical problem|0|||
156845863|NCT03350815|566189848|FG000|Period 2|Lost to Follow-up|0|||
156845864|NCT03350815|566189849|FG001|Period 2|Lost to Follow-up|3|||
156845865|NCT03350815|566189850|FG002|Period 2|Lost to Follow-up|3|||
156845866|NCT03350815|566189851|FG003|Period 2|Lost to Follow-up|0|||
156845867|NCT03350815|566189848|FG000|Period 2|Physician Decision|0|||
156845868|NCT03350815|566189849|FG001|Period 2|Physician Decision|0|||
156845869|NCT03350815|566189850|FG002|Period 2|Physician Decision|1|||
156845870|NCT03350815|566189851|FG003|Period 2|Physician Decision|0|||
156845871|NCT03350815|566189848|FG000|Period 2|Withdrawal by Subject|0|||
156845872|NCT03350815|566189849|FG001|Period 2|Withdrawal by Subject|3|||
156845873|NCT03350815|566189850|FG002|Period 2|Withdrawal by Subject|4|||
156845874|NCT03350815|566189851|FG003|Period 2|Withdrawal by Subject|0|||
156845875|NCT03350815|566189848|FG000|Period 2|Lack of Efficacy|0|||
156845876|NCT03350815|566189849|FG001|Period 2|Lack of Efficacy|6|||
156845877|NCT03350815|566189850|FG002|Period 2|Lack of Efficacy|2|||
156845878|NCT03350815|566189851|FG003|Period 2|Lack of Efficacy|0|||
156845879|NCT03350815|566189848|FG000|Period 2|Protocol Violation|0|||
156845880|NCT03350815|566189849|FG001|Period 2|Protocol Violation|0|||
156845881|NCT03350815|566189850|FG002|Period 2|Protocol Violation|1|||
156845882|NCT03350815|566189851|FG003|Period 2|Protocol Violation|0|||
156845883|NCT03350815|566189848|FG000|Period 2|New therapy for study indication|0|||
156845884|NCT03350815|566189849|FG001|Period 2|New therapy for study indication|0|||
156845885|NCT03350815|566189850|FG002|Period 2|New therapy for study indication|1|||
156845886|NCT03350815|566189851|FG003|Period 2|New therapy for study indication|0|||
156845887|NCT02517541|566189852|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
156845888|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
156845889|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
156845890|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
156845891|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
156845892|NCT02517541|566189852|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
156845893|NCT02828436|566189853|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
156845894|NCT02828436|566189854|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
156845895|NCT02828436|566189853|FG000|Period 1|Lost to Follow-up|0|||
156845896|NCT02828436|566189854|FG001|Period 1|Lost to Follow-up|1|||
156845897|NCT02828436|566189853|FG000|Period 2|Withdrawal by Subject|4|||
156845898|NCT02828436|566189854|FG001|Period 2|Withdrawal by Subject|0|||
156888080|NCT00952380|566349462|FG000|Overall Study|Non-compliant to protocol|0|||
156845899|NCT02828436|566189853|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
156845900|NCT02828436|566189854|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
156845901|NCT02828436|566189853|FG000|Period 2|Lost to Follow-up|1|||
156845902|NCT02828436|566189854|FG001|Period 2|Lost to Follow-up|0|||
156845903|NCT05258149|566189859|FG000|Period 1|Protocol Deviation|1|||
156845904|NCT05258149|566189860|FG001|Period 1|Protocol Deviation|0|||
156845905|NCT05258149|566189859|FG000|Period 1|Adverse Event|0|||
156845906|NCT05258149|566189860|FG001|Period 1|Adverse Event|1|||
156845907|NCT05258149|566189859|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
156845908|NCT05258149|566189860|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
156845909|NCT05258149|566189859|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
156845910|NCT05258149|566189860|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
156845911|NCT05258149|566189859|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
156845912|NCT05258149|566189860|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
156845913|NCT01442714|566189864|FG000|Overall Study|Death|11|||
156845914|NCT01442714|566189864|FG000|Overall Study|Withdrawal by Subject|1|||
156845915|NCT04720417|566189867|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
156845916|NCT03329092|566189868|FG000|Overall Study|Other|2|||
156845917|NCT03329092|566189869|FG001|Overall Study|Other|2|||
156845918|NCT03329092|566189868|FG000|Overall Study|Withdrawal by Subject|16|||
156845919|NCT03329092|566189869|FG001|Overall Study|Withdrawal by Subject|3|||
156845920|NCT03329092|566189868|FG000|Overall Study|Physician Decision|1|||
156845921|NCT03329092|566189869|FG001|Overall Study|Physician Decision|0|||
156845922|NCT03329092|566189868|FG000|Overall Study|Death|17|||
156845923|NCT03329092|566189869|FG001|Overall Study|Death|11|||
156845924|NCT03329092|566189868|FG000|Overall Study|Adverse Event|3|||
156845925|NCT03329092|566189869|FG001|Overall Study|Adverse Event|1|||
156845926|NCT03329092|566189868|FG000|Overall Study|Lost to Follow-up|1|||
156845927|NCT03329092|566189869|FG001|Overall Study|Lost to Follow-up|1|||
156845928|NCT03314987|566189870|FG000|Overall Study|Lost to Follow-up|13|||
156845929|NCT03314987|566189871|FG001|Overall Study|Lost to Follow-up|13|||
156845930|NCT02506192|566189872|FG000|Overall Study|Withdrawal by Subject|1|||
156845931|NCT02506192|566189873|FG001|Overall Study|Withdrawal by Subject|1|||
156845932|NCT00709618|566189874|FG000|Overall Study|Withdrawal by Subject|4|||
156845933|NCT00709618|566189874|FG000|Overall Study|Lost to Follow-up|1|||
156845934|NCT00709618|566189874|FG000|Overall Study|Study Closed/Terminated|25|||
156845935|NCT04042909|566189875|FG000|Overall Study|Withdrawal by Subject|1|||
156845936|NCT04042909|566189876|FG001|Overall Study|Withdrawal by Subject|0|||
156845937|NCT04042909|566189877|FG002|Overall Study|Withdrawal by Subject|0|||
156845938|NCT04042909|566189875|FG000|Overall Study|duplicate cases|2|||
156845939|NCT04042909|566189876|FG001|Overall Study|duplicate cases|0|||
156845940|NCT04042909|566189877|FG002|Overall Study|duplicate cases|0|||
156845941|NCT04042909|566189875|FG000|Overall Study|technical problem|0|||
156845942|NCT04042909|566189876|FG001|Overall Study|technical problem|1|||
156845943|NCT04042909|566189877|FG002|Overall Study|technical problem|0|||
156845944|NCT03785405|566189879|FG000|Overall Study|Adverse Event|16|||
156845945|NCT03785405|566189880|FG001|Overall Study|Adverse Event|1|||
156845946|NCT03785405|566189879|FG000|Overall Study|Death|6|||
156845947|NCT03785405|566189880|FG001|Overall Study|Death|4|||
156845948|NCT03785405|566189879|FG000|Overall Study|Guardian decision|4|||
156845949|NCT03785405|566189880|FG001|Overall Study|Guardian decision|1|||
156845950|NCT03785405|566189879|FG000|Overall Study|Lost to Follow-up|1|||
156845951|NCT03785405|566189880|FG001|Overall Study|Lost to Follow-up|0|||
156845952|NCT03785405|566189879|FG000|Overall Study|Physician Decision|8|||
156845953|NCT03785405|566189880|FG001|Overall Study|Physician Decision|5|||
156845954|NCT03785405|566189879|FG000|Overall Study|Participant decision|2|||
156845955|NCT03785405|566189880|FG001|Overall Study|Participant decision|0|||
156845956|NCT03785405|566189879|FG000|Overall Study|Other|1|||
156845957|NCT03785405|566189880|FG001|Overall Study|Other|0|||
156845958|NCT03785405|566189879|FG000|Overall Study|No treatment was received|0|||
156845959|NCT03785405|566189880|FG001|Overall Study|No treatment was received|1|||
156845960|NCT03705559|566189881|FG000|Overall Study|COVID Shut down|1|||
156845961|NCT00203424|566189884|FG000|Treatment Period|Withdrawal by Subject|4|||
156845962|NCT00203424|566189884|FG000|Treatment Period|Adverse Event|5|||
156845963|NCT00203424|566189884|FG000|Treatment Period|progressive disease|2|||
156845964|NCT00203424|566189884|FG000|Follow-up Period|Withdrawal by Subject|1|||
156845965|NCT00203424|566189884|FG000|Follow-up Period|progressive disease|4|||
156845966|NCT00203424|566189884|FG000|Follow-up Period|Lost to Follow-up|1|||
156845967|NCT06041919|566189885|FG000|Overall Study|Lost to Follow-up|1|||
156845968|NCT06041919|566189886|FG001|Overall Study|Lost to Follow-up|0|||
156845969|NCT06041919|566189887|FG002|Overall Study|Lost to Follow-up|0|||
156845970|NCT06041919|566189888|FG003|Overall Study|Lost to Follow-up|0|||
156845971|NCT06041919|566189889|FG004|Overall Study|Lost to Follow-up|0|||
156845972|NCT06041919|566189885|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
156845973|NCT06041919|566189886|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
156845974|NCT06041919|566189887|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
156845975|NCT06041919|566189888|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
156845976|NCT06041919|566189889|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
156845977|NCT01415401|566189895|FG000|Overall Study|Adverse Event|5|||
156845978|NCT01415401|566189895|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
156845979|NCT01415401|566189895|FG000|Overall Study|Terminated by Sponsor|1|||
156845980|NCT01147055|566189898|FG000|First Intervention Period|Lost to Follow-up|1|||
156845981|NCT01147055|566189899|FG001|First Intervention Period|Lost to Follow-up|0|||
156845982|NCT00836186|566189900|FG000|Overall Study|Blood could not be drawn|1|||
156845983|NCT04079816|566189901|FG000|Overall Study|Request of Subject|2|||
156845984|NCT04079816|566189901|FG000|Overall Study|Unable to draw samples|1|||
156845985|NCT01844778|566189907|FG000|Overall Study|Protocol deviation|0|||
156845986|NCT01844778|566189908|FG001|Overall Study|Protocol deviation|1|||
156845987|NCT01844778|566189909|FG002|Overall Study|Protocol deviation|2|||
156845988|NCT01844778|566189907|FG000|Overall Study|Withdrawal by Subject|2|||
156845989|NCT01844778|566189908|FG001|Overall Study|Withdrawal by Subject|0|||
156845990|NCT01844778|566189909|FG002|Overall Study|Withdrawal by Subject|0|||
156845991|NCT01844778|566189907|FG000|Overall Study|Adverse Event|0|||
156845992|NCT01844778|566189908|FG001|Overall Study|Adverse Event|2|||
156845993|NCT01844778|566189909|FG002|Overall Study|Adverse Event|2|||
156845994|NCT02161757|566189912|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
156845995|NCT02161757|566189913|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
156845996|NCT02161757|566189914|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
156845997|NCT02161757|566189912|FG000|Treatment Through Study Completion|Adverse Event|1|||
156845998|NCT02161757|566189913|FG001|Treatment Through Study Completion|Adverse Event|1|||
156845999|NCT02161757|566189914|FG002|Treatment Through Study Completion|Adverse Event|0|||
156846000|NCT02161757|566189912|FG000|Treatment Through Study Completion|Protocol Violation|0|||
156846001|NCT02161757|566189913|FG001|Treatment Through Study Completion|Protocol Violation|1|||
156846002|NCT02161757|566189914|FG002|Treatment Through Study Completion|Protocol Violation|2|||
156846003|NCT02161757|566189912|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
156846004|NCT02161757|566189913|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
156846005|NCT02161757|566189914|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
156846006|NCT02161757|566189912|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
156846007|NCT02161757|566189913|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
156846008|NCT02161757|566189914|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
156846009|NCT02161757|566189912|FG000|Treatment Through Study Completion|Other|20|||
156846010|NCT02161757|566189913|FG001|Treatment Through Study Completion|Other|19|||
156846011|NCT02161757|566189914|FG002|Treatment Through Study Completion|Other|12|||
156846012|NCT02161757|566189912|FG000|Treatment Through Study Completion|Death|2|||
156846013|NCT02161757|566189913|FG001|Treatment Through Study Completion|Death|1|||
156846014|NCT02161757|566189914|FG002|Treatment Through Study Completion|Death|1|||
156846015|NCT00391625|566189915|FG000|Month 14|Withdrawal by Subject|1|||
156846016|NCT00391625|566189915|FG000|Month 50|Physician Decision|1|||
156846017|NCT02106403|566189922|FG000|Follow-Up Visit 3|Other Reason|0|||
156846018|NCT02106403|566189923|FG001|Follow-Up Visit 3|Other Reason|0|||
156846019|NCT02106403|566189924|FG002|Follow-Up Visit 3|Other Reason|0|||
156846020|NCT02106403|566189925|FG003|Follow-Up Visit 3|Other Reason|0|||
156846021|NCT02106403|566189926|FG004|Follow-Up Visit 3|Other Reason|0|||
156846022|NCT02106403|566189927|FG005|Follow-Up Visit 3|Other Reason|1|||
156846023|NCT00379912|566189931|FG000|Overall Study|Lack of Efficacy|1|||
156846024|NCT00379912|566189932|FG001|Overall Study|Lack of Efficacy|0|||
156846025|NCT01128946|566189933|FG000|Period I|Protocol Violation|0|||
156846026|NCT01128946|566189934|FG001|Period I|Protocol Violation|1|||
156846027|NCT01128946|566189935|FG002|Period I|Protocol Violation|0|||
156846028|NCT01128946|566189936|FG003|Period I|Protocol Violation|0|||
156846029|NCT01128946|566189933|FG000|Period I|Withdrawal by Subject|0|||
156846030|NCT01128946|566189934|FG001|Period I|Withdrawal by Subject|0|||
156846031|NCT01128946|566189935|FG002|Period I|Withdrawal by Subject|1|||
156846032|NCT01128946|566189936|FG003|Period I|Withdrawal by Subject|1|||
156846033|NCT01128946|566189933|FG000|Period II|Protocol Violation|0|||
156846034|NCT01128946|566189934|FG001|Period II|Protocol Violation|1|||
156846035|NCT01128946|566189935|FG002|Period II|Protocol Violation|0|||
156846036|NCT01128946|566189936|FG003|Period II|Protocol Violation|0|||
156846037|NCT01128946|566189933|FG000|Period II|Withdrawal by Subject|0|||
156846038|NCT01128946|566189934|FG001|Period II|Withdrawal by Subject|0|||
156846039|NCT01128946|566189935|FG002|Period II|Withdrawal by Subject|0|||
156846040|NCT01128946|566189936|FG003|Period II|Withdrawal by Subject|1|||
156846041|NCT01128946|566189933|FG000|Period III|Protocol Violation|1|||
156846042|NCT01128946|566189934|FG001|Period III|Protocol Violation|0|||
156846043|NCT01128946|566189935|FG002|Period III|Protocol Violation|0|||
156846044|NCT01128946|566189936|FG003|Period III|Protocol Violation|0|||
156846045|NCT00145574|566189937|FG000|Double Blind|Adverse Event|0|||
156846046|NCT00145574|566189938|FG001|Double Blind|Adverse Event|3|||
156846047|NCT00145574|566189939|FG002|Double Blind|Adverse Event|1|||
156846048|NCT00145574|566189937|FG000|Double Blind|Withdrawal by Subject|1|||
156846049|NCT00145574|566189938|FG001|Double Blind|Withdrawal by Subject|1|||
156846050|NCT00145574|566189939|FG002|Double Blind|Withdrawal by Subject|1|||
156846051|NCT00145574|566189937|FG000|Double Blind|required restricted medicine|0|||
156846052|NCT00145574|566189938|FG001|Double Blind|required restricted medicine|1|||
156846053|NCT00145574|566189939|FG002|Double Blind|required restricted medicine|0|||
156846054|NCT00145574|566189937|FG000|Open Label Long-term Extension|Adverse Event|0|||
156846055|NCT00145574|566189938|FG001|Open Label Long-term Extension|Adverse Event|0|||
156846056|NCT00145574|566189939|FG002|Open Label Long-term Extension|Adverse Event|5|||
156846057|NCT00145574|566189937|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
156846058|NCT00145574|566189938|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
156846059|NCT00145574|566189939|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
156846060|NCT00145574|566189937|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
156846061|NCT00145574|566189938|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
156846062|NCT00145574|566189939|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
156846063|NCT00145574|566189937|FG000|Open Label Long-term Extension|required restricted medicine|0|||
156846064|NCT00145574|566189938|FG001|Open Label Long-term Extension|required restricted medicine|0|||
156846065|NCT00145574|566189939|FG002|Open Label Long-term Extension|required restricted medicine|1|||
156846066|NCT00621140|566189940|FG000|Overall Study|Adverse Event|4|||
156846067|NCT00621140|566189941|FG001|Overall Study|Adverse Event|5|||
156846068|NCT00621140|566189940|FG000|Overall Study|Lost to Follow-up|1|||
156846069|NCT00621140|566189941|FG001|Overall Study|Lost to Follow-up|2|||
156846070|NCT00621140|566189940|FG000|Overall Study|Withdrawal by Subject|4|||
156846071|NCT00621140|566189941|FG001|Overall Study|Withdrawal by Subject|6|||
156846072|NCT00621140|566189940|FG000|Overall Study|Other incl. lack of efficacy|6|||
156846073|NCT00621140|566189941|FG001|Overall Study|Other incl. lack of efficacy|5|||
156846074|NCT00527904|566189942|FG000|Overall Study|Adverse Event|45|||
156846075|NCT00527904|566189942|FG000|Overall Study|Withdrawal by Subject|21|||
156846076|NCT00527904|566189942|FG000|Overall Study|Lost to Follow-up|8|||
156846077|NCT00527904|566189942|FG000|Overall Study|misc|22|||
156846078|NCT00766051|566189944|FG000|Overall Study|Withdrawal by Subject|2|||
156846079|NCT00766051|566189945|FG001|Overall Study|Withdrawal by Subject|0|||
156846080|NCT00635882|566189946|FG000|Overall Study|Protocol Violation|1|||
156846081|NCT00635882|566189947|FG001|Overall Study|Protocol Violation|0|||
156846082|NCT00635882|566189948|FG002|Overall Study|Protocol Violation|0|||
156846083|NCT00635882|566189949|FG003|Overall Study|Protocol Violation|0|||
156846084|NCT00635882|566189950|FG004|Overall Study|Protocol Violation|0|||
156846085|NCT00635882|566189951|FG005|Overall Study|Protocol Violation|0|||
156846086|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
156846087|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
156846088|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
156846089|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846090|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846091|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846092|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846093|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846094|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
156846095|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Physician Decision|1|||
156846096|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Physician Decision|2|||
156846097|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Physician Decision|0|||
156846098|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Physician Decision|0|||
156846099|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Physician Decision|0|||
156846100|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Physician Decision|0|||
156846101|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Physician Decision|0|||
156846102|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Physician Decision|0|||
156846103|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Physician Decision|0|||
156846104|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
156846105|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
156846106|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
156846107|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
156846108|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
156846109|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
156846110|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
156846111|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
156846112|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
156846113|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
156846114|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846115|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846116|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846117|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846118|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846119|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846120|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846121|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
156846122|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
156846123|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
156888081|NCT00952380|566349463|FG001|Overall Study|Non-compliant to protocol|0|||
156888082|NCT00952380|566349464|FG002|Overall Study|Non-compliant to protocol|0|||
156888083|NCT00952380|566349465|FG003|Overall Study|Non-compliant to protocol|1|||
156888084|NCT00952380|566349466|FG004|Overall Study|Non-compliant to protocol|0|||
156846124|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846125|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846126|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846127|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846128|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846129|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846130|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
156846131|NCT04405076|566189952|FG000|Part A (Blinded Phase)|Other than Specified|0|||
156846132|NCT04405076|566189953|FG001|Part A (Blinded Phase)|Other than Specified|0|||
156846133|NCT04405076|566189954|FG002|Part A (Blinded Phase)|Other than Specified|3|||
156846134|NCT04405076|566189955|FG003|Part A (Blinded Phase)|Other than Specified|0|||
156846135|NCT04405076|566189956|FG004|Part A (Blinded Phase)|Other than Specified|0|||
156846136|NCT04405076|566189957|FG005|Part A (Blinded Phase)|Other than Specified|0|||
156846137|NCT04405076|566189958|FG006|Part A (Blinded Phase)|Other than Specified|0|||
156846138|NCT04405076|566189959|FG007|Part A (Blinded Phase)|Other than Specified|0|||
156846139|NCT04405076|566189960|FG008|Part A (Blinded Phase)|Other than Specified|0|||
156846140|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846141|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846142|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846143|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
156846144|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
156846145|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
156846146|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846147|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846148|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
156846149|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846150|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846151|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846152|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846153|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
156846154|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846155|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846156|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846157|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
156846158|NCT04405076|566189952|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846159|NCT04405076|566189953|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846160|NCT04405076|566189954|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846161|NCT04405076|566189955|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
156846162|NCT04405076|566189956|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
156846163|NCT04405076|566189957|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
156846164|NCT04405076|566189958|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846165|NCT04405076|566189959|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846166|NCT04405076|566189960|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
156846167|NCT04405076|566189952|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846168|NCT04405076|566189953|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156888085|NCT03400956|566349467|FG000|Treatment Period 1|Adverse Event|0|||
156888086|NCT03400956|566349468|FG001|Treatment Period 1|Adverse Event|1|||
156846169|NCT04405076|566189954|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846170|NCT04405076|566189955|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846171|NCT04405076|566189956|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846172|NCT04405076|566189957|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846173|NCT04405076|566189958|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
156846174|NCT04405076|566189959|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
156846175|NCT04405076|566189960|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
156846176|NCT04405076|566189952|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846177|NCT04405076|566189953|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846178|NCT04405076|566189954|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846179|NCT04405076|566189955|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846180|NCT04405076|566189956|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846181|NCT04405076|566189957|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156888087|NCT03400956|566349469|FG002|Treatment Period 1|Adverse Event|0|||
156846182|NCT04405076|566189958|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
156846183|NCT04405076|566189959|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846184|NCT04405076|566189960|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
156846185|NCT04310566|566189961|FG000|Period 1|Study Termination due to COVID-19|15|||
156846186|NCT04310566|566189962|FG001|Period 1|Study Termination due to COVID-19|17|||
156846187|NCT04310566|566189961|FG000|Period 1|Protocol Violation|0|||
156846188|NCT04310566|566189962|FG001|Period 1|Protocol Violation|1|||
156846189|NCT04310566|566189961|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
156846190|NCT04310566|566189962|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
156846191|NCT04310566|566189961|FG000|Period 1|Lost to Follow-up|1|||
156846192|NCT04310566|566189962|FG001|Period 1|Lost to Follow-up|0|||
156846193|NCT04310566|566189961|FG000|Period 1|Withdrawal by Subject|0|||
156846194|NCT04310566|566189962|FG001|Period 1|Withdrawal by Subject|1|||
156846195|NCT04310566|566189961|FG000|Period 2|Study Termination|7|||
156846196|NCT04310566|566189962|FG001|Period 2|Study Termination|5|||
156846197|NCT02560012|566189970|FG000|Overall Study|Study Terminated|2|||
156846198|NCT02218008|566189971|FG000|Stage 1 (S1)|Adverse Event|6|||
156846199|NCT02218008|566189972|FG001|Stage 1 (S1)|Adverse Event|5|||
156846200|NCT02218008|566189973|FG002|Stage 1 (S1)|Adverse Event|11|||
156846201|NCT02218008|566189974|FG003|Stage 1 (S1)|Adverse Event|0|||
156846202|NCT02218008|566189975|FG004|Stage 1 (S1)|Adverse Event|0|||
156846203|NCT02218008|566189976|FG005|Stage 1 (S1)|Adverse Event|0|||
156846204|NCT02218008|566189971|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
156846205|NCT02218008|566189972|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
156846206|NCT02218008|566189973|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
156846207|NCT02218008|566189974|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
156846208|NCT02218008|566189975|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
156846209|NCT02218008|566189976|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
156846210|NCT02218008|566189971|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
156846211|NCT02218008|566189972|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
156846212|NCT02218008|566189973|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
156846213|NCT02218008|566189974|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
156846214|NCT02218008|566189975|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
156846215|NCT02218008|566189976|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
156846216|NCT02218008|566189971|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
156846217|NCT02218008|566189972|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
156846218|NCT02218008|566189973|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
156846219|NCT02218008|566189974|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
156846220|NCT02218008|566189975|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
156846221|NCT02218008|566189976|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
156846222|NCT02218008|566189971|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
156846223|NCT02218008|566189972|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
156846224|NCT02218008|566189973|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846225|NCT02218008|566189974|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846226|NCT02218008|566189975|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846227|NCT02218008|566189976|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
156846228|NCT02218008|566189971|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
156846229|NCT02218008|566189972|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
156846230|NCT02218008|566189973|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
156846231|NCT02218008|566189974|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
156846232|NCT02218008|566189975|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
156846233|NCT02218008|566189976|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
156846234|NCT02218008|566189971|FG000|Stage 1 (S1)|Pregnancy|0|||
156846235|NCT02218008|566189972|FG001|Stage 1 (S1)|Pregnancy|0|||
156846236|NCT02218008|566189973|FG002|Stage 1 (S1)|Pregnancy|1|||
156846237|NCT02218008|566189974|FG003|Stage 1 (S1)|Pregnancy|0|||
156846238|NCT02218008|566189975|FG004|Stage 1 (S1)|Pregnancy|0|||
156846239|NCT02218008|566189976|FG005|Stage 1 (S1)|Pregnancy|0|||
156846240|NCT02218008|566189971|FG000|Stage 1 (S1)|Protocol Violation|0|||
156846241|NCT02218008|566189972|FG001|Stage 1 (S1)|Protocol Violation|0|||
156846242|NCT02218008|566189973|FG002|Stage 1 (S1)|Protocol Violation|1|||
156846243|NCT02218008|566189974|FG003|Stage 1 (S1)|Protocol Violation|0|||
157155162|NCT00772967|567312891|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
157155163|NCT00772967|567312892|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
157155164|NCT00772967|567312893|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
157155165|NCT00772967|567312894|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
157155166|NCT00772967|567312889|FG000|Crossover Treatment 3|Adverse Event|0|||
156846244|NCT02218008|566189975|FG004|Stage 1 (S1)|Protocol Violation|0|||
156846245|NCT02218008|566189976|FG005|Stage 1 (S1)|Protocol Violation|0|||
157155167|NCT00772967|567312890|FG001|Crossover Treatment 3|Adverse Event|0|||
157155168|NCT00772967|567312891|FG002|Crossover Treatment 3|Adverse Event|0|||
157155169|NCT00772967|567312892|FG003|Crossover Treatment 3|Adverse Event|0|||
157155170|NCT00772967|567312893|FG004|Crossover Treatment 3|Adverse Event|1|||
156846246|NCT02218008|566189971|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
156846247|NCT02218008|566189972|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846248|NCT02218008|566189973|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846249|NCT02218008|566189974|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846250|NCT02218008|566189975|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846251|NCT02218008|566189976|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
156846252|NCT02218008|566189971|FG000|Stage 2 (S2)|Adverse Event|0|||
156846253|NCT02218008|566189972|FG001|Stage 2 (S2)|Adverse Event|0|||
156846254|NCT02218008|566189973|FG002|Stage 2 (S2)|Adverse Event|0|||
156846255|NCT02218008|566189974|FG003|Stage 2 (S2)|Adverse Event|2|||
156846256|NCT02218008|566189975|FG004|Stage 2 (S2)|Adverse Event|3|||
156846257|NCT02218008|566189976|FG005|Stage 2 (S2)|Adverse Event|3|||
156846258|NCT02218008|566189971|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
156846259|NCT02218008|566189972|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
156846260|NCT02218008|566189973|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
156846261|NCT02218008|566189974|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
156846262|NCT02218008|566189975|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
156846263|NCT02218008|566189976|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
156846264|NCT02218008|566189971|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
156846265|NCT02218008|566189972|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
156846266|NCT02218008|566189973|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
156846267|NCT02218008|566189974|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
156846268|NCT02218008|566189975|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
156846269|NCT02218008|566189976|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
156846270|NCT02218008|566189971|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846271|NCT02218008|566189972|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846272|NCT02218008|566189973|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846273|NCT02218008|566189974|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
156846274|NCT02218008|566189975|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846275|NCT02218008|566189976|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
156846276|NCT02218008|566189971|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
156846277|NCT02218008|566189972|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
156846278|NCT02218008|566189973|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
156846279|NCT02218008|566189974|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
156846280|NCT02218008|566189975|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
156846281|NCT02218008|566189976|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
156846282|NCT00408434|566189977|FG000|Overall Study|Adverse Event|0|||
156846283|NCT00408434|566189978|FG001|Overall Study|Adverse Event|0|||
156846284|NCT00408434|566189979|FG002|Overall Study|Adverse Event|1|||
156846285|NCT00408434|566189980|FG003|Overall Study|Adverse Event|0|||
156846286|NCT00408434|566189981|FG004|Overall Study|Adverse Event|0|||
156846287|NCT00408434|566189982|FG005|Overall Study|Adverse Event|0|||
156846288|NCT00408434|566189983|FG006|Overall Study|Adverse Event|0|||
156846289|NCT00408434|566189977|FG000|Overall Study|Progressive disease|6|||
156846290|NCT00408434|566189978|FG001|Overall Study|Progressive disease|3|||
156846291|NCT00408434|566189979|FG002|Overall Study|Progressive disease|4|||
156846292|NCT00408434|566189980|FG003|Overall Study|Progressive disease|3|||
156846293|NCT00408434|566189981|FG004|Overall Study|Progressive disease|3|||
156846294|NCT00408434|566189982|FG005|Overall Study|Progressive disease|1|||
156846295|NCT00408434|566189983|FG006|Overall Study|Progressive disease|4|||
156846296|NCT00408434|566189977|FG000|Overall Study|Other|0|||
156846297|NCT00408434|566189978|FG001|Overall Study|Other|0|||
156846298|NCT00408434|566189979|FG002|Overall Study|Other|1|||
156846299|NCT00408434|566189980|FG003|Overall Study|Other|0|||
156846300|NCT00408434|566189981|FG004|Overall Study|Other|2|||
156846301|NCT00408434|566189982|FG005|Overall Study|Other|1|||
156846302|NCT00408434|566189983|FG006|Overall Study|Other|0|||
156846303|NCT00408434|566189977|FG000|Overall Study|Terminated by Investigator|0|||
156846304|NCT00408434|566189978|FG001|Overall Study|Terminated by Investigator|0|||
156846305|NCT00408434|566189979|FG002|Overall Study|Terminated by Investigator|0|||
156846306|NCT00408434|566189980|FG003|Overall Study|Terminated by Investigator|0|||
156846307|NCT00408434|566189981|FG004|Overall Study|Terminated by Investigator|1|||
156846308|NCT00408434|566189982|FG005|Overall Study|Terminated by Investigator|1|||
156846309|NCT00408434|566189983|FG006|Overall Study|Terminated by Investigator|0|||
156846310|NCT01088399|566189989|FG000|Overall Study|Adverse Event|211|||
156846311|NCT01088399|566189990|FG001|Overall Study|Adverse Event|16|||
156846312|NCT01088399|566189991|FG002|Overall Study|Adverse Event|0|||
156846313|NCT01088399|566189989|FG000|Overall Study|Death|204|||
156846314|NCT01088399|566189990|FG001|Overall Study|Death|45|||
156846315|NCT01088399|566189991|FG002|Overall Study|Death|0|||
156846316|NCT01088399|566189989|FG000|Overall Study|Lack of Efficacy|298|||
156846317|NCT01088399|566189990|FG001|Overall Study|Lack of Efficacy|7|||
156846318|NCT01088399|566189991|FG002|Overall Study|Lack of Efficacy|5|||
156846319|NCT01088399|566189989|FG000|Overall Study|Lost to Follow-up|1070|||
156846320|NCT01088399|566189990|FG001|Overall Study|Lost to Follow-up|278|||
156846321|NCT01088399|566189991|FG002|Overall Study|Lost to Follow-up|58|||
156846322|NCT01088399|566189989|FG000|Overall Study|Physician Decision|531|||
156846323|NCT01088399|566189990|FG001|Overall Study|Physician Decision|88|||
156846324|NCT01088399|566189991|FG002|Overall Study|Physician Decision|16|||
156846325|NCT01088399|566189989|FG000|Overall Study|Withdrawal by Subject|544|||
156846326|NCT01088399|566189990|FG001|Overall Study|Withdrawal by Subject|195|||
156846327|NCT01088399|566189991|FG002|Overall Study|Withdrawal by Subject|33|||
156846328|NCT01088399|566189989|FG000|Overall Study|Change to or start of somatropin therapy|234|||
156846329|NCT01088399|566189990|FG001|Overall Study|Change to or start of somatropin therapy|17|||
156846330|NCT01088399|566189991|FG002|Overall Study|Change to or start of somatropin therapy|12|||
156846331|NCT01088399|566189989|FG000|Overall Study|Sponsor decision|1573|||
156846332|NCT01088399|566189990|FG001|Overall Study|Sponsor decision|298|||
156846333|NCT01088399|566189991|FG002|Overall Study|Sponsor decision|7|||
156846334|NCT01088399|566189989|FG000|Overall Study|Protocol Violation|10|||
156846335|NCT01088399|566189990|FG001|Overall Study|Protocol Violation|1|||
156846336|NCT01088399|566189991|FG002|Overall Study|Protocol Violation|0|||
156846337|NCT01088399|566189989|FG000|Overall Study|Enrollment criteria not met|48|||
156846338|NCT01088399|566189990|FG001|Overall Study|Enrollment criteria not met|119|||
156846339|NCT01088399|566189991|FG002|Overall Study|Enrollment criteria not met|70|||
156846340|NCT01088399|566189989|FG000|Overall Study|Study summary visit not completed|2398|||
156846341|NCT01088399|566189990|FG001|Overall Study|Study summary visit not completed|283|||
156846342|NCT01088399|566189991|FG002|Overall Study|Study summary visit not completed|80|||
156846343|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
156846344|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
156846345|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
156846346|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
156846347|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
156846348|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
156846349|NCT04230213|566189996|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
156846350|NCT04230213|566189997|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
156846351|NCT04230213|566189998|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
156846352|NCT04230213|566189996|FG000|TP2: Week 10 to Week 16|Other|0|||
156846353|NCT04230213|566189997|FG001|TP2: Week 10 to Week 16|Other|2|||
156846354|NCT04230213|566189998|FG002|TP2: Week 10 to Week 16|Other|1|||
156846355|NCT04230213|566189996|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
156846356|NCT04230213|566189997|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
156846357|NCT04230213|566189998|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
156846358|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
156846359|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
156846360|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
156846361|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
156846362|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
156846363|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
156846364|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
156846365|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
156846366|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
156846367|NCT04230213|566189996|FG000|TP3: Week 16 to Week 22|Other|0|||
156846368|NCT04230213|566189997|FG001|TP3: Week 16 to Week 22|Other|1|||
156846369|NCT04230213|566189998|FG002|TP3: Week 16 to Week 22|Other|3|||
156846370|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Other|0|||
156846371|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Other|5|||
156846372|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Other|5|||
156846373|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
156846374|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
156846375|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
156846376|NCT04230213|566189996|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
156846377|NCT04230213|566189997|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
156846378|NCT04230213|566189998|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
156846379|NCT04230213|566189996|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
156846380|NCT04230213|566189997|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
156846381|NCT04230213|566189998|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
156846382|NCT04230213|566189996|FG000|Follow up: Week 32 to Week 36|Other|0|||
156846383|NCT04230213|566189997|FG001|Follow up: Week 32 to Week 36|Other|1|||
156846384|NCT04230213|566189998|FG002|Follow up: Week 32 to Week 36|Other|1|||
156846385|NCT00615017|566191552|FG000|Overall Study|Adverse Event|0|||
156846386|NCT00615017|566191553|FG001|Overall Study|Adverse Event|1|||
156846387|NCT00615017|566191554|FG002|Overall Study|Adverse Event|2|||
156846388|NCT00615017|566191555|FG003|Overall Study|Adverse Event|0|||
156846389|NCT00615017|566191556|FG004|Overall Study|Adverse Event|0|||
156846390|NCT00615017|566191557|FG005|Overall Study|Adverse Event|1|||
156846391|NCT00615017|566191552|FG000|Overall Study|Death|0|||
156846392|NCT00615017|566191553|FG001|Overall Study|Death|0|||
156846393|NCT00615017|566191554|FG002|Overall Study|Death|2|||
156846394|NCT00615017|566191555|FG003|Overall Study|Death|0|||
156846395|NCT00615017|566191556|FG004|Overall Study|Death|1|||
156846396|NCT00615017|566191557|FG005|Overall Study|Death|1|||
156846397|NCT00615017|566191552|FG000|Overall Study|Sepsis resolved|0|||
156846398|NCT00615017|566191553|FG001|Overall Study|Sepsis resolved|0|||
156846399|NCT00615017|566191554|FG002|Overall Study|Sepsis resolved|1|||
156846400|NCT00615017|566191555|FG003|Overall Study|Sepsis resolved|0|||
156846401|NCT00615017|566191556|FG004|Overall Study|Sepsis resolved|0|||
156846402|NCT00615017|566191557|FG005|Overall Study|Sepsis resolved|0|||
156888088|NCT03400956|566349467|FG000|Treatment Period 1|Lost to Follow-up|0|||
156846403|NCT00615017|566191552|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
156846404|NCT00615017|566191553|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
156846405|NCT00615017|566191554|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
156846406|NCT00615017|566191555|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
156846407|NCT00615017|566191556|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
156846408|NCT00615017|566191557|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
156846409|NCT00615017|566191552|FG000|Overall Study|Physician discontinued drug|0|||
156846410|NCT00615017|566191553|FG001|Overall Study|Physician discontinued drug|0|||
156846411|NCT00615017|566191554|FG002|Overall Study|Physician discontinued drug|0|||
156846412|NCT00615017|566191555|FG003|Overall Study|Physician discontinued drug|0|||
156846413|NCT00615017|566191556|FG004|Overall Study|Physician discontinued drug|0|||
156846414|NCT00615017|566191557|FG005|Overall Study|Physician discontinued drug|1|||
156846415|NCT00806988|566191558|FG000|Overall Study|Death|15|||
156846416|NCT00806988|566191559|FG001|Overall Study|Death|16|||
156846417|NCT00806988|566191558|FG000|Overall Study|Withdrawal by Subject|8|||
156846418|NCT00806988|566191559|FG001|Overall Study|Withdrawal by Subject|8|||
156846419|NCT00806988|566191558|FG000|Overall Study|Lost to Follow-up|4|||
156846420|NCT00806988|566191559|FG001|Overall Study|Lost to Follow-up|19|||
156846421|NCT04775953|566191561|FG000|Overall Study|Lost to Follow-up|6|||
156846422|NCT04775953|566191562|FG001|Overall Study|Lost to Follow-up|11|||
156846423|NCT04775953|566191561|FG000|Overall Study|Death|5|||
156846424|NCT04775953|566191562|FG001|Overall Study|Death|4|||
156846425|NCT04775953|566191561|FG000|Overall Study|Withdrawal by Subject|3|||
156846426|NCT04775953|566191562|FG001|Overall Study|Withdrawal by Subject|3|||
156846427|NCT04775953|566191561|FG000|Overall Study|Protocol Violation|2|||
156846428|NCT04775953|566191562|FG001|Overall Study|Protocol Violation|0|||
156846429|NCT04775953|566191561|FG000|Overall Study|Participant non-compliance|0|||
156846430|NCT04775953|566191562|FG001|Overall Study|Participant non-compliance|1|||
156846431|NCT01698814|566191563|FG000|Overall Study|Adverse Event|0|||
156846432|NCT01698814|566191564|FG001|Overall Study|Adverse Event|2|||
156846433|NCT01698814|566191563|FG000|Overall Study|Lost to Follow-up|0|||
156846434|NCT01698814|566191564|FG001|Overall Study|Lost to Follow-up|1|||
156846435|NCT01698814|566191563|FG000|Overall Study|Pregnancy|1|||
156846436|NCT01698814|566191564|FG001|Overall Study|Pregnancy|0|||
156846437|NCT01698814|566191563|FG000|Overall Study|Randomized in error|1|||
156846438|NCT01698814|566191564|FG001|Overall Study|Randomized in error|0|||
156846439|NCT00368641|566191567|FG000|Overall Study|Adverse Event|2|||
156846440|NCT00368641|566191568|FG001|Overall Study|Adverse Event|1|||
156846441|NCT00368641|566191567|FG000|Overall Study|Death|1|||
156846442|NCT00368641|566191568|FG001|Overall Study|Death|0|||
156846443|NCT00368641|566191567|FG000|Overall Study|Withdrawal by Subject|1|||
156846444|NCT00368641|566191568|FG001|Overall Study|Withdrawal by Subject|0|||
156846445|NCT00368641|566191567|FG000|Overall Study|Sponsor decision to terminate study|2|||
156846446|NCT00368641|566191568|FG001|Overall Study|Sponsor decision to terminate study|5|||
156846447|NCT01424501|566191569|FG000|Overall Study|Withdrawal by Subject|1|||
156846448|NCT01424501|566191570|FG001|Overall Study|Withdrawal by Subject|0|||
156846449|NCT01424501|566191571|FG002|Overall Study|Withdrawal by Subject|1|||
156846450|NCT01424501|566191572|FG003|Overall Study|Withdrawal by Subject|0|||
156846451|NCT01424501|566191573|FG004|Overall Study|Withdrawal by Subject|0|||
156846452|NCT01424501|566191574|FG005|Overall Study|Withdrawal by Subject|0|||
156846453|NCT01424501|566191569|FG000|Overall Study|Lost to Follow-up|0|||
156846454|NCT01424501|566191570|FG001|Overall Study|Lost to Follow-up|1|||
156846455|NCT01424501|566191571|FG002|Overall Study|Lost to Follow-up|1|||
156846456|NCT01424501|566191572|FG003|Overall Study|Lost to Follow-up|0|||
156846457|NCT01424501|566191573|FG004|Overall Study|Lost to Follow-up|0|||
156846458|NCT01424501|566191574|FG005|Overall Study|Lost to Follow-up|0|||
156846459|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
156888089|NCT03400956|566349468|FG001|Treatment Period 1|Lost to Follow-up|0|||
156888090|NCT03400956|566349469|FG002|Treatment Period 1|Lost to Follow-up|1|||
156888091|NCT03400956|566349467|FG000|Treatment Period 1|Protocol Violation|0|||
156888092|NCT03400956|566349468|FG001|Treatment Period 1|Protocol Violation|2|||
156888093|NCT03400956|566349469|FG002|Treatment Period 1|Protocol Violation|0|||
156846460|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846461|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157224808|NCT01521559|567569877|FG001|Overall Study|Other|2|||
156846462|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846463|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
156846464|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
156888094|NCT03400956|566349467|FG000|Treatment Period 1|Study terminated by sponsor|3|||
156888095|NCT03400956|566349468|FG001|Treatment Period 1|Study terminated by sponsor|1|||
156846465|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846466|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846467|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846468|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
156846469|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
157224809|NCT02336737|567569878|FG000|Overall Study|Withdrawal by Subject|5|||
156846470|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846471|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846472|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846473|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
156846474|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
156846475|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846476|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846477|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846478|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
156846479|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
156846480|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846481|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846482|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846483|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
156846484|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
156846485|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846486|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846487|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846488|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
156846489|NCT01173601|566191575|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
156846490|NCT01173601|566191576|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846491|NCT01173601|566191577|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846492|NCT01173601|566191578|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846493|NCT01173601|566191579|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
156846494|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
156846495|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
156846496|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
156846497|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
156846498|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
156846499|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
156888096|NCT03400956|566349469|FG002|Treatment Period 1|Study terminated by sponsor|1|||
156888097|NCT03400956|566349467|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156888098|NCT03400956|566349468|FG001|Treatment Period 1|Withdrawal by Subject|2|||
156888099|NCT03400956|566349469|FG002|Treatment Period 1|Withdrawal by Subject|4|||
156888100|NCT03400956|566349467|FG000|Treatment Period 1|Other|1|||
156888101|NCT03400956|566349468|FG001|Treatment Period 1|Other|2|||
156888102|NCT03400956|566349469|FG002|Treatment Period 1|Other|3|||
156888103|NCT03400956|566349467|FG000|Post-treatment Period 1|Adverse Event|0|||
156888104|NCT03400956|566349468|FG001|Post-treatment Period 1|Adverse Event|0|||
156888105|NCT03400956|566349469|FG002|Post-treatment Period 1|Adverse Event|1|||
156888106|NCT03400956|566349467|FG000|Post-treatment Period 1|Physician Decision|2|||
156888107|NCT03400956|566349468|FG001|Post-treatment Period 1|Physician Decision|3|||
156888108|NCT03400956|566349469|FG002|Post-treatment Period 1|Physician Decision|0|||
156888109|NCT03400956|566349467|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
156888110|NCT03400956|566349468|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
156888111|NCT03400956|566349469|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
156888112|NCT03400956|566349467|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
156888113|NCT03400956|566349468|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
156888114|NCT03400956|566349469|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
156888115|NCT03400956|566349467|FG000|Post-treatment Period 1|Other|4|||
156888116|NCT03400956|566349468|FG001|Post-treatment Period 1|Other|3|||
156888117|NCT03400956|566349469|FG002|Post-treatment Period 1|Other|4|||
156888118|NCT03400956|566349467|FG000|Treatment Period 2|Adverse Event|2|||
156888119|NCT03400956|566349468|FG001|Treatment Period 2|Adverse Event|1|||
156888120|NCT03400956|566349469|FG002|Treatment Period 2|Adverse Event|1|||
156888121|NCT03400956|566349467|FG000|Treatment Period 2|Lost to Follow-up|1|||
156888122|NCT03400956|566349468|FG001|Treatment Period 2|Lost to Follow-up|1|||
156888123|NCT03400956|566349469|FG002|Treatment Period 2|Lost to Follow-up|0|||
157155171|NCT00772967|567312894|FG005|Crossover Treatment 3|Adverse Event|0|||
157155172|NCT00231062|567312895|FG000|Overall Study|Physician Decision|6|||
157155173|NCT00803244|567312896|FG000|Overall Study|Adverse Event|1|||
157155174|NCT00803244|567312897|FG001|Overall Study|Adverse Event|2|||
156888124|NCT03400956|566349467|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156846500|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
156846501|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
156846502|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
156888125|NCT03400956|566349468|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156888126|NCT03400956|566349469|FG002|Treatment Period 2|Withdrawal by Subject|3|||
156888127|NCT03400956|566349467|FG000|Treatment Period 2|Other|1|||
156888128|NCT03400956|566349468|FG001|Treatment Period 2|Other|1|||
156888129|NCT03400956|566349469|FG002|Treatment Period 2|Other|0|||
157155175|NCT00803244|567312896|FG000|Overall Study|Withdrawal by Subject|2|||
156846503|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
156846504|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156846505|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
156846506|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
156846507|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
156846508|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
156846509|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156846510|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
156846511|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
156846512|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
156846513|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
156846514|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
156846515|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
156846516|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156846517|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
156846518|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
156846519|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
156846520|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
156846521|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
156846522|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
156846523|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
156846524|NCT01173601|566191575|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846525|NCT01173601|566191576|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846526|NCT01173601|566191577|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
156846527|NCT01173601|566191578|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
156846528|NCT01173601|566191579|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
156846529|NCT01980095|566191580|FG000|Overall Study|Lost to Follow-up|6|||
156846530|NCT01980095|566191581|FG001|Overall Study|Lost to Follow-up|7|||
156846531|NCT01980095|566191580|FG000|Overall Study|Withdrawal by Subject|2|||
156846532|NCT01980095|566191581|FG001|Overall Study|Withdrawal by Subject|3|||
156846533|NCT01980095|566191580|FG000|Overall Study|Poor compliance|5|||
156846534|NCT01980095|566191581|FG001|Overall Study|Poor compliance|0|||
156846535|NCT01980095|566191580|FG000|Overall Study|Safety issue|0|||
156846536|NCT01980095|566191581|FG001|Overall Study|Safety issue|1|||
156846537|NCT01980095|566191580|FG000|Overall Study|Study drug discontinued|1|||
156846538|NCT01980095|566191581|FG001|Overall Study|Study drug discontinued|0|||
156846539|NCT01980095|566191580|FG000|Overall Study|Randomized by mistake|1|||
156846540|NCT01980095|566191581|FG001|Overall Study|Randomized by mistake|0|||
156846541|NCT01449006|566191583|FG000|Overall Study|Lost to Follow-up|1|||
156846542|NCT01449006|566191584|FG001|Overall Study|Lost to Follow-up|0|||
156846543|NCT01449006|566191583|FG000|Overall Study|Withdrawal by Subject|1|||
156846544|NCT01449006|566191584|FG001|Overall Study|Withdrawal by Subject|0|||
156846545|NCT01449006|566191583|FG000|Overall Study|Protocol Violation|1|||
156846546|NCT01449006|566191584|FG001|Overall Study|Protocol Violation|0|||
156846547|NCT01746368|566191586|FG000|Overall Study|Lost to Follow-up|2|||
156846548|NCT01746368|566191587|FG001|Overall Study|Lost to Follow-up|0|||
156846549|NCT01746368|566191586|FG000|Overall Study|Withdrawal by Subject|0|||
156846550|NCT01746368|566191587|FG001|Overall Study|Withdrawal by Subject|1|||
156846551|NCT05636852|566191588|FG000|Overall Study|Withdrawal by Subject|1|||
156846552|NCT05636852|566191588|FG000|Overall Study|Other than specified|1|||
156846553|NCT02221674|566191591|FG000|Overall Study|Lost to Follow-up|1|||
156846554|NCT02221674|566191592|FG001|Overall Study|Lost to Follow-up|0|||
157155176|NCT00803244|567312897|FG001|Overall Study|Withdrawal by Subject|3|||
156846555|NCT02221674|566191593|FG002|Overall Study|Lost to Follow-up|0|||
156846556|NCT04390880|566191594|FG000|Overall Study|Withdrawal by Subject|1|||
156846557|NCT02557542|566191595|FG000|Overall Study|Poor recruitment|3|||
156846558|NCT02557542|566191596|FG001|Overall Study|Poor recruitment|0|||
156846559|NCT04698993|566191601|FG000|Overall Study|PCR results not accessible|2|||
156846560|NCT04698993|566191602|FG001|Overall Study|PCR results not accessible|7|||
156846561|NCT04698993|566191601|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
156846562|NCT04698993|566191602|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
156846563|NCT00958165|566191603|FG000|Overall Study|Lost to Follow-up|5|||
157155177|NCT00803244|567312896|FG000|Overall Study|Any other reason not above-mentioned|4|||
156846564|NCT00958165|566191603|FG000|Overall Study|Not eligible|9|||
156846565|NCT01371734|566191604|FG000|Overall Study|Other|2|||
156846566|NCT01371734|566191605|FG001|Overall Study|Other|1|||
156846567|NCT01371734|566191606|FG002|Overall Study|Other|2|||
156846568|NCT01371734|566191604|FG000|Overall Study|Withdrawal by Subject|3|||
156846569|NCT01371734|566191605|FG001|Overall Study|Withdrawal by Subject|4|||
156846570|NCT01371734|566191606|FG002|Overall Study|Withdrawal by Subject|9|||
156846571|NCT01371734|566191604|FG000|Overall Study|Lost to Follow-up|5|||
156846572|NCT01371734|566191605|FG001|Overall Study|Lost to Follow-up|3|||
156846573|NCT01371734|566191606|FG002|Overall Study|Lost to Follow-up|1|||
156846574|NCT01371734|566191604|FG000|Overall Study|Protocol Violation|3|||
156846575|NCT01371734|566191605|FG001|Overall Study|Protocol Violation|1|||
156846576|NCT01371734|566191606|FG002|Overall Study|Protocol Violation|2|||
156846577|NCT01371734|566191604|FG000|Overall Study|Adverse Event|8|||
156846578|NCT01371734|566191605|FG001|Overall Study|Adverse Event|8|||
156846579|NCT01371734|566191606|FG002|Overall Study|Adverse Event|3|||
156846580|NCT01371734|566191604|FG000|Overall Study|Lack of Efficacy|2|||
156846581|NCT01371734|566191605|FG001|Overall Study|Lack of Efficacy|2|||
156846582|NCT01371734|566191606|FG002|Overall Study|Lack of Efficacy|0|||
156846583|NCT00206440|566191607|FG000|Overall Study|Protocol Violation|1|||
156846584|NCT00206440|566191608|FG001|Overall Study|Protocol Violation|2|||
156846585|NCT00206440|566191607|FG000|Overall Study|Adverse Event|4|||
156846586|NCT00206440|566191608|FG001|Overall Study|Adverse Event|2|||
156846587|NCT01298765|566191609|FG000|Titration Period|Adverse Event|26|||
156846588|NCT01298765|566191609|FG000|Titration Period|Death|1|||
156846589|NCT01298765|566191609|FG000|Titration Period|Lack of Efficacy|21|||
156846590|NCT01298765|566191609|FG000|Titration Period|Lost to Follow-up|9|||
156846591|NCT01298765|566191609|FG000|Titration Period|Physician Decision|1|||
156846592|NCT01298765|566191609|FG000|Titration Period|Withdrawal by Subject|10|||
156846593|NCT01298765|566191609|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
156846594|NCT01298765|566191609|FG000|Long-Term Treatment Period|Adverse Event|19|||
156846595|NCT01298765|566191609|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
156846596|NCT01298765|566191609|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
156846597|NCT01298765|566191609|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
156846598|NCT01298765|566191609|FG000|Long-Term Treatment Period|Physician Decision|1|||
156846599|NCT01298765|566191609|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
156846600|NCT03565237|566191613|FG000|Overall Study|Non-compliance of Investigational Product|1|||
156846601|NCT03565237|566191613|FG000|Overall Study|Physician Decision|1|||
156846602|NCT01140061|566191616|FG000|Part I|Adverse Event|1|||
156846603|NCT01140061|566191617|FG001|Part I|Adverse Event|0|||
156846604|NCT01140061|566191618|FG002|Part I|Adverse Event|0|||
156846605|NCT01140061|566191619|FG003|Part I|Adverse Event|0|||
156846606|NCT01140061|566191620|FG004|Part I|Adverse Event|0|||
156846607|NCT01140061|566191621|FG005|Part I|Adverse Event|0|||
156846608|NCT01140061|566191622|FG006|Part I|Adverse Event|0|||
156846609|NCT01140061|566191623|FG007|Part I|Adverse Event|0|||
156846610|NCT01140061|566191624|FG008|Part I|Adverse Event|0|||
156846611|NCT01140061|566191625|FG009|Part I|Adverse Event|0|||
156846612|NCT01140061|566191616|FG000|Extension|Laboratory Adverse Event|0|||
156846613|NCT01140061|566191617|FG001|Extension|Laboratory Adverse Event|0|||
156846614|NCT01140061|566191618|FG002|Extension|Laboratory Adverse Event|0|||
156846615|NCT01140061|566191619|FG003|Extension|Laboratory Adverse Event|0|||
156846616|NCT01140061|566191620|FG004|Extension|Laboratory Adverse Event|0|||
156846617|NCT01140061|566191621|FG005|Extension|Laboratory Adverse Event|0|||
156846618|NCT01140061|566191622|FG006|Extension|Laboratory Adverse Event|0|||
156846619|NCT01140061|566191623|FG007|Extension|Laboratory Adverse Event|0|||
156846620|NCT01140061|566191624|FG008|Extension|Laboratory Adverse Event|0|||
156846621|NCT01140061|566191625|FG009|Extension|Laboratory Adverse Event|1|||
156846622|NCT00428389|566191627|FG000|Core Phase|Adverse Event|6|||
156846623|NCT00428389|566191628|FG001|Core Phase|Adverse Event|4|||
156846624|NCT00428389|566191627|FG000|Core Phase|Lack of Efficacy|2|||
156846625|NCT00428389|566191628|FG001|Core Phase|Lack of Efficacy|0|||
156846626|NCT00428389|566191627|FG000|Core Phase|Abnormal test procedure result(s)|0|||
156846627|NCT00428389|566191628|FG001|Core Phase|Abnormal test procedure result(s)|1|||
156846628|NCT00428389|566191627|FG000|Core Phase|Withdrawal by Subject|3|||
156846629|NCT00428389|566191628|FG001|Core Phase|Withdrawal by Subject|4|||
156888130|NCT03400956|566349467|FG000|Follow-up Period|Withdrawal by Subject|0|||
156888131|NCT03400956|566349468|FG001|Follow-up Period|Withdrawal by Subject|0|||
156888132|NCT03400956|566349469|FG002|Follow-up Period|Withdrawal by Subject|1|||
156888133|NCT03400956|566349467|FG000|Follow-up Period|Other|0|||
156846630|NCT00428389|566191627|FG000|Core Phase|Protocol deviation|0|||
156846631|NCT00428389|566191628|FG001|Core Phase|Protocol deviation|2|||
157155178|NCT00803244|567312897|FG001|Overall Study|Any other reason not above-mentioned|10|||
156846632|NCT00428389|566191627|FG000|Extension Phase|Adverse Event|17|||
156846633|NCT00428389|566191628|FG001|Extension Phase|Adverse Event|11|||
157155179|NCT03321929|567312899|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
156846634|NCT00428389|566191627|FG000|Extension Phase|Lack of Efficacy|4|||
156846635|NCT00428389|566191628|FG001|Extension Phase|Lack of Efficacy|3|||
156846636|NCT00428389|566191627|FG000|Extension Phase|Withdrawal by Subject|6|||
156846637|NCT00428389|566191628|FG001|Extension Phase|Withdrawal by Subject|6|||
156846638|NCT00428389|566191627|FG000|Extension Phase|Lost to Follow-up|0|||
156846639|NCT00428389|566191628|FG001|Extension Phase|Lost to Follow-up|3|||
156846640|NCT00428389|566191627|FG000|Extension Phase|Death|1|||
156846641|NCT00428389|566191628|FG001|Extension Phase|Death|0|||
156846642|NCT00428389|566191627|FG000|Extension Phase|Protocol Violation|3|||
156888134|NCT03400956|566349468|FG001|Follow-up Period|Other|0|||
156846643|NCT00428389|566191628|FG001|Extension Phase|Protocol Violation|2|||
156846644|NCT00428389|566191627|FG000|Extension Phase|Administrative problems|1|||
156846645|NCT00428389|566191628|FG001|Extension Phase|Administrative problems|1|||
156846646|NCT02669121|566191629|FG000|Overall Study|Adverse Event|4|||
156846647|NCT02669121|566191630|FG001|Overall Study|Adverse Event|5|||
156846648|NCT02669121|566191629|FG000|Overall Study|Lost to Follow-up|15|||
156846649|NCT02669121|566191630|FG001|Overall Study|Lost to Follow-up|27|||
156846650|NCT02669121|566191629|FG000|Overall Study|Withdrawal by Subject|132|||
156846651|NCT02669121|566191630|FG001|Overall Study|Withdrawal by Subject|140|||
156846652|NCT02669121|566191629|FG000|Overall Study|Pregnancy|0|||
156846653|NCT02669121|566191630|FG001|Overall Study|Pregnancy|1|||
156846654|NCT02669121|566191629|FG000|Overall Study|Discharged from US Military Active Service|117|||
156846655|NCT02669121|566191630|FG001|Overall Study|Discharged from US Military Active Service|91|||
156846656|NCT02669121|566191629|FG000|Overall Study|Reason not Specified|22|||
156846657|NCT02669121|566191630|FG001|Overall Study|Reason not Specified|18|||
156846658|NCT02708355|566191631|FG000|Overall Study|Adverse Event|1|||
156846659|NCT02708355|566191632|FG001|Overall Study|Adverse Event|0|||
156846660|NCT02708355|566191633|FG002|Overall Study|Adverse Event|0|||
156846661|NCT04384523|566191634|FG000|Overall Study|Lost to Follow-up|0|||
156846662|NCT04384523|566191635|FG001|Overall Study|Lost to Follow-up|0|||
156846663|NCT04384523|566191636|FG002|Overall Study|Lost to Follow-up|0|||
156846664|NCT04384523|566191637|FG003|Overall Study|Lost to Follow-up|0|||
156846665|NCT04384523|566191638|FG004|Overall Study|Lost to Follow-up|0|||
156846666|NCT04384523|566191639|FG005|Overall Study|Lost to Follow-up|1|||
156846667|NCT04384523|566191634|FG000|Overall Study|Protocol Violation|0|||
156846668|NCT04384523|566191635|FG001|Overall Study|Protocol Violation|1|||
156846669|NCT04384523|566191636|FG002|Overall Study|Protocol Violation|0|||
156846670|NCT04384523|566191637|FG003|Overall Study|Protocol Violation|0|||
156846671|NCT04384523|566191638|FG004|Overall Study|Protocol Violation|0|||
156846672|NCT04384523|566191639|FG005|Overall Study|Protocol Violation|0|||
156846673|NCT04384523|566191634|FG000|Overall Study|Withdrawal by Subject|1|||
156846674|NCT04384523|566191635|FG001|Overall Study|Withdrawal by Subject|0|||
156846675|NCT04384523|566191636|FG002|Overall Study|Withdrawal by Subject|0|||
156846676|NCT04384523|566191637|FG003|Overall Study|Withdrawal by Subject|0|||
156846677|NCT04384523|566191638|FG004|Overall Study|Withdrawal by Subject|0|||
156846678|NCT04384523|566191639|FG005|Overall Study|Withdrawal by Subject|0|||
156846679|NCT03216746|566191640|FG000|Overall Study|Lost to Follow-up|6|||
156846680|NCT03216746|566191641|FG001|Overall Study|Lost to Follow-up|8|||
156846681|NCT03216746|566191642|FG002|Overall Study|Lost to Follow-up|5|||
156846682|NCT03216746|566191643|FG003|Overall Study|Lost to Follow-up|6|||
156846683|NCT01320202|566191644|FG000|Overall Study|Adverse Event|5|||
156846684|NCT01320202|566191645|FG001|Overall Study|Adverse Event|5|||
156846685|NCT01320202|566191644|FG000|Overall Study|Death|5|||
156846686|NCT01320202|566191645|FG001|Overall Study|Death|3|||
156888135|NCT03400956|566349469|FG002|Follow-up Period|Other|1|||
156888136|NCT02048241|566349471|FG000|Overall Study|Withdrawal by Subject|0|||
156888137|NCT02048241|566349472|FG001|Overall Study|Withdrawal by Subject|1|||
156888138|NCT00534313|566349473|FG000|Short-term Period|Adverse Event|1|||
157155180|NCT00616239|567312900|FG000|Overall Study|Withdrawal by Subject|2|||
157155181|NCT02873715|567312901|FG000|Overall Study|Lost to Follow-up|84|||
157155182|NCT02873715|567312902|FG001|Overall Study|Lost to Follow-up|94|||
157155183|NCT02873715|567312901|FG000|Overall Study|Withdrawal by Subject|7|||
157155184|NCT02873715|567312902|FG001|Overall Study|Withdrawal by Subject|26|||
157155185|NCT02144220|567312905|FG000|Overall Study|technology incompatibility|9|||
157155186|NCT02144220|567312905|FG000|Overall Study|Lack of Efficacy|4|||
157155187|NCT02144220|567312905|FG000|Overall Study|Physician Decision|3|||
157155188|NCT02144220|567312905|FG000|Overall Study|Withdrawal by Subject|2|||
157155189|NCT02144220|567312905|FG000|Overall Study|Protocol Violation|1|||
157155190|NCT01558089|567312906|FG000|Overall Study|Adverse Event|1|||
157155191|NCT01558089|567312906|FG000|Overall Study|Lack of Efficacy|1|||
157155192|NCT01558089|567312906|FG000|Overall Study|Lost to Follow-up|5|||
157155193|NCT01558089|567312906|FG000|Overall Study|Withdrawal by Subject|6|||
157155194|NCT00590681|567312907|FG000|Overall Study|Withdrawal by Subject|7|||
157155195|NCT00590681|567312907|FG000|Overall Study|Adverse Event|8|||
157155196|NCT00590681|567312907|FG000|Overall Study|Death|3|||
157155197|NCT00590681|567312907|FG000|Overall Study|Lost to Follow-up|1|||
157155198|NCT00590681|567312907|FG000|Overall Study|disease progression|1|||
157155199|NCT00443430|567312910|FG000|Overall Study|Lack of Efficacy|3|||
157155200|NCT00443430|567312911|FG001|Overall Study|Lack of Efficacy|3|||
157155201|NCT00443430|567312910|FG000|Overall Study|Adverse Event|1|||
157155202|NCT00443430|567312911|FG001|Overall Study|Adverse Event|1|||
156846687|NCT01320202|566191644|FG000|Overall Study|Lost to Follow-up|1|||
156846688|NCT01320202|566191645|FG001|Overall Study|Lost to Follow-up|0|||
156846689|NCT01320202|566191644|FG000|Overall Study|Physician Decision|3|||
156846690|NCT01320202|566191645|FG001|Overall Study|Physician Decision|1|||
156846691|NCT01320202|566191644|FG000|Overall Study|Protocol Violation|2|||
156846692|NCT01320202|566191645|FG001|Overall Study|Protocol Violation|1|||
156846693|NCT01320202|566191644|FG000|Overall Study|Withdrawal by Subject|10|||
157155203|NCT00053846|567312912|FG000|Overall Study|Changed mind|8|||
156846694|NCT01320202|566191645|FG001|Overall Study|Withdrawal by Subject|3|||
156846695|NCT01320202|566191644|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
156846696|NCT01320202|566191645|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
156846697|NCT01320202|566191644|FG000|Overall Study|kidney transplant|1|||
156846698|NCT01320202|566191645|FG001|Overall Study|kidney transplant|2|||
156846699|NCT01320202|566191644|FG000|Overall Study|blood transfusion|1|||
156846700|NCT01320202|566191645|FG001|Overall Study|blood transfusion|7|||
156846701|NCT01320202|566191644|FG000|Overall Study|moved/changed dialysis|5|||
156846702|NCT01320202|566191645|FG001|Overall Study|moved/changed dialysis|2|||
156846703|NCT01320202|566191644|FG000|Overall Study|sponsor request|2|||
156846704|NCT01320202|566191645|FG001|Overall Study|sponsor request|0|||
156846705|NCT01320202|566191644|FG000|Overall Study|ineligible|3|||
156846706|NCT01320202|566191645|FG001|Overall Study|ineligible|0|||
156846707|NCT01320202|566191644|FG000|Overall Study|regained renal function|1|||
156846708|NCT01320202|566191645|FG001|Overall Study|regained renal function|0|||
156846709|NCT04090242|566191646|FG000|Overall Study|Withdrawal by Subject|1|||
156846710|NCT04090242|566191647|FG001|Overall Study|Withdrawal by Subject|0|||
156846711|NCT02687581|566191648|FG000|Overall Study|Withdrawal by Subject|1|||
156846712|NCT02687581|566191649|FG001|Overall Study|Withdrawal by Subject|0|||
156846713|NCT02687581|566191650|FG002|Overall Study|Withdrawal by Subject|0|||
156846714|NCT02687581|566191651|FG003|Overall Study|Withdrawal by Subject|1|||
156846715|NCT02687581|566191648|FG000|Overall Study|Lost to Follow-up|2|||
156846716|NCT02687581|566191649|FG001|Overall Study|Lost to Follow-up|2|||
156846717|NCT02687581|566191650|FG002|Overall Study|Lost to Follow-up|0|||
156846718|NCT02687581|566191651|FG003|Overall Study|Lost to Follow-up|0|||
156846719|NCT02687581|566191648|FG000|Overall Study|the device is too small for the patient.|1|||
156846720|NCT02687581|566191649|FG001|Overall Study|the device is too small for the patient.|0|||
156846721|NCT02687581|566191650|FG002|Overall Study|the device is too small for the patient.|0|||
156846722|NCT02687581|566191651|FG003|Overall Study|the device is too small for the patient.|0|||
156846723|NCT00835341|566191652|FG000|Overall Study|Lost to Follow-up|3|||
156846724|NCT00835341|566191653|FG001|Overall Study|Lost to Follow-up|12|||
156846725|NCT02513472|566191655|FG000|Overall Study|Radiological Disease Progression|45|||
156846726|NCT02513472|566191656|FG001|Overall Study|Radiological Disease Progression|57|||
156846727|NCT02513472|566191655|FG000|Overall Study|Clinical Disease Progression|5|||
156846728|NCT02513472|566191656|FG001|Overall Study|Clinical Disease Progression|13|||
156846729|NCT02513472|566191655|FG000|Overall Study|Adverse Event|8|||
156846730|NCT02513472|566191656|FG001|Overall Study|Adverse Event|11|||
156846731|NCT02513472|566191655|FG000|Overall Study|Withdrawal by Subject|0|||
156846732|NCT02513472|566191656|FG001|Overall Study|Withdrawal by Subject|4|||
156846733|NCT02513472|566191655|FG000|Overall Study|Subject Choice|2|||
156846734|NCT02513472|566191656|FG001|Overall Study|Subject Choice|7|||
156846735|NCT02513472|566191655|FG000|Overall Study|Treatment Completed as per Protocol|3|||
156846736|NCT02513472|566191656|FG001|Overall Study|Treatment Completed as per Protocol|3|||
156846737|NCT02513472|566191655|FG000|Overall Study|Other|3|||
156846738|NCT02513472|566191656|FG001|Overall Study|Other|6|||
156846739|NCT01098305|566191657|FG000|Overall Study|Lost to Follow-up|31|||
156846740|NCT01098305|566191658|FG001|Overall Study|Lost to Follow-up|33|||
157155204|NCT00053846|567312913|FG001|Overall Study|Changed mind|13|||
157155205|NCT00053846|567312912|FG000|Overall Study|Became too ill|8|||
157155206|NCT00053846|567312913|FG001|Overall Study|Became too ill|7|||
157155207|NCT00053846|567312912|FG000|Overall Study|Expired|5|||
157155208|NCT00053846|567312913|FG001|Overall Study|Expired|0|||
157155209|NCT00053846|567312912|FG000|Overall Study|Became ineligible|3|||
157155210|NCT00053846|567312913|FG001|Overall Study|Became ineligible|1|||
157155211|NCT00053846|567312912|FG000|Overall Study|Did not return data|1|||
157155212|NCT00053846|567312913|FG001|Overall Study|Did not return data|2|||
157155213|NCT00053846|567312912|FG000|Overall Study|Quit due to side effects|1|||
157155214|NCT00053846|567312913|FG001|Overall Study|Quit due to side effects|3|||
157155215|NCT00053846|567312912|FG000|Overall Study|Pills too large|0|||
157155216|NCT00053846|567312913|FG001|Overall Study|Pills too large|1|||
157155217|NCT00592501|567312914|FG000|Overall Study|Withdrawal by Subject|1|||
157155218|NCT00592501|567312914|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
157155219|NCT00933335|567312915|FG000|Overall Study|Lost to Follow-up|1|||
157155220|NCT00933335|567312916|FG001|Overall Study|Lost to Follow-up|3|||
157155221|NCT00933335|567312915|FG000|Overall Study|Withdrawal by Subject|0|||
157155222|NCT00933335|567312916|FG001|Overall Study|Withdrawal by Subject|1|||
157155223|NCT00933335|567312915|FG000|Overall Study|Progressive Disease|0|||
157155224|NCT00933335|567312916|FG001|Overall Study|Progressive Disease|11|||
157155225|NCT00933335|567312915|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
157155226|NCT00933335|567312916|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
157155227|NCT00933335|567312915|FG000|Overall Study|Co-morbid Illness|1|||
156846741|NCT01711645|566191662|FG000|Overall Study|Withdrawal by Subject|8|||
156846742|NCT01711645|566191662|FG000|Overall Study|Lost to Follow-up|6|||
156846743|NCT01711645|566191662|FG000|Overall Study|Physician Decision|5|||
157025257|NCT04963270|566847933|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
157155228|NCT00933335|567312916|FG001|Overall Study|Co-morbid Illness|0|||
156846744|NCT01746173|566191667|FG000|Overall Study|Disease Progression|2|||
156846745|NCT00172042|566191668|FG000|Overall Study|Adverse Event|27|||
156846746|NCT00172042|566191669|FG001|Overall Study|Adverse Event|13|||
156846747|NCT00172042|566191668|FG000|Overall Study|Abnormal laboratory value(s)|5|||
156846748|NCT00172042|566191669|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156846749|NCT00172042|566191668|FG000|Overall Study|Abnormal test procedure(s)|0|||
156846750|NCT00172042|566191669|FG001|Overall Study|Abnormal test procedure(s)|3|||
156846751|NCT00172042|566191668|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
156846752|NCT00172042|566191669|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
156846753|NCT00172042|566191668|FG000|Overall Study|Patient no longer requires study drug|10|||
156846754|NCT00172042|566191669|FG001|Overall Study|Patient no longer requires study drug|8|||
156888139|NCT00534313|566349474|FG001|Short-term Period|Adverse Event|2|||
156888140|NCT00534313|566349475|FG002|Short-term Period|Adverse Event|1|||
156888141|NCT00534313|566349476|FG003|Short-term Period|Adverse Event|3|||
156888142|NCT00534313|566349473|FG000|Short-term Period|Lack of Efficacy|3|||
156888143|NCT00534313|566349474|FG001|Short-term Period|Lack of Efficacy|4|||
156888144|NCT00534313|566349475|FG002|Short-term Period|Lack of Efficacy|0|||
156888145|NCT00534313|566349476|FG003|Short-term Period|Lack of Efficacy|3|||
157025258|NCT04963270|566847934|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
157025259|NCT04963270|566847935|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
157025260|NCT04963270|566847936|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
157025261|NCT03560609|566847941|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
157025262|NCT03560609|566847942|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
157025263|NCT02268253|566847945|FG000|Stage 1|Withdrawal by Subject|1|||
157025264|NCT02268253|566847946|FG001|Stage 1|Withdrawal by Subject|0|||
157025265|NCT02268253|566847947|FG002|Stage 1|Withdrawal by Subject|0|||
157025266|NCT02268253|566847948|FG003|Stage 1|Withdrawal by Subject|0|||
157025267|NCT02268253|566847949|FG004|Stage 1|Withdrawal by Subject|0|||
157025268|NCT02268253|566847950|FG005|Stage 1|Withdrawal by Subject|0|||
157025269|NCT02268253|566847951|FG006|Stage 1|Withdrawal by Subject|0|||
157025270|NCT02268253|566847945|FG000|Stage 1|Death|0|||
157025271|NCT02268253|566847946|FG001|Stage 1|Death|2|||
157025272|NCT02268253|566847947|FG002|Stage 1|Death|2|||
157025273|NCT02268253|566847948|FG003|Stage 1|Death|2|||
157025274|NCT02268253|566847949|FG004|Stage 1|Death|1|||
157025275|NCT02268253|566847950|FG005|Stage 1|Death|1|||
157025276|NCT02268253|566847951|FG006|Stage 1|Death|0|||
157025277|NCT02268253|566847945|FG000|Stage 2|Disease Recurrence/ Progression|0|||
157025278|NCT02268253|566847946|FG001|Stage 2|Disease Recurrence/ Progression|0|||
157025279|NCT02268253|566847947|FG002|Stage 2|Disease Recurrence/ Progression|1|||
157025280|NCT02268253|566847948|FG003|Stage 2|Disease Recurrence/ Progression|0|||
157025281|NCT02268253|566847949|FG004|Stage 2|Disease Recurrence/ Progression|0|||
157025282|NCT02268253|566847950|FG005|Stage 2|Disease Recurrence/ Progression|0|||
157025283|NCT02268253|566847951|FG006|Stage 2|Disease Recurrence/ Progression|0|||
157025284|NCT02268253|566847945|FG000|Stage 2|Withdrawal by Subject|0|||
157025285|NCT02268253|566847946|FG001|Stage 2|Withdrawal by Subject|0|||
157025286|NCT02268253|566847947|FG002|Stage 2|Withdrawal by Subject|2|||
157025287|NCT02268253|566847948|FG003|Stage 2|Withdrawal by Subject|0|||
157025288|NCT02268253|566847949|FG004|Stage 2|Withdrawal by Subject|0|||
157025289|NCT02268253|566847950|FG005|Stage 2|Withdrawal by Subject|2|||
157025290|NCT02268253|566847951|FG006|Stage 2|Withdrawal by Subject|0|||
157025291|NCT02268253|566847945|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
157025292|NCT02268253|566847946|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
157025293|NCT02268253|566847947|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
157025294|NCT02268253|566847948|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
157025295|NCT02268253|566847949|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
156888146|NCT00534313|566349473|FG000|Short-term Period|Participant not meeting study criteria|0|||
156888147|NCT00534313|566349474|FG001|Short-term Period|Participant not meeting study criteria|0|||
156888148|NCT00534313|566349475|FG002|Short-term Period|Participant not meeting study criteria|0|||
156888149|NCT00534313|566349476|FG003|Short-term Period|Participant not meeting study criteria|1|||
156888150|NCT00534313|566349473|FG000|Short-term Period|Participant withdrew consent|2|||
157025296|NCT02268253|566847950|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
157025297|NCT02268253|566847951|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
157025298|NCT02268253|566847945|FG000|Stage 2|Death|0|||
157025299|NCT02268253|566847946|FG001|Stage 2|Death|0|||
157155229|NCT02229864|567312917|FG000|Overall Study|Death|2|||
157155230|NCT02229864|567312917|FG000|Overall Study|Lost to Follow-up|1|||
157025300|NCT02268253|566847947|FG002|Stage 2|Death|19|||
156888151|NCT00534313|566349474|FG001|Short-term Period|Participant withdrew consent|0|||
156846755|NCT00172042|566191668|FG000|Overall Study|Protocol Violation|8|||
156846756|NCT00172042|566191669|FG001|Overall Study|Protocol Violation|7|||
156888152|NCT00534313|566349475|FG002|Short-term Period|Participant withdrew consent|0|||
157025301|NCT02268253|566847948|FG003|Stage 2|Death|0|||
157025302|NCT02268253|566847949|FG004|Stage 2|Death|0|||
157025303|NCT02268253|566847950|FG005|Stage 2|Death|20|||
157025304|NCT02268253|566847951|FG006|Stage 2|Death|1|||
156846757|NCT00172042|566191668|FG000|Overall Study|Withdrawal by Subject|37|||
156846758|NCT00172042|566191669|FG001|Overall Study|Withdrawal by Subject|25|||
156846759|NCT00172042|566191668|FG000|Overall Study|Lost to Follow-up|3|||
156846760|NCT00172042|566191669|FG001|Overall Study|Lost to Follow-up|5|||
156846761|NCT00172042|566191668|FG000|Overall Study|Administrative problems|13|||
156846762|NCT00172042|566191669|FG001|Overall Study|Administrative problems|10|||
156846763|NCT00172042|566191668|FG000|Overall Study|Death|42|||
156846764|NCT00172042|566191669|FG001|Overall Study|Death|42|||
156846765|NCT01278797|566191672|FG000|Period 1|Adverse Event|0|||
156846766|NCT01278797|566191673|FG001|Period 1|Adverse Event|1|||
156846767|NCT01278797|566191672|FG000|Period 1|Protocol Violation|1|||
156846768|NCT01278797|566191673|FG001|Period 1|Protocol Violation|0|||
156846769|NCT00588354|566191674|FG000|Baseline to 2 Weeks|Adverse Event|1|||
156846770|NCT00588354|566191675|FG001|Baseline to 2 Weeks|Adverse Event|0|||
156846771|NCT00588354|566191674|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
156846772|NCT00588354|566191675|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
156846773|NCT00588354|566191674|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
156846774|NCT00588354|566191675|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
156846775|NCT04522141|566191677|FG000|Overall Study|Withdrawal by Subject|1|||
156846776|NCT04522141|566191678|FG001|Overall Study|Withdrawal by Subject|0|||
156846777|NCT03052049|566191679|FG000|Overall Study|Withdrawal by Subject|2|||
156846778|NCT02328027|566191680|FG000|Overall Study|Withdrawal by Subject|0|||
156846779|NCT02328027|566191681|FG001|Overall Study|Withdrawal by Subject|1|||
156846780|NCT03304873|566191682|FG000|Overall Study|Lost to Follow-up|1|||
156846781|NCT03304873|566191683|FG001|Overall Study|Lost to Follow-up|8|||
156846782|NCT03319212|566191684|FG000|Overall Study|Discontinued as moving out of local area|0|||
156846783|NCT03319212|566191685|FG001|Overall Study|Discontinued as moving out of local area|1|||
156846784|NCT03319212|566191684|FG000|Overall Study|Adverse Event|2|||
156846785|NCT03319212|566191685|FG001|Overall Study|Adverse Event|2|||
156846786|NCT03319212|566191684|FG000|Overall Study|Withdrawal by Subject|0|||
156846787|NCT03319212|566191685|FG001|Overall Study|Withdrawal by Subject|1|||
156846788|NCT03319212|566191684|FG000|Overall Study|Lost to Follow-up|0|||
156846789|NCT03319212|566191685|FG001|Overall Study|Lost to Follow-up|1|||
156846790|NCT03319212|566191684|FG000|Overall Study|Physician Decision|1|||
157025305|NCT02268253|566847945|FG000|Stage 2|Lost to Follow-up|0|||
156846791|NCT03319212|566191685|FG001|Overall Study|Physician Decision|0|||
156846792|NCT00400569|566191689|FG000|Overall Study|Death|1|||
156846793|NCT00620113|566191690|FG000|Overall Study|Adverse Event|3|||
156846794|NCT00620113|566191691|FG001|Overall Study|Adverse Event|2|||
156846795|NCT00620113|566191692|FG002|Overall Study|Adverse Event|2|||
156846796|NCT00620113|566191693|FG003|Overall Study|Adverse Event|1|||
156846797|NCT00620113|566191690|FG000|Overall Study|Lack of Efficacy|2|||
156846798|NCT00620113|566191691|FG001|Overall Study|Lack of Efficacy|3|||
156846799|NCT00620113|566191692|FG002|Overall Study|Lack of Efficacy|0|||
156888153|NCT00534313|566349476|FG003|Short-term Period|Participant withdrew consent|2|||
156888154|NCT00534313|566349473|FG000|Short-term Period|Pregnancy|0|||
156888155|NCT00534313|566349474|FG001|Short-term Period|Pregnancy|0|||
156888156|NCT00534313|566349475|FG002|Short-term Period|Pregnancy|1|||
156888157|NCT00534313|566349476|FG003|Short-term Period|Pregnancy|0|||
156888158|NCT00534313|566349473|FG000|Long-term Period|Adverse Event|2|||
156888159|NCT00534313|566349474|FG001|Long-term Period|Adverse Event|1|||
156888160|NCT00534313|566349475|FG002|Long-term Period|Adverse Event|0|||
156888161|NCT00534313|566349476|FG003|Long-term Period|Adverse Event|1|||
156888162|NCT00534313|566349473|FG000|Long-term Period|Lack of Efficacy|14|||
156888163|NCT00534313|566349474|FG001|Long-term Period|Lack of Efficacy|10|||
156888164|NCT00534313|566349475|FG002|Long-term Period|Lack of Efficacy|14|||
156888165|NCT00534313|566349476|FG003|Long-term Period|Lack of Efficacy|12|||
156888166|NCT00534313|566349473|FG000|Long-term Period|Lost to Follow-up|1|||
156888167|NCT00534313|566349474|FG001|Long-term Period|Lost to Follow-up|2|||
156888168|NCT00534313|566349475|FG002|Long-term Period|Lost to Follow-up|0|||
156888169|NCT00534313|566349476|FG003|Long-term Period|Lost to Follow-up|0|||
156888170|NCT00534313|566349473|FG000|Long-term Period|Withdrawal by Subject|2|||
156888171|NCT00534313|566349474|FG001|Long-term Period|Withdrawal by Subject|2|||
156888172|NCT00534313|566349475|FG002|Long-term Period|Withdrawal by Subject|0|||
156888173|NCT00534313|566349476|FG003|Long-term Period|Withdrawal by Subject|0|||
156888174|NCT00534313|566349473|FG000|Long-term Period|No longer meets study criteria|0|||
156888175|NCT00534313|566349474|FG001|Long-term Period|No longer meets study criteria|1|||
156888176|NCT00534313|566349475|FG002|Long-term Period|No longer meets study criteria|0|||
156888177|NCT00534313|566349476|FG003|Long-term Period|No longer meets study criteria|0|||
156888178|NCT00534313|566349473|FG000|Long-term Period|Poor compliance/noncompliance|0|||
156888179|NCT00534313|566349474|FG001|Long-term Period|Poor compliance/noncompliance|1|||
156888180|NCT00534313|566349475|FG002|Long-term Period|Poor compliance/noncompliance|1|||
156888181|NCT00534313|566349476|FG003|Long-term Period|Poor compliance/noncompliance|0|||
156888182|NCT00534313|566349473|FG000|Long-term Period|Administrative reason by sponsor|17|||
156888183|NCT00534313|566349474|FG001|Long-term Period|Administrative reason by sponsor|15|||
156888184|NCT00534313|566349475|FG002|Long-term Period|Administrative reason by sponsor|26|||
156846800|NCT00620113|566191693|FG003|Overall Study|Lack of Efficacy|2|||
157025306|NCT02268253|566847946|FG001|Stage 2|Lost to Follow-up|0|||
157025307|NCT02268253|566847947|FG002|Stage 2|Lost to Follow-up|0|||
157025308|NCT02268253|566847948|FG003|Stage 2|Lost to Follow-up|0|||
157025309|NCT02268253|566847949|FG004|Stage 2|Lost to Follow-up|0|||
157025310|NCT02268253|566847950|FG005|Stage 2|Lost to Follow-up|4|||
157025311|NCT02268253|566847951|FG006|Stage 2|Lost to Follow-up|0|||
156846801|NCT00620113|566191690|FG000|Overall Study|Physician Decision|1|||
156846802|NCT00620113|566191691|FG001|Overall Study|Physician Decision|0|||
156846803|NCT00620113|566191692|FG002|Overall Study|Physician Decision|0|||
156846804|NCT00620113|566191693|FG003|Overall Study|Physician Decision|2|||
156846805|NCT00620113|566191690|FG000|Overall Study|Protocol Violation|2|||
156846806|NCT00620113|566191691|FG001|Overall Study|Protocol Violation|1|||
156846807|NCT00620113|566191692|FG002|Overall Study|Protocol Violation|0|||
156846808|NCT00620113|566191693|FG003|Overall Study|Protocol Violation|0|||
156846809|NCT00620113|566191690|FG000|Overall Study|Withdrawal by Subject|5|||
156846810|NCT00620113|566191691|FG001|Overall Study|Withdrawal by Subject|1|||
156846811|NCT00620113|566191692|FG002|Overall Study|Withdrawal by Subject|3|||
156846812|NCT00620113|566191693|FG003|Overall Study|Withdrawal by Subject|5|||
156846813|NCT03193736|566191694|FG000|Overall Study|Death|2|||
156846814|NCT03193736|566191694|FG000|Overall Study|Withdrawal by Subject|1|||
156846815|NCT03193736|566191694|FG000|Overall Study|Lost to Follow-up|1|||
156846816|NCT03193736|566191694|FG000|Overall Study|implant not received|1|||
156846817|NCT00852241|566191695|FG000|Overall Study|Physician Decision|18|||
156846818|NCT03848949|566191696|FG000|Overall Study|Lost to Follow-up|5|||
156846819|NCT03848949|566191697|FG001|Overall Study|Lost to Follow-up|7|||
156846820|NCT00264537|566191715|FG000|Overall Study|Death|0|||
156846821|NCT00264537|566191716|FG001|Overall Study|Death|3|||
156846822|NCT00264537|566191717|FG002|Overall Study|Death|3|||
156846823|NCT00264537|566191718|FG003|Overall Study|Death|2|||
156846824|NCT00264537|566191715|FG000|Overall Study|Lost to Follow-up|3|||
156846825|NCT00264537|566191716|FG001|Overall Study|Lost to Follow-up|4|||
156846826|NCT00264537|566191717|FG002|Overall Study|Lost to Follow-up|7|||
156846827|NCT00264537|566191718|FG003|Overall Study|Lost to Follow-up|6|||
156846828|NCT00264537|566191715|FG000|Overall Study|Adverse Event|21|||
156846829|NCT00264537|566191716|FG001|Overall Study|Adverse Event|32|||
156846830|NCT00264537|566191717|FG002|Overall Study|Adverse Event|24|||
156846831|NCT00264537|566191718|FG003|Overall Study|Adverse Event|34|||
156846832|NCT00264537|566191715|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
156846833|NCT00264537|566191716|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156846834|NCT00264537|566191717|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
156846835|NCT00264537|566191718|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
156846836|NCT00264537|566191715|FG000|Overall Study|Other|21|||
156846837|NCT00264537|566191716|FG001|Overall Study|Other|11|||
156846838|NCT00264537|566191717|FG002|Overall Study|Other|10|||
156846839|NCT00264537|566191718|FG003|Overall Study|Other|11|||
156846840|NCT00264537|566191715|FG000|Overall Study|Not treated|0|||
156846841|NCT00264537|566191716|FG001|Overall Study|Not treated|2|||
156846842|NCT00264537|566191717|FG002|Overall Study|Not treated|1|||
156846843|NCT00264537|566191718|FG003|Overall Study|Not treated|0|||
156846844|NCT02476006|566191719|FG000|Overall Study|Death|4|||
156846845|NCT02476006|566191719|FG000|Overall Study|Lack of treatment efficacy|2|||
156846846|NCT02476006|566191719|FG000|Overall Study|Pregnancy|1|||
156846847|NCT02476006|566191719|FG000|Overall Study|Participant did not wish to continue|39|||
156846848|NCT02476006|566191719|FG000|Overall Study|Adverse Event|41|||
156846849|NCT02476006|566191719|FG000|Overall Study|Poor compliance to study protocol|3|||
156846850|NCT02476006|566191719|FG000|Overall Study|Sponsor decision|6|||
156846851|NCT02476006|566191719|FG000|Overall Study|Lost to Follow-up|5|||
156846852|NCT02476006|566191719|FG000|Overall Study|Physician Decision|5|||
156846853|NCT02476006|566191719|FG000|Overall Study|Study ended treatment not available|4|||
156846854|NCT02476006|566191719|FG000|Overall Study|Switched to commercial drug|4|||
156846855|NCT02476006|566191719|FG000|Overall Study|Excluded from study|1|||
157025312|NCT02268253|566847945|FG000|Stage 2|Transferred to Hospice|0|||
157025313|NCT02268253|566847946|FG001|Stage 2|Transferred to Hospice|0|||
156846856|NCT02476006|566191719|FG000|Overall Study|Protocol Violation|1|||
156846857|NCT02476006|566191719|FG000|Overall Study|Enrolled but not treated|4|||
156846858|NCT04306510|566192981|FG000|Overall Study|Voluntarily withdrawal|1|||
156846859|NCT04306510|566192981|FG000|Overall Study|Enrolled but Not Treated|1|||
156846860|NCT02751580|566192982|FG000|Overall Study|Lost to Follow-up|4|||
156846861|NCT02751580|566192982|FG000|Overall Study|Death|2|||
156846862|NCT03755882|566192989|FG000|Period 1|Protocol Violation|1|||
156846863|NCT03755882|566192990|FG001|Period 1|Protocol Violation|0|||
156846864|NCT03755882|566192989|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
157025314|NCT02268253|566847947|FG002|Stage 2|Transferred to Hospice|0|||
156846865|NCT03755882|566192990|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
156846866|NCT00108862|566192992|FG000|Overall Study|Death|31|||
156846867|NCT00108862|566192993|FG001|Overall Study|Death|37|||
156846868|NCT00108862|566192992|FG000|Overall Study|Withdrawal by Subject|10|||
157025315|NCT02268253|566847948|FG003|Stage 2|Transferred to Hospice|0|||
157025316|NCT02268253|566847949|FG004|Stage 2|Transferred to Hospice|0|||
156846869|NCT00108862|566192993|FG001|Overall Study|Withdrawal by Subject|6|||
157025317|NCT02268253|566847950|FG005|Stage 2|Transferred to Hospice|2|||
156846870|NCT00108862|566192992|FG000|Overall Study|Lost to Follow-up|27|||
156846871|NCT00108862|566192993|FG001|Overall Study|Lost to Follow-up|19|||
156846872|NCT01076036|566192995|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
156846873|NCT05292131|566192996|FG000|Overall Study|Lost to Follow-up|1|||
156846874|NCT05292131|566192997|FG001|Overall Study|Lost to Follow-up|1|||
156846875|NCT05292131|566192996|FG000|Overall Study|Withdrawal by Subject|0|||
156846876|NCT05292131|566192997|FG001|Overall Study|Withdrawal by Subject|1|||
156846877|NCT00195091|566192998|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
156846878|NCT01345188|566192999|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
156846879|NCT01345188|566192999|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
156846880|NCT00475709|566193005|FG000|Overall Study|Did not meet eligibility criteria|8|||
156846881|NCT00475709|566193005|FG000|Overall Study|Death|41|||
156846882|NCT00475709|566193005|FG000|Overall Study|Device Explant|6|||
156846883|NCT00475709|566193005|FG000|Overall Study|Lost to Follow-up|21|||
156846884|NCT04752358|566193006|FG000|Overall Study|Death|2|||
156846885|NCT04752358|566193007|FG001|Overall Study|Death|1|||
156888185|NCT00534313|566349476|FG003|Long-term Period|Administrative reason by sponsor|18|||
156888186|NCT00534313|566349473|FG000|Long-term Period|Other|1|||
156888187|NCT00534313|566349474|FG001|Long-term Period|Other|2|||
156888188|NCT00534313|566349475|FG002|Long-term Period|Other|2|||
157155231|NCT02650284|567312920|FG000|Overall Study|Lost to Follow-up|3|||
157155232|NCT02650284|567312921|FG001|Overall Study|Lost to Follow-up|3|||
157155233|NCT02650284|567312920|FG000|Overall Study|Consent incorrectly taken|0|||
157155234|NCT02650284|567312921|FG001|Overall Study|Consent incorrectly taken|1|||
157155235|NCT02275026|567312928|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
157155236|NCT02275026|567312928|FG000|Overall Study|Withdrawal by Subject|4|||
157155237|NCT02275026|567312928|FG000|Overall Study|Ineligible due to medical history|13|||
157155238|NCT02275026|567312928|FG000|Overall Study|MRI malfunction precluded testing|1|||
156846886|NCT00555672|566193010|FG000|Overall Study|Death|0|||
156846887|NCT00555672|566193011|FG001|Overall Study|Death|2|||
156846888|NCT00555672|566193010|FG000|Overall Study|Adverse Event|8|||
156846889|NCT00555672|566193011|FG001|Overall Study|Adverse Event|2|||
156888189|NCT00534313|566349476|FG003|Long-term Period|Other|2|||
156888190|NCT00402233|566349477|FG000|Overall Study|Adverse Event|1|||
156888191|NCT00402233|566349478|FG001|Overall Study|Adverse Event|7|||
156888192|NCT00402233|566349479|FG002|Overall Study|Adverse Event|9|||
156888193|NCT00402233|566349480|FG003|Overall Study|Adverse Event|9|||
156888194|NCT00402233|566349477|FG000|Overall Study|Protocol Violation|0|||
156888195|NCT00402233|566349478|FG001|Overall Study|Protocol Violation|1|||
156888196|NCT00402233|566349479|FG002|Overall Study|Protocol Violation|0|||
156888197|NCT00402233|566349480|FG003|Overall Study|Protocol Violation|0|||
156888198|NCT00402233|566349477|FG000|Overall Study|Withdrawal by Subject|2|||
156888199|NCT00402233|566349478|FG001|Overall Study|Withdrawal by Subject|1|||
156888200|NCT00402233|566349479|FG002|Overall Study|Withdrawal by Subject|2|||
156888201|NCT00402233|566349480|FG003|Overall Study|Withdrawal by Subject|2|||
156888202|NCT00402233|566349477|FG000|Overall Study|Worsening of disease under study|2|||
156888203|NCT00402233|566349478|FG001|Overall Study|Worsening of disease under study|0|||
156888204|NCT00402233|566349479|FG002|Overall Study|Worsening of disease under study|0|||
156888205|NCT00402233|566349480|FG003|Overall Study|Worsening of disease under study|0|||
156888206|NCT00402233|566349477|FG000|Overall Study|Worsening of other pre-existing disease|0|||
156888207|NCT00402233|566349478|FG001|Overall Study|Worsening of other pre-existing disease|1|||
156888208|NCT00402233|566349479|FG002|Overall Study|Worsening of other pre-existing disease|0|||
156888209|NCT00402233|566349480|FG003|Overall Study|Worsening of other pre-existing disease|0|||
156888210|NCT03007888|566349481|FG000|First Intervention (14 Days)|Adverse Event|1|||
156888211|NCT03007888|566349482|FG001|First Intervention (14 Days)|Adverse Event|0|||
156888212|NCT00927940|566349484|FG000|Overall Study|Death|1|||
156888213|NCT04658940|566349485|FG000|Overall Study|Withdrawal by Subject|1|||
156888214|NCT03579602|566349487|FG000|Overall Study|Subject unable to receive study drug|0|||
156888215|NCT03579602|566349488|FG001|Overall Study|Subject unable to receive study drug|2|||
156888216|NCT03579602|566349487|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
156888217|NCT03579602|566349488|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
156888218|NCT01870076|566349489|FG000|Overall Study|Withdrawal by Subject|1|||
156888219|NCT01870076|566349490|FG001|Overall Study|Withdrawal by Subject|0|||
157155239|NCT02275026|567312928|FG000|Overall Study|Ineligible after MRI findings|1|||
157155240|NCT02275026|567312928|FG000|Overall Study|Lost to Follow-up|2|||
157155241|NCT02275026|567312928|FG000|Overall Study|Scanner failure|1|||
156846890|NCT00555672|566193010|FG000|Overall Study|Objective progression or relapse|11|||
156846891|NCT00555672|566193011|FG001|Overall Study|Objective progression or relapse|5|||
156846892|NCT00555672|566193010|FG000|Overall Study|Other|3|||
157155242|NCT00374907|567312929|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
156846893|NCT00555672|566193011|FG001|Overall Study|Other|1|||
156888220|NCT01870076|566349491|FG002|Overall Study|Withdrawal by Subject|1|||
156846894|NCT00555672|566193010|FG000|Overall Study|Participant refused|2|||
156888221|NCT01870076|566349492|FG003|Overall Study|Withdrawal by Subject|0|||
156888222|NCT00492063|566349493|FG000|Overall Study|Death|0|||
156846895|NCT00555672|566193011|FG001|Overall Study|Participant refused|0|||
156846896|NCT04526145|566193012|FG000|Overall Study|Withdrawal by Subject|5|||
156846897|NCT03364738|566193017|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
156846898|NCT03364738|566193017|FG000|Overall Study|Withdrawal by Subject|1|||
156846899|NCT03364738|566193017|FG000|Overall Study|Adverse Event|1|||
156846900|NCT03245398|566193018|FG000|Overall Study|Travelled to another island|1|||
156846901|NCT03245398|566193019|FG001|Overall Study|Travelled to another island|0|||
156846902|NCT02576795|566193022|FG000|Overall Study|Lost to Follow-up|0|||
156846903|NCT02576795|566193023|FG001|Overall Study|Lost to Follow-up|0|||
156846904|NCT02576795|566193024|FG002|Overall Study|Lost to Follow-up|1|||
156846905|NCT02576795|566193025|FG003|Overall Study|Lost to Follow-up|0|||
156846906|NCT01702246|566193026|FG000|Overall Study|Lost to Follow-up|2|||
156846907|NCT01702246|566193026|FG000|Overall Study|Withdrawal by Subject|2|||
156846908|NCT01702246|566193026|FG000|Overall Study|Physician Decision|1|||
156846909|NCT01518374|566193027|FG000|Overall Study|Withdrawal by Subject|2|||
156846910|NCT01518374|566193027|FG000|Overall Study|Protocol Violation|3|||
156846911|NCT01518374|566193027|FG000|Overall Study|Lost to Follow-up|2|||
156846912|NCT02123823|566193028|FG000|Overall Study|Lack of Efficacy|0|||
156846913|NCT02123823|566193029|FG001|Overall Study|Lack of Efficacy|2|||
156846914|NCT02123823|566193030|FG002|Overall Study|Lack of Efficacy|8|||
156846915|NCT02123823|566193031|FG003|Overall Study|Lack of Efficacy|10|||
156846916|NCT02123823|566193028|FG000|Overall Study|Progressive disease|3|||
156846917|NCT02123823|566193029|FG001|Overall Study|Progressive disease|19|||
156846918|NCT02123823|566193030|FG002|Overall Study|Progressive disease|52|||
156846919|NCT02123823|566193031|FG003|Overall Study|Progressive disease|53|||
156846920|NCT02123823|566193028|FG000|Overall Study|Withdrawal by Subject|0|||
156846921|NCT02123823|566193029|FG001|Overall Study|Withdrawal by Subject|0|||
156846922|NCT02123823|566193030|FG002|Overall Study|Withdrawal by Subject|7|||
156846923|NCT02123823|566193031|FG003|Overall Study|Withdrawal by Subject|2|||
156846924|NCT02123823|566193028|FG000|Overall Study|Adverse Event|0|||
156846925|NCT02123823|566193029|FG001|Overall Study|Adverse Event|0|||
156846926|NCT02123823|566193030|FG002|Overall Study|Adverse Event|3|||
156846927|NCT02123823|566193031|FG003|Overall Study|Adverse Event|5|||
156846928|NCT02023996|566193041|FG000|Overall Study|Protocol Violation|6|||
156846929|NCT00465452|566193042|FG000|Overall Study|Adverse Event|1|||
156846930|NCT01635855|566193076|FG000|Overall Study|Withdrawal by Subject|4|||
156846931|NCT03828019|566193080|FG000|Overall Study|Withdrawal by Subject|3|||
156846932|NCT03828019|566193081|FG001|Overall Study|Withdrawal by Subject|8|||
156846933|NCT03828019|566193080|FG000|Overall Study|Lost to Follow-up|1|||
156846934|NCT03828019|566193081|FG001|Overall Study|Lost to Follow-up|6|||
156846935|NCT03828019|566193080|FG000|Overall Study|Incarcerated|1|||
156846936|NCT03828019|566193081|FG001|Overall Study|Incarcerated|0|||
156846937|NCT03828019|566193080|FG000|Overall Study|Adverse Event|0|||
156846938|NCT03828019|566193081|FG001|Overall Study|Adverse Event|1|||
156846939|NCT05715242|566193082|FG000|Overall Study|Lost to Follow-up|0|||
156846940|NCT05715242|566193083|FG001|Overall Study|Lost to Follow-up|0|||
156846941|NCT05715242|566193084|FG002|Overall Study|Lost to Follow-up|1|||
156846942|NCT05715242|566193085|FG003|Overall Study|Lost to Follow-up|0|||
156846943|NCT05715242|566193086|FG004|Overall Study|Lost to Follow-up|0|||
156846944|NCT05715242|566193087|FG005|Overall Study|Lost to Follow-up|1|||
156846945|NCT05715242|566193088|FG006|Overall Study|Lost to Follow-up|0|||
156846946|NCT05715242|566193089|FG007|Overall Study|Lost to Follow-up|0|||
156846947|NCT05715242|566193090|FG008|Overall Study|Lost to Follow-up|0|||
156846948|NCT05715242|566193091|FG009|Overall Study|Lost to Follow-up|0|||
156846949|NCT05715242|566193092|FG010|Overall Study|Lost to Follow-up|0|||
156846950|NCT05715242|566193093|FG011|Overall Study|Lost to Follow-up|0|||
156846951|NCT05715242|566193094|FG012|Overall Study|Lost to Follow-up|0|||
156846952|NCT05715242|566193095|FG013|Overall Study|Lost to Follow-up|0|||
156846953|NCT05715242|566193096|FG014|Overall Study|Lost to Follow-up|0|||
156846954|NCT05715242|566193097|FG015|Overall Study|Lost to Follow-up|0|||
156846955|NCT03400176|566193098|FG000|Dose Escalation|Progressive disease|1|||
156846956|NCT03400176|566193099|FG001|Dose Escalation|Progressive disease|1|||
156846957|NCT03400176|566193100|FG002|Dose Escalation|Progressive disease|0|||
156888223|NCT00492063|566349494|FG001|Overall Study|Death|0|||
156846958|NCT03400176|566193101|FG003|Dose Escalation|Progressive disease|0|||
156846959|NCT03400176|566193102|FG004|Dose Escalation|Progressive disease|1|||
156846960|NCT03400176|566193098|FG000|Dose Escalation|Patient decision|0|||
156846961|NCT03400176|566193099|FG001|Dose Escalation|Patient decision|0|||
156846962|NCT03400176|566193100|FG002|Dose Escalation|Patient decision|0|||
156846963|NCT03400176|566193101|FG003|Dose Escalation|Patient decision|0|||
156846964|NCT03400176|566193102|FG004|Dose Escalation|Patient decision|1|||
156846965|NCT03400176|566193098|FG000|Dose Expansion|Patient decision|0|||
156846966|NCT03400176|566193099|FG001|Dose Expansion|Patient decision|0|||
156846967|NCT03400176|566193100|FG002|Dose Expansion|Patient decision|0|||
156846968|NCT03400176|566193101|FG003|Dose Expansion|Patient decision|1|||
156846969|NCT03400176|566193102|FG004|Dose Expansion|Patient decision|0|||
156846970|NCT03400176|566193098|FG000|Dose Expansion|Adverse Event|0|||
156846971|NCT03400176|566193099|FG001|Dose Expansion|Adverse Event|0|||
156846972|NCT03400176|566193100|FG002|Dose Expansion|Adverse Event|0|||
156846973|NCT03400176|566193101|FG003|Dose Expansion|Adverse Event|1|||
156846974|NCT03400176|566193102|FG004|Dose Expansion|Adverse Event|0|||
156846975|NCT03400176|566193098|FG000|Dose Expansion|Physician Decision|0|||
156846976|NCT03400176|566193099|FG001|Dose Expansion|Physician Decision|0|||
156846977|NCT03400176|566193100|FG002|Dose Expansion|Physician Decision|0|||
156846978|NCT03400176|566193101|FG003|Dose Expansion|Physician Decision|1|||
156846979|NCT03400176|566193102|FG004|Dose Expansion|Physician Decision|0|||
156846980|NCT03400176|566193098|FG000|Dose Expansion|Progressive disease|0|||
156846981|NCT03400176|566193099|FG001|Dose Expansion|Progressive disease|0|||
156846982|NCT03400176|566193100|FG002|Dose Expansion|Progressive disease|1|||
156846983|NCT03400176|566193101|FG003|Dose Expansion|Progressive disease|1|||
156846984|NCT03400176|566193102|FG004|Dose Expansion|Progressive disease|0|||
156846985|NCT01090063|566193111|FG000|Screen|Screen Failed|4|||
156846986|NCT01090063|566193111|FG000|Treatment|Withdrawal by Subject|4|||
156846987|NCT00548145|566193112|FG000|Overall Study|Death|0|||
156846988|NCT00548145|566193113|FG001|Overall Study|Death|1|||
156846989|NCT00548145|566193112|FG000|Overall Study|Withdrawal by Subject|0|||
156846990|NCT00548145|566193113|FG001|Overall Study|Withdrawal by Subject|2|||
156846991|NCT00548145|566193112|FG000|Overall Study|Physician Decision|1|||
156846992|NCT00548145|566193113|FG001|Overall Study|Physician Decision|1|||
156846993|NCT00874848|566193114|FG000|Overall Study|Adverse Event|13|||
156846994|NCT00874848|566193115|FG001|Overall Study|Adverse Event|2|||
156846995|NCT00874848|566193114|FG000|Overall Study|Progressive neoplastic disease|38|||
156846996|NCT00874848|566193115|FG001|Overall Study|Progressive neoplastic disease|18|||
156846997|NCT00874848|566193114|FG000|Overall Study|Withdrawal by Subject|7|||
156846998|NCT00874848|566193115|FG001|Overall Study|Withdrawal by Subject|4|||
156846999|NCT00874848|566193114|FG000|Overall Study|Noncompliance|1|||
156847000|NCT00874848|566193115|FG001|Overall Study|Noncompliance|1|||
156847001|NCT00874848|566193114|FG000|Overall Study|Failure to comply with protocol|0|||
156847002|NCT00874848|566193115|FG001|Overall Study|Failure to comply with protocol|1|||
156847003|NCT00874848|566193114|FG000|Overall Study|Physician Decision|0|||
156847004|NCT00874848|566193115|FG001|Overall Study|Physician Decision|2|||
156847005|NCT01019369|566193120|FG000|Overall Study|Lost to Follow-up|10|||
156847006|NCT01019369|566193121|FG001|Overall Study|Lost to Follow-up|6|||
156847007|NCT01019369|566193120|FG000|Overall Study|Withdrawal by Subject|0|||
156847008|NCT01019369|566193121|FG001|Overall Study|Withdrawal by Subject|1|||
156847009|NCT04565951|566193122|FG000|Overall Study|Lost to Follow-up|66|||
156847010|NCT04565951|566193123|FG001|Overall Study|Lost to Follow-up|38|||
156847011|NCT04565951|566193122|FG000|Overall Study|Withdrawal by Subject|14|||
156847012|NCT04565951|566193123|FG001|Overall Study|Withdrawal by Subject|7|||
156847013|NCT04565951|566193122|FG000|Overall Study|Death|0|||
156847014|NCT04565951|566193123|FG001|Overall Study|Death|1|||
156847015|NCT04677504|566193125|FG000|Overall Study|Death|51|||
156847016|NCT04677504|566193126|FG001|Overall Study|Death|49|||
156847017|NCT04677504|566193125|FG000|Overall Study|Progressive Disease|1|||
157025318|NCT02268253|566847951|FG006|Stage 2|Transferred to Hospice|0|||
156847018|NCT04677504|566193126|FG001|Overall Study|Progressive Disease|0|||
156847019|NCT04677504|566193125|FG000|Overall Study|Symptomatic Deterioration|1|||
156847020|NCT04677504|566193126|FG001|Overall Study|Symptomatic Deterioration|0|||
156847021|NCT04677504|566193125|FG000|Overall Study|Withdrawal by Subject|2|||
156847022|NCT04677504|566193126|FG001|Overall Study|Withdrawal by Subject|5|||
156847023|NCT04677504|566193125|FG000|Overall Study|Study Terminated By Sponsor|28|||
156847024|NCT04677504|566193126|FG001|Overall Study|Study Terminated By Sponsor|24|||
156847025|NCT04677504|566193125|FG000|Overall Study|Adverse Event|0|||
156847026|NCT04677504|566193126|FG001|Overall Study|Adverse Event|1|||
156847027|NCT03369236|566193127|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
156847028|NCT03369236|566193128|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
156847029|NCT03369236|566193127|FG000|Open-label Extension Period|Lack of Efficacy|2|||
156847030|NCT03369236|566193128|FG001|Open-label Extension Period|Lack of Efficacy|1|||
156847031|NCT03369236|566193127|FG000|Open-label Extension Period|Adverse Event|0|||
156847032|NCT03369236|566193128|FG001|Open-label Extension Period|Adverse Event|1|||
156847033|NCT03369236|566193127|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
156847034|NCT03369236|566193128|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
156847035|NCT00423449|566193129|FG000|Overall Study|Clinical Adverse Event|1|||
156847036|NCT00423449|566193130|FG001|Overall Study|Clinical Adverse Event|0|||
156847037|NCT00423449|566193131|FG002|Overall Study|Clinical Adverse Event|1|||
156847038|NCT00423449|566193132|FG003|Overall Study|Clinical Adverse Event|8|||
156847039|NCT00423449|566193133|FG004|Overall Study|Clinical Adverse Event|2|||
156847040|NCT00423449|566193129|FG000|Overall Study|Death|1|||
156847041|NCT00423449|566193130|FG001|Overall Study|Death|0|||
156847042|NCT00423449|566193131|FG002|Overall Study|Death|2|||
156847043|NCT00423449|566193132|FG003|Overall Study|Death|1|||
156847044|NCT00423449|566193133|FG004|Overall Study|Death|1|||
156847045|NCT00423449|566193129|FG000|Overall Study|Progressive Disease|1|||
156847046|NCT00423449|566193130|FG001|Overall Study|Progressive Disease|3|||
156847047|NCT00423449|566193131|FG002|Overall Study|Progressive Disease|8|||
156888224|NCT00492063|566349495|FG002|Overall Study|Death|1|||
156847048|NCT00423449|566193132|FG003|Overall Study|Progressive Disease|11|||
156847049|NCT00423449|566193133|FG004|Overall Study|Progressive Disease|4|||
156847050|NCT00423449|566193129|FG000|Overall Study|Laboratory Adverse Event|0|||
156847051|NCT00423449|566193130|FG001|Overall Study|Laboratory Adverse Event|1|||
156847052|NCT00423449|566193131|FG002|Overall Study|Laboratory Adverse Event|2|||
156847053|NCT00423449|566193132|FG003|Overall Study|Laboratory Adverse Event|0|||
156847054|NCT00423449|566193133|FG004|Overall Study|Laboratory Adverse Event|0|||
156847055|NCT00423449|566193129|FG000|Overall Study|Other|0|||
156847056|NCT00423449|566193130|FG001|Overall Study|Other|0|||
156847057|NCT00423449|566193131|FG002|Overall Study|Other|0|||
156847058|NCT00423449|566193132|FG003|Overall Study|Other|1|||
156847059|NCT00423449|566193133|FG004|Overall Study|Other|0|||
156847060|NCT00423449|566193129|FG000|Overall Study|Protocol Violation|0|||
156847061|NCT00423449|566193130|FG001|Overall Study|Protocol Violation|0|||
156847062|NCT00423449|566193131|FG002|Overall Study|Protocol Violation|2|||
156847063|NCT00423449|566193132|FG003|Overall Study|Protocol Violation|1|||
156847064|NCT00423449|566193133|FG004|Overall Study|Protocol Violation|0|||
156847065|NCT01153724|566193134|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156847066|NCT01153724|566193134|FG000|Treatment Period 2|Adverse Event|1|||
156847067|NCT01153724|566193134|FG000|Treatment Period 2|Other reason not defined above|1|||
156847068|NCT02697435|566193135|FG000|Overall Study|Withdrawal by Subject|1|||
156847069|NCT02697435|566193136|FG001|Overall Study|Withdrawal by Subject|0|||
156847070|NCT02697435|566193135|FG000|Overall Study|Physician Decision|0|||
156847071|NCT02697435|566193136|FG001|Overall Study|Physician Decision|4|||
156847072|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
156847073|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
156847074|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
156888225|NCT00492063|566349496|FG003|Overall Study|Death|2|||
156888226|NCT00492063|566349493|FG000|Overall Study|Withdrawal by Subject|4|||
156888227|NCT00492063|566349494|FG001|Overall Study|Withdrawal by Subject|3|||
156847075|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
156847076|NCT04371666|566193138|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
156847077|NCT04371666|566193139|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
156847078|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
156847079|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
156847080|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
156847081|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
156847082|NCT04371666|566193138|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
156847083|NCT04371666|566193139|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
156847084|NCT02092025|566193140|FG000|Overall Study|Case Report Forms Uncollected|44|||
156847085|NCT02092025|566193140|FG000|Overall Study|Protocol Deviation|24|||
156847086|NCT02927938|566193141|FG000|Overall Study|Death|0|||
156847087|NCT02927938|566193142|FG001|Overall Study|Death|1|||
156847088|NCT02927938|566193143|FG002|Overall Study|Death|0|||
156847089|NCT02927938|566193144|FG003|Overall Study|Death|4|||
156847090|NCT02927938|566193141|FG000|Overall Study|Early Study Termination|1|||
156847091|NCT02927938|566193142|FG001|Overall Study|Early Study Termination|5|||
156847092|NCT02927938|566193143|FG002|Overall Study|Early Study Termination|4|||
156847093|NCT02927938|566193144|FG003|Overall Study|Early Study Termination|3|||
156847094|NCT02834247|566193145|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
156847095|NCT02834247|566193146|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
156847096|NCT02834247|566193147|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
156847097|NCT02834247|566193148|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
156847098|NCT02834247|566193145|FG000|Dose Escalation Phase|Death|5|||
156888228|NCT00492063|566349495|FG002|Overall Study|Withdrawal by Subject|5|||
156888229|NCT00492063|566349496|FG003|Overall Study|Withdrawal by Subject|4|||
156888230|NCT00492063|566349493|FG000|Overall Study|Lost to Follow-up|6|||
156888231|NCT00492063|566349494|FG001|Overall Study|Lost to Follow-up|11|||
156888232|NCT00492063|566349495|FG002|Overall Study|Lost to Follow-up|5|||
156888233|NCT00492063|566349496|FG003|Overall Study|Lost to Follow-up|3|||
156888234|NCT00492063|566349493|FG000|Overall Study|Protocol Violation|0|||
156888235|NCT00492063|566349494|FG001|Overall Study|Protocol Violation|0|||
156888236|NCT00492063|566349495|FG002|Overall Study|Protocol Violation|0|||
156888237|NCT00492063|566349496|FG003|Overall Study|Protocol Violation|1|||
157025319|NCT02268253|566847945|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
157025320|NCT02268253|566847946|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
156888238|NCT00053898|566349499|FG000|Overall Study|No follow-up data from any source|9|||
157025321|NCT02268253|566847947|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
157025322|NCT02268253|566847948|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
157224810|NCT02336737|567569878|FG000|Overall Study|Physician Decision|8|||
156847099|NCT02834247|566193146|FG001|Dose Escalation Phase|Death|6|||
156847100|NCT02834247|566193147|FG002|Dose Escalation Phase|Death|5|||
156847101|NCT02834247|566193148|FG003|Dose Escalation Phase|Death|0|||
156847102|NCT02834247|566193145|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
156847103|NCT02834247|566193146|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
156847104|NCT02834247|566193147|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
157025323|NCT02268253|566847949|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
157025324|NCT02268253|566847950|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
157025325|NCT02268253|566847951|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
157025326|NCT02268253|566847945|FG000|Stage 3A|Withdrawal by Subject|0|||
157025327|NCT02268253|566847946|FG001|Stage 3A|Withdrawal by Subject|0|||
157025328|NCT02268253|566847947|FG002|Stage 3A|Withdrawal by Subject|2|||
157025329|NCT02268253|566847948|FG003|Stage 3A|Withdrawal by Subject|0|||
157025330|NCT02268253|566847949|FG004|Stage 3A|Withdrawal by Subject|0|||
156847105|NCT02834247|566193148|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
156847106|NCT02834247|566193145|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
156847107|NCT02834247|566193146|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
156847108|NCT02834247|566193147|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156847109|NCT02834247|566193148|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156847110|NCT02834247|566193145|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847111|NCT02834247|566193146|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847112|NCT02834247|566193147|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
156847113|NCT02834247|566193148|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
156847114|NCT02834247|566193145|FG000|Dose Expansion Phase|Death|0|||
156847115|NCT02834247|566193146|FG001|Dose Expansion Phase|Death|0|||
156847116|NCT02834247|566193147|FG002|Dose Expansion Phase|Death|0|||
156847117|NCT02834247|566193148|FG003|Dose Expansion Phase|Death|8|||
156847118|NCT02834247|566193145|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
156847119|NCT02834247|566193146|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
156847120|NCT02834247|566193147|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
156847121|NCT02834247|566193148|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
156847122|NCT02834247|566193145|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
156847123|NCT02834247|566193146|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
156847124|NCT02834247|566193147|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
156847125|NCT02834247|566193148|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
156847126|NCT00811174|566193149|FG000|Overall Study|Protocol Violation|2|||
156847127|NCT00811174|566193149|FG000|Overall Study|Sponsors Decision|1|||
156847128|NCT04829916|566194689|FG000|Overall Study|Withdrawal by Subject|1|||
156847129|NCT04829916|566194690|FG001|Overall Study|Withdrawal by Subject|0|||
156847130|NCT04343755|566194692|FG000|Overall Study|Death|11|||
156847131|NCT04343755|566194692|FG000|Overall Study|Screen Failure|1|||
156847132|NCT03329846|566194697|FG000|Overall Study|Disease progression|4|||
156847133|NCT03329846|566194698|FG001|Overall Study|Disease progression|6|||
156847134|NCT03329846|566194697|FG000|Overall Study|Study drug toxicity|1|||
156847135|NCT03329846|566194698|FG001|Overall Study|Study drug toxicity|0|||
156847136|NCT03329846|566194697|FG000|Overall Study|Participant request to discontinue treatment|0|||
156847137|NCT03329846|566194698|FG001|Overall Study|Participant request to discontinue treatment|1|||
156847138|NCT03329846|566194697|FG000|Overall Study|Participant withdrew consent|1|||
156847139|NCT03329846|566194698|FG001|Overall Study|Participant withdrew consent|0|||
156847140|NCT03329846|566194697|FG000|Overall Study|Other reasons|2|||
156847141|NCT03329846|566194698|FG001|Overall Study|Other reasons|2|||
156847142|NCT02741596|566194699|FG000|Overall Study|Adverse Event|1|||
156847143|NCT02741596|566194700|FG001|Overall Study|Adverse Event|5|||
156847144|NCT02741596|566194699|FG000|Overall Study|Lost to Follow-up|1|||
156847145|NCT02741596|566194700|FG001|Overall Study|Lost to Follow-up|1|||
156847146|NCT02741596|566194699|FG000|Overall Study|Physician Decision|2|||
156847147|NCT02741596|566194700|FG001|Overall Study|Physician Decision|1|||
157025331|NCT02268253|566847950|FG005|Stage 3A|Withdrawal by Subject|0|||
157224811|NCT00576381|567569885|FG000|Overall Study|Reoperation|3|||
156847148|NCT02741596|566194699|FG000|Overall Study|Pregnancy|3|||
156847149|NCT02741596|566194700|FG001|Overall Study|Pregnancy|1|||
156847150|NCT02741596|566194699|FG000|Overall Study|Other (Unspecified)|0|||
156847151|NCT02741596|566194700|FG001|Overall Study|Other (Unspecified)|3|||
156847152|NCT02741596|566194699|FG000|Overall Study|Subject withdrawn-Other|17|||
156847153|NCT02741596|566194700|FG001|Overall Study|Subject withdrawn-Other|4|||
156847154|NCT02741596|566194699|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
156847155|NCT02741596|566194700|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
156847156|NCT02735343|566194703|FG000|Overall Study|screen fail|0|||
156847157|NCT02735343|566194704|FG001|Overall Study|screen fail|2|||
156847158|NCT04531241|566194707|FG000|Period 1|Withdrawal by Subject|2|||
156847159|NCT04531241|566194708|FG001|Period 1|Withdrawal by Subject|0|||
156847160|NCT04531241|566194707|FG000|Period 1|Dispesed incorrect lens power|1|||
156847161|NCT04531241|566194708|FG001|Period 1|Dispesed incorrect lens power|0|||
156847162|NCT04531241|566194707|FG000|Period 1|Protocol Violation|1|||
156847163|NCT04531241|566194708|FG001|Period 1|Protocol Violation|0|||
157025332|NCT02268253|566847951|FG006|Stage 3A|Withdrawal by Subject|0|||
156847164|NCT04531241|566194707|FG000|Period 1|No longer eligible|0|||
156847165|NCT04531241|566194708|FG001|Period 1|No longer eligible|1|||
156847166|NCT04531241|566194707|FG000|Period 1|Lens Discomfort|0|||
156847167|NCT04531241|566194708|FG001|Period 1|Lens Discomfort|1|||
156847168|NCT04531241|566194707|FG000|Period 2|Covid-19 Related|1|||
157025333|NCT02268253|566847945|FG000|Stage 3A|Physician Decision|0|||
157025334|NCT02268253|566847946|FG001|Stage 3A|Physician Decision|0|||
156847169|NCT04531241|566194708|FG001|Period 2|Covid-19 Related|1|||
156847170|NCT02362464|566194709|FG000|Overall Study|Switched to alternative therapy|1|||
156847171|NCT02362464|566194709|FG000|Overall Study|Refused further treatment|1|||
156847172|NCT02362464|566194709|FG000|Overall Study|Physician Decision|4|||
156847173|NCT05870865|566194710|FG000|Randomized|Did not receive study treatment|2|||
156847174|NCT05870865|566194711|FG001|Randomized|Did not receive study treatment|4|||
156847175|NCT05870865|566194712|FG002|Randomized|Did not receive study treatment|4|||
157025335|NCT02268253|566847947|FG002|Stage 3A|Physician Decision|2|||
157025336|NCT02268253|566847948|FG003|Stage 3A|Physician Decision|0|||
157025337|NCT02268253|566847949|FG004|Stage 3A|Physician Decision|0|||
157025338|NCT02268253|566847950|FG005|Stage 3A|Physician Decision|0|||
157025339|NCT02268253|566847951|FG006|Stage 3A|Physician Decision|0|||
157025340|NCT02268253|566847945|FG000|Stage 3A|Study Terminated by Sponsor|0|||
157025341|NCT02268253|566847946|FG001|Stage 3A|Study Terminated by Sponsor|0|||
157025342|NCT02268253|566847947|FG002|Stage 3A|Study Terminated by Sponsor|2|||
157025343|NCT02268253|566847948|FG003|Stage 3A|Study Terminated by Sponsor|0|||
157025344|NCT02268253|566847949|FG004|Stage 3A|Study Terminated by Sponsor|0|||
157025345|NCT02268253|566847950|FG005|Stage 3A|Study Terminated by Sponsor|0|||
157025346|NCT02268253|566847951|FG006|Stage 3A|Study Terminated by Sponsor|0|||
157025347|NCT02268253|566847945|FG000|Stage 3A|Lost to Follow-up|0|||
157025348|NCT02268253|566847946|FG001|Stage 3A|Lost to Follow-up|0|||
157025349|NCT02268253|566847947|FG002|Stage 3A|Lost to Follow-up|1|||
157025350|NCT02268253|566847948|FG003|Stage 3A|Lost to Follow-up|0|||
157025351|NCT02268253|566847949|FG004|Stage 3A|Lost to Follow-up|0|||
157025352|NCT02268253|566847950|FG005|Stage 3A|Lost to Follow-up|0|||
156847176|NCT05870865|566194713|FG003|Randomized|Did not receive study treatment|3|||
156847177|NCT05870865|566194710|FG000|Treatment Period|Adverse Event|1|||
157025353|NCT02268253|566847951|FG006|Stage 3A|Lost to Follow-up|0|||
156847178|NCT05870865|566194711|FG001|Treatment Period|Adverse Event|1|||
156847179|NCT05870865|566194712|FG002|Treatment Period|Adverse Event|1|||
156847180|NCT05870865|566194713|FG003|Treatment Period|Adverse Event|1|||
156847181|NCT05870865|566194710|FG000|Treatment Period|Lost to Follow-up|0|||
156847182|NCT05870865|566194711|FG001|Treatment Period|Lost to Follow-up|1|||
156847183|NCT05870865|566194712|FG002|Treatment Period|Lost to Follow-up|2|||
156847184|NCT05870865|566194713|FG003|Treatment Period|Lost to Follow-up|0|||
156847185|NCT05870865|566194710|FG000|Treatment Period|Protocol Violation|0|||
156847186|NCT05870865|566194711|FG001|Treatment Period|Protocol Violation|0|||
156847187|NCT05870865|566194712|FG002|Treatment Period|Protocol Violation|0|||
156847188|NCT05870865|566194713|FG003|Treatment Period|Protocol Violation|1|||
156847189|NCT05870865|566194710|FG000|Treatment Period|Withdrawal by Subject|0|||
156847190|NCT05870865|566194711|FG001|Treatment Period|Withdrawal by Subject|1|||
156847191|NCT05870865|566194712|FG002|Treatment Period|Withdrawal by Subject|1|||
156847192|NCT05870865|566194713|FG003|Treatment Period|Withdrawal by Subject|1|||
156847193|NCT02104947|566194715|FG000|Overall Study|Withdrawal by Subject|10|||
156847194|NCT02104947|566194716|FG001|Overall Study|Withdrawal by Subject|3|||
156847195|NCT02104947|566194715|FG000|Overall Study|Lost to Follow-up|4|||
156847196|NCT02104947|566194716|FG001|Overall Study|Lost to Follow-up|4|||
156847197|NCT02104947|566194715|FG000|Overall Study|Protocol Violation|6|||
156847198|NCT02104947|566194716|FG001|Overall Study|Protocol Violation|8|||
156847199|NCT02104947|566194715|FG000|Overall Study|Adverse Event|57|||
156847200|NCT02104947|566194716|FG001|Overall Study|Adverse Event|38|||
156847201|NCT02104947|566194715|FG000|Overall Study|Other than stated above|2|||
156847202|NCT02104947|566194716|FG001|Overall Study|Other than stated above|3|||
156847203|NCT02863328|566194717|FG000|Overall Study|Lost to Follow-up|4|||
156847204|NCT02863328|566194718|FG001|Overall Study|Lost to Follow-up|10|||
156847205|NCT02863328|566194717|FG000|Overall Study|Withdrawal by Subject|7|||
156847206|NCT02863328|566194718|FG001|Overall Study|Withdrawal by Subject|12|||
156847207|NCT02863328|566194717|FG000|Overall Study|Died|0|||
156847208|NCT02863328|566194718|FG001|Overall Study|Died|1|||
156847209|NCT03301350|566194720|FG000|Overall Study|Withdrawal by Subject|4|||
156847210|NCT03301350|566194720|FG000|Overall Study|Adverse Event|1|||
156847211|NCT03301350|566194720|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
156847212|NCT03301350|566194720|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
156847213|NCT03301350|566194720|FG000|Overall Study|no detail provided|1|||
156847214|NCT00858637|566194721|FG000|Active Comparison Phase|Adverse Event|14|||
156847215|NCT00858637|566194722|FG001|Active Comparison Phase|Adverse Event|0|||
156847216|NCT00858637|566194723|FG002|Active Comparison Phase|Adverse Event|0|||
156847217|NCT00858637|566194724|FG003|Active Comparison Phase|Adverse Event|9|||
157025354|NCT02268253|566847945|FG000|Stage 3A|Death|0|||
156847218|NCT00858637|566194725|FG004|Active Comparison Phase|Adverse Event|0|||
157025355|NCT02268253|566847946|FG001|Stage 3A|Death|0|||
157025356|NCT02268253|566847947|FG002|Stage 3A|Death|5|||
157025357|NCT02268253|566847948|FG003|Stage 3A|Death|0|||
157025358|NCT02268253|566847949|FG004|Stage 3A|Death|0|||
156847219|NCT00858637|566194726|FG005|Active Comparison Phase|Adverse Event|0|||
156847220|NCT00858637|566194721|FG000|Active Comparison Phase|Death|1|||
156847221|NCT00858637|566194722|FG001|Active Comparison Phase|Death|0|||
157025359|NCT02268253|566847950|FG005|Stage 3A|Death|0|||
156847222|NCT00858637|566194723|FG002|Active Comparison Phase|Death|0|||
156847223|NCT00858637|566194724|FG003|Active Comparison Phase|Death|1|||
156847224|NCT00858637|566194725|FG004|Active Comparison Phase|Death|0|||
156847225|NCT00858637|566194726|FG005|Active Comparison Phase|Death|0|||
156847226|NCT00858637|566194721|FG000|Active Comparison Phase|Physician Decision|1|||
156847227|NCT00858637|566194722|FG001|Active Comparison Phase|Physician Decision|0|||
156847228|NCT00858637|566194723|FG002|Active Comparison Phase|Physician Decision|0|||
156847229|NCT00858637|566194724|FG003|Active Comparison Phase|Physician Decision|1|||
156847230|NCT00858637|566194725|FG004|Active Comparison Phase|Physician Decision|0|||
156847231|NCT00858637|566194726|FG005|Active Comparison Phase|Physician Decision|0|||
156847232|NCT00858637|566194721|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
156847233|NCT00858637|566194722|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
156847234|NCT00858637|566194723|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
156847235|NCT00858637|566194724|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
156847236|NCT00858637|566194725|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
156847237|NCT00858637|566194726|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
156847238|NCT00858637|566194721|FG000|Active Comparison Phase|Other Reasons|1|||
156847239|NCT00858637|566194722|FG001|Active Comparison Phase|Other Reasons|0|||
156847240|NCT00858637|566194723|FG002|Active Comparison Phase|Other Reasons|0|||
156847241|NCT00858637|566194724|FG003|Active Comparison Phase|Other Reasons|1|||
156847242|NCT00858637|566194725|FG004|Active Comparison Phase|Other Reasons|0|||
156847243|NCT00858637|566194726|FG005|Active Comparison Phase|Other Reasons|0|||
156847244|NCT00858637|566194721|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
156847245|NCT00858637|566194722|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
156847246|NCT00858637|566194723|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
156847247|NCT00858637|566194724|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
156847248|NCT00858637|566194725|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
156847249|NCT00858637|566194726|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
156847250|NCT00858637|566194721|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847251|NCT00858637|566194722|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847252|NCT00858637|566194723|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847253|NCT00858637|566194724|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847254|NCT00858637|566194725|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
156847255|NCT00858637|566194726|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
156847256|NCT02305238|566194727|FG000|Overall Study|Death|2|||
156847257|NCT02305238|566194728|FG001|Overall Study|Death|1|||
156847258|NCT02305238|566194729|FG002|Overall Study|Death|0|||
156847259|NCT02305238|566194727|FG000|Overall Study|Progressive disease|4|||
156847260|NCT02305238|566194728|FG001|Overall Study|Progressive disease|4|||
156847261|NCT02305238|566194729|FG002|Overall Study|Progressive disease|0|||
156847262|NCT02305238|566194727|FG000|Overall Study|Logistical difficulties|1|||
156847263|NCT02305238|566194728|FG001|Overall Study|Logistical difficulties|3|||
156847264|NCT02305238|566194729|FG002|Overall Study|Logistical difficulties|0|||
156847265|NCT02305238|566194727|FG000|Overall Study|Protocol Violation|0|||
156847266|NCT02305238|566194728|FG001|Overall Study|Protocol Violation|3|||
156847267|NCT02305238|566194729|FG002|Overall Study|Protocol Violation|0|||
156847268|NCT02305238|566194727|FG000|Overall Study|Physician Decision|2|||
156847269|NCT02305238|566194728|FG001|Overall Study|Physician Decision|1|||
156847270|NCT02305238|566194729|FG002|Overall Study|Physician Decision|0|||
156847271|NCT02305238|566194727|FG000|Overall Study|Adverse Event|4|||
156847272|NCT02305238|566194728|FG001|Overall Study|Adverse Event|2|||
156847273|NCT02305238|566194729|FG002|Overall Study|Adverse Event|0|||
156847274|NCT02305238|566194727|FG000|Overall Study|Withdrawal by Subject|3|||
156847275|NCT02305238|566194728|FG001|Overall Study|Withdrawal by Subject|4|||
156847276|NCT02305238|566194729|FG002|Overall Study|Withdrawal by Subject|0|||
156847277|NCT02305238|566194727|FG000|Overall Study|Randomized failure|0|||
156847278|NCT02305238|566194728|FG001|Overall Study|Randomized failure|0|||
156847279|NCT02305238|566194729|FG002|Overall Study|Randomized failure|8|||
156847280|NCT02305238|566194727|FG000|Overall Study|Required procedure failed|0|||
156847281|NCT02305238|566194728|FG001|Overall Study|Required procedure failed|1|||
156847282|NCT02305238|566194729|FG002|Overall Study|Required procedure failed|0|||
156847283|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
156847284|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
156847285|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
156847286|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Death|0|||
156847287|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Death|2|||
156847288|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Death|0|||
156847289|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
156847290|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
156847291|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
156847292|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
156847293|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
156847294|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
157025360|NCT02268253|566847951|FG006|Stage 3A|Death|0|||
156847295|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
156847296|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
156847297|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
156847298|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
156847299|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
156847300|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
156847301|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
156847302|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
156847303|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
156847304|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Recovery|1|||
156847305|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Recovery|0|||
156847306|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Recovery|1|||
156847307|NCT00195663|566194730|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
156847308|NCT00195663|566194731|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
156847309|NCT00195663|566194732|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
156847310|NCT00195663|566194730|FG000|Open-Label Extension Period|Adverse Event|21|||
156847311|NCT00195663|566194731|FG001|Open-Label Extension Period|Adverse Event|32|||
156847312|NCT00195663|566194732|FG002|Open-Label Extension Period|Adverse Event|36|||
156847313|NCT00195663|566194730|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
156847314|NCT00195663|566194731|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
156847315|NCT00195663|566194732|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
156847316|NCT00195663|566194730|FG000|Open-Label Extension Period|Recovery|0|||
156847317|NCT00195663|566194731|FG001|Open-Label Extension Period|Recovery|2|||
156847318|NCT00195663|566194732|FG002|Open-Label Extension Period|Recovery|2|||
156847319|NCT00195663|566194730|FG000|Open-Label Extension Period|Protocol Violation|3|||
156847320|NCT00195663|566194731|FG001|Open-Label Extension Period|Protocol Violation|4|||
156847321|NCT00195663|566194732|FG002|Open-Label Extension Period|Protocol Violation|4|||
156847322|NCT00195663|566194730|FG000|Open-Label Extension Period|Death|2|||
156847323|NCT00195663|566194731|FG001|Open-Label Extension Period|Death|2|||
156847324|NCT00195663|566194732|FG002|Open-Label Extension Period|Death|2|||
156847325|NCT00195663|566194730|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
156847326|NCT00195663|566194731|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
156847327|NCT00195663|566194732|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
156847328|NCT00195663|566194730|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
156847329|NCT00195663|566194731|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
156847330|NCT00195663|566194732|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
156847331|NCT00195663|566194730|FG000|Open-Label Extension Period|Administrative reasons|11|||
156847332|NCT00195663|566194731|FG001|Open-Label Extension Period|Administrative reasons|11|||
156847333|NCT00195663|566194732|FG002|Open-Label Extension Period|Administrative reasons|13|||
156847334|NCT01380834|566194733|FG000|Overall Study|Physician Decision|1|||
156847335|NCT01380834|566194734|FG001|Overall Study|Physician Decision|0|||
156847336|NCT03214406|566194735|FG000|Overall Study|did not meet enrollment criteria|9|||
156847337|NCT03214406|566194736|FG001|Overall Study|did not meet enrollment criteria|13|||
156847338|NCT03214406|566194735|FG000|Overall Study|Withdrawal by Subject|1|||
156847339|NCT03214406|566194736|FG001|Overall Study|Withdrawal by Subject|0|||
156847340|NCT03214406|566194735|FG000|Overall Study|Lost to Follow-up|0|||
156847341|NCT03214406|566194736|FG001|Overall Study|Lost to Follow-up|2|||
156847342|NCT00604695|566194737|FG000|Overall Study|Did not receive first bolus.|0|||
156847343|NCT00604695|566194738|FG001|Overall Study|Did not receive first bolus.|4|||
156847344|NCT03182907|566194748|FG000|Overall Study|Death|3|||
156847345|NCT03182907|566194749|FG001|Overall Study|Death|0|||
156847346|NCT03182907|566194748|FG000|Overall Study|Protocol Violation|4|||
156847347|NCT03182907|566194749|FG001|Overall Study|Protocol Violation|0|||
156847348|NCT03182907|566194748|FG000|Overall Study|Lost to Follow-up|1|||
156847349|NCT03182907|566194749|FG001|Overall Study|Lost to Follow-up|0|||
156847350|NCT03182907|566194748|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156847351|NCT03182907|566194749|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
156847352|NCT00429169|566194750|FG000|Overall Study|Lost to Follow-up|0|||
156847353|NCT00429169|566194751|FG001|Overall Study|Lost to Follow-up|1|||
156847354|NCT00429169|566194750|FG000|Overall Study|Ineligibility discovered after entry|2|||
156847355|NCT00429169|566194751|FG001|Overall Study|Ineligibility discovered after entry|1|||
156847356|NCT00384332|566194756|FG000|Overall Study|Lost to Follow-up|4|||
156847357|NCT00384332|566194757|FG001|Overall Study|Lost to Follow-up|0|||
156847358|NCT01771250|566194758|FG000|Period 1|Met exclusion criteria|1|||
156847359|NCT01771250|566194759|FG001|Period 1|Met exclusion criteria|0|||
156847360|NCT02058563|566194760|FG000|Overall Study|Lost to Follow-up|26|||
156847361|NCT02058563|566194761|FG001|Overall Study|Lost to Follow-up|22|||
156847362|NCT02058563|566194760|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
156847363|NCT02058563|566194761|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
156847364|NCT02058563|566194760|FG000|Overall Study|Consent Withdrawal|1|||
156847365|NCT02058563|566194761|FG001|Overall Study|Consent Withdrawal|1|||
156847366|NCT02058563|566194760|FG000|Overall Study|Other (patient incarcerated)|0|||
156847367|NCT02058563|566194761|FG001|Overall Study|Other (patient incarcerated)|1|||
156847368|NCT01180296|566194762|FG000|Overall Study|Protocol Violation|1|||
156847369|NCT01180296|566194763|FG001|Overall Study|Protocol Violation|2|||
156847370|NCT00166439|566194764|FG000|Overall Study|Ineligible|5|||
156847371|NCT00483938|566194765|FG000|Overall Study|Protocol Violation|0|||
156847372|NCT00483938|566194766|FG001|Overall Study|Protocol Violation|0|||
156847373|NCT00483938|566194767|FG002|Overall Study|Protocol Violation|0|||
156847374|NCT00483938|566194768|FG003|Overall Study|Protocol Violation|0|||
156847375|NCT00483938|566194769|FG004|Overall Study|Protocol Violation|0|||
156847376|NCT00483938|566194770|FG005|Overall Study|Protocol Violation|0|||
156847377|NCT00483938|566194771|FG006|Overall Study|Protocol Violation|3|||
156847378|NCT00483938|566194765|FG000|Overall Study|Withdrawal by Subject|1|||
156847379|NCT00483938|566194766|FG001|Overall Study|Withdrawal by Subject|6|||
156847380|NCT00483938|566194767|FG002|Overall Study|Withdrawal by Subject|0|||
156847381|NCT00483938|566194768|FG003|Overall Study|Withdrawal by Subject|0|||
156847382|NCT00483938|566194769|FG004|Overall Study|Withdrawal by Subject|1|||
156847383|NCT00483938|566194770|FG005|Overall Study|Withdrawal by Subject|3|||
156847384|NCT00483938|566194771|FG006|Overall Study|Withdrawal by Subject|2|||
156847385|NCT00483938|566194765|FG000|Overall Study|Lost to Follow-up|1|||
156847386|NCT00483938|566194766|FG001|Overall Study|Lost to Follow-up|2|||
156847387|NCT00483938|566194767|FG002|Overall Study|Lost to Follow-up|0|||
156847388|NCT00483938|566194768|FG003|Overall Study|Lost to Follow-up|2|||
156847389|NCT00483938|566194769|FG004|Overall Study|Lost to Follow-up|1|||
156847390|NCT00483938|566194770|FG005|Overall Study|Lost to Follow-up|1|||
156847391|NCT00483938|566194771|FG006|Overall Study|Lost to Follow-up|3|||
156847392|NCT00483938|566194765|FG000|Overall Study|Death|0|||
156847393|NCT00483938|566194766|FG001|Overall Study|Death|2|||
156847394|NCT00483938|566194767|FG002|Overall Study|Death|0|||
156847395|NCT00483938|566194768|FG003|Overall Study|Death|0|||
156847396|NCT00483938|566194769|FG004|Overall Study|Death|0|||
156847397|NCT00483938|566194770|FG005|Overall Study|Death|0|||
156847398|NCT00483938|566194771|FG006|Overall Study|Death|0|||
156847399|NCT00483938|566194765|FG000|Overall Study|Other|3|||
156847400|NCT00483938|566194766|FG001|Overall Study|Other|9|||
156847401|NCT00483938|566194767|FG002|Overall Study|Other|0|||
156847402|NCT00483938|566194768|FG003|Overall Study|Other|4|||
156847403|NCT00483938|566194769|FG004|Overall Study|Other|0|||
156847404|NCT00483938|566194770|FG005|Overall Study|Other|4|||
156847405|NCT00483938|566194771|FG006|Overall Study|Other|32|||
156847406|NCT00106353|566194776|FG000|Part 1|Disease progression|3|||
156847407|NCT00106353|566194777|FG001|Part 1|Disease progression|4|||
156847408|NCT00106353|566194778|FG002|Part 1|Disease progression|1|||
156847409|NCT00106353|566194779|FG003|Part 1|Disease progression|3|||
156847410|NCT00106353|566194780|FG004|Part 1|Disease progression|0|||
156847411|NCT00106353|566194781|FG005|Part 1|Disease progression|0|||
156847412|NCT00106353|566194782|FG006|Part 1|Disease progression|0|||
156847413|NCT00106353|566194776|FG000|Part 1|Withdrawal by Subject|0|||
156847414|NCT00106353|566194777|FG001|Part 1|Withdrawal by Subject|0|||
156847415|NCT00106353|566194778|FG002|Part 1|Withdrawal by Subject|1|||
156847416|NCT00106353|566194779|FG003|Part 1|Withdrawal by Subject|2|||
156847417|NCT00106353|566194780|FG004|Part 1|Withdrawal by Subject|0|||
156847418|NCT00106353|566194781|FG005|Part 1|Withdrawal by Subject|0|||
156847419|NCT00106353|566194782|FG006|Part 1|Withdrawal by Subject|0|||
156847420|NCT00106353|566194776|FG000|Part 1|Symptomatic deterioration|0|||
156847421|NCT00106353|566194777|FG001|Part 1|Symptomatic deterioration|0|||
156847422|NCT00106353|566194778|FG002|Part 1|Symptomatic deterioration|1|||
156847423|NCT00106353|566194779|FG003|Part 1|Symptomatic deterioration|0|||
156847424|NCT00106353|566194780|FG004|Part 1|Symptomatic deterioration|0|||
156847425|NCT00106353|566194781|FG005|Part 1|Symptomatic deterioration|0|||
156847426|NCT00106353|566194782|FG006|Part 1|Symptomatic deterioration|0|||
156847427|NCT00106353|566194776|FG000|Part 1|Entered follow-up phase|1|||
156847428|NCT00106353|566194777|FG001|Part 1|Entered follow-up phase|1|||
156847429|NCT00106353|566194778|FG002|Part 1|Entered follow-up phase|0|||
156847430|NCT00106353|566194779|FG003|Part 1|Entered follow-up phase|1|||
156847431|NCT00106353|566194780|FG004|Part 1|Entered follow-up phase|0|||
156847432|NCT00106353|566194781|FG005|Part 1|Entered follow-up phase|0|||
156847433|NCT00106353|566194782|FG006|Part 1|Entered follow-up phase|0|||
156847434|NCT00106353|566194776|FG000|Part 1|Adverse Event|0|||
156847435|NCT00106353|566194777|FG001|Part 1|Adverse Event|0|||
156847436|NCT00106353|566194778|FG002|Part 1|Adverse Event|0|||
156847437|NCT00106353|566194779|FG003|Part 1|Adverse Event|1|||
156847438|NCT00106353|566194780|FG004|Part 1|Adverse Event|0|||
156847439|NCT00106353|566194781|FG005|Part 1|Adverse Event|0|||
156847440|NCT00106353|566194782|FG006|Part 1|Adverse Event|0|||
156847441|NCT00106353|566194776|FG000|Part 2|Disease progression|0|||
156847442|NCT00106353|566194777|FG001|Part 2|Disease progression|0|||
156847443|NCT00106353|566194778|FG002|Part 2|Disease progression|0|||
156847444|NCT00106353|566194779|FG003|Part 2|Disease progression|0|||
156847445|NCT00106353|566194780|FG004|Part 2|Disease progression|8|||
156847446|NCT00106353|566194781|FG005|Part 2|Disease progression|14|||
156847447|NCT00106353|566194782|FG006|Part 2|Disease progression|13|||
156847448|NCT00106353|566194776|FG000|Part 2|Death|0|||
156847449|NCT00106353|566194777|FG001|Part 2|Death|0|||
156888239|NCT00053898|566349500|FG001|Overall Study|No follow-up data from any source|12|||
156888240|NCT00053898|566349499|FG000|Overall Study|Follow-up from telephone contact only|5|||
156888241|NCT00053898|566349500|FG001|Overall Study|Follow-up from telephone contact only|1|||
156888242|NCT00884377|566350530|FG000|Overall Study|Withdrawal by Subject|1|||
156888243|NCT00884377|566350531|FG001|Overall Study|Withdrawal by Subject|0|||
156888244|NCT00884377|566350530|FG000|Overall Study|Could not confirm diagnosis|1|||
156888245|NCT00884377|566350531|FG001|Overall Study|Could not confirm diagnosis|0|||
156888246|NCT00884377|566350530|FG000|Overall Study|Physician Decision|0|||
156888247|NCT00884377|566350531|FG001|Overall Study|Physician Decision|1|||
156847450|NCT00106353|566194778|FG002|Part 2|Death|0|||
156847451|NCT00106353|566194779|FG003|Part 2|Death|0|||
156847452|NCT00106353|566194780|FG004|Part 2|Death|3|||
156847453|NCT00106353|566194781|FG005|Part 2|Death|0|||
156847454|NCT00106353|566194782|FG006|Part 2|Death|1|||
156847455|NCT00106353|566194776|FG000|Part 2|Symptomatic deterioration|0|||
156847456|NCT00106353|566194777|FG001|Part 2|Symptomatic deterioration|0|||
156847457|NCT00106353|566194778|FG002|Part 2|Symptomatic deterioration|0|||
156847458|NCT00106353|566194779|FG003|Part 2|Symptomatic deterioration|0|||
156847459|NCT00106353|566194780|FG004|Part 2|Symptomatic deterioration|3|||
156847460|NCT00106353|566194781|FG005|Part 2|Symptomatic deterioration|0|||
156847461|NCT00106353|566194782|FG006|Part 2|Symptomatic deterioration|0|||
156847462|NCT00106353|566194776|FG000|Part 2|Adverse Event|0|||
156847463|NCT00106353|566194777|FG001|Part 2|Adverse Event|0|||
156847464|NCT00106353|566194778|FG002|Part 2|Adverse Event|0|||
156847465|NCT00106353|566194779|FG003|Part 2|Adverse Event|0|||
156847466|NCT00106353|566194780|FG004|Part 2|Adverse Event|0|||
156847467|NCT00106353|566194781|FG005|Part 2|Adverse Event|2|||
156847468|NCT00106353|566194782|FG006|Part 2|Adverse Event|1|||
156847469|NCT00106353|566194776|FG000|Part 2|Other|0|||
156847470|NCT00106353|566194777|FG001|Part 2|Other|0|||
156847471|NCT00106353|566194778|FG002|Part 2|Other|0|||
156847472|NCT00106353|566194779|FG003|Part 2|Other|0|||
156847473|NCT00106353|566194780|FG004|Part 2|Other|1|||
156847474|NCT00106353|566194781|FG005|Part 2|Other|1|||
156847475|NCT00106353|566194782|FG006|Part 2|Other|1|||
156847476|NCT00106353|566194776|FG000|Part 2|Withdrawal by Subject|0|||
156847477|NCT00106353|566194777|FG001|Part 2|Withdrawal by Subject|0|||
156847478|NCT00106353|566194778|FG002|Part 2|Withdrawal by Subject|0|||
156847479|NCT00106353|566194779|FG003|Part 2|Withdrawal by Subject|0|||
156847480|NCT00106353|566194780|FG004|Part 2|Withdrawal by Subject|1|||
156847481|NCT00106353|566194781|FG005|Part 2|Withdrawal by Subject|0|||
156847482|NCT00106353|566194782|FG006|Part 2|Withdrawal by Subject|0|||
156847483|NCT00106353|566194776|FG000|Part 2|Physician Decision|0|||
156847484|NCT00106353|566194777|FG001|Part 2|Physician Decision|0|||
156847485|NCT00106353|566194778|FG002|Part 2|Physician Decision|0|||
156847486|NCT00106353|566194779|FG003|Part 2|Physician Decision|0|||
156847487|NCT00106353|566194780|FG004|Part 2|Physician Decision|0|||
156847488|NCT00106353|566194781|FG005|Part 2|Physician Decision|1|||
156847489|NCT00106353|566194782|FG006|Part 2|Physician Decision|0|||
156847490|NCT04039217|566194783|FG000|Overall Study|Lost to Follow-up|1|||
156847491|NCT03364309|566194784|FG000|Induction Period|Adverse Event|4|||
156847492|NCT03364309|566194785|FG001|Induction Period|Adverse Event|0|||
156847493|NCT03364309|566194786|FG002|Induction Period|Adverse Event|1|||
156847494|NCT03364309|566194787|FG003|Induction Period|Adverse Event|0|||
156847495|NCT03364309|566194788|FG004|Induction Period|Adverse Event|0|||
156847496|NCT03364309|566194789|FG005|Induction Period|Adverse Event|0|||
156847497|NCT03364309|566194790|FG006|Induction Period|Adverse Event|0|||
156847498|NCT03364309|566194791|FG007|Induction Period|Adverse Event|0|||
156847499|NCT03364309|566194792|FG008|Induction Period|Adverse Event|0|||
156847500|NCT03364309|566194793|FG009|Induction Period|Adverse Event|0|||
156847501|NCT03364309|566194794|FG010|Induction Period|Adverse Event|0|||
156847502|NCT03364309|566194795|FG011|Induction Period|Adverse Event|0|||
156847503|NCT03364309|566194796|FG012|Induction Period|Adverse Event|0|||
156847504|NCT03364309|566194797|FG013|Induction Period|Adverse Event|0|||
156847505|NCT03364309|566194798|FG014|Induction Period|Adverse Event|0|||
156847506|NCT03364309|566194799|FG015|Induction Period|Adverse Event|0|||
156847507|NCT03364309|566194800|FG016|Induction Period|Adverse Event|0|||
156888248|NCT04085367|566350532|FG000|Overall Study|Adverse Event|1|||
156888249|NCT04085367|566350533|FG001|Overall Study|Adverse Event|1|||
157025361|NCT05714761|566847952|FG000|Overall Study|Lost to Follow-up|3|||
157025362|NCT05714761|566847952|FG000|Overall Study|Withdrawal by Subject|3|||
156847508|NCT03364309|566194801|FG017|Induction Period|Adverse Event|0|||
156847509|NCT03364309|566194802|FG018|Induction Period|Adverse Event|0|||
156847510|NCT03364309|566194784|FG000|Induction Period|Withdrawal by Subject|1|||
156847511|NCT03364309|566194785|FG001|Induction Period|Withdrawal by Subject|3|||
156847512|NCT03364309|566194786|FG002|Induction Period|Withdrawal by Subject|0|||
156847513|NCT03364309|566194787|FG003|Induction Period|Withdrawal by Subject|0|||
156847514|NCT03364309|566194788|FG004|Induction Period|Withdrawal by Subject|0|||
156847515|NCT03364309|566194789|FG005|Induction Period|Withdrawal by Subject|0|||
156847516|NCT03364309|566194790|FG006|Induction Period|Withdrawal by Subject|0|||
156847517|NCT03364309|566194791|FG007|Induction Period|Withdrawal by Subject|0|||
156847518|NCT03364309|566194792|FG008|Induction Period|Withdrawal by Subject|0|||
156847519|NCT03364309|566194793|FG009|Induction Period|Withdrawal by Subject|0|||
156847520|NCT03364309|566194794|FG010|Induction Period|Withdrawal by Subject|0|||
156847521|NCT03364309|566194795|FG011|Induction Period|Withdrawal by Subject|0|||
156847522|NCT03364309|566194796|FG012|Induction Period|Withdrawal by Subject|0|||
156847523|NCT03364309|566194797|FG013|Induction Period|Withdrawal by Subject|0|||
156847524|NCT03364309|566194798|FG014|Induction Period|Withdrawal by Subject|0|||
156847525|NCT03364309|566194799|FG015|Induction Period|Withdrawal by Subject|0|||
156847526|NCT03364309|566194800|FG016|Induction Period|Withdrawal by Subject|0|||
156847527|NCT03364309|566194801|FG017|Induction Period|Withdrawal by Subject|0|||
156847528|NCT03364309|566194802|FG018|Induction Period|Withdrawal by Subject|0|||
156847529|NCT03364309|566194784|FG000|Induction Period|Lost to Follow-up|1|||
156847530|NCT03364309|566194785|FG001|Induction Period|Lost to Follow-up|0|||
156847531|NCT03364309|566194786|FG002|Induction Period|Lost to Follow-up|0|||
156847532|NCT03364309|566194787|FG003|Induction Period|Lost to Follow-up|0|||
156847533|NCT03364309|566194788|FG004|Induction Period|Lost to Follow-up|0|||
156847534|NCT03364309|566194789|FG005|Induction Period|Lost to Follow-up|0|||
156847535|NCT03364309|566194790|FG006|Induction Period|Lost to Follow-up|0|||
156847536|NCT03364309|566194791|FG007|Induction Period|Lost to Follow-up|0|||
156847537|NCT03364309|566194792|FG008|Induction Period|Lost to Follow-up|0|||
156847538|NCT03364309|566194793|FG009|Induction Period|Lost to Follow-up|0|||
156847539|NCT03364309|566194794|FG010|Induction Period|Lost to Follow-up|0|||
156847540|NCT03364309|566194795|FG011|Induction Period|Lost to Follow-up|0|||
156847541|NCT03364309|566194796|FG012|Induction Period|Lost to Follow-up|0|||
156847542|NCT03364309|566194797|FG013|Induction Period|Lost to Follow-up|0|||
156888250|NCT04085367|566350532|FG000|Overall Study|Withdrawal by Subject|13|||
156888251|NCT04085367|566350533|FG001|Overall Study|Withdrawal by Subject|4|||
156888252|NCT04085367|566350532|FG000|Overall Study|Lost to Follow-up|3|||
156888253|NCT04085367|566350533|FG001|Overall Study|Lost to Follow-up|1|||
156888254|NCT04085367|566350532|FG000|Overall Study|Other unspecified|2|||
156888255|NCT04085367|566350533|FG001|Overall Study|Other unspecified|1|||
156888256|NCT04085367|566350532|FG000|Overall Study|Status Unknown|1|||
156888257|NCT04085367|566350533|FG001|Overall Study|Status Unknown|1|||
156888258|NCT00130442|566350537|FG000|Overall Study|Withdrawal by Subject|0|||
156888259|NCT00130442|566350538|FG001|Overall Study|Withdrawal by Subject|1|||
156888260|NCT00130442|566350537|FG000|Overall Study|did not meet criteria|1|||
156888261|NCT00130442|566350538|FG001|Overall Study|did not meet criteria|1|||
156888262|NCT00814333|566350539|FG000|Enrollment|Lost to Follow-up|1|||
156888263|NCT00814333|566350540|FG001|Enrollment|Lost to Follow-up|0|||
156888264|NCT02233946|566350541|FG000|Baseline|Withdrawal by Subject|2|||
156888265|NCT02233946|566350542|FG001|Baseline|Withdrawal by Subject|0|||
156888266|NCT02233946|566350541|FG000|3-months Follow-up|Lost to Follow-up|53|||
156888267|NCT02233946|566350542|FG001|3-months Follow-up|Lost to Follow-up|29|||
156888268|NCT02233946|566350541|FG000|6-months Follow-up|Lost to Follow-up|21|||
156888269|NCT02233946|566350542|FG001|6-months Follow-up|Lost to Follow-up|2|||
156888270|NCT02233946|566350541|FG000|9-month Follow-up|Lost to Follow-up|20|||
156888271|NCT02233946|566350542|FG001|9-month Follow-up|Lost to Follow-up|11|||
156888272|NCT02233946|566350541|FG000|12-month Follow-up|Lost to Follow-up|28|||
156888273|NCT02233946|566350542|FG001|12-month Follow-up|Lost to Follow-up|11|||
156888274|NCT01527357|566350545|FG000|Overall Study|Death|8|||
156888275|NCT01527357|566350546|FG001|Overall Study|Death|2|||
156888276|NCT01527357|566350545|FG000|Overall Study|Lost to Follow-up|6|||
156888277|NCT01527357|566350546|FG001|Overall Study|Lost to Follow-up|4|||
156888278|NCT01527357|566350545|FG000|Overall Study|Withdrew Consent|1|||
156888279|NCT01527357|566350546|FG001|Overall Study|Withdrew Consent|1|||
156888280|NCT01527357|566350545|FG000|Overall Study|Non-compliance|0|||
156888281|NCT01527357|566350546|FG001|Overall Study|Non-compliance|1|||
156888282|NCT01527357|566350545|FG000|Overall Study|No Day 29 Visit|0|||
156888283|NCT01527357|566350546|FG001|Overall Study|No Day 29 Visit|1|||
156888284|NCT01527357|566350545|FG000|Overall Study|Did Not Receive Treatment|2|||
156847543|NCT03364309|566194798|FG014|Induction Period|Lost to Follow-up|0|||
156847544|NCT03364309|566194799|FG015|Induction Period|Lost to Follow-up|0|||
156847545|NCT03364309|566194800|FG016|Induction Period|Lost to Follow-up|0|||
156847546|NCT03364309|566194801|FG017|Induction Period|Lost to Follow-up|0|||
156847547|NCT03364309|566194802|FG018|Induction Period|Lost to Follow-up|0|||
156888285|NCT01527357|566350546|FG001|Overall Study|Did Not Receive Treatment|0|||
156888286|NCT00910247|566350547|FG000|Overall Study|Adverse Event|15|||
156888287|NCT00910247|566350547|FG000|Overall Study|Death|2|||
156888288|NCT00910247|566350547|FG000|Overall Study|Lost to Follow-up|10|||
156888289|NCT00910247|566350547|FG000|Overall Study|Physician Decision|3|||
156888290|NCT00910247|566350547|FG000|Overall Study|Protocol Violation|10|||
156888291|NCT00910247|566350547|FG000|Overall Study|Withdrawal by Subject|25|||
157025363|NCT05714761|566847952|FG000|Overall Study|unblinding of sensor data|1|||
157025364|NCT05714761|566847952|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
157025365|NCT05714761|566847952|FG000|Overall Study|did not return second CGM sensor|4|||
156888292|NCT00910247|566350547|FG000|Overall Study|Not collected|4|||
156847548|NCT03364309|566194784|FG000|Induction Period|Physician Decision|0|||
156847549|NCT03364309|566194785|FG001|Induction Period|Physician Decision|1|||
156888293|NCT01879579|566350548|FG000|Overall Study|Phone incompatible with texting platform|3|||
156847550|NCT03364309|566194786|FG002|Induction Period|Physician Decision|0|||
156847551|NCT03364309|566194787|FG003|Induction Period|Physician Decision|0|||
156847552|NCT03364309|566194788|FG004|Induction Period|Physician Decision|0|||
156847553|NCT03364309|566194789|FG005|Induction Period|Physician Decision|0|||
156847554|NCT03364309|566194790|FG006|Induction Period|Physician Decision|0|||
156847555|NCT03364309|566194791|FG007|Induction Period|Physician Decision|0|||
156847556|NCT03364309|566194792|FG008|Induction Period|Physician Decision|0|||
156847557|NCT03364309|566194793|FG009|Induction Period|Physician Decision|0|||
156847558|NCT03364309|566194794|FG010|Induction Period|Physician Decision|0|||
156847559|NCT03364309|566194795|FG011|Induction Period|Physician Decision|0|||
156847560|NCT03364309|566194796|FG012|Induction Period|Physician Decision|0|||
156847561|NCT03364309|566194797|FG013|Induction Period|Physician Decision|0|||
156847562|NCT03364309|566194798|FG014|Induction Period|Physician Decision|0|||
156847563|NCT03364309|566194799|FG015|Induction Period|Physician Decision|0|||
156847564|NCT03364309|566194800|FG016|Induction Period|Physician Decision|0|||
156847565|NCT03364309|566194801|FG017|Induction Period|Physician Decision|0|||
156847566|NCT03364309|566194802|FG018|Induction Period|Physician Decision|0|||
156847567|NCT03364309|566194784|FG000|Maintenance Period|Withdrawal by Subject|0|||
156847568|NCT03364309|566194785|FG001|Maintenance Period|Withdrawal by Subject|0|||
156847569|NCT03364309|566194786|FG002|Maintenance Period|Withdrawal by Subject|0|||
156847570|NCT03364309|566194787|FG003|Maintenance Period|Withdrawal by Subject|1|||
156847571|NCT03364309|566194788|FG004|Maintenance Period|Withdrawal by Subject|3|||
156847572|NCT03364309|566194789|FG005|Maintenance Period|Withdrawal by Subject|1|||
156847573|NCT03364309|566194790|FG006|Maintenance Period|Withdrawal by Subject|3|||
156847574|NCT03364309|566194791|FG007|Maintenance Period|Withdrawal by Subject|0|||
156847575|NCT03364309|566194792|FG008|Maintenance Period|Withdrawal by Subject|1|||
156847576|NCT03364309|566194793|FG009|Maintenance Period|Withdrawal by Subject|1|||
156847577|NCT03364309|566194794|FG010|Maintenance Period|Withdrawal by Subject|2|||
156847578|NCT03364309|566194795|FG011|Maintenance Period|Withdrawal by Subject|0|||
156847579|NCT03364309|566194796|FG012|Maintenance Period|Withdrawal by Subject|0|||
156847580|NCT03364309|566194797|FG013|Maintenance Period|Withdrawal by Subject|0|||
156847581|NCT03364309|566194798|FG014|Maintenance Period|Withdrawal by Subject|0|||
156847582|NCT03364309|566194799|FG015|Maintenance Period|Withdrawal by Subject|0|||
156847583|NCT03364309|566194800|FG016|Maintenance Period|Withdrawal by Subject|0|||
156888294|NCT01879579|566350549|FG001|Overall Study|Phone incompatible with texting platform|0|||
156888295|NCT01879579|566350548|FG000|Overall Study|Did not enroll in texting platform|1|||
156888296|NCT01879579|566350549|FG001|Overall Study|Did not enroll in texting platform|0|||
156888297|NCT01879579|566350548|FG000|Overall Study|Did not initiate insulin treatment|1|||
156888298|NCT01879579|566350549|FG001|Overall Study|Did not initiate insulin treatment|0|||
156888299|NCT01879579|566350548|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
156888300|NCT01879579|566350549|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
156888301|NCT01879579|566350548|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
156888302|NCT01879579|566350549|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
156888303|NCT02927067|566350550|FG000|Overall Study|Withdrawn Consent|20|||
156888304|NCT02927067|566350551|FG001|Overall Study|Withdrawn Consent|12|||
156888305|NCT02927067|566350550|FG000|Overall Study|Death|18|||
156888306|NCT02927067|566350551|FG001|Overall Study|Death|31|||
156888307|NCT02927067|566350550|FG000|Overall Study|Adverse Event|13|||
156888308|NCT02927067|566350551|FG001|Overall Study|Adverse Event|10|||
156888309|NCT02927067|566350550|FG000|Overall Study|Noncompliance|5|||
156888310|NCT02927067|566350551|FG001|Overall Study|Noncompliance|2|||
156888311|NCT02927067|566350550|FG000|Overall Study|Reason not Specified|4|||
156888312|NCT02927067|566350551|FG001|Overall Study|Reason not Specified|6|||
156888313|NCT00134784|566350554|FG000|Overall Study|Withdrawal by Subject|2|||
156888314|NCT00134784|566350555|FG001|Overall Study|Withdrawal by Subject|2|||
156888315|NCT00134784|566350556|FG002|Overall Study|Withdrawal by Subject|2|||
157025366|NCT05672069|566847953|FG000|Overall Study|Implant removal|1|||
157025367|NCT05672069|566847953|FG000|Overall Study|Lost to Follow-up|2|||
157025368|NCT03544281|566847956|FG000|Main Study Phase|Death|3|||
157025369|NCT03544281|566847957|FG001|Main Study Phase|Death|2|||
157025370|NCT03544281|566847958|FG002|Main Study Phase|Death|6|||
157025371|NCT03544281|566847959|FG003|Main Study Phase|Death|8|||
156888316|NCT00134784|566350557|FG003|Overall Study|Withdrawal by Subject|1|||
156888317|NCT03384693|566350558|FG000|Overall Study|Adverse Event|3|||
156888318|NCT01099709|566350559|FG000|Period 1|Withdrawal by Subject|0|||
156888319|NCT01099709|566350560|FG001|Period 1|Withdrawal by Subject|1|||
157025372|NCT03544281|566847960|FG004|Main Study Phase|Death|4|||
157025373|NCT03544281|566847961|FG005|Main Study Phase|Death|2|||
156847584|NCT03364309|566194801|FG017|Maintenance Period|Withdrawal by Subject|0|||
156847585|NCT03364309|566194802|FG018|Maintenance Period|Withdrawal by Subject|0|||
156888320|NCT01099709|566350559|FG000|Period 1|Positive cotinine test|0|||
156847586|NCT03364309|566194784|FG000|Maintenance Period|Adverse Event|0|||
156847587|NCT03364309|566194785|FG001|Maintenance Period|Adverse Event|0|||
156888321|NCT01099709|566350560|FG001|Period 1|Positive cotinine test|1|||
156888322|NCT01099709|566350559|FG000|Period 1|Adverse Event|1|||
157025374|NCT03544281|566847962|FG006|Main Study Phase|Death|4|||
156847588|NCT03364309|566194786|FG002|Maintenance Period|Adverse Event|0|||
156847589|NCT03364309|566194787|FG003|Maintenance Period|Adverse Event|0|||
156847590|NCT03364309|566194788|FG004|Maintenance Period|Adverse Event|2|||
156847591|NCT03364309|566194789|FG005|Maintenance Period|Adverse Event|0|||
156847592|NCT03364309|566194790|FG006|Maintenance Period|Adverse Event|3|||
156847593|NCT03364309|566194791|FG007|Maintenance Period|Adverse Event|0|||
156847594|NCT03364309|566194792|FG008|Maintenance Period|Adverse Event|1|||
156847595|NCT03364309|566194793|FG009|Maintenance Period|Adverse Event|0|||
156847596|NCT03364309|566194794|FG010|Maintenance Period|Adverse Event|2|||
156847597|NCT03364309|566194795|FG011|Maintenance Period|Adverse Event|0|||
156847598|NCT03364309|566194796|FG012|Maintenance Period|Adverse Event|0|||
156847599|NCT03364309|566194797|FG013|Maintenance Period|Adverse Event|0|||
156847600|NCT03364309|566194798|FG014|Maintenance Period|Adverse Event|0|||
156847601|NCT03364309|566194799|FG015|Maintenance Period|Adverse Event|0|||
156847602|NCT03364309|566194800|FG016|Maintenance Period|Adverse Event|0|||
156847603|NCT03364309|566194801|FG017|Maintenance Period|Adverse Event|0|||
156847604|NCT03364309|566194802|FG018|Maintenance Period|Adverse Event|0|||
156847605|NCT03364309|566194784|FG000|Maintenance Period|Relapsed|0|||
156847606|NCT03364309|566194785|FG001|Maintenance Period|Relapsed|0|||
156847607|NCT03364309|566194786|FG002|Maintenance Period|Relapsed|0|||
156847608|NCT03364309|566194787|FG003|Maintenance Period|Relapsed|43|||
156847609|NCT03364309|566194788|FG004|Maintenance Period|Relapsed|7|||
156847610|NCT03364309|566194789|FG005|Maintenance Period|Relapsed|45|||
156847611|NCT03364309|566194790|FG006|Maintenance Period|Relapsed|10|||
156847612|NCT03364309|566194791|FG007|Maintenance Period|Relapsed|2|||
156847613|NCT03364309|566194792|FG008|Maintenance Period|Relapsed|0|||
156847614|NCT03364309|566194793|FG009|Maintenance Period|Relapsed|0|||
156847615|NCT03364309|566194794|FG010|Maintenance Period|Relapsed|0|||
156847616|NCT03364309|566194795|FG011|Maintenance Period|Relapsed|0|||
156847617|NCT03364309|566194796|FG012|Maintenance Period|Relapsed|0|||
156847618|NCT03364309|566194797|FG013|Maintenance Period|Relapsed|0|||
156847619|NCT03364309|566194798|FG014|Maintenance Period|Relapsed|0|||
156847620|NCT03364309|566194799|FG015|Maintenance Period|Relapsed|0|||
156847621|NCT03364309|566194800|FG016|Maintenance Period|Relapsed|0|||
156847622|NCT03364309|566194801|FG017|Maintenance Period|Relapsed|0|||
156847623|NCT03364309|566194802|FG018|Maintenance Period|Relapsed|0|||
156847624|NCT03364309|566194784|FG000|Maintenance Period|Lack of Efficacy|0|||
156847625|NCT03364309|566194785|FG001|Maintenance Period|Lack of Efficacy|0|||
156847626|NCT03364309|566194786|FG002|Maintenance Period|Lack of Efficacy|0|||
156847627|NCT03364309|566194787|FG003|Maintenance Period|Lack of Efficacy|0|||
156847628|NCT03364309|566194788|FG004|Maintenance Period|Lack of Efficacy|0|||
156847629|NCT03364309|566194789|FG005|Maintenance Period|Lack of Efficacy|0|||
156847630|NCT03364309|566194790|FG006|Maintenance Period|Lack of Efficacy|0|||
156847631|NCT03364309|566194791|FG007|Maintenance Period|Lack of Efficacy|0|||
156847632|NCT03364309|566194792|FG008|Maintenance Period|Lack of Efficacy|1|||
156847633|NCT03364309|566194793|FG009|Maintenance Period|Lack of Efficacy|3|||
156847634|NCT03364309|566194794|FG010|Maintenance Period|Lack of Efficacy|2|||
156847635|NCT03364309|566194795|FG011|Maintenance Period|Lack of Efficacy|0|||
156847636|NCT03364309|566194796|FG012|Maintenance Period|Lack of Efficacy|0|||
156847637|NCT03364309|566194797|FG013|Maintenance Period|Lack of Efficacy|0|||
156847638|NCT03364309|566194798|FG014|Maintenance Period|Lack of Efficacy|0|||
156847639|NCT03364309|566194799|FG015|Maintenance Period|Lack of Efficacy|0|||
156847640|NCT03364309|566194800|FG016|Maintenance Period|Lack of Efficacy|0|||
156847641|NCT03364309|566194801|FG017|Maintenance Period|Lack of Efficacy|0|||
156847642|NCT03364309|566194802|FG018|Maintenance Period|Lack of Efficacy|0|||
156847643|NCT03364309|566194784|FG000|Maintenance Period|Death|0|||
156847644|NCT03364309|566194785|FG001|Maintenance Period|Death|0|||
156847645|NCT03364309|566194786|FG002|Maintenance Period|Death|0|||
156847646|NCT03364309|566194787|FG003|Maintenance Period|Death|0|||
156847647|NCT03364309|566194788|FG004|Maintenance Period|Death|0|||
156847648|NCT03364309|566194789|FG005|Maintenance Period|Death|0|||
156847649|NCT03364309|566194790|FG006|Maintenance Period|Death|0|||
156847650|NCT03364309|566194791|FG007|Maintenance Period|Death|0|||
157224812|NCT00576381|567569885|FG000|Overall Study|Adverse Event|4|||
156847651|NCT03364309|566194792|FG008|Maintenance Period|Death|1|||
156847652|NCT03364309|566194793|FG009|Maintenance Period|Death|0|||
156847653|NCT03364309|566194794|FG010|Maintenance Period|Death|0|||
156847654|NCT03364309|566194795|FG011|Maintenance Period|Death|0|||
157224813|NCT02518113|567569886|FG000|Overall Study|Adverse Event|1|||
156847655|NCT03364309|566194796|FG012|Maintenance Period|Death|0|||
156847656|NCT03364309|566194797|FG013|Maintenance Period|Death|0|||
156847657|NCT03364309|566194798|FG014|Maintenance Period|Death|0|||
156847658|NCT03364309|566194799|FG015|Maintenance Period|Death|0|||
156847659|NCT03364309|566194800|FG016|Maintenance Period|Death|0|||
156847660|NCT03364309|566194801|FG017|Maintenance Period|Death|0|||
156847661|NCT03364309|566194802|FG018|Maintenance Period|Death|0|||
156847662|NCT03364309|566194784|FG000|Maintenance Period|Lost to Follow-up|0|||
156847663|NCT03364309|566194785|FG001|Maintenance Period|Lost to Follow-up|0|||
156847664|NCT03364309|566194786|FG002|Maintenance Period|Lost to Follow-up|0|||
156847665|NCT03364309|566194787|FG003|Maintenance Period|Lost to Follow-up|0|||
156847666|NCT03364309|566194788|FG004|Maintenance Period|Lost to Follow-up|0|||
156847667|NCT03364309|566194789|FG005|Maintenance Period|Lost to Follow-up|0|||
156847668|NCT03364309|566194790|FG006|Maintenance Period|Lost to Follow-up|0|||
156847669|NCT03364309|566194791|FG007|Maintenance Period|Lost to Follow-up|0|||
156847670|NCT03364309|566194792|FG008|Maintenance Period|Lost to Follow-up|1|||
156847671|NCT03364309|566194793|FG009|Maintenance Period|Lost to Follow-up|0|||
156847672|NCT03364309|566194794|FG010|Maintenance Period|Lost to Follow-up|0|||
156847673|NCT03364309|566194795|FG011|Maintenance Period|Lost to Follow-up|0|||
156847674|NCT03364309|566194796|FG012|Maintenance Period|Lost to Follow-up|0|||
156847675|NCT03364309|566194797|FG013|Maintenance Period|Lost to Follow-up|0|||
156847676|NCT03364309|566194798|FG014|Maintenance Period|Lost to Follow-up|0|||
156847677|NCT03364309|566194799|FG015|Maintenance Period|Lost to Follow-up|0|||
156847678|NCT03364309|566194800|FG016|Maintenance Period|Lost to Follow-up|0|||
157224814|NCT02518113|567569887|FG001|Overall Study|Adverse Event|0|||
157224815|NCT02518113|567569888|FG002|Overall Study|Adverse Event|1|||
157224816|NCT02518113|567569889|FG003|Overall Study|Adverse Event|0|||
157224817|NCT02518113|567569886|FG000|Overall Study|Death|1|||
157224818|NCT02518113|567569887|FG001|Overall Study|Death|2|||
157224819|NCT02518113|567569888|FG002|Overall Study|Death|0|||
157224820|NCT02518113|567569889|FG003|Overall Study|Death|0|||
157224821|NCT02518113|567569886|FG000|Overall Study|Physician Decision|0|||
157224822|NCT02518113|567569887|FG001|Overall Study|Physician Decision|1|||
157224823|NCT02518113|567569888|FG002|Overall Study|Physician Decision|0|||
157224824|NCT02518113|567569889|FG003|Overall Study|Physician Decision|0|||
157224825|NCT02518113|567569886|FG000|Overall Study|Progressive Disease|1|||
157224826|NCT02518113|567569887|FG001|Overall Study|Progressive Disease|2|||
157224827|NCT02518113|567569888|FG002|Overall Study|Progressive Disease|3|||
157224828|NCT02518113|567569889|FG003|Overall Study|Progressive Disease|0|||
157224829|NCT00797108|567569890|FG000|Overall Study|Adverse Event|1|||
157224830|NCT00797108|567569891|FG001|Overall Study|Adverse Event|0|||
157224831|NCT00797108|567569892|FG002|Overall Study|Adverse Event|3|||
157224832|NCT00797108|567569890|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
157224833|NCT00797108|567569891|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
157224834|NCT00797108|567569892|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
157224835|NCT00797108|567569890|FG000|Overall Study|Global Deterioration of Health Status|0|||
157224836|NCT00797108|567569891|FG001|Overall Study|Global Deterioration of Health Status|1|||
157224837|NCT00797108|567569892|FG002|Overall Study|Global Deterioration of Health Status|0|||
157224838|NCT00797108|567569890|FG000|Overall Study|Lack of Efficacy|1|||
157224839|NCT00797108|567569891|FG001|Overall Study|Lack of Efficacy|0|||
157224840|NCT00797108|567569892|FG002|Overall Study|Lack of Efficacy|1|||
157224841|NCT00797108|567569890|FG000|Overall Study|Other|0|||
157224842|NCT00797108|567569891|FG001|Overall Study|Other|0|||
156847679|NCT03364309|566194801|FG017|Maintenance Period|Lost to Follow-up|0|||
156847680|NCT03364309|566194802|FG018|Maintenance Period|Lost to Follow-up|0|||
156847681|NCT03364309|566194784|FG000|Maintenance Period|Miscellaneous|0|||
156847682|NCT03364309|566194785|FG001|Maintenance Period|Miscellaneous|0|||
156847683|NCT03364309|566194786|FG002|Maintenance Period|Miscellaneous|0|||
156847684|NCT03364309|566194787|FG003|Maintenance Period|Miscellaneous|0|||
156847685|NCT03364309|566194788|FG004|Maintenance Period|Miscellaneous|0|||
156847686|NCT03364309|566194789|FG005|Maintenance Period|Miscellaneous|0|||
156847687|NCT03364309|566194790|FG006|Maintenance Period|Miscellaneous|0|||
156847688|NCT03364309|566194791|FG007|Maintenance Period|Miscellaneous|0|||
156847689|NCT03364309|566194792|FG008|Maintenance Period|Miscellaneous|1|||
156847690|NCT03364309|566194793|FG009|Maintenance Period|Miscellaneous|0|||
156847691|NCT03364309|566194794|FG010|Maintenance Period|Miscellaneous|0|||
156847692|NCT03364309|566194795|FG011|Maintenance Period|Miscellaneous|0|||
156847693|NCT03364309|566194796|FG012|Maintenance Period|Miscellaneous|0|||
156847694|NCT03364309|566194797|FG013|Maintenance Period|Miscellaneous|0|||
156847695|NCT03364309|566194798|FG014|Maintenance Period|Miscellaneous|0|||
156847696|NCT03364309|566194799|FG015|Maintenance Period|Miscellaneous|0|||
157025375|NCT03544281|566847963|FG007|Main Study Phase|Death|5|||
157025376|NCT03544281|566847964|FG008|Main Study Phase|Death|5|||
157025377|NCT03544281|566847965|FG009|Main Study Phase|Death|8|||
157224843|NCT00797108|567569892|FG002|Overall Study|Other|2|||
156847697|NCT03364309|566194800|FG016|Maintenance Period|Miscellaneous|0|||
156847698|NCT03364309|566194801|FG017|Maintenance Period|Miscellaneous|0|||
156847699|NCT03364309|566194802|FG018|Maintenance Period|Miscellaneous|0|||
156847700|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847701|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847702|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
157025378|NCT03544281|566847966|FG010|Main Study Phase|Death|6|||
157224844|NCT00797108|567569890|FG000|Overall Study|Randomized but not Treated|2|||
157224845|NCT00797108|567569891|FG001|Overall Study|Randomized but not Treated|0|||
157224846|NCT00797108|567569892|FG002|Overall Study|Randomized but not Treated|0|||
157224847|NCT00287118|567569893|FG000|Overall Study|Adverse Event|30|||
157224848|NCT00287118|567569893|FG000|Overall Study|Death|1|||
157224849|NCT00287118|567569893|FG000|Overall Study|Lack of Efficacy|11|||
157224850|NCT00287118|567569893|FG000|Overall Study|Lost to Follow-up|1|||
157224851|NCT00287118|567569893|FG000|Overall Study|Protocol Violation|2|||
156847703|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847704|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847705|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847706|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847707|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847708|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847709|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847710|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847711|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847712|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847713|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847714|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847715|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
156847716|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847717|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847718|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
156847719|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847720|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847721|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847722|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847723|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847724|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847725|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847726|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847727|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847728|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847729|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
157224852|NCT00287118|567569893|FG000|Overall Study|Other|7|||
157224853|NCT02324465|567569894|FG000|Overall Study|device failure|0|||
157224854|NCT02324465|567569895|FG001|Overall Study|device failure|1|||
157224855|NCT01631864|567569896|FG000|Overall Study|Withdrawal by Subject|0|||
157224856|NCT01631864|567569897|FG001|Overall Study|Withdrawal by Subject|1|||
157224857|NCT01631864|567569896|FG000|Overall Study|Adverse Event|2|||
157224858|NCT01631864|567569897|FG001|Overall Study|Adverse Event|3|||
157224859|NCT01031537|567569898|FG000|Overall Study|medical reasons not related to study|3|||
157224860|NCT01031537|567569898|FG000|Overall Study|Lack of Efficacy|1|||
157224861|NCT01031537|567569898|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
157224862|NCT01031537|567569898|FG000|Overall Study|moved, met exclusion criteria|10|||
157224863|NCT01031537|567569898|FG000|Overall Study|Withdrawal by Subject|5|||
157224864|NCT01031537|567569898|FG000|Overall Study|PI removal, no longer met eligibility|12|||
157224865|NCT01506947|567569922|FG000|Overall Study|Lost to Follow-up|7|||
157224866|NCT01506947|567569922|FG000|Overall Study|Adverse Event|5|||
157224867|NCT01506947|567569922|FG000|Overall Study|Death|1|||
157224868|NCT01506947|567569922|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
157224869|NCT00290745|567569924|FG000|Overall Study|Withdrawal by Subject|4|||
157224870|NCT00290745|567569924|FG000|Overall Study|Physician Decision|2|||
157224871|NCT00290745|567569924|FG000|Overall Study|Surgery after 3 months for progression|3|||
157224872|NCT00290745|567569924|FG000|Overall Study|Baseline MRI not available|3|||
157224873|NCT01802879|567569929|FG000|Overall Study|Administrative problems|2|||
157224874|NCT01802879|567569929|FG000|Overall Study|Disease progression|6|||
157224875|NCT00266409|567569930|FG000|Overall Study|Lack of Efficacy|2|||
157224876|NCT00266409|567569931|FG001|Overall Study|Lack of Efficacy|6|||
157224877|NCT00266409|567569932|FG002|Overall Study|Lack of Efficacy|1|||
157224878|NCT00266409|567569933|FG003|Overall Study|Lack of Efficacy|2|||
157224879|NCT00266409|567569930|FG000|Overall Study|Adverse Event|7|||
157224880|NCT00266409|567569931|FG001|Overall Study|Adverse Event|2|||
157224881|NCT00266409|567569932|FG002|Overall Study|Adverse Event|1|||
157224882|NCT00266409|567569933|FG003|Overall Study|Adverse Event|1|||
157224883|NCT00266409|567569930|FG000|Overall Study|Lost to Follow-up|18|||
156847730|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847731|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847732|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847733|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
156847734|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847735|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847736|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
157224884|NCT00266409|567569931|FG001|Overall Study|Lost to Follow-up|21|||
157224885|NCT00266409|567569932|FG002|Overall Study|Lost to Follow-up|6|||
157224886|NCT00266409|567569933|FG003|Overall Study|Lost to Follow-up|8|||
157224887|NCT00266409|567569930|FG000|Overall Study|Withdrawal by Subject|6|||
157224888|NCT00266409|567569931|FG001|Overall Study|Withdrawal by Subject|10|||
157224889|NCT00266409|567569932|FG002|Overall Study|Withdrawal by Subject|3|||
157224890|NCT00266409|567569933|FG003|Overall Study|Withdrawal by Subject|9|||
157224891|NCT00266409|567569930|FG000|Overall Study|Protocol Violation|5|||
156847737|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
156847738|NCT03364309|566194784|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
156847739|NCT03364309|566194785|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
156847740|NCT03364309|566194786|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
156847741|NCT03364309|566194787|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
156847742|NCT03364309|566194788|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
156847743|NCT03364309|566194789|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
156847744|NCT03364309|566194790|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
156847745|NCT03364309|566194791|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
156847746|NCT03364309|566194792|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
156847747|NCT03364309|566194793|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
156847748|NCT03364309|566194794|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
156847749|NCT03364309|566194795|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
156847750|NCT03364309|566194796|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
156847751|NCT03364309|566194797|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
156847752|NCT03364309|566194798|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
156847753|NCT03364309|566194799|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
156847754|NCT03364309|566194800|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
156847755|NCT03364309|566194801|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
156847756|NCT03364309|566194802|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
156847757|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847758|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847759|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847760|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847761|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847762|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847763|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847764|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847765|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847766|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847767|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847768|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847769|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847770|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847771|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847772|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
156847773|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
156847774|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
156847775|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
156847776|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Adverse Event|0|||
156847777|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Adverse Event|0|||
156847778|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Adverse Event|0|||
156847779|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Adverse Event|0|||
156847780|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Adverse Event|0|||
156847781|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Adverse Event|0|||
156847782|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Adverse Event|0|||
156847783|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Adverse Event|0|||
156847784|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Adverse Event|0|||
156847785|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Adverse Event|0|||
156847786|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Adverse Event|0|||
156847787|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Adverse Event|0|||
156847788|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Adverse Event|0|||
156847789|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Adverse Event|0|||
156847790|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Adverse Event|0|||
156847791|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Adverse Event|0|||
156847792|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Adverse Event|2|||
156847793|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Adverse Event|6|||
156847794|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Adverse Event|1|||
156847795|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847796|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847797|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847798|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847799|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847800|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847801|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847802|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847803|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847804|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847805|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
157155243|NCT00374907|567312930|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
156847806|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847807|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847808|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847809|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847810|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847811|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847812|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
156847813|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
156847814|NCT03364309|566194784|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
156847815|NCT03364309|566194785|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
156847816|NCT03364309|566194786|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
156847817|NCT03364309|566194787|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
156847818|NCT03364309|566194788|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
156847819|NCT03364309|566194789|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
156847820|NCT03364309|566194790|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
156847821|NCT03364309|566194791|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
156847822|NCT03364309|566194792|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
156847823|NCT03364309|566194793|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
156847824|NCT03364309|566194794|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
156847825|NCT03364309|566194795|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
156847826|NCT03364309|566194796|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
156847827|NCT03364309|566194797|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
157224892|NCT00266409|567569931|FG001|Overall Study|Protocol Violation|3|||
157224893|NCT00266409|567569932|FG002|Overall Study|Protocol Violation|4|||
157224894|NCT00266409|567569933|FG003|Overall Study|Protocol Violation|2|||
157224895|NCT00266409|567569930|FG000|Overall Study|Other|7|||
157224896|NCT00266409|567569931|FG001|Overall Study|Other|4|||
157224897|NCT00266409|567569932|FG002|Overall Study|Other|2|||
157224898|NCT00266409|567569933|FG003|Overall Study|Other|0|||
157224899|NCT00108732|567569936|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
157224900|NCT00108732|567569936|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
157224901|NCT00108732|567569936|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
157224902|NCT00108732|567569936|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
157224903|NCT00108732|567569936|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
157224904|NCT00108732|567569936|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
157224905|NCT00108732|567569936|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
157224906|NCT02187042|567569937|FG000|Overall Study|Death|1|||
157224907|NCT02187042|567569938|FG001|Overall Study|Death|1|||
157224908|NCT02187042|567569937|FG000|Overall Study|Toxicity|6|||
157224909|NCT02187042|567569938|FG001|Overall Study|Toxicity|5|||
157224910|NCT02187042|567569937|FG000|Overall Study|Participant choice|1|||
157224911|NCT02187042|567569938|FG001|Overall Study|Participant choice|0|||
157224912|NCT02187042|567569937|FG000|Overall Study|Doctor choice|1|||
157224913|NCT02187042|567569938|FG001|Overall Study|Doctor choice|0|||
157224914|NCT02187042|567569937|FG000|Overall Study|Progressive disease|4|||
157224915|NCT02187042|567569938|FG001|Overall Study|Progressive disease|8|||
157224916|NCT01766921|567569942|FG000|Overall Study|Administrative Reason|5|||
157224917|NCT01766921|567569943|FG001|Overall Study|Administrative Reason|5|||
157224918|NCT01766921|567569942|FG000|Overall Study|Death|1|||
157224919|NCT01766921|567569943|FG001|Overall Study|Death|1|||
157224920|NCT01766921|567569942|FG000|Overall Study|Lost to Follow-up|1|||
157224921|NCT01766921|567569943|FG001|Overall Study|Lost to Follow-up|3|||
157224922|NCT01766921|567569942|FG000|Overall Study|Unclassified|2|||
157224923|NCT01766921|567569943|FG001|Overall Study|Unclassified|2|||
157224924|NCT01766921|567569942|FG000|Overall Study|Protocol Violation|1|||
157224925|NCT01766921|567569943|FG001|Overall Study|Protocol Violation|1|||
157224926|NCT01766921|567569942|FG000|Overall Study|Withdrawal by Subject|14|||
157224927|NCT01766921|567569943|FG001|Overall Study|Withdrawal by Subject|5|||
157224928|NCT01901055|567569946|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
157224929|NCT01901055|567569947|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
157224930|NCT01901055|567569946|FG000|Randomization But Not Titrated|Physician Decision|0|||
157224931|NCT01901055|567569947|FG001|Randomization But Not Titrated|Physician Decision|1|||
156847828|NCT03364309|566194798|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
156888323|NCT01099709|566350560|FG001|Period 1|Adverse Event|0|||
157224932|NCT01901055|567569946|FG000|Started Protocol to Week 6|Physician Decision|2|||
157224933|NCT01901055|567569947|FG001|Started Protocol to Week 6|Physician Decision|1|||
157224934|NCT01901055|567569946|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
157224935|NCT01901055|567569947|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
157224936|NCT01901055|567569946|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
156847829|NCT03364309|566194799|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
157224937|NCT01901055|567569947|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
157224938|NCT01901055|567569946|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
157224939|NCT01901055|567569947|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
157224940|NCT01901055|567569946|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
157224941|NCT01901055|567569947|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
157224942|NCT01901055|567569946|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
157224943|NCT01901055|567569947|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
157224944|NCT01901055|567569946|FG000|Week 24|Withdrawal by Subject|13|||
157224945|NCT01901055|567569947|FG001|Week 24|Withdrawal by Subject|19|||
157224946|NCT01901055|567569946|FG000|Week 24|Physician Decision|1|||
157224947|NCT01901055|567569947|FG001|Week 24|Physician Decision|0|||
157224948|NCT01901055|567569946|FG000|Week 36|Withdrawal by Subject|0|||
157224949|NCT01901055|567569947|FG001|Week 36|Withdrawal by Subject|5|||
157224950|NCT03019965|567569950|FG000|Overall Study|Withdrawal by Subject|1|||
157224951|NCT03019965|567569951|FG001|Overall Study|Withdrawal by Subject|0|||
157224952|NCT03019965|567569950|FG000|Overall Study|Protocol Violation|1|||
157224953|NCT03019965|567569951|FG001|Overall Study|Protocol Violation|3|||
157224954|NCT03019965|567569950|FG000|Overall Study|viral or fungal infection|3|||
157224955|NCT03019965|567569951|FG001|Overall Study|viral or fungal infection|4|||
157224956|NCT03019965|567569950|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
157224957|NCT03019965|567569951|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
157224958|NCT03019965|567569950|FG000|Overall Study|Physician Decision|1|||
157224959|NCT03019965|567569951|FG001|Overall Study|Physician Decision|1|||
157224960|NCT00635154|567569952|FG000|Overall Study|Alternative Treatment|8|||
157224961|NCT00635154|567569952|FG000|Overall Study|Other|4|||
157224962|NCT00635154|567569952|FG000|Overall Study|Still on treatment|21|||
157224963|NCT01513148|567569953|FG000|Overall Study|Protocol Violation|2|||
157224964|NCT01513148|567569954|FG001|Overall Study|Protocol Violation|2|||
157224965|NCT03552757|567569955|FG000|Overall Study|Withdrawal by Subject|10|||
157224966|NCT03552757|567569956|FG001|Overall Study|Withdrawal by Subject|5|||
157224967|NCT03552757|567569957|FG002|Overall Study|Withdrawal by Subject|12|||
156847830|NCT03364309|566194800|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
156847831|NCT03364309|566194801|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
157224968|NCT03552757|567569955|FG000|Overall Study|Lost to Follow-up|2|||
157224969|NCT03552757|567569956|FG001|Overall Study|Lost to Follow-up|7|||
156847832|NCT03364309|566194802|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
156847833|NCT01371552|566194803|FG000|Part 1, First 3 Days|Inconvenience|0|||
156847834|NCT01371552|566194804|FG001|Part 1, First 3 Days|Inconvenience|0|||
156847835|NCT01371552|566194805|FG002|Part 1, First 3 Days|Inconvenience|1|||
156847836|NCT01371552|566194806|FG003|Part 1, First 3 Days|Inconvenience|0|||
156847837|NCT01371552|566194807|FG004|Part 1, First 3 Days|Inconvenience|0|||
156847838|NCT01371552|566194808|FG005|Part 1, First 3 Days|Inconvenience|0|||
156847839|NCT00167310|566194809|FG000|Overall Study|Protocol Violation|5|||
156847840|NCT00167310|566194810|FG001|Overall Study|Protocol Violation|3|||
156847841|NCT00167310|566194809|FG000|Overall Study|Withdrawal by Subject|3|||
156847842|NCT00167310|566194810|FG001|Overall Study|Withdrawal by Subject|7|||
156847843|NCT00615992|566194811|FG000|Overall Study|Protocol Violation|67|||
156847844|NCT01868477|566194813|FG000|Overall Study|Adverse Event|2|||
156847845|NCT01868477|566194814|FG001|Overall Study|Adverse Event|4|||
157224970|NCT03552757|567569957|FG002|Overall Study|Lost to Follow-up|7|||
157224971|NCT03552757|567569955|FG000|Overall Study|Death|1|||
157224972|NCT03552757|567569956|FG001|Overall Study|Death|1|||
157224973|NCT03552757|567569957|FG002|Overall Study|Death|1|||
157224974|NCT01862328|567569966|FG000|Overall Study|Progressive Disease|3|||
157224975|NCT01862328|567569967|FG001|Overall Study|Progressive Disease|11|||
157224976|NCT01862328|567569968|FG002|Overall Study|Progressive Disease|5|||
157224977|NCT01862328|567569969|FG003|Overall Study|Progressive Disease|6|||
157224978|NCT01862328|567569970|FG004|Overall Study|Progressive Disease|7|||
156847846|NCT01868477|566194813|FG000|Overall Study|Disease progression|1|||
156847847|NCT01868477|566194814|FG001|Overall Study|Disease progression|1|||
156847848|NCT01868477|566194813|FG000|Overall Study|Withdrawal by Subject|1|||
156847849|NCT01868477|566194814|FG001|Overall Study|Withdrawal by Subject|0|||
156847850|NCT01811186|566194816|FG000|Overall Study|Adverse Event|54|||
156847851|NCT01811186|566194817|FG001|Overall Study|Adverse Event|38|||
156847852|NCT01811186|566194816|FG000|Overall Study|Protocol Violation|5|||
156847853|NCT01811186|566194817|FG001|Overall Study|Protocol Violation|6|||
156847854|NCT01811186|566194816|FG000|Overall Study|Withdrawal by Subject|5|||
156847855|NCT01811186|566194817|FG001|Overall Study|Withdrawal by Subject|10|||
156847856|NCT01811186|566194816|FG000|Overall Study|Lack of Efficacy|3|||
157224979|NCT01862328|567569971|FG005|Overall Study|Progressive Disease|4|||
157224980|NCT01862328|567569972|FG006|Overall Study|Progressive Disease|3|||
157224981|NCT01862328|567569966|FG000|Overall Study|Adverse Event|0|||
156847857|NCT01811186|566194817|FG001|Overall Study|Lack of Efficacy|6|||
156847858|NCT01811186|566194816|FG000|Overall Study|Lost to Follow-up|4|||
156847859|NCT01811186|566194817|FG001|Overall Study|Lost to Follow-up|2|||
156847860|NCT02465203|566194818|FG000|Overall Study|Protocol Violation|1|||
156847861|NCT02465203|566194819|FG001|Overall Study|Protocol Violation|1|||
157224982|NCT01862328|567569967|FG001|Overall Study|Adverse Event|4|||
156847862|NCT02465203|566194820|FG002|Overall Study|Protocol Violation|1|||
157224983|NCT01862328|567569968|FG002|Overall Study|Adverse Event|0|||
157224984|NCT01862328|567569969|FG003|Overall Study|Adverse Event|1|||
156847863|NCT02465203|566194818|FG000|Overall Study|Study terminated by sponsor|50|||
156847864|NCT02465203|566194819|FG001|Overall Study|Study terminated by sponsor|34|||
156847865|NCT02465203|566194820|FG002|Overall Study|Study terminated by sponsor|11|||
156847866|NCT02465203|566194818|FG000|Overall Study|New therapy for study indication|4|||
156847867|NCT02465203|566194819|FG001|Overall Study|New therapy for study indication|0|||
156847868|NCT02465203|566194820|FG002|Overall Study|New therapy for study indication|0|||
156847869|NCT02465203|566194818|FG000|Overall Study|Patient/guardian decision|1|||
156847870|NCT02465203|566194819|FG001|Overall Study|Patient/guardian decision|1|||
156847871|NCT02465203|566194820|FG002|Overall Study|Patient/guardian decision|1|||
156847872|NCT00042991|566194821|FG000|Overall Study|Adverse Event|1|||
156847873|NCT00042991|566194822|FG001|Overall Study|Adverse Event|4|||
156847874|NCT00042991|566194823|FG002|Overall Study|Adverse Event|2|||
156847875|NCT00042991|566194824|FG003|Overall Study|Adverse Event|0|||
156847876|NCT00042991|566194825|FG004|Overall Study|Adverse Event|0|||
156847877|NCT00042991|566194826|FG005|Overall Study|Adverse Event|1|||
156847878|NCT00042991|566194827|FG006|Overall Study|Adverse Event|0|||
156847879|NCT00042991|566194821|FG000|Overall Study|Withdrawal by Subject|0|||
156847880|NCT00042991|566194822|FG001|Overall Study|Withdrawal by Subject|7|||
156847881|NCT00042991|566194823|FG002|Overall Study|Withdrawal by Subject|2|||
156847882|NCT00042991|566194824|FG003|Overall Study|Withdrawal by Subject|0|||
156847883|NCT00042991|566194825|FG004|Overall Study|Withdrawal by Subject|1|||
156847884|NCT00042991|566194826|FG005|Overall Study|Withdrawal by Subject|0|||
156847885|NCT00042991|566194827|FG006|Overall Study|Withdrawal by Subject|0|||
156847886|NCT00042991|566194821|FG000|Overall Study|Disease Progression|5|||
156847887|NCT00042991|566194822|FG001|Overall Study|Disease Progression|29|||
156847888|NCT00042991|566194823|FG002|Overall Study|Disease Progression|2|||
156847889|NCT00042991|566194824|FG003|Overall Study|Disease Progression|2|||
156847890|NCT00042991|566194825|FG004|Overall Study|Disease Progression|1|||
156847891|NCT00042991|566194826|FG005|Overall Study|Disease Progression|4|||
156847892|NCT00042991|566194827|FG006|Overall Study|Disease Progression|2|||
157155244|NCT00374907|567312929|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
157155245|NCT00374907|567312930|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
156847893|NCT00042991|566194821|FG000|Overall Study|Alternative Therapy|0|||
156847894|NCT00042991|566194822|FG001|Overall Study|Alternative Therapy|0|||
156847895|NCT00042991|566194823|FG002|Overall Study|Alternative Therapy|0|||
156847896|NCT00042991|566194824|FG003|Overall Study|Alternative Therapy|0|||
156847897|NCT00042991|566194825|FG004|Overall Study|Alternative Therapy|1|||
156847898|NCT00042991|566194826|FG005|Overall Study|Alternative Therapy|0|||
156847899|NCT00042991|566194827|FG006|Overall Study|Alternative Therapy|0|||
156847900|NCT04072887|566194836|FG000|Overall Study|Withdrawal by Subject|3|||
156847901|NCT04072887|566194837|FG001|Overall Study|Withdrawal by Subject|8|||
156847902|NCT04072887|566194838|FG002|Overall Study|Withdrawal by Subject|1|||
156847903|NCT04072887|566194839|FG003|Overall Study|Withdrawal by Subject|3|||
156847904|NCT04072887|566194840|FG004|Overall Study|Withdrawal by Subject|3|||
156847905|NCT04072887|566194841|FG005|Overall Study|Withdrawal by Subject|13|||
156847906|NCT04072887|566194836|FG000|Overall Study|Adverse Event|2|||
156847907|NCT04072887|566194837|FG001|Overall Study|Adverse Event|4|||
156847908|NCT04072887|566194838|FG002|Overall Study|Adverse Event|1|||
156847909|NCT04072887|566194839|FG003|Overall Study|Adverse Event|4|||
156847910|NCT04072887|566194840|FG004|Overall Study|Adverse Event|0|||
156847911|NCT04072887|566194841|FG005|Overall Study|Adverse Event|1|||
156847912|NCT04072887|566194836|FG000|Overall Study|Physician Decision|2|||
156847913|NCT04072887|566194837|FG001|Overall Study|Physician Decision|0|||
157155246|NCT00374907|567312929|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
157155247|NCT00374907|567312930|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
157155248|NCT00374907|567312929|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
157155249|NCT00374907|567312930|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
157155250|NCT00374907|567312929|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
157155251|NCT00374907|567312930|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
157155252|NCT01200511|567312934|FG000|Overall Study|Lost to Follow-up|3|||
157155253|NCT01200511|567312934|FG000|Overall Study|Withdrawal by Subject|1|||
157155254|NCT01200511|567312934|FG000|Overall Study|Adverse Event|1|||
156847914|NCT04072887|566194838|FG002|Overall Study|Physician Decision|0|||
156847915|NCT04072887|566194839|FG003|Overall Study|Physician Decision|0|||
156847916|NCT04072887|566194840|FG004|Overall Study|Physician Decision|0|||
156847917|NCT04072887|566194841|FG005|Overall Study|Physician Decision|1|||
156847918|NCT04072887|566194836|FG000|Overall Study|Lost to Follow-up|1|||
156847919|NCT04072887|566194837|FG001|Overall Study|Lost to Follow-up|3|||
157155255|NCT03382899|567312939|FG000|Overall Study|Ineligibility Determined|0|||
157155256|NCT03382899|567312940|FG001|Overall Study|Ineligibility Determined|1|||
157155257|NCT03382899|567312939|FG000|Overall Study|Lost to Follow-up|0|||
157155258|NCT03382899|567312940|FG001|Overall Study|Lost to Follow-up|1|||
157155259|NCT03382899|567312939|FG000|Overall Study|Sponsor's decision|31|||
156847920|NCT04072887|566194838|FG002|Overall Study|Lost to Follow-up|0|||
156847921|NCT04072887|566194839|FG003|Overall Study|Lost to Follow-up|0|||
157155260|NCT03382899|567312940|FG001|Overall Study|Sponsor's decision|28|||
157155261|NCT03382899|567312939|FG000|Overall Study|Withdrawal by Subject|0|||
157224985|NCT01862328|567569970|FG004|Overall Study|Adverse Event|0|||
157224986|NCT01862328|567569971|FG005|Overall Study|Adverse Event|2|||
157224987|NCT01862328|567569972|FG006|Overall Study|Adverse Event|4|||
157224988|NCT01862328|567569966|FG000|Overall Study|Other|0|||
157224989|NCT01862328|567569967|FG001|Overall Study|Other|2|||
157224990|NCT01862328|567569968|FG002|Overall Study|Other|1|||
157224991|NCT01862328|567569969|FG003|Overall Study|Other|0|||
157224992|NCT01862328|567569970|FG004|Overall Study|Other|4|||
157224993|NCT01862328|567569971|FG005|Overall Study|Other|0|||
157224994|NCT01862328|567569972|FG006|Overall Study|Other|1|||
157224995|NCT01862328|567569966|FG000|Overall Study|Withdrawal by Subject|1|||
157224996|NCT01862328|567569967|FG001|Overall Study|Withdrawal by Subject|1|||
157224997|NCT01862328|567569968|FG002|Overall Study|Withdrawal by Subject|0|||
157224998|NCT01862328|567569969|FG003|Overall Study|Withdrawal by Subject|0|||
156888324|NCT01611454|566350563|FG000|Overall Study|Lack of Efficacy|18|||
157224999|NCT01862328|567569970|FG004|Overall Study|Withdrawal by Subject|1|||
157225000|NCT01862328|567569971|FG005|Overall Study|Withdrawal by Subject|1|||
157225001|NCT01862328|567569972|FG006|Overall Study|Withdrawal by Subject|1|||
157225002|NCT01862328|567569966|FG000|Overall Study|Symptomatic Deterioration|0|||
157225003|NCT01862328|567569967|FG001|Overall Study|Symptomatic Deterioration|0|||
157225004|NCT01862328|567569968|FG002|Overall Study|Symptomatic Deterioration|0|||
157225005|NCT01862328|567569969|FG003|Overall Study|Symptomatic Deterioration|0|||
157225006|NCT01862328|567569970|FG004|Overall Study|Symptomatic Deterioration|0|||
157225007|NCT01862328|567569971|FG005|Overall Study|Symptomatic Deterioration|0|||
157225008|NCT01862328|567569972|FG006|Overall Study|Symptomatic Deterioration|1|||
157225009|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
157225010|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
157225011|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Death|0|||
157225012|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Death|1|||
157225013|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
157225014|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
157225015|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
157225016|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
157225017|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
157225018|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
157225019|NCT01656889|567569973|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
157225020|NCT01656889|567569974|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
157225021|NCT01656889|567569973|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
157225022|NCT01656889|567569974|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
157225023|NCT01656889|567569973|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
157225024|NCT01656889|567569974|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
157225025|NCT01656889|567569973|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
156847922|NCT04072887|566194840|FG004|Overall Study|Lost to Follow-up|0|||
156847923|NCT04072887|566194841|FG005|Overall Study|Lost to Follow-up|0|||
156847924|NCT04072887|566194836|FG000|Overall Study|Death|0|||
157225026|NCT01656889|567569974|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
157225027|NCT01656889|567569973|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
156847925|NCT04072887|566194837|FG001|Overall Study|Death|2|||
156847926|NCT04072887|566194838|FG002|Overall Study|Death|0|||
156847927|NCT04072887|566194839|FG003|Overall Study|Death|2|||
156888325|NCT01611454|566350564|FG001|Overall Study|Lack of Efficacy|10|||
156888326|NCT01397825|566350568|FG000|Overall Study|Progressive Disease|10|||
156888327|NCT01397825|566350569|FG001|Overall Study|Progressive Disease|3|||
156888328|NCT01397825|566350570|FG002|Overall Study|Progressive Disease|11|||
156888329|NCT01397825|566350571|FG003|Overall Study|Progressive Disease|1|||
156888330|NCT01397825|566350572|FG004|Overall Study|Progressive Disease|0|||
156888331|NCT01397825|566350568|FG000|Overall Study|Symptomatic Deterioration|2|||
156847928|NCT04072887|566194840|FG004|Overall Study|Death|3|||
156888332|NCT01397825|566350569|FG001|Overall Study|Symptomatic Deterioration|0|||
156888333|NCT01397825|566350570|FG002|Overall Study|Symptomatic Deterioration|4|||
157025379|NCT03544281|566847967|FG011|Main Study Phase|Death|4|||
157225028|NCT01656889|567569974|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
157225029|NCT02486796|567569975|FG000|Overall Study|Withdrawal by Subject|1|||
157225030|NCT02486796|567569976|FG001|Overall Study|Withdrawal by Subject|1|||
156847929|NCT04072887|566194841|FG005|Overall Study|Death|0|||
157225031|NCT02486796|567569975|FG000|Overall Study|Physician Decision|1|||
156847930|NCT00856297|566194842|FG000|Overall Study|Unable to classify|2|||
157225032|NCT02486796|567569976|FG001|Overall Study|Physician Decision|0|||
157225033|NCT03276975|567569977|FG000|Overall Study|Withdrawal by Subject|1|||
156847931|NCT00856297|566194843|FG001|Overall Study|Unable to classify|0|||
156847932|NCT00856297|566194844|FG002|Overall Study|Unable to classify|0|||
156888334|NCT01397825|566350571|FG003|Overall Study|Symptomatic Deterioration|0|||
157025380|NCT03544281|566847968|FG012|Main Study Phase|Death|0|||
157025381|NCT03544281|566847969|FG013|Main Study Phase|Death|0|||
156847933|NCT00856297|566194845|FG003|Overall Study|Unable to classify|0|||
157025382|NCT03544281|566847970|FG014|Main Study Phase|Death|0|||
157225034|NCT03276975|567569978|FG001|Overall Study|Withdrawal by Subject|0|||
157225035|NCT04471428|567569979|FG000|Overall Study|Withdrawal by Subject|29|||
157225036|NCT04471428|567569980|FG001|Overall Study|Withdrawal by Subject|4|||
157225037|NCT04471428|567569979|FG000|Overall Study|Physician Decision|0|||
157225038|NCT04471428|567569980|FG001|Overall Study|Physician Decision|1|||
157225039|NCT04471428|567569979|FG000|Overall Study|Reason Not Specified|0|||
157225040|NCT04471428|567569980|FG001|Overall Study|Reason Not Specified|2|||
157225041|NCT04471428|567569979|FG000|Overall Study|Death|131|||
157225042|NCT04471428|567569980|FG001|Overall Study|Death|147|||
157225043|NCT04471428|567569979|FG000|Overall Study|Lost to Follow-up|0|||
157225044|NCT04471428|567569980|FG001|Overall Study|Lost to Follow-up|3|||
157225045|NCT04471428|567569979|FG000|Overall Study|Study Terminated by Sponsor|20|||
157225046|NCT04471428|567569980|FG001|Overall Study|Study Terminated by Sponsor|29|||
156847934|NCT00856297|566194846|FG004|Overall Study|Unable to classify|0|||
156847935|NCT02508428|566194850|FG000|Overall Study|Death|32|||
156847936|NCT02508428|566194851|FG001|Overall Study|Death|33|||
156847937|NCT02508428|566194850|FG000|Overall Study|Liner revised|3|||
156847938|NCT02508428|566194851|FG001|Overall Study|Liner revised|19|||
156847939|NCT02508428|566194850|FG000|Overall Study|Incomplete follow-up|17|||
156847940|NCT02508428|566194851|FG001|Overall Study|Incomplete follow-up|15|||
157225047|NCT02928848|567569981|FG000|Arm 2|Withdrawal by Subject|1|||
157225048|NCT02928848|567569982|FG001|Arm 2|Withdrawal by Subject|0|||
157225049|NCT01463683|567569985|FG000|Overall Study|Adverse Event|2|||
157225050|NCT01463683|567569986|FG001|Overall Study|Adverse Event|0|||
157225051|NCT01463683|567569987|FG002|Overall Study|Adverse Event|0|||
157225052|NCT01463683|567569985|FG000|Overall Study|Lost to Follow-up|10|||
157225053|NCT01463683|567569986|FG001|Overall Study|Lost to Follow-up|9|||
157225054|NCT01463683|567569987|FG002|Overall Study|Lost to Follow-up|7|||
157225055|NCT01463683|567569985|FG000|Overall Study|Physician Decision|0|||
157225056|NCT01463683|567569986|FG001|Overall Study|Physician Decision|3|||
156847941|NCT01574651|566194854|FG000|Overall Study|Lost to Follow-up|2|||
157225057|NCT01463683|567569987|FG002|Overall Study|Physician Decision|1|||
157225058|NCT01463683|567569985|FG000|Overall Study|Pregnancy|2|||
157225059|NCT01463683|567569986|FG001|Overall Study|Pregnancy|2|||
157225060|NCT01463683|567569987|FG002|Overall Study|Pregnancy|1|||
156847942|NCT01574651|566194855|FG001|Overall Study|Lost to Follow-up|4|||
156847943|NCT01574651|566194854|FG000|Overall Study|Administrative problems|0|||
156847944|NCT01574651|566194855|FG001|Overall Study|Administrative problems|1|||
156847945|NCT01574651|566194854|FG000|Overall Study|Death|3|||
156847946|NCT01574651|566194855|FG001|Overall Study|Death|3|||
156847947|NCT01574651|566194854|FG000|Overall Study|Patient's inability to use the device|0|||
156847948|NCT01574651|566194855|FG001|Overall Study|Patient's inability to use the device|1|||
156847949|NCT01574651|566194854|FG000|Overall Study|Adverse Event|36|||
156847950|NCT01574651|566194855|FG001|Overall Study|Adverse Event|27|||
156847951|NCT01574651|566194854|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156847952|NCT01574651|566194855|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156847953|NCT01574651|566194854|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156847954|NCT01574651|566194855|FG001|Overall Study|Abnormal test procedure result(s)|1|||
156847955|NCT01574651|566194854|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156847956|NCT01574651|566194855|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156847957|NCT01574651|566194854|FG000|Overall Study|Protocol Violation|3|||
156847958|NCT01574651|566194855|FG001|Overall Study|Protocol Violation|5|||
156847959|NCT01574651|566194854|FG000|Overall Study|Withdrawal by Subject|9|||
156847960|NCT01574651|566194855|FG001|Overall Study|Withdrawal by Subject|10|||
156847961|NCT00445770|566194856|FG000|Overall Study|Adverse Event|9|||
156847962|NCT00445770|566194857|FG001|Overall Study|Adverse Event|15|||
156847963|NCT00445770|566194858|FG002|Overall Study|Adverse Event|19|||
157225061|NCT01463683|567569985|FG000|Overall Study|Withdrawal by Subject|5|||
157225062|NCT01463683|567569986|FG001|Overall Study|Withdrawal by Subject|17|||
157225063|NCT01463683|567569987|FG002|Overall Study|Withdrawal by Subject|2|||
157225064|NCT03111147|567569988|FG000|Overall Study|Lost to Follow-up|2|||
157225065|NCT03111147|567569989|FG001|Overall Study|Lost to Follow-up|5|||
157225066|NCT03111147|567569988|FG000|Overall Study|Withdrawal by Subject|4|||
157225067|NCT03111147|567569989|FG001|Overall Study|Withdrawal by Subject|3|||
157225068|NCT03111147|567569988|FG000|Overall Study|Protocol Violation|2|||
157225069|NCT03111147|567569989|FG001|Overall Study|Protocol Violation|1|||
157225070|NCT03111147|567569988|FG000|Overall Study|Death|1|||
157225071|NCT03111147|567569989|FG001|Overall Study|Death|1|||
157225072|NCT03384745|567569990|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
157225073|NCT03384745|567569991|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156847964|NCT00445770|566194856|FG000|Overall Study|Lack of Efficacy|38|||
156847965|NCT00445770|566194857|FG001|Overall Study|Lack of Efficacy|13|||
156847966|NCT00445770|566194858|FG002|Overall Study|Lack of Efficacy|6|||
156847967|NCT00445770|566194856|FG000|Overall Study|Lost to Follow-up|0|||
156847968|NCT00445770|566194857|FG001|Overall Study|Lost to Follow-up|2|||
157225074|NCT03384745|567569992|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
157225075|NCT03384745|567569993|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
156847969|NCT00445770|566194858|FG002|Overall Study|Lost to Follow-up|0|||
156847970|NCT00445770|566194856|FG000|Overall Study|Other|6|||
157225076|NCT03384745|567569994|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
156847971|NCT00445770|566194857|FG001|Overall Study|Other|5|||
156847972|NCT00445770|566194858|FG002|Overall Study|Other|6|||
156847973|NCT00947115|566194859|FG000|Overall Study|Missed reporting interval|3|||
156847974|NCT00947115|566194860|FG001|Overall Study|Missed reporting interval|4|||
156847975|NCT00947115|566194861|FG002|Overall Study|Missed reporting interval|2|||
156847976|NCT00947115|566194859|FG000|Overall Study|Physician Decision|0|||
156847977|NCT00947115|566194860|FG001|Overall Study|Physician Decision|2|||
156847978|NCT00947115|566194861|FG002|Overall Study|Physician Decision|0|||
156847979|NCT00947115|566194859|FG000|Overall Study|Death|0|||
156847980|NCT00947115|566194860|FG001|Overall Study|Death|1|||
156847981|NCT00947115|566194861|FG002|Overall Study|Death|1|||
156847982|NCT00947115|566194859|FG000|Overall Study|Migrated from study area|2|||
156847983|NCT00947115|566194860|FG001|Overall Study|Migrated from study area|0|||
156847984|NCT00947115|566194861|FG002|Overall Study|Migrated from study area|0|||
156847985|NCT00947115|566194859|FG000|Overall Study|Withdrawal by Subject|1|||
156847986|NCT00947115|566194860|FG001|Overall Study|Withdrawal by Subject|3|||
156847987|NCT00947115|566194861|FG002|Overall Study|Withdrawal by Subject|4|||
156847988|NCT00947115|566194859|FG000|Overall Study|Lost to Follow-up|11|||
156847989|NCT00947115|566194860|FG001|Overall Study|Lost to Follow-up|12|||
156847990|NCT00947115|566194861|FG002|Overall Study|Lost to Follow-up|8|||
156847991|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
156847992|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
156847993|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Adverse Event|4|||
156847994|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Adverse Event|1|||
156847995|NCT00934128|566194864|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
156888335|NCT01397825|566350572|FG004|Overall Study|Symptomatic Deterioration|0|||
156888336|NCT01397825|566350568|FG000|Overall Study|Adverse Event|0|||
156888337|NCT01397825|566350569|FG001|Overall Study|Adverse Event|1|||
156888338|NCT01397825|566350570|FG002|Overall Study|Adverse Event|5|||
156888339|NCT01397825|566350571|FG003|Overall Study|Adverse Event|1|||
156888340|NCT01397825|566350572|FG004|Overall Study|Adverse Event|0|||
156888341|NCT01397825|566350568|FG000|Overall Study|Withdrawal by Subject|1|||
156888342|NCT01397825|566350569|FG001|Overall Study|Withdrawal by Subject|0|||
156888343|NCT01397825|566350570|FG002|Overall Study|Withdrawal by Subject|5|||
156888344|NCT01397825|566350571|FG003|Overall Study|Withdrawal by Subject|1|||
156888345|NCT01397825|566350572|FG004|Overall Study|Withdrawal by Subject|0|||
156888346|NCT00329901|566350574|FG000|Overall Study|Withdrawal by Subject|4|||
156888347|NCT00329901|566350575|FG001|Overall Study|Withdrawal by Subject|3|||
156888348|NCT00329901|566350576|FG002|Overall Study|Withdrawal by Subject|2|||
156888349|NCT00329901|566350574|FG000|Overall Study|Lost to Follow-up|2|||
156888350|NCT00329901|566350575|FG001|Overall Study|Lost to Follow-up|0|||
156888351|NCT00329901|566350576|FG002|Overall Study|Lost to Follow-up|1|||
156888352|NCT00329901|566350574|FG000|Overall Study|Protocol Violation|1|||
156888353|NCT00329901|566350575|FG001|Overall Study|Protocol Violation|0|||
157155262|NCT03382899|567312940|FG001|Overall Study|Withdrawal by Subject|5|||
157155263|NCT00524745|567312942|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
157155264|NCT00524745|567312943|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
157155265|NCT00524745|567312944|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
157155266|NCT00524745|567312945|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
157155267|NCT02504892|567312946|FG000|Overall Study|Adverse event-pneumonitis|2|||
157155268|NCT00540449|567312947|FG000|Overall Study|Adverse Event|12|||
157155269|NCT00540449|567312948|FG001|Overall Study|Adverse Event|32|||
157155270|NCT00540449|567312947|FG000|Overall Study|Sponsor's Decision|1|||
157155271|NCT00540449|567312948|FG001|Overall Study|Sponsor's Decision|1|||
157155272|NCT00540449|567312947|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
157155273|NCT00540449|567312948|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
157155274|NCT00540449|567312947|FG000|Overall Study|Lost to Follow-up|19|||
157155275|NCT00540449|567312948|FG001|Overall Study|Lost to Follow-up|17|||
157155276|NCT00540449|567312947|FG000|Overall Study|Subject Non-Compliant|7|||
157155277|NCT00540449|567312948|FG001|Overall Study|Subject Non-Compliant|5|||
157155278|NCT00540449|567312947|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
157155279|NCT00540449|567312948|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
157155280|NCT00540449|567312947|FG000|Overall Study|Withdrawal by Subject|10|||
157155281|NCT00540449|567312948|FG001|Overall Study|Withdrawal by Subject|10|||
157155282|NCT00540449|567312947|FG000|Overall Study|Other|1|||
157155283|NCT00540449|567312948|FG001|Overall Study|Other|4|||
156847996|NCT00934128|566194865|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
156847997|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Patient preference|1|||
156847998|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Patient preference|3|||
156847999|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Pain|1|||
156848000|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Pain|0|||
156888354|NCT00329901|566350576|FG002|Overall Study|Protocol Violation|1|||
156888355|NCT00329901|566350574|FG000|Overall Study|Unable to classify|2|||
156888356|NCT00329901|566350575|FG001|Overall Study|Unable to classify|2|||
156888357|NCT00329901|566350576|FG002|Overall Study|Unable to classify|0|||
157025383|NCT03544281|566847971|FG015|Main Study Phase|Death|0|||
156848001|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Too tired|1|||
156848002|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Too tired|0|||
156848003|NCT00934128|566194864|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
156848004|NCT00934128|566194865|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
156848005|NCT00934128|566194864|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
156848006|NCT00934128|566194865|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
156848007|NCT03228212|566194866|FG000|Period 1|Adverse Event|1|||
156848008|NCT03228212|566194867|FG001|Period 1|Adverse Event|0|||
156848009|NCT03228212|566194866|FG000|Period 1|no longer meets eligibility criteria|0|||
156848010|NCT03228212|566194867|FG001|Period 1|no longer meets eligibility criteria|1|||
156848011|NCT03228212|566194866|FG000|Period 2|Lost to Follow-up|1|||
156848012|NCT03228212|566194867|FG001|Period 2|Lost to Follow-up|0|||
157225077|NCT03384745|567569995|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
157225078|NCT03384745|567569990|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
157225079|NCT03384745|567569991|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
157225080|NCT03384745|567569992|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
157225081|NCT03384745|567569993|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
157225082|NCT03384745|567569994|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
157225083|NCT03384745|567569995|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
157225084|NCT03384745|567569990|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
156848013|NCT01807299|566194868|FG000|Overall Study|Protocol Violation|3|||
156848014|NCT01807299|566194869|FG001|Overall Study|Protocol Violation|1|||
156848015|NCT01807299|566194870|FG002|Overall Study|Protocol Violation|0|||
156848016|NCT01807299|566194871|FG003|Overall Study|Protocol Violation|2|||
156848017|NCT01392547|566196662|FG000|Overall Study|Adverse Event|2|||
156848018|NCT01392547|566196662|FG000|Overall Study|Non-compliance|2|||
156848019|NCT01392547|566196662|FG000|Overall Study|Withdrawal criteria|3|||
156848020|NCT01392547|566196662|FG000|Overall Study|Unclassified|1|||
156848021|NCT01478971|566196673|FG000|Standard of Care Period|Adverse Event|1|||
156848022|NCT01478971|566196673|FG000|Standard of Care Period|Withdrawal by Subject|3|||
156848023|NCT01478971|566196673|FG000|Standard of Care Period|Death|8|||
156848024|NCT01478971|566196673|FG000|Standard of Care Period|Lost to Follow-up|9|||
156848025|NCT01478971|566196673|FG000|Standard of Care Period|Other|4|||
156848026|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Adverse Event|1|||
156848027|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
156848028|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Death|4|||
156848029|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
156848030|NCT01478971|566196673|FG000|Peginesatide Treatment Period|Other|4|||
156848031|NCT04404556|566196674|FG000|Intervention|Withdrawal by Subject|15|||
156848032|NCT04404556|566196675|FG001|Intervention|Withdrawal by Subject|3|||
156848033|NCT04404556|566196674|FG000|Intervention|Did not complete all intervention sessions|2|||
156848034|NCT04404556|566196675|FG001|Intervention|Did not complete all intervention sessions|1|||
156848035|NCT04404556|566196674|FG000|Post-Intervention|Missing Data|1|||
156848036|NCT04404556|566196675|FG001|Post-Intervention|Missing Data|2|||
156848037|NCT04404556|566196674|FG000|Follow-up 1|Withdrawal by Subject|5|||
156848038|NCT04404556|566196675|FG001|Follow-up 1|Withdrawal by Subject|1|||
156848039|NCT04404556|566196674|FG000|Follow-up 1|Missing Data|4|||
156848040|NCT04404556|566196675|FG001|Follow-up 1|Missing Data|7|||
156848041|NCT04404556|566196674|FG000|Follow-up 2|Withdrawal by Subject|1|||
156848042|NCT04404556|566196675|FG001|Follow-up 2|Withdrawal by Subject|1|||
156848043|NCT04404556|566196674|FG000|Follow-up 2|Missing Data|6|||
156848044|NCT04404556|566196675|FG001|Follow-up 2|Missing Data|5|||
156848045|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
156848046|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
156848047|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Death|0|||
156848048|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Death|1|||
156848049|NCT02451917|566196680|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
156848050|NCT02451917|566196681|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
156848051|NCT02871635|566196682|FG000|Overall Study|Primary lack of efficacy|4|||
156848052|NCT02871635|566196683|FG001|Overall Study|Primary lack of efficacy|4|||
156848053|NCT02871635|566196682|FG000|Overall Study|Protocol Violation|3|||
156848054|NCT02871635|566196683|FG001|Overall Study|Protocol Violation|1|||
156848055|NCT02871635|566196682|FG000|Overall Study|Lost to Follow-up|1|||
156848056|NCT02871635|566196683|FG001|Overall Study|Lost to Follow-up|2|||
156848057|NCT02871635|566196682|FG000|Overall Study|Pregnancy|0|||
156848058|NCT02871635|566196683|FG001|Overall Study|Pregnancy|2|||
156848059|NCT02871635|566196682|FG000|Overall Study|Physician Decision|1|||
156848060|NCT02871635|566196683|FG001|Overall Study|Physician Decision|1|||
156848061|NCT02871635|566196682|FG000|Overall Study|Withdrawal by Subject|3|||
156848062|NCT02871635|566196683|FG001|Overall Study|Withdrawal by Subject|4|||
157025384|NCT03544281|566847972|FG016|Main Study Phase|Death|0|||
157225085|NCT03384745|567569991|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
156848063|NCT02871635|566196682|FG000|Overall Study|Adverse Event|4|||
156848064|NCT02871635|566196683|FG001|Overall Study|Adverse Event|4|||
157025385|NCT03544281|566847973|FG017|Main Study Phase|Death|0|||
156848065|NCT02871635|566196682|FG000|Overall Study|Secondary lack of efficacy|2|||
156888358|NCT05028361|566350577|FG000|Overall Study|Withdrawal by Subject|1|||
156888359|NCT05028361|566350578|FG001|Overall Study|Withdrawal by Subject|0|||
156888360|NCT01993836|566350579|FG000|Overall Study|Surgery Cancelled|3|||
156888361|NCT01993836|566350580|FG001|Overall Study|Surgery Cancelled|0|||
156888362|NCT01993836|566350581|FG002|Overall Study|Surgery Cancelled|0|||
156888363|NCT01993836|566350579|FG000|Overall Study|Physician Decision|2|||
156848066|NCT02871635|566196683|FG001|Overall Study|Secondary lack of efficacy|1|||
156848067|NCT00502671|566196684|FG000|Overall Study|Disease Progression|13|||
156848068|NCT00502671|566196684|FG000|Overall Study|Personal Reasons|22|||
156848069|NCT00502671|566196684|FG000|Overall Study|Lost to Follow-up|7|||
156848070|NCT00502671|566196684|FG000|Overall Study|Protocol Violation|16|||
156848071|NCT00502671|566196684|FG000|Overall Study|Adverse Event|19|||
156848072|NCT01402817|566196685|FG000|Overall Study|Withdrawal by Subject|3|||
156848073|NCT01402817|566196685|FG000|Overall Study|Study Suspended by FDA|8|||
156848074|NCT00681629|566196686|FG000|Overall Study|Study termination|4|||
156848075|NCT00681629|566196687|FG001|Overall Study|Study termination|2|||
156848076|NCT00681629|566196686|FG000|Overall Study|Adverse Event|1|||
156848077|NCT00681629|566196687|FG001|Overall Study|Adverse Event|0|||
156848078|NCT00853151|566196689|FG000|Overall Study|Adverse Event|1|||
156848079|NCT00853151|566196690|FG001|Overall Study|Adverse Event|4|||
156848080|NCT00853151|566196691|FG002|Overall Study|Adverse Event|2|||
156848081|NCT00853151|566196692|FG003|Overall Study|Adverse Event|0|||
156848082|NCT00853151|566196689|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
156848083|NCT00853151|566196690|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156848084|NCT00853151|566196691|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156848085|NCT00853151|566196692|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156888364|NCT01993836|566350580|FG001|Overall Study|Physician Decision|1|||
156888365|NCT01993836|566350581|FG002|Overall Study|Physician Decision|0|||
156888366|NCT01993836|566350579|FG000|Overall Study|Death|0|||
156888367|NCT01993836|566350580|FG001|Overall Study|Death|2|||
156888368|NCT01993836|566350581|FG002|Overall Study|Death|0|||
156888369|NCT01993836|566350579|FG000|Overall Study|Withdrawal by Subject|12|||
156888370|NCT01993836|566350580|FG001|Overall Study|Withdrawal by Subject|10|||
156888371|NCT01993836|566350581|FG002|Overall Study|Withdrawal by Subject|5|||
156888372|NCT02296138|566350584|FG000|Overall Study|Adverse Event|348|||
156888373|NCT02296138|566350585|FG001|Overall Study|Adverse Event|259|||
156888374|NCT02296138|566350584|FG000|Overall Study|Lack of Efficacy|59|||
156888375|NCT02296138|566350585|FG001|Overall Study|Lack of Efficacy|37|||
156888376|NCT02296138|566350584|FG000|Overall Study|Protocol Violation|35|||
156888377|NCT02296138|566350585|FG001|Overall Study|Protocol Violation|36|||
156888378|NCT02296138|566350584|FG000|Overall Study|Lost to Follow-up|9|||
156888379|NCT02296138|566350585|FG001|Overall Study|Lost to Follow-up|12|||
156888380|NCT02296138|566350584|FG000|Overall Study|Withdrawal by Subject|184|||
156888381|NCT02296138|566350585|FG001|Overall Study|Withdrawal by Subject|131|||
156888382|NCT02296138|566350584|FG000|Overall Study|Not Treated|1|||
156888383|NCT02296138|566350585|FG001|Overall Study|Not Treated|1|||
156888384|NCT02296138|566350584|FG000|Overall Study|Patients with data irregularities|10|||
156888385|NCT02296138|566350585|FG001|Overall Study|Patients with data irregularities|11|||
156888386|NCT02296138|566350584|FG000|Overall Study|Other than specified|15|||
156888387|NCT02296138|566350585|FG001|Overall Study|Other than specified|13|||
156888388|NCT03828370|566350586|FG000|3 Month Follow-up|Lost to Follow-up|4|||
156888389|NCT03828370|566350587|FG001|3 Month Follow-up|Lost to Follow-up|12|||
156888390|NCT03828370|566350586|FG000|9 Month Follow up|Lost to Follow-up|12|||
156888391|NCT03828370|566350587|FG001|9 Month Follow up|Lost to Follow-up|20|||
156888392|NCT02677324|566350588|FG000|Overall Study|Disease Progression|6|||
156888393|NCT02677324|566350588|FG000|Overall Study|Inability to Swallow pills|1|||
156888394|NCT02677324|566350588|FG000|Overall Study|Non-compliance|1|||
156888395|NCT02677324|566350588|FG000|Overall Study|Lack of Efficacy|1|||
156888396|NCT02677324|566350588|FG000|Overall Study|Medical insurance coverage|1|||
156888397|NCT02677324|566350588|FG000|Overall Study|Adverse Event|1|||
156888398|NCT02677324|566350588|FG000|Overall Study|IgM Myeloma diagnosis|1|||
156888399|NCT00761150|566350591|FG000|Open-label Period|Adverse Event|36|||
156888400|NCT00761150|566350592|FG001|Open-label Period|Adverse Event|0|||
156888401|NCT00761150|566350593|FG002|Open-label Period|Adverse Event|0|||
156888402|NCT00761150|566350591|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
156888403|NCT00761150|566350592|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
156888404|NCT00761150|566350593|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
156888405|NCT00761150|566350591|FG000|Open-label Period|Lost to Follow-up|7|||
156888406|NCT00761150|566350592|FG001|Open-label Period|Lost to Follow-up|0|||
156888407|NCT00761150|566350593|FG002|Open-label Period|Lost to Follow-up|0|||
156888408|NCT00761150|566350591|FG000|Open-label Period|Lack of Efficacy|4|||
156888409|NCT00761150|566350592|FG001|Open-label Period|Lack of Efficacy|0|||
157025386|NCT03544281|566847974|FG018|Main Study Phase|Death|0|||
156848086|NCT00853151|566196689|FG000|Overall Study|Lost to Follow-up|2|||
156848087|NCT00853151|566196690|FG001|Overall Study|Lost to Follow-up|0|||
156848088|NCT00853151|566196691|FG002|Overall Study|Lost to Follow-up|3|||
156848089|NCT00853151|566196692|FG003|Overall Study|Lost to Follow-up|0|||
156848090|NCT00853151|566196689|FG000|Overall Study|Death|1|||
156848091|NCT00853151|566196690|FG001|Overall Study|Death|0|||
156848092|NCT00853151|566196691|FG002|Overall Study|Death|0|||
156848093|NCT00853151|566196692|FG003|Overall Study|Death|1|||
156848094|NCT00853151|566196689|FG000|Overall Study|Protocol Violation|0|||
156848095|NCT00853151|566196690|FG001|Overall Study|Protocol Violation|0|||
156848096|NCT00853151|566196691|FG002|Overall Study|Protocol Violation|0|||
156848097|NCT00853151|566196692|FG003|Overall Study|Protocol Violation|1|||
156848098|NCT00853151|566196689|FG000|Overall Study|Withdrawal by Subject|5|||
156848099|NCT00853151|566196690|FG001|Overall Study|Withdrawal by Subject|4|||
156848100|NCT00853151|566196691|FG002|Overall Study|Withdrawal by Subject|2|||
156848101|NCT00853151|566196692|FG003|Overall Study|Withdrawal by Subject|1|||
156848102|NCT00853151|566196689|FG000|Overall Study|Physician Decision|0|||
156848103|NCT00853151|566196690|FG001|Overall Study|Physician Decision|2|||
156848104|NCT00853151|566196691|FG002|Overall Study|Physician Decision|1|||
156848105|NCT00853151|566196692|FG003|Overall Study|Physician Decision|0|||
156848106|NCT00853151|566196689|FG000|Overall Study|Sponsor Decision|0|||
156848107|NCT00853151|566196690|FG001|Overall Study|Sponsor Decision|3|||
156848108|NCT00853151|566196691|FG002|Overall Study|Sponsor Decision|0|||
156848109|NCT00853151|566196692|FG003|Overall Study|Sponsor Decision|0|||
156848110|NCT01751984|566196693|FG000|Overall Study|Adverse Event|5|||
156848111|NCT01751984|566196694|FG001|Overall Study|Adverse Event|3|||
156848112|NCT01751984|566196693|FG000|Overall Study|Withdrawal by Subject|0|||
156888410|NCT00761150|566350593|FG002|Open-label Period|Lack of Efficacy|0|||
157025387|NCT03544281|566847975|FG019|Main Study Phase|Death|0|||
157025388|NCT03544281|566847976|FG020|Main Study Phase|Death|0|||
157025389|NCT03544281|566847977|FG021|Main Study Phase|Death|0|||
157025390|NCT03544281|566847956|FG000|Main Study Phase|Lost to Follow-up|0|||
157025391|NCT03544281|566847957|FG001|Main Study Phase|Lost to Follow-up|0|||
157025392|NCT03544281|566847958|FG002|Main Study Phase|Lost to Follow-up|0|||
157025393|NCT03544281|566847959|FG003|Main Study Phase|Lost to Follow-up|0|||
157025394|NCT03544281|566847960|FG004|Main Study Phase|Lost to Follow-up|0|||
157025395|NCT03544281|566847961|FG005|Main Study Phase|Lost to Follow-up|0|||
157025396|NCT03544281|566847962|FG006|Main Study Phase|Lost to Follow-up|0|||
157025397|NCT03544281|566847963|FG007|Main Study Phase|Lost to Follow-up|0|||
157025398|NCT03544281|566847964|FG008|Main Study Phase|Lost to Follow-up|0|||
157025399|NCT03544281|566847965|FG009|Main Study Phase|Lost to Follow-up|0|||
157025400|NCT03544281|566847966|FG010|Main Study Phase|Lost to Follow-up|1|||
157025401|NCT03544281|566847967|FG011|Main Study Phase|Lost to Follow-up|0|||
156888411|NCT00761150|566350591|FG000|Open-label Period|Withdrawal by Subject|5|||
156888412|NCT00761150|566350592|FG001|Open-label Period|Withdrawal by Subject|0|||
157025402|NCT03544281|566847968|FG012|Main Study Phase|Lost to Follow-up|0|||
157155284|NCT01721408|567312949|FG000|Overall Study|Adverse Event|6|||
157155285|NCT01721408|567312950|FG001|Overall Study|Adverse Event|1|||
157155286|NCT01721408|567312949|FG000|Overall Study|Death|1|||
157155287|NCT01721408|567312950|FG001|Overall Study|Death|0|||
157155288|NCT01721408|567312949|FG000|Overall Study|Insufficient clinical response|15|||
157155289|NCT01721408|567312950|FG001|Overall Study|Insufficient clinical response|6|||
157155290|NCT01721408|567312949|FG000|Overall Study|No longer willing to participate study|9|||
157155291|NCT01721408|567312950|FG001|Overall Study|No longer willing to participate study|10|||
157155292|NCT01721408|567312949|FG000|Overall Study|Protocol Violation|0|||
157155293|NCT01721408|567312950|FG001|Overall Study|Protocol Violation|2|||
157155294|NCT01721408|567312949|FG000|Overall Study|Other|3|||
157155295|NCT01721408|567312950|FG001|Overall Study|Other|3|||
157155296|NCT01721408|567312949|FG000|Overall Study|Lost to Follow-up|1|||
157155297|NCT01721408|567312950|FG001|Overall Study|Lost to Follow-up|2|||
157155298|NCT01721408|567312949|FG000|Overall Study|Does not meet entrance criteria|1|||
157155299|NCT01721408|567312950|FG001|Overall Study|Does not meet entrance criteria|0|||
157155300|NCT01187901|567312953|FG000|Overall Study|Protocol Violation|1|||
157155301|NCT01187901|567312954|FG001|Overall Study|Protocol Violation|0|||
157155302|NCT01187901|567312953|FG000|Overall Study|Lost to Follow-up|1|||
157155303|NCT01187901|567312954|FG001|Overall Study|Lost to Follow-up|2|||
157155304|NCT01187901|567312953|FG000|Overall Study|Unrelated Health Reasons|1|||
157155305|NCT01187901|567312954|FG001|Overall Study|Unrelated Health Reasons|2|||
156848113|NCT01751984|566196694|FG001|Overall Study|Withdrawal by Subject|1|||
157025403|NCT03544281|566847969|FG013|Main Study Phase|Lost to Follow-up|0|||
157025404|NCT03544281|566847970|FG014|Main Study Phase|Lost to Follow-up|0|||
157025405|NCT03544281|566847971|FG015|Main Study Phase|Lost to Follow-up|0|||
157025406|NCT03544281|566847972|FG016|Main Study Phase|Lost to Follow-up|0|||
157025407|NCT03544281|566847973|FG017|Main Study Phase|Lost to Follow-up|0|||
157155306|NCT01187901|567312953|FG000|Overall Study|Suspected Allergic Reaction|1|||
157155307|NCT01187901|567312954|FG001|Overall Study|Suspected Allergic Reaction|1|||
157155308|NCT01187901|567312953|FG000|Overall Study|Adverse Event|3|||
157155309|NCT01187901|567312954|FG001|Overall Study|Adverse Event|0|||
156848114|NCT01751984|566196693|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
156848115|NCT01751984|566196694|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
156848116|NCT00950846|566196695|FG000|Overall Study|Death|6|||
156848117|NCT00950846|566196695|FG000|Overall Study|Lost to Follow-up|3|||
157225086|NCT03384745|567569992|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
157225087|NCT03384745|567569993|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
157225088|NCT03384745|567569994|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
157225089|NCT03384745|567569995|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
157225090|NCT03384745|567569990|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
157225091|NCT03384745|567569991|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
157225092|NCT03384745|567569992|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
157225093|NCT03384745|567569993|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
157225094|NCT03384745|567569994|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
157225095|NCT03384745|567569995|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
157225096|NCT03384745|567569990|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
157225097|NCT03384745|567569991|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
157225098|NCT03384745|567569992|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
157225099|NCT03384745|567569993|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
157225100|NCT03384745|567569994|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
157225101|NCT03384745|567569995|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
157225102|NCT03384745|567569990|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
157225103|NCT03384745|567569991|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
157225104|NCT03384745|567569992|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
157225105|NCT03384745|567569993|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
157225106|NCT03384745|567569994|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
157225107|NCT03384745|567569995|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
157225108|NCT03384745|567569990|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
157225109|NCT03384745|567569991|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
157225110|NCT03384745|567569992|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
157225111|NCT03384745|567569993|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
157225112|NCT03384745|567569994|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
157225113|NCT03384745|567569995|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
157225114|NCT03384745|567569990|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
157225115|NCT03384745|567569991|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
157225116|NCT03384745|567569992|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
157225117|NCT03384745|567569993|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
157225118|NCT03384745|567569994|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
157225119|NCT03384745|567569995|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
157225120|NCT03384745|567569990|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
157225121|NCT03384745|567569991|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
157225122|NCT03384745|567569992|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
157225123|NCT03384745|567569993|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
157225124|NCT03384745|567569994|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
157225125|NCT03384745|567569995|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
157225126|NCT03384745|567569990|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
157225127|NCT03384745|567569991|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
157225128|NCT03384745|567569992|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
157225129|NCT03384745|567569993|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
157225130|NCT03384745|567569994|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
157225131|NCT03384745|567569995|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
157225132|NCT03384745|567569990|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
157225133|NCT03384745|567569991|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
157225134|NCT03384745|567569992|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
157225135|NCT03384745|567569993|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
157225136|NCT03384745|567569994|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
157225137|NCT03384745|567569995|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
157225138|NCT01058421|567569998|FG000|1 Month Outcomes|Death|10|||
157225139|NCT01058421|567569999|FG001|1 Month Outcomes|Death|6|||
157225140|NCT01058421|567569998|FG000|1 Month Outcomes|Lost to Follow-up|8|||
157225141|NCT01058421|567569999|FG001|1 Month Outcomes|Lost to Follow-up|7|||
157225142|NCT01058421|567569998|FG000|1 Month Outcomes|Remained in Hospital|5|||
157225143|NCT01058421|567569999|FG001|1 Month Outcomes|Remained in Hospital|12|||
157225144|NCT01058421|567569998|FG000|1 Month Outcomes|Remained in Other Facility|16|||
157225145|NCT01058421|567569999|FG001|1 Month Outcomes|Remained in Other Facility|17|||
157225146|NCT01058421|567569998|FG000|3 Month Outcomes|Death|3|||
157225147|NCT01058421|567569999|FG001|3 Month Outcomes|Death|5|||
157225148|NCT01058421|567569998|FG000|3 Month Outcomes|Lost to Follow-up|12|||
157225149|NCT01058421|567569999|FG001|3 Month Outcomes|Lost to Follow-up|11|||
157225150|NCT01058421|567569998|FG000|3 Month Outcomes|Remained in Hospital|0|||
157225151|NCT01058421|567569999|FG001|3 Month Outcomes|Remained in Hospital|2|||
157225152|NCT01058421|567569998|FG000|3 Month Outcomes|Remained in Other Facility|5|||
157225153|NCT01058421|567569999|FG001|3 Month Outcomes|Remained in Other Facility|8|||
157225154|NCT01058421|567569998|FG000|6 Month Outcomes|Death|2|||
157225155|NCT01058421|567569999|FG001|6 Month Outcomes|Death|2|||
156848118|NCT00950846|566196695|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
156848119|NCT00587158|566196696|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
156848120|NCT00587158|566196697|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
156848121|NCT00587158|566196696|FG000|Overall Study|Physician Decision|0|||
156848122|NCT00587158|566196697|FG001|Overall Study|Physician Decision|1|||
156848123|NCT00587158|566196696|FG000|Overall Study|Lost to Follow-up|1|||
156848124|NCT00587158|566196697|FG001|Overall Study|Lost to Follow-up|2|||
156848125|NCT00587158|566196696|FG000|Overall Study|Death|0|||
156848126|NCT00587158|566196697|FG001|Overall Study|Death|1|||
156848127|NCT00587158|566196696|FG000|Overall Study|Subject did not want to take study med|0|||
156848128|NCT00587158|566196697|FG001|Overall Study|Subject did not want to take study med|1|||
156888413|NCT00761150|566350593|FG002|Open-label Period|Withdrawal by Subject|0|||
157225156|NCT01058421|567569998|FG000|6 Month Outcomes|Lost to Follow-up|16|||
157225157|NCT01058421|567569999|FG001|6 Month Outcomes|Lost to Follow-up|21|||
157225158|NCT01058421|567569998|FG000|6 Month Outcomes|Remained in Other Facility|1|||
157225159|NCT01058421|567569999|FG001|6 Month Outcomes|Remained in Other Facility|3|||
157225160|NCT02984683|567570000|FG000|Overall Study|Adverse Event|3|||
157225161|NCT02984683|567570001|FG001|Overall Study|Adverse Event|3|||
157225162|NCT02984683|567570000|FG000|Overall Study|Withdrawal by Subject|1|||
157225163|NCT02984683|567570001|FG001|Overall Study|Withdrawal by Subject|0|||
157225164|NCT02984683|567570000|FG000|Overall Study|Disease progression|7|||
157225165|NCT02984683|567570001|FG001|Overall Study|Disease progression|9|||
157225166|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
157225167|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
157225168|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
157225169|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
157225170|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
157225171|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
157225172|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
157225173|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
157225174|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
157225175|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
157225176|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
157225177|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
157225178|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
157225179|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
157225180|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
157225181|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
157225182|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
157225183|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
157225184|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
157225185|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
157225186|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
157225187|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
157225188|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
157225189|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
157225190|NCT00455533|567570004|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
157155310|NCT01187901|567312953|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
157155311|NCT01187901|567312954|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
156888414|NCT00761150|566350591|FG000|Open-label Period|Noncompliance|2|||
156888415|NCT00761150|566350592|FG001|Open-label Period|Noncompliance|0|||
156888416|NCT00761150|566350593|FG002|Open-label Period|Noncompliance|0|||
156888417|NCT00761150|566350591|FG000|Open-label Period|Other|5|||
157155312|NCT01187901|567312953|FG000|Overall Study|Pregnancy|0|||
157155313|NCT01187901|567312954|FG001|Overall Study|Pregnancy|2|||
157155314|NCT04160468|567312955|FG000|Overall Study|Lost to Follow-up|19|||
157155315|NCT04160468|567312956|FG001|Overall Study|Lost to Follow-up|4|||
157155316|NCT04160468|567312955|FG000|Overall Study|Randomized but not dosed|6|||
157155317|NCT04160468|567312956|FG001|Overall Study|Randomized but not dosed|0|||
157155318|NCT04160468|567312955|FG000|Overall Study|Withdrawal by Subject|4|||
157155319|NCT04160468|567312956|FG001|Overall Study|Withdrawal by Subject|1|||
157155320|NCT04160468|567312955|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
157155321|NCT04160468|567312956|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
157155322|NCT04160468|567312955|FG000|Overall Study|Participant incarcerated|1|||
157155323|NCT04160468|567312956|FG001|Overall Study|Participant incarcerated|0|||
157155324|NCT03987620|567312957|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
157155325|NCT03987620|567312958|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
156888418|NCT00761150|566350592|FG001|Open-label Period|Other|0|||
156888419|NCT00761150|566350593|FG002|Open-label Period|Other|0|||
156888420|NCT00761150|566350591|FG000|Double-blind Period|Lack of Efficacy|0|||
157025408|NCT03544281|566847974|FG018|Main Study Phase|Lost to Follow-up|0|||
157025409|NCT03544281|566847975|FG019|Main Study Phase|Lost to Follow-up|0|||
157025410|NCT03544281|566847976|FG020|Main Study Phase|Lost to Follow-up|0|||
157025411|NCT03544281|566847977|FG021|Main Study Phase|Lost to Follow-up|0|||
157025412|NCT03544281|566847956|FG000|Main Study Phase|Physician Decision|0|||
157025413|NCT03544281|566847957|FG001|Main Study Phase|Physician Decision|0|||
157025414|NCT03544281|566847958|FG002|Main Study Phase|Physician Decision|0|||
157025415|NCT03544281|566847959|FG003|Main Study Phase|Physician Decision|0|||
157025416|NCT03544281|566847960|FG004|Main Study Phase|Physician Decision|0|||
156848131|NCT01136408|566196699|FG000|Overall Study|Adverse Event|4|||
156848132|NCT01136408|566196700|FG001|Overall Study|Adverse Event|8|||
156848133|NCT01136408|566196701|FG002|Overall Study|Adverse Event|4|||
156848134|NCT01136408|566196699|FG000|Overall Study|Protocol Violation|1|||
156848135|NCT01136408|566196700|FG001|Overall Study|Protocol Violation|1|||
156848136|NCT01136408|566196701|FG002|Overall Study|Protocol Violation|1|||
156848137|NCT02274792|566196702|FG000|Overall Study|Withdrawal by Subject|13|||
156848138|NCT02274792|566196702|FG000|Overall Study|Lost to Follow-up|8|||
156848139|NCT02274792|566196702|FG000|Overall Study|Protocol Specified Criteria|2|||
156848140|NCT02274792|566196702|FG000|Overall Study|Sponsor Decision|2|||
156848141|NCT01510158|566196703|FG000|Overall Study|Adverse Event|7|||
157025417|NCT03544281|566847961|FG005|Main Study Phase|Physician Decision|0|||
157025418|NCT03544281|566847962|FG006|Main Study Phase|Physician Decision|0|||
157155326|NCT03987620|567312957|FG000|Overall Study|Adverse Event|3|||
157155327|NCT03987620|567312958|FG001|Overall Study|Adverse Event|0|||
157155328|NCT03987620|567312957|FG000|Overall Study|Lost to Follow-up|1|||
157155329|NCT03987620|567312958|FG001|Overall Study|Lost to Follow-up|2|||
157155330|NCT03987620|567312957|FG000|Overall Study|Physician Decision|0|||
157155331|NCT03987620|567312958|FG001|Overall Study|Physician Decision|1|||
157155332|NCT03987620|567312957|FG000|Overall Study|Pregnancy|1|||
157155333|NCT03987620|567312958|FG001|Overall Study|Pregnancy|0|||
157155334|NCT03987620|567312957|FG000|Overall Study|Withdrawal by Subject|7|||
157155335|NCT03987620|567312958|FG001|Overall Study|Withdrawal by Subject|1|||
157155336|NCT03987620|567312957|FG000|Overall Study|Other|2|||
157155337|NCT03987620|567312958|FG001|Overall Study|Other|5|||
157155338|NCT02149836|567312959|FG000|Overall Study|Withdrawal by Subject|1|||
157155339|NCT04430582|567312960|FG000|Overall Study|Found to meet exclusionary criteria|1|||
157155340|NCT04430582|567312961|FG001|Overall Study|Found to meet exclusionary criteria|0|||
157155341|NCT04430582|567312960|FG000|Overall Study|Withdrawal by Subject|0|||
157155342|NCT04430582|567312961|FG001|Overall Study|Withdrawal by Subject|1|||
157155343|NCT03607682|567312962|FG000|Overall Study|Withdrawal by Subject|1|||
157155344|NCT03607682|567312962|FG000|Overall Study|Disease progression|1|||
157155345|NCT01770353|567312963|FG000|Overall Study|Progressive disease|2|||
157155346|NCT01770353|567312964|FG001|Overall Study|Progressive disease|1|||
157155347|NCT01770353|567312963|FG000|Overall Study|Adverse Event|0|||
157155348|NCT01770353|567312964|FG001|Overall Study|Adverse Event|1|||
157155349|NCT01770353|567312963|FG000|Overall Study|Protocol Violation|1|||
157155350|NCT01770353|567312964|FG001|Overall Study|Protocol Violation|0|||
157155351|NCT01770353|567312963|FG000|Overall Study|Physician Decision|0|||
157155352|NCT01770353|567312964|FG001|Overall Study|Physician Decision|3|||
157155353|NCT01770353|567312963|FG000|Overall Study|Clinical deterioration|3|||
156848142|NCT01510158|566196704|FG001|Overall Study|Adverse Event|8|||
156848143|NCT01510158|566196705|FG002|Overall Study|Adverse Event|5|||
156848144|NCT01510158|566196703|FG000|Overall Study|Gout flare|1|||
156848145|NCT01510158|566196704|FG001|Overall Study|Gout flare|0|||
156848146|NCT01510158|566196705|FG002|Overall Study|Gout flare|0|||
156848147|NCT01510158|566196703|FG000|Overall Study|Protocol Violation|17|||
156848148|NCT01510158|566196704|FG001|Overall Study|Protocol Violation|16|||
156848149|NCT01510158|566196705|FG002|Overall Study|Protocol Violation|24|||
156848150|NCT01510158|566196703|FG000|Overall Study|Sponsor terminated study.|2|||
156848151|NCT01510158|566196704|FG001|Overall Study|Sponsor terminated study.|0|||
156848152|NCT01510158|566196705|FG002|Overall Study|Sponsor terminated study.|2|||
156848153|NCT01510158|566196703|FG000|Overall Study|Lost to Follow-up|13|||
156848154|NCT01510158|566196704|FG001|Overall Study|Lost to Follow-up|16|||
156848155|NCT01510158|566196705|FG002|Overall Study|Lost to Follow-up|9|||
156848156|NCT01510158|566196703|FG000|Overall Study|Withdrawal by Subject|10|||
156848157|NCT01510158|566196704|FG001|Overall Study|Withdrawal by Subject|13|||
156848158|NCT01510158|566196705|FG002|Overall Study|Withdrawal by Subject|10|||
157025419|NCT03544281|566847963|FG007|Main Study Phase|Physician Decision|1|||
157155354|NCT01770353|567312964|FG001|Overall Study|Clinical deterioration|6|||
157155355|NCT01770353|567312963|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
157155356|NCT01770353|567312964|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
157155357|NCT00376688|567312965|FG000|Overall Study|Adverse Event|3|||
157155358|NCT00376688|567312965|FG000|Overall Study|Death|1|||
157155359|NCT05128162|567312966|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
156848159|NCT01510158|566196703|FG000|Overall Study|Death|1|||
156848160|NCT01510158|566196704|FG001|Overall Study|Death|0|||
156848161|NCT01510158|566196705|FG002|Overall Study|Death|0|||
157025420|NCT03544281|566847964|FG008|Main Study Phase|Physician Decision|0|||
156848162|NCT03078556|566196706|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848163|NCT03078556|566196707|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
156848164|NCT03078556|566196708|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848165|NCT03078556|566196709|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
156848166|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
156848167|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
156848168|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
156848169|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
156848170|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
156848171|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
156848172|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
156848173|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
156848174|NCT03078556|566196706|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
156848175|NCT03078556|566196707|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
156848176|NCT03078556|566196708|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
156848177|NCT03078556|566196709|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
156848178|NCT00832416|566196716|FG000|Overall Study|Lack of Efficacy|17|||
156848179|NCT00832416|566196717|FG001|Overall Study|Lack of Efficacy|15|||
156848180|NCT00832416|566196718|FG002|Overall Study|Lack of Efficacy|13|||
156848181|NCT00832416|566196719|FG003|Overall Study|Lack of Efficacy|52|||
156848182|NCT00832416|566196716|FG000|Overall Study|Withdrawal by Subject|5|||
156848183|NCT00832416|566196717|FG001|Overall Study|Withdrawal by Subject|7|||
156848184|NCT00832416|566196718|FG002|Overall Study|Withdrawal by Subject|2|||
156848185|NCT00832416|566196719|FG003|Overall Study|Withdrawal by Subject|10|||
156848186|NCT00832416|566196716|FG000|Overall Study|Physician Decision|2|||
156848187|NCT00832416|566196717|FG001|Overall Study|Physician Decision|12|||
156848188|NCT00832416|566196718|FG002|Overall Study|Physician Decision|5|||
156848189|NCT00832416|566196719|FG003|Overall Study|Physician Decision|10|||
156848190|NCT00832416|566196716|FG000|Overall Study|Administrative|0|||
156848191|NCT00832416|566196717|FG001|Overall Study|Administrative|0|||
156848192|NCT00832416|566196718|FG002|Overall Study|Administrative|0|||
156848193|NCT00832416|566196719|FG003|Overall Study|Administrative|1|||
156848194|NCT00832416|566196716|FG000|Overall Study|Adverse Event|21|||
156848195|NCT00832416|566196717|FG001|Overall Study|Adverse Event|19|||
156848196|NCT00832416|566196718|FG002|Overall Study|Adverse Event|41|||
156848197|NCT00832416|566196719|FG003|Overall Study|Adverse Event|10|||
156848198|NCT00832416|566196716|FG000|Overall Study|Death|1|||
156848199|NCT00832416|566196717|FG001|Overall Study|Death|0|||
156848200|NCT00832416|566196718|FG002|Overall Study|Death|0|||
156848201|NCT00832416|566196719|FG003|Overall Study|Death|0|||
156848202|NCT02114606|566196720|FG000|Overall Study|Unable to swallow Cytosponge|6|||
156848203|NCT00981461|566196721|FG000|Overall Study|Lost to Follow-up|5|||
157025421|NCT03544281|566847965|FG009|Main Study Phase|Physician Decision|0|||
156848204|NCT00981461|566196722|FG001|Overall Study|Lost to Follow-up|2|||
156848205|NCT04421482|566196729|FG000|Overall Study|Physician Decision|1|||
156848206|NCT00483405|566196732|FG000|Overall Study|Adverse Event|8|||
156848207|NCT00483405|566196732|FG000|Overall Study|Lack of Efficacy|14|||
156848208|NCT00483405|566196732|FG000|Overall Study|Death|3|||
156848209|NCT00483405|566196732|FG000|Overall Study|Withdrawal by Subject|2|||
156848210|NCT00483405|566196732|FG000|Overall Study|Other complicating disease|1|||
156848211|NCT00571038|566196733|FG000|Overall Study|Lost to Follow-up|1|||
156848212|NCT00571038|566196734|FG001|Overall Study|Lost to Follow-up|4|||
156848213|NCT00571038|566196733|FG000|Overall Study|Death|7|||
156848214|NCT00571038|566196734|FG001|Overall Study|Death|5|||
156848215|NCT00571038|566196733|FG000|Overall Study|Withdrawal by Subject|1|||
156848216|NCT00571038|566196734|FG001|Overall Study|Withdrawal by Subject|3|||
156848217|NCT00571038|566196733|FG000|Overall Study|Moved out of state|2|||
156848218|NCT00571038|566196734|FG001|Overall Study|Moved out of state|2|||
156848219|NCT03010319|566196735|FG000|Overall Study|Adverse Event|15|||
156848220|NCT03010319|566196736|FG001|Overall Study|Adverse Event|9|||
156848221|NCT03010319|566196735|FG000|Overall Study|Withdrawal by Subject|1|||
156848222|NCT03010319|566196736|FG001|Overall Study|Withdrawal by Subject|6|||
156848223|NCT03010319|566196735|FG000|Overall Study|Physician Decision|2|||
156848224|NCT03010319|566196736|FG001|Overall Study|Physician Decision|4|||
156848225|NCT03010319|566196735|FG000|Overall Study|Sponsor requested withdrawal|2|||
156848226|NCT03010319|566196736|FG001|Overall Study|Sponsor requested withdrawal|2|||
156848227|NCT03010319|566196735|FG000|Overall Study|Death|1|||
156848228|NCT03010319|566196736|FG001|Overall Study|Death|0|||
156848229|NCT03010319|566196735|FG000|Overall Study|Lost to Follow-up|0|||
156848230|NCT03010319|566196736|FG001|Overall Study|Lost to Follow-up|1|||
156848231|NCT03010319|566196735|FG000|Overall Study|Other Reason|5|||
156848232|NCT03010319|566196736|FG001|Overall Study|Other Reason|7|||
156848233|NCT02128724|566196737|FG000|Overall Study|Death|1|||
156848234|NCT02128724|566196738|FG001|Overall Study|Death|0|||
156848235|NCT02128724|566196739|FG002|Overall Study|Death|0|||
156848236|NCT02128724|566196740|FG003|Overall Study|Death|0|||
156848237|NCT02128724|566196737|FG000|Overall Study|Adverse Event|0|||
156848238|NCT02128724|566196738|FG001|Overall Study|Adverse Event|1|||
156848239|NCT02128724|566196739|FG002|Overall Study|Adverse Event|0|||
156848240|NCT02128724|566196740|FG003|Overall Study|Adverse Event|0|||
156848241|NCT02128724|566196737|FG000|Overall Study|Physician Decision|0|||
156848242|NCT02128724|566196738|FG001|Overall Study|Physician Decision|0|||
156848243|NCT02128724|566196739|FG002|Overall Study|Physician Decision|0|||
156848244|NCT02128724|566196740|FG003|Overall Study|Physician Decision|2|||
156848245|NCT02128724|566196737|FG000|Overall Study|Withdrawal by Subject|0|||
156848246|NCT02128724|566196738|FG001|Overall Study|Withdrawal by Subject|0|||
156848247|NCT02128724|566196739|FG002|Overall Study|Withdrawal by Subject|0|||
156848248|NCT02128724|566196740|FG003|Overall Study|Withdrawal by Subject|1|||
156848249|NCT05786508|566196742|FG000|Overall Study|Withdrawal by Subject|2|||
156848250|NCT05786508|566196743|FG001|Overall Study|Withdrawal by Subject|0|||
156848251|NCT04426318|566196744|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
156848252|NCT04426318|566196745|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
157155360|NCT05128162|567312966|FG000|Overall Study|Physician Decision|1|||
157155361|NCT00370149|567312967|FG000|Overall Study|Physician Decision|16|||
157155362|NCT00370149|567312968|FG001|Overall Study|Physician Decision|16|||
156848253|NCT02588261|566196748|FG000|Overall Study|Study Terminated by Sponsor|157|||
156848254|NCT02588261|566196749|FG001|Overall Study|Study Terminated by Sponsor|142|||
156888421|NCT00761150|566350592|FG001|Double-blind Period|Lack of Efficacy|2|||
156888422|NCT00761150|566350593|FG002|Double-blind Period|Lack of Efficacy|19|||
157025422|NCT03544281|566847966|FG010|Main Study Phase|Physician Decision|0|||
157155363|NCT00370149|567312967|FG000|Overall Study|Protocol Violation|1|||
157155364|NCT00370149|567312968|FG001|Overall Study|Protocol Violation|0|||
157155365|NCT00370149|567312967|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
157155366|NCT00370149|567312968|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
157155367|NCT00370149|567312967|FG000|Overall Study|Pre-existing infection|0|||
157155368|NCT00370149|567312968|FG001|Overall Study|Pre-existing infection|1|||
157155369|NCT00370149|567312967|FG000|Overall Study|Antibiotic coated dressing placed|0|||
157155370|NCT00370149|567312968|FG001|Overall Study|Antibiotic coated dressing placed|1|||
157155371|NCT03488472|567314229|FG000|Overall Study|disease progression additional mets|1|||
157155372|NCT00028002|567314230|FG000|Overall Study|Withdrawal by Subject|3|||
157155373|NCT00028002|567314230|FG000|Overall Study|Ineligible|8|||
157155374|NCT04467164|567314233|FG000|Washout (1 Week)|Lost to Follow-up|2|||
157155375|NCT04467164|567314234|FG001|Washout (1 Week)|Lost to Follow-up|0|||
157155376|NCT05628181|567314235|FG000|Overall Study|Death|2|||
157155377|NCT05628181|567314236|FG001|Overall Study|Death|4|||
157155378|NCT05628181|567314237|FG002|Overall Study|Death|0|||
157155379|NCT04742907|567314238|FG000|Overall Study|Adverse Event|1|||
157155380|NCT04742907|567314239|FG001|Overall Study|Adverse Event|0|||
157155381|NCT04742907|567314240|FG002|Overall Study|Adverse Event|1|||
157155382|NCT04742907|567314238|FG000|Overall Study|Lost to Follow-up|3|||
157155383|NCT04742907|567314239|FG001|Overall Study|Lost to Follow-up|3|||
157155384|NCT04742907|567314240|FG002|Overall Study|Lost to Follow-up|2|||
157155385|NCT04742907|567314238|FG000|Overall Study|Physician Decision|0|||
157155386|NCT04742907|567314239|FG001|Overall Study|Physician Decision|1|||
157155387|NCT04742907|567314240|FG002|Overall Study|Physician Decision|0|||
157155388|NCT04742907|567314238|FG000|Overall Study|Protocol Violation|1|||
157155389|NCT04742907|567314239|FG001|Overall Study|Protocol Violation|1|||
157155390|NCT04742907|567314240|FG002|Overall Study|Protocol Violation|1|||
157155391|NCT04742907|567314238|FG000|Overall Study|Withdrawal by Subject|5|||
157155392|NCT04742907|567314239|FG001|Overall Study|Withdrawal by Subject|6|||
157155393|NCT04742907|567314240|FG002|Overall Study|Withdrawal by Subject|4|||
157155394|NCT04742907|567314238|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
157155395|NCT04742907|567314239|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
157155396|NCT04742907|567314240|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
157155397|NCT04742907|567314238|FG000|Overall Study|Did Not Receive the Study Drug|2|||
157155398|NCT04742907|567314239|FG001|Overall Study|Did Not Receive the Study Drug|4|||
157155399|NCT04742907|567314240|FG002|Overall Study|Did Not Receive the Study Drug|4|||
157155400|NCT01428063|567314241|FG000|Overall Study|Lack of Efficacy|8|||
157155401|NCT01428063|567314242|FG001|Overall Study|Lack of Efficacy|4|||
157155402|NCT01428063|567314243|FG002|Overall Study|Lack of Efficacy|1|||
157155403|NCT01428063|567314241|FG000|Overall Study|Adverse Event|2|||
157155404|NCT01428063|567314242|FG001|Overall Study|Adverse Event|3|||
157155405|NCT01428063|567314243|FG002|Overall Study|Adverse Event|0|||
157155406|NCT01428063|567314241|FG000|Overall Study|Lost to Follow-up|0|||
157155407|NCT01428063|567314242|FG001|Overall Study|Lost to Follow-up|2|||
157155408|NCT01428063|567314243|FG002|Overall Study|Lost to Follow-up|0|||
156848255|NCT02588261|566196748|FG000|Overall Study|Protocol Deviation|1|||
156848256|NCT02588261|566196749|FG001|Overall Study|Protocol Deviation|0|||
156848257|NCT02588261|566196748|FG000|Overall Study|Death|1|||
157025423|NCT03544281|566847967|FG011|Main Study Phase|Physician Decision|0|||
157155409|NCT01428063|567314241|FG000|Overall Study|No longer meets study criteria|0|||
157155410|NCT01428063|567314242|FG001|Overall Study|No longer meets study criteria|1|||
157155411|NCT01428063|567314243|FG002|Overall Study|No longer meets study criteria|0|||
157155412|NCT03508622|567314244|FG000|Overall Study|Protocol Violation|1|||
157155413|NCT03508622|567314245|FG001|Overall Study|Protocol Violation|0|||
157155414|NCT03508622|567314244|FG000|Overall Study|Withdrawal by Subject|1|||
157225191|NCT00455533|567570005|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
157225192|NCT00455533|567570006|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
157225193|NCT00455533|567570004|FG000|Period Two: Randomized Period|Death|0|||
157225194|NCT00455533|567570005|FG001|Period Two: Randomized Period|Death|0|||
157225195|NCT00455533|567570006|FG002|Period Two: Randomized Period|Death|3|||
157225196|NCT00455533|567570004|FG000|Period Two: Randomized Period|Disease Progression|0|||
157225197|NCT00455533|567570005|FG001|Period Two: Randomized Period|Disease Progression|1|||
157225198|NCT00455533|567570006|FG002|Period Two: Randomized Period|Disease Progression|1|||
157225199|NCT00455533|567570004|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
157225200|NCT00455533|567570005|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
157225201|NCT00455533|567570006|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
157225202|NCT00455533|567570004|FG000|Period Two: Randomized Period|Other - need reasons|0|||
157225203|NCT00455533|567570005|FG001|Period Two: Randomized Period|Other - need reasons|1|||
157225204|NCT00455533|567570006|FG002|Period Two: Randomized Period|Other - need reasons|0|||
156848258|NCT02588261|566196749|FG001|Overall Study|Death|2|||
156848259|NCT02588261|566196748|FG000|Overall Study|Withdrawal by Subject|12|||
156848260|NCT02588261|566196749|FG001|Overall Study|Withdrawal by Subject|8|||
156848261|NCT02588261|566196748|FG000|Overall Study|Noncompliance with Study Drug|0|||
156848262|NCT02588261|566196749|FG001|Overall Study|Noncompliance with Study Drug|1|||
156848263|NCT02588261|566196748|FG000|Overall Study|Miscellaneous|5|||
156848264|NCT02588261|566196749|FG001|Overall Study|Miscellaneous|4|||
157155415|NCT03508622|567314245|FG001|Overall Study|Withdrawal by Subject|0|||
157155416|NCT03508622|567314244|FG000|Overall Study|Lost to Follow-up|16|||
157155417|NCT03508622|567314245|FG001|Overall Study|Lost to Follow-up|0|||
157155418|NCT03508622|567314244|FG000|Overall Study|Incomplete data|0|||
157155419|NCT03508622|567314245|FG001|Overall Study|Incomplete data|24|||
157155420|NCT01005719|567314246|FG000|Period 1|Adverse Event|0|||
157155421|NCT01005719|567314247|FG001|Period 1|Adverse Event|0|||
157155422|NCT01005719|567314248|FG002|Period 1|Adverse Event|0|||
157155423|NCT01005719|567314249|FG003|Period 1|Adverse Event|1|||
157155424|NCT01005719|567314250|FG004|Period 1|Adverse Event|0|||
157155425|NCT01005719|567314251|FG005|Period 1|Adverse Event|0|||
157155426|NCT01005719|567314246|FG000|Period 1|Delay in completing study procedures|0|||
157155427|NCT01005719|567314247|FG001|Period 1|Delay in completing study procedures|0|||
157155428|NCT01005719|567314248|FG002|Period 1|Delay in completing study procedures|0|||
157155429|NCT01005719|567314249|FG003|Period 1|Delay in completing study procedures|0|||
157155430|NCT01005719|567314250|FG004|Period 1|Delay in completing study procedures|0|||
157155431|NCT01005719|567314251|FG005|Period 1|Delay in completing study procedures|1|||
157155432|NCT01005719|567314246|FG000|Period 2|Adverse Event|0|||
157155433|NCT01005719|567314247|FG001|Period 2|Adverse Event|0|||
157155434|NCT01005719|567314248|FG002|Period 2|Adverse Event|0|||
157155435|NCT01005719|567314249|FG003|Period 2|Adverse Event|0|||
157155436|NCT01005719|567314250|FG004|Period 2|Adverse Event|1|||
156848265|NCT02588261|566196748|FG000|Overall Study|Progressive Disease|61|||
156848266|NCT02588261|566196749|FG001|Overall Study|Progressive Disease|82|||
156848267|NCT02588261|566196748|FG000|Overall Study|Adverse Event|29|||
156848268|NCT02588261|566196749|FG001|Overall Study|Adverse Event|24|||
156848269|NCT02588261|566196748|FG000|Overall Study|Lost to Follow-up|1|||
156848270|NCT02588261|566196749|FG001|Overall Study|Lost to Follow-up|0|||
156848271|NCT03781778|566196750|FG000|Overall Study|Withdrawal by Subject|2|||
156848272|NCT03781778|566196751|FG001|Overall Study|Withdrawal by Subject|2|||
156848273|NCT02287467|566196752|FG000|Overall Study|Protocol Violation|12|||
156848274|NCT02287467|566196753|FG001|Overall Study|Protocol Violation|9|||
156848275|NCT01456169|566196755|FG000|Overall Study|Adverse Event|1|||
156848276|NCT01456169|566196756|FG001|Overall Study|Adverse Event|2|||
156848277|NCT01456169|566196757|FG002|Overall Study|Adverse Event|7|||
156848278|NCT01456169|566196755|FG000|Overall Study|Major Protocol Deviation|3|||
156848279|NCT01456169|566196756|FG001|Overall Study|Major Protocol Deviation|2|||
156848280|NCT01456169|566196757|FG002|Overall Study|Major Protocol Deviation|3|||
156848281|NCT01456169|566196755|FG000|Overall Study|Voluntary Withdrawal|3|||
156848282|NCT01456169|566196756|FG001|Overall Study|Voluntary Withdrawal|0|||
156848283|NCT01456169|566196757|FG002|Overall Study|Voluntary Withdrawal|2|||
156848284|NCT01456169|566196755|FG000|Overall Study|Lack of Efficacy|2|||
156848285|NCT01456169|566196756|FG001|Overall Study|Lack of Efficacy|0|||
156848286|NCT01456169|566196757|FG002|Overall Study|Lack of Efficacy|0|||
156848287|NCT01456169|566196755|FG000|Overall Study|Other|1|||
156848288|NCT01456169|566196756|FG001|Overall Study|Other|1|||
156848289|NCT01456169|566196757|FG002|Overall Study|Other|0|||
156848290|NCT02292446|566196758|FG000|Overall Study|Adverse Event|12|||
156848291|NCT02292446|566196758|FG000|Overall Study|Death|1|||
156848292|NCT02292446|566196758|FG000|Overall Study|Disease progression|2|||
156848293|NCT02292446|566196758|FG000|Overall Study|Subject/guardian decision|2|||
156848294|NCT02292446|566196758|FG000|Overall Study|Withdrawal by Subject|3|||
157155437|NCT01005719|567314251|FG005|Period 2|Adverse Event|1|||
157225205|NCT00455533|567570004|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
157225206|NCT00455533|567570005|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
156848295|NCT02652156|566196762|FG000|Overall Study|Physician Decision|1|||
156848296|NCT02652156|566196763|FG001|Overall Study|Physician Decision|0|||
156848297|NCT02652156|566196764|FG002|Overall Study|Physician Decision|0|||
156848298|NCT00570310|566196765|FG000|Overall Study|Adverse Event|1|||
156848299|NCT00570310|566196766|FG001|Overall Study|Adverse Event|2|||
157155438|NCT01753076|567314252|FG000|Overall Study|Adverse Event|17|||
157155439|NCT01753076|567314253|FG001|Overall Study|Adverse Event|18|||
157155440|NCT01753076|567314252|FG000|Overall Study|Lack of Efficacy|3|||
157155441|NCT01753076|567314253|FG001|Overall Study|Lack of Efficacy|1|||
157155442|NCT01753076|567314252|FG000|Overall Study|Lost to Follow-up|2|||
157155443|NCT01753076|567314253|FG001|Overall Study|Lost to Follow-up|1|||
157155444|NCT01753076|567314252|FG000|Overall Study|Physician Decision|4|||
157155445|NCT01753076|567314253|FG001|Overall Study|Physician Decision|2|||
157155446|NCT01753076|567314252|FG000|Overall Study|Withdrawal by Subject|14|||
157155447|NCT01753076|567314253|FG001|Overall Study|Withdrawal by Subject|24|||
157155448|NCT01753076|567314252|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
157155449|NCT01753076|567314253|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
157155450|NCT02575079|567314254|FG000|Overall Study|Death|3|||
157155451|NCT02575079|567314255|FG001|Overall Study|Death|0|||
157155452|NCT02575079|567314254|FG000|Overall Study|Withdrawal by Subject|3|||
157155453|NCT02575079|567314255|FG001|Overall Study|Withdrawal by Subject|0|||
157155454|NCT01259856|567314256|FG000|Overall Study|Adverse Event|12|||
157155455|NCT01259856|567314257|FG001|Overall Study|Adverse Event|9|||
157155456|NCT01259856|567314256|FG000|Overall Study|Death|0|||
157155457|NCT01259856|567314257|FG001|Overall Study|Death|1|||
157155458|NCT01259856|567314256|FG000|Overall Study|Lack of Efficacy|3|||
157155459|NCT01259856|567314257|FG001|Overall Study|Lack of Efficacy|1|||
157155460|NCT01259856|567314256|FG000|Overall Study|Lost to Follow-up|1|||
157155461|NCT01259856|567314257|FG001|Overall Study|Lost to Follow-up|1|||
157155462|NCT01259856|567314256|FG000|Overall Study|Physician Decision|2|||
157155463|NCT01259856|567314257|FG001|Overall Study|Physician Decision|1|||
157155464|NCT01259856|567314256|FG000|Overall Study|Withdrawal by Subject|9|||
157155465|NCT01259856|567314257|FG001|Overall Study|Withdrawal by Subject|10|||
157155466|NCT01259856|567314256|FG000|Overall Study|Treatment never started|0|||
157155467|NCT01259856|567314257|FG001|Overall Study|Treatment never started|6|||
157155468|NCT01259856|567314256|FG000|Overall Study|Study closure by sponsor|40|||
157155469|NCT01259856|567314257|FG001|Overall Study|Study closure by sponsor|41|||
157155470|NCT01259856|567314256|FG000|Overall Study|Patient developed other disease|0|||
157155471|NCT01259856|567314257|FG001|Overall Study|Patient developed other disease|1|||
157155472|NCT01259856|567314256|FG000|Overall Study|Transfer to another study|0|||
157155473|NCT01259856|567314257|FG001|Overall Study|Transfer to another study|1|||
157155474|NCT01259856|567314256|FG000|Overall Study|Unknown/missing|2|||
157155475|NCT01259856|567314257|FG001|Overall Study|Unknown/missing|2|||
157155476|NCT00788775|567314260|FG000|Overall Study|Progressive Disease|8|||
157155477|NCT00788775|567314261|FG001|Overall Study|Progressive Disease|6|||
157155478|NCT00788775|567314260|FG000|Overall Study|Withdrawal by Subject|0|||
157155479|NCT00788775|567314261|FG001|Overall Study|Withdrawal by Subject|2|||
157155480|NCT00788775|567314260|FG000|Overall Study|Patient Non-Compliance|1|||
157155481|NCT00788775|567314261|FG001|Overall Study|Patient Non-Compliance|0|||
157155482|NCT00788775|567314260|FG000|Overall Study|Patient's measurable disease resected.|1|||
157155483|NCT00788775|567314261|FG001|Overall Study|Patient's measurable disease resected.|0|||
157155484|NCT02890329|567314267|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
157155485|NCT02890329|567314268|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
157155486|NCT02890329|567314269|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
157155487|NCT02890329|567314270|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
157155488|NCT02890329|567314271|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
157155489|NCT02890329|567314272|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
157155490|NCT02890329|567314267|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
157155491|NCT02890329|567314268|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
157155492|NCT02890329|567314269|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
157155493|NCT02890329|567314270|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
157155494|NCT02890329|567314271|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
157155495|NCT02890329|567314272|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
157155496|NCT02890329|567314267|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
157155497|NCT02890329|567314268|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
157155498|NCT02890329|567314269|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
157155499|NCT02890329|567314270|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
157155500|NCT02890329|567314271|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
157155501|NCT02890329|567314272|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
157155502|NCT02890329|567314267|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
156848300|NCT00570310|566196765|FG000|Overall Study|Lack of Efficacy|1|||
156848301|NCT00570310|566196766|FG001|Overall Study|Lack of Efficacy|4|||
156848302|NCT00479336|566196768|FG000|Overall Study|Adverse Event|1|||
156848303|NCT00479336|566196769|FG001|Overall Study|Adverse Event|1|||
156848304|NCT00479336|566196770|FG002|Overall Study|Adverse Event|1|||
156848305|NCT00479336|566196771|FG003|Overall Study|Adverse Event|3|||
156848306|NCT00479336|566196768|FG000|Overall Study|Lack of Efficacy|1|||
156848307|NCT00479336|566196769|FG001|Overall Study|Lack of Efficacy|0|||
156848308|NCT00479336|566196770|FG002|Overall Study|Lack of Efficacy|0|||
156848309|NCT00479336|566196771|FG003|Overall Study|Lack of Efficacy|0|||
156848310|NCT00479336|566196768|FG000|Overall Study|Protocol Violation|0|||
156848311|NCT00479336|566196769|FG001|Overall Study|Protocol Violation|1|||
156848312|NCT00479336|566196770|FG002|Overall Study|Protocol Violation|0|||
156848313|NCT00479336|566196771|FG003|Overall Study|Protocol Violation|0|||
156848314|NCT00479336|566196768|FG000|Overall Study|Withdrawal by Subject|1|||
156848315|NCT00479336|566196769|FG001|Overall Study|Withdrawal by Subject|2|||
156848316|NCT00479336|566196770|FG002|Overall Study|Withdrawal by Subject|0|||
156848317|NCT00479336|566196771|FG003|Overall Study|Withdrawal by Subject|0|||
156848318|NCT00479336|566196768|FG000|Overall Study|Physician Decision|0|||
156848319|NCT00479336|566196769|FG001|Overall Study|Physician Decision|1|||
157225207|NCT00455533|567570006|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
157225208|NCT00455533|567570004|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
157225209|NCT00455533|567570005|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
157225210|NCT00455533|567570006|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
157225211|NCT04634409|567570009|FG000|Overall Study|Death|0|||
157225212|NCT04634409|567570010|FG001|Overall Study|Death|0|||
157225213|NCT04634409|567570011|FG002|Overall Study|Death|0|||
157225214|NCT04634409|567570012|FG003|Overall Study|Death|0|||
157225215|NCT04634409|567570013|FG004|Overall Study|Death|0|||
157225216|NCT04634409|567570014|FG005|Overall Study|Death|0|||
157225217|NCT04634409|567570015|FG006|Overall Study|Death|0|||
157225218|NCT04634409|567570016|FG007|Overall Study|Death|0|||
157225219|NCT04634409|567570017|FG008|Overall Study|Death|0|||
157225220|NCT04634409|567570018|FG009|Overall Study|Death|0|||
157225221|NCT04634409|567570019|FG010|Overall Study|Death|1|||
157225222|NCT04634409|567570020|FG011|Overall Study|Death|0|||
157225223|NCT04634409|567570021|FG012|Overall Study|Death|1|||
157225224|NCT04634409|567570022|FG013|Overall Study|Death|0|||
157225225|NCT04634409|567570023|FG014|Overall Study|Death|0|||
156848320|NCT00479336|566196770|FG002|Overall Study|Physician Decision|0|||
156848321|NCT00479336|566196771|FG003|Overall Study|Physician Decision|2|||
156848322|NCT00479336|566196768|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
156848323|NCT00479336|566196769|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
156848324|NCT00479336|566196770|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
156848325|NCT00479336|566196771|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
156848326|NCT03066193|566196772|FG000|Overall Study|Withdrawal by Subject|1|||
156848327|NCT04854551|566196775|FG000|Overall Study|Withdrawal by Subject|1|||
156848328|NCT04854551|566196776|FG001|Overall Study|Withdrawal by Subject|1|||
156848329|NCT01625000|566196781|FG000|Overall Study|Physician Decision|15|||
156848330|NCT01625000|566196782|FG001|Overall Study|Physician Decision|7|||
156848331|NCT01625000|566196783|FG002|Overall Study|Physician Decision|7|||
156848332|NCT01625000|566196784|FG003|Overall Study|Physician Decision|2|||
156848333|NCT01625000|566196785|FG004|Overall Study|Physician Decision|15|||
156848334|NCT01625000|566196781|FG000|Overall Study|Protocol Violation|3|||
156848335|NCT01625000|566196782|FG001|Overall Study|Protocol Violation|10|||
156848336|NCT01625000|566196783|FG002|Overall Study|Protocol Violation|4|||
156848337|NCT01625000|566196784|FG003|Overall Study|Protocol Violation|1|||
156848338|NCT01625000|566196785|FG004|Overall Study|Protocol Violation|2|||
156848339|NCT01625000|566196781|FG000|Overall Study|Withdrawal by Subject|19|||
156848340|NCT01625000|566196782|FG001|Overall Study|Withdrawal by Subject|16|||
156848341|NCT01625000|566196783|FG002|Overall Study|Withdrawal by Subject|11|||
156848342|NCT01625000|566196784|FG003|Overall Study|Withdrawal by Subject|9|||
156848343|NCT01625000|566196785|FG004|Overall Study|Withdrawal by Subject|17|||
156848344|NCT01625000|566196781|FG000|Overall Study|Adverse Event (including Death)|15|||
156848345|NCT01625000|566196782|FG001|Overall Study|Adverse Event (including Death)|19|||
156848346|NCT01625000|566196783|FG002|Overall Study|Adverse Event (including Death)|11|||
156848347|NCT01625000|566196784|FG003|Overall Study|Adverse Event (including Death)|7|||
156848348|NCT01625000|566196785|FG004|Overall Study|Adverse Event (including Death)|21|||
156848349|NCT00566852|566196786|FG000|Overall Study|Protocol Violation|22|||
156848350|NCT00566852|566196787|FG001|Overall Study|Protocol Violation|24|||
156848351|NCT00566852|566196786|FG000|Overall Study|Death|95|||
156848352|NCT00566852|566196787|FG001|Overall Study|Death|78|||
156848353|NCT00566852|566196786|FG000|Overall Study|Withdrawal by Subject|30|||
156848354|NCT00566852|566196787|FG001|Overall Study|Withdrawal by Subject|25|||
156848355|NCT00566852|566196786|FG000|Overall Study|Patient refusal|37|||
157225226|NCT04634409|567570024|FG015|Overall Study|Death|0|||
157225227|NCT04634409|567570025|FG016|Overall Study|Death|0|||
157225228|NCT04634409|567570026|FG017|Overall Study|Death|0|||
157225229|NCT04634409|567570027|FG018|Overall Study|Death|0|||
157225230|NCT04634409|567570028|FG019|Overall Study|Death|0|||
157225231|NCT04634409|567570029|FG020|Overall Study|Death|0|||
156848356|NCT00566852|566196787|FG001|Overall Study|Patient refusal|37|||
156848357|NCT00566852|566196786|FG000|Overall Study|Not tested due to disability|6|||
156848358|NCT00566852|566196787|FG001|Overall Study|Not tested due to disability|12|||
156848359|NCT00566852|566196786|FG000|Overall Study|Missing reason not specified|1|||
156848360|NCT00566852|566196787|FG001|Overall Study|Missing reason not specified|2|||
156848361|NCT00566852|566196786|FG000|Overall Study|Missing reason not reported|16|||
156848362|NCT00566852|566196787|FG001|Overall Study|Missing reason not reported|20|||
156848363|NCT00132808|566196788|FG000|Stratum I|Adverse Event|2|||
156848364|NCT00132808|566196789|FG001|Stratum I|Adverse Event|1|||
156848365|NCT00132808|566196790|FG002|Stratum I|Adverse Event|0|||
156848366|NCT00132808|566196788|FG000|Stratum I|Lost to Follow-up|3|||
156848367|NCT00132808|566196789|FG001|Stratum I|Lost to Follow-up|4|||
156848368|NCT00132808|566196790|FG002|Stratum I|Lost to Follow-up|1|||
156848369|NCT00132808|566196788|FG000|Stratum I|Withdrawal by Subject|4|||
156848370|NCT00132808|566196789|FG001|Stratum I|Withdrawal by Subject|7|||
156848371|NCT00132808|566196790|FG002|Stratum I|Withdrawal by Subject|3|||
156848372|NCT00132808|566196788|FG000|Stratum I|Abnormal test procedure result (s)|0|||
156848373|NCT00132808|566196789|FG001|Stratum I|Abnormal test procedure result (s)|0|||
156848374|NCT00132808|566196790|FG002|Stratum I|Abnormal test procedure result (s)|1|||
156848375|NCT00132808|566196788|FG000|Stratum II|Adverse Event|1|||
156848376|NCT00132808|566196789|FG001|Stratum II|Adverse Event|2|||
156848377|NCT00132808|566196790|FG002|Stratum II|Adverse Event|1|||
156848378|NCT00132808|566196788|FG000|Stratum II|Death|1|||
156848379|NCT00132808|566196789|FG001|Stratum II|Death|0|||
156848380|NCT00132808|566196790|FG002|Stratum II|Death|0|||
156848381|NCT00132808|566196788|FG000|Stratum II|Lost to Follow-up|2|||
156848382|NCT00132808|566196789|FG001|Stratum II|Lost to Follow-up|2|||
156848383|NCT00132808|566196790|FG002|Stratum II|Lost to Follow-up|1|||
156848384|NCT00132808|566196788|FG000|Stratum II|Protocol Violation|0|||
156848385|NCT00132808|566196789|FG001|Stratum II|Protocol Violation|2|||
156848386|NCT00132808|566196790|FG002|Stratum II|Protocol Violation|1|||
156848387|NCT00132808|566196788|FG000|Stratum II|Withdrawal by Subject|4|||
156848388|NCT00132808|566196789|FG001|Stratum II|Withdrawal by Subject|9|||
156888423|NCT00761150|566350591|FG000|Double-blind Period|Adverse Event|0|||
157225232|NCT04634409|567570030|FG021|Overall Study|Death|0|||
157225233|NCT04634409|567570031|FG022|Overall Study|Death|0|||
157225234|NCT04634409|567570032|FG023|Overall Study|Death|0|||
157225235|NCT04634409|567570033|FG024|Overall Study|Death|0|||
157225236|NCT04634409|567570034|FG025|Overall Study|Death|0|||
157225237|NCT04634409|567570035|FG026|Overall Study|Death|0|||
157225238|NCT04634409|567570009|FG000|Overall Study|Adverse Event|0|||
157225239|NCT04634409|567570010|FG001|Overall Study|Adverse Event|0|||
157225240|NCT04634409|567570011|FG002|Overall Study|Adverse Event|1|||
157225241|NCT04634409|567570012|FG003|Overall Study|Adverse Event|0|||
157225242|NCT04634409|567570013|FG004|Overall Study|Adverse Event|0|||
157225243|NCT04634409|567570014|FG005|Overall Study|Adverse Event|1|||
157225244|NCT04634409|567570015|FG006|Overall Study|Adverse Event|0|||
157225245|NCT04634409|567570016|FG007|Overall Study|Adverse Event|0|||
157225246|NCT04634409|567570017|FG008|Overall Study|Adverse Event|0|||
157225247|NCT04634409|567570018|FG009|Overall Study|Adverse Event|0|||
157225248|NCT04634409|567570019|FG010|Overall Study|Adverse Event|0|||
157225249|NCT04634409|567570020|FG011|Overall Study|Adverse Event|0|||
157225250|NCT04634409|567570021|FG012|Overall Study|Adverse Event|0|||
157225251|NCT04634409|567570022|FG013|Overall Study|Adverse Event|0|||
157225252|NCT04634409|567570023|FG014|Overall Study|Adverse Event|0|||
157225253|NCT04634409|567570024|FG015|Overall Study|Adverse Event|0|||
157225254|NCT04634409|567570025|FG016|Overall Study|Adverse Event|0|||
157225255|NCT04634409|567570026|FG017|Overall Study|Adverse Event|0|||
157225256|NCT04634409|567570027|FG018|Overall Study|Adverse Event|0|||
157225257|NCT04634409|567570028|FG019|Overall Study|Adverse Event|0|||
156888424|NCT00761150|566350592|FG001|Double-blind Period|Adverse Event|3|||
156888425|NCT00761150|566350593|FG002|Double-blind Period|Adverse Event|3|||
157225258|NCT04634409|567570029|FG020|Overall Study|Adverse Event|0|||
156888426|NCT00761150|566350591|FG000|Double-blind Period|Withdrawal by Subject|0|||
156888427|NCT00761150|566350592|FG001|Double-blind Period|Withdrawal by Subject|3|||
156888428|NCT00761150|566350593|FG002|Double-blind Period|Withdrawal by Subject|2|||
157225259|NCT04634409|567570030|FG021|Overall Study|Adverse Event|0|||
157225260|NCT04634409|567570031|FG022|Overall Study|Adverse Event|0|||
156888429|NCT00761150|566350591|FG000|Double-blind Period|Lost to Follow-up|0|||
156848389|NCT00132808|566196790|FG002|Stratum II|Withdrawal by Subject|6|||
157225261|NCT04634409|567570032|FG023|Overall Study|Adverse Event|0|||
157225262|NCT04634409|567570033|FG024|Overall Study|Adverse Event|0|||
157225263|NCT04634409|567570034|FG025|Overall Study|Adverse Event|0|||
156848390|NCT00577824|566196792|FG000|Overall Study|Adverse Event|6|||
156848391|NCT00577824|566196793|FG001|Overall Study|Adverse Event|18|||
156848392|NCT00577824|566196794|FG002|Overall Study|Adverse Event|1|||
157225264|NCT04634409|567570035|FG026|Overall Study|Adverse Event|0|||
156848393|NCT00577824|566196792|FG000|Overall Study|Patient decision|0|||
156848394|NCT00577824|566196793|FG001|Overall Study|Patient decision|1|||
156848395|NCT00577824|566196794|FG002|Overall Study|Patient decision|1|||
157225265|NCT04634409|567570009|FG000|Overall Study|Lost to Follow-up|3|||
156888430|NCT00761150|566350592|FG001|Double-blind Period|Lost to Follow-up|2|||
156888431|NCT00761150|566350593|FG002|Double-blind Period|Lost to Follow-up|1|||
156888432|NCT00761150|566350591|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
156888433|NCT00761150|566350592|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
156888434|NCT00761150|566350593|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
156888435|NCT00761150|566350591|FG000|Double-blind Period|Noncompliance|0|||
156888436|NCT00761150|566350592|FG001|Double-blind Period|Noncompliance|1|||
156888437|NCT00761150|566350593|FG002|Double-blind Period|Noncompliance|0|||
156888438|NCT00761150|566350591|FG000|Double-blind Period|Other|0|||
156888439|NCT00761150|566350592|FG001|Double-blind Period|Other|3|||
156888440|NCT00761150|566350593|FG002|Double-blind Period|Other|3|||
156888441|NCT01214174|566350594|FG000|Overall Study|Withdrawal by Subject|0|||
156888442|NCT01214174|566350595|FG001|Overall Study|Withdrawal by Subject|0|||
156888443|NCT01214174|566350596|FG002|Overall Study|Withdrawal by Subject|1|||
157155503|NCT02890329|567314268|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
157155504|NCT02890329|567314269|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
157155505|NCT02890329|567314270|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
157155506|NCT02890329|567314271|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
157155507|NCT02890329|567314272|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
157155508|NCT01035255|567314274|FG000|Overall Study|Death|724|||
157155509|NCT01035255|567314275|FG001|Overall Study|Death|844|||
157155510|NCT01035255|567314274|FG000|Overall Study|Lost to Follow-up|2|||
157155511|NCT01035255|567314275|FG001|Overall Study|Lost to Follow-up|5|||
157155512|NCT01035255|567314274|FG000|Overall Study|patient's request|15|||
157155513|NCT01035255|567314275|FG001|Overall Study|patient's request|13|||
157155514|NCT00195260|567314278|FG000|Part 1: Dose Escalation|Adverse Event|0|||
157155515|NCT00195260|567314279|FG001|Part 1: Dose Escalation|Adverse Event|1|||
157155516|NCT00195260|567314280|FG002|Part 1: Dose Escalation|Adverse Event|0|||
157155517|NCT00195260|567314281|FG003|Part 1: Dose Escalation|Adverse Event|1|||
157155518|NCT00195260|567314282|FG004|Part 1: Dose Escalation|Adverse Event|1|||
157155519|NCT00195260|567314283|FG005|Part 1: Dose Escalation|Adverse Event|0|||
157155520|NCT00195260|567314284|FG006|Part 1: Dose Escalation|Adverse Event|3|||
157155521|NCT00195260|567314285|FG007|Part 1: Dose Escalation|Adverse Event|0|||
157155522|NCT00195260|567314286|FG008|Part 1: Dose Escalation|Adverse Event|0|||
157155523|NCT00195260|567314287|FG009|Part 1: Dose Escalation|Adverse Event|0|||
157155524|NCT00195260|567314288|FG010|Part 1: Dose Escalation|Adverse Event|0|||
157155525|NCT00195260|567314278|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155526|NCT00195260|567314279|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155527|NCT00195260|567314280|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155528|NCT00195260|567314281|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155529|NCT00195260|567314282|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
157155530|NCT00195260|567314283|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155531|NCT00195260|567314284|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155532|NCT00195260|567314285|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
157155533|NCT00195260|567314286|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155534|NCT00195260|567314287|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155535|NCT00195260|567314288|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
157155536|NCT00195260|567314278|FG000|Part 1: Dose Escalation|Death|0|||
157155537|NCT00195260|567314279|FG001|Part 1: Dose Escalation|Death|0|||
157155538|NCT00195260|567314280|FG002|Part 1: Dose Escalation|Death|0|||
157155539|NCT00195260|567314281|FG003|Part 1: Dose Escalation|Death|0|||
157155540|NCT00195260|567314282|FG004|Part 1: Dose Escalation|Death|0|||
157155541|NCT00195260|567314283|FG005|Part 1: Dose Escalation|Death|0|||
157155542|NCT00195260|567314284|FG006|Part 1: Dose Escalation|Death|0|||
157155543|NCT00195260|567314285|FG007|Part 1: Dose Escalation|Death|1|||
157155544|NCT00195260|567314286|FG008|Part 1: Dose Escalation|Death|0|||
157155545|NCT00195260|567314287|FG009|Part 1: Dose Escalation|Death|0|||
157155546|NCT00195260|567314288|FG010|Part 1: Dose Escalation|Death|0|||
157155547|NCT00195260|567314278|FG000|Part 1: Dose Escalation|Disease Progression|3|||
157155548|NCT00195260|567314279|FG001|Part 1: Dose Escalation|Disease Progression|2|||
157155549|NCT00195260|567314280|FG002|Part 1: Dose Escalation|Disease Progression|5|||
157155550|NCT00195260|567314281|FG003|Part 1: Dose Escalation|Disease Progression|6|||
157155551|NCT00195260|567314282|FG004|Part 1: Dose Escalation|Disease Progression|4|||
157155552|NCT00195260|567314283|FG005|Part 1: Dose Escalation|Disease Progression|6|||
157155553|NCT00195260|567314284|FG006|Part 1: Dose Escalation|Disease Progression|7|||
157155554|NCT00195260|567314285|FG007|Part 1: Dose Escalation|Disease Progression|4|||
157155555|NCT00195260|567314286|FG008|Part 1: Dose Escalation|Disease Progression|0|||
157155556|NCT00195260|567314287|FG009|Part 1: Dose Escalation|Disease Progression|0|||
157155557|NCT00195260|567314288|FG010|Part 1: Dose Escalation|Disease Progression|0|||
157155558|NCT00195260|567314278|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
157155559|NCT00195260|567314279|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
157155560|NCT00195260|567314280|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
157155561|NCT00195260|567314281|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155562|NCT00195260|567314282|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
156888444|NCT00290407|566350597|FG000|Overall Study|Physician Decision|2|||
156888445|NCT00868517|566350606|FG000|Overall Study|Withdrawal by Subject|3|||
156888446|NCT00868517|566350607|FG001|Overall Study|Withdrawal by Subject|3|||
156888447|NCT00868517|566350608|FG002|Overall Study|Withdrawal by Subject|2|||
157155563|NCT00195260|567314283|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
157155564|NCT00195260|567314284|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155565|NCT00195260|567314285|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155566|NCT00195260|567314286|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155567|NCT00195260|567314287|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155568|NCT00195260|567314288|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
157155569|NCT00195260|567314278|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155570|NCT00195260|567314279|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155571|NCT00195260|567314280|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155572|NCT00195260|567314281|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155573|NCT00195260|567314282|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155574|NCT00195260|567314283|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155575|NCT00195260|567314284|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155576|NCT00195260|567314285|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
157155577|NCT00195260|567314286|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
157155578|NCT00195260|567314287|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
157155579|NCT00195260|567314288|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
157155580|NCT00195260|567314278|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155581|NCT00195260|567314279|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155582|NCT00195260|567314280|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155583|NCT00195260|567314281|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155584|NCT00195260|567314282|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155585|NCT00195260|567314283|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155586|NCT00195260|567314284|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155587|NCT00195260|567314285|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
157155588|NCT00195260|567314286|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
157155589|NCT00195260|567314287|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
157155590|NCT00195260|567314288|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
157155591|NCT00195260|567314278|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155592|NCT00195260|567314279|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155593|NCT00195260|567314280|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155594|NCT00195260|567314281|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155595|NCT00195260|567314282|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155596|NCT00195260|567314283|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155597|NCT00195260|567314284|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155598|NCT00195260|567314285|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
157155599|NCT00195260|567314286|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
157155600|NCT00195260|567314287|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
157155601|NCT00195260|567314288|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
157155602|NCT00195260|567314278|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155603|NCT00195260|567314279|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155604|NCT00195260|567314280|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155605|NCT00195260|567314281|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155606|NCT00195260|567314282|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155607|NCT00195260|567314283|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155608|NCT00195260|567314284|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155609|NCT00195260|567314285|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
157155610|NCT00195260|567314286|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
157155611|NCT00195260|567314287|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
157155612|NCT00195260|567314288|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
157155613|NCT02749721|567314289|FG000|Screening|Withdrawal by Subject|1|||
157155614|NCT02749721|567314289|FG000|Screening|Lost to Follow-up|2|||
157155615|NCT02749721|567314289|FG000|Screening|Protocol Violation|3|||
157155616|NCT02749721|567314289|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
157155617|NCT02749721|567314289|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
157155618|NCT01379534|567314290|FG000|Treatment Phase|Withdrawal by Subject|2|||
157155619|NCT01379534|567314291|FG001|Treatment Phase|Withdrawal by Subject|2|||
157155620|NCT01379534|567314290|FG000|Treatment Phase|Progressive disease|13|||
157155621|NCT01379534|567314291|FG001|Treatment Phase|Progressive disease|22|||
157155622|NCT01379534|567314290|FG000|Treatment Phase|Adverse Event|7|||
157155623|NCT01379534|567314291|FG001|Treatment Phase|Adverse Event|7|||
157155624|NCT01379534|567314290|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
157155625|NCT01379534|567314291|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
156888448|NCT00868517|566350606|FG000|Overall Study|Protocol Violation|1|||
156888449|NCT00868517|566350607|FG001|Overall Study|Protocol Violation|1|||
157225266|NCT04634409|567570010|FG001|Overall Study|Lost to Follow-up|1|||
157225267|NCT04634409|567570011|FG002|Overall Study|Lost to Follow-up|1|||
157225268|NCT04634409|567570012|FG003|Overall Study|Lost to Follow-up|3|||
157225269|NCT04634409|567570013|FG004|Overall Study|Lost to Follow-up|1|||
157225270|NCT04634409|567570014|FG005|Overall Study|Lost to Follow-up|1|||
157225271|NCT04634409|567570015|FG006|Overall Study|Lost to Follow-up|1|||
157225272|NCT04634409|567570016|FG007|Overall Study|Lost to Follow-up|3|||
157225273|NCT04634409|567570017|FG008|Overall Study|Lost to Follow-up|3|||
157225274|NCT04634409|567570018|FG009|Overall Study|Lost to Follow-up|11|||
157225275|NCT04634409|567570019|FG010|Overall Study|Lost to Follow-up|8|||
157225276|NCT04634409|567570020|FG011|Overall Study|Lost to Follow-up|15|||
157225277|NCT04634409|567570021|FG012|Overall Study|Lost to Follow-up|3|||
157225278|NCT04634409|567570022|FG013|Overall Study|Lost to Follow-up|2|||
157225279|NCT04634409|567570023|FG014|Overall Study|Lost to Follow-up|7|||
157225280|NCT04634409|567570024|FG015|Overall Study|Lost to Follow-up|0|||
157225281|NCT04634409|567570025|FG016|Overall Study|Lost to Follow-up|0|||
157225282|NCT04634409|567570026|FG017|Overall Study|Lost to Follow-up|0|||
157225283|NCT04634409|567570027|FG018|Overall Study|Lost to Follow-up|0|||
157225284|NCT04634409|567570028|FG019|Overall Study|Lost to Follow-up|0|||
157225285|NCT04634409|567570029|FG020|Overall Study|Lost to Follow-up|0|||
157225286|NCT04634409|567570030|FG021|Overall Study|Lost to Follow-up|0|||
157225287|NCT04634409|567570031|FG022|Overall Study|Lost to Follow-up|0|||
157225288|NCT04634409|567570032|FG023|Overall Study|Lost to Follow-up|0|||
157225289|NCT04634409|567570033|FG024|Overall Study|Lost to Follow-up|0|||
157225290|NCT04634409|567570034|FG025|Overall Study|Lost to Follow-up|0|||
157225291|NCT04634409|567570035|FG026|Overall Study|Lost to Follow-up|0|||
157225292|NCT04634409|567570009|FG000|Overall Study|Withdrawal by Subject|3|||
157225293|NCT04634409|567570010|FG001|Overall Study|Withdrawal by Subject|1|||
157225294|NCT04634409|567570011|FG002|Overall Study|Withdrawal by Subject|6|||
157225295|NCT04634409|567570012|FG003|Overall Study|Withdrawal by Subject|4|||
157225296|NCT04634409|567570013|FG004|Overall Study|Withdrawal by Subject|2|||
157225297|NCT04634409|567570014|FG005|Overall Study|Withdrawal by Subject|0|||
157225298|NCT04634409|567570015|FG006|Overall Study|Withdrawal by Subject|0|||
157225299|NCT04634409|567570016|FG007|Overall Study|Withdrawal by Subject|2|||
157225300|NCT04634409|567570017|FG008|Overall Study|Withdrawal by Subject|3|||
157225301|NCT04634409|567570018|FG009|Overall Study|Withdrawal by Subject|2|||
157225302|NCT04634409|567570019|FG010|Overall Study|Withdrawal by Subject|3|||
157225303|NCT04634409|567570020|FG011|Overall Study|Withdrawal by Subject|2|||
157225304|NCT04634409|567570021|FG012|Overall Study|Withdrawal by Subject|2|||
157225305|NCT04634409|567570022|FG013|Overall Study|Withdrawal by Subject|1|||
157225306|NCT04634409|567570023|FG014|Overall Study|Withdrawal by Subject|5|||
157225307|NCT04634409|567570024|FG015|Overall Study|Withdrawal by Subject|0|||
157225308|NCT04634409|567570025|FG016|Overall Study|Withdrawal by Subject|0|||
157225309|NCT04634409|567570026|FG017|Overall Study|Withdrawal by Subject|1|||
157225310|NCT04634409|567570027|FG018|Overall Study|Withdrawal by Subject|0|||
157225311|NCT04634409|567570028|FG019|Overall Study|Withdrawal by Subject|0|||
157225312|NCT04634409|567570029|FG020|Overall Study|Withdrawal by Subject|0|||
156888450|NCT00868517|566350608|FG002|Overall Study|Protocol Violation|0|||
156888451|NCT02496676|566350610|FG000|Phase 1 - Period 1|Adverse Event|0|||
156888452|NCT02496676|566350611|FG001|Phase 1 - Period 1|Adverse Event|1|||
156888453|NCT02496676|566350610|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
156888454|NCT02496676|566350611|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
156888455|NCT05442775|566350612|FG000|Overall Study|Trial terminated|61|||
156888456|NCT05442775|566350612|FG000|Overall Study|Lack of Efficacy|4|||
156888457|NCT05442775|566350612|FG000|Overall Study|Withdrawal by Subject|4|||
156888458|NCT05442775|566350612|FG000|Overall Study|Death|1|||
156888459|NCT05442775|566350612|FG000|Overall Study|Participant removed at Sponsor request|1|||
156888460|NCT03459690|566350614|FG000|Overall Study|Lost to Follow-up|0|||
156888461|NCT03459690|566350615|FG001|Overall Study|Lost to Follow-up|1|||
156888462|NCT03459690|566350614|FG000|Overall Study|Withdrawal by Subject|1|||
156888463|NCT03459690|566350615|FG001|Overall Study|Withdrawal by Subject|1|||
157225313|NCT04634409|567570030|FG021|Overall Study|Withdrawal by Subject|0|||
156888464|NCT02963831|566350616|FG000|Overall Study|Progressive Disease|3|||
156888465|NCT02963831|566350617|FG001|Overall Study|Progressive Disease|3|||
156888466|NCT02963831|566350618|FG002|Overall Study|Progressive Disease|16|||
156888467|NCT02963831|566350619|FG003|Overall Study|Progressive Disease|27|||
157225314|NCT04634409|567570031|FG022|Overall Study|Withdrawal by Subject|0|||
157225315|NCT04634409|567570032|FG023|Overall Study|Withdrawal by Subject|1|||
157225316|NCT04634409|567570033|FG024|Overall Study|Withdrawal by Subject|0|||
156888468|NCT02963831|566350616|FG000|Overall Study|Withdrawal by Subject|1|||
156888469|NCT02963831|566350617|FG001|Overall Study|Withdrawal by Subject|0|||
156888470|NCT02963831|566350618|FG002|Overall Study|Withdrawal by Subject|2|||
157225317|NCT04634409|567570034|FG025|Overall Study|Withdrawal by Subject|0|||
157225318|NCT04634409|567570035|FG026|Overall Study|Withdrawal by Subject|0|||
157225319|NCT04634409|567570009|FG000|Overall Study|Other - As reported by Investigator|1|||
157225320|NCT04634409|567570010|FG001|Overall Study|Other - As reported by Investigator|0|||
157225321|NCT04634409|567570011|FG002|Overall Study|Other - As reported by Investigator|0|||
156888471|NCT02963831|566350619|FG003|Overall Study|Withdrawal by Subject|4|||
157225322|NCT04634409|567570012|FG003|Overall Study|Other - As reported by Investigator|0|||
157225323|NCT04634409|567570013|FG004|Overall Study|Other - As reported by Investigator|0|||
157225324|NCT04634409|567570014|FG005|Overall Study|Other - As reported by Investigator|0|||
156848396|NCT00577824|566196792|FG000|Overall Study|Protocol Violation|1|||
156848397|NCT00577824|566196793|FG001|Overall Study|Protocol Violation|1|||
156848398|NCT00577824|566196794|FG002|Overall Study|Protocol Violation|0|||
156848399|NCT00048347|566196795|FG000|Overall Study|Screen failure|2|||
156848400|NCT00595478|566196796|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
156848401|NCT00595478|566196797|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
156848402|NCT00595478|566196796|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
156848403|NCT00595478|566196797|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
156848404|NCT02713828|566196800|FG000|Overall Study|Death|2|||
156848405|NCT02713828|566196801|FG001|Overall Study|Death|0|||
156848406|NCT02713828|566196800|FG000|Overall Study|Withdrawal by Subject|1|||
156848407|NCT02713828|566196801|FG001|Overall Study|Withdrawal by Subject|0|||
156848408|NCT02713828|566196800|FG000|Overall Study|study terminated but patient allowed to|2|||
156848409|NCT02713828|566196801|FG001|Overall Study|study terminated but patient allowed to|0|||
156848410|NCT03302247|566196802|FG000|Overall Study|the study has closed prematurely|2|||
156848411|NCT03302247|566196802|FG000|Overall Study|Death|1|||
156848412|NCT03508609|566196804|FG000|Overall Study|Withdrawal by Subject|1|||
156848413|NCT01445080|566196807|FG000|Overall Study|Adverse Event|5|||
156848414|NCT01445080|566196808|FG001|Overall Study|Adverse Event|3|||
156848415|NCT01445080|566196809|FG002|Overall Study|Adverse Event|11|||
156848416|NCT01445080|566196810|FG003|Overall Study|Adverse Event|6|||
156848417|NCT01445080|566196811|FG004|Overall Study|Adverse Event|2|||
157225325|NCT04634409|567570015|FG006|Overall Study|Other - As reported by Investigator|0|||
157225326|NCT04634409|567570016|FG007|Overall Study|Other - As reported by Investigator|6|||
157225327|NCT04634409|567570017|FG008|Overall Study|Other - As reported by Investigator|4|||
157225328|NCT04634409|567570018|FG009|Overall Study|Other - As reported by Investigator|0|||
157225329|NCT04634409|567570019|FG010|Overall Study|Other - As reported by Investigator|1|||
157225330|NCT04634409|567570020|FG011|Overall Study|Other - As reported by Investigator|2|||
157225331|NCT04634409|567570021|FG012|Overall Study|Other - As reported by Investigator|2|||
157225332|NCT04634409|567570022|FG013|Overall Study|Other - As reported by Investigator|1|||
157225333|NCT04634409|567570023|FG014|Overall Study|Other - As reported by Investigator|0|||
157225334|NCT04634409|567570024|FG015|Overall Study|Other - As reported by Investigator|0|||
157225335|NCT04634409|567570025|FG016|Overall Study|Other - As reported by Investigator|0|||
157225336|NCT04634409|567570026|FG017|Overall Study|Other - As reported by Investigator|0|||
157225337|NCT04634409|567570027|FG018|Overall Study|Other - As reported by Investigator|0|||
157225338|NCT04634409|567570028|FG019|Overall Study|Other - As reported by Investigator|0|||
157225339|NCT04634409|567570029|FG020|Overall Study|Other - As reported by Investigator|0|||
157225340|NCT04634409|567570030|FG021|Overall Study|Other - As reported by Investigator|0|||
157225341|NCT04634409|567570031|FG022|Overall Study|Other - As reported by Investigator|0|||
157225342|NCT04634409|567570032|FG023|Overall Study|Other - As reported by Investigator|0|||
157225343|NCT04634409|567570033|FG024|Overall Study|Other - As reported by Investigator|0|||
157225344|NCT04634409|567570034|FG025|Overall Study|Other - As reported by Investigator|0|||
157225345|NCT04634409|567570035|FG026|Overall Study|Other - As reported by Investigator|0|||
157225346|NCT03471078|567571393|FG000|Overall Study|Withdrawal by Subject|9|||
157225347|NCT03471078|567571394|FG001|Overall Study|Withdrawal by Subject|1|||
157225348|NCT03471078|567571393|FG000|Overall Study|Adverse Event|4|||
157225349|NCT03471078|567571394|FG001|Overall Study|Adverse Event|1|||
157225350|NCT03471078|567571393|FG000|Overall Study|Physician Decision|3|||
157225351|NCT03471078|567571394|FG001|Overall Study|Physician Decision|2|||
157225352|NCT03471078|567571393|FG000|Overall Study|Death|2|||
157225353|NCT03471078|567571394|FG001|Overall Study|Death|0|||
157225354|NCT03471078|567571393|FG000|Overall Study|Other|3|||
157225355|NCT03471078|567571394|FG001|Overall Study|Other|2|||
157225356|NCT00278200|567571399|FG000|Overall Study|Death|1|||
157225357|NCT00278200|567571400|FG001|Overall Study|Death|3|||
157225358|NCT00278200|567571399|FG000|Overall Study|Physician Decision|0|||
157225359|NCT00278200|567571400|FG001|Overall Study|Physician Decision|1|||
157225360|NCT05568225|567571408|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
157225361|NCT05568225|567571409|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
157225362|NCT05568225|567571410|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
157225363|NCT05568225|567571408|FG000|Primary Treatment Period|Physician Decision|0|||
157225364|NCT05568225|567571409|FG001|Primary Treatment Period|Physician Decision|1|||
157225365|NCT05568225|567571410|FG002|Primary Treatment Period|Physician Decision|0|||
157225366|NCT05568225|567571408|FG000|Primary Treatment Period|Disease progression|0|||
156848418|NCT01445080|566196812|FG005|Overall Study|Adverse Event|3|||
156848419|NCT01445080|566196813|FG006|Overall Study|Adverse Event|0|||
156848420|NCT01445080|566196814|FG007|Overall Study|Adverse Event|3|||
156848421|NCT01445080|566196815|FG008|Overall Study|Adverse Event|10|||
157225367|NCT05568225|567571409|FG001|Primary Treatment Period|Disease progression|1|||
156848422|NCT01445080|566196807|FG000|Overall Study|Physician Decision|0|||
156848423|NCT01445080|566196808|FG001|Overall Study|Physician Decision|0|||
156848424|NCT01445080|566196809|FG002|Overall Study|Physician Decision|1|||
156848425|NCT01445080|566196810|FG003|Overall Study|Physician Decision|0|||
156848426|NCT01445080|566196811|FG004|Overall Study|Physician Decision|0|||
156848427|NCT01445080|566196812|FG005|Overall Study|Physician Decision|3|||
157025424|NCT03544281|566847968|FG012|Main Study Phase|Physician Decision|0|||
157025425|NCT03544281|566847969|FG013|Main Study Phase|Physician Decision|0|||
157025426|NCT03544281|566847970|FG014|Main Study Phase|Physician Decision|0|||
157025427|NCT03544281|566847971|FG015|Main Study Phase|Physician Decision|0|||
157025428|NCT03544281|566847972|FG016|Main Study Phase|Physician Decision|0|||
157025429|NCT03544281|566847973|FG017|Main Study Phase|Physician Decision|0|||
157025430|NCT03544281|566847974|FG018|Main Study Phase|Physician Decision|0|||
157025431|NCT03544281|566847975|FG019|Main Study Phase|Physician Decision|0|||
157025432|NCT03544281|566847976|FG020|Main Study Phase|Physician Decision|0|||
157025433|NCT03544281|566847977|FG021|Main Study Phase|Physician Decision|0|||
157025434|NCT03544281|566847956|FG000|Main Study Phase|Withdrawal by Subject|2|||
157025435|NCT03544281|566847957|FG001|Main Study Phase|Withdrawal by Subject|0|||
157025436|NCT03544281|566847958|FG002|Main Study Phase|Withdrawal by Subject|1|||
157025437|NCT03544281|566847959|FG003|Main Study Phase|Withdrawal by Subject|2|||
157025438|NCT03544281|566847960|FG004|Main Study Phase|Withdrawal by Subject|0|||
157025439|NCT03544281|566847961|FG005|Main Study Phase|Withdrawal by Subject|0|||
157025440|NCT03544281|566847962|FG006|Main Study Phase|Withdrawal by Subject|0|||
157025441|NCT03544281|566847963|FG007|Main Study Phase|Withdrawal by Subject|0|||
157025442|NCT03544281|566847964|FG008|Main Study Phase|Withdrawal by Subject|2|||
157025443|NCT03544281|566847965|FG009|Main Study Phase|Withdrawal by Subject|3|||
157025444|NCT03544281|566847966|FG010|Main Study Phase|Withdrawal by Subject|0|||
157025445|NCT03544281|566847967|FG011|Main Study Phase|Withdrawal by Subject|4|||
157025446|NCT03544281|566847968|FG012|Main Study Phase|Withdrawal by Subject|0|||
157025447|NCT03544281|566847969|FG013|Main Study Phase|Withdrawal by Subject|0|||
157025448|NCT03544281|566847970|FG014|Main Study Phase|Withdrawal by Subject|0|||
157025449|NCT03544281|566847971|FG015|Main Study Phase|Withdrawal by Subject|0|||
157025450|NCT03544281|566847972|FG016|Main Study Phase|Withdrawal by Subject|0|||
157025451|NCT03544281|566847973|FG017|Main Study Phase|Withdrawal by Subject|0|||
157155626|NCT01379534|567314290|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
157155627|NCT01379534|567314291|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
157155628|NCT01379534|567314290|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
157155629|NCT01379534|567314291|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
157155630|NCT01379534|567314290|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
157155631|NCT01379534|567314291|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
157155632|NCT02691247|567314292|FG000|Overall Study|Withdrawal by Subject|1|||
157155633|NCT02691247|567314293|FG001|Overall Study|Withdrawal by Subject|2|||
157155634|NCT02691247|567314294|FG002|Overall Study|Withdrawal by Subject|2|||
157155635|NCT02691247|567314292|FG000|Overall Study|Lost to Follow-up|2|||
157155636|NCT02691247|567314293|FG001|Overall Study|Lost to Follow-up|0|||
157155637|NCT02691247|567314294|FG002|Overall Study|Lost to Follow-up|1|||
157155638|NCT01519245|567314295|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
157155639|NCT01519245|567314296|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
157155640|NCT03880227|567314304|FG000|First Visit|Withdrawal by Subject|1|||
157155641|NCT03880227|567314305|FG001|First Visit|Withdrawal by Subject|0|||
157155642|NCT03880227|567314306|FG002|First Visit|Withdrawal by Subject|0|||
157155643|NCT03880227|567314307|FG003|First Visit|Withdrawal by Subject|0|||
157155644|NCT03880227|567314304|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
157155645|NCT03880227|567314305|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
157155646|NCT03880227|567314306|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
157155647|NCT03880227|567314307|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
157155648|NCT03880227|567314304|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
157155649|NCT03880227|567314305|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
157155650|NCT03880227|567314306|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
157155651|NCT03880227|567314307|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
157155652|NCT03880227|567314304|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
157155653|NCT03880227|567314305|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
157155654|NCT03880227|567314306|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
157155655|NCT03880227|567314307|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
156848428|NCT01445080|566196813|FG006|Overall Study|Physician Decision|2|||
156848429|NCT01445080|566196814|FG007|Overall Study|Physician Decision|2|||
157025452|NCT03544281|566847974|FG018|Main Study Phase|Withdrawal by Subject|0|||
157025453|NCT03544281|566847975|FG019|Main Study Phase|Withdrawal by Subject|0|||
157025454|NCT03544281|566847976|FG020|Main Study Phase|Withdrawal by Subject|0|||
157025455|NCT03544281|566847977|FG021|Main Study Phase|Withdrawal by Subject|0|||
157025456|NCT03544281|566847956|FG000|Main Study Phase|Ongoing|3|||
157025457|NCT03544281|566847957|FG001|Main Study Phase|Ongoing|1|||
157025458|NCT03544281|566847958|FG002|Main Study Phase|Ongoing|2|||
157025459|NCT03544281|566847959|FG003|Main Study Phase|Ongoing|4|||
156848430|NCT01445080|566196815|FG008|Overall Study|Physician Decision|0|||
156848431|NCT01445080|566196807|FG000|Overall Study|Withdrawal by Subject|1|||
156848432|NCT01445080|566196808|FG001|Overall Study|Withdrawal by Subject|0|||
156848433|NCT01445080|566196809|FG002|Overall Study|Withdrawal by Subject|0|||
157225368|NCT05568225|567571410|FG002|Primary Treatment Period|Disease progression|0|||
157225369|NCT05568225|567571408|FG000|Primary Treatment Period|Lack of Efficacy|0|||
157225370|NCT05568225|567571409|FG001|Primary Treatment Period|Lack of Efficacy|1|||
157225371|NCT05568225|567571410|FG002|Primary Treatment Period|Lack of Efficacy|0|||
157225372|NCT05568225|567571408|FG000|Primary Treatment Period|Withdrawal of conset|1|||
157225373|NCT05568225|567571409|FG001|Primary Treatment Period|Withdrawal of conset|0|||
157225374|NCT05568225|567571410|FG002|Primary Treatment Period|Withdrawal of conset|4|||
157225375|NCT05568225|567571408|FG000|Primary Treatment Period|Adverse Event|1|||
157225376|NCT05568225|567571409|FG001|Primary Treatment Period|Adverse Event|0|||
157225377|NCT05568225|567571410|FG002|Primary Treatment Period|Adverse Event|0|||
157225378|NCT05568225|567571408|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
157225379|NCT05568225|567571409|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
157225380|NCT05568225|567571410|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
157225381|NCT05568225|567571408|FG000|Extension Treatment Period|Protocol Violation|0|||
157225382|NCT05568225|567571409|FG001|Extension Treatment Period|Protocol Violation|0|||
157225383|NCT05568225|567571410|FG002|Extension Treatment Period|Protocol Violation|1|||
157225384|NCT05568225|567571408|FG000|Extension Treatment Period|Lack of Efficacy|0|||
157225385|NCT05568225|567571409|FG001|Extension Treatment Period|Lack of Efficacy|0|||
157225386|NCT05568225|567571410|FG002|Extension Treatment Period|Lack of Efficacy|1|||
157225387|NCT03519256|567571416|FG000|Overall Study|Disease recurrence|4|||
157225388|NCT03519256|567571417|FG001|Overall Study|Disease recurrence|4|||
157225389|NCT03519256|567571418|FG002|Overall Study|Disease recurrence|5|||
157225390|NCT03519256|567571419|FG003|Overall Study|Disease recurrence|2|||
157225391|NCT03519256|567571416|FG000|Overall Study|Study drug toxicity|0|||
157225392|NCT03519256|567571417|FG001|Overall Study|Study drug toxicity|2|||
157225393|NCT03519256|567571418|FG002|Overall Study|Study drug toxicity|5|||
157225394|NCT03519256|567571419|FG003|Overall Study|Study drug toxicity|2|||
157225395|NCT03519256|567571416|FG000|Overall Study|Adverse event unrelated to study drug|0|||
157225396|NCT03519256|567571417|FG001|Overall Study|Adverse event unrelated to study drug|1|||
157225397|NCT03519256|567571418|FG002|Overall Study|Adverse event unrelated to study drug|1|||
157225398|NCT03519256|567571419|FG003|Overall Study|Adverse event unrelated to study drug|0|||
157225399|NCT03519256|567571416|FG000|Overall Study|Participant request to discontinue study treatment|0|||
157225400|NCT03519256|567571417|FG001|Overall Study|Participant request to discontinue study treatment|0|||
157225401|NCT03519256|567571418|FG002|Overall Study|Participant request to discontinue study treatment|0|||
157225402|NCT03519256|567571419|FG003|Overall Study|Participant request to discontinue study treatment|2|||
157225403|NCT03519256|567571416|FG000|Overall Study|Other reasons|0|||
157225404|NCT03519256|567571417|FG001|Overall Study|Other reasons|0|||
157225405|NCT03519256|567571418|FG002|Overall Study|Other reasons|2|||
157225406|NCT03519256|567571419|FG003|Overall Study|Other reasons|0|||
157225407|NCT03519256|567571416|FG000|Overall Study|Disease progression|6|||
157225408|NCT03519256|567571417|FG001|Overall Study|Disease progression|3|||
157225409|NCT03519256|567571418|FG002|Overall Study|Disease progression|2|||
156848434|NCT01445080|566196810|FG003|Overall Study|Withdrawal by Subject|1|||
156848435|NCT01445080|566196811|FG004|Overall Study|Withdrawal by Subject|0|||
156848436|NCT01445080|566196812|FG005|Overall Study|Withdrawal by Subject|0|||
156848437|NCT01445080|566196813|FG006|Overall Study|Withdrawal by Subject|0|||
156848438|NCT01445080|566196814|FG007|Overall Study|Withdrawal by Subject|0|||
156848439|NCT01445080|566196815|FG008|Overall Study|Withdrawal by Subject|2|||
156848440|NCT01445080|566196807|FG000|Overall Study|Ineligible/Inevaluable|1|||
156848441|NCT01445080|566196808|FG001|Overall Study|Ineligible/Inevaluable|2|||
156848442|NCT01445080|566196809|FG002|Overall Study|Ineligible/Inevaluable|0|||
156848443|NCT01445080|566196810|FG003|Overall Study|Ineligible/Inevaluable|1|||
156848444|NCT01445080|566196811|FG004|Overall Study|Ineligible/Inevaluable|2|||
156848445|NCT01445080|566196812|FG005|Overall Study|Ineligible/Inevaluable|3|||
156848446|NCT01445080|566196813|FG006|Overall Study|Ineligible/Inevaluable|0|||
156848447|NCT01445080|566196814|FG007|Overall Study|Ineligible/Inevaluable|0|||
156848448|NCT01445080|566196815|FG008|Overall Study|Ineligible/Inevaluable|6|||
156848449|NCT03887221|566196816|FG000|Overall Study|Protocol Violation|1|||
156848450|NCT03887221|566196817|FG001|Overall Study|Protocol Violation|0|||
156848451|NCT02487030|566196818|FG000|Overall Study|Lack of Efficacy|2|||
156848452|NCT02487030|566196819|FG001|Overall Study|Lack of Efficacy|4|||
156848453|NCT02487030|566196820|FG002|Overall Study|Lack of Efficacy|1|||
156848454|NCT02487030|566196821|FG003|Overall Study|Lack of Efficacy|0|||
156848455|NCT02487030|566196822|FG004|Overall Study|Lack of Efficacy|1|||
156848456|NCT02487030|566196823|FG005|Overall Study|Lack of Efficacy|0|||
156848457|NCT02487030|566196824|FG006|Overall Study|Lack of Efficacy|0|||
156848458|NCT02487030|566196818|FG000|Overall Study|Lost to Follow-up|0|||
156848459|NCT02487030|566196819|FG001|Overall Study|Lost to Follow-up|0|||
156848460|NCT02487030|566196820|FG002|Overall Study|Lost to Follow-up|1|||
156848461|NCT02487030|566196821|FG003|Overall Study|Lost to Follow-up|1|||
156848462|NCT02487030|566196822|FG004|Overall Study|Lost to Follow-up|0|||
157025460|NCT03544281|566847960|FG004|Main Study Phase|Ongoing|2|||
157025461|NCT03544281|566847961|FG005|Main Study Phase|Ongoing|4|||
157025462|NCT03544281|566847962|FG006|Main Study Phase|Ongoing|4|||
157025463|NCT03544281|566847963|FG007|Main Study Phase|Ongoing|0|||
157025464|NCT03544281|566847964|FG008|Main Study Phase|Ongoing|2|||
157025465|NCT03544281|566847965|FG009|Main Study Phase|Ongoing|2|||
157025466|NCT03544281|566847966|FG010|Main Study Phase|Ongoing|1|||
157025467|NCT03544281|566847967|FG011|Main Study Phase|Ongoing|0|||
157155656|NCT04590937|567314308|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
157155657|NCT01635933|567314309|FG000|Overall Study|Adverse Event|1|||
157155658|NCT01635933|567314310|FG001|Overall Study|Adverse Event|0|||
157155659|NCT01635933|567314309|FG000|Overall Study|Lost to Follow-up|0|||
156848463|NCT02487030|566196823|FG005|Overall Study|Lost to Follow-up|1|||
156848464|NCT02487030|566196824|FG006|Overall Study|Lost to Follow-up|0|||
156848465|NCT02487030|566196818|FG000|Overall Study|Adverse Event|0|||
156848466|NCT02487030|566196819|FG001|Overall Study|Adverse Event|0|||
156848467|NCT02487030|566196820|FG002|Overall Study|Adverse Event|0|||
156848468|NCT02487030|566196821|FG003|Overall Study|Adverse Event|1|||
156848469|NCT02487030|566196822|FG004|Overall Study|Adverse Event|0|||
156848470|NCT02487030|566196823|FG005|Overall Study|Adverse Event|0|||
156848471|NCT02487030|566196824|FG006|Overall Study|Adverse Event|0|||
156848472|NCT02487030|566196818|FG000|Overall Study|Death|0|||
156848473|NCT02487030|566196819|FG001|Overall Study|Death|0|||
156848474|NCT02487030|566196820|FG002|Overall Study|Death|0|||
156848475|NCT02487030|566196821|FG003|Overall Study|Death|0|||
156848476|NCT02487030|566196822|FG004|Overall Study|Death|1|||
156848477|NCT02487030|566196823|FG005|Overall Study|Death|0|||
156848478|NCT02487030|566196824|FG006|Overall Study|Death|0|||
157155660|NCT01635933|567314310|FG001|Overall Study|Lost to Follow-up|5|||
157155661|NCT01635933|567314309|FG000|Overall Study|Subject decision|1|||
156848479|NCT02123576|566196825|FG000|Overall Study|Adverse Event|1|||
156848480|NCT02123576|566196826|FG001|Overall Study|Adverse Event|0|||
156848481|NCT00999544|566199028|FG000|Overall Study|Withdrawal by Subject|1|||
156848482|NCT02936635|566199030|FG000|Overall Study|Adverse Event|43|||
156848483|NCT02936635|566199031|FG001|Overall Study|Adverse Event|25|||
156848484|NCT02936635|566199030|FG000|Overall Study|Progressive Disease|10|||
156848485|NCT02936635|566199031|FG001|Overall Study|Progressive Disease|18|||
156848486|NCT02936635|566199030|FG000|Overall Study|Sponsor Discretion|10|||
156848487|NCT02936635|566199031|FG001|Overall Study|Sponsor Discretion|16|||
156848488|NCT02936635|566199030|FG000|Overall Study|Death|9|||
156848489|NCT02936635|566199031|FG001|Overall Study|Death|15|||
156848490|NCT02936635|566199030|FG000|Overall Study|Withdrawal by Subject|8|||
156848491|NCT02936635|566199031|FG001|Overall Study|Withdrawal by Subject|15|||
156848492|NCT02936635|566199030|FG000|Overall Study|Physician Decision|2|||
156848493|NCT02936635|566199031|FG001|Overall Study|Physician Decision|9|||
156848494|NCT02936635|566199030|FG000|Overall Study|Lost to Follow-up|1|||
156848495|NCT02936635|566199031|FG001|Overall Study|Lost to Follow-up|2|||
156848496|NCT02936635|566199030|FG000|Overall Study|Protocol Violation|1|||
156848497|NCT02936635|566199031|FG001|Overall Study|Protocol Violation|0|||
156848498|NCT02936635|566199030|FG000|Overall Study|Lack of effect/Entry into other study|31|||
156848499|NCT02936635|566199031|FG001|Overall Study|Lack of effect/Entry into other study|65|||
156848500|NCT02407223|566199032|FG000|Overall Study|Adverse Event|1|||
156848501|NCT02407223|566199033|FG001|Overall Study|Adverse Event|0|||
156848502|NCT02407223|566199034|FG002|Overall Study|Adverse Event|1|||
156848503|NCT02407223|566199032|FG000|Overall Study|Lack of Efficacy|6|||
157155662|NCT01635933|567314310|FG001|Overall Study|Subject decision|1|||
157155663|NCT01635933|567314309|FG000|Overall Study|Noncompliance|0|||
156848504|NCT02407223|566199033|FG001|Overall Study|Lack of Efficacy|6|||
156848505|NCT02407223|566199034|FG002|Overall Study|Lack of Efficacy|4|||
156848506|NCT02407223|566199032|FG000|Overall Study|Lost to Follow-up|1|||
156848507|NCT02407223|566199033|FG001|Overall Study|Lost to Follow-up|0|||
156848508|NCT02407223|566199034|FG002|Overall Study|Lost to Follow-up|2|||
156848509|NCT02407223|566199032|FG000|Overall Study|Withdrawal by Subject|2|||
157025468|NCT03544281|566847968|FG012|Main Study Phase|Ongoing|0|||
157155664|NCT01635933|567314310|FG001|Overall Study|Noncompliance|1|||
156848510|NCT02407223|566199033|FG001|Overall Study|Withdrawal by Subject|4|||
156848511|NCT02407223|566199034|FG002|Overall Study|Withdrawal by Subject|4|||
156848512|NCT02407223|566199032|FG000|Overall Study|Study Terminated by Sponsor|77|||
156848513|NCT02407223|566199033|FG001|Overall Study|Study Terminated by Sponsor|80|||
156848514|NCT02407223|566199034|FG002|Overall Study|Study Terminated by Sponsor|86|||
157025469|NCT03544281|566847969|FG013|Main Study Phase|Ongoing|0|||
157155665|NCT01635933|567314309|FG000|Overall Study|No longer had transportation|0|||
156848515|NCT02407223|566199032|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
156848516|NCT02407223|566199033|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
156848517|NCT02407223|566199034|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
156848518|NCT02407223|566199032|FG000|Overall Study|Other|29|||
157025470|NCT03544281|566847970|FG014|Main Study Phase|Ongoing|0|||
157155666|NCT01635933|567314310|FG001|Overall Study|No longer had transportation|1|||
156848519|NCT02407223|566199033|FG001|Overall Study|Other|27|||
156848520|NCT02407223|566199034|FG002|Overall Study|Other|25|||
157025471|NCT03544281|566847971|FG015|Main Study Phase|Ongoing|0|||
157155667|NCT01544595|567314311|FG000|Status at Week 68|Adverse Event|3|||
157155668|NCT01544595|567314312|FG001|Status at Week 68|Adverse Event|2|||
157155669|NCT01544595|567314313|FG002|Status at Week 68|Adverse Event|1|||
157155670|NCT01544595|567314314|FG003|Status at Week 68|Adverse Event|0|||
157155671|NCT01544595|567314315|FG004|Status at Week 68|Adverse Event|0|||
157155672|NCT01544595|567314316|FG005|Status at Week 68|Adverse Event|0|||
156848521|NCT00447226|566199035|FG000|12-Week Open-label Phase|Adverse Event|0|||
156848522|NCT00447226|566199036|FG001|12-Week Open-label Phase|Adverse Event|3|||
156848523|NCT00447226|566199035|FG000|12-Week Open-label Phase|Protocol Violation|0|||
156848524|NCT00447226|566199036|FG001|12-Week Open-label Phase|Protocol Violation|1|||
156848525|NCT00447226|566199035|FG000|12-Week Open-label Phase|Disease Progression|0|||
156848526|NCT00447226|566199036|FG001|12-Week Open-label Phase|Disease Progression|20|||
156848527|NCT00447226|566199035|FG000|12-Week Open-label Phase|Physician Decision|0|||
156848528|NCT00447226|566199036|FG001|12-Week Open-label Phase|Physician Decision|1|||
156848529|NCT00447226|566199035|FG000|Double-blind Phase|Disease Progression|4|||
156848530|NCT00447226|566199036|FG001|Double-blind Phase|Disease Progression|3|||
156848531|NCT01410890|566199044|FG000|Overall Study|Withdrawal by Subject|0|||
156848532|NCT01410890|566199045|FG001|Overall Study|Withdrawal by Subject|1|||
156848533|NCT00412893|566199046|FG000|Overall Study|Adverse Event|31|||
156848534|NCT00412893|566199047|FG001|Overall Study|Adverse Event|53|||
156848535|NCT00412893|566199046|FG000|Overall Study|Death|17|||
156848536|NCT00412893|566199047|FG001|Overall Study|Death|21|||
156848537|NCT00412893|566199046|FG000|Overall Study|Insufficient Therapeutic Response|39|||
156848538|NCT00412893|566199047|FG001|Overall Study|Insufficient Therapeutic Response|23|||
156848539|NCT00412893|566199046|FG000|Overall Study|Lost to Follow-up|2|||
156848540|NCT00412893|566199047|FG001|Overall Study|Lost to Follow-up|1|||
156848541|NCT00412893|566199046|FG000|Overall Study|Violation of Selection at Entry|17|||
156848542|NCT00412893|566199047|FG001|Overall Study|Violation of Selection at Entry|10|||
156848543|NCT00412893|566199046|FG000|Overall Study|Other Protocol Violation|10|||
156848544|NCT00412893|566199047|FG001|Overall Study|Other Protocol Violation|6|||
156848545|NCT00412893|566199046|FG000|Overall Study|Did Not Cooperate|12|||
156848546|NCT00412893|566199047|FG001|Overall Study|Did Not Cooperate|9|||
156848547|NCT00412893|566199046|FG000|Overall Study|Administrative Reason|12|||
156848548|NCT00412893|566199047|FG001|Overall Study|Administrative Reason|15|||
156848549|NCT00412893|566199046|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
156848550|NCT00412893|566199047|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
156848551|NCT03951077|566199048|FG000|Overall Study|Adverse Event|1|||
156848552|NCT03951077|566199049|FG001|Overall Study|Adverse Event|0|||
156848553|NCT03951077|566199050|FG002|Overall Study|Adverse Event|0|||
156848554|NCT03951077|566199051|FG003|Overall Study|Adverse Event|0|||
156848555|NCT03951077|566199052|FG004|Overall Study|Adverse Event|0|||
156848556|NCT03951077|566199053|FG005|Overall Study|Adverse Event|0|||
156848557|NCT03951077|566199048|FG000|Overall Study|Withdrawal by Subject|3|||
156848558|NCT03951077|566199049|FG001|Overall Study|Withdrawal by Subject|3|||
156848559|NCT03951077|566199050|FG002|Overall Study|Withdrawal by Subject|0|||
156848560|NCT03951077|566199051|FG003|Overall Study|Withdrawal by Subject|3|||
156848561|NCT03951077|566199052|FG004|Overall Study|Withdrawal by Subject|3|||
156848562|NCT03951077|566199053|FG005|Overall Study|Withdrawal by Subject|2|||
156848563|NCT03951077|566199048|FG000|Overall Study|Lost to Follow-up|1|||
156848564|NCT03951077|566199049|FG001|Overall Study|Lost to Follow-up|1|||
156848565|NCT03951077|566199050|FG002|Overall Study|Lost to Follow-up|2|||
156848566|NCT03951077|566199051|FG003|Overall Study|Lost to Follow-up|3|||
156848567|NCT03951077|566199052|FG004|Overall Study|Lost to Follow-up|2|||
156848568|NCT03951077|566199053|FG005|Overall Study|Lost to Follow-up|3|||
156848569|NCT03951077|566199048|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
156848570|NCT03951077|566199049|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
156848571|NCT03951077|566199050|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
156848572|NCT03951077|566199051|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
156848573|NCT03951077|566199052|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
156848574|NCT03951077|566199053|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
156848575|NCT03951077|566199048|FG000|Overall Study|Other, Not Specified|12|||
156848576|NCT03951077|566199049|FG001|Overall Study|Other, Not Specified|10|||
156848577|NCT03951077|566199050|FG002|Overall Study|Other, Not Specified|10|||
156848578|NCT03951077|566199051|FG003|Overall Study|Other, Not Specified|5|||
156848579|NCT03951077|566199052|FG004|Overall Study|Other, Not Specified|9|||
156848580|NCT03951077|566199053|FG005|Overall Study|Other, Not Specified|6|||
156848581|NCT03951077|566199048|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
157155673|NCT01544595|567314311|FG000|Status at Week 68|Lack of Efficacy|1|||
157155674|NCT01544595|567314312|FG001|Status at Week 68|Lack of Efficacy|0|||
156848582|NCT03951077|566199049|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
156848583|NCT03951077|566199050|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
157155675|NCT01544595|567314313|FG002|Status at Week 68|Lack of Efficacy|0|||
157155676|NCT01544595|567314314|FG003|Status at Week 68|Lack of Efficacy|0|||
157155677|NCT01544595|567314315|FG004|Status at Week 68|Lack of Efficacy|0|||
156848584|NCT03951077|566199051|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
156848585|NCT03951077|566199052|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
156848586|NCT03951077|566199053|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
156848587|NCT00086047|566199055|FG000|Overall Study|Lost to Follow-up|7|||
156848588|NCT00086047|566199056|FG001|Overall Study|Lost to Follow-up|6|||
156848589|NCT00086047|566199055|FG000|Overall Study|Physician Decision|0|||
156848590|NCT00086047|566199056|FG001|Overall Study|Physician Decision|1|||
156848591|NCT01395901|566199057|FG000|Overall Study|Lost to Follow-up|4|||
156848592|NCT01395901|566199058|FG001|Overall Study|Lost to Follow-up|0|||
156848593|NCT01395901|566199057|FG000|Overall Study|Randomized but not received study drug|5|||
156848594|NCT01395901|566199058|FG001|Overall Study|Randomized but not received study drug|4|||
156888472|NCT02963831|566350616|FG000|Overall Study|Adverse Event|0|||
156888473|NCT02963831|566350617|FG001|Overall Study|Adverse Event|1|||
156888474|NCT02963831|566350618|FG002|Overall Study|Adverse Event|1|||
156888475|NCT02963831|566350619|FG003|Overall Study|Adverse Event|2|||
156888476|NCT02963831|566350616|FG000|Overall Study|Death|0|||
156888477|NCT02963831|566350617|FG001|Overall Study|Death|0|||
156888478|NCT02963831|566350618|FG002|Overall Study|Death|0|||
156888479|NCT02963831|566350619|FG003|Overall Study|Death|2|||
156888480|NCT01966432|566350621|FG000|Overall Study|Lost to Follow-up|3|||
156888481|NCT01966432|566350622|FG001|Overall Study|Lost to Follow-up|2|||
156888482|NCT01966432|566350623|FG002|Overall Study|Lost to Follow-up|5|||
156888483|NCT01966432|566350621|FG000|Overall Study|Withdrawal by Subject|1|||
156888484|NCT01966432|566350622|FG001|Overall Study|Withdrawal by Subject|3|||
156888485|NCT01966432|566350623|FG002|Overall Study|Withdrawal by Subject|0|||
156888486|NCT01966432|566350621|FG000|Overall Study|Subject Incarcerated|0|||
156888487|NCT01966432|566350622|FG001|Overall Study|Subject Incarcerated|0|||
156888488|NCT01966432|566350623|FG002|Overall Study|Subject Incarcerated|1|||
156888489|NCT01966432|566350621|FG000|Overall Study|SBIRT program ended|1|||
156888490|NCT01966432|566350622|FG001|Overall Study|SBIRT program ended|8|||
156888491|NCT01966432|566350623|FG002|Overall Study|SBIRT program ended|20|||
156888492|NCT00584740|566350624|FG000|Overall Study|Adverse Event|1|||
156888493|NCT00584740|566350625|FG001|Overall Study|Adverse Event|1|||
156888494|NCT00584740|566350624|FG000|Overall Study|Lack of Efficacy|8|||
156888495|NCT00584740|566350625|FG001|Overall Study|Lack of Efficacy|2|||
156888496|NCT00584740|566350624|FG000|Overall Study|Withdrawal by Subject|3|||
156888497|NCT00584740|566350625|FG001|Overall Study|Withdrawal by Subject|2|||
156888498|NCT00584740|566350624|FG000|Overall Study|Lost to Follow-up|0|||
156888499|NCT00584740|566350625|FG001|Overall Study|Lost to Follow-up|1|||
156888500|NCT02106923|566350627|FG000|Overall Study|Protocol Violation|0|||
156888501|NCT02106923|566350628|FG001|Overall Study|Protocol Violation|0|||
156888502|NCT02106923|566350629|FG002|Overall Study|Protocol Violation|0|||
156888503|NCT02106923|566350630|FG003|Overall Study|Protocol Violation|0|||
156888504|NCT02106923|566350631|FG004|Overall Study|Protocol Violation|0|||
156888505|NCT02106923|566350632|FG005|Overall Study|Protocol Violation|1|||
156888506|NCT03485495|566350633|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
156888507|NCT03485495|566350634|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
156888508|NCT01107379|566350638|FG000|Overall Study|Withdrawal by Subject|18|||
156888509|NCT01107379|566350638|FG000|Overall Study|Lost to Follow-up|3|||
156888510|NCT00548405|566350639|FG000|Overall Study|Adverse Event|6|||
156888511|NCT00548405|566350640|FG001|Overall Study|Adverse Event|2|||
156888512|NCT00548405|566350641|FG002|Overall Study|Adverse Event|0|||
156888513|NCT00548405|566350639|FG000|Overall Study|Lack of Efficacy|6|||
156888514|NCT00548405|566350640|FG001|Overall Study|Lack of Efficacy|0|||
156888515|NCT00548405|566350641|FG002|Overall Study|Lack of Efficacy|0|||
156888516|NCT00548405|566350639|FG000|Overall Study|Physician Decision|3|||
156888517|NCT00548405|566350640|FG001|Overall Study|Physician Decision|4|||
156888518|NCT00548405|566350641|FG002|Overall Study|Physician Decision|1|||
157025472|NCT03544281|566847972|FG016|Main Study Phase|Ongoing|0|||
157025473|NCT03544281|566847973|FG017|Main Study Phase|Ongoing|0|||
157025474|NCT03544281|566847974|FG018|Main Study Phase|Ongoing|0|||
157025475|NCT03544281|566847975|FG019|Main Study Phase|Ongoing|0|||
157025476|NCT03544281|566847976|FG020|Main Study Phase|Ongoing|0|||
157025477|NCT03544281|566847977|FG021|Main Study Phase|Ongoing|0|||
157025478|NCT03544281|566847956|FG000|Main Study Phase|Investigator Site Closed|0|||
156848595|NCT01395901|566199057|FG000|Overall Study|Adverse Event|0|||
156848596|NCT01395901|566199058|FG001|Overall Study|Adverse Event|1|||
156888519|NCT00548405|566350639|FG000|Overall Study|Pregnancy|1|||
156888520|NCT00548405|566350640|FG001|Overall Study|Pregnancy|0|||
157025479|NCT03544281|566847957|FG001|Main Study Phase|Investigator Site Closed|0|||
156888521|NCT00548405|566350641|FG002|Overall Study|Pregnancy|0|||
156888522|NCT00548405|566350639|FG000|Overall Study|Protocol Violation|1|||
156888523|NCT00548405|566350640|FG001|Overall Study|Protocol Violation|0|||
156888524|NCT00548405|566350641|FG002|Overall Study|Protocol Violation|0|||
157025480|NCT03544281|566847958|FG002|Main Study Phase|Investigator Site Closed|0|||
157025481|NCT03544281|566847959|FG003|Main Study Phase|Investigator Site Closed|0|||
156848597|NCT01395901|566199057|FG000|Overall Study|Withdrawal of consent|1|||
156888525|NCT00548405|566350639|FG000|Overall Study|Withdrawal by Subject|36|||
156888526|NCT00548405|566350640|FG001|Overall Study|Withdrawal by Subject|12|||
156888527|NCT00548405|566350641|FG002|Overall Study|Withdrawal by Subject|5|||
156888528|NCT00548405|566350639|FG000|Overall Study|Lost to Follow-up|1|||
156848598|NCT01395901|566199058|FG001|Overall Study|Withdrawal of consent|0|||
156848599|NCT03579940|566199063|FG000|Period 2|Withdrawal by Subject|0|||
156848600|NCT03579940|566199064|FG001|Period 2|Withdrawal by Subject|0|||
156848601|NCT03579940|566199065|FG002|Period 2|Withdrawal by Subject|1|||
156848602|NCT03579940|566199066|FG003|Period 2|Withdrawal by Subject|0|||
156848603|NCT03579940|566199067|FG004|Period 2|Withdrawal by Subject|0|||
156848604|NCT03579940|566199068|FG005|Period 2|Withdrawal by Subject|0|||
156848605|NCT03579940|566199069|FG006|Period 2|Withdrawal by Subject|0|||
156848606|NCT03579940|566199070|FG007|Period 2|Withdrawal by Subject|0|||
156848607|NCT03579940|566199071|FG008|Period 2|Withdrawal by Subject|0|||
156848608|NCT03579940|566199072|FG009|Period 2|Withdrawal by Subject|0|||
156848609|NCT03579940|566199073|FG010|Period 2|Withdrawal by Subject|0|||
156848610|NCT01217944|566199074|FG000|Overall Study|Protocol Violation|1|||
156848611|NCT01217944|566199075|FG001|Overall Study|Protocol Violation|1|||
156848612|NCT01217944|566199076|FG002|Overall Study|Protocol Violation|0|||
156848613|NCT01217944|566199074|FG000|Overall Study|Lost to Follow-up|3|||
156848614|NCT01217944|566199075|FG001|Overall Study|Lost to Follow-up|1|||
156848615|NCT01217944|566199076|FG002|Overall Study|Lost to Follow-up|0|||
156848616|NCT01217944|566199074|FG000|Overall Study|Withdrawal by Subject|1|||
156848617|NCT01217944|566199075|FG001|Overall Study|Withdrawal by Subject|2|||
156848618|NCT01217944|566199076|FG002|Overall Study|Withdrawal by Subject|0|||
156848619|NCT01217944|566199074|FG000|Overall Study|Lack of Efficacy|1|||
156848620|NCT01217944|566199075|FG001|Overall Study|Lack of Efficacy|0|||
156848621|NCT01217944|566199076|FG002|Overall Study|Lack of Efficacy|0|||
156848622|NCT00496080|566199083|FG000|Overall Study|Lost to Follow-up|9|||
156848623|NCT00496080|566199083|FG000|Overall Study|Surgical re-intervention|7|||
156848624|NCT00496080|566199083|FG000|Overall Study|Withdrawal by Subject|5|||
156848625|NCT00496080|566199083|FG000|Overall Study|Physician Decision|6|||
156848626|NCT04098809|566199084|FG000|Overall Study|Withdrawal by Subject|1|||
156848627|NCT04098809|566199085|FG001|Overall Study|Withdrawal by Subject|3|||
156848628|NCT04098809|566199084|FG000|Overall Study|Physician Decision|2|||
156848629|NCT04098809|566199085|FG001|Overall Study|Physician Decision|1|||
156848630|NCT02021643|566199086|FG000|Overall Study|Enrolled but Never Treated|1|||
156848631|NCT02021643|566199087|FG001|Overall Study|Enrolled but Never Treated|0|||
156848632|NCT02021643|566199088|FG002|Overall Study|Enrolled but Never Treated|0|||
156848633|NCT02021643|566199089|FG003|Overall Study|Enrolled but Never Treated|0|||
156848634|NCT02021643|566199086|FG000|Overall Study|Adverse Event|0|||
156848635|NCT02021643|566199087|FG001|Overall Study|Adverse Event|1|||
156848636|NCT02021643|566199088|FG002|Overall Study|Adverse Event|0|||
156848637|NCT02021643|566199089|FG003|Overall Study|Adverse Event|0|||
156848638|NCT02021643|566199086|FG000|Overall Study|Death|0|||
156848639|NCT02021643|566199087|FG001|Overall Study|Death|1|||
156848640|NCT02021643|566199088|FG002|Overall Study|Death|0|||
156848641|NCT02021643|566199089|FG003|Overall Study|Death|0|||
156848642|NCT02021643|566199086|FG000|Overall Study|Investigator's Discretion|1|||
156848643|NCT02021643|566199087|FG001|Overall Study|Investigator's Discretion|0|||
156848644|NCT02021643|566199088|FG002|Overall Study|Investigator's Discretion|0|||
156848645|NCT02021643|566199089|FG003|Overall Study|Investigator's Discretion|0|||
156848646|NCT02021643|566199086|FG000|Overall Study|Lack of Efficacy|7|||
156848647|NCT02021643|566199087|FG001|Overall Study|Lack of Efficacy|6|||
156848648|NCT02021643|566199088|FG002|Overall Study|Lack of Efficacy|0|||
156848649|NCT02021643|566199089|FG003|Overall Study|Lack of Efficacy|12|||
156848650|NCT02021643|566199086|FG000|Overall Study|Lost to Follow-up|0|||
156848651|NCT02021643|566199087|FG001|Overall Study|Lost to Follow-up|1|||
156848652|NCT02021643|566199088|FG002|Overall Study|Lost to Follow-up|0|||
156848653|NCT02021643|566199089|FG003|Overall Study|Lost to Follow-up|0|||
156848654|NCT02021643|566199086|FG000|Overall Study|Withdrew Consent|0|||
156848655|NCT02021643|566199087|FG001|Overall Study|Withdrew Consent|1|||
156848656|NCT02021643|566199088|FG002|Overall Study|Withdrew Consent|0|||
156848657|NCT02021643|566199089|FG003|Overall Study|Withdrew Consent|0|||
156888529|NCT00548405|566350640|FG001|Overall Study|Lost to Follow-up|1|||
156888530|NCT00548405|566350641|FG002|Overall Study|Lost to Follow-up|2|||
156888531|NCT00548405|566350639|FG000|Overall Study|Death|0|||
156888532|NCT00548405|566350640|FG001|Overall Study|Death|1|||
156848658|NCT02631551|566199090|FG000|Overall Study|Adverse Event|1|||
156848659|NCT02631551|566199091|FG001|Overall Study|Adverse Event|2|||
156848660|NCT02631551|566199092|FG002|Overall Study|Adverse Event|4|||
156848661|NCT02631551|566199093|FG003|Overall Study|Adverse Event|0|||
156848662|NCT02631551|566199090|FG000|Overall Study|Lack of Efficacy|0|||
156848663|NCT02631551|566199091|FG001|Overall Study|Lack of Efficacy|0|||
156848664|NCT02631551|566199092|FG002|Overall Study|Lack of Efficacy|1|||
156848665|NCT02631551|566199093|FG003|Overall Study|Lack of Efficacy|0|||
156848666|NCT02631551|566199090|FG000|Overall Study|Lost to Follow-up|1|||
156848667|NCT02631551|566199091|FG001|Overall Study|Lost to Follow-up|2|||
156848668|NCT02631551|566199092|FG002|Overall Study|Lost to Follow-up|0|||
156848669|NCT02631551|566199093|FG003|Overall Study|Lost to Follow-up|3|||
156848670|NCT02631551|566199090|FG000|Overall Study|Withdrawal by Subject|2|||
156888533|NCT00548405|566350641|FG002|Overall Study|Death|1|||
156888534|NCT00548405|566350639|FG000|Overall Study|Sponsor decision|1|||
156888535|NCT00548405|566350640|FG001|Overall Study|Sponsor decision|0|||
156848671|NCT02631551|566199091|FG001|Overall Study|Withdrawal by Subject|2|||
156848672|NCT02631551|566199092|FG002|Overall Study|Withdrawal by Subject|0|||
156848673|NCT02631551|566199093|FG003|Overall Study|Withdrawal by Subject|5|||
156848674|NCT02631551|566199090|FG000|Overall Study|Protocol deviation|3|||
156848675|NCT02631551|566199091|FG001|Overall Study|Protocol deviation|6|||
156848676|NCT02631551|566199092|FG002|Overall Study|Protocol deviation|3|||
156848677|NCT02631551|566199093|FG003|Overall Study|Protocol deviation|0|||
156848678|NCT02631551|566199090|FG000|Overall Study|Non-compliance with study procedures|0|||
156848679|NCT02631551|566199091|FG001|Overall Study|Non-compliance with study procedures|0|||
156848680|NCT02631551|566199092|FG002|Overall Study|Non-compliance with study procedures|1|||
156848681|NCT02631551|566199093|FG003|Overall Study|Non-compliance with study procedures|1|||
156848682|NCT02631551|566199090|FG000|Overall Study|Non-compliance with study drug|1|||
156848683|NCT02631551|566199091|FG001|Overall Study|Non-compliance with study drug|0|||
156848684|NCT02631551|566199092|FG002|Overall Study|Non-compliance with study drug|0|||
156848685|NCT02631551|566199093|FG003|Overall Study|Non-compliance with study drug|0|||
156848686|NCT02631551|566199090|FG000|Overall Study|Other, specific reasons not collected|5|||
156848687|NCT02631551|566199091|FG001|Overall Study|Other, specific reasons not collected|7|||
156848688|NCT02631551|566199092|FG002|Overall Study|Other, specific reasons not collected|2|||
156848689|NCT02631551|566199093|FG003|Overall Study|Other, specific reasons not collected|2|||
156848690|NCT02859246|566199097|FG000|Overall Study|Screen fails|3|||
156848691|NCT02859246|566199097|FG000|Overall Study|Adverse Event|1|||
156848692|NCT02859246|566199097|FG000|Overall Study|Withdrawal by Subject|1|||
156848693|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
156848694|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
156848695|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
156848696|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848697|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848698|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848699|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
156848700|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
156848701|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848702|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848703|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848704|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848705|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848706|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
156848707|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848708|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
156848709|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848710|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848711|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848712|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848713|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
156848714|NCT05280717|566199098|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848715|NCT05280717|566199099|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848716|NCT05280717|566199100|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
156848717|NCT05280717|566199101|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848718|NCT05280717|566199102|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848719|NCT05280717|566199103|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848720|NCT05280717|566199104|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
156848721|NCT05280717|566199098|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848722|NCT05280717|566199099|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848723|NCT05280717|566199100|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848724|NCT05280717|566199101|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848725|NCT05280717|566199102|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156888536|NCT00548405|566350641|FG002|Overall Study|Sponsor decision|0|||
156888537|NCT00548405|566350639|FG000|Overall Study|Randomized but not treated|1|||
157025482|NCT03544281|566847960|FG004|Main Study Phase|Investigator Site Closed|0|||
157025483|NCT03544281|566847961|FG005|Main Study Phase|Investigator Site Closed|0|||
157025484|NCT03544281|566847962|FG006|Main Study Phase|Investigator Site Closed|0|||
157025485|NCT03544281|566847963|FG007|Main Study Phase|Investigator Site Closed|0|||
157025486|NCT03544281|566847964|FG008|Main Study Phase|Investigator Site Closed|0|||
157155678|NCT01544595|567314316|FG005|Status at Week 68|Lack of Efficacy|0|||
157225410|NCT03519256|567571419|FG003|Overall Study|Disease progression|1|||
156888538|NCT00548405|566350640|FG001|Overall Study|Randomized but not treated|0|||
156888539|NCT00548405|566350641|FG002|Overall Study|Randomized but not treated|0|||
156888540|NCT00924170|566350642|FG000|Overall Study|Refused further treatment|0|||
156888541|NCT00924170|566350643|FG001|Overall Study|Refused further treatment|1|||
156888542|NCT00924170|566350642|FG000|Overall Study|Physician Decision|0|||
156888543|NCT00924170|566350643|FG001|Overall Study|Physician Decision|1|||
156888544|NCT00924170|566350642|FG000|Overall Study|Progressive disease|3|||
156888545|NCT00924170|566350643|FG001|Overall Study|Progressive disease|6|||
156888546|NCT00924170|566350642|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
156888547|NCT00924170|566350643|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
156888548|NCT00924170|566350642|FG000|Overall Study|Death|1|||
156888549|NCT00924170|566350643|FG001|Overall Study|Death|0|||
156888550|NCT05318183|566350644|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
156888551|NCT05318183|566350645|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
156888552|NCT05318183|566350644|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
156888553|NCT05318183|566350645|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156888554|NCT05318183|566350644|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
156888555|NCT05318183|566350645|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
156888556|NCT05318183|566350644|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156888557|NCT05318183|566350645|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
156888558|NCT06400251|566350646|FG000|Overall Study|Never Start Protocol Therapy|1|||
156888559|NCT06400251|566350646|FG000|Overall Study|Ineligible|2|||
156888560|NCT06400251|566350646|FG000|Overall Study|Mutation Status Not Confirmed|3|||
156888561|NCT06400251|566350646|FG000|Overall Study|Disease Progression|25|||
156888562|NCT06400251|566350646|FG000|Overall Study|Adverse Event|1|||
156888563|NCT06400251|566350646|FG000|Overall Study|Complicating Disease|1|||
156888564|NCT06400251|566350646|FG000|Overall Study|Physician Decision|2|||
156888565|NCT04672252|566350647|FG000|Overall Study|Protocol Violation|1|||
156888566|NCT04672252|566350648|FG001|Overall Study|Protocol Violation|0|||
156888567|NCT02889562|566350649|FG000|Overall Study|Physician Decision|0|||
156888568|NCT02889562|566350650|FG001|Overall Study|Physician Decision|1|||
156888569|NCT02889562|566350649|FG000|Overall Study|Withdrawal by Subject|0|||
156888570|NCT02889562|566350650|FG001|Overall Study|Withdrawal by Subject|1|||
156888571|NCT00217464|566350654|FG000|Overall Study|Progression|15|||
156888572|NCT00217464|566350654|FG000|Overall Study|Other|2|||
156888573|NCT02292784|566352151|FG000|Overall Study|Lost to Follow-up|1|||
157025487|NCT03544281|566847965|FG009|Main Study Phase|Investigator Site Closed|1|||
157025488|NCT03544281|566847966|FG010|Main Study Phase|Investigator Site Closed|0|||
157025489|NCT03544281|566847967|FG011|Main Study Phase|Investigator Site Closed|0|||
157025490|NCT03544281|566847968|FG012|Main Study Phase|Investigator Site Closed|0|||
157025491|NCT03544281|566847969|FG013|Main Study Phase|Investigator Site Closed|0|||
157025492|NCT03544281|566847970|FG014|Main Study Phase|Investigator Site Closed|0|||
157025493|NCT03544281|566847971|FG015|Main Study Phase|Investigator Site Closed|0|||
157025494|NCT03544281|566847972|FG016|Main Study Phase|Investigator Site Closed|0|||
157025495|NCT03544281|566847973|FG017|Main Study Phase|Investigator Site Closed|0|||
157025496|NCT03544281|566847974|FG018|Main Study Phase|Investigator Site Closed|0|||
156848726|NCT05280717|566199103|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
156848727|NCT05280717|566199104|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
156848728|NCT05280717|566199098|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848729|NCT05280717|566199099|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848730|NCT05280717|566199100|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848731|NCT05280717|566199101|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848732|NCT05280717|566199102|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156848733|NCT05280717|566199103|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
156848734|NCT05280717|566199104|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
156888574|NCT02292784|566352152|FG001|Overall Study|Lost to Follow-up|17|||
157155679|NCT01544595|567314311|FG000|Status at Week 68|Lost to Follow-up|1|||
156888575|NCT02292784|566352153|FG002|Overall Study|Lost to Follow-up|18|||
157155680|NCT01544595|567314312|FG001|Status at Week 68|Lost to Follow-up|1|||
157155681|NCT01544595|567314313|FG002|Status at Week 68|Lost to Follow-up|0|||
157155682|NCT01544595|567314314|FG003|Status at Week 68|Lost to Follow-up|0|||
157155683|NCT01544595|567314315|FG004|Status at Week 68|Lost to Follow-up|0|||
156888576|NCT02292784|566352151|FG000|Overall Study|Withdrawal by Subject|0|||
157025497|NCT03544281|566847975|FG019|Main Study Phase|Investigator Site Closed|0|||
157025498|NCT03544281|566847976|FG020|Main Study Phase|Investigator Site Closed|0|||
157025499|NCT03544281|566847977|FG021|Main Study Phase|Investigator Site Closed|0|||
157155684|NCT01544595|567314316|FG005|Status at Week 68|Lost to Follow-up|0|||
157155685|NCT01544595|567314311|FG000|Status at Week 68|Non-compliance with study treatment|1|||
156888577|NCT02292784|566352152|FG001|Overall Study|Withdrawal by Subject|3|||
156888578|NCT02292784|566352153|FG002|Overall Study|Withdrawal by Subject|3|||
156888579|NCT00622739|566352154|FG000|Overall Study|Physician Decision|1|||
156888580|NCT00622739|566352155|FG001|Overall Study|Physician Decision|0|||
156888581|NCT00622739|566352154|FG000|Overall Study|Adverse Event|1|||
156888582|NCT00622739|566352155|FG001|Overall Study|Adverse Event|2|||
156848735|NCT00080301|566199105|FG000|Overall Study|Randomized but Never Treated|5|||
156848736|NCT00080301|566199106|FG001|Overall Study|Randomized but Never Treated|10|||
156848737|NCT00080301|566199105|FG000|Overall Study|Still on Treatment as of CSR date|0|||
156848738|NCT00080301|566199106|FG001|Overall Study|Still on Treatment as of CSR date|1|||
156848739|NCT04390243|566199110|FG000|Overall Study|Death|1|||
156848740|NCT04390243|566199110|FG000|Overall Study|Disease Progression|4|||
156848741|NCT04390243|566199110|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
156848742|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
156848743|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
156848744|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
156848745|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
156848746|NCT01521507|566199117|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
156848747|NCT01521507|566199118|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
156848748|NCT01521507|566199117|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
156848749|NCT01521507|566199118|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
156848750|NCT01521507|566199117|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
156848751|NCT01521507|566199118|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
156848752|NCT01521507|566199117|FG000|Stage 2: Observational Design|Physician Decision|1|||
156848753|NCT01521507|566199118|FG001|Stage 2: Observational Design|Physician Decision|0|||
156848754|NCT01196026|566199119|FG000|Overall Study|Withdrawal by Subject|1|||
156848755|NCT01196026|566199120|FG001|Overall Study|Withdrawal by Subject|4|||
156848756|NCT01196026|566199121|FG002|Overall Study|Withdrawal by Subject|0|||
156848757|NCT01196026|566199122|FG003|Overall Study|Withdrawal by Subject|0|||
156848758|NCT01196026|566199123|FG004|Overall Study|Withdrawal by Subject|0|||
156848759|NCT01196026|566199124|FG005|Overall Study|Withdrawal by Subject|0|||
156848760|NCT01196026|566199119|FG000|Overall Study|Lost to Follow-up|0|||
156848761|NCT01196026|566199120|FG001|Overall Study|Lost to Follow-up|3|||
156848762|NCT01196026|566199121|FG002|Overall Study|Lost to Follow-up|0|||
156848763|NCT01196026|566199122|FG003|Overall Study|Lost to Follow-up|0|||
156848764|NCT01196026|566199123|FG004|Overall Study|Lost to Follow-up|1|||
156848765|NCT01196026|566199124|FG005|Overall Study|Lost to Follow-up|0|||
156848766|NCT01196026|566199119|FG000|Overall Study|Other|0|||
156848767|NCT01196026|566199120|FG001|Overall Study|Other|1|||
156848768|NCT01196026|566199121|FG002|Overall Study|Other|0|||
156848769|NCT01196026|566199122|FG003|Overall Study|Other|0|||
156848770|NCT01196026|566199123|FG004|Overall Study|Other|0|||
156848771|NCT01196026|566199124|FG005|Overall Study|Other|0|||
156848772|NCT04034004|566199125|FG000|Overall Study|Withdrawal by Subject|1|||
156848773|NCT04034004|566199126|FG001|Overall Study|Withdrawal by Subject|2|||
156848774|NCT04034004|566199127|FG002|Overall Study|Withdrawal by Subject|2|||
156848775|NCT04034004|566199128|FG003|Overall Study|Withdrawal by Subject|3|||
156848776|NCT04034004|566199125|FG000|Overall Study|could not find vein to administer IV|2|||
156848777|NCT04034004|566199126|FG001|Overall Study|could not find vein to administer IV|1|||
156848778|NCT04034004|566199127|FG002|Overall Study|could not find vein to administer IV|0|||
156848779|NCT04034004|566199128|FG003|Overall Study|could not find vein to administer IV|0|||
156848780|NCT04034004|566199125|FG000|Overall Study|nurse accidentally unblinded subject|0|||
156848781|NCT04034004|566199126|FG001|Overall Study|nurse accidentally unblinded subject|0|||
156848782|NCT04034004|566199127|FG002|Overall Study|nurse accidentally unblinded subject|0|||
156848783|NCT04034004|566199128|FG003|Overall Study|nurse accidentally unblinded subject|1|||
156848784|NCT04317040|566199129|FG000|Overall Study|Lost to Follow-up|2|||
156848785|NCT04317040|566199130|FG001|Overall Study|Lost to Follow-up|0|||
156848786|NCT04317040|566199129|FG000|Overall Study|Death|16|||
156848787|NCT04317040|566199130|FG001|Overall Study|Death|18|||
156848788|NCT04317040|566199129|FG000|Overall Study|Withdrawal by Subject|0|||
156848789|NCT04317040|566199130|FG001|Overall Study|Withdrawal by Subject|1|||
156848790|NCT04317040|566199129|FG000|Overall Study|Incomplete assessments|0|||
156848791|NCT04317040|566199130|FG001|Overall Study|Incomplete assessments|1|||
156848792|NCT02518971|566199131|FG000|Overall Study|Lost to Follow-up|0|||
156848793|NCT02518971|566199132|FG001|Overall Study|Lost to Follow-up|1|||
156848794|NCT02518971|566199131|FG000|Overall Study|Physician Decision|6|||
156848795|NCT02518971|566199132|FG001|Overall Study|Physician Decision|6|||
156848796|NCT02518971|566199131|FG000|Overall Study|Protocol Violation|6|||
156848797|NCT02518971|566199132|FG001|Overall Study|Protocol Violation|4|||
156848798|NCT02518971|566199131|FG000|Overall Study|Withdrawal by Subject|4|||
156848799|NCT02518971|566199132|FG001|Overall Study|Withdrawal by Subject|5|||
156848800|NCT02518971|566199131|FG000|Overall Study|Side effects|1|||
156848801|NCT02518971|566199132|FG001|Overall Study|Side effects|0|||
156848802|NCT02518971|566199131|FG000|Overall Study|medication lost in mail|0|||
156848803|NCT02518971|566199132|FG001|Overall Study|medication lost in mail|1|||
156848804|NCT02518971|566199131|FG000|Overall Study|eligibility criteria no longer met|6|||
156848805|NCT02518971|566199132|FG001|Overall Study|eligibility criteria no longer met|3|||
156848806|NCT00757237|566199133|FG000|Overall Study|Lost to Follow-up|0|||
156848807|NCT00757237|566199134|FG001|Overall Study|Lost to Follow-up|1|||
157225411|NCT03519256|567571416|FG000|Overall Study|Lost to Follow-up|0|||
157225412|NCT03519256|567571417|FG001|Overall Study|Lost to Follow-up|1|||
156848808|NCT00757237|566199133|FG000|Overall Study|Protocol Violation|0|||
156848809|NCT00757237|566199134|FG001|Overall Study|Protocol Violation|2|||
156848810|NCT00757237|566199133|FG000|Overall Study|Physician Decision|2|||
156848811|NCT00757237|566199134|FG001|Overall Study|Physician Decision|3|||
156848812|NCT00757237|566199133|FG000|Overall Study|Withdrawal by Subject|8|||
156848813|NCT00757237|566199134|FG001|Overall Study|Withdrawal by Subject|12|||
156848814|NCT00757237|566199133|FG000|Overall Study|Safety or Tolerability|3|||
156848815|NCT00757237|566199134|FG001|Overall Study|Safety or Tolerability|5|||
156848816|NCT00757237|566199133|FG000|Overall Study|Other|0|||
156848817|NCT00757237|566199134|FG001|Overall Study|Other|2|||
156848818|NCT05150990|566199139|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
156848819|NCT05150990|566199140|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
156848820|NCT05150990|566199139|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
156848821|NCT05150990|566199140|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
156848822|NCT05150990|566199139|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
156848823|NCT05150990|566199140|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
156848824|NCT05150990|566199139|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
156848825|NCT05150990|566199140|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
156848826|NCT05150990|566199139|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
156848827|NCT05150990|566199140|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
156848828|NCT05150990|566199139|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
156848829|NCT05150990|566199140|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
156848830|NCT05150990|566199139|FG000|Overall Study|Death (unrelated to the intervention)|1|||
156848831|NCT05150990|566199140|FG001|Overall Study|Death (unrelated to the intervention)|2|||
156848832|NCT01843023|566199141|FG000|Overall Study|Death|1|||
156848833|NCT01843023|566199142|FG001|Overall Study|Death|0|||
156848834|NCT01843023|566199141|FG000|Overall Study|Lost to Follow-up|24|||
156848835|NCT01843023|566199142|FG001|Overall Study|Lost to Follow-up|29|||
156848836|NCT01843023|566199141|FG000|Overall Study|Withdrawal by Subject|8|||
156848837|NCT01843023|566199142|FG001|Overall Study|Withdrawal by Subject|6|||
156848838|NCT01397461|566199144|FG000|Overall Study|Withdrawal by Subject|2|||
156848839|NCT01397461|566199145|FG001|Overall Study|Withdrawal by Subject|1|||
156848840|NCT01397461|566199146|FG002|Overall Study|Withdrawal by Subject|0|||
156848841|NCT01397461|566199144|FG000|Overall Study|Lost to Follow-up|0|||
156848842|NCT01397461|566199145|FG001|Overall Study|Lost to Follow-up|2|||
156848843|NCT01397461|566199146|FG002|Overall Study|Lost to Follow-up|1|||
156848844|NCT01397461|566199144|FG000|Overall Study|Lack of Efficacy|0|||
156848845|NCT01397461|566199145|FG001|Overall Study|Lack of Efficacy|3|||
156848846|NCT01397461|566199146|FG002|Overall Study|Lack of Efficacy|0|||
156848847|NCT01397461|566199144|FG000|Overall Study|Not treated|0|||
156848848|NCT01397461|566199145|FG001|Overall Study|Not treated|0|||
156848849|NCT01397461|566199146|FG002|Overall Study|Not treated|1|||
156848850|NCT04980612|566199163|FG000|Overall Study|Withdrawal by Subject|7|||
156848851|NCT04980612|566199164|FG001|Overall Study|Withdrawal by Subject|5|||
156848852|NCT01514201|566199167|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
156848853|NCT01514201|566199168|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848854|NCT01514201|566199169|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848855|NCT01514201|566199170|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848856|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848857|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
156848858|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
156848859|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848860|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
156848861|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
156848862|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
156848863|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848864|NCT01514201|566199167|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
156848865|NCT01514201|566199168|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
156848866|NCT01514201|566199169|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848867|NCT01514201|566199170|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848868|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848869|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848870|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
156848871|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
156848872|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
156848873|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
157225413|NCT03519256|567571418|FG002|Overall Study|Lost to Follow-up|0|||
157225414|NCT03519256|567571419|FG003|Overall Study|Lost to Follow-up|0|||
156848874|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
156848875|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
156848876|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848877|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848878|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
156848879|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
156848880|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848881|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848882|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
156848883|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
156848884|NCT01514201|566199167|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848885|NCT01514201|566199168|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848886|NCT01514201|566199169|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
156848887|NCT01514201|566199170|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
156848888|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848889|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848890|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
156848891|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
156848892|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848893|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848894|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
156848895|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
156848896|NCT01514201|566199167|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848897|NCT01514201|566199168|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848898|NCT01514201|566199169|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
156848899|NCT01514201|566199170|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
156848900|NCT00637416|566199175|FG000|Overall Study|Lost to Follow-up|1|||
156848901|NCT00637416|566199176|FG001|Overall Study|Lost to Follow-up|1|||
156848902|NCT00637416|566199175|FG000|Overall Study|Unable to take study drug|0|||
156848903|NCT00637416|566199176|FG001|Overall Study|Unable to take study drug|1|||
156848904|NCT02715609|566199188|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
156848905|NCT02715609|566199189|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
156848906|NCT02715609|566199190|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
156848907|NCT02715609|566199188|FG000|Overall Study|Withdrawal by Subject|0|||
156848908|NCT02715609|566199189|FG001|Overall Study|Withdrawal by Subject|0|||
156848909|NCT02715609|566199190|FG002|Overall Study|Withdrawal by Subject|1|||
156848910|NCT00310817|566199191|FG000|Overall Study|AE or Death|3|||
156848911|NCT00310817|566199192|FG001|Overall Study|AE or Death|1|||
156848912|NCT00310817|566199193|FG002|Overall Study|AE or Death|0|||
156848913|NCT00310817|566199194|FG003|Overall Study|AE or Death|0|||
156848914|NCT00310817|566199191|FG000|Overall Study|Withdrawal by Subject|1|||
156848915|NCT00310817|566199192|FG001|Overall Study|Withdrawal by Subject|4|||
156848916|NCT00310817|566199193|FG002|Overall Study|Withdrawal by Subject|6|||
156848917|NCT00310817|566199194|FG003|Overall Study|Withdrawal by Subject|7|||
156848918|NCT00310817|566199191|FG000|Overall Study|Lost to Follow-up|2|||
156848919|NCT00310817|566199192|FG001|Overall Study|Lost to Follow-up|1|||
156848920|NCT00310817|566199193|FG002|Overall Study|Lost to Follow-up|0|||
156848921|NCT00310817|566199194|FG003|Overall Study|Lost to Follow-up|0|||
156848922|NCT00310817|566199191|FG000|Overall Study|Inappropriate Enrollment|1|||
156848923|NCT00310817|566199192|FG001|Overall Study|Inappropriate Enrollment|0|||
156848924|NCT00310817|566199193|FG002|Overall Study|Inappropriate Enrollment|1|||
156848925|NCT00310817|566199194|FG003|Overall Study|Inappropriate Enrollment|0|||
156848926|NCT00310817|566199191|FG000|Overall Study|Protocol Violation|1|||
156848927|NCT00310817|566199192|FG001|Overall Study|Protocol Violation|1|||
156848928|NCT00310817|566199193|FG002|Overall Study|Protocol Violation|1|||
156848929|NCT00310817|566199194|FG003|Overall Study|Protocol Violation|1|||
156848930|NCT00310817|566199191|FG000|Overall Study|Unable to classify|3|||
156848931|NCT00310817|566199192|FG001|Overall Study|Unable to classify|1|||
156848932|NCT00310817|566199193|FG002|Overall Study|Unable to classify|0|||
156848933|NCT00310817|566199194|FG003|Overall Study|Unable to classify|0|||
156848934|NCT04300309|566199200|FG000|Overall Study|Lost to Follow-up|1|||
156848935|NCT04300309|566199201|FG001|Overall Study|Lost to Follow-up|0|||
156848936|NCT04607837|566199203|FG000|Overall Study|Adverse Event|8|||
156848937|NCT04607837|566199204|FG001|Overall Study|Adverse Event|2|||
156848938|NCT04607837|566199203|FG000|Overall Study|Withdrawal by Subject|8|||
156848939|NCT04607837|566199204|FG001|Overall Study|Withdrawal by Subject|7|||
156848940|NCT04607837|566199203|FG000|Overall Study|Physician Decision|2|||
156848941|NCT04607837|566199204|FG001|Overall Study|Physician Decision|0|||
156848942|NCT04607837|566199203|FG000|Overall Study|Lack of Efficacy|2|||
156848943|NCT04607837|566199204|FG001|Overall Study|Lack of Efficacy|0|||
157025500|NCT03544281|566847956|FG000|Main Study Phase|Did not receive study treatment|0|||
157025501|NCT03544281|566847957|FG001|Main Study Phase|Did not receive study treatment|0|||
156848944|NCT04607837|566199203|FG000|Overall Study|Participant terminated by sponsor|1|||
156848945|NCT04607837|566199204|FG001|Overall Study|Participant terminated by sponsor|0|||
156848946|NCT04607837|566199203|FG000|Overall Study|Disease worsening|36|||
156848947|NCT04607837|566199204|FG001|Overall Study|Disease worsening|36|||
156848948|NCT04607837|566199203|FG000|Overall Study|Other|1|||
156848949|NCT04607837|566199204|FG001|Overall Study|Other|0|||
156848950|NCT00367835|566199205|FG000|Overall Study|Adverse Event|14|||
156848951|NCT00367835|566199206|FG001|Overall Study|Adverse Event|1|||
156848952|NCT00367835|566199205|FG000|Overall Study|Protocol Violation|1|||
156848953|NCT00367835|566199206|FG001|Overall Study|Protocol Violation|7|||
156848954|NCT00367835|566199205|FG000|Overall Study|Withdrawal by Subject|7|||
156848955|NCT00367835|566199206|FG001|Overall Study|Withdrawal by Subject|6|||
156848956|NCT00367835|566199205|FG000|Overall Study|Lost to Follow-up|1|||
156848957|NCT00367835|566199206|FG001|Overall Study|Lost to Follow-up|4|||
156848958|NCT00367835|566199205|FG000|Overall Study|Lack of Efficacy|3|||
156848959|NCT00367835|566199206|FG001|Overall Study|Lack of Efficacy|12|||
156848960|NCT00367835|566199205|FG000|Overall Study|Subject in juvenile detention center|1|||
156848961|NCT00367835|566199206|FG001|Overall Study|Subject in juvenile detention center|0|||
156848962|NCT00367835|566199205|FG000|Overall Study|refused blood collection|1|||
156848963|NCT00367835|566199206|FG001|Overall Study|refused blood collection|0|||
156848964|NCT00367835|566199205|FG000|Overall Study|Did not respond to calls|1|||
156848965|NCT00367835|566199206|FG001|Overall Study|Did not respond to calls|0|||
156848966|NCT00367835|566199205|FG000|Overall Study|History of lead poisoning|0|||
156848967|NCT00367835|566199206|FG001|Overall Study|History of lead poisoning|1|||
156848968|NCT04346654|566199208|FG000|Overall Study|Adverse Event|2|||
156848969|NCT04346654|566199209|FG001|Overall Study|Adverse Event|0|||
156848970|NCT04346654|566199208|FG000|Overall Study|Non-response|1|||
156848971|NCT04346654|566199209|FG001|Overall Study|Non-response|1|||
156848972|NCT04346654|566199208|FG000|Overall Study|Withdrawal by Subject|2|||
156848973|NCT04346654|566199209|FG001|Overall Study|Withdrawal by Subject|0|||
156848974|NCT04346654|566199208|FG000|Overall Study|Lost to Follow-up|0|||
156848975|NCT04346654|566199209|FG001|Overall Study|Lost to Follow-up|1|||
156848976|NCT04346654|566199208|FG000|Overall Study|Pregnancy|0|||
156848977|NCT04346654|566199209|FG001|Overall Study|Pregnancy|1|||
156848978|NCT04209205|566199218|FG000|Overall Study|Adverse Event|2|||
156848979|NCT04209205|566199219|FG001|Overall Study|Adverse Event|3|||
156848980|NCT04209205|566199218|FG000|Overall Study|Lost to Follow-up|3|||
156848981|NCT04209205|566199219|FG001|Overall Study|Lost to Follow-up|1|||
156848982|NCT04209205|566199218|FG000|Overall Study|Physician Decision|1|||
156848983|NCT04209205|566199219|FG001|Overall Study|Physician Decision|1|||
156848984|NCT04209205|566199218|FG000|Overall Study|Subject decision|10|||
156848985|NCT04209205|566199219|FG001|Overall Study|Subject decision|10|||
156848986|NCT04209205|566199218|FG000|Overall Study|Progressive disease|1|||
156848987|NCT04209205|566199219|FG001|Overall Study|Progressive disease|0|||
156848988|NCT04209205|566199218|FG000|Overall Study|Protocol deviation|0|||
156848989|NCT04209205|566199219|FG001|Overall Study|Protocol deviation|1|||
156848990|NCT04209205|566199218|FG000|Overall Study|New therapy for study indication|1|||
156848991|NCT04209205|566199219|FG001|Overall Study|New therapy for study indication|0|||
156848992|NCT04209205|566199218|FG000|Overall Study|Adverse event - placebo not switched|0|||
156848993|NCT04209205|566199219|FG001|Overall Study|Adverse event - placebo not switched|1|||
156848994|NCT04209205|566199218|FG000|Overall Study|Subject decision - placebo not switched|0|||
156848995|NCT04209205|566199219|FG001|Overall Study|Subject decision - placebo not switched|5|||
156848996|NCT04209205|566199218|FG000|Overall Study|Death - placebo not switched|0|||
156848997|NCT04209205|566199219|FG001|Overall Study|Death - placebo not switched|1|||
156848998|NCT05236257|566199220|FG000|Overall Study|Ongoing with study treatment|29|||
156848999|NCT05236257|566199221|FG001|Overall Study|Ongoing with study treatment|1|||
156849000|NCT05236257|566199220|FG000|Overall Study|Discontinued study treatment|22|||
156849001|NCT05236257|566199221|FG001|Overall Study|Discontinued study treatment|41|||
156849002|NCT02343406|566199225|FG000|Overall Study|Progressive disease|72|||
156849003|NCT02343406|566199226|FG001|Overall Study|Progressive disease|70|||
156849004|NCT02343406|566199227|FG002|Overall Study|Progressive disease|43|||
156849005|NCT02343406|566199228|FG003|Overall Study|Progressive disease|15|||
156849006|NCT02343406|566199229|FG004|Overall Study|Progressive disease|5|||
156849007|NCT02343406|566199225|FG000|Overall Study|Adverse Event|6|||
156888583|NCT00622739|566352154|FG000|Overall Study|Lack of Efficacy|0|||
156888584|NCT00622739|566352155|FG001|Overall Study|Lack of Efficacy|2|||
156888585|NCT00622739|566352154|FG000|Overall Study|Withdrawal by Subject|0|||
156849008|NCT02343406|566199226|FG001|Overall Study|Adverse Event|8|||
156849009|NCT02343406|566199227|FG002|Overall Study|Adverse Event|6|||
156849010|NCT02343406|566199228|FG003|Overall Study|Adverse Event|3|||
156849011|NCT02343406|566199229|FG004|Overall Study|Adverse Event|0|||
156849012|NCT02343406|566199225|FG000|Overall Study|Withdrawal by Subject|6|||
156849013|NCT02343406|566199226|FG001|Overall Study|Withdrawal by Subject|4|||
156849014|NCT02343406|566199227|FG002|Overall Study|Withdrawal by Subject|8|||
156849015|NCT02343406|566199228|FG003|Overall Study|Withdrawal by Subject|3|||
156849016|NCT02343406|566199229|FG004|Overall Study|Withdrawal by Subject|0|||
157155686|NCT01544595|567314312|FG001|Status at Week 68|Non-compliance with study treatment|0|||
156849017|NCT02343406|566199225|FG000|Overall Study|Death|2|||
156849018|NCT02343406|566199226|FG001|Overall Study|Death|1|||
156849019|NCT02343406|566199227|FG002|Overall Study|Death|0|||
156849020|NCT02343406|566199228|FG003|Overall Study|Death|0|||
156849021|NCT02343406|566199229|FG004|Overall Study|Death|0|||
156849022|NCT02343406|566199225|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
156849023|NCT02343406|566199226|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
156849024|NCT02343406|566199227|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
156849025|NCT02343406|566199228|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
156849026|NCT02343406|566199229|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
156849027|NCT02343406|566199225|FG000|Overall Study|Other primary malignancy|0|||
156849028|NCT02343406|566199226|FG001|Overall Study|Other primary malignancy|1|||
156849029|NCT02343406|566199227|FG002|Overall Study|Other primary malignancy|0|||
156849030|NCT02343406|566199228|FG003|Overall Study|Other primary malignancy|0|||
156849031|NCT02343406|566199229|FG004|Overall Study|Other primary malignancy|0|||
156849032|NCT02343406|566199225|FG000|Overall Study|Other, not specified|2|||
156849033|NCT02343406|566199226|FG001|Overall Study|Other, not specified|1|||
156849034|NCT02343406|566199227|FG002|Overall Study|Other, not specified|1|||
156849035|NCT02343406|566199228|FG003|Overall Study|Other, not specified|4|||
156849036|NCT02343406|566199229|FG004|Overall Study|Other, not specified|0|||
156849037|NCT01746225|566199232|FG000|Overall Study|Death|1|||
156849038|NCT01746225|566199233|FG001|Overall Study|Death|0|||
156849039|NCT01746225|566199234|FG002|Overall Study|Death|1|||
156849040|NCT01746225|566199232|FG000|Overall Study|Withdrawal by Subject|5|||
156849041|NCT01746225|566199233|FG001|Overall Study|Withdrawal by Subject|15|||
156849042|NCT01746225|566199234|FG002|Overall Study|Withdrawal by Subject|19|||
156849043|NCT01746225|566199232|FG000|Overall Study|Physician Decision|14|||
156849044|NCT01746225|566199233|FG001|Overall Study|Physician Decision|11|||
156849045|NCT01746225|566199234|FG002|Overall Study|Physician Decision|3|||
156849046|NCT01746225|566199232|FG000|Overall Study|Adverse Event|15|||
156849047|NCT01746225|566199233|FG001|Overall Study|Adverse Event|12|||
156849048|NCT01746225|566199234|FG002|Overall Study|Adverse Event|17|||
156849049|NCT01746225|566199232|FG000|Overall Study|Continuing Treatment|5|||
156849050|NCT01746225|566199233|FG001|Overall Study|Continuing Treatment|8|||
156849051|NCT01746225|566199234|FG002|Overall Study|Continuing Treatment|3|||
156849052|NCT00999518|566199235|FG000|Overall Study|Adverse Event|1|||
156849053|NCT00999518|566199236|FG001|Overall Study|Adverse Event|6|||
156849054|NCT00999518|566199237|FG002|Overall Study|Adverse Event|3|||
156849055|NCT00999518|566199238|FG003|Overall Study|Adverse Event|1|||
156849056|NCT00999518|566199239|FG004|Overall Study|Adverse Event|2|||
156849057|NCT00999518|566199235|FG000|Overall Study|Lack of Efficacy|2|||
156849058|NCT00999518|566199236|FG001|Overall Study|Lack of Efficacy|0|||
156849059|NCT00999518|566199237|FG002|Overall Study|Lack of Efficacy|0|||
156849060|NCT00999518|566199238|FG003|Overall Study|Lack of Efficacy|2|||
156849061|NCT00999518|566199239|FG004|Overall Study|Lack of Efficacy|2|||
156849062|NCT00999518|566199235|FG000|Overall Study|Lost to Follow-up|0|||
156849063|NCT00999518|566199236|FG001|Overall Study|Lost to Follow-up|0|||
156849064|NCT00999518|566199237|FG002|Overall Study|Lost to Follow-up|0|||
156849065|NCT00999518|566199238|FG003|Overall Study|Lost to Follow-up|4|||
156849066|NCT00999518|566199239|FG004|Overall Study|Lost to Follow-up|1|||
156849067|NCT00999518|566199235|FG000|Overall Study|Did not meet entrance criteria|0|||
156849068|NCT00999518|566199236|FG001|Overall Study|Did not meet entrance criteria|0|||
156849069|NCT00999518|566199237|FG002|Overall Study|Did not meet entrance criteria|0|||
156849070|NCT00999518|566199238|FG003|Overall Study|Did not meet entrance criteria|0|||
156849071|NCT00999518|566199239|FG004|Overall Study|Did not meet entrance criteria|1|||
156849072|NCT00999518|566199235|FG000|Overall Study|Study terminated by sponsor|10|||
156849073|NCT00999518|566199236|FG001|Overall Study|Study terminated by sponsor|6|||
156849074|NCT00999518|566199237|FG002|Overall Study|Study terminated by sponsor|5|||
156849075|NCT00999518|566199238|FG003|Overall Study|Study terminated by sponsor|5|||
156849076|NCT00999518|566199239|FG004|Overall Study|Study terminated by sponsor|9|||
156849077|NCT00999518|566199235|FG000|Overall Study|Pregnancy|0|||
156849078|NCT00999518|566199236|FG001|Overall Study|Pregnancy|0|||
156849079|NCT00999518|566199237|FG002|Overall Study|Pregnancy|1|||
156849080|NCT00999518|566199238|FG003|Overall Study|Pregnancy|0|||
156849081|NCT00999518|566199239|FG004|Overall Study|Pregnancy|0|||
156849082|NCT00999518|566199235|FG000|Overall Study|Protocol Violation|0|||
156849083|NCT00999518|566199236|FG001|Overall Study|Protocol Violation|1|||
156849084|NCT00999518|566199237|FG002|Overall Study|Protocol Violation|0|||
156888586|NCT00622739|566352155|FG001|Overall Study|Withdrawal by Subject|1|||
156849085|NCT00999518|566199238|FG003|Overall Study|Protocol Violation|0|||
156849086|NCT00999518|566199239|FG004|Overall Study|Protocol Violation|2|||
156849087|NCT00999518|566199235|FG000|Overall Study|Withdrawal by Subject|5|||
156849088|NCT00999518|566199236|FG001|Overall Study|Withdrawal by Subject|4|||
156849089|NCT00999518|566199237|FG002|Overall Study|Withdrawal by Subject|10|||
156849090|NCT00999518|566199238|FG003|Overall Study|Withdrawal by Subject|6|||
156849091|NCT00999518|566199239|FG004|Overall Study|Withdrawal by Subject|1|||
156849092|NCT00999518|566199235|FG000|Overall Study|Other|5|||
156849093|NCT00999518|566199236|FG001|Overall Study|Other|7|||
156849094|NCT00999518|566199237|FG002|Overall Study|Other|1|||
156849095|NCT00999518|566199238|FG003|Overall Study|Other|4|||
156849096|NCT00999518|566199239|FG004|Overall Study|Other|5|||
156849097|NCT00999518|566199235|FG000|Overall Study|Randomized but not Treated|1|||
156849098|NCT00999518|566199236|FG001|Overall Study|Randomized but not Treated|1|||
156849099|NCT00999518|566199237|FG002|Overall Study|Randomized but not Treated|2|||
156849100|NCT00999518|566199238|FG003|Overall Study|Randomized but not Treated|0|||
156849101|NCT00999518|566199239|FG004|Overall Study|Randomized but not Treated|1|||
156849102|NCT03857542|566199243|FG000|Overall Study|Adverse Event|1|||
156849103|NCT03857542|566199244|FG001|Overall Study|Adverse Event|3|||
156849104|NCT03857542|566199243|FG000|Overall Study|Withdrawal by Subject|2|||
156849105|NCT03857542|566199244|FG001|Overall Study|Withdrawal by Subject|1|||
156849106|NCT03857542|566199243|FG000|Overall Study|Lost to Follow-up|2|||
156849107|NCT03857542|566199244|FG001|Overall Study|Lost to Follow-up|1|||
156849108|NCT03857542|566199243|FG000|Overall Study|Reason not Specified|1|||
156849109|NCT03857542|566199244|FG001|Overall Study|Reason not Specified|0|||
156849110|NCT04864639|566200924|FG000|Overall Study|Death|1|||
156849111|NCT04864639|566200924|FG000|Overall Study|Lost to Follow-up|1|||
156849112|NCT03449758|566200925|FG000|Overall Study|Major protocol deviation|1|||
156849113|NCT03449758|566200925|FG000|Overall Study|Treatment inefficacy|5|||
156849114|NCT03449758|566200925|FG000|Overall Study|Adverse Event|9|||
156849115|NCT03449758|566200925|FG000|Overall Study|Consent withdrawal|1|||
156849116|NCT03449758|566200925|FG000|Overall Study|Other unspecified reason|3|||
156849117|NCT00584012|566200931|FG000|Overall Study|Withdrawal by Subject|1|||
156849118|NCT02451943|566200935|FG000|Overall Study|Withdrawal by Subject|13|||
156849119|NCT02451943|566200936|FG001|Overall Study|Withdrawal by Subject|16|||
156849120|NCT02451943|566200935|FG000|Overall Study|Lost to Follow-up|3|||
156849121|NCT02451943|566200936|FG001|Overall Study|Lost to Follow-up|4|||
156849122|NCT02451943|566200935|FG000|Overall Study|Sponsor Decision|0|||
156849123|NCT02451943|566200936|FG001|Overall Study|Sponsor Decision|4|||
156849124|NCT03937713|566200937|FG000|Overall Study|Withdrawal by Subject|3|||
156849125|NCT03937713|566200938|FG001|Overall Study|Withdrawal by Subject|6|||
156849126|NCT03937713|566200937|FG000|Overall Study|Lost to Follow-up|1|||
156849127|NCT03937713|566200938|FG001|Overall Study|Lost to Follow-up|0|||
156849128|NCT00763386|566200941|FG000|Overall Study|Adverse Event|43|||
156849129|NCT00763386|566200942|FG001|Overall Study|Adverse Event|33|||
156849130|NCT00763386|566200941|FG000|Overall Study|Death|1|||
156849131|NCT00763386|566200942|FG001|Overall Study|Death|2|||
156849132|NCT00763386|566200941|FG000|Overall Study|Lost to Follow-up|3|||
156849133|NCT00763386|566200942|FG001|Overall Study|Lost to Follow-up|3|||
156849134|NCT00763386|566200941|FG000|Overall Study|Withdrawal by Subject|0|||
156849135|NCT00763386|566200942|FG001|Overall Study|Withdrawal by Subject|1|||
156849136|NCT00763386|566200941|FG000|Overall Study|CRF missing|0|||
156849137|NCT00763386|566200942|FG001|Overall Study|CRF missing|1|||
156849138|NCT00763386|566200941|FG000|Overall Study|Study Prosthesis Removed|1|||
156849139|NCT00763386|566200942|FG001|Overall Study|Study Prosthesis Removed|0|||
156849140|NCT00922623|566200943|FG000|Overall Study|Other|4|||
156849141|NCT00922623|566200943|FG000|Overall Study|Lost to Follow-up|1|||
156849142|NCT02420379|566200944|FG000|Overall Study|Withdrawal by Subject|0|||
156849143|NCT02420379|566200945|FG001|Overall Study|Withdrawal by Subject|3|||
156849144|NCT02420379|566200944|FG000|Overall Study|Unable to complete due to schooling|0|||
156849145|NCT02420379|566200945|FG001|Overall Study|Unable to complete due to schooling|1|||
156849146|NCT02420379|566200944|FG000|Overall Study|Transitioned to commercial drug|1|||
156849147|NCT02420379|566200945|FG001|Overall Study|Transitioned to commercial drug|0|||
156849148|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
156849149|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849150|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849151|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849152|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849153|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156888587|NCT00622739|566352154|FG000|Overall Study|Lost to Follow-up|0|||
156888588|NCT00622739|566352155|FG001|Overall Study|Lost to Follow-up|1|||
156849154|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849155|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849156|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849157|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849158|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849159|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849160|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849161|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849162|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
156849163|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849164|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156888589|NCT02519855|566352156|FG000|Overall Study|Adverse Event|0|||
156849165|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849166|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849167|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849168|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849169|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849170|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849171|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849172|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849173|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
156849174|NCT04640311|566200951|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849175|NCT04640311|566200952|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
156849176|NCT04640311|566200953|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849177|NCT04640311|566200954|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849178|NCT04640311|566200955|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849179|NCT04640311|566200956|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849180|NCT04640311|566200957|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849181|NCT04640311|566200958|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849182|NCT04640311|566200959|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849183|NCT04640311|566200960|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849184|NCT04640311|566200961|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849185|NCT04640311|566200962|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849186|NCT04640311|566200963|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849187|NCT04640311|566200951|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
156849188|NCT04640311|566200952|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
156849189|NCT04640311|566200953|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
156849190|NCT04640311|566200954|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
157155687|NCT01544595|567314313|FG002|Status at Week 68|Non-compliance with study treatment|0|||
156849191|NCT04640311|566200955|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849192|NCT04640311|566200956|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849193|NCT04640311|566200957|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849194|NCT04640311|566200958|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849195|NCT04640311|566200959|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849196|NCT04640311|566200960|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849197|NCT04640311|566200961|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849198|NCT04640311|566200962|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849199|NCT04640311|566200963|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
156849200|NCT04640311|566200951|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849201|NCT04640311|566200952|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849202|NCT04640311|566200953|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
156849203|NCT04640311|566200954|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849204|NCT04640311|566200955|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849205|NCT04640311|566200956|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849206|NCT04640311|566200957|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849207|NCT04640311|566200958|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156888590|NCT02519855|566352157|FG001|Overall Study|Adverse Event|1|||
156888591|NCT02519855|566352156|FG000|Overall Study|Lost to Follow-up|3|||
156888592|NCT02519855|566352157|FG001|Overall Study|Lost to Follow-up|3|||
156888593|NCT02919969|566352158|FG000|Overall Study|Lack of Efficacy|22|||
156888594|NCT02919969|566352158|FG000|Overall Study|Death|4|||
156888595|NCT02919969|566352158|FG000|Overall Study|Physician Decision|3|||
156888596|NCT02919969|566352158|FG000|Overall Study|Withdrawal by Subject|2|||
156888597|NCT03621475|566352159|FG000|Overall Study|No longer required restraints at initiation|0|||
156888598|NCT03621475|566352160|FG001|Overall Study|No longer required restraints at initiation|1|||
156888599|NCT01842633|566352161|FG000|Overall Study|Screen Failure|1|||
157155688|NCT01544595|567314314|FG003|Status at Week 68|Non-compliance with study treatment|1|||
157155689|NCT01544595|567314315|FG004|Status at Week 68|Non-compliance with study treatment|0|||
156849208|NCT04640311|566200959|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849209|NCT04640311|566200960|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849210|NCT04640311|566200961|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849211|NCT04640311|566200962|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849212|NCT04640311|566200963|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
156849213|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849214|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849215|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849216|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
156849217|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849218|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849219|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
156849220|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849221|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849222|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849223|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849224|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849225|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
156849226|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849227|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849228|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849229|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849230|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849231|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
156849232|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849233|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849234|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
156849235|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849236|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849237|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849238|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
156849239|NCT04640311|566200951|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849240|NCT04640311|566200952|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849241|NCT04640311|566200953|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849242|NCT04640311|566200954|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849243|NCT04640311|566200955|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849244|NCT04640311|566200956|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849245|NCT04640311|566200957|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
156849246|NCT04640311|566200958|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849247|NCT04640311|566200959|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849248|NCT04640311|566200960|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849249|NCT04640311|566200961|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
156849250|NCT04640311|566200962|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849251|NCT04640311|566200963|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
156849252|NCT04640311|566200951|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849253|NCT04640311|566200952|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849254|NCT04640311|566200953|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849255|NCT04640311|566200954|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849256|NCT04640311|566200955|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849257|NCT04640311|566200956|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849258|NCT04640311|566200957|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849259|NCT04640311|566200958|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849260|NCT04640311|566200959|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849261|NCT04640311|566200960|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849262|NCT04640311|566200961|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156888600|NCT01842633|566352162|FG001|Overall Study|Screen Failure|0|||
156888601|NCT01842633|566352163|FG002|Overall Study|Screen Failure|0|||
156888602|NCT01842633|566352161|FG000|Overall Study|Adverse Event|1|||
156888603|NCT01842633|566352162|FG001|Overall Study|Adverse Event|1|||
156888604|NCT01842633|566352163|FG002|Overall Study|Adverse Event|0|||
156888605|NCT01842633|566352161|FG000|Overall Study|Withdrawal by Subject|0|||
156888606|NCT01842633|566352162|FG001|Overall Study|Withdrawal by Subject|1|||
156888607|NCT01842633|566352163|FG002|Overall Study|Withdrawal by Subject|0|||
156888608|NCT01842633|566352161|FG000|Overall Study|Technical issues|1|||
156888609|NCT01842633|566352162|FG001|Overall Study|Technical issues|0|||
157025502|NCT03544281|566847958|FG002|Main Study Phase|Did not receive study treatment|0|||
157025503|NCT03544281|566847959|FG003|Main Study Phase|Did not receive study treatment|0|||
157025504|NCT03544281|566847960|FG004|Main Study Phase|Did not receive study treatment|0|||
157025505|NCT03544281|566847961|FG005|Main Study Phase|Did not receive study treatment|0|||
157025506|NCT03544281|566847962|FG006|Main Study Phase|Did not receive study treatment|1|||
157025507|NCT03544281|566847963|FG007|Main Study Phase|Did not receive study treatment|0|||
157025508|NCT03544281|566847964|FG008|Main Study Phase|Did not receive study treatment|0|||
157025509|NCT03544281|566847965|FG009|Main Study Phase|Did not receive study treatment|0|||
157025510|NCT03544281|566847966|FG010|Main Study Phase|Did not receive study treatment|0|||
157025511|NCT03544281|566847967|FG011|Main Study Phase|Did not receive study treatment|0|||
157025512|NCT03544281|566847968|FG012|Main Study Phase|Did not receive study treatment|0|||
157025513|NCT03544281|566847969|FG013|Main Study Phase|Did not receive study treatment|0|||
157025514|NCT03544281|566847970|FG014|Main Study Phase|Did not receive study treatment|0|||
157025515|NCT03544281|566847971|FG015|Main Study Phase|Did not receive study treatment|0|||
157025516|NCT03544281|566847972|FG016|Main Study Phase|Did not receive study treatment|0|||
157025517|NCT03544281|566847973|FG017|Main Study Phase|Did not receive study treatment|0|||
157025518|NCT03544281|566847974|FG018|Main Study Phase|Did not receive study treatment|0|||
157025519|NCT03544281|566847975|FG019|Main Study Phase|Did not receive study treatment|0|||
157025520|NCT03544281|566847976|FG020|Main Study Phase|Did not receive study treatment|0|||
157025521|NCT03544281|566847977|FG021|Main Study Phase|Did not receive study treatment|0|||
157025522|NCT03544281|566847956|FG000|PACT Phase|Adverse Event|0|||
157025523|NCT03544281|566847957|FG001|PACT Phase|Adverse Event|0|||
157025524|NCT03544281|566847958|FG002|PACT Phase|Adverse Event|0|||
157025525|NCT03544281|566847959|FG003|PACT Phase|Adverse Event|0|||
157025526|NCT03544281|566847960|FG004|PACT Phase|Adverse Event|0|||
157025527|NCT03544281|566847961|FG005|PACT Phase|Adverse Event|0|||
157025528|NCT03544281|566847962|FG006|PACT Phase|Adverse Event|0|||
157025529|NCT03544281|566847963|FG007|PACT Phase|Adverse Event|0|||
157025530|NCT03544281|566847964|FG008|PACT Phase|Adverse Event|0|||
157025531|NCT03544281|566847965|FG009|PACT Phase|Adverse Event|0|||
157025532|NCT03544281|566847966|FG010|PACT Phase|Adverse Event|0|||
157025533|NCT03544281|566847967|FG011|PACT Phase|Adverse Event|0|||
157025534|NCT03544281|566847968|FG012|PACT Phase|Adverse Event|1|||
157025535|NCT03544281|566847969|FG013|PACT Phase|Adverse Event|0|||
157025536|NCT03544281|566847970|FG014|PACT Phase|Adverse Event|0|||
157025537|NCT03544281|566847971|FG015|PACT Phase|Adverse Event|0|||
157025538|NCT03544281|566847972|FG016|PACT Phase|Adverse Event|0|||
157025539|NCT03544281|566847973|FG017|PACT Phase|Adverse Event|1|||
157025540|NCT03544281|566847974|FG018|PACT Phase|Adverse Event|1|||
157025541|NCT03544281|566847975|FG019|PACT Phase|Adverse Event|0|||
157025542|NCT03544281|566847976|FG020|PACT Phase|Adverse Event|0|||
157025543|NCT03544281|566847977|FG021|PACT Phase|Adverse Event|0|||
157025544|NCT02547233|566847978|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
157025545|NCT02547233|566847979|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
156849263|NCT04640311|566200962|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
156849264|NCT04640311|566200963|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
156849265|NCT01641601|566200964|FG000|Overall Study|Study discontinued.|3|||
156849266|NCT01641601|566200965|FG001|Overall Study|Study discontinued.|5|||
156849267|NCT01799226|566200970|FG000|Overall Study|Withdrawal by Subject|1|||
156849268|NCT01799226|566200971|FG001|Overall Study|Withdrawal by Subject|0|||
156849269|NCT01799226|566200970|FG000|Overall Study|Disqualified at Day 14|1|||
156849270|NCT01799226|566200971|FG001|Overall Study|Disqualified at Day 14|0|||
156849271|NCT02178995|566200972|FG000|Double Blind|Adverse Event|0|||
156849272|NCT02178995|566200973|FG001|Double Blind|Adverse Event|0|||
156849273|NCT02178995|566200974|FG002|Double Blind|Adverse Event|0|||
156849274|NCT02178995|566200975|FG003|Double Blind|Adverse Event|0|||
156849275|NCT02178995|566200976|FG004|Double Blind|Adverse Event|0|||
156849276|NCT02178995|566200977|FG005|Double Blind|Adverse Event|1|||
156849277|NCT02178995|566200978|FG006|Double Blind|Adverse Event|0|||
156849278|NCT02178995|566200979|FG007|Double Blind|Adverse Event|1|||
156849279|NCT02178995|566200980|FG008|Double Blind|Adverse Event|1|||
156849280|NCT02178995|566200972|FG000|Double Blind|Lost to Follow-up|0|||
156849281|NCT02178995|566200973|FG001|Double Blind|Lost to Follow-up|1|||
157025546|NCT02547233|566847978|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
157025547|NCT02547233|566847979|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
157025548|NCT02547233|566847978|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
157025549|NCT02547233|566847979|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
157025550|NCT02547233|566847978|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
157025551|NCT02547233|566847979|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
157025552|NCT02547233|566847978|FG000|12-month Follow-up|Withdrawal by Subject|10|||
157025553|NCT02547233|566847979|FG001|12-month Follow-up|Withdrawal by Subject|10|||
157025554|NCT02547233|566847978|FG000|12-month Follow-up|Lost to Follow-up|3|||
157025555|NCT02547233|566847979|FG001|12-month Follow-up|Lost to Follow-up|3|||
157025556|NCT02547233|566847978|FG000|12-month Follow-up|Lack of Efficacy|1|||
157025557|NCT02547233|566847979|FG001|12-month Follow-up|Lack of Efficacy|2|||
157025558|NCT02547233|566847978|FG000|12-month Follow-up|Protocol Violation|0|||
156849282|NCT02178995|566200974|FG002|Double Blind|Lost to Follow-up|0|||
156849283|NCT02178995|566200975|FG003|Double Blind|Lost to Follow-up|0|||
156849284|NCT02178995|566200976|FG004|Double Blind|Lost to Follow-up|0|||
156849285|NCT02178995|566200977|FG005|Double Blind|Lost to Follow-up|0|||
156849286|NCT02178995|566200978|FG006|Double Blind|Lost to Follow-up|0|||
156849287|NCT02178995|566200979|FG007|Double Blind|Lost to Follow-up|1|||
156849288|NCT02178995|566200980|FG008|Double Blind|Lost to Follow-up|0|||
156849289|NCT02178995|566200972|FG000|Open Label|Adverse Event|2|||
156849290|NCT02178995|566200973|FG001|Open Label|Adverse Event|0|||
156849291|NCT02178995|566200974|FG002|Open Label|Adverse Event|0|||
156849292|NCT02178995|566200975|FG003|Open Label|Adverse Event|0|||
156849293|NCT02178995|566200976|FG004|Open Label|Adverse Event|0|||
156849294|NCT02178995|566200977|FG005|Open Label|Adverse Event|0|||
156849295|NCT02178995|566200978|FG006|Open Label|Adverse Event|0|||
156849296|NCT02178995|566200979|FG007|Open Label|Adverse Event|0|||
156849297|NCT02178995|566200980|FG008|Open Label|Adverse Event|0|||
156849298|NCT01388907|566200981|FG000|Overall Study|Adverse Event|2|||
156849299|NCT01388907|566200982|FG001|Overall Study|Adverse Event|0|||
156849300|NCT03361293|566200983|FG000|Overall Study|Lost to Follow-up|0|||
156849301|NCT03361293|566200984|FG001|Overall Study|Lost to Follow-up|2|||
156849302|NCT03361293|566200983|FG000|Overall Study|Withdrawal by Subject|1|||
156849303|NCT03361293|566200984|FG001|Overall Study|Withdrawal by Subject|3|||
156849304|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
156849305|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
156849306|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
156849307|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
156849308|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
156849309|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
156849310|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
156849311|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
156849312|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
156849313|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
156849314|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
156849315|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
156849316|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
156849317|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
156849318|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
156849319|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
156849320|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
156849321|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
156849322|NCT01910402|566200985|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
156849323|NCT01910402|566200986|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
156849324|NCT01910402|566200987|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
156849325|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
156849326|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
156849327|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
156849328|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
156849329|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
156849330|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
156849331|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
156849332|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
156849333|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
156849334|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
156849335|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
156849336|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
156849337|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
156849338|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
156849339|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
156849340|NCT01910402|566200985|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
156849341|NCT01910402|566200986|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
156849342|NCT01910402|566200987|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
156849343|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Technical problems|0|||
156849344|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Technical problems|0|||
156849345|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Technical problems|0|||
156849346|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Technical problems|1|||
156849347|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849348|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
156849349|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849350|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
156849351|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
156849352|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
156849353|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
156849354|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
156849355|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
156849356|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
156849357|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
156849358|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
156849359|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Death|0|||
156849360|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Death|3|||
156849361|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Death|1|||
156849362|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Death|0|||
156849363|NCT02152761|566200988|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
156849364|NCT02152761|566200989|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
156849365|NCT02152761|566200990|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
156849366|NCT02152761|566200991|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
156849367|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
156849368|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
156849369|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
156849370|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
156849371|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
156849372|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
156849373|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
156849374|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
156849375|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
156849376|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849377|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849378|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
156849379|NCT02152761|566200988|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
156849380|NCT02152761|566200989|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
156849381|NCT02152761|566200990|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
156849382|NCT02152761|566200991|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
156849383|NCT01957202|566200992|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849384|NCT01957202|566200993|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
156849385|NCT01957202|566200994|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849386|NCT01957202|566200995|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849387|NCT01957202|566200996|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849388|NCT01957202|566200997|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849389|NCT01957202|566200998|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849390|NCT01957202|566200999|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849391|NCT01957202|566201000|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849392|NCT01957202|566201001|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849393|NCT01957202|566201002|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849394|NCT01957202|566201003|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849395|NCT01957202|566201004|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849396|NCT01957202|566201005|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849397|NCT01957202|566201006|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849398|NCT01957202|566201007|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849399|NCT01957202|566201008|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
156849400|NCT01957202|566201009|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
156849401|NCT01957202|566200992|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849402|NCT01957202|566200993|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
157025559|NCT02547233|566847979|FG001|12-month Follow-up|Protocol Violation|1|||
157025560|NCT02547233|566847978|FG000|12-month Follow-up|Other|0|||
157025561|NCT02547233|566847979|FG001|12-month Follow-up|Other|1|||
157025562|NCT06019559|566847981|FG000|Overall Study|Withdrawal by Subject|7|||
156849403|NCT01957202|566200994|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849404|NCT01957202|566200995|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849405|NCT01957202|566200996|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849406|NCT01957202|566200997|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
157155690|NCT01544595|567314316|FG005|Status at Week 68|Non-compliance with study treatment|0|||
157155691|NCT01544595|567314311|FG000|Status at Week 68|Protocol Violation|2|||
156849407|NCT01957202|566200998|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849408|NCT01957202|566200999|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849409|NCT01957202|566201000|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849410|NCT01957202|566201001|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849411|NCT01957202|566201002|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849412|NCT01957202|566201003|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849413|NCT01957202|566201004|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849414|NCT01957202|566201005|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
156888610|NCT01842633|566352163|FG002|Overall Study|Technical issues|0|||
156888611|NCT02093351|566352167|FG000|Part A|Adverse Event|0|||
156849415|NCT01957202|566201006|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849416|NCT01957202|566201007|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849417|NCT01957202|566201008|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
156849418|NCT01957202|566201009|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
156849419|NCT01797263|566201010|FG000|Overall Study|Withdrawal by Subject|21|||
156849420|NCT01797263|566201011|FG001|Overall Study|Withdrawal by Subject|25|||
156849421|NCT01797263|566201010|FG000|Overall Study|Death|1|||
156849422|NCT01797263|566201011|FG001|Overall Study|Death|0|||
156849423|NCT01797263|566201010|FG000|Overall Study|Lost to Follow-up|15|||
156849424|NCT01797263|566201011|FG001|Overall Study|Lost to Follow-up|15|||
156849425|NCT02342223|566201012|FG000|Overall Study|Lost to Follow-up|1|||
156849426|NCT01200368|566201013|FG000|Infant Series|Adverse Event|2|||
156849427|NCT01200368|566201014|FG001|Infant Series|Adverse Event|2|||
156849428|NCT01200368|566201015|FG002|Infant Series|Adverse Event|3|||
156849429|NCT01200368|566201013|FG000|Infant Series|Withdrawal by Subject|0|||
156849430|NCT01200368|566201014|FG001|Infant Series|Withdrawal by Subject|2|||
156849431|NCT01200368|566201015|FG002|Infant Series|Withdrawal by Subject|2|||
156849432|NCT01200368|566201013|FG000|Infant Series|Did not meet entrance criteria|0|||
156849433|NCT01200368|566201014|FG001|Infant Series|Did not meet entrance criteria|1|||
156849434|NCT01200368|566201015|FG002|Infant Series|Did not meet entrance criteria|0|||
156849435|NCT01200368|566201013|FG000|Infant Series|Randomized, not vaccinated|0|||
156849436|NCT01200368|566201014|FG001|Infant Series|Randomized, not vaccinated|1|||
156849437|NCT01200368|566201015|FG002|Infant Series|Randomized, not vaccinated|1|||
156849438|NCT01200368|566201013|FG000|Infant Series|Other|1|||
156849439|NCT01200368|566201014|FG001|Infant Series|Other|0|||
156849440|NCT01200368|566201015|FG002|Infant Series|Other|0|||
156849441|NCT01200368|566201013|FG000|After Infant Series|Adverse Event|6|||
156849442|NCT01200368|566201014|FG001|After Infant Series|Adverse Event|6|||
156849443|NCT01200368|566201015|FG002|After Infant Series|Adverse Event|3|||
156849444|NCT01200368|566201013|FG000|After Infant Series|Withdrawal by Subject|10|||
156849445|NCT01200368|566201014|FG001|After Infant Series|Withdrawal by Subject|8|||
156849446|NCT01200368|566201015|FG002|After Infant Series|Withdrawal by Subject|4|||
156849447|NCT01200368|566201013|FG000|After Infant Series|Lost to Follow-up|1|||
156849448|NCT01200368|566201014|FG001|After Infant Series|Lost to Follow-up|0|||
156849449|NCT01200368|566201015|FG002|After Infant Series|Lost to Follow-up|0|||
156849450|NCT01200368|566201013|FG000|After Infant Series|Other|1|||
156849451|NCT01200368|566201014|FG001|After Infant Series|Other|2|||
156849452|NCT01200368|566201015|FG002|After Infant Series|Other|2|||
156849453|NCT01200368|566201013|FG000|Toddler Dose|Adverse Event|0|||
156849454|NCT01200368|566201014|FG001|Toddler Dose|Adverse Event|3|||
156849455|NCT01200368|566201015|FG002|Toddler Dose|Adverse Event|1|||
156849456|NCT01290757|566201016|FG000|Overall Study|Adverse Event|1|||
156849457|NCT01290757|566201017|FG001|Overall Study|Adverse Event|0|||
156849458|NCT01290757|566201016|FG000|Overall Study|Protocol Violation|1|||
156849459|NCT01290757|566201017|FG001|Overall Study|Protocol Violation|1|||
156849460|NCT01290757|566201016|FG000|Overall Study|Other|0|||
156849461|NCT01290757|566201017|FG001|Overall Study|Other|1|||
156849462|NCT00991939|566201019|FG000|Overall Study|Lost to Follow-up|0|||
156849463|NCT00991939|566201020|FG001|Overall Study|Lost to Follow-up|1|||
156849464|NCT00991939|566201019|FG000|Overall Study|Withdrawal by Subject|1|||
156849465|NCT00991939|566201020|FG001|Overall Study|Withdrawal by Subject|0|||
156849466|NCT00991939|566201019|FG000|Overall Study|Entire study terminated|4|||
156849467|NCT00991939|566201020|FG001|Overall Study|Entire study terminated|1|||
156849468|NCT00740584|566201021|FG000|Overall Study|Withdrawal by Subject|1|||
156849469|NCT00181766|566201031|FG000|Overall Study|Lost to Follow-up|6|||
156849470|NCT00181766|566201031|FG000|Overall Study|Adverse Event|4|||
156849471|NCT00181766|566201031|FG000|Overall Study|non-compliance|2|||
156849472|NCT00687804|566201039|FG000|Core Study|Adverse Event|5|||
156849473|NCT00687804|566201040|FG001|Core Study|Adverse Event|3|||
156849474|NCT00687804|566201041|FG002|Core Study|Adverse Event|3|||
156849475|NCT00687804|566201039|FG000|Core Study|Abnormal laboratory value(s)|1|||
156849476|NCT00687804|566201040|FG001|Core Study|Abnormal laboratory value(s)|0|||
156849477|NCT00687804|566201041|FG002|Core Study|Abnormal laboratory value(s)|0|||
156849478|NCT00687804|566201039|FG000|Core Study|Lack of Efficacy|1|||
156849479|NCT00687804|566201040|FG001|Core Study|Lack of Efficacy|1|||
156849480|NCT00687804|566201041|FG002|Core Study|Lack of Efficacy|1|||
156849481|NCT00687804|566201039|FG000|Core Study|Withdrawal by Subject|4|||
156849482|NCT00687804|566201040|FG001|Core Study|Withdrawal by Subject|7|||
156849483|NCT00687804|566201041|FG002|Core Study|Withdrawal by Subject|7|||
156849484|NCT00687804|566201039|FG000|Core Study|Lost to Follow-up|0|||
156849485|NCT00687804|566201040|FG001|Core Study|Lost to Follow-up|1|||
156849486|NCT00687804|566201041|FG002|Core Study|Lost to Follow-up|0|||
156849487|NCT00687804|566201039|FG000|Core Study|Death|2|||
156849488|NCT00687804|566201040|FG001|Core Study|Death|2|||
156849489|NCT00687804|566201041|FG002|Core Study|Death|2|||
156849490|NCT00687804|566201039|FG000|Core Study|Protocol Violation|1|||
156849491|NCT00687804|566201040|FG001|Core Study|Protocol Violation|1|||
156849492|NCT00687804|566201041|FG002|Core Study|Protocol Violation|0|||
156849493|NCT00687804|566201039|FG000|Open-Label Extension Study|Adverse Event|2|||
156849494|NCT00687804|566201040|FG001|Open-Label Extension Study|Adverse Event|2|||
156849495|NCT00687804|566201041|FG002|Open-Label Extension Study|Adverse Event|2|||
156849496|NCT00687804|566201039|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
156849497|NCT00687804|566201040|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
156849498|NCT00687804|566201041|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
156849499|NCT00687804|566201039|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
156849500|NCT00687804|566201040|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
156849501|NCT00687804|566201041|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
156849502|NCT00687804|566201039|FG000|Open-Label Extension Study|Administrative problems|1|||
156849503|NCT00687804|566201040|FG001|Open-Label Extension Study|Administrative problems|1|||
156849504|NCT00687804|566201041|FG002|Open-Label Extension Study|Administrative problems|0|||
156849505|NCT00687804|566201039|FG000|Open-Label Extension Study|Death|2|||
156849506|NCT00687804|566201040|FG001|Open-Label Extension Study|Death|3|||
156849507|NCT00687804|566201041|FG002|Open-Label Extension Study|Death|3|||
156849508|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
156849509|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
156849510|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
156849511|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
156849512|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
156849513|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
156849514|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
156849515|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
156849516|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
156849517|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
156849518|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
156849519|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
156849520|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
156849521|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
156849522|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
156849523|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
156849524|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
156849525|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
156849526|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
156849527|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
156849528|NCT03573323|566201042|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
156849529|NCT03573323|566201043|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
156849530|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
156849531|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
156849532|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
156849533|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
156849534|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
156849535|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
156849536|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
156849537|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
156849538|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
156849539|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
156849540|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
156849541|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
156849542|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
156849543|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
156849544|NCT03573323|566201042|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
156849545|NCT03573323|566201043|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
156849546|NCT03188432|566201044|FG000|Overall Study|Death|3|||
156849547|NCT03188432|566201044|FG000|Overall Study|Withdrawal by Subject|15|||
156849548|NCT03188432|566201044|FG000|Overall Study|Did not complete protocol treatment|9|||
156849549|NCT00413218|566201048|FG000|Overall Study|Randomized but didn't receive study drug|2|||
156849550|NCT00413218|566201049|FG001|Overall Study|Randomized but didn't receive study drug|8|||
156849551|NCT00413218|566201048|FG000|Overall Study|Death|57|||
156849552|NCT00413218|566201049|FG001|Overall Study|Death|56|||
156849553|NCT00413218|566201048|FG000|Overall Study|Lost to Follow-up|14|||
156849554|NCT00413218|566201049|FG001|Overall Study|Lost to Follow-up|17|||
156849555|NCT00413218|566201048|FG000|Overall Study|Admin|20|||
156849556|NCT00413218|566201049|FG001|Overall Study|Admin|14|||
156849557|NCT00413218|566201048|FG000|Overall Study|Missing|1|||
156849558|NCT00413218|566201049|FG001|Overall Study|Missing|0|||
156849559|NCT00413218|566201048|FG000|Overall Study|Withdrawal by Subject|9|||
156849560|NCT00413218|566201049|FG001|Overall Study|Withdrawal by Subject|1|||
156849561|NCT01502228|566201054|FG000|Overall Study|Death|1|||
156849562|NCT05730387|566201055|FG000|Overall Study|Stillbirth|0|||
157025563|NCT06019559|566847982|FG001|Overall Study|Withdrawal by Subject|6|||
157025564|NCT06019559|566847983|FG002|Overall Study|Withdrawal by Subject|5|||
157025565|NCT06019559|566847981|FG000|Overall Study|Lost to Follow-up|2|||
157025566|NCT06019559|566847982|FG001|Overall Study|Lost to Follow-up|0|||
157025567|NCT06019559|566847983|FG002|Overall Study|Lost to Follow-up|3|||
156849563|NCT05730387|566201056|FG001|Overall Study|Stillbirth|262|||
156849564|NCT05730387|566201055|FG000|Overall Study|Died during or after delivery|2|||
156849565|NCT05730387|566201056|FG001|Overall Study|Died during or after delivery|85|||
156849566|NCT05730387|566201055|FG000|Overall Study|Died after being admitted|0|||
156849567|NCT05730387|566201056|FG001|Overall Study|Died after being admitted|44|||
156849568|NCT05730387|566201055|FG000|Overall Study|Lost to Follow-up|69|||
156849569|NCT05730387|566201056|FG001|Overall Study|Lost to Follow-up|77|||
156849570|NCT02728089|566201057|FG000|Overall Study|Physician Decision|2|||
156849571|NCT02728089|566201057|FG000|Overall Study|Withdrawal by Subject|1|||
156849572|NCT04669301|566201058|FG000|Overall Study|Lost to Follow-up|0|||
156849573|NCT04669301|566201059|FG001|Overall Study|Lost to Follow-up|1|||
156849574|NCT04669301|566201060|FG002|Overall Study|Lost to Follow-up|0|||
156849575|NCT04669301|566201058|FG000|Overall Study|Withdrawal by Subject|3|||
156849576|NCT04669301|566201059|FG001|Overall Study|Withdrawal by Subject|2|||
156849577|NCT04669301|566201060|FG002|Overall Study|Withdrawal by Subject|0|||
156849578|NCT01221350|566201063|FG000|Overall Study|Discontinued intervention (GERD)|1|||
156849579|NCT01221350|566201064|FG001|Overall Study|Discontinued intervention (GERD)|0|||
156849580|NCT01221350|566201063|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
156849581|NCT01221350|566201064|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
156849582|NCT01221350|566201063|FG000|Overall Study|Withdrawal by Subject|4|||
156849583|NCT01221350|566201064|FG001|Overall Study|Withdrawal by Subject|2|||
156849584|NCT05888181|566201066|FG000|Overall Study|Lost to Follow-up|1|||
156849585|NCT05888181|566201067|FG001|Overall Study|Lost to Follow-up|1|||
156849586|NCT05888181|566201068|FG002|Overall Study|Lost to Follow-up|0|||
156849587|NCT04137731|566201071|FG000|Overall Study|Surgery Cancellation|1|||
156849588|NCT04137731|566201072|FG001|Overall Study|Surgery Cancellation|2|||
156849589|NCT04137731|566201071|FG000|Overall Study|Withdrawal by Subject|2|||
156849590|NCT04137731|566201072|FG001|Overall Study|Withdrawal by Subject|0|||
156849591|NCT04137731|566201071|FG000|Overall Study|Protocol Violation|0|||
156849592|NCT04137731|566201072|FG001|Overall Study|Protocol Violation|1|||
156849593|NCT00362648|566201074|FG000|Overall Study|Adverse Event|12|||
156849594|NCT00362648|566201075|FG001|Overall Study|Adverse Event|21|||
156849595|NCT00362648|566201076|FG002|Overall Study|Adverse Event|1|||
156849596|NCT00362648|566201077|FG003|Overall Study|Adverse Event|0|||
156849597|NCT00362648|566201074|FG000|Overall Study|Lost to Follow-up|62|||
156849598|NCT00362648|566201075|FG001|Overall Study|Lost to Follow-up|69|||
156849599|NCT00362648|566201076|FG002|Overall Study|Lost to Follow-up|4|||
156849600|NCT00362648|566201077|FG003|Overall Study|Lost to Follow-up|3|||
156849601|NCT00362648|566201074|FG000|Overall Study|Protocol Violation|4|||
156849602|NCT00362648|566201075|FG001|Overall Study|Protocol Violation|2|||
156849603|NCT00362648|566201076|FG002|Overall Study|Protocol Violation|2|||
156849604|NCT00362648|566201077|FG003|Overall Study|Protocol Violation|2|||
156849605|NCT00362648|566201074|FG000|Overall Study|Withdrawal by Subject|48|||
156849606|NCT00362648|566201075|FG001|Overall Study|Withdrawal by Subject|42|||
156849607|NCT00362648|566201076|FG002|Overall Study|Withdrawal by Subject|2|||
156849608|NCT00362648|566201077|FG003|Overall Study|Withdrawal by Subject|6|||
156849609|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
156849610|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
156849611|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
156849612|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
156849613|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
156849614|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
156849615|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
157025568|NCT05949788|566847984|FG000|Overall Study|severe birth deformity|2|||
157025569|NCT05949788|566847985|FG001|Overall Study|severe birth deformity|7|||
157025570|NCT05949788|566847984|FG000|Overall Study|twin-twin transfusion syndrome|2|||
156849616|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
156849617|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
156849618|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
156849619|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
156849620|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
156849621|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
156849622|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
156849623|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
156888612|NCT02093351|566352168|FG001|Part A|Adverse Event|1|||
157025571|NCT05949788|566847985|FG001|Overall Study|twin-twin transfusion syndrome|7|||
157025572|NCT05949788|566847984|FG000|Overall Study|neonatal hemolytic disease|3|||
157025573|NCT05949788|566847985|FG001|Overall Study|neonatal hemolytic disease|8|||
156849624|NCT02204072|566201078|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849625|NCT02204072|566201079|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849626|NCT02204072|566201080|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
156849627|NCT02204072|566201081|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849628|NCT02204072|566201082|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
156849629|NCT03983304|566201083|FG000|Overall Study|Withdrawal by Subject|5|||
156849630|NCT03983304|566201083|FG000|Overall Study|Lost to Follow-up|2|||
156849631|NCT01587040|566201084|FG000|Overall Study|Protocol Violation|0|||
156849632|NCT01587040|566201085|FG001|Overall Study|Protocol Violation|0|||
156849633|NCT01587040|566201086|FG002|Overall Study|Protocol Violation|1|||
156849634|NCT01587040|566201087|FG003|Overall Study|Protocol Violation|0|||
156849635|NCT01587040|566201084|FG000|Overall Study|Adverse Event|0|||
156849636|NCT01587040|566201085|FG001|Overall Study|Adverse Event|1|||
156849637|NCT01587040|566201086|FG002|Overall Study|Adverse Event|10|||
156849638|NCT01587040|566201087|FG003|Overall Study|Adverse Event|0|||
156849639|NCT01587040|566201084|FG000|Overall Study|Disease progression|12|||
156849640|NCT01587040|566201085|FG001|Overall Study|Disease progression|1|||
156849641|NCT01587040|566201086|FG002|Overall Study|Disease progression|15|||
156849642|NCT01587040|566201087|FG003|Overall Study|Disease progression|3|||
156849643|NCT01587040|566201084|FG000|Overall Study|Other than specified|5|||
156849644|NCT01587040|566201085|FG001|Overall Study|Other than specified|1|||
156849645|NCT01587040|566201086|FG002|Overall Study|Other than specified|11|||
156849646|NCT01587040|566201087|FG003|Overall Study|Other than specified|1|||
156849647|NCT00286429|566201096|FG000|Overall Study|Adverse Event|4|||
156849648|NCT00286429|566201097|FG001|Overall Study|Adverse Event|1|||
156849649|NCT00286429|566201098|FG002|Overall Study|Adverse Event|6|||
156849650|NCT00286429|566201096|FG000|Overall Study|Lack of Efficacy|52|||
156849651|NCT00286429|566201097|FG001|Overall Study|Lack of Efficacy|27|||
156849652|NCT00286429|566201098|FG002|Overall Study|Lack of Efficacy|25|||
156849653|NCT00286429|566201096|FG000|Overall Study|Lost to Follow-up|2|||
156849654|NCT00286429|566201097|FG001|Overall Study|Lost to Follow-up|4|||
156849655|NCT00286429|566201098|FG002|Overall Study|Lost to Follow-up|3|||
156849656|NCT00286429|566201096|FG000|Overall Study|Physician Decision|10|||
156849657|NCT00286429|566201097|FG001|Overall Study|Physician Decision|7|||
156849658|NCT00286429|566201098|FG002|Overall Study|Physician Decision|7|||
156849659|NCT00286429|566201096|FG000|Overall Study|Protocol Violation|3|||
156849660|NCT00286429|566201097|FG001|Overall Study|Protocol Violation|5|||
156849661|NCT00286429|566201098|FG002|Overall Study|Protocol Violation|4|||
156849662|NCT00286429|566201096|FG000|Overall Study|Withdrawal by Subject|3|||
156849663|NCT00286429|566201097|FG001|Overall Study|Withdrawal by Subject|2|||
156849664|NCT00286429|566201098|FG002|Overall Study|Withdrawal by Subject|6|||
156849665|NCT00286429|566201096|FG000|Overall Study|Administrative Error|1|||
156849666|NCT00286429|566201097|FG001|Overall Study|Administrative Error|1|||
156849667|NCT00286429|566201098|FG002|Overall Study|Administrative Error|1|||
156849668|NCT00286429|566201096|FG000|Overall Study|Administrative Decision|0|||
156849669|NCT00286429|566201097|FG001|Overall Study|Administrative Decision|1|||
156849670|NCT00286429|566201098|FG002|Overall Study|Administrative Decision|0|||
156849671|NCT03197376|566201102|FG000|Primary and Booster Phase|Adverse Event|0|||
156849672|NCT03197376|566201103|FG001|Primary and Booster Phase|Adverse Event|0|||
156849673|NCT03197376|566201104|FG002|Primary and Booster Phase|Adverse Event|0|||
156849674|NCT03197376|566201105|FG003|Primary and Booster Phase|Adverse Event|1|||
156849675|NCT03197376|566201102|FG000|Primary and Booster Phase|Death|1|||
156849676|NCT03197376|566201103|FG001|Primary and Booster Phase|Death|0|||
156849677|NCT03197376|566201104|FG002|Primary and Booster Phase|Death|0|||
156849678|NCT03197376|566201105|FG003|Primary and Booster Phase|Death|2|||
156849679|NCT03197376|566201102|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
156849680|NCT03197376|566201103|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
156849681|NCT03197376|566201104|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
156849682|NCT03197376|566201105|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
156849683|NCT03197376|566201102|FG000|Primary and Booster Phase|Physician Decision|1|||
156849684|NCT03197376|566201103|FG001|Primary and Booster Phase|Physician Decision|0|||
156849685|NCT03197376|566201104|FG002|Primary and Booster Phase|Physician Decision|1|||
156849686|NCT03197376|566201105|FG003|Primary and Booster Phase|Physician Decision|3|||
156849687|NCT03197376|566201102|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
156849688|NCT03197376|566201103|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
156849689|NCT03197376|566201104|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
156849690|NCT03197376|566201105|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
156849691|NCT03197376|566201102|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
156849692|NCT03197376|566201103|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
156849693|NCT03197376|566201104|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
156849694|NCT03197376|566201105|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
156849695|NCT03197376|566201102|FG000|Primary and Booster Phase|Not vaccine related|1|||
156849696|NCT03197376|566201103|FG001|Primary and Booster Phase|Not vaccine related|2|||
156849697|NCT03197376|566201104|FG002|Primary and Booster Phase|Not vaccine related|0|||
156849698|NCT03197376|566201105|FG003|Primary and Booster Phase|Not vaccine related|6|||
157155692|NCT01544595|567314312|FG001|Status at Week 68|Protocol Violation|0|||
157155693|NCT01544595|567314313|FG002|Status at Week 68|Protocol Violation|1|||
156849699|NCT03197376|566201102|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
156849700|NCT03197376|566201103|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
156849701|NCT03197376|566201104|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
156849702|NCT03197376|566201105|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
156849703|NCT03197376|566201102|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
156849704|NCT03197376|566201103|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
156849705|NCT03197376|566201104|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
156849706|NCT03197376|566201105|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
156849707|NCT03197376|566201102|FG000|Immune Persistence Phase|Not vaccine related|1|||
156849708|NCT03197376|566201103|FG001|Immune Persistence Phase|Not vaccine related|0|||
156849709|NCT03197376|566201104|FG002|Immune Persistence Phase|Not vaccine related|1|||
156849710|NCT03197376|566201105|FG003|Immune Persistence Phase|Not vaccine related|1|||
156849711|NCT01594931|566203014|FG000|Overall Study|Adverse Event|3|||
156849712|NCT01594931|566203015|FG001|Overall Study|Adverse Event|1|||
156849713|NCT01594931|566203016|FG002|Overall Study|Adverse Event|1|||
156849714|NCT01594931|566203014|FG000|Overall Study|Withdrawal by Subject|2|||
156849715|NCT01594931|566203015|FG001|Overall Study|Withdrawal by Subject|1|||
156849716|NCT01594931|566203016|FG002|Overall Study|Withdrawal by Subject|1|||
156849717|NCT01594931|566203014|FG000|Overall Study|Lack of Efficacy|7|||
156849718|NCT01594931|566203015|FG001|Overall Study|Lack of Efficacy|2|||
156849719|NCT01594931|566203016|FG002|Overall Study|Lack of Efficacy|2|||
156849720|NCT01594931|566203014|FG000|Overall Study|Lost to Follow-up|4|||
156849721|NCT01594931|566203015|FG001|Overall Study|Lost to Follow-up|3|||
156888613|NCT02093351|566352169|FG002|Part A|Adverse Event|1|||
156888614|NCT02093351|566352170|FG003|Part A|Adverse Event|0|||
156888615|NCT02093351|566352167|FG000|Part A|Condition under investigation worsened|2|||
156888616|NCT02093351|566352168|FG001|Part A|Condition under investigation worsened|0|||
156888617|NCT02093351|566352169|FG002|Part A|Condition under investigation worsened|2|||
156888618|NCT02093351|566352170|FG003|Part A|Condition under investigation worsened|0|||
156888619|NCT02093351|566352167|FG000|Part A|Death|0|||
156888620|NCT02093351|566352168|FG001|Part A|Death|1|||
156888621|NCT02093351|566352169|FG002|Part A|Death|0|||
156888622|NCT02093351|566352170|FG003|Part A|Death|0|||
156888623|NCT02093351|566352167|FG000|Part B|Patient decision|0|||
156888624|NCT02093351|566352168|FG001|Part B|Patient decision|0|||
156888625|NCT02093351|566352169|FG002|Part B|Patient decision|0|||
156888626|NCT02093351|566352170|FG003|Part B|Patient decision|3|||
156888627|NCT02093351|566352167|FG000|Part B|Disease progression|0|||
156888628|NCT02093351|566352168|FG001|Part B|Disease progression|0|||
156888629|NCT02093351|566352169|FG002|Part B|Disease progression|0|||
156888630|NCT02093351|566352170|FG003|Part B|Disease progression|4|||
156888631|NCT02093351|566352167|FG000|Part B|Complete response|0|||
156888632|NCT02093351|566352168|FG001|Part B|Complete response|0|||
156888633|NCT02093351|566352169|FG002|Part B|Complete response|0|||
156888634|NCT02093351|566352170|FG003|Part B|Complete response|1|||
156888635|NCT02093351|566352167|FG000|Part B|Adverse event + disease progression|0|||
156888636|NCT02093351|566352168|FG001|Part B|Adverse event + disease progression|0|||
156888637|NCT02093351|566352169|FG002|Part B|Adverse event + disease progression|0|||
156888638|NCT02093351|566352170|FG003|Part B|Adverse event + disease progression|1|||
156888639|NCT02093351|566352167|FG000|Part B|Lack of therapeutic response|0|||
156888640|NCT02093351|566352168|FG001|Part B|Lack of therapeutic response|0|||
156888641|NCT02093351|566352169|FG002|Part B|Lack of therapeutic response|0|||
156888642|NCT02093351|566352170|FG003|Part B|Lack of therapeutic response|12|||
156888643|NCT02093351|566352167|FG000|Part B|Condition under investigation worsened|0|||
156888644|NCT02093351|566352168|FG001|Part B|Condition under investigation worsened|0|||
156888645|NCT02093351|566352169|FG002|Part B|Condition under investigation worsened|0|||
156888646|NCT02093351|566352170|FG003|Part B|Condition under investigation worsened|39|||
156888647|NCT02093351|566352167|FG000|Part B|Adverse Event|0|||
157155694|NCT01544595|567314314|FG003|Status at Week 68|Protocol Violation|1|||
157155695|NCT01544595|567314315|FG004|Status at Week 68|Protocol Violation|0|||
157155696|NCT01544595|567314316|FG005|Status at Week 68|Protocol Violation|0|||
156849722|NCT01594931|566203016|FG002|Overall Study|Lost to Follow-up|3|||
156888648|NCT02093351|566352168|FG001|Part B|Adverse Event|0|||
156888649|NCT02093351|566352169|FG002|Part B|Adverse Event|0|||
157155697|NCT01544595|567314311|FG000|Status at Week 68|Technical problems|1|||
156849723|NCT01594931|566203014|FG000|Overall Study|Protocol Violation|2|||
156888650|NCT02093351|566352170|FG003|Part B|Adverse Event|2|||
156888651|NCT02093351|566352167|FG000|Part B|Death|0|||
156888652|NCT02093351|566352168|FG001|Part B|Death|0|||
156888653|NCT02093351|566352169|FG002|Part B|Death|0|||
156888654|NCT02093351|566352170|FG003|Part B|Death|1|||
156888655|NCT03565367|566352171|FG000|Overall Study|No scan due to technical issues|4|||
156888656|NCT03565367|566352172|FG001|Overall Study|No scan due to technical issues|0|||
156888657|NCT00706849|566352177|FG000|Treatment Period|Adverse Event|0|||
156888658|NCT00706849|566352178|FG001|Treatment Period|Adverse Event|9|||
157155698|NCT01544595|567314312|FG001|Status at Week 68|Technical problems|0|||
156849724|NCT01594931|566203015|FG001|Overall Study|Protocol Violation|1|||
156849725|NCT01594931|566203016|FG002|Overall Study|Protocol Violation|0|||
156849726|NCT01594931|566203014|FG000|Overall Study|No defiined|11|||
156849727|NCT01594931|566203015|FG001|Overall Study|No defiined|4|||
156849728|NCT01594931|566203016|FG002|Overall Study|No defiined|7|||
156849729|NCT01525615|566203019|FG000|Overall Study|Adverse Event|11|||
156849730|NCT01525615|566203020|FG001|Overall Study|Adverse Event|7|||
156849731|NCT01525615|566203021|FG002|Overall Study|Adverse Event|5|||
156849732|NCT01525615|566203019|FG000|Overall Study|Lost to Follow-up|1|||
156849733|NCT01525615|566203020|FG001|Overall Study|Lost to Follow-up|0|||
156849734|NCT01525615|566203021|FG002|Overall Study|Lost to Follow-up|0|||
156849735|NCT01525615|566203019|FG000|Overall Study|Withdrawal by Subject|1|||
156849736|NCT01525615|566203020|FG001|Overall Study|Withdrawal by Subject|0|||
156849737|NCT01525615|566203021|FG002|Overall Study|Withdrawal by Subject|0|||
156849738|NCT01525615|566203019|FG000|Overall Study|Other reason not described above|1|||
156849739|NCT01525615|566203020|FG001|Overall Study|Other reason not described above|0|||
156849740|NCT01525615|566203021|FG002|Overall Study|Other reason not described above|1|||
156849741|NCT04050618|566203022|FG000|First Intervention|Withdrawal by Subject|2|||
156849742|NCT04050618|566203023|FG001|First Intervention|Withdrawal by Subject|0|||
156849743|NCT04050618|566203022|FG000|Second Intervention|Withdrawal by Subject|1|||
156849744|NCT04050618|566203023|FG001|Second Intervention|Withdrawal by Subject|0|||
156849745|NCT01101035|566203029|FG000|Overall Study|Adverse Event|191|||
156849746|NCT01101035|566203030|FG001|Overall Study|Adverse Event|172|||
156849747|NCT01101035|566203029|FG000|Overall Study|Major Protocol Deviation|52|||
156849748|NCT01101035|566203030|FG001|Overall Study|Major Protocol Deviation|46|||
156849749|NCT01101035|566203029|FG000|Overall Study|Lost to Follow-up|226|||
156849750|NCT01101035|566203030|FG001|Overall Study|Lost to Follow-up|223|||
156849751|NCT01101035|566203029|FG000|Overall Study|Voluntary Withdrawal|595|||
156849752|NCT01101035|566203030|FG001|Overall Study|Voluntary Withdrawal|587|||
156849753|NCT01101035|566203029|FG000|Overall Study|Reason not Specified|333|||
156849754|NCT01101035|566203030|FG001|Overall Study|Reason not Specified|363|||
156849755|NCT00217425|566203035|FG000|Overall Study|Never started treatment|2|||
156849756|NCT00217425|566203035|FG000|Overall Study|Patient ineligible|5|||
156849757|NCT00217425|566203035|FG000|Overall Study|Lack of Efficacy|13|||
156849758|NCT00217425|566203035|FG000|Overall Study|Adverse Event|8|||
156849759|NCT00217425|566203035|FG000|Overall Study|Withdrawal by Subject|4|||
156849760|NCT00217425|566203035|FG000|Overall Study|Other complicating disease|1|||
156849761|NCT00217425|566203035|FG000|Overall Study|Other|4|||
156849762|NCT00671034|566203037|FG000|Overall Study|Adverse Event|5|||
156849763|NCT00671034|566203038|FG001|Overall Study|Adverse Event|7|||
156849764|NCT00671034|566203039|FG002|Overall Study|Adverse Event|1|||
156849765|NCT00671034|566203037|FG000|Overall Study|Death|3|||
156849766|NCT00671034|566203038|FG001|Overall Study|Death|2|||
156849767|NCT00671034|566203039|FG002|Overall Study|Death|1|||
156849768|NCT00671034|566203037|FG000|Overall Study|Physician Decision|12|||
156849769|NCT00671034|566203038|FG001|Overall Study|Physician Decision|4|||
156849770|NCT00671034|566203039|FG002|Overall Study|Physician Decision|5|||
156849771|NCT00671034|566203037|FG000|Overall Study|VHR ALL feature|8|||
156849772|NCT00671034|566203038|FG001|Overall Study|VHR ALL feature|3|||
156849773|NCT00671034|566203039|FG002|Overall Study|VHR ALL feature|5|||
156849774|NCT00671034|566203037|FG000|Overall Study|Refusal|5|||
156849775|NCT00671034|566203038|FG001|Overall Study|Refusal|3|||
156849776|NCT00671034|566203039|FG002|Overall Study|Refusal|5|||
156849777|NCT00671034|566203037|FG000|Overall Study|includes Alternative therapy, etc.|6|||
156849778|NCT00671034|566203038|FG001|Overall Study|includes Alternative therapy, etc.|1|||
156849779|NCT00671034|566203039|FG002|Overall Study|includes Alternative therapy, etc.|7|||
156849780|NCT00713544|566203040|FG000|Overall Study|Adverse Event|5|||
156849781|NCT00713544|566203041|FG001|Overall Study|Adverse Event|3|||
156849782|NCT00713544|566203042|FG002|Overall Study|Adverse Event|7|||
156849783|NCT00713544|566203043|FG003|Overall Study|Adverse Event|7|||
156849784|NCT00713544|566203044|FG004|Overall Study|Adverse Event|3|||
156849785|NCT00713544|566203045|FG005|Overall Study|Adverse Event|5|||
156849786|NCT00713544|566203040|FG000|Overall Study|Withdrawal by Subject|2|||
156888659|NCT00706849|566352177|FG000|Treatment Period|Other|0|||
157025574|NCT05949788|566847984|FG000|Overall Study|death within 14 days after birth|2|||
157025575|NCT05949788|566847985|FG001|Overall Study|death within 14 days after birth|6|||
156849787|NCT00713544|566203041|FG001|Overall Study|Withdrawal by Subject|0|||
156849788|NCT00713544|566203042|FG002|Overall Study|Withdrawal by Subject|3|||
156849789|NCT00713544|566203043|FG003|Overall Study|Withdrawal by Subject|2|||
157025576|NCT05949788|566847984|FG000|Overall Study|transfer to another hospital|2|||
157025577|NCT05949788|566847985|FG001|Overall Study|transfer to another hospital|6|||
156888660|NCT00706849|566352178|FG001|Treatment Period|Other|1|||
156849790|NCT00713544|566203044|FG004|Overall Study|Withdrawal by Subject|3|||
156849791|NCT00713544|566203045|FG005|Overall Study|Withdrawal by Subject|1|||
156849792|NCT00713544|566203040|FG000|Overall Study|Protocol Violation|0|||
156849793|NCT00713544|566203041|FG001|Overall Study|Protocol Violation|0|||
156849794|NCT00713544|566203042|FG002|Overall Study|Protocol Violation|0|||
156849795|NCT00713544|566203043|FG003|Overall Study|Protocol Violation|0|||
156849796|NCT00713544|566203044|FG004|Overall Study|Protocol Violation|0|||
156849797|NCT00713544|566203045|FG005|Overall Study|Protocol Violation|1|||
156849798|NCT00713544|566203040|FG000|Overall Study|Physician Decision|0|||
156849799|NCT00713544|566203041|FG001|Overall Study|Physician Decision|0|||
156849800|NCT00713544|566203042|FG002|Overall Study|Physician Decision|0|||
156849801|NCT00713544|566203043|FG003|Overall Study|Physician Decision|0|||
156849802|NCT00713544|566203044|FG004|Overall Study|Physician Decision|0|||
156849803|NCT00713544|566203045|FG005|Overall Study|Physician Decision|2|||
156849804|NCT00713544|566203040|FG000|Overall Study|Lack of Efficacy|0|||
156849805|NCT00713544|566203041|FG001|Overall Study|Lack of Efficacy|1|||
156849806|NCT00713544|566203042|FG002|Overall Study|Lack of Efficacy|0|||
156849807|NCT00713544|566203043|FG003|Overall Study|Lack of Efficacy|1|||
156849808|NCT00713544|566203044|FG004|Overall Study|Lack of Efficacy|1|||
156849809|NCT00713544|566203045|FG005|Overall Study|Lack of Efficacy|0|||
156849810|NCT00713544|566203040|FG000|Overall Study|Lost to Follow-up|0|||
156849811|NCT00713544|566203041|FG001|Overall Study|Lost to Follow-up|0|||
156849812|NCT00713544|566203042|FG002|Overall Study|Lost to Follow-up|1|||
156849813|NCT00713544|566203043|FG003|Overall Study|Lost to Follow-up|0|||
156849814|NCT00713544|566203044|FG004|Overall Study|Lost to Follow-up|0|||
156849815|NCT00713544|566203045|FG005|Overall Study|Lost to Follow-up|0|||
156849816|NCT00713544|566203040|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849817|NCT00713544|566203041|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
156849818|NCT00713544|566203042|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849819|NCT00713544|566203043|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849820|NCT00713544|566203044|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849821|NCT00713544|566203045|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
156849822|NCT00713544|566203040|FG000|Overall Study|Incorrect enrollment|0|||
156849823|NCT00713544|566203041|FG001|Overall Study|Incorrect enrollment|1|||
156849824|NCT00713544|566203042|FG002|Overall Study|Incorrect enrollment|0|||
156849825|NCT00713544|566203043|FG003|Overall Study|Incorrect enrollment|0|||
156849826|NCT00713544|566203044|FG004|Overall Study|Incorrect enrollment|0|||
156849827|NCT00713544|566203045|FG005|Overall Study|Incorrect enrollment|0|||
156849828|NCT00713544|566203040|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
156849829|NCT00713544|566203041|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
156849830|NCT00713544|566203042|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
156849831|NCT00713544|566203043|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
156849832|NCT00713544|566203044|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
156849833|NCT00713544|566203045|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
156849834|NCT00269919|566203046|FG000|Overall Study|Other|26|||
156849835|NCT00269919|566203046|FG000|Overall Study|Started but not treated|1|||
156849836|NCT00786799|566203047|FG000|Overall Study|Lost to Follow-up|1|||
156849837|NCT00786799|566203048|FG001|Overall Study|Lost to Follow-up|1|||
156849838|NCT02544503|566203049|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
156849839|NCT02544503|566203050|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
156849840|NCT02544503|566203049|FG000|Overall Study|Lost to Follow-up|9|||
156849841|NCT02544503|566203050|FG001|Overall Study|Lost to Follow-up|0|||
156849842|NCT02544503|566203049|FG000|Overall Study|Withdrawal by Subject|1|||
156849843|NCT02544503|566203050|FG001|Overall Study|Withdrawal by Subject|0|||
156849844|NCT02380287|566203051|FG000|Overall Study|Adverse Event|0|||
156849845|NCT02380287|566203052|FG001|Overall Study|Adverse Event|0|||
156849846|NCT02380287|566203053|FG002|Overall Study|Adverse Event|1|||
156849847|NCT02380287|566203054|FG003|Overall Study|Adverse Event|0|||
156849848|NCT02380287|566203055|FG004|Overall Study|Adverse Event|0|||
156849849|NCT02380287|566203056|FG005|Overall Study|Adverse Event|0|||
156849850|NCT02380287|566203057|FG006|Overall Study|Adverse Event|0|||
156849851|NCT02380287|566203058|FG007|Overall Study|Adverse Event|0|||
156849852|NCT04473963|566203059|FG000|Overall Study|Withdrawal by Subject|1|||
156849853|NCT04473963|566203060|FG001|Overall Study|Withdrawal by Subject|1|||
156849854|NCT04473963|566203061|FG002|Overall Study|Withdrawal by Subject|0|||
157155699|NCT01544595|567314313|FG002|Status at Week 68|Technical problems|0|||
156849855|NCT04473963|566203059|FG000|Overall Study|Not inducible in AF|0|||
156849856|NCT04473963|566203060|FG001|Overall Study|Not inducible in AF|0|||
156849857|NCT04473963|566203061|FG002|Overall Study|Not inducible in AF|2|||
156849858|NCT01550757|566203062|FG000|Overall Study|Lost to Follow-up|21|||
156849859|NCT01550757|566203063|FG001|Overall Study|Lost to Follow-up|14|||
156849860|NCT01550757|566203064|FG002|Overall Study|Lost to Follow-up|42|||
156849861|NCT01550757|566203065|FG003|Overall Study|Lost to Follow-up|53|||
156849862|NCT01550757|566203062|FG000|Overall Study|Withdrawal by Subject|2|||
157025578|NCT05213390|566847986|FG000|Overall Study|Withdrawal by Subject|2|||
157155700|NCT01544595|567314314|FG003|Status at Week 68|Technical problems|1|||
156849863|NCT01550757|566203063|FG001|Overall Study|Withdrawal by Subject|0|||
156849864|NCT01550757|566203064|FG002|Overall Study|Withdrawal by Subject|3|||
156849865|NCT01550757|566203065|FG003|Overall Study|Withdrawal by Subject|1|||
156849866|NCT01426958|566203066|FG000|Overall Study|Adverse Event|2|||
156849867|NCT00855816|566203071|FG000|Overall Study|Withdrawal by Subject|22|||
156849868|NCT00855816|566203072|FG001|Overall Study|Withdrawal by Subject|15|||
156849869|NCT00855816|566203071|FG000|Overall Study|Lost to Follow-up|3|||
156849870|NCT00855816|566203072|FG001|Overall Study|Lost to Follow-up|5|||
156849871|NCT00855816|566203071|FG000|Overall Study|Death|1|||
156849872|NCT00855816|566203072|FG001|Overall Study|Death|0|||
156849873|NCT00855816|566203071|FG000|Overall Study|Became ineligible|0|||
156849874|NCT00855816|566203072|FG001|Overall Study|Became ineligible|1|||
156849875|NCT01965704|566203073|FG000|Overall Study|Withdrawal by Subject|2|||
156849876|NCT01965704|566203074|FG001|Overall Study|Withdrawal by Subject|2|||
156849877|NCT01965704|566203075|FG002|Overall Study|Withdrawal by Subject|1|||
156849878|NCT01965704|566203076|FG003|Overall Study|Withdrawal by Subject|1|||
156849879|NCT01965704|566203073|FG000|Overall Study|Delivered at home|1|||
156849880|NCT01965704|566203074|FG001|Overall Study|Delivered at home|1|||
156849881|NCT01965704|566203075|FG002|Overall Study|Delivered at home|0|||
156849882|NCT01965704|566203076|FG003|Overall Study|Delivered at home|0|||
156849883|NCT01965704|566203073|FG000|Overall Study|Experienced complications|0|||
156849884|NCT01965704|566203074|FG001|Overall Study|Experienced complications|0|||
156849885|NCT01965704|566203075|FG002|Overall Study|Experienced complications|2|||
156849886|NCT01965704|566203076|FG003|Overall Study|Experienced complications|2|||
156849887|NCT01965704|566203073|FG000|Overall Study|Adverse Event|0|||
156849888|NCT01965704|566203074|FG001|Overall Study|Adverse Event|0|||
156849889|NCT01965704|566203075|FG002|Overall Study|Adverse Event|1|||
156849890|NCT01965704|566203076|FG003|Overall Study|Adverse Event|1|||
156849891|NCT01965704|566203073|FG000|Overall Study|Did not meet inclusion criteria|0|||
156849892|NCT01965704|566203074|FG001|Overall Study|Did not meet inclusion criteria|0|||
156849893|NCT01965704|566203075|FG002|Overall Study|Did not meet inclusion criteria|1|||
156849894|NCT01965704|566203076|FG003|Overall Study|Did not meet inclusion criteria|1|||
156849895|NCT03672292|566203082|FG000|Overall Study|Adverse Event|3|||
156849896|NCT03672292|566203083|FG001|Overall Study|Adverse Event|1|||
156849897|NCT03672292|566203082|FG000|Overall Study|Physician Decision|0|||
156849898|NCT03672292|566203083|FG001|Overall Study|Physician Decision|1|||
156849899|NCT03672292|566203082|FG000|Overall Study|Withdrawal by Subject|1|||
156849900|NCT03672292|566203083|FG001|Overall Study|Withdrawal by Subject|2|||
156849901|NCT00799903|566203084|FG000|Overall Study|Investigator Site Closed|25|||
156849902|NCT00799903|566203085|FG001|Overall Study|Investigator Site Closed|23|||
156849903|NCT00799903|566203084|FG000|Overall Study|Withdrawal by Subject|179|||
156849904|NCT00799903|566203085|FG001|Overall Study|Withdrawal by Subject|175|||
156849905|NCT00799903|566203084|FG000|Overall Study|Lost to Follow-up|69|||
156849906|NCT00799903|566203085|FG001|Overall Study|Lost to Follow-up|80|||
156849907|NCT03088917|566203086|FG000|Overall Study|In care/cured elsewhere|15|||
156849908|NCT03088917|566203086|FG000|Overall Study|Refuse re-evaluation|13|||
156849909|NCT03088917|566203086|FG000|Overall Study|Contact not established|13|||
156849910|NCT03088917|566203086|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
156849911|NCT03088917|566203086|FG000|Overall Study|Moved outside study region|50|||
156849912|NCT02524171|566203087|FG000|6-month Follow-up|Lost to Follow-up|53|||
156849913|NCT02524171|566203088|FG001|6-month Follow-up|Lost to Follow-up|45|||
156849914|NCT02524171|566203087|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
156849915|NCT02524171|566203088|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
156849916|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Progressive disease|50|||
156849917|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Progressive disease|110|||
156849918|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Progressive disease|0|||
156849919|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Progressive disease|0|||
156849920|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156849921|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
156849922|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156849923|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156849924|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Adverse Event|7|||
156849925|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Adverse Event|7|||
156849926|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156849927|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Adverse Event|0|||
156849928|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Other|1|||
156849929|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Other|3|||
156849930|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Other|0|||
156849931|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Other|0|||
156849932|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Physician Decision|6|||
156849933|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Physician Decision|3|||
156849934|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Physician Decision|0|||
156849935|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Physician Decision|0|||
156849936|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Death|1|||
156849937|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Death|1|||
156849938|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Death|0|||
156849939|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Death|0|||
156849940|NCT01695135|566203091|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849941|NCT01695135|566203092|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
156849942|NCT01695135|566203093|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849943|NCT01695135|566203094|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
156849944|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
156849945|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
156849946|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
156849947|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
156849948|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
156849949|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
156849950|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
156849951|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
156849952|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
156849953|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
156849954|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
156849955|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
156849956|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Other|0|||
156849957|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Other|0|||
156849958|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Other|4|||
156849959|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Other|7|||
156849960|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
156849961|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
156849962|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
156849963|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
156849964|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Death|0|||
156849965|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Death|0|||
156849966|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Death|2|||
156849967|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Death|7|||
156849968|NCT01695135|566203091|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849969|NCT01695135|566203092|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849970|NCT01695135|566203093|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
156849971|NCT01695135|566203094|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
156849972|NCT02753946|566203097|FG000|Overall Study|Adverse Event|7|||
156849973|NCT02753946|566203098|FG001|Overall Study|Adverse Event|6|||
156849974|NCT02753946|566203097|FG000|Overall Study|Withdrawal by Subject|6|||
156849975|NCT02753946|566203098|FG001|Overall Study|Withdrawal by Subject|1|||
156849976|NCT02753946|566203097|FG000|Overall Study|Lack of Efficacy|1|||
156849977|NCT02753946|566203098|FG001|Overall Study|Lack of Efficacy|0|||
156849978|NCT02753946|566203097|FG000|Overall Study|Physician Decision|0|||
156849979|NCT02753946|566203098|FG001|Overall Study|Physician Decision|2|||
156849980|NCT02868554|566203103|FG000|Overall Study|Lost to Follow-up|3|||
156849981|NCT02868554|566203104|FG001|Overall Study|Lost to Follow-up|0|||
156849982|NCT02868554|566203105|FG002|Overall Study|Lost to Follow-up|1|||
156849983|NCT00216671|566203106|FG000|Overall Study|Adverse Event|4|||
156849984|NCT00216671|566203107|FG001|Overall Study|Adverse Event|9|||
156849985|NCT00216671|566203106|FG000|Overall Study|Pregnancy|0|||
156849986|NCT00216671|566203107|FG001|Overall Study|Pregnancy|1|||
156849987|NCT00216671|566203106|FG000|Overall Study|Withdrawal by Subject|4|||
156849988|NCT00216671|566203107|FG001|Overall Study|Withdrawal by Subject|2|||
156849989|NCT00216671|566203106|FG000|Overall Study|Refused Injections|3|||
156849990|NCT00216671|566203107|FG001|Overall Study|Refused Injections|13|||
156849991|NCT00216671|566203106|FG000|Overall Study|No Need to Continue Medication|1|||
156849992|NCT00216671|566203107|FG001|Overall Study|No Need to Continue Medication|1|||
156849993|NCT00216671|566203106|FG000|Overall Study|Insufficient Response|9|||
156849994|NCT00216671|566203107|FG001|Overall Study|Insufficient Response|4|||
156849995|NCT00216671|566203106|FG000|Overall Study|Lost to Follow-up|3|||
156849996|NCT00216671|566203107|FG001|Overall Study|Lost to Follow-up|5|||
156849997|NCT00216671|566203106|FG000|Overall Study|Non compliant|2|||
156849998|NCT00216671|566203107|FG001|Overall Study|Non compliant|2|||
156849999|NCT00216671|566203106|FG000|Overall Study|Ineligible|0|||
156850000|NCT00216671|566203107|FG001|Overall Study|Ineligible|2|||
156850001|NCT00216671|566203106|FG000|Overall Study|Physician Decision|1|||
156850002|NCT00216671|566203107|FG001|Overall Study|Physician Decision|1|||
156850003|NCT00216671|566203106|FG000|Overall Study|Protocol Violation|3|||
156850004|NCT00216671|566203107|FG001|Overall Study|Protocol Violation|5|||
156850005|NCT00216671|566203106|FG000|Overall Study|Relapse|1|||
156850006|NCT00216671|566203107|FG001|Overall Study|Relapse|0|||
156850007|NCT00216671|566203106|FG000|Overall Study|Investigator Illness|0|||
157025579|NCT05213390|566847986|FG000|Overall Study|Lost to Follow-up|12|||
156850008|NCT00216671|566203107|FG001|Overall Study|Investigator Illness|1|||
156850009|NCT00216671|566203106|FG000|Overall Study|Patient Moved|0|||
156850010|NCT00216671|566203107|FG001|Overall Study|Patient Moved|1|||
156850011|NCT00216671|566203106|FG000|Overall Study|Ineligible, no efficacy data|2|||
156850012|NCT00216671|566203107|FG001|Overall Study|Ineligible, no efficacy data|2|||
156850013|NCT00216671|566203106|FG000|Overall Study|Insufficient Response Adverse Event|2|||
156850014|NCT00216671|566203107|FG001|Overall Study|Insufficient Response Adverse Event|1|||
156850015|NCT02714569|566203108|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
157025580|NCT05213390|566847986|FG000|Overall Study|Protocol Violation|9|||
157025581|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
157025582|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
157025583|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
157025584|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
157025585|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
156850016|NCT02714569|566203109|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
156850017|NCT02714569|566203110|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
156850018|NCT02714569|566203111|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
156850019|NCT02714569|566203112|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
156850020|NCT02714569|566203113|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
156850021|NCT02714569|566203114|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
156850022|NCT02714569|566203115|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
156850023|NCT02714569|566203116|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
156850024|NCT02714569|566203117|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
156850025|NCT02714569|566203118|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
156850026|NCT02714569|566203108|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850027|NCT02714569|566203109|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850028|NCT02714569|566203110|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850029|NCT02714569|566203111|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
156850030|NCT02714569|566203112|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850031|NCT02714569|566203113|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850032|NCT02714569|566203114|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850033|NCT02714569|566203115|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850034|NCT02714569|566203116|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850035|NCT02714569|566203117|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850036|NCT02714569|566203118|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
156850037|NCT02714569|566203108|FG000|Part A Third Intervention|Adverse Event|0|||
156850038|NCT02714569|566203109|FG001|Part A Third Intervention|Adverse Event|0|||
156850039|NCT02714569|566203110|FG002|Part A Third Intervention|Adverse Event|1|||
156850040|NCT02714569|566203111|FG003|Part A Third Intervention|Adverse Event|0|||
156850041|NCT02714569|566203112|FG004|Part A Third Intervention|Adverse Event|0|||
156850042|NCT02714569|566203113|FG005|Part A Third Intervention|Adverse Event|0|||
156850043|NCT02714569|566203114|FG006|Part A Third Intervention|Adverse Event|0|||
156850044|NCT02714569|566203115|FG007|Part A Third Intervention|Adverse Event|0|||
156850045|NCT02714569|566203116|FG008|Part A Third Intervention|Adverse Event|0|||
156850046|NCT02714569|566203117|FG009|Part A Third Intervention|Adverse Event|0|||
156850047|NCT02714569|566203118|FG010|Part A Third Intervention|Adverse Event|0|||
156888661|NCT00706849|566352177|FG000|Follow-up Period|Withdrawal by Subject|0|||
156888662|NCT00706849|566352178|FG001|Follow-up Period|Withdrawal by Subject|2|||
156888663|NCT00706849|566352177|FG000|Follow-up Period|Protocol non-compliance|0|||
156888664|NCT00706849|566352178|FG001|Follow-up Period|Protocol non-compliance|1|||
156888665|NCT00920907|566352179|FG000|Induction Period|Adverse Event|0|||
156888666|NCT00920907|566352180|FG001|Induction Period|Adverse Event|2|||
156888667|NCT00920907|566352179|FG000|Induction Period|Death|1|||
156888668|NCT00920907|566352180|FG001|Induction Period|Death|1|||
156888669|NCT00920907|566352179|FG000|Induction Period|Disease Progression|12|||
156888670|NCT00920907|566352180|FG001|Induction Period|Disease Progression|11|||
156888671|NCT00920907|566352179|FG000|Induction Period|Study Drug Toxicity|8|||
156888672|NCT00920907|566352180|FG001|Induction Period|Study Drug Toxicity|6|||
157025586|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
157025587|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
157025588|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
157025589|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
157025590|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
157025591|NCT03461276|566847989|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
157025592|NCT03461276|566847990|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
157025593|NCT03461276|566847989|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
157025594|NCT03461276|566847990|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
157025595|NCT03461276|566847989|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
157025596|NCT03461276|566847990|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
157025597|NCT03461276|566847989|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
157025598|NCT03461276|566847990|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
157025599|NCT03461276|566847989|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
157225415|NCT00421174|567571420|FG000|Overall Study|Withdrawal by Subject|0|||
156850048|NCT02714569|566203108|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
156850049|NCT02714569|566203109|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156888673|NCT00920907|566352179|FG000|Induction Period|No longer meets study criteria|0|||
156888674|NCT00920907|566352180|FG001|Induction Period|No longer meets study criteria|1|||
156850050|NCT02714569|566203110|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850051|NCT02714569|566203111|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850052|NCT02714569|566203112|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850053|NCT02714569|566203113|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
156850054|NCT02714569|566203114|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850055|NCT02714569|566203115|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850056|NCT02714569|566203116|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850057|NCT02714569|566203117|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850058|NCT02714569|566203118|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
156850059|NCT02714569|566203108|FG000|Part B (Overall)|Lost to Follow-up|0|||
156850060|NCT02714569|566203109|FG001|Part B (Overall)|Lost to Follow-up|0|||
156850061|NCT02714569|566203110|FG002|Part B (Overall)|Lost to Follow-up|0|||
156850062|NCT02714569|566203111|FG003|Part B (Overall)|Lost to Follow-up|0|||
156850063|NCT02714569|566203112|FG004|Part B (Overall)|Lost to Follow-up|0|||
156850064|NCT02714569|566203113|FG005|Part B (Overall)|Lost to Follow-up|0|||
156850065|NCT02714569|566203114|FG006|Part B (Overall)|Lost to Follow-up|1|||
156850066|NCT02714569|566203115|FG007|Part B (Overall)|Lost to Follow-up|0|||
156850067|NCT02714569|566203116|FG008|Part B (Overall)|Lost to Follow-up|0|||
156850068|NCT02714569|566203117|FG009|Part B (Overall)|Lost to Follow-up|0|||
156850069|NCT02714569|566203118|FG010|Part B (Overall)|Lost to Follow-up|0|||
156850070|NCT02714569|566203108|FG000|Part B (Overall)|Withdrawal by Subject|0|||
156850071|NCT02714569|566203109|FG001|Part B (Overall)|Withdrawal by Subject|0|||
156850072|NCT02714569|566203110|FG002|Part B (Overall)|Withdrawal by Subject|0|||
156850073|NCT02714569|566203111|FG003|Part B (Overall)|Withdrawal by Subject|0|||
156850074|NCT02714569|566203112|FG004|Part B (Overall)|Withdrawal by Subject|0|||
156850075|NCT02714569|566203113|FG005|Part B (Overall)|Withdrawal by Subject|0|||
156850076|NCT02714569|566203114|FG006|Part B (Overall)|Withdrawal by Subject|0|||
156850077|NCT02714569|566203115|FG007|Part B (Overall)|Withdrawal by Subject|1|||
156850078|NCT02714569|566203116|FG008|Part B (Overall)|Withdrawal by Subject|0|||
156850079|NCT02714569|566203117|FG009|Part B (Overall)|Withdrawal by Subject|1|||
156850080|NCT02714569|566203118|FG010|Part B (Overall)|Withdrawal by Subject|0|||
156850081|NCT02714569|566203108|FG000|Part B (Overall)|Adverse Event|0|||
156850082|NCT02714569|566203109|FG001|Part B (Overall)|Adverse Event|0|||
156850083|NCT02714569|566203110|FG002|Part B (Overall)|Adverse Event|0|||
156850084|NCT02714569|566203111|FG003|Part B (Overall)|Adverse Event|0|||
156850085|NCT02714569|566203112|FG004|Part B (Overall)|Adverse Event|0|||
156850086|NCT02714569|566203113|FG005|Part B (Overall)|Adverse Event|0|||
156850087|NCT02714569|566203114|FG006|Part B (Overall)|Adverse Event|0|||
156850088|NCT02714569|566203115|FG007|Part B (Overall)|Adverse Event|0|||
156850089|NCT02714569|566203116|FG008|Part B (Overall)|Adverse Event|0|||
156850090|NCT02714569|566203117|FG009|Part B (Overall)|Adverse Event|1|||
156850091|NCT02714569|566203118|FG010|Part B (Overall)|Adverse Event|0|||
156850092|NCT00226811|566203122|FG000|Overall Study|Death|8|||
156850093|NCT00226811|566203122|FG000|Overall Study|Adverse Event|11|||
156850094|NCT00226811|566203122|FG000|Overall Study|Lack of Efficacy|55|||
156850095|NCT00226811|566203122|FG000|Overall Study|Withdrawal by Subject|2|||
156850096|NCT01633541|566203130|FG000|Overall Study|Death|1|||
156850097|NCT01633541|566203131|FG001|Overall Study|Death|0|||
156850098|NCT01010971|566203132|FG000|Overall Study|Adverse Event|2|||
156850099|NCT01010971|566203133|FG001|Overall Study|Adverse Event|4|||
156888675|NCT00920907|566352179|FG000|Induction Period|Withdrawal by Subject|1|||
156888676|NCT00920907|566352180|FG001|Induction Period|Withdrawal by Subject|1|||
156888677|NCT00920907|566352179|FG000|Maintenance Period|Disease Progression|3|||
156888678|NCT00920907|566352180|FG001|Maintenance Period|Disease Progression|7|||
156888679|NCT00920907|566352179|FG000|Maintenance Period|Administrative (study closure)|7|||
156888680|NCT00920907|566352180|FG001|Maintenance Period|Administrative (study closure)|2|||
156888681|NCT00920907|566352179|FG000|Maintenance Period|Study Drug Toxicity|0|||
156888682|NCT00920907|566352180|FG001|Maintenance Period|Study Drug Toxicity|2|||
156888683|NCT00920907|566352179|FG000|Maintenance Period|Death|1|||
157155701|NCT01544595|567314315|FG004|Status at Week 68|Technical problems|0|||
157155702|NCT01544595|567314316|FG005|Status at Week 68|Technical problems|0|||
156850100|NCT01010971|566203134|FG002|Overall Study|Adverse Event|3|||
156850101|NCT01010971|566203132|FG000|Overall Study|Withdrawal by Subject|0|||
156850102|NCT01010971|566203133|FG001|Overall Study|Withdrawal by Subject|2|||
156850103|NCT01010971|566203134|FG002|Overall Study|Withdrawal by Subject|5|||
156850104|NCT01010971|566203132|FG000|Overall Study|Lost to Follow-up|0|||
157025600|NCT03461276|566847990|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
156850105|NCT01010971|566203133|FG001|Overall Study|Lost to Follow-up|2|||
156850106|NCT01010971|566203134|FG002|Overall Study|Lost to Follow-up|3|||
156850107|NCT01010971|566203132|FG000|Overall Study|Other|1|||
156850108|NCT01010971|566203133|FG001|Overall Study|Other|0|||
156888684|NCT00920907|566352180|FG001|Maintenance Period|Death|1|||
156850109|NCT01010971|566203134|FG002|Overall Study|Other|2|||
156850110|NCT05447663|566203135|FG000|Overall Study|Study terminated by Sponsor|5|||
157025601|NCT01943409|566847995|FG000|Overall Study|resumed oral/entral|24|||
157155703|NCT01544595|567314311|FG000|Status at Week 68|Withdrawal by Subject|0|||
157025602|NCT01943409|566847996|FG001|Overall Study|resumed oral/entral|20|||
157025603|NCT01943409|566847995|FG000|Overall Study|Protocol Violation|14|||
157025604|NCT01943409|566847996|FG001|Overall Study|Protocol Violation|24|||
157025605|NCT01943409|566847995|FG000|Overall Study|Death|3|||
157025606|NCT01943409|566847996|FG001|Overall Study|Death|1|||
157025607|NCT01943409|566847995|FG000|Overall Study|Withdrawal by Subject|4|||
157025608|NCT01943409|566847996|FG001|Overall Study|Withdrawal by Subject|3|||
157025609|NCT04542317|566847997|FG000|Overall Study|Care recipients passed away|18|||
157025610|NCT04542317|566847998|FG001|Overall Study|Care recipients passed away|13|||
157025611|NCT04542317|566847997|FG000|Overall Study|No longer a primary caregiver|5|||
156850111|NCT05447663|566203135|FG000|Overall Study|Death|2|||
156850112|NCT05447663|566203135|FG000|Overall Study|Withdrawal by Subject|1|||
156850113|NCT01100320|566203136|FG000|Period 1|Withdrawal by Subject|2|||
156850114|NCT01100320|566203137|FG001|Period 1|Withdrawal by Subject|4|||
156850115|NCT01100320|566203136|FG000|Period 1|Positive Drug Screen|1|||
156850116|NCT01100320|566203137|FG001|Period 1|Positive Drug Screen|1|||
156850117|NCT01100320|566203136|FG000|Period 1|Adverse Event|2|||
156850118|NCT01100320|566203137|FG001|Period 1|Adverse Event|2|||
156850119|NCT01100320|566203136|FG000|Period 2|Withdrawal by Subject|1|||
156850120|NCT01100320|566203137|FG001|Period 2|Withdrawal by Subject|1|||
156850121|NCT04181762|566203138|FG000|Overall Study|Adverse Event|1|||
156850122|NCT04181762|566203139|FG001|Overall Study|Adverse Event|3|||
156850123|NCT04181762|566203138|FG000|Overall Study|Lost to Follow-up|1|||
156850124|NCT04181762|566203139|FG001|Overall Study|Lost to Follow-up|1|||
156850125|NCT04181762|566203138|FG000|Overall Study|Physician Decision|1|||
156850126|NCT04181762|566203139|FG001|Overall Study|Physician Decision|3|||
156850127|NCT04181762|566203138|FG000|Overall Study|Pregnancy|0|||
156850128|NCT04181762|566203139|FG001|Overall Study|Pregnancy|1|||
156850129|NCT04181762|566203138|FG000|Overall Study|Lack of Efficacy|2|||
156850130|NCT04181762|566203139|FG001|Overall Study|Lack of Efficacy|2|||
156850131|NCT04181762|566203138|FG000|Overall Study|Study terminated by sponsor|95|||
156850132|NCT04181762|566203139|FG001|Overall Study|Study terminated by sponsor|97|||
156850133|NCT04181762|566203138|FG000|Overall Study|Subject decision|11|||
156850134|NCT04181762|566203139|FG001|Overall Study|Subject decision|4|||
156850135|NCT04181762|566203138|FG000|Overall Study|Death|1|||
156850136|NCT04181762|566203139|FG001|Overall Study|Death|1|||
156850137|NCT04181762|566203138|FG000|Overall Study|Protocol deviation|1|||
156850138|NCT04181762|566203139|FG001|Overall Study|Protocol deviation|0|||
156850139|NCT04181762|566203138|FG000|Overall Study|Withdrawal of informed consent|1|||
156850140|NCT04181762|566203139|FG001|Overall Study|Withdrawal of informed consent|3|||
156850141|NCT04752332|566203144|FG000|Overall Study|Adverse Event|3|||
156850142|NCT04752332|566203145|FG001|Overall Study|Adverse Event|1|||
156850143|NCT04752332|566203144|FG000|Overall Study|Disease Relapse|1|||
156850144|NCT04752332|566203145|FG001|Overall Study|Disease Relapse|0|||
156850145|NCT04752332|566203144|FG000|Overall Study|Non-compliance With Study Drug|2|||
156850146|NCT04752332|566203145|FG001|Overall Study|Non-compliance With Study Drug|0|||
156850147|NCT04752332|566203144|FG000|Overall Study|Physician Decision|2|||
156850148|NCT04752332|566203145|FG001|Overall Study|Physician Decision|1|||
156850149|NCT04752332|566203144|FG000|Overall Study|Protocol Violation|1|||
156850150|NCT04752332|566203145|FG001|Overall Study|Protocol Violation|1|||
156850151|NCT04752332|566203144|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
156850152|NCT04752332|566203145|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
156850153|NCT04752332|566203144|FG000|Overall Study|Study Terminated by Sponsor|10|||
156850154|NCT04752332|566203145|FG001|Overall Study|Study Terminated by Sponsor|48|||
156850155|NCT04752332|566203144|FG000|Overall Study|Withdrawal by Subject|11|||
156850156|NCT04752332|566203145|FG001|Overall Study|Withdrawal by Subject|3|||
157025612|NCT04542317|566847998|FG001|Overall Study|No longer a primary caregiver|1|||
157025613|NCT04542317|566847997|FG000|Overall Study|Withdrawal by Subject|4|||
157025614|NCT04542317|566847998|FG001|Overall Study|Withdrawal by Subject|2|||
157025615|NCT04542317|566847997|FG000|Overall Study|Caregivers passed away|0|||
157025616|NCT04542317|566847998|FG001|Overall Study|Caregivers passed away|2|||
157155704|NCT01544595|567314312|FG001|Status at Week 68|Withdrawal by Subject|1|||
157155705|NCT01544595|567314313|FG002|Status at Week 68|Withdrawal by Subject|1|||
157155706|NCT01544595|567314314|FG003|Status at Week 68|Withdrawal by Subject|2|||
157155707|NCT01544595|567314315|FG004|Status at Week 68|Withdrawal by Subject|0|||
156850157|NCT02915978|566203146|FG000|Overall Study|Adverse Event|2|||
157025617|NCT02310646|566847999|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
157025618|NCT02310646|566848000|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
157155708|NCT01544595|567314316|FG005|Status at Week 68|Withdrawal by Subject|0|||
156850158|NCT02915978|566203147|FG001|Overall Study|Adverse Event|1|||
156850159|NCT02915978|566203148|FG002|Overall Study|Adverse Event|0|||
156850160|NCT00924443|566203149|FG000|Overall Study|Physician Decision|2|||
156850161|NCT00924443|566203149|FG000|Overall Study|Protocol Violation|1|||
156850162|NCT02451124|566203154|FG000|Overall Study|Withdrawal by Subject|1|||
156850163|NCT01248949|566203155|FG000|Overall Study|Lost to Follow-up|2|||
156850164|NCT01248949|566203156|FG001|Overall Study|Lost to Follow-up|2|||
156850165|NCT01248949|566203157|FG002|Overall Study|Lost to Follow-up|2|||
156850166|NCT01248949|566203158|FG003|Overall Study|Lost to Follow-up|1|||
156850167|NCT01248949|566203159|FG004|Overall Study|Lost to Follow-up|0|||
156850168|NCT01248949|566203155|FG000|Overall Study|Withdrawal by Subject|5|||
156850169|NCT01248949|566203156|FG001|Overall Study|Withdrawal by Subject|3|||
156850170|NCT01248949|566203157|FG002|Overall Study|Withdrawal by Subject|11|||
156850171|NCT01248949|566203158|FG003|Overall Study|Withdrawal by Subject|3|||
156850172|NCT01248949|566203159|FG004|Overall Study|Withdrawal by Subject|1|||
156850173|NCT01248949|566203155|FG000|Overall Study|Death|22|||
156850174|NCT01248949|566203156|FG001|Overall Study|Death|7|||
156850175|NCT01248949|566203157|FG002|Overall Study|Death|21|||
156850176|NCT01248949|566203158|FG003|Overall Study|Death|6|||
156850177|NCT01248949|566203159|FG004|Overall Study|Death|2|||
156850178|NCT01248949|566203155|FG000|Overall Study|Alternative Therapy|1|||
157155709|NCT01544595|567314311|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
157155710|NCT01544595|567314312|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
157155711|NCT01544595|567314313|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
157155712|NCT01544595|567314314|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
157155713|NCT01544595|567314315|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
157155714|NCT01544595|567314316|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
157155715|NCT01544595|567314311|FG000|Status at Week 156|Withdrawal by Subject|9|||
157155716|NCT01544595|567314312|FG001|Status at Week 156|Withdrawal by Subject|10|||
157155717|NCT01544595|567314313|FG002|Status at Week 156|Withdrawal by Subject|4|||
157155718|NCT01544595|567314314|FG003|Status at Week 156|Withdrawal by Subject|9|||
157155719|NCT01544595|567314315|FG004|Status at Week 156|Withdrawal by Subject|20|||
157155720|NCT01544595|567314316|FG005|Status at Week 156|Withdrawal by Subject|6|||
157155721|NCT01544595|567314311|FG000|Status at Week 156|Adverse Event|9|||
157155722|NCT01544595|567314312|FG001|Status at Week 156|Adverse Event|11|||
157155723|NCT01544595|567314313|FG002|Status at Week 156|Adverse Event|1|||
157155724|NCT01544595|567314314|FG003|Status at Week 156|Adverse Event|3|||
157155725|NCT01544595|567314315|FG004|Status at Week 156|Adverse Event|4|||
157155726|NCT01544595|567314316|FG005|Status at Week 156|Adverse Event|2|||
157155727|NCT01544595|567314311|FG000|Status at Week 156|Lost to Follow-up|4|||
157155728|NCT01544595|567314312|FG001|Status at Week 156|Lost to Follow-up|4|||
157155729|NCT01544595|567314313|FG002|Status at Week 156|Lost to Follow-up|0|||
157155730|NCT01544595|567314314|FG003|Status at Week 156|Lost to Follow-up|1|||
157155731|NCT01544595|567314315|FG004|Status at Week 156|Lost to Follow-up|4|||
157155732|NCT01544595|567314316|FG005|Status at Week 156|Lost to Follow-up|1|||
157155733|NCT01544595|567314311|FG000|Status at Week 156|Non-compliance with study treatement|0|||
157155734|NCT01544595|567314312|FG001|Status at Week 156|Non-compliance with study treatement|1|||
157155735|NCT01544595|567314313|FG002|Status at Week 156|Non-compliance with study treatement|0|||
157155736|NCT01544595|567314314|FG003|Status at Week 156|Non-compliance with study treatement|1|||
157155737|NCT01544595|567314315|FG004|Status at Week 156|Non-compliance with study treatement|0|||
157155738|NCT01544595|567314316|FG005|Status at Week 156|Non-compliance with study treatement|1|||
157155739|NCT01544595|567314311|FG000|Status at Week 156|Physician Decision|0|||
157155740|NCT01544595|567314312|FG001|Status at Week 156|Physician Decision|3|||
157155741|NCT01544595|567314313|FG002|Status at Week 156|Physician Decision|1|||
157155742|NCT01544595|567314314|FG003|Status at Week 156|Physician Decision|0|||
157155743|NCT01544595|567314315|FG004|Status at Week 156|Physician Decision|0|||
157155744|NCT01544595|567314316|FG005|Status at Week 156|Physician Decision|0|||
156850179|NCT01248949|566203156|FG001|Overall Study|Alternative Therapy|0|||
156850180|NCT01248949|566203157|FG002|Overall Study|Alternative Therapy|0|||
156850181|NCT01248949|566203158|FG003|Overall Study|Alternative Therapy|0|||
156850182|NCT01248949|566203159|FG004|Overall Study|Alternative Therapy|0|||
156850183|NCT01248949|566203155|FG000|Overall Study|Alternative Therapy.|1|||
156850184|NCT01248949|566203156|FG001|Overall Study|Alternative Therapy.|0|||
156850185|NCT01248949|566203157|FG002|Overall Study|Alternative Therapy.|0|||
156850186|NCT01248949|566203158|FG003|Overall Study|Alternative Therapy.|0|||
156850187|NCT01248949|566203159|FG004|Overall Study|Alternative Therapy.|0|||
156850188|NCT01248949|566203155|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
156850189|NCT01248949|566203156|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850190|NCT01248949|566203157|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850191|NCT01248949|566203158|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850192|NCT01248949|566203159|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
156850193|NCT01248949|566203155|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850194|NCT01248949|566203156|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850195|NCT01248949|566203157|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
157155745|NCT01544595|567314311|FG000|Status at Week 156|Pregnancy|2|||
157155746|NCT01544595|567314312|FG001|Status at Week 156|Pregnancy|3|||
157155747|NCT01544595|567314313|FG002|Status at Week 156|Pregnancy|0|||
157155748|NCT01544595|567314314|FG003|Status at Week 156|Pregnancy|0|||
157155749|NCT01544595|567314315|FG004|Status at Week 156|Pregnancy|0|||
157155750|NCT01544595|567314316|FG005|Status at Week 156|Pregnancy|0|||
157155751|NCT01544595|567314311|FG000|Status at Week 156|Protocol Violation|3|||
157155752|NCT01544595|567314312|FG001|Status at Week 156|Protocol Violation|1|||
157155753|NCT01544595|567314313|FG002|Status at Week 156|Protocol Violation|2|||
156850196|NCT01248949|566203158|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
156850197|NCT01248949|566203159|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
156850198|NCT01248949|566203155|FG000|Overall Study|Participant Went To Hospice|0|||
156850199|NCT01248949|566203156|FG001|Overall Study|Participant Went To Hospice|0|||
156850200|NCT01248949|566203157|FG002|Overall Study|Participant Went To Hospice|1|||
156850201|NCT01248949|566203158|FG003|Overall Study|Participant Went To Hospice|0|||
156850202|NCT01248949|566203159|FG004|Overall Study|Participant Went To Hospice|0|||
156850203|NCT01248949|566203155|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
157155754|NCT01544595|567314314|FG003|Status at Week 156|Protocol Violation|2|||
157155755|NCT01544595|567314315|FG004|Status at Week 156|Protocol Violation|0|||
157155756|NCT01544595|567314316|FG005|Status at Week 156|Protocol Violation|0|||
157155757|NCT01544595|567314311|FG000|Status at Week 156|Technical problems|3|||
157155758|NCT01544595|567314312|FG001|Status at Week 156|Technical problems|1|||
157155759|NCT01544595|567314313|FG002|Status at Week 156|Technical problems|0|||
157155760|NCT01544595|567314314|FG003|Status at Week 156|Technical problems|1|||
157155761|NCT01544595|567314315|FG004|Status at Week 156|Technical problems|0|||
157155762|NCT01544595|567314316|FG005|Status at Week 156|Technical problems|0|||
157155763|NCT01544595|567314311|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
157155764|NCT01544595|567314312|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
157155765|NCT01544595|567314313|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
157155766|NCT01544595|567314314|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
157155767|NCT01544595|567314315|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
157155768|NCT01544595|567314316|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
157155769|NCT01544595|567314311|FG000|Status at Week 156|Lack of Efficacy|1|||
157155770|NCT01544595|567314312|FG001|Status at Week 156|Lack of Efficacy|0|||
157155771|NCT01544595|567314313|FG002|Status at Week 156|Lack of Efficacy|1|||
157155772|NCT01544595|567314314|FG003|Status at Week 156|Lack of Efficacy|4|||
157155773|NCT01544595|567314315|FG004|Status at Week 156|Lack of Efficacy|10|||
157155774|NCT01544595|567314316|FG005|Status at Week 156|Lack of Efficacy|5|||
157155775|NCT01929044|567314319|FG000|Overall Study|Adverse Event|1|||
157155776|NCT01929044|567314320|FG001|Overall Study|Adverse Event|0|||
157155777|NCT01929044|567314319|FG000|Overall Study|Protocol Violation|9|||
157155778|NCT01929044|567314320|FG001|Overall Study|Protocol Violation|14|||
157155779|NCT01929044|567314319|FG000|Overall Study|Not Treated|1|||
157155780|NCT01929044|567314320|FG001|Overall Study|Not Treated|3|||
157155781|NCT02084134|567314323|FG000|Overall Study|Protocol Violation|4|||
157155782|NCT02084134|567314324|FG001|Overall Study|Protocol Violation|2|||
157155783|NCT02084134|567314323|FG000|Overall Study|Death|0|||
157155784|NCT02084134|567314324|FG001|Overall Study|Death|1|||
157155785|NCT04333433|567314325|FG000|Overall Study|Withdrawal by Subject|6|||
157155786|NCT04333433|567314326|FG001|Overall Study|Withdrawal by Subject|3|||
157155787|NCT04333433|567314325|FG000|Overall Study|Death|3|||
157155788|NCT04333433|567314326|FG001|Overall Study|Death|0|||
157155789|NCT04333433|567314325|FG000|Overall Study|Lost to Follow-up|6|||
157155790|NCT04333433|567314326|FG001|Overall Study|Lost to Follow-up|1|||
157155791|NCT04333433|567314325|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
157155792|NCT04333433|567314326|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
157155793|NCT02026271|567314327|FG000|Overall Study|Adverse Event|2|||
157155794|NCT02026271|567314328|FG001|Overall Study|Adverse Event|3|||
157155795|NCT02026271|567314329|FG002|Overall Study|Adverse Event|2|||
157155796|NCT02026271|567314330|FG003|Overall Study|Adverse Event|3|||
157155797|NCT02026271|567314331|FG004|Overall Study|Adverse Event|0|||
157155798|NCT02026271|567314327|FG000|Overall Study|Withdrawal by Subject|0|||
157155799|NCT02026271|567314328|FG001|Overall Study|Withdrawal by Subject|0|||
157155800|NCT02026271|567314329|FG002|Overall Study|Withdrawal by Subject|0|||
157155801|NCT02026271|567314330|FG003|Overall Study|Withdrawal by Subject|0|||
157155802|NCT02026271|567314331|FG004|Overall Study|Withdrawal by Subject|1|||
157155803|NCT02807454|567314332|FG000|Overall Study|Adverse Event|1|||
157155804|NCT02807454|567314333|FG001|Overall Study|Adverse Event|0|||
157225416|NCT00421174|567571421|FG001|Overall Study|Withdrawal by Subject|1|||
157225417|NCT00421174|567571420|FG000|Overall Study|Ineligible due to infection|2|||
156850204|NCT01248949|566203156|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156850205|NCT01248949|566203157|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
156850206|NCT01248949|566203158|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
157155805|NCT02807454|567314332|FG000|Overall Study|Withdrawal by Subject|0|||
156850207|NCT01248949|566203159|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
157155806|NCT02807454|567314333|FG001|Overall Study|Withdrawal by Subject|1|||
157155807|NCT02807454|567314332|FG000|Overall Study|Progressive Disease|30|||
157155808|NCT02807454|567314333|FG001|Overall Study|Progressive Disease|3|||
157155809|NCT02807454|567314332|FG000|Overall Study|Other Reasons|1|||
157155810|NCT02807454|567314333|FG001|Overall Study|Other Reasons|1|||
157155811|NCT05468086|567314336|FG000|Overall Study|Withdrawal by Subject|3|||
157155812|NCT05468086|567314336|FG000|Overall Study|Subject was found ineligible after consent|1|||
156850208|NCT01248949|566203155|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
157155813|NCT00878072|567314338|FG000|Overall Study|Withdrew consent|2|||
157155814|NCT03288779|567314344|FG000|Overall Study|Withdrawal by Subject|3|||
157155815|NCT00237796|567314345|FG000|Overall Study|Baseline and one other ILSS required|10|||
157155816|NCT00237796|567314346|FG001|Overall Study|Baseline and one other ILSS required|5|||
157155817|NCT00968253|567314347|FG000|Overall Study|Death|0|||
157155818|NCT00968253|567314348|FG001|Overall Study|Death|0|||
157155819|NCT00968253|567314349|FG002|Overall Study|Death|2|||
157155820|NCT00968253|567314347|FG000|Overall Study|Withdrawal by Subject|0|||
157155821|NCT00968253|567314348|FG001|Overall Study|Withdrawal by Subject|0|||
157155822|NCT00968253|567314349|FG002|Overall Study|Withdrawal by Subject|1|||
157155823|NCT00968253|567314347|FG000|Overall Study|Disease Progression|0|||
157155824|NCT00968253|567314348|FG001|Overall Study|Disease Progression|3|||
157155825|NCT00968253|567314349|FG002|Overall Study|Disease Progression|3|||
157155826|NCT00968253|567314347|FG000|Overall Study|Adverse Event|0|||
157155827|NCT00968253|567314348|FG001|Overall Study|Adverse Event|0|||
157155828|NCT00968253|567314349|FG002|Overall Study|Adverse Event|1|||
157155829|NCT02488759|567314355|FG000|Overall Study|Disease progression|73|||
157155830|NCT02488759|567314356|FG001|Overall Study|Disease progression|111|||
157155831|NCT02488759|567314357|FG002|Overall Study|Disease progression|62|||
157155832|NCT02488759|567314358|FG003|Overall Study|Disease progression|7|||
157155833|NCT02488759|567314359|FG004|Overall Study|Disease progression|4|||
156850209|NCT01248949|566203156|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
156850210|NCT01248949|566203157|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
156850211|NCT01248949|566203158|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
156850212|NCT01248949|566203159|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
157155834|NCT02488759|567314360|FG005|Overall Study|Disease progression|2|||
157155835|NCT02488759|567314355|FG000|Overall Study|Study drug toxicity|11|||
157155836|NCT02488759|567314356|FG001|Overall Study|Study drug toxicity|33|||
156850213|NCT01248949|566203155|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
157155837|NCT02488759|567314357|FG002|Overall Study|Study drug toxicity|31|||
157155838|NCT02488759|567314358|FG003|Overall Study|Study drug toxicity|0|||
157155839|NCT02488759|567314359|FG004|Overall Study|Study drug toxicity|0|||
157155840|NCT02488759|567314360|FG005|Overall Study|Study drug toxicity|2|||
157155841|NCT02488759|567314355|FG000|Overall Study|Adverse event unrelated to study drug|9|||
157155842|NCT02488759|567314356|FG001|Overall Study|Adverse event unrelated to study drug|11|||
157155843|NCT02488759|567314357|FG002|Overall Study|Adverse event unrelated to study drug|7|||
157155844|NCT02488759|567314358|FG003|Overall Study|Adverse event unrelated to study drug|0|||
157155845|NCT02488759|567314359|FG004|Overall Study|Adverse event unrelated to study drug|1|||
157155846|NCT02488759|567314360|FG005|Overall Study|Adverse event unrelated to study drug|0|||
157155847|NCT02488759|567314355|FG000|Overall Study|Participant request to discontinue study treatment|6|||
157155848|NCT02488759|567314356|FG001|Overall Study|Participant request to discontinue study treatment|8|||
157155849|NCT02488759|567314357|FG002|Overall Study|Participant request to discontinue study treatment|4|||
157155850|NCT02488759|567314358|FG003|Overall Study|Participant request to discontinue study treatment|0|||
157155851|NCT02488759|567314359|FG004|Overall Study|Participant request to discontinue study treatment|0|||
157155852|NCT02488759|567314360|FG005|Overall Study|Participant request to discontinue study treatment|0|||
157155853|NCT02488759|567314355|FG000|Overall Study|Withdrawal by Subject|4|||
157155854|NCT02488759|567314356|FG001|Overall Study|Withdrawal by Subject|0|||
157155855|NCT02488759|567314357|FG002|Overall Study|Withdrawal by Subject|3|||
157155856|NCT02488759|567314358|FG003|Overall Study|Withdrawal by Subject|0|||
157155857|NCT02488759|567314359|FG004|Overall Study|Withdrawal by Subject|0|||
157155858|NCT02488759|567314360|FG005|Overall Study|Withdrawal by Subject|2|||
157155859|NCT02488759|567314355|FG000|Overall Study|Lost to Follow-up|0|||
157155860|NCT02488759|567314356|FG001|Overall Study|Lost to Follow-up|0|||
157155861|NCT02488759|567314357|FG002|Overall Study|Lost to Follow-up|2|||
157155862|NCT02488759|567314358|FG003|Overall Study|Lost to Follow-up|0|||
157155863|NCT02488759|567314359|FG004|Overall Study|Lost to Follow-up|0|||
157155864|NCT02488759|567314360|FG005|Overall Study|Lost to Follow-up|0|||
157155865|NCT02488759|567314355|FG000|Overall Study|Maximum clinical benefit|3|||
157155866|NCT02488759|567314356|FG001|Overall Study|Maximum clinical benefit|0|||
157155867|NCT02488759|567314357|FG002|Overall Study|Maximum clinical benefit|1|||
156850214|NCT01248949|566203156|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
156850215|NCT01248949|566203157|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156850216|NCT01248949|566203158|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
156850217|NCT01248949|566203159|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
157025619|NCT02310646|566847999|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
157025620|NCT02310646|566848000|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
157025621|NCT03021096|566848003|FG000|Overall Study|Lost to Follow-up|4|||
157155868|NCT02488759|567314358|FG003|Overall Study|Maximum clinical benefit|0|||
157155869|NCT02488759|567314359|FG004|Overall Study|Maximum clinical benefit|0|||
157155870|NCT02488759|567314360|FG005|Overall Study|Maximum clinical benefit|0|||
157155871|NCT02488759|567314355|FG000|Overall Study|Other reasons|7|||
157155872|NCT02488759|567314356|FG001|Overall Study|Other reasons|32|||
157155873|NCT02488759|567314357|FG002|Overall Study|Other reasons|23|||
157155874|NCT02488759|567314358|FG003|Overall Study|Other reasons|1|||
157155875|NCT02488759|567314359|FG004|Overall Study|Other reasons|1|||
157155876|NCT02488759|567314360|FG005|Overall Study|Other reasons|1|||
157155877|NCT03860844|567314361|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
157155878|NCT03860844|567314362|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
157155879|NCT03860844|567314363|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
157155880|NCT03860844|567314361|FG000|Overall Study|Progressive disease|5|||
157155881|NCT03860844|567314362|FG001|Overall Study|Progressive disease|3|||
157155882|NCT03860844|567314363|FG002|Overall Study|Progressive disease|4|||
157155883|NCT03860844|567314361|FG000|Overall Study|Other, Not related to COVID-19|0|||
157155884|NCT03860844|567314362|FG001|Overall Study|Other, Not related to COVID-19|1|||
157155885|NCT03860844|567314363|FG002|Overall Study|Other, Not related to COVID-19|0|||
157155886|NCT05306873|567315830|FG000|Stage 2|Study stopped|1|||
157155887|NCT05306873|567315831|FG001|Stage 2|Study stopped|1|||
157155888|NCT05306873|567315832|FG002|Stage 2|Study stopped|0|||
157155889|NCT05306873|567315833|FG003|Stage 2|Study stopped|0|||
157155890|NCT05306873|567315830|FG000|Stage 2|Stage 2 Treatment Failure|2|||
157155891|NCT05306873|567315831|FG001|Stage 2|Stage 2 Treatment Failure|3|||
157155892|NCT05306873|567315832|FG002|Stage 2|Stage 2 Treatment Failure|0|||
157155893|NCT05306873|567315833|FG003|Stage 2|Stage 2 Treatment Failure|0|||
157155894|NCT05306873|567315830|FG000|Stage 2|Logistical issues due to participant moving|1|||
157155895|NCT05306873|567315831|FG001|Stage 2|Logistical issues due to participant moving|0|||
157155896|NCT05306873|567315832|FG002|Stage 2|Logistical issues due to participant moving|0|||
157155897|NCT05306873|567315833|FG003|Stage 2|Logistical issues due to participant moving|0|||
157155898|NCT05306873|567315830|FG000|Stage 3|Stage 3 Treatment Failure|0|||
157155899|NCT05306873|567315831|FG001|Stage 3|Stage 3 Treatment Failure|0|||
157155900|NCT05306873|567315832|FG002|Stage 3|Stage 3 Treatment Failure|0|||
157155901|NCT05306873|567315833|FG003|Stage 3|Stage 3 Treatment Failure|1|||
157155902|NCT05306873|567315830|FG000|Stage 3|Study Stopped|0|||
157155903|NCT05306873|567315831|FG001|Stage 3|Study Stopped|0|||
157155904|NCT05306873|567315832|FG002|Stage 3|Study Stopped|1|||
157155905|NCT05306873|567315833|FG003|Stage 3|Study Stopped|0|||
157155906|NCT04920084|567315839|FG000|Overall Study|Adverse Event|1|||
157155907|NCT04920084|567315839|FG000|Overall Study|Lost to Follow-up|2|||
156850218|NCT01248949|566203155|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850219|NCT01248949|566203156|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850220|NCT01248949|566203157|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
156850221|NCT01248949|566203158|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850222|NCT01248949|566203159|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
156850223|NCT03245775|566203164|FG000|Overall Study|Lost to Follow-up|25|||
156850224|NCT03245775|566203165|FG001|Overall Study|Lost to Follow-up|26|||
156850225|NCT03245775|566203166|FG002|Overall Study|Lost to Follow-up|16|||
156850226|NCT03245775|566203167|FG003|Overall Study|Lost to Follow-up|16|||
156850227|NCT00186901|566203170|FG000|Overall Study|Pregnancy|6|||
156850228|NCT00186901|566203171|FG001|Overall Study|Pregnancy|3|||
156850229|NCT00186901|566203172|FG002|Overall Study|Pregnancy|0|||
156850230|NCT00186901|566203170|FG000|Overall Study|Lost to Follow-up|6|||
156850231|NCT00186901|566203171|FG001|Overall Study|Lost to Follow-up|3|||
156850232|NCT00186901|566203172|FG002|Overall Study|Lost to Follow-up|0|||
156850233|NCT00186901|566203170|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
156850234|NCT00186901|566203171|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
156850235|NCT00186901|566203172|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
156850236|NCT00186901|566203170|FG000|Overall Study|ALL relapse or second malignancy|1|||
156850237|NCT00186901|566203171|FG001|Overall Study|ALL relapse or second malignancy|2|||
156850238|NCT00186901|566203172|FG002|Overall Study|ALL relapse or second malignancy|0|||
156850239|NCT00186901|566203170|FG000|Overall Study|Withdrawal by Subject|4|||
156850240|NCT00186901|566203171|FG001|Overall Study|Withdrawal by Subject|5|||
156850241|NCT00186901|566203172|FG002|Overall Study|Withdrawal by Subject|0|||
156850242|NCT00186901|566203170|FG000|Overall Study|Open label|3|||
156850243|NCT00186901|566203171|FG001|Overall Study|Open label|2|||
156850244|NCT00186901|566203172|FG002|Overall Study|Open label|0|||
156850245|NCT00186901|566203170|FG000|Overall Study|Limited adherence to study requirements|20|||
156888685|NCT00920907|566352179|FG000|Maintenance Period|Withdrawal by Subject|1|||
156888686|NCT00920907|566352180|FG001|Maintenance Period|Withdrawal by Subject|0|||
157025622|NCT03021096|566848003|FG000|Overall Study|Protocol Violation|2|||
156850246|NCT00186901|566203171|FG001|Overall Study|Limited adherence to study requirements|23|||
156850247|NCT00186901|566203172|FG002|Overall Study|Limited adherence to study requirements|0|||
157025623|NCT00613106|566848004|FG000|Overall Study|Adverse Event|3|||
157155908|NCT04920084|567315839|FG000|Overall Study|Withdrawal by Subject|2|||
157155909|NCT01096446|567315840|FG000|Overall Study|Death|1|||
157155910|NCT01096446|567315841|FG001|Overall Study|Death|0|||
157155911|NCT01096446|567315840|FG000|Overall Study|Protocol Violation|2|||
157155912|NCT01096446|567315841|FG001|Overall Study|Protocol Violation|0|||
157155913|NCT00074412|567315842|FG000|Overall Study|Death|30|||
157155914|NCT00074412|567315843|FG001|Overall Study|Death|26|||
157155915|NCT00074412|567315842|FG000|Overall Study|Lost to Follow-up|52|||
157155916|NCT00074412|567315843|FG001|Overall Study|Lost to Follow-up|58|||
157155917|NCT01043185|567315844|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
157155918|NCT01043185|567315845|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
157155919|NCT01043185|567315846|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
157155920|NCT01043185|567315847|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
157155921|NCT01043185|567315848|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
157155922|NCT01043185|567315849|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
156850248|NCT00186901|566203170|FG000|Overall Study|Bone Mineral Density > 0|0|||
156850249|NCT00186901|566203171|FG001|Overall Study|Bone Mineral Density > 0|0|||
156850250|NCT00186901|566203172|FG002|Overall Study|Bone Mineral Density > 0|149|||
156850251|NCT00782483|566203176|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
156850252|NCT01052077|566203177|FG000|Phase A|Lost to Follow-up|22|||
156850253|NCT01052077|566203178|FG001|Phase A|Lost to Follow-up|0|||
156850254|NCT01052077|566203179|FG002|Phase A|Lost to Follow-up|0|||
156850255|NCT01052077|566203180|FG003|Phase A|Lost to Follow-up|0|||
156850256|NCT01052077|566203177|FG000|Phase A|Adverse Event|32|||
156850257|NCT01052077|566203178|FG001|Phase A|Adverse Event|0|||
156850258|NCT01052077|566203179|FG002|Phase A|Adverse Event|0|||
156850259|NCT01052077|566203180|FG003|Phase A|Adverse Event|0|||
156850260|NCT01052077|566203177|FG000|Phase A|Met Withdrawal Criteria|26|||
156850261|NCT01052077|566203178|FG001|Phase A|Met Withdrawal Criteria|0|||
156850262|NCT01052077|566203179|FG002|Phase A|Met Withdrawal Criteria|0|||
156850263|NCT01052077|566203180|FG003|Phase A|Met Withdrawal Criteria|0|||
156850264|NCT01052077|566203177|FG000|Phase A|Physician Decision|10|||
156850265|NCT01052077|566203178|FG001|Phase A|Physician Decision|0|||
156850266|NCT01052077|566203179|FG002|Phase A|Physician Decision|0|||
156850267|NCT01052077|566203180|FG003|Phase A|Physician Decision|0|||
156850268|NCT01052077|566203177|FG000|Phase A|Withdrawal by Subject|29|||
156850269|NCT01052077|566203178|FG001|Phase A|Withdrawal by Subject|0|||
156850270|NCT01052077|566203179|FG002|Phase A|Withdrawal by Subject|0|||
156850271|NCT01052077|566203180|FG003|Phase A|Withdrawal by Subject|0|||
156850272|NCT01052077|566203177|FG000|Phase A|Protocol Deviation|27|||
156850273|NCT01052077|566203178|FG001|Phase A|Protocol Deviation|0|||
156850274|NCT01052077|566203179|FG002|Phase A|Protocol Deviation|0|||
156850275|NCT01052077|566203180|FG003|Phase A|Protocol Deviation|0|||
156850276|NCT01052077|566203177|FG000|Phase B|Lost to Follow-up|0|||
156850277|NCT01052077|566203178|FG001|Phase B|Lost to Follow-up|2|||
156850278|NCT01052077|566203179|FG002|Phase B|Lost to Follow-up|3|||
156850279|NCT01052077|566203180|FG003|Phase B|Lost to Follow-up|0|||
156850280|NCT01052077|566203177|FG000|Phase B|Adverse Event|0|||
156850281|NCT01052077|566203178|FG001|Phase B|Adverse Event|9|||
157155923|NCT01043185|567315850|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
157155924|NCT01043185|567315851|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
157155925|NCT01043185|567315852|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
157155926|NCT01043185|567315853|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
157155927|NCT00418834|567315856|FG000|Overall Study|Adverse Event|16|||
157155928|NCT00418834|567315857|FG001|Overall Study|Adverse Event|9|||
157155929|NCT00418834|567315856|FG000|Overall Study|Lost to Follow-up|0|||
157155930|NCT00418834|567315857|FG001|Overall Study|Lost to Follow-up|1|||
157155931|NCT00418834|567315856|FG000|Overall Study|Protocol Violation|4|||
157155932|NCT00418834|567315857|FG001|Overall Study|Protocol Violation|3|||
157155933|NCT00418834|567315856|FG000|Overall Study|Withdrawal by Subject|3|||
157155934|NCT00418834|567315857|FG001|Overall Study|Withdrawal by Subject|7|||
157155935|NCT01755195|567315860|FG000|Overall Study|Participant noncompliance|2|||
157155936|NCT01755195|567315860|FG000|Overall Study|Switched to alternative treatment|4|||
157155937|NCT01755195|567315860|FG000|Overall Study|Withdrawal by Subject|1|||
157155938|NCT01755195|567315860|FG000|Overall Study|Participant refused to start treatment|1|||
157155939|NCT01755195|567315860|FG000|Overall Study|Participant has been consented for another trial|1|||
157155940|NCT01755195|567315860|FG000|Overall Study|Refused further treatment|3|||
157155941|NCT01755195|567315860|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
157155942|NCT05113953|567315861|FG000|Overall Study|Adverse Event|5|||
156850282|NCT01052077|566203179|FG002|Phase B|Adverse Event|2|||
156850283|NCT01052077|566203180|FG003|Phase B|Adverse Event|0|||
156850284|NCT01052077|566203177|FG000|Phase B|Met Withdrawal Criteria|0|||
156850285|NCT01052077|566203178|FG001|Phase B|Met Withdrawal Criteria|2|||
156850286|NCT01052077|566203179|FG002|Phase B|Met Withdrawal Criteria|1|||
156850287|NCT01052077|566203180|FG003|Phase B|Met Withdrawal Criteria|0|||
156850288|NCT01052077|566203177|FG000|Phase B|Physician Decision|0|||
157155943|NCT05113953|567315862|FG001|Overall Study|Adverse Event|0|||
157155944|NCT05113953|567315863|FG002|Overall Study|Adverse Event|3|||
157155945|NCT05113953|567315861|FG000|Overall Study|Lost to Follow-up|3|||
157155946|NCT05113953|567315862|FG001|Overall Study|Lost to Follow-up|4|||
157155947|NCT05113953|567315863|FG002|Overall Study|Lost to Follow-up|2|||
157155948|NCT05113953|567315861|FG000|Overall Study|Non-compliance with Study Drug|1|||
157155949|NCT05113953|567315862|FG001|Overall Study|Non-compliance with Study Drug|0|||
157225418|NCT00421174|567571421|FG001|Overall Study|Ineligible due to infection|0|||
156850289|NCT01052077|566203178|FG001|Phase B|Physician Decision|1|||
156850290|NCT01052077|566203179|FG002|Phase B|Physician Decision|1|||
156850291|NCT01052077|566203180|FG003|Phase B|Physician Decision|0|||
157155950|NCT05113953|567315863|FG002|Overall Study|Non-compliance with Study Drug|0|||
157155951|NCT05113953|567315861|FG000|Overall Study|Withdrawal by Subject|2|||
157155952|NCT05113953|567315862|FG001|Overall Study|Withdrawal by Subject|6|||
157155953|NCT05113953|567315863|FG002|Overall Study|Withdrawal by Subject|4|||
157155954|NCT05113953|567315861|FG000|Overall Study|Reason not Specified|2|||
157155955|NCT05113953|567315862|FG001|Overall Study|Reason not Specified|0|||
157155956|NCT05113953|567315863|FG002|Overall Study|Reason not Specified|0|||
157155957|NCT02626819|567315868|FG000|Overall Study|Lost to Follow-up|3|||
157155958|NCT02626819|567315869|FG001|Overall Study|Lost to Follow-up|2|||
157155959|NCT02626819|567315868|FG000|Overall Study|Withdrawal by Subject|1|||
157155960|NCT02626819|567315869|FG001|Overall Study|Withdrawal by Subject|0|||
157155961|NCT02626819|567315868|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
157155962|NCT02626819|567315869|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
157155963|NCT04346628|567315874|FG000|Overall Study|Lost to Follow-up|4|||
157155964|NCT04346628|567315875|FG001|Overall Study|Lost to Follow-up|4|||
157155965|NCT04346628|567315874|FG000|Overall Study|Withdrew (had personal reasons)|2|||
157155966|NCT04346628|567315875|FG001|Overall Study|Withdrew (had personal reasons)|5|||
157155967|NCT04346628|567315874|FG000|Overall Study|Withdrew (medication intolerant)|0|||
157155968|NCT04346628|567315875|FG001|Overall Study|Withdrew (medication intolerant)|3|||
157155969|NCT04346628|567315874|FG000|Overall Study|Withdrew (declined intervention)|0|||
157155970|NCT04346628|567315875|FG001|Overall Study|Withdrew (declined intervention)|1|||
157155971|NCT01763905|567315876|FG000|Overall Study|Withdrawal by Subject|1|||
157155972|NCT01763905|567315877|FG001|Overall Study|Withdrawal by Subject|1|||
157155973|NCT01763905|567315878|FG002|Overall Study|Withdrawal by Subject|0|||
157155974|NCT01763905|567315879|FG003|Overall Study|Withdrawal by Subject|1|||
157155975|NCT01763905|567315876|FG000|Overall Study|Decision by sponsor|5|||
157155976|NCT01763905|567315877|FG001|Overall Study|Decision by sponsor|0|||
157155977|NCT01763905|567315878|FG002|Overall Study|Decision by sponsor|8|||
157155978|NCT01763905|567315879|FG003|Overall Study|Decision by sponsor|0|||
157155979|NCT01763905|567315876|FG000|Overall Study|Lost to Follow-up|0|||
157155980|NCT01763905|567315877|FG001|Overall Study|Lost to Follow-up|0|||
157155981|NCT01763905|567315878|FG002|Overall Study|Lost to Follow-up|1|||
157155982|NCT01763905|567315879|FG003|Overall Study|Lost to Follow-up|0|||
157155983|NCT02750800|567315886|FG000|Overall Study|Adverse Event|18|||
157155984|NCT02750800|567315886|FG000|Overall Study|Lost to Follow-up|12|||
157155985|NCT02750800|567315886|FG000|Overall Study|Investigator decision|53|||
157155986|NCT02750800|567315886|FG000|Overall Study|Patient request|12|||
157155987|NCT02750800|567315886|FG000|Overall Study|Other, not specified|3|||
157155988|NCT00643487|567315890|FG000|Overall Study|Technical difficulty|3|||
157155989|NCT03430245|567315906|FG000|Overall Study|Withdrawal by Subject|6|||
157155990|NCT03430245|567315906|FG000|Overall Study|Lost to Follow-up|1|||
157155991|NCT05761444|567315913|FG000|Overall Study|Protocol Violation|2|||
157155992|NCT05761444|567315914|FG001|Overall Study|Protocol Violation|1|||
157155993|NCT05761444|567315913|FG000|Overall Study|Adverse Event|2|||
157155994|NCT05761444|567315914|FG001|Overall Study|Adverse Event|2|||
157155995|NCT05761444|567315913|FG000|Overall Study|Withdrawal by Subject|3|||
157155996|NCT05761444|567315914|FG001|Overall Study|Withdrawal by Subject|2|||
157155997|NCT05761444|567315913|FG000|Overall Study|Other|1|||
157155998|NCT05761444|567315914|FG001|Overall Study|Other|0|||
157155999|NCT03196505|567315917|FG000|Overall Study|Physician Decision|26|||
157156000|NCT03196505|567315918|FG001|Overall Study|Physician Decision|26|||
157156001|NCT01087528|567315919|FG000|Overall Study|Withdrawal by Subject|1|||
157156002|NCT01087528|567315919|FG000|Overall Study|Incomplete CE procedure|6|||
157156003|NCT03116399|567315922|FG000|Overall Study|Death|8|||
157156004|NCT03116399|567315923|FG001|Overall Study|Death|3|||
156888687|NCT00920907|566352179|FG000|Maintenance Period|Adverse Event|0|||
156888688|NCT00920907|566352180|FG001|Maintenance Period|Adverse Event|1|||
156888689|NCT02616601|566352181|FG000|Overall Study|Withdrawal by Subject|4|||
157156005|NCT03116399|567315922|FG000|Overall Study|Lost to Follow-up|7|||
157156006|NCT03116399|567315923|FG001|Overall Study|Lost to Follow-up|11|||
157156007|NCT03116399|567315922|FG000|Overall Study|Investigator Decision|1|||
157156008|NCT03116399|567315923|FG001|Overall Study|Investigator Decision|1|||
157156009|NCT03116399|567315922|FG000|Overall Study|Withdrawal by Subject|24|||
157156010|NCT03116399|567315923|FG001|Overall Study|Withdrawal by Subject|9|||
157156011|NCT02868216|567315925|FG000|Overall Study|Death|0|||
157156012|NCT02868216|567315926|FG001|Overall Study|Death|1|||
157156013|NCT02868216|567315925|FG000|Overall Study|coronary artery bypass|1|||
157156014|NCT02868216|567315926|FG001|Overall Study|coronary artery bypass|0|||
157156015|NCT02868216|567315925|FG000|Overall Study|Withdrawal by Subject|7|||
157156016|NCT02868216|567315926|FG001|Overall Study|Withdrawal by Subject|5|||
157156017|NCT00987623|567315927|FG000|Overall Study|Lost to Follow-up|2|||
157156018|NCT00987623|567315928|FG001|Overall Study|Lost to Follow-up|1|||
157156019|NCT00987623|567315927|FG000|Overall Study|Time/job conflict|2|||
157156020|NCT00987623|567315928|FG001|Overall Study|Time/job conflict|0|||
157156021|NCT00987623|567315927|FG000|Overall Study|Discomfort|1|||
157156022|NCT00987623|567315928|FG001|Overall Study|Discomfort|0|||
157156023|NCT00987623|567315927|FG000|Overall Study|Biomicroscopy|0|||
156888690|NCT02616601|566352182|FG001|Overall Study|Withdrawal by Subject|4|||
157025624|NCT00613106|566848005|FG001|Overall Study|Adverse Event|1|||
157025625|NCT00613106|566848004|FG000|Overall Study|Withdrawal by Subject|6|||
157025626|NCT00613106|566848005|FG001|Overall Study|Withdrawal by Subject|3|||
157025627|NCT00613106|566848004|FG000|Overall Study|Lost to Follow-up|7|||
157156024|NCT00987623|567315928|FG001|Overall Study|Biomicroscopy|1|||
157156025|NCT00987623|567315927|FG000|Overall Study|Influenza|0|||
157156026|NCT00987623|567315928|FG001|Overall Study|Influenza|1|||
157156027|NCT03161678|567315931|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
157156028|NCT03161678|567315932|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
157156029|NCT03161678|567315933|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
157156030|NCT03161678|567315934|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
157156031|NCT03161678|567315935|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
157156032|NCT03161678|567315936|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
157156033|NCT03161678|567315931|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
157156034|NCT03161678|567315932|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
157156035|NCT03161678|567315933|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
157156036|NCT03161678|567315934|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
157156037|NCT03161678|567315935|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
157156038|NCT03161678|567315936|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
157156039|NCT03161678|567315931|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
157156040|NCT03161678|567315932|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
157156041|NCT03161678|567315933|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
157156042|NCT03161678|567315934|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
157156043|NCT03161678|567315935|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
157156044|NCT03161678|567315936|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
157156045|NCT03161678|567315931|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
157156046|NCT03161678|567315932|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
157156047|NCT03161678|567315933|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
157025628|NCT00613106|566848005|FG001|Overall Study|Lost to Follow-up|2|||
157025629|NCT00613106|566848004|FG000|Overall Study|misc|4|||
157025630|NCT00613106|566848005|FG001|Overall Study|misc|3|||
157025631|NCT03313076|566848012|FG000|Overall Study|Withdrawal by Subject|2|||
157025632|NCT03313076|566848013|FG001|Overall Study|Withdrawal by Subject|0|||
157025633|NCT03313076|566848014|FG002|Overall Study|Withdrawal by Subject|0|||
157025634|NCT03313076|566848015|FG003|Overall Study|Withdrawal by Subject|0|||
157025635|NCT03313076|566848012|FG000|Overall Study|Lost to Follow-up|0|||
157025636|NCT03313076|566848013|FG001|Overall Study|Lost to Follow-up|2|||
157025637|NCT03313076|566848014|FG002|Overall Study|Lost to Follow-up|2|||
157025638|NCT03313076|566848015|FG003|Overall Study|Lost to Follow-up|2|||
157025639|NCT04137367|566848018|FG000|Overall Study|Lost to Follow-up|8|||
157025640|NCT04137367|566848019|FG001|Overall Study|Lost to Follow-up|6|||
157025641|NCT04137367|566848020|FG002|Overall Study|Lost to Follow-up|4|||
157156048|NCT03161678|567315934|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
157156049|NCT03161678|567315935|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
157156050|NCT03161678|567315936|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
157025642|NCT05144009|566848021|FG000|Overall Study|Lost to Follow-up|0|||
157025643|NCT05144009|566848022|FG001|Overall Study|Lost to Follow-up|1|||
157025644|NCT05144009|566848021|FG000|Overall Study|Study Termination by the Sponsor|11|||
157025645|NCT05144009|566848022|FG001|Overall Study|Study Termination by the Sponsor|11|||
157025646|NCT05144009|566848021|FG000|Overall Study|Disease Progression|1|||
157025647|NCT05144009|566848022|FG001|Overall Study|Disease Progression|0|||
157025648|NCT05144009|566848021|FG000|Overall Study|Participant Decision|0|||
157025649|NCT05144009|566848022|FG001|Overall Study|Participant Decision|2|||
157025650|NCT05144009|566848021|FG000|Overall Study|Death|5|||
157025651|NCT05144009|566848022|FG001|Overall Study|Death|10|||
157025652|NCT04307355|566848023|FG000|Overall Study|Non-Compliance|3|||
157025653|NCT04307355|566848024|FG001|Overall Study|Non-Compliance|3|||
157025654|NCT04307355|566848025|FG002|Overall Study|Non-Compliance|0|||
157025655|NCT05269667|566848028|FG000|Overall Study|Study Terminated by Sponsor|4|||
157025656|NCT05270408|566848031|FG000|Started Treatment|Withdrawal by Subject|0|||
157156051|NCT00752609|567315937|FG000|Overall Study|Adverse Event|2|||
157156052|NCT00752609|567315938|FG001|Overall Study|Adverse Event|2|||
157025657|NCT05270408|566848032|FG001|Started Treatment|Withdrawal by Subject|0|||
157156053|NCT00752609|567315937|FG000|Overall Study|Withdrawal by Subject|3|||
157025658|NCT05270408|566848033|FG002|Started Treatment|Withdrawal by Subject|3|||
157025659|NCT05270408|566848031|FG000|Started Treatment|Adverse Event|0|||
157025660|NCT05270408|566848032|FG001|Started Treatment|Adverse Event|0|||
157025661|NCT05270408|566848033|FG002|Started Treatment|Adverse Event|1|||
157025662|NCT05270408|566848031|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
157025663|NCT05270408|566848032|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
157025664|NCT05270408|566848033|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
157156054|NCT00752609|567315938|FG001|Overall Study|Withdrawal by Subject|0|||
157156055|NCT00752609|567315937|FG000|Overall Study|Physician Decision|1|||
157156056|NCT00752609|567315938|FG001|Overall Study|Physician Decision|0|||
157156057|NCT00752609|567315937|FG000|Overall Study|Death|1|||
157156058|NCT00752609|567315938|FG001|Overall Study|Death|0|||
157156059|NCT00752609|567315937|FG000|Overall Study|Met exclusion criteria|1|||
157156060|NCT00752609|567315938|FG001|Overall Study|Met exclusion criteria|0|||
156850292|NCT01052077|566203177|FG000|Phase B|Withdrawal by Subject|0|||
156850293|NCT01052077|566203178|FG001|Phase B|Withdrawal by Subject|0|||
156850294|NCT01052077|566203179|FG002|Phase B|Withdrawal by Subject|5|||
156850295|NCT01052077|566203180|FG003|Phase B|Withdrawal by Subject|0|||
156850296|NCT01052077|566203177|FG000|Phase B|Protocol Deviation|0|||
156850297|NCT01052077|566203178|FG001|Phase B|Protocol Deviation|3|||
156850298|NCT01052077|566203179|FG002|Phase B|Protocol Deviation|4|||
156850299|NCT01052077|566203180|FG003|Phase B|Protocol Deviation|0|||
156850300|NCT01052077|566203177|FG000|Phase B|Lack of Efficacy|0|||
156850301|NCT01052077|566203178|FG001|Phase B|Lack of Efficacy|1|||
156850302|NCT01052077|566203179|FG002|Phase B|Lack of Efficacy|0|||
156850303|NCT01052077|566203180|FG003|Phase B|Lack of Efficacy|0|||
156850304|NCT01052077|566203177|FG000|Phase A+|Lost to Follow-up|0|||
156850305|NCT01052077|566203178|FG001|Phase A+|Lost to Follow-up|0|||
156850306|NCT01052077|566203179|FG002|Phase A+|Lost to Follow-up|0|||
156850307|NCT01052077|566203180|FG003|Phase A+|Lost to Follow-up|8|||
156850308|NCT01052077|566203177|FG000|Phase A+|Adverse Event|0|||
156850309|NCT01052077|566203178|FG001|Phase A+|Adverse Event|0|||
156850310|NCT01052077|566203179|FG002|Phase A+|Adverse Event|0|||
156850311|NCT01052077|566203180|FG003|Phase A+|Adverse Event|4|||
156850312|NCT01052077|566203177|FG000|Phase A+|Met Withdrawal Criteria|0|||
156850313|NCT01052077|566203178|FG001|Phase A+|Met Withdrawal Criteria|0|||
156850314|NCT01052077|566203179|FG002|Phase A+|Met Withdrawal Criteria|0|||
156850315|NCT01052077|566203180|FG003|Phase A+|Met Withdrawal Criteria|2|||
156850316|NCT01052077|566203177|FG000|Phase A+|Withdrawal by Subject|0|||
156850317|NCT01052077|566203178|FG001|Phase A+|Withdrawal by Subject|0|||
156850318|NCT01052077|566203179|FG002|Phase A+|Withdrawal by Subject|0|||
156850319|NCT01052077|566203180|FG003|Phase A+|Withdrawal by Subject|7|||
156850320|NCT01099397|566203184|FG000|Overall Study|Lost to Follow-up|4|||
156850321|NCT01099397|566203184|FG000|Overall Study|Protocol Violation|4|||
156850322|NCT01099397|566203184|FG000|Overall Study|Withdrawal by Subject|5|||
156850323|NCT02363959|566203185|FG000|Overall Study|Medical instability|1|||
156850324|NCT02363959|566203186|FG001|Overall Study|Medical instability|0|||
156850325|NCT00003199|566203188|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
156850326|NCT00003199|566203188|FG000|Overall Study|Lack of insurance clearance|2|||
156850327|NCT00003199|566203188|FG000|Overall Study|Screen fail|15|||
156850328|NCT00940498|566203189|FG000|Overall Study|Death|2|||
156850329|NCT00940498|566203190|FG001|Overall Study|Death|0|||
156850330|NCT00940498|566203191|FG002|Overall Study|Death|0|||
156850331|NCT00940498|566203192|FG003|Overall Study|Death|1|||
156850332|NCT00940498|566203193|FG004|Overall Study|Death|5|||
156850333|NCT00940498|566203194|FG005|Overall Study|Death|0|||
156850334|NCT00940498|566203195|FG006|Overall Study|Death|1|||
156850335|NCT00940498|566203196|FG007|Overall Study|Death|0|||
156850336|NCT00940498|566203189|FG000|Overall Study|Lost to Follow-up|1|||
156850337|NCT00940498|566203190|FG001|Overall Study|Lost to Follow-up|1|||
156850338|NCT00940498|566203191|FG002|Overall Study|Lost to Follow-up|2|||
156850339|NCT00940498|566203192|FG003|Overall Study|Lost to Follow-up|0|||
156850340|NCT00940498|566203193|FG004|Overall Study|Lost to Follow-up|1|||
156850341|NCT00940498|566203194|FG005|Overall Study|Lost to Follow-up|0|||
156850342|NCT00940498|566203195|FG006|Overall Study|Lost to Follow-up|0|||
156850343|NCT00940498|566203196|FG007|Overall Study|Lost to Follow-up|1|||
156850344|NCT00940498|566203189|FG000|Overall Study|Disease Progression|0|||
156850345|NCT00940498|566203190|FG001|Overall Study|Disease Progression|0|||
156850346|NCT00940498|566203191|FG002|Overall Study|Disease Progression|1|||
156850347|NCT00940498|566203192|FG003|Overall Study|Disease Progression|1|||
156850348|NCT00940498|566203193|FG004|Overall Study|Disease Progression|0|||
156850349|NCT00940498|566203194|FG005|Overall Study|Disease Progression|1|||
156850350|NCT00940498|566203195|FG006|Overall Study|Disease Progression|0|||
156850351|NCT00940498|566203196|FG007|Overall Study|Disease Progression|0|||
156850352|NCT00940498|566203189|FG000|Overall Study|Physician Decision|0|||
157156061|NCT00752609|567315937|FG000|Overall Study|Received Aranesp in error|1|||
157156062|NCT00752609|567315938|FG001|Overall Study|Received Aranesp in error|0|||
157156063|NCT05114590|567315939|FG000|Overall Study|Adverse Event|1|||
156850353|NCT00940498|566203190|FG001|Overall Study|Physician Decision|0|||
156850354|NCT00940498|566203191|FG002|Overall Study|Physician Decision|0|||
156850355|NCT00940498|566203192|FG003|Overall Study|Physician Decision|0|||
156850356|NCT00940498|566203193|FG004|Overall Study|Physician Decision|2|||
156850357|NCT00940498|566203194|FG005|Overall Study|Physician Decision|0|||
156850358|NCT00940498|566203195|FG006|Overall Study|Physician Decision|0|||
156850359|NCT00940498|566203196|FG007|Overall Study|Physician Decision|0|||
156850360|NCT00940498|566203189|FG000|Overall Study|Not treated due to disease related pain|0|||
156850361|NCT00940498|566203190|FG001|Overall Study|Not treated due to disease related pain|0|||
156850362|NCT00940498|566203191|FG002|Overall Study|Not treated due to disease related pain|0|||
156850363|NCT00940498|566203192|FG003|Overall Study|Not treated due to disease related pain|0|||
156850364|NCT00940498|566203193|FG004|Overall Study|Not treated due to disease related pain|1|||
156850365|NCT00940498|566203194|FG005|Overall Study|Not treated due to disease related pain|0|||
156850366|NCT00940498|566203195|FG006|Overall Study|Not treated due to disease related pain|0|||
156850367|NCT00940498|566203196|FG007|Overall Study|Not treated due to disease related pain|0|||
156888691|NCT02616601|566352183|FG002|Overall Study|Withdrawal by Subject|3|||
156888692|NCT02616601|566352181|FG000|Overall Study|Adverse Event|2|||
156888693|NCT02616601|566352182|FG001|Overall Study|Adverse Event|0|||
156888694|NCT02616601|566352183|FG002|Overall Study|Adverse Event|2|||
156888695|NCT02616601|566352181|FG000|Overall Study|Death|1|||
156888696|NCT02616601|566352182|FG001|Overall Study|Death|0|||
156888697|NCT02616601|566352183|FG002|Overall Study|Death|0|||
156888698|NCT02616601|566352181|FG000|Overall Study|Lost to Follow-up|1|||
156888699|NCT02616601|566352182|FG001|Overall Study|Lost to Follow-up|0|||
156888700|NCT02616601|566352183|FG002|Overall Study|Lost to Follow-up|1|||
156888701|NCT02616601|566352181|FG000|Overall Study|Non-Compliance with Test Article|1|||
156888702|NCT02616601|566352182|FG001|Overall Study|Non-Compliance with Test Article|0|||
156888703|NCT02616601|566352183|FG002|Overall Study|Non-Compliance with Test Article|1|||
156888704|NCT00718081|566352185|FG000|Overall Study|Adverse Event|0|||
156888705|NCT00718081|566352186|FG001|Overall Study|Adverse Event|1|||
156888706|NCT00718081|566352187|FG002|Overall Study|Adverse Event|0|||
156888707|NCT00718081|566352185|FG000|Overall Study|Lack of Efficacy|7|||
156888708|NCT00718081|566352186|FG001|Overall Study|Lack of Efficacy|3|||
156888709|NCT00718081|566352187|FG002|Overall Study|Lack of Efficacy|21|||
156888710|NCT01931670|566352190|FG000|Treatment Period|Exclusionary Medication Received|1|||
156888711|NCT01931670|566352191|FG001|Treatment Period|Exclusionary Medication Received|1|||
156888712|NCT01931670|566352192|FG002|Treatment Period|Exclusionary Medication Received|1|||
156888713|NCT01931670|566352190|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
156888714|NCT01931670|566352191|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
156888715|NCT01931670|566352192|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
156888716|NCT01931670|566352190|FG000|Treatment Period|Subject Noncompliant|4|||
156888717|NCT01931670|566352191|FG001|Treatment Period|Subject Noncompliant|9|||
156888718|NCT01931670|566352192|FG002|Treatment Period|Subject Noncompliant|5|||
156888719|NCT01931670|566352190|FG000|Treatment Period|Adverse Event|19|||
156888720|NCT01931670|566352191|FG001|Treatment Period|Adverse Event|8|||
156888721|NCT01931670|566352192|FG002|Treatment Period|Adverse Event|21|||
156888722|NCT01931670|566352190|FG000|Treatment Period|Lack of Efficacy|11|||
156888723|NCT01931670|566352191|FG001|Treatment Period|Lack of Efficacy|2|||
156888724|NCT01931670|566352192|FG002|Treatment Period|Lack of Efficacy|2|||
156888725|NCT01931670|566352190|FG000|Treatment Period|Pregnancy|7|||
156888726|NCT01931670|566352191|FG001|Treatment Period|Pregnancy|2|||
156888727|NCT01931670|566352192|FG002|Treatment Period|Pregnancy|0|||
156888728|NCT01931670|566352190|FG000|Treatment Period|Other|8|||
156888729|NCT01931670|566352191|FG001|Treatment Period|Other|7|||
156888730|NCT01931670|566352192|FG002|Treatment Period|Other|2|||
156888731|NCT01931670|566352190|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
156888732|NCT01931670|566352191|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
156888733|NCT01931670|566352192|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
156888734|NCT01931670|566352190|FG000|Treatment Period|Lost to Follow-up|19|||
156888735|NCT01931670|566352191|FG001|Treatment Period|Lost to Follow-up|5|||
156888736|NCT01931670|566352192|FG002|Treatment Period|Lost to Follow-up|7|||
156888737|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
156888738|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
156888739|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
156888740|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
156888741|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
156888742|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
156888743|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
156888744|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
156888745|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
156888746|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
156888747|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
156888748|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
156888749|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
156888750|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
156888751|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
156888752|NCT01931670|566352190|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
156888753|NCT01931670|566352191|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
156888754|NCT01931670|566352192|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
156888755|NCT00815516|566352193|FG000|Overall Study|Death|3|||
156888756|NCT00815516|566352194|FG001|Overall Study|Death|1|||
156888757|NCT00815516|566352193|FG000|Overall Study|Physician Decision|1|||
156888758|NCT00815516|566352194|FG001|Overall Study|Physician Decision|0|||
156888759|NCT01992159|566352204|FG000|Overall Study|Withdrawal by Subject|4|||
156888760|NCT01992159|566352205|FG001|Overall Study|Withdrawal by Subject|7|||
156888761|NCT01992159|566352206|FG002|Overall Study|Withdrawal by Subject|0|||
156888762|NCT01992159|566352207|FG003|Overall Study|Withdrawal by Subject|3|||
156888763|NCT01992159|566352204|FG000|Overall Study|Adverse Event|0|||
157156064|NCT05114590|567315939|FG000|Overall Study|Investigator decision|1|||
157156065|NCT05114590|567315939|FG000|Overall Study|Lost to Follow-up|5|||
157156066|NCT05114590|567315939|FG000|Overall Study|Withdrawal by Subject|5|||
157156067|NCT05114590|567315939|FG000|Overall Study|Other|2|||
157156068|NCT00938327|567315940|FG000|Overall Study|Adverse Event|2|||
157156069|NCT00938327|567315940|FG000|Overall Study|Protocol Violation|1|||
157156070|NCT00938327|567315940|FG000|Overall Study|Withdrawal by Subject|4|||
157156071|NCT00938327|567315940|FG000|Overall Study|Lost to Follow-up|37|||
157156072|NCT00938327|567315940|FG000|Overall Study|2nd dose received outside of the study|7|||
157156073|NCT00938327|567315940|FG000|Overall Study|Vaccine not received as out of stock|9|||
157156074|NCT01108809|567315943|FG000|Overall Study|Adverse Event|3|||
157156075|NCT01108809|567315943|FG000|Overall Study|Lost to Follow-up|1|||
157156076|NCT02379923|567315949|FG000|Overall Study|Death|5|||
157156077|NCT03643432|567315950|FG000|Overall Study|Lost to Follow-up|1|||
157156078|NCT03643432|567315951|FG001|Overall Study|Lost to Follow-up|0|||
157156079|NCT00804193|567315952|FG000|Overall Study|Lack of baseline fungus|32|||
157156080|NCT00804193|567315953|FG001|Overall Study|Lack of baseline fungus|31|||
157156081|NCT00804193|567315954|FG002|Overall Study|Lack of baseline fungus|19|||
157156082|NCT00804193|567315952|FG000|Overall Study|Adverse Event|0|||
156850368|NCT02709330|566203197|FG000|Overall Study|Death|5|||
156850369|NCT02709330|566203198|FG001|Overall Study|Death|0|||
156850370|NCT02709330|566203197|FG000|Overall Study|Lost to Follow-up|2|||
156850371|NCT02709330|566203198|FG001|Overall Study|Lost to Follow-up|0|||
156850372|NCT02709330|566203197|FG000|Overall Study|Physician Decision|2|||
156850373|NCT02709330|566203198|FG001|Overall Study|Physician Decision|0|||
156850374|NCT02709330|566203197|FG000|Overall Study|Withdrawal by Subject|4|||
157156083|NCT00804193|567315953|FG001|Overall Study|Adverse Event|0|||
157156084|NCT00804193|567315954|FG002|Overall Study|Adverse Event|2|||
157156085|NCT00804193|567315952|FG000|Overall Study|Lack of Efficacy|1|||
157156086|NCT00804193|567315953|FG001|Overall Study|Lack of Efficacy|1|||
157156087|NCT00804193|567315954|FG002|Overall Study|Lack of Efficacy|3|||
157156088|NCT00804193|567315952|FG000|Overall Study|Protocol Violation|0|||
157156089|NCT00804193|567315953|FG001|Overall Study|Protocol Violation|8|||
157156090|NCT00804193|567315954|FG002|Overall Study|Protocol Violation|2|||
157156091|NCT00804193|567315952|FG000|Overall Study|Lost to Follow-up|3|||
157156092|NCT00804193|567315953|FG001|Overall Study|Lost to Follow-up|3|||
157156093|NCT00804193|567315954|FG002|Overall Study|Lost to Follow-up|4|||
157156094|NCT00804193|567315952|FG000|Overall Study|Withdrawal by Subject|3|||
157156095|NCT00804193|567315953|FG001|Overall Study|Withdrawal by Subject|1|||
157156096|NCT00804193|567315954|FG002|Overall Study|Withdrawal by Subject|2|||
157156097|NCT01193348|567315957|FG000|Screening Period|Screen Failure|5|||
157156098|NCT01193348|567315957|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
157156099|NCT01193348|567315957|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
157156100|NCT01193348|567315957|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
157156101|NCT01193348|567315957|FG000|Extension Treatment Period|Physician Decision|1|||
157156102|NCT01193348|567315957|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
157156103|NCT01402284|567315958|FG000|Overall Study|Withdrawal consent|2|||
157156104|NCT01402284|567315958|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
157156105|NCT01402284|567315958|FG000|Overall Study|Physician Decision|1|||
157156106|NCT01402284|567315958|FG000|Overall Study|Disease progression on study|10|||
157156107|NCT02928406|567315959|FG000|Overall Study|Death|780|||
157156108|NCT02928406|567315959|FG000|Overall Study|Progressive disease|3|||
157156109|NCT02928406|567315959|FG000|Overall Study|Lost to Follow-up|49|||
157156110|NCT02928406|567315959|FG000|Overall Study|Non-compliance|2|||
157156111|NCT02928406|567315959|FG000|Overall Study|Withdrawal by Subject|40|||
157156112|NCT02928406|567315959|FG000|Overall Study|Study terminated by sponsor|57|||
157156113|NCT02928406|567315959|FG000|Overall Study|Physician Decision|1|||
156850375|NCT02709330|566203198|FG001|Overall Study|Withdrawal by Subject|0|||
156850376|NCT00859547|566204521|FG000|Overall Study|Lost to Follow-up|1|||
156850377|NCT00859547|566204521|FG000|Overall Study|Parent withdrew consent|1|||
156850378|NCT01473732|566204522|FG000|Overall Study|Adverse Event|1|||
156850379|NCT01473732|566204523|FG001|Overall Study|Adverse Event|0|||
157156114|NCT02928406|567315959|FG000|Overall Study|Various reasons|72|||
157156115|NCT01745393|567315961|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
157156116|NCT01745393|567315962|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
157156117|NCT01745393|567315961|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
157156118|NCT01745393|567315962|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
157156119|NCT01745393|567315961|FG000|12-month Follow-up|Lost to Follow-up|6|||
157156120|NCT01745393|567315962|FG001|12-month Follow-up|Lost to Follow-up|5|||
157156121|NCT00905021|567315963|FG000|Overall Study|Adverse Event|2|||
157156122|NCT01678807|567315969|FG000|Overall Study|Adverse Event|4|||
157156123|NCT01678807|567315970|FG001|Overall Study|Adverse Event|4|||
157156124|NCT01678807|567315971|FG002|Overall Study|Adverse Event|0|||
156850380|NCT01473732|566204522|FG000|Overall Study|Death|1|||
156850381|NCT01473732|566204523|FG001|Overall Study|Death|0|||
156850382|NCT00997035|566204527|FG000|3-week Followup Visit|Lost to Follow-up|9|||
156850383|NCT00997035|566204528|FG001|3-week Followup Visit|Lost to Follow-up|6|||
156850384|NCT00997035|566204527|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
156850385|NCT00997035|566204528|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
156850386|NCT02471014|566204529|FG000|Overall Study|Lost to Follow-up|2|||
156850387|NCT02471014|566204530|FG001|Overall Study|Lost to Follow-up|2|||
156850388|NCT04685798|566204531|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
156850389|NCT00824473|566204537|FG000|Overall Study|Adverse Event|4|||
156850390|NCT00824473|566204538|FG001|Overall Study|Adverse Event|5|||
156850391|NCT00824473|566204537|FG000|Overall Study|Lack of Efficacy|2|||
156850392|NCT00824473|566204538|FG001|Overall Study|Lack of Efficacy|2|||
156850393|NCT00824473|566204537|FG000|Overall Study|Protocol Violation|2|||
156850394|NCT00824473|566204538|FG001|Overall Study|Protocol Violation|0|||
156888764|NCT01992159|566352205|FG001|Overall Study|Adverse Event|1|||
156888765|NCT01992159|566352206|FG002|Overall Study|Adverse Event|0|||
156888766|NCT01992159|566352207|FG003|Overall Study|Adverse Event|1|||
156888767|NCT01992159|566352204|FG000|Overall Study|Death|0|||
156888768|NCT01992159|566352205|FG001|Overall Study|Death|0|||
156888769|NCT01992159|566352206|FG002|Overall Study|Death|1|||
156888770|NCT01992159|566352207|FG003|Overall Study|Death|0|||
156888771|NCT00470158|566352215|FG000|Overall Study|Death|0|||
156888772|NCT00470158|566352216|FG001|Overall Study|Death|0|||
156888773|NCT00470158|566352217|FG002|Overall Study|Death|0|||
156888774|NCT00470158|566352218|FG003|Overall Study|Death|0|||
156888775|NCT00470158|566352219|FG004|Overall Study|Death|2|||
156888776|NCT00470158|566352215|FG000|Overall Study|Lost to Follow-up|7|||
156888777|NCT00470158|566352216|FG001|Overall Study|Lost to Follow-up|8|||
156888778|NCT00470158|566352217|FG002|Overall Study|Lost to Follow-up|8|||
156888779|NCT00470158|566352218|FG003|Overall Study|Lost to Follow-up|5|||
156888780|NCT00470158|566352219|FG004|Overall Study|Lost to Follow-up|4|||
156888781|NCT00470158|566352215|FG000|Overall Study|Protocol Violation|1|||
156888782|NCT00470158|566352216|FG001|Overall Study|Protocol Violation|0|||
156888783|NCT00470158|566352217|FG002|Overall Study|Protocol Violation|0|||
156888784|NCT00470158|566352218|FG003|Overall Study|Protocol Violation|0|||
156888785|NCT00470158|566352219|FG004|Overall Study|Protocol Violation|0|||
156888786|NCT00880685|566352220|FG000|Memantine 10mg|Lost to Follow-up|2|||
156888787|NCT00880685|566352220|FG000|Memantine 20mg|Withdrawal by Subject|1|||
156888788|NCT04179890|566352221|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
156888789|NCT04179890|566352222|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
156888790|NCT04179890|566352221|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
156888791|NCT04179890|566352222|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
156888792|NCT04179890|566352221|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
156888793|NCT04179890|566352222|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
156888794|NCT04179890|566352221|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
156888795|NCT04179890|566352222|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
156888796|NCT04179890|566352221|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
156888797|NCT04179890|566352222|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
156888798|NCT04179890|566352221|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
156888799|NCT04179890|566352222|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
156888800|NCT04179890|566352221|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
156888801|NCT04179890|566352222|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
156888802|NCT04179890|566352221|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
156888803|NCT04179890|566352222|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
156888804|NCT04179890|566352221|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
156888805|NCT04179890|566352222|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
156888806|NCT01236118|566352223|FG000|Overall Study|Adverse Event|2|||
156888807|NCT01236118|566352224|FG001|Overall Study|Adverse Event|0|||
156888808|NCT01236118|566352225|FG002|Overall Study|Adverse Event|2|||
156888809|NCT01236118|566352223|FG000|Overall Study|Physician Decision|0|||
156888810|NCT01236118|566352224|FG001|Overall Study|Physician Decision|1|||
156888811|NCT01236118|566352225|FG002|Overall Study|Physician Decision|0|||
156888812|NCT01236118|566352223|FG000|Overall Study|Withdrawal by Subject|0|||
156850395|NCT00824473|566204537|FG000|Overall Study|Non-Compliance|4|||
156850396|NCT00824473|566204538|FG001|Overall Study|Non-Compliance|2|||
156850397|NCT00824473|566204537|FG000|Overall Study|Withdrawal by Subject|2|||
156888813|NCT01236118|566352224|FG001|Overall Study|Withdrawal by Subject|0|||
156888814|NCT01236118|566352225|FG002|Overall Study|Withdrawal by Subject|1|||
156888815|NCT04535167|566352226|FG000|Treatment|Adverse Event|0|||
156888816|NCT04535167|566352227|FG001|Treatment|Adverse Event|0|||
156888817|NCT04535167|566352228|FG002|Treatment|Adverse Event|0|||
156888818|NCT04535167|566352229|FG003|Treatment|Adverse Event|0|||
156850398|NCT00824473|566204538|FG001|Overall Study|Withdrawal by Subject|3|||
156888819|NCT04535167|566352230|FG004|Treatment|Adverse Event|0|||
157156125|NCT01678807|567315969|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
157156126|NCT01678807|567315970|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
157156127|NCT01678807|567315971|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
157156128|NCT02574312|567315972|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
157156129|NCT02574312|567315973|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
157156130|NCT03470922|567317514|FG000|Overall Study|Death|107|||
157156131|NCT03470922|567317515|FG001|Overall Study|Death|118|||
157156132|NCT03470922|567317514|FG000|Overall Study|Lost to Follow-up|5|||
157156133|NCT03470922|567317515|FG001|Overall Study|Lost to Follow-up|5|||
157156134|NCT03470922|567317514|FG000|Overall Study|Participant Withdrew Consent|4|||
157156135|NCT03470922|567317515|FG001|Overall Study|Participant Withdrew Consent|9|||
157156136|NCT03470922|567317514|FG000|Overall Study|Other reasons|1|||
157156137|NCT03470922|567317515|FG001|Overall Study|Other reasons|0|||
156888820|NCT04535167|566352231|FG005|Treatment|Adverse Event|0|||
156888821|NCT04535167|566352232|FG006|Treatment|Adverse Event|1|||
156888822|NCT04535167|566352226|FG000|Follow-Up|Death|0|||
156888823|NCT04535167|566352227|FG001|Follow-Up|Death|0|||
156888824|NCT04535167|566352228|FG002|Follow-Up|Death|0|||
156888825|NCT04535167|566352229|FG003|Follow-Up|Death|0|||
156888826|NCT04535167|566352230|FG004|Follow-Up|Death|0|||
156888827|NCT04535167|566352231|FG005|Follow-Up|Death|0|||
156888828|NCT04535167|566352232|FG006|Follow-Up|Death|1|||
156888829|NCT04535167|566352226|FG000|Follow-Up|Lost to Follow-up|0|||
156888830|NCT04535167|566352227|FG001|Follow-Up|Lost to Follow-up|0|||
156888831|NCT04535167|566352228|FG002|Follow-Up|Lost to Follow-up|0|||
156888832|NCT04535167|566352229|FG003|Follow-Up|Lost to Follow-up|1|||
156888833|NCT04535167|566352230|FG004|Follow-Up|Lost to Follow-up|0|||
156888834|NCT04535167|566352231|FG005|Follow-Up|Lost to Follow-up|0|||
156888835|NCT04535167|566352232|FG006|Follow-Up|Lost to Follow-up|0|||
156888836|NCT02455557|566352236|FG000|Overall Study|Withdrawal by Subject|2|||
156888837|NCT04656275|566352237|FG000|Overall Study|Study terminated by sponsor|2|||
156888838|NCT04656275|566352238|FG001|Overall Study|Study terminated by sponsor|4|||
156888839|NCT05954143|566352242|FG000|Overall Study|Progressive Disease|1|||
156888840|NCT05954143|566352243|FG001|Overall Study|Progressive Disease|0|||
156888841|NCT05954143|566352242|FG000|Overall Study|Physician Decision|1|||
156888842|NCT05954143|566352243|FG001|Overall Study|Physician Decision|0|||
156888843|NCT05954143|566352242|FG000|Overall Study|Study Terminated by Sponsor|2|||
156888844|NCT05954143|566352243|FG001|Overall Study|Study Terminated by Sponsor|4|||
156888845|NCT05954143|566352242|FG000|Overall Study|Death|1|||
156888846|NCT05954143|566352243|FG001|Overall Study|Death|0|||
156888847|NCT05954143|566352242|FG000|Overall Study|Withdrawal by Subject|0|||
156888848|NCT05954143|566352243|FG001|Overall Study|Withdrawal by Subject|1|||
156888849|NCT05954143|566352242|FG000|Overall Study|Other|1|||
156888850|NCT05954143|566352243|FG001|Overall Study|Other|0|||
156888851|NCT01129024|566352246|FG000|Overall Study|Physician Decision|5|||
156888852|NCT01129024|566352246|FG000|Overall Study|Study Terminated by Sponsor|8|||
156888853|NCT01129024|566352246|FG000|Overall Study|Withdrawal by Subject|2|||
156888854|NCT01129024|566352246|FG000|Overall Study|Lack of Efficacy|3|||
156888855|NCT01129024|566352246|FG000|Overall Study|Needed a Platelet Transfusion|1|||
156888856|NCT00899392|566352249|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
156888857|NCT00899392|566352250|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
156888858|NCT01903252|566352251|FG000|Double-Blind Induction|Adverse Event|20|||
156888859|NCT01903252|566352252|FG001|Double-Blind Induction|Adverse Event|18|||
156888860|NCT01903252|566352253|FG002|Double-Blind Induction|Adverse Event|0|||
156888861|NCT01903252|566352254|FG003|Double-Blind Induction|Adverse Event|0|||
156888862|NCT01903252|566352255|FG004|Double-Blind Induction|Adverse Event|0|||
156888863|NCT01903252|566352256|FG005|Double-Blind Induction|Adverse Event|0|||
156888864|NCT01903252|566352251|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
156888865|NCT01903252|566352252|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
156888866|NCT01903252|566352253|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
156888867|NCT01903252|566352254|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
156888868|NCT01903252|566352255|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
156888869|NCT01903252|566352256|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
156888870|NCT01903252|566352251|FG000|Double-Blind Induction|Physician Decision|2|||
156888871|NCT01903252|566352252|FG001|Double-Blind Induction|Physician Decision|3|||
156888872|NCT01903252|566352253|FG002|Double-Blind Induction|Physician Decision|0|||
156888873|NCT01903252|566352254|FG003|Double-Blind Induction|Physician Decision|0|||
156888874|NCT01903252|566352255|FG004|Double-Blind Induction|Physician Decision|0|||
156888875|NCT01903252|566352256|FG005|Double-Blind Induction|Physician Decision|0|||
156888876|NCT01903252|566352251|FG000|Double-Blind Induction|non-compliance,|7|||
156888877|NCT01903252|566352252|FG001|Double-Blind Induction|non-compliance,|7|||
156888878|NCT01903252|566352253|FG002|Double-Blind Induction|non-compliance,|0|||
156888879|NCT01903252|566352254|FG003|Double-Blind Induction|non-compliance,|0|||
156888880|NCT01903252|566352255|FG004|Double-Blind Induction|non-compliance,|0|||
156888881|NCT01903252|566352256|FG005|Double-Blind Induction|non-compliance,|0|||
156888882|NCT01903252|566352251|FG000|Extended Induction, Open-Label|Adverse Event|0|||
156888883|NCT01903252|566352252|FG001|Extended Induction, Open-Label|Adverse Event|0|||
156888884|NCT01903252|566352253|FG002|Extended Induction, Open-Label|Adverse Event|17|||
156850399|NCT00824473|566204537|FG000|Overall Study|Other|1|||
156850400|NCT00824473|566204538|FG001|Overall Study|Other|1|||
156850401|NCT03594773|566204540|FG000|Overall Study|Withdrawal by Subject|3|||
156850402|NCT03594773|566204541|FG001|Overall Study|Withdrawal by Subject|2|||
156850403|NCT03594773|566204540|FG000|Overall Study|Lost to Follow-up|3|||
156850404|NCT03594773|566204541|FG001|Overall Study|Lost to Follow-up|4|||
156850405|NCT02640547|566204542|FG000|Overall Study|Failure to Return|1|||
156850406|NCT02640547|566204542|FG000|Overall Study|Withdrawal by Subject|1|||
156888885|NCT01903252|566352254|FG003|Extended Induction, Open-Label|Adverse Event|0|||
156888886|NCT01903252|566352255|FG004|Extended Induction, Open-Label|Adverse Event|0|||
156888887|NCT01903252|566352256|FG005|Extended Induction, Open-Label|Adverse Event|0|||
156888888|NCT01903252|566352251|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156888889|NCT01903252|566352252|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156888890|NCT01903252|566352253|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
157156138|NCT03470922|567317514|FG000|Overall Study|Not reported|1|||
157156139|NCT03470922|567317515|FG001|Overall Study|Not reported|0|||
157156140|NCT02340819|567317516|FG000|Overall Study|Adverse Event|1|||
157156141|NCT02340819|567317516|FG000|Overall Study|Withdrawal by Subject|2|||
157156142|NCT02340819|567317516|FG000|Overall Study|Discontinued with other reason|1|||
157156143|NCT02361762|567317517|FG000|Overall Study|Withdrawal by Subject|0|||
157156144|NCT02361762|567317518|FG001|Overall Study|Withdrawal by Subject|1|||
157156145|NCT02361762|567317517|FG000|Overall Study|Lost to Follow-up|0|||
157156146|NCT02361762|567317518|FG001|Overall Study|Lost to Follow-up|1|||
157156147|NCT00502307|567317519|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
157156148|NCT00502307|567317520|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
157156149|NCT00502307|567317521|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
157156150|NCT00502307|567317519|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
157156151|NCT00502307|567317520|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
157156152|NCT00502307|567317521|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
157156153|NCT00502307|567317519|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
157156154|NCT00502307|567317520|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
157156155|NCT00502307|567317521|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
157156156|NCT00502307|567317519|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
157156157|NCT00502307|567317520|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
157156158|NCT00502307|567317521|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
157156159|NCT00502307|567317519|FG000|Maintenance Period|Progressive disease|80|||
157156160|NCT00502307|567317520|FG001|Maintenance Period|Progressive disease|0|||
157156161|NCT00502307|567317521|FG002|Maintenance Period|Progressive disease|0|||
157156162|NCT00502307|567317519|FG000|Maintenance Period|Discontinued due to other reasons|68|||
157156163|NCT00502307|567317520|FG001|Maintenance Period|Discontinued due to other reasons|0|||
157156164|NCT00502307|567317521|FG002|Maintenance Period|Discontinued due to other reasons|0|||
157156165|NCT02750813|567317522|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
157156166|NCT02750813|567317523|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
157156167|NCT02750813|567317522|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
157156168|NCT02750813|567317523|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
157156169|NCT01998581|567317524|FG000|Overall Study|Refused repeat treatment|20|||
157156170|NCT01998581|567317525|FG001|Overall Study|Refused repeat treatment|4|||
157156171|NCT01998581|567317524|FG000|Overall Study|Protocol Violation|1|||
157156172|NCT01998581|567317525|FG001|Overall Study|Protocol Violation|0|||
157156173|NCT01998581|567317524|FG000|Overall Study|Withdrawal by Subject|8|||
157156174|NCT01998581|567317525|FG001|Overall Study|Withdrawal by Subject|1|||
157156175|NCT01998581|567317524|FG000|Overall Study|Lost to Follow-up|12|||
157156176|NCT01998581|567317525|FG001|Overall Study|Lost to Follow-up|4|||
157156177|NCT01998581|567317524|FG000|Overall Study|Adverse Event|1|||
157156178|NCT01998581|567317525|FG001|Overall Study|Adverse Event|1|||
157156179|NCT01998581|567317524|FG000|Overall Study|Other reasons|3|||
157156180|NCT01998581|567317525|FG001|Overall Study|Other reasons|2|||
157156181|NCT01998581|567317524|FG000|Overall Study|Randomized but withdrew before treatment|1|||
157156182|NCT01998581|567317525|FG001|Overall Study|Randomized but withdrew before treatment|0|||
157156183|NCT02273050|567317528|FG000|Overall Study|Adverse Event|4|||
157156184|NCT02273050|567317529|FG001|Overall Study|Adverse Event|3|||
157156185|NCT02273050|567317530|FG002|Overall Study|Adverse Event|3|||
157156186|NCT02273050|567317528|FG000|Overall Study|Death|0|||
157156187|NCT02273050|567317529|FG001|Overall Study|Death|0|||
156888891|NCT01903252|566352254|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
157156188|NCT02273050|567317530|FG002|Overall Study|Death|1|||
157156189|NCT02273050|567317528|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
157156190|NCT02273050|567317529|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
157156191|NCT02273050|567317530|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
157156192|NCT02273050|567317528|FG000|Overall Study|Lack of Efficacy|0|||
157156193|NCT02273050|567317529|FG001|Overall Study|Lack of Efficacy|1|||
156850407|NCT02640547|566204542|FG000|Overall Study|Death|6|||
156850408|NCT02640547|566204542|FG000|Overall Study|Miscellaneous|3|||
157156194|NCT02273050|567317530|FG002|Overall Study|Lack of Efficacy|1|||
157156195|NCT02273050|567317528|FG000|Overall Study|Withdrawal by Subject|17|||
157156196|NCT02273050|567317529|FG001|Overall Study|Withdrawal by Subject|14|||
157156197|NCT02273050|567317530|FG002|Overall Study|Withdrawal by Subject|16|||
157156198|NCT02273050|567317528|FG000|Overall Study|Lost to Follow-up|0|||
156888892|NCT01903252|566352255|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156888893|NCT01903252|566352256|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
156888894|NCT01903252|566352251|FG000|Extended Induction, Open-Label|Physician Decision|0|||
156888895|NCT01903252|566352252|FG001|Extended Induction, Open-Label|Physician Decision|0|||
156888896|NCT01903252|566352253|FG002|Extended Induction, Open-Label|Physician Decision|1|||
156888897|NCT01903252|566352254|FG003|Extended Induction, Open-Label|Physician Decision|0|||
156888898|NCT01903252|566352255|FG004|Extended Induction, Open-Label|Physician Decision|0|||
156888899|NCT01903252|566352256|FG005|Extended Induction, Open-Label|Physician Decision|0|||
156888900|NCT01903252|566352251|FG000|Maintenance, Open-Label|Adverse Event|0|||
156888901|NCT01903252|566352252|FG001|Maintenance, Open-Label|Adverse Event|0|||
156888902|NCT01903252|566352253|FG002|Maintenance, Open-Label|Adverse Event|0|||
156888903|NCT01903252|566352254|FG003|Maintenance, Open-Label|Adverse Event|3|||
156888904|NCT01903252|566352255|FG004|Maintenance, Open-Label|Adverse Event|9|||
156888905|NCT01903252|566352256|FG005|Maintenance, Open-Label|Adverse Event|14|||
156888906|NCT01903252|566352251|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
156888907|NCT01903252|566352252|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
156888908|NCT01903252|566352253|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
156888909|NCT01903252|566352254|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
156888910|NCT01903252|566352255|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
156888911|NCT01903252|566352256|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
156888912|NCT01903252|566352251|FG000|Maintenance, Open-Label|Other|0|||
156888913|NCT01903252|566352252|FG001|Maintenance, Open-Label|Other|0|||
156888914|NCT01903252|566352253|FG002|Maintenance, Open-Label|Other|0|||
156888915|NCT01903252|566352254|FG003|Maintenance, Open-Label|Other|2|||
156888916|NCT01903252|566352255|FG004|Maintenance, Open-Label|Other|6|||
156888917|NCT01903252|566352256|FG005|Maintenance, Open-Label|Other|2|||
156888918|NCT01642732|566352257|FG000|Overall Study|Withdrawal by Subject|1|||
156888919|NCT03044574|566352265|FG000|Overall Study|Lost to Follow-up|37|||
156888920|NCT03044574|566352266|FG001|Overall Study|Lost to Follow-up|45|||
156888921|NCT03761797|566352267|FG000|Overall Study|Changing hospital|11|||
156888922|NCT03761797|566352267|FG000|Overall Study|Improvement/remission|6|||
156888923|NCT03761797|566352267|FG000|Overall Study|Withdrawal by Subject|19|||
156888924|NCT03761797|566352267|FG000|Overall Study|Lost to Follow-up|33|||
156888925|NCT03761797|566352267|FG000|Overall Study|Adverse Event|37|||
156888926|NCT03761797|566352267|FG000|Overall Study|Case report form (CRF) not collected|5|||
156888927|NCT03761797|566352267|FG000|Overall Study|No patient visit after entry|13|||
156888928|NCT03761797|566352267|FG000|Overall Study|Switch to other diabetes medication|10|||
156888929|NCT03761797|566352267|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
156888930|NCT03761797|566352267|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
156888931|NCT03761797|566352267|FG000|Overall Study|Insufficient effectives|2|||
156888932|NCT03761797|566352267|FG000|Overall Study|Excessive alcohol intake|1|||
156888933|NCT00266877|566352269|FG000|Overall Study|Death|1|||
156888934|NCT00266877|566352270|FG001|Overall Study|Death|1|||
156888935|NCT00266877|566352271|FG002|Overall Study|Death|1|||
156888936|NCT00266877|566352269|FG000|Overall Study|Adverse Event|6|||
156888937|NCT00266877|566352270|FG001|Overall Study|Adverse Event|4|||
156888938|NCT00266877|566352271|FG002|Overall Study|Adverse Event|1|||
156888939|NCT00266877|566352269|FG000|Overall Study|Physician Decision|2|||
156888940|NCT00266877|566352270|FG001|Overall Study|Physician Decision|1|||
156888941|NCT00266877|566352271|FG002|Overall Study|Physician Decision|1|||
156888942|NCT00266877|566352269|FG000|Overall Study|Withdrawal by Subject|3|||
156888943|NCT00266877|566352270|FG001|Overall Study|Withdrawal by Subject|1|||
156888944|NCT00266877|566352271|FG002|Overall Study|Withdrawal by Subject|1|||
156888945|NCT00266877|566352269|FG000|Overall Study|Disease Progression|72|||
156888946|NCT00266877|566352270|FG001|Overall Study|Disease Progression|37|||
157156199|NCT02273050|567317529|FG001|Overall Study|Lost to Follow-up|2|||
157156200|NCT02273050|567317530|FG002|Overall Study|Lost to Follow-up|3|||
156888947|NCT00266877|566352271|FG002|Overall Study|Disease Progression|23|||
156888948|NCT00266877|566352269|FG000|Overall Study|Symptomatic Deterioration|6|||
157156201|NCT02273050|567317528|FG000|Overall Study|Protocol Violation|3|||
156888949|NCT00266877|566352270|FG001|Overall Study|Symptomatic Deterioration|3|||
156888950|NCT00266877|566352271|FG002|Overall Study|Symptomatic Deterioration|1|||
156888951|NCT00266877|566352269|FG000|Overall Study|Hospitalization|1|||
156888952|NCT00266877|566352270|FG001|Overall Study|Hospitalization|0|||
156888953|NCT00266877|566352271|FG002|Overall Study|Hospitalization|0|||
156888954|NCT00266877|566352269|FG000|Overall Study|Concomitant Radiotherapy|0|||
156888955|NCT00266877|566352270|FG001|Overall Study|Concomitant Radiotherapy|1|||
156888956|NCT00266877|566352271|FG002|Overall Study|Concomitant Radiotherapy|0|||
156888957|NCT01077375|566352274|FG000|Overall Study|Adverse Event|2|||
157156202|NCT02273050|567317529|FG001|Overall Study|Protocol Violation|1|||
157156203|NCT02273050|567317530|FG002|Overall Study|Protocol Violation|4|||
157156204|NCT02273752|567317531|FG000|Overall Study|Trial was terminated early|2|||
157156205|NCT00903032|567317532|FG000|Overall Study|Withdrawal by Subject|5|||
157156206|NCT00903032|567317533|FG001|Overall Study|Withdrawal by Subject|3|||
157156207|NCT00903032|567317532|FG000|Overall Study|Lost to Follow-up|2|||
157156208|NCT00903032|567317533|FG001|Overall Study|Lost to Follow-up|2|||
157156209|NCT01429792|567317534|FG000|Overall Study|Other Reasons|67|||
157156210|NCT01429792|567317534|FG000|Overall Study|Unknown Disposition|94|||
157156211|NCT01429792|567317534|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
157156212|NCT01429792|567317534|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
157156213|NCT01429792|567317534|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
157156214|NCT01429792|567317534|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
157156215|NCT01429792|567317534|FG000|Overall Study|Withdrawal by Subject|70|||
157156216|NCT01429792|567317534|FG000|Overall Study|Lost to Follow-up|88|||
157156217|NCT02324842|567317535|FG000|Overall Study|Lost to Follow-up|1|||
157156218|NCT02324842|567317536|FG001|Overall Study|Lost to Follow-up|1|||
157156219|NCT02324842|567317537|FG002|Overall Study|Lost to Follow-up|2|||
157156220|NCT03298412|567317540|FG000|Run-in Period|Other, Not Specified|1|||
157156221|NCT03298412|567317540|FG000|Run-in Period|Disease Progression|1|||
156850409|NCT00193206|566204543|FG000|Preoperative Therapy|Lack of Efficacy|2|||
157156222|NCT03298412|567317540|FG000|Run-in Period|Ineligibility Determined|1|||
157156223|NCT03298412|567317540|FG000|Run-in Period|Decision by Sponsor|6|||
157156224|NCT03456713|567317543|FG000|Overall Study|Lost to Follow-up|1|||
157156225|NCT03456713|567317544|FG001|Overall Study|Lost to Follow-up|0|||
157156226|NCT03456713|567317545|FG002|Overall Study|Lost to Follow-up|0|||
157156227|NCT03456713|567317546|FG003|Overall Study|Lost to Follow-up|0|||
157156228|NCT01263691|567317547|FG000|Overall Study|Lost to Follow-up|1|||
157156229|NCT01263691|567317548|FG001|Overall Study|Lost to Follow-up|0|||
157156230|NCT01263691|567317549|FG002|Overall Study|Lost to Follow-up|1|||
157156231|NCT01263691|567317550|FG003|Overall Study|Lost to Follow-up|1|||
157156232|NCT01263691|567317551|FG004|Overall Study|Lost to Follow-up|0|||
157156233|NCT01263691|567317552|FG005|Overall Study|Lost to Follow-up|0|||
157156234|NCT01263691|567317547|FG000|Overall Study|Withdrawal by Subject|1|||
157156235|NCT01263691|567317548|FG001|Overall Study|Withdrawal by Subject|0|||
157156236|NCT01263691|567317549|FG002|Overall Study|Withdrawal by Subject|0|||
157156237|NCT01263691|567317550|FG003|Overall Study|Withdrawal by Subject|0|||
157156238|NCT01263691|567317551|FG004|Overall Study|Withdrawal by Subject|0|||
157156239|NCT01263691|567317552|FG005|Overall Study|Withdrawal by Subject|0|||
157156240|NCT01263691|567317547|FG000|Overall Study|Adverse Event|1|||
157156241|NCT01263691|567317548|FG001|Overall Study|Adverse Event|0|||
157156242|NCT01263691|567317549|FG002|Overall Study|Adverse Event|0|||
157156243|NCT01263691|567317550|FG003|Overall Study|Adverse Event|0|||
157156244|NCT01263691|567317551|FG004|Overall Study|Adverse Event|0|||
157156245|NCT01263691|567317552|FG005|Overall Study|Adverse Event|0|||
157156246|NCT01202227|567317553|FG000|Overall Study|Adverse Event|16|||
157156247|NCT01202227|567317553|FG000|Overall Study|Withdrawal by Subject|2|||
157156248|NCT01202227|567317553|FG000|Overall Study|Lack of Efficacy|1|||
157156249|NCT01894477|567317554|FG000|Overall Study|Protocol Violation|0|||
157156250|NCT01894477|567317555|FG001|Overall Study|Protocol Violation|1|||
157156251|NCT01894477|567317554|FG000|Overall Study|protocol changed due SC changed to cord|0|||
157156252|NCT01894477|567317555|FG001|Overall Study|protocol changed due SC changed to cord|1|||
157156253|NCT00850759|567317562|FG000|Overall Study|Lost to Follow-up|7|||
157156254|NCT00850759|567317563|FG001|Overall Study|Lost to Follow-up|5|||
157156255|NCT00850759|567317564|FG002|Overall Study|Lost to Follow-up|5|||
157156256|NCT00850759|567317565|FG003|Overall Study|Lost to Follow-up|3|||
157156257|NCT01727713|567317566|FG000|Overall Study|Lost to Follow-up|5|||
157156258|NCT01727713|567317566|FG000|Overall Study|Adverse Event|10|||
157156259|NCT01727713|567317566|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
157156260|NCT01727713|567317566|FG000|Overall Study|Withdrawal by Subject|13|||
157156261|NCT01727713|567317566|FG000|Overall Study|Protocol Deviation|2|||
157156262|NCT02389816|567317568|FG000|Overall Study|Randomized but Not Treated|1|||
157156263|NCT02389816|567317569|FG001|Overall Study|Randomized but Not Treated|0|||
157156264|NCT02389816|567317570|FG002|Overall Study|Randomized but Not Treated|0|||
157156265|NCT02389816|567317568|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
156850410|NCT00193206|566204543|FG000|Preoperative Therapy|Adverse Event|2|||
157225419|NCT02309099|567571425|FG000|Overall Study|Adverse Event|2|||
156850411|NCT00193206|566204543|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
157156266|NCT02389816|567317569|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
157156267|NCT02389816|567317570|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
157156268|NCT02389816|567317568|FG000|Overall Study|Major Protocol Deviation|1|||
157156269|NCT02389816|567317569|FG001|Overall Study|Major Protocol Deviation|0|||
157156270|NCT02389816|567317570|FG002|Overall Study|Major Protocol Deviation|0|||
157156271|NCT02389816|567317568|FG000|Overall Study|Lost to Follow-up|1|||
157156272|NCT02389816|567317569|FG001|Overall Study|Lost to Follow-up|0|||
157156273|NCT02389816|567317570|FG002|Overall Study|Lost to Follow-up|0|||
157156274|NCT02389816|567317568|FG000|Overall Study|Withdrawal of Consent|6|||
157156275|NCT02389816|567317569|FG001|Overall Study|Withdrawal of Consent|4|||
157156276|NCT02389816|567317570|FG002|Overall Study|Withdrawal of Consent|4|||
157025665|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
157156277|NCT02389816|567317568|FG000|Overall Study|Lack of Efficacy|1|||
156850412|NCT00193206|566204543|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
156850413|NCT00193206|566204543|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
156850414|NCT00193206|566204543|FG000|Postoperative Therapy|Physician Decision|3|||
156850415|NCT00193206|566204543|FG000|Postoperative Therapy|Intercurrent Illness|2|||
156850416|NCT00193206|566204543|FG000|Postoperative Therapy|Lack of Efficacy|1|||
156850417|NCT00193206|566204543|FG000|Postoperative Therapy|Protocol Violation|1|||
156850418|NCT01461707|566204550|FG000|Overall Study|Withdrawal by Subject|1|||
156850419|NCT01461707|566204551|FG001|Overall Study|Withdrawal by Subject|0|||
156850420|NCT00337207|566204554|FG000|Overall Study|Withdrawal by Subject|3|||
156850421|NCT00837213|566204555|FG000|Overall Study|Lost to Follow-up|3|||
157156278|NCT02389816|567317569|FG001|Overall Study|Lack of Efficacy|0|||
157156279|NCT02389816|567317570|FG002|Overall Study|Lack of Efficacy|0|||
157156280|NCT02389816|567317568|FG000|Overall Study|Non Compliance with Study Drug|1|||
157156281|NCT02389816|567317569|FG001|Overall Study|Non Compliance with Study Drug|1|||
157156282|NCT02389816|567317570|FG002|Overall Study|Non Compliance with Study Drug|1|||
157156283|NCT02389816|567317568|FG000|Overall Study|Reason not Specified|0|||
157156284|NCT02389816|567317569|FG001|Overall Study|Reason not Specified|2|||
157156285|NCT02389816|567317570|FG002|Overall Study|Reason not Specified|0|||
157156286|NCT00578864|567317577|FG000|Overall Study|Death|1|||
157156287|NCT00578864|567317578|FG001|Overall Study|Death|0|||
157156288|NCT01253044|567317582|FG000|Overall Study|Lost to Follow-up|38|||
157156289|NCT01253044|567317583|FG001|Overall Study|Lost to Follow-up|29|||
157156290|NCT01217190|567317584|FG000|Second Dosing|Withdrawal by Subject|0|||
157156291|NCT01217190|567317585|FG001|Second Dosing|Withdrawal by Subject|2|||
157156292|NCT01594476|567317586|FG000|Overall Study|Protocol Violation|1|||
157156293|NCT01594476|567317587|FG001|Overall Study|Protocol Violation|3|||
157156294|NCT01425190|567317588|FG000|Overall Study|Full dose not consumed.|1|||
157156295|NCT01425190|567317589|FG001|Overall Study|Full dose not consumed.|0|||
157156296|NCT01425190|567317590|FG002|Overall Study|Full dose not consumed.|0|||
157156297|NCT02552355|567317591|FG000|Overall Study|Adverse Event|0|||
157156298|NCT02552355|567317592|FG001|Overall Study|Adverse Event|2|||
157156299|NCT02552355|567317593|FG002|Overall Study|Adverse Event|2|||
157156300|NCT02552355|567317594|FG003|Overall Study|Adverse Event|0|||
157156301|NCT02552355|567317591|FG000|Overall Study|Withdrawal by Subject|0|||
157156302|NCT02552355|567317592|FG001|Overall Study|Withdrawal by Subject|0|||
156850422|NCT00837213|566204556|FG001|Overall Study|Lost to Follow-up|2|||
156850423|NCT00837213|566204555|FG000|Overall Study|Withdrawal by Subject|2|||
156850424|NCT00837213|566204556|FG001|Overall Study|Withdrawal by Subject|2|||
156850425|NCT00837213|566204555|FG000|Overall Study|not stated|1|||
156850426|NCT00837213|566204556|FG001|Overall Study|not stated|1|||
156850427|NCT01684202|566204558|FG000|Dose-escalation Period|Adverse Event|0|||
156850428|NCT01684202|566204559|FG001|Dose-escalation Period|Adverse Event|1|||
156850429|NCT01684202|566204560|FG002|Dose-escalation Period|Adverse Event|0|||
156850430|NCT01684202|566204561|FG003|Dose-escalation Period|Adverse Event|0|||
156850431|NCT01684202|566204558|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
156850432|NCT01684202|566204559|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
156850433|NCT01684202|566204560|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
156850434|NCT01684202|566204561|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
156850435|NCT01684202|566204558|FG000|Maintenance Period|Adverse Event|1|||
156850436|NCT01684202|566204559|FG001|Maintenance Period|Adverse Event|1|||
156850437|NCT01684202|566204560|FG002|Maintenance Period|Adverse Event|1|||
156850438|NCT01684202|566204561|FG003|Maintenance Period|Adverse Event|1|||
157025666|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
157025667|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
156850439|NCT01684202|566204558|FG000|Maintenance Period|Physician Decision|0|||
157156303|NCT02552355|567317593|FG002|Overall Study|Withdrawal by Subject|0|||
157225420|NCT02309099|567571426|FG001|Overall Study|Adverse Event|0|||
157156304|NCT02552355|567317594|FG003|Overall Study|Withdrawal by Subject|1|||
157156305|NCT00850460|567317597|FG000|Overall Study|Lost to Follow-up|4|||
157156306|NCT00850460|567317598|FG001|Overall Study|Lost to Follow-up|4|||
157156307|NCT03007953|567317601|FG000|Overall Study|Withdrawal by Subject|5|||
157156308|NCT03007953|567317602|FG001|Overall Study|Withdrawal by Subject|2|||
157225421|NCT02819362|567571428|FG000|Overall Study|On-site MRI could not be performed|70|||
156850440|NCT01684202|566204559|FG001|Maintenance Period|Physician Decision|1|||
157225422|NCT05456529|567571429|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
156850441|NCT01684202|566204560|FG002|Maintenance Period|Physician Decision|0|||
156850442|NCT01684202|566204561|FG003|Maintenance Period|Physician Decision|0|||
156850443|NCT01684202|566204558|FG000|Maintenance Period|Withdrawal by Subject|0|||
156850444|NCT01684202|566204559|FG001|Maintenance Period|Withdrawal by Subject|1|||
156850445|NCT01684202|566204560|FG002|Maintenance Period|Withdrawal by Subject|0|||
156850446|NCT01684202|566204561|FG003|Maintenance Period|Withdrawal by Subject|0|||
156850447|NCT00191308|566204562|FG000|Overall Study|Adverse Event|1|||
157156309|NCT03007953|567317601|FG000|Overall Study|Death|5|||
157156310|NCT03007953|567317602|FG001|Overall Study|Death|7|||
156850448|NCT00466921|566204563|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
156850449|NCT00466921|566204563|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
156850450|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
156850451|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
157225423|NCT05456529|567571429|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
157225424|NCT05456529|567571429|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
157225425|NCT05456529|567571429|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
157225426|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
156850452|NCT00466921|566204563|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
156850453|NCT00466921|566204563|FG000|Follow up for a Minimum of 1 Year|Death|6|||
156850454|NCT00779025|566204564|FG000|Overall Study|Withdrawal by Subject|1|||
156850455|NCT03710642|566204565|FG000|Overall Study|Adverse Event|5|||
156850456|NCT03710642|566204566|FG001|Overall Study|Adverse Event|1|||
156850457|NCT03710642|566204565|FG000|Overall Study|non-site physician recommendation|1|||
156850458|NCT03710642|566204566|FG001|Overall Study|non-site physician recommendation|0|||
156850459|NCT03710642|566204565|FG000|Overall Study|Participant unwilling or unable to participate|1|||
156850460|NCT03710642|566204566|FG001|Overall Study|Participant unwilling or unable to participate|1|||
157025668|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
157225427|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
157225428|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Physician Decision|2|||
157225429|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
157225430|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
157225431|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
157225432|NCT05456529|567571429|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
157225433|NCT02750761|567571430|FG000|Overall Study|Lost to Follow-up|0|||
157225434|NCT02750761|567571431|FG001|Overall Study|Lost to Follow-up|0|||
157225435|NCT02750761|567571432|FG002|Overall Study|Lost to Follow-up|1|||
157225436|NCT02750761|567571433|FG003|Overall Study|Lost to Follow-up|0|||
157225437|NCT02750761|567571434|FG004|Overall Study|Lost to Follow-up|0|||
157225438|NCT02750761|567571435|FG005|Overall Study|Lost to Follow-up|0|||
157225439|NCT01860976|567571436|FG000|Blinded Treatment|Adverse Event|1|||
157225440|NCT01860976|567571437|FG001|Blinded Treatment|Adverse Event|3|||
157225441|NCT01860976|567571436|FG000|Blinded Treatment|Lack of Efficacy|5|||
157225442|NCT01860976|567571437|FG001|Blinded Treatment|Lack of Efficacy|12|||
157225443|NCT01860976|567571436|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
157225444|NCT01860976|567571437|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
157225445|NCT01860976|567571436|FG000|Blinded Treatment|Withdrawal by Subject|3|||
157225446|NCT01860976|567571437|FG001|Blinded Treatment|Withdrawal by Subject|5|||
157225447|NCT01860976|567571436|FG000|Blinded Treatment|Subject no longer met criteria|1|||
157225448|NCT01860976|567571437|FG001|Blinded Treatment|Subject no longer met criteria|0|||
156850461|NCT03710642|566204565|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
156850462|NCT03710642|566204566|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
156850463|NCT03710642|566204565|FG000|Overall Study|NA-no code provided|1|||
157025669|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
157025670|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
157025671|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
157025672|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
157025673|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
157025674|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
157025675|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
157025676|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
157025677|NCT04338061|566848035|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
157025678|NCT04338061|566848036|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
157025679|NCT04338061|566848035|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
157025680|NCT04338061|566848036|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
157025681|NCT04338061|566848035|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
157025682|NCT04338061|566848036|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
157025683|NCT04338061|566848035|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
157025684|NCT04338061|566848036|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
157025685|NCT04338061|566848035|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
157025686|NCT04338061|566848036|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
157025687|NCT04338061|566848035|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
157025688|NCT04338061|566848036|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
157025689|NCT04492722|566848038|FG000|Overall Study|Adverse Event|7|||
157025690|NCT04492722|566848039|FG001|Overall Study|Adverse Event|2|||
157025691|NCT04492722|566848040|FG002|Overall Study|Adverse Event|3|||
157025692|NCT04492722|566848041|FG003|Overall Study|Adverse Event|0|||
157025693|NCT04492722|566848038|FG000|Overall Study|Death|0|||
157156311|NCT03007953|567317601|FG000|Overall Study|Lost to Follow-up|3|||
157156312|NCT03007953|567317602|FG001|Overall Study|Lost to Follow-up|2|||
157156313|NCT03007953|567317601|FG000|Overall Study|Enrolled in Hospice|3|||
156850464|NCT03710642|566204566|FG001|Overall Study|NA-no code provided|0|||
156850465|NCT03710642|566204565|FG000|Overall Study|Withdrawal by Subject|1|||
157156314|NCT03007953|567317602|FG001|Overall Study|Enrolled in Hospice|2|||
157156315|NCT01052012|567317603|FG000|Overall Study|Not treated|2|||
157156316|NCT01052012|567317604|FG001|Overall Study|Not treated|5|||
157156317|NCT01052012|567317605|FG002|Overall Study|Not treated|0|||
157156318|NCT01052012|567317606|FG003|Overall Study|Not treated|0|||
157156319|NCT01052012|567317607|FG004|Overall Study|Not treated|11|||
157156320|NCT01052012|567317608|FG005|Overall Study|Not treated|8|||
157156321|NCT01052012|567317603|FG000|Overall Study|Adverse Event|1|||
157156322|NCT01052012|567317604|FG001|Overall Study|Adverse Event|0|||
157156323|NCT01052012|567317605|FG002|Overall Study|Adverse Event|0|||
157156324|NCT01052012|567317606|FG003|Overall Study|Adverse Event|1|||
157156325|NCT01052012|567317607|FG004|Overall Study|Adverse Event|0|||
157156326|NCT01052012|567317608|FG005|Overall Study|Adverse Event|0|||
157156327|NCT01052012|567317603|FG000|Overall Study|Lost to Follow-up|0|||
157156328|NCT01052012|567317604|FG001|Overall Study|Lost to Follow-up|0|||
156850466|NCT03710642|566204566|FG001|Overall Study|Withdrawal by Subject|0|||
156850467|NCT02741635|566204567|FG000|Overall Study|Withdrawal by Subject|1|||
156850468|NCT01427933|566204568|FG000|Overall Study|Withdrawal by Subject|5|||
156850469|NCT01427933|566204569|FG001|Overall Study|Withdrawal by Subject|8|||
156850470|NCT01427933|566204568|FG000|Overall Study|Lost to Follow-up|1|||
156850471|NCT01427933|566204569|FG001|Overall Study|Lost to Follow-up|5|||
156850472|NCT01427933|566204568|FG000|Overall Study|Other|1|||
156850473|NCT01427933|566204569|FG001|Overall Study|Other|0|||
157156329|NCT01052012|567317605|FG002|Overall Study|Lost to Follow-up|0|||
157156330|NCT01052012|567317606|FG003|Overall Study|Lost to Follow-up|0|||
157156331|NCT01052012|567317607|FG004|Overall Study|Lost to Follow-up|1|||
157156332|NCT01052012|567317608|FG005|Overall Study|Lost to Follow-up|0|||
157156333|NCT01052012|567317603|FG000|Overall Study|Withdrawal by Subject|1|||
157156334|NCT01052012|567317604|FG001|Overall Study|Withdrawal by Subject|1|||
157156335|NCT01052012|567317605|FG002|Overall Study|Withdrawal by Subject|0|||
157156336|NCT01052012|567317606|FG003|Overall Study|Withdrawal by Subject|0|||
157156337|NCT01052012|567317607|FG004|Overall Study|Withdrawal by Subject|3|||
157156338|NCT01052012|567317608|FG005|Overall Study|Withdrawal by Subject|1|||
157156339|NCT01052012|567317603|FG000|Overall Study|Physician Decision|0|||
157156340|NCT01052012|567317604|FG001|Overall Study|Physician Decision|0|||
157156341|NCT01052012|567317605|FG002|Overall Study|Physician Decision|0|||
157156342|NCT01052012|567317606|FG003|Overall Study|Physician Decision|0|||
157156343|NCT01052012|567317607|FG004|Overall Study|Physician Decision|0|||
157156344|NCT01052012|567317608|FG005|Overall Study|Physician Decision|1|||
157156345|NCT01052012|567317603|FG000|Overall Study|Other|0|||
157156346|NCT01052012|567317604|FG001|Overall Study|Other|0|||
157156347|NCT01052012|567317605|FG002|Overall Study|Other|0|||
157156348|NCT01052012|567317606|FG003|Overall Study|Other|0|||
157156349|NCT01052012|567317607|FG004|Overall Study|Other|1|||
157156350|NCT01052012|567317608|FG005|Overall Study|Other|0|||
157156351|NCT02224846|567317609|FG000|Period 1 (Month 3)|Adverse Event|2|||
157156352|NCT02224846|567317610|FG001|Period 1 (Month 3)|Adverse Event|1|||
157156353|NCT02224846|567317609|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
157156354|NCT02224846|567317610|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
156850474|NCT01427933|566204568|FG000|Overall Study|Investigator's Decision|1|||
156850475|NCT01427933|566204569|FG001|Overall Study|Investigator's Decision|0|||
156850476|NCT03386721|566204570|FG000|Overall Study|Death|12|||
156850477|NCT03386721|566204571|FG001|Overall Study|Death|21|||
156850478|NCT03386721|566204572|FG002|Overall Study|Death|2|||
156850479|NCT03386721|566204573|FG003|Overall Study|Death|5|||
157025694|NCT04492722|566848039|FG001|Overall Study|Death|0|||
157025695|NCT04492722|566848040|FG002|Overall Study|Death|0|||
157025696|NCT04492722|566848041|FG003|Overall Study|Death|1|||
157156355|NCT02224846|567317609|FG000|Period 1 (Month 3)|Protocol Violation|4|||
157156356|NCT02224846|567317610|FG001|Period 1 (Month 3)|Protocol Violation|8|||
157156357|NCT02224846|567317609|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
157156358|NCT02224846|567317610|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
157156359|NCT02224846|567317609|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
157156360|NCT02224846|567317610|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
157156361|NCT02224846|567317609|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
157156362|NCT02224846|567317610|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
157156363|NCT02224846|567317609|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
157156364|NCT02224846|567317610|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
157156365|NCT02224846|567317609|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
157156366|NCT02224846|567317610|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
156850480|NCT03386721|566204574|FG004|Overall Study|Death|1|||
156850481|NCT03386721|566204575|FG005|Overall Study|Death|12|||
157025697|NCT04492722|566848038|FG000|Overall Study|Lost to Follow-up|0|||
157156367|NCT02224846|567317609|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
157156368|NCT02224846|567317610|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
156850482|NCT03386721|566204576|FG006|Overall Study|Death|1|||
156850483|NCT03386721|566204577|FG007|Overall Study|Death|1|||
156850484|NCT03386721|566204578|FG008|Overall Study|Death|12|||
156850485|NCT03386721|566204579|FG009|Overall Study|Death|20|||
156850486|NCT03386721|566204580|FG010|Overall Study|Death|21|||
156850487|NCT03386721|566204581|FG011|Overall Study|Death|21|||
156850488|NCT03386721|566204582|FG012|Overall Study|Death|14|||
156850489|NCT03386721|566204583|FG013|Overall Study|Death|2|||
156850490|NCT03386721|566204584|FG014|Overall Study|Death|1|||
156850491|NCT03386721|566204570|FG000|Overall Study|Lost to Follow-up|1|||
156850492|NCT03386721|566204571|FG001|Overall Study|Lost to Follow-up|3|||
156850493|NCT03386721|566204572|FG002|Overall Study|Lost to Follow-up|0|||
156850494|NCT03386721|566204573|FG003|Overall Study|Lost to Follow-up|0|||
156850495|NCT03386721|566204574|FG004|Overall Study|Lost to Follow-up|0|||
156850496|NCT03386721|566204575|FG005|Overall Study|Lost to Follow-up|2|||
156850497|NCT03386721|566204576|FG006|Overall Study|Lost to Follow-up|1|||
156850498|NCT03386721|566204577|FG007|Overall Study|Lost to Follow-up|0|||
156850499|NCT03386721|566204578|FG008|Overall Study|Lost to Follow-up|1|||
156850500|NCT03386721|566204579|FG009|Overall Study|Lost to Follow-up|2|||
156850501|NCT03386721|566204580|FG010|Overall Study|Lost to Follow-up|1|||
156850502|NCT03386721|566204581|FG011|Overall Study|Lost to Follow-up|0|||
156850503|NCT03386721|566204582|FG012|Overall Study|Lost to Follow-up|0|||
156850504|NCT03386721|566204583|FG013|Overall Study|Lost to Follow-up|0|||
156850505|NCT03386721|566204584|FG014|Overall Study|Lost to Follow-up|0|||
156850506|NCT03386721|566204570|FG000|Overall Study|Reason not specified|3|||
156850507|NCT03386721|566204571|FG001|Overall Study|Reason not specified|0|||
156850508|NCT03386721|566204572|FG002|Overall Study|Reason not specified|0|||
156850509|NCT03386721|566204573|FG003|Overall Study|Reason not specified|0|||
156850510|NCT03386721|566204574|FG004|Overall Study|Reason not specified|0|||
156850511|NCT03386721|566204575|FG005|Overall Study|Reason not specified|3|||
156850512|NCT03386721|566204576|FG006|Overall Study|Reason not specified|1|||
156850513|NCT03386721|566204577|FG007|Overall Study|Reason not specified|0|||
156850514|NCT03386721|566204578|FG008|Overall Study|Reason not specified|0|||
156850515|NCT03386721|566204579|FG009|Overall Study|Reason not specified|1|||
156850516|NCT03386721|566204580|FG010|Overall Study|Reason not specified|2|||
156850517|NCT03386721|566204581|FG011|Overall Study|Reason not specified|6|||
156850518|NCT03386721|566204582|FG012|Overall Study|Reason not specified|1|||
156850519|NCT03386721|566204583|FG013|Overall Study|Reason not specified|0|||
156850520|NCT03386721|566204584|FG014|Overall Study|Reason not specified|0|||
156850521|NCT03386721|566204570|FG000|Overall Study|Progressive Disease|0|||
156850522|NCT03386721|566204571|FG001|Overall Study|Progressive Disease|0|||
156850523|NCT03386721|566204572|FG002|Overall Study|Progressive Disease|1|||
156850524|NCT03386721|566204573|FG003|Overall Study|Progressive Disease|0|||
156850525|NCT03386721|566204574|FG004|Overall Study|Progressive Disease|0|||
156850526|NCT03386721|566204575|FG005|Overall Study|Progressive Disease|1|||
156850527|NCT03386721|566204576|FG006|Overall Study|Progressive Disease|0|||
156850528|NCT03386721|566204577|FG007|Overall Study|Progressive Disease|0|||
156850529|NCT03386721|566204578|FG008|Overall Study|Progressive Disease|2|||
156850530|NCT03386721|566204579|FG009|Overall Study|Progressive Disease|1|||
156850531|NCT03386721|566204580|FG010|Overall Study|Progressive Disease|1|||
156850532|NCT03386721|566204581|FG011|Overall Study|Progressive Disease|0|||
156850533|NCT03386721|566204582|FG012|Overall Study|Progressive Disease|1|||
156850534|NCT03386721|566204583|FG013|Overall Study|Progressive Disease|0|||
156850535|NCT03386721|566204584|FG014|Overall Study|Progressive Disease|0|||
156850536|NCT03386721|566204570|FG000|Overall Study|Site Terminated by Sponsor|5|||
156850537|NCT03386721|566204571|FG001|Overall Study|Site Terminated by Sponsor|5|||
156850538|NCT03386721|566204572|FG002|Overall Study|Site Terminated by Sponsor|0|||
156850539|NCT03386721|566204573|FG003|Overall Study|Site Terminated by Sponsor|0|||
156850540|NCT03386721|566204574|FG004|Overall Study|Site Terminated by Sponsor|1|||
156850541|NCT03386721|566204575|FG005|Overall Study|Site Terminated by Sponsor|3|||
156850542|NCT03386721|566204576|FG006|Overall Study|Site Terminated by Sponsor|0|||
156850543|NCT03386721|566204577|FG007|Overall Study|Site Terminated by Sponsor|1|||
156850544|NCT03386721|566204578|FG008|Overall Study|Site Terminated by Sponsor|4|||
156850545|NCT03386721|566204579|FG009|Overall Study|Site Terminated by Sponsor|5|||
156850546|NCT03386721|566204580|FG010|Overall Study|Site Terminated by Sponsor|3|||
156888958|NCT01077375|566352275|FG001|Overall Study|Adverse Event|15|||
156888959|NCT01077375|566352274|FG000|Overall Study|Lack of Efficacy|6|||
156888960|NCT01077375|566352275|FG001|Overall Study|Lack of Efficacy|8|||
156888961|NCT01077375|566352274|FG000|Overall Study|Withdrawal by Subject|0|||
156888962|NCT01077375|566352275|FG001|Overall Study|Withdrawal by Subject|6|||
156888963|NCT01077375|566352274|FG000|Overall Study|Lost to Follow-up|2|||
156888964|NCT01077375|566352275|FG001|Overall Study|Lost to Follow-up|5|||
156850547|NCT03386721|566204581|FG011|Overall Study|Site Terminated by Sponsor|11|||
156850548|NCT03386721|566204582|FG012|Overall Study|Site Terminated by Sponsor|6|||
156850549|NCT03386721|566204583|FG013|Overall Study|Site Terminated by Sponsor|0|||
156850550|NCT03386721|566204584|FG014|Overall Study|Site Terminated by Sponsor|0|||
156850551|NCT03386721|566204570|FG000|Overall Study|Symptomatic Deterioration|0|||
156888965|NCT01077375|566352274|FG000|Overall Study|Other Reason|0|||
156888966|NCT01077375|566352275|FG001|Overall Study|Other Reason|1|||
156850552|NCT03386721|566204571|FG001|Overall Study|Symptomatic Deterioration|0|||
156850553|NCT03386721|566204572|FG002|Overall Study|Symptomatic Deterioration|0|||
156850554|NCT03386721|566204573|FG003|Overall Study|Symptomatic Deterioration|0|||
156850555|NCT03386721|566204574|FG004|Overall Study|Symptomatic Deterioration|0|||
156850556|NCT03386721|566204575|FG005|Overall Study|Symptomatic Deterioration|0|||
156850557|NCT03386721|566204576|FG006|Overall Study|Symptomatic Deterioration|0|||
156850558|NCT03386721|566204577|FG007|Overall Study|Symptomatic Deterioration|0|||
156850559|NCT03386721|566204578|FG008|Overall Study|Symptomatic Deterioration|1|||
156850560|NCT03386721|566204579|FG009|Overall Study|Symptomatic Deterioration|0|||
156850561|NCT03386721|566204580|FG010|Overall Study|Symptomatic Deterioration|0|||
156850562|NCT03386721|566204581|FG011|Overall Study|Symptomatic Deterioration|1|||
156850563|NCT03386721|566204582|FG012|Overall Study|Symptomatic Deterioration|0|||
156850564|NCT03386721|566204583|FG013|Overall Study|Symptomatic Deterioration|0|||
156850565|NCT03386721|566204584|FG014|Overall Study|Symptomatic Deterioration|0|||
156850566|NCT03386721|566204570|FG000|Overall Study|Withdrawal by Subject|1|||
156850567|NCT03386721|566204571|FG001|Overall Study|Withdrawal by Subject|2|||
156850568|NCT03386721|566204572|FG002|Overall Study|Withdrawal by Subject|0|||
156850569|NCT03386721|566204573|FG003|Overall Study|Withdrawal by Subject|0|||
156850570|NCT03386721|566204574|FG004|Overall Study|Withdrawal by Subject|0|||
156850571|NCT03386721|566204575|FG005|Overall Study|Withdrawal by Subject|0|||
156850572|NCT03386721|566204576|FG006|Overall Study|Withdrawal by Subject|0|||
156850573|NCT03386721|566204577|FG007|Overall Study|Withdrawal by Subject|0|||
156850574|NCT03386721|566204578|FG008|Overall Study|Withdrawal by Subject|2|||
156850575|NCT03386721|566204579|FG009|Overall Study|Withdrawal by Subject|1|||
156850576|NCT03386721|566204580|FG010|Overall Study|Withdrawal by Subject|3|||
156850577|NCT03386721|566204581|FG011|Overall Study|Withdrawal by Subject|2|||
156850578|NCT03386721|566204582|FG012|Overall Study|Withdrawal by Subject|3|||
156850579|NCT03386721|566204583|FG013|Overall Study|Withdrawal by Subject|0|||
156850580|NCT03386721|566204584|FG014|Overall Study|Withdrawal by Subject|0|||
156850581|NCT00700713|566204585|FG000|Overall Study|Protocol Violation|1|||
156850582|NCT00700713|566204586|FG001|Overall Study|Protocol Violation|0|||
156850583|NCT00700713|566204587|FG002|Overall Study|Protocol Violation|1|||
156850584|NCT00700713|566204585|FG000|Overall Study|Withdrawal by Subject|0|||
156850585|NCT00700713|566204586|FG001|Overall Study|Withdrawal by Subject|0|||
156850586|NCT00700713|566204587|FG002|Overall Study|Withdrawal by Subject|1|||
156850587|NCT05729568|566204590|FG000|Overall Study|Still on Study|52|||
156850588|NCT05729568|566204591|FG001|Overall Study|Still on Study|26|||
156850589|NCT05729568|566204590|FG000|Overall Study|Randomized but Never Treated|3|||
156850590|NCT05729568|566204591|FG001|Overall Study|Randomized but Never Treated|0|||
156850591|NCT05729568|566204590|FG000|Overall Study|Adverse Event|0|||
156850592|NCT05729568|566204591|FG001|Overall Study|Adverse Event|1|||
157225449|NCT01860976|567571436|FG000|Blinded Treatment|Entered Open-Label in error|0|||
156850593|NCT05729568|566204590|FG000|Overall Study|Investigator's Discretion|1|||
156850594|NCT05729568|566204591|FG001|Overall Study|Investigator's Discretion|0|||
156850595|NCT01369784|566204594|FG000|Overall Study|Protocol Violation|12|||
156850596|NCT00596752|566204597|FG000|Overall Study|Other Reason|44|||
156850597|NCT00596752|566204598|FG001|Overall Study|Other Reason|49|||
156850598|NCT00596752|566204597|FG000|Overall Study|Adverse Event|34|||
156850599|NCT00596752|566204598|FG001|Overall Study|Adverse Event|34|||
156850600|NCT00596752|566204597|FG000|Overall Study|Lost to Follow-up|22|||
156850601|NCT00596752|566204598|FG001|Overall Study|Lost to Follow-up|38|||
156850602|NCT00596752|566204597|FG000|Overall Study|Withdrawal by Subject|12|||
156850603|NCT00596752|566204598|FG001|Overall Study|Withdrawal by Subject|9|||
156850604|NCT00596752|566204597|FG000|Overall Study|Unsatisfactory Compliance|9|||
156850605|NCT00596752|566204598|FG001|Overall Study|Unsatisfactory Compliance|6|||
156850606|NCT00596752|566204597|FG000|Overall Study|Lack of Efficacy|4|||
156850607|NCT00596752|566204598|FG001|Overall Study|Lack of Efficacy|7|||
156850608|NCT00596752|566204597|FG000|Overall Study|Protocol Violation|1|||
156850609|NCT00596752|566204598|FG001|Overall Study|Protocol Violation|0|||
156850610|NCT04797780|566204601|FG000|Overall Study|Lost to Follow-up|1|||
156850611|NCT04797780|566204602|FG001|Overall Study|Lost to Follow-up|1|||
156850612|NCT04797780|566204601|FG000|Overall Study|Withdrawal by Subject|14|||
156850613|NCT04797780|566204602|FG001|Overall Study|Withdrawal by Subject|9|||
156850614|NCT04797780|566204601|FG000|Overall Study|Death|49|||
156850615|NCT04797780|566204602|FG001|Overall Study|Death|20|||
156850616|NCT02586727|566204603|FG000|Overall Study|Lost to Follow-up|1|||
156850617|NCT02586727|566204604|FG001|Overall Study|Lost to Follow-up|0|||
156850618|NCT05167825|566204605|FG000|Overall Study|Ongoing|3|||
156850619|NCT02534909|566204617|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
156850620|NCT02326597|566204620|FG000|Overall Study|Lost to Follow-up|42|||
156850621|NCT02326597|566204621|FG001|Overall Study|Lost to Follow-up|32|||
156850622|NCT02119663|566204624|FG000|Overall Study|Disease progression|26|||
156850623|NCT02119663|566204625|FG001|Overall Study|Disease progression|27|||
156850624|NCT02119663|566204624|FG000|Overall Study|Adverse Event|5|||
156850625|NCT02119663|566204625|FG001|Overall Study|Adverse Event|5|||
156850626|NCT02119663|566204624|FG000|Overall Study|Death|3|||
157025698|NCT04492722|566848039|FG001|Overall Study|Lost to Follow-up|1|||
156850627|NCT02119663|566204625|FG001|Overall Study|Death|2|||
156850628|NCT02119663|566204624|FG000|Overall Study|Physician Decision|1|||
156850629|NCT02119663|566204625|FG001|Overall Study|Physician Decision|2|||
156850630|NCT02119663|566204624|FG000|Overall Study|Other unspecified|2|||
156850631|NCT02119663|566204625|FG001|Overall Study|Other unspecified|0|||
156850632|NCT02119663|566204624|FG000|Overall Study|Subject decision|0|||
156850633|NCT02119663|566204625|FG001|Overall Study|Subject decision|1|||
156850634|NCT02119663|566204624|FG000|Overall Study|Study Terminated by the Sponsor|3|||
156850635|NCT02119663|566204625|FG001|Overall Study|Study Terminated by the Sponsor|4|||
156850636|NCT01870726|566204626|FG000|Overall Study|Withdrawal of informed consent|0|||
156850637|NCT01870726|566204627|FG001|Overall Study|Withdrawal of informed consent|0|||
156850638|NCT01870726|566204628|FG002|Overall Study|Withdrawal of informed consent|0|||
156850639|NCT01870726|566204629|FG003|Overall Study|Withdrawal of informed consent|1|||
156850640|NCT01870726|566204630|FG004|Overall Study|Withdrawal of informed consent|0|||
156850641|NCT01870726|566204631|FG005|Overall Study|Withdrawal of informed consent|0|||
156850642|NCT01870726|566204632|FG006|Overall Study|Withdrawal of informed consent|0|||
156850643|NCT01870726|566204626|FG000|Overall Study|Withdrawal by Subject|0|||
156850644|NCT01870726|566204627|FG001|Overall Study|Withdrawal by Subject|1|||
156850645|NCT01870726|566204628|FG002|Overall Study|Withdrawal by Subject|0|||
156850646|NCT01870726|566204629|FG003|Overall Study|Withdrawal by Subject|0|||
156850647|NCT01870726|566204630|FG004|Overall Study|Withdrawal by Subject|0|||
156850648|NCT01870726|566204631|FG005|Overall Study|Withdrawal by Subject|0|||
156850649|NCT01870726|566204632|FG006|Overall Study|Withdrawal by Subject|0|||
156850650|NCT01870726|566204626|FG000|Overall Study|Adverse Event|0|||
156850651|NCT01870726|566204627|FG001|Overall Study|Adverse Event|0|||
156850652|NCT01870726|566204628|FG002|Overall Study|Adverse Event|0|||
156850653|NCT01870726|566204629|FG003|Overall Study|Adverse Event|0|||
156850654|NCT01870726|566204630|FG004|Overall Study|Adverse Event|1|||
156850655|NCT01870726|566204631|FG005|Overall Study|Adverse Event|1|||
156850656|NCT01870726|566204632|FG006|Overall Study|Adverse Event|0|||
156850657|NCT01870726|566204626|FG000|Overall Study|Progressive disease|5|||
156850658|NCT01870726|566204627|FG001|Overall Study|Progressive disease|5|||
156850659|NCT01870726|566204628|FG002|Overall Study|Progressive disease|4|||
156850660|NCT01870726|566204629|FG003|Overall Study|Progressive disease|5|||
156850661|NCT01870726|566204630|FG004|Overall Study|Progressive disease|6|||
156850662|NCT01870726|566204631|FG005|Overall Study|Progressive disease|4|||
156850663|NCT01870726|566204632|FG006|Overall Study|Progressive disease|10|||
156850664|NCT02978833|566204635|FG000|Overall Study|Study terminated|1|||
156850665|NCT02978833|566204636|FG001|Overall Study|Study terminated|1|||
156850666|NCT01123395|566204637|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
156850667|NCT01123395|566204638|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
156850668|NCT03691571|566204639|FG000|Overall Study|Withdrawal by Subject|9|||
156850669|NCT03691571|566204640|FG001|Overall Study|Withdrawal by Subject|2|||
156850670|NCT04186871|566204641|FG000|Overall Study|Lack of Efficacy|0|||
156850671|NCT04186871|566204642|FG001|Overall Study|Lack of Efficacy|1|||
156850672|NCT04186871|566204643|FG002|Overall Study|Lack of Efficacy|0|||
156850673|NCT04186871|566204644|FG003|Overall Study|Lack of Efficacy|0|||
156850674|NCT04186871|566204645|FG004|Overall Study|Lack of Efficacy|1|||
156850675|NCT04186871|566204646|FG005|Overall Study|Lack of Efficacy|1|||
156850676|NCT04186871|566204641|FG000|Overall Study|Adverse Event|1|||
156850677|NCT04186871|566204642|FG001|Overall Study|Adverse Event|1|||
156850678|NCT04186871|566204643|FG002|Overall Study|Adverse Event|0|||
156850679|NCT04186871|566204644|FG003|Overall Study|Adverse Event|0|||
156850680|NCT04186871|566204645|FG004|Overall Study|Adverse Event|0|||
156888967|NCT01924429|566352279|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
156888968|NCT01924429|566352280|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
156888969|NCT01150474|566352283|FG000|Overall Study|Withdrawal by Subject|5|||
156888970|NCT01150474|566352284|FG001|Overall Study|Withdrawal by Subject|2|||
156888971|NCT01150474|566352283|FG000|Overall Study|Cancer found|1|||
156888972|NCT01150474|566352284|FG001|Overall Study|Cancer found|0|||
156888973|NCT01150474|566352283|FG000|Overall Study|Multiple Studies|0|||
156888974|NCT01150474|566352284|FG001|Overall Study|Multiple Studies|1|||
156888975|NCT01150474|566352283|FG000|Overall Study|Rectotomy|1|||
156888976|NCT01150474|566352284|FG001|Overall Study|Rectotomy|0|||
156888977|NCT01150474|566352283|FG000|Overall Study|Drug did not arrive in time|1|||
156888978|NCT01150474|566352284|FG001|Overall Study|Drug did not arrive in time|0|||
156888979|NCT01150474|566352283|FG000|Overall Study|Drug not administered|1|||
156888980|NCT01150474|566352284|FG001|Overall Study|Drug not administered|0|||
156888981|NCT01150474|566352283|FG000|Overall Study|Surgery Changed|1|||
156888982|NCT01150474|566352284|FG001|Overall Study|Surgery Changed|0|||
156888983|NCT03021564|566352285|FG000|Overall Study|Death|84|||
156888984|NCT03021564|566352286|FG001|Overall Study|Death|466|||
156888985|NCT03021564|566352285|FG000|Overall Study|Lost to Follow-up|0|||
156850681|NCT04186871|566204646|FG005|Overall Study|Adverse Event|2|||
156850682|NCT04186871|566204641|FG000|Overall Study|Study terminated by sponsor|1|||
156850683|NCT04186871|566204642|FG001|Overall Study|Study terminated by sponsor|2|||
156850684|NCT04186871|566204643|FG002|Overall Study|Study terminated by sponsor|0|||
156850685|NCT04186871|566204644|FG003|Overall Study|Study terminated by sponsor|1|||
157156369|NCT02224846|567317609|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
157156370|NCT02224846|567317610|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
157156371|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
157156372|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
157156373|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
157156374|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
157156375|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
157156376|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
157156377|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
157156378|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
157156379|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
157156380|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
157156381|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
157156382|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
157156383|NCT02224846|567317609|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
157156384|NCT02224846|567317610|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
157156385|NCT03196297|567317614|FG000|Main Period|Withdrawal by Subject|4|||
157156386|NCT03196297|567317614|FG000|Extension Period|Withdrawal by Subject|1|||
157156387|NCT03196297|567317614|FG000|Extension Period|Lack of Efficacy|2|||
157156388|NCT02538666|567317615|FG000|Pre-Treatment|Disease progression|1|||
157156389|NCT02538666|567317616|FG001|Pre-Treatment|Disease progression|0|||
157156390|NCT02538666|567317617|FG002|Pre-Treatment|Disease progression|0|||
157156391|NCT02538666|567317615|FG000|Pre-Treatment|no longer meets study criteria|1|||
157156392|NCT02538666|567317616|FG001|Pre-Treatment|no longer meets study criteria|0|||
157156393|NCT02538666|567317617|FG002|Pre-Treatment|no longer meets study criteria|0|||
157156394|NCT02538666|567317615|FG000|Pre-Treatment|Withdrew Consent|0|||
157156395|NCT02538666|567317616|FG001|Pre-Treatment|Withdrew Consent|1|||
157156396|NCT02538666|567317617|FG002|Pre-Treatment|Withdrew Consent|1|||
157156397|NCT02538666|567317615|FG000|Treatment|Disease progression|270|||
157156398|NCT02538666|567317616|FG001|Treatment|Disease progression|227|||
157156399|NCT02538666|567317617|FG002|Treatment|Disease progression|165|||
156850686|NCT04186871|566204645|FG004|Overall Study|Study terminated by sponsor|0|||
156850687|NCT04186871|566204646|FG005|Overall Study|Study terminated by sponsor|0|||
156850688|NCT04186871|566204641|FG000|Overall Study|Other reasons|0|||
156850689|NCT04186871|566204642|FG001|Overall Study|Other reasons|0|||
156850690|NCT04186871|566204643|FG002|Overall Study|Other reasons|0|||
156850691|NCT04186871|566204644|FG003|Overall Study|Other reasons|0|||
156850692|NCT04186871|566204645|FG004|Overall Study|Other reasons|0|||
156850693|NCT04186871|566204646|FG005|Overall Study|Other reasons|1|||
157156400|NCT02538666|567317615|FG000|Treatment|Study drug toxicity|1|||
157156401|NCT02538666|567317616|FG001|Treatment|Study drug toxicity|29|||
157156402|NCT02538666|567317617|FG002|Treatment|Study drug toxicity|92|||
157156403|NCT02538666|567317615|FG000|Treatment|Death|0|||
157156404|NCT02538666|567317616|FG001|Treatment|Death|2|||
157156405|NCT02538666|567317617|FG002|Treatment|Death|3|||
157156406|NCT02538666|567317615|FG000|Treatment|Adverse event unrelated to study drug|8|||
157156407|NCT02538666|567317616|FG001|Treatment|Adverse event unrelated to study drug|10|||
157156408|NCT02538666|567317617|FG002|Treatment|Adverse event unrelated to study drug|15|||
157156409|NCT02538666|567317615|FG000|Treatment|Participant request to discontinue study treatment|3|||
157156410|NCT02538666|567317616|FG001|Treatment|Participant request to discontinue study treatment|6|||
157156411|NCT02538666|567317617|FG002|Treatment|Participant request to discontinue study treatment|11|||
157156412|NCT02538666|567317615|FG000|Treatment|Participant withdrew consent|2|||
157156413|NCT02538666|567317616|FG001|Treatment|Participant withdrew consent|5|||
157156414|NCT02538666|567317617|FG002|Treatment|Participant withdrew consent|3|||
157156415|NCT02538666|567317615|FG000|Treatment|Lost to Follow-up|0|||
157156416|NCT02538666|567317616|FG001|Treatment|Lost to Follow-up|1|||
157156417|NCT02538666|567317617|FG002|Treatment|Lost to Follow-up|1|||
156850694|NCT04186871|566204641|FG000|Overall Study|Withdrawal by Subject|0|||
156888986|NCT03021564|566352286|FG001|Overall Study|Lost to Follow-up|2|||
156888987|NCT00969280|566352287|FG000|Overall Study|Protocol Violation|2|||
156888988|NCT00969280|566352288|FG001|Overall Study|Protocol Violation|1|||
156888989|NCT00969280|566352287|FG000|Overall Study|Withdrawal by Subject|0|||
156888990|NCT00969280|566352288|FG001|Overall Study|Withdrawal by Subject|1|||
156888991|NCT00969280|566352287|FG000|Overall Study|infection of influenza A(H1N1)|0|||
157156418|NCT02538666|567317615|FG000|Treatment|Maximum clinical benefit|4|||
157156419|NCT02538666|567317616|FG001|Treatment|Maximum clinical benefit|3|||
157156420|NCT02538666|567317617|FG002|Treatment|Maximum clinical benefit|4|||
157156421|NCT02538666|567317615|FG000|Treatment|Poor/non-compliance|0|||
157156422|NCT02538666|567317616|FG001|Treatment|Poor/non-compliance|1|||
156850695|NCT04186871|566204642|FG001|Overall Study|Withdrawal by Subject|0|||
156850696|NCT04186871|566204643|FG002|Overall Study|Withdrawal by Subject|0|||
156888992|NCT00969280|566352288|FG001|Overall Study|infection of influenza A(H1N1)|1|||
157156423|NCT02538666|567317617|FG002|Treatment|Poor/non-compliance|0|||
157156424|NCT02538666|567317615|FG000|Treatment|Participant no longer meets study criteria|0|||
157156425|NCT02538666|567317616|FG001|Treatment|Participant no longer meets study criteria|2|||
157156426|NCT02538666|567317617|FG002|Treatment|Participant no longer meets study criteria|0|||
157156427|NCT02538666|567317615|FG000|Treatment|Administrative reason by sponsor|0|||
157156428|NCT02538666|567317616|FG001|Treatment|Administrative reason by sponsor|0|||
157156429|NCT02538666|567317617|FG002|Treatment|Administrative reason by sponsor|1|||
157156430|NCT02538666|567317615|FG000|Treatment|Other reasons|8|||
157156431|NCT02538666|567317616|FG001|Treatment|Other reasons|15|||
157156432|NCT02538666|567317617|FG002|Treatment|Other reasons|5|||
157156433|NCT02538666|567317615|FG000|Treatment|Not reported|2|||
157156434|NCT02538666|567317616|FG001|Treatment|Not reported|2|||
157156435|NCT02538666|567317617|FG002|Treatment|Not reported|2|||
157156436|NCT00320385|567317622|FG000|Overall Study|Lost to Follow-up|7|||
157156437|NCT00320385|567317623|FG001|Overall Study|Lost to Follow-up|10|||
157156438|NCT00320385|567317622|FG000|Overall Study|Withdrawal by Subject|6|||
157156439|NCT00320385|567317623|FG001|Overall Study|Withdrawal by Subject|7|||
157156440|NCT00320385|567317622|FG000|Overall Study|Sponsor Terminated Study|2|||
157156441|NCT00320385|567317623|FG001|Overall Study|Sponsor Terminated Study|1|||
157156442|NCT00320385|567317622|FG000|Overall Study|Investigator Decision|0|||
157156443|NCT00320385|567317623|FG001|Overall Study|Investigator Decision|1|||
157156444|NCT00320385|567317622|FG000|Overall Study|Death|1|||
157156445|NCT00320385|567317623|FG001|Overall Study|Death|2|||
157156446|NCT00320385|567317622|FG000|Overall Study|Serious Adverse Event|1|||
157156447|NCT00320385|567317623|FG001|Overall Study|Serious Adverse Event|0|||
157156448|NCT00320385|567317622|FG000|Overall Study|Withdrew Consent|1|||
157156449|NCT00320385|567317623|FG001|Overall Study|Withdrew Consent|0|||
156850697|NCT04186871|566204644|FG003|Overall Study|Withdrawal by Subject|0|||
156850698|NCT04186871|566204645|FG004|Overall Study|Withdrawal by Subject|0|||
156850699|NCT04186871|566204646|FG005|Overall Study|Withdrawal by Subject|1|||
156850700|NCT04186871|566204641|FG000|Overall Study|Lost to Follow-up|0|||
156850701|NCT04186871|566204642|FG001|Overall Study|Lost to Follow-up|0|||
156850702|NCT04186871|566204643|FG002|Overall Study|Lost to Follow-up|0|||
156850703|NCT04186871|566204644|FG003|Overall Study|Lost to Follow-up|0|||
156850704|NCT04186871|566204645|FG004|Overall Study|Lost to Follow-up|0|||
156850705|NCT04186871|566204646|FG005|Overall Study|Lost to Follow-up|1|||
156850706|NCT01546688|566204647|FG000|Overall Study|Adverse Event|0|||
156850707|NCT01546688|566204648|FG001|Overall Study|Adverse Event|4|||
156850708|NCT01546688|566204647|FG000|Overall Study|Withdrawal by Subject|2|||
157156450|NCT00320385|567317622|FG000|Overall Study|Adverse Event|0|||
157156451|NCT00320385|567317623|FG001|Overall Study|Adverse Event|1|||
157156452|NCT04370028|567317624|FG000|Overall Study|Withdrawal by Subject|695|||
157156453|NCT04370028|567317624|FG000|Overall Study|Protocol Violation|9|||
157156454|NCT04370028|567317624|FG000|Overall Study|Adverse Event|3|||
157156455|NCT02582749|567317629|FG000|Overall Study|Study terminated by funder|5|||
157156456|NCT02582749|567317630|FG001|Overall Study|Study terminated by funder|10|||
157156457|NCT02582749|567317629|FG000|Overall Study|Withdrawal by Subject|0|||
157225450|NCT01860976|567571437|FG001|Blinded Treatment|Entered Open-Label in error|1|||
157225451|NCT01860976|567571436|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
157225452|NCT01860976|567571437|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
157225453|NCT01860976|567571436|FG000|Open-Label|Adverse Event|2|||
156850709|NCT01546688|566204648|FG001|Overall Study|Withdrawal by Subject|1|||
156850710|NCT01546688|566204647|FG000|Overall Study|Lack of Efficacy|1|||
157156458|NCT02582749|567317630|FG001|Overall Study|Withdrawal by Subject|1|||
157156459|NCT02213198|567317631|FG000|Baseline|No show for intake|7|||
156850711|NCT01546688|566204648|FG001|Overall Study|Lack of Efficacy|0|||
156850712|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
156850713|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
156888993|NCT00459979|566352289|FG000|Overall Study|Withdrawal by Subject|1|||
156888994|NCT00459979|566352289|FG000|Overall Study|Protocol Violation|1|||
156888995|NCT00278915|566352292|FG000|Overall Study|Disease progression|1|||
156888996|NCT05214573|566352293|FG000|Overall Study|Physician Decision|5924|||
156888997|NCT05214573|566352294|FG001|Overall Study|Physician Decision|0|||
156888998|NCT00814801|566352295|FG000|Overall Study|Adverse Event|15|||
156888999|NCT00814801|566352296|FG001|Overall Study|Adverse Event|16|||
156889000|NCT00814801|566352297|FG002|Overall Study|Adverse Event|19|||
156889001|NCT00814801|566352295|FG000|Overall Study|Withdrawal by Subject|9|||
156889002|NCT00814801|566352296|FG001|Overall Study|Withdrawal by Subject|11|||
156889003|NCT00814801|566352297|FG002|Overall Study|Withdrawal by Subject|14|||
156889004|NCT00814801|566352295|FG000|Overall Study|Inappropriate as a subject|1|||
156889005|NCT00814801|566352296|FG001|Overall Study|Inappropriate as a subject|1|||
156889006|NCT00814801|566352297|FG002|Overall Study|Inappropriate as a subject|1|||
156889007|NCT00814801|566352295|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
156889008|NCT00814801|566352296|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
157156460|NCT02213198|567317632|FG001|Baseline|No show for intake|9|||
157156461|NCT02213198|567317631|FG000|Baseline|Withdrawal by Subject|34|||
157156462|NCT02213198|567317632|FG001|Baseline|Withdrawal by Subject|11|||
157156463|NCT02213198|567317631|FG000|Baseline|transferred out of clinic|7|||
157156464|NCT02213198|567317632|FG001|Baseline|transferred out of clinic|9|||
157156465|NCT02213198|567317631|FG000|Baseline|Lost to Follow-up|40|||
157156466|NCT02213198|567317632|FG001|Baseline|Lost to Follow-up|21|||
156850714|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
156850715|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
156850716|NCT03543137|566204649|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
157156467|NCT02213198|567317631|FG000|Baseline|incarcerated,violent|0|||
157156468|NCT02213198|567317632|FG001|Baseline|incarcerated,violent|1|||
157156469|NCT02213198|567317631|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
157156470|NCT02213198|567317632|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
157156471|NCT02213198|567317631|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
157156472|NCT02213198|567317632|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
157156473|NCT02213198|567317631|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
157156474|NCT02213198|567317632|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
157156475|NCT02213198|567317631|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
157156476|NCT02213198|567317632|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
157156477|NCT02213198|567317631|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
157156478|NCT02213198|567317632|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
157156479|NCT02213198|567317631|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
157156480|NCT02213198|567317632|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
157156481|NCT01518192|567317633|FG000|Overall Study|Lost to Follow-up|29|||
157156482|NCT01518192|567317634|FG001|Overall Study|Lost to Follow-up|26|||
157156483|NCT01518192|567317635|FG002|Overall Study|Lost to Follow-up|35|||
157156484|NCT00001262|567317636|FG000|Overall Study|Death|10|||
157156485|NCT00001262|567317637|FG001|Overall Study|Death|11|||
157156486|NCT00001262|567317638|FG002|Overall Study|Death|0|||
157156487|NCT00001262|567317636|FG000|Overall Study|Withdrawal by Subject|0|||
157156488|NCT00001262|567317637|FG001|Overall Study|Withdrawal by Subject|3|||
157156489|NCT00001262|567317638|FG002|Overall Study|Withdrawal by Subject|0|||
157156490|NCT00783705|567317640|FG000|Overall Study|Adverse Event|2|||
157156491|NCT00783705|567317641|FG001|Overall Study|Adverse Event|0|||
157156492|NCT00783705|567317640|FG000|Overall Study|Withdrawal by Subject|3|||
157156493|NCT00783705|567317641|FG001|Overall Study|Withdrawal by Subject|2|||
157156494|NCT00783705|567317640|FG000|Overall Study|Lost to Follow-up|1|||
157156495|NCT00783705|567317641|FG001|Overall Study|Lost to Follow-up|3|||
157156496|NCT00601523|567317642|FG000|Overall Study|Adverse Event|42|||
157156497|NCT00601523|567317643|FG001|Overall Study|Adverse Event|14|||
157156498|NCT00601523|567317642|FG000|Overall Study|Lack of Efficacy|3|||
157156499|NCT00601523|567317643|FG001|Overall Study|Lack of Efficacy|0|||
157156500|NCT00601523|567317642|FG000|Overall Study|Protocol Violation|5|||
157156501|NCT00601523|567317643|FG001|Overall Study|Protocol Violation|1|||
157156502|NCT00601523|567317642|FG000|Overall Study|Lost to Follow-up|0|||
157156503|NCT00601523|567317643|FG001|Overall Study|Lost to Follow-up|1|||
157156504|NCT00601523|567317642|FG000|Overall Study|Withdrawal by Subject|18|||
157156505|NCT00601523|567317643|FG001|Overall Study|Withdrawal by Subject|9|||
157156506|NCT00601523|567317642|FG000|Overall Study|Other|9|||
157156507|NCT00601523|567317643|FG001|Overall Study|Other|1|||
157156508|NCT01987986|567317644|FG000|Overall Study|Lost to Follow-up|1|||
157156509|NCT01987986|567317645|FG001|Overall Study|Lost to Follow-up|0|||
157156510|NCT01987986|567317646|FG002|Overall Study|Lost to Follow-up|0|||
157156511|NCT01987986|567317647|FG003|Overall Study|Lost to Follow-up|0|||
157156512|NCT01987986|567317644|FG000|Overall Study|Adverse Event|1|||
157156513|NCT01987986|567317645|FG001|Overall Study|Adverse Event|0|||
157156514|NCT01987986|567317646|FG002|Overall Study|Adverse Event|2|||
157156515|NCT01987986|567317647|FG003|Overall Study|Adverse Event|0|||
157156516|NCT01617434|567317648|FG000|Overall Study|Adverse Event|12|||
157156517|NCT01617434|567317649|FG001|Overall Study|Adverse Event|3|||
157156518|NCT01617434|567317648|FG000|Overall Study|Protocol Violation|8|||
157156519|NCT01617434|567317649|FG001|Overall Study|Protocol Violation|7|||
156850717|NCT03543137|566204650|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
156850718|NCT00983385|566204651|FG000|Observation Period|Not eligible to be dosed|20|||
157156520|NCT01617434|567317648|FG000|Overall Study|Withdrawal Criteria|12|||
157156521|NCT01617434|567317649|FG001|Overall Study|Withdrawal Criteria|37|||
156850719|NCT00983385|566204651|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
156850720|NCT00930930|566204652|FG000|Overall Study|Death|1|||
156850721|NCT00930930|566204653|FG001|Overall Study|Death|0|||
156850722|NCT00930930|566204652|FG000|Overall Study|Physician Decision|1|||
157156522|NCT01617434|567317648|FG000|Overall Study|Unclassified|3|||
157156523|NCT01617434|567317649|FG001|Overall Study|Unclassified|4|||
157156524|NCT00786838|567317653|FG000|Overall Study|Physician Decision|4|||
157156525|NCT00786838|567317653|FG000|Overall Study|Death|4|||
157156526|NCT00786838|567317653|FG000|Overall Study|Adverse Event|6|||
157156527|NCT00786838|567317653|FG000|Overall Study|Progressive disease|31|||
157156528|NCT00786838|567317653|FG000|Overall Study|Withdrawal by Subject|4|||
157156529|NCT04937816|567317654|FG000|Overall Study|Study drug stopped, reason missing|5|||
157156530|NCT04937816|567317655|FG001|Overall Study|Study drug stopped, reason missing|3|||
157156531|NCT04937816|567317656|FG002|Overall Study|Study drug stopped, reason missing|4|||
157156532|NCT04937816|567317657|FG003|Overall Study|Study drug stopped, reason missing|6|||
157156533|NCT04937816|567317658|FG004|Overall Study|Study drug stopped, reason missing|1|||
156850723|NCT00930930|566204653|FG001|Overall Study|Physician Decision|0|||
156850724|NCT00930930|566204652|FG000|Overall Study|Adverse Event|13|||
156850725|NCT00930930|566204653|FG001|Overall Study|Adverse Event|3|||
156850726|NCT00930930|566204652|FG000|Overall Study|Withdrawal by Subject|3|||
156850727|NCT00930930|566204653|FG001|Overall Study|Withdrawal by Subject|1|||
156850728|NCT00930930|566204652|FG000|Overall Study|Disease progression|2|||
156850729|NCT00930930|566204653|FG001|Overall Study|Disease progression|3|||
156850730|NCT00930930|566204652|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
156850731|NCT00930930|566204653|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
156850732|NCT00930930|566204652|FG000|Overall Study|patients not compliant|1|||
156850733|NCT00930930|566204653|FG001|Overall Study|patients not compliant|1|||
156850734|NCT00900029|566204654|FG000|Overall Study|Lost to Follow-up|0|||
156850735|NCT00900029|566204655|FG001|Overall Study|Lost to Follow-up|2|||
156850736|NCT00900029|566204656|FG002|Overall Study|Lost to Follow-up|1|||
156850737|NCT00900029|566204657|FG003|Overall Study|Lost to Follow-up|4|||
156850738|NCT00900029|566204658|FG004|Overall Study|Lost to Follow-up|4|||
156850739|NCT00900029|566204654|FG000|Overall Study|Withdrawal by Subject|2|||
156850740|NCT00900029|566204655|FG001|Overall Study|Withdrawal by Subject|2|||
156850741|NCT00900029|566204656|FG002|Overall Study|Withdrawal by Subject|1|||
156850742|NCT00900029|566204657|FG003|Overall Study|Withdrawal by Subject|1|||
156850743|NCT00900029|566204658|FG004|Overall Study|Withdrawal by Subject|1|||
156850744|NCT00900029|566204654|FG000|Overall Study|Adverse Event|0|||
156850745|NCT00900029|566204655|FG001|Overall Study|Adverse Event|0|||
156850746|NCT00900029|566204656|FG002|Overall Study|Adverse Event|1|||
156850747|NCT00900029|566204657|FG003|Overall Study|Adverse Event|1|||
156850748|NCT00900029|566204658|FG004|Overall Study|Adverse Event|1|||
156850749|NCT00900029|566204654|FG000|Overall Study|Death|1|||
156850750|NCT00900029|566204655|FG001|Overall Study|Death|0|||
156850751|NCT00900029|566204656|FG002|Overall Study|Death|0|||
156850752|NCT00900029|566204657|FG003|Overall Study|Death|1|||
156850753|NCT00900029|566204658|FG004|Overall Study|Death|0|||
156850754|NCT02587819|566204661|FG000|Overall Study|Adverse Event|1|||
156850755|NCT02587819|566204661|FG000|Overall Study|Lost to Follow-up|1|||
156850756|NCT01929226|566206165|FG000|Overall Study|Lost to Follow-up|4|||
156850757|NCT01929226|566206166|FG001|Overall Study|Lost to Follow-up|0|||
156850758|NCT01929226|566206165|FG000|Overall Study|Withdrawal by Subject|1|||
156850759|NCT01929226|566206166|FG001|Overall Study|Withdrawal by Subject|1|||
156850760|NCT03790111|566206169|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
156850761|NCT03811340|566206172|FG000|Overall Study|subjects did not complete the survey.|90|||
156850762|NCT00280917|566206173|FG000|Overall Study|Adverse Event|1|||
156850763|NCT00280917|566206174|FG001|Overall Study|Adverse Event|1|||
156850764|NCT00280917|566206175|FG002|Overall Study|Adverse Event|4|||
156850765|NCT00280917|566206176|FG003|Overall Study|Adverse Event|1|||
156850766|NCT00280917|566206173|FG000|Overall Study|Change Therapy|1|||
156850767|NCT00280917|566206174|FG001|Overall Study|Change Therapy|2|||
156850768|NCT00280917|566206175|FG002|Overall Study|Change Therapy|0|||
156850769|NCT00280917|566206176|FG003|Overall Study|Change Therapy|0|||
156850770|NCT00280917|566206173|FG000|Overall Study|Withdrawal by Subject|0|||
156850771|NCT00280917|566206174|FG001|Overall Study|Withdrawal by Subject|2|||
156850772|NCT00280917|566206175|FG002|Overall Study|Withdrawal by Subject|0|||
156850773|NCT00280917|566206176|FG003|Overall Study|Withdrawal by Subject|1|||
156850774|NCT00280917|566206173|FG000|Overall Study|Noncompliance|0|||
156850775|NCT00280917|566206174|FG001|Overall Study|Noncompliance|1|||
156850776|NCT00280917|566206175|FG002|Overall Study|Noncompliance|2|||
156850777|NCT00280917|566206176|FG003|Overall Study|Noncompliance|0|||
156850778|NCT03529110|566206177|FG000|Overall Study|Progressive Disease|66|||
157025699|NCT04492722|566848040|FG002|Overall Study|Lost to Follow-up|0|||
157025700|NCT04492722|566848041|FG003|Overall Study|Lost to Follow-up|1|||
157025701|NCT04492722|566848038|FG000|Overall Study|Physician Decision|0|||
157025702|NCT04492722|566848039|FG001|Overall Study|Physician Decision|3|||
157025703|NCT04492722|566848040|FG002|Overall Study|Physician Decision|1|||
157025704|NCT04492722|566848041|FG003|Overall Study|Physician Decision|1|||
157025705|NCT04492722|566848038|FG000|Overall Study|Withdrawal by Subject|6|||
157025706|NCT04492722|566848039|FG001|Overall Study|Withdrawal by Subject|6|||
157025707|NCT04492722|566848040|FG002|Overall Study|Withdrawal by Subject|0|||
157025708|NCT04492722|566848041|FG003|Overall Study|Withdrawal by Subject|3|||
157025709|NCT04492722|566848038|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
157025710|NCT04492722|566848039|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
157025711|NCT04492722|566848040|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
156850779|NCT03529110|566206178|FG001|Overall Study|Progressive Disease|158|||
156850780|NCT03529110|566206177|FG000|Overall Study|Clinical Progression|4|||
156850781|NCT03529110|566206178|FG001|Overall Study|Clinical Progression|12|||
156850782|NCT03529110|566206177|FG000|Overall Study|Adverse Event|35|||
157025712|NCT04492722|566848041|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
156850783|NCT03529110|566206178|FG001|Overall Study|Adverse Event|17|||
156850784|NCT03529110|566206177|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
156850785|NCT03529110|566206178|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
156850786|NCT03529110|566206177|FG000|Overall Study|Lack of Efficacy|3|||
156850787|NCT03529110|566206178|FG001|Overall Study|Lack of Efficacy|3|||
156850788|NCT03529110|566206177|FG000|Overall Study|Physician Decision|2|||
156850789|NCT03529110|566206178|FG001|Overall Study|Physician Decision|8|||
156850790|NCT03529110|566206177|FG000|Overall Study|Miscellaneous|2|||
156850791|NCT03529110|566206178|FG001|Overall Study|Miscellaneous|5|||
156850792|NCT05104450|566206179|FG000|Overall Study|Death|1|||
156850793|NCT05104450|566206180|FG001|Overall Study|Death|2|||
156850794|NCT05104450|566206179|FG000|Overall Study|Withdrawal by Subject|3|||
156850795|NCT05104450|566206180|FG001|Overall Study|Withdrawal by Subject|1|||
156850796|NCT00330759|566206190|FG000|Overall Study|Death|316|||
156850797|NCT00330759|566206191|FG001|Overall Study|Death|310|||
156850798|NCT00330759|566206190|FG000|Overall Study|Disease progression|104|||
156850799|NCT00330759|566206191|FG001|Overall Study|Disease progression|126|||
156850800|NCT00330759|566206190|FG000|Overall Study|Withdrawal by Subject|143|||
156850801|NCT00330759|566206191|FG001|Overall Study|Withdrawal by Subject|124|||
156850802|NCT00330759|566206190|FG000|Overall Study|Adverse Event|48|||
156850803|NCT00330759|566206191|FG001|Overall Study|Adverse Event|36|||
156850804|NCT00330759|566206190|FG000|Overall Study|Participant request|31|||
156850805|NCT00330759|566206191|FG001|Overall Study|Participant request|22|||
156850806|NCT00330759|566206190|FG000|Overall Study|Lost to Follow-up|16|||
156889009|NCT00814801|566352297|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
156889010|NCT00814801|566352295|FG000|Overall Study|Missing or change of caregiver|6|||
156889011|NCT00814801|566352296|FG001|Overall Study|Missing or change of caregiver|2|||
156889012|NCT00814801|566352297|FG002|Overall Study|Missing or change of caregiver|4|||
156889013|NCT00814801|566352295|FG000|Overall Study|Non-compliance|0|||
156889014|NCT00814801|566352296|FG001|Overall Study|Non-compliance|1|||
156889015|NCT00814801|566352297|FG002|Overall Study|Non-compliance|1|||
156889016|NCT00814801|566352295|FG000|Overall Study|Other|2|||
156889017|NCT00814801|566352296|FG001|Overall Study|Other|6|||
156889018|NCT00814801|566352297|FG002|Overall Study|Other|4|||
156889019|NCT02486718|566352300|FG000|Enrollment Phase|Death|19|||
156889020|NCT02486718|566352301|FG001|Enrollment Phase|Death|0|||
156889021|NCT02486718|566352302|FG002|Enrollment Phase|Death|0|||
156889022|NCT02486718|566352300|FG000|Enrollment Phase|Symptomatic deterioration|1|||
156889023|NCT02486718|566352301|FG001|Enrollment Phase|Symptomatic deterioration|0|||
156889024|NCT02486718|566352302|FG002|Enrollment Phase|Symptomatic deterioration|0|||
156889025|NCT02486718|566352300|FG000|Enrollment Phase|Withdrawal by Subject|86|||
156889026|NCT02486718|566352301|FG001|Enrollment Phase|Withdrawal by Subject|0|||
156889027|NCT02486718|566352302|FG002|Enrollment Phase|Withdrawal by Subject|0|||
156889028|NCT02486718|566352300|FG000|Enrollment Phase|Protocol Violation|18|||
156889029|NCT02486718|566352301|FG001|Enrollment Phase|Protocol Violation|0|||
156889030|NCT02486718|566352302|FG002|Enrollment Phase|Protocol Violation|0|||
156889031|NCT02486718|566352300|FG000|Enrollment Phase|Physician Decision|18|||
156889032|NCT02486718|566352301|FG001|Enrollment Phase|Physician Decision|0|||
156889033|NCT02486718|566352302|FG002|Enrollment Phase|Physician Decision|0|||
156889034|NCT02486718|566352300|FG000|Enrollment Phase|Reason not provided|41|||
156889035|NCT02486718|566352301|FG001|Enrollment Phase|Reason not provided|0|||
156889036|NCT02486718|566352302|FG002|Enrollment Phase|Reason not provided|0|||
156889037|NCT02486718|566352300|FG000|Enrollment Phase|Disease relapse|54|||
156889038|NCT02486718|566352301|FG001|Enrollment Phase|Disease relapse|0|||
156889039|NCT02486718|566352302|FG002|Enrollment Phase|Disease relapse|0|||
156889040|NCT02486718|566352300|FG000|Enrollment Phase|Lost to Follow-up|4|||
156889041|NCT02486718|566352301|FG001|Enrollment Phase|Lost to Follow-up|0|||
156889042|NCT02486718|566352302|FG002|Enrollment Phase|Lost to Follow-up|0|||
156889043|NCT02486718|566352300|FG000|Enrollment Phase|Adverse Event|34|||
156889044|NCT02486718|566352301|FG001|Enrollment Phase|Adverse Event|0|||
156889045|NCT02486718|566352302|FG002|Enrollment Phase|Adverse Event|0|||
157025713|NCT04492722|566848038|FG000|Overall Study|Due to Covid-19 pandemic|7|||
157156534|NCT04937816|567317659|FG005|Overall Study|Study drug stopped, reason missing|0|||
157156535|NCT04937816|567317660|FG006|Overall Study|Study drug stopped, reason missing|0|||
157156536|NCT04937816|567317654|FG000|Overall Study|Other than stated below|173|||
157156537|NCT04937816|567317655|FG001|Overall Study|Other than stated below|143|||
156850807|NCT00330759|566206191|FG001|Overall Study|Lost to Follow-up|22|||
156850808|NCT00330759|566206190|FG000|Overall Study|Noncompliance|15|||
156850809|NCT00330759|566206191|FG001|Overall Study|Noncompliance|17|||
156889046|NCT02486718|566352300|FG000|Randomized Phase|Withdrawal by Subject|0|||
156889047|NCT02486718|566352301|FG001|Randomized Phase|Withdrawal by Subject|44|||
156889048|NCT02486718|566352302|FG002|Randomized Phase|Withdrawal by Subject|47|||
156889049|NCT02486718|566352300|FG000|Randomized Phase|Protocol Violation|0|||
156889050|NCT02486718|566352301|FG001|Randomized Phase|Protocol Violation|2|||
156889051|NCT02486718|566352302|FG002|Randomized Phase|Protocol Violation|0|||
156889052|NCT02486718|566352300|FG000|Randomized Phase|Physician Decision|0|||
157156538|NCT04937816|567317656|FG002|Overall Study|Other than stated below|125|||
156850810|NCT00330759|566206190|FG000|Overall Study|Physician Decision|1|||
156850811|NCT00330759|566206191|FG001|Overall Study|Physician Decision|2|||
156850812|NCT00330759|566206190|FG000|Overall Study|Protocol deviation|0|||
156850813|NCT00330759|566206191|FG001|Overall Study|Protocol deviation|2|||
156850814|NCT00330759|566206190|FG000|Overall Study|Ineligibility determined|2|||
156850815|NCT00330759|566206191|FG001|Overall Study|Ineligibility determined|1|||
156850816|NCT00330759|566206190|FG000|Overall Study|Other|36|||
156850817|NCT00330759|566206191|FG001|Overall Study|Other|44|||
156850818|NCT00592904|566206216|FG000|Overall Study|Adverse Event|15|||
156850819|NCT00592904|566206217|FG001|Overall Study|Adverse Event|25|||
156850820|NCT00592904|566206218|FG002|Overall Study|Adverse Event|13|||
156850821|NCT00592904|566206219|FG003|Overall Study|Adverse Event|5|||
156850822|NCT00592904|566206216|FG000|Overall Study|Protocol Violation|1|||
156850823|NCT00592904|566206217|FG001|Overall Study|Protocol Violation|1|||
156850824|NCT00592904|566206218|FG002|Overall Study|Protocol Violation|0|||
156850825|NCT00592904|566206219|FG003|Overall Study|Protocol Violation|1|||
156850826|NCT00592904|566206216|FG000|Overall Study|Withdrawal by Subject|4|||
156850827|NCT00592904|566206217|FG001|Overall Study|Withdrawal by Subject|16|||
156850828|NCT00592904|566206218|FG002|Overall Study|Withdrawal by Subject|1|||
156850829|NCT00592904|566206219|FG003|Overall Study|Withdrawal by Subject|2|||
156850830|NCT00592904|566206216|FG000|Overall Study|Lack of Efficacy|2|||
156850831|NCT00592904|566206217|FG001|Overall Study|Lack of Efficacy|7|||
156850832|NCT00592904|566206218|FG002|Overall Study|Lack of Efficacy|2|||
156850833|NCT00592904|566206219|FG003|Overall Study|Lack of Efficacy|3|||
156850834|NCT00592904|566206216|FG000|Overall Study|Physician Decision|0|||
156850835|NCT00592904|566206217|FG001|Overall Study|Physician Decision|3|||
156850836|NCT00592904|566206218|FG002|Overall Study|Physician Decision|1|||
156850837|NCT00592904|566206219|FG003|Overall Study|Physician Decision|0|||
156850838|NCT00592904|566206216|FG000|Overall Study|Other|3|||
156889053|NCT02486718|566352301|FG001|Randomized Phase|Physician Decision|0|||
156889054|NCT02486718|566352302|FG002|Randomized Phase|Physician Decision|3|||
157156539|NCT04937816|567317657|FG003|Overall Study|Other than stated below|44|||
157156540|NCT04937816|567317658|FG004|Overall Study|Other than stated below|45|||
156889055|NCT02486718|566352300|FG000|Randomized Phase|Lost to Follow-up|0|||
156889056|NCT02486718|566352301|FG001|Randomized Phase|Lost to Follow-up|5|||
156889057|NCT02486718|566352302|FG002|Randomized Phase|Lost to Follow-up|11|||
156889058|NCT02486718|566352300|FG000|Randomized Phase|Disease Relapse|0|||
156889059|NCT02486718|566352301|FG001|Randomized Phase|Disease Relapse|1|||
156889060|NCT02486718|566352302|FG002|Randomized Phase|Disease Relapse|0|||
156889061|NCT02486718|566352300|FG000|Randomized Phase|Death|0|||
156889062|NCT02486718|566352301|FG001|Randomized Phase|Death|154|||
156889063|NCT02486718|566352302|FG002|Randomized Phase|Death|155|||
156889064|NCT02486718|566352300|FG000|Randomized Phase|Ongoing|0|||
156889065|NCT02486718|566352301|FG001|Randomized Phase|Ongoing|301|||
156889066|NCT02486718|566352302|FG002|Randomized Phase|Ongoing|282|||
156889067|NCT02520089|566352303|FG000|Overall Study|Lost to Follow-up|3|||
156889068|NCT02520089|566352304|FG001|Overall Study|Lost to Follow-up|4|||
156889069|NCT01037088|566352307|FG000|Overall Study|Withdrawal by Subject|3|||
156889070|NCT00978432|566354108|FG000|Overall Study|Withdrawal by Subject|0|||
156889071|NCT00978432|566354109|FG001|Overall Study|Withdrawal by Subject|0|||
156889072|NCT00978432|566354110|FG002|Overall Study|Withdrawal by Subject|1|||
156889073|NCT00978432|566354108|FG000|Overall Study|Lack of Efficacy|1|||
156889074|NCT00978432|566354109|FG001|Overall Study|Lack of Efficacy|1|||
157156541|NCT04937816|567317659|FG005|Overall Study|Other than stated below|28|||
157156542|NCT04937816|567317660|FG006|Overall Study|Other than stated below|31|||
157156543|NCT04937816|567317654|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
156889075|NCT00978432|566354110|FG002|Overall Study|Lack of Efficacy|3|||
156889076|NCT00978432|566354108|FG000|Overall Study|Adverse Event|2|||
156889077|NCT00978432|566354109|FG001|Overall Study|Adverse Event|0|||
156889078|NCT00978432|566354110|FG002|Overall Study|Adverse Event|1|||
156889079|NCT02579928|566354111|FG000|Overall Study|Withdrawal by Subject|1|||
156889080|NCT02579928|566354112|FG001|Overall Study|Withdrawal by Subject|0|||
156889081|NCT03404960|566354116|FG000|Overall Study|Adverse Event|0|||
156889082|NCT03404960|566354117|FG001|Overall Study|Adverse Event|2|||
156889083|NCT03404960|566354116|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
156889084|NCT03404960|566354117|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
157156544|NCT04937816|567317655|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
157156545|NCT04937816|567317656|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
156889085|NCT03404960|566354116|FG000|Overall Study|Bowel obstruction|0|||
156889086|NCT03404960|566354117|FG001|Overall Study|Bowel obstruction|1|||
156889087|NCT03404960|566354116|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
156889088|NCT03404960|566354117|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
157156546|NCT04937816|567317657|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
156850839|NCT00592904|566206217|FG001|Overall Study|Other|3|||
156850840|NCT00592904|566206218|FG002|Overall Study|Other|0|||
156850841|NCT00592904|566206219|FG003|Overall Study|Other|0|||
156850842|NCT01172535|566206220|FG000|Overall Study|Death|3|||
156850843|NCT01172535|566206220|FG000|Overall Study|Withdrawal by Subject|2|||
156850844|NCT01172535|566206220|FG000|Overall Study|Lost to Follow-up|1|||
156889089|NCT00075270|566354120|FG000|Overall Study|Withdrawal by Subject|28|||
156889090|NCT00075270|566354121|FG001|Overall Study|Withdrawal by Subject|21|||
156889091|NCT00075270|566354120|FG000|Overall Study|Lost to Follow-up|25|||
156850845|NCT01172535|566206220|FG000|Overall Study|Ineligible at study entry|1|||
156850846|NCT01172535|566206220|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
156850847|NCT01479868|566206223|FG000|Overall Study|Adverse Event|1|||
156850848|NCT01479868|566206223|FG000|Overall Study|Lost to Follow-up|4|||
156850849|NCT01479868|566206223|FG000|Overall Study|Protocol Violation|1|||
156850850|NCT01479868|566206223|FG000|Overall Study|Withdrawal by Subject|1|||
156850851|NCT01479868|566206223|FG000|Overall Study|Sponsor's Decision|1|||
156850852|NCT01479868|566206223|FG000|Overall Study|Initiation of new HCV Therapy|1|||
156850853|NCT01618669|566206224|FG000|Overall Study|Lost to Follow-up|1|||
156850854|NCT01618669|566206225|FG001|Overall Study|Lost to Follow-up|1|||
156850855|NCT01618669|566206224|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
156850856|NCT01618669|566206225|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
156850857|NCT01618669|566206224|FG000|Overall Study|Adverse Event|16|||
156850858|NCT01618669|566206225|FG001|Overall Study|Adverse Event|7|||
156850859|NCT01618669|566206224|FG000|Overall Study|Protocol Violation|5|||
156850860|NCT01618669|566206225|FG001|Overall Study|Protocol Violation|3|||
156850861|NCT01618669|566206224|FG000|Overall Study|Withdrawal by Subject|9|||
156850862|NCT01618669|566206225|FG001|Overall Study|Withdrawal by Subject|9|||
156850863|NCT01618669|566206224|FG000|Overall Study|Miscellaneous Reason|0|||
156850864|NCT01618669|566206225|FG001|Overall Study|Miscellaneous Reason|1|||
156850865|NCT01177007|566206226|FG000|Overall Study|Lost to Follow-up|2|||
156850866|NCT01177007|566206226|FG000|Overall Study|Death|4|||
156850867|NCT01177007|566206226|FG000|Overall Study|Entered hospice care|5|||
156850868|NCT01177007|566206226|FG000|Overall Study|Required additional Y90 treatment|6|||
156850869|NCT01177007|566206226|FG000|Overall Study|Change in treatment modality|21|||
156850870|NCT02336230|566206234|FG000|Overall Study|Adverse Event|1|||
156850871|NCT02336230|566206234|FG000|Overall Study|Withdrawal of consent|1|||
156850872|NCT02336230|566206234|FG000|Overall Study|Death|9|||
156850873|NCT02336230|566206234|FG000|Overall Study|Dose not received due to shipping delay|1|||
156850874|NCT02336230|566206234|FG000|Overall Study|Discontinuation of MSC infusion|1|||
156850875|NCT03305770|566206242|FG000|Overall Study|Physician Decision - prior to dispense|0|||
156850876|NCT03305770|566206243|FG001|Overall Study|Physician Decision - prior to dispense|1|||
156850877|NCT03305770|566206242|FG000|Overall Study|Subject moved|1|||
156850878|NCT03305770|566206243|FG001|Overall Study|Subject moved|0|||
156850879|NCT03539601|566206244|FG000|Overall Study|Withdraw by parent/guardian|1|||
156850880|NCT03539601|566206245|FG001|Overall Study|Withdraw by parent/guardian|0|||
156850881|NCT03539601|566206246|FG002|Overall Study|Withdraw by parent/guardian|1|||
156850882|NCT03539601|566206247|FG003|Overall Study|Withdraw by parent/guardian|0|||
156850883|NCT03539601|566206244|FG000|Overall Study|Adverse Event|0|||
156850884|NCT03539601|566206245|FG001|Overall Study|Adverse Event|2|||
156850885|NCT03539601|566206246|FG002|Overall Study|Adverse Event|0|||
156850886|NCT03539601|566206247|FG003|Overall Study|Adverse Event|0|||
156850887|NCT03539601|566206244|FG000|Overall Study|Lost to Follow-up|2|||
156850888|NCT03539601|566206245|FG001|Overall Study|Lost to Follow-up|4|||
156850889|NCT03539601|566206246|FG002|Overall Study|Lost to Follow-up|5|||
156850890|NCT03539601|566206247|FG003|Overall Study|Lost to Follow-up|0|||
156850891|NCT03539601|566206244|FG000|Overall Study|Withdrawal by Subject|2|||
156850892|NCT03539601|566206245|FG001|Overall Study|Withdrawal by Subject|0|||
156850893|NCT03539601|566206246|FG002|Overall Study|Withdrawal by Subject|0|||
156850894|NCT03539601|566206247|FG003|Overall Study|Withdrawal by Subject|1|||
156850895|NCT03539601|566206244|FG000|Overall Study|Randomized but not treated|1|||
156850896|NCT03539601|566206245|FG001|Overall Study|Randomized but not treated|1|||
156850897|NCT03539601|566206246|FG002|Overall Study|Randomized but not treated|0|||
156850898|NCT03539601|566206247|FG003|Overall Study|Randomized but not treated|0|||
156850899|NCT01970306|566206248|FG000|Overall Study|Not eligible|3|||
156850900|NCT01970306|566206248|FG000|Overall Study|Not able to be treated|9|||
156850901|NCT03472326|566206249|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
156850902|NCT03472326|566206250|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
157025714|NCT04492722|566848039|FG001|Overall Study|Due to Covid-19 pandemic|3|||
157156547|NCT04937816|567317658|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
157156548|NCT04937816|567317659|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
157156549|NCT04937816|567317660|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
157156550|NCT04937816|567317654|FG000|Overall Study|Lost to Follow-up|15|||
157156551|NCT04937816|567317655|FG001|Overall Study|Lost to Follow-up|9|||
156850903|NCT03472326|566206251|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
156850904|NCT03472326|566206252|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
156850905|NCT03472326|566206249|FG000|Part 2: Combination Therapy|Pregnancy|0|||
156850906|NCT03472326|566206250|FG001|Part 2: Combination Therapy|Pregnancy|0|||
156850907|NCT03472326|566206251|FG002|Part 2: Combination Therapy|Pregnancy|0|||
156850908|NCT03472326|566206252|FG003|Part 2: Combination Therapy|Pregnancy|1|||
156850909|NCT04739436|566206253|FG000|Overall Study|Lost to Follow-up|21|||
156850910|NCT04739436|566206254|FG001|Overall Study|Lost to Follow-up|23|||
156850911|NCT04739436|566206253|FG000|Overall Study|Withdrawal by Subject|4|||
156850912|NCT04739436|566206254|FG001|Overall Study|Withdrawal by Subject|6|||
156850913|NCT04739436|566206253|FG000|Overall Study|not randomized properly|1|||
156850914|NCT04739436|566206254|FG001|Overall Study|not randomized properly|0|||
156850915|NCT00428948|566206256|FG000|Overall Study|Lost to Follow-up|15|||
156850916|NCT00428948|566206257|FG001|Overall Study|Lost to Follow-up|8|||
156850917|NCT00428948|566206256|FG000|Overall Study|Adverse Event|148|||
156850918|NCT00428948|566206257|FG001|Overall Study|Adverse Event|24|||
156850919|NCT00428948|566206256|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
156850920|NCT00428948|566206257|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
156850921|NCT00428948|566206256|FG000|Overall Study|Investigator Withdrew Subject|3|||
156850922|NCT00428948|566206257|FG001|Overall Study|Investigator Withdrew Subject|4|||
156850923|NCT00428948|566206256|FG000|Overall Study|Subject Withdrew Consent|50|||
156850924|NCT00428948|566206257|FG001|Overall Study|Subject Withdrew Consent|30|||
156850925|NCT00428948|566206256|FG000|Overall Study|Protocol Deviation|1|||
156850926|NCT00428948|566206257|FG001|Overall Study|Protocol Deviation|1|||
156850927|NCT03622814|566206259|FG000|Overall Study|Lost to Follow-up|8|||
156850928|NCT03622814|566206260|FG001|Overall Study|Lost to Follow-up|14|||
156850929|NCT04417361|566206261|FG000|Overall Study|Withdrawal by Subject|1|||
156850930|NCT04417361|566206262|FG001|Overall Study|Withdrawal by Subject|0|||
156850931|NCT04417361|566206261|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
156850932|NCT04417361|566206262|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
156850933|NCT00892775|566206263|FG000|Overall Study|Protocol Violation|1|||
156850934|NCT00892775|566206264|FG001|Overall Study|Protocol Violation|0|||
156850935|NCT00892775|566206263|FG000|Overall Study|Subject difficulties with blood drawing|1|||
156850936|NCT00892775|566206264|FG001|Overall Study|Subject difficulties with blood drawing|0|||
156850937|NCT00892775|566206263|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
156850938|NCT00892775|566206264|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
156850939|NCT00892775|566206263|FG000|Overall Study|Migrated/ moved from study area|1|||
156850940|NCT00892775|566206264|FG001|Overall Study|Migrated/ moved from study area|0|||
156850941|NCT00892775|566206263|FG000|Overall Study|Withdrawal by Subject|0|||
156850942|NCT00892775|566206264|FG001|Overall Study|Withdrawal by Subject|1|||
156850943|NCT00892775|566206263|FG000|Overall Study|Lost to Follow-up|1|||
156850944|NCT00892775|566206264|FG001|Overall Study|Lost to Follow-up|0|||
156850945|NCT00699660|566206265|FG000|Overall Study|Lost to Follow-up|4|||
156850946|NCT00699660|566206266|FG001|Overall Study|Lost to Follow-up|2|||
156850947|NCT00699660|566206265|FG000|Overall Study|missing reports and recording failures|10|||
156850948|NCT00699660|566206266|FG001|Overall Study|missing reports and recording failures|6|||
156850949|NCT00250276|566206273|FG000|Overall Study|Serious Adverse Event|0|||
156850950|NCT00250276|566206274|FG001|Overall Study|Serious Adverse Event|0|||
156850951|NCT00250276|566206275|FG002|Overall Study|Serious Adverse Event|1|||
156850952|NCT00250276|566206276|FG003|Overall Study|Serious Adverse Event|0|||
156850953|NCT00250276|566206273|FG000|Overall Study|Non-serious Adverse Event|2|||
156850954|NCT00250276|566206274|FG001|Overall Study|Non-serious Adverse Event|0|||
156850955|NCT00250276|566206275|FG002|Overall Study|Non-serious Adverse Event|0|||
156850956|NCT00250276|566206276|FG003|Overall Study|Non-serious Adverse Event|2|||
156850957|NCT00250276|566206273|FG000|Overall Study|Protocol Violation|0|||
156889092|NCT00075270|566354121|FG001|Overall Study|Lost to Follow-up|28|||
156889093|NCT00075270|566354120|FG000|Overall Study|Protocol Violation|0|||
156889094|NCT00075270|566354121|FG001|Overall Study|Protocol Violation|2|||
156889095|NCT00075270|566354120|FG000|Overall Study|Death|198|||
156889096|NCT00075270|566354121|FG001|Overall Study|Death|215|||
156889097|NCT00075270|566354120|FG000|Overall Study|Other/Unknown|9|||
156889098|NCT00075270|566354121|FG001|Overall Study|Other/Unknown|5|||
156889099|NCT00075270|566354120|FG000|Overall Study|Missing|26|||
156889100|NCT00075270|566354121|FG001|Overall Study|Missing|13|||
156889101|NCT00246571|566354122|FG000|Overall Study|Adverse Event|7|||
156889102|NCT00246571|566354123|FG001|Overall Study|Adverse Event|0|||
156889103|NCT00246571|566354122|FG000|Overall Study|Protocol Violation|0|||
156889104|NCT00246571|566354123|FG001|Overall Study|Protocol Violation|1|||
156889105|NCT00246571|566354122|FG000|Overall Study|Withdrawal by Subject|2|||
156889106|NCT00246571|566354123|FG001|Overall Study|Withdrawal by Subject|3|||
156850958|NCT00250276|566206274|FG001|Overall Study|Protocol Violation|1|||
156889107|NCT00246571|566354122|FG000|Overall Study|Lack of Efficacy|84|||
156850959|NCT00250276|566206275|FG002|Overall Study|Protocol Violation|0|||
156850960|NCT00250276|566206276|FG003|Overall Study|Protocol Violation|0|||
156850961|NCT00250276|566206273|FG000|Overall Study|Withdrawal by Subject|1|||
156850962|NCT00250276|566206274|FG001|Overall Study|Withdrawal by Subject|2|||
156850963|NCT00250276|566206275|FG002|Overall Study|Withdrawal by Subject|3|||
156850964|NCT00250276|566206276|FG003|Overall Study|Withdrawal by Subject|2|||
156889108|NCT00246571|566354123|FG001|Overall Study|Lack of Efficacy|21|||
156850965|NCT00250276|566206273|FG000|Overall Study|Migrated/moved from study area|3|||
156850966|NCT00250276|566206274|FG001|Overall Study|Migrated/moved from study area|0|||
156850967|NCT00250276|566206275|FG002|Overall Study|Migrated/moved from study area|2|||
156850968|NCT00250276|566206276|FG003|Overall Study|Migrated/moved from study area|7|||
156889109|NCT00246571|566354122|FG000|Overall Study|Death|17|||
156889110|NCT00246571|566354123|FG001|Overall Study|Death|3|||
156889111|NCT00246571|566354122|FG000|Overall Study|Sponsor|0|||
156889112|NCT00246571|566354123|FG001|Overall Study|Sponsor|1|||
157156552|NCT04937816|567317656|FG002|Overall Study|Lost to Follow-up|6|||
157156553|NCT04937816|567317657|FG003|Overall Study|Lost to Follow-up|6|||
157156554|NCT04937816|567317658|FG004|Overall Study|Lost to Follow-up|16|||
157156555|NCT04937816|567317659|FG005|Overall Study|Lost to Follow-up|11|||
157156556|NCT04937816|567317660|FG006|Overall Study|Lost to Follow-up|17|||
157156557|NCT04937816|567317654|FG000|Overall Study|Protocol Violation|15|||
157156558|NCT04937816|567317655|FG001|Overall Study|Protocol Violation|15|||
157156559|NCT04937816|567317656|FG002|Overall Study|Protocol Violation|12|||
157156560|NCT04937816|567317657|FG003|Overall Study|Protocol Violation|30|||
157156561|NCT04937816|567317658|FG004|Overall Study|Protocol Violation|24|||
157156562|NCT04937816|567317659|FG005|Overall Study|Protocol Violation|5|||
157156563|NCT04937816|567317660|FG006|Overall Study|Protocol Violation|5|||
157156564|NCT04937816|567317654|FG000|Overall Study|Adverse Event|303|||
157156565|NCT04937816|567317655|FG001|Overall Study|Adverse Event|267|||
157156566|NCT04937816|567317656|FG002|Overall Study|Adverse Event|273|||
157156567|NCT04937816|567317657|FG003|Overall Study|Adverse Event|553|||
156850969|NCT00250276|566206273|FG000|Overall Study|Lost to Follow-up|11|||
156850970|NCT00250276|566206274|FG001|Overall Study|Lost to Follow-up|18|||
156850971|NCT00250276|566206275|FG002|Overall Study|Lost to Follow-up|13|||
156850972|NCT00250276|566206276|FG003|Overall Study|Lost to Follow-up|8|||
156850973|NCT00555217|566206277|FG000|Overall Study|Withdrawal by Subject|35|||
156850974|NCT00555217|566206278|FG001|Overall Study|Withdrawal by Subject|31|||
156850975|NCT00555217|566206277|FG000|Overall Study|Lost to Follow-up|19|||
156850976|NCT00555217|566206278|FG001|Overall Study|Lost to Follow-up|20|||
156850977|NCT00555217|566206277|FG000|Overall Study|close out sites|21|||
156850978|NCT00555217|566206278|FG001|Overall Study|close out sites|17|||
156850979|NCT00950248|566206286|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
156850980|NCT00950248|566206287|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
156850981|NCT00950248|566206288|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
156850982|NCT00950248|566206286|FG000|Year 1: Baseline|worsening of symptoms|2|||
156850983|NCT00950248|566206287|FG001|Year 1: Baseline|worsening of symptoms|0|||
156850984|NCT00950248|566206288|FG002|Year 1: Baseline|worsening of symptoms|0|||
156850985|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
156850986|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
156850987|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
156850988|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
156850989|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
156850990|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
156850991|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|Death|0|||
156850992|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|Death|0|||
156850993|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|Death|1|||
156850994|NCT00950248|566206286|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
156850995|NCT00950248|566206287|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
156850996|NCT00950248|566206288|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
156850997|NCT01657292|566206292|FG000|Overall Study|Adverse Event|6|||
156850998|NCT01657292|566206292|FG000|Overall Study|Withdrawal by Subject|2|||
156850999|NCT01657292|566206292|FG000|Overall Study|Violation of eligibility criteria|1|||
156851000|NCT01657292|566206292|FG000|Overall Study|Change of therapy|1|||
156851001|NCT00650845|566206294|FG000|Overall Study|Withdrawal by Subject|5|||
156851002|NCT00650845|566206295|FG001|Overall Study|Withdrawal by Subject|0|||
156851003|NCT00650845|566206294|FG000|Overall Study|Protocol Violation|0|||
156851004|NCT00650845|566206295|FG001|Overall Study|Protocol Violation|13|||
156851005|NCT01900652|566206296|FG000|Overall Study|Progressive Disease|1|||
156851006|NCT01900652|566206297|FG001|Overall Study|Progressive Disease|0|||
156889113|NCT00246571|566354122|FG000|Overall Study|Did not meet entrance criteria|2|||
156889114|NCT00246571|566354123|FG001|Overall Study|Did not meet entrance criteria|1|||
156889115|NCT00246571|566354122|FG000|Overall Study|Laboratory abnormalities|1|||
156851007|NCT01900652|566206296|FG000|Overall Study|Consent withdrawn by subject|1|||
156851008|NCT01900652|566206297|FG001|Overall Study|Consent withdrawn by subject|1|||
156851009|NCT01900652|566206296|FG000|Overall Study|Death|3|||
156889116|NCT00246571|566354123|FG001|Overall Study|Laboratory abnormalities|0|||
156889117|NCT00246571|566354122|FG000|Overall Study|Crossover participants|0|||
156889118|NCT00246571|566354123|FG001|Overall Study|Crossover participants|74|||
156889119|NCT05247398|566354124|FG000|Overall Study|Withdrawal by Subject|1|||
157156568|NCT04937816|567317658|FG004|Overall Study|Adverse Event|575|||
156851010|NCT01900652|566206297|FG001|Overall Study|Death|0|||
156889120|NCT04251156|566354125|FG000|Overall Study|Lost to Follow-up|1|||
156889121|NCT04251156|566354126|FG001|Overall Study|Lost to Follow-up|1|||
156851011|NCT01900652|566206296|FG000|Overall Study|Adverse Event|2|||
156851012|NCT01900652|566206297|FG001|Overall Study|Adverse Event|1|||
156851013|NCT01900652|566206296|FG000|Overall Study|Physician Decision|1|||
156851014|NCT01900652|566206297|FG001|Overall Study|Physician Decision|1|||
156889122|NCT04251156|566354125|FG000|Overall Study|Withdrawal by Subject|4|||
157156569|NCT04937816|567317659|FG005|Overall Study|Adverse Event|343|||
157156570|NCT04937816|567317660|FG006|Overall Study|Adverse Event|337|||
157156571|NCT04937816|567317654|FG000|Overall Study|Not treated|4|||
157156572|NCT04937816|567317655|FG001|Overall Study|Not treated|2|||
157156573|NCT04937816|567317656|FG002|Overall Study|Not treated|2|||
156851015|NCT03761810|566206298|FG000|Overall Study|Adverse Event|12|||
156851016|NCT03761810|566206299|FG001|Overall Study|Adverse Event|0|||
156851017|NCT03761810|566206298|FG000|Overall Study|Lost to Follow-up|15|||
156851018|NCT03761810|566206299|FG001|Overall Study|Lost to Follow-up|7|||
156851019|NCT03761810|566206298|FG000|Overall Study|Pregnancy|1|||
156851020|NCT03761810|566206299|FG001|Overall Study|Pregnancy|0|||
156851021|NCT03761810|566206298|FG000|Overall Study|Withdrawal by Subject|14|||
156851022|NCT03761810|566206299|FG001|Overall Study|Withdrawal by Subject|5|||
156851023|NCT03761810|566206298|FG000|Overall Study|Physician Decision|1|||
156851024|NCT03761810|566206299|FG001|Overall Study|Physician Decision|0|||
156851025|NCT03761810|566206298|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
156851026|NCT03761810|566206299|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156851027|NCT03761810|566206298|FG000|Overall Study|Other Than Specified|1|||
156851028|NCT03761810|566206299|FG001|Overall Study|Other Than Specified|0|||
156851029|NCT04178720|566206300|FG000|Overall Study|Withdrawal by Subject|2|||
156851030|NCT04178720|566206301|FG001|Overall Study|Withdrawal by Subject|0|||
156851031|NCT04178720|566206300|FG000|Overall Study|Relocation|0|||
156851032|NCT04178720|566206301|FG001|Overall Study|Relocation|1|||
156851033|NCT00869518|566206302|FG000|Overall Study|Lost to Follow-up|1|||
156851034|NCT00869518|566206303|FG001|Overall Study|Lost to Follow-up|1|||
156851035|NCT03566082|566206304|FG000|Overall Study|Death|7|||
156851036|NCT03566082|566206304|FG000|Overall Study|Failures (revision required)|2|||
156851037|NCT03566082|566206304|FG000|Overall Study|Lost to Follow-up|8|||
156851038|NCT03922620|566206305|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
156851039|NCT03922620|566206306|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
156851040|NCT02663622|566206307|FG000|Overall Study|Death|3|||
156851041|NCT02663622|566206308|FG001|Overall Study|Death|1|||
156851042|NCT02663622|566206309|FG002|Overall Study|Death|1|||
156851043|NCT02663622|566206310|FG003|Overall Study|Death|8|||
156851044|NCT02663622|566206307|FG000|Overall Study|Protocol Violation|0|||
156851045|NCT02663622|566206308|FG001|Overall Study|Protocol Violation|0|||
156851046|NCT02663622|566206309|FG002|Overall Study|Protocol Violation|0|||
156851047|NCT02663622|566206310|FG003|Overall Study|Protocol Violation|1|||
156851048|NCT04618744|566206313|FG000|Overall Study|Adverse Event|0|||
156851049|NCT04618744|566206314|FG001|Overall Study|Adverse Event|1|||
156851050|NCT04618744|566206313|FG000|Overall Study|Withdrawal by Subject|0|||
156851051|NCT04618744|566206314|FG001|Overall Study|Withdrawal by Subject|1|||
156851052|NCT00511238|566206315|FG000|Overall Study|Adverse Event|13|||
156851053|NCT00511238|566206316|FG001|Overall Study|Adverse Event|33|||
156851054|NCT00511238|566206315|FG000|Overall Study|Withdrawal by Subject|2|||
156851055|NCT00511238|566206316|FG001|Overall Study|Withdrawal by Subject|22|||
156851056|NCT00511238|566206315|FG000|Overall Study|Progressive Disease|23|||
156851057|NCT00511238|566206316|FG001|Overall Study|Progressive Disease|157|||
156851058|NCT00511238|566206315|FG000|Overall Study|various reasons|4|||
156851059|NCT00511238|566206316|FG001|Overall Study|various reasons|14|||
156851060|NCT00163020|566206317|FG000|Overall Study|Lost to Follow-up|0|||
156851061|NCT00163020|566206318|FG001|Overall Study|Lost to Follow-up|2|||
156851062|NCT03456076|566208968|FG000|Overall Study|Withdrawal by Subject|5|||
156851063|NCT03456076|566208969|FG001|Overall Study|Withdrawal by Subject|9|||
156851064|NCT03456076|566208968|FG000|Overall Study|Protocol deviation|0|||
156851065|NCT03456076|566208969|FG001|Overall Study|Protocol deviation|1|||
157156574|NCT04937816|567317657|FG003|Overall Study|Not treated|2|||
157156575|NCT04937816|567317658|FG004|Overall Study|Not treated|1|||
157156576|NCT04937816|567317659|FG005|Overall Study|Not treated|4|||
157156577|NCT04937816|567317660|FG006|Overall Study|Not treated|0|||
157156578|NCT05513053|567317661|FG000|Overall Study|Lost to Follow-up|9|||
157156579|NCT05513053|567317662|FG001|Overall Study|Lost to Follow-up|11|||
157156580|NCT05513053|567317661|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156851066|NCT03456076|566208968|FG000|Overall Study|Lost to Follow-up|0|||
156851067|NCT03456076|566208969|FG001|Overall Study|Lost to Follow-up|1|||
156851068|NCT03456076|566208968|FG000|Overall Study|Death|2|||
156851069|NCT03456076|566208969|FG001|Overall Study|Death|5|||
156851070|NCT03456076|566208968|FG000|Overall Study|Study ongoing|123|||
156851071|NCT03456076|566208969|FG001|Overall Study|Study ongoing|111|||
156851072|NCT03906071|566208970|FG000|Overall Study|Death|180|||
156851073|NCT03906071|566208971|FG001|Overall Study|Death|185|||
156851074|NCT03906071|566208970|FG000|Overall Study|Lost to Follow-up|3|||
156851075|NCT03906071|566208971|FG001|Overall Study|Lost to Follow-up|3|||
156851076|NCT03906071|566208970|FG000|Overall Study|Withdrawal by Subject|15|||
156851077|NCT03906071|566208971|FG001|Overall Study|Withdrawal by Subject|27|||
156851078|NCT03906071|566208970|FG000|Overall Study|Other|2|||
156851079|NCT03906071|566208971|FG001|Overall Study|Other|1|||
156851080|NCT01359904|566208972|FG000|Overall Study|Withdrawal by Subject|1|||
156851081|NCT01359904|566208973|FG001|Overall Study|Withdrawal by Subject|0|||
156851082|NCT03191630|566208976|FG000|Overall Study|Lost to Follow-up|7|||
156851083|NCT03191630|566208977|FG001|Overall Study|Lost to Follow-up|7|||
157156581|NCT05513053|567317662|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157156582|NCT05513053|567317661|FG000|Overall Study|Withdrawal by Subject|2|||
157225454|NCT01860976|567571437|FG001|Open-Label|Adverse Event|4|||
157156583|NCT05513053|567317662|FG001|Overall Study|Withdrawal by Subject|9|||
157156584|NCT05513053|567317661|FG000|Overall Study|Protocol Violation|6|||
157156585|NCT05513053|567317662|FG001|Overall Study|Protocol Violation|3|||
157156586|NCT05513053|567317661|FG000|Overall Study|Adverse Event|0|||
157156587|NCT05513053|567317662|FG001|Overall Study|Adverse Event|2|||
157156588|NCT04038255|567319288|FG000|Overall Study|Lost to Follow-up|0|||
157156589|NCT04038255|567319289|FG001|Overall Study|Lost to Follow-up|9|||
157156590|NCT04038255|567319290|FG002|Overall Study|Lost to Follow-up|5|||
157156591|NCT04038255|567319288|FG000|Overall Study|Withdrawal by Subject|0|||
157156592|NCT04038255|567319289|FG001|Overall Study|Withdrawal by Subject|0|||
157156593|NCT04038255|567319290|FG002|Overall Study|Withdrawal by Subject|1|||
157156594|NCT05183867|567319291|FG000|Overall Study|Withdrawal by Subject|3|||
157156595|NCT05183867|567319292|FG001|Overall Study|Withdrawal by Subject|2|||
157156596|NCT05183867|567319293|FG002|Overall Study|Withdrawal by Subject|0|||
157156597|NCT02614287|567319296|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
157156598|NCT02614287|567319297|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
157156599|NCT02614287|567319296|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
157156600|NCT02614287|567319297|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
157156601|NCT02614287|567319296|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
157156602|NCT02614287|567319297|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
157156603|NCT02614287|567319296|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
157156604|NCT02614287|567319297|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
157156605|NCT02614287|567319296|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
157156606|NCT02614287|567319297|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
157156607|NCT02614287|567319296|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
157156608|NCT02614287|567319297|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
157156609|NCT02614287|567319296|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
157156610|NCT02614287|567319297|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
157156611|NCT02614287|567319296|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
157156612|NCT02614287|567319297|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
157156613|NCT01953328|567319298|FG000|Overall Study|Withdrawal by Subject|0|||
157156614|NCT01953328|567319299|FG001|Overall Study|Withdrawal by Subject|0|||
157156615|NCT01953328|567319300|FG002|Overall Study|Withdrawal by Subject|0|||
157156616|NCT01953328|567319301|FG003|Overall Study|Withdrawal by Subject|0|||
157156617|NCT01953328|567319302|FG004|Overall Study|Withdrawal by Subject|1|||
157156618|NCT01953328|567319303|FG005|Overall Study|Withdrawal by Subject|0|||
157156619|NCT01953328|567319304|FG006|Overall Study|Withdrawal by Subject|0|||
157156620|NCT01953328|567319305|FG007|Overall Study|Withdrawal by Subject|0|||
157156621|NCT01953328|567319298|FG000|Overall Study|Lost to Follow-up|0|||
157156622|NCT01953328|567319299|FG001|Overall Study|Lost to Follow-up|0|||
157156623|NCT01953328|567319300|FG002|Overall Study|Lost to Follow-up|0|||
157156624|NCT01953328|567319301|FG003|Overall Study|Lost to Follow-up|0|||
157156625|NCT01953328|567319302|FG004|Overall Study|Lost to Follow-up|1|||
157156626|NCT01953328|567319303|FG005|Overall Study|Lost to Follow-up|0|||
156889123|NCT04251156|566354126|FG001|Overall Study|Withdrawal by Subject|4|||
156889124|NCT00934648|566354130|FG000|Overall Study|Failure to return|8|||
157156627|NCT01953328|567319304|FG006|Overall Study|Lost to Follow-up|0|||
157156628|NCT01953328|567319305|FG007|Overall Study|Lost to Follow-up|0|||
157156629|NCT02429258|567319309|FG000|Overall Study|Withdrawal by Subject|2|||
157156630|NCT02429258|567319310|FG001|Overall Study|Withdrawal by Subject|0|||
157156631|NCT02429258|567319309|FG000|Overall Study|Protocol Violation|0|||
157156632|NCT02429258|567319310|FG001|Overall Study|Protocol Violation|1|||
157156633|NCT03364335|567319312|FG000|Overall Study|Adverse Event|3|||
157156634|NCT03364335|567319313|FG001|Overall Study|Adverse Event|4|||
157156635|NCT03364335|567319314|FG002|Overall Study|Adverse Event|1|||
157156636|NCT03364335|567319315|FG003|Overall Study|Adverse Event|2|||
157156637|NCT03364335|567319316|FG004|Overall Study|Adverse Event|0|||
157225455|NCT01860976|567571436|FG000|Open-Label|Lack of Efficacy|16|||
156889125|NCT00934648|566354130|FG000|Overall Study|Withdrawal by Subject|1|||
156889126|NCT00708201|566354136|FG000|Overall Study|Adverse Event|4|||
156889127|NCT00708201|566354137|FG001|Overall Study|Adverse Event|4|||
157156638|NCT03364335|567319312|FG000|Overall Study|Lost to Follow-up|7|||
156889128|NCT00708201|566354136|FG000|Overall Study|Withdrawal by Subject|1|||
156889129|NCT00708201|566354137|FG001|Overall Study|Withdrawal by Subject|1|||
157156639|NCT03364335|567319313|FG001|Overall Study|Lost to Follow-up|7|||
157156640|NCT03364335|567319314|FG002|Overall Study|Lost to Follow-up|10|||
157156641|NCT03364335|567319315|FG003|Overall Study|Lost to Follow-up|11|||
157156642|NCT03364335|567319316|FG004|Overall Study|Lost to Follow-up|11|||
157156643|NCT00492856|567319317|FG000|Induction|Adverse Event|2|||
157156644|NCT00492856|567319318|FG001|Induction|Adverse Event|0|||
157156645|NCT00492856|567319319|FG002|Induction|Adverse Event|0|||
157156646|NCT00492856|567319320|FG003|Induction|Adverse Event|0|||
157156647|NCT00492856|567319317|FG000|Induction|Withdrawal by Subject|1|||
157156648|NCT00492856|567319318|FG001|Induction|Withdrawal by Subject|0|||
157156649|NCT00492856|567319319|FG002|Induction|Withdrawal by Subject|0|||
157156650|NCT00492856|567319320|FG003|Induction|Withdrawal by Subject|0|||
157156651|NCT00492856|567319317|FG000|Induction|Death|3|||
157156652|NCT00492856|567319318|FG001|Induction|Death|0|||
157156653|NCT00492856|567319319|FG002|Induction|Death|0|||
157156654|NCT00492856|567319320|FG003|Induction|Death|0|||
157156655|NCT00492856|567319317|FG000|Consolidation|Adverse Event|6|||
157156656|NCT00492856|567319318|FG001|Consolidation|Adverse Event|0|||
157156657|NCT00492856|567319319|FG002|Consolidation|Adverse Event|0|||
157156658|NCT00492856|567319320|FG003|Consolidation|Adverse Event|0|||
157156659|NCT00492856|567319317|FG000|Consolidation|Not protocol specified|2|||
157156660|NCT00492856|567319318|FG001|Consolidation|Not protocol specified|0|||
157156661|NCT00492856|567319319|FG002|Consolidation|Not protocol specified|0|||
157156662|NCT00492856|567319320|FG003|Consolidation|Not protocol specified|0|||
157156663|NCT00492856|567319317|FG000|Consolidation|Lost to Follow-up|1|||
157156664|NCT00492856|567319318|FG001|Consolidation|Lost to Follow-up|0|||
157156665|NCT00492856|567319319|FG002|Consolidation|Lost to Follow-up|0|||
157156666|NCT00492856|567319320|FG003|Consolidation|Lost to Follow-up|0|||
157156667|NCT00492856|567319317|FG000|Post-consolidation|Adverse Event|0|||
157156668|NCT00492856|567319318|FG001|Post-consolidation|Adverse Event|4|||
157156669|NCT00492856|567319319|FG002|Post-consolidation|Adverse Event|0|||
157156670|NCT00492856|567319320|FG003|Post-consolidation|Adverse Event|1|||
157156671|NCT00492856|567319317|FG000|Post-consolidation|Withdrawal by Subject|0|||
157156672|NCT00492856|567319318|FG001|Post-consolidation|Withdrawal by Subject|4|||
157156673|NCT00492856|567319319|FG002|Post-consolidation|Withdrawal by Subject|0|||
157156674|NCT00492856|567319320|FG003|Post-consolidation|Withdrawal by Subject|0|||
157156675|NCT00492856|567319317|FG000|Post-consolidation|Death|0|||
157156676|NCT00492856|567319318|FG001|Post-consolidation|Death|1|||
157156677|NCT00492856|567319319|FG002|Post-consolidation|Death|0|||
157156678|NCT00492856|567319320|FG003|Post-consolidation|Death|0|||
157156679|NCT00492856|567319317|FG000|Post-consolidation|Not protocol specified|0|||
157156680|NCT00492856|567319318|FG001|Post-consolidation|Not protocol specified|1|||
157156681|NCT00492856|567319319|FG002|Post-consolidation|Not protocol specified|0|||
157156682|NCT00492856|567319320|FG003|Post-consolidation|Not protocol specified|0|||
157156683|NCT00492856|567319317|FG000|Post-consolidation|Lost to Follow-up|0|||
157156684|NCT00492856|567319318|FG001|Post-consolidation|Lost to Follow-up|2|||
157156685|NCT00492856|567319319|FG002|Post-consolidation|Lost to Follow-up|0|||
157156686|NCT00492856|567319320|FG003|Post-consolidation|Lost to Follow-up|0|||
157156687|NCT00492856|567319317|FG000|Post-consolidation|Observation Arm|0|||
157156688|NCT00492856|567319318|FG001|Post-consolidation|Observation Arm|0|||
157156689|NCT00492856|567319319|FG002|Post-consolidation|Observation Arm|27|||
157156690|NCT00492856|567319320|FG003|Post-consolidation|Observation Arm|0|||
157156691|NCT03987919|567319321|FG000|Overall Study|Adverse Event|1|||
157156692|NCT03987919|567319322|FG001|Overall Study|Adverse Event|4|||
157156693|NCT03987919|567319323|FG002|Overall Study|Adverse Event|1|||
157156694|NCT03987919|567319324|FG003|Overall Study|Adverse Event|3|||
157156695|NCT03987919|567319321|FG000|Overall Study|Death|4|||
157156696|NCT03987919|567319322|FG001|Overall Study|Death|4|||
157156697|NCT03987919|567319323|FG002|Overall Study|Death|4|||
157156698|NCT03987919|567319324|FG003|Overall Study|Death|1|||
157156699|NCT03987919|567319321|FG000|Overall Study|Lost to Follow-up|5|||
157156700|NCT03987919|567319322|FG001|Overall Study|Lost to Follow-up|6|||
157156701|NCT03987919|567319323|FG002|Overall Study|Lost to Follow-up|8|||
157156702|NCT03987919|567319324|FG003|Overall Study|Lost to Follow-up|12|||
157156703|NCT03987919|567319321|FG000|Overall Study|Physician Decision|0|||
157156704|NCT03987919|567319322|FG001|Overall Study|Physician Decision|2|||
157156705|NCT03987919|567319323|FG002|Overall Study|Physician Decision|0|||
157156706|NCT03987919|567319324|FG003|Overall Study|Physician Decision|4|||
157156707|NCT03987919|567319321|FG000|Overall Study|Pregnancy|1|||
157225456|NCT01860976|567571437|FG001|Open-Label|Lack of Efficacy|8|||
156889130|NCT00708201|566354136|FG000|Overall Study|Lost to Follow-up|2|||
156889131|NCT00708201|566354137|FG001|Overall Study|Lost to Follow-up|0|||
156889132|NCT00708201|566354136|FG000|Overall Study|Protocol Violation|0|||
156889133|NCT00708201|566354137|FG001|Overall Study|Protocol Violation|1|||
157025715|NCT04492722|566848040|FG002|Overall Study|Due to Covid-19 pandemic|7|||
157156708|NCT03987919|567319322|FG001|Overall Study|Pregnancy|0|||
157156709|NCT03987919|567319323|FG002|Overall Study|Pregnancy|1|||
157156710|NCT03987919|567319324|FG003|Overall Study|Pregnancy|1|||
157156711|NCT03987919|567319321|FG000|Overall Study|Protocol Violation|0|||
157156712|NCT03987919|567319322|FG001|Overall Study|Protocol Violation|1|||
157156713|NCT03987919|567319323|FG002|Overall Study|Protocol Violation|0|||
157156714|NCT03987919|567319324|FG003|Overall Study|Protocol Violation|0|||
157156715|NCT03987919|567319321|FG000|Overall Study|Site terminated by Sponsor|0|||
157156716|NCT03987919|567319322|FG001|Overall Study|Site terminated by Sponsor|0|||
157156717|NCT03987919|567319323|FG002|Overall Study|Site terminated by Sponsor|0|||
157156718|NCT03987919|567319324|FG003|Overall Study|Site terminated by Sponsor|1|||
157156719|NCT03987919|567319321|FG000|Overall Study|Withdrawal by Subject|7|||
157156720|NCT03987919|567319322|FG001|Overall Study|Withdrawal by Subject|7|||
157156721|NCT03987919|567319323|FG002|Overall Study|Withdrawal by Subject|8|||
157025716|NCT04492722|566848041|FG003|Overall Study|Due to Covid-19 pandemic|6|||
157156722|NCT03987919|567319324|FG003|Overall Study|Withdrawal by Subject|4|||
157156723|NCT03987919|567319321|FG000|Overall Study|Other - as reported by the investigator|1|||
157156724|NCT03987919|567319322|FG001|Overall Study|Other - as reported by the investigator|3|||
157156725|NCT03987919|567319323|FG002|Overall Study|Other - as reported by the investigator|2|||
157156726|NCT03987919|567319324|FG003|Overall Study|Other - as reported by the investigator|0|||
157156727|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
157156728|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
157156729|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
157156730|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
157156731|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
157156732|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
157156733|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
157156734|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
157156735|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
157156736|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
157156737|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
157156738|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
157156739|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
157156740|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
157156741|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
157156742|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
157156743|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
157156744|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156745|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156746|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156747|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156748|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156749|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156750|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
157156751|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
157156752|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156753|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156754|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156755|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156756|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156757|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156758|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
157156759|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
157156760|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
157156761|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
157156762|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
157156763|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
157156764|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
157156765|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
157156766|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
157156767|NCT03725202|567319327|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156768|NCT03725202|567319328|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156769|NCT03725202|567319329|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
157156770|NCT03725202|567319330|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156771|NCT03725202|567319331|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156772|NCT03725202|567319332|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156773|NCT03725202|567319333|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156774|NCT03725202|567319334|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
157156775|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
157156776|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
157156777|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
157156778|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
157156779|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
156889134|NCT00761748|566354138|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
156889135|NCT00761748|566354139|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
156889136|NCT00761748|566354138|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
156889137|NCT00761748|566354139|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
156889138|NCT01857310|566354140|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
156889139|NCT01857310|566354141|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
156889140|NCT02554279|566354142|FG000|Overall Study|Adverse Event|2|||
157025717|NCT04492722|566848038|FG000|Overall Study|Failure to meet randomisation criteria|2|||
157156780|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
157156781|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
157156782|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
157156783|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
157156784|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
157156785|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
157156786|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
157156787|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
157156788|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
157156789|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
157156790|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
157156791|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
157156792|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
157156793|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
157156794|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
157156795|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
157156796|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
157156797|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
157156798|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
157156799|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156800|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156801|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156802|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156803|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156804|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156805|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
157156806|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
157156807|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156808|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156809|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
156851084|NCT03018691|566208979|FG000|Overall Study|Adverse Event|1|||
156851085|NCT03018691|566208980|FG001|Overall Study|Adverse Event|1|||
156851086|NCT03018691|566208981|FG002|Overall Study|Adverse Event|4|||
156851087|NCT03018691|566208979|FG000|Overall Study|Lack of Efficacy|0|||
156851088|NCT03018691|566208980|FG001|Overall Study|Lack of Efficacy|0|||
156851089|NCT03018691|566208981|FG002|Overall Study|Lack of Efficacy|1|||
156851090|NCT03018691|566208979|FG000|Overall Study|Withdrawal by Subject|0|||
156851091|NCT03018691|566208980|FG001|Overall Study|Withdrawal by Subject|0|||
156851092|NCT03018691|566208981|FG002|Overall Study|Withdrawal by Subject|1|||
156851093|NCT03018691|566208979|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156851094|NCT03018691|566208980|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156851095|NCT03018691|566208981|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156851096|NCT03369418|566208983|FG000|Overall Study|Withdrawal by Subject|3|||
156851097|NCT03369418|566208984|FG001|Overall Study|Withdrawal by Subject|3|||
156851098|NCT01485094|566208985|FG000|Overall Study|Adverse Event|1|||
156851099|NCT01485094|566208986|FG001|Overall Study|Adverse Event|1|||
156851100|NCT01485094|566208987|FG002|Overall Study|Adverse Event|1|||
156851101|NCT01485094|566208985|FG000|Overall Study|Lost to Follow-up|1|||
156851102|NCT01485094|566208986|FG001|Overall Study|Lost to Follow-up|0|||
156851103|NCT01485094|566208987|FG002|Overall Study|Lost to Follow-up|0|||
157025718|NCT04492722|566848039|FG001|Overall Study|Failure to meet randomisation criteria|3|||
157025719|NCT04492722|566848040|FG002|Overall Study|Failure to meet randomisation criteria|4|||
157156810|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156811|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156812|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
156851104|NCT01485094|566208985|FG000|Overall Study|Withdrawal by Subject|1|||
156851105|NCT01485094|566208986|FG001|Overall Study|Withdrawal by Subject|1|||
156851106|NCT01485094|566208987|FG002|Overall Study|Withdrawal by Subject|0|||
156851107|NCT01450761|566208988|FG000|Randomization|Subject no longer meets study criteria|1|||
156851108|NCT01450761|566208989|FG001|Randomization|Subject no longer meets study criteria|2|||
156851109|NCT01450761|566208988|FG000|Randomization|Withdrawal by Subject|2|||
156851110|NCT01450761|566208989|FG001|Randomization|Withdrawal by Subject|0|||
156851111|NCT01450761|566208988|FG000|Randomization|Disease progression|0|||
156851112|NCT01450761|566208989|FG001|Randomization|Disease progression|2|||
156851113|NCT01450761|566208988|FG000|Randomization|Adverse Event unrelated to study drug|1|||
156851114|NCT01450761|566208989|FG001|Randomization|Adverse Event unrelated to study drug|0|||
156851115|NCT01450761|566208988|FG000|Randomization|Other|0|||
156851116|NCT01450761|566208989|FG001|Randomization|Other|1|||
156851117|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Disease progression|33|||
156851118|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Disease progression|32|||
156851119|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
156851120|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
156851121|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
157156813|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156814|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
157156815|NCT03725202|567319327|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
157156816|NCT03725202|567319328|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
157156817|NCT03725202|567319329|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
157156818|NCT03725202|567319330|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
157156819|NCT03725202|567319331|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
157156820|NCT03725202|567319332|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
157156821|NCT03725202|567319333|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
157156822|NCT03725202|567319334|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
157156823|NCT01520324|567319335|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
157156824|NCT01328249|567319338|FG000|Overall Study|Adverse Event|3|||
157156825|NCT01328249|567319339|FG001|Overall Study|Adverse Event|0|||
157156826|NCT01328249|567319338|FG000|Overall Study|Disease progression|1|||
157156827|NCT01328249|567319339|FG001|Overall Study|Disease progression|0|||
157156828|NCT01328249|567319338|FG000|Overall Study|Withdrawal by Subject|1|||
157156829|NCT01328249|567319339|FG001|Overall Study|Withdrawal by Subject|1|||
157156830|NCT01328249|567319338|FG000|Overall Study|Moved before end of treatment visit|1|||
157156831|NCT01328249|567319339|FG001|Overall Study|Moved before end of treatment visit|0|||
157156832|NCT01328249|567319338|FG000|Overall Study|Subject choice|1|||
157156833|NCT01328249|567319339|FG001|Overall Study|Subject choice|1|||
157156834|NCT01328249|567319338|FG000|Overall Study|Protocol Violation|0|||
157156835|NCT01328249|567319339|FG001|Overall Study|Protocol Violation|1|||
157156836|NCT00748553|567319340|FG000|Overall Study|Adverse Event|0|||
157156837|NCT00748553|567319341|FG001|Overall Study|Adverse Event|1|||
157156838|NCT00748553|567319340|FG000|Overall Study|disease progression|2|||
157156839|NCT00748553|567319341|FG001|Overall Study|disease progression|0|||
157156840|NCT00748553|567319340|FG000|Overall Study|noncompliance|1|||
157156841|NCT00748553|567319341|FG001|Overall Study|noncompliance|0|||
157156842|NCT00948818|567319343|FG000|Overall Study|Adverse Event|10|||
157156843|NCT00948818|567319344|FG001|Overall Study|Adverse Event|32|||
157156844|NCT00948818|567319343|FG000|Overall Study|Protocol Violation|9|||
157156845|NCT00948818|567319344|FG001|Overall Study|Protocol Violation|10|||
157156846|NCT00948818|567319343|FG000|Overall Study|Withdrawal by Subject|25|||
157156847|NCT00948818|567319344|FG001|Overall Study|Withdrawal by Subject|25|||
157156848|NCT00948818|567319343|FG000|Overall Study|Lost to Follow-up|10|||
157156849|NCT00948818|567319344|FG001|Overall Study|Lost to Follow-up|17|||
157156850|NCT00948818|567319343|FG000|Overall Study|Lack of Efficacy|4|||
157156851|NCT00948818|567319344|FG001|Overall Study|Lack of Efficacy|5|||
157156852|NCT00948818|567319343|FG000|Overall Study|Other Reason|4|||
157156853|NCT00948818|567319344|FG001|Overall Study|Other Reason|5|||
157156854|NCT02330549|567319345|FG000|Overall Study|Adverse Event|1|||
157156855|NCT02330549|567319346|FG001|Overall Study|Adverse Event|0|||
157156856|NCT02330549|567319345|FG000|Overall Study|Subject withdrew consent|2|||
157156857|NCT02330549|567319346|FG001|Overall Study|Subject withdrew consent|1|||
157156858|NCT02330549|567319345|FG000|Overall Study|Failure to meet randomization criteria|1|||
157156859|NCT02330549|567319346|FG001|Overall Study|Failure to meet randomization criteria|0|||
157156860|NCT00495495|567319347|FG000|Overall Study|Protocol Violation|99|||
157156861|NCT00745368|567319348|FG000|Overall Study|Unable to provide sample|3|||
157156862|NCT00434512|567319349|FG000|Overall Study|Migrated/moved from study area|0|||
157156863|NCT00434512|567319350|FG001|Overall Study|Migrated/moved from study area|0|||
157156864|NCT00434512|567319351|FG002|Overall Study|Migrated/moved from study area|0|||
157156865|NCT00434512|567319352|FG003|Overall Study|Migrated/moved from study area|1|||
157156866|NCT00434512|567319353|FG004|Overall Study|Migrated/moved from study area|1|||
157156867|NCT00434512|567319354|FG005|Overall Study|Migrated/moved from study area|1|||
157156868|NCT00434512|567319349|FG000|Overall Study|Other|0|||
157156869|NCT00434512|567319350|FG001|Overall Study|Other|1|||
157156870|NCT00434512|567319351|FG002|Overall Study|Other|0|||
157156871|NCT00434512|567319352|FG003|Overall Study|Other|0|||
156851122|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
156851123|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
156851124|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
157156872|NCT00434512|567319353|FG004|Overall Study|Other|0|||
157156873|NCT00434512|567319354|FG005|Overall Study|Other|0|||
157156874|NCT00441441|567319360|FG000|Overall Study|Adverse Event|2|||
157156875|NCT00441441|567319361|FG001|Overall Study|Adverse Event|1|||
157156876|NCT00441441|567319360|FG000|Overall Study|Protocol Violation|4|||
157156877|NCT00441441|567319361|FG001|Overall Study|Protocol Violation|6|||
157156878|NCT00441441|567319360|FG000|Overall Study|Exacerbation of asthma|1|||
157156879|NCT00441441|567319361|FG001|Overall Study|Exacerbation of asthma|2|||
157156880|NCT00441441|567319360|FG000|Overall Study|Withdrawal by Subject|1|||
157156881|NCT00441441|567319361|FG001|Overall Study|Withdrawal by Subject|2|||
157156882|NCT00441441|567319360|FG000|Overall Study|Other|3|||
157156883|NCT00441441|567319361|FG001|Overall Study|Other|3|||
157156884|NCT05619172|567319365|FG000|Safety Cohort 1|Death|7|||
157156885|NCT05619172|567319366|FG001|Safety Cohort 1|Death|0|||
156851125|NCT01450761|566208988|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
156851126|NCT01450761|566208989|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
156851127|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Death|3|||
156851128|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Death|3|||
156851129|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Other|2|||
156851130|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Other|2|||
156851131|NCT01450761|566208988|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
156851132|NCT01450761|566208989|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
156851133|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
156851134|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
156851135|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
156851136|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
156851137|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
156851138|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
156851139|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
156851140|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
156851141|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
156851142|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
156851143|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Death|5|||
156851144|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Death|6|||
156851145|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
156851146|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
156851147|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
156851148|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
156851149|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
156851150|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
156851151|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
156851152|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
156851153|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
156851154|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
156851155|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
156851156|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
156851157|NCT01450761|566208988|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
156851158|NCT01450761|566208989|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
156851159|NCT03801174|566208994|FG000|Overall Study|Withdrawal by Subject|14|||
156851160|NCT03801174|566208995|FG001|Overall Study|Withdrawal by Subject|15|||
156851161|NCT03801174|566208994|FG000|Overall Study|Death|1|||
156851162|NCT03801174|566208995|FG001|Overall Study|Death|0|||
156851163|NCT03801174|566208994|FG000|Overall Study|Pregnancy|2|||
157156886|NCT05619172|567319365|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
157156887|NCT05619172|567319366|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
157156888|NCT05619172|567319365|FG000|Safety Cohort 2|Death|0|||
157156889|NCT05619172|567319366|FG001|Safety Cohort 2|Death|1|||
157156890|NCT05619172|567319365|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
157156891|NCT05619172|567319366|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
157156892|NCT03165721|567319368|FG000|Overall Study|Refused further treatment|3|||
157156893|NCT03165721|567319369|FG001|Overall Study|Refused further treatment|0|||
157156894|NCT03165721|567319370|FG002|Overall Study|Refused further treatment|0|||
157156895|NCT03165721|567319368|FG000|Overall Study|Physician Decision|1|||
157156896|NCT03165721|567319369|FG001|Overall Study|Physician Decision|0|||
157156897|NCT03165721|567319370|FG002|Overall Study|Physician Decision|0|||
157156898|NCT01457118|567319371|FG000|Overall Study|Adverse Event|1|||
157156899|NCT01457118|567319372|FG001|Overall Study|Adverse Event|0|||
156851164|NCT03801174|566208995|FG001|Overall Study|Pregnancy|2|||
156851165|NCT03801174|566208994|FG000|Overall Study|Lost to Follow-up|19|||
156851166|NCT03801174|566208995|FG001|Overall Study|Lost to Follow-up|10|||
156851167|NCT03801174|566208994|FG000|Overall Study|Other|4|||
156851168|NCT03801174|566208995|FG001|Overall Study|Other|3|||
156851169|NCT03801174|566208994|FG000|Overall Study|Lack of Efficacy|4|||
156889141|NCT02554279|566354143|FG001|Overall Study|Adverse Event|5|||
156889142|NCT02554279|566354142|FG000|Overall Study|Lost to Follow-up|3|||
156889143|NCT02554279|566354143|FG001|Overall Study|Lost to Follow-up|2|||
156889144|NCT02554279|566354142|FG000|Overall Study|Withdrawal by Subject|6|||
156889145|NCT02554279|566354143|FG001|Overall Study|Withdrawal by Subject|4|||
157156900|NCT01457118|567319373|FG002|Overall Study|Adverse Event|0|||
157156901|NCT01457118|567319374|FG003|Overall Study|Adverse Event|1|||
156889146|NCT02554279|566354142|FG000|Overall Study|Protocol Violation|2|||
157156902|NCT01457118|567319371|FG000|Overall Study|Clinical Progression|0|||
157156903|NCT01457118|567319372|FG001|Overall Study|Clinical Progression|1|||
157156904|NCT01457118|567319373|FG002|Overall Study|Clinical Progression|0|||
157156905|NCT01457118|567319374|FG003|Overall Study|Clinical Progression|1|||
157225457|NCT01860976|567571436|FG000|Open-Label|Lost to Follow-up|1|||
157156906|NCT01457118|567319371|FG000|Overall Study|Physician Decision|2|||
157156907|NCT01457118|567319372|FG001|Overall Study|Physician Decision|0|||
157156908|NCT01457118|567319373|FG002|Overall Study|Physician Decision|0|||
157156909|NCT01457118|567319374|FG003|Overall Study|Physician Decision|0|||
157156910|NCT01457118|567319371|FG000|Overall Study|Progressive Disease by RECIST|12|||
157156911|NCT01457118|567319372|FG001|Overall Study|Progressive Disease by RECIST|3|||
157156912|NCT01457118|567319373|FG002|Overall Study|Progressive Disease by RECIST|1|||
157156913|NCT01457118|567319374|FG003|Overall Study|Progressive Disease by RECIST|0|||
157156914|NCT01457118|567319371|FG000|Overall Study|Withdrawal by Subject|5|||
157156915|NCT01457118|567319372|FG001|Overall Study|Withdrawal by Subject|0|||
157156916|NCT01457118|567319373|FG002|Overall Study|Withdrawal by Subject|0|||
157156917|NCT01457118|567319374|FG003|Overall Study|Withdrawal by Subject|0|||
157156918|NCT03656926|567319375|FG000|Overall Study|Adverse Event|5|||
157156919|NCT03656926|567319376|FG001|Overall Study|Adverse Event|4|||
157156920|NCT03656926|567319375|FG000|Overall Study|Withdrawal by Subject|7|||
157156921|NCT03656926|567319376|FG001|Overall Study|Withdrawal by Subject|2|||
157156922|NCT03656926|567319375|FG000|Overall Study|Screen fail after randomization|1|||
157156923|NCT03656926|567319376|FG001|Overall Study|Screen fail after randomization|0|||
157156924|NCT03656926|567319375|FG000|Overall Study|PI decision due to patient condition|1|||
157156925|NCT03656926|567319376|FG001|Overall Study|PI decision due to patient condition|0|||
157156926|NCT03656926|567319375|FG000|Overall Study|Patient unresponsiveness|1|||
157156927|NCT03656926|567319376|FG001|Overall Study|Patient unresponsiveness|0|||
157156928|NCT00069095|567319377|FG000|Primary Treatment Phase|Ongoing|0|||
156851170|NCT03801174|566208995|FG001|Overall Study|Lack of Efficacy|0|||
156851171|NCT03801174|566208994|FG000|Overall Study|Unwilling to complete activities|5|||
156851172|NCT03801174|566208995|FG001|Overall Study|Unwilling to complete activities|6|||
156851173|NCT03801174|566208994|FG000|Overall Study|Moved out of area|3|||
156851174|NCT03801174|566208995|FG001|Overall Study|Moved out of area|0|||
156851175|NCT04435366|566208999|FG000|Year 1 (12 Months)|Adverse Event|3|||
156851176|NCT04435366|566209000|FG001|Year 1 (12 Months)|Adverse Event|0|||
156851177|NCT04435366|566209001|FG002|Year 1 (12 Months)|Adverse Event|2|||
156851178|NCT04435366|566208999|FG000|Year 1 (12 Months)|Death|2|||
156851179|NCT04435366|566209000|FG001|Year 1 (12 Months)|Death|0|||
156851180|NCT04435366|566209001|FG002|Year 1 (12 Months)|Death|1|||
156851181|NCT04435366|566208999|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
156851182|NCT04435366|566209000|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
156851183|NCT04435366|566209001|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
156851184|NCT04435366|566208999|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
156851185|NCT04435366|566209000|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
156851186|NCT04435366|566209001|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
156851187|NCT04435366|566208999|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
156851188|NCT04435366|566209000|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
156851189|NCT04435366|566209001|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
156851190|NCT04435366|566208999|FG000|Year 1 (12 Months)|Not treated|0|||
156851191|NCT04435366|566209000|FG001|Year 1 (12 Months)|Not treated|0|||
156851192|NCT04435366|566209001|FG002|Year 1 (12 Months)|Not treated|1|||
156851193|NCT04435366|566208999|FG000|Year 2 (12 Months)|Death|1|||
156851194|NCT04435366|566209000|FG001|Year 2 (12 Months)|Death|4|||
156851195|NCT04435366|566209001|FG002|Year 2 (12 Months)|Death|6|||
156851196|NCT04435366|566208999|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
156851197|NCT04435366|566209000|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
156851198|NCT04435366|566209001|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
156851199|NCT04435366|566208999|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
156851200|NCT04435366|566209000|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
156851201|NCT04435366|566209001|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
156851202|NCT04435366|566208999|FG000|Year 2 (12 Months)|Adverse Event|2|||
156851203|NCT04435366|566209000|FG001|Year 2 (12 Months)|Adverse Event|1|||
156851204|NCT04435366|566209001|FG002|Year 2 (12 Months)|Adverse Event|6|||
156851205|NCT04112810|566209002|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
156851206|NCT01687296|566209003|FG000|Overall Study|Lack of Efficacy|1|||
156851207|NCT01687296|566209004|FG001|Overall Study|Lack of Efficacy|1|||
156851208|NCT01687296|566209003|FG000|Overall Study|Protocol Violation|0|||
156851209|NCT01687296|566209004|FG001|Overall Study|Protocol Violation|1|||
156851210|NCT01687296|566209003|FG000|Overall Study|Withdrawal by Subject|6|||
156851211|NCT01687296|566209004|FG001|Overall Study|Withdrawal by Subject|3|||
156851212|NCT01508169|566209005|FG000|Overall Study|Adverse Event|1|||
156851213|NCT01508169|566209006|FG001|Overall Study|Adverse Event|0|||
156851214|NCT01508169|566209005|FG000|Overall Study|Withdrawal by Subject|1|||
156851215|NCT01508169|566209006|FG001|Overall Study|Withdrawal by Subject|0|||
157156929|NCT00069095|567319378|FG001|Primary Treatment Phase|Ongoing|0|||
157156930|NCT00069095|567319379|FG002|Primary Treatment Phase|Ongoing|5|||
157156931|NCT00069095|567319380|FG003|Primary Treatment Phase|Ongoing|7|||
157156932|NCT00069095|567319381|FG004|Primary Treatment Phase|Ongoing|7|||
157156933|NCT00069095|567319382|FG005|Primary Treatment Phase|Ongoing|4|||
156851216|NCT01508169|566209005|FG000|Overall Study|Lost to Follow-up|1|||
156851217|NCT01508169|566209006|FG001|Overall Study|Lost to Follow-up|2|||
156851218|NCT03600740|566209015|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
156851219|NCT01702558|566209016|FG000|Overall Study|Withdrawal by Subject|0|||
157156934|NCT00069095|567319377|FG000|Primary Treatment Phase|Admin/Other|29|||
157156935|NCT00069095|567319378|FG001|Primary Treatment Phase|Admin/Other|38|||
157156936|NCT00069095|567319379|FG002|Primary Treatment Phase|Admin/Other|31|||
157156937|NCT00069095|567319380|FG003|Primary Treatment Phase|Admin/Other|45|||
157156938|NCT00069095|567319381|FG004|Primary Treatment Phase|Admin/Other|48|||
157156939|NCT00069095|567319382|FG005|Primary Treatment Phase|Admin/Other|42|||
157156940|NCT00069095|567319377|FG000|Primary Treatment Phase|Adverse Event|99|||
157156941|NCT00069095|567319378|FG001|Primary Treatment Phase|Adverse Event|92|||
157156942|NCT00069095|567319379|FG002|Primary Treatment Phase|Adverse Event|71|||
157156943|NCT00069095|567319380|FG003|Primary Treatment Phase|Adverse Event|72|||
157156944|NCT00069095|567319381|FG004|Primary Treatment Phase|Adverse Event|109|||
157156945|NCT00069095|567319382|FG005|Primary Treatment Phase|Adverse Event|101|||
157156946|NCT00069095|567319377|FG000|Primary Treatment Phase|Death|14|||
157156947|NCT00069095|567319378|FG001|Primary Treatment Phase|Death|8|||
157156948|NCT00069095|567319379|FG002|Primary Treatment Phase|Death|2|||
157156949|NCT00069095|567319380|FG003|Primary Treatment Phase|Death|5|||
157156950|NCT00069095|567319381|FG004|Primary Treatment Phase|Death|8|||
157156951|NCT00069095|567319382|FG005|Primary Treatment Phase|Death|8|||
157156952|NCT00069095|567319377|FG000|Primary Treatment Phase|Failure to return|5|||
157156953|NCT00069095|567319378|FG001|Primary Treatment Phase|Failure to return|5|||
157156954|NCT00069095|567319379|FG002|Primary Treatment Phase|Failure to return|0|||
157156955|NCT00069095|567319380|FG003|Primary Treatment Phase|Failure to return|0|||
157156956|NCT00069095|567319381|FG004|Primary Treatment Phase|Failure to return|0|||
157156957|NCT00069095|567319382|FG005|Primary Treatment Phase|Failure to return|2|||
157156958|NCT00069095|567319377|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
157156959|NCT00069095|567319378|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
157156960|NCT00069095|567319379|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
157156961|NCT00069095|567319380|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
157156962|NCT00069095|567319381|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
157156963|NCT00069095|567319382|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
157156964|NCT00069095|567319377|FG000|Primary Treatment Phase|Refused treatment|15|||
157156965|NCT00069095|567319378|FG001|Primary Treatment Phase|Refused treatment|26|||
157156966|NCT00069095|567319379|FG002|Primary Treatment Phase|Refused treatment|17|||
157156967|NCT00069095|567319380|FG003|Primary Treatment Phase|Refused treatment|31|||
157156968|NCT00069095|567319381|FG004|Primary Treatment Phase|Refused treatment|24|||
156851220|NCT01702558|566209017|FG001|Overall Study|Withdrawal by Subject|0|||
156851221|NCT01702558|566209018|FG002|Overall Study|Withdrawal by Subject|0|||
156851222|NCT01702558|566209019|FG003|Overall Study|Withdrawal by Subject|12|||
156851223|NCT01702558|566209020|FG004|Overall Study|Withdrawal by Subject|4|||
156851224|NCT01702558|566209016|FG000|Overall Study|Lost to Follow-up|0|||
156851225|NCT01702558|566209017|FG001|Overall Study|Lost to Follow-up|0|||
156851226|NCT01702558|566209018|FG002|Overall Study|Lost to Follow-up|0|||
156851227|NCT01702558|566209019|FG003|Overall Study|Lost to Follow-up|3|||
156851228|NCT01702558|566209020|FG004|Overall Study|Lost to Follow-up|0|||
156851229|NCT01702558|566209016|FG000|Overall Study|Death|4|||
156851230|NCT01702558|566209017|FG001|Overall Study|Death|3|||
156851231|NCT01702558|566209018|FG002|Overall Study|Death|3|||
156851232|NCT01702558|566209019|FG003|Overall Study|Death|16|||
156851233|NCT01702558|566209020|FG004|Overall Study|Death|20|||
156851234|NCT01702558|566209016|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851235|NCT01702558|566209017|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851236|NCT01702558|566209018|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
156851237|NCT01702558|566209019|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851238|NCT01702558|566209020|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
156851239|NCT01702558|566209016|FG000|Overall Study|Study Terminated by Sponsor|0|||
156851240|NCT01702558|566209017|FG001|Overall Study|Study Terminated by Sponsor|1|||
156851241|NCT01702558|566209018|FG002|Overall Study|Study Terminated by Sponsor|0|||
156851242|NCT01702558|566209019|FG003|Overall Study|Study Terminated by Sponsor|0|||
156851243|NCT01702558|566209020|FG004|Overall Study|Study Terminated by Sponsor|1|||
156851244|NCT01702558|566209016|FG000|Overall Study|Other|0|||
157156969|NCT00069095|567319382|FG005|Primary Treatment Phase|Refused treatment|27|||
156851245|NCT01702558|566209017|FG001|Overall Study|Other|0|||
156851246|NCT01702558|566209018|FG002|Overall Study|Other|0|||
156851247|NCT01702558|566209019|FG003|Overall Study|Other|16|||
157156970|NCT00069095|567319377|FG000|Primary Treatment Phase|Withdrew|2|||
156851248|NCT01702558|566209020|FG004|Overall Study|Other|17|||
156851249|NCT03259087|566209023|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
157156971|NCT00069095|567319378|FG001|Primary Treatment Phase|Withdrew|3|||
157156972|NCT00069095|567319379|FG002|Primary Treatment Phase|Withdrew|8|||
157156973|NCT00069095|567319380|FG003|Primary Treatment Phase|Withdrew|2|||
157156974|NCT00069095|567319381|FG004|Primary Treatment Phase|Withdrew|4|||
157156975|NCT00069095|567319382|FG005|Primary Treatment Phase|Withdrew|9|||
156851250|NCT03259087|566209024|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156851251|NCT03259087|566209025|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
156851252|NCT03259087|566209026|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
157156976|NCT00069095|567319377|FG000|Primary Treatment Phase|Other Violation|0|||
157156977|NCT00069095|567319378|FG001|Primary Treatment Phase|Other Violation|1|||
157156978|NCT00069095|567319379|FG002|Primary Treatment Phase|Other Violation|1|||
157156979|NCT00069095|567319380|FG003|Primary Treatment Phase|Other Violation|1|||
157156980|NCT00069095|567319381|FG004|Primary Treatment Phase|Other Violation|0|||
157156981|NCT00069095|567319382|FG005|Primary Treatment Phase|Other Violation|1|||
157156982|NCT00069095|567319377|FG000|Primary Treatment Phase|Violation criteria|0|||
157156983|NCT00069095|567319378|FG001|Primary Treatment Phase|Violation criteria|2|||
157156984|NCT00069095|567319379|FG002|Primary Treatment Phase|Violation criteria|4|||
157156985|NCT00069095|567319380|FG003|Primary Treatment Phase|Violation criteria|3|||
157156986|NCT00069095|567319381|FG004|Primary Treatment Phase|Violation criteria|1|||
157156987|NCT00069095|567319382|FG005|Primary Treatment Phase|Violation criteria|5|||
157156988|NCT00069095|567319377|FG000|Post-study Treatment Phase|Missing reason|1|||
157156989|NCT00069095|567319378|FG001|Post-study Treatment Phase|Missing reason|3|||
157156990|NCT00069095|567319379|FG002|Post-study Treatment Phase|Missing reason|12|||
157156991|NCT00069095|567319380|FG003|Post-study Treatment Phase|Missing reason|8|||
157156992|NCT00069095|567319381|FG004|Post-study Treatment Phase|Missing reason|18|||
157156993|NCT00069095|567319382|FG005|Post-study Treatment Phase|Missing reason|17|||
157156994|NCT00069095|567319377|FG000|Post-study Treatment Phase|Adverse Event|2|||
157156995|NCT00069095|567319378|FG001|Post-study Treatment Phase|Adverse Event|3|||
157156996|NCT00069095|567319379|FG002|Post-study Treatment Phase|Adverse Event|1|||
157156997|NCT00069095|567319380|FG003|Post-study Treatment Phase|Adverse Event|0|||
157156998|NCT00069095|567319381|FG004|Post-study Treatment Phase|Adverse Event|5|||
157156999|NCT00069095|567319382|FG005|Post-study Treatment Phase|Adverse Event|1|||
157157000|NCT00069095|567319377|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
157157001|NCT00069095|567319378|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
157157002|NCT00069095|567319379|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
157157003|NCT00069095|567319380|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
156889147|NCT02554279|566354143|FG001|Overall Study|Protocol Violation|1|||
156889148|NCT02554279|566354142|FG000|Overall Study|Other reason|19|||
156889149|NCT02554279|566354143|FG001|Overall Study|Other reason|6|||
156889150|NCT00812487|566354144|FG000|Overall Study|Lost to Follow-up|2|||
156889151|NCT00812487|566354145|FG001|Overall Study|Lost to Follow-up|0|||
156889152|NCT00812487|566354144|FG000|Overall Study|Withdrawal by Subject|3|||
156889153|NCT00812487|566354145|FG001|Overall Study|Withdrawal by Subject|2|||
156889154|NCT00812487|566354144|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
156889155|NCT00812487|566354145|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
156889156|NCT00812487|566354144|FG000|Overall Study|Protocol Violation|0|||
157025720|NCT04492722|566848041|FG003|Overall Study|Failure to meet randomisation criteria|2|||
157025721|NCT04492722|566848038|FG000|Overall Study|Early termination from the study|54|||
157025722|NCT04492722|566848039|FG001|Overall Study|Early termination from the study|51|||
157025723|NCT04492722|566848040|FG002|Overall Study|Early termination from the study|50|||
157025724|NCT04492722|566848041|FG003|Overall Study|Early termination from the study|50|||
157157004|NCT00069095|567319381|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
157157005|NCT00069095|567319382|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
157157006|NCT00069095|567319377|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
157157007|NCT00069095|567319378|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
157157008|NCT00069095|567319379|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
157157009|NCT00069095|567319380|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
157157010|NCT00069095|567319381|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
157157011|NCT00069095|567319382|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
157157012|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
157157013|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
157157014|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
157157015|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
157157016|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
157157017|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
157157018|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant had complete response|1|||
157157019|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant had complete response|1|||
157157020|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant had complete response|0|||
157157021|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant had complete response|0|||
157157022|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant had complete response|0|||
157157023|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant had complete response|0|||
157157024|NCT00069095|567319377|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
157157025|NCT00069095|567319378|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
156889157|NCT00812487|566354145|FG001|Overall Study|Protocol Violation|1|||
156889158|NCT00998764|566354146|FG000|Overall Study|Lack of Efficacy|3|||
156889159|NCT00998764|566354147|FG001|Overall Study|Lack of Efficacy|6|||
156889160|NCT00998764|566354146|FG000|Overall Study|Adverse Event|17|||
156889161|NCT00998764|566354147|FG001|Overall Study|Adverse Event|12|||
157157026|NCT00069095|567319379|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
157157027|NCT00069095|567319380|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
157157028|NCT00069095|567319381|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
157157029|NCT00069095|567319382|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
157157030|NCT00069095|567319377|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
157157031|NCT00069095|567319378|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
157157032|NCT00069095|567319379|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
157157033|NCT00069095|567319380|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
157157034|NCT00069095|567319381|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
157157035|NCT00069095|567319382|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
157157036|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
157157037|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
157157038|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
157157039|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
156889162|NCT00998764|566354146|FG000|Overall Study|Withdrawal by Subject|19|||
156889163|NCT00998764|566354147|FG001|Overall Study|Withdrawal by Subject|25|||
156889164|NCT00998764|566354146|FG000|Overall Study|Physician Decision|3|||
156889165|NCT00998764|566354147|FG001|Overall Study|Physician Decision|3|||
156889166|NCT00998764|566354146|FG000|Overall Study|Death|3|||
156889167|NCT00998764|566354147|FG001|Overall Study|Death|1|||
156889168|NCT00998764|566354146|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
156889169|NCT00998764|566354147|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
156889170|NCT00998764|566354146|FG000|Overall Study|Protocol Violation|0|||
156889171|NCT00998764|566354147|FG001|Overall Study|Protocol Violation|1|||
156889172|NCT00998764|566354146|FG000|Overall Study|Failed to Return|1|||
156889173|NCT00998764|566354147|FG001|Overall Study|Failed to Return|1|||
156889174|NCT00998764|566354146|FG000|Overall Study|Lost to Follow-up|1|||
156889175|NCT00998764|566354147|FG001|Overall Study|Lost to Follow-up|1|||
156889176|NCT00998764|566354146|FG000|Overall Study|Loss of Caregiver|0|||
156889177|NCT00998764|566354147|FG001|Overall Study|Loss of Caregiver|3|||
156889178|NCT00998764|566354146|FG000|Overall Study|Other|4|||
156889179|NCT00998764|566354147|FG001|Overall Study|Other|4|||
156889180|NCT00998764|566354146|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
156889181|NCT00998764|566354147|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
156889182|NCT04761627|566354150|FG000|Run-in Period|Death|1|||
156889183|NCT04761627|566354151|FG001|Run-in Period|Death|0|||
156889184|NCT04761627|566354152|FG002|Run-in Period|Death|0|||
156889185|NCT04761627|566354150|FG000|Run-in Period|Required alternative therapy|2|||
156889186|NCT04761627|566354151|FG001|Run-in Period|Required alternative therapy|0|||
156889187|NCT04761627|566354152|FG002|Run-in Period|Required alternative therapy|0|||
156889188|NCT04761627|566354150|FG000|Run-in Period|Lost to Follow-up|2|||
156889189|NCT04761627|566354151|FG001|Run-in Period|Lost to Follow-up|0|||
156889190|NCT04761627|566354152|FG002|Run-in Period|Lost to Follow-up|0|||
156889191|NCT04761627|566354150|FG000|Run-in Period|Protocol Violation|3|||
156889192|NCT04761627|566354151|FG001|Run-in Period|Protocol Violation|0|||
156889193|NCT04761627|566354152|FG002|Run-in Period|Protocol Violation|0|||
156889194|NCT04761627|566354150|FG000|Run-in Period|Abnormal liver function|1|||
156889195|NCT04761627|566354151|FG001|Run-in Period|Abnormal liver function|0|||
156889196|NCT04761627|566354152|FG002|Run-in Period|Abnormal liver function|0|||
156889197|NCT04761627|566354150|FG000|Run-in Period|Adverse Event|6|||
156889198|NCT04761627|566354151|FG001|Run-in Period|Adverse Event|0|||
156889199|NCT04761627|566354152|FG002|Run-in Period|Adverse Event|0|||
156889200|NCT04761627|566354150|FG000|Run-in Period|Withdrawal by Subject|7|||
156889201|NCT04761627|566354151|FG001|Run-in Period|Withdrawal by Subject|0|||
156889202|NCT04761627|566354152|FG002|Run-in Period|Withdrawal by Subject|0|||
156889203|NCT04761627|566354150|FG000|Run-in Period|Did not meet PASI 50|15|||
157025725|NCT04492722|566848038|FG000|Overall Study|Missing|3|||
157025726|NCT04492722|566848039|FG001|Overall Study|Missing|0|||
157157040|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
157157041|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
156889204|NCT04761627|566354151|FG001|Run-in Period|Did not meet PASI 50|0|||
156889205|NCT04761627|566354152|FG002|Run-in Period|Did not meet PASI 50|0|||
156889206|NCT04761627|566354150|FG000|Run-in Period|Study site closure|2|||
156889207|NCT04761627|566354151|FG001|Run-in Period|Study site closure|0|||
156889208|NCT04761627|566354152|FG002|Run-in Period|Study site closure|0|||
156889209|NCT04761627|566354150|FG000|Run-in Period|Pregnancy|2|||
156889210|NCT04761627|566354151|FG001|Run-in Period|Pregnancy|0|||
156889211|NCT04761627|566354152|FG002|Run-in Period|Pregnancy|0|||
156889212|NCT04761627|566354150|FG000|Post-randomization Period|Military service|0|||
156889213|NCT04761627|566354151|FG001|Post-randomization Period|Military service|1|||
156889214|NCT04761627|566354152|FG002|Post-randomization Period|Military service|0|||
156889215|NCT04761627|566354150|FG000|Post-randomization Period|Adverse Event|0|||
156889216|NCT04761627|566354151|FG001|Post-randomization Period|Adverse Event|4|||
157025727|NCT04492722|566848040|FG002|Overall Study|Missing|0|||
157157042|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
157157043|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
157157044|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
157157045|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
157157046|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
157157047|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
157157048|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
157157049|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
157157050|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
157157051|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
157157052|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
157157053|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
157157054|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
157157055|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
157157056|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
157157057|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
157157058|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
157157059|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
157157060|NCT00069095|567319377|FG000|Post-study Treatment Phase|Surgery|0|||
157157061|NCT00069095|567319378|FG001|Post-study Treatment Phase|Surgery|0|||
157157062|NCT00069095|567319379|FG002|Post-study Treatment Phase|Surgery|0|||
157157063|NCT00069095|567319380|FG003|Post-study Treatment Phase|Surgery|1|||
157157064|NCT00069095|567319381|FG004|Post-study Treatment Phase|Surgery|1|||
157157065|NCT00069095|567319382|FG005|Post-study Treatment Phase|Surgery|0|||
157157066|NCT00069095|567319377|FG000|Post-study Treatment Phase|Death|0|||
157157067|NCT00069095|567319378|FG001|Post-study Treatment Phase|Death|0|||
157157068|NCT00069095|567319379|FG002|Post-study Treatment Phase|Death|0|||
157157069|NCT00069095|567319380|FG003|Post-study Treatment Phase|Death|0|||
157157070|NCT00069095|567319381|FG004|Post-study Treatment Phase|Death|1|||
157157071|NCT00069095|567319382|FG005|Post-study Treatment Phase|Death|0|||
157157072|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
157157073|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
157157074|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
157157075|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
157157076|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
157157077|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
157157078|NCT00069095|567319377|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
157157079|NCT00069095|567319378|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
157157080|NCT00069095|567319379|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
157157081|NCT00069095|567319380|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
157157082|NCT00069095|567319381|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
157157083|NCT00069095|567319382|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
157157084|NCT00069095|567319377|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
157157085|NCT00069095|567319378|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
157157086|NCT00069095|567319379|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
157157087|NCT00069095|567319380|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
157157088|NCT00069095|567319381|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
157157089|NCT00069095|567319382|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
157157090|NCT00069095|567319377|FG000|Post-study Treatment Phase|Investigator decision|0|||
157157091|NCT00069095|567319378|FG001|Post-study Treatment Phase|Investigator decision|0|||
157157092|NCT00069095|567319379|FG002|Post-study Treatment Phase|Investigator decision|0|||
156851253|NCT03259087|566209027|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
156851254|NCT03259087|566209023|FG000|Period 2 of Part 2|Adverse Event|0|||
156851255|NCT03259087|566209024|FG001|Period 2 of Part 2|Adverse Event|0|||
156851256|NCT03259087|566209025|FG002|Period 2 of Part 2|Adverse Event|0|||
156851257|NCT03259087|566209026|FG003|Period 2 of Part 2|Adverse Event|0|||
156851258|NCT03259087|566209027|FG004|Period 2 of Part 2|Adverse Event|1|||
156851259|NCT04524858|566209028|FG000|Overall Study|Adverse Event|1|||
156851260|NCT02396212|566209029|FG000|Overall Study|Adverse Event|1|||
156851261|NCT02396212|566209029|FG000|Overall Study|Lack of Efficacy|2|||
156851262|NCT01623115|566209030|FG000|Overall Study|Randomized but not treated|0|||
156851263|NCT01623115|566209031|FG001|Overall Study|Randomized but not treated|1|||
156851264|NCT01623115|566209030|FG000|Overall Study|Physician Decision|1|||
156851265|NCT01623115|566209031|FG001|Overall Study|Physician Decision|0|||
156851266|NCT01623115|566209030|FG000|Overall Study|Participants moved|1|||
156851267|NCT01623115|566209031|FG001|Overall Study|Participants moved|5|||
156851268|NCT01623115|566209030|FG000|Overall Study|Adverse Event|10|||
157157093|NCT00069095|567319380|FG003|Post-study Treatment Phase|Investigator decision|0|||
157157094|NCT00069095|567319381|FG004|Post-study Treatment Phase|Investigator decision|0|||
157157095|NCT00069095|567319382|FG005|Post-study Treatment Phase|Investigator decision|1|||
157157096|NCT00069095|567319377|FG000|Follow-up Phase|Death|174|||
157157097|NCT00069095|567319378|FG001|Follow-up Phase|Death|206|||
157157098|NCT00069095|567319379|FG002|Follow-up Phase|Death|120|||
157157099|NCT00069095|567319380|FG003|Follow-up Phase|Death|112|||
157157100|NCT00069095|567319381|FG004|Follow-up Phase|Death|92|||
157157101|NCT00069095|567319382|FG005|Follow-up Phase|Death|101|||
157157102|NCT05610176|567319383|FG000|Overall Study|Death|6|||
157157103|NCT01842308|567319387|FG000|Overall Study|Withdrawal by Subject|0|||
157157104|NCT01842308|567319388|FG001|Overall Study|Withdrawal by Subject|0|||
157157105|NCT01842308|567319389|FG002|Overall Study|Withdrawal by Subject|0|||
157157106|NCT01842308|567319390|FG003|Overall Study|Withdrawal by Subject|0|||
157157107|NCT01842308|567319391|FG004|Overall Study|Withdrawal by Subject|1|||
157157108|NCT00748540|567319395|FG000|Overall Study|Physician Decision|1|||
157157109|NCT04743635|567319396|FG000|Overall Study|Lost to Follow-up|2|||
157157110|NCT04743635|567319397|FG001|Overall Study|Lost to Follow-up|0|||
157157111|NCT01954121|567319399|FG000|Overall Study|Lack of Efficacy|94|||
157157112|NCT01954121|567319400|FG001|Overall Study|Lack of Efficacy|41|||
157157113|NCT01954121|567319399|FG000|Overall Study|Protocol Violation|0|||
157157114|NCT01954121|567319400|FG001|Overall Study|Protocol Violation|2|||
157157115|NCT01954121|567319399|FG000|Overall Study|Lost to Follow-up|5|||
157157116|NCT01954121|567319400|FG001|Overall Study|Lost to Follow-up|6|||
157157117|NCT01954121|567319399|FG000|Overall Study|Withdrawal by Subject|18|||
157157118|NCT01954121|567319400|FG001|Overall Study|Withdrawal by Subject|12|||
157157119|NCT01954121|567319399|FG000|Overall Study|Pregnancy|1|||
157157120|NCT01954121|567319400|FG001|Overall Study|Pregnancy|1|||
157157121|NCT01954121|567319399|FG000|Overall Study|AE, serious fatal|1|||
157157122|NCT01954121|567319400|FG001|Overall Study|AE, serious fatal|0|||
157157123|NCT01954121|567319399|FG000|Overall Study|AE, non-serious non-fatal|5|||
157157124|NCT01954121|567319400|FG001|Overall Study|AE, non-serious non-fatal|22|||
157157125|NCT01954121|567319399|FG000|Overall Study|SAE, non-fatal|1|||
157157126|NCT01954121|567319400|FG001|Overall Study|SAE, non-fatal|4|||
157157127|NCT01954121|567319399|FG000|Overall Study|Non-compliant with study procedures|1|||
157157128|NCT01954121|567319400|FG001|Overall Study|Non-compliant with study procedures|0|||
157157129|NCT01954121|567319399|FG000|Overall Study|Non-compliant patient|1|||
157157130|NCT01954121|567319400|FG001|Overall Study|Non-compliant patient|1|||
157157131|NCT01954121|567319399|FG000|Overall Study|Subject did not follow instructions|0|||
157157132|NCT01954121|567319400|FG001|Overall Study|Subject did not follow instructions|2|||
157157133|NCT00872170|567319401|FG000|Overall Study|Adverse Event|1|||
157157134|NCT00872170|567319402|FG001|Overall Study|Adverse Event|0|||
157157135|NCT04072146|567319403|FG000|Overall Study|Adverse Event|0|||
157157136|NCT04072146|567319404|FG001|Overall Study|Adverse Event|1|||
157157137|NCT00540436|567319408|FG000|First 12-Week Treatment Period|Adverse Event|1|||
157157138|NCT00540436|567319408|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
157157139|NCT00540436|567319408|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
157157140|NCT00540436|567319408|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
157157141|NCT01064648|567319409|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
157157142|NCT01064648|567319410|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
157157143|NCT01064648|567319411|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
157157144|NCT01064648|567319412|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
157157145|NCT01064648|567319409|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
157157146|NCT01064648|567319410|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
157157147|NCT01064648|567319411|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
157157148|NCT01064648|567319412|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
157157149|NCT01064648|567319409|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
157157150|NCT01064648|567319410|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
157157151|NCT01064648|567319411|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
157157152|NCT01064648|567319412|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
157157153|NCT01064648|567319409|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
157157154|NCT01064648|567319410|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
157157155|NCT01064648|567319411|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
157157156|NCT01064648|567319412|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
157157157|NCT01064648|567319409|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
157157158|NCT01064648|567319410|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
157157159|NCT01064648|567319411|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
157157160|NCT01064648|567319412|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
157157161|NCT01064648|567319409|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
157157162|NCT01064648|567319410|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
157157163|NCT01064648|567319411|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
157157164|NCT01064648|567319412|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
157225458|NCT01860976|567571437|FG001|Open-Label|Lost to Follow-up|2|||
156851269|NCT01623115|566209031|FG001|Overall Study|Adverse Event|13|||
157157165|NCT01064648|567319409|FG000|Phase II|Adverse Event|0|||
157157166|NCT01064648|567319410|FG001|Phase II|Adverse Event|0|||
157157167|NCT01064648|567319411|FG002|Phase II|Adverse Event|15|||
157157168|NCT01064648|567319412|FG003|Phase II|Adverse Event|8|||
157157169|NCT01064648|567319409|FG000|Phase II|Death|0|||
157157170|NCT01064648|567319410|FG001|Phase II|Death|0|||
157157171|NCT01064648|567319411|FG002|Phase II|Death|4|||
157157172|NCT01064648|567319412|FG003|Phase II|Death|5|||
157157173|NCT01064648|567319409|FG000|Phase II|Withdrawal by Subject|0|||
157157174|NCT01064648|567319410|FG001|Phase II|Withdrawal by Subject|0|||
157157175|NCT01064648|567319411|FG002|Phase II|Withdrawal by Subject|2|||
157157176|NCT01064648|567319412|FG003|Phase II|Withdrawal by Subject|5|||
157157177|NCT01064648|567319409|FG000|Phase II|Progression|0|||
157157178|NCT01064648|567319410|FG001|Phase II|Progression|0|||
157157179|NCT01064648|567319411|FG002|Phase II|Progression|21|||
157157180|NCT01064648|567319412|FG003|Phase II|Progression|27|||
157157181|NCT01064648|567319409|FG000|Phase II|Non-protocol specified|0|||
157157182|NCT01064648|567319410|FG001|Phase II|Non-protocol specified|0|||
157157183|NCT01064648|567319411|FG002|Phase II|Non-protocol specified|5|||
157157184|NCT01064648|567319412|FG003|Phase II|Non-protocol specified|3|||
157157185|NCT01064648|567319409|FG000|Phase II|Under Review|0|||
157157186|NCT01064648|567319410|FG001|Phase II|Under Review|0|||
157157187|NCT01064648|567319411|FG002|Phase II|Under Review|2|||
157157188|NCT01064648|567319412|FG003|Phase II|Under Review|0|||
156851270|NCT01623115|566209030|FG000|Overall Study|Poor compliance to protocol|4|||
156851271|NCT01623115|566209031|FG001|Overall Study|Poor compliance to protocol|10|||
156851272|NCT01623115|566209030|FG000|Overall Study|Consent withdrawn by participant|2|||
156851273|NCT01623115|566209031|FG001|Overall Study|Consent withdrawn by participant|6|||
156851274|NCT01623115|566209030|FG000|Overall Study|Related to study drug administration|0|||
156851275|NCT01623115|566209031|FG001|Overall Study|Related to study drug administration|2|||
156851276|NCT01623115|566209030|FG000|Overall Study|Last visit outside protocol visit window|14|||
156889217|NCT04761627|566354152|FG002|Post-randomization Period|Adverse Event|2|||
157157189|NCT05281523|567319413|FG000|Overall Study|Adverse Event|1|||
157157190|NCT05281523|567319414|FG001|Overall Study|Adverse Event|1|||
157157191|NCT05281523|567319413|FG000|Overall Study|Physician Decision|1|||
157157192|NCT05281523|567319414|FG001|Overall Study|Physician Decision|1|||
157157193|NCT05281523|567319413|FG000|Overall Study|Withdrawal by Subject|5|||
157157194|NCT05281523|567319414|FG001|Overall Study|Withdrawal by Subject|15|||
157157195|NCT05281523|567319413|FG000|Overall Study|GCP violations|3|||
157157196|NCT05281523|567319414|FG001|Overall Study|GCP violations|4|||
157157197|NCT05513391|567319415|FG000|Overall Study|Adverse Event|1|||
157157198|NCT05513391|567319416|FG001|Overall Study|Adverse Event|0|||
157157199|NCT05513391|567319415|FG000|Overall Study|Protocol Deviation|0|||
157157200|NCT05513391|567319416|FG001|Overall Study|Protocol Deviation|1|||
157157201|NCT05513391|567319415|FG000|Overall Study|Withdrawal by Subject|3|||
157157202|NCT05513391|567319416|FG001|Overall Study|Withdrawal by Subject|1|||
157157203|NCT05513391|567319415|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
157157204|NCT05513391|567319416|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
157157205|NCT05513391|567319415|FG000|Overall Study|Lost to Follow-up|0|||
157157206|NCT05513391|567319416|FG001|Overall Study|Lost to Follow-up|2|||
157157207|NCT02429427|567319417|FG000|Overall Study|Adverse Event|220|||
157157208|NCT02429427|567319418|FG001|Overall Study|Adverse Event|92|||
157157209|NCT02429427|567319417|FG000|Overall Study|Protocol Violation|10|||
157157210|NCT02429427|567319418|FG001|Overall Study|Protocol Violation|6|||
157157211|NCT02429427|567319417|FG000|Overall Study|Lost to Follow-up|15|||
157157212|NCT02429427|567319418|FG001|Overall Study|Lost to Follow-up|6|||
157157213|NCT02429427|567319417|FG000|Overall Study|Withdrawal by Subject|64|||
157157214|NCT02429427|567319418|FG001|Overall Study|Withdrawal by Subject|34|||
157157215|NCT02429427|567319417|FG000|Overall Study|Other|62|||
156851277|NCT01623115|566209031|FG001|Overall Study|Last visit outside protocol visit window|26|||
156851278|NCT01623115|566209030|FG000|Overall Study|Site closure|1|||
156851279|NCT01623115|566209031|FG001|Overall Study|Site closure|7|||
156851280|NCT01623115|566209030|FG000|Overall Study|Death|0|||
156851281|NCT01623115|566209031|FG001|Overall Study|Death|4|||
156851282|NCT01623115|566209030|FG000|Overall Study|Other than specified above|0|||
156851283|NCT01623115|566209031|FG001|Overall Study|Other than specified above|3|||
156889218|NCT04761627|566354150|FG000|Post-randomization Period|Lost to Follow-up|0|||
156851284|NCT04950465|566209032|FG000|Overall Study|Lost to Follow-up|1|||
156851285|NCT04950465|566209033|FG001|Overall Study|Lost to Follow-up|0|||
157157216|NCT02429427|567319418|FG001|Overall Study|Other|41|||
157157217|NCT00719732|567319419|FG000|Overall Study|Lost to Follow-up|20|||
157157218|NCT00719732|567319419|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
157157219|NCT00719732|567319419|FG000|Overall Study|Illness not associated with device|1|||
157157220|NCT00436215|567319420|FG000|Overall Study|Refused further treatment|3|||
157157221|NCT00436215|567319420|FG000|Overall Study|Small bowel obstruction|1|||
157157222|NCT04491877|567321041|FG000|Overall Study|Protocol Deviation|1|||
157157223|NCT04491877|567321042|FG001|Overall Study|Protocol Deviation|0|||
157157224|NCT04491877|567321043|FG002|Overall Study|Protocol Deviation|2|||
157157225|NCT04491877|567321044|FG003|Overall Study|Protocol Deviation|0|||
157157226|NCT04491877|567321045|FG004|Overall Study|Protocol Deviation|0|||
157157227|NCT04491877|567321046|FG005|Overall Study|Protocol Deviation|0|||
157157228|NCT04491877|567321047|FG006|Overall Study|Protocol Deviation|1|||
157157229|NCT04491877|567321048|FG007|Overall Study|Protocol Deviation|1|||
157157230|NCT04491877|567321049|FG008|Overall Study|Protocol Deviation|0|||
157157231|NCT04491877|567321041|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157157232|NCT04491877|567321042|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157157233|NCT04491877|567321043|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157157234|NCT04491877|567321044|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
157157235|NCT04491877|567321045|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
157157236|NCT04491877|567321046|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
157157237|NCT04491877|567321047|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
157157238|NCT04491877|567321048|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
157157239|NCT04491877|567321049|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
157157240|NCT04491877|567321041|FG000|Overall Study|Lost to Follow-up|0|||
157157241|NCT04491877|567321042|FG001|Overall Study|Lost to Follow-up|2|||
157157242|NCT04491877|567321043|FG002|Overall Study|Lost to Follow-up|0|||
156889219|NCT04761627|566354151|FG001|Post-randomization Period|Lost to Follow-up|6|||
156889220|NCT04761627|566354152|FG002|Post-randomization Period|Lost to Follow-up|6|||
156889221|NCT04761627|566354150|FG000|Post-randomization Period|Withdrawal by Subject|0|||
156889222|NCT04761627|566354151|FG001|Post-randomization Period|Withdrawal by Subject|7|||
156889223|NCT04761627|566354152|FG002|Post-randomization Period|Withdrawal by Subject|6|||
156889224|NCT04761627|566354150|FG000|Post-randomization Period|Pregnancy|0|||
156889225|NCT04761627|566354151|FG001|Post-randomization Period|Pregnancy|0|||
156889226|NCT04761627|566354152|FG002|Post-randomization Period|Pregnancy|1|||
156889227|NCT04761627|566354150|FG000|Post-randomization Period|Study site closure|0|||
156889228|NCT04761627|566354151|FG001|Post-randomization Period|Study site closure|0|||
156889229|NCT04761627|566354152|FG002|Post-randomization Period|Study site closure|1|||
157157243|NCT04491877|567321044|FG003|Overall Study|Lost to Follow-up|0|||
157157244|NCT04491877|567321045|FG004|Overall Study|Lost to Follow-up|0|||
157157245|NCT04491877|567321046|FG005|Overall Study|Lost to Follow-up|0|||
157157246|NCT04491877|567321047|FG006|Overall Study|Lost to Follow-up|2|||
157157247|NCT04491877|567321048|FG007|Overall Study|Lost to Follow-up|1|||
157157248|NCT04491877|567321049|FG008|Overall Study|Lost to Follow-up|1|||
157157249|NCT00683475|567321050|FG000|Overall Study|Withdrawal by Subject|1|||
157157250|NCT00683475|567321051|FG001|Overall Study|Withdrawal by Subject|0|||
157157251|NCT00683475|567321050|FG000|Overall Study|Never Treated: Adverse Event|2|||
157157252|NCT00683475|567321051|FG001|Overall Study|Never Treated: Adverse Event|3|||
157157253|NCT00683475|567321050|FG000|Overall Study|Never Treated: Progressive Disease|1|||
157157254|NCT00683475|567321051|FG001|Overall Study|Never Treated: Progressive Disease|0|||
157157255|NCT02364947|567321057|FG000|Overall Study|Withdrawal by Subject|10|||
157157256|NCT02364947|567321058|FG001|Overall Study|Withdrawal by Subject|8|||
157157257|NCT02364947|567321059|FG002|Overall Study|Withdrawal by Subject|9|||
157157258|NCT02364947|567321057|FG000|Overall Study|Adverse Event|45|||
157157259|NCT02364947|567321058|FG001|Overall Study|Adverse Event|33|||
157157260|NCT02364947|567321059|FG002|Overall Study|Adverse Event|11|||
157157261|NCT02364947|567321057|FG000|Overall Study|Protocol Violation|1|||
157157262|NCT02364947|567321058|FG001|Overall Study|Protocol Violation|1|||
157157263|NCT02364947|567321059|FG002|Overall Study|Protocol Violation|1|||
156889230|NCT04761627|566354150|FG000|Post-randomization Period|Family planning|0|||
156889231|NCT04761627|566354151|FG001|Post-randomization Period|Family planning|1|||
156889232|NCT04761627|566354152|FG002|Post-randomization Period|Family planning|0|||
157157264|NCT02364947|567321057|FG000|Overall Study|Physician Decision|3|||
157157265|NCT02364947|567321058|FG001|Overall Study|Physician Decision|2|||
157157266|NCT02364947|567321059|FG002|Overall Study|Physician Decision|5|||
157157267|NCT02364947|567321057|FG000|Overall Study|Death|0|||
157157268|NCT02364947|567321058|FG001|Overall Study|Death|1|||
157157269|NCT02364947|567321059|FG002|Overall Study|Death|0|||
157157270|NCT02702518|567321063|FG000|Overall Study|Lost to Follow-up|3|||
157157271|NCT02702518|567321064|FG001|Overall Study|Lost to Follow-up|4|||
157157272|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
157025728|NCT04492722|566848041|FG003|Overall Study|Missing|5|||
157225459|NCT01860976|567571436|FG000|Open-Label|Subject request discontinue treatment|4|||
157225460|NCT01860976|567571437|FG001|Open-Label|Subject request discontinue treatment|3|||
157157273|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
157025729|NCT04492722|566848038|FG000|Overall Study|Participants who did not receive treatment|0|||
157157274|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
157157275|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
157157276|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
157157277|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
157157278|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
157157279|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
157157280|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
156889233|NCT01933789|566354153|FG000|Overall Study|Death|0|||
156889234|NCT01933789|566354154|FG001|Overall Study|Death|0|||
157157281|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
157157282|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
157157283|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
157157284|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
157157285|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
157157286|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
156851286|NCT04950465|566209034|FG002|Overall Study|Lost to Follow-up|0|||
156851287|NCT01788566|566209049|FG000|Overall Study|Death|4|||
156851288|NCT01788566|566209049|FG000|Overall Study|Adverse Event|1|||
156851289|NCT01788566|566209049|FG000|Overall Study|Clinical Progressive Disease|3|||
156851290|NCT01338818|566209050|FG000|Overall Study|Adverse Event|8|||
156851291|NCT01338818|566209050|FG000|Overall Study|Lack of Efficacy|5|||
156851292|NCT01338818|566209050|FG000|Overall Study|no longer require study drug|1|||
156851293|NCT01338818|566209050|FG000|Overall Study|Withdrawal by Subject|11|||
156851294|NCT01338818|566209050|FG000|Overall Study|Lost to Follow-up|4|||
156851295|NCT01338818|566209050|FG000|Overall Study|Administrative problems|3|||
156851296|NCT01338818|566209050|FG000|Overall Study|Protocol Deviation|4|||
156851297|NCT00580723|566209053|FG000|Overall Study|Did not want to participate in extension|3|||
156851298|NCT00580723|566209053|FG000|Overall Study|Lost to Follow-up|5|||
156851299|NCT05202418|566209054|FG000|Overall Study|Withdrawal by Subject|2|||
156851300|NCT05202418|566209055|FG001|Overall Study|Withdrawal by Subject|1|||
156851301|NCT05202418|566209054|FG000|Overall Study|Lost to Follow-up|1|||
156851302|NCT05202418|566209055|FG001|Overall Study|Lost to Follow-up|1|||
156851303|NCT02562716|566209056|FG000|Overall Study|Adverse Event|7|||
156851304|NCT02562716|566209057|FG001|Overall Study|Adverse Event|14|||
156851305|NCT02562716|566209056|FG000|Overall Study|Withdrawal unrelated to AE|7|||
156851306|NCT02562716|566209057|FG001|Overall Study|Withdrawal unrelated to AE|1|||
156851307|NCT02562716|566209056|FG000|Overall Study|Progression|8|||
156851308|NCT02562716|566209057|FG001|Overall Study|Progression|10|||
156851309|NCT02562716|566209056|FG000|Overall Study|Death|2|||
156851310|NCT02562716|566209057|FG001|Overall Study|Death|1|||
156851311|NCT02562716|566209056|FG000|Overall Study|Not protocol specified|4|||
156851312|NCT02562716|566209057|FG001|Overall Study|Not protocol specified|2|||
156851313|NCT00684996|566209058|FG000|Overall Study|Adverse Event|1|||
156851314|NCT00684996|566209058|FG000|Overall Study|Refusal unrelated to adverse event|1|||
156851315|NCT00684996|566209058|FG000|Overall Study|Progression/relapse|2|||
156851316|NCT00684996|566209058|FG000|Overall Study|Other reasons not protocol specified|1|||
156851317|NCT00556998|566209059|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
156851318|NCT00556998|566209059|FG000|Voriconazole Intravenous (IV)|Other|4|||
156851319|NCT00556998|566209059|FG000|Voriconazole Oral|Adverse Event|1|||
156851320|NCT00556998|566209059|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
156851321|NCT02519439|566209062|FG000|Overall Study|Study Termination|19|||
156851322|NCT02519439|566209062|FG000|Overall Study|Withdrawal by Subject|1|||
156851323|NCT02519439|566209062|FG000|Overall Study|Adverse Event|1|||
156851324|NCT01539759|566209065|FG000|Overall Study|Lost to Follow-up|6|||
157157287|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
157157288|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
156851325|NCT01539759|566209066|FG001|Overall Study|Lost to Follow-up|8|||
156851326|NCT01078441|566209067|FG000|Overall Study|Withdrawal by Subject|1|||
156851327|NCT01425801|566209068|FG000|Period 1|Withdrawal by Subject|0|||
156851328|NCT01425801|566209069|FG001|Period 1|Withdrawal by Subject|0|||
156851329|NCT01425801|566209070|FG002|Period 1|Withdrawal by Subject|0|||
156851330|NCT01425801|566209071|FG003|Period 1|Withdrawal by Subject|0|||
156851331|NCT01425801|566209072|FG004|Period 1|Withdrawal by Subject|1|||
156851332|NCT01425801|566209073|FG005|Period 1|Withdrawal by Subject|0|||
156851333|NCT01425801|566209068|FG000|Period 2|Withdrawal by Subject|0|||
156851334|NCT01425801|566209069|FG001|Period 2|Withdrawal by Subject|0|||
156851335|NCT01425801|566209070|FG002|Period 2|Withdrawal by Subject|0|||
156851336|NCT01425801|566209071|FG003|Period 2|Withdrawal by Subject|0|||
156851337|NCT01425801|566209072|FG004|Period 2|Withdrawal by Subject|1|||
156851338|NCT01425801|566209073|FG005|Period 2|Withdrawal by Subject|0|||
156851339|NCT01425801|566209068|FG000|Period 3|Stability criteria not fullfilled|0|||
156851340|NCT01425801|566209069|FG001|Period 3|Stability criteria not fullfilled|0|||
156851341|NCT01425801|566209070|FG002|Period 3|Stability criteria not fullfilled|1|||
156851342|NCT01425801|566209071|FG003|Period 3|Stability criteria not fullfilled|0|||
156851343|NCT01425801|566209072|FG004|Period 3|Stability criteria not fullfilled|0|||
156851344|NCT01425801|566209073|FG005|Period 3|Stability criteria not fullfilled|0|||
156851345|NCT01425801|566209068|FG000|Period 4|Not able to maintain visit schedule|0|||
156851346|NCT01425801|566209069|FG001|Period 4|Not able to maintain visit schedule|0|||
156851347|NCT01425801|566209070|FG002|Period 4|Not able to maintain visit schedule|1|||
156851348|NCT01425801|566209071|FG003|Period 4|Not able to maintain visit schedule|0|||
156851349|NCT01425801|566209072|FG004|Period 4|Not able to maintain visit schedule|0|||
156851350|NCT01425801|566209073|FG005|Period 4|Not able to maintain visit schedule|0|||
156851351|NCT02175017|566209074|FG000|Overall Study|Did not receive the investigational product|1|||
156851352|NCT02175017|566209075|FG001|Overall Study|Did not receive the investigational product|2|||
156851353|NCT02175017|566209074|FG000|Overall Study|Withdrawal by Subject|6|||
156851354|NCT02175017|566209075|FG001|Overall Study|Withdrawal by Subject|3|||
156851355|NCT02175017|566209074|FG000|Overall Study|Met an exclusion criteria|0|||
156851356|NCT02175017|566209075|FG001|Overall Study|Met an exclusion criteria|1|||
156851357|NCT02175017|566209074|FG000|Overall Study|Adverse Event|3|||
156851358|NCT02175017|566209075|FG001|Overall Study|Adverse Event|10|||
156851359|NCT02175017|566209074|FG000|Overall Study|Disease progression|20|||
156851360|NCT02175017|566209075|FG001|Overall Study|Disease progression|27|||
156851361|NCT02175017|566209074|FG000|Overall Study|Other than above reasons|3|||
156851362|NCT02175017|566209075|FG001|Overall Study|Other than above reasons|0|||
156851363|NCT04961541|566209076|FG000|Overall Study|Adverse Event|0|||
156851364|NCT04961541|566209077|FG001|Overall Study|Adverse Event|0|||
156851365|NCT04961541|566209078|FG002|Overall Study|Adverse Event|0|||
156851366|NCT04961541|566209079|FG003|Overall Study|Adverse Event|0|||
156851367|NCT04961541|566209080|FG004|Overall Study|Adverse Event|0|||
156851368|NCT04961541|566209081|FG005|Overall Study|Adverse Event|1|||
156851369|NCT04961541|566209082|FG006|Overall Study|Adverse Event|0|||
156851370|NCT04961541|566209083|FG007|Overall Study|Adverse Event|0|||
156851371|NCT04961541|566209084|FG008|Overall Study|Adverse Event|0|||
156851372|NCT04961541|566209085|FG009|Overall Study|Adverse Event|0|||
156851373|NCT04961541|566209086|FG010|Overall Study|Adverse Event|0|||
156851374|NCT04961541|566209087|FG011|Overall Study|Adverse Event|0|||
156851375|NCT04961541|566209088|FG012|Overall Study|Adverse Event|0|||
156851376|NCT04961541|566209089|FG013|Overall Study|Adverse Event|0|||
156851377|NCT04961541|566209076|FG000|Overall Study|Lost to Follow-up|0|||
156851378|NCT04961541|566209077|FG001|Overall Study|Lost to Follow-up|0|||
156851379|NCT04961541|566209078|FG002|Overall Study|Lost to Follow-up|3|||
156851380|NCT04961541|566209079|FG003|Overall Study|Lost to Follow-up|0|||
156851381|NCT04961541|566209080|FG004|Overall Study|Lost to Follow-up|0|||
156851382|NCT04961541|566209081|FG005|Overall Study|Lost to Follow-up|0|||
156851383|NCT04961541|566209082|FG006|Overall Study|Lost to Follow-up|1|||
156851384|NCT04961541|566209083|FG007|Overall Study|Lost to Follow-up|1|||
156851385|NCT04961541|566209084|FG008|Overall Study|Lost to Follow-up|0|||
156851386|NCT04961541|566209085|FG009|Overall Study|Lost to Follow-up|1|||
156851387|NCT04961541|566209086|FG010|Overall Study|Lost to Follow-up|0|||
156851388|NCT04961541|566209087|FG011|Overall Study|Lost to Follow-up|0|||
156851389|NCT04961541|566209088|FG012|Overall Study|Lost to Follow-up|1|||
156851390|NCT04961541|566209089|FG013|Overall Study|Lost to Follow-up|0|||
156851391|NCT04961541|566209076|FG000|Overall Study|Withdrawal by Subject|0|||
156851392|NCT04961541|566209077|FG001|Overall Study|Withdrawal by Subject|0|||
156851393|NCT04961541|566209078|FG002|Overall Study|Withdrawal by Subject|1|||
156851394|NCT04961541|566209079|FG003|Overall Study|Withdrawal by Subject|1|||
156851395|NCT04961541|566209080|FG004|Overall Study|Withdrawal by Subject|0|||
156851396|NCT04961541|566209081|FG005|Overall Study|Withdrawal by Subject|0|||
156851397|NCT04961541|566209082|FG006|Overall Study|Withdrawal by Subject|0|||
156851398|NCT04961541|566209083|FG007|Overall Study|Withdrawal by Subject|0|||
156851399|NCT04961541|566209084|FG008|Overall Study|Withdrawal by Subject|0|||
156851400|NCT04961541|566209085|FG009|Overall Study|Withdrawal by Subject|1|||
156851401|NCT04961541|566209086|FG010|Overall Study|Withdrawal by Subject|0|||
156851402|NCT04961541|566209087|FG011|Overall Study|Withdrawal by Subject|0|||
156851403|NCT04961541|566209088|FG012|Overall Study|Withdrawal by Subject|0|||
156851404|NCT04961541|566209089|FG013|Overall Study|Withdrawal by Subject|0|||
156851405|NCT02330055|566209092|FG000|Overall Study|technical issues|2|||
156851406|NCT02330055|566209093|FG001|Overall Study|technical issues|0|||
156851407|NCT02330055|566209092|FG000|Overall Study|participant forgot to wear device|5|||
156851408|NCT02330055|566209093|FG001|Overall Study|participant forgot to wear device|5|||
156851409|NCT02330055|566209092|FG000|Overall Study|data for less than 60 minutes|3|||
156851410|NCT02330055|566209093|FG001|Overall Study|data for less than 60 minutes|3|||
156851411|NCT02330055|566209092|FG000|Overall Study|participant did not sleep|0|||
156851412|NCT02330055|566209093|FG001|Overall Study|participant did not sleep|1|||
156851413|NCT00550953|566209094|FG000|Overall Study|Adverse Event|4|||
156851414|NCT00550953|566209095|FG001|Overall Study|Adverse Event|3|||
156851415|NCT00550953|566209094|FG000|Overall Study|Not able to visit the site|2|||
156851416|NCT00550953|566209095|FG001|Overall Study|Not able to visit the site|3|||
156851417|NCT03797586|566209096|FG000|Overall Study|Lost to Follow-up|3|||
156851418|NCT03797586|566209097|FG001|Overall Study|Lost to Follow-up|6|||
156851419|NCT03797586|566209096|FG000|Overall Study|Death|1|||
156851420|NCT03797586|566209097|FG001|Overall Study|Death|1|||
156851421|NCT03797586|566209096|FG000|Overall Study|Adverse Event|0|||
156851422|NCT03797586|566209097|FG001|Overall Study|Adverse Event|2|||
156851423|NCT02959437|566209098|FG000|Overall Study|Death|33|||
156851424|NCT02959437|566209099|FG001|Overall Study|Death|3|||
156851425|NCT02959437|566209100|FG002|Overall Study|Death|0|||
156851426|NCT02959437|566209101|FG003|Overall Study|Death|0|||
156851427|NCT02959437|566209098|FG000|Overall Study|Lost to Follow-up|3|||
156851428|NCT02959437|566209099|FG001|Overall Study|Lost to Follow-up|1|||
156851429|NCT02959437|566209100|FG002|Overall Study|Lost to Follow-up|0|||
156851430|NCT02959437|566209101|FG003|Overall Study|Lost to Follow-up|0|||
156851431|NCT02959437|566209098|FG000|Overall Study|Withdrawal by Subject|11|||
157157289|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
157157290|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
157157291|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
157157292|NCT00423085|567321065|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
156851432|NCT02959437|566209099|FG001|Overall Study|Withdrawal by Subject|3|||
156851433|NCT02959437|566209100|FG002|Overall Study|Withdrawal by Subject|0|||
157157293|NCT00423085|567321066|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
156851434|NCT02959437|566209101|FG003|Overall Study|Withdrawal by Subject|0|||
156851435|NCT02959437|566209098|FG000|Overall Study|Progressive Disease|9|||
156851436|NCT02959437|566209099|FG001|Overall Study|Progressive Disease|1|||
156851437|NCT02959437|566209100|FG002|Overall Study|Progressive Disease|0|||
156851438|NCT02959437|566209101|FG003|Overall Study|Progressive Disease|0|||
156851439|NCT02959437|566209098|FG000|Overall Study|Study Terminated by Sponsor|4|||
156851440|NCT02959437|566209099|FG001|Overall Study|Study Terminated by Sponsor|0|||
156851441|NCT02959437|566209100|FG002|Overall Study|Study Terminated by Sponsor|0|||
156851442|NCT02959437|566209101|FG003|Overall Study|Study Terminated by Sponsor|0|||
156851443|NCT02959437|566209098|FG000|Overall Study|Other Unspecified|2|||
156851444|NCT02959437|566209099|FG001|Overall Study|Other Unspecified|0|||
156851445|NCT02959437|566209100|FG002|Overall Study|Other Unspecified|0|||
156851446|NCT02959437|566209101|FG003|Overall Study|Other Unspecified|0|||
156851447|NCT01219985|566209102|FG000|Overall Study|Physician Decision|20|||
156851448|NCT02680665|566209103|FG000|Overall Study|No visit after the first prescription|5|||
156851449|NCT02905266|566209104|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
156851450|NCT02905266|566209105|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
156851451|NCT02905266|566209104|FG000|Treatment Phase Part 1|Disease Progression|6|||
156851452|NCT02905266|566209105|FG001|Treatment Phase Part 1|Disease Progression|7|||
156851453|NCT02905266|566209104|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
156851454|NCT02905266|566209105|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
156851455|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
156851456|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
156851457|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
156851458|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
156851459|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
156851460|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
156851461|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Death|0|||
156851462|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Death|1|||
156851463|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
156851464|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
156851465|NCT02905266|566209104|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
156851466|NCT02905266|566209105|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
156851467|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Disease Progression|9|||
156851468|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Disease Progression|2|||
156851469|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
156851470|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
156851471|NCT02905266|566209104|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
156851472|NCT02905266|566209105|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
156851473|NCT02292719|566209106|FG000|Overall Study|Withdrawal by Subject|0|||
156851474|NCT02292719|566209107|FG001|Overall Study|Withdrawal by Subject|0|||
156851475|NCT02292719|566209108|FG002|Overall Study|Withdrawal by Subject|0|||
156851476|NCT02292719|566209109|FG003|Overall Study|Withdrawal by Subject|1|||
156851477|NCT02292719|566209110|FG004|Overall Study|Withdrawal by Subject|1|||
156851478|NCT02292719|566209111|FG005|Overall Study|Withdrawal by Subject|0|||
156851479|NCT02292719|566209106|FG000|Overall Study|Subject enrolled in new study.|0|||
156851480|NCT02292719|566209107|FG001|Overall Study|Subject enrolled in new study.|0|||
156851481|NCT02292719|566209108|FG002|Overall Study|Subject enrolled in new study.|1|||
156851482|NCT02292719|566209109|FG003|Overall Study|Subject enrolled in new study.|0|||
156851483|NCT02292719|566209110|FG004|Overall Study|Subject enrolled in new study.|0|||
156851484|NCT02292719|566209111|FG005|Overall Study|Subject enrolled in new study.|0|||
156851485|NCT02940496|566209112|FG000|Overall Study|Adverse Event|1|||
156851486|NCT02940496|566209113|FG001|Overall Study|Adverse Event|0|||
156851487|NCT02940496|566209112|FG000|Overall Study|Death|2|||
156851488|NCT02940496|566209113|FG001|Overall Study|Death|0|||
156851489|NCT02940496|566209112|FG000|Overall Study|Hospice Care|1|||
156851490|NCT02940496|566209113|FG001|Overall Study|Hospice Care|0|||
157157294|NCT00423085|567321067|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
157157295|NCT00423085|567321068|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
157157296|NCT00423085|567321065|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
157157297|NCT00423085|567321066|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
156851491|NCT02940496|566209112|FG000|Overall Study|No MRE Done|1|||
157157298|NCT00423085|567321067|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
156851492|NCT02940496|566209113|FG001|Overall Study|No MRE Done|0|||
156851493|NCT02940496|566209112|FG000|Overall Study|MRE Failure|1|||
156851494|NCT02940496|566209113|FG001|Overall Study|MRE Failure|0|||
156851495|NCT04089761|566209120|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
156851496|NCT04089761|566209120|FG000|"Run In Phase"|Lost to Follow-up|1|||
156851497|NCT04089761|566209120|FG000|"Treatment Phase"|No evaluable data|5|||
156851498|NCT04089761|566209120|FG000|"Treatment Phase"|Lost to Follow-up|1|||
157157299|NCT00423085|567321068|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
157157300|NCT00423085|567321065|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
157157301|NCT00423085|567321066|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
157157302|NCT00423085|567321067|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
157157303|NCT00423085|567321068|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
157157304|NCT00423085|567321065|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
157157305|NCT00423085|567321066|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
157157306|NCT00423085|567321067|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
157157307|NCT00423085|567321068|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
157157308|NCT00423085|567321065|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
157157309|NCT00423085|567321066|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
157157310|NCT00423085|567321067|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
157157311|NCT00423085|567321068|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
157157312|NCT00423085|567321065|FG000|52-Week Open-Label Extension Phase|Death|0|||
157157313|NCT00423085|567321066|FG001|52-Week Open-Label Extension Phase|Death|0|||
157157314|NCT00423085|567321067|FG002|52-Week Open-Label Extension Phase|Death|0|||
157157315|NCT00423085|567321068|FG003|52-Week Open-Label Extension Phase|Death|2|||
157157316|NCT00853489|567321069|FG000|Overall Study|Lost to Follow-up|5|||
157157317|NCT00853489|567321070|FG001|Overall Study|Lost to Follow-up|2|||
157157318|NCT03331666|567321071|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
157157319|NCT03331666|567321072|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
157157320|NCT05525975|567321073|FG000|Overall Study|Surgery cancellation|4|||
157157321|NCT05525975|567321074|FG001|Overall Study|Surgery cancellation|5|||
157157322|NCT05525975|567321073|FG000|Overall Study|didn't fill prescription|1|||
157157323|NCT05525975|567321074|FG001|Overall Study|didn't fill prescription|0|||
157157324|NCT05525975|567321073|FG000|Overall Study|Withdrawal by Subject|0|||
157157325|NCT05525975|567321074|FG001|Overall Study|Withdrawal by Subject|3|||
157157326|NCT02326467|567321075|FG000|Overall Study|Withdrawal by Subject|1|||
157157327|NCT01251276|567321077|FG000|Overall Study|Protocol Violation|1|||
157157328|NCT01251276|567321078|FG001|Overall Study|Protocol Violation|0|||
157157329|NCT01251276|567321077|FG000|Overall Study|Lost to Follow-up|0|||
157157330|NCT01251276|567321078|FG001|Overall Study|Lost to Follow-up|1|||
157157331|NCT02245568|567321079|FG000|Overall Study|Study terminated by Sponsor|346|||
157157332|NCT02245568|567321079|FG000|Overall Study|Adverse Event|144|||
157157333|NCT02245568|567321079|FG000|Overall Study|Lack of Efficacy|98|||
157157334|NCT02245568|567321079|FG000|Overall Study|Withdrawal by Caregiver|85|||
157157335|NCT02245568|567321079|FG000|Overall Study|Withdrawal by Subject|77|||
157157336|NCT02245568|567321079|FG000|Overall Study|Withdrawal by Legal Representative|31|||
157157337|NCT02245568|567321079|FG000|Overall Study|Missing (Site closure)|16|||
157157338|NCT02245568|567321079|FG000|Overall Study|Physician Decision|14|||
157157339|NCT02245568|567321079|FG000|Overall Study|Non-compliance with study drug|11|||
157157340|NCT02245568|567321079|FG000|Overall Study|Death|9|||
157157341|NCT02245568|567321079|FG000|Overall Study|Blue staining|6|||
157157342|NCT02245568|567321079|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
157157343|NCT02245568|567321079|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
157157344|NCT02245568|567321079|FG000|Overall Study|Lost to Follow-up|5|||
157157345|NCT00262080|567321083|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
157157346|NCT00262080|567321084|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
157157347|NCT00262080|567321085|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
157157348|NCT00262080|567321083|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
157157349|NCT00262080|567321084|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
157157350|NCT00262080|567321085|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
157157351|NCT00262080|567321083|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
157157352|NCT00262080|567321084|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
157157353|NCT00262080|567321085|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
157157354|NCT00262080|567321083|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
157157355|NCT00262080|567321084|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
157157356|NCT00262080|567321085|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
157157357|NCT00262080|567321083|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
157157358|NCT00262080|567321084|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
157157359|NCT00262080|567321085|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
157157360|NCT00262080|567321083|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
157025730|NCT04492722|566848039|FG001|Overall Study|Participants who did not receive treatment|1|||
157025731|NCT04492722|566848040|FG002|Overall Study|Participants who did not receive treatment|4|||
157157361|NCT00262080|567321084|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
156851499|NCT00770601|566209121|FG000|Overall Study|Withdrawal by Subject|1|||
157157362|NCT00262080|567321085|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
157157363|NCT01051986|567321086|FG000|Overall Study|Death|1|||
157157364|NCT01051986|567321087|FG001|Overall Study|Death|0|||
157157365|NCT01051986|567321086|FG000|Overall Study|Withdrawal by Subject|2|||
157157366|NCT01051986|567321087|FG001|Overall Study|Withdrawal by Subject|1|||
157157367|NCT01051986|567321086|FG000|Overall Study|Protocol Violation|2|||
157157368|NCT01051986|567321087|FG001|Overall Study|Protocol Violation|3|||
157157369|NCT01725152|567321089|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
157157370|NCT01725152|567321090|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
157157371|NCT01725152|567321089|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
157157372|NCT01725152|567321090|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
157157373|NCT01725152|567321089|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
157157374|NCT01725152|567321090|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
157157375|NCT01725152|567321089|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
157157376|NCT01725152|567321090|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
157157377|NCT02044159|567321091|FG000|Overall Study|Consent declined (deferred consent)|2|||
157157378|NCT02044159|567321092|FG001|Overall Study|Consent declined (deferred consent)|4|||
157157379|NCT02044159|567321091|FG000|Overall Study|No longer eligible, drug not given|1|||
157157380|NCT02044159|567321092|FG001|Overall Study|No longer eligible, drug not given|0|||
157157381|NCT02044159|567321091|FG000|Overall Study|Nurse declined to give study drug|1|||
157157382|NCT02044159|567321092|FG001|Overall Study|Nurse declined to give study drug|0|||
157157383|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
157157384|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
157157385|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
157157386|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
157157387|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
157157388|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
157157389|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
157157390|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
157157391|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
157157392|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
157157393|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
157157394|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
157157395|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
157157396|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
157157397|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
157157398|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
157157399|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
157157400|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
157157401|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
157157402|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
157157403|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
157157404|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
157157405|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
157157406|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
157157407|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
157157408|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
157157409|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
157157410|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
157157411|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
157157412|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
157157413|NCT01111539|567321095|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
157157414|NCT01111539|567321096|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
157157415|NCT01111539|567321097|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
157157416|NCT01111539|567321098|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
157157417|NCT01111539|567321099|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
157157418|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
157157419|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
156851500|NCT00434109|566209122|FG000|Overall Study|Physician Decision|9|||
156851501|NCT00434109|566209122|FG000|Overall Study|Adverse Event|5|||
156851502|NCT00434109|566209122|FG000|Overall Study|Protocol Violation|1|||
156851503|NCT00434109|566209122|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
157157420|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
157157421|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
157157422|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
157157423|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
157157424|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
157157425|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
157157426|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
157157427|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
157157428|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
157157429|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
157157430|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
157157431|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
157157432|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
157157433|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
157157434|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
157157435|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
157157436|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
157157437|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
157157438|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
157157439|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
157157440|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
157157441|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
157157442|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
157157443|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
157157444|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
157157445|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
156851504|NCT00103740|566209123|FG000|Period 1 - Core|Adverse Event|1|||
156851505|NCT00103740|566209124|FG001|Period 1 - Core|Adverse Event|0|||
156851506|NCT00103740|566209123|FG000|Period 1 - Core|Protocol Violation|3|||
156851507|NCT00103740|566209124|FG001|Period 1 - Core|Protocol Violation|2|||
156851508|NCT00103740|566209123|FG000|Period 1 - Core|Patient withdrew consent|3|||
156851509|NCT00103740|566209124|FG001|Period 1 - Core|Patient withdrew consent|2|||
156851510|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
156851511|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
156851512|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
156851513|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
156851514|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
156851515|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
156851516|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Death|6|||
156851517|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Death|2|||
156851518|NCT00103740|566209123|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
156851519|NCT00103740|566209124|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
156851520|NCT01463306|566209125|FG000|Overall Study|Adverse Event|6|||
156851521|NCT01463306|566209126|FG001|Overall Study|Adverse Event|9|||
156851522|NCT01463306|566209127|FG002|Overall Study|Adverse Event|3|||
156851523|NCT01463306|566209125|FG000|Overall Study|Death|3|||
156851524|NCT01463306|566209126|FG001|Overall Study|Death|3|||
156851525|NCT01463306|566209127|FG002|Overall Study|Death|0|||
156851526|NCT01463306|566209125|FG000|Overall Study|Lack of Efficacy|22|||
156851527|NCT01463306|566209126|FG001|Overall Study|Lack of Efficacy|16|||
156851528|NCT01463306|566209127|FG002|Overall Study|Lack of Efficacy|1|||
156851529|NCT01463306|566209125|FG000|Overall Study|Lost to Follow-up|5|||
156851530|NCT01463306|566209126|FG001|Overall Study|Lost to Follow-up|2|||
156851531|NCT01463306|566209127|FG002|Overall Study|Lost to Follow-up|0|||
156851532|NCT01463306|566209125|FG000|Overall Study|Protocol Violation|4|||
156851533|NCT01463306|566209126|FG001|Overall Study|Protocol Violation|0|||
156851534|NCT01463306|566209127|FG002|Overall Study|Protocol Violation|0|||
156851535|NCT01463306|566209125|FG000|Overall Study|Withdrawal by Subject|19|||
156851536|NCT01463306|566209126|FG001|Overall Study|Withdrawal by Subject|9|||
156851537|NCT01463306|566209127|FG002|Overall Study|Withdrawal by Subject|1|||
156851538|NCT01463306|566209125|FG000|Overall Study|Other|26|||
156851539|NCT01463306|566209126|FG001|Overall Study|Other|13|||
156851540|NCT01463306|566209127|FG002|Overall Study|Other|0|||
156851541|NCT01463306|566209125|FG000|Overall Study|Approval expiry at site|1|||
156851542|NCT01463306|566209126|FG001|Overall Study|Approval expiry at site|0|||
156851543|NCT01463306|566209127|FG002|Overall Study|Approval expiry at site|0|||
156851544|NCT01633788|566211612|FG000|Overall Study|Adverse Event|1|||
156851545|NCT01633788|566211613|FG001|Overall Study|Adverse Event|3|||
157025732|NCT04492722|566848041|FG003|Overall Study|Participants who did not receive treatment|0|||
157025733|NCT04719832|566848043|FG000|Overall Study|Adverse Event|2|||
156851546|NCT01633788|566211614|FG002|Overall Study|Adverse Event|3|||
156851547|NCT01633788|566211615|FG003|Overall Study|Adverse Event|3|||
156851548|NCT01633788|566211612|FG000|Overall Study|Lost to Follow-up|2|||
156851549|NCT01633788|566211613|FG001|Overall Study|Lost to Follow-up|2|||
156851550|NCT01633788|566211614|FG002|Overall Study|Lost to Follow-up|2|||
157025734|NCT04719832|566848044|FG001|Overall Study|Adverse Event|0|||
156851551|NCT01633788|566211615|FG003|Overall Study|Lost to Follow-up|0|||
156851552|NCT01633788|566211612|FG000|Overall Study|Personal Reasons|3|||
156851553|NCT01633788|566211613|FG001|Overall Study|Personal Reasons|1|||
156851554|NCT01633788|566211614|FG002|Overall Study|Personal Reasons|1|||
156851555|NCT01633788|566211615|FG003|Overall Study|Personal Reasons|3|||
156851556|NCT01633788|566211612|FG000|Overall Study|Protocol Violation|1|||
156851557|NCT01633788|566211613|FG001|Overall Study|Protocol Violation|0|||
156851558|NCT01633788|566211614|FG002|Overall Study|Protocol Violation|1|||
156851559|NCT01633788|566211615|FG003|Overall Study|Protocol Violation|0|||
156851560|NCT01633788|566211612|FG000|Overall Study|Other Reasons|0|||
156851561|NCT01633788|566211613|FG001|Overall Study|Other Reasons|2|||
156851562|NCT01633788|566211614|FG002|Overall Study|Other Reasons|3|||
156851563|NCT01633788|566211615|FG003|Overall Study|Other Reasons|7|||
156851564|NCT01389882|566211618|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
156851565|NCT01389882|566211619|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
156851566|NCT01389882|566211618|FG000|Overall Study|Withdrawal by Subject|0|||
156851567|NCT01389882|566211619|FG001|Overall Study|Withdrawal by Subject|1|||
156851568|NCT00936702|566211620|FG000|Overall Study|Disease progression|34|||
156851569|NCT00936702|566211620|FG000|Overall Study|Adverse Event|8|||
156851570|NCT00936702|566211620|FG000|Overall Study|Withdrawal by Subject|2|||
156851571|NCT00936702|566211620|FG000|Overall Study|Alternative Treatment|1|||
156851572|NCT00936702|566211620|FG000|Overall Study|Other|1|||
156851573|NCT02532465|566211621|FG000|Overall Study|Protocol Violation|1|||
156851574|NCT02532465|566211622|FG001|Overall Study|Protocol Violation|0|||
156851575|NCT02532465|566211621|FG000|Overall Study|Lack of Efficacy|0|||
156851576|NCT02532465|566211622|FG001|Overall Study|Lack of Efficacy|1|||
156851577|NCT00354679|566211627|FG000|Overall Study|Patient Not Treated|1|||
156851578|NCT00466440|566211628|FG000|Overall Study|Adverse Event|0|||
156851579|NCT00466440|566211629|FG001|Overall Study|Adverse Event|3|||
156851580|NCT00466440|566211630|FG002|Overall Study|Adverse Event|1|||
156851581|NCT00466440|566211628|FG000|Overall Study|Death|1|||
156851582|NCT00466440|566211629|FG001|Overall Study|Death|1|||
156851583|NCT00466440|566211630|FG002|Overall Study|Death|0|||
156851584|NCT00466440|566211628|FG000|Overall Study|Progressive disease|13|||
156851585|NCT00466440|566211629|FG001|Overall Study|Progressive disease|5|||
156851586|NCT00466440|566211630|FG002|Overall Study|Progressive disease|4|||
156851587|NCT00466440|566211628|FG000|Overall Study|Lost to Follow-up|0|||
156851588|NCT00466440|566211629|FG001|Overall Study|Lost to Follow-up|1|||
156851589|NCT00466440|566211630|FG002|Overall Study|Lost to Follow-up|0|||
156851590|NCT00466440|566211628|FG000|Overall Study|Physician Decision|0|||
156851591|NCT00466440|566211629|FG001|Overall Study|Physician Decision|1|||
156851592|NCT00466440|566211630|FG002|Overall Study|Physician Decision|2|||
156851593|NCT00466440|566211628|FG000|Overall Study|Protocol entry criteria not met|0|||
156851594|NCT00466440|566211629|FG001|Overall Study|Protocol entry criteria not met|0|||
156851595|NCT00466440|566211630|FG002|Overall Study|Protocol entry criteria not met|4|||
156851596|NCT00466440|566211628|FG000|Overall Study|Withdrawal by Subject|0|||
156851597|NCT00466440|566211629|FG001|Overall Study|Withdrawal by Subject|1|||
156851598|NCT00466440|566211630|FG002|Overall Study|Withdrawal by Subject|0|||
156851599|NCT00466440|566211628|FG000|Overall Study|Sponsor decision|0|||
156851600|NCT00466440|566211629|FG001|Overall Study|Sponsor decision|0|||
156851601|NCT00466440|566211630|FG002|Overall Study|Sponsor decision|1|||
156851602|NCT03187132|566211636|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
156851603|NCT03187132|566211637|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
156851604|NCT03187132|566211636|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
156851605|NCT03187132|566211637|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
156851606|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
156851607|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
156851608|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
156851609|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
156851610|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
156851611|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
156851612|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
156851613|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
156851614|NCT03187132|566211636|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
156851615|NCT03187132|566211637|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
156851616|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
156851617|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
156851618|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
157025735|NCT04719832|566848043|FG000|Overall Study|Lack of Efficacy|2|||
156851619|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
156851620|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
156851621|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
156851622|NCT03187132|566211636|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
156851623|NCT03187132|566211637|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
156851624|NCT02045095|566211638|FG000|Overall Study|Other|0|||
156851625|NCT02045095|566211639|FG001|Overall Study|Other|0|||
156851626|NCT02045095|566211640|FG002|Overall Study|Other|1|||
156851627|NCT02045095|566211641|FG003|Overall Study|Other|0|||
156851628|NCT02045095|566211642|FG004|Overall Study|Other|0|||
156851629|NCT02045095|566211643|FG005|Overall Study|Other|2|||
156851630|NCT02045095|566211644|FG006|Overall Study|Other|0|||
156851631|NCT02045095|566211638|FG000|Overall Study|Progressive Disease|3|||
156851632|NCT02045095|566211639|FG001|Overall Study|Progressive Disease|3|||
156851633|NCT02045095|566211640|FG002|Overall Study|Progressive Disease|2|||
156851634|NCT02045095|566211641|FG003|Overall Study|Progressive Disease|4|||
156851635|NCT02045095|566211642|FG004|Overall Study|Progressive Disease|2|||
156851636|NCT02045095|566211643|FG005|Overall Study|Progressive Disease|4|||
156851637|NCT02045095|566211644|FG006|Overall Study|Progressive Disease|1|||
156851638|NCT02045095|566211638|FG000|Overall Study|Withdrawal by Subject|0|||
156851639|NCT02045095|566211639|FG001|Overall Study|Withdrawal by Subject|0|||
156851640|NCT02045095|566211640|FG002|Overall Study|Withdrawal by Subject|0|||
156851641|NCT02045095|566211641|FG003|Overall Study|Withdrawal by Subject|0|||
156851642|NCT02045095|566211642|FG004|Overall Study|Withdrawal by Subject|3|||
156851643|NCT02045095|566211643|FG005|Overall Study|Withdrawal by Subject|0|||
156851644|NCT02045095|566211644|FG006|Overall Study|Withdrawal by Subject|0|||
156851645|NCT02045095|566211638|FG000|Overall Study|Adverse Event|0|||
156851646|NCT02045095|566211639|FG001|Overall Study|Adverse Event|1|||
156851647|NCT02045095|566211640|FG002|Overall Study|Adverse Event|1|||
156851648|NCT02045095|566211641|FG003|Overall Study|Adverse Event|0|||
156851649|NCT02045095|566211642|FG004|Overall Study|Adverse Event|0|||
156851650|NCT02045095|566211643|FG005|Overall Study|Adverse Event|2|||
156851651|NCT02045095|566211644|FG006|Overall Study|Adverse Event|0|||
156851652|NCT02525588|566211645|FG000|Overall Study|Death|3|||
156851653|NCT02525588|566211646|FG001|Overall Study|Death|1|||
156851654|NCT02525588|566211645|FG000|Overall Study|Lost to Follow-up|2|||
156851655|NCT02525588|566211646|FG001|Overall Study|Lost to Follow-up|0|||
156851656|NCT02525588|566211645|FG000|Overall Study|Withdrawal by Subject|1|||
156851657|NCT02525588|566211646|FG001|Overall Study|Withdrawal by Subject|1|||
156851658|NCT02525588|566211645|FG000|Overall Study|Adverse Event|0|||
156851659|NCT02525588|566211646|FG001|Overall Study|Adverse Event|1|||
156851660|NCT00714415|566211656|FG000|Overall Study|Lack of Efficacy|1|||
156851661|NCT00714415|566211657|FG001|Overall Study|Lack of Efficacy|0|||
156851662|NCT00714415|566211656|FG000|Overall Study|Death|1|||
156851663|NCT00714415|566211657|FG001|Overall Study|Death|0|||
156851664|NCT01818596|566211660|FG000|Overall Study|Enrolled but Not Treated|4|||
156851665|NCT01818596|566211661|FG001|Overall Study|Enrolled but Not Treated|0|||
156851666|NCT01818596|566211660|FG000|Overall Study|Adverse Event|7|||
156851667|NCT01818596|566211661|FG001|Overall Study|Adverse Event|0|||
156851668|NCT01818596|566211660|FG000|Overall Study|Death|3|||
156851669|NCT01818596|566211661|FG001|Overall Study|Death|0|||
156851670|NCT01818596|566211660|FG000|Overall Study|Investigator's Discretion|4|||
156851671|NCT01818596|566211661|FG001|Overall Study|Investigator's Discretion|0|||
156851672|NCT01818596|566211660|FG000|Overall Study|Protocol Violation|1|||
156851673|NCT01818596|566211661|FG001|Overall Study|Protocol Violation|0|||
156851674|NCT01818596|566211660|FG000|Overall Study|Withdrew Consent|5|||
156851675|NCT01818596|566211661|FG001|Overall Study|Withdrew Consent|0|||
156851676|NCT01818596|566211660|FG000|Overall Study|Lost to Follow-up|7|||
156851677|NCT01818596|566211661|FG001|Overall Study|Lost to Follow-up|0|||
156851678|NCT02073682|566211670|FG000|Overall Study|Low Creatinine Clearance|1|||
156851679|NCT02073682|566211671|FG001|Overall Study|Low Creatinine Clearance|2|||
156851680|NCT02073682|566211670|FG000|Overall Study|Death|86|||
156851681|NCT02073682|566211671|FG001|Overall Study|Death|100|||
156851682|NCT02073682|566211670|FG000|Overall Study|Cancer Cured|10|||
156851683|NCT02073682|566211671|FG001|Overall Study|Cancer Cured|15|||
156851684|NCT02073682|566211670|FG000|Overall Study|ID: Patient Noncompliance|1|||
156851685|NCT02073682|566211671|FG001|Overall Study|ID: Patient Noncompliance|2|||
156851686|NCT02073682|566211670|FG000|Overall Study|ID: Palliative Treatment Only|10|||
156851687|NCT02073682|566211671|FG001|Overall Study|ID: Palliative Treatment Only|7|||
156851688|NCT02073682|566211670|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
156851689|NCT02073682|566211671|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
156851690|NCT02073682|566211670|FG000|Overall Study|Platelet Count <50,000/mL|1|||
156889235|NCT01933789|566354155|FG002|Overall Study|Death|0|||
156851691|NCT02073682|566211671|FG001|Overall Study|Platelet Count <50,000/mL|2|||
156851692|NCT02073682|566211670|FG000|Overall Study|Surgery/Medical Procedure|3|||
156851693|NCT02073682|566211671|FG001|Overall Study|Surgery/Medical Procedure|1|||
156851694|NCT02073682|566211670|FG000|Overall Study|Withdrawal by Subject|6|||
156851695|NCT02073682|566211671|FG001|Overall Study|Withdrawal by Subject|8|||
156851696|NCT02073682|566211670|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
156851697|NCT02073682|566211671|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
156851698|NCT02073682|566211670|FG000|Overall Study|Cancer Progression|53|||
156851699|NCT02073682|566211671|FG001|Overall Study|Cancer Progression|33|||
156851700|NCT02073682|566211670|FG000|Overall Study|Protocol Violation|1|||
156851701|NCT02073682|566211671|FG001|Overall Study|Protocol Violation|0|||
156851702|NCT02073682|566211670|FG000|Overall Study|Adverse Event|79|||
156851703|NCT02073682|566211671|FG001|Overall Study|Adverse Event|62|||
156851704|NCT02073682|566211670|FG000|Overall Study|No reason provided|11|||
156851705|NCT02073682|566211671|FG001|Overall Study|No reason provided|9|||
156851706|NCT02073682|566211670|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
156851707|NCT02073682|566211671|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
156851708|NCT02073682|566211670|FG000|Overall Study|Lost to Follow-up|1|||
156851709|NCT02073682|566211671|FG001|Overall Study|Lost to Follow-up|1|||
156851710|NCT02073682|566211670|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
156851711|NCT02073682|566211671|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
156851712|NCT03461146|566211672|FG000|Overall Study|Adverse Event|2|||
156851713|NCT03461146|566211672|FG000|Overall Study|Physician Decision|1|||
156851714|NCT02478463|566211684|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
156851715|NCT02478463|566211684|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
156851716|NCT02478463|566211684|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
156851717|NCT01620086|566211685|FG000|Overall Study|Withdrawal by Subject|3|||
156851718|NCT01620086|566211686|FG001|Overall Study|Withdrawal by Subject|3|||
156851719|NCT01620086|566211687|FG002|Overall Study|Withdrawal by Subject|0|||
156851720|NCT01620086|566211685|FG000|Overall Study|failed study criteria|1|||
156851721|NCT01620086|566211686|FG001|Overall Study|failed study criteria|4|||
156851722|NCT01620086|566211687|FG002|Overall Study|failed study criteria|0|||
156851723|NCT01620086|566211685|FG000|Overall Study|Physician Decision|1|||
156851724|NCT01620086|566211686|FG001|Overall Study|Physician Decision|0|||
156851725|NCT01620086|566211687|FG002|Overall Study|Physician Decision|0|||
156851726|NCT03030417|566211689|FG000|Dose Expansion|Disease progression before treatment|0|||
156851727|NCT03030417|566211690|FG001|Dose Expansion|Disease progression before treatment|0|||
156851728|NCT03030417|566211691|FG002|Dose Expansion|Disease progression before treatment|0|||
156851729|NCT03030417|566211692|FG003|Dose Expansion|Disease progression before treatment|0|||
156851730|NCT03030417|566211693|FG004|Dose Expansion|Disease progression before treatment|0|||
156851731|NCT03030417|566211694|FG005|Dose Expansion|Disease progression before treatment|0|||
156851732|NCT03030417|566211695|FG006|Dose Expansion|Disease progression before treatment|0|||
156851733|NCT03030417|566211696|FG007|Dose Expansion|Disease progression before treatment|0|||
156851734|NCT03030417|566211697|FG008|Dose Expansion|Disease progression before treatment|0|||
156851735|NCT03030417|566211698|FG009|Dose Expansion|Disease progression before treatment|0|||
156851736|NCT03030417|566211699|FG010|Dose Expansion|Disease progression before treatment|0|||
156851737|NCT03030417|566211700|FG011|Dose Expansion|Disease progression before treatment|0|||
156851738|NCT03030417|566211701|FG012|Dose Expansion|Disease progression before treatment|1|||
156851739|NCT01076959|566211706|FG000|Overall Study|Adverse Event|767|||
157225461|NCT01860976|567571436|FG000|Open-Label|Withdrawal by Subject|4|||
157225462|NCT01860976|567571437|FG001|Open-Label|Withdrawal by Subject|1|||
156851740|NCT01076959|566211706|FG000|Overall Study|Lack of Efficacy|849|||
156851741|NCT01076959|566211706|FG000|Overall Study|Non-compliance|274|||
156851742|NCT01076959|566211706|FG000|Overall Study|Lost to Follow-up|241|||
156851743|NCT01076959|566211706|FG000|Overall Study|Other|119|||
156851744|NCT04915729|566211707|FG000|Overall Study|Lost to Follow-up|20|||
156851745|NCT04915729|566211708|FG001|Overall Study|Lost to Follow-up|10|||
156851746|NCT04915729|566211707|FG000|Overall Study|Withdrawal by Subject|12|||
156851747|NCT04915729|566211708|FG001|Overall Study|Withdrawal by Subject|5|||
156851748|NCT04915729|566211707|FG000|Overall Study|Death|34|||
156851749|NCT04915729|566211708|FG001|Overall Study|Death|44|||
156851750|NCT04915729|566211707|FG000|Overall Study|not treated|3|||
156851751|NCT04915729|566211708|FG001|Overall Study|not treated|6|||
156851752|NCT04915729|566211707|FG000|Overall Study|Investigator removed subject|1|||
156851753|NCT04915729|566211708|FG001|Overall Study|Investigator removed subject|2|||
156851754|NCT04915729|566211707|FG000|Overall Study|questionnaire result not evaluated|1|||
156851755|NCT04915729|566211708|FG001|Overall Study|questionnaire result not evaluated|0|||
156851756|NCT04915729|566211707|FG000|Overall Study|refuse of hospital visit|1|||
156851757|NCT04915729|566211708|FG001|Overall Study|refuse of hospital visit|3|||
156851758|NCT04915729|566211707|FG000|Overall Study|Subject withdrew|1|||
156851759|NCT04915729|566211708|FG001|Overall Study|Subject withdrew|0|||
156851760|NCT03575403|566211710|FG000|Overall Study|Adverse Event|1|||
156851761|NCT03575403|566211711|FG001|Overall Study|Adverse Event|0|||
156851762|NCT03575403|566211712|FG002|Overall Study|Adverse Event|0|||
156851763|NCT03575403|566211710|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
156851764|NCT03575403|566211711|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
156851765|NCT03575403|566211712|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
156851766|NCT03066596|566211713|FG000|Overall Study|Withdrawal by Subject|4|||
156851767|NCT03066596|566211714|FG001|Overall Study|Withdrawal by Subject|2|||
156851768|NCT03066596|566211713|FG000|Overall Study|Lost to Follow-up|14|||
156851769|NCT03066596|566211714|FG001|Overall Study|Lost to Follow-up|10|||
156851770|NCT00773513|566211715|FG000|Overall Study|Renal Transplant|254|||
156851771|NCT00773513|566211716|FG001|Overall Study|Renal Transplant|263|||
156851772|NCT00773513|566211715|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
156851773|NCT00773513|566211716|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
156851774|NCT00773513|566211715|FG000|Overall Study|Withdrew Consent|68|||
156851775|NCT00773513|566211716|FG001|Overall Study|Withdrew Consent|69|||
156851776|NCT00773513|566211715|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
156851777|NCT00773513|566211716|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
156851778|NCT00773513|566211715|FG000|Overall Study|Failure to Return|22|||
156851779|NCT00773513|566211716|FG001|Overall Study|Failure to Return|8|||
156851780|NCT00773513|566211715|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156851781|NCT00773513|566211716|FG001|Overall Study|Insufficient Therapeutic Response|18|||
156851782|NCT00773513|566211715|FG000|Overall Study|Reason Not Specified|159|||
156851783|NCT00773513|566211716|FG001|Overall Study|Reason Not Specified|126|||
156851784|NCT00773513|566211715|FG000|Overall Study|Death|531|||
156851785|NCT00773513|566211716|FG001|Overall Study|Death|545|||
156851786|NCT02864901|566211717|FG000|Overall Study|Withdrawal by Subject|1|||
156851787|NCT02864901|566211718|FG001|Overall Study|Withdrawal by Subject|0|||
156851788|NCT03359174|566211723|FG000|Overall Study|Adverse Event|1|||
156851789|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
156851790|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
156851791|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
156851792|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
156851793|NCT04445662|566211726|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
156851794|NCT04445662|566211727|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
156851795|NCT04445662|566211726|FG000|Post-treatment (12-24 weeks)|Death|1|||
156851796|NCT04445662|566211727|FG001|Post-treatment (12-24 weeks)|Death|0|||
156851797|NCT05973006|566211728|FG000|Overall Study|Early termination|3|||
156851798|NCT05973006|566211729|FG001|Overall Study|Early termination|9|||
156851799|NCT01807598|566211730|FG000|Overall Study|Withdrawal by Subject|4|||
156851800|NCT01807598|566211730|FG000|Overall Study|Adverse Event|1|||
156851801|NCT01807598|566211730|FG000|Overall Study|Other Physician Decision|1|||
156851802|NCT02488005|566211731|FG000|Overall Study|Lost to Follow-up|2|||
156851803|NCT04170543|566211736|FG000|Overall Study|Death|1|||
156851804|NCT04170543|566211737|FG001|Overall Study|Death|1|||
156851805|NCT04170543|566211738|FG002|Overall Study|Death|1|||
156851806|NCT04170543|566211739|FG003|Overall Study|Death|1|||
156851807|NCT04170543|566211740|FG004|Overall Study|Death|1|||
156851808|NCT04170543|566211736|FG000|Overall Study|Lost to Follow-up|3|||
156851809|NCT04170543|566211737|FG001|Overall Study|Lost to Follow-up|3|||
156851810|NCT04170543|566211738|FG002|Overall Study|Lost to Follow-up|0|||
156851811|NCT04170543|566211739|FG003|Overall Study|Lost to Follow-up|3|||
156851812|NCT04170543|566211740|FG004|Overall Study|Lost to Follow-up|1|||
156851813|NCT04170543|566211736|FG000|Overall Study|Withdrawal by Subject|13|||
156851814|NCT04170543|566211737|FG001|Overall Study|Withdrawal by Subject|6|||
156851815|NCT04170543|566211738|FG002|Overall Study|Withdrawal by Subject|5|||
156851816|NCT04170543|566211739|FG003|Overall Study|Withdrawal by Subject|4|||
156851817|NCT04170543|566211740|FG004|Overall Study|Withdrawal by Subject|9|||
156851818|NCT04170543|566211736|FG000|Overall Study|Not able to transition to phase 2b|8|||
156851819|NCT04170543|566211737|FG001|Overall Study|Not able to transition to phase 2b|0|||
156851820|NCT04170543|566211738|FG002|Overall Study|Not able to transition to phase 2b|10|||
156851821|NCT04170543|566211739|FG003|Overall Study|Not able to transition to phase 2b|0|||
156851822|NCT04170543|566211740|FG004|Overall Study|Not able to transition to phase 2b|6|||
156851823|NCT04170543|566211736|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
156851824|NCT04170543|566211737|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
156851825|NCT04170543|566211738|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
156851826|NCT04170543|566211739|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
156851827|NCT04170543|566211740|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
156851828|NCT04170543|566211736|FG000|Overall Study|Not Treated|0|||
156851829|NCT04170543|566211737|FG001|Overall Study|Not Treated|0|||
156851830|NCT04170543|566211738|FG002|Overall Study|Not Treated|0|||
156851831|NCT04170543|566211739|FG003|Overall Study|Not Treated|0|||
156851832|NCT04170543|566211740|FG004|Overall Study|Not Treated|2|||
156851833|NCT04170543|566211736|FG000|Overall Study|(CRF)|16|||
156851834|NCT04170543|566211737|FG001|Overall Study|(CRF)|15|||
156851835|NCT04170543|566211738|FG002|Overall Study|(CRF)|12|||
156851836|NCT04170543|566211739|FG003|Overall Study|(CRF)|17|||
156851837|NCT04170543|566211740|FG004|Overall Study|(CRF)|17|||
156851838|NCT04170543|566211736|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
156889236|NCT01933789|566354156|FG003|Overall Study|Death|0|||
156889237|NCT01933789|566354157|FG004|Overall Study|Death|21|||
156851839|NCT04170543|566211737|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
156851840|NCT04170543|566211738|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
156851841|NCT04170543|566211739|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
156851842|NCT04170543|566211740|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
156851843|NCT04378270|566211744|FG000|Overall Study|Lack of Efficacy|1|||
156851844|NCT04378270|566211744|FG000|Overall Study|Withdrawal by Subject|1|||
156851845|NCT04378270|566211744|FG000|Overall Study|Screen Failure|1|||
156851846|NCT04378270|566211744|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
156851847|NCT01156714|566211745|FG000|Overall Study|Withdrawal by Subject|9|||
156851848|NCT01156714|566211746|FG001|Overall Study|Withdrawal by Subject|4|||
156851849|NCT01156714|566211747|FG002|Overall Study|Withdrawal by Subject|3|||
156851850|NCT01236521|566211748|FG000|Overall Study|Withdrawal by Subject|12|||
157157446|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
157157447|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
157157448|NCT01111539|567321095|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
157157449|NCT01111539|567321096|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
157157450|NCT01111539|567321097|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
157157451|NCT01111539|567321098|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
156851851|NCT01236521|566211749|FG001|Overall Study|Withdrawal by Subject|17|||
156851852|NCT01236521|566211748|FG000|Overall Study|Death|2|||
156851853|NCT01236521|566211749|FG001|Overall Study|Death|1|||
156851854|NCT01236521|566211748|FG000|Overall Study|Lost to Follow-up|9|||
156851855|NCT01236521|566211749|FG001|Overall Study|Lost to Follow-up|7|||
156851856|NCT03201419|566211751|FG000|Overall Study|Adverse Event|3|||
156851857|NCT03201419|566211752|FG001|Overall Study|Adverse Event|1|||
156851858|NCT03201419|566211753|FG002|Overall Study|Adverse Event|0|||
156851859|NCT03201419|566211754|FG003|Overall Study|Adverse Event|0|||
156851860|NCT03201419|566211755|FG004|Overall Study|Adverse Event|1|||
156851861|NCT03201419|566211756|FG005|Overall Study|Adverse Event|1|||
156851862|NCT03201419|566211757|FG006|Overall Study|Adverse Event|5|||
156851863|NCT03201419|566211758|FG007|Overall Study|Adverse Event|0|||
156851864|NCT03201419|566211759|FG008|Overall Study|Adverse Event|0|||
156851865|NCT03201419|566211751|FG000|Overall Study|Lost to Follow-up|1|||
156851866|NCT03201419|566211752|FG001|Overall Study|Lost to Follow-up|0|||
156851867|NCT03201419|566211753|FG002|Overall Study|Lost to Follow-up|0|||
156851868|NCT03201419|566211754|FG003|Overall Study|Lost to Follow-up|0|||
156851869|NCT03201419|566211755|FG004|Overall Study|Lost to Follow-up|0|||
156851870|NCT03201419|566211756|FG005|Overall Study|Lost to Follow-up|0|||
156851871|NCT03201419|566211757|FG006|Overall Study|Lost to Follow-up|0|||
156851872|NCT03201419|566211758|FG007|Overall Study|Lost to Follow-up|0|||
156851873|NCT03201419|566211759|FG008|Overall Study|Lost to Follow-up|0|||
156851874|NCT03201419|566211751|FG000|Overall Study|Protocol Deviation|0|||
156851875|NCT03201419|566211752|FG001|Overall Study|Protocol Deviation|0|||
156851876|NCT03201419|566211753|FG002|Overall Study|Protocol Deviation|0|||
156851877|NCT03201419|566211754|FG003|Overall Study|Protocol Deviation|0|||
156851878|NCT03201419|566211755|FG004|Overall Study|Protocol Deviation|0|||
156851879|NCT03201419|566211756|FG005|Overall Study|Protocol Deviation|0|||
156851880|NCT03201419|566211757|FG006|Overall Study|Protocol Deviation|1|||
156851881|NCT03201419|566211758|FG007|Overall Study|Protocol Deviation|0|||
156851882|NCT03201419|566211759|FG008|Overall Study|Protocol Deviation|0|||
156851883|NCT03201419|566211751|FG000|Overall Study|Withdrawal by Subject|4|||
156851884|NCT03201419|566211752|FG001|Overall Study|Withdrawal by Subject|2|||
156851885|NCT03201419|566211753|FG002|Overall Study|Withdrawal by Subject|1|||
156851886|NCT03201419|566211754|FG003|Overall Study|Withdrawal by Subject|0|||
156851887|NCT03201419|566211755|FG004|Overall Study|Withdrawal by Subject|0|||
156851888|NCT03201419|566211756|FG005|Overall Study|Withdrawal by Subject|0|||
156851889|NCT03201419|566211757|FG006|Overall Study|Withdrawal by Subject|0|||
156851890|NCT03201419|566211758|FG007|Overall Study|Withdrawal by Subject|1|||
156851891|NCT03201419|566211759|FG008|Overall Study|Withdrawal by Subject|2|||
156851892|NCT03201419|566211751|FG000|Overall Study|Other|0|||
156889238|NCT01933789|566354158|FG005|Overall Study|Death|32|||
157157452|NCT01111539|567321099|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
157157453|NCT03580382|567321104|FG000|Overall Study|Early Termination of Study|0|||
157157454|NCT03580382|567321105|FG001|Overall Study|Early Termination of Study|3|||
157157455|NCT02808312|567321106|FG000|Overall Study|Enrolled but Never Treated|0|||
156851893|NCT03201419|566211752|FG001|Overall Study|Other|0|||
156851894|NCT03201419|566211753|FG002|Overall Study|Other|1|||
156851895|NCT03201419|566211754|FG003|Overall Study|Other|0|||
156851896|NCT03201419|566211755|FG004|Overall Study|Other|0|||
156851897|NCT03201419|566211756|FG005|Overall Study|Other|0|||
156851898|NCT03201419|566211757|FG006|Overall Study|Other|0|||
156851899|NCT03201419|566211758|FG007|Overall Study|Other|0|||
156851900|NCT03201419|566211759|FG008|Overall Study|Other|0|||
156851901|NCT02701283|566211760|FG000|Overall Study|Death|25|||
156851902|NCT02701283|566211761|FG001|Overall Study|Death|29|||
156851903|NCT02701283|566211762|FG002|Overall Study|Death|19|||
156851904|NCT02701283|566211760|FG000|Overall Study|Lost to Follow-up|3|||
156851905|NCT02701283|566211761|FG001|Overall Study|Lost to Follow-up|8|||
156851906|NCT02701283|566211762|FG002|Overall Study|Lost to Follow-up|1|||
156851907|NCT02701283|566211760|FG000|Overall Study|Withdrawal by Subject|12|||
156851908|NCT02701283|566211761|FG001|Overall Study|Withdrawal by Subject|41|||
156851909|NCT02701283|566211762|FG002|Overall Study|Withdrawal by Subject|1|||
156851910|NCT02701283|566211760|FG000|Overall Study|Missed 2-year visit|22|||
156851911|NCT02701283|566211761|FG001|Overall Study|Missed 2-year visit|27|||
157157456|NCT02808312|567321107|FG001|Overall Study|Enrolled but Never Treated|0|||
157157457|NCT02808312|567321108|FG002|Overall Study|Enrolled but Never Treated|1|||
156851912|NCT02701283|566211762|FG002|Overall Study|Missed 2-year visit|0|||
156851913|NCT02701283|566211760|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
156851914|NCT02701283|566211761|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
156851915|NCT02701283|566211762|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
156851916|NCT04544956|566211763|FG000|Overall Study|Withdrawal by Subject|1|||
156851917|NCT04266795|566211764|FG000|Overall Study|Adverse Event|10|||
156851918|NCT04266795|566211765|FG001|Overall Study|Adverse Event|19|||
156851919|NCT04266795|566211764|FG000|Overall Study|Death|7|||
156851920|NCT04266795|566211765|FG001|Overall Study|Death|8|||
156851921|NCT04266795|566211764|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
156851922|NCT04266795|566211765|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
156851923|NCT04266795|566211764|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
156851924|NCT04266795|566211765|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156851925|NCT04266795|566211764|FG000|Overall Study|Progressive Disease|12|||
156851926|NCT04266795|566211765|FG001|Overall Study|Progressive Disease|9|||
156851927|NCT04266795|566211764|FG000|Overall Study|Withdrawal by Patient|5|||
156851928|NCT04266795|566211765|FG001|Overall Study|Withdrawal by Patient|6|||
156851929|NCT04266795|566211764|FG000|Overall Study|Disease Relapse|3|||
156851930|NCT04266795|566211765|FG001|Overall Study|Disease Relapse|6|||
156851931|NCT04266795|566211764|FG000|Overall Study|Reason not Specified|12|||
156851932|NCT04266795|566211765|FG001|Overall Study|Reason not Specified|10|||
156851933|NCT04266795|566211764|FG000|Overall Study|Participants Ongoing on Treatment|25|||
156851934|NCT04266795|566211765|FG001|Overall Study|Participants Ongoing on Treatment|23|||
156851935|NCT03043872|566211766|FG000|Overall Study|Withdrawal by Subject|6|||
156851936|NCT03043872|566211767|FG001|Overall Study|Withdrawal by Subject|6|||
156851937|NCT03043872|566211768|FG002|Overall Study|Withdrawal by Subject|15|||
156851938|NCT03043872|566211766|FG000|Overall Study|Lost to Follow-up|2|||
156851939|NCT03043872|566211767|FG001|Overall Study|Lost to Follow-up|1|||
156851940|NCT03043872|566211768|FG002|Overall Study|Lost to Follow-up|1|||
156851941|NCT03043872|566211766|FG000|Overall Study|Death|270|||
156851942|NCT03043872|566211767|FG001|Overall Study|Death|269|||
156851943|NCT03043872|566211768|FG002|Overall Study|Death|296|||
156851944|NCT03868943|566211771|FG000|Overall Study|Adverse Event|1|||
156851945|NCT04896593|566211772|FG000|Overall Study|Withdrawal by Subject|2|||
156851946|NCT04896593|566211772|FG000|Overall Study|Lost to Follow-up|1|||
156851947|NCT04896593|566211772|FG000|Overall Study|Did not complete onboarding|2|||
156851948|NCT02777827|566211773|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851949|NCT02777827|566211774|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851950|NCT02777827|566211775|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
156851951|NCT02777827|566211776|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851952|NCT02777827|566211777|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851953|NCT02777827|566211778|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
156851954|NCT04551066|566211779|FG000|Overall Study|Death|5|||
156851955|NCT04551066|566211780|FG001|Overall Study|Death|3|||
156851956|NCT04551066|566211779|FG000|Overall Study|Lost to Follow-up|1|||
156851957|NCT04551066|566211780|FG001|Overall Study|Lost to Follow-up|0|||
156851958|NCT04551066|566211779|FG000|Overall Study|Sponsor Decision|104|||
156851959|NCT04551066|566211780|FG001|Overall Study|Sponsor Decision|117|||
156851960|NCT04551066|566211779|FG000|Overall Study|Withdrawal by Subject|8|||
156851961|NCT04551066|566211780|FG001|Overall Study|Withdrawal by Subject|2|||
156851962|NCT04551066|566211779|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
156851963|NCT04551066|566211780|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
156851964|NCT04551066|566211779|FG000|Overall Study|Adverse Event|2|||
156851965|NCT04551066|566211780|FG001|Overall Study|Adverse Event|0|||
156851966|NCT04551066|566211779|FG000|Overall Study|Physician Decision|2|||
156851967|NCT04551066|566211780|FG001|Overall Study|Physician Decision|0|||
156851968|NCT04551066|566211779|FG000|Overall Study|Protocol Violation|1|||
156851969|NCT04551066|566211780|FG001|Overall Study|Protocol Violation|0|||
156851970|NCT04551066|566211779|FG000|Overall Study|Lack of Efficacy|0|||
156851971|NCT04551066|566211780|FG001|Overall Study|Lack of Efficacy|1|||
156851972|NCT04551066|566211779|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
156889239|NCT01933789|566354159|FG006|Overall Study|Death|0|||
156889240|NCT01933789|566354160|FG007|Overall Study|Death|0|||
156889241|NCT01933789|566354161|FG008|Overall Study|Death|0|||
156889242|NCT01933789|566354153|FG000|Overall Study|Lost to Follow-up|0|||
156889243|NCT01933789|566354154|FG001|Overall Study|Lost to Follow-up|0|||
156889244|NCT01933789|566354155|FG002|Overall Study|Lost to Follow-up|0|||
156851973|NCT04551066|566211780|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
156851974|NCT00369577|566211781|FG000|Overall Study|Withdrawal by Subject|0|||
156851975|NCT00369577|566211782|FG001|Overall Study|Withdrawal by Subject|0|||
156851976|NCT00369577|566211783|FG002|Overall Study|Withdrawal by Subject|1|||
156851977|NCT00398320|566211784|FG000|Overall Study|Death|1|||
156889245|NCT01933789|566354156|FG003|Overall Study|Lost to Follow-up|1|||
156851978|NCT00398320|566211784|FG000|Overall Study|Adverse Event|4|||
156851979|NCT00398320|566211784|FG000|Overall Study|Physician Decision|1|||
156851980|NCT00064792|566211785|FG000|Overall Study|Withdrawal by Subject|2|||
156851981|NCT00064792|566211786|FG001|Overall Study|Withdrawal by Subject|0|||
156851982|NCT00064792|566211785|FG000|Overall Study|Adverse Event|3|||
156851983|NCT00064792|566211786|FG001|Overall Study|Adverse Event|0|||
156851984|NCT03915470|566211789|FG000|Overall Study|Death|3|||
156851985|NCT03915470|566211790|FG001|Overall Study|Death|1|||
156851986|NCT03915470|566211789|FG000|Overall Study|Adverse Event|1|||
156851987|NCT03915470|566211790|FG001|Overall Study|Adverse Event|0|||
156851988|NCT03915470|566211789|FG000|Overall Study|Physician Decision|1|||
156851989|NCT03915470|566211790|FG001|Overall Study|Physician Decision|0|||
156851990|NCT03915470|566211789|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
156851991|NCT03915470|566211790|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
156851992|NCT03160898|566211791|FG000|Overall Study|Adverse Event|4|||
156851993|NCT03160898|566211792|FG001|Overall Study|Adverse Event|8|||
156851994|NCT03160898|566211793|FG002|Overall Study|Adverse Event|7|||
156851995|NCT03160898|566211794|FG003|Overall Study|Adverse Event|10|||
156851996|NCT03160898|566211791|FG000|Overall Study|Death|1|||
156851997|NCT03160898|566211792|FG001|Overall Study|Death|0|||
156851998|NCT03160898|566211793|FG002|Overall Study|Death|0|||
156851999|NCT03160898|566211794|FG003|Overall Study|Death|1|||
156852000|NCT03160898|566211791|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
156852001|NCT03160898|566211792|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
156852002|NCT03160898|566211793|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
156852003|NCT03160898|566211794|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
156852004|NCT03160898|566211791|FG000|Overall Study|Lost to Follow-up|1|||
156852005|NCT03160898|566211792|FG001|Overall Study|Lost to Follow-up|1|||
156852006|NCT03160898|566211793|FG002|Overall Study|Lost to Follow-up|1|||
156852007|NCT03160898|566211794|FG003|Overall Study|Lost to Follow-up|2|||
156852008|NCT03160898|566211791|FG000|Overall Study|Physician Decision|1|||
156852009|NCT03160898|566211792|FG001|Overall Study|Physician Decision|0|||
156852010|NCT03160898|566211793|FG002|Overall Study|Physician Decision|0|||
156852011|NCT03160898|566211794|FG003|Overall Study|Physician Decision|1|||
156852012|NCT03160898|566211791|FG000|Overall Study|Progressive Disease|4|||
156852013|NCT03160898|566211792|FG001|Overall Study|Progressive Disease|1|||
156852014|NCT03160898|566211793|FG002|Overall Study|Progressive Disease|2|||
156852015|NCT03160898|566211794|FG003|Overall Study|Progressive Disease|1|||
156852016|NCT03160898|566211791|FG000|Overall Study|Protocol Violation|1|||
156852017|NCT03160898|566211792|FG001|Overall Study|Protocol Violation|0|||
156852018|NCT03160898|566211793|FG002|Overall Study|Protocol Violation|2|||
156852019|NCT03160898|566211794|FG003|Overall Study|Protocol Violation|0|||
156852020|NCT03160898|566211791|FG000|Overall Study|Sponsor Discretion|2|||
156852021|NCT03160898|566211792|FG001|Overall Study|Sponsor Discretion|0|||
156852022|NCT03160898|566211793|FG002|Overall Study|Sponsor Discretion|0|||
156852023|NCT03160898|566211794|FG003|Overall Study|Sponsor Discretion|0|||
156852024|NCT03160898|566211791|FG000|Overall Study|Withdrawal by Subject|1|||
156852025|NCT03160898|566211792|FG001|Overall Study|Withdrawal by Subject|3|||
156852026|NCT03160898|566211793|FG002|Overall Study|Withdrawal by Subject|2|||
156852027|NCT03160898|566211794|FG003|Overall Study|Withdrawal by Subject|1|||
156852028|NCT03160898|566211791|FG000|Overall Study|Other|2|||
156852029|NCT03160898|566211792|FG001|Overall Study|Other|0|||
156852030|NCT03160898|566211793|FG002|Overall Study|Other|2|||
156852031|NCT03160898|566211794|FG003|Overall Study|Other|2|||
156852032|NCT03405818|566211797|FG000|Overall Study|Withdrawal by Subject|4|||
156852033|NCT03405818|566211797|FG000|Overall Study|Lost to Follow-up|4|||
156852034|NCT00291486|566211804|FG000|Overall Study|Adverse Event|0|||
156852035|NCT00291486|566211805|FG001|Overall Study|Adverse Event|3|||
156852036|NCT00291486|566211806|FG002|Overall Study|Adverse Event|0|||
157157458|NCT02808312|567321109|FG003|Overall Study|Enrolled but Never Treated|0|||
157157459|NCT02808312|567321110|FG004|Overall Study|Enrolled but Never Treated|0|||
157157460|NCT03628417|567321111|FG000|Overall Study|Death|1|||
157157461|NCT03628417|567321112|FG001|Overall Study|Death|1|||
156852037|NCT00291486|566211807|FG003|Overall Study|Adverse Event|1|||
156852038|NCT00291486|566211808|FG004|Overall Study|Adverse Event|0|||
156852039|NCT00291486|566211804|FG000|Overall Study|Withdrawal by Subject|0|||
156852040|NCT00291486|566211805|FG001|Overall Study|Withdrawal by Subject|0|||
157157462|NCT02420223|567321113|FG000|Overall Study|Adverse Event|1|||
156852041|NCT00291486|566211806|FG002|Overall Study|Withdrawal by Subject|0|||
156852042|NCT00291486|566211807|FG003|Overall Study|Withdrawal by Subject|0|||
156852043|NCT00291486|566211808|FG004|Overall Study|Withdrawal by Subject|1|||
156852044|NCT00291486|566211804|FG000|Overall Study|Disease progression|1|||
156852045|NCT00291486|566211805|FG001|Overall Study|Disease progression|0|||
156852046|NCT00291486|566211806|FG002|Overall Study|Disease progression|1|||
156852047|NCT00291486|566211807|FG003|Overall Study|Disease progression|0|||
156852048|NCT00291486|566211808|FG004|Overall Study|Disease progression|0|||
156852049|NCT01045694|566211809|FG000|Overall Study|Withdrawal by Subject|2|||
156852050|NCT04725500|566211810|FG000|Screening|Screen Failure|26|||
156852051|NCT04725500|566211810|FG000|Screening|Withdrawal by Subject|1|||
156852052|NCT04725500|566211810|FG000|2 Week Take Home|Screen Fail|5|||
156852053|NCT01045967|566213724|FG000|Second Intervention|Protocol Violation|0|||
156852054|NCT01045967|566213725|FG001|Second Intervention|Protocol Violation|1|||
156852055|NCT00985673|566213726|FG000|Overall Study|Lost to Follow-up|6|||
156852056|NCT00985673|566213727|FG001|Overall Study|Lost to Follow-up|7|||
156852057|NCT00985673|566213728|FG002|Overall Study|Lost to Follow-up|6|||
156852058|NCT00985673|566213729|FG003|Overall Study|Lost to Follow-up|10|||
156852059|NCT00985673|566213730|FG004|Overall Study|Lost to Follow-up|5|||
156852060|NCT00985673|566213731|FG005|Overall Study|Lost to Follow-up|3|||
156852061|NCT00985673|566213726|FG000|Overall Study|Withdrawal by Subject|0|||
156852062|NCT00985673|566213727|FG001|Overall Study|Withdrawal by Subject|4|||
156852063|NCT00985673|566213728|FG002|Overall Study|Withdrawal by Subject|5|||
156852064|NCT00985673|566213729|FG003|Overall Study|Withdrawal by Subject|2|||
156852065|NCT00985673|566213730|FG004|Overall Study|Withdrawal by Subject|2|||
156852066|NCT00985673|566213731|FG005|Overall Study|Withdrawal by Subject|3|||
156852067|NCT00985673|566213726|FG000|Overall Study|Other|1|||
156852068|NCT00985673|566213727|FG001|Overall Study|Other|0|||
156852069|NCT00985673|566213728|FG002|Overall Study|Other|1|||
156852070|NCT00985673|566213729|FG003|Overall Study|Other|0|||
156852071|NCT00985673|566213730|FG004|Overall Study|Other|1|||
156852072|NCT00985673|566213731|FG005|Overall Study|Other|0|||
156852073|NCT02252146|566213732|FG000|Overall Study|Lack of Efficacy|4|||
156852074|NCT02252146|566213732|FG000|Overall Study|Entered hospice care|1|||
156852075|NCT02252146|566213732|FG000|Overall Study|Inability to travel to study site|1|||
156852076|NCT00531284|566213733|FG000|Overall Study|Progressive Disease|1|||
156852077|NCT00531284|566213734|FG001|Overall Study|Progressive Disease|3|||
156852078|NCT00531284|566213735|FG002|Overall Study|Progressive Disease|5|||
156852079|NCT00531284|566213736|FG003|Overall Study|Progressive Disease|42|||
156852080|NCT00531284|566213737|FG004|Overall Study|Progressive Disease|4|||
156852081|NCT00531284|566213738|FG005|Overall Study|Progressive Disease|4|||
156852082|NCT00531284|566213739|FG006|Overall Study|Progressive Disease|3|||
156852083|NCT00531284|566213740|FG007|Overall Study|Progressive Disease|8|||
156852084|NCT00531284|566213741|FG008|Overall Study|Progressive Disease|6|||
156852085|NCT00531284|566213742|FG009|Overall Study|Progressive Disease|3|||
156852086|NCT00531284|566213743|FG010|Overall Study|Progressive Disease|3|||
156852087|NCT00531284|566213744|FG011|Overall Study|Progressive Disease|14|||
156852088|NCT00531284|566213745|FG012|Overall Study|Progressive Disease|2|||
156852089|NCT00531284|566213746|FG013|Overall Study|Progressive Disease|1|||
156852090|NCT00531284|566213747|FG014|Overall Study|Progressive Disease|2|||
156852091|NCT00531284|566213748|FG015|Overall Study|Progressive Disease|11|||
156852092|NCT00531284|566213749|FG016|Overall Study|Progressive Disease|5|||
156852093|NCT00531284|566213733|FG000|Overall Study|Adverse Event|0|||
156852094|NCT00531284|566213734|FG001|Overall Study|Adverse Event|1|||
156852095|NCT00531284|566213735|FG002|Overall Study|Adverse Event|1|||
156852096|NCT00531284|566213736|FG003|Overall Study|Adverse Event|7|||
156852097|NCT00531284|566213737|FG004|Overall Study|Adverse Event|0|||
156852098|NCT00531284|566213738|FG005|Overall Study|Adverse Event|2|||
156852099|NCT00531284|566213739|FG006|Overall Study|Adverse Event|3|||
156852100|NCT00531284|566213740|FG007|Overall Study|Adverse Event|2|||
156852101|NCT00531284|566213741|FG008|Overall Study|Adverse Event|3|||
156852102|NCT00531284|566213742|FG009|Overall Study|Adverse Event|0|||
156852103|NCT00531284|566213743|FG010|Overall Study|Adverse Event|0|||
156852104|NCT00531284|566213744|FG011|Overall Study|Adverse Event|5|||
156852105|NCT00531284|566213745|FG012|Overall Study|Adverse Event|0|||
156852106|NCT00531284|566213746|FG013|Overall Study|Adverse Event|1|||
156852107|NCT00531284|566213747|FG014|Overall Study|Adverse Event|1|||
156852108|NCT00531284|566213748|FG015|Overall Study|Adverse Event|0|||
156852109|NCT00531284|566213749|FG016|Overall Study|Adverse Event|2|||
156852110|NCT00531284|566213733|FG000|Overall Study|Withdrawal by Subject|1|||
156852111|NCT00531284|566213734|FG001|Overall Study|Withdrawal by Subject|0|||
156852112|NCT00531284|566213735|FG002|Overall Study|Withdrawal by Subject|0|||
156852113|NCT00531284|566213736|FG003|Overall Study|Withdrawal by Subject|4|||
156852114|NCT00531284|566213737|FG004|Overall Study|Withdrawal by Subject|0|||
156852115|NCT00531284|566213738|FG005|Overall Study|Withdrawal by Subject|0|||
156852116|NCT00531284|566213739|FG006|Overall Study|Withdrawal by Subject|0|||
156852117|NCT00531284|566213740|FG007|Overall Study|Withdrawal by Subject|0|||
156852118|NCT00531284|566213741|FG008|Overall Study|Withdrawal by Subject|0|||
156889246|NCT01933789|566354157|FG004|Overall Study|Lost to Follow-up|8|||
156889247|NCT01933789|566354158|FG005|Overall Study|Lost to Follow-up|9|||
156889248|NCT01933789|566354159|FG006|Overall Study|Lost to Follow-up|1|||
156852119|NCT00531284|566213742|FG009|Overall Study|Withdrawal by Subject|0|||
156852120|NCT00531284|566213743|FG010|Overall Study|Withdrawal by Subject|0|||
156852121|NCT00531284|566213744|FG011|Overall Study|Withdrawal by Subject|3|||
156852122|NCT00531284|566213745|FG012|Overall Study|Withdrawal by Subject|0|||
156852123|NCT00531284|566213746|FG013|Overall Study|Withdrawal by Subject|1|||
156852124|NCT00531284|566213747|FG014|Overall Study|Withdrawal by Subject|0|||
156852125|NCT00531284|566213748|FG015|Overall Study|Withdrawal by Subject|1|||
156852126|NCT00531284|566213749|FG016|Overall Study|Withdrawal by Subject|1|||
156852127|NCT00531284|566213733|FG000|Overall Study|Other|1|||
156852128|NCT00531284|566213734|FG001|Overall Study|Other|0|||
156852129|NCT00531284|566213735|FG002|Overall Study|Other|0|||
156852130|NCT00531284|566213736|FG003|Overall Study|Other|10|||
156852131|NCT00531284|566213737|FG004|Overall Study|Other|2|||
156852132|NCT00531284|566213738|FG005|Overall Study|Other|1|||
156852133|NCT00531284|566213739|FG006|Overall Study|Other|0|||
156852134|NCT00531284|566213740|FG007|Overall Study|Other|0|||
156852135|NCT00531284|566213741|FG008|Overall Study|Other|2|||
156852136|NCT00531284|566213742|FG009|Overall Study|Other|1|||
156852137|NCT00531284|566213743|FG010|Overall Study|Other|0|||
156852138|NCT00531284|566213744|FG011|Overall Study|Other|2|||
156852139|NCT00531284|566213745|FG012|Overall Study|Other|0|||
156852140|NCT00531284|566213746|FG013|Overall Study|Other|0|||
156852141|NCT00531284|566213747|FG014|Overall Study|Other|1|||
156852142|NCT00531284|566213748|FG015|Overall Study|Other|0|||
156852143|NCT00531284|566213749|FG016|Overall Study|Other|0|||
156852144|NCT03057496|566213750|FG000|Overall Study|Withdrawal by Subject|8|||
156852145|NCT03057496|566213750|FG000|Overall Study|Lost to Follow-up|5|||
156852146|NCT03057496|566213750|FG000|Overall Study|Did not use device during home trial|3|||
156852147|NCT03057496|566213750|FG000|Overall Study|Device failure|2|||
156852148|NCT03493945|566213751|FG000|Phase I Dose Escalation|Ineligible|0|||
156852149|NCT03493945|566213752|FG001|Phase I Dose Escalation|Ineligible|0|||
156852150|NCT03493945|566213753|FG002|Phase I Dose Escalation|Ineligible|1|||
156852151|NCT03493945|566213754|FG003|Phase I Dose Escalation|Ineligible|0|||
156852152|NCT03493945|566213755|FG004|Phase I Dose Escalation|Ineligible|0|||
156852153|NCT03493945|566213756|FG005|Phase I Dose Escalation|Ineligible|0|||
156852154|NCT03493945|566213757|FG006|Phase I Dose Escalation|Ineligible|0|||
156852155|NCT03493945|566213751|FG000|Phase I Dose Escalation|New therapy|0|||
156852156|NCT03493945|566213752|FG001|Phase I Dose Escalation|New therapy|1|||
156852157|NCT03493945|566213753|FG002|Phase I Dose Escalation|New therapy|0|||
156852158|NCT03493945|566213754|FG003|Phase I Dose Escalation|New therapy|0|||
156852159|NCT03493945|566213755|FG004|Phase I Dose Escalation|New therapy|0|||
156852160|NCT03493945|566213756|FG005|Phase I Dose Escalation|New therapy|0|||
156852161|NCT03493945|566213757|FG006|Phase I Dose Escalation|New therapy|0|||
156852162|NCT03493945|566213751|FG000|Phase II Dose Expansion|Refused further treatment|0|||
156852163|NCT03493945|566213752|FG001|Phase II Dose Expansion|Refused further treatment|0|||
156852164|NCT03493945|566213753|FG002|Phase II Dose Expansion|Refused further treatment|0|||
156852165|NCT03493945|566213754|FG003|Phase II Dose Expansion|Refused further treatment|0|||
156852166|NCT03493945|566213755|FG004|Phase II Dose Expansion|Refused further treatment|1|||
156852167|NCT03493945|566213756|FG005|Phase II Dose Expansion|Refused further treatment|1|||
156852168|NCT03493945|566213757|FG006|Phase II Dose Expansion|Refused further treatment|0|||
156852169|NCT03493945|566213751|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852170|NCT03493945|566213752|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852171|NCT03493945|566213753|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852172|NCT03493945|566213754|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
156852173|NCT03493945|566213755|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852174|NCT03493945|566213756|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852175|NCT03493945|566213757|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
156852176|NCT01584232|566213758|FG000|Overall Study|Adverse Event|3|||
156852177|NCT01584232|566213759|FG001|Overall Study|Adverse Event|1|||
156889249|NCT01933789|566354160|FG007|Overall Study|Lost to Follow-up|4|||
156889250|NCT01933789|566354161|FG008|Overall Study|Lost to Follow-up|0|||
156889251|NCT01933789|566354153|FG000|Overall Study|Withdrawal by Subject|2|||
156889252|NCT01933789|566354154|FG001|Overall Study|Withdrawal by Subject|1|||
156889253|NCT01933789|566354155|FG002|Overall Study|Withdrawal by Subject|0|||
156889254|NCT01933789|566354156|FG003|Overall Study|Withdrawal by Subject|0|||
156889255|NCT01933789|566354157|FG004|Overall Study|Withdrawal by Subject|17|||
156889256|NCT01933789|566354158|FG005|Overall Study|Withdrawal by Subject|16|||
156889257|NCT01933789|566354159|FG006|Overall Study|Withdrawal by Subject|1|||
156889258|NCT01933789|566354160|FG007|Overall Study|Withdrawal by Subject|4|||
156889259|NCT01933789|566354161|FG008|Overall Study|Withdrawal by Subject|0|||
156889260|NCT01933789|566354153|FG000|Overall Study|Became Ineligible|4|||
157157463|NCT02420223|567321114|FG001|Overall Study|Adverse Event|0|||
157157464|NCT02420223|567321113|FG000|Overall Study|Physician Decision|0|||
157157465|NCT02420223|567321114|FG001|Overall Study|Physician Decision|2|||
157157466|NCT01361009|567321115|FG000|Overall Study|Protocol Violation|116|||
157157467|NCT01826422|567321116|FG000|Overall Study|Withdrawal by Subject|1|||
156852178|NCT01584232|566213758|FG000|Overall Study|Withdrawal by Subject|2|||
156852179|NCT01584232|566213759|FG001|Overall Study|Withdrawal by Subject|1|||
156852180|NCT01584232|566213758|FG000|Overall Study|Physician Decision|2|||
156852181|NCT01584232|566213759|FG001|Overall Study|Physician Decision|1|||
156852182|NCT01584232|566213758|FG000|Overall Study|Lost to Follow-up|1|||
156852183|NCT01584232|566213759|FG001|Overall Study|Lost to Follow-up|0|||
156852184|NCT02152631|566213761|FG000|Overall Study|Adverse Event|32|||
156852185|NCT02152631|566213762|FG001|Overall Study|Adverse Event|4|||
156889261|NCT01933789|566354154|FG001|Overall Study|Became Ineligible|0|||
156889262|NCT01933789|566354155|FG002|Overall Study|Became Ineligible|0|||
156889263|NCT01933789|566354156|FG003|Overall Study|Became Ineligible|0|||
156889264|NCT01933789|566354157|FG004|Overall Study|Became Ineligible|13|||
156889265|NCT01933789|566354158|FG005|Overall Study|Became Ineligible|10|||
156889266|NCT01933789|566354159|FG006|Overall Study|Became Ineligible|13|||
156889267|NCT01933789|566354160|FG007|Overall Study|Became Ineligible|6|||
157157468|NCT01826422|567321117|FG001|Overall Study|Withdrawal by Subject|3|||
157025736|NCT04719832|566848044|FG001|Overall Study|Lack of Efficacy|4|||
157025737|NCT04719832|566848043|FG000|Overall Study|Lost to Follow-up|0|||
156852186|NCT02152631|566213761|FG000|Overall Study|Withdrawal by Subject|13|||
156852187|NCT02152631|566213762|FG001|Overall Study|Withdrawal by Subject|16|||
156852188|NCT02152631|566213761|FG000|Overall Study|Noncompliance with study drug|1|||
156852189|NCT02152631|566213762|FG001|Overall Study|Noncompliance with study drug|0|||
156852190|NCT02152631|566213761|FG000|Overall Study|Physician Decision|1|||
156852191|NCT02152631|566213762|FG001|Overall Study|Physician Decision|2|||
156852192|NCT02152631|566213761|FG000|Overall Study|Lost to Follow-up|0|||
156852193|NCT02152631|566213762|FG001|Overall Study|Lost to Follow-up|1|||
156852194|NCT02152631|566213761|FG000|Overall Study|On Treatment|19|||
156852195|NCT02152631|566213762|FG001|Overall Study|On Treatment|3|||
156852196|NCT03310723|566213773|FG000|Overall Study|Withdrawal by Subject|0|||
156852197|NCT03310723|566213774|FG001|Overall Study|Withdrawal by Subject|1|||
156852198|NCT03310723|566213773|FG000|Overall Study|Protocol Violation|0|||
156852199|NCT03310723|566213774|FG001|Overall Study|Protocol Violation|2|||
156852200|NCT02098746|566213775|FG000|Overall Study|Changes of Investigator|2|||
156852201|NCT02098746|566213775|FG000|Overall Study|Other Miscellaneous Reasons|1|||
156852202|NCT02098746|566213775|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
156852203|NCT02098746|566213775|FG000|Overall Study|Data Not Available After Treatment|1|||
156852204|NCT01121146|566213779|FG000|Overall Study|Death|17|||
156852205|NCT01121146|566213780|FG001|Overall Study|Death|15|||
156852206|NCT01121146|566213779|FG000|Overall Study|Adverse Event|2|||
156852207|NCT01121146|566213780|FG001|Overall Study|Adverse Event|11|||
156852208|NCT01121146|566213779|FG000|Overall Study|Lost to Follow-up|7|||
156852209|NCT01121146|566213780|FG001|Overall Study|Lost to Follow-up|16|||
156852210|NCT01132807|566213785|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
156852211|NCT01132807|566213786|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
156852212|NCT01132807|566213787|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
156852213|NCT01132807|566213785|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
156852214|NCT01132807|566213786|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
156852215|NCT01132807|566213787|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
156852216|NCT00742183|566213788|FG000|Overall Study|Adverse Event|2|||
156852217|NCT00742183|566213789|FG001|Overall Study|Adverse Event|2|||
156852218|NCT00742183|566213788|FG000|Overall Study|Death|1|||
156852219|NCT00742183|566213789|FG001|Overall Study|Death|0|||
156852220|NCT00742183|566213788|FG000|Overall Study|Physician Decision|0|||
156852221|NCT00742183|566213789|FG001|Overall Study|Physician Decision|2|||
156852222|NCT00742183|566213788|FG000|Overall Study|Lost to Follow-up|4|||
156852223|NCT00742183|566213789|FG001|Overall Study|Lost to Follow-up|4|||
156852224|NCT00742183|566213788|FG000|Overall Study|Required skin-graft|1|||
156852225|NCT00742183|566213789|FG001|Overall Study|Required skin-graft|1|||
156852226|NCT00742183|566213788|FG000|Overall Study|Withdrawal by Subject|1|||
156852227|NCT00742183|566213789|FG001|Overall Study|Withdrawal by Subject|0|||
156852228|NCT00742183|566213788|FG000|Overall Study|Lack of Efficacy|0|||
157025738|NCT04719832|566848044|FG001|Overall Study|Lost to Follow-up|2|||
157025739|NCT04719832|566848043|FG000|Overall Study|Physician Decision|0|||
157025740|NCT04719832|566848044|FG001|Overall Study|Physician Decision|1|||
157157469|NCT04009096|567321121|FG000|Overall Study|Withdrawal by Subject|0|||
157157470|NCT04009096|567321122|FG001|Overall Study|Withdrawal by Subject|7|||
157157471|NCT04009096|567321123|FG002|Overall Study|Withdrawal by Subject|0|||
157157472|NCT04009096|567321121|FG000|Overall Study|Physician Decision|0|||
157157473|NCT04009096|567321122|FG001|Overall Study|Physician Decision|1|||
157157474|NCT04009096|567321123|FG002|Overall Study|Physician Decision|0|||
157157475|NCT00450372|567321124|FG000|Overall Study|Physician Decision|1|||
157157476|NCT00769704|567321125|FG000|Overall Study|Lost to Follow-up|3|||
157157477|NCT00769704|567321126|FG001|Overall Study|Lost to Follow-up|2|||
157157478|NCT00769704|567321125|FG000|Overall Study|Death|95|||
157157479|NCT00769704|567321126|FG001|Overall Study|Death|190|||
157225463|NCT01860976|567571436|FG000|Open-Label|Other Reasons|1|||
157225464|NCT01860976|567571437|FG001|Open-Label|Other Reasons|1|||
157225465|NCT01860976|567571436|FG000|Long Term Extension|Adverse Event|4|||
156852229|NCT00742183|566213789|FG001|Overall Study|Lack of Efficacy|3|||
157025741|NCT04719832|566848043|FG000|Overall Study|Pregnancy|1|||
157025742|NCT04719832|566848044|FG001|Overall Study|Pregnancy|1|||
157157480|NCT00769704|567321125|FG000|Overall Study|Withdrawal by Subject|12|||
157025743|NCT04719832|566848043|FG000|Overall Study|Withdrawal by Subject|5|||
156852230|NCT01080807|566213795|FG000|Overall Study|Adverse Event|9|||
156852231|NCT01080807|566213796|FG001|Overall Study|Adverse Event|1|||
156852232|NCT01080807|566213795|FG000|Overall Study|Lack of Efficacy|0|||
156852233|NCT01080807|566213796|FG001|Overall Study|Lack of Efficacy|1|||
156852234|NCT01080807|566213795|FG000|Overall Study|Withdrawal by Subject|7|||
156852235|NCT01080807|566213796|FG001|Overall Study|Withdrawal by Subject|2|||
156852236|NCT01080807|566213795|FG000|Overall Study|Protocol Violation|7|||
156852237|NCT01080807|566213796|FG001|Overall Study|Protocol Violation|6|||
156852238|NCT01080807|566213795|FG000|Overall Study|Lost to Follow-up|6|||
157157481|NCT00769704|567321126|FG001|Overall Study|Withdrawal by Subject|5|||
157157482|NCT00769704|567321125|FG000|Overall Study|Other|1|||
157157483|NCT00769704|567321126|FG001|Overall Study|Other|2|||
156852239|NCT01080807|566213796|FG001|Overall Study|Lost to Follow-up|4|||
156852240|NCT01080807|566213795|FG000|Overall Study|Noncompliance with drug administration|1|||
156852241|NCT01080807|566213796|FG001|Overall Study|Noncompliance with drug administration|1|||
156852242|NCT01080807|566213795|FG000|Overall Study|Noncompliance to study procedures|1|||
156852243|NCT01080807|566213796|FG001|Overall Study|Noncompliance to study procedures|1|||
156852244|NCT01080807|566213795|FG000|Overall Study|Began working day shift|0|||
156852245|NCT01080807|566213796|FG001|Overall Study|Began working day shift|2|||
156852246|NCT01080807|566213795|FG000|Overall Study|Laid off or terminated from job|1|||
156852247|NCT01080807|566213796|FG001|Overall Study|Laid off or terminated from job|2|||
156852248|NCT01080807|566213795|FG000|Overall Study|Stopped working consistent night shifts|0|||
156852249|NCT01080807|566213796|FG001|Overall Study|Stopped working consistent night shifts|1|||
156852250|NCT01080807|566213795|FG000|Overall Study|Work schedule changing|1|||
156852251|NCT01080807|566213796|FG001|Overall Study|Work schedule changing|1|||
156852252|NCT01080807|566213795|FG000|Overall Study|Work schedule and travel|0|||
156852253|NCT01080807|566213796|FG001|Overall Study|Work schedule and travel|1|||
156852254|NCT01080807|566213795|FG000|Overall Study|Switched to first shift|1|||
156852255|NCT01080807|566213796|FG001|Overall Study|Switched to first shift|0|||
156852256|NCT01080807|566213795|FG000|Overall Study|Moved away without notifying center|1|||
156852257|NCT01080807|566213796|FG001|Overall Study|Moved away without notifying center|0|||
156852258|NCT01020786|566213807|FG000|Induction Period|Entry Criteria Not Met|2|||
156852259|NCT01020786|566213807|FG000|Induction Period|Adverse Event|10|||
156852260|NCT01020786|566213807|FG000|Induction Period|Progressive Disease|31|||
156852261|NCT01020786|566213807|FG000|Induction Period|Investigator Decision|3|||
156852262|NCT01020786|566213807|FG000|Induction Period|Withdrawal by Subject|3|||
156852263|NCT01020786|566213807|FG000|Maintenance Period|Adverse Event|8|||
156852264|NCT01020786|566213807|FG000|Maintenance Period|Progressive Disease|43|||
156852265|NCT01020786|566213807|FG000|Maintenance Period|Withdrawal by Subject|8|||
156852266|NCT01020786|566213807|FG000|Maintenance Period|Sponsor Decision|1|||
156852267|NCT04497116|566213808|FG000|Overall Study|Lost to Follow-up|1|||
156852268|NCT04497116|566213809|FG001|Overall Study|Lost to Follow-up|0|||
156852269|NCT04497116|566213810|FG002|Overall Study|Lost to Follow-up|0|||
156852270|NCT04497116|566213811|FG003|Overall Study|Lost to Follow-up|0|||
156852271|NCT04497116|566213812|FG004|Overall Study|Lost to Follow-up|0|||
156852272|NCT04497116|566213813|FG005|Overall Study|Lost to Follow-up|0|||
156852273|NCT04497116|566213814|FG006|Overall Study|Lost to Follow-up|0|||
156852274|NCT04497116|566213815|FG007|Overall Study|Lost to Follow-up|3|||
156852275|NCT04497116|566213816|FG008|Overall Study|Lost to Follow-up|3|||
156852276|NCT04497116|566213817|FG009|Overall Study|Lost to Follow-up|0|||
156852277|NCT04497116|566213818|FG010|Overall Study|Lost to Follow-up|0|||
156852278|NCT04497116|566213819|FG011|Overall Study|Lost to Follow-up|0|||
156852279|NCT04497116|566213820|FG012|Overall Study|Lost to Follow-up|0|||
156852280|NCT04497116|566213821|FG013|Overall Study|Lost to Follow-up|0|||
156852281|NCT04497116|566213822|FG014|Overall Study|Lost to Follow-up|0|||
157157484|NCT05131451|567321127|FG000|Overall Study|Protocol Violation|1|||
157157485|NCT05131451|567321128|FG001|Overall Study|Protocol Violation|0|||
157157486|NCT01856595|567321135|FG000|Overall Study|Withdrawal by Subject|0|||
157157487|NCT01856595|567321136|FG001|Overall Study|Withdrawal by Subject|1|||
157157488|NCT01856595|567321137|FG002|Overall Study|Withdrawal by Subject|0|||
157157489|NCT01856595|567321138|FG003|Overall Study|Withdrawal by Subject|0|||
157157490|NCT01856595|567321139|FG004|Overall Study|Withdrawal by Subject|0|||
157157491|NCT01856595|567321140|FG005|Overall Study|Withdrawal by Subject|0|||
157157492|NCT01856595|567321141|FG006|Overall Study|Withdrawal by Subject|1|||
157157493|NCT01856595|567321142|FG007|Overall Study|Withdrawal by Subject|0|||
157157494|NCT01856595|567321143|FG008|Overall Study|Withdrawal by Subject|0|||
157157495|NCT04426825|567321145|FG000|Overall Study|Death|17|||
157157496|NCT04426825|567321145|FG000|Overall Study|Lost to Follow-up|1|||
157157497|NCT04426825|567321145|FG000|Overall Study|Study terminated by sponsor|5|||
157157498|NCT01863849|567321153|FG000|Overall Study|Lost to Follow-up|1|||
157157499|NCT01863849|567321154|FG001|Overall Study|Lost to Follow-up|0|||
156852282|NCT04497116|566213823|FG015|Overall Study|Lost to Follow-up|0|||
156852283|NCT04497116|566213824|FG016|Overall Study|Lost to Follow-up|0|||
156852284|NCT04497116|566213825|FG017|Overall Study|Lost to Follow-up|0|||
156852285|NCT04497116|566213826|FG018|Overall Study|Lost to Follow-up|0|||
156852286|NCT04497116|566213827|FG019|Overall Study|Lost to Follow-up|0|||
156852287|NCT04497116|566213828|FG020|Overall Study|Lost to Follow-up|0|||
156852288|NCT04497116|566213829|FG021|Overall Study|Lost to Follow-up|0|||
156852289|NCT04497116|566213830|FG022|Overall Study|Lost to Follow-up|1|||
157157500|NCT01533935|567321155|FG000|Overall Study|Adverse Event|5|||
156852290|NCT04497116|566213831|FG023|Overall Study|Lost to Follow-up|0|||
156852291|NCT04497116|566213832|FG024|Overall Study|Lost to Follow-up|0|||
156852292|NCT04497116|566213808|FG000|Overall Study|Sponsor decision to terminate study|0|||
156852293|NCT04497116|566213809|FG001|Overall Study|Sponsor decision to terminate study|0|||
156852294|NCT04497116|566213810|FG002|Overall Study|Sponsor decision to terminate study|0|||
156852295|NCT04497116|566213811|FG003|Overall Study|Sponsor decision to terminate study|0|||
157157501|NCT01533935|567321156|FG001|Overall Study|Adverse Event|7|||
157157502|NCT01533935|567321157|FG002|Overall Study|Adverse Event|1|||
157157503|NCT01533935|567321158|FG003|Overall Study|Adverse Event|5|||
156852296|NCT04497116|566213812|FG004|Overall Study|Sponsor decision to terminate study|0|||
156852297|NCT04497116|566213813|FG005|Overall Study|Sponsor decision to terminate study|0|||
156852298|NCT04497116|566213814|FG006|Overall Study|Sponsor decision to terminate study|1|||
156852299|NCT04497116|566213815|FG007|Overall Study|Sponsor decision to terminate study|0|||
156852300|NCT04497116|566213816|FG008|Overall Study|Sponsor decision to terminate study|0|||
156852301|NCT04497116|566213817|FG009|Overall Study|Sponsor decision to terminate study|1|||
156852302|NCT04497116|566213818|FG010|Overall Study|Sponsor decision to terminate study|0|||
156852303|NCT04497116|566213819|FG011|Overall Study|Sponsor decision to terminate study|0|||
156852304|NCT04497116|566213820|FG012|Overall Study|Sponsor decision to terminate study|0|||
156852305|NCT04497116|566213821|FG013|Overall Study|Sponsor decision to terminate study|0|||
156852306|NCT04497116|566213822|FG014|Overall Study|Sponsor decision to terminate study|0|||
156852307|NCT04497116|566213823|FG015|Overall Study|Sponsor decision to terminate study|0|||
156852308|NCT04497116|566213824|FG016|Overall Study|Sponsor decision to terminate study|0|||
156852309|NCT04497116|566213825|FG017|Overall Study|Sponsor decision to terminate study|0|||
156852310|NCT04497116|566213826|FG018|Overall Study|Sponsor decision to terminate study|0|||
156852311|NCT04497116|566213827|FG019|Overall Study|Sponsor decision to terminate study|1|||
156852312|NCT04497116|566213828|FG020|Overall Study|Sponsor decision to terminate study|0|||
156852313|NCT04497116|566213829|FG021|Overall Study|Sponsor decision to terminate study|0|||
156852314|NCT04497116|566213830|FG022|Overall Study|Sponsor decision to terminate study|0|||
156852315|NCT04497116|566213831|FG023|Overall Study|Sponsor decision to terminate study|0|||
156852316|NCT04497116|566213832|FG024|Overall Study|Sponsor decision to terminate study|0|||
156852317|NCT04497116|566213808|FG000|Overall Study|Death|4|||
156852318|NCT04497116|566213809|FG001|Overall Study|Death|5|||
156852319|NCT04497116|566213810|FG002|Overall Study|Death|2|||
156852320|NCT04497116|566213811|FG003|Overall Study|Death|2|||
156852321|NCT04497116|566213812|FG004|Overall Study|Death|1|||
156852322|NCT04497116|566213813|FG005|Overall Study|Death|1|||
156852323|NCT04497116|566213814|FG006|Overall Study|Death|3|||
156852324|NCT04497116|566213815|FG007|Overall Study|Death|10|||
156852325|NCT04497116|566213816|FG008|Overall Study|Death|37|||
156852326|NCT04497116|566213817|FG009|Overall Study|Death|17|||
156852327|NCT04497116|566213818|FG010|Overall Study|Death|2|||
156852328|NCT04497116|566213819|FG011|Overall Study|Death|1|||
156852329|NCT04497116|566213820|FG012|Overall Study|Death|1|||
156852330|NCT04497116|566213821|FG013|Overall Study|Death|3|||
156852331|NCT04497116|566213822|FG014|Overall Study|Death|18|||
156852332|NCT04497116|566213823|FG015|Overall Study|Death|3|||
156852333|NCT04497116|566213824|FG016|Overall Study|Death|2|||
156852334|NCT04497116|566213825|FG017|Overall Study|Death|1|||
156852335|NCT04497116|566213826|FG018|Overall Study|Death|4|||
156852336|NCT04497116|566213827|FG019|Overall Study|Death|17|||
156852337|NCT04497116|566213828|FG020|Overall Study|Death|1|||
156852338|NCT04497116|566213829|FG021|Overall Study|Death|0|||
156852339|NCT04497116|566213830|FG022|Overall Study|Death|3|||
156852340|NCT04497116|566213831|FG023|Overall Study|Death|5|||
156852341|NCT04497116|566213832|FG024|Overall Study|Death|4|||
156852342|NCT04497116|566213808|FG000|Overall Study|Withdrawal by Subject|1|||
156852343|NCT04497116|566213809|FG001|Overall Study|Withdrawal by Subject|0|||
156852344|NCT04497116|566213810|FG002|Overall Study|Withdrawal by Subject|1|||
156852345|NCT04497116|566213811|FG003|Overall Study|Withdrawal by Subject|0|||
156852346|NCT04497116|566213812|FG004|Overall Study|Withdrawal by Subject|0|||
156852347|NCT04497116|566213813|FG005|Overall Study|Withdrawal by Subject|0|||
156852348|NCT04497116|566213814|FG006|Overall Study|Withdrawal by Subject|0|||
156852349|NCT04497116|566213815|FG007|Overall Study|Withdrawal by Subject|7|||
156852350|NCT04497116|566213816|FG008|Overall Study|Withdrawal by Subject|14|||
156852351|NCT04497116|566213817|FG009|Overall Study|Withdrawal by Subject|3|||
156852352|NCT04497116|566213818|FG010|Overall Study|Withdrawal by Subject|3|||
156852353|NCT04497116|566213819|FG011|Overall Study|Withdrawal by Subject|0|||
156852354|NCT04497116|566213820|FG012|Overall Study|Withdrawal by Subject|1|||
156852355|NCT04497116|566213821|FG013|Overall Study|Withdrawal by Subject|0|||
156852356|NCT04497116|566213822|FG014|Overall Study|Withdrawal by Subject|7|||
156852357|NCT04497116|566213823|FG015|Overall Study|Withdrawal by Subject|1|||
156852358|NCT04497116|566213824|FG016|Overall Study|Withdrawal by Subject|3|||
156852359|NCT04497116|566213825|FG017|Overall Study|Withdrawal by Subject|1|||
156852360|NCT04497116|566213826|FG018|Overall Study|Withdrawal by Subject|1|||
156852361|NCT04497116|566213827|FG019|Overall Study|Withdrawal by Subject|5|||
156852362|NCT04497116|566213828|FG020|Overall Study|Withdrawal by Subject|2|||
156852363|NCT04497116|566213829|FG021|Overall Study|Withdrawal by Subject|2|||
156852364|NCT04497116|566213830|FG022|Overall Study|Withdrawal by Subject|2|||
156852365|NCT04497116|566213831|FG023|Overall Study|Withdrawal by Subject|4|||
156852366|NCT04497116|566213832|FG024|Overall Study|Withdrawal by Subject|3|||
156852367|NCT04497116|566213808|FG000|Overall Study|Physician Decision|0|||
156852368|NCT04497116|566213809|FG001|Overall Study|Physician Decision|0|||
156852369|NCT04497116|566213810|FG002|Overall Study|Physician Decision|0|||
156852370|NCT04497116|566213811|FG003|Overall Study|Physician Decision|0|||
156852371|NCT04497116|566213812|FG004|Overall Study|Physician Decision|0|||
156852372|NCT04497116|566213813|FG005|Overall Study|Physician Decision|0|||
156852373|NCT04497116|566213814|FG006|Overall Study|Physician Decision|0|||
156852374|NCT04497116|566213815|FG007|Overall Study|Physician Decision|0|||
156852375|NCT04497116|566213816|FG008|Overall Study|Physician Decision|0|||
156852376|NCT04497116|566213817|FG009|Overall Study|Physician Decision|0|||
156852377|NCT04497116|566213818|FG010|Overall Study|Physician Decision|0|||
156852378|NCT04497116|566213819|FG011|Overall Study|Physician Decision|0|||
156852379|NCT04497116|566213820|FG012|Overall Study|Physician Decision|0|||
156852380|NCT04497116|566213821|FG013|Overall Study|Physician Decision|0|||
156852381|NCT04497116|566213822|FG014|Overall Study|Physician Decision|0|||
156852382|NCT04497116|566213823|FG015|Overall Study|Physician Decision|0|||
156852383|NCT04497116|566213824|FG016|Overall Study|Physician Decision|0|||
156852384|NCT04497116|566213825|FG017|Overall Study|Physician Decision|0|||
156852385|NCT04497116|566213826|FG018|Overall Study|Physician Decision|0|||
156852386|NCT04497116|566213827|FG019|Overall Study|Physician Decision|0|||
156852387|NCT04497116|566213828|FG020|Overall Study|Physician Decision|0|||
156852388|NCT04497116|566213829|FG021|Overall Study|Physician Decision|0|||
156852389|NCT04497116|566213830|FG022|Overall Study|Physician Decision|0|||
156852390|NCT04497116|566213831|FG023|Overall Study|Physician Decision|1|||
156852391|NCT04497116|566213832|FG024|Overall Study|Physician Decision|0|||
156852392|NCT04497116|566213808|FG000|Overall Study|Clinical Progression Related|0|||
156852393|NCT04497116|566213809|FG001|Overall Study|Clinical Progression Related|0|||
156852394|NCT04497116|566213810|FG002|Overall Study|Clinical Progression Related|0|||
156852395|NCT04497116|566213811|FG003|Overall Study|Clinical Progression Related|0|||
156852396|NCT04497116|566213812|FG004|Overall Study|Clinical Progression Related|0|||
156852397|NCT04497116|566213813|FG005|Overall Study|Clinical Progression Related|0|||
156852398|NCT04497116|566213814|FG006|Overall Study|Clinical Progression Related|0|||
156852399|NCT04497116|566213815|FG007|Overall Study|Clinical Progression Related|0|||
156852400|NCT04497116|566213816|FG008|Overall Study|Clinical Progression Related|0|||
156852401|NCT04497116|566213817|FG009|Overall Study|Clinical Progression Related|1|||
156852402|NCT04497116|566213818|FG010|Overall Study|Clinical Progression Related|0|||
156852403|NCT04497116|566213819|FG011|Overall Study|Clinical Progression Related|0|||
156852404|NCT04497116|566213820|FG012|Overall Study|Clinical Progression Related|0|||
156852405|NCT04497116|566213821|FG013|Overall Study|Clinical Progression Related|0|||
156852406|NCT04497116|566213822|FG014|Overall Study|Clinical Progression Related|0|||
156852407|NCT04497116|566213823|FG015|Overall Study|Clinical Progression Related|0|||
156852408|NCT04497116|566213824|FG016|Overall Study|Clinical Progression Related|0|||
156852409|NCT04497116|566213825|FG017|Overall Study|Clinical Progression Related|0|||
156852410|NCT04497116|566213826|FG018|Overall Study|Clinical Progression Related|0|||
156852411|NCT04497116|566213827|FG019|Overall Study|Clinical Progression Related|0|||
156852412|NCT04497116|566213828|FG020|Overall Study|Clinical Progression Related|0|||
156852413|NCT04497116|566213829|FG021|Overall Study|Clinical Progression Related|0|||
156852414|NCT04497116|566213830|FG022|Overall Study|Clinical Progression Related|0|||
156852415|NCT04497116|566213831|FG023|Overall Study|Clinical Progression Related|0|||
156852416|NCT04497116|566213832|FG024|Overall Study|Clinical Progression Related|0|||
156852417|NCT05963022|566213833|FG000|Overall Study|Adverse Event|0|||
156852418|NCT05963022|566213834|FG001|Overall Study|Adverse Event|1|||
156852419|NCT05963022|566213835|FG002|Overall Study|Adverse Event|1|||
156852420|NCT05963022|566213836|FG003|Overall Study|Adverse Event|0|||
156852421|NCT05963022|566213833|FG000|Overall Study|Protocol Violation|0|||
156852422|NCT05963022|566213834|FG001|Overall Study|Protocol Violation|3|||
156852423|NCT05963022|566213835|FG002|Overall Study|Protocol Violation|0|||
156852424|NCT05963022|566213836|FG003|Overall Study|Protocol Violation|0|||
156852425|NCT05963022|566213833|FG000|Overall Study|Pregnancy|0|||
156852426|NCT05963022|566213834|FG001|Overall Study|Pregnancy|1|||
156852427|NCT05963022|566213835|FG002|Overall Study|Pregnancy|1|||
156889268|NCT01933789|566354161|FG008|Overall Study|Became Ineligible|0|||
156889269|NCT00723203|566354166|FG000|Overall Study|Withdrawal by Subject|3|||
156852428|NCT05963022|566213836|FG003|Overall Study|Pregnancy|1|||
156852429|NCT05963022|566213833|FG000|Overall Study|Withdrawal by Subject|0|||
156852430|NCT05963022|566213834|FG001|Overall Study|Withdrawal by Subject|0|||
156852431|NCT05963022|566213835|FG002|Overall Study|Withdrawal by Subject|2|||
157025744|NCT04719832|566848044|FG001|Overall Study|Withdrawal by Subject|5|||
157025745|NCT04719832|566848043|FG000|Overall Study|Randomized, not treated|0|||
157025746|NCT04719832|566848044|FG001|Overall Study|Randomized, not treated|2|||
157025747|NCT04719832|566848043|FG000|Overall Study|GCP violations|4|||
157025748|NCT04719832|566848044|FG001|Overall Study|GCP violations|7|||
157025749|NCT02485938|566849595|FG000|Overall Study|Withdrawal of consent|2|||
157025750|NCT02485938|566849596|FG001|Overall Study|Withdrawal of consent|0|||
157025751|NCT03241745|566849597|FG000|Overall Study|Adverse Event|7|||
157025752|NCT03241745|566849597|FG000|Overall Study|Death|1|||
156852432|NCT05963022|566213836|FG003|Overall Study|Withdrawal by Subject|1|||
156852433|NCT05963022|566213833|FG000|Overall Study|Lost to Follow-up|0|||
156852434|NCT05963022|566213834|FG001|Overall Study|Lost to Follow-up|0|||
156852435|NCT05963022|566213835|FG002|Overall Study|Lost to Follow-up|0|||
156889270|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
157025753|NCT03241745|566849597|FG000|Overall Study|Withdrawal by Subject|5|||
157025754|NCT03241745|566849597|FG000|Overall Study|Treatment delay >28 days|2|||
156852436|NCT05963022|566213836|FG003|Overall Study|Lost to Follow-up|1|||
156852437|NCT05963022|566213833|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852438|NCT05963022|566213834|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852439|NCT05963022|566213835|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
156852440|NCT05963022|566213836|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
156852441|NCT02698826|566213837|FG000|Overall Study|Death|13|||
156852442|NCT02698826|566213837|FG000|Overall Study|Adverse Event|1|||
156852443|NCT02915263|566213840|FG000|Overall Study|Covid|3|||
156852444|NCT02915263|566213841|FG001|Overall Study|Covid|2|||
156852445|NCT01358825|566213842|FG000|Overall Study|Blood sample not drawn|0|||
156852446|NCT01358825|566213843|FG001|Overall Study|Blood sample not drawn|1|||
156852447|NCT01879683|566213844|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
156852448|NCT03571204|566213845|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
156852449|NCT03571204|566213846|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
156852450|NCT03571204|566213847|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
156852451|NCT03571204|566213845|FG000|Overall Study|Physician Decision|0|||
156852452|NCT03571204|566213846|FG001|Overall Study|Physician Decision|1|||
156852453|NCT03571204|566213847|FG002|Overall Study|Physician Decision|0|||
156852454|NCT02721875|566213848|FG000|Overall Study|Progressive disease/relapse|1|||
156852455|NCT02721875|566213849|FG001|Overall Study|Progressive disease/relapse|0|||
156852456|NCT02888106|566213850|FG000|Overall Study|Withdrawal by Subject|1|||
156852457|NCT02888106|566213851|FG001|Overall Study|Withdrawal by Subject|2|||
156852458|NCT02888106|566213852|FG002|Overall Study|Withdrawal by Subject|0|||
156852459|NCT02888106|566213853|FG003|Overall Study|Withdrawal by Subject|1|||
156852460|NCT02888106|566213854|FG004|Overall Study|Withdrawal by Subject|0|||
156852461|NCT02888106|566213855|FG005|Overall Study|Withdrawal by Subject|0|||
156852462|NCT02888106|566213850|FG000|Overall Study|Lost to Follow-up|1|||
156852463|NCT02888106|566213851|FG001|Overall Study|Lost to Follow-up|0|||
156852464|NCT02888106|566213852|FG002|Overall Study|Lost to Follow-up|0|||
156852465|NCT02888106|566213853|FG003|Overall Study|Lost to Follow-up|1|||
156852466|NCT02888106|566213854|FG004|Overall Study|Lost to Follow-up|0|||
156852467|NCT02888106|566213855|FG005|Overall Study|Lost to Follow-up|1|||
156852468|NCT02888106|566213850|FG000|Overall Study|Adverse Event|2|||
156852469|NCT02888106|566213851|FG001|Overall Study|Adverse Event|0|||
156852470|NCT02888106|566213852|FG002|Overall Study|Adverse Event|0|||
156852471|NCT02888106|566213853|FG003|Overall Study|Adverse Event|0|||
156852472|NCT02888106|566213854|FG004|Overall Study|Adverse Event|0|||
156852473|NCT02888106|566213855|FG005|Overall Study|Adverse Event|0|||
156852474|NCT02888106|566213850|FG000|Overall Study|Withdrawal of consent|0|||
156852475|NCT02888106|566213851|FG001|Overall Study|Withdrawal of consent|0|||
156852476|NCT02888106|566213852|FG002|Overall Study|Withdrawal of consent|0|||
156852477|NCT02888106|566213853|FG003|Overall Study|Withdrawal of consent|0|||
156852478|NCT02888106|566213854|FG004|Overall Study|Withdrawal of consent|1|||
156852479|NCT02888106|566213855|FG005|Overall Study|Withdrawal of consent|0|||
156852480|NCT02888106|566213850|FG000|Overall Study|Pregnancy|1|||
156852481|NCT02888106|566213851|FG001|Overall Study|Pregnancy|0|||
156852482|NCT02888106|566213852|FG002|Overall Study|Pregnancy|0|||
156852483|NCT02888106|566213853|FG003|Overall Study|Pregnancy|0|||
156852484|NCT02888106|566213854|FG004|Overall Study|Pregnancy|0|||
156889271|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
156889272|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
156889273|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
156889274|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
156889275|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
156889276|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
156889277|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
156852485|NCT02888106|566213855|FG005|Overall Study|Pregnancy|0|||
156852486|NCT00857285|566213856|FG000|Overall Study|Adverse Event|4|||
156852487|NCT00857285|566213857|FG001|Overall Study|Adverse Event|2|||
156852488|NCT00857285|566213856|FG000|Overall Study|Lack of Efficacy|0|||
156852489|NCT00857285|566213857|FG001|Overall Study|Lack of Efficacy|2|||
156889278|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
156889279|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
156889280|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
156889281|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
156889282|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
156852490|NCT00857285|566213856|FG000|Overall Study|Protocol Violation|3|||
156852491|NCT00857285|566213857|FG001|Overall Study|Protocol Violation|1|||
156852492|NCT00857285|566213856|FG000|Overall Study|Withdrawal by Subject|4|||
156852493|NCT00857285|566213857|FG001|Overall Study|Withdrawal by Subject|0|||
156852494|NCT00857285|566213856|FG000|Overall Study|Randomization criteria not met|1|||
156852495|NCT00857285|566213857|FG001|Overall Study|Randomization criteria not met|1|||
156852496|NCT02491983|566213860|FG000|Overall Study|Physician Decision|1|||
156852497|NCT02491983|566213861|FG001|Overall Study|Physician Decision|0|||
156852498|NCT02491983|566213860|FG000|Overall Study|Not meet selection criteria|1|||
156852499|NCT02491983|566213861|FG001|Overall Study|Not meet selection criteria|0|||
156852500|NCT02491983|566213860|FG000|Overall Study|Withdrawal by Subject|0|||
156852501|NCT02491983|566213861|FG001|Overall Study|Withdrawal by Subject|1|||
156852502|NCT00782717|566213863|FG000|Overall Study|Adverse Event|2|||
156852503|NCT00782717|566213864|FG001|Overall Study|Adverse Event|5|||
156852504|NCT00782717|566213863|FG000|Overall Study|Patient decision unrelated to AE|6|||
156852505|NCT00782717|566213864|FG001|Overall Study|Patient decision unrelated to AE|3|||
156852506|NCT00782717|566213863|FG000|Overall Study|Noncompliance|2|||
156852507|NCT00782717|566213864|FG001|Overall Study|Noncompliance|1|||
156852508|NCT00782717|566213863|FG000|Overall Study|Treatment failure|3|||
156852509|NCT00782717|566213864|FG001|Overall Study|Treatment failure|14|||
156852510|NCT00782717|566213863|FG000|Overall Study|Enrollment close prior to surgery|1|||
156852511|NCT00782717|566213864|FG001|Overall Study|Enrollment close prior to surgery|0|||
156852512|NCT00782717|566213863|FG000|Overall Study|Did not meet entrance criteria|1|||
156852513|NCT00782717|566213864|FG001|Overall Study|Did not meet entrance criteria|3|||
156852514|NCT00782717|566213863|FG000|Overall Study|Exited in error|0|||
156852515|NCT00782717|566213864|FG001|Overall Study|Exited in error|2|||
156852516|NCT02446717|566213865|FG000|Overall Study|Adverse Event|0|||
156852517|NCT02446717|566213866|FG001|Overall Study|Adverse Event|0|||
156852518|NCT02446717|566213867|FG002|Overall Study|Adverse Event|1|||
156852519|NCT02446717|566213868|FG003|Overall Study|Adverse Event|0|||
156852520|NCT02446717|566213869|FG004|Overall Study|Adverse Event|0|||
156852521|NCT02446717|566213865|FG000|Overall Study|Lost to Follow-up|0|||
156852522|NCT02446717|566213866|FG001|Overall Study|Lost to Follow-up|1|||
156852523|NCT02446717|566213867|FG002|Overall Study|Lost to Follow-up|1|||
156852524|NCT02446717|566213868|FG003|Overall Study|Lost to Follow-up|0|||
156852525|NCT02446717|566213869|FG004|Overall Study|Lost to Follow-up|1|||
156852526|NCT02446717|566213865|FG000|Overall Study|Withdrew consent|0|||
156852527|NCT02446717|566213866|FG001|Overall Study|Withdrew consent|0|||
156852528|NCT02446717|566213867|FG002|Overall Study|Withdrew consent|0|||
156852529|NCT02446717|566213868|FG003|Overall Study|Withdrew consent|1|||
156852530|NCT02446717|566213869|FG004|Overall Study|Withdrew consent|0|||
156852531|NCT01332994|566213874|FG000|Overall Study|Adverse Event|34|||
156852532|NCT01332994|566213874|FG000|Overall Study|Death|1|||
156852533|NCT01332994|566213874|FG000|Overall Study|Lack of Efficacy|1|||
156852534|NCT01332994|566213874|FG000|Overall Study|Lost to Follow-up|4|||
156852535|NCT01332994|566213874|FG000|Overall Study|Protocol Violation|6|||
156852536|NCT01332994|566213874|FG000|Overall Study|Withdrawal by Subject|15|||
156852537|NCT01332994|566213874|FG000|Overall Study|Administrative Problem|2|||
156852538|NCT01332994|566213874|FG000|Overall Study|Other|8|||
156852539|NCT04661150|566213881|FG000|Overall Study|Ongoing in study|19|||
156852540|NCT04661150|566213882|FG001|Overall Study|Ongoing in study|20|||
156852541|NCT04661150|566213881|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
156852542|NCT04661150|566213882|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
156852543|NCT04661150|566213881|FG000|Overall Study|Death|2|||
156852544|NCT04661150|566213882|FG001|Overall Study|Death|0|||
156852545|NCT04965688|566213883|FG000|Overall Study|Withdrawal by Subject|2|||
156852546|NCT05864586|566213884|FG000|Overall Study|Ineligible|4|||
156852547|NCT05864586|566213885|FG001|Overall Study|Ineligible|12|||
156852548|NCT05864586|566213884|FG000|Overall Study|Pregnancy|0|||
156852549|NCT05864586|566213885|FG001|Overall Study|Pregnancy|1|||
156852550|NCT05864586|566213884|FG000|Overall Study|Withdrawal by Subject|0|||
156852551|NCT05864586|566213885|FG001|Overall Study|Withdrawal by Subject|1|||
156852552|NCT03635424|566213886|FG000|Overall Study|Adverse Event|1|||
156852553|NCT03635424|566213886|FG000|Overall Study|Death|1|||
156852554|NCT03635424|566213886|FG000|Overall Study|Device not implanted|1|||
156852555|NCT05907395|566213887|FG000|Period 1|No longer met eligibility criteria|0|||
156852556|NCT05907395|566213888|FG001|Period 1|No longer met eligibility criteria|1|||
156852557|NCT05907395|566213889|FG002|Period 1|No longer met eligibility criteria|0|||
156852558|NCT05907395|566213890|FG003|Period 1|No longer met eligibility criteria|0|||
156852559|NCT05907395|566213891|FG004|Period 1|No longer met eligibility criteria|0|||
156852560|NCT05907395|566213892|FG005|Period 1|No longer met eligibility criteria|1|||
156852561|NCT05907395|566213893|FG006|Period 1|No longer met eligibility criteria|1|||
156852562|NCT05907395|566213894|FG007|Period 1|No longer met eligibility criteria|0|||
156852563|NCT05907395|566213895|FG008|Period 1|No longer met eligibility criteria|0|||
156852564|NCT05907395|566213896|FG009|Period 1|No longer met eligibility criteria|0|||
156852565|NCT05907395|566213897|FG010|Period 1|No longer met eligibility criteria|0|||
156852566|NCT05907395|566213898|FG011|Period 1|No longer met eligibility criteria|0|||
156852567|NCT05907395|566213887|FG000|Period 2|Adverse Event|0|||
156852568|NCT05907395|566213888|FG001|Period 2|Adverse Event|0|||
156852569|NCT05907395|566213889|FG002|Period 2|Adverse Event|0|||
156852570|NCT05907395|566213890|FG003|Period 2|Adverse Event|1|||
156852571|NCT05907395|566213891|FG004|Period 2|Adverse Event|0|||
156852572|NCT05907395|566213892|FG005|Period 2|Adverse Event|0|||
156852573|NCT05907395|566213893|FG006|Period 2|Adverse Event|0|||
156852574|NCT05907395|566213894|FG007|Period 2|Adverse Event|1|||
156852575|NCT05907395|566213895|FG008|Period 2|Adverse Event|0|||
156852576|NCT05907395|566213896|FG009|Period 2|Adverse Event|0|||
156852577|NCT05907395|566213897|FG010|Period 2|Adverse Event|0|||
156852578|NCT05907395|566213898|FG011|Period 2|Adverse Event|0|||
156852579|NCT05907395|566213887|FG000|Period 2|Personal reason|0|||
156852580|NCT05907395|566213888|FG001|Period 2|Personal reason|0|||
156852581|NCT05907395|566213889|FG002|Period 2|Personal reason|0|||
156852582|NCT05907395|566213890|FG003|Period 2|Personal reason|0|||
156852583|NCT05907395|566213891|FG004|Period 2|Personal reason|0|||
156852584|NCT05907395|566213892|FG005|Period 2|Personal reason|0|||
156852585|NCT05907395|566213893|FG006|Period 2|Personal reason|0|||
156852586|NCT05907395|566213894|FG007|Period 2|Personal reason|0|||
156852587|NCT05907395|566213895|FG008|Period 2|Personal reason|0|||
156852588|NCT05907395|566213896|FG009|Period 2|Personal reason|1|||
156852589|NCT05907395|566213897|FG010|Period 2|Personal reason|0|||
156852590|NCT05907395|566213898|FG011|Period 2|Personal reason|0|||
156852591|NCT05907395|566213887|FG000|Period 3|Adverse Event|0|||
156852592|NCT05907395|566213888|FG001|Period 3|Adverse Event|0|||
156852593|NCT05907395|566213889|FG002|Period 3|Adverse Event|0|||
156852594|NCT05907395|566213890|FG003|Period 3|Adverse Event|0|||
156852595|NCT05907395|566213891|FG004|Period 3|Adverse Event|1|||
156852596|NCT05907395|566213892|FG005|Period 3|Adverse Event|0|||
156852597|NCT05907395|566213893|FG006|Period 3|Adverse Event|0|||
156852598|NCT05907395|566213894|FG007|Period 3|Adverse Event|0|||
156852599|NCT05907395|566213895|FG008|Period 3|Adverse Event|0|||
156852600|NCT05907395|566213896|FG009|Period 3|Adverse Event|0|||
156852601|NCT05907395|566213897|FG010|Period 3|Adverse Event|0|||
156852602|NCT05907395|566213898|FG011|Period 3|Adverse Event|0|||
156852603|NCT00992459|566213905|FG000|Overall Study|Withdrawal by Subject|0|||
156852604|NCT00992459|566213906|FG001|Overall Study|Withdrawal by Subject|1|||
156852605|NCT00992459|566213905|FG000|Overall Study|Adverse Event|1|||
156852606|NCT00992459|566213906|FG001|Overall Study|Adverse Event|0|||
156852607|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Adverse Event|0|||
156852608|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Adverse Event|1|||
156852609|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Adverse Event|0|||
156852610|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Adverse Event|0|||
156852611|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Adverse Event|0|||
156852612|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Adverse Event|0|||
156852613|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Adverse Event|0|||
156852614|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Adverse Event|1|||
156852615|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Adverse Event|1|||
156852616|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Adverse Event|0|||
156852617|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Adverse Event|0|||
156852618|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Physician Decision|0|||
156852619|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Physician Decision|0|||
156852620|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Physician Decision|1|||
156852621|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Physician Decision|0|||
156852622|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Physician Decision|0|||
156852623|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Physician Decision|0|||
156852624|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Physician Decision|0|||
156852625|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Physician Decision|1|||
156852626|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Physician Decision|0|||
156852627|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Physician Decision|0|||
156852628|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Physician Decision|0|||
156852629|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852630|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
156852631|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
156852632|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852633|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852634|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
156852635|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
156852636|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
156889283|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
156889284|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
156889285|NCT00274924|566354167|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
156889286|NCT00274924|566354168|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
156889287|NCT00274924|566354169|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
156889288|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
156889289|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
156889290|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
156852637|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
156852638|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
156852639|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
156852640|NCT00543387|566213911|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852641|NCT00543387|566213912|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852642|NCT00543387|566213913|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852643|NCT00543387|566213914|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852644|NCT00543387|566213915|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852645|NCT00543387|566213916|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852646|NCT00543387|566213917|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
156889291|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
156852647|NCT00543387|566213918|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852648|NCT00543387|566213919|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852649|NCT00543387|566213920|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852650|NCT00543387|566213921|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
156852651|NCT00543387|566213911|FG000|Crossover Participants|Progressive Disease|0|||
156852652|NCT00543387|566213912|FG001|Crossover Participants|Progressive Disease|0|||
156852653|NCT00543387|566213913|FG002|Crossover Participants|Progressive Disease|0|||
156852654|NCT00543387|566213914|FG003|Crossover Participants|Progressive Disease|0|||
156852655|NCT00543387|566213915|FG004|Crossover Participants|Progressive Disease|0|||
156852656|NCT00543387|566213916|FG005|Crossover Participants|Progressive Disease|0|||
156852657|NCT00543387|566213917|FG006|Crossover Participants|Progressive Disease|0|||
156852658|NCT00543387|566213918|FG007|Crossover Participants|Progressive Disease|0|||
156852659|NCT00543387|566213919|FG008|Crossover Participants|Progressive Disease|0|||
156852660|NCT00543387|566213920|FG009|Crossover Participants|Progressive Disease|1|||
156852661|NCT00543387|566213921|FG010|Crossover Participants|Progressive Disease|2|||
156852662|NCT00543387|566213911|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
156852663|NCT00543387|566213912|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
156852664|NCT00543387|566213913|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
156852665|NCT00543387|566213914|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
156852666|NCT00543387|566213915|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
156852667|NCT00543387|566213916|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
156852668|NCT00543387|566213917|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
156852669|NCT00543387|566213918|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
156889292|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
156889293|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
156889294|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
156889295|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
156889296|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
156889297|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
156889298|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
156889299|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
156889300|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
156889301|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
156889302|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
156889303|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
156889304|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
156889305|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
156889306|NCT00274924|566354167|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
156889307|NCT00274924|566354168|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
156889308|NCT00274924|566354169|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
156889309|NCT01055496|566354170|FG000|Overall Study|Withdrawal by Subject|2|||
156889310|NCT01055496|566354171|FG001|Overall Study|Withdrawal by Subject|4|||
156889311|NCT01055496|566354170|FG000|Overall Study|Death|13|||
156889312|NCT01055496|566354171|FG001|Overall Study|Death|23|||
156889313|NCT01055496|566354170|FG000|Overall Study|Lost to Follow-up|0|||
156889314|NCT01055496|566354171|FG001|Overall Study|Lost to Follow-up|2|||
156889315|NCT01055496|566354170|FG000|Overall Study|Other - Unspecified|0|||
156889316|NCT01055496|566354171|FG001|Overall Study|Other - Unspecified|1|||
156889317|NCT02915874|566354175|FG000|Overall Study|Lost to Follow-up|5|||
156889318|NCT02915874|566354176|FG001|Overall Study|Lost to Follow-up|4|||
156889319|NCT02915874|566354175|FG000|Overall Study|Withdrawal by Subject|1|||
156889320|NCT02915874|566354176|FG001|Overall Study|Withdrawal by Subject|1|||
156889321|NCT02915874|566354175|FG000|Overall Study|Started New Anxiety Medication|0|||
156889322|NCT02915874|566354176|FG001|Overall Study|Started New Anxiety Medication|1|||
156889323|NCT03562767|566354180|FG000|Overall Study|Physician Decision|2|||
156889324|NCT03562767|566354181|FG001|Overall Study|Physician Decision|0|||
156889325|NCT03562767|566354182|FG002|Overall Study|Physician Decision|0|||
156889326|NCT03562767|566354180|FG000|Overall Study|Logistic Reason|1|||
157025755|NCT03241745|566849597|FG000|Overall Study|Lack of Efficacy|14|||
157025756|NCT04802967|566849599|FG000|Part B|Withdrawal by Subject|0|||
156852670|NCT00543387|566213919|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
156852671|NCT00543387|566213920|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
156852672|NCT00543387|566213921|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
156852673|NCT00549445|566213922|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
156889327|NCT03562767|566354181|FG001|Overall Study|Logistic Reason|3|||
156889328|NCT03562767|566354182|FG002|Overall Study|Logistic Reason|0|||
156889329|NCT01589770|566354185|FG000|Overall Study|EGFR <60ml/min|6|||
156889330|NCT01589770|566354186|FG001|Overall Study|EGFR <60ml/min|4|||
156889331|NCT01589770|566354185|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
156889332|NCT01589770|566354186|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
156889333|NCT00938886|566354189|FG000|Overall Study|Death|0|||
156852674|NCT00549445|566213923|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
156852675|NCT03932760|566213926|FG000|Overall Study|Became Ineligible|2|||
156852676|NCT03932760|566213927|FG001|Overall Study|Became Ineligible|5|||
156852677|NCT03932760|566213926|FG000|Overall Study|Withdrawal by Subject|6|||
156852678|NCT03932760|566213927|FG001|Overall Study|Withdrawal by Subject|6|||
156852679|NCT01223183|566213931|FG000|Imaging Day 1|Physician Decision|0|||
156852680|NCT01223183|566213932|FG001|Imaging Day 1|Physician Decision|1|||
156852681|NCT01223183|566213931|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
156852682|NCT01223183|566213932|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
156852683|NCT01223183|566213931|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
156852684|NCT01223183|566213932|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
156852685|NCT03772665|566213934|FG000|Overall Study|Protocol Violation|1|||
156852686|NCT03772665|566213935|FG001|Overall Study|Protocol Violation|0|||
156852687|NCT03553758|566215279|FG000|Overall Study|Lost to Follow-up|1|||
156852688|NCT01467505|566215283|FG000|Overall Study|Adverse Event|1|||
156852689|NCT01467505|566215284|FG001|Overall Study|Adverse Event|0|||
156889334|NCT00938886|566354190|FG001|Overall Study|Death|1|||
156889335|NCT00938886|566354189|FG000|Overall Study|Withdrawal by Subject|4|||
156889336|NCT00938886|566354190|FG001|Overall Study|Withdrawal by Subject|7|||
156889337|NCT00938886|566354189|FG000|Overall Study|Lost to Follow-up|3|||
156889338|NCT00938886|566354190|FG001|Overall Study|Lost to Follow-up|2|||
156889339|NCT02518464|566354191|FG000|Overall Study|Adverse Event|2|||
156889340|NCT01120067|566354194|FG000|Overall Study|Lost to Follow-up|3|||
156889341|NCT01120067|566354195|FG001|Overall Study|Lost to Follow-up|1|||
156889342|NCT01120067|566354194|FG000|Overall Study|fail to engage >3 sessions|2|||
156889343|NCT01120067|566354195|FG001|Overall Study|fail to engage >3 sessions|0|||
156889344|NCT00821327|566354196|FG000|Overall Study|Adverse Event|13|||
156889345|NCT00821327|566354196|FG000|Overall Study|Patient Request|1|||
156889346|NCT00821327|566354196|FG000|Overall Study|Investigator Request|2|||
156889347|NCT00821327|566354196|FG000|Overall Study|Sponsor Request|1|||
156889348|NCT00821327|566354196|FG000|Overall Study|Disease Progression|13|||
156889349|NCT00821327|566354196|FG000|Overall Study|Other/Unknown|5|||
156889350|NCT00527488|566354197|FG000|Overall Study|Withdrawn prior to dosing|0|||
156889351|NCT00527488|566354198|FG001|Overall Study|Withdrawn prior to dosing|1|||
156889352|NCT00527488|566354199|FG002|Overall Study|Withdrawn prior to dosing|1|||
156889353|NCT00527488|566354200|FG003|Overall Study|Withdrawn prior to dosing|0|||
156889354|NCT03036800|566354201|FG000|Overall Study|Protocol Violation|1|||
156889355|NCT03036800|566354202|FG001|Overall Study|Protocol Violation|0|||
156889356|NCT03036800|566354201|FG000|Overall Study|Non-compliance|1|||
156889357|NCT03036800|566354202|FG001|Overall Study|Non-compliance|0|||
156889358|NCT03036800|566354201|FG000|Overall Study|Lost to Follow-up|1|||
156889359|NCT03036800|566354202|FG001|Overall Study|Lost to Follow-up|0|||
156889360|NCT03036800|566354201|FG000|Overall Study|Death|1|||
156889361|NCT03036800|566354202|FG001|Overall Study|Death|0|||
156889362|NCT03036800|566354201|FG000|Overall Study|Tolerance|5|||
156889363|NCT03036800|566354202|FG001|Overall Study|Tolerance|0|||
156889364|NCT03036800|566354201|FG000|Overall Study|Unknown/no reason given|50|||
156889365|NCT03036800|566354202|FG001|Overall Study|Unknown/no reason given|39|||
156889366|NCT04030026|566354203|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
156889367|NCT04030026|566354204|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
156889368|NCT04030026|566354203|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
156889369|NCT04030026|566354204|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
156889370|NCT04030026|566354203|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
156889371|NCT04030026|566354204|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
156889372|NCT04030026|566354203|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
156889373|NCT04030026|566354204|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
156889374|NCT04030026|566354203|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
156889375|NCT04030026|566354204|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
156889376|NCT04030026|566354203|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
156889377|NCT04030026|566354204|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
156889378|NCT04030026|566354203|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
156852690|NCT01467505|566215283|FG000|Overall Study|Withdrawal by Subject|4|||
156852691|NCT01467505|566215284|FG001|Overall Study|Withdrawal by Subject|0|||
156852692|NCT01467505|566215283|FG000|Overall Study|Study Terminated by Sponsor|28|||
156852693|NCT01467505|566215284|FG001|Overall Study|Study Terminated by Sponsor|3|||
156852694|NCT02719171|566215285|FG000|Overall Study|Adverse Event|1|||
156889379|NCT04030026|566354204|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
156889380|NCT02207946|566354205|FG000|Overall Study|Lost to Follow-up|1|||
156889381|NCT02207946|566354206|FG001|Overall Study|Lost to Follow-up|0|||
156889382|NCT02207946|566354205|FG000|Overall Study|Adverse Event|0|||
156889383|NCT02207946|566354206|FG001|Overall Study|Adverse Event|1|||
156889384|NCT02545543|566354207|FG000|Overall Study|Lost to Follow-up|67|||
156889385|NCT02545543|566354208|FG001|Overall Study|Lost to Follow-up|25|||
156889386|NCT02545543|566354207|FG000|Overall Study|Physician Decision|3|||
156889387|NCT02545543|566354208|FG001|Overall Study|Physician Decision|0|||
156889388|NCT02545543|566354207|FG000|Overall Study|Withdrawal by Subject|9|||
156852695|NCT02719171|566215286|FG001|Overall Study|Adverse Event|2|||
156852696|NCT02719171|566215287|FG002|Overall Study|Adverse Event|0|||
156852697|NCT02719171|566215288|FG003|Overall Study|Adverse Event|0|||
156852698|NCT02719171|566215289|FG004|Overall Study|Adverse Event|2|||
156852699|NCT02719171|566215285|FG000|Overall Study|Lost to Follow-up|0|||
156852700|NCT02719171|566215286|FG001|Overall Study|Lost to Follow-up|0|||
156852701|NCT02719171|566215287|FG002|Overall Study|Lost to Follow-up|1|||
156852702|NCT02719171|566215288|FG003|Overall Study|Lost to Follow-up|0|||
156852703|NCT02719171|566215289|FG004|Overall Study|Lost to Follow-up|0|||
156852704|NCT02719171|566215285|FG000|Overall Study|Subject Withdrawal|0|||
156852705|NCT02719171|566215286|FG001|Overall Study|Subject Withdrawal|2|||
156852706|NCT02719171|566215287|FG002|Overall Study|Subject Withdrawal|2|||
156852707|NCT02719171|566215288|FG003|Overall Study|Subject Withdrawal|1|||
156852708|NCT02719171|566215289|FG004|Overall Study|Subject Withdrawal|0|||
156852709|NCT02719171|566215285|FG000|Overall Study|Other|0|||
156852710|NCT02719171|566215286|FG001|Overall Study|Other|0|||
156852711|NCT02719171|566215287|FG002|Overall Study|Other|0|||
156852712|NCT02719171|566215288|FG003|Overall Study|Other|1|||
156852713|NCT02719171|566215289|FG004|Overall Study|Other|0|||
156852714|NCT02807623|566215290|FG000|Overall Study|Lost to Follow-up|23|||
156852715|NCT02807623|566215291|FG001|Overall Study|Lost to Follow-up|18|||
156852716|NCT02807623|566215292|FG002|Overall Study|Lost to Follow-up|22|||
156852717|NCT02807623|566215290|FG000|Overall Study|Drug intolerance|0|||
156852718|NCT02807623|566215291|FG001|Overall Study|Drug intolerance|1|||
156852719|NCT02807623|566215292|FG002|Overall Study|Drug intolerance|0|||
156852720|NCT02807623|566215290|FG000|Overall Study|incomplete blood draw|0|||
156852721|NCT02807623|566215291|FG001|Overall Study|incomplete blood draw|2|||
156852722|NCT02807623|566215292|FG002|Overall Study|incomplete blood draw|1|||
156852723|NCT02614729|566215293|FG000|Overall Study|Withdrawal by Subject|1|||
156852724|NCT02614729|566215294|FG001|Overall Study|Withdrawal by Subject|0|||
156852725|NCT00227721|566215295|FG000|Overall Study|On study, but never treated.|1|||
156852726|NCT02219464|566215308|FG000|Overall Study|Withdrawal by Subject|1|||
156852727|NCT02219464|566215309|FG001|Overall Study|Withdrawal by Subject|0|||
156852728|NCT02219464|566215308|FG000|Overall Study|case cancelled|1|||
156852729|NCT02219464|566215309|FG001|Overall Study|case cancelled|0|||
156852730|NCT02219464|566215308|FG000|Overall Study|catheter malfunction|1|||
156852731|NCT02219464|566215309|FG001|Overall Study|catheter malfunction|0|||
156852732|NCT01380769|566215312|FG000|Overall Study|Withdrawal by Subject|7|||
156852733|NCT01380769|566215313|FG001|Overall Study|Withdrawal by Subject|11|||
156852734|NCT01380769|566215312|FG000|Overall Study|Physician Decision|1|||
156852735|NCT01380769|566215313|FG001|Overall Study|Physician Decision|1|||
156852736|NCT01380769|566215312|FG000|Overall Study|Adverse Event|1|||
156852737|NCT01380769|566215313|FG001|Overall Study|Adverse Event|1|||
156852738|NCT01380769|566215312|FG000|Overall Study|Protocol Violation|0|||
156852739|NCT01380769|566215313|FG001|Overall Study|Protocol Violation|1|||
156852740|NCT03922581|566215317|FG000|Overall Study|Lost to Follow-up|20|||
156852741|NCT03922581|566215318|FG001|Overall Study|Lost to Follow-up|9|||
156852742|NCT03922581|566215317|FG000|Overall Study|Physician Decision|1|||
156852743|NCT03922581|566215318|FG001|Overall Study|Physician Decision|1|||
156852744|NCT03922581|566215317|FG000|Overall Study|Withdrawal by Subject|1|||
156852745|NCT03922581|566215318|FG001|Overall Study|Withdrawal by Subject|0|||
156852746|NCT00764699|566215321|FG000|Overall Study|PI left and study terminated|3|||
156852747|NCT01508312|566215327|FG000|Overall Study|Lost to Follow-up|1|||
156852748|NCT01508312|566215328|FG001|Overall Study|Lost to Follow-up|0|||
156889389|NCT02545543|566354208|FG001|Overall Study|Withdrawal by Subject|8|||
156889390|NCT02545543|566354207|FG000|Overall Study|Noncomplaince|1|||
156889391|NCT02545543|566354208|FG001|Overall Study|Noncomplaince|0|||
156889392|NCT02545543|566354207|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
157157504|NCT01533935|567321159|FG004|Overall Study|Adverse Event|3|||
157157505|NCT01533935|567321155|FG000|Overall Study|Protocol Violation|0|||
157157506|NCT01533935|567321156|FG001|Overall Study|Protocol Violation|2|||
157157507|NCT01533935|567321157|FG002|Overall Study|Protocol Violation|0|||
157157508|NCT01533935|567321158|FG003|Overall Study|Protocol Violation|0|||
156852749|NCT01508312|566215329|FG002|Overall Study|Lost to Follow-up|0|||
156852750|NCT01508312|566215330|FG003|Overall Study|Lost to Follow-up|0|||
156852751|NCT01508312|566215327|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852752|NCT01508312|566215328|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
156852753|NCT01508312|566215329|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852754|NCT01508312|566215330|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
156852755|NCT01508312|566215327|FG000|Overall Study|Adverse Event|0|||
156852756|NCT01508312|566215328|FG001|Overall Study|Adverse Event|0|||
156852757|NCT01508312|566215329|FG002|Overall Study|Adverse Event|2|||
156852758|NCT01508312|566215330|FG003|Overall Study|Adverse Event|0|||
156852759|NCT01508312|566215327|FG000|Overall Study|Lack of Efficacy|0|||
156852760|NCT01508312|566215328|FG001|Overall Study|Lack of Efficacy|0|||
156852761|NCT01508312|566215329|FG002|Overall Study|Lack of Efficacy|1|||
156889393|NCT02545543|566354208|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
156852762|NCT01508312|566215330|FG003|Overall Study|Lack of Efficacy|0|||
156852763|NCT01508312|566215327|FG000|Overall Study|Withdrawal by Subject|0|||
156852764|NCT01508312|566215328|FG001|Overall Study|Withdrawal by Subject|0|||
156852765|NCT01508312|566215329|FG002|Overall Study|Withdrawal by Subject|1|||
156852766|NCT01508312|566215330|FG003|Overall Study|Withdrawal by Subject|0|||
156852767|NCT02223715|566215331|FG000|Overall Study|Death|31|||
156852768|NCT02223715|566215331|FG000|Overall Study|Lost to Follow-up|73|||
156852769|NCT02222558|566215332|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
156852770|NCT02222558|566215333|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
156852771|NCT02222558|566215334|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
156852772|NCT02222558|566215335|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
156852773|NCT02222558|566215336|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
156852774|NCT02222558|566215337|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
156852775|NCT02222558|566215332|FG000|Period 3|Withdrawal by Subject|0|||
156852776|NCT02222558|566215333|FG001|Period 3|Withdrawal by Subject|0|||
156852777|NCT02222558|566215334|FG002|Period 3|Withdrawal by Subject|0|||
156852778|NCT02222558|566215335|FG003|Period 3|Withdrawal by Subject|0|||
156852779|NCT02222558|566215336|FG004|Period 3|Withdrawal by Subject|0|||
156852780|NCT02222558|566215337|FG005|Period 3|Withdrawal by Subject|1|||
156852781|NCT01745367|566215338|FG000|Overall Study|Death|1|||
156852782|NCT01745367|566215339|FG001|Overall Study|Death|0|||
156852783|NCT01745367|566215338|FG000|Overall Study|Withdrawal by Subject|1|||
156852784|NCT01745367|566215339|FG001|Overall Study|Withdrawal by Subject|2|||
156852785|NCT01745367|566215338|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
156852786|NCT01745367|566215339|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
156852787|NCT01745367|566215338|FG000|Overall Study|Other Reasons Unspecified|0|||
156889394|NCT00811642|566354209|FG000|Overall Study|Adverse Event|3|||
156889395|NCT00811642|566354209|FG000|Overall Study|Protocol Violation|1|||
156889396|NCT00811642|566354209|FG000|Overall Study|Death|2|||
156889397|NCT00811642|566354209|FG000|Overall Study|Withdrawal by Subject|7|||
156889398|NCT00811642|566354209|FG000|Overall Study|Cumulative use of antifungal agent|2|||
156889399|NCT02829944|566354217|FG000|Overall Study|Physician Decision|0|||
156889400|NCT02829944|566354218|FG001|Overall Study|Physician Decision|1|||
156889401|NCT02829944|566354217|FG000|Overall Study|Screen Failure|2|||
156889402|NCT02829944|566354218|FG001|Overall Study|Screen Failure|2|||
156889403|NCT02829944|566354217|FG000|Overall Study|Inadequate Neuraxial Block|1|||
156889404|NCT02829944|566354218|FG001|Overall Study|Inadequate Neuraxial Block|1|||
156889405|NCT02829944|566354217|FG000|Overall Study|Withdrawal by Subject|2|||
156889406|NCT02829944|566354218|FG001|Overall Study|Withdrawal by Subject|1|||
156852788|NCT01745367|566215339|FG001|Overall Study|Other Reasons Unspecified|2|||
156852789|NCT02322281|566215342|FG000|Overall Study|Progressive Disease|42|||
156852790|NCT02322281|566215343|FG001|Overall Study|Progressive Disease|14|||
156852791|NCT02322281|566215344|FG002|Overall Study|Progressive Disease|49|||
156852792|NCT02322281|566215342|FG000|Overall Study|Adverse Event|3|||
156852793|NCT02322281|566215343|FG001|Overall Study|Adverse Event|4|||
156852794|NCT02322281|566215344|FG002|Overall Study|Adverse Event|6|||
156852795|NCT02322281|566215342|FG000|Overall Study|Death|3|||
156852796|NCT02322281|566215343|FG001|Overall Study|Death|3|||
156852797|NCT02322281|566215344|FG002|Overall Study|Death|3|||
156889407|NCT02829944|566354217|FG000|Overall Study|Catheter Displacement|1|||
156889408|NCT02829944|566354218|FG001|Overall Study|Catheter Displacement|0|||
156889409|NCT02829944|566354217|FG000|Overall Study|Catheter broke|0|||
156889410|NCT02829944|566354218|FG001|Overall Study|Catheter broke|1|||
156889411|NCT02829944|566354217|FG000|Overall Study|Staff unavailable|0|||
156889412|NCT02829944|566354218|FG001|Overall Study|Staff unavailable|1|||
156889413|NCT04675151|566354222|FG000|Overall Study|Protocol Violation|1|||
156889414|NCT04675151|566354223|FG001|Overall Study|Protocol Violation|0|||
156889415|NCT04675151|566354224|FG002|Overall Study|Protocol Violation|0|||
156889416|NCT04675151|566354225|FG003|Overall Study|Protocol Violation|1|||
156889417|NCT01730937|566354226|FG000|Overall Study|Protocol Violation|5|||
157025757|NCT04802967|566849600|FG001|Part B|Withdrawal by Subject|0|||
157025758|NCT04802967|566849601|FG002|Part B|Withdrawal by Subject|0|||
157025759|NCT04802967|566849602|FG003|Part B|Withdrawal by Subject|0|||
157025760|NCT04802967|566849603|FG004|Part B|Withdrawal by Subject|0|||
156852798|NCT02322281|566215342|FG000|Overall Study|Withdrawal by Subject|1|||
156852799|NCT02322281|566215343|FG001|Overall Study|Withdrawal by Subject|1|||
156852800|NCT02322281|566215344|FG002|Overall Study|Withdrawal by Subject|6|||
156852801|NCT02322281|566215342|FG000|Overall Study|Physician Decision|2|||
156852802|NCT02322281|566215343|FG001|Overall Study|Physician Decision|0|||
156852803|NCT02322281|566215344|FG002|Overall Study|Physician Decision|5|||
156852804|NCT02322281|566215342|FG000|Overall Study|Study Terminated by Sponsor|2|||
156852805|NCT02322281|566215343|FG001|Overall Study|Study Terminated by Sponsor|0|||
156852806|NCT02322281|566215344|FG002|Overall Study|Study Terminated by Sponsor|0|||
156889418|NCT01730937|566354227|FG001|Overall Study|Protocol Violation|11|||
156889419|NCT03947684|566354228|FG000|Overall Study|Lost to Follow-up|13|||
156889420|NCT03947684|566354229|FG001|Overall Study|Lost to Follow-up|5|||
156889421|NCT03947684|566354230|FG002|Overall Study|Lost to Follow-up|1|||
156889422|NCT03947684|566354228|FG000|Overall Study|Withdrawal by Subject|11|||
156852807|NCT02322281|566215342|FG000|Overall Study|Missing|0|||
156852808|NCT02322281|566215343|FG001|Overall Study|Missing|0|||
156852809|NCT02322281|566215344|FG002|Overall Study|Missing|1|||
156852810|NCT02322281|566215342|FG000|Overall Study|Miscellaneous|0|||
156852811|NCT02322281|566215343|FG001|Overall Study|Miscellaneous|0|||
156852812|NCT02322281|566215344|FG002|Overall Study|Miscellaneous|4|||
156852813|NCT02107703|566215345|FG000|Overall Study|Withdrawal by Subject|46|||
156852814|NCT02107703|566215346|FG001|Overall Study|Withdrawal by Subject|21|||
156852815|NCT02107703|566215345|FG000|Overall Study|Lost to Follow-up|20|||
156852816|NCT02107703|566215346|FG001|Overall Study|Lost to Follow-up|9|||
156852817|NCT02107703|566215345|FG000|Overall Study|On study treatment/follow up|48|||
156852818|NCT02107703|566215346|FG001|Overall Study|On study treatment/follow up|5|||
156852819|NCT02366312|566215347|FG000|Overall Study|Lost to Follow-up|0|||
156852820|NCT02366312|566215348|FG001|Overall Study|Lost to Follow-up|1|||
156852821|NCT00965081|566215349|FG000|Overall Study|Adverse Event|14|||
156852822|NCT00965081|566215350|FG001|Overall Study|Adverse Event|9|||
156852823|NCT00965081|566215349|FG000|Overall Study|Lack of Efficacy|2|||
156852824|NCT00965081|566215350|FG001|Overall Study|Lack of Efficacy|5|||
156852825|NCT00965081|566215349|FG000|Overall Study|Lost to Follow-up|4|||
156852826|NCT00965081|566215350|FG001|Overall Study|Lost to Follow-up|5|||
156852827|NCT00965081|566215349|FG000|Overall Study|Physician Decision|2|||
156852828|NCT00965081|566215350|FG001|Overall Study|Physician Decision|0|||
156852829|NCT00965081|566215349|FG000|Overall Study|Protocol Violation|2|||
156852830|NCT00965081|566215350|FG001|Overall Study|Protocol Violation|5|||
156852831|NCT00965081|566215349|FG000|Overall Study|Sponsor Decision|1|||
156852832|NCT00965081|566215350|FG001|Overall Study|Sponsor Decision|0|||
156852833|NCT00965081|566215349|FG000|Overall Study|Withdrawal by Subject|4|||
156852834|NCT00965081|566215350|FG001|Overall Study|Withdrawal by Subject|7|||
156852835|NCT00965081|566215349|FG000|Overall Study|Switched to Rescue Arm|5|||
156852836|NCT00965081|566215350|FG001|Overall Study|Switched to Rescue Arm|12|||
156852837|NCT03901144|566215356|FG000|Overall Study|Lost to Follow-up|1|||
156852838|NCT03901144|566215357|FG001|Overall Study|Lost to Follow-up|1|||
156852839|NCT03901144|566215358|FG002|Overall Study|Lost to Follow-up|1|||
156852840|NCT03901144|566215359|FG003|Overall Study|Lost to Follow-up|1|||
156852841|NCT02021565|566215360|FG000|Baseline Through Intervention|Death|0|||
156852842|NCT02021565|566215361|FG001|Baseline Through Intervention|Death|1|||
156852843|NCT02021565|566215360|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
156852844|NCT02021565|566215361|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
156852845|NCT02021565|566215360|FG000|Baseline Through Intervention|Protocol Violation|0|||
156852846|NCT02021565|566215361|FG001|Baseline Through Intervention|Protocol Violation|7|||
156852847|NCT02021565|566215360|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
156852848|NCT02021565|566215361|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
156852849|NCT02021565|566215360|FG000|3-month Follow-up|Death|3|||
156852850|NCT02021565|566215361|FG001|3-month Follow-up|Death|0|||
156852851|NCT02021565|566215360|FG000|3-month Follow-up|Withdrawal by Subject|4|||
156852852|NCT02021565|566215361|FG001|3-month Follow-up|Withdrawal by Subject|0|||
156852853|NCT02021565|566215360|FG000|3-month Follow-up|Protocol Violation|3|||
156852854|NCT02021565|566215361|FG001|3-month Follow-up|Protocol Violation|2|||
156852855|NCT05114473|566215364|FG000|Overall Study|Lost to Follow-up|2|||
156852856|NCT05114473|566215365|FG001|Overall Study|Lost to Follow-up|2|||
156852857|NCT05114473|566215366|FG002|Overall Study|Lost to Follow-up|0|||
156852858|NCT00279916|566215370|FG000|Overall Study|Withdrawal by Subject|4|||
156852859|NCT00279916|566215371|FG001|Overall Study|Withdrawal by Subject|3|||
156852860|NCT00279916|566215370|FG000|Overall Study|Lost to Follow-up|3|||
156852861|NCT00279916|566215371|FG001|Overall Study|Lost to Follow-up|2|||
156852862|NCT00731679|566215373|FG000|Overall Study|Adverse Event|7|||
156852863|NCT00731679|566215374|FG001|Overall Study|Adverse Event|8|||
156852864|NCT00731679|566215373|FG000|Overall Study|Withdrawal by Subject|8|||
156852865|NCT00731679|566215374|FG001|Overall Study|Withdrawal by Subject|8|||
156852866|NCT00731679|566215373|FG000|Overall Study|Lost to Follow-up|7|||
156852867|NCT00731679|566215374|FG001|Overall Study|Lost to Follow-up|8|||
156852868|NCT00731679|566215373|FG000|Overall Study|Noncompliance|0|||
156852869|NCT00731679|566215374|FG001|Overall Study|Noncompliance|1|||
156852870|NCT00731679|566215373|FG000|Overall Study|Pregnancy|0|||
156852871|NCT00731679|566215374|FG001|Overall Study|Pregnancy|1|||
156852872|NCT03384940|566215377|FG000|Overall Study|Progressive disease|36|||
156852873|NCT03384940|566215378|FG001|Overall Study|Progressive disease|11|||
156852874|NCT03384940|566215379|FG002|Overall Study|Progressive disease|13|||
156852875|NCT03384940|566215377|FG000|Overall Study|Clinical progression|4|||
157025761|NCT04802967|566849604|FG005|Part B|Withdrawal by Subject|1|||
156852876|NCT03384940|566215378|FG001|Overall Study|Clinical progression|0|||
156852877|NCT03384940|566215379|FG002|Overall Study|Clinical progression|3|||
156852878|NCT03384940|566215377|FG000|Overall Study|Adverse Event|7|||
156852879|NCT03384940|566215378|FG001|Overall Study|Adverse Event|1|||
156852880|NCT03384940|566215379|FG002|Overall Study|Adverse Event|1|||
156852881|NCT03384940|566215377|FG000|Overall Study|Withdrawal by Subject|3|||
156852882|NCT03384940|566215378|FG001|Overall Study|Withdrawal by Subject|1|||
156852883|NCT03384940|566215379|FG002|Overall Study|Withdrawal by Subject|0|||
156852884|NCT03384940|566215377|FG000|Overall Study|Physician Decision|1|||
156852885|NCT03384940|566215378|FG001|Overall Study|Physician Decision|1|||
156852886|NCT03384940|566215379|FG002|Overall Study|Physician Decision|0|||
156889423|NCT03947684|566354229|FG001|Overall Study|Withdrawal by Subject|4|||
156889424|NCT03947684|566354230|FG002|Overall Study|Withdrawal by Subject|0|||
156889425|NCT03947684|566354228|FG000|Overall Study|Physician Decision|1|||
156889426|NCT03947684|566354229|FG001|Overall Study|Physician Decision|0|||
156852887|NCT03384940|566215377|FG000|Overall Study|Death|2|||
156852888|NCT03384940|566215378|FG001|Overall Study|Death|1|||
156852889|NCT03384940|566215379|FG002|Overall Study|Death|0|||
156852890|NCT03384940|566215377|FG000|Overall Study|Other|0|||
156852891|NCT03384940|566215378|FG001|Overall Study|Other|0|||
156852892|NCT03384940|566215379|FG002|Overall Study|Other|1|||
156852893|NCT03089580|566215385|FG000|Overall Study|Lost to Follow-up|2|||
156852894|NCT03087513|566215386|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
156852895|NCT04628780|566215387|FG000|Overall Study|Death|0|||
156852896|NCT04628780|566215388|FG001|Overall Study|Death|1|||
156852897|NCT04628780|566215389|FG002|Overall Study|Death|0|||
156852898|NCT04628780|566215390|FG003|Overall Study|Death|0|||
156852899|NCT04628780|566215391|FG004|Overall Study|Death|1|||
156852900|NCT04628780|566215392|FG005|Overall Study|Death|0|||
156852901|NCT04628780|566215387|FG000|Overall Study|Physician Decision|2|||
156852902|NCT04628780|566215388|FG001|Overall Study|Physician Decision|0|||
156852903|NCT04628780|566215389|FG002|Overall Study|Physician Decision|0|||
156852904|NCT04628780|566215390|FG003|Overall Study|Physician Decision|0|||
156852905|NCT04628780|566215391|FG004|Overall Study|Physician Decision|2|||
156852906|NCT04628780|566215392|FG005|Overall Study|Physician Decision|0|||
156852907|NCT04628780|566215387|FG000|Overall Study|Progressive disease|2|||
156852908|NCT04628780|566215388|FG001|Overall Study|Progressive disease|2|||
156852909|NCT04628780|566215389|FG002|Overall Study|Progressive disease|2|||
156852910|NCT04628780|566215390|FG003|Overall Study|Progressive disease|3|||
156852911|NCT04628780|566215391|FG004|Overall Study|Progressive disease|9|||
156852912|NCT04628780|566215392|FG005|Overall Study|Progressive disease|4|||
156852913|NCT04628780|566215387|FG000|Overall Study|Withdrawal by Subject|0|||
156852914|NCT04628780|566215388|FG001|Overall Study|Withdrawal by Subject|1|||
156852915|NCT04628780|566215389|FG002|Overall Study|Withdrawal by Subject|2|||
156852916|NCT04628780|566215390|FG003|Overall Study|Withdrawal by Subject|0|||
156852917|NCT04628780|566215391|FG004|Overall Study|Withdrawal by Subject|3|||
156852918|NCT04628780|566215392|FG005|Overall Study|Withdrawal by Subject|1|||
156852919|NCT04628780|566215387|FG000|Overall Study|Global deterioration of health status|0|||
156852920|NCT04628780|566215388|FG001|Overall Study|Global deterioration of health status|0|||
156852921|NCT04628780|566215389|FG002|Overall Study|Global deterioration of health status|0|||
156852922|NCT04628780|566215390|FG003|Overall Study|Global deterioration of health status|0|||
156852923|NCT04628780|566215391|FG004|Overall Study|Global deterioration of health status|1|||
156852924|NCT04628780|566215392|FG005|Overall Study|Global deterioration of health status|1|||
156852925|NCT03269994|566215393|FG000|Overall Study|Withdrawal by Subject|4|||
156852926|NCT03269994|566215394|FG001|Overall Study|Withdrawal by Subject|5|||
156852927|NCT03269994|566215393|FG000|Overall Study|Unresectable at surgery|39|||
156852928|NCT03269994|566215394|FG001|Overall Study|Unresectable at surgery|58|||
156852929|NCT03269994|566215393|FG000|Overall Study|Patient canceled surgery|5|||
156852930|NCT03269994|566215394|FG001|Overall Study|Patient canceled surgery|14|||
156852931|NCT03269994|566215393|FG000|Overall Study|Preoperative progression|14|||
156852932|NCT03269994|566215394|FG001|Overall Study|Preoperative progression|9|||
156852933|NCT03269994|566215393|FG000|Overall Study|Preoperative infection|10|||
156889427|NCT03947684|566354230|FG002|Overall Study|Physician Decision|0|||
156889428|NCT03947684|566354228|FG000|Overall Study|Lack of adherence to study protocol|2|||
156889429|NCT03947684|566354229|FG001|Overall Study|Lack of adherence to study protocol|0|||
156889430|NCT03947684|566354230|FG002|Overall Study|Lack of adherence to study protocol|0|||
156852934|NCT03269994|566215394|FG001|Overall Study|Preoperative infection|4|||
156852935|NCT03269994|566215393|FG000|Overall Study|Kidney insufficiency|1|||
156852936|NCT03269994|566215394|FG001|Overall Study|Kidney insufficiency|0|||
156852937|NCT03269994|566215393|FG000|Overall Study|Drug allergy|0|||
156852938|NCT03269994|566215394|FG001|Overall Study|Drug allergy|2|||
156852939|NCT03269994|566215393|FG000|Overall Study|Operation changed to different resection|9|||
156852940|NCT03269994|566215394|FG001|Overall Study|Operation changed to different resection|0|||
156852941|NCT03269994|566215393|FG000|Overall Study|Preoperative steroid|0|||
156852942|NCT03269994|566215394|FG001|Overall Study|Preoperative steroid|3|||
156889431|NCT01395784|566354232|FG000|Overall Study|Lost to Follow-up|7|||
157157509|NCT01533935|567321159|FG004|Overall Study|Protocol Violation|0|||
157157510|NCT01533935|567321155|FG000|Overall Study|Lost to Follow-up|0|||
156852943|NCT03269994|566215393|FG000|Overall Study|Accrual Closed|2|||
156852944|NCT03269994|566215394|FG001|Overall Study|Accrual Closed|0|||
156852945|NCT03269994|566215393|FG000|Overall Study|Operation changed to different resection|0|||
156852946|NCT03269994|566215394|FG001|Overall Study|Operation changed to different resection|10|||
156852947|NCT04303559|566215395|FG000|Overall Study|Study closed due to poor enrollment.|1|||
156852948|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
156889432|NCT01395784|566354232|FG000|Overall Study|Withdrawal by Subject|3|||
157157511|NCT01533935|567321156|FG001|Overall Study|Lost to Follow-up|0|||
156852949|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
156852950|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
156852951|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
156852952|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
156852953|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
156852954|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
156852955|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
156852956|NCT01987102|566215398|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
156852957|NCT01987102|566215399|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
156852958|NCT01987102|566215398|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
156852959|NCT01987102|566215399|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
156852960|NCT01288989|566215400|FG000|Overall Study|Death|0|||
156852961|NCT01288989|566215401|FG001|Overall Study|Death|0|||
156852962|NCT01288989|566215402|FG002|Overall Study|Death|0|||
156852963|NCT01288989|566215403|FG003|Overall Study|Death|1|||
156852964|NCT01288989|566215404|FG004|Overall Study|Death|0|||
156852965|NCT01288989|566215400|FG000|Overall Study|Dose limiting toxicity|1|||
156852966|NCT01288989|566215401|FG001|Overall Study|Dose limiting toxicity|0|||
156852967|NCT01288989|566215402|FG002|Overall Study|Dose limiting toxicity|0|||
156852968|NCT01288989|566215403|FG003|Overall Study|Dose limiting toxicity|0|||
156852969|NCT01288989|566215404|FG004|Overall Study|Dose limiting toxicity|0|||
156852970|NCT01288989|566215400|FG000|Overall Study|Adverse Event|0|||
156852971|NCT01288989|566215401|FG001|Overall Study|Adverse Event|0|||
156852972|NCT01288989|566215402|FG002|Overall Study|Adverse Event|0|||
156852973|NCT01288989|566215403|FG003|Overall Study|Adverse Event|0|||
156852974|NCT01288989|566215404|FG004|Overall Study|Adverse Event|2|||
156852975|NCT01288989|566215400|FG000|Overall Study|Physician Decision|0|||
156852976|NCT01288989|566215401|FG001|Overall Study|Physician Decision|0|||
156852977|NCT01288989|566215402|FG002|Overall Study|Physician Decision|0|||
156852978|NCT01288989|566215403|FG003|Overall Study|Physician Decision|0|||
156852979|NCT01288989|566215404|FG004|Overall Study|Physician Decision|1|||
156852980|NCT01288989|566215400|FG000|Overall Study|Withdrawal by Subject|0|||
156852981|NCT01288989|566215401|FG001|Overall Study|Withdrawal by Subject|0|||
156852982|NCT01288989|566215402|FG002|Overall Study|Withdrawal by Subject|0|||
156852983|NCT01288989|566215403|FG003|Overall Study|Withdrawal by Subject|0|||
156852984|NCT01288989|566215404|FG004|Overall Study|Withdrawal by Subject|3|||
156852985|NCT01327599|566215405|FG000|Overall Study|Adverse Event|1|||
156852986|NCT01327599|566215405|FG000|Overall Study|Could Not Attend Visit|1|||
156852987|NCT01327599|566215405|FG000|Overall Study|Withdrawal of Consent|1|||
156852988|NCT01132313|566215406|FG000|Overall Study|Lack of Efficacy|1|||
156852989|NCT01132313|566215407|FG001|Overall Study|Lack of Efficacy|0|||
156852990|NCT01132313|566215408|FG002|Overall Study|Lack of Efficacy|0|||
156852991|NCT01132313|566215409|FG003|Overall Study|Lack of Efficacy|0|||
156852992|NCT01132313|566215410|FG004|Overall Study|Lack of Efficacy|0|||
156852993|NCT01132313|566215411|FG005|Overall Study|Lack of Efficacy|0|||
156852994|NCT01132313|566215412|FG006|Overall Study|Lack of Efficacy|0|||
156852995|NCT01132313|566215413|FG007|Overall Study|Lack of Efficacy|3|||
156852996|NCT01132313|566215414|FG008|Overall Study|Lack of Efficacy|14|||
156852997|NCT01132313|566215415|FG009|Overall Study|Lack of Efficacy|16|||
156852998|NCT01132313|566215416|FG010|Overall Study|Lack of Efficacy|0|||
156852999|NCT01132313|566215417|FG011|Overall Study|Lack of Efficacy|0|||
156853000|NCT01132313|566215406|FG000|Overall Study|Not treated|2|||
156853001|NCT01132313|566215407|FG001|Overall Study|Not treated|0|||
156853002|NCT01132313|566215408|FG002|Overall Study|Not treated|0|||
157157512|NCT01533935|567321157|FG002|Overall Study|Lost to Follow-up|1|||
157157513|NCT01533935|567321158|FG003|Overall Study|Lost to Follow-up|0|||
157157514|NCT01533935|567321159|FG004|Overall Study|Lost to Follow-up|0|||
157157515|NCT01533935|567321155|FG000|Overall Study|Withdrawal by Subject|0|||
157157516|NCT01533935|567321156|FG001|Overall Study|Withdrawal by Subject|4|||
157157517|NCT01533935|567321157|FG002|Overall Study|Withdrawal by Subject|5|||
157157518|NCT01533935|567321158|FG003|Overall Study|Withdrawal by Subject|2|||
157157519|NCT01533935|567321159|FG004|Overall Study|Withdrawal by Subject|4|||
157157520|NCT01533935|567321155|FG000|Overall Study|Other reason not defined above|1|||
157157521|NCT01533935|567321156|FG001|Overall Study|Other reason not defined above|0|||
157157522|NCT01533935|567321157|FG002|Overall Study|Other reason not defined above|1|||
157157523|NCT01533935|567321158|FG003|Overall Study|Other reason not defined above|0|||
156853003|NCT01132313|566215409|FG003|Overall Study|Not treated|0|||
156853004|NCT01132313|566215410|FG004|Overall Study|Not treated|2|||
156853005|NCT01132313|566215411|FG005|Overall Study|Not treated|1|||
156853006|NCT01132313|566215412|FG006|Overall Study|Not treated|3|||
156853007|NCT01132313|566215413|FG007|Overall Study|Not treated|0|||
156853008|NCT01132313|566215414|FG008|Overall Study|Not treated|0|||
156853009|NCT01132313|566215415|FG009|Overall Study|Not treated|0|||
156853010|NCT01132313|566215416|FG010|Overall Study|Not treated|0|||
156853011|NCT01132313|566215417|FG011|Overall Study|Not treated|0|||
156853012|NCT01132313|566215406|FG000|Overall Study|Adverse Event|0|||
157157524|NCT01533935|567321159|FG004|Overall Study|Other reason not defined above|1|||
157157525|NCT01554956|567321160|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
156853013|NCT01132313|566215407|FG001|Overall Study|Adverse Event|0|||
156853014|NCT01132313|566215408|FG002|Overall Study|Adverse Event|4|||
156853015|NCT01132313|566215409|FG003|Overall Study|Adverse Event|10|||
156853016|NCT01132313|566215410|FG004|Overall Study|Adverse Event|19|||
156853017|NCT01132313|566215411|FG005|Overall Study|Adverse Event|6|||
156853018|NCT01132313|566215412|FG006|Overall Study|Adverse Event|5|||
156853019|NCT01132313|566215413|FG007|Overall Study|Adverse Event|3|||
156853020|NCT01132313|566215414|FG008|Overall Study|Adverse Event|7|||
156853021|NCT01132313|566215415|FG009|Overall Study|Adverse Event|2|||
156853022|NCT01132313|566215416|FG010|Overall Study|Adverse Event|0|||
156853023|NCT01132313|566215417|FG011|Overall Study|Adverse Event|0|||
156853024|NCT01132313|566215406|FG000|Overall Study|Protocol Violation|0|||
156853025|NCT01132313|566215407|FG001|Overall Study|Protocol Violation|0|||
156853026|NCT01132313|566215408|FG002|Overall Study|Protocol Violation|0|||
156853027|NCT01132313|566215409|FG003|Overall Study|Protocol Violation|1|||
156853028|NCT01132313|566215410|FG004|Overall Study|Protocol Violation|0|||
156853029|NCT01132313|566215411|FG005|Overall Study|Protocol Violation|0|||
156853030|NCT01132313|566215412|FG006|Overall Study|Protocol Violation|0|||
156853031|NCT01132313|566215413|FG007|Overall Study|Protocol Violation|0|||
156853032|NCT01132313|566215414|FG008|Overall Study|Protocol Violation|0|||
156853033|NCT01132313|566215415|FG009|Overall Study|Protocol Violation|0|||
156853034|NCT01132313|566215416|FG010|Overall Study|Protocol Violation|0|||
156853035|NCT01132313|566215417|FG011|Overall Study|Protocol Violation|0|||
156853036|NCT01132313|566215406|FG000|Overall Study|Lost to Follow-up|0|||
156853037|NCT01132313|566215407|FG001|Overall Study|Lost to Follow-up|0|||
156853038|NCT01132313|566215408|FG002|Overall Study|Lost to Follow-up|1|||
156853039|NCT01132313|566215409|FG003|Overall Study|Lost to Follow-up|0|||
156853040|NCT01132313|566215410|FG004|Overall Study|Lost to Follow-up|0|||
156853041|NCT01132313|566215411|FG005|Overall Study|Lost to Follow-up|0|||
156853042|NCT01132313|566215412|FG006|Overall Study|Lost to Follow-up|0|||
156853043|NCT01132313|566215413|FG007|Overall Study|Lost to Follow-up|1|||
156853044|NCT01132313|566215414|FG008|Overall Study|Lost to Follow-up|0|||
156853045|NCT01132313|566215415|FG009|Overall Study|Lost to Follow-up|0|||
156853046|NCT01132313|566215416|FG010|Overall Study|Lost to Follow-up|0|||
156853047|NCT01132313|566215417|FG011|Overall Study|Lost to Follow-up|0|||
156853048|NCT01132313|566215406|FG000|Overall Study|Withdrawal by Subject|0|||
156853049|NCT01132313|566215407|FG001|Overall Study|Withdrawal by Subject|0|||
156853050|NCT01132313|566215408|FG002|Overall Study|Withdrawal by Subject|3|||
156853051|NCT01132313|566215409|FG003|Overall Study|Withdrawal by Subject|3|||
156853052|NCT01132313|566215410|FG004|Overall Study|Withdrawal by Subject|6|||
156853053|NCT01132313|566215411|FG005|Overall Study|Withdrawal by Subject|0|||
156853054|NCT01132313|566215412|FG006|Overall Study|Withdrawal by Subject|1|||
156853055|NCT01132313|566215413|FG007|Overall Study|Withdrawal by Subject|0|||
156853056|NCT01132313|566215414|FG008|Overall Study|Withdrawal by Subject|0|||
156853057|NCT01132313|566215415|FG009|Overall Study|Withdrawal by Subject|2|||
156853058|NCT01132313|566215416|FG010|Overall Study|Withdrawal by Subject|0|||
156853059|NCT01132313|566215417|FG011|Overall Study|Withdrawal by Subject|0|||
156853060|NCT01132313|566215406|FG000|Overall Study|Lack of antiviral response|0|||
156889433|NCT01395784|566354232|FG000|Overall Study|Physician Decision|5|||
156889434|NCT05772702|566354233|FG000|Overall Study|Adverse Event|1|||
156889435|NCT04153149|566354234|FG000|Double Blind Period|Death|63|||
156889436|NCT04153149|566354235|FG001|Double Blind Period|Death|49|||
156889437|NCT04153149|566354236|FG002|Double Blind Period|Death|0|||
156889438|NCT04153149|566354237|FG003|Double Blind Period|Death|0|||
156889439|NCT04153149|566354234|FG000|Double Blind Period|Withdrawal by Subject|16|||
156889440|NCT04153149|566354235|FG001|Double Blind Period|Withdrawal by Subject|11|||
156889441|NCT04153149|566354236|FG002|Double Blind Period|Withdrawal by Subject|0|||
157157526|NCT01554956|567321161|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
157157527|NCT01554956|567321162|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
157157528|NCT01554956|567321160|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
157157529|NCT01554956|567321161|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
156853061|NCT01132313|566215407|FG001|Overall Study|Lack of antiviral response|0|||
156853062|NCT01132313|566215408|FG002|Overall Study|Lack of antiviral response|12|||
156853063|NCT01132313|566215409|FG003|Overall Study|Lack of antiviral response|18|||
156853064|NCT01132313|566215410|FG004|Overall Study|Lack of antiviral response|18|||
156853065|NCT01132313|566215411|FG005|Overall Study|Lack of antiviral response|18|||
156853066|NCT01132313|566215412|FG006|Overall Study|Lack of antiviral response|21|||
156853067|NCT01132313|566215413|FG007|Overall Study|Lack of antiviral response|0|||
156853068|NCT01132313|566215414|FG008|Overall Study|Lack of antiviral response|0|||
156853069|NCT01132313|566215415|FG009|Overall Study|Lack of antiviral response|0|||
156853070|NCT01132313|566215416|FG010|Overall Study|Lack of antiviral response|1|||
156853071|NCT01132313|566215417|FG011|Overall Study|Lack of antiviral response|0|||
156853072|NCT01132313|566215406|FG000|Overall Study|Other reason not defined above|0|||
156853073|NCT01132313|566215407|FG001|Overall Study|Other reason not defined above|0|||
156853074|NCT01132313|566215408|FG002|Overall Study|Other reason not defined above|0|||
156853075|NCT01132313|566215409|FG003|Overall Study|Other reason not defined above|0|||
156889442|NCT04153149|566354237|FG003|Double Blind Period|Withdrawal by Subject|0|||
156889443|NCT04153149|566354234|FG000|Double Blind Period|Adverse Event|6|||
156853076|NCT01132313|566215410|FG004|Overall Study|Other reason not defined above|0|||
156853077|NCT01132313|566215411|FG005|Overall Study|Other reason not defined above|0|||
156853078|NCT01132313|566215412|FG006|Overall Study|Other reason not defined above|0|||
156853079|NCT01132313|566215413|FG007|Overall Study|Other reason not defined above|1|||
156853080|NCT01132313|566215414|FG008|Overall Study|Other reason not defined above|0|||
156853081|NCT01132313|566215415|FG009|Overall Study|Other reason not defined above|0|||
156853082|NCT01132313|566215416|FG010|Overall Study|Other reason not defined above|0|||
156853083|NCT01132313|566215417|FG011|Overall Study|Other reason not defined above|0|||
156853084|NCT00165672|566215423|FG000|Overall Study|Adverse Event|0|||
156853085|NCT00165672|566215424|FG001|Overall Study|Adverse Event|1|||
156853086|NCT00176462|566215427|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
156853087|NCT00176462|566215428|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
156853088|NCT00176462|566215427|FG000|Induction (4 Weeks)|Death|1|||
156853089|NCT00176462|566215428|FG001|Induction (4 Weeks)|Death|2|||
156853090|NCT00176462|566215427|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
156853091|NCT00176462|566215428|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
156853092|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
156853093|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
156853094|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
156853095|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
156853096|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
156853097|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
156853098|NCT00176462|566215427|FG000|Consolidation (12 Weeks)|Not documented|0|||
156853099|NCT00176462|566215428|FG001|Consolidation (12 Weeks)|Not documented|1|||
156853100|NCT00176462|566215427|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
156853101|NCT00176462|566215428|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
156853102|NCT00176462|566215427|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
156853103|NCT00176462|566215428|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
156853124|NCT02539797|566217785|FG000|Overall Study|Lost to Follow-up|0|||
156853125|NCT02539797|566217786|FG001|Overall Study|Lost to Follow-up|1|||
156853126|NCT02539797|566217787|FG002|Overall Study|Lost to Follow-up|0|||
156853127|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853128|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
156853129|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853130|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853131|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
156853132|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
156853133|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
156853134|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853135|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853136|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
156853137|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
156853138|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
156853139|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156853140|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156853141|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
156889444|NCT04153149|566354235|FG001|Double Blind Period|Adverse Event|2|||
156889445|NCT04153149|566354236|FG002|Double Blind Period|Adverse Event|0|||
156853142|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
156853143|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
156853144|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
156889446|NCT04153149|566354237|FG003|Double Blind Period|Adverse Event|0|||
156889447|NCT04153149|566354234|FG000|Double Blind Period|Lost to Follow-up|2|||
156889448|NCT04153149|566354235|FG001|Double Blind Period|Lost to Follow-up|1|||
156889449|NCT04153149|566354236|FG002|Double Blind Period|Lost to Follow-up|0|||
156889450|NCT04153149|566354237|FG003|Double Blind Period|Lost to Follow-up|0|||
156889451|NCT04153149|566354234|FG000|Double Blind Period|Withdrawal by guardian|0|||
156889452|NCT04153149|566354235|FG001|Double Blind Period|Withdrawal by guardian|2|||
156889453|NCT04153149|566354236|FG002|Double Blind Period|Withdrawal by guardian|0|||
156889454|NCT04153149|566354237|FG003|Double Blind Period|Withdrawal by guardian|0|||
156889455|NCT04153149|566354234|FG000|Double Blind Period|Reason Not Specified|5|||
156889456|NCT04153149|566354235|FG001|Double Blind Period|Reason Not Specified|4|||
156889457|NCT04153149|566354236|FG002|Double Blind Period|Reason Not Specified|0|||
156889458|NCT04153149|566354237|FG003|Double Blind Period|Reason Not Specified|0|||
156889459|NCT04153149|566354234|FG000|Double Blind Period|Physician Decision|2|||
156889460|NCT04153149|566354235|FG001|Double Blind Period|Physician Decision|0|||
156889461|NCT04153149|566354236|FG002|Double Blind Period|Physician Decision|0|||
156889462|NCT04153149|566354237|FG003|Double Blind Period|Physician Decision|0|||
156889463|NCT04153149|566354234|FG000|Open Label Extension Period|Death|0|||
156889464|NCT04153149|566354235|FG001|Open Label Extension Period|Death|0|||
157025762|NCT04802967|566849605|FG006|Part B|Withdrawal by Subject|0|||
156853145|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
156853146|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
157025763|NCT04802967|566849606|FG007|Part B|Withdrawal by Subject|0|||
156853147|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
156853148|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
156853149|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853150|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853151|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
156853152|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
156853153|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
156853154|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853155|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853156|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
156853157|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
156853158|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
156853159|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853160|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853161|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
156853162|NCT02831764|566217788|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853163|NCT02831764|566217789|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
156853164|NCT02831764|566217790|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853165|NCT02831764|566217791|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853166|NCT02831764|566217792|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
156853167|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853168|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853169|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
156853170|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
156853171|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
156853172|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853173|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853174|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
156853175|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853176|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
156853177|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853178|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853179|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
156853180|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
156853181|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
156853182|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853183|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853184|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
156853185|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156889465|NCT04153149|566354236|FG002|Open Label Extension Period|Death|7|||
156889466|NCT04153149|566354237|FG003|Open Label Extension Period|Death|3|||
156889467|NCT04153149|566354234|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
156889468|NCT04153149|566354235|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
156889469|NCT04153149|566354236|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
156889470|NCT04153149|566354237|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
156889471|NCT04153149|566354234|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156889472|NCT04153149|566354235|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156889473|NCT04153149|566354236|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
156889474|NCT04153149|566354237|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
156889475|NCT04153149|566354234|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
156889476|NCT04153149|566354235|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
156889477|NCT04153149|566354236|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
156889478|NCT04153149|566354237|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
157025764|NCT04802967|566849607|FG008|Part B|Withdrawal by Subject|0|||
157025765|NCT04802967|566849608|FG009|Part B|Withdrawal by Subject|0|||
157157530|NCT01554956|567321162|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
157157531|NCT01554956|567321160|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
157157532|NCT01554956|567321161|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
157025766|NCT03339713|566849611|FG000|Overall Study|Lost to Follow-up|2|||
157025767|NCT03339713|566849612|FG001|Overall Study|Lost to Follow-up|1|||
157025768|NCT03339713|566849611|FG000|Overall Study|Protocol Violation|1|||
157025769|NCT03339713|566849612|FG001|Overall Study|Protocol Violation|0|||
156853186|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
156853187|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853188|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853189|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
156853190|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
156853191|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
156853192|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853193|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853194|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
156853195|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
156853196|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
156853197|NCT02831764|566217788|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853198|NCT02831764|566217789|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853199|NCT02831764|566217790|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
156853200|NCT02831764|566217791|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
156853201|NCT02831764|566217792|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
156853202|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853203|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853204|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853205|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
156853206|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
156853207|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853208|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853209|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853210|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
156853211|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
156853212|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853213|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853214|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853215|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
156853216|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
156853217|NCT02831764|566217788|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853218|NCT02831764|566217789|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853219|NCT02831764|566217790|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853220|NCT02831764|566217791|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
156853221|NCT02831764|566217792|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
156853222|NCT02796677|566217798|FG000|Overall Study|Adverse Event|11|||
156853223|NCT02796677|566217799|FG001|Overall Study|Adverse Event|22|||
156853224|NCT02796677|566217800|FG002|Overall Study|Adverse Event|14|||
156853225|NCT02796677|566217801|FG003|Overall Study|Adverse Event|14|||
156853226|NCT02796677|566217798|FG000|Overall Study|Protocol Violation|7|||
156853227|NCT02796677|566217799|FG001|Overall Study|Protocol Violation|5|||
156853228|NCT02796677|566217800|FG002|Overall Study|Protocol Violation|4|||
156853229|NCT02796677|566217801|FG003|Overall Study|Protocol Violation|8|||
156853230|NCT02796677|566217798|FG000|Overall Study|Lost to Follow-up|1|||
156853231|NCT02796677|566217799|FG001|Overall Study|Lost to Follow-up|5|||
156853232|NCT02796677|566217800|FG002|Overall Study|Lost to Follow-up|2|||
156853233|NCT02796677|566217801|FG003|Overall Study|Lost to Follow-up|2|||
156853234|NCT02796677|566217798|FG000|Overall Study|Lack of Efficacy|7|||
156853235|NCT02796677|566217799|FG001|Overall Study|Lack of Efficacy|9|||
156853236|NCT02796677|566217800|FG002|Overall Study|Lack of Efficacy|14|||
156853237|NCT02796677|566217801|FG003|Overall Study|Lack of Efficacy|20|||
156853238|NCT02796677|566217798|FG000|Overall Study|Withdrawal by Subject|4|||
156853239|NCT02796677|566217799|FG001|Overall Study|Withdrawal by Subject|14|||
156853240|NCT02796677|566217800|FG002|Overall Study|Withdrawal by Subject|6|||
156853241|NCT02796677|566217801|FG003|Overall Study|Withdrawal by Subject|7|||
156853242|NCT02796677|566217798|FG000|Overall Study|Progressive disease|6|||
156853243|NCT02796677|566217799|FG001|Overall Study|Progressive disease|15|||
156853244|NCT02796677|566217800|FG002|Overall Study|Progressive disease|13|||
156853245|NCT02796677|566217801|FG003|Overall Study|Progressive disease|18|||
156853246|NCT02796677|566217798|FG000|Overall Study|Reason not mentioned|2|||
156853247|NCT02796677|566217799|FG001|Overall Study|Reason not mentioned|3|||
156853248|NCT02796677|566217800|FG002|Overall Study|Reason not mentioned|0|||
156853249|NCT02796677|566217801|FG003|Overall Study|Reason not mentioned|5|||
156853250|NCT04002960|566217803|FG000|Overall Study|Withdrawn prior to Completion|2|||
157025770|NCT03339713|566849611|FG000|Overall Study|Withdrawal by Subject|1|||
156853251|NCT00961181|566217804|FG000|Overall Study|Death|2|||
156853252|NCT00961181|566217804|FG000|Overall Study|Withdrawal by Subject|2|||
156853253|NCT00961181|566217804|FG000|Overall Study|Lost to Follow-up|1|||
156853254|NCT01777308|566217807|FG000|Overall Study|Withdrawal by Subject|5|||
156853255|NCT01777308|566217808|FG001|Overall Study|Withdrawal by Subject|1|||
156853256|NCT01777308|566217807|FG000|Overall Study|Migrated/moved from study area|1|||
156853257|NCT01777308|566217808|FG001|Overall Study|Migrated/moved from study area|0|||
156853258|NCT01777308|566217807|FG000|Overall Study|Lost to Follow-up|7|||
156853259|NCT01777308|566217808|FG001|Overall Study|Lost to Follow-up|2|||
156853260|NCT01777308|566217807|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
156853261|NCT01777308|566217808|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
156853262|NCT03212326|566217809|FG000|Overall Study|Physician Decision|4|||
156853263|NCT00383786|566217821|FG000|Overall Study|Protocol Violation|2|||
156853264|NCT00383786|566217822|FG001|Overall Study|Protocol Violation|6|||
156853265|NCT00383786|566217821|FG000|Overall Study|Withdrawal by Subject|2|||
156853266|NCT00383786|566217822|FG001|Overall Study|Withdrawal by Subject|5|||
156853267|NCT00383786|566217821|FG000|Overall Study|Physician Decision|0|||
156853268|NCT00383786|566217822|FG001|Overall Study|Physician Decision|1|||
156853269|NCT02544321|566217829|FG000|Overall Study|Withdrawal by Subject|1|||
156853270|NCT02544321|566217830|FG001|Overall Study|Withdrawal by Subject|2|||
156853271|NCT02544321|566217829|FG000|Overall Study|Adverse Event|1|||
156853272|NCT02544321|566217830|FG001|Overall Study|Adverse Event|1|||
156853273|NCT02544321|566217829|FG000|Overall Study|Protocol Violation|0|||
156853274|NCT02544321|566217830|FG001|Overall Study|Protocol Violation|1|||
156853275|NCT01517750|566217831|FG000|Overall Study|Lost to Follow-up|1|||
156853276|NCT01517750|566217832|FG001|Overall Study|Lost to Follow-up|2|||
156853277|NCT01517750|566217833|FG002|Overall Study|Lost to Follow-up|4|||
156853278|NCT01517750|566217834|FG003|Overall Study|Lost to Follow-up|1|||
156853279|NCT01307319|566217835|FG000|Overall Study|Adverse Event|2|||
156853280|NCT01307319|566217836|FG001|Overall Study|Adverse Event|2|||
156853281|NCT01307319|566217837|FG002|Overall Study|Adverse Event|1|||
156853282|NCT01307319|566217835|FG000|Overall Study|Lost to Follow-up|1|||
156853283|NCT01307319|566217836|FG001|Overall Study|Lost to Follow-up|0|||
156853284|NCT01307319|566217837|FG002|Overall Study|Lost to Follow-up|1|||
156853285|NCT01307319|566217835|FG000|Overall Study|Protocol Violation|1|||
156853286|NCT01307319|566217836|FG001|Overall Study|Protocol Violation|1|||
156853287|NCT01307319|566217837|FG002|Overall Study|Protocol Violation|0|||
156853288|NCT01307319|566217835|FG000|Overall Study|Withdrawal by Subject|0|||
156853289|NCT01307319|566217836|FG001|Overall Study|Withdrawal by Subject|1|||
156853290|NCT01307319|566217837|FG002|Overall Study|Withdrawal by Subject|2|||
156853291|NCT01307319|566217835|FG000|Overall Study|Other|0|||
156853292|NCT01307319|566217836|FG001|Overall Study|Other|4|||
156853293|NCT01307319|566217837|FG002|Overall Study|Other|3|||
156853294|NCT02735239|566217838|FG000|Overall Study|Adverse Event|0|||
156853295|NCT02735239|566217839|FG001|Overall Study|Adverse Event|0|||
156853296|NCT02735239|566217840|FG002|Overall Study|Adverse Event|4|||
156853297|NCT02735239|566217841|FG003|Overall Study|Adverse Event|0|||
156853298|NCT02735239|566217842|FG004|Overall Study|Adverse Event|0|||
156853299|NCT02735239|566217843|FG005|Overall Study|Adverse Event|0|||
156889479|NCT04268823|566354238|FG000|Overall Study|Adverse Event|1|||
156889480|NCT04268823|566354239|FG001|Overall Study|Adverse Event|0|||
156889481|NCT04268823|566354238|FG000|Overall Study|Participant Decision|1|||
156889482|NCT04268823|566354239|FG001|Overall Study|Participant Decision|0|||
156889483|NCT00371761|566355469|FG000|Overall Study|Adverse Event|1|||
156889484|NCT00371761|566355470|FG001|Overall Study|Adverse Event|1|||
156889485|NCT00371761|566355469|FG000|Overall Study|Withdrawal by Subject|1|||
156889486|NCT00371761|566355470|FG001|Overall Study|Withdrawal by Subject|3|||
156853300|NCT02735239|566217838|FG000|Overall Study|Death|1|||
156853301|NCT02735239|566217839|FG001|Overall Study|Death|1|||
156853302|NCT02735239|566217840|FG002|Overall Study|Death|0|||
156853303|NCT02735239|566217841|FG003|Overall Study|Death|0|||
156889487|NCT00371761|566355469|FG000|Overall Study|Investigator Judgment|2|||
156889488|NCT00371761|566355470|FG001|Overall Study|Investigator Judgment|3|||
156889489|NCT00371761|566355469|FG000|Overall Study|Study termination|4|||
156889490|NCT00371761|566355470|FG001|Overall Study|Study termination|3|||
156889491|NCT01249118|566355471|FG000|First Washout Period|Physician Decision|0|||
156853304|NCT02735239|566217842|FG004|Overall Study|Death|0|||
156853305|NCT02735239|566217843|FG005|Overall Study|Death|0|||
156853306|NCT02735239|566217838|FG000|Overall Study|Physician Decision|0|||
156889492|NCT01249118|566355472|FG001|First Washout Period|Physician Decision|1|||
156889493|NCT01249118|566355473|FG002|First Washout Period|Physician Decision|0|||
156853307|NCT02735239|566217839|FG001|Overall Study|Physician Decision|0|||
156853308|NCT02735239|566217840|FG002|Overall Study|Physician Decision|1|||
156853309|NCT02735239|566217841|FG003|Overall Study|Physician Decision|0|||
156853310|NCT02735239|566217842|FG004|Overall Study|Physician Decision|0|||
156853311|NCT02735239|566217843|FG005|Overall Study|Physician Decision|0|||
156853312|NCT02735239|566217838|FG000|Overall Study|Progressive disease|3|||
156853313|NCT02735239|566217839|FG001|Overall Study|Progressive disease|1|||
156889494|NCT00997438|566355474|FG000|Overall Study|Blood draw difficulty|2|||
156889495|NCT00997438|566355475|FG001|Overall Study|Blood draw difficulty|0|||
156853314|NCT02735239|566217840|FG002|Overall Study|Progressive disease|3|||
156853315|NCT02735239|566217841|FG003|Overall Study|Progressive disease|0|||
156853316|NCT02735239|566217842|FG004|Overall Study|Progressive disease|0|||
156853317|NCT02735239|566217843|FG005|Overall Study|Progressive disease|2|||
156853318|NCT02735239|566217838|FG000|Overall Study|Withdrawal by Subject|0|||
156853319|NCT02735239|566217839|FG001|Overall Study|Withdrawal by Subject|1|||
156853320|NCT02735239|566217840|FG002|Overall Study|Withdrawal by Subject|0|||
156889496|NCT00997438|566355476|FG002|Overall Study|Blood draw difficulty|1|||
156889497|NCT00997438|566355474|FG000|Overall Study|Withdrawal by Subject|1|||
156889498|NCT00997438|566355475|FG001|Overall Study|Withdrawal by Subject|1|||
156889499|NCT00997438|566355476|FG002|Overall Study|Withdrawal by Subject|0|||
156889500|NCT00997438|566355474|FG000|Overall Study|Exclusion criteria at visit 1|2|||
156889501|NCT00997438|566355475|FG001|Overall Study|Exclusion criteria at visit 1|2|||
156889502|NCT00997438|566355476|FG002|Overall Study|Exclusion criteria at visit 1|3|||
156889503|NCT00095238|566355477|FG000|Overall Study|Lack of Efficacy|9|||
156889504|NCT00095238|566355478|FG001|Overall Study|Lack of Efficacy|9|||
156889505|NCT00095238|566355477|FG000|Overall Study|Adverse Event|331|||
156889506|NCT00095238|566355478|FG001|Overall Study|Adverse Event|287|||
156853321|NCT02735239|566217841|FG003|Overall Study|Withdrawal by Subject|0|||
156853322|NCT02735239|566217842|FG004|Overall Study|Withdrawal by Subject|0|||
156853323|NCT02735239|566217843|FG005|Overall Study|Withdrawal by Subject|0|||
156889507|NCT00095238|566355477|FG000|Overall Study|Subject Withdrew Consent|208|||
156889508|NCT00095238|566355478|FG001|Overall Study|Subject Withdrew Consent|223|||
156889509|NCT00095238|566355477|FG000|Overall Study|Death|154|||
156889510|NCT00095238|566355478|FG001|Overall Study|Death|170|||
156889511|NCT00095238|566355477|FG000|Overall Study|Lost to Follow-up|19|||
156889512|NCT00095238|566355478|FG001|Overall Study|Lost to Follow-up|24|||
156889513|NCT00095238|566355477|FG000|Overall Study|Noncompliance|44|||
156889514|NCT00095238|566355478|FG001|Overall Study|Noncompliance|45|||
156889515|NCT00095238|566355477|FG000|Overall Study|No longer met study criteria|4|||
156889516|NCT00095238|566355478|FG001|Overall Study|No longer met study criteria|5|||
156889517|NCT00095238|566355477|FG000|Overall Study|Study terminated by sponsor|0|||
156889518|NCT00095238|566355478|FG001|Overall Study|Study terminated by sponsor|1|||
156889519|NCT00095238|566355477|FG000|Overall Study|Missing|1|||
156889520|NCT00095238|566355478|FG001|Overall Study|Missing|0|||
156889521|NCT00095238|566355477|FG000|Overall Study|Other Reasons|87|||
156889522|NCT00095238|566355478|FG001|Overall Study|Other Reasons|88|||
156889523|NCT04300751|566355479|FG000|Overall Study|Withdrawal by Subject|1|||
156889524|NCT04972630|566355484|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
156889525|NCT04972630|566355485|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
156889526|NCT04972630|566355486|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
156889527|NCT05171816|566355489|FG000|Overall Study|Death|18|||
156889528|NCT05171816|566355490|FG001|Overall Study|Death|16|||
156889529|NCT02937571|566355491|FG000|Overall Study|Adverse Event|0|||
156889530|NCT02937571|566355492|FG001|Overall Study|Adverse Event|0|||
156889531|NCT02937571|566355493|FG002|Overall Study|Adverse Event|4|||
156889532|NCT02937571|566355491|FG000|Overall Study|Withdrawal by Subject|0|||
156889533|NCT02937571|566355492|FG001|Overall Study|Withdrawal by Subject|0|||
156889534|NCT02937571|566355493|FG002|Overall Study|Withdrawal by Subject|3|||
156889535|NCT04214288|566355494|FG000|Overall Study|Ongoing in the study|41|||
156889536|NCT04214288|566355495|FG001|Overall Study|Ongoing in the study|51|||
156889537|NCT04214288|566355496|FG002|Overall Study|Ongoing in the study|12|||
156889538|NCT04214288|566355497|FG003|Overall Study|Ongoing in the study|39|||
156889539|NCT04214288|566355494|FG000|Overall Study|Adverse Event|1|||
156889540|NCT04214288|566355495|FG001|Overall Study|Adverse Event|0|||
156889541|NCT04214288|566355496|FG002|Overall Study|Adverse Event|0|||
156889542|NCT04214288|566355497|FG003|Overall Study|Adverse Event|0|||
156889543|NCT04214288|566355494|FG000|Overall Study|Death|22|||
156889544|NCT04214288|566355495|FG001|Overall Study|Death|13|||
156889545|NCT04214288|566355496|FG002|Overall Study|Death|7|||
156889546|NCT04214288|566355497|FG003|Overall Study|Death|19|||
157025771|NCT03339713|566849612|FG001|Overall Study|Withdrawal by Subject|1|||
156853324|NCT00527735|566217847|FG000|Overall Study|Disease progression|47|||
156889547|NCT04214288|566355494|FG000|Overall Study|Lost to Follow-up|1|||
157025772|NCT03628924|566849613|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
156889548|NCT04214288|566355495|FG001|Overall Study|Lost to Follow-up|2|||
156889549|NCT04214288|566355496|FG002|Overall Study|Lost to Follow-up|1|||
156889550|NCT04214288|566355497|FG003|Overall Study|Lost to Follow-up|0|||
156853325|NCT00527735|566217848|FG001|Overall Study|Disease progression|61|||
156889551|NCT04214288|566355494|FG000|Overall Study|Other|1|||
156889552|NCT04214288|566355495|FG001|Overall Study|Other|2|||
156889553|NCT04214288|566355496|FG002|Overall Study|Other|0|||
156889554|NCT04214288|566355497|FG003|Overall Study|Other|6|||
156889555|NCT04214288|566355494|FG000|Overall Study|Protocol Violation|0|||
156889556|NCT04214288|566355495|FG001|Overall Study|Protocol Violation|1|||
156889557|NCT04214288|566355496|FG002|Overall Study|Protocol Violation|0|||
157225466|NCT01860976|567571437|FG001|Long Term Extension|Adverse Event|0|||
156853326|NCT00527735|566217849|FG002|Overall Study|Disease progression|53|||
156853327|NCT00527735|566217847|FG000|Overall Study|Death|23|||
156853328|NCT00527735|566217848|FG001|Overall Study|Death|13|||
156853329|NCT00527735|566217849|FG002|Overall Study|Death|15|||
156853330|NCT00527735|566217847|FG000|Overall Study|Completed treatment in treatment phase|14|||
156853331|NCT00527735|566217848|FG001|Overall Study|Completed treatment in treatment phase|13|||
156853332|NCT00527735|566217849|FG002|Overall Study|Completed treatment in treatment phase|18|||
156853333|NCT00527735|566217847|FG000|Overall Study|Adverse Event|10|||
156853334|NCT00527735|566217848|FG001|Overall Study|Adverse Event|6|||
156853335|NCT00527735|566217849|FG002|Overall Study|Adverse Event|7|||
156853336|NCT00527735|566217847|FG000|Overall Study|Not identified|5|||
156853337|NCT00527735|566217848|FG001|Overall Study|Not identified|5|||
156853338|NCT00527735|566217849|FG002|Overall Study|Not identified|5|||
156853339|NCT00527735|566217847|FG000|Overall Study|Withdrawal by Subject|5|||
156853340|NCT00527735|566217848|FG001|Overall Study|Withdrawal by Subject|4|||
156853341|NCT00527735|566217849|FG002|Overall Study|Withdrawal by Subject|3|||
156853342|NCT00527735|566217847|FG000|Overall Study|No longer met study criteria|2|||
156853343|NCT00527735|566217848|FG001|Overall Study|No longer met study criteria|2|||
156853344|NCT00527735|566217849|FG002|Overall Study|No longer met study criteria|1|||
156853345|NCT00527735|566217847|FG000|Overall Study|Lost to Follow-up|0|||
156853346|NCT00527735|566217848|FG001|Overall Study|Lost to Follow-up|0|||
156853347|NCT00527735|566217849|FG002|Overall Study|Lost to Follow-up|3|||
156853348|NCT00527735|566217847|FG000|Overall Study|Poor compliance or noncompliance|0|||
156853349|NCT00527735|566217848|FG001|Overall Study|Poor compliance or noncompliance|1|||
156853350|NCT00527735|566217849|FG002|Overall Study|Poor compliance or noncompliance|1|||
156853351|NCT00527735|566217847|FG000|Overall Study|Completed treatment during maintenance|2|||
156853352|NCT00527735|566217848|FG001|Overall Study|Completed treatment during maintenance|2|||
156853353|NCT00527735|566217849|FG002|Overall Study|Completed treatment during maintenance|1|||
156853354|NCT01855412|566217850|FG000|Overall Study|Death|77|||
156853355|NCT01855412|566217851|FG001|Overall Study|Death|123|||
156853356|NCT01855412|566217852|FG002|Overall Study|Death|30|||
156853357|NCT01855412|566217850|FG000|Overall Study|Lost to Follow-up|28|||
156853358|NCT01855412|566217851|FG001|Overall Study|Lost to Follow-up|46|||
156853359|NCT01855412|566217852|FG002|Overall Study|Lost to Follow-up|15|||
156853360|NCT01855412|566217850|FG000|Overall Study|Withdrawal by Subject|77|||
156853361|NCT01855412|566217851|FG001|Overall Study|Withdrawal by Subject|123|||
156853362|NCT01855412|566217852|FG002|Overall Study|Withdrawal by Subject|24|||
156853363|NCT01855412|566217850|FG000|Overall Study|Physician Decision|25|||
156853364|NCT01855412|566217851|FG001|Overall Study|Physician Decision|31|||
156853365|NCT01855412|566217852|FG002|Overall Study|Physician Decision|3|||
156853366|NCT01855412|566217850|FG000|Overall Study|Site Closure|4|||
156853367|NCT01855412|566217851|FG001|Overall Study|Site Closure|18|||
156853368|NCT01855412|566217852|FG002|Overall Study|Site Closure|1|||
156853369|NCT01855412|566217850|FG000|Overall Study|Reason not Specified|1|||
156853370|NCT01855412|566217851|FG001|Overall Study|Reason not Specified|2|||
156853371|NCT01855412|566217852|FG002|Overall Study|Reason not Specified|3|||
156853372|NCT00404651|566217853|FG000|Overall Study|Serious Adverse Event|0|||
156853373|NCT00404651|566217854|FG001|Overall Study|Serious Adverse Event|0|||
156853374|NCT00404651|566217855|FG002|Overall Study|Serious Adverse Event|2|||
156853375|NCT00404651|566217856|FG003|Overall Study|Serious Adverse Event|0|||
156853376|NCT00404651|566217853|FG000|Overall Study|Protocol Violation|10|||
156853377|NCT00404651|566217854|FG001|Overall Study|Protocol Violation|5|||
156853378|NCT00404651|566217855|FG002|Overall Study|Protocol Violation|14|||
156853379|NCT00404651|566217856|FG003|Overall Study|Protocol Violation|5|||
156853380|NCT00404651|566217853|FG000|Overall Study|Lost to Follow-up|15|||
156853381|NCT00404651|566217854|FG001|Overall Study|Lost to Follow-up|11|||
156853382|NCT00404651|566217855|FG002|Overall Study|Lost to Follow-up|13|||
156853383|NCT00404651|566217856|FG003|Overall Study|Lost to Follow-up|10|||
156853384|NCT00404651|566217853|FG000|Overall Study|Withdrawal by Subject|14|||
156853385|NCT00404651|566217854|FG001|Overall Study|Withdrawal by Subject|12|||
156853386|NCT00404651|566217855|FG002|Overall Study|Withdrawal by Subject|16|||
156853387|NCT00404651|566217856|FG003|Overall Study|Withdrawal by Subject|6|||
156853388|NCT03347123|566217859|FG000|Overall Study|Death|1|||
156853389|NCT03347123|566217860|FG001|Overall Study|Death|2|||
157025773|NCT03628924|566849614|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156853390|NCT03347123|566217861|FG002|Overall Study|Death|0|||
157025774|NCT03628924|566849615|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
157025775|NCT03628924|566849616|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
157025776|NCT03628924|566849617|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
156853391|NCT03347123|566217862|FG003|Overall Study|Death|0|||
156853392|NCT03347123|566217863|FG004|Overall Study|Death|0|||
156853393|NCT03347123|566217864|FG005|Overall Study|Death|0|||
156889558|NCT04214288|566355497|FG003|Overall Study|Protocol Violation|0|||
156853394|NCT03347123|566217865|FG006|Overall Study|Death|0|||
156853395|NCT03347123|566217859|FG000|Overall Study|Withdrawal by Subject|1|||
156853396|NCT03347123|566217860|FG001|Overall Study|Withdrawal by Subject|0|||
156853397|NCT03347123|566217861|FG002|Overall Study|Withdrawal by Subject|0|||
156853398|NCT03347123|566217862|FG003|Overall Study|Withdrawal by Subject|0|||
156853399|NCT03347123|566217863|FG004|Overall Study|Withdrawal by Subject|0|||
156853400|NCT03347123|566217864|FG005|Overall Study|Withdrawal by Subject|0|||
156853401|NCT03347123|566217865|FG006|Overall Study|Withdrawal by Subject|0|||
156853402|NCT03347123|566217859|FG000|Overall Study|Reason not Specified|3|||
156853403|NCT03347123|566217860|FG001|Overall Study|Reason not Specified|4|||
156853404|NCT03347123|566217861|FG002|Overall Study|Reason not Specified|0|||
156853405|NCT03347123|566217862|FG003|Overall Study|Reason not Specified|0|||
156853406|NCT03347123|566217863|FG004|Overall Study|Reason not Specified|0|||
156853407|NCT03347123|566217864|FG005|Overall Study|Reason not Specified|0|||
156853408|NCT03347123|566217865|FG006|Overall Study|Reason not Specified|0|||
156853409|NCT01276639|566217874|FG000|Week 0 to 16|Death|1|||
156853410|NCT01276639|566217875|FG001|Week 0 to 16|Death|0|||
156853411|NCT01276639|566217876|FG002|Week 0 to 16|Death|0|||
156853412|NCT01276639|566217877|FG003|Week 0 to 16|Death|0|||
156853413|NCT01276639|566217878|FG004|Week 0 to 16|Death|0|||
156853414|NCT01276639|566217874|FG000|Week 0 to 16|Adverse Event|11|||
156853415|NCT01276639|566217875|FG001|Week 0 to 16|Adverse Event|8|||
156853416|NCT01276639|566217876|FG002|Week 0 to 16|Adverse Event|11|||
156853417|NCT01276639|566217877|FG003|Week 0 to 16|Adverse Event|0|||
156853418|NCT01276639|566217878|FG004|Week 0 to 16|Adverse Event|0|||
156853419|NCT01276639|566217874|FG000|Week 0 to 16|Lack of Efficacy|20|||
156853420|NCT01276639|566217875|FG001|Week 0 to 16|Lack of Efficacy|15|||
156853421|NCT01276639|566217876|FG002|Week 0 to 16|Lack of Efficacy|25|||
156853422|NCT01276639|566217877|FG003|Week 0 to 16|Lack of Efficacy|0|||
156853423|NCT01276639|566217878|FG004|Week 0 to 16|Lack of Efficacy|0|||
156853424|NCT01276639|566217874|FG000|Week 0 to 16|Lost to Follow-up|3|||
156853425|NCT01276639|566217875|FG001|Week 0 to 16|Lost to Follow-up|5|||
156853426|NCT01276639|566217876|FG002|Week 0 to 16|Lost to Follow-up|3|||
156853427|NCT01276639|566217877|FG003|Week 0 to 16|Lost to Follow-up|0|||
156853428|NCT01276639|566217878|FG004|Week 0 to 16|Lost to Follow-up|0|||
156853429|NCT01276639|566217874|FG000|Week 0 to 16|Withdrawal by Subject|8|||
156853430|NCT01276639|566217875|FG001|Week 0 to 16|Withdrawal by Subject|5|||
156853431|NCT01276639|566217876|FG002|Week 0 to 16|Withdrawal by Subject|4|||
156853432|NCT01276639|566217877|FG003|Week 0 to 16|Withdrawal by Subject|0|||
156853433|NCT01276639|566217878|FG004|Week 0 to 16|Withdrawal by Subject|0|||
156853434|NCT01276639|566217874|FG000|Week 0 to 16|Other|7|||
156853435|NCT01276639|566217875|FG001|Week 0 to 16|Other|7|||
156853436|NCT01276639|566217876|FG002|Week 0 to 16|Other|2|||
156853437|NCT01276639|566217877|FG003|Week 0 to 16|Other|0|||
156853438|NCT01276639|566217878|FG004|Week 0 to 16|Other|0|||
156853439|NCT01276639|566217874|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
156853440|NCT01276639|566217875|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
156853441|NCT01276639|566217876|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
156853442|NCT01276639|566217877|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
156853443|NCT01276639|566217878|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
156853444|NCT01276639|566217874|FG000|Week 16 to 52|Death|1|||
156853445|NCT01276639|566217875|FG001|Week 16 to 52|Death|0|||
156853446|NCT01276639|566217876|FG002|Week 16 to 52|Death|0|||
156853447|NCT01276639|566217877|FG003|Week 16 to 52|Death|0|||
156853448|NCT01276639|566217878|FG004|Week 16 to 52|Death|0|||
156853449|NCT01276639|566217874|FG000|Week 16 to 52|Adverse Event|10|||
156853450|NCT01276639|566217875|FG001|Week 16 to 52|Adverse Event|13|||
156853451|NCT01276639|566217876|FG002|Week 16 to 52|Adverse Event|0|||
156853452|NCT01276639|566217877|FG003|Week 16 to 52|Adverse Event|1|||
156853453|NCT01276639|566217878|FG004|Week 16 to 52|Adverse Event|3|||
156853454|NCT01276639|566217874|FG000|Week 16 to 52|Lack of Efficacy|99|||
156853455|NCT01276639|566217875|FG001|Week 16 to 52|Lack of Efficacy|71|||
156853456|NCT01276639|566217876|FG002|Week 16 to 52|Lack of Efficacy|0|||
156853457|NCT01276639|566217877|FG003|Week 16 to 52|Lack of Efficacy|14|||
156853458|NCT01276639|566217878|FG004|Week 16 to 52|Lack of Efficacy|13|||
156853459|NCT01276639|566217874|FG000|Week 16 to 52|Lost to Follow-up|3|||
156853460|NCT01276639|566217875|FG001|Week 16 to 52|Lost to Follow-up|1|||
156853461|NCT01276639|566217876|FG002|Week 16 to 52|Lost to Follow-up|0|||
156853462|NCT01276639|566217877|FG003|Week 16 to 52|Lost to Follow-up|0|||
156853463|NCT01276639|566217878|FG004|Week 16 to 52|Lost to Follow-up|1|||
156853464|NCT01276639|566217874|FG000|Week 16 to 52|Withdrawal by Subject|4|||
156853465|NCT01276639|566217875|FG001|Week 16 to 52|Withdrawal by Subject|4|||
156853466|NCT01276639|566217876|FG002|Week 16 to 52|Withdrawal by Subject|0|||
157025777|NCT03628924|566849618|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
157025778|NCT03628924|566849619|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
157205204|NCT03926728|567496070|FG009|Overall Study|Withdrawal by Subject|1|||
156853467|NCT01276639|566217877|FG003|Week 16 to 52|Withdrawal by Subject|0|||
156853468|NCT01276639|566217878|FG004|Week 16 to 52|Withdrawal by Subject|1|||
156853469|NCT01276639|566217874|FG000|Week 16 to 52|Other|10|||
156853470|NCT01276639|566217875|FG001|Week 16 to 52|Other|12|||
156853471|NCT01276639|566217876|FG002|Week 16 to 52|Other|0|||
156853472|NCT01276639|566217877|FG003|Week 16 to 52|Other|1|||
156853473|NCT01276639|566217878|FG004|Week 16 to 52|Other|3|||
156853474|NCT03431441|566217879|FG000|Overall Study|Withdrawal by Subject|2|||
156853475|NCT03431441|566217879|FG000|Overall Study|Adverse Event|2|||
156853476|NCT03431441|566217879|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
156853477|NCT05030350|566217883|FG000|Overall Study|Adverse Event|13|||
156853478|NCT05030350|566217883|FG000|Overall Study|Lack of Efficacy|8|||
156853479|NCT05030350|566217883|FG000|Overall Study|Lost to Follow-up|35|||
156853480|NCT05030350|566217883|FG000|Overall Study|Pregnancy|2|||
156853481|NCT05030350|566217883|FG000|Overall Study|Protocol Violation|2|||
156853482|NCT05030350|566217883|FG000|Overall Study|Withdrawal by Subject|60|||
156853483|NCT05030350|566217883|FG000|Overall Study|Study terminated by sponsor|349|||
156853484|NCT05030350|566217883|FG000|Overall Study|Positive Drug Screen|4|||
156853485|NCT05030350|566217883|FG000|Overall Study|Other|8|||
156853486|NCT03654690|566217884|FG000|Overall Study|Withdrawal by Subject|1|||
156853487|NCT03654690|566217885|FG001|Overall Study|Withdrawal by Subject|0|||
156853488|NCT03654690|566217886|FG002|Overall Study|Withdrawal by Subject|0|||
156853489|NCT02711137|566217887|FG000|Overall Study|Death|1|||
156853490|NCT02711137|566217888|FG001|Overall Study|Death|4|||
156853491|NCT02711137|566217889|FG002|Overall Study|Death|5|||
156853492|NCT02711137|566217890|FG003|Overall Study|Death|5|||
156853493|NCT02711137|566217891|FG004|Overall Study|Death|3|||
156853494|NCT02711137|566217892|FG005|Overall Study|Death|1|||
156853495|NCT02711137|566217893|FG006|Overall Study|Death|61|||
156853496|NCT02711137|566217894|FG007|Overall Study|Death|3|||
156853497|NCT02711137|566217895|FG008|Overall Study|Death|0|||
156853498|NCT02711137|566217896|FG009|Overall Study|Death|1|||
156853499|NCT02711137|566217897|FG010|Overall Study|Death|1|||
156853500|NCT02711137|566217898|FG011|Overall Study|Death|1|||
156853501|NCT02711137|566217899|FG012|Overall Study|Death|0|||
156853502|NCT02711137|566217900|FG013|Overall Study|Death|0|||
156853503|NCT02711137|566217901|FG014|Overall Study|Death|0|||
156853504|NCT02711137|566217887|FG000|Overall Study|Study Terminated by Sponsor|0|||
156853505|NCT02711137|566217888|FG001|Overall Study|Study Terminated by Sponsor|0|||
156853506|NCT02711137|566217889|FG002|Overall Study|Study Terminated by Sponsor|1|||
156853507|NCT02711137|566217890|FG003|Overall Study|Study Terminated by Sponsor|0|||
156853508|NCT02711137|566217891|FG004|Overall Study|Study Terminated by Sponsor|0|||
156853509|NCT02711137|566217892|FG005|Overall Study|Study Terminated by Sponsor|0|||
156853510|NCT02711137|566217893|FG006|Overall Study|Study Terminated by Sponsor|1|||
156853511|NCT02711137|566217894|FG007|Overall Study|Study Terminated by Sponsor|0|||
156853512|NCT02711137|566217895|FG008|Overall Study|Study Terminated by Sponsor|0|||
156853513|NCT02711137|566217896|FG009|Overall Study|Study Terminated by Sponsor|0|||
156853514|NCT02711137|566217897|FG010|Overall Study|Study Terminated by Sponsor|0|||
156853515|NCT02711137|566217898|FG011|Overall Study|Study Terminated by Sponsor|0|||
156853516|NCT02711137|566217899|FG012|Overall Study|Study Terminated by Sponsor|0|||
156853517|NCT02711137|566217900|FG013|Overall Study|Study Terminated by Sponsor|0|||
156853518|NCT02711137|566217901|FG014|Overall Study|Study Terminated by Sponsor|0|||
156853519|NCT02711137|566217887|FG000|Overall Study|Physician Decision|1|||
156853520|NCT02711137|566217888|FG001|Overall Study|Physician Decision|0|||
156853521|NCT02711137|566217889|FG002|Overall Study|Physician Decision|2|||
156853522|NCT02711137|566217890|FG003|Overall Study|Physician Decision|1|||
156853523|NCT02711137|566217891|FG004|Overall Study|Physician Decision|1|||
156853524|NCT02711137|566217892|FG005|Overall Study|Physician Decision|0|||
156853525|NCT02711137|566217893|FG006|Overall Study|Physician Decision|12|||
156853526|NCT02711137|566217894|FG007|Overall Study|Physician Decision|2|||
156853527|NCT02711137|566217895|FG008|Overall Study|Physician Decision|1|||
156853528|NCT02711137|566217896|FG009|Overall Study|Physician Decision|1|||
156853529|NCT02711137|566217897|FG010|Overall Study|Physician Decision|3|||
156853530|NCT02711137|566217898|FG011|Overall Study|Physician Decision|2|||
156853531|NCT02711137|566217899|FG012|Overall Study|Physician Decision|1|||
156853532|NCT02711137|566217900|FG013|Overall Study|Physician Decision|1|||
156853533|NCT02711137|566217901|FG014|Overall Study|Physician Decision|2|||
156853534|NCT02711137|566217887|FG000|Overall Study|Other|0|||
156853535|NCT02711137|566217888|FG001|Overall Study|Other|1|||
156853536|NCT02711137|566217889|FG002|Overall Study|Other|0|||
156853537|NCT02711137|566217890|FG003|Overall Study|Other|0|||
156853538|NCT02711137|566217891|FG004|Overall Study|Other|0|||
156853539|NCT02711137|566217892|FG005|Overall Study|Other|0|||
156853540|NCT02711137|566217893|FG006|Overall Study|Other|3|||
156853541|NCT02711137|566217894|FG007|Overall Study|Other|0|||
156853542|NCT02711137|566217895|FG008|Overall Study|Other|0|||
156853543|NCT02711137|566217896|FG009|Overall Study|Other|0|||
156853544|NCT02711137|566217897|FG010|Overall Study|Other|0|||
156853545|NCT02711137|566217898|FG011|Overall Study|Other|0|||
156853546|NCT02711137|566217899|FG012|Overall Study|Other|0|||
156853547|NCT02711137|566217900|FG013|Overall Study|Other|0|||
156853548|NCT02711137|566217901|FG014|Overall Study|Other|1|||
156853549|NCT02711137|566217887|FG000|Overall Study|Withdrawal by Subject|1|||
156853550|NCT02711137|566217888|FG001|Overall Study|Withdrawal by Subject|0|||
156853551|NCT02711137|566217889|FG002|Overall Study|Withdrawal by Subject|0|||
156853552|NCT02711137|566217890|FG003|Overall Study|Withdrawal by Subject|1|||
156853553|NCT02711137|566217891|FG004|Overall Study|Withdrawal by Subject|1|||
156853554|NCT02711137|566217892|FG005|Overall Study|Withdrawal by Subject|0|||
156853555|NCT02711137|566217893|FG006|Overall Study|Withdrawal by Subject|7|||
156853556|NCT02711137|566217894|FG007|Overall Study|Withdrawal by Subject|0|||
156853557|NCT02711137|566217895|FG008|Overall Study|Withdrawal by Subject|0|||
156853558|NCT02711137|566217896|FG009|Overall Study|Withdrawal by Subject|0|||
156853559|NCT02711137|566217897|FG010|Overall Study|Withdrawal by Subject|0|||
156853560|NCT02711137|566217898|FG011|Overall Study|Withdrawal by Subject|0|||
156853561|NCT02711137|566217899|FG012|Overall Study|Withdrawal by Subject|0|||
156853562|NCT02711137|566217900|FG013|Overall Study|Withdrawal by Subject|1|||
156853563|NCT02711137|566217901|FG014|Overall Study|Withdrawal by Subject|0|||
156853564|NCT02711137|566217887|FG000|Overall Study|Lost to Follow-up|1|||
156853565|NCT02711137|566217888|FG001|Overall Study|Lost to Follow-up|0|||
156853566|NCT02711137|566217889|FG002|Overall Study|Lost to Follow-up|0|||
156853567|NCT02711137|566217890|FG003|Overall Study|Lost to Follow-up|0|||
156853568|NCT02711137|566217891|FG004|Overall Study|Lost to Follow-up|0|||
156853569|NCT02711137|566217892|FG005|Overall Study|Lost to Follow-up|0|||
156853570|NCT02711137|566217893|FG006|Overall Study|Lost to Follow-up|2|||
156853571|NCT02711137|566217894|FG007|Overall Study|Lost to Follow-up|0|||
156853572|NCT02711137|566217895|FG008|Overall Study|Lost to Follow-up|0|||
156853573|NCT02711137|566217896|FG009|Overall Study|Lost to Follow-up|0|||
156853574|NCT02711137|566217897|FG010|Overall Study|Lost to Follow-up|0|||
156853575|NCT02711137|566217898|FG011|Overall Study|Lost to Follow-up|0|||
156853576|NCT02711137|566217899|FG012|Overall Study|Lost to Follow-up|0|||
156853577|NCT02711137|566217900|FG013|Overall Study|Lost to Follow-up|0|||
156853578|NCT02711137|566217901|FG014|Overall Study|Lost to Follow-up|0|||
156853579|NCT03985761|566217902|FG000|Overall Study|Withdrawal by Subject|2|||
156853580|NCT03985761|566217903|FG001|Overall Study|Withdrawal by Subject|3|||
156853581|NCT03400852|566217904|FG000|Blinded Treatment Period|Physician Decision|0|||
156853582|NCT03400852|566217905|FG001|Blinded Treatment Period|Physician Decision|1|||
156853583|NCT03400852|566217906|FG002|Blinded Treatment Period|Physician Decision|0|||
156853584|NCT03400852|566217904|FG000|Blinded Treatment Period|Adverse Event|1|||
156853585|NCT03400852|566217905|FG001|Blinded Treatment Period|Adverse Event|1|||
156853586|NCT03400852|566217906|FG002|Blinded Treatment Period|Adverse Event|0|||
156853587|NCT03400852|566217904|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
156853588|NCT03400852|566217905|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
156853589|NCT03400852|566217906|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
156853590|NCT03400852|566217904|FG000|Open Label Period|Physician Decision|0|||
156853591|NCT03400852|566217905|FG001|Open Label Period|Physician Decision|0|||
156853592|NCT03400852|566217906|FG002|Open Label Period|Physician Decision|1|||
156853593|NCT03400852|566217904|FG000|Open Label Period|Study terminated by sponsor|0|||
156853594|NCT03400852|566217905|FG001|Open Label Period|Study terminated by sponsor|0|||
156853595|NCT03400852|566217906|FG002|Open Label Period|Study terminated by sponsor|21|||
156853596|NCT01285401|566217907|FG000|Overall Study|Prematurely withdrawn from the study|17|||
156853597|NCT01285401|566217908|FG001|Overall Study|Prematurely withdrawn from the study|29|||
156853598|NCT03719131|566217913|FG000|Overall Study|Death|1|||
156853599|NCT03719131|566217914|FG001|Overall Study|Death|2|||
156853600|NCT01544920|566217915|FG000|Overall Study|Adverse Event|0|||
156853601|NCT01544920|566217916|FG001|Overall Study|Adverse Event|3|||
156853602|NCT01544920|566217915|FG000|Overall Study|Death|0|||
156853603|NCT01544920|566217916|FG001|Overall Study|Death|1|||
156853604|NCT01544920|566217915|FG000|Overall Study|Lost to Follow-up|11|||
156853605|NCT01544920|566217916|FG001|Overall Study|Lost to Follow-up|12|||
156853606|NCT01544920|566217915|FG000|Overall Study|Protocol Violation|0|||
156853607|NCT01544920|566217916|FG001|Overall Study|Protocol Violation|2|||
156853608|NCT01544920|566217915|FG000|Overall Study|Physician Decision|4|||
156853609|NCT01544920|566217916|FG001|Overall Study|Physician Decision|1|||
156853610|NCT01544920|566217915|FG000|Overall Study|Withdrawal by Subject|4|||
156853611|NCT01544920|566217916|FG001|Overall Study|Withdrawal by Subject|4|||
156853612|NCT02420093|566217917|FG000|Overall Study|Withdrawal by Subject|1|||
156853613|NCT02420093|566217918|FG001|Overall Study|Withdrawal by Subject|1|||
156889559|NCT04214288|566355494|FG000|Overall Study|Withdrawal by Subject|8|||
157157533|NCT01554956|567321162|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
157157534|NCT00913978|567321163|FG000|Overall Study|Surgeon choice|1|||
156853614|NCT03244917|566217921|FG000|Overall Study|Lost to Follow-up|2|||
156853615|NCT03244917|566217922|FG001|Overall Study|Lost to Follow-up|2|||
156853616|NCT03001557|566217924|FG000|Core Phase|Randomized but not treated|0|||
156853617|NCT03001557|566217925|FG001|Core Phase|Randomized but not treated|0|||
156853618|NCT03001557|566217926|FG002|Core Phase|Randomized but not treated|1|||
156853619|NCT03001557|566217927|FG003|Core Phase|Randomized but not treated|0|||
156853620|NCT03001557|566217928|FG004|Core Phase|Randomized but not treated|0|||
156853621|NCT03001557|566217929|FG005|Core Phase|Randomized but not treated|0|||
156853622|NCT03001557|566217930|FG006|Core Phase|Randomized but not treated|0|||
156853623|NCT03001557|566217931|FG007|Core Phase|Randomized but not treated|0|||
156853624|NCT03001557|566217924|FG000|Extension Phase|Adverse Event|0|||
156853625|NCT03001557|566217925|FG001|Extension Phase|Adverse Event|0|||
156853626|NCT03001557|566217926|FG002|Extension Phase|Adverse Event|0|||
156853627|NCT03001557|566217927|FG003|Extension Phase|Adverse Event|0|||
156853628|NCT03001557|566217928|FG004|Extension Phase|Adverse Event|0|||
156853629|NCT03001557|566217929|FG005|Extension Phase|Adverse Event|2|||
156853630|NCT03001557|566217930|FG006|Extension Phase|Adverse Event|0|||
156853631|NCT03001557|566217931|FG007|Extension Phase|Adverse Event|0|||
156853632|NCT03001557|566217924|FG000|Extension Phase|Withdrawal by Subject|0|||
157157535|NCT00913978|567321164|FG001|Overall Study|Surgeon choice|3|||
156853633|NCT03001557|566217925|FG001|Extension Phase|Withdrawal by Subject|0|||
156853634|NCT03001557|566217926|FG002|Extension Phase|Withdrawal by Subject|0|||
156853635|NCT03001557|566217927|FG003|Extension Phase|Withdrawal by Subject|0|||
156853636|NCT03001557|566217928|FG004|Extension Phase|Withdrawal by Subject|0|||
156853637|NCT03001557|566217929|FG005|Extension Phase|Withdrawal by Subject|1|||
156853638|NCT03001557|566217930|FG006|Extension Phase|Withdrawal by Subject|5|||
156853639|NCT03001557|566217931|FG007|Extension Phase|Withdrawal by Subject|2|||
156853640|NCT03001557|566217924|FG000|Extension Phase|Lost to Follow-up|0|||
156853641|NCT03001557|566217925|FG001|Extension Phase|Lost to Follow-up|0|||
156853642|NCT03001557|566217926|FG002|Extension Phase|Lost to Follow-up|0|||
156853643|NCT03001557|566217927|FG003|Extension Phase|Lost to Follow-up|0|||
156853644|NCT03001557|566217928|FG004|Extension Phase|Lost to Follow-up|0|||
156853645|NCT03001557|566217929|FG005|Extension Phase|Lost to Follow-up|0|||
156853646|NCT03001557|566217930|FG006|Extension Phase|Lost to Follow-up|2|||
156853647|NCT03001557|566217931|FG007|Extension Phase|Lost to Follow-up|1|||
156853648|NCT03001557|566217924|FG000|Extension Phase|Administrative Reason|0|||
156853649|NCT03001557|566217925|FG001|Extension Phase|Administrative Reason|0|||
156853650|NCT03001557|566217926|FG002|Extension Phase|Administrative Reason|0|||
156853651|NCT03001557|566217927|FG003|Extension Phase|Administrative Reason|0|||
156853652|NCT03001557|566217928|FG004|Extension Phase|Administrative Reason|0|||
156853653|NCT03001557|566217929|FG005|Extension Phase|Administrative Reason|1|||
156853654|NCT03001557|566217930|FG006|Extension Phase|Administrative Reason|3|||
156853655|NCT03001557|566217931|FG007|Extension Phase|Administrative Reason|3|||
156853656|NCT03001557|566217924|FG000|Extension Phase|Loss of caregiver|0|||
156853657|NCT03001557|566217925|FG001|Extension Phase|Loss of caregiver|0|||
156853658|NCT03001557|566217926|FG002|Extension Phase|Loss of caregiver|0|||
156853659|NCT03001557|566217927|FG003|Extension Phase|Loss of caregiver|0|||
156853660|NCT03001557|566217928|FG004|Extension Phase|Loss of caregiver|0|||
156853661|NCT03001557|566217929|FG005|Extension Phase|Loss of caregiver|0|||
157157536|NCT00532948|567321165|FG000|Overall Study|Protocol Violation|1|||
157157537|NCT00532948|567321166|FG001|Overall Study|Protocol Violation|0|||
157157538|NCT00532948|567321167|FG002|Overall Study|Protocol Violation|0|||
156853662|NCT03001557|566217930|FG006|Extension Phase|Loss of caregiver|1|||
156853663|NCT03001557|566217931|FG007|Extension Phase|Loss of caregiver|0|||
156853664|NCT03001557|566217924|FG000|Extension Phase|Others|0|||
156853665|NCT03001557|566217925|FG001|Extension Phase|Others|0|||
156853666|NCT03001557|566217926|FG002|Extension Phase|Others|0|||
156853667|NCT03001557|566217927|FG003|Extension Phase|Others|0|||
156853668|NCT03001557|566217928|FG004|Extension Phase|Others|0|||
156853669|NCT03001557|566217929|FG005|Extension Phase|Others|1|||
156853670|NCT03001557|566217930|FG006|Extension Phase|Others|3|||
156853671|NCT03001557|566217931|FG007|Extension Phase|Others|0|||
156853672|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
156853673|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
156853674|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Death|1|||
156853675|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Death|2|||
156853676|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
156853677|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
156853678|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
156853679|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
156853680|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
156853681|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
156853682|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
157157539|NCT00532948|567321165|FG000|Overall Study|Death|3|||
156853683|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
156853684|NCT01794000|566217932|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
156853685|NCT01794000|566217933|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
156853686|NCT01794000|566217932|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
156853687|NCT01794000|566217933|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
156853688|NCT01272232|566217936|FG000|Weeks 0-56|Adverse Event|39|||
156853689|NCT01272232|566217937|FG001|Weeks 0-56|Adverse Event|18|||
156853690|NCT01272232|566217938|FG002|Weeks 0-56|Adverse Event|7|||
156853691|NCT01272232|566217936|FG000|Weeks 0-56|Lack of Efficacy|0|||
156853692|NCT01272232|566217937|FG001|Weeks 0-56|Lack of Efficacy|0|||
156853693|NCT01272232|566217938|FG002|Weeks 0-56|Lack of Efficacy|3|||
156853694|NCT01272232|566217936|FG000|Weeks 0-56|Protocol Violation|12|||
156853695|NCT01272232|566217937|FG001|Weeks 0-56|Protocol Violation|8|||
156853696|NCT01272232|566217938|FG002|Weeks 0-56|Protocol Violation|13|||
156853697|NCT01272232|566217936|FG000|Weeks 0-56|Withdrawal criteria|32|||
156853698|NCT01272232|566217937|FG001|Weeks 0-56|Withdrawal criteria|14|||
156853699|NCT01272232|566217938|FG002|Weeks 0-56|Withdrawal criteria|37|||
156853700|NCT01272232|566217936|FG000|Weeks 0-56|Unclassified|16|||
156853701|NCT01272232|566217937|FG001|Weeks 0-56|Unclassified|7|||
157157540|NCT00532948|567321166|FG001|Overall Study|Death|3|||
157157541|NCT00532948|567321167|FG002|Overall Study|Death|4|||
157025779|NCT03628924|566849613|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156853702|NCT01272232|566217938|FG002|Weeks 0-56|Unclassified|12|||
156853703|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
156853704|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
156853705|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
156853706|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
156853707|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
156853708|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
156853709|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
156853710|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
156853711|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
156853712|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
156853713|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
156853714|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
156853715|NCT01272232|566217936|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
156853716|NCT01272232|566217937|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
156853717|NCT01272232|566217938|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
156853718|NCT02159066|566217939|FG000|Part I|Adverse Event|7|||
156853719|NCT02159066|566217940|FG001|Part I|Adverse Event|5|||
156853720|NCT02159066|566217941|FG002|Part I|Adverse Event|0|||
156853721|NCT02159066|566217942|FG003|Part I|Adverse Event|0|||
156853722|NCT02159066|566217943|FG004|Part I|Adverse Event|0|||
156853723|NCT02159066|566217944|FG005|Part I|Adverse Event|0|||
156853724|NCT02159066|566217939|FG000|Part I|Death|11|||
156853725|NCT02159066|566217940|FG001|Part I|Death|9|||
156853726|NCT02159066|566217941|FG002|Part I|Death|0|||
156853727|NCT02159066|566217942|FG003|Part I|Death|0|||
156853728|NCT02159066|566217943|FG004|Part I|Death|0|||
156853729|NCT02159066|566217944|FG005|Part I|Death|0|||
156853730|NCT02159066|566217939|FG000|Part I|Progressive Disease|37|||
156853731|NCT02159066|566217940|FG001|Part I|Progressive Disease|46|||
156853732|NCT02159066|566217941|FG002|Part I|Progressive Disease|0|||
156853733|NCT02159066|566217942|FG003|Part I|Progressive Disease|0|||
156853734|NCT02159066|566217943|FG004|Part I|Progressive Disease|0|||
156853735|NCT02159066|566217944|FG005|Part I|Progressive Disease|0|||
156853736|NCT02159066|566217939|FG000|Part I|New Therapy for Study Indication|5|||
156853737|NCT02159066|566217940|FG001|Part I|New Therapy for Study Indication|4|||
156853738|NCT02159066|566217941|FG002|Part I|New Therapy for Study Indication|0|||
156853739|NCT02159066|566217942|FG003|Part I|New Therapy for Study Indication|0|||
156853740|NCT02159066|566217943|FG004|Part I|New Therapy for Study Indication|0|||
156853741|NCT02159066|566217944|FG005|Part I|New Therapy for Study Indication|0|||
156853742|NCT02159066|566217939|FG000|Part I|Termination of participants from the study|3|||
156853743|NCT02159066|566217940|FG001|Part I|Termination of participants from the study|3|||
156853744|NCT02159066|566217941|FG002|Part I|Termination of participants from the study|0|||
156853745|NCT02159066|566217942|FG003|Part I|Termination of participants from the study|0|||
156853746|NCT02159066|566217943|FG004|Part I|Termination of participants from the study|0|||
156853747|NCT02159066|566217944|FG005|Part I|Termination of participants from the study|0|||
156853748|NCT02159066|566217939|FG000|Part I|Physician Decision|2|||
156853749|NCT02159066|566217940|FG001|Part I|Physician Decision|9|||
156853750|NCT02159066|566217941|FG002|Part I|Physician Decision|0|||
156853751|NCT02159066|566217942|FG003|Part I|Physician Decision|0|||
156853752|NCT02159066|566217943|FG004|Part I|Physician Decision|0|||
156853753|NCT02159066|566217944|FG005|Part I|Physician Decision|0|||
156853754|NCT02159066|566217939|FG000|Part I|Participant/Guardian Decision|9|||
156853755|NCT02159066|566217940|FG001|Part I|Participant/Guardian Decision|3|||
156853756|NCT02159066|566217941|FG002|Part I|Participant/Guardian Decision|0|||
156853757|NCT02159066|566217942|FG003|Part I|Participant/Guardian Decision|0|||
156853758|NCT02159066|566217943|FG004|Part I|Participant/Guardian Decision|0|||
156853759|NCT02159066|566217944|FG005|Part I|Participant/Guardian Decision|0|||
156853760|NCT02159066|566217939|FG000|Part I|Missing Data|1|||
156853761|NCT02159066|566217940|FG001|Part I|Missing Data|0|||
156853762|NCT02159066|566217941|FG002|Part I|Missing Data|0|||
156853763|NCT02159066|566217942|FG003|Part I|Missing Data|0|||
156853764|NCT02159066|566217943|FG004|Part I|Missing Data|0|||
156853765|NCT02159066|566217944|FG005|Part I|Missing Data|0|||
156853766|NCT02159066|566217939|FG000|Part II|Adverse Event|0|||
156853767|NCT02159066|566217940|FG001|Part II|Adverse Event|0|||
156853768|NCT02159066|566217941|FG002|Part II|Adverse Event|1|||
156853769|NCT02159066|566217942|FG003|Part II|Adverse Event|0|||
156853770|NCT02159066|566217943|FG004|Part II|Adverse Event|1|||
156853771|NCT02159066|566217944|FG005|Part II|Adverse Event|1|||
156853772|NCT02159066|566217939|FG000|Part II|Death|0|||
156853773|NCT02159066|566217940|FG001|Part II|Death|0|||
156853774|NCT02159066|566217941|FG002|Part II|Death|1|||
156853775|NCT02159066|566217942|FG003|Part II|Death|0|||
156853776|NCT02159066|566217943|FG004|Part II|Death|2|||
156853777|NCT02159066|566217944|FG005|Part II|Death|1|||
156853778|NCT02159066|566217939|FG000|Part II|Progressive Disease|0|||
156853779|NCT02159066|566217940|FG001|Part II|Progressive Disease|0|||
156853780|NCT02159066|566217941|FG002|Part II|Progressive Disease|35|||
156853781|NCT02159066|566217942|FG003|Part II|Progressive Disease|1|||
156853782|NCT02159066|566217943|FG004|Part II|Progressive Disease|7|||
156853783|NCT02159066|566217944|FG005|Part II|Progressive Disease|4|||
156853784|NCT02159066|566217939|FG000|Part II|New Therapy for Study Indication|0|||
156853785|NCT02159066|566217940|FG001|Part II|New Therapy for Study Indication|0|||
156853786|NCT02159066|566217941|FG002|Part II|New Therapy for Study Indication|0|||
156853787|NCT02159066|566217942|FG003|Part II|New Therapy for Study Indication|0|||
156853788|NCT02159066|566217943|FG004|Part II|New Therapy for Study Indication|1|||
156853789|NCT02159066|566217944|FG005|Part II|New Therapy for Study Indication|0|||
156853790|NCT02159066|566217939|FG000|Part II|Physician Decision|0|||
156853791|NCT02159066|566217940|FG001|Part II|Physician Decision|0|||
156853792|NCT02159066|566217941|FG002|Part II|Physician Decision|1|||
156853793|NCT02159066|566217942|FG003|Part II|Physician Decision|0|||
156853794|NCT02159066|566217943|FG004|Part II|Physician Decision|0|||
156853795|NCT02159066|566217944|FG005|Part II|Physician Decision|0|||
156853796|NCT02159066|566217939|FG000|Part II|Participant/Guardian Decision|0|||
156853797|NCT02159066|566217940|FG001|Part II|Participant/Guardian Decision|0|||
156853798|NCT02159066|566217941|FG002|Part II|Participant/Guardian Decision|0|||
156853799|NCT02159066|566217942|FG003|Part II|Participant/Guardian Decision|0|||
156853800|NCT02159066|566217943|FG004|Part II|Participant/Guardian Decision|2|||
156853801|NCT02159066|566217944|FG005|Part II|Participant/Guardian Decision|0|||
156853802|NCT01367834|566217945|FG000|Overall Study|Withdrawal by Subject|2|||
156853803|NCT01367834|566217946|FG001|Overall Study|Withdrawal by Subject|2|||
156853804|NCT01367834|566217945|FG000|Overall Study|Study was ended.|0|||
156853805|NCT01367834|566217946|FG001|Overall Study|Study was ended.|1|||
156853806|NCT01569841|566217951|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
156853807|NCT01569841|566217952|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
156853808|NCT01859923|566217953|FG000|Overall Study|Adverse Event|0|||
156853809|NCT01859923|566217954|FG001|Overall Study|Adverse Event|0|||
156853810|NCT01859923|566217955|FG002|Overall Study|Adverse Event|1|||
156853811|NCT01859923|566217956|FG003|Overall Study|Adverse Event|1|||
156853812|NCT00113841|566217971|FG000|Overall Study|Disease progression|0|||
156853813|NCT00113841|566217972|FG001|Overall Study|Disease progression|2|||
156853814|NCT00113841|566217971|FG000|Overall Study|Non-compliant|1|||
156853815|NCT00113841|566217972|FG001|Overall Study|Non-compliant|0|||
156853816|NCT00866814|566217973|FG000|Overall Study|Lost to Follow-up|12|||
156853817|NCT00866814|566217973|FG000|Overall Study|Adverse Event|2|||
156853818|NCT00866814|566217973|FG000|Overall Study|Physician Decision|1|||
156853819|NCT00866814|566217973|FG000|Overall Study|Death|1|||
156853820|NCT00866814|566217973|FG000|Overall Study|No longer wished to participate|1|||
156853821|NCT00866814|566217973|FG000|Overall Study|Unable to meet follow-up requirements|2|||
156853822|NCT00866814|566217973|FG000|Overall Study|Moved to area without study site|1|||
156853823|NCT04491136|566217974|FG000|Overall Study|Patient withdraw informed consent|9|||
156853824|NCT04491136|566217974|FG000|Overall Study|Adverse Event|2|||
156853825|NCT04491136|566217974|FG000|Overall Study|Death|3|||
156853826|NCT04491136|566217974|FG000|Overall Study|Lost to Follow-up|3|||
156853827|NCT04491136|566217974|FG000|Overall Study|Physician Decision|45|||
156853828|NCT04491136|566217974|FG000|Overall Study|sponsor terminated the study early|16|||
156853829|NCT04491136|566217974|FG000|Overall Study|Patient/guardian's decision|1|||
156853830|NCT00319254|566217977|FG000|Overall Study|Withdrawal by Subject|4|||
156853831|NCT00319254|566217977|FG000|Overall Study|Death|46|||
156853832|NCT00319254|566217977|FG000|Overall Study|Lost to Follow-up|2|||
156853833|NCT00319254|566217977|FG000|Overall Study|Enrolled, Not Treated|2|||
156853834|NCT01712204|566217981|FG000|Overall Study|Adverse Event|3|||
156853835|NCT01712204|566217982|FG001|Overall Study|Adverse Event|1|||
156853836|NCT01712204|566217981|FG000|Overall Study|Withdrawal by Subject|3|||
156853837|NCT01712204|566217982|FG001|Overall Study|Withdrawal by Subject|3|||
156853838|NCT01712204|566217981|FG000|Overall Study|Lost to Follow-up|1|||
156853839|NCT01712204|566217982|FG001|Overall Study|Lost to Follow-up|0|||
156853840|NCT01712204|566217981|FG000|Overall Study|Protocol Violation|1|||
156853841|NCT01712204|566217982|FG001|Overall Study|Protocol Violation|1|||
156853842|NCT02452424|566217985|FG000|Overall Study|Death|2|||
156853843|NCT02452424|566217986|FG001|Overall Study|Death|2|||
156853844|NCT02452424|566217987|FG002|Overall Study|Death|2|||
156853845|NCT02452424|566217988|FG003|Overall Study|Death|6|||
156853846|NCT02452424|566217989|FG004|Overall Study|Death|2|||
156853847|NCT02452424|566217990|FG005|Overall Study|Death|0|||
156853848|NCT02452424|566217991|FG006|Overall Study|Death|5|||
156853849|NCT02452424|566217992|FG007|Overall Study|Death|1|||
156853850|NCT02452424|566217993|FG008|Overall Study|Death|3|||
156853851|NCT02452424|566217994|FG009|Overall Study|Death|1|||
156853852|NCT02452424|566217995|FG010|Overall Study|Death|0|||
156853853|NCT02452424|566217985|FG000|Overall Study|Lost to Follow-up|0|||
156853854|NCT02452424|566217986|FG001|Overall Study|Lost to Follow-up|1|||
156853855|NCT02452424|566217987|FG002|Overall Study|Lost to Follow-up|1|||
156853856|NCT02452424|566217988|FG003|Overall Study|Lost to Follow-up|0|||
156853857|NCT02452424|566217989|FG004|Overall Study|Lost to Follow-up|0|||
156853858|NCT02452424|566217990|FG005|Overall Study|Lost to Follow-up|0|||
156853859|NCT02452424|566217991|FG006|Overall Study|Lost to Follow-up|0|||
156853860|NCT02452424|566217992|FG007|Overall Study|Lost to Follow-up|0|||
156853861|NCT02452424|566217993|FG008|Overall Study|Lost to Follow-up|0|||
156853862|NCT02452424|566217994|FG009|Overall Study|Lost to Follow-up|0|||
156853863|NCT02452424|566217995|FG010|Overall Study|Lost to Follow-up|0|||
156853864|NCT02452424|566217985|FG000|Overall Study|Withdrawal by Subject|0|||
156853865|NCT02452424|566217986|FG001|Overall Study|Withdrawal by Subject|0|||
156853866|NCT02452424|566217987|FG002|Overall Study|Withdrawal by Subject|3|||
156853867|NCT02452424|566217988|FG003|Overall Study|Withdrawal by Subject|2|||
156853868|NCT02452424|566217989|FG004|Overall Study|Withdrawal by Subject|0|||
156853869|NCT02452424|566217990|FG005|Overall Study|Withdrawal by Subject|0|||
156853870|NCT02452424|566217991|FG006|Overall Study|Withdrawal by Subject|1|||
156853871|NCT02452424|566217992|FG007|Overall Study|Withdrawal by Subject|0|||
156853872|NCT02452424|566217993|FG008|Overall Study|Withdrawal by Subject|1|||
156853873|NCT02452424|566217994|FG009|Overall Study|Withdrawal by Subject|1|||
156853874|NCT02452424|566217995|FG010|Overall Study|Withdrawal by Subject|0|||
156853875|NCT02452424|566217985|FG000|Overall Study|Other|0|||
156853876|NCT02452424|566217986|FG001|Overall Study|Other|0|||
156853877|NCT02452424|566217987|FG002|Overall Study|Other|1|||
156853878|NCT02452424|566217988|FG003|Overall Study|Other|0|||
156853879|NCT02452424|566217989|FG004|Overall Study|Other|0|||
156853880|NCT02452424|566217990|FG005|Overall Study|Other|1|||
156853881|NCT02452424|566217991|FG006|Overall Study|Other|4|||
156853882|NCT02452424|566217992|FG007|Overall Study|Other|3|||
156853883|NCT02452424|566217993|FG008|Overall Study|Other|0|||
156853884|NCT02452424|566217994|FG009|Overall Study|Other|0|||
156853885|NCT02452424|566217995|FG010|Overall Study|Other|1|||
156853886|NCT02452424|566217985|FG000|Overall Study|Progressive disease (per RECIST)|0|||
156853887|NCT02452424|566217986|FG001|Overall Study|Progressive disease (per RECIST)|0|||
156853888|NCT02452424|566217987|FG002|Overall Study|Progressive disease (per RECIST)|0|||
156853889|NCT02452424|566217988|FG003|Overall Study|Progressive disease (per RECIST)|0|||
156853890|NCT02452424|566217989|FG004|Overall Study|Progressive disease (per RECIST)|0|||
156853891|NCT02452424|566217990|FG005|Overall Study|Progressive disease (per RECIST)|0|||
156853892|NCT02452424|566217991|FG006|Overall Study|Progressive disease (per RECIST)|0|||
156853893|NCT02452424|566217992|FG007|Overall Study|Progressive disease (per RECIST)|0|||
156853894|NCT02452424|566217993|FG008|Overall Study|Progressive disease (per RECIST)|2|||
156853895|NCT02452424|566217994|FG009|Overall Study|Progressive disease (per RECIST)|0|||
156853896|NCT02452424|566217995|FG010|Overall Study|Progressive disease (per RECIST)|0|||
156853897|NCT02452424|566217985|FG000|Overall Study|Adverse Event|0|||
156853898|NCT02452424|566217986|FG001|Overall Study|Adverse Event|0|||
156853899|NCT02452424|566217987|FG002|Overall Study|Adverse Event|0|||
156853900|NCT02452424|566217988|FG003|Overall Study|Adverse Event|0|||
156853901|NCT02452424|566217989|FG004|Overall Study|Adverse Event|0|||
156853902|NCT02452424|566217990|FG005|Overall Study|Adverse Event|0|||
156853903|NCT02452424|566217991|FG006|Overall Study|Adverse Event|0|||
156853904|NCT02452424|566217992|FG007|Overall Study|Adverse Event|0|||
156853905|NCT02452424|566217993|FG008|Overall Study|Adverse Event|0|||
156853906|NCT02452424|566217994|FG009|Overall Study|Adverse Event|0|||
156853907|NCT02452424|566217995|FG010|Overall Study|Adverse Event|1|||
156853908|NCT01059318|566217996|FG000|Core Study (26 Week)|Adverse Event|3|||
156853909|NCT01059318|566217996|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
156853910|NCT01059318|566217996|FG000|Extension (36 Week)|Adverse Event|3|||
156853911|NCT03790917|566217999|FG000|Overall Study|Death|1|||
156853912|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
156853913|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
156853914|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
156853915|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
156853916|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
156853917|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
156853918|NCT02679287|566218003|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
156853919|NCT02679287|566218004|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
156853920|NCT02679287|566218003|FG000|Period 2|Work/Scheduling Conflict|1|||
156853921|NCT02679287|566218004|FG001|Period 2|Work/Scheduling Conflict|0|||
156853922|NCT02679287|566218003|FG000|Period 2|Disliked Mobile System|2|||
156853923|NCT02679287|566218004|FG001|Period 2|Disliked Mobile System|0|||
156853924|NCT02679287|566218003|FG000|Period 3|Work/Scheduling Conflict|0|||
156853925|NCT02679287|566218004|FG001|Period 3|Work/Scheduling Conflict|1|||
156853926|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Death|2|||
156853927|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Death|0|||
156853928|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Death|0|||
156853929|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
156853930|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
156853931|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
156853932|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
156853933|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
156853934|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
156853935|NCT01150097|566218005|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
156853936|NCT01150097|566218006|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
156853937|NCT01150097|566218007|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
156853938|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
156853939|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
156853940|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
156853941|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
156853942|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
156853943|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
156853944|NCT01150097|566218005|FG000|Months 24 to 48 Post-transplantation|Death|2|||
156853945|NCT01150097|566218006|FG001|Months 24 to 48 Post-transplantation|Death|0|||
156853946|NCT01150097|566218007|FG002|Months 24 to 48 Post-transplantation|Death|0|||
156853947|NCT01408459|566218008|FG000|Overall Study|Withdrawal by Subject|1|||
156853948|NCT01408459|566218009|FG001|Overall Study|Withdrawal by Subject|1|||
156853949|NCT00984256|566219556|FG000|Overall Study|Withdrawal by Subject|0|||
156853950|NCT00984256|566219557|FG001|Overall Study|Withdrawal by Subject|1|||
156853951|NCT01131507|566219562|FG000|Overall Study|Adverse Event|1|||
156853952|NCT01131507|566219562|FG000|Overall Study|Lost to Follow-up|1|||
156853953|NCT01131507|566219562|FG000|Overall Study|Withdrawal by Subject|1|||
156853954|NCT01790594|566219563|FG000|Overall Study|Death|1|||
156853955|NCT01790594|566219564|FG001|Overall Study|Death|0|||
156853956|NCT01790594|566219565|FG002|Overall Study|Death|0|||
156853957|NCT01790594|566219563|FG000|Overall Study|Physician Decision|2|||
156853958|NCT01790594|566219564|FG001|Overall Study|Physician Decision|1|||
156853959|NCT01790594|566219565|FG002|Overall Study|Physician Decision|0|||
156853960|NCT01790594|566219563|FG000|Overall Study|Withdrawal by Subject|2|||
156853961|NCT01790594|566219564|FG001|Overall Study|Withdrawal by Subject|0|||
156853962|NCT01790594|566219565|FG002|Overall Study|Withdrawal by Subject|0|||
156853963|NCT01790594|566219563|FG000|Overall Study|Transplant was not done|0|||
156853964|NCT01790594|566219564|FG001|Overall Study|Transplant was not done|0|||
156853965|NCT01790594|566219565|FG002|Overall Study|Transplant was not done|3|||
156853966|NCT01790594|566219563|FG000|Overall Study|Terminated prior to week 76|0|||
156853967|NCT01790594|566219564|FG001|Overall Study|Terminated prior to week 76|2|||
156853968|NCT01790594|566219565|FG002|Overall Study|Terminated prior to week 76|0|||
156853969|NCT02038153|566219566|FG000|Overall Study|Withdrawal by Subject|1|||
156853970|NCT02647281|566219567|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853971|NCT02647281|566219568|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853972|NCT02647281|566219569|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853973|NCT02647281|566219570|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853974|NCT02647281|566219571|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853975|NCT02647281|566219572|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853976|NCT02647281|566219573|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853977|NCT02647281|566219574|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
156853978|NCT02647281|566219575|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
156853979|NCT00796666|566219581|FG000|Overall Study|Death|2|||
156853980|NCT00796666|566219582|FG001|Overall Study|Death|4|||
156853981|NCT00796666|566219581|FG000|Overall Study|Withdrawal by Subject|2|||
156853982|NCT00796666|566219582|FG001|Overall Study|Withdrawal by Subject|0|||
156853983|NCT00796666|566219581|FG000|Overall Study|Adverse Event|7|||
156853984|NCT00796666|566219582|FG001|Overall Study|Adverse Event|5|||
156853985|NCT00796666|566219581|FG000|Overall Study|Protocol Violation|1|||
156853986|NCT00796666|566219582|FG001|Overall Study|Protocol Violation|0|||
156853987|NCT00796666|566219581|FG000|Overall Study|Other|1|||
156853988|NCT00796666|566219582|FG001|Overall Study|Other|0|||
156853989|NCT00796666|566219581|FG000|Overall Study|Terminated by sponsor|53|||
157157542|NCT00532948|567321165|FG000|Overall Study|Violation of selection criteria at entry|0|||
157157543|NCT00532948|567321166|FG001|Overall Study|Violation of selection criteria at entry|1|||
157157544|NCT00532948|567321167|FG002|Overall Study|Violation of selection criteria at entry|0|||
157157545|NCT00532948|567321165|FG000|Overall Study|Failure to return|0|||
157157546|NCT00532948|567321166|FG001|Overall Study|Failure to return|1|||
156853990|NCT00796666|566219582|FG001|Overall Study|Terminated by sponsor|55|||
157157547|NCT00532948|567321167|FG002|Overall Study|Failure to return|0|||
156853991|NCT00796666|566219581|FG000|Overall Study|Randomized and not treated|1|||
156853992|NCT00796666|566219582|FG001|Overall Study|Randomized and not treated|0|||
156853993|NCT02576639|566219584|FG000|Overall Study|Withdrawal by Subject|1|||
156853994|NCT02576639|566219585|FG001|Overall Study|Withdrawal by Subject|2|||
156853995|NCT02576639|566219586|FG002|Overall Study|Withdrawal by Subject|1|||
156853996|NCT02576639|566219587|FG003|Overall Study|Withdrawal by Subject|0|||
156853997|NCT02576639|566219588|FG004|Overall Study|Withdrawal by Subject|1|||
157157548|NCT03885726|567321169|FG000|Overall Study|Staffing issues/lost interest|1|||
156853998|NCT02576639|566219584|FG000|Overall Study|Adverse Event|1|||
156853999|NCT02576639|566219585|FG001|Overall Study|Adverse Event|0|||
156854000|NCT02576639|566219586|FG002|Overall Study|Adverse Event|1|||
156854001|NCT02576639|566219587|FG003|Overall Study|Adverse Event|1|||
156854002|NCT02576639|566219588|FG004|Overall Study|Adverse Event|2|||
156854003|NCT02576639|566219584|FG000|Overall Study|Physician Decision|0|||
156854004|NCT02576639|566219585|FG001|Overall Study|Physician Decision|0|||
156854005|NCT02576639|566219586|FG002|Overall Study|Physician Decision|0|||
156854006|NCT02576639|566219587|FG003|Overall Study|Physician Decision|0|||
156854007|NCT02576639|566219588|FG004|Overall Study|Physician Decision|1|||
156854008|NCT01135134|566219589|FG000|Overall Study|Adverse Event|1|||
156854009|NCT01135134|566219590|FG001|Overall Study|Adverse Event|1|||
156854010|NCT01135134|566219589|FG000|Overall Study|Did not meet protocol eligibility|1|||
156854011|NCT01135134|566219590|FG001|Overall Study|Did not meet protocol eligibility|0|||
156854012|NCT00255190|566219591|FG000|Overall Study|Adverse Event|17|||
156854013|NCT00255190|566219592|FG001|Overall Study|Adverse Event|36|||
156854014|NCT00255190|566219591|FG000|Overall Study|Protocol Violation|2|||
156854015|NCT00255190|566219592|FG001|Overall Study|Protocol Violation|2|||
156854016|NCT00255190|566219591|FG000|Overall Study|Lost to Follow-up|10|||
156854017|NCT00255190|566219592|FG001|Overall Study|Lost to Follow-up|27|||
156854018|NCT00255190|566219591|FG000|Overall Study|Withdrew Consent|17|||
156854019|NCT00255190|566219592|FG001|Overall Study|Withdrew Consent|48|||
156854020|NCT00255190|566219591|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
156854021|NCT00255190|566219592|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156854022|NCT00255190|566219591|FG000|Overall Study|Erosive esophagitis not healed|0|||
156854023|NCT00255190|566219592|FG001|Overall Study|Erosive esophagitis not healed|20|||
156854024|NCT00255190|566219591|FG000|Overall Study|Various|4|||
156854025|NCT00255190|566219592|FG001|Overall Study|Various|23|||
156854026|NCT00628030|566219597|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
156854027|NCT00628030|566219598|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
156854028|NCT00628030|566219597|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
156854029|NCT00628030|566219598|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
156854030|NCT00628030|566219597|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
156854031|NCT00628030|566219598|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
156854032|NCT01156480|566219600|FG000|Overall Study|change in diagnosis|0|||
156854033|NCT01156480|566219601|FG001|Overall Study|change in diagnosis|1|||
156854034|NCT04537793|566219602|FG000|Part B (24 Weeks)|Adverse Event|0|||
156854035|NCT04537793|566219603|FG001|Part B (24 Weeks)|Adverse Event|1|||
156854036|NCT01255423|566219604|FG000|Overall Study|Abnormal Laboratory value|3|||
156854037|NCT01255423|566219605|FG001|Overall Study|Abnormal Laboratory value|2|||
156854038|NCT01255423|566219604|FG000|Overall Study|Use of prohibited medications|0|||
156854039|NCT01255423|566219605|FG001|Overall Study|Use of prohibited medications|1|||
156854040|NCT00988598|566219606|FG000|Overall Study|Withdrawal by Subject|2|||
156854041|NCT00988598|566219607|FG001|Overall Study|Withdrawal by Subject|0|||
156854042|NCT01176058|566219611|FG000|Overall Study|Adverse Event|1|||
156854043|NCT01176058|566219612|FG001|Overall Study|Adverse Event|0|||
156854044|NCT01176058|566219611|FG000|Overall Study|Insufficient clinical response|2|||
156854045|NCT01176058|566219612|FG001|Overall Study|Insufficient clinical response|2|||
156854046|NCT01176058|566219611|FG000|Overall Study|Insufficient mycological response|0|||
156854047|NCT01176058|566219612|FG001|Overall Study|Insufficient mycological response|1|||
156854048|NCT01176058|566219611|FG000|Overall Study|Withdrawal by Subject|1|||
156854049|NCT01176058|566219612|FG001|Overall Study|Withdrawal by Subject|0|||
156854050|NCT00256724|566219615|FG000|Overall Study|Physician Decision|2|||
156854051|NCT00256724|566219616|FG001|Overall Study|Physician Decision|5|||
156854052|NCT00256724|566219615|FG000|Overall Study|Protocol Violation|3|||
156854053|NCT00256724|566219616|FG001|Overall Study|Protocol Violation|3|||
156854054|NCT01217463|566219617|FG000|Overall Study|Adverse Event|8|||
156854055|NCT01217463|566219618|FG001|Overall Study|Adverse Event|5|||
156854056|NCT01217463|566219617|FG000|Overall Study|Physician Decision|0|||
156854057|NCT01217463|566219618|FG001|Overall Study|Physician Decision|1|||
156854058|NCT01217463|566219617|FG000|Overall Study|Withdrawal by Subject|3|||
156854059|NCT01217463|566219618|FG001|Overall Study|Withdrawal by Subject|0|||
156854060|NCT01217463|566219617|FG000|Overall Study|Surgery on the Target Limb|0|||
156854061|NCT01217463|566219618|FG001|Overall Study|Surgery on the Target Limb|1|||
156854062|NCT01217463|566219617|FG000|Overall Study|Patient Non-compliant|1|||
156854063|NCT01217463|566219618|FG001|Overall Study|Patient Non-compliant|0|||
157025780|NCT03628924|566849614|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157025781|NCT03628924|566849615|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
156854064|NCT01217463|566219617|FG000|Overall Study|Other|1|||
156854065|NCT01217463|566219618|FG001|Overall Study|Other|1|||
157025782|NCT03628924|566849616|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156854066|NCT01858363|566219627|FG000|Overall Study|Death|35|||
156854067|NCT01858363|566219628|FG001|Overall Study|Death|9|||
156854068|NCT01858363|566219627|FG000|Overall Study|Withdrawal by Subject|28|||
156854069|NCT01858363|566219628|FG001|Overall Study|Withdrawal by Subject|14|||
156854070|NCT01858363|566219627|FG000|Overall Study|Lost to Follow-up|13|||
156854071|NCT01858363|566219628|FG001|Overall Study|Lost to Follow-up|3|||
156854072|NCT00057863|566219637|FG000|Overall Study|Death|1|||
156854073|NCT00057863|566219637|FG000|Overall Study|Withdrawal by Subject|2|||
156854074|NCT00764361|566219638|FG000|Overall Study|Withdrawal by Subject|2|||
156854075|NCT00764361|566219639|FG001|Overall Study|Withdrawal by Subject|3|||
156854076|NCT00764361|566219638|FG000|Overall Study|Adverse Event|0|||
156854077|NCT00764361|566219639|FG001|Overall Study|Adverse Event|1|||
156854078|NCT02090426|566219640|FG000|Overall Study|Lost to Follow-up|12|||
156854079|NCT02090426|566219641|FG001|Overall Study|Lost to Follow-up|6|||
156854080|NCT02079038|566219645|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
156854081|NCT02079038|566219646|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
156854082|NCT02079038|566219645|FG000|Modified Intent to Treat Population|Death|1|||
156854083|NCT02079038|566219646|FG001|Modified Intent to Treat Population|Death|0|||
156854084|NCT02079038|566219645|FG000|Completed 6 Months|Lost to Follow-up|2|||
156854085|NCT02079038|566219646|FG001|Completed 6 Months|Lost to Follow-up|1|||
156854086|NCT01141712|566219647|FG000|Overall Study|Disease progression|3|||
156854087|NCT01308736|566219648|FG000|Overall Study|Did not attend a single session|6|||
156854088|NCT01308736|566219649|FG001|Overall Study|Did not attend a single session|5|||
156854089|NCT03634085|566219650|FG000|Overall Study|Adverse Event|1|||
156854090|NCT03634085|566219651|FG001|Overall Study|Adverse Event|0|||
156854091|NCT03634085|566219650|FG000|Overall Study|Withdrawal by Subject|0|||
156854092|NCT03634085|566219651|FG001|Overall Study|Withdrawal by Subject|2|||
156854093|NCT03948334|566219660|FG000|Overall Study|Adverse Event|1|||
156854094|NCT03948334|566219661|FG001|Overall Study|Adverse Event|4|||
156854095|NCT03948334|566219660|FG000|Overall Study|Lack of Efficacy|2|||
156854096|NCT03948334|566219661|FG001|Overall Study|Lack of Efficacy|0|||
156854097|NCT03948334|566219660|FG000|Overall Study|Lost to Follow-up|1|||
156854098|NCT03948334|566219661|FG001|Overall Study|Lost to Follow-up|0|||
156854099|NCT03948334|566219660|FG000|Overall Study|Physician Decision|1|||
156854100|NCT03948334|566219661|FG001|Overall Study|Physician Decision|0|||
156854101|NCT03948334|566219660|FG000|Overall Study|Pregnancy|0|||
156854102|NCT03948334|566219661|FG001|Overall Study|Pregnancy|1|||
156854103|NCT03948334|566219660|FG000|Overall Study|Protocol Deviation|1|||
156854104|NCT03948334|566219661|FG001|Overall Study|Protocol Deviation|0|||
156854105|NCT03948334|566219660|FG000|Overall Study|Study terminated by Sponsor|50|||
156854106|NCT03948334|566219661|FG001|Overall Study|Study terminated by Sponsor|51|||
156854107|NCT03948334|566219660|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
156854108|NCT03948334|566219661|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
156854109|NCT03775486|566219666|FG000|Initial Therapy Phase|Other reason provided|0|||
156854110|NCT03775486|566219667|FG001|Initial Therapy Phase|Other reason provided|15|||
156854111|NCT03775486|566219666|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
156854112|NCT03775486|566219667|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
156854113|NCT03775486|566219666|FG000|Initial Therapy Phase|Protocol Violation|0|||
156854114|NCT03775486|566219667|FG001|Initial Therapy Phase|Protocol Violation|2|||
156854115|NCT03775486|566219666|FG000|Initial Therapy Phase|Adverse Event|0|||
156854116|NCT03775486|566219667|FG001|Initial Therapy Phase|Adverse Event|34|||
156854117|NCT03775486|566219666|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
157157549|NCT03885726|567321169|FG000|Overall Study|Early discharge from hospital|3|||
156854118|NCT03775486|566219667|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
156854119|NCT03775486|566219666|FG000|Maintenance Phase|Withdrawal by Subject|13|||
156854120|NCT03775486|566219667|FG001|Maintenance Phase|Withdrawal by Subject|12|||
156854121|NCT03775486|566219666|FG000|Maintenance Phase|Death|44|||
156854122|NCT03775486|566219667|FG001|Maintenance Phase|Death|45|||
156854123|NCT05477485|566219668|FG000|Overall Study|Lost to Follow-up|0|||
156854124|NCT05477485|566219669|FG001|Overall Study|Lost to Follow-up|4|||
156854125|NCT03116685|566219670|FG000|Overall Study|Physician Decision|0|||
156854126|NCT03116685|566219671|FG001|Overall Study|Physician Decision|1|||
156854127|NCT05081219|566219672|FG000|Overall Study|Withdrawal by Subject|4|||
156854128|NCT05081219|566219673|FG001|Overall Study|Withdrawal by Subject|0|||
156854129|NCT05081219|566219674|FG002|Overall Study|Withdrawal by Subject|0|||
156854130|NCT05081219|566219675|FG003|Overall Study|Withdrawal by Subject|1|||
156854131|NCT00801216|566219676|FG000|Overall Study|Screening Failure|2|||
156889560|NCT04214288|566355495|FG001|Overall Study|Withdrawal by Subject|4|||
156889561|NCT04214288|566355496|FG002|Overall Study|Withdrawal by Subject|0|||
156889562|NCT04214288|566355497|FG003|Overall Study|Withdrawal by Subject|9|||
156889563|NCT02361580|566355498|FG000|Overall Study|Lost to Follow-up|6|||
156889564|NCT02361580|566355499|FG001|Overall Study|Lost to Follow-up|3|||
156889565|NCT02047318|566355500|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
157157550|NCT02702193|567321174|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
156854132|NCT05274958|566219677|FG000|Overall Study|Only completed 1 set of PROMs|22|||
156854133|NCT05274958|566219678|FG001|Overall Study|Only completed 1 set of PROMs|35|||
156854134|NCT06235905|566219679|FG000|Overall Study|Adverse Event|1|||
156854135|NCT06235905|566219679|FG000|Overall Study|Non-compliant with protocol procedures|1|||
156889566|NCT02047318|566355500|FG000|Core Study Period|Adverse Event|1|||
156854136|NCT01505374|566219681|FG000|Overall Study|Lost to Follow-up|1|||
156889567|NCT02047318|566355500|FG000|Core Study Period|Withdrawal by caregiver|3|||
156854137|NCT01505374|566219682|FG001|Overall Study|Lost to Follow-up|0|||
156854138|NCT00320515|566219684|FG000|Overall Study|Death|33|||
156854139|NCT00320515|566219684|FG000|Overall Study|Lost to Follow-up|6|||
156854140|NCT00320515|566219684|FG000|Overall Study|Physician Decision|2|||
156854141|NCT00320515|566219684|FG000|Overall Study|Withdrawal by Subject|8|||
156854142|NCT01114828|566219685|FG000|Overall Study|Adverse Event|1|||
156854143|NCT01114828|566219686|FG001|Overall Study|Adverse Event|1|||
156854144|NCT01114828|566219685|FG000|Overall Study|Lack of Efficacy|0|||
156854145|NCT01114828|566219686|FG001|Overall Study|Lack of Efficacy|2|||
156854146|NCT01114828|566219685|FG000|Overall Study|Protocol Violation|2|||
156854147|NCT01114828|566219686|FG001|Overall Study|Protocol Violation|0|||
156854148|NCT01114828|566219685|FG000|Overall Study|Withdrawal by Subject|0|||
156854149|NCT01114828|566219686|FG001|Overall Study|Withdrawal by Subject|1|||
156854150|NCT00851786|566219689|FG000|Overall Study|Withdrawal by Subject|0|||
156854151|NCT00851786|566219690|FG001|Overall Study|Withdrawal by Subject|1|||
156854152|NCT00851786|566219689|FG000|Overall Study|Protocol Violation|0|||
156854153|NCT00851786|566219690|FG001|Overall Study|Protocol Violation|1|||
156854154|NCT00851786|566219689|FG000|Overall Study|Lost to Follow-up|1|||
156854155|NCT00851786|566219690|FG001|Overall Study|Lost to Follow-up|0|||
156854156|NCT00851786|566219689|FG000|Overall Study|Incarceration|1|||
156854157|NCT00851786|566219690|FG001|Overall Study|Incarceration|0|||
156854158|NCT00851786|566219689|FG000|Overall Study|Site Closure|1|||
156854159|NCT00851786|566219690|FG001|Overall Study|Site Closure|0|||
156854160|NCT00851786|566219689|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
156854161|NCT00851786|566219690|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
156854162|NCT04177212|566219692|FG000|Overall Study|Withdrawal by Subject|9|||
156854163|NCT04177212|566219693|FG001|Overall Study|Withdrawal by Subject|7|||
156854164|NCT04177212|566219692|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
156854165|NCT04177212|566219693|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
156854166|NCT04177212|566219692|FG000|Overall Study|Physician Decision|1|||
156854167|NCT04177212|566219693|FG001|Overall Study|Physician Decision|0|||
156854168|NCT04177212|566219692|FG000|Overall Study|Lost to Follow-up|0|||
156854169|NCT04177212|566219693|FG001|Overall Study|Lost to Follow-up|3|||
156854170|NCT04177212|566219692|FG000|Overall Study|Adverse Event|0|||
156854171|NCT04177212|566219693|FG001|Overall Study|Adverse Event|1|||
156854172|NCT04177212|566219692|FG000|Overall Study|Other|1|||
156854173|NCT04177212|566219693|FG001|Overall Study|Other|2|||
156854174|NCT01792115|566219694|FG000|Overall Study|Lost to Follow-up|0|||
156854175|NCT01792115|566219695|FG001|Overall Study|Lost to Follow-up|1|||
156854176|NCT01792115|566219696|FG002|Overall Study|Lost to Follow-up|0|||
156854177|NCT01279681|566219697|FG000|Overall Study|Disease Progression|9|||
156854178|NCT01279681|566219698|FG001|Overall Study|Disease Progression|6|||
156854179|NCT01279681|566219697|FG000|Overall Study|Withdrawal by Subject|3|||
156854180|NCT01279681|566219698|FG001|Overall Study|Withdrawal by Subject|4|||
156854181|NCT01279681|566219697|FG000|Overall Study|Adverse Event|2|||
156854182|NCT01279681|566219698|FG001|Overall Study|Adverse Event|3|||
156854183|NCT01279681|566219697|FG000|Overall Study|Death|0|||
156854184|NCT01279681|566219698|FG001|Overall Study|Death|1|||
156854185|NCT01279681|566219697|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
156854186|NCT01279681|566219698|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
156854187|NCT01279681|566219697|FG000|Overall Study|Physician Decision|1|||
156854188|NCT01279681|566219698|FG001|Overall Study|Physician Decision|0|||
156854189|NCT01279681|566219697|FG000|Overall Study|Other Reason|0|||
156854190|NCT01279681|566219698|FG001|Overall Study|Other Reason|2|||
156854191|NCT01943591|566219699|FG000|Overall Study|Lost to Follow-up|3|||
156854192|NCT01943591|566219700|FG001|Overall Study|Lost to Follow-up|4|||
156854193|NCT01943591|566219699|FG000|Overall Study|Death|2|||
156854194|NCT01943591|566219700|FG001|Overall Study|Death|7|||
156854195|NCT00496015|566221962|FG000|Overall Study|Other|1|||
156854196|NCT00496015|566221963|FG001|Overall Study|Other|0|||
156889568|NCT02047318|566355500|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
156889569|NCT00924781|566355501|FG000|Overall Study|Study terminated by sponsor|12|||
156889570|NCT00924781|566355502|FG001|Overall Study|Study terminated by sponsor|10|||
156889571|NCT01479985|566355503|FG000|Overall Study|Tablet malfunction, no data saved|1|||
156889572|NCT01479985|566355504|FG001|Overall Study|Tablet malfunction, no data saved|1|||
156889573|NCT01479985|566355503|FG000|Overall Study|No decisional conflict scale responses|0|||
156854197|NCT00496015|566221964|FG002|Overall Study|Other|0|||
156854198|NCT00496015|566221965|FG003|Overall Study|Other|1|||
156854199|NCT00496015|566221966|FG004|Overall Study|Other|0|||
156854200|NCT02730728|566221968|FG000|Overall Study|Withdrawal by Subject|0|||
156854201|NCT02730728|566221969|FG001|Overall Study|Withdrawal by Subject|1|||
156854202|NCT02730728|566221970|FG002|Overall Study|Withdrawal by Subject|0|||
156854203|NCT02730728|566221968|FG000|Overall Study|Lack of Efficacy|0|||
156854204|NCT02730728|566221969|FG001|Overall Study|Lack of Efficacy|1|||
156854205|NCT02730728|566221970|FG002|Overall Study|Lack of Efficacy|1|||
156854206|NCT00346216|566221972|FG000|Overall Study|Other|181|||
156854207|NCT00346216|566221973|FG001|Overall Study|Other|231|||
156854208|NCT00346216|566221974|FG002|Overall Study|Other|205|||
156854209|NCT00346216|566221972|FG000|Overall Study|No longer willing to participate|600|||
156854210|NCT00346216|566221973|FG001|Overall Study|No longer willing to participate|606|||
156854211|NCT00346216|566221974|FG002|Overall Study|No longer willing to participate|585|||
156854212|NCT00346216|566221972|FG000|Overall Study|Withdrawal by Subject|661|||
156854213|NCT00346216|566221973|FG001|Overall Study|Withdrawal by Subject|692|||
156854214|NCT00346216|566221974|FG002|Overall Study|Withdrawal by Subject|651|||
156854215|NCT00346216|566221972|FG000|Overall Study|Lost to Follow-up|611|||
156854216|NCT00346216|566221973|FG001|Overall Study|Lost to Follow-up|588|||
156854217|NCT00346216|566221974|FG002|Overall Study|Lost to Follow-up|542|||
156854218|NCT00346216|566221972|FG000|Overall Study|Physician Decision|80|||
156854219|NCT00346216|566221973|FG001|Overall Study|Physician Decision|76|||
156854220|NCT00346216|566221974|FG002|Overall Study|Physician Decision|59|||
156854221|NCT00346216|566221972|FG000|Overall Study|Does not meet entrance criteria|13|||
156854222|NCT00346216|566221973|FG001|Overall Study|Does not meet entrance criteria|10|||
156854223|NCT00346216|566221974|FG002|Overall Study|Does not meet entrance criteria|8|||
156854224|NCT00346216|566221972|FG000|Overall Study|Death|189|||
156854225|NCT00346216|566221973|FG001|Overall Study|Death|192|||
156854226|NCT00346216|566221974|FG002|Overall Study|Death|228|||
156854227|NCT00346216|566221972|FG000|Overall Study|Study terminated by sponsor|11|||
156854228|NCT00346216|566221973|FG001|Overall Study|Study terminated by sponsor|4|||
156854229|NCT00346216|566221974|FG002|Overall Study|Study terminated by sponsor|8|||
156854230|NCT00346216|566221972|FG000|Overall Study|Missing Subject Summary Status|62|||
156854231|NCT00346216|566221973|FG001|Overall Study|Missing Subject Summary Status|61|||
156854232|NCT00346216|566221974|FG002|Overall Study|Missing Subject Summary Status|62|||
156854233|NCT03956550|566221980|FG000|Overall Study|Sponsor decision|65|||
156854234|NCT03956550|566221981|FG001|Overall Study|Sponsor decision|66|||
156854235|NCT03956550|566221982|FG002|Overall Study|Sponsor decision|64|||
156854236|NCT03956550|566221980|FG000|Overall Study|Adverse Event|0|||
156854237|NCT03956550|566221981|FG001|Overall Study|Adverse Event|1|||
156854238|NCT03956550|566221982|FG002|Overall Study|Adverse Event|0|||
156854239|NCT03956550|566221980|FG000|Overall Study|Withdrawal by Subject|5|||
156854240|NCT03956550|566221981|FG001|Overall Study|Withdrawal by Subject|5|||
156854241|NCT03956550|566221982|FG002|Overall Study|Withdrawal by Subject|6|||
156854242|NCT04244253|566221983|FG000|Overall Study|Adverse Event|2|||
156854243|NCT04244253|566221984|FG001|Overall Study|Adverse Event|2|||
156854244|NCT04244253|566221985|FG002|Overall Study|Adverse Event|4|||
156854245|NCT04244253|566221983|FG000|Overall Study|Protocol Violation|1|||
156854246|NCT04244253|566221984|FG001|Overall Study|Protocol Violation|2|||
156854247|NCT04244253|566221985|FG002|Overall Study|Protocol Violation|1|||
156854248|NCT04244253|566221983|FG000|Overall Study|Withdrawal by Subject|0|||
156854249|NCT04244253|566221984|FG001|Overall Study|Withdrawal by Subject|1|||
156854250|NCT04244253|566221985|FG002|Overall Study|Withdrawal by Subject|6|||
156854251|NCT04244253|566221983|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156854252|NCT04244253|566221984|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156854253|NCT04244253|566221985|FG002|Overall Study|Non-Compliance With Study Drug|1|||
156854254|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854255|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854256|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854257|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854258|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854259|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854260|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854261|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854262|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854263|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854264|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854265|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854266|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
156854267|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854268|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
156854269|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854270|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854271|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854272|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854273|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
156854274|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854275|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
156889574|NCT01479985|566355504|FG001|Overall Study|No decisional conflict scale responses|2|||
156889575|NCT01479985|566355503|FG000|Overall Study|No post-visit survey|5|||
156854276|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
156854277|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854278|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854279|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854280|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854281|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
156854282|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
156854283|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
156854284|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
156854285|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
156854286|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
156854287|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
156854288|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
156854289|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
156854290|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
156854291|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
156854292|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
156854293|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
156854294|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
156854295|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
156854296|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
156854297|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
156854298|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
156854299|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854300|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854301|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854302|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854303|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854304|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854305|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854306|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854307|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854308|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854309|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
156854310|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854311|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854312|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854313|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
156854314|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854315|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854316|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854317|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854318|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854319|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854320|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854321|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854322|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854323|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854324|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854325|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854326|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854327|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
156854328|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
156854329|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854330|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854331|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854332|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
156854333|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854334|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854335|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854336|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854337|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854338|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854339|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
156854340|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854341|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854342|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854343|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
156854344|NCT01147666|566221987|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854345|NCT01147666|566221988|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854346|NCT01147666|566221989|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854347|NCT01147666|566221990|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854348|NCT01147666|566221991|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854349|NCT01147666|566221992|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854350|NCT01147666|566221993|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854351|NCT01147666|566221994|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854352|NCT01147666|566221995|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854353|NCT01147666|566221996|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854354|NCT01147666|566221997|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854355|NCT01147666|566221998|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854356|NCT01147666|566221999|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854357|NCT01147666|566222000|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
156854358|NCT01147666|566222001|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
156854359|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
156854360|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
156854361|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
156854362|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
156854363|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
156854364|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
156854365|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
156854366|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
156854367|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
156854368|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
156854369|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
156854370|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
156854371|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
156854372|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
156854373|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
156854374|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854375|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854376|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854377|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854378|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
156854379|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854380|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854381|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854382|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854383|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854384|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854385|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854386|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
156854387|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
156854388|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
156854389|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854390|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854391|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854392|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
156854393|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854394|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854395|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854396|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854397|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854398|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854399|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854400|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854401|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854402|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854403|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
156854404|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854405|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854406|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854407|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854408|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854409|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854410|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854411|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
157157551|NCT02702193|567321175|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
157157552|NCT02702193|567321174|FG000|4 Month Follow up|Withdrawal by Subject|1|||
157157553|NCT02702193|567321175|FG001|4 Month Follow up|Withdrawal by Subject|0|||
156854412|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854413|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854414|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854415|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854416|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854417|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
156854418|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
156854419|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854420|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854421|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854422|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
156854423|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854424|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854425|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854426|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854427|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854428|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854429|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
156854430|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854431|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854432|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854433|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
156854434|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854435|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854436|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854437|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854438|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854439|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854440|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854441|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
157025783|NCT03628924|566849617|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157025784|NCT03628924|566849618|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
157025785|NCT03628924|566849619|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
156854442|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854443|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854444|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854445|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854446|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
156854447|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854448|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
156854449|NCT01147666|566221987|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854450|NCT01147666|566221988|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854451|NCT01147666|566221989|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854452|NCT01147666|566221990|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854453|NCT01147666|566221991|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854454|NCT01147666|566221992|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854455|NCT01147666|566221993|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854456|NCT01147666|566221994|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854457|NCT01147666|566221995|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854458|NCT01147666|566221996|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854459|NCT01147666|566221997|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854460|NCT01147666|566221998|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854461|NCT01147666|566221999|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
156854462|NCT01147666|566222000|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
156854463|NCT01147666|566222001|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
156854464|NCT03480152|566222015|FG000|Phase I|Signed consent. Died before treatment.|1|||
156854465|NCT03480152|566222016|FG001|Phase I|Signed consent. Died before treatment.|0|||
156854466|NCT03480152|566222017|FG002|Phase I|Signed consent. Died before treatment.|0|||
156854467|NCT04276233|566222018|FG000|Overall Study|Adverse Event|1|||
156854468|NCT04276233|566222018|FG000|Overall Study|Lost to Follow-up|3|||
156854469|NCT04276233|566222018|FG000|Overall Study|Physician Decision|4|||
156854470|NCT04276233|566222018|FG000|Overall Study|Withdrawal by Subject|2|||
156854471|NCT01946139|566222019|FG000|Overall Study|Withdrawal by Subject|8|||
156854472|NCT01946139|566222019|FG000|Overall Study|ineligible|8|||
156854473|NCT01946139|566222019|FG000|Overall Study|Specimens not available|4|||
156854474|NCT00101686|566222020|FG000|Overall Study|Progressive Disease|37|||
156854475|NCT00101686|566222021|FG001|Overall Study|Progressive Disease|28|||
156854476|NCT00101686|566222022|FG002|Overall Study|Progressive Disease|37|||
156854477|NCT00101686|566222023|FG003|Overall Study|Progressive Disease|38|||
156854478|NCT00101686|566222024|FG004|Overall Study|Progressive Disease|28|||
156854479|NCT00101686|566222025|FG005|Overall Study|Progressive Disease|25|||
156854480|NCT00101686|566222026|FG006|Overall Study|Progressive Disease|5|||
156854481|NCT00101686|566222027|FG007|Overall Study|Progressive Disease|7|||
156854482|NCT00101686|566222028|FG008|Overall Study|Progressive Disease|10|||
156854483|NCT00101686|566222029|FG009|Overall Study|Progressive Disease|8|||
156854484|NCT00101686|566222020|FG000|Overall Study|initiation other anti-cancer treatment|4|||
156854485|NCT00101686|566222021|FG001|Overall Study|initiation other anti-cancer treatment|3|||
156854486|NCT00101686|566222022|FG002|Overall Study|initiation other anti-cancer treatment|4|||
156854487|NCT00101686|566222023|FG003|Overall Study|initiation other anti-cancer treatment|3|||
156854488|NCT00101686|566222024|FG004|Overall Study|initiation other anti-cancer treatment|1|||
156854489|NCT00101686|566222025|FG005|Overall Study|initiation other anti-cancer treatment|1|||
156854490|NCT00101686|566222026|FG006|Overall Study|initiation other anti-cancer treatment|2|||
156854491|NCT00101686|566222027|FG007|Overall Study|initiation other anti-cancer treatment|2|||
156854492|NCT00101686|566222028|FG008|Overall Study|initiation other anti-cancer treatment|3|||
156854493|NCT00101686|566222029|FG009|Overall Study|initiation other anti-cancer treatment|3|||
156854494|NCT00101686|566222020|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
156854495|NCT00101686|566222021|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
156854496|NCT00101686|566222022|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
156854497|NCT00101686|566222023|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
156854498|NCT00101686|566222024|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
156854499|NCT00101686|566222025|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
156854500|NCT00101686|566222026|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
156854501|NCT00101686|566222027|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
156854502|NCT00101686|566222028|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
156854503|NCT00101686|566222029|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
156854504|NCT00101686|566222020|FG000|Overall Study|unacceptable toxicity|3|||
156854505|NCT00101686|566222021|FG001|Overall Study|unacceptable toxicity|9|||
156854506|NCT00101686|566222022|FG002|Overall Study|unacceptable toxicity|10|||
156854507|NCT00101686|566222023|FG003|Overall Study|unacceptable toxicity|6|||
156854508|NCT00101686|566222024|FG004|Overall Study|unacceptable toxicity|16|||
156854509|NCT00101686|566222025|FG005|Overall Study|unacceptable toxicity|10|||
156854510|NCT00101686|566222026|FG006|Overall Study|unacceptable toxicity|4|||
156854511|NCT00101686|566222027|FG007|Overall Study|unacceptable toxicity|2|||
156854512|NCT00101686|566222028|FG008|Overall Study|unacceptable toxicity|1|||
156854513|NCT00101686|566222029|FG009|Overall Study|unacceptable toxicity|4|||
156854514|NCT00101686|566222020|FG000|Overall Study|Randomized but did not receive treament|1|||
156854515|NCT00101686|566222021|FG001|Overall Study|Randomized but did not receive treament|6|||
156854516|NCT00101686|566222022|FG002|Overall Study|Randomized but did not receive treament|2|||
156854517|NCT00101686|566222023|FG003|Overall Study|Randomized but did not receive treament|2|||
156854518|NCT00101686|566222024|FG004|Overall Study|Randomized but did not receive treament|2|||
156854519|NCT00101686|566222025|FG005|Overall Study|Randomized but did not receive treament|2|||
156854520|NCT00101686|566222026|FG006|Overall Study|Randomized but did not receive treament|0|||
156854521|NCT00101686|566222027|FG007|Overall Study|Randomized but did not receive treament|1|||
156854522|NCT00101686|566222028|FG008|Overall Study|Randomized but did not receive treament|0|||
156854523|NCT00101686|566222029|FG009|Overall Study|Randomized but did not receive treament|1|||
156854524|NCT00101686|566222020|FG000|Overall Study|intercurrent non-cancer related illness|0|||
156854525|NCT00101686|566222021|FG001|Overall Study|intercurrent non-cancer related illness|0|||
156854526|NCT00101686|566222022|FG002|Overall Study|intercurrent non-cancer related illness|2|||
156854527|NCT00101686|566222023|FG003|Overall Study|intercurrent non-cancer related illness|0|||
156854528|NCT00101686|566222024|FG004|Overall Study|intercurrent non-cancer related illness|1|||
156854529|NCT00101686|566222025|FG005|Overall Study|intercurrent non-cancer related illness|3|||
156854530|NCT00101686|566222026|FG006|Overall Study|intercurrent non-cancer related illness|1|||
156854531|NCT00101686|566222027|FG007|Overall Study|intercurrent non-cancer related illness|0|||
156854532|NCT00101686|566222028|FG008|Overall Study|intercurrent non-cancer related illness|1|||
156854533|NCT00101686|566222029|FG009|Overall Study|intercurrent non-cancer related illness|1|||
156854534|NCT00101686|566222020|FG000|Overall Study|Physician Decision|10|||
156854535|NCT00101686|566222021|FG001|Overall Study|Physician Decision|13|||
156854536|NCT00101686|566222022|FG002|Overall Study|Physician Decision|6|||
156854537|NCT00101686|566222023|FG003|Overall Study|Physician Decision|7|||
156854538|NCT00101686|566222024|FG004|Overall Study|Physician Decision|8|||
156854539|NCT00101686|566222025|FG005|Overall Study|Physician Decision|9|||
156854540|NCT00101686|566222026|FG006|Overall Study|Physician Decision|5|||
156854541|NCT00101686|566222027|FG007|Overall Study|Physician Decision|5|||
156854542|NCT00101686|566222028|FG008|Overall Study|Physician Decision|1|||
157157554|NCT02702193|567321174|FG000|4 Month Follow up|Lost to Follow-up|17|||
156854543|NCT00101686|566222029|FG009|Overall Study|Physician Decision|1|||
156854544|NCT00101686|566222020|FG000|Overall Study|Other|1|||
156854545|NCT00101686|566222021|FG001|Overall Study|Other|4|||
156854546|NCT00101686|566222022|FG002|Overall Study|Other|1|||
156854547|NCT00101686|566222023|FG003|Overall Study|Other|6|||
156854548|NCT00101686|566222024|FG004|Overall Study|Other|2|||
156854549|NCT00101686|566222025|FG005|Overall Study|Other|12|||
156854550|NCT00101686|566222026|FG006|Overall Study|Other|1|||
156854551|NCT00101686|566222027|FG007|Overall Study|Other|5|||
156854552|NCT00101686|566222028|FG008|Overall Study|Other|3|||
156854553|NCT00101686|566222029|FG009|Overall Study|Other|3|||
156854554|NCT00101686|566222020|FG000|Overall Study|Withdrawal by Subject|9|||
156854555|NCT00101686|566222021|FG001|Overall Study|Withdrawal by Subject|8|||
156854556|NCT00101686|566222022|FG002|Overall Study|Withdrawal by Subject|6|||
156854557|NCT00101686|566222023|FG003|Overall Study|Withdrawal by Subject|8|||
156854558|NCT00101686|566222024|FG004|Overall Study|Withdrawal by Subject|8|||
156854559|NCT00101686|566222025|FG005|Overall Study|Withdrawal by Subject|7|||
156854560|NCT00101686|566222026|FG006|Overall Study|Withdrawal by Subject|7|||
156854561|NCT00101686|566222027|FG007|Overall Study|Withdrawal by Subject|7|||
156854562|NCT00101686|566222028|FG008|Overall Study|Withdrawal by Subject|8|||
156854563|NCT00101686|566222029|FG009|Overall Study|Withdrawal by Subject|9|||
156854564|NCT00296816|566222030|FG000|Overall Study|Disease Progression|37|||
156854565|NCT00296816|566222030|FG000|Overall Study|Adverse Event|18|||
156854566|NCT00296816|566222030|FG000|Overall Study|Investigator/Participant request|5|||
156854567|NCT00296816|566222030|FG000|Overall Study|Non-compliance|1|||
156854568|NCT00296816|566222030|FG000|Overall Study|Missing for end of treatment|4|||
156854569|NCT00296816|566222030|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
156854570|NCT00296816|566222030|FG000|Overall Study|Poor performance status|1|||
156854571|NCT00296816|566222030|FG000|Overall Study|Relocation to Florida|1|||
156854572|NCT00296816|566222030|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
156854573|NCT00296816|566222030|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
156854574|NCT00296816|566222030|FG000|Overall Study|Neuropathy/patient preference|1|||
156854575|NCT00296816|566222030|FG000|Overall Study|Proteinuria|1|||
156854576|NCT00296816|566222030|FG000|Overall Study|ineligibility due to radiation treatment|1|||
156854577|NCT00985465|566222031|FG000|Overall Study|Withdrawal by Subject|1|||
156854578|NCT00985465|566222032|FG001|Overall Study|Withdrawal by Subject|2|||
156854579|NCT00985465|566222031|FG000|Overall Study|Considered to be part of the other group|0|||
156854580|NCT00985465|566222032|FG001|Overall Study|Considered to be part of the other group|1|||
156854581|NCT04701333|566222033|FG000|Overall Study|Lost to Follow-up|3|||
156854582|NCT04701333|566222034|FG001|Overall Study|Lost to Follow-up|7|||
156854583|NCT04701333|566222033|FG000|Overall Study|Withdrawal by Subject|0|||
156854584|NCT04701333|566222034|FG001|Overall Study|Withdrawal by Subject|1|||
156854585|NCT01012258|566222035|FG000|Overall Study|Death|14|||
156854586|NCT01012258|566222035|FG000|Overall Study|Lost to Follow-up|1|||
156854587|NCT01012258|566222035|FG000|Overall Study|Adverse Event|1|||
156854588|NCT01012258|566222035|FG000|Overall Study|Progressive Disease (PD)|18|||
156854589|NCT01012258|566222035|FG000|Overall Study|Symptomatic Deterioration|1|||
156854590|NCT01012258|566222035|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
156854591|NCT01012258|566222035|FG000|Overall Study|Another Tumor Discovered|1|||
156854592|NCT01012258|566222035|FG000|Overall Study|Ongoing|29|||
156854593|NCT01292187|566222036|FG000|Overall Study|Adverse Event|10|||
156854594|NCT01292187|566222037|FG001|Overall Study|Adverse Event|5|||
156854595|NCT01292187|566222036|FG000|Overall Study|Withdrawal by Subject|6|||
156854596|NCT01292187|566222037|FG001|Overall Study|Withdrawal by Subject|5|||
156854597|NCT01292187|566222036|FG000|Overall Study|All other reasons|1|||
156854598|NCT01292187|566222037|FG001|Overall Study|All other reasons|3|||
156854599|NCT01814527|566222039|FG000|Overall Study|RTP greater than 30 days|6|||
156854600|NCT01814527|566222040|FG001|Overall Study|RTP greater than 30 days|1|||
156854601|NCT00687401|566222043|FG000|Overall Study|Protocol Violation|7|||
157025786|NCT03628924|566849613|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
157025787|NCT03628924|566849614|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
157025788|NCT03628924|566849615|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
157025789|NCT03628924|566849616|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
157025790|NCT03628924|566849617|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
157025791|NCT03628924|566849618|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
157025792|NCT03628924|566849619|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
157025793|NCT03628924|566849613|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156854602|NCT00687401|566222043|FG000|Overall Study|Adverse Event|6|||
156854603|NCT00687401|566222043|FG000|Overall Study|Lack of Efficacy|6|||
156854604|NCT00687401|566222043|FG000|Overall Study|Withdrawal by Subject|4|||
156854605|NCT00687401|566222043|FG000|Overall Study|Did not return for visit|3|||
156854606|NCT00687401|566222043|FG000|Overall Study|For reasons different from those above|4|||
156854607|NCT02366195|566222044|FG000|Overall Study|Protocol-specified criteria|3|||
156854608|NCT02366195|566222044|FG000|Overall Study|Withdrawal by Subject|9|||
156854609|NCT02366195|566222044|FG000|Overall Study|Lost to Follow-up|1|||
156854610|NCT02366195|566222044|FG000|Overall Study|Death|41|||
156854611|NCT02520726|566222045|FG000|Overall Study|Lost to Follow-up|3|||
156854612|NCT02520726|566222046|FG001|Overall Study|Lost to Follow-up|2|||
156854613|NCT00721396|566222049|FG000|Overall Study|Adverse Event|4|||
156854614|NCT00721396|566222050|FG001|Overall Study|Adverse Event|7|||
156854615|NCT00721396|566222051|FG002|Overall Study|Adverse Event|2|||
156854616|NCT00721396|566222052|FG003|Overall Study|Adverse Event|0|||
156854617|NCT00721396|566222049|FG000|Overall Study|Withdrawal by Subject|12|||
156854618|NCT00721396|566222050|FG001|Overall Study|Withdrawal by Subject|15|||
156854619|NCT00721396|566222051|FG002|Overall Study|Withdrawal by Subject|3|||
156854620|NCT00721396|566222052|FG003|Overall Study|Withdrawal by Subject|7|||
156854621|NCT00721396|566222049|FG000|Overall Study|Lost to Follow-up|7|||
156854622|NCT00721396|566222050|FG001|Overall Study|Lost to Follow-up|9|||
156854623|NCT00721396|566222051|FG002|Overall Study|Lost to Follow-up|3|||
156854624|NCT00721396|566222052|FG003|Overall Study|Lost to Follow-up|3|||
156854625|NCT00721396|566222049|FG000|Overall Study|Protocol Violation|4|||
156854626|NCT00721396|566222050|FG001|Overall Study|Protocol Violation|3|||
156854627|NCT00721396|566222051|FG002|Overall Study|Protocol Violation|1|||
156854628|NCT00721396|566222052|FG003|Overall Study|Protocol Violation|0|||
156854629|NCT00721396|566222049|FG000|Overall Study|Inappropriate enrollment|0|||
156854630|NCT00721396|566222050|FG001|Overall Study|Inappropriate enrollment|2|||
156854631|NCT00721396|566222051|FG002|Overall Study|Inappropriate enrollment|0|||
156854632|NCT00721396|566222052|FG003|Overall Study|Inappropriate enrollment|0|||
156854633|NCT00721396|566222049|FG000|Overall Study|Administrative reason|3|||
156854634|NCT00721396|566222050|FG001|Overall Study|Administrative reason|0|||
156854635|NCT00721396|566222051|FG002|Overall Study|Administrative reason|1|||
156854636|NCT00721396|566222052|FG003|Overall Study|Administrative reason|0|||
156854637|NCT00148759|566222053|FG000|Overall Study|Withdrawal by Subject|1|||
156854638|NCT00148759|566222054|FG001|Overall Study|Withdrawal by Subject|1|||
156854639|NCT00148759|566222053|FG000|Overall Study|Lost to Follow-up|1|||
156854640|NCT00148759|566222054|FG001|Overall Study|Lost to Follow-up|0|||
156854641|NCT00430716|566222058|FG000|Double Blind Phase|Death|1|||
156854642|NCT00430716|566222059|FG001|Double Blind Phase|Death|0|||
156854643|NCT00430716|566222060|FG002|Double Blind Phase|Death|0|||
156854644|NCT00430716|566222058|FG000|Double Blind Phase|No longer willing to participate|2|||
156854645|NCT00430716|566222059|FG001|Double Blind Phase|No longer willing to participate|1|||
156854646|NCT00430716|566222060|FG002|Double Blind Phase|No longer willing to participate|1|||
156854647|NCT00430716|566222058|FG000|Double Blind Phase|Other|0|||
156854648|NCT00430716|566222059|FG001|Double Blind Phase|Other|2|||
156854649|NCT00430716|566222060|FG002|Double Blind Phase|Other|0|||
156854650|NCT00430716|566222058|FG000|Double Blind Phase|Study terminated by sponsor|1|||
156854651|NCT00430716|566222059|FG001|Double Blind Phase|Study terminated by sponsor|1|||
156854652|NCT00430716|566222060|FG002|Double Blind Phase|Study terminated by sponsor|2|||
156854653|NCT00430716|566222058|FG000|Double Blind Phase|Adverse Event|1|||
156854654|NCT00430716|566222059|FG001|Double Blind Phase|Adverse Event|1|||
156854655|NCT00430716|566222060|FG002|Double Blind Phase|Adverse Event|3|||
156854656|NCT00430716|566222058|FG000|Double Blind Phase|Not treated|1|||
156854657|NCT00430716|566222059|FG001|Double Blind Phase|Not treated|0|||
156854658|NCT00430716|566222060|FG002|Double Blind Phase|Not treated|0|||
156854659|NCT00430716|566222058|FG000|Open Label Phase|Lost to Follow-up|1|||
156854660|NCT00430716|566222059|FG001|Open Label Phase|Lost to Follow-up|0|||
156854661|NCT00430716|566222060|FG002|Open Label Phase|Lost to Follow-up|1|||
156854662|NCT00430716|566222058|FG000|Open Label Phase|No longer willing to participate|0|||
156854663|NCT00430716|566222059|FG001|Open Label Phase|No longer willing to participate|1|||
156854664|NCT00430716|566222060|FG002|Open Label Phase|No longer willing to participate|1|||
156854665|NCT00430716|566222058|FG000|Open Label Phase|Other|3|||
156854666|NCT00430716|566222059|FG001|Open Label Phase|Other|1|||
156854667|NCT00430716|566222060|FG002|Open Label Phase|Other|1|||
156854668|NCT00430716|566222058|FG000|Open Label Phase|Protocol Violation|1|||
156854669|NCT00430716|566222059|FG001|Open Label Phase|Protocol Violation|0|||
156854670|NCT00430716|566222060|FG002|Open Label Phase|Protocol Violation|0|||
156854671|NCT00430716|566222058|FG000|Open Label Phase|Study terminated by sponsor|4|||
156854672|NCT00430716|566222059|FG001|Open Label Phase|Study terminated by sponsor|5|||
156854673|NCT00430716|566222060|FG002|Open Label Phase|Study terminated by sponsor|4|||
156854674|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
156854675|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
156889576|NCT01479985|566355504|FG001|Overall Study|No post-visit survey|3|||
157157555|NCT02702193|567321175|FG001|4 Month Follow up|Lost to Follow-up|18|||
157157556|NCT02702193|567321174|FG000|8 Month Follow up|Withdrawal by Subject|1|||
157157557|NCT02702193|567321175|FG001|8 Month Follow up|Withdrawal by Subject|0|||
157157558|NCT02702193|567321174|FG000|8 Month Follow up|Lost to Follow-up|14|||
156854676|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854677|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854678|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
156854679|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
156854680|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
156854681|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
156854682|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
157157559|NCT02702193|567321175|FG001|8 Month Follow up|Lost to Follow-up|18|||
157157560|NCT02702193|567321174|FG000|12 Month Follow up|Withdrawal by Subject|1|||
157157561|NCT02702193|567321175|FG001|12 Month Follow up|Withdrawal by Subject|0|||
157157562|NCT02702193|567321174|FG000|12 Month Follow up|Lost to Follow-up|16|||
157157563|NCT02702193|567321175|FG001|12 Month Follow up|Lost to Follow-up|18|||
157157564|NCT05692154|567321177|FG000|Overall Study|Adverse Event|0|||
156854683|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
156854684|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
156854685|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
156854686|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
156854687|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
156854688|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
156854689|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854690|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
156854691|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854692|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854693|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
156854694|NCT01329978|566222066|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854695|NCT01329978|566222067|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
156854696|NCT01329978|566222068|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854697|NCT01329978|566222069|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854698|NCT01329978|566222070|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
156854699|NCT01329978|566222066|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854700|NCT01329978|566222067|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854701|NCT01329978|566222068|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
156854702|NCT01329978|566222069|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
156854703|NCT01329978|566222070|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
156854704|NCT01329978|566222066|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854705|NCT01329978|566222067|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854706|NCT01329978|566222068|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854707|NCT01329978|566222069|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
156854708|NCT01329978|566222070|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
156854709|NCT01188772|566222074|FG000|Overall Study|Randomized but Not Treated|0|||
156854710|NCT01188772|566222075|FG001|Overall Study|Randomized but Not Treated|1|||
156854711|NCT01188772|566222076|FG002|Overall Study|Randomized but Not Treated|0|||
156854712|NCT01188772|566222077|FG003|Overall Study|Randomized but Not Treated|0|||
156854713|NCT01188772|566222074|FG000|Overall Study|Adverse Event|0|||
156854714|NCT01188772|566222075|FG001|Overall Study|Adverse Event|1|||
156854715|NCT01188772|566222076|FG002|Overall Study|Adverse Event|2|||
156854716|NCT01188772|566222077|FG003|Overall Study|Adverse Event|0|||
156854717|NCT01188772|566222074|FG000|Overall Study|Lost to Follow-up|4|||
156854718|NCT01188772|566222075|FG001|Overall Study|Lost to Follow-up|1|||
156854719|NCT01188772|566222076|FG002|Overall Study|Lost to Follow-up|1|||
156854720|NCT01188772|566222077|FG003|Overall Study|Lost to Follow-up|1|||
156854721|NCT01188772|566222074|FG000|Overall Study|Non-responder|0|||
156854722|NCT01188772|566222075|FG001|Overall Study|Non-responder|0|||
156854723|NCT01188772|566222076|FG002|Overall Study|Non-responder|3|||
156854724|NCT01188772|566222077|FG003|Overall Study|Non-responder|0|||
156854725|NCT01188772|566222074|FG000|Overall Study|Physician Decision|0|||
156854726|NCT01188772|566222075|FG001|Overall Study|Physician Decision|0|||
156854727|NCT01188772|566222076|FG002|Overall Study|Physician Decision|1|||
157157565|NCT05692154|567321178|FG001|Overall Study|Adverse Event|1|||
157157566|NCT01912729|567321181|FG000|Overall Study|Withdrawal by Subject|0|||
157157567|NCT01912729|567321182|FG001|Overall Study|Withdrawal by Subject|1|||
157157568|NCT00309777|567321194|FG000|Overall Study|Adverse Event|13|||
156854728|NCT01188772|566222077|FG003|Overall Study|Physician Decision|0|||
156854729|NCT01188772|566222074|FG000|Overall Study|Terminated by Sponsor|0|||
156854730|NCT01188772|566222075|FG001|Overall Study|Terminated by Sponsor|0|||
156854731|NCT01188772|566222076|FG002|Overall Study|Terminated by Sponsor|1|||
156854732|NCT01188772|566222077|FG003|Overall Study|Terminated by Sponsor|0|||
156854733|NCT01188772|566222074|FG000|Overall Study|Treatment Failure|0|||
156854734|NCT01188772|566222075|FG001|Overall Study|Treatment Failure|0|||
156854735|NCT01188772|566222076|FG002|Overall Study|Treatment Failure|1|||
156854736|NCT01188772|566222077|FG003|Overall Study|Treatment Failure|0|||
156889577|NCT01155479|566355507|FG000|Part I|Adverse Event|13|||
157157569|NCT00309777|567321195|FG001|Overall Study|Adverse Event|2|||
156854737|NCT01188772|566222074|FG000|Overall Study|Virologic Failure|1|||
156854738|NCT01188772|566222075|FG001|Overall Study|Virologic Failure|0|||
156854739|NCT01188772|566222076|FG002|Overall Study|Virologic Failure|0|||
156854740|NCT01188772|566222077|FG003|Overall Study|Virologic Failure|0|||
156854741|NCT01188772|566222074|FG000|Overall Study|Withdrawal by Subject|0|||
156854742|NCT01188772|566222075|FG001|Overall Study|Withdrawal by Subject|0|||
157157570|NCT00309777|567321196|FG002|Overall Study|Adverse Event|8|||
157157571|NCT00309777|567321197|FG003|Overall Study|Adverse Event|1|||
157157572|NCT00309777|567321194|FG000|Overall Study|Protocol Violation|4|||
157157573|NCT00309777|567321195|FG001|Overall Study|Protocol Violation|1|||
156854743|NCT01188772|566222076|FG002|Overall Study|Withdrawal by Subject|2|||
156854744|NCT01188772|566222077|FG003|Overall Study|Withdrawal by Subject|0|||
156854745|NCT03081884|566222081|FG000|Overall Study|deferred prostate cancer treatment|1|||
156854746|NCT03081884|566222081|FG000|Overall Study|metastasis managed with systemic therapy|3|||
156854747|NCT02294058|566222082|FG000|Overall Study|Adverse Event|16|||
156854748|NCT02294058|566222083|FG001|Overall Study|Adverse Event|7|||
156854749|NCT02294058|566222084|FG002|Overall Study|Adverse Event|13|||
156854750|NCT02294058|566222082|FG000|Overall Study|Lack of Efficacy|3|||
156854751|NCT02294058|566222083|FG001|Overall Study|Lack of Efficacy|3|||
156854752|NCT02294058|566222084|FG002|Overall Study|Lack of Efficacy|0|||
156854753|NCT02294058|566222082|FG000|Overall Study|Lost to Follow-up|1|||
156854754|NCT02294058|566222083|FG001|Overall Study|Lost to Follow-up|0|||
156854755|NCT02294058|566222084|FG002|Overall Study|Lost to Follow-up|2|||
156854756|NCT02294058|566222082|FG000|Overall Study|Withdrawal by Subject|10|||
156854757|NCT02294058|566222083|FG001|Overall Study|Withdrawal by Subject|14|||
156854758|NCT02294058|566222084|FG002|Overall Study|Withdrawal by Subject|13|||
156854759|NCT02294058|566222082|FG000|Overall Study|Physician Decision|2|||
156854760|NCT02294058|566222083|FG001|Overall Study|Physician Decision|1|||
156854761|NCT02294058|566222084|FG002|Overall Study|Physician Decision|0|||
156854762|NCT02294058|566222082|FG000|Overall Study|Miscellaneous|4|||
156854763|NCT02294058|566222083|FG001|Overall Study|Miscellaneous|1|||
156854764|NCT02294058|566222084|FG002|Overall Study|Miscellaneous|1|||
156854765|NCT03957551|566222091|FG000|Overall Study|Adverse Event|2|||
156854766|NCT03957551|566222092|FG001|Overall Study|Adverse Event|2|||
156854767|NCT03957551|566222093|FG002|Overall Study|Adverse Event|6|||
156854768|NCT03957551|566222091|FG000|Overall Study|Physician Decision|1|||
156854769|NCT03957551|566222092|FG001|Overall Study|Physician Decision|0|||
156854770|NCT03957551|566222093|FG002|Overall Study|Physician Decision|2|||
156854771|NCT03957551|566222091|FG000|Overall Study|Withdrawal by Subject|1|||
156854772|NCT03957551|566222092|FG001|Overall Study|Withdrawal by Subject|0|||
156854773|NCT03957551|566222093|FG002|Overall Study|Withdrawal by Subject|2|||
156854774|NCT03957551|566222091|FG000|Overall Study|Disease progression|1|||
156854775|NCT03957551|566222092|FG001|Overall Study|Disease progression|0|||
156854776|NCT03957551|566222093|FG002|Overall Study|Disease progression|8|||
156854777|NCT02717494|566222096|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
156854778|NCT02717494|566222097|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
156854779|NCT02717494|566222098|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
156854780|NCT02717494|566222096|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
156854781|NCT02717494|566222097|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
156854782|NCT02717494|566222098|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
156854783|NCT02717494|566222096|FG000|First Intervention (Step 1)|Death|0|||
156854784|NCT02717494|566222097|FG001|First Intervention (Step 1)|Death|0|||
156854785|NCT02717494|566222098|FG002|First Intervention (Step 1)|Death|1|||
156854786|NCT02717494|566222096|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
156854787|NCT02717494|566222097|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
156854788|NCT02717494|566222098|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
156854789|NCT00154297|566222101|FG000|Overall Study|Death|5|||
156854790|NCT00154297|566222102|FG001|Overall Study|Death|2|||
156854791|NCT00154297|566222101|FG000|Overall Study|Withdrawal by Subject|0|||
156854792|NCT00154297|566222102|FG001|Overall Study|Withdrawal by Subject|5|||
156854793|NCT00154297|566222101|FG000|Overall Study|Lost to Follow-up|3|||
156854794|NCT00154297|566222102|FG001|Overall Study|Lost to Follow-up|0|||
157157574|NCT00309777|567321196|FG002|Overall Study|Protocol Violation|3|||
156854795|NCT00650767|566222105|FG000|Overall Study|Adverse Event|0|||
156854796|NCT00650767|566222106|FG001|Overall Study|Adverse Event|3|||
156854797|NCT00650767|566222107|FG002|Overall Study|Adverse Event|10|||
156854798|NCT00650767|566222108|FG003|Overall Study|Adverse Event|8|||
156854799|NCT00650767|566222105|FG000|Overall Study|Death|1|||
156854800|NCT00650767|566222106|FG001|Overall Study|Death|0|||
156854801|NCT00650767|566222107|FG002|Overall Study|Death|0|||
156854802|NCT00650767|566222108|FG003|Overall Study|Death|0|||
156854803|NCT00650767|566222105|FG000|Overall Study|Withdrawal by Subject|2|||
156854804|NCT00650767|566222106|FG001|Overall Study|Withdrawal by Subject|4|||
156854805|NCT00650767|566222107|FG002|Overall Study|Withdrawal by Subject|3|||
156854806|NCT00650767|566222108|FG003|Overall Study|Withdrawal by Subject|3|||
156854807|NCT00650767|566222105|FG000|Overall Study|Lost to Follow-up|1|||
156854808|NCT00650767|566222106|FG001|Overall Study|Lost to Follow-up|1|||
156854809|NCT00650767|566222107|FG002|Overall Study|Lost to Follow-up|1|||
156854810|NCT00650767|566222108|FG003|Overall Study|Lost to Follow-up|0|||
156854811|NCT00650767|566222105|FG000|Overall Study|Other|1|||
156854812|NCT00650767|566222106|FG001|Overall Study|Other|1|||
157025794|NCT03628924|566849614|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
156854813|NCT00650767|566222107|FG002|Overall Study|Other|0|||
156854814|NCT00650767|566222108|FG003|Overall Study|Other|0|||
156854815|NCT03649074|566222109|FG000|Overall Study|Lost to Follow-up|2|||
156854816|NCT03649074|566222110|FG001|Overall Study|Lost to Follow-up|1|||
157157575|NCT00309777|567321197|FG003|Overall Study|Protocol Violation|1|||
156854817|NCT03649074|566222109|FG000|Overall Study|Adverse Event|1|||
156854818|NCT03649074|566222110|FG001|Overall Study|Adverse Event|0|||
156854819|NCT03649074|566222109|FG000|Overall Study|Physician Decision|1|||
156854820|NCT03649074|566222110|FG001|Overall Study|Physician Decision|0|||
156854821|NCT03649074|566222109|FG000|Overall Study|Withdrawal by Subject|0|||
156854822|NCT03649074|566222110|FG001|Overall Study|Withdrawal by Subject|2|||
156854823|NCT03649074|566222109|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
156854824|NCT03649074|566222110|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
156854825|NCT03649074|566222109|FG000|Overall Study|Other|1|||
156854826|NCT03649074|566222110|FG001|Overall Study|Other|0|||
156854827|NCT01125800|566222113|FG000|Phase I|Protocol Violation|0|||
156854828|NCT01125800|566222114|FG001|Phase I|Protocol Violation|3|||
156854829|NCT01125800|566222115|FG002|Phase I|Protocol Violation|1|||
156854830|NCT01125800|566222116|FG003|Phase I|Protocol Violation|1|||
156854831|NCT01125800|566222117|FG004|Phase I|Protocol Violation|0|||
156854832|NCT01125800|566222113|FG000|Phase I|Adverse Event|2|||
156854833|NCT01125800|566222114|FG001|Phase I|Adverse Event|2|||
156854834|NCT01125800|566222115|FG002|Phase I|Adverse Event|1|||
156854835|NCT01125800|566222116|FG003|Phase I|Adverse Event|7|||
156854836|NCT01125800|566222117|FG004|Phase I|Adverse Event|0|||
156854837|NCT01125800|566222113|FG000|Phase I|Administrative problems|1|||
156854838|NCT01125800|566222114|FG001|Phase I|Administrative problems|0|||
156854839|NCT01125800|566222115|FG002|Phase I|Administrative problems|0|||
156854840|NCT01125800|566222116|FG003|Phase I|Administrative problems|0|||
156854841|NCT01125800|566222117|FG004|Phase I|Administrative problems|0|||
156854842|NCT01125800|566222113|FG000|Phase I|Withdrawal by Subject|0|||
156854843|NCT01125800|566222114|FG001|Phase I|Withdrawal by Subject|0|||
156854844|NCT01125800|566222115|FG002|Phase I|Withdrawal by Subject|1|||
156854845|NCT01125800|566222116|FG003|Phase I|Withdrawal by Subject|0|||
156854846|NCT01125800|566222117|FG004|Phase I|Withdrawal by Subject|0|||
156854847|NCT01125800|566222113|FG000|Phase I|Disease progression|5|||
156854848|NCT01125800|566222114|FG001|Phase I|Disease progression|4|||
156854849|NCT01125800|566222115|FG002|Phase I|Disease progression|1|||
156854850|NCT01125800|566222116|FG003|Phase I|Disease progression|3|||
156854851|NCT01125800|566222117|FG004|Phase I|Disease progression|0|||
156854852|NCT01125800|566222113|FG000|Phase II|Protocol Violation|0|||
156854853|NCT01125800|566222114|FG001|Phase II|Protocol Violation|0|||
156854854|NCT01125800|566222115|FG002|Phase II|Protocol Violation|0|||
156854855|NCT01125800|566222116|FG003|Phase II|Protocol Violation|0|||
156854856|NCT01125800|566222117|FG004|Phase II|Protocol Violation|1|||
156854857|NCT01125800|566222113|FG000|Phase II|Adverse Event|0|||
156854858|NCT01125800|566222114|FG001|Phase II|Adverse Event|0|||
156854859|NCT01125800|566222115|FG002|Phase II|Adverse Event|0|||
156854860|NCT01125800|566222116|FG003|Phase II|Adverse Event|0|||
156854861|NCT01125800|566222117|FG004|Phase II|Adverse Event|2|||
156854862|NCT01125800|566222113|FG000|Phase II|Disease progression|0|||
156854863|NCT01125800|566222114|FG001|Phase II|Disease progression|0|||
156854864|NCT01125800|566222115|FG002|Phase II|Disease progression|0|||
156854865|NCT01125800|566222116|FG003|Phase II|Disease progression|1|||
156854866|NCT01125800|566222117|FG004|Phase II|Disease progression|8|||
156854867|NCT04332107|566222121|FG000|Day 3|Lost to Follow-up|23|||
156889578|NCT01155479|566355508|FG001|Part I|Adverse Event|8|||
156889579|NCT01155479|566355509|FG002|Part I|Adverse Event|18|||
156889580|NCT01155479|566355510|FG003|Part I|Adverse Event|7|||
156889581|NCT01155479|566355511|FG004|Part I|Adverse Event|6|||
156889582|NCT01155479|566355507|FG000|Part I|Administrative|2|||
156889583|NCT01155479|566355508|FG001|Part I|Administrative|2|||
156889584|NCT01155479|566355509|FG002|Part I|Administrative|2|||
157025795|NCT03628924|566849615|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
157025796|NCT03628924|566849616|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156854868|NCT04332107|566222122|FG001|Day 3|Lost to Follow-up|14|||
156854869|NCT04332107|566222121|FG000|Day 3|Missing outcome data|3|||
156854870|NCT04332107|566222122|FG001|Day 3|Missing outcome data|6|||
156854871|NCT04332107|566222121|FG000|Day 14|Lost to Follow-up|13|||
156854872|NCT04332107|566222122|FG001|Day 14|Lost to Follow-up|4|||
156854873|NCT04332107|566222121|FG000|Day 14|Missing outcome data|4|||
156854874|NCT04332107|566222122|FG001|Day 14|Missing outcome data|4|||
156854875|NCT04332107|566222121|FG000|Day 21|Lost to Follow-up|10|||
156854876|NCT04332107|566222122|FG001|Day 21|Lost to Follow-up|2|||
156854877|NCT00717249|566222123|FG000|Overall Study|Lens Discomfort|4|||
156854878|NCT00717249|566222124|FG001|Overall Study|Lens Discomfort|1|||
156854879|NCT00717249|566222123|FG000|Overall Study|Unsatisfactory visual Response|0|||
157025797|NCT03628924|566849617|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156854880|NCT00717249|566222124|FG001|Overall Study|Unsatisfactory visual Response|2|||
156854881|NCT00717249|566222123|FG000|Overall Study|Adverse Event|4|||
156854882|NCT00717249|566222124|FG001|Overall Study|Adverse Event|2|||
156854883|NCT00717249|566222123|FG000|Overall Study|Lost to Follow-up|2|||
156854884|NCT00717249|566222124|FG001|Overall Study|Lost to Follow-up|0|||
156854885|NCT00717249|566222123|FG000|Overall Study|Withdrawal by Subject|1|||
156854886|NCT00717249|566222124|FG001|Overall Study|Withdrawal by Subject|2|||
156854887|NCT00717249|566222123|FG000|Overall Study|Pregnancy|6|||
156889585|NCT01155479|566355510|FG003|Part I|Administrative|0|||
156854888|NCT00717249|566222124|FG001|Overall Study|Pregnancy|3|||
156854889|NCT00717249|566222123|FG000|Overall Study|Protocol Violation|0|||
156854890|NCT00717249|566222124|FG001|Overall Study|Protocol Violation|2|||
156854891|NCT00717249|566222123|FG000|Overall Study|Subject became Ineligible|1|||
156854892|NCT00717249|566222124|FG001|Overall Study|Subject became Ineligible|1|||
156854893|NCT00717249|566222123|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
156854894|NCT00717249|566222124|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
156854895|NCT00717249|566222123|FG000|Overall Study|Gastric Surgery|0|||
156854896|NCT00717249|566222124|FG001|Overall Study|Gastric Surgery|1|||
156854897|NCT00717249|566222123|FG000|Overall Study|Diagnosed with Diabetes|1|||
156854898|NCT00717249|566222124|FG001|Overall Study|Diagnosed with Diabetes|0|||
156854899|NCT00717249|566222123|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
156854900|NCT00717249|566222124|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
156854901|NCT00717249|566222123|FG000|Overall Study|Subject relocated|1|||
156854902|NCT00717249|566222124|FG001|Overall Study|Subject relocated|0|||
156854903|NCT00717249|566222123|FG000|Overall Study|Headaches|1|||
156854904|NCT00717249|566222124|FG001|Overall Study|Headaches|0|||
156854905|NCT01808196|566222128|FG000|Overall Study|Lost to Follow-up|1|||
156854906|NCT03370718|566222129|FG000|Overall Study|Withdrawal by Subject|1|||
156854907|NCT01670721|566222130|FG000|Overall Study|Participant's decision|15|||
156854908|NCT01670721|566222130|FG000|Overall Study|Other than specified above|38|||
156854909|NCT00479713|566222131|FG000|Overall Study|Adverse Event|8|||
156854910|NCT00479713|566222132|FG001|Overall Study|Adverse Event|6|||
156854911|NCT00479713|566222131|FG000|Overall Study|Death|1|||
156854912|NCT00479713|566222132|FG001|Overall Study|Death|0|||
156854913|NCT00479713|566222131|FG000|Overall Study|Lost to Follow-up|0|||
156854914|NCT00479713|566222132|FG001|Overall Study|Lost to Follow-up|1|||
156854915|NCT00479713|566222131|FG000|Overall Study|Protocol Violation|0|||
156854916|NCT00479713|566222132|FG001|Overall Study|Protocol Violation|1|||
156854917|NCT00479713|566222131|FG000|Overall Study|Withdrawal by Subject|4|||
156854918|NCT00479713|566222132|FG001|Overall Study|Withdrawal by Subject|1|||
156854919|NCT00141102|566222137|FG000|Overall Study|Adverse Event|233|||
156854920|NCT00141102|566222138|FG001|Overall Study|Adverse Event|305|||
156854921|NCT00141102|566222137|FG000|Overall Study|Laboratory Abnormality|9|||
156854922|NCT00141102|566222138|FG001|Overall Study|Laboratory Abnormality|33|||
156854923|NCT00141102|566222137|FG000|Overall Study|Lack of Efficacy|21|||
156854924|NCT00141102|566222138|FG001|Overall Study|Lack of Efficacy|26|||
156854925|NCT00141102|566222137|FG000|Overall Study|Lost to Follow-up|29|||
156854926|NCT00141102|566222138|FG001|Overall Study|Lost to Follow-up|32|||
156854927|NCT00141102|566222137|FG000|Overall Study|Other|87|||
156854928|NCT00141102|566222138|FG001|Overall Study|Other|76|||
156854929|NCT00141102|566222137|FG000|Overall Study|Withdrawal by Subject|112|||
156854930|NCT00141102|566222138|FG001|Overall Study|Withdrawal by Subject|142|||
156854931|NCT00141102|566222137|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
156854932|NCT00141102|566222138|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
156854933|NCT00141102|566222137|FG000|Overall Study|Death|2|||
156854934|NCT00141102|566222138|FG001|Overall Study|Death|2|||
156854935|NCT03061201|566222139|FG000|Overall Study|Participants Terminated at Month 36|0|||
156854936|NCT03061201|566222140|FG001|Overall Study|Participants Terminated at Month 36|1|||
156854937|NCT03061201|566222141|FG002|Overall Study|Participants Terminated at Month 36|0|||
156854938|NCT03061201|566222142|FG003|Overall Study|Participants Terminated at Month 36|1|||
156854939|NCT03061201|566222139|FG000|Overall Study|Lost to Follow-up|1|||
156854940|NCT03061201|566222140|FG001|Overall Study|Lost to Follow-up|0|||
156854941|NCT03061201|566222141|FG002|Overall Study|Lost to Follow-up|0|||
156854942|NCT03061201|566222142|FG003|Overall Study|Lost to Follow-up|0|||
156854943|NCT01572480|566222143|FG000|Participants Enrolled|Withdrawal by Subject|1|||
156854944|NCT01572480|566222143|FG000|Drug Administration|Discontinued drug/Off Study|1|||
156854945|NCT01572480|566222143|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
156854946|NCT01572480|566222143|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
156854947|NCT05481359|566222144|FG000|Overall Study|Lost to Follow-up|3|||
156854948|NCT05481359|566222144|FG000|Overall Study|Withdrawal by Subject|1|||
156854949|NCT00348673|566222146|FG000|Stage 1|Randomized but not Treated|0|||
157025798|NCT03628924|566849618|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
157025799|NCT03628924|566849619|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
156854950|NCT00348673|566222147|FG001|Stage 1|Randomized but not Treated|0|||
156854951|NCT00348673|566222148|FG002|Stage 1|Randomized but not Treated|1|||
156854952|NCT00348673|566222149|FG003|Stage 1|Randomized but not Treated|0|||
156854953|NCT00348673|566222150|FG004|Stage 1|Randomized but not Treated|0|||
156854954|NCT00348673|566222151|FG005|Stage 1|Randomized but not Treated|0|||
156854955|NCT00348673|566222152|FG006|Stage 1|Randomized but not Treated|0|||
156854956|NCT00348673|566222153|FG007|Stage 1|Randomized but not Treated|0|||
157025800|NCT03628924|566849613|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
156854957|NCT00348673|566222154|FG008|Stage 1|Randomized but not Treated|0|||
156854958|NCT00794950|566222156|FG000|BCG Induction|Withdrawal by Subject|2|||
156854959|NCT00794950|566222156|FG000|BCG Induction|ineligible|3|||
156854960|NCT00794950|566222156|FG000|BCG Induction|noncompliant w. BCG|1|||
156854961|NCT00794950|566222156|FG000|BCG Induction|Adverse Event|1|||
156854962|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
156854963|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
156854964|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
156854965|NCT00794950|566222156|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
156854966|NCT02485704|566222157|FG000|Overall Study|Lost to Follow-up|4|||
156854967|NCT02485704|566222158|FG001|Overall Study|Lost to Follow-up|5|||
156854968|NCT02485704|566222157|FG000|Overall Study|Withdrawal by Subject|0|||
156854969|NCT02485704|566222158|FG001|Overall Study|Withdrawal by Subject|3|||
156854970|NCT02485704|566222157|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
156854971|NCT02485704|566222158|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
156854972|NCT03798717|566223397|FG000|Overall Study|Failed Screening|0|||
156854973|NCT03798717|566223398|FG001|Overall Study|Failed Screening|0|||
156854974|NCT03798717|566223399|FG002|Overall Study|Failed Screening|0|||
156854975|NCT03798717|566223400|FG003|Overall Study|Failed Screening|0|||
156854976|NCT03798717|566223401|FG004|Overall Study|Failed Screening|0|||
156854977|NCT03798717|566223402|FG005|Overall Study|Failed Screening|1|||
156854978|NCT03798717|566223397|FG000|Overall Study|Physician Decision|1|||
156854979|NCT03798717|566223398|FG001|Overall Study|Physician Decision|0|||
156854980|NCT03798717|566223399|FG002|Overall Study|Physician Decision|1|||
156854981|NCT03798717|566223400|FG003|Overall Study|Physician Decision|0|||
156854982|NCT03798717|566223401|FG004|Overall Study|Physician Decision|0|||
156854983|NCT03798717|566223402|FG005|Overall Study|Physician Decision|0|||
156854984|NCT03798717|566223397|FG000|Overall Study|Withdrawal by Subject|0|||
156854985|NCT03798717|566223398|FG001|Overall Study|Withdrawal by Subject|0|||
156854986|NCT03798717|566223399|FG002|Overall Study|Withdrawal by Subject|0|||
156854987|NCT03798717|566223400|FG003|Overall Study|Withdrawal by Subject|1|||
156854988|NCT03798717|566223401|FG004|Overall Study|Withdrawal by Subject|0|||
156854989|NCT03798717|566223402|FG005|Overall Study|Withdrawal by Subject|0|||
156854990|NCT03798717|566223397|FG000|Overall Study|Lost to Follow-up|1|||
156854991|NCT03798717|566223398|FG001|Overall Study|Lost to Follow-up|0|||
156854992|NCT03798717|566223399|FG002|Overall Study|Lost to Follow-up|0|||
156854993|NCT03798717|566223400|FG003|Overall Study|Lost to Follow-up|1|||
156854994|NCT03798717|566223401|FG004|Overall Study|Lost to Follow-up|0|||
156854995|NCT03798717|566223402|FG005|Overall Study|Lost to Follow-up|0|||
156854996|NCT03798717|566223397|FG000|Overall Study|Adverse Event|0|||
156854997|NCT03798717|566223398|FG001|Overall Study|Adverse Event|1|||
156854998|NCT03798717|566223399|FG002|Overall Study|Adverse Event|0|||
156854999|NCT03798717|566223400|FG003|Overall Study|Adverse Event|0|||
156855000|NCT03798717|566223401|FG004|Overall Study|Adverse Event|0|||
156855001|NCT03798717|566223402|FG005|Overall Study|Adverse Event|0|||
156855002|NCT03798717|566223397|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855003|NCT03798717|566223398|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855004|NCT03798717|566223399|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855005|NCT03798717|566223400|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855006|NCT03798717|566223401|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
156855007|NCT03798717|566223402|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
156855008|NCT04388111|566223407|FG000|Overall Study|Lost to Follow-up|5|||
156855009|NCT04388111|566223408|FG001|Overall Study|Lost to Follow-up|3|||
156855010|NCT04388111|566223407|FG000|Overall Study|Adverse Event|1|||
156855011|NCT04388111|566223408|FG001|Overall Study|Adverse Event|1|||
156855012|NCT04388111|566223407|FG000|Overall Study|Protocol Violation|2|||
156855013|NCT04388111|566223408|FG001|Overall Study|Protocol Violation|4|||
156855014|NCT04388111|566223407|FG000|Overall Study|Withdrawal by Subject|1|||
156855015|NCT04388111|566223408|FG001|Overall Study|Withdrawal by Subject|0|||
156855016|NCT01474317|566223416|FG000|Overall Study|Adverse Event|1|||
156855017|NCT01474317|566223416|FG000|Overall Study|Subject ineligible for study|1|||
156855018|NCT00387881|566223417|FG000|Overall Study|Lost to Follow-up|23|||
156855019|NCT00387881|566223418|FG001|Overall Study|Lost to Follow-up|23|||
156855020|NCT00387881|566223417|FG000|Overall Study|Protocol Violation|2|||
156855021|NCT00387881|566223418|FG001|Overall Study|Protocol Violation|12|||
156855022|NCT00387881|566223417|FG000|Overall Study|Withdrawal by Subject|15|||
156855023|NCT00387881|566223418|FG001|Overall Study|Withdrawal by Subject|18|||
156855024|NCT00387881|566223417|FG000|Overall Study|Sponsor terminated Study|0|||
156855025|NCT00387881|566223418|FG001|Overall Study|Sponsor terminated Study|1|||
156855026|NCT00387881|566223417|FG000|Overall Study|Not eligible|6|||
156855027|NCT00387881|566223418|FG001|Overall Study|Not eligible|7|||
156855028|NCT00387881|566223417|FG000|Overall Study|No opportunity to treat headache|32|||
156855029|NCT00387881|566223418|FG001|Overall Study|No opportunity to treat headache|34|||
156855030|NCT00387881|566223417|FG000|Overall Study|Not otherwise specified|11|||
156855031|NCT00387881|566223418|FG001|Overall Study|Not otherwise specified|7|||
156855032|NCT00453154|566223419|FG000|Double BIind Maintenance|Adverse Event|0|||
156855033|NCT00453154|566223420|FG001|Double BIind Maintenance|Adverse Event|0|||
156855034|NCT00453154|566223421|FG002|Double BIind Maintenance|Adverse Event|3|||
156855035|NCT00453154|566223422|FG003|Double BIind Maintenance|Adverse Event|12|||
156855036|NCT00453154|566223419|FG000|Double BIind Maintenance|Death|0|||
156855037|NCT00453154|566223420|FG001|Double BIind Maintenance|Death|0|||
156855038|NCT00453154|566223421|FG002|Double BIind Maintenance|Death|2|||
156855039|NCT00453154|566223422|FG003|Double BIind Maintenance|Death|1|||
156855040|NCT00453154|566223419|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
156855041|NCT00453154|566223420|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
156855042|NCT00453154|566223421|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
156855043|NCT00453154|566223422|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
156855044|NCT00453154|566223419|FG000|Double BIind Maintenance|Progression|0|||
156855045|NCT00453154|566223420|FG001|Double BIind Maintenance|Progression|0|||
156855046|NCT00453154|566223421|FG002|Double BIind Maintenance|Progression|29|||
156855047|NCT00453154|566223422|FG003|Double BIind Maintenance|Progression|26|||
156855048|NCT00453154|566223419|FG000|Double BIind Maintenance|Medical Issues|0|||
156855049|NCT00453154|566223420|FG001|Double BIind Maintenance|Medical Issues|0|||
156855050|NCT00453154|566223421|FG002|Double BIind Maintenance|Medical Issues|3|||
156855051|NCT00453154|566223422|FG003|Double BIind Maintenance|Medical Issues|1|||
156855052|NCT00453154|566223419|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
156855053|NCT00453154|566223420|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
156855054|NCT00453154|566223421|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
156855055|NCT00453154|566223422|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
156855056|NCT05473026|566223425|FG000|Overall Study|Lost to Follow-up|5|||
156855057|NCT05473026|566223426|FG001|Overall Study|Lost to Follow-up|2|||
156855058|NCT01050634|566223427|FG000|Overall Study|Enrolled, but Not Treated|56|||
156855059|NCT01050634|566223427|FG000|Overall Study|Death|2|||
156855060|NCT01050634|566223427|FG000|Overall Study|Adverse Event|42|||
156855061|NCT01050634|566223427|FG000|Overall Study|Lost to Follow-up|2|||
156855062|NCT01050634|566223427|FG000|Overall Study|Other|21|||
156855063|NCT01050634|566223427|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
156855064|NCT00248495|566223433|FG000|Overall Study|Withdrawal by Subject|1|||
156855065|NCT05470387|566223434|FG000|Overall Study|Protocol Violation|0|||
156855066|NCT05470387|566223435|FG001|Overall Study|Protocol Violation|3|||
156855067|NCT03367858|566223436|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
156855068|NCT03367858|566223437|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
156855069|NCT03367858|566223436|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
156855070|NCT03367858|566223437|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
156855071|NCT03367858|566223436|FG000|3 Month Follow Up|Lost to Follow-up|8|||
156855072|NCT03367858|566223437|FG001|3 Month Follow Up|Lost to Follow-up|3|||
156855073|NCT03367858|566223436|FG000|3 Month Follow Up|Moved out of study area|2|||
156855074|NCT03367858|566223437|FG001|3 Month Follow Up|Moved out of study area|6|||
156855075|NCT03367858|566223436|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
156855076|NCT03367858|566223437|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
156855077|NCT03367858|566223436|FG000|3 Month Follow Up|MRI contraindication|2|||
156855078|NCT03367858|566223437|FG001|3 Month Follow Up|MRI contraindication|1|||
156855079|NCT03367858|566223436|FG000|3 Month Follow Up|Incarcerated|0|||
156855080|NCT03367858|566223437|FG001|3 Month Follow Up|Incarcerated|1|||
156855081|NCT03367858|566223436|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
156855082|NCT03367858|566223437|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
156855083|NCT03367858|566223436|FG000|6 Month Follow Up|Lost to Follow-up|5|||
156855084|NCT03367858|566223437|FG001|6 Month Follow Up|Lost to Follow-up|2|||
156855085|NCT03367858|566223436|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
156855086|NCT03367858|566223437|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
156855087|NCT03367858|566223436|FG000|12 Month Follow Up|Lost to Follow-up|3|||
156855088|NCT03367858|566223437|FG001|12 Month Follow Up|Lost to Follow-up|3|||
156855089|NCT03367858|566223436|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
156855090|NCT03367858|566223437|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
156855091|NCT01054456|566223438|FG000|Overall Study|Other|1|||
156855092|NCT01774799|566223441|FG000|Overall Study|Lost to Follow-up|1|||
156855093|NCT01774799|566223442|FG001|Overall Study|Lost to Follow-up|1|||
156855094|NCT01774799|566223443|FG002|Overall Study|Lost to Follow-up|0|||
156855095|NCT01774799|566223444|FG003|Overall Study|Lost to Follow-up|0|||
156855096|NCT06172348|566223445|FG000|Treatment Period 2|Adverse Event|0|||
156855097|NCT06172348|566223446|FG001|Treatment Period 2|Adverse Event|0|||
156889586|NCT01155479|566355511|FG004|Part I|Administrative|0|||
156889587|NCT01155479|566355507|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
156889588|NCT01155479|566355508|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
156889589|NCT01155479|566355509|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
156855098|NCT06172348|566223447|FG002|Treatment Period 2|Adverse Event|1|||
156855099|NCT06172348|566223448|FG003|Treatment Period 2|Adverse Event|0|||
156855100|NCT06172348|566223449|FG004|Treatment Period 2|Adverse Event|0|||
156855101|NCT06172348|566223450|FG005|Treatment Period 2|Adverse Event|0|||
156855102|NCT04037891|566223451|FG000|Open-label Period|Withdrawal by Subject|1|||
156855103|NCT04037891|566223452|FG001|Open-label Period|Withdrawal by Subject|0|||
156855104|NCT04037891|566223453|FG002|Open-label Period|Withdrawal by Subject|0|||
156855105|NCT04037891|566223451|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
156855106|NCT04037891|566223452|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
156889590|NCT01155479|566355510|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
156889591|NCT01155479|566355511|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
156889592|NCT01155479|566355507|FG000|Part I|Withdrawal by Subject|11|||
156889593|NCT01155479|566355508|FG001|Part I|Withdrawal by Subject|13|||
156889594|NCT01155479|566355509|FG002|Part I|Withdrawal by Subject|8|||
156889595|NCT01155479|566355510|FG003|Part I|Withdrawal by Subject|8|||
156855107|NCT04037891|566223453|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
156855108|NCT04194944|566223454|FG000|Overall Study|Lost to Follow-up|3|||
156855109|NCT04194944|566223455|FG001|Overall Study|Lost to Follow-up|0|||
156855110|NCT04194944|566223454|FG000|Overall Study|Withdrawal by Subject|2|||
156855111|NCT04194944|566223455|FG001|Overall Study|Withdrawal by Subject|2|||
156855112|NCT04194944|566223454|FG000|Overall Study|On Treatment|93|||
156855113|NCT04194944|566223455|FG001|Overall Study|On Treatment|30|||
156855114|NCT03446313|566223456|FG000|Overall Study|Lost to Follow-up|1|||
156855115|NCT03446313|566223457|FG001|Overall Study|Lost to Follow-up|2|||
156855116|NCT03446313|566223456|FG000|Overall Study|Failed primary screening|3|||
156855117|NCT03446313|566223457|FG001|Overall Study|Failed primary screening|0|||
156855118|NCT03446313|566223456|FG000|Overall Study|Diagnosed with terminal cancer|1|||
156855119|NCT03446313|566223457|FG001|Overall Study|Diagnosed with terminal cancer|0|||
156855120|NCT03446313|566223456|FG000|Overall Study|Excluded from analysis|1|||
156855121|NCT03446313|566223457|FG001|Overall Study|Excluded from analysis|1|||
156855122|NCT03100149|566223458|FG000|Overall Study|Adverse Event|0|||
156855123|NCT03100149|566223459|FG001|Overall Study|Adverse Event|1|||
156855124|NCT03100149|566223460|FG002|Overall Study|Adverse Event|0|||
156855125|NCT03100149|566223458|FG000|Overall Study|Participant Moved out of Country|0|||
156855126|NCT03100149|566223459|FG001|Overall Study|Participant Moved out of Country|0|||
156855127|NCT03100149|566223460|FG002|Overall Study|Participant Moved out of Country|1|||
156855128|NCT03100149|566223458|FG000|Overall Study|Withdrawal by Subject|0|||
156855129|NCT03100149|566223459|FG001|Overall Study|Withdrawal by Subject|3|||
156855130|NCT03100149|566223460|FG002|Overall Study|Withdrawal by Subject|1|||
156855131|NCT05214768|566223463|FG000|Induction Period|Withdrawal by Subject|1|||
156855132|NCT05214768|566223464|FG001|Induction Period|Withdrawal by Subject|0|||
156855133|NCT05214768|566223465|FG002|Induction Period|Withdrawal by Subject|0|||
156855134|NCT05214768|566223466|FG003|Induction Period|Withdrawal by Subject|0|||
156855135|NCT05214768|566223467|FG004|Induction Period|Withdrawal by Subject|0|||
156855136|NCT05214768|566223468|FG005|Induction Period|Withdrawal by Subject|0|||
156855137|NCT05214768|566223463|FG000|Induction Period|Physician Decision|1|||
156855138|NCT05214768|566223464|FG001|Induction Period|Physician Decision|0|||
156855139|NCT05214768|566223465|FG002|Induction Period|Physician Decision|0|||
156855140|NCT05214768|566223466|FG003|Induction Period|Physician Decision|0|||
156889596|NCT01155479|566355511|FG004|Part I|Withdrawal by Subject|9|||
156889597|NCT01155479|566355507|FG000|Part I|Lost to Follow-up|0|||
156889598|NCT01155479|566355508|FG001|Part I|Lost to Follow-up|0|||
156889599|NCT01155479|566355509|FG002|Part I|Lost to Follow-up|1|||
156889600|NCT01155479|566355510|FG003|Part I|Lost to Follow-up|1|||
156889601|NCT01155479|566355511|FG004|Part I|Lost to Follow-up|0|||
156889602|NCT01155479|566355507|FG000|Part I|Treatment Failure|3|||
156889603|NCT01155479|566355508|FG001|Part I|Treatment Failure|0|||
156889604|NCT01155479|566355509|FG002|Part I|Treatment Failure|3|||
156889605|NCT01155479|566355510|FG003|Part I|Treatment Failure|1|||
156889606|NCT01155479|566355511|FG004|Part I|Treatment Failure|2|||
156889607|NCT01155479|566355507|FG000|Part I|Did Not Receive Treatment|4|||
156889608|NCT01155479|566355508|FG001|Part I|Did Not Receive Treatment|2|||
156889609|NCT01155479|566355509|FG002|Part I|Did Not Receive Treatment|2|||
156889610|NCT01155479|566355510|FG003|Part I|Did Not Receive Treatment|6|||
156889611|NCT01155479|566355511|FG004|Part I|Did Not Receive Treatment|1|||
156889612|NCT01155479|566355507|FG000|Part I|Non-Compliance with Protocol|2|||
156889613|NCT01155479|566355508|FG001|Part I|Non-Compliance with Protocol|1|||
156889614|NCT01155479|566355509|FG002|Part I|Non-Compliance with Protocol|3|||
157025801|NCT03628924|566849614|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
157157576|NCT00309777|567321194|FG000|Overall Study|Withdrawal by Subject|6|||
157157577|NCT00309777|567321195|FG001|Overall Study|Withdrawal by Subject|5|||
157157578|NCT00309777|567321196|FG002|Overall Study|Withdrawal by Subject|7|||
156889615|NCT01155479|566355510|FG003|Part I|Non-Compliance with Protocol|3|||
156889616|NCT01155479|566355511|FG004|Part I|Non-Compliance with Protocol|2|||
156889617|NCT01155479|566355507|FG000|Part II|Adverse Event|7|||
157157579|NCT00309777|567321197|FG003|Overall Study|Withdrawal by Subject|2|||
157157580|NCT00309777|567321194|FG000|Overall Study|Lost to Follow-up|0|||
157157581|NCT00309777|567321195|FG001|Overall Study|Lost to Follow-up|0|||
156855141|NCT05214768|566223467|FG004|Induction Period|Physician Decision|0|||
156855142|NCT05214768|566223468|FG005|Induction Period|Physician Decision|0|||
156855143|NCT05214768|566223463|FG000|Maintenance Period|Other Reasons|0|||
156855144|NCT05214768|566223464|FG001|Maintenance Period|Other Reasons|0|||
156855145|NCT05214768|566223465|FG002|Maintenance Period|Other Reasons|1|||
156889618|NCT01155479|566355508|FG001|Part II|Adverse Event|6|||
156889619|NCT01155479|566355509|FG002|Part II|Adverse Event|8|||
156889620|NCT01155479|566355510|FG003|Part II|Adverse Event|3|||
156889621|NCT01155479|566355511|FG004|Part II|Adverse Event|4|||
156889622|NCT01155479|566355507|FG000|Part II|Administrative|43|||
157157582|NCT00309777|567321196|FG002|Overall Study|Lost to Follow-up|1|||
157157583|NCT00309777|567321197|FG003|Overall Study|Lost to Follow-up|0|||
157157584|NCT00309777|567321194|FG000|Overall Study|Death|0|||
157157585|NCT00309777|567321195|FG001|Overall Study|Death|1|||
157157586|NCT00309777|567321196|FG002|Overall Study|Death|0|||
156855146|NCT05214768|566223466|FG003|Maintenance Period|Other Reasons|1|||
156855147|NCT05214768|566223467|FG004|Maintenance Period|Other Reasons|0|||
156855148|NCT05214768|566223468|FG005|Maintenance Period|Other Reasons|0|||
156855149|NCT05214768|566223463|FG000|Maintenance Period|Withdrawal by Subject|0|||
156855150|NCT05214768|566223464|FG001|Maintenance Period|Withdrawal by Subject|0|||
156855151|NCT05214768|566223465|FG002|Maintenance Period|Withdrawal by Subject|0|||
156855152|NCT05214768|566223466|FG003|Maintenance Period|Withdrawal by Subject|1|||
156855153|NCT05214768|566223467|FG004|Maintenance Period|Withdrawal by Subject|0|||
156855154|NCT05214768|566223468|FG005|Maintenance Period|Withdrawal by Subject|0|||
156855155|NCT05214768|566223463|FG000|Maintenance Period|Lack of Efficacy|0|||
156855156|NCT05214768|566223464|FG001|Maintenance Period|Lack of Efficacy|0|||
156855157|NCT05214768|566223465|FG002|Maintenance Period|Lack of Efficacy|1|||
156855158|NCT05214768|566223466|FG003|Maintenance Period|Lack of Efficacy|0|||
156855159|NCT05214768|566223467|FG004|Maintenance Period|Lack of Efficacy|1|||
156855160|NCT05214768|566223468|FG005|Maintenance Period|Lack of Efficacy|0|||
156855161|NCT05214768|566223463|FG000|Open Label Extension Period|Physician Decision|0|||
156855162|NCT05214768|566223464|FG001|Open Label Extension Period|Physician Decision|0|||
156855163|NCT05214768|566223465|FG002|Open Label Extension Period|Physician Decision|0|||
156855164|NCT05214768|566223466|FG003|Open Label Extension Period|Physician Decision|0|||
156855165|NCT05214768|566223467|FG004|Open Label Extension Period|Physician Decision|0|||
156855166|NCT05214768|566223468|FG005|Open Label Extension Period|Physician Decision|1|||
156855167|NCT05214768|566223463|FG000|Open Label Extension Period|Lack of Efficacy|0|||
156855168|NCT05214768|566223464|FG001|Open Label Extension Period|Lack of Efficacy|0|||
156855169|NCT05214768|566223465|FG002|Open Label Extension Period|Lack of Efficacy|0|||
156855170|NCT05214768|566223466|FG003|Open Label Extension Period|Lack of Efficacy|0|||
156855171|NCT05214768|566223467|FG004|Open Label Extension Period|Lack of Efficacy|0|||
156855172|NCT05214768|566223468|FG005|Open Label Extension Period|Lack of Efficacy|1|||
156855173|NCT05214768|566223463|FG000|Open Label Extension Period|Ongoing Study|0|||
156855174|NCT05214768|566223464|FG001|Open Label Extension Period|Ongoing Study|0|||
156855175|NCT05214768|566223465|FG002|Open Label Extension Period|Ongoing Study|0|||
156855176|NCT05214768|566223466|FG003|Open Label Extension Period|Ongoing Study|0|||
156855177|NCT05214768|566223467|FG004|Open Label Extension Period|Ongoing Study|0|||
156855178|NCT05214768|566223468|FG005|Open Label Extension Period|Ongoing Study|42|||
156855179|NCT05579977|566223478|FG000|Treatment Phase|Other|0|||
156855180|NCT05579977|566223479|FG001|Treatment Phase|Other|0|||
156855181|NCT05579977|566223480|FG002|Treatment Phase|Other|0|||
156855182|NCT05579977|566223481|FG003|Treatment Phase|Other|2|||
156855183|NCT05579977|566223482|FG004|Treatment Phase|Other|1|||
156855184|NCT05579977|566223483|FG005|Treatment Phase|Other|2|||
156855185|NCT05579977|566223484|FG006|Treatment Phase|Other|1|||
156855186|NCT05579977|566223485|FG007|Treatment Phase|Other|2|||
156855187|NCT05579977|566223486|FG008|Treatment Phase|Other|2|||
156855188|NCT05579977|566223487|FG009|Treatment Phase|Other|1|||
156855189|NCT05579977|566223488|FG010|Treatment Phase|Other|0|||
156855190|NCT05579977|566223489|FG011|Treatment Phase|Other|0|||
156855191|NCT05579977|566223490|FG012|Treatment Phase|Other|3|||
156855192|NCT05579977|566223478|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
156855193|NCT05579977|566223479|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
156855194|NCT05579977|566223480|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
156855195|NCT05579977|566223481|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
156855196|NCT05579977|566223482|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
156855197|NCT05579977|566223483|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
156855198|NCT05579977|566223484|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
156855199|NCT05579977|566223485|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
156855200|NCT05579977|566223486|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
156855201|NCT05579977|566223487|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
157025802|NCT03628924|566849615|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
157157587|NCT00309777|567321197|FG003|Overall Study|Death|0|||
157157588|NCT01830543|567322821|FG000|Overall Study|Subject Decision|19|||
157157589|NCT01830543|567322822|FG001|Overall Study|Subject Decision|21|||
156855202|NCT05579977|566223488|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
156855203|NCT05579977|566223489|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
156855204|NCT05579977|566223490|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
156855205|NCT05579977|566223478|FG000|Treatment Phase|Withdrawal by Subject|2|||
156855206|NCT05579977|566223479|FG001|Treatment Phase|Withdrawal by Subject|0|||
156855207|NCT05579977|566223480|FG002|Treatment Phase|Withdrawal by Subject|0|||
156855208|NCT05579977|566223481|FG003|Treatment Phase|Withdrawal by Subject|1|||
156855209|NCT05579977|566223482|FG004|Treatment Phase|Withdrawal by Subject|2|||
157025803|NCT03628924|566849616|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
157157590|NCT01830543|567322823|FG002|Overall Study|Subject Decision|57|||
156855210|NCT05579977|566223483|FG005|Treatment Phase|Withdrawal by Subject|0|||
156855211|NCT05579977|566223484|FG006|Treatment Phase|Withdrawal by Subject|1|||
156855212|NCT05579977|566223485|FG007|Treatment Phase|Withdrawal by Subject|8|||
156855213|NCT05579977|566223486|FG008|Treatment Phase|Withdrawal by Subject|3|||
157025804|NCT03628924|566849617|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
157025805|NCT03628924|566849618|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
157025806|NCT03628924|566849619|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
157025807|NCT03628924|566849613|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
157025808|NCT03628924|566849614|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
157025809|NCT03628924|566849615|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
157025810|NCT03628924|566849616|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
157025811|NCT03628924|566849617|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
157025812|NCT03628924|566849618|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
157025813|NCT03628924|566849619|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
157025814|NCT03628924|566849613|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
157025815|NCT03628924|566849614|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
157025816|NCT03628924|566849615|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
157025817|NCT03628924|566849616|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
157025818|NCT03628924|566849617|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
157025819|NCT03628924|566849618|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
157025820|NCT03628924|566849619|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
157025821|NCT03628924|566849613|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
157025822|NCT03628924|566849614|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
157025823|NCT03628924|566849615|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
157025824|NCT03628924|566849616|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
157025825|NCT03628924|566849617|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
157025826|NCT03628924|566849618|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
157025827|NCT03628924|566849619|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
157025828|NCT03628924|566849613|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
157025829|NCT03628924|566849614|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
157025830|NCT03628924|566849615|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
157025831|NCT03628924|566849616|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
157025832|NCT03628924|566849617|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
157025833|NCT03628924|566849618|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
157225467|NCT01860976|567571436|FG000|Long Term Extension|Lack of Efficacy|2|||
156855214|NCT05579977|566223487|FG009|Treatment Phase|Withdrawal by Subject|3|||
156855215|NCT05579977|566223488|FG010|Treatment Phase|Withdrawal by Subject|5|||
156855216|NCT05579977|566223489|FG011|Treatment Phase|Withdrawal by Subject|1|||
156855217|NCT05579977|566223490|FG012|Treatment Phase|Withdrawal by Subject|3|||
156855218|NCT05579977|566223478|FG000|Treatment Phase|Study terminated by sponsor|70|||
156855219|NCT05579977|566223479|FG001|Treatment Phase|Study terminated by sponsor|70|||
156855220|NCT05579977|566223480|FG002|Treatment Phase|Study terminated by sponsor|61|||
156855221|NCT05579977|566223481|FG003|Treatment Phase|Study terminated by sponsor|59|||
156855222|NCT05579977|566223482|FG004|Treatment Phase|Study terminated by sponsor|63|||
156855223|NCT05579977|566223483|FG005|Treatment Phase|Study terminated by sponsor|53|||
156855224|NCT05579977|566223484|FG006|Treatment Phase|Study terminated by sponsor|66|||
156855225|NCT05579977|566223485|FG007|Treatment Phase|Study terminated by sponsor|48|||
156855226|NCT05579977|566223486|FG008|Treatment Phase|Study terminated by sponsor|47|||
156855227|NCT05579977|566223487|FG009|Treatment Phase|Study terminated by sponsor|37|||
156855228|NCT05579977|566223488|FG010|Treatment Phase|Study terminated by sponsor|44|||
156855229|NCT05579977|566223489|FG011|Treatment Phase|Study terminated by sponsor|36|||
156855230|NCT05579977|566223490|FG012|Treatment Phase|Study terminated by sponsor|32|||
156855231|NCT05579977|566223478|FG000|Treatment Phase|Pregnancy|0|||
156855232|NCT05579977|566223479|FG001|Treatment Phase|Pregnancy|0|||
156855233|NCT05579977|566223480|FG002|Treatment Phase|Pregnancy|0|||
156855234|NCT05579977|566223481|FG003|Treatment Phase|Pregnancy|0|||
156855235|NCT05579977|566223482|FG004|Treatment Phase|Pregnancy|0|||
156855236|NCT05579977|566223483|FG005|Treatment Phase|Pregnancy|0|||
156855237|NCT05579977|566223484|FG006|Treatment Phase|Pregnancy|0|||
156855238|NCT05579977|566223485|FG007|Treatment Phase|Pregnancy|0|||
156855239|NCT05579977|566223486|FG008|Treatment Phase|Pregnancy|0|||
156855240|NCT05579977|566223487|FG009|Treatment Phase|Pregnancy|1|||
156855241|NCT05579977|566223488|FG010|Treatment Phase|Pregnancy|0|||
156855242|NCT05579977|566223489|FG011|Treatment Phase|Pregnancy|0|||
156855243|NCT05579977|566223490|FG012|Treatment Phase|Pregnancy|0|||
156855244|NCT05579977|566223478|FG000|Treatment Phase|Physician Decision|0|||
156855245|NCT05579977|566223479|FG001|Treatment Phase|Physician Decision|0|||
156855246|NCT05579977|566223480|FG002|Treatment Phase|Physician Decision|0|||
156855247|NCT05579977|566223481|FG003|Treatment Phase|Physician Decision|0|||
156855248|NCT05579977|566223482|FG004|Treatment Phase|Physician Decision|0|||
156855249|NCT05579977|566223483|FG005|Treatment Phase|Physician Decision|0|||
157157591|NCT01830543|567322821|FG000|Overall Study|Adverse Event|91|||
157157592|NCT01830543|567322822|FG001|Overall Study|Adverse Event|77|||
157157593|NCT01830543|567322823|FG002|Overall Study|Adverse Event|76|||
157157594|NCT01830543|567322821|FG000|Overall Study|Death|20|||
156855250|NCT05579977|566223484|FG006|Treatment Phase|Physician Decision|0|||
156855251|NCT05579977|566223485|FG007|Treatment Phase|Physician Decision|0|||
156855252|NCT05579977|566223486|FG008|Treatment Phase|Physician Decision|0|||
156855253|NCT05579977|566223487|FG009|Treatment Phase|Physician Decision|0|||
156855254|NCT05579977|566223488|FG010|Treatment Phase|Physician Decision|0|||
156855255|NCT05579977|566223489|FG011|Treatment Phase|Physician Decision|1|||
156855256|NCT05579977|566223490|FG012|Treatment Phase|Physician Decision|0|||
156855257|NCT05579977|566223478|FG000|Treatment Phase|Lost to Follow-up|0|||
156855258|NCT05579977|566223479|FG001|Treatment Phase|Lost to Follow-up|0|||
156855259|NCT05579977|566223480|FG002|Treatment Phase|Lost to Follow-up|0|||
156855260|NCT05579977|566223481|FG003|Treatment Phase|Lost to Follow-up|1|||
156855261|NCT05579977|566223482|FG004|Treatment Phase|Lost to Follow-up|1|||
156855262|NCT05579977|566223483|FG005|Treatment Phase|Lost to Follow-up|1|||
156855263|NCT05579977|566223484|FG006|Treatment Phase|Lost to Follow-up|0|||
156855264|NCT05579977|566223485|FG007|Treatment Phase|Lost to Follow-up|1|||
156855265|NCT05579977|566223486|FG008|Treatment Phase|Lost to Follow-up|2|||
156855266|NCT05579977|566223487|FG009|Treatment Phase|Lost to Follow-up|2|||
156855267|NCT05579977|566223488|FG010|Treatment Phase|Lost to Follow-up|1|||
156855268|NCT05579977|566223489|FG011|Treatment Phase|Lost to Follow-up|4|||
156855269|NCT05579977|566223490|FG012|Treatment Phase|Lost to Follow-up|3|||
156855270|NCT05579977|566223478|FG000|Treatment Phase|Death|1|||
156855271|NCT05579977|566223479|FG001|Treatment Phase|Death|0|||
156855272|NCT05579977|566223480|FG002|Treatment Phase|Death|0|||
156855273|NCT05579977|566223481|FG003|Treatment Phase|Death|0|||
156855274|NCT05579977|566223482|FG004|Treatment Phase|Death|0|||
156855275|NCT05579977|566223483|FG005|Treatment Phase|Death|0|||
156855276|NCT05579977|566223484|FG006|Treatment Phase|Death|0|||
156855277|NCT05579977|566223485|FG007|Treatment Phase|Death|0|||
156855278|NCT05579977|566223486|FG008|Treatment Phase|Death|0|||
156855279|NCT05579977|566223487|FG009|Treatment Phase|Death|0|||
156855280|NCT05579977|566223488|FG010|Treatment Phase|Death|0|||
156855281|NCT05579977|566223489|FG011|Treatment Phase|Death|0|||
156855282|NCT05579977|566223490|FG012|Treatment Phase|Death|0|||
156855283|NCT05579977|566223478|FG000|Treatment Phase|Adverse Event|0|||
156855284|NCT05579977|566223479|FG001|Treatment Phase|Adverse Event|3|||
156855285|NCT05579977|566223480|FG002|Treatment Phase|Adverse Event|11|||
156855286|NCT05579977|566223481|FG003|Treatment Phase|Adverse Event|10|||
156855287|NCT05579977|566223482|FG004|Treatment Phase|Adverse Event|5|||
156855288|NCT05579977|566223483|FG005|Treatment Phase|Adverse Event|17|||
156855289|NCT05579977|566223484|FG006|Treatment Phase|Adverse Event|5|||
156855290|NCT05579977|566223485|FG007|Treatment Phase|Adverse Event|5|||
156855291|NCT05579977|566223486|FG008|Treatment Phase|Adverse Event|12|||
156855292|NCT05579977|566223487|FG009|Treatment Phase|Adverse Event|20|||
156855293|NCT05579977|566223488|FG010|Treatment Phase|Adverse Event|15|||
156855294|NCT05579977|566223489|FG011|Treatment Phase|Adverse Event|24|||
156855295|NCT05579977|566223490|FG012|Treatment Phase|Adverse Event|23|||
156855296|NCT05579977|566223478|FG000|Treatment Phase|Randomized not treated|0|||
156855297|NCT05579977|566223479|FG001|Treatment Phase|Randomized not treated|0|||
156855298|NCT05579977|566223480|FG002|Treatment Phase|Randomized not treated|0|||
156855299|NCT05579977|566223481|FG003|Treatment Phase|Randomized not treated|0|||
156855300|NCT05579977|566223482|FG004|Treatment Phase|Randomized not treated|1|||
156855301|NCT05579977|566223483|FG005|Treatment Phase|Randomized not treated|0|||
156855302|NCT05579977|566223484|FG006|Treatment Phase|Randomized not treated|0|||
156855303|NCT05579977|566223485|FG007|Treatment Phase|Randomized not treated|0|||
156855304|NCT05579977|566223486|FG008|Treatment Phase|Randomized not treated|0|||
156855305|NCT05579977|566223487|FG009|Treatment Phase|Randomized not treated|0|||
156855306|NCT05579977|566223488|FG010|Treatment Phase|Randomized not treated|0|||
157157595|NCT01830543|567322822|FG001|Overall Study|Death|22|||
156855307|NCT05579977|566223489|FG011|Treatment Phase|Randomized not treated|0|||
156855308|NCT05579977|566223490|FG012|Treatment Phase|Randomized not treated|0|||
156855309|NCT05579977|566223478|FG000|Follow up|Death|1|||
156855310|NCT05579977|566223479|FG001|Follow up|Death|0|||
156855311|NCT05579977|566223480|FG002|Follow up|Death|0|||
156855312|NCT05579977|566223481|FG003|Follow up|Death|0|||
156855313|NCT05579977|566223482|FG004|Follow up|Death|0|||
156855314|NCT05579977|566223483|FG005|Follow up|Death|0|||
156855315|NCT05579977|566223484|FG006|Follow up|Death|0|||
156855316|NCT05579977|566223485|FG007|Follow up|Death|0|||
156855317|NCT05579977|566223486|FG008|Follow up|Death|0|||
156855318|NCT05579977|566223487|FG009|Follow up|Death|0|||
156855319|NCT05579977|566223488|FG010|Follow up|Death|0|||
156855320|NCT05579977|566223489|FG011|Follow up|Death|0|||
156855321|NCT05579977|566223490|FG012|Follow up|Death|0|||
156855322|NCT05579977|566223478|FG000|Follow up|Lost to Follow-up|0|||
156855323|NCT05579977|566223479|FG001|Follow up|Lost to Follow-up|0|||
156855324|NCT05579977|566223480|FG002|Follow up|Lost to Follow-up|0|||
156855325|NCT05579977|566223481|FG003|Follow up|Lost to Follow-up|1|||
157157596|NCT01830543|567322823|FG002|Overall Study|Death|22|||
157157597|NCT01830543|567322821|FG000|Overall Study|Protocol Violation|3|||
156855326|NCT05579977|566223482|FG004|Follow up|Lost to Follow-up|1|||
156855327|NCT05579977|566223483|FG005|Follow up|Lost to Follow-up|2|||
156855328|NCT05579977|566223484|FG006|Follow up|Lost to Follow-up|1|||
156855329|NCT05579977|566223485|FG007|Follow up|Lost to Follow-up|1|||
156855330|NCT05579977|566223486|FG008|Follow up|Lost to Follow-up|3|||
156855331|NCT05579977|566223487|FG009|Follow up|Lost to Follow-up|2|||
156855332|NCT05579977|566223488|FG010|Follow up|Lost to Follow-up|2|||
156855333|NCT05579977|566223489|FG011|Follow up|Lost to Follow-up|4|||
156855334|NCT05579977|566223490|FG012|Follow up|Lost to Follow-up|4|||
156855335|NCT05579977|566223478|FG000|Follow up|Withdrawal by Subject|2|||
156855336|NCT05579977|566223479|FG001|Follow up|Withdrawal by Subject|0|||
156855337|NCT05579977|566223480|FG002|Follow up|Withdrawal by Subject|0|||
156855338|NCT05579977|566223481|FG003|Follow up|Withdrawal by Subject|0|||
156855339|NCT05579977|566223482|FG004|Follow up|Withdrawal by Subject|1|||
156855340|NCT05579977|566223483|FG005|Follow up|Withdrawal by Subject|0|||
156855341|NCT05579977|566223484|FG006|Follow up|Withdrawal by Subject|1|||
156855342|NCT05579977|566223485|FG007|Follow up|Withdrawal by Subject|4|||
156855343|NCT05579977|566223486|FG008|Follow up|Withdrawal by Subject|2|||
156855344|NCT05579977|566223487|FG009|Follow up|Withdrawal by Subject|3|||
156855345|NCT05579977|566223488|FG010|Follow up|Withdrawal by Subject|3|||
156855346|NCT05579977|566223489|FG011|Follow up|Withdrawal by Subject|1|||
156855347|NCT05579977|566223490|FG012|Follow up|Withdrawal by Subject|3|||
156855348|NCT01611194|566223492|FG000|Overall Study|Lost to Follow-up|0|||
156855349|NCT01611194|566223493|FG001|Overall Study|Lost to Follow-up|1|||
156855350|NCT01611194|566223492|FG000|Overall Study|Withdrawal by Subject|0|||
156855351|NCT01611194|566223493|FG001|Overall Study|Withdrawal by Subject|1|||
156855352|NCT01611194|566223492|FG000|Overall Study|drug use|0|||
156855353|NCT01611194|566223493|FG001|Overall Study|drug use|1|||
156855354|NCT00452790|566223494|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
156855355|NCT00452790|566223495|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
156855356|NCT00452790|566223494|FG000|Infant Series|Parent/legal guardian request|8|||
156855357|NCT00452790|566223495|FG001|Infant Series|Parent/legal guardian request|6|||
156855358|NCT00452790|566223494|FG000|Infant Series|Failed to return|4|||
156855359|NCT00452790|566223495|FG001|Infant Series|Failed to return|1|||
156855360|NCT00452790|566223494|FG000|Infant Series|Protocol Violation|1|||
156855361|NCT00452790|566223495|FG001|Infant Series|Protocol Violation|3|||
156855362|NCT00452790|566223494|FG000|Infant Series|Lost to Follow-up|2|||
156855363|NCT00452790|566223495|FG001|Infant Series|Lost to Follow-up|2|||
156855364|NCT00452790|566223494|FG000|Infant Series|Adverse Event|1|||
156855365|NCT00452790|566223495|FG001|Infant Series|Adverse Event|2|||
156855366|NCT00452790|566223494|FG000|Infant Series|Other reasons|1|||
156855367|NCT00452790|566223495|FG001|Infant Series|Other reasons|2|||
156855368|NCT00452790|566223494|FG000|Infant Series|Investigator request|0|||
156855369|NCT00452790|566223495|FG001|Infant Series|Investigator request|1|||
156855370|NCT00452790|566223494|FG000|Infant Series|Death|0|||
156855371|NCT00452790|566223495|FG001|Infant Series|Death|1|||
156855372|NCT00452790|566223494|FG000|After Infant Series|Investigator request|10|||
156855373|NCT00452790|566223495|FG001|After Infant Series|Investigator request|10|||
156855374|NCT00452790|566223494|FG000|After Infant Series|Adverse Event|4|||
156855375|NCT00452790|566223495|FG001|After Infant Series|Adverse Event|1|||
156855376|NCT00452790|566223494|FG000|After Infant Series|Parent/legal guardian request|1|||
156855377|NCT00452790|566223495|FG001|After Infant Series|Parent/legal guardian request|3|||
156855378|NCT00452790|566223494|FG000|After Infant Series|Lost to Follow-up|4|||
156855379|NCT00452790|566223495|FG001|After Infant Series|Lost to Follow-up|0|||
156855380|NCT00452790|566223494|FG000|After Infant Series|Failed to return|1|||
156855381|NCT00452790|566223495|FG001|After Infant Series|Failed to return|0|||
156855382|NCT00452790|566223494|FG000|After Infant Series|Other reasons|1|||
156855383|NCT00452790|566223495|FG001|After Infant Series|Other reasons|0|||
156855384|NCT00452790|566223494|FG000|Toddler Dose|Failed to return|0|||
156855385|NCT00452790|566223495|FG001|Toddler Dose|Failed to return|1|||
156855386|NCT00452790|566223494|FG000|Toddler Dose|Parent/legal guardian request|0|||
156855387|NCT00452790|566223495|FG001|Toddler Dose|Parent/legal guardian request|1|||
156855388|NCT01871519|566223504|FG000|Overall Study|Death|26|||
157157598|NCT01830543|567322822|FG001|Overall Study|Protocol Violation|7|||
156855389|NCT01871519|566223504|FG000|Overall Study|Lost to Follow-up|15|||
157157599|NCT01830543|567322823|FG002|Overall Study|Protocol Violation|7|||
156855390|NCT01871519|566223504|FG000|Overall Study|Withdrawal by Subject|49|||
156855391|NCT00350844|566223507|FG000|Overall Study|Lost to Follow-up|1|||
156855392|NCT01420926|566223508|FG000|Overall Study|Adverse Event|6|||
156855393|NCT01420926|566223509|FG001|Overall Study|Adverse Event|4|||
156855394|NCT01420926|566223508|FG000|Overall Study|Death|18|||
156855395|NCT01420926|566223509|FG001|Overall Study|Death|17|||
156855396|NCT01420926|566223508|FG000|Overall Study|Withdrawal by Subject|11|||
156855397|NCT01420926|566223509|FG001|Overall Study|Withdrawal by Subject|17|||
156855398|NCT01420926|566223508|FG000|Overall Study|Non-protocol treatment|17|||
156855399|NCT01420926|566223509|FG001|Overall Study|Non-protocol treatment|20|||
156855400|NCT01420926|566223508|FG000|Overall Study|Physician Decision|8|||
156855401|NCT01420926|566223509|FG001|Overall Study|Physician Decision|5|||
156855402|NCT01232868|566225145|FG000|Overall Study|Lost to Follow-up|2|||
156889623|NCT01155479|566355508|FG001|Part II|Administrative|49|||
156889624|NCT01155479|566355509|FG002|Part II|Administrative|36|||
156889625|NCT01155479|566355510|FG003|Part II|Administrative|38|||
156889626|NCT01155479|566355511|FG004|Part II|Administrative|46|||
156889627|NCT01155479|566355507|FG000|Part II|Withdrawal by Subject|8|||
156889628|NCT01155479|566355508|FG001|Part II|Withdrawal by Subject|4|||
156889629|NCT01155479|566355509|FG002|Part II|Withdrawal by Subject|12|||
156889630|NCT01155479|566355510|FG003|Part II|Withdrawal by Subject|7|||
156855403|NCT01232868|566225146|FG001|Overall Study|Lost to Follow-up|4|||
156889631|NCT01155479|566355511|FG004|Part II|Withdrawal by Subject|3|||
156855404|NCT04481243|566225147|FG000|Overall Study|Withdrawal by Subject|4|||
156855405|NCT04564846|566225148|FG000|Overall Study|Withdrawal by Subject|2|||
156855406|NCT04564846|566225149|FG001|Overall Study|Withdrawal by Subject|1|||
156855407|NCT04564846|566225148|FG000|Overall Study|Physician Decision|0|||
156855408|NCT04564846|566225149|FG001|Overall Study|Physician Decision|1|||
156855409|NCT04564846|566225148|FG000|Overall Study|Lost to Follow-up|0|||
156855410|NCT04564846|566225149|FG001|Overall Study|Lost to Follow-up|1|||
156855411|NCT04564846|566225148|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
156855412|NCT04564846|566225149|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
156855413|NCT04564846|566225148|FG000|Overall Study|Subject non-compliance|1|||
156855414|NCT04564846|566225149|FG001|Overall Study|Subject non-compliance|0|||
156855415|NCT01169103|566225159|FG000|Overall Study|Lost to Follow-up|3|||
156855416|NCT01169103|566225160|FG001|Overall Study|Lost to Follow-up|3|||
156855417|NCT01169103|566225159|FG000|Overall Study|Withdrawal by Subject|3|||
156855418|NCT01169103|566225160|FG001|Overall Study|Withdrawal by Subject|1|||
156855419|NCT03360682|566225165|FG000|Overall Study|Adverse Event|3|||
156855420|NCT01363700|566225168|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855421|NCT01363700|566225169|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
156855422|NCT01363700|566225170|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855423|NCT01363700|566225171|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855424|NCT01363700|566225172|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
156855425|NCT03827655|566225173|FG000|Overall Study|Death|0|||
156855426|NCT03827655|566225174|FG001|Overall Study|Death|0|||
156855427|NCT03827655|566225175|FG002|Overall Study|Death|0|||
156855428|NCT03827655|566225176|FG003|Overall Study|Death|0|||
156855429|NCT03827655|566225177|FG004|Overall Study|Death|1|||
156855430|NCT03827655|566225173|FG000|Overall Study|Protocol Deviation|1|||
156855431|NCT03827655|566225174|FG001|Overall Study|Protocol Deviation|0|||
156855432|NCT03827655|566225175|FG002|Overall Study|Protocol Deviation|1|||
156855433|NCT03827655|566225176|FG003|Overall Study|Protocol Deviation|1|||
156855434|NCT03827655|566225177|FG004|Overall Study|Protocol Deviation|0|||
156855435|NCT03827655|566225173|FG000|Overall Study|Withdrawal by Subject|3|||
156855436|NCT03827655|566225174|FG001|Overall Study|Withdrawal by Subject|2|||
156855437|NCT03827655|566225175|FG002|Overall Study|Withdrawal by Subject|2|||
156855438|NCT03827655|566225176|FG003|Overall Study|Withdrawal by Subject|0|||
156855439|NCT03827655|566225177|FG004|Overall Study|Withdrawal by Subject|1|||
156855440|NCT03827655|566225173|FG000|Overall Study|Reason not Specified|3|||
156855441|NCT03827655|566225174|FG001|Overall Study|Reason not Specified|1|||
156855442|NCT03827655|566225175|FG002|Overall Study|Reason not Specified|1|||
156855443|NCT03827655|566225176|FG003|Overall Study|Reason not Specified|1|||
156889632|NCT01155479|566355507|FG000|Part II|Lost to Follow-up|1|||
156889633|NCT01155479|566355508|FG001|Part II|Lost to Follow-up|0|||
156889634|NCT01155479|566355509|FG002|Part II|Lost to Follow-up|0|||
156889635|NCT01155479|566355510|FG003|Part II|Lost to Follow-up|0|||
156889636|NCT01155479|566355511|FG004|Part II|Lost to Follow-up|1|||
156889637|NCT01155479|566355507|FG000|Part II|Treatment Failure|0|||
156889638|NCT01155479|566355508|FG001|Part II|Treatment Failure|1|||
157025834|NCT03628924|566849619|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
157157600|NCT01830543|567322821|FG000|Overall Study|Physician Decision|11|||
157157601|NCT01830543|567322822|FG001|Overall Study|Physician Decision|5|||
156855444|NCT03827655|566225177|FG004|Overall Study|Reason not Specified|1|||
156889639|NCT01155479|566355509|FG002|Part II|Treatment Failure|2|||
156889640|NCT01155479|566355510|FG003|Part II|Treatment Failure|0|||
156889641|NCT01155479|566355511|FG004|Part II|Treatment Failure|1|||
156889642|NCT01155479|566355507|FG000|Part II|Non-Compliance with Protocol|0|||
156889643|NCT01155479|566355508|FG001|Part II|Non-Compliance with Protocol|1|||
157157602|NCT01830543|567322823|FG002|Overall Study|Physician Decision|12|||
156889644|NCT01155479|566355509|FG002|Part II|Non-Compliance with Protocol|0|||
157157603|NCT01830543|567322821|FG000|Overall Study|Withdrawal by consent|3|||
157157604|NCT01830543|567322822|FG001|Overall Study|Withdrawal by consent|3|||
156855445|NCT03649217|566225178|FG000|Overall Study|subject had severe ataxia not initially found|1|||
156855446|NCT03649217|566225178|FG000|Overall Study|subject had cognitive issues not initially found|1|||
156855447|NCT02552966|566225179|FG000|Overall Study|Lost to Follow-up|2|||
156889645|NCT01155479|566355510|FG003|Part II|Non-Compliance with Protocol|2|||
156889646|NCT01155479|566355511|FG004|Part II|Non-Compliance with Protocol|0|||
156889647|NCT02360605|566355512|FG000|Overall Study|Withdrawal by Subject|4|||
156889648|NCT02360605|566355513|FG001|Overall Study|Withdrawal by Subject|9|||
156855448|NCT02552966|566225179|FG000|Overall Study|Withdrawal by Subject|3|||
156855449|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855450|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855451|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855452|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
156855453|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855454|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855455|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855456|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855457|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855458|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
156855459|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
156855460|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
156855461|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855462|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
156855463|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
157157605|NCT01830543|567322823|FG002|Overall Study|Withdrawal by consent|3|||
157157606|NCT01830543|567322821|FG000|Overall Study|Other|12|||
157157607|NCT01830543|567322822|FG001|Overall Study|Other|17|||
156855464|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
156855465|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855466|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855467|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855468|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
156855469|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
156855470|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855471|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855472|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855473|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
156855474|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
156855475|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855476|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855477|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855478|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
156855479|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855480|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855481|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855482|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855483|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855484|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
156855485|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855486|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855487|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855488|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
156855489|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
156855490|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855491|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
156855492|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855493|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
156889649|NCT02360605|566355512|FG000|Overall Study|Lost to Follow-up|7|||
156889650|NCT02360605|566355513|FG001|Overall Study|Lost to Follow-up|8|||
156889651|NCT02360605|566355512|FG000|Overall Study|Death|0|||
156889652|NCT02360605|566355513|FG001|Overall Study|Death|1|||
156889653|NCT01117792|566355516|FG000|Overall Study|Death|1|||
156889654|NCT01117792|566355516|FG000|Overall Study|Adverse Event|3|||
156889655|NCT05867342|566355517|FG000|Overall Study|Investigator Decision|3|||
157157608|NCT01830543|567322823|FG002|Overall Study|Other|37|||
157157609|NCT04263142|567322824|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156855494|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855495|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855496|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156855497|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156889656|NCT05867342|566355518|FG001|Overall Study|Investigator Decision|3|||
156889657|NCT01721577|566355519|FG000|Overall Study|Lack of Efficacy|1|||
156889658|NCT01721577|566355520|FG001|Overall Study|Lack of Efficacy|0|||
156855498|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
156889659|NCT01721577|566355519|FG000|Overall Study|Death|1|||
156889660|NCT01721577|566355520|FG001|Overall Study|Death|0|||
157157610|NCT04263142|567322825|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
157157611|NCT04263142|567322826|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
157157612|NCT04263142|567322827|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
156855499|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855500|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855501|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855502|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855503|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855504|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
156855505|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855506|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855507|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855508|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
156855509|NCT02365649|566225185|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855510|NCT02365649|566225186|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855511|NCT02365649|566225187|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
156855512|NCT02365649|566225188|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855513|NCT02365649|566225189|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855514|NCT02365649|566225190|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855515|NCT02365649|566225191|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855516|NCT02365649|566225192|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855517|NCT02365649|566225193|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855518|NCT02365649|566225194|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
156855519|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855520|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855521|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855522|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855523|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855524|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855525|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
156855526|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855527|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855528|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
156855529|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855530|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855531|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855532|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855533|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855534|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855535|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
156855536|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
156855537|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
156855538|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
156855539|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855540|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855541|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855542|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855543|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855544|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
156855545|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
156855546|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
156855547|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
156855548|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
156855549|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855550|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855551|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855552|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855553|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855554|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855555|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
156855556|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
156855557|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
156855558|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
157157613|NCT04263142|567322828|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
156855559|NCT02365649|566225185|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855560|NCT02365649|566225186|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
157157614|NCT04263142|567322824|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
157157615|NCT04263142|567322825|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
157157616|NCT04263142|567322826|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
157157617|NCT04263142|567322827|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
157157618|NCT04263142|567322828|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
156855561|NCT02365649|566225187|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855562|NCT02365649|566225188|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855563|NCT02365649|566225189|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855564|NCT02365649|566225190|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855565|NCT02365649|566225191|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
156855566|NCT02365649|566225192|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855567|NCT02365649|566225193|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
156855568|NCT02365649|566225194|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
156855569|NCT01433172|566225202|FG000|Overall Study|Withdrawal by Subject|0|||
156855570|NCT01433172|566225203|FG001|Overall Study|Withdrawal by Subject|1|||
156855571|NCT01433172|566225204|FG002|Overall Study|Withdrawal by Subject|0|||
156855572|NCT01433172|566225202|FG000|Overall Study|Disease Progression|0|||
156855573|NCT01433172|566225203|FG001|Overall Study|Disease Progression|0|||
156855574|NCT01433172|566225204|FG002|Overall Study|Disease Progression|1|||
156855575|NCT01433172|566225202|FG000|Overall Study|Death|0|||
156855576|NCT01433172|566225203|FG001|Overall Study|Death|2|||
156855577|NCT01433172|566225204|FG002|Overall Study|Death|0|||
156855578|NCT01391663|566225205|FG000|Overall Study|Withdrawal by Subject|0|||
156855579|NCT01391663|566225206|FG001|Overall Study|Withdrawal by Subject|0|||
156855580|NCT01391663|566225207|FG002|Overall Study|Withdrawal by Subject|1|||
156855581|NCT01391663|566225208|FG003|Overall Study|Withdrawal by Subject|0|||
156855582|NCT00510835|566225212|FG000|Overall Study|Withdrawal by Subject|6|||
156855583|NCT00510835|566225213|FG001|Overall Study|Withdrawal by Subject|2|||
156855584|NCT00510835|566225214|FG002|Overall Study|Withdrawal by Subject|2|||
156855585|NCT03084796|566225215|FG000|Overall Study|Adverse Event|4|||
156855586|NCT03084796|566225216|FG001|Overall Study|Adverse Event|5|||
156855587|NCT03084796|566225217|FG002|Overall Study|Adverse Event|6|||
156855588|NCT03084796|566225218|FG003|Overall Study|Adverse Event|2|||
156855589|NCT03084796|566225219|FG004|Overall Study|Adverse Event|3|||
156855590|NCT03084796|566225220|FG005|Overall Study|Adverse Event|5|||
156855591|NCT03084796|566225215|FG000|Overall Study|Withdrawal by Subject|3|||
156855592|NCT03084796|566225216|FG001|Overall Study|Withdrawal by Subject|5|||
156855593|NCT03084796|566225217|FG002|Overall Study|Withdrawal by Subject|2|||
156855594|NCT03084796|566225218|FG003|Overall Study|Withdrawal by Subject|1|||
156855595|NCT03084796|566225219|FG004|Overall Study|Withdrawal by Subject|3|||
156855596|NCT03084796|566225220|FG005|Overall Study|Withdrawal by Subject|0|||
156855597|NCT03084796|566225215|FG000|Overall Study|Protocol Violation|0|||
156855598|NCT03084796|566225216|FG001|Overall Study|Protocol Violation|0|||
156855599|NCT03084796|566225217|FG002|Overall Study|Protocol Violation|1|||
156855600|NCT03084796|566225218|FG003|Overall Study|Protocol Violation|0|||
156855601|NCT03084796|566225219|FG004|Overall Study|Protocol Violation|1|||
156855602|NCT03084796|566225220|FG005|Overall Study|Protocol Violation|1|||
156855603|NCT03084796|566225215|FG000|Overall Study|Lack of Efficacy|0|||
156855604|NCT03084796|566225216|FG001|Overall Study|Lack of Efficacy|0|||
156855605|NCT03084796|566225217|FG002|Overall Study|Lack of Efficacy|1|||
156855606|NCT03084796|566225218|FG003|Overall Study|Lack of Efficacy|0|||
156855607|NCT03084796|566225219|FG004|Overall Study|Lack of Efficacy|1|||
157157619|NCT03010423|567322830|FG000|Overall Study|Study termination|8|||
156855608|NCT03084796|566225220|FG005|Overall Study|Lack of Efficacy|0|||
156855609|NCT03084796|566225215|FG000|Overall Study|Lost to Follow-up|0|||
156855610|NCT03084796|566225216|FG001|Overall Study|Lost to Follow-up|0|||
156855611|NCT03084796|566225217|FG002|Overall Study|Lost to Follow-up|1|||
156855612|NCT03084796|566225218|FG003|Overall Study|Lost to Follow-up|1|||
156855613|NCT03084796|566225219|FG004|Overall Study|Lost to Follow-up|3|||
156855614|NCT03084796|566225220|FG005|Overall Study|Lost to Follow-up|1|||
156855615|NCT03084796|566225215|FG000|Overall Study|Randomization error|0|||
156855616|NCT03084796|566225216|FG001|Overall Study|Randomization error|0|||
156855617|NCT03084796|566225217|FG002|Overall Study|Randomization error|1|||
156855618|NCT03084796|566225218|FG003|Overall Study|Randomization error|0|||
157157620|NCT00520676|567322833|FG000|Overall Study|Death|84|||
156855619|NCT03084796|566225219|FG004|Overall Study|Randomization error|0|||
156855620|NCT03084796|566225220|FG005|Overall Study|Randomization error|0|||
156855621|NCT02741245|566225229|FG000|Overall Study|Adverse Event|0|||
156855622|NCT02741245|566225230|FG001|Overall Study|Adverse Event|0|||
157157621|NCT00520676|567322834|FG001|Overall Study|Death|81|||
156855623|NCT02741245|566225231|FG002|Overall Study|Adverse Event|0|||
156855624|NCT02741245|566225232|FG003|Overall Study|Adverse Event|2|||
156855625|NCT02741245|566225233|FG004|Overall Study|Adverse Event|2|||
156855626|NCT02741245|566225229|FG000|Overall Study|Protocol Violation|0|||
156855627|NCT02741245|566225230|FG001|Overall Study|Protocol Violation|1|||
156855628|NCT02741245|566225231|FG002|Overall Study|Protocol Violation|0|||
156855629|NCT02741245|566225232|FG003|Overall Study|Protocol Violation|1|||
157157622|NCT00520676|567322833|FG000|Overall Study|Lost to Follow-up|6|||
156855630|NCT02741245|566225233|FG004|Overall Study|Protocol Violation|0|||
156855631|NCT02741245|566225229|FG000|Overall Study|Withdrawal by Subject|0|||
156855632|NCT02741245|566225230|FG001|Overall Study|Withdrawal by Subject|0|||
156855633|NCT02741245|566225231|FG002|Overall Study|Withdrawal by Subject|0|||
156855634|NCT02741245|566225232|FG003|Overall Study|Withdrawal by Subject|1|||
156855635|NCT02741245|566225233|FG004|Overall Study|Withdrawal by Subject|0|||
156855636|NCT01787461|566225237|FG000|Overall Study|Adverse Event|4|||
156855637|NCT01787461|566225238|FG001|Overall Study|Adverse Event|3|||
156855638|NCT01787461|566225237|FG000|Overall Study|Lost to Follow-up|3|||
156855639|NCT01787461|566225238|FG001|Overall Study|Lost to Follow-up|2|||
156855640|NCT01787461|566225237|FG000|Overall Study|No longer met eligibility criteria|1|||
156855641|NCT01787461|566225238|FG001|Overall Study|No longer met eligibility criteria|0|||
156855642|NCT01787461|566225237|FG000|Overall Study|Withdrawal by Subject|3|||
156855643|NCT01787461|566225238|FG001|Overall Study|Withdrawal by Subject|4|||
156855644|NCT01787461|566225237|FG000|Overall Study|Protocol Violation|3|||
156855645|NCT01787461|566225238|FG001|Overall Study|Protocol Violation|0|||
156855646|NCT00152503|566225239|FG000|Overall Study|Adverse Event|4|||
156855647|NCT03259555|566225240|FG000|Overall Study|Adverse Event|6|||
156855648|NCT03259555|566225241|FG001|Overall Study|Adverse Event|4|||
156855649|NCT03259555|566225240|FG000|Overall Study|Lack of Efficacy|6|||
156855650|NCT03259555|566225241|FG001|Overall Study|Lack of Efficacy|4|||
156855651|NCT03259555|566225240|FG000|Overall Study|Lost to Follow-up|0|||
156855652|NCT03259555|566225241|FG001|Overall Study|Lost to Follow-up|2|||
156855653|NCT03259555|566225240|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156855654|NCT03259555|566225241|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156855655|NCT03259555|566225240|FG000|Overall Study|Progressive Disease|0|||
156855656|NCT03259555|566225241|FG001|Overall Study|Progressive Disease|2|||
156855657|NCT03259555|566225240|FG000|Overall Study|Withdrawal by Subject|19|||
156855658|NCT03259555|566225241|FG001|Overall Study|Withdrawal by Subject|16|||
156855659|NCT03259555|566225240|FG000|Overall Study|Physician Decision|1|||
156855660|NCT03259555|566225241|FG001|Overall Study|Physician Decision|2|||
156855661|NCT03259555|566225240|FG000|Overall Study|Other|1|||
156855662|NCT03259555|566225241|FG001|Overall Study|Other|0|||
156855663|NCT02800863|566225242|FG000|Overall Study|Adverse Event|14|||
156855664|NCT02800863|566225242|FG000|Overall Study|Another Device Implanted|1|||
156855665|NCT02800863|566225242|FG000|Overall Study|Device Explanted|1|||
156855666|NCT02800863|566225242|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
156855667|NCT02800863|566225242|FG000|Overall Study|Health Issues|1|||
156855668|NCT02800863|566225242|FG000|Overall Study|Insurance Denial|8|||
156855669|NCT02800863|566225242|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
156855670|NCT02800863|566225242|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
156855671|NCT02800863|566225242|FG000|Overall Study|Screen Failure|1|||
156855672|NCT02800863|566225242|FG000|Overall Study|Sponsor Request|6|||
156855673|NCT02800863|566225242|FG000|Overall Study|Death|3|||
156855674|NCT02800863|566225242|FG000|Overall Study|Subject Implant at Another Facility|1|||
156855675|NCT02800863|566225242|FG000|Overall Study|Lost to Follow-up|26|||
156855676|NCT02800863|566225242|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
156855677|NCT02800863|566225242|FG000|Overall Study|Subject and/or Family Request|64|||
156855678|NCT02800863|566225242|FG000|Overall Study|Trial Failure|81|||
156855679|NCT02800863|566225242|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
156855680|NCT00607087|566225243|FG000|Overall Study|Withdrawal by Subject|9|||
156855681|NCT00607087|566225244|FG001|Overall Study|Withdrawal by Subject|4|||
156855682|NCT00607087|566225245|FG002|Overall Study|Withdrawal by Subject|4|||
156855683|NCT00607087|566225243|FG000|Overall Study|Adverse Event|3|||
156855684|NCT00607087|566225244|FG001|Overall Study|Adverse Event|2|||
156855685|NCT00607087|566225245|FG002|Overall Study|Adverse Event|3|||
156855686|NCT00607087|566225243|FG000|Overall Study|Other reason|1|||
156889661|NCT01721577|566355519|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
156889662|NCT01721577|566355520|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
156889663|NCT01721577|566355519|FG000|Overall Study|Adverse Event|0|||
156889664|NCT01721577|566355520|FG001|Overall Study|Adverse Event|2|||
157225468|NCT01860976|567571437|FG001|Long Term Extension|Lack of Efficacy|0|||
156855687|NCT00607087|566225244|FG001|Overall Study|Other reason|5|||
156855688|NCT00607087|566225245|FG002|Overall Study|Other reason|2|||
156855689|NCT00607087|566225243|FG000|Overall Study|Poor compliance to protocol|1|||
156855690|NCT00607087|566225244|FG001|Overall Study|Poor compliance to protocol|0|||
156855691|NCT00607087|566225245|FG002|Overall Study|Poor compliance to protocol|1|||
156855692|NCT00607087|566225243|FG000|Overall Study|Lost to Follow-up|1|||
156855693|NCT00607087|566225244|FG001|Overall Study|Lost to Follow-up|0|||
156855694|NCT00607087|566225245|FG002|Overall Study|Lost to Follow-up|0|||
156855695|NCT00607087|566225243|FG000|Period 1|Withdrawal by Subject|7|||
156855696|NCT00607087|566225244|FG001|Period 1|Withdrawal by Subject|2|||
156855697|NCT00607087|566225245|FG002|Period 1|Withdrawal by Subject|3|||
156855698|NCT00607087|566225243|FG000|Period 1|Adverse Event|3|||
156855699|NCT00607087|566225244|FG001|Period 1|Adverse Event|0|||
156855700|NCT00607087|566225245|FG002|Period 1|Adverse Event|0|||
156855701|NCT00607087|566225243|FG000|Period 1|Poor compliance to protocol|1|||
157157623|NCT00520676|567322834|FG001|Overall Study|Lost to Follow-up|10|||
157157624|NCT00520676|567322833|FG000|Overall Study|Physician Decision|4|||
157157625|NCT00520676|567322834|FG001|Overall Study|Physician Decision|1|||
157157626|NCT00520676|567322833|FG000|Overall Study|Withdrawal by Subject|7|||
157157627|NCT00520676|567322834|FG001|Overall Study|Withdrawal by Subject|11|||
157157628|NCT01597557|567322839|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
156855702|NCT00607087|566225244|FG001|Period 1|Poor compliance to protocol|0|||
156855703|NCT00607087|566225245|FG002|Period 1|Poor compliance to protocol|0|||
156855704|NCT00607087|566225243|FG000|Period 1|Lost to Follow-up|1|||
156855705|NCT00607087|566225244|FG001|Period 1|Lost to Follow-up|0|||
156855706|NCT00607087|566225245|FG002|Period 1|Lost to Follow-up|0|||
156855707|NCT00607087|566225243|FG000|Period 1|Other reason|0|||
156855708|NCT00607087|566225244|FG001|Period 1|Other reason|4|||
156855709|NCT00607087|566225245|FG002|Period 1|Other reason|2|||
156855710|NCT00607087|566225243|FG000|Period 2|Withdrawal by Subject|0|||
156855711|NCT00607087|566225244|FG001|Period 2|Withdrawal by Subject|1|||
156855712|NCT00607087|566225245|FG002|Period 2|Withdrawal by Subject|1|||
156855713|NCT00607087|566225243|FG000|Period 2|Other reason|1|||
156855714|NCT00607087|566225244|FG001|Period 2|Other reason|1|||
156855715|NCT00607087|566225245|FG002|Period 2|Other reason|0|||
156855716|NCT00607087|566225243|FG000|Period 2|Adverse Event|0|||
156855717|NCT00607087|566225244|FG001|Period 2|Adverse Event|1|||
156855718|NCT00607087|566225245|FG002|Period 2|Adverse Event|3|||
156855719|NCT00607087|566225243|FG000|Period 2|Poor compliance to protocol|0|||
156855720|NCT00607087|566225244|FG001|Period 2|Poor compliance to protocol|0|||
156855721|NCT00607087|566225245|FG002|Period 2|Poor compliance to protocol|1|||
157025835|NCT03628924|566849613|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156855722|NCT00607087|566225243|FG000|Period 3|Withdrawal by Subject|2|||
156855723|NCT00607087|566225244|FG001|Period 3|Withdrawal by Subject|1|||
156855724|NCT00607087|566225245|FG002|Period 3|Withdrawal by Subject|0|||
156855725|NCT00607087|566225243|FG000|Period 3|Adverse Event|0|||
156855726|NCT00607087|566225244|FG001|Period 3|Adverse Event|1|||
156855727|NCT00607087|566225245|FG002|Period 3|Adverse Event|0|||
156855728|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
156855729|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
156855730|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
156855731|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
156855732|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
156855733|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
156855734|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
156855735|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
156855736|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
156855737|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
156855738|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
156855739|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
156855740|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
156855741|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
156855742|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
156855743|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
156855744|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
156855745|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
156855746|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
156855747|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
156855748|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
156855749|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
156855750|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
156855751|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
156855752|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
157157629|NCT01597557|567322840|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
157157630|NCT00115349|567322843|FG000|Overall Study|Study closed due to low enrollment.|11|||
157157631|NCT00115349|567322844|FG001|Overall Study|Study closed due to low enrollment.|9|||
157157632|NCT04402008|567322848|FG000|Overall Study|Adverse Event|0|||
157157633|NCT04402008|567322849|FG001|Overall Study|Adverse Event|0|||
156855753|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
156855754|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
156855755|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
157157634|NCT04402008|567322850|FG002|Overall Study|Adverse Event|0|||
157157635|NCT04402008|567322851|FG003|Overall Study|Adverse Event|1|||
156855756|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
157025836|NCT03628924|566849614|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
156855757|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
156855758|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
157157636|NCT04402008|567322852|FG004|Overall Study|Adverse Event|0|||
157157637|NCT04402008|567322853|FG005|Overall Study|Adverse Event|0|||
156889665|NCT01673282|566355521|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
156889666|NCT01673282|566355522|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
156889667|NCT01673282|566355521|FG000|Overall Study|Lack of Efficacy|9|||
156889668|NCT01673282|566355522|FG001|Overall Study|Lack of Efficacy|2|||
156889669|NCT01673282|566355521|FG000|Overall Study|Lost to Follow-up|11|||
156889670|NCT01673282|566355522|FG001|Overall Study|Lost to Follow-up|10|||
156889671|NCT01673282|566355521|FG000|Overall Study|Withdrawal by Subject|3|||
156889672|NCT01673282|566355522|FG001|Overall Study|Withdrawal by Subject|3|||
156889673|NCT01673282|566355521|FG000|Overall Study|Other|1|||
156889674|NCT01673282|566355522|FG001|Overall Study|Other|6|||
156889675|NCT04391569|566355525|FG000|Overall Study|Death|15|||
156889676|NCT04391569|566355526|FG001|Overall Study|Death|10|||
156889677|NCT04391569|566355525|FG000|Overall Study|Withdrawal by Subject|1|||
156889678|NCT04391569|566355526|FG001|Overall Study|Withdrawal by Subject|0|||
156889679|NCT04391569|566355525|FG000|Overall Study|Lost to Follow-up|3|||
156889680|NCT04391569|566355526|FG001|Overall Study|Lost to Follow-up|2|||
156889681|NCT04391569|566355525|FG000|Overall Study|Lack of Efficacy|0|||
156889682|NCT04391569|566355526|FG001|Overall Study|Lack of Efficacy|1|||
156889683|NCT04391569|566355525|FG000|Overall Study|Participant discharged to hospice facility|0|||
156855759|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
156855760|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
156855761|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
156855762|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
156855763|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
156855764|NCT02586623|566225247|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
156855765|NCT02586623|566225248|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
156855766|NCT02586623|566225249|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
156855767|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
156855768|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
156855769|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
156855770|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
156855771|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
156855772|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
156855773|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
156855774|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
156855775|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
156855776|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
156855777|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
156855778|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
156855779|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
156855780|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
156855781|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
156855782|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
156855783|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
156855784|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
156855785|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
156855786|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
156855787|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
156855788|NCT02586623|566225247|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
156855789|NCT02586623|566225248|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
156855790|NCT02586623|566225249|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
156855791|NCT04393493|566225250|FG000|First 4 Days of Intervention|Early improvement|5|||
156855792|NCT04393493|566225251|FG001|First 4 Days of Intervention|Early improvement|7|||
156855793|NCT02910466|566225252|FG000|Overall Study|Adverse Event|1|||
156855794|NCT02910466|566225252|FG000|Overall Study|Withdrawal by Subject|3|||
156855795|NCT02910466|566225252|FG000|Overall Study|Lost to Follow-up|5|||
156855796|NCT02910466|566225252|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
156855797|NCT02910466|566225252|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
156889684|NCT04391569|566355526|FG001|Overall Study|Participant discharged to hospice facility|1|||
156889685|NCT04391569|566355525|FG000|Overall Study|Participant family decision|1|||
156889686|NCT04391569|566355526|FG001|Overall Study|Participant family decision|0|||
156889687|NCT04391569|566355525|FG000|Overall Study|Participant discharged prematurely|1|||
156889688|NCT04391569|566355526|FG001|Overall Study|Participant discharged prematurely|0|||
156889689|NCT00732940|566355536|FG000|Overall Study|Withdrawal by Subject|1|||
156889690|NCT00732940|566355537|FG001|Overall Study|Withdrawal by Subject|2|||
156889691|NCT00732940|566355536|FG000|Overall Study|Adverse Event|0|||
156889692|NCT00732940|566355537|FG001|Overall Study|Adverse Event|1|||
156889693|NCT00732940|566355536|FG000|Overall Study|Lost to Follow-up|1|||
156855798|NCT05051579|566225256|FG000|Overall Study|Withdrawal by Subject|3|||
156855799|NCT05051579|566225257|FG001|Overall Study|Withdrawal by Subject|5|||
156889694|NCT00732940|566355537|FG001|Overall Study|Lost to Follow-up|0|||
157025837|NCT03628924|566849615|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
157025838|NCT03628924|566849616|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
157025839|NCT03628924|566849617|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
157025840|NCT03628924|566849618|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
156855800|NCT05051579|566225258|FG002|Overall Study|Withdrawal by Subject|2|||
156855801|NCT05051579|566225259|FG003|Overall Study|Withdrawal by Subject|1|||
156855802|NCT05051579|566225260|FG004|Overall Study|Withdrawal by Subject|4|||
156855803|NCT05051579|566225261|FG005|Overall Study|Withdrawal by Subject|0|||
156855804|NCT05051579|566225262|FG006|Overall Study|Withdrawal by Subject|4|||
156855805|NCT05051579|566225256|FG000|Overall Study|Lost to Follow-up|1|||
156855806|NCT05051579|566225257|FG001|Overall Study|Lost to Follow-up|0|||
156855807|NCT05051579|566225258|FG002|Overall Study|Lost to Follow-up|0|||
156855808|NCT05051579|566225259|FG003|Overall Study|Lost to Follow-up|0|||
156855809|NCT05051579|566225260|FG004|Overall Study|Lost to Follow-up|1|||
156855810|NCT05051579|566225261|FG005|Overall Study|Lost to Follow-up|0|||
156855811|NCT05051579|566225262|FG006|Overall Study|Lost to Follow-up|1|||
156855812|NCT05051579|566225256|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855813|NCT05051579|566225257|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855814|NCT05051579|566225258|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855815|NCT05051579|566225259|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855816|NCT05051579|566225260|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855817|NCT05051579|566225261|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
156855818|NCT05051579|566225262|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
156855819|NCT05051579|566225256|FG000|Overall Study|Adverse Event|2|||
156855820|NCT05051579|566225257|FG001|Overall Study|Adverse Event|1|||
156855821|NCT05051579|566225258|FG002|Overall Study|Adverse Event|0|||
156855822|NCT05051579|566225259|FG003|Overall Study|Adverse Event|4|||
156855823|NCT05051579|566225260|FG004|Overall Study|Adverse Event|1|||
156855824|NCT05051579|566225261|FG005|Overall Study|Adverse Event|2|||
156855825|NCT05051579|566225262|FG006|Overall Study|Adverse Event|0|||
156855826|NCT05051579|566225256|FG000|Overall Study|Inadvertent Enrollment|0|||
156855827|NCT05051579|566225257|FG001|Overall Study|Inadvertent Enrollment|0|||
156855828|NCT05051579|566225258|FG002|Overall Study|Inadvertent Enrollment|0|||
156855829|NCT05051579|566225259|FG003|Overall Study|Inadvertent Enrollment|0|||
156855830|NCT05051579|566225260|FG004|Overall Study|Inadvertent Enrollment|0|||
156855831|NCT05051579|566225261|FG005|Overall Study|Inadvertent Enrollment|0|||
156855832|NCT05051579|566225262|FG006|Overall Study|Inadvertent Enrollment|1|||
156855833|NCT05051579|566225256|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855834|NCT05051579|566225257|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
156855835|NCT05051579|566225258|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
157025841|NCT03628924|566849619|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
156855836|NCT05051579|566225259|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855837|NCT05051579|566225260|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855838|NCT05051579|566225261|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855839|NCT05051579|566225262|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
156855840|NCT05051579|566225256|FG000|Overall Study|Sponsor Decision|0|||
156855841|NCT05051579|566225257|FG001|Overall Study|Sponsor Decision|0|||
156855842|NCT05051579|566225258|FG002|Overall Study|Sponsor Decision|0|||
156855843|NCT05051579|566225259|FG003|Overall Study|Sponsor Decision|0|||
156855844|NCT05051579|566225260|FG004|Overall Study|Sponsor Decision|1|||
156855845|NCT05051579|566225261|FG005|Overall Study|Sponsor Decision|0|||
156855846|NCT05051579|566225262|FG006|Overall Study|Sponsor Decision|0|||
156855847|NCT05051579|566225256|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855848|NCT05051579|566225257|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855849|NCT05051579|566225258|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855850|NCT05051579|566225259|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855851|NCT05051579|566225260|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
156855852|NCT05051579|566225261|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855853|NCT05051579|566225262|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
156855854|NCT03799341|566225265|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
157025842|NCT05362487|566849620|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
157025843|NCT03603600|566849621|FG000|Overall Study|Withdrawal by Subject|5|||
157025844|NCT03603600|566849622|FG001|Overall Study|Withdrawal by Subject|7|||
157025845|NCT03603600|566849621|FG000|Overall Study|Lost to Follow-up|2|||
157025846|NCT03603600|566849622|FG001|Overall Study|Lost to Follow-up|3|||
156855855|NCT03799341|566225266|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
156855856|NCT03799341|566225267|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
156855857|NCT03799341|566225265|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
156855858|NCT03799341|566225266|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
156855859|NCT03799341|566225267|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
156855860|NCT03799341|566225265|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
156855861|NCT03799341|566225266|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
156855862|NCT03799341|566225267|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
156855863|NCT03799341|566225265|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
156855864|NCT03799341|566225266|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
156855865|NCT03799341|566225267|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
156855866|NCT03799341|566225265|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
156855867|NCT03799341|566225266|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
156855868|NCT03799341|566225267|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
156855869|NCT03799341|566225265|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
156855870|NCT03799341|566225266|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
156855871|NCT03799341|566225267|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
156855872|NCT04539938|566225268|FG000|Overall Study|Death|30|||
156855873|NCT04539938|566225268|FG000|Overall Study|Withdrawal by Subject|4|||
156855874|NCT02360228|566225282|FG000|Overall Study|Withdrawal by Subject|1|||
156855875|NCT02360228|566225283|FG001|Overall Study|Withdrawal by Subject|0|||
156855876|NCT02360228|566225284|FG002|Overall Study|Withdrawal by Subject|0|||
156855877|NCT02360228|566225282|FG000|Overall Study|Self-discontinued medication|0|||
156855878|NCT02360228|566225283|FG001|Overall Study|Self-discontinued medication|1|||
156855879|NCT02360228|566225284|FG002|Overall Study|Self-discontinued medication|0|||
156855880|NCT02360228|566225282|FG000|Overall Study|Unstable symptoms during screening|0|||
156855881|NCT02360228|566225283|FG001|Overall Study|Unstable symptoms during screening|0|||
156855882|NCT02360228|566225284|FG002|Overall Study|Unstable symptoms during screening|1|||
156855883|NCT00865345|566226823|FG000|Overall Study|Withdrawal by Subject|2|||
156855884|NCT03737123|566226824|FG000|Study Treatment|Adverse Event|2|||
156855885|NCT03737123|566226825|FG001|Study Treatment|Adverse Event|0|||
156855886|NCT03737123|566226824|FG000|Study Treatment|Disease Progression|2|||
156855887|NCT03737123|566226825|FG001|Study Treatment|Disease Progression|0|||
156855888|NCT03737123|566226824|FG000|Study Treatment|Withdrawal by Subject|2|||
156855889|NCT03737123|566226825|FG001|Study Treatment|Withdrawal by Subject|0|||
156855890|NCT03737123|566226824|FG000|Follow up|Death|1|||
156855891|NCT03737123|566226825|FG001|Follow up|Death|0|||
156855892|NCT03737123|566226824|FG000|Follow up|Withdrawal by Subject|1|||
156855893|NCT03737123|566226825|FG001|Follow up|Withdrawal by Subject|0|||
156855894|NCT03737123|566226824|FG000|Follow up|Termination of study|4|||
156855895|NCT03737123|566226825|FG001|Follow up|Termination of study|0|||
156855896|NCT01519323|566226826|FG000|Overall Study|Death|3|||
156855897|NCT01519323|566226827|FG001|Overall Study|Death|2|||
156855898|NCT01519323|566226826|FG000|Overall Study|Study terminated by sponsor|0|||
156855899|NCT01519323|566226827|FG001|Overall Study|Study terminated by sponsor|1|||
156855900|NCT00445549|566226828|FG000|Overall Study|progressive disease|12|||
156855901|NCT03629886|566226834|FG000|Overall Study|Migrated / moved from the study area|0|||
156855902|NCT03629886|566226835|FG001|Overall Study|Migrated / moved from the study area|55|||
156855903|NCT03629886|566226834|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
156855904|NCT03629886|566226835|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
156855905|NCT03629886|566226834|FG000|Overall Study|Study vaccine not administrated|0|||
156855906|NCT03629886|566226835|FG001|Overall Study|Study vaccine not administrated|3|||
156855907|NCT03629886|566226834|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
156855908|NCT03629886|566226835|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
156855909|NCT03629886|566226834|FG000|Overall Study|Refused vaccination step of the study|0|||
156889695|NCT00645788|566355538|FG000|Overall Study|Did not receive study drug|1|||
156889696|NCT00645788|566355539|FG001|Overall Study|Did not receive study drug|1|||
156889697|NCT00645788|566355540|FG002|Overall Study|Did not receive study drug|0|||
156889698|NCT00645788|566355541|FG003|Overall Study|Did not receive study drug|0|||
156889699|NCT00645788|566355538|FG000|Overall Study|Adverse Event|4|||
156889700|NCT00645788|566355539|FG001|Overall Study|Adverse Event|9|||
156889701|NCT00645788|566355540|FG002|Overall Study|Adverse Event|5|||
156889702|NCT00645788|566355541|FG003|Overall Study|Adverse Event|3|||
156889703|NCT00645788|566355538|FG000|Overall Study|Lost to Follow-up|1|||
156889704|NCT00645788|566355539|FG001|Overall Study|Lost to Follow-up|0|||
156889705|NCT00645788|566355540|FG002|Overall Study|Lost to Follow-up|0|||
156889706|NCT00645788|566355541|FG003|Overall Study|Lost to Follow-up|0|||
157025847|NCT03603600|566849621|FG000|Overall Study|Death|3|||
156855910|NCT03629886|566226835|FG001|Overall Study|Refused vaccination step of the study|44|||
156855911|NCT03683173|566226836|FG000|Completed Follow-up|Unavailable|235|||
156855912|NCT03683173|566226837|FG001|Completed Follow-up|Unavailable|217|||
156855913|NCT03683173|566226836|FG000|Completed Follow-up|Refused|69|||
156855914|NCT03683173|566226837|FG001|Completed Follow-up|Refused|59|||
156855915|NCT03683173|566226836|FG000|Completed Follow-up|Disconnected phone|65|||
156889707|NCT00645788|566355538|FG000|Overall Study|Protocol Violation|1|||
156855916|NCT03683173|566226837|FG001|Completed Follow-up|Disconnected phone|95|||
156855917|NCT03683173|566226836|FG000|Completed Follow-up|Health issue/deceased|10|||
156855918|NCT03683173|566226837|FG001|Completed Follow-up|Health issue/deceased|4|||
156855919|NCT03683173|566226836|FG000|Completed Follow-up|Moved away|8|||
156855920|NCT03683173|566226837|FG001|Completed Follow-up|Moved away|1|||
156855921|NCT01535807|566226838|FG000|Overall Study|Withdrawal by Subject|1|||
156855922|NCT01535807|566226839|FG001|Overall Study|Withdrawal by Subject|1|||
156855923|NCT01535807|566226838|FG000|Overall Study|Data collection error|1|||
156855924|NCT01535807|566226839|FG001|Overall Study|Data collection error|1|||
156855925|NCT01329263|566226844|FG000|Overall Study|Lost to Follow-up|4|||
156855926|NCT01329263|566226845|FG001|Overall Study|Lost to Follow-up|21|||
156855927|NCT01329263|566226844|FG000|Overall Study|Withdrawal by Subject|1|||
156855928|NCT01329263|566226845|FG001|Overall Study|Withdrawal by Subject|2|||
156855929|NCT01702844|566226855|FG000|Overall Study|Adverse Event|9|||
156855930|NCT01702844|566226855|FG000|Overall Study|Death|1|||
156855931|NCT01702844|566226855|FG000|Overall Study|Withdrawal by Subject|3|||
156855932|NCT01702844|566226855|FG000|Overall Study|Physician Decision|6|||
156855933|NCT02995980|566226856|FG000|Overall Study|Lost to Follow-up|14|||
156855934|NCT00981149|566226858|FG000|Overall Study|Lost to Follow-up|1|||
156855935|NCT00981149|566226859|FG001|Overall Study|Lost to Follow-up|2|||
156855936|NCT00981149|566226858|FG000|Overall Study|Withdrawal by Subject|1|||
156855937|NCT00981149|566226859|FG001|Overall Study|Withdrawal by Subject|1|||
156855938|NCT01220167|566226862|FG000|Period 3|Urine positive for substance abuse|0|||
156855939|NCT01220167|566226863|FG001|Period 3|Urine positive for substance abuse|1|||
156855940|NCT01220167|566226864|FG002|Period 3|Urine positive for substance abuse|0|||
156855941|NCT00667628|566226865|FG000|Overall Study|Lost to Follow-up|1|||
156855942|NCT00667628|566226866|FG001|Overall Study|Lost to Follow-up|0|||
156855943|NCT00667628|566226865|FG000|Overall Study|Death|6|||
156855944|NCT00667628|566226866|FG001|Overall Study|Death|6|||
156855945|NCT00667628|566226865|FG000|Overall Study|Investigator Considers in Best Interest|1|||
156855946|NCT00667628|566226866|FG001|Overall Study|Investigator Considers in Best Interest|0|||
156855947|NCT00667628|566226865|FG000|Overall Study|Sponsor Terminated Study|17|||
156855948|NCT00667628|566226866|FG001|Overall Study|Sponsor Terminated Study|21|||
156855949|NCT00622505|566226867|FG000|Overall Study|Adverse Event|9|||
156855950|NCT00622505|566226868|FG001|Overall Study|Adverse Event|7|||
156855951|NCT00622505|566226867|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
156855952|NCT00622505|566226868|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
156855953|NCT00622505|566226867|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156855954|NCT00622505|566226868|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
156855955|NCT00622505|566226867|FG000|Overall Study|Withdrawal by Subject|12|||
156855956|NCT00622505|566226868|FG001|Overall Study|Withdrawal by Subject|5|||
156855957|NCT00622505|566226867|FG000|Overall Study|Administrative Problems|2|||
156855958|NCT00622505|566226868|FG001|Overall Study|Administrative Problems|4|||
156855959|NCT00622505|566226867|FG000|Overall Study|Death|2|||
156855960|NCT00622505|566226868|FG001|Overall Study|Death|2|||
156855961|NCT00619515|566226869|FG000|Overall Study|Study Termination by IRB|73|||
156855962|NCT04862065|566226874|FG000|Screening|Protocol Violation|54|||
156855963|NCT04862065|566226875|FG001|Screening|Protocol Violation|0|||
156855964|NCT04862065|566226876|FG002|Screening|Protocol Violation|0|||
156855965|NCT04862065|566226874|FG000|Screening|Insufficient Sample|1|||
156855966|NCT04862065|566226875|FG001|Screening|Insufficient Sample|0|||
156855967|NCT04862065|566226876|FG002|Screening|Insufficient Sample|0|||
156855968|NCT04862065|566226874|FG000|Follow-Up|Lost to Follow-up|3|||
156855969|NCT04862065|566226875|FG001|Follow-Up|Lost to Follow-up|0|||
156855970|NCT04862065|566226876|FG002|Follow-Up|Lost to Follow-up|0|||
156855971|NCT01453140|566226877|FG000|Overall Study|Adverse Event|3|||
156855972|NCT02634333|566226878|FG000|Overall Study|Completed out of Window|3|||
156855973|NCT02634333|566226879|FG001|Overall Study|Completed out of Window|2|||
156855974|NCT02634333|566226878|FG000|Overall Study|Missed Visit|5|||
156855975|NCT02634333|566226879|FG001|Overall Study|Missed Visit|2|||
156855976|NCT02634333|566226878|FG000|Overall Study|Lost to Follow-up|12|||
156855977|NCT02634333|566226879|FG001|Overall Study|Lost to Follow-up|7|||
156855978|NCT02634333|566226878|FG000|Overall Study|Withdrawal by Subject|9|||
156855979|NCT02634333|566226879|FG001|Overall Study|Withdrawal by Subject|13|||
156889708|NCT00645788|566355539|FG001|Overall Study|Protocol Violation|0|||
156889709|NCT00645788|566355540|FG002|Overall Study|Protocol Violation|2|||
156855980|NCT02634333|566226878|FG000|Overall Study|Death|11|||
156855981|NCT02634333|566226879|FG001|Overall Study|Death|8|||
156855982|NCT02611479|566226880|FG000|Baseline Enrollment|Exited study|13|||
156855983|NCT02611479|566226880|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
156855984|NCT02611479|566226880|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
156889710|NCT00645788|566355541|FG003|Overall Study|Protocol Violation|0|||
156855985|NCT02611479|566226880|FG000|Data Cleaning|No baseline function or pain metrics|2|||
156855986|NCT00743249|566226881|FG000|Overall Study|Adverse Event|0|||
156855987|NCT00743249|566226882|FG001|Overall Study|Adverse Event|4|||
156855988|NCT00743249|566226881|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
156855989|NCT00743249|566226882|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
156855990|NCT00743249|566226881|FG000|Overall Study|Unsuccessful insertion of stent|2|||
156855991|NCT00743249|566226882|FG001|Overall Study|Unsuccessful insertion of stent|1|||
156855992|NCT02748863|566226886|FG000|Treatment Period 1|Adverse Event|0|||
156855993|NCT02748863|566226887|FG001|Treatment Period 1|Adverse Event|1|||
156855994|NCT02748863|566226888|FG002|Treatment Period 1|Adverse Event|0|||
156855995|NCT02748863|566226889|FG003|Treatment Period 1|Adverse Event|0|||
156855996|NCT02748863|566226890|FG004|Treatment Period 1|Adverse Event|0|||
156855997|NCT02748863|566226886|FG000|Treatment Period 1|Lack of Efficacy|0|||
156855998|NCT02748863|566226887|FG001|Treatment Period 1|Lack of Efficacy|0|||
156855999|NCT02748863|566226888|FG002|Treatment Period 1|Lack of Efficacy|1|||
156856000|NCT02748863|566226889|FG003|Treatment Period 1|Lack of Efficacy|0|||
156856001|NCT02748863|566226890|FG004|Treatment Period 1|Lack of Efficacy|0|||
156856002|NCT02748863|566226886|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156856003|NCT02748863|566226887|FG001|Treatment Period 1|Withdrawal by Subject|1|||
156856004|NCT02748863|566226888|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156856005|NCT02748863|566226889|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156856006|NCT02748863|566226890|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156856007|NCT02748863|566226886|FG000|Treatment Period 2|Lost to Follow-up|2|||
156856008|NCT02748863|566226887|FG001|Treatment Period 2|Lost to Follow-up|0|||
156856009|NCT02748863|566226888|FG002|Treatment Period 2|Lost to Follow-up|0|||
156856010|NCT02748863|566226889|FG003|Treatment Period 2|Lost to Follow-up|0|||
156856011|NCT02748863|566226890|FG004|Treatment Period 2|Lost to Follow-up|0|||
156856012|NCT02748863|566226886|FG000|Treatment Period 2|Adverse Event|3|||
156856013|NCT02748863|566226887|FG001|Treatment Period 2|Adverse Event|2|||
156856014|NCT02748863|566226888|FG002|Treatment Period 2|Adverse Event|0|||
156856015|NCT02748863|566226889|FG003|Treatment Period 2|Adverse Event|2|||
156856016|NCT02748863|566226890|FG004|Treatment Period 2|Adverse Event|0|||
156856017|NCT02748863|566226886|FG000|Treatment Period 2|Lack of Efficacy|0|||
156856018|NCT02748863|566226887|FG001|Treatment Period 2|Lack of Efficacy|1|||
156856019|NCT02748863|566226888|FG002|Treatment Period 2|Lack of Efficacy|0|||
156856020|NCT02748863|566226889|FG003|Treatment Period 2|Lack of Efficacy|0|||
156856021|NCT02748863|566226890|FG004|Treatment Period 2|Lack of Efficacy|0|||
156856022|NCT02748863|566226886|FG000|Treatment Period 2|Pregnancy|0|||
156856023|NCT02748863|566226887|FG001|Treatment Period 2|Pregnancy|0|||
156856024|NCT02748863|566226888|FG002|Treatment Period 2|Pregnancy|0|||
156856025|NCT02748863|566226889|FG003|Treatment Period 2|Pregnancy|0|||
156856026|NCT02748863|566226890|FG004|Treatment Period 2|Pregnancy|1|||
156856027|NCT00657046|566226892|FG000|Overall Study|Adverse Event|1|||
156856028|NCT00657046|566226893|FG001|Overall Study|Adverse Event|1|||
156856029|NCT00657046|566226894|FG002|Overall Study|Adverse Event|0|||
156856030|NCT00657046|566226892|FG000|Overall Study|Protocol Violation|2|||
156856031|NCT00657046|566226893|FG001|Overall Study|Protocol Violation|2|||
156856032|NCT00657046|566226894|FG002|Overall Study|Protocol Violation|0|||
156856033|NCT00657046|566226892|FG000|Overall Study|Withdrawal by Subject|1|||
156856034|NCT00657046|566226893|FG001|Overall Study|Withdrawal by Subject|0|||
156856035|NCT00657046|566226894|FG002|Overall Study|Withdrawal by Subject|0|||
156856036|NCT00657046|566226892|FG000|Overall Study|Death|0|||
156856037|NCT00657046|566226893|FG001|Overall Study|Death|0|||
156856038|NCT00657046|566226894|FG002|Overall Study|Death|1|||
156856039|NCT00657046|566226892|FG000|Overall Study|Surgery|0|||
156856040|NCT00657046|566226893|FG001|Overall Study|Surgery|0|||
156856041|NCT00657046|566226894|FG002|Overall Study|Surgery|1|||
156856042|NCT04678115|566226897|FG000|Overall Study|Lost to Follow-up|1|||
156856043|NCT04678115|566226898|FG001|Overall Study|Lost to Follow-up|0|||
156856044|NCT00890825|566226899|FG000|Overall Study|Withdrawal by Subject|1|||
156856045|NCT00890825|566226900|FG001|Overall Study|Withdrawal by Subject|0|||
156856046|NCT00890825|566226899|FG000|Overall Study|Alive at data cut off (DCO)|13|||
156856047|NCT00890825|566226900|FG001|Overall Study|Alive at data cut off (DCO)|14|||
156856048|NCT00844376|566226901|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
156856049|NCT00844376|566226902|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
156856050|NCT02920892|566226903|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
156856051|NCT02920892|566226904|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
156856052|NCT02920892|566226905|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
156856053|NCT02920892|566226903|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
156856054|NCT02920892|566226904|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
156856055|NCT02920892|566226905|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
156856056|NCT02920892|566226903|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
156856057|NCT02920892|566226904|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
156856058|NCT02920892|566226905|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
156856059|NCT02920892|566226903|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
156856060|NCT02920892|566226904|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
156856061|NCT02920892|566226905|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
156856062|NCT02920892|566226903|FG000|Placebo-Controlled Period|Physician Decision|0|||
156856063|NCT02920892|566226904|FG001|Placebo-Controlled Period|Physician Decision|0|||
156856064|NCT02920892|566226905|FG002|Placebo-Controlled Period|Physician Decision|1|||
156856065|NCT02920892|566226903|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
156889711|NCT00645788|566355538|FG000|Overall Study|Withdrawal by Subject|0|||
156889712|NCT00645788|566355539|FG001|Overall Study|Withdrawal by Subject|1|||
156889713|NCT00645788|566355540|FG002|Overall Study|Withdrawal by Subject|0|||
156889714|NCT00645788|566355541|FG003|Overall Study|Withdrawal by Subject|2|||
156889715|NCT00645788|566355538|FG000|Overall Study|Pulmonary exacerbation|13|||
156889716|NCT00645788|566355539|FG001|Overall Study|Pulmonary exacerbation|16|||
156889717|NCT00645788|566355540|FG002|Overall Study|Pulmonary exacerbation|11|||
156889718|NCT00645788|566355541|FG003|Overall Study|Pulmonary exacerbation|9|||
156889719|NCT04231981|566355542|FG000|Overall Study|Adverse Event|1|||
156889720|NCT04231981|566355542|FG000|Overall Study|Death|16|||
156889721|NCT04231981|566355542|FG000|Overall Study|Lost to Follow-up|1|||
156889722|NCT02119676|566355543|FG000|Overall Study|Adverse Event|9|||
156889723|NCT02119676|566355544|FG001|Overall Study|Adverse Event|17|||
156889724|NCT02119676|566355545|FG002|Overall Study|Adverse Event|10|||
156889725|NCT02119676|566355546|FG003|Overall Study|Adverse Event|10|||
156889726|NCT02119676|566355543|FG000|Overall Study|Disease progression|53|||
156889727|NCT02119676|566355544|FG001|Overall Study|Disease progression|55|||
156889728|NCT02119676|566355545|FG002|Overall Study|Disease progression|68|||
156889729|NCT02119676|566355546|FG003|Overall Study|Disease progression|73|||
156889730|NCT02119676|566355543|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
156889731|NCT02119676|566355544|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
156889732|NCT02119676|566355545|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
156889733|NCT02119676|566355546|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
156889734|NCT02119676|566355543|FG000|Overall Study|Physician Decision|4|||
156889735|NCT02119676|566355544|FG001|Overall Study|Physician Decision|2|||
156889736|NCT02119676|566355545|FG002|Overall Study|Physician Decision|3|||
156889737|NCT02119676|566355546|FG003|Overall Study|Physician Decision|2|||
156889738|NCT02119676|566355543|FG000|Overall Study|Death|9|||
156856066|NCT02920892|566226904|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
156856067|NCT02920892|566226905|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
156856068|NCT02920892|566226903|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
156856069|NCT02920892|566226904|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
156856070|NCT02920892|566226905|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
156856071|NCT02920892|566226903|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
156856072|NCT02920892|566226904|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
156856073|NCT02920892|566226905|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
156856074|NCT01092728|566226906|FG000|Overall Study|Withdrawal by Subject|2|||
156856075|NCT01092728|566226907|FG001|Overall Study|Withdrawal by Subject|0|||
156856076|NCT01092728|566226906|FG000|Overall Study|Adverse Event|0|||
156856077|NCT01092728|566226907|FG001|Overall Study|Adverse Event|1|||
156856078|NCT01092728|566226906|FG000|Overall Study|Disease Progression|1|||
156856079|NCT01092728|566226907|FG001|Overall Study|Disease Progression|13|||
156856080|NCT01092728|566226906|FG000|Overall Study|Prohibited Concomitant Medications|1|||
156856081|NCT01092728|566226907|FG001|Overall Study|Prohibited Concomitant Medications|0|||
156856082|NCT02336607|566226908|FG000|Overall Study|Physician Decision|1|||
156856083|NCT02336607|566226909|FG001|Overall Study|Physician Decision|4|||
156856084|NCT02336607|566226910|FG002|Overall Study|Physician Decision|3|||
156856085|NCT02336607|566226911|FG003|Overall Study|Physician Decision|15|||
156856086|NCT02336607|566226908|FG000|Overall Study|Lack of Efficacy|1|||
156856087|NCT02336607|566226909|FG001|Overall Study|Lack of Efficacy|0|||
156856088|NCT02336607|566226910|FG002|Overall Study|Lack of Efficacy|0|||
156856089|NCT02336607|566226911|FG003|Overall Study|Lack of Efficacy|2|||
156856090|NCT02336607|566226908|FG000|Overall Study|Lost to Follow-up|2|||
156856091|NCT02336607|566226909|FG001|Overall Study|Lost to Follow-up|1|||
156856092|NCT02336607|566226910|FG002|Overall Study|Lost to Follow-up|0|||
156856093|NCT02336607|566226911|FG003|Overall Study|Lost to Follow-up|21|||
156856094|NCT02336607|566226908|FG000|Overall Study|Protocol Violation|0|||
156856095|NCT02336607|566226909|FG001|Overall Study|Protocol Violation|1|||
156889739|NCT02119676|566355544|FG001|Overall Study|Death|3|||
156889740|NCT02119676|566355545|FG002|Overall Study|Death|2|||
156889741|NCT02119676|566355546|FG003|Overall Study|Death|1|||
156889742|NCT02119676|566355543|FG000|Overall Study|Noncompliance|0|||
156889743|NCT02119676|566355544|FG001|Overall Study|Noncompliance|1|||
156889744|NCT02119676|566355545|FG002|Overall Study|Noncompliance|0|||
156889745|NCT02119676|566355546|FG003|Overall Study|Noncompliance|0|||
156889746|NCT02119676|566355543|FG000|Overall Study|Lost to Follow-up|0|||
156889747|NCT02119676|566355544|FG001|Overall Study|Lost to Follow-up|0|||
156889748|NCT02119676|566355545|FG002|Overall Study|Lost to Follow-up|1|||
156889749|NCT02119676|566355546|FG003|Overall Study|Lost to Follow-up|0|||
156856096|NCT02336607|566226910|FG002|Overall Study|Protocol Violation|1|||
156856097|NCT02336607|566226911|FG003|Overall Study|Protocol Violation|3|||
156856098|NCT02336607|566226908|FG000|Overall Study|Adverse Event|0|||
156856099|NCT02336607|566226909|FG001|Overall Study|Adverse Event|2|||
156856100|NCT02336607|566226910|FG002|Overall Study|Adverse Event|2|||
156856101|NCT02336607|566226911|FG003|Overall Study|Adverse Event|26|||
156889750|NCT02119676|566355543|FG000|Overall Study|Protocol deviation|0|||
156889751|NCT02119676|566355544|FG001|Overall Study|Protocol deviation|0|||
156889752|NCT02119676|566355545|FG002|Overall Study|Protocol deviation|1|||
157025848|NCT03603600|566849622|FG001|Overall Study|Death|1|||
157025849|NCT03603600|566849621|FG000|Overall Study|Physician Decision|2|||
157025850|NCT03603600|566849622|FG001|Overall Study|Physician Decision|1|||
157025851|NCT03603600|566849621|FG000|Overall Study|Other reason|1|||
157025852|NCT03603600|566849622|FG001|Overall Study|Other reason|0|||
157025853|NCT02191618|566849627|FG000|Overall Study|Withdrawal by Subject|3|||
157157638|NCT04402008|567322854|FG006|Overall Study|Adverse Event|0|||
157157639|NCT04402008|567322848|FG000|Overall Study|Disease Progression|3|||
157157640|NCT04402008|567322849|FG001|Overall Study|Disease Progression|2|||
157157641|NCT04402008|567322850|FG002|Overall Study|Disease Progression|3|||
157157642|NCT04402008|567322851|FG003|Overall Study|Disease Progression|3|||
156856102|NCT02336607|566226908|FG000|Overall Study|Withdrawal by Subject|0|||
156856103|NCT02336607|566226909|FG001|Overall Study|Withdrawal by Subject|2|||
156856104|NCT02336607|566226910|FG002|Overall Study|Withdrawal by Subject|0|||
156856105|NCT02336607|566226911|FG003|Overall Study|Withdrawal by Subject|20|||
156856106|NCT01721161|566226912|FG000|Overall Study|Adverse Event|2|||
156856107|NCT01721161|566226913|FG001|Overall Study|Adverse Event|3|||
156856108|NCT01721161|566226912|FG000|Overall Study|Lost to Follow-up|1|||
156856109|NCT01721161|566226913|FG001|Overall Study|Lost to Follow-up|2|||
156856110|NCT01721161|566226912|FG000|Overall Study|Withdrawal by Subject|1|||
156856111|NCT01721161|566226913|FG001|Overall Study|Withdrawal by Subject|1|||
156856112|NCT01721161|566226912|FG000|Overall Study|Other|0|||
156856113|NCT01721161|566226913|FG001|Overall Study|Other|1|||
156856114|NCT01454596|566226916|FG000|Overall Study|Death|0|||
156856115|NCT01454596|566226917|FG001|Overall Study|Death|0|||
156856116|NCT01454596|566226918|FG002|Overall Study|Death|0|||
156856117|NCT01454596|566226919|FG003|Overall Study|Death|0|||
156856118|NCT01454596|566226920|FG004|Overall Study|Death|0|||
156856119|NCT01454596|566226921|FG005|Overall Study|Death|0|||
156856120|NCT01454596|566226922|FG006|Overall Study|Death|0|||
156856121|NCT01454596|566226923|FG007|Overall Study|Death|0|||
156856122|NCT01454596|566226924|FG008|Overall Study|Death|0|||
156856123|NCT01454596|566226925|FG009|Overall Study|Death|1|||
156856124|NCT01454596|566226926|FG010|Overall Study|Death|1|||
156856125|NCT01454596|566226927|FG011|Overall Study|Death|0|||
156856126|NCT00614380|566226934|FG000|Overall Study|Adverse Event|14|||
156856127|NCT00614380|566226935|FG001|Overall Study|Adverse Event|4|||
156856128|NCT00614380|566226936|FG002|Overall Study|Adverse Event|0|||
156856129|NCT00614380|566226937|FG003|Overall Study|Adverse Event|0|||
156856130|NCT00614380|566226934|FG000|Overall Study|Lost to Follow-up|6|||
156856131|NCT00614380|566226935|FG001|Overall Study|Lost to Follow-up|1|||
156856132|NCT00614380|566226936|FG002|Overall Study|Lost to Follow-up|0|||
156856133|NCT00614380|566226937|FG003|Overall Study|Lost to Follow-up|0|||
156856134|NCT00614380|566226934|FG000|Overall Study|Non compliant with the protocol|12|||
156856135|NCT00614380|566226935|FG001|Overall Study|Non compliant with the protocol|2|||
156856136|NCT00614380|566226936|FG002|Overall Study|Non compliant with the protocol|1|||
156856137|NCT00614380|566226937|FG003|Overall Study|Non compliant with the protocol|2|||
156856138|NCT00614380|566226934|FG000|Overall Study|Consent withdrawn|3|||
156856139|NCT00614380|566226935|FG001|Overall Study|Consent withdrawn|1|||
156856140|NCT00614380|566226936|FG002|Overall Study|Consent withdrawn|0|||
156856141|NCT00614380|566226937|FG003|Overall Study|Consent withdrawn|0|||
156856142|NCT01506271|566226942|FG000|Overall Study|Progressive disease|0|||
156856143|NCT01506271|566226943|FG001|Overall Study|Progressive disease|1|||
156856144|NCT01506271|566226944|FG002|Overall Study|Progressive disease|0|||
156856145|NCT01506271|566226942|FG000|Overall Study|Protocol Violation|3|||
156856146|NCT01506271|566226943|FG001|Overall Study|Protocol Violation|1|||
156856147|NCT01506271|566226944|FG002|Overall Study|Protocol Violation|0|||
156856148|NCT01506271|566226942|FG000|Overall Study|Death|0|||
156856149|NCT01506271|566226943|FG001|Overall Study|Death|1|||
156856150|NCT01506271|566226944|FG002|Overall Study|Death|0|||
156856151|NCT01506271|566226942|FG000|Overall Study|Adverse Event|0|||
156856152|NCT01506271|566226943|FG001|Overall Study|Adverse Event|2|||
156856153|NCT01506271|566226944|FG002|Overall Study|Adverse Event|0|||
157157643|NCT04402008|567322852|FG004|Overall Study|Disease Progression|4|||
157157644|NCT04402008|567322853|FG005|Overall Study|Disease Progression|3|||
156856154|NCT01506271|566226942|FG000|Overall Study|Insufficient supply of study drug|1|||
156856155|NCT01506271|566226943|FG001|Overall Study|Insufficient supply of study drug|0|||
156856156|NCT01506271|566226944|FG002|Overall Study|Insufficient supply of study drug|0|||
156856157|NCT01506271|566226942|FG000|Overall Study|Withdrawal by Subject|0|||
156856158|NCT01506271|566226943|FG001|Overall Study|Withdrawal by Subject|1|||
156856159|NCT01506271|566226944|FG002|Overall Study|Withdrawal by Subject|1|||
156856160|NCT01506271|566226942|FG000|Overall Study|Lost to Follow-up|0|||
156856161|NCT01506271|566226943|FG001|Overall Study|Lost to Follow-up|1|||
156856162|NCT01506271|566226944|FG002|Overall Study|Lost to Follow-up|2|||
156856163|NCT04908397|566226948|FG000|Overall Study|Withdrawal by Subject|2|||
156856164|NCT03318549|566226949|FG000|Overall Study|Withdrawal by Subject|5|||
157025854|NCT02191618|566849627|FG000|Overall Study|Missed Visit|4|||
156856165|NCT03318549|566226950|FG001|Overall Study|Withdrawal by Subject|19|||
156856166|NCT03318549|566226951|FG002|Overall Study|Withdrawal by Subject|2|||
157025855|NCT03031470|566849628|FG000|Overall Study|Adverse Event|3|||
157157645|NCT04402008|567322854|FG006|Overall Study|Disease Progression|10|||
157157646|NCT04402008|567322848|FG000|Overall Study|Withdrawal by Subject|0|||
157157647|NCT04402008|567322849|FG001|Overall Study|Withdrawal by Subject|1|||
156856167|NCT03318549|566226952|FG003|Overall Study|Withdrawal by Subject|0|||
156856168|NCT03318549|566226953|FG004|Overall Study|Withdrawal by Subject|0|||
156856169|NCT03318549|566226954|FG005|Overall Study|Withdrawal by Subject|0|||
156856170|NCT03318549|566226955|FG006|Overall Study|Withdrawal by Subject|0|||
156856171|NCT03318549|566226949|FG000|Overall Study|Physician Decision|0|||
156856172|NCT03318549|566226950|FG001|Overall Study|Physician Decision|4|||
156856173|NCT03318549|566226951|FG002|Overall Study|Physician Decision|1|||
156856174|NCT03318549|566226952|FG003|Overall Study|Physician Decision|0|||
156856175|NCT03318549|566226953|FG004|Overall Study|Physician Decision|0|||
156856176|NCT03318549|566226954|FG005|Overall Study|Physician Decision|0|||
156856177|NCT03318549|566226955|FG006|Overall Study|Physician Decision|0|||
156856178|NCT03318549|566226949|FG000|Overall Study|Lost to Follow-up|0|||
156856179|NCT03318549|566226950|FG001|Overall Study|Lost to Follow-up|3|||
156856180|NCT03318549|566226951|FG002|Overall Study|Lost to Follow-up|3|||
156856181|NCT03318549|566226952|FG003|Overall Study|Lost to Follow-up|0|||
156856182|NCT03318549|566226953|FG004|Overall Study|Lost to Follow-up|0|||
156856183|NCT03318549|566226954|FG005|Overall Study|Lost to Follow-up|0|||
156856184|NCT03318549|566226955|FG006|Overall Study|Lost to Follow-up|0|||
156856185|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
156856186|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
156856187|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
156856188|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
156856189|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
156856190|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
156856191|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Death|7|||
156856192|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Death|5|||
156856193|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Death|6|||
156856194|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
156856195|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
156856196|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
156856197|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
156856198|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
156856199|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
156856200|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Other|1|||
156856201|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Other|0|||
156856202|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Other|0|||
156856203|NCT00104650|566226956|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
156856204|NCT00104650|566226957|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
156856205|NCT00104650|566226958|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
156856206|NCT00104650|566226956|FG000|Follow-up Period|Physician Decision|1|||
156856207|NCT00104650|566226957|FG001|Follow-up Period|Physician Decision|1|||
156856208|NCT00104650|566226958|FG002|Follow-up Period|Physician Decision|0|||
156856209|NCT00104650|566226956|FG000|Follow-up Period|Adverse Event|1|||
156856210|NCT00104650|566226957|FG001|Follow-up Period|Adverse Event|0|||
156856211|NCT00104650|566226958|FG002|Follow-up Period|Adverse Event|1|||
156856212|NCT00104650|566226956|FG000|Follow-up Period|Withdrawal by Subject|0|||
156856213|NCT00104650|566226957|FG001|Follow-up Period|Withdrawal by Subject|3|||
156856214|NCT00104650|566226958|FG002|Follow-up Period|Withdrawal by Subject|3|||
156856215|NCT00104650|566226956|FG000|Follow-up Period|Death|6|||
156856216|NCT00104650|566226957|FG001|Follow-up Period|Death|6|||
156856217|NCT00104650|566226958|FG002|Follow-up Period|Death|4|||
156856218|NCT00104650|566226956|FG000|Follow-up Period|Disease progression|3|||
156856219|NCT00104650|566226957|FG001|Follow-up Period|Disease progression|1|||
156856220|NCT00104650|566226958|FG002|Follow-up Period|Disease progression|0|||
156856221|NCT00104650|566226956|FG000|Follow-up Period|Lost to Follow-up|0|||
156856222|NCT00104650|566226957|FG001|Follow-up Period|Lost to Follow-up|1|||
156856223|NCT00104650|566226958|FG002|Follow-up Period|Lost to Follow-up|2|||
156856224|NCT00104650|566226956|FG000|Follow-up Period|Other|0|||
156856225|NCT00104650|566226957|FG001|Follow-up Period|Other|1|||
156856226|NCT00104650|566226958|FG002|Follow-up Period|Other|0|||
156856227|NCT03515824|566226959|FG000|Overall Study|Death|3|||
156856228|NCT03515824|566226960|FG001|Overall Study|Death|2|||
156856229|NCT03515824|566226961|FG002|Overall Study|Death|6|||
156856230|NCT03515824|566226962|FG003|Overall Study|Death|0|||
156856231|NCT03515824|566226959|FG000|Overall Study|Lost to Follow-up|0|||
156856232|NCT03515824|566226960|FG001|Overall Study|Lost to Follow-up|1|||
156856233|NCT03515824|566226961|FG002|Overall Study|Lost to Follow-up|1|||
156856234|NCT03515824|566226962|FG003|Overall Study|Lost to Follow-up|0|||
156856235|NCT03515824|566226959|FG000|Overall Study|Study terminated by sponsor|0|||
156856236|NCT03515824|566226960|FG001|Overall Study|Study terminated by sponsor|1|||
156856237|NCT03515824|566226961|FG002|Overall Study|Study terminated by sponsor|6|||
156856238|NCT03515824|566226962|FG003|Overall Study|Study terminated by sponsor|0|||
156856239|NCT03515824|566226959|FG000|Overall Study|Status not recorded|0|||
156856240|NCT03515824|566226960|FG001|Overall Study|Status not recorded|0|||
156856241|NCT03515824|566226961|FG002|Overall Study|Status not recorded|2|||
156856242|NCT03515824|566226962|FG003|Overall Study|Status not recorded|0|||
156856243|NCT00920855|566226963|FG000|Overall Study|Adverse Event|1|||
156856244|NCT00920855|566226964|FG001|Overall Study|Adverse Event|1|||
156856245|NCT00920855|566226965|FG002|Overall Study|Adverse Event|4|||
156856246|NCT00920855|566226963|FG000|Overall Study|Withdrawal by Subject|2|||
156856247|NCT00920855|566226964|FG001|Overall Study|Withdrawal by Subject|1|||
156856248|NCT00920855|566226965|FG002|Overall Study|Withdrawal by Subject|6|||
156856249|NCT00920855|566226963|FG000|Overall Study|Disease progression|2|||
156856250|NCT00920855|566226964|FG001|Overall Study|Disease progression|1|||
156856251|NCT00920855|566226965|FG002|Overall Study|Disease progression|10|||
156856252|NCT00920855|566226963|FG000|Overall Study|Noncompliance to study medication|0|||
156856253|NCT00920855|566226964|FG001|Overall Study|Noncompliance to study medication|0|||
156856254|NCT00920855|566226965|FG002|Overall Study|Noncompliance to study medication|1|||
156856255|NCT00920855|566226963|FG000|Overall Study|Response plateau; started maintenance|0|||
156856256|NCT00920855|566226964|FG001|Overall Study|Response plateau; started maintenance|0|||
156856257|NCT00920855|566226965|FG002|Overall Study|Response plateau; started maintenance|1|||
156856258|NCT01894607|566226966|FG000|Overall Study|Ineligible|1|||
156856259|NCT00539994|566226968|FG000|Overall Study|Lost to Follow-up|2|||
156856260|NCT00539994|566226969|FG001|Overall Study|Lost to Follow-up|1|||
156856261|NCT00539994|566226970|FG002|Overall Study|Lost to Follow-up|0|||
156856262|NCT00539994|566226968|FG000|Overall Study|Withdrawal by Subject|1|||
156856263|NCT00539994|566226969|FG001|Overall Study|Withdrawal by Subject|0|||
156856264|NCT00539994|566226970|FG002|Overall Study|Withdrawal by Subject|1|||
156856265|NCT00539994|566226968|FG000|Overall Study|Physician Decision|0|||
156856266|NCT00539994|566226969|FG001|Overall Study|Physician Decision|0|||
156856267|NCT00539994|566226970|FG002|Overall Study|Physician Decision|1|||
156856268|NCT05470985|566226973|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
156856269|NCT05470985|566226974|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
156856270|NCT05470985|566226973|FG000|Double Blind Treatment Period|Physician Decision|0|||
156856271|NCT05470985|566226974|FG001|Double Blind Treatment Period|Physician Decision|1|||
156856272|NCT05470985|566226973|FG000|Long Term Extension|Adverse Event|0|||
156856273|NCT05470985|566226974|FG001|Long Term Extension|Adverse Event|1|||
156856274|NCT05470985|566226973|FG000|Long Term Extension|Study terminated by sponsor|2|||
156856275|NCT05470985|566226974|FG001|Long Term Extension|Study terminated by sponsor|0|||
156856276|NCT01917747|566226975|FG000|Overall Study|Withdrawal by Subject|1|||
156856277|NCT01917747|566226976|FG001|Overall Study|Withdrawal by Subject|2|||
156856278|NCT01917747|566226975|FG000|Overall Study|Lost to Follow-up|18|||
156856279|NCT01917747|566226976|FG001|Overall Study|Lost to Follow-up|9|||
156856280|NCT01116648|566226984|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
156856281|NCT01116648|566226985|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
156856282|NCT01116648|566226986|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
156856283|NCT01116648|566226987|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
156856284|NCT01116648|566226988|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
156856285|NCT01116648|566226989|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
156856286|NCT01116648|566226990|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
156856287|NCT01116648|566226991|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
156856288|NCT01116648|566226992|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
156856289|NCT01116648|566226993|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
156856290|NCT01116648|566226994|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
156856291|NCT01116648|566226995|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
156856292|NCT01116648|566226996|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
156856293|NCT01116648|566226997|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
156856294|NCT01116648|566226998|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
156856295|NCT00990106|566226999|FG000|Overall Study|"too busy to continue"|1|||
156856296|NCT00990106|566227000|FG001|Overall Study|"too busy to continue"|2|||
156856297|NCT00990106|566226999|FG000|Overall Study|Lost to Follow-up|1|||
156856298|NCT00990106|566227000|FG001|Overall Study|Lost to Follow-up|3|||
156856299|NCT00990106|566226999|FG000|Overall Study|Withdrawal by Subject|2|||
156856300|NCT00990106|566227000|FG001|Overall Study|Withdrawal by Subject|1|||
156856301|NCT00990106|566226999|FG000|Overall Study|opted for open label prazosin|1|||
156856302|NCT00990106|566227000|FG001|Overall Study|opted for open label prazosin|1|||
156856303|NCT00990106|566226999|FG000|Overall Study|relocation/deployment|4|||
156856304|NCT00990106|566227000|FG001|Overall Study|relocation/deployment|1|||
156856305|NCT00990106|566226999|FG000|Overall Study|started exclusionary medication|0|||
156856306|NCT00990106|566227000|FG001|Overall Study|started exclusionary medication|1|||
156856307|NCT00990106|566226999|FG000|Overall Study|planned major surgery|0|||
156856308|NCT00990106|566227000|FG001|Overall Study|planned major surgery|1|||
156856309|NCT00990106|566226999|FG000|Overall Study|scheduling conflicts|0|||
156856310|NCT00990106|566227000|FG001|Overall Study|scheduling conflicts|2|||
156856311|NCT03858049|566228484|FG000|Overall Study|Adverse Event|16|||
156856312|NCT03858049|566228485|FG001|Overall Study|Adverse Event|9|||
156856313|NCT03858049|566228484|FG000|Overall Study|Other|1|||
156856314|NCT03858049|566228485|FG001|Overall Study|Other|1|||
156856315|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
156856316|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
156856317|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
156889753|NCT02119676|566355546|FG003|Overall Study|Protocol deviation|0|||
156889754|NCT02119676|566355543|FG000|Overall Study|Other, unspecified|2|||
156889755|NCT02119676|566355544|FG001|Overall Study|Other, unspecified|1|||
156889756|NCT02119676|566355545|FG002|Overall Study|Other, unspecified|3|||
156889757|NCT02119676|566355546|FG003|Overall Study|Other, unspecified|4|||
156889758|NCT02119676|566355543|FG000|Overall Study|Did not receive study med|2|||
156889759|NCT02119676|566355544|FG001|Overall Study|Did not receive study med|2|||
156889760|NCT02119676|566355545|FG002|Overall Study|Did not receive study med|4|||
156889761|NCT02119676|566355546|FG003|Overall Study|Did not receive study med|5|||
156889762|NCT00989573|566355547|FG000|Overall Study|Adverse Event|8|||
156889763|NCT00989573|566355548|FG001|Overall Study|Adverse Event|12|||
156889764|NCT00989573|566355549|FG002|Overall Study|Adverse Event|4|||
156889765|NCT00989573|566355547|FG000|Overall Study|Physician Decision|0|||
156889766|NCT00989573|566355548|FG001|Overall Study|Physician Decision|2|||
156889767|NCT00989573|566355549|FG002|Overall Study|Physician Decision|0|||
156889768|NCT00989573|566355547|FG000|Overall Study|Protocol Violation|1|||
156889769|NCT00989573|566355548|FG001|Overall Study|Protocol Violation|1|||
156856318|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
156856319|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
156856320|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
156856321|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
156856322|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
156856323|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
156856324|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
156856325|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
156856326|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
156856327|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
156856328|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
156856329|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
156856330|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
156856331|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
156856332|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
156856333|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
156856334|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
156856335|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
156856336|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
156856337|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
156856338|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
156856339|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
156856340|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
156856341|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856342|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856343|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856344|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856345|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856346|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856347|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856348|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
156856349|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856350|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856351|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856352|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856353|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
156856354|NCT02079740|566228486|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856355|NCT02079740|566228487|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856356|NCT02079740|566228488|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856357|NCT02079740|566228489|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856358|NCT02079740|566228490|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856359|NCT02079740|566228491|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156889770|NCT00989573|566355549|FG002|Overall Study|Protocol Violation|1|||
156889771|NCT00989573|566355547|FG000|Overall Study|Withdrawal by Subject|4|||
156889772|NCT00989573|566355548|FG001|Overall Study|Withdrawal by Subject|7|||
156856360|NCT02079740|566228492|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856361|NCT02079740|566228493|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
156856362|NCT02079740|566228494|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156889773|NCT00989573|566355549|FG002|Overall Study|Withdrawal by Subject|3|||
156889774|NCT02216812|566355555|FG000|Overall Study|Lost to Follow-up|10|||
156889775|NCT02216812|566355556|FG001|Overall Study|Lost to Follow-up|5|||
156889776|NCT01958827|566355561|FG000|Overall Study|Adverse Event|3|||
156856363|NCT02079740|566228495|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856364|NCT02079740|566228496|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156889777|NCT01958827|566355561|FG000|Overall Study|Lack of Efficacy|6|||
156889778|NCT01958827|566355561|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
156889779|NCT01986933|566355562|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
156889780|NCT01986933|566355563|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
156889781|NCT01986933|566355564|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
156889782|NCT01986933|566355565|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
156889783|NCT01986933|566355566|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
156889784|NCT01986933|566355562|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
156889785|NCT01986933|566355563|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156889786|NCT01986933|566355564|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156889787|NCT01986933|566355565|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
156889788|NCT01986933|566355566|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
156889789|NCT01986933|566355562|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
156889790|NCT01986933|566355563|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
156889791|NCT01986933|566355564|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
156889792|NCT01986933|566355565|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
156889793|NCT01986933|566355566|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
156889794|NCT01986933|566355562|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156889795|NCT01986933|566355563|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
156889796|NCT01986933|566355564|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156889797|NCT01986933|566355565|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
156889798|NCT01986933|566355566|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
156889799|NCT01986933|566355562|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156889800|NCT01986933|566355563|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156889801|NCT01986933|566355564|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156889802|NCT01986933|566355565|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
156889803|NCT01986933|566355566|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
156889804|NCT01986933|566355562|FG000|Active-to-active (Part B)|Adverse Event|0|||
156889805|NCT01986933|566355563|FG001|Active-to-active (Part B)|Adverse Event|2|||
156889806|NCT01986933|566355564|FG002|Active-to-active (Part B)|Adverse Event|0|||
156889807|NCT01986933|566355565|FG003|Active-to-active (Part B)|Adverse Event|1|||
156889808|NCT01986933|566355566|FG004|Active-to-active (Part B)|Adverse Event|3|||
156889809|NCT01986933|566355562|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
156889810|NCT01986933|566355563|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
156889811|NCT01986933|566355564|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
156889812|NCT01986933|566355565|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
156889813|NCT01986933|566355566|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
156889814|NCT01986933|566355562|FG000|Active-to-active (Part B)|Pregnancy|0|||
156889815|NCT01986933|566355563|FG001|Active-to-active (Part B)|Pregnancy|0|||
156889816|NCT01986933|566355564|FG002|Active-to-active (Part B)|Pregnancy|0|||
156889817|NCT01986933|566355565|FG003|Active-to-active (Part B)|Pregnancy|0|||
156889818|NCT01986933|566355566|FG004|Active-to-active (Part B)|Pregnancy|1|||
156889819|NCT01986933|566355562|FG000|Active-to-active (Part B)|Physician Decision|0|||
156889820|NCT01986933|566355563|FG001|Active-to-active (Part B)|Physician Decision|0|||
156889821|NCT01986933|566355564|FG002|Active-to-active (Part B)|Physician Decision|1|||
156856365|NCT02079740|566228497|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856366|NCT02079740|566228498|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
156856367|NCT02079740|566228486|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856368|NCT02079740|566228487|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856369|NCT02079740|566228488|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856370|NCT02079740|566228489|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856371|NCT02079740|566228490|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856372|NCT02079740|566228491|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856373|NCT02079740|566228492|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856374|NCT02079740|566228493|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856375|NCT02079740|566228494|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856376|NCT02079740|566228495|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
156856377|NCT02079740|566228496|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
156856378|NCT02079740|566228497|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
156856379|NCT02079740|566228498|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
156856380|NCT04617782|566228499|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
156856381|NCT04617782|566228499|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
156856382|NCT04617782|566228499|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
156856383|NCT04617782|566228499|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
156856384|NCT04617782|566228499|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
156856385|NCT04617782|566228499|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
156856386|NCT01405768|566228508|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
156856387|NCT01405768|566228509|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
156856388|NCT05482308|566228515|FG000|Overall Study|Withdrawal by Subject|1|||
156889822|NCT01986933|566355565|FG003|Active-to-active (Part B)|Physician Decision|1|||
156856389|NCT05482308|566228516|FG001|Overall Study|Withdrawal by Subject|0|||
156856390|NCT05482308|566228515|FG000|Overall Study|No longer meets eligibility criteria|0|||
156856391|NCT05482308|566228516|FG001|Overall Study|No longer meets eligibility criteria|1|||
156856392|NCT03016312|566228517|FG000|Overall Study|discontinued before the treatment started|0|||
156856393|NCT03016312|566228518|FG001|Overall Study|discontinued before the treatment started|1|||
156856394|NCT03016312|566228517|FG000|Overall Study|Withdrawal by Subject|37|||
156856395|NCT03016312|566228518|FG001|Overall Study|Withdrawal by Subject|44|||
156856396|NCT03016312|566228517|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
156856397|NCT03016312|566228518|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
156856398|NCT03016312|566228517|FG000|Overall Study|Physician Decision|1|||
156856399|NCT03016312|566228518|FG001|Overall Study|Physician Decision|3|||
156856400|NCT03016312|566228517|FG000|Overall Study|Lost to Follow-up|12|||
156856401|NCT03016312|566228518|FG001|Overall Study|Lost to Follow-up|12|||
156856402|NCT03016312|566228517|FG000|Overall Study|Death|210|||
156856403|NCT03016312|566228518|FG001|Overall Study|Death|184|||
156856404|NCT03016312|566228517|FG000|Overall Study|loss to contact|1|||
156856405|NCT03016312|566228518|FG001|Overall Study|loss to contact|0|||
156856406|NCT03016312|566228517|FG000|Overall Study|started a new cancer therapy|1|||
156856407|NCT03016312|566228518|FG001|Overall Study|started a new cancer therapy|0|||
156856408|NCT01631435|566228520|FG000|Overall Study|Adverse Event|2|||
156856409|NCT01631435|566228520|FG000|Overall Study|Withdrawal by Subject|2|||
156856410|NCT01631435|566228520|FG000|Overall Study|incomplete study procedure|5|||
156856411|NCT01421017|566228521|FG000|Overall Study|Withdrawal by Subject|2|||
156856412|NCT01421017|566228522|FG001|Overall Study|Withdrawal by Subject|0|||
156856413|NCT01421017|566228523|FG002|Overall Study|Withdrawal by Subject|0|||
156856414|NCT01421017|566228521|FG000|Overall Study|POD|0|||
156856415|NCT01421017|566228522|FG001|Overall Study|POD|6|||
156856416|NCT01421017|566228523|FG002|Overall Study|POD|3|||
156856417|NCT02313766|566228524|FG000|Overall Study|surgery cancelled|1|||
156856418|NCT02313766|566228525|FG001|Overall Study|surgery cancelled|0|||
156856419|NCT02313766|566228526|FG002|Overall Study|surgery cancelled|0|||
156856420|NCT02313766|566228524|FG000|Overall Study|Lost to Follow-up|0|||
156856421|NCT02313766|566228525|FG001|Overall Study|Lost to Follow-up|2|||
156856422|NCT02313766|566228526|FG002|Overall Study|Lost to Follow-up|0|||
156856423|NCT02313766|566228524|FG000|Overall Study|Adverse Event|0|||
156856424|NCT02313766|566228525|FG001|Overall Study|Adverse Event|1|||
156856425|NCT02313766|566228526|FG002|Overall Study|Adverse Event|0|||
156856426|NCT00416624|566228529|FG000|Overall Study|Withdrawal by Subject|1|||
156856427|NCT00416624|566228530|FG001|Overall Study|Withdrawal by Subject|6|||
156856428|NCT00416624|566228531|FG002|Overall Study|Withdrawal by Subject|4|||
156856429|NCT00416624|566228532|FG003|Overall Study|Withdrawal by Subject|9|||
156856430|NCT00416624|566228529|FG000|Overall Study|Death|4|||
156856431|NCT00416624|566228530|FG001|Overall Study|Death|7|||
156856432|NCT00416624|566228531|FG002|Overall Study|Death|7|||
156856433|NCT00416624|566228532|FG003|Overall Study|Death|1|||
156856434|NCT00416624|566228529|FG000|Overall Study|Adverse Event|8|||
156856435|NCT00416624|566228530|FG001|Overall Study|Adverse Event|3|||
156856436|NCT00416624|566228531|FG002|Overall Study|Adverse Event|2|||
156856437|NCT00416624|566228532|FG003|Overall Study|Adverse Event|2|||
156856438|NCT00416624|566228529|FG000|Overall Study|Other|8|||
156856439|NCT00416624|566228530|FG001|Overall Study|Other|11|||
156856440|NCT00416624|566228531|FG002|Overall Study|Other|5|||
156856441|NCT00416624|566228532|FG003|Overall Study|Other|5|||
156856442|NCT00416624|566228529|FG000|Overall Study|Cancel|1|||
156856443|NCT00416624|566228530|FG001|Overall Study|Cancel|0|||
156856444|NCT00416624|566228531|FG002|Overall Study|Cancel|0|||
156856445|NCT00416624|566228532|FG003|Overall Study|Cancel|0|||
156856446|NCT01005251|566228533|FG000|Overall Study|Withdrawal by Subject|2|||
156856447|NCT01005251|566228534|FG001|Overall Study|Withdrawal by Subject|5|||
156856448|NCT01005251|566228535|FG002|Overall Study|Withdrawal by Subject|3|||
156856449|NCT01005251|566228536|FG003|Overall Study|Withdrawal by Subject|4|||
156856450|NCT01005251|566228537|FG004|Overall Study|Withdrawal by Subject|9|||
156856451|NCT01005251|566228533|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
156856452|NCT01005251|566228534|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156856453|NCT01005251|566228535|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
156856454|NCT01005251|566228536|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156856455|NCT01005251|566228537|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156856456|NCT01005251|566228533|FG000|Overall Study|Adverse Event|2|||
156856457|NCT01005251|566228534|FG001|Overall Study|Adverse Event|6|||
156856458|NCT01005251|566228535|FG002|Overall Study|Adverse Event|8|||
156856459|NCT01005251|566228536|FG003|Overall Study|Adverse Event|5|||
156856460|NCT01005251|566228537|FG004|Overall Study|Adverse Event|4|||
156856461|NCT01005251|566228533|FG000|Overall Study|Protocol Violation|1|||
156856462|NCT01005251|566228534|FG001|Overall Study|Protocol Violation|0|||
156856463|NCT01005251|566228535|FG002|Overall Study|Protocol Violation|0|||
156856464|NCT01005251|566228536|FG003|Overall Study|Protocol Violation|0|||
156856465|NCT01005251|566228537|FG004|Overall Study|Protocol Violation|2|||
156856466|NCT01005251|566228533|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
157025856|NCT03031470|566849629|FG001|Overall Study|Adverse Event|0|||
156889823|NCT01986933|566355566|FG004|Active-to-active (Part B)|Physician Decision|0|||
156889824|NCT01986933|566355562|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
156889825|NCT01986933|566355563|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
156889826|NCT01986933|566355564|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
156889827|NCT01986933|566355565|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
157025857|NCT03031470|566849628|FG000|Overall Study|Death|3|||
157025858|NCT03031470|566849629|FG001|Overall Study|Death|1|||
157025859|NCT03031470|566849628|FG000|Overall Study|Lost to Follow-up|1|||
157025860|NCT03031470|566849629|FG001|Overall Study|Lost to Follow-up|1|||
157025861|NCT03031470|566849628|FG000|Overall Study|Withdrawal by Subject|1|||
157025862|NCT03031470|566849629|FG001|Overall Study|Withdrawal by Subject|0|||
157025863|NCT03031470|566849628|FG000|Overall Study|Protocol entry criteria not met|0|||
157025864|NCT03031470|566849629|FG001|Overall Study|Protocol entry criteria not met|1|||
157025865|NCT03031470|566849628|FG000|Overall Study|Cancel the operation|0|||
157025866|NCT03031470|566849629|FG001|Overall Study|Cancel the operation|1|||
157025867|NCT03496168|566849631|FG000|Overall Study|Other Reasons|1|||
157025868|NCT03496168|566849631|FG000|Overall Study|Adverse Event|1|||
157025869|NCT02043678|566849636|FG000|Overall Study|Never treated|11|||
157025870|NCT02043678|566849637|FG001|Overall Study|Never treated|9|||
157025871|NCT02043678|566849636|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
157025872|NCT02043678|566849637|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
157025873|NCT02043678|566849636|FG000|Overall Study|AE without clinical PD|54|||
157025874|NCT02043678|566849637|FG001|Overall Study|AE without clinical PD|36|||
157025875|NCT02043678|566849636|FG000|Overall Study|Lost to Follow-up|1|||
157025876|NCT02043678|566849637|FG001|Overall Study|Lost to Follow-up|1|||
157025877|NCT02043678|566849636|FG000|Overall Study|Other|10|||
157025878|NCT02043678|566849637|FG001|Overall Study|Other|14|||
157025879|NCT02043678|566849636|FG000|Overall Study|Clinical PD|114|||
157025880|NCT02043678|566849637|FG001|Overall Study|Clinical PD|148|||
157025881|NCT02043678|566849636|FG000|Overall Study|Radiological PD|100|||
157025882|NCT02043678|566849637|FG001|Overall Study|Radiological PD|90|||
157025883|NCT02043678|566849636|FG000|Overall Study|Protocol-driven decision point|59|||
157025884|NCT02043678|566849637|FG001|Overall Study|Protocol-driven decision point|58|||
157025885|NCT02043678|566849636|FG000|Overall Study|Withdrawal by Subject|16|||
157157648|NCT04402008|567322850|FG002|Overall Study|Withdrawal by Subject|0|||
157157649|NCT04402008|567322851|FG003|Overall Study|Withdrawal by Subject|0|||
156856467|NCT01005251|566228534|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
156856468|NCT01005251|566228535|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
156856469|NCT01005251|566228536|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
156856470|NCT01005251|566228537|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
156856471|NCT01005251|566228533|FG000|Overall Study|Lost to Follow-up|1|||
156856472|NCT01005251|566228534|FG001|Overall Study|Lost to Follow-up|4|||
156856473|NCT01005251|566228535|FG002|Overall Study|Lost to Follow-up|2|||
156856474|NCT01005251|566228536|FG003|Overall Study|Lost to Follow-up|0|||
156856475|NCT01005251|566228537|FG004|Overall Study|Lost to Follow-up|0|||
156856476|NCT01005251|566228533|FG000|Overall Study|Physician Decision|0|||
156856477|NCT01005251|566228534|FG001|Overall Study|Physician Decision|0|||
156856478|NCT01005251|566228535|FG002|Overall Study|Physician Decision|0|||
156856479|NCT01005251|566228536|FG003|Overall Study|Physician Decision|0|||
156856480|NCT01005251|566228537|FG004|Overall Study|Physician Decision|2|||
156856481|NCT01005251|566228533|FG000|Overall Study|Patient moved|1|||
156856482|NCT01005251|566228534|FG001|Overall Study|Patient moved|0|||
156856483|NCT01005251|566228535|FG002|Overall Study|Patient moved|0|||
156856484|NCT01005251|566228536|FG003|Overall Study|Patient moved|0|||
156856485|NCT01005251|566228537|FG004|Overall Study|Patient moved|0|||
156856486|NCT01005251|566228533|FG000|Overall Study|Wrong drug dispensed|0|||
156856487|NCT01005251|566228534|FG001|Overall Study|Wrong drug dispensed|1|||
156856488|NCT01005251|566228535|FG002|Overall Study|Wrong drug dispensed|0|||
156856489|NCT01005251|566228536|FG003|Overall Study|Wrong drug dispensed|0|||
156856490|NCT01005251|566228537|FG004|Overall Study|Wrong drug dispensed|0|||
156856491|NCT01005251|566228533|FG000|Overall Study|Randomized in error|0|||
156856492|NCT01005251|566228534|FG001|Overall Study|Randomized in error|0|||
156856493|NCT01005251|566228535|FG002|Overall Study|Randomized in error|1|||
156856494|NCT01005251|566228536|FG003|Overall Study|Randomized in error|1|||
157157650|NCT04402008|567322852|FG004|Overall Study|Withdrawal by Subject|1|||
157157651|NCT04402008|567322853|FG005|Overall Study|Withdrawal by Subject|0|||
157157652|NCT04402008|567322854|FG006|Overall Study|Withdrawal by Subject|0|||
157157653|NCT04402008|567322848|FG000|Overall Study|Sponsor Decision|0|||
157157654|NCT04402008|567322849|FG001|Overall Study|Sponsor Decision|0|||
156856495|NCT01005251|566228537|FG004|Overall Study|Randomized in error|0|||
156856496|NCT01005251|566228533|FG000|Overall Study|Lack of Efficacy|0|||
156856497|NCT01005251|566228534|FG001|Overall Study|Lack of Efficacy|0|||
157025886|NCT02043678|566849637|FG001|Overall Study|Withdrawal by Subject|20|||
157025887|NCT02043678|566849636|FG000|Overall Study|Protocol Violation|1|||
157025888|NCT02043678|566849637|FG001|Overall Study|Protocol Violation|0|||
156856498|NCT01005251|566228535|FG002|Overall Study|Lack of Efficacy|1|||
157157655|NCT04402008|567322850|FG002|Overall Study|Sponsor Decision|0|||
157157656|NCT04402008|567322851|FG003|Overall Study|Sponsor Decision|0|||
157157657|NCT04402008|567322852|FG004|Overall Study|Sponsor Decision|0|||
157157658|NCT04402008|567322853|FG005|Overall Study|Sponsor Decision|0|||
157157659|NCT04402008|567322854|FG006|Overall Study|Sponsor Decision|3|||
157157660|NCT04402008|567322848|FG000|Overall Study|Death|0|||
157157661|NCT04402008|567322849|FG001|Overall Study|Death|0|||
156856499|NCT01005251|566228536|FG003|Overall Study|Lack of Efficacy|1|||
156856500|NCT01005251|566228537|FG004|Overall Study|Lack of Efficacy|0|||
156856501|NCT02193776|566228538|FG000|Overall Study|Consent withdrawn|1|||
156856502|NCT02193776|566228539|FG001|Overall Study|Consent withdrawn|0|||
156856503|NCT02193776|566228540|FG002|Overall Study|Consent withdrawn|0|||
156856504|NCT02193776|566228541|FG003|Overall Study|Consent withdrawn|0|||
156856505|NCT02193776|566228538|FG000|Overall Study|Failure to comply with protocol|0|||
156856506|NCT02193776|566228539|FG001|Overall Study|Failure to comply with protocol|1|||
156856507|NCT02193776|566228540|FG002|Overall Study|Failure to comply with protocol|0|||
156856508|NCT02193776|566228541|FG003|Overall Study|Failure to comply with protocol|0|||
156856509|NCT02193776|566228538|FG000|Overall Study|Investigator/Sponsor decision|1|||
156856510|NCT02193776|566228539|FG001|Overall Study|Investigator/Sponsor decision|1|||
156856511|NCT02193776|566228540|FG002|Overall Study|Investigator/Sponsor decision|0|||
156856512|NCT02193776|566228541|FG003|Overall Study|Investigator/Sponsor decision|0|||
156856513|NCT02193776|566228538|FG000|Overall Study|Death|1|||
156856514|NCT02193776|566228539|FG001|Overall Study|Death|0|||
156856515|NCT02193776|566228540|FG002|Overall Study|Death|0|||
156856516|NCT02193776|566228541|FG003|Overall Study|Death|0|||
156856517|NCT02193776|566228538|FG000|Overall Study|Adverse event/Specific toxicity|5|||
156856518|NCT02193776|566228539|FG001|Overall Study|Adverse event/Specific toxicity|5|||
156856519|NCT02193776|566228540|FG002|Overall Study|Adverse event/Specific toxicity|2|||
156856520|NCT02193776|566228541|FG003|Overall Study|Adverse event/Specific toxicity|2|||
156856521|NCT00657540|566228543|FG000|Overall Study|Lost to Follow-up|1|||
156856522|NCT00657540|566228544|FG001|Overall Study|Lost to Follow-up|4|||
156856523|NCT01458639|566228545|FG000|Overall Study|Physician Decision|4|||
156856524|NCT01458639|566228545|FG000|Overall Study|Equipment issue|1|||
156856525|NCT01458639|566228545|FG000|Overall Study|Inability to obtain subject blood sample|1|||
156856526|NCT04245111|566228546|FG000|Overall Study|Lost to Follow-up|5|||
156856527|NCT04245111|566228547|FG001|Overall Study|Lost to Follow-up|1|||
156856528|NCT04245111|566228548|FG002|Overall Study|Lost to Follow-up|1|||
156856529|NCT01755234|566228549|FG000|Overall Study|Lost to Follow-up|11|||
156856530|NCT01755234|566228550|FG001|Overall Study|Lost to Follow-up|6|||
156856531|NCT01755234|566228549|FG000|Overall Study|Change in surgical case|2|||
156856532|NCT01755234|566228550|FG001|Overall Study|Change in surgical case|1|||
156856533|NCT01755234|566228549|FG000|Overall Study|case cancelled|1|||
156856534|NCT01755234|566228550|FG001|Overall Study|case cancelled|0|||
156856535|NCT01755234|566228549|FG000|Overall Study|Withdrawal by Subject|0|||
156856536|NCT01755234|566228550|FG001|Overall Study|Withdrawal by Subject|1|||
156856537|NCT01755234|566228549|FG000|Overall Study|unblinded|1|||
156856538|NCT01755234|566228550|FG001|Overall Study|unblinded|0|||
156856539|NCT03812380|566228551|FG000|Overall Study|Protocol Violation|3|||
156856540|NCT03812380|566228552|FG001|Overall Study|Protocol Violation|3|||
156856541|NCT03812380|566228551|FG000|Overall Study|Withdrawal by Subject|5|||
156856542|NCT03812380|566228552|FG001|Overall Study|Withdrawal by Subject|4|||
156856543|NCT03812380|566228551|FG000|Overall Study|Early termination of study|14|||
156856544|NCT03812380|566228552|FG001|Overall Study|Early termination of study|14|||
156856545|NCT01960140|566228553|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
156856546|NCT00231777|566228554|FG000|Overall Study|Lost to Follow-up|3|||
156856547|NCT00231777|566228555|FG001|Overall Study|Lost to Follow-up|0|||
156856548|NCT00231777|566228554|FG000|Overall Study|Other|3|||
156856549|NCT00231777|566228555|FG001|Overall Study|Other|2|||
156856550|NCT03935126|566228558|FG000|Overall Study|Study termination by sponsor|3|||
156856551|NCT01091675|566228563|FG000|Overall Study|Adverse Event|7|||
156856552|NCT01091675|566228563|FG000|Overall Study|Lack of Efficacy|27|||
156856553|NCT00689390|566228566|FG000|Overall Study|Adverse Event|19|||
156856554|NCT00689390|566228567|FG001|Overall Study|Adverse Event|0|||
156856555|NCT00689390|566228566|FG000|Overall Study|Lost to Follow-up|179|||
156856556|NCT00689390|566228567|FG001|Overall Study|Lost to Follow-up|7|||
156856557|NCT00689390|566228566|FG000|Overall Study|Withdrawal by Subject|117|||
156856558|NCT00689390|566228567|FG001|Overall Study|Withdrawal by Subject|3|||
156856559|NCT00689390|566228566|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
156856560|NCT00689390|566228567|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
156856561|NCT00689390|566228566|FG000|Overall Study|Non-Compliance With Protocol|21|||
156856562|NCT00689390|566228567|FG001|Overall Study|Non-Compliance With Protocol|0|||
156856563|NCT00689390|566228566|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
156856564|NCT00689390|566228567|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
156856565|NCT00689390|566228566|FG000|Overall Study|Administrative|37|||
156856566|NCT00689390|566228567|FG001|Overall Study|Administrative|0|||
156856567|NCT00462306|566228570|FG000|Overall Study|insufficient data|0|||
157157662|NCT04402008|567322850|FG002|Overall Study|Death|0|||
157157663|NCT04402008|567322851|FG003|Overall Study|Death|0|||
157157664|NCT04402008|567322852|FG004|Overall Study|Death|1|||
157025889|NCT02043678|566849636|FG000|Overall Study|Deterioration of general conditions|1|||
157025890|NCT02043678|566849637|FG001|Overall Study|Deterioration of general conditions|1|||
157025891|NCT02043678|566849636|FG000|Overall Study|Logistical difficulties|2|||
157025892|NCT02043678|566849637|FG001|Overall Study|Logistical difficulties|0|||
157157665|NCT04402008|567322853|FG005|Overall Study|Death|0|||
156856568|NCT00462306|566228571|FG001|Overall Study|insufficient data|13|||
156856569|NCT03253679|566228574|FG000|Overall Study|Screen Failure|1|||
156856570|NCT04816214|566228575|FG000|Overall Study|Progressive Disease|4|||
156856571|NCT04816214|566228576|FG001|Overall Study|Progressive Disease|0|||
156856572|NCT04816214|566228577|FG002|Overall Study|Progressive Disease|0|||
156856573|NCT04816214|566228575|FG000|Overall Study|Death|1|||
156856574|NCT04816214|566228576|FG001|Overall Study|Death|0|||
156856575|NCT04816214|566228577|FG002|Overall Study|Death|0|||
156856576|NCT04816214|566228575|FG000|Overall Study|Study Terminated by Sponsor|1|||
156856577|NCT04816214|566228576|FG001|Overall Study|Study Terminated by Sponsor|0|||
156856578|NCT04816214|566228577|FG002|Overall Study|Study Terminated by Sponsor|0|||
156856579|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856580|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856581|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
156856582|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
156856583|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856584|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856585|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
156856586|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
156856587|NCT04879628|566228578|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856588|NCT04879628|566228579|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856589|NCT04879628|566228580|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
156856590|NCT04879628|566228581|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
156856591|NCT04879628|566228578|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
156856592|NCT04879628|566228579|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
156856593|NCT04879628|566228580|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
156856594|NCT04879628|566228581|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
156856595|NCT00360412|566228587|FG000|Overall Study|Adverse Event|37|||
156856596|NCT00360412|566228588|FG001|Overall Study|Adverse Event|65|||
156856597|NCT00360412|566228587|FG000|Overall Study|Protocol Violation|2|||
156856598|NCT00360412|566228588|FG001|Overall Study|Protocol Violation|5|||
156856599|NCT00360412|566228587|FG000|Overall Study|Patient withdrew consent|27|||
156856600|NCT00360412|566228588|FG001|Overall Study|Patient withdrew consent|52|||
156856601|NCT00360412|566228587|FG000|Overall Study|Lack of therapeutic efficacy|46|||
156856602|NCT00360412|566228588|FG001|Overall Study|Lack of therapeutic efficacy|61|||
156856603|NCT00360412|566228587|FG000|Overall Study|Physician Decision|2|||
156856604|NCT00360412|566228588|FG001|Overall Study|Physician Decision|4|||
156856605|NCT00360412|566228587|FG000|Overall Study|Other|5|||
156856606|NCT00360412|566228588|FG001|Overall Study|Other|6|||
156856607|NCT00360412|566228587|FG000|Overall Study|Study termination by Sponsor|214|||
156856608|NCT00360412|566228588|FG001|Overall Study|Study termination by Sponsor|469|||
156856609|NCT03863509|566228589|FG000|Overall Study|COVID-19 shutdown period|0|||
156856610|NCT03863509|566228590|FG001|Overall Study|COVID-19 shutdown period|4|||
156856611|NCT03863509|566228591|FG002|Overall Study|COVID-19 shutdown period|0|||
156856612|NCT03863509|566228589|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
156856613|NCT03863509|566228590|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
156856614|NCT03863509|566228591|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
156856615|NCT03863509|566228589|FG000|Overall Study|Lost to Follow-up|8|||
156856616|NCT03863509|566228590|FG001|Overall Study|Lost to Follow-up|0|||
156856617|NCT03863509|566228591|FG002|Overall Study|Lost to Follow-up|2|||
156856618|NCT03863509|566228589|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
156856619|NCT03863509|566228590|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
156856620|NCT03863509|566228591|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
156856621|NCT03863509|566228589|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
156856622|NCT03863509|566228590|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
156856623|NCT03863509|566228591|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
156856624|NCT03861273|566228592|FG000|Screening Phase (3 Weeks)|Other|1|||
156856625|NCT03861273|566228592|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
156856626|NCT03861273|566228592|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
156856627|NCT03861273|566228592|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
156856628|NCT03861273|566228592|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
157025893|NCT02043678|566849636|FG000|Overall Study|Non-compliance with study drug|3|||
157157666|NCT04402008|567322854|FG006|Overall Study|Death|2|||
157157667|NCT04402008|567322848|FG000|Overall Study|Other|0|||
157157668|NCT04402008|567322849|FG001|Overall Study|Other|0|||
157157669|NCT04402008|567322850|FG002|Overall Study|Other|0|||
157157670|NCT04402008|567322851|FG003|Overall Study|Other|0|||
157157671|NCT04402008|567322852|FG004|Overall Study|Other|0|||
157157672|NCT04402008|567322853|FG005|Overall Study|Other|0|||
157157673|NCT04402008|567322854|FG006|Overall Study|Other|5|||
157157674|NCT05132569|567322858|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
157157675|NCT05132569|567322859|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
157157676|NCT05132569|567322858|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
156856629|NCT00191334|566228595|FG000|Overall Study|Adverse Event|4|||
156856630|NCT00191334|566228595|FG000|Overall Study|Disease Progression or Relapse|8|||
156856631|NCT00191334|566228595|FG000|Overall Study|Physician Decision|1|||
156856632|NCT00191334|566228595|FG000|Overall Study|Withdrawal by Subject|4|||
156856633|NCT03064490|566228596|FG000|Overall Study|Physician Decision|5|||
156856634|NCT02926638|566228599|FG000|Overall Study|Progression|2|||
156856635|NCT02926638|566228600|FG001|Overall Study|Progression|5|||
156856636|NCT02926638|566228599|FG000|Overall Study|Ineligible|1|||
156856637|NCT02926638|566228600|FG001|Overall Study|Ineligible|0|||
156856638|NCT02926638|566228599|FG000|Overall Study|Not protocol specified|1|||
156856639|NCT02926638|566228600|FG001|Overall Study|Not protocol specified|0|||
156856640|NCT02464410|566228601|FG000|Overall Study|Death|3|||
156856641|NCT02464410|566228602|FG001|Overall Study|Death|4|||
156856642|NCT02464410|566228601|FG000|Overall Study|Lost to Follow-up|7|||
156856643|NCT02464410|566228602|FG001|Overall Study|Lost to Follow-up|9|||
156856644|NCT02464410|566228601|FG000|Overall Study|Withdrawal by Subject|12|||
156856645|NCT02464410|566228602|FG001|Overall Study|Withdrawal by Subject|3|||
156856646|NCT01928927|566228604|FG000|Overall Study|Lost to Follow-up|1|||
156856647|NCT01928927|566228605|FG001|Overall Study|Lost to Follow-up|0|||
156856648|NCT01928927|566228604|FG000|Overall Study|Withdrawal by Subject|1|||
156856649|NCT01928927|566228605|FG001|Overall Study|Withdrawal by Subject|1|||
156856650|NCT01063153|566228606|FG000|Overall Study|Found Ineligible During Screening|2|||
156856651|NCT01063153|566228607|FG001|Overall Study|Found Ineligible During Screening|0|||
156856652|NCT01063153|566228606|FG000|Overall Study|Lost to Follow-up|0|||
156856653|NCT01063153|566228607|FG001|Overall Study|Lost to Follow-up|7|||
156856654|NCT01063153|566228606|FG000|Overall Study|Withdrawal by Subject|0|||
156856655|NCT01063153|566228607|FG001|Overall Study|Withdrawal by Subject|1|||
156856656|NCT01063153|566228606|FG000|Overall Study|Physician Decision|0|||
156856657|NCT01063153|566228607|FG001|Overall Study|Physician Decision|4|||
156856658|NCT01777776|566228608|FG000|Overall Study|Adverse Event|2|||
156856659|NCT01777776|566228609|FG001|Overall Study|Adverse Event|4|||
156856660|NCT01777776|566228610|FG002|Overall Study|Adverse Event|0|||
156856661|NCT01777776|566228611|FG003|Overall Study|Adverse Event|0|||
156856662|NCT01777776|566228608|FG000|Overall Study|Disease Progression|4|||
157157677|NCT05132569|567322859|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
157157678|NCT05132569|567322858|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
157157679|NCT05132569|567322859|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
157157680|NCT00210158|567322860|FG000|Overall Study|Protocol Violation|0|||
157157681|NCT00210158|567322861|FG001|Overall Study|Protocol Violation|2|||
157157682|NCT04716933|567322862|FG000|Overall Study|Sponsor Decision|36|||
157157683|NCT04716933|567322863|FG001|Overall Study|Sponsor Decision|33|||
157157684|NCT04716933|567322862|FG000|Overall Study|Death|65|||
157157685|NCT04716933|567322863|FG001|Overall Study|Death|67|||
157157686|NCT03249792|567322864|FG000|Arms 1, 2, and 4|Death|1|||
157157687|NCT03249792|567322865|FG001|Arms 1, 2, and 4|Death|1|||
157157688|NCT03249792|567322866|FG002|Arms 1, 2, and 4|Death|0|||
157157689|NCT03249792|567322867|FG003|Arms 1, 2, and 4|Death|2|||
157157690|NCT03249792|567322868|FG004|Arms 1, 2, and 4|Death|3|||
157157691|NCT03249792|567322869|FG005|Arms 1, 2, and 4|Death|2|||
157157692|NCT03249792|567322870|FG006|Arms 1, 2, and 4|Death|2|||
157157693|NCT03249792|567322871|FG007|Arms 1, 2, and 4|Death|4|||
157157694|NCT03249792|567322872|FG008|Arms 1, 2, and 4|Death|2|||
157157695|NCT03249792|567322873|FG009|Arms 1, 2, and 4|Death|1|||
157157696|NCT03249792|567322874|FG010|Arms 1, 2, and 4|Death|7|||
157157697|NCT03249792|567322875|FG011|Arms 1, 2, and 4|Death|7|||
157157698|NCT03249792|567322876|FG012|Arms 1, 2, and 4|Death|12|||
157157699|NCT03249792|567322877|FG013|Arms 1, 2, and 4|Death|7|||
157157700|NCT03249792|567322878|FG014|Arms 1, 2, and 4|Death|0|||
156856663|NCT01777776|566228609|FG001|Overall Study|Disease Progression|8|||
156856664|NCT01777776|566228610|FG002|Overall Study|Disease Progression|6|||
156856665|NCT01777776|566228611|FG003|Overall Study|Disease Progression|3|||
156856666|NCT01777776|566228608|FG000|Overall Study|Withdrawal by Subject|0|||
156856667|NCT01777776|566228609|FG001|Overall Study|Withdrawal by Subject|0|||
156856668|NCT01777776|566228610|FG002|Overall Study|Withdrawal by Subject|0|||
156856669|NCT01777776|566228611|FG003|Overall Study|Withdrawal by Subject|1|||
156856670|NCT00383552|566230713|FG000|Overall Study|Adverse Event|7|||
156856671|NCT00383552|566230714|FG001|Overall Study|Adverse Event|6|||
157157701|NCT03249792|567322879|FG015|Arms 1, 2, and 4|Death|4|||
157157702|NCT03249792|567322880|FG016|Arms 1, 2, and 4|Death|4|||
157157703|NCT03249792|567322881|FG017|Arms 1, 2, and 4|Death|12|||
157157704|NCT03249792|567322882|FG018|Arms 1, 2, and 4|Death|6|||
156856672|NCT00383552|566230715|FG002|Overall Study|Adverse Event|9|||
156856673|NCT00383552|566230716|FG003|Overall Study|Adverse Event|6|||
156856674|NCT00383552|566230713|FG000|Overall Study|Lack of Efficacy|4|||
156856675|NCT00383552|566230714|FG001|Overall Study|Lack of Efficacy|13|||
156856676|NCT00383552|566230715|FG002|Overall Study|Lack of Efficacy|29|||
156856677|NCT00383552|566230716|FG003|Overall Study|Lack of Efficacy|42|||
156856678|NCT00383552|566230713|FG000|Overall Study|Lost to Follow-up|0|||
156856679|NCT00383552|566230714|FG001|Overall Study|Lost to Follow-up|1|||
156856680|NCT00383552|566230715|FG002|Overall Study|Lost to Follow-up|5|||
156856681|NCT00383552|566230716|FG003|Overall Study|Lost to Follow-up|1|||
156856682|NCT00383552|566230713|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
156856683|NCT00383552|566230714|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
156856684|NCT00383552|566230715|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
156856685|NCT00383552|566230716|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
156856686|NCT00383552|566230713|FG000|Overall Study|Did not wish to continue (related)|1|||
156856687|NCT00383552|566230714|FG001|Overall Study|Did not wish to continue (related)|0|||
156856688|NCT00383552|566230715|FG002|Overall Study|Did not wish to continue (related)|2|||
156856689|NCT00383552|566230716|FG003|Overall Study|Did not wish to continue (related)|3|||
156856690|NCT00383552|566230713|FG000|Overall Study|Noncompliance with the protocol|11|||
156856691|NCT00383552|566230714|FG001|Overall Study|Noncompliance with the protocol|6|||
156856692|NCT00383552|566230715|FG002|Overall Study|Noncompliance with the protocol|8|||
156856693|NCT00383552|566230716|FG003|Overall Study|Noncompliance with the protocol|10|||
156856694|NCT00383552|566230713|FG000|Overall Study|Did not meet protocol eligibility|8|||
156856695|NCT00383552|566230714|FG001|Overall Study|Did not meet protocol eligibility|6|||
156856696|NCT00383552|566230715|FG002|Overall Study|Did not meet protocol eligibility|2|||
156856697|NCT00383552|566230716|FG003|Overall Study|Did not meet protocol eligibility|3|||
156856698|NCT00383552|566230713|FG000|Overall Study|Administrative|1|||
156856699|NCT00383552|566230714|FG001|Overall Study|Administrative|0|||
156856700|NCT00383552|566230715|FG002|Overall Study|Administrative|1|||
156856701|NCT00383552|566230716|FG003|Overall Study|Administrative|1|||
156856702|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
156856703|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
156856704|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
156856705|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
156856706|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
156856707|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
156856708|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
156856709|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
156856710|NCT03096834|566230717|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
156856711|NCT03096834|566230718|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
156856712|NCT03096834|566230719|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
156856713|NCT03096834|566230720|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
156856714|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
156856715|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
156856716|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
156856717|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
156856718|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
156856719|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
156856720|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
156856721|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
156856722|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
156856723|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
156856724|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
156856725|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
156856726|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
156856727|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
156856728|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
156856729|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
156856730|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
156856731|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
156856732|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
156856733|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
156856734|NCT03096834|566230717|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
157157705|NCT03249792|567322883|FG019|Arms 1, 2, and 4|Death|4|||
157157706|NCT03249792|567322884|FG020|Arms 1, 2, and 4|Death|2|||
157157707|NCT03249792|567322885|FG021|Arms 1, 2, and 4|Death|3|||
157157708|NCT03249792|567322886|FG022|Arms 1, 2, and 4|Death|1|||
156856735|NCT03096834|566230718|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
156856736|NCT03096834|566230719|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
156856737|NCT03096834|566230720|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
156856738|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
156856739|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
156889828|NCT01986933|566355566|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
156889829|NCT01986933|566355562|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
156889830|NCT01986933|566355563|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
156889831|NCT01986933|566355564|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
156889832|NCT01986933|566355565|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
156889833|NCT01986933|566355566|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
156889834|NCT01986933|566355562|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
156889835|NCT01986933|566355563|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156889836|NCT01986933|566355564|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
156889837|NCT01986933|566355565|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156889838|NCT01986933|566355566|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
156889839|NCT01986933|566355562|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
156889840|NCT01986933|566355563|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
156889841|NCT01986933|566355564|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
156889842|NCT01986933|566355565|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
156889843|NCT01986933|566355566|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
156889844|NCT01986933|566355562|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156889845|NCT01986933|566355563|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156889846|NCT01986933|566355564|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156889847|NCT01986933|566355565|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
156889848|NCT01986933|566355566|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
156889849|NCT01986933|566355562|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
156889850|NCT01986933|566355563|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
156889851|NCT01986933|566355564|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
156889852|NCT01986933|566355565|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
156889853|NCT01986933|566355566|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
156889854|NCT01986933|566355562|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
156889855|NCT01986933|566355563|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
156889856|NCT01986933|566355564|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
156889857|NCT01986933|566355565|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
156889858|NCT01986933|566355566|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
156889859|NCT01986933|566355562|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156889860|NCT01986933|566355563|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
156889861|NCT01986933|566355564|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156889862|NCT01986933|566355565|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156889863|NCT01986933|566355566|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
156889864|NCT01077154|566355567|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
156889865|NCT01077154|566355568|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
156889866|NCT01077154|566355567|FG000|Overall Study|Withdrawal by Subject|369|||
156889867|NCT01077154|566355568|FG001|Overall Study|Withdrawal by Subject|385|||
156889868|NCT01077154|566355567|FG000|Overall Study|Death|215|||
156889869|NCT01077154|566355568|FG001|Overall Study|Death|214|||
156889870|NCT01077154|566355567|FG000|Overall Study|Lost to Follow-up|43|||
156889871|NCT01077154|566355568|FG001|Overall Study|Lost to Follow-up|35|||
156889872|NCT01077154|566355567|FG000|Overall Study|Noncompliance|22|||
156889873|NCT01077154|566355568|FG001|Overall Study|Noncompliance|20|||
156889874|NCT01077154|566355567|FG000|Overall Study|Disease Progression|18|||
156889875|NCT01077154|566355568|FG001|Overall Study|Disease Progression|20|||
156889876|NCT01077154|566355567|FG000|Overall Study|Ineligibility Determined|10|||
156889877|NCT01077154|566355568|FG001|Overall Study|Ineligibility Determined|14|||
156889878|NCT01077154|566355567|FG000|Overall Study|Other|14|||
156889879|NCT01077154|566355568|FG001|Overall Study|Other|11|||
156889880|NCT01077154|566355567|FG000|Overall Study|Adverse Event|9|||
156889881|NCT01077154|566355568|FG001|Overall Study|Adverse Event|9|||
156889882|NCT01077154|566355567|FG000|Overall Study|Administrative Decision|1|||
156889883|NCT01077154|566355568|FG001|Overall Study|Administrative Decision|6|||
156889884|NCT01077154|566355567|FG000|Overall Study|Protocol Deviation|1|||
156889885|NCT01077154|566355568|FG001|Overall Study|Protocol Deviation|0|||
156889886|NCT05856760|566355569|FG000|Overall Study|Adverse Event|2|||
156889887|NCT05856760|566355569|FG000|Overall Study|Physician Decision|1|||
156889888|NCT05856760|566355569|FG000|Overall Study|Protocol Violation|1|||
156889889|NCT05856760|566355569|FG000|Overall Study|Withdrawal by Subject|3|||
156889890|NCT04035486|566355570|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
156889891|NCT04035486|566355571|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
156889892|NCT04035486|566355572|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
156889893|NCT04035486|566355573|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
156889894|NCT04035486|566355570|FG000|Overall Study|Death|6|||
156889895|NCT04035486|566355571|FG001|Overall Study|Death|3|||
156889896|NCT04035486|566355572|FG002|Overall Study|Death|70|||
156889897|NCT04035486|566355573|FG003|Overall Study|Death|77|||
156889898|NCT04035486|566355570|FG000|Overall Study|Screen Failure|0|||
156889899|NCT04035486|566355571|FG001|Overall Study|Screen Failure|0|||
156889900|NCT04035486|566355572|FG002|Overall Study|Screen Failure|1|||
156889901|NCT04035486|566355573|FG003|Overall Study|Screen Failure|1|||
156856740|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
156856741|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
156856742|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
156856743|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
156856744|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
156856745|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
156856746|NCT03096834|566230717|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856747|NCT03096834|566230718|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856748|NCT03096834|566230719|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
156856749|NCT03096834|566230720|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
156856750|NCT00966654|566230721|FG000|Overall Study|Study was terminated,PI left institution|12|||
156856751|NCT01600326|566230728|FG000|Overall Study|Lost to Follow-up|1|||
156856752|NCT01600326|566230729|FG001|Overall Study|Lost to Follow-up|1|||
156856753|NCT04456504|566230730|FG000|Overall Study|Lost to Follow-up|2|||
156856754|NCT00762359|566230731|FG000|Overall Study|Adverse Event|20|||
156856755|NCT00762359|566230732|FG001|Overall Study|Adverse Event|23|||
156856756|NCT00762359|566230731|FG000|Overall Study|Protocol Violation|21|||
156856757|NCT00762359|566230732|FG001|Overall Study|Protocol Violation|13|||
156856758|NCT00762359|566230731|FG000|Overall Study|Withdrawal by Subject|13|||
156856759|NCT00762359|566230732|FG001|Overall Study|Withdrawal by Subject|10|||
156856760|NCT00762359|566230731|FG000|Overall Study|Lack of Efficacy|0|||
156856761|NCT00762359|566230732|FG001|Overall Study|Lack of Efficacy|4|||
156856762|NCT00762359|566230731|FG000|Overall Study|Institution closed|2|||
156856763|NCT00762359|566230732|FG001|Overall Study|Institution closed|3|||
156856764|NCT00762359|566230731|FG000|Overall Study|Physician Decision|2|||
156856765|NCT00762359|566230732|FG001|Overall Study|Physician Decision|3|||
156856766|NCT00762359|566230731|FG000|Overall Study|Removal|0|||
156856767|NCT00762359|566230732|FG001|Overall Study|Removal|1|||
156856768|NCT00762359|566230731|FG000|Overall Study|Withdrew consent|1|||
156856769|NCT00762359|566230732|FG001|Overall Study|Withdrew consent|0|||
156856770|NCT00882440|566230733|FG000|Overall Study|Adverse Event|2|||
156856771|NCT00882440|566230734|FG001|Overall Study|Adverse Event|2|||
156856772|NCT00882440|566230735|FG002|Overall Study|Adverse Event|2|||
156856773|NCT00882440|566230736|FG003|Overall Study|Adverse Event|1|||
156856774|NCT00882440|566230737|FG004|Overall Study|Adverse Event|1|||
156856775|NCT00882440|566230738|FG005|Overall Study|Adverse Event|4|||
156856776|NCT00882440|566230739|FG006|Overall Study|Adverse Event|2|||
156856777|NCT00882440|566230733|FG000|Overall Study|Lack of Efficacy|3|||
156856778|NCT00882440|566230734|FG001|Overall Study|Lack of Efficacy|5|||
156856779|NCT00882440|566230735|FG002|Overall Study|Lack of Efficacy|2|||
156856780|NCT00882440|566230736|FG003|Overall Study|Lack of Efficacy|0|||
156856781|NCT00882440|566230737|FG004|Overall Study|Lack of Efficacy|0|||
156856782|NCT00882440|566230738|FG005|Overall Study|Lack of Efficacy|3|||
156856783|NCT00882440|566230739|FG006|Overall Study|Lack of Efficacy|0|||
156856784|NCT00882440|566230733|FG000|Overall Study|Lost to Follow-up|2|||
156856785|NCT00882440|566230734|FG001|Overall Study|Lost to Follow-up|0|||
156856786|NCT00882440|566230735|FG002|Overall Study|Lost to Follow-up|1|||
156856787|NCT00882440|566230736|FG003|Overall Study|Lost to Follow-up|1|||
156856788|NCT00882440|566230737|FG004|Overall Study|Lost to Follow-up|1|||
156856789|NCT00882440|566230738|FG005|Overall Study|Lost to Follow-up|0|||
156856790|NCT00882440|566230739|FG006|Overall Study|Lost to Follow-up|1|||
156856791|NCT00882440|566230733|FG000|Overall Study|Protocol Violation|0|||
156856792|NCT00882440|566230734|FG001|Overall Study|Protocol Violation|0|||
156856793|NCT00882440|566230735|FG002|Overall Study|Protocol Violation|1|||
156856794|NCT00882440|566230736|FG003|Overall Study|Protocol Violation|1|||
156856795|NCT00882440|566230737|FG004|Overall Study|Protocol Violation|1|||
156856796|NCT00882440|566230738|FG005|Overall Study|Protocol Violation|0|||
156856797|NCT00882440|566230739|FG006|Overall Study|Protocol Violation|0|||
156856798|NCT00882440|566230733|FG000|Overall Study|Withdrawal by Subject|2|||
156856799|NCT00882440|566230734|FG001|Overall Study|Withdrawal by Subject|1|||
156856800|NCT00882440|566230735|FG002|Overall Study|Withdrawal by Subject|1|||
156856801|NCT00882440|566230736|FG003|Overall Study|Withdrawal by Subject|0|||
156856802|NCT00882440|566230737|FG004|Overall Study|Withdrawal by Subject|6|||
156856803|NCT00882440|566230738|FG005|Overall Study|Withdrawal by Subject|0|||
156856804|NCT00882440|566230739|FG006|Overall Study|Withdrawal by Subject|1|||
156856805|NCT00882440|566230733|FG000|Overall Study|Patient Uncooperative|2|||
156856806|NCT00882440|566230734|FG001|Overall Study|Patient Uncooperative|0|||
156856807|NCT00882440|566230735|FG002|Overall Study|Patient Uncooperative|0|||
157157709|NCT03249792|567322887|FG023|Arms 1, 2, and 4|Death|1|||
157157710|NCT03249792|567322888|FG024|Arms 1, 2, and 4|Death|4|||
156856808|NCT00882440|566230736|FG003|Overall Study|Patient Uncooperative|0|||
156856809|NCT00882440|566230737|FG004|Overall Study|Patient Uncooperative|1|||
156856810|NCT00882440|566230738|FG005|Overall Study|Patient Uncooperative|0|||
156856811|NCT00882440|566230739|FG006|Overall Study|Patient Uncooperative|0|||
156856812|NCT01342913|566230740|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
156856813|NCT01342913|566230741|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156856814|NCT01342913|566230742|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
156856815|NCT01342913|566230740|FG000|2-week Run-in Period|Physician Decision|6|||
156889902|NCT04035486|566355570|FG000|Overall Study|Withdrawal by Subject|1|||
156889903|NCT04035486|566355571|FG001|Overall Study|Withdrawal by Subject|1|||
156889904|NCT04035486|566355572|FG002|Overall Study|Withdrawal by Subject|11|||
156889905|NCT04035486|566355573|FG003|Overall Study|Withdrawal by Subject|9|||
156889906|NCT01006603|566355574|FG000|Overall Study|Withdrawal by Subject|17|||
156889907|NCT01006603|566355575|FG001|Overall Study|Withdrawal by Subject|19|||
156889908|NCT01006603|566355574|FG000|Overall Study|Lost to Follow-up|0|||
156889909|NCT01006603|566355575|FG001|Overall Study|Lost to Follow-up|1|||
156889910|NCT01006603|566355574|FG000|Overall Study|Safety reason|1|||
156889911|NCT01006603|566355575|FG001|Overall Study|Safety reason|1|||
156889912|NCT01006603|566355574|FG000|Overall Study|Protocol Violation|1|||
156889913|NCT01006603|566355575|FG001|Overall Study|Protocol Violation|3|||
156889914|NCT01006603|566355574|FG000|Overall Study|Incorrect enrolment|0|||
156889915|NCT01006603|566355575|FG001|Overall Study|Incorrect enrolment|2|||
156889916|NCT01006603|566355574|FG000|Overall Study|Adverse Event|15|||
156889917|NCT01006603|566355575|FG001|Overall Study|Adverse Event|7|||
156889918|NCT01006603|566355574|FG000|Overall Study|Death|1|||
156889919|NCT01006603|566355575|FG001|Overall Study|Death|1|||
156889920|NCT01006603|566355574|FG000|Overall Study|Study specific discontinuation criteria|33|||
156889921|NCT01006603|566355575|FG001|Overall Study|Study specific discontinuation criteria|34|||
156889922|NCT01006603|566355574|FG000|Overall Study|Other|3|||
156889923|NCT01006603|566355575|FG001|Overall Study|Other|7|||
156889924|NCT03875235|566355578|FG000|Overall Study|Ongoing study treatment|63|||
156889925|NCT03875235|566355579|FG001|Overall Study|Ongoing study treatment|20|||
156889926|NCT03875235|566355578|FG000|Overall Study|Off treatment|77|||
156889927|NCT03875235|566355579|FG001|Overall Study|Off treatment|91|||
156889928|NCT03875235|566355578|FG000|Overall Study|Withdrawal by Subject|3|||
156889929|NCT03875235|566355579|FG001|Overall Study|Withdrawal by Subject|10|||
156889930|NCT03875235|566355578|FG000|Overall Study|Death|198|||
156889931|NCT03875235|566355579|FG001|Overall Study|Death|223|||
156889932|NCT00625742|566357063|FG000|Overall Study|Disease Progression|2|||
156889933|NCT00625742|566357063|FG000|Overall Study|Withdrawal by Subject|1|||
156889934|NCT00625742|566357063|FG000|Overall Study|Adverse Event|4|||
156889935|NCT00625742|566357063|FG000|Overall Study|Lost to Follow-up|4|||
156889936|NCT00625742|566357063|FG000|Overall Study|Ineligible|1|||
156889937|NCT03387150|566357065|FG000|Overall Study|Withdrawal by Subject|3|||
156889938|NCT03387150|566357066|FG001|Overall Study|Withdrawal by Subject|0|||
156889939|NCT03387150|566357067|FG002|Overall Study|Withdrawal by Subject|3|||
156889940|NCT03387150|566357068|FG003|Overall Study|Withdrawal by Subject|4|||
156889941|NCT03387150|566357069|FG004|Overall Study|Withdrawal by Subject|1|||
156889942|NCT03387150|566357070|FG005|Overall Study|Withdrawal by Subject|2|||
156889943|NCT03387150|566357071|FG006|Overall Study|Withdrawal by Subject|0|||
156889944|NCT03387150|566357065|FG000|Overall Study|Lost to Follow-up|3|||
156889945|NCT03387150|566357066|FG001|Overall Study|Lost to Follow-up|2|||
156889946|NCT03387150|566357067|FG002|Overall Study|Lost to Follow-up|2|||
156889947|NCT03387150|566357068|FG003|Overall Study|Lost to Follow-up|3|||
156889948|NCT03387150|566357069|FG004|Overall Study|Lost to Follow-up|3|||
156889949|NCT03387150|566357070|FG005|Overall Study|Lost to Follow-up|3|||
156889950|NCT03387150|566357071|FG006|Overall Study|Lost to Follow-up|0|||
156889951|NCT03387150|566357065|FG000|Overall Study|Participant unable to adhere to visit|0|||
156889952|NCT03387150|566357066|FG001|Overall Study|Participant unable to adhere to visit|1|||
156889953|NCT03387150|566357067|FG002|Overall Study|Participant unable to adhere to visit|0|||
156889954|NCT03387150|566357068|FG003|Overall Study|Participant unable to adhere to visit|0|||
156889955|NCT03387150|566357069|FG004|Overall Study|Participant unable to adhere to visit|2|||
156889956|NCT03387150|566357070|FG005|Overall Study|Participant unable to adhere to visit|2|||
156889957|NCT03387150|566357071|FG006|Overall Study|Participant unable to adhere to visit|0|||
156889958|NCT04078178|566357072|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
156889959|NCT04078178|566357073|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
156889960|NCT04078178|566357072|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
156889961|NCT04078178|566357073|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
156889962|NCT04078178|566357072|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
156889963|NCT04078178|566357073|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
156889964|NCT04078178|566357072|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
156889965|NCT04078178|566357073|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
156889966|NCT04078178|566357072|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
156889967|NCT04078178|566357073|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
156889968|NCT04006119|566357074|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
156889969|NCT04006119|566357074|FG000|End of Treatment Veledimex|Adverse Event|2|||
156889970|NCT04006119|566357074|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
156889971|NCT04006119|566357074|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
156889972|NCT04006119|566357074|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
156889973|NCT04006119|566357074|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
156889974|NCT02316548|566357075|FG000|Overall Study|Protocol Violation|0|||
156889975|NCT02316548|566357076|FG001|Overall Study|Protocol Violation|1|||
156889976|NCT03269552|566357077|FG000|Overall Study|Adverse Event|2|||
156889977|NCT02186301|566357078|FG000|Overall Study|Progressive Disease|7|||
156889978|NCT02186301|566357079|FG001|Overall Study|Progressive Disease|22|||
157157711|NCT03249792|567322889|FG025|Arms 1, 2, and 4|Death|0|||
157157712|NCT03249792|567322890|FG026|Arms 1, 2, and 4|Death|0|||
157157713|NCT03249792|567322891|FG027|Arms 1, 2, and 4|Death|0|||
157157714|NCT03249792|567322892|FG028|Arms 1, 2, and 4|Death|0|||
157157715|NCT03249792|567322893|FG029|Arms 1, 2, and 4|Death|0|||
157157716|NCT03249792|567322894|FG030|Arms 1, 2, and 4|Death|0|||
156889979|NCT02186301|566357080|FG002|Overall Study|Progressive Disease|27|||
156889980|NCT02186301|566357078|FG000|Overall Study|Adverse Event|5|||
156889981|NCT02186301|566357079|FG001|Overall Study|Adverse Event|5|||
156889982|NCT02186301|566357080|FG002|Overall Study|Adverse Event|5|||
156889983|NCT02186301|566357078|FG000|Overall Study|Death|1|||
156889984|NCT02186301|566357079|FG001|Overall Study|Death|0|||
156889985|NCT02186301|566357080|FG002|Overall Study|Death|0|||
156889986|NCT02186301|566357078|FG000|Overall Study|Withdrawal by Subject|5|||
156889987|NCT02186301|566357079|FG001|Overall Study|Withdrawal by Subject|1|||
156889988|NCT02186301|566357080|FG002|Overall Study|Withdrawal by Subject|3|||
156889989|NCT02186301|566357078|FG000|Overall Study|Physician Decision|1|||
156889990|NCT02186301|566357079|FG001|Overall Study|Physician Decision|0|||
156889991|NCT02186301|566357080|FG002|Overall Study|Physician Decision|1|||
156889992|NCT02186301|566357078|FG000|Overall Study|Study Terminated by Sponsor|1|||
156889993|NCT02186301|566357079|FG001|Overall Study|Study Terminated by Sponsor|0|||
156889994|NCT02186301|566357080|FG002|Overall Study|Study Terminated by Sponsor|11|||
156889995|NCT02186301|566357078|FG000|Overall Study|Protocol Deviation|0|||
156889996|NCT02186301|566357079|FG001|Overall Study|Protocol Deviation|2|||
156889997|NCT02186301|566357080|FG002|Overall Study|Protocol Deviation|0|||
156889998|NCT02186301|566357078|FG000|Overall Study|Missing|0|||
156889999|NCT02186301|566357079|FG001|Overall Study|Missing|0|||
156890000|NCT02186301|566357080|FG002|Overall Study|Missing|2|||
156890001|NCT02186301|566357078|FG000|Overall Study|Other|0|||
156890002|NCT02186301|566357079|FG001|Overall Study|Other|0|||
156890003|NCT02186301|566357080|FG002|Overall Study|Other|1|||
156890004|NCT01343823|566357081|FG000|Overall Study|Study Terminated|1|||
156890005|NCT01343823|566357082|FG001|Overall Study|Study Terminated|0|||
156890006|NCT01343823|566357083|FG002|Overall Study|Study Terminated|0|||
156890007|NCT01343823|566357084|FG003|Overall Study|Study Terminated|1|||
156890008|NCT01343823|566357081|FG000|Overall Study|Withdrawal by Subject|1|||
156890009|NCT01343823|566357082|FG001|Overall Study|Withdrawal by Subject|0|||
156890010|NCT01343823|566357083|FG002|Overall Study|Withdrawal by Subject|0|||
156890011|NCT01343823|566357084|FG003|Overall Study|Withdrawal by Subject|0|||
156890012|NCT03468543|566357087|FG000|Overall Study|Protocol stopping rules met|3|||
156890013|NCT04393298|566357088|FG000|Overall Study|Adverse Event|0|||
156890014|NCT04393298|566357089|FG001|Overall Study|Adverse Event|0|||
156890015|NCT04393298|566357090|FG002|Overall Study|Adverse Event|0|||
156890016|NCT04393298|566357091|FG003|Overall Study|Adverse Event|0|||
156890017|NCT04393298|566357092|FG004|Overall Study|Adverse Event|1|||
156890018|NCT04393298|566357093|FG005|Overall Study|Adverse Event|0|||
156890019|NCT04393298|566357094|FG006|Overall Study|Adverse Event|0|||
156890020|NCT04393298|566357095|FG007|Overall Study|Adverse Event|0|||
156890021|NCT04393298|566357096|FG008|Overall Study|Adverse Event|2|||
156890022|NCT04393298|566357097|FG009|Overall Study|Adverse Event|0|||
156890023|NCT04393298|566357098|FG010|Overall Study|Adverse Event|0|||
156890024|NCT04393298|566357099|FG011|Overall Study|Adverse Event|0|||
156890025|NCT04393298|566357100|FG012|Overall Study|Adverse Event|1|||
156890026|NCT04393298|566357101|FG013|Overall Study|Adverse Event|1|||
156890027|NCT04393298|566357102|FG014|Overall Study|Adverse Event|0|||
157157717|NCT03249792|567322895|FG031|Arms 1, 2, and 4|Death|0|||
157157718|NCT03249792|567322896|FG032|Arms 1, 2, and 4|Death|0|||
157157719|NCT03249792|567322864|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157720|NCT03249792|567322865|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157721|NCT03249792|567322866|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
157157722|NCT03249792|567322867|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157723|NCT03249792|567322868|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157724|NCT03249792|567322869|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
156890028|NCT04393298|566357088|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890029|NCT04393298|566357089|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890030|NCT04393298|566357090|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
157157725|NCT03249792|567322870|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
157157726|NCT03249792|567322871|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156890031|NCT04393298|566357091|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890032|NCT04393298|566357092|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
157157727|NCT03249792|567322872|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
156890033|NCT04393298|566357093|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890034|NCT04393298|566357094|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890035|NCT04393298|566357095|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890036|NCT04393298|566357096|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890037|NCT04393298|566357097|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890038|NCT04393298|566357098|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890039|NCT04393298|566357099|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890040|NCT04393298|566357100|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
157157728|NCT03249792|567322873|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
157157729|NCT03249792|567322874|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
157157730|NCT03249792|567322875|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
157157731|NCT03249792|567322876|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
156890041|NCT04393298|566357101|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
156890042|NCT04393298|566357102|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
156890043|NCT04393298|566357088|FG000|Overall Study|Lack of Efficacy|0|||
156890044|NCT04393298|566357089|FG001|Overall Study|Lack of Efficacy|0|||
156890045|NCT04393298|566357090|FG002|Overall Study|Lack of Efficacy|0|||
156890046|NCT04393298|566357091|FG003|Overall Study|Lack of Efficacy|0|||
156890047|NCT04393298|566357092|FG004|Overall Study|Lack of Efficacy|0|||
156890048|NCT04393298|566357093|FG005|Overall Study|Lack of Efficacy|0|||
156890049|NCT04393298|566357094|FG006|Overall Study|Lack of Efficacy|0|||
156890050|NCT04393298|566357095|FG007|Overall Study|Lack of Efficacy|0|||
156890051|NCT04393298|566357096|FG008|Overall Study|Lack of Efficacy|0|||
156890052|NCT04393298|566357097|FG009|Overall Study|Lack of Efficacy|0|||
156890053|NCT04393298|566357098|FG010|Overall Study|Lack of Efficacy|0|||
156890054|NCT04393298|566357099|FG011|Overall Study|Lack of Efficacy|0|||
156890055|NCT04393298|566357100|FG012|Overall Study|Lack of Efficacy|0|||
156890056|NCT04393298|566357101|FG013|Overall Study|Lack of Efficacy|0|||
156890057|NCT04393298|566357102|FG014|Overall Study|Lack of Efficacy|1|||
156890058|NCT04393298|566357088|FG000|Overall Study|Progression|1|||
156890059|NCT04393298|566357089|FG001|Overall Study|Progression|0|||
156890060|NCT04393298|566357090|FG002|Overall Study|Progression|0|||
156890061|NCT04393298|566357091|FG003|Overall Study|Progression|0|||
156890062|NCT04393298|566357092|FG004|Overall Study|Progression|0|||
156890063|NCT04393298|566357093|FG005|Overall Study|Progression|0|||
156890064|NCT04393298|566357094|FG006|Overall Study|Progression|0|||
156890065|NCT04393298|566357095|FG007|Overall Study|Progression|0|||
156890066|NCT04393298|566357096|FG008|Overall Study|Progression|0|||
156890067|NCT04393298|566357097|FG009|Overall Study|Progression|0|||
156890068|NCT04393298|566357098|FG010|Overall Study|Progression|1|||
156890069|NCT04393298|566357099|FG011|Overall Study|Progression|1|||
156890070|NCT04393298|566357100|FG012|Overall Study|Progression|0|||
156890071|NCT04393298|566357101|FG013|Overall Study|Progression|0|||
156890072|NCT04393298|566357102|FG014|Overall Study|Progression|0|||
156890073|NCT04393298|566357088|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
156890074|NCT04393298|566357089|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890075|NCT04393298|566357090|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890076|NCT04393298|566357091|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890077|NCT04393298|566357092|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890078|NCT04393298|566357093|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890079|NCT04393298|566357094|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890080|NCT04393298|566357095|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890081|NCT04393298|566357096|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890082|NCT04393298|566357097|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890083|NCT04393298|566357098|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890084|NCT04393298|566357099|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890085|NCT04393298|566357100|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890086|NCT04393298|566357101|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890087|NCT04393298|566357102|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
156890088|NCT04393298|566357088|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890089|NCT04393298|566357089|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
157157732|NCT03249792|567322877|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
156890090|NCT04393298|566357090|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890091|NCT04393298|566357091|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890092|NCT04393298|566357092|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890093|NCT04393298|566357093|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890094|NCT04393298|566357094|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890095|NCT04393298|566357095|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890096|NCT04393298|566357096|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890097|NCT04393298|566357097|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890098|NCT04393298|566357098|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890099|NCT04393298|566357099|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890100|NCT04393298|566357100|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890101|NCT04393298|566357101|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890102|NCT04393298|566357102|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
156890103|NCT04393298|566357088|FG000|Overall Study|Clinical Progression|0|||
157157733|NCT03249792|567322878|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156890104|NCT04393298|566357089|FG001|Overall Study|Clinical Progression|2|||
157025894|NCT02043678|566849637|FG001|Overall Study|Non-compliance with study drug|1|||
157157734|NCT03249792|567322879|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157735|NCT03249792|567322880|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
157157736|NCT03249792|567322881|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157737|NCT03249792|567322882|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
157157738|NCT03249792|567322883|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157739|NCT03249792|567322884|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157740|NCT03249792|567322885|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157741|NCT03249792|567322886|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
157157742|NCT03249792|567322887|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
157157743|NCT03249792|567322888|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157744|NCT03249792|567322889|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157745|NCT03249792|567322890|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157746|NCT03249792|567322891|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156856816|NCT01342913|566230741|FG001|2-week Run-in Period|Physician Decision|0|||
156856817|NCT01342913|566230742|FG002|2-week Run-in Period|Physician Decision|0|||
156856818|NCT01342913|566230740|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
156856819|NCT01342913|566230741|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156856820|NCT01342913|566230742|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156856821|NCT01342913|566230740|FG000|2-week Run-in Period|Adverse Event|2|||
156856822|NCT01342913|566230741|FG001|2-week Run-in Period|Adverse Event|0|||
156856823|NCT01342913|566230742|FG002|2-week Run-in Period|Adverse Event|0|||
156856824|NCT01342913|566230740|FG000|2-week Run-in Period|Protocol Violation|5|||
156856825|NCT01342913|566230741|FG001|2-week Run-in Period|Protocol Violation|0|||
156856826|NCT01342913|566230742|FG002|2-week Run-in Period|Protocol Violation|0|||
156856827|NCT01342913|566230740|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
156856828|NCT01342913|566230741|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
156856829|NCT01342913|566230742|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
156856830|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156856831|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Adverse Event|3|||
156856832|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Adverse Event|6|||
156856833|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156856834|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
156856835|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
156856836|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156856837|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
156856838|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
156856839|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156856840|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
156856841|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
156856842|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Physician Decision|0|||
156856843|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Physician Decision|2|||
156856844|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Physician Decision|0|||
156856845|NCT01342913|566230740|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156856846|NCT01342913|566230741|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
156856847|NCT01342913|566230742|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
157025895|NCT02043678|566849636|FG000|Overall Study|Physician Decision|4|||
157025896|NCT02043678|566849637|FG001|Overall Study|Physician Decision|3|||
157025897|NCT02043678|566849636|FG000|Overall Study|Subject decision|0|||
157025898|NCT02043678|566849637|FG001|Overall Study|Subject decision|1|||
157025899|NCT02043678|566849636|FG000|Overall Study|Switching to other therapy|3|||
156856853|NCT04319198|566230748|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
156856854|NCT04319198|566230749|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
156856855|NCT04319198|566230750|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
156856856|NCT04319198|566230748|FG000|Overall Study|Death|0|||
156856857|NCT04319198|566230749|FG001|Overall Study|Death|3|||
156856858|NCT04319198|566230750|FG002|Overall Study|Death|3|||
156856859|NCT04319198|566230748|FG000|Overall Study|Reason Not Specified|0|||
156856860|NCT04319198|566230749|FG001|Overall Study|Reason Not Specified|2|||
156856861|NCT04319198|566230750|FG002|Overall Study|Reason Not Specified|4|||
156856862|NCT04319198|566230748|FG000|Overall Study|Withdrawal of Consent|0|||
157157747|NCT03249792|567322892|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156856863|NCT04319198|566230749|FG001|Overall Study|Withdrawal of Consent|0|||
156856864|NCT04319198|566230750|FG002|Overall Study|Withdrawal of Consent|5|||
156856865|NCT04319198|566230748|FG000|Overall Study|Site Terminated by Sponsor|0|||
156856866|NCT04319198|566230749|FG001|Overall Study|Site Terminated by Sponsor|1|||
156856867|NCT04319198|566230750|FG002|Overall Study|Site Terminated by Sponsor|0|||
156856868|NCT02123134|566230760|FG000|Overall Study|Withdrawal of consent|3|||
156856869|NCT02123134|566230761|FG001|Overall Study|Withdrawal of consent|2|||
156856870|NCT02123134|566230760|FG000|Overall Study|Administrative decision|0|||
156856871|NCT02123134|566230761|FG001|Overall Study|Administrative decision|1|||
157025900|NCT02043678|566849637|FG001|Overall Study|Switching to other therapy|2|||
156856872|NCT00962208|566230762|FG000|Overall Study|Could not achieve good vision|9|||
156890105|NCT04393298|566357090|FG002|Overall Study|Clinical Progression|0|||
156890106|NCT04393298|566357091|FG003|Overall Study|Clinical Progression|0|||
156890107|NCT04393298|566357092|FG004|Overall Study|Clinical Progression|0|||
156890108|NCT04393298|566357093|FG005|Overall Study|Clinical Progression|0|||
156890109|NCT04393298|566357094|FG006|Overall Study|Clinical Progression|0|||
156890110|NCT04393298|566357095|FG007|Overall Study|Clinical Progression|0|||
156890111|NCT04393298|566357096|FG008|Overall Study|Clinical Progression|0|||
156890112|NCT04393298|566357097|FG009|Overall Study|Clinical Progression|0|||
156890113|NCT04393298|566357098|FG010|Overall Study|Clinical Progression|0|||
156890114|NCT04393298|566357099|FG011|Overall Study|Clinical Progression|0|||
156890115|NCT04393298|566357100|FG012|Overall Study|Clinical Progression|0|||
156890116|NCT04393298|566357101|FG013|Overall Study|Clinical Progression|0|||
156890117|NCT04393298|566357102|FG014|Overall Study|Clinical Progression|0|||
156890118|NCT04393298|566357088|FG000|Overall Study|Disease Progression|0|||
156890119|NCT04393298|566357089|FG001|Overall Study|Disease Progression|1|||
156890120|NCT04393298|566357090|FG002|Overall Study|Disease Progression|0|||
156890121|NCT04393298|566357091|FG003|Overall Study|Disease Progression|0|||
156890122|NCT04393298|566357092|FG004|Overall Study|Disease Progression|0|||
156890123|NCT04393298|566357093|FG005|Overall Study|Disease Progression|3|||
156890124|NCT04393298|566357094|FG006|Overall Study|Disease Progression|2|||
156890125|NCT04393298|566357095|FG007|Overall Study|Disease Progression|1|||
156890126|NCT04393298|566357096|FG008|Overall Study|Disease Progression|2|||
156890127|NCT04393298|566357097|FG009|Overall Study|Disease Progression|1|||
156890128|NCT04393298|566357098|FG010|Overall Study|Disease Progression|0|||
156890129|NCT04393298|566357099|FG011|Overall Study|Disease Progression|3|||
156890130|NCT04393298|566357100|FG012|Overall Study|Disease Progression|0|||
156890131|NCT04393298|566357101|FG013|Overall Study|Disease Progression|0|||
156890132|NCT04393298|566357102|FG014|Overall Study|Disease Progression|1|||
156890133|NCT04393298|566357088|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890134|NCT04393298|566357089|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890135|NCT04393298|566357090|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
156890136|NCT04393298|566357091|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890137|NCT04393298|566357092|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890138|NCT04393298|566357093|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890139|NCT04393298|566357094|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890140|NCT04393298|566357095|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890141|NCT04393298|566357096|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890142|NCT04393298|566357097|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890143|NCT04393298|566357098|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890144|NCT04393298|566357099|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890145|NCT04393298|566357100|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890146|NCT04393298|566357101|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890147|NCT04393298|566357102|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
156890148|NCT04393298|566357088|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890149|NCT04393298|566357089|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890150|NCT04393298|566357090|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
156890151|NCT04393298|566357091|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890152|NCT04393298|566357092|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890153|NCT04393298|566357093|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890154|NCT04393298|566357094|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890155|NCT04393298|566357095|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890156|NCT04393298|566357096|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890157|NCT04393298|566357097|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890158|NCT04393298|566357098|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890159|NCT04393298|566357099|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890160|NCT04393298|566357100|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890161|NCT04393298|566357101|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890162|NCT04393298|566357102|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
156890163|NCT04393298|566357088|FG000|Overall Study|Progressive Disease (PD)|0|||
156890164|NCT04393298|566357089|FG001|Overall Study|Progressive Disease (PD)|0|||
157025901|NCT02043678|566849636|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
157025902|NCT02043678|566849637|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
157025903|NCT02043678|566849636|FG000|Overall Study|Missing|1|||
156890165|NCT04393298|566357090|FG002|Overall Study|Progressive Disease (PD)|0|||
156890166|NCT04393298|566357091|FG003|Overall Study|Progressive Disease (PD)|3|||
156890167|NCT04393298|566357092|FG004|Overall Study|Progressive Disease (PD)|0|||
156890168|NCT04393298|566357093|FG005|Overall Study|Progressive Disease (PD)|0|||
156890169|NCT04393298|566357094|FG006|Overall Study|Progressive Disease (PD)|0|||
156890170|NCT04393298|566357095|FG007|Overall Study|Progressive Disease (PD)|0|||
156890171|NCT04393298|566357096|FG008|Overall Study|Progressive Disease (PD)|0|||
156890172|NCT04393298|566357097|FG009|Overall Study|Progressive Disease (PD)|0|||
156890173|NCT04393298|566357098|FG010|Overall Study|Progressive Disease (PD)|0|||
156890174|NCT04393298|566357099|FG011|Overall Study|Progressive Disease (PD)|0|||
156890175|NCT04393298|566357100|FG012|Overall Study|Progressive Disease (PD)|0|||
156890176|NCT04393298|566357101|FG013|Overall Study|Progressive Disease (PD)|0|||
156890177|NCT04393298|566357102|FG014|Overall Study|Progressive Disease (PD)|0|||
156890178|NCT04393298|566357088|FG000|Overall Study|Started a New Cancer Treatment|0|||
156890179|NCT04393298|566357089|FG001|Overall Study|Started a New Cancer Treatment|0|||
156890180|NCT04393298|566357090|FG002|Overall Study|Started a New Cancer Treatment|0|||
156890181|NCT04393298|566357091|FG003|Overall Study|Started a New Cancer Treatment|0|||
156890182|NCT04393298|566357092|FG004|Overall Study|Started a New Cancer Treatment|1|||
156890183|NCT04393298|566357093|FG005|Overall Study|Started a New Cancer Treatment|0|||
156890184|NCT04393298|566357094|FG006|Overall Study|Started a New Cancer Treatment|0|||
156890185|NCT04393298|566357095|FG007|Overall Study|Started a New Cancer Treatment|0|||
156890186|NCT04393298|566357096|FG008|Overall Study|Started a New Cancer Treatment|0|||
156890187|NCT04393298|566357097|FG009|Overall Study|Started a New Cancer Treatment|0|||
156890188|NCT04393298|566357098|FG010|Overall Study|Started a New Cancer Treatment|0|||
156890189|NCT04393298|566357099|FG011|Overall Study|Started a New Cancer Treatment|0|||
156890190|NCT04393298|566357100|FG012|Overall Study|Started a New Cancer Treatment|0|||
156890191|NCT04393298|566357101|FG013|Overall Study|Started a New Cancer Treatment|0|||
156890192|NCT04393298|566357102|FG014|Overall Study|Started a New Cancer Treatment|0|||
156890193|NCT04393298|566357088|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890194|NCT04393298|566357089|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890195|NCT04393298|566357090|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890196|NCT04393298|566357091|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890197|NCT04393298|566357092|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
156890198|NCT04393298|566357093|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890199|NCT04393298|566357094|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890200|NCT04393298|566357095|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890201|NCT04393298|566357096|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890202|NCT04393298|566357097|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890203|NCT04393298|566357098|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890204|NCT04393298|566357099|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890205|NCT04393298|566357100|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890206|NCT04393298|566357101|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
156890207|NCT04393298|566357102|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
157225469|NCT01860976|567571436|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
157225470|NCT01860976|567571437|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
156856873|NCT00962208|566230763|FG001|Overall Study|Could not achieve good vision|0|||
156856874|NCT00962208|566230762|FG000|Overall Study|Contraindicated to continue study|5|||
156856875|NCT00962208|566230763|FG001|Overall Study|Contraindicated to continue study|1|||
156856876|NCT00962208|566230762|FG000|Overall Study|Lost to Follow-up|0|||
156856877|NCT00962208|566230763|FG001|Overall Study|Lost to Follow-up|9|||
156856878|NCT01731912|566230770|FG000|Overall Study|noncompliance|2|||
156856879|NCT00141453|566230771|FG000|Overall Study|Protocol Violation|6|||
156856880|NCT00141453|566230772|FG001|Overall Study|Protocol Violation|5|||
156856881|NCT02043938|566230773|FG000|Overall Study|Withdrawal by Subject|7|||
156856882|NCT02043938|566230773|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
156856883|NCT02043938|566230773|FG000|Overall Study|No show by subject|1|||
156856884|NCT02043938|566230773|FG000|Overall Study|Investigator decision|1|||
156856885|NCT03010527|566230776|FG000|Overall Study|Death|0|||
156856886|NCT03010527|566230777|FG001|Overall Study|Death|0|||
156856887|NCT03010527|566230778|FG002|Overall Study|Death|1|||
156890208|NCT04393298|566357088|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890209|NCT04393298|566357089|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890210|NCT04393298|566357090|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890211|NCT04393298|566357091|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890212|NCT04393298|566357092|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890213|NCT04393298|566357093|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
156890214|NCT04393298|566357094|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890215|NCT04393298|566357095|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890216|NCT04393298|566357096|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890217|NCT04393298|566357097|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890218|NCT04393298|566357098|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156856888|NCT03010527|566230776|FG000|Overall Study|Adverse Event|0|||
156890219|NCT04393298|566357099|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
157025904|NCT02043678|566849637|FG001|Overall Study|Missing|0|||
156856889|NCT03010527|566230777|FG001|Overall Study|Adverse Event|4|||
156856890|NCT03010527|566230778|FG002|Overall Study|Adverse Event|2|||
156890220|NCT04393298|566357100|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890221|NCT04393298|566357101|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890222|NCT04393298|566357102|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
156890223|NCT04393298|566357088|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890224|NCT04393298|566357089|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890225|NCT04393298|566357090|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890226|NCT04393298|566357091|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890227|NCT04393298|566357092|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890228|NCT04393298|566357093|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
156890229|NCT04393298|566357094|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890230|NCT04393298|566357095|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890231|NCT04393298|566357096|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890232|NCT04393298|566357097|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890233|NCT04393298|566357098|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890234|NCT04393298|566357099|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890235|NCT04393298|566357100|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890236|NCT04393298|566357101|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
156890237|NCT04393298|566357102|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
156890238|NCT04393298|566357088|FG000|Overall Study|Death|0|||
156890239|NCT04393298|566357089|FG001|Overall Study|Death|0|||
156890240|NCT04393298|566357090|FG002|Overall Study|Death|0|||
156890241|NCT04393298|566357091|FG003|Overall Study|Death|0|||
156890242|NCT04393298|566357092|FG004|Overall Study|Death|0|||
156890243|NCT04393298|566357093|FG005|Overall Study|Death|1|||
156890244|NCT04393298|566357094|FG006|Overall Study|Death|1|||
156890245|NCT04393298|566357095|FG007|Overall Study|Death|0|||
156890246|NCT04393298|566357096|FG008|Overall Study|Death|1|||
156890247|NCT04393298|566357097|FG009|Overall Study|Death|1|||
156890248|NCT04393298|566357098|FG010|Overall Study|Death|0|||
156890249|NCT04393298|566357099|FG011|Overall Study|Death|1|||
156890250|NCT04393298|566357100|FG012|Overall Study|Death|1|||
156890251|NCT04393298|566357101|FG013|Overall Study|Death|0|||
156890252|NCT04393298|566357102|FG014|Overall Study|Death|1|||
156890253|NCT04393298|566357088|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890254|NCT04393298|566357089|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890255|NCT04393298|566357090|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890256|NCT04393298|566357091|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890257|NCT04393298|566357092|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890258|NCT04393298|566357093|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
156890259|NCT04393298|566357094|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890260|NCT04393298|566357095|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890261|NCT04393298|566357096|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890262|NCT04393298|566357097|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890263|NCT04393298|566357098|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890264|NCT04393298|566357099|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890265|NCT04393298|566357100|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890266|NCT04393298|566357101|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890267|NCT04393298|566357102|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
156890268|NCT04393298|566357088|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
156890269|NCT04393298|566357089|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
156890270|NCT04393298|566357090|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
156890271|NCT04393298|566357091|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
156890272|NCT04393298|566357092|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
156890273|NCT04393298|566357093|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
156890274|NCT04393298|566357094|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
156890275|NCT04393298|566357095|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
156890276|NCT04393298|566357096|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
157157748|NCT03249792|567322893|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157749|NCT03249792|567322894|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157750|NCT03249792|567322895|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
157157751|NCT03249792|567322896|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
156890277|NCT04393298|566357097|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
156890278|NCT04393298|566357098|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
156890279|NCT04393298|566357099|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
156890280|NCT04393298|566357100|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
156890281|NCT04393298|566357101|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
157157752|NCT03249792|567322864|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
157157753|NCT03249792|567322865|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
157157754|NCT03249792|567322866|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
157157755|NCT03249792|567322867|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
157157756|NCT03249792|567322868|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
157157757|NCT03249792|567322869|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
157157758|NCT03249792|567322870|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
157157759|NCT03249792|567322871|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
157157760|NCT03249792|567322872|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
156890282|NCT04393298|566357102|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
156890283|NCT04393298|566357088|FG000|Overall Study|Patient Passed Away|0|||
156890284|NCT04393298|566357089|FG001|Overall Study|Patient Passed Away|0|||
156890285|NCT04393298|566357090|FG002|Overall Study|Patient Passed Away|0|||
156890286|NCT04393298|566357091|FG003|Overall Study|Patient Passed Away|0|||
156890287|NCT04393298|566357092|FG004|Overall Study|Patient Passed Away|0|||
156890288|NCT04393298|566357093|FG005|Overall Study|Patient Passed Away|0|||
156890289|NCT04393298|566357094|FG006|Overall Study|Patient Passed Away|0|||
156890290|NCT04393298|566357095|FG007|Overall Study|Patient Passed Away|1|||
156890291|NCT04393298|566357096|FG008|Overall Study|Patient Passed Away|0|||
156890292|NCT04393298|566357097|FG009|Overall Study|Patient Passed Away|0|||
156890293|NCT04393298|566357098|FG010|Overall Study|Patient Passed Away|0|||
156890294|NCT04393298|566357099|FG011|Overall Study|Patient Passed Away|0|||
156890295|NCT04393298|566357100|FG012|Overall Study|Patient Passed Away|0|||
156890296|NCT04393298|566357101|FG013|Overall Study|Patient Passed Away|0|||
156890297|NCT04393298|566357102|FG014|Overall Study|Patient Passed Away|0|||
156890298|NCT04393298|566357088|FG000|Overall Study|Patient Deceased|0|||
156890299|NCT04393298|566357089|FG001|Overall Study|Patient Deceased|0|||
156890300|NCT04393298|566357090|FG002|Overall Study|Patient Deceased|0|||
156890301|NCT04393298|566357091|FG003|Overall Study|Patient Deceased|0|||
156890302|NCT04393298|566357092|FG004|Overall Study|Patient Deceased|0|||
156890303|NCT04393298|566357093|FG005|Overall Study|Patient Deceased|0|||
156890304|NCT04393298|566357094|FG006|Overall Study|Patient Deceased|0|||
156890305|NCT04393298|566357095|FG007|Overall Study|Patient Deceased|1|||
156890306|NCT04393298|566357096|FG008|Overall Study|Patient Deceased|0|||
156890307|NCT04393298|566357097|FG009|Overall Study|Patient Deceased|0|||
156890308|NCT04393298|566357098|FG010|Overall Study|Patient Deceased|0|||
156890309|NCT04393298|566357099|FG011|Overall Study|Patient Deceased|0|||
156890310|NCT04393298|566357100|FG012|Overall Study|Patient Deceased|0|||
156890311|NCT04393298|566357101|FG013|Overall Study|Patient Deceased|0|||
156890312|NCT04393298|566357102|FG014|Overall Study|Patient Deceased|0|||
156890313|NCT04393298|566357088|FG000|Overall Study|Patient Discharged to Hospice|0|||
156890314|NCT04393298|566357089|FG001|Overall Study|Patient Discharged to Hospice|0|||
156890315|NCT04393298|566357090|FG002|Overall Study|Patient Discharged to Hospice|0|||
156890316|NCT04393298|566357091|FG003|Overall Study|Patient Discharged to Hospice|0|||
156890317|NCT04393298|566357092|FG004|Overall Study|Patient Discharged to Hospice|0|||
156890318|NCT04393298|566357093|FG005|Overall Study|Patient Discharged to Hospice|0|||
156890319|NCT04393298|566357094|FG006|Overall Study|Patient Discharged to Hospice|0|||
156890320|NCT04393298|566357095|FG007|Overall Study|Patient Discharged to Hospice|0|||
156890321|NCT04393298|566357096|FG008|Overall Study|Patient Discharged to Hospice|1|||
156890322|NCT04393298|566357097|FG009|Overall Study|Patient Discharged to Hospice|0|||
156890323|NCT04393298|566357098|FG010|Overall Study|Patient Discharged to Hospice|0|||
156890324|NCT04393298|566357099|FG011|Overall Study|Patient Discharged to Hospice|0|||
156890325|NCT04393298|566357100|FG012|Overall Study|Patient Discharged to Hospice|0|||
157025905|NCT02043678|566849636|FG000|Overall Study|Adverse Event|0|||
157157761|NCT03249792|567322873|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
157157762|NCT03249792|567322874|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
157157763|NCT03249792|567322875|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
157157764|NCT03249792|567322876|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
157157765|NCT03249792|567322877|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
157157766|NCT03249792|567322878|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
156890326|NCT04393298|566357101|FG013|Overall Study|Patient Discharged to Hospice|0|||
156890327|NCT04393298|566357102|FG014|Overall Study|Patient Discharged to Hospice|0|||
156890328|NCT04393298|566357088|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890329|NCT04393298|566357089|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890330|NCT04393298|566357090|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890331|NCT04393298|566357091|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890332|NCT04393298|566357092|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890333|NCT04393298|566357093|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890334|NCT04393298|566357094|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890335|NCT04393298|566357095|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890336|NCT04393298|566357096|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890337|NCT04393298|566357097|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
156890338|NCT04393298|566357098|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890339|NCT04393298|566357099|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
157157767|NCT03249792|567322879|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
157157768|NCT03249792|567322880|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
157157769|NCT03249792|567322881|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
157157770|NCT03249792|567322882|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
157157771|NCT03249792|567322883|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
157157772|NCT03249792|567322884|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
157157773|NCT03249792|567322885|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
157157774|NCT03249792|567322886|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
156856891|NCT03010527|566230776|FG000|Overall Study|Protocol Violation|0|||
156856892|NCT03010527|566230777|FG001|Overall Study|Protocol Violation|1|||
156856893|NCT03010527|566230778|FG002|Overall Study|Protocol Violation|0|||
156856894|NCT03010527|566230776|FG000|Overall Study|Lost to Follow-up|0|||
156856895|NCT03010527|566230777|FG001|Overall Study|Lost to Follow-up|2|||
156856896|NCT03010527|566230778|FG002|Overall Study|Lost to Follow-up|1|||
156856897|NCT03010527|566230776|FG000|Overall Study|Withdrawal by Subject|0|||
156856898|NCT03010527|566230777|FG001|Overall Study|Withdrawal by Subject|3|||
156856899|NCT03010527|566230778|FG002|Overall Study|Withdrawal by Subject|4|||
156856900|NCT03010527|566230776|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
156856901|NCT03010527|566230777|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
156856902|NCT03010527|566230778|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
156856903|NCT03010527|566230776|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
156856904|NCT03010527|566230777|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
156856905|NCT03010527|566230778|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
156856906|NCT03010527|566230776|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
156856907|NCT03010527|566230777|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
156856908|NCT03010527|566230778|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
156856909|NCT02656017|566230779|FG000|Overall Study|Study burden|3|||
156856910|NCT02656017|566230780|FG001|Overall Study|Study burden|3|||
156856911|NCT02656017|566230779|FG000|Overall Study|Adverse Event|2|||
156856912|NCT02656017|566230780|FG001|Overall Study|Adverse Event|1|||
156856913|NCT02656017|566230779|FG000|Overall Study|Unable/unwilling to take study medication|2|||
156856914|NCT02656017|566230780|FG001|Overall Study|Unable/unwilling to take study medication|1|||
156856915|NCT02656017|566230779|FG000|Overall Study|Began Tolvaptan|1|||
156856916|NCT02656017|566230780|FG001|Overall Study|Began Tolvaptan|1|||
156856917|NCT02656017|566230779|FG000|Overall Study|Withdrawal by Subject|1|||
156856918|NCT02656017|566230780|FG001|Overall Study|Withdrawal by Subject|0|||
156856919|NCT06039579|566230783|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856920|NCT06039579|566230784|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856921|NCT06039579|566230785|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856922|NCT06039579|566230786|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856923|NCT06039579|566230787|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856924|NCT06039579|566230788|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856925|NCT06039579|566230789|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
156856926|NCT06039579|566230790|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
156856927|NCT02792231|566230795|FG000|Overall Study|Patient/guardian decision|32|||
156856928|NCT02792231|566230796|FG001|Overall Study|Patient/guardian decision|42|||
156856929|NCT02792231|566230795|FG000|Overall Study|Adverse Event|15|||
156856930|NCT02792231|566230796|FG001|Overall Study|Adverse Event|11|||
156856931|NCT02792231|566230795|FG000|Overall Study|Physician Decision|14|||
156856932|NCT02792231|566230796|FG001|Overall Study|Physician Decision|12|||
156856933|NCT02792231|566230795|FG000|Overall Study|Lack of Efficacy|7|||
156856934|NCT02792231|566230796|FG001|Overall Study|Lack of Efficacy|9|||
156856935|NCT02792231|566230795|FG000|Overall Study|Lost to Follow-up|9|||
156856936|NCT02792231|566230796|FG001|Overall Study|Lost to Follow-up|5|||
156856937|NCT02792231|566230795|FG000|Overall Study|Pregnancy|1|||
156856938|NCT02792231|566230796|FG001|Overall Study|Pregnancy|3|||
156856939|NCT02792231|566230795|FG000|Overall Study|Non-compliance with study treatment|2|||
156856940|NCT02792231|566230796|FG001|Overall Study|Non-compliance with study treatment|1|||
156856941|NCT02792231|566230795|FG000|Overall Study|Protocol deviation|2|||
156856942|NCT02792231|566230796|FG001|Overall Study|Protocol deviation|0|||
156856943|NCT02792231|566230795|FG000|Overall Study|Technical problems|0|||
156856944|NCT02792231|566230796|FG001|Overall Study|Technical problems|1|||
156856945|NCT02469623|566230797|FG000|Overall Study|Not consented for long-term follow-up|4|||
156856946|NCT02469623|566230797|FG000|Overall Study|Lost to Follow-up|4|||
156856947|NCT02469623|566230797|FG000|Overall Study|Withdrawal by Subject|2|||
156856948|NCT02469623|566230797|FG000|Overall Study|Death|3|||
156856949|NCT04073186|566230798|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
156856950|NCT04073186|566230798|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
156856951|NCT04073186|566230798|FG000|First Wearing Cycle|Protocol Violation|1|||
156856952|NCT04073186|566230798|FG000|First Wearing Cycle|Lens Discomfort|2|||
156856953|NCT04073186|566230798|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
156856954|NCT04073186|566230798|FG000|Second Wearing Cycle|Adverse Event|1|||
156856955|NCT03309878|566230799|FG000|Overall Study|Adverse Event|1|||
156856956|NCT03309878|566230800|FG001|Overall Study|Adverse Event|0|||
157025906|NCT02043678|566849637|FG001|Overall Study|Adverse Event|1|||
156856957|NCT03309878|566230801|FG002|Overall Study|Adverse Event|0|||
156856958|NCT03309878|566230802|FG003|Overall Study|Adverse Event|0|||
156856959|NCT03309878|566230799|FG000|Overall Study|Did not maintain eligibility|2|||
157157775|NCT03249792|567322887|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
157025907|NCT02815566|566849640|FG000|Overall Study|Adverse Event|1|||
157025908|NCT02815566|566849641|FG001|Overall Study|Adverse Event|1|||
157157776|NCT03249792|567322888|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
157157777|NCT03249792|567322889|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
156890340|NCT04393298|566357100|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890341|NCT04393298|566357101|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890342|NCT04393298|566357102|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
156890343|NCT04393298|566357088|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
156890344|NCT04393298|566357089|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
156890345|NCT04393298|566357090|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
156890346|NCT04393298|566357091|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
156890347|NCT04393298|566357092|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
156890348|NCT04393298|566357093|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
156890349|NCT04393298|566357094|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
156890350|NCT04393298|566357095|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
156890351|NCT04393298|566357096|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
156890352|NCT04393298|566357097|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
156890353|NCT04393298|566357098|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
156890354|NCT04393298|566357099|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
156890355|NCT04393298|566357100|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
156890356|NCT04393298|566357101|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
156890357|NCT04393298|566357102|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
156890358|NCT03754972|566357105|FG000|Overall Study|Protocol Violation|25|||
156890359|NCT02311582|566357106|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156890360|NCT02311582|566357107|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156890361|NCT02311582|566357108|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
156890362|NCT02311582|566357109|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
156890363|NCT02311582|566357110|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
156890364|NCT06460493|566357111|FG000|Overall Study|Withdrawal by Subject|2|||
156890365|NCT03422627|566357112|FG000|Overall Study|Protocol-specified Criteria|1|||
156890366|NCT03422627|566357113|FG001|Overall Study|Protocol-specified Criteria|1|||
156890367|NCT03422627|566357114|FG002|Overall Study|Protocol-specified Criteria|0|||
156890368|NCT03422627|566357115|FG003|Overall Study|Protocol-specified Criteria|0|||
156890369|NCT03422627|566357116|FG004|Overall Study|Protocol-specified Criteria|2|||
156890370|NCT03422627|566357112|FG000|Overall Study|Requirement for Alternative Therapy|1|||
156890371|NCT03422627|566357113|FG001|Overall Study|Requirement for Alternative Therapy|1|||
156890372|NCT03422627|566357114|FG002|Overall Study|Requirement for Alternative Therapy|2|||
156890373|NCT03422627|566357115|FG003|Overall Study|Requirement for Alternative Therapy|0|||
156890374|NCT03422627|566357116|FG004|Overall Study|Requirement for Alternative Therapy|0|||
156890375|NCT03422627|566357112|FG000|Overall Study|Disease Progression|1|||
156890376|NCT03422627|566357113|FG001|Overall Study|Disease Progression|0|||
156890377|NCT03422627|566357114|FG002|Overall Study|Disease Progression|1|||
156890378|NCT03422627|566357115|FG003|Overall Study|Disease Progression|2|||
156890379|NCT03422627|566357116|FG004|Overall Study|Disease Progression|0|||
156890380|NCT03422627|566357112|FG000|Overall Study|Adverse Event|2|||
156890381|NCT03422627|566357113|FG001|Overall Study|Adverse Event|1|||
156890382|NCT03422627|566357114|FG002|Overall Study|Adverse Event|0|||
156890383|NCT03422627|566357115|FG003|Overall Study|Adverse Event|0|||
156890384|NCT03422627|566357116|FG004|Overall Study|Adverse Event|2|||
156890385|NCT03422627|566357112|FG000|Overall Study|Ineligibility Determined|0|||
156890386|NCT03422627|566357113|FG001|Overall Study|Ineligibility Determined|1|||
156890387|NCT03422627|566357114|FG002|Overall Study|Ineligibility Determined|0|||
156890388|NCT03422627|566357115|FG003|Overall Study|Ineligibility Determined|0|||
157157778|NCT03249792|567322890|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
157157779|NCT03249792|567322891|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
156890389|NCT03422627|566357116|FG004|Overall Study|Ineligibility Determined|0|||
156890390|NCT03422627|566357112|FG000|Overall Study|Death|0|||
156890391|NCT03422627|566357113|FG001|Overall Study|Death|1|||
156890392|NCT03422627|566357114|FG002|Overall Study|Death|1|||
157157780|NCT03249792|567322892|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
157157781|NCT03249792|567322893|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
156890393|NCT03422627|566357115|FG003|Overall Study|Death|0|||
156890394|NCT03422627|566357116|FG004|Overall Study|Death|0|||
156890395|NCT03422627|566357112|FG000|Overall Study|Withdrawal by Subject|0|||
156890396|NCT03422627|566357113|FG001|Overall Study|Withdrawal by Subject|0|||
156890397|NCT03422627|566357114|FG002|Overall Study|Withdrawal by Subject|0|||
156890398|NCT03422627|566357115|FG003|Overall Study|Withdrawal by Subject|1|||
156890399|NCT03422627|566357116|FG004|Overall Study|Withdrawal by Subject|0|||
156890400|NCT03675321|566357117|FG000|Overall Study|Lack of Efficacy|2|||
156890401|NCT03675321|566357118|FG001|Overall Study|Lack of Efficacy|2|||
156890402|NCT03675321|566357117|FG000|Overall Study|Withdrawal by Subject|1|||
157025909|NCT02815566|566849640|FG000|Overall Study|Withdrawal by Subject|1|||
157157782|NCT03249792|567322894|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
156890403|NCT03675321|566357118|FG001|Overall Study|Withdrawal by Subject|3|||
156890404|NCT00807027|566357119|FG000|Overall Study|Withdrawal by Subject|13|||
156890405|NCT00807027|566357120|FG001|Overall Study|Withdrawal by Subject|14|||
156890406|NCT00807027|566357119|FG000|Overall Study|Protocol Violation|1|||
156890407|NCT00807027|566357120|FG001|Overall Study|Protocol Violation|1|||
156890408|NCT00807027|566357119|FG000|Overall Study|Adverse Event|2|||
156890409|NCT00807027|566357120|FG001|Overall Study|Adverse Event|2|||
156890410|NCT03997383|566357121|FG000|Double-blind Treatment Period|Adverse Event|4|||
156890411|NCT03997383|566357122|FG001|Double-blind Treatment Period|Adverse Event|3|||
156890412|NCT03997383|566357121|FG000|Double-blind Treatment Period|Death|4|||
156890413|NCT03997383|566357122|FG001|Double-blind Treatment Period|Death|4|||
156890414|NCT03997383|566357121|FG000|Double-blind Treatment Period|Physician Decision|2|||
156890415|NCT03997383|566357122|FG001|Double-blind Treatment Period|Physician Decision|0|||
156890416|NCT03997383|566357121|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
156890417|NCT03997383|566357122|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
156890418|NCT03997383|566357121|FG000|Open-label Extension Period|Ongoing|148|||
156890419|NCT03997383|566357122|FG001|Open-label Extension Period|Ongoing|151|||
156890420|NCT03997383|566357121|FG000|Open-label Extension Period|Adverse Event|4|||
156890421|NCT03997383|566357122|FG001|Open-label Extension Period|Adverse Event|1|||
156890422|NCT03997383|566357121|FG000|Open-label Extension Period|Death|8|||
156890423|NCT03997383|566357122|FG001|Open-label Extension Period|Death|9|||
156890424|NCT03997383|566357121|FG000|Open-label Extension Period|Physician Decision|1|||
156890425|NCT03997383|566357122|FG001|Open-label Extension Period|Physician Decision|1|||
156890426|NCT03997383|566357121|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
156890427|NCT03997383|566357122|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
156890428|NCT03997383|566357121|FG000|Open-label Extension Period|Reason Not Specified|2|||
156890429|NCT03997383|566357122|FG001|Open-label Extension Period|Reason Not Specified|0|||
156890430|NCT02278341|566357123|FG000|Overall Study|Randomized but never received study drug|1|||
156890431|NCT02278341|566357124|FG001|Overall Study|Randomized but never received study drug|1|||
156890432|NCT02278341|566357123|FG000|Overall Study|Adverse Event|3|||
156890433|NCT02278341|566357124|FG001|Overall Study|Adverse Event|0|||
156890434|NCT02278341|566357123|FG000|Overall Study|Death|68|||
156890435|NCT02278341|566357124|FG001|Overall Study|Death|56|||
156890436|NCT02278341|566357123|FG000|Overall Study|Withdrawal by Subject|30|||
156890437|NCT02278341|566357124|FG001|Overall Study|Withdrawal by Subject|19|||
157025910|NCT02815566|566849641|FG001|Overall Study|Withdrawal by Subject|0|||
157025911|NCT02815566|566849640|FG000|Overall Study|Lost to Follow-up|0|||
157025912|NCT02815566|566849641|FG001|Overall Study|Lost to Follow-up|1|||
156890438|NCT02278341|566357123|FG000|Overall Study|Lost to Follow-up|0|||
156890439|NCT02278341|566357124|FG001|Overall Study|Lost to Follow-up|1|||
156890440|NCT02278341|566357123|FG000|Overall Study|Physician Decision|1|||
156890441|NCT02278341|566357124|FG001|Overall Study|Physician Decision|1|||
156890442|NCT02278341|566357123|FG000|Overall Study|Miscellaneous|15|||
156890443|NCT02278341|566357124|FG001|Overall Study|Miscellaneous|14|||
156890444|NCT04902326|566357127|FG000|Overall Study|Withdrawal by Subject|1|||
156890445|NCT04902326|566357128|FG001|Overall Study|Withdrawal by Subject|3|||
156890446|NCT04902326|566357129|FG002|Overall Study|Withdrawal by Subject|0|||
156890447|NCT04902326|566357130|FG003|Overall Study|Withdrawal by Subject|1|||
156890448|NCT04902326|566357127|FG000|Overall Study|Lost to Follow-up|14|||
156890449|NCT04902326|566357128|FG001|Overall Study|Lost to Follow-up|14|||
156890450|NCT04902326|566357129|FG002|Overall Study|Lost to Follow-up|14|||
156890451|NCT04902326|566357130|FG003|Overall Study|Lost to Follow-up|6|||
156890452|NCT01487577|566357131|FG000|Overall Study|Became ineligible after signing consent|1|||
156890453|NCT01653782|566357135|FG000|Overall Study|Withdrawal by Subject|9|||
156890454|NCT01653782|566357136|FG001|Overall Study|Withdrawal by Subject|15|||
156890455|NCT01653782|566357137|FG002|Overall Study|Withdrawal by Subject|4|||
156890456|NCT01653782|566357135|FG000|Overall Study|Lost to Follow-up|7|||
156890457|NCT01653782|566357136|FG001|Overall Study|Lost to Follow-up|3|||
156890458|NCT01653782|566357137|FG002|Overall Study|Lost to Follow-up|2|||
156890459|NCT01634178|566357141|FG000|Treatment Period 1|Adverse Event|0|||
157025913|NCT02861300|566849644|FG000|Overall Study|Death|0|||
157157783|NCT03249792|567322895|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
156890460|NCT01634178|566357142|FG001|Treatment Period 1|Adverse Event|1|||
156890461|NCT01634178|566357141|FG000|Treatment Period 2|Adverse Event|1|||
156890462|NCT01634178|566357142|FG001|Treatment Period 2|Adverse Event|0|||
156890463|NCT01903525|566357143|FG000|Overall Study|Lost to Follow-up|5|||
156890464|NCT01903525|566357144|FG001|Overall Study|Lost to Follow-up|9|||
156890465|NCT01903525|566357143|FG000|Overall Study|Adverse Event|0|||
156890466|NCT01903525|566357144|FG001|Overall Study|Adverse Event|1|||
156890467|NCT03977454|566357145|FG000|Overall Study|immediate postoperative revision|2|||
156890468|NCT03977454|566357146|FG001|Overall Study|immediate postoperative revision|2|||
156890469|NCT04365257|566357147|FG000|Overall Study|Physician Decision|1|||
157025914|NCT02861300|566849645|FG001|Overall Study|Death|0|||
157025915|NCT02861300|566849646|FG002|Overall Study|Death|0|||
157025916|NCT02861300|566849647|FG003|Overall Study|Death|0|||
157025917|NCT02861300|566849648|FG004|Overall Study|Death|0|||
157157784|NCT03249792|567322896|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
156856960|NCT03309878|566230800|FG001|Overall Study|Did not maintain eligibility|1|||
156856961|NCT03309878|566230801|FG002|Overall Study|Did not maintain eligibility|0|||
156856962|NCT03309878|566230802|FG003|Overall Study|Did not maintain eligibility|0|||
156856963|NCT03309878|566230799|FG000|Overall Study|Withdrawal by Subject|0|||
156856964|NCT03309878|566230800|FG001|Overall Study|Withdrawal by Subject|1|||
156856965|NCT03309878|566230801|FG002|Overall Study|Withdrawal by Subject|0|||
156856966|NCT03309878|566230802|FG003|Overall Study|Withdrawal by Subject|0|||
156856967|NCT01884077|566230803|FG000|Overall Study|screen fail|0|||
156856968|NCT01884077|566230804|FG001|Overall Study|screen fail|2|||
156856969|NCT01884077|566230803|FG000|Overall Study|canceled surgery|2|||
156856970|NCT01884077|566230804|FG001|Overall Study|canceled surgery|0|||
156856971|NCT01884077|566230803|FG000|Overall Study|Lost to Follow-up|0|||
156856972|NCT01884077|566230804|FG001|Overall Study|Lost to Follow-up|4|||
156856973|NCT01884077|566230803|FG000|Overall Study|study closed|6|||
156856974|NCT01884077|566230804|FG001|Overall Study|study closed|4|||
156856975|NCT00473434|566230805|FG000|Overall Study|Physician Decision|3|||
156856976|NCT00473434|566230805|FG000|Overall Study|Withdrawal by Subject|9|||
156856977|NCT00473434|566230805|FG000|Overall Study|Compliance|3|||
156856978|NCT00473434|566230805|FG000|Overall Study|Lack of Efficacy|3|||
156856979|NCT00473434|566230805|FG000|Overall Study|Adverse Event|3|||
156856980|NCT00473434|566230805|FG000|Overall Study|Patient was selling medication to others|1|||
156856981|NCT00473434|566230805|FG000|Overall Study|Safety evaluation|1|||
156856982|NCT00473434|566230805|FG000|Overall Study|Reason not specified|6|||
156856983|NCT00473434|566230805|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
156856984|NCT00473434|566230805|FG000|Overall Study|Switching to trial medication|1|||
156856985|NCT00473434|566230805|FG000|Overall Study|No longer required|1|||
156856986|NCT02836652|566230806|FG000|Overall Study|Death|3|||
156856987|NCT02836652|566230807|FG001|Overall Study|Death|3|||
156856988|NCT02836652|566230806|FG000|Overall Study|Transplant/Explant|3|||
156856989|NCT02836652|566230807|FG001|Overall Study|Transplant/Explant|4|||
156856990|NCT02836652|566230806|FG000|Overall Study|Withdrawn|9|||
156856991|NCT02836652|566230807|FG001|Overall Study|Withdrawn|9|||
156856992|NCT02836652|566230806|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
156856993|NCT02836652|566230807|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
156856994|NCT02349633|566230808|FG000|Overall Study|Death|0|||
156856995|NCT02349633|566230809|FG001|Overall Study|Death|1|||
156856996|NCT02349633|566230810|FG002|Overall Study|Death|0|||
156856997|NCT02349633|566230811|FG003|Overall Study|Death|0|||
156856998|NCT02349633|566230812|FG004|Overall Study|Death|0|||
156856999|NCT02349633|566230813|FG005|Overall Study|Death|1|||
156857000|NCT02349633|566230814|FG006|Overall Study|Death|1|||
156857001|NCT02349633|566230815|FG007|Overall Study|Death|1|||
156857002|NCT02349633|566230816|FG008|Overall Study|Death|0|||
156857003|NCT02349633|566230817|FG009|Overall Study|Death|1|||
156857004|NCT02349633|566230818|FG010|Overall Study|Death|0|||
156857005|NCT02349633|566230819|FG011|Overall Study|Death|0|||
156857006|NCT02349633|566230820|FG012|Overall Study|Death|0|||
156857007|NCT02349633|566230821|FG013|Overall Study|Death|0|||
156857008|NCT02349633|566230808|FG000|Overall Study|Withdrawal by Subject|0|||
156857009|NCT02349633|566230809|FG001|Overall Study|Withdrawal by Subject|0|||
156857010|NCT02349633|566230810|FG002|Overall Study|Withdrawal by Subject|0|||
156857011|NCT02349633|566230811|FG003|Overall Study|Withdrawal by Subject|1|||
156857012|NCT02349633|566230812|FG004|Overall Study|Withdrawal by Subject|0|||
156857013|NCT02349633|566230813|FG005|Overall Study|Withdrawal by Subject|0|||
156857014|NCT02349633|566230814|FG006|Overall Study|Withdrawal by Subject|0|||
156857015|NCT02349633|566230815|FG007|Overall Study|Withdrawal by Subject|2|||
156857016|NCT02349633|566230816|FG008|Overall Study|Withdrawal by Subject|2|||
156857017|NCT02349633|566230817|FG009|Overall Study|Withdrawal by Subject|1|||
156857018|NCT02349633|566230818|FG010|Overall Study|Withdrawal by Subject|0|||
156857019|NCT02349633|566230819|FG011|Overall Study|Withdrawal by Subject|0|||
156857020|NCT02349633|566230820|FG012|Overall Study|Withdrawal by Subject|0|||
156857021|NCT02349633|566230821|FG013|Overall Study|Withdrawal by Subject|0|||
156857022|NCT02349633|566230808|FG000|Overall Study|Withdrawal of informed consent|0|||
157025918|NCT02861300|566849649|FG005|Overall Study|Death|0|||
156857023|NCT02349633|566230809|FG001|Overall Study|Withdrawal of informed consent|0|||
156857024|NCT02349633|566230810|FG002|Overall Study|Withdrawal of informed consent|0|||
156857025|NCT02349633|566230811|FG003|Overall Study|Withdrawal of informed consent|1|||
156857026|NCT02349633|566230812|FG004|Overall Study|Withdrawal of informed consent|1|||
156857027|NCT02349633|566230813|FG005|Overall Study|Withdrawal of informed consent|0|||
156857028|NCT02349633|566230814|FG006|Overall Study|Withdrawal of informed consent|0|||
156857029|NCT02349633|566230815|FG007|Overall Study|Withdrawal of informed consent|3|||
156857030|NCT02349633|566230816|FG008|Overall Study|Withdrawal of informed consent|0|||
156857031|NCT02349633|566230817|FG009|Overall Study|Withdrawal of informed consent|0|||
156857032|NCT02349633|566230818|FG010|Overall Study|Withdrawal of informed consent|0|||
156857033|NCT02349633|566230819|FG011|Overall Study|Withdrawal of informed consent|0|||
156857034|NCT02349633|566230820|FG012|Overall Study|Withdrawal of informed consent|0|||
156857035|NCT02349633|566230821|FG013|Overall Study|Withdrawal of informed consent|0|||
157025919|NCT02861300|566849650|FG006|Overall Study|Death|24|||
156890470|NCT04365257|566357148|FG001|Overall Study|Physician Decision|0|||
156890471|NCT04365257|566357147|FG000|Overall Study|Patient Noncompliance|1|||
156890472|NCT04365257|566357148|FG001|Overall Study|Patient Noncompliance|0|||
156890473|NCT04365257|566357147|FG000|Overall Study|Withdrawal by Subject|0|||
156890474|NCT04365257|566357148|FG001|Overall Study|Withdrawal by Subject|1|||
156890475|NCT02129777|566357151|FG000|Double-Blind Period|Adverse Event|0|||
156890476|NCT02129777|566357152|FG001|Double-Blind Period|Adverse Event|0|||
156890477|NCT02129777|566357153|FG002|Double-Blind Period|Adverse Event|0|||
156890478|NCT02129777|566357154|FG003|Double-Blind Period|Adverse Event|0|||
156890479|NCT02129777|566357155|FG004|Double-Blind Period|Adverse Event|1|||
156890480|NCT02129777|566357156|FG005|Double-Blind Period|Adverse Event|0|||
156890481|NCT02129777|566357157|FG006|Double-Blind Period|Adverse Event|0|||
156890482|NCT02129777|566357151|FG000|Double-Blind Period|Lost to Follow-up|1|||
156890483|NCT02129777|566357152|FG001|Double-Blind Period|Lost to Follow-up|1|||
156890484|NCT02129777|566357153|FG002|Double-Blind Period|Lost to Follow-up|1|||
156890485|NCT02129777|566357154|FG003|Double-Blind Period|Lost to Follow-up|2|||
156890486|NCT02129777|566357155|FG004|Double-Blind Period|Lost to Follow-up|0|||
156890487|NCT02129777|566357156|FG005|Double-Blind Period|Lost to Follow-up|0|||
156890488|NCT02129777|566357157|FG006|Double-Blind Period|Lost to Follow-up|0|||
156890489|NCT02129777|566357151|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156890490|NCT02129777|566357152|FG001|Double-Blind Period|Withdrawal by Subject|4|||
156890491|NCT02129777|566357153|FG002|Double-Blind Period|Withdrawal by Subject|3|||
156890492|NCT02129777|566357154|FG003|Double-Blind Period|Withdrawal by Subject|2|||
156890493|NCT02129777|566357155|FG004|Double-Blind Period|Withdrawal by Subject|3|||
156890494|NCT02129777|566357156|FG005|Double-Blind Period|Withdrawal by Subject|0|||
156890495|NCT02129777|566357157|FG006|Double-Blind Period|Withdrawal by Subject|0|||
156890496|NCT02129777|566357151|FG000|Double-Blind Period|Pregnancy|0|||
156890497|NCT02129777|566357152|FG001|Double-Blind Period|Pregnancy|0|||
156890498|NCT02129777|566357153|FG002|Double-Blind Period|Pregnancy|0|||
156890499|NCT02129777|566357154|FG003|Double-Blind Period|Pregnancy|0|||
156890500|NCT02129777|566357155|FG004|Double-Blind Period|Pregnancy|1|||
156890501|NCT02129777|566357156|FG005|Double-Blind Period|Pregnancy|0|||
156890502|NCT02129777|566357157|FG006|Double-Blind Period|Pregnancy|0|||
156890503|NCT02129777|566357151|FG000|Double-Blind Period|Lack of Efficacy|3|||
156890504|NCT02129777|566357152|FG001|Double-Blind Period|Lack of Efficacy|1|||
156890505|NCT02129777|566357153|FG002|Double-Blind Period|Lack of Efficacy|0|||
156890506|NCT02129777|566357154|FG003|Double-Blind Period|Lack of Efficacy|3|||
156890507|NCT02129777|566357155|FG004|Double-Blind Period|Lack of Efficacy|2|||
156890508|NCT02129777|566357156|FG005|Double-Blind Period|Lack of Efficacy|0|||
156890509|NCT02129777|566357157|FG006|Double-Blind Period|Lack of Efficacy|0|||
156890510|NCT02129777|566357151|FG000|Double-Blind Period|Other|1|||
156890511|NCT02129777|566357152|FG001|Double-Blind Period|Other|2|||
156890512|NCT02129777|566357153|FG002|Double-Blind Period|Other|0|||
156890513|NCT02129777|566357154|FG003|Double-Blind Period|Other|0|||
156890514|NCT02129777|566357155|FG004|Double-Blind Period|Other|0|||
156890515|NCT02129777|566357156|FG005|Double-Blind Period|Other|0|||
156890516|NCT02129777|566357157|FG006|Double-Blind Period|Other|0|||
156890517|NCT02129777|566357151|FG000|Open-Label Period|Lack of Efficacy|0|||
156890518|NCT02129777|566357152|FG001|Open-Label Period|Lack of Efficacy|0|||
156890519|NCT02129777|566357153|FG002|Open-Label Period|Lack of Efficacy|0|||
156890520|NCT02129777|566357154|FG003|Open-Label Period|Lack of Efficacy|0|||
156890521|NCT02129777|566357155|FG004|Open-Label Period|Lack of Efficacy|0|||
156890522|NCT02129777|566357156|FG005|Open-Label Period|Lack of Efficacy|0|||
156890523|NCT02129777|566357157|FG006|Open-Label Period|Lack of Efficacy|5|||
156890524|NCT02129777|566357151|FG000|Open-Label Period|Lost to Follow-up|0|||
156890525|NCT02129777|566357152|FG001|Open-Label Period|Lost to Follow-up|0|||
156890526|NCT02129777|566357153|FG002|Open-Label Period|Lost to Follow-up|0|||
156890527|NCT02129777|566357154|FG003|Open-Label Period|Lost to Follow-up|0|||
156890528|NCT02129777|566357155|FG004|Open-Label Period|Lost to Follow-up|0|||
156890529|NCT02129777|566357156|FG005|Open-Label Period|Lost to Follow-up|1|||
156890530|NCT02129777|566357157|FG006|Open-Label Period|Lost to Follow-up|1|||
156890531|NCT02129777|566357151|FG000|Open-Label Period|Withdrawal by Subject|0|||
156890532|NCT02129777|566357152|FG001|Open-Label Period|Withdrawal by Subject|0|||
157157785|NCT03249792|567322864|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157786|NCT03249792|567322865|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157787|NCT03249792|567322866|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157788|NCT03249792|567322867|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
156890533|NCT02129777|566357153|FG002|Open-Label Period|Withdrawal by Subject|0|||
156890534|NCT02129777|566357154|FG003|Open-Label Period|Withdrawal by Subject|0|||
156890535|NCT02129777|566357155|FG004|Open-Label Period|Withdrawal by Subject|0|||
156890536|NCT02129777|566357156|FG005|Open-Label Period|Withdrawal by Subject|1|||
156890537|NCT02129777|566357157|FG006|Open-Label Period|Withdrawal by Subject|3|||
156890538|NCT02129777|566357151|FG000|Open-Label Period|Study Termination|0|||
156890539|NCT02129777|566357152|FG001|Open-Label Period|Study Termination|0|||
156890540|NCT02129777|566357153|FG002|Open-Label Period|Study Termination|0|||
156890541|NCT02129777|566357154|FG003|Open-Label Period|Study Termination|0|||
156890542|NCT02129777|566357155|FG004|Open-Label Period|Study Termination|0|||
156890543|NCT02129777|566357156|FG005|Open-Label Period|Study Termination|10|||
156890544|NCT02129777|566357157|FG006|Open-Label Period|Study Termination|39|||
156890545|NCT01609478|566357158|FG000|Overall Study|Adverse Event|3|||
156890546|NCT01609478|566357159|FG001|Overall Study|Adverse Event|1|||
156890547|NCT01609478|566357160|FG002|Overall Study|Adverse Event|5|||
156890548|NCT01609478|566357158|FG000|Overall Study|Protocol Deviation|0|||
156890549|NCT01609478|566357159|FG001|Overall Study|Protocol Deviation|1|||
156890550|NCT01609478|566357160|FG002|Overall Study|Protocol Deviation|1|||
156890551|NCT01609478|566357158|FG000|Overall Study|Non-Compliance with study treatment|1|||
156890552|NCT01609478|566357159|FG001|Overall Study|Non-Compliance with study treatment|0|||
156890553|NCT01609478|566357160|FG002|Overall Study|Non-Compliance with study treatment|0|||
156890554|NCT01609478|566357158|FG000|Overall Study|Physician Decision|1|||
156890555|NCT01609478|566357159|FG001|Overall Study|Physician Decision|0|||
156890556|NCT01609478|566357160|FG002|Overall Study|Physician Decision|1|||
156890557|NCT01609478|566357158|FG000|Overall Study|Withdrawal by Subject|2|||
156890558|NCT01609478|566357159|FG001|Overall Study|Withdrawal by Subject|0|||
156890559|NCT01609478|566357160|FG002|Overall Study|Withdrawal by Subject|2|||
156890560|NCT01470989|566357180|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
156890561|NCT01470989|566357181|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
156890562|NCT01470989|566357180|FG000|Overall Study|Adverse Event|2|||
156890563|NCT01470989|566357181|FG001|Overall Study|Adverse Event|5|||
156890564|NCT01470989|566357180|FG000|Overall Study|Abnormal laboratory value|1|||
156890565|NCT01470989|566357181|FG001|Overall Study|Abnormal laboratory value|1|||
156890566|NCT01470989|566357180|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156890567|NCT01470989|566357181|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
156890568|NCT01470989|566357180|FG000|Overall Study|Withdrawal by Subject|19|||
156890569|NCT01470989|566357181|FG001|Overall Study|Withdrawal by Subject|17|||
156890570|NCT01470989|566357180|FG000|Overall Study|Lost to Follow-up|18|||
156890571|NCT01470989|566357181|FG001|Overall Study|Lost to Follow-up|13|||
156890572|NCT01470989|566357180|FG000|Overall Study|Administrative problems|2|||
156890573|NCT01470989|566357181|FG001|Overall Study|Administrative problems|4|||
156890574|NCT01470989|566357180|FG000|Overall Study|Death|2|||
156890575|NCT01470989|566357181|FG001|Overall Study|Death|2|||
156890576|NCT01470989|566357180|FG000|Overall Study|Protocol deviation|1|||
156890577|NCT01470989|566357181|FG001|Overall Study|Protocol deviation|2|||
156890578|NCT01233687|566357182|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
156890579|NCT01233687|566357182|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
156890580|NCT01233687|566357182|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
156890581|NCT02197234|566357185|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
156890582|NCT02197234|566357185|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
156890583|NCT02197234|566357185|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
156890584|NCT02197234|566357185|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
156890585|NCT02197234|566357185|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
156890586|NCT02197234|566357185|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
156890587|NCT00219544|566357186|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
156890588|NCT00219544|566357187|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
156890589|NCT00219544|566357186|FG000|Single Blind Treatment Period|Adverse Event|9|||
156890590|NCT00219544|566357187|FG001|Single Blind Treatment Period|Adverse Event|0|||
156890591|NCT00219544|566357186|FG000|Single Blind Treatment Period|Protocol Violation|4|||
156890592|NCT00219544|566357187|FG001|Single Blind Treatment Period|Protocol Violation|0|||
156890593|NCT00219544|566357186|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
156890594|NCT00219544|566357187|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
156890595|NCT00219544|566357186|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
156890596|NCT00219544|566357187|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
156890597|NCT00219544|566357186|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
156890598|NCT00219544|566357187|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
156890599|NCT01445886|566357188|FG000|Overall Study|Lost to Follow-up|2|||
156890600|NCT01445886|566357188|FG000|Overall Study|Protocol Violation|3|||
156890601|NCT02751931|566357189|FG000|Overall Study|Adverse Event|3|||
156890602|NCT02751931|566357190|FG001|Overall Study|Adverse Event|0|||
156890603|NCT02751931|566357189|FG000|Overall Study|Other: Miscelleneous|10|||
156890604|NCT02751931|566357190|FG001|Overall Study|Other: Miscelleneous|8|||
156890605|NCT04090411|566357192|FG000|Induction Period|Adverse Event|3|||
156890606|NCT04090411|566357193|FG001|Induction Period|Adverse Event|1|||
156890607|NCT04090411|566357194|FG002|Induction Period|Adverse Event|1|||
156890608|NCT04090411|566357195|FG003|Induction Period|Adverse Event|1|||
156890609|NCT04090411|566357196|FG004|Induction Period|Adverse Event|0|||
156890610|NCT04090411|566357197|FG005|Induction Period|Adverse Event|0|||
156890611|NCT04090411|566357198|FG006|Induction Period|Adverse Event|0|||
156890612|NCT04090411|566357199|FG007|Induction Period|Adverse Event|0|||
156890613|NCT04090411|566357200|FG008|Induction Period|Adverse Event|0|||
156890614|NCT04090411|566357201|FG009|Induction Period|Adverse Event|0|||
156890615|NCT04090411|566357202|FG010|Induction Period|Adverse Event|0|||
156890616|NCT04090411|566357203|FG011|Induction Period|Adverse Event|0|||
157025920|NCT02861300|566849644|FG000|Overall Study|Delay in treatment|0|||
157025921|NCT02861300|566849645|FG001|Overall Study|Delay in treatment|0|||
157025922|NCT02861300|566849646|FG002|Overall Study|Delay in treatment|0|||
157025923|NCT02861300|566849647|FG003|Overall Study|Delay in treatment|0|||
156857036|NCT02349633|566230808|FG000|Overall Study|Transition to compassionate use|0|||
156857037|NCT02349633|566230809|FG001|Overall Study|Transition to compassionate use|0|||
156857038|NCT02349633|566230810|FG002|Overall Study|Transition to compassionate use|0|||
156857039|NCT02349633|566230811|FG003|Overall Study|Transition to compassionate use|0|||
156857040|NCT02349633|566230812|FG004|Overall Study|Transition to compassionate use|1|||
156857041|NCT02349633|566230813|FG005|Overall Study|Transition to compassionate use|0|||
156857042|NCT02349633|566230814|FG006|Overall Study|Transition to compassionate use|0|||
156857043|NCT02349633|566230815|FG007|Overall Study|Transition to compassionate use|3|||
156857044|NCT02349633|566230816|FG008|Overall Study|Transition to compassionate use|0|||
156857045|NCT02349633|566230817|FG009|Overall Study|Transition to compassionate use|1|||
156857046|NCT02349633|566230818|FG010|Overall Study|Transition to compassionate use|0|||
156857047|NCT02349633|566230819|FG011|Overall Study|Transition to compassionate use|0|||
156857048|NCT02349633|566230820|FG012|Overall Study|Transition to compassionate use|0|||
156857049|NCT02349633|566230821|FG013|Overall Study|Transition to compassionate use|0|||
156857050|NCT02349633|566230808|FG000|Overall Study|Early termination of survival follow-up|0|||
156857051|NCT02349633|566230809|FG001|Overall Study|Early termination of survival follow-up|0|||
156857052|NCT02349633|566230810|FG002|Overall Study|Early termination of survival follow-up|0|||
156857053|NCT02349633|566230811|FG003|Overall Study|Early termination of survival follow-up|0|||
156857054|NCT02349633|566230812|FG004|Overall Study|Early termination of survival follow-up|0|||
156857055|NCT02349633|566230813|FG005|Overall Study|Early termination of survival follow-up|0|||
156857056|NCT02349633|566230814|FG006|Overall Study|Early termination of survival follow-up|0|||
156857057|NCT02349633|566230815|FG007|Overall Study|Early termination of survival follow-up|4|||
156857058|NCT02349633|566230816|FG008|Overall Study|Early termination of survival follow-up|0|||
156857059|NCT02349633|566230817|FG009|Overall Study|Early termination of survival follow-up|0|||
156857060|NCT02349633|566230818|FG010|Overall Study|Early termination of survival follow-up|0|||
156857061|NCT02349633|566230819|FG011|Overall Study|Early termination of survival follow-up|0|||
156857062|NCT02349633|566230820|FG012|Overall Study|Early termination of survival follow-up|0|||
156857063|NCT02349633|566230821|FG013|Overall Study|Early termination of survival follow-up|0|||
156857064|NCT02349633|566230808|FG000|Overall Study|Termination by sponsor|0|||
156857065|NCT02349633|566230809|FG001|Overall Study|Termination by sponsor|0|||
156857066|NCT02349633|566230810|FG002|Overall Study|Termination by sponsor|0|||
156857067|NCT02349633|566230811|FG003|Overall Study|Termination by sponsor|0|||
156857068|NCT02349633|566230812|FG004|Overall Study|Termination by sponsor|0|||
156857069|NCT02349633|566230813|FG005|Overall Study|Termination by sponsor|0|||
156857070|NCT02349633|566230814|FG006|Overall Study|Termination by sponsor|0|||
156857071|NCT02349633|566230815|FG007|Overall Study|Termination by sponsor|1|||
156857072|NCT02349633|566230816|FG008|Overall Study|Termination by sponsor|0|||
156857073|NCT02349633|566230817|FG009|Overall Study|Termination by sponsor|2|||
156857074|NCT02349633|566230818|FG010|Overall Study|Termination by sponsor|0|||
156857075|NCT02349633|566230819|FG011|Overall Study|Termination by sponsor|0|||
156857076|NCT02349633|566230820|FG012|Overall Study|Termination by sponsor|0|||
156857077|NCT02349633|566230821|FG013|Overall Study|Termination by sponsor|0|||
156857078|NCT02349633|566230808|FG000|Overall Study|Other|0|||
156857079|NCT02349633|566230809|FG001|Overall Study|Other|0|||
156857080|NCT02349633|566230810|FG002|Overall Study|Other|0|||
156857081|NCT02349633|566230811|FG003|Overall Study|Other|0|||
156857082|NCT02349633|566230812|FG004|Overall Study|Other|0|||
156857083|NCT02349633|566230813|FG005|Overall Study|Other|0|||
156857084|NCT02349633|566230814|FG006|Overall Study|Other|0|||
156857085|NCT02349633|566230815|FG007|Overall Study|Other|2|||
156857086|NCT02349633|566230816|FG008|Overall Study|Other|0|||
156857087|NCT02349633|566230817|FG009|Overall Study|Other|0|||
156857088|NCT02349633|566230818|FG010|Overall Study|Other|0|||
156857089|NCT02349633|566230819|FG011|Overall Study|Other|0|||
156857090|NCT02349633|566230820|FG012|Overall Study|Other|0|||
156857091|NCT02349633|566230821|FG013|Overall Study|Other|0|||
156857092|NCT01008943|566230827|FG000|Overall Study|Withdrawal by Subject|1|||
156857093|NCT00861705|566230828|FG000|Overall Study|Never Began Treatment|7|||
156857094|NCT00861705|566230829|FG001|Overall Study|Never Began Treatment|3|||
157025924|NCT02861300|566849648|FG004|Overall Study|Delay in treatment|0|||
156857095|NCT00861705|566230830|FG002|Overall Study|Never Began Treatment|0|||
156857096|NCT00861705|566230831|FG003|Overall Study|Never Began Treatment|1|||
156857097|NCT05789745|566230832|FG000|Overall Study|Withdrawal by Subject|0|||
156857098|NCT05789745|566230833|FG001|Overall Study|Withdrawal by Subject|0|||
156857099|NCT05789745|566230834|FG002|Overall Study|Withdrawal by Subject|0|||
156857100|NCT05789745|566230835|FG003|Overall Study|Withdrawal by Subject|0|||
157025925|NCT02861300|566849649|FG005|Overall Study|Delay in treatment|1|||
156857101|NCT05789745|566230836|FG004|Overall Study|Withdrawal by Subject|1|||
157025926|NCT02861300|566849650|FG006|Overall Study|Delay in treatment|0|||
156857102|NCT04663321|566230837|FG000|Overall Study|Study terminated by Sponsor|2|||
157025927|NCT02861300|566849644|FG000|Overall Study|Disease Progression|0|||
156890617|NCT04090411|566357204|FG012|Induction Period|Adverse Event|0|||
156890618|NCT04090411|566357192|FG000|Induction Period|Lack of Efficacy|0|||
156890619|NCT04090411|566357193|FG001|Induction Period|Lack of Efficacy|0|||
156890620|NCT04090411|566357194|FG002|Induction Period|Lack of Efficacy|1|||
156890621|NCT04090411|566357195|FG003|Induction Period|Lack of Efficacy|1|||
156890622|NCT04090411|566357196|FG004|Induction Period|Lack of Efficacy|0|||
156890623|NCT04090411|566357197|FG005|Induction Period|Lack of Efficacy|0|||
156890624|NCT04090411|566357198|FG006|Induction Period|Lack of Efficacy|0|||
156890625|NCT04090411|566357199|FG007|Induction Period|Lack of Efficacy|0|||
156890626|NCT04090411|566357200|FG008|Induction Period|Lack of Efficacy|0|||
156890627|NCT04090411|566357201|FG009|Induction Period|Lack of Efficacy|0|||
156890628|NCT04090411|566357202|FG010|Induction Period|Lack of Efficacy|0|||
156890629|NCT04090411|566357203|FG011|Induction Period|Lack of Efficacy|0|||
156890630|NCT04090411|566357204|FG012|Induction Period|Lack of Efficacy|0|||
156890631|NCT04090411|566357192|FG000|Induction Period|Physician Decision|0|||
156890632|NCT04090411|566357193|FG001|Induction Period|Physician Decision|0|||
156890633|NCT04090411|566357194|FG002|Induction Period|Physician Decision|1|||
156890634|NCT04090411|566357195|FG003|Induction Period|Physician Decision|0|||
156890635|NCT04090411|566357196|FG004|Induction Period|Physician Decision|0|||
156890636|NCT04090411|566357197|FG005|Induction Period|Physician Decision|0|||
156890637|NCT04090411|566357198|FG006|Induction Period|Physician Decision|0|||
156890638|NCT04090411|566357199|FG007|Induction Period|Physician Decision|0|||
156890639|NCT04090411|566357200|FG008|Induction Period|Physician Decision|0|||
156890640|NCT04090411|566357201|FG009|Induction Period|Physician Decision|0|||
156890641|NCT04090411|566357202|FG010|Induction Period|Physician Decision|0|||
156890642|NCT04090411|566357203|FG011|Induction Period|Physician Decision|0|||
156890643|NCT04090411|566357204|FG012|Induction Period|Physician Decision|0|||
156890644|NCT04090411|566357192|FG000|Induction Period|Protocol Violation|0|||
156890645|NCT04090411|566357193|FG001|Induction Period|Protocol Violation|0|||
156890646|NCT04090411|566357194|FG002|Induction Period|Protocol Violation|0|||
156890647|NCT04090411|566357195|FG003|Induction Period|Protocol Violation|1|||
156890648|NCT04090411|566357196|FG004|Induction Period|Protocol Violation|0|||
156890649|NCT04090411|566357197|FG005|Induction Period|Protocol Violation|0|||
156890650|NCT04090411|566357198|FG006|Induction Period|Protocol Violation|0|||
156890651|NCT04090411|566357199|FG007|Induction Period|Protocol Violation|0|||
156890652|NCT04090411|566357200|FG008|Induction Period|Protocol Violation|0|||
156890653|NCT04090411|566357201|FG009|Induction Period|Protocol Violation|0|||
156890654|NCT04090411|566357202|FG010|Induction Period|Protocol Violation|0|||
156890655|NCT04090411|566357203|FG011|Induction Period|Protocol Violation|0|||
156890656|NCT04090411|566357204|FG012|Induction Period|Protocol Violation|0|||
156890657|NCT04090411|566357192|FG000|Induction Period|Withdrawal by Subject|2|||
156890658|NCT04090411|566357193|FG001|Induction Period|Withdrawal by Subject|0|||
156890659|NCT04090411|566357194|FG002|Induction Period|Withdrawal by Subject|1|||
156890660|NCT04090411|566357195|FG003|Induction Period|Withdrawal by Subject|5|||
156890661|NCT04090411|566357196|FG004|Induction Period|Withdrawal by Subject|0|||
156890662|NCT04090411|566357197|FG005|Induction Period|Withdrawal by Subject|0|||
156890663|NCT04090411|566357198|FG006|Induction Period|Withdrawal by Subject|0|||
156890664|NCT04090411|566357199|FG007|Induction Period|Withdrawal by Subject|0|||
156890665|NCT04090411|566357200|FG008|Induction Period|Withdrawal by Subject|0|||
156890666|NCT04090411|566357201|FG009|Induction Period|Withdrawal by Subject|0|||
156890667|NCT04090411|566357202|FG010|Induction Period|Withdrawal by Subject|0|||
156890668|NCT04090411|566357203|FG011|Induction Period|Withdrawal by Subject|0|||
156890669|NCT04090411|566357204|FG012|Induction Period|Withdrawal by Subject|0|||
156890670|NCT04090411|566357192|FG000|Chronic Period|Adverse Event|0|||
156890671|NCT04090411|566357193|FG001|Chronic Period|Adverse Event|0|||
156890672|NCT04090411|566357194|FG002|Chronic Period|Adverse Event|0|||
156890673|NCT04090411|566357195|FG003|Chronic Period|Adverse Event|0|||
156890674|NCT04090411|566357196|FG004|Chronic Period|Adverse Event|0|||
156890675|NCT04090411|566357197|FG005|Chronic Period|Adverse Event|1|||
156890676|NCT04090411|566357198|FG006|Chronic Period|Adverse Event|0|||
156890677|NCT04090411|566357199|FG007|Chronic Period|Adverse Event|3|||
156890678|NCT04090411|566357200|FG008|Chronic Period|Adverse Event|0|||
156890679|NCT04090411|566357201|FG009|Chronic Period|Adverse Event|0|||
156890680|NCT04090411|566357202|FG010|Chronic Period|Adverse Event|5|||
156890681|NCT04090411|566357203|FG011|Chronic Period|Adverse Event|1|||
156890682|NCT04090411|566357204|FG012|Chronic Period|Adverse Event|1|||
156890683|NCT04090411|566357192|FG000|Chronic Period|Lack of Efficacy|0|||
156890684|NCT04090411|566357193|FG001|Chronic Period|Lack of Efficacy|0|||
156890685|NCT04090411|566357194|FG002|Chronic Period|Lack of Efficacy|0|||
156890686|NCT04090411|566357195|FG003|Chronic Period|Lack of Efficacy|0|||
157225471|NCT01860976|567571436|FG000|Long Term Extension|Lost to Follow-up|2|||
157225472|NCT01860976|567571437|FG001|Long Term Extension|Lost to Follow-up|0|||
156890687|NCT04090411|566357196|FG004|Chronic Period|Lack of Efficacy|0|||
156890688|NCT04090411|566357197|FG005|Chronic Period|Lack of Efficacy|0|||
156890689|NCT04090411|566357198|FG006|Chronic Period|Lack of Efficacy|1|||
156890690|NCT04090411|566357199|FG007|Chronic Period|Lack of Efficacy|4|||
156890691|NCT04090411|566357200|FG008|Chronic Period|Lack of Efficacy|2|||
156890692|NCT04090411|566357201|FG009|Chronic Period|Lack of Efficacy|2|||
156890693|NCT04090411|566357202|FG010|Chronic Period|Lack of Efficacy|2|||
156890694|NCT04090411|566357203|FG011|Chronic Period|Lack of Efficacy|1|||
156890695|NCT04090411|566357204|FG012|Chronic Period|Lack of Efficacy|2|||
156890696|NCT04090411|566357192|FG000|Chronic Period|Relocation|0|||
156890697|NCT04090411|566357193|FG001|Chronic Period|Relocation|0|||
156890698|NCT04090411|566357194|FG002|Chronic Period|Relocation|0|||
156890699|NCT04090411|566357195|FG003|Chronic Period|Relocation|0|||
156890700|NCT04090411|566357196|FG004|Chronic Period|Relocation|0|||
156890701|NCT04090411|566357197|FG005|Chronic Period|Relocation|0|||
156890702|NCT04090411|566357198|FG006|Chronic Period|Relocation|0|||
156890703|NCT04090411|566357199|FG007|Chronic Period|Relocation|1|||
156890704|NCT04090411|566357200|FG008|Chronic Period|Relocation|0|||
156890705|NCT04090411|566357201|FG009|Chronic Period|Relocation|0|||
156890706|NCT04090411|566357202|FG010|Chronic Period|Relocation|0|||
156890707|NCT04090411|566357203|FG011|Chronic Period|Relocation|0|||
156890708|NCT04090411|566357204|FG012|Chronic Period|Relocation|0|||
156890709|NCT04090411|566357192|FG000|Chronic Period|Physician Decision|0|||
156890710|NCT04090411|566357193|FG001|Chronic Period|Physician Decision|0|||
156890711|NCT04090411|566357194|FG002|Chronic Period|Physician Decision|0|||
156890712|NCT04090411|566357195|FG003|Chronic Period|Physician Decision|0|||
156890713|NCT04090411|566357196|FG004|Chronic Period|Physician Decision|1|||
156890714|NCT04090411|566357197|FG005|Chronic Period|Physician Decision|0|||
156890715|NCT04090411|566357198|FG006|Chronic Period|Physician Decision|0|||
156890716|NCT04090411|566357199|FG007|Chronic Period|Physician Decision|1|||
156890717|NCT04090411|566357200|FG008|Chronic Period|Physician Decision|0|||
156890718|NCT04090411|566357201|FG009|Chronic Period|Physician Decision|0|||
156890719|NCT04090411|566357202|FG010|Chronic Period|Physician Decision|0|||
156890720|NCT04090411|566357203|FG011|Chronic Period|Physician Decision|1|||
156890721|NCT04090411|566357204|FG012|Chronic Period|Physician Decision|1|||
156890722|NCT04090411|566357192|FG000|Chronic Period|Protocol Violation|0|||
156890723|NCT04090411|566357193|FG001|Chronic Period|Protocol Violation|0|||
156890724|NCT04090411|566357194|FG002|Chronic Period|Protocol Violation|0|||
156890725|NCT04090411|566357195|FG003|Chronic Period|Protocol Violation|0|||
156890726|NCT04090411|566357196|FG004|Chronic Period|Protocol Violation|0|||
156890727|NCT04090411|566357197|FG005|Chronic Period|Protocol Violation|0|||
156890728|NCT04090411|566357198|FG006|Chronic Period|Protocol Violation|0|||
156890729|NCT04090411|566357199|FG007|Chronic Period|Protocol Violation|0|||
156890730|NCT04090411|566357200|FG008|Chronic Period|Protocol Violation|0|||
156890731|NCT04090411|566357201|FG009|Chronic Period|Protocol Violation|0|||
156890732|NCT04090411|566357202|FG010|Chronic Period|Protocol Violation|0|||
156890733|NCT04090411|566357203|FG011|Chronic Period|Protocol Violation|0|||
156890734|NCT04090411|566357204|FG012|Chronic Period|Protocol Violation|1|||
156890735|NCT04090411|566357192|FG000|Chronic Period|Withdrawal by Subject|0|||
156890736|NCT04090411|566357193|FG001|Chronic Period|Withdrawal by Subject|0|||
156890737|NCT04090411|566357194|FG002|Chronic Period|Withdrawal by Subject|0|||
156890738|NCT04090411|566357195|FG003|Chronic Period|Withdrawal by Subject|0|||
156890739|NCT04090411|566357196|FG004|Chronic Period|Withdrawal by Subject|0|||
156890740|NCT04090411|566357197|FG005|Chronic Period|Withdrawal by Subject|1|||
156890741|NCT04090411|566357198|FG006|Chronic Period|Withdrawal by Subject|1|||
156890742|NCT04090411|566357199|FG007|Chronic Period|Withdrawal by Subject|3|||
156890743|NCT04090411|566357200|FG008|Chronic Period|Withdrawal by Subject|3|||
156890744|NCT04090411|566357201|FG009|Chronic Period|Withdrawal by Subject|3|||
156890745|NCT04090411|566357202|FG010|Chronic Period|Withdrawal by Subject|1|||
156890746|NCT04090411|566357203|FG011|Chronic Period|Withdrawal by Subject|3|||
156890747|NCT04090411|566357204|FG012|Chronic Period|Withdrawal by Subject|0|||
156890748|NCT03473548|566357206|FG000|Overall Study|Did not attempt HST testing|3|||
156890749|NCT03473548|566357207|FG001|Overall Study|Did not attempt HST testing|0|||
156890750|NCT03764033|566357214|FG000|Treatment Phase|Withdrawal by Subject|8|||
156890751|NCT03764033|566357215|FG001|Treatment Phase|Withdrawal by Subject|3|||
156890752|NCT03764033|566357214|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
156890753|NCT03764033|566357215|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
156890754|NCT03764033|566357214|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
156890755|NCT03764033|566357215|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
157157789|NCT03249792|567322868|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
156890756|NCT02477696|566357216|FG000|Overall Study|Death|89|||
156890757|NCT02477696|566357217|FG001|Overall Study|Death|106|||
156890758|NCT02477696|566357216|FG000|Overall Study|Lost to Follow-up|7|||
156890759|NCT02477696|566357217|FG001|Overall Study|Lost to Follow-up|5|||
156890760|NCT02477696|566357216|FG000|Overall Study|Withdrawal by Subject|37|||
156890761|NCT02477696|566357217|FG001|Overall Study|Withdrawal by Subject|34|||
156890762|NCT02477696|566357216|FG000|Overall Study|Physician Decision|7|||
156890763|NCT02477696|566357217|FG001|Overall Study|Physician Decision|9|||
156890764|NCT02477696|566357216|FG000|Overall Study|Study terminated by sponsor|103|||
156890765|NCT02477696|566357217|FG001|Overall Study|Study terminated by sponsor|99|||
157157790|NCT03249792|567322869|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
156890766|NCT02477696|566357216|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
156890767|NCT02477696|566357217|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
156890768|NCT02477696|566357216|FG000|Overall Study|Missing/Unknown|2|||
157157791|NCT03249792|567322870|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157792|NCT03249792|567322871|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157793|NCT03249792|567322872|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
157157794|NCT03249792|567322873|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157795|NCT03249792|567322874|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157796|NCT03249792|567322875|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157797|NCT03249792|567322876|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157798|NCT03249792|567322877|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157799|NCT03249792|567322878|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157800|NCT03249792|567322879|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157801|NCT03249792|567322880|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
157157802|NCT03249792|567322881|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
157157803|NCT03249792|567322882|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157804|NCT03249792|567322883|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
157157805|NCT03249792|567322884|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157806|NCT03249792|567322885|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157807|NCT03249792|567322886|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157808|NCT03249792|567322887|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157809|NCT03249792|567322888|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
156857103|NCT04663321|566230838|FG001|Overall Study|Study terminated by Sponsor|1|||
156857104|NCT04663321|566230839|FG002|Overall Study|Study terminated by Sponsor|2|||
156857105|NCT04663321|566230837|FG000|Overall Study|Withdrawal by Subject|10|||
156857106|NCT04663321|566230838|FG001|Overall Study|Withdrawal by Subject|3|||
156857107|NCT04663321|566230839|FG002|Overall Study|Withdrawal by Subject|2|||
156857108|NCT04663321|566230837|FG000|Overall Study|Not provided|0|||
156857109|NCT04663321|566230838|FG001|Overall Study|Not provided|0|||
156857110|NCT04663321|566230839|FG002|Overall Study|Not provided|1|||
156857111|NCT03294590|566230840|FG000|Overall Study|Lost to Follow-up|105|||
156857112|NCT03294590|566230841|FG001|Overall Study|Lost to Follow-up|107|||
156857113|NCT01962441|566230842|FG000|Randomized Period|Randomized but Never Treated|4|||
156857114|NCT01962441|566230843|FG001|Randomized Period|Randomized but Never Treated|2|||
156857115|NCT01962441|566230844|FG002|Randomized Period|Randomized but Never Treated|3|||
156857116|NCT01962441|566230842|FG000|Randomized Period|Lost to Follow-up|2|||
156857117|NCT01962441|566230843|FG001|Randomized Period|Lost to Follow-up|4|||
156857118|NCT01962441|566230844|FG002|Randomized Period|Lost to Follow-up|4|||
156857119|NCT01962441|566230842|FG000|Randomized Period|Withdrew Consent|3|||
156857120|NCT01962441|566230843|FG001|Randomized Period|Withdrew Consent|3|||
156857121|NCT01962441|566230844|FG002|Randomized Period|Withdrew Consent|2|||
156857122|NCT01962441|566230842|FG000|Randomized Period|Adverse Event|1|||
156857123|NCT01962441|566230843|FG001|Randomized Period|Adverse Event|1|||
156857124|NCT01962441|566230844|FG002|Randomized Period|Adverse Event|0|||
156857125|NCT01962441|566230842|FG000|Randomized Period|Death|0|||
156857126|NCT01962441|566230843|FG001|Randomized Period|Death|0|||
156857127|NCT01962441|566230844|FG002|Randomized Period|Death|2|||
156857128|NCT01962441|566230842|FG000|Randomized Period|Protocol Violation|0|||
156857129|NCT01962441|566230843|FG001|Randomized Period|Protocol Violation|1|||
156857130|NCT01962441|566230844|FG002|Randomized Period|Protocol Violation|0|||
156857131|NCT01962441|566230842|FG000|Retreatment Substudy|Lack of Efficacy|1|||
156857132|NCT01962441|566230843|FG001|Retreatment Substudy|Lack of Efficacy|0|||
156857133|NCT01962441|566230844|FG002|Retreatment Substudy|Lack of Efficacy|0|||
156857134|NCT01962441|566230842|FG000|Retreatment Substudy|Lost to Follow-up|1|||
156857135|NCT01962441|566230843|FG001|Retreatment Substudy|Lost to Follow-up|0|||
156857136|NCT01962441|566230844|FG002|Retreatment Substudy|Lost to Follow-up|0|||
156857137|NCT02055898|566230845|FG000|First Intervention (5 Days)|Physician Decision|2|||
156857138|NCT02055898|566230846|FG001|First Intervention (5 Days)|Physician Decision|0|||
156857139|NCT02055898|566230845|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
156857140|NCT02055898|566230846|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
156857141|NCT02269124|566230847|FG000|Overall Study|Lost to Follow-up|1|||
156857142|NCT02269124|566230848|FG001|Overall Study|Lost to Follow-up|0|||
156857143|NCT02269124|566230847|FG000|Overall Study|Withdrawal by Subject|0|||
156857144|NCT02269124|566230848|FG001|Overall Study|Withdrawal by Subject|2|||
156857145|NCT03452540|566230849|FG000|Overall Study|Adverse Event|1|||
156857146|NCT03452540|566230849|FG000|Overall Study|Withdrawal by Subject|1|||
156857147|NCT03452540|566230849|FG000|Overall Study|Other SAE and AE|2|||
156890769|NCT02477696|566357217|FG001|Overall Study|Missing/Unknown|0|||
157025928|NCT02861300|566849645|FG001|Overall Study|Disease Progression|1|||
157157810|NCT03249792|567322889|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
156857148|NCT01009060|566230856|FG000|Overall Study|Adverse Event|1|||
156857149|NCT01009060|566230857|FG001|Overall Study|Adverse Event|2|||
156857150|NCT01009060|566230856|FG000|Overall Study|Protocol Violation|0|||
156857151|NCT01009060|566230857|FG001|Overall Study|Protocol Violation|1|||
156857152|NCT01009060|566230856|FG000|Overall Study|Lost to Follow-up|1|||
156857153|NCT01009060|566230857|FG001|Overall Study|Lost to Follow-up|0|||
156857154|NCT01009060|566230856|FG000|Overall Study|Physician Decision|1|||
156857155|NCT01009060|566230857|FG001|Overall Study|Physician Decision|1|||
157157811|NCT03249792|567322890|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157812|NCT03249792|567322891|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
156890770|NCT03587727|566357218|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
156890771|NCT03587727|566357218|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
156890772|NCT00562627|566358049|FG000|Overall Study|Protocol Violation|1|||
156890773|NCT00562627|566358050|FG001|Overall Study|Protocol Violation|1|||
156890774|NCT00562627|566358051|FG002|Overall Study|Protocol Violation|1|||
156890775|NCT05313009|566358052|FG000|Overall Study|Death|1|||
156890776|NCT05313009|566358053|FG001|Overall Study|Death|0|||
156890777|NCT00749580|566358058|FG000|Overall Study|Lost to Follow-up|4|||
156890778|NCT00749580|566358059|FG001|Overall Study|Lost to Follow-up|8|||
156890779|NCT00749580|566358058|FG000|Overall Study|Adverse Event|0|||
156890780|NCT00749580|566358059|FG001|Overall Study|Adverse Event|1|||
156890781|NCT02987660|566358063|FG000|Overall Study|Study terminated by sponsor|10|||
156890782|NCT02987660|566358064|FG001|Overall Study|Study terminated by sponsor|10|||
156890783|NCT02497976|566358066|FG000|Overall Study|Withdrawal by Subject|2|||
156890784|NCT02497976|566358067|FG001|Overall Study|Withdrawal by Subject|0|||
156890785|NCT02497976|566358066|FG000|Overall Study|Moved out of area|0|||
156890786|NCT02497976|566358067|FG001|Overall Study|Moved out of area|1|||
156890787|NCT00058539|566358071|FG000|Overall Study|Disease progression|24|||
156890788|NCT00058539|566358071|FG000|Overall Study|Adverse Event|3|||
156890789|NCT00058539|566358071|FG000|Overall Study|Withdrawal by Subject|5|||
156890790|NCT00058539|566358071|FG000|Overall Study|Physician Decision|9|||
156890791|NCT00058539|566358071|FG000|Overall Study|Death|1|||
156890792|NCT02483533|566358074|FG000|Overall Study|Lack of Efficacy|50|||
156857156|NCT01009060|566230856|FG000|Overall Study|Withdrawal by Subject|1|||
156857157|NCT01009060|566230857|FG001|Overall Study|Withdrawal by Subject|1|||
156857158|NCT00739401|566230863|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
156857159|NCT00739401|566230863|FG000|Overall Study|Death|3|||
156857160|NCT00739401|566230863|FG000|Overall Study|Withdrawal by Subject|4|||
156857161|NCT01239381|566230864|FG000|Overall Study|Protocol Violation|1|||
156857162|NCT01239381|566230864|FG000|Overall Study|Withdrawal by Subject|1|||
156857163|NCT03275740|566230865|FG000|Overall Study|Adverse Event|0|||
156857164|NCT03275740|566230866|FG001|Overall Study|Adverse Event|0|||
156857165|NCT03275740|566230867|FG002|Overall Study|Adverse Event|0|||
156857166|NCT03275740|566230868|FG003|Overall Study|Adverse Event|0|||
156857167|NCT03275740|566230869|FG004|Overall Study|Adverse Event|1|||
156857168|NCT03275740|566230870|FG005|Overall Study|Adverse Event|0|||
156857169|NCT03275740|566230871|FG006|Overall Study|Adverse Event|0|||
156857170|NCT03275740|566230872|FG007|Overall Study|Adverse Event|0|||
156857171|NCT03275740|566230873|FG008|Overall Study|Adverse Event|0|||
156857172|NCT03275740|566230874|FG009|Overall Study|Adverse Event|0|||
156857173|NCT03275740|566230875|FG010|Overall Study|Adverse Event|0|||
156857174|NCT03275740|566230876|FG011|Overall Study|Adverse Event|0|||
156857175|NCT03275740|566230865|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857176|NCT03275740|566230866|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857177|NCT03275740|566230867|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857178|NCT03275740|566230868|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857179|NCT03275740|566230869|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857180|NCT03275740|566230870|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
156857181|NCT03275740|566230871|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857182|NCT03275740|566230872|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857183|NCT03275740|566230873|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857184|NCT03275740|566230874|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857185|NCT03275740|566230875|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857186|NCT03275740|566230876|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
156857187|NCT03275740|566230865|FG000|Overall Study|Withdrawal by Subject|0|||
156857188|NCT03275740|566230866|FG001|Overall Study|Withdrawal by Subject|0|||
156857189|NCT03275740|566230867|FG002|Overall Study|Withdrawal by Subject|0|||
156857190|NCT03275740|566230868|FG003|Overall Study|Withdrawal by Subject|0|||
156857191|NCT03275740|566230869|FG004|Overall Study|Withdrawal by Subject|0|||
156857192|NCT03275740|566230870|FG005|Overall Study|Withdrawal by Subject|0|||
156857193|NCT03275740|566230871|FG006|Overall Study|Withdrawal by Subject|0|||
156857194|NCT03275740|566230872|FG007|Overall Study|Withdrawal by Subject|0|||
156857195|NCT03275740|566230873|FG008|Overall Study|Withdrawal by Subject|1|||
156857196|NCT03275740|566230874|FG009|Overall Study|Withdrawal by Subject|1|||
156857197|NCT03275740|566230875|FG010|Overall Study|Withdrawal by Subject|0|||
157225473|NCT01860976|567571436|FG000|Long Term Extension|subject withdrew consent|7|||
156890793|NCT02483533|566358075|FG001|Overall Study|Lack of Efficacy|50|||
156890794|NCT01323920|566358076|FG000|Overall Study|Death|5|||
156890795|NCT01323920|566358076|FG000|Overall Study|Withdrawal by Subject|1|||
157225474|NCT01860976|567571437|FG001|Long Term Extension|subject withdrew consent|0|||
156857198|NCT03275740|566230876|FG011|Overall Study|Withdrawal by Subject|0|||
156857199|NCT00988884|566230877|FG000|Overall Study|Adverse Event|0|||
156857200|NCT00988884|566230878|FG001|Overall Study|Adverse Event|1|||
156890796|NCT04973137|566358083|FG000|Double Blind Phase|Adverse Event|4|||
157157813|NCT03249792|567322892|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157814|NCT03249792|567322893|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157815|NCT03249792|567322894|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157816|NCT03249792|567322895|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
157157817|NCT03249792|567322896|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
156857201|NCT00988884|566230877|FG000|Overall Study|Lost to Follow-up|20|||
156857202|NCT00988884|566230878|FG001|Overall Study|Lost to Follow-up|16|||
156857203|NCT00988884|566230877|FG000|Overall Study|Protocol Violation|0|||
156857204|NCT00988884|566230878|FG001|Overall Study|Protocol Violation|1|||
156857205|NCT00988884|566230877|FG000|Overall Study|Withdrawal by Subject|15|||
156857206|NCT00988884|566230878|FG001|Overall Study|Withdrawal by Subject|18|||
156857207|NCT02738008|566230879|FG000|Overall Study|Study Terminated by Sponsor|1|||
156857208|NCT02738008|566230880|FG001|Overall Study|Study Terminated by Sponsor|5|||
156857209|NCT02738008|566230881|FG002|Overall Study|Study Terminated by Sponsor|3|||
156857210|NCT02738008|566230879|FG000|Overall Study|Adverse Event|0|||
156857211|NCT02738008|566230880|FG001|Overall Study|Adverse Event|1|||
156857212|NCT02738008|566230881|FG002|Overall Study|Adverse Event|2|||
156857213|NCT04621448|566230882|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
156857214|NCT04621448|566230883|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
156857215|NCT04621448|566230884|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
156857216|NCT04621448|566230885|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
156857217|NCT04621448|566230882|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
156857218|NCT04621448|566230883|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
156857219|NCT04621448|566230884|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
156857220|NCT04621448|566230885|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
156857221|NCT04621448|566230882|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
156857222|NCT04621448|566230883|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
156857223|NCT04621448|566230884|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
156857224|NCT04621448|566230885|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
156857225|NCT04621448|566230882|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
156857226|NCT04621448|566230883|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
156857227|NCT04621448|566230884|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
156857228|NCT04621448|566230885|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
156857229|NCT04486235|566230892|FG000|Overall Study|Pregnancy|1|||
156857230|NCT04486235|566230893|FG001|Overall Study|Pregnancy|0|||
156857231|NCT04486235|566230892|FG000|Overall Study|Lost to Follow-up|1|||
156857232|NCT04486235|566230893|FG001|Overall Study|Lost to Follow-up|0|||
156857233|NCT04590014|566230894|FG000|Overall Study|Withdrawal by Subject|1|||
156857234|NCT04590014|566230895|FG001|Overall Study|Withdrawal by Subject|0|||
156857235|NCT00468299|566230896|FG000|Overall Study|Withdrawal by Subject|0|||
156857236|NCT00468299|566230897|FG001|Overall Study|Withdrawal by Subject|1|||
156857237|NCT01216202|566230898|FG000|Overall Study|Withdrawal by Subject|8|||
156857238|NCT01216202|566230899|FG001|Overall Study|Withdrawal by Subject|0|||
156857239|NCT01216202|566230898|FG000|Overall Study|Death|0|||
156857240|NCT01216202|566230899|FG001|Overall Study|Death|2|||
156857241|NCT01216202|566230898|FG000|Overall Study|Lost to Follow-up|14|||
156857242|NCT01216202|566230899|FG001|Overall Study|Lost to Follow-up|0|||
156857243|NCT03546621|566230900|FG000|Overall Study|Withdrawal by Subject|0|||
156857244|NCT03546621|566230901|FG001|Overall Study|Withdrawal by Subject|1|||
156857245|NCT03546621|566230902|FG002|Overall Study|Withdrawal by Subject|2|||
156857246|NCT03546621|566230903|FG003|Overall Study|Withdrawal by Subject|1|||
156857247|NCT03546621|566230900|FG000|Overall Study|Lost to Follow-up|0|||
156857248|NCT03546621|566230901|FG001|Overall Study|Lost to Follow-up|1|||
156857249|NCT03546621|566230902|FG002|Overall Study|Lost to Follow-up|0|||
156857250|NCT03546621|566230903|FG003|Overall Study|Lost to Follow-up|0|||
156857251|NCT03546621|566230900|FG000|Overall Study|Adverse Event|0|||
156857252|NCT03546621|566230901|FG001|Overall Study|Adverse Event|1|||
156857253|NCT03546621|566230902|FG002|Overall Study|Adverse Event|0|||
156857254|NCT03546621|566230903|FG003|Overall Study|Adverse Event|1|||
156857255|NCT03546621|566230900|FG000|Overall Study|Progressive disease|0|||
156857256|NCT03546621|566230901|FG001|Overall Study|Progressive disease|0|||
156857257|NCT03546621|566230902|FG002|Overall Study|Progressive disease|0|||
156857258|NCT03546621|566230903|FG003|Overall Study|Progressive disease|1|||
156857259|NCT00660192|566230909|FG000|Overall Study|Lost to Follow-up|2|||
156857260|NCT00660192|566230910|FG001|Overall Study|Lost to Follow-up|3|||
156857261|NCT00377520|566230911|FG000|Overall Study|Ineligible (Prior radiation)|1|||
156857262|NCT02775916|566230912|FG000|Overall Study|Adverse Event|1|||
156857263|NCT02775916|566230913|FG001|Overall Study|Adverse Event|0|||
156857264|NCT02775916|566230912|FG000|Overall Study|Subject/Guardian Decision|2|||
156857265|NCT02775916|566230913|FG001|Overall Study|Subject/Guardian Decision|0|||
156857266|NCT00179621|566232447|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
156857267|NCT00179621|566232448|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
156857268|NCT00179621|566232449|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
156857269|NCT00179621|566232450|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
156857270|NCT00179621|566232447|FG000|Double-Blind Period|Adverse Event|2|||
156857271|NCT00179621|566232448|FG001|Double-Blind Period|Adverse Event|7|||
156857272|NCT00179621|566232449|FG002|Double-Blind Period|Adverse Event|4|||
157157818|NCT03249792|567322864|FG000|Switch Over Period|Withdrawal by Subject|0|||
157157819|NCT03249792|567322865|FG001|Switch Over Period|Withdrawal by Subject|0|||
157157820|NCT03249792|567322866|FG002|Switch Over Period|Withdrawal by Subject|0|||
157157821|NCT03249792|567322867|FG003|Switch Over Period|Withdrawal by Subject|0|||
157157822|NCT03249792|567322868|FG004|Switch Over Period|Withdrawal by Subject|0|||
157157823|NCT03249792|567322869|FG005|Switch Over Period|Withdrawal by Subject|0|||
157157824|NCT03249792|567322870|FG006|Switch Over Period|Withdrawal by Subject|0|||
157157825|NCT03249792|567322871|FG007|Switch Over Period|Withdrawal by Subject|0|||
157157826|NCT03249792|567322872|FG008|Switch Over Period|Withdrawal by Subject|0|||
157157827|NCT03249792|567322873|FG009|Switch Over Period|Withdrawal by Subject|0|||
157157828|NCT03249792|567322874|FG010|Switch Over Period|Withdrawal by Subject|0|||
157157829|NCT03249792|567322875|FG011|Switch Over Period|Withdrawal by Subject|0|||
157157830|NCT03249792|567322876|FG012|Switch Over Period|Withdrawal by Subject|0|||
157157831|NCT03249792|567322877|FG013|Switch Over Period|Withdrawal by Subject|0|||
157157832|NCT03249792|567322878|FG014|Switch Over Period|Withdrawal by Subject|0|||
157157833|NCT03249792|567322879|FG015|Switch Over Period|Withdrawal by Subject|0|||
157157834|NCT03249792|567322880|FG016|Switch Over Period|Withdrawal by Subject|0|||
157157835|NCT03249792|567322881|FG017|Switch Over Period|Withdrawal by Subject|0|||
157157836|NCT03249792|567322882|FG018|Switch Over Period|Withdrawal by Subject|0|||
156857273|NCT00179621|566232450|FG003|Double-Blind Period|Adverse Event|0|||
156857274|NCT00179621|566232447|FG000|Double-Blind Period|Withdrawal by Subject|2|||
156857275|NCT00179621|566232448|FG001|Double-Blind Period|Withdrawal by Subject|1|||
156857276|NCT00179621|566232449|FG002|Double-Blind Period|Withdrawal by Subject|3|||
156857277|NCT00179621|566232450|FG003|Double-Blind Period|Withdrawal by Subject|0|||
156857278|NCT00179621|566232447|FG000|Double-Blind Period|Death|0|||
156857279|NCT00179621|566232448|FG001|Double-Blind Period|Death|1|||
156857280|NCT00179621|566232449|FG002|Double-Blind Period|Death|2|||
156857281|NCT00179621|566232450|FG003|Double-Blind Period|Death|0|||
156857282|NCT00179621|566232447|FG000|Double-Blind Period|Protocol Violation|1|||
156857283|NCT00179621|566232448|FG001|Double-Blind Period|Protocol Violation|0|||
156857284|NCT00179621|566232449|FG002|Double-Blind Period|Protocol Violation|0|||
156857285|NCT00179621|566232450|FG003|Double-Blind Period|Protocol Violation|0|||
156857286|NCT00179621|566232447|FG000|Double-Blind Period|Other|0|||
156857287|NCT00179621|566232448|FG001|Double-Blind Period|Other|2|||
156857288|NCT00179621|566232449|FG002|Double-Blind Period|Other|2|||
156857289|NCT00179621|566232450|FG003|Double-Blind Period|Other|0|||
156857290|NCT00179621|566232447|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
156857291|NCT00179621|566232448|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
156857292|NCT00179621|566232449|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
156857293|NCT00179621|566232450|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
156857294|NCT00179621|566232447|FG000|Open-Label Period|Adverse Event|0|||
156857295|NCT00179621|566232448|FG001|Open-Label Period|Adverse Event|6|||
156857296|NCT00179621|566232449|FG002|Open-Label Period|Adverse Event|5|||
156857297|NCT00179621|566232450|FG003|Open-Label Period|Adverse Event|6|||
156857298|NCT00179621|566232447|FG000|Open-Label Period|Withdrawal by Subject|0|||
156857299|NCT00179621|566232448|FG001|Open-Label Period|Withdrawal by Subject|2|||
156857300|NCT00179621|566232449|FG002|Open-Label Period|Withdrawal by Subject|2|||
156857301|NCT00179621|566232450|FG003|Open-Label Period|Withdrawal by Subject|2|||
156857302|NCT00179621|566232447|FG000|Open-Label Period|Death|0|||
156857303|NCT00179621|566232448|FG001|Open-Label Period|Death|0|||
156857304|NCT00179621|566232449|FG002|Open-Label Period|Death|1|||
156857305|NCT00179621|566232450|FG003|Open-Label Period|Death|2|||
156857306|NCT00179621|566232447|FG000|Open-Label Period|Other|0|||
156857307|NCT00179621|566232448|FG001|Open-Label Period|Other|1|||
156857308|NCT00179621|566232449|FG002|Open-Label Period|Other|1|||
156857309|NCT00179621|566232450|FG003|Open-Label Period|Other|2|||
156857310|NCT02426580|566232457|FG000|Overall Study|Death|2|||
156857311|NCT02426580|566232458|FG001|Overall Study|Death|2|||
156857312|NCT02426580|566232457|FG000|Overall Study|Lost to Follow-up|0|||
156857313|NCT02426580|566232458|FG001|Overall Study|Lost to Follow-up|9|||
156857314|NCT02426580|566232457|FG000|Overall Study|transfer to hemodialysis|5|||
156857315|NCT02426580|566232458|FG001|Overall Study|transfer to hemodialysis|5|||
156857316|NCT02426580|566232457|FG000|Overall Study|Kidney transplant|3|||
156857317|NCT02426580|566232458|FG001|Overall Study|Kidney transplant|0|||
156857318|NCT02426580|566232457|FG000|Overall Study|Allergic to egg white|1|||
156857319|NCT02426580|566232458|FG001|Overall Study|Allergic to egg white|0|||
156857320|NCT02869633|566232459|FG000|Overall Study|Death|2|||
156857321|NCT02869633|566232460|FG001|Overall Study|Death|1|||
156857322|NCT02869633|566232459|FG000|Overall Study|Patient refused follow-up|1|||
156857323|NCT02869633|566232460|FG001|Overall Study|Patient refused follow-up|0|||
156857324|NCT02869633|566232459|FG000|Overall Study|Provider discretion|1|||
156857325|NCT02869633|566232460|FG001|Overall Study|Provider discretion|0|||
156857326|NCT02869633|566232459|FG000|Overall Study|Investigator decision|1|||
156857327|NCT02869633|566232460|FG001|Overall Study|Investigator decision|0|||
156857328|NCT02869633|566232459|FG000|Overall Study|Lost to Follow-up|0|||
156857329|NCT02869633|566232460|FG001|Overall Study|Lost to Follow-up|1|||
157157837|NCT03249792|567322883|FG019|Switch Over Period|Withdrawal by Subject|0|||
156857330|NCT02869633|566232459|FG000|Overall Study|Not eligible|6|||
157157838|NCT03249792|567322884|FG020|Switch Over Period|Withdrawal by Subject|0|||
157157839|NCT03249792|567322885|FG021|Switch Over Period|Withdrawal by Subject|0|||
156890797|NCT04973137|566358084|FG001|Double Blind Phase|Adverse Event|0|||
156890798|NCT04973137|566358083|FG000|Double Blind Phase|Death|25|||
156890799|NCT04973137|566358084|FG001|Double Blind Phase|Death|15|||
156890800|NCT04973137|566358083|FG000|Double Blind Phase|Physician Decision|5|||
156890801|NCT04973137|566358084|FG001|Double Blind Phase|Physician Decision|1|||
157025929|NCT02861300|566849646|FG002|Overall Study|Disease Progression|0|||
157025930|NCT02861300|566849647|FG003|Overall Study|Disease Progression|0|||
157025931|NCT02861300|566849648|FG004|Overall Study|Disease Progression|0|||
157025932|NCT02861300|566849649|FG005|Overall Study|Disease Progression|0|||
157025933|NCT02861300|566849650|FG006|Overall Study|Disease Progression|2|||
157025934|NCT02861300|566849644|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
157025935|NCT02861300|566849645|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
157025936|NCT02861300|566849646|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
157025937|NCT02861300|566849647|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
157025938|NCT02861300|566849648|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
157025939|NCT02861300|566849649|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
157025940|NCT02861300|566849650|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
157025941|NCT02861300|566849644|FG000|Overall Study|Clinical Complications|0|||
157025942|NCT02861300|566849645|FG001|Overall Study|Clinical Complications|0|||
157025943|NCT02861300|566849646|FG002|Overall Study|Clinical Complications|0|||
157025944|NCT02861300|566849647|FG003|Overall Study|Clinical Complications|0|||
157025945|NCT02861300|566849648|FG004|Overall Study|Clinical Complications|0|||
157025946|NCT02861300|566849649|FG005|Overall Study|Clinical Complications|0|||
157025947|NCT02861300|566849650|FG006|Overall Study|Clinical Complications|1|||
157025948|NCT04992520|566849654|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
157025949|NCT04992520|566849655|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
157025950|NCT04992520|566849656|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
157025951|NCT04992520|566849657|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
157025952|NCT04992520|566849658|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
157025953|NCT04992520|566849659|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
157025954|NCT04992520|566849654|FG000|Part A: First Challenge|Non-compliance|0|||
157025955|NCT04992520|566849655|FG001|Part A: First Challenge|Non-compliance|0|||
157025956|NCT04992520|566849656|FG002|Part A: First Challenge|Non-compliance|0|||
157025957|NCT04992520|566849657|FG003|Part A: First Challenge|Non-compliance|1|||
157157840|NCT03249792|567322886|FG022|Switch Over Period|Withdrawal by Subject|0|||
157157841|NCT03249792|567322887|FG023|Switch Over Period|Withdrawal by Subject|0|||
157157842|NCT03249792|567322888|FG024|Switch Over Period|Withdrawal by Subject|0|||
157157843|NCT03249792|567322889|FG025|Switch Over Period|Withdrawal by Subject|0|||
157157844|NCT03249792|567322890|FG026|Switch Over Period|Withdrawal by Subject|0|||
157157845|NCT03249792|567322891|FG027|Switch Over Period|Withdrawal by Subject|0|||
156890802|NCT04973137|566358083|FG000|Double Blind Phase|Withdrawal by Subject|6|||
156890803|NCT04973137|566358084|FG001|Double Blind Phase|Withdrawal by Subject|1|||
156890804|NCT04973137|566358083|FG000|Double Blind Phase|Other|2|||
156890805|NCT04973137|566358084|FG001|Double Blind Phase|Other|2|||
156890806|NCT04973137|566358083|FG000|Open Label Extension Phase|Death|3|||
156890807|NCT04973137|566358084|FG001|Open Label Extension Phase|Death|0|||
156890808|NCT04973137|566358083|FG000|Open Label Extension Phase|Physician Decision|0|||
156890809|NCT04973137|566358084|FG001|Open Label Extension Phase|Physician Decision|1|||
156890810|NCT04973137|566358083|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
156890811|NCT04973137|566358084|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
156890812|NCT04973137|566358083|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
157025958|NCT04992520|566849658|FG004|Part A: First Challenge|Non-compliance|0|||
157025959|NCT04992520|566849659|FG005|Part A: First Challenge|Non-compliance|0|||
157025960|NCT04992520|566849654|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
157157846|NCT03249792|567322892|FG028|Switch Over Period|Withdrawal by Subject|0|||
157157847|NCT03249792|567322893|FG029|Switch Over Period|Withdrawal by Subject|0|||
157025961|NCT04992520|566849655|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
157025962|NCT04992520|566849656|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
157025963|NCT04992520|566849657|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
157025964|NCT04992520|566849658|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
157157848|NCT03249792|567322894|FG030|Switch Over Period|Withdrawal by Subject|0|||
156857331|NCT02869633|566232460|FG001|Overall Study|Not eligible|1|||
156857332|NCT02869633|566232459|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
156857333|NCT02869633|566232460|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
156857334|NCT02869633|566232459|FG000|Overall Study|Withdrawal by Subject|0|||
156857335|NCT02869633|566232460|FG001|Overall Study|Withdrawal by Subject|1|||
156857336|NCT03287791|566232461|FG000|Overall Study|Insufficient Therapeutic Response|0|||
156857337|NCT03287791|566232462|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156857338|NCT03287791|566232463|FG002|Overall Study|Insufficient Therapeutic Response|1|||
156857339|NCT03287791|566232461|FG000|Overall Study|Adverse Event|0|||
156857340|NCT03287791|566232462|FG001|Overall Study|Adverse Event|4|||
156857341|NCT03287791|566232463|FG002|Overall Study|Adverse Event|3|||
156857342|NCT03287791|566232461|FG000|Overall Study|Withdrawal by Subject|12|||
156890813|NCT04973137|566358084|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
156890814|NCT04973137|566358083|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
156890815|NCT04973137|566358084|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
156890816|NCT05040971|566358085|FG000|Overall Study|Withdrawal by Subject|0|||
156890817|NCT05040971|566358086|FG001|Overall Study|Withdrawal by Subject|2|||
156890818|NCT05040971|566358085|FG000|Overall Study|Lost to Follow-up|8|||
156890819|NCT05040971|566358086|FG001|Overall Study|Lost to Follow-up|3|||
156890820|NCT05040971|566358085|FG000|Overall Study|Death|2|||
156890821|NCT05040971|566358086|FG001|Overall Study|Death|0|||
156890822|NCT02283177|566358094|FG000|Overall Study|Withdrawal by Subject|1|||
156890823|NCT02283177|566358095|FG001|Overall Study|Withdrawal by Subject|1|||
156890824|NCT01101191|566358096|FG000|Period 1|Withdrawal by Subject|1|||
156890825|NCT01101191|566358097|FG001|Period 1|Withdrawal by Subject|0|||
156890826|NCT01101191|566358096|FG000|Period 1|Adverse Event|1|||
156890827|NCT01101191|566358097|FG001|Period 1|Adverse Event|2|||
156890828|NCT00879879|566358102|FG000|Overall Study|Death|1|||
156890829|NCT00879879|566358102|FG000|Overall Study|Withdrawal by Subject|1|||
156890830|NCT00879879|566358102|FG000|Overall Study|Physician Decision|1|||
156890831|NCT00327470|566358106|FG000|Overall Study|Randomized, but not treated|0|||
156890832|NCT00327470|566358107|FG001|Overall Study|Randomized, but not treated|2|||
156890833|NCT00327470|566358106|FG000|Overall Study|Adverse Event|9|||
156890834|NCT00327470|566358107|FG001|Overall Study|Adverse Event|14|||
156890835|NCT00327470|566358106|FG000|Overall Study|Lack of Efficacy|7|||
156890836|NCT00327470|566358107|FG001|Overall Study|Lack of Efficacy|19|||
156890837|NCT00327470|566358106|FG000|Overall Study|Other|5|||
156890838|NCT00327470|566358107|FG001|Overall Study|Other|9|||
156890839|NCT00327470|566358106|FG000|Overall Study|Lost to Follow-up|1|||
156890840|NCT00327470|566358107|FG001|Overall Study|Lost to Follow-up|3|||
156890841|NCT00327470|566358106|FG000|Overall Study|Withdrawal by Subject|6|||
156890842|NCT00327470|566358107|FG001|Overall Study|Withdrawal by Subject|12|||
156890843|NCT00327470|566358106|FG000|Overall Study|Death|1|||
156890844|NCT00327470|566358107|FG001|Overall Study|Death|4|||
156890845|NCT02581943|566358108|FG000|Overall Study|Death|5|||
156890846|NCT02581943|566358109|FG001|Overall Study|Death|2|||
156890847|NCT02581943|566358108|FG000|Overall Study|Disease Progression|12|||
156890848|NCT02581943|566358109|FG001|Overall Study|Disease Progression|15|||
156890849|NCT02581943|566358108|FG000|Overall Study|Withdrawal by Subject|1|||
156890850|NCT02581943|566358109|FG001|Overall Study|Withdrawal by Subject|2|||
156890851|NCT03783702|566358110|FG000|Overall Study|Lost to Follow-up|6|||
156890852|NCT03783702|566358111|FG001|Overall Study|Lost to Follow-up|8|||
156890853|NCT03783702|566358110|FG000|Overall Study|Protocol Violation|1|||
156890854|NCT03783702|566358111|FG001|Overall Study|Protocol Violation|3|||
156890855|NCT01076075|566358112|FG000|Overall Study|Adverse Event|3|||
156890856|NCT01076075|566358113|FG001|Overall Study|Adverse Event|9|||
156890857|NCT01076075|566358112|FG000|Overall Study|Lack of Efficacy|5|||
156890858|NCT01076075|566358113|FG001|Overall Study|Lack of Efficacy|4|||
156890859|NCT01076075|566358112|FG000|Overall Study|Lost to Follow-up|6|||
156890860|NCT01076075|566358113|FG001|Overall Study|Lost to Follow-up|5|||
156890861|NCT01076075|566358112|FG000|Overall Study|other|19|||
156890862|NCT01076075|566358113|FG001|Overall Study|other|9|||
156890863|NCT01076075|566358112|FG000|Overall Study|Protocol Violation|0|||
156890864|NCT01076075|566358113|FG001|Overall Study|Protocol Violation|1|||
156890865|NCT01076075|566358112|FG000|Overall Study|Withdrawal by Subject|8|||
156890866|NCT01076075|566358113|FG001|Overall Study|Withdrawal by Subject|19|||
156890867|NCT01163032|566358119|FG000|Randomization Phase|Withdrawal by Subject|2|||
157025965|NCT04992520|566849659|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
157025966|NCT04992520|566849654|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
157025967|NCT04992520|566849655|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
157025968|NCT04992520|566849656|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
157025969|NCT04992520|566849657|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
156890868|NCT01163032|566358120|FG001|Randomization Phase|Withdrawal by Subject|3|||
157025970|NCT04992520|566849658|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
157025971|NCT04992520|566849659|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
157157849|NCT03249792|567322895|FG031|Switch Over Period|Withdrawal by Subject|1|||
157157850|NCT03249792|567322896|FG032|Switch Over Period|Withdrawal by Subject|0|||
156890869|NCT01163032|566358121|FG002|Randomization Phase|Withdrawal by Subject|0|||
156890870|NCT01163032|566358119|FG000|Randomization Phase|Adverse Event|3|||
156890871|NCT01163032|566358120|FG001|Randomization Phase|Adverse Event|3|||
156890872|NCT01163032|566358121|FG002|Randomization Phase|Adverse Event|0|||
156890873|NCT01163032|566358119|FG000|Randomization Phase|Protocol Violation|0|||
156890874|NCT01163032|566358120|FG001|Randomization Phase|Protocol Violation|1|||
156890875|NCT01163032|566358121|FG002|Randomization Phase|Protocol Violation|0|||
156890876|NCT01163032|566358119|FG000|Randomization Phase|Various*|5|||
156890877|NCT01163032|566358120|FG001|Randomization Phase|Various*|4|||
156890878|NCT01163032|566358121|FG002|Randomization Phase|Various*|0|||
156890879|NCT01163032|566358119|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
156890880|NCT01163032|566358120|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
156890881|NCT01163032|566358121|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
156890882|NCT01163032|566358119|FG000|Open Label Extension Phase|Adverse Event|0|||
156890883|NCT01163032|566358120|FG001|Open Label Extension Phase|Adverse Event|0|||
156890884|NCT01163032|566358121|FG002|Open Label Extension Phase|Adverse Event|3|||
156890885|NCT01163032|566358119|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
156890886|NCT01163032|566358120|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
156890887|NCT01163032|566358121|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
156890888|NCT01163032|566358119|FG000|Open Label Extension Phase|Protocol Violation|0|||
156890889|NCT01163032|566358120|FG001|Open Label Extension Phase|Protocol Violation|0|||
156890890|NCT01163032|566358121|FG002|Open Label Extension Phase|Protocol Violation|1|||
156890891|NCT01163032|566358119|FG000|Open Label Extension Phase|Study Termination|0|||
156890892|NCT01163032|566358120|FG001|Open Label Extension Phase|Study Termination|0|||
156890893|NCT01163032|566358121|FG002|Open Label Extension Phase|Study Termination|7|||
156890894|NCT01163032|566358119|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
156890895|NCT01163032|566358120|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
156890896|NCT01163032|566358121|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
156890897|NCT03326206|566358123|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
156890898|NCT03326206|566358124|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
156890899|NCT03326206|566358123|FG000|Overall Study - 24 months|Death|8|||
156890900|NCT03326206|566358124|FG001|Overall Study - 24 months|Death|92|||
156890901|NCT03326206|566358123|FG000|Overall Study - 24 months|Observational data not available|43|||
156890902|NCT03326206|566358124|FG001|Overall Study - 24 months|Observational data not available|2879|||
156890903|NCT03326206|566358123|FG000|12 months|Unable to match cases with controls|17|||
156890904|NCT03326206|566358124|FG001|12 months|Unable to match cases with controls|22721|||
156890905|NCT03326206|566358123|FG000|12 months|Death|2|||
156890906|NCT03326206|566358124|FG001|12 months|Death|50|||
156890907|NCT03326206|566358123|FG000|12 months|Observational data not available|49|||
156890908|NCT03326206|566358124|FG001|12 months|Observational data not available|2921|||
156890909|NCT01615029|566358131|FG000|Overall Study|Adverse Event|1|||
156890910|NCT01615029|566358132|FG001|Overall Study|Adverse Event|0|||
156890911|NCT01615029|566358133|FG002|Overall Study|Adverse Event|3|||
156890912|NCT01615029|566358134|FG003|Overall Study|Adverse Event|0|||
156890913|NCT01615029|566358135|FG004|Overall Study|Adverse Event|4|||
156890914|NCT01615029|566358131|FG000|Overall Study|Progressive disease|1|||
156890915|NCT01615029|566358132|FG001|Overall Study|Progressive disease|1|||
156890916|NCT01615029|566358133|FG002|Overall Study|Progressive disease|1|||
156890917|NCT01615029|566358134|FG003|Overall Study|Progressive disease|1|||
156890918|NCT01615029|566358135|FG004|Overall Study|Progressive disease|10|||
156890919|NCT01615029|566358131|FG000|Overall Study|Physician Decision|0|||
156890920|NCT01615029|566358132|FG001|Overall Study|Physician Decision|0|||
156890921|NCT01615029|566358133|FG002|Overall Study|Physician Decision|0|||
156890922|NCT01615029|566358134|FG003|Overall Study|Physician Decision|0|||
156890923|NCT01615029|566358135|FG004|Overall Study|Physician Decision|2|||
156890924|NCT02003365|566358886|FG000|Overall Study|Lost to Follow-up|0|||
156890925|NCT02003365|566358887|FG001|Overall Study|Lost to Follow-up|0|||
156890926|NCT02003365|566358888|FG002|Overall Study|Lost to Follow-up|1|||
156890927|NCT05710185|566358892|FG000|Overall Study|Adverse Event|1|||
156890928|NCT05710185|566358892|FG000|Overall Study|Lack of Efficacy|1|||
156890929|NCT04617795|566358895|FG000|Main Study|Lost to Follow-up|1|||
156890930|NCT04617795|566358896|FG001|Main Study|Lost to Follow-up|0|||
156890931|NCT00472459|566358897|FG000|Overall Study|Adverse Event|13|||
156890932|NCT00472459|566358898|FG001|Overall Study|Adverse Event|13|||
156890933|NCT00472459|566358897|FG000|Overall Study|Withdrawal by Subject|5|||
156890934|NCT00472459|566358898|FG001|Overall Study|Withdrawal by Subject|5|||
156890935|NCT00472459|566358897|FG000|Overall Study|Protocol Violation|3|||
156890936|NCT00472459|566358898|FG001|Overall Study|Protocol Violation|3|||
156890937|NCT00472459|566358897|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
156890938|NCT00472459|566358898|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
156890939|NCT00472459|566358897|FG000|Overall Study|Lost to Follow-up|1|||
156890940|NCT00472459|566358898|FG001|Overall Study|Lost to Follow-up|1|||
156890941|NCT04850313|566358899|FG000|Overall Study|Withdrawal by Subject|0|||
156890942|NCT04850313|566358900|FG001|Overall Study|Withdrawal by Subject|1|||
156890943|NCT03505671|566358901|FG000|Overall Study|Withdrawal by Subject|2|||
156890944|NCT03505671|566358902|FG001|Overall Study|Withdrawal by Subject|1|||
156890945|NCT03505671|566358901|FG000|Overall Study|Lost to Follow-up|1|||
156890946|NCT03505671|566358902|FG001|Overall Study|Lost to Follow-up|0|||
157025972|NCT01175356|566849669|FG000|Overall Study|Death|1|||
157225475|NCT00419926|567571438|FG000|Overall Study|Withdrawal by Subject|7|||
156890947|NCT02038829|566358903|FG000|Washout Period 1|Death|0|||
157025973|NCT01175356|566849669|FG000|Overall Study|Lack of Efficacy|12|||
157225476|NCT00419926|567571439|FG001|Overall Study|Withdrawal by Subject|3|||
156890948|NCT02038829|566358904|FG001|Washout Period 1|Death|0|||
156890949|NCT02038829|566358905|FG002|Washout Period 1|Death|0|||
156890950|NCT02038829|566358906|FG003|Washout Period 1|Death|0|||
156890951|NCT02038829|566358907|FG004|Washout Period 1|Death|1|||
156890952|NCT02038829|566358908|FG005|Washout Period 1|Death|0|||
156890953|NCT02038829|566358909|FG006|Washout Period 1|Death|0|||
156890954|NCT02038829|566358910|FG007|Washout Period 1|Death|0|||
156890955|NCT02038829|566358911|FG008|Washout Period 1|Death|0|||
156890956|NCT02038829|566358912|FG009|Washout Period 1|Death|0|||
156890957|NCT02038829|566358913|FG010|Washout Period 1|Death|0|||
156890958|NCT02038829|566358914|FG011|Washout Period 1|Death|0|||
156890959|NCT02038829|566358903|FG000|Treatment Period 2|Adverse Event|0|||
156890960|NCT02038829|566358904|FG001|Treatment Period 2|Adverse Event|0|||
156890961|NCT02038829|566358905|FG002|Treatment Period 2|Adverse Event|0|||
156890962|NCT02038829|566358906|FG003|Treatment Period 2|Adverse Event|0|||
156890963|NCT02038829|566358907|FG004|Treatment Period 2|Adverse Event|0|||
156890964|NCT02038829|566358908|FG005|Treatment Period 2|Adverse Event|0|||
156890965|NCT02038829|566358909|FG006|Treatment Period 2|Adverse Event|0|||
156890966|NCT02038829|566358910|FG007|Treatment Period 2|Adverse Event|0|||
156890967|NCT02038829|566358911|FG008|Treatment Period 2|Adverse Event|0|||
156890968|NCT02038829|566358912|FG009|Treatment Period 2|Adverse Event|0|||
156890969|NCT02038829|566358913|FG010|Treatment Period 2|Adverse Event|1|||
156890970|NCT02038829|566358914|FG011|Treatment Period 2|Adverse Event|0|||
156890971|NCT02038829|566358903|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156890972|NCT02038829|566358904|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156890973|NCT02038829|566358905|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156890974|NCT02038829|566358906|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156890975|NCT02038829|566358907|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156890976|NCT02038829|566358908|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156890977|NCT02038829|566358909|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156890978|NCT02038829|566358910|FG007|Treatment Period 2|Withdrawal by Subject|0|||
156890979|NCT02038829|566358911|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156890980|NCT02038829|566358912|FG009|Treatment Period 2|Withdrawal by Subject|0|||
156890981|NCT02038829|566358913|FG010|Treatment Period 2|Withdrawal by Subject|0|||
156890982|NCT02038829|566358914|FG011|Treatment Period 2|Withdrawal by Subject|0|||
156890983|NCT02038829|566358903|FG000|Washout Period 2|Adverse Event|0|||
156890984|NCT02038829|566358904|FG001|Washout Period 2|Adverse Event|0|||
156890985|NCT02038829|566358905|FG002|Washout Period 2|Adverse Event|0|||
156890986|NCT02038829|566358906|FG003|Washout Period 2|Adverse Event|0|||
156890987|NCT02038829|566358907|FG004|Washout Period 2|Adverse Event|0|||
156890988|NCT02038829|566358908|FG005|Washout Period 2|Adverse Event|0|||
156890989|NCT02038829|566358909|FG006|Washout Period 2|Adverse Event|0|||
156890990|NCT02038829|566358910|FG007|Washout Period 2|Adverse Event|0|||
156890991|NCT02038829|566358911|FG008|Washout Period 2|Adverse Event|1|||
156890992|NCT02038829|566358912|FG009|Washout Period 2|Adverse Event|0|||
156890993|NCT02038829|566358913|FG010|Washout Period 2|Adverse Event|0|||
156890994|NCT02038829|566358914|FG011|Washout Period 2|Adverse Event|0|||
156890995|NCT02038829|566358903|FG000|Washout Period 2|Withdrawal by Subject|0|||
156890996|NCT02038829|566358904|FG001|Washout Period 2|Withdrawal by Subject|0|||
156890997|NCT02038829|566358905|FG002|Washout Period 2|Withdrawal by Subject|0|||
156890998|NCT02038829|566358906|FG003|Washout Period 2|Withdrawal by Subject|0|||
156890999|NCT02038829|566358907|FG004|Washout Period 2|Withdrawal by Subject|0|||
156891000|NCT02038829|566358908|FG005|Washout Period 2|Withdrawal by Subject|1|||
156891001|NCT02038829|566358909|FG006|Washout Period 2|Withdrawal by Subject|0|||
156891002|NCT02038829|566358910|FG007|Washout Period 2|Withdrawal by Subject|0|||
156891003|NCT02038829|566358911|FG008|Washout Period 2|Withdrawal by Subject|0|||
156891004|NCT02038829|566358912|FG009|Washout Period 2|Withdrawal by Subject|0|||
156891005|NCT02038829|566358913|FG010|Washout Period 2|Withdrawal by Subject|0|||
157225477|NCT00419926|567571438|FG000|Overall Study|Administrative Problem|4|||
157225478|NCT00419926|567571439|FG001|Overall Study|Administrative Problem|4|||
156891006|NCT02038829|566358914|FG011|Washout Period 2|Withdrawal by Subject|0|||
156891007|NCT02038829|566358903|FG000|Treatment Period 4|Adverse Event|0|||
156891008|NCT02038829|566358904|FG001|Treatment Period 4|Adverse Event|1|||
156891009|NCT02038829|566358905|FG002|Treatment Period 4|Adverse Event|0|||
156891010|NCT02038829|566358906|FG003|Treatment Period 4|Adverse Event|0|||
156891011|NCT02038829|566358907|FG004|Treatment Period 4|Adverse Event|0|||
156891012|NCT02038829|566358908|FG005|Treatment Period 4|Adverse Event|0|||
156891013|NCT02038829|566358909|FG006|Treatment Period 4|Adverse Event|0|||
156891014|NCT02038829|566358910|FG007|Treatment Period 4|Adverse Event|0|||
156891015|NCT02038829|566358911|FG008|Treatment Period 4|Adverse Event|0|||
156891016|NCT02038829|566358912|FG009|Treatment Period 4|Adverse Event|0|||
156891017|NCT02038829|566358913|FG010|Treatment Period 4|Adverse Event|0|||
156891018|NCT02038829|566358914|FG011|Treatment Period 4|Adverse Event|0|||
156891019|NCT02038829|566358903|FG000|Washout Period 4|Adverse Event|0|||
156891020|NCT02038829|566358904|FG001|Washout Period 4|Adverse Event|0|||
156891021|NCT02038829|566358905|FG002|Washout Period 4|Adverse Event|0|||
156891022|NCT02038829|566358906|FG003|Washout Period 4|Adverse Event|0|||
156891023|NCT02038829|566358907|FG004|Washout Period 4|Adverse Event|0|||
156891024|NCT02038829|566358908|FG005|Washout Period 4|Adverse Event|0|||
156891025|NCT02038829|566358909|FG006|Washout Period 4|Adverse Event|1|||
156891026|NCT02038829|566358910|FG007|Washout Period 4|Adverse Event|0|||
156891027|NCT02038829|566358911|FG008|Washout Period 4|Adverse Event|0|||
156891028|NCT02038829|566358912|FG009|Washout Period 4|Adverse Event|0|||
156891029|NCT02038829|566358913|FG010|Washout Period 4|Adverse Event|0|||
156891030|NCT02038829|566358914|FG011|Washout Period 4|Adverse Event|0|||
156857343|NCT03287791|566232462|FG001|Overall Study|Withdrawal by Subject|12|||
156857344|NCT03287791|566232463|FG002|Overall Study|Withdrawal by Subject|17|||
156857345|NCT03287791|566232461|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
156857346|NCT03287791|566232462|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
156857347|NCT03287791|566232463|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
156857348|NCT03287791|566232461|FG000|Overall Study|Lost to Follow-up|8|||
156857349|NCT03287791|566232462|FG001|Overall Study|Lost to Follow-up|14|||
156857350|NCT03287791|566232463|FG002|Overall Study|Lost to Follow-up|11|||
156857351|NCT03287791|566232461|FG000|Overall Study|Protocol Violation|7|||
156857352|NCT03287791|566232462|FG001|Overall Study|Protocol Violation|2|||
156857353|NCT03287791|566232463|FG002|Overall Study|Protocol Violation|1|||
156857354|NCT03287791|566232461|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
156857355|NCT03287791|566232462|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
156857356|NCT03287791|566232463|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
156857357|NCT03287791|566232461|FG000|Overall Study|Too much time between 2 visits|0|||
156857358|NCT03287791|566232462|FG001|Overall Study|Too much time between 2 visits|1|||
156857359|NCT03287791|566232463|FG002|Overall Study|Too much time between 2 visits|0|||
156857360|NCT03287791|566232461|FG000|Overall Study|Non-compliance|0|||
156857361|NCT03287791|566232462|FG001|Overall Study|Non-compliance|1|||
156857362|NCT03287791|566232463|FG002|Overall Study|Non-compliance|0|||
156857363|NCT03287791|566232461|FG000|Overall Study|Did not meet inclusion criteria|1|||
156857364|NCT03287791|566232462|FG001|Overall Study|Did not meet inclusion criteria|0|||
156857365|NCT03287791|566232463|FG002|Overall Study|Did not meet inclusion criteria|0|||
156857366|NCT01381016|566232465|FG000|Overall Study|Lost to Follow-up|1|||
156857367|NCT01381016|566232466|FG001|Overall Study|Lost to Follow-up|1|||
156857368|NCT01381016|566232465|FG000|Overall Study|Screen Failure|2|||
156857369|NCT01381016|566232466|FG001|Overall Study|Screen Failure|2|||
156857370|NCT01381016|566232465|FG000|Overall Study|Withdrawal by Subject|0|||
156857371|NCT01381016|566232466|FG001|Overall Study|Withdrawal by Subject|1|||
156857372|NCT01381016|566232465|FG000|Overall Study|Physician Decision|0|||
156857373|NCT01381016|566232466|FG001|Overall Study|Physician Decision|2|||
156857374|NCT04607668|566232471|FG000|Overall Study|Death|49|||
156857375|NCT04607668|566232472|FG001|Overall Study|Death|26|||
156857376|NCT04607668|566232471|FG000|Overall Study|Lost to Follow-up|3|||
156857377|NCT04607668|566232472|FG001|Overall Study|Lost to Follow-up|4|||
156857378|NCT04607668|566232471|FG000|Overall Study|Study terminated by Sponsor|92|||
156857379|NCT04607668|566232472|FG001|Overall Study|Study terminated by Sponsor|114|||
156857380|NCT04607668|566232471|FG000|Overall Study|Withdrawal by Subject|12|||
156857381|NCT04607668|566232472|FG001|Overall Study|Withdrawal by Subject|11|||
156857382|NCT04607668|566232471|FG000|Overall Study|Other, unspecified|8|||
156857383|NCT04607668|566232472|FG001|Overall Study|Other, unspecified|7|||
156857384|NCT01838694|566232473|FG000|Overall Study|Adverse Event|0|||
156857385|NCT01838694|566232474|FG001|Overall Study|Adverse Event|1|||
156857386|NCT01096316|566232475|FG000|Overall Study|Lost to Follow-up|15|||
156857387|NCT01096316|566232476|FG001|Overall Study|Lost to Follow-up|9|||
156857388|NCT06418152|566232477|FG000|Overall Study|Frequent DBS setting changes|1|||
156857389|NCT06418152|566232477|FG000|Overall Study|Withdrawal by Subject|2|||
156857390|NCT02529852|566232482|FG000|Overall Study|Withdrawal by Subject|2|||
156857391|NCT00718510|566232484|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
156857392|NCT00718510|566232485|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156857393|NCT00718510|566232484|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
156857394|NCT00718510|566232485|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
156857395|NCT02201524|566232486|FG000|Overall Study|Adverse Event|0|||
156857396|NCT02201524|566232487|FG001|Overall Study|Adverse Event|2|||
156857397|NCT02201524|566232488|FG002|Overall Study|Adverse Event|1|||
156857398|NCT02201524|566232489|FG003|Overall Study|Adverse Event|0|||
156857399|NCT02201524|566232486|FG000|Overall Study|Insufficient clinical response|1|||
156857400|NCT02201524|566232487|FG001|Overall Study|Insufficient clinical response|0|||
156857401|NCT02201524|566232488|FG002|Overall Study|Insufficient clinical response|0|||
156857402|NCT02201524|566232489|FG003|Overall Study|Insufficient clinical response|0|||
156857403|NCT02201524|566232486|FG000|Overall Study|Lost to Follow-up|0|||
156857404|NCT02201524|566232487|FG001|Overall Study|Lost to Follow-up|0|||
156857405|NCT02201524|566232488|FG002|Overall Study|Lost to Follow-up|2|||
156857406|NCT02201524|566232489|FG003|Overall Study|Lost to Follow-up|0|||
156857407|NCT02201524|566232486|FG000|Overall Study|No longer meets eligibility criteria|0|||
156857408|NCT02201524|566232487|FG001|Overall Study|No longer meets eligibility criteria|0|||
156857409|NCT02201524|566232488|FG002|Overall Study|No longer meets eligibility criteria|0|||
156857410|NCT02201524|566232489|FG003|Overall Study|No longer meets eligibility criteria|2|||
156857411|NCT02201524|566232486|FG000|Overall Study|Protocol Violation|0|||
156857412|NCT02201524|566232487|FG001|Overall Study|Protocol Violation|0|||
156857413|NCT02201524|566232488|FG002|Overall Study|Protocol Violation|0|||
156857414|NCT02201524|566232489|FG003|Overall Study|Protocol Violation|1|||
156857415|NCT02201524|566232486|FG000|Overall Study|Withdrawal by Subject|0|||
156857416|NCT02201524|566232487|FG001|Overall Study|Withdrawal by Subject|0|||
156857417|NCT02201524|566232488|FG002|Overall Study|Withdrawal by Subject|1|||
157157851|NCT03249792|567322864|FG000|Switch Over Period|Progressive Disease|0|||
157157852|NCT03249792|567322865|FG001|Switch Over Period|Progressive Disease|0|||
157157853|NCT03249792|567322866|FG002|Switch Over Period|Progressive Disease|0|||
157157854|NCT03249792|567322867|FG003|Switch Over Period|Progressive Disease|0|||
157157855|NCT03249792|567322868|FG004|Switch Over Period|Progressive Disease|0|||
157157856|NCT03249792|567322869|FG005|Switch Over Period|Progressive Disease|0|||
157157857|NCT03249792|567322870|FG006|Switch Over Period|Progressive Disease|0|||
157157858|NCT03249792|567322871|FG007|Switch Over Period|Progressive Disease|0|||
156857418|NCT02201524|566232489|FG003|Overall Study|Withdrawal by Subject|1|||
156857419|NCT02201524|566232486|FG000|Overall Study|Other|1|||
156857420|NCT02201524|566232487|FG001|Overall Study|Other|1|||
156857421|NCT02201524|566232488|FG002|Overall Study|Other|0|||
156857422|NCT02201524|566232489|FG003|Overall Study|Other|0|||
156857423|NCT00423657|566232490|FG000|Overall Study|Withdrew consent|10|||
156857424|NCT00423657|566232491|FG001|Overall Study|Withdrew consent|8|||
156857425|NCT00423657|566232490|FG000|Overall Study|Non-compliance|0|||
156857426|NCT00423657|566232491|FG001|Overall Study|Non-compliance|1|||
156857427|NCT00423657|566232490|FG000|Overall Study|Other|15|||
156857428|NCT00423657|566232491|FG001|Overall Study|Other|16|||
156857429|NCT00423657|566232490|FG000|Overall Study|Request of sponsor/investigator|1|||
156857430|NCT00423657|566232491|FG001|Overall Study|Request of sponsor/investigator|0|||
156857431|NCT02314052|566232492|FG000|Cycle One|Adverse Event|0|||
156857432|NCT02314052|566232493|FG001|Cycle One|Adverse Event|0|||
156857433|NCT02314052|566232494|FG002|Cycle One|Adverse Event|0|||
156857434|NCT02314052|566232495|FG003|Cycle One|Adverse Event|1|||
156857435|NCT02314052|566232496|FG004|Cycle One|Adverse Event|0|||
156857436|NCT02314052|566232497|FG005|Cycle One|Adverse Event|0|||
156857437|NCT00474955|566232498|FG000|Overall Study|Adverse Event|2|||
156857438|NCT00474955|566232498|FG000|Overall Study|Drug unavailability|1|||
156857439|NCT00474955|566232498|FG000|Overall Study|Personal reasons|5|||
156857440|NCT02653326|566232499|FG000|Overall Study|Lost to Follow-up|10|||
156857441|NCT02653326|566232500|FG001|Overall Study|Lost to Follow-up|7|||
156857442|NCT02422498|566232501|FG000|Overall Study|Inevaluable|4|||
156857443|NCT01620060|566232505|FG000|Overall Study|Adverse Event|9|||
156857444|NCT01620060|566232505|FG000|Overall Study|Protocol Violation|1|||
156857445|NCT01620060|566232505|FG000|Overall Study|Withdrawal by Subject|1|||
156857446|NCT01620060|566232505|FG000|Overall Study|Did not comply with Study Produre|1|||
156857447|NCT01620060|566232505|FG000|Overall Study|Family emergency|1|||
156857448|NCT01620060|566232505|FG000|Overall Study|Per Sponsor Decision|2|||
156857449|NCT04664153|566232508|FG000|Overall Study|Lack of Efficacy|0|||
156857450|NCT04664153|566232509|FG001|Overall Study|Lack of Efficacy|0|||
156857451|NCT04664153|566232510|FG002|Overall Study|Lack of Efficacy|1|||
156857452|NCT04664153|566232511|FG003|Overall Study|Lack of Efficacy|0|||
156857453|NCT04664153|566232508|FG000|Overall Study|Physician Decision|0|||
156857454|NCT04664153|566232509|FG001|Overall Study|Physician Decision|0|||
156857455|NCT04664153|566232510|FG002|Overall Study|Physician Decision|1|||
156857456|NCT04664153|566232511|FG003|Overall Study|Physician Decision|0|||
156857457|NCT04664153|566232508|FG000|Overall Study|Withdrawal by Subject|3|||
156857458|NCT04664153|566232509|FG001|Overall Study|Withdrawal by Subject|2|||
156857459|NCT04664153|566232510|FG002|Overall Study|Withdrawal by Subject|1|||
156857460|NCT04664153|566232511|FG003|Overall Study|Withdrawal by Subject|2|||
156857461|NCT04664153|566232508|FG000|Overall Study|Other|0|||
156857462|NCT04664153|566232509|FG001|Overall Study|Other|1|||
156857463|NCT04664153|566232510|FG002|Overall Study|Other|0|||
156857464|NCT04664153|566232511|FG003|Overall Study|Other|0|||
156857465|NCT04664153|566232508|FG000|Overall Study|Adverse Event|4|||
156857466|NCT04664153|566232509|FG001|Overall Study|Adverse Event|0|||
156857467|NCT04664153|566232510|FG002|Overall Study|Adverse Event|1|||
156857468|NCT04664153|566232511|FG003|Overall Study|Adverse Event|0|||
156857469|NCT01045460|566232512|FG000|Overall Study|Physician Decision|3|||
156857470|NCT01045460|566232513|FG001|Overall Study|Physician Decision|2|||
156857471|NCT01045460|566232512|FG000|Overall Study|Lost to Follow-up|0|||
156857472|NCT01045460|566232513|FG001|Overall Study|Lost to Follow-up|1|||
156857473|NCT01045460|566232512|FG000|Overall Study|Lack of Efficacy|3|||
156857474|NCT01045460|566232513|FG001|Overall Study|Lack of Efficacy|0|||
156857475|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
157157859|NCT03249792|567322872|FG008|Switch Over Period|Progressive Disease|0|||
156857476|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
156857477|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
157157860|NCT03249792|567322873|FG009|Switch Over Period|Progressive Disease|0|||
156857478|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
156857479|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
157225479|NCT00419926|567571438|FG000|Overall Study|Lost to Follow-up|1|||
156857480|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
156857481|NCT00097500|566232514|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
156857482|NCT00097500|566232515|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
156857483|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
157157861|NCT03249792|567322874|FG010|Switch Over Period|Progressive Disease|0|||
157225480|NCT00419926|567571439|FG001|Overall Study|Lost to Follow-up|2|||
156857484|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
156857485|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
157225481|NCT00419926|567571438|FG000|Overall Study|Death|2|||
156857486|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
156857487|NCT00097500|566232514|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
156857488|NCT00097500|566232515|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
156857489|NCT00524485|566232519|FG000|Overall Study|Withdrawal by Subject|5|||
156857490|NCT01600885|566232522|FG000|First Period|Adverse Event|1|||
156857491|NCT01600885|566232523|FG001|First Period|Adverse Event|1|||
156857492|NCT01600885|566232522|FG000|First Period|moved out of area|1|||
156857493|NCT01600885|566232523|FG001|First Period|moved out of area|0|||
156857494|NCT00642356|566232529|FG000|Overall Study|Adverse Event|1|||
156857495|NCT00642356|566232530|FG001|Overall Study|Adverse Event|0|||
156857496|NCT00642356|566232529|FG000|Overall Study|Protocol Violation|0|||
156857497|NCT00642356|566232530|FG001|Overall Study|Protocol Violation|3|||
156857498|NCT00642356|566232529|FG000|Overall Study|Lack of Efficacy|1|||
156857499|NCT00642356|566232530|FG001|Overall Study|Lack of Efficacy|0|||
156857500|NCT04551989|566232533|FG000|Overall Study|Adverse Event|4|||
156857501|NCT04551989|566232533|FG000|Overall Study|Protocol Violation|3|||
156857502|NCT04551989|566232533|FG000|Overall Study|Lost to Follow-up|1|||
156857503|NCT04551989|566232533|FG000|Overall Study|Physician Decision|3|||
156857504|NCT04201431|566232534|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
156857505|NCT04201431|566232535|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
156857506|NCT04201431|566232536|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
156857507|NCT02694744|566232541|FG000|Overall Study|Adverse Event|2|||
156857508|NCT02694744|566232542|FG001|Overall Study|Adverse Event|1|||
156857509|NCT02694744|566232541|FG000|Overall Study|Withdrawal by Subject|2|||
156857510|NCT02694744|566232542|FG001|Overall Study|Withdrawal by Subject|1|||
156857511|NCT02694744|566232541|FG000|Overall Study|Physician Decision|1|||
156857512|NCT02694744|566232542|FG001|Overall Study|Physician Decision|2|||
156857513|NCT02694744|566232541|FG000|Overall Study|Lost to Follow-up|1|||
156857514|NCT02694744|566232542|FG001|Overall Study|Lost to Follow-up|0|||
156857515|NCT02694744|566232541|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
156857516|NCT02694744|566232542|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
156857517|NCT00686777|566232543|FG000|Overall Study|Adverse Event|2|||
156857518|NCT00686777|566232543|FG000|Overall Study|Pregnancy|1|||
156857519|NCT00686777|566232543|FG000|Overall Study|Withdrawal by Subject|2|||
156857520|NCT00686777|566232543|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
156857521|NCT00686777|566232543|FG000|Overall Study|No Visit|1|||
156857522|NCT00667888|566232544|FG000|Overall Study|Death|1|||
156857523|NCT00667888|566232545|FG001|Overall Study|Death|1|||
156857524|NCT00667888|566232544|FG000|Overall Study|Withdrawal by Subject|6|||
156857525|NCT00667888|566232545|FG001|Overall Study|Withdrawal by Subject|3|||
156857526|NCT00667888|566232544|FG000|Overall Study|Proceed with other treatment|3|||
156857527|NCT00667888|566232545|FG001|Overall Study|Proceed with other treatment|3|||
156857528|NCT00667888|566232544|FG000|Overall Study|Ineligible after SIM|0|||
156857529|NCT00667888|566232545|FG001|Overall Study|Ineligible after SIM|2|||
156857530|NCT01945021|566232546|FG000|Overall Study|Adverse Event|1|||
156857531|NCT01945021|566232546|FG000|Overall Study|Withdrawal of consent|12|||
156857532|NCT01945021|566232546|FG000|Overall Study|Lost to Follow-up|5|||
156857533|NCT01945021|566232546|FG000|Overall Study|Death|65|||
156857534|NCT00499681|566232547|FG000|Overall Study|toxicity|0|||
156857535|NCT00499681|566232548|FG001|Overall Study|toxicity|1|||
156857536|NCT00499681|566232547|FG000|Overall Study|disease progression|0|||
156857537|NCT00499681|566232548|FG001|Overall Study|disease progression|1|||
156857538|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
156857539|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
156857540|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Disease progression|75|||
156857541|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Disease progression|59|||
156857542|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Adverse Event|16|||
156857543|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Adverse Event|16|||
156857544|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Death|2|||
156857545|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Death|3|||
156857546|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
156857547|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
156857548|NCT00883779|566232549|FG000|Primary Study Treatment Phase|Other|3|||
156857549|NCT00883779|566232550|FG001|Primary Study Treatment Phase|Other|0|||
156857550|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Adverse Event|2|||
156857551|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Adverse Event|3|||
156857552|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Death|1|||
156857553|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Death|3|||
156857554|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
156857555|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
156857556|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
156857557|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
156891031|NCT02038829|566358903|FG000|Treatment Period 6|Adverse Event|0|||
156891032|NCT02038829|566358904|FG001|Treatment Period 6|Adverse Event|0|||
156891033|NCT02038829|566358905|FG002|Treatment Period 6|Adverse Event|1|||
156891034|NCT02038829|566358906|FG003|Treatment Period 6|Adverse Event|0|||
156891035|NCT02038829|566358907|FG004|Treatment Period 6|Adverse Event|0|||
156891036|NCT02038829|566358908|FG005|Treatment Period 6|Adverse Event|0|||
156891037|NCT02038829|566358909|FG006|Treatment Period 6|Adverse Event|0|||
156891038|NCT02038829|566358910|FG007|Treatment Period 6|Adverse Event|0|||
156891039|NCT02038829|566358911|FG008|Treatment Period 6|Adverse Event|0|||
156891040|NCT02038829|566358912|FG009|Treatment Period 6|Adverse Event|0|||
156891041|NCT02038829|566358913|FG010|Treatment Period 6|Adverse Event|0|||
156891042|NCT02038829|566358914|FG011|Treatment Period 6|Adverse Event|0|||
156891043|NCT05128929|566358915|FG000|Overall Study|Adverse Event|0|||
156891044|NCT05128929|566358916|FG001|Overall Study|Adverse Event|1|||
156891045|NCT03707184|566358919|FG000|Overall Study|Withdrawal by Subject|2|||
156891046|NCT04704154|566358920|FG000|Overall Study|Adverse Event|3|||
156891047|NCT04704154|566358921|FG001|Overall Study|Adverse Event|2|||
156891048|NCT04704154|566358922|FG002|Overall Study|Adverse Event|4|||
156891049|NCT04704154|566358923|FG003|Overall Study|Adverse Event|2|||
156891050|NCT04704154|566358924|FG004|Overall Study|Adverse Event|3|||
156891051|NCT04704154|566358925|FG005|Overall Study|Adverse Event|0|||
156891052|NCT04704154|566358920|FG000|Overall Study|Death|3|||
156891053|NCT04704154|566358921|FG001|Overall Study|Death|0|||
156891054|NCT04704154|566358922|FG002|Overall Study|Death|0|||
156891055|NCT04704154|566358923|FG003|Overall Study|Death|0|||
156891056|NCT04704154|566358924|FG004|Overall Study|Death|3|||
156891057|NCT04704154|566358925|FG005|Overall Study|Death|0|||
156891058|NCT04704154|566358920|FG000|Overall Study|Physician Decision|1|||
156891059|NCT04704154|566358921|FG001|Overall Study|Physician Decision|0|||
156891060|NCT04704154|566358922|FG002|Overall Study|Physician Decision|1|||
156891061|NCT04704154|566358923|FG003|Overall Study|Physician Decision|0|||
156891062|NCT04704154|566358924|FG004|Overall Study|Physician Decision|2|||
156891063|NCT04704154|566358925|FG005|Overall Study|Physician Decision|0|||
156891064|NCT04704154|566358920|FG000|Overall Study|Participant Decision|1|||
156891065|NCT04704154|566358921|FG001|Overall Study|Participant Decision|1|||
156891066|NCT04704154|566358922|FG002|Overall Study|Participant Decision|0|||
156891067|NCT04704154|566358923|FG003|Overall Study|Participant Decision|0|||
156891068|NCT04704154|566358924|FG004|Overall Study|Participant Decision|0|||
156891069|NCT04704154|566358925|FG005|Overall Study|Participant Decision|0|||
156891070|NCT04704154|566358920|FG000|Overall Study|Progressive Disease|19|||
156891071|NCT04704154|566358921|FG001|Overall Study|Progressive Disease|17|||
156891072|NCT04704154|566358922|FG002|Overall Study|Progressive Disease|20|||
156891073|NCT04704154|566358923|FG003|Overall Study|Progressive Disease|18|||
156891074|NCT04704154|566358924|FG004|Overall Study|Progressive Disease|36|||
156891075|NCT04704154|566358925|FG005|Overall Study|Progressive Disease|30|||
156891076|NCT04704154|566358920|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
156891077|NCT04704154|566358921|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156891078|NCT04704154|566358922|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
156891079|NCT04704154|566358923|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156891080|NCT04704154|566358924|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
157225482|NCT00419926|567571439|FG001|Overall Study|Death|1|||
156891081|NCT04704154|566358925|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
156891082|NCT04704154|566358920|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
156891083|NCT04704154|566358921|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
156891084|NCT04704154|566358922|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
156891085|NCT04704154|566358923|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
156891086|NCT04704154|566358924|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
156891087|NCT04704154|566358925|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
156891088|NCT04950608|566358926|FG000|Overall Study|Withdrawal by Subject|2|||
156891089|NCT04950608|566358926|FG000|Overall Study|Physician Decision|3|||
156891090|NCT03553836|566358927|FG000|Overall Study|Ongoing in Study|460|||
156891091|NCT03553836|566358928|FG001|Overall Study|Ongoing in Study|459|||
156891092|NCT03553836|566358927|FG000|Overall Study|Withdrawal by Subject|9|||
156891093|NCT03553836|566358928|FG001|Overall Study|Withdrawal by Subject|10|||
156891094|NCT03553836|566358927|FG000|Overall Study|Lost to Follow-up|1|||
156891095|NCT03553836|566358928|FG001|Overall Study|Lost to Follow-up|3|||
156891096|NCT03553836|566358927|FG000|Overall Study|Death|17|||
156891097|NCT03553836|566358928|FG001|Overall Study|Death|17|||
156891098|NCT03220438|566358929|FG000|Overall Study|Lost to Follow-up|0|||
156891099|NCT03220438|566358930|FG001|Overall Study|Lost to Follow-up|0|||
156891100|NCT03220438|566358931|FG002|Overall Study|Lost to Follow-up|1|||
156891101|NCT03220438|566358932|FG003|Overall Study|Lost to Follow-up|0|||
156891102|NCT04190680|566358933|FG000|Overall Study|Not meeting criteria for data analysis|1|||
156891103|NCT04190680|566358934|FG001|Overall Study|Not meeting criteria for data analysis|15|||
156891104|NCT04190680|566358933|FG000|Overall Study|Administrative error|0|||
156891105|NCT04190680|566358934|FG001|Overall Study|Administrative error|18|||
156891106|NCT05660850|566358935|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
156891107|NCT05660850|566358936|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
156891108|NCT05660850|566358937|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
156891109|NCT05660850|566358938|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
156891110|NCT01302834|566358951|FG000|Overall Study|Protocol Violation|17|||
156891111|NCT01302834|566358952|FG001|Overall Study|Protocol Violation|23|||
156891112|NCT01302834|566358951|FG000|Overall Study|HIV positive|1|||
156891113|NCT01302834|566358952|FG001|Overall Study|HIV positive|3|||
156891114|NCT04779216|566358953|FG000|Overall Study|Lost to Follow-up|1|||
156891115|NCT04779216|566358954|FG001|Overall Study|Lost to Follow-up|0|||
156891116|NCT04779216|566358953|FG000|Overall Study|Withdrawal by Subject|1|||
156891117|NCT04779216|566358954|FG001|Overall Study|Withdrawal by Subject|0|||
156891118|NCT02674854|566358955|FG000|Overall Study|Adverse Event|17|||
156891119|NCT02674854|566358956|FG001|Overall Study|Adverse Event|15|||
156891120|NCT02674854|566358957|FG002|Overall Study|Adverse Event|5|||
156891121|NCT02674854|566358955|FG000|Overall Study|Withdrawal by Subject|1|||
156891122|NCT02674854|566358956|FG001|Overall Study|Withdrawal by Subject|5|||
156891123|NCT02674854|566358957|FG002|Overall Study|Withdrawal by Subject|4|||
156891124|NCT02674854|566358955|FG000|Overall Study|No-compliant subject|1|||
156891125|NCT02674854|566358956|FG001|Overall Study|No-compliant subject|0|||
156891126|NCT02674854|566358957|FG002|Overall Study|No-compliant subject|1|||
156891127|NCT02674854|566358955|FG000|Overall Study|Lost to Follow-up|1|||
156891128|NCT02674854|566358956|FG001|Overall Study|Lost to Follow-up|0|||
156891129|NCT02674854|566358957|FG002|Overall Study|Lost to Follow-up|2|||
156891130|NCT02674854|566358955|FG000|Overall Study|Lack of Efficacy|0|||
156891131|NCT02674854|566358956|FG001|Overall Study|Lack of Efficacy|3|||
156891132|NCT02674854|566358957|FG002|Overall Study|Lack of Efficacy|0|||
156891133|NCT02674854|566358955|FG000|Overall Study|Disallowed Concurrent Medication|2|||
156891134|NCT02674854|566358956|FG001|Overall Study|Disallowed Concurrent Medication|2|||
156891135|NCT02674854|566358957|FG002|Overall Study|Disallowed Concurrent Medication|0|||
156891136|NCT02674854|566358955|FG000|Overall Study|Protocol Violation|1|||
156891137|NCT02674854|566358956|FG001|Overall Study|Protocol Violation|1|||
156891138|NCT02674854|566358957|FG002|Overall Study|Protocol Violation|2|||
156891139|NCT02674854|566358955|FG000|Overall Study|Death|0|||
156891140|NCT02674854|566358956|FG001|Overall Study|Death|1|||
156891141|NCT02674854|566358957|FG002|Overall Study|Death|0|||
156891142|NCT02674854|566358955|FG000|Overall Study|Subject missed V6.2|1|||
156891143|NCT02674854|566358956|FG001|Overall Study|Subject missed V6.2|0|||
156891144|NCT02674854|566358957|FG002|Overall Study|Subject missed V6.2|0|||
156891145|NCT02274038|566358958|FG000|Overall Study|Death|1|||
156891146|NCT00745615|566358959|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
156891147|NCT00745615|566358960|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
156891148|NCT00745615|566358961|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156891149|NCT00745615|566358962|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
156891150|NCT00745615|566358963|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156891151|NCT00745615|566358964|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
156891152|NCT00745615|566358959|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156891153|NCT00745615|566358960|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
156891154|NCT00745615|566358961|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156891155|NCT00745615|566358962|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156891156|NCT00745615|566358963|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156891157|NCT00745615|566358964|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
156891158|NCT00745615|566358959|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
156891159|NCT00745615|566358960|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
156891160|NCT00745615|566358961|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
156891161|NCT00745615|566358962|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
156891162|NCT00745615|566358963|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
156891163|NCT00745615|566358964|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
156891164|NCT00745615|566358959|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156891165|NCT00745615|566358960|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
156891166|NCT00745615|566358961|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156891167|NCT00745615|566358962|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156891168|NCT00745615|566358963|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156891169|NCT00745615|566358964|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
156891170|NCT00745615|566358959|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156891171|NCT00745615|566358960|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
156891172|NCT00745615|566358961|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156891173|NCT00745615|566358962|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156891174|NCT00745615|566358963|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156891175|NCT00745615|566358964|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
156891176|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156891177|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156891178|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156891179|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
156891180|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
156891181|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
156891182|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156891183|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156891184|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156891185|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
156891186|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
156891187|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
156891188|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156891189|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156891190|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156891191|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
156891192|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
156891193|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
156891194|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156891195|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156891196|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156891197|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
156891198|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
156891199|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
156891200|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156891201|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156891202|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156891203|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
156891204|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
156891205|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
156891206|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156891207|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156891208|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156891209|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
156891210|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
156891211|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
156891212|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156891213|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156891214|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156891215|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156891216|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
156891217|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
156891218|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
156891219|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
156891220|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
156891221|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
156891222|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
156891223|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
156891224|NCT00745615|566358959|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156891225|NCT00745615|566358960|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156891226|NCT00745615|566358961|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156891227|NCT00745615|566358962|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
156891228|NCT00745615|566358963|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
156891229|NCT00745615|566358964|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
156891230|NCT00570232|566358965|FG000|Overall Study|Adverse Event|10|||
156891231|NCT00570232|566358965|FG000|Overall Study|discontinued due to medical condition|3|||
157025974|NCT01175356|566849669|FG000|Overall Study|Lost to Follow-up|1|||
157025975|NCT01175356|566849669|FG000|Overall Study|Physician Decision|23|||
157025976|NCT01175356|566849669|FG000|Overall Study|Ineligible|1|||
157157862|NCT03249792|567322875|FG011|Switch Over Period|Progressive Disease|0|||
157157863|NCT03249792|567322876|FG012|Switch Over Period|Progressive Disease|0|||
157157864|NCT03249792|567322877|FG013|Switch Over Period|Progressive Disease|0|||
157157865|NCT03249792|567322878|FG014|Switch Over Period|Progressive Disease|0|||
156891232|NCT00570232|566358965|FG000|Overall Study|discontinued due to recurrence|8|||
156891233|NCT00570232|566358965|FG000|Overall Study|discontinued due to noncompliance|2|||
156891234|NCT01163318|566358968|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
156891235|NCT01163318|566358968|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
157025977|NCT01175356|566849669|FG000|Overall Study|Treatment Slot Not Available|18|||
156891236|NCT01163318|566358968|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
156891237|NCT01163318|566358968|FG000|Overall Study|Participants Without Case Report Form|7|||
156891238|NCT01163318|566358968|FG000|Overall Study|Multiple Reasons Per Participant|224|||
156891239|NCT03610555|566358972|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
156891240|NCT03610555|566358973|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
156891241|NCT03610555|566358974|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
156891242|NCT03610555|566358975|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
156891243|NCT01892722|566358976|FG000|Overall Study|Protocol deviation|0|||
156891244|NCT01892722|566358977|FG001|Overall Study|Protocol deviation|1|||
156891245|NCT01892722|566358976|FG000|Overall Study|Administrative problems|0|||
156891246|NCT01892722|566358977|FG001|Overall Study|Administrative problems|1|||
156891247|NCT01892722|566358976|FG000|Overall Study|Patient/guardian decision|0|||
156891248|NCT01892722|566358977|FG001|Overall Study|Patient/guardian decision|2|||
156891249|NCT01892722|566358976|FG000|Overall Study|Physician Decision|1|||
156891250|NCT01892722|566358977|FG001|Overall Study|Physician Decision|2|||
156891251|NCT01892722|566358976|FG000|Overall Study|Adverse Event|3|||
156891252|NCT01892722|566358977|FG001|Overall Study|Adverse Event|2|||
156891253|NCT01892722|566358976|FG000|Overall Study|Lack of Efficacy|0|||
156891254|NCT01892722|566358977|FG001|Overall Study|Lack of Efficacy|7|||
156891255|NCT01892722|566358976|FG000|Overall Study|Withdrawal by Subject|3|||
156891256|NCT01892722|566358977|FG001|Overall Study|Withdrawal by Subject|5|||
156891257|NCT04285580|566360209|FG000|Overall Study|Protocol Violation|0|||
156891258|NCT04285580|566360210|FG001|Overall Study|Protocol Violation|1|||
156891259|NCT02582255|566360211|FG000|Overall Study|Protocol Violation|0|||
156891260|NCT02582255|566360212|FG001|Overall Study|Protocol Violation|3|||
156891261|NCT01709578|566360214|FG000|Overall Study|Rescued and entered in long term safety|63|||
156891262|NCT01709578|566360215|FG001|Overall Study|Rescued and entered in long term safety|25|||
156891263|NCT01709578|566360216|FG002|Overall Study|Rescued and entered in long term safety|26|||
156891264|NCT01709578|566360214|FG000|Overall Study|Adverse Event|9|||
156891265|NCT01709578|566360215|FG001|Overall Study|Adverse Event|18|||
156891266|NCT01709578|566360216|FG002|Overall Study|Adverse Event|17|||
156891267|NCT01709578|566360214|FG000|Overall Study|Lack of Efficacy|5|||
156891268|NCT01709578|566360215|FG001|Overall Study|Lack of Efficacy|4|||
156891269|NCT01709578|566360216|FG002|Overall Study|Lack of Efficacy|2|||
156891270|NCT01709578|566360214|FG000|Overall Study|Poor compliance to protocol|1|||
156891271|NCT01709578|566360215|FG001|Overall Study|Poor compliance to protocol|2|||
156891272|NCT01709578|566360216|FG002|Overall Study|Poor compliance to protocol|1|||
156891273|NCT01709578|566360214|FG000|Overall Study|Other, not related to safety or efficacy|2|||
156891274|NCT01709578|566360215|FG001|Overall Study|Other, not related to safety or efficacy|7|||
156891275|NCT01709578|566360216|FG002|Overall Study|Other, not related to safety or efficacy|5|||
156891276|NCT04050371|566360217|FG000|Overall Study|Withdrawal by Subject|1|||
156891277|NCT04050371|566360218|FG001|Overall Study|Withdrawal by Subject|0|||
156891278|NCT01107418|566360219|FG000|Overall Study|Disease Progression|45|||
156891279|NCT01107418|566360219|FG000|Overall Study|Adverse Event|3|||
156891280|NCT01107418|566360219|FG000|Overall Study|Withdrawal by Subject|1|||
156891281|NCT01107418|566360219|FG000|Overall Study|Study Closing|1|||
156891282|NCT01107418|566360219|FG000|Overall Study|Started Other Therapy|1|||
156891283|NCT01107418|566360219|FG000|Overall Study|Entered Extension Study|1|||
156891284|NCT00597701|566360220|FG000|Overall Study|Withdrawal by Subject|5|||
156891285|NCT00597701|566360221|FG001|Overall Study|Withdrawal by Subject|5|||
156891286|NCT00597701|566360220|FG000|Overall Study|Death|0|||
156891287|NCT00597701|566360221|FG001|Overall Study|Death|1|||
156891288|NCT00597701|566360220|FG000|Overall Study|Physician Decision|2|||
156891289|NCT00597701|566360221|FG001|Overall Study|Physician Decision|0|||
156891290|NCT00597701|566360220|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
156891291|NCT00597701|566360221|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
156891292|NCT01741012|566360223|FG000|Overall Study|Lost to Follow-up|1|||
156891293|NCT01741012|566360223|FG000|Overall Study|Withdrawal by Subject|2|||
156891294|NCT02604017|566360235|FG000|Overall Study|Withdrew Consent|0|||
156891295|NCT02604017|566360236|FG001|Overall Study|Withdrew Consent|2|||
156891296|NCT02604017|566360235|FG000|Overall Study|Lost to Follow-up|5|||
156891297|NCT02604017|566360236|FG001|Overall Study|Lost to Follow-up|6|||
156891298|NCT02604017|566360235|FG000|Overall Study|Other|1|||
157025978|NCT01175356|566849669|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
157025979|NCT01175356|566849669|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
157025980|NCT01175356|566849669|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
156891299|NCT02604017|566360236|FG001|Overall Study|Other|0|||
156891300|NCT04104438|566360237|FG000|Overall Study|Death|2|||
156891301|NCT04104438|566360238|FG001|Overall Study|Death|1|||
156891302|NCT04104438|566360239|FG002|Overall Study|Death|2|||
156891303|NCT04104438|566360237|FG000|Overall Study|Adverse Event|0|||
156891304|NCT04104438|566360238|FG001|Overall Study|Adverse Event|3|||
156891305|NCT04104438|566360239|FG002|Overall Study|Adverse Event|0|||
156891306|NCT04104438|566360237|FG000|Overall Study|Withdrawal by Subject|0|||
156891307|NCT04104438|566360238|FG001|Overall Study|Withdrawal by Subject|1|||
157025981|NCT01175356|566849669|FG000|Overall Study|Inadequate stem cell for transplant|1|||
156891308|NCT04104438|566360239|FG002|Overall Study|Withdrawal by Subject|0|||
156891309|NCT04104438|566360237|FG000|Overall Study|Disenrolled due to noncompliance|0|||
156891310|NCT04104438|566360238|FG001|Overall Study|Disenrolled due to noncompliance|1|||
156891311|NCT04104438|566360239|FG002|Overall Study|Disenrolled due to noncompliance|0|||
156891312|NCT04104438|566360237|FG000|Overall Study|stopped due to possible operation|0|||
156891313|NCT04104438|566360238|FG001|Overall Study|stopped due to possible operation|1|||
156891314|NCT04104438|566360239|FG002|Overall Study|stopped due to possible operation|0|||
156891315|NCT04104438|566360237|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
156891316|NCT04104438|566360238|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
156891317|NCT04104438|566360239|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
156891318|NCT01315236|566360242|FG000|Double-blind Phase|Death|1|||
156891319|NCT01315236|566360243|FG001|Double-blind Phase|Death|0|||
156891320|NCT01315236|566360242|FG000|Double-blind Phase|Adverse Event|1|||
156891321|NCT01315236|566360243|FG001|Double-blind Phase|Adverse Event|0|||
156891322|NCT01315236|566360242|FG000|Double-blind Phase|Withdrawal of Consent|1|||
156891323|NCT01315236|566360243|FG001|Double-blind Phase|Withdrawal of Consent|0|||
156891324|NCT01315236|566360242|FG000|Double-blind Phase|Lost to Follow-up|1|||
156891325|NCT01315236|566360243|FG001|Double-blind Phase|Lost to Follow-up|0|||
156891326|NCT01315236|566360242|FG000|Open-label Phase|Death|1|||
156891327|NCT01315236|566360243|FG001|Open-label Phase|Death|0|||
156891328|NCT01315236|566360242|FG000|Open-label Phase|Adverse Event|0|||
156891329|NCT01315236|566360243|FG001|Open-label Phase|Adverse Event|1|||
156891330|NCT01315236|566360242|FG000|Open-label Phase|Other|0|||
156891331|NCT01315236|566360243|FG001|Open-label Phase|Other|1|||
156891332|NCT01315236|566360242|FG000|12-Month Follow-up Period|Death|0|||
156891333|NCT01315236|566360243|FG001|12-Month Follow-up Period|Death|1|||
156891334|NCT01315236|566360242|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
156891335|NCT01315236|566360243|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
156891336|NCT01923168|566360244|FG000|Overall Study|Protocol Violation|1|||
156891337|NCT01923168|566360245|FG001|Overall Study|Protocol Violation|1|||
156891338|NCT01923168|566360246|FG002|Overall Study|Protocol Violation|0|||
156891339|NCT01923168|566360244|FG000|Overall Study|Subject/guardian decision|14|||
156891340|NCT01923168|566360245|FG001|Overall Study|Subject/guardian decision|14|||
156891341|NCT01923168|566360246|FG002|Overall Study|Subject/guardian decision|4|||
156891342|NCT01923168|566360244|FG000|Overall Study|Adverse Event|12|||
156891343|NCT01923168|566360245|FG001|Overall Study|Adverse Event|12|||
156891344|NCT01923168|566360246|FG002|Overall Study|Adverse Event|0|||
156891345|NCT01923168|566360244|FG000|Overall Study|Physician Decision|6|||
156891346|NCT01923168|566360245|FG001|Overall Study|Physician Decision|9|||
156891347|NCT01923168|566360246|FG002|Overall Study|Physician Decision|5|||
156891348|NCT01923168|566360244|FG000|Overall Study|Progressive disease|4|||
156891349|NCT01923168|566360245|FG001|Overall Study|Progressive disease|3|||
156891350|NCT01923168|566360246|FG002|Overall Study|Progressive disease|7|||
156891351|NCT01923168|566360244|FG000|Overall Study|Death|0|||
156891352|NCT01923168|566360245|FG001|Overall Study|Death|0|||
156891353|NCT01923168|566360246|FG002|Overall Study|Death|1|||
156891354|NCT03116347|566360247|FG000|Overall Study|Withdrawal by Subject|1|||
156891355|NCT03116347|566360248|FG001|Overall Study|Withdrawal by Subject|2|||
156891356|NCT04193410|566360249|FG000|Overall Study|Lost to Follow-up|7|||
156891357|NCT04193410|566360250|FG001|Overall Study|Lost to Follow-up|6|||
156891358|NCT01293799|566360251|FG000|Overall Study|Kidney transplantation|109|||
156891359|NCT01293799|566360252|FG001|Overall Study|Kidney transplantation|96|||
156891360|NCT01293799|566360251|FG000|Overall Study|Transfer to hemodialysis|70|||
156891361|NCT01293799|566360252|FG001|Overall Study|Transfer to hemodialysis|90|||
156891362|NCT01293799|566360251|FG000|Overall Study|Death|27|||
156891363|NCT01293799|566360252|FG001|Overall Study|Death|29|||
156891364|NCT01293799|566360251|FG000|Overall Study|Transfer to assisted PD|24|||
156891365|NCT01293799|566360252|FG001|Overall Study|Transfer to assisted PD|18|||
156891366|NCT01293799|566360251|FG000|Overall Study|Withdrawal by Subject|26|||
156891367|NCT01293799|566360252|FG001|Overall Study|Withdrawal by Subject|0|||
156891368|NCT01293799|566360251|FG000|Overall Study|Investigator decision|5|||
156891369|NCT01293799|566360252|FG001|Overall Study|Investigator decision|2|||
156891370|NCT01293799|566360251|FG000|Overall Study|Kidney function improved|6|||
156891371|NCT01293799|566360252|FG001|Overall Study|Kidney function improved|7|||
156891372|NCT01293799|566360251|FG000|Overall Study|Other causes|6|||
156891373|NCT01293799|566360252|FG001|Overall Study|Other causes|3|||
156891374|NCT02241889|566360255|FG000|Overall Study|device issues|0|||
156891375|NCT02241889|566360256|FG001|Overall Study|device issues|0|||
156891376|NCT02241889|566360257|FG002|Overall Study|device issues|1|||
156891377|NCT02241889|566360258|FG003|Overall Study|device issues|0|||
156891378|NCT02241889|566360259|FG004|Overall Study|device issues|0|||
156891379|NCT02241889|566360260|FG005|Overall Study|device issues|0|||
156891380|NCT02241889|566360255|FG000|Overall Study|Withdrawal by Subject|0|||
157025982|NCT01175356|566849669|FG000|Overall Study|Initiation other tx prior to completion|9|||
156891381|NCT02241889|566360256|FG001|Overall Study|Withdrawal by Subject|0|||
156891382|NCT02241889|566360257|FG002|Overall Study|Withdrawal by Subject|0|||
156891383|NCT02241889|566360258|FG003|Overall Study|Withdrawal by Subject|0|||
156891384|NCT02241889|566360259|FG004|Overall Study|Withdrawal by Subject|0|||
156891385|NCT02241889|566360260|FG005|Overall Study|Withdrawal by Subject|1|||
156891386|NCT00773838|566360261|FG000|Overall Study|Adverse Event|29|||
156891387|NCT00773838|566360261|FG000|Overall Study|Lost to Follow-up|1|||
156891388|NCT00773838|566360261|FG000|Overall Study|Physician Decision|8|||
156891389|NCT00773838|566360261|FG000|Overall Study|Progressive Disease|82|||
156891390|NCT00773838|566360261|FG000|Overall Study|Protocol Violation|2|||
156891391|NCT00773838|566360261|FG000|Overall Study|Withdrawal by Subject|21|||
156891392|NCT00459056|566360263|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
156891393|NCT00459056|566360264|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
156891394|NCT01658813|566360265|FG000|Overall Study|Disease progression|3|||
156891395|NCT04473482|566360270|FG000|Overall Study|Death|0|||
156891396|NCT04473482|566360271|FG001|Overall Study|Death|3|||
156891397|NCT04473482|566360270|FG000|Overall Study|Lost to Follow-up|9|||
156891398|NCT04473482|566360271|FG001|Overall Study|Lost to Follow-up|7|||
156891399|NCT04473482|566360270|FG000|Overall Study|Withdrawal by Subject|2|||
156891400|NCT04473482|566360271|FG001|Overall Study|Withdrawal by Subject|1|||
156891401|NCT04594369|566360272|FG000|Overall Study|Adverse Event|10|||
156891402|NCT04594369|566360273|FG001|Overall Study|Adverse Event|10|||
156891403|NCT04594369|566360274|FG002|Overall Study|Adverse Event|9|||
156891404|NCT04594369|566360272|FG000|Overall Study|Death|2|||
156891405|NCT04594369|566360273|FG001|Overall Study|Death|4|||
156891406|NCT04594369|566360274|FG002|Overall Study|Death|8|||
156891407|NCT04594369|566360272|FG000|Overall Study|Lost to Follow-up|10|||
156891408|NCT04594369|566360273|FG001|Overall Study|Lost to Follow-up|2|||
156891409|NCT04594369|566360274|FG002|Overall Study|Lost to Follow-up|4|||
156891410|NCT04594369|566360272|FG000|Overall Study|Physician Decision|2|||
156891411|NCT04594369|566360273|FG001|Overall Study|Physician Decision|2|||
156891412|NCT04594369|566360274|FG002|Overall Study|Physician Decision|3|||
156891413|NCT04594369|566360272|FG000|Overall Study|Protocol deviation|1|||
156891414|NCT04594369|566360273|FG001|Overall Study|Protocol deviation|3|||
156891415|NCT04594369|566360274|FG002|Overall Study|Protocol deviation|2|||
156891416|NCT04594369|566360272|FG000|Overall Study|Withdrawal by Subject|40|||
156891417|NCT04594369|566360273|FG001|Overall Study|Withdrawal by Subject|32|||
156891418|NCT04594369|566360274|FG002|Overall Study|Withdrawal by Subject|37|||
156891419|NCT04594369|566360272|FG000|Overall Study|Reason not specified|60|||
156891420|NCT04594369|566360273|FG001|Overall Study|Reason not specified|56|||
156891421|NCT04594369|566360274|FG002|Overall Study|Reason not specified|43|||
156891422|NCT01602666|566360275|FG000|Induction Chemotherapy|Death|2|||
156891423|NCT01602666|566360276|FG001|Induction Chemotherapy|Death|1|||
156891424|NCT01602666|566360275|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
156891425|NCT01602666|566360276|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
156891426|NCT01602666|566360275|FG000|Induction Chemotherapy|Physician Decision|12|||
156891427|NCT01602666|566360276|FG001|Induction Chemotherapy|Physician Decision|5|||
156891428|NCT01602666|566360275|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
156891429|NCT01602666|566360276|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
156891430|NCT01602666|566360275|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
156891431|NCT01602666|566360276|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
156891432|NCT01602666|566360275|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
156891433|NCT01602666|566360276|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
156891434|NCT01602666|566360275|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
156891435|NCT01602666|566360276|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
156891436|NCT01602666|566360275|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
156891437|NCT01602666|566360276|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
156891438|NCT01602666|566360275|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
156891439|NCT01602666|566360276|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
156891440|NCT01602666|566360275|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
156891441|NCT01602666|566360276|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
156891442|NCT01602666|566360275|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
157157866|NCT03249792|567322879|FG015|Switch Over Period|Progressive Disease|0|||
157157867|NCT03249792|567322880|FG016|Switch Over Period|Progressive Disease|0|||
157157868|NCT03249792|567322881|FG017|Switch Over Period|Progressive Disease|0|||
157157869|NCT03249792|567322882|FG018|Switch Over Period|Progressive Disease|0|||
156891443|NCT01602666|566360276|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
157157870|NCT03249792|567322883|FG019|Switch Over Period|Progressive Disease|0|||
156891444|NCT05458648|566360277|FG000|Overall Study|Physician Decision|1|||
156891445|NCT05458648|566360277|FG000|Overall Study|Patient presented in atrial flutter|1|||
156891446|NCT02275910|566360278|FG000|Overall Study|Subject Choice|0|||
156891447|NCT02275910|566360279|FG001|Overall Study|Subject Choice|0|||
156891448|NCT02275910|566360280|FG002|Overall Study|Subject Choice|0|||
156891449|NCT02275910|566360281|FG003|Overall Study|Subject Choice|0|||
156891450|NCT02275910|566360282|FG004|Overall Study|Subject Choice|0|||
157157871|NCT03249792|567322884|FG020|Switch Over Period|Progressive Disease|0|||
157157872|NCT03249792|567322885|FG021|Switch Over Period|Progressive Disease|0|||
157225483|NCT02204371|567571442|FG000|Overall Study|Adverse Event|1|||
156891451|NCT02275910|566360283|FG005|Overall Study|Subject Choice|0|||
156891452|NCT02275910|566360284|FG006|Overall Study|Subject Choice|0|||
157157873|NCT03249792|567322886|FG022|Switch Over Period|Progressive Disease|0|||
157157874|NCT03249792|567322887|FG023|Switch Over Period|Progressive Disease|0|||
156891453|NCT02275910|566360285|FG007|Overall Study|Subject Choice|0|||
156891454|NCT02275910|566360286|FG008|Overall Study|Subject Choice|1|||
156891455|NCT02275910|566360287|FG009|Overall Study|Subject Choice|0|||
156891456|NCT02275910|566360288|FG010|Overall Study|Subject Choice|0|||
156891457|NCT02275910|566360289|FG011|Overall Study|Subject Choice|0|||
156891458|NCT02275910|566360278|FG000|Overall Study|Radiological Disease Progression|0|||
156891459|NCT02275910|566360279|FG001|Overall Study|Radiological Disease Progression|0|||
156891460|NCT02275910|566360280|FG002|Overall Study|Radiological Disease Progression|0|||
156891461|NCT02275910|566360281|FG003|Overall Study|Radiological Disease Progression|0|||
156891462|NCT02275910|566360282|FG004|Overall Study|Radiological Disease Progression|0|||
156891463|NCT02275910|566360283|FG005|Overall Study|Radiological Disease Progression|0|||
156891464|NCT02275910|566360284|FG006|Overall Study|Radiological Disease Progression|1|||
156891465|NCT02275910|566360285|FG007|Overall Study|Radiological Disease Progression|1|||
156891466|NCT02275910|566360286|FG008|Overall Study|Radiological Disease Progression|0|||
156891467|NCT02275910|566360287|FG009|Overall Study|Radiological Disease Progression|1|||
156891468|NCT02275910|566360288|FG010|Overall Study|Radiological Disease Progression|0|||
156891469|NCT02275910|566360289|FG011|Overall Study|Radiological Disease Progression|0|||
156891470|NCT05217927|566360297|FG000|DBT Phase|Adverse Event|7|||
156891471|NCT05217927|566360298|FG001|DBT Phase|Adverse Event|2|||
156891472|NCT05217927|566360299|FG002|DBT Phase|Adverse Event|5|||
156891473|NCT05217927|566360297|FG000|DBT Phase|Lack of Efficacy|1|||
156891474|NCT05217927|566360298|FG001|DBT Phase|Lack of Efficacy|0|||
156891475|NCT05217927|566360299|FG002|DBT Phase|Lack of Efficacy|0|||
156891476|NCT05217927|566360297|FG000|DBT Phase|Lost to Follow-up|0|||
156891477|NCT05217927|566360298|FG001|DBT Phase|Lost to Follow-up|2|||
156891478|NCT05217927|566360299|FG002|DBT Phase|Lost to Follow-up|0|||
156891479|NCT05217927|566360297|FG000|DBT Phase|Non-compliance|1|||
156891480|NCT05217927|566360298|FG001|DBT Phase|Non-compliance|0|||
156891481|NCT05217927|566360299|FG002|DBT Phase|Non-compliance|0|||
156891482|NCT05217927|566360297|FG000|DBT Phase|Pregnancy|0|||
156891483|NCT05217927|566360298|FG001|DBT Phase|Pregnancy|0|||
156891484|NCT05217927|566360299|FG002|DBT Phase|Pregnancy|1|||
156891485|NCT05217927|566360297|FG000|DBT Phase|Protocol Violation|0|||
156891486|NCT05217927|566360298|FG001|DBT Phase|Protocol Violation|2|||
156891487|NCT05217927|566360299|FG002|DBT Phase|Protocol Violation|1|||
156891488|NCT05217927|566360297|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
156891489|NCT05217927|566360298|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
156891490|NCT05217927|566360299|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
156891491|NCT05217927|566360297|FG000|DBT Phase|Withdrawal of consent|8|||
156891492|NCT05217927|566360298|FG001|DBT Phase|Withdrawal of consent|5|||
156891493|NCT05217927|566360299|FG002|DBT Phase|Withdrawal of consent|7|||
156891494|NCT05217927|566360297|FG000|DBT Phase|Other|7|||
156891495|NCT05217927|566360298|FG001|DBT Phase|Other|3|||
156891496|NCT05217927|566360299|FG002|DBT Phase|Other|4|||
156891497|NCT05217927|566360297|FG000|DBT Phase|Randomized, not treated|2|||
156891498|NCT05217927|566360298|FG001|DBT Phase|Randomized, not treated|3|||
156891499|NCT05217927|566360299|FG002|DBT Phase|Randomized, not treated|2|||
156891500|NCT05217927|566360297|FG000|OLE Phase|Adverse Event|4|||
156891501|NCT05217927|566360298|FG001|OLE Phase|Adverse Event|1|||
156891502|NCT05217927|566360299|FG002|OLE Phase|Adverse Event|1|||
156891503|NCT05217927|566360297|FG000|OLE Phase|Extension phase eligibility failure|1|||
156891504|NCT05217927|566360298|FG001|OLE Phase|Extension phase eligibility failure|0|||
156891505|NCT05217927|566360299|FG002|OLE Phase|Extension phase eligibility failure|0|||
156891506|NCT05217927|566360297|FG000|OLE Phase|Lost to Follow-up|1|||
157157875|NCT03249792|567322888|FG024|Switch Over Period|Progressive Disease|0|||
157157876|NCT03249792|567322889|FG025|Switch Over Period|Progressive Disease|0|||
157157877|NCT03249792|567322890|FG026|Switch Over Period|Progressive Disease|1|||
157157878|NCT03249792|567322891|FG027|Switch Over Period|Progressive Disease|0|||
157157879|NCT03249792|567322892|FG028|Switch Over Period|Progressive Disease|1|||
156891507|NCT05217927|566360298|FG001|OLE Phase|Lost to Follow-up|2|||
156891508|NCT05217927|566360299|FG002|OLE Phase|Lost to Follow-up|1|||
156891509|NCT05217927|566360297|FG000|OLE Phase|Non-compliance|0|||
156891510|NCT05217927|566360298|FG001|OLE Phase|Non-compliance|0|||
156891511|NCT05217927|566360299|FG002|OLE Phase|Non-compliance|1|||
156891512|NCT05217927|566360297|FG000|OLE Phase|Other|3|||
156891513|NCT05217927|566360298|FG001|OLE Phase|Other|5|||
156891514|NCT05217927|566360299|FG002|OLE Phase|Other|4|||
156891515|NCT05217927|566360297|FG000|OLE Phase|Withdrawal of consent|3|||
156891516|NCT05217927|566360298|FG001|OLE Phase|Withdrawal of consent|1|||
156891517|NCT05217927|566360299|FG002|OLE Phase|Withdrawal of consent|5|||
156891518|NCT00076024|566361373|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
156891519|NCT00076024|566361374|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
156891520|NCT00076024|566361375|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
157157880|NCT03249792|567322893|FG029|Switch Over Period|Progressive Disease|2|||
157157881|NCT03249792|567322894|FG030|Switch Over Period|Progressive Disease|1|||
156891521|NCT00076024|566361376|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
156891522|NCT00076024|566361373|FG000|Phase 1, Lead-in|Adverse Event|1|||
156891523|NCT00076024|566361374|FG001|Phase 1, Lead-in|Adverse Event|0|||
156891524|NCT00076024|566361375|FG002|Phase 1, Lead-in|Adverse Event|0|||
156891525|NCT00076024|566361376|FG003|Phase 1, Lead-in|Adverse Event|0|||
156891526|NCT00076024|566361373|FG000|Phase 1, Lead-in|Clinical progression|1|||
156891527|NCT00076024|566361374|FG001|Phase 1, Lead-in|Clinical progression|0|||
156891528|NCT00076024|566361375|FG002|Phase 1, Lead-in|Clinical progression|0|||
156891529|NCT00076024|566361376|FG003|Phase 1, Lead-in|Clinical progression|0|||
156891530|NCT00076024|566361373|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
156891531|NCT00076024|566361374|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
156891532|NCT00076024|566361375|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
156891533|NCT00076024|566361376|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
156891534|NCT00076024|566361373|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
156891535|NCT00076024|566361374|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
156891536|NCT00076024|566361375|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
156891537|NCT00076024|566361376|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
156891538|NCT00076024|566361373|FG000|Phase 2, Double-blind|Adverse Event|0|||
157025983|NCT03020199|566849670|FG000|Treatment Period|Adverse Event|0|||
157025984|NCT03020199|566849671|FG001|Treatment Period|Adverse Event|2|||
157025985|NCT03020199|566849670|FG000|Treatment Period|Lack of Efficacy|1|||
157025986|NCT03020199|566849671|FG001|Treatment Period|Lack of Efficacy|6|||
157025987|NCT03020199|566849670|FG000|Treatment Period|Lost to Follow-up|1|||
157025988|NCT03020199|566849671|FG001|Treatment Period|Lost to Follow-up|6|||
157025989|NCT03020199|566849670|FG000|Treatment Period|Physician Decision|0|||
157025990|NCT03020199|566849671|FG001|Treatment Period|Physician Decision|1|||
157025991|NCT03020199|566849670|FG000|Treatment Period|Subject/guardian decision|8|||
157025992|NCT03020199|566849671|FG001|Treatment Period|Subject/guardian decision|15|||
157025993|NCT03020199|566849670|FG000|Treatment Period|Subjects not treated|3|||
157025994|NCT03020199|566849671|FG001|Treatment Period|Subjects not treated|4|||
157025995|NCT03020199|566849670|FG000|Follow-up Period|Disease relapse|32|||
157025996|NCT03020199|566849671|FG001|Follow-up Period|Disease relapse|7|||
157025997|NCT03020199|566849670|FG000|Follow-up Period|Lack of Efficacy|1|||
157025998|NCT03020199|566849671|FG001|Follow-up Period|Lack of Efficacy|2|||
157025999|NCT03020199|566849670|FG000|Follow-up Period|Lost to Follow-up|4|||
157026000|NCT03020199|566849671|FG001|Follow-up Period|Lost to Follow-up|6|||
157026001|NCT03020199|566849670|FG000|Follow-up Period|Physician Decision|2|||
157026002|NCT03020199|566849671|FG001|Follow-up Period|Physician Decision|2|||
157026003|NCT03020199|566849670|FG000|Follow-up Period|Protocol Violation|1|||
157026004|NCT03020199|566849671|FG001|Follow-up Period|Protocol Violation|2|||
157026005|NCT03020199|566849670|FG000|Follow-up Period|Study terminated by Sponsor|6|||
157026006|NCT03020199|566849671|FG001|Follow-up Period|Study terminated by Sponsor|3|||
157026007|NCT03020199|566849670|FG000|Follow-up Period|Subject/guardian decision|14|||
157026008|NCT03020199|566849671|FG001|Follow-up Period|Subject/guardian decision|9|||
157026009|NCT04313972|566849672|FG000|Overall Study|Withdrawal by Subject|0|||
157026010|NCT04313972|566849673|FG001|Overall Study|Withdrawal by Subject|1|||
157026011|NCT05201079|566849687|FG000|Overall Study|Adverse Event|7|||
157026012|NCT05201079|566849688|FG001|Overall Study|Adverse Event|11|||
157026013|NCT05201079|566849687|FG000|Overall Study|Death|1|||
157026014|NCT05201079|566849688|FG001|Overall Study|Death|1|||
157026015|NCT05201079|566849687|FG000|Overall Study|Lack of Efficacy|0|||
157026016|NCT05201079|566849688|FG001|Overall Study|Lack of Efficacy|2|||
157026017|NCT05201079|566849687|FG000|Overall Study|Lost to Follow-up|0|||
157026018|NCT05201079|566849688|FG001|Overall Study|Lost to Follow-up|1|||
157026019|NCT05201079|566849687|FG000|Overall Study|Physician Decision|1|||
157026020|NCT05201079|566849688|FG001|Overall Study|Physician Decision|1|||
157026021|NCT05201079|566849687|FG000|Overall Study|Protocol Violation|1|||
157026022|NCT05201079|566849688|FG001|Overall Study|Protocol Violation|0|||
157026023|NCT05201079|566849687|FG000|Overall Study|Withdrawal by Subject|1|||
157026024|NCT05201079|566849688|FG001|Overall Study|Withdrawal by Subject|0|||
157026025|NCT05201079|566849687|FG000|Overall Study|Forbidden medication|9|||
157026026|NCT05201079|566849688|FG001|Overall Study|Forbidden medication|5|||
157026027|NCT05201079|566849687|FG000|Overall Study|Transfer to another hospital|0|||
157026028|NCT05201079|566849688|FG001|Overall Study|Transfer to another hospital|1|||
157026029|NCT05201079|566849687|FG000|Overall Study|Clinical condition|1|||
157026030|NCT05201079|566849688|FG001|Overall Study|Clinical condition|0|||
157026031|NCT05201079|566849687|FG000|Overall Study|SAE and sepsis|1|||
157026032|NCT05201079|566849688|FG001|Overall Study|SAE and sepsis|0|||
157026033|NCT01210807|566849695|FG000|Overall Study|Lost to Follow-up|1|||
157026034|NCT01210807|566849696|FG001|Overall Study|Lost to Follow-up|2|||
157026035|NCT01210807|566849695|FG000|Overall Study|Not implanted bilaterally|2|||
157026036|NCT01210807|566849696|FG001|Overall Study|Not implanted bilaterally|1|||
157225484|NCT03594123|567571445|FG000|Overall Study|Lost to Follow-up|0|||
156891539|NCT00076024|566361374|FG001|Phase 2, Double-blind|Adverse Event|25|||
157026037|NCT05792085|566849697|FG000|Overall Study|Death|0|||
157026038|NCT05792085|566849698|FG001|Overall Study|Death|0|||
157225485|NCT03594123|567571446|FG001|Overall Study|Lost to Follow-up|1|||
156891540|NCT00076024|566361375|FG002|Phase 2, Double-blind|Adverse Event|6|||
156891541|NCT00076024|566361376|FG003|Phase 2, Double-blind|Adverse Event|0|||
156891542|NCT00076024|566361373|FG000|Phase 2, Double-blind|Un-specified|0|||
156891543|NCT00076024|566361374|FG001|Phase 2, Double-blind|Un-specified|14|||
156891544|NCT00076024|566361375|FG002|Phase 2, Double-blind|Un-specified|6|||
156891545|NCT00076024|566361376|FG003|Phase 2, Double-blind|Un-specified|0|||
156891546|NCT00076024|566361373|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
156891547|NCT00076024|566361374|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
156891548|NCT00076024|566361375|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
156891549|NCT00076024|566361376|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
156891550|NCT00076024|566361373|FG000|Phase 2, Open-label|Adverse Event|0|||
156891551|NCT00076024|566361374|FG001|Phase 2, Open-label|Adverse Event|0|||
156891552|NCT00076024|566361375|FG002|Phase 2, Open-label|Adverse Event|0|||
156891553|NCT00076024|566361376|FG003|Phase 2, Open-label|Adverse Event|2|||
156891554|NCT00076024|566361373|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
156891555|NCT00076024|566361374|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
156891556|NCT00076024|566361375|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
156891557|NCT00076024|566361376|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
156891558|NCT00076024|566361373|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
156891559|NCT00076024|566361374|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
156891560|NCT00076024|566361375|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
156891561|NCT00076024|566361376|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
156891562|NCT00076024|566361373|FG000|Phase 2, Open-label|Other|0|||
156891563|NCT00076024|566361374|FG001|Phase 2, Open-label|Other|0|||
156891564|NCT00076024|566361375|FG002|Phase 2, Open-label|Other|0|||
156891565|NCT00076024|566361376|FG003|Phase 2, Open-label|Other|2|||
156891566|NCT01155219|566361383|FG000|Overall Study|Adverse Event|3|||
156891567|NCT01155219|566361384|FG001|Overall Study|Adverse Event|1|||
156891568|NCT01155219|566361383|FG000|Overall Study|non-medical reason|1|||
156891569|NCT01155219|566361384|FG001|Overall Study|non-medical reason|2|||
156891570|NCT03052764|566361386|FG000|Double-Blind Treatment Period|Adverse Event|2|||
156891571|NCT03052764|566361387|FG001|Double-Blind Treatment Period|Adverse Event|0|||
156891572|NCT03052764|566361386|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
156891573|NCT03052764|566361387|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
156891574|NCT03052764|566361386|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
156891575|NCT03052764|566361387|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
156891576|NCT03052764|566361386|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
156891577|NCT03052764|566361387|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156891578|NCT03052764|566361386|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
156891579|NCT03052764|566361387|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
156891580|NCT01314911|566361388|FG000|Overall Study|Lost to Follow-up|3|||
156891581|NCT01314911|566361389|FG001|Overall Study|Lost to Follow-up|2|||
156891582|NCT01314911|566361388|FG000|Overall Study|Withdrawal by Subject|1|||
156891583|NCT01314911|566361389|FG001|Overall Study|Withdrawal by Subject|3|||
156891584|NCT01314911|566361388|FG000|Overall Study|Received Non-randomized Study Drug|0|||
156891585|NCT01314911|566361389|FG001|Overall Study|Received Non-randomized Study Drug|1|||
156891586|NCT01314911|566361388|FG000|Overall Study|Never Started Treatment|1|||
156891587|NCT01314911|566361389|FG001|Overall Study|Never Started Treatment|0|||
156891588|NCT03150485|566361393|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156891589|NCT03150485|566361394|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156891590|NCT03150485|566361395|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
156891591|NCT03150485|566361396|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
156891592|NCT03150485|566361397|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
156891593|NCT03150485|566361398|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
156891594|NCT01394718|566361400|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
156891595|NCT01394718|566361401|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
156891596|NCT04626310|566361407|FG000|Overall Study|4-miss from treatment|6|||
156891597|NCT04626310|566361408|FG001|Overall Study|4-miss from treatment|5|||
156891598|NCT04626310|566361409|FG002|Overall Study|4-miss from treatment|5|||
156891599|NCT04626310|566361407|FG000|Overall Study|Withdrawal by Subject|1|||
156891600|NCT04626310|566361408|FG001|Overall Study|Withdrawal by Subject|0|||
157157882|NCT03249792|567322895|FG031|Switch Over Period|Progressive Disease|0|||
156891601|NCT04626310|566361409|FG002|Overall Study|Withdrawal by Subject|3|||
156891602|NCT01282203|566361412|FG000|Overall Study|Adverse Event|1|||
156891603|NCT00930982|566361413|FG000|Overall Study|Adverse Event|19|||
156891604|NCT00930982|566361414|FG001|Overall Study|Adverse Event|23|||
156891605|NCT00930982|566361413|FG000|Overall Study|Protocol Violation|1|||
156891606|NCT00930982|566361414|FG001|Overall Study|Protocol Violation|5|||
156891607|NCT00930982|566361413|FG000|Overall Study|Withdrawal by Subject|1|||
156891608|NCT00930982|566361414|FG001|Overall Study|Withdrawal by Subject|1|||
156891609|NCT00991952|566361415|FG000|Overall Study|Adverse Event|0|||
156891610|NCT00991952|566361416|FG001|Overall Study|Adverse Event|1|||
156891611|NCT00518973|566361417|FG000|Overall Study|Withdrawal by Subject|3|||
157157883|NCT03249792|567322896|FG032|Switch Over Period|Progressive Disease|1|||
157157884|NCT03249792|567322864|FG000|Switch Over Period|Adverse Event|0|||
156891612|NCT00518973|566361418|FG001|Overall Study|Withdrawal by Subject|2|||
156891613|NCT03452527|566361419|FG000|Overall Study|Withdrawal by Subject|1|||
156891614|NCT03452527|566361420|FG001|Overall Study|Withdrawal by Subject|1|||
156891615|NCT03452527|566361419|FG000|Overall Study|Study Terminated|2|||
156891616|NCT03452527|566361420|FG001|Overall Study|Study Terminated|3|||
156891617|NCT00582816|566361421|FG000|Overall Study|Engraftment Failure|3|||
156891618|NCT01565499|566361424|FG000|Overall Study|Physician Decision|1|||
156891619|NCT01565499|566361424|FG000|Overall Study|Adverse Event|5|||
156891620|NCT01565499|566361424|FG000|Overall Study|Withdrawal by Subject|2|||
156891621|NCT01255787|566361425|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
156891622|NCT01255787|566361426|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
156891623|NCT01255787|566361427|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
156891624|NCT01255787|566361428|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
156891625|NCT01255787|566361425|FG000|Overall Study|Major Protocol Deviation|1|||
156891626|NCT01255787|566361426|FG001|Overall Study|Major Protocol Deviation|1|||
156891627|NCT01255787|566361427|FG002|Overall Study|Major Protocol Deviation|0|||
156891628|NCT01255787|566361428|FG003|Overall Study|Major Protocol Deviation|4|||
156891629|NCT01255787|566361425|FG000|Overall Study|Lost to Follow-up|1|||
156891630|NCT01255787|566361426|FG001|Overall Study|Lost to Follow-up|2|||
156891631|NCT01255787|566361427|FG002|Overall Study|Lost to Follow-up|4|||
156891632|NCT01255787|566361428|FG003|Overall Study|Lost to Follow-up|2|||
156891633|NCT01255787|566361425|FG000|Overall Study|Withdrawal of Consent|3|||
156891634|NCT01255787|566361426|FG001|Overall Study|Withdrawal of Consent|9|||
156891635|NCT01255787|566361427|FG002|Overall Study|Withdrawal of Consent|3|||
156891636|NCT01255787|566361428|FG003|Overall Study|Withdrawal of Consent|4|||
156891637|NCT01255787|566361425|FG000|Overall Study|Pregnancy|0|||
156891638|NCT01255787|566361426|FG001|Overall Study|Pregnancy|0|||
156891639|NCT01255787|566361427|FG002|Overall Study|Pregnancy|0|||
156891640|NCT01255787|566361428|FG003|Overall Study|Pregnancy|1|||
156891641|NCT01255787|566361425|FG000|Overall Study|Lack of Efficacy|2|||
156891642|NCT01255787|566361426|FG001|Overall Study|Lack of Efficacy|2|||
156891643|NCT01255787|566361427|FG002|Overall Study|Lack of Efficacy|2|||
156891644|NCT01255787|566361428|FG003|Overall Study|Lack of Efficacy|2|||
156891645|NCT01255787|566361425|FG000|Overall Study|Noncompliance with Study Drug|3|||
156891646|NCT01255787|566361426|FG001|Overall Study|Noncompliance with Study Drug|1|||
156891647|NCT01255787|566361427|FG002|Overall Study|Noncompliance with Study Drug|0|||
156891648|NCT01255787|566361428|FG003|Overall Study|Noncompliance with Study Drug|0|||
156891649|NCT00476047|566361429|FG000|Overall Study|Lost to Follow-up|1|||
156891650|NCT00768469|566361430|FG000|Overall Study|Adverse Event|0|||
156891651|NCT00768469|566361431|FG001|Overall Study|Adverse Event|2|||
156891652|NCT00768469|566361430|FG000|Overall Study|Disease Progression|3|||
156891653|NCT00768469|566361431|FG001|Overall Study|Disease Progression|4|||
156891654|NCT00768469|566361430|FG000|Overall Study|Withdrawal by Subject|0|||
156891655|NCT00768469|566361431|FG001|Overall Study|Withdrawal by Subject|1|||
156891656|NCT04966741|566361432|FG000|Overall Study|Lost to Follow-up|1|||
156891657|NCT04966741|566361433|FG001|Overall Study|Lost to Follow-up|0|||
156891658|NCT02635646|566361436|FG000|Overall Study|Lost to Follow-up|24|||
156891659|NCT02635646|566361437|FG001|Overall Study|Lost to Follow-up|25|||
156891660|NCT02635646|566361436|FG000|Overall Study|Pregnancy|1|||
156891661|NCT02635646|566361437|FG001|Overall Study|Pregnancy|1|||
156891662|NCT03149848|566361440|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
156891663|NCT03149848|566361440|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
156891664|NCT04738318|566361443|FG000|Overall Study|Protocol Violation|1|||
156891665|NCT04738318|566361444|FG001|Overall Study|Protocol Violation|0|||
156891666|NCT01226121|566361445|FG000|Overall Study|Lost to Follow-up|2|||
156891667|NCT01226121|566361446|FG001|Overall Study|Lost to Follow-up|0|||
156891668|NCT01226121|566361447|FG002|Overall Study|Lost to Follow-up|1|||
156891669|NCT00378079|566361448|FG000|Overall Study|Lost to Follow-up|6|||
156891670|NCT00378079|566361449|FG001|Overall Study|Lost to Follow-up|1|||
156891671|NCT00378079|566361450|FG002|Overall Study|Lost to Follow-up|0|||
156891672|NCT00586664|566361457|FG000|Overall Study|Withdrawal by Subject|3|||
156891673|NCT00586664|566361458|FG001|Overall Study|Withdrawal by Subject|7|||
156891674|NCT00586664|566361459|FG002|Overall Study|Withdrawal by Subject|1|||
156891675|NCT00586664|566361457|FG000|Overall Study|Exclusion criteria met|2|||
156891676|NCT00586664|566361458|FG001|Overall Study|Exclusion criteria met|0|||
156891677|NCT00586664|566361459|FG002|Overall Study|Exclusion criteria met|0|||
156891678|NCT06785857|566361467|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
156891679|NCT06785857|566361468|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
156891680|NCT03576274|566361470|FG000|Overall Study|Lost to Follow-up|3|||
156891681|NCT03576274|566361471|FG001|Overall Study|Lost to Follow-up|2|||
156891682|NCT03576274|566361472|FG002|Overall Study|Lost to Follow-up|3|||
156891683|NCT03576274|566361473|FG003|Overall Study|Lost to Follow-up|1|||
156891684|NCT03576274|566361474|FG004|Overall Study|Lost to Follow-up|3|||
156891685|NCT03576274|566361470|FG000|Overall Study|Withdrawal by Subject|5|||
156891686|NCT03576274|566361471|FG001|Overall Study|Withdrawal by Subject|3|||
156891687|NCT03576274|566361472|FG002|Overall Study|Withdrawal by Subject|2|||
156891688|NCT03576274|566361473|FG003|Overall Study|Withdrawal by Subject|8|||
157157885|NCT03249792|567322865|FG001|Switch Over Period|Adverse Event|0|||
157157886|NCT03249792|567322866|FG002|Switch Over Period|Adverse Event|0|||
157157887|NCT03249792|567322867|FG003|Switch Over Period|Adverse Event|0|||
157157888|NCT03249792|567322868|FG004|Switch Over Period|Adverse Event|0|||
157157889|NCT03249792|567322869|FG005|Switch Over Period|Adverse Event|0|||
157157890|NCT03249792|567322870|FG006|Switch Over Period|Adverse Event|0|||
157157891|NCT03249792|567322871|FG007|Switch Over Period|Adverse Event|0|||
157157892|NCT03249792|567322872|FG008|Switch Over Period|Adverse Event|0|||
156891689|NCT03576274|566361474|FG004|Overall Study|Withdrawal by Subject|6|||
156891690|NCT05952401|566361483|FG000|Overall Study|Lost to Follow-up|4|||
156891691|NCT05952401|566361484|FG001|Overall Study|Lost to Follow-up|1|||
156891692|NCT00096954|566363315|FG000|Overall Study|Adverse Event|3|||
156891693|NCT00096954|566363316|FG001|Overall Study|Adverse Event|1|||
156891694|NCT00096954|566363315|FG000|Overall Study|Withdrawal by Subject|9|||
156891695|NCT00096954|566363316|FG001|Overall Study|Withdrawal by Subject|8|||
156891696|NCT00096954|566363315|FG000|Overall Study|Physician Decision|1|||
156891697|NCT00096954|566363316|FG001|Overall Study|Physician Decision|1|||
156891698|NCT00096954|566363315|FG000|Overall Study|Sponsors Decision|1|||
156891699|NCT00096954|566363316|FG001|Overall Study|Sponsors Decision|1|||
156891700|NCT00096954|566363315|FG000|Overall Study|Pregnancy|1|||
156891701|NCT00096954|566363316|FG001|Overall Study|Pregnancy|1|||
156891702|NCT00096954|566363315|FG000|Overall Study|Initiation of immunotherapy|1|||
156891703|NCT00096954|566363316|FG001|Overall Study|Initiation of immunotherapy|0|||
156891704|NCT00096954|566363315|FG000|Overall Study|Non-compliance|0|||
156891705|NCT00096954|566363316|FG001|Overall Study|Non-compliance|3|||
156891706|NCT00096954|566363315|FG000|Overall Study|Lost to Follow-up|8|||
156891707|NCT00096954|566363316|FG001|Overall Study|Lost to Follow-up|5|||
156891708|NCT01695005|566363317|FG000|Overall Study|Lost to Follow-up|0|||
156891709|NCT01695005|566363318|FG001|Overall Study|Lost to Follow-up|1|||
156891710|NCT01695005|566363319|FG002|Overall Study|Lost to Follow-up|1|||
156891711|NCT01695005|566363320|FG003|Overall Study|Lost to Follow-up|0|||
156891712|NCT01695005|566363321|FG004|Overall Study|Lost to Follow-up|0|||
156891713|NCT01695005|566363322|FG005|Overall Study|Lost to Follow-up|1|||
156891714|NCT01695005|566363323|FG006|Overall Study|Lost to Follow-up|1|||
156891715|NCT01695005|566363324|FG007|Overall Study|Lost to Follow-up|1|||
156891716|NCT01695005|566363325|FG008|Overall Study|Lost to Follow-up|3|||
156891717|NCT01695005|566363326|FG009|Overall Study|Lost to Follow-up|3|||
156891718|NCT01695005|566363327|FG010|Overall Study|Lost to Follow-up|8|||
156891719|NCT01695005|566363328|FG011|Overall Study|Lost to Follow-up|5|||
156891720|NCT01695005|566363329|FG012|Overall Study|Lost to Follow-up|2|||
156891721|NCT01695005|566363330|FG013|Overall Study|Lost to Follow-up|5|||
156891722|NCT01695005|566363331|FG014|Overall Study|Lost to Follow-up|0|||
156891723|NCT01695005|566363332|FG015|Overall Study|Lost to Follow-up|4|||
156891724|NCT01695005|566363333|FG016|Overall Study|Lost to Follow-up|0|||
156891725|NCT01695005|566363334|FG017|Overall Study|Lost to Follow-up|0|||
156891726|NCT01695005|566363335|FG018|Overall Study|Lost to Follow-up|0|||
156891727|NCT01695005|566363336|FG019|Overall Study|Lost to Follow-up|1|||
156891728|NCT01695005|566363337|FG020|Overall Study|Lost to Follow-up|1|||
156891729|NCT01695005|566363338|FG021|Overall Study|Lost to Follow-up|0|||
156891730|NCT01695005|566363339|FG022|Overall Study|Lost to Follow-up|2|||
156891731|NCT01695005|566363340|FG023|Overall Study|Lost to Follow-up|4|||
156891732|NCT01695005|566363341|FG024|Overall Study|Lost to Follow-up|2|||
156891733|NCT01695005|566363342|FG025|Overall Study|Lost to Follow-up|0|||
156891734|NCT01695005|566363343|FG026|Overall Study|Lost to Follow-up|0|||
156891735|NCT01695005|566363344|FG027|Overall Study|Lost to Follow-up|0|||
156891736|NCT01695005|566363345|FG028|Overall Study|Lost to Follow-up|1|||
156891737|NCT01695005|566363317|FG000|Overall Study|Withdrawal by Subject|0|||
156891738|NCT01695005|566363318|FG001|Overall Study|Withdrawal by Subject|0|||
156891739|NCT01695005|566363319|FG002|Overall Study|Withdrawal by Subject|0|||
156891740|NCT01695005|566363320|FG003|Overall Study|Withdrawal by Subject|2|||
156891741|NCT01695005|566363321|FG004|Overall Study|Withdrawal by Subject|0|||
156891742|NCT01695005|566363322|FG005|Overall Study|Withdrawal by Subject|1|||
156891743|NCT01695005|566363323|FG006|Overall Study|Withdrawal by Subject|0|||
156891744|NCT01695005|566363324|FG007|Overall Study|Withdrawal by Subject|1|||
156891745|NCT01695005|566363325|FG008|Overall Study|Withdrawal by Subject|0|||
156891746|NCT01695005|566363326|FG009|Overall Study|Withdrawal by Subject|1|||
156891747|NCT01695005|566363327|FG010|Overall Study|Withdrawal by Subject|2|||
156891748|NCT01695005|566363328|FG011|Overall Study|Withdrawal by Subject|1|||
156891749|NCT01695005|566363329|FG012|Overall Study|Withdrawal by Subject|1|||
156891750|NCT01695005|566363330|FG013|Overall Study|Withdrawal by Subject|0|||
156891751|NCT01695005|566363331|FG014|Overall Study|Withdrawal by Subject|0|||
156891752|NCT01695005|566363332|FG015|Overall Study|Withdrawal by Subject|0|||
156891753|NCT01695005|566363333|FG016|Overall Study|Withdrawal by Subject|0|||
156891754|NCT01695005|566363334|FG017|Overall Study|Withdrawal by Subject|0|||
156891755|NCT01695005|566363335|FG018|Overall Study|Withdrawal by Subject|2|||
156891756|NCT01695005|566363336|FG019|Overall Study|Withdrawal by Subject|0|||
156891757|NCT01695005|566363337|FG020|Overall Study|Withdrawal by Subject|1|||
157157893|NCT03249792|567322873|FG009|Switch Over Period|Adverse Event|0|||
157157894|NCT03249792|567322874|FG010|Switch Over Period|Adverse Event|0|||
156891758|NCT01695005|566363338|FG021|Overall Study|Withdrawal by Subject|0|||
156891759|NCT01695005|566363339|FG022|Overall Study|Withdrawal by Subject|0|||
156891760|NCT01695005|566363340|FG023|Overall Study|Withdrawal by Subject|0|||
156891761|NCT01695005|566363341|FG024|Overall Study|Withdrawal by Subject|1|||
156891762|NCT01695005|566363342|FG025|Overall Study|Withdrawal by Subject|0|||
156891763|NCT01695005|566363343|FG026|Overall Study|Withdrawal by Subject|0|||
156891764|NCT01695005|566363344|FG027|Overall Study|Withdrawal by Subject|1|||
156891765|NCT01695005|566363345|FG028|Overall Study|Withdrawal by Subject|0|||
156891766|NCT04478123|566363346|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
156891767|NCT04478123|566363346|FG000|Overall Study|NE|1|||
156891768|NCT02395016|566363347|FG000|Overall Study|Adverse Event|4|||
156891769|NCT02395016|566363348|FG001|Overall Study|Adverse Event|3|||
156891770|NCT02395016|566363347|FG000|Overall Study|Withdrawal by Subject|9|||
156891771|NCT02395016|566363348|FG001|Overall Study|Withdrawal by Subject|6|||
156891772|NCT02395016|566363347|FG000|Overall Study|Protocol Violation|2|||
156891773|NCT02395016|566363348|FG001|Overall Study|Protocol Violation|3|||
156891774|NCT01547780|566363349|FG000|Baseline PET Scan|Physician Decision|1|||
156891775|NCT01547780|566363350|FG001|Baseline PET Scan|Physician Decision|0|||
156891776|NCT01547780|566363351|FG002|Baseline PET Scan|Physician Decision|1|||
156891777|NCT01547780|566363352|FG003|Baseline PET Scan|Physician Decision|0|||
156891778|NCT01547780|566363349|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
156891779|NCT01547780|566363350|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
156891780|NCT01547780|566363351|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
156891781|NCT01547780|566363352|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
157157895|NCT03249792|567322875|FG011|Switch Over Period|Adverse Event|0|||
157157896|NCT03249792|567322876|FG012|Switch Over Period|Adverse Event|0|||
157157897|NCT03249792|567322877|FG013|Switch Over Period|Adverse Event|0|||
156891782|NCT00814879|566363354|FG000|By Week 24|Cancer Diagnosis|1|||
156891783|NCT00814879|566363355|FG001|By Week 24|Cancer Diagnosis|0|||
156891784|NCT00814879|566363354|FG000|By Week 24|Incarceration|0|||
156891785|NCT00814879|566363355|FG001|By Week 24|Incarceration|1|||
156891786|NCT00814879|566363354|FG000|By Week 48|Lost to Follow-up|2|||
156891787|NCT00814879|566363355|FG001|By Week 48|Lost to Follow-up|2|||
156891788|NCT00814879|566363354|FG000|By Week 48|Death|0|||
156891789|NCT00814879|566363355|FG001|By Week 48|Death|1|||
156891790|NCT00588952|566363356|FG000|Overall Study|Adverse Event|0|||
156891791|NCT00588952|566363357|FG001|Overall Study|Adverse Event|2|||
156891792|NCT00588952|566363356|FG000|Overall Study|Withdrawal by Subject|3|||
156891793|NCT00588952|566363357|FG001|Overall Study|Withdrawal by Subject|5|||
156891794|NCT01461057|566363358|FG000|Overall Study|Death|10|||
156891795|NCT01461057|566363359|FG001|Overall Study|Death|9|||
156891796|NCT01461057|566363358|FG000|Overall Study|Withdrawal by Subject|2|||
156891797|NCT01461057|566363359|FG001|Overall Study|Withdrawal by Subject|3|||
156891798|NCT01461057|566363358|FG000|Overall Study|Physician Decision|0|||
156891799|NCT01461057|566363359|FG001|Overall Study|Physician Decision|2|||
156891800|NCT01461057|566363358|FG000|Overall Study|Adverse Event|0|||
156891801|NCT01461057|566363359|FG001|Overall Study|Adverse Event|1|||
156891802|NCT01461057|566363358|FG000|Overall Study|Progression of Disease|1|||
156891803|NCT01461057|566363359|FG001|Overall Study|Progression of Disease|0|||
156891804|NCT01461057|566363358|FG000|Overall Study|Study Terminated by Sponsor|2|||
156891805|NCT01461057|566363359|FG001|Overall Study|Study Terminated by Sponsor|0|||
156891806|NCT01288976|566363360|FG000|Overall Study|Withdrawal by Subject|58|||
156891807|NCT01288976|566363361|FG001|Overall Study|Withdrawal by Subject|12|||
156891808|NCT01288976|566363362|FG002|Overall Study|Withdrawal by Subject|9|||
156891809|NCT01288976|566363360|FG000|Overall Study|Death|98|||
156891810|NCT01288976|566363361|FG001|Overall Study|Death|6|||
156891811|NCT01288976|566363362|FG002|Overall Study|Death|4|||
156891812|NCT01288976|566363360|FG000|Overall Study|Data unavailable|22|||
157157898|NCT03249792|567322878|FG014|Switch Over Period|Adverse Event|0|||
156891813|NCT01288976|566363361|FG001|Overall Study|Data unavailable|9|||
156891814|NCT01288976|566363362|FG002|Overall Study|Data unavailable|7|||
156891815|NCT03560739|566363364|FG000|Overall Study|Adverse Event|0|||
156891816|NCT03560739|566363365|FG001|Overall Study|Adverse Event|1|||
156891817|NCT03560739|566363366|FG002|Overall Study|Adverse Event|0|||
156891818|NCT03560739|566363367|FG003|Overall Study|Adverse Event|0|||
157157899|NCT03249792|567322879|FG015|Switch Over Period|Adverse Event|0|||
157157900|NCT03249792|567322880|FG016|Switch Over Period|Adverse Event|0|||
156891819|NCT01362595|566363368|FG000|Overall Study|Screen failure|10|||
156891820|NCT01362595|566363368|FG000|Overall Study|Withdrawal by Subject|2|||
156891821|NCT00959374|566363369|FG000|Overall Study|Withdrawal by Subject|2|||
156891822|NCT00959374|566363369|FG000|Overall Study|Lost to Follow-up|14|||
157157901|NCT03249792|567322881|FG017|Switch Over Period|Adverse Event|0|||
156891823|NCT00959374|566363369|FG000|Overall Study|Death|1|||
156891824|NCT00959374|566363369|FG000|Overall Study|Protocol Violation|1|||
156891825|NCT00959374|566363369|FG000|Overall Study|Implant Removed/Not Replaced|4|||
156891826|NCT00959374|566363369|FG000|Overall Study|Physician Decision|1|||
156891827|NCT02448680|566363370|FG000|Overall Study|Physician Decision|1|||
156891828|NCT02448680|566363371|FG001|Overall Study|Physician Decision|1|||
157157902|NCT03249792|567322882|FG018|Switch Over Period|Adverse Event|0|||
156891829|NCT02448680|566363370|FG000|Overall Study|Withdrawal by Subject|0|||
156891830|NCT02448680|566363371|FG001|Overall Study|Withdrawal by Subject|2|||
156891831|NCT01739400|566363372|FG000|Overall Study|Physician Decision|3|||
156891832|NCT01739400|566363373|FG001|Overall Study|Physician Decision|0|||
156891833|NCT01739400|566363372|FG000|Overall Study|Lost to Follow-up|2|||
156891834|NCT01739400|566363373|FG001|Overall Study|Lost to Follow-up|0|||
156891835|NCT01739400|566363372|FG000|Overall Study|Death|5|||
156891836|NCT01739400|566363373|FG001|Overall Study|Death|2|||
156891837|NCT01739400|566363372|FG000|Overall Study|Withdrawal by Subject|7|||
156891838|NCT01739400|566363373|FG001|Overall Study|Withdrawal by Subject|7|||
156891839|NCT01736657|566363374|FG000|Overall Study|insufficient vascular access|1|||
156891840|NCT03350984|566363375|FG000|Overall Study|Death|1|||
156891841|NCT03350984|566363376|FG001|Overall Study|Death|0|||
156891842|NCT03350984|566363375|FG000|Overall Study|Lost to Follow-up|5|||
156891843|NCT03350984|566363376|FG001|Overall Study|Lost to Follow-up|6|||
156891844|NCT03350984|566363375|FG000|Overall Study|Protocol Violation|1|||
156891845|NCT03350984|566363376|FG001|Overall Study|Protocol Violation|2|||
156891846|NCT03350984|566363375|FG000|Overall Study|Physician Decision|1|||
156891847|NCT03350984|566363376|FG001|Overall Study|Physician Decision|0|||
156891848|NCT00642473|566363385|FG000|Overall Study|Withdrawal by Subject|0|||
156891849|NCT00642473|566363386|FG001|Overall Study|Withdrawal by Subject|5|||
156891850|NCT00642473|566363385|FG000|Overall Study|Progression or death|2|||
156891851|NCT00642473|566363386|FG001|Overall Study|Progression or death|4|||
156891852|NCT00642473|566363385|FG000|Overall Study|Other|2|||
156891853|NCT00642473|566363386|FG001|Overall Study|Other|2|||
156891854|NCT04533880|566363387|FG000|Overall Study|Lost to Follow-up|0|||
156891855|NCT04533880|566363388|FG001|Overall Study|Lost to Follow-up|1|||
156891856|NCT04533880|566363389|FG002|Overall Study|Lost to Follow-up|1|||
156891857|NCT02284178|566363390|FG000|Overall Study|Met exclusion criteria|49|||
156891858|NCT02284178|566363391|FG001|Overall Study|Met exclusion criteria|54|||
156891859|NCT04123665|566363392|FG000|Overall Study|Withdrawal by Subject|7|||
156891860|NCT04123665|566363393|FG001|Overall Study|Withdrawal by Subject|0|||
156891861|NCT04123665|566363392|FG000|Overall Study|Lost to Follow-up|1|||
156891862|NCT04123665|566363393|FG001|Overall Study|Lost to Follow-up|0|||
156891863|NCT01711879|566363396|FG000|Overall Study|Death|1|||
156891864|NCT01711879|566363397|FG001|Overall Study|Death|0|||
156891865|NCT01466179|566363398|FG000|Overall Study|Ongoing in core study|2|||
156891866|NCT01466179|566363398|FG000|Overall Study|Physician Decision|46|||
156891867|NCT01466179|566363398|FG000|Overall Study|Progressive disease|43|||
157157903|NCT03249792|567322883|FG019|Switch Over Period|Adverse Event|0|||
157157904|NCT03249792|567322884|FG020|Switch Over Period|Adverse Event|0|||
157157905|NCT03249792|567322885|FG021|Switch Over Period|Adverse Event|0|||
157157906|NCT03249792|567322886|FG022|Switch Over Period|Adverse Event|0|||
157157907|NCT03249792|567322887|FG023|Switch Over Period|Adverse Event|0|||
157157908|NCT03249792|567322888|FG024|Switch Over Period|Adverse Event|0|||
157157909|NCT03249792|567322889|FG025|Switch Over Period|Adverse Event|1|||
157157910|NCT03249792|567322890|FG026|Switch Over Period|Adverse Event|0|||
157225486|NCT03594123|567571445|FG000|Overall Study|Adverse Event|8|||
156891868|NCT01466179|566363398|FG000|Overall Study|Adverse Event|32|||
156891869|NCT01466179|566363398|FG000|Overall Study|Disease relapse|23|||
156891870|NCT01466179|566363398|FG000|Overall Study|Lack of Efficacy|14|||
156891871|NCT01466179|566363398|FG000|Overall Study|Death|7|||
156891872|NCT01466179|566363398|FG000|Overall Study|Withdrawal by Subject|7|||
156891873|NCT01466179|566363398|FG000|Overall Study|Protocol Violation|2|||
156891874|NCT01466179|566363398|FG000|Overall Study|Other|3|||
157225487|NCT03594123|567571446|FG001|Overall Study|Adverse Event|5|||
156891875|NCT04062123|566363399|FG000|Overall Study|Withdrawal by Subject|0|||
156891876|NCT04062123|566363400|FG001|Overall Study|Withdrawal by Subject|1|||
156891877|NCT04062123|566363401|FG002|Overall Study|Withdrawal by Subject|0|||
156891878|NCT02011893|566363402|FG000|Enrollment to Randomization|Adverse Event|2|||
156891879|NCT02011893|566363403|FG001|Enrollment to Randomization|Adverse Event|0|||
156891880|NCT02011893|566363404|FG002|Enrollment to Randomization|Adverse Event|0|||
156891881|NCT02011893|566363402|FG000|Enrollment to Randomization|Physician Decision|10|||
156891882|NCT02011893|566363403|FG001|Enrollment to Randomization|Physician Decision|0|||
156891883|NCT02011893|566363404|FG002|Enrollment to Randomization|Physician Decision|0|||
156891884|NCT02011893|566363402|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
156891885|NCT02011893|566363403|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
157157911|NCT03249792|567322891|FG027|Switch Over Period|Adverse Event|1|||
157225488|NCT03594123|567571445|FG000|Overall Study|Site Terminated by Sponsor|4|||
156891886|NCT02011893|566363404|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
156891887|NCT02011893|566363402|FG000|Enrollment to Randomization|Screening Failure|29|||
156891888|NCT02011893|566363403|FG001|Enrollment to Randomization|Screening Failure|0|||
156891889|NCT02011893|566363404|FG002|Enrollment to Randomization|Screening Failure|0|||
156891890|NCT02011893|566363402|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
156891891|NCT02011893|566363403|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
156891892|NCT02011893|566363404|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
157157912|NCT03249792|567322892|FG028|Switch Over Period|Adverse Event|0|||
157157913|NCT03249792|567322893|FG029|Switch Over Period|Adverse Event|0|||
156891893|NCT02011893|566363402|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
156891894|NCT02011893|566363403|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
156891895|NCT02011893|566363404|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
156891896|NCT02011893|566363402|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
156891897|NCT02011893|566363403|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
156891898|NCT02011893|566363404|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
156891899|NCT02011893|566363402|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
156891900|NCT02011893|566363403|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
156891901|NCT02011893|566363404|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
156891902|NCT02011893|566363402|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
156891903|NCT02011893|566363403|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
156891904|NCT02011893|566363404|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
156891905|NCT01001299|566363406|FG000|Overall Study|Insufficient Therapeutic Response|20|||
156891906|NCT01001299|566363406|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
156891907|NCT01001299|566363406|FG000|Overall Study|Death|1|||
156891908|NCT01001299|566363406|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
156891909|NCT01001299|566363406|FG000|Overall Study|Withdrew Consent|1|||
156891910|NCT05101317|566363407|FG000|Week1-13|Adverse Event|0|||
156891911|NCT05101317|566363408|FG001|Week1-13|Adverse Event|1|||
156891912|NCT05101317|566363409|FG002|Week1-13|Adverse Event|0|||
156891913|NCT05101317|566363410|FG003|Week1-13|Adverse Event|0|||
156891914|NCT05101317|566363407|FG000|Week1-13|Withdrawal by Subject|0|||
156891915|NCT05101317|566363408|FG001|Week1-13|Withdrawal by Subject|2|||
156891916|NCT05101317|566363409|FG002|Week1-13|Withdrawal by Subject|0|||
156891917|NCT05101317|566363410|FG003|Week1-13|Withdrawal by Subject|0|||
156891918|NCT05101317|566363407|FG000|Week1-13|Early Withdrawl|0|||
156891919|NCT05101317|566363408|FG001|Week1-13|Early Withdrawl|0|||
156891920|NCT05101317|566363409|FG002|Week1-13|Early Withdrawl|0|||
156891921|NCT05101317|566363410|FG003|Week1-13|Early Withdrawl|1|||
156891922|NCT05101317|566363407|FG000|Week 13-25|Lost to Follow-up|0|||
156891923|NCT05101317|566363408|FG001|Week 13-25|Lost to Follow-up|0|||
156891924|NCT05101317|566363409|FG002|Week 13-25|Lost to Follow-up|1|||
156891925|NCT05101317|566363410|FG003|Week 13-25|Lost to Follow-up|0|||
156891926|NCT05101317|566363407|FG000|Week 13-25|Withdrawal by Subject|1|||
156891927|NCT05101317|566363408|FG001|Week 13-25|Withdrawal by Subject|1|||
156891928|NCT05101317|566363409|FG002|Week 13-25|Withdrawal by Subject|0|||
156891929|NCT05101317|566363410|FG003|Week 13-25|Withdrawal by Subject|0|||
156891930|NCT05101317|566363407|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
156891931|NCT05101317|566363408|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
156891932|NCT05101317|566363409|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
156891933|NCT05101317|566363410|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
156891934|NCT05764265|566363411|FG000|Overall Study|Adverse Event|1|||
156891935|NCT05764265|566363412|FG001|Overall Study|Adverse Event|0|||
156891936|NCT05764265|566363411|FG000|Overall Study|Physician Decision|1|||
156891937|NCT05764265|566363412|FG001|Overall Study|Physician Decision|8|||
156891938|NCT05764265|566363411|FG000|Overall Study|Study Terminated By Sponsor|20|||
156891939|NCT05764265|566363412|FG001|Overall Study|Study Terminated By Sponsor|0|||
156891940|NCT05764265|566363411|FG000|Overall Study|Participant Decision|1|||
156891941|NCT05764265|566363412|FG001|Overall Study|Participant Decision|0|||
156891942|NCT02522871|566363415|FG000|Overall Study|Protocol Violation|1|||
156891943|NCT02522871|566363416|FG001|Overall Study|Protocol Violation|4|||
156891944|NCT02522871|566363415|FG000|Overall Study|Treated without randomization|1|||
156891945|NCT02522871|566363416|FG001|Overall Study|Treated without randomization|0|||
156891946|NCT02522871|566363415|FG000|Overall Study|Death|9|||
156891947|NCT02522871|566363416|FG001|Overall Study|Death|9|||
156891948|NCT02522871|566363415|FG000|Overall Study|Died in operating room prior to transplant|0|||
156891949|NCT02522871|566363416|FG001|Overall Study|Died in operating room prior to transplant|1|||
156891950|NCT00509262|566363417|FG000|Overall Study|Adverse Event|16|||
156891951|NCT00509262|566363418|FG001|Overall Study|Adverse Event|18|||
156891952|NCT00509262|566363417|FG000|Overall Study|Other|2|||
156891953|NCT00509262|566363418|FG001|Overall Study|Other|2|||
156891954|NCT00509262|566363417|FG000|Overall Study|Lack of Efficacy|1|||
156891955|NCT00509262|566363418|FG001|Overall Study|Lack of Efficacy|0|||
156891956|NCT00509262|566363417|FG000|Overall Study|Lost to Follow-up|1|||
157157914|NCT03249792|567322894|FG030|Switch Over Period|Adverse Event|0|||
157157915|NCT03249792|567322895|FG031|Switch Over Period|Adverse Event|0|||
156891957|NCT00509262|566363418|FG001|Overall Study|Lost to Follow-up|6|||
156891958|NCT00509262|566363417|FG000|Overall Study|Physician Decision|1|||
156891959|NCT00509262|566363418|FG001|Overall Study|Physician Decision|3|||
156891960|NCT00509262|566363417|FG000|Overall Study|Protocol Violation|2|||
156891961|NCT00509262|566363418|FG001|Overall Study|Protocol Violation|2|||
156891962|NCT00509262|566363417|FG000|Overall Study|Withdrawal by Subject|24|||
156891963|NCT00509262|566363418|FG001|Overall Study|Withdrawal by Subject|11|||
156891964|NCT00725842|566363419|FG000|Overall Study|Lost to Follow-up|19|||
156891965|NCT00725842|566363419|FG000|Overall Study|Death|1|||
157157916|NCT03249792|567322896|FG032|Switch Over Period|Adverse Event|0|||
156891966|NCT00725842|566363419|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
156891967|NCT00725842|566363419|FG000|Overall Study|Consent date prior to study start date|5|||
156891968|NCT00725842|566363419|FG000|Overall Study|Inclusion criterion not met|1|||
156891969|NCT00725842|566363419|FG000|Overall Study|No Visit 1 data|1|||
156891970|NCT01853618|566363420|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
156891971|NCT01853618|566363421|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
156891972|NCT01853618|566363422|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
156891973|NCT01853618|566363423|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
156891974|NCT01853618|566363424|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
156891975|NCT01853618|566363420|FG000|Overall Study|Progressive disease|1|||
156891976|NCT01853618|566363421|FG001|Overall Study|Progressive disease|1|||
156891977|NCT01853618|566363422|FG002|Overall Study|Progressive disease|1|||
156891978|NCT01853618|566363423|FG003|Overall Study|Progressive disease|1|||
156891979|NCT01853618|566363424|FG004|Overall Study|Progressive disease|2|||
156891980|NCT01853618|566363420|FG000|Overall Study|Physician Decision|0|||
156891981|NCT01853618|566363421|FG001|Overall Study|Physician Decision|1|||
156891982|NCT01853618|566363422|FG002|Overall Study|Physician Decision|1|||
156891983|NCT01853618|566363423|FG003|Overall Study|Physician Decision|0|||
156891984|NCT01853618|566363424|FG004|Overall Study|Physician Decision|0|||
156891985|NCT01853618|566363420|FG000|Overall Study|Refused further treatment|0|||
156891986|NCT01853618|566363421|FG001|Overall Study|Refused further treatment|0|||
156891987|NCT01853618|566363422|FG002|Overall Study|Refused further treatment|0|||
156891988|NCT01853618|566363423|FG003|Overall Study|Refused further treatment|0|||
156891989|NCT01853618|566363424|FG004|Overall Study|Refused further treatment|1|||
156891990|NCT02398227|566363431|FG000|Overall Study|Lost to Follow-up|21|||
156891991|NCT02398227|566363432|FG001|Overall Study|Lost to Follow-up|12|||
156891992|NCT02398227|566363431|FG000|Overall Study|Withdrawal by Subject|5|||
156891993|NCT02398227|566363432|FG001|Overall Study|Withdrawal by Subject|6|||
156891994|NCT02398227|566363431|FG000|Overall Study|Removed from treatment and dropped out|1|||
156891995|NCT02398227|566363432|FG001|Overall Study|Removed from treatment and dropped out|0|||
156891996|NCT01715129|566363433|FG000|Overall Study|Adverse Event, fatal|1|||
156891997|NCT01715129|566363433|FG000|Overall Study|Lack of Efficacy|3|||
156891998|NCT01715129|566363433|FG000|Overall Study|Protocol Violation|1|||
156891999|NCT01715129|566363433|FG000|Overall Study|Consent Withdrawn|2|||
156892000|NCT01715129|566363433|FG000|Overall Study|Lost to Follow-up|1|||
156892001|NCT01715129|566363433|FG000|Overall Study|Other|1|||
156892002|NCT02793622|566363435|FG000|Overall Study|Lost to Follow-up|31|||
156892003|NCT02793622|566363436|FG001|Overall Study|Lost to Follow-up|19|||
156892004|NCT02793622|566363435|FG000|Overall Study|Withdrawal by Subject|21|||
156892005|NCT02793622|566363436|FG001|Overall Study|Withdrawal by Subject|17|||
156892006|NCT02793622|566363435|FG000|Overall Study|Adverse Event|0|||
156892007|NCT02793622|566363436|FG001|Overall Study|Adverse Event|1|||
156892008|NCT02793622|566363435|FG000|Overall Study|Protocol Violation|1|||
156892009|NCT02793622|566363436|FG001|Overall Study|Protocol Violation|5|||
156892010|NCT02009384|566363437|FG000|Overall Study|Death|2|||
156892011|NCT01146860|566363438|FG000|Overall Study|Withdrawal by Subject|0|||
156892012|NCT01146860|566363439|FG001|Overall Study|Withdrawal by Subject|1|||
156892013|NCT01092832|566363440|FG000|Overall Study|Other|1|||
156892014|NCT01092832|566363441|FG001|Overall Study|Other|0|||
156892015|NCT00722371|566363442|FG000|Overall Study|Adverse Event|6|||
156892016|NCT00722371|566363443|FG001|Overall Study|Adverse Event|13|||
156892017|NCT00722371|566363444|FG002|Overall Study|Adverse Event|9|||
156892018|NCT00722371|566363445|FG003|Overall Study|Adverse Event|10|||
156892019|NCT00722371|566363446|FG004|Overall Study|Adverse Event|6|||
156892020|NCT00722371|566363447|FG005|Overall Study|Adverse Event|8|||
156892021|NCT00722371|566363448|FG006|Overall Study|Adverse Event|4|||
156892022|NCT00722371|566363442|FG000|Overall Study|Contraindication|0|||
156892023|NCT00722371|566363443|FG001|Overall Study|Contraindication|0|||
156892024|NCT00722371|566363444|FG002|Overall Study|Contraindication|1|||
156892025|NCT00722371|566363445|FG003|Overall Study|Contraindication|0|||
156892026|NCT00722371|566363446|FG004|Overall Study|Contraindication|0|||
156892027|NCT00722371|566363447|FG005|Overall Study|Contraindication|0|||
156892028|NCT00722371|566363448|FG006|Overall Study|Contraindication|0|||
156892029|NCT00722371|566363442|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
157157917|NCT00995345|567322899|FG000|Overall Study|Withdrawal by Subject|4|||
156892030|NCT00722371|566363443|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
156892031|NCT00722371|566363444|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
156892032|NCT00722371|566363445|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
156892033|NCT00722371|566363446|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
156892034|NCT00722371|566363447|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
156892035|NCT00722371|566363448|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
156892036|NCT00722371|566363442|FG000|Overall Study|Excluded medication|0|||
156892037|NCT00722371|566363443|FG001|Overall Study|Excluded medication|1|||
156892038|NCT00722371|566363444|FG002|Overall Study|Excluded medication|1|||
156892039|NCT00722371|566363445|FG003|Overall Study|Excluded medication|0|||
156892040|NCT00722371|566363446|FG004|Overall Study|Excluded medication|0|||
157157918|NCT00995345|567322900|FG001|Overall Study|Withdrawal by Subject|2|||
156892041|NCT00722371|566363447|FG005|Overall Study|Excluded medication|0|||
156892042|NCT00722371|566363448|FG006|Overall Study|Excluded medication|1|||
156892043|NCT00722371|566363442|FG000|Overall Study|Hyperglycemia|2|||
156892044|NCT00722371|566363443|FG001|Overall Study|Hyperglycemia|6|||
156892045|NCT00722371|566363444|FG002|Overall Study|Hyperglycemia|4|||
156892046|NCT00722371|566363445|FG003|Overall Study|Hyperglycemia|2|||
156892047|NCT00722371|566363446|FG004|Overall Study|Hyperglycemia|5|||
156892048|NCT00722371|566363447|FG005|Overall Study|Hyperglycemia|1|||
156892049|NCT00722371|566363448|FG006|Overall Study|Hyperglycemia|1|||
156892050|NCT00722371|566363442|FG000|Overall Study|Hypoglycemia|1|||
156892051|NCT00722371|566363443|FG001|Overall Study|Hypoglycemia|0|||
156892052|NCT00722371|566363444|FG002|Overall Study|Hypoglycemia|0|||
156892053|NCT00722371|566363445|FG003|Overall Study|Hypoglycemia|0|||
156892054|NCT00722371|566363446|FG004|Overall Study|Hypoglycemia|0|||
156892055|NCT00722371|566363447|FG005|Overall Study|Hypoglycemia|0|||
156892056|NCT00722371|566363448|FG006|Overall Study|Hypoglycemia|0|||
156892057|NCT00722371|566363442|FG000|Overall Study|Lack of Efficacy|4|||
156892058|NCT00722371|566363443|FG001|Overall Study|Lack of Efficacy|6|||
156892059|NCT00722371|566363444|FG002|Overall Study|Lack of Efficacy|6|||
156892060|NCT00722371|566363445|FG003|Overall Study|Lack of Efficacy|6|||
156892061|NCT00722371|566363446|FG004|Overall Study|Lack of Efficacy|2|||
156892062|NCT00722371|566363447|FG005|Overall Study|Lack of Efficacy|3|||
156892063|NCT00722371|566363448|FG006|Overall Study|Lack of Efficacy|0|||
156892064|NCT00722371|566363442|FG000|Overall Study|Lost to Follow-up|11|||
156892065|NCT00722371|566363443|FG001|Overall Study|Lost to Follow-up|14|||
156892066|NCT00722371|566363444|FG002|Overall Study|Lost to Follow-up|21|||
156892067|NCT00722371|566363445|FG003|Overall Study|Lost to Follow-up|13|||
156892068|NCT00722371|566363446|FG004|Overall Study|Lost to Follow-up|8|||
156892069|NCT00722371|566363447|FG005|Overall Study|Lost to Follow-up|16|||
156892070|NCT00722371|566363448|FG006|Overall Study|Lost to Follow-up|13|||
156892071|NCT00722371|566363442|FG000|Overall Study|Physician Decision|5|||
156892072|NCT00722371|566363443|FG001|Overall Study|Physician Decision|2|||
156892073|NCT00722371|566363444|FG002|Overall Study|Physician Decision|2|||
156892074|NCT00722371|566363445|FG003|Overall Study|Physician Decision|5|||
156892075|NCT00722371|566363446|FG004|Overall Study|Physician Decision|2|||
156892076|NCT00722371|566363447|FG005|Overall Study|Physician Decision|3|||
156892077|NCT00722371|566363448|FG006|Overall Study|Physician Decision|4|||
156892078|NCT00722371|566363442|FG000|Overall Study|Pregnancy|1|||
156892079|NCT00722371|566363443|FG001|Overall Study|Pregnancy|1|||
156892080|NCT00722371|566363444|FG002|Overall Study|Pregnancy|0|||
156892081|NCT00722371|566363445|FG003|Overall Study|Pregnancy|0|||
156892082|NCT00722371|566363446|FG004|Overall Study|Pregnancy|0|||
156892083|NCT00722371|566363447|FG005|Overall Study|Pregnancy|1|||
156892084|NCT00722371|566363448|FG006|Overall Study|Pregnancy|0|||
156892085|NCT00722371|566363442|FG000|Overall Study|Protocol Violation|6|||
156892086|NCT00722371|566363443|FG001|Overall Study|Protocol Violation|1|||
156892087|NCT00722371|566363444|FG002|Overall Study|Protocol Violation|0|||
156892088|NCT00722371|566363445|FG003|Overall Study|Protocol Violation|1|||
156892089|NCT00722371|566363446|FG004|Overall Study|Protocol Violation|4|||
156892090|NCT00722371|566363447|FG005|Overall Study|Protocol Violation|2|||
156892091|NCT00722371|566363448|FG006|Overall Study|Protocol Violation|1|||
156892092|NCT00722371|566363442|FG000|Overall Study|Withdrawal by Subject|18|||
156892093|NCT00722371|566363443|FG001|Overall Study|Withdrawal by Subject|27|||
156892094|NCT00722371|566363444|FG002|Overall Study|Withdrawal by Subject|19|||
156892095|NCT00722371|566363445|FG003|Overall Study|Withdrawal by Subject|23|||
156892096|NCT00722371|566363446|FG004|Overall Study|Withdrawal by Subject|19|||
156892097|NCT00722371|566363447|FG005|Overall Study|Withdrawal by Subject|18|||
156892098|NCT00722371|566363448|FG006|Overall Study|Withdrawal by Subject|26|||
156892099|NCT01075191|566363449|FG000|Overall Study|Death|1|||
156892100|NCT01075191|566363449|FG000|Overall Study|Intensification|3|||
156892101|NCT01075191|566363449|FG000|Overall Study|Co-morbidities|1|||
156892102|NCT01075191|566363449|FG000|Overall Study|Adverse Event|4|||
157157919|NCT00995345|567322901|FG002|Overall Study|Withdrawal by Subject|1|||
156892103|NCT01075191|566363449|FG000|Overall Study|Noncompliance|3|||
156892104|NCT01075191|566363449|FG000|Overall Study|Therapy Break|3|||
156892105|NCT01075191|566363449|FG000|Overall Study|Patient's Wish|2|||
156892106|NCT01075191|566363449|FG000|Overall Study|Unknown Reasons|1|||
156892107|NCT00718237|566363454|FG000|Overall Study|Adverse Event|1|||
156892108|NCT00718237|566363455|FG001|Overall Study|Adverse Event|3|||
156892109|NCT00718237|566363454|FG000|Overall Study|Lost to Follow-up|2|||
156892110|NCT00718237|566363455|FG001|Overall Study|Lost to Follow-up|2|||
156892111|NCT00718237|566363454|FG000|Overall Study|Physician Decision|1|||
156892112|NCT00718237|566363455|FG001|Overall Study|Physician Decision|0|||
156892113|NCT00718237|566363454|FG000|Overall Study|Withdrawal by Subject|9|||
156892114|NCT00718237|566363455|FG001|Overall Study|Withdrawal by Subject|10|||
156892115|NCT01244490|566363456|FG000|Overall Study|Lack of Efficacy|14|||
156892116|NCT01244490|566363457|FG001|Overall Study|Lack of Efficacy|5|||
156892117|NCT01244490|566363458|FG002|Overall Study|Lack of Efficacy|5|||
156892118|NCT01244490|566363456|FG000|Overall Study|Withdrawal by Subject|4|||
156892119|NCT01244490|566363457|FG001|Overall Study|Withdrawal by Subject|4|||
157157920|NCT00995345|567322902|FG003|Overall Study|Withdrawal by Subject|3|||
157157921|NCT00995345|567322903|FG004|Overall Study|Withdrawal by Subject|1|||
156892120|NCT01244490|566363458|FG002|Overall Study|Withdrawal by Subject|9|||
156892121|NCT01244490|566363456|FG000|Overall Study|Adverse Event|1|||
156892122|NCT01244490|566363457|FG001|Overall Study|Adverse Event|9|||
156892123|NCT01244490|566363458|FG002|Overall Study|Adverse Event|5|||
156892124|NCT01244490|566363456|FG000|Overall Study|Lost to Follow-up|0|||
156892125|NCT01244490|566363457|FG001|Overall Study|Lost to Follow-up|6|||
156892126|NCT01244490|566363458|FG002|Overall Study|Lost to Follow-up|3|||
156892127|NCT01244490|566363456|FG000|Overall Study|Other|0|||
156892128|NCT01244490|566363457|FG001|Overall Study|Other|0|||
156892129|NCT01244490|566363458|FG002|Overall Study|Other|1|||
156892130|NCT00400153|566363459|FG000|Overall Study|AE due to study disease worsening|14|||
156892131|NCT00400153|566363460|FG001|Overall Study|AE due to study disease worsening|19|||
156892132|NCT00400153|566363461|FG002|Overall Study|AE due to study disease worsening|20|||
156892133|NCT00400153|566363459|FG000|Overall Study|AE due to other disease worsening|2|||
156892134|NCT00400153|566363460|FG001|Overall Study|AE due to other disease worsening|1|||
156892135|NCT00400153|566363461|FG002|Overall Study|AE due to other disease worsening|0|||
156892136|NCT00400153|566363459|FG000|Overall Study|AE due to other condition|3|||
156892137|NCT00400153|566363460|FG001|Overall Study|AE due to other condition|14|||
156892138|NCT00400153|566363461|FG002|Overall Study|AE due to other condition|15|||
156892139|NCT00400153|566363459|FG000|Overall Study|Protocol Violation|7|||
156892140|NCT00400153|566363460|FG001|Overall Study|Protocol Violation|4|||
156892141|NCT00400153|566363461|FG002|Overall Study|Protocol Violation|9|||
156892142|NCT00400153|566363459|FG000|Overall Study|Lost to Follow-up|2|||
156892143|NCT00400153|566363460|FG001|Overall Study|Lost to Follow-up|1|||
156892144|NCT00400153|566363461|FG002|Overall Study|Lost to Follow-up|4|||
156892145|NCT00400153|566363459|FG000|Overall Study|Withdrawal by Subject|12|||
156892146|NCT00400153|566363460|FG001|Overall Study|Withdrawal by Subject|11|||
156892147|NCT00400153|566363461|FG002|Overall Study|Withdrawal by Subject|10|||
156892148|NCT00400153|566363459|FG000|Overall Study|Other reasons - not mentioned above|8|||
156892149|NCT00400153|566363460|FG001|Overall Study|Other reasons - not mentioned above|5|||
156892150|NCT00400153|566363461|FG002|Overall Study|Other reasons - not mentioned above|3|||
156892151|NCT01423604|566363465|FG000|Safety Run-In|Adverse Event|3|||
156892152|NCT01423604|566363466|FG001|Safety Run-In|Adverse Event|0|||
156892153|NCT01423604|566363465|FG000|Safety Run-In|Death|1|||
156892154|NCT01423604|566363466|FG001|Safety Run-In|Death|0|||
156892155|NCT01423604|566363465|FG000|Safety Run-In|Physician Decision|1|||
156892156|NCT01423604|566363466|FG001|Safety Run-In|Physician Decision|0|||
156892157|NCT01423604|566363465|FG000|Safety Run-In|Disease progression|3|||
156892158|NCT01423604|566363466|FG001|Safety Run-In|Disease progression|0|||
156892159|NCT01423604|566363465|FG000|Safety Run-In|Patient decision|1|||
156892160|NCT01423604|566363466|FG001|Safety Run-In|Patient decision|0|||
156892161|NCT01423604|566363465|FG000|Randomized|Adverse Event|4|||
156892162|NCT01423604|566363466|FG001|Randomized|Adverse Event|10|||
156892163|NCT01423604|566363465|FG000|Randomized|Death|1|||
156892164|NCT01423604|566363466|FG001|Randomized|Death|0|||
156892165|NCT01423604|566363465|FG000|Randomized|Physician Decision|16|||
156892166|NCT01423604|566363466|FG001|Randomized|Physician Decision|13|||
156892167|NCT01423604|566363465|FG000|Randomized|Other - unspecified|37|||
156892168|NCT01423604|566363466|FG001|Randomized|Other - unspecified|31|||
156892169|NCT01423604|566363465|FG000|Randomized|Patient decision|5|||
156892170|NCT01423604|566363466|FG001|Randomized|Patient decision|9|||
156892171|NCT02414139|566363470|FG000|Treatment Period|Adverse Event|11|||
156892172|NCT02414139|566363471|FG001|Treatment Period|Adverse Event|6|||
156892173|NCT02414139|566363472|FG002|Treatment Period|Adverse Event|8|||
156892174|NCT02414139|566363473|FG003|Treatment Period|Adverse Event|5|||
156892175|NCT02414139|566363474|FG004|Treatment Period|Adverse Event|14|||
156892176|NCT02414139|566363475|FG005|Treatment Period|Adverse Event|3|||
156892177|NCT02414139|566363476|FG006|Treatment Period|Adverse Event|6|||
156892178|NCT02414139|566363477|FG007|Treatment Period|Adverse Event|1|||
156892179|NCT02414139|566363478|FG008|Treatment Period|Adverse Event|6|||
157157922|NCT00995345|567322899|FG000|Overall Study|Adverse Event|3|||
157157923|NCT00995345|567322900|FG001|Overall Study|Adverse Event|1|||
156892180|NCT02414139|566363479|FG009|Treatment Period|Adverse Event|8|||
156892181|NCT02414139|566363470|FG000|Treatment Period|Death|0|||
156892182|NCT02414139|566363471|FG001|Treatment Period|Death|0|||
157157924|NCT00995345|567322901|FG002|Overall Study|Adverse Event|2|||
156892183|NCT02414139|566363472|FG002|Treatment Period|Death|1|||
156892184|NCT02414139|566363473|FG003|Treatment Period|Death|1|||
156892185|NCT02414139|566363474|FG004|Treatment Period|Death|0|||
156892186|NCT02414139|566363475|FG005|Treatment Period|Death|0|||
156892187|NCT02414139|566363476|FG006|Treatment Period|Death|0|||
156892188|NCT02414139|566363477|FG007|Treatment Period|Death|0|||
156892189|NCT02414139|566363478|FG008|Treatment Period|Death|0|||
156892190|NCT02414139|566363479|FG009|Treatment Period|Death|1|||
156892191|NCT02414139|566363470|FG000|Treatment Period|Physician Decision|5|||
156892192|NCT02414139|566363471|FG001|Treatment Period|Physician Decision|4|||
156892193|NCT02414139|566363472|FG002|Treatment Period|Physician Decision|6|||
156892194|NCT02414139|566363473|FG003|Treatment Period|Physician Decision|1|||
157157925|NCT00995345|567322902|FG003|Overall Study|Adverse Event|0|||
157157926|NCT00995345|567322903|FG004|Overall Study|Adverse Event|1|||
157157927|NCT00995345|567322899|FG000|Overall Study|Lost to Follow-up|2|||
156892195|NCT02414139|566363474|FG004|Treatment Period|Physician Decision|4|||
156892196|NCT02414139|566363475|FG005|Treatment Period|Physician Decision|0|||
156892197|NCT02414139|566363476|FG006|Treatment Period|Physician Decision|2|||
156892198|NCT02414139|566363477|FG007|Treatment Period|Physician Decision|0|||
156892199|NCT02414139|566363478|FG008|Treatment Period|Physician Decision|1|||
156892200|NCT02414139|566363479|FG009|Treatment Period|Physician Decision|4|||
156892201|NCT02414139|566363470|FG000|Treatment Period|Progressive disease|48|||
156892202|NCT02414139|566363471|FG001|Treatment Period|Progressive disease|31|||
156892203|NCT02414139|566363472|FG002|Treatment Period|Progressive disease|37|||
156892204|NCT02414139|566363473|FG003|Treatment Period|Progressive disease|21|||
156892205|NCT02414139|566363474|FG004|Treatment Period|Progressive disease|43|||
156892206|NCT02414139|566363475|FG005|Treatment Period|Progressive disease|12|||
156892207|NCT02414139|566363476|FG006|Treatment Period|Progressive disease|16|||
156892208|NCT02414139|566363477|FG007|Treatment Period|Progressive disease|2|||
156892209|NCT02414139|566363478|FG008|Treatment Period|Progressive disease|20|||
156892210|NCT02414139|566363479|FG009|Treatment Period|Progressive disease|14|||
156892211|NCT02414139|566363470|FG000|Treatment Period|Protocol deviation|0|||
156892212|NCT02414139|566363471|FG001|Treatment Period|Protocol deviation|0|||
156892213|NCT02414139|566363472|FG002|Treatment Period|Protocol deviation|1|||
156892214|NCT02414139|566363473|FG003|Treatment Period|Protocol deviation|0|||
156892215|NCT02414139|566363474|FG004|Treatment Period|Protocol deviation|0|||
156892216|NCT02414139|566363475|FG005|Treatment Period|Protocol deviation|0|||
156892217|NCT02414139|566363476|FG006|Treatment Period|Protocol deviation|0|||
156892218|NCT02414139|566363477|FG007|Treatment Period|Protocol deviation|0|||
156892219|NCT02414139|566363478|FG008|Treatment Period|Protocol deviation|0|||
156892220|NCT02414139|566363479|FG009|Treatment Period|Protocol deviation|0|||
156892221|NCT02414139|566363470|FG000|Treatment Period|Subject/Guardian decision|5|||
156892222|NCT02414139|566363471|FG001|Treatment Period|Subject/Guardian decision|1|||
156892223|NCT02414139|566363472|FG002|Treatment Period|Subject/Guardian decision|1|||
156892224|NCT02414139|566363473|FG003|Treatment Period|Subject/Guardian decision|2|||
156892225|NCT02414139|566363474|FG004|Treatment Period|Subject/Guardian decision|5|||
156892226|NCT02414139|566363475|FG005|Treatment Period|Subject/Guardian decision|0|||
156892227|NCT02414139|566363476|FG006|Treatment Period|Subject/Guardian decision|2|||
156892228|NCT02414139|566363477|FG007|Treatment Period|Subject/Guardian decision|0|||
156892229|NCT02414139|566363478|FG008|Treatment Period|Subject/Guardian decision|1|||
156892230|NCT02414139|566363479|FG009|Treatment Period|Subject/Guardian decision|1|||
156892231|NCT02414139|566363470|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892232|NCT02414139|566363471|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892233|NCT02414139|566363472|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892234|NCT02414139|566363473|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892235|NCT02414139|566363474|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
156892236|NCT02414139|566363475|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892237|NCT02414139|566363476|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
156892238|NCT02414139|566363477|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
156892239|NCT02414139|566363478|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
156892240|NCT02414139|566363479|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
156892241|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
156892242|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892243|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892244|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892245|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
156892246|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892247|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892248|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892249|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892250|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
156892251|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Death|0|||
156892252|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Death|1|||
156892253|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Death|0|||
156892254|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Death|0|||
156892255|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Death|1|||
156892256|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Death|0|||
156892257|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Death|0|||
156892258|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Death|0|||
156892259|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Death|0|||
157026039|NCT05792085|566849699|FG002|Overall Study|Death|0|||
157026040|NCT05792085|566849700|FG003|Overall Study|Death|0|||
156892260|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Death|1|||
157026041|NCT05792085|566849701|FG004|Overall Study|Death|1|||
157157928|NCT00995345|567322900|FG001|Overall Study|Lost to Follow-up|2|||
157157929|NCT00995345|567322901|FG002|Overall Study|Lost to Follow-up|2|||
157157930|NCT00995345|567322902|FG003|Overall Study|Lost to Follow-up|1|||
156857558|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Disease progression|103|||
156857559|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Disease progression|122|||
156857560|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Other|3|||
156857561|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Other|0|||
156857562|NCT00883779|566232549|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
156857563|NCT00883779|566232550|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
156857564|NCT00883779|566232549|FG000|Off-study Phase|Death|185|||
156857565|NCT00883779|566232550|FG001|Off-study Phase|Death|174|||
156857566|NCT00883779|566232549|FG000|Off-study Phase|Refused treatment|1|||
156857567|NCT00883779|566232550|FG001|Off-study Phase|Refused treatment|1|||
156857568|NCT00883779|566232549|FG000|Off-study Phase|Failure to return|5|||
156857569|NCT00883779|566232550|FG001|Off-study Phase|Failure to return|6|||
156857570|NCT00883779|566232549|FG000|Off-study Phase|Other|18|||
156857571|NCT00883779|566232550|FG001|Off-study Phase|Other|21|||
156857572|NCT04575155|566232551|FG000|2 Month|Withdrawal by Subject|1|||
156857573|NCT04575155|566232552|FG001|2 Month|Withdrawal by Subject|1|||
156857574|NCT04575155|566232551|FG000|2 Month|Lost to Follow-up|5|||
156857575|NCT04575155|566232552|FG001|2 Month|Lost to Follow-up|3|||
156857576|NCT04575155|566232551|FG000|2 Month|Ineligible|1|||
156857577|NCT04575155|566232552|FG001|2 Month|Ineligible|0|||
156857578|NCT06237049|566232554|FG000|Overall Study|Death|0|||
156857579|NCT06237049|566232555|FG001|Overall Study|Death|0|||
156857580|NCT06237049|566232556|FG002|Overall Study|Death|0|||
156857581|NCT06237049|566232557|FG003|Overall Study|Death|1|||
156857582|NCT06237049|566232554|FG000|Overall Study|Lost to Follow-up|11|||
156857583|NCT06237049|566232555|FG001|Overall Study|Lost to Follow-up|5|||
156857584|NCT06237049|566232556|FG002|Overall Study|Lost to Follow-up|8|||
156857585|NCT06237049|566232557|FG003|Overall Study|Lost to Follow-up|8|||
156857586|NCT06237049|566232554|FG000|Overall Study|Protocol Violation|0|||
156857587|NCT06237049|566232555|FG001|Overall Study|Protocol Violation|1|||
156857588|NCT06237049|566232556|FG002|Overall Study|Protocol Violation|0|||
156857589|NCT06237049|566232557|FG003|Overall Study|Protocol Violation|1|||
156857590|NCT06237049|566232554|FG000|Overall Study|Withdrawal by Subject|4|||
156857591|NCT06237049|566232555|FG001|Overall Study|Withdrawal by Subject|2|||
156857592|NCT06237049|566232556|FG002|Overall Study|Withdrawal by Subject|1|||
156857593|NCT06237049|566232557|FG003|Overall Study|Withdrawal by Subject|0|||
156857594|NCT03748823|566232558|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
156857595|NCT03748823|566232559|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
156857596|NCT03748823|566232558|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
156857597|NCT03748823|566232559|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
156857598|NCT03748823|566232558|FG000|Extension Period|Withdrawal by Subject|9|||
156857599|NCT03748823|566232559|FG001|Extension Period|Withdrawal by Subject|12|||
156857600|NCT03748823|566232558|FG000|Extension Period|Death|2|||
156857601|NCT03748823|566232559|FG001|Extension Period|Death|2|||
156857602|NCT03748823|566232558|FG000|Extension Period|Other than Specified|0|||
156857603|NCT03748823|566232559|FG001|Extension Period|Other than Specified|1|||
156857604|NCT03748823|566232558|FG000|Extension Period|Protocol Violation|1|||
156857605|NCT03748823|566232559|FG001|Extension Period|Protocol Violation|0|||
156857606|NCT03748823|566232558|FG000|Extension Period|Lost to Follow-up|0|||
156857607|NCT03748823|566232559|FG001|Extension Period|Lost to Follow-up|1|||
156857608|NCT03748823|566232558|FG000|Extension Period|Lack of Efficacy|0|||
156857609|NCT03748823|566232559|FG001|Extension Period|Lack of Efficacy|1|||
156857610|NCT03748823|566232558|FG000|Extension Period|Physician Decision|1|||
156857611|NCT03748823|566232559|FG001|Extension Period|Physician Decision|2|||
156857612|NCT00982735|566232563|FG000|Overall Study|Lost to Follow-up|6|||
156857613|NCT00982735|566232563|FG000|Overall Study|Patient ineligible for trial|224|||
156857614|NCT02898454|566232565|FG000|Overall Study|Adverse Event|4|||
156857615|NCT02898454|566232566|FG001|Overall Study|Adverse Event|1|||
156857616|NCT02898454|566232567|FG002|Overall Study|Adverse Event|2|||
157157931|NCT00995345|567322903|FG004|Overall Study|Lost to Follow-up|0|||
157157932|NCT00995345|567322899|FG000|Overall Study|all other reasons combined|2|||
157157933|NCT00995345|567322900|FG001|Overall Study|all other reasons combined|2|||
157157934|NCT00995345|567322901|FG002|Overall Study|all other reasons combined|2|||
157157935|NCT00995345|567322902|FG003|Overall Study|all other reasons combined|1|||
157157936|NCT00995345|567322903|FG004|Overall Study|all other reasons combined|3|||
156857617|NCT02898454|566232565|FG000|Overall Study|Protocol Violation|1|||
156857618|NCT02898454|566232566|FG001|Overall Study|Protocol Violation|0|||
156857619|NCT02898454|566232567|FG002|Overall Study|Protocol Violation|1|||
156857620|NCT02898454|566232565|FG000|Overall Study|Lack of Efficacy|4|||
156857621|NCT02898454|566232566|FG001|Overall Study|Lack of Efficacy|1|||
156857622|NCT02898454|566232567|FG002|Overall Study|Lack of Efficacy|0|||
156857623|NCT02898454|566232565|FG000|Overall Study|Withdrawal by Subject|6|||
156857624|NCT02898454|566232566|FG001|Overall Study|Withdrawal by Subject|3|||
156857625|NCT02898454|566232567|FG002|Overall Study|Withdrawal by Subject|3|||
156857626|NCT02898454|566232565|FG000|Overall Study|Lost to Follow-up|1|||
156857627|NCT02898454|566232566|FG001|Overall Study|Lost to Follow-up|0|||
156857628|NCT02898454|566232567|FG002|Overall Study|Lost to Follow-up|0|||
156892261|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
156892262|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892263|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892264|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892265|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892266|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892267|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892268|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892269|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892270|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
156892271|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156892272|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156892273|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156892274|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
156892275|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
156892276|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156892277|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156892278|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156892279|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
156892280|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
156892281|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
156892282|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156892283|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
156892284|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156892285|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
156892286|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
156892287|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
156892288|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
156892289|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156892290|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
156892291|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892292|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
156892293|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892294|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892295|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892296|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892297|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892298|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892299|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
156892300|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
156892301|NCT02414139|566363470|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
156892302|NCT02414139|566363471|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156892303|NCT02414139|566363472|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
156892304|NCT02414139|566363473|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156892305|NCT02414139|566363474|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156892306|NCT02414139|566363475|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
156892307|NCT02414139|566363476|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156892308|NCT02414139|566363477|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156892309|NCT02414139|566363478|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
156892310|NCT02414139|566363479|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
156892311|NCT02290431|566363480|FG000|Overall Study|Adverse Event|20|||
156892312|NCT02290431|566363480|FG000|Overall Study|Progressive disease|4|||
156892313|NCT02290431|566363480|FG000|Overall Study|Study terminated by Sponsor|1|||
156892314|NCT02290431|566363480|FG000|Overall Study|Physician Decision|2|||
156892315|NCT00686998|566363483|FG000|Overall Study|Adverse Event|3|||
156892316|NCT00686998|566363484|FG001|Overall Study|Adverse Event|2|||
156892317|NCT00686998|566363485|FG002|Overall Study|Adverse Event|1|||
156892318|NCT00686998|566363483|FG000|Overall Study|Withdrawal by Subject|2|||
156892319|NCT00686998|566363484|FG001|Overall Study|Withdrawal by Subject|1|||
156892320|NCT00686998|566363485|FG002|Overall Study|Withdrawal by Subject|2|||
156892321|NCT00686998|566363483|FG000|Overall Study|Lack of Efficacy|7|||
156892322|NCT00686998|566363484|FG001|Overall Study|Lack of Efficacy|5|||
156892323|NCT00686998|566363485|FG002|Overall Study|Lack of Efficacy|0|||
156892324|NCT00686998|566363483|FG000|Overall Study|Other|0|||
156892325|NCT00686998|566363484|FG001|Overall Study|Other|0|||
156892326|NCT00686998|566363485|FG002|Overall Study|Other|1|||
156892327|NCT00686998|566363483|FG000|Overall Study|Safety Reasons|1|||
156892328|NCT00686998|566363484|FG001|Overall Study|Safety Reasons|0|||
156892329|NCT00686998|566363485|FG002|Overall Study|Safety Reasons|0|||
156892330|NCT02361346|566363486|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892331|NCT02361346|566363487|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892332|NCT02361346|566363488|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892333|NCT02361346|566363489|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
156892334|NCT02361346|566363490|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892335|NCT02361346|566363491|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892336|NCT02361346|566363492|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892337|NCT02361346|566363493|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892338|NCT02361346|566363494|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
156892339|NCT02361346|566363486|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892340|NCT02361346|566363487|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892341|NCT02361346|566363488|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892342|NCT02361346|566363489|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892343|NCT02361346|566363490|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
156892344|NCT02361346|566363491|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892345|NCT02361346|566363492|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892346|NCT02361346|566363493|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892347|NCT02361346|566363494|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
156892348|NCT02361346|566363486|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
156892349|NCT02361346|566363487|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
156892350|NCT02361346|566363488|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
156892351|NCT02361346|566363489|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
156892352|NCT02361346|566363490|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
156892353|NCT02361346|566363491|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
156892354|NCT02361346|566363492|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
156892355|NCT02361346|566363493|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
156892356|NCT02361346|566363494|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
156892357|NCT02361346|566363486|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892358|NCT02361346|566363487|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892359|NCT02361346|566363488|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892360|NCT02361346|566363489|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892361|NCT02361346|566363490|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892362|NCT02361346|566363491|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892363|NCT02361346|566363492|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892364|NCT02361346|566363493|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
156892365|NCT02361346|566363494|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
156892366|NCT02361346|566363486|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892367|NCT02361346|566363487|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892368|NCT02361346|566363488|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892369|NCT02361346|566363489|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892370|NCT02361346|566363490|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892371|NCT02361346|566363491|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892372|NCT02361346|566363492|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892373|NCT02361346|566363493|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
156892374|NCT02361346|566363494|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
156892375|NCT02361346|566363486|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892376|NCT02361346|566363487|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892377|NCT02361346|566363488|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892378|NCT02361346|566363489|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892379|NCT02361346|566363490|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892380|NCT02361346|566363491|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892381|NCT02361346|566363492|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892382|NCT02361346|566363493|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
156892383|NCT02361346|566363494|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
156892384|NCT04369053|566364140|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
156892385|NCT04369053|566364140|FG000|Overall Study|Withdrawal by Subject|773|||
156892386|NCT04369053|566364140|FG000|Overall Study|Lost to Follow-up|182|||
156892387|NCT04369053|566364140|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
156892388|NCT00958789|566364144|FG000|Overall Study|Death|5|||
156892389|NCT00958789|566364144|FG000|Overall Study|Lost to Follow-up|14|||
156892390|NCT00958789|566364144|FG000|Overall Study|Withdrawal by Subject|17|||
156892391|NCT00958789|566364144|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
156892392|NCT00958789|566364144|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
157157937|NCT02509598|567322905|FG000|Overall Study|Withdrawal by Subject|1|||
157157938|NCT01201798|567322906|FG000|Overall Study|Adverse Event|2|||
157157939|NCT01201798|567322907|FG001|Overall Study|Adverse Event|0|||
156892393|NCT00958789|566364144|FG000|Overall Study|Subject terminated|2|||
156892394|NCT00958789|566364144|FG000|Overall Study|Revision|7|||
157157940|NCT01201798|567322906|FG000|Overall Study|Lost to Follow-up|3|||
156892395|NCT00478881|566364147|FG000|Overall Study|Adverse Event|31|||
156892396|NCT00478881|566364148|FG001|Overall Study|Adverse Event|12|||
156892397|NCT00478881|566364147|FG000|Overall Study|Lack of Efficacy|0|||
156892398|NCT00478881|566364148|FG001|Overall Study|Lack of Efficacy|3|||
156892399|NCT00478881|566364147|FG000|Overall Study|Lost to Follow-up|0|||
156892400|NCT00478881|566364148|FG001|Overall Study|Lost to Follow-up|1|||
156892401|NCT00478881|566364147|FG000|Overall Study|Protocol Violation|2|||
156892402|NCT00478881|566364148|FG001|Overall Study|Protocol Violation|2|||
156892403|NCT00478881|566364147|FG000|Overall Study|Withdrawal by Subject|6|||
156892404|NCT00478881|566364148|FG001|Overall Study|Withdrawal by Subject|2|||
156892405|NCT00478881|566364147|FG000|Overall Study|Non-Compliance with Study Medication|0|||
156892406|NCT00478881|566364148|FG001|Overall Study|Non-Compliance with Study Medication|2|||
156892407|NCT01083173|566364151|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
156892408|NCT01083173|566364152|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
156892409|NCT01083173|566364151|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
156892410|NCT01083173|566364152|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
156892411|NCT01083173|566364151|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
156892412|NCT01083173|566364152|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
156892413|NCT01083173|566364151|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
156892414|NCT01083173|566364152|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
156892415|NCT01083173|566364151|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
156892416|NCT01083173|566364152|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
156892417|NCT01083173|566364151|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
156892418|NCT01083173|566364152|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
156892419|NCT01083173|566364151|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
156892420|NCT01083173|566364152|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
156892421|NCT01083173|566364151|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
156892422|NCT01083173|566364152|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
156892423|NCT01083173|566364151|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
156892424|NCT01083173|566364152|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
156892425|NCT01083173|566364151|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
156892426|NCT01083173|566364152|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
156892427|NCT01083173|566364151|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
156892428|NCT01083173|566364152|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
156892429|NCT03410823|566364153|FG000|Overall Study|Death|1|||
156892430|NCT03410823|566364153|FG000|Overall Study|Withdrawal by Subject|2|||
156892431|NCT03410823|566364153|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
156892432|NCT04148911|566364155|FG000|Overall Study|Death|104|||
156892433|NCT04148911|566364155|FG000|Overall Study|Lost to Follow-up|5|||
156892434|NCT04148911|566364155|FG000|Overall Study|Withdrawal by Subject|17|||
156892435|NCT04148911|566364155|FG000|Overall Study|Study Ended by Sponsor|56|||
156892436|NCT00740246|566364160|FG000|Overall Study|Received Blood Transfusion|0|||
156892437|NCT00740246|566364161|FG001|Overall Study|Received Blood Transfusion|1|||
156892438|NCT00740246|566364160|FG000|Overall Study|Adverse Event|1|||
156892439|NCT00740246|566364161|FG001|Overall Study|Adverse Event|2|||
156892440|NCT00740246|566364160|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
156892441|NCT00740246|566364161|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
156892442|NCT00740246|566364160|FG000|Overall Study|Lost to Follow-up|2|||
156892443|NCT00740246|566364161|FG001|Overall Study|Lost to Follow-up|2|||
156892444|NCT00740246|566364160|FG000|Overall Study|Withdrawal by Subject|4|||
156892445|NCT00740246|566364161|FG001|Overall Study|Withdrawal by Subject|3|||
156892446|NCT00740246|566364160|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
156892447|NCT00740246|566364161|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
156892448|NCT00740246|566364160|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
156892449|NCT00740246|566364161|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
156892450|NCT00740246|566364160|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
156892451|NCT00740246|566364161|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
156892452|NCT00740246|566364160|FG000|Overall Study|Unable To Comply With Study Visits|2|||
156892453|NCT00740246|566364161|FG001|Overall Study|Unable To Comply With Study Visits|0|||
156892454|NCT00740246|566364160|FG000|Overall Study|Unable to Access Vein|0|||
156892455|NCT00740246|566364161|FG001|Overall Study|Unable to Access Vein|2|||
156892456|NCT00740246|566364160|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
156892457|NCT00740246|566364161|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
156892458|NCT01041495|566364162|FG000|Overall Study|Withdrawal by Subject|2|||
156892459|NCT01041495|566364163|FG001|Overall Study|Withdrawal by Subject|5|||
156892460|NCT01041495|566364162|FG000|Overall Study|Adverse Event|2|||
156892461|NCT01041495|566364163|FG001|Overall Study|Adverse Event|1|||
157157941|NCT01201798|567322907|FG001|Overall Study|Lost to Follow-up|5|||
157157942|NCT01201798|567322906|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
157157943|NCT01201798|567322907|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
157157944|NCT01201798|567322906|FG000|Overall Study|Noncompliance|1|||
156892462|NCT01041495|566364162|FG000|Overall Study|Lost to Follow-up|0|||
156892463|NCT01041495|566364163|FG001|Overall Study|Lost to Follow-up|1|||
156892464|NCT03584373|566364164|FG000|Overall Study|Lost to Follow-up|7|||
156892465|NCT03584373|566364165|FG001|Overall Study|Lost to Follow-up|8|||
156892466|NCT03780400|566364167|FG000|Overall Study|Lost to Follow-up|5|||
156892467|NCT03780400|566364167|FG000|Overall Study|Withdrawal by Subject|2|||
156892468|NCT01850602|566364168|FG000|Overall Study|Adverse Event|7|||
156892469|NCT01850602|566364169|FG001|Overall Study|Adverse Event|10|||
156892470|NCT01850602|566364168|FG000|Overall Study|Physician Decision|2|||
156892471|NCT01850602|566364169|FG001|Overall Study|Physician Decision|1|||
156892472|NCT01850602|566364168|FG000|Overall Study|Withdrawal by Subject|2|||
156892473|NCT01850602|566364169|FG001|Overall Study|Withdrawal by Subject|4|||
156892474|NCT01850602|566364168|FG000|Overall Study|Decrease in serum calcium|2|||
156892475|NCT01850602|566364169|FG001|Overall Study|Decrease in serum calcium|3|||
156892476|NCT01850602|566364168|FG000|Overall Study|Increase in serum ferritin|1|||
156892477|NCT01850602|566364169|FG001|Overall Study|Increase in serum ferritin|0|||
156892478|NCT00366340|566364170|FG000|Infant Series|Protocol Violation|3|||
156892479|NCT00366340|566364171|FG001|Infant Series|Protocol Violation|4|||
156892480|NCT00366340|566364170|FG000|Infant Series|Withdrawal by Subject|3|||
156892481|NCT00366340|566364171|FG001|Infant Series|Withdrawal by Subject|3|||
156892482|NCT00366340|566364170|FG000|Infant Series|Adverse Event|0|||
156892483|NCT00366340|566364171|FG001|Infant Series|Adverse Event|2|||
156892484|NCT00366340|566364170|FG000|Infant Series|Lost to Follow-up|1|||
156892485|NCT00366340|566364171|FG001|Infant Series|Lost to Follow-up|1|||
156892486|NCT00366340|566364170|FG000|Infant Series|Failure to return|1|||
156892487|NCT00366340|566364171|FG001|Infant Series|Failure to return|0|||
156892488|NCT00366340|566364170|FG000|After the Infant Series|Parent/legal guardian request|1|||
156892489|NCT00366340|566364171|FG001|After the Infant Series|Parent/legal guardian request|1|||
156892490|NCT00366340|566364170|FG000|After the Infant Series|Failed to return|0|||
156892491|NCT00366340|566364171|FG001|After the Infant Series|Failed to return|1|||
156892492|NCT00366340|566364170|FG000|After the Infant Series|Protocol Violation|2|||
156892493|NCT00366340|566364171|FG001|After the Infant Series|Protocol Violation|2|||
156892494|NCT00366340|566364170|FG000|After the Infant Series|Adverse Event|0|||
156892495|NCT00366340|566364171|FG001|After the Infant Series|Adverse Event|1|||
156892496|NCT00366340|566364170|FG000|After the Infant Series|Lost to Follow-up|0|||
156892497|NCT00366340|566364171|FG001|After the Infant Series|Lost to Follow-up|1|||
156892498|NCT00366340|566364170|FG000|Toddler Dose|Failed to return|1|||
156892499|NCT00366340|566364171|FG001|Toddler Dose|Failed to return|0|||
156892500|NCT00366340|566364170|FG000|Toddler Dose|Parent/legal guardian request|0|||
156892501|NCT00366340|566364171|FG001|Toddler Dose|Parent/legal guardian request|1|||
156892502|NCT00367770|566364172|FG000|Overall Study|Adverse Event|1|||
156892503|NCT00367770|566364172|FG000|Overall Study|Withdrawal by Subject|1|||
156892504|NCT03282565|566364177|FG000|Overall Study|COVID-19 Research Shutdown|0|||
156892505|NCT03282565|566364178|FG001|Overall Study|COVID-19 Research Shutdown|2|||
156892506|NCT03282565|566364179|FG002|Overall Study|COVID-19 Research Shutdown|2|||
156892507|NCT00740051|566364180|FG000|Overall Study|Lack of Efficacy|2|||
156892508|NCT00740051|566364181|FG001|Overall Study|Lack of Efficacy|5|||
156892509|NCT00740051|566364180|FG000|Overall Study|Adverse Event|1|||
156892510|NCT00740051|566364181|FG001|Overall Study|Adverse Event|4|||
156892511|NCT00740051|566364180|FG000|Overall Study|Protocol Violation|2|||
156892512|NCT00740051|566364181|FG001|Overall Study|Protocol Violation|6|||
156892513|NCT00740051|566364180|FG000|Overall Study|Lost to Follow-up|3|||
156892514|NCT00740051|566364181|FG001|Overall Study|Lost to Follow-up|8|||
156892515|NCT00740051|566364180|FG000|Overall Study|Withdrawal by Subject|6|||
156892516|NCT00740051|566364181|FG001|Overall Study|Withdrawal by Subject|8|||
156892517|NCT00740051|566364180|FG000|Overall Study|Other reason (not specified)|4|||
156892518|NCT00740051|566364181|FG001|Overall Study|Other reason (not specified)|1|||
156892519|NCT03324581|566364182|FG000|Overall Study|Adverse Event|18|||
156892520|NCT03324581|566364183|FG001|Overall Study|Adverse Event|11|||
156892521|NCT03324581|566364184|FG002|Overall Study|Adverse Event|7|||
156892522|NCT03324581|566364182|FG000|Overall Study|Lack of Efficacy|0|||
156892523|NCT03324581|566364183|FG001|Overall Study|Lack of Efficacy|1|||
156892524|NCT03324581|566364184|FG002|Overall Study|Lack of Efficacy|0|||
156892525|NCT03324581|566364182|FG000|Overall Study|Lost to Follow-up|5|||
156892526|NCT03324581|566364183|FG001|Overall Study|Lost to Follow-up|3|||
156892527|NCT03324581|566364184|FG002|Overall Study|Lost to Follow-up|6|||
156892528|NCT03324581|566364182|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
156892529|NCT03324581|566364183|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
156892530|NCT03324581|566364184|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
156892531|NCT03324581|566364182|FG000|Overall Study|Physician Decision|0|||
156892532|NCT03324581|566364183|FG001|Overall Study|Physician Decision|1|||
156892533|NCT03324581|566364184|FG002|Overall Study|Physician Decision|2|||
156892534|NCT03324581|566364182|FG000|Overall Study|Protocol Deviation|8|||
156892535|NCT03324581|566364183|FG001|Overall Study|Protocol Deviation|9|||
156892536|NCT03324581|566364184|FG002|Overall Study|Protocol Deviation|4|||
156892537|NCT03324581|566364182|FG000|Overall Study|Withdrawal by Subject|6|||
156892538|NCT03324581|566364183|FG001|Overall Study|Withdrawal by Subject|8|||
156892539|NCT03324581|566364184|FG002|Overall Study|Withdrawal by Subject|6|||
156892540|NCT03324581|566364182|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
156892541|NCT03324581|566364183|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
156892542|NCT03324581|566364184|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
156892543|NCT00321893|566364185|FG000|Overall Study|Non-Compliance/Refusal|16|||
156892544|NCT00321893|566364186|FG001|Overall Study|Non-Compliance/Refusal|10|||
156892545|NCT00321893|566364185|FG000|Overall Study|Lost to Follow-up|2|||
156892546|NCT00321893|566364186|FG001|Overall Study|Lost to Follow-up|1|||
156892547|NCT00321893|566364185|FG000|Overall Study|Adverse Event|6|||
156892548|NCT00321893|566364186|FG001|Overall Study|Adverse Event|3|||
156892549|NCT03455764|566364187|FG000|Overall Study|Adverse Event|1|||
156892550|NCT03455764|566364188|FG001|Overall Study|Adverse Event|0|||
156892551|NCT03455764|566364189|FG002|Overall Study|Adverse Event|0|||
156892552|NCT03455764|566364190|FG003|Overall Study|Adverse Event|0|||
156892553|NCT03455764|566364191|FG004|Overall Study|Adverse Event|0|||
156892554|NCT03455764|566364187|FG000|Overall Study|Disease Progression|4|||
157157945|NCT01201798|567322907|FG001|Overall Study|Noncompliance|0|||
157157946|NCT01201798|567322906|FG000|Overall Study|Protocol Violation|1|||
156857629|NCT02898454|566232565|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
156857630|NCT02898454|566232566|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
156857631|NCT02898454|566232567|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
156857632|NCT02343263|566232568|FG000|Overall Study|Physician Decision|5|||
156857633|NCT02343263|566232569|FG001|Overall Study|Physician Decision|3|||
156857634|NCT02343263|566232570|FG002|Overall Study|Physician Decision|1|||
156857635|NCT03040141|566232571|FG000|Overall Study|Death|1|||
156857636|NCT03040141|566232572|FG001|Overall Study|Death|2|||
156857637|NCT03040141|566232573|FG002|Overall Study|Death|3|||
156857638|NCT03040141|566232571|FG000|Overall Study|Withdrawal by Subject|3|||
156857639|NCT03040141|566232572|FG001|Overall Study|Withdrawal by Subject|1|||
156857640|NCT03040141|566232573|FG002|Overall Study|Withdrawal by Subject|1|||
156857641|NCT03040141|566232571|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
156857642|NCT03040141|566232572|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
156857643|NCT03040141|566232573|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
156857644|NCT03040141|566232571|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
156857645|NCT03040141|566232572|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
156857646|NCT03040141|566232573|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
156857647|NCT01384734|566232575|FG000|Overall Study|Adverse Event|0|||
156857648|NCT01384734|566232576|FG001|Overall Study|Adverse Event|3|||
156857649|NCT01384734|566232577|FG002|Overall Study|Adverse Event|0|||
156857650|NCT01384734|566232578|FG003|Overall Study|Adverse Event|2|||
156857651|NCT01384734|566232579|FG004|Overall Study|Adverse Event|7|||
156857652|NCT01384734|566232575|FG000|Overall Study|Death|1|||
156857653|NCT01384734|566232576|FG001|Overall Study|Death|0|||
156857654|NCT01384734|566232577|FG002|Overall Study|Death|1|||
156857655|NCT01384734|566232578|FG003|Overall Study|Death|0|||
156857656|NCT01384734|566232579|FG004|Overall Study|Death|0|||
156857657|NCT01384734|566232575|FG000|Overall Study|Continuation criteria not met|0|||
156857658|NCT01384734|566232576|FG001|Overall Study|Continuation criteria not met|0|||
156857659|NCT01384734|566232577|FG002|Overall Study|Continuation criteria not met|1|||
156857660|NCT01384734|566232578|FG003|Overall Study|Continuation criteria not met|1|||
156857661|NCT01384734|566232579|FG004|Overall Study|Continuation criteria not met|0|||
156857662|NCT01384734|566232575|FG000|Overall Study|Lack of Efficacy|3|||
156857663|NCT01384734|566232576|FG001|Overall Study|Lack of Efficacy|7|||
156857664|NCT01384734|566232577|FG002|Overall Study|Lack of Efficacy|4|||
156857665|NCT01384734|566232578|FG003|Overall Study|Lack of Efficacy|4|||
156857666|NCT01384734|566232579|FG004|Overall Study|Lack of Efficacy|2|||
156857667|NCT01384734|566232575|FG000|Overall Study|Lost to Follow-up|5|||
156857668|NCT01384734|566232576|FG001|Overall Study|Lost to Follow-up|3|||
156857669|NCT01384734|566232577|FG002|Overall Study|Lost to Follow-up|3|||
156892555|NCT03455764|566364188|FG001|Overall Study|Disease Progression|0|||
156892556|NCT03455764|566364189|FG002|Overall Study|Disease Progression|0|||
156892557|NCT03455764|566364190|FG003|Overall Study|Disease Progression|0|||
156892558|NCT03455764|566364191|FG004|Overall Study|Disease Progression|0|||
156892559|NCT03455764|566364187|FG000|Overall Study|On Treatment|1|||
156892560|NCT03455764|566364188|FG001|Overall Study|On Treatment|0|||
156892561|NCT03455764|566364189|FG002|Overall Study|On Treatment|0|||
156892562|NCT03455764|566364190|FG003|Overall Study|On Treatment|0|||
156892563|NCT03455764|566364191|FG004|Overall Study|On Treatment|0|||
156892564|NCT01585584|566364192|FG000|Overall Study|Lack of Efficacy|1|||
156892565|NCT01585584|566364192|FG000|Overall Study|Withdrawal by Subject|1|||
157157947|NCT01201798|567322907|FG001|Overall Study|Protocol Violation|1|||
156892566|NCT01585584|566364192|FG000|Overall Study|Physician Decision|2|||
156892567|NCT00662532|566364578|FG000|Overall Study|Adverse Event|0|||
156892568|NCT00662532|566364579|FG001|Overall Study|Adverse Event|1|||
156892569|NCT00662532|566364578|FG000|Overall Study|Lost to Follow-up|0|||
156892570|NCT00662532|566364579|FG001|Overall Study|Lost to Follow-up|1|||
156892571|NCT00442468|566364583|FG000|Overall Study|Adverse Event|4|||
156892572|NCT00442468|566364583|FG000|Overall Study|Withdrawal by Subject|91|||
156892573|NCT00442468|566364583|FG000|Overall Study|Did not complete all study procedures|88|||
156892574|NCT00589784|566364584|FG000|Overall Study|Withdrawal by Subject|0|||
156892575|NCT00589784|566364585|FG001|Overall Study|Withdrawal by Subject|6|||
156892576|NCT00589784|566364584|FG000|Overall Study|Patient inevaluable|1|||
156892577|NCT00589784|566364585|FG001|Overall Study|Patient inevaluable|0|||
156892578|NCT00589784|566364584|FG000|Overall Study|Adverse Event|0|||
156892579|NCT00589784|566364585|FG001|Overall Study|Adverse Event|4|||
156892580|NCT00287079|566364587|FG000|Overall Study|Qualifying relapse|12|||
156892581|NCT00287079|566364588|FG001|Overall Study|Qualifying relapse|1|||
156892582|NCT00287079|566364587|FG000|Overall Study|Non-qualifying relapse|1|||
156892583|NCT00287079|566364588|FG001|Overall Study|Non-qualifying relapse|0|||
156892584|NCT00287079|566364587|FG000|Overall Study|Adverse Event|5|||
156892585|NCT00287079|566364588|FG001|Overall Study|Adverse Event|0|||
156892586|NCT00287079|566364587|FG000|Overall Study|Protocol Violation|1|||
156892587|NCT00287079|566364588|FG001|Overall Study|Protocol Violation|0|||
156892588|NCT00287079|566364587|FG000|Overall Study|Other|3|||
156892589|NCT00287079|566364588|FG001|Overall Study|Other|0|||
156892590|NCT00470184|566364589|FG000|Overall Study|Not Treated(became ineligible)|4|||
156892591|NCT00470184|566364589|FG000|Overall Study|Not treated (other)|1|||
156892592|NCT00470184|566364589|FG000|Overall Study|disease Progression|4|||
156892593|NCT00470184|566364589|FG000|Overall Study|Adverse Event|3|||
156892594|NCT00470184|566364589|FG000|Overall Study|Withdrawal by Subject|4|||
156892595|NCT00470184|566364589|FG000|Overall Study|other|5|||
156892596|NCT00470184|566364589|FG000|Overall Study|recurrence|1|||
156892597|NCT03882008|566364590|FG000|Overall Study|Withdrawal by Subject|1|||
156892598|NCT03882008|566364590|FG000|Overall Study|Lost to Follow-up|1|||
156892599|NCT01185834|566364593|FG000|Overall Study|Lost to Follow-up|2|||
156892600|NCT01185834|566364593|FG000|Overall Study|Discomfort|4|||
156892601|NCT01185834|566364593|FG000|Overall Study|Biomicroscopy|4|||
156892602|NCT01185834|566364593|FG000|Overall Study|Time/Job Conflict|2|||
156892603|NCT01185834|566364593|FG000|Overall Study|Early exit - Site error|2|||
156892604|NCT04777331|566364594|FG000|DBT Period|Death|2|||
156892605|NCT04777331|566364595|FG001|DBT Period|Death|1|||
156892606|NCT04777331|566364596|FG002|DBT Period|Death|0|||
156892607|NCT04777331|566364594|FG000|DBT Period|Reason not Specified|1|||
156892608|NCT04777331|566364595|FG001|DBT Period|Reason not Specified|1|||
156892609|NCT04777331|566364596|FG002|DBT Period|Reason not Specified|0|||
156892610|NCT04777331|566364594|FG000|DBT Period|Physician Decision|4|||
156892611|NCT04777331|566364595|FG001|DBT Period|Physician Decision|0|||
156892612|NCT04777331|566364596|FG002|DBT Period|Physician Decision|0|||
156892613|NCT04777331|566364594|FG000|DBT Period|Withdrawal by Subject|12|||
156892614|NCT04777331|566364595|FG001|DBT Period|Withdrawal by Subject|11|||
156892615|NCT04777331|566364596|FG002|DBT Period|Withdrawal by Subject|0|||
156892616|NCT04777331|566364594|FG000|DBT Period|Randomized but not Treated|1|||
156892617|NCT04777331|566364595|FG001|DBT Period|Randomized but not Treated|3|||
156892618|NCT04777331|566364596|FG002|DBT Period|Randomized but not Treated|0|||
156892619|NCT04777331|566364594|FG000|OLE Period|Ongoing in OLE|0|||
156892620|NCT04777331|566364595|FG001|OLE Period|Ongoing in OLE|0|||
156892621|NCT04777331|566364596|FG002|OLE Period|Ongoing in OLE|534|||
156892622|NCT01401959|566364597|FG000|Enrolled|Withdrawal by Subject|1|||
156892623|NCT01401959|566364598|FG001|Enrolled|Withdrawal by Subject|0|||
156892624|NCT01401959|566364599|FG002|Enrolled|Withdrawal by Subject|0|||
156892625|NCT01401959|566364597|FG000|Treated|Disease Progression|2|||
156892626|NCT01401959|566364598|FG001|Treated|Disease Progression|2|||
156892627|NCT01401959|566364599|FG002|Treated|Disease Progression|1|||
156892628|NCT01401959|566364597|FG000|Treated|Adverse Event|4|||
156892629|NCT01401959|566364598|FG001|Treated|Adverse Event|3|||
157026042|NCT04898673|566849702|FG000|Overall Study|Screenfail|1|||
157026043|NCT04898673|566849703|FG001|Overall Study|Screenfail|0|||
156892630|NCT01401959|566364599|FG002|Treated|Adverse Event|2|||
156892631|NCT01401959|566364597|FG000|Treated|Withdrawal by Subject|1|||
156892632|NCT01401959|566364598|FG001|Treated|Withdrawal by Subject|2|||
156892633|NCT01401959|566364599|FG002|Treated|Withdrawal by Subject|2|||
156892634|NCT01401959|566364597|FG000|Treated|Protocol Violation|0|||
156892635|NCT01401959|566364598|FG001|Treated|Protocol Violation|1|||
156892636|NCT01401959|566364599|FG002|Treated|Protocol Violation|0|||
156892637|NCT02694718|566364604|FG000|Overall Study|Death|1|||
156892638|NCT02694718|566364604|FG000|Overall Study|Withdrawal by Subject|1|||
156892639|NCT00322153|566364605|FG000|Overall Study|Adverse Event|21|||
156892640|NCT00322153|566364606|FG001|Overall Study|Adverse Event|34|||
156892641|NCT00322153|566364605|FG000|Overall Study|Protocol Violation|6|||
156892642|NCT00322153|566364606|FG001|Overall Study|Protocol Violation|14|||
156892643|NCT00322153|566364605|FG000|Overall Study|Withdrawal by Subject|18|||
156892644|NCT00322153|566364606|FG001|Overall Study|Withdrawal by Subject|10|||
156892645|NCT00322153|566364605|FG000|Overall Study|Lack of Efficacy|8|||
156892646|NCT00322153|566364606|FG001|Overall Study|Lack of Efficacy|3|||
156892647|NCT00322153|566364605|FG000|Overall Study|Lost to Follow-up|5|||
156892648|NCT00322153|566364606|FG001|Overall Study|Lost to Follow-up|4|||
156892649|NCT00322153|566364605|FG000|Overall Study|Withdrawn for other reasons|5|||
156892650|NCT00322153|566364606|FG001|Overall Study|Withdrawn for other reasons|4|||
156892651|NCT03523000|566364608|FG000|Overall Study|Withdrawal by Subject|3|||
156892652|NCT03523000|566364609|FG001|Overall Study|Withdrawal by Subject|0|||
156892653|NCT03523000|566364608|FG000|Overall Study|Unsuccessful trial|2|||
156892654|NCT03523000|566364609|FG001|Overall Study|Unsuccessful trial|0|||
156892655|NCT03993379|566364610|FG000|Overall Study|The study was terminated early due to business decision.|0|||
156892656|NCT03993379|566364611|FG001|Overall Study|The study was terminated early due to business decision.|2|||
156892657|NCT03993379|566364612|FG002|Overall Study|The study was terminated early due to business decision.|0|||
156892658|NCT03993379|566364613|FG003|Overall Study|The study was terminated early due to business decision.|0|||
156892659|NCT03993379|566364610|FG000|Overall Study|Withdrawal by Subject|0|||
156892660|NCT03993379|566364611|FG001|Overall Study|Withdrawal by Subject|1|||
156892661|NCT03993379|566364612|FG002|Overall Study|Withdrawal by Subject|0|||
156892662|NCT03993379|566364613|FG003|Overall Study|Withdrawal by Subject|0|||
156892663|NCT06374394|566364617|FG000|Overall Study|Adverse Event|0|||
156892664|NCT06374394|566364618|FG001|Overall Study|Adverse Event|2|||
156892665|NCT06374394|566364617|FG000|Overall Study|Lost to Follow-up|6|||
156892666|NCT06374394|566364618|FG001|Overall Study|Lost to Follow-up|9|||
156892667|NCT06374394|566364617|FG000|Overall Study|Withdrawal by Subject|1|||
156892668|NCT06374394|566364618|FG001|Overall Study|Withdrawal by Subject|7|||
156892669|NCT06374394|566364617|FG000|Overall Study|Other|1|||
156892670|NCT06374394|566364618|FG001|Overall Study|Other|0|||
156892671|NCT00356122|566364622|FG000|TREATMENT|Lack of Efficacy|26|||
156892672|NCT00356122|566364622|FG000|TREATMENT|Adverse Event|10|||
156892673|NCT00356122|566364622|FG000|TREATMENT|Subject's request|4|||
156892674|NCT00356122|566364622|FG000|TREATMENT|Other|4|||
156892675|NCT00356122|566364622|FG000|TREATMENT|Did not receive study medication|1|||
156892676|NCT00356122|566364622|FG000|FOLLOW-UP|Death|37|||
156892677|NCT00356122|566364622|FG000|FOLLOW-UP|Lost to Follow-up|2|||
156892678|NCT00356122|566364622|FG000|FOLLOW-UP|Other|2|||
156892679|NCT02483429|566364630|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
156892680|NCT02483429|566364631|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
156892681|NCT01683019|566365916|FG000|Overall Study|Withdrawal by Subject|2|||
156892682|NCT01683019|566365917|FG001|Overall Study|Withdrawal by Subject|1|||
156892683|NCT01683019|566365918|FG002|Overall Study|Withdrawal by Subject|4|||
156892684|NCT00543855|566365919|FG000|Overall Study|Adverse Event|3|||
156892685|NCT00543855|566365920|FG001|Overall Study|Adverse Event|1|||
156892686|NCT00543855|566365921|FG002|Overall Study|Adverse Event|3|||
156892687|NCT00543855|566365922|FG003|Overall Study|Adverse Event|4|||
156892688|NCT00543855|566365919|FG000|Overall Study|Lost to Follow-up|0|||
156892689|NCT00543855|566365920|FG001|Overall Study|Lost to Follow-up|0|||
156892690|NCT00543855|566365921|FG002|Overall Study|Lost to Follow-up|1|||
156892691|NCT00543855|566365922|FG003|Overall Study|Lost to Follow-up|0|||
156892692|NCT00543855|566365919|FG000|Overall Study|Withdrawal by Subject|0|||
156892693|NCT00543855|566365920|FG001|Overall Study|Withdrawal by Subject|1|||
156892694|NCT00543855|566365921|FG002|Overall Study|Withdrawal by Subject|2|||
156892695|NCT00543855|566365922|FG003|Overall Study|Withdrawal by Subject|0|||
156892696|NCT00543855|566365919|FG000|Overall Study|Protocol Violation|1|||
156892697|NCT00543855|566365920|FG001|Overall Study|Protocol Violation|0|||
156892698|NCT00543855|566365921|FG002|Overall Study|Protocol Violation|0|||
156892699|NCT00543855|566365922|FG003|Overall Study|Protocol Violation|0|||
156857670|NCT01384734|566232578|FG003|Overall Study|Lost to Follow-up|8|||
156857671|NCT01384734|566232579|FG004|Overall Study|Lost to Follow-up|5|||
156857672|NCT01384734|566232575|FG000|Overall Study|Non-compliance with study drug|1|||
156857673|NCT01384734|566232576|FG001|Overall Study|Non-compliance with study drug|2|||
156857674|NCT01384734|566232577|FG002|Overall Study|Non-compliance with study drug|6|||
156857675|NCT01384734|566232578|FG003|Overall Study|Non-compliance with study drug|0|||
156857676|NCT01384734|566232579|FG004|Overall Study|Non-compliance with study drug|2|||
156857677|NCT01384734|566232575|FG000|Overall Study|Pregnancy|0|||
156857678|NCT01384734|566232576|FG001|Overall Study|Pregnancy|1|||
156857679|NCT01384734|566232577|FG002|Overall Study|Pregnancy|0|||
156857680|NCT01384734|566232578|FG003|Overall Study|Pregnancy|0|||
156857681|NCT01384734|566232579|FG004|Overall Study|Pregnancy|1|||
156857682|NCT01384734|566232575|FG000|Overall Study|Sponsor terminated|0|||
156857683|NCT01384734|566232576|FG001|Overall Study|Sponsor terminated|0|||
156857684|NCT01384734|566232577|FG002|Overall Study|Sponsor terminated|0|||
156857685|NCT01384734|566232578|FG003|Overall Study|Sponsor terminated|0|||
156857686|NCT01384734|566232579|FG004|Overall Study|Sponsor terminated|1|||
156857687|NCT01384734|566232575|FG000|Overall Study|Withdrawal by Subject|5|||
156857688|NCT01384734|566232576|FG001|Overall Study|Withdrawal by Subject|5|||
156857689|NCT01384734|566232577|FG002|Overall Study|Withdrawal by Subject|6|||
156857690|NCT01384734|566232578|FG003|Overall Study|Withdrawal by Subject|7|||
156857691|NCT01384734|566232579|FG004|Overall Study|Withdrawal by Subject|9|||
156892700|NCT00301821|566365925|FG000|Overall Study|Ineligible|25|||
156892701|NCT00301821|566365925|FG000|Overall Study|Cancel|1|||
156892702|NCT02294773|566365926|FG000|Overall Study|Withdrawal by Subject|0|||
156892703|NCT02294773|566365927|FG001|Overall Study|Withdrawal by Subject|2|||
156892704|NCT01865084|566365928|FG000|Double Blind Period (DB)|Adverse Event|2|||
156892705|NCT01865084|566365929|FG001|Double Blind Period (DB)|Adverse Event|2|||
156892706|NCT01865084|566365930|FG002|Double Blind Period (DB)|Adverse Event|1|||
156892707|NCT01865084|566365928|FG000|Double Blind Period (DB)|Protocol Violation|0|||
156892708|NCT01865084|566365929|FG001|Double Blind Period (DB)|Protocol Violation|0|||
156892709|NCT01865084|566365930|FG002|Double Blind Period (DB)|Protocol Violation|1|||
156892710|NCT01865084|566365928|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
156892711|NCT01865084|566365929|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
156892712|NCT01865084|566365930|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
156892713|NCT01865084|566365928|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
156892714|NCT01865084|566365929|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
156892715|NCT01865084|566365930|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
156892716|NCT01865084|566365928|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
156892717|NCT01865084|566365929|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
156892718|NCT01865084|566365930|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
156892719|NCT01865084|566365928|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
156892720|NCT01865084|566365929|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
156892721|NCT01865084|566365930|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
156892722|NCT01865084|566365928|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
156892723|NCT01865084|566365929|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
156892724|NCT01865084|566365930|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
156892725|NCT01865084|566365928|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
156892726|NCT01865084|566365929|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
156892727|NCT01865084|566365930|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
156892728|NCT01865084|566365928|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
156892729|NCT01865084|566365929|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
156892730|NCT01865084|566365930|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
156892731|NCT02469038|566365931|FG000|Overall Study|Physician Decision|4|||
156892732|NCT02469038|566365932|FG001|Overall Study|Physician Decision|5|||
156892733|NCT03435640|566365933|FG000|Overall Study|Withdrawal by Subject|0|||
156892734|NCT03435640|566365934|FG001|Overall Study|Withdrawal by Subject|1|||
156892735|NCT03435640|566365935|FG002|Overall Study|Withdrawal by Subject|0|||
156892736|NCT03435640|566365936|FG003|Overall Study|Withdrawal by Subject|2|||
156892737|NCT03435640|566365937|FG004|Overall Study|Withdrawal by Subject|0|||
156892738|NCT03435640|566365938|FG005|Overall Study|Withdrawal by Subject|0|||
156892739|NCT03435640|566365939|FG006|Overall Study|Withdrawal by Subject|3|||
156892740|NCT03435640|566365940|FG007|Overall Study|Withdrawal by Subject|0|||
156892741|NCT03435640|566365941|FG008|Overall Study|Withdrawal by Subject|0|||
156892742|NCT03435640|566365942|FG009|Overall Study|Withdrawal by Subject|2|||
156892743|NCT03435640|566365943|FG010|Overall Study|Withdrawal by Subject|3|||
156892744|NCT03435640|566365933|FG000|Overall Study|Lost to Follow-up|0|||
156892745|NCT03435640|566365934|FG001|Overall Study|Lost to Follow-up|0|||
156892746|NCT03435640|566365935|FG002|Overall Study|Lost to Follow-up|1|||
156892747|NCT03435640|566365936|FG003|Overall Study|Lost to Follow-up|0|||
156892748|NCT03435640|566365937|FG004|Overall Study|Lost to Follow-up|0|||
156892749|NCT03435640|566365938|FG005|Overall Study|Lost to Follow-up|0|||
156892750|NCT03435640|566365939|FG006|Overall Study|Lost to Follow-up|0|||
156892751|NCT03435640|566365940|FG007|Overall Study|Lost to Follow-up|0|||
156892752|NCT03435640|566365941|FG008|Overall Study|Lost to Follow-up|0|||
156892753|NCT03435640|566365942|FG009|Overall Study|Lost to Follow-up|0|||
156892754|NCT03435640|566365943|FG010|Overall Study|Lost to Follow-up|0|||
156892755|NCT00510874|566365944|FG000|Overall Study|Withdrawal by Subject|1|||
156892756|NCT00510874|566365945|FG001|Overall Study|Withdrawal by Subject|1|||
156892757|NCT00510874|566365946|FG002|Overall Study|Withdrawal by Subject|0|||
156892758|NCT00510874|566365947|FG003|Overall Study|Withdrawal by Subject|0|||
156892759|NCT00510874|566365948|FG004|Overall Study|Withdrawal by Subject|3|||
156892760|NCT00510874|566365949|FG005|Overall Study|Withdrawal by Subject|0|||
156892761|NCT00510874|566365950|FG006|Overall Study|Withdrawal by Subject|0|||
156892762|NCT00510874|566365944|FG000|Overall Study|Lost to Follow-up|2|||
157026044|NCT04797897|566849704|FG000|Overall Study|Study Termination by Sponsor|1|||
156892763|NCT00510874|566365945|FG001|Overall Study|Lost to Follow-up|3|||
156892764|NCT00510874|566365946|FG002|Overall Study|Lost to Follow-up|1|||
156892765|NCT00510874|566365947|FG003|Overall Study|Lost to Follow-up|3|||
156892766|NCT00510874|566365948|FG004|Overall Study|Lost to Follow-up|4|||
156892767|NCT00510874|566365949|FG005|Overall Study|Lost to Follow-up|0|||
156892768|NCT00510874|566365950|FG006|Overall Study|Lost to Follow-up|1|||
156892769|NCT03954041|566365955|FG000|Overall Study|Lost to Follow-up|3|||
156892770|NCT03954041|566365956|FG001|Overall Study|Lost to Follow-up|3|||
156892771|NCT03954041|566365957|FG002|Overall Study|Lost to Follow-up|6|||
157026045|NCT04797897|566849705|FG001|Overall Study|Study Termination by Sponsor|1|||
156892772|NCT03954041|566365955|FG000|Overall Study|Death|4|||
156892773|NCT03954041|566365956|FG001|Overall Study|Death|0|||
156892774|NCT03954041|566365957|FG002|Overall Study|Death|1|||
156892775|NCT03954041|566365955|FG000|Overall Study|Death by neurologic criteria|0|||
156892776|NCT03954041|566365956|FG001|Overall Study|Death by neurologic criteria|0|||
156892777|NCT03954041|566365957|FG002|Overall Study|Death by neurologic criteria|1|||
156892778|NCT03954041|566365955|FG000|Overall Study|Reason not specified|7|||
156892779|NCT03954041|566365956|FG001|Overall Study|Reason not specified|4|||
156892780|NCT03954041|566365957|FG002|Overall Study|Reason not specified|2|||
156892781|NCT03954041|566365955|FG000|Overall Study|Withdrew prior to dosing|4|||
156892782|NCT03954041|566365956|FG001|Overall Study|Withdrew prior to dosing|2|||
156892783|NCT03954041|566365957|FG002|Overall Study|Withdrew prior to dosing|0|||
156892784|NCT04565236|566365960|FG000|Overall Study|Patient/Guardian Decision|0|||
156892785|NCT04565236|566365961|FG001|Overall Study|Patient/Guardian Decision|0|||
156892786|NCT04565236|566365962|FG002|Overall Study|Patient/Guardian Decision|1|||
156892787|NCT04565236|566365963|FG003|Overall Study|Patient/Guardian Decision|0|||
156892788|NCT00174291|566365965|FG000|Overall Study|Lost to Follow-up|1|||
156892789|NCT00174291|566365966|FG001|Overall Study|Lost to Follow-up|1|||
156892790|NCT00174291|566365965|FG000|Overall Study|Protocol Violation|0|||
156892791|NCT00174291|566365966|FG001|Overall Study|Protocol Violation|2|||
156892792|NCT00174291|566365965|FG000|Overall Study|Study terminated by sponsor|1|||
156892793|NCT00174291|566365966|FG001|Overall Study|Study terminated by sponsor|0|||
156892794|NCT00174291|566365965|FG000|Overall Study|Withdrawal by Subject|3|||
156892795|NCT00174291|566365966|FG001|Overall Study|Withdrawal by Subject|3|||
156892796|NCT00450112|566365967|FG000|Overall Study|Other Treatment Required|5|||
156892797|NCT00450112|566365968|FG001|Overall Study|Other Treatment Required|1|||
156892798|NCT00450112|566365967|FG000|Overall Study|Withdrawal by Subject|4|||
156892799|NCT00450112|566365968|FG001|Overall Study|Withdrawal by Subject|1|||
156892800|NCT00450112|566365967|FG000|Overall Study|Lost to Follow-up|2|||
156892801|NCT00450112|566365968|FG001|Overall Study|Lost to Follow-up|1|||
156892802|NCT00450112|566365967|FG000|Overall Study|Others|2|||
156892803|NCT00450112|566365968|FG001|Overall Study|Others|3|||
156892804|NCT03418571|566365969|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
156892805|NCT03418571|566365970|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
156892806|NCT03595774|566365971|FG000|Overall Study|Adverse Event|1|||
156892807|NCT03595774|566365972|FG001|Overall Study|Adverse Event|0|||
156892808|NCT03595774|566365973|FG002|Overall Study|Adverse Event|1|||
156892809|NCT03595774|566365974|FG003|Overall Study|Adverse Event|0|||
156892810|NCT03595774|566365971|FG000|Overall Study|screen failure|0|||
156892811|NCT03595774|566365972|FG001|Overall Study|screen failure|1|||
156892812|NCT03595774|566365973|FG002|Overall Study|screen failure|0|||
156892813|NCT03595774|566365974|FG003|Overall Study|screen failure|1|||
156892814|NCT01582854|566365980|FG000|Overall Study|Death|8|||
156892815|NCT01582854|566365981|FG001|Overall Study|Death|5|||
156892816|NCT01582854|566365980|FG000|Overall Study|Adverse Event|2|||
156892817|NCT01582854|566365981|FG001|Overall Study|Adverse Event|3|||
156892818|NCT01582854|566365980|FG000|Overall Study|Withdrawal by Participant|8|||
156892819|NCT01582854|566365981|FG001|Overall Study|Withdrawal by Participant|11|||
156892820|NCT01582854|566365980|FG000|Overall Study|Lost to Follow-up|1|||
156892821|NCT01582854|566365981|FG001|Overall Study|Lost to Follow-up|2|||
156892822|NCT01582854|566365980|FG000|Overall Study|Physician Decision|0|||
156892823|NCT01582854|566365981|FG001|Overall Study|Physician Decision|1|||
156892824|NCT01582854|566365980|FG000|Overall Study|Recurrent Stroke|13|||
156892825|NCT01582854|566365981|FG001|Overall Study|Recurrent Stroke|8|||
156892826|NCT01582854|566365980|FG000|Overall Study|Disallowed Concomitant Medication|3|||
156892827|NCT01582854|566365981|FG001|Overall Study|Disallowed Concomitant Medication|2|||
156892828|NCT01582854|566365980|FG000|Overall Study|Carotid or Neurosurgery|0|||
156892829|NCT01582854|566365981|FG001|Overall Study|Carotid or Neurosurgery|1|||
156892830|NCT01582854|566365980|FG000|Overall Study|General Anaesthesia|0|||
156892831|NCT01582854|566365981|FG001|Overall Study|General Anaesthesia|1|||
156892832|NCT01582854|566365980|FG000|Overall Study|Other Miscellaneous Reason|1|||
156892833|NCT01582854|566365981|FG001|Overall Study|Other Miscellaneous Reason|0|||
156892834|NCT03101267|566365982|FG000|Primary Study Period|Withdrawal by Subject|1|||
156892835|NCT03101267|566365983|FG001|Primary Study Period|Withdrawal by Subject|2|||
156892836|NCT03101267|566365984|FG002|Primary Study Period|Withdrawal by Subject|3|||
156892837|NCT03101267|566365982|FG000|Primary Study Period|Miscellaneous|2|||
156892838|NCT03101267|566365983|FG001|Primary Study Period|Miscellaneous|0|||
156892839|NCT03101267|566365984|FG002|Primary Study Period|Miscellaneous|0|||
156892840|NCT04068896|566365985|FG000|Overall Study|Adverse Event|2|||
156892841|NCT04068896|566365986|FG001|Overall Study|Adverse Event|0|||
156892842|NCT04068896|566365987|FG002|Overall Study|Adverse Event|1|||
156892843|NCT04068896|566365988|FG003|Overall Study|Adverse Event|0|||
156892844|NCT04068896|566365989|FG004|Overall Study|Adverse Event|0|||
156892845|NCT04068896|566365990|FG005|Overall Study|Adverse Event|0|||
156892846|NCT04068896|566365985|FG000|Overall Study|Death|3|||
156892847|NCT04068896|566365986|FG001|Overall Study|Death|1|||
156892848|NCT04068896|566365987|FG002|Overall Study|Death|3|||
156892849|NCT04068896|566365988|FG003|Overall Study|Death|19|||
156892850|NCT04068896|566365989|FG004|Overall Study|Death|17|||
156892851|NCT04068896|566365990|FG005|Overall Study|Death|0|||
156892852|NCT04068896|566365985|FG000|Overall Study|Physician Decision|0|||
156892853|NCT04068896|566365986|FG001|Overall Study|Physician Decision|0|||
156892854|NCT04068896|566365987|FG002|Overall Study|Physician Decision|0|||
156892855|NCT04068896|566365988|FG003|Overall Study|Physician Decision|1|||
156892856|NCT04068896|566365989|FG004|Overall Study|Physician Decision|0|||
156892857|NCT04068896|566365990|FG005|Overall Study|Physician Decision|0|||
156892858|NCT04068896|566365985|FG000|Overall Study|progressive disease|3|||
156892859|NCT04068896|566365986|FG001|Overall Study|progressive disease|5|||
156892860|NCT04068896|566365987|FG002|Overall Study|progressive disease|3|||
156892861|NCT04068896|566365988|FG003|Overall Study|progressive disease|2|||
156892862|NCT04068896|566365989|FG004|Overall Study|progressive disease|1|||
156892863|NCT04068896|566365990|FG005|Overall Study|progressive disease|2|||
156892864|NCT04068896|566365985|FG000|Overall Study|Study terminated by sponsor|0|||
156892865|NCT04068896|566365986|FG001|Overall Study|Study terminated by sponsor|0|||
156892866|NCT04068896|566365987|FG002|Overall Study|Study terminated by sponsor|1|||
156892867|NCT04068896|566365988|FG003|Overall Study|Study terminated by sponsor|2|||
156892868|NCT04068896|566365989|FG004|Overall Study|Study terminated by sponsor|1|||
156892869|NCT04068896|566365990|FG005|Overall Study|Study terminated by sponsor|4|||
156892870|NCT04068896|566365985|FG000|Overall Study|Protocol Violation|0|||
156892871|NCT04068896|566365986|FG001|Overall Study|Protocol Violation|0|||
156892872|NCT04068896|566365987|FG002|Overall Study|Protocol Violation|0|||
156892873|NCT04068896|566365988|FG003|Overall Study|Protocol Violation|1|||
156892874|NCT04068896|566365989|FG004|Overall Study|Protocol Violation|0|||
156892875|NCT04068896|566365990|FG005|Overall Study|Protocol Violation|0|||
156892876|NCT04068896|566365985|FG000|Overall Study|Withdrawal by Subject|0|||
156892877|NCT04068896|566365986|FG001|Overall Study|Withdrawal by Subject|3|||
156892878|NCT04068896|566365987|FG002|Overall Study|Withdrawal by Subject|0|||
156892879|NCT04068896|566365988|FG003|Overall Study|Withdrawal by Subject|2|||
156892880|NCT04068896|566365989|FG004|Overall Study|Withdrawal by Subject|1|||
156892881|NCT04068896|566365990|FG005|Overall Study|Withdrawal by Subject|0|||
156892882|NCT04068896|566365985|FG000|Overall Study|Symptomatic deterioration|2|||
156892883|NCT04068896|566365986|FG001|Overall Study|Symptomatic deterioration|0|||
156892884|NCT04068896|566365987|FG002|Overall Study|Symptomatic deterioration|0|||
156892885|NCT04068896|566365988|FG003|Overall Study|Symptomatic deterioration|0|||
156892886|NCT04068896|566365989|FG004|Overall Study|Symptomatic deterioration|0|||
156892887|NCT04068896|566365990|FG005|Overall Study|Symptomatic deterioration|0|||
156892888|NCT01222403|566365993|FG000|Overall Study|Inappropriate enrollment|0|||
156892889|NCT01222403|566365994|FG001|Overall Study|Inappropriate enrollment|2|||
156892890|NCT02068768|566365996|FG000|Overall Study|Lost to Follow-up|5|||
156892891|NCT02068768|566365996|FG000|Overall Study|Early Termination by Sponsor|2|||
156892892|NCT01262352|566365997|FG000|Period 1|Illness after randomization|1|||
156892893|NCT01262352|566365998|FG001|Period 1|Illness after randomization|0|||
156892894|NCT01262352|566365997|FG000|Washout|Adverse Event|1|||
156892895|NCT01262352|566365998|FG001|Washout|Adverse Event|1|||
156892896|NCT01262352|566365997|FG000|Washout|Extended Washout|0|||
156892897|NCT01262352|566365998|FG001|Washout|Extended Washout|1|||
156892898|NCT00913692|566366000|FG000|Screening (4 Months)|Physician Decision|3|||
156892899|NCT00913692|566366000|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
156892900|NCT00913692|566366000|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
156892901|NCT02925793|566366001|FG000|Overall Study|Adverse Event|3|||
156892902|NCT02925793|566366002|FG001|Overall Study|Adverse Event|3|||
156892903|NCT02925793|566366003|FG002|Overall Study|Adverse Event|6|||
156892904|NCT02925793|566366001|FG000|Overall Study|Withdrawal by Subject|16|||
156892905|NCT02925793|566366002|FG001|Overall Study|Withdrawal by Subject|15|||
156892906|NCT02925793|566366003|FG002|Overall Study|Withdrawal by Subject|13|||
156892907|NCT02925793|566366001|FG000|Overall Study|Investigator Discretion|0|||
156892908|NCT02925793|566366002|FG001|Overall Study|Investigator Discretion|1|||
156892909|NCT02925793|566366003|FG002|Overall Study|Investigator Discretion|1|||
156892910|NCT02925793|566366001|FG000|Overall Study|Lost to Follow-up|2|||
156892911|NCT02925793|566366002|FG001|Overall Study|Lost to Follow-up|3|||
156892912|NCT02925793|566366003|FG002|Overall Study|Lost to Follow-up|1|||
156892913|NCT02925793|566366001|FG000|Overall Study|Lack of Efficacy|2|||
156892914|NCT02925793|566366002|FG001|Overall Study|Lack of Efficacy|6|||
156892915|NCT02925793|566366003|FG002|Overall Study|Lack of Efficacy|4|||
156892916|NCT02925793|566366001|FG000|Overall Study|Other:|2|||
156892917|NCT02925793|566366002|FG001|Overall Study|Other:|1|||
156892918|NCT02925793|566366003|FG002|Overall Study|Other:|3|||
156892919|NCT00393042|566366006|FG000|First Intervention|Withdrawal by Subject|1|||
156892920|NCT00393042|566366007|FG001|First Intervention|Withdrawal by Subject|2|||
156892921|NCT00393042|566366006|FG000|First Intervention|Lost to Follow-up|3|||
156892922|NCT00393042|566366007|FG001|First Intervention|Lost to Follow-up|3|||
156892923|NCT00393042|566366006|FG000|First Intervention|Protocol Violation|1|||
156892924|NCT00393042|566366007|FG001|First Intervention|Protocol Violation|0|||
156892925|NCT00393042|566366006|FG000|First Intervention|Adverse Event|0|||
156892926|NCT00393042|566366007|FG001|First Intervention|Adverse Event|1|||
156892927|NCT00393042|566366006|FG000|Second Intervetion|Adverse Event|0|||
157157948|NCT01201798|567322906|FG000|Overall Study|Treatment Failure|1|||
157157949|NCT01201798|567322907|FG001|Overall Study|Treatment Failure|8|||
157157950|NCT05122650|567322915|FG000|Overall Study|Adverse Event|4|||
156892928|NCT00393042|566366007|FG001|Second Intervetion|Adverse Event|3|||
156892929|NCT00393042|566366006|FG000|Second Intervetion|Withdrawal by Subject|0|||
156892930|NCT00393042|566366007|FG001|Second Intervetion|Withdrawal by Subject|2|||
156892931|NCT00393042|566366006|FG000|Second Intervetion|Lack of Efficacy|1|||
156892932|NCT00393042|566366007|FG001|Second Intervetion|Lack of Efficacy|0|||
156892933|NCT00393042|566366006|FG000|Second Intervetion|Lost to Follow-up|0|||
156892934|NCT00393042|566366007|FG001|Second Intervetion|Lost to Follow-up|2|||
156892935|NCT00393042|566366006|FG000|Second Intervetion|Protocol Violation|1|||
156892936|NCT00393042|566366007|FG001|Second Intervetion|Protocol Violation|1|||
156892937|NCT02045303|566366011|FG000|Overall Study|Protocol Violation|2|||
156892938|NCT02045303|566366012|FG001|Overall Study|Protocol Violation|1|||
156892939|NCT02045303|566366013|FG002|Overall Study|Protocol Violation|0|||
156892940|NCT02045303|566366011|FG000|Overall Study|Withdrawal by Subject|0|||
156892941|NCT02045303|566366012|FG001|Overall Study|Withdrawal by Subject|2|||
156892942|NCT02045303|566366013|FG002|Overall Study|Withdrawal by Subject|0|||
156892943|NCT00829283|566366014|FG000|Overall Study|Lost to Follow-up|7|||
156892944|NCT00829283|566366015|FG001|Overall Study|Lost to Follow-up|25|||
156892945|NCT00256282|566366016|FG000|Overall Study|Disease progression, relapse during acti|12|||
156892946|NCT00256282|566366016|FG000|Overall Study|Adverse Event|3|||
156892947|NCT00256282|566366016|FG000|Overall Study|Physician Decision|1|||
156892948|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
156892949|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
156892950|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Other|2|||
156892951|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Other|2|||
156892952|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Personal reasons|2|||
156892953|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Personal reasons|2|||
156892954|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
156892955|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
156892956|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
156892957|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
156892958|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
156892959|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
156892960|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
156892961|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
156892962|NCT00667446|566366017|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
156892963|NCT00667446|566366018|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
156892964|NCT00667446|566366017|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
156892965|NCT00667446|566366018|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
156892966|NCT03631355|566366019|FG000|Overall Study|Lost to Follow-up|1|||
156892967|NCT03631355|566366020|FG001|Overall Study|Lost to Follow-up|2|||
156892968|NCT00772070|566366023|FG000|Overall Study|Lost to Follow-up|0|||
156892969|NCT00772070|566366024|FG001|Overall Study|Lost to Follow-up|8|||
156892970|NCT00772070|566366023|FG000|Overall Study|Withdrawal by Subject|0|||
156892971|NCT00772070|566366024|FG001|Overall Study|Withdrawal by Subject|2|||
156892972|NCT00772070|566366023|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
156892973|NCT00772070|566366024|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
156892974|NCT01309308|566366025|FG000|Overall Study|Lost to Follow-up|6|||
156892975|NCT01309308|566366026|FG001|Overall Study|Lost to Follow-up|4|||
156892976|NCT01307020|566366029|FG000|Overall Study|Lost to Follow-up|0|||
156892977|NCT01307020|566366030|FG001|Overall Study|Lost to Follow-up|0|||
156892978|NCT01307020|566366031|FG002|Overall Study|Lost to Follow-up|1|||
156892979|NCT01307020|566366032|FG003|Overall Study|Lost to Follow-up|1|||
156892980|NCT01307020|566366033|FG004|Overall Study|Lost to Follow-up|0|||
156892981|NCT01307020|566366034|FG005|Overall Study|Lost to Follow-up|0|||
156892982|NCT01307020|566366035|FG006|Overall Study|Lost to Follow-up|1|||
156892983|NCT01307020|566366036|FG007|Overall Study|Lost to Follow-up|0|||
156892984|NCT01307020|566366037|FG008|Overall Study|Lost to Follow-up|0|||
156892985|NCT01307020|566366038|FG009|Overall Study|Lost to Follow-up|0|||
156892986|NCT01307020|566366029|FG000|Overall Study|Electronic data capture failure|0|||
156892987|NCT01307020|566366030|FG001|Overall Study|Electronic data capture failure|1|||
156892988|NCT01307020|566366031|FG002|Overall Study|Electronic data capture failure|0|||
156892989|NCT01307020|566366032|FG003|Overall Study|Electronic data capture failure|0|||
156892990|NCT01307020|566366033|FG004|Overall Study|Electronic data capture failure|0|||
156892991|NCT01307020|566366034|FG005|Overall Study|Electronic data capture failure|0|||
156892992|NCT01307020|566366035|FG006|Overall Study|Electronic data capture failure|0|||
156892993|NCT01307020|566366036|FG007|Overall Study|Electronic data capture failure|0|||
156892994|NCT01307020|566366037|FG008|Overall Study|Electronic data capture failure|0|||
156892995|NCT01307020|566366038|FG009|Overall Study|Electronic data capture failure|0|||
156892996|NCT02380690|566366039|FG000|Overall Study|Lost to Follow-up|14|||
157157951|NCT05122650|567322916|FG001|Overall Study|Adverse Event|16|||
156892997|NCT02380690|566366040|FG001|Overall Study|Lost to Follow-up|4|||
157157952|NCT05122650|567322917|FG002|Overall Study|Adverse Event|11|||
157157953|NCT05122650|567322918|FG003|Overall Study|Adverse Event|12|||
157157954|NCT05122650|567322915|FG000|Overall Study|Lack of Efficacy|0|||
157157955|NCT05122650|567322916|FG001|Overall Study|Lack of Efficacy|1|||
157157956|NCT05122650|567322917|FG002|Overall Study|Lack of Efficacy|1|||
156857692|NCT01384734|566232575|FG000|Overall Study|Investigator relocating|0|||
156857693|NCT01384734|566232576|FG001|Overall Study|Investigator relocating|2|||
156857694|NCT01384734|566232577|FG002|Overall Study|Investigator relocating|0|||
156857695|NCT01384734|566232578|FG003|Overall Study|Investigator relocating|3|||
156857696|NCT01384734|566232579|FG004|Overall Study|Investigator relocating|1|||
156857697|NCT01384734|566232575|FG000|Overall Study|Unable to come back for visit|1|||
156857698|NCT01384734|566232576|FG001|Overall Study|Unable to come back for visit|0|||
156857699|NCT01384734|566232577|FG002|Overall Study|Unable to come back for visit|1|||
156857700|NCT01384734|566232578|FG003|Overall Study|Unable to come back for visit|1|||
156857701|NCT01384734|566232579|FG004|Overall Study|Unable to come back for visit|0|||
156857702|NCT01384734|566232575|FG000|Overall Study|Prison|0|||
156857703|NCT01384734|566232576|FG001|Overall Study|Prison|0|||
156857704|NCT01384734|566232577|FG002|Overall Study|Prison|1|||
156857705|NCT01384734|566232578|FG003|Overall Study|Prison|0|||
156857706|NCT01384734|566232579|FG004|Overall Study|Prison|0|||
156857707|NCT01384734|566232575|FG000|Overall Study|As per Exclusion criteria|0|||
156857708|NCT01384734|566232576|FG001|Overall Study|As per Exclusion criteria|1|||
156857709|NCT01384734|566232577|FG002|Overall Study|As per Exclusion criteria|0|||
156857710|NCT01384734|566232578|FG003|Overall Study|As per Exclusion criteria|0|||
156857711|NCT01384734|566232579|FG004|Overall Study|As per Exclusion criteria|0|||
156857712|NCT01384734|566232575|FG000|Overall Study|Missed End of treatment visit|0|||
156857713|NCT01384734|566232576|FG001|Overall Study|Missed End of treatment visit|0|||
156857714|NCT01384734|566232577|FG002|Overall Study|Missed End of treatment visit|0|||
156857715|NCT01384734|566232578|FG003|Overall Study|Missed End of treatment visit|1|||
156857716|NCT01384734|566232579|FG004|Overall Study|Missed End of treatment visit|0|||
156857717|NCT01384734|566232575|FG000|Overall Study|Adhesion problem|0|||
156857718|NCT01384734|566232576|FG001|Overall Study|Adhesion problem|0|||
156857719|NCT01384734|566232577|FG002|Overall Study|Adhesion problem|0|||
156857720|NCT01384734|566232578|FG003|Overall Study|Adhesion problem|1|||
156857721|NCT01384734|566232579|FG004|Overall Study|Adhesion problem|0|||
156857722|NCT01384734|566232575|FG000|Overall Study|Early termination|0|||
156857723|NCT01384734|566232576|FG001|Overall Study|Early termination|0|||
156857724|NCT01384734|566232577|FG002|Overall Study|Early termination|0|||
156857725|NCT01384734|566232578|FG003|Overall Study|Early termination|0|||
156857726|NCT01384734|566232579|FG004|Overall Study|Early termination|1|||
156857727|NCT01384734|566232575|FG000|Overall Study|Physician Decision|1|||
156857728|NCT01384734|566232576|FG001|Overall Study|Physician Decision|0|||
156857729|NCT01384734|566232577|FG002|Overall Study|Physician Decision|0|||
156857730|NCT01384734|566232578|FG003|Overall Study|Physician Decision|0|||
156857731|NCT01384734|566232579|FG004|Overall Study|Physician Decision|0|||
156857732|NCT02922725|566232580|FG000|Overall Study|Withdrawal by Subject|1|||
156857733|NCT02922725|566232581|FG001|Overall Study|Withdrawal by Subject|0|||
156857734|NCT02922725|566232582|FG002|Overall Study|Withdrawal by Subject|0|||
156857735|NCT01300234|566232583|FG000|Overall Study|Adverse Event|1|||
156857736|NCT01300234|566232584|FG001|Overall Study|Adverse Event|1|||
156857737|NCT01300234|566232583|FG000|Overall Study|Protocol Violation|2|||
156857738|NCT01300234|566232584|FG001|Overall Study|Protocol Violation|3|||
156857739|NCT01300234|566232583|FG000|Overall Study|Withdrawal by Subject|5|||
156857740|NCT01300234|566232584|FG001|Overall Study|Withdrawal by Subject|9|||
156857741|NCT01300234|566232583|FG000|Overall Study|Lost to Follow-up|14|||
156857742|NCT01300234|566232584|FG001|Overall Study|Lost to Follow-up|12|||
156857743|NCT01300234|566232583|FG000|Overall Study|Pregnancy|2|||
156857744|NCT01300234|566232584|FG001|Overall Study|Pregnancy|1|||
156857745|NCT01300234|566232583|FG000|Overall Study|Participant reached stopping critera|2|||
156857746|NCT01300234|566232584|FG001|Overall Study|Participant reached stopping critera|0|||
156857747|NCT01300234|566232583|FG000|Overall Study|Participant stopped medication|1|||
156857748|NCT01300234|566232584|FG001|Overall Study|Participant stopped medication|1|||
156857749|NCT01300234|566232583|FG000|Overall Study|Participant refused return to hospital|1|||
156857750|NCT01300234|566232584|FG001|Overall Study|Participant refused return to hospital|0|||
157157957|NCT05122650|567322918|FG003|Overall Study|Lack of Efficacy|2|||
157157958|NCT05122650|567322915|FG000|Overall Study|Lost to Follow-up|1|||
157157959|NCT05122650|567322916|FG001|Overall Study|Lost to Follow-up|1|||
157157960|NCT05122650|567322917|FG002|Overall Study|Lost to Follow-up|3|||
156857751|NCT04612725|566232586|FG000|Overall Study|Adverse Event|1|||
156857752|NCT04612725|566232587|FG001|Overall Study|Adverse Event|3|||
156857753|NCT04612725|566232588|FG002|Overall Study|Adverse Event|1|||
156857754|NCT04612725|566232589|FG003|Overall Study|Adverse Event|0|||
156857755|NCT04612725|566232590|FG004|Overall Study|Adverse Event|1|||
156857756|NCT04612725|566232586|FG000|Overall Study|Lost to Follow-up|0|||
156857757|NCT04612725|566232587|FG001|Overall Study|Lost to Follow-up|1|||
156857758|NCT04612725|566232588|FG002|Overall Study|Lost to Follow-up|0|||
157157961|NCT05122650|567322918|FG003|Overall Study|Lost to Follow-up|0|||
156857759|NCT04612725|566232589|FG003|Overall Study|Lost to Follow-up|0|||
156857760|NCT04612725|566232590|FG004|Overall Study|Lost to Follow-up|0|||
156857761|NCT04612725|566232586|FG000|Overall Study|Physician Decision|2|||
156857762|NCT04612725|566232587|FG001|Overall Study|Physician Decision|0|||
156857763|NCT04612725|566232588|FG002|Overall Study|Physician Decision|0|||
156857764|NCT04612725|566232589|FG003|Overall Study|Physician Decision|0|||
156857765|NCT04612725|566232590|FG004|Overall Study|Physician Decision|0|||
156857766|NCT04612725|566232586|FG000|Overall Study|Study terminated by sponsor|3|||
156857767|NCT04612725|566232587|FG001|Overall Study|Study terminated by sponsor|1|||
156857768|NCT04612725|566232588|FG002|Overall Study|Study terminated by sponsor|2|||
156857769|NCT04612725|566232589|FG003|Overall Study|Study terminated by sponsor|4|||
156857770|NCT04612725|566232590|FG004|Overall Study|Study terminated by sponsor|5|||
156857771|NCT04612725|566232586|FG000|Overall Study|Withdrawal by Subject|8|||
156857772|NCT04612725|566232587|FG001|Overall Study|Withdrawal by Subject|3|||
156857773|NCT04612725|566232588|FG002|Overall Study|Withdrawal by Subject|5|||
156857774|NCT04612725|566232589|FG003|Overall Study|Withdrawal by Subject|1|||
156857775|NCT04612725|566232590|FG004|Overall Study|Withdrawal by Subject|9|||
156857776|NCT04612725|566232586|FG000|Overall Study|Other|0|||
156857777|NCT04612725|566232587|FG001|Overall Study|Other|0|||
156857778|NCT04612725|566232588|FG002|Overall Study|Other|0|||
156857779|NCT04612725|566232589|FG003|Overall Study|Other|0|||
156857780|NCT04612725|566232590|FG004|Overall Study|Other|1|||
156857781|NCT00948064|566234622|FG000|Phase I|No treatment received|1|||
156857782|NCT00948064|566234623|FG001|Phase I|No treatment received|0|||
156857783|NCT00948064|566234624|FG002|Phase I|No treatment received|0|||
156857784|NCT00948064|566234622|FG000|Phase II|Physician Decision|0|||
156857785|NCT00948064|566234623|FG001|Phase II|Physician Decision|0|||
156857786|NCT00948064|566234624|FG002|Phase II|Physician Decision|1|||
156857787|NCT00948064|566234622|FG000|Phase II|Withdrawal by Subject|0|||
156857788|NCT00948064|566234623|FG001|Phase II|Withdrawal by Subject|1|||
156857789|NCT00948064|566234624|FG002|Phase II|Withdrawal by Subject|0|||
156857790|NCT02973100|566234625|FG000|Overall Study|Adverse Event|1|||
156857791|NCT02973100|566234626|FG001|Overall Study|Adverse Event|2|||
156857792|NCT02973100|566234627|FG002|Overall Study|Adverse Event|1|||
156857793|NCT02973100|566234628|FG003|Overall Study|Adverse Event|2|||
156857794|NCT02973100|566234625|FG000|Overall Study|Lost to Follow-up|3|||
156857795|NCT02973100|566234626|FG001|Overall Study|Lost to Follow-up|1|||
156857796|NCT02973100|566234627|FG002|Overall Study|Lost to Follow-up|1|||
156857797|NCT02973100|566234628|FG003|Overall Study|Lost to Follow-up|0|||
156857798|NCT02973100|566234625|FG000|Overall Study|Withdrawal by Subject|3|||
156857799|NCT02973100|566234626|FG001|Overall Study|Withdrawal by Subject|5|||
156857800|NCT02973100|566234627|FG002|Overall Study|Withdrawal by Subject|1|||
156857801|NCT02973100|566234628|FG003|Overall Study|Withdrawal by Subject|4|||
156857802|NCT02973100|566234625|FG000|Overall Study|Notification of change in address|0|||
156857803|NCT02973100|566234626|FG001|Overall Study|Notification of change in address|0|||
156857804|NCT02973100|566234627|FG002|Overall Study|Notification of change in address|0|||
156857805|NCT02973100|566234628|FG003|Overall Study|Notification of change in address|1|||
156857806|NCT02973100|566234625|FG000|Overall Study|Failed to attend Safety followup period|0|||
156857807|NCT02973100|566234626|FG001|Overall Study|Failed to attend Safety followup period|0|||
156857808|NCT02973100|566234627|FG002|Overall Study|Failed to attend Safety followup period|1|||
156857809|NCT02973100|566234628|FG003|Overall Study|Failed to attend Safety followup period|0|||
156857810|NCT01419236|566234631|FG000|Overall Study|Adverse Event|1|||
156857811|NCT01419236|566234632|FG001|Overall Study|Adverse Event|0|||
156857812|NCT01419236|566234631|FG000|Overall Study|Lack of Efficacy|0|||
156857813|NCT01419236|566234632|FG001|Overall Study|Lack of Efficacy|1|||
156857814|NCT01419236|566234631|FG000|Overall Study|Lost to Follow-up|1|||
156857815|NCT01419236|566234632|FG001|Overall Study|Lost to Follow-up|0|||
156857816|NCT01419236|566234631|FG000|Overall Study|Physician Decision|1|||
156857817|NCT01419236|566234632|FG001|Overall Study|Physician Decision|0|||
156857818|NCT01419236|566234631|FG000|Overall Study|Withdrawal by Subject|1|||
156857819|NCT01419236|566234632|FG001|Overall Study|Withdrawal by Subject|4|||
156857820|NCT01419236|566234631|FG000|Overall Study|Entry Criteria Not Met|1|||
156857821|NCT01419236|566234632|FG001|Overall Study|Entry Criteria Not Met|0|||
156857822|NCT01393158|566234634|FG000|Overall Study|Adverse Event|1|||
156857823|NCT01393158|566234635|FG001|Overall Study|Adverse Event|0|||
156857824|NCT04233801|566234637|FG000|Overall Study|Other than listed|0|||
156857825|NCT04233801|566234638|FG001|Overall Study|Other than listed|0|||
156857826|NCT04233801|566234639|FG002|Overall Study|Other than listed|1|||
156857827|NCT04233801|566234637|FG000|Overall Study|Withdrawal by Subject|0|||
156857828|NCT04233801|566234638|FG001|Overall Study|Withdrawal by Subject|2|||
156857829|NCT04233801|566234639|FG002|Overall Study|Withdrawal by Subject|3|||
156857830|NCT01690052|566234644|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
156857831|NCT01690052|566234645|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
156857832|NCT01453049|566234646|FG000|Overall Study|Protocol Violation|2|||
156857833|NCT01453049|566234647|FG001|Overall Study|Protocol Violation|5|||
156857834|NCT01453049|566234646|FG000|Overall Study|Lost to Follow-up|2|||
156857835|NCT01453049|566234647|FG001|Overall Study|Lost to Follow-up|1|||
156857836|NCT01453049|566234646|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
156892998|NCT02380690|566366039|FG000|Overall Study|Withdrawal by Subject|20|||
156892999|NCT02380690|566366040|FG001|Overall Study|Withdrawal by Subject|8|||
156893000|NCT00266864|566366041|FG000|Overall Study|Lost to Follow-up|4|||
156893001|NCT00266864|566366042|FG001|Overall Study|Lost to Follow-up|1|||
156893002|NCT00266864|566366041|FG000|Overall Study|Withdrawal by Subject|1|||
156893003|NCT00266864|566366042|FG001|Overall Study|Withdrawal by Subject|1|||
156893004|NCT00727532|566366043|FG000|Overall Study|Adverse Event|1|||
156893005|NCT00727532|566366043|FG000|Overall Study|Withdrawal by Subject|1|||
156893006|NCT00829933|566366044|FG000|Overall Study|Adverse Event|2|||
156893007|NCT00829933|566366045|FG001|Overall Study|Adverse Event|3|||
156893008|NCT00829933|566366046|FG002|Overall Study|Adverse Event|2|||
156893009|NCT00829933|566366047|FG003|Overall Study|Adverse Event|1|||
156893010|NCT00829933|566366044|FG000|Overall Study|Death|0|||
156893011|NCT00829933|566366045|FG001|Overall Study|Death|0|||
156893012|NCT00829933|566366046|FG002|Overall Study|Death|1|||
156893013|NCT00829933|566366047|FG003|Overall Study|Death|1|||
156893014|NCT00829933|566366044|FG000|Overall Study|Lack of Efficacy|0|||
156893015|NCT00829933|566366045|FG001|Overall Study|Lack of Efficacy|1|||
156893016|NCT00829933|566366046|FG002|Overall Study|Lack of Efficacy|0|||
156893017|NCT00829933|566366047|FG003|Overall Study|Lack of Efficacy|0|||
156893018|NCT00829933|566366044|FG000|Overall Study|Physician Decision|5|||
156893019|NCT00829933|566366045|FG001|Overall Study|Physician Decision|7|||
156893020|NCT00829933|566366046|FG002|Overall Study|Physician Decision|8|||
156893021|NCT00829933|566366047|FG003|Overall Study|Physician Decision|1|||
156893022|NCT00829933|566366044|FG000|Overall Study|Pregnancy|0|||
156893023|NCT00829933|566366045|FG001|Overall Study|Pregnancy|0|||
156893024|NCT00829933|566366046|FG002|Overall Study|Pregnancy|0|||
156893025|NCT00829933|566366047|FG003|Overall Study|Pregnancy|2|||
156893026|NCT00829933|566366044|FG000|Overall Study|Protocol Violation|2|||
156893027|NCT00829933|566366045|FG001|Overall Study|Protocol Violation|1|||
156893028|NCT00829933|566366046|FG002|Overall Study|Protocol Violation|0|||
156893029|NCT00829933|566366047|FG003|Overall Study|Protocol Violation|0|||
156893030|NCT00829933|566366044|FG000|Overall Study|withdrew before treatment started|5|||
156893031|NCT00829933|566366045|FG001|Overall Study|withdrew before treatment started|1|||
156893032|NCT00829933|566366046|FG002|Overall Study|withdrew before treatment started|2|||
156893033|NCT00829933|566366047|FG003|Overall Study|withdrew before treatment started|9|||
156893034|NCT03687970|566366051|FG000|Overall Study|visit scheduling conflicts|2|||
156893035|NCT03687970|566366052|FG001|Overall Study|visit scheduling conflicts|0|||
156893036|NCT05985980|566366059|FG000|Overall Study|Withdrawal by Subject|1|||
156893037|NCT05985980|566366059|FG000|Overall Study|Withdrawal by Subject|1|||
156893038|NCT05985980|566366059|FG000|Overall Study|Withdrawal by Subject|1|||
156893039|NCT05985980|566366059|FG000|Overall Study|Withdrawal by Subject|1|||
156893040|NCT00523367|566366060|FG000|Overall Study|19 screen failures|19|||
156893041|NCT00523367|566366060|FG000|Overall Study|4 Withdrawn by PI|4|||
156893042|NCT04480424|566366061|FG000|Overall Study|Withdrawal by Subject|0|||
156893043|NCT04480424|566366062|FG001|Overall Study|Withdrawal by Subject|2|||
156893044|NCT04480424|566366061|FG000|Overall Study|Lost to Follow-up|3|||
156893045|NCT04480424|566366062|FG001|Overall Study|Lost to Follow-up|3|||
156893046|NCT04480424|566366061|FG000|Overall Study|Death|14|||
156893047|NCT04480424|566366062|FG001|Overall Study|Death|16|||
156893048|NCT04480424|566366061|FG000|Overall Study|Reason not Specified|5|||
156893049|NCT04480424|566366062|FG001|Overall Study|Reason not Specified|5|||
156893050|NCT04090957|566366063|FG000|Overall Study|Lost to Follow-up|22|||
156893051|NCT04090957|566366064|FG001|Overall Study|Lost to Follow-up|25|||
156893052|NCT04090957|566366065|FG002|Overall Study|Lost to Follow-up|25|||
156893053|NCT04090957|566366066|FG003|Overall Study|Lost to Follow-up|36|||
156893054|NCT04090957|566366063|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
156893055|NCT04090957|566366064|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
156893056|NCT04090957|566366065|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
157026046|NCT05526430|566849706|FG000|Overall Study|Withdrawal by Subject|0|||
156893057|NCT04090957|566366066|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
156893058|NCT04090957|566366063|FG000|Overall Study|Adverse Event|19|||
156893059|NCT04090957|566366064|FG001|Overall Study|Adverse Event|25|||
156893060|NCT04090957|566366065|FG002|Overall Study|Adverse Event|8|||
156893061|NCT04090957|566366066|FG003|Overall Study|Adverse Event|104|||
156893062|NCT04090957|566366063|FG000|Overall Study|Other|10|||
156893063|NCT04090957|566366064|FG001|Overall Study|Other|6|||
156893064|NCT04090957|566366065|FG002|Overall Study|Other|5|||
156893065|NCT04090957|566366066|FG003|Overall Study|Other|12|||
156893066|NCT04090957|566366063|FG000|Overall Study|Serious Adverse Event|7|||
156893067|NCT04090957|566366064|FG001|Overall Study|Serious Adverse Event|11|||
156893068|NCT04090957|566366065|FG002|Overall Study|Serious Adverse Event|1|||
156893069|NCT04090957|566366066|FG003|Overall Study|Serious Adverse Event|32|||
156893070|NCT04090957|566366063|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
156893071|NCT04090957|566366064|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
156893072|NCT04090957|566366065|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
156893073|NCT04090957|566366066|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
156893074|NCT04090957|566366063|FG000|Overall Study|Lack of Efficacy|1|||
156893075|NCT04090957|566366064|FG001|Overall Study|Lack of Efficacy|1|||
156893076|NCT04090957|566366065|FG002|Overall Study|Lack of Efficacy|9|||
156893077|NCT04090957|566366066|FG003|Overall Study|Lack of Efficacy|0|||
156893078|NCT04090957|566366063|FG000|Overall Study|Protocol Violation|3|||
156893079|NCT04090957|566366064|FG001|Overall Study|Protocol Violation|5|||
156893080|NCT04090957|566366065|FG002|Overall Study|Protocol Violation|2|||
156893081|NCT04090957|566366066|FG003|Overall Study|Protocol Violation|1|||
156893082|NCT04090957|566366063|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
156893083|NCT04090957|566366064|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
156893084|NCT04090957|566366065|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
156893085|NCT04090957|566366066|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
156893086|NCT04090957|566366063|FG000|Overall Study|COVID-19|2|||
156893087|NCT04090957|566366064|FG001|Overall Study|COVID-19|2|||
156893088|NCT04090957|566366065|FG002|Overall Study|COVID-19|3|||
156893089|NCT04090957|566366066|FG003|Overall Study|COVID-19|7|||
156893090|NCT04090957|566366063|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
156893091|NCT04090957|566366064|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
156893092|NCT04090957|566366065|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
156893093|NCT04090957|566366066|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
156893094|NCT04090957|566366063|FG000|Overall Study|Physician Decision|2|||
156893095|NCT04090957|566366064|FG001|Overall Study|Physician Decision|1|||
156893096|NCT04090957|566366065|FG002|Overall Study|Physician Decision|1|||
156893097|NCT04090957|566366066|FG003|Overall Study|Physician Decision|5|||
156893098|NCT04090957|566366063|FG000|Overall Study|Sponsor Decision|1|||
156893099|NCT04090957|566366064|FG001|Overall Study|Sponsor Decision|1|||
156893100|NCT04090957|566366065|FG002|Overall Study|Sponsor Decision|1|||
156893101|NCT04090957|566366066|FG003|Overall Study|Sponsor Decision|3|||
156893102|NCT04090957|566366063|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
156893103|NCT04090957|566366064|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
156893104|NCT04090957|566366065|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
156893105|NCT04090957|566366066|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
156893106|NCT04090957|566366063|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
156893107|NCT04090957|566366064|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
156893108|NCT04090957|566366065|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
156893109|NCT04090957|566366066|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
156893110|NCT04090957|566366063|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156893111|NCT04090957|566366064|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156893112|NCT04090957|566366065|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
156893113|NCT04090957|566366066|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
156893114|NCT04090957|566366063|FG000|Overall Study|Death|1|||
156893115|NCT04090957|566366064|FG001|Overall Study|Death|0|||
156893116|NCT04090957|566366065|FG002|Overall Study|Death|0|||
156893117|NCT04090957|566366066|FG003|Overall Study|Death|0|||
156893118|NCT04090957|566366063|FG000|Overall Study|No Treatment Administered|2|||
156893119|NCT04090957|566366064|FG001|Overall Study|No Treatment Administered|1|||
156893120|NCT04090957|566366065|FG002|Overall Study|No Treatment Administered|2|||
156893121|NCT04090957|566366066|FG003|Overall Study|No Treatment Administered|1|||
156977436|NCT04534114|566670718|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
156977437|NCT04534114|566670719|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
156977438|NCT04534114|566670720|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
156977439|NCT04534114|566670717|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156977440|NCT04534114|566670718|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
156977441|NCT04534114|566670719|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
156977442|NCT04534114|566670720|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156977443|NCT04534114|566670717|FG000|Main Treatment Period|Physician Decision|0|||
156977444|NCT04534114|566670718|FG001|Main Treatment Period|Physician Decision|0|||
156977445|NCT04534114|566670719|FG002|Main Treatment Period|Physician Decision|0|||
156977446|NCT04534114|566670720|FG003|Main Treatment Period|Physician Decision|1|||
156977447|NCT04534114|566670717|FG000|Main Treatment Period|Death|1|||
156977448|NCT04534114|566670718|FG001|Main Treatment Period|Death|0|||
156977449|NCT04534114|566670719|FG002|Main Treatment Period|Death|0|||
156977450|NCT04534114|566670720|FG003|Main Treatment Period|Death|1|||
156977451|NCT04534114|566670717|FG000|Main Treatment Period|Other reason|1|||
156977452|NCT04534114|566670718|FG001|Main Treatment Period|Other reason|1|||
156977453|NCT04534114|566670719|FG002|Main Treatment Period|Other reason|0|||
156977454|NCT04534114|566670720|FG003|Main Treatment Period|Other reason|0|||
156977455|NCT04534114|566670717|FG000|Main Treatment Period|Participant decision|1|||
156977456|NCT04534114|566670718|FG001|Main Treatment Period|Participant decision|3|||
156977457|NCT04534114|566670719|FG002|Main Treatment Period|Participant decision|3|||
156977458|NCT04534114|566670720|FG003|Main Treatment Period|Participant decision|1|||
157157962|NCT05122650|567322915|FG000|Overall Study|Non-compliance with study intervention|0|||
156893122|NCT03437512|566368341|FG000|Randomized|Withdrawal by Subject|0|||
156893123|NCT03437512|566368342|FG001|Randomized|Withdrawal by Subject|2|||
156893124|NCT03437512|566368341|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
156893125|NCT03437512|566368342|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
156893126|NCT04854642|566368343|FG000|Overall Study|Adverse Event|1|||
156893127|NCT04854642|566368344|FG001|Overall Study|Adverse Event|2|||
156893128|NCT04854642|566368343|FG000|Overall Study|Withdrawal by Subject|0|||
156893129|NCT04854642|566368344|FG001|Overall Study|Withdrawal by Subject|1|||
156893130|NCT05828095|566368347|FG000|Overall Study|Lost to Follow-up|1|||
156893131|NCT05828095|566368348|FG001|Overall Study|Lost to Follow-up|0|||
156893132|NCT05828095|566368347|FG000|Overall Study|Reactogenicity symptom|0|||
156893133|NCT05828095|566368348|FG001|Overall Study|Reactogenicity symptom|1|||
156893134|NCT01994590|566368351|FG000|Overall Study|Adverse Event|1|||
156893135|NCT01994590|566368351|FG000|Overall Study|Trial Terminated|1|||
156893136|NCT03206073|566368352|FG000|Overall Study|Participant Noncompliance|0|||
156893137|NCT03206073|566368353|FG001|Overall Study|Participant Noncompliance|1|||
156893138|NCT03206073|566368354|FG002|Overall Study|Participant Noncompliance|0|||
156893139|NCT03206073|566368355|FG003|Overall Study|Participant Noncompliance|0|||
156893140|NCT03206073|566368352|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
156893141|NCT03206073|566368353|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156893142|NCT03206073|566368354|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156893143|NCT03206073|566368355|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
156893144|NCT03206073|566368352|FG000|Overall Study|Death|0|||
156893145|NCT03206073|566368353|FG001|Overall Study|Death|0|||
156893146|NCT03206073|566368354|FG002|Overall Study|Death|1|||
156893147|NCT03206073|566368355|FG003|Overall Study|Death|0|||
156893148|NCT03206073|566368352|FG000|Overall Study|Taken off active treatment|0|||
156893149|NCT03206073|566368353|FG001|Overall Study|Taken off active treatment|0|||
156893150|NCT03206073|566368354|FG002|Overall Study|Taken off active treatment|3|||
156893151|NCT03206073|566368355|FG003|Overall Study|Taken off active treatment|0|||
156893152|NCT03332771|566368357|FG000|Overall Study|Adverse Event|6|||
156893153|NCT03332771|566368358|FG001|Overall Study|Adverse Event|4|||
156893154|NCT03332771|566368359|FG002|Overall Study|Adverse Event|1|||
156893155|NCT03332771|566368360|FG003|Overall Study|Adverse Event|3|||
156893156|NCT03332771|566368357|FG000|Overall Study|Poor Compliance to Protocol|0|||
156893157|NCT03332771|566368358|FG001|Overall Study|Poor Compliance to Protocol|1|||
156893158|NCT03332771|566368359|FG002|Overall Study|Poor Compliance to Protocol|0|||
156893159|NCT03332771|566368360|FG003|Overall Study|Poor Compliance to Protocol|1|||
156893160|NCT03332771|566368357|FG000|Overall Study|Lost to Follow-up|2|||
156893161|NCT03332771|566368358|FG001|Overall Study|Lost to Follow-up|2|||
156893162|NCT03332771|566368359|FG002|Overall Study|Lost to Follow-up|1|||
156893163|NCT03332771|566368360|FG003|Overall Study|Lost to Follow-up|2|||
156893164|NCT03332771|566368357|FG000|Overall Study|At the Participant's own request|20|||
156893165|NCT03332771|566368358|FG001|Overall Study|At the Participant's own request|26|||
156893166|NCT03332771|566368359|FG002|Overall Study|At the Participant's own request|14|||
156893167|NCT03332771|566368360|FG003|Overall Study|At the Participant's own request|23|||
156893168|NCT03332771|566368357|FG000|Overall Study|Reason Not Specified|6|||
156893169|NCT03332771|566368358|FG001|Overall Study|Reason Not Specified|18|||
156893170|NCT03332771|566368359|FG002|Overall Study|Reason Not Specified|16|||
156893171|NCT03332771|566368360|FG003|Overall Study|Reason Not Specified|19|||
156893172|NCT03442764|566368361|FG000|Overall Study|Adverse Event|1|||
156893173|NCT03442764|566368362|FG001|Overall Study|Adverse Event|0|||
156893174|NCT03442764|566368363|FG002|Overall Study|Adverse Event|0|||
156893175|NCT01801072|566368364|FG000|Overall Study|Lost to Follow-up|17|||
156893176|NCT01801072|566368365|FG001|Overall Study|Lost to Follow-up|14|||
156893177|NCT01801072|566368364|FG000|Overall Study|Physician Decision|2|||
156893178|NCT01801072|566368365|FG001|Overall Study|Physician Decision|3|||
156893179|NCT01801072|566368364|FG000|Overall Study|Withdrawal by Subject|1|||
156893180|NCT01801072|566368365|FG001|Overall Study|Withdrawal by Subject|0|||
156893181|NCT01801072|566368364|FG000|Overall Study|Protocol Violation|2|||
156893182|NCT01801072|566368365|FG001|Overall Study|Protocol Violation|0|||
156893183|NCT01801072|566368364|FG000|Overall Study|Death|7|||
156893184|NCT01801072|566368365|FG001|Overall Study|Death|8|||
156893185|NCT00719264|566368366|FG000|Overall Study|Adverse Event|41|||
157157963|NCT05122650|567322916|FG001|Overall Study|Non-compliance with study intervention|0|||
156893186|NCT00719264|566368367|FG001|Overall Study|Adverse Event|49|||
156893187|NCT00719264|566368366|FG000|Overall Study|Death|13|||
156893188|NCT00719264|566368367|FG001|Overall Study|Death|10|||
156893189|NCT00719264|566368366|FG000|Overall Study|Administrative Problems|6|||
156893190|NCT00719264|566368367|FG001|Overall Study|Administrative Problems|4|||
156893191|NCT00719264|566368366|FG000|Overall Study|Lost to Follow-up|1|||
156893192|NCT00719264|566368367|FG001|Overall Study|Lost to Follow-up|1|||
156893193|NCT00719264|566368366|FG000|Overall Study|Withdrawal by Subject|12|||
156893194|NCT00719264|566368367|FG001|Overall Study|Withdrawal by Subject|7|||
156893195|NCT00719264|566368366|FG000|Overall Study|Protocol Deviation|1|||
156893196|NCT00719264|566368367|FG001|Overall Study|Protocol Deviation|3|||
156893197|NCT00719264|566368366|FG000|Overall Study|New Cancer Therapy|4|||
156893198|NCT00719264|566368367|FG001|Overall Study|New Cancer Therapy|2|||
156893199|NCT00719264|566368366|FG000|Overall Study|Disease Progression|104|||
157157964|NCT05122650|567322917|FG002|Overall Study|Non-compliance with study intervention|0|||
157157965|NCT05122650|567322918|FG003|Overall Study|Non-compliance with study intervention|2|||
156893200|NCT00719264|566368367|FG001|Overall Study|Disease Progression|107|||
156893201|NCT01277042|566368368|FG000|Overall Study|Adverse Event|4|||
156893202|NCT01277042|566368369|FG001|Overall Study|Adverse Event|3|||
156893203|NCT01277042|566368368|FG000|Overall Study|Lost to Follow-up|2|||
156893204|NCT01277042|566368369|FG001|Overall Study|Lost to Follow-up|2|||
156893205|NCT01277042|566368368|FG000|Overall Study|Withdrawal by Subject|2|||
156893206|NCT01277042|566368369|FG001|Overall Study|Withdrawal by Subject|0|||
156893207|NCT03034200|566368370|FG000|Overall Study|Disease progression|8|||
156893208|NCT03034200|566368371|FG001|Overall Study|Disease progression|10|||
156893209|NCT03034200|566368372|FG002|Overall Study|Disease progression|4|||
156893210|NCT03034200|566368370|FG000|Overall Study|Physician Decision|2|||
156893211|NCT03034200|566368371|FG001|Overall Study|Physician Decision|0|||
156893212|NCT03034200|566368372|FG002|Overall Study|Physician Decision|3|||
156893213|NCT03034200|566368370|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
156893214|NCT03034200|566368371|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
156893215|NCT03034200|566368372|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
156893216|NCT03034200|566368370|FG000|Overall Study|Adjuvant Therapy|0|||
156893217|NCT03034200|566368371|FG001|Overall Study|Adjuvant Therapy|0|||
156893218|NCT03034200|566368372|FG002|Overall Study|Adjuvant Therapy|1|||
156893219|NCT03581786|566368379|FG000|Overall Study|Death|67|||
156893220|NCT03581786|566368380|FG001|Overall Study|Death|47|||
156893221|NCT03581786|566368379|FG000|Overall Study|Withdrawal by Subject|2|||
156893222|NCT03581786|566368380|FG001|Overall Study|Withdrawal by Subject|5|||
156893223|NCT03581786|566368379|FG000|Overall Study|Lost to Follow-up|7|||
156893224|NCT03581786|566368380|FG001|Overall Study|Lost to Follow-up|4|||
156893225|NCT03581786|566368379|FG000|Overall Study|reason other than specified above|0|||
156893226|NCT03581786|566368380|FG001|Overall Study|reason other than specified above|1|||
156893227|NCT00636987|566368381|FG000|Overall Study|Death|44|||
156893228|NCT00636987|566368381|FG000|Overall Study|Explanted|13|||
156893229|NCT00636987|566368381|FG000|Overall Study|Lost to Follow-up|63|||
156893230|NCT00636987|566368381|FG000|Overall Study|5 year visit window not complete|69|||
156893231|NCT01251146|566368382|FG000|Overall Study|Lost to Follow-up|3|||
156893232|NCT01251146|566368383|FG001|Overall Study|Lost to Follow-up|10|||
156893233|NCT01347307|566368384|FG000|Overall Study|Death|0|||
156893234|NCT01347307|566368385|FG001|Overall Study|Death|4|||
156893235|NCT01347307|566368384|FG000|Overall Study|Physician Decision|0|||
156893236|NCT01347307|566368385|FG001|Overall Study|Physician Decision|1|||
156893237|NCT01483690|566368389|FG000|Overall Study|Adverse Event|1|||
156893238|NCT01483690|566368390|FG001|Overall Study|Adverse Event|2|||
156893239|NCT01483690|566368389|FG000|Overall Study|clinical deterioration|1|||
156893240|NCT01483690|566368390|FG001|Overall Study|clinical deterioration|0|||
156893241|NCT01483690|566368389|FG000|Overall Study|Physician Decision|0|||
156893242|NCT01483690|566368390|FG001|Overall Study|Physician Decision|2|||
156893243|NCT01483690|566368389|FG000|Overall Study|exclusionary procedure|0|||
156893244|NCT01483690|566368390|FG001|Overall Study|exclusionary procedure|1|||
156893245|NCT02239224|566368391|FG000|Overall Study|Administrative|0|||
156893246|NCT02239224|566368392|FG001|Overall Study|Administrative|0|||
156893247|NCT02239224|566368393|FG002|Overall Study|Administrative|3|||
156893248|NCT02239224|566368394|FG003|Overall Study|Administrative|1|||
156893249|NCT03183778|566368395|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
157157966|NCT05122650|567322915|FG000|Overall Study|Protocol Violation|0|||
157157967|NCT05122650|567322916|FG001|Overall Study|Protocol Violation|1|||
157157968|NCT05122650|567322917|FG002|Overall Study|Protocol Violation|0|||
157157969|NCT05122650|567322918|FG003|Overall Study|Protocol Violation|1|||
157157970|NCT05122650|567322915|FG000|Overall Study|Randomized by mistake|0|||
157157971|NCT05122650|567322916|FG001|Overall Study|Randomized by mistake|0|||
156893250|NCT00737464|566368398|FG000|Overall Study|Adverse Event|1|||
156893251|NCT00737464|566368398|FG000|Overall Study|Death|6|||
156893252|NCT00737464|566368398|FG000|Overall Study|Other - Failure to Return|1|||
156893253|NCT00737464|566368398|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
156893254|NCT00737464|566368398|FG000|Overall Study|Other reasons|4|||
156893255|NCT03228420|566368406|FG000|Overall Study|Lost to Follow-up|5|||
156893256|NCT03228420|566368407|FG001|Overall Study|Lost to Follow-up|3|||
156893257|NCT03228420|566368406|FG000|Overall Study|Withdrawal by Subject|10|||
156893258|NCT03228420|566368407|FG001|Overall Study|Withdrawal by Subject|0|||
156893259|NCT03228420|566368406|FG000|Overall Study|Adverse Event|5|||
156893260|NCT03228420|566368407|FG001|Overall Study|Adverse Event|2|||
157157972|NCT05122650|567322917|FG002|Overall Study|Randomized by mistake|3|||
157157973|NCT05122650|567322918|FG003|Overall Study|Randomized by mistake|2|||
156893261|NCT03868124|566368408|FG000|Overall Study|Withdrawal by Subject|4|||
156893262|NCT03868124|566368409|FG001|Overall Study|Withdrawal by Subject|0|||
156893263|NCT03868124|566368410|FG002|Overall Study|Withdrawal by Subject|1|||
156893264|NCT03868124|566368408|FG000|Overall Study|Physician Decision|1|||
156893265|NCT03868124|566368409|FG001|Overall Study|Physician Decision|0|||
156893266|NCT03868124|566368410|FG002|Overall Study|Physician Decision|1|||
156893267|NCT03868124|566368408|FG000|Overall Study|Lost to Follow-up|1|||
156893268|NCT03868124|566368409|FG001|Overall Study|Lost to Follow-up|1|||
156893269|NCT03868124|566368410|FG002|Overall Study|Lost to Follow-up|2|||
156893270|NCT03868124|566368408|FG000|Overall Study|Death|1|||
156893271|NCT03868124|566368409|FG001|Overall Study|Death|1|||
156893272|NCT03868124|566368410|FG002|Overall Study|Death|2|||
156893273|NCT03868124|566368408|FG000|Overall Study|Adverse Event|0|||
156893274|NCT03868124|566368409|FG001|Overall Study|Adverse Event|0|||
156893275|NCT03868124|566368410|FG002|Overall Study|Adverse Event|3|||
156893276|NCT03868124|566368408|FG000|Overall Study|Explanted|2|||
156893277|NCT03868124|566368409|FG001|Overall Study|Explanted|1|||
156893278|NCT03868124|566368410|FG002|Overall Study|Explanted|0|||
156893279|NCT03868124|566368408|FG000|Overall Study|Ongoing in study|176|||
156893280|NCT03868124|566368409|FG001|Overall Study|Ongoing in study|180|||
156893281|NCT03868124|566368410|FG002|Overall Study|Ongoing in study|183|||
156893282|NCT04177355|566368411|FG000|Overall Study|Lost to Follow-up|0|||
156893283|NCT04177355|566368412|FG001|Overall Study|Lost to Follow-up|2|||
156893284|NCT04177355|566368413|FG002|Overall Study|Lost to Follow-up|0|||
156893285|NCT04177355|566368414|FG003|Overall Study|Lost to Follow-up|1|||
156893286|NCT04177355|566368415|FG004|Overall Study|Lost to Follow-up|2|||
156893287|NCT04177355|566368416|FG005|Overall Study|Lost to Follow-up|0|||
156893288|NCT04177355|566368417|FG006|Overall Study|Lost to Follow-up|1|||
156893289|NCT04177355|566368418|FG007|Overall Study|Lost to Follow-up|0|||
156893290|NCT04177355|566368419|FG008|Overall Study|Lost to Follow-up|0|||
156893291|NCT04177355|566368420|FG009|Overall Study|Lost to Follow-up|0|||
156893292|NCT04177355|566368421|FG010|Overall Study|Lost to Follow-up|0|||
156893293|NCT04177355|566368411|FG000|Overall Study|Withdrawal by Subject|0|||
157157974|NCT05122650|567322915|FG000|Overall Study|Sponsor request|0|||
157157975|NCT05122650|567322916|FG001|Overall Study|Sponsor request|1|||
157157976|NCT05122650|567322917|FG002|Overall Study|Sponsor request|1|||
156893294|NCT04177355|566368412|FG001|Overall Study|Withdrawal by Subject|0|||
156893295|NCT04177355|566368413|FG002|Overall Study|Withdrawal by Subject|0|||
156893296|NCT04177355|566368414|FG003|Overall Study|Withdrawal by Subject|1|||
156893297|NCT04177355|566368415|FG004|Overall Study|Withdrawal by Subject|1|||
156893298|NCT04177355|566368416|FG005|Overall Study|Withdrawal by Subject|0|||
156893299|NCT04177355|566368417|FG006|Overall Study|Withdrawal by Subject|0|||
156893300|NCT04177355|566368418|FG007|Overall Study|Withdrawal by Subject|0|||
156893301|NCT04177355|566368419|FG008|Overall Study|Withdrawal by Subject|1|||
156893302|NCT04177355|566368420|FG009|Overall Study|Withdrawal by Subject|0|||
156893303|NCT04177355|566368421|FG010|Overall Study|Withdrawal by Subject|0|||
156893304|NCT03981822|566368422|FG000|Overall Study|Lost to Follow-up|0|||
156893305|NCT03981822|566368423|FG001|Overall Study|Lost to Follow-up|1|||
156893306|NCT03981822|566368424|FG002|Overall Study|Lost to Follow-up|1|||
156893307|NCT03981822|566368425|FG003|Overall Study|Lost to Follow-up|0|||
156893308|NCT03981822|566368426|FG004|Overall Study|Lost to Follow-up|6|||
157157977|NCT05122650|567322918|FG003|Overall Study|Sponsor request|2|||
157157978|NCT05122650|567322915|FG000|Overall Study|Withdrawal by Subject|3|||
156893309|NCT03981822|566368427|FG005|Overall Study|Lost to Follow-up|4|||
156893310|NCT03981822|566368428|FG006|Overall Study|Lost to Follow-up|4|||
157157979|NCT05122650|567322916|FG001|Overall Study|Withdrawal by Subject|7|||
157157980|NCT05122650|567322917|FG002|Overall Study|Withdrawal by Subject|4|||
157157981|NCT05122650|567322918|FG003|Overall Study|Withdrawal by Subject|8|||
157157982|NCT05122650|567322915|FG000|Overall Study|Other|5|||
157157983|NCT05122650|567322916|FG001|Overall Study|Other|0|||
157157984|NCT05122650|567322917|FG002|Overall Study|Other|0|||
157157985|NCT05122650|567322918|FG003|Overall Study|Other|0|||
157157986|NCT03609359|567322921|FG000|Overall Study|Progression of primary disease (PD)|25|||
157157987|NCT03609359|567322921|FG000|Overall Study|Patient's refusal|1|||
157157988|NCT03609359|567322921|FG000|Overall Study|Physician Decision|1|||
157157989|NCT03609359|567322921|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
156893311|NCT03981822|566368429|FG007|Overall Study|Lost to Follow-up|2|||
156893312|NCT03981822|566368422|FG000|Overall Study|Withdrawal by Subject|0|||
156893313|NCT03981822|566368423|FG001|Overall Study|Withdrawal by Subject|1|||
156893314|NCT03981822|566368424|FG002|Overall Study|Withdrawal by Subject|0|||
156893315|NCT03981822|566368425|FG003|Overall Study|Withdrawal by Subject|0|||
156893316|NCT03981822|566368426|FG004|Overall Study|Withdrawal by Subject|0|||
156893317|NCT03981822|566368427|FG005|Overall Study|Withdrawal by Subject|1|||
156893318|NCT03981822|566368428|FG006|Overall Study|Withdrawal by Subject|0|||
156893319|NCT03981822|566368429|FG007|Overall Study|Withdrawal by Subject|2|||
157026047|NCT05526430|566849707|FG001|Overall Study|Withdrawal by Subject|2|||
157157990|NCT00988559|567322923|FG000|Overall Study|Withdrawal by Subject|1|||
157157991|NCT00988559|567322924|FG001|Overall Study|Withdrawal by Subject|1|||
156893320|NCT03981822|566368422|FG000|Overall Study|COVID-19 Related|0|||
156893321|NCT03981822|566368423|FG001|Overall Study|COVID-19 Related|0|||
157157992|NCT00988559|567322925|FG002|Overall Study|Withdrawal by Subject|0|||
156893322|NCT03981822|566368424|FG002|Overall Study|COVID-19 Related|0|||
157157993|NCT00988559|567322926|FG003|Overall Study|Withdrawal by Subject|1|||
157157994|NCT00988559|567322923|FG000|Overall Study|Pregnancy|0|||
157157995|NCT00988559|567322924|FG001|Overall Study|Pregnancy|1|||
157157996|NCT00988559|567322925|FG002|Overall Study|Pregnancy|1|||
157157997|NCT00988559|567322926|FG003|Overall Study|Pregnancy|0|||
157157998|NCT00988559|567322923|FG000|Overall Study|Lost to Follow-up|0|||
157157999|NCT00988559|567322924|FG001|Overall Study|Lost to Follow-up|0|||
156857837|NCT01453049|566234647|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
156857838|NCT01453049|566234646|FG000|Overall Study|Withdrawal by Subject|1|||
156857839|NCT01453049|566234647|FG001|Overall Study|Withdrawal by Subject|0|||
156857840|NCT01453049|566234646|FG000|Overall Study|Randomized in Error|1|||
156857841|NCT01453049|566234647|FG001|Overall Study|Randomized in Error|0|||
156857842|NCT02421172|566234648|FG000|Period 1|Adverse Event|1|||
156857843|NCT02421172|566234649|FG001|Period 1|Adverse Event|0|||
156857844|NCT02421172|566234650|FG002|Period 1|Adverse Event|0|||
156857845|NCT02421172|566234651|FG003|Period 1|Adverse Event|0|||
156857846|NCT02421172|566234652|FG004|Period 1|Adverse Event|0|||
156857847|NCT02421172|566234648|FG000|Period 1|Lost to Follow-up|3|||
156857848|NCT02421172|566234649|FG001|Period 1|Lost to Follow-up|1|||
156857849|NCT02421172|566234650|FG002|Period 1|Lost to Follow-up|0|||
156857850|NCT02421172|566234651|FG003|Period 1|Lost to Follow-up|0|||
156857851|NCT02421172|566234652|FG004|Period 1|Lost to Follow-up|0|||
156857852|NCT02421172|566234648|FG000|Period 1|Patient/guardian decision|0|||
156857853|NCT02421172|566234649|FG001|Period 1|Patient/guardian decision|1|||
156857854|NCT02421172|566234650|FG002|Period 1|Patient/guardian decision|0|||
156857855|NCT02421172|566234651|FG003|Period 1|Patient/guardian decision|0|||
156857856|NCT02421172|566234652|FG004|Period 1|Patient/guardian decision|0|||
156857857|NCT02421172|566234648|FG000|Period 2|Adverse Event|0|||
156857858|NCT02421172|566234649|FG001|Period 2|Adverse Event|0|||
156857859|NCT02421172|566234650|FG002|Period 2|Adverse Event|4|||
156857860|NCT02421172|566234651|FG003|Period 2|Adverse Event|0|||
156857861|NCT02421172|566234652|FG004|Period 2|Adverse Event|0|||
156857862|NCT02421172|566234648|FG000|Period 2|Lost to Follow-up|0|||
156857863|NCT02421172|566234649|FG001|Period 2|Lost to Follow-up|0|||
156857864|NCT02421172|566234650|FG002|Period 2|Lost to Follow-up|0|||
156857865|NCT02421172|566234651|FG003|Period 2|Lost to Follow-up|1|||
156857866|NCT02421172|566234652|FG004|Period 2|Lost to Follow-up|0|||
156857867|NCT02421172|566234648|FG000|Period 2|Patient/guardian decision|0|||
156857868|NCT02421172|566234649|FG001|Period 2|Patient/guardian decision|0|||
156857869|NCT02421172|566234650|FG002|Period 2|Patient/guardian decision|3|||
156857870|NCT02421172|566234651|FG003|Period 2|Patient/guardian decision|2|||
156857871|NCT02421172|566234652|FG004|Period 2|Patient/guardian decision|1|||
156857872|NCT00928486|566234653|FG000|Overall Study|Adverse Event|2|||
156857873|NCT00928486|566234653|FG000|Overall Study|Disease Progression|7|||
156857874|NCT00928486|566234653|FG000|Overall Study|Withdrawal by Subject|1|||
156857875|NCT00683878|566234658|FG000|Overall Study|Lack of Efficacy|3|||
156857876|NCT00683878|566234659|FG001|Overall Study|Lack of Efficacy|0|||
156857877|NCT00683878|566234660|FG002|Overall Study|Lack of Efficacy|1|||
156857878|NCT00683878|566234658|FG000|Overall Study|Adverse Event|4|||
156857879|NCT00683878|566234659|FG001|Overall Study|Adverse Event|3|||
156857880|NCT00683878|566234660|FG002|Overall Study|Adverse Event|3|||
156857881|NCT00683878|566234658|FG000|Overall Study|Withdrawal by Subject|9|||
156857882|NCT00683878|566234659|FG001|Overall Study|Withdrawal by Subject|8|||
156857883|NCT00683878|566234660|FG002|Overall Study|Withdrawal by Subject|6|||
156857884|NCT00683878|566234658|FG000|Overall Study|Death|0|||
156857885|NCT00683878|566234659|FG001|Overall Study|Death|1|||
156857886|NCT00683878|566234660|FG002|Overall Study|Death|0|||
156857887|NCT00683878|566234658|FG000|Overall Study|Lost to Follow-up|4|||
156857888|NCT00683878|566234659|FG001|Overall Study|Lost to Follow-up|2|||
156893323|NCT03981822|566368425|FG003|Overall Study|COVID-19 Related|0|||
156857889|NCT00683878|566234660|FG002|Overall Study|Lost to Follow-up|4|||
156857890|NCT00683878|566234658|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
156857891|NCT00683878|566234659|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
156857892|NCT00683878|566234660|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
156857893|NCT04024891|566234661|FG000|Overall Study|Pregnancy|0|||
156857894|NCT04024891|566234662|FG001|Overall Study|Pregnancy|1|||
156857895|NCT03095651|566234670|FG000|Overall Study|Lost to Follow-up|1|||
156857896|NCT03095651|566234671|FG001|Overall Study|Lost to Follow-up|1|||
156893324|NCT03981822|566368426|FG004|Overall Study|COVID-19 Related|2|||
156857897|NCT03095651|566234672|FG002|Overall Study|Lost to Follow-up|0|||
156857898|NCT03095651|566234673|FG003|Overall Study|Lost to Follow-up|1|||
157158000|NCT00988559|567322925|FG002|Overall Study|Lost to Follow-up|1|||
157158001|NCT00988559|567322926|FG003|Overall Study|Lost to Follow-up|0|||
156857899|NCT03095651|566234674|FG004|Overall Study|Lost to Follow-up|0|||
156857900|NCT03095651|566234675|FG005|Overall Study|Lost to Follow-up|0|||
156857901|NCT03095651|566234676|FG006|Overall Study|Lost to Follow-up|0|||
156857902|NCT03095651|566234677|FG007|Overall Study|Lost to Follow-up|0|||
156857903|NCT03095651|566234670|FG000|Overall Study|Withdrawal by Subject|0|||
156857904|NCT03095651|566234671|FG001|Overall Study|Withdrawal by Subject|0|||
156857905|NCT03095651|566234672|FG002|Overall Study|Withdrawal by Subject|0|||
156893325|NCT03981822|566368427|FG005|Overall Study|COVID-19 Related|1|||
156893326|NCT03981822|566368428|FG006|Overall Study|COVID-19 Related|2|||
156893327|NCT03981822|566368429|FG007|Overall Study|COVID-19 Related|1|||
156893328|NCT02742246|566368430|FG000|Overall Study|Never initiated treatment|5|||
156893329|NCT02742246|566368431|FG001|Overall Study|Never initiated treatment|3|||
156893330|NCT02742246|566368432|FG002|Overall Study|Never initiated treatment|1|||
156893331|NCT02742246|566368430|FG000|Overall Study|dropped out during treatment|7|||
156893332|NCT02742246|566368431|FG001|Overall Study|dropped out during treatment|13|||
156893333|NCT02742246|566368432|FG002|Overall Study|dropped out during treatment|10|||
156893334|NCT02742246|566368430|FG000|Overall Study|Death|1|||
156893335|NCT02742246|566368431|FG001|Overall Study|Death|0|||
156893336|NCT02742246|566368432|FG002|Overall Study|Death|0|||
156893337|NCT00054717|566368434|FG000|Overall Study|Randomized but not treated|2|||
156893338|NCT00054717|566368435|FG001|Overall Study|Randomized but not treated|8|||
156893339|NCT00054717|566368434|FG000|Overall Study|Adverse Event|70|||
156893340|NCT00054717|566368435|FG001|Overall Study|Adverse Event|22|||
156893341|NCT00054717|566368434|FG000|Overall Study|Protocol Violation|18|||
156893342|NCT00054717|566368435|FG001|Overall Study|Protocol Violation|19|||
156893343|NCT00054717|566368434|FG000|Overall Study|Lost to Follow-up|23|||
156893344|NCT00054717|566368435|FG001|Overall Study|Lost to Follow-up|13|||
156893345|NCT00054717|566368434|FG000|Overall Study|Withdrawal by Subject|32|||
156893346|NCT00054717|566368435|FG001|Overall Study|Withdrawal by Subject|20|||
156893347|NCT00054717|566368434|FG000|Overall Study|Other reason not defined above|117|||
156893348|NCT00054717|566368435|FG001|Overall Study|Other reason not defined above|217|||
156893349|NCT05007717|566368438|FG000|Overall Study|Death|3|||
156893350|NCT05007717|566368439|FG001|Overall Study|Death|2|||
156893351|NCT01117051|566368446|FG000|Overall Study|Withdrawal by Subject|5|||
156893352|NCT01117051|566368447|FG001|Overall Study|Withdrawal by Subject|3|||
157026048|NCT05526430|566849708|FG002|Overall Study|Withdrawal by Subject|0|||
157026049|NCT05526430|566849709|FG003|Overall Study|Withdrawal by Subject|0|||
157026050|NCT03701763|566849710|FG000|Placebo-controlled Phase|Adverse Event|1|||
157026051|NCT03701763|566849711|FG001|Placebo-controlled Phase|Adverse Event|5|||
157026052|NCT03701763|566849712|FG002|Placebo-controlled Phase|Adverse Event|0|||
157026053|NCT03701763|566849713|FG003|Placebo-controlled Phase|Adverse Event|0|||
157026054|NCT03701763|566849710|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
157026055|NCT03701763|566849711|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
157026056|NCT03701763|566849712|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
157026057|NCT03701763|566849713|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
157026058|NCT03701763|566849710|FG000|Placebo-controlled Phase|Miscellaneous|2|||
157026059|NCT03701763|566849711|FG001|Placebo-controlled Phase|Miscellaneous|0|||
157026060|NCT03701763|566849712|FG002|Placebo-controlled Phase|Miscellaneous|0|||
157026061|NCT03701763|566849713|FG003|Placebo-controlled Phase|Miscellaneous|0|||
157026062|NCT03701763|566849710|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
157026063|NCT03701763|566849711|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
157026064|NCT03701763|566849712|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
157026065|NCT03701763|566849713|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
157026066|NCT03701763|566849710|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
157026067|NCT03701763|566849711|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
157026068|NCT03701763|566849712|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
157026069|NCT03701763|566849713|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
157026070|NCT03701763|566849710|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
157026071|NCT03701763|566849711|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
157026072|NCT03701763|566849712|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
157026073|NCT03701763|566849713|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
157026074|NCT03701763|566849710|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
157026075|NCT03701763|566849711|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
157026076|NCT03701763|566849712|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
157026077|NCT03701763|566849713|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
157026078|NCT03701763|566849710|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
157026079|NCT03701763|566849711|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
157026080|NCT03701763|566849712|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
157026081|NCT03701763|566849713|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
157026082|NCT03701763|566849710|FG000|Apremilast Extension Phase|Adverse Event|0|||
157026083|NCT03701763|566849711|FG001|Apremilast Extension Phase|Adverse Event|0|||
157026084|NCT03701763|566849712|FG002|Apremilast Extension Phase|Adverse Event|3|||
156893353|NCT01117051|566368446|FG000|Overall Study|Adverse Event|4|||
156893354|NCT01117051|566368447|FG001|Overall Study|Adverse Event|3|||
156893355|NCT01117051|566368446|FG000|Overall Study|Lost to Follow-up|0|||
156893356|NCT01117051|566368447|FG001|Overall Study|Lost to Follow-up|1|||
156893357|NCT01117051|566368446|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
156893358|NCT01117051|566368447|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
157026085|NCT03701763|566849713|FG003|Apremilast Extension Phase|Adverse Event|1|||
156893359|NCT01117051|566368446|FG000|Overall Study|Sponsor's decision|3|||
156893360|NCT01117051|566368447|FG001|Overall Study|Sponsor's decision|1|||
157026086|NCT03701763|566849710|FG000|Apremilast Extension Phase|Miscellaneous|0|||
156857906|NCT03095651|566234673|FG003|Overall Study|Withdrawal by Subject|0|||
156857907|NCT03095651|566234674|FG004|Overall Study|Withdrawal by Subject|0|||
156857908|NCT03095651|566234675|FG005|Overall Study|Withdrawal by Subject|1|||
156857909|NCT03095651|566234676|FG006|Overall Study|Withdrawal by Subject|0|||
156857910|NCT03095651|566234677|FG007|Overall Study|Withdrawal by Subject|0|||
156857911|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
156893361|NCT01117051|566368446|FG000|Overall Study|Surgical procedure|0|||
156893362|NCT01117051|566368447|FG001|Overall Study|Surgical procedure|1|||
156893363|NCT01117051|566368446|FG000|Overall Study|Randomized by mistake|0|||
156893364|NCT01117051|566368447|FG001|Overall Study|Randomized by mistake|1|||
156893365|NCT01117051|566368446|FG000|Overall Study|Convenience issue|1|||
156893366|NCT01117051|566368447|FG001|Overall Study|Convenience issue|0|||
156893367|NCT00427960|566368449|FG000|Overall Study|Adverse Event|2|||
156893368|NCT00427960|566368450|FG001|Overall Study|Adverse Event|0|||
156893369|NCT00427960|566368449|FG000|Overall Study|Withdrawal by Subject|0|||
156893370|NCT00427960|566368450|FG001|Overall Study|Withdrawal by Subject|3|||
156893371|NCT00427960|566368449|FG000|Overall Study|Other|0|||
156893372|NCT00427960|566368450|FG001|Overall Study|Other|1|||
156893373|NCT01142128|566368451|FG000|Overall Study|Physician Decision|1|||
156893374|NCT01142128|566368451|FG000|Overall Study|Lost to Follow-up|1|||
156893375|NCT01142128|566368451|FG000|Overall Study|Withdrawal by Subject|2|||
156893376|NCT03355664|566368452|FG000|Overall Study|Adverse Event|1|||
156893377|NCT03355664|566368453|FG001|Overall Study|Adverse Event|2|||
156893378|NCT03355664|566368452|FG000|Overall Study|Lost to Follow-up|11|||
156893379|NCT03355664|566368453|FG001|Overall Study|Lost to Follow-up|7|||
156893380|NCT03355664|566368452|FG000|Overall Study|Protocol Violation|1|||
156893381|NCT03355664|566368453|FG001|Overall Study|Protocol Violation|2|||
156893382|NCT03355664|566368452|FG000|Overall Study|Withdrawal by Subject|2|||
156893383|NCT03355664|566368453|FG001|Overall Study|Withdrawal by Subject|1|||
156893384|NCT03823378|566368457|FG000|Overall Study|Adverse Event|2|||
156893385|NCT03823378|566368458|FG001|Overall Study|Adverse Event|2|||
156893386|NCT03823378|566368459|FG002|Overall Study|Adverse Event|0|||
156893387|NCT03823378|566368460|FG003|Overall Study|Adverse Event|0|||
156893388|NCT03823378|566368461|FG004|Overall Study|Adverse Event|0|||
156893389|NCT03823378|566368462|FG005|Overall Study|Adverse Event|0|||
156893390|NCT03823378|566368457|FG000|Overall Study|Lost to Follow-up|0|||
156893391|NCT03823378|566368458|FG001|Overall Study|Lost to Follow-up|1|||
156893392|NCT03823378|566368459|FG002|Overall Study|Lost to Follow-up|0|||
156893393|NCT03823378|566368460|FG003|Overall Study|Lost to Follow-up|0|||
156893394|NCT03823378|566368461|FG004|Overall Study|Lost to Follow-up|1|||
156893395|NCT03823378|566368462|FG005|Overall Study|Lost to Follow-up|0|||
156893396|NCT03823378|566368457|FG000|Overall Study|Withdrawal by Subject|0|||
156893397|NCT03823378|566368458|FG001|Overall Study|Withdrawal by Subject|1|||
156893398|NCT03823378|566368459|FG002|Overall Study|Withdrawal by Subject|4|||
156893399|NCT03823378|566368460|FG003|Overall Study|Withdrawal by Subject|2|||
156893400|NCT03823378|566368461|FG004|Overall Study|Withdrawal by Subject|0|||
156893401|NCT03823378|566368462|FG005|Overall Study|Withdrawal by Subject|1|||
156893402|NCT03823378|566368457|FG000|Overall Study|Other, not specified|19|||
156893403|NCT03823378|566368458|FG001|Overall Study|Other, not specified|12|||
156893404|NCT03823378|566368459|FG002|Overall Study|Other, not specified|6|||
156893405|NCT03823378|566368460|FG003|Overall Study|Other, not specified|8|||
156893406|NCT03823378|566368461|FG004|Overall Study|Other, not specified|17|||
156857912|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
156857913|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
156857914|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
156857915|NCT02891174|566234678|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
156857916|NCT02891174|566234679|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
156857917|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
156893407|NCT03823378|566368462|FG005|Overall Study|Other, not specified|7|||
156893408|NCT04163718|566368463|FG000|Overall Study|Study terminated|12|||
156893409|NCT01606254|566368464|FG000|Overall Study|Withdrawal by Subject|1|||
156893410|NCT01606254|566368465|FG001|Overall Study|Withdrawal by Subject|3|||
156893411|NCT01606254|566368466|FG002|Overall Study|Withdrawal by Subject|0|||
156893412|NCT01606254|566368467|FG003|Overall Study|Withdrawal by Subject|2|||
156893413|NCT01606254|566368464|FG000|Overall Study|Adverse Event|1|||
156893414|NCT01606254|566368465|FG001|Overall Study|Adverse Event|1|||
156893415|NCT01606254|566368466|FG002|Overall Study|Adverse Event|0|||
156893416|NCT01606254|566368467|FG003|Overall Study|Adverse Event|1|||
156893417|NCT04543409|566368473|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156893418|NCT04543409|566368474|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
156893419|NCT04543409|566368473|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
156893420|NCT04543409|566368474|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
156893421|NCT04543409|566368473|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
156857918|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
156893422|NCT04543409|566368474|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
156893423|NCT04543409|566368473|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
156893424|NCT04543409|566368474|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
156893425|NCT04543409|566368473|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
156893426|NCT04543409|566368474|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
156893427|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
156893428|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
156893429|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
156893430|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
156893431|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
156893432|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
156893433|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
156893434|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
156893435|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
156893436|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
156893437|NCT04543409|566368473|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
156893438|NCT04543409|566368474|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
156893439|NCT01289782|566368475|FG000|Overall Study|Lost to Follow-up|14|||
156893440|NCT01289782|566368476|FG001|Overall Study|Lost to Follow-up|7|||
156893441|NCT01289782|566368475|FG000|Overall Study|Protocol Violation|1|||
156893442|NCT01289782|566368476|FG001|Overall Study|Protocol Violation|1|||
156893443|NCT01289782|566368475|FG000|Overall Study|Withdrawal by Subject|8|||
156893444|NCT01289782|566368476|FG001|Overall Study|Withdrawal by Subject|2|||
156893445|NCT01289782|566368475|FG000|Overall Study|Sponsor's Decision|1|||
156893446|NCT01289782|566368476|FG001|Overall Study|Sponsor's Decision|0|||
156893447|NCT01289782|566368475|FG000|Overall Study|Reason not specified|1|||
156893448|NCT01289782|566368476|FG001|Overall Study|Reason not specified|2|||
156893449|NCT02131532|566368477|FG000|Overall Study|Withdrawal by Subject|1|||
156893450|NCT02131532|566368477|FG000|Overall Study|Physician Decision|1|||
156893451|NCT02131532|566368477|FG000|Overall Study|Other health conditions|2|||
156893452|NCT02093026|566368478|FG000|Overall Study|Adverse Event|26|||
156893453|NCT02093026|566368478|FG000|Overall Study|Death|10|||
156893454|NCT02093026|566368478|FG000|Overall Study|Other|157|||
156893455|NCT02195011|566368488|FG000|Overall Study|Adverse Event|4|||
156893456|NCT02195011|566368489|FG001|Overall Study|Adverse Event|0|||
156893457|NCT02195011|566368488|FG000|Overall Study|Progressive Disease|18|||
156893458|NCT02195011|566368489|FG001|Overall Study|Progressive Disease|1|||
156893459|NCT02195011|566368488|FG000|Overall Study|Withdrawal by Subject|3|||
156893460|NCT02195011|566368489|FG001|Overall Study|Withdrawal by Subject|0|||
156893461|NCT03170232|566368494|FG000|Overall Study|Adverse Event|0|||
156893462|NCT03170232|566368495|FG001|Overall Study|Adverse Event|1|||
156893463|NCT03170232|566368494|FG000|Overall Study|Protocol Violation|0|||
156893464|NCT03170232|566368495|FG001|Overall Study|Protocol Violation|1|||
156893465|NCT03170232|566368494|FG000|Overall Study|Lack of Efficacy|0|||
156893466|NCT03170232|566368495|FG001|Overall Study|Lack of Efficacy|1|||
156893467|NCT03170232|566368494|FG000|Overall Study|Study closed/terminated|26|||
156893468|NCT03170232|566368495|FG001|Overall Study|Study closed/terminated|23|||
156893469|NCT03170232|566368494|FG000|Overall Study|Lost to Follow-up|1|||
156893470|NCT03170232|566368495|FG001|Overall Study|Lost to Follow-up|0|||
156893471|NCT03170232|566368494|FG000|Overall Study|Withdrawal by Subject|0|||
156893472|NCT03170232|566368495|FG001|Overall Study|Withdrawal by Subject|1|||
156893473|NCT01056380|566368496|FG000|Overall Study|Lost to Follow-up|2|||
156893474|NCT01056380|566368497|FG001|Overall Study|Lost to Follow-up|3|||
156893475|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
156893476|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
156893477|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
156893478|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
156893479|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
156893480|NCT00586326|566368498|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
156893481|NCT00586326|566368498|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
157158002|NCT05372575|567322927|FG000|Overall Study|Protocol Violation|7|||
157158003|NCT05372575|567322928|FG001|Overall Study|Protocol Violation|16|||
157158004|NCT00829166|567322929|FG000|Overall Study|Death|305|||
157158005|NCT00829166|567322930|FG001|Overall Study|Death|333|||
157158006|NCT00829166|567322929|FG000|Overall Study|Lost to Follow-up|5|||
157158007|NCT00829166|567322930|FG001|Overall Study|Lost to Follow-up|4|||
157158008|NCT00829166|567322929|FG000|Overall Study|Physician's Decision|4|||
157158009|NCT00829166|567322930|FG001|Overall Study|Physician's Decision|3|||
157158010|NCT00829166|567322929|FG000|Overall Study|Subject's Decision|41|||
157158011|NCT00829166|567322930|FG001|Overall Study|Subject's Decision|55|||
157158012|NCT00829166|567322929|FG000|Overall Study|Sponsor's Decision|137|||
157158013|NCT00829166|567322930|FG001|Overall Study|Sponsor's Decision|98|||
157158014|NCT00829166|567322929|FG000|Overall Study|Reason Not Specified|3|||
157158015|NCT00829166|567322930|FG001|Overall Study|Reason Not Specified|3|||
157158016|NCT03510663|567322931|FG000|Overall Study|Withdrawal by Subject|0|||
157158017|NCT03510663|567322932|FG001|Overall Study|Withdrawal by Subject|1|||
157158018|NCT03510663|567322933|FG002|Overall Study|Withdrawal by Subject|0|||
157158019|NCT03510663|567322934|FG003|Overall Study|Withdrawal by Subject|0|||
157158020|NCT03510663|567322935|FG004|Overall Study|Withdrawal by Subject|0|||
157158021|NCT03510663|567322936|FG005|Overall Study|Withdrawal by Subject|0|||
157158022|NCT03510663|567322937|FG006|Overall Study|Withdrawal by Subject|0|||
157158023|NCT03510663|567322938|FG007|Overall Study|Withdrawal by Subject|0|||
157158024|NCT02761993|567322943|FG000|Overall Study|Adverse Event|0|||
157158025|NCT02761993|567322944|FG001|Overall Study|Adverse Event|2|||
157158026|NCT02761993|567322945|FG002|Overall Study|Adverse Event|0|||
157158027|NCT02761993|567322943|FG000|Overall Study|Lost to Follow-up|1|||
156893482|NCT00586326|566368498|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
156893483|NCT00586326|566368498|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
156893484|NCT00586326|566368498|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
156893485|NCT00586326|566368498|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
156893486|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
156893487|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
156893488|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
156893489|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
156893490|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
156893491|NCT00586326|566368498|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
156893492|NCT02953509|566368499|FG000|Overall Study|Death|1|||
156893493|NCT02953509|566368500|FG001|Overall Study|Death|3|||
156893494|NCT02953509|566368501|FG002|Overall Study|Death|3|||
156893495|NCT02953509|566368502|FG003|Overall Study|Death|4|||
156893496|NCT02953509|566368503|FG004|Overall Study|Death|12|||
156893497|NCT02953509|566368504|FG005|Overall Study|Death|3|||
156893498|NCT02953509|566368505|FG006|Overall Study|Death|25|||
156893499|NCT02953509|566368506|FG007|Overall Study|Death|10|||
156893500|NCT02953509|566368507|FG008|Overall Study|Death|21|||
156893501|NCT02953509|566368508|FG009|Overall Study|Death|20|||
156893502|NCT02953509|566368499|FG000|Overall Study|Reason Not Specified|0|||
156893503|NCT02953509|566368500|FG001|Overall Study|Reason Not Specified|2|||
156893504|NCT02953509|566368501|FG002|Overall Study|Reason Not Specified|8|||
156893505|NCT02953509|566368502|FG003|Overall Study|Reason Not Specified|2|||
156893506|NCT02953509|566368503|FG004|Overall Study|Reason Not Specified|11|||
156893507|NCT02953509|566368504|FG005|Overall Study|Reason Not Specified|4|||
156893508|NCT02953509|566368505|FG006|Overall Study|Reason Not Specified|12|||
156893509|NCT02953509|566368506|FG007|Overall Study|Reason Not Specified|2|||
156893510|NCT02953509|566368507|FG008|Overall Study|Reason Not Specified|7|||
156893511|NCT02953509|566368508|FG009|Overall Study|Reason Not Specified|2|||
156893512|NCT02953509|566368499|FG000|Overall Study|Consent Withdrawn|1|||
156893513|NCT02953509|566368500|FG001|Overall Study|Consent Withdrawn|1|||
156893514|NCT02953509|566368501|FG002|Overall Study|Consent Withdrawn|2|||
156893515|NCT02953509|566368502|FG003|Overall Study|Consent Withdrawn|1|||
156893516|NCT02953509|566368503|FG004|Overall Study|Consent Withdrawn|3|||
156893517|NCT02953509|566368504|FG005|Overall Study|Consent Withdrawn|0|||
156893518|NCT02953509|566368505|FG006|Overall Study|Consent Withdrawn|4|||
156893519|NCT02953509|566368506|FG007|Overall Study|Consent Withdrawn|1|||
156893520|NCT02953509|566368507|FG008|Overall Study|Consent Withdrawn|1|||
156893521|NCT02953509|566368508|FG009|Overall Study|Consent Withdrawn|4|||
156893522|NCT02953509|566368499|FG000|Overall Study|Lost to Follow-up|0|||
156893523|NCT02953509|566368500|FG001|Overall Study|Lost to Follow-up|0|||
156893524|NCT02953509|566368501|FG002|Overall Study|Lost to Follow-up|0|||
156893525|NCT02953509|566368502|FG003|Overall Study|Lost to Follow-up|0|||
156893526|NCT02953509|566368503|FG004|Overall Study|Lost to Follow-up|0|||
156893527|NCT02953509|566368504|FG005|Overall Study|Lost to Follow-up|0|||
156893528|NCT02953509|566368505|FG006|Overall Study|Lost to Follow-up|1|||
156893529|NCT02953509|566368506|FG007|Overall Study|Lost to Follow-up|1|||
156893530|NCT02953509|566368507|FG008|Overall Study|Lost to Follow-up|1|||
156893531|NCT02953509|566368508|FG009|Overall Study|Lost to Follow-up|1|||
156893532|NCT02953509|566368499|FG000|Overall Study|Study terminated by sponsor|1|||
156893533|NCT02953509|566368500|FG001|Overall Study|Study terminated by sponsor|0|||
156893534|NCT02953509|566368501|FG002|Overall Study|Study terminated by sponsor|0|||
156893535|NCT02953509|566368502|FG003|Overall Study|Study terminated by sponsor|0|||
156893536|NCT02953509|566368503|FG004|Overall Study|Study terminated by sponsor|0|||
156893537|NCT02953509|566368504|FG005|Overall Study|Study terminated by sponsor|0|||
156893538|NCT02953509|566368505|FG006|Overall Study|Study terminated by sponsor|1|||
156893539|NCT02953509|566368506|FG007|Overall Study|Study terminated by sponsor|0|||
156893540|NCT02953509|566368507|FG008|Overall Study|Study terminated by sponsor|1|||
156893541|NCT02953509|566368508|FG009|Overall Study|Study terminated by sponsor|1|||
157158028|NCT02761993|567322944|FG001|Overall Study|Lost to Follow-up|3|||
156893542|NCT01856023|566368509|FG000|Overall Study|Death|1|||
156893543|NCT01856023|566368510|FG001|Overall Study|Death|2|||
156893544|NCT01856023|566368509|FG000|Overall Study|Adverse Event|2|||
156893545|NCT01856023|566368510|FG001|Overall Study|Adverse Event|1|||
156893546|NCT01856023|566368509|FG000|Overall Study|Lack of Efficacy|5|||
156893547|NCT01856023|566368510|FG001|Overall Study|Lack of Efficacy|5|||
156893548|NCT01856023|566368509|FG000|Overall Study|non compliance, study closure|1|||
156893549|NCT01856023|566368510|FG001|Overall Study|non compliance, study closure|3|||
156893550|NCT01856023|566368509|FG000|Overall Study|Withdrawal by Subject|1|||
156893551|NCT01856023|566368510|FG001|Overall Study|Withdrawal by Subject|1|||
156893552|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
156893553|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
156893554|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
156893555|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
156893556|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
156893557|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
156893558|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
156893559|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
156893560|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
156893561|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
156893562|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
156893563|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
156893564|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
156893565|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
156893566|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
156893567|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
156893568|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
156893569|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
156893570|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
156893571|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
156893572|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
156893573|NCT02431247|566368511|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
156893574|NCT02431247|566368512|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
156893575|NCT02431247|566368513|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
156893576|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156893577|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
156893578|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
156893579|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156893580|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
156893581|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
156893582|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156893583|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
156893584|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
156893585|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156893586|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
156893587|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
156893588|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156893589|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
156893590|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
156893591|NCT02431247|566368511|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156893592|NCT02431247|566368512|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
156893593|NCT02431247|566368513|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
156893594|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
156893595|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
156893596|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
156893597|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
156893598|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
156893599|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
156893600|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
156893601|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
156893602|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
156893603|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156893604|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156893605|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
156893606|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
156893607|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
157026087|NCT03701763|566849711|FG001|Apremilast Extension Phase|Miscellaneous|0|||
157026088|NCT03701763|566849712|FG002|Apremilast Extension Phase|Miscellaneous|2|||
157026089|NCT03701763|566849713|FG003|Apremilast Extension Phase|Miscellaneous|1|||
156893608|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
156893609|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
156893610|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
156893611|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
157158029|NCT02761993|567322945|FG002|Overall Study|Lost to Follow-up|2|||
157158030|NCT02761993|567322943|FG000|Overall Study|Withdrawal by Subject|1|||
157158031|NCT02761993|567322944|FG001|Overall Study|Withdrawal by Subject|1|||
157158032|NCT02761993|567322945|FG002|Overall Study|Withdrawal by Subject|2|||
157158033|NCT01465178|567322946|FG000|Overall Study|Withdrawal by Subject|1|||
156857919|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
156857920|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
156857921|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
156857922|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
156857923|NCT02891174|566234678|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
156857924|NCT02891174|566234679|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
156857925|NCT02250326|566234687|FG000|Treatment|Death|1|||
156857926|NCT02250326|566234688|FG001|Treatment|Death|13|||
156857927|NCT02250326|566234689|FG002|Treatment|Death|2|||
156857928|NCT02250326|566234687|FG000|Treatment|Adverse Event|8|||
156857929|NCT02250326|566234688|FG001|Treatment|Adverse Event|8|||
156857930|NCT02250326|566234689|FG002|Treatment|Adverse Event|9|||
156857931|NCT02250326|566234687|FG000|Treatment|Progressive Disease|42|||
156857932|NCT02250326|566234688|FG001|Treatment|Progressive Disease|40|||
156857933|NCT02250326|566234689|FG002|Treatment|Progressive Disease|47|||
156857934|NCT02250326|566234687|FG000|Treatment|Symptomatic Deterioration|9|||
156857935|NCT02250326|566234688|FG001|Treatment|Symptomatic Deterioration|4|||
156857936|NCT02250326|566234689|FG002|Treatment|Symptomatic Deterioration|10|||
156857937|NCT02250326|566234687|FG000|Treatment|Withdrawal by Subject|11|||
156857938|NCT02250326|566234688|FG001|Treatment|Withdrawal by Subject|6|||
156857939|NCT02250326|566234689|FG002|Treatment|Withdrawal by Subject|4|||
156857940|NCT02250326|566234687|FG000|Treatment|Other reasons|8|||
156857941|NCT02250326|566234688|FG001|Treatment|Other reasons|7|||
156857942|NCT02250326|566234689|FG002|Treatment|Other reasons|7|||
156857943|NCT02250326|566234687|FG000|Extension Period|Progressive Disease|0|||
156857944|NCT02250326|566234688|FG001|Extension Period|Progressive Disease|2|||
156857945|NCT02250326|566234689|FG002|Extension Period|Progressive Disease|0|||
156857946|NCT02250326|566234687|FG000|Extension Period|Withdrawal by Subject|0|||
156857947|NCT02250326|566234688|FG001|Extension Period|Withdrawal by Subject|1|||
156857948|NCT02250326|566234689|FG002|Extension Period|Withdrawal by Subject|0|||
156857949|NCT02250326|566234687|FG000|Extension Period|Withdrawal by investigator|0|||
156857950|NCT02250326|566234688|FG001|Extension Period|Withdrawal by investigator|1|||
156857951|NCT02250326|566234689|FG002|Extension Period|Withdrawal by investigator|0|||
156857952|NCT01693029|566234690|FG000|Overall Study|Withdrawal by Subject|15|||
156857953|NCT01693029|566234691|FG001|Overall Study|Withdrawal by Subject|22|||
156857954|NCT01693029|566234690|FG000|Overall Study|Kidney transplantation|7|||
156857955|NCT01693029|566234691|FG001|Overall Study|Kidney transplantation|7|||
156857956|NCT01693029|566234690|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
156857957|NCT01693029|566234691|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
156857958|NCT01693029|566234690|FG000|Overall Study|Protocol Violation|6|||
156857959|NCT01693029|566234691|FG001|Overall Study|Protocol Violation|7|||
156857960|NCT01693029|566234690|FG000|Overall Study|Change in dialysis modality|2|||
156857961|NCT01693029|566234691|FG001|Overall Study|Change in dialysis modality|1|||
156857962|NCT01693029|566234690|FG000|Overall Study|Physician Decision|0|||
156857963|NCT01693029|566234691|FG001|Overall Study|Physician Decision|2|||
156857964|NCT01693029|566234690|FG000|Overall Study|Lost to Follow-up|0|||
156857965|NCT01693029|566234691|FG001|Overall Study|Lost to Follow-up|1|||
156857966|NCT01693029|566234690|FG000|Overall Study|Adverse Event|1|||
156857967|NCT01693029|566234691|FG001|Overall Study|Adverse Event|6|||
156857968|NCT01693029|566234690|FG000|Overall Study|Death|5|||
156857969|NCT01693029|566234691|FG001|Overall Study|Death|8|||
156857970|NCT01693029|566234690|FG000|Overall Study|Non-compliance|2|||
156857971|NCT01693029|566234691|FG001|Overall Study|Non-compliance|1|||
156857972|NCT05801991|566234692|FG000|Overall Study|Lost to Follow-up|1|||
156857973|NCT05801991|566234693|FG001|Overall Study|Lost to Follow-up|0|||
156857974|NCT01451723|566234694|FG000|Overall Study|study halted|6|||
156857975|NCT01451723|566234695|FG001|Overall Study|study halted|5|||
156857976|NCT00833040|566234696|FG000|Overall Study|Adverse Event|0|||
156857977|NCT00833040|566234697|FG001|Overall Study|Adverse Event|0|||
156857978|NCT00833040|566234698|FG002|Overall Study|Adverse Event|0|||
156857979|NCT00833040|566234699|FG003|Overall Study|Adverse Event|0|||
156857980|NCT00833040|566234700|FG004|Overall Study|Adverse Event|0|||
156857981|NCT00833040|566234701|FG005|Overall Study|Adverse Event|1|||
156857982|NCT03489863|566234706|FG000|Overall Study|Withdrawal by Subject|0|||
156857983|NCT03489863|566234707|FG001|Overall Study|Withdrawal by Subject|1|||
156857984|NCT05196828|566234710|FG000|Overall Study|Withdrawal by Subject|2|||
156857985|NCT05196828|566234711|FG001|Overall Study|Withdrawal by Subject|0|||
156857986|NCT05196828|566234710|FG000|Overall Study|Lost to Follow-up|0|||
156857987|NCT05196828|566234711|FG001|Overall Study|Lost to Follow-up|4|||
156857988|NCT05196828|566234710|FG000|Overall Study|Adverse Event|1|||
156857989|NCT05196828|566234711|FG001|Overall Study|Adverse Event|0|||
157158034|NCT01465178|567322947|FG001|Overall Study|Withdrawal by Subject|0|||
157158035|NCT02993224|567322950|FG000|Core Phase - Period 1|Adverse Event|4|||
156893612|NCT00591578|566368514|FG000|Double-Blind Treatment Phase|Other|4|||
156893613|NCT00591578|566368515|FG001|Double-Blind Treatment Phase|Other|9|||
156893614|NCT00591578|566368516|FG002|Double-Blind Treatment Phase|Other|4|||
156893615|NCT00591578|566368514|FG000|Open-Label Extension Phase|Adverse Event|3|||
156893616|NCT00591578|566368515|FG001|Open-Label Extension Phase|Adverse Event|5|||
156893617|NCT00591578|566368516|FG002|Open-Label Extension Phase|Adverse Event|0|||
156893618|NCT00591578|566368514|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
156893619|NCT00591578|566368515|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
156893620|NCT00591578|566368516|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156893621|NCT00591578|566368514|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
156893622|NCT00591578|566368515|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
156893623|NCT00591578|566368516|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
156893624|NCT00591578|566368514|FG000|Open-Label Extension Phase|Other|1|||
156893625|NCT00591578|566368515|FG001|Open-Label Extension Phase|Other|0|||
156893626|NCT00591578|566368516|FG002|Open-Label Extension Phase|Other|0|||
156893627|NCT00473746|566368518|FG000|Period 1 (Phase 1)|Adverse Event|1|||
156893628|NCT00473746|566368519|FG001|Period 1 (Phase 1)|Adverse Event|0|||
156893629|NCT00473746|566368520|FG002|Period 1 (Phase 1)|Adverse Event|0|||
156893630|NCT00473746|566368521|FG003|Period 1 (Phase 1)|Adverse Event|0|||
156893631|NCT00473746|566368522|FG004|Period 1 (Phase 1)|Adverse Event|0|||
156893632|NCT00473746|566368518|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156893633|NCT00473746|566368519|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
156893634|NCT00473746|566368520|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156893635|NCT00473746|566368521|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156893636|NCT00473746|566368522|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
156893637|NCT00473746|566368518|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
156893638|NCT00473746|566368519|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
156893639|NCT00473746|566368520|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
156893640|NCT00473746|566368521|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
156893641|NCT00473746|566368522|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
156893642|NCT00473746|566368518|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156893643|NCT00473746|566368519|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
156893644|NCT00473746|566368520|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156893645|NCT00473746|566368521|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156893646|NCT00473746|566368522|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
156893647|NCT00473746|566368518|FG000|Period 1 (Phase 1)|Reason not specified|0|||
156893648|NCT00473746|566368519|FG001|Period 1 (Phase 1)|Reason not specified|1|||
156893649|NCT00473746|566368520|FG002|Period 1 (Phase 1)|Reason not specified|0|||
156893650|NCT00473746|566368521|FG003|Period 1 (Phase 1)|Reason not specified|0|||
156893651|NCT00473746|566368522|FG004|Period 1 (Phase 1)|Reason not specified|0|||
156893652|NCT00473746|566368518|FG000|Period 2 (Phase 2)|Adverse Event|0|||
156893653|NCT00473746|566368519|FG001|Period 2 (Phase 2)|Adverse Event|0|||
156893654|NCT00473746|566368520|FG002|Period 2 (Phase 2)|Adverse Event|0|||
156893655|NCT00473746|566368521|FG003|Period 2 (Phase 2)|Adverse Event|0|||
156893656|NCT00473746|566368522|FG004|Period 2 (Phase 2)|Adverse Event|3|||
156893657|NCT00473746|566368518|FG000|Period 2 (Phase 2)|Death|0|||
156893658|NCT00473746|566368519|FG001|Period 2 (Phase 2)|Death|0|||
156893659|NCT00473746|566368520|FG002|Period 2 (Phase 2)|Death|0|||
156893660|NCT00473746|566368521|FG003|Period 2 (Phase 2)|Death|0|||
156893661|NCT00473746|566368522|FG004|Period 2 (Phase 2)|Death|1|||
156893662|NCT00473746|566368518|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
156893663|NCT00473746|566368519|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
156893664|NCT00473746|566368520|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
156893665|NCT00473746|566368521|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
156893666|NCT00473746|566368522|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
156893667|NCT00473746|566368518|FG000|Period 2 (Phase 2)|Reason not specified|0|||
156893668|NCT00473746|566368519|FG001|Period 2 (Phase 2)|Reason not specified|0|||
156893669|NCT00473746|566368520|FG002|Period 2 (Phase 2)|Reason not specified|0|||
156893670|NCT00473746|566368521|FG003|Period 2 (Phase 2)|Reason not specified|0|||
156893671|NCT00473746|566368522|FG004|Period 2 (Phase 2)|Reason not specified|3|||
156893672|NCT00782795|566368523|FG000|Overall Study|Withdrawal by Subject|1|||
156893673|NCT00782795|566368524|FG001|Overall Study|Withdrawal by Subject|2|||
156893674|NCT03693170|566370235|FG000|Overall Study|Disease Progression|48|||
156893675|NCT03693170|566370235|FG000|Overall Study|Adverse Event|16|||
156893676|NCT03693170|566370235|FG000|Overall Study|Physician Decision|6|||
156893677|NCT03693170|566370235|FG000|Overall Study|Protocol Violation|2|||
156893678|NCT03693170|566370235|FG000|Overall Study|Death|1|||
156893679|NCT03693170|566370235|FG000|Overall Study|Non compliance with study drug|1|||
156893680|NCT03693170|566370235|FG000|Overall Study|Withdrawal by Subject|1|||
156893681|NCT04444895|566370236|FG000|Overall Study|Adverse Event|2|||
156893682|NCT04444895|566370236|FG000|Overall Study|Lost to Follow-up|2|||
156893683|NCT04444895|566370236|FG000|Overall Study|Withdrawal by Subject|5|||
156893684|NCT05523323|566370237|FG000|Overall Study|Death|26|||
156893685|NCT05523323|566370238|FG001|Overall Study|Death|21|||
156893686|NCT05523323|566370237|FG000|Overall Study|Ongoing participants|35|||
156893687|NCT05523323|566370238|FG001|Overall Study|Ongoing participants|30|||
156893688|NCT00920829|566370239|FG000|Allocation|No post randomization data|3|||
156893689|NCT00920829|566370240|FG001|Allocation|No post randomization data|1|||
156893690|NCT00920829|566370241|FG002|Allocation|No post randomization data|0|||
156893691|NCT00920829|566370242|FG003|Allocation|No post randomization data|2|||
156893692|NCT00920829|566370239|FG000|Available for Analysis|Withdrawal by Subject|6|||
156893693|NCT00920829|566370240|FG001|Available for Analysis|Withdrawal by Subject|6|||
156893694|NCT00920829|566370241|FG002|Available for Analysis|Withdrawal by Subject|6|||
156893695|NCT00920829|566370242|FG003|Available for Analysis|Withdrawal by Subject|10|||
156893696|NCT00920829|566370239|FG000|Available for Analysis|Required Medical Treatment|0|||
156893697|NCT00920829|566370240|FG001|Available for Analysis|Required Medical Treatment|1|||
156893698|NCT00920829|566370241|FG002|Available for Analysis|Required Medical Treatment|2|||
156893699|NCT00920829|566370242|FG003|Available for Analysis|Required Medical Treatment|0|||
156893700|NCT00920829|566370239|FG000|Available for Analysis|Adverse Event|1|||
156893701|NCT00920829|566370240|FG001|Available for Analysis|Adverse Event|2|||
156893702|NCT00920829|566370241|FG002|Available for Analysis|Adverse Event|1|||
156893703|NCT00920829|566370242|FG003|Available for Analysis|Adverse Event|0|||
156893704|NCT00920829|566370239|FG000|Available for Analysis|Death|1|||
156893705|NCT00920829|566370240|FG001|Available for Analysis|Death|0|||
156893706|NCT00920829|566370241|FG002|Available for Analysis|Death|0|||
156893707|NCT00920829|566370242|FG003|Available for Analysis|Death|0|||
156893708|NCT00920829|566370239|FG000|Available for Analysis|Protocol Violation|0|||
156893709|NCT00920829|566370240|FG001|Available for Analysis|Protocol Violation|0|||
156893710|NCT00920829|566370241|FG002|Available for Analysis|Protocol Violation|1|||
156893711|NCT00920829|566370242|FG003|Available for Analysis|Protocol Violation|0|||
156893712|NCT00920829|566370239|FG000|Available for Analysis|Required more treatment|0|||
156893713|NCT00920829|566370240|FG001|Available for Analysis|Required more treatment|2|||
156893714|NCT00920829|566370241|FG002|Available for Analysis|Required more treatment|0|||
156893715|NCT00920829|566370242|FG003|Available for Analysis|Required more treatment|1|||
156893716|NCT00053365|566370245|FG000|Overall Study|Incorrect cell type|1|||
156893717|NCT00053365|566370245|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
156893718|NCT00053365|566370245|FG000|Overall Study|Never treated|4|||
156893719|NCT02423109|566370254|FG000|Lens 1|Adverse Event|1|||
156893720|NCT02423109|566370255|FG001|Lens 1|Adverse Event|0|||
156893721|NCT03347188|566370256|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
156893722|NCT03347188|566370257|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
156893723|NCT03347188|566370256|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
156893724|NCT03347188|566370257|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
156893725|NCT03347188|566370256|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
156893726|NCT03347188|566370257|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
156893727|NCT03347188|566370256|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
156893728|NCT03347188|566370257|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
156893729|NCT03347188|566370256|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
156893730|NCT03347188|566370257|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
156893731|NCT03347188|566370256|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
156893732|NCT03347188|566370257|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
156893733|NCT03347188|566370256|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
156893734|NCT03347188|566370257|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
156893735|NCT03347188|566370256|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
156893736|NCT03347188|566370257|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
156893737|NCT03489551|566370258|FG000|Overall Study|Withdrawal by Subject|2|||
156893738|NCT03139604|566370259|FG000|Overall Study|Other|7|||
156893739|NCT03139604|566370260|FG001|Overall Study|Other|3|||
156893740|NCT03139604|566370259|FG000|Overall Study|Withdrawal by Subject|16|||
156893741|NCT03139604|566370260|FG001|Overall Study|Withdrawal by Subject|17|||
156893742|NCT03139604|566370259|FG000|Overall Study|Physician Decision|1|||
156893743|NCT03139604|566370260|FG001|Overall Study|Physician Decision|2|||
156893744|NCT03139604|566370259|FG000|Overall Study|Lost to Follow-up|3|||
156893745|NCT03139604|566370260|FG001|Overall Study|Lost to Follow-up|1|||
156893746|NCT03139604|566370259|FG000|Overall Study|Death|65|||
156893747|NCT03139604|566370260|FG001|Overall Study|Death|67|||
156893748|NCT03139604|566370259|FG000|Overall Study|Study Terminated by Sponsor|122|||
156893749|NCT03139604|566370260|FG001|Overall Study|Study Terminated by Sponsor|127|||
156893750|NCT03139604|566370259|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
156893751|NCT03139604|566370260|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
156893752|NCT00206076|566370262|FG000|Overall Study|Physician Decision|2|||
156893753|NCT00206076|566370263|FG001|Overall Study|Physician Decision|0|||
156893754|NCT00206076|566370262|FG000|Overall Study|Withdrawal by Subject|1|||
156893755|NCT00206076|566370263|FG001|Overall Study|Withdrawal by Subject|1|||
156893756|NCT00521001|566370267|FG000|Overall Study|Ineligible|1|||
156893757|NCT02821910|566370268|FG000|Overall Study|Withdrawal by Subject|0|||
156893758|NCT02821910|566370269|FG001|Overall Study|Withdrawal by Subject|0|||
156893759|NCT02821910|566370270|FG002|Overall Study|Withdrawal by Subject|1|||
156893760|NCT02821910|566370271|FG003|Overall Study|Withdrawal by Subject|0|||
157158036|NCT02993224|567322950|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
157158037|NCT02993224|567322950|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
157158038|NCT02993224|567322950|FG000|Core Phase- Period 2|Adverse Event|1|||
157158039|NCT02993224|567322950|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
157158040|NCT02993224|567322950|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
157158041|NCT02993224|567322950|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
157158042|NCT02993224|567322950|FG000|Extension Phase|Adverse Event|3|||
157158043|NCT02993224|567322950|FG000|Extension Phase|Withdrawal by Subject|3|||
156893761|NCT02821910|566370272|FG004|Overall Study|Withdrawal by Subject|0|||
156893762|NCT02821910|566370273|FG005|Overall Study|Withdrawal by Subject|1|||
156893763|NCT02821910|566370268|FG000|Overall Study|Other than specified|1|||
156893764|NCT02821910|566370269|FG001|Overall Study|Other than specified|0|||
156893765|NCT02821910|566370270|FG002|Overall Study|Other than specified|1|||
156893766|NCT02821910|566370271|FG003|Overall Study|Other than specified|0|||
156893767|NCT02821910|566370272|FG004|Overall Study|Other than specified|0|||
156893768|NCT02821910|566370273|FG005|Overall Study|Other than specified|0|||
156893769|NCT00423670|566370274|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
156893770|NCT00423670|566370275|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893771|NCT00423670|566370276|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893772|NCT00423670|566370277|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893773|NCT00423670|566370278|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893774|NCT00423670|566370279|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893775|NCT00423670|566370280|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893776|NCT00423670|566370281|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
156893777|NCT00423670|566370274|FG000|Treatment Period|Adverse Event|8|||
156893778|NCT00423670|566370275|FG001|Treatment Period|Adverse Event|12|||
156893779|NCT00423670|566370276|FG002|Treatment Period|Adverse Event|15|||
156893780|NCT00423670|566370277|FG003|Treatment Period|Adverse Event|20|||
156893781|NCT00423670|566370278|FG004|Treatment Period|Adverse Event|9|||
156893782|NCT00423670|566370279|FG005|Treatment Period|Adverse Event|4|||
156893783|NCT00423670|566370280|FG006|Treatment Period|Adverse Event|7|||
156893784|NCT00423670|566370281|FG007|Treatment Period|Adverse Event|2|||
156893785|NCT00423670|566370274|FG000|Treatment Period|Protocol-defined clinical event|0|||
156893786|NCT00423670|566370275|FG001|Treatment Period|Protocol-defined clinical event|7|||
156893787|NCT00423670|566370276|FG002|Treatment Period|Protocol-defined clinical event|4|||
156893788|NCT00423670|566370277|FG003|Treatment Period|Protocol-defined clinical event|12|||
156893789|NCT00423670|566370278|FG004|Treatment Period|Protocol-defined clinical event|5|||
156893790|NCT00423670|566370279|FG005|Treatment Period|Protocol-defined clinical event|4|||
156893791|NCT00423670|566370280|FG006|Treatment Period|Protocol-defined clinical event|16|||
156893792|NCT00423670|566370281|FG007|Treatment Period|Protocol-defined clinical event|15|||
156893793|NCT00423670|566370274|FG000|Treatment Period|Lost to Follow-up|2|||
156893794|NCT00423670|566370275|FG001|Treatment Period|Lost to Follow-up|1|||
156893795|NCT00423670|566370276|FG002|Treatment Period|Lost to Follow-up|3|||
156893796|NCT00423670|566370277|FG003|Treatment Period|Lost to Follow-up|1|||
156893797|NCT00423670|566370278|FG004|Treatment Period|Lost to Follow-up|6|||
156893798|NCT00423670|566370279|FG005|Treatment Period|Lost to Follow-up|0|||
156893799|NCT00423670|566370280|FG006|Treatment Period|Lost to Follow-up|3|||
156893800|NCT00423670|566370281|FG007|Treatment Period|Lost to Follow-up|1|||
156893801|NCT00423670|566370274|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
156893802|NCT00423670|566370275|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
156893803|NCT00423670|566370276|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
156893804|NCT00423670|566370277|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
156893805|NCT00423670|566370278|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
156893806|NCT00423670|566370279|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
156893807|NCT00423670|566370280|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
156893808|NCT00423670|566370281|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
156893809|NCT00423670|566370274|FG000|Treatment Period|Investigator decision|0|||
156893810|NCT00423670|566370275|FG001|Treatment Period|Investigator decision|0|||
157158044|NCT02993224|567322950|FG000|Extension Phase|Lost to Follow-up|2|||
157158045|NCT02993224|567322950|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
157158046|NCT03342469|567322953|FG000|Overall Study|Withdrawal by Subject|0|||
157158047|NCT03342469|567322954|FG001|Overall Study|Withdrawal by Subject|1|||
157158048|NCT03342469|567322955|FG002|Overall Study|Withdrawal by Subject|0|||
157158049|NCT03342469|567322956|FG003|Overall Study|Withdrawal by Subject|0|||
156893811|NCT00423670|566370276|FG002|Treatment Period|Investigator decision|0|||
156893812|NCT00423670|566370277|FG003|Treatment Period|Investigator decision|0|||
156893813|NCT00423670|566370278|FG004|Treatment Period|Investigator decision|0|||
156893814|NCT00423670|566370279|FG005|Treatment Period|Investigator decision|0|||
156893815|NCT00423670|566370280|FG006|Treatment Period|Investigator decision|0|||
156893816|NCT00423670|566370281|FG007|Treatment Period|Investigator decision|1|||
156893817|NCT00423670|566370274|FG000|Treatment Period|Non-compliance with protocol|3|||
156893818|NCT00423670|566370275|FG001|Treatment Period|Non-compliance with protocol|1|||
156893819|NCT00423670|566370276|FG002|Treatment Period|Non-compliance with protocol|1|||
156893820|NCT00423670|566370277|FG003|Treatment Period|Non-compliance with protocol|3|||
156893821|NCT00423670|566370278|FG004|Treatment Period|Non-compliance with protocol|2|||
156893822|NCT00423670|566370279|FG005|Treatment Period|Non-compliance with protocol|0|||
156893823|NCT00423670|566370280|FG006|Treatment Period|Non-compliance with protocol|2|||
156893824|NCT00423670|566370281|FG007|Treatment Period|Non-compliance with protocol|2|||
156893825|NCT00423670|566370274|FG000|Follow-up Period|Lost to Follow-up|0|||
156893826|NCT00423670|566370275|FG001|Follow-up Period|Lost to Follow-up|12|||
156893827|NCT00423670|566370276|FG002|Follow-up Period|Lost to Follow-up|8|||
156893828|NCT00423670|566370277|FG003|Follow-up Period|Lost to Follow-up|3|||
156893829|NCT00423670|566370278|FG004|Follow-up Period|Lost to Follow-up|1|||
156893830|NCT00423670|566370279|FG005|Follow-up Period|Lost to Follow-up|0|||
156893831|NCT00423670|566370280|FG006|Follow-up Period|Lost to Follow-up|5|||
156893832|NCT00423670|566370281|FG007|Follow-up Period|Lost to Follow-up|0|||
156893833|NCT00423670|566370274|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
156893834|NCT00423670|566370275|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
156893835|NCT00423670|566370276|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
156893836|NCT00423670|566370277|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
156893837|NCT00423670|566370278|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
156893838|NCT00423670|566370279|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
156893839|NCT00423670|566370280|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
156893840|NCT00423670|566370281|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
156893841|NCT00423670|566370274|FG000|Follow-up Period|Non-compliance with protocol|2|||
156893842|NCT00423670|566370275|FG001|Follow-up Period|Non-compliance with protocol|0|||
156893843|NCT00423670|566370276|FG002|Follow-up Period|Non-compliance with protocol|1|||
156893844|NCT00423670|566370277|FG003|Follow-up Period|Non-compliance with protocol|1|||
156893845|NCT00423670|566370278|FG004|Follow-up Period|Non-compliance with protocol|0|||
156893846|NCT00423670|566370279|FG005|Follow-up Period|Non-compliance with protocol|0|||
156893847|NCT00423670|566370280|FG006|Follow-up Period|Non-compliance with protocol|3|||
156893848|NCT00423670|566370281|FG007|Follow-up Period|Non-compliance with protocol|2|||
156893849|NCT00900601|566370282|FG000|Overall Study|Physician Decision|1|||
156893850|NCT01082640|566370284|FG000|Overall Study|Adverse Event|9|||
156893851|NCT01082640|566370285|FG001|Overall Study|Adverse Event|5|||
156893852|NCT01082640|566370286|FG002|Overall Study|Adverse Event|3|||
156893853|NCT01082640|566370284|FG000|Overall Study|Withdrawal by Subject|3|||
156893854|NCT01082640|566370285|FG001|Overall Study|Withdrawal by Subject|3|||
156893855|NCT01082640|566370286|FG002|Overall Study|Withdrawal by Subject|2|||
156893856|NCT01082640|566370284|FG000|Overall Study|Major protocol deviation|3|||
156893857|NCT01082640|566370285|FG001|Overall Study|Major protocol deviation|3|||
156893858|NCT01082640|566370286|FG002|Overall Study|Major protocol deviation|0|||
156893859|NCT01082640|566370284|FG000|Overall Study|Lost to Follow-up|0|||
156893860|NCT01082640|566370285|FG001|Overall Study|Lost to Follow-up|3|||
156893861|NCT01082640|566370286|FG002|Overall Study|Lost to Follow-up|0|||
156893862|NCT01082640|566370284|FG000|Overall Study|Other|2|||
156893863|NCT01082640|566370285|FG001|Overall Study|Other|1|||
156893864|NCT01082640|566370286|FG002|Overall Study|Other|3|||
156893865|NCT03190369|566370291|FG000|Overall Study|Poor compliance to protocol|0|||
156893866|NCT03190369|566370292|FG001|Overall Study|Poor compliance to protocol|1|||
156893867|NCT03190369|566370291|FG000|Overall Study|Withdraw before treatment|1|||
156893868|NCT03190369|566370292|FG001|Overall Study|Withdraw before treatment|5|||
156893869|NCT03190369|566370291|FG000|Overall Study|Randomized but not treated|0|||
156893870|NCT03190369|566370292|FG001|Overall Study|Randomized but not treated|2|||
156893871|NCT01052844|566370295|FG000|Overall Study|Adverse Event|0|||
156893872|NCT01052844|566370296|FG001|Overall Study|Adverse Event|1|||
156893873|NCT00559754|566370305|FG000|Overall Study|Disease progression|1|||
156893874|NCT00559754|566370305|FG000|Overall Study|Adverse Event|5|||
156893875|NCT00559754|566370305|FG000|Overall Study|Protocol Violation|1|||
156893876|NCT00559754|566370305|FG000|Overall Study|Investigator criteria|2|||
156893877|NCT00559754|566370305|FG000|Overall Study|Withdrawal by Subject|2|||
156893878|NCT01264016|566370306|FG000|Overall Study|Withdrawal by Subject|1|||
157158050|NCT02689219|567322957|FG000|Overall Study|Death|1|||
157158051|NCT02689219|567322958|FG001|Overall Study|Death|1|||
157158052|NCT02689219|567322957|FG000|Overall Study|Disease Progression|10|||
156893879|NCT01264016|566370306|FG000|Overall Study|Felt faint at sight of blood|1|||
157158053|NCT02689219|567322958|FG001|Overall Study|Disease Progression|6|||
157158054|NCT01477892|567322959|FG000|Overall Study|Withdrawal by Subject|0|||
157158055|NCT01477892|567322960|FG001|Overall Study|Withdrawal by Subject|2|||
156893880|NCT01629706|566370307|FG000|Phase 1 PureVision|Screen Failure|4|||
156893881|NCT01629706|566370307|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
156893882|NCT01629706|566370307|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
156893883|NCT01629706|566370307|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
156893884|NCT01629706|566370307|FG000|Phase 2 Habitual|Screen Failure|6|||
156893885|NCT01629706|566370307|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
157158056|NCT05515601|567322965|FG000|Overall Study|Withdrawal by Subject|1|||
157158057|NCT05515601|567322966|FG001|Overall Study|Withdrawal by Subject|3|||
157158058|NCT05515601|567322967|FG002|Overall Study|Withdrawal by Subject|2|||
157158059|NCT05515601|567322968|FG003|Overall Study|Withdrawal by Subject|1|||
157158060|NCT05515601|567322969|FG004|Overall Study|Withdrawal by Subject|1|||
157158061|NCT05515601|567322970|FG005|Overall Study|Withdrawal by Subject|1|||
157158062|NCT05515601|567322965|FG000|Overall Study|Lost to Follow-up|0|||
157158063|NCT05515601|567322966|FG001|Overall Study|Lost to Follow-up|0|||
157158064|NCT05515601|567322967|FG002|Overall Study|Lost to Follow-up|0|||
157158065|NCT05515601|567322968|FG003|Overall Study|Lost to Follow-up|0|||
157158066|NCT05515601|567322969|FG004|Overall Study|Lost to Follow-up|1|||
157158067|NCT05515601|567322970|FG005|Overall Study|Lost to Follow-up|0|||
157158068|NCT00364845|567322971|FG000|Overall Study|Adverse Event|1|||
157158069|NCT00364845|567322972|FG001|Overall Study|Adverse Event|0|||
157158070|NCT00364845|567322971|FG000|Overall Study|Withdrawal by Subject|2|||
157158071|NCT00364845|567322972|FG001|Overall Study|Withdrawal by Subject|1|||
157158072|NCT00364845|567322971|FG000|Overall Study|Physician Decision|8|||
157158073|NCT00364845|567322972|FG001|Overall Study|Physician Decision|8|||
157158074|NCT00364845|567322971|FG000|Overall Study|Lost to Follow-up|0|||
157158075|NCT00364845|567322972|FG001|Overall Study|Lost to Follow-up|1|||
156857990|NCT02763644|566234712|FG000|Overall Study|Patient/guardian decision|1|||
156857991|NCT02763644|566234713|FG001|Overall Study|Patient/guardian decision|0|||
156857992|NCT02763644|566234712|FG000|Overall Study|Death|1|||
156857993|NCT02763644|566234713|FG001|Overall Study|Death|1|||
156857994|NCT02763644|566234712|FG000|Overall Study|Adverse Event|1|||
156857995|NCT02763644|566234713|FG001|Overall Study|Adverse Event|1|||
156857996|NCT02648204|566234714|FG000|Overall Study|Withdrawal by Subject|12|||
156857997|NCT02648204|566234715|FG001|Overall Study|Withdrawal by Subject|8|||
156857998|NCT02648204|566234716|FG002|Overall Study|Withdrawal by Subject|2|||
156857999|NCT02648204|566234717|FG003|Overall Study|Withdrawal by Subject|6|||
156858000|NCT02648204|566234714|FG000|Overall Study|Lost to Follow-up|5|||
156858001|NCT02648204|566234715|FG001|Overall Study|Lost to Follow-up|8|||
156858002|NCT02648204|566234716|FG002|Overall Study|Lost to Follow-up|4|||
156858003|NCT02648204|566234717|FG003|Overall Study|Lost to Follow-up|6|||
156858004|NCT02648204|566234714|FG000|Overall Study|Missing follow-up information|4|||
156858005|NCT02648204|566234715|FG001|Overall Study|Missing follow-up information|4|||
156858006|NCT02648204|566234716|FG002|Overall Study|Missing follow-up information|4|||
156858007|NCT02648204|566234717|FG003|Overall Study|Missing follow-up information|2|||
156858008|NCT02648204|566234714|FG000|Overall Study|Death|1|||
156858009|NCT02648204|566234715|FG001|Overall Study|Death|1|||
156858010|NCT02648204|566234716|FG002|Overall Study|Death|2|||
156858011|NCT02648204|566234717|FG003|Overall Study|Death|2|||
156858012|NCT02648204|566234714|FG000|Overall Study|Adverse Event|0|||
156858013|NCT02648204|566234715|FG001|Overall Study|Adverse Event|0|||
156858014|NCT02648204|566234716|FG002|Overall Study|Adverse Event|1|||
156858015|NCT02648204|566234717|FG003|Overall Study|Adverse Event|0|||
156858016|NCT02356159|566234718|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858017|NCT02356159|566234719|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858018|NCT02356159|566234720|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858019|NCT02356159|566234721|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858020|NCT02356159|566234722|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
156858021|NCT02356159|566234723|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
156858022|NCT01582061|566234724|FG000|Overall Study|Lack of Efficacy|3|||
156858023|NCT01582061|566234725|FG001|Overall Study|Lack of Efficacy|23|||
156858024|NCT01582061|566234724|FG000|Overall Study|Adverse Event|12|||
156858025|NCT01582061|566234725|FG001|Overall Study|Adverse Event|8|||
156858026|NCT01582061|566234724|FG000|Overall Study|Withdrawal by Subject|10|||
156858027|NCT01582061|566234725|FG001|Overall Study|Withdrawal by Subject|4|||
156858028|NCT01582061|566234724|FG000|Overall Study|Abnormal laboratory value(s)|1|||
156858029|NCT01582061|566234725|FG001|Overall Study|Abnormal laboratory value(s)|0|||
156858030|NCT01582061|566234724|FG000|Overall Study|Death|0|||
156858031|NCT01582061|566234725|FG001|Overall Study|Death|1|||
156858032|NCT01582061|566234724|FG000|Overall Study|condition no longer requires study drug|1|||
156858033|NCT01582061|566234725|FG001|Overall Study|condition no longer requires study drug|0|||
156858034|NCT01582061|566234724|FG000|Overall Study|Lost to Follow-up|1|||
156858035|NCT01582061|566234725|FG001|Overall Study|Lost to Follow-up|0|||
156858036|NCT00005906|566234726|FG000|Overall Study|Lack of Efficacy|3|||
156858037|NCT00088530|566234727|FG000|Overall Study|Progressive/Relapsed Disease|28|||
156858038|NCT00088530|566234728|FG001|Overall Study|Progressive/Relapsed Disease|39|||
156858039|NCT00088530|566234727|FG000|Overall Study|Adverse Event|15|||
156858040|NCT00088530|566234728|FG001|Overall Study|Adverse Event|9|||
156858041|NCT00088530|566234727|FG000|Overall Study|Withdrawal by Subject|2|||
157158076|NCT00364845|567322971|FG000|Overall Study|Death|0|||
157158077|NCT00364845|567322972|FG001|Overall Study|Death|1|||
157158078|NCT03255291|567322975|FG000|Overall Study|Determined to be ineligible|10|||
157158079|NCT03255291|567322976|FG001|Overall Study|Determined to be ineligible|12|||
157158080|NCT03255291|567322977|FG002|Overall Study|Determined to be ineligible|6|||
157026090|NCT03701763|566849710|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
156858042|NCT00088530|566234728|FG001|Overall Study|Withdrawal by Subject|5|||
156858043|NCT00088530|566234727|FG000|Overall Study|Lost to Follow-up|2|||
156858044|NCT00088530|566234728|FG001|Overall Study|Lost to Follow-up|0|||
156858045|NCT00088530|566234727|FG000|Overall Study|Physician Decision|2|||
156858046|NCT00088530|566234728|FG001|Overall Study|Physician Decision|0|||
156858047|NCT00088530|566234727|FG000|Overall Study|Sponsor decision|0|||
156858048|NCT00088530|566234728|FG001|Overall Study|Sponsor decision|1|||
156858049|NCT00088530|566234727|FG000|Overall Study|Patient never treated|1|||
156858050|NCT00088530|566234728|FG001|Overall Study|Patient never treated|0|||
156858051|NCT00300755|566234729|FG000|Overall Study|Adverse Event|1|||
156858052|NCT00300755|566234730|FG001|Overall Study|Adverse Event|2|||
156858053|NCT00300755|566234731|FG002|Overall Study|Adverse Event|1|||
156858054|NCT00300755|566234729|FG000|Overall Study|Withdrawal by Subject|0|||
156858055|NCT00300755|566234730|FG001|Overall Study|Withdrawal by Subject|2|||
156858056|NCT00300755|566234731|FG002|Overall Study|Withdrawal by Subject|0|||
156858057|NCT00300755|566234729|FG000|Overall Study|Protocol Violation|0|||
156858058|NCT00300755|566234730|FG001|Overall Study|Protocol Violation|0|||
156858059|NCT00300755|566234731|FG002|Overall Study|Protocol Violation|1|||
156858060|NCT04571944|566234732|FG000|Overall Study|Death|1|||
156858061|NCT04571944|566234733|FG001|Overall Study|Death|0|||
156858062|NCT04571944|566234732|FG000|Overall Study|Withdrawal by Subject|3|||
156858063|NCT04571944|566234733|FG001|Overall Study|Withdrawal by Subject|0|||
156858064|NCT04571944|566234732|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
156858065|NCT04571944|566234733|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
156858066|NCT02163902|566234734|FG000|Overall Study|Subject's Request|3|||
156858067|NCT02163902|566234735|FG001|Overall Study|Subject's Request|4|||
156858068|NCT02163902|566234734|FG000|Overall Study|Lost to Follow-up|6|||
156858069|NCT02163902|566234735|FG001|Overall Study|Lost to Follow-up|7|||
156858070|NCT02163902|566234734|FG000|Overall Study|Administrative Decision|2|||
156858071|NCT02163902|566234735|FG001|Overall Study|Administrative Decision|2|||
156858072|NCT02140047|566234736|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156858073|NCT02140047|566234737|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156858074|NCT02140047|566234738|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156858075|NCT03119259|566234739|FG000|Overall Study|Withdrawn as no longer eligible|1|||
156858076|NCT03119259|566234740|FG001|Overall Study|Withdrawn as no longer eligible|0|||
156858077|NCT03119259|566234739|FG000|Overall Study|Withdrawal by Subject|4|||
156858078|NCT03119259|566234740|FG001|Overall Study|Withdrawal by Subject|2|||
156858079|NCT03119259|566234739|FG000|Overall Study|Lost to Follow-up|0|||
156858080|NCT03119259|566234740|FG001|Overall Study|Lost to Follow-up|1|||
156858081|NCT03915717|566234747|FG000|Overall Study|EchoMark Not Implanted|6|||
156858082|NCT04079296|566234748|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858083|NCT04079296|566234749|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858084|NCT04079296|566234750|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
156858085|NCT04079296|566234751|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
156858086|NCT04079296|566234752|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
156858087|NCT04079296|566234748|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858088|NCT04079296|566234749|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858089|NCT04079296|566234750|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
156858090|NCT04079296|566234751|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
156858091|NCT04079296|566234752|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
156858092|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858093|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858094|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858095|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
156858096|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
156858097|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858098|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858099|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858100|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
156858101|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
156858102|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858103|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858104|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858105|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
156858106|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
156858107|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858108|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858109|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
156858110|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
156893886|NCT01629706|566370307|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
156893887|NCT01629706|566370307|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
156893888|NCT01629706|566370307|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
156893889|NCT01439347|566370308|FG000|Overall Study|Death|10|||
156893890|NCT01439347|566370309|FG001|Overall Study|Death|9|||
156858111|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
156858112|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858113|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858114|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
156858115|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
156858116|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
156858117|NCT04079296|566234748|FG000|Dose Expansion Phase (168 Days)|Death|0|||
156858118|NCT04079296|566234749|FG001|Dose Expansion Phase (168 Days)|Death|0|||
156858119|NCT04079296|566234750|FG002|Dose Expansion Phase (168 Days)|Death|0|||
156858120|NCT04079296|566234751|FG003|Dose Expansion Phase (168 Days)|Death|1|||
156858121|NCT04079296|566234752|FG004|Dose Expansion Phase (168 Days)|Death|0|||
156858122|NCT00467740|566234753|FG000|Overall Study|Adverse Event|0|||
156858123|NCT00467740|566234754|FG001|Overall Study|Adverse Event|0|||
156858124|NCT00467740|566234755|FG002|Overall Study|Adverse Event|1|||
156858125|NCT00467740|566234756|FG003|Overall Study|Adverse Event|0|||
156858126|NCT00467740|566234757|FG004|Overall Study|Adverse Event|0|||
156858127|NCT00467740|566234753|FG000|Overall Study|Protocol Violation|0|||
156858128|NCT00467740|566234754|FG001|Overall Study|Protocol Violation|0|||
156858129|NCT00467740|566234755|FG002|Overall Study|Protocol Violation|1|||
156858130|NCT00467740|566234756|FG003|Overall Study|Protocol Violation|0|||
156858131|NCT00467740|566234757|FG004|Overall Study|Protocol Violation|0|||
156858132|NCT00467740|566234753|FG000|Overall Study|Lost to Follow-up|0|||
156858133|NCT00467740|566234754|FG001|Overall Study|Lost to Follow-up|1|||
156858134|NCT00467740|566234755|FG002|Overall Study|Lost to Follow-up|0|||
156858135|NCT00467740|566234756|FG003|Overall Study|Lost to Follow-up|0|||
156858136|NCT00467740|566234757|FG004|Overall Study|Lost to Follow-up|0|||
156858137|NCT00467740|566234753|FG000|Overall Study|Withdrawal by Subject|1|||
156858138|NCT00467740|566234754|FG001|Overall Study|Withdrawal by Subject|1|||
156858139|NCT00467740|566234755|FG002|Overall Study|Withdrawal by Subject|0|||
156858140|NCT00467740|566234756|FG003|Overall Study|Withdrawal by Subject|1|||
156858141|NCT00467740|566234757|FG004|Overall Study|Withdrawal by Subject|0|||
156858142|NCT00467740|566234753|FG000|Overall Study|Lack of Efficacy|0|||
156858143|NCT00467740|566234754|FG001|Overall Study|Lack of Efficacy|1|||
156858144|NCT00467740|566234755|FG002|Overall Study|Lack of Efficacy|0|||
156858145|NCT00467740|566234756|FG003|Overall Study|Lack of Efficacy|0|||
156858146|NCT00467740|566234757|FG004|Overall Study|Lack of Efficacy|0|||
156858147|NCT03550378|566234761|FG000|Overall Study|Death|0|||
156858148|NCT03550378|566234762|FG001|Overall Study|Death|1|||
156858149|NCT00626275|566234763|FG000|Part A - Treatment Period 1|Adverse Event|1|||
156858150|NCT00626275|566234764|FG001|Part A - Treatment Period 1|Adverse Event|0|||
156858151|NCT00626275|566234765|FG002|Part A - Treatment Period 1|Adverse Event|0|||
156858152|NCT00626275|566234766|FG003|Part A - Treatment Period 1|Adverse Event|0|||
156858153|NCT00626275|566234767|FG004|Part A - Treatment Period 1|Adverse Event|0|||
156858154|NCT00626275|566234768|FG005|Part A - Treatment Period 1|Adverse Event|0|||
156858155|NCT00626275|566234769|FG006|Part A - Treatment Period 1|Adverse Event|0|||
156858156|NCT00626275|566234770|FG007|Part A - Treatment Period 1|Adverse Event|0|||
156858157|NCT00626275|566234763|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858158|NCT00626275|566234764|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858159|NCT00626275|566234765|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
156858160|NCT00626275|566234766|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858161|NCT00626275|566234767|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858162|NCT00626275|566234768|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858163|NCT00626275|566234769|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858164|NCT00626275|566234770|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
156858165|NCT00626275|566234763|FG000|Part B|Lost to Follow-up|0|||
156858166|NCT00626275|566234764|FG001|Part B|Lost to Follow-up|0|||
156858167|NCT00626275|566234765|FG002|Part B|Lost to Follow-up|0|||
156858168|NCT00626275|566234766|FG003|Part B|Lost to Follow-up|0|||
156858169|NCT00626275|566234767|FG004|Part B|Lost to Follow-up|0|||
156858170|NCT00626275|566234768|FG005|Part B|Lost to Follow-up|0|||
156858171|NCT00626275|566234769|FG006|Part B|Lost to Follow-up|1|||
156858172|NCT00626275|566234770|FG007|Part B|Lost to Follow-up|0|||
156858173|NCT00626275|566234763|FG000|Part B|Withdrawal by Subject|0|||
156858174|NCT00626275|566234764|FG001|Part B|Withdrawal by Subject|0|||
156858175|NCT00626275|566234765|FG002|Part B|Withdrawal by Subject|0|||
156858176|NCT00626275|566234766|FG003|Part B|Withdrawal by Subject|0|||
156858177|NCT00626275|566234767|FG004|Part B|Withdrawal by Subject|0|||
156858178|NCT00626275|566234768|FG005|Part B|Withdrawal by Subject|0|||
156893891|NCT01439347|566370308|FG000|Overall Study|Withdrawal by Subject|0|||
156858179|NCT00626275|566234769|FG006|Part B|Withdrawal by Subject|0|||
156858180|NCT00626275|566234770|FG007|Part B|Withdrawal by Subject|1|||
156858181|NCT01362348|566234771|FG000|Overall Study|Protocol-defined stopping criteria|9|||
156858182|NCT01362348|566234771|FG000|Overall Study|Study closed/terminated|5|||
156858183|NCT00399516|566234772|FG000|Overall Study|Lost to Follow-up|2|||
156893892|NCT01439347|566370309|FG001|Overall Study|Withdrawal by Subject|1|||
156893893|NCT01439347|566370308|FG000|Overall Study|Physician Decision|1|||
156893894|NCT01439347|566370309|FG001|Overall Study|Physician Decision|0|||
156893895|NCT01439347|566370308|FG000|Overall Study|Sponsor Terminated Study|2|||
156893896|NCT01439347|566370309|FG001|Overall Study|Sponsor Terminated Study|3|||
156893897|NCT03519386|566370311|FG000|Overall Study|Withdrawal by Subject|4|||
156893898|NCT03519386|566370312|FG001|Overall Study|Withdrawal by Subject|1|||
156893899|NCT03519386|566370313|FG002|Overall Study|Withdrawal by Subject|2|||
156893900|NCT03519386|566370311|FG000|Overall Study|Physician Decision|1|||
156893901|NCT03519386|566370312|FG001|Overall Study|Physician Decision|1|||
156893902|NCT03519386|566370313|FG002|Overall Study|Physician Decision|1|||
156893903|NCT03519386|566370311|FG000|Overall Study|Lost to Follow-up|0|||
156893904|NCT03519386|566370312|FG001|Overall Study|Lost to Follow-up|1|||
156893905|NCT03519386|566370313|FG002|Overall Study|Lost to Follow-up|1|||
156858184|NCT00539981|566234775|FG000|Overall Study|Adverse events (AE)|3|||
156858185|NCT00539981|566234776|FG001|Overall Study|Adverse events (AE)|3|||
156858186|NCT00539981|566234775|FG000|Overall Study|Lost to Follow-up|260|||
156858187|NCT00539981|566234776|FG001|Overall Study|Lost to Follow-up|251|||
156858188|NCT00539981|566234775|FG000|Overall Study|Withdrew consent|22|||
156858189|NCT00539981|566234776|FG001|Overall Study|Withdrew consent|14|||
156858190|NCT00539981|566234775|FG000|Overall Study|Death|1|||
156858191|NCT00539981|566234776|FG001|Overall Study|Death|1|||
156858192|NCT00539981|566234775|FG000|Overall Study|Other reason-unspecified|9|||
156858193|NCT00539981|566234776|FG001|Overall Study|Other reason-unspecified|13|||
156858194|NCT02051764|566234779|FG000|Overall Study|Study terminated by sponsor|0|||
156858195|NCT02051764|566234780|FG001|Overall Study|Study terminated by sponsor|7|||
156858196|NCT03289208|566234784|FG000|Overall Study|Adverse Event|1|||
156858197|NCT03289208|566234785|FG001|Overall Study|Adverse Event|0|||
156858198|NCT03289208|566234786|FG002|Overall Study|Adverse Event|0|||
156858199|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858200|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858201|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858202|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
156858203|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
156858204|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
156858205|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
156858206|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
156858207|NCT00647296|566234787|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858208|NCT00647296|566234788|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
156858209|NCT00647296|566234789|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858210|NCT00647296|566234790|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
156858211|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
156858212|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858213|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858214|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
156858215|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
156858216|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858217|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858218|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
156858219|NCT00647296|566234787|FG000|Part 2: 4-week Placebo Washout|Death|3|||
156858220|NCT00647296|566234788|FG001|Part 2: 4-week Placebo Washout|Death|0|||
156858221|NCT00647296|566234789|FG002|Part 2: 4-week Placebo Washout|Death|0|||
156858222|NCT00647296|566234790|FG003|Part 2: 4-week Placebo Washout|Death|0|||
156858223|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858224|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
156858225|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
156858226|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
156858227|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
156858228|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
156858229|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
156858230|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
156858231|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858232|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
156858233|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858234|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
156858235|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
156858236|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
156858237|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
156858238|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
156893906|NCT03519386|566370311|FG000|Overall Study|Death|1|||
156893907|NCT03519386|566370312|FG001|Overall Study|Death|0|||
156893908|NCT03519386|566370313|FG002|Overall Study|Death|4|||
156893909|NCT03519386|566370311|FG000|Overall Study|Adverse Event|2|||
156893910|NCT03519386|566370312|FG001|Overall Study|Adverse Event|1|||
156893911|NCT03519386|566370313|FG002|Overall Study|Adverse Event|2|||
156893912|NCT03519386|566370311|FG000|Overall Study|Explanted|2|||
156893913|NCT03519386|566370312|FG001|Overall Study|Explanted|1|||
156893914|NCT03519386|566370313|FG002|Overall Study|Explanted|0|||
156893915|NCT03519386|566370311|FG000|Overall Study|Ongoing in study|190|||
156893916|NCT03519386|566370312|FG001|Overall Study|Ongoing in study|192|||
156893917|NCT03519386|566370313|FG002|Overall Study|Ongoing in study|183|||
156893918|NCT00484185|566370315|FG000|Overall Study|Lost to Follow-up|44|||
156893919|NCT00484185|566370315|FG000|Overall Study|Other|20|||
156893920|NCT00484185|566370315|FG000|Overall Study|Randomized but not treated|5|||
156893921|NCT00484185|566370315|FG000|Overall Study|Death|2|||
156893922|NCT02325791|566370318|FG000|Overall Study|Adverse Event|0|||
156893923|NCT02325791|566370319|FG001|Overall Study|Adverse Event|1|||
156893924|NCT02325791|566370320|FG002|Overall Study|Adverse Event|1|||
156893925|NCT02325791|566370321|FG003|Overall Study|Adverse Event|0|||
156893926|NCT02325791|566370318|FG000|Overall Study|Death|0|||
156893927|NCT02325791|566370319|FG001|Overall Study|Death|3|||
156893928|NCT02325791|566370320|FG002|Overall Study|Death|0|||
156893929|NCT02325791|566370321|FG003|Overall Study|Death|1|||
156893930|NCT02325791|566370318|FG000|Overall Study|Lost to Follow-up|0|||
156893931|NCT02325791|566370319|FG001|Overall Study|Lost to Follow-up|15|||
157158081|NCT03255291|567322978|FG003|Overall Study|Determined to be ineligible|6|||
157158082|NCT03255291|567322979|FG004|Overall Study|Determined to be ineligible|5|||
157158083|NCT03255291|567322980|FG005|Overall Study|Determined to be ineligible|10|||
157158084|NCT03255291|567322975|FG000|Overall Study|Baseline data collection issues|3|||
157158085|NCT03255291|567322976|FG001|Overall Study|Baseline data collection issues|0|||
156858239|NCT00647296|566234787|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
156858240|NCT00647296|566234788|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
156858241|NCT00647296|566234789|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
156858242|NCT00647296|566234790|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
156858243|NCT00871871|566234791|FG000|Part I|Adverse Event|0|||
156858244|NCT00871871|566234792|FG001|Part I|Adverse Event|2|||
156858245|NCT00871871|566234793|FG002|Part I|Adverse Event|0|||
156858246|NCT00871871|566234794|FG003|Part I|Adverse Event|0|||
156858247|NCT00871871|566234791|FG000|Part I|Withdrawal by Subject|3|||
156858248|NCT00871871|566234792|FG001|Part I|Withdrawal by Subject|0|||
156858249|NCT00871871|566234793|FG002|Part I|Withdrawal by Subject|0|||
156858250|NCT00871871|566234794|FG003|Part I|Withdrawal by Subject|0|||
156858251|NCT00871871|566234791|FG000|Part I|Laboratory abnormality|0|||
156858252|NCT00871871|566234792|FG001|Part I|Laboratory abnormality|1|||
156858253|NCT00871871|566234793|FG002|Part I|Laboratory abnormality|0|||
156858254|NCT00871871|566234794|FG003|Part I|Laboratory abnormality|0|||
156858255|NCT00871871|566234791|FG000|Part II|Lack of Efficacy|0|||
156858256|NCT00871871|566234792|FG001|Part II|Lack of Efficacy|0|||
156858257|NCT00871871|566234793|FG002|Part II|Lack of Efficacy|1|||
156858258|NCT00871871|566234794|FG003|Part II|Lack of Efficacy|0|||
156858259|NCT00871871|566234791|FG000|Part II|Withdrawal by Subject|0|||
156858260|NCT00871871|566234792|FG001|Part II|Withdrawal by Subject|0|||
156858261|NCT00871871|566234793|FG002|Part II|Withdrawal by Subject|2|||
156858262|NCT00871871|566234794|FG003|Part II|Withdrawal by Subject|1|||
156858263|NCT00871871|566234791|FG000|Part II|Adverse Event|0|||
156858264|NCT00871871|566234792|FG001|Part II|Adverse Event|0|||
156858265|NCT00871871|566234793|FG002|Part II|Adverse Event|1|||
156858266|NCT00871871|566234794|FG003|Part II|Adverse Event|2|||
156858267|NCT00871871|566234791|FG000|Part II|Protocol Violation|0|||
156858268|NCT00871871|566234792|FG001|Part II|Protocol Violation|0|||
156858269|NCT00871871|566234793|FG002|Part II|Protocol Violation|0|||
156858270|NCT00871871|566234794|FG003|Part II|Protocol Violation|1|||
156858271|NCT02354235|566234795|FG000|Overall Study|Adverse Event|2|||
156858272|NCT02354235|566234796|FG001|Overall Study|Adverse Event|2|||
156858273|NCT02354235|566234795|FG000|Overall Study|Physician Decision|0|||
156858274|NCT02354235|566234796|FG001|Overall Study|Physician Decision|1|||
156858275|NCT02354235|566234795|FG000|Overall Study|Withdrawal by Subject|1|||
156858276|NCT02354235|566234796|FG001|Overall Study|Withdrawal by Subject|3|||
156858277|NCT02354235|566234795|FG000|Overall Study|Conflict with the stopping criteria|0|||
156858278|NCT02354235|566234796|FG001|Overall Study|Conflict with the stopping criteria|1|||
156893932|NCT02325791|566370320|FG002|Overall Study|Lost to Follow-up|14|||
156893933|NCT02325791|566370321|FG003|Overall Study|Lost to Follow-up|9|||
156858279|NCT03069352|566234797|FG000|Overall Study|Ongoing|12|||
156858280|NCT03069352|566234798|FG001|Overall Study|Ongoing|40|||
156858281|NCT02621424|566234799|FG000|Overall Study|Withdrawal by Subject|1|||
156858282|NCT02621424|566234800|FG001|Overall Study|Withdrawal by Subject|2|||
156858283|NCT05148234|566234801|FG000|Phase I|Ineligible|0|||
156893934|NCT02325791|566370318|FG000|Overall Study|Physician Decision|0|||
156858284|NCT05148234|566234802|FG001|Phase I|Ineligible|0|||
156858285|NCT05148234|566234803|FG002|Phase I|Ineligible|0|||
156893935|NCT02325791|566370319|FG001|Overall Study|Physician Decision|1|||
157158086|NCT03255291|567322977|FG002|Overall Study|Baseline data collection issues|0|||
156893936|NCT02325791|566370320|FG002|Overall Study|Physician Decision|1|||
156893937|NCT02325791|566370321|FG003|Overall Study|Physician Decision|0|||
156893938|NCT02325791|566370318|FG000|Overall Study|Protocol Violation|0|||
156893939|NCT02325791|566370319|FG001|Overall Study|Protocol Violation|0|||
156893940|NCT02325791|566370320|FG002|Overall Study|Protocol Violation|1|||
156893941|NCT02325791|566370321|FG003|Overall Study|Protocol Violation|0|||
156893942|NCT02325791|566370318|FG000|Overall Study|Withdrawal by Subject|0|||
156893943|NCT02325791|566370319|FG001|Overall Study|Withdrawal by Subject|5|||
156893944|NCT02325791|566370320|FG002|Overall Study|Withdrawal by Subject|8|||
156893945|NCT02325791|566370321|FG003|Overall Study|Withdrawal by Subject|16|||
156893946|NCT00555425|566370322|FG000|Overall Study|Missed Medication > 1 wk|34|||
156893947|NCT00555425|566370323|FG001|Overall Study|Missed Medication > 1 wk|15|||
156893948|NCT00555425|566370322|FG000|Overall Study|Missed 3 physician management visits|1|||
156893949|NCT00555425|566370323|FG001|Overall Study|Missed 3 physician management visits|0|||
156893950|NCT00555425|566370322|FG000|Overall Study|Met criteria for protective transfer|16|||
156893951|NCT00555425|566370323|FG001|Overall Study|Met criteria for protective transfer|3|||
156893952|NCT00555425|566370322|FG000|Overall Study|Became pregnant and transferred care|0|||
156893953|NCT00555425|566370323|FG001|Overall Study|Became pregnant and transferred care|1|||
156893954|NCT01298193|566370324|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
156893955|NCT01298193|566370324|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
156893956|NCT01298193|566370324|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
156893957|NCT01298193|566370324|FG000|Efficacy Phase (Second Cycle)|Death|1|||
156893958|NCT01975831|566370325|FG000|Overall Study|Adverse Event|1|||
156893959|NCT01975831|566370326|FG001|Overall Study|Adverse Event|2|||
156893960|NCT01975831|566370327|FG002|Overall Study|Adverse Event|2|||
156893961|NCT01975831|566370328|FG003|Overall Study|Adverse Event|0|||
156893962|NCT01975831|566370329|FG004|Overall Study|Adverse Event|1|||
156893963|NCT01975831|566370330|FG005|Overall Study|Adverse Event|1|||
156893964|NCT01975831|566370331|FG006|Overall Study|Adverse Event|3|||
156893965|NCT01975831|566370332|FG007|Overall Study|Adverse Event|4|||
156893966|NCT01975831|566370333|FG008|Overall Study|Adverse Event|1|||
156893967|NCT01975831|566370325|FG000|Overall Study|Death|1|||
156893968|NCT01975831|566370326|FG001|Overall Study|Death|1|||
156893969|NCT01975831|566370327|FG002|Overall Study|Death|0|||
156893970|NCT01975831|566370328|FG003|Overall Study|Death|0|||
156893971|NCT01975831|566370329|FG004|Overall Study|Death|1|||
156893972|NCT01975831|566370330|FG005|Overall Study|Death|0|||
156893973|NCT01975831|566370331|FG006|Overall Study|Death|1|||
156893974|NCT01975831|566370332|FG007|Overall Study|Death|0|||
156893975|NCT01975831|566370333|FG008|Overall Study|Death|0|||
156893976|NCT01975831|566370325|FG000|Overall Study|Progressive Disease|1|||
156893977|NCT01975831|566370326|FG001|Overall Study|Progressive Disease|3|||
156893978|NCT01975831|566370327|FG002|Overall Study|Progressive Disease|2|||
156893979|NCT01975831|566370328|FG003|Overall Study|Progressive Disease|4|||
156893980|NCT01975831|566370329|FG004|Overall Study|Progressive Disease|13|||
156893981|NCT01975831|566370330|FG005|Overall Study|Progressive Disease|9|||
156893982|NCT01975831|566370331|FG006|Overall Study|Progressive Disease|10|||
156893983|NCT01975831|566370332|FG007|Overall Study|Progressive Disease|8|||
156893984|NCT01975831|566370333|FG008|Overall Study|Progressive Disease|10|||
156893985|NCT01975831|566370325|FG000|Overall Study|Withdrawal by Subject|0|||
156893986|NCT01975831|566370326|FG001|Overall Study|Withdrawal by Subject|3|||
156893987|NCT01975831|566370327|FG002|Overall Study|Withdrawal by Subject|0|||
156893988|NCT01975831|566370328|FG003|Overall Study|Withdrawal by Subject|0|||
156893989|NCT01975831|566370329|FG004|Overall Study|Withdrawal by Subject|3|||
156893990|NCT01975831|566370330|FG005|Overall Study|Withdrawal by Subject|1|||
156893991|NCT01975831|566370331|FG006|Overall Study|Withdrawal by Subject|1|||
156893992|NCT01975831|566370332|FG007|Overall Study|Withdrawal by Subject|0|||
156893993|NCT01975831|566370333|FG008|Overall Study|Withdrawal by Subject|0|||
156893994|NCT01975831|566370325|FG000|Overall Study|Physician Decision|0|||
156893995|NCT01975831|566370326|FG001|Overall Study|Physician Decision|0|||
156893996|NCT01975831|566370327|FG002|Overall Study|Physician Decision|0|||
156893997|NCT01975831|566370328|FG003|Overall Study|Physician Decision|0|||
156893998|NCT01975831|566370329|FG004|Overall Study|Physician Decision|0|||
156893999|NCT01975831|566370330|FG005|Overall Study|Physician Decision|1|||
156894000|NCT01975831|566370331|FG006|Overall Study|Physician Decision|0|||
156894001|NCT01975831|566370332|FG007|Overall Study|Physician Decision|1|||
156894002|NCT01975831|566370333|FG008|Overall Study|Physician Decision|0|||
156894003|NCT01975831|566370325|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
156894004|NCT01975831|566370326|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
156894005|NCT01975831|566370327|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
156894006|NCT01975831|566370328|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
156894007|NCT01975831|566370329|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
156894008|NCT01975831|566370330|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
156894009|NCT01975831|566370331|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
156894010|NCT01975831|566370332|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
156894011|NCT01975831|566370333|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
156894012|NCT01975831|566370325|FG000|Overall Study|Entered Hospice|0|||
156894013|NCT01975831|566370326|FG001|Overall Study|Entered Hospice|0|||
156894014|NCT01975831|566370327|FG002|Overall Study|Entered Hospice|0|||
156894015|NCT01975831|566370328|FG003|Overall Study|Entered Hospice|0|||
156894016|NCT01975831|566370329|FG004|Overall Study|Entered Hospice|0|||
156894017|NCT01975831|566370330|FG005|Overall Study|Entered Hospice|1|||
156894018|NCT01975831|566370331|FG006|Overall Study|Entered Hospice|0|||
156894019|NCT01975831|566370332|FG007|Overall Study|Entered Hospice|0|||
156894020|NCT01975831|566370333|FG008|Overall Study|Entered Hospice|0|||
156894021|NCT01975831|566370325|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894022|NCT01975831|566370326|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894023|NCT01975831|566370327|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894024|NCT01975831|566370328|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894025|NCT01975831|566370329|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894026|NCT01975831|566370330|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894027|NCT01975831|566370331|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
156894028|NCT01975831|566370332|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
156894029|NCT01975831|566370333|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
156894030|NCT01642407|566370334|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
156894031|NCT01642407|566370334|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
156894032|NCT01642407|566370334|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
156894033|NCT00424255|566370335|FG000|Overall Study|Death|115|||
156894034|NCT00424255|566370336|FG001|Overall Study|Death|111|||
156894035|NCT00424255|566370335|FG000|Overall Study|Lost to Follow-up|26|||
156894036|NCT00424255|566370336|FG001|Overall Study|Lost to Follow-up|20|||
156894037|NCT00424255|566370335|FG000|Overall Study|Protocol Violation|0|||
156894038|NCT00424255|566370336|FG001|Overall Study|Protocol Violation|1|||
156894039|NCT00424255|566370335|FG000|Overall Study|Withdrawal by Subject|34|||
156894040|NCT00424255|566370336|FG001|Overall Study|Withdrawal by Subject|38|||
156894041|NCT00424255|566370335|FG000|Overall Study|Physician Decision|3|||
156894042|NCT00424255|566370336|FG001|Overall Study|Physician Decision|7|||
156894043|NCT00424255|566370335|FG000|Overall Study|Cognitive Disturbance|1|||
156894044|NCT00424255|566370336|FG001|Overall Study|Cognitive Disturbance|0|||
156894045|NCT00424255|566370335|FG000|Overall Study|Non-compliance by Participants|1|||
156894046|NCT00424255|566370336|FG001|Overall Study|Non-compliance by Participants|0|||
156894047|NCT00424255|566370335|FG000|Overall Study|Fatigue|1|||
156894048|NCT00424255|566370336|FG001|Overall Study|Fatigue|0|||
156894049|NCT00424255|566370335|FG000|Overall Study|Disease Progression|0|||
156894050|NCT00424255|566370336|FG001|Overall Study|Disease Progression|2|||
156894051|NCT00424255|566370335|FG000|Overall Study|Sponsor Terminated Study|161|||
156894052|NCT00424255|566370336|FG001|Overall Study|Sponsor Terminated Study|167|||
156894053|NCT02810340|566370338|FG000|Overall Study|Withdrawal by Subject|1|||
156894054|NCT02810340|566370339|FG001|Overall Study|Withdrawal by Subject|0|||
156894055|NCT02810340|566370340|FG002|Overall Study|Withdrawal by Subject|0|||
156894056|NCT02810340|566370338|FG000|Overall Study|Incarceration|0|||
156894057|NCT02810340|566370339|FG001|Overall Study|Incarceration|1|||
156894058|NCT02810340|566370340|FG002|Overall Study|Incarceration|0|||
156894059|NCT02810340|566370338|FG000|Overall Study|Lost to Follow-up|0|||
156894060|NCT02810340|566370339|FG001|Overall Study|Lost to Follow-up|0|||
156894061|NCT02810340|566370340|FG002|Overall Study|Lost to Follow-up|1|||
156894062|NCT00870233|566370346|FG000|Overall Study|Withdrawal by Subject|18|||
156894063|NCT00870233|566370346|FG000|Overall Study|Did not undergo laparotomy|3|||
156894064|NCT00870233|566370346|FG000|Overall Study|Incompatible internet browser|2|||
156894065|NCT00870233|566370346|FG000|Overall Study|Death|1|||
156894066|NCT00769483|566370349|FG000|Overall Study|Withdrawal by Subject|0|||
156894067|NCT00769483|566370350|FG001|Overall Study|Withdrawal by Subject|1|||
156894068|NCT00769483|566370351|FG002|Overall Study|Withdrawal by Subject|0|||
156894069|NCT00769483|566370352|FG003|Overall Study|Withdrawal by Subject|0|||
157158087|NCT03255291|567322978|FG003|Overall Study|Baseline data collection issues|0|||
157158088|NCT03255291|567322979|FG004|Overall Study|Baseline data collection issues|2|||
157158089|NCT03255291|567322980|FG005|Overall Study|Baseline data collection issues|0|||
157158090|NCT01515306|567322981|FG000|Overall Study|Adverse Event|3|||
157158091|NCT01515306|567322982|FG001|Overall Study|Adverse Event|2|||
157158092|NCT01515306|567322981|FG000|Overall Study|Progressive Disease|19|||
156858286|NCT05148234|566234804|FG003|Phase I|Ineligible|0|||
156858287|NCT05148234|566234805|FG004|Phase I|Ineligible|0|||
156858288|NCT05148234|566234806|FG005|Phase I|Ineligible|0|||
156858289|NCT05148234|566234807|FG006|Phase I|Ineligible|0|||
156858290|NCT05148234|566234808|FG007|Phase I|Ineligible|1|||
156858291|NCT05148234|566234801|FG000|Phase I|Company closed the trial.|0|||
156858292|NCT05148234|566234802|FG001|Phase I|Company closed the trial.|1|||
156858293|NCT05148234|566234803|FG002|Phase I|Company closed the trial.|0|||
156858294|NCT05148234|566234804|FG003|Phase I|Company closed the trial.|0|||
156858295|NCT05148234|566234805|FG004|Phase I|Company closed the trial.|0|||
156858296|NCT05148234|566234806|FG005|Phase I|Company closed the trial.|0|||
156858297|NCT05148234|566234807|FG006|Phase I|Company closed the trial.|0|||
156894070|NCT00769483|566370353|FG004|Overall Study|Withdrawal by Subject|1|||
157158093|NCT01515306|567322982|FG001|Overall Study|Progressive Disease|9|||
156894071|NCT00769483|566370354|FG005|Overall Study|Withdrawal by Subject|0|||
156894072|NCT01306877|566370355|FG000|Overall Study|Lost to Follow-up|3|||
156894073|NCT01306877|566370356|FG001|Overall Study|Lost to Follow-up|3|||
156894074|NCT01306877|566370355|FG000|Overall Study|Physician Decision|0|||
156894075|NCT01306877|566370356|FG001|Overall Study|Physician Decision|1|||
156894076|NCT00999921|566370373|FG000|Overall Study|Lost to Follow-up|10|||
156894077|NCT00999921|566370374|FG001|Overall Study|Lost to Follow-up|19|||
156894078|NCT00495131|566370381|FG000|Overall Study|Adverse Event|6|||
156894079|NCT00495131|566370382|FG001|Overall Study|Adverse Event|2|||
156894080|NCT00495131|566370381|FG000|Overall Study|Lack of Efficacy|0|||
156894081|NCT00495131|566370382|FG001|Overall Study|Lack of Efficacy|2|||
156894082|NCT00495131|566370381|FG000|Overall Study|Lost to Follow-up|0|||
156894083|NCT00495131|566370382|FG001|Overall Study|Lost to Follow-up|2|||
156894084|NCT00495131|566370381|FG000|Overall Study|Withdrawal by Subject|1|||
156894085|NCT00495131|566370382|FG001|Overall Study|Withdrawal by Subject|0|||
156894086|NCT01280955|566370383|FG000|Overall Study|Death|2|||
156894087|NCT01280955|566370383|FG000|Overall Study|Withdrawal by Subject|1|||
156894088|NCT00976573|566370390|FG000|Overall Study|Ineligible|0|||
156894089|NCT00976573|566370391|FG001|Overall Study|Ineligible|1|||
156894090|NCT00976573|566370390|FG000|Overall Study|Cancel prior to receiving treatment|4|||
156894091|NCT00976573|566370391|FG001|Overall Study|Cancel prior to receiving treatment|2|||
156894092|NCT02117427|566370392|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
156894093|NCT02117427|566370393|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
156894094|NCT02117427|566370394|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
156894095|NCT02117427|566370392|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
156894096|NCT02117427|566370393|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
156894097|NCT02117427|566370394|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
156894098|NCT02117427|566370392|FG000|Overall Study|Physician Decision|0|||
156894099|NCT02117427|566370393|FG001|Overall Study|Physician Decision|2|||
156894100|NCT02117427|566370394|FG002|Overall Study|Physician Decision|0|||
156894101|NCT02117427|566370392|FG000|Overall Study|No longer meets inclusion criteria|0|||
156894102|NCT02117427|566370393|FG001|Overall Study|No longer meets inclusion criteria|1|||
156894103|NCT02117427|566370394|FG002|Overall Study|No longer meets inclusion criteria|0|||
156894104|NCT02117427|566370392|FG000|Overall Study|Death|0|||
156894105|NCT02117427|566370393|FG001|Overall Study|Death|1|||
156894106|NCT02117427|566370394|FG002|Overall Study|Death|0|||
156894107|NCT02730208|566370395|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156894108|NCT02730208|566370396|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156894109|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
156894110|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
156894111|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
156894112|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
156894113|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
156894114|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
156894115|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
156894116|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
156894117|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
156894118|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
156894119|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
156894120|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
156894121|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
156894122|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
156894123|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
156894124|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
156894125|NCT00491556|566370414|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
156894126|NCT00491556|566370415|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
156894127|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
156894128|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
156894129|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
156894130|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
157158094|NCT01515306|567322981|FG000|Overall Study|Withdrawal by Subject|1|||
157158095|NCT01515306|567322982|FG001|Overall Study|Withdrawal by Subject|2|||
157158096|NCT01515306|567322981|FG000|Overall Study|Physician Decision|1|||
157158097|NCT01515306|567322982|FG001|Overall Study|Physician Decision|1|||
156894131|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
157158098|NCT01204658|567322985|FG000|Primary Phase|Adverse Event|0|||
156894132|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
156894133|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
156894134|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
156894135|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
157158099|NCT01204658|567322986|FG001|Primary Phase|Adverse Event|0|||
157158100|NCT01204658|567322987|FG002|Primary Phase|Adverse Event|1|||
156894136|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
156894137|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
156894138|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
156894139|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
156894140|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
156894141|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
156894142|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
156894143|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
156894144|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
156894145|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
156894146|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
157225489|NCT03594123|567571446|FG001|Overall Study|Site Terminated by Sponsor|1|||
157225490|NCT03594123|567571445|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
156858298|NCT05148234|566234808|FG007|Phase I|Company closed the trial.|0|||
156858299|NCT04750642|566234810|FG000|Overall Study|Adverse Event|1|||
156858300|NCT04750642|566234811|FG001|Overall Study|Adverse Event|0|||
156894147|NCT00491556|566370414|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
156894148|NCT00491556|566370415|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
156894149|NCT02418156|566370416|FG000|Overall Study|Lost to Follow-up|12|||
156894150|NCT02418156|566370416|FG000|Overall Study|Death|2|||
156894151|NCT02418156|566370416|FG000|Overall Study|Physician Decision|1|||
156858301|NCT04750642|566234810|FG000|Overall Study|Withdrawal by Subject|0|||
156858302|NCT04750642|566234811|FG001|Overall Study|Withdrawal by Subject|1|||
156858303|NCT04750642|566234810|FG000|Overall Study|Protocol Violation|0|||
156858304|NCT04750642|566234811|FG001|Overall Study|Protocol Violation|1|||
156858305|NCT01650194|566234813|FG000|Overall Study|Progressive Disease (PD)|35|||
156858306|NCT01650194|566234813|FG000|Overall Study|Withdrawal by Subject|2|||
156858307|NCT01650194|566234813|FG000|Overall Study|Miscellaneous|10|||
156858308|NCT03409796|566236594|FG000|Overall Study|Adverse Event|2|||
156858309|NCT03409796|566236595|FG001|Overall Study|Adverse Event|0|||
156858310|NCT03409796|566236594|FG000|Overall Study|Other|0|||
156858311|NCT03409796|566236595|FG001|Overall Study|Other|1|||
156858312|NCT00740220|566236596|FG000|Overall Study|screen failures (non-COPD patients)|9|||
156858313|NCT00633477|566236597|FG000|Overall Study|Death|1|||
156858314|NCT00633477|566236598|FG001|Overall Study|Death|0|||
156858315|NCT00633477|566236597|FG000|Overall Study|Randomized but not treated|1|||
156858316|NCT00633477|566236598|FG001|Overall Study|Randomized but not treated|0|||
156858317|NCT00770653|566236602|FG000|Overall Study|Adverse Event|13|||
156858318|NCT00770653|566236603|FG001|Overall Study|Adverse Event|5|||
156858319|NCT00770653|566236602|FG000|Overall Study|Protocol Violation|8|||
156858320|NCT00770653|566236603|FG001|Overall Study|Protocol Violation|6|||
156858321|NCT00770653|566236602|FG000|Overall Study|Withdrawal by Subject|4|||
156858322|NCT00770653|566236603|FG001|Overall Study|Withdrawal by Subject|7|||
156858323|NCT00770653|566236602|FG000|Overall Study|Lack of Compliance|1|||
156858324|NCT00770653|566236603|FG001|Overall Study|Lack of Compliance|4|||
156858325|NCT00770653|566236602|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
156858326|NCT00770653|566236603|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
156858327|NCT00770653|566236602|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
156858328|NCT00770653|566236603|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
156858329|NCT00770653|566236602|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
156858330|NCT00770653|566236603|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
156858331|NCT00770653|566236602|FG000|Overall Study|Lost to Follow-up|1|||
156858332|NCT00770653|566236603|FG001|Overall Study|Lost to Follow-up|2|||
156858333|NCT00770653|566236602|FG000|Overall Study|Physician Decision|1|||
156858334|NCT00770653|566236603|FG001|Overall Study|Physician Decision|0|||
156858335|NCT04906499|566236609|FG000|Overall Study|Lack of time|1|||
156858336|NCT00644423|566236612|FG000|Overall Study|Lost to Follow-up|1|||
156858337|NCT00644423|566236613|FG001|Overall Study|Lost to Follow-up|1|||
156858338|NCT01908426|566236614|FG000|Overall Study|Adverse Event|98|||
156858339|NCT01908426|566236615|FG001|Overall Study|Adverse Event|11|||
156858340|NCT01908426|566236614|FG000|Overall Study|Clinical Deterioration|72|||
156894152|NCT02418156|566370416|FG000|Overall Study|Withdrawal by Subject|1|||
156894153|NCT02418156|566370416|FG000|Overall Study|Subject refused to return|1|||
156894154|NCT01909453|566370417|FG000|Overall Study|Ongoing|118|||
156858341|NCT01908426|566236615|FG001|Overall Study|Clinical Deterioration|38|||
156858342|NCT01908426|566236614|FG000|Overall Study|Lack of Efficacy|3|||
156858343|NCT01908426|566236615|FG001|Overall Study|Lack of Efficacy|0|||
156858344|NCT01908426|566236614|FG000|Overall Study|Lost to Follow-up|0|||
156858345|NCT01908426|566236615|FG001|Overall Study|Lost to Follow-up|1|||
156858346|NCT01908426|566236614|FG000|Overall Study|Physician Decision|3|||
156858347|NCT01908426|566236615|FG001|Overall Study|Physician Decision|3|||
156858348|NCT01908426|566236614|FG000|Overall Study|Withdrawal by Subject|11|||
156858349|NCT01908426|566236615|FG001|Overall Study|Withdrawal by Subject|6|||
156858350|NCT01908426|566236614|FG000|Overall Study|Progressive Disease|206|||
157225491|NCT03594123|567571446|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
156858351|NCT01908426|566236615|FG001|Overall Study|Progressive Disease|152|||
156894155|NCT01909453|566370418|FG001|Overall Study|Ongoing|103|||
156894156|NCT01909453|566370419|FG002|Overall Study|Ongoing|83|||
156894157|NCT01909453|566370420|FG003|Overall Study|Ongoing|164|||
156894158|NCT01909453|566370421|FG004|Overall Study|Ongoing|50|||
156894159|NCT01909453|566370417|FG000|Overall Study|Death|69|||
156894160|NCT01909453|566370418|FG001|Overall Study|Death|74|||
156894161|NCT01909453|566370419|FG002|Overall Study|Death|88|||
156894162|NCT01909453|566370420|FG003|Overall Study|Death|86|||
156894163|NCT01909453|566370421|FG004|Overall Study|Death|29|||
156894164|NCT01909453|566370417|FG000|Overall Study|Lost to Follow-up|3|||
156894165|NCT01909453|566370418|FG001|Overall Study|Lost to Follow-up|4|||
156894166|NCT01909453|566370419|FG002|Overall Study|Lost to Follow-up|4|||
156894167|NCT01909453|566370420|FG003|Overall Study|Lost to Follow-up|3|||
156894168|NCT01909453|566370421|FG004|Overall Study|Lost to Follow-up|3|||
156894169|NCT01909453|566370417|FG000|Overall Study|Withdrawal by Subject|2|||
156894170|NCT01909453|566370418|FG001|Overall Study|Withdrawal by Subject|13|||
156894171|NCT01909453|566370419|FG002|Overall Study|Withdrawal by Subject|16|||
156894172|NCT01909453|566370420|FG003|Overall Study|Withdrawal by Subject|5|||
156894173|NCT01909453|566370421|FG004|Overall Study|Withdrawal by Subject|4|||
156894174|NCT01897714|566372065|FG000|Phase I (Dose Escalation)|Disease progression|3|||
156894175|NCT01897714|566372066|FG001|Phase I (Dose Escalation)|Disease progression|5|||
156894176|NCT01897714|566372067|FG002|Phase I (Dose Escalation)|Disease progression|1|||
156894177|NCT01897714|566372068|FG003|Phase I (Dose Escalation)|Disease progression|3|||
156894178|NCT01897714|566372069|FG004|Phase I (Dose Escalation)|Disease progression|0|||
156894179|NCT01897714|566372070|FG005|Phase I (Dose Escalation)|Disease progression|0|||
156894180|NCT01897714|566372065|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
156894181|NCT01897714|566372066|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
156894182|NCT01897714|566372067|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
156894183|NCT01897714|566372068|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
156894184|NCT01897714|566372069|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
156894185|NCT01897714|566372070|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
156894186|NCT01897714|566372065|FG000|Phase I (Dose Escalation)|Other|0|||
156894187|NCT01897714|566372066|FG001|Phase I (Dose Escalation)|Other|1|||
156894188|NCT01897714|566372067|FG002|Phase I (Dose Escalation)|Other|0|||
156894189|NCT01897714|566372068|FG003|Phase I (Dose Escalation)|Other|0|||
156894190|NCT01897714|566372069|FG004|Phase I (Dose Escalation)|Other|0|||
156894191|NCT01897714|566372070|FG005|Phase I (Dose Escalation)|Other|0|||
156894192|NCT01897714|566372065|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
156894193|NCT01897714|566372066|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
156894194|NCT01897714|566372067|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
156894195|NCT01897714|566372068|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
156894196|NCT01897714|566372069|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
156894197|NCT01897714|566372070|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
156894198|NCT01897714|566372065|FG000|Phase II (MTD)|Lost to Follow-up|0|||
156894199|NCT01897714|566372066|FG001|Phase II (MTD)|Lost to Follow-up|0|||
156894200|NCT01897714|566372067|FG002|Phase II (MTD)|Lost to Follow-up|0|||
156894201|NCT01897714|566372068|FG003|Phase II (MTD)|Lost to Follow-up|0|||
156894202|NCT01897714|566372069|FG004|Phase II (MTD)|Lost to Follow-up|1|||
156894203|NCT01897714|566372070|FG005|Phase II (MTD)|Lost to Follow-up|0|||
156894204|NCT01897714|566372065|FG000|Phase II (MTD)|Death|0|||
156894205|NCT01897714|566372066|FG001|Phase II (MTD)|Death|0|||
156894206|NCT01897714|566372067|FG002|Phase II (MTD)|Death|0|||
156894207|NCT01897714|566372068|FG003|Phase II (MTD)|Death|0|||
156894208|NCT01897714|566372069|FG004|Phase II (MTD)|Death|25|||
156894209|NCT01897714|566372070|FG005|Phase II (MTD)|Death|10|||
156894210|NCT01897714|566372065|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
156894211|NCT01897714|566372066|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
156894212|NCT01897714|566372067|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
156894213|NCT01897714|566372068|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
156894214|NCT01897714|566372069|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
156894215|NCT01897714|566372070|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
156894216|NCT01897714|566372065|FG000|Phase II (MTD)|Other|0|||
156894217|NCT01897714|566372066|FG001|Phase II (MTD)|Other|0|||
156894218|NCT01897714|566372067|FG002|Phase II (MTD)|Other|0|||
156894219|NCT01897714|566372068|FG003|Phase II (MTD)|Other|0|||
156894220|NCT01897714|566372069|FG004|Phase II (MTD)|Other|3|||
156894221|NCT01897714|566372070|FG005|Phase II (MTD)|Other|0|||
156894222|NCT00048061|566372077|FG000|Overall Study|Adverse Event|41|||
156894223|NCT00048061|566372078|FG001|Overall Study|Adverse Event|32|||
156894224|NCT00048061|566372079|FG002|Overall Study|Adverse Event|44|||
156894225|NCT00048061|566372080|FG003|Overall Study|Adverse Event|37|||
156894226|NCT00048061|566372077|FG000|Overall Study|Lost to Follow-up|3|||
156894227|NCT00048061|566372078|FG001|Overall Study|Lost to Follow-up|2|||
156894228|NCT00048061|566372079|FG002|Overall Study|Lost to Follow-up|4|||
156894229|NCT00048061|566372080|FG003|Overall Study|Lost to Follow-up|5|||
156894230|NCT00048061|566372077|FG000|Overall Study|Withdrawal by Subject|20|||
156894231|NCT00048061|566372078|FG001|Overall Study|Withdrawal by Subject|29|||
156894232|NCT00048061|566372079|FG002|Overall Study|Withdrawal by Subject|29|||
156894233|NCT00048061|566372080|FG003|Overall Study|Withdrawal by Subject|32|||
156894234|NCT00048061|566372077|FG000|Overall Study|Did not follow-up|5|||
156894235|NCT00048061|566372078|FG001|Overall Study|Did not follow-up|5|||
156894236|NCT00048061|566372079|FG002|Overall Study|Did not follow-up|4|||
156894237|NCT00048061|566372080|FG003|Overall Study|Did not follow-up|5|||
156894238|NCT00048061|566372077|FG000|Overall Study|Early improvement|6|||
156894239|NCT00048061|566372078|FG001|Overall Study|Early improvement|5|||
156894240|NCT00048061|566372079|FG002|Overall Study|Early improvement|3|||
156894241|NCT00048061|566372080|FG003|Overall Study|Early improvement|0|||
156894242|NCT03189381|566372082|FG000|Overall Study|Death|1|||
156894243|NCT03189381|566372083|FG001|Overall Study|Death|0|||
156894244|NCT00107952|566372084|FG000|Overall Study|Death|75|||
156894245|NCT00107952|566372085|FG001|Overall Study|Death|61|||
156894246|NCT00107952|566372084|FG000|Overall Study|Lost to Follow-up|0|||
156894247|NCT00107952|566372085|FG001|Overall Study|Lost to Follow-up|3|||
156894248|NCT00107952|566372084|FG000|Overall Study|Withdrawal by Subject|9|||
156894249|NCT00107952|566372085|FG001|Overall Study|Withdrawal by Subject|6|||
156894250|NCT00107952|566372084|FG000|Overall Study|Other|2|||
156894251|NCT00107952|566372085|FG001|Overall Study|Other|5|||
156894252|NCT00107952|566372084|FG000|Overall Study|Never received study treatment|9|||
156894253|NCT00107952|566372085|FG001|Overall Study|Never received study treatment|6|||
156894254|NCT00251004|566372086|FG000|Overall Study|Withdrawal by Subject|23|||
156894255|NCT00251004|566372087|FG001|Overall Study|Withdrawal by Subject|16|||
156894256|NCT00251004|566372088|FG002|Overall Study|Withdrawal by Subject|14|||
156894257|NCT00251004|566372086|FG000|Overall Study|Death|9|||
156894258|NCT00251004|566372087|FG001|Overall Study|Death|10|||
156894259|NCT00251004|566372088|FG002|Overall Study|Death|8|||
156894260|NCT00251004|566372086|FG000|Overall Study|Lost to Follow-up|1|||
156894261|NCT00251004|566372087|FG001|Overall Study|Lost to Follow-up|2|||
156894262|NCT00251004|566372088|FG002|Overall Study|Lost to Follow-up|1|||
156894263|NCT00251004|566372086|FG000|Overall Study|Graft Loss|12|||
156894264|NCT00251004|566372087|FG001|Overall Study|Graft Loss|13|||
156894265|NCT00251004|566372088|FG002|Overall Study|Graft Loss|8|||
156894266|NCT03475875|566372089|FG000|Period 1|Lost to Follow-up|1|||
156894267|NCT03475875|566372090|FG001|Period 1|Lost to Follow-up|0|||
156894268|NCT03475875|566372089|FG000|Period 1|Adverse Event|2|||
156894269|NCT03475875|566372090|FG001|Period 1|Adverse Event|1|||
156894270|NCT03475875|566372089|FG000|Period 2|Adverse Event|3|||
156894271|NCT03475875|566372090|FG001|Period 2|Adverse Event|0|||
156894272|NCT03475875|566372089|FG000|Period 2|Protocol Violation|0|||
156894273|NCT03475875|566372090|FG001|Period 2|Protocol Violation|1|||
156894274|NCT02632838|566372093|FG000|Overall Study|Withdrawal by Subject|3|||
156894275|NCT02632838|566372094|FG001|Overall Study|Withdrawal by Subject|0|||
156894276|NCT02632838|566372093|FG000|Overall Study|Lost to Follow-up|0|||
156894277|NCT02632838|566372094|FG001|Overall Study|Lost to Follow-up|2|||
156894278|NCT03945175|566372095|FG000|Overall Study|Did not meet inclusion criteria|31|||
156894279|NCT03945175|566372095|FG000|Overall Study|Withdrew consent|2|||
156894280|NCT03945175|566372095|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
156894281|NCT03945175|566372095|FG000|Overall Study|Early termination during Mydayis treatment|1|||
156894282|NCT01369485|566372096|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
156894283|NCT01369485|566372097|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
156894284|NCT01369485|566372096|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
157158101|NCT01204658|567322988|FG003|Primary Phase|Adverse Event|0|||
157158102|NCT04594239|567322993|FG000|Overall Study|Withdrawal by Subject|3|||
157158103|NCT04594239|567322994|FG001|Overall Study|Withdrawal by Subject|4|||
157158104|NCT04594239|567322995|FG002|Overall Study|Withdrawal by Subject|2|||
157158105|NCT04594239|567322996|FG003|Overall Study|Withdrawal by Subject|4|||
157158106|NCT04594239|567322993|FG000|Overall Study|Lost to Follow-up|8|||
157158107|NCT04594239|567322994|FG001|Overall Study|Lost to Follow-up|5|||
156894285|NCT01369485|566372097|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
156894286|NCT01369485|566372096|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
156894287|NCT01369485|566372097|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
156894288|NCT01369485|566372096|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
156894289|NCT01369485|566372097|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
156894290|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
156894291|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
157158108|NCT04594239|567322995|FG002|Overall Study|Lost to Follow-up|4|||
156894292|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
156894293|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
156894294|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
156894295|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
156894296|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
156894297|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
156894298|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
157158109|NCT04594239|567322996|FG003|Overall Study|Lost to Follow-up|6|||
156894299|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
157158110|NCT04594239|567322993|FG000|Overall Study|Subject relocated|0|||
156894300|NCT01369485|566372096|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
156894301|NCT01369485|566372097|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
156894302|NCT02942576|566372098|FG000|Overall Study|Adverse Event|28|||
156894303|NCT02942576|566372099|FG001|Overall Study|Adverse Event|6|||
156894304|NCT02942576|566372098|FG000|Overall Study|Withdrawal by Subject|7|||
156894305|NCT02942576|566372099|FG001|Overall Study|Withdrawal by Subject|5|||
156894306|NCT02942576|566372098|FG000|Overall Study|Physician Decision|1|||
156894307|NCT02942576|566372099|FG001|Overall Study|Physician Decision|4|||
156894308|NCT02942576|566372098|FG000|Overall Study|Other|10|||
156894309|NCT02942576|566372099|FG001|Overall Study|Other|8|||
156894310|NCT00006389|566372100|FG000|Overall Study|Adverse Event|1|||
156894311|NCT01017575|566372110|FG000|Overall Study|Lack of Efficacy|0|||
156894312|NCT01017575|566372111|FG001|Overall Study|Lack of Efficacy|1|||
156894313|NCT01017575|566372112|FG002|Overall Study|Lack of Efficacy|0|||
156894314|NCT01017575|566372113|FG003|Overall Study|Lack of Efficacy|1|||
156894315|NCT01017575|566372114|FG004|Overall Study|Lack of Efficacy|1|||
156894316|NCT01017575|566372110|FG000|Overall Study|Adverse Event|0|||
156894317|NCT01017575|566372111|FG001|Overall Study|Adverse Event|1|||
156894318|NCT01017575|566372112|FG002|Overall Study|Adverse Event|0|||
156894319|NCT01017575|566372113|FG003|Overall Study|Adverse Event|0|||
156894320|NCT01017575|566372114|FG004|Overall Study|Adverse Event|2|||
156894321|NCT01017575|566372110|FG000|Overall Study|Withdrawal by Subject|1|||
156894322|NCT01017575|566372111|FG001|Overall Study|Withdrawal by Subject|0|||
156894323|NCT01017575|566372112|FG002|Overall Study|Withdrawal by Subject|0|||
156894324|NCT01017575|566372113|FG003|Overall Study|Withdrawal by Subject|0|||
156894325|NCT01017575|566372114|FG004|Overall Study|Withdrawal by Subject|0|||
156894326|NCT01962922|566372115|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
156894327|NCT01962922|566372116|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
156894328|NCT01962922|566372115|FG000|PK Portion Day 7|non-compliance|1|||
156894329|NCT01962922|566372116|FG001|PK Portion Day 7|non-compliance|0|||
156894330|NCT01962922|566372115|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
156894331|NCT01962922|566372116|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
156894332|NCT01962922|566372115|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
156894333|NCT01962922|566372116|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
156894334|NCT03224546|566372120|FG000|Overall Study|Lost to Follow-up|9|||
156894335|NCT03224546|566372121|FG001|Overall Study|Lost to Follow-up|8|||
156894336|NCT03224546|566372122|FG002|Overall Study|Lost to Follow-up|3|||
156894337|NCT03224546|566372120|FG000|Overall Study|Withdrawal by Subject|7|||
156894338|NCT03224546|566372121|FG001|Overall Study|Withdrawal by Subject|14|||
156894339|NCT03224546|566372122|FG002|Overall Study|Withdrawal by Subject|12|||
156894340|NCT00744471|566372123|FG000|Overall Study|Randomized but not treated|1|||
156894341|NCT00744471|566372124|FG001|Overall Study|Randomized but not treated|1|||
156894342|NCT00744471|566372125|FG002|Overall Study|Randomized but not treated|4|||
156894343|NCT00744471|566372126|FG003|Overall Study|Randomized but not treated|0|||
156858352|NCT01908426|566236614|FG000|Overall Study|Protocol Violation|1|||
156858353|NCT01908426|566236615|FG001|Overall Study|Protocol Violation|0|||
156858354|NCT01908426|566236614|FG000|Overall Study|No Study Treatment Given|3|||
156858355|NCT01908426|566236615|FG001|Overall Study|No Study Treatment Given|0|||
156858356|NCT03525444|566236616|FG000|Overall Study|Adverse Event|0|||
156858357|NCT03525444|566236617|FG001|Overall Study|Adverse Event|1|||
156858358|NCT03525444|566236616|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156858359|NCT03525444|566236617|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
156858360|NCT03525444|566236616|FG000|Overall Study|Other|0|||
156858361|NCT03525444|566236617|FG001|Overall Study|Other|1|||
156858362|NCT00262860|566236620|FG000|Overall Study|Adverse Event|2|||
156858363|NCT00878501|566236629|FG000|Overall Study|Adverse Event|11|||
156858364|NCT00878501|566236630|FG001|Overall Study|Adverse Event|3|||
156858365|NCT00878501|566236631|FG002|Overall Study|Adverse Event|3|||
156858366|NCT00878501|566236629|FG000|Overall Study|Lack of Efficacy|2|||
156858367|NCT00878501|566236630|FG001|Overall Study|Lack of Efficacy|1|||
156858368|NCT00878501|566236631|FG002|Overall Study|Lack of Efficacy|0|||
156858369|NCT00878501|566236629|FG000|Overall Study|Withdrawal by Subject|2|||
156858370|NCT00878501|566236630|FG001|Overall Study|Withdrawal by Subject|1|||
156858371|NCT00878501|566236631|FG002|Overall Study|Withdrawal by Subject|2|||
156858372|NCT00878501|566236629|FG000|Overall Study|Protocol Violation|0|||
156858373|NCT00878501|566236630|FG001|Overall Study|Protocol Violation|0|||
156858374|NCT00878501|566236631|FG002|Overall Study|Protocol Violation|1|||
156858375|NCT00878501|566236629|FG000|Overall Study|Incorrect enrolment|1|||
156858376|NCT00878501|566236630|FG001|Overall Study|Incorrect enrolment|2|||
156858377|NCT00878501|566236631|FG002|Overall Study|Incorrect enrolment|0|||
156858378|NCT00878501|566236629|FG000|Overall Study|Intake of prohibited concom. medication|0|||
156858379|NCT00878501|566236630|FG001|Overall Study|Intake of prohibited concom. medication|0|||
156858380|NCT00878501|566236631|FG002|Overall Study|Intake of prohibited concom. medication|1|||
156858381|NCT00878501|566236629|FG000|Overall Study|Mis-randomisation of patient|1|||
156858382|NCT00878501|566236630|FG001|Overall Study|Mis-randomisation of patient|0|||
156858383|NCT00878501|566236631|FG002|Overall Study|Mis-randomisation of patient|0|||
156894344|NCT00744471|566372123|FG000|Overall Study|Death|0|||
156894345|NCT00744471|566372124|FG001|Overall Study|Death|0|||
156894346|NCT00744471|566372125|FG002|Overall Study|Death|0|||
156894347|NCT00744471|566372126|FG003|Overall Study|Death|1|||
156894348|NCT00744471|566372123|FG000|Overall Study|Adverse Event|6|||
156894349|NCT00744471|566372124|FG001|Overall Study|Adverse Event|7|||
156894350|NCT00744471|566372125|FG002|Overall Study|Adverse Event|5|||
156894351|NCT00744471|566372126|FG003|Overall Study|Adverse Event|9|||
156894352|NCT00744471|566372123|FG000|Overall Study|Withdrawal by Subject|9|||
156894353|NCT00744471|566372124|FG001|Overall Study|Withdrawal by Subject|9|||
156894354|NCT00744471|566372125|FG002|Overall Study|Withdrawal by Subject|15|||
156894355|NCT00744471|566372126|FG003|Overall Study|Withdrawal by Subject|12|||
156894356|NCT00744471|566372123|FG000|Overall Study|Protocol Violation|1|||
156894357|NCT00744471|566372124|FG001|Overall Study|Protocol Violation|4|||
156894358|NCT00744471|566372125|FG002|Overall Study|Protocol Violation|1|||
156894359|NCT00744471|566372126|FG003|Overall Study|Protocol Violation|2|||
156894360|NCT00744471|566372123|FG000|Overall Study|Entered extension study|41|||
156894361|NCT00744471|566372124|FG001|Overall Study|Entered extension study|84|||
156894362|NCT00744471|566372125|FG002|Overall Study|Entered extension study|100|||
156894363|NCT00744471|566372126|FG003|Overall Study|Entered extension study|91|||
156894364|NCT00744471|566372123|FG000|Overall Study|Other|2|||
156894365|NCT00744471|566372124|FG001|Overall Study|Other|3|||
156894366|NCT00744471|566372125|FG002|Overall Study|Other|6|||
156894367|NCT00744471|566372126|FG003|Overall Study|Other|2|||
156894368|NCT00744471|566372123|FG000|Overall Study|Lack of Efficacy|83|||
156894369|NCT00744471|566372124|FG001|Overall Study|Lack of Efficacy|37|||
156894370|NCT00744471|566372125|FG002|Overall Study|Lack of Efficacy|19|||
156894371|NCT00744471|566372126|FG003|Overall Study|Lack of Efficacy|31|||
156894372|NCT00744471|566372123|FG000|Overall Study|Lost to Follow-up|0|||
156894373|NCT00744471|566372124|FG001|Overall Study|Lost to Follow-up|0|||
156894374|NCT00744471|566372125|FG002|Overall Study|Lost to Follow-up|2|||
156894375|NCT00744471|566372126|FG003|Overall Study|Lost to Follow-up|0|||
156894376|NCT04706416|566372127|FG000|Overall Study|Lost to Follow-up|2|||
156894377|NCT04706416|566372128|FG001|Overall Study|Lost to Follow-up|0|||
156894378|NCT01484054|566372132|FG000|Period 1|Withdrawal by Subject|0|||
156894379|NCT01484054|566372133|FG001|Period 1|Withdrawal by Subject|1|||
156894380|NCT05281601|566372134|FG000|Overall Study|Physician Decision|2|||
156894381|NCT05281601|566372135|FG001|Overall Study|Physician Decision|0|||
156894382|NCT05281601|566372134|FG000|Overall Study|Lost to Follow-up|2|||
156894383|NCT05281601|566372135|FG001|Overall Study|Lost to Follow-up|0|||
156894384|NCT05281601|566372134|FG000|Overall Study|Death|1|||
156894385|NCT05281601|566372135|FG001|Overall Study|Death|0|||
156894386|NCT05281601|566372134|FG000|Overall Study|Withdrawal by parent/guardian|2|||
156894387|NCT05281601|566372135|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156894388|NCT00995865|566372142|FG000|Overall Study|Protocol Violation|2|||
156894389|NCT00995865|566372143|FG001|Overall Study|Protocol Violation|0|||
156894390|NCT00995865|566372144|FG002|Overall Study|Protocol Violation|0|||
156894391|NCT00995865|566372142|FG000|Overall Study|Lost to Follow-up|0|||
156894392|NCT00995865|566372143|FG001|Overall Study|Lost to Follow-up|0|||
156894393|NCT00995865|566372144|FG002|Overall Study|Lost to Follow-up|1|||
156894394|NCT02021656|566372152|FG000|Overall Study|Adverse Event|1|||
156894395|NCT02021656|566372152|FG000|Overall Study|Lack of Efficacy|2|||
156894396|NCT02021656|566372152|FG000|Overall Study|Lost to Follow-up|1|||
156894397|NCT02021656|566372152|FG000|Overall Study|Withdrew Consent|2|||
156894398|NCT00510952|566372153|FG000|Overall Study|Adverse Event|1|||
156894399|NCT00510952|566372154|FG001|Overall Study|Adverse Event|0|||
156894400|NCT00510952|566372153|FG000|Overall Study|Entry Criteria Not Met|3|||
156894401|NCT00510952|566372154|FG001|Overall Study|Entry Criteria Not Met|1|||
156894402|NCT00510952|566372153|FG000|Overall Study|Lost to Follow-up|5|||
156894403|NCT00510952|566372154|FG001|Overall Study|Lost to Follow-up|3|||
156894404|NCT00510952|566372153|FG000|Overall Study|Physician Decision|1|||
156894405|NCT00510952|566372154|FG001|Overall Study|Physician Decision|1|||
156894406|NCT00510952|566372153|FG000|Overall Study|Protocol Violation|7|||
156894407|NCT00510952|566372154|FG001|Overall Study|Protocol Violation|4|||
156894408|NCT00510952|566372153|FG000|Overall Study|Sponsor Decision|1|||
156894409|NCT00510952|566372154|FG001|Overall Study|Sponsor Decision|0|||
156894410|NCT00510952|566372153|FG000|Overall Study|Withdrawal by Subject|6|||
156894411|NCT00510952|566372154|FG001|Overall Study|Withdrawal by Subject|7|||
156894412|NCT00510952|566372153|FG000|Overall Study|Did Not Receive Study Drug|2|||
156894413|NCT00510952|566372154|FG001|Overall Study|Did Not Receive Study Drug|0|||
156894414|NCT03119701|566372156|FG000|6-day Dosing|Death|4|||
156894415|NCT03119701|566372157|FG001|6-day Dosing|Death|1|||
156894416|NCT03119701|566372156|FG000|6-day Dosing|Adverse Event|3|||
156894417|NCT03119701|566372157|FG001|6-day Dosing|Adverse Event|0|||
156894418|NCT03119701|566372156|FG000|6-day Dosing|Physician Decision|0|||
156894419|NCT03119701|566372157|FG001|6-day Dosing|Physician Decision|1|||
156894420|NCT03119701|566372156|FG000|6-day Dosing|Withdrawal by Subject|0|||
156894421|NCT03119701|566372157|FG001|6-day Dosing|Withdrawal by Subject|1|||
156894422|NCT03119701|566372156|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
156894423|NCT03119701|566372157|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
156894424|NCT00596362|566372159|FG000|Overall Study|Progressive Disease|1|||
156894425|NCT00817479|566372160|FG000|Overall Study|Physician Decision|1|||
156894426|NCT00817479|566372161|FG001|Overall Study|Physician Decision|1|||
156894427|NCT02793128|566372164|FG000|Overall Study|Death|4|||
156894428|NCT02793128|566372164|FG000|Overall Study|Withdrawal by Subject|2|||
156894429|NCT02793128|566372164|FG000|Overall Study|Physician Decision|1|||
156894430|NCT02793128|566372164|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
156894431|NCT02793128|566372164|FG000|Overall Study|Patient elected nephroureterectomy|1|||
156894432|NCT02359851|566372165|FG000|Overall Study|Death|1|||
156894433|NCT02359851|566372165|FG000|Overall Study|Disease progression|1|||
156894434|NCT00055471|566372166|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
156894435|NCT00055471|566372167|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
156894436|NCT00055471|566372168|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
156894437|NCT00055471|566372166|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
156894438|NCT00055471|566372167|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
156894439|NCT00055471|566372168|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
156894440|NCT00055471|566372166|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
156894441|NCT00055471|566372167|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
156894442|NCT00055471|566372168|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
156894443|NCT01854944|566372169|FG000|Overall Study|Withdrawal by Subject|0|||
156894444|NCT01854944|566372170|FG001|Overall Study|Withdrawal by Subject|0|||
156894445|NCT01854944|566372171|FG002|Overall Study|Withdrawal by Subject|1|||
156894446|NCT00282347|566372174|FG000|Treatment Period|Death|2|||
156894447|NCT00282347|566372175|FG001|Treatment Period|Death|0|||
156894448|NCT00282347|566372174|FG000|Treatment Period|Lost to Follow-up|2|||
156894449|NCT00282347|566372175|FG001|Treatment Period|Lost to Follow-up|5|||
156894450|NCT00282347|566372174|FG000|Treatment Period|Withdrawal by Subject|1|||
156894451|NCT00282347|566372175|FG001|Treatment Period|Withdrawal by Subject|3|||
156894452|NCT00282347|566372174|FG000|Treatment Period|Physician Decision|0|||
156894453|NCT00282347|566372175|FG001|Treatment Period|Physician Decision|1|||
156894454|NCT00282347|566372174|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
156894455|NCT00282347|566372175|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
156894456|NCT00282347|566372174|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
156894457|NCT00282347|566372175|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
156894458|NCT00282347|566372174|FG000|Safety Follow-up Period|Physician Decision|1|||
156894459|NCT00282347|566372175|FG001|Safety Follow-up Period|Physician Decision|1|||
156894460|NCT00282347|566372174|FG000|Safety Follow-up Period|Protocol Deviation|0|||
156894461|NCT00282347|566372175|FG001|Safety Follow-up Period|Protocol Deviation|2|||
156894462|NCT00282347|566372174|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
156894463|NCT00282347|566372175|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
156894464|NCT00282347|566372174|FG000|B Cell Follow-up Period|Physician Decision|1|||
156894465|NCT00282347|566372175|FG001|B Cell Follow-up Period|Physician Decision|0|||
156894466|NCT00282347|566372174|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
156894467|NCT00282347|566372175|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
156894468|NCT02101112|566372176|FG000|Overall Study|Adverse Event|0|||
156894469|NCT02101112|566372177|FG001|Overall Study|Adverse Event|0|||
156894470|NCT02101112|566372178|FG002|Overall Study|Adverse Event|1|||
156894471|NCT02101112|566372179|FG003|Overall Study|Adverse Event|0|||
156894472|NCT02101112|566372180|FG004|Overall Study|Adverse Event|0|||
156894473|NCT02101112|566372181|FG005|Overall Study|Adverse Event|0|||
156894474|NCT02101112|566372176|FG000|Overall Study|Withdrawal by Subject|0|||
156894475|NCT02101112|566372177|FG001|Overall Study|Withdrawal by Subject|0|||
156894476|NCT02101112|566372178|FG002|Overall Study|Withdrawal by Subject|0|||
156894477|NCT02101112|566372179|FG003|Overall Study|Withdrawal by Subject|0|||
156894478|NCT02101112|566372180|FG004|Overall Study|Withdrawal by Subject|1|||
156894479|NCT02101112|566372181|FG005|Overall Study|Withdrawal by Subject|0|||
156894480|NCT02125604|566372182|FG000|Overall Study|Other|4|||
156894481|NCT02125604|566372182|FG000|Overall Study|Investigator Decision|1|||
156894482|NCT02125604|566372182|FG000|Overall Study|Lost to Follow-up|2|||
156894483|NCT02125604|566372182|FG000|Overall Study|Consent Withdrawn|4|||
156894484|NCT02125604|566372182|FG000|Overall Study|Adverse Event|20|||
156894485|NCT04340063|566372183|FG000|Overall Study|Withdrawal by Subject|1|||
156894486|NCT04340063|566372184|FG001|Overall Study|Withdrawal by Subject|2|||
157026091|NCT03701763|566849711|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
157026092|NCT03701763|566849712|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
157026093|NCT03701763|566849713|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
156894487|NCT04340063|566372183|FG000|Overall Study|Lost to Follow-up|3|||
156894488|NCT04340063|566372184|FG001|Overall Study|Lost to Follow-up|1|||
157026094|NCT03701763|566849710|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
157026095|NCT03701763|566849711|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
156894489|NCT04340063|566372183|FG000|Overall Study|Protocol Violation|0|||
156894490|NCT04340063|566372184|FG001|Overall Study|Protocol Violation|1|||
156894491|NCT02782923|566372187|FG000|Overall Study|Lost to Follow-up|15|||
156894492|NCT00993044|566372190|FG000|Irinotecan 50 mg|Physician Decision|1|||
156894493|NCT00734747|566372192|FG000|SRS Procedure|No staples placed|3|||
156894494|NCT00734747|566372192|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
156894495|NCT05063318|566372198|FG000|Overall Study|Progressive disease|2|||
156894496|NCT05063318|566372199|FG001|Overall Study|Progressive disease|0|||
156894497|NCT05063318|566372200|FG002|Overall Study|Progressive disease|3|||
156894498|NCT05063318|566372198|FG000|Overall Study|Compassionate use|1|||
156894499|NCT05063318|566372199|FG001|Overall Study|Compassionate use|3|||
156894500|NCT05063318|566372200|FG002|Overall Study|Compassionate use|3|||
156894501|NCT05063318|566372198|FG000|Overall Study|Adverse Event|0|||
156894502|NCT05063318|566372199|FG001|Overall Study|Adverse Event|1|||
156894503|NCT05063318|566372200|FG002|Overall Study|Adverse Event|0|||
156894504|NCT05063318|566372198|FG000|Overall Study|Withdrawal by Subject|0|||
156894505|NCT05063318|566372199|FG001|Overall Study|Withdrawal by Subject|1|||
156894506|NCT05063318|566372200|FG002|Overall Study|Withdrawal by Subject|0|||
156894507|NCT03287635|566372201|FG000|Overall Study|Lost to Follow-up|5|||
156894508|NCT03287635|566372201|FG000|Overall Study|Withdrawal by Subject|1|||
156894509|NCT03287635|566372201|FG000|Overall Study|Physician Decision|1|||
156894510|NCT00323869|566372204|FG000|Overall Study|Death|1|||
156894511|NCT03172910|566373665|FG000|Overall Study|Adverse Event|0|||
156894512|NCT03172910|566373666|FG001|Overall Study|Adverse Event|0|||
156894513|NCT03172910|566373667|FG002|Overall Study|Adverse Event|0|||
156894514|NCT03172910|566373668|FG003|Overall Study|Adverse Event|0|||
156894515|NCT03172910|566373669|FG004|Overall Study|Adverse Event|1|||
156894516|NCT01659658|566373670|FG000|Overall Study|Withdrawal by Patient|18|||
156894517|NCT01659658|566373671|FG001|Overall Study|Withdrawal by Patient|4|||
156894518|NCT01659658|566373672|FG002|Overall Study|Withdrawal by Patient|2|||
156894519|NCT01659658|566373673|FG003|Overall Study|Withdrawal by Patient|0|||
156894520|NCT01659658|566373674|FG004|Overall Study|Withdrawal by Patient|11|||
156894521|NCT01659658|566373670|FG000|Overall Study|Study Terminated by Sponsor|9|||
156894522|NCT01659658|566373671|FG001|Overall Study|Study Terminated by Sponsor|7|||
156894523|NCT01659658|566373672|FG002|Overall Study|Study Terminated by Sponsor|0|||
156894524|NCT01659658|566373673|FG003|Overall Study|Study Terminated by Sponsor|1|||
156894525|NCT01659658|566373674|FG004|Overall Study|Study Terminated by Sponsor|4|||
156894526|NCT01659658|566373670|FG000|Overall Study|Reason not Specified|61|||
156894527|NCT01659658|566373671|FG001|Overall Study|Reason not Specified|15|||
156894528|NCT01659658|566373672|FG002|Overall Study|Reason not Specified|8|||
156894529|NCT01659658|566373673|FG003|Overall Study|Reason not Specified|1|||
156894530|NCT01659658|566373674|FG004|Overall Study|Reason not Specified|34|||
156894531|NCT01659658|566373670|FG000|Overall Study|Lost to Follow-up|2|||
156894532|NCT01659658|566373671|FG001|Overall Study|Lost to Follow-up|0|||
156894533|NCT01659658|566373672|FG002|Overall Study|Lost to Follow-up|0|||
156894534|NCT01659658|566373673|FG003|Overall Study|Lost to Follow-up|0|||
156894535|NCT01659658|566373674|FG004|Overall Study|Lost to Follow-up|0|||
156894536|NCT03875118|566373684|FG000|Overall Study|Withdrawal by Subject|4|||
156894537|NCT03875118|566373685|FG001|Overall Study|Withdrawal by Subject|4|||
156894538|NCT02237911|566373686|FG000|Overall Study|Withdrawal by Subject|4|||
156894539|NCT02237911|566373687|FG001|Overall Study|Withdrawal by Subject|7|||
156894540|NCT02237911|566373688|FG002|Overall Study|Withdrawal by Subject|2|||
156894541|NCT02237911|566373686|FG000|Overall Study|Lost to Follow-up|3|||
156894542|NCT02237911|566373687|FG001|Overall Study|Lost to Follow-up|1|||
156894543|NCT02237911|566373688|FG002|Overall Study|Lost to Follow-up|1|||
156894544|NCT00721123|566373689|FG000|Overall Study|Adverse Event|96|||
156894545|NCT00721123|566373689|FG000|Overall Study|Death|10|||
156894546|NCT00721123|566373689|FG000|Overall Study|Insufficient Therapeutic Response|21|||
156894547|NCT00721123|566373689|FG000|Overall Study|Protocol Violation|1|||
156894548|NCT00721123|566373689|FG000|Overall Study|Refused Treatment|41|||
156894549|NCT00721123|566373689|FG000|Overall Study|Failure to Return|9|||
156894550|NCT00721123|566373689|FG000|Overall Study|Withdrawal by Subject|5|||
156894551|NCT02428608|566373692|FG000|Overall Study|Pregnancy|2|||
157026096|NCT03701763|566849712|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
157158111|NCT04594239|567322994|FG001|Overall Study|Subject relocated|0|||
157158112|NCT04594239|567322995|FG002|Overall Study|Subject relocated|0|||
157158113|NCT04594239|567322996|FG003|Overall Study|Subject relocated|1|||
157158114|NCT02678780|567322997|FG000|Overall Study|Adverse Event|11|||
156894552|NCT02428608|566373692|FG000|Overall Study|Lost to Follow-up|37|||
156894553|NCT02428608|566373692|FG000|Overall Study|Withdrawal by Subject|2|||
156894554|NCT02428608|566373692|FG000|Overall Study|scheduling conflicts|15|||
156894555|NCT02428608|566373692|FG000|Overall Study|moved away|10|||
156894556|NCT02428608|566373692|FG000|Overall Study|Death|1|||
156894557|NCT02428608|566373692|FG000|Overall Study|various|16|||
156894558|NCT03468985|566373693|FG000|Overall Study|Adverse Event|0|||
156894559|NCT03468985|566373694|FG001|Overall Study|Adverse Event|2|||
156894560|NCT03468985|566373695|FG002|Overall Study|Adverse Event|0|||
156894561|NCT03468985|566373696|FG003|Overall Study|Adverse Event|0|||
156894562|NCT03468985|566373693|FG000|Overall Study|Withdrawal by Subject|0|||
156894563|NCT03468985|566373694|FG001|Overall Study|Withdrawal by Subject|0|||
156894564|NCT03468985|566373695|FG002|Overall Study|Withdrawal by Subject|0|||
156894565|NCT03468985|566373696|FG003|Overall Study|Withdrawal by Subject|1|||
157158115|NCT02678780|567322998|FG001|Overall Study|Adverse Event|14|||
156894566|NCT00397943|566373697|FG000|Overall Study|Unspecified reasons|12|||
156894567|NCT00397943|566373698|FG001|Overall Study|Unspecified reasons|9|||
156894568|NCT00397943|566373699|FG002|Overall Study|Unspecified reasons|0|||
156894569|NCT00397943|566373700|FG003|Overall Study|Unspecified reasons|0|||
156894570|NCT00397943|566373701|FG004|Overall Study|Unspecified reasons|0|||
156894571|NCT02806973|566373702|FG000|Period 1|Withdrawal by Subject|0|||
156894572|NCT02806973|566373703|FG001|Period 1|Withdrawal by Subject|2|||
156894573|NCT02806973|566373704|FG002|Period 1|Withdrawal by Subject|1|||
156894574|NCT02806973|566373705|FG003|Period 1|Withdrawal by Subject|1|||
156894575|NCT02806973|566373702|FG000|Period 1|Adverse Event|0|||
156894576|NCT02806973|566373703|FG001|Period 1|Adverse Event|0|||
156894577|NCT02806973|566373704|FG002|Period 1|Adverse Event|0|||
156894578|NCT02806973|566373705|FG003|Period 1|Adverse Event|1|||
156894579|NCT02806973|566373702|FG000|Period 3|Withdrawal by Subject|0|||
156894580|NCT02806973|566373703|FG001|Period 3|Withdrawal by Subject|0|||
156894581|NCT02806973|566373704|FG002|Period 3|Withdrawal by Subject|0|||
156894582|NCT02806973|566373705|FG003|Period 3|Withdrawal by Subject|3|||
156894583|NCT02806973|566373702|FG000|Period 3|Adverse Event|0|||
156894584|NCT02806973|566373703|FG001|Period 3|Adverse Event|0|||
156894585|NCT02806973|566373704|FG002|Period 3|Adverse Event|1|||
156894586|NCT02806973|566373705|FG003|Period 3|Adverse Event|0|||
156894587|NCT04209426|566373708|FG000|Overall Study|Lost to Follow-up|3|||
156894588|NCT04209426|566373709|FG001|Overall Study|Lost to Follow-up|2|||
156894589|NCT04060862|566373710|FG000|Overall Study|Symptomatic Deterioration|1|||
156894590|NCT04060862|566373710|FG000|Overall Study|Un-specified|6|||
156894591|NCT04060862|566373710|FG000|Overall Study|Progressive disease|12|||
156894592|NCT04060862|566373710|FG000|Overall Study|Physician Decision|1|||
156894593|NCT01751802|566373720|FG000|Overall Study|Adverse Event|4|||
156894594|NCT01751802|566373721|FG001|Overall Study|Adverse Event|2|||
156894595|NCT01229397|566373722|FG000|Overall Study|Withdrawal by Subject|3|||
156894596|NCT01229397|566373723|FG001|Overall Study|Withdrawal by Subject|3|||
156894597|NCT01229397|566373722|FG000|Overall Study|Lost to Follow-up|7|||
156894598|NCT01229397|566373723|FG001|Overall Study|Lost to Follow-up|6|||
156894599|NCT01229397|566373722|FG000|Overall Study|Migrated/moved from study area|1|||
156894600|NCT01229397|566373723|FG001|Overall Study|Migrated/moved from study area|0|||
156894601|NCT01869725|566373725|FG000|Overall Study|ineligible after registration|1|||
156894602|NCT01869725|566373725|FG000|Overall Study|Death|1|||
156894603|NCT01869725|566373725|FG000|Overall Study|Lost to Follow-up|2|||
156894604|NCT01143207|566373726|FG000|Overall Study|Lost to Follow-up|2|||
156894605|NCT03416374|566373727|FG000|Between Treatment Period I and II|Other|0|||
156894606|NCT03416374|566373728|FG001|Between Treatment Period I and II|Other|9|||
156894607|NCT03416374|566373727|FG000|Treatment Period II|Lack of Efficacy|3|||
156894608|NCT03416374|566373728|FG001|Treatment Period II|Lack of Efficacy|11|||
156894609|NCT03416374|566373727|FG000|Treatment Period II|Adverse Event|1|||
156894610|NCT03416374|566373728|FG001|Treatment Period II|Adverse Event|4|||
156894611|NCT03416374|566373727|FG000|Treatment Period II|Death|0|||
156894612|NCT03416374|566373728|FG001|Treatment Period II|Death|1|||
156894613|NCT03416374|566373727|FG000|Treatment Period II|Other|0|||
156894614|NCT03416374|566373728|FG001|Treatment Period II|Other|2|||
156894615|NCT03463031|566373731|FG000|Overall Study|Withdrawal by Subject|4|||
156894616|NCT03463031|566373732|FG001|Overall Study|Withdrawal by Subject|2|||
156894617|NCT03463031|566373731|FG000|Overall Study|Investigator/Sponsor Decision|0|||
156894618|NCT03463031|566373732|FG001|Overall Study|Investigator/Sponsor Decision|1|||
156894619|NCT03463031|566373731|FG000|Overall Study|Lost to Follow-up|1|||
156894620|NCT03463031|566373732|FG001|Overall Study|Lost to Follow-up|1|||
156894621|NCT03463031|566373731|FG000|Overall Study|Adverse Event|4|||
156894622|NCT03463031|566373732|FG001|Overall Study|Adverse Event|1|||
156894623|NCT03463031|566373731|FG000|Overall Study|Use of prohibited medication by subject|1|||
156894624|NCT03463031|566373732|FG001|Overall Study|Use of prohibited medication by subject|0|||
156894625|NCT01241240|566373733|FG000|Overall Study|Adverse Event|5|||
156894626|NCT01241240|566373734|FG001|Overall Study|Adverse Event|4|||
156894627|NCT01241240|566373733|FG000|Overall Study|Lost to Follow-up|2|||
156894628|NCT01241240|566373734|FG001|Overall Study|Lost to Follow-up|4|||
156894629|NCT01241240|566373733|FG000|Overall Study|Personal Reasons|1|||
156894630|NCT01241240|566373734|FG001|Overall Study|Personal Reasons|1|||
156894631|NCT01025154|566373735|FG000|Overall Study|Lost to Follow-up|1|||
156894632|NCT01025154|566373735|FG000|Overall Study|Withdrawal by Subject|1|||
156894633|NCT01810432|566373736|FG000|Washout|Protocol Violation|0|||
156894634|NCT01810432|566373737|FG001|Washout|Protocol Violation|1|||
156894635|NCT01810432|566373736|FG000|Washout|Adverse Event|1|||
156894636|NCT01810432|566373737|FG001|Washout|Adverse Event|0|||
156894637|NCT01810432|566373736|FG000|Period 2|Withdrawal by Subject|2|||
156894638|NCT01810432|566373737|FG001|Period 2|Withdrawal by Subject|1|||
156894639|NCT01810432|566373736|FG000|Period 2|Physician Decision|1|||
156894640|NCT01810432|566373737|FG001|Period 2|Physician Decision|0|||
156894641|NCT01810432|566373736|FG000|Period 2|Lost to Follow-up|1|||
156894642|NCT01810432|566373737|FG001|Period 2|Lost to Follow-up|1|||
156894643|NCT01466595|566373738|FG000|Overall Study|Withdrawal by Subject|0|||
156894644|NCT01466595|566373739|FG001|Overall Study|Withdrawal by Subject|1|||
156894645|NCT02376829|566373740|FG000|Overall Study|Withdrawal by Subject|27|||
156894646|NCT02376829|566373741|FG001|Overall Study|Withdrawal by Subject|44|||
156894647|NCT00057954|566373742|FG000|Overall Study|Death|1|||
156894648|NCT00057954|566373742|FG000|Overall Study|Disease progression|1|||
156894649|NCT02117414|566373743|FG000|Overall Study|Death|5|||
156894650|NCT02117414|566373744|FG001|Overall Study|Death|2|||
156894651|NCT02117414|566373743|FG000|Overall Study|Withdrawal by Subject|10|||
156894652|NCT02117414|566373744|FG001|Overall Study|Withdrawal by Subject|4|||
156894653|NCT02537574|566373746|FG000|Overall Study|Adverse Event|1|||
156894654|NCT02537574|566373747|FG001|Overall Study|Adverse Event|3|||
156894655|NCT02537574|566373748|FG002|Overall Study|Adverse Event|2|||
156894656|NCT02537574|566373746|FG000|Overall Study|Lost to Follow-up|40|||
156894657|NCT02537574|566373747|FG001|Overall Study|Lost to Follow-up|51|||
156894658|NCT02537574|566373748|FG002|Overall Study|Lost to Follow-up|55|||
156894659|NCT02537574|566373746|FG000|Overall Study|Noncompliance with study drug|0|||
156894660|NCT02537574|566373747|FG001|Overall Study|Noncompliance with study drug|1|||
156894661|NCT02537574|566373748|FG002|Overall Study|Noncompliance with study drug|1|||
156894662|NCT02537574|566373746|FG000|Overall Study|Physician Decision|2|||
156894663|NCT02537574|566373747|FG001|Overall Study|Physician Decision|0|||
156894664|NCT02537574|566373748|FG002|Overall Study|Physician Decision|0|||
156894665|NCT02537574|566373746|FG000|Overall Study|Protocol Violation|4|||
156894666|NCT02537574|566373747|FG001|Overall Study|Protocol Violation|2|||
156894667|NCT02537574|566373748|FG002|Overall Study|Protocol Violation|3|||
156894668|NCT02537574|566373746|FG000|Overall Study|Withdrawal by Subject|37|||
156894669|NCT02537574|566373747|FG001|Overall Study|Withdrawal by Subject|27|||
156894670|NCT02537574|566373748|FG002|Overall Study|Withdrawal by Subject|29|||
156894671|NCT02537574|566373746|FG000|Overall Study|Lack of Efficacy|14|||
156894672|NCT02537574|566373747|FG001|Overall Study|Lack of Efficacy|16|||
156894673|NCT02537574|566373748|FG002|Overall Study|Lack of Efficacy|15|||
156894674|NCT02537574|566373746|FG000|Overall Study|Duplicate Patient|1|||
156894675|NCT02537574|566373747|FG001|Overall Study|Duplicate Patient|0|||
156894676|NCT02537574|566373748|FG002|Overall Study|Duplicate Patient|0|||
156894677|NCT02537574|566373746|FG000|Overall Study|Patient not Stable|0|||
156894678|NCT02537574|566373747|FG001|Overall Study|Patient not Stable|1|||
156894679|NCT02537574|566373748|FG002|Overall Study|Patient not Stable|0|||
156894680|NCT02537574|566373746|FG000|Overall Study|Incarceration|0|||
156894681|NCT02537574|566373747|FG001|Overall Study|Incarceration|1|||
156894682|NCT02537574|566373748|FG002|Overall Study|Incarceration|0|||
156894683|NCT02537574|566373746|FG000|Overall Study|Failed Naloxone Challenge|0|||
156894684|NCT02537574|566373747|FG001|Overall Study|Failed Naloxone Challenge|1|||
156894685|NCT02537574|566373748|FG002|Overall Study|Failed Naloxone Challenge|0|||
156894686|NCT02537574|566373746|FG000|Overall Study|Transportation Issues|0|||
156894687|NCT02537574|566373747|FG001|Overall Study|Transportation Issues|0|||
156894688|NCT02537574|566373748|FG002|Overall Study|Transportation Issues|1|||
157158116|NCT02678780|567322997|FG000|Overall Study|Withdrawal by Subject|2|||
157158117|NCT02678780|567322998|FG001|Overall Study|Withdrawal by Subject|1|||
157158118|NCT02678780|567322997|FG000|Overall Study|Sponsor discontinuation|7|||
157158119|NCT02678780|567322998|FG001|Overall Study|Sponsor discontinuation|4|||
157158120|NCT02678780|567322997|FG000|Overall Study|Death|1|||
157158121|NCT02678780|567322998|FG001|Overall Study|Death|1|||
157158122|NCT02678780|567322997|FG000|Overall Study|Other|6|||
157158123|NCT02678780|567322998|FG001|Overall Study|Other|8|||
157158124|NCT03050359|567324516|FG000|Overall Study|Randomized But Not Treated|2|||
157158125|NCT03050359|567324517|FG001|Overall Study|Randomized But Not Treated|0|||
157158126|NCT03050359|567324516|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
157158127|NCT03050359|567324517|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
157158128|NCT03050359|567324516|FG000|Overall Study|Significant Protocol Deviation|2|||
157158129|NCT03050359|567324517|FG001|Overall Study|Significant Protocol Deviation|3|||
157158130|NCT03050359|567324516|FG000|Overall Study|Lost to Follow-up|2|||
157158131|NCT03050359|567324517|FG001|Overall Study|Lost to Follow-up|1|||
157158132|NCT03050359|567324516|FG000|Overall Study|Voluntary Withdrawal|4|||
157158133|NCT03050359|567324517|FG001|Overall Study|Voluntary Withdrawal|6|||
157158134|NCT03050359|567324516|FG000|Overall Study|Pregnancy|1|||
157158135|NCT03050359|567324517|FG001|Overall Study|Pregnancy|0|||
156858384|NCT00878501|566236629|FG000|Overall Study|Administrative|0|||
156858385|NCT00878501|566236630|FG001|Overall Study|Administrative|0|||
156858386|NCT00878501|566236631|FG002|Overall Study|Administrative|1|||
156858387|NCT04416204|566236634|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858388|NCT04416204|566236635|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
156858389|NCT04416204|566236636|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858390|NCT04416204|566236637|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
156858391|NCT01959503|566236641|FG000|Overall Study|Death|2|||
156858392|NCT01959503|566236642|FG001|Overall Study|Death|1|||
156858393|NCT01959503|566236641|FG000|Overall Study|Randomized but not treated|1|||
156858394|NCT01959503|566236642|FG001|Overall Study|Randomized but not treated|1|||
156858395|NCT02173769|566236644|FG000|Overall Study|Protocol Violation|4|||
156858396|NCT03224130|566236645|FG000|Overall Study|consent issue|0|||
156858397|NCT03224130|566236646|FG001|Overall Study|consent issue|1|||
156858398|NCT04124939|566236656|FG000|Overall Study|Lost to Follow-up|1|||
156894689|NCT02537574|566373746|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
156894690|NCT02537574|566373747|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
156894691|NCT02537574|566373748|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
156894692|NCT02537574|566373746|FG000|Overall Study|Noncompliance with Protocol|0|||
156894693|NCT02537574|566373747|FG001|Overall Study|Noncompliance with Protocol|0|||
156894694|NCT02537574|566373748|FG002|Overall Study|Noncompliance with Protocol|1|||
156894695|NCT02663687|566373749|FG000|Overall Study|Adverse Event|1|||
156894696|NCT02663687|566373750|FG001|Overall Study|Adverse Event|0|||
156894697|NCT02663687|566373751|FG002|Overall Study|Adverse Event|0|||
156894698|NCT02663687|566373752|FG003|Overall Study|Adverse Event|0|||
156894699|NCT02663687|566373753|FG004|Overall Study|Adverse Event|0|||
156894700|NCT02663687|566373749|FG000|Overall Study|Other|1|||
156894701|NCT02663687|566373750|FG001|Overall Study|Other|0|||
156894702|NCT02663687|566373751|FG002|Overall Study|Other|1|||
156894703|NCT02663687|566373752|FG003|Overall Study|Other|0|||
156894704|NCT02663687|566373753|FG004|Overall Study|Other|0|||
156894705|NCT00417482|566373754|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
156894706|NCT00417482|566373755|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
156894707|NCT00417482|566373756|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
156894708|NCT00417482|566373754|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
156894709|NCT00417482|566373755|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
156894710|NCT00417482|566373756|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
156894711|NCT00417482|566373754|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
156894712|NCT00417482|566373755|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
156894713|NCT00417482|566373756|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
156894714|NCT00417482|566373754|FG000|Phase B 1st 16 Weeks|Death|1|||
156894715|NCT00417482|566373755|FG001|Phase B 1st 16 Weeks|Death|0|||
156894716|NCT00417482|566373756|FG002|Phase B 1st 16 Weeks|Death|0|||
156894717|NCT00417482|566373754|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
156858399|NCT04124939|566236657|FG001|Overall Study|Lost to Follow-up|3|||
156858400|NCT02210000|566236659|FG000|Overall Study|Study Terminated|11|||
156858401|NCT02210000|566236660|FG001|Overall Study|Study Terminated|12|||
156858402|NCT02210000|566236659|FG000|Overall Study|Withdrawal by Subject|7|||
156858403|NCT02210000|566236660|FG001|Overall Study|Withdrawal by Subject|1|||
156858404|NCT02210000|566236659|FG000|Overall Study|Adverse Event|1|||
156858405|NCT02210000|566236660|FG001|Overall Study|Adverse Event|5|||
156858406|NCT02210000|566236659|FG000|Overall Study|Lost to Follow-up|0|||
156858407|NCT02210000|566236660|FG001|Overall Study|Lost to Follow-up|2|||
156858408|NCT02210000|566236659|FG000|Overall Study|Physician Decision|0|||
156858409|NCT02210000|566236660|FG001|Overall Study|Physician Decision|1|||
156858410|NCT00308139|566236661|FG000|Overall Study|Adverse Event|20|||
156858411|NCT00308139|566236662|FG001|Overall Study|Adverse Event|14|||
156858412|NCT00308139|566236661|FG000|Overall Study|Lost to Follow-up|13|||
156858413|NCT00308139|566236662|FG001|Overall Study|Lost to Follow-up|8|||
156858414|NCT00308139|566236661|FG000|Overall Study|Protocol Violation|3|||
156858415|NCT00308139|566236662|FG001|Overall Study|Protocol Violation|2|||
156858416|NCT00308139|566236661|FG000|Overall Study|Withdrawal of Consent|40|||
156858417|NCT00308139|566236662|FG001|Overall Study|Withdrawal of Consent|42|||
156858418|NCT00308139|566236661|FG000|Overall Study|Investigator Decision|11|||
156858419|NCT00308139|566236662|FG001|Overall Study|Investigator Decision|10|||
156858420|NCT00308139|566236661|FG000|Overall Study|Loss of Glucose Control|5|||
156858421|NCT00308139|566236662|FG001|Overall Study|Loss of Glucose Control|7|||
156858422|NCT00308139|566236661|FG000|Overall Study|Administrative|1|||
156858423|NCT00308139|566236662|FG001|Overall Study|Administrative|4|||
156858424|NCT00308139|566236661|FG000|Overall Study|Other|1|||
156858425|NCT00308139|566236662|FG001|Overall Study|Other|0|||
156858426|NCT01751061|566236668|FG000|Overall Study|Death|1|||
156858427|NCT01751061|566236669|FG001|Overall Study|Death|0|||
156858428|NCT01751061|566236668|FG000|Overall Study|patient death|5|||
156858429|NCT01751061|566236669|FG001|Overall Study|patient death|0|||
156858430|NCT01751061|566236668|FG000|Overall Study|Lost to Follow-up|40|||
156858431|NCT01751061|566236669|FG001|Overall Study|Lost to Follow-up|25|||
156858432|NCT01751061|566236668|FG000|Overall Study|patient regained decisional capacity|4|||
156858433|NCT01751061|566236669|FG001|Overall Study|patient regained decisional capacity|8|||
156858434|NCT01751061|566236668|FG000|Overall Study|Withdrawal by Subject|4|||
156858435|NCT01751061|566236669|FG001|Overall Study|Withdrawal by Subject|1|||
156858436|NCT01751061|566236668|FG000|Overall Study|Physician Decision|2|||
156858437|NCT01751061|566236669|FG001|Overall Study|Physician Decision|0|||
156858438|NCT00768989|566236674|FG000|Prior to Week 24|Withdrawal by Subject|1|||
156858439|NCT00768989|566236675|FG001|Prior to Week 24|Withdrawal by Subject|0|||
156858440|NCT00768989|566236674|FG000|Prior to Week 24|Adverse Event|3|||
156858441|NCT00768989|566236675|FG001|Prior to Week 24|Adverse Event|0|||
156858442|NCT00768989|566236674|FG000|Prior to Week 24|Lost to Follow-up|0|||
156858443|NCT00768989|566236675|FG001|Prior to Week 24|Lost to Follow-up|1|||
156858444|NCT00768989|566236674|FG000|Prior to Week 24|Protocol Violation|0|||
156858445|NCT00768989|566236675|FG001|Prior to Week 24|Protocol Violation|2|||
156858446|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
156894718|NCT00417482|566373755|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
156894719|NCT00417482|566373756|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
156894720|NCT00417482|566373754|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
156894721|NCT00417482|566373755|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
156894722|NCT00417482|566373756|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
156894723|NCT00417482|566373754|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
156894724|NCT00417482|566373755|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
156894725|NCT00417482|566373756|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
156894726|NCT00417482|566373754|FG000|Phase B 2nd 16 Weeks|Death|1|||
156894727|NCT00417482|566373755|FG001|Phase B 2nd 16 Weeks|Death|1|||
156894728|NCT00417482|566373756|FG002|Phase B 2nd 16 Weeks|Death|0|||
156894729|NCT03343067|566373759|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
156894730|NCT03343067|566373760|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
156894731|NCT03343067|566373761|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
156894732|NCT00116168|566373762|FG000|Overall Study|Lost to Follow-up|6|||
156894733|NCT00116168|566373763|FG001|Overall Study|Lost to Follow-up|5|||
156894734|NCT00116168|566373764|FG002|Overall Study|Lost to Follow-up|0|||
156894735|NCT00116168|566373765|FG003|Overall Study|Lost to Follow-up|0|||
156894736|NCT03583073|566373766|FG000|Overall Study|Lost to Follow-up|8|||
156894737|NCT03583073|566373767|FG001|Overall Study|Lost to Follow-up|12|||
156894738|NCT04025710|566373776|FG000|Overall Study|Death|3|||
156894739|NCT04025710|566373776|FG000|Overall Study|Lost to Follow-up|5|||
156894740|NCT04025710|566373776|FG000|Overall Study|Withdrawal by Subject|1|||
156894741|NCT04025710|566373776|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
156894742|NCT04025710|566373776|FG000|Overall Study|Drop-out according to protocol|34|||
156894743|NCT04718103|566373777|FG000|Overall Study|Adverse Event|1|||
156894744|NCT04718103|566373778|FG001|Overall Study|Adverse Event|1|||
156894745|NCT04718103|566373777|FG000|Overall Study|Lack of Efficacy|4|||
156894746|NCT04718103|566373778|FG001|Overall Study|Lack of Efficacy|1|||
156894747|NCT04718103|566373777|FG000|Overall Study|Lost to Follow-up|2|||
156894748|NCT04718103|566373778|FG001|Overall Study|Lost to Follow-up|2|||
156894749|NCT04718103|566373777|FG000|Overall Study|Physician Decision|2|||
156894750|NCT04718103|566373778|FG001|Overall Study|Physician Decision|0|||
156894751|NCT04718103|566373777|FG000|Overall Study|Pregnancy|0|||
156894752|NCT04718103|566373778|FG001|Overall Study|Pregnancy|1|||
156894753|NCT04718103|566373777|FG000|Overall Study|Withdrawal by Subject|10|||
156894754|NCT04718103|566373778|FG001|Overall Study|Withdrawal by Subject|6|||
156894755|NCT04718103|566373777|FG000|Overall Study|Randomized, not treated|4|||
156894756|NCT04718103|566373778|FG001|Overall Study|Randomized, not treated|1|||
156894757|NCT04718103|566373777|FG000|Overall Study|GCP violations|7|||
156894758|NCT04718103|566373778|FG001|Overall Study|GCP violations|5|||
156894759|NCT02764190|566373779|FG000|Overall Study|Lost to Follow-up|17|||
156894760|NCT02764190|566373780|FG001|Overall Study|Lost to Follow-up|13|||
156894761|NCT02140775|566373785|FG000|Overall Study|Withdrawal by Subject|30|||
156894762|NCT02140775|566373786|FG001|Overall Study|Withdrawal by Subject|7|||
156894763|NCT01858636|566373787|FG000|Overall Study|No Device Deployment Attempted|24|||
156894764|NCT01858636|566373787|FG000|Overall Study|Physician Decision|1|||
156894765|NCT01858636|566373787|FG000|Overall Study|Death|1|||
156894766|NCT01858636|566373787|FG000|Overall Study|Lost to Follow-up|1|||
156894767|NCT01858636|566373787|FG000|Overall Study|Withdrawal by Subject|1|||
156894768|NCT04650854|566373794|FG000|Overall Study|Adverse Event|1|||
156894769|NCT04650854|566373795|FG001|Overall Study|Adverse Event|12|||
156894770|NCT04650854|566373796|FG002|Overall Study|Adverse Event|14|||
156894771|NCT04650854|566373794|FG000|Overall Study|Lack of Efficacy|1|||
156894772|NCT04650854|566373795|FG001|Overall Study|Lack of Efficacy|3|||
156894773|NCT04650854|566373796|FG002|Overall Study|Lack of Efficacy|6|||
156894774|NCT04650854|566373794|FG000|Overall Study|Lost to Follow-up|1|||
156894775|NCT04650854|566373795|FG001|Overall Study|Lost to Follow-up|1|||
156894776|NCT04650854|566373796|FG002|Overall Study|Lost to Follow-up|0|||
156894777|NCT04650854|566373794|FG000|Overall Study|Withdrawal by Subject|2|||
157158136|NCT03050359|567324516|FG000|Overall Study|Reason Not Specified|1|||
157158137|NCT03050359|567324517|FG001|Overall Study|Reason Not Specified|0|||
157158138|NCT03484923|567324519|FG000|Overall Study|Adverse Event|3|||
157158139|NCT03484923|567324520|FG001|Overall Study|Adverse Event|3|||
157158140|NCT03484923|567324521|FG002|Overall Study|Adverse Event|5|||
157158141|NCT03484923|567324522|FG003|Overall Study|Adverse Event|11|||
157158142|NCT03484923|567324523|FG004|Overall Study|Adverse Event|1|||
156894778|NCT04650854|566373795|FG001|Overall Study|Withdrawal by Subject|17|||
156894779|NCT04650854|566373796|FG002|Overall Study|Withdrawal by Subject|9|||
156894780|NCT04650854|566373794|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
156894781|NCT04650854|566373795|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
156894782|NCT04650854|566373796|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
156894783|NCT04650854|566373794|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
156894784|NCT04650854|566373795|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
156894785|NCT04650854|566373796|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
157158143|NCT03484923|567324519|FG000|Overall Study|Death|2|||
157158144|NCT03484923|567324520|FG001|Overall Study|Death|2|||
156894786|NCT04650854|566373794|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
156894787|NCT04650854|566373795|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
156894788|NCT04650854|566373796|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
156894789|NCT04650854|566373794|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
156894790|NCT04650854|566373795|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
156894791|NCT04650854|566373796|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
156894792|NCT04650854|566373794|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
156894793|NCT04650854|566373795|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
156894794|NCT04650854|566373796|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
156894795|NCT04650854|566373794|FG000|Overall Study|Use of Rescue Medication|0|||
156894796|NCT04650854|566373795|FG001|Overall Study|Use of Rescue Medication|0|||
156894797|NCT04650854|566373796|FG002|Overall Study|Use of Rescue Medication|1|||
156894798|NCT04650854|566373794|FG000|Overall Study|Last Treatment Per Sponsor|0|||
156894799|NCT04650854|566373795|FG001|Overall Study|Last Treatment Per Sponsor|0|||
156894800|NCT04650854|566373796|FG002|Overall Study|Last Treatment Per Sponsor|2|||
156894801|NCT04650854|566373794|FG000|Overall Study|Rescue Medication|0|||
156894802|NCT04650854|566373795|FG001|Overall Study|Rescue Medication|0|||
156894803|NCT04650854|566373796|FG002|Overall Study|Rescue Medication|1|||
156894804|NCT04650854|566373794|FG000|Overall Study|Participant Want to Start a Family|0|||
157026097|NCT03701763|566849713|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
157026098|NCT03701763|566849710|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
157026099|NCT03701763|566849711|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
157026100|NCT03701763|566849712|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
156894805|NCT04650854|566373795|FG001|Overall Study|Participant Want to Start a Family|0|||
156894806|NCT04650854|566373796|FG002|Overall Study|Participant Want to Start a Family|1|||
156894807|NCT04650854|566373794|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
156894808|NCT04650854|566373795|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
156894809|NCT04650854|566373796|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
156894810|NCT04650854|566373794|FG000|Overall Study|Participant Screened For MG0020|0|||
156894811|NCT04650854|566373795|FG001|Overall Study|Participant Screened For MG0020|2|||
156894812|NCT04650854|566373796|FG002|Overall Study|Participant Screened For MG0020|3|||
156894813|NCT04650854|566373794|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
156894814|NCT04650854|566373795|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
156894815|NCT04650854|566373796|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
156894816|NCT04650854|566373794|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
156894817|NCT04650854|566373795|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
156894818|NCT04650854|566373796|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
156894819|NCT04650854|566373794|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
156894820|NCT04650854|566373795|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
156894821|NCT04650854|566373796|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
156894822|NCT04650854|566373794|FG000|Overall Study|End Of Study|0|||
156894823|NCT04650854|566373795|FG001|Overall Study|End Of Study|2|||
156894824|NCT04650854|566373796|FG002|Overall Study|End Of Study|1|||
156894825|NCT04650854|566373794|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
156894826|NCT04650854|566373795|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
156894827|NCT04650854|566373796|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
156894828|NCT04650854|566373794|FG000|Overall Study|Participant Received Rescue Medication|0|||
156894829|NCT04650854|566373795|FG001|Overall Study|Participant Received Rescue Medication|1|||
156894830|NCT04650854|566373796|FG002|Overall Study|Participant Received Rescue Medication|0|||
156894831|NCT04650854|566373794|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
156894832|NCT04650854|566373795|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
156894833|NCT04650854|566373796|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
156894834|NCT04650854|566373794|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
156894835|NCT04650854|566373795|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
156894836|NCT04650854|566373796|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
156894837|NCT04650854|566373794|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
157026101|NCT03701763|566849713|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
157026102|NCT03701763|566849710|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
157026103|NCT03701763|566849711|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
157026104|NCT03701763|566849712|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
157026105|NCT03701763|566849713|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
157026106|NCT03701763|566849710|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
157026107|NCT03701763|566849711|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
156894838|NCT04650854|566373795|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
157026108|NCT03701763|566849712|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
157026109|NCT03701763|566849713|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
157026110|NCT03701763|566849710|FG000|14-Week Observational Follow-up Phase|Other|0|||
156894839|NCT04650854|566373796|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
156894840|NCT04650854|566373794|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
156894841|NCT04650854|566373795|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
156894842|NCT04650854|566373796|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
156894843|NCT04650854|566373794|FG000|Overall Study|Enrollment Cup|0|||
156894844|NCT04650854|566373795|FG001|Overall Study|Enrollment Cup|0|||
156894845|NCT04650854|566373796|FG002|Overall Study|Enrollment Cup|1|||
156894846|NCT00667420|566373800|FG000|Overall Study|Adverse Event|2|||
156894847|NCT00667420|566373800|FG000|Overall Study|Lack of Efficacy|5|||
156894848|NCT00667420|566373800|FG000|Overall Study|Physician Decision|1|||
156894849|NCT00667420|566373800|FG000|Overall Study|Withdrawal by Subject|2|||
156894850|NCT00095628|566373801|FG000|Overall Study|Disease progression prior to treatment|1|||
156894851|NCT04223232|566373802|FG000|Overall Study|Withdrawal by Subject|1|||
156894852|NCT00122278|566375547|FG000|Overall Study|Lost to Follow-up|2|||
156894853|NCT00122278|566375548|FG001|Overall Study|Lost to Follow-up|0|||
156894854|NCT01002482|566375549|FG000|Overall Study|Withdrawal by Subject|14|||
156894855|NCT01002482|566375550|FG001|Overall Study|Withdrawal by Subject|21|||
156894856|NCT01002482|566375549|FG000|Overall Study|Included twice|1|||
156894857|NCT01002482|566375550|FG001|Overall Study|Included twice|0|||
156894858|NCT01251744|566375551|FG000|Overall Study|Lost to Follow-up|1|||
156894859|NCT01251744|566375552|FG001|Overall Study|Lost to Follow-up|0|||
156894860|NCT02147184|566375553|FG000|Overall Study|Lost to Follow-up|28|||
156894861|NCT02147184|566375554|FG001|Overall Study|Lost to Follow-up|15|||
156894862|NCT02147184|566375553|FG000|Overall Study|Study Burden|11|||
156894863|NCT02147184|566375554|FG001|Overall Study|Study Burden|7|||
156894864|NCT02147184|566375553|FG000|Overall Study|Pregnancy|6|||
156894865|NCT02147184|566375554|FG001|Overall Study|Pregnancy|0|||
156894866|NCT02147184|566375553|FG000|Overall Study|Moved out of state|3|||
156894867|NCT02147184|566375554|FG001|Overall Study|Moved out of state|3|||
156894868|NCT02147184|566375553|FG000|Overall Study|Physician Decision|0|||
156894869|NCT02147184|566375554|FG001|Overall Study|Physician Decision|2|||
156894870|NCT02147184|566375553|FG000|Overall Study|Other|1|||
156894871|NCT02147184|566375554|FG001|Overall Study|Other|0|||
156894872|NCT01151098|566375555|FG000|Overall Study|Adverse Event|82|||
156894873|NCT01151098|566375555|FG000|Overall Study|Lost to Follow-up|6|||
156894874|NCT01151098|566375555|FG000|Overall Study|Lack of Efficacy|15|||
156894875|NCT01151098|566375555|FG000|Overall Study|Protocol Violation|1|||
156894876|NCT01151098|566375555|FG000|Overall Study|Miscellaneous|13|||
156894877|NCT00542451|566375556|FG000|Overall Study|Adverse Event|31|||
156894878|NCT00542451|566375556|FG000|Overall Study|Withdrawal by Subject|30|||
156894879|NCT00542451|566375556|FG000|Overall Study|Physician Decision|4|||
156894880|NCT00542451|566375556|FG000|Overall Study|Recurrent disease|1|||
156894881|NCT00542451|566375556|FG000|Overall Study|unknown reason|1|||
156894882|NCT00542451|566375556|FG000|Overall Study|Death|2|||
156894883|NCT00542451|566375556|FG000|Overall Study|Lost to Follow-up|10|||
156894884|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
156894885|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
156894886|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
156894887|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
156894888|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156894889|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
156894890|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156894891|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
156894892|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
156894893|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
156894894|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
156894895|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
156894896|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156894897|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
156894898|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156894899|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
156894900|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Program Termination|3|||
156894901|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Program Termination|0|||
156894902|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Program Termination|1|||
156894903|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Program Termination|1|||
156894904|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
156894905|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156894906|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156894907|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
156894908|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
156894909|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
156894910|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
156894911|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
156894912|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
156894913|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
156894914|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
156894915|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
156894916|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156894917|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
156894918|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156894919|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
156894920|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
156894921|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
156894922|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
156894923|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
156894924|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156894925|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
156894926|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156894927|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
156894928|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
156894929|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
156894930|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
156894931|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
156894932|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156894933|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156894934|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
156894935|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
156894936|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156894937|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156894938|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
156894939|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
156894940|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156894941|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156894942|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
156894943|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
156894944|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156894945|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156894946|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
156894947|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
156894948|NCT03739840|566375557|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156894949|NCT03739840|566375558|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156894950|NCT03739840|566375559|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
156894951|NCT03739840|566375560|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
156894952|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
156894953|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156894954|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156894955|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
156894956|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156894957|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156894958|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
156894959|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
156894960|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
156894961|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156894962|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156894963|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
156894964|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156894965|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
156894966|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156894967|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
156894968|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156894969|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
156894970|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156894971|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
156894972|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156894973|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156894974|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
156894975|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
156894976|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
156894977|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
157158145|NCT03484923|567324521|FG002|Overall Study|Death|3|||
157158146|NCT03484923|567324522|FG003|Overall Study|Death|0|||
157225492|NCT03594123|567571445|FG000|Overall Study|Lack of Efficacy|1|||
156858447|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
156858448|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
156858449|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
156858450|NCT00768989|566236674|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
156858451|NCT00768989|566236675|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
156858452|NCT00768989|566236674|FG000|On or After Week 36|Lack of Efficacy|1|||
156858453|NCT00768989|566236675|FG001|On or After Week 36|Lack of Efficacy|0|||
156858454|NCT00768989|566236674|FG000|On or After Week 36|Adverse Event|0|||
156858455|NCT00768989|566236675|FG001|On or After Week 36|Adverse Event|1|||
156858456|NCT00768989|566236674|FG000|On or After Week 36|Lost to Follow-up|1|||
156858457|NCT00768989|566236675|FG001|On or After Week 36|Lost to Follow-up|0|||
156858458|NCT00768989|566236674|FG000|On or After Week 36|Poor Compliance|1|||
156858459|NCT00768989|566236675|FG001|On or After Week 36|Poor Compliance|0|||
156858460|NCT00768989|566236674|FG000|On or After Week 36|Protocol Violation|1|||
156858461|NCT00768989|566236675|FG001|On or After Week 36|Protocol Violation|0|||
156858462|NCT00768989|566236674|FG000|On or After Week 36|Did not attend termination visit|2|||
156858463|NCT00768989|566236675|FG001|On or After Week 36|Did not attend termination visit|0|||
156858464|NCT00768989|566236674|FG000|On or After Week 36|Sponsor Termination|45|||
156858465|NCT00768989|566236675|FG001|On or After Week 36|Sponsor Termination|26|||
156858466|NCT02153086|566236676|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
156858467|NCT02153086|566236676|FG000|Overall Study|Other|2|||
156858468|NCT00791388|566236677|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858469|NCT00791388|566236678|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
156858470|NCT00791388|566236679|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858471|NCT00791388|566236680|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858472|NCT00791388|566236681|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
156858473|NCT00791388|566236677|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
156858474|NCT00791388|566236678|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858475|NCT00791388|566236679|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858476|NCT00791388|566236680|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858477|NCT00791388|566236681|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
156858478|NCT00791388|566236677|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858479|NCT00791388|566236678|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858480|NCT00791388|566236679|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858481|NCT00791388|566236680|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
156858482|NCT00791388|566236681|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
156858483|NCT01194830|566236682|FG000|Overall Study|Adverse Event|3|||
156858484|NCT01194830|566236683|FG001|Overall Study|Adverse Event|2|||
156858485|NCT01194830|566236682|FG000|Overall Study|Protocol Violation|5|||
156858486|NCT01194830|566236683|FG001|Overall Study|Protocol Violation|4|||
156858487|NCT01194830|566236682|FG000|Overall Study|Lost to Follow-up|9|||
156858488|NCT01194830|566236683|FG001|Overall Study|Lost to Follow-up|7|||
156858489|NCT01194830|566236682|FG000|Overall Study|Withdrawal by Subject|2|||
156858490|NCT01194830|566236683|FG001|Overall Study|Withdrawal by Subject|1|||
156858491|NCT01194830|566236682|FG000|Overall Study|Lack of Efficacy|1|||
156858492|NCT01194830|566236683|FG001|Overall Study|Lack of Efficacy|1|||
156858493|NCT01194830|566236682|FG000|Overall Study|Non-compliance issues|4|||
156858494|NCT01194830|566236683|FG001|Overall Study|Non-compliance issues|4|||
156858495|NCT01194830|566236682|FG000|Overall Study|Other Reason|12|||
156858496|NCT01194830|566236683|FG001|Overall Study|Other Reason|8|||
156858497|NCT03115359|566236684|FG000|Overall Study|Withdrawal by Subject|29|||
156858498|NCT03115359|566236685|FG001|Overall Study|Withdrawal by Subject|39|||
156858499|NCT03115359|566236684|FG000|Overall Study|Scheduling conflict|25|||
156858500|NCT03115359|566236685|FG001|Overall Study|Scheduling conflict|23|||
156858501|NCT03115359|566236684|FG000|Overall Study|Personal reasons including health|12|||
156858502|NCT03115359|566236685|FG001|Overall Study|Personal reasons including health|9|||
156858503|NCT03115359|566236684|FG000|Overall Study|Transportation barriers|3|||
156858504|NCT03115359|566236685|FG001|Overall Study|Transportation barriers|0|||
156858505|NCT03115359|566236684|FG000|Overall Study|No longer interested|5|||
156858506|NCT03115359|566236685|FG001|Overall Study|No longer interested|4|||
156858507|NCT03115359|566236684|FG000|Overall Study|No reason provided|45|||
156858508|NCT03115359|566236685|FG001|Overall Study|No reason provided|47|||
156858509|NCT01317472|566236686|FG000|Overall Study|Withdrawal by Subject|1|||
156858510|NCT01317472|566236687|FG001|Overall Study|Withdrawal by Subject|0|||
156858511|NCT01317472|566236686|FG000|Overall Study|Unrelated hospitalization|1|||
156858512|NCT01317472|566236687|FG001|Overall Study|Unrelated hospitalization|0|||
156858513|NCT01815918|566236688|FG000|Overall Study|Patient samples not analyzable|3|||
156858514|NCT01815918|566236689|FG001|Overall Study|Patient samples not analyzable|4|||
156858515|NCT01815918|566236688|FG000|Overall Study|Lack of Efficacy|15|||
156858516|NCT01815918|566236689|FG001|Overall Study|Lack of Efficacy|15|||
156858517|NCT03206216|566236699|FG000|Overall Study|Withdrawal by Subject|0|||
156858518|NCT03206216|566236700|FG001|Overall Study|Withdrawal by Subject|1|||
156858519|NCT02174731|566236701|FG000|Overall Study|Participant decision|67|||
157158147|NCT03484923|567324523|FG004|Overall Study|Death|1|||
156894978|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
156894979|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
156894980|NCT03739840|566375557|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156894981|NCT03739840|566375558|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156894982|NCT03739840|566375559|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
156894983|NCT03739840|566375560|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
156894984|NCT01058265|566375563|FG000|Overall Study|Lost to Follow-up|11|||
156894985|NCT01058265|566375564|FG001|Overall Study|Lost to Follow-up|12|||
156894986|NCT01243671|566375565|FG000|Overall Study|Adverse Event|3|||
156894987|NCT01243671|566375565|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
156894988|NCT01243671|566375565|FG000|Overall Study|Other|1|||
156894989|NCT02869438|566375566|FG000|Overall Study|Lost to Follow-up|1|||
156894990|NCT02869438|566375567|FG001|Overall Study|Lost to Follow-up|0|||
156894991|NCT02869438|566375566|FG000|Overall Study|Adverse Event|1|||
156894992|NCT02869438|566375567|FG001|Overall Study|Adverse Event|0|||
156894993|NCT02869438|566375566|FG000|Overall Study|Withdrawal by Subject|1|||
157158148|NCT03484923|567324519|FG000|Overall Study|Physician Decision|6|||
157158149|NCT03484923|567324520|FG001|Overall Study|Physician Decision|7|||
157158150|NCT03484923|567324521|FG002|Overall Study|Physician Decision|6|||
157158151|NCT03484923|567324522|FG003|Overall Study|Physician Decision|3|||
157158152|NCT03484923|567324523|FG004|Overall Study|Physician Decision|2|||
157158153|NCT03484923|567324519|FG000|Overall Study|Progressive disease|33|||
157158154|NCT03484923|567324520|FG001|Overall Study|Progressive disease|28|||
157158155|NCT03484923|567324521|FG002|Overall Study|Progressive disease|26|||
157158156|NCT03484923|567324522|FG003|Overall Study|Progressive disease|30|||
157158157|NCT03484923|567324523|FG004|Overall Study|Progressive disease|16|||
157158158|NCT03484923|567324519|FG000|Overall Study|Subject Decision|1|||
157158159|NCT03484923|567324520|FG001|Overall Study|Subject Decision|3|||
157158160|NCT03484923|567324521|FG002|Overall Study|Subject Decision|3|||
157158161|NCT03484923|567324522|FG003|Overall Study|Subject Decision|0|||
157158162|NCT03484923|567324523|FG004|Overall Study|Subject Decision|1|||
157158163|NCT03439748|567324524|FG000|Overall Study|Withdrawal by Subject|11|||
157158164|NCT03439748|567324525|FG001|Overall Study|Withdrawal by Subject|17|||
157158165|NCT01028651|567324526|FG000|Overall Study|Death|2|||
157158166|NCT01028651|567324526|FG000|Overall Study|Adverse Event|1|||
157158167|NCT00390416|567324527|FG000|Overall Study|Withdrawal by Subject|1|||
156858520|NCT02174731|566236702|FG001|Overall Study|Participant decision|64|||
156858521|NCT02174731|566236701|FG000|Overall Study|Incorrect enrolment before randomization|0|||
156858522|NCT02174731|566236702|FG001|Overall Study|Incorrect enrolment before randomization|1|||
156858523|NCT02174731|566236701|FG000|Overall Study|Missing|2|||
156858524|NCT02174731|566236702|FG001|Overall Study|Missing|0|||
156858525|NCT00325897|566236703|FG000|Overall Study|Lost to Follow-up|12|||
156858526|NCT00325897|566236704|FG001|Overall Study|Lost to Follow-up|13|||
156858527|NCT02903160|566236705|FG000|Overall Study|Adverse Event|2|||
156858528|NCT02903160|566236705|FG000|Overall Study|Death|1|||
156858529|NCT02903160|566236705|FG000|Overall Study|Lost to Follow-up|2|||
156858530|NCT02903160|566236705|FG000|Overall Study|Withdrawal by Subject|1|||
156858531|NCT02903160|566236705|FG000|Overall Study|Medical Insurance Barriers|1|||
156858532|NCT01664910|566236708|FG000|Overall Study|Adverse Event|0|||
156858533|NCT01664910|566236709|FG001|Overall Study|Adverse Event|0|||
156858534|NCT01664910|566236710|FG002|Overall Study|Adverse Event|1|||
156858535|NCT02240485|566236711|FG000|3 Months Post-admission|Lost to Follow-up|1|||
156858536|NCT02240485|566236712|FG001|3 Months Post-admission|Lost to Follow-up|5|||
156858537|NCT02240485|566236711|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
156858538|NCT02240485|566236712|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
156858539|NCT02240485|566236711|FG000|9 Months Post-admission|Lost to Follow-up|3|||
156858540|NCT02240485|566236712|FG001|9 Months Post-admission|Lost to Follow-up|1|||
156858541|NCT02240485|566236711|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
156858542|NCT02240485|566236712|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
156858543|NCT02240485|566236711|FG000|18 Months Post-admission|Lost to Follow-up|1|||
156858544|NCT02240485|566236712|FG001|18 Months Post-admission|Lost to Follow-up|1|||
156858545|NCT02240485|566236711|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
156858546|NCT02240485|566236712|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
156858547|NCT02525471|566236713|FG000|Overall Study|Screen Failure|6|||
156858548|NCT02525471|566236713|FG000|Overall Study|Withdrawal by Subject|4|||
156858549|NCT02525471|566236713|FG000|Overall Study|Death|1|||
156858550|NCT00867165|566236714|FG000|Overall Study|Adverse Event|3|||
156858551|NCT00867165|566236715|FG001|Overall Study|Adverse Event|0|||
156858552|NCT00867165|566236714|FG000|Overall Study|Withdrawal by Subject|1|||
156858553|NCT00867165|566236715|FG001|Overall Study|Withdrawal by Subject|0|||
156858554|NCT01759420|566236716|FG000|Overall Study|Screen failure|5|||
156858555|NCT01759420|566236716|FG000|Overall Study|Inaccurate EKG machine readings|1|||
157158168|NCT00390416|567324527|FG000|Overall Study|Not treated|3|||
157158169|NCT01592409|567324528|FG000|Overall Study|Withdrawal by Subject|0|||
157158170|NCT01592409|567324529|FG001|Overall Study|Withdrawal by Subject|1|||
157158171|NCT01728584|567324532|FG000|Overall Study|Adverse Event|1|||
156894994|NCT02869438|566375567|FG001|Overall Study|Withdrawal by Subject|2|||
156894995|NCT02962765|566375568|FG000|Overall Study|Protocol Violation|9|||
156894996|NCT02962765|566375568|FG000|Overall Study|Withdrawal by Subject|3|||
156894997|NCT02962765|566375568|FG000|Overall Study|Lost to Follow-up|1|||
156894998|NCT02962765|566375568|FG000|Overall Study|Death|1|||
156894999|NCT02962765|566375568|FG000|Overall Study|Limited access to study medication|3|||
156895000|NCT02169284|566375571|FG000|Overall Study|Physician Decision|0|||
156895001|NCT02169284|566375572|FG001|Overall Study|Physician Decision|1|||
156895002|NCT01569464|566375573|FG000|Overall Study|Adverse Event|4|||
156895003|NCT01569464|566375574|FG001|Overall Study|Adverse Event|0|||
156895004|NCT01569464|566375573|FG000|Overall Study|Lack of Efficacy|1|||
156895005|NCT01569464|566375574|FG001|Overall Study|Lack of Efficacy|0|||
156895006|NCT01569464|566375573|FG000|Overall Study|Protocol Violation|1|||
156895007|NCT01569464|566375574|FG001|Overall Study|Protocol Violation|0|||
156895008|NCT01569464|566375573|FG000|Overall Study|Lost to Follow-up|2|||
156895009|NCT01569464|566375574|FG001|Overall Study|Lost to Follow-up|3|||
156895010|NCT01569464|566375573|FG000|Overall Study|Withdrawal by Subject|1|||
156895011|NCT01569464|566375574|FG001|Overall Study|Withdrawal by Subject|1|||
156895012|NCT01569464|566375573|FG000|Overall Study|Other|1|||
156895013|NCT01569464|566375574|FG001|Overall Study|Other|1|||
156895014|NCT03063203|566375575|FG000|Overall Study|Chose alternative therapy|3|||
156895015|NCT03063203|566375575|FG000|Overall Study|Death|2|||
156895016|NCT03063203|566375575|FG000|Overall Study|Disease progression|4|||
156895017|NCT03063203|566375575|FG000|Overall Study|Physician Decision|5|||
156895018|NCT00245583|566375576|FG000|Overall Study|Lost to Follow-up|1|||
156895019|NCT00245583|566375577|FG001|Overall Study|Lost to Follow-up|5|||
156895020|NCT00245583|566375576|FG000|Overall Study|Adverse Event|2|||
156895021|NCT00245583|566375577|FG001|Overall Study|Adverse Event|1|||
156895022|NCT00245583|566375576|FG000|Overall Study|Lack of Efficacy|1|||
156895023|NCT00245583|566375577|FG001|Overall Study|Lack of Efficacy|0|||
156895024|NCT00245583|566375576|FG000|Overall Study|Withdrawal by Subject|2|||
156895025|NCT00245583|566375577|FG001|Overall Study|Withdrawal by Subject|3|||
156895026|NCT01309893|566375578|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
156895027|NCT01309893|566375579|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
156895028|NCT01309893|566375578|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
156895029|NCT01309893|566375579|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
156895030|NCT01343901|566375580|FG000|Overall Study|Death|85|||
156895031|NCT01343901|566375580|FG000|Overall Study|Physician Decision|4|||
156895032|NCT01343901|566375580|FG000|Overall Study|Lost to Follow-up|12|||
156895033|NCT01343901|566375580|FG000|Overall Study|Management by another medical team|11|||
156895034|NCT01343901|566375580|FG000|Overall Study|Participant decision|1|||
156895035|NCT01484938|566375581|FG000|Overall Study|Adverse Event|2|||
156895036|NCT01484938|566375581|FG000|Overall Study|Lost to Follow-up|1|||
156895037|NCT01484938|566375581|FG000|Overall Study|Noncompliance|1|||
156895038|NCT00938964|566375586|FG000|Overall Study|Death|3|||
156895039|NCT00938964|566375587|FG001|Overall Study|Death|3|||
156895040|NCT00938964|566375586|FG000|Overall Study|Lost to Follow-up|2|||
156895041|NCT00938964|566375587|FG001|Overall Study|Lost to Follow-up|3|||
156895042|NCT00938964|566375586|FG000|Overall Study|Withdrawal by Subject|22|||
156895043|NCT00938964|566375587|FG001|Overall Study|Withdrawal by Subject|18|||
156895044|NCT00938964|566375586|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
156895045|NCT00938964|566375587|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
156895046|NCT01172275|566375588|FG000|Overall Study|Lost to Follow-up|1|||
156895047|NCT01172275|566375589|FG001|Overall Study|Lost to Follow-up|0|||
156895048|NCT01172275|566375588|FG000|Overall Study|Protocol Violation|1|||
156895049|NCT01172275|566375589|FG001|Overall Study|Protocol Violation|0|||
156895050|NCT01227564|566375592|FG000|Overall Study|No Longer Willing to Participate|4|||
156895051|NCT01227564|566375593|FG001|Overall Study|No Longer Willing to Participate|2|||
156895052|NCT01227564|566375594|FG002|Overall Study|No Longer Willing to Participate|5|||
156895053|NCT01227564|566375592|FG000|Overall Study|Participant moved to another town|0|||
156895054|NCT01227564|566375593|FG001|Overall Study|Participant moved to another town|0|||
156895055|NCT01227564|566375594|FG002|Overall Study|Participant moved to another town|1|||
156895056|NCT05308290|566375607|FG000|Overall Study|Death|1|||
156895057|NCT05308290|566375608|FG001|Overall Study|Death|0|||
156895058|NCT05308290|566375607|FG000|Overall Study|Lost to Follow-up|2|||
156895059|NCT05308290|566375608|FG001|Overall Study|Lost to Follow-up|1|||
156895060|NCT05308290|566375607|FG000|Overall Study|still in study followup|0|||
156895061|NCT05308290|566375608|FG001|Overall Study|still in study followup|1|||
156895062|NCT01285960|566375609|FG000|Overall Study|Withdrawal by Subject|2|||
156895063|NCT01285960|566375609|FG000|Overall Study|Lost to Follow-up|2|||
156895064|NCT01285960|566375609|FG000|Overall Study|2 subjects received less 10 sonications|2|||
156895065|NCT03500679|566375610|FG000|Overall Study|Lost to Follow-up|6|||
156895066|NCT03500679|566375611|FG001|Overall Study|Lost to Follow-up|3|||
156895067|NCT03500679|566375610|FG000|Overall Study|Withdrawal by Subject|3|||
156895068|NCT03500679|566375611|FG001|Overall Study|Withdrawal by Subject|0|||
156895069|NCT04271280|566375613|FG000|Overall Study|Lost to Follow-up|300|||
156895070|NCT04271280|566375613|FG000|Overall Study|Death|153|||
156895071|NCT04271280|566375613|FG000|Overall Study|Withdrawal of consent by patient|59|||
156895072|NCT04271280|566375613|FG000|Overall Study|Other|51|||
156895073|NCT04271280|566375613|FG000|Overall Study|No end of study information|42|||
156895074|NCT00901927|566375623|FG000|Overall Study|Lack of Efficacy|1|||
156895075|NCT00901927|566375623|FG000|Overall Study|Protocol Violation|3|||
156895076|NCT00901927|566375623|FG000|Overall Study|Withdrawal by Subject|2|||
156895077|NCT00586846|566375624|FG000|Overall Study|Physician Decision|1|||
156895078|NCT00586846|566375624|FG000|Overall Study|Death|1|||
156895079|NCT00586846|566375624|FG000|Overall Study|Evaluable for Toxicity Only|4|||
156895080|NCT00410202|566375630|FG000|On-Treatment|Continuing treatment|69|||
156895081|NCT00410202|566375631|FG001|On-Treatment|Continuing treatment|71|||
156895082|NCT00410202|566375632|FG002|On-Treatment|Continuing treatment|66|||
156895083|NCT00410202|566375630|FG000|On-Treatment|Adverse Event|1|||
156895084|NCT00410202|566375631|FG001|On-Treatment|Adverse Event|3|||
157026111|NCT03701763|566849711|FG001|14-Week Observational Follow-up Phase|Other|0|||
157026112|NCT03701763|566849712|FG002|14-Week Observational Follow-up Phase|Other|1|||
157026113|NCT03701763|566849713|FG003|14-Week Observational Follow-up Phase|Other|0|||
157026114|NCT03701763|566849710|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
157026115|NCT03701763|566849711|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
156895085|NCT00410202|566375632|FG002|On-Treatment|Adverse Event|2|||
156895086|NCT00410202|566375630|FG000|On-Treatment|Death|1|||
156895087|NCT00410202|566375631|FG001|On-Treatment|Death|0|||
156895088|NCT00410202|566375632|FG002|On-Treatment|Death|0|||
157026116|NCT03701763|566849712|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
157026117|NCT03701763|566849713|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
157026118|NCT03701763|566849710|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
157026119|NCT03701763|566849711|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
157026120|NCT03701763|566849712|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
157026121|NCT03701763|566849713|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
157026122|NCT04049643|566849720|FG000|Overall Study|Lack of Efficacy|1|||
157026123|NCT04049643|566849721|FG001|Overall Study|Lack of Efficacy|1|||
157026124|NCT04049643|566849722|FG002|Overall Study|Lack of Efficacy|0|||
157026125|NCT04049643|566849720|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
157026126|NCT04049643|566849721|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
157026127|NCT04049643|566849722|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
157026128|NCT04081103|566849723|FG000|Overall Study|Adverse Event|1|||
157026129|NCT04081103|566849724|FG001|Overall Study|Adverse Event|1|||
157026130|NCT04081103|566849725|FG002|Overall Study|Adverse Event|1|||
157026131|NCT04081103|566849723|FG000|Overall Study|Physician Decision|0|||
157026132|NCT04081103|566849724|FG001|Overall Study|Physician Decision|0|||
157026133|NCT04081103|566849725|FG002|Overall Study|Physician Decision|1|||
157026134|NCT03365882|566849728|FG000|Randomization|Still Receiving Protocol Treatment|2|||
157026135|NCT03365882|566849729|FG001|Randomization|Still Receiving Protocol Treatment|0|||
157026136|NCT03365882|566849728|FG000|Randomization|Adverse Event|1|||
157026137|NCT03365882|566849729|FG001|Randomization|Adverse Event|2|||
157026138|NCT03365882|566849728|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
157026139|NCT03365882|566849729|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
157026140|NCT03365882|566849728|FG000|Randomization|Progression/Relapse|21|||
157026141|NCT03365882|566849729|FG001|Randomization|Progression/Relapse|3|||
157026142|NCT03365882|566849728|FG000|Randomization|Death|1|||
156895089|NCT00410202|566375630|FG000|On-Treatment|Lost to Follow-up|1|||
156895090|NCT00410202|566375631|FG001|On-Treatment|Lost to Follow-up|0|||
156895091|NCT00410202|566375632|FG002|On-Treatment|Lost to Follow-up|1|||
156895092|NCT00410202|566375630|FG000|On-Treatment|Lack of Efficacy|1|||
156895093|NCT00410202|566375631|FG001|On-Treatment|Lack of Efficacy|4|||
156895094|NCT00410202|566375632|FG002|On-Treatment|Lack of Efficacy|0|||
156895095|NCT00410202|566375630|FG000|On-Treatment|Withdrawal by Subject|2|||
157026143|NCT03365882|566849729|FG001|Randomization|Death|0|||
157026144|NCT03365882|566849728|FG000|Randomization|Other - Not Protocol Specified|1|||
157026145|NCT03365882|566849729|FG001|Randomization|Other - Not Protocol Specified|1|||
157026146|NCT03365882|566849728|FG000|Randomization|Major Protocol Deviation|0|||
157026147|NCT03365882|566849729|FG001|Randomization|Major Protocol Deviation|1|||
157026148|NCT03365882|566849728|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
157158172|NCT01728584|567324533|FG001|Overall Study|Adverse Event|0|||
157158173|NCT01728584|567324534|FG002|Overall Study|Adverse Event|0|||
156858556|NCT01129622|566236719|FG000|Overall Study|Withdrawal by Subject|2|||
156858557|NCT00591006|566236720|FG000|Overall Study|Withdrawal by Subject|0|||
156858558|NCT00591006|566236721|FG001|Overall Study|Withdrawal by Subject|0|||
156858559|NCT00591006|566236722|FG002|Overall Study|Withdrawal by Subject|0|||
156858560|NCT00591006|566236723|FG003|Overall Study|Withdrawal by Subject|0|||
156858561|NCT00591006|566236724|FG004|Overall Study|Withdrawal by Subject|0|||
156858562|NCT00591006|566236725|FG005|Overall Study|Withdrawal by Subject|0|||
156858563|NCT00591006|566236726|FG006|Overall Study|Withdrawal by Subject|0|||
156858564|NCT00591006|566236727|FG007|Overall Study|Withdrawal by Subject|0|||
156858565|NCT00591006|566236728|FG008|Overall Study|Withdrawal by Subject|0|||
156858566|NCT00591006|566236729|FG009|Overall Study|Withdrawal by Subject|0|||
156895096|NCT00410202|566375631|FG001|On-Treatment|Withdrawal by Subject|1|||
156895097|NCT00410202|566375632|FG002|On-Treatment|Withdrawal by Subject|1|||
156895098|NCT00410202|566375630|FG000|On-Treatment|Other Reason|0|||
156895099|NCT00410202|566375631|FG001|On-Treatment|Other Reason|0|||
156895100|NCT00410202|566375632|FG002|On-Treatment|Other Reason|1|||
156895101|NCT00410202|566375630|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
156895102|NCT00410202|566375631|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
156895103|NCT00410202|566375632|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
156895104|NCT00410202|566375630|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
156895105|NCT00410202|566375631|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
156895106|NCT00410202|566375632|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
156895107|NCT00410202|566375630|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
156895108|NCT00410202|566375631|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
156895109|NCT00410202|566375632|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
156895110|NCT00144027|566375633|FG000|Overall Study|Lost to Follow-up|1|||
156895111|NCT00144027|566375634|FG001|Overall Study|Lost to Follow-up|3|||
156895112|NCT00144027|566375633|FG000|Overall Study|Withdrawal by Subject|2|||
156895113|NCT00144027|566375634|FG001|Overall Study|Withdrawal by Subject|2|||
156895114|NCT00144027|566375633|FG000|Overall Study|did not complete baseline assessment|0|||
156895115|NCT00144027|566375634|FG001|Overall Study|did not complete baseline assessment|6|||
156895116|NCT01178073|566375635|FG000|Overall Study|Adverse Event|34|||
156895117|NCT01178073|566375636|FG001|Overall Study|Adverse Event|27|||
156895118|NCT01178073|566375637|FG002|Overall Study|Adverse Event|24|||
156895119|NCT01178073|566375635|FG000|Overall Study|Protocol Violation|1|||
156895120|NCT01178073|566375636|FG001|Overall Study|Protocol Violation|1|||
156895121|NCT01178073|566375637|FG002|Overall Study|Protocol Violation|1|||
156895122|NCT01178073|566375635|FG000|Overall Study|Lost to Follow-up|2|||
156895123|NCT01178073|566375636|FG001|Overall Study|Lost to Follow-up|0|||
156895124|NCT01178073|566375637|FG002|Overall Study|Lost to Follow-up|3|||
156895125|NCT01178073|566375635|FG000|Overall Study|Physician Decision|14|||
156895126|NCT01178073|566375636|FG001|Overall Study|Physician Decision|10|||
156895127|NCT01178073|566375637|FG002|Overall Study|Physician Decision|10|||
156895128|NCT01178073|566375635|FG000|Overall Study|Withdrawal by Subject|10|||
156895129|NCT01178073|566375636|FG001|Overall Study|Withdrawal by Subject|6|||
156895130|NCT01178073|566375637|FG002|Overall Study|Withdrawal by Subject|8|||
156895131|NCT01178073|566375635|FG000|Overall Study|Missing Completion Status|1|||
156895132|NCT01178073|566375636|FG001|Overall Study|Missing Completion Status|0|||
156895133|NCT01178073|566375637|FG002|Overall Study|Missing Completion Status|0|||
156895134|NCT01674634|566375640|FG000|Overall Study|Withdrawal by Subject|3|||
156895135|NCT01674634|566375640|FG000|Overall Study|Lost to Follow-up|3|||
156895136|NCT05080660|566375641|FG000|Overall Study|Adverse Event|4|||
156895137|NCT05080660|566375642|FG001|Overall Study|Adverse Event|0|||
156895138|NCT05080660|566375641|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
156895139|NCT05080660|566375642|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
156895140|NCT05080660|566375641|FG000|Overall Study|Physician Decision|1|||
156895141|NCT05080660|566375642|FG001|Overall Study|Physician Decision|0|||
156895142|NCT05080660|566375641|FG000|Overall Study|Protocol Deviation|2|||
156895143|NCT05080660|566375642|FG001|Overall Study|Protocol Deviation|0|||
156895144|NCT05080660|566375641|FG000|Overall Study|Withdrawal by Subject|5|||
156895145|NCT05080660|566375642|FG001|Overall Study|Withdrawal by Subject|2|||
156895146|NCT00937391|566375643|FG000|Stage 2|Withdrawal by Subject|1|||
156895147|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
156895148|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
156895149|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
156895150|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
156895151|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156895152|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
156895153|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156895154|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
156895155|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
156895156|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156895157|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156895158|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
156895159|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
156895160|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
156895161|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
156895162|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
156895163|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156895164|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
157158174|NCT01728584|567324535|FG003|Overall Study|Adverse Event|0|||
157158175|NCT01728584|567324532|FG000|Overall Study|Physician Decision|4|||
157158176|NCT01728584|567324533|FG001|Overall Study|Physician Decision|0|||
157158177|NCT01728584|567324534|FG002|Overall Study|Physician Decision|1|||
156895165|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156895166|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
156895167|NCT01226043|566375656|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
156895168|NCT01226043|566375657|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
156895169|NCT01226043|566375658|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
156895170|NCT01226043|566375659|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
156895171|NCT01226043|566375656|FG000|6-week Re-randomization Phase|Adverse Event|0|||
156895172|NCT01226043|566375657|FG001|6-week Re-randomization Phase|Adverse Event|0|||
156895173|NCT01226043|566375658|FG002|6-week Re-randomization Phase|Adverse Event|1|||
156895174|NCT01226043|566375659|FG003|6-week Re-randomization Phase|Adverse Event|1|||
156895175|NCT01226043|566375656|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
156895176|NCT01226043|566375657|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
156895177|NCT01226043|566375658|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
156895178|NCT01226043|566375659|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
156895179|NCT01226043|566375656|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
156895180|NCT01226043|566375657|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
156895181|NCT01226043|566375658|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
156895182|NCT01226043|566375659|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
156895183|NCT01226043|566375656|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
156895184|NCT01226043|566375657|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
156895185|NCT01226043|566375658|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
156895186|NCT01226043|566375659|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
156895187|NCT01226043|566375656|FG000|6-week Re-randomization Phase|Physician Decision|0|||
156895188|NCT01226043|566375657|FG001|6-week Re-randomization Phase|Physician Decision|0|||
156895189|NCT01226043|566375658|FG002|6-week Re-randomization Phase|Physician Decision|3|||
156895190|NCT01226043|566375659|FG003|6-week Re-randomization Phase|Physician Decision|2|||
156895191|NCT01226043|566375656|FG000|6-week Re-randomization Phase|completed in error|0|||
156895192|NCT01226043|566375657|FG001|6-week Re-randomization Phase|completed in error|0|||
156895193|NCT01226043|566375658|FG002|6-week Re-randomization Phase|completed in error|0|||
156895194|NCT01226043|566375659|FG003|6-week Re-randomization Phase|completed in error|1|||
156895195|NCT01226043|566375656|FG000|30-week Observational Phase|Adverse Event|0|||
156895196|NCT01226043|566375657|FG001|30-week Observational Phase|Adverse Event|0|||
156895197|NCT01226043|566375658|FG002|30-week Observational Phase|Adverse Event|1|||
156895198|NCT01226043|566375659|FG003|30-week Observational Phase|Adverse Event|1|||
156895199|NCT01226043|566375656|FG000|30-week Observational Phase|Protocol Violation|0|||
156895200|NCT01226043|566375657|FG001|30-week Observational Phase|Protocol Violation|0|||
156895201|NCT01226043|566375658|FG002|30-week Observational Phase|Protocol Violation|0|||
156895202|NCT01226043|566375659|FG003|30-week Observational Phase|Protocol Violation|1|||
156895203|NCT01226043|566375656|FG000|30-week Observational Phase|Lost to Follow-up|0|||
156895204|NCT01226043|566375657|FG001|30-week Observational Phase|Lost to Follow-up|0|||
156895205|NCT01226043|566375658|FG002|30-week Observational Phase|Lost to Follow-up|2|||
156895206|NCT01226043|566375659|FG003|30-week Observational Phase|Lost to Follow-up|2|||
156895207|NCT01226043|566375656|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
156895208|NCT01226043|566375657|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
156895209|NCT01226043|566375658|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
156895210|NCT01226043|566375659|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
156895211|NCT01226043|566375656|FG000|30-week Observational Phase|Physician Decision|0|||
156895212|NCT01226043|566375657|FG001|30-week Observational Phase|Physician Decision|0|||
156895213|NCT01226043|566375658|FG002|30-week Observational Phase|Physician Decision|2|||
156895214|NCT01226043|566375659|FG003|30-week Observational Phase|Physician Decision|2|||
156895215|NCT01702571|566375662|FG000|Overall Study|Death|1067|||
156895216|NCT01702571|566375663|FG001|Overall Study|Death|76|||
156895217|NCT01702571|566375662|FG000|Overall Study|Lost to Follow-up|144|||
156895218|NCT01702571|566375663|FG001|Overall Study|Lost to Follow-up|10|||
157158178|NCT01728584|567324535|FG003|Overall Study|Physician Decision|0|||
157158179|NCT01728584|567324532|FG000|Overall Study|Withdrawal by Subject|1|||
157158180|NCT01728584|567324533|FG001|Overall Study|Withdrawal by Subject|0|||
156895219|NCT01702571|566375662|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
156895220|NCT01702571|566375663|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
156895221|NCT01702571|566375662|FG000|Overall Study|Investigator Decision|5|||
156895222|NCT01702571|566375663|FG001|Overall Study|Investigator Decision|0|||
156895223|NCT01702571|566375662|FG000|Overall Study|Not Classifiable|1|||
156895224|NCT01702571|566375663|FG001|Overall Study|Not Classifiable|0|||
157158181|NCT01728584|567324534|FG002|Overall Study|Withdrawal by Subject|0|||
156895225|NCT01702571|566375662|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
156895226|NCT01702571|566375663|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
156895227|NCT01702571|566375662|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
156895228|NCT01702571|566375663|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
156895229|NCT01702571|566375662|FG000|Overall Study|Progressive Disease|3|||
156895230|NCT01702571|566375663|FG001|Overall Study|Progressive Disease|0|||
157158182|NCT01728584|567324535|FG003|Overall Study|Withdrawal by Subject|0|||
156895231|NCT01702571|566375662|FG000|Overall Study|Protocol Violation|2|||
156895232|NCT01702571|566375663|FG001|Overall Study|Protocol Violation|0|||
156895233|NCT01702571|566375662|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
156895234|NCT01702571|566375663|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
156895235|NCT01702571|566375662|FG000|Overall Study|Termination By Sponsor|4|||
156895236|NCT01702571|566375663|FG001|Overall Study|Termination By Sponsor|0|||
156895237|NCT01702571|566375662|FG000|Overall Study|Withdrawal by Subject|177|||
156895238|NCT01702571|566375663|FG001|Overall Study|Withdrawal by Subject|29|||
156895239|NCT01977937|566375666|FG000|Overall Study|Withdrawal by Subject|2|||
156895240|NCT01977937|566375667|FG001|Overall Study|Withdrawal by Subject|1|||
156895241|NCT01977937|566375666|FG000|Overall Study|Adverse Event|1|||
156895242|NCT01977937|566375667|FG001|Overall Study|Adverse Event|0|||
156895243|NCT01977937|566375666|FG000|Overall Study|Physician Decision|0|||
156895244|NCT01977937|566375667|FG001|Overall Study|Physician Decision|1|||
157158183|NCT01728584|567324532|FG000|Overall Study|Screen failure|1|||
157158184|NCT01728584|567324533|FG001|Overall Study|Screen failure|0|||
157158185|NCT01728584|567324534|FG002|Overall Study|Screen failure|0|||
157158186|NCT01728584|567324535|FG003|Overall Study|Screen failure|0|||
157158187|NCT01728584|567324532|FG000|Overall Study|Other reason (not specified)|1|||
157158188|NCT01728584|567324533|FG001|Overall Study|Other reason (not specified)|0|||
157158189|NCT01728584|567324534|FG002|Overall Study|Other reason (not specified)|0|||
157158190|NCT01728584|567324535|FG003|Overall Study|Other reason (not specified)|1|||
157158191|NCT02935634|567324536|FG000|Randomization|Participant withdrew consent|0|||
157158192|NCT02935634|567324537|FG001|Randomization|Participant withdrew consent|1|||
157158193|NCT02935634|567324538|FG002|Randomization|Participant withdrew consent|0|||
157158194|NCT02935634|567324539|FG003|Randomization|Participant withdrew consent|0|||
157158195|NCT02935634|567324540|FG004|Randomization|Participant withdrew consent|0|||
157158196|NCT02935634|567324541|FG005|Randomization|Participant withdrew consent|0|||
157158197|NCT02935634|567324536|FG000|Randomization|Death|2|||
157158198|NCT02935634|567324537|FG001|Randomization|Death|1|||
156895245|NCT03004443|566375671|FG000|Overall Study|Pregnancy|0|||
156895246|NCT03004443|566375672|FG001|Overall Study|Pregnancy|1|||
156895247|NCT00828854|566375673|FG000|Overall Study|Disease Progression|17|||
156895248|NCT00828854|566375673|FG000|Overall Study|Adverse Event|9|||
156895249|NCT00828854|566375673|FG000|Overall Study|Reason not Specified|1|||
156895250|NCT04221230|566375674|FG000|Overall Study|Lost to Follow-up|12|||
156895251|NCT04221230|566375675|FG001|Overall Study|Lost to Follow-up|12|||
156895252|NCT04221230|566375674|FG000|Overall Study|Protocol Violation|2|||
156895253|NCT04221230|566375675|FG001|Overall Study|Protocol Violation|2|||
156895254|NCT04221230|566375674|FG000|Overall Study|Adverse Event|0|||
156895255|NCT04221230|566375675|FG001|Overall Study|Adverse Event|8|||
156895256|NCT04221230|566375674|FG000|Overall Study|Physician Decision|1|||
156895257|NCT04221230|566375675|FG001|Overall Study|Physician Decision|0|||
156895258|NCT04221230|566375674|FG000|Overall Study|Withdrawal by Subject|13|||
156895259|NCT04221230|566375675|FG001|Overall Study|Withdrawal by Subject|11|||
156895260|NCT04221230|566375674|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156895261|NCT04221230|566375675|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156895262|NCT04221230|566375674|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156895263|NCT04221230|566375675|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
156895264|NCT04221230|566375674|FG000|Overall Study|Pregnancy|0|||
156895265|NCT04221230|566375675|FG001|Overall Study|Pregnancy|1|||
156895266|NCT04221230|566375674|FG000|Overall Study|Other|1|||
156895267|NCT04221230|566375675|FG001|Overall Study|Other|2|||
156895268|NCT00915356|566375676|FG000|Overall Study|Withdrawal by Subject|1|||
157158199|NCT02935634|567324538|FG002|Randomization|Death|1|||
157158200|NCT02935634|567324539|FG003|Randomization|Death|0|||
157158201|NCT02935634|567324540|FG004|Randomization|Death|0|||
157158202|NCT02935634|567324541|FG005|Randomization|Death|0|||
157158203|NCT02935634|567324536|FG000|Randomization|Other reasons|0|||
157158204|NCT02935634|567324537|FG001|Randomization|Other reasons|2|||
157158205|NCT02935634|567324538|FG002|Randomization|Other reasons|2|||
157158206|NCT02935634|567324539|FG003|Randomization|Other reasons|0|||
157158207|NCT02935634|567324540|FG004|Randomization|Other reasons|0|||
157225493|NCT03594123|567571446|FG001|Overall Study|Lack of Efficacy|0|||
156895269|NCT00915356|566375677|FG001|Overall Study|Withdrawal by Subject|0|||
156895270|NCT00915356|566375678|FG002|Overall Study|Withdrawal by Subject|0|||
156895271|NCT00915356|566375679|FG003|Overall Study|Withdrawal by Subject|0|||
156895272|NCT00915356|566375680|FG004|Overall Study|Withdrawal by Subject|0|||
156895273|NCT00191646|566375683|FG000|Overall Study|Toxicity|26|||
156895274|NCT00191646|566375684|FG001|Overall Study|Toxicity|37|||
156895275|NCT00191646|566375683|FG000|Overall Study|Disease Progression|5|||
156895276|NCT00191646|566375684|FG001|Overall Study|Disease Progression|6|||
157158208|NCT02935634|567324541|FG005|Randomization|Other reasons|0|||
157158209|NCT02935634|567324536|FG000|Treatment: Track 1|Disease progression|15|||
156895277|NCT00191646|566375683|FG000|Overall Study|Physician Decision|20|||
156895278|NCT00191646|566375684|FG001|Overall Study|Physician Decision|11|||
156895279|NCT00191646|566375683|FG000|Overall Study|Withdrawal by Subject|58|||
156895280|NCT00191646|566375684|FG001|Overall Study|Withdrawal by Subject|39|||
156895281|NCT00191646|566375683|FG000|Overall Study|Protocol Violation|5|||
156895282|NCT00191646|566375684|FG001|Overall Study|Protocol Violation|7|||
156895283|NCT00191646|566375683|FG000|Overall Study|Death|6|||
156895284|NCT00191646|566375684|FG001|Overall Study|Death|8|||
156895285|NCT00191646|566375683|FG000|Overall Study|Other|33|||
156895286|NCT00191646|566375684|FG001|Overall Study|Other|34|||
156895287|NCT00191646|566375683|FG000|Overall Study|Missing Data|18|||
156895288|NCT00191646|566375684|FG001|Overall Study|Missing Data|11|||
156895289|NCT05211284|566375689|FG000|Overall Study|Study Terminated|3|||
156895290|NCT05211284|566375690|FG001|Overall Study|Study Terminated|1|||
156895291|NCT00406718|566375691|FG000|Overall Study|Withdrawal by Subject|2|||
156895292|NCT00406718|566375692|FG001|Overall Study|Withdrawal by Subject|9|||
156895293|NCT00406718|566375693|FG002|Overall Study|Withdrawal by Subject|4|||
156895294|NCT00406718|566375691|FG000|Overall Study|Lost to Follow-up|2|||
156895295|NCT00406718|566375692|FG001|Overall Study|Lost to Follow-up|5|||
156895296|NCT00406718|566375693|FG002|Overall Study|Lost to Follow-up|4|||
156895297|NCT01888003|566375696|FG000|Overall Study|Study Terminated|5|||
156895298|NCT01888003|566375697|FG001|Overall Study|Study Terminated|6|||
156895299|NCT01888003|566375698|FG002|Overall Study|Study Terminated|40|||
156895300|NCT03187756|566375699|FG000|Overall Study|Termination of study|4|||
156895301|NCT02247531|566377208|FG000|Overall Study|Adverse Event|3|||
156895302|NCT02247531|566377209|FG001|Overall Study|Adverse Event|4|||
156895303|NCT02247531|566377210|FG002|Overall Study|Adverse Event|9|||
156895304|NCT02247531|566377208|FG000|Overall Study|Death|8|||
156895305|NCT02247531|566377209|FG001|Overall Study|Death|9|||
156895306|NCT02247531|566377210|FG002|Overall Study|Death|5|||
156895307|NCT02247531|566377208|FG000|Overall Study|Lost to Follow-up|1|||
156895308|NCT02247531|566377209|FG001|Overall Study|Lost to Follow-up|8|||
156895309|NCT02247531|566377210|FG002|Overall Study|Lost to Follow-up|3|||
156895310|NCT02247531|566377208|FG000|Overall Study|Non-compliance|2|||
156895311|NCT02247531|566377209|FG001|Overall Study|Non-compliance|2|||
156895312|NCT02247531|566377210|FG002|Overall Study|Non-compliance|0|||
156895313|NCT02247531|566377208|FG000|Overall Study|Withdrawal by Subject|26|||
156895314|NCT02247531|566377209|FG001|Overall Study|Withdrawal by Subject|31|||
156895315|NCT02247531|566377210|FG002|Overall Study|Withdrawal by Subject|25|||
156895316|NCT02247531|566377208|FG000|Overall Study|Study Terminated by Sponsor|64|||
156895317|NCT02247531|566377209|FG001|Overall Study|Study Terminated by Sponsor|66|||
156895318|NCT02247531|566377210|FG002|Overall Study|Study Terminated by Sponsor|62|||
156895319|NCT02247531|566377208|FG000|Overall Study|Physician Decision|0|||
156895320|NCT02247531|566377209|FG001|Overall Study|Physician Decision|2|||
156895321|NCT02247531|566377210|FG002|Overall Study|Physician Decision|2|||
156895322|NCT02247531|566377208|FG000|Overall Study|Unspecified Reason|2|||
156895323|NCT02247531|566377209|FG001|Overall Study|Unspecified Reason|3|||
156895324|NCT02247531|566377210|FG002|Overall Study|Unspecified Reason|4|||
156895325|NCT00736957|566377211|FG000|Overall Study|Adverse Event|43|||
156895326|NCT00736957|566377211|FG000|Overall Study|Withdrawal by Subject|49|||
156895327|NCT00736957|566377211|FG000|Overall Study|violation of eligibility criteria|2|||
156895328|NCT00736957|566377211|FG000|Overall Study|did not attend hospital appointments|1|||
156895329|NCT00736957|566377211|FG000|Overall Study|not eligible for Treatment Period I|22|||
156895330|NCT00736957|566377211|FG000|Overall Study|Physician Decision|5|||
156895331|NCT04521777|566377212|FG000|Overall Study|Death|2|||
156895332|NCT04521777|566377212|FG000|Overall Study|Withdrawal by Subject|2|||
156895333|NCT00608543|566377213|FG000|Overall Study|Adverse Event|4|||
156895334|NCT02788474|566377221|FG000|Double Blind Treatment Period|Not treated|1|||
156895335|NCT02788474|566377222|FG001|Double Blind Treatment Period|Not treated|0|||
156895336|NCT02788474|566377221|FG000|Double Blind Treatment Period|Patient's refusal|3|||
156895337|NCT02788474|566377222|FG001|Double Blind Treatment Period|Patient's refusal|0|||
156895338|NCT02788474|566377221|FG000|Double Blind Treatment Period|Adverse Event|6|||
156895339|NCT02788474|566377222|FG001|Double Blind Treatment Period|Adverse Event|4|||
156895340|NCT02788474|566377221|FG000|Open Label Treatment Period|Adverse Event|29|||
156895341|NCT02788474|566377222|FG001|Open Label Treatment Period|Adverse Event|9|||
156895342|NCT02788474|566377221|FG000|Open Label Treatment Period|Other than reason specified|1|||
156895343|NCT02788474|566377222|FG001|Open Label Treatment Period|Other than reason specified|0|||
156895344|NCT02788474|566377221|FG000|Open Label Treatment Period|Patient's refusal|1|||
156895345|NCT02788474|566377222|FG001|Open Label Treatment Period|Patient's refusal|3|||
156895346|NCT02788474|566377221|FG000|Open Label Treatment Period|Non-compliance|1|||
156895347|NCT02788474|566377222|FG001|Open Label Treatment Period|Non-compliance|0|||
156895348|NCT05153473|566377223|FG000|Overall Study|Death|46|||
156895349|NCT05153473|566377223|FG000|Overall Study|Lost to Follow-up|3|||
156895350|NCT03555435|566377224|FG000|Overall Study|Lost to Follow-up|17|||
156895351|NCT03555435|566377225|FG001|Overall Study|Lost to Follow-up|19|||
157158210|NCT02935634|567324537|FG001|Treatment: Track 1|Disease progression|17|||
156895352|NCT03555435|566377226|FG002|Overall Study|Lost to Follow-up|8|||
156895353|NCT01323946|566377229|FG000|Overall Study|Lost to Follow-up|0|||
156895354|NCT01323946|566377230|FG001|Overall Study|Lost to Follow-up|1|||
156895355|NCT01323946|566377231|FG002|Overall Study|Lost to Follow-up|0|||
156895356|NCT01323946|566377229|FG000|Overall Study|Parents refused the last blood draw|1|||
156895357|NCT01323946|566377230|FG001|Overall Study|Parents refused the last blood draw|0|||
156895358|NCT01323946|566377231|FG002|Overall Study|Parents refused the last blood draw|0|||
156895359|NCT01323946|566377229|FG000|Overall Study|Withdrawal by Subject|2|||
156895360|NCT01323946|566377230|FG001|Overall Study|Withdrawal by Subject|2|||
156895361|NCT01323946|566377231|FG002|Overall Study|Withdrawal by Subject|0|||
156895362|NCT02964507|566377232|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
157158211|NCT02935634|567324538|FG002|Treatment: Track 1|Disease progression|28|||
157158212|NCT02935634|567324539|FG003|Treatment: Track 1|Disease progression|4|||
157158213|NCT02935634|567324540|FG004|Treatment: Track 1|Disease progression|6|||
157158214|NCT02935634|567324541|FG005|Treatment: Track 1|Disease progression|2|||
157158215|NCT02935634|567324536|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
157158216|NCT02935634|567324537|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
157158217|NCT02935634|567324538|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
156895363|NCT02964507|566377233|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
156895364|NCT02964507|566377234|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
156895365|NCT02964507|566377235|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
157158218|NCT02935634|567324539|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
156895366|NCT02964507|566377236|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
156895367|NCT02964507|566377237|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
156895368|NCT02964507|566377238|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
156895369|NCT02964507|566377239|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
156895370|NCT02964507|566377232|FG000|Overall Study|Study terminated by Sponsor|9|||
156895371|NCT02964507|566377233|FG001|Overall Study|Study terminated by Sponsor|1|||
156895372|NCT02964507|566377234|FG002|Overall Study|Study terminated by Sponsor|9|||
156895373|NCT02964507|566377235|FG003|Overall Study|Study terminated by Sponsor|3|||
156895374|NCT02964507|566377236|FG004|Overall Study|Study terminated by Sponsor|3|||
156895375|NCT02964507|566377237|FG005|Overall Study|Study terminated by Sponsor|2|||
156895376|NCT02964507|566377238|FG006|Overall Study|Study terminated by Sponsor|0|||
156895377|NCT02964507|566377239|FG007|Overall Study|Study terminated by Sponsor|0|||
156895378|NCT02964507|566377232|FG000|Overall Study|Other|3|||
156895379|NCT02964507|566377233|FG001|Overall Study|Other|0|||
156895380|NCT02964507|566377234|FG002|Overall Study|Other|0|||
156895381|NCT02964507|566377235|FG003|Overall Study|Other|0|||
157158219|NCT02935634|567324540|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
157158220|NCT02935634|567324541|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
157158221|NCT02935634|567324536|FG000|Treatment: Track 1|Lost to Follow-up|1|||
157158222|NCT02935634|567324537|FG001|Treatment: Track 1|Lost to Follow-up|0|||
157158223|NCT02935634|567324538|FG002|Treatment: Track 1|Lost to Follow-up|0|||
157158224|NCT02935634|567324539|FG003|Treatment: Track 1|Lost to Follow-up|0|||
157158225|NCT02935634|567324540|FG004|Treatment: Track 1|Lost to Follow-up|0|||
157158226|NCT02935634|567324541|FG005|Treatment: Track 1|Lost to Follow-up|0|||
157225494|NCT03594123|567571445|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
157225495|NCT03594123|567571446|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
157225496|NCT02483975|567571447|FG000|Overall Study|Adverse Event|0|||
157225497|NCT02483975|567571448|FG001|Overall Study|Adverse Event|1|||
156858567|NCT00591006|566236730|FG010|Overall Study|Withdrawal by Subject|0|||
156858568|NCT00591006|566236731|FG011|Overall Study|Withdrawal by Subject|0|||
157225498|NCT02483975|567571447|FG000|Overall Study|Lost to Follow-up|0|||
156858569|NCT00591006|566236732|FG012|Overall Study|Withdrawal by Subject|0|||
156858570|NCT00591006|566236733|FG013|Overall Study|Withdrawal by Subject|0|||
156858571|NCT00591006|566236734|FG014|Overall Study|Withdrawal by Subject|0|||
156858572|NCT00591006|566236735|FG015|Overall Study|Withdrawal by Subject|1|||
156858573|NCT00591006|566236736|FG016|Overall Study|Withdrawal by Subject|0|||
156858574|NCT00591006|566236737|FG017|Overall Study|Withdrawal by Subject|0|||
156858575|NCT00591006|566236738|FG018|Overall Study|Withdrawal by Subject|0|||
156858576|NCT00591006|566236739|FG019|Overall Study|Withdrawal by Subject|0|||
156858577|NCT00591006|566236740|FG020|Overall Study|Withdrawal by Subject|0|||
156858578|NCT00591006|566236741|FG021|Overall Study|Withdrawal by Subject|0|||
156858579|NCT00591006|566236742|FG022|Overall Study|Withdrawal by Subject|0|||
156858580|NCT00591006|566236743|FG023|Overall Study|Withdrawal by Subject|1|||
156858581|NCT00591006|566236720|FG000|Overall Study|Adverse Event|0|||
156858582|NCT00591006|566236721|FG001|Overall Study|Adverse Event|0|||
156858583|NCT00591006|566236722|FG002|Overall Study|Adverse Event|0|||
156858584|NCT00591006|566236723|FG003|Overall Study|Adverse Event|0|||
156858585|NCT00591006|566236724|FG004|Overall Study|Adverse Event|0|||
156858586|NCT00591006|566236725|FG005|Overall Study|Adverse Event|0|||
156858587|NCT00591006|566236726|FG006|Overall Study|Adverse Event|0|||
157225499|NCT02483975|567571448|FG001|Overall Study|Lost to Follow-up|1|||
156858588|NCT00591006|566236727|FG007|Overall Study|Adverse Event|0|||
156858589|NCT00591006|566236728|FG008|Overall Study|Adverse Event|0|||
156858590|NCT00591006|566236729|FG009|Overall Study|Adverse Event|0|||
156858591|NCT00591006|566236730|FG010|Overall Study|Adverse Event|0|||
156895382|NCT02964507|566377236|FG004|Overall Study|Other|1|||
156895383|NCT02964507|566377237|FG005|Overall Study|Other|0|||
156895384|NCT02964507|566377238|FG006|Overall Study|Other|0|||
156895385|NCT02964507|566377239|FG007|Overall Study|Other|0|||
156895386|NCT02964507|566377232|FG000|Overall Study|Death|11|||
156895387|NCT02964507|566377233|FG001|Overall Study|Death|9|||
156895388|NCT02964507|566377234|FG002|Overall Study|Death|12|||
156895389|NCT02964507|566377235|FG003|Overall Study|Death|2|||
156895390|NCT02964507|566377236|FG004|Overall Study|Death|10|||
156895391|NCT02964507|566377237|FG005|Overall Study|Death|5|||
156895392|NCT02964507|566377238|FG006|Overall Study|Death|0|||
156895393|NCT02964507|566377239|FG007|Overall Study|Death|0|||
156895394|NCT02964507|566377232|FG000|Overall Study|Withdrawal by Subject|1|||
156895395|NCT02964507|566377233|FG001|Overall Study|Withdrawal by Subject|0|||
156895396|NCT02964507|566377234|FG002|Overall Study|Withdrawal by Subject|1|||
156895397|NCT02964507|566377235|FG003|Overall Study|Withdrawal by Subject|1|||
156895398|NCT02964507|566377236|FG004|Overall Study|Withdrawal by Subject|0|||
156895399|NCT02964507|566377237|FG005|Overall Study|Withdrawal by Subject|1|||
156895400|NCT02964507|566377238|FG006|Overall Study|Withdrawal by Subject|0|||
156895401|NCT02964507|566377239|FG007|Overall Study|Withdrawal by Subject|0|||
156895402|NCT02964507|566377232|FG000|Overall Study|Physician Decision|2|||
156895403|NCT02964507|566377233|FG001|Overall Study|Physician Decision|0|||
156895404|NCT02964507|566377234|FG002|Overall Study|Physician Decision|3|||
156895405|NCT02964507|566377235|FG003|Overall Study|Physician Decision|0|||
156895406|NCT02964507|566377236|FG004|Overall Study|Physician Decision|1|||
156895407|NCT02964507|566377237|FG005|Overall Study|Physician Decision|0|||
156895408|NCT02964507|566377238|FG006|Overall Study|Physician Decision|0|||
156895409|NCT02964507|566377239|FG007|Overall Study|Physician Decision|0|||
156895410|NCT04341662|566377240|FG000|Overall Study|Did not have source-verified blood loss data|423|||
156895411|NCT04341662|566377241|FG001|Overall Study|Did not have source-verified blood loss data|514|||
156895412|NCT02675231|566377242|FG000|Overall Study|Withdrawal by Subject|2|||
156895413|NCT02675231|566377243|FG001|Overall Study|Withdrawal by Subject|4|||
156895414|NCT02675231|566377244|FG002|Overall Study|Withdrawal by Subject|2|||
156895415|NCT02675231|566377242|FG000|Overall Study|Lost to Follow-up|3|||
156895416|NCT02675231|566377243|FG001|Overall Study|Lost to Follow-up|4|||
156895417|NCT02675231|566377244|FG002|Overall Study|Lost to Follow-up|3|||
156895418|NCT02652767|566377246|FG000|Overall Study|Death|2|||
156895419|NCT02652767|566377246|FG000|Overall Study|Lost to Follow-up|1|||
156895420|NCT02652767|566377246|FG000|Overall Study|Withdrawal by Subject|1|||
156895421|NCT03953183|566377247|FG000|Overall Study|Physician Decision|0|||
156895422|NCT03953183|566377248|FG001|Overall Study|Physician Decision|1|||
156895423|NCT03953183|566377247|FG000|Overall Study|Withdrawal by Subject|0|||
156895424|NCT03953183|566377248|FG001|Overall Study|Withdrawal by Subject|1|||
156895425|NCT00887744|566377251|FG000|Overall Study|Adverse Event|3|||
156895426|NCT00887744|566377251|FG000|Overall Study|Death|1|||
156895427|NCT00887744|566377251|FG000|Overall Study|Lost to Follow-up|3|||
156895428|NCT00887744|566377251|FG000|Overall Study|Withdrawal by Subject|18|||
156895429|NCT00887744|566377251|FG000|Overall Study|Various reasons|9|||
156895430|NCT03533686|566377252|FG000|Overall Study|Withdrawal by Subject|1|||
156895431|NCT03533686|566377253|FG001|Overall Study|Withdrawal by Subject|0|||
156895432|NCT03533686|566377254|FG002|Overall Study|Withdrawal by Subject|0|||
156895433|NCT03533686|566377255|FG003|Overall Study|Withdrawal by Subject|3|||
156895434|NCT03533686|566377256|FG004|Overall Study|Withdrawal by Subject|5|||
156895435|NCT03533686|566377257|FG005|Overall Study|Withdrawal by Subject|1|||
156895436|NCT03533686|566377252|FG000|Overall Study|Lost to Follow-up|0|||
156895437|NCT03533686|566377253|FG001|Overall Study|Lost to Follow-up|1|||
156895438|NCT03533686|566377254|FG002|Overall Study|Lost to Follow-up|0|||
156895439|NCT03533686|566377255|FG003|Overall Study|Lost to Follow-up|0|||
156895440|NCT03533686|566377256|FG004|Overall Study|Lost to Follow-up|2|||
156895441|NCT03533686|566377257|FG005|Overall Study|Lost to Follow-up|0|||
156895442|NCT03533686|566377252|FG000|Overall Study|Screen Failure|0|||
156895443|NCT03533686|566377253|FG001|Overall Study|Screen Failure|0|||
157158227|NCT02935634|567324536|FG000|Treatment: Track 1|Study drug toxicity|2|||
157158228|NCT02935634|567324537|FG001|Treatment: Track 1|Study drug toxicity|1|||
157158229|NCT02935634|567324538|FG002|Treatment: Track 1|Study drug toxicity|3|||
157158230|NCT02935634|567324539|FG003|Treatment: Track 1|Study drug toxicity|0|||
157158231|NCT02935634|567324540|FG004|Treatment: Track 1|Study drug toxicity|0|||
156895444|NCT03533686|566377254|FG002|Overall Study|Screen Failure|0|||
156895445|NCT03533686|566377255|FG003|Overall Study|Screen Failure|2|||
156895446|NCT03533686|566377256|FG004|Overall Study|Screen Failure|0|||
156895447|NCT03533686|566377257|FG005|Overall Study|Screen Failure|0|||
157158232|NCT02935634|567324541|FG005|Treatment: Track 1|Study drug toxicity|1|||
157158233|NCT02935634|567324536|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
156895448|NCT01562873|566377258|FG000|Overall Study|Disease Progression per RECIST|10|||
156895449|NCT01562873|566377259|FG001|Overall Study|Disease Progression per RECIST|0|||
156895450|NCT01562873|566377258|FG000|Overall Study|Adverse Event|1|||
156895451|NCT01562873|566377259|FG001|Overall Study|Adverse Event|0|||
156895452|NCT01562873|566377258|FG000|Overall Study|Clinical Disease Progression|9|||
156895453|NCT01562873|566377259|FG001|Overall Study|Clinical Disease Progression|0|||
156895454|NCT01562873|566377258|FG000|Overall Study|Clinical PD and adverse event|1|||
156895455|NCT01562873|566377259|FG001|Overall Study|Clinical PD and adverse event|0|||
156895456|NCT03370289|566377262|FG000|Overall Study|Screen Failure|1|||
157158234|NCT02935634|567324537|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
157158235|NCT02935634|567324538|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
157158236|NCT02935634|567324539|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
156895457|NCT03370289|566377262|FG000|Overall Study|Sample Size Sufficient|4|||
156895458|NCT03309046|566377264|FG000|Overall Study|Withdrawal by Subject|4|||
156895459|NCT03309046|566377265|FG001|Overall Study|Withdrawal by Subject|17|||
156895460|NCT00873860|566377266|FG000|Overall Study|Lost to Follow-up|1|||
156895461|NCT00873860|566377267|FG001|Overall Study|Lost to Follow-up|0|||
156895462|NCT00873860|566377268|FG002|Overall Study|Lost to Follow-up|0|||
156895463|NCT00873860|566377269|FG003|Overall Study|Lost to Follow-up|1|||
156895464|NCT00873860|566377266|FG000|Overall Study|Withdrawal by Subject|1|||
156895465|NCT00873860|566377267|FG001|Overall Study|Withdrawal by Subject|0|||
156895466|NCT00873860|566377268|FG002|Overall Study|Withdrawal by Subject|2|||
156895467|NCT00873860|566377269|FG003|Overall Study|Withdrawal by Subject|0|||
156895468|NCT00873860|566377266|FG000|Overall Study|Death|1|||
156895469|NCT00873860|566377267|FG001|Overall Study|Death|0|||
156895470|NCT00873860|566377268|FG002|Overall Study|Death|0|||
156895471|NCT00873860|566377269|FG003|Overall Study|Death|0|||
156895472|NCT00873860|566377266|FG000|Overall Study|Other|1|||
156895473|NCT00873860|566377267|FG001|Overall Study|Other|0|||
156895474|NCT00873860|566377268|FG002|Overall Study|Other|1|||
156895475|NCT00873860|566377269|FG003|Overall Study|Other|0|||
156895476|NCT02862600|566377270|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
156895477|NCT02862600|566377270|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
156895478|NCT02862600|566377270|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
156895479|NCT02862600|566377270|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
156895480|NCT00194675|566377273|FG000|Overall Study|Lost to Follow-up|1|||
156895481|NCT00194675|566377274|FG001|Overall Study|Lost to Follow-up|1|||
156895482|NCT00194675|566377273|FG000|Overall Study|lack of interest|1|||
156895483|NCT00194675|566377274|FG001|Overall Study|lack of interest|1|||
156895484|NCT00194675|566377273|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
156895485|NCT00194675|566377274|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
156895486|NCT00194675|566377273|FG000|Overall Study|Protocol Violation|1|||
156895487|NCT00194675|566377274|FG001|Overall Study|Protocol Violation|0|||
156895488|NCT00194675|566377273|FG000|Overall Study|Death|1|||
156895489|NCT00194675|566377274|FG001|Overall Study|Death|0|||
156895490|NCT00704808|566377275|FG000|Overall Study|Discontinued prior to starting treatment|14|||
156895491|NCT00704808|566377275|FG000|Overall Study|Death|7|||
156895492|NCT00704808|566377275|FG000|Overall Study|Tumor progression|80|||
156895493|NCT00704808|566377275|FG000|Overall Study|Patient's decision|11|||
156895494|NCT00704808|566377275|FG000|Overall Study|Early therapy discontinuation|16|||
156895495|NCT00704808|566377275|FG000|Overall Study|Adverse Event|1|||
156895496|NCT00704808|566377275|FG000|Overall Study|Lost to Follow-up|1|||
156895497|NCT00704808|566377275|FG000|Overall Study|Treatment change|1|||
156895498|NCT04437368|566377279|FG000|Overall Study|Death|3|||
156895499|NCT04437368|566377280|FG001|Overall Study|Death|0|||
156895500|NCT04437368|566377281|FG002|Overall Study|Death|2|||
156895501|NCT04437368|566377279|FG000|Overall Study|Study terminated by sponsor|16|||
156895502|NCT04437368|566377280|FG001|Overall Study|Study terminated by sponsor|1|||
156895503|NCT04437368|566377281|FG002|Overall Study|Study terminated by sponsor|25|||
156895504|NCT04437368|566377279|FG000|Overall Study|Withdrawal by Subject|4|||
156895505|NCT04437368|566377280|FG001|Overall Study|Withdrawal by Subject|0|||
156895506|NCT04437368|566377281|FG002|Overall Study|Withdrawal by Subject|3|||
156895507|NCT04437368|566377279|FG000|Overall Study|Sponsor instructions|23|||
156895508|NCT04437368|566377280|FG001|Overall Study|Sponsor instructions|0|||
156895509|NCT04437368|566377281|FG002|Overall Study|Sponsor instructions|0|||
157158237|NCT02935634|567324540|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
157158238|NCT02935634|567324541|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
157158239|NCT02935634|567324536|FG000|Treatment: Track 1|Participant withdrew consent|2|||
157158240|NCT02935634|567324537|FG001|Treatment: Track 1|Participant withdrew consent|0|||
157158241|NCT02935634|567324538|FG002|Treatment: Track 1|Participant withdrew consent|1|||
157158242|NCT02935634|567324539|FG003|Treatment: Track 1|Participant withdrew consent|0|||
156895510|NCT00364130|566377284|FG000|Intervention Period|Lost to Follow-up|4|||
156895511|NCT00364130|566377285|FG001|Intervention Period|Lost to Follow-up|3|||
156895512|NCT00364130|566377284|FG000|Intervention Period|Pregnancy|1|||
156895513|NCT00364130|566377285|FG001|Intervention Period|Pregnancy|0|||
156895514|NCT00364130|566377284|FG000|Intervention Period|Withdrawal by Subject|4|||
156895515|NCT00364130|566377285|FG001|Intervention Period|Withdrawal by Subject|5|||
156895516|NCT00364130|566377284|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
156895517|NCT00364130|566377285|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
156895518|NCT00237185|566377288|FG000|Core|Adverse Event|3|||
156895519|NCT00237185|566377289|FG001|Core|Adverse Event|4|||
156895520|NCT00237185|566377288|FG000|Core|Abnormal laboratory value|0|||
156895521|NCT00237185|566377289|FG001|Core|Abnormal laboratory value|4|||
156895522|NCT00237185|566377288|FG000|Core|Abnormal test procedure results|1|||
156895523|NCT00237185|566377289|FG001|Core|Abnormal test procedure results|0|||
156895524|NCT00237185|566377288|FG000|Core|Lack of Efficacy|30|||
156895525|NCT00237185|566377289|FG001|Core|Lack of Efficacy|23|||
156895526|NCT00237185|566377288|FG000|Core|Protocol Violation|1|||
156895527|NCT00237185|566377289|FG001|Core|Protocol Violation|1|||
156895528|NCT00237185|566377288|FG000|Core|Withdrawal by Subject|4|||
156895529|NCT00237185|566377289|FG001|Core|Withdrawal by Subject|4|||
156895530|NCT00237185|566377288|FG000|Core|Administrative problems|0|||
156895531|NCT00237185|566377289|FG001|Core|Administrative problems|1|||
156895532|NCT00237185|566377288|FG000|Core|Death|4|||
156895533|NCT00237185|566377289|FG001|Core|Death|0|||
156895534|NCT00237185|566377288|FG000|Core|Determined ineligible post randomization|1|||
156895535|NCT00237185|566377289|FG001|Core|Determined ineligible post randomization|0|||
156895536|NCT00237185|566377288|FG000|Extension|Adverse Event|1|||
156895537|NCT00237185|566377289|FG001|Extension|Adverse Event|0|||
156895538|NCT00237185|566377288|FG000|Extension|Abnormal laboratory value|0|||
156895539|NCT00237185|566377289|FG001|Extension|Abnormal laboratory value|1|||
156895540|NCT00237185|566377288|FG000|Extension|Lack of Efficacy|9|||
156895541|NCT00237185|566377289|FG001|Extension|Lack of Efficacy|14|||
156895542|NCT00237185|566377288|FG000|Extension|Condition no longer required study drug|0|||
156895543|NCT00237185|566377289|FG001|Extension|Condition no longer required study drug|1|||
156895544|NCT00237185|566377288|FG000|Extension|Withdrawal by Subject|3|||
156895545|NCT00237185|566377289|FG001|Extension|Withdrawal by Subject|2|||
156895546|NCT00237185|566377288|FG000|Extension|Lost to Follow-up|1|||
156895547|NCT00237185|566377289|FG001|Extension|Lost to Follow-up|0|||
156895548|NCT00237185|566377288|FG000|Extension|Administrative problems|1|||
156895549|NCT00237185|566377289|FG001|Extension|Administrative problems|0|||
156895550|NCT00237185|566377288|FG000|Extension|Death|1|||
156895551|NCT00237185|566377289|FG001|Extension|Death|1|||
156895552|NCT00910988|566377290|FG000|Overall Study|Lost to Follow-up|2|||
156895553|NCT00910988|566377291|FG001|Overall Study|Lost to Follow-up|4|||
156895554|NCT00910988|566377292|FG002|Overall Study|Lost to Follow-up|3|||
156895555|NCT00910988|566377293|FG003|Overall Study|Lost to Follow-up|0|||
156895556|NCT03194490|566377304|FG000|Overall Study|Lost to Follow-up|1|||
157158243|NCT02935634|567324540|FG004|Treatment: Track 1|Participant withdrew consent|1|||
156895557|NCT03194490|566377305|FG001|Overall Study|Lost to Follow-up|3|||
156895558|NCT03194490|566377304|FG000|Overall Study|participant developed specific neck pain|1|||
156895559|NCT03194490|566377305|FG001|Overall Study|participant developed specific neck pain|0|||
156895560|NCT01758289|566377306|FG000|Overall Study|Premature Study Termination|44|||
156895561|NCT01758289|566377306|FG000|Overall Study|Adverse Event|9|||
156895562|NCT01574079|566377307|FG000|Overall Study|Physician Decision|0|||
156895563|NCT01574079|566377308|FG001|Overall Study|Physician Decision|2|||
156895564|NCT01574079|566377307|FG000|Overall Study|Lost to Follow-up|1|||
156895565|NCT01574079|566377308|FG001|Overall Study|Lost to Follow-up|0|||
156895566|NCT03640559|566377314|FG000|Overall Study|Physician Decision|1|||
156895567|NCT03640559|566377315|FG001|Overall Study|Physician Decision|1|||
156895568|NCT03640559|566377314|FG000|Overall Study|Withdrawal by Subject|1|||
156895569|NCT03640559|566377315|FG001|Overall Study|Withdrawal by Subject|0|||
156895570|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
156895571|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
156895572|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
156895573|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
156895574|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
156895575|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
156895576|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
156895577|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
156895578|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
156895579|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
156895580|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
156895581|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
156895582|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
156895583|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156895584|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
156895585|NCT01436162|566377316|FG000|Single-blind Lead-in Phase|Other|107|||
156895586|NCT01436162|566377317|FG001|Single-blind Lead-in Phase|Other|0|||
156895587|NCT01436162|566377318|FG002|Single-blind Lead-in Phase|Other|0|||
156895588|NCT01436162|566377316|FG000|Randomized Phase|Adverse Event|1|||
156895589|NCT01436162|566377317|FG001|Randomized Phase|Adverse Event|5|||
157158244|NCT02935634|567324541|FG005|Treatment: Track 1|Participant withdrew consent|0|||
157158245|NCT02935634|567324536|FG000|Treatment: Track 1|Other reasons|0|||
157158246|NCT02935634|567324537|FG001|Treatment: Track 1|Other reasons|0|||
156895590|NCT01436162|566377318|FG002|Randomized Phase|Adverse Event|6|||
156895591|NCT01436162|566377316|FG000|Randomized Phase|Protocol Violation|4|||
156895592|NCT01436162|566377317|FG001|Randomized Phase|Protocol Violation|4|||
156895593|NCT01436162|566377318|FG002|Randomized Phase|Protocol Violation|2|||
156895594|NCT01436162|566377316|FG000|Randomized Phase|Withdrawal by Subject|16|||
156895595|NCT01436162|566377317|FG001|Randomized Phase|Withdrawal by Subject|9|||
156895596|NCT01436162|566377318|FG002|Randomized Phase|Withdrawal by Subject|8|||
156895597|NCT01436162|566377316|FG000|Randomized Phase|Lost to Follow-up|17|||
156895598|NCT01436162|566377317|FG001|Randomized Phase|Lost to Follow-up|5|||
156895599|NCT01436162|566377318|FG002|Randomized Phase|Lost to Follow-up|4|||
156895600|NCT01436162|566377316|FG000|Randomized Phase|Lack of Efficacy|0|||
156895601|NCT01436162|566377317|FG001|Randomized Phase|Lack of Efficacy|1|||
156895602|NCT01436162|566377318|FG002|Randomized Phase|Lack of Efficacy|1|||
156895603|NCT01436162|566377316|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
156895604|NCT01436162|566377317|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
156895605|NCT01436162|566377318|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
156895606|NCT01436162|566377316|FG000|Randomized Phase|Other|2|||
156895607|NCT01436162|566377317|FG001|Randomized Phase|Other|5|||
156895608|NCT01436162|566377318|FG002|Randomized Phase|Other|4|||
156895609|NCT02750943|566377323|FG000|Overall Study|Lost to Follow-up|1|||
156895610|NCT02750943|566377324|FG001|Overall Study|Lost to Follow-up|2|||
156895611|NCT02750943|566377323|FG000|Overall Study|Withdrawal by Subject|5|||
156895612|NCT02750943|566377324|FG001|Overall Study|Withdrawal by Subject|7|||
156895613|NCT04597918|566377325|FG000|Overall Study|Withdrawal by Subject|6|||
156895614|NCT04597918|566377325|FG000|Overall Study|Lost to Follow-up|3|||
156895615|NCT04597918|566377325|FG000|Overall Study|Death|1|||
156895616|NCT00458536|566377328|FG000|Overall Study|Disease progression prior to treatment|7|||
156895617|NCT00458536|566377328|FG000|Overall Study|Unable to make vaccine|3|||
156895618|NCT00458536|566377328|FG000|Overall Study|No measurable disease after surgery|2|||
156895619|NCT00458536|566377328|FG000|Overall Study|Did not have renal cell carcinoma|2|||
156895620|NCT00458536|566377328|FG000|Overall Study|Patient did not have surgery|1|||
156895621|NCT00458536|566377328|FG000|Overall Study|Ineligible due to toxicity|1|||
156895622|NCT00458536|566377328|FG000|Overall Study|Withdrawal by Subject|1|||
157225500|NCT02483975|567571447|FG000|Overall Study|Physician Decision|2|||
156858592|NCT00591006|566236731|FG011|Overall Study|Adverse Event|0|||
156858593|NCT00591006|566236732|FG012|Overall Study|Adverse Event|0|||
156858594|NCT00591006|566236733|FG013|Overall Study|Adverse Event|0|||
156858595|NCT00591006|566236734|FG014|Overall Study|Adverse Event|0|||
156858596|NCT00591006|566236735|FG015|Overall Study|Adverse Event|0|||
156858597|NCT00591006|566236736|FG016|Overall Study|Adverse Event|0|||
156858598|NCT00591006|566236737|FG017|Overall Study|Adverse Event|0|||
156858599|NCT00591006|566236738|FG018|Overall Study|Adverse Event|0|||
156858600|NCT00591006|566236739|FG019|Overall Study|Adverse Event|0|||
156858601|NCT00591006|566236740|FG020|Overall Study|Adverse Event|0|||
156858602|NCT00591006|566236741|FG021|Overall Study|Adverse Event|0|||
156858603|NCT00591006|566236742|FG022|Overall Study|Adverse Event|1|||
156858604|NCT00591006|566236743|FG023|Overall Study|Adverse Event|0|||
156858605|NCT03071263|566236744|FG000|Overall Study|Adverse Event|1|||
156858606|NCT03071263|566236745|FG001|Overall Study|Adverse Event|3|||
156858607|NCT03071263|566236744|FG000|Overall Study|Withdrawal by Subject|1|||
156858608|NCT03071263|566236745|FG001|Overall Study|Withdrawal by Subject|3|||
156858609|NCT03071263|566236744|FG000|Overall Study|Physician Decision|1|||
156858610|NCT03071263|566236745|FG001|Overall Study|Physician Decision|0|||
156858611|NCT03071263|566236744|FG000|Overall Study|Participant moved to another city|0|||
156858612|NCT03071263|566236745|FG001|Overall Study|Participant moved to another city|1|||
156858613|NCT04158583|566236752|FG000|Overall Study|Withdrawal by Subject|1|||
156858614|NCT04158583|566236753|FG001|Overall Study|Withdrawal by Subject|1|||
156858615|NCT04158583|566236754|FG002|Overall Study|Withdrawal by Subject|0|||
156858616|NCT04158583|566236755|FG003|Overall Study|Withdrawal by Subject|0|||
156858617|NCT04158583|566236756|FG004|Overall Study|Withdrawal by Subject|1|||
156858618|NCT04158583|566236757|FG005|Overall Study|Withdrawal by Subject|0|||
156858619|NCT04158583|566236758|FG006|Overall Study|Withdrawal by Subject|0|||
156858620|NCT04158583|566236759|FG007|Overall Study|Withdrawal by Subject|0|||
156858621|NCT04158583|566236760|FG008|Overall Study|Withdrawal by Subject|2|||
156858622|NCT04158583|566236761|FG009|Overall Study|Withdrawal by Subject|0|||
156858623|NCT04158583|566236752|FG000|Overall Study|Study Terminated by Sponsor|0|||
156858624|NCT04158583|566236753|FG001|Overall Study|Study Terminated by Sponsor|0|||
156858625|NCT04158583|566236754|FG002|Overall Study|Study Terminated by Sponsor|0|||
156858626|NCT04158583|566236755|FG003|Overall Study|Study Terminated by Sponsor|1|||
156858627|NCT04158583|566236756|FG004|Overall Study|Study Terminated by Sponsor|0|||
156858628|NCT04158583|566236757|FG005|Overall Study|Study Terminated by Sponsor|0|||
156858629|NCT04158583|566236758|FG006|Overall Study|Study Terminated by Sponsor|0|||
156858630|NCT04158583|566236759|FG007|Overall Study|Study Terminated by Sponsor|0|||
156895623|NCT00458536|566377328|FG000|Overall Study|Progressive disease during treatment|2|||
156895624|NCT05140382|566377329|FG000|Overall Study|Death|3|||
156895625|NCT05140382|566377330|FG001|Overall Study|Death|0|||
156895626|NCT05140382|566377331|FG002|Overall Study|Death|0|||
156895627|NCT05140382|566377329|FG000|Overall Study|Investigator decision|1|||
156895628|NCT05140382|566377330|FG001|Overall Study|Investigator decision|0|||
156858631|NCT04158583|566236760|FG008|Overall Study|Study Terminated by Sponsor|0|||
156858632|NCT04158583|566236761|FG009|Overall Study|Study Terminated by Sponsor|0|||
156858633|NCT04158583|566236752|FG000|Overall Study|Progressive Disease|1|||
156858634|NCT04158583|566236753|FG001|Overall Study|Progressive Disease|0|||
156858635|NCT04158583|566236754|FG002|Overall Study|Progressive Disease|3|||
156895629|NCT05140382|566377331|FG002|Overall Study|Investigator decision|0|||
156895630|NCT05140382|566377329|FG000|Overall Study|Other|4|||
156895631|NCT05140382|566377330|FG001|Overall Study|Other|0|||
156895632|NCT05140382|566377331|FG002|Overall Study|Other|1|||
156895633|NCT05140382|566377329|FG000|Overall Study|Progressive disease|20|||
156895634|NCT05140382|566377330|FG001|Overall Study|Progressive disease|1|||
156895635|NCT05140382|566377331|FG002|Overall Study|Progressive disease|12|||
156895636|NCT05140382|566377329|FG000|Overall Study|Subjective disease progression|2|||
156895637|NCT05140382|566377330|FG001|Overall Study|Subjective disease progression|1|||
156895638|NCT05140382|566377331|FG002|Overall Study|Subjective disease progression|0|||
156895639|NCT05140382|566377329|FG000|Overall Study|Unknown at data cut-off|0|||
156895640|NCT05140382|566377330|FG001|Overall Study|Unknown at data cut-off|0|||
156895641|NCT05140382|566377331|FG002|Overall Study|Unknown at data cut-off|1|||
156895642|NCT05140382|566377329|FG000|Overall Study|Withdrawal by Subject|1|||
156895643|NCT05140382|566377330|FG001|Overall Study|Withdrawal by Subject|0|||
156895644|NCT05140382|566377331|FG002|Overall Study|Withdrawal by Subject|4|||
156895645|NCT05140382|566377329|FG000|Overall Study|Withdrawal of consent|0|||
156895646|NCT05140382|566377330|FG001|Overall Study|Withdrawal of consent|0|||
156895647|NCT05140382|566377331|FG002|Overall Study|Withdrawal of consent|1|||
156895648|NCT05419908|566377333|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
156895649|NCT05419908|566377334|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
156895650|NCT05419908|566377333|FG000|Overall Study|Serious Adverse Event|0|||
156895651|NCT05419908|566377334|FG001|Overall Study|Serious Adverse Event|2|||
156895652|NCT05419908|566377333|FG000|Overall Study|Withdrawal by Subject|2|||
156895653|NCT05419908|566377334|FG001|Overall Study|Withdrawal by Subject|0|||
156895654|NCT05419908|566377333|FG000|Overall Study|Miscellaneous|1|||
156895655|NCT05419908|566377334|FG001|Overall Study|Miscellaneous|1|||
156895656|NCT01442038|566378538|FG000|Overall Study|Death|35|||
156895657|NCT01442038|566378539|FG001|Overall Study|Death|29|||
156895658|NCT01442038|566378538|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
156895659|NCT01442038|566378539|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
156895660|NCT01442038|566378538|FG000|Overall Study|Participant Withdrew Consent|137|||
156895661|NCT01442038|566378539|FG001|Overall Study|Participant Withdrew Consent|102|||
156895662|NCT01442038|566378538|FG000|Overall Study|Lost to Follow-up|37|||
156895663|NCT01442038|566378539|FG001|Overall Study|Lost to Follow-up|51|||
156895664|NCT01442038|566378538|FG000|Overall Study|Adverse Event|26|||
156895665|NCT01442038|566378539|FG001|Overall Study|Adverse Event|15|||
156895666|NCT01442038|566378538|FG000|Overall Study|Protocol Deviation|9|||
156895667|NCT01442038|566378539|FG001|Overall Study|Protocol Deviation|20|||
156895668|NCT01442038|566378538|FG000|Overall Study|Investigator's Discretion|13|||
156895669|NCT01442038|566378539|FG001|Overall Study|Investigator's Discretion|16|||
156895670|NCT01442038|566378538|FG000|Overall Study|Study Terminated By Sponsor|2|||
156895671|NCT01442038|566378539|FG001|Overall Study|Study Terminated By Sponsor|3|||
156895672|NCT04879225|566378542|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
156895673|NCT04879225|566378542|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
156895674|NCT01298531|566378545|FG000|Overall Study|Lack of Efficacy|0|||
156895675|NCT01298531|566378546|FG001|Overall Study|Lack of Efficacy|1|||
156895676|NCT01298531|566378545|FG000|Overall Study|Lost to Follow-up|2|||
156895677|NCT01298531|566378546|FG001|Overall Study|Lost to Follow-up|0|||
156895678|NCT01298531|566378545|FG000|Overall Study|Protocol Violation|1|||
156895679|NCT01298531|566378546|FG001|Overall Study|Protocol Violation|1|||
156895680|NCT01298531|566378545|FG000|Overall Study|Adverse Event|4|||
156895681|NCT01298531|566378546|FG001|Overall Study|Adverse Event|3|||
156895682|NCT01298531|566378545|FG000|Overall Study|Does not meet entrance criteria|0|||
156895683|NCT01298531|566378546|FG001|Overall Study|Does not meet entrance criteria|1|||
156895684|NCT01298531|566378545|FG000|Overall Study|Other|2|||
156895685|NCT01298531|566378546|FG001|Overall Study|Other|1|||
156895686|NCT03646643|566378547|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
156895687|NCT03646643|566378548|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
156895688|NCT03646643|566378547|FG000|Overall Study|Lost to Follow-up|0|||
157158247|NCT02935634|567324538|FG002|Treatment: Track 1|Other reasons|2|||
156895689|NCT03646643|566378548|FG001|Overall Study|Lost to Follow-up|1|||
156895690|NCT05314478|566378551|FG000|Overall Study|Physician Decision|1|||
156895691|NCT03583164|566378554|FG000|Overall Study|Death in Main Phase|35|||
156895692|NCT03583164|566378554|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
156895693|NCT03583164|566378554|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
156895694|NCT03583164|566378554|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
156895695|NCT03583164|566378554|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
156895696|NCT03583164|566378554|FG000|Overall Study|Physician decision in Main Phase|1|||
156895697|NCT03583164|566378554|FG000|Overall Study|Physician decision in Extended Phase|2|||
156895698|NCT03583164|566378554|FG000|Overall Study|Death in Extended Phase|13|||
156895699|NCT03583164|566378554|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
156895700|NCT03583164|566378554|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
156895701|NCT03583164|566378554|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
156895702|NCT03583164|566378554|FG000|Overall Study|Treatment failure in Main Phase|2|||
156895703|NCT03583164|566378554|FG000|Overall Study|Treatment failure in Extended Phase|4|||
156895704|NCT03583164|566378554|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
156895705|NCT03583164|566378554|FG000|Overall Study|Other not specified reason in Main Phase|2|||
156895706|NCT01031381|566378555|FG000|Overall Study|Physician Decision|3|||
156895707|NCT01031381|566378555|FG000|Overall Study|Withdrawal by Subject|6|||
156895708|NCT00214500|566378556|FG000|Treatment Period|Adverse Event|1|||
156895709|NCT00214500|566378556|FG000|Extension Period|Withdrawal by Subject|2|||
156895710|NCT01068652|566378557|FG000|Overall Study|Adverse Event|4|||
156895711|NCT01068652|566378558|FG001|Overall Study|Adverse Event|0|||
156895712|NCT01068652|566378557|FG000|Overall Study|Lack of Efficacy|0|||
156895713|NCT01068652|566378558|FG001|Overall Study|Lack of Efficacy|2|||
156895714|NCT01068652|566378557|FG000|Overall Study|Lost to Follow-up|2|||
156895715|NCT01068652|566378558|FG001|Overall Study|Lost to Follow-up|1|||
156895716|NCT01068652|566378557|FG000|Overall Study|Protocol Violation|3|||
156895717|NCT01068652|566378558|FG001|Overall Study|Protocol Violation|6|||
156895718|NCT01068652|566378557|FG000|Overall Study|Withdrawal criteria|1|||
156895719|NCT01068652|566378558|FG001|Overall Study|Withdrawal criteria|2|||
156895720|NCT01068652|566378557|FG000|Overall Study|Patient was not eligible|1|||
156895721|NCT01068652|566378558|FG001|Overall Study|Patient was not eligible|0|||
156895722|NCT01068652|566378557|FG000|Overall Study|Unclassified|7|||
156895723|NCT01068652|566378558|FG001|Overall Study|Unclassified|4|||
156895724|NCT00147251|566378559|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
156895725|NCT00147251|566378560|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
156895726|NCT01367119|566378570|FG000|Overall Study|Adverse Event|1|||
156895727|NCT01367119|566378571|FG001|Overall Study|Adverse Event|0|||
156895728|NCT01367119|566378570|FG000|Overall Study|Withdrawal by Subject|1|||
156895729|NCT01367119|566378571|FG001|Overall Study|Withdrawal by Subject|1|||
156895730|NCT05323656|566378574|FG000|Overall Study|Still On-Treatment|6|||
156895731|NCT05323656|566378575|FG001|Overall Study|Still On-Treatment|6|||
156895732|NCT05323656|566378574|FG000|Overall Study|Progressive Disease|15|||
156895733|NCT05323656|566378575|FG001|Overall Study|Progressive Disease|14|||
156895734|NCT05323656|566378574|FG000|Overall Study|Adverse Event|2|||
156895735|NCT05323656|566378575|FG001|Overall Study|Adverse Event|3|||
156895736|NCT05323656|566378574|FG000|Overall Study|Death|1|||
156895737|NCT05323656|566378575|FG001|Overall Study|Death|2|||
156895738|NCT05323656|566378574|FG000|Overall Study|Withdrawal by Subject|1|||
156895739|NCT05323656|566378575|FG001|Overall Study|Withdrawal by Subject|0|||
156895740|NCT05323656|566378574|FG000|Overall Study|Clinical disease progression|0|||
156895741|NCT05323656|566378575|FG001|Overall Study|Clinical disease progression|1|||
156895742|NCT05323656|566378574|FG000|Overall Study|Patient and Investigator decision|1|||
156895743|NCT05323656|566378575|FG001|Overall Study|Patient and Investigator decision|0|||
156895744|NCT05323656|566378574|FG000|Overall Study|Physician Decision|0|||
156895745|NCT05323656|566378575|FG001|Overall Study|Physician Decision|1|||
156895746|NCT02495233|566378576|FG000|Overall Study|Miscellaneous|0|||
156895747|NCT02495233|566378577|FG001|Overall Study|Miscellaneous|1|||
156895748|NCT03880461|566378578|FG000|Overall Study|Determined ineligible after enrollment|45|||
156895749|NCT03880461|566378579|FG001|Overall Study|Determined ineligible after enrollment|44|||
156895750|NCT03880461|566378578|FG000|Overall Study|No weight measurement after enrollment|24|||
156895751|NCT03880461|566378579|FG001|Overall Study|No weight measurement after enrollment|17|||
156895752|NCT01028378|566378581|FG000|Overall Study|Lost to Follow-up|12|||
156895753|NCT01028378|566378581|FG000|Overall Study|Withdrawal by Subject|1|||
156895754|NCT01028378|566378581|FG000|Overall Study|Adminstrative Reasons|4|||
156895755|NCT01115803|566378593|FG000|Overall Study|Withdrawal by Subject|0|||
157158248|NCT02935634|567324539|FG003|Treatment: Track 1|Other reasons|0|||
157158249|NCT02935634|567324540|FG004|Treatment: Track 1|Other reasons|0|||
156895756|NCT01115803|566378594|FG001|Overall Study|Withdrawal by Subject|0|||
156895757|NCT01115803|566378595|FG002|Overall Study|Withdrawal by Subject|0|||
156895758|NCT01115803|566378596|FG003|Overall Study|Withdrawal by Subject|0|||
156895759|NCT01115803|566378597|FG004|Overall Study|Withdrawal by Subject|0|||
156895760|NCT01115803|566378598|FG005|Overall Study|Withdrawal by Subject|0|||
156895761|NCT01115803|566378599|FG006|Overall Study|Withdrawal by Subject|1|||
156895762|NCT01115803|566378593|FG000|Overall Study|Lost to Follow-up|0|||
156895763|NCT01115803|566378594|FG001|Overall Study|Lost to Follow-up|0|||
156895764|NCT01115803|566378595|FG002|Overall Study|Lost to Follow-up|1|||
156895765|NCT01115803|566378596|FG003|Overall Study|Lost to Follow-up|0|||
156895766|NCT01115803|566378597|FG004|Overall Study|Lost to Follow-up|0|||
156895767|NCT01115803|566378598|FG005|Overall Study|Lost to Follow-up|0|||
156895768|NCT01115803|566378599|FG006|Overall Study|Lost to Follow-up|0|||
156895769|NCT01115803|566378593|FG000|Overall Study|Progressive Disease during Cycle1|0|||
156895770|NCT01115803|566378594|FG001|Overall Study|Progressive Disease during Cycle1|0|||
156895771|NCT01115803|566378595|FG002|Overall Study|Progressive Disease during Cycle1|0|||
156895772|NCT01115803|566378596|FG003|Overall Study|Progressive Disease during Cycle1|0|||
156895773|NCT01115803|566378597|FG004|Overall Study|Progressive Disease during Cycle1|0|||
156895774|NCT01115803|566378598|FG005|Overall Study|Progressive Disease during Cycle1|0|||
156895775|NCT01115803|566378599|FG006|Overall Study|Progressive Disease during Cycle1|1|||
156895776|NCT00064298|566378600|FG000|Overall Study|Withdrawal by Subject|2|||
156895777|NCT00064298|566378601|FG001|Overall Study|Withdrawal by Subject|1|||
156895778|NCT00064298|566378600|FG000|Overall Study|Lost to Follow-up|2|||
156895779|NCT00064298|566378601|FG001|Overall Study|Lost to Follow-up|2|||
156895780|NCT00064298|566378600|FG000|Overall Study|Death|0|||
156895781|NCT00064298|566378601|FG001|Overall Study|Death|1|||
156895782|NCT00064298|566378600|FG000|Overall Study|Disease Progression|2|||
156895783|NCT00064298|566378601|FG001|Overall Study|Disease Progression|1|||
156895784|NCT02273739|566378602|FG000|Overall Study|Progression of Disease|3|||
156895785|NCT02273739|566378603|FG001|Overall Study|Progression of Disease|4|||
156895786|NCT02273739|566378604|FG002|Overall Study|Progression of Disease|5|||
156895787|NCT02273739|566378605|FG003|Overall Study|Progression of Disease|2|||
156895788|NCT02273739|566378602|FG000|Overall Study|Death|0|||
156895789|NCT02273739|566378603|FG001|Overall Study|Death|0|||
156895790|NCT02273739|566378604|FG002|Overall Study|Death|0|||
156895791|NCT02273739|566378605|FG003|Overall Study|Death|2|||
156895792|NCT02273739|566378602|FG000|Overall Study|Adverse Event|0|||
156895793|NCT02273739|566378603|FG001|Overall Study|Adverse Event|0|||
156895794|NCT02273739|566378604|FG002|Overall Study|Adverse Event|0|||
156895795|NCT02273739|566378605|FG003|Overall Study|Adverse Event|1|||
156895796|NCT02273739|566378602|FG000|Overall Study|Withdrawal by Subject|0|||
156895797|NCT02273739|566378603|FG001|Overall Study|Withdrawal by Subject|0|||
156895798|NCT02273739|566378604|FG002|Overall Study|Withdrawal by Subject|2|||
156895799|NCT02273739|566378605|FG003|Overall Study|Withdrawal by Subject|1|||
156895800|NCT02273739|566378602|FG000|Overall Study|Physician Decision|0|||
156895801|NCT02273739|566378603|FG001|Overall Study|Physician Decision|0|||
156895802|NCT02273739|566378604|FG002|Overall Study|Physician Decision|0|||
156895803|NCT02273739|566378605|FG003|Overall Study|Physician Decision|1|||
156895804|NCT02017171|566378607|FG000|Overall Study|Death|10|||
156895805|NCT02017171|566378608|FG001|Overall Study|Death|4|||
156895806|NCT02017171|566378607|FG000|Overall Study|Withdrawal by Subject|23|||
156895807|NCT02017171|566378608|FG001|Overall Study|Withdrawal by Subject|17|||
156895808|NCT02017171|566378607|FG000|Overall Study|Lost to Follow-up|21|||
156895809|NCT02017171|566378608|FG001|Overall Study|Lost to Follow-up|20|||
156895810|NCT02017171|566378607|FG000|Overall Study|ESKD|6|||
156895811|NCT02017171|566378608|FG001|Overall Study|ESKD|2|||
156895812|NCT02017171|566378607|FG000|Overall Study|Miscellaneous|2|||
156895813|NCT02017171|566378608|FG001|Overall Study|Miscellaneous|3|||
156895814|NCT02220998|566378609|FG000|Overall Study|Randomized but Never Treated|1|||
156895815|NCT02220998|566378610|FG001|Overall Study|Randomized but Never Treated|2|||
156895816|NCT02220998|566378609|FG000|Overall Study|Death|2|||
156895817|NCT02220998|566378610|FG001|Overall Study|Death|0|||
156895818|NCT02220998|566378609|FG000|Overall Study|Lack of Efficacy|0|||
156895819|NCT02220998|566378610|FG001|Overall Study|Lack of Efficacy|5|||
156895820|NCT02220998|566378609|FG000|Overall Study|Lost to Follow-up|4|||
156895821|NCT02220998|566378610|FG001|Overall Study|Lost to Follow-up|4|||
156895822|NCT01982331|566378612|FG000|Received Vaccination 2|Adverse Event|1|||
156895823|NCT01982331|566378613|FG001|Received Vaccination 2|Adverse Event|2|||
156895824|NCT01982331|566378612|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
156895825|NCT01982331|566378613|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
156895826|NCT01982331|566378612|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
156895827|NCT01982331|566378613|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
156895828|NCT01539317|566378614|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
156895829|NCT01539317|566378615|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
156895830|NCT02961218|566378616|FG000|Overall Study|Lost to Follow-up|0|||
156895831|NCT02961218|566378617|FG001|Overall Study|Lost to Follow-up|2|||
156895832|NCT02961218|566378616|FG000|Overall Study|Physician Decision|0|||
156895833|NCT02961218|566378617|FG001|Overall Study|Physician Decision|2|||
156895834|NCT02961218|566378616|FG000|Overall Study|Subject/Guardian Decision|3|||
156895835|NCT02961218|566378617|FG001|Overall Study|Subject/Guardian Decision|1|||
156895836|NCT00591266|566378618|FG000|Overall Study|Adverse Event|2|||
156895837|NCT00591266|566378619|FG001|Overall Study|Adverse Event|2|||
156895838|NCT00591266|566378620|FG002|Overall Study|Adverse Event|3|||
156895839|NCT00591266|566378618|FG000|Overall Study|Lost to Follow-up|0|||
156895840|NCT00591266|566378619|FG001|Overall Study|Lost to Follow-up|1|||
156895841|NCT00591266|566378620|FG002|Overall Study|Lost to Follow-up|0|||
156895842|NCT00591266|566378618|FG000|Overall Study|Protocol Violation|0|||
156895843|NCT00591266|566378619|FG001|Overall Study|Protocol Violation|0|||
156895844|NCT00591266|566378620|FG002|Overall Study|Protocol Violation|1|||
156895845|NCT00591266|566378618|FG000|Overall Study|Withdrawal by Subject|6|||
157026149|NCT03365882|566849729|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
157158250|NCT02935634|567324541|FG005|Treatment: Track 1|Other reasons|0|||
156895846|NCT00591266|566378619|FG001|Overall Study|Withdrawal by Subject|2|||
156895847|NCT00591266|566378620|FG002|Overall Study|Withdrawal by Subject|5|||
156895848|NCT00591266|566378618|FG000|Overall Study|Lack of Efficacy|0|||
156895849|NCT00591266|566378619|FG001|Overall Study|Lack of Efficacy|2|||
156895850|NCT00591266|566378620|FG002|Overall Study|Lack of Efficacy|0|||
156895851|NCT00591266|566378618|FG000|Overall Study|Other|1|||
156895852|NCT00591266|566378619|FG001|Overall Study|Other|4|||
156895853|NCT00591266|566378620|FG002|Overall Study|Other|5|||
156895854|NCT02393690|566378621|FG000|Overall Study|Ineligible|0|||
156895855|NCT02393690|566378622|FG001|Overall Study|Ineligible|1|||
156895856|NCT03488927|566378623|FG000|Overall Study|Withdrawal by Subject|44|||
156895857|NCT03488927|566378624|FG001|Overall Study|Withdrawal by Subject|118|||
156895858|NCT03488927|566378625|FG002|Overall Study|Withdrawal by Subject|217|||
156895859|NCT03497676|566378626|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156895860|NCT03497676|566378627|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
156895861|NCT03497676|566378628|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156895862|NCT03497676|566378629|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
156895863|NCT03497676|566378626|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
156895864|NCT03497676|566378627|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
156895865|NCT03497676|566378628|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
156895866|NCT03497676|566378629|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
156895867|NCT03497676|566378626|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
156895868|NCT03497676|566378627|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
156895869|NCT03497676|566378628|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
156895870|NCT03497676|566378629|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
156895871|NCT03497676|566378626|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156895872|NCT03497676|566378627|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
156895873|NCT03497676|566378628|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156895874|NCT03497676|566378629|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
156895875|NCT03497676|566378626|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156895876|NCT03497676|566378627|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156895877|NCT03497676|566378628|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
156895878|NCT03497676|566378629|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
156895879|NCT03497676|566378626|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156895880|NCT03497676|566378627|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156895881|NCT03497676|566378628|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
156895882|NCT03497676|566378629|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
156895883|NCT03497676|566378626|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156895884|NCT03497676|566378627|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156895885|NCT03497676|566378628|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
156895886|NCT03497676|566378629|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
156895887|NCT03497676|566378626|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156895888|NCT03497676|566378627|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156895889|NCT03497676|566378628|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
156895890|NCT03497676|566378629|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
156895891|NCT02204007|566378636|FG000|Overall Study|Surgery Canceled|1|||
156895892|NCT02204007|566378637|FG001|Overall Study|Surgery Canceled|1|||
156895893|NCT03911843|566378638|FG000|Overall Study|Adverse Event|2|||
156895894|NCT03911843|566378639|FG001|Overall Study|Adverse Event|0|||
156895895|NCT03911843|566378638|FG000|Overall Study|Protocol Violation|2|||
156895896|NCT03911843|566378639|FG001|Overall Study|Protocol Violation|0|||
156895897|NCT03911843|566378638|FG000|Overall Study|Lost to Follow-up|0|||
156895898|NCT03911843|566378639|FG001|Overall Study|Lost to Follow-up|1|||
156895899|NCT02819518|566378640|FG000|Overall Study|Death|9|||
156895900|NCT02819518|566378641|FG001|Overall Study|Death|12|||
156895901|NCT02819518|566378642|FG002|Overall Study|Death|9|||
156895902|NCT02819518|566378643|FG003|Overall Study|Death|475|||
156895903|NCT02819518|566378644|FG004|Overall Study|Death|244|||
156895904|NCT02819518|566378640|FG000|Overall Study|Withdrawal by Subject|0|||
156895905|NCT02819518|566378641|FG001|Overall Study|Withdrawal by Subject|0|||
156895906|NCT02819518|566378642|FG002|Overall Study|Withdrawal by Subject|0|||
156895907|NCT02819518|566378643|FG003|Overall Study|Withdrawal by Subject|25|||
156895908|NCT02819518|566378644|FG004|Overall Study|Withdrawal by Subject|8|||
156895909|NCT02819518|566378640|FG000|Overall Study|Lost to Follow-up|0|||
156895910|NCT02819518|566378641|FG001|Overall Study|Lost to Follow-up|0|||
156895911|NCT02819518|566378642|FG002|Overall Study|Lost to Follow-up|0|||
156895912|NCT02819518|566378643|FG003|Overall Study|Lost to Follow-up|0|||
156895913|NCT02819518|566378644|FG004|Overall Study|Lost to Follow-up|1|||
156895914|NCT02819518|566378640|FG000|Overall Study|Sponsor Decision|1|||
156895915|NCT02819518|566378641|FG001|Overall Study|Sponsor Decision|1|||
156895916|NCT02819518|566378642|FG002|Overall Study|Sponsor Decision|0|||
156895917|NCT02819518|566378643|FG003|Overall Study|Sponsor Decision|34|||
156895918|NCT02819518|566378644|FG004|Overall Study|Sponsor Decision|17|||
157026150|NCT03365882|566849728|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
156895919|NCT02819518|566378640|FG000|Overall Study|Transferred to extension study|1|||
156895920|NCT02819518|566378641|FG001|Overall Study|Transferred to extension study|1|||
156895921|NCT02819518|566378642|FG002|Overall Study|Transferred to extension study|1|||
157026151|NCT03365882|566849729|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
156895922|NCT02819518|566378643|FG003|Overall Study|Transferred to extension study|32|||
156895923|NCT02819518|566378644|FG004|Overall Study|Transferred to extension study|11|||
156895924|NCT00880165|566378645|FG000|Overall Study|Withdrawal by Subject|27|||
156895925|NCT00880165|566378646|FG001|Overall Study|Withdrawal by Subject|23|||
156895926|NCT00880165|566378645|FG000|Overall Study|Not diagnosed with OSA|14|||
156895927|NCT00880165|566378646|FG001|Overall Study|Not diagnosed with OSA|8|||
156895928|NCT00880165|566378645|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
156895929|NCT00880165|566378646|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
156895930|NCT00880165|566378645|FG000|Overall Study|Lost to follow|9|||
156895931|NCT00880165|566378646|FG001|Overall Study|Lost to follow|15|||
156895932|NCT01505647|566378647|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
156895933|NCT01505647|566378648|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
156895934|NCT01505647|566378647|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
156895935|NCT01505647|566378648|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
156895936|NCT01505647|566378647|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
156895937|NCT01505647|566378648|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
156895938|NCT01505647|566378647|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
156895939|NCT01505647|566378648|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
156895940|NCT01505647|566378647|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
156895941|NCT01505647|566378648|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
156895942|NCT01927341|566380391|FG000|Phase 1b|Lost to Follow-up|1|||
156895943|NCT01927341|566380392|FG001|Phase 1b|Lost to Follow-up|0|||
156895944|NCT01927341|566380393|FG002|Phase 1b|Lost to Follow-up|0|||
156895945|NCT01927341|566380394|FG003|Phase 1b|Lost to Follow-up|0|||
156895946|NCT01927341|566380395|FG004|Phase 1b|Lost to Follow-up|0|||
156895947|NCT01927341|566380391|FG000|Phase 1b|Death|2|||
156895948|NCT01927341|566380392|FG001|Phase 1b|Death|0|||
156895949|NCT01927341|566380393|FG002|Phase 1b|Death|0|||
156895950|NCT01927341|566380394|FG003|Phase 1b|Death|0|||
156895951|NCT01927341|566380395|FG004|Phase 1b|Death|0|||
156895952|NCT01927341|566380391|FG000|Phase 1b|Follow-up completed|7|||
156895953|NCT01927341|566380392|FG001|Phase 1b|Follow-up completed|0|||
156895954|NCT01927341|566380393|FG002|Phase 1b|Follow-up completed|0|||
156895955|NCT01927341|566380394|FG003|Phase 1b|Follow-up completed|0|||
156895956|NCT01927341|566380395|FG004|Phase 1b|Follow-up completed|0|||
156895957|NCT01927341|566380391|FG000|Phase 2|Lost to Follow-up|0|||
156895958|NCT01927341|566380392|FG001|Phase 2|Lost to Follow-up|1|||
156895959|NCT01927341|566380393|FG002|Phase 2|Lost to Follow-up|0|||
156895960|NCT01927341|566380394|FG003|Phase 2|Lost to Follow-up|0|||
156895961|NCT01927341|566380395|FG004|Phase 2|Lost to Follow-up|0|||
156895962|NCT01927341|566380391|FG000|Phase 2|Participant withdrew consent|0|||
156895963|NCT01927341|566380392|FG001|Phase 2|Participant withdrew consent|2|||
156895964|NCT01927341|566380393|FG002|Phase 2|Participant withdrew consent|1|||
156895965|NCT01927341|566380394|FG003|Phase 2|Participant withdrew consent|2|||
156895966|NCT01927341|566380395|FG004|Phase 2|Participant withdrew consent|3|||
156895967|NCT01927341|566380391|FG000|Phase 2|Death|0|||
156895968|NCT01927341|566380392|FG001|Phase 2|Death|4|||
156895969|NCT01927341|566380393|FG002|Phase 2|Death|0|||
156895970|NCT01927341|566380394|FG003|Phase 2|Death|3|||
156895971|NCT01927341|566380395|FG004|Phase 2|Death|2|||
156895972|NCT01927341|566380391|FG000|Phase 2|New cancer therapy|0|||
156895973|NCT01927341|566380392|FG001|Phase 2|New cancer therapy|1|||
156895974|NCT01927341|566380393|FG002|Phase 2|New cancer therapy|0|||
156895975|NCT01927341|566380394|FG003|Phase 2|New cancer therapy|4|||
156895976|NCT01927341|566380395|FG004|Phase 2|New cancer therapy|1|||
156895977|NCT01927341|566380391|FG000|Phase 2|Disease progression|0|||
156895978|NCT01927341|566380392|FG001|Phase 2|Disease progression|1|||
156895979|NCT01927341|566380393|FG002|Phase 2|Disease progression|1|||
156895980|NCT01927341|566380394|FG003|Phase 2|Disease progression|1|||
156895981|NCT01927341|566380395|FG004|Phase 2|Disease progression|0|||
156895982|NCT01927341|566380391|FG000|Phase 2|Follow-up completed|0|||
157158251|NCT02935634|567324536|FG000|Treatment: Track 2|Disease progression|13|||
157158252|NCT02935634|567324537|FG001|Treatment: Track 2|Disease progression|26|||
157158253|NCT02935634|567324538|FG002|Treatment: Track 2|Disease progression|20|||
156895983|NCT01927341|566380392|FG001|Phase 2|Follow-up completed|6|||
156895984|NCT01927341|566380393|FG002|Phase 2|Follow-up completed|3|||
156895985|NCT01927341|566380394|FG003|Phase 2|Follow-up completed|5|||
156895986|NCT01927341|566380395|FG004|Phase 2|Follow-up completed|2|||
156895987|NCT01104701|566380396|FG000|Overall Study|Withdrawal by Subject|0|||
156895988|NCT01104701|566380397|FG001|Overall Study|Withdrawal by Subject|1|||
156895989|NCT01104701|566380398|FG002|Overall Study|Withdrawal by Subject|2|||
156895990|NCT01104701|566380399|FG003|Overall Study|Withdrawal by Subject|1|||
156895991|NCT01104701|566380396|FG000|Overall Study|Adverse Event|0|||
156895992|NCT01104701|566380397|FG001|Overall Study|Adverse Event|0|||
156895993|NCT01104701|566380398|FG002|Overall Study|Adverse Event|0|||
156895994|NCT01104701|566380399|FG003|Overall Study|Adverse Event|1|||
156895995|NCT01104701|566380396|FG000|Overall Study|Physician Decision|0|||
156895996|NCT01104701|566380397|FG001|Overall Study|Physician Decision|2|||
156895997|NCT01104701|566380398|FG002|Overall Study|Physician Decision|0|||
156895998|NCT01104701|566380399|FG003|Overall Study|Physician Decision|0|||
156895999|NCT01397201|566380400|FG000|Overall Study|Not treated|0|||
156896000|NCT01397201|566380401|FG001|Overall Study|Not treated|0|||
156896001|NCT01397201|566380402|FG002|Overall Study|Not treated|1|||
156896002|NCT01397201|566380403|FG003|Overall Study|Not treated|0|||
156896003|NCT01397201|566380404|FG004|Overall Study|Not treated|0|||
156896004|NCT01397201|566380400|FG000|Overall Study|Not yet defined|3|||
156896005|NCT01397201|566380401|FG001|Overall Study|Not yet defined|6|||
156896006|NCT01397201|566380402|FG002|Overall Study|Not yet defined|5|||
156896007|NCT01397201|566380403|FG003|Overall Study|Not yet defined|5|||
156896008|NCT01397201|566380404|FG004|Overall Study|Not yet defined|4|||
156896009|NCT01397201|566380400|FG000|Overall Study|Adverse Event|2|||
156896010|NCT01397201|566380401|FG001|Overall Study|Adverse Event|0|||
156896011|NCT01397201|566380402|FG002|Overall Study|Adverse Event|0|||
156896012|NCT01397201|566380403|FG003|Overall Study|Adverse Event|0|||
156896013|NCT01397201|566380404|FG004|Overall Study|Adverse Event|0|||
156896014|NCT00423722|566380408|FG000|Overall Study|Death|4|||
156896015|NCT00423722|566380409|FG001|Overall Study|Death|4|||
156896016|NCT00423722|566380408|FG000|Overall Study|Declined to participate|2|||
156896017|NCT00423722|566380409|FG001|Overall Study|Declined to participate|3|||
156896018|NCT00423722|566380408|FG000|Overall Study|Unable to complete questionnaires|4|||
156896019|NCT00423722|566380409|FG001|Overall Study|Unable to complete questionnaires|4|||
156896020|NCT00423722|566380408|FG000|Overall Study|Withdrawal by Subject|4|||
156896021|NCT00423722|566380409|FG001|Overall Study|Withdrawal by Subject|2|||
156896022|NCT00215683|566380412|FG000|Overall Study|Adverse Event|15|||
156896023|NCT00215683|566380413|FG001|Overall Study|Adverse Event|16|||
156896024|NCT00215683|566380414|FG002|Overall Study|Adverse Event|15|||
156896025|NCT00215683|566380412|FG000|Overall Study|Lack of Efficacy|5|||
156896026|NCT00215683|566380413|FG001|Overall Study|Lack of Efficacy|1|||
156896027|NCT00215683|566380414|FG002|Overall Study|Lack of Efficacy|2|||
156896028|NCT00215683|566380412|FG000|Overall Study|Lost to Follow-up|0|||
156896029|NCT00215683|566380413|FG001|Overall Study|Lost to Follow-up|2|||
156896030|NCT00215683|566380414|FG002|Overall Study|Lost to Follow-up|1|||
156896031|NCT00215683|566380412|FG000|Overall Study|Withdrawal by Subject|9|||
156896032|NCT00215683|566380413|FG001|Overall Study|Withdrawal by Subject|4|||
156896033|NCT00215683|566380414|FG002|Overall Study|Withdrawal by Subject|13|||
156896034|NCT00215683|566380412|FG000|Overall Study|Physician Decision|0|||
156896035|NCT00215683|566380413|FG001|Overall Study|Physician Decision|0|||
156896036|NCT00215683|566380414|FG002|Overall Study|Physician Decision|1|||
156896037|NCT00215683|566380412|FG000|Overall Study|Difficult to attend visits|0|||
156896038|NCT00215683|566380413|FG001|Overall Study|Difficult to attend visits|1|||
156896039|NCT00215683|566380414|FG002|Overall Study|Difficult to attend visits|0|||
156896040|NCT00215683|566380412|FG000|Overall Study|No study drug available|0|||
156896041|NCT00215683|566380413|FG001|Overall Study|No study drug available|1|||
156896042|NCT00215683|566380414|FG002|Overall Study|No study drug available|0|||
156896043|NCT00215683|566380412|FG000|Overall Study|Intermittent therapy required|0|||
156896044|NCT00215683|566380413|FG001|Overall Study|Intermittent therapy required|1|||
156896045|NCT00215683|566380414|FG002|Overall Study|Intermittent therapy required|0|||
156896046|NCT02171065|566380415|FG000|Overall Study|Withdrawal by Subject|1|||
156896047|NCT02171065|566380416|FG001|Overall Study|Withdrawal by Subject|0|||
156896048|NCT02171065|566380417|FG002|Overall Study|Withdrawal by Subject|0|||
156896049|NCT02171065|566380415|FG000|Overall Study|Lost to Follow-up|0|||
156896050|NCT02171065|566380416|FG001|Overall Study|Lost to Follow-up|0|||
156896051|NCT02171065|566380417|FG002|Overall Study|Lost to Follow-up|1|||
156896052|NCT00674973|566380418|FG000|Overall Study|Insufficient Therapeutic Response|77|||
156896053|NCT00674973|566380419|FG001|Overall Study|Insufficient Therapeutic Response|72|||
156896054|NCT00674973|566380418|FG000|Overall Study|Refused Treatment|1|||
156896055|NCT00674973|566380419|FG001|Overall Study|Refused Treatment|5|||
156896056|NCT00674973|566380418|FG000|Overall Study|Failure to Return|1|||
156896057|NCT00674973|566380419|FG001|Overall Study|Failure to Return|0|||
156896058|NCT00674973|566380418|FG000|Overall Study|Adverse Event|2|||
156896059|NCT00674973|566380419|FG001|Overall Study|Adverse Event|9|||
156896060|NCT00674973|566380418|FG000|Overall Study|Death|19|||
156896061|NCT00674973|566380419|FG001|Overall Study|Death|15|||
157026152|NCT03365882|566849728|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
157158254|NCT02935634|567324539|FG003|Treatment: Track 2|Disease progression|5|||
157158255|NCT02935634|567324540|FG004|Treatment: Track 2|Disease progression|1|||
156896062|NCT00674973|566380418|FG000|Overall Study|Protocol Violation|0|||
156896063|NCT00674973|566380419|FG001|Overall Study|Protocol Violation|1|||
156896064|NCT00451451|566380420|FG000|Overall Study|Adverse Event|11|||
156896065|NCT00451451|566380421|FG001|Overall Study|Adverse Event|21|||
156896066|NCT00451451|566380422|FG002|Overall Study|Adverse Event|26|||
156896067|NCT00451451|566380423|FG003|Overall Study|Adverse Event|10|||
156896068|NCT00451451|566380420|FG000|Overall Study|Lost to Follow-up|11|||
156896069|NCT00451451|566380421|FG001|Overall Study|Lost to Follow-up|9|||
156896070|NCT00451451|566380422|FG002|Overall Study|Lost to Follow-up|8|||
156896071|NCT00451451|566380423|FG003|Overall Study|Lost to Follow-up|11|||
156896072|NCT00451451|566380420|FG000|Overall Study|Consent Withdrawn|14|||
156896073|NCT00451451|566380421|FG001|Overall Study|Consent Withdrawn|9|||
156896074|NCT00451451|566380422|FG002|Overall Study|Consent Withdrawn|17|||
156896075|NCT00451451|566380423|FG003|Overall Study|Consent Withdrawn|17|||
156896076|NCT00451451|566380420|FG000|Overall Study|Investigator Decision|6|||
156896077|NCT00451451|566380421|FG001|Overall Study|Investigator Decision|2|||
156896078|NCT00451451|566380422|FG002|Overall Study|Investigator Decision|1|||
156896079|NCT00451451|566380423|FG003|Overall Study|Investigator Decision|2|||
156896080|NCT00451451|566380420|FG000|Overall Study|Subject Non-Compliance|8|||
156896081|NCT00451451|566380421|FG001|Overall Study|Subject Non-Compliance|4|||
156896082|NCT00451451|566380422|FG002|Overall Study|Subject Non-Compliance|3|||
156896083|NCT00451451|566380423|FG003|Overall Study|Subject Non-Compliance|3|||
156896084|NCT00451451|566380420|FG000|Overall Study|Death|1|||
156896085|NCT00451451|566380421|FG001|Overall Study|Death|0|||
156896086|NCT00451451|566380422|FG002|Overall Study|Death|0|||
156896087|NCT00451451|566380423|FG003|Overall Study|Death|1|||
156896088|NCT00451451|566380420|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
156896089|NCT00451451|566380421|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
156896090|NCT00451451|566380422|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
156896091|NCT00451451|566380423|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
156896092|NCT00084838|566380426|FG000|Overall Study|Death|1|||
156896093|NCT00084838|566380426|FG000|Overall Study|Adverse Event|2|||
156896094|NCT00084838|566380426|FG000|Overall Study|Withdrawal by Subject|1|||
156896095|NCT00084838|566380426|FG000|Overall Study|Progressive Disease|4|||
156896096|NCT00084838|566380426|FG000|Overall Study|Pt Non-Compliance|1|||
156896097|NCT00084838|566380426|FG000|Overall Study|Ineligible|4|||
156896098|NCT00518687|566380427|FG000|Overall Study|Adverse Event|201|||
156896099|NCT00518687|566380428|FG001|Overall Study|Adverse Event|177|||
156896100|NCT00518687|566380427|FG000|Overall Study|Lost to Follow-up|144|||
156896101|NCT00518687|566380428|FG001|Overall Study|Lost to Follow-up|155|||
156896102|NCT00518687|566380427|FG000|Overall Study|Physician Decision|42|||
156896103|NCT00518687|566380428|FG001|Overall Study|Physician Decision|48|||
156896104|NCT00518687|566380427|FG000|Overall Study|Progressive disease|2|||
156896105|NCT00518687|566380428|FG001|Overall Study|Progressive disease|2|||
156896106|NCT00518687|566380427|FG000|Overall Study|Protocol Violation|8|||
156896107|NCT00518687|566380428|FG001|Overall Study|Protocol Violation|10|||
156896108|NCT00518687|566380427|FG000|Overall Study|Study terminated by sponsor|930|||
156896109|NCT00518687|566380428|FG001|Overall Study|Study terminated by sponsor|918|||
156896110|NCT00518687|566380427|FG000|Overall Study|Withdrawal by Subject|110|||
156896111|NCT00518687|566380428|FG001|Overall Study|Withdrawal by Subject|110|||
156896112|NCT00851630|566380433|FG000|Overall Study|Death|2|||
156896113|NCT00851630|566380434|FG001|Overall Study|Death|1|||
156896114|NCT00851630|566380433|FG000|Overall Study|Clinical failure|0|||
156896115|NCT00851630|566380434|FG001|Overall Study|Clinical failure|1|||
156896116|NCT00401531|566380435|FG000|Overall Study|Adverse Event|2|||
156896117|NCT00401531|566380436|FG001|Overall Study|Adverse Event|0|||
156896118|NCT00401531|566380435|FG000|Overall Study|Protocol Violation|3|||
156896119|NCT00401531|566380436|FG001|Overall Study|Protocol Violation|7|||
156896120|NCT00401531|566380435|FG000|Overall Study|Lost to Follow-up|1|||
156896121|NCT00401531|566380436|FG001|Overall Study|Lost to Follow-up|1|||
156896122|NCT00401531|566380435|FG000|Overall Study|Withdrawal by Subject|3|||
156896123|NCT00401531|566380436|FG001|Overall Study|Withdrawal by Subject|2|||
156896124|NCT00089284|566380443|FG000|Overall Study|Adverse event before starting treatment|0|||
156896125|NCT00089284|566380444|FG001|Overall Study|Adverse event before starting treatment|0|||
156896126|NCT00089284|566380445|FG002|Overall Study|Adverse event before starting treatment|0|||
156896127|NCT00089284|566380446|FG003|Overall Study|Adverse event before starting treatment|0|||
156896128|NCT00089284|566380447|FG004|Overall Study|Adverse event before starting treatment|0|||
156896129|NCT00089284|566380448|FG005|Overall Study|Adverse event before starting treatment|0|||
156896130|NCT00089284|566380449|FG006|Overall Study|Adverse event before starting treatment|1|||
156896131|NCT01614600|566380450|FG000|Overall Study|Unacceptable fit|1|||
156896132|NCT01614600|566380450|FG000|Overall Study|Discomfort|1|||
156896133|NCT01614600|566380450|FG000|Overall Study|Unable to remove lens at the end of day|1|||
156896134|NCT01614600|566380450|FG000|Overall Study|Protocol deviation|1|||
156896135|NCT02437513|566380451|FG000|Overall Study|Withdrawal by Subject|2|||
156896136|NCT03956056|566380452|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
156896137|NCT03956056|566380452|FG000|Overall Study|Lack of Efficacy|1|||
156896138|NCT03403374|566380453|FG000|Overall Study|Lost to Follow-up|1|||
156896139|NCT00422097|566380457|FG000|Dose Level 2|Still on treatment|0|||
156896140|NCT00422097|566380458|FG001|Dose Level 2|Still on treatment|1|||
156896141|NCT00422097|566380459|FG002|Dose Level 2|Still on treatment|0|||
156896142|NCT00422097|566380460|FG003|Dose Level 2|Still on treatment|0|||
156896143|NCT00422097|566380461|FG004|Dose Level 2|Still on treatment|0|||
157158256|NCT02935634|567324541|FG005|Treatment: Track 2|Disease progression|4|||
156896144|NCT00422097|566380462|FG005|Dose Level 2|Still on treatment|0|||
156896145|NCT00422097|566380463|FG006|Dose Level 2|Still on treatment|0|||
156896146|NCT00422097|566380464|FG007|Dose Level 2|Still on treatment|0|||
156896147|NCT02360995|566380465|FG000|Overall Study|Lost to Follow-up|2|||
156896148|NCT02360995|566380466|FG001|Overall Study|Lost to Follow-up|0|||
156896149|NCT02360995|566380467|FG002|Overall Study|Lost to Follow-up|2|||
156896150|NCT02360995|566380465|FG000|Overall Study|Withdrawal by Subject|0|||
156896151|NCT02360995|566380466|FG001|Overall Study|Withdrawal by Subject|1|||
156896152|NCT02360995|566380467|FG002|Overall Study|Withdrawal by Subject|0|||
156896153|NCT02231918|566380468|FG000|Overall Study|Withdrawal by Subject|0|||
156896154|NCT02231918|566380469|FG001|Overall Study|Withdrawal by Subject|1|||
156896155|NCT02231918|566380470|FG002|Overall Study|Withdrawal by Subject|0|||
156896156|NCT02231918|566380468|FG000|Overall Study|Adverse Event|0|||
156896157|NCT02231918|566380469|FG001|Overall Study|Adverse Event|0|||
156896158|NCT02231918|566380470|FG002|Overall Study|Adverse Event|1|||
156896159|NCT02395666|566380471|FG000|Overall Study|Physician Decision|3|||
156896160|NCT02395666|566380472|FG001|Overall Study|Physician Decision|0|||
156896161|NCT02395666|566380471|FG000|Overall Study|Lost to Follow-up|1|||
156896162|NCT02395666|566380472|FG001|Overall Study|Lost to Follow-up|0|||
156896163|NCT02395666|566380471|FG000|Overall Study|Withdrawal by Subject|2|||
156896164|NCT02395666|566380472|FG001|Overall Study|Withdrawal by Subject|1|||
156896165|NCT01092507|566380473|FG000|Overall Study|Withdrawal by Subject|2|||
156896166|NCT01092507|566380474|FG001|Overall Study|Withdrawal by Subject|0|||
156896167|NCT04629508|566380475|FG000|Overall Study|Adverse Event|1|||
156896168|NCT04629508|566380475|FG000|Overall Study|Death|2|||
156896169|NCT04629508|566380475|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
156896170|NCT04073368|566380480|FG000|Overall Study|Adverse Event|2|||
156896171|NCT04073368|566380481|FG001|Overall Study|Adverse Event|0|||
156896172|NCT04073368|566380482|FG002|Overall Study|Adverse Event|1|||
156896173|NCT04073368|566380483|FG003|Overall Study|Adverse Event|1|||
156896174|NCT04073368|566380480|FG000|Overall Study|Withdrawal by Subject|2|||
156896175|NCT04073368|566380481|FG001|Overall Study|Withdrawal by Subject|2|||
156896176|NCT04073368|566380482|FG002|Overall Study|Withdrawal by Subject|1|||
156896177|NCT04073368|566380483|FG003|Overall Study|Withdrawal by Subject|1|||
156896178|NCT04073368|566380480|FG000|Overall Study|Lost to Follow-up|1|||
156896179|NCT04073368|566380481|FG001|Overall Study|Lost to Follow-up|1|||
156896180|NCT04073368|566380482|FG002|Overall Study|Lost to Follow-up|1|||
156896181|NCT04073368|566380483|FG003|Overall Study|Lost to Follow-up|0|||
156896182|NCT04073368|566380480|FG000|Overall Study|Protocol Violation|0|||
156896183|NCT04073368|566380481|FG001|Overall Study|Protocol Violation|1|||
156896184|NCT04073368|566380482|FG002|Overall Study|Protocol Violation|0|||
156896185|NCT04073368|566380483|FG003|Overall Study|Protocol Violation|0|||
156896186|NCT04073368|566380480|FG000|Overall Study|Subject noncompliance|7|||
156896187|NCT04073368|566380481|FG001|Overall Study|Subject noncompliance|4|||
156896188|NCT04073368|566380482|FG002|Overall Study|Subject noncompliance|0|||
156896189|NCT04073368|566380483|FG003|Overall Study|Subject noncompliance|0|||
156896190|NCT00145600|566380484|FG000|Overall Study|Death|1|||
156896191|NCT00145600|566380485|FG001|Overall Study|Death|2|||
156896192|NCT00145600|566380486|FG002|Overall Study|Death|2|||
156896193|NCT00145600|566380487|FG003|Overall Study|Death|6|||
156896194|NCT00145600|566380484|FG000|Overall Study|Ineligible|3|||
156896195|NCT00145600|566380485|FG001|Overall Study|Ineligible|0|||
156896196|NCT00145600|566380486|FG002|Overall Study|Ineligible|1|||
156896197|NCT00145600|566380487|FG003|Overall Study|Ineligible|5|||
156896198|NCT00145600|566380484|FG000|Overall Study|Lost to Follow-up|2|||
156896199|NCT00145600|566380485|FG001|Overall Study|Lost to Follow-up|6|||
156896200|NCT00145600|566380486|FG002|Overall Study|Lost to Follow-up|2|||
156896201|NCT00145600|566380487|FG003|Overall Study|Lost to Follow-up|4|||
156896202|NCT00145600|566380484|FG000|Overall Study|Noncompliance|1|||
156896203|NCT00145600|566380485|FG001|Overall Study|Noncompliance|0|||
156896204|NCT00145600|566380486|FG002|Overall Study|Noncompliance|0|||
156896205|NCT00145600|566380487|FG003|Overall Study|Noncompliance|0|||
156896206|NCT00145600|566380484|FG000|Overall Study|Withdrawal by Subject|1|||
156896207|NCT00145600|566380485|FG001|Overall Study|Withdrawal by Subject|2|||
156896208|NCT00145600|566380486|FG002|Overall Study|Withdrawal by Subject|0|||
156896209|NCT00145600|566380487|FG003|Overall Study|Withdrawal by Subject|1|||
156896210|NCT04087213|566380490|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
156896211|NCT04087213|566380490|FG000|In-Facility Introduction|Adverse Event|1|||
156896212|NCT04087213|566380490|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
156896213|NCT04087213|566380490|FG000|Assisted Evaluable Period|Personal reasons|3|||
156896214|NCT04087213|566380490|FG000|Transition Period B|Renal Transplantation|1|||
156896215|NCT00736879|566380491|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
156896216|NCT00736879|566380492|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
156896217|NCT00736879|566380493|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
156896218|NCT00736879|566380494|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
156896219|NCT00736879|566380491|FG000|Double Blind Treatment Period|Adverse Event|0|||
156896220|NCT00736879|566380492|FG001|Double Blind Treatment Period|Adverse Event|1|||
156896221|NCT00736879|566380493|FG002|Double Blind Treatment Period|Adverse Event|1|||
156896222|NCT00736879|566380494|FG003|Double Blind Treatment Period|Adverse Event|0|||
156896223|NCT00736879|566380491|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
156896224|NCT00736879|566380492|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156896225|NCT00736879|566380493|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
156896226|NCT00736879|566380494|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
156896227|NCT00736879|566380491|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
156896228|NCT00736879|566380492|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
156896229|NCT00736879|566380493|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
156896230|NCT00736879|566380494|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
156896231|NCT00736879|566380491|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
156896232|NCT00736879|566380492|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
156896233|NCT00736879|566380493|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
156896234|NCT00736879|566380494|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
156896235|NCT00736879|566380491|FG000|Double Blind Treatment Period|No longer met criteria|0|||
156896236|NCT00736879|566380492|FG001|Double Blind Treatment Period|No longer met criteria|1|||
156896237|NCT00736879|566380493|FG002|Double Blind Treatment Period|No longer met criteria|0|||
156896238|NCT00736879|566380494|FG003|Double Blind Treatment Period|No longer met criteria|0|||
156896239|NCT00736879|566380491|FG000|Double Blind Treatment Period|non-specified|0|||
156896240|NCT00736879|566380492|FG001|Double Blind Treatment Period|non-specified|1|||
156896241|NCT00736879|566380493|FG002|Double Blind Treatment Period|non-specified|0|||
156896242|NCT00736879|566380494|FG003|Double Blind Treatment Period|non-specified|0|||
156896243|NCT00736879|566380491|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156896244|NCT00736879|566380492|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
156896245|NCT00736879|566380493|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156896246|NCT00736879|566380494|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
156896247|NCT00736879|566380491|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
156896248|NCT00736879|566380492|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
156896249|NCT00736879|566380493|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
156896250|NCT00736879|566380494|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
156896251|NCT00735254|566380499|FG000|Overall Study|Protocol Violation|1|||
156896252|NCT00735254|566380500|FG001|Overall Study|Protocol Violation|1|||
156896253|NCT00735254|566380501|FG002|Overall Study|Protocol Violation|1|||
156896254|NCT00735254|566380502|FG003|Overall Study|Protocol Violation|0|||
156896255|NCT02694523|566380506|FG000|Part A|Adverse Event|7|||
156896256|NCT02694523|566380507|FG001|Part A|Adverse Event|3|||
156896257|NCT02694523|566380508|FG002|Part A|Adverse Event|0|||
156896258|NCT02694523|566380509|FG003|Part A|Adverse Event|0|||
156896259|NCT02694523|566380510|FG004|Part A|Adverse Event|0|||
156896260|NCT02694523|566380511|FG005|Part A|Adverse Event|0|||
156896261|NCT02694523|566380512|FG006|Part A|Adverse Event|0|||
156896262|NCT02694523|566380506|FG000|Part A|Protocol Violation|1|||
156896263|NCT02694523|566380507|FG001|Part A|Protocol Violation|0|||
156896264|NCT02694523|566380508|FG002|Part A|Protocol Violation|0|||
156896265|NCT02694523|566380509|FG003|Part A|Protocol Violation|0|||
156896266|NCT02694523|566380510|FG004|Part A|Protocol Violation|0|||
156896267|NCT02694523|566380511|FG005|Part A|Protocol Violation|0|||
156896268|NCT02694523|566380512|FG006|Part A|Protocol Violation|0|||
157158257|NCT02935634|567324536|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
156896269|NCT02694523|566380506|FG000|Part A|Lost to Follow-up|1|||
156896270|NCT02694523|566380507|FG001|Part A|Lost to Follow-up|2|||
156896271|NCT02694523|566380508|FG002|Part A|Lost to Follow-up|0|||
156896272|NCT02694523|566380509|FG003|Part A|Lost to Follow-up|0|||
156896273|NCT02694523|566380510|FG004|Part A|Lost to Follow-up|0|||
156896274|NCT02694523|566380511|FG005|Part A|Lost to Follow-up|0|||
156896275|NCT02694523|566380512|FG006|Part A|Lost to Follow-up|0|||
156896276|NCT02694523|566380506|FG000|Part A|Withdrawal by Subject|3|||
156896277|NCT02694523|566380507|FG001|Part A|Withdrawal by Subject|1|||
156896278|NCT02694523|566380508|FG002|Part A|Withdrawal by Subject|0|||
156896279|NCT02694523|566380509|FG003|Part A|Withdrawal by Subject|0|||
156896280|NCT02694523|566380510|FG004|Part A|Withdrawal by Subject|0|||
156896281|NCT02694523|566380511|FG005|Part A|Withdrawal by Subject|0|||
156896282|NCT02694523|566380512|FG006|Part A|Withdrawal by Subject|0|||
156896283|NCT02694523|566380506|FG000|Part A|Other|1|||
156896284|NCT02694523|566380507|FG001|Part A|Other|1|||
156896285|NCT02694523|566380508|FG002|Part A|Other|0|||
156896286|NCT02694523|566380509|FG003|Part A|Other|0|||
157158258|NCT02935634|567324537|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
157158259|NCT02935634|567324538|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
157158260|NCT02935634|567324539|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156896287|NCT02694523|566380510|FG004|Part A|Other|0|||
156896288|NCT02694523|566380511|FG005|Part A|Other|0|||
157158261|NCT02935634|567324540|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156896289|NCT02694523|566380512|FG006|Part A|Other|0|||
157158262|NCT02935634|567324541|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
156896290|NCT02694523|566380506|FG000|Part B|Adverse Event|0|||
157158263|NCT02935634|567324536|FG000|Treatment: Track 2|Study drug toxicity|7|||
156896291|NCT02694523|566380507|FG001|Part B|Adverse Event|0|||
156896292|NCT02694523|566380508|FG002|Part B|Adverse Event|7|||
156896293|NCT02694523|566380509|FG003|Part B|Adverse Event|1|||
156896294|NCT02694523|566380510|FG004|Part B|Adverse Event|1|||
156896295|NCT02694523|566380511|FG005|Part B|Adverse Event|2|||
156896296|NCT02694523|566380512|FG006|Part B|Adverse Event|0|||
156896297|NCT02694523|566380506|FG000|Part B|Protocol Violation|0|||
156896298|NCT02694523|566380507|FG001|Part B|Protocol Violation|0|||
156896299|NCT02694523|566380508|FG002|Part B|Protocol Violation|1|||
156896300|NCT02694523|566380509|FG003|Part B|Protocol Violation|0|||
156896301|NCT02694523|566380510|FG004|Part B|Protocol Violation|0|||
156896302|NCT02694523|566380511|FG005|Part B|Protocol Violation|0|||
156896303|NCT02694523|566380512|FG006|Part B|Protocol Violation|0|||
156896304|NCT02694523|566380506|FG000|Part B|Lost to Follow-up|0|||
156896305|NCT02694523|566380507|FG001|Part B|Lost to Follow-up|0|||
156896306|NCT02694523|566380508|FG002|Part B|Lost to Follow-up|2|||
156896307|NCT02694523|566380509|FG003|Part B|Lost to Follow-up|3|||
156896308|NCT02694523|566380510|FG004|Part B|Lost to Follow-up|2|||
156896309|NCT02694523|566380511|FG005|Part B|Lost to Follow-up|0|||
156896310|NCT02694523|566380512|FG006|Part B|Lost to Follow-up|1|||
156896311|NCT02694523|566380506|FG000|Part B|Withdrawal by Subject|0|||
156896312|NCT02694523|566380507|FG001|Part B|Withdrawal by Subject|0|||
156896313|NCT02694523|566380508|FG002|Part B|Withdrawal by Subject|9|||
156896314|NCT02694523|566380509|FG003|Part B|Withdrawal by Subject|0|||
156896315|NCT02694523|566380510|FG004|Part B|Withdrawal by Subject|1|||
156896316|NCT02694523|566380511|FG005|Part B|Withdrawal by Subject|3|||
156896317|NCT02694523|566380512|FG006|Part B|Withdrawal by Subject|0|||
156896318|NCT02694523|566380506|FG000|Part B|Other|0|||
156896319|NCT02694523|566380507|FG001|Part B|Other|0|||
156896320|NCT02694523|566380508|FG002|Part B|Other|1|||
156896321|NCT02694523|566380509|FG003|Part B|Other|0|||
156896322|NCT02694523|566380510|FG004|Part B|Other|0|||
156896323|NCT02694523|566380511|FG005|Part B|Other|0|||
156896324|NCT02694523|566380512|FG006|Part B|Other|1|||
156896325|NCT00136604|566380513|FG000|Overall Study|Lost to Follow-up|1|||
156896326|NCT00136604|566380514|FG001|Overall Study|Lost to Follow-up|0|||
156896327|NCT00136604|566380515|FG002|Overall Study|Lost to Follow-up|0|||
156896328|NCT00136604|566380516|FG003|Overall Study|Lost to Follow-up|0|||
156896329|NCT00136604|566380517|FG004|Overall Study|Lost to Follow-up|1|||
156896330|NCT00136604|566380513|FG000|Overall Study|Migrated/moved from study area|0|||
156896331|NCT00136604|566380514|FG001|Overall Study|Migrated/moved from study area|1|||
156896332|NCT00136604|566380515|FG002|Overall Study|Migrated/moved from study area|0|||
156896333|NCT00136604|566380516|FG003|Overall Study|Migrated/moved from study area|0|||
156896334|NCT00136604|566380517|FG004|Overall Study|Migrated/moved from study area|0|||
156896335|NCT02280473|566380524|FG000|Overall Study|Adverse Event|1|||
156896336|NCT02280473|566380525|FG001|Overall Study|Adverse Event|1|||
156896337|NCT02280473|566380524|FG000|Overall Study|Lack of Efficacy|0|||
156896338|NCT02280473|566380525|FG001|Overall Study|Lack of Efficacy|1|||
156896339|NCT02280473|566380524|FG000|Overall Study|Lost to Follow-up|0|||
156896340|NCT02280473|566380525|FG001|Overall Study|Lost to Follow-up|1|||
156896341|NCT01462227|566380526|FG000|Second Assignment|Lost to Follow-up|1|||
156896342|NCT01462227|566380527|FG001|Second Assignment|Lost to Follow-up|0|||
156896343|NCT01462227|566380528|FG002|Second Assignment|Lost to Follow-up|0|||
156896344|NCT01462227|566380529|FG003|Second Assignment|Lost to Follow-up|0|||
156896345|NCT01462227|566380526|FG000|Second Assignment|Protocol Violation|0|||
156896346|NCT01462227|566380527|FG001|Second Assignment|Protocol Violation|1|||
156896347|NCT01462227|566380528|FG002|Second Assignment|Protocol Violation|1|||
156896348|NCT01462227|566380529|FG003|Second Assignment|Protocol Violation|0|||
156896349|NCT05298306|566380530|FG000|Overall Study|Physician Decision|0|||
156896350|NCT05298306|566380531|FG001|Overall Study|Physician Decision|0|||
156896351|NCT05298306|566380532|FG002|Overall Study|Physician Decision|0|||
156896352|NCT05298306|566380533|FG003|Overall Study|Physician Decision|1|||
156896353|NCT05298306|566380534|FG004|Overall Study|Physician Decision|0|||
156896354|NCT05298306|566380535|FG005|Overall Study|Physician Decision|0|||
156896355|NCT00667602|566380539|FG000|Overall Study|Withdrawal by Subject|4|||
156896356|NCT00667602|566380540|FG001|Overall Study|Withdrawal by Subject|9|||
156896357|NCT00667602|566380541|FG002|Overall Study|Withdrawal by Subject|10|||
156896358|NCT00667602|566380539|FG000|Overall Study|Lost to Follow-up|4|||
156896359|NCT00667602|566380540|FG001|Overall Study|Lost to Follow-up|5|||
156896360|NCT00667602|566380541|FG002|Overall Study|Lost to Follow-up|6|||
157225501|NCT02483975|567571448|FG001|Overall Study|Physician Decision|0|||
157225502|NCT03365375|567571449|FG000|Overall Study|Withdrawal by Subject|0|||
157225503|NCT03365375|567571450|FG001|Overall Study|Withdrawal by Subject|1|||
156896361|NCT00667602|566380539|FG000|Overall Study|Administrative reason|0|||
156896362|NCT00667602|566380540|FG001|Overall Study|Administrative reason|0|||
156896363|NCT00667602|566380541|FG002|Overall Study|Administrative reason|2|||
156896364|NCT00667602|566380539|FG000|Overall Study|Protocol Violation|0|||
156896365|NCT00667602|566380540|FG001|Overall Study|Protocol Violation|1|||
156896366|NCT00667602|566380541|FG002|Overall Study|Protocol Violation|0|||
156896367|NCT00760084|566380545|FG000|Overall Study|Physician Decision|5|||
156896368|NCT00760084|566380545|FG000|Overall Study|Withdrawal by Subject|2|||
157091558|NCT00994682|567089165|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
156896369|NCT00760084|566380545|FG000|Overall Study|Progressive Disease|3|||
156896370|NCT02301988|566380546|FG000|Overall Study|Withdrawal by Subject|2|||
156896371|NCT02301988|566380547|FG001|Overall Study|Withdrawal by Subject|1|||
156896372|NCT02301988|566380546|FG000|Overall Study|Physician Decision|2|||
156896373|NCT02301988|566380547|FG001|Overall Study|Physician Decision|2|||
156896374|NCT02301988|566380546|FG000|Overall Study|Unknown Reason|1|||
157158264|NCT02935634|567324537|FG001|Treatment: Track 2|Study drug toxicity|3|||
157158265|NCT02935634|567324538|FG002|Treatment: Track 2|Study drug toxicity|0|||
157158266|NCT02935634|567324539|FG003|Treatment: Track 2|Study drug toxicity|0|||
157158267|NCT02935634|567324540|FG004|Treatment: Track 2|Study drug toxicity|0|||
157158268|NCT02935634|567324541|FG005|Treatment: Track 2|Study drug toxicity|0|||
156896375|NCT02301988|566380547|FG001|Overall Study|Unknown Reason|3|||
156896376|NCT02301988|566380546|FG000|Overall Study|Lack of Efficacy|3|||
156896377|NCT02301988|566380547|FG001|Overall Study|Lack of Efficacy|2|||
156896378|NCT02301988|566380546|FG000|Overall Study|Death|1|||
156896379|NCT02301988|566380547|FG001|Overall Study|Death|0|||
156896380|NCT02301988|566380546|FG000|Overall Study|Adverse Event|1|||
156896381|NCT02301988|566380547|FG001|Overall Study|Adverse Event|1|||
156896382|NCT02891161|566380550|FG000|Study Treatment|Disease Progression|2|||
156896383|NCT02891161|566380551|FG001|Study Treatment|Disease Progression|4|||
156896384|NCT02891161|566380550|FG000|Study Treatment|AE/Side Effects/Complications|1|||
156896385|NCT02891161|566380551|FG001|Study Treatment|AE/Side Effects/Complications|5|||
156896386|NCT02891161|566380550|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
156896387|NCT02891161|566380551|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
156896388|NCT02891161|566380550|FG000|Follow up|Death|4|||
156896389|NCT02891161|566380551|FG001|Follow up|Death|8|||
156896390|NCT02891161|566380550|FG000|Follow up|Refused to Follow up|0|||
156896391|NCT02891161|566380551|FG001|Follow up|Refused to Follow up|2|||
156896392|NCT02891161|566380550|FG000|Follow up|Symptomatic deterioration|0|||
156896393|NCT02891161|566380551|FG001|Follow up|Symptomatic deterioration|1|||
156896394|NCT02891161|566380550|FG000|Follow up|Study terminated|0|||
156896395|NCT02891161|566380551|FG001|Follow up|Study terminated|6|||
156896396|NCT01931202|566380553|FG000|Overall Study|Withdrawal by Subject|0|||
156896397|NCT01931202|566380554|FG001|Overall Study|Withdrawal by Subject|0|||
156896398|NCT01931202|566380555|FG002|Overall Study|Withdrawal by Subject|2|||
156896399|NCT01931202|566380553|FG000|Overall Study|Lost to Follow-up|0|||
156896400|NCT01931202|566380554|FG001|Overall Study|Lost to Follow-up|5|||
156896401|NCT01931202|566380555|FG002|Overall Study|Lost to Follow-up|2|||
156896402|NCT01074047|566380562|FG000|Treatment Phase|Adverse Event|89|||
156896403|NCT01074047|566380563|FG001|Treatment Phase|Adverse Event|66|||
156896404|NCT01074047|566380562|FG000|Treatment Phase|Disease Progression|16|||
156896405|NCT01074047|566380563|FG001|Treatment Phase|Disease Progression|21|||
156896406|NCT01074047|566380562|FG000|Treatment Phase|Withdrawal by Subject|27|||
156896407|NCT01074047|566380563|FG001|Treatment Phase|Withdrawal by Subject|48|||
156896408|NCT01074047|566380562|FG000|Treatment Phase|Death|53|||
156896409|NCT01074047|566380563|FG001|Treatment Phase|Death|58|||
156896410|NCT01074047|566380562|FG000|Treatment Phase|Lost to Follow-up|0|||
156896411|NCT01074047|566380563|FG001|Treatment Phase|Lost to Follow-up|1|||
156896412|NCT01074047|566380562|FG000|Treatment Phase|Protocol Violation|0|||
156896413|NCT01074047|566380563|FG001|Treatment Phase|Protocol Violation|1|||
156896414|NCT01074047|566380562|FG000|Treatment Phase|Miscellaneous|32|||
156896415|NCT01074047|566380563|FG001|Treatment Phase|Miscellaneous|39|||
156896416|NCT01074047|566380562|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
156896417|NCT01074047|566380563|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
156896418|NCT01074047|566380562|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
156896419|NCT01074047|566380563|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
156896420|NCT01074047|566380562|FG000|Survival Follow-Up Phase|Death|116|||
156896421|NCT01074047|566380563|FG001|Survival Follow-Up Phase|Death|124|||
156896422|NCT01074047|566380562|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
156896423|NCT01074047|566380563|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
157158269|NCT02935634|567324536|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
157158270|NCT02935634|567324537|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
157158271|NCT02935634|567324538|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
157158272|NCT02935634|567324539|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
157158273|NCT02935634|567324540|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
157158274|NCT02935634|567324541|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
157158275|NCT02935634|567324536|FG000|Treatment: Track 2|Participant withdrew consent|0|||
157158276|NCT02935634|567324537|FG001|Treatment: Track 2|Participant withdrew consent|1|||
157158277|NCT02935634|567324538|FG002|Treatment: Track 2|Participant withdrew consent|1|||
157158278|NCT02935634|567324539|FG003|Treatment: Track 2|Participant withdrew consent|0|||
157225504|NCT03365375|567571449|FG000|Overall Study|Lost to Follow-up|0|||
156896424|NCT01074047|566380562|FG000|Extension Phase|Physician Decision|1|||
156896425|NCT01074047|566380563|FG001|Extension Phase|Physician Decision|0|||
156896426|NCT01074047|566380562|FG000|Extension Phase|Adverse Event|5|||
156896427|NCT01074047|566380563|FG001|Extension Phase|Adverse Event|0|||
156896428|NCT01074047|566380562|FG000|Extension Phase|Disease Progression|9|||
156896429|NCT01074047|566380563|FG001|Extension Phase|Disease Progression|0|||
156896430|NCT01074047|566380562|FG000|Extension Phase|Withdrawal by Subject|2|||
156896431|NCT01074047|566380563|FG001|Extension Phase|Withdrawal by Subject|0|||
156896432|NCT01074047|566380562|FG000|Extension Phase|Death|5|||
156896433|NCT01074047|566380563|FG001|Extension Phase|Death|0|||
156896434|NCT01876810|566380564|FG000|Overall Study|Physician Decision|0|||
156896435|NCT01876810|566380565|FG001|Overall Study|Physician Decision|1|||
156896436|NCT05169567|566380569|FG000|Overall Study|On study treatment|116|||
156896437|NCT05169567|566380570|FG001|Overall Study|On study treatment|128|||
156896438|NCT05169567|566380569|FG000|Overall Study|Lost to Follow-up|1|||
156896439|NCT05169567|566380570|FG001|Overall Study|Lost to Follow-up|0|||
156896440|NCT05169567|566380569|FG000|Overall Study|Withdrawal by Subject|25|||
156896441|NCT05169567|566380570|FG001|Overall Study|Withdrawal by Subject|21|||
156896442|NCT02211638|566380571|FG000|Overall Study|Case Report Forms Uncollected|291|||
156896443|NCT02211638|566380571|FG000|Overall Study|Protocol Violation|692|||
156896444|NCT04041700|566380574|FG000|Overall Study|Pregnancy|1|||
156896445|NCT04041700|566380574|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
156896446|NCT02775903|566380575|FG000|Overall Study|Death|7|||
156896447|NCT02775903|566380576|FG001|Overall Study|Death|11|||
156896448|NCT02775903|566380577|FG002|Overall Study|Death|12|||
156896449|NCT02775903|566380578|FG003|Overall Study|Death|11|||
156896450|NCT02775903|566380575|FG000|Overall Study|Adverse Event|0|||
156896451|NCT02775903|566380576|FG001|Overall Study|Adverse Event|1|||
156896452|NCT02775903|566380577|FG002|Overall Study|Adverse Event|12|||
156896453|NCT02775903|566380578|FG003|Overall Study|Adverse Event|3|||
156896454|NCT02775903|566380575|FG000|Overall Study|Progressive disease|15|||
156896455|NCT02775903|566380576|FG001|Overall Study|Progressive disease|14|||
156896456|NCT02775903|566380577|FG002|Overall Study|Progressive disease|30|||
156896457|NCT02775903|566380578|FG003|Overall Study|Progressive disease|20|||
156896458|NCT02775903|566380575|FG000|Overall Study|Lack of Efficacy|2|||
156896459|NCT02775903|566380576|FG001|Overall Study|Lack of Efficacy|2|||
156896460|NCT02775903|566380577|FG002|Overall Study|Lack of Efficacy|2|||
156896461|NCT02775903|566380578|FG003|Overall Study|Lack of Efficacy|6|||
156896462|NCT02775903|566380575|FG000|Overall Study|Withdrawal by Subject|7|||
156896463|NCT02775903|566380576|FG001|Overall Study|Withdrawal by Subject|5|||
156896464|NCT02775903|566380577|FG002|Overall Study|Withdrawal by Subject|5|||
156896465|NCT02775903|566380578|FG003|Overall Study|Withdrawal by Subject|8|||
156896466|NCT02775903|566380575|FG000|Overall Study|Other reasons|7|||
156896467|NCT02775903|566380576|FG001|Overall Study|Other reasons|8|||
156896468|NCT02775903|566380577|FG002|Overall Study|Other reasons|2|||
156896469|NCT02775903|566380578|FG003|Overall Study|Other reasons|12|||
156896470|NCT03120624|566380581|FG000|Overall Study|Withdrawal by Subject|0|||
156896471|NCT03120624|566380582|FG001|Overall Study|Withdrawal by Subject|1|||
156896472|NCT03120624|566380583|FG002|Overall Study|Withdrawal by Subject|0|||
156896473|NCT03120624|566380584|FG003|Overall Study|Withdrawal by Subject|0|||
156896474|NCT03120624|566380585|FG004|Overall Study|Withdrawal by Subject|0|||
156896475|NCT03120624|566380586|FG005|Overall Study|Withdrawal by Subject|0|||
156896476|NCT03120624|566380587|FG006|Overall Study|Withdrawal by Subject|0|||
156896477|NCT03120624|566380588|FG007|Overall Study|Withdrawal by Subject|0|||
156896478|NCT03670836|566380589|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
156896479|NCT03670836|566380590|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
156896480|NCT03670836|566380589|FG000|Per Protocol Population (PP)|Physician Decision|9|||
156896481|NCT03670836|566380590|FG001|Per Protocol Population (PP)|Physician Decision|10|||
156896482|NCT03670836|566380589|FG000|Per Protocol Population (PP)|Physician Decision|4|||
156896483|NCT03670836|566380590|FG001|Per Protocol Population (PP)|Physician Decision|6|||
156896484|NCT03670836|566380589|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
156896485|NCT03670836|566380590|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
156896486|NCT02160782|566382119|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
156896487|NCT02160782|566382120|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
156896488|NCT02160782|566382121|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
156896489|NCT02160782|566382122|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
156896490|NCT02160782|566382123|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
156896491|NCT02160782|566382119|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156896492|NCT02160782|566382120|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156896493|NCT02160782|566382121|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156896494|NCT02160782|566382122|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
156896495|NCT02160782|566382123|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
156896496|NCT02160782|566382119|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156896497|NCT02160782|566382120|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156896498|NCT02160782|566382121|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156896499|NCT02160782|566382122|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
156896500|NCT02160782|566382123|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
156896501|NCT02160782|566382119|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156896502|NCT02160782|566382120|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156896503|NCT02160782|566382121|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156896504|NCT02160782|566382122|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
156896505|NCT02160782|566382123|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
156896506|NCT02160782|566382119|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156896507|NCT02160782|566382120|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156896508|NCT02160782|566382121|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156896509|NCT02160782|566382122|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
156896510|NCT02160782|566382123|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
156896511|NCT02160782|566382119|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156896512|NCT02160782|566382120|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156896513|NCT02160782|566382121|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156896514|NCT02160782|566382122|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
156896515|NCT02160782|566382123|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
156896516|NCT02160782|566382119|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156896517|NCT02160782|566382120|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156896518|NCT02160782|566382121|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156896519|NCT02160782|566382122|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
156896520|NCT02160782|566382123|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
156896521|NCT02598960|566382128|FG000|Treatment Period|Disease Progression|4|||
156896522|NCT02598960|566382129|FG001|Treatment Period|Disease Progression|4|||
156896523|NCT02598960|566382130|FG002|Treatment Period|Disease Progression|4|||
156896524|NCT02598960|566382131|FG003|Treatment Period|Disease Progression|6|||
156896525|NCT02598960|566382132|FG004|Treatment Period|Disease Progression|8|||
156896526|NCT02598960|566382133|FG005|Treatment Period|Disease Progression|2|||
156896527|NCT02598960|566382134|FG006|Treatment Period|Disease Progression|2|||
156896528|NCT02598960|566382135|FG007|Treatment Period|Disease Progression|3|||
156896529|NCT02598960|566382136|FG008|Treatment Period|Disease Progression|7|||
156896530|NCT02598960|566382137|FG009|Treatment Period|Disease Progression|9|||
156896531|NCT02598960|566382138|FG010|Treatment Period|Disease Progression|7|||
156896532|NCT02598960|566382139|FG011|Treatment Period|Disease Progression|143|||
156896533|NCT02598960|566382140|FG012|Treatment Period|Disease Progression|23|||
156896534|NCT02598960|566382128|FG000|Treatment Period|Study drug toxicity|0|||
156896535|NCT02598960|566382129|FG001|Treatment Period|Study drug toxicity|0|||
156896536|NCT02598960|566382130|FG002|Treatment Period|Study drug toxicity|0|||
156896537|NCT02598960|566382131|FG003|Treatment Period|Study drug toxicity|0|||
156896538|NCT02598960|566382132|FG004|Treatment Period|Study drug toxicity|0|||
156896539|NCT02598960|566382133|FG005|Treatment Period|Study drug toxicity|0|||
156896540|NCT02598960|566382134|FG006|Treatment Period|Study drug toxicity|0|||
156896541|NCT02598960|566382135|FG007|Treatment Period|Study drug toxicity|0|||
156896542|NCT02598960|566382136|FG008|Treatment Period|Study drug toxicity|0|||
156896543|NCT02598960|566382137|FG009|Treatment Period|Study drug toxicity|1|||
156896544|NCT02598960|566382138|FG010|Treatment Period|Study drug toxicity|0|||
156896545|NCT02598960|566382139|FG011|Treatment Period|Study drug toxicity|3|||
156896546|NCT02598960|566382140|FG012|Treatment Period|Study drug toxicity|0|||
156896547|NCT02598960|566382128|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
156896548|NCT02598960|566382129|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
156896549|NCT02598960|566382130|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
156896550|NCT02598960|566382131|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
156896551|NCT02598960|566382132|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
156896552|NCT02598960|566382133|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
156896553|NCT02598960|566382134|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
156896554|NCT02598960|566382135|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
156896555|NCT02598960|566382136|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
156896556|NCT02598960|566382137|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
156896557|NCT02598960|566382138|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
156896558|NCT02598960|566382139|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
156896559|NCT02598960|566382140|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
156896560|NCT02598960|566382128|FG000|Treatment Period|participant request to discontinue|0|||
156896561|NCT02598960|566382129|FG001|Treatment Period|participant request to discontinue|1|||
156896562|NCT02598960|566382130|FG002|Treatment Period|participant request to discontinue|0|||
156896563|NCT02598960|566382131|FG003|Treatment Period|participant request to discontinue|0|||
156896564|NCT02598960|566382132|FG004|Treatment Period|participant request to discontinue|1|||
156896565|NCT02598960|566382133|FG005|Treatment Period|participant request to discontinue|0|||
156896566|NCT02598960|566382134|FG006|Treatment Period|participant request to discontinue|0|||
156896567|NCT02598960|566382135|FG007|Treatment Period|participant request to discontinue|0|||
156896568|NCT02598960|566382136|FG008|Treatment Period|participant request to discontinue|0|||
156896569|NCT02598960|566382137|FG009|Treatment Period|participant request to discontinue|0|||
156896570|NCT02598960|566382138|FG010|Treatment Period|participant request to discontinue|1|||
156896571|NCT02598960|566382139|FG011|Treatment Period|participant request to discontinue|4|||
157225505|NCT03365375|567571450|FG001|Overall Study|Lost to Follow-up|4|||
156896572|NCT02598960|566382140|FG012|Treatment Period|participant request to discontinue|0|||
156896573|NCT02598960|566382128|FG000|Treatment Period|participant withdrew consent|0|||
156896574|NCT02598960|566382129|FG001|Treatment Period|participant withdrew consent|0|||
156896575|NCT02598960|566382130|FG002|Treatment Period|participant withdrew consent|0|||
156896576|NCT02598960|566382131|FG003|Treatment Period|participant withdrew consent|0|||
156896577|NCT02598960|566382132|FG004|Treatment Period|participant withdrew consent|0|||
156896578|NCT02598960|566382133|FG005|Treatment Period|participant withdrew consent|0|||
156896579|NCT02598960|566382134|FG006|Treatment Period|participant withdrew consent|0|||
156896580|NCT02598960|566382135|FG007|Treatment Period|participant withdrew consent|0|||
156896581|NCT02598960|566382136|FG008|Treatment Period|participant withdrew consent|0|||
156896582|NCT02598960|566382137|FG009|Treatment Period|participant withdrew consent|0|||
156896583|NCT02598960|566382138|FG010|Treatment Period|participant withdrew consent|0|||
156896584|NCT02598960|566382139|FG011|Treatment Period|participant withdrew consent|3|||
156896585|NCT02598960|566382140|FG012|Treatment Period|participant withdrew consent|0|||
156896586|NCT02598960|566382128|FG000|Treatment Period|No longer meets study criteria|0|||
156896587|NCT02598960|566382129|FG001|Treatment Period|No longer meets study criteria|0|||
156896588|NCT02598960|566382130|FG002|Treatment Period|No longer meets study criteria|0|||
156896589|NCT02598960|566382131|FG003|Treatment Period|No longer meets study criteria|0|||
156896590|NCT02598960|566382132|FG004|Treatment Period|No longer meets study criteria|0|||
156896591|NCT02598960|566382133|FG005|Treatment Period|No longer meets study criteria|0|||
156896592|NCT02598960|566382134|FG006|Treatment Period|No longer meets study criteria|0|||
156896593|NCT02598960|566382135|FG007|Treatment Period|No longer meets study criteria|0|||
156896594|NCT02598960|566382136|FG008|Treatment Period|No longer meets study criteria|0|||
156896595|NCT02598960|566382137|FG009|Treatment Period|No longer meets study criteria|0|||
156896596|NCT02598960|566382138|FG010|Treatment Period|No longer meets study criteria|0|||
156896597|NCT02598960|566382139|FG011|Treatment Period|No longer meets study criteria|1|||
156896598|NCT02598960|566382140|FG012|Treatment Period|No longer meets study criteria|0|||
156896599|NCT02598960|566382128|FG000|Treatment Period|Other Reasons|0|||
156896600|NCT02598960|566382129|FG001|Treatment Period|Other Reasons|0|||
156896601|NCT02598960|566382130|FG002|Treatment Period|Other Reasons|0|||
156896602|NCT02598960|566382131|FG003|Treatment Period|Other Reasons|0|||
156896603|NCT02598960|566382132|FG004|Treatment Period|Other Reasons|0|||
156896604|NCT02598960|566382133|FG005|Treatment Period|Other Reasons|0|||
156896605|NCT02598960|566382134|FG006|Treatment Period|Other Reasons|0|||
156896606|NCT02598960|566382135|FG007|Treatment Period|Other Reasons|0|||
156896607|NCT02598960|566382136|FG008|Treatment Period|Other Reasons|0|||
156896608|NCT02598960|566382137|FG009|Treatment Period|Other Reasons|0|||
156896609|NCT02598960|566382138|FG010|Treatment Period|Other Reasons|0|||
156896610|NCT02598960|566382139|FG011|Treatment Period|Other Reasons|0|||
156896611|NCT02598960|566382140|FG012|Treatment Period|Other Reasons|1|||
156896612|NCT02598960|566382128|FG000|Participants Entering Follow Up Period|Death|1|||
156896613|NCT02598960|566382129|FG001|Participants Entering Follow Up Period|Death|0|||
156896614|NCT02598960|566382130|FG002|Participants Entering Follow Up Period|Death|0|||
156896615|NCT02598960|566382131|FG003|Participants Entering Follow Up Period|Death|0|||
156896616|NCT02598960|566382132|FG004|Participants Entering Follow Up Period|Death|0|||
156896617|NCT02598960|566382133|FG005|Participants Entering Follow Up Period|Death|0|||
156896618|NCT02598960|566382134|FG006|Participants Entering Follow Up Period|Death|0|||
156896619|NCT02598960|566382135|FG007|Participants Entering Follow Up Period|Death|0|||
156896620|NCT02598960|566382136|FG008|Participants Entering Follow Up Period|Death|0|||
156896621|NCT02598960|566382137|FG009|Participants Entering Follow Up Period|Death|1|||
156896622|NCT02598960|566382138|FG010|Participants Entering Follow Up Period|Death|0|||
156896623|NCT02598960|566382139|FG011|Participants Entering Follow Up Period|Death|11|||
156896624|NCT02598960|566382140|FG012|Participants Entering Follow Up Period|Death|2|||
156896625|NCT02598960|566382128|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896626|NCT02598960|566382129|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896627|NCT02598960|566382130|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896628|NCT02598960|566382131|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896629|NCT02598960|566382132|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896630|NCT02598960|566382133|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896631|NCT02598960|566382134|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896632|NCT02598960|566382135|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896633|NCT02598960|566382136|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896634|NCT02598960|566382137|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896635|NCT02598960|566382138|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896636|NCT02598960|566382139|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
156896637|NCT02598960|566382140|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
156896638|NCT02598960|566382128|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
156896639|NCT02598960|566382129|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
157091559|NCT00994682|567089164|FG000|Pioglitazone Open Label|Physician Decision|6|||
156896640|NCT02598960|566382130|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
156896641|NCT02598960|566382131|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
156896642|NCT02598960|566382132|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
156896643|NCT02598960|566382133|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
156896644|NCT02598960|566382134|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
156896645|NCT02598960|566382135|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
156896646|NCT02598960|566382136|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
156896647|NCT02598960|566382137|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
156896648|NCT02598960|566382138|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
156896649|NCT02598960|566382139|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
156896650|NCT02598960|566382140|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
156896651|NCT02598960|566382128|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896652|NCT02598960|566382129|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896653|NCT02598960|566382130|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896654|NCT02598960|566382131|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896655|NCT02598960|566382132|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896656|NCT02598960|566382133|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896657|NCT02598960|566382134|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896658|NCT02598960|566382135|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896659|NCT02598960|566382136|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896660|NCT02598960|566382137|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896661|NCT02598960|566382138|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896662|NCT02598960|566382139|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
156896663|NCT02598960|566382140|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
156896664|NCT02598960|566382128|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
156896665|NCT02598960|566382129|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
156896666|NCT02598960|566382130|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
156896667|NCT02598960|566382131|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
156896668|NCT02598960|566382132|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
156896669|NCT02598960|566382133|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
156896670|NCT02598960|566382134|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
156896671|NCT02598960|566382135|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
156896672|NCT02598960|566382136|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
156896673|NCT02598960|566382137|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
156896674|NCT02598960|566382138|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
156896675|NCT02598960|566382139|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
156896676|NCT02598960|566382140|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
156896677|NCT00398411|566382141|FG000|Overall Study|Death|0|||
156896678|NCT00398411|566382142|FG001|Overall Study|Death|1|||
156896679|NCT03061097|566382147|FG000|Overall Study|Withdrawal by Subject|0|||
156896680|NCT03061097|566382148|FG001|Overall Study|Withdrawal by Subject|3|||
156896681|NCT00595465|566382149|FG000|Overall Study|Adverse Event|4|||
156896682|NCT00595465|566382150|FG001|Overall Study|Adverse Event|3|||
156896683|NCT00595465|566382151|FG002|Overall Study|Adverse Event|3|||
156896684|NCT00595465|566382149|FG000|Overall Study|Pregnancy|0|||
156896685|NCT00595465|566382150|FG001|Overall Study|Pregnancy|0|||
156896686|NCT00595465|566382151|FG002|Overall Study|Pregnancy|1|||
156896687|NCT00595465|566382149|FG000|Overall Study|Protocol Violation|2|||
156896688|NCT00595465|566382150|FG001|Overall Study|Protocol Violation|1|||
156896689|NCT00595465|566382151|FG002|Overall Study|Protocol Violation|0|||
156896690|NCT00595465|566382149|FG000|Overall Study|Lost to Follow-up|0|||
156896691|NCT00595465|566382150|FG001|Overall Study|Lost to Follow-up|0|||
156896692|NCT00595465|566382151|FG002|Overall Study|Lost to Follow-up|2|||
156896693|NCT00595465|566382149|FG000|Overall Study|administrative reason|0|||
156896694|NCT00595465|566382150|FG001|Overall Study|administrative reason|0|||
156896695|NCT00595465|566382151|FG002|Overall Study|administrative reason|1|||
156896696|NCT00107783|566382152|FG000|Overall Study|Adverse Event|0|||
156896697|NCT00107783|566382153|FG001|Overall Study|Adverse Event|2|||
156896698|NCT00107783|566382152|FG000|Overall Study|Death|0|||
156896699|NCT00107783|566382153|FG001|Overall Study|Death|1|||
156896700|NCT00107783|566382152|FG000|Overall Study|Withdrawal by Subject|2|||
156896701|NCT00107783|566382153|FG001|Overall Study|Withdrawal by Subject|0|||
156896702|NCT00107783|566382152|FG000|Overall Study|Second hip replacement|1|||
156896703|NCT00107783|566382153|FG001|Overall Study|Second hip replacement|1|||
156896704|NCT00137631|566382159|FG000|Overall Study|Lost to Follow-up|37|||
156896705|NCT00137631|566382160|FG001|Overall Study|Lost to Follow-up|41|||
156896706|NCT02611960|566382161|FG000|Overall Study|Adverse Event|7|||
156896707|NCT02611960|566382162|FG001|Overall Study|Adverse Event|8|||
156896708|NCT02611960|566382161|FG000|Overall Study|Death|98|||
156896709|NCT02611960|566382162|FG001|Overall Study|Death|92|||
156896710|NCT02611960|566382161|FG000|Overall Study|Withdrawal by Subject|1|||
156896711|NCT02611960|566382162|FG001|Overall Study|Withdrawal by Subject|5|||
156896712|NCT02611960|566382161|FG000|Overall Study|Sponsor Decision|11|||
156896713|NCT02611960|566382162|FG001|Overall Study|Sponsor Decision|11|||
156896714|NCT00085709|566382174|FG000|Overall Study|Adverse Event|8|||
156896715|NCT00085709|566382175|FG001|Overall Study|Adverse Event|0|||
156896716|NCT00085709|566382174|FG000|Overall Study|Death|8|||
156896717|NCT00085709|566382175|FG001|Overall Study|Death|2|||
156896718|NCT00085709|566382174|FG000|Overall Study|Refusal unrelated to adverse events|1|||
156896719|NCT00085709|566382175|FG001|Overall Study|Refusal unrelated to adverse events|2|||
156896720|NCT00085709|566382174|FG000|Overall Study|Progression|3|||
156896721|NCT00085709|566382175|FG001|Overall Study|Progression|4|||
156896722|NCT00085709|566382174|FG000|Overall Study|Not protocol specified|12|||
156896723|NCT00085709|566382175|FG001|Overall Study|Not protocol specified|22|||
156896724|NCT00085709|566382174|FG000|Overall Study|Not eligible|19|||
156896725|NCT00085709|566382175|FG001|Overall Study|Not eligible|19|||
156896726|NCT00085709|566382174|FG000|Overall Study|Withdrawal by Subject|2|||
156896727|NCT00085709|566382175|FG001|Overall Study|Withdrawal by Subject|1|||
156896728|NCT04131556|566382176|FG000|Overall Study|Adverse Event|1|||
156896729|NCT04131556|566382176|FG000|Overall Study|Withdrawal by Subject|1|||
156896730|NCT04622735|566382177|FG000|Overall Study|Lost to Follow-up|1|||
156896731|NCT04622735|566382178|FG001|Overall Study|Lost to Follow-up|2|||
156896732|NCT04622735|566382179|FG002|Overall Study|Lost to Follow-up|1|||
156896733|NCT04622735|566382177|FG000|Overall Study|Adverse Event|0|||
156896734|NCT04622735|566382178|FG001|Overall Study|Adverse Event|0|||
156896735|NCT04622735|566382179|FG002|Overall Study|Adverse Event|1|||
156896736|NCT04622735|566382177|FG000|Overall Study|Protocol Violation|1|||
156896737|NCT04622735|566382178|FG001|Overall Study|Protocol Violation|0|||
156896738|NCT04622735|566382179|FG002|Overall Study|Protocol Violation|0|||
156896739|NCT03026088|566382181|FG000|Overall Study|Study termination|20|||
156896740|NCT00950911|566382182|FG000|Overall Study|Adverse Event|0|||
156896741|NCT00950911|566382183|FG001|Overall Study|Adverse Event|2|||
156896742|NCT00950911|566382182|FG000|Overall Study|Death|4|||
156896743|NCT00950911|566382183|FG001|Overall Study|Death|6|||
156896744|NCT00950911|566382182|FG000|Overall Study|Disease progression|2|||
156896745|NCT00950911|566382183|FG001|Overall Study|Disease progression|2|||
156896746|NCT00950911|566382182|FG000|Overall Study|Consent withdrawn|1|||
156896747|NCT00950911|566382183|FG001|Overall Study|Consent withdrawn|3|||
156896748|NCT00950911|566382182|FG000|Overall Study|Administrative decision|3|||
156896749|NCT00950911|566382183|FG001|Overall Study|Administrative decision|1|||
156896750|NCT00950911|566382182|FG000|Overall Study|Ineligibility determined|1|||
156896751|NCT00950911|566382183|FG001|Overall Study|Ineligibility determined|0|||
156896752|NCT00950911|566382182|FG000|Overall Study|Noncompliance|1|||
156896753|NCT00950911|566382183|FG001|Overall Study|Noncompliance|0|||
156896754|NCT00950911|566382182|FG000|Overall Study|Poor performance status|0|||
156896755|NCT00950911|566382183|FG001|Overall Study|Poor performance status|1|||
156896756|NCT06400979|566382185|FG000|Overall Study|Lost to Follow-up|29|||
156896757|NCT06400979|566382185|FG000|Overall Study|Withdrawal by Subject|1|||
156896758|NCT00573248|566382190|FG000|Overall Study|scheduling conflicts|15|||
157091560|NCT00994682|567089165|FG001|Pioglitazone Open Label|Physician Decision|1|||
156896759|NCT00573248|566382191|FG001|Overall Study|scheduling conflicts|11|||
156896760|NCT04505540|566382192|FG000|Baseline|Protocol Violation|10|||
156896761|NCT04505540|566382192|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
156896762|NCT04505540|566382192|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
156896763|NCT04505540|566382192|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
156896764|NCT04505540|566382192|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
156896765|NCT04505540|566382192|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
156896766|NCT04505540|566382192|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
156896767|NCT04505540|566382192|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
156896768|NCT04505540|566382192|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
156896769|NCT04505540|566382192|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
156896770|NCT04505540|566382192|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
156896771|NCT04505540|566382192|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
156896772|NCT04505540|566382192|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
156896773|NCT05342532|566382193|FG000|Overall Study|Adverse Event|5|||
156896774|NCT05342532|566382194|FG001|Overall Study|Adverse Event|20|||
156896775|NCT05342532|566382193|FG000|Overall Study|Lost to Follow-up|10|||
156896776|NCT05342532|566382194|FG001|Overall Study|Lost to Follow-up|15|||
156896777|NCT02057393|566382197|FG000|Overall Study|Withdrawal by Subject|1|||
156896778|NCT02057393|566382197|FG000|Overall Study|Patient did not meet criteria|1|||
156896779|NCT03180684|566382198|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
156896780|NCT03180684|566382199|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
156896781|NCT03180684|566382198|FG000|Overall Study|Physician Decision|1|||
156896782|NCT03180684|566382199|FG001|Overall Study|Physician Decision|0|||
157091561|NCT01323972|567089166|FG000|Overall Study|Withdrawal by Subject|1|||
156896783|NCT03180684|566382198|FG000|Overall Study|Lost to Follow-up|1|||
156896784|NCT03180684|566382199|FG001|Overall Study|Lost to Follow-up|0|||
156896785|NCT03180684|566382198|FG000|Overall Study|Progressive Disease|1|||
156896786|NCT03180684|566382199|FG001|Overall Study|Progressive Disease|0|||
156896787|NCT01130103|566382202|FG000|Randomized Treatment|Adverse Event|1|||
156896788|NCT01130103|566382203|FG001|Randomized Treatment|Adverse Event|1|||
156896789|NCT01130103|566382202|FG000|Randomized Treatment|Lost to Follow-up|1|||
156896790|NCT01130103|566382203|FG001|Randomized Treatment|Lost to Follow-up|0|||
156896791|NCT01130103|566382202|FG000|Randomized Treatment|Protocol Violation|3|||
156896792|NCT01130103|566382203|FG001|Randomized Treatment|Protocol Violation|2|||
156896793|NCT01130103|566382202|FG000|Randomized Treatment|Withdrawal by Subject|1|||
156896794|NCT01130103|566382203|FG001|Randomized Treatment|Withdrawal by Subject|2|||
156896795|NCT01130103|566382202|FG000|Maintenance Treatment|Lack of Efficacy|0|||
156896796|NCT01130103|566382203|FG001|Maintenance Treatment|Lack of Efficacy|1|||
156896797|NCT01130103|566382202|FG000|Maintenance Treatment|Lost to Follow-up|1|||
156896798|NCT01130103|566382203|FG001|Maintenance Treatment|Lost to Follow-up|1|||
156896799|NCT01130103|566382202|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
156896800|NCT01130103|566382203|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
156896801|NCT00450385|566382204|FG000|Overall Study|Death|3|||
156896802|NCT00450385|566382204|FG000|Overall Study|Protocol Violation|1|||
156896803|NCT00450385|566382204|FG000|Overall Study|Withdrawal by Subject|2|||
156896804|NCT00450385|566382204|FG000|Overall Study|Lack of Efficacy|2|||
156896805|NCT00450385|566382204|FG000|Overall Study|Adverse Event|1|||
156896806|NCT00450385|566382204|FG000|Overall Study|Physician Decision|1|||
156896807|NCT00450385|566382204|FG000|Overall Study|Other|3|||
156896808|NCT03614975|566382205|FG000|Overall Study|Physician Decision|7|||
156896809|NCT03614975|566382206|FG001|Overall Study|Physician Decision|5|||
156896810|NCT03614975|566382205|FG000|Overall Study|Withdrawal by Subject|2|||
156896811|NCT03614975|566382206|FG001|Overall Study|Withdrawal by Subject|2|||
156896812|NCT03614975|566382205|FG000|Overall Study|Specimens not in lab batch shipment|1|||
156896813|NCT03614975|566382206|FG001|Overall Study|Specimens not in lab batch shipment|1|||
156896814|NCT01390220|566382209|FG000|Test Dose Phase|Adverse Event|17|||
156896815|NCT01390220|566382210|FG001|Test Dose Phase|Adverse Event|0|||
156896816|NCT01390220|566382211|FG002|Test Dose Phase|Adverse Event|0|||
156896817|NCT01390220|566382209|FG000|Test Dose Phase|Withdrawal by Subject|8|||
156896818|NCT01390220|566382210|FG001|Test Dose Phase|Withdrawal by Subject|0|||
156896819|NCT01390220|566382211|FG002|Test Dose Phase|Withdrawal by Subject|0|||
156896820|NCT01390220|566382209|FG000|Test Dose Phase|Lost to Follow-up|2|||
156896821|NCT01390220|566382210|FG001|Test Dose Phase|Lost to Follow-up|0|||
156896822|NCT01390220|566382211|FG002|Test Dose Phase|Lost to Follow-up|0|||
156896823|NCT01390220|566382209|FG000|Test Dose Phase|Protocol Violation|8|||
156896824|NCT01390220|566382210|FG001|Test Dose Phase|Protocol Violation|0|||
156896825|NCT01390220|566382211|FG002|Test Dose Phase|Protocol Violation|0|||
156896826|NCT01390220|566382209|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
156896827|NCT01390220|566382210|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
156896828|NCT01390220|566382211|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
156896829|NCT01390220|566382209|FG000|Test Dose Phase|Study/Site closure|6|||
156896830|NCT01390220|566382210|FG001|Test Dose Phase|Study/Site closure|0|||
156896831|NCT01390220|566382211|FG002|Test Dose Phase|Study/Site closure|0|||
156896832|NCT01390220|566382209|FG000|Test Dose Phase|Caregiver no longer available|5|||
156896833|NCT01390220|566382210|FG001|Test Dose Phase|Caregiver no longer available|0|||
156896834|NCT01390220|566382211|FG002|Test Dose Phase|Caregiver no longer available|0|||
156896835|NCT01390220|566382209|FG000|Test Dose Phase|Noncompliance|2|||
156896836|NCT01390220|566382210|FG001|Test Dose Phase|Noncompliance|0|||
156896837|NCT01390220|566382211|FG002|Test Dose Phase|Noncompliance|0|||
156896838|NCT01390220|566382209|FG000|Test Dose Phase|Logistical|6|||
156896839|NCT01390220|566382210|FG001|Test Dose Phase|Logistical|0|||
156896840|NCT01390220|566382211|FG002|Test Dose Phase|Logistical|0|||
156896841|NCT01390220|566382209|FG000|Comparative Phase|Withdrawal by Subject|0|||
156896842|NCT01390220|566382210|FG001|Comparative Phase|Withdrawal by Subject|1|||
156896843|NCT01390220|566382211|FG002|Comparative Phase|Withdrawal by Subject|0|||
156896844|NCT00249288|566382212|FG000|Overall Study|Lost to Follow-up|3|||
156896845|NCT00249288|566382213|FG001|Overall Study|Lost to Follow-up|3|||
156896846|NCT00249288|566382212|FG000|Overall Study|Withdrawal by Subject|2|||
156896847|NCT00249288|566382213|FG001|Overall Study|Withdrawal by Subject|2|||
156896848|NCT03059446|566382214|FG000|Overall Study|Adverse Event|11|||
156896849|NCT03059446|566382214|FG000|Overall Study|Withdrawal of Consent|16|||
156896850|NCT03059446|566382214|FG000|Overall Study|Lost to Follow-up|3|||
156896851|NCT03059446|566382214|FG000|Overall Study|Protocol Violation|1|||
156896852|NCT03059446|566382214|FG000|Overall Study|Study Terminated by Sponsor|131|||
156896853|NCT03059446|566382214|FG000|Overall Study|Reason not Specified|5|||
156896854|NCT03091777|566382215|FG000|Overall Study|Pregnancy|2|||
156896855|NCT03091777|566382216|FG001|Overall Study|Pregnancy|1|||
156896856|NCT03091777|566382217|FG002|Overall Study|Pregnancy|0|||
157091562|NCT01323972|567089167|FG001|Overall Study|Withdrawal by Subject|0|||
156896857|NCT03091777|566382215|FG000|Overall Study|Adverse Event|2|||
156896858|NCT03091777|566382216|FG001|Overall Study|Adverse Event|1|||
156896859|NCT03091777|566382217|FG002|Overall Study|Adverse Event|4|||
156896860|NCT03091777|566382215|FG000|Overall Study|Withdrawal by Subject|4|||
156896861|NCT03091777|566382216|FG001|Overall Study|Withdrawal by Subject|2|||
156896862|NCT03091777|566382217|FG002|Overall Study|Withdrawal by Subject|6|||
156896863|NCT03091777|566382215|FG000|Overall Study|Protocol Violation|2|||
156896864|NCT03091777|566382216|FG001|Overall Study|Protocol Violation|1|||
156896865|NCT03091777|566382217|FG002|Overall Study|Protocol Violation|1|||
156896866|NCT03091777|566382215|FG000|Overall Study|Lost to Follow-up|12|||
156896867|NCT03091777|566382216|FG001|Overall Study|Lost to Follow-up|14|||
156896868|NCT03091777|566382217|FG002|Overall Study|Lost to Follow-up|7|||
156896869|NCT03091777|566382215|FG000|Overall Study|Lack of Efficacy|0|||
156896870|NCT03091777|566382216|FG001|Overall Study|Lack of Efficacy|0|||
156896871|NCT03091777|566382217|FG002|Overall Study|Lack of Efficacy|5|||
156896872|NCT03091777|566382215|FG000|Overall Study|Noncompliance with study drug|2|||
156896873|NCT03091777|566382216|FG001|Overall Study|Noncompliance with study drug|3|||
156896874|NCT03091777|566382217|FG002|Overall Study|Noncompliance with study drug|1|||
156896875|NCT03091777|566382215|FG000|Overall Study|Physician Decision|1|||
156896876|NCT03091777|566382216|FG001|Overall Study|Physician Decision|0|||
156896877|NCT03091777|566382217|FG002|Overall Study|Physician Decision|1|||
156896878|NCT03091777|566382215|FG000|Overall Study|Abnormal Laboratory Value|7|||
156896879|NCT03091777|566382216|FG001|Overall Study|Abnormal Laboratory Value|11|||
156896880|NCT03091777|566382217|FG002|Overall Study|Abnormal Laboratory Value|12|||
156896881|NCT02536833|566382218|FG000|Overall Study|Discontinued Before Treatment|0|||
156896882|NCT02536833|566382219|FG001|Overall Study|Discontinued Before Treatment|0|||
156896883|NCT02536833|566382220|FG002|Overall Study|Discontinued Before Treatment|1|||
156896884|NCT02536833|566382221|FG003|Overall Study|Discontinued Before Treatment|2|||
156896885|NCT02536833|566382218|FG000|Overall Study|Adverse Event|1|||
156896886|NCT02536833|566382219|FG001|Overall Study|Adverse Event|3|||
156896887|NCT02536833|566382220|FG002|Overall Study|Adverse Event|4|||
156896888|NCT02536833|566382221|FG003|Overall Study|Adverse Event|1|||
156896889|NCT02536833|566382218|FG000|Overall Study|Lost to Follow-up|2|||
156896890|NCT02536833|566382219|FG001|Overall Study|Lost to Follow-up|1|||
156896891|NCT02536833|566382220|FG002|Overall Study|Lost to Follow-up|2|||
156896892|NCT02536833|566382221|FG003|Overall Study|Lost to Follow-up|2|||
156896893|NCT02536833|566382218|FG000|Overall Study|Physician Decision|0|||
156896894|NCT02536833|566382219|FG001|Overall Study|Physician Decision|0|||
156896895|NCT02536833|566382220|FG002|Overall Study|Physician Decision|0|||
156896896|NCT02536833|566382221|FG003|Overall Study|Physician Decision|1|||
156896897|NCT02536833|566382218|FG000|Overall Study|Site Terminated by Sponsor|2|||
156896898|NCT02536833|566382219|FG001|Overall Study|Site Terminated by Sponsor|2|||
156896899|NCT02536833|566382220|FG002|Overall Study|Site Terminated by Sponsor|2|||
156896900|NCT02536833|566382221|FG003|Overall Study|Site Terminated by Sponsor|2|||
156896901|NCT02536833|566382218|FG000|Overall Study|Subject Non-Compliance|0|||
156896902|NCT02536833|566382219|FG001|Overall Study|Subject Non-Compliance|1|||
156896903|NCT02536833|566382220|FG002|Overall Study|Subject Non-Compliance|1|||
156896904|NCT02536833|566382221|FG003|Overall Study|Subject Non-Compliance|0|||
157158279|NCT02935634|567324540|FG004|Treatment: Track 2|Participant withdrew consent|1|||
156896905|NCT02536833|566382218|FG000|Overall Study|Withdrawal by Subject|4|||
156896906|NCT02536833|566382219|FG001|Overall Study|Withdrawal by Subject|3|||
156896907|NCT02536833|566382220|FG002|Overall Study|Withdrawal by Subject|5|||
156896908|NCT02536833|566382221|FG003|Overall Study|Withdrawal by Subject|11|||
156896909|NCT00089674|566382222|FG000|Overall Study|Physician Decision|4|||
156896910|NCT00089674|566382223|FG001|Overall Study|Physician Decision|2|||
156896911|NCT00089674|566382222|FG000|Overall Study|Adverse Event|23|||
156896912|NCT00089674|566382223|FG001|Overall Study|Adverse Event|29|||
156896913|NCT00089674|566382222|FG000|Overall Study|Withdrawal by Subject|143|||
156896914|NCT00089674|566382223|FG001|Overall Study|Withdrawal by Subject|127|||
156896915|NCT00089674|566382222|FG000|Overall Study|Death|43|||
156896916|NCT00089674|566382223|FG001|Overall Study|Death|43|||
156896917|NCT00089674|566382222|FG000|Overall Study|Disease progression|21|||
156896918|NCT00089674|566382223|FG001|Overall Study|Disease progression|23|||
156896919|NCT00089674|566382222|FG000|Overall Study|Ineligibility determined|8|||
156896920|NCT00089674|566382223|FG001|Overall Study|Ineligibility determined|10|||
156896921|NCT00089674|566382222|FG000|Overall Study|Lost to Follow-up|21|||
156896922|NCT00089674|566382223|FG001|Overall Study|Lost to Follow-up|17|||
156896923|NCT00089674|566382222|FG000|Overall Study|Noncompliance|7|||
156896924|NCT00089674|566382223|FG001|Overall Study|Noncompliance|3|||
156896925|NCT00089674|566382222|FG000|Overall Study|Other|5|||
156896926|NCT00089674|566382223|FG001|Overall Study|Other|9|||
156896927|NCT00089674|566382222|FG000|Overall Study|Requirement for alternative therapy|14|||
156896928|NCT00089674|566382223|FG001|Overall Study|Requirement for alternative therapy|4|||
157158280|NCT02935634|567324541|FG005|Treatment: Track 2|Participant withdrew consent|0|||
157158281|NCT06150573|567324545|FG000|Overall Study|Did not meet study criteria|1|||
156896929|NCT01528215|566382224|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
156896930|NCT01528215|566382225|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
156896931|NCT01528215|566382224|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
156896932|NCT01528215|566382225|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
157158282|NCT06150573|567324546|FG001|Overall Study|Did not meet study criteria|0|||
157158283|NCT06150573|567324545|FG000|Overall Study|Adverse Event|1|||
157158284|NCT06150573|567324546|FG001|Overall Study|Adverse Event|0|||
157158285|NCT06150573|567324545|FG000|Overall Study|Lost to Follow-up|0|||
157158286|NCT06150573|567324546|FG001|Overall Study|Lost to Follow-up|1|||
157158287|NCT06150573|567324545|FG000|Overall Study|Protocol Violation|0|||
157158288|NCT06150573|567324546|FG001|Overall Study|Protocol Violation|1|||
157158289|NCT06150573|567324545|FG000|Overall Study|Withdrawal by Subject|2|||
157158290|NCT06150573|567324546|FG001|Overall Study|Withdrawal by Subject|0|||
157158291|NCT01327651|567324547|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
157158292|NCT01327651|567324548|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
157158293|NCT01327651|567324549|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
156896933|NCT01528215|566382224|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
156896934|NCT01528215|566382225|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
157158294|NCT01327651|567324550|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
157158295|NCT01327651|567324551|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
157158296|NCT01327651|567324552|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
157158297|NCT01327651|567324553|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
156858636|NCT04158583|566236755|FG003|Overall Study|Progressive Disease|5|||
156858637|NCT04158583|566236756|FG004|Overall Study|Progressive Disease|0|||
156858638|NCT04158583|566236757|FG005|Overall Study|Progressive Disease|1|||
156858639|NCT04158583|566236758|FG006|Overall Study|Progressive Disease|6|||
156858640|NCT04158583|566236759|FG007|Overall Study|Progressive Disease|2|||
156858641|NCT04158583|566236760|FG008|Overall Study|Progressive Disease|1|||
156858642|NCT04158583|566236761|FG009|Overall Study|Progressive Disease|2|||
156858643|NCT04158583|566236752|FG000|Overall Study|Lost to Follow-up|0|||
156858644|NCT04158583|566236753|FG001|Overall Study|Lost to Follow-up|0|||
156858645|NCT04158583|566236754|FG002|Overall Study|Lost to Follow-up|1|||
156858646|NCT04158583|566236755|FG003|Overall Study|Lost to Follow-up|1|||
156858647|NCT04158583|566236756|FG004|Overall Study|Lost to Follow-up|1|||
156858648|NCT04158583|566236757|FG005|Overall Study|Lost to Follow-up|0|||
156858649|NCT04158583|566236758|FG006|Overall Study|Lost to Follow-up|0|||
156858650|NCT04158583|566236759|FG007|Overall Study|Lost to Follow-up|0|||
156858651|NCT04158583|566236760|FG008|Overall Study|Lost to Follow-up|0|||
156858652|NCT04158583|566236761|FG009|Overall Study|Lost to Follow-up|0|||
156858653|NCT04158583|566236752|FG000|Overall Study|Due To Patient Status|0|||
156858654|NCT04158583|566236753|FG001|Overall Study|Due To Patient Status|0|||
156858655|NCT04158583|566236754|FG002|Overall Study|Due To Patient Status|0|||
156858656|NCT04158583|566236755|FG003|Overall Study|Due To Patient Status|0|||
156858657|NCT04158583|566236756|FG004|Overall Study|Due To Patient Status|0|||
156858658|NCT04158583|566236757|FG005|Overall Study|Due To Patient Status|0|||
156858659|NCT04158583|566236758|FG006|Overall Study|Due To Patient Status|0|||
156858660|NCT04158583|566236759|FG007|Overall Study|Due To Patient Status|0|||
156858661|NCT04158583|566236760|FG008|Overall Study|Due To Patient Status|1|||
156858662|NCT04158583|566236761|FG009|Overall Study|Due To Patient Status|0|||
156858663|NCT04158583|566236752|FG000|Overall Study|Death|3|||
156858664|NCT04158583|566236753|FG001|Overall Study|Death|4|||
156858665|NCT04158583|566236754|FG002|Overall Study|Death|2|||
156858666|NCT04158583|566236755|FG003|Overall Study|Death|2|||
156858667|NCT04158583|566236756|FG004|Overall Study|Death|4|||
156858668|NCT04158583|566236757|FG005|Overall Study|Death|3|||
156858669|NCT04158583|566236758|FG006|Overall Study|Death|5|||
156858670|NCT04158583|566236759|FG007|Overall Study|Death|2|||
156858671|NCT04158583|566236760|FG008|Overall Study|Death|0|||
156858672|NCT04158583|566236761|FG009|Overall Study|Death|1|||
156858673|NCT04158583|566236752|FG000|Overall Study|Clinical Progression Disease|0|||
156858674|NCT04158583|566236753|FG001|Overall Study|Clinical Progression Disease|0|||
156858675|NCT04158583|566236754|FG002|Overall Study|Clinical Progression Disease|0|||
156858676|NCT04158583|566236755|FG003|Overall Study|Clinical Progression Disease|1|||
156858677|NCT04158583|566236756|FG004|Overall Study|Clinical Progression Disease|0|||
156858678|NCT04158583|566236757|FG005|Overall Study|Clinical Progression Disease|0|||
156858679|NCT04158583|566236758|FG006|Overall Study|Clinical Progression Disease|0|||
156858680|NCT04158583|566236759|FG007|Overall Study|Clinical Progression Disease|0|||
156858681|NCT04158583|566236760|FG008|Overall Study|Clinical Progression Disease|0|||
156858682|NCT04158583|566236761|FG009|Overall Study|Clinical Progression Disease|0|||
156858683|NCT04158583|566236752|FG000|Overall Study|Clinical Progression|0|||
156858684|NCT04158583|566236753|FG001|Overall Study|Clinical Progression|0|||
156858685|NCT04158583|566236754|FG002|Overall Study|Clinical Progression|0|||
156858686|NCT04158583|566236755|FG003|Overall Study|Clinical Progression|0|||
156858687|NCT04158583|566236756|FG004|Overall Study|Clinical Progression|1|||
156858688|NCT04158583|566236757|FG005|Overall Study|Clinical Progression|0|||
156858689|NCT04158583|566236758|FG006|Overall Study|Clinical Progression|2|||
156858690|NCT04158583|566236759|FG007|Overall Study|Clinical Progression|0|||
156858691|NCT04158583|566236760|FG008|Overall Study|Clinical Progression|0|||
156858692|NCT04158583|566236761|FG009|Overall Study|Clinical Progression|0|||
156896935|NCT01528215|566382224|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
156896936|NCT01528215|566382225|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
156896937|NCT00586066|566382226|FG000|Overall Study|Lost to Follow-up|6|||
156896938|NCT00586066|566382227|FG001|Overall Study|Lost to Follow-up|3|||
156896939|NCT00586066|566382226|FG000|Overall Study|Lack of Efficacy|5|||
156896940|NCT00586066|566382227|FG001|Overall Study|Lack of Efficacy|3|||
156896941|NCT00586066|566382226|FG000|Overall Study|Adverse Event|2|||
156896942|NCT00586066|566382227|FG001|Overall Study|Adverse Event|2|||
156896943|NCT00586066|566382226|FG000|Overall Study|Physician Decision|1|||
156896944|NCT00586066|566382227|FG001|Overall Study|Physician Decision|0|||
156896945|NCT00586066|566382226|FG000|Overall Study|Withdrawal of consent|4|||
156896946|NCT00586066|566382227|FG001|Overall Study|Withdrawal of consent|2|||
156896947|NCT02766465|566382228|FG000|Overall Study|Withdrawal by Subject|0|||
156896948|NCT02766465|566382229|FG001|Overall Study|Withdrawal by Subject|10|||
156896949|NCT01907100|566382230|FG000|Overall Study|PD based on modified RECIST criteria|31|||
156896950|NCT01907100|566382231|FG001|Overall Study|PD based on modified RECIST criteria|32|||
156896951|NCT01907100|566382232|FG002|Overall Study|PD based on modified RECIST criteria|95|||
156896952|NCT01907100|566382233|FG003|Overall Study|PD based on modified RECIST criteria|92|||
156896953|NCT01907100|566382230|FG000|Overall Study|Withdrawal by Subject|2|||
156896954|NCT01907100|566382231|FG001|Overall Study|Withdrawal by Subject|5|||
156896955|NCT01907100|566382232|FG002|Overall Study|Withdrawal by Subject|10|||
156896956|NCT01907100|566382233|FG003|Overall Study|Withdrawal by Subject|13|||
156896957|NCT01907100|566382230|FG000|Overall Study|Protocol Violation|0|||
156896958|NCT01907100|566382231|FG001|Overall Study|Protocol Violation|0|||
156896959|NCT01907100|566382232|FG002|Overall Study|Protocol Violation|1|||
156896960|NCT01907100|566382233|FG003|Overall Study|Protocol Violation|1|||
156896961|NCT01907100|566382230|FG000|Overall Study|Lost to Follow-up|0|||
156896962|NCT01907100|566382231|FG001|Overall Study|Lost to Follow-up|0|||
156896963|NCT01907100|566382232|FG002|Overall Study|Lost to Follow-up|0|||
156896964|NCT01907100|566382233|FG003|Overall Study|Lost to Follow-up|1|||
156896965|NCT01907100|566382230|FG000|Overall Study|Not treated|2|||
156896966|NCT01907100|566382231|FG001|Overall Study|Not treated|0|||
156896967|NCT01907100|566382232|FG002|Overall Study|Not treated|1|||
156896968|NCT01907100|566382233|FG003|Overall Study|Not treated|2|||
156896969|NCT01907100|566382230|FG000|Overall Study|Other than reasons specified|1|||
156896970|NCT01907100|566382231|FG001|Overall Study|Other than reasons specified|0|||
156896971|NCT01907100|566382232|FG002|Overall Study|Other than reasons specified|10|||
156896972|NCT01907100|566382233|FG003|Overall Study|Other than reasons specified|6|||
156896973|NCT01907100|566382230|FG000|Overall Study|Adverse event (AE)|6|||
156896974|NCT01907100|566382231|FG001|Overall Study|Adverse event (AE)|3|||
156896975|NCT01907100|566382232|FG002|Overall Study|Adverse event (AE)|22|||
156896976|NCT01907100|566382233|FG003|Overall Study|Adverse event (AE)|23|||
156896977|NCT01907100|566382230|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
156896978|NCT01907100|566382231|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
156896979|NCT01907100|566382232|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
156896980|NCT01907100|566382233|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
156896981|NCT02567552|566382240|FG000|Overall Study|Adverse Event|0|||
156896982|NCT02567552|566382241|FG001|Overall Study|Adverse Event|1|||
156896983|NCT00171054|566382242|FG000|Overall Study|Protocol Violation|1|||
156896984|NCT00171054|566382243|FG001|Overall Study|Protocol Violation|2|||
156896985|NCT00171054|566382242|FG000|Overall Study|Patient withdrew consent|1|||
156896986|NCT00171054|566382243|FG001|Overall Study|Patient withdrew consent|0|||
156896987|NCT00171054|566382242|FG000|Overall Study|Lost to Follow-up|0|||
156896988|NCT00171054|566382243|FG001|Overall Study|Lost to Follow-up|1|||
156896989|NCT00171054|566382242|FG000|Overall Study|Adverse Event|8|||
156896990|NCT00171054|566382243|FG001|Overall Study|Adverse Event|8|||
156896991|NCT00171054|566382242|FG000|Overall Study|Condition no longer required study drug|0|||
156896992|NCT00171054|566382243|FG001|Overall Study|Condition no longer required study drug|1|||
156896993|NCT00395538|566382244|FG000|Overall Study|Did not re-consent to revised protocol|1|||
156896994|NCT00395538|566382245|FG001|Overall Study|Did not re-consent to revised protocol|10|||
156896995|NCT00395538|566382246|FG002|Overall Study|Did not re-consent to revised protocol|0|||
156896996|NCT00395538|566382244|FG000|Overall Study|FDA partial hold on PTH|0|||
156896997|NCT00395538|566382245|FG001|Overall Study|FDA partial hold on PTH|0|||
156896998|NCT00395538|566382246|FG002|Overall Study|FDA partial hold on PTH|11|||
156896999|NCT00395538|566382244|FG000|Overall Study|Failed screening|0|||
156897000|NCT00395538|566382245|FG001|Overall Study|Failed screening|0|||
156897001|NCT00395538|566382246|FG002|Overall Study|Failed screening|4|||
156897002|NCT00395538|566382244|FG000|Overall Study|Switch to Natpara|0|||
156897003|NCT00395538|566382245|FG001|Overall Study|Switch to Natpara|0|||
156897004|NCT00395538|566382246|FG002|Overall Study|Switch to Natpara|3|||
156897005|NCT00395538|566382244|FG000|Overall Study|Adverse Event|1|||
156897006|NCT00395538|566382245|FG001|Overall Study|Adverse Event|0|||
156897007|NCT00395538|566382246|FG002|Overall Study|Adverse Event|2|||
156897008|NCT00395538|566382244|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
156897009|NCT00395538|566382245|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
156897010|NCT00395538|566382246|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
156897011|NCT00395538|566382244|FG000|Overall Study|Non-compliance with study protocol|0|||
156897012|NCT00395538|566382245|FG001|Overall Study|Non-compliance with study protocol|1|||
156897013|NCT00395538|566382246|FG002|Overall Study|Non-compliance with study protocol|0|||
156897014|NCT00395538|566382244|FG000|Overall Study|PTH resistance|0|||
156897015|NCT00395538|566382245|FG001|Overall Study|PTH resistance|0|||
156897016|NCT00395538|566382246|FG002|Overall Study|PTH resistance|1|||
156897017|NCT00395538|566382244|FG000|Overall Study|Pregnancy|1|||
156897018|NCT00395538|566382245|FG001|Overall Study|Pregnancy|0|||
156897019|NCT00395538|566382246|FG002|Overall Study|Pregnancy|0|||
156897020|NCT00395538|566382244|FG000|Overall Study|Partial recovery of parathyroid function|0|||
156897021|NCT00395538|566382245|FG001|Overall Study|Partial recovery of parathyroid function|0|||
156897022|NCT00395538|566382246|FG002|Overall Study|Partial recovery of parathyroid function|1|||
156897023|NCT00395538|566382244|FG000|Overall Study|Participant elected to discontinue|0|||
156897024|NCT00395538|566382245|FG001|Overall Study|Participant elected to discontinue|0|||
156897025|NCT00395538|566382246|FG002|Overall Study|Participant elected to discontinue|1|||
156897026|NCT04669535|566382248|FG000|Overall Study|Death|1|||
156897027|NCT04669535|566382249|FG001|Overall Study|Death|1|||
156897028|NCT04669535|566382250|FG002|Overall Study|Death|0|||
156897029|NCT04669535|566382251|FG003|Overall Study|Death|0|||
156897030|NCT04382755|566382252|FG000|Overall Study|Withdrawal by Subject|1|||
156897031|NCT04382755|566382253|FG001|Overall Study|Withdrawal by Subject|0|||
156897032|NCT04382755|566382252|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
156897033|NCT04382755|566382253|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
156897034|NCT04382755|566382252|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
156897035|NCT04382755|566382253|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
156897036|NCT00285207|566382263|FG000|Overall Study|Lost to Follow-up|3|||
156897037|NCT00285207|566382264|FG001|Overall Study|Lost to Follow-up|2|||
156897038|NCT00285207|566382263|FG000|Overall Study|Withdrawal by Subject|5|||
156897039|NCT00285207|566382264|FG001|Overall Study|Withdrawal by Subject|2|||
156897040|NCT00285207|566382263|FG000|Overall Study|Pregnancy|1|||
156897041|NCT00285207|566382264|FG001|Overall Study|Pregnancy|1|||
156897042|NCT00285207|566382263|FG000|Overall Study|non-compliance|0|||
156897043|NCT00285207|566382264|FG001|Overall Study|non-compliance|1|||
156897044|NCT03552965|566382265|FG000|Overall Study|Death|1|||
156897045|NCT03552965|566382266|FG001|Overall Study|Death|1|||
156897046|NCT03552965|566382265|FG000|Overall Study|Lost to Follow-up|1|||
156897047|NCT03552965|566382266|FG001|Overall Study|Lost to Follow-up|1|||
156897048|NCT03552965|566382265|FG000|Overall Study|Physician Decision|1|||
156897049|NCT03552965|566382266|FG001|Overall Study|Physician Decision|1|||
156897050|NCT03552965|566382265|FG000|Overall Study|Withdrawal by Subject|0|||
156897051|NCT03552965|566382266|FG001|Overall Study|Withdrawal by Subject|2|||
156897052|NCT03552965|566382265|FG000|Overall Study|Continuation not in patient best interest|1|||
156897053|NCT03552965|566382266|FG001|Overall Study|Continuation not in patient best interest|0|||
156897054|NCT03552965|566382265|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
156897055|NCT03552965|566382266|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
156897056|NCT04571515|566382267|FG000|Overall Study|Physician Decision|0|||
156897057|NCT04571515|566382268|FG001|Overall Study|Physician Decision|0|||
156897058|NCT04571515|566382269|FG002|Overall Study|Physician Decision|0|||
156897059|NCT04571515|566382270|FG003|Overall Study|Physician Decision|0|||
156897060|NCT04571515|566382271|FG004|Overall Study|Physician Decision|1|||
156897061|NCT04571515|566382267|FG000|Overall Study|Withdrawal by Subject|0|||
156897062|NCT04571515|566382268|FG001|Overall Study|Withdrawal by Subject|0|||
156897063|NCT04571515|566382269|FG002|Overall Study|Withdrawal by Subject|0|||
156897064|NCT04571515|566382270|FG003|Overall Study|Withdrawal by Subject|0|||
156897065|NCT04571515|566382271|FG004|Overall Study|Withdrawal by Subject|1|||
156897066|NCT04571515|566382267|FG000|Overall Study|insufficient pain|1|||
156897067|NCT04571515|566382268|FG001|Overall Study|insufficient pain|0|||
156897068|NCT04571515|566382269|FG002|Overall Study|insufficient pain|0|||
156897069|NCT04571515|566382270|FG003|Overall Study|insufficient pain|0|||
156897070|NCT04571515|566382271|FG004|Overall Study|insufficient pain|1|||
156897071|NCT01846104|566383502|FG000|Overall Study|Withdrawal by Subject|1|||
156897072|NCT00331864|566383505|FG000|Overall Study|Adverse Event|30|||
156897073|NCT00331864|566383506|FG001|Overall Study|Adverse Event|1|||
156897074|NCT00331864|566383505|FG000|Overall Study|Lack of Efficacy|4|||
156897075|NCT00331864|566383506|FG001|Overall Study|Lack of Efficacy|0|||
156897076|NCT00331864|566383505|FG000|Overall Study|Protocol Violation|3|||
156897077|NCT00331864|566383506|FG001|Overall Study|Protocol Violation|0|||
156897078|NCT00331864|566383505|FG000|Overall Study|Withdrawal by Subject|10|||
156897079|NCT00331864|566383506|FG001|Overall Study|Withdrawal by Subject|0|||
156897080|NCT00331864|566383505|FG000|Overall Study|Lost to Follow-up|4|||
156897081|NCT00331864|566383506|FG001|Overall Study|Lost to Follow-up|3|||
156897082|NCT00331864|566383505|FG000|Overall Study|Administrative Problems|1|||
156897083|NCT00331864|566383506|FG001|Overall Study|Administrative Problems|0|||
156897084|NCT00331864|566383505|FG000|Overall Study|Death|6|||
156897085|NCT00331864|566383506|FG001|Overall Study|Death|0|||
156897086|NCT01409434|566383507|FG000|Overall Study|Protocol Violation|4|||
156897087|NCT00293215|566383508|FG000|Overall Study|Progressive disease|3|||
156897088|NCT00293215|566383509|FG001|Overall Study|Progressive disease|1|||
156897089|NCT00293215|566383508|FG000|Overall Study|Adverse Event|2|||
156897090|NCT00293215|566383509|FG001|Overall Study|Adverse Event|2|||
156897091|NCT01229371|566383510|FG000|Overall Study|Withdrawal by Subject|0|||
156897092|NCT01229371|566383511|FG001|Overall Study|Withdrawal by Subject|1|||
156897093|NCT01229371|566383512|FG002|Overall Study|Withdrawal by Subject|0|||
156897094|NCT01229371|566383513|FG003|Overall Study|Withdrawal by Subject|0|||
156897095|NCT02213042|566383514|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
156897096|NCT02213042|566383515|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
156897097|NCT02213042|566383516|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
156897098|NCT02213042|566383514|FG000|Overall Study|Adverse Event|2|||
156897099|NCT02213042|566383515|FG001|Overall Study|Adverse Event|1|||
156897100|NCT02213042|566383516|FG002|Overall Study|Adverse Event|0|||
156897101|NCT02213042|566383514|FG000|Overall Study|Withdrawal by Subject|0|||
156897102|NCT02213042|566383515|FG001|Overall Study|Withdrawal by Subject|1|||
156897103|NCT02213042|566383516|FG002|Overall Study|Withdrawal by Subject|1|||
156897104|NCT02213042|566383514|FG000|Overall Study|Protocol Violation|1|||
156897105|NCT02213042|566383515|FG001|Overall Study|Protocol Violation|0|||
156897106|NCT02213042|566383516|FG002|Overall Study|Protocol Violation|0|||
156897107|NCT02213042|566383514|FG000|Overall Study|Investigator discretion|0|||
156897108|NCT02213042|566383515|FG001|Overall Study|Investigator discretion|0|||
156897109|NCT02213042|566383516|FG002|Overall Study|Investigator discretion|1|||
156897110|NCT00761579|566383519|FG000|Overall Study|Adverse Event|10|||
156897111|NCT00761579|566383519|FG000|Overall Study|Death|2|||
156897112|NCT00761579|566383519|FG000|Overall Study|Lack of Efficacy|21|||
156897113|NCT00761579|566383519|FG000|Overall Study|Lost to Follow-up|16|||
156897114|NCT00761579|566383519|FG000|Overall Study|Pregnancy|1|||
156897115|NCT00761579|566383519|FG000|Overall Study|Withdrawal by Subject|34|||
156897116|NCT00761579|566383519|FG000|Overall Study|Lack of compliance|2|||
156897117|NCT00761579|566383519|FG000|Overall Study|Protocol deviation|1|||
156897118|NCT00761579|566383519|FG000|Overall Study|Drug overdose|1|||
156897119|NCT00761579|566383519|FG000|Overall Study|Aggravation of depression|1|||
156897120|NCT00761579|566383519|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
156897121|NCT00761579|566383519|FG000|Overall Study|Lost survey form|1|||
156897122|NCT00761579|566383519|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
156897123|NCT02063880|566383521|FG000|Overall Study|Death|21|||
156897124|NCT02063880|566383522|FG001|Overall Study|Death|18|||
156897125|NCT02063880|566383521|FG000|Overall Study|Lost to Follow-up|7|||
156897126|NCT02063880|566383522|FG001|Overall Study|Lost to Follow-up|7|||
156897127|NCT02063880|566383521|FG000|Overall Study|Ineligible|0|||
156897128|NCT02063880|566383522|FG001|Overall Study|Ineligible|2|||
156897129|NCT02600351|566383523|FG000|Overall Study|Lack of Efficacy|3|||
156897130|NCT02600351|566383524|FG001|Overall Study|Lack of Efficacy|0|||
156897131|NCT02600351|566383525|FG002|Overall Study|Lack of Efficacy|5|||
156897132|NCT02600351|566383526|FG003|Overall Study|Lack of Efficacy|2|||
156897133|NCT02600351|566383523|FG000|Overall Study|Lost to Follow-up|1|||
156897134|NCT02600351|566383524|FG001|Overall Study|Lost to Follow-up|0|||
156897135|NCT02600351|566383525|FG002|Overall Study|Lost to Follow-up|0|||
156897136|NCT02600351|566383526|FG003|Overall Study|Lost to Follow-up|0|||
156897137|NCT02600351|566383523|FG000|Overall Study|Randomized but Not Treated|1|||
156897138|NCT02600351|566383524|FG001|Overall Study|Randomized but Not Treated|0|||
156897139|NCT02600351|566383525|FG002|Overall Study|Randomized but Not Treated|1|||
156897140|NCT02600351|566383526|FG003|Overall Study|Randomized but Not Treated|3|||
156897141|NCT00567593|566383527|FG000|Overall Study|Adverse Event|1|||
156897142|NCT00567593|566383527|FG000|Overall Study|Physician Decision|1|||
156897143|NCT02106910|566383530|FG000|Overall Study|Lost to Follow-up|1|||
156897144|NCT02106910|566383531|FG001|Overall Study|Lost to Follow-up|1|||
156897145|NCT02476422|566383532|FG000|Overall Study|Subject/guardian decision|0|||
156897146|NCT02476422|566383533|FG001|Overall Study|Subject/guardian decision|1|||
156897147|NCT03960554|566383539|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
156897148|NCT03960554|566383540|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
156897149|NCT02545075|566383543|FG000|Randomization|Lost to Follow-up|0|||
156897150|NCT02545075|566383544|FG001|Randomization|Lost to Follow-up|1|||
157026153|NCT03365882|566849729|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
157026154|NCT03365882|566849728|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
156897151|NCT02545075|566383543|FG000|Randomization|Withdrawal by Subject|0|||
156897152|NCT02545075|566383544|FG001|Randomization|Withdrawal by Subject|6|||
156897153|NCT02545075|566383543|FG000|Treatment|Disease progression|71|||
156897154|NCT02545075|566383544|FG001|Treatment|Disease progression|32|||
156897155|NCT02545075|566383543|FG000|Treatment|Participant dicontinued study treatment|7|||
156897156|NCT02545075|566383544|FG001|Treatment|Participant dicontinued study treatment|9|||
156897157|NCT02545075|566383543|FG000|Treatment|Withdrawal by Subject|1|||
156897158|NCT02545075|566383544|FG001|Treatment|Withdrawal by Subject|0|||
156897159|NCT02545075|566383543|FG000|Treatment|Adverse event not related to study drug|1|||
156897160|NCT02545075|566383544|FG001|Treatment|Adverse event not related to study drug|0|||
156897161|NCT02545075|566383543|FG000|Treatment|Death|1|||
156897162|NCT02545075|566383544|FG001|Treatment|Death|0|||
156897163|NCT02545075|566383543|FG000|Treatment|Participant drug toxicity|1|||
156897164|NCT02545075|566383544|FG001|Treatment|Participant drug toxicity|0|||
157026155|NCT03365882|566849729|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
157026156|NCT04437615|566849730|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
157026157|NCT04828005|566849731|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
157026158|NCT04828005|566849732|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
157026159|NCT04828005|566849733|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
156897165|NCT02545075|566383543|FG000|Treatment|Completed treatment|40|||
156897166|NCT02545075|566383544|FG001|Treatment|Completed treatment|12|||
156897167|NCT01272661|566383554|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
156897168|NCT01272661|566383555|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
156897169|NCT01272661|566383556|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
156897170|NCT01086423|566383557|FG000|Overall Study|Protocol Violation|0|||
156897171|NCT01086423|566383558|FG001|Overall Study|Protocol Violation|0|||
156897172|NCT01086423|566383559|FG002|Overall Study|Protocol Violation|1|||
156897173|NCT01086423|566383557|FG000|Overall Study|Migrated/moved from study area|2|||
156897174|NCT01086423|566383558|FG001|Overall Study|Migrated/moved from study area|0|||
156897175|NCT01086423|566383559|FG002|Overall Study|Migrated/moved from study area|4|||
156897176|NCT01086423|566383557|FG000|Overall Study|Adverse event, fatal|1|||
156897177|NCT01086423|566383558|FG001|Overall Study|Adverse event, fatal|1|||
156897178|NCT01086423|566383559|FG002|Overall Study|Adverse event, fatal|0|||
156897179|NCT01086423|566383557|FG000|Overall Study|Adverse event, non-fatal|2|||
156897180|NCT01086423|566383558|FG001|Overall Study|Adverse event, non-fatal|1|||
156897181|NCT01086423|566383559|FG002|Overall Study|Adverse event, non-fatal|0|||
156897182|NCT01086423|566383557|FG000|Overall Study|Withdrawal by Subject|5|||
156897183|NCT01086423|566383558|FG001|Overall Study|Withdrawal by Subject|1|||
156897184|NCT01086423|566383559|FG002|Overall Study|Withdrawal by Subject|3|||
156897185|NCT01086423|566383557|FG000|Overall Study|Lost to Follow-up|0|||
156897186|NCT01086423|566383558|FG001|Overall Study|Lost to Follow-up|0|||
156897187|NCT01086423|566383559|FG002|Overall Study|Lost to Follow-up|1|||
156897188|NCT00925990|566383560|FG000|Overall Study|Adverse Event|1|||
156897189|NCT00925990|566383561|FG001|Overall Study|Adverse Event|3|||
156897190|NCT00925990|566383560|FG000|Overall Study|Withdrawal by Subject|2|||
156897191|NCT00925990|566383561|FG001|Overall Study|Withdrawal by Subject|2|||
156897192|NCT00925990|566383560|FG000|Overall Study|Lost to Follow-up|1|||
156897193|NCT00925990|566383561|FG001|Overall Study|Lost to Follow-up|3|||
156897194|NCT00925990|566383560|FG000|Overall Study|Physician Decision|1|||
156897195|NCT00925990|566383561|FG001|Overall Study|Physician Decision|1|||
156897196|NCT00925990|566383560|FG000|Overall Study|moved out of state, missed medication|0|||
156897197|NCT00925990|566383561|FG001|Overall Study|moved out of state, missed medication|2|||
156897198|NCT00750880|566383562|FG000|Overall Study|Adverse Event|76|||
156897199|NCT00750880|566383562|FG000|Overall Study|Death|4|||
156897200|NCT00750880|566383562|FG000|Overall Study|Lack of Efficacy|46|||
156897201|NCT00750880|566383562|FG000|Overall Study|Lost to Follow-up|10|||
156897202|NCT00750880|566383562|FG000|Overall Study|Protocol Violation|15|||
156897203|NCT00750880|566383562|FG000|Overall Study|Withdrawal by Subject|33|||
156897204|NCT00750880|566383562|FG000|Overall Study|Physician Decision|20|||
156897205|NCT00750880|566383562|FG000|Overall Study|Administrative|11|||
156897206|NCT01123850|566383567|FG000|Overall Study|Slow enrollment|45|||
156897207|NCT02314143|566383569|FG000|Overall Study|Adverse Event|0|||
156897208|NCT02314143|566383570|FG001|Overall Study|Adverse Event|6|||
156897209|NCT02314143|566383571|FG002|Overall Study|Adverse Event|4|||
156897210|NCT02314143|566383569|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
156897211|NCT02314143|566383570|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
156897212|NCT02314143|566383571|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
156897213|NCT02314143|566383569|FG000|Overall Study|Physician Decision|2|||
156897214|NCT02314143|566383570|FG001|Overall Study|Physician Decision|1|||
156897215|NCT02314143|566383571|FG002|Overall Study|Physician Decision|0|||
156897216|NCT02314143|566383569|FG000|Overall Study|Withdrawal by Subject|1|||
156897217|NCT02314143|566383570|FG001|Overall Study|Withdrawal by Subject|0|||
156897218|NCT02314143|566383571|FG002|Overall Study|Withdrawal by Subject|1|||
156897219|NCT03963401|566383573|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
157026160|NCT04828005|566849734|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
157026161|NCT04828005|566849731|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
156897220|NCT03963401|566383574|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
156897221|NCT03963401|566383575|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
156897222|NCT03963401|566383576|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
156897223|NCT03963401|566383577|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
156897224|NCT03963401|566383578|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
156897225|NCT03963401|566383573|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156897226|NCT03963401|566383574|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156897227|NCT03963401|566383575|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
156897228|NCT03963401|566383576|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
156897229|NCT03963401|566383577|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
157158298|NCT01327651|567324554|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
157158299|NCT01327651|567324555|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
157158300|NCT01327651|567324547|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
157158301|NCT01327651|567324548|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156897230|NCT03963401|566383578|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
156897231|NCT03963401|566383573|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
156897232|NCT03963401|566383574|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156897233|NCT03963401|566383575|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156897234|NCT03963401|566383576|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
156897235|NCT03963401|566383577|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
156897236|NCT03963401|566383578|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
156897237|NCT03963401|566383573|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156897238|NCT03963401|566383574|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
156897239|NCT03963401|566383575|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156897240|NCT03963401|566383576|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156897241|NCT03963401|566383577|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156897242|NCT03963401|566383578|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
156897243|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
156897244|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
156897245|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
156897246|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
156897247|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
156897248|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
156897249|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
156897250|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156897251|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
156897252|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156897253|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156897254|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
156897255|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156897256|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156897257|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
156897258|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156897259|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156897260|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
156897261|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
156897262|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156897263|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156897264|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156897265|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156897266|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
156897267|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
156897268|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156897269|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
156897270|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
156897271|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156897272|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
156897273|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
156897274|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156897275|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156897276|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156897277|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156897278|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
156897279|NCT03963401|566383573|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
156897280|NCT03963401|566383574|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
156897281|NCT03963401|566383575|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
156897282|NCT03963401|566383576|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
156897283|NCT03963401|566383577|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
156897284|NCT03963401|566383578|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
156897285|NCT01476644|566383579|FG000|Overall Study|Death|5|||
156897286|NCT01476644|566383579|FG000|Overall Study|moved to another state|2|||
157158302|NCT01327651|567324549|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156897287|NCT01476644|566383579|FG000|Overall Study|Lost to Follow-up|19|||
156897288|NCT01476644|566383579|FG000|Overall Study|Withdrawal by Subject|13|||
156897289|NCT00471146|566383580|FG000|Overall Study|Adverse Event|32|||
156897290|NCT00471146|566383581|FG001|Overall Study|Adverse Event|33|||
156897291|NCT00471146|566383580|FG000|Overall Study|Withdrawal by Subject|14|||
156897292|NCT00471146|566383581|FG001|Overall Study|Withdrawal by Subject|11|||
156897293|NCT00471146|566383580|FG000|Overall Study|Death|11|||
156897294|NCT00471146|566383581|FG001|Overall Study|Death|12|||
156897295|NCT00471146|566383580|FG000|Overall Study|Lost to Follow-up|4|||
156897296|NCT00471146|566383581|FG001|Overall Study|Lost to Follow-up|2|||
156897297|NCT00471146|566383580|FG000|Overall Study|Protocol Violation|2|||
156897298|NCT00471146|566383581|FG001|Overall Study|Protocol Violation|2|||
156897299|NCT00471146|566383580|FG000|Overall Study|Objective progression or relapse|84|||
156897300|NCT00471146|566383581|FG001|Overall Study|Objective progression or relapse|87|||
156897301|NCT00471146|566383580|FG000|Overall Study|Global deterioration of health status|12|||
156897302|NCT00471146|566383581|FG001|Overall Study|Global deterioration of health status|14|||
156897303|NCT00471146|566383580|FG000|Overall Study|Randomized but not treated|9|||
156897304|NCT00471146|566383581|FG001|Overall Study|Randomized but not treated|8|||
156897305|NCT00471146|566383580|FG000|Overall Study|Other|4|||
156897306|NCT00471146|566383581|FG001|Overall Study|Other|5|||
156897307|NCT02676466|566383582|FG000|Overall Study|Death|0|||
156897308|NCT02676466|566383583|FG001|Overall Study|Death|2|||
156897309|NCT02676466|566383584|FG002|Overall Study|Death|1|||
156897310|NCT02676466|566383585|FG003|Overall Study|Death|0|||
156897311|NCT02676466|566383586|FG004|Overall Study|Death|0|||
156897312|NCT02676466|566383587|FG005|Overall Study|Death|0|||
156897313|NCT02676466|566383588|FG006|Overall Study|Death|0|||
156897314|NCT02676466|566383589|FG007|Overall Study|Death|0|||
156897315|NCT02676466|566383582|FG000|Overall Study|Withdrawal by Subject|4|||
156897316|NCT02676466|566383583|FG001|Overall Study|Withdrawal by Subject|3|||
156897317|NCT02676466|566383584|FG002|Overall Study|Withdrawal by Subject|1|||
156897318|NCT02676466|566383585|FG003|Overall Study|Withdrawal by Subject|0|||
156897319|NCT02676466|566383586|FG004|Overall Study|Withdrawal by Subject|3|||
156897320|NCT02676466|566383587|FG005|Overall Study|Withdrawal by Subject|1|||
156897321|NCT02676466|566383588|FG006|Overall Study|Withdrawal by Subject|1|||
156897322|NCT02676466|566383589|FG007|Overall Study|Withdrawal by Subject|1|||
156897323|NCT01090973|566383597|FG000|Overall Study|Disease progression|1|||
156897324|NCT00445978|566383598|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
156897325|NCT00445978|566383598|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
156897326|NCT00445978|566383598|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
156897327|NCT00445978|566383598|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
156897328|NCT00445978|566383598|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
156897329|NCT00445978|566383598|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
156897330|NCT00445978|566383598|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
156897331|NCT00445978|566383598|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
156897332|NCT00445978|566383598|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
156897333|NCT02059005|566383599|FG000|Overall Study|Death|1|||
156897334|NCT02059005|566383600|FG001|Overall Study|Death|3|||
156897335|NCT02059005|566383599|FG000|Overall Study|Lost to Follow-up|19|||
156897336|NCT02059005|566383600|FG001|Overall Study|Lost to Follow-up|19|||
156897337|NCT02059005|566383599|FG000|Overall Study|Incarceration|0|||
156897338|NCT02059005|566383600|FG001|Overall Study|Incarceration|1|||
156897339|NCT02059005|566383599|FG000|Overall Study|Inpatient|0|||
156897340|NCT02059005|566383600|FG001|Overall Study|Inpatient|1|||
156897341|NCT00908011|566383601|FG000|Overall Study|Withdrawal by Subject|2|||
156897342|NCT00908011|566383602|FG001|Overall Study|Withdrawal by Subject|2|||
156897343|NCT00739596|566383603|FG000|Overall Study|Adverse Event|12|||
157026162|NCT04828005|566849732|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
157026163|NCT04828005|566849733|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
157026164|NCT04828005|566849734|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
157026165|NCT04828005|566849731|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
157026166|NCT04828005|566849732|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
157026167|NCT04828005|566849733|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
157158303|NCT01327651|567324550|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
157158304|NCT01327651|567324551|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156897344|NCT00739596|566383604|FG001|Overall Study|Adverse Event|6|||
156897345|NCT00739596|566383603|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
156897346|NCT00739596|566383604|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
156897347|NCT00739596|566383603|FG000|Overall Study|Patient Withdrew Consent|8|||
156897348|NCT00739596|566383604|FG001|Overall Study|Patient Withdrew Consent|8|||
156897349|NCT00739596|566383603|FG000|Overall Study|Lost to Follow-up|0|||
156897350|NCT00739596|566383604|FG001|Overall Study|Lost to Follow-up|2|||
156897351|NCT00739596|566383603|FG000|Overall Study|Protocol Deviation|1|||
156897352|NCT00739596|566383604|FG001|Overall Study|Protocol Deviation|1|||
156897353|NCT00843726|566383609|FG000|Overall Study|Death|1|||
156897354|NCT00843726|566383610|FG001|Overall Study|Death|0|||
156897355|NCT00843726|566383609|FG000|Overall Study|Withdrawal by Subject|0|||
156897356|NCT00843726|566383610|FG001|Overall Study|Withdrawal by Subject|1|||
156897357|NCT02520661|566383611|FG000|Overall Study|Lost to Follow-up|7|||
156897358|NCT02520661|566383612|FG001|Overall Study|Lost to Follow-up|3|||
156897359|NCT02520661|566383611|FG000|Overall Study|Admitted from ED|49|||
156897360|NCT02520661|566383612|FG001|Overall Study|Admitted from ED|48|||
156897361|NCT02520661|566383611|FG000|Overall Study|ED greater than 24 hours|29|||
156897362|NCT02520661|566383612|FG001|Overall Study|ED greater than 24 hours|38|||
156897363|NCT02520661|566383611|FG000|Overall Study|other ineligibility|14|||
156897364|NCT02520661|566383612|FG001|Overall Study|other ineligibility|22|||
156897365|NCT02520661|566383611|FG000|Overall Study|Withdrawal by Subject|7|||
156897366|NCT02520661|566383612|FG001|Overall Study|Withdrawal by Subject|16|||
156897367|NCT01857583|566383615|FG000|Overall Study|Adverse Event|0|||
156897368|NCT01857583|566383616|FG001|Overall Study|Adverse Event|0|||
156897369|NCT01857583|566383617|FG002|Overall Study|Adverse Event|1|||
156897370|NCT01857583|566383618|FG003|Overall Study|Adverse Event|1|||
156897371|NCT01857583|566383615|FG000|Overall Study|Death|0|||
156897372|NCT01857583|566383616|FG001|Overall Study|Death|1|||
156897373|NCT01857583|566383617|FG002|Overall Study|Death|1|||
156897374|NCT01857583|566383618|FG003|Overall Study|Death|0|||
156897375|NCT01857583|566383615|FG000|Overall Study|Physician Decision|0|||
156897376|NCT01857583|566383616|FG001|Overall Study|Physician Decision|0|||
156897377|NCT01857583|566383617|FG002|Overall Study|Physician Decision|0|||
156897378|NCT01857583|566383618|FG003|Overall Study|Physician Decision|1|||
156897379|NCT01857583|566383615|FG000|Overall Study|Withdrawal by Subject|1|||
156897380|NCT01857583|566383616|FG001|Overall Study|Withdrawal by Subject|0|||
156897381|NCT01857583|566383617|FG002|Overall Study|Withdrawal by Subject|1|||
156897382|NCT01857583|566383618|FG003|Overall Study|Withdrawal by Subject|2|||
156897383|NCT02007512|566385091|FG000|Double Blind Treatment Period|Adverse Event|4|||
156897384|NCT02007512|566385092|FG001|Double Blind Treatment Period|Adverse Event|6|||
156897385|NCT02007512|566385093|FG002|Double Blind Treatment Period|Adverse Event|2|||
156897386|NCT02007512|566385094|FG003|Double Blind Treatment Period|Adverse Event|2|||
156897387|NCT02007512|566385091|FG000|Double Blind Treatment Period|Death|1|||
156897388|NCT02007512|566385092|FG001|Double Blind Treatment Period|Death|0|||
156897389|NCT02007512|566385093|FG002|Double Blind Treatment Period|Death|0|||
156897390|NCT02007512|566385094|FG003|Double Blind Treatment Period|Death|0|||
156897391|NCT02007512|566385091|FG000|Double Blind Treatment Period|Disease progression|51|||
156897392|NCT02007512|566385092|FG001|Double Blind Treatment Period|Disease progression|50|||
156897393|NCT02007512|566385093|FG002|Double Blind Treatment Period|Disease progression|57|||
156897394|NCT02007512|566385094|FG003|Double Blind Treatment Period|Disease progression|52|||
156897395|NCT02007512|566385091|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
156897396|NCT02007512|566385092|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
156897397|NCT02007512|566385093|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
156897398|NCT02007512|566385094|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
156897399|NCT02007512|566385091|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156897400|NCT02007512|566385092|FG001|Double Blind Treatment Period|Protocol Violation|0|||
156897401|NCT02007512|566385093|FG002|Double Blind Treatment Period|Protocol Violation|0|||
156897402|NCT02007512|566385094|FG003|Double Blind Treatment Period|Protocol Violation|1|||
156897403|NCT02007512|566385091|FG000|Double Blind Treatment Period|Other|2|||
156897404|NCT02007512|566385092|FG001|Double Blind Treatment Period|Other|1|||
156897405|NCT02007512|566385093|FG002|Double Blind Treatment Period|Other|1|||
156897406|NCT02007512|566385094|FG003|Double Blind Treatment Period|Other|2|||
156897407|NCT02007512|566385091|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
156897408|NCT02007512|566385092|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
156897409|NCT02007512|566385093|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
156897410|NCT02007512|566385094|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
156897411|NCT02007512|566385091|FG000|Open Label Treatment Period|Adverse Event|1|||
156897412|NCT02007512|566385092|FG001|Open Label Treatment Period|Adverse Event|0|||
156897413|NCT02007512|566385093|FG002|Open Label Treatment Period|Adverse Event|0|||
156897414|NCT02007512|566385094|FG003|Open Label Treatment Period|Adverse Event|0|||
156897415|NCT02007512|566385091|FG000|Open Label Treatment Period|Other|1|||
156897416|NCT02007512|566385092|FG001|Open Label Treatment Period|Other|1|||
156897417|NCT02007512|566385093|FG002|Open Label Treatment Period|Other|0|||
156897418|NCT02007512|566385094|FG003|Open Label Treatment Period|Other|0|||
156897419|NCT02007512|566385091|FG000|Open Label Treatment Period|Disease progression|23|||
156897420|NCT02007512|566385092|FG001|Open Label Treatment Period|Disease progression|11|||
156897421|NCT02007512|566385093|FG002|Open Label Treatment Period|Disease progression|0|||
156897422|NCT02007512|566385094|FG003|Open Label Treatment Period|Disease progression|0|||
156897423|NCT03611010|566385095|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
156897424|NCT03611010|566385096|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156897425|NCT03611010|566385097|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156897426|NCT03611010|566385098|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
156897427|NCT02413372|566385103|FG000|Treatment|Lost to Follow-up|0|||
156897428|NCT02413372|566385104|FG001|Treatment|Lost to Follow-up|2|||
156897429|NCT02413372|566385105|FG002|Treatment|Lost to Follow-up|1|||
156897430|NCT02413372|566385103|FG000|Treatment|Withdrawal by Subject|1|||
156897431|NCT02413372|566385104|FG001|Treatment|Withdrawal by Subject|0|||
156897432|NCT02413372|566385105|FG002|Treatment|Withdrawal by Subject|0|||
156897433|NCT02413372|566385103|FG000|Follow-up|Lost to Follow-up|1|||
156897434|NCT02413372|566385104|FG001|Follow-up|Lost to Follow-up|1|||
156897435|NCT02413372|566385105|FG002|Follow-up|Lost to Follow-up|0|||
156897436|NCT02413372|566385103|FG000|Follow-up|Subject Withdrew Consent|1|||
156897437|NCT02413372|566385104|FG001|Follow-up|Subject Withdrew Consent|0|||
156897438|NCT02413372|566385105|FG002|Follow-up|Subject Withdrew Consent|1|||
156897439|NCT02413372|566385103|FG000|Follow-up|Subject unable to return for visit|0|||
156897440|NCT02413372|566385104|FG001|Follow-up|Subject unable to return for visit|0|||
156897441|NCT02413372|566385105|FG002|Follow-up|Subject unable to return for visit|1|||
156897442|NCT00760214|566385112|FG000|Overall Study|Adverse Event|8|||
156897443|NCT00760214|566385113|FG001|Overall Study|Adverse Event|9|||
156897444|NCT00760214|566385114|FG002|Overall Study|Adverse Event|12|||
156897445|NCT00760214|566385112|FG000|Overall Study|Protocol Violation|3|||
156897446|NCT00760214|566385113|FG001|Overall Study|Protocol Violation|0|||
156897447|NCT00760214|566385114|FG002|Overall Study|Protocol Violation|3|||
156897448|NCT00760214|566385112|FG000|Overall Study|Lost to Follow-up|0|||
156897449|NCT00760214|566385113|FG001|Overall Study|Lost to Follow-up|0|||
156897450|NCT00760214|566385114|FG002|Overall Study|Lost to Follow-up|1|||
156897451|NCT00760214|566385112|FG000|Overall Study|Withdrawal by Subject|12|||
156897452|NCT00760214|566385113|FG001|Overall Study|Withdrawal by Subject|14|||
156897453|NCT00760214|566385114|FG002|Overall Study|Withdrawal by Subject|13|||
156897454|NCT00760214|566385112|FG000|Overall Study|Lack of Efficacy|3|||
156897455|NCT00760214|566385113|FG001|Overall Study|Lack of Efficacy|2|||
156897456|NCT00760214|566385114|FG002|Overall Study|Lack of Efficacy|4|||
156897457|NCT00760214|566385112|FG000|Overall Study|Pregnancy|0|||
156897458|NCT00760214|566385113|FG001|Overall Study|Pregnancy|0|||
156897459|NCT00760214|566385114|FG002|Overall Study|Pregnancy|1|||
156897460|NCT00760214|566385112|FG000|Overall Study|Physician Decision|1|||
156897461|NCT00760214|566385113|FG001|Overall Study|Physician Decision|1|||
156897462|NCT00760214|566385114|FG002|Overall Study|Physician Decision|1|||
156897463|NCT00760214|566385112|FG000|Overall Study|Other|3|||
156897464|NCT00760214|566385113|FG001|Overall Study|Other|4|||
156897465|NCT00760214|566385114|FG002|Overall Study|Other|6|||
156897466|NCT00700570|566385115|FG000|Overall Study|Adverse Event|2|||
156897467|NCT00700570|566385116|FG001|Overall Study|Adverse Event|6|||
156897468|NCT00700570|566385115|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
156897469|NCT00700570|566385116|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
156897470|NCT00700570|566385115|FG000|Overall Study|Disease Progression|8|||
156897471|NCT00700570|566385116|FG001|Overall Study|Disease Progression|11|||
156897472|NCT00700570|566385115|FG000|Overall Study|Withdrawal by Subject|1|||
156897473|NCT00700570|566385116|FG001|Overall Study|Withdrawal by Subject|6|||
156897474|NCT01134315|566385117|FG000|Overall Study|Adverse Event|1|||
156897475|NCT01134315|566385118|FG001|Overall Study|Adverse Event|2|||
156897476|NCT01134315|566385117|FG000|Overall Study|Other Reason|8|||
156897477|NCT01134315|566385118|FG001|Overall Study|Other Reason|17|||
156897478|NCT04587271|566385119|FG000|Overall Study|Lost to Follow-up|2|||
156897479|NCT04587271|566385120|FG001|Overall Study|Lost to Follow-up|2|||
156897480|NCT04587271|566385121|FG002|Overall Study|Lost to Follow-up|0|||
156897481|NCT04587271|566385122|FG003|Overall Study|Lost to Follow-up|2|||
156897482|NCT04587271|566385123|FG004|Overall Study|Lost to Follow-up|2|||
156897483|NCT04587271|566385124|FG005|Overall Study|Lost to Follow-up|0|||
156897484|NCT04587271|566385119|FG000|Overall Study|Caregiver brought child to visits|0|||
156897485|NCT04587271|566385120|FG001|Overall Study|Caregiver brought child to visits|0|||
156897486|NCT04587271|566385121|FG002|Overall Study|Caregiver brought child to visits|0|||
156897487|NCT04587271|566385122|FG003|Overall Study|Caregiver brought child to visits|1|||
156897488|NCT04587271|566385123|FG004|Overall Study|Caregiver brought child to visits|0|||
156897489|NCT04587271|566385124|FG005|Overall Study|Caregiver brought child to visits|0|||
156897490|NCT02360111|566385125|FG000|Overall Study|Death|2|||
156897491|NCT02180165|566385126|FG000|Overall Study|Not Treated|0|||
156897492|NCT02180165|566385127|FG001|Overall Study|Not Treated|0|||
157026168|NCT04828005|566849734|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
156897493|NCT02180165|566385128|FG002|Overall Study|Not Treated|1|||
156897494|NCT02180165|566385129|FG003|Overall Study|Not Treated|0|||
156897495|NCT02180165|566385126|FG000|Overall Study|Adverse Event|7|||
156897496|NCT02180165|566385127|FG001|Overall Study|Adverse Event|0|||
156897497|NCT02180165|566385128|FG002|Overall Study|Adverse Event|18|||
156897498|NCT02180165|566385129|FG003|Overall Study|Adverse Event|3|||
156897499|NCT02180165|566385126|FG000|Overall Study|Lack of Efficacy|0|||
156897500|NCT02180165|566385127|FG001|Overall Study|Lack of Efficacy|1|||
156897501|NCT02180165|566385128|FG002|Overall Study|Lack of Efficacy|3|||
156897502|NCT02180165|566385129|FG003|Overall Study|Lack of Efficacy|2|||
156897503|NCT02180165|566385126|FG000|Overall Study|Physician Decision|1|||
157026169|NCT04828005|566849731|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
156897504|NCT02180165|566385127|FG001|Overall Study|Physician Decision|0|||
156897505|NCT02180165|566385128|FG002|Overall Study|Physician Decision|5|||
156897506|NCT02180165|566385129|FG003|Overall Study|Physician Decision|0|||
156897507|NCT02180165|566385126|FG000|Overall Study|Withdrawal by Subject|3|||
156897508|NCT02180165|566385127|FG001|Overall Study|Withdrawal by Subject|0|||
156897509|NCT02180165|566385128|FG002|Overall Study|Withdrawal by Subject|2|||
156897510|NCT02180165|566385129|FG003|Overall Study|Withdrawal by Subject|1|||
156897511|NCT01933217|566385130|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
156897512|NCT01933217|566385131|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
156897513|NCT01933217|566385130|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
156897514|NCT01933217|566385131|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
156897515|NCT03923738|566385135|FG000|Period 1|Adverse Event|1|||
156897516|NCT03923738|566385135|FG000|Period 1|Withdrawal by Subject|1|||
156897517|NCT05246397|566385136|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
156897518|NCT03875768|566385137|FG000|Overall Study|Lost to Follow-up|16|||
156897519|NCT03875768|566385138|FG001|Overall Study|Lost to Follow-up|13|||
156897520|NCT03875768|566385137|FG000|Overall Study|Withdrawal by Subject|10|||
156897521|NCT03875768|566385138|FG001|Overall Study|Withdrawal by Subject|21|||
156897522|NCT03875768|566385137|FG000|Overall Study|Did not complete assessment|21|||
156897523|NCT03875768|566385138|FG001|Overall Study|Did not complete assessment|12|||
156897524|NCT03875768|566385137|FG000|Overall Study|Became ineligible|1|||
156897525|NCT03875768|566385138|FG001|Overall Study|Became ineligible|0|||
156897526|NCT01925274|566385139|FG000|Overall Study|Death|1|||
156897527|NCT01925274|566385140|FG001|Overall Study|Death|0|||
156897528|NCT01925274|566385141|FG002|Overall Study|Death|0|||
156897529|NCT01925274|566385139|FG000|Overall Study|Lost to Follow-up|0|||
156897530|NCT01925274|566385140|FG001|Overall Study|Lost to Follow-up|1|||
156897531|NCT01925274|566385141|FG002|Overall Study|Lost to Follow-up|0|||
156897532|NCT01925274|566385139|FG000|Overall Study|Withdrawal by Subject|1|||
156897533|NCT01925274|566385140|FG001|Overall Study|Withdrawal by Subject|2|||
156897534|NCT01925274|566385141|FG002|Overall Study|Withdrawal by Subject|0|||
156897535|NCT01925274|566385139|FG000|Overall Study|Study terminated by sponsor|4|||
156897536|NCT01925274|566385140|FG001|Overall Study|Study terminated by sponsor|0|||
156897537|NCT01925274|566385141|FG002|Overall Study|Study terminated by sponsor|0|||
156897538|NCT01925274|566385139|FG000|Overall Study|Protocol amendment|1|||
156897539|NCT01925274|566385140|FG001|Overall Study|Protocol amendment|3|||
156897540|NCT01925274|566385141|FG002|Overall Study|Protocol amendment|6|||
156897541|NCT04327674|566385143|FG000|Overall Study|Protocol Violation|19|||
156897542|NCT00723398|566385148|FG000|Overall Study|Withdrawal by Subject|2|||
156897543|NCT00723398|566385149|FG001|Overall Study|Withdrawal by Subject|6|||
156897544|NCT00723398|566385150|FG002|Overall Study|Withdrawal by Subject|4|||
156897545|NCT00723398|566385151|FG003|Overall Study|Withdrawal by Subject|4|||
156897546|NCT00723398|566385152|FG004|Overall Study|Withdrawal by Subject|4|||
156897547|NCT00723398|566385148|FG000|Overall Study|Protocol Violation|2|||
156897548|NCT00723398|566385149|FG001|Overall Study|Protocol Violation|1|||
156897549|NCT00723398|566385150|FG002|Overall Study|Protocol Violation|5|||
156897550|NCT00723398|566385151|FG003|Overall Study|Protocol Violation|0|||
156897551|NCT00723398|566385152|FG004|Overall Study|Protocol Violation|0|||
156897552|NCT00723398|566385148|FG000|Overall Study|Physician Decision|2|||
156897553|NCT00723398|566385149|FG001|Overall Study|Physician Decision|2|||
156897554|NCT00723398|566385150|FG002|Overall Study|Physician Decision|5|||
156897555|NCT00723398|566385151|FG003|Overall Study|Physician Decision|0|||
156897556|NCT00723398|566385152|FG004|Overall Study|Physician Decision|1|||
156897557|NCT00723398|566385148|FG000|Overall Study|Adverse Event|0|||
156897558|NCT00723398|566385149|FG001|Overall Study|Adverse Event|5|||
156897559|NCT00723398|566385150|FG002|Overall Study|Adverse Event|3|||
156897560|NCT00723398|566385151|FG003|Overall Study|Adverse Event|1|||
156897561|NCT00723398|566385152|FG004|Overall Study|Adverse Event|4|||
156897562|NCT00723398|566385148|FG000|Overall Study|Lost to Follow-up|0|||
156897563|NCT00723398|566385149|FG001|Overall Study|Lost to Follow-up|1|||
156897564|NCT00723398|566385150|FG002|Overall Study|Lost to Follow-up|0|||
156897565|NCT00723398|566385151|FG003|Overall Study|Lost to Follow-up|0|||
156897566|NCT00723398|566385152|FG004|Overall Study|Lost to Follow-up|0|||
156897567|NCT00267189|566385153|FG000|Overall Study|Patient withdrew consent|1|||
156897568|NCT00267189|566385154|FG001|Overall Study|Patient withdrew consent|1|||
156897569|NCT00267189|566385153|FG000|Overall Study|Death|1|||
156897570|NCT00267189|566385154|FG001|Overall Study|Death|0|||
156897571|NCT00267189|566385153|FG000|Overall Study|Missing|3|||
157158305|NCT01327651|567324552|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156897572|NCT00267189|566385154|FG001|Overall Study|Missing|0|||
157158306|NCT01327651|567324553|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
156897573|NCT00751621|566385155|FG000|Overall Study|Adverse Event|1|||
156897574|NCT00751621|566385155|FG000|Overall Study|Withdrawal by Subject|1|||
156897575|NCT00751621|566385155|FG000|Overall Study|Subject moved to another country|1|||
156897576|NCT00751621|566385155|FG000|Overall Study|Poor adherence to asthma treatment|1|||
156897577|NCT01225887|566385159|FG000|Overall Study|Ineligible:required test not done|2|||
156897578|NCT01225887|566385159|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
156897579|NCT01225887|566385159|FG000|Overall Study|Ineligible:inadequate pathology|2|||
156897580|NCT01400815|566385167|FG000|Overall Study|Adverse Event|3|||
156897581|NCT01400815|566385168|FG001|Overall Study|Adverse Event|0|||
156897582|NCT01400815|566385167|FG000|Overall Study|Death|0|||
156897583|NCT01400815|566385168|FG001|Overall Study|Death|1|||
156897584|NCT01400815|566385167|FG000|Overall Study|Lost to Follow-up|18|||
157158307|NCT01327651|567324554|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
157158308|NCT01327651|567324555|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
157158309|NCT01327651|567324547|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
157158310|NCT01327651|567324548|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
157158311|NCT01327651|567324549|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
157158312|NCT01327651|567324550|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
157158313|NCT01327651|567324551|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
157158314|NCT01327651|567324552|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
157158315|NCT01327651|567324553|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
157158316|NCT01327651|567324554|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
157158317|NCT01327651|567324555|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
157158318|NCT01327651|567324547|FG000|Post Study Follow-up|Lost to Follow-up|0|||
157158319|NCT01327651|567324548|FG001|Post Study Follow-up|Lost to Follow-up|1|||
157158320|NCT01327651|567324549|FG002|Post Study Follow-up|Lost to Follow-up|1|||
157158321|NCT01327651|567324550|FG003|Post Study Follow-up|Lost to Follow-up|0|||
157158322|NCT01327651|567324551|FG004|Post Study Follow-up|Lost to Follow-up|0|||
156897585|NCT01400815|566385168|FG001|Overall Study|Lost to Follow-up|11|||
156897586|NCT01400815|566385167|FG000|Overall Study|Protocol Violation|0|||
156897587|NCT01400815|566385168|FG001|Overall Study|Protocol Violation|1|||
156897588|NCT01400815|566385167|FG000|Overall Study|Physician Decision|1|||
156897589|NCT01400815|566385168|FG001|Overall Study|Physician Decision|0|||
156897590|NCT01400815|566385167|FG000|Overall Study|Withdrawal by Subject|15|||
156897591|NCT01400815|566385168|FG001|Overall Study|Withdrawal by Subject|8|||
156897592|NCT01400815|566385167|FG000|Overall Study|Subject in jail|1|||
156897593|NCT01400815|566385168|FG001|Overall Study|Subject in jail|0|||
156897594|NCT00857415|566385177|FG000|Overall Study|Image acquisition failure|2|||
156897595|NCT00857415|566385178|FG001|Overall Study|Image acquisition failure|0|||
156897596|NCT00857415|566385177|FG000|Overall Study|Invalid image or not imaged|3|||
156897597|NCT00857415|566385178|FG001|Overall Study|Invalid image or not imaged|0|||
156897598|NCT00857415|566385177|FG000|Overall Study|Subject still living at end of study|110|||
156897599|NCT00857415|566385178|FG001|Overall Study|Subject still living at end of study|0|||
156897600|NCT00857415|566385177|FG000|Overall Study|Deceased with no autopsy|2|||
156897601|NCT00857415|566385178|FG001|Overall Study|Deceased with no autopsy|0|||
156897602|NCT04508140|566385179|FG000|Overall Study|Adverse Event|2|||
156897603|NCT04508140|566385180|FG001|Overall Study|Adverse Event|2|||
156897604|NCT04508140|566385179|FG000|Overall Study|Withdrawal by Subject|0|||
156897605|NCT04508140|566385180|FG001|Overall Study|Withdrawal by Subject|2|||
156897606|NCT04508140|566385179|FG000|Overall Study|progressive disease|9|||
156897607|NCT04508140|566385180|FG001|Overall Study|progressive disease|3|||
156897608|NCT01822678|566385181|FG000|Overall Study|Withdrawal by Subject|5|||
156897609|NCT01822678|566385182|FG001|Overall Study|Withdrawal by Subject|4|||
156897610|NCT01822678|566385183|FG002|Overall Study|Withdrawal by Subject|4|||
156897611|NCT01822678|566385181|FG000|Overall Study|Adverse Event|4|||
156897612|NCT01822678|566385182|FG001|Overall Study|Adverse Event|3|||
156897613|NCT01822678|566385183|FG002|Overall Study|Adverse Event|1|||
156897614|NCT01822678|566385181|FG000|Overall Study|Lack of Efficacy|3|||
156897615|NCT01822678|566385182|FG001|Overall Study|Lack of Efficacy|6|||
156897616|NCT01822678|566385183|FG002|Overall Study|Lack of Efficacy|5|||
156897617|NCT01822678|566385181|FG000|Overall Study|Lost to Follow-up|0|||
156897618|NCT01822678|566385182|FG001|Overall Study|Lost to Follow-up|2|||
156897619|NCT01822678|566385183|FG002|Overall Study|Lost to Follow-up|1|||
156897620|NCT00764504|566385184|FG000|Overall Study|Death|12|||
156897621|NCT00764504|566385185|FG001|Overall Study|Death|6|||
156897622|NCT00764504|566385186|FG002|Overall Study|Death|13|||
156897623|NCT00764504|566385184|FG000|Overall Study|Revision of Device|12|||
156897624|NCT00764504|566385185|FG001|Overall Study|Revision of Device|23|||
156897625|NCT00764504|566385186|FG002|Overall Study|Revision of Device|14|||
156897626|NCT00764504|566385184|FG000|Overall Study|Physician Decision|1|||
156897627|NCT00764504|566385185|FG001|Overall Study|Physician Decision|0|||
156897628|NCT00764504|566385186|FG002|Overall Study|Physician Decision|0|||
156897629|NCT00764504|566385184|FG000|Overall Study|Withdrawal by Subject|1|||
157158323|NCT01327651|567324552|FG005|Post Study Follow-up|Lost to Follow-up|0|||
157158324|NCT01327651|567324553|FG006|Post Study Follow-up|Lost to Follow-up|4|||
157158325|NCT01327651|567324554|FG007|Post Study Follow-up|Lost to Follow-up|1|||
157158326|NCT01327651|567324555|FG008|Post Study Follow-up|Lost to Follow-up|2|||
157158327|NCT02284906|567324560|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156897630|NCT00764504|566385185|FG001|Overall Study|Withdrawal by Subject|7|||
156897631|NCT00764504|566385186|FG002|Overall Study|Withdrawal by Subject|4|||
156897632|NCT00764504|566385184|FG000|Overall Study|Lost to Follow-up|40|||
156897633|NCT00764504|566385185|FG001|Overall Study|Lost to Follow-up|34|||
156897634|NCT00764504|566385186|FG002|Overall Study|Lost to Follow-up|72|||
156897635|NCT02448810|566385190|FG000|Overall Study|Adverse Event|0|||
156897636|NCT02448810|566385191|FG001|Overall Study|Adverse Event|0|||
156897637|NCT02448810|566385192|FG002|Overall Study|Adverse Event|1|||
156897638|NCT02448810|566385193|FG003|Overall Study|Adverse Event|0|||
156897639|NCT02448810|566385194|FG004|Overall Study|Adverse Event|0|||
156897640|NCT02448810|566385195|FG005|Overall Study|Adverse Event|0|||
156897641|NCT02448810|566385196|FG006|Overall Study|Adverse Event|0|||
156897642|NCT02448810|566385197|FG007|Overall Study|Adverse Event|0|||
156897643|NCT02448810|566385190|FG000|Overall Study|Withdrawal by Subject|0|||
156897644|NCT02448810|566385191|FG001|Overall Study|Withdrawal by Subject|0|||
156897645|NCT02448810|566385192|FG002|Overall Study|Withdrawal by Subject|1|||
156897646|NCT02448810|566385193|FG003|Overall Study|Withdrawal by Subject|0|||
156897647|NCT02448810|566385194|FG004|Overall Study|Withdrawal by Subject|3|||
156897648|NCT02448810|566385195|FG005|Overall Study|Withdrawal by Subject|5|||
156897649|NCT02448810|566385196|FG006|Overall Study|Withdrawal by Subject|0|||
156897650|NCT02448810|566385197|FG007|Overall Study|Withdrawal by Subject|2|||
156897651|NCT02448810|566385190|FG000|Overall Study|Other (study terminated by sponsor)|0|||
156897652|NCT02448810|566385191|FG001|Overall Study|Other (study terminated by sponsor)|0|||
156897653|NCT02448810|566385192|FG002|Overall Study|Other (study terminated by sponsor)|0|||
156897654|NCT02448810|566385193|FG003|Overall Study|Other (study terminated by sponsor)|0|||
156897655|NCT02448810|566385194|FG004|Overall Study|Other (study terminated by sponsor)|4|||
156897656|NCT02448810|566385195|FG005|Overall Study|Other (study terminated by sponsor)|2|||
156897657|NCT02448810|566385196|FG006|Overall Study|Other (study terminated by sponsor)|2|||
156897658|NCT02448810|566385197|FG007|Overall Study|Other (study terminated by sponsor)|1|||
156897659|NCT02448810|566385190|FG000|Overall Study|Death|1|||
156897660|NCT02448810|566385191|FG001|Overall Study|Death|0|||
156897661|NCT02448810|566385192|FG002|Overall Study|Death|1|||
156897662|NCT02448810|566385193|FG003|Overall Study|Death|0|||
156897663|NCT02448810|566385194|FG004|Overall Study|Death|1|||
156897664|NCT02448810|566385195|FG005|Overall Study|Death|0|||
156897665|NCT02448810|566385196|FG006|Overall Study|Death|0|||
156897666|NCT02448810|566385197|FG007|Overall Study|Death|0|||
156897667|NCT02448810|566385190|FG000|Overall Study|Other (Progressive disease)|2|||
156897668|NCT02448810|566385191|FG001|Overall Study|Other (Progressive disease)|2|||
156897669|NCT02448810|566385192|FG002|Overall Study|Other (Progressive disease)|0|||
156897670|NCT02448810|566385193|FG003|Overall Study|Other (Progressive disease)|3|||
156897671|NCT02448810|566385194|FG004|Overall Study|Other (Progressive disease)|23|||
156897672|NCT02448810|566385195|FG005|Overall Study|Other (Progressive disease)|9|||
156897673|NCT02448810|566385196|FG006|Overall Study|Other (Progressive disease)|14|||
156897674|NCT02448810|566385197|FG007|Overall Study|Other (Progressive disease)|5|||
156897675|NCT02448810|566385190|FG000|Overall Study|Lost to Follow-up|0|||
156897676|NCT02448810|566385191|FG001|Overall Study|Lost to Follow-up|1|||
156897677|NCT02448810|566385192|FG002|Overall Study|Lost to Follow-up|0|||
156897678|NCT02448810|566385193|FG003|Overall Study|Lost to Follow-up|0|||
156897679|NCT02448810|566385194|FG004|Overall Study|Lost to Follow-up|0|||
156897680|NCT02448810|566385195|FG005|Overall Study|Lost to Follow-up|0|||
156897681|NCT02448810|566385196|FG006|Overall Study|Lost to Follow-up|0|||
156897682|NCT02448810|566385197|FG007|Overall Study|Lost to Follow-up|0|||
156897683|NCT02448810|566385190|FG000|Overall Study|Other (unspecified)|0|||
156897684|NCT02448810|566385191|FG001|Overall Study|Other (unspecified)|0|||
156897685|NCT02448810|566385192|FG002|Overall Study|Other (unspecified)|0|||
156897686|NCT02448810|566385193|FG003|Overall Study|Other (unspecified)|0|||
156897687|NCT02448810|566385194|FG004|Overall Study|Other (unspecified)|0|||
156897688|NCT02448810|566385195|FG005|Overall Study|Other (unspecified)|0|||
156897689|NCT02448810|566385196|FG006|Overall Study|Other (unspecified)|2|||
156897690|NCT02448810|566385197|FG007|Overall Study|Other (unspecified)|0|||
156897691|NCT04795622|566385200|FG000|Overall Study|Adverse Event|1|||
156897692|NCT04795622|566385201|FG001|Overall Study|Adverse Event|0|||
156897693|NCT04795622|566385200|FG000|Overall Study|Withdrawal by Subject|3|||
156897694|NCT04795622|566385201|FG001|Overall Study|Withdrawal by Subject|3|||
156897695|NCT04795622|566385200|FG000|Overall Study|Protocol Violation|0|||
156897696|NCT04795622|566385201|FG001|Overall Study|Protocol Violation|2|||
156897697|NCT04795622|566385200|FG000|Overall Study|Lost to Follow-up|2|||
156897698|NCT04795622|566385201|FG001|Overall Study|Lost to Follow-up|3|||
156897699|NCT04795622|566385200|FG000|Overall Study|Other|7|||
156897700|NCT04795622|566385201|FG001|Overall Study|Other|8|||
156897701|NCT00470847|566385202|FG000|Overall Study|Pt still receiving treatment|1|||
156897702|NCT01437878|566385210|FG000|Overall Study|Withdrawal by Subject|1|||
156897703|NCT01437878|566385211|FG001|Overall Study|Withdrawal by Subject|0|||
156897704|NCT01070043|566385212|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
156897705|NCT01070043|566385213|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
156897706|NCT01070043|566385214|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
156897707|NCT01070043|566385212|FG000|Double-Blind Treatment|Adverse Event|0|||
156897708|NCT01070043|566385213|FG001|Double-Blind Treatment|Adverse Event|0|||
156897709|NCT01070043|566385214|FG002|Double-Blind Treatment|Adverse Event|2|||
156897710|NCT01610271|566385216|FG000|Overall Study|Surgery not complete|0|||
156897711|NCT01610271|566385217|FG001|Overall Study|Surgery not complete|1|||
156897712|NCT01610271|566385216|FG000|Overall Study|Prosthesis not implanted|2|||
156897713|NCT01610271|566385217|FG001|Overall Study|Prosthesis not implanted|3|||
156897714|NCT01638819|566385218|FG000|Overall Study|Lost to Follow-up|1|||
156897715|NCT01638819|566385219|FG001|Overall Study|Lost to Follow-up|0|||
156897716|NCT00467610|566385224|FG000|Overall Study|Withdrawal by Subject|1|||
156897717|NCT01369615|566385225|FG000|Overall Study|Withdrawal by Subject|0|||
156897718|NCT01369615|566385226|FG001|Overall Study|Withdrawal by Subject|1|||
156897719|NCT01369615|566385225|FG000|Overall Study|Lost to Follow-up|0|||
156897720|NCT01369615|566385226|FG001|Overall Study|Lost to Follow-up|1|||
156897721|NCT04263454|566385227|FG000|Overall Study|Adverse Event|0|||
156897722|NCT04263454|566385228|FG001|Overall Study|Adverse Event|2|||
156897723|NCT04263454|566385227|FG000|Overall Study|Physician Decision|3|||
156897724|NCT04263454|566385228|FG001|Overall Study|Physician Decision|5|||
156897725|NCT04263454|566385227|FG000|Overall Study|Poor Data Quality|0|||
156897726|NCT04263454|566385228|FG001|Overall Study|Poor Data Quality|1|||
156897727|NCT00986479|566385229|FG000|Period 1|Improved mood|1|||
156897728|NCT00986479|566385230|FG001|Period 1|Improved mood|0|||
156897729|NCT00986479|566385229|FG000|Period 1|Administrative reasons|1|||
156897730|NCT00986479|566385230|FG001|Period 1|Administrative reasons|0|||
156897731|NCT01721070|566385231|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
156897732|NCT02035475|566385232|FG000|Overall Study|Withdrawal by Subject|4|||
156897733|NCT02035475|566385232|FG000|Overall Study|Physician Decision|1|||
156897734|NCT02035475|566385232|FG000|Overall Study|Equipment Error|1|||
156897735|NCT01460368|566385233|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897736|NCT01460368|566385234|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897737|NCT01460368|566385235|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897738|NCT01460368|566385236|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897739|NCT01460368|566385237|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
156897740|NCT01460368|566385238|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897741|NCT01460368|566385239|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
156897742|NCT01460368|566385233|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156897743|NCT01460368|566385234|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
156897744|NCT01460368|566385235|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156897745|NCT01460368|566385236|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156897746|NCT01460368|566385237|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156897747|NCT01460368|566385238|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
156897748|NCT01460368|566385239|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
156897749|NCT01460368|566385233|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897750|NCT01460368|566385234|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
156897751|NCT01460368|566385235|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897752|NCT01460368|566385236|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897753|NCT01460368|566385237|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897754|NCT01460368|566385238|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897755|NCT01460368|566385239|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
156897756|NCT01460368|566385233|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897757|NCT01460368|566385234|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897758|NCT01460368|566385235|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
156897759|NCT01460368|566385236|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897760|NCT01460368|566385237|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897761|NCT01460368|566385238|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897762|NCT01460368|566385239|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
156897763|NCT01460368|566385233|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156897764|NCT01460368|566385234|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156897765|NCT01460368|566385235|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156897766|NCT01460368|566385236|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156897767|NCT01460368|566385237|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156897768|NCT01460368|566385238|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
156897769|NCT01460368|566385239|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
156897770|NCT02322021|566385240|FG000|Core Phase|Adverse Event|1|||
156897771|NCT02322021|566385241|FG001|Core Phase|Adverse Event|3|||
156897772|NCT02322021|566385242|FG002|Core Phase|Adverse Event|4|||
156897773|NCT02322021|566385243|FG003|Core Phase|Adverse Event|2|||
156897774|NCT02322021|566385244|FG004|Core Phase|Adverse Event|0|||
156897775|NCT02322021|566385240|FG000|Core Phase|Participant Choice|4|||
156897776|NCT02322021|566385241|FG001|Core Phase|Participant Choice|5|||
156897777|NCT02322021|566385242|FG002|Core Phase|Participant Choice|4|||
156897778|NCT02322021|566385243|FG003|Core Phase|Participant Choice|2|||
157225506|NCT00818883|567571451|FG000|Overall Study|Adverse Event|28|||
156897779|NCT02322021|566385244|FG004|Core Phase|Participant Choice|0|||
156897780|NCT02322021|566385240|FG000|Core Phase|Lost to Follow-up|0|||
156897781|NCT02322021|566385241|FG001|Core Phase|Lost to Follow-up|0|||
156897782|NCT02322021|566385242|FG002|Core Phase|Lost to Follow-up|0|||
156897783|NCT02322021|566385243|FG003|Core Phase|Lost to Follow-up|1|||
156897784|NCT02322021|566385244|FG004|Core Phase|Lost to Follow-up|0|||
156897785|NCT02322021|566385240|FG000|Core Phase|Other|0|||
156897786|NCT02322021|566385241|FG001|Core Phase|Other|0|||
156897787|NCT02322021|566385242|FG002|Core Phase|Other|1|||
156897788|NCT02322021|566385243|FG003|Core Phase|Other|0|||
156897789|NCT02322021|566385244|FG004|Core Phase|Other|0|||
156897790|NCT02322021|566385240|FG000|Extension Phase|Adverse Event|0|||
156897791|NCT02322021|566385241|FG001|Extension Phase|Adverse Event|0|||
156897792|NCT02322021|566385242|FG002|Extension Phase|Adverse Event|0|||
156897793|NCT02322021|566385243|FG003|Extension Phase|Adverse Event|0|||
156897794|NCT02322021|566385244|FG004|Extension Phase|Adverse Event|3|||
156897795|NCT02322021|566385240|FG000|Extension Phase|Participant Choice|0|||
156897796|NCT02322021|566385241|FG001|Extension Phase|Participant Choice|0|||
156897797|NCT02322021|566385242|FG002|Extension Phase|Participant Choice|0|||
156897798|NCT02322021|566385243|FG003|Extension Phase|Participant Choice|0|||
156897799|NCT02322021|566385244|FG004|Extension Phase|Participant Choice|6|||
156897800|NCT02322021|566385240|FG000|Extension Phase|Other|0|||
156897801|NCT02322021|566385241|FG001|Extension Phase|Other|0|||
156897802|NCT02322021|566385242|FG002|Extension Phase|Other|0|||
156897803|NCT02322021|566385243|FG003|Extension Phase|Other|0|||
156897804|NCT02322021|566385244|FG004|Extension Phase|Other|3|||
156897805|NCT02322021|566385240|FG000|Extension Phase|Lost to Follow-up|0|||
156897806|NCT02322021|566385241|FG001|Extension Phase|Lost to Follow-up|0|||
156897807|NCT02322021|566385242|FG002|Extension Phase|Lost to Follow-up|0|||
156897808|NCT02322021|566385243|FG003|Extension Phase|Lost to Follow-up|0|||
156897809|NCT02322021|566385244|FG004|Extension Phase|Lost to Follow-up|1|||
156897810|NCT02322021|566385240|FG000|Extension Phase|Study terminated by sponsor|0|||
156897811|NCT02322021|566385241|FG001|Extension Phase|Study terminated by sponsor|0|||
156897812|NCT02322021|566385242|FG002|Extension Phase|Study terminated by sponsor|0|||
156897813|NCT02322021|566385243|FG003|Extension Phase|Study terminated by sponsor|0|||
156897814|NCT02322021|566385244|FG004|Extension Phase|Study terminated by sponsor|28|||
156897815|NCT02047227|566385245|FG000|Overall Study|Adverse Event|2|||
156897816|NCT02047227|566385246|FG001|Overall Study|Adverse Event|4|||
156897817|NCT02047227|566385245|FG000|Overall Study|Lost to Follow-up|0|||
156897818|NCT02047227|566385246|FG001|Overall Study|Lost to Follow-up|3|||
156897819|NCT02047227|566385245|FG000|Overall Study|Protocol Violation|1|||
156897820|NCT02047227|566385246|FG001|Overall Study|Protocol Violation|0|||
156897821|NCT02047227|566385245|FG000|Overall Study|Spontaneous pregnancy|1|||
156897822|NCT02047227|566385246|FG001|Overall Study|Spontaneous pregnancy|0|||
156897823|NCT02047227|566385245|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
156897824|NCT02047227|566385246|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
156897825|NCT02047227|566385245|FG000|Overall Study|No oocytes retrieved|21|||
156897826|NCT02047227|566385246|FG001|Overall Study|No oocytes retrieved|20|||
156897827|NCT02047227|566385245|FG000|Overall Study|No fertilization|61|||
156897828|NCT02047227|566385246|FG001|Overall Study|No fertilization|51|||
156897829|NCT02047227|566385245|FG000|Overall Study|Intention to freeze all embryos|1|||
156897830|NCT02047227|566385246|FG001|Overall Study|Intention to freeze all embryos|0|||
156897831|NCT02047227|566385245|FG000|Overall Study|All embryos discarded|12|||
156897832|NCT02047227|566385246|FG001|Overall Study|All embryos discarded|11|||
156897833|NCT02047227|566385245|FG000|Overall Study|Other|10|||
156897834|NCT02047227|566385246|FG001|Overall Study|Other|9|||
156897835|NCT01385371|566385253|FG000|Overall Study|Adverse Event|54|||
156897836|NCT01385371|566385254|FG001|Overall Study|Adverse Event|19|||
156897837|NCT01385371|566385253|FG000|Overall Study|Lost to Follow-up|16|||
156897838|NCT01385371|566385254|FG001|Overall Study|Lost to Follow-up|16|||
156897839|NCT01385371|566385253|FG000|Overall Study|Withdrawal by Subject|52|||
156897840|NCT01385371|566385254|FG001|Overall Study|Withdrawal by Subject|39|||
156897841|NCT01385371|566385253|FG000|Overall Study|Protocol Violation|25|||
156897842|NCT01385371|566385254|FG001|Overall Study|Protocol Violation|21|||
156897843|NCT01385371|566385253|FG000|Overall Study|Administrative|2|||
156897844|NCT01385371|566385254|FG001|Overall Study|Administrative|2|||
156897845|NCT02001181|566385257|FG000|Overall Study|Adverse Event|0|||
156897846|NCT02001181|566385258|FG001|Overall Study|Adverse Event|2|||
156897847|NCT02001181|566385257|FG000|Overall Study|Lost to Follow-up|1|||
156897848|NCT02001181|566385258|FG001|Overall Study|Lost to Follow-up|0|||
156897849|NCT02001181|566385257|FG000|Overall Study|Withdrawal by Subject|0|||
156897850|NCT02001181|566385258|FG001|Overall Study|Withdrawal by Subject|1|||
157158328|NCT02284906|567324561|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156897851|NCT00891462|566387128|FG000|Overall Study|Withdrawal by Subject|9|||
157158329|NCT02284906|567324562|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156897852|NCT00891462|566387129|FG001|Overall Study|Withdrawal by Subject|6|||
156897853|NCT00891462|566387130|FG002|Overall Study|Withdrawal by Subject|7|||
156897854|NCT00891462|566387128|FG000|Overall Study|Adverse Event|7|||
156897855|NCT00891462|566387129|FG001|Overall Study|Adverse Event|8|||
156897856|NCT00891462|566387130|FG002|Overall Study|Adverse Event|7|||
156897857|NCT00891462|566387128|FG000|Overall Study|Lack of Efficacy|10|||
156897858|NCT00891462|566387129|FG001|Overall Study|Lack of Efficacy|5|||
156897859|NCT00891462|566387130|FG002|Overall Study|Lack of Efficacy|1|||
156897860|NCT00891462|566387128|FG000|Overall Study|COPD exacerbation|7|||
156897861|NCT00891462|566387129|FG001|Overall Study|COPD exacerbation|4|||
156897862|NCT00891462|566387130|FG002|Overall Study|COPD exacerbation|1|||
156897863|NCT00891462|566387128|FG000|Overall Study|Other Reason|2|||
156897864|NCT00891462|566387129|FG001|Overall Study|Other Reason|5|||
156897865|NCT00891462|566387130|FG002|Overall Study|Other Reason|3|||
156897866|NCT00891462|566387128|FG000|Overall Study|Protocol Violation|2|||
156897867|NCT00891462|566387129|FG001|Overall Study|Protocol Violation|1|||
156897868|NCT00891462|566387130|FG002|Overall Study|Protocol Violation|3|||
156897869|NCT00891462|566387128|FG000|Overall Study|Inclusion/exclusion criteria|0|||
156897870|NCT00891462|566387129|FG001|Overall Study|Inclusion/exclusion criteria|2|||
156897871|NCT00891462|566387130|FG002|Overall Study|Inclusion/exclusion criteria|2|||
156897872|NCT00891462|566387128|FG000|Overall Study|Lost to Follow-up|0|||
156897873|NCT00891462|566387129|FG001|Overall Study|Lost to Follow-up|2|||
156897874|NCT00891462|566387130|FG002|Overall Study|Lost to Follow-up|0|||
156897875|NCT01083485|566387131|FG000|Overall Study|Adverse Event|0|||
156897876|NCT01083485|566387132|FG001|Overall Study|Adverse Event|1|||
156897877|NCT01083485|566387131|FG000|Overall Study|Protocol Violation|1|||
156897878|NCT01083485|566387132|FG001|Overall Study|Protocol Violation|0|||
156897879|NCT01083485|566387131|FG000|Overall Study|Withdrawal by Subject|5|||
156897880|NCT01083485|566387132|FG001|Overall Study|Withdrawal by Subject|2|||
156897881|NCT01083485|566387131|FG000|Overall Study|Other|1|||
156897882|NCT01083485|566387132|FG001|Overall Study|Other|0|||
156897883|NCT05108922|566387133|FG000|Overall Study|Adverse Event|2|||
156897884|NCT05108922|566387134|FG001|Overall Study|Adverse Event|3|||
156897885|NCT05108922|566387133|FG000|Overall Study|Lost to Follow-up|2|||
156897886|NCT05108922|566387134|FG001|Overall Study|Lost to Follow-up|1|||
156897887|NCT05108922|566387133|FG000|Overall Study|Inadvertent enrollment|0|||
156897888|NCT05108922|566387134|FG001|Overall Study|Inadvertent enrollment|1|||
156897889|NCT05108922|566387133|FG000|Overall Study|Physician Decision|2|||
156897890|NCT05108922|566387134|FG001|Overall Study|Physician Decision|3|||
156897891|NCT05108922|566387133|FG000|Overall Study|Protocol deviation|1|||
156897892|NCT05108922|566387134|FG001|Overall Study|Protocol deviation|0|||
156897893|NCT05108922|566387133|FG000|Overall Study|Screen failure|1|||
156897894|NCT05108922|566387134|FG001|Overall Study|Screen failure|0|||
156897895|NCT05108922|566387133|FG000|Overall Study|Withdrawal by Subject|11|||
156897896|NCT05108922|566387134|FG001|Overall Study|Withdrawal by Subject|8|||
156897897|NCT05036369|566387135|FG000|Overall Study|Run In non compliance|1|||
156897898|NCT05036369|566387136|FG001|Overall Study|Run In non compliance|2|||
156897899|NCT05036369|566387135|FG000|Overall Study|Change in eligibility criteria|0|||
156897900|NCT05036369|566387136|FG001|Overall Study|Change in eligibility criteria|1|||
156897901|NCT02095223|566387138|FG000|Overall Study|Withdrawal by Subject|1|||
156897902|NCT02095223|566387139|FG001|Overall Study|Withdrawal by Subject|0|||
156897903|NCT01397162|566387140|FG000|Overall Study|Adverse Event|4|||
156897904|NCT01397162|566387141|FG001|Overall Study|Adverse Event|0|||
156897905|NCT01397162|566387142|FG002|Overall Study|Adverse Event|0|||
156897906|NCT01397162|566387143|FG003|Overall Study|Adverse Event|0|||
156897907|NCT01397162|566387144|FG004|Overall Study|Adverse Event|0|||
156897908|NCT01397162|566387140|FG000|Overall Study|Not yet defined|3|||
156897909|NCT01397162|566387141|FG001|Overall Study|Not yet defined|4|||
156897910|NCT01397162|566387142|FG002|Overall Study|Not yet defined|3|||
156897911|NCT01397162|566387143|FG003|Overall Study|Not yet defined|5|||
156897912|NCT01397162|566387144|FG004|Overall Study|Not yet defined|3|||
156897913|NCT01507298|566387149|FG000|Overall Study|Protocol Violation|0|||
156897914|NCT01507298|566387150|FG001|Overall Study|Protocol Violation|6|||
156897915|NCT01854658|566387151|FG000|Overall Study|Protocol Violation|6|||
157158330|NCT02284906|567324560|FG000|Overall Study|Major Protocol Deviation|0|||
157158331|NCT02284906|567324561|FG001|Overall Study|Major Protocol Deviation|1|||
157158332|NCT02284906|567324562|FG002|Overall Study|Major Protocol Deviation|0|||
157158333|NCT02284906|567324560|FG000|Overall Study|Voluntary Withdrawal|2|||
157158334|NCT02284906|567324561|FG001|Overall Study|Voluntary Withdrawal|4|||
157158335|NCT02284906|567324562|FG002|Overall Study|Voluntary Withdrawal|5|||
157158336|NCT02284906|567324560|FG000|Overall Study|Study Termination|0|||
157158337|NCT02284906|567324561|FG001|Overall Study|Study Termination|11|||
156897916|NCT01854658|566387152|FG001|Overall Study|Protocol Violation|2|||
156897917|NCT01854658|566387153|FG002|Overall Study|Protocol Violation|2|||
156897918|NCT01854658|566387154|FG003|Overall Study|Protocol Violation|1|||
156897919|NCT01854658|566387151|FG000|Overall Study|Physician Decision|7|||
156897920|NCT01854658|566387152|FG001|Overall Study|Physician Decision|5|||
156897921|NCT01854658|566387153|FG002|Overall Study|Physician Decision|2|||
156897922|NCT01854658|566387154|FG003|Overall Study|Physician Decision|4|||
156897923|NCT01854658|566387151|FG000|Overall Study|Lost to Follow-up|8|||
156897924|NCT01854658|566387152|FG001|Overall Study|Lost to Follow-up|9|||
156897925|NCT01854658|566387153|FG002|Overall Study|Lost to Follow-up|8|||
156897926|NCT01854658|566387154|FG003|Overall Study|Lost to Follow-up|4|||
156897927|NCT01854658|566387151|FG000|Overall Study|Withdrawal by Subject|28|||
156897928|NCT01854658|566387152|FG001|Overall Study|Withdrawal by Subject|21|||
156897929|NCT01854658|566387153|FG002|Overall Study|Withdrawal by Subject|29|||
156897930|NCT01854658|566387154|FG003|Overall Study|Withdrawal by Subject|15|||
156897931|NCT01854658|566387151|FG000|Overall Study|Protocol-specified criteria|15|||
156897932|NCT01854658|566387152|FG001|Overall Study|Protocol-specified criteria|15|||
156897933|NCT01854658|566387153|FG002|Overall Study|Protocol-specified criteria|10|||
156897934|NCT01854658|566387154|FG003|Overall Study|Protocol-specified criteria|7|||
156897935|NCT01854658|566387151|FG000|Overall Study|Lack of Efficacy|3|||
157158338|NCT02284906|567324562|FG002|Overall Study|Study Termination|14|||
156897936|NCT01854658|566387152|FG001|Overall Study|Lack of Efficacy|8|||
156897937|NCT01854658|566387153|FG002|Overall Study|Lack of Efficacy|4|||
156897938|NCT01854658|566387154|FG003|Overall Study|Lack of Efficacy|7|||
156897939|NCT01854658|566387151|FG000|Overall Study|Adverse Event|21|||
156897940|NCT01854658|566387152|FG001|Overall Study|Adverse Event|14|||
156897941|NCT01854658|566387153|FG002|Overall Study|Adverse Event|23|||
156897942|NCT01854658|566387154|FG003|Overall Study|Adverse Event|19|||
156897943|NCT01854658|566387151|FG000|Overall Study|Administrative reasons|5|||
156897944|NCT01854658|566387152|FG001|Overall Study|Administrative reasons|1|||
156897945|NCT01854658|566387153|FG002|Overall Study|Administrative reasons|2|||
156897946|NCT01854658|566387154|FG003|Overall Study|Administrative reasons|2|||
156897947|NCT03906461|566387155|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
156897948|NCT03906461|566387155|FG000|Completed 12-month Follow-up|Missed Visit|6|||
156897949|NCT01920555|566387156|FG000|Overall Study|Physician Decision|1|||
156897950|NCT01920555|566387157|FG001|Overall Study|Physician Decision|2|||
156897951|NCT01920555|566387158|FG002|Overall Study|Physician Decision|1|||
156897952|NCT01920555|566387159|FG003|Overall Study|Physician Decision|2|||
156897953|NCT01920555|566387160|FG004|Overall Study|Physician Decision|0|||
156897954|NCT01920555|566387156|FG000|Overall Study|Lack of Efficacy|2|||
156897955|NCT01920555|566387157|FG001|Overall Study|Lack of Efficacy|0|||
156897956|NCT01920555|566387158|FG002|Overall Study|Lack of Efficacy|0|||
156897957|NCT01920555|566387159|FG003|Overall Study|Lack of Efficacy|0|||
156897958|NCT01920555|566387160|FG004|Overall Study|Lack of Efficacy|0|||
156897959|NCT01920555|566387156|FG000|Overall Study|Travel Difficulties|1|||
156897960|NCT01920555|566387157|FG001|Overall Study|Travel Difficulties|1|||
156897961|NCT01920555|566387158|FG002|Overall Study|Travel Difficulties|0|||
156897962|NCT01920555|566387159|FG003|Overall Study|Travel Difficulties|0|||
156897963|NCT01920555|566387160|FG004|Overall Study|Travel Difficulties|1|||
156897964|NCT01920555|566387156|FG000|Overall Study|Lost to Follow-up|0|||
156897965|NCT01920555|566387157|FG001|Overall Study|Lost to Follow-up|1|||
156897966|NCT01920555|566387158|FG002|Overall Study|Lost to Follow-up|0|||
156897967|NCT01920555|566387159|FG003|Overall Study|Lost to Follow-up|1|||
156897968|NCT01920555|566387160|FG004|Overall Study|Lost to Follow-up|0|||
156897969|NCT01795638|566387163|FG000|Overall Study|Death|0|||
156897970|NCT01795638|566387164|FG001|Overall Study|Death|3|||
156897971|NCT01795638|566387163|FG000|Overall Study|transferred to quaternary hospital|2|||
156897972|NCT01795638|566387164|FG001|Overall Study|transferred to quaternary hospital|3|||
156897973|NCT01795638|566387163|FG000|Overall Study|Protocol Violation|3|||
156897974|NCT01795638|566387164|FG001|Overall Study|Protocol Violation|0|||
156897975|NCT01795638|566387163|FG000|Overall Study|discharged from hospital|7|||
156897976|NCT01795638|566387164|FG001|Overall Study|discharged from hospital|5|||
156897977|NCT01795638|566387163|FG000|Overall Study|Withdrawal by Subject|1|||
156897978|NCT01795638|566387164|FG001|Overall Study|Withdrawal by Subject|0|||
156897979|NCT02570074|566387167|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
156897980|NCT02570074|566387168|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
156897981|NCT01859143|566387169|FG000|Overall Study|Lost to Follow-up|2|||
156897982|NCT01859143|566387170|FG001|Overall Study|Lost to Follow-up|0|||
156897983|NCT00611533|566387171|FG000|First Intervention (6 Weeks)|Never started study|0|||
156897984|NCT00611533|566387172|FG001|First Intervention (6 Weeks)|Never started study|1|||
156897985|NCT00611533|566387171|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
156897986|NCT00611533|566387172|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156897987|NCT00611533|566387171|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
157026170|NCT04828005|566849732|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
157158339|NCT02284906|567324560|FG000|Overall Study|Reason not Specified|1|||
157158340|NCT02284906|567324561|FG001|Overall Study|Reason not Specified|1|||
157158341|NCT02284906|567324562|FG002|Overall Study|Reason not Specified|0|||
157158342|NCT01409031|567324563|FG000|Overall Study|transferred to other hosp|1|||
157158343|NCT01409031|567324564|FG001|Overall Study|transferred to other hosp|0|||
157158344|NCT04056455|567324565|FG000|Overall Study|Adverse Event|1|||
157158345|NCT04056455|567324566|FG001|Overall Study|Adverse Event|0|||
157158346|NCT03521687|567324568|FG000|Overall Study|Adverse Event|4|||
157158347|NCT03521687|567324568|FG000|Overall Study|Physician Decision|1|||
157158348|NCT04891770|567324575|FG000|Overall Study|Withdrew consent|1|||
157158349|NCT04891770|567324576|FG001|Overall Study|Withdrew consent|3|||
156897988|NCT00611533|566387172|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
157158350|NCT04891770|567324577|FG002|Overall Study|Withdrew consent|0|||
157158351|NCT04891770|567324575|FG000|Overall Study|Enrolled but never treated|0|||
157158352|NCT04891770|567324576|FG001|Overall Study|Enrolled but never treated|0|||
157158353|NCT04891770|567324577|FG002|Overall Study|Enrolled but never treated|1|||
156897989|NCT02943460|566387175|FG000|Blinded Study Phase|Adverse Event|3|||
156897990|NCT02943460|566387176|FG001|Blinded Study Phase|Adverse Event|0|||
156897991|NCT02943460|566387177|FG002|Blinded Study Phase|Adverse Event|0|||
156897992|NCT02943460|566387175|FG000|Blinded Study Phase|Withdrew Consent|0|||
156897993|NCT02943460|566387176|FG001|Blinded Study Phase|Withdrew Consent|1|||
156897994|NCT02943460|566387177|FG002|Blinded Study Phase|Withdrew Consent|0|||
156897995|NCT02943460|566387175|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
156897996|NCT02943460|566387176|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
156897997|NCT02943460|566387177|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
156897998|NCT02943460|566387175|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
156897999|NCT02943460|566387176|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
156898000|NCT02943460|566387177|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
156898001|NCT02943460|566387175|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
156898002|NCT02943460|566387176|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
156898003|NCT02943460|566387177|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
156898004|NCT00809354|566387181|FG000|Overall Study|Adverse Event|32|||
156898005|NCT00809354|566387182|FG001|Overall Study|Adverse Event|45|||
156898006|NCT00809354|566387183|FG002|Overall Study|Adverse Event|37|||
156898007|NCT00809354|566387184|FG003|Overall Study|Adverse Event|53|||
156898008|NCT00809354|566387185|FG004|Overall Study|Adverse Event|26|||
156898009|NCT00809354|566387186|FG005|Overall Study|Adverse Event|33|||
156898010|NCT00809354|566387187|FG006|Overall Study|Adverse Event|44|||
156898011|NCT00809354|566387188|FG007|Overall Study|Adverse Event|40|||
156898012|NCT00809354|566387189|FG008|Overall Study|Adverse Event|46|||
156898013|NCT00809354|566387190|FG009|Overall Study|Adverse Event|26|||
156898014|NCT00809354|566387181|FG000|Overall Study|Lack of Efficacy|23|||
156898015|NCT00809354|566387182|FG001|Overall Study|Lack of Efficacy|23|||
156898016|NCT00809354|566387183|FG002|Overall Study|Lack of Efficacy|22|||
156898017|NCT00809354|566387184|FG003|Overall Study|Lack of Efficacy|15|||
156898018|NCT00809354|566387185|FG004|Overall Study|Lack of Efficacy|40|||
156898019|NCT00809354|566387186|FG005|Overall Study|Lack of Efficacy|19|||
156898020|NCT00809354|566387187|FG006|Overall Study|Lack of Efficacy|21|||
156898021|NCT00809354|566387188|FG007|Overall Study|Lack of Efficacy|15|||
156898022|NCT00809354|566387189|FG008|Overall Study|Lack of Efficacy|18|||
156898023|NCT00809354|566387190|FG009|Overall Study|Lack of Efficacy|38|||
156898024|NCT00809354|566387181|FG000|Overall Study|Lost to Follow-up|10|||
156898025|NCT00809354|566387182|FG001|Overall Study|Lost to Follow-up|11|||
156898026|NCT00809354|566387183|FG002|Overall Study|Lost to Follow-up|8|||
156898027|NCT00809354|566387184|FG003|Overall Study|Lost to Follow-up|13|||
156898028|NCT00809354|566387185|FG004|Overall Study|Lost to Follow-up|6|||
156898029|NCT00809354|566387186|FG005|Overall Study|Lost to Follow-up|2|||
156898030|NCT00809354|566387187|FG006|Overall Study|Lost to Follow-up|0|||
156898031|NCT00809354|566387188|FG007|Overall Study|Lost to Follow-up|5|||
156898032|NCT00809354|566387189|FG008|Overall Study|Lost to Follow-up|4|||
156898033|NCT00809354|566387190|FG009|Overall Study|Lost to Follow-up|0|||
156898034|NCT00809354|566387181|FG000|Overall Study|Protocol Violation|7|||
156898035|NCT00809354|566387182|FG001|Overall Study|Protocol Violation|14|||
156898036|NCT00809354|566387183|FG002|Overall Study|Protocol Violation|14|||
156898037|NCT00809354|566387184|FG003|Overall Study|Protocol Violation|12|||
156898038|NCT00809354|566387185|FG004|Overall Study|Protocol Violation|14|||
156898039|NCT00809354|566387186|FG005|Overall Study|Protocol Violation|6|||
156898040|NCT00809354|566387187|FG006|Overall Study|Protocol Violation|4|||
156898041|NCT00809354|566387188|FG007|Overall Study|Protocol Violation|6|||
156898042|NCT00809354|566387189|FG008|Overall Study|Protocol Violation|9|||
156898043|NCT00809354|566387190|FG009|Overall Study|Protocol Violation|3|||
156898044|NCT00809354|566387181|FG000|Overall Study|Withdrawal by Subject|32|||
156898045|NCT00809354|566387182|FG001|Overall Study|Withdrawal by Subject|27|||
156898046|NCT00809354|566387183|FG002|Overall Study|Withdrawal by Subject|31|||
156898047|NCT00809354|566387184|FG003|Overall Study|Withdrawal by Subject|33|||
156898048|NCT00809354|566387185|FG004|Overall Study|Withdrawal by Subject|34|||
156898049|NCT00809354|566387186|FG005|Overall Study|Withdrawal by Subject|29|||
156898050|NCT00809354|566387187|FG006|Overall Study|Withdrawal by Subject|27|||
156898051|NCT00809354|566387188|FG007|Overall Study|Withdrawal by Subject|19|||
156898052|NCT00809354|566387189|FG008|Overall Study|Withdrawal by Subject|18|||
156898053|NCT00809354|566387190|FG009|Overall Study|Withdrawal by Subject|20|||
156898054|NCT00809354|566387181|FG000|Overall Study|Other|10|||
156898055|NCT00809354|566387182|FG001|Overall Study|Other|2|||
156898056|NCT00809354|566387183|FG002|Overall Study|Other|7|||
156898057|NCT00809354|566387184|FG003|Overall Study|Other|10|||
156898058|NCT00809354|566387185|FG004|Overall Study|Other|5|||
156898059|NCT00809354|566387186|FG005|Overall Study|Other|3|||
156898060|NCT00809354|566387187|FG006|Overall Study|Other|2|||
156898061|NCT00809354|566387188|FG007|Overall Study|Other|3|||
156898062|NCT00809354|566387189|FG008|Overall Study|Other|4|||
156898063|NCT00809354|566387190|FG009|Overall Study|Other|3|||
156898064|NCT00809354|566387181|FG000|Overall Study|Study terminated by sponsor|138|||
156898065|NCT00809354|566387182|FG001|Overall Study|Study terminated by sponsor|134|||
156898066|NCT00809354|566387183|FG002|Overall Study|Study terminated by sponsor|129|||
156898067|NCT00809354|566387184|FG003|Overall Study|Study terminated by sponsor|120|||
156898068|NCT00809354|566387185|FG004|Overall Study|Study terminated by sponsor|126|||
156898069|NCT00809354|566387186|FG005|Overall Study|Study terminated by sponsor|133|||
156898070|NCT00809354|566387187|FG006|Overall Study|Study terminated by sponsor|124|||
156898071|NCT00809354|566387188|FG007|Overall Study|Study terminated by sponsor|148|||
156898072|NCT00809354|566387189|FG008|Overall Study|Study terminated by sponsor|127|||
156898073|NCT00809354|566387190|FG009|Overall Study|Study terminated by sponsor|135|||
156898074|NCT00809354|566387181|FG000|Overall Study|Withdrawn due to pregnancy|0|||
156898075|NCT00809354|566387182|FG001|Overall Study|Withdrawn due to pregnancy|1|||
156898076|NCT00809354|566387183|FG002|Overall Study|Withdrawn due to pregnancy|0|||
156898077|NCT00809354|566387184|FG003|Overall Study|Withdrawn due to pregnancy|0|||
156898078|NCT00809354|566387185|FG004|Overall Study|Withdrawn due to pregnancy|0|||
156898079|NCT00809354|566387186|FG005|Overall Study|Withdrawn due to pregnancy|0|||
156898080|NCT00809354|566387187|FG006|Overall Study|Withdrawn due to pregnancy|0|||
156898081|NCT00809354|566387188|FG007|Overall Study|Withdrawn due to pregnancy|0|||
156898082|NCT00809354|566387189|FG008|Overall Study|Withdrawn due to pregnancy|0|||
156898083|NCT00809354|566387190|FG009|Overall Study|Withdrawn due to pregnancy|0|||
156898084|NCT00809354|566387181|FG000|Overall Study|Randomized but not Treated|3|||
156898085|NCT00809354|566387182|FG001|Overall Study|Randomized but not Treated|1|||
156898086|NCT00809354|566387183|FG002|Overall Study|Randomized but not Treated|6|||
156898087|NCT00809354|566387184|FG003|Overall Study|Randomized but not Treated|0|||
156898088|NCT00809354|566387185|FG004|Overall Study|Randomized but not Treated|5|||
156898089|NCT00809354|566387186|FG005|Overall Study|Randomized but not Treated|0|||
156898090|NCT00809354|566387187|FG006|Overall Study|Randomized but not Treated|1|||
156898091|NCT00809354|566387188|FG007|Overall Study|Randomized but not Treated|1|||
156898092|NCT00809354|566387189|FG008|Overall Study|Randomized but not Treated|2|||
156898093|NCT00809354|566387190|FG009|Overall Study|Randomized but not Treated|1|||
156898094|NCT00809354|566387181|FG000|Overall Study|Death|0|||
156898095|NCT00809354|566387182|FG001|Overall Study|Death|0|||
156898096|NCT00809354|566387183|FG002|Overall Study|Death|0|||
156898097|NCT00809354|566387184|FG003|Overall Study|Death|0|||
156898098|NCT00809354|566387185|FG004|Overall Study|Death|0|||
156898099|NCT00809354|566387186|FG005|Overall Study|Death|0|||
156898100|NCT00809354|566387187|FG006|Overall Study|Death|0|||
156898101|NCT00809354|566387188|FG007|Overall Study|Death|1|||
156898102|NCT00809354|566387189|FG008|Overall Study|Death|0|||
156898103|NCT00809354|566387190|FG009|Overall Study|Death|0|||
156898104|NCT00566501|566387201|FG000|Overall Study|Adverse Event|68|||
156898105|NCT00566501|566387202|FG001|Overall Study|Adverse Event|59|||
156898106|NCT00566501|566387201|FG000|Overall Study|Medication Non-compliance|5|||
156898107|NCT00566501|566387202|FG001|Overall Study|Medication Non-compliance|0|||
156898108|NCT00566501|566387201|FG000|Overall Study|Protocol Violation|2|||
156898109|NCT00566501|566387202|FG001|Overall Study|Protocol Violation|2|||
156898110|NCT00566501|566387201|FG000|Overall Study|Request of Investigator or Sponsor|6|||
156898111|NCT00566501|566387202|FG001|Overall Study|Request of Investigator or Sponsor|7|||
156898112|NCT00566501|566387201|FG000|Overall Study|Withdrawal by Subject|33|||
156898113|NCT00566501|566387202|FG001|Overall Study|Withdrawal by Subject|30|||
156898114|NCT00566501|566387201|FG000|Overall Study|Lack of Efficacy|8|||
156898115|NCT00566501|566387202|FG001|Overall Study|Lack of Efficacy|3|||
156898116|NCT00566501|566387201|FG000|Overall Study|Other|25|||
156898117|NCT00566501|566387202|FG001|Overall Study|Other|21|||
156898118|NCT00437320|566387208|FG000|Overall Study|Participant request|2|||
156898119|NCT00437320|566387209|FG001|Overall Study|Participant request|1|||
156898120|NCT00437320|566387210|FG002|Overall Study|Participant request|4|||
156898121|NCT01698905|566387211|FG000|Overall Study|Adverse Event|4|||
156898122|NCT01698905|566387211|FG000|Overall Study|Physician Decision|2|||
156898123|NCT01698905|566387211|FG000|Overall Study|Pregnancy|1|||
156898124|NCT01698905|566387211|FG000|Overall Study|Protocol Violation|1|||
156898125|NCT01698905|566387211|FG000|Overall Study|Subject/guardian decision|2|||
156898126|NCT01698905|566387211|FG000|Overall Study|Death|1|||
156898127|NCT01231347|566387213|FG000|Overall Study|Full Consent withdrawn|19|||
156898128|NCT01231347|566387214|FG001|Overall Study|Full Consent withdrawn|19|||
156898129|NCT01231347|566387215|FG002|Overall Study|Full Consent withdrawn|11|||
156898130|NCT01231347|566387213|FG000|Overall Study|Lost to Follow-up|4|||
156898131|NCT01231347|566387214|FG001|Overall Study|Lost to Follow-up|2|||
156898132|NCT01231347|566387215|FG002|Overall Study|Lost to Follow-up|2|||
156898133|NCT01231347|566387213|FG000|Overall Study|Death|202|||
156898134|NCT01231347|566387214|FG001|Overall Study|Death|210|||
156898135|NCT01231347|566387215|FG002|Overall Study|Death|101|||
156898136|NCT01231347|566387213|FG000|Overall Study|other event|7|||
156898137|NCT01231347|566387214|FG001|Overall Study|other event|9|||
156898138|NCT01231347|566387215|FG002|Overall Study|other event|3|||
156898139|NCT02979197|566387234|FG000|Overall Study|Adverse Event|4|||
156898140|NCT02979197|566387235|FG001|Overall Study|Adverse Event|2|||
156898141|NCT02979197|566387236|FG002|Overall Study|Adverse Event|0|||
156898142|NCT02979197|566387234|FG000|Overall Study|Protocol Violation|0|||
156898143|NCT02979197|566387235|FG001|Overall Study|Protocol Violation|1|||
156898144|NCT02979197|566387236|FG002|Overall Study|Protocol Violation|0|||
157026171|NCT04828005|566849733|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
156898145|NCT02979197|566387234|FG000|Overall Study|Subject unable to commit to study dates|0|||
156898146|NCT02979197|566387235|FG001|Overall Study|Subject unable to commit to study dates|1|||
156898147|NCT02979197|566387236|FG002|Overall Study|Subject unable to commit to study dates|0|||
156898148|NCT03438383|566387237|FG000|Overall Study|Protocol Violation|9|||
156898149|NCT03438383|566387238|FG001|Overall Study|Protocol Violation|3|||
156898150|NCT02435069|566387239|FG000|Dose Response - First Intervention|Adverse Event|0|||
156898151|NCT02435069|566387240|FG001|Dose Response - First Intervention|Adverse Event|1|||
156898152|NCT02435069|566387241|FG002|Dose Response - First Intervention|Adverse Event|1|||
156898153|NCT02435069|566387242|FG003|Dose Response - First Intervention|Adverse Event|0|||
156898154|NCT02435069|566387243|FG004|Dose Response - First Intervention|Adverse Event|0|||
156898155|NCT02435069|566387239|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156898156|NCT02435069|566387240|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156898157|NCT02435069|566387241|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156898158|NCT02435069|566387242|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
156898159|NCT02435069|566387243|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
156898160|NCT01528033|566387244|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
156898161|NCT01528033|566387245|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
156898162|NCT01528033|566387244|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
156898163|NCT01528033|566387245|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
156898164|NCT01528033|566387244|FG000|Primary Endpoint Assessment ITT|Death|2|||
156898165|NCT01528033|566387245|FG001|Primary Endpoint Assessment ITT|Death|2|||
156898166|NCT01528033|566387244|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
156898167|NCT01528033|566387245|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
156898168|NCT01528033|566387244|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
156898169|NCT01528033|566387245|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
156898170|NCT01528033|566387244|FG000|Follow Up|No data available|46|||
156898171|NCT01528033|566387245|FG001|Follow Up|No data available|44|||
156898172|NCT03112590|566387246|FG000|Overall Study|Adverse Event|0|||
156898173|NCT03112590|566387247|FG001|Overall Study|Adverse Event|1|||
156898174|NCT03112590|566387248|FG002|Overall Study|Adverse Event|0|||
156898175|NCT02436681|566387251|FG000|Overall Study|Lost to Follow-up|10|||
156898176|NCT02436681|566387251|FG000|Overall Study|Withdrawal by Subject|2|||
156898177|NCT02436681|566387251|FG000|Overall Study|Death|2|||
156898178|NCT02030938|566387252|FG000|Overall Study|Lost to Follow-up|4|||
156898179|NCT02030938|566387252|FG000|Overall Study|Withdrawal by Subject|1|||
156898180|NCT03954132|566387256|FG000|Overall Study|Adverse Event|2|||
156898181|NCT03954132|566387257|FG001|Overall Study|Adverse Event|0|||
156898182|NCT03954132|566387256|FG000|Overall Study|Patient's wish|5|||
156898183|NCT03954132|566387257|FG001|Overall Study|Patient's wish|0|||
156898184|NCT03954132|566387256|FG000|Overall Study|Lost to Follow-up|10|||
156898185|NCT03954132|566387257|FG001|Overall Study|Lost to Follow-up|0|||
156898186|NCT03954132|566387256|FG000|Overall Study|Screening failure|0|||
156898187|NCT03954132|566387257|FG001|Overall Study|Screening failure|1|||
156898188|NCT03954132|566387256|FG000|Overall Study|No registration after Visit 1|5|||
156898189|NCT03954132|566387257|FG001|Overall Study|No registration after Visit 1|2|||
156898190|NCT03954132|566387256|FG000|Overall Study|Other reason than listed|2|||
156898191|NCT03954132|566387257|FG001|Overall Study|Other reason than listed|2|||
156898192|NCT03954132|566387256|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
156898193|NCT03954132|566387257|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
156898194|NCT03954132|566387256|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
156898195|NCT03954132|566387257|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
156898196|NCT01414608|566387260|FG000|Overall Study|Ineligible|5|||
156898197|NCT01414608|566387261|FG001|Overall Study|Ineligible|2|||
156898198|NCT05156073|566387262|FG000|Overall Study|Patient canceled appointment with PCP|1|||
156898199|NCT03635788|566387266|FG000|Step 1|Death|1|||
156898200|NCT03635788|566387267|FG001|Step 1|Death|0|||
156898201|NCT03635788|566387268|FG002|Step 1|Death|0|||
156898202|NCT03635788|566387266|FG000|Step 1|Lost to Follow-up|31|||
156898203|NCT03635788|566387267|FG001|Step 1|Lost to Follow-up|0|||
156898204|NCT03635788|566387268|FG002|Step 1|Lost to Follow-up|0|||
156898205|NCT03635788|566387266|FG000|Step 1|Pregnancy|1|||
156898206|NCT03635788|566387267|FG001|Step 1|Pregnancy|0|||
156898207|NCT03635788|566387268|FG002|Step 1|Pregnancy|0|||
156898208|NCT03635788|566387266|FG000|Step 1|Protocol Violation|8|||
156898209|NCT03635788|566387267|FG001|Step 1|Protocol Violation|0|||
156898210|NCT03635788|566387268|FG002|Step 1|Protocol Violation|0|||
156898211|NCT03635788|566387266|FG000|Step 1|Withdrawal by Subject|13|||
156898212|NCT03635788|566387267|FG001|Step 1|Withdrawal by Subject|0|||
156898213|NCT03635788|566387268|FG002|Step 1|Withdrawal by Subject|0|||
156898214|NCT03635788|566387266|FG000|Step 1|Other reasons|12|||
156898215|NCT03635788|566387267|FG001|Step 1|Other reasons|0|||
157225507|NCT00818883|567571452|FG001|Overall Study|Adverse Event|19|||
156898216|NCT03635788|566387268|FG002|Step 1|Other reasons|0|||
156898217|NCT03635788|566387266|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
156898218|NCT03635788|566387267|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
156898219|NCT03635788|566387268|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
156898220|NCT03635788|566387266|FG000|Step 2|Lost to Follow-up|0|||
156898221|NCT03635788|566387267|FG001|Step 2|Lost to Follow-up|8|||
156898222|NCT03635788|566387268|FG002|Step 2|Lost to Follow-up|15|||
156898223|NCT03635788|566387266|FG000|Step 2|Withdrawal by Subject|0|||
156898224|NCT03635788|566387267|FG001|Step 2|Withdrawal by Subject|6|||
156898225|NCT03635788|566387268|FG002|Step 2|Withdrawal by Subject|6|||
156898226|NCT03635788|566387266|FG000|Step 2|Death|0|||
156898227|NCT03635788|566387267|FG001|Step 2|Death|2|||
156898228|NCT03635788|566387268|FG002|Step 2|Death|0|||
156898229|NCT03635788|566387266|FG000|Step 2|Incarceration|0|||
156898230|NCT03635788|566387267|FG001|Step 2|Incarceration|2|||
156898231|NCT03635788|566387268|FG002|Step 2|Incarceration|0|||
156898232|NCT03635788|566387266|FG000|Step 2|Non-Compliance With Study Requirements|0|||
156898233|NCT03635788|566387267|FG001|Step 2|Non-Compliance With Study Requirements|1|||
156898234|NCT03635788|566387268|FG002|Step 2|Non-Compliance With Study Requirements|1|||
156898235|NCT03635788|566387266|FG000|Step 2|Confounding Medical Condition|0|||
156898236|NCT03635788|566387267|FG001|Step 2|Confounding Medical Condition|0|||
156898237|NCT03635788|566387268|FG002|Step 2|Confounding Medical Condition|1|||
156898238|NCT03635788|566387266|FG000|Step 2|Out Of State With No Plan To Return|0|||
156898239|NCT03635788|566387267|FG001|Step 2|Out Of State With No Plan To Return|1|||
156898240|NCT03635788|566387268|FG002|Step 2|Out Of State With No Plan To Return|0|||
156898241|NCT03635788|566387266|FG000|Step 2|Switched To Injectables|0|||
156898242|NCT03635788|566387267|FG001|Step 2|Switched To Injectables|0|||
156898243|NCT03635788|566387268|FG002|Step 2|Switched To Injectables|1|||
156898244|NCT03635788|566387266|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
156898245|NCT03635788|566387267|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
156898246|NCT03635788|566387268|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
156898247|NCT05430022|566387269|FG000|Overall Study|Withdrawal by Subject|4|||
156898248|NCT05430022|566387270|FG001|Overall Study|Withdrawal by Subject|4|||
156898249|NCT05521906|566387271|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
156898250|NCT05521906|566387272|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
156898251|NCT03148275|566387277|FG000|Overall Study|Death|6|||
156898252|NCT03148275|566387277|FG000|Overall Study|Adverse Event|3|||
156898253|NCT03148275|566387277|FG000|Overall Study|Liver transplant|2|||
156898254|NCT03148275|566387277|FG000|Overall Study|Patient decision|5|||
156898255|NCT03148275|566387277|FG000|Overall Study|transition to commercial drug|1|||
156898256|NCT03148275|566387277|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
156898257|NCT05098938|566387278|FG000|Overall Study|Adverse Event|4|||
156898258|NCT05098938|566387279|FG001|Overall Study|Adverse Event|3|||
156898259|NCT05098938|566387278|FG000|Overall Study|inclusion/exclusion criteria change|11|||
156898260|NCT05098938|566387279|FG001|Overall Study|inclusion/exclusion criteria change|5|||
156898261|NCT05098938|566387278|FG000|Overall Study|lack of compliance|26|||
156898262|NCT05098938|566387279|FG001|Overall Study|lack of compliance|19|||
156898263|NCT05098938|566387278|FG000|Overall Study|Lost to Follow-up|37|||
156898264|NCT05098938|566387279|FG001|Overall Study|Lost to Follow-up|40|||
156898265|NCT05098938|566387278|FG000|Overall Study|Lost in treatment period|17|||
156898266|NCT05098938|566387279|FG001|Overall Study|Lost in treatment period|13|||
156898267|NCT05098938|566387278|FG000|Overall Study|Met an exclusion criterion|0|||
156898268|NCT05098938|566387279|FG001|Overall Study|Met an exclusion criterion|3|||
156898269|NCT05098938|566387278|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
156898270|NCT05098938|566387279|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
156898271|NCT05098938|566387278|FG000|Overall Study|Physician Decision|25|||
156898272|NCT05098938|566387279|FG001|Overall Study|Physician Decision|32|||
156898273|NCT05098938|566387278|FG000|Overall Study|Run in failure in treatment phase|1|||
156898274|NCT05098938|566387279|FG001|Overall Study|Run in failure in treatment phase|1|||
156898275|NCT05098938|566387278|FG000|Overall Study|Withdrawal by Subject|0|||
156898276|NCT05098938|566387279|FG001|Overall Study|Withdrawal by Subject|3|||
156898277|NCT05098938|566387278|FG000|Overall Study|Run-in Failure in early study|505|||
156898278|NCT05098938|566387279|FG001|Overall Study|Run-in Failure in early study|514|||
156898279|NCT05098938|566387278|FG000|Overall Study|IMP delivery missed|1|||
156898280|NCT05098938|566387279|FG001|Overall Study|IMP delivery missed|5|||
156898281|NCT05098938|566387278|FG000|Overall Study|6 months visit was missed|2|||
156898282|NCT05098938|566387279|FG001|Overall Study|6 months visit was missed|0|||
156898283|NCT05098938|566387278|FG000|Overall Study|fit for use was not completed within window|3|||
156898284|NCT05098938|566387279|FG001|Overall Study|fit for use was not completed within window|0|||
156898285|NCT05098938|566387278|FG000|Overall Study|V2 visit was not completed within window|0|||
156898286|NCT05098938|566387279|FG001|Overall Study|V2 visit was not completed within window|1|||
156898287|NCT05098938|566387278|FG000|Overall Study|exclusionary medication use|1|||
157026172|NCT04828005|566849734|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
157026173|NCT04828005|566849731|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
157026174|NCT04828005|566849732|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
157026175|NCT04828005|566849733|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
157026176|NCT04828005|566849734|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
157026177|NCT04828005|566849731|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
157026178|NCT04828005|566849732|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
157026179|NCT04828005|566849733|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
157026180|NCT04828005|566849734|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
157026181|NCT04828005|566849731|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
157026182|NCT04828005|566849732|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
157026183|NCT04828005|566849733|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
157026184|NCT04828005|566849734|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
156898288|NCT05098938|566387279|FG001|Overall Study|exclusionary medication use|2|||
156898289|NCT05098938|566387278|FG000|Overall Study|change in medication|1|||
156898290|NCT05098938|566387279|FG001|Overall Study|change in medication|0|||
156898291|NCT05098938|566387278|FG000|Overall Study|treatment failure|2|||
156898292|NCT05098938|566387279|FG001|Overall Study|treatment failure|1|||
156898293|NCT01828320|566387280|FG000|Overall Study|Lost to Follow-up|1|||
156898294|NCT01828320|566387281|FG001|Overall Study|Lost to Follow-up|3|||
156898295|NCT01828320|566387280|FG000|Overall Study|Withdrawal by Subject|7|||
156898296|NCT01828320|566387281|FG001|Overall Study|Withdrawal by Subject|2|||
156898297|NCT03803683|566387282|FG000|Overall Study|Lost to Follow-up|41|||
156898298|NCT03803683|566387283|FG001|Overall Study|Lost to Follow-up|18|||
156898299|NCT03803683|566387284|FG002|Overall Study|Lost to Follow-up|12|||
156898300|NCT03803683|566387282|FG000|Overall Study|Withdrawal by Subject|9|||
156898301|NCT03803683|566387283|FG001|Overall Study|Withdrawal by Subject|1|||
156898302|NCT03803683|566387284|FG002|Overall Study|Withdrawal by Subject|4|||
156898303|NCT00492050|566387285|FG000|Overall Study|Adverse Event|1|||
156898304|NCT00492050|566387285|FG000|Overall Study|Lack of Efficacy|1|||
156898305|NCT00492050|566387285|FG000|Overall Study|Withdrawal by Subject|3|||
156898306|NCT00492050|566387285|FG000|Overall Study|Unable to collect SCT|2|||
156898307|NCT00492050|566387285|FG000|Overall Study|Progressive Disease|2|||
156898308|NCT00195273|566389363|FG000|Overall Study|Adverse Event|9|||
156898309|NCT00195273|566389364|FG001|Overall Study|Adverse Event|9|||
156898310|NCT00195273|566389363|FG000|Overall Study|Protocol deviation|0|||
156898311|NCT00195273|566389364|FG001|Overall Study|Protocol deviation|1|||
156898312|NCT00195273|566389363|FG000|Overall Study|Lack of Efficacy|3|||
156898313|NCT00195273|566389364|FG001|Overall Study|Lack of Efficacy|1|||
156898314|NCT00195273|566389363|FG000|Overall Study|Procedural complications|9|||
156898315|NCT00195273|566389364|FG001|Overall Study|Procedural complications|3|||
156898316|NCT02367131|566389365|FG000|Overall Study|Adverse Event|64|||
156898317|NCT02367131|566389365|FG000|Overall Study|No visit since the first visit|3|||
156898318|NCT02367131|566389365|FG000|Overall Study|Request by patient|53|||
156898319|NCT02367131|566389365|FG000|Overall Study|Improvement/remission|2|||
156898320|NCT02367131|566389365|FG000|Overall Study|No change/progressive disease|78|||
156898321|NCT02367131|566389365|FG000|Overall Study|Other than stated above|20|||
156898322|NCT02367131|566389365|FG000|Overall Study|Not treated|2|||
156898323|NCT05061966|566389378|FG000|Overall Study|Lost to Follow-up|13|||
156898324|NCT05061966|566389379|FG001|Overall Study|Lost to Follow-up|13|||
156898325|NCT02923427|566389380|FG000|Overall Study|convert to laparatomy|2|||
156898326|NCT02923427|566389381|FG001|Overall Study|convert to laparatomy|2|||
156898327|NCT02923427|566389380|FG000|Overall Study|destaturation|1|||
156898328|NCT02923427|566389381|FG001|Overall Study|destaturation|0|||
156898329|NCT02923427|566389380|FG000|Overall Study|can not replace LMA|1|||
156898330|NCT02923427|566389381|FG001|Overall Study|can not replace LMA|0|||
156898331|NCT01325623|566389382|FG000|Overall Study|Withdrawal by Subject|3|||
156898332|NCT01539642|566389388|FG000|Overall Study|Lack of Efficacy|20|||
156898333|NCT01539642|566389389|FG001|Overall Study|Lack of Efficacy|18|||
156898334|NCT01539642|566389388|FG000|Overall Study|Patient ready for early discharge|8|||
156898335|NCT01539642|566389389|FG001|Overall Study|Patient ready for early discharge|7|||
156898336|NCT01539642|566389388|FG000|Overall Study|Adverse Event|6|||
156898337|NCT01539642|566389389|FG001|Overall Study|Adverse Event|4|||
156898338|NCT01539642|566389388|FG000|Overall Study|Withdrawal by Subject|2|||
156898339|NCT01539642|566389389|FG001|Overall Study|Withdrawal by Subject|2|||
156898340|NCT00598702|566389390|FG000|Overall Study|Other|0|||
156898341|NCT00598702|566389391|FG001|Overall Study|Other|2|||
156898342|NCT00598702|566389392|FG002|Overall Study|Other|0|||
156898343|NCT00598702|566389393|FG003|Overall Study|Other|0|||
156898344|NCT00598702|566389394|FG004|Overall Study|Other|0|||
156898345|NCT00598702|566389395|FG005|Overall Study|Other|1|||
156898346|NCT00598702|566389396|FG006|Overall Study|Other|0|||
156898347|NCT00598702|566389397|FG007|Overall Study|Other|0|||
156898348|NCT00598702|566389390|FG000|Overall Study|Early discharge from hospital|0|||
156898349|NCT00598702|566389391|FG001|Overall Study|Early discharge from hospital|0|||
156898350|NCT00598702|566389392|FG002|Overall Study|Early discharge from hospital|2|||
156898351|NCT00598702|566389393|FG003|Overall Study|Early discharge from hospital|5|||
156898352|NCT00598702|566389394|FG004|Overall Study|Early discharge from hospital|0|||
156898353|NCT00598702|566389395|FG005|Overall Study|Early discharge from hospital|10|||
156898354|NCT00598702|566389396|FG006|Overall Study|Early discharge from hospital|1|||
156898355|NCT00598702|566389397|FG007|Overall Study|Early discharge from hospital|0|||
157158354|NCT04891770|567324575|FG000|Overall Study|Investigator's discretion|0|||
156898356|NCT00598702|566389390|FG000|Overall Study|Adverse Event|0|||
156898357|NCT00598702|566389391|FG001|Overall Study|Adverse Event|0|||
156898358|NCT00598702|566389392|FG002|Overall Study|Adverse Event|0|||
156898359|NCT00598702|566389393|FG003|Overall Study|Adverse Event|1|||
156898360|NCT00598702|566389394|FG004|Overall Study|Adverse Event|0|||
156898361|NCT00598702|566389395|FG005|Overall Study|Adverse Event|0|||
156898362|NCT00598702|566389396|FG006|Overall Study|Adverse Event|0|||
156898363|NCT00598702|566389397|FG007|Overall Study|Adverse Event|0|||
156898364|NCT00598702|566389390|FG000|Overall Study|Withdrawal by Subject|0|||
156898365|NCT00598702|566389391|FG001|Overall Study|Withdrawal by Subject|0|||
156898366|NCT00598702|566389392|FG002|Overall Study|Withdrawal by Subject|0|||
156898367|NCT00598702|566389393|FG003|Overall Study|Withdrawal by Subject|1|||
156898368|NCT00598702|566389394|FG004|Overall Study|Withdrawal by Subject|1|||
156898369|NCT00598702|566389395|FG005|Overall Study|Withdrawal by Subject|0|||
156898370|NCT00598702|566389396|FG006|Overall Study|Withdrawal by Subject|0|||
156898371|NCT00598702|566389397|FG007|Overall Study|Withdrawal by Subject|0|||
156898372|NCT00598702|566389390|FG000|Overall Study|Physician Decision|0|||
156898373|NCT00598702|566389391|FG001|Overall Study|Physician Decision|0|||
156898374|NCT00598702|566389392|FG002|Overall Study|Physician Decision|0|||
156898375|NCT00598702|566389393|FG003|Overall Study|Physician Decision|0|||
156898376|NCT00598702|566389394|FG004|Overall Study|Physician Decision|1|||
156898377|NCT00598702|566389395|FG005|Overall Study|Physician Decision|0|||
156898378|NCT00598702|566389396|FG006|Overall Study|Physician Decision|0|||
156898379|NCT00598702|566389397|FG007|Overall Study|Physician Decision|0|||
156898380|NCT00598702|566389390|FG000|Overall Study|Dose limiting toxicity|0|||
156898381|NCT00598702|566389391|FG001|Overall Study|Dose limiting toxicity|0|||
156898382|NCT00598702|566389392|FG002|Overall Study|Dose limiting toxicity|0|||
156898383|NCT00598702|566389393|FG003|Overall Study|Dose limiting toxicity|1|||
156898384|NCT00598702|566389394|FG004|Overall Study|Dose limiting toxicity|1|||
156898385|NCT00598702|566389395|FG005|Overall Study|Dose limiting toxicity|1|||
156898386|NCT00598702|566389396|FG006|Overall Study|Dose limiting toxicity|0|||
156898387|NCT00598702|566389397|FG007|Overall Study|Dose limiting toxicity|0|||
156898388|NCT02556203|566389398|FG000|Overall Study|Withdrawal by Subject|21|||
156898389|NCT02556203|566389399|FG001|Overall Study|Withdrawal by Subject|21|||
156898390|NCT02556203|566389398|FG000|Overall Study|Lost to Follow-up|5|||
156898391|NCT02556203|566389399|FG001|Overall Study|Lost to Follow-up|5|||
156898392|NCT02556203|566389398|FG000|Overall Study|Adverse Event|1|||
156898393|NCT02556203|566389399|FG001|Overall Study|Adverse Event|0|||
156898394|NCT04171765|566389404|FG000|Overall Study|Adverse Event|2|||
156898395|NCT04171765|566389405|FG001|Overall Study|Adverse Event|0|||
156898396|NCT04171765|566389406|FG002|Overall Study|Adverse Event|1|||
156898397|NCT04171765|566389407|FG003|Overall Study|Adverse Event|0|||
156898398|NCT04171765|566389404|FG000|Overall Study|Lost to Follow-up|0|||
156898399|NCT04171765|566389405|FG001|Overall Study|Lost to Follow-up|2|||
156898400|NCT04171765|566389406|FG002|Overall Study|Lost to Follow-up|2|||
156898401|NCT04171765|566389407|FG003|Overall Study|Lost to Follow-up|2|||
156898402|NCT04171765|566389404|FG000|Overall Study|Week 58 visit missed|0|||
156898403|NCT04171765|566389405|FG001|Overall Study|Week 58 visit missed|0|||
156898404|NCT04171765|566389406|FG002|Overall Study|Week 58 visit missed|1|||
156898405|NCT04171765|566389407|FG003|Overall Study|Week 58 visit missed|0|||
156898406|NCT04171765|566389404|FG000|Overall Study|Study terminated by sponsor|2|||
156898407|NCT04171765|566389405|FG001|Overall Study|Study terminated by sponsor|0|||
156898408|NCT04171765|566389406|FG002|Overall Study|Study terminated by sponsor|0|||
156898409|NCT04171765|566389407|FG003|Overall Study|Study terminated by sponsor|0|||
156898410|NCT04171765|566389404|FG000|Overall Study|Withdrawal by Subject|1|||
156898411|NCT04171765|566389405|FG001|Overall Study|Withdrawal by Subject|0|||
156898412|NCT04171765|566389406|FG002|Overall Study|Withdrawal by Subject|0|||
156898413|NCT04171765|566389407|FG003|Overall Study|Withdrawal by Subject|3|||
156898414|NCT04137224|566389413|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
156898415|NCT04137224|566389414|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
156898416|NCT04137224|566389413|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
156898417|NCT04137224|566389414|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
156898418|NCT04137224|566389413|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
156898419|NCT04137224|566389414|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
156898420|NCT01669928|566389415|FG000|First Intervention|Withdrawal by Subject|3|||
156898421|NCT01669928|566389416|FG001|First Intervention|Withdrawal by Subject|5|||
156898422|NCT01954342|566389419|FG000|Overall Study|Missing data from 13-16week study visit|0|||
156898423|NCT01954342|566389420|FG001|Overall Study|Missing data from 13-16week study visit|0|||
156898424|NCT01954342|566389421|FG002|Overall Study|Missing data from 13-16week study visit|0|||
156898425|NCT01954342|566389422|FG003|Overall Study|Missing data from 13-16week study visit|1|||
156898426|NCT01954342|566389419|FG000|Overall Study|Miscarriage|0|||
156898427|NCT01954342|566389420|FG001|Overall Study|Miscarriage|0|||
156898428|NCT01954342|566389421|FG002|Overall Study|Miscarriage|0|||
156898429|NCT01954342|566389422|FG003|Overall Study|Miscarriage|3|||
156898430|NCT01954342|566389419|FG000|Overall Study|Lost to Follow-up|0|||
156898431|NCT01954342|566389420|FG001|Overall Study|Lost to Follow-up|0|||
156898432|NCT01954342|566389421|FG002|Overall Study|Lost to Follow-up|0|||
156898433|NCT01954342|566389422|FG003|Overall Study|Lost to Follow-up|5|||
156898434|NCT01954342|566389419|FG000|Overall Study|Preterm delivery|0|||
156898435|NCT01954342|566389420|FG001|Overall Study|Preterm delivery|0|||
156898436|NCT01954342|566389421|FG002|Overall Study|Preterm delivery|0|||
156898437|NCT01954342|566389422|FG003|Overall Study|Preterm delivery|3|||
156898438|NCT01954342|566389419|FG000|Overall Study|Pre-eclampsia|0|||
156898439|NCT01954342|566389420|FG001|Overall Study|Pre-eclampsia|0|||
156898440|NCT01954342|566389421|FG002|Overall Study|Pre-eclampsia|0|||
156898441|NCT01954342|566389422|FG003|Overall Study|Pre-eclampsia|4|||
156898442|NCT01954342|566389419|FG000|Overall Study|Unreliable Data|0|||
156898443|NCT01954342|566389420|FG001|Overall Study|Unreliable Data|0|||
156898444|NCT01954342|566389421|FG002|Overall Study|Unreliable Data|0|||
156858693|NCT04158583|566236752|FG000|Overall Study|Clinical Deterioration|0|||
156858694|NCT04158583|566236753|FG001|Overall Study|Clinical Deterioration|0|||
156858695|NCT04158583|566236754|FG002|Overall Study|Clinical Deterioration|0|||
156858696|NCT04158583|566236755|FG003|Overall Study|Clinical Deterioration|1|||
156858697|NCT04158583|566236756|FG004|Overall Study|Clinical Deterioration|0|||
156858698|NCT04158583|566236757|FG005|Overall Study|Clinical Deterioration|0|||
156858699|NCT04158583|566236758|FG006|Overall Study|Clinical Deterioration|0|||
156858700|NCT04158583|566236759|FG007|Overall Study|Clinical Deterioration|0|||
156858701|NCT04158583|566236760|FG008|Overall Study|Clinical Deterioration|0|||
156858702|NCT04158583|566236761|FG009|Overall Study|Clinical Deterioration|1|||
156858703|NCT02412306|566238562|FG000|Overall Study|Lost to Follow-up|0|||
156858704|NCT02412306|566238563|FG001|Overall Study|Lost to Follow-up|1|||
156858705|NCT02412306|566238564|FG002|Overall Study|Lost to Follow-up|0|||
156858706|NCT02412306|566238565|FG003|Overall Study|Lost to Follow-up|0|||
156858707|NCT02412306|566238566|FG004|Overall Study|Lost to Follow-up|0|||
156858708|NCT02412306|566238562|FG000|Overall Study|Withdrawal by Subject|0|||
156858709|NCT02412306|566238563|FG001|Overall Study|Withdrawal by Subject|0|||
156858710|NCT02412306|566238564|FG002|Overall Study|Withdrawal by Subject|1|||
156858711|NCT02412306|566238565|FG003|Overall Study|Withdrawal by Subject|0|||
156858712|NCT02412306|566238566|FG004|Overall Study|Withdrawal by Subject|0|||
156858713|NCT02412306|566238562|FG000|Overall Study|Death|5|||
156858714|NCT02412306|566238563|FG001|Overall Study|Death|7|||
156858715|NCT02412306|566238564|FG002|Overall Study|Death|15|||
156858716|NCT02412306|566238565|FG003|Overall Study|Death|0|||
156858717|NCT02412306|566238566|FG004|Overall Study|Death|2|||
156858718|NCT00443040|566238574|FG000|Overall Study|Withdrawal by Subject|1|||
156858719|NCT00443040|566238575|FG001|Overall Study|Withdrawal by Subject|0|||
156858720|NCT00443040|566238576|FG002|Overall Study|Withdrawal by Subject|0|||
156858721|NCT00443040|566238574|FG000|Overall Study|Converted to an open laparotomy|3|||
156858722|NCT00443040|566238575|FG001|Overall Study|Converted to an open laparotomy|0|||
156858723|NCT00443040|566238576|FG002|Overall Study|Converted to an open laparotomy|1|||
156858724|NCT00866177|566238577|FG000|Overall Study|Withdrawal by Subject|1|||
156858725|NCT00866177|566238577|FG000|Overall Study|Not Treated|151|||
156858726|NCT00435409|566238580|FG000|Overall Study|Protocol Violation|1|||
156858727|NCT00435409|566238581|FG001|Overall Study|Protocol Violation|2|||
156858728|NCT00435409|566238582|FG002|Overall Study|Protocol Violation|0|||
156858729|NCT00435409|566238580|FG000|Overall Study|Lost to Follow-up|1|||
156858730|NCT00435409|566238581|FG001|Overall Study|Lost to Follow-up|2|||
156858731|NCT00435409|566238582|FG002|Overall Study|Lost to Follow-up|0|||
156858732|NCT00435409|566238580|FG000|Overall Study|Death|8|||
156858733|NCT00435409|566238581|FG001|Overall Study|Death|6|||
156858734|NCT00435409|566238582|FG002|Overall Study|Death|6|||
156858735|NCT00435409|566238580|FG000|Overall Study|Objective progression or relapse|158|||
156858736|NCT00435409|566238581|FG001|Overall Study|Objective progression or relapse|93|||
156858737|NCT00435409|566238582|FG002|Overall Study|Objective progression or relapse|58|||
156858738|NCT00435409|566238580|FG000|Overall Study|Global deterioration of health status|0|||
156858739|NCT00435409|566238581|FG001|Overall Study|Global deterioration of health status|0|||
156858740|NCT00435409|566238582|FG002|Overall Study|Global deterioration of health status|4|||
156858741|NCT00435409|566238580|FG000|Overall Study|Withdrawal by Subject|8|||
156858742|NCT00435409|566238581|FG001|Overall Study|Withdrawal by Subject|7|||
156858743|NCT00435409|566238582|FG002|Overall Study|Withdrawal by Subject|1|||
156858744|NCT00435409|566238580|FG000|Overall Study|Other|45|||
156858745|NCT00435409|566238581|FG001|Overall Study|Other|30|||
156858746|NCT00435409|566238582|FG002|Overall Study|Other|1|||
156858747|NCT00435409|566238580|FG000|Overall Study|Adverse Event|0|||
156858748|NCT00435409|566238581|FG001|Overall Study|Adverse Event|0|||
156858749|NCT00435409|566238582|FG002|Overall Study|Adverse Event|8|||
156858750|NCT00435409|566238580|FG000|Overall Study|Sponsor decision|0|||
156858751|NCT00435409|566238581|FG001|Overall Study|Sponsor decision|3|||
157225508|NCT00818883|567571451|FG000|Overall Study|Protocol Violation|2|||
156858752|NCT00435409|566238582|FG002|Overall Study|Sponsor decision|0|||
156858753|NCT05635461|566238585|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858754|NCT05635461|566238586|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858755|NCT05635461|566238587|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858756|NCT05635461|566238588|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858757|NCT05635461|566238589|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
156858758|NCT05635461|566238590|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
156858759|NCT05635461|566238585|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858760|NCT05635461|566238586|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
156858761|NCT05635461|566238587|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858762|NCT05635461|566238588|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858763|NCT05635461|566238589|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
157026185|NCT04828005|566849731|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
156858764|NCT05635461|566238590|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
156858765|NCT05635461|566238585|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858766|NCT05635461|566238586|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156898445|NCT01954342|566389422|FG003|Overall Study|Unreliable Data|2|||
156898446|NCT00057876|566389423|FG000|Overall Study|Adverse Event|8|||
156898447|NCT00057876|566389424|FG001|Overall Study|Adverse Event|8|||
156898448|NCT00057876|566389423|FG000|Overall Study|Death|2|||
156898449|NCT00057876|566389424|FG001|Overall Study|Death|1|||
156898450|NCT00057876|566389423|FG000|Overall Study|Withdrawal by Subject|5|||
156898451|NCT00057876|566389424|FG001|Overall Study|Withdrawal by Subject|6|||
156898452|NCT00057876|566389423|FG000|Overall Study|Lack of Efficacy|10|||
156898453|NCT00057876|566389424|FG001|Overall Study|Lack of Efficacy|8|||
156898454|NCT00057876|566389423|FG000|Overall Study|Ineligible|1|||
156898455|NCT00057876|566389424|FG001|Overall Study|Ineligible|2|||
156898456|NCT00057876|566389423|FG000|Overall Study|other reason|2|||
156898457|NCT00057876|566389424|FG001|Overall Study|other reason|2|||
156898458|NCT00057876|566389423|FG000|Overall Study|other complicating disease|1|||
156898459|NCT00057876|566389424|FG001|Overall Study|other complicating disease|0|||
156898460|NCT01368432|566389427|FG000|Overall Study|Lost to Follow-up|0|||
156898461|NCT01368432|566389428|FG001|Overall Study|Lost to Follow-up|1|||
156898462|NCT02758171|566389429|FG000|Wash-out|Withdrawal by Subject|1|||
156898463|NCT02758171|566389430|FG001|Wash-out|Withdrawal by Subject|0|||
156898464|NCT02758171|566389429|FG000|Wash-out|Other reason|1|||
156898465|NCT02758171|566389430|FG001|Wash-out|Other reason|0|||
156898466|NCT00984568|566389431|FG000|Overall Study|Withdrawal by Subject|1|||
156898467|NCT00984568|566389432|FG001|Overall Study|Withdrawal by Subject|2|||
156898468|NCT00984568|566389431|FG000|Overall Study|Lack of Efficacy|2|||
156898469|NCT00984568|566389432|FG001|Overall Study|Lack of Efficacy|0|||
156898470|NCT00984568|566389431|FG000|Overall Study|Adverse Event|2|||
156898471|NCT00984568|566389432|FG001|Overall Study|Adverse Event|0|||
156898472|NCT00984568|566389431|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
156898473|NCT00984568|566389432|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
156898474|NCT00984568|566389431|FG000|Overall Study|Lost to Follow-up|0|||
156898475|NCT00984568|566389432|FG001|Overall Study|Lost to Follow-up|1|||
156898476|NCT00984568|566389431|FG000|Overall Study|Opportunistic Infection|1|||
156898477|NCT00984568|566389432|FG001|Overall Study|Opportunistic Infection|0|||
156898478|NCT00984568|566389431|FG000|Overall Study|Unknown Reason|1|||
156898479|NCT00984568|566389432|FG001|Overall Study|Unknown Reason|3|||
156898480|NCT01649804|566389440|FG000|Overall Study|Administrative/Other|8|||
156898481|NCT03719586|566389441|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
156898482|NCT03719586|566389442|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
156898483|NCT03719586|566389443|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
156898484|NCT03719586|566389444|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
156898485|NCT02791594|566389445|FG000|Overall Study|Physician Decision|2|||
156898486|NCT02310321|566389447|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
156898487|NCT02310321|566389448|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156898488|NCT02310321|566389449|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156898489|NCT02310321|566389447|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
156898490|NCT02310321|566389448|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156898491|NCT02310321|566389449|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156898492|NCT02310321|566389447|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
156898493|NCT02310321|566389448|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156898494|NCT02310321|566389449|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
156898495|NCT02310321|566389447|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
156898496|NCT02310321|566389448|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
156898497|NCT02310321|566389449|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
156898498|NCT02310321|566389447|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156898499|NCT02310321|566389448|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
156898500|NCT02310321|566389449|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
156898501|NCT02310321|566389447|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
157158355|NCT04891770|567324576|FG001|Overall Study|Investigator's discretion|1|||
157158356|NCT04891770|567324577|FG002|Overall Study|Investigator's discretion|0|||
157158357|NCT00830037|567324581|FG000|Overall Study|Withdrawal by Subject|2|||
157158358|NCT00830037|567324582|FG001|Overall Study|Withdrawal by Subject|3|||
157158359|NCT00830037|567324581|FG000|Overall Study|Lost to Follow-up|1|||
157158360|NCT00830037|567324582|FG001|Overall Study|Lost to Follow-up|2|||
157158361|NCT00830037|567324581|FG000|Overall Study|Active when terminated by DSMB|15|||
157158362|NCT00830037|567324582|FG001|Overall Study|Active when terminated by DSMB|14|||
156898502|NCT02310321|566389448|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
157158363|NCT01952834|567324584|FG000|Overall Study|Adverse Event|1|||
156898503|NCT02310321|566389449|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
156898504|NCT02310321|566389447|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
157026186|NCT04828005|566849732|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
157158364|NCT04285346|567324585|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
156898505|NCT02310321|566389448|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
156898506|NCT02310321|566389449|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
156898507|NCT02310321|566389447|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
156898508|NCT02310321|566389448|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
156898509|NCT02310321|566389449|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
156898510|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
156898511|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
156898512|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
156898513|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
156898514|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
156898515|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
156898516|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
156898517|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
156898518|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
156898519|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
156898520|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
156898521|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
156898522|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
156898523|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
156898524|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
156898525|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
156898526|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
156898527|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
156898528|NCT02310321|566389447|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
156898529|NCT02310321|566389448|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
156898530|NCT02310321|566389449|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
156898531|NCT02310321|566389447|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
156898532|NCT02310321|566389448|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
156898533|NCT02310321|566389449|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
156898534|NCT02310321|566389447|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
156898535|NCT02310321|566389448|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
156898536|NCT02310321|566389449|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
156898537|NCT02310321|566389447|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
156898538|NCT02310321|566389448|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
156898539|NCT02310321|566389449|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
156898540|NCT02310321|566389447|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
156898541|NCT02310321|566389448|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
156898542|NCT02310321|566389449|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
156898543|NCT02310321|566389447|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
156898544|NCT02310321|566389448|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
156898545|NCT02310321|566389449|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
156898546|NCT02310321|566389447|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
156898547|NCT02310321|566389448|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
156898548|NCT02310321|566389449|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
156898549|NCT02310321|566389447|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
156898550|NCT02310321|566389448|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
156898551|NCT02310321|566389449|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
156898552|NCT02310321|566389447|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
156898553|NCT02310321|566389448|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
156898554|NCT02310321|566389449|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
156898555|NCT04950166|566389450|FG000|Overall Study|Withdrawal by Subject|1|||
156898556|NCT05896748|566389451|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
156898557|NCT05896748|566389451|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
156898558|NCT05896748|566389451|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
156898559|NCT05896748|566389451|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
156898560|NCT05896748|566389451|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
156898561|NCT01199731|566389452|FG000|Overall Study|Adverse Event|0|||
156898562|NCT01199731|566389453|FG001|Overall Study|Adverse Event|1|||
156898563|NCT01199731|566389454|FG002|Overall Study|Adverse Event|0|||
156898564|NCT01199731|566389452|FG000|Overall Study|Study closed/terminated|7|||
156898565|NCT01199731|566389453|FG001|Overall Study|Study closed/terminated|9|||
156898566|NCT01199731|566389454|FG002|Overall Study|Study closed/terminated|7|||
156898567|NCT01199731|566389452|FG000|Overall Study|Lost to Follow-up|0|||
157158365|NCT04285346|567324586|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
157158366|NCT04285346|567324585|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
157158367|NCT04285346|567324586|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
157158368|NCT04285346|567324585|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
157158369|NCT04285346|567324586|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
157158370|NCT01975272|567324589|FG000|Overall Study|Excluded after protocol amendment|1|||
157158371|NCT01975272|567324590|FG001|Overall Study|Excluded after protocol amendment|1|||
157158372|NCT01975272|567324591|FG002|Overall Study|Excluded after protocol amendment|2|||
157158373|NCT00610935|567324592|FG000|Overall Study|Lost to Follow-up|0|||
157158374|NCT00610935|567324593|FG001|Overall Study|Lost to Follow-up|1|||
157158375|NCT00610935|567324592|FG000|Overall Study|Withdrawal by Subject|0|||
156898568|NCT01199731|566389453|FG001|Overall Study|Lost to Follow-up|0|||
156898569|NCT01199731|566389454|FG002|Overall Study|Lost to Follow-up|2|||
156898570|NCT01199731|566389452|FG000|Overall Study|Physician Decision|0|||
156898571|NCT01199731|566389453|FG001|Overall Study|Physician Decision|1|||
156898572|NCT01199731|566389454|FG002|Overall Study|Physician Decision|1|||
156898573|NCT01199731|566389452|FG000|Overall Study|Withdrawal by Subject|2|||
156898574|NCT01199731|566389453|FG001|Overall Study|Withdrawal by Subject|0|||
156898575|NCT01199731|566389454|FG002|Overall Study|Withdrawal by Subject|0|||
156898576|NCT02456103|566389455|FG000|Overall Study|Study Closure|207|||
156898577|NCT02456103|566389455|FG000|Overall Study|Physician Decision|1|||
156898578|NCT02456103|566389455|FG000|Overall Study|Required prohibited medications|5|||
156898579|NCT02456103|566389455|FG000|Overall Study|Protocol Violation|1|||
156898580|NCT02456103|566389455|FG000|Overall Study|Adverse Event|5|||
156898581|NCT02456103|566389455|FG000|Overall Study|Abnormal Laboratory Value|2|||
156898582|NCT02456103|566389455|FG000|Overall Study|Lost to Follow-up|1|||
156898583|NCT02456103|566389455|FG000|Overall Study|Withdrawal by Subject|24|||
156898584|NCT01465191|566389456|FG000|Overall Study|Protocol Violation|6|||
156898585|NCT01465191|566389457|FG001|Overall Study|Protocol Violation|3|||
156898586|NCT01465191|566389458|FG002|Overall Study|Protocol Violation|3|||
156898587|NCT01465191|566389456|FG000|Overall Study|Lost to Follow-up|3|||
156898588|NCT01465191|566389457|FG001|Overall Study|Lost to Follow-up|6|||
156898589|NCT01465191|566389458|FG002|Overall Study|Lost to Follow-up|4|||
156898590|NCT00943124|566389459|FG000|Period 1|Withdrawal by Subject|1|||
156898591|NCT00943124|566389460|FG001|Period 1|Withdrawal by Subject|1|||
156898592|NCT00943124|566389459|FG000|Period 1|Did Not Follow Study Procedures|1|||
156898593|NCT00943124|566389460|FG001|Period 1|Did Not Follow Study Procedures|0|||
156898594|NCT00943124|566389459|FG000|Period 1|Personal Reasons|0|||
156898595|NCT00943124|566389460|FG001|Period 1|Personal Reasons|1|||
156898596|NCT02992132|566389461|FG000|Overall Study|Adverse Event|4|||
156898597|NCT02992132|566389462|FG001|Overall Study|Adverse Event|1|||
156898598|NCT02992132|566389463|FG002|Overall Study|Adverse Event|3|||
156898599|NCT02992132|566389461|FG000|Overall Study|Lack of Efficacy|2|||
156898600|NCT02992132|566389462|FG001|Overall Study|Lack of Efficacy|0|||
156898601|NCT02992132|566389463|FG002|Overall Study|Lack of Efficacy|0|||
156898602|NCT02992132|566389461|FG000|Overall Study|Non-compliance with study drug|2|||
156898603|NCT02992132|566389462|FG001|Overall Study|Non-compliance with study drug|0|||
156898604|NCT02992132|566389463|FG002|Overall Study|Non-compliance with study drug|0|||
156898605|NCT02992132|566389461|FG000|Overall Study|Progressive disease|1|||
156898606|NCT02992132|566389462|FG001|Overall Study|Progressive disease|0|||
156898607|NCT02992132|566389463|FG002|Overall Study|Progressive disease|0|||
156898608|NCT02992132|566389461|FG000|Overall Study|Protocol Violation|2|||
156898609|NCT02992132|566389462|FG001|Overall Study|Protocol Violation|2|||
156898610|NCT02992132|566389463|FG002|Overall Study|Protocol Violation|0|||
156898611|NCT02992132|566389461|FG000|Overall Study|Caregiver withdrew consent|2|||
156898612|NCT02992132|566389462|FG001|Overall Study|Caregiver withdrew consent|3|||
157158376|NCT00610935|567324593|FG001|Overall Study|Withdrawal by Subject|2|||
156898613|NCT02992132|566389463|FG002|Overall Study|Caregiver withdrew consent|2|||
156898614|NCT02992132|566389461|FG000|Overall Study|Withdrawal by Subject|0|||
156898615|NCT02992132|566389462|FG001|Overall Study|Withdrawal by Subject|2|||
156898616|NCT02992132|566389463|FG002|Overall Study|Withdrawal by Subject|1|||
156898617|NCT02992132|566389461|FG000|Overall Study|Physician Decision|0|||
156898618|NCT02992132|566389462|FG001|Overall Study|Physician Decision|0|||
156898619|NCT02992132|566389463|FG002|Overall Study|Physician Decision|1|||
156898620|NCT01916967|566389469|FG000|Overall Study|Adverse Event|0|||
156898621|NCT01916967|566389470|FG001|Overall Study|Adverse Event|0|||
156898622|NCT01916967|566389471|FG002|Overall Study|Adverse Event|2|||
157158377|NCT00610935|567324592|FG000|Overall Study|Sponsor Discontinuation|1|||
157158378|NCT00610935|567324593|FG001|Overall Study|Sponsor Discontinuation|0|||
156898623|NCT01916967|566389469|FG000|Overall Study|Lack of Efficacy|0|||
156898624|NCT01916967|566389470|FG001|Overall Study|Lack of Efficacy|0|||
156898625|NCT01916967|566389471|FG002|Overall Study|Lack of Efficacy|6|||
156898626|NCT01916967|566389469|FG000|Overall Study|Physician Decision|0|||
156898627|NCT01916967|566389470|FG001|Overall Study|Physician Decision|0|||
156898628|NCT01916967|566389471|FG002|Overall Study|Physician Decision|1|||
156898629|NCT01916967|566389469|FG000|Overall Study|Protocol Violation|0|||
156898630|NCT01916967|566389470|FG001|Overall Study|Protocol Violation|1|||
156898631|NCT01916967|566389471|FG002|Overall Study|Protocol Violation|0|||
156898632|NCT00568685|566389472|FG000|Overall Study|Adverse Event|2|||
156898633|NCT00568685|566389473|FG001|Overall Study|Adverse Event|3|||
156898634|NCT00568685|566389474|FG002|Overall Study|Adverse Event|3|||
156898635|NCT00568685|566389472|FG000|Overall Study|Withdrawal by Subject|7|||
156898636|NCT00568685|566389473|FG001|Overall Study|Withdrawal by Subject|2|||
156898637|NCT00568685|566389474|FG002|Overall Study|Withdrawal by Subject|2|||
156898638|NCT00568685|566389472|FG000|Overall Study|Protocol Violation|1|||
156898639|NCT00568685|566389473|FG001|Overall Study|Protocol Violation|0|||
156898640|NCT00568685|566389474|FG002|Overall Study|Protocol Violation|0|||
156898641|NCT00764491|566389476|FG000|Overall Study|Lost to Follow-up|35|||
156898642|NCT00764491|566389477|FG001|Overall Study|Lost to Follow-up|17|||
156898643|NCT00923936|566389479|FG000|Overall Study|progressive disease on study|2|||
156898644|NCT00923936|566389480|FG001|Overall Study|progressive disease on study|1|||
156898645|NCT00923936|566389479|FG000|Overall Study|Adverse Event|2|||
156898646|NCT00923936|566389480|FG001|Overall Study|Adverse Event|1|||
156898647|NCT00923936|566389479|FG000|Overall Study|Lost to follow up|2|||
156898648|NCT00923936|566389480|FG001|Overall Study|Lost to follow up|0|||
156898649|NCT00923936|566389479|FG000|Overall Study|Continuing in follow up period|2|||
156898650|NCT00923936|566389480|FG001|Overall Study|Continuing in follow up period|1|||
156898651|NCT03538431|566389481|FG000|Overall Study|Physician Decision|0|||
156898652|NCT03538431|566389482|FG001|Overall Study|Physician Decision|1|||
156898653|NCT03538431|566389481|FG000|Overall Study|Withdrawal by Subject|1|||
156898654|NCT03538431|566389482|FG001|Overall Study|Withdrawal by Subject|0|||
156898655|NCT02038452|566389483|FG000|Overall Study|Withdrawal by Subject|7|||
156898656|NCT02038452|566389484|FG001|Overall Study|Withdrawal by Subject|9|||
156898657|NCT02038452|566389483|FG000|Overall Study|Lost to Follow-up|31|||
156898658|NCT02038452|566389484|FG001|Overall Study|Lost to Follow-up|28|||
156898659|NCT05394350|566389485|FG000|Overall Study|Death|2|||
156898660|NCT05394350|566389486|FG001|Overall Study|Death|2|||
156898661|NCT05394350|566389487|FG002|Overall Study|Death|4|||
156898662|NCT05394350|566389488|FG003|Overall Study|Death|0|||
156898663|NCT05394350|566389489|FG004|Overall Study|Death|1|||
156898664|NCT05394350|566389490|FG005|Overall Study|Death|0|||
156898665|NCT05394350|566389485|FG000|Overall Study|Study terminated by sponsor|1|||
156898666|NCT05394350|566389486|FG001|Overall Study|Study terminated by sponsor|1|||
156898667|NCT05394350|566389487|FG002|Overall Study|Study terminated by sponsor|7|||
156898668|NCT05394350|566389488|FG003|Overall Study|Study terminated by sponsor|3|||
156898669|NCT05394350|566389489|FG004|Overall Study|Study terminated by sponsor|2|||
156898670|NCT05394350|566389490|FG005|Overall Study|Study terminated by sponsor|4|||
156898671|NCT02027376|566389493|FG000|Overall Study|Death|1|||
156898672|NCT02027376|566389494|FG001|Overall Study|Death|0|||
156898673|NCT02027376|566389495|FG002|Overall Study|Death|0|||
156898674|NCT01626495|566389496|FG000|Overall Study|Adverse Event|3|||
156898675|NCT01626495|566389496|FG000|Overall Study|Disease progression|27|||
156898676|NCT01626495|566389496|FG000|Overall Study|Withdrawal by Subject|1|||
156898677|NCT01626495|566389496|FG000|Overall Study|Administrative problem|1|||
156898678|NCT01626495|566389496|FG000|Overall Study|Death|2|||
156898679|NCT01626495|566389496|FG000|Overall Study|Physician Decision|1|||
156898680|NCT01626495|566389496|FG000|Overall Study|New cancer therapy|16|||
156898681|NCT01626495|566389496|FG000|Overall Study|Manufacturing failure|1|||
156898682|NCT01934972|566389497|FG000|Overall Study|Withdrawal by Subject|9|||
156898683|NCT01934972|566389498|FG001|Overall Study|Withdrawal by Subject|6|||
156898684|NCT01278160|566389499|FG000|Overall Study|Adverse Event|1|||
156898685|NCT01278160|566389500|FG001|Overall Study|Adverse Event|1|||
156898686|NCT01278160|566389499|FG000|Overall Study|Lost to Follow-up|0|||
156898687|NCT01278160|566389500|FG001|Overall Study|Lost to Follow-up|1|||
156898688|NCT01278160|566389499|FG000|Overall Study|Withdrawal by Subject|3|||
157026187|NCT04828005|566849733|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
157026188|NCT04828005|566849734|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
157026189|NCT04828005|566849731|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
157026190|NCT04828005|566849732|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
157026191|NCT04828005|566849733|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
157026192|NCT04828005|566849734|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
157026193|NCT04195698|566851479|FG000|Overall Study|Adverse Event|4|||
157026194|NCT04195698|566851480|FG001|Overall Study|Adverse Event|11|||
157026195|NCT04195698|566851479|FG000|Overall Study|Withdrawal by Subject|9|||
157026196|NCT04195698|566851480|FG001|Overall Study|Withdrawal by Subject|10|||
156898689|NCT01278160|566389500|FG001|Overall Study|Withdrawal by Subject|2|||
156898690|NCT01278160|566389499|FG000|Overall Study|Unclassified|1|||
156898691|NCT01278160|566389500|FG001|Overall Study|Unclassified|2|||
156898692|NCT00304239|566389502|FG000|Overall Study|Protocol Deviations/Violations|15|||
156898693|NCT00304239|566389503|FG001|Overall Study|Protocol Deviations/Violations|0|||
156898694|NCT00304239|566389502|FG000|Overall Study|Adverse Event|2|||
156898695|NCT00304239|566389503|FG001|Overall Study|Adverse Event|0|||
156898696|NCT03643159|566389504|FG000|Overall Study|Adverse Event|1|||
156898697|NCT03643159|566389504|FG000|Overall Study|Withdrawal by Subject|1|||
156898698|NCT00932737|566389507|FG000|Overall Study|Not treated in second episode|1|||
156898699|NCT00932737|566389508|FG001|Overall Study|Not treated in second episode|0|||
156898700|NCT00932737|566389507|FG000|Overall Study|Adverse Event|0|||
156898701|NCT00932737|566389508|FG001|Overall Study|Adverse Event|1|||
156898702|NCT02949700|566389511|FG000|Phase I|Withdrawal by Subject|1|||
157158379|NCT00740779|567324599|FG000|Overall Study|Adverse Event|4|||
157158380|NCT00740779|567324600|FG001|Overall Study|Adverse Event|6|||
157158381|NCT00740779|567324601|FG002|Overall Study|Adverse Event|3|||
157158382|NCT00740779|567324599|FG000|Overall Study|Protocol Violation|1|||
157158383|NCT00740779|567324600|FG001|Overall Study|Protocol Violation|1|||
157158384|NCT00740779|567324601|FG002|Overall Study|Protocol Violation|1|||
157158385|NCT00740779|567324599|FG000|Overall Study|Lack of Efficacy|0|||
157158386|NCT00740779|567324600|FG001|Overall Study|Lack of Efficacy|0|||
156858767|NCT05635461|566238587|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858768|NCT05635461|566238588|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
156858769|NCT05635461|566238589|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858770|NCT05635461|566238590|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
156858771|NCT04750824|566238594|FG000|Overall Study|Toxicity/intolerability|3|||
156858772|NCT04750824|566238595|FG001|Overall Study|Toxicity/intolerability|1|||
156858773|NCT04750824|566238594|FG000|Overall Study|Death|1|||
156858774|NCT04750824|566238595|FG001|Overall Study|Death|3|||
156858775|NCT04750824|566238594|FG000|Overall Study|Scheduled duration of therapy complete|1|||
156858776|NCT04750824|566238595|FG001|Overall Study|Scheduled duration of therapy complete|9|||
156858777|NCT04750824|566238594|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
156858778|NCT04750824|566238595|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
156858779|NCT03192176|566238600|FG000|Overall Study|Adverse Event|1|||
156858780|NCT03192176|566238601|FG001|Overall Study|Adverse Event|0|||
156858781|NCT03192176|566238602|FG002|Overall Study|Adverse Event|4|||
156858782|NCT03192176|566238603|FG003|Overall Study|Adverse Event|5|||
156858783|NCT03192176|566238604|FG004|Overall Study|Adverse Event|3|||
156858784|NCT03192176|566238605|FG005|Overall Study|Adverse Event|2|||
156858785|NCT03192176|566238606|FG006|Overall Study|Adverse Event|3|||
156858786|NCT03192176|566238607|FG007|Overall Study|Adverse Event|3|||
156858787|NCT03192176|566238600|FG000|Overall Study|Lost to Follow-up|0|||
156858788|NCT03192176|566238601|FG001|Overall Study|Lost to Follow-up|0|||
156858789|NCT03192176|566238602|FG002|Overall Study|Lost to Follow-up|1|||
156858790|NCT03192176|566238603|FG003|Overall Study|Lost to Follow-up|2|||
156858791|NCT03192176|566238604|FG004|Overall Study|Lost to Follow-up|3|||
156858792|NCT03192176|566238605|FG005|Overall Study|Lost to Follow-up|1|||
156858793|NCT03192176|566238606|FG006|Overall Study|Lost to Follow-up|1|||
156858794|NCT03192176|566238607|FG007|Overall Study|Lost to Follow-up|1|||
156858795|NCT03192176|566238600|FG000|Overall Study|Physician Decision|1|||
156858796|NCT03192176|566238601|FG001|Overall Study|Physician Decision|0|||
156858797|NCT03192176|566238602|FG002|Overall Study|Physician Decision|0|||
156858798|NCT03192176|566238603|FG003|Overall Study|Physician Decision|0|||
156858799|NCT03192176|566238604|FG004|Overall Study|Physician Decision|0|||
156858800|NCT03192176|566238605|FG005|Overall Study|Physician Decision|2|||
156858801|NCT03192176|566238606|FG006|Overall Study|Physician Decision|1|||
156858802|NCT03192176|566238607|FG007|Overall Study|Physician Decision|0|||
156858803|NCT03192176|566238600|FG000|Overall Study|Protocol Deviation|1|||
156858804|NCT03192176|566238601|FG001|Overall Study|Protocol Deviation|1|||
156858805|NCT03192176|566238602|FG002|Overall Study|Protocol Deviation|0|||
156858806|NCT03192176|566238603|FG003|Overall Study|Protocol Deviation|0|||
156858807|NCT03192176|566238604|FG004|Overall Study|Protocol Deviation|2|||
156858808|NCT03192176|566238605|FG005|Overall Study|Protocol Deviation|0|||
156858809|NCT03192176|566238606|FG006|Overall Study|Protocol Deviation|0|||
156858810|NCT03192176|566238607|FG007|Overall Study|Protocol Deviation|0|||
156858811|NCT03192176|566238600|FG000|Overall Study|Withdrawal by Subject|3|||
156858812|NCT03192176|566238601|FG001|Overall Study|Withdrawal by Subject|4|||
156858813|NCT03192176|566238602|FG002|Overall Study|Withdrawal by Subject|0|||
156858814|NCT03192176|566238603|FG003|Overall Study|Withdrawal by Subject|4|||
156858815|NCT03192176|566238604|FG004|Overall Study|Withdrawal by Subject|3|||
156858816|NCT03192176|566238605|FG005|Overall Study|Withdrawal by Subject|4|||
156858817|NCT03192176|566238606|FG006|Overall Study|Withdrawal by Subject|4|||
156858818|NCT03192176|566238607|FG007|Overall Study|Withdrawal by Subject|2|||
156858819|NCT03192176|566238600|FG000|Overall Study|Miscellaneous|1|||
156858820|NCT03192176|566238601|FG001|Overall Study|Miscellaneous|0|||
157158387|NCT00740779|567324601|FG002|Overall Study|Lack of Efficacy|2|||
157158388|NCT00740779|567324599|FG000|Overall Study|Withdrawal by Subject|2|||
157158389|NCT00740779|567324600|FG001|Overall Study|Withdrawal by Subject|4|||
157158390|NCT00740779|567324601|FG002|Overall Study|Withdrawal by Subject|2|||
156858821|NCT03192176|566238602|FG002|Overall Study|Miscellaneous|1|||
156858822|NCT03192176|566238603|FG003|Overall Study|Miscellaneous|1|||
156858823|NCT03192176|566238604|FG004|Overall Study|Miscellaneous|1|||
156858824|NCT03192176|566238605|FG005|Overall Study|Miscellaneous|2|||
156858825|NCT03192176|566238606|FG006|Overall Study|Miscellaneous|0|||
156858826|NCT03192176|566238607|FG007|Overall Study|Miscellaneous|1|||
156858827|NCT03532542|566238610|FG000|Overall Study|Death|1|||
156858828|NCT03532542|566238611|FG001|Overall Study|Death|0|||
156858829|NCT03532542|566238610|FG000|Overall Study|Study Terminated by Sponsor|41|||
156858830|NCT03532542|566238611|FG001|Overall Study|Study Terminated by Sponsor|65|||
156858831|NCT03532542|566238610|FG000|Overall Study|Withdrawal by Subject|6|||
156858832|NCT03532542|566238611|FG001|Overall Study|Withdrawal by Subject|5|||
156858833|NCT00117637|566238612|FG000|First Intervention (Period 1)|Adverse Event|11|||
157026197|NCT04195698|566851479|FG000|Overall Study|Lost to Follow-up|5|||
157026198|NCT04195698|566851480|FG001|Overall Study|Lost to Follow-up|4|||
157026199|NCT04195698|566851479|FG000|Overall Study|Lack of Efficacy|2|||
157026200|NCT04195698|566851480|FG001|Overall Study|Lack of Efficacy|10|||
156858834|NCT00117637|566238613|FG001|First Intervention (Period 1)|Adverse Event|16|||
156858835|NCT00117637|566238612|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
156858836|NCT00117637|566238613|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
156858837|NCT00117637|566238612|FG000|First Intervention (Period 1)|Protocol Violation|1|||
156858838|NCT00117637|566238613|FG001|First Intervention (Period 1)|Protocol Violation|0|||
156858839|NCT00117637|566238612|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
156858840|NCT00117637|566238613|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
156858841|NCT00117637|566238612|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
156858842|NCT00117637|566238613|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
156858843|NCT00117637|566238612|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
156858844|NCT00117637|566238613|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
156858845|NCT00117637|566238612|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
156858846|NCT00117637|566238613|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
156858847|NCT00117637|566238612|FG000|First Intervention (Period 1)|reason not reported|0|||
156858848|NCT00117637|566238613|FG001|First Intervention (Period 1)|reason not reported|1|||
156858849|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Adverse Event|0|||
156858850|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Adverse Event|9|||
156858851|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
156858852|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
156858853|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
156858854|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
156858855|NCT00117637|566238612|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
156858856|NCT00117637|566238613|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
156858857|NCT00117637|566238612|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
156858858|NCT00117637|566238613|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
156858859|NCT00117637|566238612|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
156858860|NCT00117637|566238613|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
156858861|NCT00117637|566238612|FG000|Second Intervention (Period 2)|reason not reported|1|||
156858862|NCT00117637|566238613|FG001|Second Intervention (Period 2)|reason not reported|0|||
156858863|NCT02914639|566238621|FG000|Overall Study|Withdrawal by Subject|0|||
156858864|NCT02914639|566238622|FG001|Overall Study|Withdrawal by Subject|2|||
156858865|NCT00189540|566238623|FG000|Overall Study|Withdrawal by Subject|3|||
156858866|NCT00189540|566238624|FG001|Overall Study|Withdrawal by Subject|0|||
156858867|NCT00189540|566238623|FG000|Overall Study|Death|4|||
156858868|NCT00189540|566238624|FG001|Overall Study|Death|1|||
156858869|NCT01924845|566238625|FG000|Overall Study|Adverse Event|3|||
156858870|NCT01924845|566238625|FG000|Overall Study|Withdrawal by Subject|2|||
156858871|NCT01924845|566238625|FG000|Overall Study|Protocol Violation|1|||
156858872|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
156858873|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
156858874|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
156858875|NCT00062439|566238626|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
156858876|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Death|1|||
156858877|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Disease progression|2|||
156858878|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
156858879|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
156858880|NCT00062439|566238626|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
156858881|NCT00062439|566238626|FG000|Surgery|Physician Decision|4|||
156858882|NCT00062439|566238626|FG000|Surgery|Death|1|||
156858883|NCT00062439|566238626|FG000|Surgery|Adverse Event|2|||
156858884|NCT00062439|566238626|FG000|Consolidation Chemotherapy|Adverse Event|2|||
156858885|NCT01903356|566238627|FG000|Overall Study|Lost to Follow-up|7|||
156858886|NCT01903356|566238627|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
156858887|NCT01903356|566238627|FG000|Overall Study|Violated the dosage and administration|3|||
156858888|NCT00286442|566238628|FG000|Overall Study|Hyperglycemic Rescue|19|||
156858889|NCT00286442|566238629|FG001|Overall Study|Hyperglycemic Rescue|17|||
156858890|NCT00286442|566238630|FG002|Overall Study|Hyperglycemic Rescue|25|||
156858891|NCT00286442|566238628|FG000|Overall Study|Adverse Event|7|||
156858892|NCT00286442|566238629|FG001|Overall Study|Adverse Event|6|||
156858893|NCT00286442|566238630|FG002|Overall Study|Adverse Event|1|||
156858894|NCT00286442|566238628|FG000|Overall Study|Protocol Violation|2|||
156858895|NCT00286442|566238629|FG001|Overall Study|Protocol Violation|4|||
156858896|NCT00286442|566238630|FG002|Overall Study|Protocol Violation|2|||
156858897|NCT00286442|566238628|FG000|Overall Study|Lost to Follow-up|5|||
156858898|NCT00286442|566238629|FG001|Overall Study|Lost to Follow-up|2|||
156858899|NCT00286442|566238630|FG002|Overall Study|Lost to Follow-up|1|||
157026201|NCT04195698|566851479|FG000|Overall Study|Other|5|||
156898703|NCT02949700|566389512|FG001|Phase I|Withdrawal by Subject|1|||
156898704|NCT02949700|566389513|FG002|Phase I|Withdrawal by Subject|0|||
156898705|NCT02949700|566389514|FG003|Phase I|Withdrawal by Subject|0|||
156898706|NCT02949700|566389511|FG000|Phase I|Protocol Violation|1|||
156898707|NCT02949700|566389512|FG001|Phase I|Protocol Violation|0|||
156898708|NCT02949700|566389513|FG002|Phase I|Protocol Violation|0|||
156898709|NCT02949700|566389514|FG003|Phase I|Protocol Violation|0|||
156898710|NCT02949700|566389511|FG000|Phase II|Withdrawal by Subject|0|||
156898711|NCT02949700|566389512|FG001|Phase II|Withdrawal by Subject|0|||
156898712|NCT02949700|566389513|FG002|Phase II|Withdrawal by Subject|0|||
156898713|NCT02949700|566389514|FG003|Phase II|Withdrawal by Subject|2|||
156898714|NCT02949700|566389511|FG000|Phase II|Protocol Violation|0|||
156898715|NCT02949700|566389512|FG001|Phase II|Protocol Violation|0|||
156898716|NCT02949700|566389513|FG002|Phase II|Protocol Violation|1|||
156898717|NCT02949700|566389514|FG003|Phase II|Protocol Violation|3|||
156898718|NCT00973349|566389515|FG000|Overall Study|Adverse Event|0|||
156898719|NCT00973349|566389516|FG001|Overall Study|Adverse Event|0|||
156898720|NCT00973349|566389517|FG002|Overall Study|Adverse Event|0|||
156898721|NCT00973349|566389518|FG003|Overall Study|Adverse Event|0|||
156898722|NCT00973349|566389519|FG004|Overall Study|Adverse Event|1|||
156898723|NCT00973349|566389520|FG005|Overall Study|Adverse Event|0|||
156898724|NCT00973349|566389521|FG006|Overall Study|Adverse Event|0|||
156898725|NCT00973349|566389522|FG007|Overall Study|Adverse Event|0|||
156898726|NCT00973349|566389523|FG008|Overall Study|Adverse Event|1|||
156898727|NCT00973349|566389524|FG009|Overall Study|Adverse Event|0|||
156898728|NCT00973349|566389525|FG010|Overall Study|Adverse Event|0|||
156898729|NCT00973349|566389526|FG011|Overall Study|Adverse Event|0|||
156898730|NCT00973349|566389527|FG012|Overall Study|Adverse Event|0|||
156898731|NCT00973349|566389528|FG013|Overall Study|Adverse Event|0|||
156898732|NCT00973349|566389529|FG014|Overall Study|Adverse Event|1|||
156898733|NCT00973349|566389530|FG015|Overall Study|Adverse Event|0|||
156898734|NCT00973349|566389515|FG000|Overall Study|Withdrawal by Subject|1|||
156898735|NCT00973349|566389516|FG001|Overall Study|Withdrawal by Subject|2|||
156898736|NCT00973349|566389517|FG002|Overall Study|Withdrawal by Subject|2|||
156898737|NCT00973349|566389518|FG003|Overall Study|Withdrawal by Subject|3|||
156898738|NCT00973349|566389519|FG004|Overall Study|Withdrawal by Subject|2|||
156898739|NCT00973349|566389520|FG005|Overall Study|Withdrawal by Subject|0|||
156898740|NCT00973349|566389521|FG006|Overall Study|Withdrawal by Subject|2|||
156898741|NCT00973349|566389522|FG007|Overall Study|Withdrawal by Subject|2|||
156898742|NCT00973349|566389523|FG008|Overall Study|Withdrawal by Subject|0|||
156898743|NCT00973349|566389524|FG009|Overall Study|Withdrawal by Subject|2|||
156898744|NCT00973349|566389525|FG010|Overall Study|Withdrawal by Subject|0|||
156898745|NCT00973349|566389526|FG011|Overall Study|Withdrawal by Subject|1|||
156898746|NCT00973349|566389527|FG012|Overall Study|Withdrawal by Subject|0|||
156898747|NCT00973349|566389528|FG013|Overall Study|Withdrawal by Subject|0|||
156898748|NCT00973349|566389529|FG014|Overall Study|Withdrawal by Subject|0|||
156898749|NCT00973349|566389530|FG015|Overall Study|Withdrawal by Subject|0|||
156898750|NCT00973349|566389515|FG000|Overall Study|Lost to Follow-up|3|||
156898751|NCT00973349|566389516|FG001|Overall Study|Lost to Follow-up|1|||
156898752|NCT00973349|566389517|FG002|Overall Study|Lost to Follow-up|2|||
156898753|NCT00973349|566389518|FG003|Overall Study|Lost to Follow-up|2|||
156898754|NCT00973349|566389519|FG004|Overall Study|Lost to Follow-up|1|||
156898755|NCT00973349|566389520|FG005|Overall Study|Lost to Follow-up|3|||
156898756|NCT00973349|566389521|FG006|Overall Study|Lost to Follow-up|0|||
156898757|NCT00973349|566389522|FG007|Overall Study|Lost to Follow-up|1|||
156898758|NCT00973349|566389523|FG008|Overall Study|Lost to Follow-up|2|||
156898759|NCT00973349|566389524|FG009|Overall Study|Lost to Follow-up|1|||
156898760|NCT00973349|566389525|FG010|Overall Study|Lost to Follow-up|0|||
156898761|NCT00973349|566389526|FG011|Overall Study|Lost to Follow-up|1|||
156898762|NCT00973349|566389527|FG012|Overall Study|Lost to Follow-up|0|||
156898763|NCT00973349|566389528|FG013|Overall Study|Lost to Follow-up|0|||
156898764|NCT00973349|566389529|FG014|Overall Study|Lost to Follow-up|0|||
156898765|NCT00973349|566389530|FG015|Overall Study|Lost to Follow-up|1|||
156898766|NCT00973349|566389515|FG000|Overall Study|Inappropriate enrolment|0|||
156898767|NCT00973349|566389516|FG001|Overall Study|Inappropriate enrolment|0|||
156898768|NCT00973349|566389517|FG002|Overall Study|Inappropriate enrolment|1|||
156898769|NCT00973349|566389518|FG003|Overall Study|Inappropriate enrolment|0|||
156898770|NCT00973349|566389519|FG004|Overall Study|Inappropriate enrolment|0|||
156898771|NCT00973349|566389520|FG005|Overall Study|Inappropriate enrolment|0|||
156898772|NCT00973349|566389521|FG006|Overall Study|Inappropriate enrolment|0|||
156898773|NCT00973349|566389522|FG007|Overall Study|Inappropriate enrolment|0|||
156898774|NCT00973349|566389523|FG008|Overall Study|Inappropriate enrolment|0|||
156898775|NCT00973349|566389524|FG009|Overall Study|Inappropriate enrolment|2|||
156898776|NCT00973349|566389525|FG010|Overall Study|Inappropriate enrolment|0|||
156898777|NCT00973349|566389526|FG011|Overall Study|Inappropriate enrolment|0|||
156898778|NCT00973349|566389527|FG012|Overall Study|Inappropriate enrolment|1|||
156898779|NCT00973349|566389528|FG013|Overall Study|Inappropriate enrolment|0|||
156898780|NCT00973349|566389529|FG014|Overall Study|Inappropriate enrolment|1|||
156898781|NCT00973349|566389530|FG015|Overall Study|Inappropriate enrolment|1|||
156898782|NCT00973349|566389515|FG000|Overall Study|Protocol Violation|0|||
156898783|NCT00973349|566389516|FG001|Overall Study|Protocol Violation|0|||
156898784|NCT00973349|566389517|FG002|Overall Study|Protocol Violation|0|||
156898785|NCT00973349|566389518|FG003|Overall Study|Protocol Violation|0|||
156898786|NCT00973349|566389519|FG004|Overall Study|Protocol Violation|0|||
156898787|NCT00973349|566389520|FG005|Overall Study|Protocol Violation|0|||
156898788|NCT00973349|566389521|FG006|Overall Study|Protocol Violation|0|||
156898789|NCT00973349|566389522|FG007|Overall Study|Protocol Violation|0|||
156898790|NCT00973349|566389523|FG008|Overall Study|Protocol Violation|1|||
156898791|NCT00973349|566389524|FG009|Overall Study|Protocol Violation|0|||
156898792|NCT00973349|566389525|FG010|Overall Study|Protocol Violation|0|||
156898793|NCT00973349|566389526|FG011|Overall Study|Protocol Violation|0|||
156898794|NCT00973349|566389527|FG012|Overall Study|Protocol Violation|0|||
156898795|NCT00973349|566389528|FG013|Overall Study|Protocol Violation|0|||
156898796|NCT00973349|566389529|FG014|Overall Study|Protocol Violation|0|||
156898797|NCT00973349|566389530|FG015|Overall Study|Protocol Violation|0|||
156898798|NCT00973349|566389515|FG000|Overall Study|Unable to classify|0|||
156898799|NCT00973349|566389516|FG001|Overall Study|Unable to classify|0|||
156898800|NCT00973349|566389517|FG002|Overall Study|Unable to classify|0|||
156898801|NCT00973349|566389518|FG003|Overall Study|Unable to classify|0|||
156898802|NCT00973349|566389519|FG004|Overall Study|Unable to classify|1|||
156898803|NCT00973349|566389520|FG005|Overall Study|Unable to classify|1|||
156898804|NCT00973349|566389521|FG006|Overall Study|Unable to classify|0|||
156898805|NCT00973349|566389522|FG007|Overall Study|Unable to classify|0|||
156898806|NCT00973349|566389523|FG008|Overall Study|Unable to classify|0|||
156898807|NCT00973349|566389524|FG009|Overall Study|Unable to classify|1|||
156898808|NCT00973349|566389525|FG010|Overall Study|Unable to classify|0|||
156898809|NCT00973349|566389526|FG011|Overall Study|Unable to classify|0|||
156898810|NCT00973349|566389527|FG012|Overall Study|Unable to classify|0|||
156898811|NCT00973349|566389528|FG013|Overall Study|Unable to classify|0|||
156898812|NCT00973349|566389529|FG014|Overall Study|Unable to classify|0|||
156898813|NCT00973349|566389530|FG015|Overall Study|Unable to classify|0|||
156898814|NCT02898116|566389535|FG000|Overall Study|Adverse Event|1|||
156898815|NCT02898116|566389535|FG000|Overall Study|Progressive disease|1|||
156898816|NCT05597020|566389536|FG000|Washout|Forbidden medication|2|||
156898817|NCT05597020|566389537|FG001|Washout|Forbidden medication|0|||
156898818|NCT05597020|566389536|FG000|Treatment Period II|Advice from primary care physician|1|||
156898819|NCT05597020|566389537|FG001|Treatment Period II|Advice from primary care physician|0|||
156898820|NCT05597020|566389536|FG000|Treatment Period II|Subject lost investigational product|1|||
156898821|NCT05597020|566389537|FG001|Treatment Period II|Subject lost investigational product|0|||
156898822|NCT05597020|566389536|FG000|Treatment Period II|Private reasons|0|||
156898823|NCT05597020|566389537|FG001|Treatment Period II|Private reasons|1|||
156898824|NCT01015131|566389538|FG000|Overall Study|Physician Decision|1|||
156898825|NCT01015131|566389538|FG000|Overall Study|Protocol Violation|1|||
156898826|NCT01015131|566389538|FG000|Overall Study|Withdrawal by Subject|2|||
156898827|NCT01015131|566389538|FG000|Overall Study|Other Protocol Specified Criteria|4|||
156898828|NCT02452697|566389541|FG000|Overall Study|Physician Decision|4|||
156898829|NCT02452697|566389542|FG001|Overall Study|Physician Decision|4|||
156898830|NCT02452697|566389543|FG002|Overall Study|Physician Decision|3|||
156898831|NCT02452697|566389544|FG003|Overall Study|Physician Decision|2|||
156898832|NCT02452697|566389541|FG000|Overall Study|Withdrawal by Subject|1|||
156898833|NCT02452697|566389542|FG001|Overall Study|Withdrawal by Subject|0|||
156898834|NCT02452697|566389543|FG002|Overall Study|Withdrawal by Subject|0|||
156898835|NCT02452697|566389544|FG003|Overall Study|Withdrawal by Subject|0|||
156898836|NCT02452697|566389541|FG000|Overall Study|still in follow-up|2|||
156898837|NCT02452697|566389542|FG001|Overall Study|still in follow-up|2|||
156898838|NCT02452697|566389543|FG002|Overall Study|still in follow-up|1|||
156898839|NCT02452697|566389544|FG003|Overall Study|still in follow-up|3|||
156898840|NCT00560885|566389545|FG000|Overall Study|Death|7|||
156898841|NCT00560885|566389545|FG000|Overall Study|Withdrawal by Subject|1|||
156898842|NCT02887859|566389546|FG000|Overall Study|Ongoing|6|||
156898843|NCT02887859|566389546|FG000|Overall Study|Adverse Event|7|||
156898844|NCT02887859|566389546|FG000|Overall Study|Death|1|||
156898845|NCT02887859|566389546|FG000|Overall Study|Physician Decision|1|||
156898846|NCT01554397|566389547|FG000|Overall Study|Withdrawal by Subject|1|||
156898847|NCT01554397|566389548|FG001|Overall Study|Withdrawal by Subject|0|||
156898848|NCT01554397|566389547|FG000|Overall Study|Ineligible|7|||
156898849|NCT01554397|566389548|FG001|Overall Study|Ineligible|0|||
156898850|NCT04493333|566391288|FG000|Overall Study|Withdrawal by Subject|1|||
156898851|NCT04493333|566391289|FG001|Overall Study|Withdrawal by Subject|1|||
156898852|NCT04493333|566391288|FG000|Overall Study|Ineligible|0|||
156898853|NCT04493333|566391289|FG001|Overall Study|Ineligible|1|||
156898854|NCT04493333|566391288|FG000|Overall Study|Noncompliance|2|||
156898855|NCT04493333|566391289|FG001|Overall Study|Noncompliance|1|||
156898856|NCT02206048|566391295|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
156898857|NCT02925923|566391296|FG000|Overall Study|blood samples hemolyzed|0|||
156898858|NCT02925923|566391297|FG001|Overall Study|blood samples hemolyzed|2|||
156898859|NCT00866788|566391301|FG000|Overall Study|Adverse Event|0|||
156898860|NCT00866788|566391302|FG001|Overall Study|Adverse Event|2|||
157158391|NCT00740779|567324599|FG000|Overall Study|Lost to Follow-up|2|||
156858900|NCT00286442|566238628|FG000|Overall Study|Physician Decision|1|||
156858901|NCT00286442|566238629|FG001|Overall Study|Physician Decision|1|||
156858902|NCT00286442|566238630|FG002|Overall Study|Physician Decision|1|||
156858903|NCT00286442|566238628|FG000|Overall Study|Administrative Error|1|||
156858904|NCT00286442|566238629|FG001|Overall Study|Administrative Error|1|||
156858905|NCT00286442|566238630|FG002|Overall Study|Administrative Error|0|||
156858906|NCT00286442|566238628|FG000|Overall Study|Withdrawal by Subject|2|||
156858907|NCT00286442|566238629|FG001|Overall Study|Withdrawal by Subject|14|||
156858908|NCT00286442|566238630|FG002|Overall Study|Withdrawal by Subject|2|||
156858909|NCT00079040|566238631|FG000|Overall Study|Withdrew before treatment|1|||
156858910|NCT00079040|566238631|FG000|Overall Study|Ineligible|1|||
156858911|NCT01919229|566238632|FG000|Overall Study|Subject/guardian decision|0|||
156858912|NCT01919229|566238633|FG001|Overall Study|Subject/guardian decision|0|||
156858913|NCT01919229|566238634|FG002|Overall Study|Subject/guardian decision|1|||
156858914|NCT01632020|566238635|FG000|Overall Study|Withdrawal by Subject|1|||
156858915|NCT01632020|566238636|FG001|Overall Study|Withdrawal by Subject|0|||
156858916|NCT01632020|566238635|FG000|Overall Study|Adverse Event|1|||
156858917|NCT01632020|566238636|FG001|Overall Study|Adverse Event|0|||
156858918|NCT00549640|566238638|FG000|Overall Study|Withdrawal by Subject|6|||
156858919|NCT00549640|566238639|FG001|Overall Study|Withdrawal by Subject|12|||
156858920|NCT00549640|566238638|FG000|Overall Study|Adverse Event|5|||
156858921|NCT00549640|566238639|FG001|Overall Study|Adverse Event|0|||
156858922|NCT00549640|566238638|FG000|Overall Study|Lost to Follow-up|7|||
156858923|NCT00549640|566238639|FG001|Overall Study|Lost to Follow-up|4|||
156858924|NCT04999839|566238644|FG000|Overall Study|Adverse Event|1|||
156858925|NCT04999839|566238645|FG001|Overall Study|Adverse Event|1|||
156858926|NCT04999839|566238646|FG002|Overall Study|Adverse Event|1|||
156858927|NCT04999839|566238647|FG003|Overall Study|Adverse Event|1|||
156858928|NCT04999839|566238648|FG004|Overall Study|Adverse Event|1|||
156858929|NCT04999839|566238644|FG000|Overall Study|Lost to Follow-up|2|||
156858930|NCT04999839|566238645|FG001|Overall Study|Lost to Follow-up|0|||
156858931|NCT04999839|566238646|FG002|Overall Study|Lost to Follow-up|2|||
156858932|NCT04999839|566238647|FG003|Overall Study|Lost to Follow-up|4|||
156858933|NCT04999839|566238648|FG004|Overall Study|Lost to Follow-up|1|||
156858934|NCT04999839|566238644|FG000|Overall Study|Withdrawal by Subject|6|||
156858935|NCT04999839|566238645|FG001|Overall Study|Withdrawal by Subject|5|||
156858936|NCT04999839|566238646|FG002|Overall Study|Withdrawal by Subject|3|||
156858937|NCT04999839|566238647|FG003|Overall Study|Withdrawal by Subject|2|||
156858938|NCT04999839|566238648|FG004|Overall Study|Withdrawal by Subject|2|||
156858939|NCT04999839|566238644|FG000|Overall Study|Lack of Efficacy|0|||
156858940|NCT04999839|566238645|FG001|Overall Study|Lack of Efficacy|1|||
156858941|NCT04999839|566238646|FG002|Overall Study|Lack of Efficacy|0|||
156858942|NCT04999839|566238647|FG003|Overall Study|Lack of Efficacy|0|||
156858943|NCT04999839|566238648|FG004|Overall Study|Lack of Efficacy|0|||
156858944|NCT04999839|566238644|FG000|Overall Study|Physician Decision|0|||
156858945|NCT04999839|566238645|FG001|Overall Study|Physician Decision|0|||
156858946|NCT04999839|566238646|FG002|Overall Study|Physician Decision|0|||
156858947|NCT04999839|566238647|FG003|Overall Study|Physician Decision|0|||
156858948|NCT04999839|566238648|FG004|Overall Study|Physician Decision|1|||
156858949|NCT04999839|566238644|FG000|Overall Study|Sponsor request|0|||
156858950|NCT04999839|566238645|FG001|Overall Study|Sponsor request|1|||
156858951|NCT04999839|566238646|FG002|Overall Study|Sponsor request|0|||
156858952|NCT04999839|566238647|FG003|Overall Study|Sponsor request|0|||
156858953|NCT04999839|566238648|FG004|Overall Study|Sponsor request|0|||
156858954|NCT04999839|566238644|FG000|Overall Study|Other|0|||
156858955|NCT04999839|566238645|FG001|Overall Study|Other|0|||
156858956|NCT04999839|566238646|FG002|Overall Study|Other|1|||
156858957|NCT04999839|566238647|FG003|Overall Study|Other|0|||
156858958|NCT04999839|566238648|FG004|Overall Study|Other|0|||
156858959|NCT02734693|566238649|FG000|Overall Study|Adverse Event|1|||
156858960|NCT02734693|566238650|FG001|Overall Study|Adverse Event|3|||
156858961|NCT02734693|566238651|FG002|Overall Study|Adverse Event|3|||
157158392|NCT00740779|567324600|FG001|Overall Study|Lost to Follow-up|3|||
157158393|NCT00740779|567324601|FG002|Overall Study|Lost to Follow-up|5|||
157158394|NCT03280550|567324607|FG000|Overall Study|Withdrawal by Subject|2|||
156858962|NCT02734693|566238649|FG000|Overall Study|Lack of Efficacy|1|||
156858963|NCT02734693|566238650|FG001|Overall Study|Lack of Efficacy|0|||
156858964|NCT02734693|566238651|FG002|Overall Study|Lack of Efficacy|0|||
156858965|NCT02734693|566238649|FG000|Overall Study|Lost to Follow-up|2|||
156858966|NCT02734693|566238650|FG001|Overall Study|Lost to Follow-up|0|||
156858967|NCT02734693|566238651|FG002|Overall Study|Lost to Follow-up|0|||
156858968|NCT02734693|566238649|FG000|Overall Study|Protocol Violation|1|||
156858969|NCT02734693|566238650|FG001|Overall Study|Protocol Violation|0|||
156858970|NCT02734693|566238651|FG002|Overall Study|Protocol Violation|0|||
156858971|NCT02734693|566238649|FG000|Overall Study|Withdrawal by Subject|1|||
156858972|NCT02734693|566238650|FG001|Overall Study|Withdrawal by Subject|0|||
156858973|NCT02734693|566238651|FG002|Overall Study|Withdrawal by Subject|0|||
156858974|NCT03740048|566238652|FG000|Overall Study|Withdrawal by Subject|1|||
156898861|NCT00866788|566391303|FG002|Overall Study|Adverse Event|0|||
157158395|NCT03280550|567324608|FG001|Overall Study|Withdrawal by Subject|2|||
157158396|NCT03280550|567324607|FG000|Overall Study|Physician Decision|0|||
157158397|NCT03280550|567324608|FG001|Overall Study|Physician Decision|1|||
157158398|NCT03345836|567324609|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
157158399|NCT03345836|567324610|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
157158400|NCT03345836|567324611|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
157158401|NCT03345836|567324612|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
157158402|NCT03345836|567324613|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
157158403|NCT03345836|567324614|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
157158404|NCT03345836|567324609|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
157225509|NCT00818883|567571452|FG001|Overall Study|Protocol Violation|2|||
156858975|NCT03740048|566238653|FG001|Overall Study|Withdrawal by Subject|1|||
156858976|NCT03740048|566238652|FG000|Overall Study|Death|1|||
156858977|NCT03740048|566238653|FG001|Overall Study|Death|6|||
156858978|NCT03740048|566238652|FG000|Overall Study|Switched to thrice-weekly HD|2|||
156858979|NCT03740048|566238653|FG001|Overall Study|Switched to thrice-weekly HD|0|||
156858980|NCT03740048|566238652|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
156858981|NCT03740048|566238653|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
156858982|NCT03740048|566238652|FG000|Overall Study|Lost to Follow-up|0|||
156858983|NCT03740048|566238653|FG001|Overall Study|Lost to Follow-up|1|||
156858984|NCT03740048|566238652|FG000|Overall Study|Non-compliance with HD|0|||
156858985|NCT03740048|566238653|FG001|Overall Study|Non-compliance with HD|1|||
156858986|NCT03261336|566238654|FG000|Overall Study|Adverse Event|1|||
156858987|NCT01069484|566238656|FG000|Overall Study|Death-in-near-family|1|||
156858988|NCT01069484|566238657|FG001|Overall Study|Death-in-near-family|0|||
156858989|NCT01069484|566238656|FG000|Overall Study|No specific reason|8|||
156858990|NCT01069484|566238657|FG001|Overall Study|No specific reason|2|||
156858991|NCT01069484|566238656|FG000|Overall Study|Illness mother or child|3|||
156858992|NCT01069484|566238657|FG001|Overall Study|Illness mother or child|1|||
156858993|NCT00292942|566238658|FG000|Overall Study|Withdrawal by Subject|0|||
156858994|NCT00292942|566238659|FG001|Overall Study|Withdrawal by Subject|0|||
156858995|NCT00292942|566238660|FG002|Overall Study|Withdrawal by Subject|1|||
156858996|NCT00292942|566238661|FG003|Overall Study|Withdrawal by Subject|0|||
156858997|NCT00292942|566238658|FG000|Overall Study|Adverse Event|0|||
156858998|NCT00292942|566238659|FG001|Overall Study|Adverse Event|0|||
156858999|NCT00292942|566238660|FG002|Overall Study|Adverse Event|0|||
156859000|NCT00292942|566238661|FG003|Overall Study|Adverse Event|1|||
156859001|NCT00644358|566238662|FG000|Overall Study|Adverse Event|124|||
156859002|NCT00644358|566238662|FG000|Overall Study|Lost to Follow-up|105|||
156859003|NCT00644358|566238662|FG000|Overall Study|Consent Withdrawal|64|||
156859004|NCT00644358|566238662|FG000|Overall Study|Lack of Effectiveness|39|||
156859005|NCT00644358|566238662|FG000|Overall Study|Protocol Violation|5|||
156859006|NCT00644358|566238662|FG000|Overall Study|Noncompliance|14|||
156859007|NCT00644358|566238662|FG000|Overall Study|Other Unspecified|11|||
156859008|NCT00651924|566238667|FG000|Overall Study|Withdrawal by PI|0|||
156859009|NCT00651924|566238668|FG001|Overall Study|Withdrawal by PI|2|||
156859010|NCT00651924|566238667|FG000|Overall Study|Withdrawal by Subject|0|||
156859011|NCT00651924|566238668|FG001|Overall Study|Withdrawal by Subject|5|||
156859012|NCT00758771|566238669|FG000|Overall Study|Withdrawal by Subject|1|||
156859013|NCT00758771|566238670|FG001|Overall Study|Withdrawal by Subject|1|||
156859014|NCT00758771|566238669|FG000|Overall Study|Did not meet eligibility criteria|2|||
156859015|NCT00758771|566238670|FG001|Overall Study|Did not meet eligibility criteria|4|||
156859016|NCT00960063|566238671|FG000|Overall Study|Adverse Event|1|||
156859017|NCT00960063|566238672|FG001|Overall Study|Adverse Event|0|||
156859018|NCT00960063|566238673|FG002|Overall Study|Adverse Event|0|||
156859019|NCT00960063|566238671|FG000|Overall Study|Progression of Disease|0|||
156859020|NCT00960063|566238672|FG001|Overall Study|Progression of Disease|0|||
156859021|NCT00960063|566238673|FG002|Overall Study|Progression of Disease|3|||
156859022|NCT05083351|566238678|FG000|Overall Study|Adverse Event|3|||
156859023|NCT05083351|566238678|FG000|Overall Study|Did not meet data inclusion criteria|8|||
156859024|NCT05083351|566238678|FG000|Overall Study|Did not meet eligibility criteria|19|||
156859025|NCT05083351|566238678|FG000|Overall Study|Study Staff Decision|19|||
156859026|NCT01611792|566238679|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
156859027|NCT01611792|566238680|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
156859028|NCT01611792|566238679|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
156859029|NCT01611792|566238680|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
156859030|NCT00083889|566238686|FG000|Overall Study|Adverse Event|76|||
156859031|NCT00083889|566238687|FG001|Overall Study|Adverse Event|86|||
156859032|NCT00083889|566238686|FG000|Overall Study|Protocol Violation|2|||
156859033|NCT00083889|566238687|FG001|Overall Study|Protocol Violation|2|||
156859034|NCT00083889|566238686|FG000|Overall Study|Withdrawal by Subject|22|||
156859035|NCT00083889|566238687|FG001|Overall Study|Withdrawal by Subject|24|||
156859036|NCT00083889|566238686|FG000|Overall Study|Lack of Efficacy|240|||
156859037|NCT00083889|566238687|FG001|Overall Study|Lack of Efficacy|219|||
156859038|NCT00083889|566238686|FG000|Overall Study|Decision of sponsor|32|||
156859039|NCT00083889|566238687|FG001|Overall Study|Decision of sponsor|4|||
157158405|NCT03345836|567324610|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
157158406|NCT03345836|567324611|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
157158407|NCT03345836|567324612|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
157158408|NCT03345836|567324613|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
157158409|NCT03345836|567324614|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
157158410|NCT03345836|567324609|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
157158411|NCT03345836|567324610|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
157158412|NCT03345836|567324611|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
157158413|NCT03345836|567324612|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
157158414|NCT03345836|567324613|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
157158415|NCT03345836|567324614|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
157158416|NCT03345836|567324609|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
157158417|NCT03345836|567324610|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
157158418|NCT03345836|567324611|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
157158419|NCT03345836|567324612|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
157158420|NCT03345836|567324613|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
157158421|NCT03345836|567324614|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
156898862|NCT00866788|566391304|FG003|Overall Study|Adverse Event|1|||
156898863|NCT00866788|566391301|FG000|Overall Study|Lost to Follow-up|1|||
156898864|NCT00866788|566391302|FG001|Overall Study|Lost to Follow-up|1|||
156898865|NCT00866788|566391303|FG002|Overall Study|Lost to Follow-up|0|||
156898866|NCT00866788|566391304|FG003|Overall Study|Lost to Follow-up|2|||
156898867|NCT00866788|566391301|FG000|Overall Study|Withdrawal by Subject|2|||
156898868|NCT00866788|566391302|FG001|Overall Study|Withdrawal by Subject|1|||
156898869|NCT00866788|566391303|FG002|Overall Study|Withdrawal by Subject|0|||
156898870|NCT00866788|566391304|FG003|Overall Study|Withdrawal by Subject|1|||
156898871|NCT00866788|566391301|FG000|Overall Study|Pregnancy|0|||
156898872|NCT00866788|566391302|FG001|Overall Study|Pregnancy|1|||
156898873|NCT00866788|566391303|FG002|Overall Study|Pregnancy|0|||
156898874|NCT00866788|566391304|FG003|Overall Study|Pregnancy|0|||
156898875|NCT00866788|566391301|FG000|Overall Study|Disease progression|3|||
156898876|NCT00866788|566391302|FG001|Overall Study|Disease progression|1|||
156898877|NCT00866788|566391303|FG002|Overall Study|Disease progression|1|||
156898878|NCT00866788|566391304|FG003|Overall Study|Disease progression|0|||
156898879|NCT00866788|566391301|FG000|Overall Study|Physician Decision|0|||
156898880|NCT00866788|566391302|FG001|Overall Study|Physician Decision|0|||
156898881|NCT00866788|566391303|FG002|Overall Study|Physician Decision|1|||
156898882|NCT00866788|566391304|FG003|Overall Study|Physician Decision|1|||
156898883|NCT02349061|566391305|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
156898884|NCT02349061|566391306|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
156898885|NCT02349061|566391307|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
156898886|NCT02349061|566391305|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
156898887|NCT02349061|566391306|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
156898888|NCT02349061|566391307|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
156898889|NCT02349061|566391305|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
156898890|NCT02349061|566391306|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
156898891|NCT02349061|566391307|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
156898892|NCT02349061|566391305|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
156898893|NCT02349061|566391306|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
156898894|NCT02349061|566391307|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
156898895|NCT02349061|566391305|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
156898896|NCT02349061|566391306|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
156898897|NCT02349061|566391307|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
156898898|NCT02349061|566391305|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
156898899|NCT02349061|566391306|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
156898900|NCT02349061|566391307|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
156898901|NCT02349061|566391305|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
156898902|NCT02349061|566391306|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
156898903|NCT02349061|566391307|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
156898904|NCT02349061|566391305|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
156898905|NCT02349061|566391306|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
156898906|NCT02349061|566391307|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
157158422|NCT03345836|567324609|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
157158423|NCT03345836|567324610|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
157225510|NCT00818883|567571451|FG000|Overall Study|Lost to Follow-up|3|||
156898907|NCT02349061|566391305|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
156898908|NCT02349061|566391306|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
156898909|NCT02349061|566391307|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
156898910|NCT02349061|566391305|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
156898911|NCT02349061|566391306|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
156898912|NCT02349061|566391307|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
156898913|NCT02349061|566391305|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
156898914|NCT02349061|566391306|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
156898915|NCT02349061|566391307|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
156898916|NCT02349061|566391305|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
156898917|NCT02349061|566391306|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
156898918|NCT02349061|566391307|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
156898919|NCT02349061|566391305|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
156898920|NCT02349061|566391306|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
156898921|NCT02349061|566391307|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
156898922|NCT02339285|566391308|FG000|Overall Study|Withdrawal by Subject|0|||
156898923|NCT02339285|566391309|FG001|Overall Study|Withdrawal by Subject|1|||
156898924|NCT02339285|566391310|FG002|Overall Study|Withdrawal by Subject|1|||
156898925|NCT02339285|566391308|FG000|Overall Study|Lost to Follow-up|1|||
156898926|NCT02339285|566391309|FG001|Overall Study|Lost to Follow-up|1|||
156898927|NCT02339285|566391310|FG002|Overall Study|Lost to Follow-up|1|||
156898928|NCT02339285|566391308|FG000|Overall Study|Protocol Deviation|0|||
156898929|NCT02339285|566391309|FG001|Overall Study|Protocol Deviation|1|||
156898930|NCT02339285|566391310|FG002|Overall Study|Protocol Deviation|0|||
156898931|NCT00282412|566391313|FG000|Overall Study|Death|2|||
156898932|NCT00697073|566391314|FG000|Overall Study|Withdrawal by Subject|2|||
156898933|NCT00697073|566391314|FG000|Overall Study|Pregnancy|1|||
156898934|NCT00697073|566391314|FG000|Overall Study|non compliance and other|6|||
156898935|NCT00426231|566391315|FG000|Overall Study|Withdrawal by Subject|9|||
156898936|NCT00426231|566391316|FG001|Overall Study|Withdrawal by Subject|12|||
156898937|NCT03911713|566391317|FG000|Overall Study|Lost to Follow-up|0|||
156898938|NCT03911713|566391318|FG001|Overall Study|Lost to Follow-up|2|||
156898939|NCT03911713|566391319|FG002|Overall Study|Lost to Follow-up|0|||
156898940|NCT03911713|566391320|FG003|Overall Study|Lost to Follow-up|0|||
156898941|NCT03911713|566391321|FG004|Overall Study|Lost to Follow-up|0|||
156898942|NCT03911713|566391317|FG000|Overall Study|Other|0|||
156898943|NCT03911713|566391318|FG001|Overall Study|Other|0|||
156898944|NCT03911713|566391319|FG002|Overall Study|Other|0|||
156898945|NCT03911713|566391320|FG003|Overall Study|Other|1|||
156898946|NCT03911713|566391321|FG004|Overall Study|Other|0|||
156898947|NCT03911713|566391317|FG000|Overall Study|Randomized, Never Dosed|1|||
156898948|NCT03911713|566391318|FG001|Overall Study|Randomized, Never Dosed|0|||
156898949|NCT03911713|566391319|FG002|Overall Study|Randomized, Never Dosed|0|||
156898950|NCT03911713|566391320|FG003|Overall Study|Randomized, Never Dosed|1|||
156898951|NCT03911713|566391321|FG004|Overall Study|Randomized, Never Dosed|0|||
156898952|NCT00108433|566391323|FG000|Overall Study|Lack of Efficacy|1|||
156898953|NCT00108433|566391324|FG001|Overall Study|Lack of Efficacy|2|||
156898954|NCT00108433|566391323|FG000|Overall Study|Death|3|||
156898955|NCT00108433|566391324|FG001|Overall Study|Death|0|||
156898956|NCT00108433|566391323|FG000|Overall Study|Adverse Event|3|||
156898957|NCT00108433|566391324|FG001|Overall Study|Adverse Event|1|||
156898958|NCT00108433|566391323|FG000|Overall Study|Other|14|||
156898959|NCT00108433|566391324|FG001|Overall Study|Other|14|||
156898960|NCT02203071|566391325|FG000|Overall Study|Lost to Follow-up|3|||
156898961|NCT02203071|566391326|FG001|Overall Study|Lost to Follow-up|1|||
156898962|NCT01193660|566391327|FG000|Overall Study|Withdrawal by Subject|2|||
156898963|NCT01193660|566391328|FG001|Overall Study|Withdrawal by Subject|3|||
156898964|NCT01193660|566391329|FG002|Overall Study|Withdrawal by Subject|1|||
156898965|NCT01193660|566391327|FG000|Overall Study|Death|1|||
156898966|NCT01193660|566391328|FG001|Overall Study|Death|0|||
156898967|NCT01193660|566391329|FG002|Overall Study|Death|0|||
156898968|NCT01193660|566391327|FG000|Overall Study|Physician Decision|1|||
157026202|NCT04195698|566851480|FG001|Overall Study|Other|4|||
157026203|NCT05459688|566851481|FG000|Overall Study|Lost to Follow-up|6|||
157026204|NCT05459688|566851481|FG000|Overall Study|Physician Decision|1|||
157026205|NCT05459688|566851481|FG000|Overall Study|Withdrawal by Subject|19|||
157026206|NCT05459688|566851481|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
157026207|NCT05540665|566851482|FG000|Overall Study|Study terminated by sponsor|6|||
157225511|NCT00818883|567571452|FG001|Overall Study|Lost to Follow-up|2|||
156898969|NCT01193660|566391328|FG001|Overall Study|Physician Decision|0|||
156898970|NCT01193660|566391329|FG002|Overall Study|Physician Decision|1|||
156898971|NCT02595970|566391330|FG000|Overall Study|Withdrawal by Subject|2|||
156898972|NCT02595970|566391330|FG000|Overall Study|Physician Decision|2|||
156898973|NCT02595970|566391330|FG000|Overall Study|Protocol Violation|4|||
156898974|NCT02595970|566391330|FG000|Overall Study|Adverse Event|5|||
156898975|NCT02595970|566391330|FG000|Overall Study|Lack of Efficacy|7|||
156898976|NCT01886716|566391331|FG000|Week 1|Lost to Follow-up|0|||
157026208|NCT05540665|566851483|FG001|Overall Study|Study terminated by sponsor|6|||
156898977|NCT01886716|566391332|FG001|Week 1|Lost to Follow-up|0|||
156898978|NCT01886716|566391333|FG002|Week 1|Lost to Follow-up|2|||
156898979|NCT01886716|566391334|FG003|Week 1|Lost to Follow-up|2|||
156898980|NCT01886716|566391331|FG000|Week 2|Lost to Follow-up|3|||
156898981|NCT01886716|566391332|FG001|Week 2|Lost to Follow-up|2|||
157225512|NCT00818883|567571451|FG000|Overall Study|Withdrawal by Subject|16|||
156898982|NCT01886716|566391333|FG002|Week 2|Lost to Follow-up|1|||
156898983|NCT01886716|566391334|FG003|Week 2|Lost to Follow-up|3|||
156898984|NCT01886716|566391331|FG000|Week 3|Lost to Follow-up|1|||
156898985|NCT01886716|566391332|FG001|Week 3|Lost to Follow-up|1|||
156898986|NCT01886716|566391333|FG002|Week 3|Lost to Follow-up|0|||
156898987|NCT01886716|566391334|FG003|Week 3|Lost to Follow-up|1|||
156898988|NCT02572388|566391335|FG000|Overall Study|Withdrawal by Subject|1|||
156898989|NCT02572388|566391336|FG001|Overall Study|Withdrawal by Subject|1|||
156898990|NCT02572388|566391337|FG002|Overall Study|Withdrawal by Subject|2|||
156898991|NCT02572388|566391338|FG003|Overall Study|Withdrawal by Subject|2|||
156898992|NCT00810108|566391340|FG000|Overall Study|Withdrawal by Subject|1|||
156898993|NCT00810108|566391341|FG001|Overall Study|Withdrawal by Subject|0|||
156898994|NCT01051466|566391342|FG000|Overall Study|Adverse Event|1|||
156898995|NCT01051466|566391343|FG001|Overall Study|Adverse Event|0|||
156898996|NCT01051466|566391342|FG000|Overall Study|Lost to Follow-up|1|||
156898997|NCT01051466|566391343|FG001|Overall Study|Lost to Follow-up|1|||
156898998|NCT01051466|566391342|FG000|Overall Study|Withdrawal by Subject|5|||
156898999|NCT01051466|566391343|FG001|Overall Study|Withdrawal by Subject|1|||
156899000|NCT01051466|566391342|FG000|Overall Study|Entry Criteria Not Met|0|||
156899001|NCT01051466|566391343|FG001|Overall Study|Entry Criteria Not Met|3|||
156899002|NCT01051466|566391342|FG000|Overall Study|Physician Decision|1|||
156899003|NCT01051466|566391343|FG001|Overall Study|Physician Decision|0|||
156899004|NCT04806503|566391344|FG000|Overall Study|Lost to Follow-up|0|||
156899005|NCT04806503|566391345|FG001|Overall Study|Lost to Follow-up|0|||
156899006|NCT04806503|566391346|FG002|Overall Study|Lost to Follow-up|1|||
156899007|NCT04806503|566391347|FG003|Overall Study|Lost to Follow-up|0|||
156899008|NCT04806503|566391348|FG004|Overall Study|Lost to Follow-up|0|||
156899009|NCT04806503|566391344|FG000|Overall Study|Withdrawal by Subject|1|||
156899010|NCT04806503|566391345|FG001|Overall Study|Withdrawal by Subject|0|||
156899011|NCT04806503|566391346|FG002|Overall Study|Withdrawal by Subject|1|||
156899012|NCT04806503|566391347|FG003|Overall Study|Withdrawal by Subject|1|||
156899013|NCT04806503|566391348|FG004|Overall Study|Withdrawal by Subject|1|||
156899014|NCT04806503|566391344|FG000|Overall Study|Adverse Event|1|||
156899015|NCT04806503|566391345|FG001|Overall Study|Adverse Event|1|||
156899016|NCT04806503|566391346|FG002|Overall Study|Adverse Event|0|||
156899017|NCT04806503|566391347|FG003|Overall Study|Adverse Event|1|||
156899018|NCT04806503|566391348|FG004|Overall Study|Adverse Event|0|||
156899019|NCT03589469|566391349|FG000|Overall Study|Withdrawal by Subject|8|||
156899020|NCT03589469|566391349|FG000|Overall Study|Physician Decision|20|||
156899021|NCT03589469|566391349|FG000|Overall Study|Death|97|||
156899022|NCT03589469|566391349|FG000|Overall Study|Lost to Follow-up|8|||
156899023|NCT03589469|566391349|FG000|Overall Study|Miscellaneous|1|||
156899024|NCT01973569|566391354|FG000|Overall Study|Adverse Event|9|||
156899025|NCT01973569|566391355|FG001|Overall Study|Adverse Event|2|||
156899026|NCT01973569|566391356|FG002|Overall Study|Adverse Event|4|||
156899027|NCT01973569|566391354|FG000|Overall Study|Protocol Violation|2|||
156899028|NCT01973569|566391355|FG001|Overall Study|Protocol Violation|1|||
156899029|NCT01973569|566391356|FG002|Overall Study|Protocol Violation|3|||
156899030|NCT01973569|566391354|FG000|Overall Study|Withdrawal by Subject|7|||
156899031|NCT01973569|566391355|FG001|Overall Study|Withdrawal by Subject|5|||
156899032|NCT01973569|566391356|FG002|Overall Study|Withdrawal by Subject|2|||
156899033|NCT01973569|566391354|FG000|Overall Study|Invasive dental treatment|3|||
156899034|NCT01973569|566391355|FG001|Overall Study|Invasive dental treatment|5|||
156899035|NCT01973569|566391356|FG002|Overall Study|Invasive dental treatment|6|||
156899036|NCT01973569|566391354|FG000|Overall Study|Prohibited concomitant d|1|||
157158424|NCT03345836|567324611|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
157158425|NCT03345836|567324612|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
156899037|NCT01973569|566391355|FG001|Overall Study|Prohibited concomitant d|5|||
156899038|NCT01973569|566391356|FG002|Overall Study|Prohibited concomitant d|0|||
156899039|NCT01973569|566391354|FG000|Overall Study|Disease progression|0|||
156899040|NCT01973569|566391355|FG001|Overall Study|Disease progression|3|||
156899041|NCT01973569|566391356|FG002|Overall Study|Disease progression|0|||
156899042|NCT01973569|566391354|FG000|Overall Study|Other|1|||
157158426|NCT03345836|567324613|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
157158427|NCT03345836|567324614|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
156899043|NCT01973569|566391355|FG001|Overall Study|Other|1|||
156899044|NCT01973569|566391356|FG002|Overall Study|Other|0|||
156899045|NCT01973569|566391354|FG000|Overall Study|Did not receive study drug|6|||
156899046|NCT01973569|566391355|FG001|Overall Study|Did not receive study drug|3|||
156899047|NCT01973569|566391356|FG002|Overall Study|Did not receive study drug|3|||
156899048|NCT03793556|566391357|FG000|Overall Study|Withdrawal by Subject|12|||
157158428|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
156899049|NCT03793556|566391358|FG001|Overall Study|Withdrawal by Subject|1|||
156899050|NCT03793556|566391357|FG000|Overall Study|Lost to Follow-up|1|||
156899051|NCT03793556|566391358|FG001|Overall Study|Lost to Follow-up|1|||
156899052|NCT04416633|566391359|FG000|Overall Study|Death|1|||
156899053|NCT04416633|566391359|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
156899054|NCT04416633|566391359|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
157158429|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
157158430|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
157158431|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
157158432|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
157158433|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
157158434|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
157158435|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
157158436|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
157158437|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
157158438|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
157158439|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
157158440|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
157158441|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
157158442|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
157158443|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
157158444|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
157158445|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
157158446|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
157158447|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
157158448|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
157158449|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
157158450|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
157158451|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
157158452|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
157158453|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
157158454|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
157158455|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
157158456|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
157158457|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
157158458|NCT03345836|567324609|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
157158459|NCT03345836|567324610|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
156899055|NCT04416633|566391359|FG000|Overall Study|Adverse Event|6|||
156899056|NCT04416633|566391359|FG000|Overall Study|Withdrawal by Subject|6|||
156899057|NCT05021081|566391361|FG000|Phase 2|Subject enrolled in error|1|||
156899058|NCT05021081|566391362|FG001|Phase 2|Subject enrolled in error|1|||
156899059|NCT05021081|566391363|FG002|Phase 2|Subject enrolled in error|0|||
156899060|NCT03633617|566391364|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
156899061|NCT03633617|566391365|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
156899062|NCT03633617|566391366|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899063|NCT03633617|566391367|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899064|NCT03633617|566391368|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899065|NCT03633617|566391369|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899066|NCT03633617|566391370|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899067|NCT03633617|566391371|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899068|NCT03633617|566391372|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899069|NCT03633617|566391373|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899070|NCT03633617|566391374|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
156899071|NCT03633617|566391364|FG000|Part A|Unconfirmed early termination visit|1|||
156899072|NCT03633617|566391365|FG001|Part A|Unconfirmed early termination visit|0|||
156899073|NCT03633617|566391366|FG002|Part A|Unconfirmed early termination visit|0|||
156899074|NCT03633617|566391367|FG003|Part A|Unconfirmed early termination visit|0|||
156899075|NCT03633617|566391368|FG004|Part A|Unconfirmed early termination visit|0|||
156899076|NCT03633617|566391369|FG005|Part A|Unconfirmed early termination visit|0|||
156899077|NCT03633617|566391370|FG006|Part A|Unconfirmed early termination visit|0|||
156899078|NCT03633617|566391371|FG007|Part A|Unconfirmed early termination visit|0|||
156899079|NCT03633617|566391372|FG008|Part A|Unconfirmed early termination visit|0|||
156899080|NCT03633617|566391373|FG009|Part A|Unconfirmed early termination visit|0|||
156899081|NCT03633617|566391374|FG010|Part A|Unconfirmed early termination visit|0|||
156899082|NCT03633617|566391364|FG000|Part A|Adverse Event|0|||
156899083|NCT03633617|566391365|FG001|Part A|Adverse Event|1|||
156899084|NCT03633617|566391366|FG002|Part A|Adverse Event|0|||
156899085|NCT03633617|566391367|FG003|Part A|Adverse Event|0|||
156899086|NCT03633617|566391368|FG004|Part A|Adverse Event|0|||
156899087|NCT03633617|566391369|FG005|Part A|Adverse Event|0|||
156899088|NCT03633617|566391370|FG006|Part A|Adverse Event|0|||
156899089|NCT03633617|566391371|FG007|Part A|Adverse Event|0|||
156899090|NCT03633617|566391372|FG008|Part A|Adverse Event|0|||
157158460|NCT03345836|567324611|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
157158461|NCT03345836|567324612|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
157158462|NCT03345836|567324613|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
157158463|NCT03345836|567324614|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
157158464|NCT00222729|567324615|FG000|Overall Study|Adverse Event|3|||
156899091|NCT03633617|566391373|FG009|Part A|Adverse Event|0|||
156899092|NCT03633617|566391374|FG010|Part A|Adverse Event|0|||
156899093|NCT03633617|566391364|FG000|Part A|Pregnancy|1|||
156899094|NCT03633617|566391365|FG001|Part A|Pregnancy|0|||
156899095|NCT03633617|566391366|FG002|Part A|Pregnancy|0|||
156899096|NCT03633617|566391367|FG003|Part A|Pregnancy|0|||
156899097|NCT03633617|566391368|FG004|Part A|Pregnancy|0|||
156899098|NCT03633617|566391369|FG005|Part A|Pregnancy|0|||
156899099|NCT03633617|566391370|FG006|Part A|Pregnancy|0|||
156899100|NCT03633617|566391371|FG007|Part A|Pregnancy|0|||
156899101|NCT03633617|566391372|FG008|Part A|Pregnancy|0|||
156899102|NCT03633617|566391373|FG009|Part A|Pregnancy|0|||
156899103|NCT03633617|566391374|FG010|Part A|Pregnancy|0|||
156899104|NCT03633617|566391364|FG000|Part A|Withdrawal by Subject|0|||
156899105|NCT03633617|566391365|FG001|Part A|Withdrawal by Subject|1|||
156899106|NCT03633617|566391366|FG002|Part A|Withdrawal by Subject|0|||
156899107|NCT03633617|566391367|FG003|Part A|Withdrawal by Subject|0|||
156899108|NCT03633617|566391368|FG004|Part A|Withdrawal by Subject|0|||
156899109|NCT03633617|566391369|FG005|Part A|Withdrawal by Subject|0|||
156899110|NCT03633617|566391370|FG006|Part A|Withdrawal by Subject|0|||
156899111|NCT03633617|566391371|FG007|Part A|Withdrawal by Subject|0|||
156899112|NCT03633617|566391372|FG008|Part A|Withdrawal by Subject|0|||
156899113|NCT03633617|566391373|FG009|Part A|Withdrawal by Subject|0|||
156899114|NCT03633617|566391374|FG010|Part A|Withdrawal by Subject|0|||
156899115|NCT03633617|566391364|FG000|Part B|Adverse Event|0|||
156899116|NCT03633617|566391365|FG001|Part B|Adverse Event|0|||
156899117|NCT03633617|566391366|FG002|Part B|Adverse Event|2|||
156899118|NCT03633617|566391367|FG003|Part B|Adverse Event|2|||
156899119|NCT03633617|566391368|FG004|Part B|Adverse Event|1|||
156899120|NCT03633617|566391369|FG005|Part B|Adverse Event|0|||
156899121|NCT03633617|566391370|FG006|Part B|Adverse Event|0|||
156899122|NCT03633617|566391371|FG007|Part B|Adverse Event|0|||
156899123|NCT03633617|566391372|FG008|Part B|Adverse Event|0|||
156899124|NCT03633617|566391373|FG009|Part B|Adverse Event|0|||
156899125|NCT03633617|566391374|FG010|Part B|Adverse Event|0|||
156899126|NCT03633617|566391364|FG000|Part B|Withdrawal by Subject|0|||
156899127|NCT03633617|566391365|FG001|Part B|Withdrawal by Subject|0|||
156899128|NCT03633617|566391366|FG002|Part B|Withdrawal by Subject|1|||
156899129|NCT03633617|566391367|FG003|Part B|Withdrawal by Subject|0|||
156899130|NCT03633617|566391368|FG004|Part B|Withdrawal by Subject|2|||
156899131|NCT03633617|566391369|FG005|Part B|Withdrawal by Subject|0|||
156899132|NCT03633617|566391370|FG006|Part B|Withdrawal by Subject|0|||
156899133|NCT03633617|566391371|FG007|Part B|Withdrawal by Subject|0|||
156899134|NCT03633617|566391372|FG008|Part B|Withdrawal by Subject|0|||
157158465|NCT01915849|567324618|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
157158466|NCT01915849|567324619|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
156899135|NCT03633617|566391373|FG009|Part B|Withdrawal by Subject|0|||
156899136|NCT03633617|566391374|FG010|Part B|Withdrawal by Subject|0|||
156899137|NCT03633617|566391364|FG000|Part B|Lost to Follow-up|0|||
156899138|NCT03633617|566391365|FG001|Part B|Lost to Follow-up|0|||
156899139|NCT03633617|566391366|FG002|Part B|Lost to Follow-up|0|||
156899140|NCT03633617|566391367|FG003|Part B|Lost to Follow-up|0|||
156899141|NCT03633617|566391368|FG004|Part B|Lost to Follow-up|1|||
156899142|NCT03633617|566391369|FG005|Part B|Lost to Follow-up|0|||
157026209|NCT05540665|566851484|FG002|Overall Study|Study terminated by sponsor|7|||
157026210|NCT03462030|566851485|FG000|Overall Study|Withdrawal by Subject|1|||
157026211|NCT03462030|566851486|FG001|Overall Study|Withdrawal by Subject|1|||
156899143|NCT03633617|566391370|FG006|Part B|Lost to Follow-up|0|||
156899144|NCT03633617|566391371|FG007|Part B|Lost to Follow-up|0|||
156899145|NCT03633617|566391372|FG008|Part B|Lost to Follow-up|0|||
156899146|NCT03633617|566391373|FG009|Part B|Lost to Follow-up|0|||
156899147|NCT03633617|566391374|FG010|Part B|Lost to Follow-up|0|||
157026212|NCT02675751|566851487|FG000|Overall Study|Lost to Follow-up|16|||
157158467|NCT01915849|567324620|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
156899148|NCT03633617|566391364|FG000|Part B|Physician Decision|0|||
156899149|NCT03633617|566391365|FG001|Part B|Physician Decision|0|||
156899150|NCT03633617|566391366|FG002|Part B|Physician Decision|0|||
156899151|NCT03633617|566391367|FG003|Part B|Physician Decision|0|||
156899152|NCT03633617|566391368|FG004|Part B|Physician Decision|1|||
156899153|NCT03633617|566391369|FG005|Part B|Physician Decision|0|||
156899154|NCT03633617|566391370|FG006|Part B|Physician Decision|0|||
156899155|NCT03633617|566391371|FG007|Part B|Physician Decision|0|||
156899156|NCT03633617|566391372|FG008|Part B|Physician Decision|0|||
156899157|NCT03633617|566391373|FG009|Part B|Physician Decision|0|||
156899158|NCT03633617|566391374|FG010|Part B|Physician Decision|0|||
156899159|NCT03633617|566391364|FG000|Part B|COVID-19 Restrictions|0|||
156899160|NCT03633617|566391365|FG001|Part B|COVID-19 Restrictions|0|||
157026213|NCT03371381|566851488|FG000|Overall Study|Death|5|||
156899161|NCT03633617|566391366|FG002|Part B|COVID-19 Restrictions|1|||
156899162|NCT03633617|566391367|FG003|Part B|COVID-19 Restrictions|0|||
156899163|NCT03633617|566391368|FG004|Part B|COVID-19 Restrictions|0|||
156899164|NCT03633617|566391369|FG005|Part B|COVID-19 Restrictions|0|||
156899165|NCT03633617|566391370|FG006|Part B|COVID-19 Restrictions|0|||
156899166|NCT03633617|566391371|FG007|Part B|COVID-19 Restrictions|0|||
156899167|NCT03633617|566391372|FG008|Part B|COVID-19 Restrictions|0|||
156899168|NCT03633617|566391373|FG009|Part B|COVID-19 Restrictions|0|||
156899169|NCT03633617|566391374|FG010|Part B|COVID-19 Restrictions|0|||
156899170|NCT03633617|566391364|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899171|NCT03633617|566391365|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899172|NCT03633617|566391366|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
156899173|NCT03633617|566391367|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899174|NCT03633617|566391368|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899175|NCT03633617|566391369|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899176|NCT03633617|566391370|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899177|NCT03633617|566391371|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899178|NCT03633617|566391372|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899179|NCT03633617|566391373|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899180|NCT03633617|566391374|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
156899181|NCT03633617|566391364|FG000|Part C (& Follow-up)|Adverse Event|0|||
156899182|NCT03633617|566391365|FG001|Part C (& Follow-up)|Adverse Event|0|||
156899183|NCT03633617|566391366|FG002|Part C (& Follow-up)|Adverse Event|0|||
156899184|NCT03633617|566391367|FG003|Part C (& Follow-up)|Adverse Event|0|||
156899185|NCT03633617|566391368|FG004|Part C (& Follow-up)|Adverse Event|0|||
156899186|NCT03633617|566391369|FG005|Part C (& Follow-up)|Adverse Event|1|||
156899187|NCT03633617|566391370|FG006|Part C (& Follow-up)|Adverse Event|0|||
156899188|NCT03633617|566391371|FG007|Part C (& Follow-up)|Adverse Event|1|||
156899189|NCT03633617|566391372|FG008|Part C (& Follow-up)|Adverse Event|0|||
156899190|NCT03633617|566391373|FG009|Part C (& Follow-up)|Adverse Event|0|||
156899191|NCT03633617|566391374|FG010|Part C (& Follow-up)|Adverse Event|0|||
156899192|NCT03633617|566391364|FG000|Part C (& Follow-up)|Pregnancy|0|||
156899193|NCT03633617|566391365|FG001|Part C (& Follow-up)|Pregnancy|0|||
156899194|NCT03633617|566391366|FG002|Part C (& Follow-up)|Pregnancy|0|||
156899195|NCT03633617|566391367|FG003|Part C (& Follow-up)|Pregnancy|0|||
156899196|NCT03633617|566391368|FG004|Part C (& Follow-up)|Pregnancy|0|||
156899197|NCT03633617|566391369|FG005|Part C (& Follow-up)|Pregnancy|0|||
156899198|NCT03633617|566391370|FG006|Part C (& Follow-up)|Pregnancy|0|||
156899199|NCT03633617|566391371|FG007|Part C (& Follow-up)|Pregnancy|0|||
156899200|NCT03633617|566391372|FG008|Part C (& Follow-up)|Pregnancy|0|||
156899201|NCT03633617|566391373|FG009|Part C (& Follow-up)|Pregnancy|1|||
156899202|NCT03633617|566391374|FG010|Part C (& Follow-up)|Pregnancy|0|||
156899203|NCT03633617|566391364|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899204|NCT03633617|566391365|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899205|NCT03633617|566391366|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899206|NCT03633617|566391367|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899207|NCT03633617|566391368|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899208|NCT03633617|566391369|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
156899209|NCT03633617|566391370|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
156899210|NCT03633617|566391371|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
156899211|NCT03633617|566391372|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
156899212|NCT03633617|566391373|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
156899213|NCT03633617|566391374|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
156899214|NCT03633617|566391364|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
156899215|NCT03633617|566391365|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
156899216|NCT03633617|566391366|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
156899217|NCT03633617|566391367|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
156899218|NCT03633617|566391368|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
156899219|NCT03633617|566391369|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
156899220|NCT03633617|566391370|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
156899221|NCT03633617|566391371|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
156899222|NCT03633617|566391372|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
156899223|NCT03633617|566391373|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
156899224|NCT03633617|566391374|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
156899225|NCT03633617|566391364|FG000|Part C (& Follow-up)|Physician Decision|0|||
156899226|NCT03633617|566391365|FG001|Part C (& Follow-up)|Physician Decision|0|||
156899227|NCT03633617|566391366|FG002|Part C (& Follow-up)|Physician Decision|0|||
156899228|NCT03633617|566391367|FG003|Part C (& Follow-up)|Physician Decision|0|||
156899229|NCT03633617|566391368|FG004|Part C (& Follow-up)|Physician Decision|0|||
156899230|NCT03633617|566391369|FG005|Part C (& Follow-up)|Physician Decision|0|||
156899231|NCT03633617|566391370|FG006|Part C (& Follow-up)|Physician Decision|0|||
157158468|NCT01915849|567324621|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
157158469|NCT01915849|567324618|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
156899232|NCT03633617|566391371|FG007|Part C (& Follow-up)|Physician Decision|1|||
156899233|NCT03633617|566391372|FG008|Part C (& Follow-up)|Physician Decision|0|||
156899234|NCT03633617|566391373|FG009|Part C (& Follow-up)|Physician Decision|0|||
156899235|NCT03633617|566391374|FG010|Part C (& Follow-up)|Physician Decision|1|||
156899236|NCT03633617|566391364|FG000|Part C (& Follow-up)|COVID-19 related|0|||
156899237|NCT03633617|566391365|FG001|Part C (& Follow-up)|COVID-19 related|0|||
156899238|NCT03633617|566391366|FG002|Part C (& Follow-up)|COVID-19 related|0|||
156899239|NCT03633617|566391367|FG003|Part C (& Follow-up)|COVID-19 related|0|||
156899240|NCT03633617|566391368|FG004|Part C (& Follow-up)|COVID-19 related|0|||
156899241|NCT03633617|566391369|FG005|Part C (& Follow-up)|COVID-19 related|1|||
156899242|NCT03633617|566391370|FG006|Part C (& Follow-up)|COVID-19 related|0|||
156899243|NCT03633617|566391371|FG007|Part C (& Follow-up)|COVID-19 related|0|||
156899244|NCT03633617|566391372|FG008|Part C (& Follow-up)|COVID-19 related|0|||
156899245|NCT03633617|566391373|FG009|Part C (& Follow-up)|COVID-19 related|0|||
156899246|NCT03633617|566391374|FG010|Part C (& Follow-up)|COVID-19 related|0|||
156899247|NCT03633617|566391364|FG000|Part C (& Follow-up)|Protocol Violation|0|||
156899248|NCT03633617|566391365|FG001|Part C (& Follow-up)|Protocol Violation|0|||
156899249|NCT03633617|566391366|FG002|Part C (& Follow-up)|Protocol Violation|0|||
156899250|NCT03633617|566391367|FG003|Part C (& Follow-up)|Protocol Violation|0|||
156899251|NCT03633617|566391368|FG004|Part C (& Follow-up)|Protocol Violation|0|||
156899252|NCT03633617|566391369|FG005|Part C (& Follow-up)|Protocol Violation|0|||
156899253|NCT03633617|566391370|FG006|Part C (& Follow-up)|Protocol Violation|0|||
156899254|NCT03633617|566391371|FG007|Part C (& Follow-up)|Protocol Violation|0|||
156899255|NCT03633617|566391372|FG008|Part C (& Follow-up)|Protocol Violation|0|||
156899256|NCT03633617|566391373|FG009|Part C (& Follow-up)|Protocol Violation|3|||
156899257|NCT03633617|566391374|FG010|Part C (& Follow-up)|Protocol Violation|1|||
156899258|NCT03633617|566391364|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
156899259|NCT03633617|566391365|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
156899260|NCT03633617|566391366|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
156899261|NCT03633617|566391367|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
156899262|NCT03633617|566391368|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
156899263|NCT03633617|566391369|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
156899264|NCT03633617|566391370|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
156899265|NCT03633617|566391371|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
156899266|NCT03633617|566391372|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
156899267|NCT03633617|566391373|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
156899268|NCT03633617|566391374|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
156899269|NCT00100178|566391375|FG000|Overall Study|Lost to Follow-up|0|||
156899270|NCT00100178|566391376|FG001|Overall Study|Lost to Follow-up|6|||
156899271|NCT00100178|566391377|FG002|Overall Study|Lost to Follow-up|5|||
156899272|NCT00100178|566391375|FG000|Overall Study|Adverse Event|2|||
156899273|NCT00100178|566391376|FG001|Overall Study|Adverse Event|2|||
156899274|NCT00100178|566391377|FG002|Overall Study|Adverse Event|1|||
156899275|NCT00100178|566391375|FG000|Overall Study|Withdrawal by Subject|1|||
156899276|NCT00100178|566391376|FG001|Overall Study|Withdrawal by Subject|1|||
156899277|NCT00100178|566391377|FG002|Overall Study|Withdrawal by Subject|1|||
156899278|NCT00100178|566391375|FG000|Overall Study|Physician Decision|6|||
156899279|NCT00100178|566391376|FG001|Overall Study|Physician Decision|1|||
156899280|NCT00100178|566391377|FG002|Overall Study|Physician Decision|3|||
156899281|NCT02477839|566391380|FG000|Overall Study|Adverse Event|0|||
156899282|NCT02477839|566391381|FG001|Overall Study|Adverse Event|1|||
156899283|NCT02477839|566391380|FG000|Overall Study|Protocol Violation|0|||
156899284|NCT02477839|566391381|FG001|Overall Study|Protocol Violation|2|||
156899285|NCT02477839|566391380|FG000|Overall Study|Withdrawal by Subject|3|||
156899286|NCT02477839|566391381|FG001|Overall Study|Withdrawal by Subject|3|||
156899287|NCT02477839|566391380|FG000|Overall Study|Participant had PGS during V6|0|||
156899288|NCT02477839|566391381|FG001|Overall Study|Participant had PGS during V6|1|||
156899289|NCT02477839|566391380|FG000|Overall Study|Parents decided to stop medication|0|||
156899290|NCT02477839|566391381|FG001|Overall Study|Parents decided to stop medication|1|||
156899291|NCT02477839|566391380|FG000|Overall Study|Lack of tolerability|0|||
156899292|NCT02477839|566391381|FG001|Overall Study|Lack of tolerability|1|||
156899293|NCT02477839|566391380|FG000|Overall Study|Exclusion criterion|0|||
156899294|NCT02477839|566391381|FG001|Overall Study|Exclusion criterion|1|||
156899295|NCT01439568|566391382|FG000|Overall Study|Lost to Follow-up|1|||
156899296|NCT01439568|566391383|FG001|Overall Study|Lost to Follow-up|0|||
156899297|NCT01439568|566391382|FG000|Overall Study|Withdrawal by Subject|2|||
156899298|NCT01439568|566391383|FG001|Overall Study|Withdrawal by Subject|2|||
156899299|NCT03161093|566391388|FG000|Overall Study|Protocol Violation|11|||
156899300|NCT03161093|566391389|FG001|Overall Study|Protocol Violation|14|||
157026214|NCT03371381|566851488|FG000|Overall Study|Study terminated by sponsor|3|||
156899301|NCT03161093|566391390|FG002|Overall Study|Protocol Violation|6|||
156899302|NCT03161093|566391391|FG003|Overall Study|Protocol Violation|13|||
156899303|NCT03161093|566391392|FG004|Overall Study|Protocol Violation|1|||
156899304|NCT03161093|566391393|FG005|Overall Study|Protocol Violation|0|||
156899305|NCT03161093|566391388|FG000|Overall Study|Adverse Event|5|||
156899306|NCT03161093|566391389|FG001|Overall Study|Adverse Event|21|||
156899307|NCT03161093|566391390|FG002|Overall Study|Adverse Event|16|||
156899308|NCT03161093|566391391|FG003|Overall Study|Adverse Event|35|||
156899309|NCT03161093|566391392|FG004|Overall Study|Adverse Event|2|||
156899310|NCT03161093|566391393|FG005|Overall Study|Adverse Event|1|||
156899311|NCT03161093|566391388|FG000|Overall Study|Lack of Efficacy|9|||
156899312|NCT03161093|566391389|FG001|Overall Study|Lack of Efficacy|13|||
156899313|NCT03161093|566391390|FG002|Overall Study|Lack of Efficacy|9|||
156899314|NCT03161093|566391391|FG003|Overall Study|Lack of Efficacy|24|||
156899315|NCT03161093|566391392|FG004|Overall Study|Lack of Efficacy|4|||
156899316|NCT03161093|566391393|FG005|Overall Study|Lack of Efficacy|1|||
156899317|NCT03161093|566391388|FG000|Overall Study|Physician Decision|0|||
156899318|NCT03161093|566391389|FG001|Overall Study|Physician Decision|1|||
156899319|NCT03161093|566391390|FG002|Overall Study|Physician Decision|0|||
156899320|NCT03161093|566391391|FG003|Overall Study|Physician Decision|2|||
156899321|NCT03161093|566391392|FG004|Overall Study|Physician Decision|17|||
156899322|NCT03161093|566391393|FG005|Overall Study|Physician Decision|15|||
156899323|NCT03161093|566391388|FG000|Overall Study|Withdrawal by Subject|24|||
156899324|NCT03161093|566391389|FG001|Overall Study|Withdrawal by Subject|73|||
156899325|NCT03161093|566391390|FG002|Overall Study|Withdrawal by Subject|44|||
156899326|NCT03161093|566391391|FG003|Overall Study|Withdrawal by Subject|97|||
156899327|NCT03161093|566391392|FG004|Overall Study|Withdrawal by Subject|11|||
156899328|NCT03161093|566391393|FG005|Overall Study|Withdrawal by Subject|10|||
156899329|NCT03161093|566391388|FG000|Overall Study|Lost to Follow-up|3|||
156899330|NCT03161093|566391389|FG001|Overall Study|Lost to Follow-up|12|||
156899331|NCT03161093|566391390|FG002|Overall Study|Lost to Follow-up|4|||
156899332|NCT03161093|566391391|FG003|Overall Study|Lost to Follow-up|7|||
156899333|NCT03161093|566391392|FG004|Overall Study|Lost to Follow-up|8|||
156899334|NCT03161093|566391393|FG005|Overall Study|Lost to Follow-up|13|||
156899335|NCT03161093|566391388|FG000|Overall Study|Death|3|||
156899336|NCT03161093|566391389|FG001|Overall Study|Death|9|||
156899337|NCT03161093|566391390|FG002|Overall Study|Death|7|||
156899338|NCT03161093|566391391|FG003|Overall Study|Death|9|||
157026215|NCT03371381|566851488|FG000|Overall Study|Other|4|||
157026216|NCT01593917|566851498|FG000|Overall Study|Death|67|||
157026217|NCT01593917|566851498|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
157158470|NCT01915849|567324619|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157158471|NCT01915849|567324620|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157158472|NCT01915849|567324621|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157158473|NCT05091060|567324622|FG000|Overall Study|Lost to Follow-up|1|||
157158474|NCT02775864|567324623|FG000|Overall Study|Data ended end of 2010|1764|||
157158475|NCT02775864|567324624|FG001|Overall Study|Data ended end of 2010|2880|||
157158476|NCT02775864|567324625|FG002|Overall Study|Data ended end of 2010|1140|||
157158477|NCT02775864|567324626|FG003|Overall Study|Data ended end of 2010|1194|||
157158478|NCT02775864|567324623|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
157158479|NCT02775864|567324624|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
156899339|NCT03161093|566391392|FG004|Overall Study|Death|0|||
156899340|NCT03161093|566391393|FG005|Overall Study|Death|0|||
156899341|NCT03161093|566391388|FG000|Overall Study|Unknown - Not reported|0|||
156899342|NCT03161093|566391389|FG001|Overall Study|Unknown - Not reported|1|||
156899343|NCT03161093|566391390|FG002|Overall Study|Unknown - Not reported|0|||
156899344|NCT03161093|566391391|FG003|Overall Study|Unknown - Not reported|0|||
156899345|NCT03161093|566391392|FG004|Overall Study|Unknown - Not reported|0|||
156899346|NCT03161093|566391393|FG005|Overall Study|Unknown - Not reported|1|||
156899347|NCT00570765|566391394|FG000|DB Phase|Withdrawal by Subject|1|||
156899348|NCT00570765|566391395|FG001|DB Phase|Withdrawal by Subject|0|||
156899349|NCT00570765|566391396|FG002|DB Phase|Withdrawal by Subject|0|||
156899350|NCT00570765|566391397|FG003|DB Phase|Withdrawal by Subject|0|||
156899351|NCT00570765|566391394|FG000|DB Phase|Protocol Violation|0|||
156899352|NCT00570765|566391395|FG001|DB Phase|Protocol Violation|1|||
157158480|NCT02775864|567324625|FG002|Overall Study|Medicaid eligibility discontinued|720|||
157158481|NCT02775864|567324626|FG003|Overall Study|Medicaid eligibility discontinued|890|||
156899353|NCT00570765|566391396|FG002|DB Phase|Protocol Violation|0|||
156899354|NCT00570765|566391397|FG003|DB Phase|Protocol Violation|0|||
156899355|NCT00570765|566391394|FG000|DB Phase|Adverse Event|3|||
156899356|NCT00570765|566391395|FG001|DB Phase|Adverse Event|6|||
156899357|NCT00570765|566391396|FG002|DB Phase|Adverse Event|0|||
156899358|NCT00570765|566391397|FG003|DB Phase|Adverse Event|0|||
156899359|NCT00570765|566391394|FG000|DB Phase|Did Not Receive Study Drug|0|||
156899360|NCT00570765|566391395|FG001|DB Phase|Did Not Receive Study Drug|0|||
156899361|NCT00570765|566391396|FG002|DB Phase|Did Not Receive Study Drug|1|||
156899362|NCT00570765|566391397|FG003|DB Phase|Did Not Receive Study Drug|0|||
156899363|NCT00570765|566391394|FG000|LTSE Phase|Withdrawal by Subject|0|||
156899364|NCT00570765|566391395|FG001|LTSE Phase|Withdrawal by Subject|0|||
156899365|NCT00570765|566391396|FG002|LTSE Phase|Withdrawal by Subject|0|||
156899366|NCT00570765|566391397|FG003|LTSE Phase|Withdrawal by Subject|1|||
156899367|NCT00570765|566391394|FG000|LTSE Phase|Adverse Event|0|||
156899368|NCT00570765|566391395|FG001|LTSE Phase|Adverse Event|0|||
156899369|NCT00570765|566391396|FG002|LTSE Phase|Adverse Event|0|||
156899370|NCT00570765|566391397|FG003|LTSE Phase|Adverse Event|7|||
156899371|NCT00570765|566391394|FG000|LTSE Phase|Physician Decision|0|||
156899372|NCT00570765|566391395|FG001|LTSE Phase|Physician Decision|0|||
156899373|NCT00570765|566391396|FG002|LTSE Phase|Physician Decision|0|||
156899374|NCT00570765|566391397|FG003|LTSE Phase|Physician Decision|4|||
156899375|NCT02124161|566391398|FG000|Overall Study|Other unspecified|0|||
156899376|NCT02124161|566391399|FG001|Overall Study|Other unspecified|1|||
156899377|NCT02124161|566391398|FG000|Overall Study|Death|1|||
156899378|NCT02124161|566391399|FG001|Overall Study|Death|0|||
156899379|NCT02124161|566391398|FG000|Overall Study|Protocol Violation|2|||
156899380|NCT02124161|566391399|FG001|Overall Study|Protocol Violation|1|||
156899381|NCT02124161|566391398|FG000|Overall Study|Withdrawal by Subject|1|||
156899382|NCT02124161|566391399|FG001|Overall Study|Withdrawal by Subject|2|||
156899383|NCT02124161|566391398|FG000|Overall Study|Adverse Event|2|||
156899384|NCT02124161|566391399|FG001|Overall Study|Adverse Event|0|||
156899385|NCT02124161|566391398|FG000|Overall Study|Does not meet entrance criteria|2|||
156899386|NCT02124161|566391399|FG001|Overall Study|Does not meet entrance criteria|3|||
156899387|NCT02124161|566391398|FG000|Overall Study|No longer meets eligibility criteria|5|||
156899388|NCT02124161|566391399|FG001|Overall Study|No longer meets eligibility criteria|4|||
156899389|NCT02124161|566391398|FG000|Overall Study|Lost to Follow-up|3|||
157026218|NCT01593917|566851498|FG000|Overall Study|Withdrawal by Subject|23|||
157026219|NCT01593917|566851498|FG000|Overall Study|Lost to Follow-up|12|||
157026220|NCT01593917|566851498|FG000|Overall Study|Protocol Violation|5|||
157026221|NCT01593917|566851498|FG000|Overall Study|Physician Decision|3|||
157026222|NCT02683447|566851499|FG000|Overall Study|Lost to Follow-up|2|||
157026223|NCT04663737|566851500|FG000|Overall Study|Withdrawal by Subject|2|||
157026224|NCT04663737|566851501|FG001|Overall Study|Withdrawal by Subject|0|||
157026225|NCT04016662|566851502|FG000|Run-In Phase|Death|1|||
157026226|NCT04016662|566851502|FG000|Run-In Phase|Withdrawal by Subject|11|||
157026227|NCT04016662|566851502|FG000|Run-In Phase|Not meeting screening eligibility|9|||
157026228|NCT04016662|566851502|FG000|Run-In Phase|Physician Decision|3|||
157026229|NCT04016662|566851502|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
157026230|NCT04016662|566851502|FG000|PLGS (12 Weeks)|Death|1|||
157026231|NCT04016662|566851502|FG000|SAP (12 Weeks)|Death|1|||
157026232|NCT02489903|566851506|FG000|Screening|Screen Failure|24|||
157026233|NCT02489903|566851507|FG001|Screening|Screen Failure|0|||
157026234|NCT02489903|566851508|FG002|Screening|Screen Failure|0|||
157026235|NCT02489903|566851509|FG003|Screening|Screen Failure|8|||
157026236|NCT02489903|566851506|FG000|Randomized and Received Treatment|Protocol Violation|0|||
157026237|NCT02489903|566851507|FG001|Randomized and Received Treatment|Protocol Violation|1|||
157026238|NCT02489903|566851508|FG002|Randomized and Received Treatment|Protocol Violation|0|||
157026239|NCT02489903|566851509|FG003|Randomized and Received Treatment|Protocol Violation|0|||
157026240|NCT02489903|566851506|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
157026241|NCT02489903|566851507|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
157026242|NCT02489903|566851508|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
157026243|NCT02489903|566851509|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
157026244|NCT02489903|566851506|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
157026245|NCT02489903|566851507|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
157026246|NCT02489903|566851508|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
157026247|NCT02489903|566851509|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
157026248|NCT02489903|566851506|FG000|Randomized and Received Treatment|Death|10|||
157026249|NCT02489903|566851507|FG001|Randomized and Received Treatment|Death|1|||
157026250|NCT02489903|566851508|FG002|Randomized and Received Treatment|Death|0|||
157026251|NCT02489903|566851509|FG003|Randomized and Received Treatment|Death|0|||
157026252|NCT03216057|566851510|FG000|Overall Study|Lost to Follow-up|2|||
157026253|NCT03216057|566851511|FG001|Overall Study|Lost to Follow-up|2|||
157026254|NCT05126433|566851512|FG000|Overall Study|Withdrawal by Subject|3|||
157026255|NCT05126433|566851513|FG001|Overall Study|Withdrawal by Subject|0|||
157026256|NCT05126433|566851514|FG002|Overall Study|Withdrawal by Subject|4|||
157026257|NCT05126433|566851512|FG000|Overall Study|Death|9|||
157026258|NCT05126433|566851513|FG001|Overall Study|Death|3|||
157026259|NCT05126433|566851514|FG002|Overall Study|Death|5|||
156899390|NCT02124161|566391399|FG001|Overall Study|Lost to Follow-up|4|||
156899391|NCT05085730|566391402|FG000|Overall Study|Withdrawal by Subject|4|||
157026260|NCT05126433|566851512|FG000|Overall Study|Study Terminated by sponsor|0|||
157026261|NCT05126433|566851513|FG001|Overall Study|Study Terminated by sponsor|1|||
157026262|NCT05126433|566851514|FG002|Overall Study|Study Terminated by sponsor|2|||
156899392|NCT05085730|566391402|FG000|Overall Study|Physician Decision|1|||
156899393|NCT04010539|566391403|FG000|Overall Study|Withdrawal by Subject|4|||
156899394|NCT04010539|566391404|FG001|Overall Study|Withdrawal by Subject|1|||
157026263|NCT05126433|566851512|FG000|Overall Study|Progressive Disease|1|||
157026264|NCT05126433|566851513|FG001|Overall Study|Progressive Disease|4|||
157026265|NCT05126433|566851514|FG002|Overall Study|Progressive Disease|3|||
156899395|NCT04010539|566391403|FG000|Overall Study|Physician Decision|0|||
156899396|NCT04010539|566391404|FG001|Overall Study|Physician Decision|2|||
156899397|NCT04010539|566391403|FG000|Overall Study|Lost to Follow-up|10|||
156899398|NCT04010539|566391404|FG001|Overall Study|Lost to Follow-up|14|||
156899399|NCT04010539|566391403|FG000|Overall Study|Adverse Event|3|||
156899400|NCT04010539|566391404|FG001|Overall Study|Adverse Event|0|||
156899401|NCT04010539|566391403|FG000|Overall Study|Participant Did Not Receive IP|0|||
156899402|NCT04010539|566391404|FG001|Overall Study|Participant Did Not Receive IP|1|||
156899403|NCT04010539|566391403|FG000|Overall Study|Protocol Deviation|0|||
156899404|NCT04010539|566391404|FG001|Overall Study|Protocol Deviation|1|||
156899405|NCT04010539|566391403|FG000|Overall Study|Randomized in Error/ Mistake|2|||
156899406|NCT04010539|566391404|FG001|Overall Study|Randomized in Error/ Mistake|0|||
156899407|NCT04010539|566391403|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
156899408|NCT04010539|566391404|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
156899409|NCT00381381|566391412|FG000|Overall Study|Adverse Event|3|||
156899410|NCT00381381|566391412|FG000|Overall Study|Lost to Follow-up|52|||
156899411|NCT00381381|566391412|FG000|Overall Study|Withdrawal by Subject|9|||
156899412|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Adverse Event|10|||
156899413|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Adverse Event|0|||
156899414|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
156899415|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
156899416|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
156899417|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
156899418|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
156899419|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
156899420|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
156899421|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
156899422|NCT02787551|566391416|FG000|Core Period: 26 Weeks|Other than specified|3|||
156899423|NCT02787551|566391417|FG001|Core Period: 26 Weeks|Other than specified|1|||
156899424|NCT02787551|566391416|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
156899425|NCT02787551|566391417|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
156899426|NCT02787551|566391416|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
156899427|NCT02787551|566391417|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
156899428|NCT02787551|566391416|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
156899429|NCT02787551|566391417|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
156899430|NCT03799211|566391418|FG000|Overall Study|Lost to Follow-up|2|||
156899431|NCT03799211|566391419|FG001|Overall Study|Lost to Follow-up|13|||
156899432|NCT03799211|566391418|FG000|Overall Study|Withdrawal by Subject|2|||
156899433|NCT03799211|566391419|FG001|Overall Study|Withdrawal by Subject|0|||
156899434|NCT03139279|566391420|FG000|Overall Study|Physician Decision|2|||
156899435|NCT03139279|566391421|FG001|Overall Study|Physician Decision|0|||
156899436|NCT03139279|566391420|FG000|Overall Study|Protocol Violation|5|||
156899437|NCT03139279|566391421|FG001|Overall Study|Protocol Violation|4|||
156899438|NCT03139279|566391420|FG000|Overall Study|Withdrawal by Subject|0|||
156899439|NCT03139279|566391421|FG001|Overall Study|Withdrawal by Subject|2|||
156899440|NCT01336569|566391422|FG000|Overall Study|Lost to Follow-up|4|||
156899441|NCT02337738|566391423|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
156899442|NCT02337738|566391424|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
156899443|NCT02337738|566391425|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
156899444|NCT02337738|566391423|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156899445|NCT02337738|566391424|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
156899446|NCT02337738|566391425|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
156899447|NCT02337738|566391423|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
156899448|NCT02337738|566391424|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
156899449|NCT02337738|566391425|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
156899450|NCT02337738|566391423|FG000|Overall Study|Voluntary Withdrawal|10|||
156899451|NCT02337738|566391424|FG001|Overall Study|Voluntary Withdrawal|5|||
156899452|NCT02337738|566391425|FG002|Overall Study|Voluntary Withdrawal|2|||
156899453|NCT02337738|566391423|FG000|Overall Study|Lack of Efficacy|2|||
156899454|NCT02337738|566391424|FG001|Overall Study|Lack of Efficacy|4|||
156899455|NCT02337738|566391425|FG002|Overall Study|Lack of Efficacy|0|||
156899456|NCT02337738|566391423|FG000|Overall Study|Investigator's Judgment|1|||
156899457|NCT02337738|566391424|FG001|Overall Study|Investigator's Judgment|1|||
156899458|NCT02337738|566391425|FG002|Overall Study|Investigator's Judgment|3|||
156899459|NCT00406354|566391426|FG000|All Randomized Patients|Protocol Violation|0|||
156899460|NCT00406354|566391427|FG001|All Randomized Patients|Protocol Violation|0|||
156899461|NCT00406354|566391428|FG002|All Randomized Patients|Protocol Violation|1|||
156899462|NCT00406354|566391426|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
156899463|NCT00406354|566391427|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
156899464|NCT00406354|566391428|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
156899465|NCT00406354|566391426|FG000|All Randomized and Treated Patients|Adverse Event|6|||
156899466|NCT00406354|566391427|FG001|All Randomized and Treated Patients|Adverse Event|2|||
157158482|NCT01318083|567324627|FG000|Overall Study|Adverse Event|4|||
157158483|NCT01318083|567324628|FG001|Overall Study|Adverse Event|1|||
157158484|NCT01318083|567324629|FG002|Overall Study|Adverse Event|2|||
156899467|NCT00406354|566391428|FG002|All Randomized and Treated Patients|Adverse Event|1|||
156899468|NCT00406354|566391426|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
157158485|NCT01318083|567324627|FG000|Overall Study|Withdrawal by Subject|1|||
157158486|NCT01318083|567324628|FG001|Overall Study|Withdrawal by Subject|0|||
157158487|NCT01318083|567324629|FG002|Overall Study|Withdrawal by Subject|2|||
157158488|NCT01318083|567324627|FG000|Overall Study|Lack of Efficacy|0|||
157158489|NCT01318083|567324628|FG001|Overall Study|Lack of Efficacy|0|||
157158490|NCT01318083|567324629|FG002|Overall Study|Lack of Efficacy|1|||
156899469|NCT00406354|566391427|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
156899470|NCT00406354|566391428|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
156899471|NCT00406354|566391426|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
156899472|NCT00406354|566391427|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
156899473|NCT00406354|566391428|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
156899474|NCT00406354|566391426|FG000|All Randomized and Treated Patients|Physician Decision|0|||
156899475|NCT00406354|566391427|FG001|All Randomized and Treated Patients|Physician Decision|0|||
156899476|NCT00406354|566391428|FG002|All Randomized and Treated Patients|Physician Decision|1|||
156899477|NCT01565642|566391431|FG000|Overall Study|Withdrawal by Subject|2|||
156899478|NCT01565642|566391432|FG001|Overall Study|Withdrawal by Subject|1|||
156899479|NCT01631812|566391433|FG000|Overall Study|Adverse Event|25|||
156899480|NCT01631812|566391433|FG000|Overall Study|Lack of Efficacy|5|||
156899481|NCT01631812|566391433|FG000|Overall Study|Withdrawal by Subject|4|||
156899482|NCT01631812|566391433|FG000|Overall Study|Physician Decision|3|||
156899483|NCT02130024|566391444|FG000|Overall Study|Adverse Event|10|||
156899484|NCT02130024|566391445|FG001|Overall Study|Adverse Event|11|||
156899485|NCT02130024|566391444|FG000|Overall Study|Death|2|||
156899486|NCT02130024|566391445|FG001|Overall Study|Death|2|||
156899487|NCT02130024|566391444|FG000|Overall Study|Lost to Follow-up|1|||
156899488|NCT02130024|566391445|FG001|Overall Study|Lost to Follow-up|1|||
156899489|NCT02130024|566391444|FG000|Overall Study|Physician Decision|1|||
156899490|NCT02130024|566391445|FG001|Overall Study|Physician Decision|3|||
156899491|NCT02130024|566391444|FG000|Overall Study|Protocol Deviation|4|||
156899492|NCT02130024|566391445|FG001|Overall Study|Protocol Deviation|0|||
156899493|NCT02130024|566391444|FG000|Overall Study|Site Administration Problems|1|||
156899494|NCT02130024|566391445|FG001|Overall Study|Site Administration Problems|0|||
157026266|NCT05126433|566851512|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
157026267|NCT05126433|566851513|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
157026268|NCT05126433|566851514|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
157026269|NCT03768505|566851525|FG000|Overall Study|sponsor decision|76|||
157026270|NCT03768505|566851525|FG000|Overall Study|Death|35|||
157026271|NCT03768505|566851525|FG000|Overall Study|Other -Various|30|||
157026272|NCT03768505|566851525|FG000|Overall Study|Withdrawal by Subject|22|||
157026273|NCT03768505|566851525|FG000|Overall Study|Lost to Follow-up|6|||
157026274|NCT04948697|566851526|FG000|Overall Study|Progressive disease|27|||
157026275|NCT04948697|566851527|FG001|Overall Study|Progressive disease|18|||
157026276|NCT04948697|566851526|FG000|Overall Study|Adverse Event|14|||
157026277|NCT04948697|566851527|FG001|Overall Study|Adverse Event|4|||
157026278|NCT04948697|566851526|FG000|Overall Study|Participant moved to long term extension study|7|||
157026279|NCT04948697|566851527|FG001|Overall Study|Participant moved to long term extension study|4|||
157026280|NCT04948697|566851526|FG000|Overall Study|Withdrawal by Subject|10|||
157026281|NCT04948697|566851527|FG001|Overall Study|Withdrawal by Subject|0|||
157026282|NCT04948697|566851526|FG000|Overall Study|Closed by Sponsor|3|||
157026283|NCT04948697|566851527|FG001|Overall Study|Closed by Sponsor|2|||
157026284|NCT04948697|566851526|FG000|Overall Study|Physician Decision|0|||
157026285|NCT04948697|566851527|FG001|Overall Study|Physician Decision|2|||
157026286|NCT04948697|566851526|FG000|Overall Study|Lost to Follow-up|0|||
157026287|NCT04948697|566851527|FG001|Overall Study|Lost to Follow-up|1|||
157026288|NCT04948697|566851526|FG000|Overall Study|Other-Miscellaneous|1|||
157026289|NCT04948697|566851527|FG001|Overall Study|Other-Miscellaneous|0|||
157026290|NCT04948697|566851526|FG000|Overall Study|Randomized but not treated|0|||
157026291|NCT04948697|566851527|FG001|Overall Study|Randomized but not treated|1|||
157026292|NCT04599062|566851529|FG000|Overall Study|Physician Decision|1|||
157026293|NCT04599062|566851530|FG001|Overall Study|Physician Decision|0|||
157026294|NCT04032704|566851531|FG000|Part A|Withdrawal by Subject|0|||
157158491|NCT01318083|567324627|FG000|Overall Study|Treatment Complications|1|||
157158492|NCT01318083|567324628|FG001|Overall Study|Treatment Complications|0|||
157158493|NCT01318083|567324629|FG002|Overall Study|Treatment Complications|0|||
157158494|NCT01318083|567324627|FG000|Overall Study|Lack of Study Medication Compliance|0|||
156899495|NCT02130024|566391444|FG000|Overall Study|Subject Withdrew Consent|6|||
156899496|NCT02130024|566391445|FG001|Overall Study|Subject Withdrew Consent|14|||
156899497|NCT02024555|566391446|FG000|Overall Study|Lost to Follow-up|1|||
156899498|NCT02024555|566391447|FG001|Overall Study|Lost to Follow-up|1|||
157026295|NCT04032704|566851532|FG001|Part A|Withdrawal by Subject|0|||
157026296|NCT04032704|566851533|FG002|Part A|Withdrawal by Subject|3|||
157026297|NCT04032704|566851534|FG003|Part A|Withdrawal by Subject|0|||
157026298|NCT04032704|566851535|FG004|Part A|Withdrawal by Subject|1|||
156899499|NCT02024555|566391446|FG000|Overall Study|Withdrawal by Subject|5|||
156899500|NCT02024555|566391447|FG001|Overall Study|Withdrawal by Subject|1|||
156899501|NCT02718300|566391448|FG000|Overall Study|Death|4|||
156899502|NCT02718300|566391449|FG001|Overall Study|Death|5|||
156899503|NCT02718300|566391450|FG002|Overall Study|Death|17|||
156899504|NCT02718300|566391448|FG000|Overall Study|Lost to Follow-up|1|||
156899505|NCT02718300|566391449|FG001|Overall Study|Lost to Follow-up|0|||
156899506|NCT02718300|566391450|FG002|Overall Study|Lost to Follow-up|2|||
156899507|NCT02718300|566391448|FG000|Overall Study|Physician Decision|1|||
156899508|NCT02718300|566391449|FG001|Overall Study|Physician Decision|0|||
156899509|NCT02718300|566391450|FG002|Overall Study|Physician Decision|2|||
156899510|NCT02718300|566391448|FG000|Overall Study|Study Terminated by Sponsor|6|||
156899511|NCT02718300|566391449|FG001|Overall Study|Study Terminated by Sponsor|3|||
156899512|NCT02718300|566391450|FG002|Overall Study|Study Terminated by Sponsor|4|||
156899513|NCT02718300|566391448|FG000|Overall Study|Withdrawal by Subject|0|||
156899514|NCT02718300|566391449|FG001|Overall Study|Withdrawal by Subject|4|||
156899515|NCT02718300|566391450|FG002|Overall Study|Withdrawal by Subject|3|||
156899516|NCT02718300|566391448|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
156899517|NCT02718300|566391449|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
156899518|NCT02718300|566391450|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
156899519|NCT00257608|566393152|FG000|Chemotherapy Phase|Adverse Event|138|||
156899520|NCT00257608|566393153|FG001|Chemotherapy Phase|Adverse Event|0|||
156899521|NCT00257608|566393154|FG002|Chemotherapy Phase|Adverse Event|0|||
156899522|NCT00257608|566393152|FG000|Chemotherapy Phase|Disease progression|139|||
156899523|NCT00257608|566393153|FG001|Chemotherapy Phase|Disease progression|0|||
156899524|NCT00257608|566393154|FG002|Chemotherapy Phase|Disease progression|0|||
156899525|NCT00257608|566393152|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
156899526|NCT00257608|566393153|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
156899527|NCT00257608|566393154|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
156899528|NCT00257608|566393152|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
156899529|NCT00257608|566393153|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156899530|NCT00257608|566393154|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156899531|NCT00257608|566393152|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
156899532|NCT00257608|566393153|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
156899533|NCT00257608|566393154|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
156899534|NCT00257608|566393152|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
156899535|NCT00257608|566393153|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
156899536|NCT00257608|566393154|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
156899537|NCT00257608|566393152|FG000|Chemotherapy Phase|Physician Decision|28|||
156899538|NCT00257608|566393153|FG001|Chemotherapy Phase|Physician Decision|0|||
156899539|NCT00257608|566393154|FG002|Chemotherapy Phase|Physician Decision|0|||
156899540|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Adverse Event|0|||
156899541|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Adverse Event|34|||
156899542|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Adverse Event|38|||
156899543|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Disease progression|0|||
156899544|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Disease progression|204|||
156899545|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Disease progression|168|||
156899546|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
156899547|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
156899548|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
156899549|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
156899550|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
156899551|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
156899552|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
156899553|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
156899554|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
156899555|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
156899556|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
156899557|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
156899558|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
156899559|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
156899560|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
156899561|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Physician Decision|0|||
156899562|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Physician Decision|8|||
156899563|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Physician Decision|11|||
156899564|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
156899565|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
156899566|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
156899567|NCT00257608|566393152|FG000|Post Chemotherapy Phase|Not treated|0|||
157225513|NCT00818883|567571452|FG001|Overall Study|Withdrawal by Subject|14|||
156899568|NCT00257608|566393153|FG001|Post Chemotherapy Phase|Not treated|4|||
156899569|NCT00257608|566393154|FG002|Post Chemotherapy Phase|Not treated|7|||
156899570|NCT03673046|566393155|FG000|Overall Study|Adverse Event|1|||
156899571|NCT03673046|566393156|FG001|Overall Study|Adverse Event|1|||
156899572|NCT03673046|566393155|FG000|Overall Study|Withdrawal by Subject|8|||
156899573|NCT03673046|566393156|FG001|Overall Study|Withdrawal by Subject|2|||
156899574|NCT03817879|566393157|FG000|Overall Study|Drop out|5|||
156899575|NCT03817879|566393158|FG001|Overall Study|Drop out|12|||
156899576|NCT03817879|566393157|FG000|Overall Study|Withdrawal by Subject|0|||
156899577|NCT03817879|566393158|FG001|Overall Study|Withdrawal by Subject|1|||
156899578|NCT03693300|566393159|FG000|Overall Study|Withdrawal by Subject|6|||
156899579|NCT03693300|566393160|FG001|Overall Study|Withdrawal by Subject|0|||
156899580|NCT03693300|566393159|FG000|Overall Study|Death|50|||
156899581|NCT03693300|566393160|FG001|Overall Study|Death|2|||
156899582|NCT03693300|566393159|FG000|Overall Study|Lost to Follow-up|2|||
156899583|NCT03693300|566393160|FG001|Overall Study|Lost to Follow-up|0|||
156899584|NCT02742441|566393161|FG000|Overall Study|Lost to Follow-up|4|||
156899585|NCT02742441|566393162|FG001|Overall Study|Lost to Follow-up|4|||
156899586|NCT02742441|566393161|FG000|Overall Study|Withdrawal by Subject|2|||
156899587|NCT02742441|566393162|FG001|Overall Study|Withdrawal by Subject|2|||
156899588|NCT02742441|566393161|FG000|Overall Study|Adverse Event|0|||
156899589|NCT02742441|566393162|FG001|Overall Study|Adverse Event|2|||
156899590|NCT00537238|566393163|FG000|Overall Study|Death|1|||
156899591|NCT00537238|566393164|FG001|Overall Study|Death|2|||
156899592|NCT00537238|566393163|FG000|Overall Study|Adverse Event|31|||
156899593|NCT00537238|566393164|FG001|Overall Study|Adverse Event|22|||
156899594|NCT00537238|566393163|FG000|Overall Study|Lack of Efficacy|20|||
156899595|NCT00537238|566393164|FG001|Overall Study|Lack of Efficacy|21|||
156899596|NCT00537238|566393163|FG000|Overall Study|Lost to Follow-up|12|||
156899597|NCT00537238|566393164|FG001|Overall Study|Lost to Follow-up|8|||
156899598|NCT00537238|566393163|FG000|Overall Study|Withdrawal by Subject|51|||
156899599|NCT00537238|566393164|FG001|Overall Study|Withdrawal by Subject|47|||
156899600|NCT00537238|566393163|FG000|Overall Study|Protocol Violation|15|||
156899601|NCT00537238|566393164|FG001|Overall Study|Protocol Violation|19|||
157158495|NCT01318083|567324628|FG001|Overall Study|Lack of Study Medication Compliance|1|||
156899602|NCT00537238|566393163|FG000|Overall Study|Does not meet entrance criteria|0|||
156899603|NCT00537238|566393164|FG001|Overall Study|Does not meet entrance criteria|2|||
156899604|NCT00537238|566393163|FG000|Overall Study|Other|44|||
156899605|NCT00537238|566393164|FG001|Overall Study|Other|52|||
156899606|NCT03265665|566393169|FG000|24-week Data Collection|Withdrawal by Subject|2|||
156899607|NCT03265665|566393170|FG001|24-week Data Collection|Withdrawal by Subject|2|||
156899608|NCT03265665|566393169|FG000|24-week Data Collection|Lost to Follow-up|4|||
156899609|NCT03265665|566393170|FG001|24-week Data Collection|Lost to Follow-up|5|||
156899610|NCT03265665|566393169|FG000|36-week Data Collection|Lost to Follow-up|6|||
156899611|NCT03265665|566393170|FG001|36-week Data Collection|Lost to Follow-up|8|||
156899612|NCT01845818|566393173|FG000|Overall Study|Withdrawal by Subject|0|||
156899613|NCT01845818|566393174|FG001|Overall Study|Withdrawal by Subject|1|||
156899614|NCT01845818|566393173|FG000|Overall Study|Lost to Follow-up|7|||
156899615|NCT01845818|566393174|FG001|Overall Study|Lost to Follow-up|5|||
156899616|NCT01845818|566393173|FG000|Overall Study|Administrative Reasons|3|||
156899617|NCT01845818|566393174|FG001|Overall Study|Administrative Reasons|1|||
156899618|NCT01845818|566393173|FG000|Overall Study|Serious Adverse Event|1|||
156899619|NCT01845818|566393174|FG001|Overall Study|Serious Adverse Event|1|||
156899620|NCT01845818|566393173|FG000|Overall Study|Other|25|||
156899621|NCT01845818|566393174|FG001|Overall Study|Other|8|||
156899622|NCT01845818|566393173|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
156899623|NCT01845818|566393174|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
156899624|NCT01845818|566393173|FG000|Overall Study|No Follow-Up Data Available|4|||
156899625|NCT01845818|566393174|FG001|Overall Study|No Follow-Up Data Available|1|||
156899626|NCT01680965|566393175|FG000|Overall Study|Death|0|||
157158496|NCT01318083|567324629|FG002|Overall Study|Lack of Study Medication Compliance|0|||
157158497|NCT02028338|567324633|FG000|Overall Study|Withdrawal by Subject|3|||
156899627|NCT01680965|566393176|FG001|Overall Study|Death|0|||
156899628|NCT01680965|566393177|FG002|Overall Study|Death|0|||
156899629|NCT01680965|566393178|FG003|Overall Study|Death|6|||
156899630|NCT02202837|566393183|FG000|Overall Study|Enbrel treatment discontinued|36|||
156899631|NCT02202837|566393184|FG001|Overall Study|Enbrel treatment discontinued|4|||
156899632|NCT02202837|566393183|FG000|Overall Study|Other|10|||
156899633|NCT02202837|566393184|FG001|Overall Study|Other|0|||
156899634|NCT02202837|566393183|FG000|Overall Study|Lost to Follow-up|7|||
157158498|NCT02028338|567324634|FG001|Overall Study|Withdrawal by Subject|1|||
156899635|NCT02202837|566393184|FG001|Overall Study|Lost to Follow-up|1|||
156899636|NCT00231842|566393190|FG000|Overall Study|Withdrawal by Subject|3|||
156899637|NCT00231842|566393190|FG000|Overall Study|Did not complete the last 3 cycle|8|||
156899638|NCT02422303|566393191|FG000|Overall Study|Lost to Follow-up|1|||
156899639|NCT02422303|566393192|FG001|Overall Study|Lost to Follow-up|1|||
156899640|NCT00850343|566393193|FG000|Overall Study|Withdrawal by Subject|11|||
156899641|NCT00850343|566393194|FG001|Overall Study|Withdrawal by Subject|0|||
156899642|NCT00850343|566393195|FG002|Overall Study|Withdrawal by Subject|3|||
156899643|NCT00850343|566393196|FG003|Overall Study|Withdrawal by Subject|2|||
156899644|NCT00850343|566393193|FG000|Overall Study|Adverse Event|15|||
156899645|NCT00850343|566393194|FG001|Overall Study|Adverse Event|2|||
156899646|NCT00850343|566393195|FG002|Overall Study|Adverse Event|6|||
156899647|NCT00850343|566393196|FG003|Overall Study|Adverse Event|6|||
157158499|NCT02028338|567324633|FG000|Overall Study|Unable to contact participant|1|||
157158500|NCT02028338|567324634|FG001|Overall Study|Unable to contact participant|0|||
157158501|NCT03552549|567324635|FG000|Overall Study|Disease progression|25|||
157158502|NCT03552549|567324636|FG001|Overall Study|Disease progression|17|||
157158503|NCT03552549|567324635|FG000|Overall Study|Adverse event in first 12 months|12|||
157158504|NCT03552549|567324636|FG001|Overall Study|Adverse event in first 12 months|8|||
156899648|NCT00850343|566393193|FG000|Overall Study|Pregnancy|0|||
156899649|NCT00850343|566393194|FG001|Overall Study|Pregnancy|0|||
156899650|NCT00850343|566393195|FG002|Overall Study|Pregnancy|0|||
156899651|NCT00850343|566393196|FG003|Overall Study|Pregnancy|1|||
156899652|NCT00850343|566393193|FG000|Overall Study|Lack of Efficacy|17|||
156899653|NCT00850343|566393194|FG001|Overall Study|Lack of Efficacy|0|||
156899654|NCT00850343|566393195|FG002|Overall Study|Lack of Efficacy|3|||
156899655|NCT00850343|566393196|FG003|Overall Study|Lack of Efficacy|2|||
156899656|NCT00850343|566393193|FG000|Overall Study|Non-compliance with Study Procedures|1|||
156899657|NCT00850343|566393194|FG001|Overall Study|Non-compliance with Study Procedures|0|||
156899658|NCT00850343|566393195|FG002|Overall Study|Non-compliance with Study Procedures|1|||
156899659|NCT00850343|566393196|FG003|Overall Study|Non-compliance with Study Procedures|1|||
156899660|NCT00850343|566393193|FG000|Overall Study|Physician Decision|2|||
156899661|NCT00850343|566393194|FG001|Overall Study|Physician Decision|1|||
156899662|NCT00850343|566393195|FG002|Overall Study|Physician Decision|1|||
156899663|NCT00850343|566393196|FG003|Overall Study|Physician Decision|1|||
156899664|NCT00639678|566393197|FG000|Overall Study|Withdrawal by Subject|3|||
156899665|NCT00639678|566393198|FG001|Overall Study|Withdrawal by Subject|0|||
156899666|NCT00639678|566393199|FG002|Overall Study|Withdrawal by Subject|4|||
156899667|NCT00639678|566393200|FG003|Overall Study|Withdrawal by Subject|0|||
156899668|NCT00639678|566393197|FG000|Overall Study|Lost to Follow-up|1|||
157026299|NCT04032704|566851536|FG005|Part A|Withdrawal by Subject|7|||
157026300|NCT04032704|566851537|FG006|Part A|Withdrawal by Subject|0|||
157026301|NCT04032704|566851538|FG007|Part A|Withdrawal by Subject|0|||
157026302|NCT04032704|566851539|FG008|Part A|Withdrawal by Subject|0|||
157026303|NCT04032704|566851540|FG009|Part A|Withdrawal by Subject|0|||
157026304|NCT04032704|566851541|FG010|Part A|Withdrawal by Subject|0|||
157026305|NCT04032704|566851542|FG011|Part A|Withdrawal by Subject|0|||
157026306|NCT04032704|566851543|FG012|Part A|Withdrawal by Subject|0|||
157026307|NCT04032704|566851544|FG013|Part A|Withdrawal by Subject|0|||
157026308|NCT04032704|566851545|FG014|Part A|Withdrawal by Subject|0|||
157026309|NCT04032704|566851546|FG015|Part A|Withdrawal by Subject|0|||
157026310|NCT04032704|566851547|FG016|Part A|Withdrawal by Subject|0|||
157026311|NCT04032704|566851548|FG017|Part A|Withdrawal by Subject|0|||
157026312|NCT04032704|566851531|FG000|Part A|Lost to Follow-up|1|||
157026313|NCT04032704|566851532|FG001|Part A|Lost to Follow-up|0|||
157026314|NCT04032704|566851533|FG002|Part A|Lost to Follow-up|0|||
157026315|NCT04032704|566851534|FG003|Part A|Lost to Follow-up|0|||
157026316|NCT04032704|566851535|FG004|Part A|Lost to Follow-up|0|||
157026317|NCT04032704|566851536|FG005|Part A|Lost to Follow-up|0|||
157158505|NCT03552549|567324635|FG000|Overall Study|Withdrawal by Subject|7|||
157158506|NCT03552549|567324636|FG001|Overall Study|Withdrawal by Subject|7|||
157225514|NCT00818883|567571451|FG000|Overall Study|Lack of Efficacy|0|||
156859040|NCT00083889|566238686|FG000|Overall Study|Randomized: did not take study drug|0|||
156859041|NCT00083889|566238687|FG001|Overall Study|Randomized: did not take study drug|15|||
156859042|NCT00083889|566238686|FG000|Overall Study|Completed on marketed sunitinub|3|||
156859043|NCT00083889|566238687|FG001|Overall Study|Completed on marketed sunitinub|0|||
156859044|NCT00083889|566238686|FG000|Overall Study|Crossover to SU011248|0|||
156859045|NCT00083889|566238687|FG001|Overall Study|Crossover to SU011248|25|||
156859046|NCT03473236|566238688|FG000|Overall Study|Withdrawal by Subject|0|||
156859047|NCT03473236|566238689|FG001|Overall Study|Withdrawal by Subject|0|||
156859048|NCT03473236|566238690|FG002|Overall Study|Withdrawal by Subject|0|||
156859049|NCT03473236|566238691|FG003|Overall Study|Withdrawal by Subject|0|||
156859050|NCT03473236|566238692|FG004|Overall Study|Withdrawal by Subject|0|||
156859051|NCT03473236|566238693|FG005|Overall Study|Withdrawal by Subject|1|||
156859052|NCT03473236|566238694|FG006|Overall Study|Withdrawal by Subject|0|||
156859053|NCT03473236|566238695|FG007|Overall Study|Withdrawal by Subject|0|||
156859054|NCT03473236|566238696|FG008|Overall Study|Withdrawal by Subject|1|||
156899669|NCT00639678|566393198|FG001|Overall Study|Lost to Follow-up|0|||
156899670|NCT00639678|566393199|FG002|Overall Study|Lost to Follow-up|6|||
156899671|NCT00639678|566393200|FG003|Overall Study|Lost to Follow-up|0|||
156899672|NCT00639678|566393197|FG000|Overall Study|Adverse Event|0|||
157026318|NCT04032704|566851537|FG006|Part A|Lost to Follow-up|0|||
157026319|NCT04032704|566851538|FG007|Part A|Lost to Follow-up|0|||
157026320|NCT04032704|566851539|FG008|Part A|Lost to Follow-up|0|||
157026321|NCT04032704|566851540|FG009|Part A|Lost to Follow-up|0|||
157026322|NCT04032704|566851541|FG010|Part A|Lost to Follow-up|0|||
156899673|NCT00639678|566393198|FG001|Overall Study|Adverse Event|1|||
156899674|NCT00639678|566393199|FG002|Overall Study|Adverse Event|0|||
156899675|NCT00639678|566393200|FG003|Overall Study|Adverse Event|0|||
156899676|NCT00639678|566393197|FG000|Overall Study|Lack of Compliance|0|||
156899677|NCT00639678|566393198|FG001|Overall Study|Lack of Compliance|0|||
156899678|NCT00639678|566393199|FG002|Overall Study|Lack of Compliance|1|||
156899679|NCT00639678|566393200|FG003|Overall Study|Lack of Compliance|0|||
156899680|NCT00371826|566393201|FG000|Core Phase (12 Months)|Adverse Event|15|||
156899681|NCT00371826|566393202|FG001|Core Phase (12 Months)|Adverse Event|4|||
156899682|NCT00371826|566393203|FG002|Core Phase (12 Months)|Adverse Event|9|||
156899683|NCT00371826|566393201|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
156899684|NCT00371826|566393202|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
156899685|NCT00371826|566393203|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
156899686|NCT00371826|566393201|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
156899687|NCT00371826|566393202|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
156899688|NCT00371826|566393203|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
156899689|NCT00371826|566393201|FG000|Core Phase (12 Months)|Protocol Violation|1|||
156899690|NCT00371826|566393202|FG001|Core Phase (12 Months)|Protocol Violation|0|||
156899691|NCT00371826|566393203|FG002|Core Phase (12 Months)|Protocol Violation|1|||
156899692|NCT00371826|566393201|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
156899693|NCT00371826|566393202|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
156899694|NCT00371826|566393203|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
156899695|NCT00371826|566393201|FG000|Core Phase (12 Months)|Administrative problems|1|||
156899696|NCT00371826|566393202|FG001|Core Phase (12 Months)|Administrative problems|0|||
156899697|NCT00371826|566393203|FG002|Core Phase (12 Months)|Administrative problems|8|||
156899698|NCT00371826|566393201|FG000|Core Phase (12 Months)|Graft Loss|0|||
156899699|NCT00371826|566393202|FG001|Core Phase (12 Months)|Graft Loss|1|||
156899700|NCT00371826|566393203|FG002|Core Phase (12 Months)|Graft Loss|0|||
156899701|NCT00371826|566393201|FG000|Extension Phase (24 Months)|Adverse Event|4|||
156899702|NCT00371826|566393202|FG001|Extension Phase (24 Months)|Adverse Event|5|||
156899703|NCT00371826|566393203|FG002|Extension Phase (24 Months)|Adverse Event|0|||
156899704|NCT00371826|566393201|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
156899705|NCT00371826|566393202|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
156899706|NCT00371826|566393203|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
156899707|NCT00371826|566393201|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
156899708|NCT00371826|566393202|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
156899709|NCT00371826|566393203|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
156899710|NCT00371826|566393201|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
156899711|NCT00371826|566393202|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
156899712|NCT00371826|566393203|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
156899713|NCT00371826|566393201|FG000|Extension Phase (24 Months)|Administrative problems|0|||
156899714|NCT00371826|566393202|FG001|Extension Phase (24 Months)|Administrative problems|0|||
156899715|NCT00371826|566393203|FG002|Extension Phase (24 Months)|Administrative problems|2|||
156899716|NCT02436304|566393204|FG000|Overall Study|Lost to Follow-up|0|||
156899717|NCT02436304|566393205|FG001|Overall Study|Lost to Follow-up|1|||
156899718|NCT02436304|566393206|FG002|Overall Study|Lost to Follow-up|0|||
156899719|NCT02436304|566393204|FG000|Overall Study|Withdrawal by Subject|0|||
156899720|NCT02436304|566393205|FG001|Overall Study|Withdrawal by Subject|1|||
156899721|NCT02436304|566393206|FG002|Overall Study|Withdrawal by Subject|0|||
156899722|NCT02436304|566393204|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
156899723|NCT02436304|566393205|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
156899724|NCT02436304|566393206|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
156899725|NCT00785928|566393212|FG000|Treatment Phase|Adverse Event|1|||
156899726|NCT00785928|566393213|FG001|Treatment Phase|Adverse Event|1|||
156899727|NCT00785928|566393214|FG002|Treatment Phase|Adverse Event|2|||
156899728|NCT00785928|566393215|FG003|Treatment Phase|Adverse Event|0|||
156899729|NCT00785928|566393216|FG004|Treatment Phase|Adverse Event|0|||
156899730|NCT00785928|566393217|FG005|Treatment Phase|Adverse Event|0|||
156899731|NCT00785928|566393218|FG006|Treatment Phase|Adverse Event|2|||
156899732|NCT00785928|566393212|FG000|Treatment Phase|Inadequate Response|0|||
156899733|NCT00785928|566393213|FG001|Treatment Phase|Inadequate Response|1|||
156899734|NCT00785928|566393214|FG002|Treatment Phase|Inadequate Response|0|||
156899735|NCT00785928|566393215|FG003|Treatment Phase|Inadequate Response|0|||
156899736|NCT00785928|566393216|FG004|Treatment Phase|Inadequate Response|0|||
156899737|NCT00785928|566393217|FG005|Treatment Phase|Inadequate Response|0|||
157225515|NCT00818883|567571452|FG001|Overall Study|Lack of Efficacy|2|||
156899738|NCT00785928|566393218|FG006|Treatment Phase|Inadequate Response|0|||
156899739|NCT00785928|566393212|FG000|Treatment Phase|Lack of Efficacy|0|||
156899740|NCT00785928|566393213|FG001|Treatment Phase|Lack of Efficacy|1|||
156899741|NCT00785928|566393214|FG002|Treatment Phase|Lack of Efficacy|1|||
156899742|NCT00785928|566393215|FG003|Treatment Phase|Lack of Efficacy|0|||
156899743|NCT00785928|566393216|FG004|Treatment Phase|Lack of Efficacy|0|||
156899744|NCT00785928|566393217|FG005|Treatment Phase|Lack of Efficacy|0|||
156899745|NCT00785928|566393218|FG006|Treatment Phase|Lack of Efficacy|0|||
156899746|NCT00785928|566393212|FG000|Treatment Phase|Physician Decision|0|||
156899747|NCT00785928|566393213|FG001|Treatment Phase|Physician Decision|0|||
157026323|NCT04032704|566851542|FG011|Part A|Lost to Follow-up|0|||
157026324|NCT04032704|566851543|FG012|Part A|Lost to Follow-up|0|||
157026325|NCT04032704|566851544|FG013|Part A|Lost to Follow-up|0|||
157026326|NCT04032704|566851545|FG014|Part A|Lost to Follow-up|0|||
157026327|NCT04032704|566851546|FG015|Part A|Lost to Follow-up|0|||
157026328|NCT04032704|566851547|FG016|Part A|Lost to Follow-up|0|||
157026329|NCT04032704|566851548|FG017|Part A|Lost to Follow-up|0|||
157026330|NCT04032704|566851531|FG000|Part A|Death|9|||
157026331|NCT04032704|566851532|FG001|Part A|Death|2|||
157026332|NCT04032704|566851533|FG002|Part A|Death|10|||
157026333|NCT04032704|566851534|FG003|Part A|Death|7|||
157026334|NCT04032704|566851535|FG004|Part A|Death|4|||
157026335|NCT04032704|566851536|FG005|Part A|Death|5|||
157026336|NCT04032704|566851537|FG006|Part A|Death|0|||
157026337|NCT04032704|566851538|FG007|Part A|Death|0|||
157026338|NCT04032704|566851539|FG008|Part A|Death|0|||
157026339|NCT04032704|566851540|FG009|Part A|Death|0|||
157026340|NCT04032704|566851541|FG010|Part A|Death|0|||
157026341|NCT04032704|566851542|FG011|Part A|Death|0|||
157026342|NCT04032704|566851543|FG012|Part A|Death|0|||
157026343|NCT04032704|566851544|FG013|Part A|Death|0|||
157026344|NCT04032704|566851545|FG014|Part A|Death|0|||
157026345|NCT04032704|566851546|FG015|Part A|Death|0|||
157026346|NCT04032704|566851547|FG016|Part A|Death|0|||
157026347|NCT04032704|566851548|FG017|Part A|Death|0|||
157026348|NCT04032704|566851531|FG000|Part B|Other|0|||
157026349|NCT04032704|566851532|FG001|Part B|Other|0|||
157026350|NCT04032704|566851533|FG002|Part B|Other|0|||
157026351|NCT04032704|566851534|FG003|Part B|Other|0|||
157026352|NCT04032704|566851535|FG004|Part B|Other|0|||
157026353|NCT04032704|566851536|FG005|Part B|Other|0|||
157225516|NCT00818883|567571451|FG000|Overall Study|Other|2|||
157225517|NCT00818883|567571452|FG001|Overall Study|Other|7|||
156859055|NCT03473236|566238697|FG009|Overall Study|Withdrawal by Subject|0|||
156859056|NCT04264442|566238698|FG000|Overall Study|Lack of Efficacy|6|||
156859057|NCT04264442|566238698|FG000|Overall Study|Lost to Follow-up|2|||
156859058|NCT04264442|566238698|FG000|Overall Study|Sponsor Decision|23|||
156859059|NCT04264442|566238698|FG000|Overall Study|Withdrawal by Subject|11|||
156859060|NCT04264442|566238698|FG000|Overall Study|Study Termination|5|||
156859061|NCT01290523|566238703|FG000|Overall Study|Death|3|||
156859062|NCT00584415|566238705|FG000|Overall Study|Adverse Event|7|||
156859063|NCT00556894|566238706|FG000|Overall Study|Adverse Event|2|||
156859064|NCT00556894|566238707|FG001|Overall Study|Adverse Event|3|||
156859065|NCT00556894|566238708|FG002|Overall Study|Adverse Event|3|||
156859066|NCT00556894|566238706|FG000|Overall Study|Death|1|||
156859067|NCT00556894|566238707|FG001|Overall Study|Death|0|||
156859068|NCT00556894|566238708|FG002|Overall Study|Death|0|||
156859069|NCT00556894|566238706|FG000|Overall Study|regulatory decision in Bulgaria|10|||
156859070|NCT00556894|566238707|FG001|Overall Study|regulatory decision in Bulgaria|14|||
156859071|NCT00556894|566238708|FG002|Overall Study|regulatory decision in Bulgaria|13|||
156859072|NCT00556894|566238706|FG000|Overall Study|Change in therapy|2|||
156859073|NCT00556894|566238707|FG001|Overall Study|Change in therapy|1|||
156859074|NCT00556894|566238708|FG002|Overall Study|Change in therapy|2|||
156859075|NCT00556894|566238706|FG000|Overall Study|Withdrawal by Subject|1|||
156859076|NCT00556894|566238707|FG001|Overall Study|Withdrawal by Subject|1|||
156859077|NCT00556894|566238708|FG002|Overall Study|Withdrawal by Subject|1|||
156859078|NCT03883581|566238709|FG000|Overall Study|Withdrawal by Subject|4|||
156859079|NCT01602224|566241119|FG000|Overall Study|Adverse Event|0|||
156859080|NCT01602224|566241120|FG001|Overall Study|Adverse Event|1|||
156859081|NCT01602224|566241121|FG002|Overall Study|Adverse Event|0|||
156859082|NCT01602224|566241119|FG000|Overall Study|Investigator Decison|1|||
156859083|NCT01602224|566241120|FG001|Overall Study|Investigator Decison|0|||
156859084|NCT01602224|566241121|FG002|Overall Study|Investigator Decison|0|||
156859085|NCT01602224|566241119|FG000|Overall Study|Lost to Follow-up|0|||
156859086|NCT01602224|566241120|FG001|Overall Study|Lost to Follow-up|0|||
156859087|NCT01602224|566241121|FG002|Overall Study|Lost to Follow-up|1|||
156859088|NCT01602224|566241119|FG000|Overall Study|Protocol Violation|0|||
157026354|NCT04032704|566851537|FG006|Part B|Other|0|||
157026355|NCT04032704|566851538|FG007|Part B|Other|1|||
157026356|NCT04032704|566851539|FG008|Part B|Other|2|||
157026357|NCT04032704|566851540|FG009|Part B|Other|1|||
156899748|NCT00785928|566393214|FG002|Treatment Phase|Physician Decision|0|||
156859089|NCT01602224|566241120|FG001|Overall Study|Protocol Violation|1|||
156859090|NCT01602224|566241121|FG002|Overall Study|Protocol Violation|0|||
156899749|NCT00785928|566393215|FG003|Treatment Phase|Physician Decision|0|||
157026358|NCT04032704|566851541|FG010|Part B|Other|1|||
157026359|NCT04032704|566851542|FG011|Part B|Other|1|||
157026360|NCT04032704|566851543|FG012|Part B|Other|5|||
157026361|NCT04032704|566851544|FG013|Part B|Other|13|||
157026362|NCT04032704|566851545|FG014|Part B|Other|0|||
157026363|NCT04032704|566851546|FG015|Part B|Other|0|||
157026364|NCT04032704|566851547|FG016|Part B|Other|0|||
157026365|NCT04032704|566851548|FG017|Part B|Other|0|||
156899750|NCT00785928|566393216|FG004|Treatment Phase|Physician Decision|1|||
156899751|NCT00785928|566393217|FG005|Treatment Phase|Physician Decision|0|||
156899752|NCT00785928|566393218|FG006|Treatment Phase|Physician Decision|0|||
156899753|NCT00785928|566393212|FG000|Treatment Phase|Sponsor Decision|1|||
156899754|NCT00785928|566393213|FG001|Treatment Phase|Sponsor Decision|0|||
156899755|NCT00785928|566393214|FG002|Treatment Phase|Sponsor Decision|0|||
156899756|NCT00785928|566393215|FG003|Treatment Phase|Sponsor Decision|0|||
156899757|NCT00785928|566393216|FG004|Treatment Phase|Sponsor Decision|0|||
156899758|NCT00785928|566393217|FG005|Treatment Phase|Sponsor Decision|0|||
156899759|NCT00785928|566393218|FG006|Treatment Phase|Sponsor Decision|1|||
156899760|NCT00785928|566393212|FG000|Treatment Phase|Withdrawal by Subject|1|||
156899761|NCT00785928|566393213|FG001|Treatment Phase|Withdrawal by Subject|2|||
156899762|NCT00785928|566393214|FG002|Treatment Phase|Withdrawal by Subject|0|||
156899763|NCT00785928|566393215|FG003|Treatment Phase|Withdrawal by Subject|0|||
156899764|NCT00785928|566393216|FG004|Treatment Phase|Withdrawal by Subject|1|||
156899765|NCT00785928|566393217|FG005|Treatment Phase|Withdrawal by Subject|0|||
156899766|NCT00785928|566393218|FG006|Treatment Phase|Withdrawal by Subject|0|||
156899767|NCT01675427|566393224|FG000|Overall Study|Withdrawal by Subject|7|||
156899768|NCT01675427|566393224|FG000|Overall Study|Participant Refused Sample Collection|18|||
156899769|NCT01675427|566393224|FG000|Overall Study|Sample not Collected by Mistake|2|||
156899770|NCT01675427|566393224|FG000|Overall Study|Lost to Follow-up|5|||
156899771|NCT01675427|566393224|FG000|Overall Study|Other|2|||
156899772|NCT00369122|566393231|FG000|Overall Study|Ineligible|10|||
156899773|NCT00369122|566393231|FG000|Overall Study|No protocol treatment|1|||
156899774|NCT00408629|566393234|FG000|Overall Study|Adverse Event|13|||
156899775|NCT00408629|566393235|FG001|Overall Study|Adverse Event|27|||
156899776|NCT00408629|566393234|FG000|Overall Study|Withdrawal by Subject|8|||
156899777|NCT00408629|566393235|FG001|Overall Study|Withdrawal by Subject|4|||
156899778|NCT00408629|566393234|FG000|Overall Study|Lost to Follow-up|1|||
156899779|NCT00408629|566393235|FG001|Overall Study|Lost to Follow-up|1|||
156899780|NCT00408629|566393234|FG000|Overall Study|Lack of Efficacy|63|||
156899781|NCT00408629|566393235|FG001|Overall Study|Lack of Efficacy|73|||
156899782|NCT00408629|566393234|FG000|Overall Study|Protocol Violation|1|||
156899783|NCT00408629|566393235|FG001|Overall Study|Protocol Violation|5|||
156899784|NCT00408629|566393234|FG000|Overall Study|Miscellaneous|11|||
156899785|NCT00408629|566393235|FG001|Overall Study|Miscellaneous|15|||
156899786|NCT01461980|566393236|FG000|Overall Study|Other|9|||
156899787|NCT01461980|566393237|FG001|Overall Study|Other|8|||
156899788|NCT01461980|566393238|FG002|Overall Study|Other|6|||
156899789|NCT01461980|566393236|FG000|Overall Study|Medication error|7|||
156899790|NCT01461980|566393237|FG001|Overall Study|Medication error|5|||
156899791|NCT01461980|566393238|FG002|Overall Study|Medication error|6|||
156899792|NCT01461980|566393236|FG000|Overall Study|Adverse Event|12|||
156899793|NCT01461980|566393237|FG001|Overall Study|Adverse Event|5|||
156899794|NCT01461980|566393238|FG002|Overall Study|Adverse Event|6|||
156899795|NCT01461980|566393236|FG000|Overall Study|Protocol Violation|12|||
156899796|NCT01461980|566393237|FG001|Overall Study|Protocol Violation|19|||
156899797|NCT01461980|566393238|FG002|Overall Study|Protocol Violation|16|||
156899798|NCT01461980|566393236|FG000|Overall Study|No longer meets eligibility criteria|18|||
156899799|NCT01461980|566393237|FG001|Overall Study|No longer meets eligibility criteria|9|||
156899800|NCT01461980|566393238|FG002|Overall Study|No longer meets eligibility criteria|19|||
156899801|NCT01461980|566393236|FG000|Overall Study|Lost to Follow-up|52|||
156899802|NCT01461980|566393237|FG001|Overall Study|Lost to Follow-up|53|||
156899803|NCT01461980|566393238|FG002|Overall Study|Lost to Follow-up|51|||
156899804|NCT01461980|566393236|FG000|Overall Study|No longer willing to participate|52|||
156899805|NCT01461980|566393237|FG001|Overall Study|No longer willing to participate|38|||
156899806|NCT01461980|566393238|FG002|Overall Study|No longer willing to participate|54|||
156899807|NCT01461980|566393236|FG000|Overall Study|Randomized but not vaccinated|4|||
156899808|NCT01461980|566393237|FG001|Overall Study|Randomized but not vaccinated|8|||
156899809|NCT01461980|566393238|FG002|Overall Study|Randomized but not vaccinated|7|||
156899810|NCT00122109|566393239|FG000|Overall Study|Did not meet criteria|6|||
156899811|NCT00122109|566393240|FG001|Overall Study|Did not meet criteria|7|||
156899812|NCT01890746|566393241|FG000|Overall Study|Death|39|||
156899813|NCT01890746|566393242|FG001|Overall Study|Death|30|||
156899814|NCT01890746|566393241|FG000|Overall Study|Adverse Event|1|||
156899815|NCT01890746|566393242|FG001|Overall Study|Adverse Event|0|||
156899816|NCT01890746|566393241|FG000|Overall Study|Lost to Follow-up|4|||
156899817|NCT01890746|566393242|FG001|Overall Study|Lost to Follow-up|1|||
157225518|NCT01659567|567571457|FG000|Overall Study|Lack of Efficacy|22|||
156899818|NCT01890746|566393241|FG000|Overall Study|Physician Decision|3|||
156899819|NCT01890746|566393242|FG001|Overall Study|Physician Decision|2|||
156899820|NCT01890746|566393241|FG000|Overall Study|Withdrawal by Subject|5|||
156899821|NCT01890746|566393242|FG001|Overall Study|Withdrawal by Subject|8|||
156899822|NCT03257371|566393245|FG000|Overall Study|Lost to Follow-up|1|||
156899823|NCT01578330|566393247|FG000|Overall Study|Adverse Event|2|||
156899824|NCT01578330|566393247|FG000|Overall Study|Protocol Violation|5|||
156899825|NCT01050543|566393248|FG000|Overall Study|Withdrawal by Subject|0|||
156899826|NCT01050543|566393249|FG001|Overall Study|Withdrawal by Subject|2|||
157158507|NCT03552549|567324635|FG000|Overall Study|Unknown (no reason provided)|4|||
157158508|NCT03552549|567324636|FG001|Overall Study|Unknown (no reason provided)|2|||
157158509|NCT03552549|567324635|FG000|Overall Study|Not in participant's best interest|2|||
157158510|NCT03552549|567324636|FG001|Overall Study|Not in participant's best interest|1|||
157158511|NCT03552549|567324635|FG000|Overall Study|Did not complete study treatment|2|||
156899827|NCT01050543|566393248|FG000|Overall Study|Protocol Violation|0|||
156899828|NCT01050543|566393249|FG001|Overall Study|Protocol Violation|1|||
156899829|NCT01050543|566393248|FG000|Overall Study|Administrative|4|||
156899830|NCT01050543|566393249|FG001|Overall Study|Administrative|1|||
156899831|NCT03053271|566393250|FG000|Overall Study|Did not meet randomization criteria|3|||
156899832|NCT03053271|566393250|FG000|Overall Study|Withdrawal by Subject|1|||
156899833|NCT00580970|566393251|FG000|Pre-treatment|Non-compliance|1|||
156899834|NCT00580970|566393251|FG000|Treatment (Lovastatin)|Non-compliance|6|||
156899835|NCT00580970|566393251|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
156899836|NCT00580970|566393251|FG000|Treatment (Lovastatin)|Physician Decision|4|||
156899837|NCT00580970|566393251|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
156899838|NCT00580970|566393251|FG000|Treatment (Lovastatin)|Death|1|||
156899839|NCT01031706|566393252|FG000|Overall Study|Adverse Event|1|||
156899840|NCT01031706|566393253|FG001|Overall Study|Adverse Event|0|||
156899841|NCT01031706|566393252|FG000|Overall Study|Withdrawal by Subject|1|||
156899842|NCT01031706|566393253|FG001|Overall Study|Withdrawal by Subject|1|||
156899843|NCT03114488|566393254|FG000|Time Period 2|Withdrawal by Subject|1|||
156899844|NCT03114488|566393255|FG001|Time Period 2|Withdrawal by Subject|3|||
156899845|NCT03711266|566393257|FG000|Overall Study|Lost to Follow-up|10|||
156899846|NCT03387683|566393258|FG000|Overall Study|In receipt of disallowed medication|1|||
156899847|NCT03387683|566393259|FG001|Overall Study|In receipt of disallowed medication|0|||
156899848|NCT03387683|566393258|FG000|Overall Study|Did not receive treatment|1|||
156899849|NCT03387683|566393259|FG001|Overall Study|Did not receive treatment|0|||
156899850|NCT01646073|566393260|FG000|Period A (12 Weeks)|Adverse Event|0|||
156899851|NCT01646073|566393261|FG001|Period A (12 Weeks)|Adverse Event|2|||
156899852|NCT01646073|566393260|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
156899853|NCT01646073|566393261|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
156899854|NCT01646073|566393260|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
156899855|NCT01646073|566393261|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
156899856|NCT01646073|566393260|FG000|Period A (12 Weeks)|Protocol Violation|0|||
156899857|NCT01646073|566393261|FG001|Period A (12 Weeks)|Protocol Violation|1|||
156899858|NCT01646073|566393260|FG000|Period A (12 Weeks)|Other|0|||
156899859|NCT01646073|566393261|FG001|Period A (12 Weeks)|Other|1|||
156899860|NCT01646073|566393260|FG000|Period B (12 Weeks)|Adverse Event|0|||
156899861|NCT01646073|566393261|FG001|Period B (12 Weeks)|Adverse Event|7|||
156899862|NCT01646073|566393260|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
156899863|NCT01646073|566393261|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
156899864|NCT01646073|566393260|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
156899865|NCT01646073|566393261|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
156899866|NCT03845543|566393264|FG000|Overall Study|Death|25|||
156899867|NCT03845543|566393264|FG000|Overall Study|Withdrawal by Subject|2|||
156899868|NCT03845543|566393264|FG000|Overall Study|Lost to Follow-up|12|||
156899869|NCT03845543|566393264|FG000|Overall Study|Adverse Event|17|||
156899870|NCT02028871|566393269|FG000|Overall Study|Positive urine drug screen|1|||
156899871|NCT02028871|566393270|FG001|Overall Study|Positive urine drug screen|1|||
156899872|NCT02028871|566393269|FG000|Overall Study|Withdrawal by Subject|1|||
156899873|NCT02028871|566393270|FG001|Overall Study|Withdrawal by Subject|2|||
156899874|NCT02028871|566393269|FG000|Overall Study|IV placement difficulty|1|||
156899875|NCT02028871|566393270|FG001|Overall Study|IV placement difficulty|0|||
156899876|NCT02028871|566393269|FG000|Overall Study|Current Illness|1|||
156899877|NCT02028871|566393270|FG001|Overall Study|Current Illness|0|||
156899878|NCT02633501|566393273|FG000|Overall Study|Adverse Event|0|||
156899879|NCT02633501|566393274|FG001|Overall Study|Adverse Event|0|||
156899880|NCT02633501|566393275|FG002|Overall Study|Adverse Event|1|||
156899881|NCT02633501|566393276|FG003|Overall Study|Adverse Event|0|||
156899882|NCT02633501|566393277|FG004|Overall Study|Adverse Event|1|||
156899883|NCT02633501|566393278|FG005|Overall Study|Adverse Event|1|||
156899884|NCT02633501|566393273|FG000|Overall Study|Withdrawal by Subject|2|||
156899885|NCT02633501|566393274|FG001|Overall Study|Withdrawal by Subject|1|||
156899886|NCT02633501|566393275|FG002|Overall Study|Withdrawal by Subject|2|||
156899887|NCT02633501|566393276|FG003|Overall Study|Withdrawal by Subject|2|||
156899888|NCT02633501|566393277|FG004|Overall Study|Withdrawal by Subject|1|||
156899889|NCT02633501|566393278|FG005|Overall Study|Withdrawal by Subject|3|||
156899890|NCT02633501|566393273|FG000|Overall Study|Various other reasons|0|||
156899891|NCT02633501|566393274|FG001|Overall Study|Various other reasons|2|||
156899892|NCT02633501|566393275|FG002|Overall Study|Various other reasons|4|||
156899893|NCT02633501|566393276|FG003|Overall Study|Various other reasons|1|||
157158512|NCT03552549|567324636|FG001|Overall Study|Did not complete study treatment|3|||
156899894|NCT02633501|566393277|FG004|Overall Study|Various other reasons|7|||
156899895|NCT02633501|566393278|FG005|Overall Study|Various other reasons|11|||
157158513|NCT03552549|567324635|FG000|Overall Study|Did not meet eligibility criteria|1|||
156899896|NCT02633501|566393273|FG000|Overall Study|Lost to Follow-up|0|||
156899897|NCT02633501|566393274|FG001|Overall Study|Lost to Follow-up|0|||
156899898|NCT02633501|566393275|FG002|Overall Study|Lost to Follow-up|0|||
156899899|NCT02633501|566393276|FG003|Overall Study|Lost to Follow-up|1|||
156899900|NCT02633501|566393277|FG004|Overall Study|Lost to Follow-up|2|||
156899901|NCT02633501|566393278|FG005|Overall Study|Lost to Follow-up|0|||
156899902|NCT01484132|566393279|FG000|Overall Study|Lost to Follow-up|8|||
156899903|NCT01484132|566393279|FG000|Overall Study|Difficulty with time commitment|2|||
156899904|NCT01484132|566393279|FG000|Overall Study|Ineligible|1|||
156899905|NCT01484132|566393279|FG000|Overall Study|No pre-treatment urine sample collected|1|||
156899906|NCT01484132|566393279|FG000|Overall Study|No post-treatment urine sample collected|10|||
156899907|NCT01912963|566393280|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
156899908|NCT01912963|566393281|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
156899909|NCT01912963|566393282|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
156899910|NCT01912963|566393280|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
156899911|NCT01912963|566393281|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
156899912|NCT01912963|566393282|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
156899913|NCT01912963|566393280|FG000|Overall Study|Adverse Event|0|||
156899914|NCT01912963|566393281|FG001|Overall Study|Adverse Event|1|||
156899915|NCT01912963|566393282|FG002|Overall Study|Adverse Event|1|||
156899916|NCT01912963|566393280|FG000|Overall Study|Withdrawal by Subject|0|||
156899917|NCT01912963|566393281|FG001|Overall Study|Withdrawal by Subject|1|||
156899918|NCT01912963|566393282|FG002|Overall Study|Withdrawal by Subject|0|||
156899919|NCT01912963|566393280|FG000|Overall Study|Sought treatment locally|0|||
156899920|NCT01912963|566393281|FG001|Overall Study|Sought treatment locally|1|||
156899921|NCT01912963|566393282|FG002|Overall Study|Sought treatment locally|0|||
156899922|NCT00620464|566393283|FG000|Overall Study|Adverse Event|15|||
156899923|NCT00620464|566393284|FG001|Overall Study|Adverse Event|17|||
156899924|NCT00620464|566393283|FG000|Overall Study|Lost to Follow-up|1|||
156899925|NCT00620464|566393284|FG001|Overall Study|Lost to Follow-up|1|||
156899926|NCT00620464|566393283|FG000|Overall Study|Planning Pregnancy|1|||
156899927|NCT00620464|566393284|FG001|Overall Study|Planning Pregnancy|4|||
156899928|NCT00620464|566393283|FG000|Overall Study|Personal|2|||
156899929|NCT00620464|566393284|FG001|Overall Study|Personal|2|||
156899930|NCT00620464|566393283|FG000|Overall Study|Used prohibited medication|1|||
156899931|NCT00620464|566393284|FG001|Overall Study|Used prohibited medication|0|||
156899932|NCT05736224|566393290|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
156899933|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
156899934|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899935|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899936|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899937|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899938|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899939|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
156899940|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
156899941|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899942|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899943|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899944|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899945|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899946|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
156899947|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
156899948|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899949|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899950|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899951|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899952|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899953|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
156899954|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
156899955|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899956|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899957|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899958|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899959|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899960|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
156899961|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
156899962|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899963|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899964|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899965|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899966|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899967|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
156899968|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
156899969|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899970|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899971|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899972|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899973|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899974|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
156899975|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
156899976|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899977|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899978|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899979|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899980|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899981|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
156899982|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
156899983|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899984|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899985|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899986|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899987|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899988|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
156899989|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
156899990|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899991|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899992|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899993|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899994|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899995|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
156899996|NCT04526509|566393291|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
157158514|NCT03552549|567324636|FG001|Overall Study|Did not meet eligibility criteria|0|||
157158515|NCT03552549|567324635|FG000|Overall Study|Administrative|0|||
157158516|NCT03552549|567324636|FG001|Overall Study|Administrative|14|||
157158517|NCT00256867|567324641|FG000|Overall Study|Adverse Event|0|||
157158518|NCT00256867|567324642|FG001|Overall Study|Adverse Event|1|||
157158519|NCT00256867|567324643|FG002|Overall Study|Adverse Event|1|||
157158520|NCT00256867|567324644|FG003|Overall Study|Adverse Event|1|||
157158521|NCT00256867|567324645|FG004|Overall Study|Adverse Event|2|||
157158522|NCT00256867|567324646|FG005|Overall Study|Adverse Event|2|||
156899997|NCT04526509|566393292|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156899998|NCT04526509|566393293|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156899999|NCT04526509|566393294|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156900000|NCT04526509|566393295|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156900001|NCT04526509|566393296|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156900002|NCT04526509|566393297|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
156900003|NCT04526509|566393291|FG000|Enrolled|Study Terminated by Sponsor|0|||
156900004|NCT04526509|566393292|FG001|Enrolled|Study Terminated by Sponsor|0|||
156900005|NCT04526509|566393293|FG002|Enrolled|Study Terminated by Sponsor|0|||
156900006|NCT04526509|566393294|FG003|Enrolled|Study Terminated by Sponsor|0|||
156900007|NCT04526509|566393295|FG004|Enrolled|Study Terminated by Sponsor|0|||
156900008|NCT04526509|566393296|FG005|Enrolled|Study Terminated by Sponsor|0|||
156900009|NCT04526509|566393297|FG006|Enrolled|Study Terminated by Sponsor|1|||
156900010|NCT04526509|566393291|FG000|Enrolled|Death prior to lymphodepletion|0|||
156900011|NCT04526509|566393292|FG001|Enrolled|Death prior to lymphodepletion|0|||
156900012|NCT04526509|566393293|FG002|Enrolled|Death prior to lymphodepletion|0|||
156900013|NCT04526509|566393294|FG003|Enrolled|Death prior to lymphodepletion|1|||
156900014|NCT04526509|566393295|FG004|Enrolled|Death prior to lymphodepletion|0|||
156900015|NCT04526509|566393296|FG005|Enrolled|Death prior to lymphodepletion|0|||
156900016|NCT04526509|566393297|FG006|Enrolled|Death prior to lymphodepletion|0|||
156900017|NCT04526509|566393291|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900018|NCT04526509|566393292|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900019|NCT04526509|566393293|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900020|NCT04526509|566393294|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
156900021|NCT04526509|566393295|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900022|NCT04526509|566393296|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900023|NCT04526509|566393297|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
156900024|NCT04526509|566393291|FG000|Enrolled|Physician Decision|0|||
156900025|NCT04526509|566393292|FG001|Enrolled|Physician Decision|1|||
156900026|NCT04526509|566393293|FG002|Enrolled|Physician Decision|0|||
156900027|NCT04526509|566393294|FG003|Enrolled|Physician Decision|0|||
156900028|NCT04526509|566393295|FG004|Enrolled|Physician Decision|0|||
157026366|NCT04032704|566851531|FG000|Part B|Study termination by Sponsor|0|||
157026367|NCT04032704|566851532|FG001|Part B|Study termination by Sponsor|0|||
157026368|NCT04032704|566851533|FG002|Part B|Study termination by Sponsor|0|||
157158523|NCT00256867|567324647|FG006|Overall Study|Adverse Event|1|||
157158524|NCT00256867|567324648|FG007|Overall Study|Adverse Event|4|||
157158525|NCT00256867|567324641|FG000|Overall Study|Lost to Follow-up|2|||
157158526|NCT00256867|567324642|FG001|Overall Study|Lost to Follow-up|2|||
157158527|NCT00256867|567324643|FG002|Overall Study|Lost to Follow-up|2|||
157158528|NCT00256867|567324644|FG003|Overall Study|Lost to Follow-up|3|||
157158529|NCT00256867|567324645|FG004|Overall Study|Lost to Follow-up|2|||
157158530|NCT00256867|567324646|FG005|Overall Study|Lost to Follow-up|0|||
157158531|NCT00256867|567324647|FG006|Overall Study|Lost to Follow-up|1|||
157158532|NCT00256867|567324648|FG007|Overall Study|Lost to Follow-up|2|||
157158533|NCT00256867|567324641|FG000|Overall Study|Protocol Violation|0|||
157158534|NCT00256867|567324642|FG001|Overall Study|Protocol Violation|0|||
157158535|NCT00256867|567324643|FG002|Overall Study|Protocol Violation|0|||
157158536|NCT00256867|567324644|FG003|Overall Study|Protocol Violation|1|||
157158537|NCT00256867|567324645|FG004|Overall Study|Protocol Violation|0|||
157158538|NCT00256867|567324646|FG005|Overall Study|Protocol Violation|1|||
157158539|NCT00256867|567324647|FG006|Overall Study|Protocol Violation|0|||
157158540|NCT00256867|567324648|FG007|Overall Study|Protocol Violation|1|||
157158541|NCT00256867|567324641|FG000|Overall Study|Withdrawal by Subject|0|||
157158542|NCT00256867|567324642|FG001|Overall Study|Withdrawal by Subject|0|||
157158543|NCT00256867|567324643|FG002|Overall Study|Withdrawal by Subject|1|||
157158544|NCT00256867|567324644|FG003|Overall Study|Withdrawal by Subject|1|||
157158545|NCT00256867|567324645|FG004|Overall Study|Withdrawal by Subject|2|||
157158546|NCT00256867|567324646|FG005|Overall Study|Withdrawal by Subject|2|||
157158547|NCT00256867|567324647|FG006|Overall Study|Withdrawal by Subject|3|||
157158548|NCT00256867|567324648|FG007|Overall Study|Withdrawal by Subject|2|||
157158549|NCT00256867|567324641|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
157158550|NCT00256867|567324642|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
157158551|NCT00256867|567324643|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
157158552|NCT00256867|567324644|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
157158553|NCT00256867|567324645|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
157158554|NCT00256867|567324646|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
157158555|NCT00256867|567324647|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156900029|NCT04526509|566393296|FG005|Enrolled|Physician Decision|0|||
157026369|NCT04032704|566851534|FG003|Part B|Study termination by Sponsor|0|||
157158556|NCT00256867|567324648|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
156900030|NCT04526509|566393297|FG006|Enrolled|Physician Decision|0|||
156900031|NCT00631696|566394929|FG000|Overall Study|Entered, not randomized to treatment|1|||
156900032|NCT00631696|566394930|FG001|Overall Study|Entered, not randomized to treatment|1|||
156900033|NCT00631696|566394929|FG000|Overall Study|Discontinued after database release date|1|||
156900034|NCT00631696|566394930|FG001|Overall Study|Discontinued after database release date|0|||
156900035|NCT00631696|566394929|FG000|Overall Study|Follow up after database release date|1|||
156900036|NCT00631696|566394930|FG001|Overall Study|Follow up after database release date|0|||
156900037|NCT00631696|566394929|FG000|Overall Study|Lost to Follow-up|7|||
156900038|NCT00631696|566394930|FG001|Overall Study|Lost to Follow-up|10|||
156900039|NCT00631696|566394929|FG000|Overall Study|Withdrawal by Subject|2|||
156900040|NCT00631696|566394930|FG001|Overall Study|Withdrawal by Subject|9|||
156900041|NCT00631696|566394929|FG000|Overall Study|Other|8|||
156900042|NCT00631696|566394930|FG001|Overall Study|Other|8|||
156900043|NCT00631696|566394929|FG000|Overall Study|Protocol Violation|9|||
156900044|NCT00631696|566394930|FG001|Overall Study|Protocol Violation|9|||
156900045|NCT00631696|566394929|FG000|Overall Study|Study terminated by sponsor|3|||
156900046|NCT00631696|566394930|FG001|Overall Study|Study terminated by sponsor|3|||
156900047|NCT00631696|566394929|FG000|Overall Study|Adverse Event|5|||
156900048|NCT00631696|566394930|FG001|Overall Study|Adverse Event|0|||
156900049|NCT01134731|566394933|FG000|Overall Study|Adverse Event|3|||
156900050|NCT01134731|566394934|FG001|Overall Study|Adverse Event|2|||
156900051|NCT01134731|566394935|FG002|Overall Study|Adverse Event|1|||
156900052|NCT01134731|566394933|FG000|Overall Study|Physician Decision|2|||
156900053|NCT01134731|566394934|FG001|Overall Study|Physician Decision|2|||
157158557|NCT00256867|567324641|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158558|NCT00256867|567324642|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158559|NCT00256867|567324643|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158560|NCT00256867|567324644|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158561|NCT00256867|567324645|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158562|NCT00256867|567324646|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
156900054|NCT01134731|566394935|FG002|Overall Study|Physician Decision|2|||
156900055|NCT01134731|566394933|FG000|Overall Study|Lack of Efficacy|0|||
156900056|NCT01134731|566394934|FG001|Overall Study|Lack of Efficacy|0|||
156900057|NCT01134731|566394935|FG002|Overall Study|Lack of Efficacy|1|||
156900058|NCT01134731|566394933|FG000|Overall Study|Withdrawal by Subject|3|||
156900059|NCT01134731|566394934|FG001|Overall Study|Withdrawal by Subject|3|||
156900060|NCT01134731|566394935|FG002|Overall Study|Withdrawal by Subject|1|||
156900061|NCT01134731|566394933|FG000|Overall Study|Lost to Follow-up|5|||
156900062|NCT01134731|566394934|FG001|Overall Study|Lost to Follow-up|4|||
156900063|NCT01134731|566394935|FG002|Overall Study|Lost to Follow-up|3|||
156900064|NCT02517866|566394936|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156900065|NCT02517866|566394937|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156900066|NCT02517866|566394938|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156900067|NCT02517866|566394936|FG000|Overall Study|Significant Protocol Deviation|4|||
156900068|NCT02517866|566394937|FG001|Overall Study|Significant Protocol Deviation|1|||
156900069|NCT02517866|566394938|FG002|Overall Study|Significant Protocol Deviation|0|||
156900070|NCT02517866|566394936|FG000|Overall Study|Lost to Follow-up|1|||
156900071|NCT02517866|566394937|FG001|Overall Study|Lost to Follow-up|0|||
156900072|NCT02517866|566394938|FG002|Overall Study|Lost to Follow-up|0|||
156900073|NCT02517866|566394936|FG000|Overall Study|Voluntary Withdrawal|2|||
156900074|NCT02517866|566394937|FG001|Overall Study|Voluntary Withdrawal|2|||
156900075|NCT02517866|566394938|FG002|Overall Study|Voluntary Withdrawal|0|||
156900076|NCT02517866|566394936|FG000|Overall Study|Investigator Decision|2|||
156900077|NCT02517866|566394937|FG001|Overall Study|Investigator Decision|1|||
156900078|NCT02517866|566394938|FG002|Overall Study|Investigator Decision|0|||
156900079|NCT02517866|566394936|FG000|Overall Study|Reason not specified|2|||
156900080|NCT02517866|566394937|FG001|Overall Study|Reason not specified|0|||
156900081|NCT02517866|566394938|FG002|Overall Study|Reason not specified|0|||
156900082|NCT05095454|566394939|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
156900083|NCT05095454|566394940|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
157026370|NCT04032704|566851535|FG004|Part B|Study termination by Sponsor|0|||
157026371|NCT04032704|566851536|FG005|Part B|Study termination by Sponsor|0|||
157026372|NCT04032704|566851537|FG006|Part B|Study termination by Sponsor|0|||
157158563|NCT00256867|567324647|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
157158564|NCT00256867|567324648|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
156900084|NCT00679055|566394941|FG000|Overall Study|Adverse Event|0|||
156900085|NCT00679055|566394942|FG001|Overall Study|Adverse Event|1|||
156900086|NCT00679055|566394941|FG000|Overall Study|Other|0|||
156900087|NCT00679055|566394942|FG001|Overall Study|Other|3|||
156900088|NCT00679055|566394941|FG000|Overall Study|Study Terminated|2|||
156900089|NCT00679055|566394942|FG001|Overall Study|Study Terminated|1|||
156900090|NCT00629772|566394943|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
156900091|NCT00629772|566394944|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
157026373|NCT04032704|566851538|FG007|Part B|Study termination by Sponsor|0|||
156900092|NCT00629772|566394943|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
156900093|NCT00629772|566394944|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
156900094|NCT01393301|566394945|FG000|Overall Study|Lost to Follow-up|5|||
156900095|NCT01393301|566394946|FG001|Overall Study|Lost to Follow-up|3|||
156900096|NCT01393301|566394945|FG000|Overall Study|Withdrawal by Subject|2|||
156900097|NCT01393301|566394946|FG001|Overall Study|Withdrawal by Subject|0|||
156900098|NCT01393301|566394945|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
156900099|NCT01393301|566394946|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
156900100|NCT00853073|566394947|FG000|Overall Study|Withdrawal by Subject|3|||
156900101|NCT00853073|566394948|FG001|Overall Study|Withdrawal by Subject|2|||
157158565|NCT00256867|567324641|FG000|Overall Study|Investigator's Decision|0|||
156900102|NCT01999114|566394949|FG000|Overall Study|Adverse Event|8|||
156900103|NCT01999114|566394950|FG001|Overall Study|Adverse Event|7|||
156900104|NCT01999114|566394951|FG002|Overall Study|Adverse Event|2|||
156900105|NCT01999114|566394952|FG003|Overall Study|Adverse Event|2|||
156900106|NCT01999114|566394953|FG004|Overall Study|Adverse Event|1|||
156900107|NCT01999114|566394949|FG000|Overall Study|Withdrawal by Subject|0|||
156900108|NCT01999114|566394950|FG001|Overall Study|Withdrawal by Subject|0|||
156900109|NCT01999114|566394951|FG002|Overall Study|Withdrawal by Subject|1|||
156900110|NCT01999114|566394952|FG003|Overall Study|Withdrawal by Subject|0|||
156900111|NCT01999114|566394953|FG004|Overall Study|Withdrawal by Subject|1|||
156900112|NCT01999114|566394949|FG000|Overall Study|Lost to Follow-up|0|||
156900113|NCT01999114|566394950|FG001|Overall Study|Lost to Follow-up|0|||
156900114|NCT01999114|566394951|FG002|Overall Study|Lost to Follow-up|1|||
156900115|NCT01999114|566394952|FG003|Overall Study|Lost to Follow-up|0|||
156900116|NCT01999114|566394953|FG004|Overall Study|Lost to Follow-up|0|||
156900117|NCT01999114|566394949|FG000|Overall Study|Administrative|0|||
156900118|NCT01999114|566394950|FG001|Overall Study|Administrative|0|||
156900119|NCT01999114|566394951|FG002|Overall Study|Administrative|1|||
156900120|NCT01999114|566394952|FG003|Overall Study|Administrative|1|||
156900121|NCT01999114|566394953|FG004|Overall Study|Administrative|2|||
156900122|NCT03840174|566394954|FG000|Overall Study|Withdrawal by Subject|1|||
156900123|NCT03840174|566394955|FG001|Overall Study|Withdrawal by Subject|0|||
156900124|NCT03840174|566394956|FG002|Overall Study|Withdrawal by Subject|0|||
156900125|NCT03840174|566394957|FG003|Overall Study|Withdrawal by Subject|0|||
156900126|NCT03342963|566394958|FG000|Overall Study|Adverse Event|1|||
156900127|NCT03342963|566394959|FG001|Overall Study|Adverse Event|2|||
156900128|NCT03342963|566394960|FG002|Overall Study|Adverse Event|0|||
156900129|NCT03342963|566394961|FG003|Overall Study|Adverse Event|0|||
156900130|NCT03342963|566394958|FG000|Overall Study|Withdrawal by Subject|1|||
156900131|NCT03342963|566394959|FG001|Overall Study|Withdrawal by Subject|0|||
156900132|NCT03342963|566394960|FG002|Overall Study|Withdrawal by Subject|0|||
156900133|NCT03342963|566394961|FG003|Overall Study|Withdrawal by Subject|0|||
156900134|NCT01008150|566394962|FG000|Overall Study|did not receive study drug|1|||
156900135|NCT01008150|566394963|FG001|Overall Study|did not receive study drug|1|||
156900136|NCT01008150|566394964|FG002|Overall Study|did not receive study drug|1|||
156900137|NCT01008150|566394965|FG003|Overall Study|did not receive study drug|0|||
156900138|NCT01309165|566394966|FG000|Overall Study|Lost to Follow-up|4|||
156900139|NCT01309165|566394967|FG001|Overall Study|Lost to Follow-up|3|||
156900140|NCT01309165|566394966|FG000|Overall Study|Return to work|1|||
156900141|NCT01309165|566394967|FG001|Overall Study|Return to work|2|||
156900142|NCT01309165|566394966|FG000|Overall Study|Left country|0|||
157158566|NCT00256867|567324642|FG001|Overall Study|Investigator's Decision|0|||
157158567|NCT00256867|567324643|FG002|Overall Study|Investigator's Decision|0|||
157158568|NCT00256867|567324644|FG003|Overall Study|Investigator's Decision|0|||
157158569|NCT00256867|567324645|FG004|Overall Study|Investigator's Decision|1|||
157158570|NCT00256867|567324646|FG005|Overall Study|Investigator's Decision|0|||
157158571|NCT00256867|567324647|FG006|Overall Study|Investigator's Decision|0|||
157158572|NCT00256867|567324648|FG007|Overall Study|Investigator's Decision|0|||
157158573|NCT00256867|567324641|FG000|Overall Study|Non-compliance with study medication|0|||
156900143|NCT01309165|566394967|FG001|Overall Study|Left country|1|||
156900144|NCT01309165|566394966|FG000|Overall Study|No transportation|0|||
156900145|NCT01309165|566394967|FG001|Overall Study|No transportation|1|||
156900146|NCT01309165|566394966|FG000|Overall Study|Admitted to hospital for second stroke|1|||
156900147|NCT01309165|566394967|FG001|Overall Study|Admitted to hospital for second stroke|0|||
156900148|NCT01497275|566394968|FG000|Overall Study|Death|1|||
156900149|NCT01497275|566394968|FG000|Overall Study|Adverse Event|1|||
157158574|NCT00256867|567324642|FG001|Overall Study|Non-compliance with study medication|0|||
156900150|NCT01950169|566394969|FG000|Overall Study|Withdrawal by Subject|2|||
157158575|NCT00256867|567324643|FG002|Overall Study|Non-compliance with study medication|0|||
156900151|NCT01950169|566394970|FG001|Overall Study|Withdrawal by Subject|8|||
156900152|NCT01950169|566394971|FG002|Overall Study|Withdrawal by Subject|1|||
156900153|NCT01950169|566394969|FG000|Overall Study|Death|1|||
156900154|NCT01950169|566394970|FG001|Overall Study|Death|0|||
156900155|NCT01950169|566394971|FG002|Overall Study|Death|0|||
156900156|NCT01938573|566394972|FG000|Overall Study|Lack of Efficacy|1|||
156900157|NCT01938573|566394973|FG001|Overall Study|Lack of Efficacy|0|||
157158576|NCT00256867|567324644|FG003|Overall Study|Non-compliance with study medication|0|||
157158577|NCT00256867|567324645|FG004|Overall Study|Non-compliance with study medication|0|||
157158578|NCT00256867|567324646|FG005|Overall Study|Non-compliance with study medication|0|||
157158579|NCT00256867|567324647|FG006|Overall Study|Non-compliance with study medication|0|||
157158580|NCT00256867|567324648|FG007|Overall Study|Non-compliance with study medication|1|||
157158581|NCT00256867|567324641|FG000|Overall Study|Participant travelled Overseas|0|||
157158582|NCT00256867|567324642|FG001|Overall Study|Participant travelled Overseas|1|||
157158583|NCT00256867|567324643|FG002|Overall Study|Participant travelled Overseas|0|||
157158584|NCT00256867|567324644|FG003|Overall Study|Participant travelled Overseas|0|||
157158585|NCT00256867|567324645|FG004|Overall Study|Participant travelled Overseas|0|||
157158586|NCT00256867|567324646|FG005|Overall Study|Participant travelled Overseas|0|||
157158587|NCT00256867|567324647|FG006|Overall Study|Participant travelled Overseas|0|||
157158588|NCT00256867|567324648|FG007|Overall Study|Participant travelled Overseas|0|||
157158589|NCT00256867|567324641|FG000|Overall Study|Participant out of assessment window|0|||
157158590|NCT00256867|567324642|FG001|Overall Study|Participant out of assessment window|0|||
157158591|NCT00256867|567324643|FG002|Overall Study|Participant out of assessment window|1|||
157158592|NCT00256867|567324644|FG003|Overall Study|Participant out of assessment window|0|||
157158593|NCT00256867|567324645|FG004|Overall Study|Participant out of assessment window|0|||
156900158|NCT01938573|566394972|FG000|Overall Study|Operation at other hospital|1|||
156900159|NCT01938573|566394973|FG001|Overall Study|Operation at other hospital|0|||
156900160|NCT02410551|566394978|FG000|Overall Study|Adverse Event|1|||
156900161|NCT02410551|566394978|FG000|Overall Study|Withdrawal by Subject|1|||
156900162|NCT02410551|566394978|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
156900163|NCT01739309|566394979|FG000|Overall Study|Adverse Event|1|||
156900164|NCT01739309|566394979|FG000|Overall Study|Withdrawal by Subject|1|||
156900165|NCT05469113|566394980|FG000|Period 2|Adverse Event|0|||
156900166|NCT05469113|566394981|FG001|Period 2|Adverse Event|3|||
156900167|NCT05447897|566394982|FG000|Overall Study|Did not participate in survey|2|||
156900168|NCT04553679|566394983|FG000|Overall Study|Withdrawal by Subject|2|||
156900169|NCT04553679|566394984|FG001|Overall Study|Withdrawal by Subject|0|||
156900170|NCT04553679|566394983|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
156900171|NCT04553679|566394984|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
156900172|NCT00178633|566394985|FG000|Overall Study|Lost to Follow-up|6|||
156900173|NCT01986140|566394990|FG000|Overall Study|Withdrawal by Subject|31|||
156900174|NCT01986140|566394991|FG001|Overall Study|Withdrawal by Subject|25|||
156900175|NCT01986140|566394990|FG000|Overall Study|alternative treatment|1|||
156900176|NCT01986140|566394991|FG001|Overall Study|alternative treatment|1|||
156900177|NCT01986140|566394990|FG000|Overall Study|found not eligible|3|||
156900178|NCT01986140|566394991|FG001|Overall Study|found not eligible|0|||
156900179|NCT01986140|566394990|FG000|Overall Study|Adverse Event|0|||
156900180|NCT01986140|566394991|FG001|Overall Study|Adverse Event|1|||
156900181|NCT01986140|566394990|FG000|Overall Study|progression disease|0|||
156900182|NCT01986140|566394991|FG001|Overall Study|progression disease|1|||
156900183|NCT01104155|566394996|FG000|Overall Study|Adverse Event|15|||
156900184|NCT01104155|566394997|FG001|Overall Study|Adverse Event|8|||
156900185|NCT01104155|566394996|FG000|Overall Study|Participant choice|6|||
156900186|NCT01104155|566394997|FG001|Overall Study|Participant choice|5|||
156900187|NCT01104155|566394996|FG000|Overall Study|Withdrawal of consent|1|||
157158594|NCT00256867|567324646|FG005|Overall Study|Participant out of assessment window|0|||
157158595|NCT00256867|567324647|FG006|Overall Study|Participant out of assessment window|0|||
157158596|NCT00256867|567324648|FG007|Overall Study|Participant out of assessment window|0|||
157158597|NCT00256867|567324641|FG000|Overall Study|Withdrawal by participant|0|||
157158598|NCT00256867|567324642|FG001|Overall Study|Withdrawal by participant|0|||
157158599|NCT00256867|567324643|FG002|Overall Study|Withdrawal by participant|0|||
157158600|NCT00256867|567324644|FG003|Overall Study|Withdrawal by participant|0|||
157158601|NCT00256867|567324645|FG004|Overall Study|Withdrawal by participant|0|||
157158602|NCT00256867|567324646|FG005|Overall Study|Withdrawal by participant|1|||
157158603|NCT00256867|567324647|FG006|Overall Study|Withdrawal by participant|0|||
157158604|NCT00256867|567324648|FG007|Overall Study|Withdrawal by participant|0|||
157158605|NCT01930799|567324654|FG000|Overall Study|Withdrawal by Subject|3|||
156900188|NCT01104155|566394997|FG001|Overall Study|Withdrawal of consent|1|||
156900189|NCT01104155|566394996|FG000|Overall Study|Other|3|||
156900190|NCT01104155|566394997|FG001|Overall Study|Other|4|||
156900191|NCT01069627|566395010|FG000|Overall Study|Disease progression|7|||
156900192|NCT01069627|566395010|FG000|Overall Study|Adverse Event|12|||
157158606|NCT01930799|567324654|FG000|Overall Study|Lost to Follow-up|5|||
156900193|NCT01069627|566395010|FG000|Overall Study|Protocol Violation|1|||
156900194|NCT02963935|566395016|FG000|Overall Study|Adverse Event|12|||
156900195|NCT02963935|566395017|FG001|Overall Study|Adverse Event|6|||
156900196|NCT02963935|566395016|FG000|Overall Study|Protocol Violation|2|||
156900197|NCT02963935|566395017|FG001|Overall Study|Protocol Violation|1|||
156900198|NCT02963935|566395016|FG000|Overall Study|Lack of Efficacy|0|||
156900199|NCT02963935|566395017|FG001|Overall Study|Lack of Efficacy|2|||
157158607|NCT00875017|567324655|FG000|First Intervention|Withdrawal by Subject|1|||
157158608|NCT00875017|567324656|FG001|First Intervention|Withdrawal by Subject|0|||
157158609|NCT00875017|567324657|FG002|First Intervention|Withdrawal by Subject|1|||
157158610|NCT00875017|567324658|FG003|First Intervention|Withdrawal by Subject|0|||
157158611|NCT00875017|567324659|FG004|First Intervention|Withdrawal by Subject|0|||
157158612|NCT00875017|567324660|FG005|First Intervention|Withdrawal by Subject|0|||
157158613|NCT00875017|567324655|FG000|First Intervention|Adverse Event|0|||
157158614|NCT00875017|567324656|FG001|First Intervention|Adverse Event|0|||
157158615|NCT00875017|567324657|FG002|First Intervention|Adverse Event|0|||
157158616|NCT00875017|567324658|FG003|First Intervention|Adverse Event|1|||
157158617|NCT00875017|567324659|FG004|First Intervention|Adverse Event|0|||
157158618|NCT00875017|567324660|FG005|First Intervention|Adverse Event|0|||
157158619|NCT00875017|567324655|FG000|First Intervention|Problems collecting rectal effluent|1|||
157158620|NCT00875017|567324656|FG001|First Intervention|Problems collecting rectal effluent|0|||
157158621|NCT00875017|567324657|FG002|First Intervention|Problems collecting rectal effluent|0|||
156900200|NCT02963935|566395016|FG000|Overall Study|Lost to Follow-up|1|||
156900201|NCT02963935|566395017|FG001|Overall Study|Lost to Follow-up|6|||
156900202|NCT02963935|566395016|FG000|Overall Study|Unclassified|13|||
156900203|NCT02963935|566395017|FG001|Overall Study|Unclassified|22|||
156900204|NCT00464269|566395018|FG000|Overall Study|Lack of Efficacy|1|||
156900205|NCT00464269|566395019|FG001|Overall Study|Lack of Efficacy|0|||
156900206|NCT00464269|566395020|FG002|Overall Study|Lack of Efficacy|0|||
156900207|NCT00464269|566395021|FG003|Overall Study|Lack of Efficacy|0|||
156900208|NCT00464269|566395018|FG000|Overall Study|Lost to Follow-up|0|||
156900209|NCT00464269|566395019|FG001|Overall Study|Lost to Follow-up|4|||
156900210|NCT00464269|566395020|FG002|Overall Study|Lost to Follow-up|0|||
156900211|NCT00464269|566395021|FG003|Overall Study|Lost to Follow-up|1|||
156900212|NCT00464269|566395018|FG000|Overall Study|Withdrawal by Subject|0|||
156900213|NCT00464269|566395019|FG001|Overall Study|Withdrawal by Subject|2|||
156900214|NCT00464269|566395020|FG002|Overall Study|Withdrawal by Subject|1|||
156900215|NCT00464269|566395021|FG003|Overall Study|Withdrawal by Subject|1|||
156900216|NCT00464269|566395018|FG000|Overall Study|Other reason|3|||
156900217|NCT00464269|566395019|FG001|Overall Study|Other reason|3|||
156900218|NCT00464269|566395020|FG002|Overall Study|Other reason|1|||
156900219|NCT00464269|566395021|FG003|Overall Study|Other reason|1|||
156900220|NCT00464269|566395018|FG000|Overall Study|AE, serious fatal|0|||
156900221|NCT00464269|566395019|FG001|Overall Study|AE, serious fatal|0|||
156900222|NCT00464269|566395020|FG002|Overall Study|AE, serious fatal|1|||
156900223|NCT00464269|566395021|FG003|Overall Study|AE, serious fatal|1|||
156900224|NCT00464269|566395018|FG000|Overall Study|SAE, non-fatal|0|||
156900225|NCT00464269|566395019|FG001|Overall Study|SAE, non-fatal|0|||
156900226|NCT00464269|566395020|FG002|Overall Study|SAE, non-fatal|0|||
156900227|NCT00464269|566395021|FG003|Overall Study|SAE, non-fatal|1|||
156900228|NCT00464269|566395018|FG000|Overall Study|AE, non-serious non-fatal|2|||
156900229|NCT00464269|566395019|FG001|Overall Study|AE, non-serious non-fatal|8|||
156900230|NCT00464269|566395020|FG002|Overall Study|AE, non-serious non-fatal|3|||
156900231|NCT00464269|566395021|FG003|Overall Study|AE, non-serious non-fatal|4|||
156900232|NCT00464269|566395018|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156900233|NCT00464269|566395019|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156900234|NCT00464269|566395020|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
156900235|NCT00464269|566395021|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
156900236|NCT03911154|566395022|FG000|Overall Study|Withdrawal by Subject|1|||
156900237|NCT05055128|566395023|FG000|Overall Study|Adverse Event|0|||
156900238|NCT05055128|566395024|FG001|Overall Study|Adverse Event|0|||
156900239|NCT05055128|566395025|FG002|Overall Study|Adverse Event|0|||
156900240|NCT05055128|566395026|FG003|Overall Study|Adverse Event|1|||
156900241|NCT05055128|566395027|FG004|Overall Study|Adverse Event|1|||
156900242|NCT05055128|566395023|FG000|Overall Study|Protocol Violation|0|||
156900243|NCT05055128|566395024|FG001|Overall Study|Protocol Violation|0|||
156900244|NCT05055128|566395025|FG002|Overall Study|Protocol Violation|0|||
156900245|NCT05055128|566395026|FG003|Overall Study|Protocol Violation|1|||
156900246|NCT05055128|566395027|FG004|Overall Study|Protocol Violation|0|||
156900247|NCT05055128|566395023|FG000|Overall Study|Withdrawal by Subject|5|||
157158622|NCT00875017|567324658|FG003|First Intervention|Problems collecting rectal effluent|0|||
157158623|NCT00875017|567324659|FG004|First Intervention|Problems collecting rectal effluent|0|||
156900248|NCT05055128|566395024|FG001|Overall Study|Withdrawal by Subject|2|||
156900249|NCT05055128|566395025|FG002|Overall Study|Withdrawal by Subject|2|||
156900250|NCT05055128|566395026|FG003|Overall Study|Withdrawal by Subject|4|||
156900251|NCT05055128|566395027|FG004|Overall Study|Withdrawal by Subject|2|||
156900252|NCT05055128|566395023|FG000|Overall Study|Randomized By Mistake|0|||
156900253|NCT05055128|566395024|FG001|Overall Study|Randomized By Mistake|1|||
156900254|NCT05055128|566395025|FG002|Overall Study|Randomized By Mistake|0|||
157158624|NCT00875017|567324660|FG005|First Intervention|Problems collecting rectal effluent|0|||
157158625|NCT00875017|567324655|FG000|First Intervention|Intolerance to nasogastric tube|0|||
156900255|NCT05055128|566395026|FG003|Overall Study|Randomized By Mistake|0|||
156900256|NCT05055128|566395027|FG004|Overall Study|Randomized By Mistake|0|||
156900257|NCT05055128|566395023|FG000|Overall Study|Other|1|||
156900258|NCT05055128|566395024|FG001|Overall Study|Other|0|||
156900259|NCT05055128|566395025|FG002|Overall Study|Other|0|||
156900260|NCT05055128|566395026|FG003|Overall Study|Other|0|||
156900261|NCT05055128|566395027|FG004|Overall Study|Other|0|||
156900262|NCT00292318|566395035|FG000|Overall Study|Study terminated by officials|2|||
156900263|NCT00292318|566395036|FG001|Overall Study|Study terminated by officials|1|||
156900264|NCT02955797|566395037|FG000|Overall Study|Protocol Violation|1|||
156900265|NCT02955797|566395038|FG001|Overall Study|Protocol Violation|0|||
156900266|NCT02955797|566395039|FG002|Overall Study|Protocol Violation|0|||
156900267|NCT02955797|566395040|FG003|Overall Study|Protocol Violation|1|||
156900268|NCT02955797|566395037|FG000|Overall Study|Withdrawal by Subject|2|||
156900269|NCT02955797|566395038|FG001|Overall Study|Withdrawal by Subject|2|||
156900270|NCT02955797|566395039|FG002|Overall Study|Withdrawal by Subject|0|||
156900271|NCT02955797|566395040|FG003|Overall Study|Withdrawal by Subject|1|||
156900272|NCT02955797|566395037|FG000|Overall Study|Lost to Follow-up|0|||
156900273|NCT02955797|566395038|FG001|Overall Study|Lost to Follow-up|1|||
156900274|NCT02955797|566395039|FG002|Overall Study|Lost to Follow-up|0|||
156900275|NCT02955797|566395040|FG003|Overall Study|Lost to Follow-up|0|||
156900276|NCT01822496|566395041|FG000|Overall Study|Protocol Violation|2|||
156900277|NCT01822496|566395042|FG001|Overall Study|Protocol Violation|2|||
156900278|NCT01822496|566395043|FG002|Overall Study|Protocol Violation|0|||
156900279|NCT01822496|566395044|FG003|Overall Study|Protocol Violation|1|||
156900280|NCT01822496|566395041|FG000|Overall Study|Withdrawal by Subject|0|||
156900281|NCT01822496|566395042|FG001|Overall Study|Withdrawal by Subject|0|||
156900282|NCT01822496|566395043|FG002|Overall Study|Withdrawal by Subject|0|||
156900283|NCT01822496|566395044|FG003|Overall Study|Withdrawal by Subject|3|||
156900284|NCT00543543|566395045|FG000|Base Study|Adverse Event|1|||
156900285|NCT00543543|566395046|FG001|Base Study|Adverse Event|11|||
156900286|NCT00543543|566395047|FG002|Base Study|Adverse Event|0|||
156900287|NCT00543543|566395048|FG003|Base Study|Adverse Event|5|||
156900288|NCT00543543|566395045|FG000|Base Study|Lost to Follow-up|12|||
156900289|NCT00543543|566395046|FG001|Base Study|Lost to Follow-up|749|||
156900290|NCT00543543|566395047|FG002|Base Study|Lost to Follow-up|9|||
156900291|NCT00543543|566395048|FG003|Base Study|Lost to Follow-up|701|||
156900292|NCT00543543|566395045|FG000|Base Study|Physician Decision|0|||
156900293|NCT00543543|566395046|FG001|Base Study|Physician Decision|4|||
156900294|NCT00543543|566395047|FG002|Base Study|Physician Decision|0|||
156900295|NCT00543543|566395048|FG003|Base Study|Physician Decision|7|||
156900296|NCT00543543|566395045|FG000|Base Study|Protocol Violation|0|||
156900297|NCT00543543|566395046|FG001|Base Study|Protocol Violation|6|||
156900298|NCT00543543|566395047|FG002|Base Study|Protocol Violation|0|||
156900299|NCT00543543|566395048|FG003|Base Study|Protocol Violation|6|||
156900300|NCT00543543|566395045|FG000|Base Study|Withdrawal by Subject|7|||
156900301|NCT00543543|566395046|FG001|Base Study|Withdrawal by Subject|482|||
156900302|NCT00543543|566395047|FG002|Base Study|Withdrawal by Subject|5|||
156900303|NCT00543543|566395048|FG003|Base Study|Withdrawal by Subject|503|||
156900304|NCT00543543|566395045|FG000|Extension Study|Adverse Event|0|||
156900305|NCT00543543|566395046|FG001|Extension Study|Adverse Event|0|||
156900306|NCT00543543|566395047|FG002|Extension Study|Adverse Event|0|||
156900307|NCT00543543|566395048|FG003|Extension Study|Adverse Event|5|||
156900308|NCT00543543|566395045|FG000|Extension Study|Lost to Follow-up|0|||
156900309|NCT00543543|566395046|FG001|Extension Study|Lost to Follow-up|0|||
156900310|NCT00543543|566395047|FG002|Extension Study|Lost to Follow-up|0|||
157026374|NCT04032704|566851539|FG008|Part B|Study termination by Sponsor|1|||
157026375|NCT04032704|566851540|FG009|Part B|Study termination by Sponsor|0|||
157026376|NCT04032704|566851541|FG010|Part B|Study termination by Sponsor|0|||
157026377|NCT04032704|566851542|FG011|Part B|Study termination by Sponsor|0|||
157026378|NCT04032704|566851543|FG012|Part B|Study termination by Sponsor|0|||
157158626|NCT00875017|567324656|FG001|First Intervention|Intolerance to nasogastric tube|0|||
157026379|NCT04032704|566851544|FG013|Part B|Study termination by Sponsor|0|||
156900311|NCT00543543|566395048|FG003|Extension Study|Lost to Follow-up|77|||
156900312|NCT00543543|566395045|FG000|Extension Study|Physician Decision|0|||
156900313|NCT00543543|566395046|FG001|Extension Study|Physician Decision|0|||
156900314|NCT00543543|566395047|FG002|Extension Study|Physician Decision|0|||
156900315|NCT00543543|566395048|FG003|Extension Study|Physician Decision|7|||
156900316|NCT00543543|566395045|FG000|Extension Study|Pregnancy|0|||
156900317|NCT00543543|566395046|FG001|Extension Study|Pregnancy|0|||
156900318|NCT00543543|566395047|FG002|Extension Study|Pregnancy|0|||
156900319|NCT00543543|566395048|FG003|Extension Study|Pregnancy|6|||
156900320|NCT00543543|566395045|FG000|Extension Study|Protocol Violation|0|||
156900321|NCT00543543|566395046|FG001|Extension Study|Protocol Violation|0|||
156900322|NCT00543543|566395047|FG002|Extension Study|Protocol Violation|0|||
156900323|NCT00543543|566395048|FG003|Extension Study|Protocol Violation|11|||
156900324|NCT00543543|566395045|FG000|Extension Study|Withdrawal by Subject|0|||
156900325|NCT00543543|566395046|FG001|Extension Study|Withdrawal by Subject|0|||
156900326|NCT00543543|566395047|FG002|Extension Study|Withdrawal by Subject|0|||
156900327|NCT00543543|566395048|FG003|Extension Study|Withdrawal by Subject|120|||
156900328|NCT00945555|566395049|FG000|Overall Study|Referred to another hospital|5|||
157026380|NCT04032704|566851545|FG014|Part B|Study termination by Sponsor|0|||
157158627|NCT00875017|567324657|FG002|First Intervention|Intolerance to nasogastric tube|0|||
157158628|NCT00875017|567324658|FG003|First Intervention|Intolerance to nasogastric tube|0|||
157158629|NCT00875017|567324659|FG004|First Intervention|Intolerance to nasogastric tube|1|||
157158630|NCT00875017|567324660|FG005|First Intervention|Intolerance to nasogastric tube|0|||
157158631|NCT00875017|567324655|FG000|Washout|Problem collecting rectal effluent|0|||
157158632|NCT00875017|567324656|FG001|Washout|Problem collecting rectal effluent|0|||
157158633|NCT00875017|567324657|FG002|Washout|Problem collecting rectal effluent|1|||
157158634|NCT00875017|567324658|FG003|Washout|Problem collecting rectal effluent|0|||
157158635|NCT00875017|567324659|FG004|Washout|Problem collecting rectal effluent|0|||
157158636|NCT00875017|567324660|FG005|Washout|Problem collecting rectal effluent|0|||
157158637|NCT00875017|567324655|FG000|Second Intervention|Adverse Event|0|||
157158638|NCT00875017|567324656|FG001|Second Intervention|Adverse Event|0|||
157158639|NCT00875017|567324657|FG002|Second Intervention|Adverse Event|0|||
157158640|NCT00875017|567324658|FG003|Second Intervention|Adverse Event|1|||
157158641|NCT00875017|567324659|FG004|Second Intervention|Adverse Event|0|||
157158642|NCT00875017|567324660|FG005|Second Intervention|Adverse Event|0|||
157158643|NCT00875017|567324655|FG000|Washout|Problems collecting rectal effluent|0|||
157158644|NCT00875017|567324656|FG001|Washout|Problems collecting rectal effluent|1|||
157026381|NCT04032704|566851546|FG015|Part B|Study termination by Sponsor|0|||
157026382|NCT04032704|566851547|FG016|Part B|Study termination by Sponsor|0|||
157158645|NCT00875017|567324657|FG002|Washout|Problems collecting rectal effluent|0|||
157158646|NCT00875017|567324658|FG003|Washout|Problems collecting rectal effluent|0|||
157158647|NCT00875017|567324659|FG004|Washout|Problems collecting rectal effluent|0|||
156900329|NCT00945555|566395049|FG000|Overall Study|Worsening condition, intensive care unit|1|||
156900330|NCT00945555|566395049|FG000|Overall Study|Withdrawal by Subject|2|||
156900331|NCT00945555|566395049|FG000|Overall Study|Participant continued treatment at home|1|||
156900332|NCT00945555|566395049|FG000|Overall Study|Death|18|||
156900333|NCT00945555|566395049|FG000|Overall Study|Other|1|||
156900334|NCT04502979|566395051|FG000|Overall Study|Lost to Follow-up|1|||
156900335|NCT04502979|566395052|FG001|Overall Study|Lost to Follow-up|3|||
156900336|NCT04502979|566395051|FG000|Overall Study|Withdrawal by Subject|2|||
156900337|NCT04502979|566395052|FG001|Overall Study|Withdrawal by Subject|1|||
156900338|NCT02906332|566395057|FG000|Overall Study|Withdrawal by Subject|1|||
156900339|NCT03945266|566395061|FG000|Overall Study|Withdrawal by Subject|1|||
156900340|NCT03945266|566395062|FG001|Overall Study|Withdrawal by Subject|0|||
156900341|NCT03945266|566395061|FG000|Overall Study|Miscarriage|0|||
156900342|NCT03945266|566395062|FG001|Overall Study|Miscarriage|2|||
156900343|NCT03945266|566395061|FG000|Overall Study|Lost to Follow-up|1|||
156900344|NCT03945266|566395062|FG001|Overall Study|Lost to Follow-up|0|||
156900345|NCT02734433|566395063|FG000|Overall Study|Disease progression|1|||
156900346|NCT02734433|566395064|FG001|Overall Study|Disease progression|5|||
156900347|NCT02734433|566395063|FG000|Overall Study|Clinical progression|0|||
156900348|NCT02734433|566395064|FG001|Overall Study|Clinical progression|1|||
156900349|NCT02734433|566395063|FG000|Overall Study|Withdrawal by Subject|1|||
156900350|NCT02734433|566395064|FG001|Overall Study|Withdrawal by Subject|2|||
156900351|NCT03698331|566395068|FG000|Overall Study|Adverse Event|2|||
156900352|NCT03698331|566395069|FG001|Overall Study|Adverse Event|3|||
156900353|NCT03698331|566395068|FG000|Overall Study|Withdrawal by Subject|1|||
156900354|NCT03698331|566395069|FG001|Overall Study|Withdrawal by Subject|1|||
156900355|NCT03698331|566395068|FG000|Overall Study|Lost to Follow-up|0|||
156900356|NCT03698331|566395069|FG001|Overall Study|Lost to Follow-up|2|||
156900357|NCT03698331|566395068|FG000|Overall Study|Non-compliance with study drug|1|||
156900358|NCT03698331|566395069|FG001|Overall Study|Non-compliance with study drug|0|||
156900359|NCT04916769|566395073|FG000|Period 1|Physician Decision|0|||
156900360|NCT04916769|566395074|FG001|Period 1|Physician Decision|0|||
156900361|NCT04916769|566395075|FG002|Period 1|Physician Decision|0|||
156900362|NCT04916769|566395076|FG003|Period 1|Physician Decision|0|||
156900363|NCT04916769|566395077|FG004|Period 1|Physician Decision|0|||
156900364|NCT04916769|566395078|FG005|Period 1|Physician Decision|1|||
156900365|NCT04916769|566395073|FG000|Period 2|Physician Decision|0|||
156900366|NCT04916769|566395074|FG001|Period 2|Physician Decision|1|||
156900367|NCT04916769|566395075|FG002|Period 2|Physician Decision|0|||
156900368|NCT04916769|566395076|FG003|Period 2|Physician Decision|0|||
156900369|NCT04916769|566395077|FG004|Period 2|Physician Decision|0|||
156900370|NCT04916769|566395078|FG005|Period 2|Physician Decision|0|||
157158648|NCT00875017|567324660|FG005|Washout|Problems collecting rectal effluent|0|||
156900371|NCT04246372|566396580|FG000|Overall Study|Adverse Event|1|||
157158649|NCT00875017|567324655|FG000|Third Intervention|Adverse Event|0|||
156900372|NCT04246372|566396580|FG000|Overall Study|Withdrawal by Subject|1|||
157158650|NCT00875017|567324656|FG001|Third Intervention|Adverse Event|1|||
157158651|NCT00875017|567324657|FG002|Third Intervention|Adverse Event|1|||
157158652|NCT00875017|567324658|FG003|Third Intervention|Adverse Event|0|||
156900373|NCT04246372|566396580|FG000|Overall Study|Protocol Violation|2|||
156900374|NCT04246372|566396580|FG000|Overall Study|Physician Decision|1|||
156900375|NCT01896050|566396582|FG000|Overall Study|Adverse Event|37|||
157026383|NCT04032704|566851548|FG017|Part B|Study termination by Sponsor|0|||
157158653|NCT00875017|567324659|FG004|Third Intervention|Adverse Event|0|||
157158654|NCT00875017|567324660|FG005|Third Intervention|Adverse Event|0|||
157158655|NCT00875017|567324655|FG000|Washout|Withdrawal by Subject|0|||
157158656|NCT00875017|567324656|FG001|Washout|Withdrawal by Subject|0|||
157158657|NCT00875017|567324657|FG002|Washout|Withdrawal by Subject|0|||
157158658|NCT00875017|567324658|FG003|Washout|Withdrawal by Subject|0|||
157158659|NCT00875017|567324659|FG004|Washout|Withdrawal by Subject|1|||
157158660|NCT00875017|567324660|FG005|Washout|Withdrawal by Subject|0|||
157158661|NCT00875017|567324655|FG000|Fourth Intervention|Inability to comply with fasting|0|||
157158662|NCT00875017|567324656|FG001|Fourth Intervention|Inability to comply with fasting|0|||
157158663|NCT00875017|567324657|FG002|Fourth Intervention|Inability to comply with fasting|0|||
157158664|NCT00875017|567324658|FG003|Fourth Intervention|Inability to comply with fasting|0|||
157158665|NCT00875017|567324659|FG004|Fourth Intervention|Inability to comply with fasting|0|||
157158666|NCT00875017|567324660|FG005|Fourth Intervention|Inability to comply with fasting|1|||
157158667|NCT01921257|567324663|FG000|Overall Study|Adverse Event|1|||
157158668|NCT01921257|567324663|FG000|Overall Study|Protocol Violation|1|||
157158669|NCT01921257|567324663|FG000|Overall Study|Withdrawal by Subject|1|||
157158670|NCT02426658|567324667|FG000|Overall Study|Withdrawal by Subject|1|||
157158671|NCT02426658|567324667|FG000|Overall Study|Patient expired before treatment|2|||
157158672|NCT01423617|567324668|FG000|Overall Study|Lost to Follow-up|0|||
157158673|NCT01423617|567324669|FG001|Overall Study|Lost to Follow-up|1|||
157158674|NCT00634244|567324670|FG000|Overall Study|Never started treatment|0|||
157158675|NCT00634244|567324671|FG001|Overall Study|Never started treatment|1|||
157158676|NCT00634244|567324672|FG002|Overall Study|Never started treatment|0|||
157158677|NCT00634244|567324670|FG000|Overall Study|Death|1|||
157158678|NCT00634244|567324671|FG001|Overall Study|Death|6|||
157158679|NCT00634244|567324672|FG002|Overall Study|Death|0|||
157158680|NCT00634244|567324670|FG000|Overall Study|Adverse Event|0|||
157158681|NCT00634244|567324671|FG001|Overall Study|Adverse Event|2|||
156859091|NCT01602224|566241119|FG000|Overall Study|Sponsor Decision|2|||
156859092|NCT01602224|566241120|FG001|Overall Study|Sponsor Decision|3|||
156859093|NCT01602224|566241121|FG002|Overall Study|Sponsor Decision|2|||
156859094|NCT01602224|566241119|FG000|Overall Study|Withdrawal by Subject|5|||
156859095|NCT01602224|566241120|FG001|Overall Study|Withdrawal by Subject|3|||
156859096|NCT01602224|566241121|FG002|Overall Study|Withdrawal by Subject|3|||
156859097|NCT03346434|566241122|FG000|Overall Study|Randomized in Error|0|||
156859098|NCT03346434|566241123|FG001|Overall Study|Randomized in Error|0|||
156859099|NCT03346434|566241124|FG002|Overall Study|Randomized in Error|0|||
156859100|NCT03346434|566241125|FG003|Overall Study|Randomized in Error|0|||
156859101|NCT03346434|566241126|FG004|Overall Study|Randomized in Error|1|||
156859102|NCT03346434|566241127|FG005|Overall Study|Randomized in Error|0|||
156859103|NCT03346434|566241122|FG000|Overall Study|Withdrawal by Subject|0|||
156859104|NCT03346434|566241123|FG001|Overall Study|Withdrawal by Subject|0|||
156859105|NCT03346434|566241124|FG002|Overall Study|Withdrawal by Subject|1|||
156859106|NCT03346434|566241125|FG003|Overall Study|Withdrawal by Subject|0|||
156859107|NCT03346434|566241126|FG004|Overall Study|Withdrawal by Subject|1|||
156859108|NCT03346434|566241127|FG005|Overall Study|Withdrawal by Subject|0|||
156859109|NCT03346434|566241122|FG000|Overall Study|Lost to Follow-up|0|||
156859110|NCT03346434|566241123|FG001|Overall Study|Lost to Follow-up|0|||
156859111|NCT03346434|566241124|FG002|Overall Study|Lost to Follow-up|0|||
156859112|NCT03346434|566241125|FG003|Overall Study|Lost to Follow-up|0|||
156859113|NCT03346434|566241126|FG004|Overall Study|Lost to Follow-up|1|||
156859114|NCT03346434|566241127|FG005|Overall Study|Lost to Follow-up|1|||
156859115|NCT03346434|566241122|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859116|NCT03346434|566241123|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859117|NCT03346434|566241124|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859118|NCT03346434|566241125|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
156859119|NCT03346434|566241126|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
156859120|NCT03346434|566241127|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
156859121|NCT02741128|566241129|FG000|Overall Study|Protocol Violation|4|||
156859122|NCT02741128|566241130|FG001|Overall Study|Protocol Violation|1|||
156859123|NCT02741128|566241129|FG000|Overall Study|Withdrawal by Subject|2|||
156859124|NCT02741128|566241130|FG001|Overall Study|Withdrawal by Subject|0|||
156859125|NCT02741128|566241129|FG000|Overall Study|Lost to Follow-up|1|||
156859126|NCT02741128|566241130|FG001|Overall Study|Lost to Follow-up|0|||
156859127|NCT02081677|566241131|FG000|Overall Study|Adverse Event|0|||
156859128|NCT02081677|566241132|FG001|Overall Study|Adverse Event|0|||
156859129|NCT02081677|566241133|FG002|Overall Study|Adverse Event|1|||
157158682|NCT00634244|567324672|FG002|Overall Study|Adverse Event|0|||
157158683|NCT00634244|567324670|FG000|Overall Study|Withdrawal by Subject|0|||
157158684|NCT00634244|567324671|FG001|Overall Study|Withdrawal by Subject|1|||
156859130|NCT02081677|566241134|FG003|Overall Study|Adverse Event|0|||
156859131|NCT02081677|566241131|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859132|NCT02081677|566241132|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859133|NCT02081677|566241133|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
157158685|NCT00634244|567324672|FG002|Overall Study|Withdrawal by Subject|0|||
157158686|NCT00634244|567324670|FG000|Overall Study|Physician Decision|0|||
157158687|NCT00634244|567324671|FG001|Overall Study|Physician Decision|1|||
157158688|NCT00634244|567324672|FG002|Overall Study|Physician Decision|0|||
157158689|NCT00634244|567324670|FG000|Overall Study|Disease progression/relapse|0|||
157158690|NCT00634244|567324671|FG001|Overall Study|Disease progression/relapse|1|||
157158691|NCT00634244|567324672|FG002|Overall Study|Disease progression/relapse|0|||
156900376|NCT01896050|566396583|FG001|Overall Study|Adverse Event|2|||
156900377|NCT01896050|566396582|FG000|Overall Study|Death|1|||
156900378|NCT01896050|566396583|FG001|Overall Study|Death|0|||
156900379|NCT00392015|566396584|FG000|Overall Study|Lost to Follow-up|2|||
156900380|NCT00392015|566396585|FG001|Overall Study|Lost to Follow-up|0|||
156900381|NCT00392015|566396586|FG002|Overall Study|Lost to Follow-up|2|||
156900382|NCT00392015|566396587|FG003|Overall Study|Lost to Follow-up|1|||
156900383|NCT00392015|566396588|FG004|Overall Study|Lost to Follow-up|1|||
156900384|NCT00392015|566396589|FG005|Overall Study|Lost to Follow-up|0|||
156900385|NCT00392015|566396584|FG000|Overall Study|Withdrawal by Subject|0|||
156900386|NCT00392015|566396585|FG001|Overall Study|Withdrawal by Subject|0|||
156900387|NCT00392015|566396586|FG002|Overall Study|Withdrawal by Subject|2|||
156900388|NCT00392015|566396587|FG003|Overall Study|Withdrawal by Subject|0|||
156900389|NCT00392015|566396588|FG004|Overall Study|Withdrawal by Subject|0|||
157158692|NCT00634244|567324670|FG000|Overall Study|Other complicating disease|0|||
157158693|NCT00634244|567324671|FG001|Overall Study|Other complicating disease|1|||
157158694|NCT00634244|567324672|FG002|Overall Study|Other complicating disease|0|||
157158695|NCT03591146|567324680|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
157158696|NCT03591146|567324681|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
157158697|NCT03591146|567324682|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
157158698|NCT03591146|567324683|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
157158699|NCT03591146|567324684|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
157158700|NCT03591146|567324680|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
157158701|NCT03591146|567324681|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
157158702|NCT03591146|567324682|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156859134|NCT02081677|566241134|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156859135|NCT02081677|566241131|FG000|Overall Study|Not comfortable with lens care system|1|||
156859136|NCT02081677|566241132|FG001|Overall Study|Not comfortable with lens care system|0|||
156859137|NCT02081677|566241133|FG002|Overall Study|Not comfortable with lens care system|0|||
156859138|NCT02081677|566241134|FG003|Overall Study|Not comfortable with lens care system|0|||
156859139|NCT02081677|566241131|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156859140|NCT02081677|566241132|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156859141|NCT02081677|566241133|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
156859142|NCT02081677|566241134|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
156859143|NCT01419769|566241135|FG000|Overall Study|Did not receive the AXIOS stent|3|||
156859144|NCT01419769|566241135|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
156859145|NCT00812708|566241138|FG000|Overall Study|Device could not be implanted|2|||
156859146|NCT00812708|566241138|FG000|Overall Study|Lack of medical insurance|1|||
156859147|NCT00812708|566241138|FG000|Overall Study|Switched to another study|1|||
156859148|NCT00812708|566241138|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
156859149|NCT00812708|566241138|FG000|Overall Study|Signed consent but later withdrew|3|||
156859150|NCT03598036|566241144|FG000|Overall Study|Withdrawal by Subject|1|||
156859151|NCT03598036|566241145|FG001|Overall Study|Withdrawal by Subject|0|||
156859152|NCT04235140|566241146|FG000|Overall Study|Adverse Event|2|||
156859153|NCT04235140|566241146|FG000|Overall Study|Lost to Follow-up|1|||
156859154|NCT04235140|566241146|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
156859155|NCT04235140|566241146|FG000|Overall Study|Commercial drug is available for participants|7|||
156859156|NCT02587520|566241147|FG000|Overall Study|Protocol Violation|2|||
156859157|NCT02587520|566241148|FG001|Overall Study|Protocol Violation|0|||
156859158|NCT02587520|566241149|FG002|Overall Study|Protocol Violation|0|||
156859159|NCT02587520|566241150|FG003|Overall Study|Protocol Violation|2|||
156859160|NCT02587520|566241151|FG004|Overall Study|Protocol Violation|0|||
156859161|NCT02587520|566241152|FG005|Overall Study|Protocol Violation|1|||
156859162|NCT02587520|566241153|FG006|Overall Study|Protocol Violation|1|||
156859163|NCT02587520|566241154|FG007|Overall Study|Protocol Violation|1|||
156859164|NCT02587520|566241155|FG008|Overall Study|Protocol Violation|3|||
156859165|NCT02587520|566241156|FG009|Overall Study|Protocol Violation|3|||
156859166|NCT02587520|566241157|FG010|Overall Study|Protocol Violation|1|||
156859167|NCT02587520|566241158|FG011|Overall Study|Protocol Violation|2|||
156859168|NCT02587520|566241159|FG012|Overall Study|Protocol Violation|0|||
156859169|NCT02587520|566241160|FG013|Overall Study|Protocol Violation|0|||
156859170|NCT02587520|566241161|FG014|Overall Study|Protocol Violation|0|||
156859171|NCT02587520|566241162|FG015|Overall Study|Protocol Violation|0|||
156859172|NCT02587520|566241163|FG016|Overall Study|Protocol Violation|0|||
156859173|NCT02587520|566241164|FG017|Overall Study|Protocol Violation|0|||
156859174|NCT02587520|566241147|FG000|Overall Study|Adverse Event|0|||
156859175|NCT02587520|566241148|FG001|Overall Study|Adverse Event|0|||
156859176|NCT02587520|566241149|FG002|Overall Study|Adverse Event|0|||
156859177|NCT02587520|566241150|FG003|Overall Study|Adverse Event|0|||
156900390|NCT00392015|566396589|FG005|Overall Study|Withdrawal by Subject|0|||
156900391|NCT00392015|566396584|FG000|Overall Study|Adverse Event|0|||
156900392|NCT00392015|566396585|FG001|Overall Study|Adverse Event|0|||
156900393|NCT00392015|566396586|FG002|Overall Study|Adverse Event|0|||
156900394|NCT00392015|566396587|FG003|Overall Study|Adverse Event|0|||
156900395|NCT00392015|566396588|FG004|Overall Study|Adverse Event|1|||
156900396|NCT00392015|566396589|FG005|Overall Study|Adverse Event|0|||
156900397|NCT00392015|566396584|FG000|Overall Study|Previous trial recipient|0|||
156900398|NCT00392015|566396585|FG001|Overall Study|Previous trial recipient|0|||
156900399|NCT00392015|566396586|FG002|Overall Study|Previous trial recipient|0|||
156900400|NCT00392015|566396587|FG003|Overall Study|Previous trial recipient|0|||
156900401|NCT00392015|566396588|FG004|Overall Study|Previous trial recipient|1|||
156900402|NCT00392015|566396589|FG005|Overall Study|Previous trial recipient|0|||
156900403|NCT01858376|566396590|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
156900404|NCT03894046|566396594|FG000|Overall Study|Protocol Violation|1|||
156900405|NCT03894046|566396595|FG001|Overall Study|Protocol Violation|0|||
156900406|NCT03894046|566396596|FG002|Overall Study|Protocol Violation|0|||
156900407|NCT03894046|566396594|FG000|Overall Study|Adverse Event|0|||
156900408|NCT03894046|566396595|FG001|Overall Study|Adverse Event|1|||
156900409|NCT03894046|566396596|FG002|Overall Study|Adverse Event|0|||
156900410|NCT03894046|566396594|FG000|Overall Study|Withdrawal by Subject|2|||
156900411|NCT03894046|566396595|FG001|Overall Study|Withdrawal by Subject|3|||
156900412|NCT03894046|566396596|FG002|Overall Study|Withdrawal by Subject|1|||
156900413|NCT03894046|566396594|FG000|Overall Study|Death|15|||
156900414|NCT03894046|566396595|FG001|Overall Study|Death|21|||
156900415|NCT03894046|566396596|FG002|Overall Study|Death|4|||
156900416|NCT03894046|566396594|FG000|Overall Study|No growth of ABC|2|||
156900417|NCT03894046|566396595|FG001|Overall Study|No growth of ABC|1|||
156900418|NCT03894046|566396596|FG002|Overall Study|No growth of ABC|0|||
156900419|NCT03894046|566396594|FG000|Overall Study|Physician Decision|1|||
156900420|NCT03894046|566396595|FG001|Overall Study|Physician Decision|1|||
156900421|NCT03894046|566396596|FG002|Overall Study|Physician Decision|1|||
156900422|NCT03894046|566396594|FG000|Overall Study|Prohibited concomitant medication|1|||
156900423|NCT03894046|566396595|FG001|Overall Study|Prohibited concomitant medication|0|||
156900424|NCT03894046|566396596|FG002|Overall Study|Prohibited concomitant medication|0|||
156900425|NCT03894046|566396594|FG000|Overall Study|Transferred to other arm/group|1|||
156900426|NCT03894046|566396595|FG001|Overall Study|Transferred to other arm/group|1|||
156900427|NCT03894046|566396596|FG002|Overall Study|Transferred to other arm/group|0|||
156900428|NCT01824342|566396603|FG000|Overall Study|Withdrawal by Subject|0|||
156900429|NCT01824342|566396604|FG001|Overall Study|Withdrawal by Subject|3|||
156900430|NCT01824342|566396603|FG000|Overall Study|Adverse Event|1|||
156900431|NCT01824342|566396604|FG001|Overall Study|Adverse Event|1|||
156900432|NCT01824342|566396603|FG000|Overall Study|Disease Progression|1|||
156900433|NCT01824342|566396604|FG001|Overall Study|Disease Progression|1|||
156900434|NCT01824342|566396603|FG000|Overall Study|Physician Decision|5|||
156900435|NCT01824342|566396604|FG001|Overall Study|Physician Decision|0|||
156900436|NCT01824342|566396603|FG000|Overall Study|Death|2|||
156900437|NCT01824342|566396604|FG001|Overall Study|Death|0|||
156900438|NCT02486302|566396607|FG000|Overall Study|Discontinued prematurely|410|||
156900439|NCT02486302|566396607|FG000|Overall Study|Documentation not completed|255|||
156900440|NCT02486302|566396607|FG000|Overall Study|Excluded due to legal reasons|8|||
156900441|NCT02486302|566396607|FG000|Overall Study|Not treated|3|||
156900442|NCT01871142|566396610|FG000|Overall Study|Adverse Event|1|||
156900443|NCT00734474|566396615|FG000|Overall Study|Entry Criteria Not Met|0|||
156900444|NCT00734474|566396616|FG001|Overall Study|Entry Criteria Not Met|0|||
156900445|NCT00734474|566396617|FG002|Overall Study|Entry Criteria Not Met|5|||
156900446|NCT00734474|566396618|FG003|Overall Study|Entry Criteria Not Met|0|||
156900447|NCT00734474|566396619|FG004|Overall Study|Entry Criteria Not Met|3|||
156900448|NCT00734474|566396620|FG005|Overall Study|Entry Criteria Not Met|1|||
156900449|NCT00734474|566396621|FG006|Overall Study|Entry Criteria Not Met|0|||
156900450|NCT00734474|566396622|FG007|Overall Study|Entry Criteria Not Met|1|||
156900451|NCT00734474|566396623|FG008|Overall Study|Entry Criteria Not Met|1|||
156900452|NCT00734474|566396615|FG000|Overall Study|Lost to Follow-up|1|||
156900453|NCT00734474|566396616|FG001|Overall Study|Lost to Follow-up|0|||
156900454|NCT00734474|566396617|FG002|Overall Study|Lost to Follow-up|13|||
156900455|NCT00734474|566396618|FG003|Overall Study|Lost to Follow-up|0|||
157026384|NCT04032704|566851531|FG000|Part B|Withdrawal by Subject|0|||
157026385|NCT04032704|566851532|FG001|Part B|Withdrawal by Subject|0|||
157158703|NCT03591146|567324683|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
156900456|NCT00734474|566396619|FG004|Overall Study|Lost to Follow-up|11|||
156900457|NCT00734474|566396620|FG005|Overall Study|Lost to Follow-up|1|||
156900458|NCT00734474|566396621|FG006|Overall Study|Lost to Follow-up|0|||
156900459|NCT00734474|566396622|FG007|Overall Study|Lost to Follow-up|9|||
156900460|NCT00734474|566396623|FG008|Overall Study|Lost to Follow-up|4|||
156900461|NCT00734474|566396615|FG000|Overall Study|Withdrawal by Subject|2|||
156900462|NCT00734474|566396616|FG001|Overall Study|Withdrawal by Subject|1|||
156900463|NCT00734474|566396617|FG002|Overall Study|Withdrawal by Subject|18|||
156900464|NCT00734474|566396618|FG003|Overall Study|Withdrawal by Subject|0|||
156900465|NCT00734474|566396619|FG004|Overall Study|Withdrawal by Subject|24|||
156900466|NCT00734474|566396620|FG005|Overall Study|Withdrawal by Subject|2|||
156900467|NCT00734474|566396621|FG006|Overall Study|Withdrawal by Subject|0|||
156900468|NCT00734474|566396622|FG007|Overall Study|Withdrawal by Subject|36|||
156900469|NCT00734474|566396623|FG008|Overall Study|Withdrawal by Subject|21|||
156900470|NCT00734474|566396615|FG000|Overall Study|Physician Decision|0|||
156900471|NCT00734474|566396616|FG001|Overall Study|Physician Decision|0|||
156900472|NCT00734474|566396617|FG002|Overall Study|Physician Decision|4|||
156900473|NCT00734474|566396618|FG003|Overall Study|Physician Decision|1|||
156900474|NCT00734474|566396619|FG004|Overall Study|Physician Decision|11|||
156900475|NCT00734474|566396620|FG005|Overall Study|Physician Decision|0|||
156900476|NCT00734474|566396621|FG006|Overall Study|Physician Decision|0|||
156900477|NCT00734474|566396622|FG007|Overall Study|Physician Decision|9|||
156900478|NCT00734474|566396623|FG008|Overall Study|Physician Decision|9|||
156900479|NCT00734474|566396615|FG000|Overall Study|Adverse Event|4|||
156900480|NCT00734474|566396616|FG001|Overall Study|Adverse Event|4|||
156900481|NCT00734474|566396617|FG002|Overall Study|Adverse Event|63|||
156900482|NCT00734474|566396618|FG003|Overall Study|Adverse Event|1|||
156900483|NCT00734474|566396619|FG004|Overall Study|Adverse Event|64|||
156900484|NCT00734474|566396620|FG005|Overall Study|Adverse Event|0|||
156900485|NCT00734474|566396621|FG006|Overall Study|Adverse Event|1|||
156900486|NCT00734474|566396622|FG007|Overall Study|Adverse Event|65|||
156900487|NCT00734474|566396623|FG008|Overall Study|Adverse Event|39|||
156900488|NCT00734474|566396615|FG000|Overall Study|Protocol Violation|0|||
156900489|NCT00734474|566396616|FG001|Overall Study|Protocol Violation|0|||
156900490|NCT00734474|566396617|FG002|Overall Study|Protocol Violation|4|||
156900491|NCT00734474|566396618|FG003|Overall Study|Protocol Violation|0|||
156900492|NCT00734474|566396619|FG004|Overall Study|Protocol Violation|3|||
156900493|NCT00734474|566396620|FG005|Overall Study|Protocol Violation|0|||
157158704|NCT03591146|567324684|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
157158705|NCT03591146|567324680|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
157158706|NCT03591146|567324681|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
156900494|NCT00734474|566396621|FG006|Overall Study|Protocol Violation|0|||
156900495|NCT00734474|566396622|FG007|Overall Study|Protocol Violation|3|||
156900496|NCT00734474|566396623|FG008|Overall Study|Protocol Violation|1|||
156900497|NCT00734474|566396615|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
156900498|NCT00734474|566396616|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
156900499|NCT00734474|566396617|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156900500|NCT00734474|566396618|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
156900501|NCT00734474|566396619|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156900502|NCT00734474|566396620|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
156900503|NCT00734474|566396621|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
156900504|NCT00734474|566396622|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156900505|NCT00734474|566396623|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
156900506|NCT00734474|566396615|FG000|Overall Study|Sponsor Decision|0|||
156900507|NCT00734474|566396616|FG001|Overall Study|Sponsor Decision|0|||
156900508|NCT00734474|566396617|FG002|Overall Study|Sponsor Decision|0|||
156900509|NCT00734474|566396618|FG003|Overall Study|Sponsor Decision|0|||
156900510|NCT00734474|566396619|FG004|Overall Study|Sponsor Decision|2|||
156900511|NCT00734474|566396620|FG005|Overall Study|Sponsor Decision|0|||
156900512|NCT00734474|566396621|FG006|Overall Study|Sponsor Decision|0|||
156900513|NCT00734474|566396622|FG007|Overall Study|Sponsor Decision|0|||
156900514|NCT00734474|566396623|FG008|Overall Study|Sponsor Decision|0|||
156900515|NCT00734474|566396615|FG000|Overall Study|Death|0|||
156900516|NCT00734474|566396616|FG001|Overall Study|Death|0|||
156900517|NCT00734474|566396617|FG002|Overall Study|Death|1|||
156900518|NCT00734474|566396618|FG003|Overall Study|Death|0|||
156900519|NCT00734474|566396619|FG004|Overall Study|Death|0|||
156900520|NCT00734474|566396620|FG005|Overall Study|Death|0|||
156900521|NCT00734474|566396621|FG006|Overall Study|Death|0|||
157158707|NCT03591146|567324682|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
157158708|NCT03591146|567324683|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
157158709|NCT03591146|567324684|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
156900522|NCT00734474|566396622|FG007|Overall Study|Death|2|||
156900523|NCT00734474|566396623|FG008|Overall Study|Death|1|||
156900524|NCT00734474|566396615|FG000|Overall Study|Lack of Efficacy|0|||
156900525|NCT00734474|566396616|FG001|Overall Study|Lack of Efficacy|0|||
156900526|NCT00734474|566396617|FG002|Overall Study|Lack of Efficacy|4|||
156900527|NCT00734474|566396618|FG003|Overall Study|Lack of Efficacy|0|||
156900528|NCT00734474|566396619|FG004|Overall Study|Lack of Efficacy|0|||
156900529|NCT00734474|566396620|FG005|Overall Study|Lack of Efficacy|0|||
156900530|NCT00734474|566396621|FG006|Overall Study|Lack of Efficacy|0|||
156900531|NCT00734474|566396622|FG007|Overall Study|Lack of Efficacy|4|||
156900532|NCT00734474|566396623|FG008|Overall Study|Lack of Efficacy|6|||
156900533|NCT02104752|566396624|FG000|Overall Study|Withdrawal by Subject|1|||
156900534|NCT02104752|566396625|FG001|Overall Study|Withdrawal by Subject|0|||
156900535|NCT02104752|566396624|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
156900536|NCT02104752|566396625|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
157026386|NCT04032704|566851533|FG002|Part B|Withdrawal by Subject|0|||
156900537|NCT02899299|566396626|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
156900538|NCT02899299|566396627|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
156900539|NCT02899299|566396626|FG000|Pre-treatment|Participant withdrew consent|1|||
156900540|NCT02899299|566396627|FG001|Pre-treatment|Participant withdrew consent|11|||
156900541|NCT02899299|566396626|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
156900542|NCT02899299|566396627|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
156900543|NCT02899299|566396626|FG000|Pre-treatment|Not reported|0|||
156900544|NCT02899299|566396627|FG001|Pre-treatment|Not reported|1|||
156900545|NCT02899299|566396626|FG000|Treatment|Disease Progression|182|||
156900546|NCT02899299|566396627|FG001|Treatment|Disease Progression|43|||
156900547|NCT02899299|566396626|FG000|Treatment|Study Drug Toxicity|60|||
156900548|NCT02899299|566396627|FG001|Treatment|Study Drug Toxicity|24|||
156900549|NCT02899299|566396626|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
156900550|NCT02899299|566396627|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
156900551|NCT02899299|566396626|FG000|Treatment|Participant request to discontinue Study treatment|4|||
156900552|NCT02899299|566396627|FG001|Treatment|Participant request to discontinue Study treatment|10|||
156900553|NCT02899299|566396626|FG000|Treatment|Participant withdrew consent|6|||
156900554|NCT02899299|566396627|FG001|Treatment|Participant withdrew consent|3|||
156900555|NCT02899299|566396626|FG000|Treatment|Lost to Follow-up|0|||
156900556|NCT02899299|566396627|FG001|Treatment|Lost to Follow-up|2|||
156900557|NCT02899299|566396626|FG000|Treatment|Maximum Clinical Benefit|11|||
156900558|NCT02899299|566396627|FG001|Treatment|Maximum Clinical Benefit|2|||
156900559|NCT02899299|566396626|FG000|Treatment|Poor/Non-compliance|1|||
156900560|NCT02899299|566396627|FG001|Treatment|Poor/Non-compliance|0|||
156900561|NCT02899299|566396626|FG000|Treatment|Participant no longer meets Study criteria|4|||
156900562|NCT02899299|566396627|FG001|Treatment|Participant no longer meets Study criteria|0|||
156900563|NCT02899299|566396626|FG000|Treatment|Administrative reason by Sponsor|2|||
156900564|NCT02899299|566396627|FG001|Treatment|Administrative reason by Sponsor|0|||
156900565|NCT02899299|566396626|FG000|Treatment|Other reasons|12|||
156900566|NCT02899299|566396627|FG001|Treatment|Other reasons|2|||
156900567|NCT02899299|566396626|FG000|Treatment|Not reported|7|||
156900568|NCT02899299|566396627|FG001|Treatment|Not reported|0|||
156900569|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
156900570|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
156900571|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
156900572|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
156900573|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
156900574|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
156900575|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
156900576|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
156900577|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
156900578|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
156900579|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
156900580|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
156900581|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
156900582|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
156900583|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
156900584|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
156900585|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
156900586|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
156900587|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
156900588|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
156900589|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
156900590|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
156900591|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
156900592|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
156900593|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
156900594|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
156900595|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
156900596|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
156900597|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
156900598|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
156900599|NCT00313300|566396629|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
156900600|NCT00313300|566396630|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
157026387|NCT04032704|566851534|FG003|Part B|Withdrawal by Subject|0|||
157026388|NCT04032704|566851535|FG004|Part B|Withdrawal by Subject|0|||
156900601|NCT00313300|566396631|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156900602|NCT00313300|566396632|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
156900603|NCT00313300|566396633|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
157026389|NCT04032704|566851536|FG005|Part B|Withdrawal by Subject|0|||
156900604|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
156900605|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
156900606|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
156900607|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
156900608|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
156900609|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
156900610|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
156900611|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
156900612|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
156900613|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
156900614|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
156900615|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
156900616|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
156900617|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
156900618|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
156900619|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
156900620|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
156900621|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
156900622|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
156900623|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
156900624|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
156900625|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
156900626|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
156900627|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
156900628|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
156900629|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
156900630|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
156900631|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
156900632|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
156900633|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
156900634|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
156900635|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
156900636|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
156900637|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
156900638|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
156900639|NCT00313300|566396629|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
156900640|NCT00313300|566396630|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
156900641|NCT00313300|566396631|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
156900642|NCT00313300|566396632|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
156900643|NCT00313300|566396633|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
156900644|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
156900645|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
156900646|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
156900647|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
156900648|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
156900649|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
156900650|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
156900651|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
156900652|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
156900653|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
156900654|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156900655|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
156900656|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
156900657|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156900658|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
156900659|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
156900660|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
156900661|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
156900662|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
156900663|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
156900664|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156900665|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156900666|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
156900667|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
156900668|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
156900669|NCT00313300|566396629|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
156900670|NCT00313300|566396630|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156900671|NCT00313300|566396631|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156900672|NCT00313300|566396632|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
156900673|NCT00313300|566396633|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
156900674|NCT00428792|566396634|FG000|Overall Study|Lack of Efficacy|1|||
156900675|NCT00428792|566396635|FG001|Overall Study|Lack of Efficacy|3|||
156900676|NCT00428792|566396634|FG000|Overall Study|Lost to Follow-up|0|||
157158710|NCT03591146|567324680|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
156900677|NCT00428792|566396635|FG001|Overall Study|Lost to Follow-up|1|||
156900678|NCT05274815|566396638|FG000|Overall Study|Adverse Event|1|||
156900679|NCT05274815|566396638|FG000|Overall Study|Death|2|||
156900680|NCT05274815|566396638|FG000|Overall Study|Lost to Follow-up|4|||
156900681|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
156900682|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
156900683|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
156900684|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
156900685|NCT05274815|566396638|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
156900686|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
156900687|NCT05274815|566396638|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
156900688|NCT05274815|566396638|FG000|Overall Study|Withdrawal by Subject|11|||
156900689|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Death|1|||
156900690|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Death|1|||
156900691|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Death|0|||
156900692|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Death|0|||
156900693|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
156900694|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156900695|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156900696|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
156900697|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
156900698|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
156900699|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
156900700|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
156900701|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
156900702|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
156900703|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
156900704|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
156900705|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
156900706|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
156900707|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
156900708|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
156900709|NCT04612790|566396639|FG000|DB Period (Up to 36 Weeks)|Other|1|||
156900710|NCT04612790|566396640|FG001|DB Period (Up to 36 Weeks)|Other|0|||
156900711|NCT04612790|566396641|FG002|DB Period (Up to 36 Weeks)|Other|0|||
156900712|NCT04612790|566396642|FG003|DB Period (Up to 36 Weeks)|Other|0|||
156900713|NCT04612790|566396639|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156900714|NCT04612790|566396640|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156900715|NCT04612790|566396641|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
156900716|NCT04612790|566396642|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
156900717|NCT04612790|566396639|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
156900718|NCT04612790|566396640|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
156900719|NCT04612790|566396641|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
156900720|NCT04612790|566396642|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
156900721|NCT04612790|566396639|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
156900722|NCT04612790|566396640|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
156900723|NCT04612790|566396641|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
156900724|NCT04612790|566396642|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
156900725|NCT04612790|566396639|FG000|OLE Period (Up to 1 Year)|Other|0|||
156900726|NCT04612790|566396640|FG001|OLE Period (Up to 1 Year)|Other|0|||
156900727|NCT04612790|566396641|FG002|OLE Period (Up to 1 Year)|Other|0|||
156900728|NCT04612790|566396642|FG003|OLE Period (Up to 1 Year)|Other|1|||
156900729|NCT03323502|566396646|FG000|Overall Study|Resident could not be linked to CMS data|594|||
156900730|NCT03323502|566396647|FG001|Overall Study|Resident could not be linked to CMS data|435|||
156900731|NCT03323502|566396646|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
156900732|NCT03323502|566396647|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
156900733|NCT03323502|566396646|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
156977459|NCT04534114|566670717|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
156977460|NCT04534114|566670718|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
156977461|NCT04534114|566670719|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
156900734|NCT03323502|566396647|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
156900735|NCT03323502|566396646|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
156900736|NCT03323502|566396647|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
156900737|NCT03323502|566396646|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
156900738|NCT03323502|566396647|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
156900739|NCT03615326|566396648|FG000|Overall Study|Death|266|||
156900740|NCT03615326|566396649|FG001|Overall Study|Death|286|||
156900741|NCT03615326|566396650|FG002|Overall Study|Death|14|||
156900742|NCT03615326|566396651|FG003|Overall Study|Death|17|||
156900743|NCT03615326|566396648|FG000|Overall Study|Lost to Follow-up|0|||
156900744|NCT03615326|566396649|FG001|Overall Study|Lost to Follow-up|1|||
156900745|NCT03615326|566396650|FG002|Overall Study|Lost to Follow-up|0|||
156900746|NCT03615326|566396651|FG003|Overall Study|Lost to Follow-up|0|||
156900747|NCT03615326|566396648|FG000|Overall Study|Withdrawal by Subject|1|||
156900748|NCT03615326|566396649|FG001|Overall Study|Withdrawal by Subject|3|||
156900749|NCT03615326|566396650|FG002|Overall Study|Withdrawal by Subject|0|||
156900750|NCT03615326|566396651|FG003|Overall Study|Withdrawal by Subject|0|||
156900751|NCT03615326|566396648|FG000|Overall Study|Participants Ongoing|83|||
156900752|NCT03615326|566396649|FG001|Overall Study|Participants Ongoing|58|||
156900753|NCT03615326|566396650|FG002|Overall Study|Participants Ongoing|6|||
156900754|NCT03615326|566396651|FG003|Overall Study|Participants Ongoing|3|||
156900755|NCT02651467|566396656|FG000|Overall Study|Withdrawal by Subject|0|||
156900756|NCT02651467|566396657|FG001|Overall Study|Withdrawal by Subject|0|||
156900757|NCT02651467|566396658|FG002|Overall Study|Withdrawal by Subject|2|||
156900758|NCT02651467|566396656|FG000|Overall Study|Other (Not specified)|1|||
156900759|NCT02651467|566396657|FG001|Overall Study|Other (Not specified)|0|||
156900760|NCT02651467|566396658|FG002|Overall Study|Other (Not specified)|2|||
156900761|NCT00004635|566396659|FG000|Period One|refused|2|||
156900762|NCT00004635|566396660|FG001|Period One|refused|1|||
156900763|NCT00004635|566396659|FG000|Period One|Withdrawal by Subject|1|||
156900764|NCT00004635|566396660|FG001|Period One|Withdrawal by Subject|1|||
156900765|NCT00004635|566396659|FG000|Period One|Protocol Violation|1|||
156900766|NCT00004635|566396660|FG001|Period One|Protocol Violation|0|||
156900767|NCT00004635|566396659|FG000|Period One|PSA did not go <5 ng/mL|1|||
156900768|NCT00004635|566396660|FG001|Period One|PSA did not go <5 ng/mL|0|||
156900769|NCT00004635|566396659|FG000|Period One|second malignancy|1|||
156900770|NCT00004635|566396660|FG001|Period One|second malignancy|0|||
156900771|NCT00004635|566396659|FG000|Period One|progressed|0|||
156900772|NCT00004635|566396660|FG001|Period One|progressed|2|||
156900773|NCT00004635|566396659|FG000|Period One|health problem|0|||
156900774|NCT00004635|566396660|FG001|Period One|health problem|1|||
156900775|NCT00004635|566396659|FG000|Period One|discrepancy in data entry|0|||
156900776|NCT00004635|566396660|FG001|Period One|discrepancy in data entry|1|||
156900777|NCT00004635|566396659|FG000|Period Two|progression|2|||
156900778|NCT00004635|566396660|FG001|Period Two|progression|3|||
156900779|NCT00004635|566396659|FG000|Period Two|Adverse Event|1|||
156900780|NCT00004635|566396660|FG001|Period Two|Adverse Event|0|||
156900781|NCT00004635|566396659|FG000|Period Two|refused|0|||
156900782|NCT00004635|566396660|FG001|Period Two|refused|2|||
156900783|NCT00004635|566396659|FG000|Period Two|health problem|1|||
156900784|NCT00004635|566396660|FG001|Period Two|health problem|1|||
156900785|NCT00004635|566396659|FG000|Period Two|travel issues|0|||
156900786|NCT00004635|566396660|FG001|Period Two|travel issues|1|||
156900787|NCT00004635|566396659|FG000|Period Two|secondary malignancy|1|||
156900788|NCT00004635|566396660|FG001|Period Two|secondary malignancy|1|||
156900789|NCT00004635|566396659|FG000|Period Two|Lost to Follow-up|1|||
156900790|NCT00004635|566396660|FG001|Period Two|Lost to Follow-up|0|||
156900791|NCT00004635|566396659|FG000|Period Two|discrepancy in data entry|0|||
156900792|NCT00004635|566396660|FG001|Period Two|discrepancy in data entry|1|||
156900793|NCT00191906|566396661|FG000|Study Period II|Adverse Event|0|||
156900794|NCT00191906|566396662|FG001|Study Period II|Adverse Event|1|||
156900795|NCT00191906|566396663|FG002|Study Period II|Adverse Event|0|||
156900796|NCT00191906|566396664|FG003|Study Period II|Adverse Event|0|||
157026390|NCT04032704|566851537|FG006|Part B|Withdrawal by Subject|3|||
157026391|NCT04032704|566851538|FG007|Part B|Withdrawal by Subject|2|||
157026392|NCT04032704|566851539|FG008|Part B|Withdrawal by Subject|2|||
156900797|NCT00191906|566396661|FG000|Study Period II|Withdrawal by Subject|0|||
156900798|NCT00191906|566396662|FG001|Study Period II|Withdrawal by Subject|3|||
156900799|NCT00191906|566396663|FG002|Study Period II|Withdrawal by Subject|0|||
156900800|NCT00191906|566396664|FG003|Study Period II|Withdrawal by Subject|0|||
156900801|NCT00191906|566396661|FG000|Study Period II|Parent/Caregiver Decision|0|||
156900802|NCT00191906|566396662|FG001|Study Period II|Parent/Caregiver Decision|1|||
156900803|NCT00191906|566396663|FG002|Study Period II|Parent/Caregiver Decision|0|||
156900804|NCT00191906|566396664|FG003|Study Period II|Parent/Caregiver Decision|0|||
156900805|NCT00191906|566396661|FG000|Study Period II|Entry Criteria Exclusion|0|||
156900806|NCT00191906|566396662|FG001|Study Period II|Entry Criteria Exclusion|0|||
157026393|NCT04032704|566851540|FG009|Part B|Withdrawal by Subject|1|||
156900807|NCT00191906|566396663|FG002|Study Period II|Entry Criteria Exclusion|1|||
156900808|NCT00191906|566396664|FG003|Study Period II|Entry Criteria Exclusion|0|||
156900809|NCT00191906|566396661|FG000|Study Period III|Adverse Event|1|||
156900810|NCT00191906|566396662|FG001|Study Period III|Adverse Event|0|||
156900811|NCT00191906|566396663|FG002|Study Period III|Adverse Event|0|||
156900812|NCT00191906|566396664|FG003|Study Period III|Adverse Event|0|||
156900813|NCT00191906|566396661|FG000|Study Period III|Lost to Follow-up|0|||
157158711|NCT03591146|567324681|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
157158712|NCT03591146|567324682|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
157158713|NCT03591146|567324683|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
156900814|NCT00191906|566396662|FG001|Study Period III|Lost to Follow-up|1|||
156900815|NCT00191906|566396663|FG002|Study Period III|Lost to Follow-up|0|||
156900816|NCT00191906|566396664|FG003|Study Period III|Lost to Follow-up|0|||
156900817|NCT00191906|566396661|FG000|Study Period III|Parent/Caregiver Decision|1|||
156900818|NCT00191906|566396662|FG001|Study Period III|Parent/Caregiver Decision|0|||
156900819|NCT00191906|566396663|FG002|Study Period III|Parent/Caregiver Decision|0|||
156900820|NCT00191906|566396664|FG003|Study Period III|Parent/Caregiver Decision|0|||
156900821|NCT00191906|566396661|FG000|Study Period III|Lack of Efficacy|3|||
156900822|NCT00191906|566396662|FG001|Study Period III|Lack of Efficacy|3|||
156900823|NCT00191906|566396663|FG002|Study Period III|Lack of Efficacy|0|||
156900824|NCT00191906|566396664|FG003|Study Period III|Lack of Efficacy|0|||
156900825|NCT00573937|566396665|FG000|Overall Study|Study Terminated|0|||
156900826|NCT00573937|566396666|FG001|Overall Study|Study Terminated|1|||
156900827|NCT00333801|566396667|FG000|Overall Study|Moved to another state|5|||
156900828|NCT00333801|566396668|FG001|Overall Study|Moved to another state|3|||
156900829|NCT00333801|566396667|FG000|Overall Study|Lost to Follow-up|2|||
156900830|NCT00333801|566396668|FG001|Overall Study|Lost to Follow-up|0|||
156900831|NCT00333801|566396667|FG000|Overall Study|Incarcerated|1|||
156900832|NCT00333801|566396668|FG001|Overall Study|Incarcerated|2|||
156900833|NCT00333801|566396667|FG000|Overall Study|Withdrawal by Subject|0|||
156900834|NCT00333801|566396668|FG001|Overall Study|Withdrawal by Subject|1|||
156900835|NCT00777205|566396669|FG000|Overall Study|Lost to Follow-up|25|||
156900836|NCT00777205|566396670|FG001|Overall Study|Lost to Follow-up|9|||
156900837|NCT00777205|566396669|FG000|Overall Study|Withdrawal by Subject|6|||
156900838|NCT00777205|566396670|FG001|Overall Study|Withdrawal by Subject|4|||
156900839|NCT00777205|566396669|FG000|Overall Study|Death|0|||
156900840|NCT00777205|566396670|FG001|Overall Study|Death|2|||
156900841|NCT00777205|566396669|FG000|Overall Study|Protocol Violation|0|||
156900842|NCT00777205|566396670|FG001|Overall Study|Protocol Violation|56|||
156900843|NCT03198078|566396674|FG000|Overall Study|Adverse Event|0|||
156900844|NCT03198078|566396675|FG001|Overall Study|Adverse Event|1|||
156900845|NCT03198078|566396676|FG002|Overall Study|Adverse Event|2|||
156900846|NCT03198078|566396674|FG000|Overall Study|Lack of Efficacy|0|||
156900847|NCT03198078|566396675|FG001|Overall Study|Lack of Efficacy|0|||
156900848|NCT03198078|566396676|FG002|Overall Study|Lack of Efficacy|3|||
156900849|NCT03198078|566396674|FG000|Overall Study|Lost to Follow-up|1|||
156900850|NCT03198078|566396675|FG001|Overall Study|Lost to Follow-up|0|||
156900851|NCT03198078|566396676|FG002|Overall Study|Lost to Follow-up|0|||
156900852|NCT03198078|566396674|FG000|Overall Study|Pregnancy|0|||
156900853|NCT03198078|566396675|FG001|Overall Study|Pregnancy|1|||
156900854|NCT03198078|566396676|FG002|Overall Study|Pregnancy|0|||
156900855|NCT03198078|566396674|FG000|Overall Study|Withdrawal by Subject|1|||
156900856|NCT03198078|566396675|FG001|Overall Study|Withdrawal by Subject|0|||
156900857|NCT03198078|566396676|FG002|Overall Study|Withdrawal by Subject|2|||
156900858|NCT03198078|566396674|FG000|Overall Study|Withdrawal by Caregiver|1|||
156900859|NCT03198078|566396675|FG001|Overall Study|Withdrawal by Caregiver|3|||
156900860|NCT03198078|566396676|FG002|Overall Study|Withdrawal by Caregiver|5|||
156900861|NCT01676727|566396677|FG000|Overall Study|Death|18|||
156900862|NCT01676727|566396677|FG000|Overall Study|Withdrawal by Subject|6|||
156900863|NCT01676727|566396677|FG000|Overall Study|Screening failure|5|||
156900864|NCT01676727|566396677|FG000|Overall Study|Not willing to attend 1-year visit|2|||
157158714|NCT03591146|567324684|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
157158715|NCT04737031|567324685|FG000|Overall Study|Patients who did not have a treatment visit|0|||
157158716|NCT04737031|567324686|FG001|Overall Study|Patients who did not have a treatment visit|31|||
156900865|NCT01676727|566396677|FG000|Overall Study|Valve explanted|1|||
156900866|NCT00737438|566396683|FG000|Overall Study|Withdrawal by Subject|2|||
156900867|NCT00737438|566396683|FG000|Overall Study|Patient ineligible|1|||
156900868|NCT04810481|566396685|FG000|Overall Study|Disqualified data sets|10|||
156900869|NCT04810481|566396686|FG001|Overall Study|Disqualified data sets|28|||
156900870|NCT04102098|566396689|FG000|Main Study Period|Ongoing in study|302|||
156900871|NCT04102098|566396690|FG001|Main Study Period|Ongoing in study|291|||
156900872|NCT04102098|566396689|FG000|Main Study Period|Death|20|||
156900873|NCT04102098|566396690|FG001|Main Study Period|Death|27|||
156900874|NCT04102098|566396689|FG000|Main Study Period|Lost to Follow-up|1|||
156900875|NCT04102098|566396690|FG001|Main Study Period|Lost to Follow-up|1|||
156900876|NCT04102098|566396689|FG000|Main Study Period|Physician Decision|0|||
156900877|NCT04102098|566396690|FG001|Main Study Period|Physician Decision|1|||
156900878|NCT04102098|566396689|FG000|Main Study Period|Withdrawal by Subject|11|||
156900879|NCT04102098|566396690|FG001|Main Study Period|Withdrawal by Subject|14|||
156900880|NCT04102098|566396689|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
156900881|NCT04102098|566396690|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
156900882|NCT04102098|566396689|FG000|Crossover: AS Who Crossed Over|Death|11|||
156900883|NCT04102098|566396690|FG001|Crossover: AS Who Crossed Over|Death|0|||
156900884|NCT04102098|566396689|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
156900885|NCT04102098|566396690|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
156900886|NCT03755791|566396693|FG000|Overall Study|Did not receive any study treatment|3|||
156900887|NCT03755791|566396694|FG001|Overall Study|Did not receive any study treatment|0|||
156900888|NCT03755791|566396695|FG002|Overall Study|Did not receive any study treatment|10|||
156900889|NCT03755791|566396693|FG000|Overall Study|Radiographic progression|204|||
156900890|NCT03755791|566396694|FG001|Overall Study|Radiographic progression|92|||
156900891|NCT03755791|566396695|FG002|Overall Study|Radiographic progression|115|||
156900892|NCT03755791|566396693|FG000|Overall Study|Adverse Event|140|||
156900893|NCT03755791|566396694|FG001|Overall Study|Adverse Event|60|||
156900894|NCT03755791|566396695|FG002|Overall Study|Adverse Event|51|||
156900895|NCT03755791|566396693|FG000|Overall Study|Lack of Efficacy|12|||
156900896|NCT03755791|566396694|FG001|Overall Study|Lack of Efficacy|6|||
156900897|NCT03755791|566396695|FG002|Overall Study|Lack of Efficacy|6|||
156900898|NCT03755791|566396693|FG000|Overall Study|Withdrawal by Subject|26|||
156900899|NCT03755791|566396694|FG001|Overall Study|Withdrawal by Subject|23|||
156900900|NCT03755791|566396695|FG002|Overall Study|Withdrawal by Subject|24|||
156900901|NCT03755791|566396693|FG000|Overall Study|Sponsor decision,|41|||
156900902|NCT03755791|566396694|FG001|Overall Study|Sponsor decision,|5|||
156900903|NCT03755791|566396695|FG002|Overall Study|Sponsor decision,|7|||
156900904|NCT03755791|566396693|FG000|Overall Study|Lost to Follow-up|1|||
156900905|NCT03755791|566396694|FG001|Overall Study|Lost to Follow-up|0|||
156900906|NCT03755791|566396695|FG002|Overall Study|Lost to Follow-up|2|||
156900907|NCT03755791|566396693|FG000|Overall Study|Protocol Violation|0|||
156900908|NCT03755791|566396694|FG001|Overall Study|Protocol Violation|0|||
156900909|NCT03755791|566396695|FG002|Overall Study|Protocol Violation|2|||
156900910|NCT03755791|566396693|FG000|Overall Study|Other than specified|5|||
156900911|NCT03755791|566396694|FG001|Overall Study|Other than specified|2|||
156900912|NCT03755791|566396695|FG002|Overall Study|Other than specified|0|||
156900913|NCT02905149|566396696|FG000|Overall Study|Lost to Follow-up|2|||
156900914|NCT02905149|566396697|FG001|Overall Study|Lost to Follow-up|0|||
156900915|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
156900916|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
156900917|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Physician Decision|1|||
156900918|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Physician Decision|0|||
156900919|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
156900920|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
156900921|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
156900922|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
156900923|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Adverse Event|15|||
156900924|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Adverse Event|0|||
156900925|NCT03277690|566396698|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
156900926|NCT03277690|566396699|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
156900927|NCT03277690|566396698|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
156900928|NCT03277690|566396699|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
156900929|NCT00747812|566396700|FG000|Overall Study|Research Site Staff Relocation|5|||
156900930|NCT00747812|566396701|FG001|Overall Study|Research Site Staff Relocation|3|||
156900931|NCT03109847|566396702|FG000|Overall Study|Withdrawal by Subject|1|||
156900932|NCT03109847|566396703|FG001|Overall Study|Withdrawal by Subject|0|||
156900933|NCT04209348|566396704|FG000|Overall Study|Lost to Follow-up|1|||
156900934|NCT04209348|566396705|FG001|Overall Study|Lost to Follow-up|0|||
156900935|NCT00747461|566396706|FG000|Overall Study|study terminated by sponsor|5|||
156900936|NCT02149875|566396707|FG000|Overall Study|Lost to Follow-up|3|||
156900937|NCT02149875|566396708|FG001|Overall Study|Lost to Follow-up|4|||
156900938|NCT02149875|566396709|FG002|Overall Study|Lost to Follow-up|5|||
156900939|NCT02149875|566396707|FG000|Overall Study|Withdrawal by Subject|3|||
156900940|NCT02149875|566396708|FG001|Overall Study|Withdrawal by Subject|2|||
156900941|NCT02149875|566396709|FG002|Overall Study|Withdrawal by Subject|2|||
156900942|NCT02149875|566396707|FG000|Overall Study|Physician Decision|1|||
157026394|NCT04032704|566851541|FG010|Part B|Withdrawal by Subject|4|||
157026395|NCT04032704|566851542|FG011|Part B|Withdrawal by Subject|6|||
156900943|NCT02149875|566396708|FG001|Overall Study|Physician Decision|2|||
156900944|NCT02149875|566396709|FG002|Overall Study|Physician Decision|2|||
156900945|NCT00771316|566396711|FG000|Overall Study|Adverse Event|0|||
156900946|NCT00771316|566396712|FG001|Overall Study|Adverse Event|1|||
156900947|NCT00771316|566396711|FG000|Overall Study|Patient withdrew consent|1|||
156900948|NCT00771316|566396712|FG001|Overall Study|Patient withdrew consent|0|||
156900949|NCT00771316|566396711|FG000|Overall Study|Discontinued due to early termination|1|||
157026396|NCT04032704|566851543|FG012|Part B|Withdrawal by Subject|2|||
156900950|NCT00771316|566396712|FG001|Overall Study|Discontinued due to early termination|0|||
156900951|NCT03131453|566396713|FG000|Overall Study|Study terminated by Sponsor|424|||
156900952|NCT03131453|566396714|FG001|Overall Study|Study terminated by Sponsor|222|||
156900953|NCT03131453|566396715|FG002|Overall Study|Study terminated by Sponsor|438|||
156900954|NCT03131453|566396713|FG000|Overall Study|Withdrawal by Subject|18|||
156900955|NCT03131453|566396714|FG001|Overall Study|Withdrawal by Subject|7|||
156900956|NCT03131453|566396715|FG002|Overall Study|Withdrawal by Subject|13|||
156900957|NCT03131453|566396713|FG000|Overall Study|Adverse Event|10|||
156900958|NCT03131453|566396714|FG001|Overall Study|Adverse Event|3|||
156900959|NCT03131453|566396715|FG002|Overall Study|Adverse Event|3|||
156900960|NCT03131453|566396713|FG000|Overall Study|Lost to Follow-up|1|||
156900961|NCT03131453|566396714|FG001|Overall Study|Lost to Follow-up|0|||
156900962|NCT03131453|566396715|FG002|Overall Study|Lost to Follow-up|1|||
156900963|NCT03131453|566396713|FG000|Overall Study|Physician Decision|1|||
156900964|NCT03131453|566396714|FG001|Overall Study|Physician Decision|0|||
156900965|NCT03131453|566396715|FG002|Overall Study|Physician Decision|1|||
156900966|NCT03131453|566396713|FG000|Overall Study|Non-compliance with study treatment|1|||
156900967|NCT03131453|566396714|FG001|Overall Study|Non-compliance with study treatment|0|||
156900968|NCT03131453|566396715|FG002|Overall Study|Non-compliance with study treatment|0|||
156900969|NCT03131453|566396713|FG000|Overall Study|Technical problems|1|||
156900970|NCT03131453|566396714|FG001|Overall Study|Technical problems|0|||
156900971|NCT03131453|566396715|FG002|Overall Study|Technical problems|0|||
156900972|NCT03131453|566396713|FG000|Overall Study|Protocol deviation|0|||
156900973|NCT03131453|566396714|FG001|Overall Study|Protocol deviation|1|||
156900974|NCT03131453|566396715|FG002|Overall Study|Protocol deviation|0|||
156900975|NCT02081183|566396716|FG000|Overall Study|Lost to Follow-up|0|||
156900976|NCT02081183|566396717|FG001|Overall Study|Lost to Follow-up|1|||
156900977|NCT02081183|566396716|FG000|Overall Study|Protocol Violation|1|||
156900978|NCT02081183|566396717|FG001|Overall Study|Protocol Violation|0|||
156900979|NCT02081183|566396716|FG000|Overall Study|Other|3|||
156900980|NCT02081183|566396717|FG001|Overall Study|Other|3|||
156900981|NCT04308304|566396718|FG000|Overall Study|Withdrawal by Subject|4|||
156900982|NCT04308304|566396719|FG001|Overall Study|Withdrawal by Subject|0|||
156900983|NCT04308304|566396718|FG000|Overall Study|Protocol Violation|1|||
156900984|NCT04308304|566396719|FG001|Overall Study|Protocol Violation|0|||
156900985|NCT05628103|566396725|FG000|Overall Study|Adverse Event|7|||
156900986|NCT05628103|566396725|FG000|Overall Study|Withdrawal by Subject|3|||
156900987|NCT05628103|566396725|FG000|Overall Study|Lost to Follow-up|3|||
156900988|NCT05628103|566396725|FG000|Overall Study|Lack of Efficacy|1|||
156900989|NCT05628103|566396725|FG000|Overall Study|Non-Compliance With Study Drug|4|||
156900990|NCT04840888|566396726|FG000|Period 1|Withdrawal by Subject|0|||
156900991|NCT04840888|566396727|FG001|Period 1|Withdrawal by Subject|0|||
156900992|NCT04840888|566396728|FG002|Period 1|Withdrawal by Subject|0|||
156900993|NCT04840888|566396729|FG003|Period 1|Withdrawal by Subject|0|||
156900994|NCT04840888|566396730|FG004|Period 1|Withdrawal by Subject|1|||
156900995|NCT04840888|566396731|FG005|Period 1|Withdrawal by Subject|0|||
156900996|NCT04840888|566396726|FG000|Period 1|Adverse Event|0|||
156900997|NCT04840888|566396727|FG001|Period 1|Adverse Event|0|||
156900998|NCT04840888|566396728|FG002|Period 1|Adverse Event|1|||
156900999|NCT04840888|566396729|FG003|Period 1|Adverse Event|1|||
156901000|NCT04840888|566396730|FG004|Period 1|Adverse Event|10|||
156901001|NCT04840888|566396731|FG005|Period 1|Adverse Event|1|||
156901002|NCT02719327|566396734|FG000|Overall Study|Withdrawal by Subject|11|||
156901003|NCT02719327|566396735|FG001|Overall Study|Withdrawal by Subject|8|||
156901004|NCT04340193|566396736|FG000|Overall Study|Other reason|0|||
156901005|NCT04340193|566396737|FG001|Overall Study|Other reason|0|||
156901006|NCT04340193|566396738|FG002|Overall Study|Other reason|1|||
156901007|NCT04340193|566396736|FG000|Overall Study|Disease recurrence|0|||
157026397|NCT04032704|566851544|FG013|Part B|Withdrawal by Subject|1|||
157026398|NCT04032704|566851545|FG014|Part B|Withdrawal by Subject|0|||
157026399|NCT04032704|566851546|FG015|Part B|Withdrawal by Subject|1|||
157026400|NCT04032704|566851547|FG016|Part B|Withdrawal by Subject|0|||
157026401|NCT04032704|566851548|FG017|Part B|Withdrawal by Subject|0|||
157026402|NCT04032704|566851531|FG000|Part B|Lost to Follow-up|0|||
157026403|NCT04032704|566851532|FG001|Part B|Lost to Follow-up|0|||
157026404|NCT04032704|566851533|FG002|Part B|Lost to Follow-up|0|||
156901008|NCT04340193|566396737|FG001|Overall Study|Disease recurrence|1|||
156901009|NCT04340193|566396738|FG002|Overall Study|Disease recurrence|0|||
157026405|NCT04032704|566851534|FG003|Part B|Lost to Follow-up|0|||
157158717|NCT04737031|567324687|FG002|Overall Study|Patients who did not have a treatment visit|93|||
156901010|NCT04340193|566396736|FG000|Overall Study|Study drug toxicity|1|||
156901011|NCT04340193|566396737|FG001|Overall Study|Study drug toxicity|0|||
156901012|NCT04340193|566396738|FG002|Overall Study|Study drug toxicity|0|||
156901013|NCT04340193|566396736|FG000|Overall Study|Disease progression|1|||
156901014|NCT04340193|566396737|FG001|Overall Study|Disease progression|2|||
156901015|NCT04340193|566396738|FG002|Overall Study|Disease progression|3|||
156901016|NCT04340193|566396736|FG000|Overall Study|Administrative reasons by sponsor|0|||
156901017|NCT04340193|566396737|FG001|Overall Study|Administrative reasons by sponsor|1|||
157026406|NCT04032704|566851535|FG004|Part B|Lost to Follow-up|0|||
157026407|NCT04032704|566851536|FG005|Part B|Lost to Follow-up|0|||
157158718|NCT04737031|567324688|FG003|Overall Study|Patients who did not have a treatment visit|227|||
157158719|NCT04369430|567324689|FG000|Overall Study|Adverse Event|2|||
157158720|NCT04369430|567324690|FG001|Overall Study|Adverse Event|3|||
157158721|NCT04369430|567324689|FG000|Overall Study|Death|1|||
157158722|NCT04369430|567324690|FG001|Overall Study|Death|0|||
157158723|NCT04369430|567324689|FG000|Overall Study|Withdrawal by Subject|4|||
157158724|NCT04369430|567324690|FG001|Overall Study|Withdrawal by Subject|3|||
157158725|NCT04369430|567324689|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
157158726|NCT04369430|567324690|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
157158727|NCT04369430|567324689|FG000|Overall Study|Lost to Follow-up|0|||
157158728|NCT04369430|567324690|FG001|Overall Study|Lost to Follow-up|1|||
157158729|NCT03453151|567324693|FG000|Overall Study|Withdrawal by Subject|1|||
157158730|NCT03453151|567324693|FG000|Overall Study|Physician Decision|3|||
157158731|NCT00142519|567324694|FG000|Overall Study|Not Treated|7|||
157158732|NCT00142519|567324695|FG001|Overall Study|Not Treated|9|||
157158733|NCT00142519|567324694|FG000|Overall Study|Protocol Violation|1|||
157158734|NCT00142519|567324695|FG001|Overall Study|Protocol Violation|0|||
157158735|NCT00142519|567324694|FG000|Overall Study|Withdrawal by Subject|10|||
157158736|NCT00142519|567324695|FG001|Overall Study|Withdrawal by Subject|7|||
157158737|NCT01468909|567324696|FG000|Overall Study|Never Treated|2|||
157158738|NCT01468909|567324697|FG001|Overall Study|Never Treated|2|||
157158739|NCT03229759|567324703|FG000|Overall Study|Screen Failure|30|||
157158740|NCT02020031|567326746|FG000|Overall Study|Physician Decision|1|||
157158741|NCT02020031|567326747|FG001|Overall Study|Physician Decision|1|||
157158742|NCT00755846|567326750|FG000|Overall Study|Adverse Event|0|||
157158743|NCT00755846|567326751|FG001|Overall Study|Adverse Event|0|||
157158744|NCT00755846|567326752|FG002|Overall Study|Adverse Event|0|||
157158745|NCT00755846|567326753|FG003|Overall Study|Adverse Event|1|||
157158746|NCT00755846|567326754|FG004|Overall Study|Adverse Event|3|||
157158747|NCT00755846|567326755|FG005|Overall Study|Adverse Event|2|||
157158748|NCT00755846|567326750|FG000|Overall Study|Protocol Violation|1|||
157158749|NCT00755846|567326751|FG001|Overall Study|Protocol Violation|1|||
157158750|NCT00755846|567326752|FG002|Overall Study|Protocol Violation|1|||
157158751|NCT00755846|567326753|FG003|Overall Study|Protocol Violation|1|||
157158752|NCT00755846|567326754|FG004|Overall Study|Protocol Violation|1|||
157158753|NCT00755846|567326755|FG005|Overall Study|Protocol Violation|1|||
156901018|NCT04340193|566396738|FG002|Overall Study|Administrative reasons by sponsor|0|||
156901019|NCT04340193|566396736|FG000|Overall Study|Adverse Event|1|||
156901020|NCT04340193|566396737|FG001|Overall Study|Adverse Event|1|||
156901021|NCT04340193|566396738|FG002|Overall Study|Adverse Event|0|||
156901022|NCT04063384|566398330|FG000|Overall Study|placebo manipulation issue|1|||
156901023|NCT04063384|566398331|FG001|Overall Study|placebo manipulation issue|2|||
156901024|NCT04063384|566398332|FG002|Overall Study|placebo manipulation issue|1|||
156901025|NCT04063384|566398333|FG003|Overall Study|placebo manipulation issue|1|||
156901026|NCT04195906|566398334|FG000|Part 1|Adverse Event|3|||
156901027|NCT04195906|566398335|FG001|Part 1|Adverse Event|7|||
156901028|NCT04195906|566398334|FG000|Part 1|Withdrawal by Subject|0|||
156901029|NCT04195906|566398335|FG001|Part 1|Withdrawal by Subject|1|||
156901030|NCT04195906|566398334|FG000|Part 2|Adverse Event|1|||
156901031|NCT04195906|566398335|FG001|Part 2|Adverse Event|1|||
156901032|NCT04195906|566398334|FG000|Part 2|Withdrawal by Subject|0|||
156901033|NCT04195906|566398335|FG001|Part 2|Withdrawal by Subject|3|||
156901034|NCT04195906|566398334|FG000|Part 2|Other|1|||
156901035|NCT04195906|566398335|FG001|Part 2|Other|3|||
156901036|NCT01926015|566398339|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156901037|NCT01926015|566398340|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156901038|NCT01926015|566398339|FG000|Overall Study|Randomized not treated|2|||
156901039|NCT01926015|566398340|FG001|Overall Study|Randomized not treated|0|||
156901040|NCT01364649|566398341|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
156901041|NCT01364649|566398342|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
156901042|NCT01364649|566398341|FG000|Overall Study|Lack of Efficacy|6|||
156901043|NCT01364649|566398342|FG001|Overall Study|Lack of Efficacy|0|||
156901044|NCT01364649|566398341|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
157158754|NCT00755846|567326750|FG000|Overall Study|Lost to Follow-up|0|||
157158755|NCT00755846|567326751|FG001|Overall Study|Lost to Follow-up|2|||
157158756|NCT00755846|567326752|FG002|Overall Study|Lost to Follow-up|1|||
157158757|NCT00755846|567326753|FG003|Overall Study|Lost to Follow-up|0|||
156901045|NCT01364649|566398342|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
156901046|NCT01364649|566398341|FG000|Overall Study|Protocol Deviations|4|||
156901047|NCT01364649|566398342|FG001|Overall Study|Protocol Deviations|8|||
157158758|NCT00755846|567326754|FG004|Overall Study|Lost to Follow-up|4|||
157158759|NCT00755846|567326755|FG005|Overall Study|Lost to Follow-up|2|||
157158760|NCT00755846|567326750|FG000|Overall Study|Withdrawal by Subject|2|||
156901048|NCT01364649|566398341|FG000|Overall Study|Withdrawal of Consent|9|||
156901049|NCT01364649|566398342|FG001|Overall Study|Withdrawal of Consent|7|||
156901050|NCT01364649|566398341|FG000|Overall Study|Lost to Follow-up|12|||
156901051|NCT01364649|566398342|FG001|Overall Study|Lost to Follow-up|13|||
157158761|NCT00755846|567326751|FG001|Overall Study|Withdrawal by Subject|3|||
157158762|NCT00755846|567326752|FG002|Overall Study|Withdrawal by Subject|5|||
156901052|NCT01364649|566398341|FG000|Overall Study|Other|4|||
156901053|NCT01364649|566398342|FG001|Overall Study|Other|1|||
156901054|NCT02468232|566398343|FG000|Core Part of Study|Adverse Event|0|||
156901055|NCT02468232|566398344|FG001|Core Part of Study|Adverse Event|1|||
156901056|NCT02468232|566398345|FG002|Core Part of Study|Adverse Event|0|||
156901057|NCT02468232|566398346|FG003|Core Part of Study|Adverse Event|0|||
156901058|NCT02468232|566398343|FG000|Core Part of Study|Death|20|||
156901059|NCT02468232|566398344|FG001|Core Part of Study|Death|17|||
156901060|NCT02468232|566398345|FG002|Core Part of Study|Death|0|||
156901061|NCT02468232|566398346|FG003|Core Part of Study|Death|0|||
156901062|NCT02468232|566398343|FG000|Core Part of Study|Technical Problems|1|||
156901063|NCT02468232|566398344|FG001|Core Part of Study|Technical Problems|1|||
156901064|NCT02468232|566398345|FG002|Core Part of Study|Technical Problems|0|||
156901065|NCT02468232|566398346|FG003|Core Part of Study|Technical Problems|0|||
156901066|NCT02468232|566398343|FG000|OLE Part of Study|Adverse Event|0|||
156901067|NCT02468232|566398344|FG001|OLE Part of Study|Adverse Event|0|||
156901068|NCT02468232|566398345|FG002|OLE Part of Study|Adverse Event|4|||
156901069|NCT02468232|566398346|FG003|OLE Part of Study|Adverse Event|5|||
156901070|NCT02468232|566398343|FG000|OLE Part of Study|Death|0|||
156901071|NCT02468232|566398344|FG001|OLE Part of Study|Death|0|||
156901072|NCT02468232|566398345|FG002|OLE Part of Study|Death|4|||
156901073|NCT02468232|566398346|FG003|OLE Part of Study|Death|2|||
156901074|NCT02468232|566398343|FG000|OLE Part of Study|Physician Decision|0|||
156901075|NCT02468232|566398344|FG001|OLE Part of Study|Physician Decision|0|||
156901076|NCT02468232|566398345|FG002|OLE Part of Study|Physician Decision|4|||
156901077|NCT02468232|566398346|FG003|OLE Part of Study|Physician Decision|0|||
156901078|NCT02468232|566398343|FG000|OLE Part of Study|Subject/Guardian decision|0|||
156901079|NCT02468232|566398344|FG001|OLE Part of Study|Subject/Guardian decision|0|||
156901080|NCT02468232|566398345|FG002|OLE Part of Study|Subject/Guardian decision|2|||
156901081|NCT02468232|566398346|FG003|OLE Part of Study|Subject/Guardian decision|5|||
156901082|NCT01826604|566398347|FG000|Overall Study|Lost to Follow-up|8|||
156901083|NCT01826604|566398348|FG001|Overall Study|Lost to Follow-up|9|||
156901084|NCT04540497|566398351|FG000|Overall Study|Adverse Event|0|||
156901085|NCT04540497|566398352|FG001|Overall Study|Adverse Event|2|||
156901086|NCT04540497|566398351|FG000|Overall Study|Lost to Follow-up|1|||
156901087|NCT04540497|566398352|FG001|Overall Study|Lost to Follow-up|0|||
156901088|NCT04540497|566398351|FG000|Overall Study|Withdrawal by Subject|1|||
156901089|NCT04540497|566398352|FG001|Overall Study|Withdrawal by Subject|1|||
156901090|NCT04540497|566398351|FG000|Overall Study|Miscellaneous|2|||
156901091|NCT04540497|566398352|FG001|Overall Study|Miscellaneous|1|||
156901092|NCT06132659|566398353|FG000|Overall Study|Lost to Follow-up|0|||
156901093|NCT06132659|566398354|FG001|Overall Study|Lost to Follow-up|1|||
156901094|NCT06132659|566398355|FG002|Overall Study|Lost to Follow-up|0|||
156901095|NCT03914326|566398356|FG000|Overall Study|Withdrawal by Subject|27|||
156901096|NCT03914326|566398357|FG001|Overall Study|Withdrawal by Subject|34|||
156901097|NCT03914326|566398356|FG000|Overall Study|Lost to Follow-up|43|||
156901098|NCT03914326|566398357|FG001|Overall Study|Lost to Follow-up|51|||
156901099|NCT03914326|566398356|FG000|Overall Study|Randomised more than once|0|||
156901100|NCT03914326|566398357|FG001|Overall Study|Randomised more than once|1|||
156901101|NCT03794583|566398358|FG000|Overall Study|Death|8|||
156901102|NCT03794583|566398358|FG000|Overall Study|Study Terminated by Sponsor|24|||
156901103|NCT03794583|566398358|FG000|Overall Study|Withdrawal by Subject|9|||
156901104|NCT04798781|566398359|FG000|Overall Study|Withdrawal by Subject|1|||
156901105|NCT02497612|566398361|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
156901106|NCT02497612|566398362|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
156901107|NCT02497612|566398363|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
156901108|NCT02497612|566398364|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
156901109|NCT02497612|566398361|FG000|Overall Study|Participant's request|2|||
156901110|NCT02497612|566398362|FG001|Overall Study|Participant's request|3|||
156901111|NCT02497612|566398363|FG002|Overall Study|Participant's request|4|||
156901112|NCT02497612|566398364|FG003|Overall Study|Participant's request|1|||
156901113|NCT02497612|566398361|FG000|Overall Study|Investigator's judgement|1|||
156901114|NCT02497612|566398362|FG001|Overall Study|Investigator's judgement|0|||
156901115|NCT02497612|566398363|FG002|Overall Study|Investigator's judgement|0|||
156901116|NCT02497612|566398364|FG003|Overall Study|Investigator's judgement|2|||
156901117|NCT02497612|566398361|FG000|Overall Study|Adverse Event|3|||
156901118|NCT02497612|566398362|FG001|Overall Study|Adverse Event|1|||
156901119|NCT02497612|566398363|FG002|Overall Study|Adverse Event|4|||
156901120|NCT02497612|566398364|FG003|Overall Study|Adverse Event|1|||
157026408|NCT04032704|566851537|FG006|Part B|Lost to Follow-up|0|||
157026409|NCT04032704|566851538|FG007|Part B|Lost to Follow-up|0|||
157026410|NCT04032704|566851539|FG008|Part B|Lost to Follow-up|0|||
156901121|NCT02497612|566398361|FG000|Overall Study|Lost to Follow-up|1|||
156901122|NCT02497612|566398362|FG001|Overall Study|Lost to Follow-up|1|||
156901123|NCT02497612|566398363|FG002|Overall Study|Lost to Follow-up|0|||
156901124|NCT02497612|566398364|FG003|Overall Study|Lost to Follow-up|1|||
156901125|NCT02497612|566398361|FG000|Overall Study|Other unspecified|1|||
156901126|NCT02497612|566398362|FG001|Overall Study|Other unspecified|1|||
157026411|NCT04032704|566851540|FG009|Part B|Lost to Follow-up|0|||
156901127|NCT02497612|566398363|FG002|Overall Study|Other unspecified|2|||
156901128|NCT02497612|566398364|FG003|Overall Study|Other unspecified|0|||
156901129|NCT02497612|566398361|FG000|Overall Study|Not eligible|1|||
156901130|NCT02497612|566398362|FG001|Overall Study|Not eligible|0|||
156901131|NCT02497612|566398363|FG002|Overall Study|Not eligible|0|||
156901132|NCT02497612|566398364|FG003|Overall Study|Not eligible|1|||
156901133|NCT00902668|566398365|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
156901134|NCT01914757|566398366|FG000|Overall Study|Severe non-compliance to protocol|3|||
156901135|NCT01914757|566398367|FG001|Overall Study|Severe non-compliance to protocol|1|||
156901136|NCT01914757|566398368|FG002|Overall Study|Severe non-compliance to protocol|2|||
156901137|NCT01914757|566398366|FG000|Overall Study|Lost to Follow-up|5|||
156901138|NCT01914757|566398367|FG001|Overall Study|Lost to Follow-up|8|||
156901139|NCT01914757|566398368|FG002|Overall Study|Lost to Follow-up|6|||
156901140|NCT01914757|566398366|FG000|Overall Study|Withdrawal by Subject|15|||
156901141|NCT01914757|566398367|FG001|Overall Study|Withdrawal by Subject|27|||
156901142|NCT01914757|566398368|FG002|Overall Study|Withdrawal by Subject|19|||
156901143|NCT01914757|566398366|FG000|Overall Study|Death|2|||
156901144|NCT01914757|566398367|FG001|Overall Study|Death|2|||
156901145|NCT01914757|566398368|FG002|Overall Study|Death|1|||
156901146|NCT01914757|566398366|FG000|Overall Study|Adverse Event|4|||
156901147|NCT01914757|566398367|FG001|Overall Study|Adverse Event|3|||
156901148|NCT01914757|566398368|FG002|Overall Study|Adverse Event|4|||
156901149|NCT01914757|566398366|FG000|Overall Study|Study specific withdrawal criteria|0|||
156901150|NCT01914757|566398367|FG001|Overall Study|Study specific withdrawal criteria|1|||
156901151|NCT01914757|566398368|FG002|Overall Study|Study specific withdrawal criteria|0|||
156901152|NCT01914757|566398366|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156901153|NCT01914757|566398367|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156901154|NCT01914757|566398368|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
156901155|NCT01914757|566398366|FG000|Overall Study|Other reasons|5|||
156901156|NCT01914757|566398367|FG001|Overall Study|Other reasons|9|||
156901157|NCT01914757|566398368|FG002|Overall Study|Other reasons|4|||
156901158|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
156901159|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
156901160|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
156901161|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
156901162|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
156901163|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
156901164|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
156901165|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
156901166|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
156901167|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
156901168|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
156901169|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
156901170|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
156901171|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
156901172|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
156901173|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
156901174|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
156901175|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
156901176|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
156901177|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
156901178|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
156901179|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
156901180|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
156901181|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
156901182|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Death|2|||
156901183|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Death|1|||
156901184|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Death|0|||
156901185|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Death|0|||
156901186|NCT02607930|566398369|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
156901187|NCT02607930|566398370|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156901188|NCT02607930|566398371|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156901189|NCT02607930|566398372|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
156901190|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156901191|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
156901192|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
156901193|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
156901194|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
156901195|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
156901196|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
156901197|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
157158763|NCT00755846|567326753|FG003|Overall Study|Withdrawal by Subject|2|||
157158764|NCT00755846|567326754|FG004|Overall Study|Withdrawal by Subject|0|||
157158765|NCT00755846|567326755|FG005|Overall Study|Withdrawal by Subject|1|||
157158766|NCT00755846|567326750|FG000|Overall Study|Hyperglycemic Rescue|21|||
157158767|NCT00755846|567326751|FG001|Overall Study|Hyperglycemic Rescue|7|||
157158768|NCT00755846|567326752|FG002|Overall Study|Hyperglycemic Rescue|5|||
157158769|NCT00755846|567326753|FG003|Overall Study|Hyperglycemic Rescue|8|||
157158770|NCT00755846|567326754|FG004|Overall Study|Hyperglycemic Rescue|8|||
157158771|NCT00755846|567326755|FG005|Overall Study|Hyperglycemic Rescue|7|||
157158772|NCT00755846|567326750|FG000|Overall Study|Physician Decision|1|||
157158773|NCT00755846|567326751|FG001|Overall Study|Physician Decision|3|||
157158774|NCT00755846|567326752|FG002|Overall Study|Physician Decision|0|||
157158775|NCT00755846|567326753|FG003|Overall Study|Physician Decision|1|||
157158776|NCT00755846|567326754|FG004|Overall Study|Physician Decision|0|||
156901198|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
156901199|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
156901200|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
156901201|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
156901202|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
156901203|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
156901204|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
156901205|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
156901206|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
156901207|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
156901208|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
156901209|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
156901210|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
156901211|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
156901212|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
156901213|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
156901214|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
156901215|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
156901216|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
156901217|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
156901218|NCT02607930|566398369|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156901219|NCT02607930|566398370|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156901220|NCT02607930|566398371|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
156901221|NCT02607930|566398372|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
156901222|NCT00722423|566398373|FG000|Overall Study|Protocol Violation|0|||
156901223|NCT00722423|566398374|FG001|Overall Study|Protocol Violation|1|||
156901224|NCT02083081|566398386|FG000|Overall Study|Lost to Follow-up|31|||
156901225|NCT02083081|566398387|FG001|Overall Study|Lost to Follow-up|9|||
156901226|NCT01230710|566398390|FG000|Overall Study|Disease Progression|41|||
156901227|NCT01230710|566398390|FG000|Overall Study|Lost to Follow-up|3|||
156901228|NCT01230710|566398390|FG000|Overall Study|Death|4|||
156901229|NCT01230710|566398390|FG000|Overall Study|Withdrawal of Consent|1|||
156901230|NCT04043728|566398398|FG000|Overall Study|Lost to Follow-up|1|||
156901231|NCT04043728|566398399|FG001|Overall Study|Lost to Follow-up|2|||
156901232|NCT04043728|566398400|FG002|Overall Study|Lost to Follow-up|0|||
156901233|NCT03841448|566398401|FG000|Double-blind Treatment (DBT) Period|Death|1|||
156901234|NCT03841448|566398402|FG001|Double-blind Treatment (DBT) Period|Death|1|||
156901235|NCT03841448|566398403|FG002|Double-blind Treatment (DBT) Period|Death|0|||
156901236|NCT03841448|566398404|FG003|Double-blind Treatment (DBT) Period|Death|0|||
156901237|NCT03841448|566398401|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
156901238|NCT03841448|566398402|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
156901239|NCT03841448|566398403|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
156901240|NCT03841448|566398404|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
156901241|NCT03841448|566398401|FG000|Open-Label Extension (OLE) Period|Death|0|||
156901242|NCT03841448|566398402|FG001|Open-Label Extension (OLE) Period|Death|0|||
156901243|NCT03841448|566398403|FG002|Open-Label Extension (OLE) Period|Death|0|||
156901244|NCT03841448|566398404|FG003|Open-Label Extension (OLE) Period|Death|1|||
156901245|NCT03841448|566398401|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
156901246|NCT03841448|566398402|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
156901247|NCT03841448|566398403|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
156901248|NCT03841448|566398404|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
156901249|NCT03841448|566398401|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
156901250|NCT03841448|566398402|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
156901251|NCT03841448|566398403|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
157158777|NCT00755846|567326755|FG005|Overall Study|Physician Decision|1|||
157158778|NCT00755846|567326750|FG000|Overall Study|Administrative Error|0|||
157225519|NCT01659567|567571457|FG000|Overall Study|Switched to Pegferon|6|||
157225520|NCT01659567|567571457|FG000|Overall Study|Adverse Event|12|||
157158779|NCT00755846|567326751|FG001|Overall Study|Administrative Error|1|||
157158780|NCT00755846|567326752|FG002|Overall Study|Administrative Error|0|||
157158781|NCT00755846|567326753|FG003|Overall Study|Administrative Error|0|||
157158782|NCT00755846|567326754|FG004|Overall Study|Administrative Error|0|||
156901252|NCT03841448|566398404|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
156901253|NCT03841448|566398401|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
156901254|NCT03841448|566398402|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
156901255|NCT03841448|566398403|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
156901256|NCT03841448|566398404|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
156901257|NCT00165984|566398405|FG000|Overall Study|Death|15|||
156901258|NCT02649894|566398406|FG000|Overall Study|Adverse Event|1|||
156901259|NCT02649894|566398407|FG001|Overall Study|Adverse Event|0|||
156901260|NCT02649894|566398406|FG000|Overall Study|Physician Decision|0|||
156901261|NCT02649894|566398407|FG001|Overall Study|Physician Decision|1|||
156901262|NCT02649894|566398406|FG000|Overall Study|Withdrawal by Subject|5|||
156901263|NCT02649894|566398407|FG001|Overall Study|Withdrawal by Subject|2|||
156901264|NCT02649894|566398406|FG000|Overall Study|Lost to Follow-up|2|||
156901265|NCT02649894|566398407|FG001|Overall Study|Lost to Follow-up|1|||
156901266|NCT02649894|566398406|FG000|Overall Study|Death|30|||
156901267|NCT02649894|566398407|FG001|Overall Study|Death|7|||
156901268|NCT02649894|566398406|FG000|Overall Study|Other, not specified|6|||
156901269|NCT02649894|566398407|FG001|Overall Study|Other, not specified|0|||
156901270|NCT01686828|566398408|FG000|Overall Study|Physician Decision|1|||
156901271|NCT01686828|566398409|FG001|Overall Study|Physician Decision|0|||
156901272|NCT01686828|566398410|FG002|Overall Study|Physician Decision|0|||
156901273|NCT01686828|566398411|FG003|Overall Study|Physician Decision|0|||
156901274|NCT01686828|566398408|FG000|Overall Study|New Job|0|||
156901275|NCT01686828|566398409|FG001|Overall Study|New Job|1|||
156901276|NCT01686828|566398410|FG002|Overall Study|New Job|0|||
156901277|NCT01686828|566398411|FG003|Overall Study|New Job|0|||
156901278|NCT01686828|566398408|FG000|Overall Study|Weight Loss|0|||
156901279|NCT01686828|566398409|FG001|Overall Study|Weight Loss|0|||
156901280|NCT01686828|566398410|FG002|Overall Study|Weight Loss|1|||
156901281|NCT01686828|566398411|FG003|Overall Study|Weight Loss|0|||
156901282|NCT04430738|566398414|FG000|Phase 1: Dose Escalation|Death|1|||
156901283|NCT04430738|566398415|FG001|Phase 1: Dose Escalation|Death|4|||
156901284|NCT04430738|566398416|FG002|Phase 1: Dose Escalation|Death|4|||
156901285|NCT04430738|566398417|FG003|Phase 1: Dose Escalation|Death|1|||
156901286|NCT04430738|566398418|FG004|Phase 1: Dose Escalation|Death|6|||
156901287|NCT04430738|566398419|FG005|Phase 1: Dose Escalation|Death|0|||
156901288|NCT04430738|566398414|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
156901289|NCT04430738|566398415|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156901290|NCT04430738|566398416|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
156901291|NCT04430738|566398417|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156901292|NCT04430738|566398418|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
156901293|NCT04430738|566398419|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
156901294|NCT04430738|566398414|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156901295|NCT04430738|566398415|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
156901296|NCT04430738|566398416|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156901297|NCT04430738|566398417|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
156901298|NCT04430738|566398418|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156901299|NCT04430738|566398419|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
156901300|NCT04430738|566398414|FG000|Phase 1: Dose Escalation|Other|1|||
156901301|NCT04430738|566398415|FG001|Phase 1: Dose Escalation|Other|0|||
156901302|NCT04430738|566398416|FG002|Phase 1: Dose Escalation|Other|0|||
156901303|NCT04430738|566398417|FG003|Phase 1: Dose Escalation|Other|0|||
156901304|NCT04430738|566398418|FG004|Phase 1: Dose Escalation|Other|0|||
156901305|NCT04430738|566398419|FG005|Phase 1: Dose Escalation|Other|0|||
156901306|NCT04430738|566398414|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
157026412|NCT04032704|566851541|FG010|Part B|Lost to Follow-up|0|||
157026413|NCT04032704|566851542|FG011|Part B|Lost to Follow-up|1|||
157158783|NCT00755846|567326755|FG005|Overall Study|Administrative Error|0|||
157158784|NCT00755846|567326750|FG000|Overall Study|Participant Non-compliance|0|||
157158785|NCT00755846|567326751|FG001|Overall Study|Participant Non-compliance|0|||
157158786|NCT00755846|567326752|FG002|Overall Study|Participant Non-compliance|0|||
157158787|NCT00755846|567326753|FG003|Overall Study|Participant Non-compliance|0|||
157158788|NCT00755846|567326754|FG004|Overall Study|Participant Non-compliance|1|||
156901307|NCT04430738|566398415|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156901308|NCT04430738|566398416|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156901309|NCT04430738|566398417|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
156901310|NCT04430738|566398418|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
157026414|NCT04032704|566851543|FG012|Part B|Lost to Follow-up|0|||
157158789|NCT00755846|567326755|FG005|Overall Study|Participant Non-compliance|0|||
157158790|NCT02723604|567326768|FG000|Overall Study|ineligible|1|||
156901311|NCT04430738|566398419|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
156901312|NCT04430738|566398414|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156901313|NCT04430738|566398415|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156901314|NCT04430738|566398416|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156901315|NCT04430738|566398417|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156901316|NCT04430738|566398418|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
156901317|NCT04430738|566398419|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
156901318|NCT01736124|566398420|FG000|Post-intervention Assessment|Death|2|||
156901319|NCT01736124|566398421|FG001|Post-intervention Assessment|Death|2|||
156901320|NCT01736124|566398420|FG000|Post-intervention Assessment|lost computer access|1|||
156901321|NCT01736124|566398421|FG001|Post-intervention Assessment|lost computer access|1|||
156901322|NCT01736124|566398420|FG000|Post-intervention Assessment|Moved away|3|||
156901323|NCT01736124|566398421|FG001|Post-intervention Assessment|Moved away|1|||
156901324|NCT01736124|566398420|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
156901325|NCT01736124|566398421|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
156901326|NCT01736124|566398420|FG000|Post-intervention Assessment|Illness|3|||
156901327|NCT01736124|566398421|FG001|Post-intervention Assessment|Illness|2|||
156901328|NCT01736124|566398420|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
156901329|NCT01736124|566398421|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
156901330|NCT01736124|566398420|FG000|Post-intervention Assessment|Temporarily away|3|||
156901331|NCT01736124|566398421|FG001|Post-intervention Assessment|Temporarily away|1|||
156901332|NCT01736124|566398420|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
156901333|NCT01736124|566398421|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
156901334|NCT01736124|566398420|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
156901335|NCT01736124|566398421|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
156901336|NCT01736124|566398420|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
156901337|NCT01736124|566398421|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
156901338|NCT01736124|566398420|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
156901339|NCT01736124|566398421|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
156901340|NCT01736124|566398420|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
156901341|NCT01736124|566398421|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
156901342|NCT01736124|566398420|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
156901343|NCT01736124|566398421|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
156901344|NCT01736124|566398420|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
156901345|NCT01736124|566398421|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
156901346|NCT01736124|566398420|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
156901347|NCT01736124|566398421|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
156901348|NCT01736124|566398420|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
156901349|NCT01736124|566398421|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
156901350|NCT04176705|566398422|FG000|Overall Study|Withdrawal by Subject|4|||
156901351|NCT04176705|566398423|FG001|Overall Study|Withdrawal by Subject|4|||
156901352|NCT04176705|566398422|FG000|Overall Study|Death|1|||
156901353|NCT04176705|566398423|FG001|Overall Study|Death|1|||
156901354|NCT04176705|566398422|FG000|Overall Study|Lost to Follow-up|3|||
156901355|NCT04176705|566398423|FG001|Overall Study|Lost to Follow-up|3|||
156901356|NCT00309985|566398425|FG000|Overall Study|Disease progression|12|||
156901357|NCT00309985|566398426|FG001|Overall Study|Disease progression|0|||
156901358|NCT00309985|566398425|FG000|Overall Study|Adverse Event|30|||
156901359|NCT00309985|566398426|FG001|Overall Study|Adverse Event|0|||
156901360|NCT00309985|566398425|FG000|Overall Study|Death|2|||
156901361|NCT00309985|566398426|FG001|Overall Study|Death|0|||
156901362|NCT00309985|566398425|FG000|Overall Study|Withdrawal by Subject|5|||
156901363|NCT00309985|566398426|FG001|Overall Study|Withdrawal by Subject|1|||
156901364|NCT00309985|566398425|FG000|Overall Study|Physician Decision|3|||
156901365|NCT00309985|566398426|FG001|Overall Study|Physician Decision|0|||
156901366|NCT00309985|566398425|FG000|Overall Study|Never started treatment|7|||
156901367|NCT00309985|566398426|FG001|Overall Study|Never started treatment|0|||
156901368|NCT00309985|566398425|FG000|Overall Study|Complicating disease|1|||
156901369|NCT00309985|566398426|FG001|Overall Study|Complicating disease|0|||
156901370|NCT00309985|566398425|FG000|Overall Study|Non-compliance|1|||
156901371|NCT00309985|566398426|FG001|Overall Study|Non-compliance|0|||
156901372|NCT00309985|566398425|FG000|Overall Study|Chemotherapy discontinued only|1|||
156901373|NCT00309985|566398426|FG001|Overall Study|Chemotherapy discontinued only|0|||
156901374|NCT03659916|566398427|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
156901375|NCT03659916|566398428|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
156901376|NCT03659916|566398429|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
156901377|NCT03659916|566398427|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
156901378|NCT03659916|566398428|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
156901379|NCT03659916|566398429|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
156901380|NCT03659916|566398427|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
156901381|NCT03659916|566398428|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
156901382|NCT03659916|566398429|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
156901383|NCT03659916|566398427|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
156901384|NCT03659916|566398428|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
156901385|NCT03659916|566398429|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
156901386|NCT03659916|566398427|FG000|Treatment Period (72 Weeks)|Other|1|||
156901387|NCT03659916|566398428|FG001|Treatment Period (72 Weeks)|Other|3|||
156901388|NCT03659916|566398429|FG002|Treatment Period (72 Weeks)|Other|9|||
156901389|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
156901390|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
156901391|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
156901392|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
156901393|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
156901394|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
156901395|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
156901396|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
156901397|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
156901398|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
156901399|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
156901400|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
156901401|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
156901402|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
156901403|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
156901404|NCT03659916|566398427|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
156901405|NCT03659916|566398428|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
156901406|NCT03659916|566398429|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
156901407|NCT04941456|566398430|FG000|Overall Study|Withdrawal by Subject|1|||
156901408|NCT04941456|566398431|FG001|Overall Study|Withdrawal by Subject|0|||
156901409|NCT04941456|566398430|FG000|Overall Study|Protocol Violation|1|||
156901410|NCT04941456|566398431|FG001|Overall Study|Protocol Violation|0|||
156901411|NCT02296684|566398432|FG000|Overall Study|Withdrawal by Subject|0|||
156901412|NCT02296684|566398433|FG001|Overall Study|Withdrawal by Subject|1|||
156901413|NCT02296684|566398434|FG002|Overall Study|Withdrawal by Subject|1|||
156901414|NCT02296684|566398432|FG000|Overall Study|Death|2|||
156901415|NCT02296684|566398433|FG001|Overall Study|Death|0|||
156901416|NCT02296684|566398434|FG002|Overall Study|Death|0|||
156901417|NCT04026711|566398435|FG000|Overall Study|Withdrawal by Subject|1|||
156901418|NCT04026711|566398436|FG001|Overall Study|Withdrawal by Subject|0|||
156901419|NCT04026711|566398435|FG000|Overall Study|mental health crisis|1|||
156901420|NCT04026711|566398436|FG001|Overall Study|mental health crisis|0|||
156901421|NCT05741528|566398437|FG000|Overall Study|Withdrawal by Subject|11|||
156901422|NCT05741528|566398437|FG000|Overall Study|Lost to Follow-up|3|||
156901423|NCT05741528|566398437|FG000|Overall Study|Adverse Event|2|||
156901424|NCT05741528|566398437|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156901425|NCT05741528|566398437|FG000|Overall Study|Reason Not Specified|1|||
156901426|NCT04823650|566398438|FG000|Overall Study|Withdrawal by Subject|0|||
156901427|NCT04823650|566398439|FG001|Overall Study|Withdrawal by Subject|0|||
156901428|NCT04823650|566398440|FG002|Overall Study|Withdrawal by Subject|0|||
156901429|NCT04823650|566398441|FG003|Overall Study|Withdrawal by Subject|0|||
156901430|NCT04823650|566398442|FG004|Overall Study|Withdrawal by Subject|1|||
156901431|NCT04823650|566398443|FG005|Overall Study|Withdrawal by Subject|0|||
156901432|NCT01314703|566399647|FG000|Overall Study|screen failure and closed enrollment|8|||
156901433|NCT02281773|566399653|FG000|Overall Study|Adverse Event|6|||
156901434|NCT02281773|566399654|FG001|Overall Study|Adverse Event|1|||
156901435|NCT02281773|566399655|FG002|Overall Study|Adverse Event|4|||
156901436|NCT02281773|566399656|FG003|Overall Study|Adverse Event|8|||
156901437|NCT02281773|566399657|FG004|Overall Study|Adverse Event|9|||
156901438|NCT02281773|566399653|FG000|Overall Study|Protocol Violation|1|||
156901439|NCT02281773|566399654|FG001|Overall Study|Protocol Violation|0|||
156901440|NCT02281773|566399655|FG002|Overall Study|Protocol Violation|0|||
156901441|NCT02281773|566399656|FG003|Overall Study|Protocol Violation|2|||
156901442|NCT02281773|566399657|FG004|Overall Study|Protocol Violation|2|||
156901443|NCT02281773|566399653|FG000|Overall Study|Lost to Follow-up|2|||
156901444|NCT02281773|566399654|FG001|Overall Study|Lost to Follow-up|2|||
156901445|NCT02281773|566399655|FG002|Overall Study|Lost to Follow-up|6|||
156901446|NCT02281773|566399656|FG003|Overall Study|Lost to Follow-up|2|||
156901447|NCT02281773|566399657|FG004|Overall Study|Lost to Follow-up|10|||
156901448|NCT02281773|566399653|FG000|Overall Study|Withdrawal by Subject|2|||
156901449|NCT02281773|566399654|FG001|Overall Study|Withdrawal by Subject|8|||
156901450|NCT02281773|566399655|FG002|Overall Study|Withdrawal by Subject|6|||
157026415|NCT04032704|566851544|FG013|Part B|Lost to Follow-up|0|||
157026416|NCT04032704|566851545|FG014|Part B|Lost to Follow-up|0|||
156901451|NCT02281773|566399656|FG003|Overall Study|Withdrawal by Subject|6|||
156901452|NCT02281773|566399657|FG004|Overall Study|Withdrawal by Subject|8|||
156901453|NCT02281773|566399653|FG000|Overall Study|Other Reason|0|||
156901454|NCT02281773|566399654|FG001|Overall Study|Other Reason|4|||
156901455|NCT02281773|566399655|FG002|Overall Study|Other Reason|2|||
156901456|NCT02281773|566399656|FG003|Overall Study|Other Reason|3|||
156901457|NCT02281773|566399657|FG004|Overall Study|Other Reason|1|||
156901458|NCT00385762|566399658|FG000|Overall Study|Adverse Event|1|||
156901459|NCT00385762|566399658|FG000|Overall Study|Lost to Follow-up|1|||
156901460|NCT00573183|566399659|FG000|Overall Study|Lost to Follow-up|52|||
156901461|NCT00573183|566399660|FG001|Overall Study|Lost to Follow-up|50|||
156901462|NCT00573183|566399659|FG000|Overall Study|Withdrawal by Subject|8|||
156901463|NCT00573183|566399660|FG001|Overall Study|Withdrawal by Subject|2|||
156901464|NCT00573183|566399659|FG000|Overall Study|Death|0|||
156901465|NCT00573183|566399660|FG001|Overall Study|Death|1|||
156901466|NCT00573183|566399659|FG000|Overall Study|Adverse Event|2|||
156901467|NCT00573183|566399660|FG001|Overall Study|Adverse Event|0|||
156901468|NCT00573183|566399659|FG000|Overall Study|Incarceration|5|||
156901469|NCT00573183|566399660|FG001|Overall Study|Incarceration|8|||
156901470|NCT00573183|566399659|FG000|Overall Study|Other|5|||
156901471|NCT00573183|566399660|FG001|Overall Study|Other|2|||
156901472|NCT05439941|566399661|FG000|Overall Study|Lack of Efficacy|8|||
156901473|NCT05439941|566399662|FG001|Overall Study|Lack of Efficacy|5|||
156901474|NCT05439941|566399663|FG002|Overall Study|Lack of Efficacy|3|||
156901475|NCT05439941|566399661|FG000|Overall Study|Treatment Failure|0|||
156901476|NCT05439941|566399662|FG001|Overall Study|Treatment Failure|1|||
156901477|NCT05439941|566399663|FG002|Overall Study|Treatment Failure|0|||
156901478|NCT05439941|566399661|FG000|Overall Study|Adverse Event|1|||
156901479|NCT05439941|566399662|FG001|Overall Study|Adverse Event|3|||
156901480|NCT05439941|566399663|FG002|Overall Study|Adverse Event|0|||
156901481|NCT05439941|566399661|FG000|Overall Study|Adverse Event - Parent Study|1|||
156901482|NCT05439941|566399662|FG001|Overall Study|Adverse Event - Parent Study|0|||
156901483|NCT05439941|566399663|FG002|Overall Study|Adverse Event - Parent Study|0|||
156901484|NCT05439941|566399661|FG000|Overall Study|Pregnancy|1|||
156901485|NCT05439941|566399662|FG001|Overall Study|Pregnancy|0|||
156901486|NCT05439941|566399663|FG002|Overall Study|Pregnancy|0|||
156901487|NCT05439941|566399661|FG000|Overall Study|Withdrawal by Subject|9|||
156901488|NCT05439941|566399662|FG001|Overall Study|Withdrawal by Subject|6|||
156901489|NCT05439941|566399663|FG002|Overall Study|Withdrawal by Subject|10|||
156901490|NCT05439941|566399661|FG000|Overall Study|Non-Compliance|1|||
156901491|NCT05439941|566399662|FG001|Overall Study|Non-Compliance|1|||
156901492|NCT05439941|566399663|FG002|Overall Study|Non-Compliance|1|||
156901493|NCT05439941|566399661|FG000|Overall Study|Lost to Follow-up|2|||
156901494|NCT05439941|566399662|FG001|Overall Study|Lost to Follow-up|2|||
156901495|NCT05439941|566399663|FG002|Overall Study|Lost to Follow-up|0|||
156901496|NCT05439941|566399661|FG000|Overall Study|Physician Decision|1|||
156901497|NCT05439941|566399662|FG001|Overall Study|Physician Decision|0|||
156901498|NCT05439941|566399663|FG002|Overall Study|Physician Decision|0|||
156901499|NCT05439941|566399661|FG000|Overall Study|Trial Termination by Sponsor|78|||
156901500|NCT05439941|566399662|FG001|Overall Study|Trial Termination by Sponsor|83|||
156901501|NCT05439941|566399663|FG002|Overall Study|Trial Termination by Sponsor|65|||
156901502|NCT05439941|566399661|FG000|Overall Study|Other than Reasons Listed|2|||
156901503|NCT05439941|566399662|FG001|Overall Study|Other than Reasons Listed|1|||
156901504|NCT05439941|566399663|FG002|Overall Study|Other than Reasons Listed|0|||
156901505|NCT02699697|566399666|FG000|Overall Study|Death|18|||
156901506|NCT02699697|566399667|FG001|Overall Study|Death|15|||
156901507|NCT02699697|566399666|FG000|Overall Study|Physician Decision|0|||
156901508|NCT02699697|566399667|FG001|Overall Study|Physician Decision|1|||
156901509|NCT02699697|566399666|FG000|Overall Study|Lost to Follow-up|2|||
156901510|NCT02699697|566399667|FG001|Overall Study|Lost to Follow-up|3|||
157026417|NCT04032704|566851546|FG015|Part B|Lost to Follow-up|0|||
157026418|NCT04032704|566851547|FG016|Part B|Lost to Follow-up|0|||
157026419|NCT04032704|566851548|FG017|Part B|Lost to Follow-up|0|||
157026420|NCT04032704|566851531|FG000|Part B|Death|0|||
157026421|NCT04032704|566851532|FG001|Part B|Death|0|||
157026422|NCT04032704|566851533|FG002|Part B|Death|0|||
157026423|NCT04032704|566851534|FG003|Part B|Death|0|||
157026424|NCT04032704|566851535|FG004|Part B|Death|0|||
157026425|NCT04032704|566851536|FG005|Part B|Death|0|||
157026426|NCT04032704|566851537|FG006|Part B|Death|13|||
157026427|NCT04032704|566851538|FG007|Part B|Death|13|||
157026428|NCT04032704|566851539|FG008|Part B|Death|14|||
156901511|NCT02699697|566399666|FG000|Overall Study|Refused to follow up|1|||
156901512|NCT02699697|566399667|FG001|Overall Study|Refused to follow up|1|||
156901513|NCT02699697|566399666|FG000|Overall Study|Entered hospice care|5|||
156901514|NCT02699697|566399667|FG001|Overall Study|Entered hospice care|2|||
156901515|NCT02699697|566399666|FG000|Overall Study|Missing reason for discontinuation|6|||
156901516|NCT02699697|566399667|FG001|Overall Study|Missing reason for discontinuation|5|||
156901517|NCT02362035|566399668|FG000|Overall Study|Death|67|||
156901518|NCT02362035|566399668|FG000|Overall Study|Lost to Follow-up|3|||
156901519|NCT02362035|566399668|FG000|Overall Study|Adverse Event|1|||
157026429|NCT04032704|566851540|FG009|Part B|Death|12|||
157026430|NCT04032704|566851541|FG010|Part B|Death|12|||
157026431|NCT04032704|566851542|FG011|Part B|Death|13|||
157026432|NCT04032704|566851543|FG012|Part B|Death|7|||
157026433|NCT04032704|566851544|FG013|Part B|Death|17|||
156901520|NCT02362035|566399668|FG000|Overall Study|Physician Decision|1|||
156901521|NCT02362035|566399668|FG000|Overall Study|Subject started another cancer therapy|10|||
156901522|NCT02362035|566399668|FG000|Overall Study|Study terminated by sponsor|45|||
156901523|NCT02362035|566399668|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
156901524|NCT02362035|566399668|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
156901525|NCT02362035|566399668|FG000|Overall Study|Disease progression|11|||
156901526|NCT02362035|566399668|FG000|Overall Study|Withdrawal by Subject|20|||
156901527|NCT03270644|566399669|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
156901528|NCT03270644|566399669|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
156901529|NCT00615108|566399670|FG000|Overall Study|Adverse Event|122|||
156901530|NCT00615108|566399670|FG000|Overall Study|Other|370|||
156901531|NCT00615108|566399670|FG000|Overall Study|Lost to Follow-up|15|||
156901532|NCT02476201|566399671|FG000|Overall Study|Unable to program MPP|9|||
156901533|NCT02476201|566399671|FG000|Overall Study|Study echo not performed|5|||
156901534|NCT02476201|566399671|FG000|Overall Study|Adverse Event|4|||
156901535|NCT02476201|566399671|FG000|Overall Study|Death|2|||
156901536|NCT02476201|566399671|FG000|Overall Study|Lost to Follow-up|2|||
156901537|NCT02476201|566399671|FG000|Overall Study|MPP programmed to OFF|2|||
156901538|NCT02476201|566399671|FG000|Overall Study|Withdrawal by Subject|1|||
156901539|NCT02476201|566399671|FG000|Overall Study|Unsuccessful implant|1|||
156901540|NCT01797731|566399672|FG000|Overall Study|Didn't have proper radiographs required|3|||
156901541|NCT01797731|566399673|FG001|Overall Study|Didn't have proper radiographs required|3|||
156901542|NCT01189604|566399675|FG000|Overall Study|Impossible to visit|0|||
156901543|NCT01189604|566399676|FG001|Overall Study|Impossible to visit|0|||
156901544|NCT01189604|566399677|FG002|Overall Study|Impossible to visit|0|||
156901545|NCT01189604|566399678|FG003|Overall Study|Impossible to visit|0|||
156901546|NCT01189604|566399679|FG004|Overall Study|Impossible to visit|0|||
156901547|NCT01189604|566399680|FG005|Overall Study|Impossible to visit|1|||
156901548|NCT01189604|566399681|FG006|Overall Study|Impossible to visit|0|||
156901549|NCT01189604|566399675|FG000|Overall Study|Adverse Event|0|||
156901550|NCT01189604|566399676|FG001|Overall Study|Adverse Event|1|||
156901551|NCT01189604|566399677|FG002|Overall Study|Adverse Event|0|||
156901552|NCT01189604|566399678|FG003|Overall Study|Adverse Event|0|||
156901553|NCT01189604|566399679|FG004|Overall Study|Adverse Event|2|||
156901554|NCT01189604|566399680|FG005|Overall Study|Adverse Event|0|||
156901555|NCT01189604|566399681|FG006|Overall Study|Adverse Event|1|||
156901556|NCT01189604|566399675|FG000|Overall Study|Withdrawal by Subject|1|||
156901557|NCT01189604|566399676|FG001|Overall Study|Withdrawal by Subject|0|||
156901558|NCT01189604|566399677|FG002|Overall Study|Withdrawal by Subject|0|||
156901559|NCT01189604|566399678|FG003|Overall Study|Withdrawal by Subject|0|||
156901560|NCT01189604|566399679|FG004|Overall Study|Withdrawal by Subject|0|||
156901561|NCT01189604|566399680|FG005|Overall Study|Withdrawal by Subject|0|||
156901562|NCT01189604|566399681|FG006|Overall Study|Withdrawal by Subject|0|||
156901563|NCT03945214|566399682|FG000|Overall Study|Lost to Follow-up|3|||
156901564|NCT03945214|566399683|FG001|Overall Study|Lost to Follow-up|4|||
156901565|NCT03945214|566399684|FG002|Overall Study|Lost to Follow-up|7|||
156901566|NCT03945214|566399685|FG003|Overall Study|Lost to Follow-up|4|||
156901567|NCT02191137|566399696|FG000|Treatment|Death|4|||
156901568|NCT02191137|566399696|FG000|Treatment|Withdrawal by Subject|3|||
156901569|NCT02191137|566399696|FG000|Treatment|Adverse Event|2|||
156901570|NCT02191137|566399696|FG000|Treatment|Other|1|||
156901571|NCT02191137|566399696|FG000|Follow-up|Lost to Follow-up|2|||
156901572|NCT02191137|566399696|FG000|Follow-up|Ongoing/unknown|2|||
156901573|NCT02191137|566399696|FG000|Follow-up|Adverse Event|1|||
156901574|NCT02853344|566399701|FG000|Overall Study|Lost to Follow-up|1|||
156901575|NCT02853344|566399702|FG001|Overall Study|Lost to Follow-up|1|||
156901576|NCT02853344|566399701|FG000|Overall Study|Withdrawal by Subject|2|||
156901577|NCT02853344|566399702|FG001|Overall Study|Withdrawal by Subject|4|||
156901578|NCT02853344|566399701|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
156901579|NCT02853344|566399702|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
156901580|NCT02853344|566399701|FG000|Overall Study|Death|70|||
157026434|NCT04032704|566851545|FG014|Part B|Death|2|||
157026435|NCT04032704|566851546|FG015|Part B|Death|1|||
157026436|NCT04032704|566851547|FG016|Part B|Death|2|||
157026437|NCT04032704|566851548|FG017|Part B|Death|2|||
157026438|NCT03133546|566851556|FG000|Overall Study|Death|46|||
157026439|NCT03133546|566851557|FG001|Overall Study|Death|43|||
157026440|NCT03133546|566851556|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
157225521|NCT01659567|567571457|FG000|Overall Study|Good result at early stage of treatment|5|||
157225522|NCT01659567|567571457|FG000|Overall Study|Withdrawal by Subject|64|||
157225523|NCT01659567|567571457|FG000|Overall Study|Progression of the main disease|1|||
156901581|NCT02853344|566399702|FG001|Overall Study|Death|112|||
156901582|NCT00299182|566399703|FG000|Overall Study|Withdrawal by Subject|0|||
156901583|NCT00299182|566399704|FG001|Overall Study|Withdrawal by Subject|0|||
156901584|NCT00299182|566399705|FG002|Overall Study|Withdrawal by Subject|1|||
156901585|NCT00299182|566399706|FG003|Overall Study|Withdrawal by Subject|0|||
157026441|NCT03133546|566851557|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
157026442|NCT02993159|566851558|FG000|Overall Study|Withdrawal by Subject|1|||
156901586|NCT00299182|566399707|FG004|Overall Study|Withdrawal by Subject|1|||
156901587|NCT00299182|566399708|FG005|Overall Study|Withdrawal by Subject|2|||
156901588|NCT00299182|566399709|FG006|Overall Study|Withdrawal by Subject|0|||
156901589|NCT00299182|566399703|FG000|Overall Study|Chemotherapy Changed|0|||
156901590|NCT00299182|566399704|FG001|Overall Study|Chemotherapy Changed|0|||
156901591|NCT00299182|566399705|FG002|Overall Study|Chemotherapy Changed|1|||
156901592|NCT00299182|566399706|FG003|Overall Study|Chemotherapy Changed|0|||
156901593|NCT00299182|566399707|FG004|Overall Study|Chemotherapy Changed|1|||
156901594|NCT00299182|566399708|FG005|Overall Study|Chemotherapy Changed|0|||
156901595|NCT00299182|566399709|FG006|Overall Study|Chemotherapy Changed|1|||
156901596|NCT00299182|566399703|FG000|Overall Study|Adverse Event|0|||
156901597|NCT00299182|566399704|FG001|Overall Study|Adverse Event|0|||
156901598|NCT00299182|566399705|FG002|Overall Study|Adverse Event|0|||
156901599|NCT00299182|566399706|FG003|Overall Study|Adverse Event|0|||
156901600|NCT00299182|566399707|FG004|Overall Study|Adverse Event|0|||
156901601|NCT00299182|566399708|FG005|Overall Study|Adverse Event|1|||
156901602|NCT00299182|566399709|FG006|Overall Study|Adverse Event|0|||
156901603|NCT00299182|566399703|FG000|Overall Study|Not Eligible|0|||
156901604|NCT00299182|566399704|FG001|Overall Study|Not Eligible|0|||
156901605|NCT00299182|566399705|FG002|Overall Study|Not Eligible|0|||
156901606|NCT00299182|566399706|FG003|Overall Study|Not Eligible|0|||
156901607|NCT00299182|566399707|FG004|Overall Study|Not Eligible|1|||
156901608|NCT00299182|566399708|FG005|Overall Study|Not Eligible|0|||
156901609|NCT00299182|566399709|FG006|Overall Study|Not Eligible|0|||
156901610|NCT04068610|566399710|FG000|Overall Study|Death|4|||
156901611|NCT04068610|566399711|FG001|Overall Study|Death|8|||
156901612|NCT04068610|566399712|FG002|Overall Study|Death|13|||
156901613|NCT04068610|566399710|FG000|Overall Study|Lost to Follow-up|0|||
156901614|NCT04068610|566399711|FG001|Overall Study|Lost to Follow-up|2|||
156901615|NCT04068610|566399712|FG002|Overall Study|Lost to Follow-up|0|||
156901616|NCT04068610|566399710|FG000|Overall Study|Withdrawal by Subject|0|||
156901617|NCT04068610|566399711|FG001|Overall Study|Withdrawal by Subject|4|||
156901618|NCT04068610|566399712|FG002|Overall Study|Withdrawal by Subject|2|||
156901619|NCT04068610|566399710|FG000|Overall Study|Other|3|||
156901620|NCT04068610|566399711|FG001|Overall Study|Other|12|||
156901621|NCT04068610|566399712|FG002|Overall Study|Other|11|||
156901622|NCT05535972|566399713|FG000|Overall Study|Withdrawal by Subject|31|||
156901623|NCT05535972|566399713|FG000|Overall Study|Lost to Follow-up|5|||
156901624|NCT05535972|566399713|FG000|Overall Study|Adverse Event|6|||
156901625|NCT05535972|566399713|FG000|Overall Study|Protocol Deviation|2|||
156901626|NCT00586625|566399714|FG000|Overall Study|Adverse Event|6|||
156901627|NCT00586625|566399715|FG001|Overall Study|Adverse Event|6|||
156901628|NCT00586625|566399714|FG000|Overall Study|Protocol Violation|3|||
156901629|NCT00586625|566399715|FG001|Overall Study|Protocol Violation|0|||
156901630|NCT00586625|566399714|FG000|Overall Study|Withdrawal by Subject|32|||
156901631|NCT00586625|566399715|FG001|Overall Study|Withdrawal by Subject|10|||
156901632|NCT00586625|566399714|FG000|Overall Study|Subject non-compliance|0|||
156901633|NCT00586625|566399715|FG001|Overall Study|Subject non-compliance|1|||
156901634|NCT00586625|566399714|FG000|Overall Study|Subject unable to return for visit|2|||
156901635|NCT00586625|566399715|FG001|Overall Study|Subject unable to return for visit|0|||
156901636|NCT04590963|566399717|FG000|Overall Study|Death|118|||
156901637|NCT04590963|566399718|FG001|Overall Study|Death|59|||
156901638|NCT04590963|566399717|FG000|Overall Study|Lost to Follow-up|1|||
156901639|NCT04590963|566399718|FG001|Overall Study|Lost to Follow-up|1|||
156901640|NCT04590963|566399717|FG000|Overall Study|Progressive disease|0|||
156901641|NCT04590963|566399718|FG001|Overall Study|Progressive disease|1|||
156901642|NCT04590963|566399717|FG000|Overall Study|Study terminated by sponsor|103|||
156901643|NCT04590963|566399718|FG001|Overall Study|Study terminated by sponsor|50|||
156901644|NCT04590963|566399717|FG000|Overall Study|Withdrawal by Subject|15|||
156901645|NCT04590963|566399718|FG001|Overall Study|Withdrawal by Subject|8|||
156901646|NCT04590963|566399717|FG000|Overall Study|Ongoing at data cut-off|9|||
156901647|NCT04590963|566399718|FG001|Overall Study|Ongoing at data cut-off|4|||
156901648|NCT04590963|566399717|FG000|Overall Study|Screen failure|1|||
156901649|NCT04590963|566399718|FG001|Overall Study|Screen failure|0|||
156901650|NCT02628769|566399720|FG000|First Intervention|Adverse Event|1|||
156901651|NCT02628769|566399721|FG001|First Intervention|Adverse Event|0|||
156901652|NCT02628769|566399720|FG000|First Intervention|Withdrawal by Subject|0|||
156901653|NCT02628769|566399721|FG001|First Intervention|Withdrawal by Subject|1|||
156901654|NCT02628769|566399720|FG000|Second Intervention|Adverse Event|2|||
156901655|NCT02628769|566399721|FG001|Second Intervention|Adverse Event|0|||
156901656|NCT02628769|566399720|FG000|Second Intervention|Physician Decision|0|||
156901657|NCT02628769|566399721|FG001|Second Intervention|Physician Decision|1|||
156901658|NCT01467583|566399722|FG000|Overall Study|Death|1|||
156901659|NCT01467583|566399723|FG001|Overall Study|Death|1|||
156901660|NCT01467583|566399724|FG002|Overall Study|Death|0|||
156901661|NCT01467583|566399722|FG000|Overall Study|Withdrawal by Subject|1|||
156901662|NCT01467583|566399723|FG001|Overall Study|Withdrawal by Subject|0|||
156901663|NCT01467583|566399724|FG002|Overall Study|Withdrawal by Subject|0|||
156901664|NCT01467583|566399722|FG000|Overall Study|Protocol Violation|0|||
156901665|NCT01467583|566399723|FG001|Overall Study|Protocol Violation|0|||
156901666|NCT01467583|566399724|FG002|Overall Study|Protocol Violation|2|||
156901667|NCT03805646|566399725|FG000|Overall Study|Death|40|||
156901668|NCT03805646|566399726|FG001|Overall Study|Death|49|||
156901669|NCT03805646|566399725|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
156901670|NCT03805646|566399726|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
156901671|NCT05171777|566399727|FG000|Treatment Crossover Period|Adverse Event|9|||
156901672|NCT05171777|566399728|FG001|Treatment Crossover Period|Adverse Event|6|||
156901673|NCT05171777|566399729|FG002|Treatment Crossover Period|Adverse Event|0|||
156901674|NCT05171777|566399730|FG003|Treatment Crossover Period|Adverse Event|0|||
156901675|NCT05171777|566399727|FG000|Treatment Crossover Period|Death|5|||
157026443|NCT02993159|566851559|FG001|Overall Study|Withdrawal by Subject|3|||
157026444|NCT02993159|566851558|FG000|Overall Study|Protocol Violation|1|||
157026445|NCT02993159|566851559|FG001|Overall Study|Protocol Violation|0|||
157026446|NCT02993159|566851558|FG000|Overall Study|Opted out of surgery|2|||
157026447|NCT02993159|566851559|FG001|Overall Study|Opted out of surgery|0|||
157026448|NCT02993159|566851558|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
157026449|NCT02993159|566851559|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
157026450|NCT02993159|566851558|FG000|Overall Study|Physician Decision|0|||
157026451|NCT02993159|566851559|FG001|Overall Study|Physician Decision|1|||
157026452|NCT05034328|566851560|FG000|Overall Study|Protocol Violation|1|||
157026453|NCT05034328|566851561|FG001|Overall Study|Protocol Violation|0|||
157026454|NCT05034328|566851560|FG000|Overall Study|Lost to Follow-up|0|||
157026455|NCT05034328|566851561|FG001|Overall Study|Lost to Follow-up|10|||
157026456|NCT05399459|566851564|FG000|Overall Study|Randomized but not treated|29|||
157026457|NCT05399459|566851565|FG001|Overall Study|Randomized but not treated|30|||
157026458|NCT05399459|566851566|FG002|Overall Study|Randomized but not treated|38|||
157026459|NCT05399459|566851564|FG000|Overall Study|Lost to Follow-up|1|||
157026460|NCT05399459|566851565|FG001|Overall Study|Lost to Follow-up|0|||
157026461|NCT05399459|566851566|FG002|Overall Study|Lost to Follow-up|0|||
157026462|NCT02231164|566851567|FG000|Overall Study|Adverse Event|1|||
157026463|NCT02231164|566851568|FG001|Overall Study|Adverse Event|1|||
157026464|NCT02231164|566851567|FG000|Overall Study|Lack of Efficacy|4|||
157026465|NCT02231164|566851568|FG001|Overall Study|Lack of Efficacy|3|||
157026466|NCT02231164|566851567|FG000|Overall Study|Withdrawal by Subject|1|||
157026467|NCT02231164|566851568|FG001|Overall Study|Withdrawal by Subject|2|||
157026468|NCT02969707|566851569|FG000|Overall Study|Withdrawal by Subject|6|||
157026469|NCT02969707|566851570|FG001|Overall Study|Withdrawal by Subject|5|||
157026470|NCT02969707|566851569|FG000|Overall Study|Severe anxiety|0|||
157026471|NCT02969707|566851570|FG001|Overall Study|Severe anxiety|1|||
157026472|NCT02969707|566851569|FG000|Overall Study|Positive toxicology screen|0|||
157026473|NCT02969707|566851570|FG001|Overall Study|Positive toxicology screen|2|||
157026474|NCT02969707|566851569|FG000|Overall Study|Claustrophobia|2|||
157026475|NCT02969707|566851570|FG001|Overall Study|Claustrophobia|2|||
157026476|NCT02969707|566851569|FG000|Overall Study|Non-compliance|1|||
157026477|NCT02969707|566851570|FG001|Overall Study|Non-compliance|2|||
157026478|NCT00248287|566851577|FG000|Overall Study|Adverse Event|11|||
157026479|NCT00248287|566851578|FG001|Overall Study|Adverse Event|10|||
157026480|NCT00248287|566851577|FG000|Overall Study|Death|1|||
157026481|NCT00248287|566851578|FG001|Overall Study|Death|0|||
157026482|NCT00248287|566851577|FG000|Overall Study|Lost to Follow-up|0|||
157026483|NCT00248287|566851578|FG001|Overall Study|Lost to Follow-up|1|||
157026484|NCT00248287|566851577|FG000|Overall Study|Investigator Request|4|||
157026485|NCT00248287|566851578|FG001|Overall Study|Investigator Request|3|||
157026486|NCT00248287|566851577|FG000|Overall Study|Patient Request|5|||
157026487|NCT00248287|566851578|FG001|Overall Study|Patient Request|3|||
157026488|NCT00248287|566851577|FG000|Overall Study|Other|3|||
157026489|NCT00248287|566851578|FG001|Overall Study|Other|2|||
157026490|NCT02714257|566851579|FG000|Overall Study|Withdrawal by Subject|6|||
157026491|NCT02714257|566851580|FG001|Overall Study|Withdrawal by Subject|11|||
157026492|NCT02714257|566851579|FG000|Overall Study|Death|3|||
157026493|NCT02714257|566851580|FG001|Overall Study|Death|4|||
157026494|NCT02714257|566851579|FG000|Overall Study|Lost to Follow-up|1|||
157026495|NCT02714257|566851580|FG001|Overall Study|Lost to Follow-up|6|||
156901676|NCT05171777|566399728|FG001|Treatment Crossover Period|Death|5|||
156901677|NCT05171777|566399729|FG002|Treatment Crossover Period|Death|0|||
157026496|NCT05808257|566851581|FG000|Overall Study|Lost to Follow-up|8|||
157026497|NCT05808257|566851582|FG001|Overall Study|Lost to Follow-up|8|||
157026498|NCT04568486|566851583|FG000|Overall Study|Withdrawal by Subject|26|||
156901678|NCT05171777|566399730|FG003|Treatment Crossover Period|Death|0|||
156901679|NCT05171777|566399727|FG000|Treatment Crossover Period|Disease Relapse|1|||
156901680|NCT05171777|566399728|FG001|Treatment Crossover Period|Disease Relapse|0|||
157026499|NCT04568486|566851583|FG000|Overall Study|Lost to Follow-up|7|||
157026500|NCT05281562|566851593|FG000|Overall Study|Ineligible patient|1|||
157026501|NCT05281562|566851594|FG001|Overall Study|Ineligible patient|0|||
157026502|NCT00324805|566851595|FG000|Overall Study|Adverse Event|62|||
157026503|NCT00324805|566851596|FG001|Overall Study|Adverse Event|203|||
157026504|NCT00324805|566851595|FG000|Overall Study|Progression|7|||
157026505|NCT00324805|566851596|FG001|Overall Study|Progression|35|||
156901681|NCT05171777|566399729|FG002|Treatment Crossover Period|Disease Relapse|0|||
156901682|NCT05171777|566399730|FG003|Treatment Crossover Period|Disease Relapse|0|||
156901683|NCT05171777|566399727|FG000|Treatment Crossover Period|Reason not Specified|1|||
156901684|NCT05171777|566399728|FG001|Treatment Crossover Period|Reason not Specified|1|||
156901685|NCT05171777|566399729|FG002|Treatment Crossover Period|Reason not Specified|0|||
156901686|NCT05171777|566399730|FG003|Treatment Crossover Period|Reason not Specified|0|||
156901687|NCT05171777|566399727|FG000|Treatment Crossover Period|Physician Decision|0|||
156901688|NCT05171777|566399728|FG001|Treatment Crossover Period|Physician Decision|1|||
156901689|NCT05171777|566399729|FG002|Treatment Crossover Period|Physician Decision|0|||
156901690|NCT05171777|566399730|FG003|Treatment Crossover Period|Physician Decision|0|||
156901691|NCT05171777|566399727|FG000|Treatment Crossover Period|Progressive Disease|14|||
156901692|NCT05171777|566399728|FG001|Treatment Crossover Period|Progressive Disease|10|||
156901693|NCT05171777|566399729|FG002|Treatment Crossover Period|Progressive Disease|0|||
156901694|NCT05171777|566399730|FG003|Treatment Crossover Period|Progressive Disease|0|||
156901695|NCT05171777|566399727|FG000|Treatment Crossover Period|Protocol Violation|0|||
156901696|NCT05171777|566399728|FG001|Treatment Crossover Period|Protocol Violation|2|||
156901697|NCT05171777|566399729|FG002|Treatment Crossover Period|Protocol Violation|0|||
156901698|NCT05171777|566399730|FG003|Treatment Crossover Period|Protocol Violation|0|||
156901699|NCT05171777|566399727|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
156901700|NCT05171777|566399728|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
156901701|NCT05171777|566399729|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
156901702|NCT05171777|566399730|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
156901703|NCT05171777|566399727|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
156901704|NCT05171777|566399728|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
156901705|NCT05171777|566399729|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
156901706|NCT05171777|566399730|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
156901707|NCT05171777|566399727|FG000|Treatment Continuation Period|Adverse Event|0|||
156901708|NCT05171777|566399728|FG001|Treatment Continuation Period|Adverse Event|0|||
156901709|NCT05171777|566399729|FG002|Treatment Continuation Period|Adverse Event|3|||
156901710|NCT05171777|566399730|FG003|Treatment Continuation Period|Adverse Event|6|||
156901711|NCT05171777|566399727|FG000|Treatment Continuation Period|Death|0|||
156901712|NCT05171777|566399728|FG001|Treatment Continuation Period|Death|0|||
156901713|NCT05171777|566399729|FG002|Treatment Continuation Period|Death|1|||
156901714|NCT05171777|566399730|FG003|Treatment Continuation Period|Death|3|||
156901715|NCT05171777|566399727|FG000|Treatment Continuation Period|Disease Relapse|0|||
156901716|NCT05171777|566399728|FG001|Treatment Continuation Period|Disease Relapse|0|||
156901717|NCT05171777|566399729|FG002|Treatment Continuation Period|Disease Relapse|1|||
156901718|NCT05171777|566399730|FG003|Treatment Continuation Period|Disease Relapse|0|||
156901719|NCT05171777|566399727|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
156901720|NCT05171777|566399728|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
156901721|NCT05171777|566399729|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
156901722|NCT05171777|566399730|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
156901723|NCT05171777|566399727|FG000|Treatment Continuation Period|Physician Decision|0|||
156901724|NCT05171777|566399728|FG001|Treatment Continuation Period|Physician Decision|0|||
156901725|NCT05171777|566399729|FG002|Treatment Continuation Period|Physician Decision|0|||
156901726|NCT05171777|566399730|FG003|Treatment Continuation Period|Physician Decision|4|||
157026506|NCT00324805|566851595|FG000|Overall Study|Withdrawal by Subject|51|||
157026507|NCT00324805|566851596|FG001|Overall Study|Withdrawal by Subject|174|||
157026508|NCT00324805|566851595|FG000|Overall Study|Death|6|||
157026509|NCT00324805|566851596|FG001|Overall Study|Death|9|||
157026510|NCT00324805|566851595|FG000|Overall Study|Alternative therapy|4|||
157026511|NCT00324805|566851596|FG001|Overall Study|Alternative therapy|8|||
156901727|NCT05171777|566399727|FG000|Treatment Continuation Period|Progressive Disease|0|||
156901728|NCT05171777|566399728|FG001|Treatment Continuation Period|Progressive Disease|0|||
156901729|NCT05171777|566399729|FG002|Treatment Continuation Period|Progressive Disease|6|||
156901730|NCT05171777|566399730|FG003|Treatment Continuation Period|Progressive Disease|20|||
156901731|NCT05171777|566399727|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
156901732|NCT05171777|566399728|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
156901733|NCT05171777|566399729|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
156901734|NCT05171777|566399730|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
156901735|NCT05171777|566399727|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
156901736|NCT05171777|566399728|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
156901737|NCT05171777|566399729|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
156901738|NCT05171777|566399730|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
156901739|NCT05171777|566399727|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
156901740|NCT05171777|566399728|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
156901741|NCT05171777|566399729|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
156901742|NCT05171777|566399730|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
157026512|NCT00324805|566851595|FG000|Overall Study|Other complicating disease|1|||
157158791|NCT02723604|567326768|FG000|Overall Study|never received treatment|1|||
157158792|NCT00111475|567326769|FG000|Overall Study|Lost to Follow-up|0|||
157158793|NCT00111475|567326770|FG001|Overall Study|Lost to Follow-up|0|||
156901743|NCT02364713|566399731|FG000|Overall Study|Ineligible|2|||
156901744|NCT02364713|566399732|FG001|Overall Study|Ineligible|2|||
156901745|NCT04686786|566399733|FG000|Overall Study|Adverse Event|9|||
156901746|NCT04686786|566399733|FG000|Overall Study|Death|1|||
156901747|NCT04686786|566399733|FG000|Overall Study|Lack of Efficacy|25|||
156901748|NCT04686786|566399733|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
156901749|NCT04686786|566399733|FG000|Overall Study|Study Terminated by Sponsor|14|||
156901750|NCT04686786|566399733|FG000|Overall Study|Withdrawal by Subject|15|||
156901751|NCT04686786|566399733|FG000|Overall Study|Other than specified|1|||
156901752|NCT03924869|566399734|FG000|Overall Study|Death|73|||
156901753|NCT03924869|566399735|FG001|Overall Study|Death|62|||
156901754|NCT03924869|566399734|FG000|Overall Study|Lost to Follow-up|3|||
156901755|NCT03924869|566399735|FG001|Overall Study|Lost to Follow-up|0|||
156901756|NCT03924869|566399734|FG000|Overall Study|Physician Decision|0|||
156901757|NCT03924869|566399735|FG001|Overall Study|Physician Decision|3|||
156901758|NCT03924869|566399734|FG000|Overall Study|Withdrawal by Subject|7|||
156901759|NCT03924869|566399735|FG001|Overall Study|Withdrawal by Subject|3|||
156901760|NCT03924869|566399734|FG000|Overall Study|Study Terminated By Sponsor|144|||
156901761|NCT03924869|566399735|FG001|Overall Study|Study Terminated By Sponsor|153|||
156901762|NCT03001882|566399738|FG000|Overall Study|Death|1|||
156901763|NCT03001882|566399739|FG001|Overall Study|Death|0|||
156901764|NCT03001882|566399740|FG002|Overall Study|Death|0|||
156901765|NCT03001882|566399741|FG003|Overall Study|Death|3|||
156901766|NCT03001882|566399738|FG000|Overall Study|Participant withdrew consent|0|||
156901767|NCT03001882|566399739|FG001|Overall Study|Participant withdrew consent|1|||
156901768|NCT03001882|566399740|FG002|Overall Study|Participant withdrew consent|0|||
156901769|NCT03001882|566399741|FG003|Overall Study|Participant withdrew consent|5|||
156901770|NCT03001882|566399738|FG000|Overall Study|Other reasons|1|||
156901771|NCT03001882|566399739|FG001|Overall Study|Other reasons|2|||
156901772|NCT03001882|566399740|FG002|Overall Study|Other reasons|0|||
156901773|NCT03001882|566399741|FG003|Overall Study|Other reasons|5|||
156901774|NCT03001882|566399738|FG000|Overall Study|Administrative reason by sponsor|0|||
156901775|NCT03001882|566399739|FG001|Overall Study|Administrative reason by sponsor|0|||
156901776|NCT03001882|566399740|FG002|Overall Study|Administrative reason by sponsor|0|||
156901777|NCT03001882|566399741|FG003|Overall Study|Administrative reason by sponsor|1|||
156901778|NCT03001882|566399738|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156901779|NCT03001882|566399739|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
156901780|NCT03001882|566399740|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156901781|NCT03001882|566399741|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
156901782|NCT03001882|566399738|FG000|Overall Study|Not reported|0|||
156901783|NCT03001882|566399739|FG001|Overall Study|Not reported|0|||
156901784|NCT03001882|566399740|FG002|Overall Study|Not reported|0|||
156901785|NCT03001882|566399741|FG003|Overall Study|Not reported|6|||
156901786|NCT03001882|566399738|FG000|Overall Study|Maximum clinical benefit|2|||
156901787|NCT03001882|566399739|FG001|Overall Study|Maximum clinical benefit|3|||
156901788|NCT03001882|566399740|FG002|Overall Study|Maximum clinical benefit|0|||
156901789|NCT03001882|566399741|FG003|Overall Study|Maximum clinical benefit|10|||
156901790|NCT03001882|566399738|FG000|Overall Study|AE unrelated to study drug|3|||
156901791|NCT03001882|566399739|FG001|Overall Study|AE unrelated to study drug|3|||
156901792|NCT03001882|566399740|FG002|Overall Study|AE unrelated to study drug|0|||
156901793|NCT03001882|566399741|FG003|Overall Study|AE unrelated to study drug|11|||
156901794|NCT03001882|566399738|FG000|Overall Study|Study Drug Toxicity|8|||
156901795|NCT03001882|566399739|FG001|Overall Study|Study Drug Toxicity|5|||
156901796|NCT03001882|566399740|FG002|Overall Study|Study Drug Toxicity|0|||
156901797|NCT03001882|566399741|FG003|Overall Study|Study Drug Toxicity|37|||
156901798|NCT03001882|566399738|FG000|Overall Study|Disease progression|16|||
156901799|NCT03001882|566399739|FG001|Overall Study|Disease progression|14|||
156901800|NCT03001882|566399740|FG002|Overall Study|Disease progression|1|||
156901801|NCT03001882|566399741|FG003|Overall Study|Disease progression|90|||
156901802|NCT03507400|566399742|FG000|Overall Study|discontinued|5|||
156901803|NCT03507400|566399743|FG001|Overall Study|discontinued|1|||
156901804|NCT03507400|566399742|FG000|Overall Study|Lost to Follow-up|8|||
156901805|NCT03507400|566399743|FG001|Overall Study|Lost to Follow-up|6|||
156901806|NCT03507400|566399742|FG000|Overall Study|Protocol Violation|0|||
156901807|NCT03507400|566399743|FG001|Overall Study|Protocol Violation|1|||
156901808|NCT01555983|566399744|FG000|Overall Study|Withdrawal by Subject|1|||
157158794|NCT00111475|567326771|FG002|Overall Study|Lost to Follow-up|0|||
156901809|NCT01555983|566399745|FG001|Overall Study|Withdrawal by Subject|0|||
156901810|NCT01555983|566399746|FG002|Overall Study|Withdrawal by Subject|0|||
156901811|NCT01555983|566399747|FG003|Overall Study|Withdrawal by Subject|0|||
156901812|NCT01555983|566399748|FG004|Overall Study|Withdrawal by Subject|1|||
156901813|NCT01555983|566399749|FG005|Overall Study|Withdrawal by Subject|1|||
156901814|NCT05985395|566399755|FG000|Overall Study|Physician Decision|2|||
156901815|NCT05985395|566399756|FG001|Overall Study|Physician Decision|1|||
156901816|NCT05985395|566399755|FG000|Overall Study|Withdrawal by Subject|1|||
157026513|NCT00324805|566851596|FG001|Overall Study|Other complicating disease|9|||
157026514|NCT00324805|566851595|FG000|Overall Study|Other reasons|7|||
157026515|NCT00324805|566851596|FG001|Overall Study|Other reasons|26|||
157026516|NCT00324805|566851595|FG000|Overall Study|Other|0|||
157158795|NCT00111475|567326772|FG003|Overall Study|Lost to Follow-up|0|||
156901817|NCT05985395|566399756|FG001|Overall Study|Withdrawal by Subject|0|||
156901818|NCT05938920|566399759|FG000|Overall Study|Adverse Event|1|||
156901819|NCT05938920|566399760|FG001|Overall Study|Adverse Event|3|||
156901820|NCT05938920|566399761|FG002|Overall Study|Adverse Event|2|||
156901821|NCT05938920|566399762|FG003|Overall Study|Adverse Event|1|||
156901822|NCT05938920|566399759|FG000|Overall Study|Death|0|||
156901823|NCT05938920|566399760|FG001|Overall Study|Death|1|||
156901824|NCT05938920|566399761|FG002|Overall Study|Death|0|||
156901825|NCT05938920|566399762|FG003|Overall Study|Death|0|||
156901826|NCT05938920|566399759|FG000|Overall Study|Lost to Follow-up|0|||
156901827|NCT05938920|566399760|FG001|Overall Study|Lost to Follow-up|0|||
156901828|NCT05938920|566399761|FG002|Overall Study|Lost to Follow-up|1|||
156901829|NCT05938920|566399762|FG003|Overall Study|Lost to Follow-up|0|||
156901830|NCT05938920|566399759|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
156901831|NCT05938920|566399760|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156901832|NCT05938920|566399761|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156901833|NCT05938920|566399762|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
156901834|NCT05938920|566399759|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156901835|NCT05938920|566399760|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156901836|NCT05938920|566399761|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
156901837|NCT05938920|566399762|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
156901838|NCT05938920|566399759|FG000|Overall Study|Participant Refused to Come In|0|||
156901839|NCT05938920|566399760|FG001|Overall Study|Participant Refused to Come In|0|||
156901840|NCT05938920|566399761|FG002|Overall Study|Participant Refused to Come In|1|||
156901841|NCT05938920|566399762|FG003|Overall Study|Participant Refused to Come In|0|||
156901842|NCT01251861|566399763|FG000|Overall Study|Disease progression|6|||
156901843|NCT01251861|566399764|FG001|Overall Study|Disease progression|6|||
156901844|NCT01251861|566399763|FG000|Overall Study|Adverse Event|2|||
156901845|NCT01251861|566399764|FG001|Overall Study|Adverse Event|17|||
156901846|NCT01251861|566399763|FG000|Overall Study|Withdrawal by Subject|2|||
156901847|NCT01251861|566399764|FG001|Overall Study|Withdrawal by Subject|2|||
156901848|NCT01251861|566399763|FG000|Overall Study|Alternative therapy|1|||
156901849|NCT01251861|566399764|FG001|Overall Study|Alternative therapy|0|||
156901850|NCT01251861|566399763|FG000|Overall Study|Other complicating disease|0|||
156901851|NCT01251861|566399764|FG001|Overall Study|Other complicating disease|1|||
156901852|NCT01251861|566399763|FG000|Overall Study|Physician Decision|1|||
156901853|NCT01251861|566399764|FG001|Overall Study|Physician Decision|0|||
156901854|NCT01251861|566399763|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
156901855|NCT01251861|566399764|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
156901856|NCT01251861|566399763|FG000|Overall Study|Other|1|||
156901857|NCT01251861|566399764|FG001|Overall Study|Other|0|||
156901858|NCT01251861|566399763|FG000|Overall Study|Never started therapy|4|||
156901859|NCT01251861|566399764|FG001|Overall Study|Never started therapy|1|||
156901860|NCT01251861|566399763|FG000|Overall Study|Potential interaction of drugs|0|||
156901861|NCT01251861|566399764|FG001|Overall Study|Potential interaction of drugs|1|||
156901862|NCT00717093|566401316|FG000|Overall Study|Adverse Event|19|||
156901863|NCT00717093|566401317|FG001|Overall Study|Adverse Event|9|||
156901864|NCT00717093|566401316|FG000|Overall Study|Lack of Efficacy|3|||
156901865|NCT00717093|566401317|FG001|Overall Study|Lack of Efficacy|13|||
156901866|NCT00717093|566401316|FG000|Overall Study|Lost to Follow-up|9|||
156901867|NCT00717093|566401317|FG001|Overall Study|Lost to Follow-up|6|||
156901868|NCT00717093|566401316|FG000|Overall Study|Withdrawal by Subject|12|||
156901869|NCT00717093|566401317|FG001|Overall Study|Withdrawal by Subject|19|||
156901870|NCT00717093|566401316|FG000|Overall Study|Other|0|||
156901871|NCT00717093|566401317|FG001|Overall Study|Other|1|||
156901872|NCT00717093|566401316|FG000|Overall Study|Randomized but not treated|1|||
156901873|NCT00717093|566401317|FG001|Overall Study|Randomized but not treated|0|||
156901874|NCT01543698|566401322|FG000|Phase 1b|Disease progression|2|||
156901875|NCT01543698|566401323|FG001|Phase 1b|Disease progression|4|||
156901876|NCT01543698|566401324|FG002|Phase 1b|Disease progression|3|||
157158796|NCT00111475|567326773|FG004|Overall Study|Lost to Follow-up|0|||
157158797|NCT00111475|567326774|FG005|Overall Study|Lost to Follow-up|1|||
157158798|NCT00111475|567326775|FG006|Overall Study|Lost to Follow-up|0|||
156901877|NCT01543698|566401325|FG003|Phase 1b|Disease progression|2|||
156901878|NCT01543698|566401326|FG004|Phase 1b|Disease progression|10|||
156901879|NCT01543698|566401327|FG005|Phase 1b|Disease progression|6|||
156901880|NCT01543698|566401328|FG006|Phase 1b|Disease progression|5|||
156901881|NCT01543698|566401329|FG007|Phase 1b|Disease progression|3|||
156901882|NCT01543698|566401330|FG008|Phase 1b|Disease progression|4|||
156901883|NCT01543698|566401331|FG009|Phase 1b|Disease progression|5|||
157026517|NCT00324805|566851596|FG001|Overall Study|Other|2|||
156901884|NCT01543698|566401332|FG010|Phase 1b|Disease progression|1|||
156901885|NCT01543698|566401333|FG011|Phase 1b|Disease progression|0|||
156901886|NCT01543698|566401334|FG012|Phase 1b|Disease progression|0|||
156901887|NCT01543698|566401335|FG013|Phase 1b|Disease progression|0|||
156901888|NCT01543698|566401336|FG014|Phase 1b|Disease progression|0|||
156901889|NCT01543698|566401322|FG000|Phase 1b|Death|0|||
156901890|NCT01543698|566401323|FG001|Phase 1b|Death|0|||
156901891|NCT01543698|566401324|FG002|Phase 1b|Death|1|||
156901892|NCT01543698|566401325|FG003|Phase 1b|Death|1|||
156901893|NCT01543698|566401326|FG004|Phase 1b|Death|0|||
156901894|NCT01543698|566401327|FG005|Phase 1b|Death|0|||
156901895|NCT01543698|566401328|FG006|Phase 1b|Death|0|||
156901896|NCT01543698|566401329|FG007|Phase 1b|Death|0|||
156901897|NCT01543698|566401330|FG008|Phase 1b|Death|0|||
156901898|NCT01543698|566401331|FG009|Phase 1b|Death|0|||
156901899|NCT01543698|566401332|FG010|Phase 1b|Death|1|||
156901900|NCT01543698|566401333|FG011|Phase 1b|Death|0|||
156901901|NCT01543698|566401334|FG012|Phase 1b|Death|0|||
156901902|NCT01543698|566401335|FG013|Phase 1b|Death|0|||
156901903|NCT01543698|566401336|FG014|Phase 1b|Death|0|||
156901904|NCT01543698|566401322|FG000|Phase 1b|Withdrawal by Subject|0|||
156901905|NCT01543698|566401323|FG001|Phase 1b|Withdrawal by Subject|1|||
156901906|NCT01543698|566401324|FG002|Phase 1b|Withdrawal by Subject|0|||
156901907|NCT01543698|566401325|FG003|Phase 1b|Withdrawal by Subject|1|||
156901908|NCT01543698|566401326|FG004|Phase 1b|Withdrawal by Subject|0|||
156901909|NCT01543698|566401327|FG005|Phase 1b|Withdrawal by Subject|0|||
156901910|NCT01543698|566401328|FG006|Phase 1b|Withdrawal by Subject|1|||
156901911|NCT01543698|566401329|FG007|Phase 1b|Withdrawal by Subject|0|||
156901912|NCT01543698|566401330|FG008|Phase 1b|Withdrawal by Subject|0|||
156901913|NCT01543698|566401331|FG009|Phase 1b|Withdrawal by Subject|0|||
156901914|NCT01543698|566401332|FG010|Phase 1b|Withdrawal by Subject|0|||
156901915|NCT01543698|566401333|FG011|Phase 1b|Withdrawal by Subject|0|||
156901916|NCT01543698|566401334|FG012|Phase 1b|Withdrawal by Subject|0|||
156901917|NCT01543698|566401335|FG013|Phase 1b|Withdrawal by Subject|0|||
156901918|NCT01543698|566401336|FG014|Phase 1b|Withdrawal by Subject|0|||
156901919|NCT01543698|566401322|FG000|Phase 1b|Adverse Event|1|||
156901920|NCT01543698|566401323|FG001|Phase 1b|Adverse Event|0|||
156901921|NCT01543698|566401324|FG002|Phase 1b|Adverse Event|0|||
156901922|NCT01543698|566401325|FG003|Phase 1b|Adverse Event|1|||
156901923|NCT01543698|566401326|FG004|Phase 1b|Adverse Event|2|||
156901924|NCT01543698|566401327|FG005|Phase 1b|Adverse Event|2|||
156901925|NCT01543698|566401328|FG006|Phase 1b|Adverse Event|0|||
156901926|NCT01543698|566401329|FG007|Phase 1b|Adverse Event|0|||
156901927|NCT01543698|566401330|FG008|Phase 1b|Adverse Event|1|||
156901928|NCT01543698|566401331|FG009|Phase 1b|Adverse Event|1|||
156901929|NCT01543698|566401332|FG010|Phase 1b|Adverse Event|2|||
156901930|NCT01543698|566401333|FG011|Phase 1b|Adverse Event|0|||
156901931|NCT01543698|566401334|FG012|Phase 1b|Adverse Event|0|||
156901932|NCT01543698|566401335|FG013|Phase 1b|Adverse Event|0|||
156901933|NCT01543698|566401336|FG014|Phase 1b|Adverse Event|0|||
156901934|NCT01543698|566401322|FG000|Phase 1b|Administrative problems|1|||
156901935|NCT01543698|566401323|FG001|Phase 1b|Administrative problems|0|||
156901936|NCT01543698|566401324|FG002|Phase 1b|Administrative problems|0|||
156901937|NCT01543698|566401325|FG003|Phase 1b|Administrative problems|0|||
156901938|NCT01543698|566401326|FG004|Phase 1b|Administrative problems|1|||
156901939|NCT01543698|566401327|FG005|Phase 1b|Administrative problems|0|||
156901940|NCT01543698|566401328|FG006|Phase 1b|Administrative problems|0|||
156901941|NCT01543698|566401329|FG007|Phase 1b|Administrative problems|1|||
156901942|NCT01543698|566401330|FG008|Phase 1b|Administrative problems|0|||
156901943|NCT01543698|566401331|FG009|Phase 1b|Administrative problems|0|||
156901944|NCT01543698|566401332|FG010|Phase 1b|Administrative problems|2|||
156901945|NCT01543698|566401333|FG011|Phase 1b|Administrative problems|0|||
156901946|NCT01543698|566401334|FG012|Phase 1b|Administrative problems|0|||
156901947|NCT01543698|566401335|FG013|Phase 1b|Administrative problems|0|||
156901948|NCT01543698|566401336|FG014|Phase 1b|Administrative problems|0|||
156901949|NCT01543698|566401322|FG000|Phase 1b|Protocol Violation|2|||
156901950|NCT01543698|566401323|FG001|Phase 1b|Protocol Violation|0|||
156901951|NCT01543698|566401324|FG002|Phase 1b|Protocol Violation|0|||
156901952|NCT01543698|566401325|FG003|Phase 1b|Protocol Violation|0|||
156901953|NCT01543698|566401326|FG004|Phase 1b|Protocol Violation|0|||
156901954|NCT01543698|566401327|FG005|Phase 1b|Protocol Violation|0|||
156901955|NCT01543698|566401328|FG006|Phase 1b|Protocol Violation|0|||
156901956|NCT01543698|566401329|FG007|Phase 1b|Protocol Violation|0|||
156901957|NCT01543698|566401330|FG008|Phase 1b|Protocol Violation|0|||
156901958|NCT01543698|566401331|FG009|Phase 1b|Protocol Violation|0|||
156901959|NCT01543698|566401332|FG010|Phase 1b|Protocol Violation|0|||
156901960|NCT01543698|566401333|FG011|Phase 1b|Protocol Violation|0|||
156901961|NCT01543698|566401334|FG012|Phase 1b|Protocol Violation|0|||
156901962|NCT01543698|566401335|FG013|Phase 1b|Protocol Violation|0|||
156901963|NCT01543698|566401336|FG014|Phase 1b|Protocol Violation|0|||
156901964|NCT01543698|566401322|FG000|Phase 2|Protocol Violation|0|||
156901965|NCT01543698|566401323|FG001|Phase 2|Protocol Violation|0|||
156901966|NCT01543698|566401324|FG002|Phase 2|Protocol Violation|0|||
156901967|NCT01543698|566401325|FG003|Phase 2|Protocol Violation|0|||
156901968|NCT01543698|566401326|FG004|Phase 2|Protocol Violation|0|||
156901969|NCT01543698|566401327|FG005|Phase 2|Protocol Violation|0|||
156901970|NCT01543698|566401328|FG006|Phase 2|Protocol Violation|0|||
156901971|NCT01543698|566401329|FG007|Phase 2|Protocol Violation|0|||
156901972|NCT01543698|566401330|FG008|Phase 2|Protocol Violation|0|||
156901973|NCT01543698|566401331|FG009|Phase 2|Protocol Violation|0|||
156901974|NCT01543698|566401332|FG010|Phase 2|Protocol Violation|0|||
156901975|NCT01543698|566401333|FG011|Phase 2|Protocol Violation|0|||
156901976|NCT01543698|566401334|FG012|Phase 2|Protocol Violation|1|||
156901977|NCT01543698|566401335|FG013|Phase 2|Protocol Violation|0|||
156901978|NCT01543698|566401336|FG014|Phase 2|Protocol Violation|0|||
156901979|NCT01543698|566401322|FG000|Phase 2|Disease progression|0|||
156901980|NCT01543698|566401323|FG001|Phase 2|Disease progression|0|||
156901981|NCT01543698|566401324|FG002|Phase 2|Disease progression|0|||
156901982|NCT01543698|566401325|FG003|Phase 2|Disease progression|0|||
156901983|NCT01543698|566401326|FG004|Phase 2|Disease progression|0|||
156901984|NCT01543698|566401327|FG005|Phase 2|Disease progression|0|||
156901985|NCT01543698|566401328|FG006|Phase 2|Disease progression|0|||
156901986|NCT01543698|566401329|FG007|Phase 2|Disease progression|0|||
156901987|NCT01543698|566401330|FG008|Phase 2|Disease progression|0|||
156901988|NCT01543698|566401331|FG009|Phase 2|Disease progression|0|||
156901989|NCT01543698|566401332|FG010|Phase 2|Disease progression|0|||
156901990|NCT01543698|566401333|FG011|Phase 2|Disease progression|10|||
156901991|NCT01543698|566401334|FG012|Phase 2|Disease progression|21|||
156901992|NCT01543698|566401335|FG013|Phase 2|Disease progression|30|||
156901993|NCT01543698|566401336|FG014|Phase 2|Disease progression|25|||
156901994|NCT01543698|566401322|FG000|Phase 2|Death|0|||
156901995|NCT01543698|566401323|FG001|Phase 2|Death|0|||
156901996|NCT01543698|566401324|FG002|Phase 2|Death|0|||
156901997|NCT01543698|566401325|FG003|Phase 2|Death|0|||
156901998|NCT01543698|566401326|FG004|Phase 2|Death|0|||
156901999|NCT01543698|566401327|FG005|Phase 2|Death|0|||
156902000|NCT01543698|566401328|FG006|Phase 2|Death|0|||
156902001|NCT01543698|566401329|FG007|Phase 2|Death|0|||
156902002|NCT01543698|566401330|FG008|Phase 2|Death|0|||
156902003|NCT01543698|566401331|FG009|Phase 2|Death|0|||
156902004|NCT01543698|566401332|FG010|Phase 2|Death|0|||
156902005|NCT01543698|566401333|FG011|Phase 2|Death|0|||
156902006|NCT01543698|566401334|FG012|Phase 2|Death|1|||
156902007|NCT01543698|566401335|FG013|Phase 2|Death|1|||
156902008|NCT01543698|566401336|FG014|Phase 2|Death|1|||
156902009|NCT01543698|566401322|FG000|Phase 2|Administrative problems|0|||
156902010|NCT01543698|566401323|FG001|Phase 2|Administrative problems|0|||
156902011|NCT01543698|566401324|FG002|Phase 2|Administrative problems|0|||
156902012|NCT01543698|566401325|FG003|Phase 2|Administrative problems|0|||
156902013|NCT01543698|566401326|FG004|Phase 2|Administrative problems|0|||
156902014|NCT01543698|566401327|FG005|Phase 2|Administrative problems|0|||
156902015|NCT01543698|566401328|FG006|Phase 2|Administrative problems|0|||
156902016|NCT01543698|566401329|FG007|Phase 2|Administrative problems|0|||
156902017|NCT01543698|566401330|FG008|Phase 2|Administrative problems|0|||
156902018|NCT01543698|566401331|FG009|Phase 2|Administrative problems|0|||
156902019|NCT01543698|566401332|FG010|Phase 2|Administrative problems|0|||
156902020|NCT01543698|566401333|FG011|Phase 2|Administrative problems|0|||
156902021|NCT01543698|566401334|FG012|Phase 2|Administrative problems|0|||
156902022|NCT01543698|566401335|FG013|Phase 2|Administrative problems|3|||
156902023|NCT01543698|566401336|FG014|Phase 2|Administrative problems|1|||
156902024|NCT01543698|566401322|FG000|Phase 2|Withdrawal by Subject|0|||
156902025|NCT01543698|566401323|FG001|Phase 2|Withdrawal by Subject|0|||
156902026|NCT01543698|566401324|FG002|Phase 2|Withdrawal by Subject|0|||
156902027|NCT01543698|566401325|FG003|Phase 2|Withdrawal by Subject|0|||
156902028|NCT01543698|566401326|FG004|Phase 2|Withdrawal by Subject|0|||
156902029|NCT01543698|566401327|FG005|Phase 2|Withdrawal by Subject|0|||
156902030|NCT01543698|566401328|FG006|Phase 2|Withdrawal by Subject|0|||
156902031|NCT01543698|566401329|FG007|Phase 2|Withdrawal by Subject|0|||
156902032|NCT01543698|566401330|FG008|Phase 2|Withdrawal by Subject|0|||
156902033|NCT01543698|566401331|FG009|Phase 2|Withdrawal by Subject|0|||
156902034|NCT01543698|566401332|FG010|Phase 2|Withdrawal by Subject|0|||
156902035|NCT01543698|566401333|FG011|Phase 2|Withdrawal by Subject|0|||
157026518|NCT00324805|566851595|FG000|Overall Study|Did not start therapy|12|||
157026519|NCT00324805|566851596|FG001|Overall Study|Did not start therapy|17|||
157026520|NCT05977530|566851604|FG000|Overall Study|Withdrawal by Subject|1|||
156902036|NCT01543698|566401334|FG012|Phase 2|Withdrawal by Subject|0|||
156902037|NCT01543698|566401335|FG013|Phase 2|Withdrawal by Subject|3|||
156902038|NCT01543698|566401336|FG014|Phase 2|Withdrawal by Subject|1|||
156902039|NCT01543698|566401322|FG000|Phase 2|Adverse Event|0|||
156902040|NCT01543698|566401323|FG001|Phase 2|Adverse Event|0|||
156902041|NCT01543698|566401324|FG002|Phase 2|Adverse Event|0|||
156902042|NCT01543698|566401325|FG003|Phase 2|Adverse Event|0|||
156902043|NCT01543698|566401326|FG004|Phase 2|Adverse Event|0|||
156902044|NCT01543698|566401327|FG005|Phase 2|Adverse Event|0|||
156902045|NCT01543698|566401328|FG006|Phase 2|Adverse Event|0|||
156902046|NCT01543698|566401329|FG007|Phase 2|Adverse Event|0|||
156902047|NCT01543698|566401330|FG008|Phase 2|Adverse Event|0|||
156902048|NCT01543698|566401331|FG009|Phase 2|Adverse Event|0|||
156902049|NCT01543698|566401332|FG010|Phase 2|Adverse Event|0|||
157158799|NCT00111475|567326776|FG007|Overall Study|Lost to Follow-up|0|||
157158800|NCT00111475|567326777|FG008|Overall Study|Lost to Follow-up|0|||
157158801|NCT00111475|567326778|FG009|Overall Study|Lost to Follow-up|0|||
157158802|NCT03303092|567326779|FG000|Overall Study|Adverse Event|1|||
157158803|NCT03303092|567326780|FG001|Overall Study|Adverse Event|0|||
157158804|NCT03303092|567326781|FG002|Overall Study|Adverse Event|1|||
157158805|NCT03303092|567326779|FG000|Overall Study|Protocol Violation|1|||
157158806|NCT03303092|567326780|FG001|Overall Study|Protocol Violation|5|||
157158807|NCT03303092|567326781|FG002|Overall Study|Protocol Violation|1|||
157158808|NCT03303092|567326779|FG000|Overall Study|Withdrawal by Subject|1|||
157158809|NCT03303092|567326780|FG001|Overall Study|Withdrawal by Subject|1|||
157158810|NCT03303092|567326781|FG002|Overall Study|Withdrawal by Subject|3|||
157158811|NCT01995136|567326787|FG000|Overall Study|Change in residence|1|||
157158812|NCT00833248|567326791|FG000|Overall Study|Adverse Event|3|||
157158813|NCT00833248|567326792|FG001|Overall Study|Adverse Event|0|||
157158814|NCT00833248|567326791|FG000|Overall Study|Protocol Violation|1|||
157158815|NCT00833248|567326792|FG001|Overall Study|Protocol Violation|2|||
157158816|NCT00833248|567326791|FG000|Overall Study|Withdrawal by Subject|0|||
157158817|NCT00833248|567326792|FG001|Overall Study|Withdrawal by Subject|1|||
157158818|NCT01030458|567326797|FG000|Overall Study|Lost to Follow-up|9|||
157158819|NCT01030458|567326798|FG001|Overall Study|Lost to Follow-up|10|||
157158820|NCT01030458|567326797|FG000|Overall Study|Withdrawal by Subject|2|||
157158821|NCT01030458|567326798|FG001|Overall Study|Withdrawal by Subject|3|||
157158822|NCT01030458|567326797|FG000|Overall Study|Logistical reasons|9|||
157158823|NCT01030458|567326798|FG001|Overall Study|Logistical reasons|5|||
157158824|NCT01030458|567326797|FG000|Overall Study|Moved or changed job|6|||
157158825|NCT01030458|567326798|FG001|Overall Study|Moved or changed job|13|||
157158826|NCT01030458|567326797|FG000|Overall Study|Side effect of medication|1|||
157158827|NCT01030458|567326798|FG001|Overall Study|Side effect of medication|1|||
157158828|NCT00839423|567326801|FG000|Overall Study|Adverse Event|4|||
157158829|NCT00839423|567326802|FG001|Overall Study|Adverse Event|3|||
157158830|NCT00839423|567326803|FG002|Overall Study|Adverse Event|7|||
157158831|NCT00839423|567326804|FG003|Overall Study|Adverse Event|16|||
157158832|NCT00839423|567326801|FG000|Overall Study|Lack of Efficacy|6|||
156859178|NCT02587520|566241151|FG004|Overall Study|Adverse Event|0|||
156859179|NCT02587520|566241152|FG005|Overall Study|Adverse Event|0|||
156859180|NCT02587520|566241153|FG006|Overall Study|Adverse Event|0|||
156859181|NCT02587520|566241154|FG007|Overall Study|Adverse Event|0|||
156859182|NCT02587520|566241155|FG008|Overall Study|Adverse Event|0|||
156859183|NCT02587520|566241156|FG009|Overall Study|Adverse Event|0|||
156859184|NCT02587520|566241157|FG010|Overall Study|Adverse Event|0|||
156859185|NCT02587520|566241158|FG011|Overall Study|Adverse Event|1|||
156859186|NCT02587520|566241159|FG012|Overall Study|Adverse Event|0|||
156859187|NCT02587520|566241160|FG013|Overall Study|Adverse Event|0|||
156859188|NCT02587520|566241161|FG014|Overall Study|Adverse Event|0|||
156859189|NCT02587520|566241162|FG015|Overall Study|Adverse Event|0|||
156859190|NCT02587520|566241163|FG016|Overall Study|Adverse Event|0|||
156859191|NCT02587520|566241164|FG017|Overall Study|Adverse Event|0|||
156859192|NCT02587520|566241147|FG000|Overall Study|Withdrawal by Subject|0|||
156859193|NCT02587520|566241148|FG001|Overall Study|Withdrawal by Subject|0|||
156859194|NCT02587520|566241149|FG002|Overall Study|Withdrawal by Subject|1|||
156859195|NCT02587520|566241150|FG003|Overall Study|Withdrawal by Subject|1|||
156859196|NCT02587520|566241151|FG004|Overall Study|Withdrawal by Subject|0|||
156859197|NCT02587520|566241152|FG005|Overall Study|Withdrawal by Subject|1|||
156859198|NCT02587520|566241153|FG006|Overall Study|Withdrawal by Subject|1|||
156859199|NCT02587520|566241154|FG007|Overall Study|Withdrawal by Subject|0|||
156859200|NCT02587520|566241155|FG008|Overall Study|Withdrawal by Subject|0|||
156859201|NCT02587520|566241156|FG009|Overall Study|Withdrawal by Subject|0|||
156859202|NCT02587520|566241157|FG010|Overall Study|Withdrawal by Subject|0|||
156859203|NCT02587520|566241158|FG011|Overall Study|Withdrawal by Subject|0|||
156859204|NCT02587520|566241159|FG012|Overall Study|Withdrawal by Subject|0|||
156859205|NCT02587520|566241160|FG013|Overall Study|Withdrawal by Subject|1|||
156859206|NCT02587520|566241161|FG014|Overall Study|Withdrawal by Subject|0|||
156859207|NCT02587520|566241162|FG015|Overall Study|Withdrawal by Subject|0|||
156859208|NCT02587520|566241163|FG016|Overall Study|Withdrawal by Subject|0|||
156859209|NCT02587520|566241164|FG017|Overall Study|Withdrawal by Subject|0|||
156859210|NCT02587520|566241147|FG000|Overall Study|Lost to Follow-up|0|||
156859211|NCT02587520|566241148|FG001|Overall Study|Lost to Follow-up|2|||
156859212|NCT02587520|566241149|FG002|Overall Study|Lost to Follow-up|0|||
156859213|NCT02587520|566241150|FG003|Overall Study|Lost to Follow-up|2|||
156859214|NCT02587520|566241151|FG004|Overall Study|Lost to Follow-up|0|||
156859215|NCT02587520|566241152|FG005|Overall Study|Lost to Follow-up|1|||
156859216|NCT02587520|566241153|FG006|Overall Study|Lost to Follow-up|1|||
156859217|NCT02587520|566241154|FG007|Overall Study|Lost to Follow-up|1|||
156859218|NCT02587520|566241155|FG008|Overall Study|Lost to Follow-up|0|||
157158833|NCT00839423|567326802|FG001|Overall Study|Lack of Efficacy|6|||
157158834|NCT00839423|567326803|FG002|Overall Study|Lack of Efficacy|3|||
157158835|NCT00839423|567326804|FG003|Overall Study|Lack of Efficacy|2|||
157158836|NCT00839423|567326801|FG000|Overall Study|Non-compliance|0|||
156902050|NCT01543698|566401333|FG011|Phase 2|Adverse Event|1|||
156902051|NCT01543698|566401334|FG012|Phase 2|Adverse Event|3|||
156902052|NCT01543698|566401335|FG013|Phase 2|Adverse Event|5|||
156902053|NCT01543698|566401336|FG014|Phase 2|Adverse Event|14|||
156902054|NCT00217620|566401337|FG000|Overall Study|Adverse Event|2|||
156902055|NCT00217620|566401337|FG000|Overall Study|Progression|31|||
156902056|NCT00217620|566401337|FG000|Overall Study|Not Protocol Specified|4|||
156902057|NCT00217620|566401337|FG000|Overall Study|Ineligible|13|||
156902058|NCT00217620|566401337|FG000|Overall Study|Never received treatment|1|||
156902059|NCT01863953|566401351|FG000|Overall Study|Adverse Event|0|||
156902060|NCT01863953|566401352|FG001|Overall Study|Adverse Event|0|||
156902061|NCT01863953|566401353|FG002|Overall Study|Adverse Event|1|||
156902062|NCT02008318|566401359|FG000|Overall Study|Adverse Event|4|||
156902063|NCT02008318|566401360|FG001|Overall Study|Adverse Event|0|||
156902064|NCT02008318|566401359|FG000|Overall Study|Physician Decision|2|||
156902065|NCT02008318|566401360|FG001|Overall Study|Physician Decision|0|||
156902066|NCT02008318|566401359|FG000|Overall Study|Progressive Disease|2|||
156902067|NCT02008318|566401360|FG001|Overall Study|Progressive Disease|0|||
156902068|NCT02008318|566401359|FG000|Overall Study|Protocol Violation|1|||
156902069|NCT02008318|566401360|FG001|Overall Study|Protocol Violation|1|||
156902070|NCT02008318|566401359|FG000|Overall Study|Withdrawal by Subject|3|||
156902071|NCT02008318|566401360|FG001|Overall Study|Withdrawal by Subject|0|||
156902072|NCT02336373|566401363|FG000|Overall Study|Protocol closed early|4|||
156902073|NCT02336373|566401363|FG000|Overall Study|Physician Decision|14|||
156902074|NCT02024529|566401366|FG000|Overall Study|Withdrawal by Subject|11|||
156902075|NCT02024529|566401367|FG001|Overall Study|Withdrawal by Subject|21|||
156902076|NCT02024529|566401366|FG000|Overall Study|Lost to Follow-up|2|||
156902077|NCT02024529|566401367|FG001|Overall Study|Lost to Follow-up|4|||
156902078|NCT02642029|566401368|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
156902079|NCT02642029|566401369|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156902080|NCT02642029|566401370|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156902081|NCT02642029|566401371|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156902082|NCT02642029|566401372|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156902083|NCT02642029|566401373|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
156902084|NCT02642029|566401368|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156902085|NCT02642029|566401369|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
156902086|NCT02642029|566401370|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156902087|NCT02642029|566401371|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156902088|NCT02642029|566401372|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156902089|NCT02642029|566401373|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
156902090|NCT02642029|566401368|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156902091|NCT02642029|566401369|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156902092|NCT02642029|566401370|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156902093|NCT02642029|566401371|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156902094|NCT02642029|566401372|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
156902095|NCT02642029|566401373|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
156902096|NCT02642029|566401368|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
156902097|NCT02642029|566401369|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
156902098|NCT02642029|566401370|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
156902099|NCT02642029|566401371|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
156902100|NCT02642029|566401372|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
156902101|NCT02642029|566401373|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
156902102|NCT02642029|566401368|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
156902103|NCT02642029|566401369|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
157225524|NCT01659567|567571457|FG000|Overall Study|Other|13|||
156902104|NCT02642029|566401370|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156902105|NCT02642029|566401371|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156902106|NCT02642029|566401372|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156902107|NCT02642029|566401373|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
156902108|NCT02642029|566401368|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
156902109|NCT02642029|566401369|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156902110|NCT02642029|566401370|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
157026521|NCT05977530|566851604|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
156902111|NCT02642029|566401371|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156902112|NCT02642029|566401372|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
156902113|NCT02642029|566401373|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
157026522|NCT04524442|566851607|FG000|Overall Study|Subject Decision|1|||
157225525|NCT01179919|567571458|FG000|Overall Study|Protocol Violation|1|||
156902114|NCT00691301|566401376|FG000|Overall Study|Adverse Event|10|||
157225526|NCT01179919|567571458|FG000|Overall Study|Adverse Event|1|||
157225527|NCT00698685|567571459|FG000|Overall Study|Sister withdrew as donor|1|||
156902115|NCT00691301|566401376|FG000|Overall Study|Death|2|||
156902116|NCT00691301|566401376|FG000|Overall Study|Lack of Efficacy|32|||
156902117|NCT00691301|566401376|FG000|Overall Study|Withdrawal by Subject|4|||
156902118|NCT00691301|566401376|FG000|Overall Study|Concurrent illness|2|||
156902119|NCT00691301|566401376|FG000|Overall Study|other reason|3|||
156902120|NCT00691301|566401376|FG000|Overall Study|Did not initiate study treatment|1|||
156902121|NCT01823146|566401377|FG000|Overall Study|Withdrawal by Subject|0|||
156902122|NCT01823146|566401378|FG001|Overall Study|Withdrawal by Subject|1|||
156902123|NCT01823146|566401377|FG000|Overall Study|Lost to Follow-up|2|||
156902124|NCT01823146|566401378|FG001|Overall Study|Lost to Follow-up|1|||
156902125|NCT00463580|566401379|FG000|Overall Study|Lost to Follow-up|1|||
156902126|NCT00463580|566401380|FG001|Overall Study|Lost to Follow-up|0|||
156902127|NCT00463580|566401379|FG000|Overall Study|Schedule conflict|2|||
156902128|NCT00463580|566401380|FG001|Overall Study|Schedule conflict|0|||
156902129|NCT00463580|566401379|FG000|Overall Study|Medical/psychiatric complications|0|||
156902130|NCT00463580|566401380|FG001|Overall Study|Medical/psychiatric complications|2|||
156902131|NCT00538291|566401381|FG000|Overall Study|Adverse Event|2|||
156902132|NCT00538291|566401381|FG000|Overall Study|Withdrawal by Subject|1|||
156902133|NCT00694707|566401382|FG000|Overall Study|Did Not Receive Treatment|0|||
156902134|NCT00694707|566401383|FG001|Overall Study|Did Not Receive Treatment|0|||
156902135|NCT00694707|566401384|FG002|Overall Study|Did Not Receive Treatment|1|||
156902136|NCT00694707|566401385|FG003|Overall Study|Did Not Receive Treatment|1|||
156902137|NCT00694707|566401386|FG004|Overall Study|Did Not Receive Treatment|1|||
156902138|NCT00694707|566401382|FG000|Overall Study|Adverse Event|22|||
156902139|NCT00694707|566401383|FG001|Overall Study|Adverse Event|14|||
156902140|NCT00694707|566401384|FG002|Overall Study|Adverse Event|8|||
156902141|NCT00694707|566401385|FG003|Overall Study|Adverse Event|12|||
156902142|NCT00694707|566401386|FG004|Overall Study|Adverse Event|13|||
157026523|NCT03085810|566851624|FG000|Main Study|Withdrawal by Subject|77|||
156859219|NCT02587520|566241156|FG009|Overall Study|Lost to Follow-up|2|||
156859220|NCT02587520|566241157|FG010|Overall Study|Lost to Follow-up|2|||
156859221|NCT02587520|566241158|FG011|Overall Study|Lost to Follow-up|1|||
156859222|NCT02587520|566241159|FG012|Overall Study|Lost to Follow-up|0|||
156859223|NCT02587520|566241160|FG013|Overall Study|Lost to Follow-up|0|||
156859224|NCT02587520|566241161|FG014|Overall Study|Lost to Follow-up|0|||
156859225|NCT02587520|566241162|FG015|Overall Study|Lost to Follow-up|0|||
156859226|NCT02587520|566241163|FG016|Overall Study|Lost to Follow-up|0|||
156859227|NCT02587520|566241164|FG017|Overall Study|Lost to Follow-up|0|||
156859228|NCT00672555|566241165|FG000|Overall Study|Lost to Follow-up|4|||
156859229|NCT00672555|566241165|FG000|Overall Study|Did not want to answer questionnaire|2|||
156859230|NCT04516746|566241168|FG000|Overall Study|Randomized but not Treated|51|||
156859231|NCT04516746|566241169|FG001|Overall Study|Randomized but not Treated|19|||
156859232|NCT04516746|566241168|FG000|Overall Study|Adverse Event|0|||
156859233|NCT04516746|566241169|FG001|Overall Study|Adverse Event|1|||
156859234|NCT04516746|566241168|FG000|Overall Study|Death|62|||
156859235|NCT04516746|566241169|FG001|Overall Study|Death|32|||
156859236|NCT04516746|566241168|FG000|Overall Study|Lost to Follow-up|3431|||
156859237|NCT04516746|566241169|FG001|Overall Study|Lost to Follow-up|1831|||
156859238|NCT04516746|566241168|FG000|Overall Study|Withdrawal by Subject|1946|||
156859239|NCT04516746|566241169|FG001|Overall Study|Withdrawal by Subject|1696|||
156859240|NCT04516746|566241168|FG000|Overall Study|Physician Decision|10|||
156859241|NCT04516746|566241169|FG001|Overall Study|Physician Decision|8|||
156859242|NCT04516746|566241168|FG000|Overall Study|Other|35|||
156859243|NCT04516746|566241169|FG001|Overall Study|Other|16|||
156859244|NCT00446849|566241171|FG000|Acute Phase|Lack of Efficacy|64|||
156859245|NCT00446849|566241171|FG000|Acute Phase|Protocol Violation|10|||
156859246|NCT00446849|566241171|FG000|Acute Phase|Consent withdrawn|4|||
156859247|NCT00446849|566241171|FG000|Acute Phase|Lost to Follow-up|2|||
156859248|NCT00446849|566241171|FG000|Acute Phase|Physician Decision|1|||
156859249|NCT00446849|566241171|FG000|Acute Phase|noncompliance|1|||
156859250|NCT00446849|566241171|FG000|Maintenance Phase|Lack of Efficacy|40|||
156859251|NCT00446849|566241171|FG000|Maintenance Phase|Protocol Violation|7|||
156859252|NCT00446849|566241171|FG000|Maintenance Phase|Adverse Event|6|||
156859253|NCT00446849|566241171|FG000|Maintenance Phase|Consent withdrawn|5|||
156859254|NCT00446849|566241171|FG000|Maintenance Phase|Lost to Follow-up|3|||
156859255|NCT00446849|566241171|FG000|Maintenance Phase|Pregnancy|1|||
156859256|NCT00446849|566241171|FG000|Maintenance Phase|noncompliance|2|||
156859257|NCT00446849|566241171|FG000|Maintenance Phase|prohibited medication use|2|||
156859258|NCT00446849|566241171|FG000|Maintenance Phase|antibiotic use|1|||
156859259|NCT00446849|566241171|FG000|Maintenance Phase|study closure|1|||
156859260|NCT00446849|566241171|FG000|Maintenance Phase|hydrocodone use|1|||
156859261|NCT00446849|566241171|FG000|Maintenance Phase|concomitant medication use|1|||
156859262|NCT05546476|566241175|FG000|Period 1: Part A|Adverse Event|2|||
156859263|NCT05546476|566241176|FG001|Period 1: Part A|Adverse Event|0|||
156859264|NCT05546476|566241177|FG002|Period 1: Part A|Adverse Event|0|||
156902143|NCT00694707|566401382|FG000|Overall Study|Insufficient Therapeutic Response|33|||
156902144|NCT00694707|566401383|FG001|Overall Study|Insufficient Therapeutic Response|18|||
156859265|NCT05546476|566241178|FG003|Period 1: Part A|Adverse Event|1|||
156859266|NCT05546476|566241175|FG000|Period 1: Part A|Death|4|||
156902145|NCT00694707|566401384|FG002|Overall Study|Insufficient Therapeutic Response|17|||
156902146|NCT00694707|566401385|FG003|Overall Study|Insufficient Therapeutic Response|15|||
156902147|NCT00694707|566401386|FG004|Overall Study|Insufficient Therapeutic Response|10|||
156902148|NCT00694707|566401382|FG000|Overall Study|Protocol Violation|1|||
156902149|NCT00694707|566401383|FG001|Overall Study|Protocol Violation|2|||
156902150|NCT00694707|566401384|FG002|Overall Study|Protocol Violation|1|||
156902151|NCT00694707|566401385|FG003|Overall Study|Protocol Violation|3|||
156902152|NCT00694707|566401386|FG004|Overall Study|Protocol Violation|1|||
156902153|NCT00694707|566401382|FG000|Overall Study|Withdrawal of Consent|14|||
156902154|NCT00694707|566401383|FG001|Overall Study|Withdrawal of Consent|18|||
156902155|NCT00694707|566401384|FG002|Overall Study|Withdrawal of Consent|22|||
156902156|NCT00694707|566401385|FG003|Overall Study|Withdrawal of Consent|16|||
156902157|NCT00694707|566401386|FG004|Overall Study|Withdrawal of Consent|15|||
156902158|NCT00694707|566401382|FG000|Overall Study|Lost to Follow-up|0|||
156902159|NCT00694707|566401383|FG001|Overall Study|Lost to Follow-up|1|||
156902160|NCT00694707|566401384|FG002|Overall Study|Lost to Follow-up|2|||
156902161|NCT00694707|566401385|FG003|Overall Study|Lost to Follow-up|0|||
156902162|NCT00694707|566401386|FG004|Overall Study|Lost to Follow-up|0|||
156902163|NCT00694707|566401382|FG000|Overall Study|Jeopardizing Parole Status|1|||
156902164|NCT00694707|566401383|FG001|Overall Study|Jeopardizing Parole Status|0|||
156902165|NCT00694707|566401384|FG002|Overall Study|Jeopardizing Parole Status|0|||
156902166|NCT00694707|566401385|FG003|Overall Study|Jeopardizing Parole Status|0|||
156902167|NCT00694707|566401386|FG004|Overall Study|Jeopardizing Parole Status|0|||
156902168|NCT00694707|566401382|FG000|Overall Study|Death in the Family|1|||
156902169|NCT00694707|566401383|FG001|Overall Study|Death in the Family|0|||
156902170|NCT00694707|566401384|FG002|Overall Study|Death in the Family|0|||
156902171|NCT00694707|566401385|FG003|Overall Study|Death in the Family|0|||
156902172|NCT00694707|566401386|FG004|Overall Study|Death in the Family|0|||
156902173|NCT00694707|566401382|FG000|Overall Study|Arrest by Police|0|||
156902174|NCT00694707|566401383|FG001|Overall Study|Arrest by Police|1|||
156902175|NCT00694707|566401384|FG002|Overall Study|Arrest by Police|0|||
156902176|NCT00694707|566401385|FG003|Overall Study|Arrest by Police|0|||
156902177|NCT00694707|566401386|FG004|Overall Study|Arrest by Police|0|||
156902178|NCT00694707|566401382|FG000|Overall Study|Administrative Reasons|0|||
156902179|NCT00694707|566401383|FG001|Overall Study|Administrative Reasons|1|||
156902180|NCT00694707|566401384|FG002|Overall Study|Administrative Reasons|0|||
156902181|NCT00694707|566401385|FG003|Overall Study|Administrative Reasons|2|||
156902182|NCT00694707|566401386|FG004|Overall Study|Administrative Reasons|0|||
156902183|NCT00694707|566401382|FG000|Overall Study|Notification of Past Head Injury|0|||
156902184|NCT00694707|566401383|FG001|Overall Study|Notification of Past Head Injury|0|||
156902185|NCT00694707|566401384|FG002|Overall Study|Notification of Past Head Injury|0|||
156902186|NCT00694707|566401385|FG003|Overall Study|Notification of Past Head Injury|1|||
156902187|NCT00694707|566401386|FG004|Overall Study|Notification of Past Head Injury|0|||
156902188|NCT01904058|566401394|FG000|Overall Study|Adverse Event|2|||
156902189|NCT01904058|566401395|FG001|Overall Study|Adverse Event|0|||
156902190|NCT01904058|566401396|FG002|Overall Study|Adverse Event|0|||
156902191|NCT01904058|566401397|FG003|Overall Study|Adverse Event|0|||
156902192|NCT01904058|566401394|FG000|Overall Study|Withdrawal by Subject|1|||
156902193|NCT01904058|566401395|FG001|Overall Study|Withdrawal by Subject|0|||
156902194|NCT01904058|566401396|FG002|Overall Study|Withdrawal by Subject|1|||
156902195|NCT01904058|566401397|FG003|Overall Study|Withdrawal by Subject|0|||
156902196|NCT01904058|566401394|FG000|Overall Study|Pregnancy|0|||
156902197|NCT01904058|566401395|FG001|Overall Study|Pregnancy|0|||
156902198|NCT01904058|566401396|FG002|Overall Study|Pregnancy|0|||
156902199|NCT01904058|566401397|FG003|Overall Study|Pregnancy|1|||
156902200|NCT03096483|566401399|FG000|Overall Study|Withdrawal by site|1|||
156902201|NCT00369707|566401400|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
156902202|NCT00369707|566401400|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
156902203|NCT00369707|566401400|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
156902204|NCT00369707|566401400|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
156902205|NCT00369707|566401400|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
156902206|NCT00369707|566401400|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
156902207|NCT00369707|566401400|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
156902208|NCT00369707|566401400|FG000|Follow up for 2 Years After Treatment|Death|1|||
156902209|NCT00369707|566401400|FG000|Follow up for 2 Years After Treatment|Other|2|||
156902210|NCT03449901|566401401|FG000|Overall Study|Progression|57|||
156902211|NCT03449901|566401402|FG001|Overall Study|Progression|12|||
156902212|NCT03449901|566401401|FG000|Overall Study|Adverse Event|3|||
157158837|NCT00839423|567326802|FG001|Overall Study|Non-compliance|0|||
156902213|NCT03449901|566401402|FG001|Overall Study|Adverse Event|0|||
156902214|NCT03449901|566401401|FG000|Overall Study|Death|6|||
156902215|NCT03449901|566401402|FG001|Overall Study|Death|2|||
156902216|NCT03449901|566401401|FG000|Overall Study|Withdrawal by Subject|12|||
156902217|NCT03449901|566401402|FG001|Overall Study|Withdrawal by Subject|1|||
156902218|NCT03449901|566401401|FG000|Overall Study|Physician Decision|1|||
156902219|NCT03449901|566401402|FG001|Overall Study|Physician Decision|0|||
157026524|NCT03085810|566851625|FG001|Main Study|Withdrawal by Subject|0|||
156902220|NCT03449901|566401401|FG000|Overall Study|Patient elected for surgical intervention|1|||
156902221|NCT03449901|566401402|FG001|Overall Study|Patient elected for surgical intervention|0|||
156902222|NCT03449901|566401401|FG000|Overall Study|Patient off for other complicating disease|1|||
156902223|NCT03449901|566401402|FG001|Overall Study|Patient off for other complicating disease|0|||
156902224|NCT03150173|566401403|FG000|Overall Study|Lost to Follow-up|13|||
156902225|NCT03150173|566401404|FG001|Overall Study|Lost to Follow-up|5|||
156902226|NCT02046733|566401408|FG000|Overall Study|never initiated 'treatment visits'|6|||
156902227|NCT02046733|566401409|FG001|Overall Study|never initiated 'treatment visits'|0|||
156902228|NCT03605212|566401410|FG000|Treatment Period|Adverse Event|1|||
156902229|NCT03605212|566401411|FG001|Treatment Period|Adverse Event|0|||
156902230|NCT03605212|566401412|FG002|Treatment Period|Adverse Event|0|||
156902231|NCT03605212|566401413|FG003|Treatment Period|Adverse Event|0|||
156902232|NCT03605212|566401414|FG004|Treatment Period|Adverse Event|0|||
156902233|NCT03605212|566401410|FG000|Treatment Period|Physician Decision|0|||
156902234|NCT03605212|566401411|FG001|Treatment Period|Physician Decision|0|||
156902235|NCT03605212|566401412|FG002|Treatment Period|Physician Decision|0|||
157158838|NCT00839423|567326803|FG002|Overall Study|Non-compliance|0|||
157158839|NCT00839423|567326804|FG003|Overall Study|Non-compliance|1|||
157158840|NCT00839423|567326801|FG000|Overall Study|Protocol Violation|0|||
157158841|NCT00839423|567326802|FG001|Overall Study|Protocol Violation|1|||
157158842|NCT00839423|567326803|FG002|Overall Study|Protocol Violation|2|||
157158843|NCT00839423|567326804|FG003|Overall Study|Protocol Violation|0|||
157158844|NCT00839423|567326801|FG000|Overall Study|Withdrawal of consent|4|||
157158845|NCT00839423|567326802|FG001|Overall Study|Withdrawal of consent|0|||
157158846|NCT00839423|567326803|FG002|Overall Study|Withdrawal of consent|4|||
157158847|NCT00839423|567326804|FG003|Overall Study|Withdrawal of consent|1|||
157158848|NCT00839423|567326801|FG000|Overall Study|Lost to Follow-up|1|||
157158849|NCT00839423|567326802|FG001|Overall Study|Lost to Follow-up|0|||
157158850|NCT00839423|567326803|FG002|Overall Study|Lost to Follow-up|1|||
157158851|NCT00839423|567326804|FG003|Overall Study|Lost to Follow-up|0|||
157158852|NCT00839423|567326801|FG000|Overall Study|Administrative or other reasons|3|||
157158853|NCT00839423|567326802|FG001|Overall Study|Administrative or other reasons|0|||
157158854|NCT00839423|567326803|FG002|Overall Study|Administrative or other reasons|1|||
157158855|NCT00839423|567326804|FG003|Overall Study|Administrative or other reasons|0|||
157158856|NCT01071096|567326805|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
157158857|NCT01071096|567326806|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
157158858|NCT02585999|567326807|FG000|Overall Study|Lost to Follow-up|1|||
157158859|NCT02585999|567326807|FG000|Overall Study|Protocol Violation|1|||
157158860|NCT01332019|567326808|FG000|Overall Study|Was Not Dosed|1|||
157158861|NCT01332019|567326809|FG001|Overall Study|Was Not Dosed|0|||
157158862|NCT01332019|567326808|FG000|Overall Study|Other|16|||
157158863|NCT01332019|567326809|FG001|Overall Study|Other|18|||
157158864|NCT01332019|567326808|FG000|Overall Study|Death|2|||
157158865|NCT01332019|567326809|FG001|Overall Study|Death|1|||
157158866|NCT01332019|567326808|FG000|Overall Study|Physician Decision|4|||
157158867|NCT01332019|567326809|FG001|Overall Study|Physician Decision|3|||
157158868|NCT01332019|567326808|FG000|Overall Study|Withdrawal by Subject|73|||
157158869|NCT01332019|567326809|FG001|Overall Study|Withdrawal by Subject|71|||
157158870|NCT01332019|567326808|FG000|Overall Study|Lost to Follow-up|4|||
157158871|NCT01332019|567326809|FG001|Overall Study|Lost to Follow-up|7|||
157158872|NCT01332019|567326808|FG000|Overall Study|Adverse Event|13|||
157158873|NCT01332019|567326809|FG001|Overall Study|Adverse Event|22|||
157158874|NCT01369849|567326812|FG000|Overall Study|Ineligible prior to treatment|0|||
157158875|NCT01369849|567326813|FG001|Overall Study|Ineligible prior to treatment|0|||
157158876|NCT01369849|567326814|FG002|Overall Study|Ineligible prior to treatment|1|||
157158877|NCT01369849|567326812|FG000|Overall Study|Ineligible after receiving treatment|0|||
157158878|NCT01369849|567326813|FG001|Overall Study|Ineligible after receiving treatment|1|||
157158879|NCT01369849|567326814|FG002|Overall Study|Ineligible after receiving treatment|0|||
157158880|NCT00871377|567326815|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
157158881|NCT00871377|567326816|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
157158882|NCT00871377|567326817|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
157158883|NCT00871377|567326818|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
157158884|NCT00871377|567326819|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
157158885|NCT00871377|567326820|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156902236|NCT03605212|566401413|FG003|Treatment Period|Physician Decision|0|||
156902237|NCT03605212|566401414|FG004|Treatment Period|Physician Decision|1|||
157158886|NCT00871377|567326815|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
157158887|NCT00871377|567326816|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
157158888|NCT00871377|567326817|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
157158889|NCT00871377|567326818|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
157158890|NCT00871377|567326819|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
157158891|NCT00871377|567326820|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
157158892|NCT00871377|567326815|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
157158893|NCT00871377|567326816|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158894|NCT00871377|567326817|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
156902238|NCT01254292|566401415|FG000|Comparative Phase|Adverse Event|25|||
156902239|NCT01254292|566401416|FG001|Comparative Phase|Adverse Event|25|||
156902240|NCT01254292|566401415|FG000|Comparative Phase|Lost to Follow-up|3|||
156902241|NCT01254292|566401416|FG001|Comparative Phase|Lost to Follow-up|21|||
156902242|NCT01254292|566401415|FG000|Comparative Phase|Pregnancy|2|||
156902243|NCT01254292|566401416|FG001|Comparative Phase|Pregnancy|6|||
156902244|NCT01254292|566401415|FG000|Comparative Phase|Withdrawal by Subject|20|||
156902245|NCT01254292|566401416|FG001|Comparative Phase|Withdrawal by Subject|21|||
156902246|NCT01254292|566401415|FG000|Comparative Phase|Protocol Violation|1|||
156902247|NCT01254292|566401416|FG001|Comparative Phase|Protocol Violation|2|||
156902248|NCT01254292|566401415|FG000|Comparative Phase|Wish for pregnancy|4|||
156902249|NCT01254292|566401416|FG001|Comparative Phase|Wish for pregnancy|6|||
156902250|NCT01254292|566401415|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
156902251|NCT01254292|566401416|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
156902252|NCT01254292|566401415|FG000|LCS12 Extension Phase|Adverse Event|9|||
156902253|NCT01254292|566401416|FG001|LCS12 Extension Phase|Adverse Event|0|||
156902254|NCT01254292|566401415|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
156902255|NCT01254292|566401416|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
156902256|NCT01254292|566401415|FG000|LCS12 Extension Phase|Other unknown|4|||
156902257|NCT01254292|566401416|FG001|LCS12 Extension Phase|Other unknown|0|||
156902258|NCT01254292|566401415|FG000|LCS12 Extension Phase|Pregnancy|2|||
156902259|NCT01254292|566401416|FG001|LCS12 Extension Phase|Pregnancy|0|||
156902260|NCT01254292|566401415|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
156902261|NCT01254292|566401416|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
156902262|NCT01708161|566401425|FG000|Overall Study|Adverse Event|1|||
156902263|NCT01708161|566401426|FG001|Overall Study|Adverse Event|3|||
156902264|NCT01708161|566401427|FG002|Overall Study|Adverse Event|4|||
156902265|NCT01708161|566401428|FG003|Overall Study|Adverse Event|2|||
156902266|NCT01708161|566401429|FG004|Overall Study|Adverse Event|3|||
156902267|NCT01708161|566401430|FG005|Overall Study|Adverse Event|0|||
156902268|NCT01708161|566401425|FG000|Overall Study|Death|0|||
156902269|NCT01708161|566401426|FG001|Overall Study|Death|0|||
156902270|NCT01708161|566401427|FG002|Overall Study|Death|0|||
156902271|NCT01708161|566401428|FG003|Overall Study|Death|1|||
156902272|NCT01708161|566401429|FG004|Overall Study|Death|0|||
156902273|NCT01708161|566401430|FG005|Overall Study|Death|1|||
156902274|NCT01708161|566401425|FG000|Overall Study|Withdrawal by Subject|0|||
156902275|NCT01708161|566401426|FG001|Overall Study|Withdrawal by Subject|1|||
156902276|NCT01708161|566401427|FG002|Overall Study|Withdrawal by Subject|1|||
156902277|NCT01708161|566401428|FG003|Overall Study|Withdrawal by Subject|0|||
156902278|NCT01708161|566401429|FG004|Overall Study|Withdrawal by Subject|0|||
156902279|NCT01708161|566401430|FG005|Overall Study|Withdrawal by Subject|0|||
156902280|NCT01708161|566401425|FG000|Overall Study|Administrative problems|0|||
156902281|NCT01708161|566401426|FG001|Overall Study|Administrative problems|1|||
156902282|NCT01708161|566401427|FG002|Overall Study|Administrative problems|0|||
156902283|NCT01708161|566401428|FG003|Overall Study|Administrative problems|0|||
156902284|NCT01708161|566401429|FG004|Overall Study|Administrative problems|0|||
156902285|NCT01708161|566401430|FG005|Overall Study|Administrative problems|0|||
156902286|NCT01708161|566401425|FG000|Overall Study|Disease progression|3|||
156902287|NCT01708161|566401426|FG001|Overall Study|Disease progression|5|||
156902288|NCT01708161|566401427|FG002|Overall Study|Disease progression|5|||
156902289|NCT01708161|566401428|FG003|Overall Study|Disease progression|13|||
156902290|NCT01708161|566401429|FG004|Overall Study|Disease progression|3|||
156902291|NCT01708161|566401430|FG005|Overall Study|Disease progression|0|||
156902292|NCT01268150|566401431|FG000|Treatment Phase|Progression of disease|18|||
156902293|NCT01268150|566401431|FG000|Treatment Phase|Adverse Event|3|||
156902294|NCT01268150|566401431|FG000|Treatment Phase|Withdrawal by Subject|3|||
156902295|NCT01268150|566401431|FG000|Treatment Phase|Other|4|||
156902296|NCT01268150|566401431|FG000|Extension Phase|Adverse Event|3|||
156902297|NCT01268150|566401431|FG000|Extension Phase|Disease progression|18|||
156902298|NCT01268150|566401431|FG000|Extension Phase|Other|6|||
156902299|NCT01672736|566401432|FG000|Overall Study|Available drug expired on 31 May 16|3|||
156902300|NCT01697358|566401433|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
156902301|NCT01697358|566401434|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
156902302|NCT01697358|566401433|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
156902303|NCT01697358|566401434|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
156902304|NCT01697358|566401433|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
156902305|NCT01697358|566401434|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
156902306|NCT01697358|566401433|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
156902307|NCT01697358|566401434|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
156902308|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
156902309|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
156902310|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
157026525|NCT03085810|566851626|FG002|Main Study|Withdrawal by Subject|0|||
157026526|NCT03085810|566851624|FG000|Main Study|Terminated By Sponsor|14|||
156902311|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
156902312|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
156902313|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
156902314|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
156902315|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
156902316|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
156902317|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
156902318|NCT01697358|566401433|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
156902319|NCT01697358|566401434|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
156902320|NCT04251273|566401435|FG000|Overall Study|Lost to Follow-up|331|||
156902321|NCT04251273|566401436|FG001|Overall Study|Lost to Follow-up|290|||
156902322|NCT00810693|566401437|FG000|Treatment Period|Adverse Event|8|||
156902323|NCT00810693|566401438|FG001|Treatment Period|Adverse Event|1|||
156902324|NCT00810693|566401439|FG002|Treatment Period|Adverse Event|7|||
156902325|NCT00810693|566401437|FG000|Treatment Period|Death|0|||
156902326|NCT00810693|566401438|FG001|Treatment Period|Death|1|||
156902327|NCT00810693|566401439|FG002|Treatment Period|Death|2|||
156902328|NCT00810693|566401437|FG000|Treatment Period|Lack of Efficacy|0|||
156902329|NCT00810693|566401438|FG001|Treatment Period|Lack of Efficacy|0|||
156902330|NCT00810693|566401439|FG002|Treatment Period|Lack of Efficacy|1|||
156902331|NCT00810693|566401437|FG000|Treatment Period|Lost to Follow-up|1|||
156902332|NCT00810693|566401438|FG001|Treatment Period|Lost to Follow-up|0|||
156902333|NCT00810693|566401439|FG002|Treatment Period|Lost to Follow-up|0|||
156902334|NCT00810693|566401437|FG000|Treatment Period|Non-compliance|1|||
156902335|NCT00810693|566401438|FG001|Treatment Period|Non-compliance|0|||
156902336|NCT00810693|566401439|FG002|Treatment Period|Non-compliance|0|||
156902337|NCT00810693|566401437|FG000|Treatment Period|Protocol Violation|1|||
156902338|NCT00810693|566401438|FG001|Treatment Period|Protocol Violation|2|||
156902339|NCT00810693|566401439|FG002|Treatment Period|Protocol Violation|2|||
156902340|NCT00810693|566401437|FG000|Treatment Period|Withdrawal by Subject|6|||
156902341|NCT00810693|566401438|FG001|Treatment Period|Withdrawal by Subject|2|||
156902342|NCT00810693|566401439|FG002|Treatment Period|Withdrawal by Subject|3|||
156902343|NCT00810693|566401437|FG000|Treatment Period|Not treated|0|||
156902344|NCT00810693|566401438|FG001|Treatment Period|Not treated|1|||
156902345|NCT00810693|566401439|FG002|Treatment Period|Not treated|1|||
156902346|NCT00810693|566401437|FG000|Follow-up Period (FUP)|Adverse Event|3|||
156902347|NCT00810693|566401438|FG001|Follow-up Period (FUP)|Adverse Event|1|||
156902348|NCT00810693|566401439|FG002|Follow-up Period (FUP)|Adverse Event|1|||
156902349|NCT00810693|566401437|FG000|Follow-up Period (FUP)|Death|2|||
156902350|NCT00810693|566401438|FG001|Follow-up Period (FUP)|Death|0|||
156902351|NCT00810693|566401439|FG002|Follow-up Period (FUP)|Death|1|||
156902352|NCT00810693|566401437|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
156902353|NCT00810693|566401438|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
156902354|NCT00810693|566401439|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
156902355|NCT00810693|566401437|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
156902356|NCT00810693|566401438|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
156902357|NCT00810693|566401439|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
156902358|NCT00810693|566401437|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
157158895|NCT00871377|567326818|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158896|NCT00871377|567326819|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158897|NCT00871377|567326820|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158898|NCT00871377|567326815|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158899|NCT00871377|567326816|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158900|NCT00871377|567326817|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158901|NCT00871377|567326818|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158902|NCT00871377|567326819|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
157158903|NCT00871377|567326820|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
157158904|NCT00871377|567326815|FG000|Third Intervention (10 Weeks)|Death|0|||
157158905|NCT00871377|567326816|FG001|Third Intervention (10 Weeks)|Death|0|||
157158906|NCT00871377|567326817|FG002|Third Intervention (10 Weeks)|Death|0|||
157158907|NCT00871377|567326818|FG003|Third Intervention (10 Weeks)|Death|1|||
157158908|NCT00871377|567326819|FG004|Third Intervention (10 Weeks)|Death|0|||
157158909|NCT00871377|567326820|FG005|Third Intervention (10 Weeks)|Death|0|||
157158910|NCT04281030|567326821|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
156902359|NCT00810693|566401438|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
156902360|NCT00810693|566401439|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
156902361|NCT00936611|566401446|FG000|Overall Study|Progressive Disease|3|||
156902362|NCT00936611|566401446|FG000|Overall Study|New Systemic Therapy|22|||
156902363|NCT00936611|566401446|FG000|Overall Study|Lost to Follow-up|1|||
156902364|NCT00936611|566401446|FG000|Overall Study|Withdrawal by Subject|2|||
156902365|NCT00936611|566401446|FG000|Overall Study|Still on Follow-up|1|||
156902366|NCT00936611|566401446|FG000|Overall Study|Still on Active Therapy|7|||
157158911|NCT04281030|567326822|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
157158912|NCT04281030|567326821|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
157225528|NCT00698685|567571459|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
156902367|NCT00936611|566401446|FG000|Overall Study|Ineligible for Study Drug|3|||
156902368|NCT02282358|566401447|FG000|Overall Study|Nonevaluable|1|||
156902369|NCT01898208|566401448|FG000|Overall Study|Positive blood culture|17|||
156902370|NCT01898208|566401449|FG001|Overall Study|Positive blood culture|23|||
156902371|NCT01898208|566401450|FG002|Overall Study|Positive blood culture|15|||
156902372|NCT01898208|566401448|FG000|Overall Study|Death/comfort care within 24 hours|10|||
156902373|NCT01898208|566401449|FG001|Overall Study|Death/comfort care within 24 hours|9|||
156902374|NCT01898208|566401450|FG002|Overall Study|Death/comfort care within 24 hours|8|||
156902375|NCT01898208|566401448|FG000|Overall Study|Negative Gram Stain|6|||
156902376|NCT01898208|566401449|FG001|Overall Study|Negative Gram Stain|9|||
156902377|NCT01898208|566401450|FG002|Overall Study|Negative Gram Stain|6|||
156902378|NCT01898208|566401448|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
156902379|NCT01898208|566401449|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
156902380|NCT01898208|566401450|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
156902381|NCT01898208|566401448|FG000|Overall Study|System/Technical Error|1|||
156902382|NCT01898208|566401449|FG001|Overall Study|System/Technical Error|2|||
156902383|NCT01898208|566401450|FG002|Overall Study|System/Technical Error|3|||
156902384|NCT01898208|566401448|FG000|Overall Study|Lost to Follow-up|3|||
156902385|NCT01898208|566401449|FG001|Overall Study|Lost to Follow-up|1|||
156902386|NCT01898208|566401450|FG002|Overall Study|Lost to Follow-up|1|||
156902387|NCT00961649|566401451|FG000|Overall Study|Adverse Event|4|||
156902388|NCT00961649|566401452|FG001|Overall Study|Adverse Event|0|||
156902389|NCT00961649|566401453|FG002|Overall Study|Adverse Event|0|||
156902390|NCT00961649|566401454|FG003|Overall Study|Adverse Event|2|||
156902391|NCT00961649|566401451|FG000|Overall Study|Inadequate control of IOP|0|||
156902392|NCT00961649|566401452|FG001|Overall Study|Inadequate control of IOP|0|||
156902393|NCT00961649|566401453|FG002|Overall Study|Inadequate control of IOP|0|||
156902394|NCT00961649|566401454|FG003|Overall Study|Inadequate control of IOP|1|||
156902395|NCT00961649|566401451|FG000|Overall Study|Patient has travel plans during holidays|0|||
156902396|NCT00961649|566401452|FG001|Overall Study|Patient has travel plans during holidays|0|||
156902397|NCT00961649|566401453|FG002|Overall Study|Patient has travel plans during holidays|1|||
156902398|NCT00961649|566401454|FG003|Overall Study|Patient has travel plans during holidays|0|||
156902399|NCT00961649|566401451|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
156902400|NCT00961649|566401452|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
156902401|NCT00961649|566401453|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
156902402|NCT00961649|566401454|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
156902403|NCT00961649|566401451|FG000|Overall Study|Study terminated by sponsor|4|||
156902404|NCT00961649|566401452|FG001|Overall Study|Study terminated by sponsor|4|||
156902405|NCT00961649|566401453|FG002|Overall Study|Study terminated by sponsor|4|||
156902406|NCT00961649|566401454|FG003|Overall Study|Study terminated by sponsor|1|||
156902407|NCT02155881|566401455|FG000|Overall Study|Withdrawal by Subject|0|||
156902408|NCT02155881|566401456|FG001|Overall Study|Withdrawal by Subject|2|||
156902409|NCT02155881|566401455|FG000|Overall Study|Inappropriately randomized|2|||
156902410|NCT02155881|566401456|FG001|Overall Study|Inappropriately randomized|2|||
156902411|NCT00072176|566401457|FG000|Overall Study|Withdrawal by Subject|1|||
156902412|NCT00072176|566401458|FG001|Overall Study|Withdrawal by Subject|0|||
156902413|NCT00072176|566401457|FG000|Overall Study|Protocol Violation|0|||
156902414|NCT00072176|566401458|FG001|Overall Study|Protocol Violation|1|||
156902415|NCT04128371|566401461|FG000|Overall Study|Lack of Efficacy|1|||
156902416|NCT02840721|566401463|FG000|Treatment Period|Adverse Event|1|||
156902417|NCT02840721|566401463|FG000|Follow-Up|Lack of Efficacy|1|||
156902418|NCT02840721|566401463|FG000|Follow-Up|Withdrawal by Subject|4|||
156902419|NCT02840721|566401463|FG000|Follow-Up|Withdrawal of Consent|2|||
156902420|NCT03594994|566401466|FG000|Overall Study|Adverse Event|1|||
156902421|NCT03594994|566401467|FG001|Overall Study|Adverse Event|0|||
156902422|NCT03594994|566401466|FG000|Overall Study|Withdrawal by Subject|0|||
156902423|NCT03594994|566401467|FG001|Overall Study|Withdrawal by Subject|1|||
156902424|NCT05274165|566401470|FG000|Overall Study|Withdrawal by Subject|3|||
156902425|NCT05274165|566401471|FG001|Overall Study|Withdrawal by Subject|3|||
156902426|NCT03672643|566401473|FG000|Overall Study|Adverse Event|3|||
156902427|NCT03672643|566401473|FG000|Overall Study|Death|2|||
156902428|NCT03672643|566401473|FG000|Overall Study|Withdrawal by Subject|1|||
156902429|NCT03672643|566401473|FG000|Overall Study|Progressive disease|11|||
156902430|NCT03672643|566401473|FG000|Overall Study|Global deterioration of health status|1|||
156902431|NCT03672643|566401473|FG000|Overall Study|Refused further treatment|7|||
156902432|NCT03672643|566401473|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
156902433|NCT04452344|566401474|FG000|Overall Study|Withdrawal by Subject|3|||
156902434|NCT04452344|566401475|FG001|Overall Study|Withdrawal by Subject|6|||
156902435|NCT04452344|566401474|FG000|Overall Study|Adverse Event|1|||
156902436|NCT04452344|566401475|FG001|Overall Study|Adverse Event|2|||
156902437|NCT04452344|566401474|FG000|Overall Study|Lost to Follow-up|2|||
156902438|NCT04452344|566401475|FG001|Overall Study|Lost to Follow-up|2|||
156902439|NCT04452344|566401474|FG000|Overall Study|No Post-Op Visit|6|||
156902440|NCT04452344|566401475|FG001|Overall Study|No Post-Op Visit|7|||
156902441|NCT03350620|566401477|FG000|Stage 2|Adverse Event|0|||
156902442|NCT03350620|566401478|FG001|Stage 2|Adverse Event|1|||
156902443|NCT03350620|566401479|FG002|Stage 2|Adverse Event|1|||
156902444|NCT03350620|566401477|FG000|Stage 2|Lack of Efficacy|0|||
156902445|NCT03350620|566401478|FG001|Stage 2|Lack of Efficacy|2|||
156902446|NCT03350620|566401479|FG002|Stage 2|Lack of Efficacy|0|||
156902447|NCT03350620|566401477|FG000|Stage 2|Lost to Follow-up|1|||
156902448|NCT03350620|566401478|FG001|Stage 2|Lost to Follow-up|2|||
156902449|NCT03350620|566401479|FG002|Stage 2|Lost to Follow-up|2|||
156902450|NCT03350620|566401477|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
156902451|NCT03350620|566401478|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
156902452|NCT03350620|566401479|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
156902453|NCT05268055|566401480|FG000|Overall Study|Lost to Follow-up|68|||
156902454|NCT05268055|566401481|FG001|Overall Study|Lost to Follow-up|68|||
156902455|NCT05268055|566401480|FG000|Overall Study|Withdrawal by Subject|12|||
156902456|NCT05268055|566401481|FG001|Overall Study|Withdrawal by Subject|8|||
156902457|NCT04102189|566401482|FG000|Overall Study|Withdrawal by Subject|1|||
156902458|NCT04102189|566401483|FG001|Overall Study|Withdrawal by Subject|2|||
156902459|NCT04102189|566401482|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156902460|NCT04102189|566401483|FG001|Overall Study|Withdrawal by parent/guardian|1|||
156902461|NCT04102189|566401482|FG000|Overall Study|Lost to Follow-up|1|||
156902462|NCT04102189|566401483|FG001|Overall Study|Lost to Follow-up|0|||
156902463|NCT03774082|566401484|FG000|Overall Study|Death|6|||
156902464|NCT03774082|566401485|FG001|Overall Study|Death|3|||
156902465|NCT03774082|566401486|FG002|Overall Study|Death|2|||
156902466|NCT03774082|566401484|FG000|Overall Study|Subject decision|0|||
156902467|NCT03774082|566401485|FG001|Overall Study|Subject decision|3|||
156902468|NCT03774082|566401486|FG002|Overall Study|Subject decision|0|||
156902469|NCT03774082|566401484|FG000|Overall Study|Lost to Follow-up|2|||
156902470|NCT03774082|566401485|FG001|Overall Study|Lost to Follow-up|0|||
156902471|NCT03774082|566401486|FG002|Overall Study|Lost to Follow-up|0|||
156902472|NCT03774082|566401484|FG000|Overall Study|Guardian decision|0|||
156902473|NCT03774082|566401485|FG001|Overall Study|Guardian decision|0|||
156902474|NCT03774082|566401486|FG002|Overall Study|Guardian decision|1|||
156902475|NCT03774082|566401484|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
156902476|NCT03774082|566401485|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
156902477|NCT03774082|566401486|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
156902478|NCT01950390|566401487|FG000|Overall Study|Never started treatment|3|||
156902479|NCT01950390|566401488|FG001|Overall Study|Never started treatment|2|||
156902480|NCT01950390|566401487|FG000|Overall Study|Disease progression|45|||
156902481|NCT01950390|566401488|FG001|Overall Study|Disease progression|52|||
156902482|NCT01950390|566401487|FG000|Overall Study|Adverse Event|22|||
156902483|NCT01950390|566401488|FG001|Overall Study|Adverse Event|16|||
156902484|NCT01950390|566401487|FG000|Overall Study|Death|5|||
156902485|NCT01950390|566401488|FG001|Overall Study|Death|3|||
156902486|NCT01950390|566401487|FG000|Overall Study|Withdrawal by Subject|5|||
156902487|NCT01950390|566401488|FG001|Overall Study|Withdrawal by Subject|1|||
156902488|NCT01950390|566401487|FG000|Overall Study|Alternative therapy|0|||
156902489|NCT01950390|566401488|FG001|Overall Study|Alternative therapy|3|||
156902490|NCT01950390|566401487|FG000|Overall Study|Complicating disease|1|||
156902491|NCT01950390|566401488|FG001|Overall Study|Complicating disease|0|||
156902492|NCT01950390|566401487|FG000|Overall Study|On treatment|1|||
156902493|NCT01950390|566401488|FG001|Overall Study|On treatment|0|||
156902494|NCT01950390|566401487|FG000|Overall Study|Symptomatic deterioration|2|||
156902495|NCT01950390|566401488|FG001|Overall Study|Symptomatic deterioration|1|||
156902496|NCT01950390|566401487|FG000|Overall Study|Physician Decision|0|||
156902497|NCT01950390|566401488|FG001|Overall Study|Physician Decision|4|||
156902498|NCT01950390|566401487|FG000|Overall Study|Lack of clinical benefit|0|||
156902499|NCT01950390|566401488|FG001|Overall Study|Lack of clinical benefit|1|||
156902500|NCT01950390|566401487|FG000|Overall Study|Maintained PR and moved to observation only|0|||
156902501|NCT01950390|566401488|FG001|Overall Study|Maintained PR and moved to observation only|1|||
156902502|NCT00354614|566403089|FG000|Overall Study|Lack of Efficacy|28|||
157026527|NCT03085810|566851625|FG001|Main Study|Terminated By Sponsor|0|||
156902503|NCT03650556|566403090|FG000|Overall Study|Death|2|||
156902504|NCT03650556|566403090|FG000|Overall Study|Withdrawal by Subject|20|||
157158913|NCT04281030|567326822|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
156902505|NCT03650556|566403090|FG000|Overall Study|Physician Decision|2|||
156902506|NCT03650556|566403090|FG000|Overall Study|Lost to Follow-up|8|||
156902507|NCT03650556|566403090|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
156902508|NCT03650556|566403090|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
156902509|NCT00736944|566403091|FG000|Induction|Death|1|||
157158914|NCT00288860|567326827|FG000|Overall Study|Did not complete intake|4|||
156902510|NCT00736944|566403091|FG000|Definitive Treatment|Physician Decision|1|||
156902511|NCT01426438|566403092|FG000|Overall Study|Lost to Follow-up|1|||
156902512|NCT01426438|566403093|FG001|Overall Study|Lost to Follow-up|3|||
157026528|NCT03085810|566851626|FG002|Main Study|Terminated By Sponsor|0|||
156902513|NCT01426438|566403092|FG000|Overall Study|Off study Treatment|9|||
156902514|NCT01426438|566403093|FG001|Overall Study|Off study Treatment|3|||
156902515|NCT01426438|566403092|FG000|Overall Study|Poor scan quality|3|||
156902516|NCT01426438|566403093|FG001|Overall Study|Poor scan quality|2|||
156902517|NCT01426438|566403092|FG000|Overall Study|Missed Scan|2|||
156902518|NCT01426438|566403093|FG001|Overall Study|Missed Scan|2|||
156902519|NCT01788046|566403094|FG000|Overall Study|Withdrawal by Subject|12|||
156902520|NCT01788046|566403095|FG001|Overall Study|Withdrawal by Subject|12|||
156902521|NCT01788046|566403094|FG000|Overall Study|Lost to Follow-up|12|||
156902522|NCT01788046|566403095|FG001|Overall Study|Lost to Follow-up|19|||
156902523|NCT01788046|566403094|FG000|Overall Study|Death|7|||
156902524|NCT01788046|566403095|FG001|Overall Study|Death|5|||
156902525|NCT01788046|566403094|FG000|Overall Study|Protocol Specified Criteria|25|||
156902526|NCT01788046|566403095|FG001|Overall Study|Protocol Specified Criteria|1|||
156902527|NCT01147640|566403101|FG000|Overall Study|Adverse Event|2|||
156902528|NCT01147640|566403102|FG001|Overall Study|Adverse Event|0|||
156902529|NCT01147640|566403101|FG000|Overall Study|Physician Decision|1|||
156902530|NCT01147640|566403102|FG001|Overall Study|Physician Decision|0|||
156902531|NCT01147640|566403101|FG000|Overall Study|Withdrawal by Subject|1|||
156902532|NCT01147640|566403102|FG001|Overall Study|Withdrawal by Subject|0|||
156902533|NCT01147640|566403101|FG000|Overall Study|Lost to Follow-up|0|||
156902534|NCT01147640|566403102|FG001|Overall Study|Lost to Follow-up|1|||
156902535|NCT01147640|566403101|FG000|Overall Study|Didn't meet eligibility criteria|1|||
156902536|NCT01147640|566403102|FG001|Overall Study|Didn't meet eligibility criteria|0|||
156902537|NCT01604408|566403103|FG000|Treatment Period 1|Protocol Violation|0|||
156902538|NCT01604408|566403104|FG001|Treatment Period 1|Protocol Violation|1|||
156902539|NCT01604408|566403103|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156902540|NCT01604408|566403104|FG001|Treatment Period 2|Withdrawal by Subject|1|||
156902541|NCT01604408|566403103|FG000|Treatment Period 2|Protocol Violation|1|||
156902542|NCT01604408|566403104|FG001|Treatment Period 2|Protocol Violation|0|||
156902543|NCT01604408|566403103|FG000|Treatment Period 2|Adverse Event|0|||
156902544|NCT01604408|566403104|FG001|Treatment Period 2|Adverse Event|1|||
156902545|NCT01604408|566403103|FG000|Treatment Period 3|Protocol Violation|1|||
156902546|NCT01604408|566403104|FG001|Treatment Period 3|Protocol Violation|1|||
156902547|NCT01604408|566403103|FG000|Treatment Period 3|Adverse Event|0|||
156902548|NCT01604408|566403104|FG001|Treatment Period 3|Adverse Event|3|||
156902549|NCT01604408|566403103|FG000|Treatment Period 3|Withdrawal by Subject|3|||
156902550|NCT01604408|566403104|FG001|Treatment Period 3|Withdrawal by Subject|1|||
156902551|NCT01604408|566403103|FG000|Treatment Period 3|Sponsor Decision|1|||
156902552|NCT01604408|566403104|FG001|Treatment Period 3|Sponsor Decision|0|||
156902553|NCT01604408|566403103|FG000|Treatment Period 4|Death|1|||
156902554|NCT01604408|566403104|FG001|Treatment Period 4|Death|0|||
156902555|NCT01604408|566403103|FG000|Treatment Period 4|Withdrawal by Subject|2|||
156902556|NCT01604408|566403104|FG001|Treatment Period 4|Withdrawal by Subject|1|||
156902557|NCT01604408|566403103|FG000|Treatment Period 4|Adverse Event|0|||
156902558|NCT01604408|566403104|FG001|Treatment Period 4|Adverse Event|1|||
156902559|NCT01604408|566403103|FG000|Treatment Period 5|Adverse Event|4|||
156902560|NCT01604408|566403104|FG001|Treatment Period 5|Adverse Event|0|||
156902561|NCT01604408|566403103|FG000|Treatment Period 6|Lost to Follow-up|0|||
156902562|NCT01604408|566403104|FG001|Treatment Period 6|Lost to Follow-up|1|||
156902563|NCT01604408|566403103|FG000|Treatment Period 6|Adverse Event|2|||
156902564|NCT01604408|566403104|FG001|Treatment Period 6|Adverse Event|0|||
156902565|NCT01604408|566403103|FG000|Treatment Period 6|Sponsor decision|0|||
156902566|NCT01604408|566403104|FG001|Treatment Period 6|Sponsor decision|1|||
156902567|NCT01604408|566403103|FG000|Observation Period|Adverse Event|1|||
156902568|NCT01604408|566403104|FG001|Observation Period|Adverse Event|1|||
156902569|NCT01604408|566403103|FG000|Observation Period|Withdrawal by Subject|0|||
156902570|NCT01604408|566403104|FG001|Observation Period|Withdrawal by Subject|2|||
156902571|NCT00091442|566403105|FG000|Overall Study|Progressive Disease|220|||
156902572|NCT00091442|566403106|FG001|Overall Study|Progressive Disease|189|||
156902573|NCT00091442|566403105|FG000|Overall Study|Physician Decision|61|||
156902574|NCT00091442|566403106|FG001|Overall Study|Physician Decision|58|||
156902575|NCT00091442|566403105|FG000|Overall Study|Withdrawal by Subject|38|||
156902576|NCT00091442|566403106|FG001|Overall Study|Withdrawal by Subject|46|||
156902577|NCT00091442|566403105|FG000|Overall Study|Adverse Event|29|||
156902578|NCT00091442|566403106|FG001|Overall Study|Adverse Event|48|||
156902579|NCT00091442|566403105|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
156902580|NCT00091442|566403106|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
156902581|NCT00091442|566403105|FG000|Overall Study|Death|9|||
156902582|NCT00091442|566403106|FG001|Overall Study|Death|7|||
156902583|NCT00091442|566403105|FG000|Overall Study|Lost to Follow-up|1|||
156902584|NCT00091442|566403106|FG001|Overall Study|Lost to Follow-up|3|||
156902585|NCT00091442|566403105|FG000|Overall Study|Other|2|||
156902586|NCT00091442|566403106|FG001|Overall Study|Other|6|||
156902587|NCT00917501|566403107|FG000|Overall Study|Lost to Follow-up|4|||
156902588|NCT00917501|566403108|FG001|Overall Study|Lost to Follow-up|1|||
156902589|NCT00917501|566403107|FG000|Overall Study|Withdrawal by Subject|3|||
156902590|NCT00917501|566403108|FG001|Overall Study|Withdrawal by Subject|1|||
156902591|NCT00917501|566403107|FG000|Overall Study|Lack of Efficacy|1|||
157225529|NCT01325207|567571460|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
157225530|NCT01325207|567571461|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
157225531|NCT01325207|567571462|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
157225532|NCT01325207|567571463|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
157225533|NCT01325207|567571464|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
157225534|NCT01325207|567571465|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
157225535|NCT01325207|567571460|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
157225536|NCT01325207|567571461|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
157225537|NCT01325207|567571462|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
157225538|NCT01325207|567571463|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
157225539|NCT01325207|567571464|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
157225540|NCT01325207|567571465|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
157225541|NCT01325207|567571460|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
157225542|NCT01325207|567571461|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
157225543|NCT01325207|567571462|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
157225544|NCT01325207|567571463|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
157225545|NCT01325207|567571464|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
157225546|NCT01325207|567571465|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
157225547|NCT01325207|567571460|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
157225548|NCT01325207|567571461|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
157225549|NCT01325207|567571462|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
157225550|NCT01325207|567571463|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
157225551|NCT01325207|567571464|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
157225552|NCT01325207|567571465|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
157225553|NCT01325207|567571460|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
157225554|NCT01325207|567571461|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
157225555|NCT01325207|567571462|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
157225556|NCT01325207|567571463|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
157225557|NCT01325207|567571464|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
157225558|NCT01325207|567571465|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
157225559|NCT01325207|567571460|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
157225560|NCT01325207|567571461|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
157225561|NCT01325207|567571462|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
157225562|NCT01325207|567571463|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
157225563|NCT01325207|567571464|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
156902592|NCT00917501|566403108|FG001|Overall Study|Lack of Efficacy|2|||
156902593|NCT00917501|566403107|FG000|Overall Study|trouble swollowing capsules|0|||
156902594|NCT00917501|566403108|FG001|Overall Study|trouble swollowing capsules|1|||
156902595|NCT00986830|566403115|FG000|Overall Study|Death|1|||
156902596|NCT00986830|566403115|FG000|Overall Study|Lost to Follow-up|1|||
156902597|NCT00986830|566403115|FG000|Overall Study|Lack of Efficacy|1|||
156902598|NCT00986830|566403115|FG000|Overall Study|Unable to access sinus with device|5|||
156902599|NCT01495975|566403116|FG000|Overall Study|Lost to Follow-up|1|||
156902600|NCT01495975|566403117|FG001|Overall Study|Lost to Follow-up|0|||
156902601|NCT00808483|566403118|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
156902602|NCT00808483|566403119|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
156902603|NCT00808483|566403118|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
156902604|NCT00808483|566403119|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
156902605|NCT00808483|566403118|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
156902606|NCT00808483|566403119|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
156902607|NCT02038881|566403120|FG000|Overall Study|Withdrawal by Subject|0|||
156902608|NCT02038881|566403121|FG001|Overall Study|Withdrawal by Subject|0|||
156902609|NCT02038881|566403122|FG002|Overall Study|Withdrawal by Subject|1|||
156902610|NCT02038881|566403120|FG000|Overall Study|Lost to Follow-up|2|||
156902611|NCT02038881|566403121|FG001|Overall Study|Lost to Follow-up|0|||
156902612|NCT02038881|566403122|FG002|Overall Study|Lost to Follow-up|0|||
156902613|NCT02038881|566403120|FG000|Overall Study|incarcerated|1|||
156902614|NCT02038881|566403121|FG001|Overall Study|incarcerated|0|||
156902615|NCT02038881|566403122|FG002|Overall Study|incarcerated|0|||
156902616|NCT00333840|566403123|FG000|First-line Treatment Period|Adverse Event|38|||
156902617|NCT00333840|566403124|FG001|First-line Treatment Period|Adverse Event|37|||
156902618|NCT00333840|566403125|FG002|First-line Treatment Period|Adverse Event|0|||
156902619|NCT00333840|566403126|FG003|First-line Treatment Period|Adverse Event|0|||
156902620|NCT00333840|566403123|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
156902621|NCT00333840|566403124|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
156902622|NCT00333840|566403125|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
156902623|NCT00333840|566403126|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
157026529|NCT03085810|566851624|FG000|Main Study|Protocol Violation|15|||
156902624|NCT00333840|566403123|FG000|First-line Treatment Period|Abnormal procedure|2|||
156902625|NCT00333840|566403124|FG001|First-line Treatment Period|Abnormal procedure|0|||
156902626|NCT00333840|566403125|FG002|First-line Treatment Period|Abnormal procedure|0|||
156902627|NCT00333840|566403126|FG003|First-line Treatment Period|Abnormal procedure|0|||
156902628|NCT00333840|566403123|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
156902629|NCT00333840|566403124|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
156902630|NCT00333840|566403125|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156902631|NCT00333840|566403126|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156902632|NCT00333840|566403123|FG000|First-line Treatment Period|No longer required study drug|21|||
156902633|NCT00333840|566403124|FG001|First-line Treatment Period|No longer required study drug|8|||
156902634|NCT00333840|566403125|FG002|First-line Treatment Period|No longer required study drug|0|||
156902635|NCT00333840|566403126|FG003|First-line Treatment Period|No longer required study drug|0|||
156902636|NCT00333840|566403123|FG000|First-line Treatment Period|Protocol Violation|17|||
156902637|NCT00333840|566403124|FG001|First-line Treatment Period|Protocol Violation|17|||
156902638|NCT00333840|566403125|FG002|First-line Treatment Period|Protocol Violation|0|||
156902639|NCT00333840|566403126|FG003|First-line Treatment Period|Protocol Violation|0|||
156902640|NCT00333840|566403123|FG000|First-line Treatment Period|Subject withdrew consent|57|||
156902641|NCT00333840|566403124|FG001|First-line Treatment Period|Subject withdrew consent|77|||
156902642|NCT00333840|566403125|FG002|First-line Treatment Period|Subject withdrew consent|0|||
156902643|NCT00333840|566403126|FG003|First-line Treatment Period|Subject withdrew consent|0|||
156902644|NCT00333840|566403123|FG000|First-line Treatment Period|Lost to Follow-up|15|||
156902645|NCT00333840|566403124|FG001|First-line Treatment Period|Lost to Follow-up|6|||
157026530|NCT03085810|566851625|FG001|Main Study|Protocol Violation|0|||
157026531|NCT03085810|566851626|FG002|Main Study|Protocol Violation|0|||
157026532|NCT03085810|566851624|FG000|Main Study|Physician Decision|13|||
156902646|NCT00333840|566403125|FG002|First-line Treatment Period|Lost to Follow-up|0|||
156902647|NCT00333840|566403126|FG003|First-line Treatment Period|Lost to Follow-up|0|||
156902648|NCT00333840|566403123|FG000|First-line Treatment Period|Administrative problems|12|||
156902649|NCT00333840|566403124|FG001|First-line Treatment Period|Administrative problems|6|||
156902650|NCT00333840|566403125|FG002|First-line Treatment Period|Administrative problems|0|||
157026533|NCT03085810|566851625|FG001|Main Study|Physician Decision|0|||
157026534|NCT03085810|566851626|FG002|Main Study|Physician Decision|0|||
157026535|NCT03085810|566851624|FG000|Main Study|Lost to Follow-up|17|||
157026536|NCT03085810|566851625|FG001|Main Study|Lost to Follow-up|0|||
157026537|NCT03085810|566851626|FG002|Main Study|Lost to Follow-up|0|||
157026538|NCT03085810|566851624|FG000|Main Study|Adverse Event|25|||
157026539|NCT03085810|566851625|FG001|Main Study|Adverse Event|0|||
157026540|NCT03085810|566851626|FG002|Main Study|Adverse Event|0|||
157026541|NCT03085810|566851624|FG000|Main Study|Pregnancy|7|||
157026542|NCT03085810|566851625|FG001|Main Study|Pregnancy|0|||
157026543|NCT03085810|566851626|FG002|Main Study|Pregnancy|0|||
157026544|NCT03085810|566851624|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
157026545|NCT03085810|566851625|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
157026546|NCT03085810|566851626|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
157026547|NCT03085810|566851624|FG000|Main Study|Lack of Efficacy|10|||
157026548|NCT03085810|566851625|FG001|Main Study|Lack of Efficacy|0|||
157026549|NCT03085810|566851626|FG002|Main Study|Lack of Efficacy|0|||
157026550|NCT03085810|566851624|FG000|Main Study|Death|12|||
157026551|NCT03085810|566851625|FG001|Main Study|Death|0|||
157026552|NCT03085810|566851626|FG002|Main Study|Death|0|||
157026553|NCT03085810|566851624|FG000|Main Study|Disease progression|1|||
157026554|NCT03085810|566851625|FG001|Main Study|Disease progression|0|||
157026555|NCT03085810|566851626|FG002|Main Study|Disease progression|0|||
157026556|NCT03085810|566851624|FG000|Main Study|Site Closure|3|||
157026557|NCT03085810|566851625|FG001|Main Study|Site Closure|0|||
157026558|NCT03085810|566851626|FG002|Main Study|Site Closure|0|||
157026559|NCT03085810|566851624|FG000|Main Study|Planned pregnancy|17|||
157026560|NCT03085810|566851625|FG001|Main Study|Planned pregnancy|0|||
157026561|NCT03085810|566851626|FG002|Main Study|Planned pregnancy|0|||
157026562|NCT03085810|566851624|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
157026563|NCT03085810|566851625|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
157026564|NCT03085810|566851626|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
157026565|NCT03085810|566851624|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
157026566|NCT03085810|566851625|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
157026567|NCT03085810|566851626|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
157026568|NCT03085810|566851624|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
157026569|NCT03085810|566851625|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
157026570|NCT03085810|566851626|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
157026571|NCT03085810|566851624|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
157026572|NCT03085810|566851625|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
157026573|NCT03085810|566851626|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
157026574|NCT02601313|566851627|FG000|Overall Study|Death|2|||
157158915|NCT00288860|567326828|FG001|Overall Study|Did not complete intake|8|||
157158916|NCT00288860|567326827|FG000|Overall Study|Death|4|||
157158917|NCT00288860|567326828|FG001|Overall Study|Death|3|||
157158918|NCT00288860|567326827|FG000|Overall Study|Withdrawal by Subject|20|||
157158919|NCT00288860|567326828|FG001|Overall Study|Withdrawal by Subject|15|||
157158920|NCT00288860|567326827|FG000|Overall Study|Lost to Follow-up|74|||
157158921|NCT00288860|567326828|FG001|Overall Study|Lost to Follow-up|71|||
157158922|NCT05142332|567326829|FG000|Overall Study|Withdrawal by Subject|0|||
157158923|NCT05142332|567326830|FG001|Overall Study|Withdrawal by Subject|1|||
157158924|NCT05142332|567326831|FG002|Overall Study|Withdrawal by Subject|2|||
157158925|NCT05142332|567326832|FG003|Overall Study|Withdrawal by Subject|0|||
157158926|NCT05142332|567326833|FG004|Overall Study|Withdrawal by Subject|0|||
157158927|NCT05142332|567326834|FG005|Overall Study|Withdrawal by Subject|2|||
157158928|NCT05142332|567326835|FG006|Overall Study|Withdrawal by Subject|6|||
157158929|NCT05142332|567326829|FG000|Overall Study|Left ED|3|||
157158930|NCT05142332|567326830|FG001|Overall Study|Left ED|0|||
157158931|NCT05142332|567326831|FG002|Overall Study|Left ED|4|||
157158932|NCT05142332|567326832|FG003|Overall Study|Left ED|6|||
157026575|NCT02601313|566851628|FG001|Overall Study|Death|41|||
157026576|NCT02601313|566851629|FG002|Overall Study|Death|6|||
157026577|NCT02601313|566851627|FG000|Overall Study|Enrolled but never treated|0|||
157026578|NCT02601313|566851628|FG001|Overall Study|Enrolled but never treated|6|||
157026579|NCT02601313|566851629|FG002|Overall Study|Enrolled but never treated|3|||
157026580|NCT02601313|566851627|FG000|Overall Study|Enrolled, did not initiate AC|4|||
157026581|NCT02601313|566851628|FG001|Overall Study|Enrolled, did not initiate AC|0|||
157026582|NCT02601313|566851629|FG002|Overall Study|Enrolled, did not initiate AC|0|||
157026583|NCT02601313|566851627|FG000|Overall Study|Full consent withdrawal|0|||
157026584|NCT02601313|566851628|FG001|Overall Study|Full consent withdrawal|3|||
157026585|NCT02601313|566851629|FG002|Overall Study|Full consent withdrawal|2|||
157026586|NCT02601313|566851627|FG000|Overall Study|Lost to Follow-up|0|||
157026587|NCT02601313|566851628|FG001|Overall Study|Lost to Follow-up|1|||
157026588|NCT02601313|566851629|FG002|Overall Study|Lost to Follow-up|1|||
157026589|NCT05239455|566851634|FG000|Overall Study|Adverse Event|1|||
157026590|NCT05239455|566851634|FG000|Overall Study|Sponsor Decision|5|||
157026591|NCT05239455|566851634|FG000|Overall Study|Incomplete Blood Collection|1|||
157026592|NCT03800654|566851635|FG000|Overall Study|Time constraints|3|||
157026593|NCT03800654|566851636|FG001|Overall Study|Time constraints|3|||
157026594|NCT03800654|566851637|FG002|Overall Study|Time constraints|3|||
157026595|NCT03800654|566851635|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
157026596|NCT03800654|566851636|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
157026597|NCT03800654|566851637|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
157026598|NCT03800654|566851635|FG000|Overall Study|Lost to Follow-up|2|||
157026599|NCT03800654|566851636|FG001|Overall Study|Lost to Follow-up|1|||
157026600|NCT03800654|566851637|FG002|Overall Study|Lost to Follow-up|6|||
157026601|NCT03800654|566851635|FG000|Overall Study|Medical Health Issue|0|||
157026602|NCT03800654|566851636|FG001|Overall Study|Medical Health Issue|0|||
157026603|NCT03800654|566851637|FG002|Overall Study|Medical Health Issue|1|||
157026604|NCT03800654|566851635|FG000|Overall Study|Personal Issues|0|||
157026605|NCT03800654|566851636|FG001|Overall Study|Personal Issues|2|||
157026606|NCT03800654|566851637|FG002|Overall Study|Personal Issues|0|||
157026607|NCT03800654|566851635|FG000|Overall Study|Protocol Violation|0|||
157026608|NCT03800654|566851636|FG001|Overall Study|Protocol Violation|1|||
157026609|NCT03800654|566851637|FG002|Overall Study|Protocol Violation|0|||
157026610|NCT03459729|566851638|FG000|Overall Study|Physician Decision|2|||
157026611|NCT06182033|566851639|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
157026612|NCT06182033|566851640|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
157026613|NCT06182033|566851639|FG000|Overall Study|Target child relocation|1|||
157026614|NCT06182033|566851640|FG001|Overall Study|Target child relocation|1|||
157026615|NCT06182033|566851639|FG000|Overall Study|Withdrawal by Subject|1|||
157026616|NCT06182033|566851640|FG001|Overall Study|Withdrawal by Subject|0|||
157026617|NCT02626533|566851642|FG000|Overall Study|Protocol Violation|14|||
157026618|NCT02626533|566851642|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
157026619|NCT02626533|566851642|FG000|Overall Study|Withdrawal by Subject|1|||
157026620|NCT05576155|566851647|FG000|Overall Study|Withdrawal by Subject|1|||
157026621|NCT05576155|566851648|FG001|Overall Study|Withdrawal by Subject|1|||
157026622|NCT04515849|566851649|FG000|Overall Study|Adverse Event|0|||
157158933|NCT05142332|567326833|FG004|Overall Study|Left ED|1|||
157158934|NCT05142332|567326834|FG005|Overall Study|Left ED|2|||
157158935|NCT05142332|567326835|FG006|Overall Study|Left ED|6|||
157158936|NCT05142332|567326829|FG000|Overall Study|Physician Decision|0|||
157026623|NCT04515849|566851650|FG001|Overall Study|Adverse Event|0|||
157026624|NCT04515849|566851651|FG002|Overall Study|Adverse Event|0|||
157026625|NCT04515849|566851652|FG003|Overall Study|Adverse Event|1|||
157026626|NCT04515849|566851653|FG004|Overall Study|Adverse Event|2|||
157026627|NCT04515849|566851649|FG000|Overall Study|Death|2|||
157026628|NCT04515849|566851650|FG001|Overall Study|Death|0|||
157158937|NCT05142332|567326830|FG001|Overall Study|Physician Decision|0|||
157158938|NCT05142332|567326831|FG002|Overall Study|Physician Decision|2|||
156902651|NCT00333840|566403126|FG003|First-line Treatment Period|Administrative problems|0|||
156902652|NCT00333840|566403123|FG000|First-line Treatment Period|Death|19|||
156902653|NCT00333840|566403124|FG001|First-line Treatment Period|Death|2|||
156902654|NCT00333840|566403125|FG002|First-line Treatment Period|Death|0|||
156902655|NCT00333840|566403126|FG003|First-line Treatment Period|Death|0|||
156902656|NCT00333840|566403123|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
156902657|NCT00333840|566403124|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
156902658|NCT00333840|566403125|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
156902659|NCT00333840|566403126|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
156902660|NCT00333840|566403123|FG000|Second-line Treatment Period|Adverse Event|0|||
156902661|NCT00333840|566403124|FG001|Second-line Treatment Period|Adverse Event|0|||
156902662|NCT00333840|566403125|FG002|Second-line Treatment Period|Adverse Event|3|||
156902663|NCT00333840|566403126|FG003|Second-line Treatment Period|Adverse Event|34|||
156902664|NCT00333840|566403123|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156902665|NCT00333840|566403124|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156902666|NCT00333840|566403125|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
156902667|NCT00333840|566403126|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
156902668|NCT00333840|566403123|FG000|Second-line Treatment Period|Abnormal procedure|0|||
156902669|NCT00333840|566403124|FG001|Second-line Treatment Period|Abnormal procedure|0|||
156902670|NCT00333840|566403125|FG002|Second-line Treatment Period|Abnormal procedure|0|||
156902671|NCT00333840|566403126|FG003|Second-line Treatment Period|Abnormal procedure|1|||
156902672|NCT00333840|566403123|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156902673|NCT00333840|566403124|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
156902674|NCT00333840|566403125|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
156902675|NCT00333840|566403126|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
156902676|NCT00333840|566403123|FG000|Second-line Treatment Period|No longer required study drug|0|||
156902677|NCT00333840|566403124|FG001|Second-line Treatment Period|No longer required study drug|0|||
156902678|NCT00333840|566403125|FG002|Second-line Treatment Period|No longer required study drug|1|||
156902679|NCT00333840|566403126|FG003|Second-line Treatment Period|No longer required study drug|14|||
156902680|NCT00333840|566403123|FG000|Second-line Treatment Period|Protocol Violation|0|||
156902681|NCT00333840|566403124|FG001|Second-line Treatment Period|Protocol Violation|0|||
156902682|NCT00333840|566403125|FG002|Second-line Treatment Period|Protocol Violation|1|||
156902683|NCT00333840|566403126|FG003|Second-line Treatment Period|Protocol Violation|10|||
156902684|NCT00333840|566403123|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
156902685|NCT00333840|566403124|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
156902686|NCT00333840|566403125|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
156902687|NCT00333840|566403126|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
156902688|NCT00333840|566403123|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
156902689|NCT00333840|566403124|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
156902690|NCT00333840|566403125|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
156902691|NCT00333840|566403126|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
156902692|NCT00333840|566403123|FG000|Second-line Treatment Period|Administrative problems|0|||
156902693|NCT00333840|566403124|FG001|Second-line Treatment Period|Administrative problems|0|||
156902694|NCT00333840|566403125|FG002|Second-line Treatment Period|Administrative problems|0|||
156902695|NCT00333840|566403126|FG003|Second-line Treatment Period|Administrative problems|7|||
156902696|NCT00333840|566403123|FG000|Second-line Treatment Period|Death|0|||
156902697|NCT00333840|566403124|FG001|Second-line Treatment Period|Death|0|||
156902698|NCT00333840|566403125|FG002|Second-line Treatment Period|Death|0|||
156902699|NCT00333840|566403126|FG003|Second-line Treatment Period|Death|9|||
156902700|NCT02357979|566403127|FG000|Overall Study|Lost to Follow-up|5|||
156902701|NCT02357979|566403128|FG001|Overall Study|Lost to Follow-up|5|||
156902702|NCT00845858|566403129|FG000|Overall Study|Withdrawal by Subject|5|||
156902703|NCT00845858|566403130|FG001|Overall Study|Withdrawal by Subject|1|||
156902704|NCT00845858|566403131|FG002|Overall Study|Withdrawal by Subject|1|||
156902705|NCT00845858|566403129|FG000|Overall Study|Adverse Event|3|||
156902706|NCT00845858|566403130|FG001|Overall Study|Adverse Event|8|||
156902707|NCT00845858|566403131|FG002|Overall Study|Adverse Event|4|||
156902708|NCT00845858|566403129|FG000|Overall Study|Protocol Violation|0|||
156902709|NCT00845858|566403130|FG001|Overall Study|Protocol Violation|0|||
156902710|NCT00845858|566403131|FG002|Overall Study|Protocol Violation|1|||
156902711|NCT00845858|566403129|FG000|Overall Study|not eligible|0|||
156902712|NCT00845858|566403130|FG001|Overall Study|not eligible|3|||
156902713|NCT00845858|566403131|FG002|Overall Study|not eligible|2|||
156902714|NCT01453725|566403132|FG000|Overall Study|Adverse Event|3|||
156902715|NCT01453725|566403133|FG001|Overall Study|Adverse Event|3|||
156902716|NCT01453725|566403132|FG000|Overall Study|Lost to Follow-up|4|||
156902717|NCT01453725|566403133|FG001|Overall Study|Lost to Follow-up|0|||
156902718|NCT01453725|566403132|FG000|Overall Study|Non-compliance With Protocol|1|||
156902719|NCT01453725|566403133|FG001|Overall Study|Non-compliance With Protocol|2|||
156902720|NCT01453725|566403132|FG000|Overall Study|Protocol Violation|1|||
156902721|NCT01453725|566403133|FG001|Overall Study|Protocol Violation|0|||
156902722|NCT01453725|566403132|FG000|Overall Study|Withdrawal by Subject|2|||
156902723|NCT01453725|566403133|FG001|Overall Study|Withdrawal by Subject|3|||
156902724|NCT01453725|566403132|FG000|Overall Study|Pregnancy Wish|0|||
156902725|NCT01453725|566403133|FG001|Overall Study|Pregnancy Wish|2|||
156902726|NCT01453725|566403132|FG000|Overall Study|Pregnancy|1|||
156902727|NCT01453725|566403133|FG001|Overall Study|Pregnancy|0|||
156902728|NCT01453725|566403132|FG000|Overall Study|Physician Decision|1|||
156902729|NCT01453725|566403133|FG001|Overall Study|Physician Decision|1|||
156902730|NCT00875979|566403137|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
156902731|NCT00875979|566403138|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
156902732|NCT00875979|566403137|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
156902733|NCT00875979|566403138|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
156902734|NCT00875979|566403137|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
156902735|NCT00875979|566403138|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
156902736|NCT00875979|566403137|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
156902737|NCT00875979|566403138|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
156902738|NCT00875979|566403137|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
156902739|NCT00875979|566403138|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
156902740|NCT00875979|566403137|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
156902741|NCT00875979|566403138|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
156902742|NCT00875979|566403137|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
156902743|NCT00875979|566403138|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
156902744|NCT00875979|566403137|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
156902745|NCT00875979|566403138|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
156902746|NCT00875979|566403137|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
156902747|NCT00875979|566403138|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
156902748|NCT00216476|566403140|FG000|Overall Study|Withdrawal by Subject|59|||
156902749|NCT00216476|566403141|FG001|Overall Study|Withdrawal by Subject|72|||
156902750|NCT00216476|566403142|FG002|Overall Study|Withdrawal by Subject|9|||
156902751|NCT00216476|566403140|FG000|Overall Study|Lost to Follow-up|10|||
156902752|NCT00216476|566403141|FG001|Overall Study|Lost to Follow-up|9|||
156902753|NCT00216476|566403142|FG002|Overall Study|Lost to Follow-up|1|||
156902754|NCT00216476|566403140|FG000|Overall Study|Adverse Event|6|||
156902755|NCT00216476|566403141|FG001|Overall Study|Adverse Event|10|||
156902756|NCT00216476|566403142|FG002|Overall Study|Adverse Event|1|||
156902757|NCT00216476|566403140|FG000|Overall Study|Lack of Efficacy|4|||
156902758|NCT00216476|566403141|FG001|Overall Study|Lack of Efficacy|3|||
156902759|NCT00216476|566403142|FG002|Overall Study|Lack of Efficacy|0|||
156902760|NCT00216476|566403140|FG000|Overall Study|Death|2|||
156902761|NCT00216476|566403141|FG001|Overall Study|Death|0|||
156902762|NCT00216476|566403142|FG002|Overall Study|Death|0|||
156902763|NCT00216476|566403140|FG000|Overall Study|Pregnancy|0|||
156902764|NCT00216476|566403141|FG001|Overall Study|Pregnancy|1|||
156902765|NCT00216476|566403142|FG002|Overall Study|Pregnancy|1|||
156902766|NCT00216476|566403140|FG000|Overall Study|Other|0|||
156902767|NCT00216476|566403141|FG001|Overall Study|Other|0|||
156902768|NCT00216476|566403142|FG002|Overall Study|Other|1|||
156902769|NCT00216476|566403140|FG000|Overall Study|Refuses Injection|11|||
156902770|NCT00216476|566403141|FG001|Overall Study|Refuses Injection|0|||
156902771|NCT00216476|566403142|FG002|Overall Study|Refuses Injection|0|||
156902772|NCT00216476|566403140|FG000|Overall Study|No Further Need for Treatment|3|||
156902773|NCT00216476|566403141|FG001|Overall Study|No Further Need for Treatment|4|||
156902774|NCT00216476|566403142|FG002|Overall Study|No Further Need for Treatment|1|||
156902775|NCT00216476|566403140|FG000|Overall Study|Non-compliance|0|||
156902776|NCT00216476|566403141|FG001|Overall Study|Non-compliance|4|||
156902777|NCT00216476|566403142|FG002|Overall Study|Non-compliance|1|||
156902778|NCT00216476|566403140|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
156902779|NCT00216476|566403141|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
156902780|NCT00216476|566403142|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
156902781|NCT00216476|566403140|FG000|Overall Study|Administrative Reasons|1|||
156902782|NCT00216476|566403141|FG001|Overall Study|Administrative Reasons|1|||
156902783|NCT00216476|566403142|FG002|Overall Study|Administrative Reasons|0|||
156902784|NCT00216476|566403140|FG000|Overall Study|Protocol Deviation|5|||
156902785|NCT00216476|566403141|FG001|Overall Study|Protocol Deviation|1|||
156902786|NCT00216476|566403142|FG002|Overall Study|Protocol Deviation|0|||
156902787|NCT00216476|566403140|FG000|Overall Study|Patient Moved|2|||
156902788|NCT00216476|566403141|FG001|Overall Study|Patient Moved|2|||
156902789|NCT00216476|566403142|FG002|Overall Study|Patient Moved|0|||
156902790|NCT01696695|566403143|FG000|Overall Study|Disease progression|373|||
156902791|NCT01696695|566403143|FG000|Overall Study|Death|29|||
156902792|NCT01696695|566403143|FG000|Overall Study|Adverse Event|74|||
156902793|NCT01696695|566403143|FG000|Overall Study|Withdrawal by Subject|92|||
156902794|NCT01696695|566403143|FG000|Overall Study|Lost to Follow-up|48|||
156902795|NCT01696695|566403143|FG000|Overall Study|Other|74|||
156902796|NCT01696695|566403143|FG000|Overall Study|Major Protocol Violation|192|||
156902797|NCT01756053|566403149|FG000|Period 1 (10 Days)|Protocol Violation|1|||
157158939|NCT05142332|567326832|FG003|Overall Study|Physician Decision|1|||
157158940|NCT05142332|567326833|FG004|Overall Study|Physician Decision|0|||
157158941|NCT05142332|567326834|FG005|Overall Study|Physician Decision|0|||
157158942|NCT05142332|567326835|FG006|Overall Study|Physician Decision|3|||
156859267|NCT05546476|566241176|FG001|Period 1: Part A|Death|4|||
156859268|NCT05546476|566241177|FG002|Period 1: Part A|Death|5|||
156859269|NCT05546476|566241178|FG003|Period 1: Part A|Death|6|||
156859270|NCT05546476|566241175|FG000|Period 1: Part A|Lack of Efficacy|0|||
156859271|NCT05546476|566241176|FG001|Period 1: Part A|Lack of Efficacy|0|||
156859272|NCT05546476|566241177|FG002|Period 1: Part A|Lack of Efficacy|0|||
156859273|NCT05546476|566241178|FG003|Period 1: Part A|Lack of Efficacy|1|||
156859274|NCT05546476|566241175|FG000|Period 1: Part A|Lost to Follow-up|0|||
156859275|NCT05546476|566241176|FG001|Period 1: Part A|Lost to Follow-up|0|||
156859276|NCT05546476|566241177|FG002|Period 1: Part A|Lost to Follow-up|0|||
156859277|NCT05546476|566241178|FG003|Period 1: Part A|Lost to Follow-up|1|||
156859278|NCT05546476|566241175|FG000|Period 1: Part A|Physician Decision|1|||
156859279|NCT05546476|566241176|FG001|Period 1: Part A|Physician Decision|0|||
156859280|NCT05546476|566241177|FG002|Period 1: Part A|Physician Decision|0|||
156859281|NCT05546476|566241178|FG003|Period 1: Part A|Physician Decision|0|||
156859282|NCT05546476|566241175|FG000|Period 1: Part A|Progressive disease|3|||
156859283|NCT05546476|566241176|FG001|Period 1: Part A|Progressive disease|5|||
156859284|NCT05546476|566241177|FG002|Period 1: Part A|Progressive disease|0|||
156859285|NCT05546476|566241178|FG003|Period 1: Part A|Progressive disease|1|||
156859286|NCT05546476|566241175|FG000|Period 1: Part A|Withdrawal by Subject|1|||
156859287|NCT05546476|566241176|FG001|Period 1: Part A|Withdrawal by Subject|1|||
156859288|NCT05546476|566241177|FG002|Period 1: Part A|Withdrawal by Subject|1|||
156859289|NCT05546476|566241178|FG003|Period 1: Part A|Withdrawal by Subject|2|||
156859290|NCT05546476|566241175|FG000|Period 1: Part A|Global deterioration of health status|2|||
156859291|NCT05546476|566241176|FG001|Period 1: Part A|Global deterioration of health status|2|||
156859292|NCT05546476|566241177|FG002|Period 1: Part A|Global deterioration of health status|1|||
156859293|NCT05546476|566241178|FG003|Period 1: Part A|Global deterioration of health status|4|||
156859294|NCT05546476|566241175|FG000|Period 1: Part A|Other: Unspecified|0|||
156859295|NCT05546476|566241176|FG001|Period 1: Part A|Other: Unspecified|2|||
156859296|NCT05546476|566241177|FG002|Period 1: Part A|Other: Unspecified|0|||
156859297|NCT05546476|566241178|FG003|Period 1: Part A|Other: Unspecified|0|||
156859298|NCT05546476|566241175|FG000|Period 2: Part B|Ongoing|26|||
156859299|NCT05546476|566241176|FG001|Period 2: Part B|Ongoing|27|||
156859300|NCT05546476|566241177|FG002|Period 2: Part B|Ongoing|35|||
156859301|NCT05546476|566241178|FG003|Period 2: Part B|Ongoing|29|||
156859302|NCT03585660|566241184|FG000|Overall Study|operator error|1|||
156859303|NCT03585660|566241184|FG000|Overall Study|technical error|2|||
156859304|NCT03585660|566241184|FG000|Overall Study|hip prosthesis|2|||
156859305|NCT03585660|566241184|FG000|Overall Study|did not undergo biopsy|8|||
156859306|NCT03585660|566241184|FG000|Overall Study|scanner problem|2|||
156859307|NCT03661723|566241187|FG000|Overall Study|Disease Progression|4|||
156859308|NCT03661723|566241188|FG001|Overall Study|Disease Progression|24|||
156859309|NCT03661723|566241189|FG002|Overall Study|Disease Progression|4|||
156859310|NCT03661723|566241190|FG003|Overall Study|Disease Progression|19|||
156859311|NCT03661723|566241187|FG000|Overall Study|Withdrawal by Subject|1|||
156859312|NCT03661723|566241188|FG001|Overall Study|Withdrawal by Subject|0|||
156859313|NCT03661723|566241189|FG002|Overall Study|Withdrawal by Subject|2|||
156859314|NCT03661723|566241190|FG003|Overall Study|Withdrawal by Subject|4|||
156859315|NCT03661723|566241187|FG000|Overall Study|Physician Decision|1|||
156859316|NCT03661723|566241188|FG001|Overall Study|Physician Decision|0|||
156859317|NCT03661723|566241189|FG002|Overall Study|Physician Decision|0|||
156859318|NCT03661723|566241190|FG003|Overall Study|Physician Decision|0|||
156859319|NCT03661723|566241187|FG000|Overall Study|Clinical Deterioration|0|||
156859320|NCT03661723|566241188|FG001|Overall Study|Clinical Deterioration|0|||
156859321|NCT03661723|566241189|FG002|Overall Study|Clinical Deterioration|0|||
156859322|NCT03661723|566241190|FG003|Overall Study|Clinical Deterioration|1|||
156859323|NCT03760029|566241191|FG000|Overall Study|Death|1|||
156859324|NCT03760029|566241192|FG001|Overall Study|Death|0|||
156859325|NCT03760029|566241193|FG002|Overall Study|Death|0|||
156859326|NCT03760029|566241191|FG000|Overall Study|Lost to Follow-up|0|||
156859327|NCT03760029|566241192|FG001|Overall Study|Lost to Follow-up|2|||
156859328|NCT03760029|566241193|FG002|Overall Study|Lost to Follow-up|1|||
156859329|NCT03760029|566241191|FG000|Overall Study|Withdrawal by Subject|1|||
156859330|NCT03760029|566241192|FG001|Overall Study|Withdrawal by Subject|4|||
156859331|NCT03760029|566241193|FG002|Overall Study|Withdrawal by Subject|1|||
156859332|NCT03760029|566241191|FG000|Overall Study|Withdrawal by parent/guardian|4|||
156859333|NCT03760029|566241192|FG001|Overall Study|Withdrawal by parent/guardian|4|||
156859334|NCT03760029|566241193|FG002|Overall Study|Withdrawal by parent/guardian|1|||
156859335|NCT03760029|566241191|FG000|Overall Study|Other|2|||
156859336|NCT03760029|566241192|FG001|Overall Study|Other|1|||
157158943|NCT05142332|567326829|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
156859337|NCT03760029|566241193|FG002|Overall Study|Other|0|||
156859338|NCT04890652|566241201|FG000|Overall Study|Withdrawal by Subject|2|||
156859339|NCT00807911|566241202|FG000|Overall Study|Withdrawal by Subject|12|||
156902798|NCT01756053|566403150|FG001|Period 1 (10 Days)|Protocol Violation|1|||
156902799|NCT01756053|566403149|FG000|Period 2 (10 Days)|Protocol Violation|0|||
156902800|NCT01756053|566403150|FG001|Period 2 (10 Days)|Protocol Violation|2|||
156902801|NCT00285818|566403151|FG000|Overall Study|Withdrawal by Subject|3|||
156902802|NCT00285818|566403152|FG001|Overall Study|Withdrawal by Subject|2|||
156902803|NCT00285818|566403151|FG000|Overall Study|Lost to Follow-up|1|||
156902804|NCT00285818|566403152|FG001|Overall Study|Lost to Follow-up|0|||
156902805|NCT04041375|566403153|FG000|Intervention Phase|Withdrawal by Subject|2|||
156902806|NCT04041375|566403154|FG001|Intervention Phase|Withdrawal by Subject|2|||
156902807|NCT04041375|566403153|FG000|Follow-up Phase|Death|2|||
156902808|NCT04041375|566403154|FG001|Follow-up Phase|Death|0|||
156902809|NCT04041375|566403153|FG000|Follow-up Phase|Lost to Follow-up|2|||
156902810|NCT04041375|566403154|FG001|Follow-up Phase|Lost to Follow-up|1|||
156902811|NCT04041375|566403153|FG000|Follow-up Phase|Too ill|3|||
156902812|NCT04041375|566403154|FG001|Follow-up Phase|Too ill|0|||
156902813|NCT04674644|566403155|FG000|Overall Study|with missing data|37|||
156902814|NCT02404220|566403156|FG000|Overall Study|Adverse Event|0|||
156902815|NCT02404220|566403157|FG001|Overall Study|Adverse Event|0|||
156902816|NCT02404220|566403158|FG002|Overall Study|Adverse Event|1|||
156902817|NCT02404220|566403159|FG003|Overall Study|Adverse Event|0|||
156902818|NCT02404220|566403156|FG000|Overall Study|Death|5|||
156902819|NCT02404220|566403157|FG001|Overall Study|Death|5|||
156902820|NCT02404220|566403158|FG002|Overall Study|Death|3|||
156902821|NCT02404220|566403159|FG003|Overall Study|Death|8|||
156902822|NCT02404220|566403156|FG000|Overall Study|Progressive Disease|0|||
156902823|NCT02404220|566403157|FG001|Overall Study|Progressive Disease|0|||
156902824|NCT02404220|566403158|FG002|Overall Study|Progressive Disease|1|||
156902825|NCT02404220|566403159|FG003|Overall Study|Progressive Disease|1|||
156902826|NCT02404220|566403156|FG000|Overall Study|Study Terminated by Sponsor|0|||
156902827|NCT02404220|566403157|FG001|Overall Study|Study Terminated by Sponsor|0|||
156902828|NCT02404220|566403158|FG002|Overall Study|Study Terminated by Sponsor|2|||
156902829|NCT02404220|566403159|FG003|Overall Study|Study Terminated by Sponsor|1|||
156902830|NCT02404220|566403156|FG000|Overall Study|Withdrawal by Subject|0|||
156902831|NCT02404220|566403157|FG001|Overall Study|Withdrawal by Subject|1|||
156902832|NCT02404220|566403158|FG002|Overall Study|Withdrawal by Subject|0|||
156902833|NCT02404220|566403159|FG003|Overall Study|Withdrawal by Subject|0|||
156902834|NCT02404220|566403156|FG000|Overall Study|Enrolled but Never Treated|0|||
156902835|NCT02404220|566403157|FG001|Overall Study|Enrolled but Never Treated|2|||
156902836|NCT02404220|566403158|FG002|Overall Study|Enrolled but Never Treated|0|||
156902837|NCT02404220|566403159|FG003|Overall Study|Enrolled but Never Treated|0|||
156902838|NCT01024231|566403161|FG000|Overall Study|Other Reasons|1|||
156902839|NCT01024231|566403162|FG001|Overall Study|Other Reasons|2|||
156902840|NCT01024231|566403163|FG002|Overall Study|Other Reasons|0|||
156902841|NCT01024231|566403164|FG003|Overall Study|Other Reasons|0|||
156902842|NCT01024231|566403165|FG004|Overall Study|Other Reasons|2|||
156902843|NCT01024231|566403166|FG005|Overall Study|Other Reasons|0|||
156902844|NCT01024231|566403167|FG006|Overall Study|Other Reasons|1|||
156902845|NCT01024231|566403161|FG000|Overall Study|Maximum Clinical Benefit|1|||
156902846|NCT01024231|566403162|FG001|Overall Study|Maximum Clinical Benefit|2|||
156902847|NCT01024231|566403163|FG002|Overall Study|Maximum Clinical Benefit|0|||
156902848|NCT01024231|566403164|FG003|Overall Study|Maximum Clinical Benefit|1|||
156902849|NCT01024231|566403165|FG004|Overall Study|Maximum Clinical Benefit|1|||
156902850|NCT01024231|566403166|FG005|Overall Study|Maximum Clinical Benefit|0|||
156902851|NCT01024231|566403167|FG006|Overall Study|Maximum Clinical Benefit|0|||
156902852|NCT01024231|566403161|FG000|Overall Study|Disease Progression|3|||
156902853|NCT01024231|566403162|FG001|Overall Study|Disease Progression|1|||
156902854|NCT01024231|566403163|FG002|Overall Study|Disease Progression|3|||
156902855|NCT01024231|566403164|FG003|Overall Study|Disease Progression|0|||
156902856|NCT01024231|566403165|FG004|Overall Study|Disease Progression|4|||
156902857|NCT01024231|566403166|FG005|Overall Study|Disease Progression|11|||
156902858|NCT01024231|566403167|FG006|Overall Study|Disease Progression|6|||
156902859|NCT01024231|566403161|FG000|Overall Study|AE unrelated to Study Drug|0|||
156902860|NCT01024231|566403162|FG001|Overall Study|AE unrelated to Study Drug|1|||
156902861|NCT01024231|566403163|FG002|Overall Study|AE unrelated to Study Drug|0|||
156902862|NCT01024231|566403164|FG003|Overall Study|AE unrelated to Study Drug|0|||
156902863|NCT01024231|566403165|FG004|Overall Study|AE unrelated to Study Drug|0|||
156902864|NCT01024231|566403166|FG005|Overall Study|AE unrelated to Study Drug|0|||
156902865|NCT01024231|566403167|FG006|Overall Study|AE unrelated to Study Drug|0|||
156902866|NCT01024231|566403161|FG000|Overall Study|No longer meets criteria|0|||
156902867|NCT01024231|566403162|FG001|Overall Study|No longer meets criteria|0|||
156902868|NCT01024231|566403163|FG002|Overall Study|No longer meets criteria|0|||
156902869|NCT01024231|566403164|FG003|Overall Study|No longer meets criteria|0|||
156902870|NCT01024231|566403165|FG004|Overall Study|No longer meets criteria|1|||
156902871|NCT01024231|566403166|FG005|Overall Study|No longer meets criteria|0|||
156902872|NCT01024231|566403167|FG006|Overall Study|No longer meets criteria|1|||
156902873|NCT01024231|566403161|FG000|Overall Study|Study Drug Toxicity|1|||
156902874|NCT01024231|566403162|FG001|Overall Study|Study Drug Toxicity|6|||
156902875|NCT01024231|566403163|FG002|Overall Study|Study Drug Toxicity|6|||
156902876|NCT01024231|566403164|FG003|Overall Study|Study Drug Toxicity|4|||
156902877|NCT01024231|566403165|FG004|Overall Study|Study Drug Toxicity|2|||
157158944|NCT05142332|567326830|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
157158945|NCT05142332|567326831|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
157158946|NCT05142332|567326832|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
157158947|NCT05142332|567326833|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
157158948|NCT05142332|567326834|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
157158949|NCT05142332|567326835|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
157158950|NCT02116660|567326836|FG000|Overall Study|Deteriorating renal function|0|||
157158951|NCT02116660|567326837|FG001|Overall Study|Deteriorating renal function|1|||
157158952|NCT02116660|567326836|FG000|Overall Study|Adverse Event|1|||
157158953|NCT02116660|567326837|FG001|Overall Study|Adverse Event|1|||
157158954|NCT02116660|567326836|FG000|Overall Study|Withdrawal by Subject|0|||
157158955|NCT02116660|567326837|FG001|Overall Study|Withdrawal by Subject|2|||
157158956|NCT02116660|567326836|FG000|Overall Study|Organization reason|1|||
157158957|NCT02116660|567326837|FG001|Overall Study|Organization reason|0|||
157158958|NCT00411788|567326842|FG000|Overall Study|Protocol Violation|1|||
157158959|NCT00411788|567326842|FG000|Overall Study|Adverse Event|1|||
157158960|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
157158961|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
157158962|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
157158963|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
157158964|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
157158965|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
157158966|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
157158967|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
157158968|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
157158969|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
157158970|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
157158971|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
157158972|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
157158973|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
157158974|NCT00848549|567326843|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
157158975|NCT00848549|567326844|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
157158976|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
157158977|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
157158978|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
157158979|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
157158980|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
157158981|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
157158982|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
157158983|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
157158984|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
157158985|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
157158986|NCT00848549|567326843|FG000|E2090-E044-314 (Extension Study)|Other|5|||
157158987|NCT00848549|567326844|FG001|E2090-E044-314 (Extension Study)|Other|6|||
157158988|NCT02561299|567326845|FG000|Overall Study|Death|2|||
157158989|NCT02561299|567326846|FG001|Overall Study|Death|4|||
157158990|NCT02561299|567326845|FG000|Overall Study|Lost to Follow-up|1|||
157158991|NCT02561299|567326846|FG001|Overall Study|Lost to Follow-up|0|||
157158992|NCT02561299|567326845|FG000|Overall Study|Withdrawal by Subject|2|||
157158993|NCT02561299|567326846|FG001|Overall Study|Withdrawal by Subject|2|||
157158994|NCT05631548|567326847|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
157158995|NCT05631548|567326848|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
157158996|NCT01219959|567326849|FG000|Overall Study|Adverse Event|6|||
157158997|NCT01219959|567326850|FG001|Overall Study|Adverse Event|14|||
157158998|NCT01219959|567326849|FG000|Overall Study|Physician Decision|0|||
157158999|NCT01219959|567326850|FG001|Overall Study|Physician Decision|4|||
157159000|NCT01219959|567326849|FG000|Overall Study|Withdrawal by Subject|0|||
157159001|NCT01219959|567326850|FG001|Overall Study|Withdrawal by Subject|2|||
157159002|NCT01219959|567326849|FG000|Overall Study|Renal Transplantation|0|||
157159003|NCT01219959|567326850|FG001|Overall Study|Renal Transplantation|3|||
157159004|NCT01219959|567326849|FG000|Overall Study|Other|1|||
156902878|NCT01024231|566403166|FG005|Overall Study|Study Drug Toxicity|0|||
157159005|NCT01219959|567326850|FG001|Overall Study|Other|0|||
156902879|NCT01024231|566403167|FG006|Overall Study|Study Drug Toxicity|7|||
157159006|NCT00471536|567326862|FG000|Overall Study|Withdrawal by Subject|1|||
157159007|NCT01980706|567326863|FG000|Overall Study|Withdrawal by Subject|9|||
157159008|NCT01980706|567326864|FG001|Overall Study|Withdrawal by Subject|6|||
156902880|NCT01024231|566403161|FG000|Overall Study|Death|6|||
156902881|NCT01024231|566403162|FG001|Overall Study|Death|2|||
156902882|NCT01024231|566403163|FG002|Overall Study|Death|1|||
156902883|NCT01024231|566403164|FG003|Overall Study|Death|0|||
156902884|NCT01024231|566403165|FG004|Overall Study|Death|4|||
156902885|NCT01024231|566403166|FG005|Overall Study|Death|3|||
156902886|NCT01024231|566403167|FG006|Overall Study|Death|5|||
156902887|NCT01024231|566403161|FG000|Overall Study|Lost to Follow-up|0|||
156902888|NCT01024231|566403162|FG001|Overall Study|Lost to Follow-up|0|||
156902889|NCT01024231|566403163|FG002|Overall Study|Lost to Follow-up|0|||
156902890|NCT01024231|566403164|FG003|Overall Study|Lost to Follow-up|0|||
156902891|NCT01024231|566403165|FG004|Overall Study|Lost to Follow-up|0|||
156902892|NCT01024231|566403166|FG005|Overall Study|Lost to Follow-up|0|||
156902893|NCT01024231|566403167|FG006|Overall Study|Lost to Follow-up|1|||
156902894|NCT01024231|566403161|FG000|Overall Study|Withdrew Consent|0|||
156902895|NCT01024231|566403162|FG001|Overall Study|Withdrew Consent|1|||
156902896|NCT01024231|566403163|FG002|Overall Study|Withdrew Consent|0|||
156902897|NCT01024231|566403164|FG003|Overall Study|Withdrew Consent|0|||
156902898|NCT01024231|566403165|FG004|Overall Study|Withdrew Consent|0|||
156902899|NCT01024231|566403166|FG005|Overall Study|Withdrew Consent|0|||
156902900|NCT01024231|566403167|FG006|Overall Study|Withdrew Consent|0|||
156902901|NCT01024231|566403161|FG000|Overall Study|Continuing on Treatment|0|||
156902902|NCT01024231|566403162|FG001|Overall Study|Continuing on Treatment|0|||
156902903|NCT01024231|566403163|FG002|Overall Study|Continuing on Treatment|0|||
156902904|NCT01024231|566403164|FG003|Overall Study|Continuing on Treatment|0|||
156902905|NCT01024231|566403165|FG004|Overall Study|Continuing on Treatment|3|||
156902906|NCT01024231|566403166|FG005|Overall Study|Continuing on Treatment|2|||
156902907|NCT01024231|566403167|FG006|Overall Study|Continuing on Treatment|0|||
156902908|NCT00395733|566403168|FG000|Period 2|Withdrawal by Subject|1|||
156902909|NCT00395733|566403169|FG001|Period 2|Withdrawal by Subject|2|||
156902910|NCT00395733|566403168|FG000|Period 2|Protocol Violation|0|||
156902911|NCT00395733|566403169|FG001|Period 2|Protocol Violation|1|||
156902912|NCT00395733|566403168|FG000|Period 2|Adverse Event|0|||
156902913|NCT00395733|566403169|FG001|Period 2|Adverse Event|2|||
156902914|NCT00395733|566403168|FG000|Period 2|Technical problems|1|||
156902915|NCT00395733|566403169|FG001|Period 2|Technical problems|0|||
156902916|NCT03725852|566403170|FG000|Overall Study|Death|1|||
156902917|NCT03725852|566403171|FG001|Overall Study|Death|0|||
156902918|NCT03725852|566403170|FG000|Overall Study|Withdrawal by Subject|1|||
156902919|NCT03725852|566403171|FG001|Overall Study|Withdrawal by Subject|0|||
156902920|NCT03725852|566403170|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
156902921|NCT03725852|566403171|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
156902922|NCT01147172|566403177|FG000|Overall Study|Withdrawal by Subject|2|||
156902923|NCT01147172|566403177|FG000|Overall Study|Lost to Follow-up|2|||
156902924|NCT02913612|566403182|FG000|Overall Study|Lost to Follow-up|6|||
156902925|NCT02913612|566403183|FG001|Overall Study|Lost to Follow-up|5|||
156902926|NCT02913612|566403184|FG002|Overall Study|Lost to Follow-up|2|||
156902927|NCT02913612|566403185|FG003|Overall Study|Lost to Follow-up|0|||
156902928|NCT02913612|566403182|FG000|Overall Study|Physician Decision|1|||
156902929|NCT02913612|566403183|FG001|Overall Study|Physician Decision|4|||
156902930|NCT02913612|566403184|FG002|Overall Study|Physician Decision|1|||
156902931|NCT02913612|566403185|FG003|Overall Study|Physician Decision|0|||
156902932|NCT02913612|566403182|FG000|Overall Study|Withdrawal by Subject|2|||
156902933|NCT02913612|566403183|FG001|Overall Study|Withdrawal by Subject|4|||
156902934|NCT02913612|566403184|FG002|Overall Study|Withdrawal by Subject|0|||
156902935|NCT02913612|566403185|FG003|Overall Study|Withdrawal by Subject|0|||
156902936|NCT02913612|566403182|FG000|Overall Study|Hemangioma resolved|1|||
156902937|NCT02913612|566403183|FG001|Overall Study|Hemangioma resolved|0|||
156902938|NCT02913612|566403184|FG002|Overall Study|Hemangioma resolved|0|||
157026629|NCT04515849|566851651|FG002|Overall Study|Death|0|||
157026630|NCT04515849|566851652|FG003|Overall Study|Death|0|||
157026631|NCT04515849|566851653|FG004|Overall Study|Death|0|||
157026632|NCT04515849|566851649|FG000|Overall Study|Other:family emergency|0|||
156902939|NCT02913612|566403185|FG003|Overall Study|Hemangioma resolved|0|||
156902940|NCT02913612|566403182|FG000|Overall Study|Local IRB decision|1|||
156902941|NCT02913612|566403183|FG001|Overall Study|Local IRB decision|0|||
156902942|NCT02913612|566403184|FG002|Overall Study|Local IRB decision|0|||
156902943|NCT02913612|566403185|FG003|Overall Study|Local IRB decision|0|||
156902944|NCT02913612|566403182|FG000|Overall Study|Study drug non-compliance|1|||
156902945|NCT02913612|566403183|FG001|Overall Study|Study drug non-compliance|1|||
156902946|NCT02913612|566403184|FG002|Overall Study|Study drug non-compliance|0|||
156902947|NCT02913612|566403185|FG003|Overall Study|Study drug non-compliance|0|||
156902948|NCT02913612|566403182|FG000|Overall Study|Insurance issues|0|||
156902949|NCT02913612|566403183|FG001|Overall Study|Insurance issues|1|||
156902950|NCT02913612|566403184|FG002|Overall Study|Insurance issues|0|||
156902951|NCT02913612|566403185|FG003|Overall Study|Insurance issues|0|||
156902952|NCT02913612|566403182|FG000|Overall Study|Needed to treat second hemangioma|0|||
156902953|NCT02913612|566403183|FG001|Overall Study|Needed to treat second hemangioma|1|||
156902954|NCT02913612|566403184|FG002|Overall Study|Needed to treat second hemangioma|0|||
156902955|NCT02913612|566403185|FG003|Overall Study|Needed to treat second hemangioma|0|||
157026633|NCT04515849|566851650|FG001|Overall Study|Other:family emergency|0|||
156902956|NCT02913612|566403182|FG000|Overall Study|Study completion criteria not met|0|||
156902957|NCT02913612|566403183|FG001|Overall Study|Study completion criteria not met|1|||
156902958|NCT02913612|566403184|FG002|Overall Study|Study completion criteria not met|0|||
156902959|NCT02913612|566403185|FG003|Overall Study|Study completion criteria not met|0|||
156902960|NCT02913612|566403182|FG000|Overall Study|Ineligible|0|||
156902961|NCT02913612|566403183|FG001|Overall Study|Ineligible|1|||
156902962|NCT02913612|566403184|FG002|Overall Study|Ineligible|0|||
156902963|NCT02913612|566403185|FG003|Overall Study|Ineligible|0|||
156902964|NCT00669396|566403186|FG000|Overall Study|Lost to Follow-up|10|||
156902965|NCT00669396|566403187|FG001|Overall Study|Lost to Follow-up|12|||
156902966|NCT01262573|566403188|FG000|Overall Study|Withdrawal by Subject|0|||
156902967|NCT01262573|566403189|FG001|Overall Study|Withdrawal by Subject|1|||
156902968|NCT04402060|566403190|FG000|Overall Study|Death|1|||
156902969|NCT04402060|566403191|FG001|Overall Study|Death|12|||
156902970|NCT04402060|566403192|FG002|Overall Study|Death|7|||
156902971|NCT04402060|566403190|FG000|Overall Study|Adverse Event|0|||
156902972|NCT04402060|566403191|FG001|Overall Study|Adverse Event|0|||
156902973|NCT04402060|566403192|FG002|Overall Study|Adverse Event|1|||
156902974|NCT04402060|566403190|FG000|Overall Study|Withdrawal by Subject|0|||
156902975|NCT04402060|566403191|FG001|Overall Study|Withdrawal by Subject|1|||
156902976|NCT04402060|566403192|FG002|Overall Study|Withdrawal by Subject|2|||
156902977|NCT04402060|566403190|FG000|Overall Study|Sponsor Request|0|||
156902978|NCT04402060|566403191|FG001|Overall Study|Sponsor Request|2|||
156902979|NCT04402060|566403192|FG002|Overall Study|Sponsor Request|0|||
156902980|NCT04402060|566403190|FG000|Overall Study|Physician Decision|0|||
156902981|NCT04402060|566403191|FG001|Overall Study|Physician Decision|0|||
156902982|NCT04402060|566403192|FG002|Overall Study|Physician Decision|1|||
156902983|NCT04402060|566403190|FG000|Overall Study|Other|0|||
156902984|NCT04402060|566403191|FG001|Overall Study|Other|1|||
156902985|NCT04402060|566403192|FG002|Overall Study|Other|0|||
156902986|NCT02711345|566403194|FG000|Overall Study|Adverse Event|0|||
156902987|NCT02711345|566403195|FG001|Overall Study|Adverse Event|0|||
156902988|NCT02711345|566403196|FG002|Overall Study|Adverse Event|0|||
156902989|NCT02711345|566403197|FG003|Overall Study|Adverse Event|1|||
156902990|NCT02711345|566403198|FG004|Overall Study|Adverse Event|1|||
156902991|NCT02711345|566403199|FG005|Overall Study|Adverse Event|2|||
156902992|NCT02711345|566403200|FG006|Overall Study|Adverse Event|1|||
156902993|NCT02711345|566403201|FG007|Overall Study|Adverse Event|0|||
156902994|NCT02711345|566403202|FG008|Overall Study|Adverse Event|0|||
156902995|NCT02711345|566403203|FG009|Overall Study|Adverse Event|2|||
156902996|NCT02711345|566403194|FG000|Overall Study|Physician Decision|0|||
156902997|NCT02711345|566403195|FG001|Overall Study|Physician Decision|0|||
156902998|NCT02711345|566403196|FG002|Overall Study|Physician Decision|1|||
156902999|NCT02711345|566403197|FG003|Overall Study|Physician Decision|0|||
156903000|NCT02711345|566403198|FG004|Overall Study|Physician Decision|0|||
156903001|NCT02711345|566403199|FG005|Overall Study|Physician Decision|0|||
156903002|NCT02711345|566403200|FG006|Overall Study|Physician Decision|0|||
156903003|NCT02711345|566403201|FG007|Overall Study|Physician Decision|0|||
156903004|NCT02711345|566403202|FG008|Overall Study|Physician Decision|1|||
156903005|NCT02711345|566403203|FG009|Overall Study|Physician Decision|0|||
156903006|NCT02711345|566403194|FG000|Overall Study|Progressive disease|1|||
156903007|NCT02711345|566403195|FG001|Overall Study|Progressive disease|3|||
156903008|NCT02711345|566403196|FG002|Overall Study|Progressive disease|5|||
156903009|NCT02711345|566403197|FG003|Overall Study|Progressive disease|3|||
156903010|NCT02711345|566403198|FG004|Overall Study|Progressive disease|7|||
156903011|NCT02711345|566403199|FG005|Overall Study|Progressive disease|2|||
157225564|NCT01325207|567571465|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
156903012|NCT02711345|566403200|FG006|Overall Study|Progressive disease|8|||
157026634|NCT04515849|566851651|FG002|Overall Study|Other:family emergency|0|||
157026635|NCT04515849|566851652|FG003|Overall Study|Other:family emergency|1|||
157026636|NCT04515849|566851653|FG004|Overall Study|Other:family emergency|0|||
157026637|NCT04515849|566851649|FG000|Overall Study|Other:randomised by error|0|||
157026638|NCT04515849|566851650|FG001|Overall Study|Other:randomised by error|1|||
156903013|NCT02711345|566403201|FG007|Overall Study|Progressive disease|4|||
156903014|NCT02711345|566403202|FG008|Overall Study|Progressive disease|5|||
156903015|NCT02711345|566403203|FG009|Overall Study|Progressive disease|6|||
156903016|NCT02711345|566403194|FG000|Overall Study|Subject/guardian decision|0|||
156903017|NCT02711345|566403195|FG001|Overall Study|Subject/guardian decision|0|||
156903018|NCT02711345|566403196|FG002|Overall Study|Subject/guardian decision|0|||
156903019|NCT02711345|566403197|FG003|Overall Study|Subject/guardian decision|0|||
156903020|NCT02711345|566403198|FG004|Overall Study|Subject/guardian decision|0|||
156903021|NCT02711345|566403199|FG005|Overall Study|Subject/guardian decision|2|||
157026639|NCT04515849|566851651|FG002|Overall Study|Other:randomised by error|0|||
156903022|NCT02711345|566403200|FG006|Overall Study|Subject/guardian decision|3|||
156903023|NCT02711345|566403201|FG007|Overall Study|Subject/guardian decision|1|||
156903024|NCT02711345|566403202|FG008|Overall Study|Subject/guardian decision|0|||
156903025|NCT02711345|566403203|FG009|Overall Study|Subject/guardian decision|4|||
156903026|NCT02711345|566403194|FG000|Overall Study|Death|1|||
156903027|NCT02711345|566403195|FG001|Overall Study|Death|0|||
156903028|NCT02711345|566403196|FG002|Overall Study|Death|0|||
156903029|NCT02711345|566403197|FG003|Overall Study|Death|0|||
156903030|NCT02711345|566403198|FG004|Overall Study|Death|0|||
156903031|NCT02711345|566403199|FG005|Overall Study|Death|0|||
156903032|NCT02711345|566403200|FG006|Overall Study|Death|0|||
156903033|NCT02711345|566403201|FG007|Overall Study|Death|1|||
156903034|NCT02711345|566403202|FG008|Overall Study|Death|0|||
156903035|NCT02711345|566403203|FG009|Overall Study|Death|0|||
156903036|NCT04357782|566403204|FG000|Overall Study|Discharged from hospital|1|||
156903037|NCT04357782|566403205|FG001|Overall Study|Discharged from hospital|0|||
156903038|NCT04357782|566403204|FG000|Overall Study|Death|0|||
156903039|NCT04357782|566403205|FG001|Overall Study|Death|2|||
156903040|NCT01786148|566403206|FG000|Overall Study|Lost to Follow-up|21|||
156903041|NCT01786148|566403207|FG001|Overall Study|Lost to Follow-up|13|||
156903042|NCT01786148|566403206|FG000|Overall Study|Death|0|||
156903043|NCT01786148|566403207|FG001|Overall Study|Death|1|||
156903044|NCT01786148|566403206|FG000|Overall Study|Withdrawal by Subject|0|||
156903045|NCT01786148|566403207|FG001|Overall Study|Withdrawal by Subject|7|||
156903046|NCT01786148|566403206|FG000|Overall Study|Incarceration|1|||
156903047|NCT01786148|566403207|FG001|Overall Study|Incarceration|1|||
156903048|NCT03780543|566403209|FG000|Overall Study|Adverse Event|1|||
156903049|NCT03780543|566403210|FG001|Overall Study|Adverse Event|0|||
156903050|NCT03780543|566403211|FG002|Overall Study|Adverse Event|2|||
156903051|NCT03780543|566403209|FG000|Overall Study|Lost to Follow-up|2|||
156903052|NCT03780543|566403210|FG001|Overall Study|Lost to Follow-up|0|||
156903053|NCT03780543|566403211|FG002|Overall Study|Lost to Follow-up|1|||
156903054|NCT03780543|566403209|FG000|Overall Study|Study terminated by Sponsor|8|||
156903055|NCT03780543|566403210|FG001|Overall Study|Study terminated by Sponsor|7|||
156903056|NCT03780543|566403211|FG002|Overall Study|Study terminated by Sponsor|13|||
156903057|NCT03780543|566403209|FG000|Overall Study|Withdrawal by Subject|1|||
156903058|NCT03780543|566403210|FG001|Overall Study|Withdrawal by Subject|8|||
156903059|NCT03780543|566403211|FG002|Overall Study|Withdrawal by Subject|1|||
156903060|NCT03780543|566403209|FG000|Overall Study|Noncompliance with study drug|1|||
156903061|NCT03780543|566403210|FG001|Overall Study|Noncompliance with study drug|0|||
156903062|NCT03780543|566403211|FG002|Overall Study|Noncompliance with study drug|0|||
156903063|NCT01033851|566403212|FG000|Overall Study|Withdrawal by Subject|3|||
156903064|NCT01033851|566403213|FG001|Overall Study|Withdrawal by Subject|7|||
156903065|NCT03896165|566403216|FG000|Overall Study|Withdrawal by Subject|2|||
156903066|NCT03181893|566403217|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903067|NCT03181893|566403218|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
156903068|NCT03181893|566403219|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903069|NCT03181893|566403220|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903070|NCT03181893|566403221|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903071|NCT03181893|566403222|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903072|NCT03181893|566403223|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903073|NCT03181893|566403224|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903074|NCT03181893|566403225|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903075|NCT03181893|566403226|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903076|NCT03181893|566403227|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
156903077|NCT03181893|566403217|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
156903078|NCT03181893|566403218|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
156903079|NCT03181893|566403219|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903080|NCT03181893|566403220|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903081|NCT03181893|566403221|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903082|NCT03181893|566403222|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903083|NCT03181893|566403223|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903084|NCT03181893|566403224|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903085|NCT03181893|566403225|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903086|NCT03181893|566403226|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
157026640|NCT04515849|566851652|FG003|Overall Study|Other:randomised by error|0|||
157026641|NCT04515849|566851653|FG004|Overall Study|Other:randomised by error|0|||
157225565|NCT01325207|567571460|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156903087|NCT03181893|566403227|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
156903088|NCT03181893|566403217|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903089|NCT03181893|566403218|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903090|NCT03181893|566403219|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903091|NCT03181893|566403220|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
157225566|NCT01325207|567571461|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156903092|NCT03181893|566403221|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903093|NCT03181893|566403222|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903094|NCT03181893|566403223|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903095|NCT03181893|566403224|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
156903096|NCT03181893|566403225|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
156903097|NCT03181893|566403226|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903098|NCT03181893|566403227|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
156903099|NCT03181893|566403217|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903100|NCT03181893|566403218|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903101|NCT03181893|566403219|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903102|NCT03181893|566403220|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903103|NCT03181893|566403221|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903104|NCT03181893|566403222|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903105|NCT03181893|566403223|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903106|NCT03181893|566403224|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903107|NCT03181893|566403225|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903108|NCT03181893|566403226|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
156903109|NCT03181893|566403227|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
156903110|NCT03181893|566403217|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903111|NCT03181893|566403218|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903112|NCT03181893|566403219|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903113|NCT03181893|566403220|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903114|NCT03181893|566403221|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903115|NCT03181893|566403222|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903116|NCT03181893|566403223|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903117|NCT03181893|566403224|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903118|NCT03181893|566403225|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903119|NCT03181893|566403226|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
156903120|NCT03181893|566403227|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
156903121|NCT04815031|566403228|FG000|Overall Study|No adverse event information (missing information)|33|||
156903122|NCT01361568|566403231|FG000|Overall Study|Adverse Event|0|||
156903123|NCT01361568|566403232|FG001|Overall Study|Adverse Event|0|||
156903124|NCT01361568|566403233|FG002|Overall Study|Adverse Event|0|||
156903125|NCT01361568|566403234|FG003|Overall Study|Adverse Event|0|||
157159009|NCT01980706|567326865|FG002|Overall Study|Withdrawal by Subject|2|||
157159010|NCT01980706|567326863|FG000|Overall Study|Adverse Event|1|||
157159011|NCT01980706|567326864|FG001|Overall Study|Adverse Event|2|||
157159012|NCT01980706|567326865|FG002|Overall Study|Adverse Event|5|||
157159013|NCT01980706|567326863|FG000|Overall Study|Lost to Follow-up|3|||
157159014|NCT01980706|567326864|FG001|Overall Study|Lost to Follow-up|4|||
157159015|NCT01980706|567326865|FG002|Overall Study|Lost to Follow-up|3|||
157159016|NCT01980706|567326863|FG000|Overall Study|miscellaneous|4|||
157159017|NCT01980706|567326864|FG001|Overall Study|miscellaneous|5|||
157159018|NCT01980706|567326865|FG002|Overall Study|miscellaneous|3|||
157159019|NCT02546674|567326868|FG000|Overall Study|Adverse Event|19|||
157159020|NCT02546674|567326868|FG000|Overall Study|Death|1|||
157159021|NCT02546674|567326868|FG000|Overall Study|Lost to Follow-up|1|||
157159022|NCT02546674|567326868|FG000|Overall Study|Physician Decision|13|||
157159023|NCT02546674|567326868|FG000|Overall Study|Pregnancy|1|||
157159024|NCT02546674|567326868|FG000|Overall Study|Progressive Disease|2|||
157159025|NCT02546674|567326868|FG000|Overall Study|Protocol Deviation|2|||
157159026|NCT02546674|567326868|FG000|Overall Study|Subject/Guardian Decision|6|||
157159027|NCT02546674|567326868|FG000|Overall Study|Withdrawal of Informed Consent|3|||
157159028|NCT01094730|567326871|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
157159029|NCT01094730|567326872|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
157159030|NCT01094730|567326871|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
157159031|NCT01094730|567326872|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
157159032|NCT01094730|567326871|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
157159033|NCT01094730|567326872|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
157159034|NCT01094730|567326871|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
157159035|NCT01094730|567326872|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
157159036|NCT01094730|567326871|FG000|Period 2 (14 Days)|Protocol Violation|2|||
157159037|NCT01094730|567326872|FG001|Period 2 (14 Days)|Protocol Violation|0|||
157159038|NCT01094730|567326871|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
157159039|NCT01094730|567326872|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
157159040|NCT01094730|567326871|FG000|Period 2 (14 Days)|Adverse Event|0|||
157159041|NCT01094730|567326872|FG001|Period 2 (14 Days)|Adverse Event|1|||
157159042|NCT01094730|567326871|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
156903126|NCT01361568|566403235|FG004|Overall Study|Adverse Event|1|||
157159043|NCT01094730|567326872|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
157159044|NCT02232087|567326873|FG000|Overall Study|Withdrawal by Subject|2|||
157159045|NCT02232087|567326874|FG001|Overall Study|Withdrawal by Subject|0|||
157159046|NCT02232087|567326875|FG002|Overall Study|Withdrawal by Subject|0|||
157159047|NCT02232087|567326876|FG003|Overall Study|Withdrawal by Subject|0|||
157159048|NCT02232087|567326877|FG004|Overall Study|Withdrawal by Subject|0|||
157159049|NCT02232087|567326878|FG005|Overall Study|Withdrawal by Subject|1|||
157159050|NCT02232087|567326873|FG000|Overall Study|poor inhalation technique|0|||
157159051|NCT02232087|567326874|FG001|Overall Study|poor inhalation technique|1|||
156903127|NCT01361568|566403236|FG005|Overall Study|Adverse Event|0|||
156903128|NCT01361568|566403231|FG000|Overall Study|Physician Decision|0|||
156903129|NCT01361568|566403232|FG001|Overall Study|Physician Decision|0|||
156903130|NCT01361568|566403233|FG002|Overall Study|Physician Decision|0|||
156903131|NCT01361568|566403234|FG003|Overall Study|Physician Decision|0|||
156903132|NCT01361568|566403235|FG004|Overall Study|Physician Decision|0|||
156903133|NCT01361568|566403236|FG005|Overall Study|Physician Decision|1|||
156903134|NCT01361568|566403231|FG000|Overall Study|Withdrawal by Subject|2|||
156903135|NCT01361568|566403232|FG001|Overall Study|Withdrawal by Subject|1|||
156903136|NCT01361568|566403233|FG002|Overall Study|Withdrawal by Subject|0|||
156903137|NCT01361568|566403234|FG003|Overall Study|Withdrawal by Subject|0|||
156903138|NCT01361568|566403235|FG004|Overall Study|Withdrawal by Subject|0|||
156903139|NCT01361568|566403236|FG005|Overall Study|Withdrawal by Subject|1|||
156903140|NCT02728596|566403237|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156903141|NCT02728596|566403238|FG001|Overall Study|Refusal unrelated to adverse event|6|||
156903142|NCT02728596|566403239|FG002|Overall Study|Refusal unrelated to adverse event|7|||
156903143|NCT02728596|566403240|FG003|Overall Study|Refusal unrelated to adverse event|7|||
156903144|NCT02728596|566403237|FG000|Overall Study|Death|44|||
156903145|NCT02728596|566403238|FG001|Overall Study|Death|42|||
156903146|NCT02728596|566403239|FG002|Overall Study|Death|123|||
156903147|NCT02728596|566403240|FG003|Overall Study|Death|68|||
156903148|NCT00531934|566405148|FG000|Overall Study|Adverse Event|4|||
156903149|NCT00531934|566405149|FG001|Overall Study|Adverse Event|8|||
156903150|NCT00531934|566405148|FG000|Overall Study|Progression|52|||
156903151|NCT00531934|566405149|FG001|Overall Study|Progression|42|||
156903152|NCT00531934|566405148|FG000|Overall Study|Death|7|||
156903153|NCT00531934|566405149|FG001|Overall Study|Death|10|||
156903154|NCT00531934|566405148|FG000|Overall Study|Withdrawal by Subject|1|||
156903155|NCT00531934|566405149|FG001|Overall Study|Withdrawal by Subject|1|||
156903156|NCT00531934|566405148|FG000|Overall Study|Other|2|||
156903157|NCT00531934|566405149|FG001|Overall Study|Other|2|||
156903158|NCT00150709|566405150|FG000|Overall Study|Protocol Violation|7|||
156903159|NCT00150709|566405151|FG001|Overall Study|Protocol Violation|8|||
156903160|NCT00150709|566405152|FG002|Overall Study|Protocol Violation|3|||
156903161|NCT00150709|566405153|FG003|Overall Study|Protocol Violation|1|||
156903162|NCT00150709|566405150|FG000|Overall Study|Adverse Event|8|||
156903163|NCT00150709|566405151|FG001|Overall Study|Adverse Event|2|||
156903164|NCT00150709|566405152|FG002|Overall Study|Adverse Event|2|||
156903165|NCT00150709|566405153|FG003|Overall Study|Adverse Event|3|||
156903166|NCT00150709|566405150|FG000|Overall Study|Lack of Efficacy|6|||
156903167|NCT00150709|566405151|FG001|Overall Study|Lack of Efficacy|11|||
156903168|NCT00150709|566405152|FG002|Overall Study|Lack of Efficacy|9|||
156903169|NCT00150709|566405153|FG003|Overall Study|Lack of Efficacy|0|||
156903170|NCT00150709|566405150|FG000|Overall Study|Withdrawal by Subject|7|||
156903171|NCT00150709|566405151|FG001|Overall Study|Withdrawal by Subject|10|||
156903172|NCT00150709|566405152|FG002|Overall Study|Withdrawal by Subject|5|||
156903173|NCT00150709|566405153|FG003|Overall Study|Withdrawal by Subject|0|||
156903174|NCT00150709|566405150|FG000|Overall Study|Lost to Follow-up|3|||
156903175|NCT00150709|566405151|FG001|Overall Study|Lost to Follow-up|2|||
156903176|NCT00150709|566405152|FG002|Overall Study|Lost to Follow-up|0|||
156903177|NCT00150709|566405153|FG003|Overall Study|Lost to Follow-up|0|||
156903178|NCT00150709|566405150|FG000|Overall Study|Sponsor decision|0|||
156903179|NCT00150709|566405151|FG001|Overall Study|Sponsor decision|0|||
156903180|NCT00150709|566405152|FG002|Overall Study|Sponsor decision|0|||
156903181|NCT00150709|566405153|FG003|Overall Study|Sponsor decision|1|||
156903182|NCT00150709|566405150|FG000|Overall Study|Site/Investigator discontinued the study|5|||
156903183|NCT00150709|566405151|FG001|Overall Study|Site/Investigator discontinued the study|5|||
156903184|NCT00150709|566405152|FG002|Overall Study|Site/Investigator discontinued the study|2|||
156903185|NCT00150709|566405153|FG003|Overall Study|Site/Investigator discontinued the study|0|||
156903186|NCT00150709|566405150|FG000|Overall Study|Decision of parent(s)|1|||
156903187|NCT00150709|566405151|FG001|Overall Study|Decision of parent(s)|2|||
157159052|NCT02232087|567326875|FG002|Overall Study|poor inhalation technique|0|||
157159053|NCT02232087|567326876|FG003|Overall Study|poor inhalation technique|0|||
157159054|NCT02232087|567326877|FG004|Overall Study|poor inhalation technique|0|||
156903188|NCT00150709|566405152|FG002|Overall Study|Decision of parent(s)|0|||
156903189|NCT00150709|566405153|FG003|Overall Study|Decision of parent(s)|0|||
156903190|NCT00150709|566405150|FG000|Overall Study|Decision of parent(s) and investigator|3|||
156903191|NCT00150709|566405151|FG001|Overall Study|Decision of parent(s) and investigator|0|||
156903192|NCT00150709|566405152|FG002|Overall Study|Decision of parent(s) and investigator|0|||
156903193|NCT00150709|566405153|FG003|Overall Study|Decision of parent(s) and investigator|0|||
156903194|NCT00150709|566405150|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
156903195|NCT00150709|566405151|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
157159055|NCT02232087|567326878|FG005|Overall Study|poor inhalation technique|2|||
156903196|NCT00150709|566405152|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
156903197|NCT00150709|566405153|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
156903198|NCT00150709|566405150|FG000|Overall Study|Investigator decision|1|||
156903199|NCT00150709|566405151|FG001|Overall Study|Investigator decision|0|||
156903200|NCT00150709|566405152|FG002|Overall Study|Investigator decision|0|||
156903201|NCT00150709|566405153|FG003|Overall Study|Investigator decision|1|||
156903202|NCT00150709|566405150|FG000|Overall Study|Subject relocated|2|||
156903203|NCT00150709|566405151|FG001|Overall Study|Subject relocated|2|||
156903204|NCT00150709|566405152|FG002|Overall Study|Subject relocated|1|||
156903205|NCT00150709|566405153|FG003|Overall Study|Subject relocated|0|||
156903206|NCT00150709|566405150|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
156903207|NCT00150709|566405151|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
156903208|NCT00150709|566405152|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
156903209|NCT00150709|566405153|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
156903210|NCT00150709|566405150|FG000|Overall Study|Convenience|0|||
156903211|NCT00150709|566405151|FG001|Overall Study|Convenience|1|||
156903212|NCT00150709|566405152|FG002|Overall Study|Convenience|0|||
156903213|NCT00150709|566405153|FG003|Overall Study|Convenience|0|||
156903214|NCT00150709|566405150|FG000|Overall Study|Subject entered new drug study|0|||
156903215|NCT00150709|566405151|FG001|Overall Study|Subject entered new drug study|1|||
156903216|NCT00150709|566405152|FG002|Overall Study|Subject entered new drug study|0|||
156903217|NCT00150709|566405153|FG003|Overall Study|Subject entered new drug study|0|||
156903218|NCT00150709|566405150|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
156903219|NCT00150709|566405151|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
156903220|NCT00150709|566405152|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
156903221|NCT00150709|566405153|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
156903222|NCT00150709|566405150|FG000|Overall Study|Lack of ease of swallowing|0|||
156903223|NCT00150709|566405151|FG001|Overall Study|Lack of ease of swallowing|1|||
156903224|NCT00150709|566405152|FG002|Overall Study|Lack of ease of swallowing|0|||
156903225|NCT00150709|566405153|FG003|Overall Study|Lack of ease of swallowing|0|||
156903226|NCT00316719|566405154|FG000|Overall Study|Adverse Event|0|||
156903227|NCT00316719|566405155|FG001|Overall Study|Adverse Event|6|||
156903228|NCT00316719|566405154|FG000|Overall Study|Consent withdrawn|2|||
156903229|NCT00316719|566405155|FG001|Overall Study|Consent withdrawn|0|||
156903230|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Adverse Event|16|||
156903231|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Adverse Event|17|||
156903232|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Adverse Event|13|||
156903233|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Adverse Event|18|||
156903234|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Adverse Event|0|||
156903235|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Adverse Event|0|||
156903236|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Adverse Event|0|||
156903237|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Adverse Event|0|||
156903238|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
156903239|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
156903240|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
156903241|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
156903242|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
156903243|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
156903244|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
156903245|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
156903246|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
156903247|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
156903248|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
157159056|NCT02232087|567326873|FG000|Overall Study|protocol stop criteria|0|||
157159057|NCT02232087|567326874|FG001|Overall Study|protocol stop criteria|1|||
157159058|NCT02232087|567326875|FG002|Overall Study|protocol stop criteria|0|||
157159059|NCT02232087|567326876|FG003|Overall Study|protocol stop criteria|1|||
157159060|NCT02232087|567326877|FG004|Overall Study|protocol stop criteria|0|||
157159061|NCT02232087|567326878|FG005|Overall Study|protocol stop criteria|0|||
157159062|NCT02232087|567326873|FG000|Overall Study|Adverse Event|0|||
157159063|NCT02232087|567326874|FG001|Overall Study|Adverse Event|0|||
157159064|NCT02232087|567326875|FG002|Overall Study|Adverse Event|0|||
157159065|NCT02232087|567326876|FG003|Overall Study|Adverse Event|0|||
157159066|NCT02232087|567326877|FG004|Overall Study|Adverse Event|1|||
157225567|NCT01325207|567571462|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
156903249|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
156903250|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
156903251|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
156903252|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
156903253|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
156903254|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
156903255|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
156903256|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
156903257|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
156903258|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
156903259|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
156903260|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
156903261|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
157159067|NCT02232087|567326878|FG005|Overall Study|Adverse Event|0|||
157159068|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
156903262|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
156903263|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156903264|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
156903265|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
156903266|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156903267|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156903268|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156903269|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
156903270|NCT02975336|566405156|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
156903271|NCT02975336|566405157|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
156903272|NCT02975336|566405158|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
156859340|NCT00807911|566241203|FG001|Overall Study|Withdrawal by Subject|10|||
156859341|NCT00807911|566241202|FG000|Overall Study|Ineligible|0|||
156859342|NCT00807911|566241203|FG001|Overall Study|Ineligible|4|||
156859343|NCT03562195|566241206|FG000|Overall Study|Adverse Event|0|||
156859344|NCT03562195|566241207|FG001|Overall Study|Adverse Event|6|||
156859345|NCT03562195|566241206|FG000|Overall Study|Lack of Efficacy|0|||
156859346|NCT03562195|566241207|FG001|Overall Study|Lack of Efficacy|5|||
156859347|NCT03562195|566241206|FG000|Overall Study|Protocol Violation|0|||
156859348|NCT03562195|566241207|FG001|Overall Study|Protocol Violation|1|||
156859349|NCT03562195|566241206|FG000|Overall Study|Lost to Follow-up|0|||
156859350|NCT03562195|566241207|FG001|Overall Study|Lost to Follow-up|1|||
156859351|NCT03562195|566241206|FG000|Overall Study|Physician Decision|1|||
156859352|NCT03562195|566241207|FG001|Overall Study|Physician Decision|0|||
156859353|NCT03562195|566241206|FG000|Overall Study|Withdrawal by Subject|3|||
156859354|NCT03562195|566241207|FG001|Overall Study|Withdrawal by Subject|0|||
156859355|NCT00836589|566241208|FG000|Overall Study|Lost to Follow-up|246|||
156859356|NCT00836589|566241208|FG000|Overall Study|Death|429|||
156859357|NCT00836589|566241208|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
156859358|NCT00614575|566241209|FG000|Overall Study|Adverse Event|106|||
156859359|NCT00614575|566241209|FG000|Overall Study|Lost to Follow-up|55|||
156859360|NCT00614575|566241209|FG000|Overall Study|Lack of Efficacy|14|||
156859361|NCT00614575|566241209|FG000|Overall Study|Withdrawal by Subject|6|||
156859362|NCT00614575|566241209|FG000|Overall Study|Death|3|||
156859363|NCT00614575|566241209|FG000|Overall Study|Physician Decision|2|||
156859364|NCT00614575|566241209|FG000|Overall Study|No data were collected.|18|||
156859365|NCT00614575|566241209|FG000|Overall Study|Irregularly enrolled patients|23|||
156859366|NCT00614575|566241209|FG000|Overall Study|No treatment|1|||
156859367|NCT01018030|566241210|FG000|Overall Study|Adverse Event|10|||
156859368|NCT01018030|566241211|FG001|Overall Study|Adverse Event|5|||
156859369|NCT01018030|566241212|FG002|Overall Study|Adverse Event|5|||
156859370|NCT01018030|566241210|FG000|Overall Study|Withdrawal by Subject|2|||
156859371|NCT01018030|566241211|FG001|Overall Study|Withdrawal by Subject|2|||
156859372|NCT01018030|566241212|FG002|Overall Study|Withdrawal by Subject|4|||
156859373|NCT01018030|566241210|FG000|Overall Study|Lost to Follow-up|2|||
156859374|NCT01018030|566241211|FG001|Overall Study|Lost to Follow-up|0|||
156859375|NCT01018030|566241212|FG002|Overall Study|Lost to Follow-up|3|||
156859376|NCT01018030|566241210|FG000|Overall Study|Protocol Violation|2|||
156859377|NCT01018030|566241211|FG001|Overall Study|Protocol Violation|1|||
156859378|NCT01018030|566241212|FG002|Overall Study|Protocol Violation|0|||
156859379|NCT01018030|566241210|FG000|Overall Study|Physician Decision|1|||
156859380|NCT01018030|566241211|FG001|Overall Study|Physician Decision|0|||
156859381|NCT01018030|566241212|FG002|Overall Study|Physician Decision|1|||
156859382|NCT01018030|566241210|FG000|Overall Study|Lack of Efficacy|1|||
156859383|NCT01018030|566241211|FG001|Overall Study|Lack of Efficacy|0|||
156859384|NCT01018030|566241212|FG002|Overall Study|Lack of Efficacy|0|||
156859385|NCT01018030|566241210|FG000|Overall Study|Did Not Receive Study Drug|1|||
156859386|NCT01018030|566241211|FG001|Overall Study|Did Not Receive Study Drug|3|||
156859387|NCT01018030|566241212|FG002|Overall Study|Did Not Receive Study Drug|0|||
156859388|NCT00436332|566241216|FG000|Overall Study|Adverse Event|9|||
156859389|NCT00436332|566241216|FG000|Overall Study|Withdrawal by Subject|2|||
156859390|NCT00436332|566241216|FG000|Overall Study|Progression|59|||
156859391|NCT00436332|566241216|FG000|Overall Study|Death|2|||
156859392|NCT00436332|566241216|FG000|Overall Study|Not Protocol Specified|6|||
156859393|NCT00436332|566241216|FG000|Overall Study|Ineligible|2|||
156859394|NCT00436332|566241216|FG000|Overall Study|Never Received Treatment|3|||
156859395|NCT00472108|566241217|FG000|Overall Study|Lost to Follow-up|0|||
156859396|NCT00472108|566241218|FG001|Overall Study|Lost to Follow-up|1|||
156859397|NCT00265564|566241223|FG000|Overall Study|Lost to Follow-up|5|||
156859398|NCT00265564|566241224|FG001|Overall Study|Lost to Follow-up|7|||
156859399|NCT00265564|566241223|FG000|Overall Study|met exclusion criteria|5|||
156903273|NCT02975336|566405159|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
156859400|NCT00265564|566241224|FG001|Overall Study|met exclusion criteria|2|||
156859401|NCT01553084|566241227|FG000|Overall Study|Withdrawal by Subject|15|||
156859402|NCT01553084|566241228|FG001|Overall Study|Withdrawal by Subject|13|||
156859403|NCT01553084|566241229|FG002|Overall Study|Withdrawal by Subject|35|||
156859404|NCT04698343|566241230|FG000|Overall Study|Withdrawal by Subject|6|||
156859405|NCT04698343|566241230|FG000|Overall Study|Physician Decision|2|||
157159069|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
157159070|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
157159071|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
157159072|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
157159073|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
157159074|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
157159075|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
157159076|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
157159077|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
157159078|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
157159079|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
157159080|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
157159081|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
156859406|NCT04698343|566241230|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
156859407|NCT04698343|566241230|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
156859408|NCT04698343|566241230|FG000|Overall Study|Personal reasons|3|||
156859409|NCT04698343|566241230|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
156859410|NCT02756338|566241234|FG000|Overall Study|Withdrawn by Investigator|1|||
156859411|NCT02756338|566241234|FG000|Overall Study|Device Replaced with Pacemaker|4|||
156859412|NCT01339689|566241237|FG000|Overall Study|Adverse Event|1|||
156859413|NCT01339689|566241238|FG001|Overall Study|Adverse Event|2|||
156859414|NCT01339689|566241237|FG000|Overall Study|Lost to Follow-up|9|||
156859415|NCT01339689|566241238|FG001|Overall Study|Lost to Follow-up|3|||
156859416|NCT01339689|566241237|FG000|Overall Study|Withdrawal by Subject|3|||
156859417|NCT01339689|566241238|FG001|Overall Study|Withdrawal by Subject|0|||
156859418|NCT01339689|566241237|FG000|Overall Study|Noncompliance|1|||
156859419|NCT01339689|566241238|FG001|Overall Study|Noncompliance|0|||
156859420|NCT01339689|566241237|FG000|Overall Study|Relocated out of area|0|||
156859421|NCT01339689|566241238|FG001|Overall Study|Relocated out of area|1|||
156859422|NCT01339689|566241237|FG000|Overall Study|Other|2|||
156859423|NCT01339689|566241238|FG001|Overall Study|Other|2|||
156859424|NCT01339689|566241237|FG000|Overall Study|multiple reasons|1|||
156859425|NCT01339689|566241238|FG001|Overall Study|multiple reasons|1|||
156859426|NCT03582215|566241239|FG000|Overall Study|Adverse Event|1|||
156859427|NCT03582215|566241240|FG001|Overall Study|Adverse Event|0|||
156859428|NCT03582215|566241241|FG002|Overall Study|Adverse Event|0|||
156859429|NCT03582215|566241242|FG003|Overall Study|Adverse Event|0|||
156859430|NCT03582215|566241243|FG004|Overall Study|Adverse Event|0|||
156859431|NCT03582215|566241244|FG005|Overall Study|Adverse Event|0|||
156859432|NCT03582215|566241245|FG006|Overall Study|Adverse Event|2|||
156859433|NCT03582215|566241246|FG007|Overall Study|Adverse Event|2|||
156859434|NCT01791244|566241247|FG000|Overall Study|Adverse Event|5|||
156859435|NCT01791244|566241248|FG001|Overall Study|Adverse Event|7|||
156859436|NCT01791244|566241247|FG000|Overall Study|Insufficient clinical response|10|||
156859437|NCT01791244|566241248|FG001|Overall Study|Insufficient clinical response|10|||
156859438|NCT01791244|566241247|FG000|Overall Study|Laboratory Abnormality|0|||
156859439|NCT01791244|566241248|FG001|Overall Study|Laboratory Abnormality|1|||
156859440|NCT00703014|566241251|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
156859441|NCT00703014|566241252|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
156859442|NCT00703014|566241253|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859443|NCT00703014|566241254|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859444|NCT00703014|566241251|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859445|NCT00703014|566241252|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
156859446|NCT00703014|566241253|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
156859447|NCT00703014|566241254|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
156859448|NCT04949191|566241255|FG000|Overall Study|Non-compliance with Study Drug|1|||
156859449|NCT04949191|566241256|FG001|Overall Study|Non-compliance with Study Drug|0|||
156859450|NCT04949191|566241257|FG002|Overall Study|Non-compliance with Study Drug|0|||
156859451|NCT04949191|566241258|FG003|Overall Study|Non-compliance with Study Drug|0|||
156859452|NCT04949191|566241255|FG000|Overall Study|Progressive Disease|0|||
156859453|NCT04949191|566241256|FG001|Overall Study|Progressive Disease|1|||
156859454|NCT04949191|566241257|FG002|Overall Study|Progressive Disease|0|||
156859455|NCT04949191|566241258|FG003|Overall Study|Progressive Disease|0|||
156859456|NCT04949191|566241255|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859457|NCT04949191|566241256|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
156859458|NCT04949191|566241257|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859459|NCT04949191|566241258|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
156859460|NCT04949191|566241255|FG000|Overall Study|Sponsor Terminated Study|0|||
156859461|NCT04949191|566241256|FG001|Overall Study|Sponsor Terminated Study|0|||
156859462|NCT04949191|566241257|FG002|Overall Study|Sponsor Terminated Study|1|||
156903274|NCT02975336|566405160|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
156903275|NCT02975336|566405161|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
156903276|NCT02975336|566405162|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
156903277|NCT02975336|566405163|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
156903278|NCT02975336|566405156|FG000|LTE (104 Weeks)|Adverse Event|0|||
156903279|NCT02975336|566405157|FG001|LTE (104 Weeks)|Adverse Event|0|||
156903280|NCT02975336|566405158|FG002|LTE (104 Weeks)|Adverse Event|0|||
156903281|NCT02975336|566405159|FG003|LTE (104 Weeks)|Adverse Event|0|||
156903282|NCT02975336|566405160|FG004|LTE (104 Weeks)|Adverse Event|7|||
156903283|NCT02975336|566405161|FG005|LTE (104 Weeks)|Adverse Event|4|||
156903284|NCT02975336|566405162|FG006|LTE (104 Weeks)|Adverse Event|2|||
156903285|NCT02975336|566405163|FG007|LTE (104 Weeks)|Adverse Event|0|||
156903286|NCT02975336|566405156|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
157026642|NCT04515849|566851649|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
157026643|NCT04515849|566851650|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
157026644|NCT04515849|566851651|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
157026645|NCT04515849|566851652|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
157026646|NCT04515849|566851653|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
157159082|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
157159083|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
157159084|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
156859463|NCT04949191|566241258|FG003|Overall Study|Sponsor Terminated Study|1|||
156859464|NCT05121766|566241259|FG000|Overall Study|Covid reinfection|3|||
156859465|NCT05121766|566241260|FG001|Overall Study|Covid reinfection|0|||
156859466|NCT05121766|566241259|FG000|Overall Study|Withdrawal by Subject|3|||
156859467|NCT05121766|566241260|FG001|Overall Study|Withdrawal by Subject|1|||
156859468|NCT05121766|566241259|FG000|Overall Study|Adverse Event|2|||
156859469|NCT05121766|566241260|FG001|Overall Study|Adverse Event|4|||
156859470|NCT05121766|566241259|FG000|Overall Study|Lost to Follow-up|0|||
156859471|NCT05121766|566241260|FG001|Overall Study|Lost to Follow-up|1|||
156859472|NCT00730158|566241261|FG000|Overall Study|Withdrawal by Subject|1|||
156859473|NCT00730158|566241262|FG001|Overall Study|Withdrawal by Subject|1|||
156859474|NCT03535974|566241264|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
156859475|NCT03535974|566241265|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
156859476|NCT03535974|566241266|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
156859477|NCT03535974|566241264|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
156859478|NCT03535974|566241265|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
156859479|NCT03535974|566241266|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
156859480|NCT04059549|566241267|FG000|Overall Study|Withdrawal by Subject|2|||
156859481|NCT04059549|566241268|FG001|Overall Study|Withdrawal by Subject|0|||
156859482|NCT03259230|566241270|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
156859483|NCT03259230|566241271|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
156859484|NCT02678351|566241272|FG000|Overall Study|Withdrawal by Subject|1|||
156859485|NCT01033240|566241273|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
156859486|NCT01033240|566241274|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
156859487|NCT01033240|566241275|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
156859488|NCT01033240|566241273|FG000|Overall Study|Death|2|||
156859489|NCT01033240|566241274|FG001|Overall Study|Death|0|||
156859490|NCT01033240|566241275|FG002|Overall Study|Death|0|||
156859491|NCT01033240|566241273|FG000|Overall Study|Withdrew Consent|2|||
156859492|NCT01033240|566241274|FG001|Overall Study|Withdrew Consent|9|||
156859493|NCT01033240|566241275|FG002|Overall Study|Withdrew Consent|2|||
156859494|NCT01033240|566241273|FG000|Overall Study|Disease Progression|35|||
156859495|NCT01033240|566241274|FG001|Overall Study|Disease Progression|32|||
156859496|NCT01033240|566241275|FG002|Overall Study|Disease Progression|41|||
156859497|NCT01033240|566241273|FG000|Overall Study|Investigator Discretion|0|||
156859498|NCT01033240|566241274|FG001|Overall Study|Investigator Discretion|0|||
156859499|NCT01033240|566241275|FG002|Overall Study|Investigator Discretion|2|||
156859500|NCT01033240|566241273|FG000|Overall Study|Other|0|||
156859501|NCT01033240|566241274|FG001|Overall Study|Other|1|||
156859502|NCT01033240|566241275|FG002|Overall Study|Other|2|||
156859503|NCT02913482|566241276|FG000|Overall Study|Death|0|||
156859504|NCT02913482|566241277|FG001|Overall Study|Death|2|||
156859505|NCT02913482|566241278|FG002|Overall Study|Death|2|||
156859506|NCT02913482|566241276|FG000|Overall Study|Progressive Disease|1|||
156859507|NCT02913482|566241277|FG001|Overall Study|Progressive Disease|1|||
156859508|NCT02913482|566241278|FG002|Overall Study|Progressive Disease|1|||
156859509|NCT02913482|566241276|FG000|Overall Study|Reason not specified|0|||
156859510|NCT02913482|566241277|FG001|Overall Study|Reason not specified|0|||
156859511|NCT02913482|566241278|FG002|Overall Study|Reason not specified|1|||
156903287|NCT02975336|566405157|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
156859512|NCT02913482|566241276|FG000|Overall Study|Withdrawal by Subject|0|||
156903288|NCT02975336|566405158|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
156903289|NCT02975336|566405159|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
156903290|NCT02975336|566405160|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
156903291|NCT02975336|566405161|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
156903292|NCT02975336|566405162|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
156903293|NCT02975336|566405163|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
156903294|NCT02975336|566405156|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
156903295|NCT02975336|566405157|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
156903296|NCT02975336|566405158|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
156903297|NCT02975336|566405159|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
156903298|NCT02975336|566405160|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
156903299|NCT02975336|566405161|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
156903300|NCT02975336|566405162|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
156903301|NCT02975336|566405163|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
156903302|NCT02975336|566405156|FG000|LTE (104 Weeks)|Other|0|||
156903303|NCT02975336|566405157|FG001|LTE (104 Weeks)|Other|0|||
156903304|NCT02975336|566405158|FG002|LTE (104 Weeks)|Other|0|||
156903305|NCT02975336|566405159|FG003|LTE (104 Weeks)|Other|0|||
156903306|NCT02975336|566405160|FG004|LTE (104 Weeks)|Other|55|||
156903307|NCT02975336|566405161|FG005|LTE (104 Weeks)|Other|63|||
156903308|NCT02975336|566405162|FG006|LTE (104 Weeks)|Other|76|||
156903309|NCT02975336|566405163|FG007|LTE (104 Weeks)|Other|72|||
156903310|NCT01816074|566405164|FG000|Phase 1|Time commitment issues|0|||
156903311|NCT01816074|566405165|FG001|Phase 1|Time commitment issues|0|||
156903312|NCT01816074|566405166|FG002|Phase 1|Time commitment issues|1|||
156903313|NCT01816074|566405167|FG003|Phase 1|Time commitment issues|0|||
156903314|NCT01816074|566405164|FG000|Phase 2|Time commitment Issues|0|||
156903315|NCT01816074|566405165|FG001|Phase 2|Time commitment Issues|2|||
156903316|NCT01816074|566405166|FG002|Phase 2|Time commitment Issues|0|||
156903317|NCT01816074|566405167|FG003|Phase 2|Time commitment Issues|0|||
156903318|NCT01816074|566405164|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
156903319|NCT01816074|566405165|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
156903320|NCT01816074|566405166|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
156903321|NCT01816074|566405167|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
156903322|NCT01816074|566405164|FG000|Phase 2|Physician Decision|0|||
156903323|NCT01816074|566405165|FG001|Phase 2|Physician Decision|0|||
156903324|NCT01816074|566405166|FG002|Phase 2|Physician Decision|0|||
156903325|NCT01816074|566405167|FG003|Phase 2|Physician Decision|1|||
156903326|NCT01816074|566405164|FG000|Phase 2|Withdrawal by Subject|1|||
156903327|NCT01816074|566405165|FG001|Phase 2|Withdrawal by Subject|0|||
156903328|NCT01816074|566405166|FG002|Phase 2|Withdrawal by Subject|0|||
156903329|NCT01816074|566405167|FG003|Phase 2|Withdrawal by Subject|0|||
156903330|NCT01303861|566405179|FG000|Overall Study|Lost to Follow-up|34|||
156903331|NCT01303861|566405180|FG001|Overall Study|Lost to Follow-up|14|||
156903332|NCT01303861|566405181|FG002|Overall Study|Lost to Follow-up|27|||
156903333|NCT01303861|566405182|FG003|Overall Study|Lost to Follow-up|31|||
156903334|NCT01303861|566405179|FG000|Overall Study|Lack of Efficacy|3|||
156903335|NCT01303861|566405180|FG001|Overall Study|Lack of Efficacy|2|||
156903336|NCT01303861|566405181|FG002|Overall Study|Lack of Efficacy|1|||
156903337|NCT01303861|566405182|FG003|Overall Study|Lack of Efficacy|0|||
156903338|NCT01303861|566405179|FG000|Overall Study|Withdrawal by Subject|16|||
156903339|NCT01303861|566405180|FG001|Overall Study|Withdrawal by Subject|8|||
156903340|NCT01303861|566405181|FG002|Overall Study|Withdrawal by Subject|8|||
156903341|NCT01303861|566405182|FG003|Overall Study|Withdrawal by Subject|23|||
156903342|NCT01303861|566405179|FG000|Overall Study|Adverse Event|4|||
156903343|NCT01303861|566405180|FG001|Overall Study|Adverse Event|1|||
156903344|NCT01303861|566405181|FG002|Overall Study|Adverse Event|0|||
156903345|NCT01303861|566405182|FG003|Overall Study|Adverse Event|5|||
156903346|NCT01303861|566405179|FG000|Overall Study|Pregnancy|1|||
156903347|NCT01303861|566405180|FG001|Overall Study|Pregnancy|0|||
156903348|NCT01303861|566405181|FG002|Overall Study|Pregnancy|0|||
156903349|NCT01303861|566405182|FG003|Overall Study|Pregnancy|0|||
156903350|NCT00850070|566405184|FG000|Overall Study|Lack of Efficacy|1|||
156903351|NCT00850070|566405185|FG001|Overall Study|Lack of Efficacy|1|||
156903352|NCT00850070|566405184|FG000|Overall Study|Adverse Event|2|||
156903353|NCT00850070|566405185|FG001|Overall Study|Adverse Event|0|||
156903354|NCT01436396|566405188|FG000|Overall Study|Protocol Violation|7|||
156903355|NCT01436396|566405189|FG001|Overall Study|Protocol Violation|5|||
156903356|NCT01436396|566405188|FG000|Overall Study|Adverse Event|1|||
156903357|NCT01436396|566405189|FG001|Overall Study|Adverse Event|2|||
156903358|NCT01436396|566405188|FG000|Overall Study|Withdrawal by Subject|19|||
156903359|NCT01436396|566405189|FG001|Overall Study|Withdrawal by Subject|29|||
156903360|NCT01436396|566405188|FG000|Overall Study|Serious adverse event|2|||
156903361|NCT01436396|566405189|FG001|Overall Study|Serious adverse event|3|||
156903362|NCT01436396|566405188|FG000|Overall Study|Lost to Follow-up|3|||
156903363|NCT01436396|566405189|FG001|Overall Study|Lost to Follow-up|3|||
156903364|NCT01522248|566405192|FG000|Overall Study|Lost to Follow-up|1|||
156903365|NCT01522248|566405193|FG001|Overall Study|Lost to Follow-up|0|||
156903366|NCT01332331|566405194|FG000|Overall Study|Lost to Follow-up|0|||
156903367|NCT01332331|566405195|FG001|Overall Study|Lost to Follow-up|1|||
156903368|NCT01332331|566405194|FG000|Overall Study|Adverse Event|1|||
156903369|NCT01332331|566405195|FG001|Overall Study|Adverse Event|1|||
156903370|NCT01332331|566405194|FG000|Overall Study|Physician Decision|1|||
156903371|NCT01332331|566405195|FG001|Overall Study|Physician Decision|0|||
156903372|NCT04515394|566405197|FG000|Overall Study|Participant did not receive treatment|1|||
156903373|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
156903374|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
156903375|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Death|1|||
156903376|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Death|0|||
156903377|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
156903378|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
156903379|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
156903380|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
156903381|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
156903382|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
156903383|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
156903384|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
157159085|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
157159086|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
157159087|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
157159088|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
157159089|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
157159090|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
157159091|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
157159092|NCT01106625|567326879|FG000|Core Period: Baseline to Week 26|Other|8|||
157159093|NCT01106625|567326880|FG001|Core Period: Baseline to Week 26|Other|7|||
157159094|NCT01106625|567326881|FG002|Core Period: Baseline to Week 26|Other|4|||
157159095|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
157159096|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
157159097|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
157159098|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
157159099|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
157159100|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
157159101|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
157159102|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
157159103|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
157159104|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
157159105|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
157159106|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
157159107|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
156903385|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
156903386|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
156903387|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
156903388|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
156903389|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
156903390|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
156903391|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
156903392|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
156903393|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
156903394|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
156903395|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
156903396|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
156903397|NCT02927262|566405199|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
156903398|NCT02927262|566405200|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
156903399|NCT02927262|566405199|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
156903400|NCT02927262|566405200|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
156903401|NCT02927262|566405199|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
156903402|NCT02927262|566405200|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
157159108|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
156903403|NCT02927262|566405199|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
156903404|NCT02927262|566405200|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
156903405|NCT02507973|566405201|FG000|Overall Study|Adverse Event|1|||
156903406|NCT04295772|566405204|FG000|Overall Study|Protocol Violation|1|||
156903407|NCT04295772|566405205|FG001|Overall Study|Protocol Violation|0|||
156903408|NCT04295772|566405204|FG000|Overall Study|Ongoing for safety monitoring|14|||
156903409|NCT04295772|566405205|FG001|Overall Study|Ongoing for safety monitoring|1|||
156903410|NCT04295772|566405204|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
156903411|NCT04295772|566405205|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
156903412|NCT00331422|566405206|FG000|Overall Study|Did not receive entire study regimen|5|||
156903413|NCT02345226|566405207|FG000|Double-Blind Phase|Adverse Event|5|||
156903414|NCT02345226|566405208|FG001|Double-Blind Phase|Adverse Event|6|||
156903415|NCT02345226|566405207|FG000|Double-Blind Phase|Death|3|||
156903416|NCT02345226|566405208|FG001|Double-Blind Phase|Death|0|||
156903417|NCT02345226|566405207|FG000|Double-Blind Phase|Pregnancy|0|||
156903418|NCT02345226|566405208|FG001|Double-Blind Phase|Pregnancy|1|||
156903419|NCT02345226|566405207|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156903420|NCT02345226|566405208|FG001|Double-Blind Phase|Lack of Efficacy|0|||
156903421|NCT02345226|566405207|FG000|Double-Blind Phase|Investigator's Discretion|4|||
156903422|NCT02345226|566405208|FG001|Double-Blind Phase|Investigator's Discretion|3|||
156903423|NCT02345226|566405207|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
156903424|NCT02345226|566405208|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
156903425|NCT02345226|566405207|FG000|Double-Blind Phase|Withdrew Consent|41|||
156903426|NCT02345226|566405208|FG001|Double-Blind Phase|Withdrew Consent|39|||
156903427|NCT02345226|566405207|FG000|Double-Blind Phase|Lost to Follow-up|12|||
156903428|NCT02345226|566405208|FG001|Double-Blind Phase|Lost to Follow-up|16|||
156903429|NCT02345226|566405207|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
156903430|NCT02345226|566405208|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
156903431|NCT02345226|566405207|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156903432|NCT02345226|566405208|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
156903433|NCT03386474|566405218|FG000|Overall Study|Death|1|||
156903434|NCT03386474|566405219|FG001|Overall Study|Death|0|||
156903435|NCT03386474|566405218|FG000|Overall Study|Adverse Event|0|||
156903436|NCT03386474|566405219|FG001|Overall Study|Adverse Event|1|||
156903437|NCT00066729|566405226|FG000|Overall Study|Lost to Follow-up|1|||
156903438|NCT00066729|566405226|FG000|Overall Study|Disease progression|1|||
156903439|NCT00338104|566405227|FG000|Overall Study|Protocol Violation|2|||
156903440|NCT00338104|566405228|FG001|Overall Study|Protocol Violation|1|||
156903441|NCT00338104|566405229|FG002|Overall Study|Protocol Violation|3|||
156903442|NCT02362269|566405232|FG000|Overall Study|Moved|1|||
156903443|NCT02362269|566405233|FG001|Overall Study|Moved|0|||
156903444|NCT02362269|566405232|FG000|Overall Study|Lost to Follow-up|0|||
156903445|NCT02362269|566405233|FG001|Overall Study|Lost to Follow-up|6|||
156903446|NCT02349542|566405234|FG000|Overall Study|Withdrawal by Subject|5|||
156903447|NCT02215096|566405235|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
156903448|NCT02215096|566405236|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
156903449|NCT02215096|566405237|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
156903450|NCT02215096|566405238|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
156903451|NCT02215096|566405239|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
156903452|NCT02215096|566405235|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156903453|NCT02215096|566405236|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156903454|NCT02215096|566405237|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156903455|NCT02215096|566405238|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
156903456|NCT02215096|566405239|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
156903457|NCT02215096|566405235|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156903458|NCT02215096|566405236|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156903459|NCT02215096|566405237|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156903460|NCT02215096|566405238|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
156903461|NCT02215096|566405239|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
156903462|NCT02215096|566405235|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
156903463|NCT02215096|566405236|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
156903464|NCT02215096|566405237|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
156903465|NCT02215096|566405238|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
156903466|NCT02215096|566405239|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
156903467|NCT01011738|566405240|FG000|Overall Study|Death|12|||
156903468|NCT01011738|566405241|FG001|Overall Study|Death|3|||
156903469|NCT01011738|566405242|FG002|Overall Study|Death|0|||
157159109|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
157026647|NCT04515849|566851649|FG000|Overall Study|Physician Decision|0|||
157205205|NCT03926728|567496071|FG010|Overall Study|Withdrawal by Subject|0|||
156903470|NCT01011738|566405240|FG000|Overall Study|Unknown reasons|312|||
156903471|NCT01011738|566405241|FG001|Overall Study|Unknown reasons|291|||
156903472|NCT01011738|566405242|FG002|Overall Study|Unknown reasons|17|||
156903473|NCT01163266|566405243|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
156903474|NCT01163266|566405244|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
156903475|NCT01163266|566405245|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
156903476|NCT01163266|566405243|FG000|Overall Study|Lack of Efficacy|1|||
156903477|NCT01163266|566405244|FG001|Overall Study|Lack of Efficacy|3|||
157159110|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
157159111|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
157159112|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
157159113|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
157159114|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
157159115|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
157159116|NCT01106625|567326879|FG000|Extension Period: Week 26 to Week 52|Other|5|||
157159117|NCT01106625|567326880|FG001|Extension Period: Week 26 to Week 52|Other|5|||
157159118|NCT01106625|567326881|FG002|Extension Period: Week 26 to Week 52|Other|4|||
157159119|NCT01864018|567326884|FG000|Overall Study|Ineligible|3|||
157159120|NCT01864018|567326885|FG001|Overall Study|Ineligible|1|||
157159121|NCT02512068|567326887|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
157159122|NCT02512068|567326888|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
157159123|NCT02512068|567326887|FG000|Overall Study|Major Protocol Deviation|1|||
157159124|NCT02512068|567326888|FG001|Overall Study|Major Protocol Deviation|0|||
157159125|NCT02512068|567326887|FG000|Overall Study|Voluntary Withdrawal|0|||
157159126|NCT02512068|567326888|FG001|Overall Study|Voluntary Withdrawal|1|||
157159127|NCT02512068|567326887|FG000|Overall Study|Lack of Efficacy|0|||
157159128|NCT02512068|567326888|FG001|Overall Study|Lack of Efficacy|1|||
157159129|NCT02512068|567326887|FG000|Overall Study|Reason Not Specified|3|||
157159130|NCT02512068|567326888|FG001|Overall Study|Reason Not Specified|5|||
157159131|NCT01401010|567326891|FG000|Overall Study|Could not interpret assay results|1|||
157159132|NCT01401010|567326892|FG001|Overall Study|Could not interpret assay results|0|||
157159133|NCT02399813|567326895|FG000|Overall Study|Progressive Disease-Radiographic|2|||
156903478|NCT01163266|566405245|FG002|Overall Study|Lack of Efficacy|1|||
156903479|NCT01163266|566405243|FG000|Overall Study|Noncompliance with Study Drug|0|||
156903480|NCT01163266|566405244|FG001|Overall Study|Noncompliance with Study Drug|2|||
156903481|NCT01163266|566405245|FG002|Overall Study|Noncompliance with Study Drug|0|||
156903482|NCT01163266|566405243|FG000|Overall Study|Protocol Deviations|2|||
156903483|NCT01163266|566405244|FG001|Overall Study|Protocol Deviations|2|||
156903484|NCT01163266|566405245|FG002|Overall Study|Protocol Deviations|5|||
156903485|NCT01163266|566405243|FG000|Overall Study|Withdrawal of Consent|5|||
156903486|NCT01163266|566405244|FG001|Overall Study|Withdrawal of Consent|7|||
156903487|NCT01163266|566405245|FG002|Overall Study|Withdrawal of Consent|3|||
156903488|NCT01163266|566405243|FG000|Overall Study|Lost to Follow-up|7|||
156903489|NCT01163266|566405244|FG001|Overall Study|Lost to Follow-up|7|||
156903490|NCT01163266|566405245|FG002|Overall Study|Lost to Follow-up|10|||
156903491|NCT01163266|566405243|FG000|Overall Study|Other|1|||
156903492|NCT01163266|566405244|FG001|Overall Study|Other|1|||
156903493|NCT01163266|566405245|FG002|Overall Study|Other|2|||
156903494|NCT02586064|566405246|FG000|Overall Study|Other Obligations|6|||
156903495|NCT02586064|566405247|FG001|Overall Study|Other Obligations|6|||
156903496|NCT02586064|566405246|FG000|Overall Study|Other|3|||
156903497|NCT02586064|566405247|FG001|Overall Study|Other|7|||
156903498|NCT02586064|566405246|FG000|Overall Study|Never Started|3|||
156903499|NCT02586064|566405247|FG001|Overall Study|Never Started|3|||
157159134|NCT02399813|567326895|FG000|Overall Study|Death|20|||
157159135|NCT02399813|567326895|FG000|Overall Study|Withdrawal by Subject|3|||
157159136|NCT02399813|567326895|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
157159137|NCT02399813|567326895|FG000|Overall Study|Lost to Follow-up|2|||
157159138|NCT02399813|567326895|FG000|Overall Study|Other than specified|5|||
156903500|NCT02586064|566405246|FG000|Overall Study|Lost Interest|1|||
156903501|NCT02586064|566405247|FG001|Overall Study|Lost Interest|4|||
156903502|NCT02586064|566405246|FG000|Overall Study|Miscellaneous Life Issues|0|||
156903503|NCT02586064|566405247|FG001|Overall Study|Miscellaneous Life Issues|5|||
156903504|NCT02586064|566405246|FG000|Overall Study|Infrequent Attendance|2|||
156903505|NCT02586064|566405247|FG001|Overall Study|Infrequent Attendance|1|||
156903506|NCT02586064|566405246|FG000|Overall Study|Timed Out|2|||
156903507|NCT02586064|566405247|FG001|Overall Study|Timed Out|0|||
156903508|NCT02586064|566405246|FG000|Overall Study|AUD relapse|0|||
156903509|NCT02586064|566405247|FG001|Overall Study|AUD relapse|2|||
157159139|NCT01798706|567326900|FG000|Overall Study|Adverse Event|15|||
157159140|NCT01798706|567326901|FG001|Overall Study|Adverse Event|10|||
157159141|NCT01798706|567326900|FG000|Overall Study|Lack of Efficacy|0|||
157159142|NCT01798706|567326901|FG001|Overall Study|Lack of Efficacy|2|||
156903510|NCT02586064|566405246|FG000|Overall Study|Legal Issue|1|||
156903511|NCT02586064|566405247|FG001|Overall Study|Legal Issue|0|||
156903512|NCT02158975|566405248|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
156903513|NCT01967173|566405249|FG000|Overall Study|Lost to Follow-up|5|||
157159143|NCT01798706|567326900|FG000|Overall Study|Poor compliance to protocol|1|||
157159144|NCT01798706|567326901|FG001|Overall Study|Poor compliance to protocol|0|||
157159145|NCT01798706|567326900|FG000|Overall Study|Other than specified above|5|||
157159146|NCT01798706|567326901|FG001|Overall Study|Other than specified above|9|||
156903514|NCT01967173|566405250|FG001|Overall Study|Lost to Follow-up|3|||
156903515|NCT01967173|566405251|FG002|Overall Study|Lost to Follow-up|2|||
156903516|NCT01967173|566405252|FG003|Overall Study|Lost to Follow-up|4|||
157159147|NCT05896761|567326902|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
157159148|NCT05896761|567326903|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
156903517|NCT01967173|566405253|FG004|Overall Study|Lost to Follow-up|8|||
156903518|NCT01967173|566405254|FG005|Overall Study|Lost to Follow-up|12|||
156903519|NCT01967173|566405255|FG006|Overall Study|Lost to Follow-up|6|||
156903520|NCT01967173|566405256|FG007|Overall Study|Lost to Follow-up|8|||
156903521|NCT01967173|566405249|FG000|Overall Study|Physician Decision|2|||
156903522|NCT01967173|566405250|FG001|Overall Study|Physician Decision|0|||
156903523|NCT01967173|566405251|FG002|Overall Study|Physician Decision|2|||
156903524|NCT01967173|566405252|FG003|Overall Study|Physician Decision|1|||
156903525|NCT01967173|566405253|FG004|Overall Study|Physician Decision|1|||
156903526|NCT01967173|566405254|FG005|Overall Study|Physician Decision|1|||
156903527|NCT01967173|566405255|FG006|Overall Study|Physician Decision|1|||
156903528|NCT01967173|566405256|FG007|Overall Study|Physician Decision|0|||
156903529|NCT01967173|566405249|FG000|Overall Study|Lack of Efficacy|2|||
156903530|NCT01967173|566405250|FG001|Overall Study|Lack of Efficacy|0|||
156903531|NCT01967173|566405251|FG002|Overall Study|Lack of Efficacy|2|||
156903532|NCT01967173|566405252|FG003|Overall Study|Lack of Efficacy|2|||
156903533|NCT01967173|566405253|FG004|Overall Study|Lack of Efficacy|0|||
156903534|NCT01967173|566405254|FG005|Overall Study|Lack of Efficacy|1|||
156903535|NCT01967173|566405255|FG006|Overall Study|Lack of Efficacy|0|||
156903536|NCT01967173|566405256|FG007|Overall Study|Lack of Efficacy|2|||
156903537|NCT01967173|566405249|FG000|Overall Study|Pregnancy|0|||
156903538|NCT01967173|566405250|FG001|Overall Study|Pregnancy|0|||
156903539|NCT01967173|566405251|FG002|Overall Study|Pregnancy|0|||
156903540|NCT01967173|566405252|FG003|Overall Study|Pregnancy|0|||
156903541|NCT01967173|566405253|FG004|Overall Study|Pregnancy|0|||
156903542|NCT01967173|566405254|FG005|Overall Study|Pregnancy|0|||
156903543|NCT01967173|566405255|FG006|Overall Study|Pregnancy|1|||
156903544|NCT01967173|566405256|FG007|Overall Study|Pregnancy|1|||
156903545|NCT01967173|566405249|FG000|Overall Study|Adverse Event|0|||
156903546|NCT01967173|566405250|FG001|Overall Study|Adverse Event|0|||
156903547|NCT01967173|566405251|FG002|Overall Study|Adverse Event|0|||
156903548|NCT01967173|566405252|FG003|Overall Study|Adverse Event|0|||
156903549|NCT01967173|566405253|FG004|Overall Study|Adverse Event|0|||
156903550|NCT01967173|566405254|FG005|Overall Study|Adverse Event|0|||
156903551|NCT01967173|566405255|FG006|Overall Study|Adverse Event|0|||
156903552|NCT01967173|566405256|FG007|Overall Study|Adverse Event|1|||
156903553|NCT01967173|566405249|FG000|Overall Study|Withdrawal by Subject|15|||
156903554|NCT01967173|566405250|FG001|Overall Study|Withdrawal by Subject|14|||
156903555|NCT01967173|566405251|FG002|Overall Study|Withdrawal by Subject|10|||
156903556|NCT01967173|566405252|FG003|Overall Study|Withdrawal by Subject|7|||
156903557|NCT01967173|566405253|FG004|Overall Study|Withdrawal by Subject|8|||
156903558|NCT01967173|566405254|FG005|Overall Study|Withdrawal by Subject|9|||
156903559|NCT01967173|566405255|FG006|Overall Study|Withdrawal by Subject|10|||
156903560|NCT01967173|566405256|FG007|Overall Study|Withdrawal by Subject|12|||
156903561|NCT03021304|566405257|FG000|Overall Study|Lack of Efficacy|1|||
156903562|NCT00484094|566405258|FG000|Overall Study|Discontinued|39|||
156903563|NCT00484094|566405258|FG000|Overall Study|Other|3|||
156903564|NCT03439657|566405259|FG000|Overall Study|Adverse Event|2|||
156903565|NCT03439657|566405260|FG001|Overall Study|Adverse Event|3|||
156903566|NCT03439657|566405259|FG000|Overall Study|Lost to Follow-up|1|||
156903567|NCT03439657|566405260|FG001|Overall Study|Lost to Follow-up|0|||
156903568|NCT03439657|566405259|FG000|Overall Study|Protocol Violation|1|||
156903569|NCT03439657|566405260|FG001|Overall Study|Protocol Violation|1|||
156903570|NCT03439657|566405259|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
156903571|NCT03439657|566405260|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
156903572|NCT03308786|566405263|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
156903573|NCT01999868|566405264|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
156903574|NCT01999868|566405265|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
156903575|NCT01999868|566405266|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
156903576|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
156903577|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
156903578|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
156903579|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
157159149|NCT05896761|567326902|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
157159150|NCT05896761|567326903|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
157159151|NCT01511419|567326904|FG000|Dose 2|Physician Decision|1|||
157159152|NCT01511419|567326905|FG001|Dose 2|Physician Decision|0|||
157159153|NCT00937768|567326906|FG000|Overall Study|Refused Further Treatment|3|||
156903580|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
156903581|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
156903582|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
156903583|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
156903584|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
156903585|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
157159154|NCT00937768|567326907|FG001|Overall Study|Refused Further Treatment|2|||
157159155|NCT00937768|567326906|FG000|Overall Study|Disease Progression|1|||
157159156|NCT00937768|567326907|FG001|Overall Study|Disease Progression|1|||
157159157|NCT00937768|567326906|FG000|Overall Study|Alternate Treatment|0|||
157159158|NCT00937768|567326907|FG001|Overall Study|Alternate Treatment|1|||
157159159|NCT00937768|567326906|FG000|Overall Study|No Further Funding|4|||
157159160|NCT00937768|567326907|FG001|Overall Study|No Further Funding|4|||
157159161|NCT01687413|567326912|FG000|Overall Study|Withdrawal by Subject|0|||
157159162|NCT01687413|567326913|FG001|Overall Study|Withdrawal by Subject|2|||
157159163|NCT01687413|567326912|FG000|Overall Study|Not eligible|0|||
157159164|NCT01687413|567326913|FG001|Overall Study|Not eligible|2|||
157159165|NCT01687413|567326912|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
157159166|NCT01687413|567326913|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
157159167|NCT04973228|567326914|FG000|Overall Study|Adverse Event|2|||
157159168|NCT04973228|567326915|FG001|Overall Study|Adverse Event|3|||
157159169|NCT04973228|567326914|FG000|Overall Study|Lack of Efficacy|1|||
157159170|NCT04973228|567326915|FG001|Overall Study|Lack of Efficacy|3|||
157159171|NCT04973228|567326914|FG000|Overall Study|Lost to Follow-up|12|||
157159172|NCT04973228|567326915|FG001|Overall Study|Lost to Follow-up|4|||
157159173|NCT04973228|567326914|FG000|Overall Study|Withdrawal by Subject|11|||
157159174|NCT04973228|567326915|FG001|Overall Study|Withdrawal by Subject|4|||
157159175|NCT04973228|567326914|FG000|Overall Study|Did not tolerate application|1|||
157159176|NCT04973228|567326915|FG001|Overall Study|Did not tolerate application|0|||
157159177|NCT04973228|567326914|FG000|Overall Study|Wanted to early terminate and use own product|0|||
157225568|NCT01325207|567571463|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
157225569|NCT01325207|567571464|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
156903586|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
156903587|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
156903588|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
156903589|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
156903590|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
156903591|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
156903592|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
156903593|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
156903594|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
156903595|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
156903596|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
156903597|NCT01999868|566405264|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
156903598|NCT01999868|566405265|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
156903599|NCT01999868|566405266|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
156903600|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
156903601|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
156903602|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
156903603|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
156903604|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
156903605|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
156903606|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
156903607|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
156903608|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
156903609|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
156903610|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
156903611|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
156903612|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
156903613|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
156903614|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
156903615|NCT01999868|566405264|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
156903616|NCT01999868|566405265|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
156903617|NCT01999868|566405266|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
156903618|NCT00289016|566405267|FG000|Overall Study|Disease Progression|29|||
156903619|NCT00289016|566405267|FG000|Overall Study|Death|2|||
156903620|NCT00289016|566405267|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
157026648|NCT04515849|566851650|FG001|Overall Study|Physician Decision|1|||
157159178|NCT04973228|567326915|FG001|Overall Study|Wanted to early terminate and use own product|1|||
157159179|NCT04973228|567326914|FG000|Overall Study|Missed visits due to new work schedule|1|||
157159180|NCT04973228|567326915|FG001|Overall Study|Missed visits due to new work schedule|0|||
157159181|NCT00091390|567326920|FG000|Overall Study|Protocol Violation|1|||
157026649|NCT04515849|566851651|FG002|Overall Study|Physician Decision|0|||
157026650|NCT04515849|566851652|FG003|Overall Study|Physician Decision|0|||
157225570|NCT01325207|567571465|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
157225571|NCT00708422|567571466|FG000|Overall Study|Adverse Event|3|||
156903621|NCT00289016|566405267|FG000|Overall Study|Withdrawal by Subject|2|||
156903622|NCT00289016|566405267|FG000|Overall Study|Adverse Event|1|||
156903623|NCT00289016|566405267|FG000|Overall Study|Other|1|||
156903624|NCT00319501|566405268|FG000|Double-blind Period|Withdrawal by Subject|0|||
156903625|NCT00319501|566405269|FG001|Double-blind Period|Withdrawal by Subject|3|||
156903626|NCT00319501|566405268|FG000|Double-blind Period|Sponsor Request|1|||
156903627|NCT00319501|566405269|FG001|Double-blind Period|Sponsor Request|0|||
156903628|NCT00319501|566405268|FG000|Double-blind Period|Did not receive treatment|42|||
156903629|NCT00319501|566405269|FG001|Double-blind Period|Did not receive treatment|29|||
156903630|NCT00319501|566405268|FG000|Open-label Period|Adverse Event|5|||
156903631|NCT00319501|566405269|FG001|Open-label Period|Adverse Event|0|||
156903632|NCT00319501|566405268|FG000|Open-label Period|Protocol Violation|6|||
156903633|NCT00319501|566405269|FG001|Open-label Period|Protocol Violation|0|||
156903634|NCT00319501|566405268|FG000|Open-label Period|Withdrawal by Subject|38|||
156903635|NCT00319501|566405269|FG001|Open-label Period|Withdrawal by Subject|0|||
156903636|NCT00319501|566405268|FG000|Open-label Period|Principal Investigator decision|6|||
156903637|NCT00319501|566405269|FG001|Open-label Period|Principal Investigator decision|0|||
156903638|NCT00319501|566405268|FG000|Open-label Period|Sponsor request|12|||
156903639|NCT00319501|566405269|FG001|Open-label Period|Sponsor request|0|||
156903640|NCT00319501|566405268|FG000|Open-label Period|Lost to Follow-up|5|||
156903641|NCT00319501|566405269|FG001|Open-label Period|Lost to Follow-up|0|||
156903642|NCT00319501|566405268|FG000|Open-label Period|Did not receive treatment|33|||
156903643|NCT00319501|566405269|FG001|Open-label Period|Did not receive treatment|0|||
156903644|NCT00319501|566405268|FG000|Open-label Period|Other|11|||
156903645|NCT00319501|566405269|FG001|Open-label Period|Other|0|||
156903646|NCT00319501|566405268|FG000|Open-label Extension Period|Adverse Event|2|||
156903647|NCT00319501|566405269|FG001|Open-label Extension Period|Adverse Event|0|||
156903648|NCT00319501|566405268|FG000|Open-label Extension Period|Did not receive treatment|18|||
156903649|NCT00319501|566405269|FG001|Open-label Extension Period|Did not receive treatment|0|||
156903650|NCT00319501|566405268|FG000|Open-label Extension Period|Other|1|||
156903651|NCT00319501|566405269|FG001|Open-label Extension Period|Other|0|||
156903652|NCT00319501|566405268|FG000|Open-label Extension Period|Principal investigator decision|2|||
156903653|NCT00319501|566405269|FG001|Open-label Extension Period|Principal investigator decision|0|||
156903654|NCT00319501|566405268|FG000|Open-label Extension Period|Sponsor request|26|||
156903655|NCT00319501|566405269|FG001|Open-label Extension Period|Sponsor request|0|||
156903656|NCT00319501|566405268|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
156903657|NCT00319501|566405269|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
156903658|NCT00667875|566405271|FG000|Overall Study|Adverse Event|0|||
156903659|NCT00667875|566405272|FG001|Overall Study|Adverse Event|2|||
156903660|NCT00667875|566405273|FG002|Overall Study|Adverse Event|6|||
156903661|NCT00667875|566405271|FG000|Overall Study|Withdrawal by Subject|10|||
156903662|NCT00667875|566405272|FG001|Overall Study|Withdrawal by Subject|9|||
156903663|NCT00667875|566405273|FG002|Overall Study|Withdrawal by Subject|7|||
156903664|NCT03553927|566405274|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
156903665|NCT03553927|566405275|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
156903666|NCT03553927|566405274|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
156903667|NCT03553927|566405275|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
156903668|NCT01558739|566405276|FG000|Overall Study|Adverse Event|7|||
156903669|NCT01558739|566405276|FG000|Overall Study|Withdrawal by Subject|2|||
156903670|NCT01558739|566405276|FG000|Overall Study|Death|3|||
156903671|NCT01558739|566405276|FG000|Overall Study|Disease Progression|4|||
156903672|NCT01558739|566405276|FG000|Overall Study|Protocol Violation|1|||
156903673|NCT02612129|566405277|FG000|Single Dose Treatment Period|Screening Failure|1|||
156903674|NCT02612129|566405278|FG001|Single Dose Treatment Period|Screening Failure|0|||
157026651|NCT04515849|566851653|FG004|Overall Study|Physician Decision|0|||
157026652|NCT04515849|566851649|FG000|Overall Study|Withdrawal by Subject|1|||
157026653|NCT04515849|566851650|FG001|Overall Study|Withdrawal by Subject|2|||
157026654|NCT04515849|566851651|FG002|Overall Study|Withdrawal by Subject|1|||
157026655|NCT04515849|566851652|FG003|Overall Study|Withdrawal by Subject|0|||
157026656|NCT04515849|566851653|FG004|Overall Study|Withdrawal by Subject|0|||
157026657|NCT05623228|566851655|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
157225572|NCT00708422|567571467|FG001|Overall Study|Adverse Event|1|||
156903675|NCT02612129|566405279|FG002|Single Dose Treatment Period|Screening Failure|0|||
156903676|NCT02612129|566405277|FG000|Continuous Treatment Period|Early Escape|0|||
156903677|NCT02612129|566405278|FG001|Continuous Treatment Period|Early Escape|2|||
156903678|NCT02612129|566405279|FG002|Continuous Treatment Period|Early Escape|0|||
156903679|NCT02612129|566405277|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
156903680|NCT02612129|566405278|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
157026658|NCT05623228|566851656|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156903681|NCT02612129|566405279|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
156903682|NCT02612129|566405277|FG000|Continuous Treatment Period|Safety Reasons|0|||
156903683|NCT02612129|566405278|FG001|Continuous Treatment Period|Safety Reasons|3|||
156903684|NCT02612129|566405279|FG002|Continuous Treatment Period|Safety Reasons|0|||
156903685|NCT02612129|566405277|FG000|Continuous Treatment Period|Death|0|||
156903686|NCT02612129|566405278|FG001|Continuous Treatment Period|Death|1|||
156903687|NCT02612129|566405279|FG002|Continuous Treatment Period|Death|0|||
156903688|NCT02612129|566405277|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
156903689|NCT02612129|566405278|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
156903690|NCT02612129|566405279|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
156903691|NCT01066000|566405280|FG000|Overall Study|Protocol Violation|4|||
156903692|NCT01066000|566405280|FG000|Overall Study|Death|3|||
156903693|NCT01066000|566405280|FG000|Overall Study|Withdrawal by Subject|1|||
156903694|NCT01066000|566405280|FG000|Overall Study|Adverse Event|1|||
156903695|NCT01386008|566405281|FG000|Overall Study|exited w/o incident /study discontinued|17|||
156903696|NCT01386008|566405281|FG000|Overall Study|Adverse Event|3|||
156903697|NCT00566111|566405282|FG000|Overall Study|Adverse Event|0|||
156903698|NCT00566111|566405283|FG001|Overall Study|Adverse Event|2|||
156903699|NCT04449861|566405284|FG000|Overall Study|Withdrawal by Subject|4|||
156903700|NCT04449861|566405284|FG000|Overall Study|Lost to Follow-up|5|||
156903701|NCT04449861|566405284|FG000|Overall Study|Death|112|||
156903702|NCT00976677|566405285|FG000|Overall Study|Adverse Event|1|||
156903703|NCT00976677|566405286|FG001|Overall Study|Adverse Event|0|||
156903704|NCT00976677|566405285|FG000|Overall Study|Withdrawal by Subject|0|||
156903705|NCT00976677|566405286|FG001|Overall Study|Withdrawal by Subject|2|||
156903706|NCT00976677|566405285|FG000|Overall Study|Disease progression|1|||
156903707|NCT00976677|566405286|FG001|Overall Study|Disease progression|1|||
156903708|NCT00976677|566405285|FG000|Overall Study|Trial unblinded|2|||
156903709|NCT00976677|566405286|FG001|Overall Study|Trial unblinded|2|||
156903710|NCT00976677|566405285|FG000|Overall Study|Unknown/Missing|1|||
156903711|NCT00976677|566405286|FG001|Overall Study|Unknown/Missing|0|||
156903712|NCT03355365|566407054|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
156903713|NCT03355365|566407055|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
156903714|NCT03355365|566407054|FG000|Year 1, First Intervention|Protocol Violation|1|||
156903715|NCT03355365|566407055|FG001|Year 1, First Intervention|Protocol Violation|0|||
156903716|NCT03355365|566407054|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
156903717|NCT03355365|566407055|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
156903718|NCT03355365|566407054|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
156903719|NCT03355365|566407055|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
156903720|NCT03355365|566407054|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
156903721|NCT03355365|566407055|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
156903722|NCT03355365|566407054|FG000|Year 2, Crossover Intervention|severe COVID|0|||
156903723|NCT03355365|566407055|FG001|Year 2, Crossover Intervention|severe COVID|1|||
156903724|NCT03355365|566407054|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
156903725|NCT03355365|566407055|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
156903726|NCT03917459|566407062|FG000|Overall Study|Adverse Event|1|||
156903727|NCT03917459|566407063|FG001|Overall Study|Adverse Event|0|||
156903728|NCT03917459|566407062|FG000|Overall Study|Withdrawal by Subject|0|||
156903729|NCT03917459|566407063|FG001|Overall Study|Withdrawal by Subject|1|||
156903730|NCT00676338|566407064|FG000|Overall Study|Adverse Event|6|||
156903731|NCT00676338|566407065|FG001|Overall Study|Adverse Event|6|||
156903732|NCT00676338|566407066|FG002|Overall Study|Adverse Event|5|||
156903733|NCT00676338|566407067|FG003|Overall Study|Adverse Event|1|||
156903734|NCT00676338|566407064|FG000|Overall Study|Lost to Follow-up|4|||
156903735|NCT00676338|566407065|FG001|Overall Study|Lost to Follow-up|1|||
156903736|NCT00676338|566407066|FG002|Overall Study|Lost to Follow-up|3|||
156903737|NCT00676338|566407067|FG003|Overall Study|Lost to Follow-up|4|||
156903738|NCT00676338|566407064|FG000|Overall Study|Physician Decision|3|||
156903739|NCT00676338|566407065|FG001|Overall Study|Physician Decision|3|||
156903740|NCT00676338|566407066|FG002|Overall Study|Physician Decision|2|||
156903741|NCT00676338|566407067|FG003|Overall Study|Physician Decision|3|||
156903742|NCT00676338|566407064|FG000|Overall Study|Protocol Violation|5|||
156903743|NCT00676338|566407065|FG001|Overall Study|Protocol Violation|9|||
156903744|NCT00676338|566407066|FG002|Overall Study|Protocol Violation|2|||
157225573|NCT00708422|567571466|FG000|Overall Study|Withdrawal by Subject|1|||
157026659|NCT05623228|566851657|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
157225574|NCT00708422|567571467|FG001|Overall Study|Withdrawal by Subject|0|||
156903745|NCT00676338|566407067|FG003|Overall Study|Protocol Violation|5|||
156903746|NCT00676338|566407064|FG000|Overall Study|Withdrawal by Subject|17|||
156903747|NCT00676338|566407065|FG001|Overall Study|Withdrawal by Subject|9|||
156903748|NCT00676338|566407066|FG002|Overall Study|Withdrawal by Subject|12|||
156903749|NCT00676338|566407067|FG003|Overall Study|Withdrawal by Subject|6|||
157026660|NCT05623228|566851658|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156859513|NCT02913482|566241277|FG001|Overall Study|Withdrawal by Subject|1|||
156903750|NCT00676338|566407064|FG000|Overall Study|Entry Criteria Not Met|0|||
156903751|NCT00676338|566407065|FG001|Overall Study|Entry Criteria Not Met|2|||
156903752|NCT00676338|566407066|FG002|Overall Study|Entry Criteria Not Met|1|||
156903753|NCT00676338|566407067|FG003|Overall Study|Entry Criteria Not Met|1|||
156903754|NCT00676338|566407064|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156903755|NCT00676338|566407065|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156903756|NCT00676338|566407066|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
156903757|NCT00676338|566407067|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
156903758|NCT02122458|566407068|FG000|Overall Study|Withdrawal by Subject|0|||
156859514|NCT02913482|566241278|FG002|Overall Study|Withdrawal by Subject|1|||
156859515|NCT01011673|566241279|FG000|Randomized|Secondary headache|2|||
156859516|NCT01011673|566241280|FG001|Randomized|Secondary headache|1|||
156859517|NCT01011673|566241279|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
156859518|NCT01011673|566241280|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
156859519|NCT04716426|566241281|FG000|Overall Study|Vaccination|1|||
156859520|NCT04716426|566241282|FG001|Overall Study|Vaccination|1|||
156859521|NCT04716426|566241281|FG000|Overall Study|Contamination|1|||
156859522|NCT04716426|566241282|FG001|Overall Study|Contamination|0|||
156859523|NCT01046565|566241283|FG000|Overall Study|Adverse Event|2|||
156859524|NCT01046565|566241283|FG000|Overall Study|Withdrawal by Subject|7|||
156859525|NCT05190120|566241286|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859526|NCT05190120|566241287|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859527|NCT05190120|566241288|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
156859528|NCT05190120|566241289|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
156859529|NCT05190120|566241286|FG000|Overall Study|Lost to Follow-up|5|||
156859530|NCT05190120|566241287|FG001|Overall Study|Lost to Follow-up|0|||
156859531|NCT05190120|566241288|FG002|Overall Study|Lost to Follow-up|2|||
156859532|NCT05190120|566241289|FG003|Overall Study|Lost to Follow-up|3|||
156859533|NCT03062358|566241290|FG000|Overall Study|Death|269|||
156859534|NCT03062358|566241291|FG001|Overall Study|Death|145|||
156859535|NCT03062358|566241290|FG000|Overall Study|Withdrawal by Subject|2|||
156859536|NCT03062358|566241291|FG001|Overall Study|Withdrawal by Subject|1|||
156859537|NCT03062358|566241290|FG000|Overall Study|Sponsor Decision|29|||
156859538|NCT03062358|566241291|FG001|Overall Study|Sponsor Decision|7|||
156859539|NCT05893862|566241292|FG000|Overall Study|Physician Decision|0|||
156859540|NCT05893862|566241293|FG001|Overall Study|Physician Decision|1|||
156859541|NCT05893862|566241294|FG002|Overall Study|Physician Decision|0|||
156859542|NCT05893862|566241295|FG003|Overall Study|Physician Decision|0|||
156859543|NCT05893862|566241296|FG004|Overall Study|Physician Decision|1|||
156859544|NCT05893862|566241297|FG005|Overall Study|Physician Decision|0|||
156859545|NCT05893862|566241292|FG000|Overall Study|Withdrawal by Subject|1|||
156859546|NCT05893862|566241293|FG001|Overall Study|Withdrawal by Subject|7|||
156859547|NCT05893862|566241294|FG002|Overall Study|Withdrawal by Subject|1|||
156859548|NCT05893862|566241295|FG003|Overall Study|Withdrawal by Subject|3|||
156859549|NCT05893862|566241296|FG004|Overall Study|Withdrawal by Subject|3|||
156859550|NCT05893862|566241297|FG005|Overall Study|Withdrawal by Subject|2|||
156859551|NCT05893862|566241292|FG000|Overall Study|Adverse Event|1|||
156859552|NCT05893862|566241293|FG001|Overall Study|Adverse Event|4|||
156859553|NCT05893862|566241294|FG002|Overall Study|Adverse Event|2|||
156859554|NCT05893862|566241295|FG003|Overall Study|Adverse Event|2|||
156859555|NCT05893862|566241296|FG004|Overall Study|Adverse Event|1|||
156859556|NCT05893862|566241297|FG005|Overall Study|Adverse Event|0|||
156859557|NCT01400698|566241298|FG000|Overall Study|Lost to Follow-up|2|||
156859558|NCT01400698|566241299|FG001|Overall Study|Lost to Follow-up|5|||
156859559|NCT01400698|566241300|FG002|Overall Study|Lost to Follow-up|2|||
156859560|NCT01400698|566241301|FG003|Overall Study|Lost to Follow-up|1|||
156859561|NCT01400698|566241302|FG004|Overall Study|Lost to Follow-up|4|||
156859562|NCT01400698|566241303|FG005|Overall Study|Lost to Follow-up|3|||
156859563|NCT01400698|566241298|FG000|Overall Study|Withdrawal by Subject|8|||
156859564|NCT01400698|566241299|FG001|Overall Study|Withdrawal by Subject|2|||
156859565|NCT01400698|566241300|FG002|Overall Study|Withdrawal by Subject|0|||
156859566|NCT01400698|566241301|FG003|Overall Study|Withdrawal by Subject|4|||
156859567|NCT01400698|566241302|FG004|Overall Study|Withdrawal by Subject|1|||
156859568|NCT01400698|566241303|FG005|Overall Study|Withdrawal by Subject|3|||
156859569|NCT01400698|566241298|FG000|Overall Study|Protocol Violation|0|||
156859570|NCT01400698|566241299|FG001|Overall Study|Protocol Violation|1|||
156859571|NCT01400698|566241300|FG002|Overall Study|Protocol Violation|0|||
156859572|NCT01400698|566241301|FG003|Overall Study|Protocol Violation|0|||
156859573|NCT01400698|566241302|FG004|Overall Study|Protocol Violation|1|||
156859574|NCT01400698|566241303|FG005|Overall Study|Protocol Violation|0|||
156859575|NCT01400698|566241298|FG000|Overall Study|Non-compliance|0|||
156859576|NCT01400698|566241299|FG001|Overall Study|Non-compliance|1|||
156859577|NCT01400698|566241300|FG002|Overall Study|Non-compliance|0|||
156903759|NCT02122458|566407069|FG001|Overall Study|Withdrawal by Subject|0|||
157159182|NCT00091390|567326920|FG000|Overall Study|No protocol treatment|3|||
157159183|NCT00406640|567326921|FG000|Acute Phase|Adverse Event|18|||
157159184|NCT00406640|567326922|FG001|Acute Phase|Adverse Event|13|||
157159185|NCT00406640|567326921|FG000|Acute Phase|Failed to Return|5|||
157159186|NCT00406640|567326922|FG001|Acute Phase|Failed to Return|1|||
156903760|NCT02122458|566407070|FG002|Overall Study|Withdrawal by Subject|0|||
156903761|NCT02122458|566407071|FG003|Overall Study|Withdrawal by Subject|4|||
156903762|NCT02122458|566407072|FG004|Overall Study|Withdrawal by Subject|4|||
156903763|NCT02122458|566407073|FG005|Overall Study|Withdrawal by Subject|4|||
156903764|NCT02122458|566407074|FG006|Overall Study|Withdrawal by Subject|0|||
156903765|NCT02122458|566407068|FG000|Overall Study|Lost to Follow-up|1|||
156903766|NCT02122458|566407069|FG001|Overall Study|Lost to Follow-up|3|||
156903767|NCT02122458|566407070|FG002|Overall Study|Lost to Follow-up|0|||
156903768|NCT02122458|566407071|FG003|Overall Study|Lost to Follow-up|7|||
156903769|NCT02122458|566407072|FG004|Overall Study|Lost to Follow-up|5|||
156903770|NCT02122458|566407073|FG005|Overall Study|Lost to Follow-up|15|||
156903771|NCT02122458|566407074|FG006|Overall Study|Lost to Follow-up|1|||
156903772|NCT02122458|566407068|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
156903773|NCT02122458|566407069|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903774|NCT02122458|566407070|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903775|NCT02122458|566407071|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903776|NCT02122458|566407072|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903777|NCT02122458|566407073|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903778|NCT02122458|566407074|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
156903779|NCT02122458|566407068|FG000|Overall Study|Adverse Event|1|||
156903780|NCT02122458|566407069|FG001|Overall Study|Adverse Event|0|||
156903781|NCT02122458|566407070|FG002|Overall Study|Adverse Event|0|||
156903782|NCT02122458|566407071|FG003|Overall Study|Adverse Event|0|||
156903783|NCT02122458|566407072|FG004|Overall Study|Adverse Event|0|||
156903784|NCT02122458|566407073|FG005|Overall Study|Adverse Event|0|||
156903785|NCT02122458|566407074|FG006|Overall Study|Adverse Event|0|||
156903786|NCT02122458|566407068|FG000|Overall Study|Experimental Error|0|||
156903787|NCT02122458|566407069|FG001|Overall Study|Experimental Error|0|||
156903788|NCT02122458|566407070|FG002|Overall Study|Experimental Error|0|||
156903789|NCT02122458|566407071|FG003|Overall Study|Experimental Error|0|||
156903790|NCT02122458|566407072|FG004|Overall Study|Experimental Error|3|||
156903791|NCT02122458|566407073|FG005|Overall Study|Experimental Error|0|||
156903792|NCT02122458|566407074|FG006|Overall Study|Experimental Error|0|||
156903793|NCT02122458|566407068|FG000|Overall Study|Deployed or Moved|0|||
156903794|NCT02122458|566407069|FG001|Overall Study|Deployed or Moved|0|||
156903795|NCT02122458|566407070|FG002|Overall Study|Deployed or Moved|0|||
156903796|NCT02122458|566407071|FG003|Overall Study|Deployed or Moved|0|||
156903797|NCT02122458|566407072|FG004|Overall Study|Deployed or Moved|1|||
156903798|NCT02122458|566407073|FG005|Overall Study|Deployed or Moved|0|||
156903799|NCT02122458|566407074|FG006|Overall Study|Deployed or Moved|0|||
156903800|NCT02122458|566407068|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
156903801|NCT02122458|566407069|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
156903802|NCT02122458|566407070|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
156903803|NCT02122458|566407071|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
156903804|NCT02122458|566407072|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
156903805|NCT02122458|566407073|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
156903806|NCT02122458|566407074|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
156903807|NCT02122458|566407068|FG000|Overall Study|Noncompliance|0|||
156903808|NCT02122458|566407069|FG001|Overall Study|Noncompliance|1|||
156903809|NCT02122458|566407070|FG002|Overall Study|Noncompliance|0|||
156903810|NCT02122458|566407071|FG003|Overall Study|Noncompliance|0|||
156903811|NCT02122458|566407072|FG004|Overall Study|Noncompliance|0|||
156903812|NCT02122458|566407073|FG005|Overall Study|Noncompliance|0|||
156903813|NCT02122458|566407074|FG006|Overall Study|Noncompliance|0|||
156903814|NCT00412542|566407075|FG000|Overall Study|Withdrawal by Subject|0|||
156903815|NCT00412542|566407076|FG001|Overall Study|Withdrawal by Subject|2|||
157159187|NCT00406640|567326921|FG000|Acute Phase|Physician Decision|0|||
156903816|NCT00412542|566407075|FG000|Overall Study|Not Eligible|0|||
156903817|NCT00412542|566407076|FG001|Overall Study|Not Eligible|1|||
157159188|NCT00406640|567326922|FG001|Acute Phase|Physician Decision|1|||
156903818|NCT02833350|566407077|FG000|Overall Study|Adverse Event|0|||
156903819|NCT02833350|566407078|FG001|Overall Study|Adverse Event|3|||
156903820|NCT02833350|566407079|FG002|Overall Study|Adverse Event|4|||
157026661|NCT05623228|566851659|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
157026662|NCT05623228|566851660|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156903821|NCT02833350|566407080|FG003|Overall Study|Adverse Event|4|||
156903822|NCT02833350|566407081|FG004|Overall Study|Adverse Event|1|||
156903823|NCT02833350|566407082|FG005|Overall Study|Adverse Event|0|||
156903824|NCT02833350|566407083|FG006|Overall Study|Adverse Event|1|||
156903825|NCT02833350|566407077|FG000|Overall Study|Death|0|||
157159189|NCT00406640|567326921|FG000|Acute Phase|Lost to Follow-up|7|||
157159190|NCT00406640|567326922|FG001|Acute Phase|Lost to Follow-up|4|||
157159191|NCT00406640|567326921|FG000|Acute Phase|Protocol deviation|4|||
157159192|NCT00406640|567326922|FG001|Acute Phase|Protocol deviation|10|||
157159193|NCT00406640|567326921|FG000|Acute Phase|Protocol Violation|3|||
157159194|NCT00406640|567326922|FG001|Acute Phase|Protocol Violation|2|||
157159195|NCT00406640|567326921|FG000|Acute Phase|Withdrawal by Subject|11|||
157159196|NCT00406640|567326922|FG001|Acute Phase|Withdrawal by Subject|9|||
157159197|NCT00406640|567326921|FG000|Acute Phase|Lack of Efficacy|3|||
157159198|NCT00406640|567326922|FG001|Acute Phase|Lack of Efficacy|3|||
157159199|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
156859578|NCT01400698|566241301|FG003|Overall Study|Non-compliance|1|||
156859579|NCT01400698|566241302|FG004|Overall Study|Non-compliance|0|||
156859580|NCT01400698|566241303|FG005|Overall Study|Non-compliance|0|||
156859581|NCT01400698|566241298|FG000|Overall Study|Adverse Event|1|||
156859582|NCT01400698|566241299|FG001|Overall Study|Adverse Event|0|||
156859583|NCT01400698|566241300|FG002|Overall Study|Adverse Event|0|||
156859584|NCT01400698|566241301|FG003|Overall Study|Adverse Event|0|||
156859585|NCT01400698|566241302|FG004|Overall Study|Adverse Event|0|||
156859586|NCT01400698|566241303|FG005|Overall Study|Adverse Event|0|||
156859587|NCT01400698|566241298|FG000|Overall Study|Other|4|||
156859588|NCT01400698|566241299|FG001|Overall Study|Other|2|||
156859589|NCT01400698|566241300|FG002|Overall Study|Other|0|||
156859590|NCT01400698|566241301|FG003|Overall Study|Other|2|||
156859591|NCT01400698|566241302|FG004|Overall Study|Other|1|||
156859592|NCT01400698|566241303|FG005|Overall Study|Other|0|||
156859593|NCT01352117|566243115|FG000|Overall Study|Death|15|||
156859594|NCT01352117|566243116|FG001|Overall Study|Death|16|||
156859595|NCT01352117|566243115|FG000|Overall Study|Withdrawal by Subject|1|||
156859596|NCT01352117|566243116|FG001|Overall Study|Withdrawal by Subject|0|||
156859597|NCT01352117|566243115|FG000|Overall Study|Lost to Follow-up|2|||
156859598|NCT01352117|566243116|FG001|Overall Study|Lost to Follow-up|7|||
156859599|NCT01352117|566243115|FG000|Overall Study|Non-adherent to study requirements|1|||
156859600|NCT01352117|566243116|FG001|Overall Study|Non-adherent to study requirements|1|||
156859601|NCT01352117|566243115|FG000|Overall Study|Did not initiate study treatment|1|||
156859602|NCT01352117|566243116|FG001|Overall Study|Did not initiate study treatment|0|||
156859603|NCT01352117|566243115|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
156859604|NCT01352117|566243116|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
156859605|NCT01766050|566243117|FG000|Overall Study|Adverse Event|1|||
156859606|NCT01766050|566243117|FG000|Overall Study|Lost to Follow-up|1|||
156859607|NCT01766050|566243117|FG000|Overall Study|Withdrawal by Subject|2|||
156859608|NCT01021020|566243118|FG000|Period I|Protocol Violation|1|||
156859609|NCT01021020|566243118|FG000|Period I|Withdrawal by Subject|1|||
156859610|NCT01021020|566243118|FG000|14 Day Washout Period A|Physician Decision|1|||
156859611|NCT01706458|566243120|FG000|Overall Study|Physician Decision|3|||
156859612|NCT01706458|566243121|FG001|Overall Study|Physician Decision|4|||
156859613|NCT02766023|566243123|FG000|Overall Study|Lost to Follow-up|23|||
156859614|NCT02766023|566243124|FG001|Overall Study|Lost to Follow-up|11|||
156859615|NCT02766023|566243123|FG000|Overall Study|Pregnancy|1|||
156859616|NCT02766023|566243124|FG001|Overall Study|Pregnancy|0|||
156859617|NCT02766023|566243123|FG000|Overall Study|Adverse Event|1|||
156859618|NCT02766023|566243124|FG001|Overall Study|Adverse Event|0|||
156859619|NCT02766023|566243123|FG000|Overall Study|Withdrawal by Subject|4|||
156859620|NCT02766023|566243124|FG001|Overall Study|Withdrawal by Subject|5|||
156859621|NCT02766023|566243123|FG000|Overall Study|Physician Decision|1|||
156859622|NCT02766023|566243124|FG001|Overall Study|Physician Decision|0|||
156859623|NCT02766023|566243123|FG000|Overall Study|Not Eligible at Enrollment|0|||
156859624|NCT02766023|566243124|FG001|Overall Study|Not Eligible at Enrollment|1|||
156859625|NCT02384551|566243128|FG000|Overall Study|Lost to Follow-up|13|||
156859626|NCT02384551|566243129|FG001|Overall Study|Lost to Follow-up|14|||
156859627|NCT02384551|566243130|FG002|Overall Study|Lost to Follow-up|14|||
156859628|NCT02384551|566243131|FG003|Overall Study|Lost to Follow-up|14|||
156859629|NCT04349891|566243132|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
156859630|NCT04349891|566243133|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
156859631|NCT04349891|566243132|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
156859632|NCT04349891|566243133|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
156859633|NCT04349891|566243132|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
156859634|NCT04349891|566243133|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
156859635|NCT04349891|566243132|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
156859636|NCT04349891|566243133|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
156859637|NCT02923726|566243138|FG000|Overall Study|Death|196|||
156859638|NCT02923726|566243139|FG001|Overall Study|Death|175|||
156859639|NCT02923726|566243138|FG000|Overall Study|Withdrawal by Subject|337|||
156859640|NCT02923726|566243139|FG001|Overall Study|Withdrawal by Subject|307|||
156859641|NCT02399215|566243153|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
156859642|NCT02399215|566243153|FG000|Overall Study|Withdrawal by Subject|1|||
156859643|NCT00772538|566243154|FG000|Overall Study|Adverse Event|6|||
156859644|NCT00772538|566243155|FG001|Overall Study|Adverse Event|6|||
157159200|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
156903826|NCT02833350|566407078|FG001|Overall Study|Death|0|||
156903827|NCT02833350|566407079|FG002|Overall Study|Death|1|||
156903828|NCT02833350|566407080|FG003|Overall Study|Death|0|||
156903829|NCT02833350|566407081|FG004|Overall Study|Death|0|||
156903830|NCT02833350|566407082|FG005|Overall Study|Death|0|||
156903831|NCT02833350|566407083|FG006|Overall Study|Death|0|||
156903832|NCT02833350|566407077|FG000|Overall Study|Lack of Efficacy|0|||
156903833|NCT02833350|566407078|FG001|Overall Study|Lack of Efficacy|2|||
156903834|NCT02833350|566407079|FG002|Overall Study|Lack of Efficacy|1|||
156903835|NCT02833350|566407080|FG003|Overall Study|Lack of Efficacy|4|||
156903836|NCT02833350|566407081|FG004|Overall Study|Lack of Efficacy|0|||
156903837|NCT02833350|566407082|FG005|Overall Study|Lack of Efficacy|1|||
156903838|NCT02833350|566407083|FG006|Overall Study|Lack of Efficacy|1|||
156903839|NCT02833350|566407077|FG000|Overall Study|Lost to Follow-up|0|||
156903840|NCT02833350|566407078|FG001|Overall Study|Lost to Follow-up|1|||
156903841|NCT02833350|566407079|FG002|Overall Study|Lost to Follow-up|0|||
156903842|NCT02833350|566407080|FG003|Overall Study|Lost to Follow-up|0|||
156903843|NCT02833350|566407081|FG004|Overall Study|Lost to Follow-up|0|||
156903844|NCT02833350|566407082|FG005|Overall Study|Lost to Follow-up|0|||
156903845|NCT02833350|566407083|FG006|Overall Study|Lost to Follow-up|1|||
156903846|NCT02833350|566407077|FG000|Overall Study|Withdrawal by Subject|3|||
156903847|NCT02833350|566407078|FG001|Overall Study|Withdrawal by Subject|3|||
156903848|NCT02833350|566407079|FG002|Overall Study|Withdrawal by Subject|2|||
156903849|NCT02833350|566407080|FG003|Overall Study|Withdrawal by Subject|0|||
156903850|NCT02833350|566407081|FG004|Overall Study|Withdrawal by Subject|2|||
156903851|NCT02833350|566407082|FG005|Overall Study|Withdrawal by Subject|0|||
156903852|NCT02833350|566407083|FG006|Overall Study|Withdrawal by Subject|2|||
156903853|NCT01500031|566407086|FG000|Overall Study|Death|1|||
156903854|NCT01500031|566407086|FG000|Overall Study|Withdrawal by Subject|4|||
156903855|NCT01856907|566407087|FG000|Overall Study|Pregnancy|0|||
156903856|NCT01856907|566407088|FG001|Overall Study|Pregnancy|1|||
156903857|NCT01856907|566407089|FG002|Overall Study|Pregnancy|0|||
156903858|NCT01856907|566407087|FG000|Overall Study|Pregnancy|0|||
156903859|NCT01856907|566407088|FG001|Overall Study|Pregnancy|1|||
156903860|NCT01856907|566407089|FG002|Overall Study|Pregnancy|0|||
156903861|NCT01856907|566407087|FG000|Overall Study|Withdrawal by Subject|0|||
156903862|NCT01856907|566407088|FG001|Overall Study|Withdrawal by Subject|1|||
156903863|NCT01856907|566407089|FG002|Overall Study|Withdrawal by Subject|0|||
156903864|NCT00075218|566407092|FG000|Double-Blind Treatment|Adverse Event|23|||
156903865|NCT00075218|566407093|FG001|Double-Blind Treatment|Adverse Event|4|||
156903866|NCT00075218|566407094|FG002|Double-Blind Treatment|Adverse Event|0|||
156903867|NCT00075218|566407092|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
156903868|NCT00075218|566407093|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
156903869|NCT00075218|566407094|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
156903870|NCT00075218|566407092|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
156903871|NCT00075218|566407093|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
156903872|NCT00075218|566407094|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
156903873|NCT00075218|566407092|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
156903874|NCT00075218|566407093|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
156903875|NCT00075218|566407094|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
156903876|NCT00075218|566407092|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
156903877|NCT00075218|566407093|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
156903878|NCT00075218|566407094|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
156903879|NCT00075218|566407092|FG000|Double-Blind Treatment|No study medication taken|2|||
156903880|NCT00075218|566407093|FG001|Double-Blind Treatment|No study medication taken|0|||
156903881|NCT00075218|566407094|FG002|Double-Blind Treatment|No study medication taken|0|||
156903882|NCT00075218|566407092|FG000|Open-Label Treatment|Lack of Efficacy|0|||
156903883|NCT00075218|566407093|FG001|Open-Label Treatment|Lack of Efficacy|0|||
156903884|NCT00075218|566407094|FG002|Open-Label Treatment|Lack of Efficacy|174|||
156903885|NCT00075218|566407092|FG000|Open-Label Treatment|Adverse Event|0|||
157026663|NCT05623228|566851661|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
157225575|NCT01254409|567571468|FG000|Overall Study|Adverse Event|0|||
156903886|NCT00075218|566407093|FG001|Open-Label Treatment|Adverse Event|0|||
156903887|NCT00075218|566407094|FG002|Open-Label Treatment|Adverse Event|51|||
156903888|NCT00075218|566407092|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
156903889|NCT00075218|566407093|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
156903890|NCT00075218|566407094|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
156903891|NCT00075218|566407092|FG000|Open-Label Treatment|Decision of Sponsor|0|||
156903892|NCT00075218|566407093|FG001|Open-Label Treatment|Decision of Sponsor|0|||
156903893|NCT00075218|566407094|FG002|Open-Label Treatment|Decision of Sponsor|8|||
156903894|NCT00075218|566407092|FG000|Open-Label Treatment|Protocol Violation|0|||
156903895|NCT00075218|566407093|FG001|Open-Label Treatment|Protocol Violation|0|||
156903896|NCT00075218|566407094|FG002|Open-Label Treatment|Protocol Violation|1|||
156903897|NCT00075218|566407092|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
156903898|NCT00075218|566407093|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
156903899|NCT00075218|566407094|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
156903900|NCT00131508|566407095|FG000|Overall Study|Disease progression|0|||
157159201|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Death|1|||
157159202|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Death|0|||
157159203|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
157159204|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
157159205|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
157159206|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
157159207|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
157159208|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
157159209|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|non-compliance|7|||
157159210|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|non-compliance|5|||
157159211|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
157159212|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
157159213|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
157159214|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
157159215|NCT00406640|567326921|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
156903901|NCT00131508|566407096|FG001|Overall Study|Disease progression|2|||
156903902|NCT00131508|566407095|FG000|Overall Study|Non-Compliance|2|||
156903903|NCT00131508|566407096|FG001|Overall Study|Non-Compliance|4|||
156903904|NCT00131508|566407095|FG000|Overall Study|Withdrawal by Subject|1|||
156903905|NCT00131508|566407096|FG001|Overall Study|Withdrawal by Subject|2|||
156903906|NCT03643575|566407097|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
156903907|NCT03643575|566407098|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
156903908|NCT03643575|566407099|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
156903909|NCT03643575|566407100|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
156903910|NCT03643575|566407101|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
156903911|NCT03643575|566407102|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
156903912|NCT03643575|566407097|FG000|Washout: 7 Days|Adverse Event|1|||
156903913|NCT03643575|566407098|FG001|Washout: 7 Days|Adverse Event|0|||
156903914|NCT03643575|566407099|FG002|Washout: 7 Days|Adverse Event|0|||
156903915|NCT03643575|566407100|FG003|Washout: 7 Days|Adverse Event|0|||
156903916|NCT03643575|566407101|FG004|Washout: 7 Days|Adverse Event|0|||
156903917|NCT03643575|566407102|FG005|Washout: 7 Days|Adverse Event|0|||
156903918|NCT03643575|566407097|FG000|Washout: 7 Days|Non compliance check in|0|||
156903919|NCT03643575|566407098|FG001|Washout: 7 Days|Non compliance check in|1|||
156903920|NCT03643575|566407099|FG002|Washout: 7 Days|Non compliance check in|0|||
156903921|NCT03643575|566407100|FG003|Washout: 7 Days|Non compliance check in|0|||
156903922|NCT03643575|566407101|FG004|Washout: 7 Days|Non compliance check in|0|||
156903923|NCT03643575|566407102|FG005|Washout: 7 Days|Non compliance check in|0|||
156903924|NCT00199875|566407111|FG000|Overall Study|Withdrawal by Subject|0|||
156903925|NCT00199875|566407112|FG001|Overall Study|Withdrawal by Subject|0|||
156903926|NCT00199875|566407113|FG002|Overall Study|Withdrawal by Subject|0|||
156903927|NCT00199875|566407114|FG003|Overall Study|Withdrawal by Subject|0|||
156903928|NCT00199875|566407115|FG004|Overall Study|Withdrawal by Subject|1|||
156903929|NCT03469934|566407118|FG000|Overall Study|Withdrawal by Subject|0|||
156903930|NCT03469934|566407119|FG001|Overall Study|Withdrawal by Subject|1|||
156903931|NCT01691898|566407122|FG000|Overall Study|Death|34|||
156903932|NCT01691898|566407123|FG001|Overall Study|Death|32|||
156903933|NCT01691898|566407124|FG002|Overall Study|Death|6|||
156903934|NCT01691898|566407125|FG003|Overall Study|Death|3|||
156903935|NCT01691898|566407126|FG004|Overall Study|Death|8|||
156903936|NCT01691898|566407127|FG005|Overall Study|Death|31|||
156903937|NCT01691898|566407122|FG000|Overall Study|Adverse Event|0|||
156903938|NCT01691898|566407123|FG001|Overall Study|Adverse Event|1|||
156903939|NCT01691898|566407124|FG002|Overall Study|Adverse Event|0|||
156903940|NCT01691898|566407125|FG003|Overall Study|Adverse Event|1|||
156903941|NCT01691898|566407126|FG004|Overall Study|Adverse Event|1|||
156903942|NCT01691898|566407127|FG005|Overall Study|Adverse Event|0|||
156903943|NCT01691898|566407122|FG000|Overall Study|Progression of Disease|1|||
156903944|NCT01691898|566407123|FG001|Overall Study|Progression of Disease|2|||
156903945|NCT01691898|566407124|FG002|Overall Study|Progression of Disease|1|||
156903946|NCT01691898|566407125|FG003|Overall Study|Progression of Disease|0|||
157159216|NCT00406640|567326922|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
156903947|NCT01691898|566407126|FG004|Overall Study|Progression of Disease|0|||
156903948|NCT01691898|566407127|FG005|Overall Study|Progression of Disease|1|||
156903949|NCT01691898|566407122|FG000|Overall Study|Lost to Follow-up|3|||
157159217|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
156903950|NCT01691898|566407123|FG001|Overall Study|Lost to Follow-up|1|||
156903951|NCT01691898|566407124|FG002|Overall Study|Lost to Follow-up|0|||
156903952|NCT01691898|566407125|FG003|Overall Study|Lost to Follow-up|0|||
156903953|NCT01691898|566407126|FG004|Overall Study|Lost to Follow-up|1|||
156903954|NCT01691898|566407127|FG005|Overall Study|Lost to Follow-up|0|||
156903955|NCT01691898|566407122|FG000|Overall Study|Withdrawal by Subject|9|||
156903956|NCT01691898|566407123|FG001|Overall Study|Withdrawal by Subject|8|||
156903957|NCT01691898|566407124|FG002|Overall Study|Withdrawal by Subject|2|||
156903958|NCT01691898|566407125|FG003|Overall Study|Withdrawal by Subject|1|||
156903959|NCT01691898|566407126|FG004|Overall Study|Withdrawal by Subject|3|||
156903960|NCT01691898|566407127|FG005|Overall Study|Withdrawal by Subject|3|||
156903961|NCT01691898|566407122|FG000|Overall Study|Non-Compliance|0|||
156903962|NCT01691898|566407123|FG001|Overall Study|Non-Compliance|0|||
156903963|NCT01691898|566407124|FG002|Overall Study|Non-Compliance|0|||
156903964|NCT01691898|566407125|FG003|Overall Study|Non-Compliance|0|||
156903965|NCT01691898|566407126|FG004|Overall Study|Non-Compliance|1|||
156903966|NCT01691898|566407127|FG005|Overall Study|Non-Compliance|0|||
156903967|NCT01013350|566407128|FG000|Overall Study|Lost to Follow-up|15|||
156903968|NCT01013350|566407129|FG001|Overall Study|Lost to Follow-up|95|||
156903969|NCT01013350|566407128|FG000|Overall Study|Adverse Event|0|||
156903970|NCT01013350|566407129|FG001|Overall Study|Adverse Event|1|||
156903971|NCT01013350|566407128|FG000|Overall Study|Physician Decision|4|||
156903972|NCT01013350|566407129|FG001|Overall Study|Physician Decision|20|||
156903973|NCT01013350|566407128|FG000|Overall Study|Withdrawal by Subject|15|||
156903974|NCT01013350|566407129|FG001|Overall Study|Withdrawal by Subject|38|||
156903975|NCT01013350|566407128|FG000|Overall Study|Death|3|||
156903976|NCT01013350|566407129|FG001|Overall Study|Death|5|||
156903977|NCT01013350|566407128|FG000|Overall Study|Participant entered interventional study|0|||
156903978|NCT01013350|566407129|FG001|Overall Study|Participant entered interventional study|8|||
156903979|NCT01013350|566407128|FG000|Overall Study|Other|1|||
156903980|NCT01013350|566407129|FG001|Overall Study|Other|25|||
156903981|NCT02019277|566407136|FG000|Overall Study|Withdrawal by Subject|3|||
156903982|NCT02019277|566407136|FG000|Overall Study|Death|7|||
156903983|NCT02019277|566407136|FG000|Overall Study|Did no Cooperate|1|||
156903984|NCT02019277|566407136|FG000|Overall Study|Adverse Event|1|||
156903985|NCT04738734|566407137|FG000|Overall Study|Withdrawal by Subject|2|||
156903986|NCT04738734|566407138|FG001|Overall Study|Withdrawal by Subject|4|||
156903987|NCT04738734|566407137|FG000|Overall Study|Lost to Follow-up|5|||
156903988|NCT04738734|566407138|FG001|Overall Study|Lost to Follow-up|2|||
156903989|NCT04738734|566407137|FG000|Overall Study|Physician Decision|0|||
156903990|NCT04738734|566407138|FG001|Overall Study|Physician Decision|1|||
156903991|NCT04738734|566407137|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
156903992|NCT04738734|566407138|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
156903993|NCT02808650|566407139|FG000|Overall Study|Death|0|||
156903994|NCT02808650|566407140|FG001|Overall Study|Death|0|||
156903995|NCT02808650|566407141|FG002|Overall Study|Death|0|||
156903996|NCT02808650|566407142|FG003|Overall Study|Death|0|||
156903997|NCT02808650|566407143|FG004|Overall Study|Death|1|||
156903998|NCT02808650|566407139|FG000|Overall Study|Lack of Efficacy|5|||
156903999|NCT02808650|566407140|FG001|Overall Study|Lack of Efficacy|5|||
156904000|NCT02808650|566407141|FG002|Overall Study|Lack of Efficacy|6|||
156904001|NCT02808650|566407142|FG003|Overall Study|Lack of Efficacy|5|||
156904002|NCT02808650|566407143|FG004|Overall Study|Lack of Efficacy|4|||
156904003|NCT02808650|566407139|FG000|Overall Study|Physician Decision|1|||
156904004|NCT02808650|566407140|FG001|Overall Study|Physician Decision|1|||
156904005|NCT02808650|566407141|FG002|Overall Study|Physician Decision|0|||
156904006|NCT02808650|566407142|FG003|Overall Study|Physician Decision|0|||
156904007|NCT02808650|566407143|FG004|Overall Study|Physician Decision|0|||
156904008|NCT02808650|566407139|FG000|Overall Study|Withdrawal by Subject|0|||
156904009|NCT02808650|566407140|FG001|Overall Study|Withdrawal by Subject|0|||
156904010|NCT02808650|566407141|FG002|Overall Study|Withdrawal by Subject|0|||
156904011|NCT02808650|566407142|FG003|Overall Study|Withdrawal by Subject|1|||
156904012|NCT02808650|566407143|FG004|Overall Study|Withdrawal by Subject|1|||
156904013|NCT00113087|566407149|FG000|Overall Study|Death or Transplant|14|||
156904014|NCT00113087|566407150|FG001|Overall Study|Death or Transplant|16|||
156904015|NCT00113087|566407149|FG000|Overall Study|Family or MD withdrew subject|10|||
156904016|NCT00113087|566407150|FG001|Overall Study|Family or MD withdrew subject|5|||
156904017|NCT03452228|566407151|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156904018|NCT03452228|566407152|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156904019|NCT03452228|566407153|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
157159218|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
157159219|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
156904020|NCT03452228|566407151|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156904021|NCT03452228|566407152|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156904022|NCT03452228|566407153|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156904023|NCT03452228|566407151|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
157026664|NCT05623228|566851662|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
156904024|NCT03452228|566407152|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
156904025|NCT03452228|566407153|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
156904026|NCT03452228|566407151|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156904027|NCT03452228|566407152|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
156904028|NCT03452228|566407153|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
156904029|NCT00386607|566407154|FG000|Core|Adverse Event|40|||
156904030|NCT00386607|566407155|FG001|Core|Adverse Event|0|||
156904031|NCT00386607|566407154|FG000|Core|Abnormal laboratory value(s)|3|||
156904032|NCT00386607|566407155|FG001|Core|Abnormal laboratory value(s)|0|||
156904033|NCT00386607|566407154|FG000|Core|Unsatisfactory therapeutic effect|23|||
156904034|NCT00386607|566407155|FG001|Core|Unsatisfactory therapeutic effect|0|||
156904035|NCT00386607|566407154|FG000|Core|Condition no longer requires study drug|4|||
156904036|NCT00386607|566407155|FG001|Core|Condition no longer requires study drug|0|||
156904037|NCT00386607|566407154|FG000|Core|Patient withdrew consent|15|||
156904038|NCT00386607|566407155|FG001|Core|Patient withdrew consent|0|||
156904039|NCT00386607|566407154|FG000|Core|Lost to Follow-up|23|||
156904040|NCT00386607|566407155|FG001|Core|Lost to Follow-up|0|||
156904041|NCT00386607|566407154|FG000|Core|Administrative problems|1|||
156904042|NCT00386607|566407155|FG001|Core|Administrative problems|0|||
156904043|NCT00386607|566407154|FG000|Core|Protocol Deviation|6|||
156904044|NCT00386607|566407155|FG001|Core|Protocol Deviation|0|||
156904045|NCT00386607|566407154|FG000|Extension|Adverse Event|0|||
156904046|NCT00386607|566407155|FG001|Extension|Adverse Event|6|||
156904047|NCT00386607|566407154|FG000|Extension|Abnormal laboratory value(s)|0|||
156904048|NCT00386607|566407155|FG001|Extension|Abnormal laboratory value(s)|1|||
156904049|NCT00386607|566407154|FG000|Extension|Administrative problems|0|||
156904050|NCT00386607|566407155|FG001|Extension|Administrative problems|1|||
156904051|NCT00386607|566407154|FG000|Extension|Lost to Follow-up|0|||
156904052|NCT00386607|566407155|FG001|Extension|Lost to Follow-up|3|||
156904053|NCT00386607|566407154|FG000|Extension|Patient withdrew consent|0|||
156904054|NCT00386607|566407155|FG001|Extension|Patient withdrew consent|5|||
156904055|NCT00386607|566407154|FG000|Extension|Unsatisfactory therapeutic effect|0|||
156904056|NCT00386607|566407155|FG001|Extension|Unsatisfactory therapeutic effect|1|||
156904057|NCT01710046|566407157|FG000|Overall Study|Lost to Follow-up|1|||
156904058|NCT01710046|566407158|FG001|Overall Study|Lost to Follow-up|0|||
156904059|NCT02919696|566407159|FG000|Overall Study|Adverse Event|1|||
156904060|NCT02919696|566407160|FG001|Overall Study|Adverse Event|2|||
156904061|NCT02919696|566407159|FG000|Overall Study|Withdrawal by Subject|2|||
156904062|NCT02919696|566407160|FG001|Overall Study|Withdrawal by Subject|1|||
156904063|NCT02919696|566407159|FG000|Overall Study|Sponsor Decision|1|||
156904064|NCT02919696|566407160|FG001|Overall Study|Sponsor Decision|1|||
156904065|NCT02919696|566407159|FG000|Overall Study|Never Treated|0|||
156904066|NCT02919696|566407160|FG001|Overall Study|Never Treated|1|||
156904067|NCT00968864|566407161|FG000|Overall Study|Protocol exception/ not evaluable|1|||
156904068|NCT03666624|566407167|FG000|Overall Study|participant grieving over recent death of parent|1|||
156904069|NCT03666624|566407168|FG001|Overall Study|participant grieving over recent death of parent|0|||
156904070|NCT00423514|566407174|FG000|Overall Study|Ineligible|1|||
156904071|NCT00423514|566407175|FG001|Overall Study|Ineligible|0|||
156904072|NCT00397215|566407176|FG000|Month 0 (Day 0)|Adverse Event|0|||
156904073|NCT00397215|566407177|FG001|Month 0 (Day 0)|Adverse Event|1|||
156904074|NCT00397215|566407178|FG002|Month 0 (Day 0)|Adverse Event|0|||
156904075|NCT00397215|566407179|FG003|Month 0 (Day 0)|Adverse Event|0|||
157026665|NCT05623228|566851655|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
157026666|NCT05623228|566851656|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
157026667|NCT05623228|566851657|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
157026668|NCT05623228|566851658|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
157026669|NCT05623228|566851659|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
157026670|NCT05623228|566851660|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
157026671|NCT05623228|566851661|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
157026672|NCT05623228|566851662|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
157026673|NCT05579899|566853259|FG000|Overall Study|Lost to Follow-up|3|||
157026674|NCT05579899|566853260|FG001|Overall Study|Lost to Follow-up|1|||
157026675|NCT05579899|566853259|FG000|Overall Study|Adverse Event|0|||
157026676|NCT05579899|566853260|FG001|Overall Study|Adverse Event|3|||
157026677|NCT05579899|566853259|FG000|Overall Study|Pregnancy|0|||
157026678|NCT05579899|566853260|FG001|Overall Study|Pregnancy|1|||
156904076|NCT00397215|566407176|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
156904077|NCT00397215|566407177|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
156904078|NCT00397215|566407178|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
156904079|NCT00397215|566407179|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
156904080|NCT00397215|566407176|FG000|Month 0 (Day 0)|Other|4|||
156904081|NCT00397215|566407177|FG001|Month 0 (Day 0)|Other|1|||
156904082|NCT00397215|566407178|FG002|Month 0 (Day 0)|Other|3|||
156904083|NCT00397215|566407179|FG003|Month 0 (Day 0)|Other|3|||
156904084|NCT00397215|566407176|FG000|Month 6 (Day 180)|Adverse Event|0|||
156904085|NCT00397215|566407177|FG001|Month 6 (Day 180)|Adverse Event|3|||
156904086|NCT00397215|566407178|FG002|Month 6 (Day 180)|Adverse Event|2|||
156904087|NCT00397215|566407179|FG003|Month 6 (Day 180)|Adverse Event|0|||
156904088|NCT00397215|566407176|FG000|Month 6 (Day 180)|Other|2|||
156904089|NCT00397215|566407177|FG001|Month 6 (Day 180)|Other|0|||
156904090|NCT00397215|566407178|FG002|Month 6 (Day 180)|Other|3|||
156904091|NCT00397215|566407179|FG003|Month 6 (Day 180)|Other|0|||
156904092|NCT01254630|566407180|FG000|Overall Study|Adverse Event|36|||
156904093|NCT01254630|566407181|FG001|Overall Study|Adverse Event|15|||
156904094|NCT01254630|566407182|FG002|Overall Study|Adverse Event|40|||
156904095|NCT01254630|566407183|FG003|Overall Study|Adverse Event|8|||
156904096|NCT01254630|566407180|FG000|Overall Study|Death|461|||
156904097|NCT01254630|566407181|FG001|Overall Study|Death|151|||
156904098|NCT01254630|566407182|FG002|Overall Study|Death|478|||
156904099|NCT01254630|566407183|FG003|Overall Study|Death|139|||
156904100|NCT01254630|566407180|FG000|Overall Study|Lost to Follow-up|80|||
156904101|NCT01254630|566407181|FG001|Overall Study|Lost to Follow-up|26|||
156904102|NCT01254630|566407182|FG002|Overall Study|Lost to Follow-up|89|||
156904103|NCT01254630|566407183|FG003|Overall Study|Lost to Follow-up|32|||
156904104|NCT01254630|566407180|FG000|Overall Study|Physician Decision|24|||
156904105|NCT01254630|566407181|FG001|Overall Study|Physician Decision|8|||
156904106|NCT01254630|566407182|FG002|Overall Study|Physician Decision|16|||
156904107|NCT01254630|566407183|FG003|Overall Study|Physician Decision|7|||
156904108|NCT01254630|566407180|FG000|Overall Study|Withdrawal by Subject|201|||
156904109|NCT01254630|566407181|FG001|Overall Study|Withdrawal by Subject|94|||
156904110|NCT01254630|566407182|FG002|Overall Study|Withdrawal by Subject|188|||
156904111|NCT01254630|566407183|FG003|Overall Study|Withdrawal by Subject|89|||
156904112|NCT01254630|566407180|FG000|Overall Study|Study terminated by sponsor|0|||
156904113|NCT01254630|566407181|FG001|Overall Study|Study terminated by sponsor|994|||
156904114|NCT01254630|566407182|FG002|Overall Study|Study terminated by sponsor|0|||
156904115|NCT01254630|566407183|FG003|Overall Study|Study terminated by sponsor|1010|||
156904116|NCT01254630|566407180|FG000|Overall Study|Status not recorded|0|||
156904117|NCT01254630|566407181|FG001|Overall Study|Status not recorded|0|||
156904118|NCT01254630|566407182|FG002|Overall Study|Status not recorded|1|||
156904119|NCT01254630|566407183|FG003|Overall Study|Status not recorded|0|||
156904120|NCT02959983|566407184|FG000|Overall Study|Protocol Violation|0|||
156904121|NCT02959983|566407185|FG001|Overall Study|Protocol Violation|1|||
156904122|NCT02959983|566407184|FG000|Overall Study|Lack of Efficacy|0|||
156904123|NCT02959983|566407185|FG001|Overall Study|Lack of Efficacy|1|||
156904124|NCT02959983|566407184|FG000|Overall Study|Lost to Follow-up|12|||
156904125|NCT02959983|566407185|FG001|Overall Study|Lost to Follow-up|9|||
156904126|NCT02959983|566407184|FG000|Overall Study|Other|1|||
156904127|NCT02959983|566407185|FG001|Overall Study|Other|1|||
156904128|NCT02959983|566407184|FG000|Overall Study|Physician Decision|1|||
156904129|NCT02959983|566407185|FG001|Overall Study|Physician Decision|0|||
156904130|NCT02959983|566407184|FG000|Overall Study|Adverse Event|5|||
156904131|NCT02959983|566407185|FG001|Overall Study|Adverse Event|1|||
156904132|NCT02959983|566407184|FG000|Overall Study|Withdrawal by Subject|7|||
156904133|NCT02959983|566407185|FG001|Overall Study|Withdrawal by Subject|12|||
156904134|NCT04032652|566407186|FG000|Overall Study|The study was terminated and the PI has|1|||
156904135|NCT04032652|566407187|FG001|Overall Study|The study was terminated and the PI has|1|||
156904136|NCT01787331|566407188|FG000|Overall Study|Physician Decision|1|||
156904137|NCT01787331|566407188|FG000|Overall Study|Withdrawal by Subject|1|||
156904138|NCT00761631|566407190|FG000|Overall Study|Parent/legal guardian request|8|||
156904139|NCT00761631|566407191|FG001|Overall Study|Parent/legal guardian request|3|||
156904140|NCT00761631|566407192|FG002|Overall Study|Parent/legal guardian request|8|||
156904141|NCT00761631|566407193|FG003|Overall Study|Parent/legal guardian request|0|||
156904142|NCT00761631|566407194|FG004|Overall Study|Parent/legal guardian request|5|||
156904143|NCT00761631|566407195|FG005|Overall Study|Parent/legal guardian request|0|||
156904144|NCT00761631|566407190|FG000|Overall Study|Lost to Follow-up|2|||
156904145|NCT00761631|566407191|FG001|Overall Study|Lost to Follow-up|4|||
156904146|NCT00761631|566407192|FG002|Overall Study|Lost to Follow-up|7|||
156904147|NCT00761631|566407193|FG003|Overall Study|Lost to Follow-up|1|||
156904148|NCT00761631|566407194|FG004|Overall Study|Lost to Follow-up|6|||
156904149|NCT00761631|566407195|FG005|Overall Study|Lost to Follow-up|1|||
156904150|NCT00761631|566407190|FG000|Overall Study|Protocol Violation|2|||
156904151|NCT00761631|566407191|FG001|Overall Study|Protocol Violation|0|||
156904152|NCT00761631|566407192|FG002|Overall Study|Protocol Violation|0|||
156904153|NCT00761631|566407193|FG003|Overall Study|Protocol Violation|1|||
156904154|NCT00761631|566407194|FG004|Overall Study|Protocol Violation|5|||
156904155|NCT00761631|566407195|FG005|Overall Study|Protocol Violation|1|||
156904156|NCT00761631|566407190|FG000|Overall Study|Randomized, not treated|1|||
156904157|NCT00761631|566407191|FG001|Overall Study|Randomized, not treated|0|||
156904158|NCT00761631|566407192|FG002|Overall Study|Randomized, not treated|0|||
156904159|NCT00761631|566407193|FG003|Overall Study|Randomized, not treated|0|||
156904160|NCT00761631|566407194|FG004|Overall Study|Randomized, not treated|0|||
156904161|NCT00761631|566407195|FG005|Overall Study|Randomized, not treated|0|||
156904162|NCT00761631|566407190|FG000|Overall Study|Failed to return|1|||
156904163|NCT00761631|566407191|FG001|Overall Study|Failed to return|0|||
156904164|NCT00761631|566407192|FG002|Overall Study|Failed to return|1|||
157159220|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
156904165|NCT00761631|566407193|FG003|Overall Study|Failed to return|1|||
156904166|NCT00761631|566407194|FG004|Overall Study|Failed to return|5|||
156904167|NCT00761631|566407195|FG005|Overall Study|Failed to return|2|||
156904168|NCT00761631|566407190|FG000|Overall Study|Physician Decision|1|||
156904169|NCT00761631|566407191|FG001|Overall Study|Physician Decision|0|||
156904170|NCT00761631|566407192|FG002|Overall Study|Physician Decision|0|||
156904171|NCT00761631|566407193|FG003|Overall Study|Physician Decision|0|||
156904172|NCT00761631|566407194|FG004|Overall Study|Physician Decision|0|||
156904173|NCT00761631|566407195|FG005|Overall Study|Physician Decision|0|||
156904174|NCT00761631|566407190|FG000|Overall Study|Other|0|||
156904175|NCT00761631|566407191|FG001|Overall Study|Other|0|||
156904176|NCT00761631|566407192|FG002|Overall Study|Other|0|||
156904177|NCT00761631|566407193|FG003|Overall Study|Other|0|||
156904178|NCT00761631|566407194|FG004|Overall Study|Other|1|||
156904179|NCT00761631|566407195|FG005|Overall Study|Other|1|||
156904180|NCT01441180|566407202|FG000|Overall Study|Lost to Follow-up|1|||
156904181|NCT01441180|566407203|FG001|Overall Study|Lost to Follow-up|1|||
156904182|NCT01441180|566407204|FG002|Overall Study|Lost to Follow-up|1|||
156904183|NCT01441180|566407202|FG000|Overall Study|Discontinued|0|||
156904184|NCT01441180|566407203|FG001|Overall Study|Discontinued|0|||
156904185|NCT01441180|566407204|FG002|Overall Study|Discontinued|2|||
156904186|NCT00142298|566407207|FG000|Overall Study|Adverse Event|10|||
156904187|NCT00142298|566407208|FG001|Overall Study|Adverse Event|10|||
156904188|NCT00142298|566407209|FG002|Overall Study|Adverse Event|1|||
156904189|NCT00142298|566407210|FG003|Overall Study|Adverse Event|5|||
156904190|NCT00142298|566407211|FG004|Overall Study|Adverse Event|2|||
156904191|NCT00142298|566407212|FG005|Overall Study|Adverse Event|2|||
156904192|NCT00142298|566407213|FG006|Overall Study|Adverse Event|0|||
156904193|NCT00142298|566407214|FG007|Overall Study|Adverse Event|0|||
156904194|NCT00142298|566407215|FG008|Overall Study|Adverse Event|0|||
156904195|NCT00142298|566407216|FG009|Overall Study|Adverse Event|0|||
156904196|NCT00142298|566407207|FG000|Overall Study|Clinical disease progression|1|||
156904197|NCT00142298|566407208|FG001|Overall Study|Clinical disease progression|0|||
156904198|NCT00142298|566407209|FG002|Overall Study|Clinical disease progression|0|||
156904199|NCT00142298|566407210|FG003|Overall Study|Clinical disease progression|0|||
156904200|NCT00142298|566407211|FG004|Overall Study|Clinical disease progression|0|||
156904201|NCT00142298|566407212|FG005|Overall Study|Clinical disease progression|0|||
156904202|NCT00142298|566407213|FG006|Overall Study|Clinical disease progression|0|||
156904203|NCT00142298|566407214|FG007|Overall Study|Clinical disease progression|0|||
156904204|NCT00142298|566407215|FG008|Overall Study|Clinical disease progression|0|||
156904205|NCT00142298|566407216|FG009|Overall Study|Clinical disease progression|0|||
156904206|NCT00142298|566407207|FG000|Overall Study|Death|1|||
156904207|NCT00142298|566407208|FG001|Overall Study|Death|1|||
156904208|NCT00142298|566407209|FG002|Overall Study|Death|1|||
156904209|NCT00142298|566407210|FG003|Overall Study|Death|0|||
156904210|NCT00142298|566407211|FG004|Overall Study|Death|0|||
156904211|NCT00142298|566407212|FG005|Overall Study|Death|6|||
156904212|NCT00142298|566407213|FG006|Overall Study|Death|0|||
156904213|NCT00142298|566407214|FG007|Overall Study|Death|0|||
156904214|NCT00142298|566407215|FG008|Overall Study|Death|0|||
156904215|NCT00142298|566407216|FG009|Overall Study|Death|0|||
156904216|NCT00142298|566407207|FG000|Overall Study|Lack of Efficacy|44|||
156904217|NCT00142298|566407208|FG001|Overall Study|Lack of Efficacy|62|||
156904218|NCT00142298|566407209|FG002|Overall Study|Lack of Efficacy|9|||
156904219|NCT00142298|566407210|FG003|Overall Study|Lack of Efficacy|12|||
156904220|NCT00142298|566407211|FG004|Overall Study|Lack of Efficacy|1|||
156904221|NCT00142298|566407212|FG005|Overall Study|Lack of Efficacy|0|||
156904222|NCT00142298|566407213|FG006|Overall Study|Lack of Efficacy|0|||
156904223|NCT00142298|566407214|FG007|Overall Study|Lack of Efficacy|1|||
156904224|NCT00142298|566407215|FG008|Overall Study|Lack of Efficacy|0|||
156904225|NCT00142298|566407216|FG009|Overall Study|Lack of Efficacy|0|||
156904226|NCT00142298|566407207|FG000|Overall Study|Non-compliance|15|||
156904227|NCT00142298|566407208|FG001|Overall Study|Non-compliance|13|||
156904228|NCT00142298|566407209|FG002|Overall Study|Non-compliance|0|||
156904229|NCT00142298|566407210|FG003|Overall Study|Non-compliance|6|||
156904230|NCT00142298|566407211|FG004|Overall Study|Non-compliance|1|||
156904231|NCT00142298|566407212|FG005|Overall Study|Non-compliance|0|||
156904232|NCT00142298|566407213|FG006|Overall Study|Non-compliance|0|||
157159221|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
157159222|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
156904233|NCT00142298|566407214|FG007|Overall Study|Non-compliance|3|||
156904234|NCT00142298|566407215|FG008|Overall Study|Non-compliance|3|||
156904235|NCT00142298|566407216|FG009|Overall Study|Non-compliance|0|||
156904236|NCT00142298|566407207|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
156904237|NCT00142298|566407208|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
156904238|NCT00142298|566407209|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
156904239|NCT00142298|566407210|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
156904240|NCT00142298|566407211|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
156904241|NCT00142298|566407212|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
156904242|NCT00142298|566407213|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
156904243|NCT00142298|566407214|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
156904244|NCT00142298|566407215|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
156904245|NCT00142298|566407216|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
156904246|NCT00142298|566407207|FG000|Overall Study|Pregnancy|4|||
156904247|NCT00142298|566407208|FG001|Overall Study|Pregnancy|4|||
156904248|NCT00142298|566407209|FG002|Overall Study|Pregnancy|2|||
156904249|NCT00142298|566407210|FG003|Overall Study|Pregnancy|3|||
156904250|NCT00142298|566407211|FG004|Overall Study|Pregnancy|0|||
156904251|NCT00142298|566407212|FG005|Overall Study|Pregnancy|0|||
156904252|NCT00142298|566407213|FG006|Overall Study|Pregnancy|0|||
156904253|NCT00142298|566407214|FG007|Overall Study|Pregnancy|0|||
156904254|NCT00142298|566407215|FG008|Overall Study|Pregnancy|1|||
156904255|NCT00142298|566407216|FG009|Overall Study|Pregnancy|0|||
156904256|NCT00142298|566407207|FG000|Overall Study|Virologic breakthrough|19|||
156904257|NCT00142298|566407208|FG001|Overall Study|Virologic breakthrough|23|||
156904258|NCT00142298|566407209|FG002|Overall Study|Virologic breakthrough|9|||
156904259|NCT00142298|566407210|FG003|Overall Study|Virologic breakthrough|7|||
156904260|NCT00142298|566407211|FG004|Overall Study|Virologic breakthrough|2|||
156904261|NCT00142298|566407212|FG005|Overall Study|Virologic breakthrough|3|||
156904262|NCT00142298|566407213|FG006|Overall Study|Virologic breakthrough|3|||
156904263|NCT00142298|566407214|FG007|Overall Study|Virologic breakthrough|0|||
156904264|NCT00142298|566407215|FG008|Overall Study|Virologic breakthrough|0|||
156904265|NCT00142298|566407216|FG009|Overall Study|Virologic breakthrough|0|||
156904266|NCT00142298|566407207|FG000|Overall Study|Other- not specified|0|||
156904267|NCT00142298|566407208|FG001|Overall Study|Other- not specified|3|||
156904268|NCT00142298|566407209|FG002|Overall Study|Other- not specified|0|||
156904269|NCT00142298|566407210|FG003|Overall Study|Other- not specified|1|||
156904270|NCT00142298|566407211|FG004|Overall Study|Other- not specified|0|||
156904271|NCT00142298|566407212|FG005|Overall Study|Other- not specified|0|||
156904272|NCT00142298|566407213|FG006|Overall Study|Other- not specified|0|||
156904273|NCT00142298|566407214|FG007|Overall Study|Other- not specified|0|||
156904274|NCT00142298|566407215|FG008|Overall Study|Other- not specified|0|||
156904275|NCT00142298|566407216|FG009|Overall Study|Other- not specified|0|||
156904276|NCT00142298|566407207|FG000|Overall Study|Lost to Follow-up|0|||
157159223|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
157159224|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
157159225|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
157159226|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
157159227|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
157159228|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
157159229|NCT00406640|567326921|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
157159230|NCT00406640|567326922|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
157159231|NCT02669862|567329437|FG000|Overall Study|Lost to Follow-up|0|||
157159232|NCT02669862|567329438|FG001|Overall Study|Lost to Follow-up|2|||
157159233|NCT02669862|567329439|FG002|Overall Study|Lost to Follow-up|1|||
156904277|NCT00142298|566407208|FG001|Overall Study|Lost to Follow-up|0|||
156904278|NCT00142298|566407209|FG002|Overall Study|Lost to Follow-up|0|||
156904279|NCT00142298|566407210|FG003|Overall Study|Lost to Follow-up|0|||
156904280|NCT00142298|566407211|FG004|Overall Study|Lost to Follow-up|0|||
156904281|NCT00142298|566407212|FG005|Overall Study|Lost to Follow-up|0|||
156904282|NCT00142298|566407213|FG006|Overall Study|Lost to Follow-up|2|||
156904283|NCT00142298|566407214|FG007|Overall Study|Lost to Follow-up|0|||
156904284|NCT00142298|566407215|FG008|Overall Study|Lost to Follow-up|0|||
156904285|NCT00142298|566407216|FG009|Overall Study|Lost to Follow-up|0|||
156904286|NCT00142298|566407207|FG000|Overall Study|Treatment Failure|0|||
156904287|NCT00142298|566407208|FG001|Overall Study|Treatment Failure|0|||
156904288|NCT00142298|566407209|FG002|Overall Study|Treatment Failure|0|||
156904289|NCT00142298|566407210|FG003|Overall Study|Treatment Failure|0|||
156904290|NCT00142298|566407211|FG004|Overall Study|Treatment Failure|0|||
157026679|NCT05579899|566853259|FG000|Overall Study|Withdrawal by Subject|0|||
157026680|NCT05579899|566853260|FG001|Overall Study|Withdrawal by Subject|3|||
157026681|NCT03023410|566853261|FG000|Overall Study|study termination|0|||
157026682|NCT03023410|566853262|FG001|Overall Study|study termination|1|||
157026683|NCT04987320|566853268|FG000|Overall Study|Withdrawal by Subject|0|||
157026684|NCT04987320|566853269|FG001|Overall Study|Withdrawal by Subject|1|||
157026685|NCT00085735|566853270|FG000|Overall Study|Adverse Event|1|||
157026686|NCT00085735|566853271|FG001|Overall Study|Adverse Event|0|||
157026687|NCT00085735|566853272|FG002|Overall Study|Adverse Event|0|||
157026688|NCT00085735|566853273|FG003|Overall Study|Adverse Event|0|||
157026689|NCT00085735|566853274|FG004|Overall Study|Adverse Event|0|||
157026690|NCT00085735|566853275|FG005|Overall Study|Adverse Event|0|||
157026691|NCT00085735|566853270|FG000|Overall Study|Lack of Efficacy|2|||
157026692|NCT00085735|566853271|FG001|Overall Study|Lack of Efficacy|4|||
157026693|NCT00085735|566853272|FG002|Overall Study|Lack of Efficacy|6|||
156904291|NCT00142298|566407212|FG005|Overall Study|Treatment Failure|2|||
156904292|NCT00142298|566407213|FG006|Overall Study|Treatment Failure|2|||
156904293|NCT00142298|566407214|FG007|Overall Study|Treatment Failure|0|||
156904294|NCT00142298|566407215|FG008|Overall Study|Treatment Failure|0|||
156904295|NCT00142298|566407216|FG009|Overall Study|Treatment Failure|0|||
156904296|NCT02423772|566407218|FG000|Overall Study|Lost to Follow-up|3|||
156904297|NCT02423772|566407219|FG001|Overall Study|Lost to Follow-up|3|||
157026694|NCT00085735|566853273|FG003|Overall Study|Lack of Efficacy|3|||
157026695|NCT00085735|566853274|FG004|Overall Study|Lack of Efficacy|4|||
157225576|NCT01254409|567571469|FG001|Overall Study|Adverse Event|1|||
157026696|NCT00085735|566853275|FG005|Overall Study|Lack of Efficacy|3|||
156904298|NCT02423772|566407218|FG000|Overall Study|Did not begin intervention|2|||
156904299|NCT02423772|566407219|FG001|Overall Study|Did not begin intervention|5|||
156904300|NCT02557295|566407221|FG000|Overall Study|Withdrawal by Subject|9|||
156904301|NCT02557295|566407222|FG001|Overall Study|Withdrawal by Subject|2|||
156904302|NCT02557295|566407223|FG002|Overall Study|Withdrawal by Subject|4|||
156904303|NCT02557295|566407224|FG003|Overall Study|Withdrawal by Subject|0|||
156904304|NCT02557295|566407225|FG004|Overall Study|Withdrawal by Subject|0|||
156904305|NCT02557295|566407226|FG005|Overall Study|Withdrawal by Subject|0|||
156904306|NCT02557295|566407227|FG006|Overall Study|Withdrawal by Subject|15|||
156904307|NCT02557295|566407228|FG007|Overall Study|Withdrawal by Subject|1|||
156904308|NCT02557295|566407229|FG008|Overall Study|Withdrawal by Subject|3|||
156904309|NCT02557295|566407221|FG000|Overall Study|Disease Progression|0|||
156904310|NCT02557295|566407222|FG001|Overall Study|Disease Progression|0|||
156904311|NCT02557295|566407223|FG002|Overall Study|Disease Progression|0|||
156904312|NCT02557295|566407224|FG003|Overall Study|Disease Progression|0|||
156904313|NCT02557295|566407225|FG004|Overall Study|Disease Progression|0|||
156904314|NCT02557295|566407226|FG005|Overall Study|Disease Progression|0|||
156904315|NCT02557295|566407227|FG006|Overall Study|Disease Progression|1|||
156904316|NCT02557295|566407228|FG007|Overall Study|Disease Progression|0|||
156904317|NCT02557295|566407229|FG008|Overall Study|Disease Progression|0|||
156904318|NCT02557295|566407221|FG000|Overall Study|Lack of Efficacy|24|||
156904319|NCT02557295|566407222|FG001|Overall Study|Lack of Efficacy|1|||
156904320|NCT02557295|566407223|FG002|Overall Study|Lack of Efficacy|3|||
156904321|NCT02557295|566407224|FG003|Overall Study|Lack of Efficacy|0|||
156904322|NCT02557295|566407225|FG004|Overall Study|Lack of Efficacy|0|||
156904323|NCT02557295|566407226|FG005|Overall Study|Lack of Efficacy|0|||
156904324|NCT02557295|566407227|FG006|Overall Study|Lack of Efficacy|12|||
156904325|NCT02557295|566407228|FG007|Overall Study|Lack of Efficacy|1|||
156904326|NCT02557295|566407229|FG008|Overall Study|Lack of Efficacy|0|||
156904327|NCT02557295|566407221|FG000|Overall Study|Adverse Event|16|||
156904328|NCT02557295|566407222|FG001|Overall Study|Adverse Event|2|||
156904329|NCT02557295|566407223|FG002|Overall Study|Adverse Event|3|||
156904330|NCT02557295|566407224|FG003|Overall Study|Adverse Event|0|||
156904331|NCT02557295|566407225|FG004|Overall Study|Adverse Event|0|||
156904332|NCT02557295|566407226|FG005|Overall Study|Adverse Event|0|||
156904333|NCT02557295|566407227|FG006|Overall Study|Adverse Event|2|||
156904334|NCT02557295|566407228|FG007|Overall Study|Adverse Event|1|||
156904335|NCT02557295|566407229|FG008|Overall Study|Adverse Event|1|||
156904336|NCT02557295|566407221|FG000|Overall Study|Lost to Follow-up|4|||
156904337|NCT02557295|566407222|FG001|Overall Study|Lost to Follow-up|0|||
156904338|NCT02557295|566407223|FG002|Overall Study|Lost to Follow-up|0|||
156904339|NCT02557295|566407224|FG003|Overall Study|Lost to Follow-up|0|||
156904340|NCT02557295|566407225|FG004|Overall Study|Lost to Follow-up|0|||
156904341|NCT02557295|566407226|FG005|Overall Study|Lost to Follow-up|0|||
156904342|NCT02557295|566407227|FG006|Overall Study|Lost to Follow-up|9|||
156904343|NCT02557295|566407228|FG007|Overall Study|Lost to Follow-up|0|||
156904344|NCT02557295|566407229|FG008|Overall Study|Lost to Follow-up|0|||
156904345|NCT02557295|566407221|FG000|Overall Study|Study Close|54|||
156904346|NCT02557295|566407222|FG001|Overall Study|Study Close|3|||
156904347|NCT02557295|566407223|FG002|Overall Study|Study Close|5|||
156904348|NCT02557295|566407224|FG003|Overall Study|Study Close|3|||
156904349|NCT02557295|566407225|FG004|Overall Study|Study Close|0|||
156904350|NCT02557295|566407226|FG005|Overall Study|Study Close|0|||
156904351|NCT02557295|566407227|FG006|Overall Study|Study Close|37|||
156904352|NCT02557295|566407228|FG007|Overall Study|Study Close|3|||
156904353|NCT02557295|566407229|FG008|Overall Study|Study Close|19|||
156904354|NCT02557295|566407221|FG000|Overall Study|except for study close|4|||
156904355|NCT02557295|566407222|FG001|Overall Study|except for study close|0|||
156904356|NCT02557295|566407223|FG002|Overall Study|except for study close|0|||
156904357|NCT02557295|566407224|FG003|Overall Study|except for study close|0|||
156904358|NCT02557295|566407225|FG004|Overall Study|except for study close|0|||
156904359|NCT02557295|566407226|FG005|Overall Study|except for study close|0|||
156904360|NCT02557295|566407227|FG006|Overall Study|except for study close|5|||
156904361|NCT02557295|566407228|FG007|Overall Study|except for study close|1|||
156904362|NCT02557295|566407229|FG008|Overall Study|except for study close|0|||
156904363|NCT01067976|566407230|FG000|Overall Study|Study drug never administered|20|||
156904364|NCT01067976|566407230|FG000|Overall Study|Study prematurely discontinued|2|||
156904365|NCT03487549|566407235|FG000|Overall Study|Protocol Violation|0|||
156904366|NCT03487549|566407236|FG001|Overall Study|Protocol Violation|1|||
157225577|NCT01254409|567571470|FG002|Overall Study|Adverse Event|0|||
156904367|NCT03487549|566407235|FG000|Overall Study|Lost to Follow-up|2|||
156904368|NCT03487549|566407236|FG001|Overall Study|Lost to Follow-up|1|||
156904369|NCT03487549|566407235|FG000|Overall Study|Withdrawal by Subject|2|||
156904370|NCT03487549|566407236|FG001|Overall Study|Withdrawal by Subject|0|||
156904371|NCT02323113|566408667|FG000|Overall Study|Adverse Event|3|||
156904372|NCT02323113|566408668|FG001|Overall Study|Adverse Event|3|||
156904373|NCT02323113|566408669|FG002|Overall Study|Adverse Event|2|||
156904374|NCT02323113|566408670|FG003|Overall Study|Adverse Event|5|||
156904375|NCT02323113|566408671|FG004|Overall Study|Adverse Event|8|||
156904376|NCT02323113|566408672|FG005|Overall Study|Adverse Event|3|||
156904377|NCT02323113|566408673|FG006|Overall Study|Adverse Event|6|||
156904378|NCT02323113|566408674|FG007|Overall Study|Adverse Event|0|||
156904379|NCT02323113|566408667|FG000|Overall Study|Progressive Disease|0|||
156904380|NCT02323113|566408668|FG001|Overall Study|Progressive Disease|1|||
156904381|NCT02323113|566408669|FG002|Overall Study|Progressive Disease|1|||
156904382|NCT02323113|566408670|FG003|Overall Study|Progressive Disease|0|||
156904383|NCT02323113|566408671|FG004|Overall Study|Progressive Disease|0|||
156904384|NCT02323113|566408672|FG005|Overall Study|Progressive Disease|3|||
156904385|NCT02323113|566408673|FG006|Overall Study|Progressive Disease|0|||
156904386|NCT02323113|566408674|FG007|Overall Study|Progressive Disease|0|||
156904387|NCT02323113|566408667|FG000|Overall Study|Symptomatic Deterioration|0|||
156904388|NCT02323113|566408668|FG001|Overall Study|Symptomatic Deterioration|0|||
156904389|NCT02323113|566408669|FG002|Overall Study|Symptomatic Deterioration|1|||
156904390|NCT02323113|566408670|FG003|Overall Study|Symptomatic Deterioration|0|||
156904391|NCT02323113|566408671|FG004|Overall Study|Symptomatic Deterioration|1|||
156904392|NCT02323113|566408672|FG005|Overall Study|Symptomatic Deterioration|0|||
156904393|NCT02323113|566408673|FG006|Overall Study|Symptomatic Deterioration|0|||
156904394|NCT02323113|566408674|FG007|Overall Study|Symptomatic Deterioration|0|||
156904395|NCT02323113|566408667|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
156904396|NCT02323113|566408668|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
156904397|NCT02323113|566408669|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156904398|NCT02323113|566408670|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
156904399|NCT02323113|566408671|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
156904400|NCT02323113|566408672|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
156904401|NCT02323113|566408673|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
156904402|NCT02323113|566408674|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
156904403|NCT02323113|566408667|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904404|NCT02323113|566408668|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
156904405|NCT02323113|566408669|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904406|NCT02323113|566408670|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904407|NCT02323113|566408671|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904408|NCT02323113|566408672|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904409|NCT02323113|566408673|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904410|NCT02323113|566408674|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
156904411|NCT04092582|566408675|FG000|Overall Study|Death|1|||
156904412|NCT04092582|566408676|FG001|Overall Study|Death|1|||
156904413|NCT04092582|566408675|FG000|Overall Study|Withdrawal by Subject|4|||
156904414|NCT04092582|566408676|FG001|Overall Study|Withdrawal by Subject|1|||
156904415|NCT04092582|566408675|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
156904416|NCT04092582|566408676|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
156904417|NCT02280304|566408679|FG000|Overall Study|Lost to Follow-up|7|||
156904418|NCT02280304|566408680|FG001|Overall Study|Lost to Follow-up|8|||
156904419|NCT01313858|566408683|FG000|Overall Study|Premature Treatment Termination|251|||
156904420|NCT01313858|566408684|FG001|Overall Study|Premature Treatment Termination|219|||
156904421|NCT01313858|566408685|FG002|Overall Study|Premature Treatment Termination|191|||
156904422|NCT01313858|566408683|FG000|Overall Study|Lost to Follow-up|35|||
156904423|NCT01313858|566408684|FG001|Overall Study|Lost to Follow-up|51|||
156904424|NCT01313858|566408685|FG002|Overall Study|Lost to Follow-up|47|||
156904425|NCT03689530|566408687|FG000|Overall Study|Withdrawal by Subject|53|||
156904426|NCT03689530|566408688|FG001|Overall Study|Withdrawal by Subject|16|||
156904427|NCT01392443|566408689|FG000|Overall Study|Disease progression|30|||
156904428|NCT01392443|566408689|FG000|Overall Study|Adverse Event|24|||
156904429|NCT01392443|566408689|FG000|Overall Study|Death|7|||
156904430|NCT01392443|566408689|FG000|Overall Study|Withdrawal by Subject|5|||
156904431|NCT01392443|566408689|FG000|Overall Study|Lost to Follow-up|1|||
156904432|NCT01392443|566408689|FG000|Overall Study|Protocol Violation|1|||
156904433|NCT01977794|566408690|FG000|Overall Study|Adverse Event|2|||
156904434|NCT01977794|566408691|FG001|Overall Study|Adverse Event|2|||
156904435|NCT01977794|566408690|FG000|Overall Study|Lost to Follow-up|2|||
156904436|NCT01977794|566408691|FG001|Overall Study|Lost to Follow-up|1|||
156904437|NCT01977794|566408690|FG000|Overall Study|Protocol Violation|1|||
156904438|NCT01977794|566408691|FG001|Overall Study|Protocol Violation|0|||
156904439|NCT01977794|566408690|FG000|Overall Study|Death|1|||
156904440|NCT01977794|566408691|FG001|Overall Study|Death|1|||
156904441|NCT01977794|566408690|FG000|Overall Study|Withdrew consent|2|||
156904442|NCT01977794|566408691|FG001|Overall Study|Withdrew consent|1|||
156904443|NCT01977794|566408690|FG000|Overall Study|Other|0|||
156904444|NCT01977794|566408691|FG001|Overall Study|Other|1|||
156904445|NCT01626456|566408695|FG000|Overall Study|Withdrawal by Subject|21|||
157026697|NCT00085735|566853270|FG000|Overall Study|Lost to Follow-up|0|||
157159234|NCT02669862|567329437|FG000|Overall Study|Withdrawal by Subject|2|||
156904446|NCT01626456|566408696|FG001|Overall Study|Withdrawal by Subject|46|||
156904447|NCT01626456|566408695|FG000|Overall Study|Adverse Event|2|||
156904448|NCT01626456|566408696|FG001|Overall Study|Adverse Event|27|||
156904449|NCT01626456|566408695|FG000|Overall Study|Lost to Follow-up|2|||
156904450|NCT01626456|566408696|FG001|Overall Study|Lost to Follow-up|27|||
156904451|NCT01626456|566408695|FG000|Overall Study|Lack of Efficacy|6|||
156904452|NCT01626456|566408696|FG001|Overall Study|Lack of Efficacy|7|||
156904453|NCT01626456|566408695|FG000|Overall Study|Physician Decision|1|||
156904454|NCT01626456|566408696|FG001|Overall Study|Physician Decision|4|||
156904455|NCT01626456|566408695|FG000|Overall Study|Protocol Violation|1|||
156904456|NCT01626456|566408696|FG001|Overall Study|Protocol Violation|1|||
156904457|NCT01626456|566408695|FG000|Overall Study|Site Closure|2|||
156904458|NCT01626456|566408696|FG001|Overall Study|Site Closure|3|||
156904459|NCT01626456|566408695|FG000|Overall Study|Incarceration|0|||
156904460|NCT01626456|566408696|FG001|Overall Study|Incarceration|2|||
156904461|NCT00713323|566408697|FG000|Overall Study|Adverse Event|75|||
156904462|NCT00713323|566408697|FG000|Overall Study|Withdrawal by Subject|15|||
156904463|NCT00713323|566408697|FG000|Overall Study|Lost to Follow-up|11|||
156904464|NCT00713323|566408697|FG000|Overall Study|Lack of Efficacy|36|||
156904465|NCT00713323|566408697|FG000|Overall Study|Low creatine clearance at screening|1|||
156904466|NCT00713323|566408697|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
156904467|NCT00713323|566408697|FG000|Overall Study|Surgery cured allodynic pain|1|||
156904468|NCT00713323|566408697|FG000|Overall Study|Pain free|1|||
156904469|NCT00713323|566408697|FG000|Overall Study|Non-compliance|1|||
156904470|NCT00713323|566408697|FG000|Overall Study|Pain resolved|1|||
156904471|NCT00713323|566408697|FG000|Overall Study|Subject travelling to USA|1|||
156904472|NCT00713323|566408697|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
156904473|NCT00713323|566408697|FG000|Overall Study|Treatment that may interact with Sativex|1|||
156904474|NCT00506662|566408698|FG000|Overall Study|Adverse Event|0|||
156904475|NCT00506662|566408699|FG001|Overall Study|Adverse Event|2|||
156904476|NCT00506662|566408698|FG000|Overall Study|Lack of Efficacy|1|||
156904477|NCT00506662|566408699|FG001|Overall Study|Lack of Efficacy|0|||
156904478|NCT00506662|566408698|FG000|Overall Study|Protocol Violation|2|||
156904479|NCT00506662|566408699|FG001|Overall Study|Protocol Violation|4|||
156904480|NCT00506662|566408698|FG000|Overall Study|Trial terminated|10|||
156904481|NCT00506662|566408699|FG001|Overall Study|Trial terminated|16|||
156904482|NCT00506662|566408698|FG000|Overall Study|Not recorded|4|||
156904483|NCT00506662|566408699|FG001|Overall Study|Not recorded|6|||
156904484|NCT00491075|566408701|FG000|Overall Study|Withdrawal by Subject|1|||
156904485|NCT00491075|566408701|FG000|Overall Study|Physician Decision|1|||
156904486|NCT01603355|566408702|FG000|Overall Study|Lack of Efficacy|2|||
156904487|NCT00246753|566408704|FG000|Overall Study|Withdrawal by Subject|2|||
156904488|NCT00246753|566408704|FG000|Overall Study|Physician Decision|2|||
156904489|NCT00246753|566408704|FG000|Overall Study|Adverse Event|2|||
156904490|NCT00246753|566408704|FG000|Overall Study|Unacceptable toxicity|2|||
156904491|NCT03019185|566408708|FG000|Overall Study|Lost to Follow-up|3|||
156904492|NCT03019185|566408709|FG001|Overall Study|Lost to Follow-up|0|||
156904493|NCT03019185|566408710|FG002|Overall Study|Lost to Follow-up|2|||
156904494|NCT03019185|566408708|FG000|Overall Study|Withdrawal by Subject|1|||
156904495|NCT03019185|566408709|FG001|Overall Study|Withdrawal by Subject|1|||
156904496|NCT03019185|566408710|FG002|Overall Study|Withdrawal by Subject|0|||
156904497|NCT03019185|566408708|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
156904498|NCT03019185|566408709|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
156904499|NCT03019185|566408710|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
156904500|NCT03019185|566408708|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
156904501|NCT03019185|566408709|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
156904502|NCT03019185|566408710|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
156904503|NCT01868503|566408711|FG000|Overall Study|Withdrawal by Subject|1|||
156904504|NCT01868503|566408711|FG000|Overall Study|Protocol Violation|1|||
156904505|NCT00894166|566408714|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
156904506|NCT00894166|566408715|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
156904507|NCT00894166|566408716|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
156904508|NCT00894166|566408717|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
156904509|NCT00894166|566408718|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
156904510|NCT00894166|566408719|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
156904511|NCT00894166|566408720|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
156904512|NCT00894166|566408721|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
156904513|NCT00894166|566408714|FG000|Overall Study|Death|0|||
156904514|NCT00894166|566408715|FG001|Overall Study|Death|0|||
156904515|NCT00894166|566408716|FG002|Overall Study|Death|0|||
156904516|NCT00894166|566408717|FG003|Overall Study|Death|1|||
156904517|NCT00894166|566408718|FG004|Overall Study|Death|0|||
156904518|NCT00894166|566408719|FG005|Overall Study|Death|0|||
156904519|NCT00894166|566408720|FG006|Overall Study|Death|0|||
156904520|NCT00894166|566408721|FG007|Overall Study|Death|0|||
156904521|NCT01601132|566408723|FG000|Overall Study|Patient withdrew consent|1|||
156904522|NCT01601132|566408723|FG000|Overall Study|Protocol deviation|1|||
156904523|NCT04093414|566408727|FG000|3 Month Follow up|Physician Decision|0|||
156904524|NCT04093414|566408728|FG001|3 Month Follow up|Physician Decision|1|||
156904525|NCT04093414|566408727|FG000|6month Follow up|Physician Decision|1|||
156904526|NCT04093414|566408728|FG001|6month Follow up|Physician Decision|3|||
156904527|NCT04889222|566408729|FG000|Overall Study|Did not meet eligibility criteria|8|||
156904528|NCT04889222|566408729|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
156904529|NCT04889222|566408729|FG000|Overall Study|Did not proceed due to time constraints|5|||
156904530|NCT02639546|566408730|FG000|Overall Study|Death|2|||
156904531|NCT02639546|566408731|FG001|Overall Study|Death|2|||
156904532|NCT02639546|566408732|FG002|Overall Study|Death|1|||
156904533|NCT02639546|566408733|FG003|Overall Study|Death|2|||
156904534|NCT02639546|566408734|FG004|Overall Study|Death|2|||
156904535|NCT02639546|566408735|FG005|Overall Study|Death|2|||
156904536|NCT02639546|566408736|FG006|Overall Study|Death|0|||
156904537|NCT02639546|566408737|FG007|Overall Study|Death|0|||
156904538|NCT02639546|566408730|FG000|Overall Study|Lost to Follow-up|0|||
156904539|NCT02639546|566408731|FG001|Overall Study|Lost to Follow-up|0|||
156904540|NCT02639546|566408732|FG002|Overall Study|Lost to Follow-up|1|||
156904541|NCT02639546|566408733|FG003|Overall Study|Lost to Follow-up|0|||
156904542|NCT02639546|566408734|FG004|Overall Study|Lost to Follow-up|1|||
156904543|NCT02639546|566408735|FG005|Overall Study|Lost to Follow-up|1|||
156904544|NCT02639546|566408736|FG006|Overall Study|Lost to Follow-up|0|||
156904545|NCT02639546|566408737|FG007|Overall Study|Lost to Follow-up|1|||
156904546|NCT02639546|566408730|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
156904547|NCT02639546|566408731|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
156904548|NCT02639546|566408732|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
156904549|NCT02639546|566408733|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
156904550|NCT02639546|566408734|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
156904551|NCT02639546|566408735|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
156904552|NCT02639546|566408736|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
156904553|NCT02639546|566408737|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
156904554|NCT02639546|566408730|FG000|Overall Study|Study Terminated By Sponsor|0|||
156904555|NCT02639546|566408731|FG001|Overall Study|Study Terminated By Sponsor|2|||
156904556|NCT02639546|566408732|FG002|Overall Study|Study Terminated By Sponsor|3|||
156904557|NCT02639546|566408733|FG003|Overall Study|Study Terminated By Sponsor|4|||
156904558|NCT02639546|566408734|FG004|Overall Study|Study Terminated By Sponsor|4|||
156904559|NCT02639546|566408735|FG005|Overall Study|Study Terminated By Sponsor|3|||
156904560|NCT02639546|566408736|FG006|Overall Study|Study Terminated By Sponsor|3|||
156904561|NCT02639546|566408737|FG007|Overall Study|Study Terminated By Sponsor|9|||
156904562|NCT02639546|566408730|FG000|Overall Study|Withdrawal by Subject|2|||
156904563|NCT02639546|566408731|FG001|Overall Study|Withdrawal by Subject|2|||
156904564|NCT02639546|566408732|FG002|Overall Study|Withdrawal by Subject|1|||
156904565|NCT02639546|566408733|FG003|Overall Study|Withdrawal by Subject|0|||
156904566|NCT02639546|566408734|FG004|Overall Study|Withdrawal by Subject|0|||
156904567|NCT02639546|566408735|FG005|Overall Study|Withdrawal by Subject|1|||
156904568|NCT02639546|566408736|FG006|Overall Study|Withdrawal by Subject|2|||
156904569|NCT02639546|566408737|FG007|Overall Study|Withdrawal by Subject|1|||
156904570|NCT02761733|566408738|FG000|Overall Study|Death|3|||
156904571|NCT02761733|566408739|FG001|Overall Study|Death|5|||
156904572|NCT02761733|566408740|FG002|Overall Study|Death|1|||
156904573|NCT02761733|566408741|FG003|Overall Study|Death|1|||
156904574|NCT02761733|566408738|FG000|Overall Study|Lost to Follow-up|6|||
156904575|NCT02761733|566408739|FG001|Overall Study|Lost to Follow-up|7|||
156904576|NCT02761733|566408740|FG002|Overall Study|Lost to Follow-up|0|||
156904577|NCT02761733|566408741|FG003|Overall Study|Lost to Follow-up|3|||
156904578|NCT02761733|566408738|FG000|Overall Study|Physician Decision|4|||
156904579|NCT02761733|566408739|FG001|Overall Study|Physician Decision|0|||
156904580|NCT02761733|566408740|FG002|Overall Study|Physician Decision|0|||
156904581|NCT02761733|566408741|FG003|Overall Study|Physician Decision|0|||
156904582|NCT02761733|566408738|FG000|Overall Study|Withdrawal by Subject|2|||
156904583|NCT02761733|566408739|FG001|Overall Study|Withdrawal by Subject|0|||
156904584|NCT02761733|566408740|FG002|Overall Study|Withdrawal by Subject|0|||
156904585|NCT02761733|566408741|FG003|Overall Study|Withdrawal by Subject|0|||
156904586|NCT02761733|566408738|FG000|Overall Study|Discharged from Study Site|10|||
156904587|NCT02761733|566408739|FG001|Overall Study|Discharged from Study Site|9|||
156904588|NCT02761733|566408740|FG002|Overall Study|Discharged from Study Site|25|||
156904589|NCT02761733|566408741|FG003|Overall Study|Discharged from Study Site|11|||
156904590|NCT02761733|566408738|FG000|Overall Study|Cognitive Impairment|5|||
156904591|NCT02761733|566408739|FG001|Overall Study|Cognitive Impairment|0|||
156904592|NCT02761733|566408740|FG002|Overall Study|Cognitive Impairment|1|||
156904593|NCT02761733|566408741|FG003|Overall Study|Cognitive Impairment|0|||
156904594|NCT02713204|566408742|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
156904595|NCT02713204|566408743|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904596|NCT02713204|566408744|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
156904597|NCT02713204|566408745|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904598|NCT02713204|566408746|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904599|NCT02713204|566408747|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904600|NCT02713204|566408748|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904601|NCT02713204|566408749|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
156904602|NCT02713204|566408742|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904603|NCT02713204|566408743|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904604|NCT02713204|566408744|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
156904605|NCT02713204|566408745|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904606|NCT02713204|566408746|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904607|NCT02713204|566408747|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904608|NCT02713204|566408748|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904609|NCT02713204|566408749|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
156904610|NCT02713204|566408742|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904611|NCT02713204|566408743|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
156904612|NCT02713204|566408744|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904613|NCT02713204|566408745|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904614|NCT02713204|566408746|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904615|NCT02713204|566408747|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904616|NCT02713204|566408748|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904617|NCT02713204|566408749|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
156904618|NCT02713204|566408742|FG000|From Week 12 up to Week 36|Adverse Event|1|||
156904619|NCT02713204|566408743|FG001|From Week 12 up to Week 36|Adverse Event|0|||
156904620|NCT02713204|566408744|FG002|From Week 12 up to Week 36|Adverse Event|0|||
156904621|NCT02713204|566408745|FG003|From Week 12 up to Week 36|Adverse Event|1|||
156904622|NCT02713204|566408746|FG004|From Week 12 up to Week 36|Adverse Event|1|||
156904623|NCT02713204|566408747|FG005|From Week 12 up to Week 36|Adverse Event|0|||
156904624|NCT02713204|566408748|FG006|From Week 12 up to Week 36|Adverse Event|2|||
156904625|NCT02713204|566408749|FG007|From Week 12 up to Week 36|Adverse Event|1|||
156904626|NCT02713204|566408742|FG000|From Week 12 up to Week 36|Death|0|||
156904627|NCT02713204|566408743|FG001|From Week 12 up to Week 36|Death|0|||
156904628|NCT02713204|566408744|FG002|From Week 12 up to Week 36|Death|0|||
156904629|NCT02713204|566408745|FG003|From Week 12 up to Week 36|Death|1|||
156904630|NCT02713204|566408746|FG004|From Week 12 up to Week 36|Death|0|||
156904631|NCT02713204|566408747|FG005|From Week 12 up to Week 36|Death|1|||
156904632|NCT02713204|566408748|FG006|From Week 12 up to Week 36|Death|0|||
156904633|NCT02713204|566408749|FG007|From Week 12 up to Week 36|Death|3|||
156904634|NCT02713204|566408742|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904635|NCT02713204|566408743|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904636|NCT02713204|566408744|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904637|NCT02713204|566408745|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
156904638|NCT02713204|566408746|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904639|NCT02713204|566408747|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904640|NCT02713204|566408748|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904641|NCT02713204|566408749|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
156904642|NCT02713204|566408742|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
156904643|NCT02713204|566408743|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
156904644|NCT02713204|566408744|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
156904645|NCT02713204|566408745|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
156904646|NCT02713204|566408746|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
156904647|NCT02713204|566408747|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
156904648|NCT02713204|566408748|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
156904649|NCT02713204|566408749|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
156904650|NCT03212690|566408754|FG000|Overall Study|Protocol Violation|1|||
156904651|NCT01297920|566408755|FG000|Overall Study|Adverse Event|42|||
156904652|NCT01297920|566408756|FG001|Overall Study|Adverse Event|10|||
156904653|NCT01297920|566408757|FG002|Overall Study|Adverse Event|38|||
156904654|NCT01297920|566408755|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
156904655|NCT01297920|566408756|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
156904656|NCT01297920|566408757|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
156904657|NCT01297920|566408755|FG000|Overall Study|Noncompliance|1|||
156904658|NCT01297920|566408756|FG001|Overall Study|Noncompliance|0|||
156904659|NCT01297920|566408757|FG002|Overall Study|Noncompliance|0|||
156904660|NCT01297920|566408755|FG000|Overall Study|Protocol Violation|1|||
156904661|NCT01297920|566408756|FG001|Overall Study|Protocol Violation|3|||
156904662|NCT01297920|566408757|FG002|Overall Study|Protocol Violation|0|||
156904663|NCT01297920|566408755|FG000|Overall Study|Inadequate Control of IOP|7|||
156904664|NCT01297920|566408756|FG001|Overall Study|Inadequate Control of IOP|9|||
156904665|NCT01297920|566408757|FG002|Overall Study|Inadequate Control of IOP|17|||
156904666|NCT01297920|566408755|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
156904667|NCT01297920|566408756|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
156904668|NCT01297920|566408757|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
156904669|NCT00474760|566408758|FG000|Overall Study|Death|0|||
156904670|NCT00474760|566408759|FG001|Overall Study|Death|0|||
156904671|NCT00474760|566408760|FG002|Overall Study|Death|0|||
156904672|NCT00474760|566408761|FG003|Overall Study|Death|0|||
156904673|NCT00474760|566408762|FG004|Overall Study|Death|2|||
156904674|NCT00474760|566408763|FG005|Overall Study|Death|0|||
156904675|NCT00474760|566408764|FG006|Overall Study|Death|0|||
156904676|NCT00474760|566408758|FG000|Overall Study|Adverse Event|0|||
156904677|NCT00474760|566408759|FG001|Overall Study|Adverse Event|0|||
156904678|NCT00474760|566408760|FG002|Overall Study|Adverse Event|0|||
156904679|NCT00474760|566408761|FG003|Overall Study|Adverse Event|0|||
156904680|NCT00474760|566408762|FG004|Overall Study|Adverse Event|1|||
156904681|NCT00474760|566408763|FG005|Overall Study|Adverse Event|7|||
156904682|NCT00474760|566408764|FG006|Overall Study|Adverse Event|0|||
156904683|NCT00474760|566408758|FG000|Overall Study|Laboratory abnormality|0|||
156904684|NCT00474760|566408759|FG001|Overall Study|Laboratory abnormality|0|||
156904685|NCT00474760|566408760|FG002|Overall Study|Laboratory abnormality|0|||
156904686|NCT00474760|566408761|FG003|Overall Study|Laboratory abnormality|0|||
156904687|NCT00474760|566408762|FG004|Overall Study|Laboratory abnormality|0|||
156904688|NCT00474760|566408763|FG005|Overall Study|Laboratory abnormality|1|||
156904689|NCT00474760|566408764|FG006|Overall Study|Laboratory abnormality|0|||
156904690|NCT00474760|566408758|FG000|Overall Study|Withdrawal by Subject|0|||
156904691|NCT00474760|566408759|FG001|Overall Study|Withdrawal by Subject|0|||
156904692|NCT00474760|566408760|FG002|Overall Study|Withdrawal by Subject|0|||
156904693|NCT00474760|566408761|FG003|Overall Study|Withdrawal by Subject|1|||
156904694|NCT00474760|566408762|FG004|Overall Study|Withdrawal by Subject|0|||
156904695|NCT00474760|566408763|FG005|Overall Study|Withdrawal by Subject|1|||
156904696|NCT00474760|566408764|FG006|Overall Study|Withdrawal by Subject|1|||
156904697|NCT00474760|566408758|FG000|Overall Study|Other|0|||
156904698|NCT00474760|566408759|FG001|Overall Study|Other|1|||
156904699|NCT00474760|566408760|FG002|Overall Study|Other|0|||
156904700|NCT00474760|566408761|FG003|Overall Study|Other|0|||
156904701|NCT00474760|566408762|FG004|Overall Study|Other|1|||
156904702|NCT00474760|566408763|FG005|Overall Study|Other|0|||
156904703|NCT00474760|566408764|FG006|Overall Study|Other|0|||
156904704|NCT00474760|566408758|FG000|Overall Study|Progressive disease|3|||
156904705|NCT00474760|566408759|FG001|Overall Study|Progressive disease|2|||
156904706|NCT00474760|566408760|FG002|Overall Study|Progressive disease|3|||
156904707|NCT00474760|566408761|FG003|Overall Study|Progressive disease|2|||
156904708|NCT00474760|566408762|FG004|Overall Study|Progressive disease|8|||
156904709|NCT00474760|566408763|FG005|Overall Study|Progressive disease|20|||
156904710|NCT00474760|566408764|FG006|Overall Study|Progressive disease|7|||
156904711|NCT00474760|566408758|FG000|Overall Study|Terminated by sponsor|0|||
156904712|NCT00474760|566408759|FG001|Overall Study|Terminated by sponsor|0|||
156904713|NCT00474760|566408760|FG002|Overall Study|Terminated by sponsor|0|||
156904714|NCT00474760|566408761|FG003|Overall Study|Terminated by sponsor|0|||
156904715|NCT00474760|566408762|FG004|Overall Study|Terminated by sponsor|0|||
156904716|NCT00474760|566408763|FG005|Overall Study|Terminated by sponsor|0|||
156904717|NCT00474760|566408764|FG006|Overall Study|Terminated by sponsor|2|||
156904718|NCT01927627|566408765|FG000|Overall Study|Adverse Event|3|||
156904719|NCT01927627|566408765|FG000|Overall Study|Lack of Efficacy|1|||
156904720|NCT01927627|566408765|FG000|Overall Study|Financial Concerns|1|||
156904721|NCT00788073|566408766|FG000|STX209 Then Placebo|Adverse Event|1|||
156904722|NCT00788073|566408767|FG001|STX209 Then Placebo|Adverse Event|0|||
156904723|NCT00788073|566408766|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
156904724|NCT00788073|566408767|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
156904725|NCT00788073|566408766|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
156904726|NCT00788073|566408767|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
156904727|NCT00788073|566408766|FG000|STX209 Then Placebo|unable to return due to travel|0|||
156904728|NCT00788073|566408767|FG001|STX209 Then Placebo|unable to return due to travel|1|||
156904729|NCT00788073|566408766|FG000|Placebo Then STX209|Adverse Event|2|||
156904730|NCT00788073|566408767|FG001|Placebo Then STX209|Adverse Event|0|||
156904731|NCT00788073|566408766|FG000|Placebo Then STX209|Protocol Violation|0|||
156904732|NCT00788073|566408767|FG001|Placebo Then STX209|Protocol Violation|1|||
156904733|NCT03608254|566408768|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
156904734|NCT03608254|566408768|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
156904735|NCT01346969|566408770|FG000|Overall Study|Withdrawal by Subject|0|||
156904736|NCT01346969|566408771|FG001|Overall Study|Withdrawal by Subject|0|||
156904737|NCT01346969|566408772|FG002|Overall Study|Withdrawal by Subject|1|||
156904738|NCT01346969|566408773|FG003|Overall Study|Withdrawal by Subject|0|||
156904739|NCT01346969|566408770|FG000|Overall Study|Lost to Follow-up|1|||
156904740|NCT01346969|566408771|FG001|Overall Study|Lost to Follow-up|0|||
156904741|NCT01346969|566408772|FG002|Overall Study|Lost to Follow-up|2|||
156904742|NCT01346969|566408773|FG003|Overall Study|Lost to Follow-up|0|||
156904743|NCT01346969|566408770|FG000|Overall Study|Physician Decision|0|||
156904744|NCT01346969|566408771|FG001|Overall Study|Physician Decision|0|||
156904745|NCT01346969|566408772|FG002|Overall Study|Physician Decision|0|||
156904746|NCT01346969|566408773|FG003|Overall Study|Physician Decision|1|||
156904747|NCT01346969|566408770|FG000|Overall Study|Randomized but not treated|1|||
156904748|NCT01346969|566408771|FG001|Overall Study|Randomized but not treated|0|||
156904749|NCT01346969|566408772|FG002|Overall Study|Randomized but not treated|0|||
156904750|NCT01346969|566408773|FG003|Overall Study|Randomized but not treated|0|||
156904751|NCT05213481|566408775|FG000|Overall Study|Adverse Event|3|||
156904752|NCT05213481|566408775|FG000|Overall Study|Lost to Follow-up|1|||
156904753|NCT04122534|566408776|FG000|Overall Study|Lost to Follow-up|4|||
156904754|NCT02128932|566408784|FG000|Overall Study|Withdrawal by Subject|11|||
157225578|NCT01254409|567571471|FG003|Overall Study|Adverse Event|0|||
157225579|NCT00337571|567571474|FG000|Overall Study|Lack of Efficacy|3|||
156904755|NCT02128932|566408785|FG001|Overall Study|Withdrawal by Subject|7|||
156904756|NCT02128932|566408786|FG002|Overall Study|Withdrawal by Subject|8|||
156904757|NCT02128932|566408784|FG000|Overall Study|Death|2|||
156904758|NCT02128932|566408785|FG001|Overall Study|Death|0|||
156904759|NCT02128932|566408786|FG002|Overall Study|Death|2|||
156904760|NCT02128932|566408784|FG000|Overall Study|Lost to Follow-up|2|||
156904761|NCT02128932|566408785|FG001|Overall Study|Lost to Follow-up|1|||
156904762|NCT02128932|566408786|FG002|Overall Study|Lost to Follow-up|1|||
156904763|NCT02128932|566408784|FG000|Overall Study|No reason for withdrawal|12|||
156904764|NCT02128932|566408785|FG001|Overall Study|No reason for withdrawal|11|||
156904765|NCT02128932|566408786|FG002|Overall Study|No reason for withdrawal|7|||
156904766|NCT02925117|566408795|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
156904767|NCT02925117|566408796|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
156904768|NCT02925117|566408797|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
156904769|NCT02925117|566408798|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
156904770|NCT02925117|566408799|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904771|NCT02925117|566408800|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904772|NCT02925117|566408801|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904773|NCT02925117|566408802|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904774|NCT02925117|566408803|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904775|NCT02925117|566408804|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904776|NCT02925117|566408805|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904777|NCT02925117|566408806|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
156904778|NCT02925117|566408795|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
156904779|NCT02925117|566408796|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
156904780|NCT02925117|566408797|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
156904781|NCT02925117|566408798|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904782|NCT02925117|566408799|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904783|NCT02925117|566408800|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904784|NCT02925117|566408801|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904785|NCT02925117|566408802|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904786|NCT02925117|566408803|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904787|NCT02925117|566408804|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904788|NCT02925117|566408805|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904789|NCT02925117|566408806|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
156904790|NCT02925117|566408795|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
156904791|NCT02925117|566408796|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
156904792|NCT02925117|566408797|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904793|NCT02925117|566408798|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904794|NCT02925117|566408799|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904795|NCT02925117|566408800|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904796|NCT02925117|566408801|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904797|NCT02925117|566408802|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904798|NCT02925117|566408803|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904799|NCT02925117|566408804|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904800|NCT02925117|566408805|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904801|NCT02925117|566408806|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
156904802|NCT02925117|566408795|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
156904803|NCT02925117|566408796|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
156904804|NCT02925117|566408797|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
156904805|NCT02925117|566408798|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
156904806|NCT02925117|566408799|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
156904807|NCT02925117|566408800|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
156904808|NCT02925117|566408801|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
156904809|NCT02925117|566408802|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
156904810|NCT02925117|566408803|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
156904811|NCT02925117|566408804|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
156904812|NCT02925117|566408805|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
156904813|NCT02925117|566408806|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
156904814|NCT02925117|566408795|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904815|NCT02925117|566408796|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904816|NCT02925117|566408797|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904817|NCT02925117|566408798|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904818|NCT02925117|566408799|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904819|NCT02925117|566408800|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
156904820|NCT02925117|566408801|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904821|NCT02925117|566408802|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904822|NCT02925117|566408803|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904823|NCT02925117|566408804|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
156904824|NCT02925117|566408805|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
156904825|NCT02925117|566408806|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
156904826|NCT02925117|566408795|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156904827|NCT02925117|566408796|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156904828|NCT02925117|566408797|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156904829|NCT02925117|566408798|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156904830|NCT02925117|566408799|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
156904831|NCT02925117|566408800|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
156904832|NCT02925117|566408801|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
156904833|NCT02925117|566408802|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
156904834|NCT02925117|566408803|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156904835|NCT02925117|566408804|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156904836|NCT02925117|566408805|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156904837|NCT02925117|566408806|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
156904838|NCT02925117|566408795|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904839|NCT02925117|566408796|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904840|NCT02925117|566408797|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904841|NCT02925117|566408798|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904842|NCT02925117|566408799|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156904843|NCT02925117|566408800|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
156904844|NCT02925117|566408801|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156904845|NCT02925117|566408802|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156904846|NCT02925117|566408803|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156904847|NCT02925117|566408804|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904848|NCT02925117|566408805|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
156904849|NCT02925117|566408806|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
156904850|NCT02925117|566408795|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
156904851|NCT02925117|566408796|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
156904852|NCT02925117|566408797|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
156904853|NCT02925117|566408798|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
156904854|NCT02925117|566408799|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
156904855|NCT02925117|566408800|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
156904856|NCT02925117|566408801|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
156904857|NCT02925117|566408802|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
156904858|NCT02925117|566408803|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
156904859|NCT02925117|566408804|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
156904860|NCT02925117|566408805|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
156904861|NCT02925117|566408806|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
156904862|NCT02663908|566408807|FG000|Overall Study|Withdrawal by Subject|8|||
156904863|NCT02663908|566408808|FG001|Overall Study|Withdrawal by Subject|5|||
156904864|NCT02663908|566408807|FG000|Overall Study|Lost to Follow-up|1|||
156904865|NCT02663908|566408808|FG001|Overall Study|Lost to Follow-up|5|||
156904866|NCT02663908|566408807|FG000|Overall Study|Adverse Event|13|||
156904867|NCT02663908|566408808|FG001|Overall Study|Adverse Event|11|||
156904868|NCT02663908|566408807|FG000|Overall Study|Protocol Violation|1|||
156904869|NCT02663908|566408808|FG001|Overall Study|Protocol Violation|2|||
156904870|NCT02663908|566408807|FG000|Overall Study|Lack of therapeutic response|2|||
156904871|NCT02663908|566408808|FG001|Overall Study|Lack of therapeutic response|0|||
156904872|NCT02663908|566408807|FG000|Overall Study|COVID-19|1|||
156904873|NCT02663908|566408808|FG001|Overall Study|COVID-19|0|||
156904874|NCT02663908|566408807|FG000|Overall Study|Site closed|1|||
156904875|NCT02663908|566408808|FG001|Overall Study|Site closed|0|||
156904876|NCT02663908|566408807|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
156904877|NCT02663908|566408808|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
156904878|NCT02663908|566408807|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
156904879|NCT02663908|566408808|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
156904880|NCT02663908|566408807|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
156904881|NCT02663908|566408808|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
156904882|NCT02663908|566408807|FG000|Overall Study|Death|1|||
156904883|NCT02663908|566408808|FG001|Overall Study|Death|0|||
156904884|NCT02663908|566408807|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
156904885|NCT02663908|566408808|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
156904886|NCT02663908|566408807|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
156904887|NCT02663908|566408808|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
157159235|NCT02669862|567329438|FG001|Overall Study|Withdrawal by Subject|2|||
157159236|NCT02669862|567329439|FG002|Overall Study|Withdrawal by Subject|3|||
157159237|NCT02669862|567329437|FG000|Overall Study|moved|0|||
157159238|NCT02669862|567329438|FG001|Overall Study|moved|1|||
157159239|NCT02669862|567329439|FG002|Overall Study|moved|0|||
157159240|NCT02669862|567329437|FG000|Overall Study|Protocol Violation|0|||
157159241|NCT02669862|567329438|FG001|Overall Study|Protocol Violation|0|||
157159242|NCT02669862|567329439|FG002|Overall Study|Protocol Violation|1|||
157159243|NCT00311181|567329440|FG000|Overall Study|Final DFTs were not obtained|96|||
156904888|NCT00370071|566408809|FG000|Overall Study|Withdrawal by Subject|2|||
156904889|NCT02004522|566408810|FG000|Overall Study|Adverse Event|55|||
156904890|NCT02004522|566408811|FG001|Overall Study|Adverse Event|6|||
156904891|NCT02004522|566408810|FG000|Overall Study|Withdrawal by Subject|13|||
156904892|NCT02004522|566408811|FG001|Overall Study|Withdrawal by Subject|7|||
156904893|NCT02004522|566408810|FG000|Overall Study|Death|12|||
156904894|NCT02004522|566408811|FG001|Overall Study|Death|3|||
156904895|NCT02004522|566408810|FG000|Overall Study|Physician Decision|3|||
156904896|NCT02004522|566408811|FG001|Overall Study|Physician Decision|4|||
156904897|NCT02004522|566408810|FG000|Overall Study|Protocol Violation|1|||
156904898|NCT02004522|566408811|FG001|Overall Study|Protocol Violation|0|||
156904899|NCT02004522|566408810|FG000|Overall Study|Other is reason listed by PI|4|||
156904900|NCT02004522|566408811|FG001|Overall Study|Other is reason listed by PI|1|||
156904901|NCT02004522|566408810|FG000|Overall Study|Never Dosed|2|||
156904902|NCT02004522|566408811|FG001|Overall Study|Never Dosed|4|||
156904903|NCT02004522|566408810|FG000|Overall Study|Disease Progression|35|||
156904904|NCT02004522|566408811|FG001|Overall Study|Disease Progression|31|||
156904905|NCT02004522|566408810|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
156904906|NCT02004522|566408811|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
156904907|NCT00450255|566408812|FG000|Overall Study|Prior RFA ablation of liver|1|||
156904908|NCT01790932|566408813|FG000|Overall Study|Disease Progression|41|||
156904909|NCT01790932|566408813|FG000|Overall Study|Adverse Event|7|||
156904910|NCT01790932|566408813|FG000|Overall Study|Physician Decision|1|||
156904911|NCT01790932|566408813|FG000|Overall Study|Withdrawal by Subject|1|||
156904912|NCT01193842|566408816|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156904913|NCT01193842|566408817|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
156904914|NCT01193842|566408818|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156904915|NCT01193842|566408819|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156904916|NCT01193842|566408820|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
156904917|NCT01193842|566408816|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
156904918|NCT01193842|566408817|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156904919|NCT01193842|566408818|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156904920|NCT01193842|566408819|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156904921|NCT01193842|566408820|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
156904922|NCT01193842|566408816|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156904923|NCT01193842|566408817|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156904924|NCT01193842|566408818|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
156904925|NCT01193842|566408819|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156904926|NCT01193842|566408820|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
156904927|NCT01193842|566408816|FG000|Phase II: Randomized Groups|Death|0|||
156904928|NCT01193842|566408817|FG001|Phase II: Randomized Groups|Death|0|||
156904929|NCT01193842|566408818|FG002|Phase II: Randomized Groups|Death|0|||
156904930|NCT01193842|566408819|FG003|Phase II: Randomized Groups|Death|1|||
156904931|NCT01193842|566408820|FG004|Phase II: Randomized Groups|Death|1|||
156904932|NCT01193842|566408816|FG000|Phase II: Randomized Groups|Adverse Event|0|||
156904933|NCT01193842|566408817|FG001|Phase II: Randomized Groups|Adverse Event|0|||
156904934|NCT01193842|566408818|FG002|Phase II: Randomized Groups|Adverse Event|0|||
156904935|NCT01193842|566408819|FG003|Phase II: Randomized Groups|Adverse Event|5|||
156904936|NCT01193842|566408820|FG004|Phase II: Randomized Groups|Adverse Event|3|||
156904937|NCT01193842|566408816|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156904938|NCT01193842|566408817|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156904939|NCT01193842|566408818|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
156904940|NCT01193842|566408819|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
156904941|NCT01193842|566408820|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
156904942|NCT01193842|566408816|FG000|Phase II: Randomized Groups|Ineligible|0|||
156904943|NCT01193842|566408817|FG001|Phase II: Randomized Groups|Ineligible|0|||
156904944|NCT01193842|566408818|FG002|Phase II: Randomized Groups|Ineligible|0|||
156904945|NCT01193842|566408819|FG003|Phase II: Randomized Groups|Ineligible|0|||
156904946|NCT01193842|566408820|FG004|Phase II: Randomized Groups|Ineligible|1|||
156904947|NCT01193842|566408816|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156904948|NCT01193842|566408817|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156904949|NCT01193842|566408818|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
156904950|NCT01193842|566408819|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
156904951|NCT01193842|566408820|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
156904952|NCT01798004|566410256|FG000|Overall Study|Death|2|||
156904953|NCT01798004|566410256|FG000|Overall Study|Lack of Efficacy|8|||
156904954|NCT01798004|566410256|FG000|Overall Study|Physician Decision|25|||
156904955|NCT01798004|566410256|FG000|Overall Study|Withdrawal by Subject|4|||
156904956|NCT01798004|566410256|FG000|Overall Study|Ineligible|4|||
156904957|NCT01798004|566410256|FG000|Overall Study|Patient/parent refusal|7|||
156904958|NCT01798004|566410256|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
156904959|NCT01798004|566410256|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
156904960|NCT03320057|566410257|FG000|Overall Study|Lost to Follow-up|4|||
156904961|NCT03320057|566410258|FG001|Overall Study|Lost to Follow-up|17|||
156904962|NCT03320057|566410257|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
156904963|NCT03320057|566410258|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
156904964|NCT04805541|566410261|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
156904965|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
156904966|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
156904967|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
156904968|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
156904969|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
156904970|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
156904971|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
156904972|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
156904973|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
156904974|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904975|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904976|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904977|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904978|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904979|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904980|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
156904981|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
156904982|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904983|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904984|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904985|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904986|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904987|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904988|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
156904989|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
157026698|NCT00085735|566853271|FG001|Overall Study|Lost to Follow-up|1|||
157026699|NCT00085735|566853272|FG002|Overall Study|Lost to Follow-up|0|||
157026700|NCT00085735|566853273|FG003|Overall Study|Lost to Follow-up|0|||
157026701|NCT00085735|566853274|FG004|Overall Study|Lost to Follow-up|1|||
157026702|NCT00085735|566853275|FG005|Overall Study|Lost to Follow-up|0|||
157026703|NCT00085735|566853270|FG000|Overall Study|Physician Decision|2|||
157026704|NCT00085735|566853271|FG001|Overall Study|Physician Decision|3|||
157026705|NCT00085735|566853272|FG002|Overall Study|Physician Decision|2|||
157026706|NCT00085735|566853273|FG003|Overall Study|Physician Decision|3|||
157026707|NCT00085735|566853274|FG004|Overall Study|Physician Decision|11|||
157026708|NCT00085735|566853275|FG005|Overall Study|Physician Decision|8|||
157026709|NCT00085735|566853270|FG000|Overall Study|Protocol Violation|1|||
157026710|NCT00085735|566853271|FG001|Overall Study|Protocol Violation|0|||
157026711|NCT00085735|566853272|FG002|Overall Study|Protocol Violation|0|||
157026712|NCT00085735|566853273|FG003|Overall Study|Protocol Violation|0|||
157026713|NCT00085735|566853274|FG004|Overall Study|Protocol Violation|0|||
157026714|NCT00085735|566853275|FG005|Overall Study|Protocol Violation|0|||
157026715|NCT00085735|566853270|FG000|Overall Study|Withdrawal by Subject|1|||
156904990|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904991|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904992|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904993|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904994|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904995|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904996|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
156904997|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
156904998|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156904999|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156905000|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156905001|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156905002|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156905003|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
156905004|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
157026716|NCT00085735|566853271|FG001|Overall Study|Withdrawal by Subject|0|||
157026717|NCT00085735|566853272|FG002|Overall Study|Withdrawal by Subject|4|||
157026718|NCT00085735|566853273|FG003|Overall Study|Withdrawal by Subject|5|||
157026719|NCT00085735|566853274|FG004|Overall Study|Withdrawal by Subject|7|||
157026720|NCT00085735|566853275|FG005|Overall Study|Withdrawal by Subject|8|||
156905005|NCT00533897|566410267|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
156905006|NCT00533897|566410268|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905007|NCT00533897|566410269|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905008|NCT00533897|566410270|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905009|NCT00533897|566410271|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905010|NCT00533897|566410272|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905011|NCT00533897|566410273|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905012|NCT00533897|566410274|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
156905013|NCT00533897|566410267|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905014|NCT00533897|566410268|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
156905015|NCT00533897|566410269|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
156905016|NCT00533897|566410270|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905017|NCT00533897|566410271|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905018|NCT00533897|566410272|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905019|NCT00533897|566410273|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905020|NCT00533897|566410274|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
156905021|NCT00533897|566410267|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905022|NCT00533897|566410268|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905023|NCT00533897|566410269|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
156905024|NCT00533897|566410270|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905025|NCT00533897|566410271|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905026|NCT00533897|566410272|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905027|NCT00533897|566410273|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905028|NCT00533897|566410274|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
156905029|NCT00533897|566410267|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905030|NCT00533897|566410268|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905031|NCT00533897|566410269|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905032|NCT00533897|566410270|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905033|NCT00533897|566410271|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905034|NCT00533897|566410272|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
156905035|NCT00533897|566410273|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905036|NCT00533897|566410274|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
156905037|NCT00533897|566410267|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905038|NCT00533897|566410268|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905039|NCT00533897|566410269|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905040|NCT00533897|566410270|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905041|NCT00533897|566410271|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905042|NCT00533897|566410272|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
156905043|NCT00533897|566410273|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905044|NCT00533897|566410274|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
156905045|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905046|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905047|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905048|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905049|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905050|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
156905051|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
156905052|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
156905053|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Death|0|||
156905054|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Death|0|||
157026721|NCT00085735|566853270|FG000|Overall Study|Patient ineligible|1|||
157026722|NCT00085735|566853271|FG001|Overall Study|Patient ineligible|0|||
157026723|NCT00085735|566853272|FG002|Overall Study|Patient ineligible|3|||
157026724|NCT00085735|566853273|FG003|Overall Study|Patient ineligible|7|||
157026725|NCT00085735|566853274|FG004|Overall Study|Patient ineligible|17|||
157026726|NCT00085735|566853275|FG005|Overall Study|Patient ineligible|8|||
157026727|NCT00085735|566853270|FG000|Overall Study|Excess residual disease|2|||
157026728|NCT00085735|566853271|FG001|Overall Study|Excess residual disease|2|||
157026729|NCT00085735|566853272|FG002|Overall Study|Excess residual disease|1|||
157026730|NCT00085735|566853273|FG003|Overall Study|Excess residual disease|1|||
157026731|NCT00085735|566853274|FG004|Overall Study|Excess residual disease|1|||
157026732|NCT00085735|566853275|FG005|Overall Study|Excess residual disease|4|||
157026733|NCT00085735|566853270|FG000|Overall Study|Reason not documented|1|||
157026734|NCT00085735|566853271|FG001|Overall Study|Reason not documented|0|||
157026735|NCT00085735|566853272|FG002|Overall Study|Reason not documented|1|||
157026736|NCT00085735|566853273|FG003|Overall Study|Reason not documented|0|||
156905055|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Death|0|||
157026737|NCT00085735|566853274|FG004|Overall Study|Reason not documented|1|||
157026738|NCT00085735|566853275|FG005|Overall Study|Reason not documented|0|||
157026739|NCT00085735|566853270|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
157026740|NCT00085735|566853271|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
157225580|NCT00337571|567571475|FG001|Overall Study|Lack of Efficacy|0|||
156905056|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Death|0|||
156905057|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Death|0|||
156905058|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Death|0|||
156905059|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Death|1|||
156905060|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Death|3|||
156905061|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905062|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905063|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905064|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905065|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905066|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
156905067|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
156905068|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
156905069|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905070|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905071|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905072|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905073|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905074|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905075|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
156905076|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
156905077|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Adverse Event|0|||
156905078|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Adverse Event|0|||
156905079|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Adverse Event|0|||
156905080|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Adverse Event|0|||
156905081|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Adverse Event|0|||
156905082|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Adverse Event|0|||
156905083|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Adverse Event|2|||
156905084|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Adverse Event|5|||
156905085|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Pregnancy|0|||
156905086|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Pregnancy|0|||
156905087|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Pregnancy|0|||
156905088|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Pregnancy|0|||
156905089|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Pregnancy|0|||
156905090|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Pregnancy|0|||
156905091|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Pregnancy|0|||
156905092|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Pregnancy|2|||
156905093|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905094|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905095|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905096|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905097|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905098|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
156905099|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
156905100|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
156905101|NCT00533897|566410267|FG000|Long Term Extension (LTE)|Other|0|||
156905102|NCT00533897|566410268|FG001|Long Term Extension (LTE)|Other|0|||
156905103|NCT00533897|566410269|FG002|Long Term Extension (LTE)|Other|0|||
156905104|NCT00533897|566410270|FG003|Long Term Extension (LTE)|Other|0|||
156905105|NCT00533897|566410271|FG004|Long Term Extension (LTE)|Other|0|||
156905106|NCT00533897|566410272|FG005|Long Term Extension (LTE)|Other|0|||
156905107|NCT00533897|566410273|FG006|Long Term Extension (LTE)|Other|1|||
156905108|NCT00533897|566410274|FG007|Long Term Extension (LTE)|Other|6|||
156905109|NCT01546207|566410286|FG000|Overall Study|Death|1|||
156905110|NCT05154578|566410288|FG000|Overall Study|Withdrawal by Subject|2|||
156905111|NCT05154578|566410289|FG001|Overall Study|Withdrawal by Subject|3|||
156905112|NCT05154578|566410290|FG002|Overall Study|Withdrawal by Subject|2|||
156905113|NCT05154578|566410291|FG003|Overall Study|Withdrawal by Subject|4|||
156905114|NCT05154578|566410292|FG004|Overall Study|Withdrawal by Subject|0|||
156905115|NCT05154578|566410288|FG000|Overall Study|Lost to Follow-up|0|||
156905116|NCT05154578|566410289|FG001|Overall Study|Lost to Follow-up|1|||
156905117|NCT05154578|566410290|FG002|Overall Study|Lost to Follow-up|0|||
156905118|NCT05154578|566410291|FG003|Overall Study|Lost to Follow-up|3|||
156905119|NCT05154578|566410292|FG004|Overall Study|Lost to Follow-up|0|||
156905120|NCT05154578|566410288|FG000|Overall Study|Adverse Event|0|||
156905121|NCT05154578|566410289|FG001|Overall Study|Adverse Event|0|||
156905122|NCT05154578|566410290|FG002|Overall Study|Adverse Event|0|||
156905123|NCT05154578|566410291|FG003|Overall Study|Adverse Event|1|||
156905124|NCT05154578|566410292|FG004|Overall Study|Adverse Event|0|||
156905125|NCT05154578|566410288|FG000|Overall Study|Relocated to another province|0|||
156905126|NCT05154578|566410289|FG001|Overall Study|Relocated to another province|0|||
156905127|NCT05154578|566410290|FG002|Overall Study|Relocated to another province|1|||
156905128|NCT05154578|566410291|FG003|Overall Study|Relocated to another province|0|||
156905129|NCT05154578|566410292|FG004|Overall Study|Relocated to another province|1|||
156905130|NCT05154578|566410288|FG000|Overall Study|Baby loss|0|||
156905131|NCT05154578|566410289|FG001|Overall Study|Baby loss|1|||
156905132|NCT05154578|566410290|FG002|Overall Study|Baby loss|0|||
156905133|NCT05154578|566410291|FG003|Overall Study|Baby loss|0|||
156905134|NCT05154578|566410292|FG004|Overall Study|Baby loss|0|||
156905135|NCT02764333|566410298|FG000|Overall Study|Ineligible|1|||
156905136|NCT00491764|566410299|FG000|Overall Study|Adverse Event|1|||
156905137|NCT00491764|566410300|FG001|Overall Study|Adverse Event|2|||
156905138|NCT00491764|566410301|FG002|Overall Study|Adverse Event|4|||
156905139|NCT00491764|566410302|FG003|Overall Study|Adverse Event|4|||
156905140|NCT00491764|566410303|FG004|Overall Study|Adverse Event|0|||
156905141|NCT00491764|566410304|FG005|Overall Study|Adverse Event|1|||
156905142|NCT00491764|566410299|FG000|Overall Study|Lost to Follow-up|0|||
156905143|NCT00491764|566410300|FG001|Overall Study|Lost to Follow-up|1|||
156905144|NCT00491764|566410301|FG002|Overall Study|Lost to Follow-up|0|||
156905145|NCT00491764|566410302|FG003|Overall Study|Lost to Follow-up|1|||
156905146|NCT00491764|566410303|FG004|Overall Study|Lost to Follow-up|0|||
156905147|NCT00491764|566410304|FG005|Overall Study|Lost to Follow-up|3|||
156905148|NCT00491764|566410299|FG000|Overall Study|Withdrawal by Subject|2|||
156905149|NCT00491764|566410300|FG001|Overall Study|Withdrawal by Subject|3|||
156905150|NCT00491764|566410301|FG002|Overall Study|Withdrawal by Subject|1|||
156905151|NCT00491764|566410302|FG003|Overall Study|Withdrawal by Subject|2|||
156905152|NCT00491764|566410303|FG004|Overall Study|Withdrawal by Subject|2|||
156905153|NCT00491764|566410304|FG005|Overall Study|Withdrawal by Subject|4|||
156905154|NCT00491764|566410299|FG000|Overall Study|Non Compliance with the Protocol|1|||
156905155|NCT00491764|566410300|FG001|Overall Study|Non Compliance with the Protocol|0|||
156905156|NCT00491764|566410301|FG002|Overall Study|Non Compliance with the Protocol|0|||
156905157|NCT00491764|566410302|FG003|Overall Study|Non Compliance with the Protocol|0|||
156905158|NCT00491764|566410303|FG004|Overall Study|Non Compliance with the Protocol|0|||
156905159|NCT00491764|566410304|FG005|Overall Study|Non Compliance with the Protocol|0|||
156905160|NCT00491764|566410299|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
156905161|NCT00491764|566410300|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
156905162|NCT00491764|566410301|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
156905163|NCT00491764|566410302|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
156905164|NCT00491764|566410303|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
156905165|NCT00491764|566410304|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
156905166|NCT00491764|566410299|FG000|Overall Study|Administrative|1|||
156905167|NCT00491764|566410300|FG001|Overall Study|Administrative|0|||
156905168|NCT00491764|566410301|FG002|Overall Study|Administrative|2|||
156905169|NCT00491764|566410302|FG003|Overall Study|Administrative|1|||
156905170|NCT00491764|566410303|FG004|Overall Study|Administrative|0|||
156905171|NCT00491764|566410304|FG005|Overall Study|Administrative|0|||
156905172|NCT05350410|566410305|FG000|Overall Study|Withdrawal by Subject|1|||
156905173|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Adverse Event|3|||
156905174|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Adverse Event|0|||
156905175|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
156905176|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
156905177|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
156905178|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
156905179|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Physician Decision|0|||
156905180|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Physician Decision|2|||
156905181|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
156905182|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
156905183|NCT02110238|566410306|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
156905184|NCT02110238|566410307|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
156905185|NCT02110238|566410306|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
156905186|NCT02110238|566410307|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
157026741|NCT00085735|566853272|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
157026742|NCT00085735|566853273|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
157026743|NCT00085735|566853274|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
157026744|NCT00085735|566853275|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
156905187|NCT02110238|566410306|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
156905188|NCT02110238|566410307|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
156905189|NCT02110238|566410306|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
157026745|NCT01824875|566853276|FG000|Overall Study|Disease progression|22|||
156905190|NCT02110238|566410307|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
156905191|NCT02110238|566410306|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
156905192|NCT02110238|566410307|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
156905193|NCT02110238|566410306|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
156905194|NCT02110238|566410307|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
156905195|NCT00142935|566410311|FG000|Overall Study|Other reason|1|||
156905196|NCT00142935|566410312|FG001|Overall Study|Other reason|1|||
156905197|NCT00142935|566410313|FG002|Overall Study|Other reason|1|||
156905198|NCT00142935|566410311|FG000|Overall Study|Lost to Follow-up|2|||
156905199|NCT00142935|566410312|FG001|Overall Study|Lost to Follow-up|5|||
156905200|NCT00142935|566410313|FG002|Overall Study|Lost to Follow-up|5|||
156905201|NCT00142935|566410311|FG000|Overall Study|Death|0|||
156905202|NCT00142935|566410312|FG001|Overall Study|Death|2|||
156905203|NCT00142935|566410313|FG002|Overall Study|Death|1|||
156905204|NCT01330030|566410316|FG000|Overall Study|Lost to Follow-up|16|||
156905205|NCT01330030|566410317|FG001|Overall Study|Lost to Follow-up|17|||
156905206|NCT03626168|566410318|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156905207|NCT03626168|566410319|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
156905208|NCT03626168|566410318|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
156905209|NCT03626168|566410319|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
156905210|NCT03626168|566410318|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156905211|NCT03626168|566410319|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
156905212|NCT01419626|566410320|FG000|Overall Study|Protocol Violation|3|||
156905213|NCT01419626|566410321|FG001|Overall Study|Protocol Violation|2|||
156905214|NCT01419626|566410322|FG002|Overall Study|Protocol Violation|2|||
156905215|NCT01419626|566410320|FG000|Overall Study|Withdrawal by Subject|1|||
156905216|NCT01419626|566410321|FG001|Overall Study|Withdrawal by Subject|0|||
156905217|NCT01419626|566410322|FG002|Overall Study|Withdrawal by Subject|0|||
156905218|NCT01419626|566410320|FG000|Overall Study|Lost to Follow-up|0|||
156905219|NCT01419626|566410321|FG001|Overall Study|Lost to Follow-up|1|||
156905220|NCT01419626|566410322|FG002|Overall Study|Lost to Follow-up|1|||
156905221|NCT01365052|566410323|FG000|Overall Study|Adverse Event|4|||
156905222|NCT01365052|566410324|FG001|Overall Study|Adverse Event|4|||
156905223|NCT01146912|566410325|FG000|Overall Study|Already received influenza vaccination|817|||
156905224|NCT01146912|566410326|FG001|Overall Study|Already received influenza vaccination|822|||
156905225|NCT01146912|566410327|FG002|Overall Study|Already received influenza vaccination|13|||
156905226|NCT01146912|566410328|FG003|Overall Study|Already received influenza vaccination|15|||
156905227|NCT01146912|566410329|FG004|Overall Study|Already received influenza vaccination|41|||
156905228|NCT01146912|566410330|FG005|Overall Study|Already received influenza vaccination|61|||
156905229|NCT01146912|566410331|FG006|Overall Study|Already received influenza vaccination|56|||
156905230|NCT01146912|566410332|FG007|Overall Study|Already received influenza vaccination|0|||
156905231|NCT01146912|566410325|FG000|Overall Study|< 14 weeks gestational age|0|||
156905232|NCT01146912|566410326|FG001|Overall Study|< 14 weeks gestational age|0|||
156905233|NCT01146912|566410327|FG002|Overall Study|< 14 weeks gestational age|3|||
156905234|NCT01146912|566410328|FG003|Overall Study|< 14 weeks gestational age|2|||
156905235|NCT01146912|566410329|FG004|Overall Study|< 14 weeks gestational age|0|||
156905236|NCT01146912|566410330|FG005|Overall Study|< 14 weeks gestational age|0|||
156905237|NCT01146912|566410331|FG006|Overall Study|< 14 weeks gestational age|0|||
156905238|NCT01146912|566410332|FG007|Overall Study|< 14 weeks gestational age|0|||
156905239|NCT01146912|566410325|FG000|Overall Study|Duplicate patient|0|||
156905240|NCT01146912|566410326|FG001|Overall Study|Duplicate patient|0|||
156905241|NCT01146912|566410327|FG002|Overall Study|Duplicate patient|1|||
156905242|NCT01146912|566410328|FG003|Overall Study|Duplicate patient|0|||
156905243|NCT01146912|566410329|FG004|Overall Study|Duplicate patient|0|||
156905244|NCT01146912|566410330|FG005|Overall Study|Duplicate patient|0|||
156905245|NCT01146912|566410331|FG006|Overall Study|Duplicate patient|0|||
156905246|NCT01146912|566410332|FG007|Overall Study|Duplicate patient|0|||
156905247|NCT02980783|566410333|FG000|Overall Study|Lost to Follow-up|1|||
156905248|NCT00880542|566410334|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
156905249|NCT00880542|566410334|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
156905250|NCT00880542|566410334|FG000|REP: Surgical Resection|progressive disease|1|||
156905251|NCT05047770|566410335|FG000|Overall Study|Withdrawal by Subject|15|||
156905252|NCT05047770|566410336|FG001|Overall Study|Withdrawal by Subject|10|||
156905253|NCT05047770|566410337|FG002|Overall Study|Withdrawal by Subject|6|||
156905254|NCT05047770|566410338|FG003|Overall Study|Withdrawal by Subject|12|||
156905255|NCT05047770|566410335|FG000|Overall Study|Lost to Follow-up|7|||
156905256|NCT05047770|566410336|FG001|Overall Study|Lost to Follow-up|5|||
156905257|NCT05047770|566410337|FG002|Overall Study|Lost to Follow-up|12|||
156905258|NCT05047770|566410338|FG003|Overall Study|Lost to Follow-up|13|||
156905259|NCT05047770|566410335|FG000|Overall Study|Other|1|||
156905260|NCT05047770|566410336|FG001|Overall Study|Other|0|||
157026746|NCT01824875|566853277|FG001|Overall Study|Disease progression|15|||
157026747|NCT01824875|566853276|FG000|Overall Study|Withdrawal by Subject|5|||
157159244|NCT02294318|567329441|FG000|Overall Study|Worsening of drinking|3|||
157159245|NCT02294318|567329442|FG001|Overall Study|Worsening of drinking|0|||
156905261|NCT05047770|566410337|FG002|Overall Study|Other|1|||
156905262|NCT05047770|566410338|FG003|Overall Study|Other|0|||
156905263|NCT01772160|566410339|FG000|Overall Study|Death|3|||
156905264|NCT01772160|566410339|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
156905265|NCT01772160|566410339|FG000|Overall Study|Consent withdrawal|3|||
156905266|NCT01772160|566410339|FG000|Overall Study|Migrated / moved from the study area|4|||
156905267|NCT01772160|566410339|FG000|Overall Study|Lost to Follow-up|30|||
156905268|NCT01772160|566410339|FG000|Overall Study|Other|5|||
156905269|NCT02202980|566410340|FG000|Overall Study|Lack of Efficacy|1|||
156905270|NCT02202980|566410341|FG001|Overall Study|Lack of Efficacy|0|||
157026748|NCT01824875|566853277|FG001|Overall Study|Withdrawal by Subject|4|||
156905271|NCT02202980|566410342|FG002|Overall Study|Lack of Efficacy|7|||
156905272|NCT02202980|566410343|FG003|Overall Study|Lack of Efficacy|0|||
156905273|NCT02202980|566410344|FG004|Overall Study|Lack of Efficacy|3|||
156905274|NCT02202980|566410345|FG005|Overall Study|Lack of Efficacy|1|||
156905275|NCT02202980|566410346|FG006|Overall Study|Lack of Efficacy|11|||
156905276|NCT02202980|566410347|FG007|Overall Study|Lack of Efficacy|2|||
156905277|NCT02202980|566410348|FG008|Overall Study|Lack of Efficacy|2|||
156905278|NCT02202980|566410349|FG009|Overall Study|Lack of Efficacy|0|||
156905279|NCT02202980|566410350|FG010|Overall Study|Lack of Efficacy|0|||
156905280|NCT02202980|566410351|FG011|Overall Study|Lack of Efficacy|3|||
156905281|NCT02202980|566410352|FG012|Overall Study|Lack of Efficacy|10|||
156905282|NCT02202980|566410353|FG013|Overall Study|Lack of Efficacy|0|||
156905283|NCT02202980|566410340|FG000|Overall Study|Protocol Violation|0|||
156905284|NCT02202980|566410341|FG001|Overall Study|Protocol Violation|0|||
156905285|NCT02202980|566410342|FG002|Overall Study|Protocol Violation|0|||
156905286|NCT02202980|566410343|FG003|Overall Study|Protocol Violation|3|||
156905287|NCT02202980|566410344|FG004|Overall Study|Protocol Violation|3|||
156905288|NCT02202980|566410345|FG005|Overall Study|Protocol Violation|0|||
156905289|NCT02202980|566410346|FG006|Overall Study|Protocol Violation|0|||
156905290|NCT02202980|566410347|FG007|Overall Study|Protocol Violation|0|||
156905291|NCT02202980|566410348|FG008|Overall Study|Protocol Violation|0|||
156905292|NCT02202980|566410349|FG009|Overall Study|Protocol Violation|0|||
156905293|NCT02202980|566410350|FG010|Overall Study|Protocol Violation|0|||
156905294|NCT02202980|566410351|FG011|Overall Study|Protocol Violation|0|||
156905295|NCT02202980|566410352|FG012|Overall Study|Protocol Violation|0|||
156905296|NCT02202980|566410353|FG013|Overall Study|Protocol Violation|0|||
156905297|NCT02202980|566410340|FG000|Overall Study|Lost to Follow-up|0|||
156905298|NCT02202980|566410341|FG001|Overall Study|Lost to Follow-up|1|||
156905299|NCT02202980|566410342|FG002|Overall Study|Lost to Follow-up|1|||
156905300|NCT02202980|566410343|FG003|Overall Study|Lost to Follow-up|1|||
156905301|NCT02202980|566410344|FG004|Overall Study|Lost to Follow-up|0|||
156905302|NCT02202980|566410345|FG005|Overall Study|Lost to Follow-up|0|||
156905303|NCT02202980|566410346|FG006|Overall Study|Lost to Follow-up|0|||
156905304|NCT02202980|566410347|FG007|Overall Study|Lost to Follow-up|1|||
156905305|NCT02202980|566410348|FG008|Overall Study|Lost to Follow-up|1|||
156905306|NCT02202980|566410349|FG009|Overall Study|Lost to Follow-up|0|||
156905307|NCT02202980|566410350|FG010|Overall Study|Lost to Follow-up|0|||
156905308|NCT02202980|566410351|FG011|Overall Study|Lost to Follow-up|0|||
156905309|NCT02202980|566410352|FG012|Overall Study|Lost to Follow-up|1|||
156905310|NCT02202980|566410353|FG013|Overall Study|Lost to Follow-up|0|||
156905311|NCT02202980|566410340|FG000|Overall Study|Withdrew Consent|0|||
156905312|NCT02202980|566410341|FG001|Overall Study|Withdrew Consent|1|||
156905313|NCT02202980|566410342|FG002|Overall Study|Withdrew Consent|2|||
156905314|NCT02202980|566410343|FG003|Overall Study|Withdrew Consent|0|||
156905315|NCT02202980|566410344|FG004|Overall Study|Withdrew Consent|0|||
156905316|NCT02202980|566410345|FG005|Overall Study|Withdrew Consent|0|||
156905317|NCT02202980|566410346|FG006|Overall Study|Withdrew Consent|0|||
156905318|NCT02202980|566410347|FG007|Overall Study|Withdrew Consent|0|||
156905319|NCT02202980|566410348|FG008|Overall Study|Withdrew Consent|1|||
156905320|NCT02202980|566410349|FG009|Overall Study|Withdrew Consent|0|||
156905321|NCT02202980|566410350|FG010|Overall Study|Withdrew Consent|0|||
156905322|NCT02202980|566410351|FG011|Overall Study|Withdrew Consent|0|||
156905323|NCT02202980|566410352|FG012|Overall Study|Withdrew Consent|0|||
156905324|NCT02202980|566410353|FG013|Overall Study|Withdrew Consent|0|||
156905325|NCT01952145|566410354|FG000|Overall Study|Protocol Violation|2|||
156905326|NCT01952145|566410355|FG001|Overall Study|Protocol Violation|1|||
156905327|NCT01952145|566410354|FG000|Overall Study|Death|0|||
156905328|NCT01952145|566410355|FG001|Overall Study|Death|1|||
156905329|NCT01952145|566410354|FG000|Overall Study|Adverse Event|9|||
156905330|NCT01952145|566410355|FG001|Overall Study|Adverse Event|0|||
156905331|NCT01952145|566410354|FG000|Overall Study|Withdrawal Criteria|16|||
156905332|NCT01952145|566410355|FG001|Overall Study|Withdrawal Criteria|11|||
156905333|NCT01952145|566410354|FG000|Overall Study|Unclassified|1|||
156905334|NCT01952145|566410355|FG001|Overall Study|Unclassified|1|||
156905335|NCT01540838|566410356|FG000|Overall Study|Open nasogastric tube|9|||
156905336|NCT01540838|566410357|FG001|Overall Study|Open nasogastric tube|7|||
156905337|NCT01540838|566410356|FG000|Overall Study|Treatment doses missing|8|||
156905338|NCT01540838|566410357|FG001|Overall Study|Treatment doses missing|12|||
156905339|NCT01540838|566410356|FG000|Overall Study|Additional antibiotic treatment|1|||
156905340|NCT01540838|566410357|FG001|Overall Study|Additional antibiotic treatment|2|||
156905341|NCT01540838|566410356|FG000|Overall Study|Died before treatment initiation|1|||
156905342|NCT01540838|566410357|FG001|Overall Study|Died before treatment initiation|1|||
156905343|NCT01540838|566410356|FG000|Overall Study|Not BM. Other treatment|3|||
156905344|NCT01540838|566410357|FG001|Overall Study|Not BM. Other treatment|1|||
156905345|NCT02130570|566410358|FG000|Overall Study|Death|3|||
156905346|NCT02130570|566410359|FG001|Overall Study|Death|5|||
156905347|NCT02130570|566410358|FG000|Overall Study|Withdrawal by Subject|6|||
156905348|NCT02130570|566410359|FG001|Overall Study|Withdrawal by Subject|3|||
156905349|NCT02130570|566410358|FG000|Overall Study|Part of practice that discontinued study|0|||
156905350|NCT02130570|566410359|FG001|Overall Study|Part of practice that discontinued study|5|||
157159246|NCT02294318|567329441|FG000|Overall Study|Not exposed to intervention|0|||
157159247|NCT02294318|567329442|FG001|Overall Study|Not exposed to intervention|2|||
157159248|NCT01694420|567329446|FG000|Overall Study|Lost to Follow-up|3|||
157159249|NCT00506948|567329449|FG000|Overall Study|Death|4|||
157159250|NCT00506948|567329449|FG000|Overall Study|Adverse Event|5|||
157159251|NCT00506948|567329449|FG000|Overall Study|Physician Decision|1|||
157159252|NCT02395653|567329450|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
157159253|NCT02395653|567329450|FG000|Overall Study|Consent Withdrawn at Screening|1|||
157159254|NCT02395653|567329450|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
157159255|NCT02395653|567329450|FG000|Overall Study|Investigator Decision at Screening|1|||
157159256|NCT02395653|567329450|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
157159257|NCT02395653|567329450|FG000|Overall Study|Withdrawal by Subject|1|||
157159258|NCT02395653|567329450|FG000|Overall Study|Lost to Follow-up|1|||
157159259|NCT00762372|567329451|FG000|Overall Study|Adverse Event|1|||
157159260|NCT00762372|567329452|FG001|Overall Study|Adverse Event|0|||
157159261|NCT00762372|567329453|FG002|Overall Study|Adverse Event|0|||
157159262|NCT01194804|567329454|FG000|Overall Study|Withdrawal by Subject|1|||
157159263|NCT02670915|567329455|FG000|Overall Study|Withdrawal by Subject|0|||
157159264|NCT02670915|567329456|FG001|Overall Study|Withdrawal by Subject|1|||
157159265|NCT02670915|567329457|FG002|Overall Study|Withdrawal by Subject|4|||
157159266|NCT02670915|567329455|FG000|Overall Study|Withdrawal by parent/guardian|4|||
157159267|NCT02670915|567329456|FG001|Overall Study|Withdrawal by parent/guardian|4|||
157159268|NCT02670915|567329457|FG002|Overall Study|Withdrawal by parent/guardian|1|||
157159269|NCT02670915|567329455|FG000|Overall Study|Unclassified|0|||
157159270|NCT02670915|567329456|FG001|Overall Study|Unclassified|3|||
157159271|NCT02670915|567329457|FG002|Overall Study|Unclassified|0|||
157159272|NCT00818207|567329458|FG000|Overall Study|Adverse Event|6|||
157159273|NCT00818207|567329459|FG001|Overall Study|Adverse Event|0|||
157159274|NCT00818207|567329458|FG000|Overall Study|Lost to Follow-up|160|||
157159275|NCT00818207|567329459|FG001|Overall Study|Lost to Follow-up|146|||
156859645|NCT00772538|566243154|FG000|Overall Study|Protocol Violation|3|||
156859646|NCT00772538|566243155|FG001|Overall Study|Protocol Violation|3|||
156859647|NCT00772538|566243154|FG000|Overall Study|Lost to Follow-up|1|||
156859648|NCT00772538|566243155|FG001|Overall Study|Lost to Follow-up|1|||
156859649|NCT00772538|566243154|FG000|Overall Study|Withdrawal by Subject|3|||
156859650|NCT00772538|566243155|FG001|Overall Study|Withdrawal by Subject|8|||
156859651|NCT00772538|566243154|FG000|Overall Study|Lack of Efficacy|0|||
156859652|NCT00772538|566243155|FG001|Overall Study|Lack of Efficacy|1|||
156859653|NCT00772538|566243154|FG000|Overall Study|Other|7|||
156859654|NCT00772538|566243155|FG001|Overall Study|Other|7|||
156859655|NCT00001832|566243158|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
156859656|NCT00001832|566243159|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
156859657|NCT00001832|566243160|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
156859658|NCT00001832|566243161|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
156859659|NCT00001832|566243162|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
156859660|NCT00001832|566243163|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
156859661|NCT00001832|566243164|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
156859662|NCT00001832|566243165|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
156859663|NCT00001832|566243166|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
156859664|NCT00001832|566243167|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
156859665|NCT00001832|566243168|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
156859666|NCT00001832|566243169|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
156859667|NCT00001832|566243170|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
156859668|NCT00001832|566243171|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
156859669|NCT00001832|566243172|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
156859670|NCT00001832|566243158|FG000|Treatment Period|Death during treatment|0|||
156859671|NCT00001832|566243159|FG001|Treatment Period|Death during treatment|0|||
156859672|NCT00001832|566243160|FG002|Treatment Period|Death during treatment|0|||
156859673|NCT00001832|566243161|FG003|Treatment Period|Death during treatment|0|||
156859674|NCT00001832|566243162|FG004|Treatment Period|Death during treatment|0|||
156859675|NCT00001832|566243163|FG005|Treatment Period|Death during treatment|1|||
156859676|NCT00001832|566243164|FG006|Treatment Period|Death during treatment|0|||
156859677|NCT00001832|566243165|FG007|Treatment Period|Death during treatment|0|||
156859678|NCT00001832|566243166|FG008|Treatment Period|Death during treatment|0|||
156859679|NCT00001832|566243167|FG009|Treatment Period|Death during treatment|0|||
156859680|NCT00001832|566243168|FG010|Treatment Period|Death during treatment|0|||
156859681|NCT00001832|566243169|FG011|Treatment Period|Death during treatment|0|||
156859682|NCT00001832|566243170|FG012|Treatment Period|Death during treatment|0|||
156859683|NCT00001832|566243171|FG013|Treatment Period|Death during treatment|0|||
156859684|NCT00001832|566243172|FG014|Treatment Period|Death during treatment|0|||
156859685|NCT00001832|566243158|FG000|Treatment Period|Not treated|0|||
156859686|NCT00001832|566243159|FG001|Treatment Period|Not treated|0|||
156859687|NCT00001832|566243160|FG002|Treatment Period|Not treated|0|||
156859688|NCT00001832|566243161|FG003|Treatment Period|Not treated|0|||
157159276|NCT00818207|567329458|FG000|Overall Study|Multiple reasons|11|||
156905351|NCT05224141|566410366|FG000|Overall Study|Ongoing|75|||
156905352|NCT05224141|566410367|FG001|Overall Study|Ongoing|88|||
156905353|NCT05224141|566410366|FG000|Overall Study|Withdrawal by Subject|2|||
156905354|NCT05224141|566410367|FG001|Overall Study|Withdrawal by Subject|4|||
156905355|NCT05224141|566410366|FG000|Overall Study|Death|153|||
156905356|NCT05224141|566410367|FG001|Overall Study|Death|138|||
156905357|NCT00619177|566410371|FG000|Overall Study|Adverse Event|18|||
156905358|NCT00619177|566410371|FG000|Overall Study|Lost to Follow-up|2|||
156905359|NCT00619177|566410371|FG000|Overall Study|Lack of Efficacy|1|||
156905360|NCT00619177|566410371|FG000|Overall Study|Missing termination information|481|||
156905361|NCT00619177|566410371|FG000|Overall Study|Not specified reasons|6|||
156905362|NCT02764697|566410372|FG000|Overall Study|Lack of Efficacy|3|||
156905363|NCT00302107|566410373|FG000|Overall Study|Lost to Follow-up|6|||
156905364|NCT00302107|566410374|FG001|Overall Study|Lost to Follow-up|5|||
156905365|NCT00302107|566410373|FG000|Overall Study|Protocol Violation|1|||
156905366|NCT00302107|566410374|FG001|Overall Study|Protocol Violation|0|||
156905367|NCT00302107|566410373|FG000|Overall Study|Relocation|0|||
156905368|NCT00302107|566410374|FG001|Overall Study|Relocation|1|||
156905369|NCT00302107|566410373|FG000|Overall Study|Withdrawal by Subject|0|||
156905370|NCT00302107|566410374|FG001|Overall Study|Withdrawal by Subject|3|||
156905371|NCT00302107|566410373|FG000|Overall Study|Adverse Event|1|||
156905372|NCT00302107|566410374|FG001|Overall Study|Adverse Event|0|||
156905373|NCT00437983|566410375|FG000|Overall Study|Adverse Event|6|||
156905374|NCT00437983|566410376|FG001|Overall Study|Adverse Event|6|||
156905375|NCT00437983|566410375|FG000|Overall Study|Protocol Violation|2|||
156905376|NCT00437983|566410376|FG001|Overall Study|Protocol Violation|1|||
156905377|NCT00437983|566410375|FG000|Overall Study|Withdrawal by Subject|5|||
156905378|NCT00437983|566410376|FG001|Overall Study|Withdrawal by Subject|6|||
156905379|NCT00621959|566410377|FG000|Overall Study|Adverse Event|4|||
156905380|NCT00621959|566410378|FG001|Overall Study|Adverse Event|2|||
156905381|NCT00621959|566410377|FG000|Overall Study|Lack of Efficacy|1|||
156905382|NCT00621959|566410378|FG001|Overall Study|Lack of Efficacy|1|||
156905383|NCT00621959|566410377|FG000|Overall Study|Lost to Follow-up|0|||
156905384|NCT00621959|566410378|FG001|Overall Study|Lost to Follow-up|2|||
156905385|NCT00621959|566410377|FG000|Overall Study|Withdrawal by Subject|1|||
156905386|NCT00621959|566410378|FG001|Overall Study|Withdrawal by Subject|1|||
156905387|NCT00621959|566410377|FG000|Overall Study|Other|1|||
156905388|NCT00621959|566410378|FG001|Overall Study|Other|3|||
156905389|NCT01402011|566410386|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
156905390|NCT01402011|566410387|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
156905391|NCT01402011|566410388|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
156905392|NCT01402011|566410386|FG000|Active Treatment Period|Withdrawal by Subject|1|||
156905393|NCT01402011|566410387|FG001|Active Treatment Period|Withdrawal by Subject|3|||
156905394|NCT01402011|566410388|FG002|Active Treatment Period|Withdrawal by Subject|0|||
156905395|NCT01402011|566410386|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
156905396|NCT01402011|566410387|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
156905397|NCT01402011|566410388|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
156905398|NCT02484690|566410391|FG000|Overall Study|Adverse Event|1|||
156905399|NCT02484690|566410392|FG001|Overall Study|Adverse Event|3|||
156905400|NCT02484690|566410393|FG002|Overall Study|Adverse Event|0|||
156905401|NCT02484690|566410394|FG003|Overall Study|Adverse Event|0|||
156905402|NCT02484690|566410395|FG004|Overall Study|Adverse Event|5|||
156905403|NCT02484690|566410391|FG000|Overall Study|Death|0|||
156905404|NCT02484690|566410392|FG001|Overall Study|Death|0|||
156905405|NCT02484690|566410393|FG002|Overall Study|Death|0|||
156905406|NCT02484690|566410394|FG003|Overall Study|Death|0|||
156905407|NCT02484690|566410395|FG004|Overall Study|Death|1|||
156905408|NCT02484690|566410391|FG000|Overall Study|Withdrawal by Subject|1|||
156905409|NCT02484690|566410392|FG001|Overall Study|Withdrawal by Subject|3|||
156905410|NCT02484690|566410393|FG002|Overall Study|Withdrawal by Subject|1|||
156905411|NCT02484690|566410394|FG003|Overall Study|Withdrawal by Subject|2|||
157159277|NCT00818207|567329459|FG001|Overall Study|Multiple reasons|12|||
157159278|NCT00818207|567329458|FG000|Overall Study|Withdrawal by Subject|42|||
157159279|NCT00818207|567329459|FG001|Overall Study|Withdrawal by Subject|104|||
157159280|NCT00818207|567329458|FG000|Overall Study|Death|3|||
156905412|NCT02484690|566410395|FG004|Overall Study|Withdrawal by Subject|0|||
156905413|NCT02484690|566410391|FG000|Overall Study|Physician Decision|2|||
156905414|NCT02484690|566410392|FG001|Overall Study|Physician Decision|0|||
156905415|NCT02484690|566410393|FG002|Overall Study|Physician Decision|1|||
156905416|NCT02484690|566410394|FG003|Overall Study|Physician Decision|0|||
156905417|NCT02484690|566410395|FG004|Overall Study|Physician Decision|0|||
156905418|NCT02484690|566410391|FG000|Overall Study|Lost to Follow-up|0|||
156905419|NCT02484690|566410392|FG001|Overall Study|Lost to Follow-up|0|||
156905420|NCT02484690|566410393|FG002|Overall Study|Lost to Follow-up|1|||
156905421|NCT02484690|566410394|FG003|Overall Study|Lost to Follow-up|0|||
156905422|NCT02484690|566410395|FG004|Overall Study|Lost to Follow-up|0|||
156905423|NCT03360747|566410396|FG000|Overall Study|Voluntary Withdrawal|1|||
156905424|NCT01759511|566410397|FG000|Overall Study|Adverse Event|4|||
157159281|NCT00818207|567329459|FG001|Overall Study|Death|5|||
157159282|NCT02494778|567329460|FG000|Overall Study|Death|3|||
157159283|NCT02494778|567329460|FG000|Overall Study|Other|173|||
157159284|NCT02494778|567329460|FG000|Overall Study|Lack of Efficacy|4|||
157159285|NCT02494778|567329460|FG000|Overall Study|Adverse Event|18|||
157159286|NCT02494778|567329460|FG000|Overall Study|Withdrawal by Subject|20|||
156905425|NCT01759511|566410397|FG000|Overall Study|Death|2|||
156905426|NCT01759511|566410397|FG000|Overall Study|Lack of Efficacy|2|||
156905427|NCT01759511|566410397|FG000|Overall Study|Physician Decision|1|||
156905428|NCT01759511|566410397|FG000|Overall Study|Progressive Disease|5|||
156905429|NCT01759511|566410397|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
156905430|NCT01759511|566410397|FG000|Overall Study|Study Terminated by Sponsor|13|||
156905431|NCT01759511|566410397|FG000|Overall Study|Withdrawal by Subject|3|||
156905432|NCT02569671|566410400|FG000|Overall Study|Lost to Follow-up|2|||
156905433|NCT02569671|566410401|FG001|Overall Study|Lost to Follow-up|1|||
156905434|NCT02569671|566410400|FG000|Overall Study|Withdrawal by Subject|1|||
156905435|NCT02569671|566410401|FG001|Overall Study|Withdrawal by Subject|3|||
156905436|NCT01757535|566410402|FG000|Overall Study|Disease Relapse|151|||
156905437|NCT01757535|566410403|FG001|Overall Study|Disease Relapse|181|||
156905438|NCT01757535|566410402|FG000|Overall Study|Other Reasons|28|||
156905439|NCT01757535|566410403|FG001|Overall Study|Other Reasons|27|||
156905440|NCT01757535|566410402|FG000|Overall Study|Adverse Event|31|||
156905441|NCT01757535|566410403|FG001|Overall Study|Adverse Event|11|||
156905442|NCT01757535|566410402|FG000|Overall Study|Withdrew Consent|19|||
156905443|NCT01757535|566410403|FG001|Overall Study|Withdrew Consent|13|||
156905444|NCT01757535|566410402|FG000|Overall Study|Physician Decision|7|||
156905445|NCT01757535|566410403|FG001|Overall Study|Physician Decision|0|||
156905446|NCT01757535|566410402|FG000|Overall Study|Death|2|||
156905447|NCT01757535|566410403|FG001|Overall Study|Death|2|||
156905448|NCT00589290|566410404|FG000|Overall Study|Withdrawal by Subject|1|||
156905449|NCT06238362|566410405|FG000|Overall Study|Insufficient total sleep time|1|||
156905450|NCT06238362|566410406|FG001|Overall Study|Insufficient total sleep time|0|||
156905451|NCT06238362|566410405|FG000|Overall Study|Inadequate signal quality|1|||
156905452|NCT06238362|566410406|FG001|Overall Study|Inadequate signal quality|0|||
156905453|NCT06956170|566412416|FG000|Overall Study|Death|2|||
156905454|NCT06956170|566412417|FG001|Overall Study|Death|1|||
156905455|NCT06956170|566412416|FG000|Overall Study|Withdrawal by Subject|1|||
156905456|NCT06956170|566412417|FG001|Overall Study|Withdrawal by Subject|0|||
156905457|NCT06956170|566412416|FG000|Overall Study|Ongoing|7|||
156905458|NCT06956170|566412417|FG001|Overall Study|Ongoing|10|||
156905459|NCT04015336|566412420|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
156905460|NCT04622306|566412422|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156905461|NCT04622306|566412423|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156905462|NCT04622306|566412424|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
156905463|NCT04622306|566412425|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
156905464|NCT04622306|566412426|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
156905465|NCT04622306|566412427|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
156905466|NCT04622306|566412422|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156905467|NCT04622306|566412423|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156905468|NCT04622306|566412424|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
156905469|NCT04622306|566412425|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
156905470|NCT04622306|566412426|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156905471|NCT04622306|566412427|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
156905472|NCT01200524|566412428|FG000|Overall Study|Withdrawal by Subject|1|||
156905473|NCT01200524|566412429|FG001|Overall Study|Withdrawal by Subject|1|||
156905474|NCT01200524|566412430|FG002|Overall Study|Withdrawal by Subject|3|||
156905475|NCT01200524|566412428|FG000|Overall Study|Adverse Event|1|||
156905476|NCT01200524|566412429|FG001|Overall Study|Adverse Event|0|||
156905477|NCT01200524|566412430|FG002|Overall Study|Adverse Event|0|||
156905478|NCT01200524|566412428|FG000|Overall Study|Non availability of study nurse|0|||
156905479|NCT01200524|566412429|FG001|Overall Study|Non availability of study nurse|0|||
156905480|NCT01200524|566412430|FG002|Overall Study|Non availability of study nurse|1|||
156905481|NCT00697788|566412437|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905482|NCT00697788|566412438|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
156905483|NCT00697788|566412439|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905484|NCT00697788|566412440|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905485|NCT00697788|566412441|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905486|NCT00697788|566412442|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905487|NCT00697788|566412443|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905488|NCT00697788|566412444|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
156905489|NCT00697788|566412437|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905490|NCT00697788|566412438|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905491|NCT00697788|566412439|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
157159287|NCT02494778|567329460|FG000|Overall Study|Lost to Follow-up|2|||
156905492|NCT00697788|566412440|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905493|NCT00697788|566412441|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
156905494|NCT00697788|566412442|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905495|NCT00697788|566412443|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905496|NCT00697788|566412444|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
156905497|NCT03228433|566412446|FG000|Overall Study|Lost to Follow-up|1|||
156905498|NCT03228433|566412447|FG001|Overall Study|Lost to Follow-up|0|||
156905499|NCT03228433|566412448|FG002|Overall Study|Lost to Follow-up|0|||
156905500|NCT03228433|566412449|FG003|Overall Study|Lost to Follow-up|0|||
156905501|NCT03228433|566412450|FG004|Overall Study|Lost to Follow-up|0|||
156905502|NCT03228433|566412451|FG005|Overall Study|Lost to Follow-up|0|||
156905503|NCT03228433|566412446|FG000|Overall Study|Positive alcohol test|0|||
156905504|NCT03228433|566412447|FG001|Overall Study|Positive alcohol test|0|||
156905505|NCT03228433|566412448|FG002|Overall Study|Positive alcohol test|0|||
156905506|NCT03228433|566412449|FG003|Overall Study|Positive alcohol test|1|||
156905507|NCT03228433|566412450|FG004|Overall Study|Positive alcohol test|0|||
156905508|NCT03228433|566412451|FG005|Overall Study|Positive alcohol test|0|||
156905509|NCT01180985|566412456|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
156905510|NCT01180985|566412457|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
156905511|NCT00705289|566412458|FG000|Overall Study|Subject or treating physician's choice|131|||
156905512|NCT01030536|566412459|FG000|Overall Study|Withdrawal by Subject|0|||
156905513|NCT01030536|566412460|FG001|Overall Study|Withdrawal by Subject|0|||
156905514|NCT01030536|566412461|FG002|Overall Study|Withdrawal by Subject|1|||
156905515|NCT01030536|566412462|FG003|Overall Study|Withdrawal by Subject|0|||
156905516|NCT01030536|566412463|FG004|Overall Study|Withdrawal by Subject|0|||
156905517|NCT01030536|566412459|FG000|Overall Study|undefined|1|||
156905518|NCT01030536|566412460|FG001|Overall Study|undefined|0|||
156905519|NCT01030536|566412461|FG002|Overall Study|undefined|1|||
156905520|NCT01030536|566412462|FG003|Overall Study|undefined|1|||
156905521|NCT01030536|566412463|FG004|Overall Study|undefined|0|||
156905522|NCT01030536|566412459|FG000|Overall Study|Adverse Event|0|||
156905523|NCT01030536|566412460|FG001|Overall Study|Adverse Event|3|||
156905524|NCT01030536|566412461|FG002|Overall Study|Adverse Event|1|||
156905525|NCT01030536|566412462|FG003|Overall Study|Adverse Event|0|||
156905526|NCT01030536|566412463|FG004|Overall Study|Adverse Event|1|||
156905527|NCT01030536|566412459|FG000|Overall Study|Progressive disease|6|||
156905528|NCT01030536|566412460|FG001|Overall Study|Progressive disease|2|||
156905529|NCT01030536|566412461|FG002|Overall Study|Progressive disease|3|||
156905530|NCT01030536|566412462|FG003|Overall Study|Progressive disease|2|||
156905531|NCT01030536|566412463|FG004|Overall Study|Progressive disease|0|||
156905532|NCT01030536|566412459|FG000|Overall Study|Death|0|||
156905533|NCT01030536|566412460|FG001|Overall Study|Death|1|||
156905534|NCT01030536|566412461|FG002|Overall Study|Death|0|||
156905535|NCT01030536|566412462|FG003|Overall Study|Death|0|||
156905536|NCT01030536|566412463|FG004|Overall Study|Death|0|||
156905537|NCT02601027|566412467|FG000|Registration to Surgery|Withdrawal by Subject|20|||
156905538|NCT02601027|566412468|FG001|Registration to Surgery|Withdrawal by Subject|10|||
156905539|NCT04545060|566412471|FG000|Overall Study|Adverse Event|0|||
156905540|NCT04545060|566412472|FG001|Overall Study|Adverse Event|1|||
156905541|NCT04545060|566412471|FG000|Overall Study|Death|0|||
156905542|NCT04545060|566412472|FG001|Overall Study|Death|5|||
156905543|NCT04545060|566412471|FG000|Overall Study|Lost to Follow-up|10|||
156905544|NCT04545060|566412472|FG001|Overall Study|Lost to Follow-up|13|||
156905545|NCT04545060|566412471|FG000|Overall Study|Physician Decision|3|||
156905546|NCT04545060|566412472|FG001|Overall Study|Physician Decision|0|||
156905547|NCT04545060|566412471|FG000|Overall Study|Withdrawal by Subject|17|||
156905548|NCT04545060|566412472|FG001|Overall Study|Withdrawal by Subject|22|||
157026749|NCT01824875|566853276|FG000|Overall Study|Adverse Event|4|||
157026750|NCT01824875|566853277|FG001|Overall Study|Adverse Event|10|||
156905549|NCT02435147|566412474|FG000|Overall Study|non-evaluable DXA scan|11|||
156905550|NCT02939079|566412475|FG000|Overall Study|Adverse Event|2|||
156905551|NCT02939079|566412476|FG001|Overall Study|Adverse Event|1|||
156905552|NCT02939079|566412475|FG000|Overall Study|Lost to Follow-up|0|||
156905553|NCT02939079|566412476|FG001|Overall Study|Lost to Follow-up|2|||
156905554|NCT02939079|566412475|FG000|Overall Study|Protocol Violation|1|||
156905555|NCT02939079|566412476|FG001|Overall Study|Protocol Violation|0|||
156905556|NCT02939079|566412475|FG000|Overall Study|Withdrawal by Subject|0|||
156905557|NCT02939079|566412476|FG001|Overall Study|Withdrawal by Subject|1|||
156905558|NCT02939079|566412475|FG000|Overall Study|relapse during the study|1|||
156905559|NCT02939079|566412476|FG001|Overall Study|relapse during the study|1|||
156905560|NCT00071396|566412487|FG000|Overall Study|Withdrawal by Subject|1|||
156905561|NCT00071396|566412487|FG000|Overall Study|Physician Decision|2|||
156905562|NCT04545554|566412488|FG000|Overall Study|Withdrawal by Subject|0|||
156905563|NCT04545554|566412489|FG001|Overall Study|Withdrawal by Subject|0|||
156905564|NCT04545554|566412490|FG002|Overall Study|Withdrawal by Subject|0|||
156905565|NCT04545554|566412491|FG003|Overall Study|Withdrawal by Subject|1|||
156905566|NCT04545554|566412492|FG004|Overall Study|Withdrawal by Subject|0|||
156905567|NCT04545554|566412493|FG005|Overall Study|Withdrawal by Subject|0|||
156905568|NCT02478372|566412494|FG000|Overall Study|Protocol Violation|12|||
156905569|NCT02478372|566412495|FG001|Overall Study|Protocol Violation|8|||
156905570|NCT02478372|566412494|FG000|Overall Study|Lost to Follow-up|1|||
156905571|NCT02478372|566412495|FG001|Overall Study|Lost to Follow-up|4|||
156905572|NCT02478372|566412494|FG000|Overall Study|Death|0|||
156905573|NCT02478372|566412495|FG001|Overall Study|Death|2|||
156905574|NCT00116428|566412496|FG000|Overall Study|Withdrawal by Subject|2|||
156905575|NCT00116428|566412497|FG001|Overall Study|Withdrawal by Subject|5|||
156905576|NCT00116428|566412496|FG000|Overall Study|Did not meet inclusion criteria|1|||
156905577|NCT00116428|566412497|FG001|Overall Study|Did not meet inclusion criteria|0|||
156905578|NCT01032174|566412498|FG000|Overall Study|Adverse Event|0|||
156905579|NCT01032174|566412499|FG001|Overall Study|Adverse Event|1|||
156905580|NCT02635776|566412504|FG000|Overall Study|Physician Decision|1|||
156905581|NCT02635776|566412505|FG001|Overall Study|Physician Decision|0|||
156905582|NCT02635776|566412504|FG000|Overall Study|Adverse Event|51|||
156905583|NCT02635776|566412505|FG001|Overall Study|Adverse Event|3|||
156905584|NCT02635776|566412504|FG000|Overall Study|Withdrawal by Subject|41|||
156905585|NCT02635776|566412505|FG001|Overall Study|Withdrawal by Subject|7|||
156905586|NCT02635776|566412504|FG000|Overall Study|Lost to Follow-up|4|||
156905587|NCT02635776|566412505|FG001|Overall Study|Lost to Follow-up|0|||
156905588|NCT02635776|566412504|FG000|Overall Study|Other reasons|5|||
156905589|NCT02635776|566412505|FG001|Overall Study|Other reasons|1|||
156905590|NCT00910273|566412506|FG000|Overall Study|Lack of Efficacy|6|||
156905591|NCT00910273|566412507|FG001|Overall Study|Lack of Efficacy|9|||
156905592|NCT00910273|566412506|FG000|Overall Study|Adverse Event|1|||
156905593|NCT00910273|566412507|FG001|Overall Study|Adverse Event|1|||
156905594|NCT00910273|566412506|FG000|Overall Study|Withdrawal by Subject|1|||
156905595|NCT00910273|566412507|FG001|Overall Study|Withdrawal by Subject|0|||
156905596|NCT00910273|566412506|FG000|Overall Study|Discontinuation of study by sponsor|8|||
156905597|NCT00910273|566412507|FG001|Overall Study|Discontinuation of study by sponsor|2|||
156905598|NCT00910273|566412506|FG000|Overall Study|Protocol Violation|1|||
156905599|NCT00910273|566412507|FG001|Overall Study|Protocol Violation|0|||
156905600|NCT00910273|566412506|FG000|Overall Study|Lost to Follow-up|1|||
156905601|NCT00910273|566412507|FG001|Overall Study|Lost to Follow-up|1|||
156905602|NCT03208127|566412508|FG000|Overall Study|Death|1|||
156905603|NCT00660673|566412509|FG000|Overall Study|Adverse Event|84|||
156905604|NCT00660673|566412509|FG000|Overall Study|Lack of Efficacy|7|||
156905605|NCT00660673|566412509|FG000|Overall Study|Withdrawal by Subject|22|||
156905606|NCT00660673|566412509|FG000|Overall Study|Administrative|2|||
156905607|NCT00660673|566412509|FG000|Overall Study|Protocol Violation|2|||
156905608|NCT00579098|566412510|FG000|Overall Study|Lost to Follow-up|2|||
156905609|NCT00579098|566412511|FG001|Overall Study|Lost to Follow-up|0|||
156905610|NCT00579098|566412510|FG000|Overall Study|Adverse Event|2|||
156905611|NCT00579098|566412511|FG001|Overall Study|Adverse Event|3|||
156905612|NCT00579098|566412510|FG000|Overall Study|Withdrawal by Subject|2|||
156905613|NCT00579098|566412511|FG001|Overall Study|Withdrawal by Subject|3|||
156905614|NCT00579098|566412510|FG000|Overall Study|AF returned after ablation|3|||
156905615|NCT00579098|566412511|FG001|Overall Study|AF returned after ablation|2|||
156905616|NCT01254331|566412521|FG000|Initial Phase|Adverse Event|3|||
156905617|NCT01254331|566412521|FG000|Initial Phase|Withdrawal by Subject|1|||
156905618|NCT01254331|566412521|FG000|Initial Phase|Pregnancy|1|||
156905619|NCT01254331|566412521|FG000|Extension Phase|Lack of Efficacy|1|||
156905620|NCT01254331|566412521|FG000|Extension Phase|Lost to Follow-up|3|||
156905621|NCT00633750|566412522|FG000|Overall Study|Adverse Event|2|||
156905622|NCT00633750|566412522|FG000|Overall Study|Withdrawal by Subject|3|||
156905623|NCT01903031|566412523|FG000|Overall Study|Not Able to Attend Clinic|1|||
156905624|NCT01903031|566412524|FG001|Overall Study|Not Able to Attend Clinic|1|||
156905625|NCT01903031|566412525|FG002|Overall Study|Not Able to Attend Clinic|0|||
156905626|NCT01903031|566412523|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
156905627|NCT01903031|566412524|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
156905628|NCT01903031|566412525|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
156905629|NCT01903031|566412523|FG000|Overall Study|Adverse Event|0|||
156905630|NCT01903031|566412524|FG001|Overall Study|Adverse Event|1|||
156905631|NCT01903031|566412525|FG002|Overall Study|Adverse Event|0|||
156905632|NCT01903031|566412523|FG000|Overall Study|Withdrawal by Subject|0|||
156905633|NCT01903031|566412524|FG001|Overall Study|Withdrawal by Subject|1|||
156905634|NCT01903031|566412525|FG002|Overall Study|Withdrawal by Subject|1|||
156905635|NCT01903031|566412523|FG000|Overall Study|Protocol Violation|0|||
156905636|NCT01903031|566412524|FG001|Overall Study|Protocol Violation|0|||
156905637|NCT01903031|566412525|FG002|Overall Study|Protocol Violation|2|||
156905638|NCT01903031|566412523|FG000|Overall Study|Lost to Follow-up|0|||
156905639|NCT01903031|566412524|FG001|Overall Study|Lost to Follow-up|0|||
156905640|NCT01903031|566412525|FG002|Overall Study|Lost to Follow-up|1|||
156905641|NCT01903031|566412523|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
156905642|NCT01903031|566412524|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
156905643|NCT01903031|566412525|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
156905644|NCT01811225|566412526|FG000|Treatment Period 1|Adverse Event|2|||
156905645|NCT01811225|566412527|FG001|Treatment Period 1|Adverse Event|3|||
156905646|NCT01811225|566412526|FG000|Treatment Period 1|Lost to Follow-up|12|||
156905647|NCT01811225|566412527|FG001|Treatment Period 1|Lost to Follow-up|8|||
156905648|NCT01811225|566412526|FG000|Treatment Period 1|transporation|1|||
156905649|NCT01811225|566412527|FG001|Treatment Period 1|transporation|0|||
156905650|NCT01811225|566412526|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
156905651|NCT01811225|566412527|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
156905652|NCT01811225|566412526|FG000|Treatment Period 2|Lost to Follow-up|1|||
156905653|NCT01811225|566412527|FG001|Treatment Period 2|Lost to Follow-up|2|||
156905654|NCT01811225|566412526|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
156905655|NCT01811225|566412527|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
156905656|NCT00287365|566412528|FG000|Overall Study|sample not acquired|13|||
156905657|NCT03000569|566412529|FG000|Overall Study|Withdrawal by Subject|1|||
156905658|NCT03000569|566412530|FG001|Overall Study|Withdrawal by Subject|0|||
156905659|NCT02298023|566412531|FG000|Overall Study|Withdrawal by Subject|1|||
156905660|NCT02298023|566412532|FG001|Overall Study|Withdrawal by Subject|0|||
156905661|NCT02298023|566412533|FG002|Overall Study|Withdrawal by Subject|0|||
156905662|NCT03540030|566412536|FG000|Overall Study|Withdrawal by Subject|2|||
156905663|NCT03540030|566412537|FG001|Overall Study|Withdrawal by Subject|1|||
156905664|NCT03540030|566412536|FG000|Overall Study|screen fail|7|||
156905665|NCT03540030|566412537|FG001|Overall Study|screen fail|1|||
156905666|NCT03540030|566412536|FG000|Overall Study|never had surgery after signing consent|9|||
156905667|NCT03540030|566412537|FG001|Overall Study|never had surgery after signing consent|1|||
156905668|NCT00569270|566412538|FG000|Period: First Intervention|Protocol Violation|0|||
156905669|NCT00569270|566412539|FG001|Period: First Intervention|Protocol Violation|1|||
156905670|NCT00447005|566412541|FG000|Overall Study|Adverse Event|1|||
156905671|NCT00447005|566412541|FG000|Overall Study|Lack of Efficacy|11|||
156905672|NCT00492531|566412542|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
156905673|NCT00492531|566412543|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
156905674|NCT03685123|566412547|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
156905675|NCT03685123|566412548|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
156905676|NCT03685123|566412549|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
156905677|NCT03685123|566412547|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
156905678|NCT03685123|566412548|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
156905679|NCT03685123|566412549|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
156905680|NCT03685123|566412547|FG000|Weight Loss Phase|Lost to Follow-up|1|||
156905681|NCT03685123|566412548|FG001|Weight Loss Phase|Lost to Follow-up|0|||
156905682|NCT03685123|566412549|FG002|Weight Loss Phase|Lost to Follow-up|0|||
156905683|NCT03685123|566412547|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
156905684|NCT03685123|566412548|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
156905685|NCT03685123|566412549|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
156905686|NCT03685123|566412547|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
156905687|NCT03685123|566412548|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
156905688|NCT03685123|566412549|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
156905689|NCT03685123|566412547|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
156905690|NCT03685123|566412548|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
156905691|NCT03685123|566412549|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
156905692|NCT00400764|566412551|FG000|Phase Ib|Adverse Event|1|||
156905693|NCT00400764|566412552|FG001|Phase Ib|Adverse Event|0|||
156905694|NCT00400764|566412553|FG002|Phase Ib|Adverse Event|0|||
156905695|NCT00400764|566412554|FG003|Phase Ib|Adverse Event|0|||
156905696|NCT00400764|566412555|FG004|Phase Ib|Adverse Event|0|||
156905697|NCT00400764|566412551|FG000|Phase Ib|Death|1|||
156905698|NCT00400764|566412552|FG001|Phase Ib|Death|0|||
156905699|NCT00400764|566412553|FG002|Phase Ib|Death|0|||
156905700|NCT00400764|566412554|FG003|Phase Ib|Death|0|||
156905701|NCT00400764|566412555|FG004|Phase Ib|Death|0|||
156905702|NCT00400764|566412551|FG000|Phase Ib|Disease Progression|4|||
156905703|NCT00400764|566412552|FG001|Phase Ib|Disease Progression|4|||
156905704|NCT00400764|566412553|FG002|Phase Ib|Disease Progression|0|||
156905705|NCT00400764|566412554|FG003|Phase Ib|Disease Progression|0|||
156905706|NCT00400764|566412555|FG004|Phase Ib|Disease Progression|0|||
156905707|NCT00400764|566412551|FG000|Phase II|Death|0|||
156905708|NCT00400764|566412552|FG001|Phase II|Death|0|||
156905709|NCT00400764|566412553|FG002|Phase II|Death|1|||
156905710|NCT00400764|566412554|FG003|Phase II|Death|2|||
156905711|NCT00400764|566412555|FG004|Phase II|Death|0|||
157026751|NCT01824875|566853276|FG000|Overall Study|Alternative therapy|3|||
156905712|NCT00400764|566412551|FG000|Phase II|Lost to Follow-up|0|||
156905713|NCT00400764|566412552|FG001|Phase II|Lost to Follow-up|0|||
156905714|NCT00400764|566412553|FG002|Phase II|Lost to Follow-up|1|||
156905715|NCT00400764|566412554|FG003|Phase II|Lost to Follow-up|0|||
156905716|NCT00400764|566412555|FG004|Phase II|Lost to Follow-up|0|||
156905717|NCT00400764|566412551|FG000|Phase II|Physician Decision|0|||
156905718|NCT00400764|566412552|FG001|Phase II|Physician Decision|0|||
156905719|NCT00400764|566412553|FG002|Phase II|Physician Decision|1|||
156905720|NCT00400764|566412554|FG003|Phase II|Physician Decision|1|||
156905721|NCT00400764|566412555|FG004|Phase II|Physician Decision|0|||
157026752|NCT01824875|566853277|FG001|Overall Study|Alternative therapy|0|||
157159288|NCT02494778|567329460|FG000|Overall Study|Noncompliant with study drug admin.|1|||
157159289|NCT02616185|567329461|FG000|Overall Study|Death|0|||
157159290|NCT02616185|567329462|FG001|Overall Study|Death|0|||
157159291|NCT02616185|567329463|FG002|Overall Study|Death|0|||
157159292|NCT02616185|567329464|FG003|Overall Study|Death|1|||
157159293|NCT02616185|567329465|FG004|Overall Study|Death|2|||
157159294|NCT02616185|567329466|FG005|Overall Study|Death|0|||
156905722|NCT00400764|566412551|FG000|Phase II|Sponsor's decision to terminate|0|||
156905723|NCT00400764|566412552|FG001|Phase II|Sponsor's decision to terminate|0|||
156905724|NCT00400764|566412553|FG002|Phase II|Sponsor's decision to terminate|18|||
156905725|NCT00400764|566412554|FG003|Phase II|Sponsor's decision to terminate|22|||
156905726|NCT00400764|566412555|FG004|Phase II|Sponsor's decision to terminate|11|||
156905727|NCT00400764|566412551|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
156905728|NCT00400764|566412552|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
156905729|NCT00400764|566412553|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
156905730|NCT00400764|566412554|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
156905731|NCT00400764|566412555|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
156905732|NCT00400764|566412551|FG000|Phase II|Withdrawal by Subject|0|||
156905733|NCT00400764|566412552|FG001|Phase II|Withdrawal by Subject|0|||
156905734|NCT00400764|566412553|FG002|Phase II|Withdrawal by Subject|1|||
156905735|NCT00400764|566412554|FG003|Phase II|Withdrawal by Subject|1|||
156905736|NCT00400764|566412555|FG004|Phase II|Withdrawal by Subject|0|||
156905737|NCT02020577|566412556|FG000|Overall Study|Progressive disease|3|||
156905738|NCT02020577|566412557|FG001|Overall Study|Progressive disease|38|||
156905739|NCT02020577|566412556|FG000|Overall Study|Other AE or clinical progression|0|||
156905740|NCT02020577|566412557|FG001|Overall Study|Other AE or clinical progression|15|||
156905741|NCT02020577|566412556|FG000|Overall Study|Withdrawal by Subject|0|||
156905742|NCT02020577|566412557|FG001|Overall Study|Withdrawal by Subject|1|||
156905743|NCT02020577|566412556|FG000|Overall Study|Other than stated above|0|||
156905744|NCT02020577|566412557|FG001|Overall Study|Other than stated above|1|||
156905745|NCT01758523|566412560|FG000|Overall Study|Adverse Event|2|||
156905746|NCT01758523|566412561|FG001|Overall Study|Adverse Event|1|||
156905747|NCT01758523|566412560|FG000|Overall Study|Lack of Efficacy|4|||
156905748|NCT01758523|566412561|FG001|Overall Study|Lack of Efficacy|2|||
156905749|NCT01758523|566412560|FG000|Overall Study|Lost to Follow-up|3|||
156905750|NCT01758523|566412561|FG001|Overall Study|Lost to Follow-up|4|||
156905751|NCT01758523|566412560|FG000|Overall Study|Withdrawal by Subject|12|||
156905752|NCT01758523|566412561|FG001|Overall Study|Withdrawal by Subject|7|||
156905753|NCT01893203|566412562|FG000|Overall Study|Withdrawal by Subject|1|||
156905754|NCT00722800|566412563|FG000|Overall Study|Withdrawal by Subject|1|||
156905755|NCT00722800|566412564|FG001|Overall Study|Withdrawal by Subject|0|||
156905756|NCT00722800|566412563|FG000|Overall Study|Physician Decision|1|||
156905757|NCT00722800|566412564|FG001|Overall Study|Physician Decision|0|||
156905758|NCT04729621|566412565|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
156905759|NCT04729621|566412566|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
156905760|NCT04729621|566412567|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156905761|NCT04729621|566412568|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156905762|NCT04729621|566412569|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
156905763|NCT04729621|566412565|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
156905764|NCT04729621|566412566|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
156905765|NCT04729621|566412567|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156905766|NCT04729621|566412568|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156905767|NCT04729621|566412569|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
156905768|NCT04729621|566412565|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
156905769|NCT04729621|566412566|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
156905770|NCT04729621|566412567|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156905771|NCT04729621|566412568|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156905772|NCT04729621|566412569|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
156905773|NCT04729621|566412565|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156905774|NCT04729621|566412566|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
156905775|NCT04729621|566412567|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
156905776|NCT04729621|566412568|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
156905777|NCT04729621|566412569|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
156905778|NCT04729621|566412565|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156905779|NCT04729621|566412566|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156905780|NCT04729621|566412567|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156905781|NCT04729621|566412568|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
156905782|NCT04729621|566412569|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
156905783|NCT04729621|566412565|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
156905784|NCT04729621|566412566|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
156905785|NCT04729621|566412567|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
156905786|NCT04729621|566412568|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
156905787|NCT04729621|566412569|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
156905788|NCT00913380|566412570|FG000|Clinical Outcomes|Lost to Follow-up|6|||
156905789|NCT00913380|566412571|FG001|Clinical Outcomes|Lost to Follow-up|6|||
156905790|NCT01788228|566412572|FG000|Overall Study|Migrated/moved from study area|1|||
156905791|NCT01788228|566412573|FG001|Overall Study|Migrated/moved from study area|0|||
156905792|NCT03113071|566412577|FG000|Overall Study|Withdrawal by Subject|1|||
156905793|NCT03113071|566412578|FG001|Overall Study|Withdrawal by Subject|0|||
156905794|NCT01602120|566412581|FG000|Overall Study|Adverse Event|3|||
156905795|NCT01602120|566412582|FG001|Overall Study|Adverse Event|6|||
156905796|NCT01602120|566412583|FG002|Overall Study|Adverse Event|0|||
156905797|NCT01602120|566412584|FG003|Overall Study|Adverse Event|2|||
156905798|NCT01602120|566412581|FG000|Overall Study|Death|0|||
157159295|NCT02616185|567329467|FG006|Overall Study|Death|0|||
157159296|NCT02616185|567329468|FG007|Overall Study|Death|2|||
157159297|NCT02616185|567329469|FG008|Overall Study|Death|1|||
157159298|NCT02616185|567329461|FG000|Overall Study|Study terminated by sponsor|0|||
157159299|NCT02616185|567329462|FG001|Overall Study|Study terminated by sponsor|0|||
157159300|NCT02616185|567329463|FG002|Overall Study|Study terminated by sponsor|1|||
156905799|NCT01602120|566412582|FG001|Overall Study|Death|4|||
156905800|NCT01602120|566412583|FG002|Overall Study|Death|0|||
156905801|NCT01602120|566412584|FG003|Overall Study|Death|0|||
156905802|NCT01602120|566412581|FG000|Overall Study|Lost to Follow-up|0|||
156905803|NCT01602120|566412582|FG001|Overall Study|Lost to Follow-up|1|||
156905804|NCT01602120|566412583|FG002|Overall Study|Lost to Follow-up|0|||
156905805|NCT01602120|566412584|FG003|Overall Study|Lost to Follow-up|1|||
156905806|NCT01602120|566412581|FG000|Overall Study|Protocol Violation|1|||
156905807|NCT01602120|566412582|FG001|Overall Study|Protocol Violation|1|||
156905808|NCT01602120|566412583|FG002|Overall Study|Protocol Violation|0|||
156905809|NCT01602120|566412584|FG003|Overall Study|Protocol Violation|0|||
156905810|NCT01602120|566412581|FG000|Overall Study|Non-compliance|0|||
156905811|NCT01602120|566412582|FG001|Overall Study|Non-compliance|3|||
156905812|NCT01602120|566412583|FG002|Overall Study|Non-compliance|0|||
156905813|NCT01602120|566412584|FG003|Overall Study|Non-compliance|1|||
156905814|NCT01602120|566412581|FG000|Overall Study|Withdrawal by Subject|8|||
156905815|NCT01602120|566412582|FG001|Overall Study|Withdrawal by Subject|17|||
156905816|NCT01602120|566412583|FG002|Overall Study|Withdrawal by Subject|0|||
156905817|NCT01602120|566412584|FG003|Overall Study|Withdrawal by Subject|3|||
156905818|NCT01602120|566412581|FG000|Overall Study|Study Terminated by Sponsor|12|||
156905819|NCT01602120|566412582|FG001|Overall Study|Study Terminated by Sponsor|24|||
156905820|NCT01602120|566412583|FG002|Overall Study|Study Terminated by Sponsor|17|||
156905821|NCT01602120|566412584|FG003|Overall Study|Study Terminated by Sponsor|44|||
156905822|NCT01602120|566412581|FG000|Overall Study|Physician Decision|2|||
156905823|NCT01602120|566412582|FG001|Overall Study|Physician Decision|3|||
156905824|NCT01602120|566412583|FG002|Overall Study|Physician Decision|0|||
156905825|NCT01602120|566412584|FG003|Overall Study|Physician Decision|0|||
156905826|NCT01602120|566412581|FG000|Overall Study|Unspecified Reason|3|||
156905827|NCT01602120|566412582|FG001|Overall Study|Unspecified Reason|1|||
156905828|NCT01602120|566412583|FG002|Overall Study|Unspecified Reason|0|||
156905829|NCT01602120|566412584|FG003|Overall Study|Unspecified Reason|2|||
156905830|NCT01187433|566412591|FG000|Overall Study|Protocol Violation|6|||
156905831|NCT01187433|566412592|FG001|Overall Study|Protocol Violation|2|||
156905832|NCT01187433|566412591|FG000|Overall Study|Withdrawal by Subject|5|||
156905833|NCT01187433|566412592|FG001|Overall Study|Withdrawal by Subject|2|||
156905834|NCT04223973|566412593|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
156905835|NCT04223973|566412594|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
156905836|NCT04223973|566412593|FG000|Overall Study|Adverse Event|4|||
156905837|NCT04223973|566412594|FG001|Overall Study|Adverse Event|0|||
156905838|NCT04223973|566412593|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
156905839|NCT04223973|566412594|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
156905840|NCT04223973|566412593|FG000|Overall Study|Physician Decision|1|||
156905841|NCT04223973|566412594|FG001|Overall Study|Physician Decision|1|||
156905842|NCT04223973|566412593|FG000|Overall Study|Withdrawal by Subject|0|||
156905843|NCT04223973|566412594|FG001|Overall Study|Withdrawal by Subject|1|||
156905844|NCT00594659|566412597|FG000|Overall Study|Lost to Follow-up|13|||
156905845|NCT00594659|566412598|FG001|Overall Study|Lost to Follow-up|9|||
156905846|NCT00594659|566412599|FG002|Overall Study|Lost to Follow-up|7|||
156905847|NCT04439201|566412607|FG000|Overall Study|Ineligible|2|||
156905848|NCT04439201|566412607|FG000|Overall Study|Never start protocol therapy|1|||
156905849|NCT04439201|566412607|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
156905850|NCT04439201|566412607|FG000|Overall Study|Mutation status not confirmed|4|||
156905851|NCT04439201|566412607|FG000|Overall Study|Adverse Event|1|||
156905852|NCT04439201|566412607|FG000|Overall Study|Death|7|||
156905853|NCT04439201|566412607|FG000|Overall Study|Withdrawal by Subject|2|||
156905854|NCT04439201|566412607|FG000|Overall Study|Disease progression|20|||
156905855|NCT04439201|566412607|FG000|Overall Study|Alternative therapy|1|||
156905856|NCT04439201|566412607|FG000|Overall Study|Physician Decision|1|||
156905857|NCT05136690|566412608|FG000|Period 1|Withdrawal by Subject|0|||
156905858|NCT05136690|566412609|FG001|Period 1|Withdrawal by Subject|1|||
156905859|NCT05136690|566412608|FG000|Period 2|Lost to Follow-up|0|||
156905860|NCT05136690|566412609|FG001|Period 2|Lost to Follow-up|3|||
156905861|NCT05136690|566412608|FG000|Period 2|Withdrawal by Subject|0|||
156905862|NCT05136690|566412609|FG001|Period 2|Withdrawal by Subject|1|||
156905863|NCT03730012|566412611|FG000|Overall Study|Adverse Event|0|||
156905864|NCT03730012|566412612|FG001|Overall Study|Adverse Event|1|||
156905865|NCT03730012|566412611|FG000|Overall Study|Lack of Efficacy|1|||
156905866|NCT03730012|566412612|FG001|Overall Study|Lack of Efficacy|5|||
156905867|NCT03730012|566412611|FG000|Overall Study|Withdrawal by Subject|0|||
156905868|NCT03730012|566412612|FG001|Overall Study|Withdrawal by Subject|1|||
156905869|NCT03730012|566412611|FG000|Overall Study|Miscellaneous|2|||
156905870|NCT03730012|566412612|FG001|Overall Study|Miscellaneous|1|||
156905871|NCT01995825|566414446|FG000|Overall Study|Withdrawal by Subject|1|||
156905872|NCT01995825|566414447|FG001|Overall Study|Withdrawal by Subject|0|||
156905873|NCT01367002|566414448|FG000|Overall Study|Withdrawal by Subject|1|||
156905874|NCT01367002|566414449|FG001|Overall Study|Withdrawal by Subject|0|||
156905875|NCT01367002|566414448|FG000|Overall Study|Physician Decision|0|||
156905876|NCT01367002|566414449|FG001|Overall Study|Physician Decision|2|||
156905877|NCT01516437|566414450|FG000|Overall Study|Reason not specified|0|||
156905878|NCT01516437|566414451|FG001|Overall Study|Reason not specified|0|||
156905879|NCT01516437|566414452|FG002|Overall Study|Reason not specified|1|||
156905880|NCT01516437|566414453|FG003|Overall Study|Reason not specified|1|||
156905881|NCT00403234|566414454|FG000|Overall Study|Withdrawal by Subject|0|||
156905882|NCT00403234|566414455|FG001|Overall Study|Withdrawal by Subject|1|||
156905883|NCT00403234|566414456|FG002|Overall Study|Withdrawal by Subject|0|||
156905884|NCT00403234|566414457|FG003|Overall Study|Withdrawal by Subject|0|||
156905885|NCT00403234|566414454|FG000|Overall Study|Adverse Event|1|||
156905886|NCT00403234|566414455|FG001|Overall Study|Adverse Event|0|||
156905887|NCT00403234|566414456|FG002|Overall Study|Adverse Event|1|||
156905888|NCT00403234|566414457|FG003|Overall Study|Adverse Event|0|||
156905889|NCT02763462|566414462|FG000|Overall Study|Protocol Violation|6|||
156905890|NCT00129272|566414463|FG000|Overall Study|Lost to Follow-up|12|||
156905891|NCT00129272|566414464|FG001|Overall Study|Lost to Follow-up|11|||
156905892|NCT00129272|566414463|FG000|Overall Study|Withdrawal by Subject|5|||
156905893|NCT00129272|566414464|FG001|Overall Study|Withdrawal by Subject|11|||
156905894|NCT00675948|566414465|FG000|Overall Study|Adverse Event|23|||
156905895|NCT00675948|566414466|FG001|Overall Study|Adverse Event|1|||
156905896|NCT00675948|566414465|FG000|Overall Study|Lack of Efficacy|3|||
156905897|NCT00675948|566414466|FG001|Overall Study|Lack of Efficacy|0|||
156905898|NCT00675948|566414465|FG000|Overall Study|Withdrawal by Subject|7|||
156905899|NCT00675948|566414466|FG001|Overall Study|Withdrawal by Subject|0|||
156905900|NCT00675948|566414465|FG000|Overall Study|Lost to Follow-up|2|||
156905901|NCT00675948|566414466|FG001|Overall Study|Lost to Follow-up|0|||
156905902|NCT00675948|566414465|FG000|Overall Study|Protocol Violation|1|||
156905903|NCT00675948|566414466|FG001|Overall Study|Protocol Violation|0|||
156905904|NCT00675948|566414465|FG000|Overall Study|Pain under control|1|||
156905905|NCT00675948|566414466|FG001|Overall Study|Pain under control|0|||
156905906|NCT00675948|566414465|FG000|Overall Study|Sponsor decision|0|||
156905907|NCT00675948|566414466|FG001|Overall Study|Sponsor decision|1|||
156905908|NCT00675948|566414465|FG000|Overall Study|Patient died|1|||
156905909|NCT00675948|566414466|FG001|Overall Study|Patient died|0|||
156905910|NCT00675948|566414465|FG000|Overall Study|Patient unable to comply with diaries|1|||
156905911|NCT00675948|566414466|FG001|Overall Study|Patient unable to comply with diaries|0|||
156905912|NCT00675948|566414465|FG000|Overall Study|Patient feels unable to take medication|0|||
156905913|NCT00675948|566414466|FG001|Overall Study|Patient feels unable to take medication|1|||
156905914|NCT02100514|566414470|FG000|Treatment Period|Adverse Event|0|||
156905915|NCT02100514|566414471|FG001|Treatment Period|Adverse Event|5|||
156905916|NCT02100514|566414472|FG002|Treatment Period|Adverse Event|0|||
156905917|NCT02100514|566414473|FG003|Treatment Period|Adverse Event|0|||
156905918|NCT02100514|566414474|FG004|Treatment Period|Adverse Event|0|||
156905919|NCT02100514|566414470|FG000|Treatment Period|Death|2|||
156905920|NCT02100514|566414471|FG001|Treatment Period|Death|2|||
156905921|NCT02100514|566414472|FG002|Treatment Period|Death|0|||
156905922|NCT02100514|566414473|FG003|Treatment Period|Death|0|||
156905923|NCT02100514|566414474|FG004|Treatment Period|Death|0|||
156905924|NCT02100514|566414470|FG000|Treatment Period|Lost to Follow-up|5|||
156905925|NCT02100514|566414471|FG001|Treatment Period|Lost to Follow-up|17|||
156905926|NCT02100514|566414472|FG002|Treatment Period|Lost to Follow-up|0|||
156905927|NCT02100514|566414473|FG003|Treatment Period|Lost to Follow-up|0|||
156905928|NCT02100514|566414474|FG004|Treatment Period|Lost to Follow-up|0|||
156905929|NCT02100514|566414470|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
156905930|NCT02100514|566414471|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
156905931|NCT02100514|566414472|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
156905932|NCT02100514|566414473|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
156905933|NCT02100514|566414474|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
156905934|NCT02100514|566414470|FG000|Treatment Period|Protocol Violation|1|||
156905935|NCT02100514|566414471|FG001|Treatment Period|Protocol Violation|1|||
156905936|NCT02100514|566414472|FG002|Treatment Period|Protocol Violation|0|||
156905937|NCT02100514|566414473|FG003|Treatment Period|Protocol Violation|0|||
156905938|NCT02100514|566414474|FG004|Treatment Period|Protocol Violation|0|||
156905939|NCT02100514|566414470|FG000|Treatment Period|Withdrawal by Subject|12|||
156905940|NCT02100514|566414471|FG001|Treatment Period|Withdrawal by Subject|37|||
156905941|NCT02100514|566414472|FG002|Treatment Period|Withdrawal by Subject|0|||
156905942|NCT02100514|566414473|FG003|Treatment Period|Withdrawal by Subject|0|||
156905943|NCT02100514|566414474|FG004|Treatment Period|Withdrawal by Subject|0|||
156905944|NCT02100514|566414470|FG000|Treatment Period|Other|9|||
156905945|NCT02100514|566414471|FG001|Treatment Period|Other|11|||
156905946|NCT02100514|566414472|FG002|Treatment Period|Other|0|||
156905947|NCT02100514|566414473|FG003|Treatment Period|Other|0|||
156905948|NCT02100514|566414474|FG004|Treatment Period|Other|0|||
156905949|NCT02100514|566414470|FG000|Extension Period|Withdrew consent|0|||
156905950|NCT02100514|566414471|FG001|Extension Period|Withdrew consent|0|||
156905951|NCT02100514|566414472|FG002|Extension Period|Withdrew consent|2|||
156905952|NCT02100514|566414473|FG003|Extension Period|Withdrew consent|0|||
156905953|NCT02100514|566414474|FG004|Extension Period|Withdrew consent|0|||
156905954|NCT01896102|566414475|FG000|Overall Study|Death|1|||
156905955|NCT01896102|566414475|FG000|Overall Study|Participant to receive allogenic transplant|2|||
156905956|NCT00074984|566414477|FG000|Overall Study|Death|1|||
156905957|NCT00074984|566414478|FG001|Overall Study|Death|2|||
156905958|NCT00074984|566414477|FG000|Overall Study|Withdrawal by Subject|2|||
156905959|NCT00074984|566414478|FG001|Overall Study|Withdrawal by Subject|3|||
156905960|NCT00074984|566414477|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
156905961|NCT00074984|566414478|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
156905962|NCT04289623|566414479|FG000|Wave 1 Emails|Email was not delivered|268|||
156905963|NCT04289623|566414480|FG001|Wave 1 Emails|Email was not delivered|257|||
156905964|NCT04289623|566414481|FG002|Wave 1 Emails|Email was not delivered|0|||
156905965|NCT04289623|566414482|FG003|Wave 1 Emails|Email was not delivered|0|||
156905966|NCT04289623|566414483|FG004|Wave 1 Emails|Email was not delivered|0|||
156905967|NCT04289623|566414484|FG005|Wave 1 Emails|Email was not delivered|0|||
156905968|NCT03758443|566414486|FG000|Induction Period|Adverse Event|2|||
156905969|NCT03758443|566414487|FG001|Induction Period|Adverse Event|4|||
156905970|NCT03758443|566414488|FG002|Induction Period|Adverse Event|2|||
156905971|NCT03758443|566414489|FG003|Induction Period|Adverse Event|3|||
156905972|NCT03758443|566414486|FG000|Induction Period|Physician Decision|1|||
156905973|NCT03758443|566414487|FG001|Induction Period|Physician Decision|1|||
156905974|NCT03758443|566414488|FG002|Induction Period|Physician Decision|3|||
156905975|NCT03758443|566414489|FG003|Induction Period|Physician Decision|0|||
156905976|NCT03758443|566414486|FG000|Induction Period|Protocol Violation|0|||
156905977|NCT03758443|566414487|FG001|Induction Period|Protocol Violation|0|||
156905978|NCT03758443|566414488|FG002|Induction Period|Protocol Violation|0|||
156905979|NCT03758443|566414489|FG003|Induction Period|Protocol Violation|1|||
156905980|NCT03758443|566414486|FG000|Induction Period|Withdrawal by Subject|3|||
156905981|NCT03758443|566414487|FG001|Induction Period|Withdrawal by Subject|2|||
156905982|NCT03758443|566414488|FG002|Induction Period|Withdrawal by Subject|2|||
156905983|NCT03758443|566414489|FG003|Induction Period|Withdrawal by Subject|4|||
156905984|NCT03758443|566414486|FG000|Extended Induction Period|Adverse Event|1|||
156905985|NCT03758443|566414487|FG001|Extended Induction Period|Adverse Event|1|||
156905986|NCT03758443|566414488|FG002|Extended Induction Period|Adverse Event|0|||
156905987|NCT03758443|566414489|FG003|Extended Induction Period|Adverse Event|1|||
156905988|NCT03758443|566414486|FG000|Extended Induction Period|Lost to Follow-up|1|||
156905989|NCT03758443|566414487|FG001|Extended Induction Period|Lost to Follow-up|0|||
156905990|NCT03758443|566414488|FG002|Extended Induction Period|Lost to Follow-up|0|||
156905991|NCT03758443|566414489|FG003|Extended Induction Period|Lost to Follow-up|0|||
156905992|NCT03758443|566414486|FG000|Extended Induction Period|Physician Decision|2|||
157026753|NCT01824875|566853276|FG000|Overall Study|Complicating disease|1|||
157159301|NCT02616185|567329464|FG003|Overall Study|Study terminated by sponsor|0|||
157159302|NCT02616185|567329465|FG004|Overall Study|Study terminated by sponsor|0|||
157159303|NCT02616185|567329466|FG005|Overall Study|Study terminated by sponsor|0|||
157159304|NCT02616185|567329467|FG006|Overall Study|Study terminated by sponsor|5|||
157159305|NCT02616185|567329468|FG007|Overall Study|Study terminated by sponsor|2|||
156905993|NCT03758443|566414487|FG001|Extended Induction Period|Physician Decision|1|||
156905994|NCT03758443|566414488|FG002|Extended Induction Period|Physician Decision|2|||
157026754|NCT01824875|566853277|FG001|Overall Study|Complicating disease|0|||
157159306|NCT02616185|567329469|FG008|Overall Study|Study terminated by sponsor|0|||
157159307|NCT02616185|567329461|FG000|Overall Study|Participant refused further follow-up|1|||
157225581|NCT00337571|567571476|FG002|Overall Study|Lack of Efficacy|0|||
156905995|NCT03758443|566414489|FG003|Extended Induction Period|Physician Decision|2|||
156905996|NCT03758443|566414486|FG000|Extended Induction Period|Protocol Violation|0|||
156905997|NCT03758443|566414487|FG001|Extended Induction Period|Protocol Violation|0|||
156905998|NCT03758443|566414488|FG002|Extended Induction Period|Protocol Violation|0|||
156905999|NCT03758443|566414489|FG003|Extended Induction Period|Protocol Violation|1|||
156906000|NCT03758443|566414486|FG000|Extended Induction Period|Withdrawal by Subject|8|||
156906001|NCT03758443|566414487|FG001|Extended Induction Period|Withdrawal by Subject|1|||
156906002|NCT03758443|566414488|FG002|Extended Induction Period|Withdrawal by Subject|7|||
156906003|NCT03758443|566414489|FG003|Extended Induction Period|Withdrawal by Subject|3|||
156906004|NCT03758443|566414486|FG000|Extended Induction Period|Miscellaneous|1|||
156906005|NCT03758443|566414487|FG001|Extended Induction Period|Miscellaneous|0|||
156906006|NCT03758443|566414488|FG002|Extended Induction Period|Miscellaneous|0|||
156906007|NCT03758443|566414489|FG003|Extended Induction Period|Miscellaneous|0|||
156906008|NCT03758443|566414486|FG000|Maintenance Period|Adverse Event|1|||
156906009|NCT03758443|566414487|FG001|Maintenance Period|Adverse Event|2|||
156906010|NCT03758443|566414488|FG002|Maintenance Period|Adverse Event|0|||
156906011|NCT03758443|566414489|FG003|Maintenance Period|Adverse Event|0|||
156906012|NCT03758443|566414486|FG000|Maintenance Period|Lost to Follow-up|0|||
156906013|NCT03758443|566414487|FG001|Maintenance Period|Lost to Follow-up|0|||
156906014|NCT03758443|566414488|FG002|Maintenance Period|Lost to Follow-up|0|||
156906015|NCT03758443|566414489|FG003|Maintenance Period|Lost to Follow-up|1|||
156906016|NCT03758443|566414486|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
156906017|NCT03758443|566414487|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
156906018|NCT03758443|566414488|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
156906019|NCT03758443|566414489|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
156906020|NCT03758443|566414486|FG000|Maintenance Period|Protocol Violation|0|||
156906021|NCT03758443|566414487|FG001|Maintenance Period|Protocol Violation|1|||
156906022|NCT03758443|566414488|FG002|Maintenance Period|Protocol Violation|0|||
156906023|NCT03758443|566414489|FG003|Maintenance Period|Protocol Violation|0|||
156906024|NCT03758443|566414486|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
156906025|NCT03758443|566414487|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
156906026|NCT03758443|566414488|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
156906027|NCT03758443|566414489|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
156906028|NCT03758443|566414486|FG000|Maintenance Period|Withdrawal by Subject|1|||
156906029|NCT03758443|566414487|FG001|Maintenance Period|Withdrawal by Subject|0|||
156906030|NCT03758443|566414488|FG002|Maintenance Period|Withdrawal by Subject|1|||
156906031|NCT03758443|566414489|FG003|Maintenance Period|Withdrawal by Subject|1|||
156906032|NCT03758443|566414486|FG000|Maintenance Period|Miscellaneous|0|||
156906033|NCT03758443|566414487|FG001|Maintenance Period|Miscellaneous|0|||
156906034|NCT03758443|566414488|FG002|Maintenance Period|Miscellaneous|1|||
156906035|NCT03758443|566414489|FG003|Maintenance Period|Miscellaneous|0|||
157026755|NCT01824875|566853276|FG000|Overall Study|Physician Decision|0|||
157026756|NCT01824875|566853277|FG001|Overall Study|Physician Decision|1|||
157026757|NCT01824875|566853276|FG000|Overall Study|Non-compliance|1|||
157026758|NCT01824875|566853277|FG001|Overall Study|Non-compliance|1|||
157026759|NCT01824875|566853276|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
157026760|NCT01824875|566853277|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
157026761|NCT01824875|566853276|FG000|Overall Study|Administrative issues|0|||
157026762|NCT01824875|566853277|FG001|Overall Study|Administrative issues|2|||
157026763|NCT01824875|566853276|FG000|Overall Study|Ineligible or never started treatment|9|||
157026764|NCT01824875|566853277|FG001|Overall Study|Ineligible or never started treatment|5|||
157026765|NCT01824875|566853276|FG000|Overall Study|Other|0|||
157026766|NCT01824875|566853277|FG001|Overall Study|Other|2|||
157026767|NCT00433329|566853280|FG000|Overall Study|Adverse Event|9|||
157026768|NCT00433329|566853280|FG000|Overall Study|Death|4|||
157026769|NCT00433329|566853280|FG000|Overall Study|Withdrew consent|3|||
157026770|NCT00433329|566853280|FG000|Overall Study|Discontinued sildenafil|2|||
157026771|NCT00433329|566853280|FG000|Overall Study|Moved out of state|1|||
157026772|NCT00433329|566853280|FG000|Overall Study|Lost to Follow-up|1|||
157026773|NCT00433329|566853280|FG000|Overall Study|Physician Decision|1|||
157026774|NCT03907878|566853282|FG000|Treatment Period|Withdrawal by Subject|5|||
157026775|NCT03907878|566853282|FG000|Treatment Period|Adverse Event|4|||
157026776|NCT03907878|566853282|FG000|Treatment Period|Lack of Efficacy|1|||
157026777|NCT03907878|566853282|FG000|Treatment Period|Protocol Violation|1|||
157026778|NCT03907878|566853282|FG000|Follow-up Period|Adverse Event|3|||
157026779|NCT03907878|566853282|FG000|Follow-up Period|Withdrawal by Subject|3|||
157026780|NCT03904147|566853287|FG000|Overall Study|Death|15|||
157026781|NCT03904147|566853288|FG001|Overall Study|Death|13|||
156906036|NCT03080454|566414490|FG000|Baseline|Adverse Event|2|||
156906037|NCT03080454|566414490|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
156906038|NCT03080454|566414490|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
156906039|NCT04138810|566414494|FG000|Overall Study|Withdrawal by Subject|0|||
157026782|NCT03904147|566853289|FG002|Overall Study|Death|15|||
156906040|NCT04138810|566414495|FG001|Overall Study|Withdrawal by Subject|1|||
156906041|NCT04138810|566414494|FG000|Overall Study|Subject cancelled surgery|1|||
156906042|NCT04138810|566414495|FG001|Overall Study|Subject cancelled surgery|0|||
157026783|NCT03904147|566853287|FG000|Overall Study|Withdrawal by Subject|7|||
157026784|NCT03904147|566853288|FG001|Overall Study|Withdrawal by Subject|12|||
157026785|NCT03904147|566853289|FG002|Overall Study|Withdrawal by Subject|1|||
157225582|NCT00337571|567571477|FG003|Overall Study|Lack of Efficacy|0|||
157159308|NCT02616185|567329462|FG001|Overall Study|Participant refused further follow-up|1|||
157159309|NCT02616185|567329463|FG002|Overall Study|Participant refused further follow-up|2|||
157159310|NCT02616185|567329464|FG003|Overall Study|Participant refused further follow-up|3|||
157159311|NCT02616185|567329465|FG004|Overall Study|Participant refused further follow-up|4|||
157159312|NCT02616185|567329466|FG005|Overall Study|Participant refused further follow-up|0|||
157159313|NCT02616185|567329467|FG006|Overall Study|Participant refused further follow-up|3|||
157159314|NCT02616185|567329468|FG007|Overall Study|Participant refused further follow-up|4|||
157159315|NCT02616185|567329469|FG008|Overall Study|Participant refused further follow-up|3|||
157159316|NCT02616185|567329461|FG000|Overall Study|Not reported|0|||
157159317|NCT02616185|567329462|FG001|Overall Study|Not reported|0|||
157159318|NCT02616185|567329463|FG002|Overall Study|Not reported|0|||
157159319|NCT02616185|567329464|FG003|Overall Study|Not reported|1|||
157159320|NCT02616185|567329465|FG004|Overall Study|Not reported|3|||
157159321|NCT02616185|567329466|FG005|Overall Study|Not reported|1|||
157159322|NCT02616185|567329467|FG006|Overall Study|Not reported|0|||
157159323|NCT02616185|567329468|FG007|Overall Study|Not reported|5|||
157159324|NCT02616185|567329469|FG008|Overall Study|Not reported|2|||
157159325|NCT01303380|567329470|FG000|Overall Study|Lack of compliance to study procedures|1|||
157159326|NCT03621943|567329471|FG000|First Randomized Intervention|Lost to Follow-up|51|||
157159327|NCT03621943|567329472|FG001|First Randomized Intervention|Lost to Follow-up|54|||
157159328|NCT03621943|567329471|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
157159329|NCT03621943|567329472|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
157159330|NCT03621943|567329471|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
157159331|NCT03621943|567329472|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
157159332|NCT03621943|567329471|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
157159333|NCT03621943|567329472|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
157159334|NCT00967226|567329473|FG000|Overall Study|Adverse Event|0|||
157159335|NCT00967226|567329474|FG001|Overall Study|Adverse Event|5|||
156859689|NCT00001832|566243162|FG004|Treatment Period|Not treated|0|||
156859690|NCT00001832|566243163|FG005|Treatment Period|Not treated|0|||
156859691|NCT00001832|566243164|FG006|Treatment Period|Not treated|0|||
156859692|NCT00001832|566243165|FG007|Treatment Period|Not treated|1|||
156859693|NCT00001832|566243166|FG008|Treatment Period|Not treated|0|||
156859694|NCT00001832|566243167|FG009|Treatment Period|Not treated|0|||
156859695|NCT00001832|566243168|FG010|Treatment Period|Not treated|0|||
156859696|NCT00001832|566243169|FG011|Treatment Period|Not treated|0|||
156859697|NCT00001832|566243170|FG012|Treatment Period|Not treated|0|||
156859698|NCT00001832|566243171|FG013|Treatment Period|Not treated|0|||
156859699|NCT00001832|566243172|FG014|Treatment Period|Not treated|0|||
156859700|NCT00713609|566243173|FG000|Overall Study|Adverse Event|2|||
156859701|NCT00713609|566243174|FG001|Overall Study|Adverse Event|0|||
156859702|NCT00713609|566243175|FG002|Overall Study|Adverse Event|2|||
156859703|NCT00713609|566243176|FG003|Overall Study|Adverse Event|2|||
156859704|NCT00713609|566243177|FG004|Overall Study|Adverse Event|3|||
156859705|NCT00713609|566243178|FG005|Overall Study|Adverse Event|1|||
156859706|NCT00713609|566243173|FG000|Overall Study|Lost to Follow-up|5|||
156859707|NCT00713609|566243174|FG001|Overall Study|Lost to Follow-up|7|||
156859708|NCT00713609|566243175|FG002|Overall Study|Lost to Follow-up|5|||
156859709|NCT00713609|566243176|FG003|Overall Study|Lost to Follow-up|5|||
156859710|NCT00713609|566243177|FG004|Overall Study|Lost to Follow-up|7|||
156859711|NCT00713609|566243178|FG005|Overall Study|Lost to Follow-up|0|||
156859712|NCT00713609|566243173|FG000|Overall Study|Lack of Efficacy|1|||
156859713|NCT00713609|566243174|FG001|Overall Study|Lack of Efficacy|3|||
156859714|NCT00713609|566243175|FG002|Overall Study|Lack of Efficacy|0|||
156859715|NCT00713609|566243176|FG003|Overall Study|Lack of Efficacy|0|||
156859716|NCT00713609|566243177|FG004|Overall Study|Lack of Efficacy|1|||
156859717|NCT00713609|566243178|FG005|Overall Study|Lack of Efficacy|0|||
156859718|NCT00713609|566243173|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
156859719|NCT00713609|566243174|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
156859720|NCT00713609|566243175|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
156859721|NCT00713609|566243176|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
156859722|NCT00713609|566243177|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
156859723|NCT00713609|566243178|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
156859724|NCT00713609|566243173|FG000|Overall Study|Withdrawal by Subject|6|||
156859725|NCT00713609|566243174|FG001|Overall Study|Withdrawal by Subject|1|||
156859726|NCT00713609|566243175|FG002|Overall Study|Withdrawal by Subject|5|||
156859727|NCT00713609|566243176|FG003|Overall Study|Withdrawal by Subject|1|||
156859728|NCT00713609|566243177|FG004|Overall Study|Withdrawal by Subject|5|||
156859729|NCT00713609|566243178|FG005|Overall Study|Withdrawal by Subject|7|||
156859730|NCT00713609|566243173|FG000|Overall Study|Protocol Violation|6|||
156859731|NCT00713609|566243174|FG001|Overall Study|Protocol Violation|3|||
156859732|NCT00713609|566243175|FG002|Overall Study|Protocol Violation|1|||
156859733|NCT00713609|566243176|FG003|Overall Study|Protocol Violation|1|||
156859734|NCT00713609|566243177|FG004|Overall Study|Protocol Violation|2|||
156859735|NCT00713609|566243178|FG005|Overall Study|Protocol Violation|0|||
156859736|NCT04529083|566243179|FG000|Overall Study|Withdrawal by Subject|3|||
157159336|NCT00967226|567329473|FG000|Overall Study|Protocol Violation|2|||
157159337|NCT00967226|567329474|FG001|Overall Study|Protocol Violation|0|||
157159338|NCT00967226|567329473|FG000|Overall Study|Physician Decision|0|||
157159339|NCT00967226|567329474|FG001|Overall Study|Physician Decision|1|||
157159340|NCT02174861|567329475|FG000|Overall Study|Decision by sponsor|8|||
157159341|NCT02174861|567329475|FG000|Overall Study|Withdrawal by Subject|124|||
157159342|NCT02174861|567329475|FG000|Overall Study|Lost to Follow-up|26|||
157159343|NCT01215734|567329476|FG000|Overall Study|Death|0|||
157159344|NCT01215734|567329477|FG001|Overall Study|Death|1|||
157159345|NCT00315705|567329478|FG000|Phase 1|Refused further treatment|1|||
157159346|NCT00315705|567329478|FG000|Phase 1|Failure to achieve response|8|||
157159347|NCT00315705|567329478|FG000|Phase 1|Disease relapse|4|||
157159348|NCT00315705|567329478|FG000|Phase 1|Scheduled for transplant|9|||
157159349|NCT00315705|567329478|FG000|Phase 1|Death|3|||
157159350|NCT00315705|567329478|FG000|Phase 2|Physician Decision|4|||
157159351|NCT00315705|567329478|FG000|Phase 2|Adverse Event|1|||
157159352|NCT00315705|567329478|FG000|Phase 2|Failure to achieve response|3|||
157159353|NCT00315705|567329478|FG000|Phase 2|Disease relapse|1|||
157159354|NCT00315705|567329478|FG000|Phase 2|Scheduled for transplant|8|||
157159355|NCT00315705|567329478|FG000|Phase 2|Other|1|||
157159356|NCT00315705|567329478|FG000|Phase 2|Death|7|||
157159357|NCT01346371|567329479|FG000|Overall Study|Lost to Follow-up|2|||
157159358|NCT01346371|567329480|FG001|Overall Study|Lost to Follow-up|0|||
157159359|NCT01716533|567329481|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
157159360|NCT01716533|567329482|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
157159361|NCT01716533|567329483|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
157159362|NCT01716533|567329484|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
157159363|NCT01716533|567329481|FG000|Overall Study|Withdrawal by Subject|0|||
157159364|NCT01716533|567329482|FG001|Overall Study|Withdrawal by Subject|0|||
157159365|NCT01716533|567329483|FG002|Overall Study|Withdrawal by Subject|0|||
157159366|NCT01716533|567329484|FG003|Overall Study|Withdrawal by Subject|5|||
157159367|NCT01716533|567329481|FG000|Overall Study|Death|0|||
157159368|NCT01716533|567329482|FG001|Overall Study|Death|0|||
157159369|NCT01716533|567329483|FG002|Overall Study|Death|0|||
157159370|NCT01716533|567329484|FG003|Overall Study|Death|2|||
157159371|NCT01716533|567329481|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
157159372|NCT01716533|567329482|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
157159373|NCT01716533|567329483|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
157159374|NCT01716533|567329484|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
157159375|NCT01670656|567329494|FG000|Overall Study|Non-compliance with study drug|0|||
157159376|NCT01670656|567329495|FG001|Overall Study|Non-compliance with study drug|0|||
157159377|NCT01670656|567329496|FG002|Overall Study|Non-compliance with study drug|3|||
157159378|NCT01670656|567329497|FG003|Overall Study|Non-compliance with study drug|0|||
157159379|NCT01670656|567329498|FG004|Overall Study|Non-compliance with study drug|1|||
157159380|NCT01670656|567329494|FG000|Overall Study|Pregnancy|0|||
157159381|NCT01670656|567329495|FG001|Overall Study|Pregnancy|0|||
157159382|NCT01670656|567329496|FG002|Overall Study|Pregnancy|0|||
157159383|NCT01670656|567329497|FG003|Overall Study|Pregnancy|0|||
157159384|NCT01670656|567329498|FG004|Overall Study|Pregnancy|1|||
156859737|NCT03305666|566243184|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
156859738|NCT03305666|566243185|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
156859739|NCT04196686|566243186|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
156859740|NCT04196686|566243187|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
156859741|NCT03780452|566243191|FG000|Overall Study|Screening failure|2|||
156859742|NCT00914849|566243192|FG000|Overall Study|Withdrawal by Subject|1|||
156859743|NCT00914849|566243193|FG001|Overall Study|Withdrawal by Subject|0|||
156859744|NCT00914849|566243192|FG000|Overall Study|Not eligible|0|||
156859745|NCT00914849|566243193|FG001|Overall Study|Not eligible|1|||
156859746|NCT01001221|566243196|FG000|Overall Study|Adverse Event|1|||
156859747|NCT01001221|566243197|FG001|Overall Study|Adverse Event|2|||
156859748|NCT01001221|566243198|FG002|Overall Study|Adverse Event|0|||
156859749|NCT01001221|566243199|FG003|Overall Study|Adverse Event|2|||
156859750|NCT01001221|566243200|FG004|Overall Study|Adverse Event|0|||
156859751|NCT01001221|566243196|FG000|Overall Study|Disease progression|3|||
156859752|NCT01001221|566243197|FG001|Overall Study|Disease progression|2|||
156859753|NCT01001221|566243198|FG002|Overall Study|Disease progression|2|||
156859754|NCT01001221|566243199|FG003|Overall Study|Disease progression|4|||
156859755|NCT01001221|566243200|FG004|Overall Study|Disease progression|0|||
157159385|NCT01670656|567329494|FG000|Overall Study|Withdrawal by Subject|1|||
157159386|NCT01670656|567329495|FG001|Overall Study|Withdrawal by Subject|1|||
157159387|NCT01670656|567329496|FG002|Overall Study|Withdrawal by Subject|0|||
157159388|NCT01670656|567329497|FG003|Overall Study|Withdrawal by Subject|0|||
157159389|NCT01670656|567329498|FG004|Overall Study|Withdrawal by Subject|0|||
157159390|NCT01670656|567329494|FG000|Overall Study|Non-compliance with protocol|0|||
157159391|NCT01670656|567329495|FG001|Overall Study|Non-compliance with protocol|3|||
157159392|NCT01670656|567329496|FG002|Overall Study|Non-compliance with protocol|1|||
157159393|NCT01670656|567329497|FG003|Overall Study|Non-compliance with protocol|1|||
157159394|NCT01670656|567329498|FG004|Overall Study|Non-compliance with protocol|2|||
156906043|NCT00696800|566414496|FG000|Overall Study|Adverse Event|16|||
156906044|NCT00696800|566414497|FG001|Overall Study|Adverse Event|3|||
156906045|NCT00696800|566414496|FG000|Overall Study|Insufficient compliance with medication|2|||
156906046|NCT00696800|566414497|FG001|Overall Study|Insufficient compliance with medication|1|||
156906047|NCT00696800|566414496|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
156906048|NCT00696800|566414497|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
156906049|NCT00696800|566414496|FG000|Overall Study|Insufficient ovarian response|4|||
156906050|NCT00696800|566414497|FG001|Overall Study|Insufficient ovarian response|1|||
156906051|NCT00696800|566414496|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
156906052|NCT00696800|566414497|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
156906053|NCT00696800|566414496|FG000|Overall Study|Too high ovarian response|6|||
156906054|NCT00696800|566414497|FG001|Overall Study|Too high ovarian response|1|||
156906055|NCT00696800|566414496|FG000|Overall Study|No/too few/bad quality oocytes|4|||
156906056|NCT00696800|566414497|FG001|Overall Study|No/too few/bad quality oocytes|3|||
156906057|NCT00696800|566414496|FG000|Overall Study|No/abnormal fertilization|11|||
156906058|NCT00696800|566414497|FG001|Overall Study|No/abnormal fertilization|13|||
156906059|NCT00696800|566414496|FG000|Overall Study|No/too few/bad quality embryos|24|||
156906060|NCT00696800|566414497|FG001|Overall Study|No/too few/bad quality embryos|18|||
156906061|NCT00696800|566414496|FG000|Overall Study|Other Reasons|5|||
156906062|NCT00696800|566414497|FG001|Overall Study|Other Reasons|3|||
156906063|NCT00696800|566414496|FG000|Overall Study|Not treated|1|||
156906064|NCT00696800|566414497|FG001|Overall Study|Not treated|2|||
156906065|NCT00413244|566414503|FG000|Overall Study|Withdrawal by Subject|10|||
156906066|NCT00413244|566414504|FG001|Overall Study|Withdrawal by Subject|1|||
156906067|NCT01058655|566414506|FG000|Overall Study|Withdrawal by Subject|1|||
156906068|NCT01058655|566414507|FG001|Overall Study|Withdrawal by Subject|0|||
156906069|NCT01058655|566414508|FG002|Overall Study|Withdrawal by Subject|3|||
156906070|NCT01058655|566414509|FG003|Overall Study|Withdrawal by Subject|4|||
156906071|NCT01058655|566414506|FG000|Overall Study|Prolonged Treatment Delay|0|||
156906072|NCT01058655|566414507|FG001|Overall Study|Prolonged Treatment Delay|0|||
156906073|NCT01058655|566414508|FG002|Overall Study|Prolonged Treatment Delay|0|||
156906074|NCT01058655|566414509|FG003|Overall Study|Prolonged Treatment Delay|2|||
156906075|NCT01058655|566414506|FG000|Overall Study|Symptomatic Deterioration|0|||
156906076|NCT01058655|566414507|FG001|Overall Study|Symptomatic Deterioration|0|||
156906077|NCT01058655|566414508|FG002|Overall Study|Symptomatic Deterioration|0|||
156906078|NCT01058655|566414509|FG003|Overall Study|Symptomatic Deterioration|1|||
156906079|NCT01058655|566414506|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
156906080|NCT01058655|566414507|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
156906081|NCT01058655|566414508|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
156906082|NCT01058655|566414509|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
156906083|NCT01058655|566414506|FG000|Overall Study|Death|0|||
156906084|NCT01058655|566414507|FG001|Overall Study|Death|1|||
156906085|NCT01058655|566414508|FG002|Overall Study|Death|1|||
156906086|NCT01058655|566414509|FG003|Overall Study|Death|0|||
156906087|NCT01058655|566414506|FG000|Overall Study|Disease Progression|1|||
156906088|NCT01058655|566414507|FG001|Overall Study|Disease Progression|2|||
156906089|NCT01058655|566414508|FG002|Overall Study|Disease Progression|4|||
156906090|NCT01058655|566414509|FG003|Overall Study|Disease Progression|24|||
156906091|NCT01058655|566414506|FG000|Overall Study|Other|0|||
156906092|NCT01058655|566414507|FG001|Overall Study|Other|0|||
156906093|NCT01058655|566414508|FG002|Overall Study|Other|0|||
157159395|NCT01670656|567329494|FG000|Overall Study|Adverse Event|2|||
157159396|NCT01670656|567329495|FG001|Overall Study|Adverse Event|2|||
157159397|NCT01670656|567329496|FG002|Overall Study|Adverse Event|2|||
157159398|NCT01670656|567329497|FG003|Overall Study|Adverse Event|3|||
157159399|NCT01670656|567329498|FG004|Overall Study|Adverse Event|3|||
157159400|NCT01670656|567329494|FG000|Overall Study|Subject withdrew consent|0|||
157159401|NCT01670656|567329495|FG001|Overall Study|Subject withdrew consent|1|||
157159402|NCT01670656|567329496|FG002|Overall Study|Subject withdrew consent|2|||
156906094|NCT01058655|566414509|FG003|Overall Study|Other|4|||
156906095|NCT01609231|566414510|FG000|Overall Study|Adverse Event|1|||
156906096|NCT01609231|566414511|FG001|Overall Study|Adverse Event|3|||
156906097|NCT01609231|566414510|FG000|Overall Study|Physician Decision|1|||
156906098|NCT01609231|566414511|FG001|Overall Study|Physician Decision|0|||
156906099|NCT01609231|566414510|FG000|Overall Study|Withdrawal by Subject|1|||
156906100|NCT01609231|566414511|FG001|Overall Study|Withdrawal by Subject|0|||
156906101|NCT01180647|566414512|FG000|Overall Study|Lost to Follow-up|5|||
156906102|NCT01180647|566414513|FG001|Overall Study|Lost to Follow-up|6|||
156906103|NCT00494299|566414522|FG000|Overall Study|Adverse Event|93|||
156906104|NCT00494299|566414523|FG001|Overall Study|Adverse Event|13|||
156906105|NCT00494299|566414522|FG000|Overall Study|Lost to Follow-up|1|||
156906106|NCT00494299|566414523|FG001|Overall Study|Lost to Follow-up|0|||
156906107|NCT00494299|566414522|FG000|Overall Study|Physician Decision|0|||
156906108|NCT00494299|566414523|FG001|Overall Study|Physician Decision|2|||
156906109|NCT00494299|566414522|FG000|Overall Study|Protocol Violation|1|||
157159403|NCT01670656|567329497|FG003|Overall Study|Subject withdrew consent|1|||
156906110|NCT00494299|566414523|FG001|Overall Study|Protocol Violation|2|||
156906111|NCT00494299|566414522|FG000|Overall Study|Withdrawal by Subject|8|||
156906112|NCT00494299|566414523|FG001|Overall Study|Withdrawal by Subject|3|||
156906113|NCT00494299|566414522|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
156906114|NCT00494299|566414523|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
156906115|NCT00494299|566414522|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
156906116|NCT00494299|566414523|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
156906117|NCT00494299|566414522|FG000|Overall Study|Site Closed by Sponsor|6|||
156906118|NCT00494299|566414523|FG001|Overall Study|Site Closed by Sponsor|0|||
156906119|NCT00494299|566414522|FG000|Overall Study|Protocol Driven Decision Point|11|||
156906120|NCT00494299|566414523|FG001|Overall Study|Protocol Driven Decision Point|22|||
156906121|NCT00369824|566414528|FG000|Overall Study|Adverse Event|0|||
156906122|NCT00369824|566414529|FG001|Overall Study|Adverse Event|2|||
156906123|NCT00369824|566414530|FG002|Overall Study|Adverse Event|0|||
156906124|NCT00369824|566414531|FG003|Overall Study|Adverse Event|0|||
156906125|NCT00369824|566414532|FG004|Overall Study|Adverse Event|1|||
156906126|NCT00369824|566414533|FG005|Overall Study|Adverse Event|0|||
156906127|NCT00369824|566414528|FG000|Overall Study|Protocol Violation|0|||
156906128|NCT00369824|566414529|FG001|Overall Study|Protocol Violation|1|||
156906129|NCT00369824|566414530|FG002|Overall Study|Protocol Violation|0|||
156906130|NCT00369824|566414531|FG003|Overall Study|Protocol Violation|1|||
156906131|NCT00369824|566414532|FG004|Overall Study|Protocol Violation|1|||
156906132|NCT00369824|566414533|FG005|Overall Study|Protocol Violation|0|||
156906133|NCT00369824|566414528|FG000|Overall Study|Withdrawal by Subject|9|||
156906134|NCT00369824|566414529|FG001|Overall Study|Withdrawal by Subject|5|||
156906135|NCT00369824|566414530|FG002|Overall Study|Withdrawal by Subject|5|||
156906136|NCT00369824|566414531|FG003|Overall Study|Withdrawal by Subject|4|||
156906137|NCT00369824|566414532|FG004|Overall Study|Withdrawal by Subject|6|||
156906138|NCT00369824|566414533|FG005|Overall Study|Withdrawal by Subject|2|||
156906139|NCT00369824|566414528|FG000|Overall Study|Lost to Follow-up|6|||
156906140|NCT00369824|566414529|FG001|Overall Study|Lost to Follow-up|11|||
156906141|NCT00369824|566414530|FG002|Overall Study|Lost to Follow-up|7|||
156906142|NCT00369824|566414531|FG003|Overall Study|Lost to Follow-up|8|||
156906143|NCT00369824|566414532|FG004|Overall Study|Lost to Follow-up|9|||
156906144|NCT00369824|566414533|FG005|Overall Study|Lost to Follow-up|6|||
156906145|NCT00369824|566414528|FG000|Overall Study|Other|0|||
156906146|NCT00369824|566414529|FG001|Overall Study|Other|0|||
156906147|NCT00369824|566414530|FG002|Overall Study|Other|0|||
156906148|NCT00369824|566414531|FG003|Overall Study|Other|2|||
156906149|NCT00369824|566414532|FG004|Overall Study|Other|1|||
156906150|NCT00369824|566414533|FG005|Overall Study|Other|3|||
156906151|NCT03822182|566414536|FG000|Overall Study|Protocol Violation|0|||
156906152|NCT03822182|566414537|FG001|Overall Study|Protocol Violation|1|||
156906153|NCT03822182|566414538|FG002|Overall Study|Protocol Violation|1|||
156906154|NCT00810355|566414539|FG000|Overall Study|Lost to Follow-up|13|||
156906155|NCT00810355|566414540|FG001|Overall Study|Lost to Follow-up|17|||
156906156|NCT00810355|566414541|FG002|Overall Study|Lost to Follow-up|11|||
156906157|NCT00810355|566414539|FG000|Overall Study|Withdrawal by Subject|1|||
156906158|NCT00810355|566414540|FG001|Overall Study|Withdrawal by Subject|0|||
156906159|NCT00810355|566414541|FG002|Overall Study|Withdrawal by Subject|0|||
156906160|NCT01612858|566414543|FG000|Overall Study|Withdrawal by Subject|5|||
156906161|NCT01612858|566414544|FG001|Overall Study|Withdrawal by Subject|1|||
156906162|NCT01484275|566414545|FG000|Overall Study|Study terminated by sponsor|28|||
156906163|NCT01484275|566414546|FG001|Overall Study|Study terminated by sponsor|32|||
156906164|NCT01484275|566414545|FG000|Overall Study|Other|10|||
156906165|NCT01484275|566414546|FG001|Overall Study|Other|0|||
156906166|NCT01484275|566414545|FG000|Overall Study|Death|3|||
156906167|NCT01484275|566414546|FG001|Overall Study|Death|4|||
156906168|NCT01484275|566414545|FG000|Overall Study|Withdrawal by Subject|1|||
156906169|NCT01484275|566414546|FG001|Overall Study|Withdrawal by Subject|5|||
156906170|NCT01484275|566414545|FG000|Overall Study|Lost to Follow-up|1|||
156906171|NCT01484275|566414546|FG001|Overall Study|Lost to Follow-up|1|||
157159404|NCT01670656|567329498|FG004|Overall Study|Subject withdrew consent|1|||
156906172|NCT03113916|566414550|FG000|Overall Study|Withdrawal by Subject|9|||
156906173|NCT03113916|566414551|FG001|Overall Study|Withdrawal by Subject|7|||
156906174|NCT03113916|566414550|FG000|Overall Study|Pregnancy|1|||
156906175|NCT03113916|566414551|FG001|Overall Study|Pregnancy|3|||
156906176|NCT03113916|566414550|FG000|Overall Study|Lost to Follow-up|1|||
156906177|NCT03113916|566414551|FG001|Overall Study|Lost to Follow-up|2|||
156906178|NCT00347360|566414572|FG000|Overall Study|Adverse Event|1|||
156906179|NCT00347360|566414573|FG001|Overall Study|Adverse Event|2|||
156906180|NCT00347360|566414574|FG002|Overall Study|Adverse Event|0|||
156906181|NCT00347360|566414575|FG003|Overall Study|Adverse Event|4|||
156906182|NCT00347360|566414576|FG004|Overall Study|Adverse Event|1|||
156906183|NCT00347360|566414577|FG005|Overall Study|Adverse Event|2|||
156906184|NCT00347360|566414578|FG006|Overall Study|Adverse Event|2|||
156906185|NCT00347360|566414579|FG007|Overall Study|Adverse Event|0|||
156906186|NCT00347360|566414580|FG008|Overall Study|Adverse Event|2|||
156906187|NCT00347360|566414581|FG009|Overall Study|Adverse Event|3|||
156906188|NCT00347360|566414582|FG010|Overall Study|Adverse Event|3|||
156906189|NCT00347360|566414583|FG011|Overall Study|Adverse Event|1|||
156906190|NCT00347360|566414584|FG012|Overall Study|Adverse Event|3|||
156906191|NCT00347360|566414585|FG013|Overall Study|Adverse Event|2|||
156906192|NCT00347360|566414586|FG014|Overall Study|Adverse Event|2|||
156906193|NCT00347360|566414572|FG000|Overall Study|Lost to Follow-up|0|||
156906194|NCT00347360|566414573|FG001|Overall Study|Lost to Follow-up|0|||
156906195|NCT00347360|566414574|FG002|Overall Study|Lost to Follow-up|0|||
156906196|NCT00347360|566414575|FG003|Overall Study|Lost to Follow-up|2|||
156906197|NCT00347360|566414576|FG004|Overall Study|Lost to Follow-up|1|||
156906198|NCT00347360|566414577|FG005|Overall Study|Lost to Follow-up|1|||
156906199|NCT00347360|566414578|FG006|Overall Study|Lost to Follow-up|0|||
156906200|NCT00347360|566414579|FG007|Overall Study|Lost to Follow-up|1|||
156906201|NCT00347360|566414580|FG008|Overall Study|Lost to Follow-up|1|||
156906202|NCT00347360|566414581|FG009|Overall Study|Lost to Follow-up|2|||
156906203|NCT00347360|566414582|FG010|Overall Study|Lost to Follow-up|0|||
156906204|NCT00347360|566414583|FG011|Overall Study|Lost to Follow-up|0|||
156906205|NCT00347360|566414584|FG012|Overall Study|Lost to Follow-up|1|||
156906206|NCT00347360|566414585|FG013|Overall Study|Lost to Follow-up|0|||
156906207|NCT00347360|566414586|FG014|Overall Study|Lost to Follow-up|0|||
156906208|NCT00347360|566414572|FG000|Overall Study|Protocol Violation|2|||
156906209|NCT00347360|566414573|FG001|Overall Study|Protocol Violation|3|||
156906210|NCT00347360|566414574|FG002|Overall Study|Protocol Violation|1|||
156906211|NCT00347360|566414575|FG003|Overall Study|Protocol Violation|2|||
156906212|NCT00347360|566414576|FG004|Overall Study|Protocol Violation|1|||
156906213|NCT00347360|566414577|FG005|Overall Study|Protocol Violation|2|||
156906214|NCT00347360|566414578|FG006|Overall Study|Protocol Violation|0|||
156906215|NCT00347360|566414579|FG007|Overall Study|Protocol Violation|0|||
156906216|NCT00347360|566414580|FG008|Overall Study|Protocol Violation|1|||
156906217|NCT00347360|566414581|FG009|Overall Study|Protocol Violation|2|||
156906218|NCT00347360|566414582|FG010|Overall Study|Protocol Violation|0|||
156906219|NCT00347360|566414583|FG011|Overall Study|Protocol Violation|0|||
156906220|NCT00347360|566414584|FG012|Overall Study|Protocol Violation|0|||
156906221|NCT00347360|566414585|FG013|Overall Study|Protocol Violation|1|||
156906222|NCT00347360|566414586|FG014|Overall Study|Protocol Violation|0|||
156906223|NCT00347360|566414572|FG000|Overall Study|Withdrawal by Subject|0|||
156906224|NCT00347360|566414573|FG001|Overall Study|Withdrawal by Subject|1|||
156906225|NCT00347360|566414574|FG002|Overall Study|Withdrawal by Subject|2|||
156906226|NCT00347360|566414575|FG003|Overall Study|Withdrawal by Subject|4|||
156906227|NCT00347360|566414576|FG004|Overall Study|Withdrawal by Subject|1|||
156906228|NCT00347360|566414577|FG005|Overall Study|Withdrawal by Subject|2|||
156906229|NCT00347360|566414578|FG006|Overall Study|Withdrawal by Subject|1|||
156906230|NCT00347360|566414579|FG007|Overall Study|Withdrawal by Subject|1|||
156906231|NCT00347360|566414580|FG008|Overall Study|Withdrawal by Subject|1|||
156906232|NCT00347360|566414581|FG009|Overall Study|Withdrawal by Subject|1|||
156906233|NCT00347360|566414582|FG010|Overall Study|Withdrawal by Subject|0|||
156906234|NCT00347360|566414583|FG011|Overall Study|Withdrawal by Subject|3|||
156906235|NCT00347360|566414584|FG012|Overall Study|Withdrawal by Subject|4|||
156906236|NCT00347360|566414585|FG013|Overall Study|Withdrawal by Subject|2|||
156906237|NCT00347360|566414586|FG014|Overall Study|Withdrawal by Subject|1|||
156906238|NCT00347360|566414572|FG000|Overall Study|Lack of Efficacy|1|||
156906239|NCT00347360|566414573|FG001|Overall Study|Lack of Efficacy|1|||
156906240|NCT00347360|566414574|FG002|Overall Study|Lack of Efficacy|3|||
156906241|NCT00347360|566414575|FG003|Overall Study|Lack of Efficacy|1|||
156906242|NCT00347360|566414576|FG004|Overall Study|Lack of Efficacy|0|||
156906243|NCT00347360|566414577|FG005|Overall Study|Lack of Efficacy|1|||
156906244|NCT00347360|566414578|FG006|Overall Study|Lack of Efficacy|0|||
156906245|NCT00347360|566414579|FG007|Overall Study|Lack of Efficacy|1|||
156906246|NCT00347360|566414580|FG008|Overall Study|Lack of Efficacy|1|||
156906247|NCT00347360|566414581|FG009|Overall Study|Lack of Efficacy|0|||
156906248|NCT00347360|566414582|FG010|Overall Study|Lack of Efficacy|0|||
156906249|NCT00347360|566414583|FG011|Overall Study|Lack of Efficacy|0|||
156906250|NCT00347360|566414584|FG012|Overall Study|Lack of Efficacy|0|||
156906251|NCT00347360|566414585|FG013|Overall Study|Lack of Efficacy|0|||
156906252|NCT00347360|566414586|FG014|Overall Study|Lack of Efficacy|0|||
156906253|NCT00347360|566414572|FG000|Overall Study|Reason not listed/blank|1|||
156906254|NCT00347360|566414573|FG001|Overall Study|Reason not listed/blank|0|||
156906255|NCT00347360|566414574|FG002|Overall Study|Reason not listed/blank|0|||
156906256|NCT00347360|566414575|FG003|Overall Study|Reason not listed/blank|0|||
156906257|NCT00347360|566414576|FG004|Overall Study|Reason not listed/blank|0|||
156906258|NCT00347360|566414577|FG005|Overall Study|Reason not listed/blank|0|||
156906259|NCT00347360|566414578|FG006|Overall Study|Reason not listed/blank|1|||
157159405|NCT01670656|567329494|FG000|Overall Study|Lost to Follow-up|0|||
156906260|NCT00347360|566414579|FG007|Overall Study|Reason not listed/blank|0|||
156906261|NCT00347360|566414580|FG008|Overall Study|Reason not listed/blank|0|||
156906262|NCT00347360|566414581|FG009|Overall Study|Reason not listed/blank|0|||
156906263|NCT00347360|566414582|FG010|Overall Study|Reason not listed/blank|0|||
156906264|NCT00347360|566414583|FG011|Overall Study|Reason not listed/blank|0|||
156906265|NCT00347360|566414584|FG012|Overall Study|Reason not listed/blank|0|||
157159406|NCT01670656|567329495|FG001|Overall Study|Lost to Follow-up|0|||
157159407|NCT01670656|567329496|FG002|Overall Study|Lost to Follow-up|0|||
157159408|NCT01670656|567329497|FG003|Overall Study|Lost to Follow-up|0|||
157159409|NCT01670656|567329498|FG004|Overall Study|Lost to Follow-up|3|||
157159410|NCT01670656|567329494|FG000|Overall Study|Subject moved|0|||
157159411|NCT01670656|567329495|FG001|Overall Study|Subject moved|0|||
157159412|NCT01670656|567329496|FG002|Overall Study|Subject moved|0|||
157159413|NCT01670656|567329497|FG003|Overall Study|Subject moved|1|||
157159414|NCT01670656|567329498|FG004|Overall Study|Subject moved|0|||
157159415|NCT00789958|567329499|FG000|Overall Study|Adverse Event|3|||
157159416|NCT00789958|567329499|FG000|Overall Study|Withdrawal by Subject|4|||
157159417|NCT00789958|567329499|FG000|Overall Study|Progression|3|||
157159418|NCT00789958|567329499|FG000|Overall Study|not protocol specified|1|||
157159419|NCT00789958|567329499|FG000|Overall Study|Not eligible/not analyzable|26|||
157159420|NCT02622724|567329500|FG000|Overall Study|Death|51|||
157159421|NCT02622724|567329501|FG001|Overall Study|Death|53|||
157159422|NCT02622724|567329500|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
157159423|NCT02622724|567329501|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
157159424|NCT02622724|567329500|FG000|Overall Study|Early termination of study|38|||
157159425|NCT02622724|567329501|FG001|Overall Study|Early termination of study|43|||
157159426|NCT00487084|567329502|FG000|Overall Study|Did not receive intervention|4|||
157159427|NCT00487084|567329503|FG001|Overall Study|Did not receive intervention|3|||
157159428|NCT00487084|567329504|FG002|Overall Study|Did not receive intervention|5|||
157159429|NCT00254293|567329505|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
157159430|NCT00254293|567329506|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
157159431|NCT00254293|567329507|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
157159432|NCT00254293|567329508|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
156859756|NCT01001221|566243196|FG000|Overall Study|Other|1|||
156859757|NCT01001221|566243197|FG001|Overall Study|Other|1|||
156859758|NCT01001221|566243198|FG002|Overall Study|Other|0|||
156859759|NCT01001221|566243199|FG003|Overall Study|Other|0|||
156859760|NCT01001221|566243200|FG004|Overall Study|Other|0|||
156859761|NCT01001221|566243196|FG000|Overall Study|Not treated; protocol exclusion|0|||
156859762|NCT01001221|566243197|FG001|Overall Study|Not treated; protocol exclusion|0|||
156859763|NCT01001221|566243198|FG002|Overall Study|Not treated; protocol exclusion|1|||
156859764|NCT01001221|566243199|FG003|Overall Study|Not treated; protocol exclusion|0|||
156859765|NCT01001221|566243200|FG004|Overall Study|Not treated; protocol exclusion|0|||
156859766|NCT02388269|566243201|FG000|Overall Study|Adverse Event|2|||
156859767|NCT02388269|566243202|FG001|Overall Study|Adverse Event|0|||
156859768|NCT02388269|566243203|FG002|Overall Study|Adverse Event|0|||
156859769|NCT02388269|566243201|FG000|Overall Study|Withdrawal by Subject|1|||
156859770|NCT02388269|566243202|FG001|Overall Study|Withdrawal by Subject|2|||
156859771|NCT02388269|566243203|FG002|Overall Study|Withdrawal by Subject|0|||
156859772|NCT02388269|566243201|FG000|Overall Study|less than 50% stimulations|1|||
156859773|NCT02388269|566243202|FG001|Overall Study|less than 50% stimulations|0|||
156859774|NCT02388269|566243203|FG002|Overall Study|less than 50% stimulations|0|||
156859775|NCT02388269|566243201|FG000|Overall Study|no diary data|3|||
156859776|NCT02388269|566243202|FG001|Overall Study|no diary data|0|||
156859777|NCT02388269|566243203|FG002|Overall Study|no diary data|0|||
156859778|NCT02388269|566243201|FG000|Overall Study|Protocol Violation|2|||
156859779|NCT02388269|566243202|FG001|Overall Study|Protocol Violation|0|||
156859780|NCT02388269|566243203|FG002|Overall Study|Protocol Violation|0|||
156859781|NCT02388269|566243201|FG000|Overall Study|Screen Failure|0|||
156859782|NCT02388269|566243202|FG001|Overall Study|Screen Failure|0|||
156859783|NCT02388269|566243203|FG002|Overall Study|Screen Failure|10|||
156859784|NCT05106959|566243204|FG000|Overall Study|Lost to Follow-up|1|||
156859785|NCT00087152|566243205|FG000|Overall Study|Ineligible|6|||
156859786|NCT01292486|566243206|FG000|Overall Study|Protocol Violation|2|||
156859787|NCT01292486|566243206|FG000|Overall Study|Did not meet screening criteria|2|||
156859788|NCT01292486|566243206|FG000|Overall Study|Adverse Event|1|||
156859789|NCT01292486|566243206|FG000|Overall Study|Physician Decision|1|||
156859790|NCT03882021|566243213|FG000|Enrollment|Procedure aborted/cancelled|2|||
156859791|NCT03882021|566243213|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
156859792|NCT03882021|566243213|FG000|Enrollment to 3-Month|Death|1|||
156859793|NCT03882021|566243213|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
156859794|NCT03882021|566243213|FG000|Enrollment to 3-Month|Missed Visit|4|||
156859795|NCT03882021|566243213|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
156859796|NCT03882021|566243213|FG000|6-Month to 12-Month Visit|Death|1|||
157159433|NCT00254293|567329509|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
157159434|NCT00254293|567329510|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
156859797|NCT03882021|566243213|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
156859798|NCT01546857|566243215|FG000|Overall Study|Withdrawal by Subject|2|||
156859799|NCT01546857|566243216|FG001|Overall Study|Withdrawal by Subject|3|||
157159435|NCT00254293|567329511|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
157159436|NCT00254293|567329505|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
157159437|NCT00254293|567329506|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
157159438|NCT00254293|567329507|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
157159439|NCT00254293|567329508|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
157159440|NCT00254293|567329509|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
156906266|NCT00347360|566414585|FG013|Overall Study|Reason not listed/blank|1|||
156906267|NCT00347360|566414586|FG014|Overall Study|Reason not listed/blank|0|||
156906268|NCT00347360|566414572|FG000|Overall Study|Per sponsors instruction|0|||
156906269|NCT00347360|566414573|FG001|Overall Study|Per sponsors instruction|1|||
156906270|NCT00347360|566414574|FG002|Overall Study|Per sponsors instruction|0|||
156906271|NCT00347360|566414575|FG003|Overall Study|Per sponsors instruction|0|||
156906272|NCT00347360|566414576|FG004|Overall Study|Per sponsors instruction|0|||
156906273|NCT00347360|566414577|FG005|Overall Study|Per sponsors instruction|0|||
156906274|NCT00347360|566414578|FG006|Overall Study|Per sponsors instruction|0|||
156906275|NCT00347360|566414579|FG007|Overall Study|Per sponsors instruction|0|||
156906276|NCT00347360|566414580|FG008|Overall Study|Per sponsors instruction|0|||
156906277|NCT00347360|566414581|FG009|Overall Study|Per sponsors instruction|0|||
156906278|NCT00347360|566414582|FG010|Overall Study|Per sponsors instruction|0|||
156906279|NCT00347360|566414583|FG011|Overall Study|Per sponsors instruction|0|||
156906280|NCT00347360|566414584|FG012|Overall Study|Per sponsors instruction|0|||
156906281|NCT00347360|566414585|FG013|Overall Study|Per sponsors instruction|0|||
156906282|NCT00347360|566414586|FG014|Overall Study|Per sponsors instruction|0|||
156906283|NCT00347360|566414572|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
156906284|NCT00347360|566414573|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
156906285|NCT00347360|566414574|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
156906286|NCT00347360|566414575|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
156906287|NCT00347360|566414576|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
156906288|NCT00347360|566414577|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
156906289|NCT00347360|566414578|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
156906290|NCT00347360|566414579|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
156906291|NCT00347360|566414580|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
156906292|NCT00347360|566414581|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
156906293|NCT00347360|566414582|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
156906294|NCT00347360|566414583|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
156906295|NCT00347360|566414584|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
156906296|NCT00347360|566414585|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
156906297|NCT00347360|566414586|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
156906298|NCT00347360|566414572|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
156906299|NCT00347360|566414573|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
156906300|NCT00347360|566414574|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
156906301|NCT00347360|566414575|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
156906302|NCT00347360|566414576|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
156906303|NCT00347360|566414577|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
156906304|NCT00347360|566414578|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
156906305|NCT00347360|566414579|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
156906306|NCT00347360|566414580|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
156906307|NCT00347360|566414581|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
156906308|NCT00347360|566414582|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
156906309|NCT00347360|566414583|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
156906310|NCT00347360|566414584|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
156906311|NCT00347360|566414585|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
156906312|NCT00347360|566414586|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
156906313|NCT00347360|566414572|FG000|Overall Study|Abnormal lab values|0|||
156906314|NCT00347360|566414573|FG001|Overall Study|Abnormal lab values|0|||
156906315|NCT00347360|566414574|FG002|Overall Study|Abnormal lab values|0|||
156906316|NCT00347360|566414575|FG003|Overall Study|Abnormal lab values|0|||
156906317|NCT00347360|566414576|FG004|Overall Study|Abnormal lab values|0|||
156906318|NCT00347360|566414577|FG005|Overall Study|Abnormal lab values|0|||
156906319|NCT00347360|566414578|FG006|Overall Study|Abnormal lab values|1|||
157159441|NCT00254293|567329510|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
157159442|NCT00254293|567329511|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
157159443|NCT00254293|567329505|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
157225583|NCT00337571|567571474|FG000|Overall Study|Adverse Event|4|||
156906320|NCT00347360|566414579|FG007|Overall Study|Abnormal lab values|0|||
156906321|NCT00347360|566414580|FG008|Overall Study|Abnormal lab values|0|||
156906322|NCT00347360|566414581|FG009|Overall Study|Abnormal lab values|0|||
156906323|NCT00347360|566414582|FG010|Overall Study|Abnormal lab values|0|||
156906324|NCT00347360|566414583|FG011|Overall Study|Abnormal lab values|0|||
156906325|NCT00347360|566414584|FG012|Overall Study|Abnormal lab values|0|||
156906326|NCT00347360|566414585|FG013|Overall Study|Abnormal lab values|0|||
156906327|NCT00347360|566414586|FG014|Overall Study|Abnormal lab values|0|||
156906328|NCT00347360|566414572|FG000|Overall Study|PI recommended early withdrawal|0|||
156906329|NCT00347360|566414573|FG001|Overall Study|PI recommended early withdrawal|0|||
156906330|NCT00347360|566414574|FG002|Overall Study|PI recommended early withdrawal|0|||
156906331|NCT00347360|566414575|FG003|Overall Study|PI recommended early withdrawal|0|||
156906332|NCT00347360|566414576|FG004|Overall Study|PI recommended early withdrawal|0|||
156906333|NCT00347360|566414577|FG005|Overall Study|PI recommended early withdrawal|0|||
156906334|NCT00347360|566414578|FG006|Overall Study|PI recommended early withdrawal|0|||
156906335|NCT00347360|566414579|FG007|Overall Study|PI recommended early withdrawal|0|||
156906336|NCT00347360|566414580|FG008|Overall Study|PI recommended early withdrawal|0|||
156906337|NCT00347360|566414581|FG009|Overall Study|PI recommended early withdrawal|1|||
156906338|NCT00347360|566414582|FG010|Overall Study|PI recommended early withdrawal|0|||
156906339|NCT00347360|566414583|FG011|Overall Study|PI recommended early withdrawal|0|||
156906340|NCT00347360|566414584|FG012|Overall Study|PI recommended early withdrawal|0|||
156906341|NCT00347360|566414585|FG013|Overall Study|PI recommended early withdrawal|0|||
156906342|NCT00347360|566414586|FG014|Overall Study|PI recommended early withdrawal|0|||
156906343|NCT00347360|566414572|FG000|Overall Study|Did not meet criteria before ABPM|0|||
156906344|NCT00347360|566414573|FG001|Overall Study|Did not meet criteria before ABPM|0|||
156906345|NCT00347360|566414574|FG002|Overall Study|Did not meet criteria before ABPM|0|||
156906346|NCT00347360|566414575|FG003|Overall Study|Did not meet criteria before ABPM|0|||
156906347|NCT00347360|566414576|FG004|Overall Study|Did not meet criteria before ABPM|0|||
156906348|NCT00347360|566414577|FG005|Overall Study|Did not meet criteria before ABPM|0|||
156906349|NCT00347360|566414578|FG006|Overall Study|Did not meet criteria before ABPM|0|||
156906350|NCT00347360|566414579|FG007|Overall Study|Did not meet criteria before ABPM|0|||
156906351|NCT00347360|566414580|FG008|Overall Study|Did not meet criteria before ABPM|0|||
156906352|NCT00347360|566414581|FG009|Overall Study|Did not meet criteria before ABPM|0|||
156906353|NCT00347360|566414582|FG010|Overall Study|Did not meet criteria before ABPM|1|||
156906354|NCT00347360|566414583|FG011|Overall Study|Did not meet criteria before ABPM|0|||
156906355|NCT00347360|566414584|FG012|Overall Study|Did not meet criteria before ABPM|0|||
156906356|NCT00347360|566414585|FG013|Overall Study|Did not meet criteria before ABPM|0|||
156906357|NCT00347360|566414586|FG014|Overall Study|Did not meet criteria before ABPM|0|||
156906358|NCT00347360|566414572|FG000|Overall Study|Randomized in error|0|||
156906359|NCT00347360|566414573|FG001|Overall Study|Randomized in error|0|||
156906360|NCT00347360|566414574|FG002|Overall Study|Randomized in error|0|||
156906361|NCT00347360|566414575|FG003|Overall Study|Randomized in error|0|||
156906362|NCT00347360|566414576|FG004|Overall Study|Randomized in error|0|||
156906363|NCT00347360|566414577|FG005|Overall Study|Randomized in error|0|||
156906364|NCT00347360|566414578|FG006|Overall Study|Randomized in error|0|||
156906365|NCT00347360|566414579|FG007|Overall Study|Randomized in error|0|||
156906366|NCT00347360|566414580|FG008|Overall Study|Randomized in error|0|||
156906367|NCT00347360|566414581|FG009|Overall Study|Randomized in error|0|||
156906368|NCT00347360|566414582|FG010|Overall Study|Randomized in error|0|||
156906369|NCT00347360|566414583|FG011|Overall Study|Randomized in error|1|||
156906370|NCT00347360|566414584|FG012|Overall Study|Randomized in error|0|||
156906371|NCT00347360|566414585|FG013|Overall Study|Randomized in error|0|||
156906372|NCT00347360|566414586|FG014|Overall Study|Randomized in error|0|||
156906373|NCT00347360|566414572|FG000|Overall Study|Failed inclusion criteria #4|0|||
156906374|NCT00347360|566414573|FG001|Overall Study|Failed inclusion criteria #4|0|||
156906375|NCT00347360|566414574|FG002|Overall Study|Failed inclusion criteria #4|0|||
156906376|NCT00347360|566414575|FG003|Overall Study|Failed inclusion criteria #4|0|||
156906377|NCT00347360|566414576|FG004|Overall Study|Failed inclusion criteria #4|0|||
156906378|NCT00347360|566414577|FG005|Overall Study|Failed inclusion criteria #4|0|||
156906379|NCT00347360|566414578|FG006|Overall Study|Failed inclusion criteria #4|0|||
156906380|NCT00347360|566414579|FG007|Overall Study|Failed inclusion criteria #4|0|||
156906381|NCT00347360|566414580|FG008|Overall Study|Failed inclusion criteria #4|0|||
156906382|NCT00347360|566414581|FG009|Overall Study|Failed inclusion criteria #4|0|||
156906383|NCT00347360|566414582|FG010|Overall Study|Failed inclusion criteria #4|0|||
156906384|NCT00347360|566414583|FG011|Overall Study|Failed inclusion criteria #4|1|||
156906385|NCT00347360|566414584|FG012|Overall Study|Failed inclusion criteria #4|0|||
156906386|NCT00347360|566414585|FG013|Overall Study|Failed inclusion criteria #4|0|||
156906387|NCT00347360|566414586|FG014|Overall Study|Failed inclusion criteria #4|0|||
156906388|NCT00347360|566414572|FG000|Overall Study|Prolonged duration between visits|0|||
156906389|NCT00347360|566414573|FG001|Overall Study|Prolonged duration between visits|0|||
156906390|NCT00347360|566414574|FG002|Overall Study|Prolonged duration between visits|0|||
157026786|NCT03904147|566853287|FG000|Overall Study|1Y visit completed after 365 days|1|||
157159444|NCT00254293|567329506|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
157159445|NCT00254293|567329507|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
157159446|NCT00254293|567329508|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
157159447|NCT00254293|567329509|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
157159448|NCT00254293|567329510|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
156906391|NCT00347360|566414575|FG003|Overall Study|Prolonged duration between visits|0|||
156906392|NCT00347360|566414576|FG004|Overall Study|Prolonged duration between visits|0|||
156906393|NCT00347360|566414577|FG005|Overall Study|Prolonged duration between visits|0|||
156906394|NCT00347360|566414578|FG006|Overall Study|Prolonged duration between visits|0|||
156906395|NCT00347360|566414579|FG007|Overall Study|Prolonged duration between visits|0|||
156906396|NCT00347360|566414580|FG008|Overall Study|Prolonged duration between visits|0|||
156906397|NCT00347360|566414581|FG009|Overall Study|Prolonged duration between visits|0|||
156906398|NCT00347360|566414582|FG010|Overall Study|Prolonged duration between visits|0|||
156906399|NCT00347360|566414583|FG011|Overall Study|Prolonged duration between visits|0|||
156906400|NCT00347360|566414584|FG012|Overall Study|Prolonged duration between visits|1|||
156906401|NCT00347360|566414585|FG013|Overall Study|Prolonged duration between visits|0|||
156906402|NCT00347360|566414586|FG014|Overall Study|Prolonged duration between visits|0|||
156906403|NCT00347360|566414572|FG000|Overall Study|Subject left town, ran out of study drug|0|||
156906404|NCT00347360|566414573|FG001|Overall Study|Subject left town, ran out of study drug|0|||
156906405|NCT00347360|566414574|FG002|Overall Study|Subject left town, ran out of study drug|0|||
156906406|NCT00347360|566414575|FG003|Overall Study|Subject left town, ran out of study drug|0|||
156906407|NCT00347360|566414576|FG004|Overall Study|Subject left town, ran out of study drug|0|||
156906408|NCT00347360|566414577|FG005|Overall Study|Subject left town, ran out of study drug|0|||
156906409|NCT00347360|566414578|FG006|Overall Study|Subject left town, ran out of study drug|0|||
156906410|NCT00347360|566414579|FG007|Overall Study|Subject left town, ran out of study drug|0|||
156906411|NCT00347360|566414580|FG008|Overall Study|Subject left town, ran out of study drug|0|||
156906412|NCT00347360|566414581|FG009|Overall Study|Subject left town, ran out of study drug|0|||
156906413|NCT00347360|566414582|FG010|Overall Study|Subject left town, ran out of study drug|0|||
156906414|NCT00347360|566414583|FG011|Overall Study|Subject left town, ran out of study drug|0|||
156906415|NCT00347360|566414584|FG012|Overall Study|Subject left town, ran out of study drug|0|||
156906416|NCT00347360|566414585|FG013|Overall Study|Subject left town, ran out of study drug|1|||
156906417|NCT00347360|566414586|FG014|Overall Study|Subject left town, ran out of study drug|0|||
156906418|NCT00347360|566414572|FG000|Overall Study|Subject refuse to sign updated consent|0|||
156906419|NCT00347360|566414573|FG001|Overall Study|Subject refuse to sign updated consent|0|||
156906420|NCT00347360|566414574|FG002|Overall Study|Subject refuse to sign updated consent|0|||
156906421|NCT00347360|566414575|FG003|Overall Study|Subject refuse to sign updated consent|0|||
156906422|NCT00347360|566414576|FG004|Overall Study|Subject refuse to sign updated consent|0|||
156906423|NCT00347360|566414577|FG005|Overall Study|Subject refuse to sign updated consent|0|||
156906424|NCT00347360|566414578|FG006|Overall Study|Subject refuse to sign updated consent|0|||
156906425|NCT00347360|566414579|FG007|Overall Study|Subject refuse to sign updated consent|0|||
156906426|NCT00347360|566414580|FG008|Overall Study|Subject refuse to sign updated consent|0|||
156906427|NCT00347360|566414581|FG009|Overall Study|Subject refuse to sign updated consent|0|||
156906428|NCT00347360|566414582|FG010|Overall Study|Subject refuse to sign updated consent|0|||
156906429|NCT00347360|566414583|FG011|Overall Study|Subject refuse to sign updated consent|0|||
156906430|NCT00347360|566414584|FG012|Overall Study|Subject refuse to sign updated consent|0|||
156906431|NCT00347360|566414585|FG013|Overall Study|Subject refuse to sign updated consent|0|||
156906432|NCT00347360|566414586|FG014|Overall Study|Subject refuse to sign updated consent|1|||
156906433|NCT00347360|566414572|FG000|Overall Study|Visits conflicted with new job|0|||
156906434|NCT00347360|566414573|FG001|Overall Study|Visits conflicted with new job|0|||
156906435|NCT00347360|566414574|FG002|Overall Study|Visits conflicted with new job|0|||
156906436|NCT00347360|566414575|FG003|Overall Study|Visits conflicted with new job|0|||
156906437|NCT00347360|566414576|FG004|Overall Study|Visits conflicted with new job|0|||
156906438|NCT00347360|566414577|FG005|Overall Study|Visits conflicted with new job|0|||
156906439|NCT00347360|566414578|FG006|Overall Study|Visits conflicted with new job|1|||
156906440|NCT00347360|566414579|FG007|Overall Study|Visits conflicted with new job|0|||
156906441|NCT00347360|566414580|FG008|Overall Study|Visits conflicted with new job|0|||
156906442|NCT00347360|566414581|FG009|Overall Study|Visits conflicted with new job|0|||
156906443|NCT00347360|566414582|FG010|Overall Study|Visits conflicted with new job|0|||
156906444|NCT00347360|566414583|FG011|Overall Study|Visits conflicted with new job|0|||
156906445|NCT00347360|566414584|FG012|Overall Study|Visits conflicted with new job|0|||
156906446|NCT00347360|566414585|FG013|Overall Study|Visits conflicted with new job|0|||
156906447|NCT00347360|566414586|FG014|Overall Study|Visits conflicted with new job|0|||
156906448|NCT01449539|566414587|FG000|Overall Study|Withdrawal by Subject|3|||
156906449|NCT01449539|566414587|FG000|Overall Study|Toxicity not study related|1|||
156906450|NCT01387789|566414590|FG000|Overall Study|Adverse Event|5|||
156906451|NCT01387789|566414590|FG000|Overall Study|Lack of Efficacy|2|||
156906452|NCT01387789|566414590|FG000|Overall Study|Lost to Follow-up|1|||
156906453|NCT02187744|566414591|FG000|Study|Participant refused further follow-up|1|||
157159449|NCT00254293|567329511|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
157159450|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Death|0|||
157159451|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Death|0|||
157159452|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Death|1|||
157159453|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Death|0|||
157159454|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Death|0|||
157159455|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Death|0|||
157159456|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Death|0|||
157159457|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
157225584|NCT00337571|567571475|FG001|Overall Study|Adverse Event|5|||
157159458|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
157159459|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
157159460|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
157159461|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
157159462|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
156906454|NCT02187744|566414592|FG001|Study|Participant refused further follow-up|0|||
156906455|NCT02187744|566414591|FG000|Study|Other|2|||
156906456|NCT02187744|566414592|FG001|Study|Other|1|||
156906457|NCT02187744|566414591|FG000|Study|Lost to Follow-up|0|||
156906458|NCT02187744|566414592|FG001|Study|Lost to Follow-up|2|||
156906459|NCT02187744|566414591|FG000|Study|Related adverse event, not serious|0|||
156906460|NCT02187744|566414592|FG001|Study|Related adverse event, not serious|2|||
156906461|NCT02187744|566414591|FG000|Study|Death|1|||
156906462|NCT02187744|566414592|FG001|Study|Death|0|||
156906463|NCT02187744|566414591|FG000|Study|Related adverse event, serious non-fatal|0|||
156906464|NCT02187744|566414592|FG001|Study|Related adverse event, serious non-fatal|1|||
156906465|NCT02187744|566414591|FG000|Treatment|Death|1|||
156906466|NCT02187744|566414592|FG001|Treatment|Death|0|||
156906467|NCT02187744|566414591|FG000|Treatment|Related adverse event, serious non-fatal|0|||
156906468|NCT02187744|566414592|FG001|Treatment|Related adverse event, serious non-fatal|1|||
156906469|NCT02187744|566414591|FG000|Treatment|Related adverse event, not serious|0|||
156906470|NCT02187744|566414592|FG001|Treatment|Related adverse event, not serious|2|||
156906471|NCT02187744|566414591|FG000|Treatment|Lost to Follow-up|0|||
156906472|NCT02187744|566414592|FG001|Treatment|Lost to Follow-up|1|||
156906473|NCT02187744|566414591|FG000|Treatment|Other|2|||
156906474|NCT02187744|566414592|FG001|Treatment|Other|0|||
156906475|NCT02187744|566414591|FG000|Treatment|Participant refused continued treatment|1|||
156906476|NCT02187744|566414592|FG001|Treatment|Participant refused continued treatment|1|||
156906477|NCT01972568|566414597|FG000|Overall Study|Other events|3|||
156906478|NCT01972568|566414598|FG001|Overall Study|Other events|0|||
156906479|NCT01972568|566414599|FG002|Overall Study|Other events|0|||
156906480|NCT01972568|566414597|FG000|Overall Study|Lack of Efficacy|0|||
156906481|NCT01972568|566414598|FG001|Overall Study|Lack of Efficacy|1|||
156906482|NCT01972568|566414599|FG002|Overall Study|Lack of Efficacy|2|||
156906483|NCT01972568|566414597|FG000|Overall Study|Protocol Violation|1|||
156906484|NCT01972568|566414598|FG001|Overall Study|Protocol Violation|2|||
156906485|NCT01972568|566414599|FG002|Overall Study|Protocol Violation|2|||
156906486|NCT01972568|566414597|FG000|Overall Study|Withdrawal by Subject|6|||
156906487|NCT01972568|566414598|FG001|Overall Study|Withdrawal by Subject|3|||
157026787|NCT03904147|566853288|FG001|Overall Study|1Y visit completed after 365 days|1|||
157026788|NCT03904147|566853289|FG002|Overall Study|1Y visit completed after 365 days|0|||
157026789|NCT03625167|566853291|FG000|Overall Study|Protocol Violation|5|||
157026790|NCT06103188|566853292|FG000|Overall Study|Lost to Follow-up|1|||
157026791|NCT06103188|566853293|FG001|Overall Study|Lost to Follow-up|6|||
157026792|NCT06103188|566853294|FG002|Overall Study|Lost to Follow-up|4|||
157026793|NCT05583578|566853295|FG000|Overall Study|Withdrawal by Subject|2|||
157026794|NCT05583578|566853296|FG001|Overall Study|Withdrawal by Subject|0|||
157026795|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
157026796|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
157026797|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
157026798|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
157026799|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
157026800|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
157026801|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
157026802|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
157026803|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
157026804|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
157159463|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
157159464|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
156859800|NCT02542865|566243217|FG000|Overall Study|Identified as screen failure|1|||
156859801|NCT02542865|566243218|FG001|Overall Study|Identified as screen failure|0|||
156859802|NCT02542865|566243217|FG000|Overall Study|Withdrawal by Subject|16|||
156859803|NCT02542865|566243218|FG001|Overall Study|Withdrawal by Subject|0|||
156859804|NCT01469221|566243219|FG000|Double Blind Phase|Protocol Violation|1|||
156859805|NCT01469221|566243220|FG001|Double Blind Phase|Protocol Violation|0|||
156859806|NCT01469221|566243221|FG002|Double Blind Phase|Protocol Violation|0|||
156859807|NCT01469221|566243219|FG000|Double Blind Phase|Physician Decision|1|||
156859808|NCT01469221|566243220|FG001|Double Blind Phase|Physician Decision|1|||
156859809|NCT01469221|566243221|FG002|Double Blind Phase|Physician Decision|0|||
156906488|NCT01972568|566414599|FG002|Overall Study|Withdrawal by Subject|7|||
156906489|NCT01972568|566414597|FG000|Overall Study|Lost to Follow-up|1|||
156906490|NCT01972568|566414598|FG001|Overall Study|Lost to Follow-up|0|||
156906491|NCT01972568|566414599|FG002|Overall Study|Lost to Follow-up|0|||
156906492|NCT01972568|566414597|FG000|Overall Study|Adverse Event|5|||
156906493|NCT01972568|566414598|FG001|Overall Study|Adverse Event|6|||
156906494|NCT01972568|566414599|FG002|Overall Study|Adverse Event|5|||
156906495|NCT02059408|566414602|FG000|Overall Study|Did not get tested|0|||
156906496|NCT02059408|566414603|FG001|Overall Study|Did not get tested|330|||
156906497|NCT02059408|566414604|FG002|Overall Study|Did not get tested|358|||
156906498|NCT00508755|566414605|FG000|Overall Study|Withdrawal by Subject|1|||
156906499|NCT00957580|566414606|FG000|Overall Study|Ongoing at data cut-off|0|||
156906500|NCT00957580|566414607|FG001|Overall Study|Ongoing at data cut-off|1|||
156906501|NCT00957580|566414608|FG002|Overall Study|Ongoing at data cut-off|0|||
156906502|NCT00957580|566414606|FG000|Overall Study|Enrolled but not treated|0|||
156906503|NCT00957580|566414607|FG001|Overall Study|Enrolled but not treated|1|||
157159465|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156906504|NCT00957580|566414608|FG002|Overall Study|Enrolled but not treated|0|||
156906505|NCT00945893|566414609|FG000|Overall Study|Lost to Follow-up|2|||
156906506|NCT00945893|566414610|FG001|Overall Study|Lost to Follow-up|8|||
156906507|NCT00945893|566414609|FG000|Overall Study|Withdrawal of consent|1|||
156906508|NCT00945893|566414610|FG001|Overall Study|Withdrawal of consent|2|||
156906509|NCT04502433|566414611|FG000|Overall Study|Death|2|||
156906510|NCT04502433|566414612|FG001|Overall Study|Death|4|||
156906511|NCT04502433|566414611|FG000|Overall Study|Lost to Follow-up|1|||
156906512|NCT04502433|566414612|FG001|Overall Study|Lost to Follow-up|0|||
156906513|NCT04502433|566414611|FG000|Overall Study|Physician Decision|0|||
156906514|NCT04502433|566414612|FG001|Overall Study|Physician Decision|1|||
156906515|NCT04203797|566414620|FG000|Overall Study|Adverse Event|1|||
156906516|NCT04203797|566414621|FG001|Overall Study|Adverse Event|0|||
156906517|NCT04203797|566414620|FG000|Overall Study|Did not complete End of Study follow-up|1|||
156906518|NCT04203797|566414621|FG001|Overall Study|Did not complete End of Study follow-up|0|||
156906519|NCT00300274|566414622|FG000|Overall Study|Withdrawal by Subject|12|||
156906520|NCT00300274|566414623|FG001|Overall Study|Withdrawal by Subject|3|||
156906521|NCT00300274|566414624|FG002|Overall Study|Withdrawal by Subject|14|||
156906522|NCT00300274|566414622|FG000|Overall Study|Lost to Follow-up|3|||
156906523|NCT00300274|566414623|FG001|Overall Study|Lost to Follow-up|4|||
156906524|NCT00300274|566414624|FG002|Overall Study|Lost to Follow-up|5|||
156906525|NCT00300274|566414622|FG000|Overall Study|Death|31|||
156906526|NCT00300274|566414623|FG001|Overall Study|Death|20|||
156906527|NCT00300274|566414624|FG002|Overall Study|Death|25|||
156906528|NCT00300274|566414622|FG000|Overall Study|Re-transplant|0|||
156906529|NCT00300274|566414623|FG001|Overall Study|Re-transplant|0|||
156906530|NCT00300274|566414624|FG002|Overall Study|Re-transplant|1|||
156906531|NCT00242216|566414625|FG000|Overall Study|Lost to Follow-up|12|||
156906532|NCT00242216|566414626|FG001|Overall Study|Lost to Follow-up|17|||
156906533|NCT00242216|566414625|FG000|Overall Study|Death|4|||
156906534|NCT00242216|566414626|FG001|Overall Study|Death|2|||
156906535|NCT00242216|566414625|FG000|Overall Study|Lack of Efficacy|1|||
156906536|NCT00242216|566414626|FG001|Overall Study|Lack of Efficacy|2|||
156906537|NCT00242216|566414625|FG000|Overall Study|no medicaiton dispensed|1|||
156906538|NCT00242216|566414626|FG001|Overall Study|no medicaiton dispensed|1|||
156906539|NCT01453361|566414627|FG000|Overall Study|Disease Progression|6|||
156906540|NCT01453361|566414627|FG000|Overall Study|Screen-Failures|10|||
156906541|NCT01752985|566414628|FG000|Treatment Period|Subject request to discontinue treatment|1|||
156906542|NCT01752985|566414629|FG001|Treatment Period|Subject request to discontinue treatment|0|||
156906543|NCT01752985|566414630|FG002|Treatment Period|Subject request to discontinue treatment|1|||
156906544|NCT01752985|566414628|FG000|Treatment Period|Subject no longer meets study criteria|0|||
156906545|NCT01752985|566414629|FG001|Treatment Period|Subject no longer meets study criteria|1|||
157159466|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
157159467|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156906546|NCT01752985|566414630|FG002|Treatment Period|Subject no longer meets study criteria|1|||
156906547|NCT01752985|566414628|FG000|Treatment Period|Adverse Event|2|||
156906548|NCT01752985|566414629|FG001|Treatment Period|Adverse Event|1|||
156906549|NCT01752985|566414630|FG002|Treatment Period|Adverse Event|2|||
156906550|NCT01752985|566414628|FG000|Treatment Period|Withdrawal by Subject|1|||
157159468|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
157159469|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
157159470|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
156906551|NCT01752985|566414629|FG001|Treatment Period|Withdrawal by Subject|1|||
156906552|NCT01752985|566414630|FG002|Treatment Period|Withdrawal by Subject|0|||
156906553|NCT01752985|566414628|FG000|Treatment Period|Lost to Follow-up|0|||
157159471|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157225585|NCT00337571|567571476|FG002|Overall Study|Adverse Event|8|||
156906554|NCT01752985|566414629|FG001|Treatment Period|Lost to Follow-up|0|||
156906555|NCT01752985|566414630|FG002|Treatment Period|Lost to Follow-up|1|||
156906556|NCT00825682|566415732|FG000|Overall Study|personal reasons/ inconvenience|13|||
156906557|NCT00825682|566415733|FG001|Overall Study|personal reasons/ inconvenience|5|||
156906558|NCT00560105|566415734|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
156906559|NCT00560105|566415735|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
156906560|NCT03281577|566415737|FG000|Overall Study|Adverse Event|0|||
156906561|NCT03281577|566415738|FG001|Overall Study|Adverse Event|0|||
157159472|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157159473|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
157159474|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157159475|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157159476|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157159477|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
157159478|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159479|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159480|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
157159481|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159482|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159483|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159484|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
157159485|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159486|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159487|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
157159488|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159489|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159490|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159491|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
157159492|NCT00254293|567329505|FG000|LTE Open Label Variable SC Dosing|Other|0|||
157159493|NCT00254293|567329506|FG001|LTE Open Label Variable SC Dosing|Other|0|||
157159494|NCT00254293|567329507|FG002|LTE Open Label Variable SC Dosing|Other|2|||
157159495|NCT00254293|567329508|FG003|LTE Open Label Variable SC Dosing|Other|0|||
157159496|NCT00254293|567329509|FG004|LTE Open Label Variable SC Dosing|Other|0|||
157159497|NCT00254293|567329510|FG005|LTE Open Label Variable SC Dosing|Other|0|||
156906562|NCT03281577|566415739|FG002|Overall Study|Adverse Event|0|||
156906563|NCT03281577|566415740|FG003|Overall Study|Adverse Event|1|||
156906564|NCT03281577|566415737|FG000|Overall Study|Withdrawal by Subject|1|||
156906565|NCT03281577|566415738|FG001|Overall Study|Withdrawal by Subject|0|||
156906566|NCT03281577|566415739|FG002|Overall Study|Withdrawal by Subject|0|||
156906567|NCT03281577|566415740|FG003|Overall Study|Withdrawal by Subject|0|||
156906568|NCT01550289|566415741|FG000|Overall Study|Protocol Violation|1|||
156906569|NCT01550289|566415742|FG001|Overall Study|Protocol Violation|0|||
156906570|NCT01550289|566415741|FG000|Overall Study|Lost to Follow-up|1|||
156906571|NCT01550289|566415742|FG001|Overall Study|Lost to Follow-up|1|||
156906572|NCT01550289|566415741|FG000|Overall Study|Withdrawal by Subject|11|||
156906573|NCT01550289|566415742|FG001|Overall Study|Withdrawal by Subject|3|||
156906574|NCT03539081|566415746|FG000|Overall Study|Withdrawal by Subject|2|||
156906575|NCT03539081|566415747|FG001|Overall Study|Withdrawal by Subject|3|||
156906576|NCT03539081|566415748|FG002|Overall Study|Withdrawal by Subject|0|||
156906577|NCT03539081|566415746|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
156906578|NCT03539081|566415747|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
156906579|NCT03539081|566415748|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
156906580|NCT02025621|566415749|FG000|Overall Study|Withdrawal by Subject|1|||
156906581|NCT02025621|566415750|FG001|Overall Study|Withdrawal by Subject|0|||
156906582|NCT02025621|566415749|FG000|Overall Study|Death|0|||
156906583|NCT02025621|566415750|FG001|Overall Study|Death|1|||
156906584|NCT02025621|566415749|FG000|Overall Study|No longer eligible|10|||
156906585|NCT02025621|566415750|FG001|Overall Study|No longer eligible|15|||
156906586|NCT02025621|566415749|FG000|Overall Study|Surgery initiated before infusion|3|||
156906587|NCT02025621|566415750|FG001|Overall Study|Surgery initiated before infusion|3|||
156906588|NCT00739674|566415751|FG000|Overall Study|Screening failures|19|||
156906589|NCT00739674|566415752|FG001|Overall Study|Screening failures|17|||
156906590|NCT00739674|566415751|FG000|Overall Study|Site 212 removal|19|||
156906591|NCT00739674|566415752|FG001|Overall Study|Site 212 removal|13|||
156906592|NCT00739674|566415751|FG000|Overall Study|No follow-up data|33|||
157026805|NCT04103580|566853299|FG000|Phase 1 Active Caregiving|Other|3|||
157159498|NCT00254293|567329511|FG006|LTE Open Label Variable SC Dosing|Other|0|||
156906593|NCT00739674|566415752|FG001|Overall Study|No follow-up data|18|||
156906594|NCT00739674|566415751|FG000|Overall Study|Dietician consultation >30 days|1|||
156906595|NCT00739674|566415752|FG001|Overall Study|Dietician consultation >30 days|9|||
156906596|NCT00739674|566415751|FG000|Overall Study|Adverse Event|22|||
156906597|NCT00739674|566415752|FG001|Overall Study|Adverse Event|13|||
157159499|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Death|0|||
157159500|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Death|0|||
157159501|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Death|0|||
157159502|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Death|0|||
157159503|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Death|0|||
156906598|NCT00739674|566415751|FG000|Overall Study|Death|1|||
156906599|NCT00739674|566415752|FG001|Overall Study|Death|0|||
156906600|NCT00739674|566415751|FG000|Overall Study|Lack of Efficacy|1|||
156906601|NCT00739674|566415752|FG001|Overall Study|Lack of Efficacy|0|||
156906602|NCT00739674|566415751|FG000|Overall Study|Lost to Follow-up|52|||
156906603|NCT00739674|566415752|FG001|Overall Study|Lost to Follow-up|30|||
156906604|NCT00739674|566415751|FG000|Overall Study|Protocol Violation|5|||
156906605|NCT00739674|566415752|FG001|Overall Study|Protocol Violation|5|||
156906606|NCT00739674|566415751|FG000|Overall Study|Withdrawal by Subject|9|||
156906607|NCT00739674|566415752|FG001|Overall Study|Withdrawal by Subject|9|||
156906608|NCT00739674|566415751|FG000|Overall Study|Reason missing|2|||
156906609|NCT00739674|566415752|FG001|Overall Study|Reason missing|0|||
156906610|NCT00739674|566415751|FG000|Overall Study|Clinic closed|6|||
156906611|NCT00739674|566415752|FG001|Overall Study|Clinic closed|4|||
156906612|NCT00739674|566415751|FG000|Overall Study|Patient moved|3|||
156906613|NCT00739674|566415752|FG001|Overall Study|Patient moved|2|||
156906614|NCT00739674|566415751|FG000|Overall Study|Non compliant|4|||
156906615|NCT00739674|566415752|FG001|Overall Study|Non compliant|0|||
156906616|NCT00739674|566415751|FG000|Overall Study|Unable to attend visit|3|||
156906617|NCT00739674|566415752|FG001|Overall Study|Unable to attend visit|1|||
156906618|NCT00739674|566415751|FG000|Overall Study|Home monitoring off meds|1|||
156906619|NCT00739674|566415752|FG001|Overall Study|Home monitoring off meds|0|||
156906620|NCT00739674|566415751|FG000|Overall Study|Erectile dysfunction|0|||
156906621|NCT00739674|566415752|FG001|Overall Study|Erectile dysfunction|1|||
156906622|NCT01897454|566415757|FG000|Overall Study|Withdrawal by Subject|1|||
156906623|NCT00983437|566415760|FG000|Overall Study|Adverse Event|9|||
156906624|NCT00983437|566415760|FG000|Overall Study|Lack of Efficacy|1|||
156906625|NCT00983437|566415760|FG000|Overall Study|Withdrawal by Subject|8|||
156906626|NCT00983437|566415760|FG000|Overall Study|Noncompliance to Study Procedures|1|||
156906627|NCT00983437|566415760|FG000|Overall Study|Lost to Follow-up|2|||
156906628|NCT00983437|566415760|FG000|Overall Study|Other Reason|26|||
156906629|NCT00064337|566415762|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
156906630|NCT00064337|566415762|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
156906631|NCT00064337|566415762|FG000|PBSCC or Induction/PBSCC|Progression|3|||
156906632|NCT00064337|566415762|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
156906633|NCT00064337|566415762|FG000|PBSCC or Induction/PBSCC|Death|2|||
156906634|NCT00064337|566415762|FG000|Transplant|Adverse Event|9|||
156906635|NCT00064337|566415762|FG000|Transplant|Not protocol-specified|5|||
156906636|NCT00064337|566415762|FG000|Transplant|Death|3|||
156906637|NCT00064337|566415762|FG000|Transplant|Patient Refusal|2|||
156906638|NCT00064337|566415762|FG000|Transplant|Progression|2|||
156906639|NCT00064337|566415762|FG000|Maintenance|Adverse Event|3|||
156906640|NCT00064337|566415762|FG000|Maintenance|Progression|2|||
156906641|NCT00064337|566415762|FG000|Maintenance|On treatment at time of analysis|2|||
156906642|NCT00064337|566415762|FG000|Maintenance|Not protocol-specified|2|||
156906643|NCT00064337|566415762|FG000|Maintenance|Death|1|||
156906644|NCT00617851|566415765|FG000|Overall Study|Death|0|||
156906645|NCT00617851|566415766|FG001|Overall Study|Death|0|||
156906646|NCT00617851|566415767|FG002|Overall Study|Death|0|||
156906647|NCT00617851|566415768|FG003|Overall Study|Death|1|||
156906648|NCT00617851|566415765|FG000|Overall Study|Withdrawal by Subject|14|||
156906649|NCT00617851|566415766|FG001|Overall Study|Withdrawal by Subject|7|||
156906650|NCT00617851|566415767|FG002|Overall Study|Withdrawal by Subject|12|||
156906651|NCT00617851|566415768|FG003|Overall Study|Withdrawal by Subject|4|||
156906652|NCT00617851|566415765|FG000|Overall Study|Lost to Follow-up|27|||
156906653|NCT00617851|566415766|FG001|Overall Study|Lost to Follow-up|29|||
156906654|NCT00617851|566415767|FG002|Overall Study|Lost to Follow-up|31|||
156906655|NCT00617851|566415768|FG003|Overall Study|Lost to Follow-up|19|||
156906656|NCT00617851|566415765|FG000|Overall Study|Inappropriate Enrollment|5|||
156906657|NCT00617851|566415766|FG001|Overall Study|Inappropriate Enrollment|4|||
156906658|NCT00617851|566415767|FG002|Overall Study|Inappropriate Enrollment|1|||
156906659|NCT00617851|566415768|FG003|Overall Study|Inappropriate Enrollment|1|||
157159504|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Death|0|||
157159505|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Death|3|||
157159506|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159507|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159508|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159509|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159510|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159511|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
157159512|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
156906660|NCT00617851|566415765|FG000|Overall Study|Unable to classify|1|||
156906661|NCT00617851|566415766|FG001|Overall Study|Unable to classify|0|||
156906662|NCT00617851|566415767|FG002|Overall Study|Unable to classify|1|||
156906663|NCT00617851|566415768|FG003|Overall Study|Unable to classify|0|||
156906664|NCT03750955|566415775|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
156906665|NCT03750955|566415776|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
156906666|NCT03750955|566415775|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
156906667|NCT03750955|566415776|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
156906668|NCT03345914|566415779|FG000|Overall Study|Transition to another study at week 16|80|||
157159513|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
156906669|NCT03345914|566415780|FG001|Overall Study|Transition to another study at week 16|86|||
156906670|NCT03345914|566415781|FG002|Overall Study|Transition to another study at week 16|78|||
156906671|NCT03345914|566415779|FG000|Overall Study|Transition to OLE during follow-up|37|||
156906672|NCT03345914|566415780|FG001|Overall Study|Transition to OLE during follow-up|33|||
156906673|NCT03345914|566415781|FG002|Overall Study|Transition to OLE during follow-up|39|||
156906674|NCT03345914|566415779|FG000|Overall Study|Physician Decision|0|||
156906675|NCT03345914|566415780|FG001|Overall Study|Physician Decision|1|||
156906676|NCT03345914|566415781|FG002|Overall Study|Physician Decision|1|||
156906677|NCT03345914|566415779|FG000|Overall Study|Withdrawal by Subject|5|||
156906678|NCT03345914|566415780|FG001|Overall Study|Withdrawal by Subject|1|||
156906679|NCT03345914|566415781|FG002|Overall Study|Withdrawal by Subject|2|||
156906680|NCT03345914|566415779|FG000|Overall Study|Other|1|||
156906681|NCT03345914|566415780|FG001|Overall Study|Other|1|||
156906682|NCT03345914|566415781|FG002|Overall Study|Other|1|||
156906683|NCT03345914|566415779|FG000|Overall Study|Ongoing|0|||
156906684|NCT03345914|566415780|FG001|Overall Study|Ongoing|0|||
156906685|NCT03345914|566415781|FG002|Overall Study|Ongoing|1|||
156906686|NCT02248701|566415784|FG000|Overall Study|Withdrawal by Subject|2|||
156906687|NCT02248701|566415785|FG001|Overall Study|Withdrawal by Subject|1|||
156906688|NCT02248701|566415784|FG000|Overall Study|Physician Decision|0|||
156906689|NCT02248701|566415785|FG001|Overall Study|Physician Decision|1|||
156906690|NCT02248701|566415784|FG000|Overall Study|Adverse Event|1|||
156906691|NCT02248701|566415785|FG001|Overall Study|Adverse Event|0|||
156906692|NCT02248701|566415784|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
156906693|NCT02248701|566415785|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
156906694|NCT00319553|566415788|FG000|Overall Study|Protocol Violation|1|||
156906695|NCT00319553|566415789|FG001|Overall Study|Protocol Violation|2|||
156906696|NCT00319553|566415788|FG000|Overall Study|Lost to Follow-up|2|||
156906697|NCT00319553|566415789|FG001|Overall Study|Lost to Follow-up|1|||
156906698|NCT00319553|566415788|FG000|Overall Study|Withdrawal by Subject|1|||
156906699|NCT00319553|566415789|FG001|Overall Study|Withdrawal by Subject|1|||
156906700|NCT01145625|566415792|FG000|Overall Study|Lost to Follow-up|8|||
156906701|NCT01145625|566415793|FG001|Overall Study|Lost to Follow-up|9|||
156906702|NCT01145625|566415792|FG000|Overall Study|Adverse Event|6|||
156906703|NCT01145625|566415793|FG001|Overall Study|Adverse Event|4|||
156906704|NCT01145625|566415792|FG000|Overall Study|Protocol Violation|3|||
156906705|NCT01145625|566415793|FG001|Overall Study|Protocol Violation|1|||
156906706|NCT01145625|566415792|FG000|Overall Study|Withdrawal by Subject|7|||
156906707|NCT01145625|566415793|FG001|Overall Study|Withdrawal by Subject|16|||
156906708|NCT01145625|566415792|FG000|Overall Study|Pregnancy|0|||
156906709|NCT01145625|566415793|FG001|Overall Study|Pregnancy|1|||
156906710|NCT01751178|566415794|FG000|Overall Study|Adverse Event|2|||
156906711|NCT01751178|566415795|FG001|Overall Study|Adverse Event|0|||
156906712|NCT01751178|566415796|FG002|Overall Study|Adverse Event|0|||
156906713|NCT01751178|566415794|FG000|Overall Study|Other Reason (unknown)|1|||
156906714|NCT01751178|566415795|FG001|Overall Study|Other Reason (unknown)|0|||
156906715|NCT01751178|566415796|FG002|Overall Study|Other Reason (unknown)|2|||
156906716|NCT00885846|566415797|FG000|Overall Study|Withdrawal by Subject|2|||
156906717|NCT00885846|566415798|FG001|Overall Study|Withdrawal by Subject|5|||
156906718|NCT00885846|566415799|FG002|Overall Study|Withdrawal by Subject|2|||
156906719|NCT02747875|566415802|FG000|Overall Study|Physician Decision|1|||
156906720|NCT02747875|566415803|FG001|Overall Study|Physician Decision|0|||
156906721|NCT02747875|566415802|FG000|Overall Study|Adverse Event|0|||
156906722|NCT02747875|566415803|FG001|Overall Study|Adverse Event|1|||
156906723|NCT00762385|566415805|FG000|First Intervention|Lens Issue|1|||
156906724|NCT00762385|566415806|FG001|First Intervention|Lens Issue|1|||
156906725|NCT00762385|566415805|FG000|First Intervention|Lost to Follow-up|0|||
156906726|NCT00762385|566415806|FG001|First Intervention|Lost to Follow-up|2|||
156906727|NCT00762385|566415805|FG000|First Intervention|Ineligible|1|||
156906728|NCT00762385|566415806|FG001|First Intervention|Ineligible|0|||
156906729|NCT00762385|566415805|FG000|First Intervention|Protocol Violation|0|||
156906730|NCT00762385|566415806|FG001|First Intervention|Protocol Violation|1|||
156906731|NCT00762385|566415805|FG000|Second Intervention|Protocol Violation|3|||
156906732|NCT00762385|566415806|FG001|Second Intervention|Protocol Violation|3|||
156906733|NCT00591344|566415809|FG000|Overall Study|Transportation issues|1|||
156906734|NCT00591344|566415810|FG001|Overall Study|Transportation issues|0|||
156906735|NCT00591344|566415809|FG000|Overall Study|Moved out of state|1|||
156906736|NCT00591344|566415810|FG001|Overall Study|Moved out of state|0|||
156906737|NCT00591344|566415809|FG000|Overall Study|Medical complications|1|||
156906738|NCT00591344|566415810|FG001|Overall Study|Medical complications|3|||
156906739|NCT00591344|566415809|FG000|Overall Study|Underwent DBS|2|||
156906740|NCT00591344|566415810|FG001|Overall Study|Underwent DBS|2|||
156906741|NCT00591344|566415809|FG000|Overall Study|Death|0|||
156906742|NCT00591344|566415810|FG001|Overall Study|Death|1|||
156906743|NCT00591344|566415809|FG000|Overall Study|Lost to Follow-up|0|||
156906744|NCT00591344|566415810|FG001|Overall Study|Lost to Follow-up|1|||
156906745|NCT00591344|566415809|FG000|Overall Study|Did not want to come off medication|0|||
157026806|NCT04103580|566853300|FG001|Phase 1 Active Caregiving|Other|3|||
156906746|NCT00591344|566415810|FG001|Overall Study|Did not want to come off medication|1|||
156906747|NCT00493025|566415811|FG000|Overall Study|Physician Decision|19|||
156906748|NCT03863197|566415812|FG000|Overall Study|Lost to Follow-up|2|||
156906749|NCT03863197|566415813|FG001|Overall Study|Lost to Follow-up|3|||
156906750|NCT03863197|566415812|FG000|Overall Study|Withdrawal by Subject|4|||
156906751|NCT03863197|566415813|FG001|Overall Study|Withdrawal by Subject|0|||
156906752|NCT03863197|566415812|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
156906753|NCT03863197|566415813|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
156906754|NCT01065597|566415814|FG000|Overall Study|Adverse Event|1|||
156906755|NCT01781975|566415815|FG000|Overall Study|Death|1|||
156906756|NCT01781975|566415816|FG001|Overall Study|Death|0|||
156906757|NCT01781975|566415815|FG000|Overall Study|Withdrawal by Subject|1|||
156906758|NCT01781975|566415816|FG001|Overall Study|Withdrawal by Subject|1|||
156906759|NCT01622231|566415817|FG000|Overall Study|Physician Decision|1|||
156906760|NCT01622231|566415817|FG000|Overall Study|Withdrawal by Subject|1|||
156906761|NCT02329080|566415818|FG000|Overall Study|Adverse Event|1|||
156906762|NCT02329080|566415818|FG000|Overall Study|Death|4|||
156906763|NCT02329080|566415818|FG000|Overall Study|Lack of Efficacy|22|||
156906764|NCT02329080|566415818|FG000|Overall Study|Lost to Follow-up|1|||
156906765|NCT02329080|566415818|FG000|Overall Study|Physician Decision|2|||
156906766|NCT02329080|566415818|FG000|Overall Study|Partial response|4|||
156906767|NCT02329080|566415818|FG000|Overall Study|Complete response|4|||
156906768|NCT00973674|566415822|FG000|Overall Study|Protocol Violation|2|||
156906769|NCT00973674|566415823|FG001|Overall Study|Protocol Violation|0|||
156906770|NCT03082261|566415826|FG000|Overall Study|Death|4|||
156906771|NCT03082261|566415826|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
156906772|NCT03082261|566415826|FG000|Overall Study|Insurance denial|1|||
156906773|NCT03082261|566415826|FG000|Overall Study|Peripheral lead added|1|||
156906774|NCT03082261|566415826|FG000|Overall Study|Withdrawal by Subject|40|||
156906775|NCT03082261|566415826|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
156906776|NCT03082261|566415826|FG000|Overall Study|Subject implanted with device other than study device|1|||
156906777|NCT03082261|566415826|FG000|Overall Study|Lost to Follow-up|14|||
156906778|NCT03082261|566415826|FG000|Overall Study|Subject moved to a different state|1|||
156906779|NCT03082261|566415826|FG000|Overall Study|Subject non-compliance|2|||
156906780|NCT03082261|566415826|FG000|Overall Study|Subject participation terminated by investigator|9|||
156906781|NCT03082261|566415826|FG000|Overall Study|Subject participation terminated by sponsor|4|||
156906782|NCT03082261|566415826|FG000|Overall Study|System explant|19|||
156906783|NCT03082261|566415826|FG000|Overall Study|Unable to place lead(s)|2|||
156906784|NCT03082261|566415826|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
156906785|NCT00839852|566415827|FG000|Overall Study|Adverse Event|10|||
156906786|NCT00839852|566415827|FG000|Overall Study|Insufficient Therapeutic Response|3|||
156906787|NCT00839852|566415827|FG000|Overall Study|Protocol Violation|9|||
156906788|NCT00839852|566415827|FG000|Overall Study|Withdrawal of Consent|16|||
156906789|NCT00839852|566415827|FG000|Overall Study|Lost to Follow-up|7|||
156906790|NCT00839852|566415827|FG000|Overall Study|Lack of Compliance While in Jail|1|||
156906791|NCT00839852|566415827|FG000|Overall Study|Pregnancy|1|||
156906792|NCT01281137|566415829|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
156906793|NCT01281137|566415830|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
156906794|NCT01281137|566415829|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
156906795|NCT01281137|566415830|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
156906796|NCT01281137|566415829|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
156906797|NCT01281137|566415830|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
156906798|NCT01281137|566415829|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
156906799|NCT01281137|566415830|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
156906800|NCT01281137|566415829|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
156906801|NCT01281137|566415830|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
157159514|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
157159515|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
157159516|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
157159517|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
157159518|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
157159519|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
157159520|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156906802|NCT02846324|566415831|FG000|Overall Study|Other|1|||
156906803|NCT02846324|566415832|FG001|Overall Study|Other|0|||
156906804|NCT02846324|566415833|FG002|Overall Study|Other|0|||
156906805|NCT02846324|566415834|FG003|Overall Study|Other|0|||
157159521|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156906806|NCT02846324|566415831|FG000|Overall Study|Withdrawal by Subject|1|||
156906807|NCT02846324|566415832|FG001|Overall Study|Withdrawal by Subject|0|||
156906808|NCT02846324|566415833|FG002|Overall Study|Withdrawal by Subject|4|||
156906809|NCT02846324|566415834|FG003|Overall Study|Withdrawal by Subject|0|||
156906810|NCT00003487|566415843|FG000|Overall Study|Not evaluable|2|||
156906811|NCT04154930|566415844|FG000|Overall Study|Withdrawal by Subject|15|||
156906812|NCT04154930|566415845|FG001|Overall Study|Withdrawal by Subject|6|||
156906813|NCT04154930|566415844|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
156906814|NCT04154930|566415845|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
156906815|NCT04154930|566415844|FG000|Overall Study|Lost to Follow-up|14|||
156906816|NCT04154930|566415845|FG001|Overall Study|Lost to Follow-up|6|||
156906817|NCT04154930|566415844|FG000|Overall Study|Other|6|||
156906818|NCT04154930|566415845|FG001|Overall Study|Other|0|||
156906819|NCT00657358|566415846|FG000|Overall Study|Lack of Efficacy|6|||
156906820|NCT02130297|566415850|FG000|Overall Study|Lost to Follow-up|4|||
156906821|NCT01999179|566415851|FG000|Overall Study|Adverse Event|1|||
156906822|NCT01999179|566415851|FG000|Overall Study|Lost to Follow-up|1|||
156906823|NCT01999179|566415851|FG000|Overall Study|Change in Therapy|3|||
156906824|NCT01999179|566415851|FG000|Overall Study|New catheter|2|||
156906825|NCT00678080|566415855|FG000|Overall Study|Physician Decision|2|||
156906826|NCT00678080|566415856|FG001|Overall Study|Physician Decision|0|||
156906827|NCT00678080|566415855|FG000|Overall Study|Lost to Follow-up|1|||
156906828|NCT00678080|566415856|FG001|Overall Study|Lost to Follow-up|0|||
156906829|NCT00678080|566415855|FG000|Overall Study|Withdrawal by Subject|0|||
156906830|NCT00678080|566415856|FG001|Overall Study|Withdrawal by Subject|1|||
156906831|NCT02400333|566417235|FG000|Overall Study|Withdrawal by Subject|0|||
156906832|NCT02400333|566417236|FG001|Overall Study|Withdrawal by Subject|1|||
156906833|NCT02400333|566417237|FG002|Overall Study|Withdrawal by Subject|0|||
156906834|NCT02400333|566417238|FG003|Overall Study|Withdrawal by Subject|1|||
156906835|NCT02400333|566417235|FG000|Overall Study|Protocol Violation|1|||
156906836|NCT02400333|566417236|FG001|Overall Study|Protocol Violation|0|||
156906837|NCT02400333|566417237|FG002|Overall Study|Protocol Violation|2|||
156906838|NCT02400333|566417238|FG003|Overall Study|Protocol Violation|1|||
156906839|NCT02468674|566417239|FG000|Overall Study|Adverse Event|0|||
156906840|NCT02468674|566417240|FG001|Overall Study|Adverse Event|0|||
156906841|NCT02468674|566417241|FG002|Overall Study|Adverse Event|0|||
156906842|NCT02468674|566417242|FG003|Overall Study|Adverse Event|1|||
156906843|NCT02468674|566417243|FG004|Overall Study|Adverse Event|0|||
156906844|NCT02468674|566417244|FG005|Overall Study|Adverse Event|1|||
156906845|NCT02468674|566417245|FG006|Overall Study|Adverse Event|0|||
156906846|NCT02468674|566417246|FG007|Overall Study|Adverse Event|0|||
156906847|NCT02468674|566417247|FG008|Overall Study|Adverse Event|0|||
156906848|NCT02468674|566417239|FG000|Overall Study|Lost to Follow-up|1|||
156906849|NCT02468674|566417240|FG001|Overall Study|Lost to Follow-up|0|||
156906850|NCT02468674|566417241|FG002|Overall Study|Lost to Follow-up|0|||
156906851|NCT02468674|566417242|FG003|Overall Study|Lost to Follow-up|0|||
156906852|NCT02468674|566417243|FG004|Overall Study|Lost to Follow-up|0|||
156906853|NCT02468674|566417244|FG005|Overall Study|Lost to Follow-up|0|||
156906854|NCT02468674|566417245|FG006|Overall Study|Lost to Follow-up|0|||
156906855|NCT02468674|566417246|FG007|Overall Study|Lost to Follow-up|1|||
156906856|NCT02468674|566417247|FG008|Overall Study|Lost to Follow-up|1|||
156906857|NCT02468674|566417239|FG000|Overall Study|Physician Decision|0|||
156906858|NCT02468674|566417240|FG001|Overall Study|Physician Decision|0|||
156906859|NCT02468674|566417241|FG002|Overall Study|Physician Decision|0|||
156906860|NCT02468674|566417242|FG003|Overall Study|Physician Decision|0|||
156906861|NCT02468674|566417243|FG004|Overall Study|Physician Decision|0|||
156906862|NCT02468674|566417244|FG005|Overall Study|Physician Decision|0|||
156906863|NCT02468674|566417245|FG006|Overall Study|Physician Decision|1|||
156906864|NCT02468674|566417246|FG007|Overall Study|Physician Decision|0|||
156906865|NCT02468674|566417247|FG008|Overall Study|Physician Decision|0|||
156906866|NCT02468674|566417239|FG000|Overall Study|Patient/Guardian Decision|0|||
157159522|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
156906867|NCT02468674|566417240|FG001|Overall Study|Patient/Guardian Decision|0|||
156906868|NCT02468674|566417241|FG002|Overall Study|Patient/Guardian Decision|0|||
156906869|NCT02468674|566417242|FG003|Overall Study|Patient/Guardian Decision|0|||
156906870|NCT02468674|566417243|FG004|Overall Study|Patient/Guardian Decision|1|||
156906871|NCT02468674|566417244|FG005|Overall Study|Patient/Guardian Decision|0|||
156906872|NCT02468674|566417245|FG006|Overall Study|Patient/Guardian Decision|0|||
156906873|NCT02468674|566417246|FG007|Overall Study|Patient/Guardian Decision|2|||
156906874|NCT02468674|566417247|FG008|Overall Study|Patient/Guardian Decision|1|||
156906875|NCT02468674|566417239|FG000|Overall Study|Protocol Deviation|0|||
156906876|NCT02468674|566417240|FG001|Overall Study|Protocol Deviation|0|||
156906877|NCT02468674|566417241|FG002|Overall Study|Protocol Deviation|0|||
156906878|NCT02468674|566417242|FG003|Overall Study|Protocol Deviation|0|||
156906879|NCT02468674|566417243|FG004|Overall Study|Protocol Deviation|0|||
156906880|NCT02468674|566417244|FG005|Overall Study|Protocol Deviation|0|||
156906881|NCT02468674|566417245|FG006|Overall Study|Protocol Deviation|0|||
156906882|NCT02468674|566417246|FG007|Overall Study|Protocol Deviation|1|||
156906883|NCT02468674|566417247|FG008|Overall Study|Protocol Deviation|1|||
156906884|NCT01644565|566417254|FG000|Overall Study|Undisclosed Medical History|1|||
156906885|NCT01644565|566417255|FG001|Overall Study|Undisclosed Medical History|0|||
156906886|NCT01644565|566417256|FG002|Overall Study|Undisclosed Medical History|0|||
156906887|NCT01644565|566417257|FG003|Overall Study|Undisclosed Medical History|0|||
156906888|NCT01644565|566417258|FG004|Overall Study|Undisclosed Medical History|0|||
156906889|NCT01644565|566417259|FG005|Overall Study|Undisclosed Medical History|0|||
156906890|NCT01644565|566417260|FG006|Overall Study|Undisclosed Medical History|0|||
156906891|NCT01644565|566417261|FG007|Overall Study|Undisclosed Medical History|0|||
156906892|NCT01644565|566417262|FG008|Overall Study|Undisclosed Medical History|0|||
156906893|NCT01644565|566417254|FG000|Overall Study|Lost to Follow-up|0|||
156906894|NCT01644565|566417255|FG001|Overall Study|Lost to Follow-up|0|||
156906895|NCT01644565|566417256|FG002|Overall Study|Lost to Follow-up|0|||
156906896|NCT01644565|566417257|FG003|Overall Study|Lost to Follow-up|1|||
156906897|NCT01644565|566417258|FG004|Overall Study|Lost to Follow-up|0|||
156906898|NCT01644565|566417259|FG005|Overall Study|Lost to Follow-up|0|||
156906899|NCT01644565|566417260|FG006|Overall Study|Lost to Follow-up|0|||
156906900|NCT01644565|566417261|FG007|Overall Study|Lost to Follow-up|2|||
156906901|NCT01644565|566417262|FG008|Overall Study|Lost to Follow-up|0|||
156906902|NCT01644565|566417254|FG000|Overall Study|Family emergency|0|||
156906903|NCT01644565|566417255|FG001|Overall Study|Family emergency|0|||
156906904|NCT01644565|566417256|FG002|Overall Study|Family emergency|0|||
156906905|NCT01644565|566417257|FG003|Overall Study|Family emergency|0|||
156906906|NCT01644565|566417258|FG004|Overall Study|Family emergency|1|||
156906907|NCT01644565|566417259|FG005|Overall Study|Family emergency|0|||
156906908|NCT01644565|566417260|FG006|Overall Study|Family emergency|0|||
156906909|NCT01644565|566417261|FG007|Overall Study|Family emergency|0|||
156906910|NCT01644565|566417262|FG008|Overall Study|Family emergency|0|||
156906911|NCT01644565|566417254|FG000|Overall Study|Relocation|0|||
156906912|NCT01644565|566417255|FG001|Overall Study|Relocation|0|||
156906913|NCT01644565|566417256|FG002|Overall Study|Relocation|0|||
156906914|NCT01644565|566417257|FG003|Overall Study|Relocation|0|||
156906915|NCT01644565|566417258|FG004|Overall Study|Relocation|0|||
156906916|NCT01644565|566417259|FG005|Overall Study|Relocation|0|||
156906917|NCT01644565|566417260|FG006|Overall Study|Relocation|0|||
156906918|NCT01644565|566417261|FG007|Overall Study|Relocation|0|||
156906919|NCT01644565|566417262|FG008|Overall Study|Relocation|1|||
156906920|NCT01687998|566417263|FG000|Overall Study|Withdrawal by Subject|49|||
156906921|NCT01687998|566417264|FG001|Overall Study|Withdrawal by Subject|51|||
156906922|NCT01687998|566417263|FG000|Overall Study|Known to be Alive at Study End|54|||
156906923|NCT01687998|566417264|FG001|Overall Study|Known to be Alive at Study End|62|||
156906924|NCT01687998|566417263|FG000|Overall Study|Lost to Follow-up|9|||
156906925|NCT01687998|566417264|FG001|Overall Study|Lost to Follow-up|7|||
156906926|NCT00443261|566417265|FG000|Overall Study|Death|1|||
156906927|NCT01663532|566417266|FG000|Overall Study|Lost to Follow-up|9|||
156906928|NCT01663532|566417267|FG001|Overall Study|Lost to Follow-up|10|||
156906929|NCT01663532|566417266|FG000|Overall Study|Adverse Event|7|||
156906930|NCT01663532|566417267|FG001|Overall Study|Adverse Event|13|||
156906931|NCT01663532|566417266|FG000|Overall Study|Met Withdrawal Criteria|7|||
156906932|NCT01663532|566417267|FG001|Overall Study|Met Withdrawal Criteria|6|||
156906933|NCT01663532|566417266|FG000|Overall Study|Physician Decision|1|||
156906934|NCT01663532|566417267|FG001|Overall Study|Physician Decision|1|||
156906935|NCT01663532|566417266|FG000|Overall Study|Withdrawal by Subject|35|||
156906936|NCT01663532|566417267|FG001|Overall Study|Withdrawal by Subject|17|||
156906937|NCT01663532|566417266|FG000|Overall Study|Lack of Efficacy|15|||
156906938|NCT01663532|566417267|FG001|Overall Study|Lack of Efficacy|60|||
156906939|NCT01560403|566417271|FG000|Overall Study|Lost to Follow-up|0|||
156906940|NCT01560403|566417272|FG001|Overall Study|Lost to Follow-up|1|||
156906941|NCT00354744|566417273|FG000|Overall Study|Adverse Event|2|||
156906942|NCT00354744|566417273|FG000|Overall Study|Death|2|||
156906943|NCT00354744|566417273|FG000|Overall Study|Lack of Efficacy|11|||
157159523|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
157159524|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
157159525|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
157026807|NCT04103580|566853299|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
157159526|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
156906944|NCT00354744|566417273|FG000|Overall Study|Lost to Follow-up|2|||
156906945|NCT00354744|566417273|FG000|Overall Study|Physician Decision|11|||
156906946|NCT00354744|566417273|FG000|Overall Study|Withdrawal by Subject|14|||
156906947|NCT00094172|566417275|FG000|Overall Study|Adverse Event|0|||
156906948|NCT00094172|566417276|FG001|Overall Study|Adverse Event|1|||
156906949|NCT00094172|566417275|FG000|Overall Study|Lost to Follow-up|2|||
156906950|NCT00094172|566417276|FG001|Overall Study|Lost to Follow-up|0|||
156906951|NCT00094172|566417275|FG000|Overall Study|Protocol Violation|0|||
156906952|NCT00094172|566417276|FG001|Overall Study|Protocol Violation|1|||
156906953|NCT00094172|566417275|FG000|Overall Study|Withdrawal by Subject|10|||
156906954|NCT00094172|566417276|FG001|Overall Study|Withdrawal by Subject|5|||
156906955|NCT00094172|566417275|FG000|Overall Study|Primary endpoint met.|1|||
156906956|NCT00094172|566417276|FG001|Overall Study|Primary endpoint met.|0|||
156906957|NCT00094172|566417275|FG000|Overall Study|Started other MS therapy due to disease|1|||
156906958|NCT00094172|566417276|FG001|Overall Study|Started other MS therapy due to disease|0|||
156906959|NCT00289133|566417281|FG000|Overall Study|Non-study device implanted|12|||
156906960|NCT00289133|566417282|FG001|Overall Study|Non-study device implanted|0|||
156906961|NCT00289133|566417281|FG000|Overall Study|Protocol Violation|32|||
156906962|NCT00289133|566417282|FG001|Overall Study|Protocol Violation|38|||
156906963|NCT00289133|566417281|FG000|Overall Study|Withdrawal by Subject|9|||
156906964|NCT00289133|566417282|FG001|Overall Study|Withdrawal by Subject|10|||
156906965|NCT00289133|566417281|FG000|Overall Study|Death|5|||
156906966|NCT00289133|566417282|FG001|Overall Study|Death|10|||
156906967|NCT00289133|566417281|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
156906968|NCT00289133|566417282|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
156906969|NCT00289133|566417281|FG000|Overall Study|Physician Decision|41|||
156906970|NCT00289133|566417282|FG001|Overall Study|Physician Decision|45|||
156906971|NCT00289133|566417281|FG000|Overall Study|Revision|8|||
156906972|NCT00289133|566417282|FG001|Overall Study|Revision|6|||
156906973|NCT00289133|566417281|FG000|Overall Study|Lost to Follow-up|92|||
156906974|NCT00289133|566417282|FG001|Overall Study|Lost to Follow-up|115|||
156906975|NCT03372096|566417283|FG000|Overall Study|Study Closed|8|||
156906976|NCT00541931|566417284|FG000|Overall Study|Adverse Event|1|||
156906977|NCT00541931|566417285|FG001|Overall Study|Adverse Event|0|||
156906978|NCT00541931|566417284|FG000|Overall Study|Lost to Follow-up|3|||
156906979|NCT00541931|566417285|FG001|Overall Study|Lost to Follow-up|3|||
156906980|NCT00541931|566417284|FG000|Overall Study|Withdrawal by Subject|1|||
156906981|NCT00541931|566417285|FG001|Overall Study|Withdrawal by Subject|0|||
156906982|NCT00541931|566417284|FG000|Overall Study|Transportation Issue|0|||
156906983|NCT00541931|566417285|FG001|Overall Study|Transportation Issue|1|||
156906984|NCT00680017|566417286|FG000|Overall Study|Adverse Event|13|||
156906985|NCT00680017|566417287|FG001|Overall Study|Adverse Event|7|||
156906986|NCT00680017|566417286|FG000|Overall Study|Withdrawal by Subject|2|||
156906987|NCT00680017|566417287|FG001|Overall Study|Withdrawal by Subject|5|||
156906988|NCT00680017|566417286|FG000|Overall Study|Lost to Follow-up|2|||
156906989|NCT00680017|566417287|FG001|Overall Study|Lost to Follow-up|0|||
156906990|NCT02555683|566417291|FG000|Overall Study|Physician Decision|1|||
156906991|NCT02555683|566417292|FG001|Overall Study|Physician Decision|0|||
156906992|NCT02555683|566417293|FG002|Overall Study|Physician Decision|2|||
156906993|NCT02555683|566417291|FG000|Overall Study|Lost to Follow-up|2|||
156906994|NCT02555683|566417292|FG001|Overall Study|Lost to Follow-up|1|||
156906995|NCT02555683|566417293|FG002|Overall Study|Lost to Follow-up|2|||
156906996|NCT02555683|566417291|FG000|Overall Study|Technical Problems|1|||
156906997|NCT02555683|566417292|FG001|Overall Study|Technical Problems|1|||
156906998|NCT02555683|566417293|FG002|Overall Study|Technical Problems|0|||
156906999|NCT02555683|566417291|FG000|Overall Study|Protocol deviation|0|||
156907000|NCT02555683|566417292|FG001|Overall Study|Protocol deviation|1|||
156907001|NCT02555683|566417293|FG002|Overall Study|Protocol deviation|0|||
156907002|NCT02555683|566417291|FG000|Overall Study|Lack of Efficacy|2|||
156907003|NCT02555683|566417292|FG001|Overall Study|Lack of Efficacy|0|||
156907004|NCT02555683|566417293|FG002|Overall Study|Lack of Efficacy|0|||
156907005|NCT02555683|566417291|FG000|Overall Study|Death|0|||
156907006|NCT02555683|566417292|FG001|Overall Study|Death|1|||
156907007|NCT02555683|566417293|FG002|Overall Study|Death|2|||
156907008|NCT02555683|566417291|FG000|Overall Study|Adverse Event|1|||
156907009|NCT02555683|566417292|FG001|Overall Study|Adverse Event|0|||
156907010|NCT02555683|566417293|FG002|Overall Study|Adverse Event|1|||
156907011|NCT02555683|566417291|FG000|Overall Study|Subject/guardian decision|12|||
156907012|NCT02555683|566417292|FG001|Overall Study|Subject/guardian decision|12|||
156907013|NCT02555683|566417293|FG002|Overall Study|Subject/guardian decision|22|||
156907014|NCT02555683|566417291|FG000|Overall Study|Death post Treatment/safety period|0|||
156907015|NCT02555683|566417292|FG001|Overall Study|Death post Treatment/safety period|1|||
156907016|NCT02555683|566417293|FG002|Overall Study|Death post Treatment/safety period|0|||
156907017|NCT00612040|566417298|FG000|Overall Study|Adverse Event|0|||
156907018|NCT00612040|566417299|FG001|Overall Study|Adverse Event|2|||
156907019|NCT00612040|566417300|FG002|Overall Study|Adverse Event|1|||
156907020|NCT00612040|566417298|FG000|Overall Study|Protocol Violation|1|||
156907021|NCT00612040|566417299|FG001|Overall Study|Protocol Violation|2|||
156907022|NCT00612040|566417300|FG002|Overall Study|Protocol Violation|1|||
156907023|NCT00612040|566417298|FG000|Overall Study|Lack of Efficacy|2|||
156907024|NCT00612040|566417299|FG001|Overall Study|Lack of Efficacy|1|||
156907025|NCT00612040|566417300|FG002|Overall Study|Lack of Efficacy|0|||
156907026|NCT00612040|566417298|FG000|Overall Study|Unclassified|2|||
156907027|NCT00612040|566417299|FG001|Overall Study|Unclassified|2|||
156907028|NCT00612040|566417300|FG002|Overall Study|Unclassified|5|||
156907029|NCT02835820|566417301|FG000|Overall Study|Baseline Screen Failure|0|||
156907030|NCT02835820|566417302|FG001|Overall Study|Baseline Screen Failure|3|||
156907031|NCT01397890|566417311|FG000|Overall Study|Withdrawal by Subject|7|||
156907032|NCT01397890|566417312|FG001|Overall Study|Withdrawal by Subject|11|||
156907033|NCT01397890|566417311|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
156907034|NCT01397890|566417312|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
156907035|NCT01397890|566417311|FG000|Overall Study|Death|2|||
156907036|NCT01397890|566417312|FG001|Overall Study|Death|3|||
157159527|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
157159528|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
157159529|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
157159530|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
156907037|NCT01397890|566417311|FG000|Overall Study|Lost to Follow-up|1|||
156907038|NCT01397890|566417312|FG001|Overall Study|Lost to Follow-up|4|||
156907039|NCT01397890|566417311|FG000|Overall Study|Condition under Investigation Worsened|1|||
156907040|NCT01397890|566417312|FG001|Overall Study|Condition under Investigation Worsened|3|||
157159531|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
157159532|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
157159533|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
157159534|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159535|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159536|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159537|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159538|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159539|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
157159540|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
157159541|NCT00254293|567329505|FG000|LTE Open Label Fixed Dosing|Other|0|||
157159542|NCT00254293|567329506|FG001|LTE Open Label Fixed Dosing|Other|0|||
157159543|NCT00254293|567329507|FG002|LTE Open Label Fixed Dosing|Other|0|||
157159544|NCT00254293|567329508|FG003|LTE Open Label Fixed Dosing|Other|0|||
157159545|NCT00254293|567329509|FG004|LTE Open Label Fixed Dosing|Other|0|||
157159546|NCT00254293|567329510|FG005|LTE Open Label Fixed Dosing|Other|0|||
157159547|NCT00254293|567329511|FG006|LTE Open Label Fixed Dosing|Other|1|||
157159548|NCT02681055|567329514|FG000|Weeks 5-12|Adverse Event|1|||
157159549|NCT02695524|567329515|FG000|Overall Study|Lost to Follow-up|3|||
157159550|NCT02695524|567329516|FG001|Overall Study|Lost to Follow-up|2|||
157159551|NCT02695524|567329515|FG000|Overall Study|Death|0|||
157159552|NCT02695524|567329516|FG001|Overall Study|Death|1|||
157159553|NCT04348656|567329517|FG000|Overall Study|Withdrawal by Subject|2|||
157159554|NCT04348656|567329518|FG001|Overall Study|Withdrawal by Subject|0|||
157159555|NCT04348656|567329517|FG000|Overall Study|Lost to Follow-up|11|||
157159556|NCT04348656|567329518|FG001|Overall Study|Lost to Follow-up|6|||
157159557|NCT01718509|567329521|FG000|Overall Study|Lost to Follow-up|18|||
157159558|NCT01718509|567329522|FG001|Overall Study|Lost to Follow-up|15|||
157159559|NCT01718509|567329521|FG000|Overall Study|Withdrawal by Subject|7|||
157159560|NCT01718509|567329522|FG001|Overall Study|Withdrawal by Subject|13|||
157159561|NCT01718509|567329521|FG000|Overall Study|Adverse Event|5|||
157159562|NCT01718509|567329522|FG001|Overall Study|Adverse Event|7|||
157159563|NCT01718509|567329521|FG000|Overall Study|Other|13|||
157159564|NCT01718509|567329522|FG001|Overall Study|Other|11|||
157159565|NCT01718509|567329521|FG000|Overall Study|Protocol Violation|4|||
157159566|NCT01718509|567329522|FG001|Overall Study|Protocol Violation|2|||
157159567|NCT01718509|567329521|FG000|Overall Study|Lack of Efficacy|1|||
157159568|NCT01718509|567329522|FG001|Overall Study|Lack of Efficacy|0|||
157159569|NCT05906732|567329525|FG000|Overall Study|Withdrawal by Subject|1|||
157159570|NCT05906732|567329526|FG001|Overall Study|Withdrawal by Subject|0|||
156859810|NCT01469221|566243219|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
156859811|NCT01469221|566243220|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
156859812|NCT01469221|566243221|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
156859813|NCT00475670|566243222|FG000|Overall Study|Death|0|||
156859814|NCT00475670|566243223|FG001|Overall Study|Death|1|||
156859815|NCT00475670|566243222|FG000|Overall Study|Lack of Efficacy|3|||
156859816|NCT00475670|566243223|FG001|Overall Study|Lack of Efficacy|34|||
156859817|NCT00475670|566243222|FG000|Overall Study|Refused treatment|0|||
156859818|NCT00475670|566243223|FG001|Overall Study|Refused treatment|2|||
156859819|NCT00475670|566243222|FG000|Overall Study|Failure to Return|0|||
156859820|NCT00475670|566243223|FG001|Overall Study|Failure to Return|1|||
156859821|NCT00475670|566243222|FG000|Overall Study|Other|0|||
156859822|NCT00475670|566243223|FG001|Overall Study|Other|3|||
156859823|NCT01168349|566243224|FG000|Overall Study|Death|157|||
156859824|NCT01168349|566243224|FG000|Overall Study|Lost to Follow-up|34|||
156859825|NCT01168349|566243224|FG000|Overall Study|Withdrawal by Subject|9|||
156859826|NCT01168349|566243224|FG000|Overall Study|Kidney transplantation|3|||
156859827|NCT01168349|566243224|FG000|Overall Study|Other|22|||
156859828|NCT01168349|566243224|FG000|Overall Study|Protocol Violation|76|||
156859829|NCT05468814|566243225|FG000|Overall Study|Lost to Follow-up|5|||
156859830|NCT05468814|566243226|FG001|Overall Study|Lost to Follow-up|6|||
156859831|NCT01650558|566243232|FG000|Overall Study|Migration out of study area|61|||
156859832|NCT01650558|566243233|FG001|Overall Study|Migration out of study area|71|||
156859833|NCT01650558|566243234|FG002|Overall Study|Migration out of study area|56|||
156859834|NCT01650558|566243232|FG000|Overall Study|Lost to Follow-up|10|||
157159571|NCT05906732|567329527|FG002|Overall Study|Withdrawal by Subject|0|||
157159572|NCT05906732|567329528|FG003|Overall Study|Withdrawal by Subject|0|||
157159573|NCT05906732|567329525|FG000|Overall Study|Physician Decision|2|||
157159574|NCT05906732|567329526|FG001|Overall Study|Physician Decision|4|||
157159575|NCT05906732|567329527|FG002|Overall Study|Physician Decision|0|||
157159576|NCT05906732|567329528|FG003|Overall Study|Physician Decision|0|||
157159577|NCT01248130|567329529|FG000|Overall Study|Protocol Violation|1|||
156907041|NCT01397890|566417311|FG000|Overall Study|Adverse Event|1|||
156907042|NCT01397890|566417312|FG001|Overall Study|Adverse Event|2|||
156907043|NCT01397890|566417311|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
156907044|NCT01397890|566417312|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
156907045|NCT01397890|566417311|FG000|Overall Study|Others|2|||
156907046|NCT01397890|566417312|FG001|Overall Study|Others|1|||
156907047|NCT03094169|566417313|FG000|Overall Study|Lack of Efficacy|0|||
156907048|NCT03094169|566417314|FG001|Overall Study|Lack of Efficacy|0|||
156907049|NCT03094169|566417315|FG002|Overall Study|Lack of Efficacy|0|||
156907050|NCT03094169|566417316|FG003|Overall Study|Lack of Efficacy|0|||
156907051|NCT03094169|566417317|FG004|Overall Study|Lack of Efficacy|0|||
156907052|NCT03094169|566417318|FG005|Overall Study|Lack of Efficacy|0|||
156907053|NCT03094169|566417319|FG006|Overall Study|Lack of Efficacy|0|||
156907054|NCT03094169|566417320|FG007|Overall Study|Lack of Efficacy|21|||
156907055|NCT03094169|566417313|FG000|Overall Study|Adverse Event|0|||
156907056|NCT03094169|566417314|FG001|Overall Study|Adverse Event|0|||
156907057|NCT03094169|566417315|FG002|Overall Study|Adverse Event|0|||
156907058|NCT03094169|566417316|FG003|Overall Study|Adverse Event|0|||
156907059|NCT03094169|566417317|FG004|Overall Study|Adverse Event|0|||
156907060|NCT03094169|566417318|FG005|Overall Study|Adverse Event|0|||
156907061|NCT03094169|566417319|FG006|Overall Study|Adverse Event|0|||
156907062|NCT03094169|566417320|FG007|Overall Study|Adverse Event|2|||
156907063|NCT03094169|566417313|FG000|Overall Study|Withdrawal by Subject|0|||
156907064|NCT03094169|566417314|FG001|Overall Study|Withdrawal by Subject|0|||
156907065|NCT03094169|566417315|FG002|Overall Study|Withdrawal by Subject|0|||
156907066|NCT03094169|566417316|FG003|Overall Study|Withdrawal by Subject|0|||
156907067|NCT03094169|566417317|FG004|Overall Study|Withdrawal by Subject|0|||
156907068|NCT03094169|566417318|FG005|Overall Study|Withdrawal by Subject|0|||
156907069|NCT03094169|566417319|FG006|Overall Study|Withdrawal by Subject|1|||
156907070|NCT03094169|566417320|FG007|Overall Study|Withdrawal by Subject|1|||
156907071|NCT03094169|566417313|FG000|Overall Study|Trial Termination|0|||
156907072|NCT03094169|566417314|FG001|Overall Study|Trial Termination|0|||
156907073|NCT03094169|566417315|FG002|Overall Study|Trial Termination|0|||
156907074|NCT03094169|566417316|FG003|Overall Study|Trial Termination|0|||
156907075|NCT03094169|566417317|FG004|Overall Study|Trial Termination|0|||
156907076|NCT03094169|566417318|FG005|Overall Study|Trial Termination|0|||
156907077|NCT03094169|566417319|FG006|Overall Study|Trial Termination|0|||
156907078|NCT03094169|566417320|FG007|Overall Study|Trial Termination|1|||
156907079|NCT04645953|566417321|FG000|Overall Study|Lost to Follow-up|2|||
156907080|NCT04645953|566417322|FG001|Overall Study|Lost to Follow-up|1|||
156907081|NCT04645953|566417323|FG002|Overall Study|Lost to Follow-up|1|||
156907082|NCT04645953|566417321|FG000|Overall Study|Withdrawal by Subject|0|||
156907083|NCT04645953|566417322|FG001|Overall Study|Withdrawal by Subject|1|||
156907084|NCT04645953|566417323|FG002|Overall Study|Withdrawal by Subject|0|||
156907085|NCT04645953|566417321|FG000|Overall Study|Physician Decision|0|||
156907086|NCT04645953|566417322|FG001|Overall Study|Physician Decision|1|||
156907087|NCT04645953|566417323|FG002|Overall Study|Physician Decision|0|||
156907088|NCT04645953|566417321|FG000|Overall Study|Discontinued Prior to Dosing|0|||
156907089|NCT04645953|566417322|FG001|Overall Study|Discontinued Prior to Dosing|0|||
156907090|NCT04645953|566417323|FG002|Overall Study|Discontinued Prior to Dosing|2|||
157159578|NCT01248130|567329530|FG001|Overall Study|Protocol Violation|0|||
157159579|NCT01248130|567329529|FG000|Overall Study|Ineligible|1|||
156907091|NCT04613375|566417324|FG000|Overall Study|Death|198|||
156907092|NCT04613375|566417324|FG000|Overall Study|Withdrawal by Subject|3|||
156907093|NCT00002651|566417325|FG000|Induction|Adverse Event|44|||
156907094|NCT00002651|566417326|FG001|Induction|Adverse Event|0|||
157159580|NCT01248130|567329530|FG001|Overall Study|Ineligible|0|||
157159581|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
156907095|NCT00002651|566417327|FG002|Induction|Adverse Event|0|||
156907096|NCT00002651|566417325|FG000|Induction|Refusal unrelated to adverse event|50|||
156907097|NCT00002651|566417326|FG001|Induction|Refusal unrelated to adverse event|0|||
156907098|NCT00002651|566417327|FG002|Induction|Refusal unrelated to adverse event|0|||
156907099|NCT00002651|566417325|FG000|Induction|Progression/relapse|274|||
156907100|NCT00002651|566417326|FG001|Induction|Progression/relapse|0|||
156907101|NCT00002651|566417327|FG002|Induction|Progression/relapse|0|||
156907102|NCT00002651|566417325|FG000|Induction|Death|62|||
156907103|NCT00002651|566417326|FG001|Induction|Death|0|||
156907104|NCT00002651|566417327|FG002|Induction|Death|0|||
156907105|NCT00002651|566417325|FG000|Induction|Other|823|||
156907106|NCT00002651|566417326|FG001|Induction|Other|0|||
157159582|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
157159583|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
156907107|NCT00002651|566417327|FG002|Induction|Other|0|||
156907108|NCT00002651|566417325|FG000|Induction|not eligible|90|||
157225586|NCT00337571|567571477|FG003|Overall Study|Adverse Event|4|||
156907109|NCT00002651|566417326|FG001|Induction|not eligible|0|||
156907110|NCT00002651|566417327|FG002|Induction|not eligible|0|||
156907111|NCT00002651|566417325|FG000|Consolidation and Randomization|Adverse Event|0|||
156907112|NCT00002651|566417326|FG001|Consolidation and Randomization|Adverse Event|36|||
156907113|NCT00002651|566417327|FG002|Consolidation and Randomization|Adverse Event|14|||
156907114|NCT00002651|566417325|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
156907115|NCT00002651|566417326|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
156907116|NCT00002651|566417327|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
156907117|NCT00002651|566417325|FG000|Consolidation and Randomization|Progression/relapse|0|||
156907118|NCT00002651|566417326|FG001|Consolidation and Randomization|Progression/relapse|295|||
156907119|NCT00002651|566417327|FG002|Consolidation and Randomization|Progression/relapse|298|||
156907120|NCT00002651|566417325|FG000|Consolidation and Randomization|Death|0|||
156907121|NCT00002651|566417326|FG001|Consolidation and Randomization|Death|38|||
156907122|NCT00002651|566417327|FG002|Consolidation and Randomization|Death|48|||
156907123|NCT00002651|566417325|FG000|Consolidation and Randomization|Other|0|||
156907124|NCT00002651|566417326|FG001|Consolidation and Randomization|Other|314|||
156907125|NCT00002651|566417327|FG002|Consolidation and Randomization|Other|313|||
156907126|NCT00002651|566417325|FG000|Consolidation and Randomization|not eligible|0|||
156907127|NCT00002651|566417326|FG001|Consolidation and Randomization|not eligible|102|||
156907128|NCT00002651|566417327|FG002|Consolidation and Randomization|not eligible|112|||
156907129|NCT01705730|566417328|FG000|Overall Study|Lack of Efficacy|1|||
156907130|NCT01705730|566417328|FG000|Overall Study|Adverse Event|3|||
156907131|NCT01705730|566417328|FG000|Overall Study|Lost to Follow-up|1|||
156907132|NCT01705730|566417328|FG000|Overall Study|Reason not Specified|4|||
156907133|NCT01773733|566417329|FG000|Overall Study|Adverse Event|3286|||
156907134|NCT01773733|566417330|FG001|Overall Study|Adverse Event|540|||
156907135|NCT01773733|566417329|FG000|Overall Study|Pregnancy|28|||
156907136|NCT01773733|566417330|FG001|Overall Study|Pregnancy|0|||
156907137|NCT01773733|566417329|FG000|Overall Study|Other different categories of not compl|55415|||
157159584|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
157159585|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
157159586|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
157159587|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156907138|NCT01773733|566417330|FG001|Overall Study|Other different categories of not compl|7781|||
156907139|NCT00467857|566417332|FG000|Overall Study|Adverse Event|1|||
156907140|NCT00467857|566417333|FG001|Overall Study|Adverse Event|0|||
156907141|NCT00467857|566417332|FG000|Overall Study|Withdrew consent|2|||
156907142|NCT00467857|566417333|FG001|Overall Study|Withdrew consent|0|||
156907143|NCT00467857|566417332|FG000|Overall Study|Death|0|||
156907144|NCT00467857|566417333|FG001|Overall Study|Death|1|||
156907145|NCT00467857|566417332|FG000|Overall Study|Discharged from court service|0|||
156907146|NCT00467857|566417333|FG001|Overall Study|Discharged from court service|1|||
156907147|NCT00467857|566417332|FG000|Overall Study|Emergency care required|0|||
156907148|NCT00467857|566417333|FG001|Overall Study|Emergency care required|1|||
156907149|NCT00467857|566417332|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
156907150|NCT00467857|566417333|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
156907151|NCT00467857|566417332|FG000|Overall Study|Discontinuation reason missing|0|||
156907152|NCT00467857|566417333|FG001|Overall Study|Discontinuation reason missing|3|||
156907153|NCT03576495|566417337|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
156907154|NCT03576495|566417338|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
156907155|NCT00516074|566417342|FG000|Overall Study|Adverse Event|0|||
156907156|NCT00516074|566417343|FG001|Overall Study|Adverse Event|1|||
156907157|NCT00516074|566417342|FG000|Overall Study|Subject Decision|4|||
156907158|NCT00516074|566417343|FG001|Overall Study|Subject Decision|2|||
156907159|NCT00516074|566417342|FG000|Overall Study|Loss of Glucose Control|2|||
156907160|NCT00516074|566417343|FG001|Overall Study|Loss of Glucose Control|0|||
156907161|NCT02628938|566417344|FG000|Overall Study|Did not attend the follow up recall|2|||
156907162|NCT02628938|566417345|FG001|Overall Study|Did not attend the follow up recall|2|||
156907163|NCT02628938|566417346|FG002|Overall Study|Did not attend the follow up recall|1|||
156907164|NCT02628938|566417344|FG000|Overall Study|Failure to comply with the instructions|3|||
156907165|NCT02628938|566417345|FG001|Overall Study|Failure to comply with the instructions|0|||
156907166|NCT02628938|566417346|FG002|Overall Study|Failure to comply with the instructions|3|||
156907167|NCT02058693|566417347|FG000|Phase 1|Withdrawal by Subject|3|||
156907168|NCT02058693|566417348|FG001|Phase 1|Withdrawal by Subject|2|||
156907169|NCT02058693|566417347|FG000|Phase 1|Adverse Event|0|||
156907170|NCT02058693|566417348|FG001|Phase 1|Adverse Event|1|||
156907171|NCT02058693|566417347|FG000|Phase 1|Lack of Efficacy|1|||
156907172|NCT02058693|566417348|FG001|Phase 1|Lack of Efficacy|0|||
156907173|NCT02058693|566417347|FG000|Phase 1|Physician Decision|1|||
156907174|NCT02058693|566417348|FG001|Phase 1|Physician Decision|1|||
156907175|NCT02058693|566417347|FG000|Phase 2|Withdrawal by Subject|0|||
156907176|NCT02058693|566417348|FG001|Phase 2|Withdrawal by Subject|2|||
156907177|NCT03855228|566417349|FG000|Overall Study|Adverse Event|2|||
156907178|NCT03855228|566417350|FG001|Overall Study|Adverse Event|4|||
156907179|NCT03855228|566417351|FG002|Overall Study|Adverse Event|4|||
157026808|NCT04103580|566853300|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
157159588|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
157159589|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
157159590|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
157159591|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
157159592|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
157159593|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
157159594|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
157159595|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159596|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159597|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159598|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159599|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159600|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159601|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159602|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
157159603|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
156859835|NCT01650558|566243233|FG001|Overall Study|Lost to Follow-up|13|||
156859836|NCT01650558|566243234|FG002|Overall Study|Lost to Follow-up|6|||
156859837|NCT01650558|566243232|FG000|Overall Study|Death|10|||
156859838|NCT01650558|566243233|FG001|Overall Study|Death|6|||
156859839|NCT01650558|566243234|FG002|Overall Study|Death|8|||
156859840|NCT01650558|566243232|FG000|Overall Study|Withdrawal by Subject|1|||
156859841|NCT01650558|566243233|FG001|Overall Study|Withdrawal by Subject|1|||
156859842|NCT01650558|566243234|FG002|Overall Study|Withdrawal by Subject|3|||
156859843|NCT01650558|566243232|FG000|Overall Study|Non-compliant participant|1|||
156859844|NCT01650558|566243233|FG001|Overall Study|Non-compliant participant|0|||
156859845|NCT01650558|566243234|FG002|Overall Study|Non-compliant participant|2|||
156859846|NCT01650558|566243232|FG000|Overall Study|Physician Decision|0|||
156859847|NCT01650558|566243233|FG001|Overall Study|Physician Decision|1|||
156859848|NCT01650558|566243234|FG002|Overall Study|Physician Decision|0|||
156859849|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
156859850|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
156859851|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
156859852|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
156859853|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
156859854|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
156859855|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
156859856|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
156859857|NCT02960217|566243235|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
156859858|NCT02960217|566243236|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
156859859|NCT02960217|566243235|FG000|Open-Label Extension Phase|Adverse Event|1|||
156859860|NCT02960217|566243236|FG001|Open-Label Extension Phase|Adverse Event|0|||
156859861|NCT02960217|566243235|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
156859862|NCT02960217|566243236|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
156859863|NCT02960217|566243235|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
156859864|NCT02960217|566243236|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
156859865|NCT02960217|566243235|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
156859866|NCT02960217|566243236|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
156859867|NCT00918385|566243237|FG000|Monotherapy|Adverse Event|1|||
156859868|NCT00918385|566243238|FG001|Monotherapy|Adverse Event|6|||
156859869|NCT00918385|566243237|FG000|Monotherapy|Complicating illness|1|||
156859870|NCT00918385|566243238|FG001|Monotherapy|Complicating illness|0|||
156859871|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
156859872|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
156859873|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
156859874|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
156859875|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
156859876|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
156859877|NCT00918385|566243237|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
156859878|NCT00918385|566243238|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
156859879|NCT00528957|566243240|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
156859880|NCT00528957|566243241|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
156859881|NCT00528957|566243240|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
156859882|NCT00528957|566243241|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
156859883|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
157159604|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
157159605|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
157159606|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
157159607|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
157159608|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
157159609|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
157159610|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
156907180|NCT03855228|566417352|FG003|Overall Study|Adverse Event|8|||
156907181|NCT03855228|566417349|FG000|Overall Study|Treatment Failure|1|||
156907182|NCT03855228|566417350|FG001|Overall Study|Treatment Failure|2|||
156907183|NCT03855228|566417351|FG002|Overall Study|Treatment Failure|1|||
157159611|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156907184|NCT03855228|566417352|FG003|Overall Study|Treatment Failure|8|||
156907185|NCT03855228|566417349|FG000|Overall Study|Lost to Follow-up|0|||
156907186|NCT03855228|566417350|FG001|Overall Study|Lost to Follow-up|0|||
156907187|NCT03855228|566417351|FG002|Overall Study|Lost to Follow-up|0|||
156907188|NCT03855228|566417352|FG003|Overall Study|Lost to Follow-up|1|||
156907189|NCT03855228|566417349|FG000|Overall Study|Protocol Violation|0|||
156907190|NCT03855228|566417350|FG001|Overall Study|Protocol Violation|1|||
156907191|NCT03855228|566417351|FG002|Overall Study|Protocol Violation|2|||
156907192|NCT03855228|566417352|FG003|Overall Study|Protocol Violation|1|||
156907193|NCT03855228|566417349|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
156907194|NCT03855228|566417350|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
156907195|NCT03855228|566417351|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
156907196|NCT03855228|566417352|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
156907197|NCT02993757|566417353|FG000|Overall Study|Non compliance with the protocol|155|||
156907198|NCT02993757|566417354|FG001|Overall Study|Non compliance with the protocol|170|||
156907199|NCT02993757|566417353|FG000|Overall Study|Lost to Follow-up|1|||
156907200|NCT02993757|566417354|FG001|Overall Study|Lost to Follow-up|0|||
156907201|NCT02993757|566417353|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
156907202|NCT02993757|566417354|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
156907203|NCT01611155|566417356|FG000|Overall Study|Adverse Event|1|||
156907204|NCT01611155|566417357|FG001|Overall Study|Adverse Event|1|||
156907205|NCT01611155|566417356|FG000|Overall Study|Refused further treatment|6|||
156907206|NCT01611155|566417357|FG001|Overall Study|Refused further treatment|4|||
156907207|NCT01611155|566417356|FG000|Overall Study|Disease progression|1|||
156907208|NCT01611155|566417357|FG001|Overall Study|Disease progression|0|||
156907209|NCT01611155|566417356|FG000|Overall Study|Withdrawal by Subject|1|||
156907210|NCT01611155|566417357|FG001|Overall Study|Withdrawal by Subject|0|||
156907211|NCT01611155|566417356|FG000|Overall Study|Alternative treatment|0|||
156907212|NCT01611155|566417357|FG001|Overall Study|Alternative treatment|1|||
156907213|NCT01611155|566417356|FG000|Overall Study|Ineligible patient|0|||
156907214|NCT01611155|566417357|FG001|Overall Study|Ineligible patient|1|||
156907215|NCT00087607|566417360|FG000|Overall Study|Adverse Event|14|||
156907216|NCT00087607|566417361|FG001|Overall Study|Adverse Event|24|||
156907217|NCT00087607|566417360|FG000|Overall Study|Death|0|||
156907218|NCT00087607|566417361|FG001|Overall Study|Death|1|||
156907219|NCT00087607|566417360|FG000|Overall Study|Insufficient Therapeutic Response|53|||
156907220|NCT00087607|566417361|FG001|Overall Study|Insufficient Therapeutic Response|42|||
156907221|NCT00087607|566417360|FG000|Overall Study|Failure to return|21|||
156907222|NCT00087607|566417361|FG001|Overall Study|Failure to return|17|||
156907223|NCT00087607|566417360|FG000|Overall Study|Withdrew Consent|12|||
156907224|NCT00087607|566417361|FG001|Overall Study|Withdrew Consent|16|||
156907225|NCT00087607|566417360|FG000|Overall Study|Administrative|12|||
156907226|NCT00087607|566417361|FG001|Overall Study|Administrative|12|||
156907227|NCT00087607|566417360|FG000|Overall Study|Refused Treatment|5|||
156907228|NCT00087607|566417361|FG001|Overall Study|Refused Treatment|7|||
157159612|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
157159613|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159614|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159615|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
156907229|NCT00087607|566417360|FG000|Overall Study|Other Protocol Violation|5|||
156907230|NCT00087607|566417361|FG001|Overall Study|Other Protocol Violation|2|||
156907231|NCT00087607|566417360|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
156907232|NCT00087607|566417361|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156907233|NCT00190671|566417362|FG000|Overall Study|Satisfactory Response|4|||
156907234|NCT00190671|566417363|FG001|Overall Study|Satisfactory Response|7|||
156907235|NCT00190671|566417362|FG000|Overall Study|Lack of Efficacy|19|||
156907236|NCT00190671|566417363|FG001|Overall Study|Lack of Efficacy|24|||
156907237|NCT00190671|566417362|FG000|Overall Study|Death from Study Disease|1|||
156907238|NCT00190671|566417363|FG001|Overall Study|Death from Study Disease|1|||
156907239|NCT00190671|566417362|FG000|Overall Study|Adverse Event|3|||
156907240|NCT00190671|566417363|FG001|Overall Study|Adverse Event|2|||
156907241|NCT00190671|566417362|FG000|Overall Study|Clinical Relapse|0|||
156907242|NCT00190671|566417363|FG001|Overall Study|Clinical Relapse|1|||
156907243|NCT00190671|566417362|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
156907244|NCT00190671|566417363|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
156907245|NCT00190671|566417362|FG000|Overall Study|Death from Other Causes|0|||
156907246|NCT00190671|566417363|FG001|Overall Study|Death from Other Causes|2|||
156907247|NCT00190671|566417362|FG000|Overall Study|Protocol Violation|0|||
156907248|NCT00190671|566417363|FG001|Overall Study|Protocol Violation|1|||
156907249|NCT00190671|566417362|FG000|Overall Study|Withdrawal by Subject|0|||
156907250|NCT00190671|566417363|FG001|Overall Study|Withdrawal by Subject|2|||
156907251|NCT02699593|566417364|FG000|Period 1|Unsatisfactory Visual Response|0|||
156907252|NCT02699593|566417365|FG001|Period 1|Unsatisfactory Visual Response|1|||
156907253|NCT02699593|566417364|FG000|Period 1|Torn Contact Len|4|||
156907254|NCT02699593|566417365|FG001|Period 1|Torn Contact Len|3|||
156907255|NCT02699593|566417364|FG000|Period 1|Protocol Violation|0|||
156907256|NCT02699593|566417365|FG001|Period 1|Protocol Violation|1|||
156907257|NCT02699593|566417364|FG000|Period 1|Withdrawal by Subject|0|||
156907258|NCT02699593|566417365|FG001|Period 1|Withdrawal by Subject|1|||
156907259|NCT02699593|566417364|FG000|Period 1|Adverse Event|1|||
156907260|NCT02699593|566417365|FG001|Period 1|Adverse Event|1|||
156907261|NCT02699593|566417364|FG000|Period 2|Adverse Event|1|||
156907262|NCT02699593|566417365|FG001|Period 2|Adverse Event|1|||
156907263|NCT02699593|566417364|FG000|Period 2|Lost Contact Lens|0|||
156907264|NCT02699593|566417365|FG001|Period 2|Lost Contact Lens|1|||
156907265|NCT02699593|566417364|FG000|Period 2|Torn Contact Lens|1|||
157026809|NCT04103580|566853299|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
157026810|NCT04103580|566853300|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
157026811|NCT04103580|566853299|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
157026812|NCT04103580|566853300|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
157026813|NCT04103580|566853299|FG000|Phase 2 Bereavement|Other|8|||
157026814|NCT04103580|566853300|FG001|Phase 2 Bereavement|Other|6|||
157026815|NCT04145440|566853301|FG000|Overall Study|Physician Decision|3|||
157026816|NCT04145440|566853302|FG001|Overall Study|Physician Decision|0|||
157026817|NCT04145440|566853301|FG000|Overall Study|Use of prohibited therapy|2|||
157026818|NCT04145440|566853302|FG001|Overall Study|Use of prohibited therapy|3|||
157026819|NCT04042233|566853307|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
157026820|NCT04042233|566853308|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
157026821|NCT04042233|566853307|FG000|Overall Study|Protocol Violation|0|||
157026822|NCT04042233|566853308|FG001|Overall Study|Protocol Violation|2|||
157026823|NCT04248725|566853313|FG000|Post-Treatment|Lost to Follow-up|6|||
157026824|NCT04248725|566853314|FG001|Post-Treatment|Lost to Follow-up|5|||
157026825|NCT04248725|566853313|FG000|6-Month Follow Up|Lost to Follow-up|9|||
157026826|NCT04248725|566853314|FG001|6-Month Follow Up|Lost to Follow-up|8|||
157026827|NCT04436276|566853317|FG000|Overall Study|Adverse Event|0|||
157026828|NCT04436276|566853318|FG001|Overall Study|Adverse Event|0|||
157026829|NCT04436276|566853319|FG002|Overall Study|Adverse Event|0|||
157026830|NCT04436276|566853320|FG003|Overall Study|Adverse Event|0|||
157026831|NCT04436276|566853321|FG004|Overall Study|Adverse Event|0|||
157026832|NCT04436276|566853322|FG005|Overall Study|Adverse Event|0|||
157026833|NCT04436276|566853323|FG006|Overall Study|Adverse Event|0|||
157026834|NCT04436276|566853324|FG007|Overall Study|Adverse Event|0|||
157026835|NCT04436276|566853325|FG008|Overall Study|Adverse Event|0|||
157026836|NCT04436276|566853326|FG009|Overall Study|Adverse Event|0|||
157026837|NCT04436276|566853327|FG010|Overall Study|Adverse Event|0|||
157026838|NCT04436276|566853328|FG011|Overall Study|Adverse Event|0|||
157026839|NCT04436276|566853329|FG012|Overall Study|Adverse Event|0|||
157026840|NCT04436276|566853330|FG013|Overall Study|Adverse Event|0|||
157026841|NCT04436276|566853331|FG014|Overall Study|Adverse Event|0|||
157026842|NCT04436276|566853332|FG015|Overall Study|Adverse Event|0|||
157026843|NCT04436276|566853333|FG016|Overall Study|Adverse Event|1|||
157026844|NCT04436276|566853334|FG017|Overall Study|Adverse Event|0|||
157026845|NCT04436276|566853335|FG018|Overall Study|Adverse Event|0|||
157026846|NCT04436276|566853336|FG019|Overall Study|Adverse Event|0|||
157026847|NCT04436276|566853337|FG020|Overall Study|Adverse Event|0|||
157026848|NCT04436276|566853338|FG021|Overall Study|Adverse Event|0|||
156907266|NCT02699593|566417365|FG001|Period 2|Torn Contact Lens|0|||
157026849|NCT04436276|566853339|FG022|Overall Study|Adverse Event|0|||
157026850|NCT04436276|566853317|FG000|Overall Study|Death|0|||
157026851|NCT04436276|566853318|FG001|Overall Study|Death|0|||
156907267|NCT02369016|566417366|FG000|Overall Study|AE associated with clinical disease progression|2|||
156907268|NCT02369016|566417367|FG001|Overall Study|AE associated with clinical disease progression|1|||
157026852|NCT04436276|566853319|FG002|Overall Study|Death|0|||
157026853|NCT04436276|566853320|FG003|Overall Study|Death|0|||
157026854|NCT04436276|566853321|FG004|Overall Study|Death|0|||
157026855|NCT04436276|566853322|FG005|Overall Study|Death|0|||
157026856|NCT04436276|566853323|FG006|Overall Study|Death|0|||
157026857|NCT04436276|566853324|FG007|Overall Study|Death|0|||
156907269|NCT02369016|566417366|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
156907270|NCT02369016|566417367|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
156907271|NCT02369016|566417366|FG000|Overall Study|Progressive disease - clinical progression|1|||
156907272|NCT02369016|566417367|FG001|Overall Study|Progressive disease - clinical progression|4|||
156907273|NCT02369016|566417366|FG000|Overall Study|withdrawal by patient|4|||
156907274|NCT02369016|566417367|FG001|Overall Study|withdrawal by patient|0|||
156907275|NCT02369016|566417366|FG000|Overall Study|Progressive disease - radiological progression|6|||
156907276|NCT02369016|566417367|FG001|Overall Study|Progressive disease - radiological progression|2|||
156907277|NCT02229383|566417370|FG000|Overall Study|Adverse Event|7|||
156907278|NCT02229383|566417371|FG001|Overall Study|Adverse Event|4|||
156907279|NCT02229383|566417370|FG000|Overall Study|Death|0|||
156907280|NCT02229383|566417371|FG001|Overall Study|Death|1|||
156907281|NCT02229383|566417370|FG000|Overall Study|Lost to Follow-up|5|||
156907282|NCT02229383|566417371|FG001|Overall Study|Lost to Follow-up|3|||
156907283|NCT02229383|566417370|FG000|Overall Study|Withdrawal by Subject|4|||
156907284|NCT02229383|566417371|FG001|Overall Study|Withdrawal by Subject|6|||
156907285|NCT02229383|566417370|FG000|Overall Study|Did not receive treatment|1|||
156907286|NCT02229383|566417371|FG001|Overall Study|Did not receive treatment|0|||
156907287|NCT02229383|566417370|FG000|Overall Study|Other|3|||
156907288|NCT02229383|566417371|FG001|Overall Study|Other|8|||
156907289|NCT01696071|566417377|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
156907290|NCT01696071|566417378|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
156907291|NCT03298867|566417397|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
156907292|NCT03298867|566417398|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
156907293|NCT03298867|566417397|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
156907294|NCT03298867|566417398|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
156907295|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
156907296|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
156907297|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
156907298|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
156907299|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
156907300|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
156907301|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
156907302|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
156907303|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
156907304|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
156907305|NCT03298867|566417397|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
156907306|NCT03298867|566417398|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
156907307|NCT03298867|566417397|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
156907308|NCT03298867|566417398|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
157026858|NCT04436276|566853325|FG008|Overall Study|Death|0|||
157026859|NCT04436276|566853326|FG009|Overall Study|Death|0|||
157026860|NCT04436276|566853327|FG010|Overall Study|Death|0|||
156907309|NCT01385566|566419601|FG000|Overall Study|Lost to Follow-up|1|||
156907310|NCT01385566|566419602|FG001|Overall Study|Lost to Follow-up|0|||
156907311|NCT01385566|566419603|FG002|Overall Study|Lost to Follow-up|0|||
156907312|NCT01385566|566419604|FG003|Overall Study|Lost to Follow-up|0|||
156907313|NCT01385566|566419605|FG004|Overall Study|Lost to Follow-up|0|||
156907314|NCT01385566|566419606|FG005|Overall Study|Lost to Follow-up|0|||
156907315|NCT01385566|566419601|FG000|Overall Study|Withdrawal by Subject|0|||
156907316|NCT01385566|566419602|FG001|Overall Study|Withdrawal by Subject|0|||
156907317|NCT01385566|566419603|FG002|Overall Study|Withdrawal by Subject|0|||
156907318|NCT01385566|566419604|FG003|Overall Study|Withdrawal by Subject|1|||
156907319|NCT01385566|566419605|FG004|Overall Study|Withdrawal by Subject|0|||
156907320|NCT01385566|566419606|FG005|Overall Study|Withdrawal by Subject|0|||
156907321|NCT00967668|566419607|FG000|Overall Study|Withdrawal by Subject|13|||
156907322|NCT00967668|566419608|FG001|Overall Study|Withdrawal by Subject|8|||
157026861|NCT04436276|566853328|FG011|Overall Study|Death|0|||
157026862|NCT04436276|566853329|FG012|Overall Study|Death|1|||
157026863|NCT04436276|566853330|FG013|Overall Study|Death|0|||
157026864|NCT04436276|566853331|FG014|Overall Study|Death|1|||
157026865|NCT04436276|566853332|FG015|Overall Study|Death|0|||
157026866|NCT04436276|566853333|FG016|Overall Study|Death|0|||
157026867|NCT04436276|566853334|FG017|Overall Study|Death|0|||
157205206|NCT03926728|567496072|FG011|Overall Study|Withdrawal by Subject|0|||
157026868|NCT04436276|566853335|FG018|Overall Study|Death|0|||
157026869|NCT04436276|566853336|FG019|Overall Study|Death|2|||
156907323|NCT00967668|566419609|FG002|Overall Study|Withdrawal by Subject|8|||
156907324|NCT00967668|566419607|FG000|Overall Study|Death|0|||
156907325|NCT00967668|566419608|FG001|Overall Study|Death|2|||
156907326|NCT00967668|566419609|FG002|Overall Study|Death|4|||
156907327|NCT00967668|566419607|FG000|Overall Study|Removed due to behavior|1|||
156907328|NCT00967668|566419608|FG001|Overall Study|Removed due to behavior|1|||
156907329|NCT00967668|566419609|FG002|Overall Study|Removed due to behavior|2|||
157026870|NCT04436276|566853337|FG020|Overall Study|Death|0|||
156907330|NCT00967668|566419607|FG000|Overall Study|Refused Year 2|11|||
156907331|NCT00967668|566419608|FG001|Overall Study|Refused Year 2|6|||
156907332|NCT00967668|566419609|FG002|Overall Study|Refused Year 2|4|||
156907333|NCT00967668|566419607|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
156907334|NCT00967668|566419608|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
156907335|NCT00967668|566419609|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
156907336|NCT00967668|566419607|FG000|Overall Study|Lost to Follow-up|15|||
156907337|NCT00967668|566419608|FG001|Overall Study|Lost to Follow-up|9|||
156907338|NCT00967668|566419609|FG002|Overall Study|Lost to Follow-up|16|||
156907339|NCT00967668|566419607|FG000|Overall Study|Refused 12-mo assessment|3|||
156907340|NCT00967668|566419608|FG001|Overall Study|Refused 12-mo assessment|1|||
156907341|NCT00967668|566419609|FG002|Overall Study|Refused 12-mo assessment|9|||
156907342|NCT00967668|566419607|FG000|Overall Study|Pregnancy|1|||
156907343|NCT00967668|566419608|FG001|Overall Study|Pregnancy|0|||
156907344|NCT00967668|566419609|FG002|Overall Study|Pregnancy|0|||
156907345|NCT01594281|566419610|FG000|Interventional Core Phase|Protocol Deviation|1|||
156907346|NCT01594281|566419611|FG001|Interventional Core Phase|Protocol Deviation|0|||
156907347|NCT01594281|566419612|FG002|Interventional Core Phase|Protocol Deviation|0|||
156907348|NCT01594281|566419610|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
156907349|NCT01594281|566419611|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
156907350|NCT01594281|566419612|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
156907351|NCT01594281|566419610|FG000|Interventional Core Phase|Death|1|||
156907352|NCT01594281|566419611|FG001|Interventional Core Phase|Death|1|||
156907353|NCT01594281|566419612|FG002|Interventional Core Phase|Death|2|||
156907354|NCT01594281|566419610|FG000|Interventional Core Phase|Lost to Follow-up|1|||
157026871|NCT04436276|566853338|FG021|Overall Study|Death|1|||
157026872|NCT04436276|566853339|FG022|Overall Study|Death|0|||
157026873|NCT04436276|566853317|FG000|Overall Study|Lost to Follow-up|0|||
157026874|NCT04436276|566853318|FG001|Overall Study|Lost to Follow-up|2|||
157026875|NCT04436276|566853319|FG002|Overall Study|Lost to Follow-up|2|||
157026876|NCT04436276|566853320|FG003|Overall Study|Lost to Follow-up|1|||
157026877|NCT04436276|566853321|FG004|Overall Study|Lost to Follow-up|4|||
157026878|NCT04436276|566853322|FG005|Overall Study|Lost to Follow-up|1|||
157026879|NCT04436276|566853323|FG006|Overall Study|Lost to Follow-up|0|||
157026880|NCT04436276|566853324|FG007|Overall Study|Lost to Follow-up|0|||
157026881|NCT04436276|566853325|FG008|Overall Study|Lost to Follow-up|1|||
157026882|NCT04436276|566853326|FG009|Overall Study|Lost to Follow-up|0|||
157026883|NCT04436276|566853327|FG010|Overall Study|Lost to Follow-up|5|||
157026884|NCT04436276|566853328|FG011|Overall Study|Lost to Follow-up|5|||
157026885|NCT04436276|566853329|FG012|Overall Study|Lost to Follow-up|4|||
157026886|NCT04436276|566853330|FG013|Overall Study|Lost to Follow-up|1|||
157026887|NCT04436276|566853331|FG014|Overall Study|Lost to Follow-up|7|||
157026888|NCT04436276|566853332|FG015|Overall Study|Lost to Follow-up|7|||
157026889|NCT04436276|566853333|FG016|Overall Study|Lost to Follow-up|1|||
157026890|NCT04436276|566853334|FG017|Overall Study|Lost to Follow-up|0|||
157026891|NCT04436276|566853335|FG018|Overall Study|Lost to Follow-up|1|||
157026892|NCT04436276|566853336|FG019|Overall Study|Lost to Follow-up|1|||
157026893|NCT04436276|566853337|FG020|Overall Study|Lost to Follow-up|2|||
157026894|NCT04436276|566853338|FG021|Overall Study|Lost to Follow-up|1|||
157026895|NCT04436276|566853339|FG022|Overall Study|Lost to Follow-up|1|||
157026896|NCT04436276|566853317|FG000|Overall Study|Physician Decision|1|||
157026897|NCT04436276|566853318|FG001|Overall Study|Physician Decision|0|||
157026898|NCT04436276|566853319|FG002|Overall Study|Physician Decision|2|||
157026899|NCT04436276|566853320|FG003|Overall Study|Physician Decision|1|||
157026900|NCT04436276|566853321|FG004|Overall Study|Physician Decision|0|||
157026901|NCT04436276|566853322|FG005|Overall Study|Physician Decision|0|||
157026902|NCT04436276|566853323|FG006|Overall Study|Physician Decision|0|||
157026903|NCT04436276|566853324|FG007|Overall Study|Physician Decision|0|||
157026904|NCT04436276|566853325|FG008|Overall Study|Physician Decision|0|||
157026905|NCT04436276|566853326|FG009|Overall Study|Physician Decision|0|||
157026906|NCT04436276|566853327|FG010|Overall Study|Physician Decision|0|||
157026907|NCT04436276|566853328|FG011|Overall Study|Physician Decision|1|||
157026908|NCT04436276|566853329|FG012|Overall Study|Physician Decision|2|||
157026909|NCT04436276|566853330|FG013|Overall Study|Physician Decision|0|||
157026910|NCT04436276|566853331|FG014|Overall Study|Physician Decision|0|||
157026911|NCT04436276|566853332|FG015|Overall Study|Physician Decision|0|||
157026912|NCT04436276|566853333|FG016|Overall Study|Physician Decision|0|||
157026913|NCT04436276|566853334|FG017|Overall Study|Physician Decision|0|||
157026914|NCT04436276|566853335|FG018|Overall Study|Physician Decision|0|||
157026915|NCT04436276|566853336|FG019|Overall Study|Physician Decision|0|||
157026916|NCT04436276|566853337|FG020|Overall Study|Physician Decision|1|||
157026917|NCT04436276|566853338|FG021|Overall Study|Physician Decision|2|||
156907355|NCT01594281|566419611|FG001|Interventional Core Phase|Lost to Follow-up|4|||
156907356|NCT01594281|566419612|FG002|Interventional Core Phase|Lost to Follow-up|1|||
156907357|NCT01594281|566419610|FG000|Interventional Core Phase|Adverse Event|4|||
157026918|NCT04436276|566853339|FG022|Overall Study|Physician Decision|0|||
157026919|NCT04436276|566853317|FG000|Overall Study|Protocol Violation|0|||
157026920|NCT04436276|566853318|FG001|Overall Study|Protocol Violation|0|||
157026921|NCT04436276|566853319|FG002|Overall Study|Protocol Violation|0|||
156907358|NCT01594281|566419611|FG001|Interventional Core Phase|Adverse Event|4|||
156907359|NCT01594281|566419612|FG002|Interventional Core Phase|Adverse Event|4|||
156907360|NCT01594281|566419610|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
156907361|NCT01594281|566419611|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
156907362|NCT01594281|566419612|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
156907363|NCT01594281|566419610|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
156907364|NCT01594281|566419611|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
156907365|NCT01594281|566419612|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
156907366|NCT01594281|566419610|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
156907367|NCT01594281|566419611|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
156907368|NCT01594281|566419612|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
156907369|NCT00283400|566419613|FG000|Overall Study|Withdrawal by Subject|1|||
156907370|NCT00283400|566419614|FG001|Overall Study|Withdrawal by Subject|1|||
156907371|NCT00283400|566419615|FG002|Overall Study|Withdrawal by Subject|0|||
156907372|NCT00283400|566419616|FG003|Overall Study|Withdrawal by Subject|0|||
156907373|NCT00283400|566419613|FG000|Overall Study|Death|1|||
156907374|NCT00283400|566419614|FG001|Overall Study|Death|0|||
156907375|NCT00283400|566419615|FG002|Overall Study|Death|1|||
156907376|NCT00283400|566419616|FG003|Overall Study|Death|0|||
156907377|NCT02550106|566419620|FG000|Overall Study|Adverse Event|1|||
156907378|NCT02550106|566419620|FG000|Overall Study|Lack of Efficacy|3|||
156907379|NCT02550106|566419620|FG000|Overall Study|Protocol Violation|6|||
156907380|NCT02550106|566419620|FG000|Overall Study|Withdrawal by Subject|2|||
156907381|NCT02195583|566419621|FG000|Overall Study|Lost to Follow-up|1|||
156907382|NCT02195583|566419621|FG000|Overall Study|Withdrawal by Subject|4|||
156907383|NCT02195583|566419621|FG000|Overall Study|Adverse Event|2|||
156907384|NCT02195583|566419621|FG000|Overall Study|Other Reason|2|||
156907385|NCT04019288|566419622|FG000|Overall Study|Death|1|||
156907386|NCT04019288|566419623|FG001|Overall Study|Death|0|||
156907387|NCT04019288|566419624|FG002|Overall Study|Death|0|||
156907388|NCT01020981|566419628|FG000|Overall Study|Did not return mailed survey|74|||
156907389|NCT01020981|566419629|FG001|Overall Study|Did not return mailed survey|58|||
156907390|NCT01020981|566419628|FG000|Overall Study|Survey returned undeliverable|8|||
156907391|NCT01020981|566419629|FG001|Overall Study|Survey returned undeliverable|32|||
156907392|NCT01020981|566419628|FG000|Overall Study|Participant declined to complete survey|2|||
156907393|NCT01020981|566419629|FG001|Overall Study|Participant declined to complete survey|0|||
156907394|NCT00040365|566419636|FG000|Overall Study|Death|1|||
156907395|NCT00040365|566419636|FG000|Overall Study|Progressive disease|7|||
156907396|NCT00040365|566419636|FG000|Overall Study|Lost to Follow-up|3|||
156907397|NCT01947582|566419639|FG000|Overall Study|Withdrawal by Subject|1|||
156907398|NCT02279420|566419640|FG000|Overall Study|Lost to Follow-up|23|||
156907399|NCT03535844|566419641|FG000|Overall Study|Withdrawal by Subject|0|||
156907400|NCT03535844|566419642|FG001|Overall Study|Withdrawal by Subject|1|||
156907401|NCT00297830|566419645|FG000|6 Month Visit|Death|1|||
156907402|NCT00297830|566419646|FG001|6 Month Visit|Death|0|||
156907403|NCT00297830|566419647|FG002|6 Month Visit|Death|2|||
157026922|NCT04436276|566853320|FG003|Overall Study|Protocol Violation|0|||
157026923|NCT04436276|566853321|FG004|Overall Study|Protocol Violation|0|||
157026924|NCT04436276|566853322|FG005|Overall Study|Protocol Violation|0|||
157026925|NCT04436276|566853323|FG006|Overall Study|Protocol Violation|0|||
157026926|NCT04436276|566853324|FG007|Overall Study|Protocol Violation|0|||
157026927|NCT04436276|566853325|FG008|Overall Study|Protocol Violation|0|||
157026928|NCT04436276|566853326|FG009|Overall Study|Protocol Violation|0|||
157026929|NCT04436276|566853327|FG010|Overall Study|Protocol Violation|0|||
157026930|NCT04436276|566853328|FG011|Overall Study|Protocol Violation|0|||
157026931|NCT04436276|566853329|FG012|Overall Study|Protocol Violation|0|||
157026932|NCT04436276|566853330|FG013|Overall Study|Protocol Violation|1|||
157026933|NCT04436276|566853331|FG014|Overall Study|Protocol Violation|0|||
157026934|NCT04436276|566853332|FG015|Overall Study|Protocol Violation|1|||
157026935|NCT04436276|566853333|FG016|Overall Study|Protocol Violation|0|||
157026936|NCT04436276|566853334|FG017|Overall Study|Protocol Violation|0|||
157026937|NCT04436276|566853335|FG018|Overall Study|Protocol Violation|0|||
157026938|NCT04436276|566853336|FG019|Overall Study|Protocol Violation|0|||
157026939|NCT04436276|566853337|FG020|Overall Study|Protocol Violation|0|||
156907404|NCT00297830|566419645|FG000|6 Month Visit|Withdrawal by Subject|2|||
156907405|NCT00297830|566419646|FG001|6 Month Visit|Withdrawal by Subject|1|||
156907406|NCT00297830|566419647|FG002|6 Month Visit|Withdrawal by Subject|1|||
156907407|NCT00297830|566419645|FG000|6 Month Visit|Adverse Event|0|||
156907408|NCT00297830|566419646|FG001|6 Month Visit|Adverse Event|1|||
156907409|NCT00297830|566419647|FG002|6 Month Visit|Adverse Event|0|||
156907410|NCT00297830|566419645|FG000|12 Month Visit|Lost to Follow-up|1|||
157026940|NCT04436276|566853338|FG021|Overall Study|Protocol Violation|0|||
157026941|NCT04436276|566853339|FG022|Overall Study|Protocol Violation|0|||
156907411|NCT00297830|566419646|FG001|12 Month Visit|Lost to Follow-up|0|||
157026942|NCT04436276|566853317|FG000|Overall Study|Withdrawal by Subject|25|||
157026943|NCT04436276|566853318|FG001|Overall Study|Withdrawal by Subject|22|||
157026944|NCT04436276|566853319|FG002|Overall Study|Withdrawal by Subject|24|||
156907412|NCT00297830|566419647|FG002|12 Month Visit|Lost to Follow-up|0|||
156907413|NCT00297830|566419645|FG000|12 Month Visit|Adverse Event|0|||
156907414|NCT00297830|566419646|FG001|12 Month Visit|Adverse Event|3|||
156907415|NCT00297830|566419647|FG002|12 Month Visit|Adverse Event|0|||
156907416|NCT00297830|566419645|FG000|12 Month Visit|Withdrawal by Subject|0|||
156907417|NCT00297830|566419646|FG001|12 Month Visit|Withdrawal by Subject|3|||
156907418|NCT00297830|566419647|FG002|12 Month Visit|Withdrawal by Subject|0|||
156907419|NCT05096221|566419648|FG000|Part 2|Physician Decision|0|||
156907420|NCT05096221|566419649|FG001|Part 2|Physician Decision|1|||
156907421|NCT02478632|566419652|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
156907422|NCT02478632|566419653|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
156907423|NCT02478632|566419652|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
156907424|NCT02478632|566419653|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
156907425|NCT02478632|566419652|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
156907426|NCT02478632|566419653|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
156907427|NCT01086033|566419654|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
156907428|NCT01086033|566419654|FG000|Overall Study|Lost to Follow-up|86|||
156907429|NCT01086033|566419654|FG000|Overall Study|Adverse Event|42|||
156907430|NCT01086033|566419654|FG000|Overall Study|Withdrawal by Subject|41|||
156907431|NCT01086033|566419654|FG000|Overall Study|Other|14|||
156907432|NCT01086033|566419654|FG000|Overall Study|Other|13|||
156907433|NCT01086033|566419654|FG000|Overall Study|AE and Withdrew Consent|5|||
156907434|NCT01086033|566419654|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
156907435|NCT01086033|566419654|FG000|Overall Study|Withdrew consent and Other Reason|4|||
156907436|NCT01086033|566419654|FG000|Overall Study|AE and Lack of Efficacy|4|||
156907437|NCT01086033|566419654|FG000|Overall Study|Death|1|||
156907438|NCT01086033|566419654|FG000|Overall Study|AE and Lost to Follow-up|1|||
156907439|NCT01086033|566419654|FG000|Overall Study|AE and Other Reason|1|||
156907440|NCT01086033|566419654|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
156907441|NCT02193867|566419656|FG000|Overall Study|Death|2|||
156907442|NCT02193867|566419656|FG000|Overall Study|Sponsor Study Termination|2|||
156907443|NCT02924571|566419657|FG000|Overall Study|Lost to Follow-up|1|||
156907444|NCT02924571|566419658|FG001|Overall Study|Lost to Follow-up|1|||
156907445|NCT02924571|566419659|FG002|Overall Study|Lost to Follow-up|0|||
156907446|NCT00434954|566419663|FG000|Overall Study|Adverse Event|17|||
156907447|NCT00434954|566419664|FG001|Overall Study|Adverse Event|2|||
156907448|NCT00434954|566419663|FG000|Overall Study|Entry criteria not met|14|||
156907449|NCT00434954|566419664|FG001|Overall Study|Entry criteria not met|16|||
156907450|NCT00434954|566419663|FG000|Overall Study|Lost to Follow-up|0|||
156907451|NCT00434954|566419664|FG001|Overall Study|Lost to Follow-up|1|||
156907452|NCT00434954|566419663|FG000|Overall Study|Physician Decision|6|||
156907453|NCT00434954|566419664|FG001|Overall Study|Physician Decision|3|||
156907454|NCT00434954|566419663|FG000|Overall Study|Protocol Violation|36|||
156907455|NCT00434954|566419664|FG001|Overall Study|Protocol Violation|27|||
156907456|NCT00434954|566419663|FG000|Overall Study|Sponsor decision|1|||
156907457|NCT00434954|566419664|FG001|Overall Study|Sponsor decision|0|||
156907458|NCT00434954|566419663|FG000|Overall Study|Subject decision|8|||
156907459|NCT00434954|566419664|FG001|Overall Study|Subject decision|22|||
156907460|NCT03741062|566419667|FG000|Overall Study|Protocol Violation|1|||
156907461|NCT03741062|566419668|FG001|Overall Study|Protocol Violation|0|||
156907462|NCT00446251|566419676|FG000|Overall Study|On-study Transplants|2|||
156907463|NCT00446251|566419676|FG000|Overall Study|Rituximab Infusion Reaction|2|||
156907464|NCT00446251|566419676|FG000|Overall Study|Lost to Follow-up|1|||
156907465|NCT02693119|566419677|FG000|Open-Label Period|Withdrawal by Subject|0|||
156907466|NCT02693119|566419678|FG001|Open-Label Period|Withdrawal by Subject|1|||
156907467|NCT01719783|566419679|FG000|Dose 2|Physician Decision|1|||
156907468|NCT01719783|566419680|FG001|Dose 2|Physician Decision|0|||
156907469|NCT02319837|566419681|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
156907470|NCT02319837|566419682|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
156907471|NCT02319837|566419683|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
156907472|NCT02319837|566419681|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
156907473|NCT02319837|566419682|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
156907474|NCT02319837|566419683|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
156907475|NCT02319837|566419681|FG000|Study Treatment Phase|Adverse Event|73|||
156907476|NCT02319837|566419682|FG001|Study Treatment Phase|Adverse Event|36|||
156907477|NCT02319837|566419683|FG002|Study Treatment Phase|Adverse Event|63|||
156907478|NCT02319837|566419681|FG000|Study Treatment Phase|Development of castration resistance|0|||
156907479|NCT02319837|566419682|FG001|Study Treatment Phase|Development of castration resistance|2|||
156907480|NCT02319837|566419683|FG002|Study Treatment Phase|Development of castration resistance|0|||
156907481|NCT02319837|566419681|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
156907482|NCT02319837|566419682|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
156907483|NCT02319837|566419683|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
156907484|NCT02319837|566419681|FG000|Study Treatment Phase|Protocol Violation|2|||
156907485|NCT02319837|566419682|FG001|Study Treatment Phase|Protocol Violation|2|||
156907486|NCT02319837|566419683|FG002|Study Treatment Phase|Protocol Violation|1|||
156907487|NCT02319837|566419681|FG000|Study Treatment Phase|Lost to Follow-up|0|||
156907488|NCT02319837|566419682|FG001|Study Treatment Phase|Lost to Follow-up|1|||
156907489|NCT02319837|566419683|FG002|Study Treatment Phase|Lost to Follow-up|0|||
156907490|NCT02319837|566419681|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
156907491|NCT02319837|566419682|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
156907492|NCT02319837|566419683|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
156907493|NCT02319837|566419681|FG000|Study Treatment Phase|Other|0|||
156907494|NCT02319837|566419682|FG001|Study Treatment Phase|Other|1|||
156907495|NCT02319837|566419683|FG002|Study Treatment Phase|Other|0|||
156907496|NCT02319837|566419681|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
156907497|NCT02319837|566419682|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
156907498|NCT02319837|566419683|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
156907499|NCT02319837|566419681|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
156907500|NCT02319837|566419682|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
156907501|NCT02319837|566419683|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
156907502|NCT02319837|566419681|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
156907503|NCT02319837|566419682|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
156907504|NCT02319837|566419683|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
156907505|NCT02319837|566419681|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
156907506|NCT02319837|566419682|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
156907507|NCT02319837|566419683|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
156907508|NCT02319837|566419681|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
156907509|NCT02319837|566419682|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
156907510|NCT02319837|566419683|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
156907511|NCT02319837|566419681|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
156907512|NCT02319837|566419682|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
156907513|NCT02319837|566419683|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
156907514|NCT02319837|566419681|FG000|Long-Term Follow-Up Phase|Death|33|||
156907515|NCT02319837|566419682|FG001|Long-Term Follow-Up Phase|Death|54|||
156907516|NCT02319837|566419683|FG002|Long-Term Follow-Up Phase|Death|42|||
156907517|NCT00753766|566419684|FG000|Overall Study|Physician Decision|1|||
156907518|NCT00753766|566419685|FG001|Overall Study|Physician Decision|0|||
156907519|NCT01986907|566419688|FG000|Overall Study|Adverse Event|11|||
156907520|NCT01986907|566419688|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
156907521|NCT01986907|566419688|FG000|Overall Study|Protocol Violation|4|||
156907522|NCT01986907|566419688|FG000|Overall Study|Withdrawal by Subject|76|||
156907523|NCT01986907|566419688|FG000|Overall Study|Lost to Follow-up|38|||
156907524|NCT01986907|566419688|FG000|Overall Study|Death|9|||
156907525|NCT03800173|566419692|FG000|Overall Study|Lost to Follow-up|0|||
156907526|NCT03800173|566419693|FG001|Overall Study|Lost to Follow-up|0|||
156907527|NCT03800173|566419694|FG002|Overall Study|Lost to Follow-up|0|||
156907528|NCT03800173|566419695|FG003|Overall Study|Lost to Follow-up|0|||
156907529|NCT03800173|566419696|FG004|Overall Study|Lost to Follow-up|1|||
156907530|NCT01313312|566419697|FG000|Overall Study|Adverse Event|5|||
156907531|NCT01313312|566419697|FG000|Overall Study|Withdrawal by Subject|18|||
156907532|NCT01313312|566419697|FG000|Overall Study|Lack of Efficacy|3|||
156907533|NCT01313312|566419697|FG000|Overall Study|Investigator Decision|1|||
156907534|NCT01313312|566419697|FG000|Overall Study|Observational Phase|1|||
156907535|NCT01313312|566419697|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
156907536|NCT01313312|566419697|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
156907537|NCT01206166|566419702|FG000|Overall Study|No evaluable data|2|||
156907538|NCT01206166|566419703|FG001|Overall Study|No evaluable data|3|||
156907539|NCT02716805|566419704|FG000|Overall Study|Progressive disease|2|||
156907540|NCT02716805|566419705|FG001|Overall Study|Progressive disease|0|||
156907541|NCT02716805|566419706|FG002|Overall Study|Progressive disease|0|||
156907542|NCT02716805|566419707|FG003|Overall Study|Progressive disease|0|||
157159616|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
157159617|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
156907543|NCT00932126|566419708|FG000|Overall Study|Adverse Event|0|||
156907544|NCT00932126|566419709|FG001|Overall Study|Adverse Event|0|||
156907545|NCT00932126|566419710|FG002|Overall Study|Adverse Event|0|||
156907546|NCT00932126|566419711|FG003|Overall Study|Adverse Event|0|||
156907547|NCT00932126|566419712|FG004|Overall Study|Adverse Event|0|||
156907548|NCT00932126|566419713|FG005|Overall Study|Adverse Event|0|||
156907549|NCT00932126|566419714|FG006|Overall Study|Adverse Event|1|||
157159618|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156907550|NCT00932126|566419715|FG007|Overall Study|Adverse Event|2|||
156907551|NCT00932126|566419708|FG000|Overall Study|Protocol Violation|0|||
156907552|NCT00932126|566419709|FG001|Overall Study|Protocol Violation|0|||
156907553|NCT00932126|566419710|FG002|Overall Study|Protocol Violation|0|||
156907554|NCT00932126|566419711|FG003|Overall Study|Protocol Violation|0|||
156907555|NCT00932126|566419712|FG004|Overall Study|Protocol Violation|1|||
156907556|NCT00932126|566419713|FG005|Overall Study|Protocol Violation|0|||
156907557|NCT00932126|566419714|FG006|Overall Study|Protocol Violation|0|||
156907558|NCT00932126|566419715|FG007|Overall Study|Protocol Violation|0|||
156907559|NCT00932126|566419708|FG000|Overall Study|Withdrawal by Subject|0|||
156907560|NCT00932126|566419709|FG001|Overall Study|Withdrawal by Subject|0|||
156907561|NCT00932126|566419710|FG002|Overall Study|Withdrawal by Subject|1|||
156907562|NCT00932126|566419711|FG003|Overall Study|Withdrawal by Subject|0|||
156907563|NCT00932126|566419712|FG004|Overall Study|Withdrawal by Subject|0|||
156907564|NCT00932126|566419713|FG005|Overall Study|Withdrawal by Subject|0|||
156907565|NCT00932126|566419714|FG006|Overall Study|Withdrawal by Subject|0|||
156907566|NCT00932126|566419715|FG007|Overall Study|Withdrawal by Subject|1|||
156907567|NCT00932126|566419708|FG000|Overall Study|Objective progression or relapse|3|||
156907568|NCT00932126|566419709|FG001|Overall Study|Objective progression or relapse|3|||
156907569|NCT00932126|566419710|FG002|Overall Study|Objective progression or relapse|2|||
156907570|NCT00932126|566419711|FG003|Overall Study|Objective progression or relapse|3|||
156907571|NCT00932126|566419712|FG004|Overall Study|Objective progression or relapse|3|||
156907572|NCT00932126|566419713|FG005|Overall Study|Objective progression or relapse|3|||
156907573|NCT00932126|566419714|FG006|Overall Study|Objective progression or relapse|3|||
156907574|NCT00932126|566419715|FG007|Overall Study|Objective progression or relapse|5|||
157026945|NCT04436276|566853320|FG003|Overall Study|Withdrawal by Subject|23|||
157026946|NCT04436276|566853321|FG004|Overall Study|Withdrawal by Subject|14|||
157026947|NCT04436276|566853322|FG005|Overall Study|Withdrawal by Subject|0|||
157026948|NCT04436276|566853323|FG006|Overall Study|Withdrawal by Subject|0|||
157026949|NCT04436276|566853324|FG007|Overall Study|Withdrawal by Subject|1|||
157026950|NCT04436276|566853325|FG008|Overall Study|Withdrawal by Subject|0|||
157026951|NCT04436276|566853326|FG009|Overall Study|Withdrawal by Subject|1|||
157026952|NCT04436276|566853327|FG010|Overall Study|Withdrawal by Subject|17|||
157026953|NCT04436276|566853328|FG011|Overall Study|Withdrawal by Subject|7|||
157026954|NCT04436276|566853329|FG012|Overall Study|Withdrawal by Subject|10|||
157026955|NCT04436276|566853330|FG013|Overall Study|Withdrawal by Subject|6|||
157026956|NCT04436276|566853331|FG014|Overall Study|Withdrawal by Subject|20|||
157026957|NCT04436276|566853332|FG015|Overall Study|Withdrawal by Subject|6|||
157026958|NCT04436276|566853333|FG016|Overall Study|Withdrawal by Subject|11|||
157026959|NCT04436276|566853334|FG017|Overall Study|Withdrawal by Subject|4|||
157026960|NCT04436276|566853335|FG018|Overall Study|Withdrawal by Subject|14|||
157026961|NCT04436276|566853336|FG019|Overall Study|Withdrawal by Subject|24|||
157026962|NCT04436276|566853337|FG020|Overall Study|Withdrawal by Subject|24|||
156907575|NCT00932126|566419708|FG000|Overall Study|Other|0|||
156907576|NCT00932126|566419709|FG001|Overall Study|Other|0|||
156907577|NCT00932126|566419710|FG002|Overall Study|Other|0|||
156907578|NCT00932126|566419711|FG003|Overall Study|Other|0|||
156907579|NCT00932126|566419712|FG004|Overall Study|Other|1|||
156907580|NCT00932126|566419713|FG005|Overall Study|Other|0|||
156907581|NCT00932126|566419714|FG006|Overall Study|Other|1|||
156907582|NCT00932126|566419715|FG007|Overall Study|Other|2|||
156907583|NCT00066365|566419716|FG000|Overall Study|Adverse Event|1|||
156907584|NCT00066365|566419717|FG001|Overall Study|Adverse Event|0|||
156907585|NCT00066365|566419716|FG000|Overall Study|Lack of Efficacy|15|||
156907586|NCT00066365|566419717|FG001|Overall Study|Lack of Efficacy|12|||
156907587|NCT00066365|566419716|FG000|Overall Study|Physician Decision|1|||
156907588|NCT00066365|566419717|FG001|Overall Study|Physician Decision|0|||
156907589|NCT00066365|566419716|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
156907590|NCT00066365|566419717|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
156907591|NCT00066365|566419716|FG000|Overall Study|Ineligible|4|||
156907592|NCT00066365|566419717|FG001|Overall Study|Ineligible|2|||
156907593|NCT05306977|566419724|FG000|Overall Study|Withdrawal by Subject|1|||
156907594|NCT00415168|566419725|FG000|Overall Study|Death|26|||
156907595|NCT00415168|566419725|FG000|Overall Study|Lost to Follow-up|3|||
156907596|NCT00415168|566419725|FG000|Overall Study|Physician Decision|13|||
156907597|NCT00415168|566419725|FG000|Overall Study|Sponsor Decision|4|||
157026963|NCT04436276|566853338|FG021|Overall Study|Withdrawal by Subject|16|||
157026964|NCT04436276|566853339|FG022|Overall Study|Withdrawal by Subject|14|||
157026965|NCT04436276|566853317|FG000|Overall Study|Other|3|||
157026966|NCT04436276|566853318|FG001|Overall Study|Other|2|||
157026967|NCT04436276|566853319|FG002|Overall Study|Other|5|||
157026968|NCT04436276|566853320|FG003|Overall Study|Other|9|||
156907598|NCT00415168|566419725|FG000|Overall Study|Withdrawal by Subject|6|||
156907599|NCT00241358|566419726|FG000|Overall Study|Determined to be not ineligible|0|||
156907600|NCT00241358|566419727|FG001|Overall Study|Determined to be not ineligible|1|||
156907601|NCT00241358|566419728|FG002|Overall Study|Determined to be not ineligible|1|||
157026969|NCT04436276|566853321|FG004|Overall Study|Other|23|||
157026970|NCT04436276|566853322|FG005|Overall Study|Other|1|||
156907602|NCT00843856|566419729|FG000|Overall Study|Lost to Follow-up|1|||
156907603|NCT00843856|566419730|FG001|Overall Study|Lost to Follow-up|2|||
156907604|NCT00590135|566419731|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
156907605|NCT02015754|566419738|FG000|Overall Study|Disease progression|5|||
156907606|NCT02015754|566419738|FG000|Overall Study|Change in treatment modality|5|||
156907607|NCT02015754|566419738|FG000|Overall Study|Lost to Follow-up|1|||
156907608|NCT01681472|566419739|FG000|Overall Study|Adverse Event|0|||
156907609|NCT01681472|566419740|FG001|Overall Study|Adverse Event|1|||
156907610|NCT01681472|566419741|FG002|Overall Study|Adverse Event|0|||
156907611|NCT01681472|566419742|FG003|Overall Study|Adverse Event|0|||
156907612|NCT00672646|566419743|FG000|Overall Study|Lost to Follow-up|0|||
156907613|NCT00672646|566419744|FG001|Overall Study|Lost to Follow-up|1|||
156907614|NCT00672646|566419745|FG002|Overall Study|Lost to Follow-up|2|||
156907615|NCT00672646|566419743|FG000|Overall Study|Withdrawal by Subject|0|||
156907616|NCT00672646|566419744|FG001|Overall Study|Withdrawal by Subject|0|||
156907617|NCT00672646|566419745|FG002|Overall Study|Withdrawal by Subject|1|||
156907618|NCT00289783|566419746|FG000|Primary Phase|Adverse Event|10|||
157026971|NCT04436276|566853323|FG006|Overall Study|Other|0|||
157026972|NCT04436276|566853324|FG007|Overall Study|Other|0|||
157026973|NCT04436276|566853325|FG008|Overall Study|Other|0|||
157026974|NCT04436276|566853326|FG009|Overall Study|Other|0|||
157026975|NCT04436276|566853327|FG010|Overall Study|Other|3|||
157026976|NCT04436276|566853328|FG011|Overall Study|Other|1|||
157026977|NCT04436276|566853329|FG012|Overall Study|Other|1|||
157026978|NCT04436276|566853330|FG013|Overall Study|Other|2|||
157026979|NCT04436276|566853331|FG014|Overall Study|Other|3|||
157026980|NCT04436276|566853332|FG015|Overall Study|Other|0|||
157026981|NCT04436276|566853333|FG016|Overall Study|Other|0|||
157026982|NCT04436276|566853334|FG017|Overall Study|Other|6|||
157026983|NCT04436276|566853335|FG018|Overall Study|Other|1|||
157026984|NCT04436276|566853336|FG019|Overall Study|Other|0|||
157026985|NCT04436276|566853337|FG020|Overall Study|Other|2|||
157026986|NCT04436276|566853338|FG021|Overall Study|Other|2|||
157026987|NCT04436276|566853339|FG022|Overall Study|Other|60|||
157026988|NCT06457802|566853349|FG000|Overall Study|Early termination of study prior to participant completion|2|||
157026989|NCT06457802|566853350|FG001|Overall Study|Early termination of study prior to participant completion|2|||
157026990|NCT05496231|566853351|FG000|Overall Study|Adverse Event|1|||
157026991|NCT05496231|566853352|FG001|Overall Study|Adverse Event|1|||
157026992|NCT05496231|566853353|FG002|Overall Study|Adverse Event|0|||
157026993|NCT05496231|566853354|FG003|Overall Study|Adverse Event|4|||
157026994|NCT05496231|566853351|FG000|Overall Study|Withdrawal by Subject|5|||
157026995|NCT05496231|566853352|FG001|Overall Study|Withdrawal by Subject|5|||
157026996|NCT05496231|566853353|FG002|Overall Study|Withdrawal by Subject|4|||
157026997|NCT05496231|566853354|FG003|Overall Study|Withdrawal by Subject|11|||
157026998|NCT05496231|566853351|FG000|Overall Study|Migrated/moved from the study area|3|||
157026999|NCT05496231|566853352|FG001|Overall Study|Migrated/moved from the study area|5|||
157027000|NCT05496231|566853353|FG002|Overall Study|Migrated/moved from the study area|3|||
157027001|NCT05496231|566853354|FG003|Overall Study|Migrated/moved from the study area|3|||
157027002|NCT05496231|566853351|FG000|Overall Study|Lost to Follow-up|13|||
157027003|NCT05496231|566853352|FG001|Overall Study|Lost to Follow-up|6|||
157027004|NCT05496231|566853353|FG002|Overall Study|Lost to Follow-up|11|||
157027005|NCT05496231|566853354|FG003|Overall Study|Lost to Follow-up|6|||
157027006|NCT05496231|566853351|FG000|Overall Study|Other|9|||
157027007|NCT05496231|566853352|FG001|Overall Study|Other|7|||
157027008|NCT05496231|566853353|FG002|Overall Study|Other|7|||
157027009|NCT05496231|566853354|FG003|Overall Study|Other|8|||
157027010|NCT04880863|566853356|FG000|Overall Study|Adverse Event|1|||
157027011|NCT04880863|566853356|FG000|Overall Study|Patient decision|2|||
157027012|NCT04880863|566853356|FG000|Overall Study|Confirmed Disease Progression|15|||
157027013|NCT04880863|566853356|FG000|Overall Study|Death|3|||
156907619|NCT00289783|566419747|FG001|Primary Phase|Adverse Event|1|||
156907620|NCT00289783|566419746|FG000|Primary Phase|Protocol Violation|27|||
156907621|NCT00289783|566419747|FG001|Primary Phase|Protocol Violation|6|||
157027014|NCT04880863|566853356|FG000|Overall Study|Physician Decision|4|||
157027015|NCT04880863|566853356|FG000|Overall Study|Unconfirmed Disease Progression|4|||
157027016|NCT04880863|566853356|FG000|Overall Study|Withdrawal by Subject|2|||
157027017|NCT04880863|566853356|FG000|Overall Study|Study discontinuation by the sponsor|4|||
157027018|NCT04880863|566853356|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
157027019|NCT04880863|566853356|FG000|Overall Study|Not received study drug NAP|2|||
157027020|NCT03899259|566853357|FG000|Overall Study|Adverse Event|5|||
157027021|NCT03899259|566853358|FG001|Overall Study|Adverse Event|4|||
157027022|NCT03899259|566853359|FG002|Overall Study|Adverse Event|6|||
157027023|NCT03899259|566853357|FG000|Overall Study|Lack of Efficacy|5|||
156907622|NCT00289783|566419746|FG000|Primary Phase|Withdrawal by Subject|93|||
156907623|NCT00289783|566419747|FG001|Primary Phase|Withdrawal by Subject|40|||
156907624|NCT00289783|566419746|FG000|Primary Phase|Lost to Follow-up|60|||
157027024|NCT03899259|566853358|FG001|Overall Study|Lack of Efficacy|0|||
157027025|NCT03899259|566853359|FG002|Overall Study|Lack of Efficacy|2|||
157027026|NCT03899259|566853357|FG000|Overall Study|Pregnancy|3|||
157027027|NCT03899259|566853358|FG001|Overall Study|Pregnancy|0|||
157027028|NCT03899259|566853359|FG002|Overall Study|Pregnancy|1|||
157027029|NCT03899259|566853357|FG000|Overall Study|Physician Decision|0|||
157027030|NCT03899259|566853358|FG001|Overall Study|Physician Decision|1|||
157027031|NCT03899259|566853359|FG002|Overall Study|Physician Decision|0|||
157027032|NCT03899259|566853357|FG000|Overall Study|Protocol Deviation|1|||
157027033|NCT03899259|566853358|FG001|Overall Study|Protocol Deviation|1|||
157027034|NCT03899259|566853359|FG002|Overall Study|Protocol Deviation|1|||
157027035|NCT03899259|566853357|FG000|Overall Study|Withdrawal by Subject|8|||
157027036|NCT03899259|566853358|FG001|Overall Study|Withdrawal by Subject|10|||
157027037|NCT03899259|566853359|FG002|Overall Study|Withdrawal by Subject|12|||
157027038|NCT03899259|566853357|FG000|Overall Study|Lost to Follow-up|5|||
157027039|NCT03899259|566853358|FG001|Overall Study|Lost to Follow-up|6|||
157027040|NCT03899259|566853359|FG002|Overall Study|Lost to Follow-up|2|||
157027041|NCT03899259|566853357|FG000|Overall Study|Lack of Adherence|1|||
157027042|NCT03899259|566853358|FG001|Overall Study|Lack of Adherence|0|||
157027043|NCT03899259|566853359|FG002|Overall Study|Lack of Adherence|0|||
157027044|NCT03899259|566853357|FG000|Overall Study|Screen Failure|1|||
157027045|NCT03899259|566853358|FG001|Overall Study|Screen Failure|0|||
157027046|NCT03899259|566853359|FG002|Overall Study|Screen Failure|0|||
157027047|NCT03899259|566853357|FG000|Overall Study|Ongoing Study Participation|127|||
157027048|NCT03899259|566853358|FG001|Overall Study|Ongoing Study Participation|134|||
157027049|NCT03899259|566853359|FG002|Overall Study|Ongoing Study Participation|210|||
157027050|NCT01544114|566853363|FG000|Overall Study|Withdrawal by Subject|0|||
157027051|NCT01544114|566853364|FG001|Overall Study|Withdrawal by Subject|0|||
157027052|NCT01544114|566853365|FG002|Overall Study|Withdrawal by Subject|3|||
157027053|NCT01544114|566853363|FG000|Overall Study|Lost to Follow-up|0|||
157027054|NCT01544114|566853364|FG001|Overall Study|Lost to Follow-up|2|||
157027055|NCT01544114|566853365|FG002|Overall Study|Lost to Follow-up|0|||
157027056|NCT01544114|566853363|FG000|Overall Study|Adverse Event|1|||
157027057|NCT01544114|566853364|FG001|Overall Study|Adverse Event|1|||
157027058|NCT01544114|566853365|FG002|Overall Study|Adverse Event|2|||
157027059|NCT01544114|566853363|FG000|Overall Study|Protocol Violation|0|||
157027060|NCT01544114|566853364|FG001|Overall Study|Protocol Violation|1|||
157027061|NCT01544114|566853365|FG002|Overall Study|Protocol Violation|0|||
157027062|NCT01733316|566853370|FG000|RP103 Phase|Non-compliance|1|||
157027063|NCT01733316|566853370|FG000|Long Term Extension Phase|Adverse Event|1|||
157027064|NCT01733316|566853370|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
157027065|NCT01733316|566853370|FG000|Long Term Extension Phase|Sponsor Decision|2|||
157027066|NCT04508309|566853371|FG000|Overall Study|Death|0|||
157027067|NCT04508309|566853372|FG001|Overall Study|Death|0|||
156907625|NCT00289783|566419747|FG001|Primary Phase|Lost to Follow-up|14|||
156907626|NCT00289783|566419746|FG000|Primary Phase|Migration from the study area|26|||
156907627|NCT00289783|566419747|FG001|Primary Phase|Migration from the study area|10|||
156907628|NCT00289783|566419746|FG000|Primary Phase|Other|32|||
156907629|NCT00289783|566419747|FG001|Primary Phase|Other|12|||
156907630|NCT00289783|566419746|FG000|Fourth Dose Phase|Adverse Event|1|||
156907631|NCT00289783|566419747|FG001|Fourth Dose Phase|Adverse Event|0|||
156907632|NCT00289783|566419746|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
156907633|NCT00289783|566419747|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
156907634|NCT00289783|566419746|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
156907635|NCT00289783|566419747|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
156907636|NCT00289783|566419746|FG000|Fourth Dose Phase|Migration from the study area|1|||
156907637|NCT00289783|566419747|FG001|Fourth Dose Phase|Migration from the study area|1|||
156907638|NCT00289783|566419746|FG000|Fourth Dose Phase|Other|22|||
156907639|NCT00289783|566419747|FG001|Fourth Dose Phase|Other|10|||
156907640|NCT03128411|566419751|FG000|Treatment Phase|Adverse Event|21|||
156907641|NCT03128411|566419751|FG000|Treatment Phase|Physician Decision|1|||
156907642|NCT03128411|566419751|FG000|Treatment Phase|Other|2|||
156907643|NCT03128411|566419751|FG000|Long Term Follow-up Phase|Death|2|||
156907644|NCT01218113|566421530|FG000|Overall Study|Withdrawal by Subject|1|||
157027068|NCT04508309|566853373|FG002|Overall Study|Death|0|||
157027069|NCT04508309|566853374|FG003|Overall Study|Death|0|||
157027070|NCT04508309|566853375|FG004|Overall Study|Death|1|||
157027071|NCT04508309|566853371|FG000|Overall Study|Lost to Follow-up|0|||
156907645|NCT01218113|566421531|FG001|Overall Study|Withdrawal by Subject|0|||
156907646|NCT01218113|566421532|FG002|Overall Study|Withdrawal by Subject|1|||
156907647|NCT01218113|566421530|FG000|Overall Study|Lost to Follow-up|4|||
156907648|NCT01218113|566421531|FG001|Overall Study|Lost to Follow-up|1|||
156907649|NCT01218113|566421532|FG002|Overall Study|Lost to Follow-up|4|||
156907650|NCT01218113|566421530|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
156907651|NCT01218113|566421531|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
156907652|NCT01218113|566421532|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
157027072|NCT04508309|566853372|FG001|Overall Study|Lost to Follow-up|0|||
157027073|NCT04508309|566853373|FG002|Overall Study|Lost to Follow-up|1|||
157027074|NCT04508309|566853374|FG003|Overall Study|Lost to Follow-up|1|||
157027075|NCT04508309|566853375|FG004|Overall Study|Lost to Follow-up|0|||
157027076|NCT04508309|566853371|FG000|Overall Study|Withdrawal by Subject|0|||
157027077|NCT04508309|566853372|FG001|Overall Study|Withdrawal by Subject|0|||
156907653|NCT01871532|566421535|FG000|Overall Study|Withdrawal by Subject|1|||
156907654|NCT01871532|566421536|FG001|Overall Study|Withdrawal by Subject|2|||
156907655|NCT01673867|566421538|FG000|Randomization|Adverse event unrelated to study drug|1|||
156907656|NCT01673867|566421539|FG001|Randomization|Adverse event unrelated to study drug|0|||
156907657|NCT01673867|566421538|FG000|Randomization|Participant request to discontinue study treatment|0|||
156907658|NCT01673867|566421539|FG001|Randomization|Participant request to discontinue study treatment|4|||
156907659|NCT01673867|566421538|FG000|Randomization|Withdrawal by participant|0|||
156907660|NCT01673867|566421539|FG001|Randomization|Withdrawal by participant|12|||
156907661|NCT01673867|566421538|FG000|Randomization|Lost to Follow-up|0|||
156907662|NCT01673867|566421539|FG001|Randomization|Lost to Follow-up|1|||
156907663|NCT01673867|566421538|FG000|Randomization|Participant no longer meets study criteria|4|||
156907664|NCT01673867|566421539|FG001|Randomization|Participant no longer meets study criteria|5|||
156907665|NCT01673867|566421538|FG000|Treatment|Disease Progression|208|||
156907666|NCT01673867|566421539|FG001|Treatment|Disease Progression|178|||
156907667|NCT01673867|566421538|FG000|Treatment|Study Drug Toxicity|23|||
157027078|NCT04508309|566853373|FG002|Overall Study|Withdrawal by Subject|0|||
157027079|NCT04508309|566853374|FG003|Overall Study|Withdrawal by Subject|0|||
157027080|NCT04508309|566853375|FG004|Overall Study|Withdrawal by Subject|1|||
157027081|NCT03058289|566853382|FG000|Overall Study|Radiographic Deterioration|0|||
157027082|NCT03058289|566853383|FG001|Overall Study|Radiographic Deterioration|3|||
157027083|NCT03058289|566853384|FG002|Overall Study|Radiographic Deterioration|1|||
157027084|NCT03058289|566853385|FG003|Overall Study|Radiographic Deterioration|2|||
157027085|NCT03058289|566853386|FG004|Overall Study|Radiographic Deterioration|6|||
157027086|NCT03058289|566853387|FG005|Overall Study|Radiographic Deterioration|3|||
157027087|NCT03058289|566853388|FG006|Overall Study|Radiographic Deterioration|0|||
157027088|NCT03058289|566853389|FG007|Overall Study|Radiographic Deterioration|4|||
157027089|NCT03058289|566853390|FG008|Overall Study|Radiographic Deterioration|2|||
157027090|NCT03058289|566853382|FG000|Overall Study|Adverse Event|2|||
157027091|NCT03058289|566853383|FG001|Overall Study|Adverse Event|0|||
157027092|NCT03058289|566853384|FG002|Overall Study|Adverse Event|1|||
157027093|NCT03058289|566853385|FG003|Overall Study|Adverse Event|3|||
157027094|NCT03058289|566853386|FG004|Overall Study|Adverse Event|1|||
157027095|NCT03058289|566853387|FG005|Overall Study|Adverse Event|0|||
157027096|NCT03058289|566853388|FG006|Overall Study|Adverse Event|1|||
157159619|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159620|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159621|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159622|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159623|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159624|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159625|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
157159626|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
156859884|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
156859885|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
156859886|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
156859887|NCT00528957|566243240|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
156859888|NCT00528957|566243241|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
156859889|NCT00528957|566243240|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
156859890|NCT00528957|566243241|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
156859891|NCT00528957|566243240|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
156859892|NCT00528957|566243241|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
156859893|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
156859894|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
156859895|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
156859896|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
156859897|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
156859898|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
156859899|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
156859900|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
156859901|NCT00528957|566243240|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
156859902|NCT00528957|566243241|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
156859903|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
156859904|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
156859905|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
157027097|NCT03058289|566853389|FG007|Overall Study|Adverse Event|3|||
157027098|NCT03058289|566853390|FG008|Overall Study|Adverse Event|0|||
157027099|NCT03058289|566853382|FG000|Overall Study|Withdrawal by Subject|0|||
157027100|NCT03058289|566853383|FG001|Overall Study|Withdrawal by Subject|0|||
157027101|NCT03058289|566853384|FG002|Overall Study|Withdrawal by Subject|0|||
157027102|NCT03058289|566853385|FG003|Overall Study|Withdrawal by Subject|2|||
157027103|NCT03058289|566853386|FG004|Overall Study|Withdrawal by Subject|0|||
157027104|NCT03058289|566853387|FG005|Overall Study|Withdrawal by Subject|2|||
157027105|NCT03058289|566853388|FG006|Overall Study|Withdrawal by Subject|0|||
157027106|NCT03058289|566853389|FG007|Overall Study|Withdrawal by Subject|4|||
157027107|NCT03058289|566853390|FG008|Overall Study|Withdrawal by Subject|1|||
157027108|NCT03058289|566853382|FG000|Overall Study|Physician Decision|1|||
157027109|NCT03058289|566853383|FG001|Overall Study|Physician Decision|0|||
157027110|NCT03058289|566853384|FG002|Overall Study|Physician Decision|0|||
157027111|NCT03058289|566853385|FG003|Overall Study|Physician Decision|2|||
157027112|NCT03058289|566853386|FG004|Overall Study|Physician Decision|1|||
157027113|NCT03058289|566853387|FG005|Overall Study|Physician Decision|0|||
157027114|NCT03058289|566853388|FG006|Overall Study|Physician Decision|2|||
157027115|NCT03058289|566853389|FG007|Overall Study|Physician Decision|3|||
157027116|NCT03058289|566853390|FG008|Overall Study|Physician Decision|0|||
157027117|NCT03058289|566853382|FG000|Overall Study|Clinical Deterioration|2|||
157027118|NCT03058289|566853383|FG001|Overall Study|Clinical Deterioration|0|||
157027119|NCT03058289|566853384|FG002|Overall Study|Clinical Deterioration|0|||
157027120|NCT03058289|566853385|FG003|Overall Study|Clinical Deterioration|2|||
157027121|NCT03058289|566853386|FG004|Overall Study|Clinical Deterioration|1|||
157027122|NCT03058289|566853387|FG005|Overall Study|Clinical Deterioration|1|||
157027123|NCT03058289|566853388|FG006|Overall Study|Clinical Deterioration|0|||
157027124|NCT03058289|566853389|FG007|Overall Study|Clinical Deterioration|3|||
157027125|NCT03058289|566853390|FG008|Overall Study|Clinical Deterioration|2|||
157027126|NCT03058289|566853382|FG000|Overall Study|Lost to Follow-up|0|||
157027127|NCT03058289|566853383|FG001|Overall Study|Lost to Follow-up|0|||
157027128|NCT03058289|566853384|FG002|Overall Study|Lost to Follow-up|0|||
157027129|NCT03058289|566853385|FG003|Overall Study|Lost to Follow-up|0|||
157027130|NCT03058289|566853386|FG004|Overall Study|Lost to Follow-up|1|||
157027131|NCT03058289|566853387|FG005|Overall Study|Lost to Follow-up|0|||
157027132|NCT03058289|566853388|FG006|Overall Study|Lost to Follow-up|0|||
157027133|NCT03058289|566853389|FG007|Overall Study|Lost to Follow-up|0|||
157027134|NCT03058289|566853390|FG008|Overall Study|Lost to Follow-up|0|||
157027135|NCT03058289|566853382|FG000|Overall Study|Refused Further Treatment|0|||
157027136|NCT03058289|566853383|FG001|Overall Study|Refused Further Treatment|0|||
157027137|NCT03058289|566853384|FG002|Overall Study|Refused Further Treatment|1|||
156907668|NCT01673867|566421539|FG001|Treatment|Study Drug Toxicity|43|||
156907669|NCT01673867|566421538|FG000|Treatment|Death|2|||
156907670|NCT01673867|566421539|FG001|Treatment|Death|3|||
156907671|NCT01673867|566421538|FG000|Treatment|Adverse event unrelated to study drug|23|||
156907672|NCT01673867|566421539|FG001|Treatment|Adverse event unrelated to study drug|10|||
156907673|NCT01673867|566421538|FG000|Treatment|Participant request to discontinue study treatment|7|||
156907674|NCT01673867|566421539|FG001|Treatment|Participant request to discontinue study treatment|17|||
156907675|NCT01673867|566421538|FG000|Treatment|Withdrawal by participant|5|||
156907676|NCT01673867|566421539|FG001|Treatment|Withdrawal by participant|5|||
156907677|NCT01673867|566421538|FG000|Treatment|Maximum clinical benefit|1|||
156907678|NCT01673867|566421539|FG001|Treatment|Maximum clinical benefit|10|||
156907679|NCT01673867|566421538|FG000|Treatment|Participant no longer meets study criteria|2|||
156907680|NCT01673867|566421539|FG001|Treatment|Participant no longer meets study criteria|0|||
156907681|NCT01673867|566421538|FG000|Treatment|Administrative reason by sponsor|3|||
156907682|NCT01673867|566421539|FG001|Treatment|Administrative reason by sponsor|0|||
156907683|NCT01673867|566421538|FG000|Treatment|Other reason|11|||
156907684|NCT01673867|566421539|FG001|Treatment|Other reason|2|||
156907685|NCT04218695|566421542|FG000|Overall Study|Adverse Event|1|||
156907686|NCT04218695|566421543|FG001|Overall Study|Adverse Event|0|||
156907687|NCT01890473|566421544|FG000|Overall Study|Lost to Follow-up|1|||
156907688|NCT01890473|566421545|FG001|Overall Study|Lost to Follow-up|0|||
156907689|NCT01890473|566421544|FG000|Overall Study|Poor/non-compliance|1|||
156907690|NCT01890473|566421545|FG001|Overall Study|Poor/non-compliance|0|||
157027138|NCT03058289|566853385|FG003|Overall Study|Refused Further Treatment|0|||
156907691|NCT03166735|566421546|FG000|Overall Study|Not Treated|1|||
156907692|NCT03166735|566421547|FG001|Overall Study|Not Treated|0|||
157027139|NCT03058289|566853386|FG004|Overall Study|Refused Further Treatment|1|||
156907693|NCT03166735|566421548|FG002|Overall Study|Not Treated|0|||
157027140|NCT03058289|566853387|FG005|Overall Study|Refused Further Treatment|0|||
157027141|NCT03058289|566853388|FG006|Overall Study|Refused Further Treatment|0|||
157027142|NCT03058289|566853389|FG007|Overall Study|Refused Further Treatment|0|||
157027143|NCT03058289|566853390|FG008|Overall Study|Refused Further Treatment|0|||
157027144|NCT03058289|566853382|FG000|Overall Study|Rapid Progression of Disease|0|||
157027145|NCT03058289|566853383|FG001|Overall Study|Rapid Progression of Disease|0|||
157027146|NCT03058289|566853384|FG002|Overall Study|Rapid Progression of Disease|0|||
156907694|NCT03166735|566421549|FG003|Overall Study|Not Treated|0|||
156907695|NCT03166735|566421550|FG004|Overall Study|Not Treated|0|||
157027147|NCT03058289|566853385|FG003|Overall Study|Rapid Progression of Disease|1|||
156907696|NCT03166735|566421546|FG000|Overall Study|follow-up not completed as planned|0|||
157159627|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159628|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159629|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159630|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159631|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159632|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159633|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159634|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159635|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159636|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
156907697|NCT03166735|566421547|FG001|Overall Study|follow-up not completed as planned|1|||
157159637|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159638|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159639|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159640|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
157159641|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159642|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159643|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159644|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159645|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159646|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159647|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159648|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159649|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
157159650|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
157159651|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
157159652|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
157159653|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
157159654|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
157159655|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
157159656|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
157159657|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
157159658|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
157159659|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
157159660|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
157159661|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
157159662|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
157159663|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
157159664|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
157159665|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
157159666|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
157159667|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
157159668|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
157159669|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
157159670|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
157159671|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
157159672|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
157159673|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159674|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159675|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159676|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159677|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159678|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159679|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159680|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159681|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
157159682|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156907698|NCT03166735|566421548|FG002|Overall Study|follow-up not completed as planned|1|||
156907699|NCT03166735|566421549|FG003|Overall Study|follow-up not completed as planned|0|||
156907700|NCT03166735|566421550|FG004|Overall Study|follow-up not completed as planned|1|||
156907701|NCT03166735|566421546|FG000|Overall Study|Withdrawal by Subject|0|||
156907702|NCT03166735|566421547|FG001|Overall Study|Withdrawal by Subject|0|||
157159683|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159684|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159685|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156907703|NCT03166735|566421548|FG002|Overall Study|Withdrawal by Subject|1|||
156907704|NCT03166735|566421549|FG003|Overall Study|Withdrawal by Subject|1|||
156907705|NCT03166735|566421550|FG004|Overall Study|Withdrawal by Subject|2|||
156907706|NCT03166735|566421546|FG000|Overall Study|Lost to Follow-up|0|||
156907707|NCT03166735|566421547|FG001|Overall Study|Lost to Follow-up|2|||
156907708|NCT03166735|566421548|FG002|Overall Study|Lost to Follow-up|1|||
156907709|NCT03166735|566421549|FG003|Overall Study|Lost to Follow-up|0|||
156907710|NCT03166735|566421550|FG004|Overall Study|Lost to Follow-up|1|||
156907711|NCT01543958|566421551|FG000|Overall Study|Loss to follow-up|3|||
156907712|NCT01543958|566421551|FG000|Overall Study|ART initiation|1|||
156907713|NCT00934089|566421552|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
156907714|NCT00934089|566421553|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
156907715|NCT00934089|566421552|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
156907716|NCT00934089|566421553|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
156907717|NCT01945281|566421554|FG000|Overall Study|Adverse Event|1|||
156907718|NCT01945281|566421555|FG001|Overall Study|Adverse Event|0|||
156907719|NCT01945281|566421554|FG000|Overall Study|Death|3|||
156907720|NCT01945281|566421555|FG001|Overall Study|Death|3|||
156907721|NCT01945281|566421554|FG000|Overall Study|Physician Decision|1|||
156907722|NCT01945281|566421555|FG001|Overall Study|Physician Decision|1|||
156907723|NCT01945281|566421554|FG000|Overall Study|Technical Problems|1|||
156907724|NCT01945281|566421555|FG001|Overall Study|Technical Problems|0|||
156907725|NCT00926328|566421556|FG000|Overall Study|Lost to Follow-up|12|||
156907726|NCT00926328|566421557|FG001|Overall Study|Lost to Follow-up|14|||
156907727|NCT00726986|566421558|FG000|Induction Phase|Adverse Event|4|||
156907728|NCT00726986|566421558|FG000|Induction Phase|Withdrawal by Subject|2|||
156907729|NCT00726986|566421558|FG000|Induction Phase|Death|2|||
156907730|NCT00726986|566421558|FG000|Induction Phase|Lack of Efficacy|5|||
156907731|NCT00726986|566421558|FG000|Induction Phase|Secondary Disease|2|||
156907732|NCT00726986|566421558|FG000|Maintenance Phase|Adverse Event|1|||
156907733|NCT00726986|566421558|FG000|Maintenance Phase|Lack of Efficacy|2|||
156907734|NCT03486223|566421564|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
156907735|NCT03486223|566421565|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
156907736|NCT01819831|566421566|FG000|Overall Study|Withdrawal by Subject|1|||
156907737|NCT01513343|566421567|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
156907738|NCT01513343|566421568|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
156907739|NCT01513343|566421567|FG000|Post Data Collection|Dropped/withdrew from study|7|||
156907740|NCT01513343|566421568|FG001|Post Data Collection|Dropped/withdrew from study|1|||
156907741|NCT01513343|566421567|FG000|Post Data Collection|Lost to Follow-up|10|||
156907742|NCT01513343|566421568|FG001|Post Data Collection|Lost to Follow-up|23|||
156907743|NCT01513343|566421567|FG000|6-month Follow-up|Lost to Follow-up|28|||
156907744|NCT01513343|566421568|FG001|6-month Follow-up|Lost to Follow-up|17|||
156907745|NCT01513343|566421567|FG000|12-month Follow-up|Lost to Follow-up|10|||
156907746|NCT01513343|566421568|FG001|12-month Follow-up|Lost to Follow-up|3|||
156907747|NCT01434667|566421569|FG000|Overall Study|Lost to Follow-up|5|||
156907748|NCT01434667|566421570|FG001|Overall Study|Lost to Follow-up|10|||
156907749|NCT02034110|566421573|FG000|Overall Study|Physician Decision|0|||
156907750|NCT02034110|566421574|FG001|Overall Study|Physician Decision|0|||
156907751|NCT02034110|566421575|FG002|Overall Study|Physician Decision|0|||
156907752|NCT02034110|566421576|FG003|Overall Study|Physician Decision|0|||
156907753|NCT02034110|566421577|FG004|Overall Study|Physician Decision|2|||
156907754|NCT02034110|566421578|FG005|Overall Study|Physician Decision|0|||
156907755|NCT02034110|566421579|FG006|Overall Study|Physician Decision|1|||
156907756|NCT02034110|566421580|FG007|Overall Study|Physician Decision|0|||
156907757|NCT02034110|566421573|FG000|Overall Study|Lost to Follow-up|1|||
156907758|NCT02034110|566421574|FG001|Overall Study|Lost to Follow-up|0|||
156907759|NCT02034110|566421575|FG002|Overall Study|Lost to Follow-up|0|||
156907760|NCT02034110|566421576|FG003|Overall Study|Lost to Follow-up|0|||
156907761|NCT02034110|566421577|FG004|Overall Study|Lost to Follow-up|1|||
156907762|NCT02034110|566421578|FG005|Overall Study|Lost to Follow-up|0|||
156907763|NCT02034110|566421579|FG006|Overall Study|Lost to Follow-up|1|||
156907764|NCT02034110|566421580|FG007|Overall Study|Lost to Follow-up|0|||
156907765|NCT02034110|566421573|FG000|Overall Study|Withdrawal by Subject|5|||
156907766|NCT02034110|566421574|FG001|Overall Study|Withdrawal by Subject|7|||
156907767|NCT02034110|566421575|FG002|Overall Study|Withdrawal by Subject|0|||
156907768|NCT02034110|566421576|FG003|Overall Study|Withdrawal by Subject|3|||
156907769|NCT02034110|566421577|FG004|Overall Study|Withdrawal by Subject|7|||
156907770|NCT02034110|566421578|FG005|Overall Study|Withdrawal by Subject|0|||
156907771|NCT02034110|566421579|FG006|Overall Study|Withdrawal by Subject|3|||
156907772|NCT02034110|566421580|FG007|Overall Study|Withdrawal by Subject|1|||
156907773|NCT02034110|566421573|FG000|Overall Study|Study closed by sponsor|6|||
156907774|NCT02034110|566421574|FG001|Overall Study|Study closed by sponsor|2|||
156907775|NCT02034110|566421575|FG002|Overall Study|Study closed by sponsor|0|||
156907776|NCT02034110|566421576|FG003|Overall Study|Study closed by sponsor|6|||
156907777|NCT02034110|566421577|FG004|Overall Study|Study closed by sponsor|7|||
157027148|NCT03058289|566853386|FG004|Overall Study|Rapid Progression of Disease|0|||
156859906|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
156859907|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
156859908|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
156859909|NCT00528957|566243240|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
156859910|NCT00528957|566243241|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
156859911|NCT01323582|566243242|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
156859912|NCT01323582|566243243|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
156859913|NCT01323582|566243242|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
156859914|NCT01323582|566243243|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
156859915|NCT01323582|566243242|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
156859916|NCT01323582|566243243|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
156859917|NCT00960375|566243244|FG000|Overall Study|Lost to Follow-up|20|||
156859918|NCT00960375|566243245|FG001|Overall Study|Lost to Follow-up|22|||
156859919|NCT03353675|566243248|FG000|Overall Study|Adverse Event|4|||
156859920|NCT00402168|566243249|FG000|Randomized|Lost to Follow-up|1|||
156859921|NCT00402168|566243250|FG001|Randomized|Lost to Follow-up|0|||
156859922|NCT00402168|566243249|FG000|Randomized|Withdrawal by Subject|0|||
156859923|NCT00402168|566243250|FG001|Randomized|Withdrawal by Subject|1|||
156859924|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|Death|0|||
156859925|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|Death|1|||
156859926|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
156859927|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
156859928|NCT00402168|566243249|FG000|Treatment (up to 12 Months)|non-specified|0|||
156859929|NCT00402168|566243250|FG001|Treatment (up to 12 Months)|non-specified|1|||
156859930|NCT00402168|566243249|FG000|Long Term (LT)|Adverse Event|1|||
156859931|NCT00402168|566243250|FG001|Long Term (LT)|Adverse Event|5|||
156859932|NCT00402168|566243249|FG000|Long Term (LT)|Withdrawal by Subject|4|||
156859933|NCT00402168|566243250|FG001|Long Term (LT)|Withdrawal by Subject|7|||
156859934|NCT00402168|566243249|FG000|Long Term (LT)|Pregnancy|0|||
156859935|NCT00402168|566243250|FG001|Long Term (LT)|Pregnancy|1|||
156859936|NCT00402168|566243249|FG000|Long Term (LT)|Lost to Follow-up|1|||
156859937|NCT00402168|566243250|FG001|Long Term (LT)|Lost to Follow-up|0|||
156859938|NCT00402168|566243249|FG000|Long Term (LT)|Death|4|||
156859939|NCT00402168|566243250|FG001|Long Term (LT)|Death|0|||
156859940|NCT00402168|566243249|FG000|Long Term (LT)|Lack of Efficacy|0|||
156859941|NCT00402168|566243250|FG001|Long Term (LT)|Lack of Efficacy|2|||
156859942|NCT00402168|566243249|FG000|Long Term (LT)|non-specified|1|||
156859943|NCT00402168|566243250|FG001|Long Term (LT)|non-specified|2|||
156859944|NCT00402168|566243249|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
156859945|NCT00402168|566243250|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
156859946|NCT00402168|566243249|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
156859947|NCT00402168|566243250|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
156859948|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
156859949|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
156859950|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
156859951|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
156859952|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
156859953|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
156859954|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
156859955|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
156859956|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
156859957|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
156859958|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
156859959|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
156859960|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
156859961|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
156859962|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
156859963|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
156859964|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
156859965|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
156859966|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
156859967|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
156859968|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
156859969|NCT00550407|566243251|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
156859970|NCT00550407|566243252|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
156859971|NCT00550407|566243253|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
156859972|NCT00550407|566243251|FG000|26-Week Randomized Phase|Adverse Event|0|||
156859973|NCT00550407|566243252|FG001|26-Week Randomized Phase|Adverse Event|5|||
156859974|NCT00550407|566243253|FG002|26-Week Randomized Phase|Adverse Event|2|||
157159686|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
156907778|NCT02034110|566421578|FG005|Overall Study|Study closed by sponsor|0|||
156907779|NCT02034110|566421579|FG006|Overall Study|Study closed by sponsor|42|||
156907780|NCT02034110|566421580|FG007|Overall Study|Study closed by sponsor|0|||
156907781|NCT02587234|566421581|FG000|Overall Study|Withdrawal by Subject|1|||
156907782|NCT02587234|566421582|FG001|Overall Study|Withdrawal by Subject|1|||
156907783|NCT02587234|566421581|FG000|Overall Study|Lost to Follow-up|0|||
156907784|NCT02587234|566421582|FG001|Overall Study|Lost to Follow-up|2|||
156907785|NCT02165215|566421583|FG000|Induction Phase|Adverse Event|1|||
156907786|NCT02165215|566421584|FG001|Induction Phase|Adverse Event|0|||
156907787|NCT02165215|566421585|FG002|Induction Phase|Adverse Event|0|||
156907788|NCT02165215|566421583|FG000|Induction Phase|Withdrawal by Subject|10|||
156907789|NCT02165215|566421584|FG001|Induction Phase|Withdrawal by Subject|0|||
156907790|NCT02165215|566421585|FG002|Induction Phase|Withdrawal by Subject|0|||
156907791|NCT02165215|566421583|FG000|Induction Phase|Protocol Violation|1|||
156907792|NCT02165215|566421584|FG001|Induction Phase|Protocol Violation|0|||
156907793|NCT02165215|566421585|FG002|Induction Phase|Protocol Violation|0|||
156907794|NCT02165215|566421583|FG000|Induction Phase|Physician Decision|1|||
156907795|NCT02165215|566421584|FG001|Induction Phase|Physician Decision|0|||
156907796|NCT02165215|566421585|FG002|Induction Phase|Physician Decision|0|||
156907797|NCT02165215|566421583|FG000|Induction Phase|Lack of Efficacy|2|||
156907798|NCT02165215|566421584|FG001|Induction Phase|Lack of Efficacy|0|||
156907799|NCT02165215|566421585|FG002|Induction Phase|Lack of Efficacy|0|||
156907800|NCT02165215|566421583|FG000|Induction Phase|Non-Compliance|2|||
156907801|NCT02165215|566421584|FG001|Induction Phase|Non-Compliance|0|||
156907802|NCT02165215|566421585|FG002|Induction Phase|Non-Compliance|0|||
156907803|NCT02165215|566421583|FG000|Induction Phase|Lost to Follow-up|6|||
156907804|NCT02165215|566421584|FG001|Induction Phase|Lost to Follow-up|0|||
156907805|NCT02165215|566421585|FG002|Induction Phase|Lost to Follow-up|0|||
156907806|NCT02165215|566421583|FG000|Maintenance Phase|Withdrawal by Subject|0|||
156907807|NCT02165215|566421584|FG001|Maintenance Phase|Withdrawal by Subject|7|||
156907808|NCT02165215|566421585|FG002|Maintenance Phase|Withdrawal by Subject|3|||
156907809|NCT02165215|566421583|FG000|Maintenance Phase|Multiple reasons|0|||
156907810|NCT02165215|566421584|FG001|Maintenance Phase|Multiple reasons|2|||
156907811|NCT02165215|566421585|FG002|Maintenance Phase|Multiple reasons|1|||
156907812|NCT02165215|566421583|FG000|Maintenance Phase|Lost to Follow-up|0|||
156907813|NCT02165215|566421584|FG001|Maintenance Phase|Lost to Follow-up|2|||
156907814|NCT02165215|566421585|FG002|Maintenance Phase|Lost to Follow-up|0|||
156907815|NCT02165215|566421583|FG000|Maintenance Phase|Adverse Event|0|||
156907816|NCT02165215|566421584|FG001|Maintenance Phase|Adverse Event|1|||
156907817|NCT02165215|566421585|FG002|Maintenance Phase|Adverse Event|1|||
156907818|NCT05074667|566421586|FG000|Overall Study|Death|1|||
156907819|NCT05074667|566421586|FG000|Overall Study|Withdrawal by Subject|4|||
156907820|NCT05074667|566421586|FG000|Overall Study|Lost to Follow-up|10|||
156907821|NCT01153347|566421589|FG000|Overall Study|Withdrawal by Subject|7|||
156907822|NCT01153347|566421590|FG001|Overall Study|Withdrawal by Subject|7|||
156907823|NCT01153347|566421591|FG002|Overall Study|Withdrawal by Subject|7|||
156907824|NCT01153347|566421592|FG003|Overall Study|Withdrawal by Subject|7|||
156907825|NCT01153347|566421589|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156907826|NCT01153347|566421590|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156907827|NCT01153347|566421591|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
156907828|NCT01153347|566421592|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156907829|NCT01153347|566421589|FG000|Overall Study|Adverse Event|3|||
156907830|NCT01153347|566421590|FG001|Overall Study|Adverse Event|9|||
156907831|NCT01153347|566421591|FG002|Overall Study|Adverse Event|21|||
156907832|NCT01153347|566421592|FG003|Overall Study|Adverse Event|7|||
157027149|NCT03058289|566853387|FG005|Overall Study|Rapid Progression of Disease|0|||
157159687|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159688|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159689|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159690|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159691|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159692|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159693|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157225587|NCT00337571|567571474|FG000|Overall Study|Withdrawal by Subject|2|||
156907833|NCT01153347|566421589|FG000|Overall Study|Severe non-compliance to protocol|6|||
156907834|NCT01153347|566421590|FG001|Overall Study|Severe non-compliance to protocol|7|||
156907835|NCT01153347|566421591|FG002|Overall Study|Severe non-compliance to protocol|4|||
156907836|NCT01153347|566421592|FG003|Overall Study|Severe non-compliance to protocol|3|||
156907837|NCT01153347|566421589|FG000|Overall Study|Condition under investigation worsened|1|||
156907838|NCT01153347|566421590|FG001|Overall Study|Condition under investigation worsened|1|||
156907839|NCT01153347|566421591|FG002|Overall Study|Condition under investigation worsened|0|||
156907840|NCT01153347|566421592|FG003|Overall Study|Condition under investigation worsened|0|||
156907841|NCT01153347|566421589|FG000|Overall Study|Lack of Efficacy|2|||
156907842|NCT01153347|566421590|FG001|Overall Study|Lack of Efficacy|2|||
156907843|NCT01153347|566421591|FG002|Overall Study|Lack of Efficacy|0|||
156907844|NCT01153347|566421592|FG003|Overall Study|Lack of Efficacy|4|||
156907845|NCT01153347|566421589|FG000|Overall Study|Study-specific withdrawal criteria|4|||
156907846|NCT01153347|566421590|FG001|Overall Study|Study-specific withdrawal criteria|3|||
156907847|NCT01153347|566421591|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156907848|NCT01153347|566421592|FG003|Overall Study|Study-specific withdrawal criteria|2|||
156907849|NCT01153347|566421589|FG000|Overall Study|Lost to Follow-up|4|||
156907850|NCT01153347|566421590|FG001|Overall Study|Lost to Follow-up|9|||
156907851|NCT01153347|566421591|FG002|Overall Study|Lost to Follow-up|11|||
156907852|NCT01153347|566421592|FG003|Overall Study|Lost to Follow-up|8|||
156907853|NCT01153347|566421589|FG000|Overall Study|Other|5|||
156907854|NCT01153347|566421590|FG001|Overall Study|Other|5|||
156907855|NCT01153347|566421591|FG002|Overall Study|Other|4|||
156907856|NCT01153347|566421592|FG003|Overall Study|Other|0|||
156907857|NCT01153347|566421589|FG000|Overall Study|Death|1|||
156907858|NCT01153347|566421590|FG001|Overall Study|Death|0|||
156907859|NCT01153347|566421591|FG002|Overall Study|Death|0|||
156907860|NCT01153347|566421592|FG003|Overall Study|Death|0|||
156907861|NCT00003473|566421595|FG000|Overall Study|Three patients were not evaluable.|3|||
156907862|NCT04401423|566421596|FG000|Overall Study|Withdrawal by Subject|3|||
156907863|NCT04401423|566421597|FG001|Overall Study|Withdrawal by Subject|1|||
156907864|NCT04401423|566421596|FG000|Overall Study|Physician Decision|2|||
156907865|NCT04401423|566421597|FG001|Overall Study|Physician Decision|1|||
156907866|NCT00827502|566421598|FG000|Overall Study|randomized but not treated|11|||
156907867|NCT00827502|566421598|FG000|Overall Study|Adverse Event|1|||
156907868|NCT00827502|566421598|FG000|Overall Study|Lost to Follow-up|4|||
156907869|NCT00827502|566421598|FG000|Overall Study|Withdrawal by Subject|5|||
156907870|NCT04678661|566421600|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
156907871|NCT04678661|566421601|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
157027150|NCT03058289|566853388|FG006|Overall Study|Rapid Progression of Disease|0|||
157027151|NCT03058289|566853389|FG007|Overall Study|Rapid Progression of Disease|0|||
157027152|NCT03058289|566853390|FG008|Overall Study|Rapid Progression of Disease|0|||
157027153|NCT05940194|566853391|FG000|Overall Study|Adverse Event|0|||
157027154|NCT05940194|566853392|FG001|Overall Study|Adverse Event|1|||
157027155|NCT05940194|566853393|FG002|Overall Study|Adverse Event|0|||
157027156|NCT05940194|566853391|FG000|Overall Study|Migrated/Moved from the study area|2|||
157027157|NCT05940194|566853392|FG001|Overall Study|Migrated/Moved from the study area|2|||
157027158|NCT05940194|566853393|FG002|Overall Study|Migrated/Moved from the study area|4|||
157027159|NCT02151981|566853395|FG000|Overall Study|Death|184|||
156907872|NCT04678661|566421600|FG000|Overall Study|Protocol Violation|2|||
156907873|NCT04678661|566421601|FG001|Overall Study|Protocol Violation|0|||
156907874|NCT04678661|566421600|FG000|Overall Study|Withdrawal by Subject|1|||
156907875|NCT04678661|566421601|FG001|Overall Study|Withdrawal by Subject|0|||
156907876|NCT04678661|566421600|FG000|Overall Study|Lost to Follow-up|2|||
156907877|NCT04678661|566421601|FG001|Overall Study|Lost to Follow-up|0|||
156907878|NCT04678661|566421600|FG000|Overall Study|Death|2|||
156907879|NCT04678661|566421601|FG001|Overall Study|Death|0|||
156907880|NCT01867424|566421602|FG000|Overall Study|Patient noncompliance|2|||
156907881|NCT01867424|566421603|FG001|Overall Study|Patient noncompliance|1|||
156907882|NCT00864721|566421604|FG000|Overall Study|Patient request|11|||
156907883|NCT00864721|566421604|FG000|Overall Study|Hospitalized|1|||
156907884|NCT00864721|566421604|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
156907885|NCT00864721|566421604|FG000|Overall Study|Adverse Event|21|||
156907886|NCT01921387|566421605|FG000|Overall Study|Adverse Event|1|||
156907887|NCT03417219|566421606|FG000|Overall Study|Lost to Follow-up|0|||
156907888|NCT03417219|566421607|FG001|Overall Study|Lost to Follow-up|3|||
156907889|NCT02527161|566421609|FG000|Overall Study|Failed MRI|52|||
156907890|NCT02527161|566421609|FG000|Overall Study|Withdrawal by Subject|19|||
156907891|NCT02527161|566421609|FG000|Overall Study|Delay in or unfit for surgery|16|||
156907892|NCT02527161|566421609|FG000|Overall Study|MRI contraindication|6|||
156907893|NCT02527161|566421609|FG000|Overall Study|Consent violation|4|||
156907894|NCT02527161|566421609|FG000|Overall Study|Only Recruited to Part A|27|||
156907895|NCT02527161|566421609|FG000|Overall Study|Physician Decision|1|||
156907896|NCT02527161|566421609|FG000|Overall Study|Adverse Event|1|||
157027160|NCT02151981|566853396|FG001|Overall Study|Death|88|||
157027161|NCT02151981|566853395|FG000|Overall Study|Lost to Follow-up|7|||
156907897|NCT02527161|566421609|FG000|Overall Study|Lost to Follow-up|6|||
156907898|NCT00762229|566421612|FG000|Overall Study|Lost to Follow-up|1|||
156907899|NCT00762229|566421613|FG001|Overall Study|Lost to Follow-up|1|||
156907900|NCT00762229|566421612|FG000|Overall Study|did not recveive intervention|0|||
156907901|NCT00762229|566421613|FG001|Overall Study|did not recveive intervention|1|||
156907902|NCT02609828|566421614|FG000|Overall Study|Adverse Event|8|||
157027162|NCT02151981|566853396|FG001|Overall Study|Lost to Follow-up|1|||
156907903|NCT02609828|566421615|FG001|Overall Study|Adverse Event|1|||
156907904|NCT02609828|566421616|FG002|Overall Study|Adverse Event|0|||
156907905|NCT02609828|566421617|FG003|Overall Study|Adverse Event|6|||
156907906|NCT02609828|566421614|FG000|Overall Study|Death|15|||
156907907|NCT02609828|566421615|FG001|Overall Study|Death|1|||
156907908|NCT02609828|566421616|FG002|Overall Study|Death|1|||
156907909|NCT02609828|566421617|FG003|Overall Study|Death|19|||
156907910|NCT02609828|566421614|FG000|Overall Study|Insufficient clinical response|2|||
156907911|NCT02609828|566421615|FG001|Overall Study|Insufficient clinical response|1|||
156907912|NCT02609828|566421616|FG002|Overall Study|Insufficient clinical response|0|||
156907913|NCT02609828|566421617|FG003|Overall Study|Insufficient clinical response|0|||
156907914|NCT02609828|566421614|FG000|Overall Study|Lost to Follow-up|0|||
156907915|NCT02609828|566421615|FG001|Overall Study|Lost to Follow-up|0|||
156907916|NCT02609828|566421616|FG002|Overall Study|Lost to Follow-up|0|||
156907917|NCT02609828|566421617|FG003|Overall Study|Lost to Follow-up|1|||
156907918|NCT02609828|566421614|FG000|Overall Study|Protocol Violation|2|||
156907919|NCT02609828|566421615|FG001|Overall Study|Protocol Violation|0|||
156907920|NCT02609828|566421616|FG002|Overall Study|Protocol Violation|0|||
156907921|NCT02609828|566421617|FG003|Overall Study|Protocol Violation|1|||
156907922|NCT02609828|566421614|FG000|Overall Study|Withdrawal by Subject|12|||
156907923|NCT02609828|566421615|FG001|Overall Study|Withdrawal by Subject|1|||
156907924|NCT02609828|566421616|FG002|Overall Study|Withdrawal by Subject|0|||
156907925|NCT02609828|566421617|FG003|Overall Study|Withdrawal by Subject|10|||
156907926|NCT02609828|566421614|FG000|Overall Study|Other|3|||
156907927|NCT02609828|566421615|FG001|Overall Study|Other|0|||
156907928|NCT02609828|566421616|FG002|Overall Study|Other|0|||
156907929|NCT02609828|566421617|FG003|Overall Study|Other|6|||
156907930|NCT02609828|566421614|FG000|Overall Study|Randomized but not treated|1|||
156907931|NCT02609828|566421615|FG001|Overall Study|Randomized but not treated|0|||
156907932|NCT02609828|566421616|FG002|Overall Study|Randomized but not treated|0|||
156907933|NCT02609828|566421617|FG003|Overall Study|Randomized but not treated|0|||
156907934|NCT01081678|566421619|FG000|Overall Study|Ineligibility Determined|0|||
156907935|NCT01081678|566421620|FG001|Overall Study|Ineligibility Determined|0|||
156907936|NCT01081678|566421621|FG002|Overall Study|Ineligibility Determined|1|||
156907937|NCT01081678|566421622|FG003|Overall Study|Ineligibility Determined|1|||
156907938|NCT01081678|566421619|FG000|Overall Study|Noncompliance|3|||
156907939|NCT01081678|566421620|FG001|Overall Study|Noncompliance|4|||
156907940|NCT01081678|566421621|FG002|Overall Study|Noncompliance|5|||
156907941|NCT01081678|566421622|FG003|Overall Study|Noncompliance|2|||
156907942|NCT01081678|566421619|FG000|Overall Study|Adverse Event|2|||
156907943|NCT01081678|566421620|FG001|Overall Study|Adverse Event|1|||
156907944|NCT01081678|566421621|FG002|Overall Study|Adverse Event|2|||
156907945|NCT01081678|566421622|FG003|Overall Study|Adverse Event|2|||
156907946|NCT01081678|566421619|FG000|Overall Study|Withdrawal by Subject|15|||
156907947|NCT01081678|566421620|FG001|Overall Study|Withdrawal by Subject|7|||
156907948|NCT01081678|566421621|FG002|Overall Study|Withdrawal by Subject|17|||
156907949|NCT01081678|566421622|FG003|Overall Study|Withdrawal by Subject|14|||
156907950|NCT01081678|566421619|FG000|Overall Study|Administrative Decision|1|||
156907951|NCT01081678|566421620|FG001|Overall Study|Administrative Decision|0|||
156907952|NCT01081678|566421621|FG002|Overall Study|Administrative Decision|0|||
156907953|NCT01081678|566421622|FG003|Overall Study|Administrative Decision|1|||
156907954|NCT01081678|566421619|FG000|Overall Study|Lost to Follow-up|4|||
156907955|NCT01081678|566421620|FG001|Overall Study|Lost to Follow-up|1|||
156907956|NCT01081678|566421621|FG002|Overall Study|Lost to Follow-up|4|||
156907957|NCT01081678|566421622|FG003|Overall Study|Lost to Follow-up|3|||
156907958|NCT01081678|566421619|FG000|Overall Study|Death|2|||
156907959|NCT01081678|566421620|FG001|Overall Study|Death|2|||
156907960|NCT01081678|566421621|FG002|Overall Study|Death|2|||
156907961|NCT01081678|566421622|FG003|Overall Study|Death|6|||
156907962|NCT01081678|566421619|FG000|Overall Study|Other|0|||
156907963|NCT01081678|566421620|FG001|Overall Study|Other|1|||
156907964|NCT01081678|566421621|FG002|Overall Study|Other|0|||
156907965|NCT01081678|566421622|FG003|Overall Study|Other|0|||
156907966|NCT01281865|566421623|FG000|Overall Study|Adverse Event|1|||
156907967|NCT01281865|566421624|FG001|Overall Study|Adverse Event|1|||
156907968|NCT01281865|566421623|FG000|Overall Study|Withdrawal by Subject|1|||
156907969|NCT01281865|566421624|FG001|Overall Study|Withdrawal by Subject|0|||
156907970|NCT01281865|566421623|FG000|Overall Study|Lack of Efficacy|1|||
156907971|NCT01281865|566421624|FG001|Overall Study|Lack of Efficacy|0|||
156907972|NCT03478657|566421625|FG000|Overall Study|Withdrawal by Subject|0|||
156907973|NCT03478657|566421626|FG001|Overall Study|Withdrawal by Subject|1|||
156907974|NCT03733470|566421627|FG000|Overall Study|PI Decision|1|||
156907975|NCT03733470|566421628|FG001|Overall Study|PI Decision|1|||
156907976|NCT01786668|566421631|FG000|Overall Study|Adverse Event|0|||
156907977|NCT01786668|566421632|FG001|Overall Study|Adverse Event|1|||
156907978|NCT01786668|566421633|FG002|Overall Study|Adverse Event|1|||
156907979|NCT01786668|566421634|FG003|Overall Study|Adverse Event|2|||
156907980|NCT01786668|566421631|FG000|Overall Study|Withdrawal by Subject|0|||
156907981|NCT01786668|566421632|FG001|Overall Study|Withdrawal by Subject|0|||
156907982|NCT01786668|566421633|FG002|Overall Study|Withdrawal by Subject|3|||
156907983|NCT01786668|566421634|FG003|Overall Study|Withdrawal by Subject|1|||
156907984|NCT01786668|566421631|FG000|Overall Study|Pregnancy|0|||
156907985|NCT01786668|566421632|FG001|Overall Study|Pregnancy|0|||
156907986|NCT01786668|566421633|FG002|Overall Study|Pregnancy|0|||
156907987|NCT01786668|566421634|FG003|Overall Study|Pregnancy|1|||
156907988|NCT01786668|566421631|FG000|Overall Study|Lost to Follow-up|1|||
156907989|NCT01786668|566421632|FG001|Overall Study|Lost to Follow-up|0|||
156907990|NCT01786668|566421633|FG002|Overall Study|Lost to Follow-up|1|||
156907991|NCT01786668|566421634|FG003|Overall Study|Lost to Follow-up|0|||
156907992|NCT01776840|566421642|FG000|Overall Study|Lost to Follow-up|12|||
156907993|NCT01776840|566421643|FG001|Overall Study|Lost to Follow-up|7|||
156907994|NCT01776840|566421642|FG000|Overall Study|Withdrawal by Subject|32|||
156907995|NCT01776840|566421643|FG001|Overall Study|Withdrawal by Subject|48|||
156907996|NCT01776840|566421642|FG000|Overall Study|Sponsor decision|89|||
156907997|NCT01776840|566421643|FG001|Overall Study|Sponsor decision|87|||
156907998|NCT03641339|566421644|FG000|Overall Study|Physician Decision|1|||
156907999|NCT03641339|566421645|FG001|Overall Study|Physician Decision|0|||
156908000|NCT03641339|566421646|FG002|Overall Study|Physician Decision|0|||
156908001|NCT03641339|566421647|FG003|Overall Study|Physician Decision|0|||
156908002|NCT03641339|566421648|FG004|Overall Study|Physician Decision|0|||
156908003|NCT03641339|566421649|FG005|Overall Study|Physician Decision|0|||
156908004|NCT03641339|566421644|FG000|Overall Study|Withdrawal by Subject|0|||
156908005|NCT03641339|566421645|FG001|Overall Study|Withdrawal by Subject|2|||
156908006|NCT03641339|566421646|FG002|Overall Study|Withdrawal by Subject|0|||
156908007|NCT03641339|566421647|FG003|Overall Study|Withdrawal by Subject|2|||
156908008|NCT03641339|566421648|FG004|Overall Study|Withdrawal by Subject|0|||
156908009|NCT03641339|566421649|FG005|Overall Study|Withdrawal by Subject|1|||
156908010|NCT05338216|566421651|FG000|Overall Study|Withdrawal by Subject|1|||
156908011|NCT05338216|566421652|FG001|Overall Study|Withdrawal by Subject|1|||
156908012|NCT04457336|566421653|FG000|Period 2: Part A|Withdrawal by Subject|0|||
156908013|NCT04457336|566421654|FG001|Period 2: Part A|Withdrawal by Subject|1|||
156908014|NCT04457336|566421655|FG002|Period 2: Part A|Withdrawal by Subject|1|||
156908015|NCT04457336|566421656|FG003|Period 2: Part A|Withdrawal by Subject|1|||
156908016|NCT04457336|566421657|FG004|Period 2: Part A|Withdrawal by Subject|0|||
156908017|NCT04457336|566421658|FG005|Period 2: Part A|Withdrawal by Subject|0|||
156908018|NCT04457336|566421659|FG006|Period 2: Part A|Withdrawal by Subject|0|||
156908019|NCT04457336|566421660|FG007|Period 2: Part A|Withdrawal by Subject|0|||
156908020|NCT04457336|566421653|FG000|Period 2: Part A|Adverse Event|0|||
156908021|NCT04457336|566421654|FG001|Period 2: Part A|Adverse Event|0|||
156908022|NCT04457336|566421655|FG002|Period 2: Part A|Adverse Event|1|||
156908023|NCT04457336|566421656|FG003|Period 2: Part A|Adverse Event|1|||
156908024|NCT04457336|566421657|FG004|Period 2: Part A|Adverse Event|0|||
156908025|NCT04457336|566421658|FG005|Period 2: Part A|Adverse Event|0|||
156908026|NCT04457336|566421659|FG006|Period 2: Part A|Adverse Event|0|||
156908027|NCT04457336|566421660|FG007|Period 2: Part A|Adverse Event|0|||
156908028|NCT04457336|566421653|FG000|Period 2: Part A|Study Terminated|0|||
156908029|NCT04457336|566421654|FG001|Period 2: Part A|Study Terminated|0|||
156908030|NCT04457336|566421655|FG002|Period 2: Part A|Study Terminated|1|||
156908031|NCT04457336|566421656|FG003|Period 2: Part A|Study Terminated|0|||
156908032|NCT04457336|566421657|FG004|Period 2: Part A|Study Terminated|0|||
156908033|NCT04457336|566421658|FG005|Period 2: Part A|Study Terminated|0|||
156908034|NCT04457336|566421659|FG006|Period 2: Part A|Study Terminated|0|||
156908035|NCT04457336|566421660|FG007|Period 2: Part A|Study Terminated|0|||
156908036|NCT04457336|566421653|FG000|Period 2: Part A|Protocol Violation|0|||
156908037|NCT04457336|566421654|FG001|Period 2: Part A|Protocol Violation|1|||
156908038|NCT04457336|566421655|FG002|Period 2: Part A|Protocol Violation|0|||
156908039|NCT04457336|566421656|FG003|Period 2: Part A|Protocol Violation|0|||
156908040|NCT04457336|566421657|FG004|Period 2: Part A|Protocol Violation|0|||
156908041|NCT04457336|566421658|FG005|Period 2: Part A|Protocol Violation|0|||
156908042|NCT04457336|566421659|FG006|Period 2: Part A|Protocol Violation|0|||
156908043|NCT04457336|566421660|FG007|Period 2: Part A|Protocol Violation|0|||
156908044|NCT04457336|566421653|FG000|Period 2: Part A|Lost to Follow-up|0|||
156908045|NCT04457336|566421654|FG001|Period 2: Part A|Lost to Follow-up|1|||
156908046|NCT04457336|566421655|FG002|Period 2: Part A|Lost to Follow-up|0|||
156908047|NCT04457336|566421656|FG003|Period 2: Part A|Lost to Follow-up|0|||
156908048|NCT04457336|566421657|FG004|Period 2: Part A|Lost to Follow-up|0|||
156908049|NCT04457336|566421658|FG005|Period 2: Part A|Lost to Follow-up|0|||
156908050|NCT04457336|566421659|FG006|Period 2: Part A|Lost to Follow-up|0|||
156908051|NCT04457336|566421660|FG007|Period 2: Part A|Lost to Follow-up|0|||
156908052|NCT04457336|566421653|FG000|Period 2: Part A|Other|0|||
156908053|NCT04457336|566421654|FG001|Period 2: Part A|Other|1|||
156908054|NCT04457336|566421655|FG002|Period 2: Part A|Other|0|||
156908055|NCT04457336|566421656|FG003|Period 2: Part A|Other|0|||
156908056|NCT04457336|566421657|FG004|Period 2: Part A|Other|0|||
156908057|NCT04457336|566421658|FG005|Period 2: Part A|Other|0|||
156908058|NCT04457336|566421659|FG006|Period 2: Part A|Other|0|||
156908059|NCT04457336|566421660|FG007|Period 2: Part A|Other|0|||
156908060|NCT04457336|566421653|FG000|Period 2: Part A|Physician Decision|0|||
156908061|NCT04457336|566421654|FG001|Period 2: Part A|Physician Decision|0|||
156908062|NCT04457336|566421655|FG002|Period 2: Part A|Physician Decision|0|||
156908063|NCT04457336|566421656|FG003|Period 2: Part A|Physician Decision|1|||
156908064|NCT04457336|566421657|FG004|Period 2: Part A|Physician Decision|0|||
156908065|NCT04457336|566421658|FG005|Period 2: Part A|Physician Decision|0|||
156908066|NCT04457336|566421659|FG006|Period 2: Part A|Physician Decision|0|||
156908067|NCT04457336|566421660|FG007|Period 2: Part A|Physician Decision|0|||
157159694|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
157159695|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
156908068|NCT04457336|566421653|FG000|Period 3: Part B|Study Terminated|0|||
156908069|NCT04457336|566421654|FG001|Period 3: Part B|Study Terminated|0|||
156908070|NCT04457336|566421655|FG002|Period 3: Part B|Study Terminated|0|||
156908071|NCT04457336|566421656|FG003|Period 3: Part B|Study Terminated|0|||
156908072|NCT04457336|566421657|FG004|Period 3: Part B|Study Terminated|1|||
156908073|NCT04457336|566421658|FG005|Period 3: Part B|Study Terminated|10|||
156908074|NCT04457336|566421659|FG006|Period 3: Part B|Study Terminated|13|||
156908075|NCT04457336|566421660|FG007|Period 3: Part B|Study Terminated|0|||
156908076|NCT04457336|566421653|FG000|Period 3: Part B|Withdrawal by Subject|0|||
156908077|NCT04457336|566421654|FG001|Period 3: Part B|Withdrawal by Subject|0|||
156908078|NCT04457336|566421655|FG002|Period 3: Part B|Withdrawal by Subject|0|||
156908079|NCT04457336|566421656|FG003|Period 3: Part B|Withdrawal by Subject|0|||
156908080|NCT04457336|566421657|FG004|Period 3: Part B|Withdrawal by Subject|0|||
156908081|NCT04457336|566421658|FG005|Period 3: Part B|Withdrawal by Subject|1|||
156908082|NCT04457336|566421659|FG006|Period 3: Part B|Withdrawal by Subject|2|||
156908083|NCT04457336|566421660|FG007|Period 3: Part B|Withdrawal by Subject|0|||
156908084|NCT04457336|566421653|FG000|Period 4: Part C|Study Terminated|0|||
156908085|NCT04457336|566421654|FG001|Period 4: Part C|Study Terminated|0|||
156908086|NCT04457336|566421655|FG002|Period 4: Part C|Study Terminated|0|||
156908087|NCT04457336|566421656|FG003|Period 4: Part C|Study Terminated|0|||
156908088|NCT04457336|566421657|FG004|Period 4: Part C|Study Terminated|0|||
156908089|NCT04457336|566421658|FG005|Period 4: Part C|Study Terminated|0|||
156908090|NCT04457336|566421659|FG006|Period 4: Part C|Study Terminated|0|||
156908091|NCT04457336|566421660|FG007|Period 4: Part C|Study Terminated|30|||
156908092|NCT04457336|566421653|FG000|Period 4: Part C|Adverse Event|0|||
156908093|NCT04457336|566421654|FG001|Period 4: Part C|Adverse Event|0|||
156908094|NCT04457336|566421655|FG002|Period 4: Part C|Adverse Event|0|||
156908095|NCT04457336|566421656|FG003|Period 4: Part C|Adverse Event|0|||
156908096|NCT04457336|566421657|FG004|Period 4: Part C|Adverse Event|0|||
156908097|NCT04457336|566421658|FG005|Period 4: Part C|Adverse Event|0|||
156908098|NCT04457336|566421659|FG006|Period 4: Part C|Adverse Event|0|||
156908099|NCT04457336|566421660|FG007|Period 4: Part C|Adverse Event|2|||
156908100|NCT04457336|566421653|FG000|Period 4: Part C|Site Terminated|0|||
156908101|NCT04457336|566421654|FG001|Period 4: Part C|Site Terminated|0|||
156908102|NCT04457336|566421655|FG002|Period 4: Part C|Site Terminated|0|||
156908103|NCT04457336|566421656|FG003|Period 4: Part C|Site Terminated|0|||
156908104|NCT04457336|566421657|FG004|Period 4: Part C|Site Terminated|0|||
156908105|NCT04457336|566421658|FG005|Period 4: Part C|Site Terminated|0|||
156908106|NCT04457336|566421659|FG006|Period 4: Part C|Site Terminated|0|||
156908107|NCT04457336|566421660|FG007|Period 4: Part C|Site Terminated|1|||
156908108|NCT04457336|566421653|FG000|Period 4: Part C|Other|0|||
156908109|NCT04457336|566421654|FG001|Period 4: Part C|Other|0|||
156908110|NCT04457336|566421655|FG002|Period 4: Part C|Other|0|||
157027163|NCT02151981|566853395|FG000|Overall Study|Withdrawal by Subject|27|||
157027164|NCT02151981|566853396|FG001|Overall Study|Withdrawal by Subject|21|||
157027165|NCT02151981|566853395|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157027166|NCT02151981|566853396|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
157159696|NCT02052778|567329531|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159697|NCT02052778|567329532|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159698|NCT02052778|567329533|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159699|NCT02052778|567329534|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159700|NCT02052778|567329535|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159701|NCT02052778|567329536|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
157159702|NCT02052778|567329537|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159703|NCT02052778|567329538|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159704|NCT02052778|567329539|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157027167|NCT02151981|566853395|FG000|Overall Study|Other reasons|1|||
157027168|NCT02151981|566853396|FG001|Overall Study|Other reasons|2|||
157027169|NCT05446168|566853397|FG000|Overall Study|Physician Decision|0|||
157027170|NCT05446168|566853398|FG001|Overall Study|Physician Decision|1|||
157159705|NCT02052778|567329540|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159706|NCT02052778|567329541|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156908111|NCT04457336|566421656|FG003|Period 4: Part C|Other|0|||
156908112|NCT04457336|566421657|FG004|Period 4: Part C|Other|0|||
156908113|NCT04457336|566421658|FG005|Period 4: Part C|Other|0|||
156908114|NCT04457336|566421659|FG006|Period 4: Part C|Other|0|||
156908115|NCT04457336|566421660|FG007|Period 4: Part C|Other|2|||
156908116|NCT04457336|566421653|FG000|Period 4: Part C|Withdrawal by Subject|0|||
156908117|NCT04457336|566421654|FG001|Period 4: Part C|Withdrawal by Subject|0|||
157027171|NCT01129102|566856043|FG000|Overall Study|No study drug treatment|2|||
156908118|NCT04457336|566421655|FG002|Period 4: Part C|Withdrawal by Subject|0|||
156908119|NCT04457336|566421656|FG003|Period 4: Part C|Withdrawal by Subject|0|||
156908120|NCT04457336|566421657|FG004|Period 4: Part C|Withdrawal by Subject|0|||
156908121|NCT04457336|566421658|FG005|Period 4: Part C|Withdrawal by Subject|0|||
156908122|NCT04457336|566421659|FG006|Period 4: Part C|Withdrawal by Subject|0|||
156908123|NCT04457336|566421660|FG007|Period 4: Part C|Withdrawal by Subject|3|||
156908124|NCT05379231|566421661|FG000|Home Visit|Withdrawal by Subject|2|||
156908125|NCT05379231|566421661|FG000|In-lab Visit|Withdrawal by Subject|2|||
156908126|NCT01350492|566421671|FG000|Intervention|Lost to Follow-up|2|||
156908127|NCT01350492|566421672|FG001|Intervention|Lost to Follow-up|5|||
156908128|NCT01350492|566421671|FG000|Intervention|Withdrawal by Subject|3|||
156908129|NCT01350492|566421672|FG001|Intervention|Withdrawal by Subject|1|||
156908130|NCT01350492|566421671|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
156908131|NCT01350492|566421672|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
156908132|NCT01350492|566421671|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
156908133|NCT01350492|566421672|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
156908134|NCT00702689|566421673|FG000|Overall Study|Withdrawal by Subject|4|||
156908135|NCT00702689|566421673|FG000|Overall Study|Recurrent malignancy|1|||
156908136|NCT00702689|566421673|FG000|Overall Study|Adverse Event|1|||
156908137|NCT02805972|566421678|FG000|Washout Period|Lost to Follow-up|3|||
156908138|NCT02805972|566421679|FG001|Washout Period|Lost to Follow-up|0|||
156908139|NCT02121522|566421680|FG000|Overall Study|Adverse Event|1|||
156908140|NCT05147428|566421681|FG000|Overall Study|Removed prior to mailing|289|||
156908141|NCT05147428|566421682|FG001|Overall Study|Removed prior to mailing|306|||
156908142|NCT05147428|566421683|FG002|Overall Study|Removed prior to mailing|270|||
156908143|NCT05147428|566421681|FG000|Overall Study|Died or disenrolled during blackout period|239|||
156908144|NCT05147428|566421682|FG001|Overall Study|Died or disenrolled during blackout period|278|||
156908145|NCT05147428|566421683|FG002|Overall Study|Died or disenrolled during blackout period|273|||
156908146|NCT03128047|566421684|FG000|Overall Study|Withdrawal by Subject|1|||
156908147|NCT03749447|566422945|FG000|Overall Study|Adverse Event|11|||
156908148|NCT03749447|566422946|FG001|Overall Study|Adverse Event|3|||
156908149|NCT03749447|566422945|FG000|Overall Study|Death|1|||
156908150|NCT03749447|566422946|FG001|Overall Study|Death|1|||
156908151|NCT03749447|566422945|FG000|Overall Study|Lost to Follow-up|2|||
156908152|NCT03749447|566422946|FG001|Overall Study|Lost to Follow-up|2|||
156908153|NCT03749447|566422945|FG000|Overall Study|Reason Not Specified|0|||
156908154|NCT03749447|566422946|FG001|Overall Study|Reason Not Specified|3|||
156908155|NCT03749447|566422945|FG000|Overall Study|Physician Decision|4|||
156908156|NCT03749447|566422946|FG001|Overall Study|Physician Decision|3|||
156908157|NCT03749447|566422945|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
156908158|NCT03749447|566422946|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
156908159|NCT03749447|566422945|FG000|Overall Study|Study Terminated By Sponsor|112|||
156908160|NCT03749447|566422946|FG001|Overall Study|Study Terminated By Sponsor|105|||
156908161|NCT03749447|566422945|FG000|Overall Study|Withdrawal by Subject|12|||
156908162|NCT03749447|566422946|FG001|Overall Study|Withdrawal by Subject|6|||
156908163|NCT03749447|566422945|FG000|Overall Study|Non-compliance With Study Drug|0|||
156908164|NCT03749447|566422946|FG001|Overall Study|Non-compliance With Study Drug|1|||
156908165|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
156908166|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
156908167|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
156908168|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
156908169|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
156908170|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
156908171|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
156908172|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
156908173|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
156908174|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
156908175|NCT00787891|566422949|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
156908176|NCT00787891|566422950|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
157027172|NCT01129102|566856044|FG001|Overall Study|No study drug treatment|3|||
157027173|NCT01129102|566856045|FG002|Overall Study|No study drug treatment|1|||
157027174|NCT01129102|566856043|FG000|Overall Study|Withdrawal by Subject|2|||
157027175|NCT01129102|566856044|FG001|Overall Study|Withdrawal by Subject|0|||
157027176|NCT01129102|566856045|FG002|Overall Study|Withdrawal by Subject|3|||
157027177|NCT01129102|566856043|FG000|Overall Study|Protocol Violation|0|||
157027178|NCT01129102|566856044|FG001|Overall Study|Protocol Violation|1|||
157027179|NCT01129102|566856045|FG002|Overall Study|Protocol Violation|1|||
156908177|NCT00787891|566422949|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
156908178|NCT00787891|566422950|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
156908179|NCT00787891|566422949|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
157027180|NCT01129102|566856043|FG000|Overall Study|Pregnancy|0|||
157027181|NCT01129102|566856044|FG001|Overall Study|Pregnancy|0|||
157027182|NCT01129102|566856045|FG002|Overall Study|Pregnancy|1|||
157027183|NCT01129102|566856043|FG000|Overall Study|Adverse Event|2|||
157159707|NCT02052778|567329542|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159708|NCT02052778|567329543|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
156908180|NCT00787891|566422950|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
156908181|NCT00787891|566422949|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
156908182|NCT00787891|566422950|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
156908183|NCT00787891|566422949|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
156908184|NCT00787891|566422950|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
156908185|NCT00799383|566422951|FG000|Overall Study|Protocol Violation|1|||
156908186|NCT00799383|566422952|FG001|Overall Study|Protocol Violation|1|||
156908187|NCT00799383|566422951|FG000|Overall Study|Adverse Event|0|||
156908188|NCT00799383|566422952|FG001|Overall Study|Adverse Event|1|||
156908189|NCT00799383|566422951|FG000|Overall Study|Lost to Follow-up|1|||
156908190|NCT00799383|566422952|FG001|Overall Study|Lost to Follow-up|2|||
156908191|NCT00799383|566422951|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
156908192|NCT00799383|566422952|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
156908193|NCT00799383|566422951|FG000|Overall Study|Withdrawal by Subject|0|||
156908194|NCT00799383|566422952|FG001|Overall Study|Withdrawal by Subject|1|||
156908195|NCT01619423|566422960|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
156908196|NCT01619423|566422961|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
156908197|NCT01619423|566422962|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
156908198|NCT01619423|566422963|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
156908199|NCT02590003|566422971|FG000|Overall Study|Death|1|||
156908200|NCT02590003|566422972|FG001|Overall Study|Death|2|||
156908201|NCT02589405|566422976|FG000|Overall Study|Adverse Event|3|||
156908202|NCT02589405|566422976|FG000|Overall Study|Withdrawal by Subject|1|||
156908203|NCT03330288|566422979|FG000|Overall Study|Other reason|1|||
156908204|NCT03330288|566422980|FG001|Overall Study|Other reason|1|||
156908205|NCT03330288|566422979|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
156908206|NCT03330288|566422980|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
156908207|NCT03330288|566422979|FG000|Overall Study|Adverse Event|1|||
156908208|NCT03330288|566422980|FG001|Overall Study|Adverse Event|0|||
156908209|NCT03330288|566422979|FG000|Overall Study|Withdrawal by Subject|1|||
156908210|NCT03330288|566422980|FG001|Overall Study|Withdrawal by Subject|0|||
156908211|NCT03330288|566422979|FG000|Overall Study|Lost to Follow-up|26|||
156908212|NCT03330288|566422980|FG001|Overall Study|Lost to Follow-up|7|||
156908213|NCT02264639|566422982|FG000|Overall Study|Death (after completing single-dose phase)|1|||
156908214|NCT02264639|566422983|FG001|Overall Study|Death (after completing single-dose phase)|0|||
156908215|NCT02264639|566422984|FG002|Overall Study|Death (after completing single-dose phase)|0|||
156908216|NCT02264639|566422985|FG003|Overall Study|Death (after completing single-dose phase)|0|||
156908217|NCT02264639|566422986|FG004|Overall Study|Death (after completing single-dose phase)|0|||
156908218|NCT02264639|566422982|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
156908219|NCT02264639|566422983|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156908220|NCT02264639|566422984|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156908221|NCT02264639|566422985|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156908222|NCT02264639|566422986|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
156908223|NCT02264639|566422982|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156908224|NCT02264639|566422983|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156908225|NCT02264639|566422984|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
156908226|NCT02264639|566422985|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156908227|NCT02264639|566422986|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
156908228|NCT02264639|566422982|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156908229|NCT02264639|566422983|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156908230|NCT02264639|566422984|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156908231|NCT02264639|566422985|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
156908232|NCT02264639|566422986|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
156908233|NCT01416272|566422990|FG000|Overall Study|Unacceptable distance visual acuity|2|||
156908234|NCT01416272|566422990|FG000|Overall Study|Lost to Follow-up|1|||
156908235|NCT01416272|566422990|FG000|Overall Study|Study related complaints|1|||
156908236|NCT00939640|566422996|FG000|Overall Study|Physician Decision|1|||
156908237|NCT00239590|566422997|FG000|Randomized|Lost to Follow-up|0|||
156908238|NCT00239590|566422998|FG001|Randomized|Lost to Follow-up|1|||
156908239|NCT00239590|566422997|FG000|Randomized|Withdrawal by Subject|0|||
156908240|NCT00239590|566422998|FG001|Randomized|Withdrawal by Subject|1|||
156908241|NCT00239590|566422997|FG000|Completed Study Protocol|Adverse Event|1|||
156908242|NCT00239590|566422998|FG001|Completed Study Protocol|Adverse Event|1|||
157027184|NCT01129102|566856044|FG001|Overall Study|Adverse Event|2|||
156908243|NCT00239590|566422997|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
156908244|NCT00239590|566422998|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
156908245|NCT00892047|566423004|FG000|Overall Study|Adverse Event|2|||
156908246|NCT00892047|566423005|FG001|Overall Study|Adverse Event|2|||
156908247|NCT00892047|566423004|FG000|Overall Study|subject burden|2|||
156908248|NCT00892047|566423005|FG001|Overall Study|subject burden|3|||
156908249|NCT00892047|566423004|FG000|Overall Study|Lack of Efficacy|0|||
156908250|NCT00892047|566423005|FG001|Overall Study|Lack of Efficacy|2|||
156908251|NCT01235689|566423006|FG000|Overall Study|Adverse Event|12|||
156908252|NCT01235689|566423007|FG001|Overall Study|Adverse Event|16|||
156908253|NCT01235689|566423006|FG000|Overall Study|Lack of Efficacy|12|||
156908254|NCT01235689|566423007|FG001|Overall Study|Lack of Efficacy|5|||
156908255|NCT01235689|566423006|FG000|Overall Study|Withdrawal by Subject|3|||
156908256|NCT01235689|566423007|FG001|Overall Study|Withdrawal by Subject|4|||
156908257|NCT01235689|566423006|FG000|Overall Study|Lost to Follow-up|1|||
156908258|NCT01235689|566423007|FG001|Overall Study|Lost to Follow-up|2|||
156908259|NCT01235689|566423006|FG000|Overall Study|Miscellaneous|1|||
156908260|NCT01235689|566423007|FG001|Overall Study|Miscellaneous|5|||
156908261|NCT01443078|566423008|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
156908262|NCT01443078|566423008|FG000|Overall Study|Withdrawal by Subject|1|||
156908263|NCT01443078|566423008|FG000|Overall Study|Patient had brain mets|1|||
156908264|NCT02217878|566423009|FG000|Overall Study|required morphine due to chest pain|1|||
156908265|NCT02217878|566423010|FG001|Overall Study|required morphine due to chest pain|2|||
156908266|NCT02217878|566423009|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
156908267|NCT02217878|566423010|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
156908268|NCT01390649|566423011|FG000|Overall Study|Physician Decision|1|||
156908269|NCT00389597|566423016|FG000|Overall Study|Lost to Follow-up|8|||
156908270|NCT00389597|566423017|FG001|Overall Study|Lost to Follow-up|6|||
156908271|NCT00389597|566423018|FG002|Overall Study|Lost to Follow-up|4|||
156908272|NCT00389597|566423019|FG003|Overall Study|Lost to Follow-up|6|||
156908273|NCT02106975|566423024|FG000|Overall Study|Death|25|||
156908274|NCT02106975|566423025|FG001|Overall Study|Death|39|||
156908275|NCT00005044|566423026|FG000|Overall Study|Protocol Violation|37|||
156908276|NCT00005044|566423027|FG001|Overall Study|Protocol Violation|46|||
156908277|NCT00005044|566423026|FG000|Overall Study|Withdrawal by Subject|1|||
156908278|NCT00005044|566423027|FG001|Overall Study|Withdrawal by Subject|5|||
156908279|NCT00005044|566423026|FG000|Overall Study|No protocol treatment|0|||
156908280|NCT00005044|566423027|FG001|Overall Study|No protocol treatment|1|||
156908281|NCT00806351|566423030|FG000|Overall Study|Death|5|||
156908282|NCT00806351|566423031|FG001|Overall Study|Death|4|||
156908283|NCT00306189|566423032|FG000|Overall Study|Physician Decision|0|||
156908284|NCT00306189|566423033|FG001|Overall Study|Physician Decision|0|||
156908285|NCT00306189|566423034|FG002|Overall Study|Physician Decision|0|||
156908286|NCT00306189|566423035|FG003|Overall Study|Physician Decision|1|||
156908287|NCT00306189|566423032|FG000|Overall Study|Adverse Event|3|||
156908288|NCT00306189|566423033|FG001|Overall Study|Adverse Event|3|||
156908289|NCT00306189|566423034|FG002|Overall Study|Adverse Event|2|||
156908290|NCT00306189|566423035|FG003|Overall Study|Adverse Event|2|||
156908291|NCT00306189|566423032|FG000|Overall Study|Withdrawal by Subject|4|||
156908292|NCT00306189|566423033|FG001|Overall Study|Withdrawal by Subject|2|||
156908293|NCT00306189|566423034|FG002|Overall Study|Withdrawal by Subject|8|||
156908294|NCT00306189|566423035|FG003|Overall Study|Withdrawal by Subject|1|||
157027185|NCT01129102|566856045|FG002|Overall Study|Adverse Event|1|||
157027186|NCT01129102|566856043|FG000|Overall Study|Lost to Follow-up|2|||
157027187|NCT01129102|566856044|FG001|Overall Study|Lost to Follow-up|0|||
157027188|NCT01129102|566856045|FG002|Overall Study|Lost to Follow-up|0|||
157027189|NCT03379675|566856048|FG000|Overall Study|Lost to Follow-up|0|||
157027190|NCT03379675|566856049|FG001|Overall Study|Lost to Follow-up|1|||
157027191|NCT03379675|566856050|FG002|Overall Study|Lost to Follow-up|0|||
157027192|NCT03379675|566856048|FG000|Overall Study|Adverse Event|2|||
157027193|NCT03379675|566856049|FG001|Overall Study|Adverse Event|0|||
157027194|NCT03379675|566856050|FG002|Overall Study|Adverse Event|0|||
157027195|NCT03379675|566856048|FG000|Overall Study|Withdrawal by Subject|2|||
157027196|NCT03379675|566856049|FG001|Overall Study|Withdrawal by Subject|1|||
157027197|NCT03379675|566856050|FG002|Overall Study|Withdrawal by Subject|2|||
157027198|NCT02817776|566856051|FG000|Overall Study|Excluded|33|||
157027199|NCT02817776|566856051|FG000|Overall Study|Lost to Follow-up|20|||
157027200|NCT02817776|566856051|FG000|Overall Study|Withdrawal by Subject|33|||
157027201|NCT02817776|566856051|FG000|Overall Study|Death|2|||
156908295|NCT00306189|566423032|FG000|Overall Study|Ineligibility determined|1|||
156908296|NCT00306189|566423033|FG001|Overall Study|Ineligibility determined|1|||
156908297|NCT00306189|566423034|FG002|Overall Study|Ineligibility determined|1|||
156908298|NCT00306189|566423035|FG003|Overall Study|Ineligibility determined|1|||
156908299|NCT00306189|566423032|FG000|Overall Study|Other|1|||
156908300|NCT00306189|566423033|FG001|Overall Study|Other|0|||
156908301|NCT00306189|566423034|FG002|Overall Study|Other|0|||
156908302|NCT00306189|566423035|FG003|Overall Study|Other|0|||
156908303|NCT00259610|566423036|FG000|Overall Study|Withdrawal by Subject|33|||
156908304|NCT00259610|566423037|FG001|Overall Study|Withdrawal by Subject|25|||
157027202|NCT03381196|566856056|FG000|Overall Study|Withdrawal by Subject|7|||
157027203|NCT03381196|566856057|FG001|Overall Study|Withdrawal by Subject|7|||
157027204|NCT03381196|566856056|FG000|Overall Study|Other|0|||
157027205|NCT03381196|566856057|FG001|Overall Study|Other|1|||
157159709|NCT02052778|567329544|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
156908305|NCT00259610|566423038|FG002|Overall Study|Withdrawal by Subject|29|||
156908306|NCT00259610|566423039|FG003|Overall Study|Withdrawal by Subject|19|||
156908307|NCT00259610|566423036|FG000|Overall Study|Lost to Follow-up|19|||
156908308|NCT00259610|566423037|FG001|Overall Study|Lost to Follow-up|8|||
156908309|NCT00259610|566423038|FG002|Overall Study|Lost to Follow-up|18|||
156908310|NCT00259610|566423039|FG003|Overall Study|Lost to Follow-up|15|||
156908311|NCT00259610|566423036|FG000|Overall Study|Physician Decision|6|||
156908312|NCT00259610|566423037|FG001|Overall Study|Physician Decision|4|||
156908313|NCT00259610|566423038|FG002|Overall Study|Physician Decision|7|||
156908314|NCT00259610|566423039|FG003|Overall Study|Physician Decision|2|||
156908315|NCT00259610|566423036|FG000|Overall Study|Death|1|||
156908316|NCT00259610|566423037|FG001|Overall Study|Death|1|||
156908317|NCT00259610|566423038|FG002|Overall Study|Death|2|||
156908318|NCT00259610|566423039|FG003|Overall Study|Death|0|||
156908319|NCT00259610|566423036|FG000|Overall Study|non medical reason|6|||
156908320|NCT00259610|566423037|FG001|Overall Study|non medical reason|2|||
156908321|NCT00259610|566423038|FG002|Overall Study|non medical reason|10|||
156908322|NCT00259610|566423039|FG003|Overall Study|non medical reason|3|||
156908323|NCT00259610|566423036|FG000|Overall Study|Adverse Event|3|||
156908324|NCT00259610|566423037|FG001|Overall Study|Adverse Event|4|||
156908325|NCT00259610|566423038|FG002|Overall Study|Adverse Event|5|||
156908326|NCT00259610|566423039|FG003|Overall Study|Adverse Event|2|||
156908327|NCT00259610|566423036|FG000|Overall Study|Serious Adverse Event|8|||
156908328|NCT00259610|566423037|FG001|Overall Study|Serious Adverse Event|2|||
156908329|NCT00259610|566423038|FG002|Overall Study|Serious Adverse Event|2|||
156908330|NCT00259610|566423039|FG003|Overall Study|Serious Adverse Event|2|||
156908331|NCT01201785|566423043|FG000|Overall Study|Lost to Follow-up|16|||
157159710|NCT02052778|567329545|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159711|NCT02052778|567329546|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159712|NCT02052778|567329547|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159713|NCT02052778|567329548|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159714|NCT02052778|567329549|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159715|NCT02052778|567329550|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159716|NCT02052778|567329551|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159717|NCT02052778|567329552|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159718|NCT02052778|567329553|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
157159719|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159720|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159721|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159722|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159723|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159724|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159725|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159726|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159727|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159728|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159729|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159730|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159731|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159732|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159733|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
157159734|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
157159735|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
156908332|NCT02151110|566423044|FG000|Overall Study|Withdrawal by Subject|0|||
156908333|NCT02151110|566423045|FG001|Overall Study|Withdrawal by Subject|0|||
156908334|NCT02151110|566423046|FG002|Overall Study|Withdrawal by Subject|0|||
156908335|NCT02151110|566423047|FG003|Overall Study|Withdrawal by Subject|0|||
156908336|NCT02151110|566423048|FG004|Overall Study|Withdrawal by Subject|0|||
156908337|NCT02151110|566423049|FG005|Overall Study|Withdrawal by Subject|0|||
156908338|NCT02151110|566423050|FG006|Overall Study|Withdrawal by Subject|0|||
156908339|NCT02151110|566423051|FG007|Overall Study|Withdrawal by Subject|1|||
156908340|NCT02151110|566423044|FG000|Overall Study|Lost to Follow-up|0|||
156908341|NCT02151110|566423045|FG001|Overall Study|Lost to Follow-up|0|||
156908342|NCT02151110|566423046|FG002|Overall Study|Lost to Follow-up|0|||
156908343|NCT02151110|566423047|FG003|Overall Study|Lost to Follow-up|0|||
156908344|NCT02151110|566423048|FG004|Overall Study|Lost to Follow-up|0|||
156908345|NCT02151110|566423049|FG005|Overall Study|Lost to Follow-up|0|||
156908346|NCT02151110|566423050|FG006|Overall Study|Lost to Follow-up|0|||
156908347|NCT02151110|566423051|FG007|Overall Study|Lost to Follow-up|2|||
156908348|NCT05248867|566423052|FG000|Double-blind Period|Lost to Follow-up|0|||
156908349|NCT05248867|566423053|FG001|Double-blind Period|Lost to Follow-up|3|||
156908350|NCT05248867|566423054|FG002|Double-blind Period|Lost to Follow-up|0|||
156908351|NCT05248867|566423055|FG003|Double-blind Period|Lost to Follow-up|0|||
156908352|NCT05248867|566423056|FG004|Double-blind Period|Lost to Follow-up|0|||
156908353|NCT05248867|566423057|FG005|Double-blind Period|Lost to Follow-up|0|||
156908354|NCT05248867|566423052|FG000|Double-blind Period|Withdrawal by Subject|5|||
156908355|NCT05248867|566423053|FG001|Double-blind Period|Withdrawal by Subject|14|||
156908356|NCT05248867|566423054|FG002|Double-blind Period|Withdrawal by Subject|0|||
156908357|NCT05248867|566423055|FG003|Double-blind Period|Withdrawal by Subject|0|||
157159736|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
157159737|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
157159738|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
157159739|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
157159740|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
157159741|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
157159742|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159743|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159744|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159745|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159746|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159747|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159748|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159749|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159750|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156908358|NCT05248867|566423056|FG004|Double-blind Period|Withdrawal by Subject|0|||
156908359|NCT05248867|566423057|FG005|Double-blind Period|Withdrawal by Subject|0|||
156908360|NCT05248867|566423052|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156908361|NCT05248867|566423053|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
156908362|NCT05248867|566423054|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156908363|NCT05248867|566423055|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156908364|NCT05248867|566423056|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156908365|NCT05248867|566423057|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
156908366|NCT05248867|566423052|FG000|Double-blind Period|Other, not specified|3|||
156908367|NCT05248867|566423053|FG001|Double-blind Period|Other, not specified|8|||
156908368|NCT05248867|566423054|FG002|Double-blind Period|Other, not specified|0|||
156908369|NCT05248867|566423055|FG003|Double-blind Period|Other, not specified|0|||
156908370|NCT05248867|566423056|FG004|Double-blind Period|Other, not specified|0|||
156908371|NCT05248867|566423057|FG005|Double-blind Period|Other, not specified|0|||
156908372|NCT05248867|566423052|FG000|Open-label Period|Withdrawal by Subject|0|||
156908373|NCT05248867|566423053|FG001|Open-label Period|Withdrawal by Subject|0|||
156908374|NCT05248867|566423054|FG002|Open-label Period|Withdrawal by Subject|3|||
156908375|NCT05248867|566423055|FG003|Open-label Period|Withdrawal by Subject|1|||
156908376|NCT05248867|566423056|FG004|Open-label Period|Withdrawal by Subject|7|||
156908377|NCT05248867|566423057|FG005|Open-label Period|Withdrawal by Subject|9|||
156908378|NCT05248867|566423052|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156908379|NCT05248867|566423053|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156908380|NCT05248867|566423054|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156908381|NCT05248867|566423055|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
156908382|NCT05248867|566423056|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156908383|NCT05248867|566423057|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
156908384|NCT05248867|566423052|FG000|Open-label Period|Lost to Follow-up|0|||
156908385|NCT05248867|566423053|FG001|Open-label Period|Lost to Follow-up|0|||
156908386|NCT05248867|566423054|FG002|Open-label Period|Lost to Follow-up|0|||
156908387|NCT05248867|566423055|FG003|Open-label Period|Lost to Follow-up|0|||
156908388|NCT05248867|566423056|FG004|Open-label Period|Lost to Follow-up|5|||
156908389|NCT05248867|566423057|FG005|Open-label Period|Lost to Follow-up|2|||
156908390|NCT05248867|566423052|FG000|Open-label Period|COVID-19 Infection|0|||
156908391|NCT05248867|566423053|FG001|Open-label Period|COVID-19 Infection|0|||
156908392|NCT05248867|566423054|FG002|Open-label Period|COVID-19 Infection|0|||
156908393|NCT05248867|566423055|FG003|Open-label Period|COVID-19 Infection|0|||
157159751|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159752|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156908394|NCT05248867|566423056|FG004|Open-label Period|COVID-19 Infection|1|||
156908395|NCT05248867|566423057|FG005|Open-label Period|COVID-19 Infection|0|||
156908396|NCT05248867|566423052|FG000|Open-label Period|Other, not specified|0|||
156908397|NCT05248867|566423053|FG001|Open-label Period|Other, not specified|0|||
156908398|NCT05248867|566423054|FG002|Open-label Period|Other, not specified|0|||
156908399|NCT05248867|566423055|FG003|Open-label Period|Other, not specified|0|||
157159753|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159754|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159755|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
156908400|NCT05248867|566423056|FG004|Open-label Period|Other, not specified|4|||
156908401|NCT05248867|566423057|FG005|Open-label Period|Other, not specified|0|||
156908402|NCT01064310|566423058|FG000|Period 1|Adverse Event|7|||
156908403|NCT01064310|566423059|FG001|Period 1|Adverse Event|10|||
156908404|NCT01064310|566423060|FG002|Period 1|Adverse Event|0|||
156908405|NCT01064310|566423058|FG000|Period 1|Physician Decision|1|||
156908406|NCT01064310|566423059|FG001|Period 1|Physician Decision|0|||
156908407|NCT01064310|566423060|FG002|Period 1|Physician Decision|0|||
157159756|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
157159757|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
157159758|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159759|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
157159760|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
157159761|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
157159762|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
157159763|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
157159764|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
157159765|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159766|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
156908408|NCT01064310|566423058|FG000|Period 1|Withdrawal by Subject|2|||
156908409|NCT01064310|566423059|FG001|Period 1|Withdrawal by Subject|2|||
156908410|NCT01064310|566423060|FG002|Period 1|Withdrawal by Subject|0|||
156908411|NCT01064310|566423058|FG000|Period 1|Lack of Efficacy|3|||
156908412|NCT01064310|566423059|FG001|Period 1|Lack of Efficacy|5|||
156908413|NCT01064310|566423060|FG002|Period 1|Lack of Efficacy|0|||
156908414|NCT01064310|566423058|FG000|Period 1|Entered Open-label Period|1|||
156908415|NCT01064310|566423059|FG001|Period 1|Entered Open-label Period|1|||
157159767|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159768|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159769|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159770|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159771|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159772|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159773|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159774|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159775|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159776|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159777|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159778|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159779|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
157159780|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
157159781|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
157159782|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159783|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
157159784|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
157159785|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159786|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159787|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
157159788|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159789|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159790|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159791|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159792|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156908416|NCT01064310|566423060|FG002|Period 1|Entered Open-label Period|0|||
156908417|NCT01064310|566423058|FG000|Period 2|Adverse Event|2|||
157159793|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159794|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159795|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159796|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156908418|NCT01064310|566423059|FG001|Period 2|Adverse Event|1|||
156908419|NCT01064310|566423060|FG002|Period 2|Adverse Event|0|||
156908420|NCT01064310|566423058|FG000|Period 2|Physician Decision|0|||
156908421|NCT01064310|566423059|FG001|Period 2|Physician Decision|1|||
156908422|NCT01064310|566423060|FG002|Period 2|Physician Decision|0|||
157027206|NCT03381196|566856056|FG000|Overall Study|Lost to Follow-up|5|||
156908423|NCT01064310|566423058|FG000|Period 2|Entered Open-label Period|1|||
156908424|NCT01064310|566423059|FG001|Period 2|Entered Open-label Period|0|||
156908425|NCT01064310|566423060|FG002|Period 2|Entered Open-label Period|0|||
156908426|NCT01064310|566423058|FG000|Period 2|Lack of Efficacy|1|||
156908427|NCT01064310|566423059|FG001|Period 2|Lack of Efficacy|4|||
156908428|NCT01064310|566423060|FG002|Period 2|Lack of Efficacy|0|||
156908429|NCT01064310|566423058|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
156908430|NCT01064310|566423059|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
156908431|NCT01064310|566423060|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
156908432|NCT01064310|566423058|FG000|Open Label Pazopinib|Adverse Event|0|||
156908433|NCT01064310|566423059|FG001|Open Label Pazopinib|Adverse Event|0|||
156908434|NCT01064310|566423060|FG002|Open Label Pazopinib|Adverse Event|12|||
156908435|NCT01064310|566423058|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
156908436|NCT01064310|566423059|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
156908437|NCT01064310|566423060|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
156908438|NCT01064310|566423058|FG000|Open Label Pazopinib|Physician Decision|0|||
156908439|NCT01064310|566423059|FG001|Open Label Pazopinib|Physician Decision|0|||
156908440|NCT01064310|566423060|FG002|Open Label Pazopinib|Physician Decision|20|||
156908441|NCT00001880|566423061|FG000|Overall Study|Death|14|||
156908442|NCT02639065|566423062|FG000|Study Treatment|Disease Progression|13|||
156908443|NCT02639065|566423062|FG000|Study Treatment|Adverse Event|9|||
156908444|NCT02639065|566423062|FG000|Study Treatment|Withdrawal by Subject|1|||
156908445|NCT02639065|566423062|FG000|Follow up|Subject refused to follow up|1|||
156908446|NCT02639065|566423062|FG000|Follow up|Symptomatic Deterioration|2|||
156908447|NCT02639065|566423062|FG000|Follow up|Death|2|||
156908448|NCT02639065|566423062|FG000|Follow up|Study Terminated|1|||
156908449|NCT02639065|566423062|FG000|Follow up|Disease Progression|3|||
156908450|NCT00873015|566423063|FG000|Overall Study|Withdrawal by Subject|0|||
156908451|NCT00873015|566423064|FG001|Overall Study|Withdrawal by Subject|1|||
156908452|NCT00873015|566423065|FG002|Overall Study|Withdrawal by Subject|0|||
156908453|NCT00873015|566423066|FG003|Overall Study|Withdrawal by Subject|0|||
156908454|NCT00345839|566423067|FG000|Overall Study|Withdrawal by Subject|91|||
156908455|NCT00345839|566423068|FG001|Overall Study|Withdrawal by Subject|98|||
156908456|NCT00345839|566423067|FG000|Overall Study|Lost to Follow-up|58|||
156908457|NCT00345839|566423068|FG001|Overall Study|Lost to Follow-up|61|||
156908458|NCT00660699|566423074|FG000|Overall Study|Withdrawal by Subject|2|||
156908459|NCT06934993|566423079|FG000|Overall Study|Withdrawal by Subject|29|||
156908460|NCT06934993|566423079|FG000|Overall Study|elevated postoperative creatinine level|11|||
156908461|NCT06934993|566423079|FG000|Overall Study|Death|3|||
156908462|NCT00688753|566424433|FG000|Overall Study|Disease progression|55|||
156908463|NCT00688753|566424433|FG000|Overall Study|Missing|1|||
156908464|NCT00688753|566424433|FG000|Overall Study|Death|9|||
156908465|NCT00688753|566424433|FG000|Overall Study|Withdrawal by Subject|3|||
156908466|NCT00688753|566424433|FG000|Overall Study|Adverse Event|20|||
156908467|NCT00688753|566424433|FG000|Overall Study|Protocol Violation|1|||
156908468|NCT00688753|566424433|FG000|Overall Study|Lost to Follow-up|3|||
156908469|NCT05996718|566424435|FG000|Overall Study|Lost to Follow-up|3|||
156908470|NCT01713686|566424436|FG000|Overall Study|Lost to Follow-up|9|||
156908471|NCT01713686|566424436|FG000|Overall Study|Withdrawal by Subject|6|||
156908472|NCT03187197|566424437|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
156908473|NCT03187197|566424438|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
156908474|NCT03187197|566424439|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
156908475|NCT03187197|566424437|FG000|Overall Study|Withdrawal by Subject|8|||
156908476|NCT03187197|566424438|FG001|Overall Study|Withdrawal by Subject|63|||
156908477|NCT03187197|566424439|FG002|Overall Study|Withdrawal by Subject|4|||
156908478|NCT03187197|566424437|FG000|Overall Study|Lost to Follow-up|1|||
156908479|NCT03187197|566424438|FG001|Overall Study|Lost to Follow-up|60|||
156908480|NCT03187197|566424439|FG002|Overall Study|Lost to Follow-up|7|||
156908481|NCT03187197|566424437|FG000|Overall Study|Adverse Event|6|||
156908482|NCT03187197|566424438|FG001|Overall Study|Adverse Event|29|||
156908483|NCT03187197|566424439|FG002|Overall Study|Adverse Event|0|||
156908484|NCT03187197|566424437|FG000|Overall Study|Death|0|||
156908485|NCT03187197|566424438|FG001|Overall Study|Death|11|||
156908486|NCT03187197|566424439|FG002|Overall Study|Death|0|||
156908487|NCT03187197|566424437|FG000|Overall Study|Administrative problem|1|||
156908488|NCT03187197|566424438|FG001|Overall Study|Administrative problem|1|||
156908489|NCT03187197|566424439|FG002|Overall Study|Administrative problem|0|||
156908490|NCT03187197|566424437|FG000|Overall Study|Reason not listed|2|||
156908491|NCT03187197|566424438|FG001|Overall Study|Reason not listed|54|||
156908492|NCT03187197|566424439|FG002|Overall Study|Reason not listed|1|||
156908493|NCT03187197|566424437|FG000|Overall Study|Missing|1|||
156908494|NCT03187197|566424438|FG001|Overall Study|Missing|32|||
156908495|NCT03187197|566424439|FG002|Overall Study|Missing|3|||
156908496|NCT03187197|566424437|FG000|Overall Study|Status missing|2|||
156908497|NCT03187197|566424438|FG001|Overall Study|Status missing|33|||
156908498|NCT03187197|566424439|FG002|Overall Study|Status missing|3|||
156908499|NCT03187197|566424437|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
156908500|NCT03187197|566424438|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
156908501|NCT03187197|566424439|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
156908502|NCT02385045|566424440|FG000|Overall Study|Endoscopy could not be completed|4|||
156908503|NCT00115739|566424441|FG000|Overall Study|Lost to Follow-up|3|||
156908504|NCT00259649|566424444|FG000|Overall Study|Lost to Follow-up|7|||
156908505|NCT00259649|566424444|FG000|Overall Study|irregular menses|3|||
156908506|NCT01235351|566424445|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
156908507|NCT01235351|566424446|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
156908508|NCT00745823|566424447|FG000|Overall Study|Adverse Event|5|||
156908509|NCT00745823|566424448|FG001|Overall Study|Adverse Event|3|||
156908510|NCT00745823|566424447|FG000|Overall Study|Lack of Efficacy|20|||
156908511|NCT00745823|566424448|FG001|Overall Study|Lack of Efficacy|6|||
156908512|NCT00745823|566424447|FG000|Overall Study|Lost to Follow-up|10|||
156908513|NCT00745823|566424448|FG001|Overall Study|Lost to Follow-up|11|||
156908514|NCT00745823|566424447|FG000|Overall Study|Physician Decision|10|||
156908515|NCT00745823|566424448|FG001|Overall Study|Physician Decision|5|||
156908516|NCT00745823|566424447|FG000|Overall Study|Pregnancy|0|||
156908517|NCT00745823|566424448|FG001|Overall Study|Pregnancy|4|||
156908518|NCT00745823|566424447|FG000|Overall Study|Withdrawal by Subject|14|||
156908519|NCT00745823|566424448|FG001|Overall Study|Withdrawal by Subject|8|||
156908520|NCT00745823|566424447|FG000|Overall Study|Study Terminated by Sponsor|326|||
156908521|NCT00745823|566424448|FG001|Overall Study|Study Terminated by Sponsor|349|||
156908522|NCT02955602|566424456|FG000|Overall Study|Adverse Event|0|||
156908523|NCT02955602|566424457|FG001|Overall Study|Adverse Event|3|||
156908524|NCT02955602|566424458|FG002|Overall Study|Adverse Event|0|||
156908525|NCT02955602|566424456|FG000|Overall Study|Withdrawal of informed consent|1|||
156908526|NCT02955602|566424457|FG001|Overall Study|Withdrawal of informed consent|3|||
156908527|NCT02955602|566424458|FG002|Overall Study|Withdrawal of informed consent|2|||
156908528|NCT02955602|566424456|FG000|Overall Study|Lost to Follow-up|0|||
156908529|NCT02955602|566424457|FG001|Overall Study|Lost to Follow-up|0|||
156908530|NCT02955602|566424458|FG002|Overall Study|Lost to Follow-up|1|||
156908531|NCT02955602|566424456|FG000|Overall Study|Other|0|||
156908532|NCT02955602|566424457|FG001|Overall Study|Other|1|||
156908533|NCT02955602|566424458|FG002|Overall Study|Other|3|||
156908534|NCT02980601|566424461|FG000|Overall Study|Lost to Follow-up|2|||
156908535|NCT02980601|566424462|FG001|Overall Study|Lost to Follow-up|2|||
156908536|NCT02980601|566424461|FG000|Overall Study|Death|0|||
156908537|NCT02980601|566424462|FG001|Overall Study|Death|1|||
156908538|NCT02980601|566424461|FG000|Overall Study|Graft loss|1|||
156908539|NCT02980601|566424462|FG001|Overall Study|Graft loss|0|||
156908540|NCT02980601|566424461|FG000|Overall Study|Failed to sign consent|2|||
156908541|NCT02980601|566424462|FG001|Overall Study|Failed to sign consent|0|||
156908542|NCT01575769|566424463|FG000|Overall Study|Adverse Event|1|||
156908543|NCT01575769|566424463|FG000|Overall Study|Study terminated by sponsor|40|||
156908544|NCT01709513|566424464|FG000|Overall Study|Randomized but not treated|0|||
156908545|NCT01709513|566424465|FG001|Overall Study|Randomized but not treated|1|||
156908546|NCT01709513|566424466|FG002|Overall Study|Randomized but not treated|0|||
156908547|NCT01709513|566424464|FG000|Overall Study|Adverse Event|16|||
156908548|NCT01709513|566424465|FG001|Overall Study|Adverse Event|31|||
156908549|NCT01709513|566424466|FG002|Overall Study|Adverse Event|23|||
156908550|NCT01709513|566424464|FG000|Overall Study|Poor compliance to protocol|2|||
156908551|NCT01709513|566424465|FG001|Overall Study|Poor compliance to protocol|0|||
156908552|NCT01709513|566424466|FG002|Overall Study|Poor compliance to protocol|0|||
156908553|NCT01709513|566424464|FG000|Overall Study|Other|3|||
156908554|NCT01709513|566424465|FG001|Overall Study|Other|11|||
156908555|NCT01709513|566424466|FG002|Overall Study|Other|7|||
156908556|NCT01034631|566424467|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
156908557|NCT01034631|566424468|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
156908558|NCT01034631|566424469|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
156908559|NCT01034631|566424467|FG000|Phase II|Not Evaluable per protocol|0|||
156908560|NCT01034631|566424468|FG001|Phase II|Not Evaluable per protocol|0|||
156908561|NCT01034631|566424469|FG002|Phase II|Not Evaluable per protocol|2|||
156908562|NCT01034631|566424467|FG000|Phase II|Determined Ineligible per protocol|0|||
156908563|NCT01034631|566424468|FG001|Phase II|Determined Ineligible per protocol|1|||
156908564|NCT01034631|566424469|FG002|Phase II|Determined Ineligible per protocol|0|||
156908565|NCT01193530|566424470|FG000|Overall Study|Withdrawal by Subject|2|||
156908566|NCT01193530|566424471|FG001|Overall Study|Withdrawal by Subject|2|||
156908567|NCT01193530|566424470|FG000|Overall Study|Began Contraindicated Therapy|1|||
156908568|NCT01193530|566424471|FG001|Overall Study|Began Contraindicated Therapy|0|||
156908569|NCT01193530|566424470|FG000|Overall Study|Lost Light Box|0|||
156908570|NCT01193530|566424471|FG001|Overall Study|Lost Light Box|1|||
156908571|NCT01193530|566424470|FG000|Overall Study|Returned home - out of state|0|||
156908572|NCT01193530|566424471|FG001|Overall Study|Returned home - out of state|1|||
156908573|NCT01193530|566424470|FG000|Overall Study|Non-Compliance|0|||
156908574|NCT01193530|566424471|FG001|Overall Study|Non-Compliance|1|||
156908575|NCT00599924|566424483|FG000|Overall Study|Lack of Efficacy|3|||
156908576|NCT00599924|566424484|FG001|Overall Study|Lack of Efficacy|5|||
156908577|NCT00599924|566424485|FG002|Overall Study|Lack of Efficacy|1|||
156908578|NCT00599924|566424486|FG003|Overall Study|Lack of Efficacy|2|||
156908579|NCT00599924|566424487|FG004|Overall Study|Lack of Efficacy|3|||
156908580|NCT00599924|566424488|FG005|Overall Study|Lack of Efficacy|2|||
156908581|NCT00599924|566424489|FG006|Overall Study|Lack of Efficacy|0|||
156908582|NCT00599924|566424483|FG000|Overall Study|Adverse Event|0|||
156908583|NCT00599924|566424484|FG001|Overall Study|Adverse Event|0|||
156908584|NCT00599924|566424485|FG002|Overall Study|Adverse Event|0|||
156908585|NCT00599924|566424486|FG003|Overall Study|Adverse Event|2|||
156908586|NCT00599924|566424487|FG004|Overall Study|Adverse Event|0|||
156908587|NCT00599924|566424488|FG005|Overall Study|Adverse Event|0|||
156908588|NCT00599924|566424489|FG006|Overall Study|Adverse Event|2|||
156908589|NCT00599924|566424483|FG000|Overall Study|Death|0|||
156908590|NCT00599924|566424484|FG001|Overall Study|Death|0|||
156908591|NCT00599924|566424485|FG002|Overall Study|Death|0|||
156908592|NCT00599924|566424486|FG003|Overall Study|Death|2|||
156908593|NCT00599924|566424487|FG004|Overall Study|Death|0|||
156908594|NCT00599924|566424488|FG005|Overall Study|Death|2|||
156908595|NCT00599924|566424489|FG006|Overall Study|Death|1|||
156908596|NCT00599924|566424483|FG000|Overall Study|Protocol Violation|0|||
156908597|NCT00599924|566424484|FG001|Overall Study|Protocol Violation|0|||
156908598|NCT00599924|566424485|FG002|Overall Study|Protocol Violation|0|||
156908599|NCT00599924|566424486|FG003|Overall Study|Protocol Violation|1|||
156908600|NCT00599924|566424487|FG004|Overall Study|Protocol Violation|0|||
156908601|NCT00599924|566424488|FG005|Overall Study|Protocol Violation|0|||
156908602|NCT00599924|566424489|FG006|Overall Study|Protocol Violation|0|||
156908603|NCT00599924|566424483|FG000|Overall Study|Withdrawal by Subject|0|||
156908604|NCT00599924|566424484|FG001|Overall Study|Withdrawal by Subject|0|||
156908605|NCT00599924|566424485|FG002|Overall Study|Withdrawal by Subject|1|||
156908606|NCT00599924|566424486|FG003|Overall Study|Withdrawal by Subject|0|||
156908607|NCT00599924|566424487|FG004|Overall Study|Withdrawal by Subject|1|||
156908608|NCT00599924|566424488|FG005|Overall Study|Withdrawal by Subject|0|||
156908609|NCT00599924|566424489|FG006|Overall Study|Withdrawal by Subject|0|||
156908610|NCT00599924|566424483|FG000|Overall Study|Other|0|||
156908611|NCT00599924|566424484|FG001|Overall Study|Other|0|||
156908612|NCT00599924|566424485|FG002|Overall Study|Other|0|||
156908613|NCT00599924|566424486|FG003|Overall Study|Other|1|||
156908614|NCT00599924|566424487|FG004|Overall Study|Other|2|||
156908615|NCT00599924|566424488|FG005|Overall Study|Other|0|||
156908616|NCT00599924|566424489|FG006|Overall Study|Other|2|||
156908617|NCT01806298|566424490|FG000|Overall Study|Adverse Event|3|||
156908618|NCT01806298|566424490|FG000|Overall Study|Protocol Non-compliance|1|||
156908619|NCT01806298|566424490|FG000|Overall Study|Withdrawal by Subject|1|||
156908620|NCT01806298|566424490|FG000|Overall Study|Other|5|||
156908621|NCT01877265|566424491|FG000|Treatment Period 1|Sponsor Decision|0|||
156908622|NCT01877265|566424492|FG001|Treatment Period 1|Sponsor Decision|0|||
156908623|NCT01877265|566424493|FG002|Treatment Period 1|Sponsor Decision|1|||
156908624|NCT01877265|566424494|FG003|Treatment Period 1|Sponsor Decision|0|||
156908625|NCT01877265|566424495|FG004|Treatment Period 1|Sponsor Decision|0|||
156908626|NCT01877265|566424496|FG005|Treatment Period 1|Sponsor Decision|0|||
156908627|NCT01877265|566424491|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156908628|NCT01877265|566424492|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156908629|NCT01877265|566424493|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156908630|NCT01877265|566424494|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156908631|NCT01877265|566424495|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
156908632|NCT01877265|566424496|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
156908633|NCT01877265|566424491|FG000|Treatment Period 3|Lost to Follow-up|1|||
156908634|NCT01877265|566424492|FG001|Treatment Period 3|Lost to Follow-up|0|||
156908635|NCT01877265|566424493|FG002|Treatment Period 3|Lost to Follow-up|0|||
156908636|NCT01877265|566424494|FG003|Treatment Period 3|Lost to Follow-up|0|||
156908637|NCT01877265|566424495|FG004|Treatment Period 3|Lost to Follow-up|0|||
156908638|NCT01877265|566424496|FG005|Treatment Period 3|Lost to Follow-up|0|||
156908639|NCT00592384|566424499|FG000|Overall Study|Withdrawal by Subject|5|||
156908640|NCT00592384|566424500|FG001|Overall Study|Withdrawal by Subject|6|||
156908641|NCT00590720|566424508|FG000|Overall Study|Lost to Follow-up|1|||
156908642|NCT00590720|566424509|FG001|Overall Study|Lost to Follow-up|0|||
156908643|NCT00590720|566424508|FG000|Overall Study|Withdrawal by Subject|0|||
156908644|NCT00590720|566424509|FG001|Overall Study|Withdrawal by Subject|1|||
156908645|NCT03039283|566424514|FG000|Overall Study|Protocol Violation|2|||
156908646|NCT00867568|566424515|FG000|Overall Study|Lack of Efficacy|10|||
156908647|NCT00867568|566424515|FG000|Overall Study|Adverse Event|4|||
156908648|NCT00867568|566424515|FG000|Overall Study|Withdrawal by Subject|1|||
156908649|NCT01056653|566424516|FG000|Overall Study|Lost to Follow-up|0|||
156908650|NCT01056653|566424517|FG001|Overall Study|Lost to Follow-up|0|||
156908651|NCT01056653|566424518|FG002|Overall Study|Lost to Follow-up|2|||
156908652|NCT03639935|566424519|FG000|Overall Study|Death|3|||
156908653|NCT03639935|566424519|FG000|Overall Study|Adverse Event|1|||
156908654|NCT06333613|566424521|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
156908655|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
156908656|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
156908657|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
156908658|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
156908659|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908660|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908661|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908662|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908663|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908664|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908665|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
156908666|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
156908667|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
156908668|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
156908669|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
156908670|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908671|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908672|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908673|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908674|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908675|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908676|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
156908677|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
156908678|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
156908679|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
156908680|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
156908681|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908682|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908683|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908684|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908685|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908686|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908687|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
156908688|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908689|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908690|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908691|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
156908692|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908693|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908694|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908695|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908696|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908697|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908698|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
156908699|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
156908700|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
156908701|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
156908702|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
156908703|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908704|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908705|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908706|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908707|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908708|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908709|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
156908710|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
156908711|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
156908712|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
156908713|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
156908714|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908715|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908716|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908717|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908718|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908719|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908720|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
156908721|NCT01847274|566424522|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
156908722|NCT01847274|566424523|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
156908723|NCT01847274|566424524|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
156908724|NCT01847274|566424525|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
156908725|NCT01847274|566424526|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908726|NCT01847274|566424527|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908727|NCT01847274|566424528|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908728|NCT01847274|566424529|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908729|NCT01847274|566424530|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908730|NCT01847274|566424531|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908731|NCT01847274|566424532|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
156908732|NCT01847274|566424522|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908733|NCT01847274|566424523|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908734|NCT01847274|566424524|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908735|NCT01847274|566424525|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908736|NCT01847274|566424526|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908737|NCT01847274|566424527|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
156908738|NCT01847274|566424528|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908739|NCT01847274|566424529|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908740|NCT01847274|566424530|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908741|NCT01847274|566424531|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908742|NCT01847274|566424532|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
156908743|NCT01847274|566424522|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908744|NCT01847274|566424523|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908745|NCT01847274|566424524|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908746|NCT01847274|566424525|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908747|NCT01847274|566424526|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
156908748|NCT01847274|566424527|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908749|NCT01847274|566424528|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908750|NCT01847274|566424529|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908751|NCT01847274|566424530|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908752|NCT01847274|566424531|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908753|NCT01847274|566424532|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
156908754|NCT01847274|566424522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908755|NCT01847274|566424523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908756|NCT01847274|566424524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908757|NCT01847274|566424525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908758|NCT01847274|566424526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908759|NCT01847274|566424527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908760|NCT01847274|566424528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
156908761|NCT01847274|566424529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908762|NCT01847274|566424530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908763|NCT01847274|566424531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908764|NCT01847274|566424532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
156908765|NCT01847274|566424522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908766|NCT01847274|566424523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908767|NCT01847274|566424524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908768|NCT01847274|566424525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908769|NCT01847274|566424526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908770|NCT01847274|566424527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908771|NCT01847274|566424528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
156908772|NCT01847274|566424529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908773|NCT01847274|566424530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908774|NCT01847274|566424531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908775|NCT01847274|566424532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
156908776|NCT01847274|566424522|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
157159797|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159798|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159799|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159800|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
156908777|NCT01847274|566424523|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908778|NCT01847274|566424524|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
157027207|NCT03381196|566856057|FG001|Overall Study|Lost to Follow-up|4|||
156908779|NCT01847274|566424525|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908780|NCT01847274|566424526|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908781|NCT01847274|566424527|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908782|NCT01847274|566424528|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
156908783|NCT01847274|566424529|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908784|NCT01847274|566424530|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908785|NCT01847274|566424531|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908786|NCT01847274|566424532|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
156908787|NCT01847274|566424522|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908788|NCT01847274|566424523|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908789|NCT01847274|566424524|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908790|NCT01847274|566424525|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908791|NCT01847274|566424526|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908792|NCT01847274|566424527|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908793|NCT01847274|566424528|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
156908794|NCT01847274|566424529|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
156908795|NCT01847274|566424530|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
156908796|NCT01847274|566424531|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
156908797|NCT01847274|566424532|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
156908798|NCT01847274|566424522|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908799|NCT01847274|566424523|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908800|NCT01847274|566424524|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908801|NCT01847274|566424525|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908802|NCT01847274|566424526|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908803|NCT01847274|566424527|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908804|NCT01847274|566424528|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908805|NCT01847274|566424529|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
156908806|NCT01847274|566424530|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908807|NCT01847274|566424531|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
156908808|NCT01847274|566424532|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
156908809|NCT01847274|566424522|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908810|NCT01847274|566424523|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908811|NCT01847274|566424524|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908812|NCT01847274|566424525|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908813|NCT01847274|566424526|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908814|NCT01847274|566424527|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908815|NCT01847274|566424528|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908816|NCT01847274|566424529|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
156908817|NCT01847274|566424530|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
156908818|NCT01847274|566424531|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
156908819|NCT01847274|566424532|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
156908820|NCT01847274|566424522|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908821|NCT01847274|566424523|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908822|NCT01847274|566424524|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908823|NCT01847274|566424525|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908824|NCT01847274|566424526|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908825|NCT01847274|566424527|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908826|NCT01847274|566424528|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908827|NCT01847274|566424529|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908828|NCT01847274|566424530|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908829|NCT01847274|566424531|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
156908830|NCT01847274|566424532|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
156908831|NCT00261807|566424534|FG000|Overall Study|Lost to Follow-up|2|||
156908832|NCT00261807|566424534|FG000|Overall Study|Adverse Event|2|||
156908833|NCT00261807|566424534|FG000|Overall Study|Death|1|||
156908834|NCT00261807|566424534|FG000|Overall Study|Protocol Violation|2|||
156908835|NCT01706146|566424535|FG000|Overall Study|Withdrawal by Subject|1|||
156908836|NCT01706146|566424535|FG000|Overall Study|Adverse Event|3|||
156908837|NCT01706146|566424535|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
156908838|NCT02582983|566424537|FG000|Overall Study|Death|3|||
156908839|NCT02582983|566424537|FG000|Overall Study|Withdrawal by Subject|2|||
156908840|NCT02582983|566424537|FG000|Overall Study|Adverse Event|1|||
156908841|NCT02059395|566424538|FG000|Overall Study|Lost to Follow-up|2|||
156908842|NCT02059395|566424539|FG001|Overall Study|Lost to Follow-up|4|||
156859975|NCT00550407|566243251|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
156859976|NCT00550407|566243252|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
156859977|NCT00550407|566243253|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
156859978|NCT00550407|566243251|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
156859979|NCT00550407|566243252|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
156859980|NCT00550407|566243253|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
156859981|NCT00550407|566243251|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
156859982|NCT00550407|566243252|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
156859983|NCT00550407|566243253|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
156859984|NCT02370420|566243254|FG000|Overall Study|Physician Decision|3|||
156859985|NCT02370420|566243255|FG001|Overall Study|Physician Decision|3|||
156859986|NCT02370420|566243254|FG000|Overall Study|Lost to Follow-up|11|||
156859987|NCT02370420|566243255|FG001|Overall Study|Lost to Follow-up|9|||
156859988|NCT02919761|566243260|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
156859989|NCT02919761|566243261|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
156859990|NCT02919761|566243262|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
156859991|NCT02919761|566243260|FG000|Part 1: Open Label|Adverse Event|1|||
156859992|NCT02919761|566243261|FG001|Part 1: Open Label|Adverse Event|0|||
156859993|NCT02919761|566243262|FG002|Part 1: Open Label|Adverse Event|0|||
156859994|NCT02919761|566243260|FG000|Part 1: Open Label|Lost to Follow-up|1|||
156859995|NCT02919761|566243261|FG001|Part 1: Open Label|Lost to Follow-up|0|||
156859996|NCT02919761|566243262|FG002|Part 1: Open Label|Lost to Follow-up|0|||
156859997|NCT02919761|566243260|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
156859998|NCT02919761|566243261|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
156859999|NCT02919761|566243262|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
156860000|NCT02919761|566243260|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
156860001|NCT02919761|566243261|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
156860002|NCT02919761|566243262|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
156860003|NCT02919761|566243260|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
156860004|NCT02919761|566243261|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
156860005|NCT02919761|566243262|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
156860006|NCT02919761|566243260|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
156860007|NCT02919761|566243261|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
156860008|NCT02919761|566243262|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
156860009|NCT02919761|566243260|FG000|Part 1: Open Label|Termination by Sponsor|1|||
156860010|NCT02919761|566243261|FG001|Part 1: Open Label|Termination by Sponsor|0|||
156860011|NCT02919761|566243262|FG002|Part 1: Open Label|Termination by Sponsor|0|||
156860012|NCT02919761|566243260|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
156860013|NCT02919761|566243261|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
156860014|NCT02919761|566243262|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
156860015|NCT02919761|566243260|FG000|Part 2: Double-blind|Adverse Event|0|||
156860016|NCT02919761|566243261|FG001|Part 2: Double-blind|Adverse Event|1|||
156860017|NCT02919761|566243262|FG002|Part 2: Double-blind|Adverse Event|0|||
156860018|NCT02919761|566243260|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
156860019|NCT02919761|566243261|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
156860020|NCT02919761|566243262|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
156860021|NCT02919761|566243260|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
156860022|NCT02919761|566243261|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
156860023|NCT02919761|566243262|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
156860024|NCT02919761|566243260|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
156860025|NCT02919761|566243261|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
156860026|NCT02919761|566243262|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
156860027|NCT02919761|566243260|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
156860028|NCT02919761|566243261|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
156860029|NCT02919761|566243262|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
156860030|NCT02919761|566243260|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
156860031|NCT02919761|566243261|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
156860032|NCT02919761|566243262|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
156860033|NCT02919761|566243260|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
156860034|NCT02919761|566243261|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
156860035|NCT02919761|566243262|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
156860036|NCT00410956|566243263|FG000|Overall Study|Adverse Event|1|||
156860037|NCT00410956|566243263|FG000|Overall Study|Death|2|||
156860038|NCT00410956|566243263|FG000|Overall Study|Lack of Efficacy|10|||
156860039|NCT00410956|566243263|FG000|Overall Study|Physician Decision|6|||
156860040|NCT00755183|566244643|FG000|Overall Study|Adverse Event|5|||
156860041|NCT00755183|566244644|FG001|Overall Study|Adverse Event|2|||
156860042|NCT00755183|566244643|FG000|Overall Study|Protocol Violation|0|||
156860043|NCT00755183|566244644|FG001|Overall Study|Protocol Violation|1|||
156860044|NCT00755183|566244643|FG000|Overall Study|Withdrawal by Subject|0|||
156860045|NCT00755183|566244644|FG001|Overall Study|Withdrawal by Subject|2|||
156860046|NCT00755183|566244643|FG000|Overall Study|Administrative|2|||
156860047|NCT00755183|566244644|FG001|Overall Study|Administrative|1|||
156908843|NCT05209360|566424540|FG000|Overall Study|Withdrawal by Subject|0|||
156908844|NCT05209360|566424541|FG001|Overall Study|Withdrawal by Subject|0|||
156908845|NCT05209360|566424542|FG002|Overall Study|Withdrawal by Subject|1|||
156908846|NCT05209360|566424543|FG003|Overall Study|Withdrawal by Subject|0|||
156908847|NCT05209360|566424544|FG004|Overall Study|Withdrawal by Subject|0|||
156908848|NCT05209360|566424545|FG005|Overall Study|Withdrawal by Subject|0|||
156908849|NCT00134082|566424546|FG000|Overall Study|Adverse Event|2|||
156908850|NCT00134082|566424546|FG000|Overall Study|Death|1|||
156908851|NCT00724932|566424549|FG000|Overall Study|Lost to Follow-up|1|||
156908852|NCT00724932|566424550|FG001|Overall Study|Lost to Follow-up|0|||
156908853|NCT00724932|566424549|FG000|Overall Study|Not treated|4|||
156908854|NCT00724932|566424550|FG001|Overall Study|Not treated|3|||
156908855|NCT02021331|566424551|FG000|Overall Study|Adverse Event|0|||
156908856|NCT02021331|566424552|FG001|Overall Study|Adverse Event|2|||
156908857|NCT02849678|566424553|FG000|Overall Study|Protocol Violation|3|||
156908858|NCT02849678|566424554|FG001|Overall Study|Protocol Violation|6|||
156908859|NCT00289991|566424560|FG000|Overall Study|Death|35|||
156908860|NCT00289991|566424561|FG001|Overall Study|Death|38|||
156908861|NCT00289991|566424560|FG000|Overall Study|Adverse Event|15|||
156908862|NCT00289991|566424561|FG001|Overall Study|Adverse Event|13|||
156908863|NCT00289991|566424560|FG000|Overall Study|Failure of prophylaxis|1|||
156908864|NCT00289991|566424561|FG001|Overall Study|Failure of prophylaxis|1|||
156908865|NCT00289991|566424560|FG000|Overall Study|Fungal breakthrough infection|0|||
156908866|NCT00289991|566424561|FG001|Overall Study|Fungal breakthrough infection|1|||
156908867|NCT00289991|566424560|FG000|Overall Study|Lost to Follow-up|0|||
156908868|NCT00289991|566424561|FG001|Overall Study|Lost to Follow-up|1|||
156908869|NCT00289991|566424560|FG000|Overall Study|Withdrawal by Subject|2|||
156908870|NCT00289991|566424561|FG001|Overall Study|Withdrawal by Subject|12|||
156908871|NCT00289991|566424560|FG000|Overall Study|Other|5|||
156908872|NCT00289991|566424561|FG001|Overall Study|Other|14|||
156908873|NCT02340975|566424562|FG000|Overall Study|Death|6|||
156908874|NCT02340975|566424563|FG001|Overall Study|Death|23|||
156908875|NCT02340975|566424564|FG002|Overall Study|Death|21|||
156908876|NCT02340975|566424565|FG003|Overall Study|Death|7|||
156908877|NCT02340975|566424566|FG004|Overall Study|Death|21|||
156908878|NCT02340975|566424567|FG005|Overall Study|Death|13|||
157027208|NCT03381196|566856056|FG000|Overall Study|Death|0|||
157027209|NCT03381196|566856057|FG001|Overall Study|Death|1|||
157027210|NCT03381196|566856056|FG000|Overall Study|Adverse Event|1|||
157027211|NCT03381196|566856057|FG001|Overall Study|Adverse Event|0|||
157027212|NCT03381196|566856056|FG000|Overall Study|Randomized, not treated|3|||
157027213|NCT03381196|566856057|FG001|Overall Study|Randomized, not treated|6|||
157027214|NCT02359890|566856058|FG000|Overall Study|Not meeting eligibility|4|||
157027215|NCT02359890|566856058|FG000|Overall Study|Never treated with study catheter|6|||
157159801|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159802|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
157159803|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
157159804|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159805|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159806|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159807|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159808|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159809|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159810|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
157159811|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159812|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156908879|NCT02340975|566424562|FG000|Overall Study|Lost to Follow-up|0|||
156908880|NCT02340975|566424563|FG001|Overall Study|Lost to Follow-up|0|||
156908881|NCT02340975|566424564|FG002|Overall Study|Lost to Follow-up|0|||
156908882|NCT02340975|566424565|FG003|Overall Study|Lost to Follow-up|0|||
156908883|NCT02340975|566424566|FG004|Overall Study|Lost to Follow-up|2|||
156908884|NCT02340975|566424567|FG005|Overall Study|Lost to Follow-up|0|||
156908885|NCT02340975|566424562|FG000|Overall Study|Withdrawal by Subject|0|||
156908886|NCT02340975|566424563|FG001|Overall Study|Withdrawal by Subject|0|||
156908887|NCT02340975|566424564|FG002|Overall Study|Withdrawal by Subject|3|||
156908888|NCT02340975|566424565|FG003|Overall Study|Withdrawal by Subject|3|||
156908889|NCT02340975|566424566|FG004|Overall Study|Withdrawal by Subject|2|||
156908890|NCT02340975|566424567|FG005|Overall Study|Withdrawal by Subject|0|||
156908891|NCT02340975|566424562|FG000|Overall Study|Other|0|||
156908892|NCT02340975|566424563|FG001|Overall Study|Other|4|||
156908893|NCT02340975|566424564|FG002|Overall Study|Other|0|||
156908894|NCT02340975|566424565|FG003|Overall Study|Other|2|||
156908895|NCT02340975|566424566|FG004|Overall Study|Other|0|||
156908896|NCT02340975|566424567|FG005|Overall Study|Other|6|||
156908897|NCT01007812|566424568|FG000|Period 1, One Week|Lost to Follow-up|0|||
157027216|NCT03854227|566856063|FG000|Overall Study|Adverse Event|0|||
157027217|NCT03854227|566856064|FG001|Overall Study|Adverse Event|0|||
156908898|NCT01007812|566424569|FG001|Period 1, One Week|Lost to Follow-up|1|||
156908899|NCT01007812|566424568|FG000|Period 1, One Week|Discomfort|1|||
156908900|NCT01007812|566424569|FG001|Period 1, One Week|Discomfort|0|||
156908901|NCT01091974|566424570|FG000|Overall Study|Did not start intervention|3|||
156908902|NCT01091974|566424571|FG001|Overall Study|Did not start intervention|1|||
156908903|NCT01091974|566424572|FG002|Overall Study|Did not start intervention|3|||
156908904|NCT01091974|566424573|FG003|Overall Study|Did not start intervention|1|||
156908905|NCT01091974|566424570|FG000|Overall Study|resumed sleep medication|0|||
156908906|NCT01091974|566424571|FG001|Overall Study|resumed sleep medication|0|||
156908907|NCT01091974|566424572|FG002|Overall Study|resumed sleep medication|1|||
156908908|NCT01091974|566424573|FG003|Overall Study|resumed sleep medication|2|||
156908909|NCT01091974|566424570|FG000|Overall Study|Withdrawal by Subject|1|||
156908910|NCT01091974|566424571|FG001|Overall Study|Withdrawal by Subject|3|||
156908911|NCT01091974|566424572|FG002|Overall Study|Withdrawal by Subject|2|||
156908912|NCT01091974|566424573|FG003|Overall Study|Withdrawal by Subject|2|||
156908913|NCT01091974|566424570|FG000|Overall Study|side-effects|1|||
156908914|NCT01091974|566424571|FG001|Overall Study|side-effects|1|||
156908915|NCT01091974|566424572|FG002|Overall Study|side-effects|0|||
156908916|NCT01091974|566424573|FG003|Overall Study|side-effects|2|||
156908917|NCT04891978|566424574|FG000|Baseline|Protocol Violation|2|||
156908918|NCT04891978|566424575|FG001|Baseline|Protocol Violation|1|||
156908919|NCT04891978|566424576|FG002|Baseline|Protocol Violation|0|||
156908920|NCT04891978|566424574|FG000|Baseline|Missing AIRQ|1|||
156908921|NCT04891978|566424575|FG001|Baseline|Missing AIRQ|0|||
156908922|NCT04891978|566424576|FG002|Baseline|Missing AIRQ|0|||
156908923|NCT04891978|566424574|FG000|Baseline|Did not attend a baseline visit|0|||
156908924|NCT04891978|566424575|FG001|Baseline|Did not attend a baseline visit|0|||
156908925|NCT04891978|566424576|FG002|Baseline|Did not attend a baseline visit|9|||
156908926|NCT03948581|566424577|FG000|Overall Study|Lost to Follow-up|0|||
156908927|NCT03948581|566424578|FG001|Overall Study|Lost to Follow-up|1|||
156908928|NCT03068455|566424579|FG000|Pre-treatment Period|Disease progression|0|||
156908929|NCT03068455|566424580|FG001|Pre-treatment Period|Disease progression|1|||
156908930|NCT03068455|566424579|FG000|Pre-treatment Period|Participant withdrew consent|1|||
156908931|NCT03068455|566424580|FG001|Pre-treatment Period|Participant withdrew consent|1|||
156908932|NCT03068455|566424579|FG000|Pre-treatment Period|Poor/non-compliance|0|||
156908933|NCT03068455|566424580|FG001|Pre-treatment Period|Poor/non-compliance|1|||
156908934|NCT03068455|566424579|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
156908935|NCT03068455|566424580|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
156908936|NCT03068455|566424579|FG000|Pre-treatment Period|Not reported|2|||
156908937|NCT03068455|566424580|FG001|Pre-treatment Period|Not reported|1|||
156908938|NCT03068455|566424579|FG000|Treatment Period|Disease progression|166|||
156908939|NCT03068455|566424580|FG001|Treatment Period|Disease progression|208|||
156908940|NCT03068455|566424579|FG000|Treatment Period|Study drug toxicity|317|||
156908941|NCT03068455|566424580|FG001|Treatment Period|Study drug toxicity|104|||
156908942|NCT03068455|566424579|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
156908943|NCT03068455|566424580|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
156908944|NCT03068455|566424579|FG000|Treatment Period|Participant request to stop therapy|33|||
156908945|NCT03068455|566424580|FG001|Treatment Period|Participant request to stop therapy|20|||
156908946|NCT03068455|566424579|FG000|Treatment Period|Participant withdrew consent|5|||
156908947|NCT03068455|566424580|FG001|Treatment Period|Participant withdrew consent|10|||
156908948|NCT03068455|566424579|FG000|Treatment Period|Poor/non-compliance|3|||
156908949|NCT03068455|566424580|FG001|Treatment Period|Poor/non-compliance|0|||
156908950|NCT03068455|566424579|FG000|Treatment Period|Participant no longer meets study criteria|1|||
156908951|NCT03068455|566424580|FG001|Treatment Period|Participant no longer meets study criteria|3|||
156908952|NCT03068455|566424579|FG000|Treatment Period|Other reasons|12|||
156908953|NCT03068455|566424580|FG001|Treatment Period|Other reasons|4|||
156908954|NCT03192462|566426132|FG000|Overall Study|Death|13|||
156908955|NCT03192462|566426133|FG001|Overall Study|Death|11|||
156908956|NCT03192462|566426134|FG002|Overall Study|Death|10|||
156908957|NCT03192462|566426132|FG000|Overall Study|Lost to Follow-up|0|||
156908958|NCT03192462|566426133|FG001|Overall Study|Lost to Follow-up|1|||
156908959|NCT03192462|566426134|FG002|Overall Study|Lost to Follow-up|0|||
156908960|NCT02200211|566426136|FG000|Overall Study|Lost to Follow-up|7|||
156908961|NCT02200211|566426137|FG001|Overall Study|Lost to Follow-up|7|||
156908962|NCT02200211|566426138|FG002|Overall Study|Lost to Follow-up|1|||
156908963|NCT02200211|566426139|FG003|Overall Study|Lost to Follow-up|2|||
156908964|NCT02200211|566426136|FG000|Overall Study|Withdrawal by Subject|1|||
156908965|NCT02200211|566426137|FG001|Overall Study|Withdrawal by Subject|0|||
156908966|NCT02200211|566426138|FG002|Overall Study|Withdrawal by Subject|0|||
156908967|NCT02200211|566426139|FG003|Overall Study|Withdrawal by Subject|0|||
156908968|NCT00381485|566426140|FG000|Open-Label Run-In Period|Adverse Event|9|||
156908969|NCT00381485|566426141|FG001|Open-Label Run-In Period|Adverse Event|0|||
156908970|NCT00381485|566426142|FG002|Open-Label Run-In Period|Adverse Event|0|||
156908971|NCT00381485|566426143|FG003|Open-Label Run-In Period|Adverse Event|0|||
156908972|NCT00381485|566426140|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
157027218|NCT03854227|566856065|FG002|Overall Study|Adverse Event|0|||
156908973|NCT00381485|566426141|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156908974|NCT00381485|566426142|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156908975|NCT00381485|566426143|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
156908976|NCT00381485|566426140|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
156908977|NCT00381485|566426141|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
157027219|NCT03854227|566856066|FG003|Overall Study|Adverse Event|1|||
157027220|NCT03854227|566856067|FG004|Overall Study|Adverse Event|0|||
157027221|NCT03854227|566856068|FG005|Overall Study|Adverse Event|0|||
157027222|NCT03854227|566856069|FG006|Overall Study|Adverse Event|1|||
157027223|NCT03854227|566856070|FG007|Overall Study|Adverse Event|0|||
157027224|NCT03854227|566856071|FG008|Overall Study|Adverse Event|0|||
157027225|NCT03854227|566856072|FG009|Overall Study|Adverse Event|3|||
157027226|NCT03854227|566856073|FG010|Overall Study|Adverse Event|0|||
156908978|NCT00381485|566426142|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
156908979|NCT00381485|566426143|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
156908980|NCT00381485|566426140|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
156908981|NCT00381485|566426141|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156908982|NCT00381485|566426142|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156908983|NCT00381485|566426143|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
156908984|NCT00381485|566426140|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
156908985|NCT00381485|566426141|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
156908986|NCT00381485|566426142|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
156908987|NCT00381485|566426143|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
156908988|NCT00381485|566426140|FG000|Open-Label Run-In Period|Treatment failure|1|||
156908989|NCT00381485|566426141|FG001|Open-Label Run-In Period|Treatment failure|0|||
156908990|NCT00381485|566426142|FG002|Open-Label Run-In Period|Treatment failure|0|||
156908991|NCT00381485|566426143|FG003|Open-Label Run-In Period|Treatment failure|0|||
156908992|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156908993|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Adverse Event|2|||
156908994|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Adverse Event|2|||
156908995|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Adverse Event|5|||
156908996|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
156908997|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
156908998|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
156908999|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
156909000|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156909001|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
156909002|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
156909003|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
156909004|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
156909005|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
156909006|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
156909007|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
156909008|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
156909009|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156909010|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
156909011|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156909012|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
156909013|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
156909014|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
156909015|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
156909016|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156909017|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156909018|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
156909019|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
156909020|NCT00381485|566426140|FG000|Double-Blind Treatment Period|Administrative|0|||
156909021|NCT00381485|566426141|FG001|Double-Blind Treatment Period|Administrative|1|||
156909022|NCT00381485|566426142|FG002|Double-Blind Treatment Period|Administrative|0|||
156909023|NCT00381485|566426143|FG003|Double-Blind Treatment Period|Administrative|1|||
156909024|NCT01433991|566426146|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
156909025|NCT01433991|566426147|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
156909026|NCT01433991|566426148|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
157027227|NCT03854227|566856074|FG011|Overall Study|Adverse Event|1|||
157027228|NCT03854227|566856063|FG000|Overall Study|Death|0|||
157159813|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157027229|NCT03854227|566856064|FG001|Overall Study|Death|0|||
156909027|NCT01433991|566426149|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
156909028|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
156909029|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
156909030|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
156909031|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
156909032|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156909033|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156909034|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
156909035|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
156909036|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
156909037|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
157027230|NCT03854227|566856065|FG002|Overall Study|Death|0|||
157027231|NCT03854227|566856066|FG003|Overall Study|Death|0|||
157027232|NCT03854227|566856067|FG004|Overall Study|Death|0|||
157159814|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156860048|NCT04199351|566244647|FG000|Overall Study|Decision by sponsor|0|||
156860049|NCT04199351|566244648|FG001|Overall Study|Decision by sponsor|0|||
156860050|NCT04199351|566244649|FG002|Overall Study|Decision by sponsor|0|||
156860051|NCT04199351|566244650|FG003|Overall Study|Decision by sponsor|2|||
156860052|NCT04199351|566244651|FG004|Overall Study|Decision by sponsor|0|||
156860053|NCT04199351|566244652|FG005|Overall Study|Decision by sponsor|0|||
156860054|NCT04199351|566244653|FG006|Overall Study|Decision by sponsor|0|||
156860055|NCT04199351|566244654|FG007|Overall Study|Decision by sponsor|0|||
156860056|NCT04199351|566244655|FG008|Overall Study|Decision by sponsor|0|||
156860057|NCT04199351|566244656|FG009|Overall Study|Decision by sponsor|6|||
156860058|NCT04199351|566244647|FG000|Overall Study|Lost to Follow-up|0|||
156860059|NCT04199351|566244648|FG001|Overall Study|Lost to Follow-up|0|||
156860060|NCT04199351|566244649|FG002|Overall Study|Lost to Follow-up|1|||
156860061|NCT04199351|566244650|FG003|Overall Study|Lost to Follow-up|0|||
156860062|NCT04199351|566244651|FG004|Overall Study|Lost to Follow-up|0|||
156860063|NCT04199351|566244652|FG005|Overall Study|Lost to Follow-up|1|||
156860064|NCT04199351|566244653|FG006|Overall Study|Lost to Follow-up|0|||
156860065|NCT04199351|566244654|FG007|Overall Study|Lost to Follow-up|0|||
156860066|NCT04199351|566244655|FG008|Overall Study|Lost to Follow-up|0|||
156860067|NCT04199351|566244656|FG009|Overall Study|Lost to Follow-up|0|||
156860068|NCT04199351|566244647|FG000|Overall Study|Withdrawal by Subject|0|||
156860069|NCT04199351|566244648|FG001|Overall Study|Withdrawal by Subject|1|||
156860070|NCT04199351|566244649|FG002|Overall Study|Withdrawal by Subject|0|||
156860071|NCT04199351|566244650|FG003|Overall Study|Withdrawal by Subject|0|||
156860072|NCT04199351|566244651|FG004|Overall Study|Withdrawal by Subject|1|||
156860073|NCT04199351|566244652|FG005|Overall Study|Withdrawal by Subject|4|||
156860074|NCT04199351|566244653|FG006|Overall Study|Withdrawal by Subject|2|||
156860075|NCT04199351|566244654|FG007|Overall Study|Withdrawal by Subject|0|||
156860076|NCT04199351|566244655|FG008|Overall Study|Withdrawal by Subject|3|||
156860077|NCT04199351|566244656|FG009|Overall Study|Withdrawal by Subject|0|||
156860078|NCT04742556|566244657|FG000|Overall Study|Withdrawal by Subject|0|||
156860079|NCT04742556|566244658|FG001|Overall Study|Withdrawal by Subject|1|||
156860080|NCT04742556|566244659|FG002|Overall Study|Withdrawal by Subject|0|||
156860081|NCT04742556|566244657|FG000|Overall Study|Adverse Event|0|||
156860082|NCT04742556|566244658|FG001|Overall Study|Adverse Event|0|||
156860083|NCT04742556|566244659|FG002|Overall Study|Adverse Event|2|||
156860084|NCT04742556|566244657|FG000|Overall Study|Clinical disease progression|0|||
156860085|NCT04742556|566244658|FG001|Overall Study|Clinical disease progression|1|||
156860086|NCT04742556|566244659|FG002|Overall Study|Clinical disease progression|2|||
156860087|NCT04742556|566244657|FG000|Overall Study|Objective disease progression|3|||
156860088|NCT04742556|566244658|FG001|Overall Study|Objective disease progression|2|||
156860089|NCT04742556|566244659|FG002|Overall Study|Objective disease progression|4|||
156860090|NCT04247347|566244660|FG000|Overall Study|Withdrawal by Subject|2|||
156860091|NCT04247347|566244661|FG001|Overall Study|Withdrawal by Subject|3|||
156860092|NCT04247347|566244662|FG002|Overall Study|Withdrawal by Subject|3|||
156860093|NCT04247347|566244660|FG000|Overall Study|Lost to Follow-up|1|||
156860094|NCT04247347|566244661|FG001|Overall Study|Lost to Follow-up|1|||
156860095|NCT04247347|566244662|FG002|Overall Study|Lost to Follow-up|1|||
156860096|NCT03035032|566244663|FG000|Overall Study|Adverse Event|2|||
156860097|NCT03035032|566244663|FG000|Overall Study|Death|9|||
156860098|NCT03035032|566244663|FG000|Overall Study|Lost to Follow-up|1|||
156860099|NCT03035032|566244663|FG000|Overall Study|Progressive Disease|22|||
156860100|NCT03035032|566244663|FG000|Overall Study|Protocol Violation|2|||
156860101|NCT03035032|566244663|FG000|Overall Study|Withdrawal by Subject|2|||
156860102|NCT03035032|566244663|FG000|Overall Study|Physician Decision|5|||
156860103|NCT01089504|566244669|FG000|Overall Study|Lost to Follow-up|1|||
156860104|NCT01089504|566244670|FG001|Overall Study|Lost to Follow-up|1|||
156860105|NCT01089504|566244669|FG000|Overall Study|Withdrawal by Subject|2|||
156860106|NCT01089504|566244670|FG001|Overall Study|Withdrawal by Subject|0|||
156860107|NCT03448406|566244671|FG000|Overall Study|Noncompliance of scheduled visits|1|||
156860108|NCT03448406|566244672|FG001|Overall Study|Noncompliance of scheduled visits|2|||
156909038|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
156909039|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
156909040|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
156909041|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
156909042|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
156909043|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
156909044|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
156909045|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
156909046|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
156909047|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
156909048|NCT01433991|566426146|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156909049|NCT01433991|566426147|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156909050|NCT01433991|566426148|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
156909051|NCT01433991|566426149|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
156909052|NCT00290888|566426152|FG000|Overall Study|Physician Decision|3|||
156909053|NCT00290888|566426153|FG001|Overall Study|Physician Decision|1|||
156909054|NCT01473836|566426154|FG000|Overall Study|Adverse Event|4|||
156909055|NCT01473836|566426154|FG000|Overall Study|Lack of Efficacy|1|||
156909056|NCT01473836|566426154|FG000|Overall Study|Does not meet entrance criteria|1|||
156909057|NCT01001377|566426155|FG000|Overall Study|Ineligibility determined|2|||
156909058|NCT01001377|566426156|FG001|Overall Study|Ineligibility determined|0|||
156909059|NCT01001377|566426155|FG000|Overall Study|Withdrawal by Subject|19|||
156909060|NCT01001377|566426156|FG001|Overall Study|Withdrawal by Subject|20|||
156909061|NCT01001377|566426155|FG000|Overall Study|Lost to Follow-up|14|||
156909062|NCT01001377|566426156|FG001|Overall Study|Lost to Follow-up|17|||
156909063|NCT01001377|566426155|FG000|Overall Study|Death|391|||
156909064|NCT01001377|566426156|FG001|Overall Study|Death|384|||
156909065|NCT03727230|566426159|FG000|Overall Study|Lost to Follow-up|12|||
156909066|NCT00288054|566426160|FG000|Overall Study|Protocol Violation|2|||
156909067|NCT00288054|566426160|FG000|Overall Study|Lack of Efficacy|16|||
156909068|NCT00288054|566426160|FG000|Overall Study|Adverse Event|3|||
156909069|NCT00288054|566426160|FG000|Overall Study|Withdrawal by Subject|1|||
156909070|NCT00288054|566426160|FG000|Overall Study|Not protocol specified|2|||
156909071|NCT01849783|566426171|FG000|Overall Study|Adverse Event|5|||
156909072|NCT01849783|566426171|FG000|Overall Study|Death|2|||
156909073|NCT01849783|566426171|FG000|Overall Study|Physician Decision|1|||
156909074|NCT01849783|566426171|FG000|Overall Study|Withdrawal by Subject|1|||
156909075|NCT01849783|566426171|FG000|Overall Study|Unable to comply|2|||
156909076|NCT01849783|566426171|FG000|Overall Study|Disease progression|11|||
156909077|NCT03173313|566426174|FG000|Overall Study|Lost to Follow-up|2|||
156909078|NCT03173313|566426175|FG001|Overall Study|Lost to Follow-up|3|||
156909079|NCT03173313|566426174|FG000|Overall Study|Withdrawal by Subject|0|||
156909080|NCT03173313|566426175|FG001|Overall Study|Withdrawal by Subject|1|||
156909081|NCT03173313|566426174|FG000|Overall Study|Death|5|||
156909082|NCT03173313|566426175|FG001|Overall Study|Death|0|||
156909083|NCT03173313|566426174|FG000|Overall Study|Physician Decision|1|||
156909084|NCT03173313|566426175|FG001|Overall Study|Physician Decision|0|||
156909085|NCT03173313|566426174|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
157027233|NCT03854227|566856068|FG005|Overall Study|Death|1|||
157027234|NCT03854227|566856069|FG006|Overall Study|Death|0|||
157027235|NCT03854227|566856070|FG007|Overall Study|Death|0|||
157027236|NCT03854227|566856071|FG008|Overall Study|Death|0|||
157027237|NCT03854227|566856072|FG009|Overall Study|Death|1|||
157027238|NCT03854227|566856073|FG010|Overall Study|Death|0|||
157027239|NCT03854227|566856074|FG011|Overall Study|Death|1|||
157027240|NCT03854227|566856063|FG000|Overall Study|Physician Decision|0|||
157027241|NCT03854227|566856064|FG001|Overall Study|Physician Decision|0|||
157027242|NCT03854227|566856065|FG002|Overall Study|Physician Decision|0|||
157027243|NCT03854227|566856066|FG003|Overall Study|Physician Decision|0|||
157027244|NCT03854227|566856067|FG004|Overall Study|Physician Decision|0|||
157027245|NCT03854227|566856068|FG005|Overall Study|Physician Decision|1|||
157027246|NCT03854227|566856069|FG006|Overall Study|Physician Decision|0|||
156909086|NCT03173313|566426175|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
156909087|NCT03173313|566426174|FG000|Overall Study|Bone Fracture|1|||
156909088|NCT03173313|566426175|FG001|Overall Study|Bone Fracture|0|||
156909089|NCT01876420|566426176|FG000|Overall Study|Missed 30 day visit|1|||
157027247|NCT03854227|566856070|FG007|Overall Study|Physician Decision|0|||
156909090|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
156909091|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
156909092|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
156909093|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
156909094|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
156909095|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156909096|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
156909097|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
157027248|NCT03854227|566856071|FG008|Overall Study|Physician Decision|1|||
156909098|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156909099|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
156909100|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
156909101|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
156909102|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
156909103|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
156909104|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
156909105|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
156909106|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
156909107|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
156909108|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
156909109|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
156909110|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
156909111|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
156909112|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
156909113|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
156909114|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
156909115|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156909116|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156909117|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
156909118|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156909119|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
156909120|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
156909121|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156909122|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156909123|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156909124|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
156909125|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156909126|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
156909127|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156909128|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156909129|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
156909130|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156909131|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
156909132|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156909133|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
156909134|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
156909135|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156909136|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156909137|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
156909138|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156909139|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
156909140|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
156909141|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
156909142|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
156909143|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
156909144|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
156909145|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
156909146|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
156909147|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
156909148|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
156909149|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
156909150|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156909151|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156909152|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156909153|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
156909154|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
156909155|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156909156|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156909157|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
156909158|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
156909159|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
157027249|NCT03854227|566856072|FG009|Overall Study|Physician Decision|1|||
157159815|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159816|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159817|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159818|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159819|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159820|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159821|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159822|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156909160|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Change of location|0|||
156909161|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Change of location|0|||
156909162|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Change of location|0|||
156909163|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Change of location|1|||
156909164|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Change of location|0|||
156909165|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
156909166|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
156909167|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
156909168|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
156909169|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
156909170|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156909171|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156909172|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156909173|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
156909174|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
156909175|NCT00730405|566426182|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
156909176|NCT00730405|566426183|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156909177|NCT00730405|566426184|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156909178|NCT00730405|566426185|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156909179|NCT00730405|566426186|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
156909180|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
156909181|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
156909182|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
156909183|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
156909184|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
156909185|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
156909186|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
156909187|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
156909188|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
156909189|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
156909190|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
156909191|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
156909192|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
156909193|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
156909194|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
156909195|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Death|0|||
156909196|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Death|1|||
156909197|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Death|0|||
156909198|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Death|1|||
156909199|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Death|0|||
156909200|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Change of location|1|||
156909201|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Change of location|1|||
156909202|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Change of location|0|||
156909203|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Change of location|1|||
156909204|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Change of location|0|||
156909205|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
156909206|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
156909207|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
156909208|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
156909209|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
156909210|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156909211|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
157027250|NCT03854227|566856073|FG010|Overall Study|Physician Decision|0|||
157027251|NCT03854227|566856074|FG011|Overall Study|Physician Decision|1|||
157027252|NCT03854227|566856063|FG000|Overall Study|Progressive disease|1|||
157027253|NCT03854227|566856064|FG001|Overall Study|Progressive disease|1|||
157027254|NCT03854227|566856065|FG002|Overall Study|Progressive disease|1|||
156909212|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
157027255|NCT03854227|566856066|FG003|Overall Study|Progressive disease|2|||
157027256|NCT03854227|566856067|FG004|Overall Study|Progressive disease|3|||
156909213|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156909214|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
156909215|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156909216|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156909217|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
156909218|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156909219|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
156909220|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156909221|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156909222|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156909223|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
156909224|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
156909225|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
156909226|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156909227|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156909228|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156909229|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
156909230|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156909231|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156909232|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156909233|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
156909234|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
156909235|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156909236|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
156909237|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
156909238|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156909239|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
156909240|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
156909241|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
156909242|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156909243|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156909244|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
156909245|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
156909246|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
156909247|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
156909248|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
156909249|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
156909250|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
156909251|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
156909252|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
156909253|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
156909254|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
156909255|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Missing|0|||
156909256|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Missing|0|||
156909257|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Missing|2|||
156909258|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Missing|0|||
156909259|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Missing|0|||
156909260|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156909261|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156909262|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156909263|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
156909264|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
156909265|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156909266|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156909267|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
156909268|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156909269|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
156909270|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
156909271|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
156909272|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
156909273|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
156909274|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
156909275|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
157159823|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159824|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159825|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
157159826|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
156909276|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
156909277|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
156909278|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
156909279|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
156909280|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156909281|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156909282|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156909283|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
156909284|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
156909285|NCT00730405|566426182|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
156909286|NCT00730405|566426183|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156909287|NCT00730405|566426184|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156909288|NCT00730405|566426185|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156909289|NCT00730405|566426186|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
156909290|NCT01496807|566426187|FG000|Overall Study|Progressive Disease|21|||
156909291|NCT01496807|566426187|FG000|Overall Study|Participant preference/toxicity|8|||
156909292|NCT01496807|566426187|FG000|Overall Study|Change in diagnosis|1|||
156909293|NCT03095612|566426191|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909294|NCT03095612|566426192|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
156909295|NCT03095612|566426193|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909296|NCT03095612|566426194|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909297|NCT03095612|566426195|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909298|NCT03095612|566426196|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909299|NCT03095612|566426197|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
156909300|NCT04447794|566426198|FG000|Overall Study|Lost to Follow-up|2|||
156909301|NCT04447794|566426199|FG001|Overall Study|Lost to Follow-up|3|||
156909302|NCT04447794|566426200|FG002|Overall Study|Lost to Follow-up|8|||
156909303|NCT04447794|566426198|FG000|Overall Study|Withdrawal by Subject|1|||
156909304|NCT04447794|566426199|FG001|Overall Study|Withdrawal by Subject|1|||
156909305|NCT04447794|566426200|FG002|Overall Study|Withdrawal by Subject|0|||
156909306|NCT01042678|566426201|FG000|Overall Study|Physician Decision|1|||
156909307|NCT01042678|566426202|FG001|Overall Study|Physician Decision|0|||
156909308|NCT01042678|566426203|FG002|Overall Study|Physician Decision|0|||
156909309|NCT01042678|566426204|FG003|Overall Study|Physician Decision|0|||
156909310|NCT01042678|566426205|FG004|Overall Study|Physician Decision|0|||
156909311|NCT01042678|566426206|FG005|Overall Study|Physician Decision|0|||
156909312|NCT00963937|566426215|FG000|Overall Study|Protocol Violation|1|||
156909313|NCT00963937|566426216|FG001|Overall Study|Protocol Violation|1|||
156909314|NCT00963937|566426217|FG002|Overall Study|Protocol Violation|0|||
156909315|NCT00963937|566426215|FG000|Overall Study|Physician Decision|18|||
156909316|NCT00963937|566426216|FG001|Overall Study|Physician Decision|10|||
156909317|NCT00963937|566426217|FG002|Overall Study|Physician Decision|4|||
156909318|NCT00205881|566426218|FG000|Overall Study|Withdrawal by Subject|16|||
156909319|NCT04203498|566426224|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
156909320|NCT04203498|566426225|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
156909321|NCT04203498|566426224|FG000|Overall Study|Withdrawal of patient consent|7|||
156909322|NCT04203498|566426225|FG001|Overall Study|Withdrawal of patient consent|2|||
156909323|NCT04203498|566426224|FG000|Overall Study|Adverse Event|4|||
156909324|NCT04203498|566426225|FG001|Overall Study|Adverse Event|1|||
156909325|NCT04203498|566426224|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
156909326|NCT04203498|566426225|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
156909327|NCT04203498|566426224|FG000|Overall Study|Did not receive IMP|2|||
157159827|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159828|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159829|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
157159830|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
156909328|NCT04203498|566426225|FG001|Overall Study|Did not receive IMP|0|||
156909329|NCT03546062|566426230|FG000|Overall Study|Adverse Event|6|||
156909330|NCT03546062|566426231|FG001|Overall Study|Adverse Event|5|||
156909331|NCT03546062|566426232|FG002|Overall Study|Adverse Event|8|||
156909332|NCT00181155|566426233|FG000|Overall Study|Physician Decision|1|||
156909333|NCT00181155|566426234|FG001|Overall Study|Physician Decision|0|||
156909334|NCT00181155|566426233|FG000|Overall Study|Withdrawal by Subject|1|||
156909335|NCT00181155|566426234|FG001|Overall Study|Withdrawal by Subject|0|||
156909336|NCT02083965|566426235|FG000|Treatment Period|Other|1|||
156909337|NCT02083965|566426236|FG001|Treatment Period|Other|0|||
156909338|NCT00282984|566426238|FG000|Overall Study|Death|2|||
156909339|NCT00282984|566426239|FG001|Overall Study|Death|5|||
156909340|NCT00282984|566426238|FG000|Overall Study|Adverse Event|8|||
156909341|NCT00282984|566426239|FG001|Overall Study|Adverse Event|5|||
156909342|NCT00282984|566426238|FG000|Overall Study|Lack of Efficacy|0|||
156909343|NCT00282984|566426239|FG001|Overall Study|Lack of Efficacy|2|||
156909344|NCT00282984|566426238|FG000|Overall Study|Lost to Follow-up|14|||
156909345|NCT00282984|566426239|FG001|Overall Study|Lost to Follow-up|10|||
156909346|NCT00282984|566426238|FG000|Overall Study|Withdrawal by Participant|22|||
156909347|NCT00282984|566426239|FG001|Overall Study|Withdrawal by Participant|34|||
156909348|NCT00282984|566426238|FG000|Overall Study|Participant stopped study medication|2|||
156909349|NCT00282984|566426239|FG001|Overall Study|Participant stopped study medication|2|||
156909350|NCT00282984|566426238|FG000|Overall Study|Participant only allowed phone follow-up|0|||
156909351|NCT00282984|566426239|FG001|Overall Study|Participant only allowed phone follow-up|1|||
156909352|NCT00282984|566426238|FG000|Overall Study|Participant used antipsychosis meds|0|||
156909353|NCT00282984|566426239|FG001|Overall Study|Participant used antipsychosis meds|1|||
156909354|NCT00282984|566426238|FG000|Overall Study|lack of motivation|1|||
156909355|NCT00282984|566426239|FG001|Overall Study|lack of motivation|0|||
156909356|NCT00282984|566426238|FG000|Overall Study|in prison|0|||
156909357|NCT00282984|566426239|FG001|Overall Study|in prison|1|||
156909358|NCT00282984|566426238|FG000|Overall Study|Protocol Violation|2|||
156909359|NCT00282984|566426239|FG001|Overall Study|Protocol Violation|0|||
156909360|NCT00868608|566426240|FG000|Overall Study|Withdrawal by Subject|3|||
156909361|NCT00868608|566426241|FG001|Overall Study|Withdrawal by Subject|1|||
156909362|NCT00868608|566426242|FG002|Overall Study|Withdrawal by Subject|0|||
156909363|NCT00868608|566426240|FG000|Overall Study|Lost to Follow-up|3|||
156909364|NCT00868608|566426241|FG001|Overall Study|Lost to Follow-up|0|||
156909365|NCT00868608|566426242|FG002|Overall Study|Lost to Follow-up|1|||
156909366|NCT00868608|566426240|FG000|Overall Study|Death|16|||
156909367|NCT00868608|566426241|FG001|Overall Study|Death|2|||
156909368|NCT00868608|566426242|FG002|Overall Study|Death|4|||
156909369|NCT00868608|566426240|FG000|Overall Study|Other - Unspecified|1|||
156909370|NCT00868608|566426241|FG001|Overall Study|Other - Unspecified|0|||
156909371|NCT00868608|566426242|FG002|Overall Study|Other - Unspecified|0|||
156909372|NCT00911547|566426243|FG000|Overall Study|Adverse Event|8|||
156909373|NCT00911547|566426244|FG001|Overall Study|Adverse Event|27|||
156909374|NCT00911547|566426245|FG002|Overall Study|Adverse Event|11|||
156909375|NCT00911547|566426246|FG003|Overall Study|Adverse Event|6|||
156909376|NCT00911547|566426243|FG000|Overall Study|Lost to Follow-up|0|||
156909377|NCT00911547|566426244|FG001|Overall Study|Lost to Follow-up|0|||
156909378|NCT00911547|566426245|FG002|Overall Study|Lost to Follow-up|2|||
157159831|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156909379|NCT00911547|566426246|FG003|Overall Study|Lost to Follow-up|1|||
156909380|NCT00911547|566426243|FG000|Overall Study|Protocol Violation|0|||
156909381|NCT00911547|566426244|FG001|Overall Study|Protocol Violation|5|||
156909382|NCT00911547|566426245|FG002|Overall Study|Protocol Violation|5|||
156909383|NCT00911547|566426246|FG003|Overall Study|Protocol Violation|1|||
156909384|NCT00911547|566426243|FG000|Overall Study|Withdrawal by Subject|3|||
156909385|NCT00911547|566426244|FG001|Overall Study|Withdrawal by Subject|10|||
156909386|NCT00911547|566426245|FG002|Overall Study|Withdrawal by Subject|4|||
156909387|NCT00911547|566426246|FG003|Overall Study|Withdrawal by Subject|8|||
156909388|NCT00457301|566426247|FG000|Overall Study|Withdrawal by Subject|3|||
156909389|NCT00457301|566426248|FG001|Overall Study|Withdrawal by Subject|3|||
156909390|NCT00457301|566426247|FG000|Overall Study|Censored out of the study|15|||
156909391|NCT00457301|566426248|FG001|Overall Study|Censored out of the study|14|||
156909392|NCT00457301|566426247|FG000|Overall Study|Death|5|||
156909393|NCT00457301|566426248|FG001|Overall Study|Death|7|||
157159832|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156909394|NCT00191269|566426249|FG000|Overall Study|Protocol Violation|0|||
156909395|NCT00191269|566426250|FG001|Overall Study|Protocol Violation|2|||
156909396|NCT00191269|566426249|FG000|Overall Study|Adverse Event|1|||
156909397|NCT00191269|566426250|FG001|Overall Study|Adverse Event|4|||
157159833|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
156909398|NCT00191269|566426249|FG000|Overall Study|Progression of Disease|4|||
156909399|NCT00191269|566426250|FG001|Overall Study|Progression of Disease|42|||
156909400|NCT00191269|566426249|FG000|Overall Study|Lack of Efficacy|1|||
156909401|NCT00191269|566426250|FG001|Overall Study|Lack of Efficacy|5|||
156909402|NCT00191269|566426249|FG000|Overall Study|Withdrawal by Subject|0|||
156909403|NCT00191269|566426250|FG001|Overall Study|Withdrawal by Subject|1|||
156909404|NCT00191269|566426249|FG000|Overall Study|Pathologic Aggrevation|0|||
156909405|NCT00191269|566426250|FG001|Overall Study|Pathologic Aggrevation|1|||
156909406|NCT00191269|566426249|FG000|Overall Study|Physician Decision|0|||
156909407|NCT00191269|566426250|FG001|Overall Study|Physician Decision|3|||
156909408|NCT00674362|566426253|FG000|Double Blind|Adverse Event|6|||
156909409|NCT00674362|566426254|FG001|Double Blind|Adverse Event|6|||
156909410|NCT00674362|566426253|FG000|Double Blind|Lack of Efficacy|2|||
156909411|NCT00674362|566426254|FG001|Double Blind|Lack of Efficacy|6|||
156909412|NCT00674362|566426253|FG000|Double Blind|Loss of efficacy|0|||
156909413|NCT00674362|566426254|FG001|Double Blind|Loss of efficacy|1|||
156909414|NCT00674362|566426253|FG000|Double Blind|Withdrawal by Subject|4|||
156909415|NCT00674362|566426254|FG001|Double Blind|Withdrawal by Subject|3|||
156909416|NCT00674362|566426253|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
156909417|NCT00674362|566426254|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
156909418|NCT00674362|566426253|FG000|Double Blind|Other: Surgery|0|||
156909419|NCT00674362|566426254|FG001|Double Blind|Other: Surgery|1|||
156909420|NCT00674362|566426253|FG000|Open Label|Adverse Event|1|||
156909421|NCT00674362|566426254|FG001|Open Label|Adverse Event|0|||
156909422|NCT00674362|566426253|FG000|Open Label|Other: Subject moved to extension study|1|||
156909423|NCT00674362|566426254|FG001|Open Label|Other: Subject moved to extension study|0|||
156909424|NCT00939770|566426257|FG000|Overall Study|Adverse Event|1|||
156909425|NCT00939770|566426258|FG001|Overall Study|Adverse Event|1|||
156909426|NCT00939770|566426259|FG002|Overall Study|Adverse Event|0|||
156909427|NCT00939770|566426260|FG003|Overall Study|Adverse Event|0|||
156909428|NCT00939770|566426261|FG004|Overall Study|Adverse Event|6|||
156909429|NCT00939770|566426262|FG005|Overall Study|Adverse Event|2|||
156909430|NCT00939770|566426263|FG006|Overall Study|Adverse Event|1|||
156909431|NCT00939770|566426264|FG007|Overall Study|Adverse Event|1|||
156909432|NCT00939770|566426257|FG000|Overall Study|Lack of Efficacy|4|||
156909433|NCT00939770|566426258|FG001|Overall Study|Lack of Efficacy|6|||
156909434|NCT00939770|566426259|FG002|Overall Study|Lack of Efficacy|13|||
156909435|NCT00939770|566426260|FG003|Overall Study|Lack of Efficacy|9|||
156909436|NCT00939770|566426261|FG004|Overall Study|Lack of Efficacy|16|||
156909437|NCT00939770|566426262|FG005|Overall Study|Lack of Efficacy|8|||
156909438|NCT00939770|566426263|FG006|Overall Study|Lack of Efficacy|11|||
156909439|NCT00939770|566426264|FG007|Overall Study|Lack of Efficacy|1|||
156909440|NCT00939770|566426257|FG000|Overall Study|Lost to Follow-up|0|||
156909441|NCT00939770|566426258|FG001|Overall Study|Lost to Follow-up|0|||
156909442|NCT00939770|566426259|FG002|Overall Study|Lost to Follow-up|0|||
156909443|NCT00939770|566426260|FG003|Overall Study|Lost to Follow-up|0|||
156909444|NCT00939770|566426261|FG004|Overall Study|Lost to Follow-up|1|||
156909445|NCT00939770|566426262|FG005|Overall Study|Lost to Follow-up|0|||
156909446|NCT00939770|566426263|FG006|Overall Study|Lost to Follow-up|0|||
156909447|NCT00939770|566426264|FG007|Overall Study|Lost to Follow-up|0|||
156909448|NCT00939770|566426257|FG000|Overall Study|Physician Decision|0|||
156909449|NCT00939770|566426258|FG001|Overall Study|Physician Decision|0|||
156909450|NCT00939770|566426259|FG002|Overall Study|Physician Decision|2|||
156909451|NCT00939770|566426260|FG003|Overall Study|Physician Decision|0|||
156909452|NCT00939770|566426261|FG004|Overall Study|Physician Decision|7|||
156909453|NCT00939770|566426262|FG005|Overall Study|Physician Decision|1|||
156909454|NCT00939770|566426263|FG006|Overall Study|Physician Decision|0|||
156909455|NCT00939770|566426264|FG007|Overall Study|Physician Decision|6|||
156909456|NCT00939770|566426257|FG000|Overall Study|Protocol Violation|0|||
156909457|NCT00939770|566426258|FG001|Overall Study|Protocol Violation|0|||
156909458|NCT00939770|566426259|FG002|Overall Study|Protocol Violation|0|||
156909459|NCT00939770|566426260|FG003|Overall Study|Protocol Violation|0|||
156909460|NCT00939770|566426261|FG004|Overall Study|Protocol Violation|1|||
156909461|NCT00939770|566426262|FG005|Overall Study|Protocol Violation|0|||
156909462|NCT00939770|566426263|FG006|Overall Study|Protocol Violation|0|||
156909463|NCT00939770|566426264|FG007|Overall Study|Protocol Violation|0|||
156909464|NCT00939770|566426257|FG000|Overall Study|Withdrawal by Subject|0|||
156909465|NCT00939770|566426258|FG001|Overall Study|Withdrawal by Subject|1|||
156909466|NCT00939770|566426259|FG002|Overall Study|Withdrawal by Subject|5|||
156909467|NCT00939770|566426260|FG003|Overall Study|Withdrawal by Subject|2|||
156909468|NCT00939770|566426261|FG004|Overall Study|Withdrawal by Subject|6|||
156909469|NCT00939770|566426262|FG005|Overall Study|Withdrawal by Subject|0|||
156909470|NCT00939770|566426263|FG006|Overall Study|Withdrawal by Subject|2|||
156909471|NCT00939770|566426264|FG007|Overall Study|Withdrawal by Subject|2|||
156909472|NCT04066023|566426265|FG000|Overall Study|Adverse Event|0|||
156909473|NCT04066023|566426266|FG001|Overall Study|Adverse Event|0|||
156909474|NCT04066023|566426267|FG002|Overall Study|Adverse Event|1|||
157027257|NCT03854227|566856068|FG005|Overall Study|Progressive disease|1|||
156909475|NCT04066023|566426265|FG000|Overall Study|Sponsor decision|3|||
156909476|NCT04066023|566426266|FG001|Overall Study|Sponsor decision|6|||
156909477|NCT04066023|566426267|FG002|Overall Study|Sponsor decision|2|||
156909478|NCT04066023|566426265|FG000|Overall Study|Physician Decision|0|||
156909479|NCT04066023|566426266|FG001|Overall Study|Physician Decision|0|||
156909480|NCT04066023|566426267|FG002|Overall Study|Physician Decision|1|||
156909481|NCT04066023|566426265|FG000|Overall Study|Lost to Follow-up|0|||
156909482|NCT04066023|566426266|FG001|Overall Study|Lost to Follow-up|1|||
156909483|NCT04066023|566426267|FG002|Overall Study|Lost to Follow-up|1|||
156909484|NCT04066023|566426265|FG000|Overall Study|Noncompliance|0|||
156909485|NCT04066023|566426266|FG001|Overall Study|Noncompliance|1|||
156909486|NCT04066023|566426267|FG002|Overall Study|Noncompliance|1|||
156909487|NCT04665856|566426268|FG000|Overall Study|Site Terminated by Sponsor|1|||
156909488|NCT04665856|566426269|FG001|Overall Study|Site Terminated by Sponsor|0|||
156909489|NCT04665856|566426268|FG000|Overall Study|Withdrawal by Subject|2|||
157027258|NCT03854227|566856069|FG006|Overall Study|Progressive disease|2|||
156909490|NCT04665856|566426269|FG001|Overall Study|Withdrawal by Subject|0|||
156909491|NCT04665856|566426268|FG000|Overall Study|Lost to Follow-up|3|||
156909492|NCT04665856|566426269|FG001|Overall Study|Lost to Follow-up|2|||
156909493|NCT04665856|566426268|FG000|Overall Study|Death|39|||
156909494|NCT04665856|566426269|FG001|Overall Study|Death|44|||
156909495|NCT04665856|566426268|FG000|Overall Study|Ongoing in study|17|||
156909496|NCT04665856|566426269|FG001|Overall Study|Ongoing in study|15|||
156909497|NCT03386448|566426270|FG000|Overall Study|Adverse Event|0|||
156909498|NCT03386448|566426271|FG001|Overall Study|Adverse Event|2|||
156909499|NCT03338010|566426272|FG000|Overall Study|Withdrawal by Subject|14|||
156909500|NCT03338010|566426273|FG001|Overall Study|Withdrawal by Subject|8|||
156909501|NCT03338010|566426272|FG000|Overall Study|Lost to Follow-up|4|||
156909502|NCT03338010|566426273|FG001|Overall Study|Lost to Follow-up|2|||
156909503|NCT03338010|566426272|FG000|Overall Study|Adverse Event|3|||
156909504|NCT03338010|566426273|FG001|Overall Study|Adverse Event|2|||
156909505|NCT03338010|566426272|FG000|Overall Study|Physician Decision|2|||
156909506|NCT03338010|566426273|FG001|Overall Study|Physician Decision|2|||
156909507|NCT03338010|566426272|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156909508|NCT03338010|566426273|FG001|Overall Study|Non-Compliance with Study Drug|3|||
156909509|NCT03338010|566426272|FG000|Overall Study|Protocol Violation|0|||
156909510|NCT03338010|566426273|FG001|Overall Study|Protocol Violation|1|||
156909511|NCT01146665|566426274|FG000|Overall Study|Withdrawal by Subject|10|||
156909512|NCT01146665|566426275|FG001|Overall Study|Withdrawal by Subject|16|||
156909513|NCT02564796|566426280|FG000|Overall Study|Physician Decision|2|||
156909514|NCT02564796|566426281|FG001|Overall Study|Physician Decision|2|||
156909515|NCT00293033|566426282|FG000|Open-label Titration Period|Adverse Event|10|||
156909516|NCT00293033|566426282|FG000|Open-label Titration Period|Death|3|||
156909517|NCT00293033|566426282|FG000|Open-label Titration Period|Lack of Efficacy|5|||
156909518|NCT00293033|566426282|FG000|Open-label Titration Period|Protocol Violation|2|||
156909519|NCT00293033|566426282|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
156909520|NCT00293033|566426282|FG000|Open-label Titration Period|Noncompliance and other|27|||
156909521|NCT00293033|566426282|FG000|Double-blind Treatment Period|Adverse Event|3|||
156909522|NCT00293033|566426282|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
156909523|NCT00293033|566426282|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
156909524|NCT00293033|566426282|FG000|Double-blind Treatment Period|Noncompliance|4|||
156909525|NCT00743483|566426288|FG000|Baseline Period|Physician Decision|1|||
156909526|NCT00743483|566426288|FG000|Treatment Period|Adverse Event|1|||
156909527|NCT00873912|566426290|FG000|Overall Study|Withdrawal by Subject|1|||
156909528|NCT00873912|566426291|FG001|Overall Study|Withdrawal by Subject|0|||
156909529|NCT00873912|566426290|FG000|Overall Study|Lost to Follow-up|2|||
156909530|NCT00873912|566426291|FG001|Overall Study|Lost to Follow-up|0|||
156909531|NCT04840615|566428020|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
156909532|NCT04840615|566428021|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
156909533|NCT04840615|566428022|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
156909534|NCT00126191|566428025|FG000|Overall Study|Physician Decision|0|||
156909535|NCT00126191|566428026|FG001|Overall Study|Physician Decision|1|||
156909536|NCT00126191|566428025|FG000|Overall Study|Death|0|||
156909537|NCT00126191|566428026|FG001|Overall Study|Death|1|||
156909538|NCT00307294|566428027|FG000|Overall Study|Withdrawal by Subject|1|||
156909539|NCT02954237|566428038|FG000|Overall Study|Withdrawal by Subject|25|||
156909540|NCT02954237|566428038|FG000|Overall Study|Missed visit|16|||
156909541|NCT02954237|566428038|FG000|Overall Study|Death|2|||
156909542|NCT00674700|566428039|FG000|Year 1|Adverse Event|17|||
156909543|NCT00674700|566428040|FG001|Year 1|Adverse Event|20|||
156909544|NCT00674700|566428041|FG002|Year 1|Adverse Event|5|||
156909545|NCT00674700|566428039|FG000|Year 1|Withdrawal by Subject|7|||
156909546|NCT00674700|566428040|FG001|Year 1|Withdrawal by Subject|7|||
156909547|NCT00674700|566428041|FG002|Year 1|Withdrawal by Subject|6|||
156909548|NCT00674700|566428039|FG000|Year 1|Any other reason not above-mentioned|7|||
156909549|NCT00674700|566428040|FG001|Year 1|Any other reason not above-mentioned|7|||
156909550|NCT00674700|566428041|FG002|Year 1|Any other reason not above-mentioned|6|||
156909551|NCT00674700|566428039|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
156909552|NCT00674700|566428040|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
157159834|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
157159835|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
157159836|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
156909553|NCT00674700|566428041|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
156909554|NCT00674700|566428039|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
156909555|NCT00674700|566428040|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
156909556|NCT00674700|566428041|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
156909557|NCT00674700|566428039|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
156909558|NCT00674700|566428040|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
157027259|NCT03854227|566856070|FG007|Overall Study|Progressive disease|5|||
156909559|NCT00674700|566428041|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
157159837|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
156909560|NCT00395304|566428042|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156909561|NCT00395304|566428043|FG001|Treatment Period 1|Withdrawal by Subject|3|||
156909562|NCT00395304|566428044|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156909563|NCT00395304|566428045|FG003|Treatment Period 1|Withdrawal by Subject|2|||
156909564|NCT00395304|566428046|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156909565|NCT00395304|566428047|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156909566|NCT00395304|566428042|FG000|Treatment Period 1|Lost to Follow-up|1|||
156909567|NCT00395304|566428043|FG001|Treatment Period 1|Lost to Follow-up|0|||
156909568|NCT00395304|566428044|FG002|Treatment Period 1|Lost to Follow-up|0|||
156909569|NCT00395304|566428045|FG003|Treatment Period 1|Lost to Follow-up|1|||
156909570|NCT00395304|566428046|FG004|Treatment Period 1|Lost to Follow-up|0|||
156909571|NCT00395304|566428047|FG005|Treatment Period 1|Lost to Follow-up|1|||
156909572|NCT00395304|566428042|FG000|Treatment Period 1|Physician Decision|0|||
156909573|NCT00395304|566428043|FG001|Treatment Period 1|Physician Decision|1|||
156909574|NCT00395304|566428044|FG002|Treatment Period 1|Physician Decision|0|||
156909575|NCT00395304|566428045|FG003|Treatment Period 1|Physician Decision|0|||
156909576|NCT00395304|566428046|FG004|Treatment Period 1|Physician Decision|0|||
156909577|NCT00395304|566428047|FG005|Treatment Period 1|Physician Decision|0|||
156909578|NCT00395304|566428042|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156909579|NCT00395304|566428043|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156909580|NCT00395304|566428044|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156909581|NCT00395304|566428045|FG003|Treatment Period 2|Withdrawal by Subject|1|||
156909582|NCT00395304|566428046|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156909583|NCT00395304|566428047|FG005|Treatment Period 2|Withdrawal by Subject|2|||
156909584|NCT00395304|566428042|FG000|Treatment Period 2|Lost to Follow-up|0|||
156909585|NCT00395304|566428043|FG001|Treatment Period 2|Lost to Follow-up|3|||
156909586|NCT00395304|566428044|FG002|Treatment Period 2|Lost to Follow-up|0|||
156909587|NCT00395304|566428045|FG003|Treatment Period 2|Lost to Follow-up|0|||
156909588|NCT00395304|566428046|FG004|Treatment Period 2|Lost to Follow-up|0|||
156909589|NCT00395304|566428047|FG005|Treatment Period 2|Lost to Follow-up|0|||
156909590|NCT00395304|566428042|FG000|Treatment Period 2|Physician Decision|0|||
156909591|NCT00395304|566428043|FG001|Treatment Period 2|Physician Decision|0|||
156909592|NCT00395304|566428044|FG002|Treatment Period 2|Physician Decision|1|||
156909593|NCT00395304|566428045|FG003|Treatment Period 2|Physician Decision|0|||
156909594|NCT00395304|566428046|FG004|Treatment Period 2|Physician Decision|0|||
156909595|NCT00395304|566428047|FG005|Treatment Period 2|Physician Decision|0|||
156909596|NCT00395304|566428042|FG000|Treatment Period 2|Other|0|||
156909597|NCT00395304|566428043|FG001|Treatment Period 2|Other|1|||
156909598|NCT00395304|566428044|FG002|Treatment Period 2|Other|0|||
156909599|NCT00395304|566428045|FG003|Treatment Period 2|Other|0|||
156909600|NCT00395304|566428046|FG004|Treatment Period 2|Other|0|||
156909601|NCT00395304|566428047|FG005|Treatment Period 2|Other|0|||
156909602|NCT00395304|566428042|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156909603|NCT00395304|566428043|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156909604|NCT00395304|566428044|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156909605|NCT00395304|566428045|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156909606|NCT00395304|566428046|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156909607|NCT00395304|566428047|FG005|Treatment Period 3|Withdrawal by Subject|1|||
156909608|NCT00395304|566428042|FG000|Treatment Period 3|Lost to Follow-up|1|||
156909609|NCT00395304|566428043|FG001|Treatment Period 3|Lost to Follow-up|1|||
156909610|NCT00395304|566428044|FG002|Treatment Period 3|Lost to Follow-up|0|||
156909611|NCT00395304|566428045|FG003|Treatment Period 3|Lost to Follow-up|0|||
156909612|NCT00395304|566428046|FG004|Treatment Period 3|Lost to Follow-up|0|||
156909613|NCT00395304|566428047|FG005|Treatment Period 3|Lost to Follow-up|0|||
156909614|NCT00395304|566428042|FG000|Treatment Period 3|Physician Decision|0|||
156909615|NCT00395304|566428043|FG001|Treatment Period 3|Physician Decision|1|||
156909616|NCT00395304|566428044|FG002|Treatment Period 3|Physician Decision|0|||
156909617|NCT00395304|566428045|FG003|Treatment Period 3|Physician Decision|0|||
156909618|NCT00395304|566428046|FG004|Treatment Period 3|Physician Decision|0|||
156909619|NCT00395304|566428047|FG005|Treatment Period 3|Physician Decision|0|||
156909620|NCT00395304|566428042|FG000|Treatment Period 3|Other|0|||
156909621|NCT00395304|566428043|FG001|Treatment Period 3|Other|0|||
156909622|NCT00395304|566428044|FG002|Treatment Period 3|Other|0|||
156909623|NCT00395304|566428045|FG003|Treatment Period 3|Other|1|||
156909624|NCT00395304|566428046|FG004|Treatment Period 3|Other|0|||
156909625|NCT00395304|566428047|FG005|Treatment Period 3|Other|0|||
156909626|NCT00621985|566428058|FG000|Dexamethasone Admission|Adverse Event|1|||
156909627|NCT03068130|566428059|FG000|Overall Study|Adverse Event|19|||
156909628|NCT03068130|566428059|FG000|Overall Study|Death|14|||
156909629|NCT03068130|566428059|FG000|Overall Study|Lost to Follow-up|4|||
156909630|NCT03068130|566428059|FG000|Overall Study|Withdrawal by Subject|26|||
156909631|NCT03068130|566428059|FG000|Overall Study|Administrative Reasons|3|||
156909632|NCT03068130|566428059|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
156909633|NCT03068130|566428059|FG000|Overall Study|Study terminated by sponsor|194|||
156909634|NCT00964860|566428060|FG000|Overall Study|Withdrawal by Subject|0|||
156909635|NCT00964860|566428061|FG001|Overall Study|Withdrawal by Subject|1|||
156909636|NCT05275400|566428062|FG000|Treatment Period|Adverse Event|7|||
157159838|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
157159839|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
157159840|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
157159841|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
157159842|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
157159843|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
157159844|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
157159845|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
157159846|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
157159847|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
157159848|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
157159849|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
157159850|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
157159851|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
157159852|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
157159853|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
157159854|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
157159855|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
157159856|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
157159857|NCT02052778|567329531|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159858|NCT02052778|567329532|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159859|NCT02052778|567329533|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159860|NCT02052778|567329534|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159861|NCT02052778|567329535|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159862|NCT02052778|567329536|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159863|NCT02052778|567329537|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159864|NCT02052778|567329538|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159865|NCT02052778|567329539|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159866|NCT02052778|567329540|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159867|NCT02052778|567329541|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159868|NCT02052778|567329542|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159869|NCT02052778|567329543|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159870|NCT02052778|567329544|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159871|NCT02052778|567329545|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
157159872|NCT02052778|567329546|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
157159873|NCT02052778|567329547|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
157159874|NCT02052778|567329548|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159875|NCT02052778|567329549|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
157159876|NCT02052778|567329550|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159877|NCT02052778|567329551|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
157159878|NCT02052778|567329552|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156909637|NCT05275400|566428063|FG001|Treatment Period|Adverse Event|1|||
156909638|NCT05275400|566428062|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
156909639|NCT05275400|566428063|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
156909640|NCT05275400|566428062|FG000|Treatment Period|Death|5|||
156909641|NCT05275400|566428063|FG001|Treatment Period|Death|2|||
156909642|NCT05275400|566428062|FG000|Treatment Period|Protocol Violation|1|||
156909643|NCT05275400|566428063|FG001|Treatment Period|Protocol Violation|0|||
156909644|NCT05275400|566428062|FG000|Treatment Period|Physician Decision|5|||
156909645|NCT05275400|566428063|FG001|Treatment Period|Physician Decision|4|||
156909646|NCT05275400|566428062|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
156909647|NCT05275400|566428063|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
156909648|NCT05275400|566428062|FG000|Treatment Period|Withdrawal by Subject|30|||
156909649|NCT05275400|566428063|FG001|Treatment Period|Withdrawal by Subject|12|||
156909650|NCT05275400|566428062|FG000|Treatment Period|Lost to Follow-up|1|||
156909651|NCT05275400|566428063|FG001|Treatment Period|Lost to Follow-up|5|||
156909652|NCT05275400|566428062|FG000|Treatment Period|Lack of Efficacy|1|||
156909653|NCT05275400|566428063|FG001|Treatment Period|Lack of Efficacy|0|||
156909654|NCT05275400|566428062|FG000|Treatment Period|Sponsor Decision|1|||
156909655|NCT05275400|566428063|FG001|Treatment Period|Sponsor Decision|0|||
156909656|NCT05275400|566428062|FG000|Follow-Up Period|Death|2|||
156909657|NCT05275400|566428063|FG001|Follow-Up Period|Death|0|||
157159879|NCT02052778|567329553|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
156909658|NCT05275400|566428062|FG000|Follow-Up Period|Protocol Violation|1|||
156909659|NCT05275400|566428063|FG001|Follow-Up Period|Protocol Violation|0|||
156909660|NCT05275400|566428062|FG000|Follow-Up Period|Withdrawal by Subject|3|||
156909661|NCT05275400|566428063|FG001|Follow-Up Period|Withdrawal by Subject|0|||
156909662|NCT00334958|566428065|FG000|Overall Study|Medication Noncompliance|0|||
157159880|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159881|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
156909663|NCT00334958|566428066|FG001|Overall Study|Medication Noncompliance|3|||
157159882|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159883|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159884|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159885|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159886|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159887|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159888|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159889|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159890|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159891|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159892|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159893|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159894|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159895|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159896|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159897|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159898|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159899|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159900|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159901|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
157159902|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
157159903|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159904|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159905|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159906|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159907|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159908|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159909|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159910|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159911|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159912|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159913|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159914|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159915|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159916|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156909664|NCT00334958|566428065|FG000|Overall Study|Protocol Violation|2|||
156909665|NCT00334958|566428066|FG001|Overall Study|Protocol Violation|2|||
156909666|NCT00334958|566428065|FG000|Overall Study|Request of the investigator or sponsor|0|||
156909667|NCT00334958|566428066|FG001|Overall Study|Request of the investigator or sponsor|1|||
156909668|NCT00334958|566428065|FG000|Overall Study|Withdrawal by Subject|7|||
156909669|NCT00334958|566428066|FG001|Overall Study|Withdrawal by Subject|4|||
156909670|NCT00334958|566428065|FG000|Overall Study|Adverse Event|27|||
156909671|NCT00334958|566428066|FG001|Overall Study|Adverse Event|12|||
156909672|NCT00334958|566428065|FG000|Overall Study|Other|1|||
156909673|NCT00334958|566428066|FG001|Overall Study|Other|2|||
156909674|NCT00781274|566428067|FG000|Overall Study|Withdrawal by Subject|2|||
156909675|NCT02572401|566428068|FG000|Overall Study|Lost to Follow-up|5|||
156909676|NCT02572401|566428069|FG001|Overall Study|Lost to Follow-up|8|||
156909677|NCT02572401|566428070|FG002|Overall Study|Lost to Follow-up|9|||
156909678|NCT02572401|566428071|FG003|Overall Study|Lost to Follow-up|9|||
156909679|NCT02572401|566428068|FG000|Overall Study|Death|0|||
156909680|NCT02572401|566428069|FG001|Overall Study|Death|0|||
156909681|NCT02572401|566428070|FG002|Overall Study|Death|0|||
156909682|NCT02572401|566428071|FG003|Overall Study|Death|1|||
156909683|NCT01548287|566428072|FG000|Screening|No reason provided|0|||
156909684|NCT01548287|566428073|FG001|Screening|No reason provided|0|||
156909685|NCT01548287|566428074|FG002|Screening|No reason provided|0|||
156909686|NCT01548287|566428075|FG003|Screening|No reason provided|0|||
156909687|NCT01548287|566428076|FG004|Screening|No reason provided|9|||
156909688|NCT01548287|566428072|FG000|Screening|Did not meet eligibility criteria|0|||
156909689|NCT01548287|566428073|FG001|Screening|Did not meet eligibility criteria|0|||
157159917|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159918|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159919|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156909690|NCT01548287|566428074|FG002|Screening|Did not meet eligibility criteria|0|||
156909691|NCT01548287|566428075|FG003|Screening|Did not meet eligibility criteria|0|||
156909692|NCT01548287|566428076|FG004|Screening|Did not meet eligibility criteria|74|||
156909693|NCT01548287|566428072|FG000|Randomized Period|Did not meet inclusion criteria|0|||
156909694|NCT01548287|566428073|FG001|Randomized Period|Did not meet inclusion criteria|0|||
156909695|NCT01548287|566428074|FG002|Randomized Period|Did not meet inclusion criteria|2|||
156909696|NCT01548287|566428075|FG003|Randomized Period|Did not meet inclusion criteria|0|||
156909697|NCT01548287|566428076|FG004|Randomized Period|Did not meet inclusion criteria|0|||
156909698|NCT01548287|566428072|FG000|Randomized Period|Adverse Event|0|||
156909699|NCT01548287|566428073|FG001|Randomized Period|Adverse Event|2|||
156909700|NCT01548287|566428074|FG002|Randomized Period|Adverse Event|5|||
156909701|NCT01548287|566428075|FG003|Randomized Period|Adverse Event|0|||
156909702|NCT01548287|566428076|FG004|Randomized Period|Adverse Event|0|||
156909703|NCT02762578|566428083|FG000|Overall Study|Adverse Event|1|||
156909704|NCT02762578|566428084|FG001|Overall Study|Adverse Event|6|||
156909705|NCT02762578|566428083|FG000|Overall Study|Protocol Violation|4|||
156909706|NCT02762578|566428084|FG001|Overall Study|Protocol Violation|2|||
156909707|NCT02762578|566428083|FG000|Overall Study|Withdrawal by Subject|4|||
156909708|NCT02762578|566428084|FG001|Overall Study|Withdrawal by Subject|2|||
156909709|NCT02762578|566428083|FG000|Overall Study|Unclassified|6|||
156909710|NCT02762578|566428084|FG001|Overall Study|Unclassified|0|||
156909711|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156909712|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156909713|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156909714|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
156909715|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156909716|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156909717|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
156909718|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
156909719|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909720|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
156909721|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909722|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909723|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909724|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909725|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
156909726|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
156909727|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909728|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909729|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
156909730|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909731|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909732|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909733|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909734|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909735|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Other|0|||
156909736|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Other|0|||
156909737|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Other|1|||
156909738|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Other|1|||
156909739|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Other|2|||
156909740|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Other|0|||
156909741|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Other|0|||
156909742|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Other|0|||
156909743|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909744|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909745|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
157159920|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156909746|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909747|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
156909748|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909749|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909750|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
156909751|NCT01090492|566428085|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
156909752|NCT01090492|566428086|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
156909753|NCT01090492|566428087|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
157159921|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159922|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
156909754|NCT01090492|566428088|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
156909755|NCT01090492|566428089|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
156909756|NCT01090492|566428090|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
156909757|NCT01090492|566428091|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
156909758|NCT01090492|566428092|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
156909759|NCT01090492|566428085|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156909760|NCT01090492|566428086|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156909761|NCT01090492|566428087|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156909762|NCT01090492|566428088|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
157159923|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159924|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
157159925|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
157159926|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159927|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159928|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159929|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159930|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159931|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159932|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159933|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159934|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159935|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159936|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159937|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156909763|NCT01090492|566428089|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156909764|NCT01090492|566428090|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
156909765|NCT01090492|566428091|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156909766|NCT01090492|566428092|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
156909767|NCT01090492|566428085|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909768|NCT01090492|566428086|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
156909769|NCT01090492|566428087|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909770|NCT01090492|566428088|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909771|NCT01090492|566428089|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909772|NCT01090492|566428090|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909773|NCT01090492|566428091|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909774|NCT01090492|566428092|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
156909775|NCT01090492|566428085|FG000|Second Intervention Period (4 Weeks)|Other|0|||
156909776|NCT01090492|566428086|FG001|Second Intervention Period (4 Weeks)|Other|1|||
156909777|NCT01090492|566428087|FG002|Second Intervention Period (4 Weeks)|Other|1|||
156909778|NCT01090492|566428088|FG003|Second Intervention Period (4 Weeks)|Other|0|||
156909779|NCT01090492|566428089|FG004|Second Intervention Period (4 Weeks)|Other|0|||
156909780|NCT01090492|566428090|FG005|Second Intervention Period (4 Weeks)|Other|0|||
156909781|NCT01090492|566428091|FG006|Second Intervention Period (4 Weeks)|Other|0|||
156909782|NCT01090492|566428092|FG007|Second Intervention Period (4 Weeks)|Other|0|||
156909783|NCT01090492|566428085|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156909784|NCT01090492|566428086|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156909785|NCT01090492|566428087|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156909786|NCT01090492|566428088|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
156909787|NCT01090492|566428089|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156909788|NCT01090492|566428090|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156909789|NCT01090492|566428091|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
156909790|NCT01090492|566428092|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
156909791|NCT01090492|566428085|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909792|NCT01090492|566428086|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909793|NCT01090492|566428087|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909794|NCT01090492|566428088|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909795|NCT01090492|566428089|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909796|NCT01090492|566428090|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909797|NCT01090492|566428091|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
156909798|NCT01090492|566428092|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
156909799|NCT01768286|566428093|FG000|Overall Study|Randomized But Not Treated|0|||
156909800|NCT01768286|566428094|FG001|Overall Study|Randomized But Not Treated|0|||
156909801|NCT01768286|566428095|FG002|Overall Study|Randomized But Not Treated|1|||
156909802|NCT01768286|566428096|FG003|Overall Study|Randomized But Not Treated|0|||
156909803|NCT01768286|566428093|FG000|Overall Study|Lack of Efficacy|7|||
156909804|NCT01768286|566428094|FG001|Overall Study|Lack of Efficacy|4|||
156909805|NCT01768286|566428095|FG002|Overall Study|Lack of Efficacy|0|||
156909806|NCT01768286|566428096|FG003|Overall Study|Lack of Efficacy|1|||
156909807|NCT01768286|566428093|FG000|Overall Study|Withdrew Consent|0|||
156909808|NCT01768286|566428094|FG001|Overall Study|Withdrew Consent|0|||
156909809|NCT01768286|566428095|FG002|Overall Study|Withdrew Consent|1|||
156909810|NCT01768286|566428096|FG003|Overall Study|Withdrew Consent|0|||
156909811|NCT03583697|566428102|FG000|Overall Study|Withdrawal by Subject|0|||
157159938|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156909812|NCT03583697|566428103|FG001|Overall Study|Withdrawal by Subject|0|||
156909813|NCT03583697|566428104|FG002|Overall Study|Withdrawal by Subject|1|||
156909814|NCT03583697|566428102|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
156909815|NCT03583697|566428103|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
156909816|NCT03583697|566428104|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
156909817|NCT00365508|566428107|FG000|Overall Study|Lost to Follow-up|139|||
156909818|NCT00365508|566428108|FG001|Overall Study|Lost to Follow-up|154|||
156909819|NCT03724032|566428109|FG000|Overall Study|Physician Decision|1|||
156909820|NCT03724032|566428110|FG001|Overall Study|Physician Decision|0|||
156909821|NCT03724032|566428111|FG002|Overall Study|Physician Decision|0|||
156909822|NCT03724032|566428109|FG000|Overall Study|Protocol Violation|2|||
156909823|NCT03724032|566428110|FG001|Overall Study|Protocol Violation|2|||
156909824|NCT03724032|566428111|FG002|Overall Study|Protocol Violation|1|||
156909825|NCT02538029|566428113|FG000|Overall Study|unable to complete cognitive assessments|1|||
156909826|NCT02538029|566428114|FG001|Overall Study|unable to complete cognitive assessments|0|||
156909827|NCT02538029|566428115|FG002|Overall Study|unable to complete cognitive assessments|1|||
156909828|NCT00404235|566428118|FG000|Overall Study|Withdrawal by Subject|1|||
156909829|NCT00404235|566428119|FG001|Overall Study|Withdrawal by Subject|2|||
156909830|NCT00679432|566428120|FG000|Overall Study|Adverse Event|5|||
156909831|NCT00679432|566428121|FG001|Overall Study|Adverse Event|6|||
156909832|NCT00679432|566428122|FG002|Overall Study|Adverse Event|10|||
156909833|NCT00679432|566428123|FG003|Overall Study|Adverse Event|7|||
156909834|NCT00679432|566428120|FG000|Overall Study|Protocol Violation|1|||
156909835|NCT00679432|566428121|FG001|Overall Study|Protocol Violation|1|||
156909836|NCT00679432|566428122|FG002|Overall Study|Protocol Violation|2|||
156909837|NCT00679432|566428123|FG003|Overall Study|Protocol Violation|1|||
156909838|NCT00679432|566428120|FG000|Overall Study|Withdrawal by Subject|8|||
156909839|NCT00679432|566428121|FG001|Overall Study|Withdrawal by Subject|11|||
156909840|NCT00679432|566428122|FG002|Overall Study|Withdrawal by Subject|10|||
156909841|NCT00679432|566428123|FG003|Overall Study|Withdrawal by Subject|9|||
156909842|NCT00679432|566428120|FG000|Overall Study|Lost to Follow-up|1|||
156909843|NCT00679432|566428121|FG001|Overall Study|Lost to Follow-up|5|||
156909844|NCT00679432|566428122|FG002|Overall Study|Lost to Follow-up|4|||
156909845|NCT00679432|566428123|FG003|Overall Study|Lost to Follow-up|2|||
156909846|NCT00679432|566428120|FG000|Overall Study|Physician Decision|3|||
156909847|NCT00679432|566428121|FG001|Overall Study|Physician Decision|2|||
156909848|NCT00679432|566428122|FG002|Overall Study|Physician Decision|2|||
156909849|NCT00679432|566428123|FG003|Overall Study|Physician Decision|2|||
156909850|NCT00679432|566428120|FG000|Overall Study|Sponsor decision|1|||
156909851|NCT00679432|566428121|FG001|Overall Study|Sponsor decision|0|||
156909852|NCT00679432|566428122|FG002|Overall Study|Sponsor decision|0|||
156909853|NCT00679432|566428123|FG003|Overall Study|Sponsor decision|0|||
156909854|NCT00679432|566428120|FG000|Overall Study|Lack of Efficacy|13|||
156909855|NCT00679432|566428121|FG001|Overall Study|Lack of Efficacy|9|||
156909856|NCT00679432|566428122|FG002|Overall Study|Lack of Efficacy|14|||
156909857|NCT00679432|566428123|FG003|Overall Study|Lack of Efficacy|8|||
156909858|NCT00679432|566428120|FG000|Overall Study|Infectious colitis, normal histology|5|||
156909859|NCT00679432|566428121|FG001|Overall Study|Infectious colitis, normal histology|4|||
156909860|NCT00679432|566428122|FG002|Overall Study|Infectious colitis, normal histology|8|||
156909861|NCT00679432|566428123|FG003|Overall Study|Infectious colitis, normal histology|3|||
156909862|NCT00679432|566428120|FG000|Overall Study|Randomization error, return to prior Rx|0|||
157159939|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159940|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159941|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159942|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159943|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159944|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159945|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
156909863|NCT00679432|566428121|FG001|Overall Study|Randomization error, return to prior Rx|0|||
156909864|NCT00679432|566428122|FG002|Overall Study|Randomization error, return to prior Rx|3|||
156909865|NCT00679432|566428123|FG003|Overall Study|Randomization error, return to prior Rx|0|||
156909866|NCT00824720|566428124|FG000|Overall Study|failed plug insertion|3|||
156909867|NCT00824720|566428125|FG001|Overall Study|failed plug insertion|1|||
156909868|NCT00824720|566428126|FG002|Overall Study|failed plug insertion|0|||
156909869|NCT00824720|566428124|FG000|Overall Study|Protocol Violation|0|||
156909870|NCT00824720|566428125|FG001|Overall Study|Protocol Violation|0|||
156909871|NCT00824720|566428126|FG002|Overall Study|Protocol Violation|1|||
156909872|NCT00481078|566428127|FG000|Overall Study|Progression of disease|11|||
156909873|NCT00481078|566428128|FG001|Overall Study|Progression of disease|11|||
156909874|NCT00481078|566428127|FG000|Overall Study|Adverse Event|15|||
156909875|NCT00481078|566428128|FG001|Overall Study|Adverse Event|3|||
156909876|NCT00481078|566428127|FG000|Overall Study|Death|5|||
156909877|NCT00481078|566428128|FG001|Overall Study|Death|3|||
156909878|NCT00481078|566428127|FG000|Overall Study|Intercurrent illness|1|||
157027260|NCT03854227|566856071|FG008|Overall Study|Progressive disease|2|||
156909879|NCT00481078|566428128|FG001|Overall Study|Intercurrent illness|0|||
156909880|NCT00481078|566428127|FG000|Overall Study|Withdrawal by Subject|7|||
156909881|NCT00481078|566428128|FG001|Overall Study|Withdrawal by Subject|1|||
156909882|NCT00481078|566428127|FG000|Overall Study|Information not available|1|||
156909883|NCT00481078|566428128|FG001|Overall Study|Information not available|0|||
156909884|NCT00481078|566428127|FG000|Overall Study|Received other treatment|2|||
156909885|NCT00481078|566428128|FG001|Overall Study|Received other treatment|1|||
156909886|NCT00481078|566428127|FG000|Overall Study|Brain metastasis|0|||
156909887|NCT00481078|566428128|FG001|Overall Study|Brain metastasis|1|||
156909888|NCT01558271|566428129|FG000|Overall Study|Adverse Event|6|||
156909889|NCT01558271|566428130|FG001|Overall Study|Adverse Event|3|||
156909890|NCT01558271|566428131|FG002|Overall Study|Adverse Event|4|||
156909891|NCT01558271|566428129|FG000|Overall Study|Lost to Follow-up|1|||
156909892|NCT01558271|566428130|FG001|Overall Study|Lost to Follow-up|0|||
156909893|NCT01558271|566428131|FG002|Overall Study|Lost to Follow-up|0|||
156909894|NCT01558271|566428129|FG000|Overall Study|Protocol Violation|1|||
156909895|NCT01558271|566428130|FG001|Overall Study|Protocol Violation|0|||
156909896|NCT01558271|566428131|FG002|Overall Study|Protocol Violation|0|||
156909897|NCT01558271|566428129|FG000|Overall Study|Withdrawal by Subject|10|||
156909898|NCT01558271|566428130|FG001|Overall Study|Withdrawal by Subject|6|||
156909899|NCT01558271|566428131|FG002|Overall Study|Withdrawal by Subject|12|||
156909900|NCT01558271|566428129|FG000|Overall Study|Physician Decision|0|||
156909901|NCT01558271|566428130|FG001|Overall Study|Physician Decision|2|||
156909902|NCT01558271|566428131|FG002|Overall Study|Physician Decision|1|||
156909903|NCT02339584|566428132|FG000|Overall Study|Adverse Event|11|||
156909904|NCT02339584|566428133|FG001|Overall Study|Adverse Event|7|||
156909905|NCT02339584|566428132|FG000|Overall Study|Lack of Efficacy|0|||
156909906|NCT02339584|566428133|FG001|Overall Study|Lack of Efficacy|1|||
156909907|NCT02339584|566428132|FG000|Overall Study|Physician Decision|1|||
156909908|NCT02339584|566428133|FG001|Overall Study|Physician Decision|2|||
156909909|NCT02339584|566428132|FG000|Overall Study|Protocol Violation|1|||
156909910|NCT02339584|566428133|FG001|Overall Study|Protocol Violation|1|||
156909911|NCT02339584|566428132|FG000|Overall Study|Withdrawal by Subject|2|||
156909912|NCT02339584|566428133|FG001|Overall Study|Withdrawal by Subject|4|||
156909913|NCT02610725|566428134|FG000|Overall Study|Lost to Follow-up|197|||
156909914|NCT02610725|566428134|FG000|Overall Study|self-reported contraindication|9|||
156909915|NCT04094883|566428135|FG000|Overall Study|Withdrawal by Subject|1|||
156909916|NCT01084083|566428136|FG000|Overall Study|Adverse Event|5|||
156909917|NCT01084083|566428136|FG000|Overall Study|Death|1|||
156909918|NCT01084083|566428136|FG000|Overall Study|Withdrawal by Subject|2|||
156909919|NCT01084083|566428136|FG000|Overall Study|Complicating disease|1|||
156909920|NCT01084083|566428136|FG000|Overall Study|Other|2|||
156909921|NCT01084083|566428136|FG000|Overall Study|Never started assigned therapy|1|||
156909922|NCT00228384|566428137|FG000|Overall Study|Death|9|||
156909923|NCT00228384|566428138|FG001|Overall Study|Death|3|||
156909924|NCT00228384|566428137|FG000|Overall Study|Lost to Follow-up|6|||
156909925|NCT00228384|566428138|FG001|Overall Study|Lost to Follow-up|10|||
156909926|NCT00228384|566428137|FG000|Overall Study|Surgical Intervention (bypass)|5|||
156909927|NCT00228384|566428138|FG001|Overall Study|Surgical Intervention (bypass)|5|||
156909928|NCT00228384|566428137|FG000|Overall Study|Withdrawal by Subject|9|||
156909929|NCT00228384|566428138|FG001|Overall Study|Withdrawal by Subject|10|||
156909930|NCT00228384|566428137|FG000|Overall Study|Physician Decision|0|||
156909931|NCT00228384|566428138|FG001|Overall Study|Physician Decision|1|||
156909932|NCT01466153|566428140|FG000|Overall Study|Disease Progression|2|||
156909933|NCT01466153|566428141|FG001|Overall Study|Disease Progression|2|||
156909934|NCT01466153|566428142|FG002|Overall Study|Disease Progression|0|||
156909935|NCT01466153|566428140|FG000|Overall Study|Adverse Event|14|||
156909936|NCT01466153|566428141|FG001|Overall Study|Adverse Event|13|||
156909937|NCT01466153|566428142|FG002|Overall Study|Adverse Event|17|||
156909938|NCT01466153|566428140|FG000|Overall Study|Withdrawal of Consent|2|||
156909939|NCT01466153|566428141|FG001|Overall Study|Withdrawal of Consent|0|||
156909940|NCT01466153|566428142|FG002|Overall Study|Withdrawal of Consent|0|||
156909941|NCT01466153|566428140|FG000|Overall Study|Investigator Discretion|3|||
156909942|NCT01466153|566428141|FG001|Overall Study|Investigator Discretion|2|||
156909943|NCT01466153|566428142|FG002|Overall Study|Investigator Discretion|2|||
156909944|NCT01466153|566428140|FG000|Overall Study|Randomized-Not Treated|2|||
156909945|NCT01466153|566428141|FG001|Overall Study|Randomized-Not Treated|3|||
156909946|NCT01466153|566428142|FG002|Overall Study|Randomized-Not Treated|4|||
156909947|NCT01466153|566428140|FG000|Overall Study|Other-Unspecified|6|||
156909948|NCT01466153|566428141|FG001|Overall Study|Other-Unspecified|4|||
156909949|NCT01466153|566428142|FG002|Overall Study|Other-Unspecified|2|||
156909950|NCT01785069|566428143|FG000|Overall Study|Implanted with nonstudy device|1|||
156909951|NCT01785069|566428144|FG001|Overall Study|Implanted with nonstudy device|2|||
156909952|NCT01785069|566428145|FG002|Overall Study|Implanted with nonstudy device|1|||
156909953|NCT01785069|566428146|FG003|Overall Study|Implanted with nonstudy device|0|||
156909954|NCT01785069|566428143|FG000|Overall Study|Death|0|||
156909955|NCT01785069|566428144|FG001|Overall Study|Death|0|||
156909956|NCT01785069|566428145|FG002|Overall Study|Death|2|||
156909957|NCT01785069|566428146|FG003|Overall Study|Death|0|||
156909958|NCT01785069|566428143|FG000|Overall Study|Subject choice|2|||
156909959|NCT01785069|566428144|FG001|Overall Study|Subject choice|2|||
156909960|NCT01785069|566428145|FG002|Overall Study|Subject choice|0|||
156909961|NCT01785069|566428146|FG003|Overall Study|Subject choice|1|||
156909962|NCT01785069|566428143|FG000|Overall Study|Lost to Follow-up|1|||
156909963|NCT01785069|566428144|FG001|Overall Study|Lost to Follow-up|2|||
156909964|NCT01785069|566428145|FG002|Overall Study|Lost to Follow-up|4|||
156909965|NCT01785069|566428146|FG003|Overall Study|Lost to Follow-up|1|||
156909966|NCT01785069|566428143|FG000|Overall Study|Reason not Specified|1|||
156909967|NCT01785069|566428144|FG001|Overall Study|Reason not Specified|2|||
156909968|NCT01785069|566428145|FG002|Overall Study|Reason not Specified|1|||
156909969|NCT01785069|566428146|FG003|Overall Study|Reason not Specified|4|||
156909970|NCT01785069|566428143|FG000|Overall Study|Not evaluable|7|||
156909971|NCT01785069|566428144|FG001|Overall Study|Not evaluable|4|||
156909972|NCT01785069|566428145|FG002|Overall Study|Not evaluable|5|||
156909973|NCT01785069|566428146|FG003|Overall Study|Not evaluable|8|||
156909974|NCT01088997|566428149|FG000|Overall Study|Physician Decision|1|||
156909975|NCT01088997|566428150|FG001|Overall Study|Physician Decision|1|||
156909976|NCT01088997|566428149|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
156909977|NCT01088997|566428150|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
156909978|NCT01088997|566428149|FG000|Overall Study|Excluded prior to receiving drug|1|||
156909979|NCT01088997|566428150|FG001|Overall Study|Excluded prior to receiving drug|1|||
156909980|NCT05570500|566428155|FG000|Overall Study|Lost to Follow-up|7|||
156909981|NCT05570500|566428156|FG001|Overall Study|Lost to Follow-up|5|||
156909982|NCT01095731|566428157|FG000|Overall Study|Protocol Violation|1|||
156909983|NCT01095731|566428158|FG001|Overall Study|Protocol Violation|1|||
156909984|NCT01095731|566428157|FG000|Overall Study|Withdrawal by Subject|0|||
156909985|NCT01095731|566428158|FG001|Overall Study|Withdrawal by Subject|1|||
156909986|NCT02302807|566428161|FG000|Overall Study|Withdrawal by Subject|28|||
156909987|NCT02302807|566428162|FG001|Overall Study|Withdrawal by Subject|11|||
156909988|NCT02302807|566428161|FG000|Overall Study|Lost to Follow-up|4|||
156909989|NCT02302807|566428162|FG001|Overall Study|Lost to Follow-up|6|||
156909990|NCT02302807|566428161|FG000|Overall Study|Death|397|||
156909991|NCT02302807|566428162|FG001|Overall Study|Death|385|||
156909992|NCT02302807|566428161|FG000|Overall Study|Study Terminated By Sponsor|35|||
156909993|NCT02302807|566428162|FG001|Overall Study|Study Terminated By Sponsor|64|||
156909994|NCT02302807|566428161|FG000|Overall Study|Physician Decision|0|||
156909995|NCT02302807|566428162|FG001|Overall Study|Physician Decision|1|||
156909996|NCT01980940|566428164|FG000|Overall Study|Protocol Violation|0|||
156909997|NCT01980940|566428165|FG001|Overall Study|Protocol Violation|0|||
156909998|NCT01980940|566428166|FG002|Overall Study|Protocol Violation|0|||
156909999|NCT01980940|566428167|FG003|Overall Study|Protocol Violation|0|||
156910000|NCT01980940|566428168|FG004|Overall Study|Protocol Violation|0|||
156910001|NCT01980940|566428169|FG005|Overall Study|Protocol Violation|2|||
156910002|NCT01980940|566428170|FG006|Overall Study|Protocol Violation|0|||
156910003|NCT01980940|566428171|FG007|Overall Study|Protocol Violation|0|||
156910004|NCT00837811|566428172|FG000|Overall Study|Adverse Event|4|||
156910005|NCT00837811|566428173|FG001|Overall Study|Adverse Event|6|||
156910006|NCT00837811|566428174|FG002|Overall Study|Adverse Event|0|||
156910007|NCT00837811|566428172|FG000|Overall Study|Death|1|||
156910008|NCT00837811|566428173|FG001|Overall Study|Death|1|||
156910009|NCT00837811|566428174|FG002|Overall Study|Death|0|||
156910010|NCT00837811|566428172|FG000|Overall Study|Lack of Efficacy|0|||
156910011|NCT00837811|566428173|FG001|Overall Study|Lack of Efficacy|11|||
156910012|NCT00837811|566428174|FG002|Overall Study|Lack of Efficacy|0|||
156910013|NCT00837811|566428172|FG000|Overall Study|Lost to Follow-up|1|||
156910014|NCT00837811|566428173|FG001|Overall Study|Lost to Follow-up|3|||
156910015|NCT00837811|566428174|FG002|Overall Study|Lost to Follow-up|0|||
156910016|NCT00837811|566428172|FG000|Overall Study|Physician Decision|0|||
156910017|NCT00837811|566428173|FG001|Overall Study|Physician Decision|2|||
156910018|NCT00837811|566428174|FG002|Overall Study|Physician Decision|1|||
156910019|NCT00837811|566428172|FG000|Overall Study|Withdrawal by Subject|1|||
156910020|NCT00837811|566428173|FG001|Overall Study|Withdrawal by Subject|9|||
156910021|NCT00837811|566428174|FG002|Overall Study|Withdrawal by Subject|0|||
156910022|NCT00837811|566428172|FG000|Overall Study|Sponsor Decision|0|||
156910023|NCT00837811|566428173|FG001|Overall Study|Sponsor Decision|2|||
156910024|NCT00837811|566428174|FG002|Overall Study|Sponsor Decision|0|||
156910025|NCT05695209|566428178|FG000|3-months|Withdrawal by Subject|2|||
156910026|NCT05695209|566428179|FG001|3-months|Withdrawal by Subject|0|||
156910027|NCT05695209|566428178|FG000|3-months|Unable to contact for 3-month data collection|0|||
156910028|NCT05695209|566428179|FG001|3-months|Unable to contact for 3-month data collection|1|||
156910029|NCT05695209|566428178|FG000|6-months|Lost to Follow-up|1|||
156910030|NCT05695209|566428179|FG001|6-months|Lost to Follow-up|1|||
156910031|NCT04362072|566428185|FG000|Treatment|Adverse Event|1|||
156910032|NCT04362072|566428185|FG000|Treatment|Death|9|||
156910033|NCT04362072|566428185|FG000|Treatment|Physician Decision|2|||
156910034|NCT04362072|566428185|FG000|Treatment|Progressive disease|27|||
156910035|NCT04362072|566428185|FG000|Treatment|Withdrawal by Subject|4|||
156910036|NCT04362072|566428185|FG000|Treatment|Global deterioration of health status|1|||
156910037|NCT04362072|566428185|FG000|Treatment|Switched to commercial Lorlatinib|13|||
156910038|NCT04362072|566428185|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
156910039|NCT04362072|566428185|FG000|Treatment|Other|3|||
156910040|NCT04362072|566428185|FG000|Follow up|Death|2|||
156910041|NCT04362072|566428185|FG000|Follow up|Other|2|||
156910042|NCT01133522|566428186|FG000|Overall Study|Withdrawal by Subject|0|||
156910043|NCT01133522|566428187|FG001|Overall Study|Withdrawal by Subject|1|||
156910044|NCT01133522|566428188|FG002|Overall Study|Withdrawal by Subject|0|||
156910045|NCT01133522|566428189|FG003|Overall Study|Withdrawal by Subject|1|||
156910046|NCT01133522|566428190|FG004|Overall Study|Withdrawal by Subject|0|||
156910047|NCT01133522|566428191|FG005|Overall Study|Withdrawal by Subject|0|||
156910048|NCT01133522|566428192|FG006|Overall Study|Withdrawal by Subject|0|||
156910049|NCT01133522|566428193|FG007|Overall Study|Withdrawal by Subject|0|||
156910050|NCT01133522|566428194|FG008|Overall Study|Withdrawal by Subject|0|||
156910051|NCT01133522|566428195|FG009|Overall Study|Withdrawal by Subject|0|||
156910052|NCT01133522|566428186|FG000|Overall Study|Physician Decision|0|||
156910053|NCT01133522|566428187|FG001|Overall Study|Physician Decision|0|||
156910054|NCT01133522|566428188|FG002|Overall Study|Physician Decision|0|||
156910055|NCT01133522|566428189|FG003|Overall Study|Physician Decision|0|||
156910056|NCT01133522|566428190|FG004|Overall Study|Physician Decision|1|||
156910057|NCT01133522|566428191|FG005|Overall Study|Physician Decision|0|||
156910058|NCT01133522|566428192|FG006|Overall Study|Physician Decision|0|||
156910059|NCT01133522|566428193|FG007|Overall Study|Physician Decision|0|||
156910060|NCT01133522|566428194|FG008|Overall Study|Physician Decision|0|||
156910061|NCT01133522|566428195|FG009|Overall Study|Physician Decision|0|||
156910062|NCT04731363|566428201|FG000|Overall Study|Could not obtain samples|0|||
156910063|NCT04731363|566428202|FG001|Overall Study|Could not obtain samples|1|||
156910064|NCT04731363|566428203|FG002|Overall Study|Could not obtain samples|0|||
156910065|NCT04731363|566428204|FG003|Overall Study|Could not obtain samples|0|||
156910066|NCT04731363|566428201|FG000|Overall Study|Physician Decision|0|||
157027261|NCT03854227|566856072|FG009|Overall Study|Progressive disease|5|||
157027262|NCT03854227|566856073|FG010|Overall Study|Progressive disease|1|||
157159946|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159947|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
157159948|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
157159949|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159950|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159951|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159952|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159953|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159954|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159955|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159956|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159957|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159958|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159959|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159960|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159961|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159962|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159963|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159964|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159965|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159966|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159967|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159968|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159969|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159970|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
157159971|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
157159972|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159973|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157225588|NCT00337571|567571475|FG001|Overall Study|Withdrawal by Subject|2|||
156910067|NCT04731363|566428202|FG001|Overall Study|Physician Decision|1|||
156910068|NCT04731363|566428203|FG002|Overall Study|Physician Decision|0|||
156910069|NCT04731363|566428204|FG003|Overall Study|Physician Decision|0|||
156910070|NCT01918774|566430260|FG000|Overall Study|Lost prior to first CBTw session|4|||
156910071|NCT01918774|566430260|FG000|Overall Study|Lost to Follow-up|1|||
157225589|NCT00337571|567571476|FG002|Overall Study|Withdrawal by Subject|1|||
157027263|NCT03854227|566856074|FG011|Overall Study|Progressive disease|6|||
156910072|NCT00717197|566430265|FG000|Overall Study|Unable to purchase study drug|5|||
157027264|NCT03854227|566856063|FG000|Overall Study|Study terminated by sponsor|0|||
157027265|NCT03854227|566856064|FG001|Overall Study|Study terminated by sponsor|0|||
156910073|NCT00717197|566430265|FG000|Overall Study|Tumor Progression|1|||
157159974|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159975|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910074|NCT00717197|566430265|FG000|Overall Study|Physician Decision|1|||
156910075|NCT00982137|566430266|FG000|Overall Study|Lost to Follow-up|0|||
156910076|NCT00982137|566430267|FG001|Overall Study|Lost to Follow-up|0|||
156910077|NCT00982137|566430268|FG002|Overall Study|Lost to Follow-up|0|||
156910078|NCT00982137|566430269|FG003|Overall Study|Lost to Follow-up|1|||
156910079|NCT00982137|566430266|FG000|Overall Study|Withdrawal by Subject|0|||
156910080|NCT00982137|566430267|FG001|Overall Study|Withdrawal by Subject|1|||
156910081|NCT00982137|566430268|FG002|Overall Study|Withdrawal by Subject|0|||
156910082|NCT00982137|566430269|FG003|Overall Study|Withdrawal by Subject|0|||
156910083|NCT01898806|566430272|FG000|Overall Study|Withdrawal by Subject|2|||
156910084|NCT01898806|566430272|FG000|Overall Study|Physician Decision|1|||
156910085|NCT03003390|566430273|FG000|Overall Study|Physician Decision|2|||
156910086|NCT03003390|566430274|FG001|Overall Study|Physician Decision|0|||
156910087|NCT03003390|566430273|FG000|Overall Study|Parent refused intervention|2|||
156910088|NCT03003390|566430274|FG001|Overall Study|Parent refused intervention|0|||
156910089|NCT02469298|566430291|FG000|Overall Study|Protocol Violation|0|||
156910090|NCT02469298|566430292|FG001|Overall Study|Protocol Violation|1|||
156910091|NCT02469298|566430293|FG002|Overall Study|Protocol Violation|1|||
156910092|NCT02469298|566430294|FG003|Overall Study|Protocol Violation|0|||
156910093|NCT02469298|566430291|FG000|Overall Study|Lost to Follow-up|1|||
156910094|NCT02469298|566430292|FG001|Overall Study|Lost to Follow-up|0|||
156910095|NCT02469298|566430293|FG002|Overall Study|Lost to Follow-up|1|||
156910096|NCT02469298|566430294|FG003|Overall Study|Lost to Follow-up|0|||
156910097|NCT02469298|566430291|FG000|Overall Study|Physician Decision|0|||
156910098|NCT02469298|566430292|FG001|Overall Study|Physician Decision|0|||
156910099|NCT02469298|566430293|FG002|Overall Study|Physician Decision|0|||
156910100|NCT02469298|566430294|FG003|Overall Study|Physician Decision|1|||
156910101|NCT02469298|566430291|FG000|Overall Study|Withdrawal by Subject|0|||
156910102|NCT02469298|566430292|FG001|Overall Study|Withdrawal by Subject|0|||
156910103|NCT02469298|566430293|FG002|Overall Study|Withdrawal by Subject|0|||
156910104|NCT02469298|566430294|FG003|Overall Study|Withdrawal by Subject|1|||
156910105|NCT03000439|566430297|FG000|Open Label Part 1|Adverse Event|6|||
156910106|NCT03000439|566430298|FG001|Open Label Part 1|Adverse Event|0|||
156910107|NCT03000439|566430299|FG002|Open Label Part 1|Adverse Event|0|||
156910108|NCT03000439|566430300|FG003|Open Label Part 1|Adverse Event|0|||
156910109|NCT03000439|566430297|FG000|Open Label Part 1|Other|2|||
156910110|NCT03000439|566430298|FG001|Open Label Part 1|Other|0|||
156910111|NCT03000439|566430299|FG002|Open Label Part 1|Other|0|||
156910112|NCT03000439|566430300|FG003|Open Label Part 1|Other|0|||
156910113|NCT03000439|566430297|FG000|Open Label Part 1|Insufficient clinical response|16|||
156910114|NCT03000439|566430298|FG001|Open Label Part 1|Insufficient clinical response|0|||
156910115|NCT03000439|566430299|FG002|Open Label Part 1|Insufficient clinical response|0|||
156910116|NCT03000439|566430300|FG003|Open Label Part 1|Insufficient clinical response|0|||
156910117|NCT03000439|566430297|FG000|Open Label Part 2|Other|0|||
156910118|NCT03000439|566430298|FG001|Open Label Part 2|Other|5|||
156910119|NCT03000439|566430299|FG002|Open Label Part 2|Other|0|||
156910120|NCT03000439|566430300|FG003|Open Label Part 2|Other|0|||
156910121|NCT03000439|566430297|FG000|Open Label Part 2|Insufficient clinical response|0|||
156910122|NCT03000439|566430298|FG001|Open Label Part 2|Insufficient clinical response|12|||
156910123|NCT03000439|566430299|FG002|Open Label Part 2|Insufficient clinical response|0|||
156910124|NCT03000439|566430300|FG003|Open Label Part 2|Insufficient clinical response|0|||
156910125|NCT03000439|566430297|FG000|Double Blind Phase|Adverse Event|0|||
156910126|NCT03000439|566430298|FG001|Double Blind Phase|Adverse Event|0|||
156910127|NCT03000439|566430299|FG002|Double Blind Phase|Adverse Event|2|||
156910128|NCT03000439|566430300|FG003|Double Blind Phase|Adverse Event|1|||
156910129|NCT03000439|566430297|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
156910130|NCT03000439|566430298|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
156910131|NCT03000439|566430299|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
156910132|NCT03000439|566430300|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
156910133|NCT03000439|566430297|FG000|Double Blind Phase|Other|0|||
156910134|NCT03000439|566430298|FG001|Double Blind Phase|Other|0|||
157159976|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159977|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159978|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159979|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910135|NCT03000439|566430299|FG002|Double Blind Phase|Other|10|||
156910136|NCT03000439|566430300|FG003|Double Blind Phase|Other|11|||
156910137|NCT03000439|566430297|FG000|Double Blind Phase|Insufficient clinical response|0|||
156910138|NCT03000439|566430298|FG001|Double Blind Phase|Insufficient clinical response|0|||
156910139|NCT03000439|566430299|FG002|Double Blind Phase|Insufficient clinical response|0|||
157159980|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910140|NCT03000439|566430300|FG003|Double Blind Phase|Insufficient clinical response|2|||
156910141|NCT02501473|566430303|FG000|Overall Study|Study Terminated|2|||
156910142|NCT02501473|566430304|FG001|Overall Study|Study Terminated|3|||
156910143|NCT02501473|566430305|FG002|Overall Study|Study Terminated|7|||
156910144|NCT02501473|566430306|FG003|Overall Study|Study Terminated|9|||
156910145|NCT02501473|566430307|FG004|Overall Study|Study Terminated|2|||
156910146|NCT02501473|566430308|FG005|Overall Study|Study Terminated|10|||
156910147|NCT02501473|566430309|FG006|Overall Study|Study Terminated|1|||
156910148|NCT02501473|566430310|FG007|Overall Study|Study Terminated|0|||
156910149|NCT02501473|566430303|FG000|Overall Study|Withdrawal by Subject|0|||
156910150|NCT02501473|566430304|FG001|Overall Study|Withdrawal by Subject|0|||
156910151|NCT02501473|566430305|FG002|Overall Study|Withdrawal by Subject|3|||
156910152|NCT02501473|566430306|FG003|Overall Study|Withdrawal by Subject|3|||
156910153|NCT02501473|566430307|FG004|Overall Study|Withdrawal by Subject|2|||
156910154|NCT02501473|566430308|FG005|Overall Study|Withdrawal by Subject|2|||
156910155|NCT02501473|566430309|FG006|Overall Study|Withdrawal by Subject|0|||
156910156|NCT02501473|566430310|FG007|Overall Study|Withdrawal by Subject|0|||
156910157|NCT02501473|566430303|FG000|Overall Study|Death|0|||
156910158|NCT02501473|566430304|FG001|Overall Study|Death|0|||
156910159|NCT02501473|566430305|FG002|Overall Study|Death|1|||
156910160|NCT02501473|566430306|FG003|Overall Study|Death|1|||
156910161|NCT02501473|566430307|FG004|Overall Study|Death|0|||
156910162|NCT02501473|566430308|FG005|Overall Study|Death|1|||
156910163|NCT02501473|566430309|FG006|Overall Study|Death|0|||
156910164|NCT02501473|566430310|FG007|Overall Study|Death|0|||
156910165|NCT02501473|566430303|FG000|Overall Study|Lost to Follow-up|1|||
156910166|NCT02501473|566430304|FG001|Overall Study|Lost to Follow-up|0|||
156910167|NCT02501473|566430305|FG002|Overall Study|Lost to Follow-up|1|||
156910168|NCT02501473|566430306|FG003|Overall Study|Lost to Follow-up|0|||
156910169|NCT02501473|566430307|FG004|Overall Study|Lost to Follow-up|0|||
156910170|NCT02501473|566430308|FG005|Overall Study|Lost to Follow-up|1|||
156910171|NCT02501473|566430309|FG006|Overall Study|Lost to Follow-up|0|||
156910172|NCT02501473|566430310|FG007|Overall Study|Lost to Follow-up|0|||
156910173|NCT02501473|566430303|FG000|Overall Study|Reason not specified|0|||
156910174|NCT02501473|566430304|FG001|Overall Study|Reason not specified|0|||
156910175|NCT02501473|566430305|FG002|Overall Study|Reason not specified|1|||
156910176|NCT02501473|566430306|FG003|Overall Study|Reason not specified|1|||
156910177|NCT02501473|566430307|FG004|Overall Study|Reason not specified|0|||
156910178|NCT02501473|566430308|FG005|Overall Study|Reason not specified|0|||
156910179|NCT02501473|566430309|FG006|Overall Study|Reason not specified|0|||
156910180|NCT02501473|566430310|FG007|Overall Study|Reason not specified|0|||
156910181|NCT01581931|566430311|FG000|Washout|Adverse Event|0|||
156910182|NCT01581931|566430312|FG001|Washout|Adverse Event|1|||
156910183|NCT01389817|566430315|FG000|Overall Study|Physician Decision|1|||
156910184|NCT01389817|566430316|FG001|Overall Study|Physician Decision|0|||
156910185|NCT01389817|566430315|FG000|Overall Study|Lost to Follow-up|1|||
156910186|NCT01389817|566430316|FG001|Overall Study|Lost to Follow-up|0|||
156910187|NCT01389817|566430315|FG000|Overall Study|Withdrawal by Subject|2|||
156910188|NCT01389817|566430316|FG001|Overall Study|Withdrawal by Subject|0|||
156910189|NCT01749137|566430317|FG000|Overall Study|Adverse Event|4|||
156910190|NCT01749137|566430318|FG001|Overall Study|Adverse Event|4|||
156910191|NCT01749137|566430317|FG000|Overall Study|Lost to Follow-up|2|||
156910192|NCT01749137|566430318|FG001|Overall Study|Lost to Follow-up|3|||
156910193|NCT01749137|566430317|FG000|Overall Study|Physician Decision|1|||
156910194|NCT01749137|566430318|FG001|Overall Study|Physician Decision|0|||
156910195|NCT01749137|566430317|FG000|Overall Study|Withdrawal by Subject|8|||
156910196|NCT01749137|566430318|FG001|Overall Study|Withdrawal by Subject|4|||
156910197|NCT00980057|566430324|FG000|Overall Study|Death|13|||
157159981|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159982|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159983|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159984|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910198|NCT00980057|566430325|FG001|Overall Study|Death|3|||
156910199|NCT00980057|566430324|FG000|Overall Study|Adverse Event|0|||
156910200|NCT00980057|566430325|FG001|Overall Study|Adverse Event|1|||
156910201|NCT00980057|566430324|FG000|Overall Study|Physician Decision|4|||
156910202|NCT00980057|566430325|FG001|Overall Study|Physician Decision|0|||
156910203|NCT00980057|566430324|FG000|Overall Study|Lost to Follow-up|1|||
156910204|NCT00980057|566430325|FG001|Overall Study|Lost to Follow-up|0|||
156910205|NCT00980057|566430324|FG000|Overall Study|Withdrawal by Subject|1|||
156910206|NCT00980057|566430325|FG001|Overall Study|Withdrawal by Subject|1|||
156910207|NCT00691015|566430329|FG000|Overall Study|Refused further treatment|1|||
156910208|NCT04160195|566430332|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
156910209|NCT04160195|566430333|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
156910210|NCT03130257|566430336|FG000|Overall Study|Withdrawal by Subject|1|||
157027266|NCT03854227|566856065|FG002|Overall Study|Study terminated by sponsor|0|||
156910211|NCT03130257|566430337|FG001|Overall Study|Withdrawal by Subject|0|||
156910212|NCT03130257|566430338|FG002|Overall Study|Withdrawal by Subject|2|||
156910213|NCT02064894|566430339|FG000|Overall Study|Withdrawal by Subject|43|||
156910214|NCT02064894|566430340|FG001|Overall Study|Withdrawal by Subject|102|||
156910215|NCT02064894|566430341|FG002|Overall Study|Withdrawal by Subject|115|||
157159985|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910216|NCT03766581|566430342|FG000|Randomization|Other reasons|2|||
156910217|NCT03766581|566430343|FG001|Randomization|Other reasons|1|||
156910218|NCT03766581|566430344|FG002|Randomization|Other reasons|0|||
156910219|NCT03766581|566430345|FG003|Randomization|Other reasons|1|||
156910220|NCT03766581|566430346|FG004|Randomization|Other reasons|0|||
156910221|NCT03766581|566430347|FG005|Randomization|Other reasons|0|||
156910222|NCT03766581|566430348|FG006|Randomization|Other reasons|0|||
156910223|NCT03766581|566430349|FG007|Randomization|Other reasons|0|||
156910224|NCT03766581|566430342|FG000|Randomization|Participant no longer meets study criteria|5|||
156910225|NCT03766581|566430343|FG001|Randomization|Participant no longer meets study criteria|3|||
156910226|NCT03766581|566430344|FG002|Randomization|Participant no longer meets study criteria|4|||
156910227|NCT03766581|566430345|FG003|Randomization|Participant no longer meets study criteria|0|||
156910228|NCT03766581|566430346|FG004|Randomization|Participant no longer meets study criteria|2|||
156910229|NCT03766581|566430347|FG005|Randomization|Participant no longer meets study criteria|3|||
156910230|NCT03766581|566430348|FG006|Randomization|Participant no longer meets study criteria|0|||
156910231|NCT03766581|566430349|FG007|Randomization|Participant no longer meets study criteria|1|||
156910232|NCT03766581|566430342|FG000|Randomization|Participant request to discontinue study treatment|1|||
156910233|NCT03766581|566430343|FG001|Randomization|Participant request to discontinue study treatment|0|||
156910234|NCT03766581|566430344|FG002|Randomization|Participant request to discontinue study treatment|0|||
156910235|NCT03766581|566430345|FG003|Randomization|Participant request to discontinue study treatment|0|||
156910236|NCT03766581|566430346|FG004|Randomization|Participant request to discontinue study treatment|1|||
156910237|NCT03766581|566430347|FG005|Randomization|Participant request to discontinue study treatment|2|||
156910238|NCT03766581|566430348|FG006|Randomization|Participant request to discontinue study treatment|0|||
156910239|NCT03766581|566430349|FG007|Randomization|Participant request to discontinue study treatment|0|||
156910240|NCT03766581|566430342|FG000|Randomization|Participant withdrew consent|1|||
156910241|NCT03766581|566430343|FG001|Randomization|Participant withdrew consent|0|||
156910242|NCT03766581|566430344|FG002|Randomization|Participant withdrew consent|1|||
156910243|NCT03766581|566430345|FG003|Randomization|Participant withdrew consent|2|||
156910244|NCT03766581|566430346|FG004|Randomization|Participant withdrew consent|1|||
156910245|NCT03766581|566430347|FG005|Randomization|Participant withdrew consent|1|||
156910246|NCT03766581|566430348|FG006|Randomization|Participant withdrew consent|0|||
156910247|NCT03766581|566430349|FG007|Randomization|Participant withdrew consent|0|||
156910248|NCT03766581|566430342|FG000|Treatment|Adverse Event|82|||
156910249|NCT03766581|566430343|FG001|Treatment|Adverse Event|44|||
156910250|NCT03766581|566430344|FG002|Treatment|Adverse Event|47|||
156910251|NCT03766581|566430345|FG003|Treatment|Adverse Event|46|||
156910252|NCT03766581|566430346|FG004|Treatment|Adverse Event|50|||
156910253|NCT03766581|566430347|FG005|Treatment|Adverse Event|77|||
156910254|NCT03766581|566430348|FG006|Treatment|Adverse Event|5|||
156910255|NCT03766581|566430349|FG007|Treatment|Adverse Event|2|||
156910256|NCT03766581|566430342|FG000|Treatment|Participant request to discontinue treatment|34|||
156910257|NCT03766581|566430343|FG001|Treatment|Participant request to discontinue treatment|6|||
156910258|NCT03766581|566430344|FG002|Treatment|Participant request to discontinue treatment|10|||
156910259|NCT03766581|566430345|FG003|Treatment|Participant request to discontinue treatment|10|||
156910260|NCT03766581|566430346|FG004|Treatment|Participant request to discontinue treatment|14|||
156910261|NCT03766581|566430347|FG005|Treatment|Participant request to discontinue treatment|15|||
156910262|NCT03766581|566430348|FG006|Treatment|Participant request to discontinue treatment|0|||
156910263|NCT03766581|566430349|FG007|Treatment|Participant request to discontinue treatment|1|||
156910264|NCT03766581|566430342|FG000|Treatment|Participant withdrew consent|11|||
156910265|NCT03766581|566430343|FG001|Treatment|Participant withdrew consent|4|||
156910266|NCT03766581|566430344|FG002|Treatment|Participant withdrew consent|5|||
156910267|NCT03766581|566430345|FG003|Treatment|Participant withdrew consent|5|||
156910268|NCT03766581|566430346|FG004|Treatment|Participant withdrew consent|4|||
156910269|NCT03766581|566430347|FG005|Treatment|Participant withdrew consent|4|||
156910270|NCT03766581|566430348|FG006|Treatment|Participant withdrew consent|0|||
156910271|NCT03766581|566430349|FG007|Treatment|Participant withdrew consent|0|||
156910272|NCT03766581|566430342|FG000|Treatment|Death|1|||
156910273|NCT03766581|566430343|FG001|Treatment|Death|0|||
156910274|NCT03766581|566430344|FG002|Treatment|Death|0|||
156910275|NCT03766581|566430345|FG003|Treatment|Death|0|||
156910276|NCT03766581|566430346|FG004|Treatment|Death|0|||
156910277|NCT03766581|566430347|FG005|Treatment|Death|0|||
156910278|NCT03766581|566430348|FG006|Treatment|Death|0|||
156910279|NCT03766581|566430349|FG007|Treatment|Death|0|||
156910280|NCT03766581|566430342|FG000|Treatment|Lost to Follow-up|1|||
156910281|NCT03766581|566430343|FG001|Treatment|Lost to Follow-up|0|||
156910282|NCT03766581|566430344|FG002|Treatment|Lost to Follow-up|0|||
156910283|NCT03766581|566430345|FG003|Treatment|Lost to Follow-up|1|||
156910284|NCT03766581|566430346|FG004|Treatment|Lost to Follow-up|0|||
156910285|NCT03766581|566430347|FG005|Treatment|Lost to Follow-up|0|||
156910286|NCT03766581|566430348|FG006|Treatment|Lost to Follow-up|0|||
156910287|NCT03766581|566430349|FG007|Treatment|Lost to Follow-up|0|||
156910288|NCT03766581|566430342|FG000|Treatment|Poor/Non compliance|2|||
157159986|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910289|NCT03766581|566430343|FG001|Treatment|Poor/Non compliance|2|||
156910290|NCT03766581|566430344|FG002|Treatment|Poor/Non compliance|1|||
156910291|NCT03766581|566430345|FG003|Treatment|Poor/Non compliance|1|||
156910292|NCT03766581|566430346|FG004|Treatment|Poor/Non compliance|1|||
156910293|NCT03766581|566430347|FG005|Treatment|Poor/Non compliance|1|||
156910294|NCT03766581|566430348|FG006|Treatment|Poor/Non compliance|0|||
156910295|NCT03766581|566430349|FG007|Treatment|Poor/Non compliance|0|||
156910296|NCT03766581|566430342|FG000|Treatment|Participant no longer meets study criteria|9|||
156910297|NCT03766581|566430343|FG001|Treatment|Participant no longer meets study criteria|1|||
156910298|NCT03766581|566430344|FG002|Treatment|Participant no longer meets study criteria|5|||
156910299|NCT03766581|566430345|FG003|Treatment|Participant no longer meets study criteria|4|||
156910300|NCT03766581|566430346|FG004|Treatment|Participant no longer meets study criteria|4|||
156910301|NCT03766581|566430347|FG005|Treatment|Participant no longer meets study criteria|4|||
156910302|NCT03766581|566430348|FG006|Treatment|Participant no longer meets study criteria|2|||
156910303|NCT03766581|566430349|FG007|Treatment|Participant no longer meets study criteria|0|||
156910304|NCT03766581|566430342|FG000|Treatment|Other reasons|13|||
156910305|NCT03766581|566430343|FG001|Treatment|Other reasons|8|||
156910306|NCT03766581|566430344|FG002|Treatment|Other reasons|3|||
156910307|NCT03766581|566430345|FG003|Treatment|Other reasons|7|||
156910308|NCT03766581|566430346|FG004|Treatment|Other reasons|3|||
156910309|NCT03766581|566430347|FG005|Treatment|Other reasons|3|||
156910310|NCT03766581|566430348|FG006|Treatment|Other reasons|0|||
156910311|NCT03766581|566430349|FG007|Treatment|Other reasons|0|||
156910312|NCT02732119|566430350|FG000|Phase I|Adverse Event|1|||
156910313|NCT02732119|566430351|FG001|Phase I|Adverse Event|3|||
156910314|NCT02732119|566430352|FG002|Phase I|Adverse Event|1|||
156910315|NCT02732119|566430353|FG003|Phase I|Adverse Event|0|||
156910316|NCT02732119|566430354|FG004|Phase I|Adverse Event|0|||
156910317|NCT02732119|566430350|FG000|Phase I|Progressive disease|7|||
156910318|NCT02732119|566430351|FG001|Phase I|Progressive disease|3|||
156910319|NCT02732119|566430352|FG002|Phase I|Progressive disease|2|||
156910320|NCT02732119|566430353|FG003|Phase I|Progressive disease|0|||
156910321|NCT02732119|566430354|FG004|Phase I|Progressive disease|0|||
156910322|NCT02732119|566430350|FG000|Phase I|Protocol deviation|0|||
156910323|NCT02732119|566430351|FG001|Phase I|Protocol deviation|1|||
156910324|NCT02732119|566430352|FG002|Phase I|Protocol deviation|0|||
156910325|NCT02732119|566430353|FG003|Phase I|Protocol deviation|0|||
156910326|NCT02732119|566430354|FG004|Phase I|Protocol deviation|0|||
156910327|NCT02732119|566430350|FG000|Phase I|Physician Decision|0|||
156910328|NCT02732119|566430351|FG001|Phase I|Physician Decision|3|||
156910329|NCT02732119|566430352|FG002|Phase I|Physician Decision|4|||
156910330|NCT02732119|566430353|FG003|Phase I|Physician Decision|0|||
156910331|NCT02732119|566430354|FG004|Phase I|Physician Decision|0|||
156910332|NCT02732119|566430350|FG000|Phase II|Adverse Event|0|||
156910333|NCT02732119|566430351|FG001|Phase II|Adverse Event|0|||
156910334|NCT02732119|566430352|FG002|Phase II|Adverse Event|0|||
156910335|NCT02732119|566430353|FG003|Phase II|Adverse Event|3|||
156910336|NCT02732119|566430354|FG004|Phase II|Adverse Event|3|||
156910337|NCT02732119|566430350|FG000|Phase II|Death|0|||
156910338|NCT02732119|566430351|FG001|Phase II|Death|0|||
156910339|NCT02732119|566430352|FG002|Phase II|Death|0|||
156910340|NCT02732119|566430353|FG003|Phase II|Death|1|||
156910341|NCT02732119|566430354|FG004|Phase II|Death|0|||
156910342|NCT02732119|566430350|FG000|Phase II|Progressive dissease|0|||
156910343|NCT02732119|566430351|FG001|Phase II|Progressive dissease|0|||
156910344|NCT02732119|566430352|FG002|Phase II|Progressive dissease|0|||
156910345|NCT02732119|566430353|FG003|Phase II|Progressive dissease|30|||
156910346|NCT02732119|566430354|FG004|Phase II|Progressive dissease|23|||
156910347|NCT02732119|566430350|FG000|Phase II|Study terminated by sponsor|0|||
156910348|NCT02732119|566430351|FG001|Phase II|Study terminated by sponsor|0|||
156910349|NCT02732119|566430352|FG002|Phase II|Study terminated by sponsor|0|||
156910350|NCT02732119|566430353|FG003|Phase II|Study terminated by sponsor|2|||
156910351|NCT02732119|566430354|FG004|Phase II|Study terminated by sponsor|2|||
156910352|NCT02732119|566430350|FG000|Phase II|Other|0|||
156910353|NCT02732119|566430351|FG001|Phase II|Other|0|||
156910354|NCT02732119|566430352|FG002|Phase II|Other|0|||
156910355|NCT02732119|566430353|FG003|Phase II|Other|2|||
156910356|NCT02732119|566430354|FG004|Phase II|Other|0|||
156910357|NCT02732119|566430350|FG000|Phase II|Physician Decision|0|||
156910358|NCT02732119|566430351|FG001|Phase II|Physician Decision|0|||
156910359|NCT02732119|566430352|FG002|Phase II|Physician Decision|0|||
156910360|NCT02732119|566430353|FG003|Phase II|Physician Decision|8|||
156910361|NCT02732119|566430354|FG004|Phase II|Physician Decision|5|||
156910362|NCT03716024|566430355|FG000|Overall Study|Randomized, not Treated|7|||
156910363|NCT03716024|566430356|FG001|Overall Study|Randomized, not Treated|8|||
156910364|NCT03716024|566430355|FG000|Overall Study|Adverse Event|1|||
156910365|NCT03716024|566430356|FG001|Overall Study|Adverse Event|2|||
156910366|NCT03716024|566430355|FG000|Overall Study|Treatment Failure|1|||
156910367|NCT03716024|566430356|FG001|Overall Study|Treatment Failure|0|||
156910368|NCT03716024|566430355|FG000|Overall Study|Lost to Follow-up|2|||
156910369|NCT03716024|566430356|FG001|Overall Study|Lost to Follow-up|6|||
156910370|NCT03716024|566430355|FG000|Overall Study|Withdrawal by Subject|0|||
156910371|NCT03716024|566430356|FG001|Overall Study|Withdrawal by Subject|1|||
156910372|NCT03716024|566430355|FG000|Overall Study|Missing Reason|0|||
156910373|NCT03716024|566430356|FG001|Overall Study|Missing Reason|1|||
156910374|NCT04343261|566430357|FG000|Overall Study|Adverse Event|1|||
156910375|NCT04343261|566430357|FG000|Overall Study|received inadequate amount of antibodies|7|||
156910376|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Physician Decision|0|||
156910377|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Physician Decision|1|||
156910378|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Physician Decision|0|||
156910379|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
156910380|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
156910381|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
156910382|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
156910383|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
156910384|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
156910385|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Other|4|||
156910386|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Other|4|||
156910387|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Other|0|||
156910388|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
156910389|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
156910390|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
156910391|NCT02585960|566430358|FG000|PK/Safety Assessment Period|Screen Failure|0|||
156910392|NCT02585960|566430359|FG001|PK/Safety Assessment Period|Screen Failure|0|||
156910393|NCT02585960|566430360|FG002|PK/Safety Assessment Period|Screen Failure|1|||
156910394|NCT02585960|566430358|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
156910395|NCT02585960|566430359|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
156910396|NCT02585960|566430360|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
156910397|NCT02585960|566430358|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
156910398|NCT02585960|566430359|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
156910399|NCT02585960|566430360|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
156910400|NCT01651039|566430362|FG000|Overall Study|Non-evaluables|5|||
156910401|NCT01651039|566430362|FG000|Overall Study|Physician Decision|2|||
156910402|NCT01651039|566430362|FG000|Overall Study|Withdrawal by Subject|1|||
156910403|NCT01651039|566430362|FG000|Overall Study|Progressive Disease|22|||
156910404|NCT03600818|566430363|FG000|Overall Study|Adverse Event|4|||
156910405|NCT03600818|566430364|FG001|Overall Study|Adverse Event|7|||
156910406|NCT03600818|566430363|FG000|Overall Study|Lack of Efficacy|9|||
156910407|NCT03600818|566430364|FG001|Overall Study|Lack of Efficacy|4|||
156910408|NCT03600818|566430363|FG000|Overall Study|Withdrawal by Subject|4|||
156910409|NCT03600818|566430364|FG001|Overall Study|Withdrawal by Subject|3|||
156910410|NCT03600818|566430363|FG000|Overall Study|Other-unspecified|5|||
156910411|NCT03600818|566430364|FG001|Overall Study|Other-unspecified|3|||
156910412|NCT03600818|566430363|FG000|Overall Study|Randomized and not treated|0|||
156910413|NCT03600818|566430364|FG001|Overall Study|Randomized and not treated|1|||
156910414|NCT04930965|566430367|FG000|Overall Study|Lost to Follow-up|7|||
156910415|NCT04930965|566430368|FG001|Overall Study|Lost to Follow-up|5|||
156910416|NCT04377620|566430369|FG000|Overall Study|Death|42|||
156910417|NCT04377620|566430370|FG001|Overall Study|Death|48|||
156910418|NCT04377620|566430371|FG002|Overall Study|Death|36|||
156910419|NCT04377620|566430369|FG000|Overall Study|Withdrawal by Subject|0|||
156910420|NCT04377620|566430370|FG001|Overall Study|Withdrawal by Subject|2|||
156910421|NCT04377620|566430371|FG002|Overall Study|Withdrawal by Subject|0|||
157027267|NCT03854227|566856066|FG003|Overall Study|Study terminated by sponsor|0|||
157027268|NCT03854227|566856067|FG004|Overall Study|Study terminated by sponsor|0|||
157027269|NCT03854227|566856068|FG005|Overall Study|Study terminated by sponsor|0|||
157027270|NCT03854227|566856069|FG006|Overall Study|Study terminated by sponsor|0|||
157027271|NCT03854227|566856070|FG007|Overall Study|Study terminated by sponsor|0|||
157027272|NCT03854227|566856071|FG008|Overall Study|Study terminated by sponsor|0|||
157027273|NCT03854227|566856072|FG009|Overall Study|Study terminated by sponsor|1|||
157027274|NCT03854227|566856073|FG010|Overall Study|Study terminated by sponsor|0|||
157027275|NCT03854227|566856074|FG011|Overall Study|Study terminated by sponsor|0|||
156910422|NCT01488370|566430372|FG000|Overall Study|Protocol Violation|0|||
156910423|NCT01488370|566430373|FG001|Overall Study|Protocol Violation|1|||
156910424|NCT01488370|566430374|FG002|Overall Study|Protocol Violation|1|||
156910425|NCT04189081|566430376|FG000|Overall Study|Lost to Follow-up|1|||
156910426|NCT04189081|566430377|FG001|Overall Study|Lost to Follow-up|0|||
156910427|NCT04189081|566430378|FG002|Overall Study|Lost to Follow-up|0|||
156910428|NCT04189081|566430376|FG000|Overall Study|Withdrawal by Subject|0|||
156910429|NCT04189081|566430377|FG001|Overall Study|Withdrawal by Subject|0|||
156910430|NCT04189081|566430378|FG002|Overall Study|Withdrawal by Subject|1|||
157027276|NCT03854227|566856063|FG000|Overall Study|Withdrawal by Subject|0|||
156910431|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
156910432|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
156910433|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
156910434|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
156910435|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
156910436|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
156910437|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
156910438|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
156910439|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
156910440|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
156910441|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
156910442|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
156910443|NCT00044083|566430379|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
156910444|NCT00044083|566430380|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
156910445|NCT00044083|566430379|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
156910446|NCT00044083|566430380|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
156910447|NCT00044083|566430379|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
156910448|NCT00044083|566430380|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
156910449|NCT00044083|566430379|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
156910450|NCT00044083|566430380|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
156910451|NCT00444912|566430386|FG000|Overall Study|Death|1|||
156910452|NCT00444912|566430387|FG001|Overall Study|Death|2|||
156910453|NCT00444912|566430386|FG000|Overall Study|Lost to Follow-up|1|||
156910454|NCT00444912|566430387|FG001|Overall Study|Lost to Follow-up|0|||
156910455|NCT00444912|566430386|FG000|Overall Study|Participant Failed Mobilization|1|||
156910456|NCT00444912|566430387|FG001|Overall Study|Participant Failed Mobilization|0|||
156910457|NCT01606007|566430388|FG000|Overall Study|Reason 'Other' in the protocol|0|||
156910458|NCT01606007|566430389|FG001|Overall Study|Reason 'Other' in the protocol|1|||
156910459|NCT01606007|566430390|FG002|Overall Study|Reason 'Other' in the protocol|1|||
156910460|NCT01606007|566430388|FG000|Overall Study|Pregnancy|0|||
156910461|NCT01606007|566430389|FG001|Overall Study|Pregnancy|1|||
156910462|NCT01606007|566430390|FG002|Overall Study|Pregnancy|1|||
156910463|NCT01606007|566430388|FG000|Overall Study|Withdrawal by Subject|8|||
156910464|NCT01606007|566430389|FG001|Overall Study|Withdrawal by Subject|6|||
156910465|NCT01606007|566430390|FG002|Overall Study|Withdrawal by Subject|1|||
156910466|NCT01606007|566430388|FG000|Overall Study|Adverse Event|0|||
156910467|NCT01606007|566430389|FG001|Overall Study|Adverse Event|1|||
156910468|NCT01606007|566430390|FG002|Overall Study|Adverse Event|1|||
156910469|NCT01606007|566430388|FG000|Overall Study|discontinue study treatment|0|||
156910470|NCT01606007|566430389|FG001|Overall Study|discontinue study treatment|2|||
156910471|NCT01606007|566430390|FG002|Overall Study|discontinue study treatment|1|||
156910472|NCT01606007|566430388|FG000|Overall Study|Lost to Follow-up|6|||
156910473|NCT01606007|566430389|FG001|Overall Study|Lost to Follow-up|8|||
156910474|NCT01606007|566430390|FG002|Overall Study|Lost to Follow-up|5|||
156910475|NCT01606007|566430388|FG000|Overall Study|Poor/Non-compliance|1|||
156910476|NCT01606007|566430389|FG001|Overall Study|Poor/Non-compliance|0|||
156910477|NCT01606007|566430390|FG002|Overall Study|Poor/Non-compliance|0|||
156910478|NCT03758066|566430391|FG000|Overall Study|Lost to Follow-up|14|||
156910479|NCT00851747|566430395|FG000|Overall Study|Physician Decision|6|||
156910480|NCT00851747|566430396|FG001|Overall Study|Physician Decision|6|||
156910481|NCT00851747|566430397|FG002|Overall Study|Physician Decision|6|||
156910482|NCT03570697|566430404|FG000|Overall Study|Lost to Follow-up|0|||
156910483|NCT03570697|566430405|FG001|Overall Study|Lost to Follow-up|1|||
156910484|NCT03570697|566430404|FG000|Overall Study|Death|2|||
156910485|NCT03570697|566430405|FG001|Overall Study|Death|0|||
156910486|NCT03570697|566430404|FG000|Overall Study|Withdrawal by Subject|4|||
156910487|NCT03570697|566430405|FG001|Overall Study|Withdrawal by Subject|2|||
156910488|NCT03988088|566430406|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156910489|NCT03988088|566430407|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
156910490|NCT03988088|566430408|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156910491|NCT03988088|566430409|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
156910492|NCT03988088|566430406|FG000|Open-Label Addendum|Lost to Follow-up|0|||
156910493|NCT03988088|566430407|FG001|Open-Label Addendum|Lost to Follow-up|0|||
156910494|NCT03988088|566430408|FG002|Open-Label Addendum|Lost to Follow-up|1|||
156910495|NCT03988088|566430409|FG003|Open-Label Addendum|Lost to Follow-up|0|||
156910496|NCT02935842|566430410|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
156910497|NCT02935842|566430411|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156910498|NCT02935842|566430412|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156910499|NCT02935842|566430413|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
156910500|NCT02935842|566430410|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
156910501|NCT02935842|566430411|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
156910502|NCT02935842|566430412|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
156910503|NCT02935842|566430413|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
156910504|NCT02935842|566430410|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
156910505|NCT02935842|566430411|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
156910506|NCT02935842|566430412|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
156910507|NCT02935842|566430413|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
156910508|NCT02935842|566430410|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
156910509|NCT02935842|566430411|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
156910510|NCT02935842|566430412|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
156910511|NCT02935842|566430413|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
156910512|NCT02935842|566430410|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156910513|NCT02935842|566430411|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156910514|NCT02935842|566430412|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
156910515|NCT02935842|566430413|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
156910516|NCT03344796|566430414|FG000|Overall Study|Lost to Follow-up|0|||
156910517|NCT03344796|566430415|FG001|Overall Study|Lost to Follow-up|0|||
156910518|NCT03344796|566430416|FG002|Overall Study|Lost to Follow-up|0|||
156910519|NCT03344796|566430417|FG003|Overall Study|Lost to Follow-up|0|||
156910520|NCT03344796|566430418|FG004|Overall Study|Lost to Follow-up|0|||
156910521|NCT03344796|566430419|FG005|Overall Study|Lost to Follow-up|2|||
156910522|NCT00923156|566430429|FG000|Overall Study|Adverse Event|0|||
156910523|NCT00923156|566430430|FG001|Overall Study|Adverse Event|2|||
156910524|NCT00923156|566430431|FG002|Overall Study|Adverse Event|1|||
156910525|NCT00923156|566430429|FG000|Overall Study|Abnormal laboratory values|0|||
156910526|NCT00923156|566430430|FG001|Overall Study|Abnormal laboratory values|0|||
156910527|NCT00923156|566430431|FG002|Overall Study|Abnormal laboratory values|1|||
156910528|NCT00923156|566430429|FG000|Overall Study|Withdrawal by Subject|0|||
156910529|NCT00923156|566430430|FG001|Overall Study|Withdrawal by Subject|1|||
156910530|NCT00923156|566430431|FG002|Overall Study|Withdrawal by Subject|0|||
156910531|NCT00923156|566430429|FG000|Overall Study|Death|0|||
156910532|NCT00923156|566430430|FG001|Overall Study|Death|1|||
156910533|NCT00923156|566430431|FG002|Overall Study|Death|0|||
156910534|NCT00923156|566430429|FG000|Overall Study|Lack of Efficacy|0|||
156910535|NCT00923156|566430430|FG001|Overall Study|Lack of Efficacy|0|||
156910536|NCT00923156|566430431|FG002|Overall Study|Lack of Efficacy|1|||
156910537|NCT03137537|566430432|FG000|Overall Study|Adverse Event|0|||
156910538|NCT03137537|566430433|FG001|Overall Study|Adverse Event|1|||
156910539|NCT01552694|566430434|FG000|Overall Study|Lost to Follow-up|0|||
156910540|NCT01552694|566430435|FG001|Overall Study|Lost to Follow-up|1|||
156910541|NCT01552694|566430434|FG000|Overall Study|Protocol Violation|0|||
156910542|NCT01552694|566430435|FG001|Overall Study|Protocol Violation|1|||
156910543|NCT00191139|566430436|FG000|Overall Study|Adverse Event|2|||
156910544|NCT00191139|566430437|FG001|Overall Study|Adverse Event|6|||
156910545|NCT00191139|566430436|FG000|Overall Study|Death|2|||
156910546|NCT00191139|566430437|FG001|Overall Study|Death|0|||
156910547|NCT00191139|566430436|FG000|Overall Study|Withdrawal by Subject|0|||
156910548|NCT00191139|566430437|FG001|Overall Study|Withdrawal by Subject|3|||
156910549|NCT00191139|566430436|FG000|Overall Study|Disease Progression|0|||
156910550|NCT00191139|566430437|FG001|Overall Study|Disease Progression|1|||
156910551|NCT00191139|566430436|FG000|Overall Study|Other|1|||
156910552|NCT00191139|566430437|FG001|Overall Study|Other|2|||
156910553|NCT00816595|566430441|FG000|Overall Study|Withdrawal by Subject|2|||
156910554|NCT00816595|566430442|FG001|Overall Study|Withdrawal by Subject|0|||
156910555|NCT00453063|566430443|FG000|Overall Study|Adverse Event|1|||
156910556|NCT00453063|566430444|FG001|Overall Study|Adverse Event|2|||
156910557|NCT00453063|566430443|FG000|Overall Study|Withdrawal by Subject|1|||
156910558|NCT00453063|566430444|FG001|Overall Study|Withdrawal by Subject|1|||
156910559|NCT00453063|566430443|FG000|Overall Study|Protocol Violation|1|||
156910560|NCT00453063|566430444|FG001|Overall Study|Protocol Violation|0|||
156910561|NCT00114530|566430445|FG000|Overall Study|Death|3|||
156910562|NCT00114530|566430446|FG001|Overall Study|Death|11|||
157159987|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910563|NCT00114530|566430445|FG000|Overall Study|Lost to Follow-up|1|||
156910564|NCT00114530|566430446|FG001|Overall Study|Lost to Follow-up|1|||
156910565|NCT00114530|566430445|FG000|Overall Study|Physician Decision|1|||
156910566|NCT00114530|566430446|FG001|Overall Study|Physician Decision|1|||
156910567|NCT00114530|566430445|FG000|Overall Study|Withdrawal by Subject|2|||
156910568|NCT00114530|566430446|FG001|Overall Study|Withdrawal by Subject|6|||
156910569|NCT00114530|566430445|FG000|Overall Study|Breast Cancer|1|||
156910570|NCT00114530|566430446|FG001|Overall Study|Breast Cancer|0|||
156910571|NCT00114530|566430445|FG000|Overall Study|Subject decision after endpoint failure|0|||
156910572|NCT00114530|566430446|FG001|Overall Study|Subject decision after endpoint failure|1|||
156910573|NCT00114530|566430445|FG000|Overall Study|Ineligible|1|||
156910574|NCT00114530|566430446|FG001|Overall Study|Ineligible|0|||
156910575|NCT01817530|566430447|FG000|Overall Study|Exclusionary Medication Received|0|||
156910576|NCT01817530|566430448|FG001|Overall Study|Exclusionary Medication Received|0|||
156910577|NCT01817530|566430449|FG002|Overall Study|Exclusionary Medication Received|0|||
156910578|NCT01817530|566430450|FG003|Overall Study|Exclusionary Medication Received|0|||
156910579|NCT01817530|566430451|FG004|Overall Study|Exclusionary Medication Received|1|||
156910580|NCT01817530|566430452|FG005|Overall Study|Exclusionary Medication Received|0|||
156910581|NCT01817530|566430453|FG006|Overall Study|Exclusionary Medication Received|0|||
156910582|NCT01817530|566430454|FG007|Overall Study|Exclusionary Medication Received|0|||
156910583|NCT01817530|566430447|FG000|Overall Study|Adverse Event|6|||
156910584|NCT01817530|566430448|FG001|Overall Study|Adverse Event|3|||
156910585|NCT01817530|566430449|FG002|Overall Study|Adverse Event|2|||
156910586|NCT01817530|566430450|FG003|Overall Study|Adverse Event|5|||
156910587|NCT01817530|566430451|FG004|Overall Study|Adverse Event|0|||
156910588|NCT01817530|566430452|FG005|Overall Study|Adverse Event|10|||
157159988|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910589|NCT01817530|566430453|FG006|Overall Study|Adverse Event|5|||
156910590|NCT01817530|566430454|FG007|Overall Study|Adverse Event|8|||
156910591|NCT01817530|566430447|FG000|Overall Study|Subject Noncompliant|3|||
156910592|NCT01817530|566430448|FG001|Overall Study|Subject Noncompliant|1|||
156910593|NCT01817530|566430449|FG002|Overall Study|Subject Noncompliant|0|||
156910594|NCT01817530|566430450|FG003|Overall Study|Subject Noncompliant|4|||
156910595|NCT01817530|566430451|FG004|Overall Study|Subject Noncompliant|0|||
156910596|NCT01817530|566430452|FG005|Overall Study|Subject Noncompliant|1|||
156910597|NCT01817530|566430453|FG006|Overall Study|Subject Noncompliant|1|||
156910598|NCT01817530|566430454|FG007|Overall Study|Subject Noncompliant|1|||
156910599|NCT01817530|566430447|FG000|Overall Study|Lack of Efficacy|1|||
156910600|NCT01817530|566430448|FG001|Overall Study|Lack of Efficacy|0|||
156910601|NCT01817530|566430449|FG002|Overall Study|Lack of Efficacy|0|||
156910602|NCT01817530|566430450|FG003|Overall Study|Lack of Efficacy|0|||
156910603|NCT01817530|566430451|FG004|Overall Study|Lack of Efficacy|0|||
156910604|NCT01817530|566430452|FG005|Overall Study|Lack of Efficacy|1|||
156910605|NCT01817530|566430453|FG006|Overall Study|Lack of Efficacy|0|||
156910606|NCT01817530|566430454|FG007|Overall Study|Lack of Efficacy|1|||
156910607|NCT01817530|566430447|FG000|Overall Study|Pregnancy|0|||
156910608|NCT01817530|566430448|FG001|Overall Study|Pregnancy|0|||
156910609|NCT01817530|566430449|FG002|Overall Study|Pregnancy|0|||
156910610|NCT01817530|566430450|FG003|Overall Study|Pregnancy|0|||
156910611|NCT01817530|566430451|FG004|Overall Study|Pregnancy|0|||
156910612|NCT01817530|566430452|FG005|Overall Study|Pregnancy|1|||
156910613|NCT01817530|566430453|FG006|Overall Study|Pregnancy|0|||
156910614|NCT01817530|566430454|FG007|Overall Study|Pregnancy|0|||
156910615|NCT01817530|566430447|FG000|Overall Study|Other|0|||
156910616|NCT01817530|566430448|FG001|Overall Study|Other|1|||
156910617|NCT01817530|566430449|FG002|Overall Study|Other|0|||
156910618|NCT01817530|566430450|FG003|Overall Study|Other|0|||
156910619|NCT01817530|566430451|FG004|Overall Study|Other|1|||
156910620|NCT01817530|566430452|FG005|Overall Study|Other|0|||
156910621|NCT01817530|566430453|FG006|Overall Study|Other|5|||
156910622|NCT01817530|566430454|FG007|Overall Study|Other|0|||
156910623|NCT01817530|566430447|FG000|Overall Study|Surgery or Invasive Intervention|1|||
156910624|NCT01817530|566430448|FG001|Overall Study|Surgery or Invasive Intervention|0|||
156910625|NCT01817530|566430449|FG002|Overall Study|Surgery or Invasive Intervention|0|||
156910626|NCT01817530|566430450|FG003|Overall Study|Surgery or Invasive Intervention|0|||
156910627|NCT01817530|566430451|FG004|Overall Study|Surgery or Invasive Intervention|1|||
156910628|NCT01817530|566430452|FG005|Overall Study|Surgery or Invasive Intervention|1|||
156910629|NCT01817530|566430453|FG006|Overall Study|Surgery or Invasive Intervention|1|||
156910630|NCT01817530|566430454|FG007|Overall Study|Surgery or Invasive Intervention|0|||
156910631|NCT01817530|566430447|FG000|Overall Study|Consent Withdrawn by Subject|3|||
156910632|NCT01817530|566430448|FG001|Overall Study|Consent Withdrawn by Subject|4|||
156910633|NCT01817530|566430449|FG002|Overall Study|Consent Withdrawn by Subject|7|||
156910634|NCT01817530|566430450|FG003|Overall Study|Consent Withdrawn by Subject|3|||
156910635|NCT01817530|566430451|FG004|Overall Study|Consent Withdrawn by Subject|5|||
156910636|NCT01817530|566430452|FG005|Overall Study|Consent Withdrawn by Subject|3|||
156910637|NCT01817530|566430453|FG006|Overall Study|Consent Withdrawn by Subject|3|||
156910638|NCT01817530|566430454|FG007|Overall Study|Consent Withdrawn by Subject|10|||
156910639|NCT01817530|566430447|FG000|Overall Study|Lost to Follow-up|1|||
156910640|NCT01817530|566430448|FG001|Overall Study|Lost to Follow-up|4|||
156910641|NCT01817530|566430449|FG002|Overall Study|Lost to Follow-up|2|||
156910642|NCT01817530|566430450|FG003|Overall Study|Lost to Follow-up|1|||
156910643|NCT01817530|566430451|FG004|Overall Study|Lost to Follow-up|3|||
156910644|NCT01817530|566430452|FG005|Overall Study|Lost to Follow-up|2|||
156910645|NCT01817530|566430453|FG006|Overall Study|Lost to Follow-up|8|||
156910646|NCT01817530|566430454|FG007|Overall Study|Lost to Follow-up|4|||
156910647|NCT00566995|566430455|FG000|Overall Study|Toxicity|4|||
156910648|NCT00566995|566430455|FG000|Overall Study|Withdrew consent|3|||
156910649|NCT00705484|566432610|FG000|Overall Study|Adverse Event|28|||
156910650|NCT00705484|566432611|FG001|Overall Study|Adverse Event|27|||
156910651|NCT00705484|566432610|FG000|Overall Study|Lost to Follow-up|169|||
156910652|NCT00705484|566432611|FG001|Overall Study|Lost to Follow-up|250|||
156910653|NCT00705484|566432610|FG000|Overall Study|Withdrawal by Subject|96|||
156910654|NCT00705484|566432611|FG001|Overall Study|Withdrawal by Subject|72|||
156910655|NCT00705484|566432610|FG000|Overall Study|Administrative|89|||
156910656|NCT00705484|566432611|FG001|Overall Study|Administrative|59|||
156910657|NCT02197247|566432612|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
156910658|NCT02197247|566432612|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
156910659|NCT02197247|566432612|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
156910660|NCT02197247|566432612|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
156910661|NCT02197247|566432612|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
156910662|NCT02197247|566432612|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
156910663|NCT02197247|566432612|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
156910664|NCT02197247|566432612|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
156910665|NCT02499783|566432615|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
156910666|NCT02499783|566432616|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
156910667|NCT02499783|566432617|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
156910668|NCT02499783|566432615|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
156910669|NCT02499783|566432616|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
156910670|NCT02499783|566432617|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
156910671|NCT02499783|566432615|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
156910672|NCT02499783|566432616|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
156910673|NCT02499783|566432617|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
156910674|NCT02499783|566432615|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
156910675|NCT02499783|566432616|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
156910676|NCT02499783|566432617|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
156910677|NCT02499783|566432615|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
156910678|NCT02499783|566432616|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
156910679|NCT02499783|566432617|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
156910680|NCT02499783|566432615|FG000|DB Period: Weeks 0-8|Other|1|||
156910681|NCT02499783|566432616|FG001|DB Period: Weeks 0-8|Other|1|||
156910682|NCT02499783|566432617|FG002|DB Period: Weeks 0-8|Other|0|||
156910683|NCT02499783|566432615|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
156910684|NCT02499783|566432616|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
156910685|NCT02499783|566432617|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
156910686|NCT02499783|566432615|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
156910687|NCT02499783|566432616|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
156910688|NCT02499783|566432617|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
156910689|NCT02499783|566432615|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
156910690|NCT02499783|566432616|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
156910691|NCT02499783|566432617|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
156910692|NCT02499783|566432615|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
156910693|NCT02499783|566432616|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
156910694|NCT02499783|566432617|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
156910695|NCT02228460|566432618|FG000|Overall Study|Adverse Event|1|||
156910696|NCT02228460|566432618|FG000|Overall Study|Lost to Follow-up|1|||
156910697|NCT01243892|566432619|FG000|Overall Study|Did not meet eligibility criteria|2|||
156910698|NCT01243892|566432620|FG001|Overall Study|Did not meet eligibility criteria|0|||
156910699|NCT00119106|566432621|FG000|Overall Study|HIV infected at baseline|179|||
156910700|NCT00119106|566432622|FG001|Overall Study|HIV infected at baseline|178|||
156910701|NCT01010061|566432623|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
156910702|NCT01010061|566432624|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
156910703|NCT01010061|566432623|FG000|Overall Study|Disease Progression|2|||
156910704|NCT01010061|566432624|FG001|Overall Study|Disease Progression|8|||
156910705|NCT01010061|566432623|FG000|Overall Study|Withdrew Consent|5|||
156910706|NCT01010061|566432624|FG001|Overall Study|Withdrew Consent|1|||
156910707|NCT01010061|566432623|FG000|Overall Study|Death|3|||
156910708|NCT01010061|566432624|FG001|Overall Study|Death|6|||
156910709|NCT01010061|566432623|FG000|Overall Study|Administrative/Other|0|||
156910710|NCT01010061|566432624|FG001|Overall Study|Administrative/Other|1|||
156910711|NCT01010061|566432623|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
156910712|NCT01010061|566432624|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
156910713|NCT01010061|566432623|FG000|Overall Study|Insufficient Therapeutic Response|1|||
157159989|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159990|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
157159991|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910714|NCT01010061|566432624|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156910715|NCT01010061|566432623|FG000|Overall Study|Violation of Selection Criteria|0|||
156910716|NCT01010061|566432624|FG001|Overall Study|Violation of Selection Criteria|1|||
156910717|NCT01010061|566432623|FG000|Overall Study|Did Not Receive Treatment|2|||
156910718|NCT01010061|566432624|FG001|Overall Study|Did Not Receive Treatment|2|||
156910719|NCT01866293|566432625|FG000|Overall Study|Adverse Event|2|||
156910720|NCT03066804|566432626|FG000|Overall Study|Physician Decision|0|||
156910721|NCT03066804|566432627|FG001|Overall Study|Physician Decision|4|||
156910722|NCT03066804|566432626|FG000|Overall Study|Death|23|||
156910723|NCT03066804|566432627|FG001|Overall Study|Death|17|||
156910724|NCT03066804|566432626|FG000|Overall Study|Withdrawal by Subject|19|||
156910725|NCT03066804|566432627|FG001|Overall Study|Withdrawal by Subject|25|||
156910726|NCT03066804|566432626|FG000|Overall Study|Lost to Follow-up|2|||
156910727|NCT03066804|566432627|FG001|Overall Study|Lost to Follow-up|0|||
156910728|NCT03066804|566432626|FG000|Overall Study|Adverse Event|2|||
156910729|NCT03066804|566432627|FG001|Overall Study|Adverse Event|3|||
156910730|NCT03066804|566432626|FG000|Overall Study|Technical problems|5|||
156910731|NCT03066804|566432627|FG001|Overall Study|Technical problems|1|||
156910732|NCT03982368|566432633|FG000|Overall Study|Adverse Event|6|||
156910733|NCT03982368|566432634|FG001|Overall Study|Adverse Event|4|||
156910734|NCT03982368|566432635|FG002|Overall Study|Adverse Event|3|||
156910735|NCT03982368|566432633|FG000|Overall Study|Lost to Follow-up|2|||
156910736|NCT03982368|566432634|FG001|Overall Study|Lost to Follow-up|1|||
156910737|NCT03982368|566432635|FG002|Overall Study|Lost to Follow-up|0|||
156910738|NCT03982368|566432633|FG000|Overall Study|Withdrawal by Subject|1|||
156910739|NCT03982368|566432634|FG001|Overall Study|Withdrawal by Subject|2|||
156910740|NCT03982368|566432635|FG002|Overall Study|Withdrawal by Subject|0|||
156910741|NCT03982368|566432633|FG000|Overall Study|unknow|4|||
156910742|NCT03982368|566432634|FG001|Overall Study|unknow|0|||
156910743|NCT03982368|566432635|FG002|Overall Study|unknow|2|||
156910744|NCT00518284|566432636|FG000|Overall Study|Adverse Event|0|||
156910745|NCT00518284|566432637|FG001|Overall Study|Adverse Event|1|||
156910746|NCT00518284|566432638|FG002|Overall Study|Adverse Event|0|||
156910747|NCT00518284|566432639|FG003|Overall Study|Adverse Event|0|||
156910748|NCT00518284|566432636|FG000|Overall Study|Study Termination|0|||
156910749|NCT00518284|566432637|FG001|Overall Study|Study Termination|2|||
156910750|NCT00518284|566432638|FG002|Overall Study|Study Termination|1|||
156910751|NCT00518284|566432639|FG003|Overall Study|Study Termination|2|||
156910752|NCT03768414|566432640|FG000|Overall Study|Adverse Event or side effects|72|||
156910753|NCT03768414|566432641|FG001|Overall Study|Adverse Event or side effects|28|||
156910754|NCT03768414|566432640|FG000|Overall Study|Refusal unrelated to adverse event|33|||
156910755|NCT03768414|566432641|FG001|Overall Study|Refusal unrelated to adverse event|33|||
156910756|NCT03768414|566432640|FG000|Overall Study|Progression/relapse|132|||
156910757|NCT03768414|566432641|FG001|Overall Study|Progression/relapse|60|||
156910758|NCT03768414|566432640|FG000|Overall Study|Death|9|||
156910759|NCT03768414|566432641|FG001|Overall Study|Death|6|||
156910760|NCT03768414|566432640|FG000|Overall Study|Other - not protocol specified|45|||
156910761|NCT03768414|566432641|FG001|Overall Study|Other - not protocol specified|18|||
156910762|NCT03768414|566432640|FG000|Overall Study|Reason under review|3|||
156910763|NCT03768414|566432641|FG001|Overall Study|Reason under review|2|||
156910764|NCT02571777|566432643|FG000|Overall Study|Subject/guardian decision|34|||
156910765|NCT02571777|566432644|FG001|Overall Study|Subject/guardian decision|26|||
156910766|NCT02571777|566432645|FG002|Overall Study|Subject/guardian decision|26|||
156910767|NCT02571777|566432646|FG003|Overall Study|Subject/guardian decision|25|||
156910768|NCT02571777|566432647|FG004|Overall Study|Subject/guardian decision|27|||
156910769|NCT02571777|566432643|FG000|Overall Study|Protocol Deviation|2|||
156910770|NCT02571777|566432644|FG001|Overall Study|Protocol Deviation|3|||
156910771|NCT02571777|566432645|FG002|Overall Study|Protocol Deviation|4|||
156910772|NCT02571777|566432646|FG003|Overall Study|Protocol Deviation|8|||
156910773|NCT02571777|566432647|FG004|Overall Study|Protocol Deviation|4|||
156910774|NCT02571777|566432643|FG000|Overall Study|Death|1|||
156910775|NCT02571777|566432644|FG001|Overall Study|Death|1|||
156910776|NCT02571777|566432645|FG002|Overall Study|Death|4|||
156910777|NCT02571777|566432646|FG003|Overall Study|Death|0|||
156910778|NCT02571777|566432647|FG004|Overall Study|Death|0|||
156910779|NCT02571777|566432643|FG000|Overall Study|Lost to Follow-up|1|||
156910780|NCT02571777|566432644|FG001|Overall Study|Lost to Follow-up|1|||
156910781|NCT02571777|566432645|FG002|Overall Study|Lost to Follow-up|2|||
156910782|NCT02571777|566432646|FG003|Overall Study|Lost to Follow-up|0|||
156910783|NCT02571777|566432647|FG004|Overall Study|Lost to Follow-up|1|||
156910784|NCT02571777|566432643|FG000|Overall Study|Physician Decision|1|||
156910785|NCT02571777|566432644|FG001|Overall Study|Physician Decision|7|||
156910786|NCT02571777|566432645|FG002|Overall Study|Physician Decision|5|||
156910787|NCT02571777|566432646|FG003|Overall Study|Physician Decision|2|||
156910788|NCT02571777|566432647|FG004|Overall Study|Physician Decision|4|||
157159992|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910789|NCT02571777|566432643|FG000|Overall Study|Pregnancy|0|||
156910790|NCT02571777|566432644|FG001|Overall Study|Pregnancy|0|||
157159993|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
156910791|NCT02571777|566432645|FG002|Overall Study|Pregnancy|0|||
156910792|NCT02571777|566432646|FG003|Overall Study|Pregnancy|2|||
156910793|NCT02571777|566432647|FG004|Overall Study|Pregnancy|0|||
156910794|NCT03706079|566432648|FG000|Predecessor Study|Death|0|||
156910795|NCT03706079|566432649|FG001|Predecessor Study|Death|2|||
156910796|NCT03706079|566432650|FG002|Predecessor Study|Death|0|||
156910797|NCT03706079|566432651|FG003|Predecessor Study|Death|1|||
156910798|NCT03706079|566432652|FG004|Predecessor Study|Death|0|||
156910799|NCT03706079|566432653|FG005|Predecessor Study|Death|0|||
156910800|NCT03706079|566432648|FG000|Predecessor Study|Lost to Follow-up|5|||
156910801|NCT03706079|566432649|FG001|Predecessor Study|Lost to Follow-up|2|||
156910802|NCT03706079|566432650|FG002|Predecessor Study|Lost to Follow-up|0|||
156910803|NCT03706079|566432651|FG003|Predecessor Study|Lost to Follow-up|0|||
157159994|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
157159995|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
156910804|NCT03706079|566432652|FG004|Predecessor Study|Lost to Follow-up|1|||
156910805|NCT03706079|566432653|FG005|Predecessor Study|Lost to Follow-up|0|||
156910806|NCT03706079|566432648|FG000|Predecessor Study|Withdrawal by Subject|8|||
156910807|NCT03706079|566432649|FG001|Predecessor Study|Withdrawal by Subject|15|||
156910808|NCT03706079|566432650|FG002|Predecessor Study|Withdrawal by Subject|0|||
156910809|NCT03706079|566432651|FG003|Predecessor Study|Withdrawal by Subject|5|||
156910810|NCT03706079|566432652|FG004|Predecessor Study|Withdrawal by Subject|2|||
156910811|NCT03706079|566432653|FG005|Predecessor Study|Withdrawal by Subject|0|||
156910812|NCT03706079|566432648|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
156910813|NCT03706079|566432649|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
156910814|NCT03706079|566432650|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156910815|NCT03706079|566432651|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156910816|NCT03706079|566432652|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156910817|NCT03706079|566432653|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
156910818|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156910819|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156910820|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156910821|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156910822|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
156910823|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
156910824|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
156910825|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156910826|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
156910827|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156910828|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156910829|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
156910830|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
156910831|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
156910832|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
156910833|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
156910834|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
156910835|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
156910836|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156910837|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156910838|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156910839|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
156910840|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
156910841|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
156910842|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
156910843|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156910844|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156910845|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
156910846|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
156910847|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
156910848|NCT03706079|566432648|FG000|Long Term Extension (DESTINATION)|Death|8|||
156910849|NCT03706079|566432649|FG001|Long Term Extension (DESTINATION)|Death|2|||
156910850|NCT03706079|566432650|FG002|Long Term Extension (DESTINATION)|Death|2|||
156910851|NCT03706079|566432651|FG003|Long Term Extension (DESTINATION)|Death|1|||
156910852|NCT03706079|566432652|FG004|Long Term Extension (DESTINATION)|Death|0|||
156910853|NCT03706079|566432653|FG005|Long Term Extension (DESTINATION)|Death|0|||
156910854|NCT00329238|566432654|FG000|Overall Study|Adverse Event|147|||
156910855|NCT00329238|566432655|FG001|Overall Study|Adverse Event|129|||
156910856|NCT00329238|566432654|FG000|Overall Study|Protocol Violation|23|||
156910857|NCT00329238|566432655|FG001|Overall Study|Protocol Violation|34|||
156910858|NCT00329238|566432654|FG000|Overall Study|Lost to Follow-up|2|||
156910859|NCT00329238|566432655|FG001|Overall Study|Lost to Follow-up|6|||
156910860|NCT00329238|566432654|FG000|Overall Study|Withdrawal by Subject|64|||
156910861|NCT00329238|566432655|FG001|Overall Study|Withdrawal by Subject|58|||
157159996|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
157159997|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
156910862|NCT00329238|566432654|FG000|Overall Study|Other reason (not specified)|40|||
157159998|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
157159999|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
156910863|NCT00329238|566432655|FG001|Overall Study|Other reason (not specified)|54|||
156910864|NCT00801632|566432656|FG000|Overall Study|Re-transplant|1|||
156910865|NCT03851705|566432668|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
156910866|NCT03851705|566432669|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156910867|NCT03851705|566432670|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156910868|NCT03851705|566432671|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
156910869|NCT03851705|566432668|FG000|Part 1: Double-Blind Period|Other reason|1|||
156910870|NCT03851705|566432669|FG001|Part 1: Double-Blind Period|Other reason|0|||
156910871|NCT03851705|566432670|FG002|Part 1: Double-Blind Period|Other reason|0|||
156910872|NCT03851705|566432671|FG003|Part 1: Double-Blind Period|Other reason|0|||
156910873|NCT03851705|566432668|FG000|Part 2: Open-Label Period|Other reason|0|||
156910874|NCT03851705|566432669|FG001|Part 2: Open-Label Period|Other reason|0|||
156910875|NCT03851705|566432670|FG002|Part 2: Open-Label Period|Other reason|0|||
156910876|NCT03851705|566432671|FG003|Part 2: Open-Label Period|Other reason|1|||
156910877|NCT03851705|566432668|FG000|Part 2: Open-Label Period|Death|0|||
156910878|NCT03851705|566432669|FG001|Part 2: Open-Label Period|Death|0|||
156910879|NCT03851705|566432670|FG002|Part 2: Open-Label Period|Death|3|||
156910880|NCT03851705|566432671|FG003|Part 2: Open-Label Period|Death|0|||
156910881|NCT03851705|566432668|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156910882|NCT03851705|566432669|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156910883|NCT03851705|566432670|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
156910884|NCT03851705|566432671|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
156910885|NCT00621582|566432672|FG000|Overall Study|Adverse Event|7|||
156910886|NCT00621582|566432672|FG000|Overall Study|Protocol Violation|57|||
156910887|NCT00621582|566432672|FG000|Overall Study|Lost to Follow-up|24|||
156910888|NCT00621582|566432672|FG000|Overall Study|issues not identified by investigators|18|||
156910889|NCT03617185|566432673|FG000|Baseline|Lost to Follow-up|0|||
156910890|NCT03617185|566432674|FG001|Baseline|Lost to Follow-up|2|||
156910891|NCT03617185|566432675|FG002|Baseline|Lost to Follow-up|1|||
156910892|NCT03617185|566432676|FG003|Baseline|Lost to Follow-up|1|||
156910893|NCT03617185|566432673|FG000|Baseline|Withdrawal by Subject|0|||
156910894|NCT03617185|566432674|FG001|Baseline|Withdrawal by Subject|1|||
156910895|NCT03617185|566432675|FG002|Baseline|Withdrawal by Subject|0|||
156910896|NCT03617185|566432676|FG003|Baseline|Withdrawal by Subject|1|||
156910897|NCT03617185|566432673|FG000|Baseline|Driving Distance/Travel|0|||
156910898|NCT03617185|566432674|FG001|Baseline|Driving Distance/Travel|0|||
156910899|NCT03617185|566432675|FG002|Baseline|Driving Distance/Travel|2|||
156910900|NCT03617185|566432676|FG003|Baseline|Driving Distance/Travel|0|||
156910901|NCT03617185|566432673|FG000|Baseline|Family Obligations|0|||
156910902|NCT03617185|566432674|FG001|Baseline|Family Obligations|0|||
156910903|NCT03617185|566432675|FG002|Baseline|Family Obligations|0|||
156910904|NCT03617185|566432676|FG003|Baseline|Family Obligations|1|||
156910905|NCT03617185|566432673|FG000|3 Months|Lost to Follow-up|4|||
156910906|NCT03617185|566432674|FG001|3 Months|Lost to Follow-up|1|||
156910907|NCT03617185|566432675|FG002|3 Months|Lost to Follow-up|0|||
156910908|NCT03617185|566432676|FG003|3 Months|Lost to Follow-up|2|||
156910909|NCT03617185|566432673|FG000|3 Months|Withdrawal by Subject|1|||
156910910|NCT03617185|566432674|FG001|3 Months|Withdrawal by Subject|3|||
156910911|NCT03617185|566432675|FG002|3 Months|Withdrawal by Subject|0|||
156910912|NCT03617185|566432676|FG003|3 Months|Withdrawal by Subject|0|||
156910913|NCT03617185|566432673|FG000|3 Months|Driving Distance/Travel|1|||
156910914|NCT03617185|566432674|FG001|3 Months|Driving Distance/Travel|0|||
156910915|NCT03617185|566432675|FG002|3 Months|Driving Distance/Travel|0|||
156910916|NCT03617185|566432676|FG003|3 Months|Driving Distance/Travel|0|||
156910917|NCT03617185|566432673|FG000|3 Months|Family Obligations|0|||
156910918|NCT03617185|566432674|FG001|3 Months|Family Obligations|0|||
156910919|NCT03617185|566432675|FG002|3 Months|Family Obligations|0|||
156910920|NCT03617185|566432676|FG003|3 Months|Family Obligations|1|||
156910921|NCT03617185|566432673|FG000|12 Months|Lost to Follow-up|3|||
156910922|NCT03617185|566432674|FG001|12 Months|Lost to Follow-up|1|||
156910923|NCT03617185|566432675|FG002|12 Months|Lost to Follow-up|3|||
156910924|NCT03617185|566432676|FG003|12 Months|Lost to Follow-up|0|||
156910925|NCT03617185|566432673|FG000|12 Months|Withdrawal by Subject|0|||
156910926|NCT03617185|566432674|FG001|12 Months|Withdrawal by Subject|0|||
156910927|NCT03617185|566432675|FG002|12 Months|Withdrawal by Subject|0|||
156910928|NCT03617185|566432676|FG003|12 Months|Withdrawal by Subject|1|||
156910929|NCT03617185|566432673|FG000|12 Months|Driving Distance/Travel|0|||
156910930|NCT03617185|566432674|FG001|12 Months|Driving Distance/Travel|0|||
156910931|NCT03617185|566432675|FG002|12 Months|Driving Distance/Travel|1|||
156910932|NCT03617185|566432676|FG003|12 Months|Driving Distance/Travel|0|||
156910933|NCT01387932|566432677|FG000|Randomized and Treated|Physician Decision|3|||
156910934|NCT01387932|566432678|FG001|Randomized and Treated|Physician Decision|2|||
156910935|NCT01387932|566432677|FG000|Randomized and Treated|Withdrawal by Subject|4|||
156910936|NCT01387932|566432678|FG001|Randomized and Treated|Withdrawal by Subject|2|||
156910937|NCT01387932|566432677|FG000|Survival Follow-up|Liver Transplant|24|||
156910938|NCT01387932|566432678|FG001|Survival Follow-up|Liver Transplant|28|||
156910939|NCT01387932|566432677|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
156977462|NCT04534114|566670720|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
156910940|NCT01387932|566432678|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
156910941|NCT01387932|566432677|FG000|Survival Follow-up|Withdrawal by Subject|2|||
156910942|NCT01387932|566432678|FG001|Survival Follow-up|Withdrawal by Subject|4|||
156910943|NCT01387932|566432677|FG000|Survival Follow-up|Lost to Follow-up|6|||
156910944|NCT01387932|566432678|FG001|Survival Follow-up|Lost to Follow-up|5|||
156910945|NCT01964430|566432679|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
156910946|NCT01964430|566432680|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
156910947|NCT01964430|566432679|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
156910948|NCT01964430|566432680|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
156910949|NCT01964430|566432679|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
156910950|NCT01964430|566432680|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
156910951|NCT01964430|566432679|FG000|Treatment Period|Adverse Event|71|||
156910952|NCT01964430|566432680|FG001|Treatment Period|Adverse Event|37|||
156910953|NCT01964430|566432679|FG000|Treatment Period|Withdrawal by Subject|36|||
156910954|NCT01964430|566432680|FG001|Treatment Period|Withdrawal by Subject|27|||
156910955|NCT01964430|566432679|FG000|Treatment Period|Death|1|||
156910956|NCT01964430|566432680|FG001|Treatment Period|Death|3|||
156910957|NCT01964430|566432679|FG000|Treatment Period|Protocol Deviation|0|||
156910958|NCT01964430|566432680|FG001|Treatment Period|Protocol Deviation|1|||
156910959|NCT01964430|566432679|FG000|Treatment Period|Physician Decision|5|||
156910960|NCT01964430|566432680|FG001|Treatment Period|Physician Decision|4|||
156910961|NCT01964430|566432679|FG000|Treatment Period|Disease Relapse|28|||
156910962|NCT01964430|566432680|FG001|Treatment Period|Disease Relapse|38|||
156910963|NCT01964430|566432679|FG000|Treatment Period|Other reasons|1|||
156910964|NCT01964430|566432680|FG001|Treatment Period|Other reasons|3|||
156910965|NCT02591290|566432681|FG000|Overall Study|Withdrawal by Subject|2|||
156910966|NCT02197520|566432685|FG000|Period 1|Withdrawal by Subject|1|||
156910967|NCT02197520|566432686|FG001|Period 1|Withdrawal by Subject|0|||
156910968|NCT02197520|566432685|FG000|Period 2|Adverse Event|0|||
156910969|NCT02197520|566432686|FG001|Period 2|Adverse Event|2|||
156910970|NCT02197520|566432685|FG000|Period 2|Withdrawal by Subject|1|||
156910971|NCT02197520|566432686|FG001|Period 2|Withdrawal by Subject|0|||
156910972|NCT00913497|566432687|FG000|Overall Study|Adverse Event|1|||
156910973|NCT00913497|566432687|FG000|Overall Study|Withdrawal by Subject|2|||
156910974|NCT01306942|566432688|FG000|Phase I|Adverse Event|2|||
156910975|NCT01306942|566432689|FG001|Phase I|Adverse Event|2|||
156910976|NCT01306942|566432690|FG002|Phase I|Adverse Event|0|||
156910977|NCT01306942|566432691|FG003|Phase I|Adverse Event|0|||
156910978|NCT01306942|566432688|FG000|Phase I|Physician Decision|3|||
156910979|NCT01306942|566432689|FG001|Phase I|Physician Decision|1|||
156910980|NCT01306942|566432690|FG002|Phase I|Physician Decision|0|||
156910981|NCT01306942|566432691|FG003|Phase I|Physician Decision|0|||
156910982|NCT01306942|566432688|FG000|Phase II|Adverse Event|0|||
156910983|NCT01306942|566432689|FG001|Phase II|Adverse Event|0|||
156910984|NCT01306942|566432690|FG002|Phase II|Adverse Event|0|||
156910985|NCT01306942|566432691|FG003|Phase II|Adverse Event|6|||
156910986|NCT01306942|566432688|FG000|Phase II|Physician Decision|2|||
156910987|NCT01306942|566432689|FG001|Phase II|Physician Decision|0|||
156910988|NCT01306942|566432690|FG002|Phase II|Physician Decision|0|||
156910989|NCT01306942|566432691|FG003|Phase II|Physician Decision|5|||
156910990|NCT01306942|566432688|FG000|Phase II|Withdrawal by Subject|0|||
156910991|NCT01306942|566432689|FG001|Phase II|Withdrawal by Subject|0|||
156910992|NCT01306942|566432690|FG002|Phase II|Withdrawal by Subject|0|||
156910993|NCT01306942|566432691|FG003|Phase II|Withdrawal by Subject|2|||
156910994|NCT01306942|566432688|FG000|Phase II|Death|0|||
156910995|NCT01306942|566432689|FG001|Phase II|Death|0|||
156910996|NCT01306942|566432690|FG002|Phase II|Death|0|||
156910997|NCT01306942|566432691|FG003|Phase II|Death|1|||
156910998|NCT01306942|566432688|FG000|Phase II|Not finished treatment|0|||
156910999|NCT01306942|566432689|FG001|Phase II|Not finished treatment|0|||
156911000|NCT01306942|566432690|FG002|Phase II|Not finished treatment|0|||
156911001|NCT01306942|566432691|FG003|Phase II|Not finished treatment|1|||
156911002|NCT01306942|566432688|FG000|Phase II|Protocol Violation|0|||
156911003|NCT01306942|566432689|FG001|Phase II|Protocol Violation|0|||
156911004|NCT01306942|566432690|FG002|Phase II|Protocol Violation|0|||
156911005|NCT01306942|566432691|FG003|Phase II|Protocol Violation|1|||
156911006|NCT03190915|566432692|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
156911007|NCT03190915|566432692|FG000|Overall Study|Progressive Disease|3|||
156911008|NCT04431453|566432693|FG000|Overall Study|Withdrew Consent|0|||
156911009|NCT04431453|566432694|FG001|Overall Study|Withdrew Consent|1|||
156911010|NCT04431453|566432695|FG002|Overall Study|Withdrew Consent|0|||
156911011|NCT04431453|566432696|FG003|Overall Study|Withdrew Consent|2|||
156911012|NCT04431453|566432697|FG004|Overall Study|Withdrew Consent|0|||
156911013|NCT04431453|566432698|FG005|Overall Study|Withdrew Consent|0|||
156911014|NCT04431453|566432699|FG006|Overall Study|Withdrew Consent|0|||
156911015|NCT04431453|566432700|FG007|Overall Study|Withdrew Consent|0|||
156911016|NCT04431453|566432693|FG000|Overall Study|Death|1|||
156911017|NCT04431453|566432694|FG001|Overall Study|Death|0|||
156911018|NCT04431453|566432695|FG002|Overall Study|Death|0|||
157027277|NCT03854227|566856064|FG001|Overall Study|Withdrawal by Subject|0|||
157027278|NCT03854227|566856065|FG002|Overall Study|Withdrawal by Subject|1|||
156911019|NCT04431453|566432696|FG003|Overall Study|Death|0|||
156911020|NCT04431453|566432697|FG004|Overall Study|Death|0|||
156911021|NCT04431453|566432698|FG005|Overall Study|Death|0|||
156911022|NCT04431453|566432699|FG006|Overall Study|Death|0|||
156911023|NCT04431453|566432700|FG007|Overall Study|Death|1|||
156911024|NCT04431453|566432693|FG000|Overall Study|Lost to Follow-up|0|||
156911025|NCT04431453|566432694|FG001|Overall Study|Lost to Follow-up|0|||
156911026|NCT04431453|566432695|FG002|Overall Study|Lost to Follow-up|1|||
156911027|NCT04431453|566432696|FG003|Overall Study|Lost to Follow-up|1|||
156911028|NCT04431453|566432697|FG004|Overall Study|Lost to Follow-up|0|||
156911029|NCT04431453|566432698|FG005|Overall Study|Lost to Follow-up|0|||
156911030|NCT04431453|566432699|FG006|Overall Study|Lost to Follow-up|0|||
156911031|NCT04431453|566432700|FG007|Overall Study|Lost to Follow-up|0|||
156911032|NCT04431453|566432693|FG000|Overall Study|Enrolled but Never Treated|0|||
156911033|NCT04431453|566432694|FG001|Overall Study|Enrolled but Never Treated|0|||
156911034|NCT04431453|566432695|FG002|Overall Study|Enrolled but Never Treated|0|||
156911035|NCT04431453|566432696|FG003|Overall Study|Enrolled but Never Treated|0|||
156911036|NCT04431453|566432697|FG004|Overall Study|Enrolled but Never Treated|1|||
156911037|NCT04431453|566432698|FG005|Overall Study|Enrolled but Never Treated|0|||
156911038|NCT04431453|566432699|FG006|Overall Study|Enrolled but Never Treated|0|||
156911039|NCT04431453|566432700|FG007|Overall Study|Enrolled but Never Treated|0|||
156911040|NCT03385564|566432701|FG000|Overall Study|Adverse Event|0|||
156911041|NCT03385564|566432702|FG001|Overall Study|Adverse Event|0|||
156911042|NCT03385564|566432703|FG002|Overall Study|Adverse Event|3|||
156911043|NCT03385564|566432704|FG003|Overall Study|Adverse Event|3|||
156911044|NCT03385564|566432701|FG000|Overall Study|Other than listed|0|||
156911045|NCT03385564|566432702|FG001|Overall Study|Other than listed|0|||
156911046|NCT03385564|566432703|FG002|Overall Study|Other than listed|0|||
156911047|NCT03385564|566432704|FG003|Overall Study|Other than listed|5|||
156911048|NCT03385564|566432701|FG000|Overall Study|Withdrawal by Subject|0|||
156911049|NCT03385564|566432702|FG001|Overall Study|Withdrawal by Subject|1|||
156911050|NCT03385564|566432703|FG002|Overall Study|Withdrawal by Subject|1|||
156911051|NCT03385564|566432704|FG003|Overall Study|Withdrawal by Subject|0|||
156911052|NCT03385564|566432701|FG000|Overall Study|Lack of Efficacy|0|||
156911053|NCT03385564|566432702|FG001|Overall Study|Lack of Efficacy|0|||
156911054|NCT03385564|566432703|FG002|Overall Study|Lack of Efficacy|0|||
156911055|NCT03385564|566432704|FG003|Overall Study|Lack of Efficacy|1|||
156911056|NCT03385564|566432701|FG000|Overall Study|Death|0|||
156911057|NCT03385564|566432702|FG001|Overall Study|Death|0|||
156911058|NCT03385564|566432703|FG002|Overall Study|Death|1|||
156911059|NCT03385564|566432704|FG003|Overall Study|Death|0|||
156911060|NCT00622401|566432705|FG000|Overall Study|Disease progression prior to treatment|3|||
156911061|NCT00622401|566432706|FG001|Overall Study|Disease progression prior to treatment|2|||
156911062|NCT00622401|566432707|FG002|Overall Study|Disease progression prior to treatment|0|||
156911063|NCT03087643|566432720|FG000|Overall Study|Withdrawal by Subject|2|||
156911064|NCT03087643|566432721|FG001|Overall Study|Withdrawal by Subject|4|||
156911065|NCT03087643|566432720|FG000|Overall Study|Death|2|||
156911066|NCT03087643|566432721|FG001|Overall Study|Death|2|||
156911067|NCT01546883|566432728|FG000|Overall Study|Withdrawal by Subject|3|||
156911068|NCT01546883|566432728|FG000|Overall Study|Adverse Event|4|||
156911069|NCT01546883|566432728|FG000|Overall Study|Lost to Follow-up|2|||
156911070|NCT01546883|566432728|FG000|Overall Study|early closure of study|2|||
156911071|NCT01546883|566432728|FG000|Overall Study|other unrelated illness|1|||
156911072|NCT02021773|566432729|FG000|Overall Study|Adverse Event|1|||
156911073|NCT02021773|566432730|FG001|Overall Study|Adverse Event|4|||
156911074|NCT02021773|566432731|FG002|Overall Study|Adverse Event|3|||
156911075|NCT02021773|566432729|FG000|Overall Study|Lack of Efficacy|2|||
156911076|NCT02021773|566432730|FG001|Overall Study|Lack of Efficacy|2|||
156911077|NCT02021773|566432731|FG002|Overall Study|Lack of Efficacy|2|||
156911078|NCT02021773|566432729|FG000|Overall Study|Protocol Violation|2|||
156911079|NCT02021773|566432730|FG001|Overall Study|Protocol Violation|3|||
156911080|NCT02021773|566432731|FG002|Overall Study|Protocol Violation|1|||
156911081|NCT02021773|566432729|FG000|Overall Study|Withdrawal by Subject|3|||
157027279|NCT03854227|566856066|FG003|Overall Study|Withdrawal by Subject|0|||
156911082|NCT02021773|566432730|FG001|Overall Study|Withdrawal by Subject|4|||
156911083|NCT02021773|566432731|FG002|Overall Study|Withdrawal by Subject|5|||
157027280|NCT03854227|566856067|FG004|Overall Study|Withdrawal by Subject|0|||
157027281|NCT03854227|566856068|FG005|Overall Study|Withdrawal by Subject|0|||
157027282|NCT03854227|566856069|FG006|Overall Study|Withdrawal by Subject|0|||
157027283|NCT03854227|566856070|FG007|Overall Study|Withdrawal by Subject|0|||
157027284|NCT03854227|566856071|FG008|Overall Study|Withdrawal by Subject|0|||
157160000|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
156911084|NCT02021773|566432729|FG000|Overall Study|Lost to Follow-up|1|||
156911085|NCT02021773|566432730|FG001|Overall Study|Lost to Follow-up|3|||
156911086|NCT02021773|566432731|FG002|Overall Study|Lost to Follow-up|0|||
156911087|NCT02021773|566432729|FG000|Overall Study|Reason not specified|3|||
156911088|NCT02021773|566432730|FG001|Overall Study|Reason not specified|0|||
157160001|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
157160002|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
157160003|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
157160004|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
157160005|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
156911089|NCT02021773|566432731|FG002|Overall Study|Reason not specified|0|||
156911090|NCT02243696|566432733|FG000|Overall Study|Death|282|||
156911091|NCT02243696|566432733|FG000|Overall Study|Withdrawal by Subject|79|||
156911092|NCT02243696|566432733|FG000|Overall Study|Lost to Follow-up|57|||
156911093|NCT02243696|566432733|FG000|Overall Study|Subject No Longer has Study System|42|||
156911094|NCT02243696|566432733|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
156911095|NCT02243696|566432733|FG000|Overall Study|Study Terminated for EP PASSION|961|||
156911096|NCT00622284|566432734|FG000|Overall Study|Lack of Efficacy|45|||
156911097|NCT00622284|566432735|FG001|Overall Study|Lack of Efficacy|15|||
156911098|NCT00622284|566432734|FG000|Overall Study|Adverse Event|61|||
156911099|NCT00622284|566432735|FG001|Overall Study|Adverse Event|90|||
156911100|NCT00622284|566432734|FG000|Overall Study|Protocol Violation|12|||
156911101|NCT00622284|566432735|FG001|Overall Study|Protocol Violation|5|||
156911102|NCT00622284|566432734|FG000|Overall Study|Lost to Follow-up|11|||
156911103|NCT00622284|566432735|FG001|Overall Study|Lost to Follow-up|13|||
156911104|NCT00622284|566432734|FG000|Overall Study|Withdrawal by Subject|27|||
156911105|NCT00622284|566432735|FG001|Overall Study|Withdrawal by Subject|24|||
156911106|NCT00622284|566432734|FG000|Overall Study|Other reason (not specified)|33|||
156911107|NCT00622284|566432735|FG001|Overall Study|Other reason (not specified)|24|||
156911108|NCT00915278|566432736|FG000|Overall Study|Death|1|||
156911109|NCT00915278|566432737|FG001|Overall Study|Death|0|||
156911110|NCT00915278|566432738|FG002|Overall Study|Death|0|||
156911111|NCT00915278|566432739|FG003|Overall Study|Death|0|||
156911112|NCT00915278|566432740|FG004|Overall Study|Death|0|||
156911113|NCT00915278|566432741|FG005|Overall Study|Death|0|||
156911114|NCT00915278|566432736|FG000|Overall Study|Lost to Follow-up|0|||
156911115|NCT00915278|566432737|FG001|Overall Study|Lost to Follow-up|1|||
156911116|NCT00915278|566432738|FG002|Overall Study|Lost to Follow-up|0|||
156911117|NCT00915278|566432739|FG003|Overall Study|Lost to Follow-up|0|||
156911118|NCT00915278|566432740|FG004|Overall Study|Lost to Follow-up|0|||
156911119|NCT00915278|566432741|FG005|Overall Study|Lost to Follow-up|0|||
156911120|NCT00915278|566432736|FG000|Overall Study|Withdrawal by Subject|0|||
156911121|NCT00915278|566432737|FG001|Overall Study|Withdrawal by Subject|1|||
156911122|NCT00915278|566432738|FG002|Overall Study|Withdrawal by Subject|0|||
156911123|NCT00915278|566432739|FG003|Overall Study|Withdrawal by Subject|0|||
156911124|NCT00915278|566432740|FG004|Overall Study|Withdrawal by Subject|1|||
156911125|NCT00915278|566432741|FG005|Overall Study|Withdrawal by Subject|4|||
156911126|NCT00915278|566432736|FG000|Overall Study|Adverse Event|4|||
156911127|NCT00915278|566432737|FG001|Overall Study|Adverse Event|1|||
156911128|NCT00915278|566432738|FG002|Overall Study|Adverse Event|0|||
156911129|NCT00915278|566432739|FG003|Overall Study|Adverse Event|0|||
156911130|NCT00915278|566432740|FG004|Overall Study|Adverse Event|0|||
156911131|NCT00915278|566432741|FG005|Overall Study|Adverse Event|0|||
156911132|NCT00915278|566432736|FG000|Overall Study|Progressive disease/clinical progression|0|||
156911133|NCT00915278|566432737|FG001|Overall Study|Progressive disease/clinical progression|0|||
156911134|NCT00915278|566432738|FG002|Overall Study|Progressive disease/clinical progression|0|||
156911135|NCT00915278|566432739|FG003|Overall Study|Progressive disease/clinical progression|3|||
156911136|NCT00915278|566432740|FG004|Overall Study|Progressive disease/clinical progression|1|||
156911137|NCT00915278|566432741|FG005|Overall Study|Progressive disease/clinical progression|2|||
156911138|NCT00915278|566432736|FG000|Overall Study|Infusion related AEs|0|||
156911139|NCT00915278|566432737|FG001|Overall Study|Infusion related AEs|0|||
157160006|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
157160007|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
156911140|NCT00915278|566432738|FG002|Overall Study|Infusion related AEs|0|||
156911141|NCT00915278|566432739|FG003|Overall Study|Infusion related AEs|0|||
156911142|NCT00915278|566432740|FG004|Overall Study|Infusion related AEs|0|||
156911143|NCT00915278|566432741|FG005|Overall Study|Infusion related AEs|2|||
156911144|NCT00915278|566432736|FG000|Overall Study|Admission to hospice|0|||
156911145|NCT00915278|566432737|FG001|Overall Study|Admission to hospice|0|||
156911146|NCT00915278|566432738|FG002|Overall Study|Admission to hospice|1|||
157160008|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
157160009|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
156911147|NCT00915278|566432739|FG003|Overall Study|Admission to hospice|0|||
156911148|NCT00915278|566432740|FG004|Overall Study|Admission to hospice|0|||
156911149|NCT00915278|566432741|FG005|Overall Study|Admission to hospice|0|||
156911150|NCT02412618|566432742|FG000|Overall Study|Withdrawal by Subject|1|||
156911151|NCT02412618|566432743|FG001|Overall Study|Withdrawal by Subject|1|||
156911152|NCT02412618|566432742|FG000|Overall Study|Expulsion|1|||
156911153|NCT02412618|566432743|FG001|Overall Study|Expulsion|1|||
156911154|NCT01253408|566432744|FG000|Overall Study|Adverse Event|0|||
156911155|NCT01253408|566432745|FG001|Overall Study|Adverse Event|1|||
156911156|NCT01253408|566432746|FG002|Overall Study|Adverse Event|0|||
156911157|NCT03408483|566432747|FG000|Overall Study|Physician Decision|3|||
156911158|NCT03408483|566432748|FG001|Overall Study|Physician Decision|3|||
156911159|NCT03408483|566432747|FG000|Overall Study|Lost to Follow-up|3|||
156911160|NCT03408483|566432748|FG001|Overall Study|Lost to Follow-up|0|||
156911161|NCT00478231|566432749|FG000|Overall Study|Death|7|||
156911162|NCT00478231|566432749|FG000|Overall Study|Lack of Efficacy|47|||
156911163|NCT00478231|566432749|FG000|Overall Study|Lost to Follow-up|7|||
156911164|NCT00478231|566432749|FG000|Overall Study|Withdrawal by Subject|6|||
156911165|NCT00478231|566432749|FG000|Overall Study|Other|9|||
156911166|NCT00478231|566432749|FG000|Overall Study|Adverse Event|5|||
156911167|NCT00478231|566432749|FG000|Overall Study|Randomized, not treated|3|||
156911168|NCT01702961|566432750|FG000|Overall Study|Additional treatment|3|||
156911169|NCT01702961|566432750|FG000|Overall Study|Progressive disease|5|||
156911170|NCT01702961|566432750|FG000|Overall Study|Relapse|20|||
156911171|NCT01702961|566432750|FG000|Overall Study|Death|6|||
156911172|NCT01702961|566432750|FG000|Overall Study|Lost to Follow-up|2|||
156911173|NCT01702961|566432750|FG000|Overall Study|Ongoing|11|||
156911174|NCT00602797|566432753|FG000|Overall Study|Adverse Event|1|||
156911175|NCT01201850|566432756|FG000|Overall Study|Tumor progression|4|||
156911176|NCT02465515|566432757|FG000|Overall Study|Investigator site closed|4|||
156911177|NCT02465515|566432758|FG001|Overall Study|Investigator site closed|5|||
156911178|NCT02465515|566432757|FG000|Overall Study|Withdrawal by Subject|74|||
156911179|NCT02465515|566432758|FG001|Overall Study|Withdrawal by Subject|43|||
156911180|NCT02465515|566432757|FG000|Overall Study|Physician Decision|8|||
156911181|NCT02465515|566432758|FG001|Overall Study|Physician Decision|12|||
156911182|NCT02465515|566432757|FG000|Overall Study|Lost to Follow-up|68|||
156911183|NCT02465515|566432758|FG001|Overall Study|Lost to Follow-up|51|||
156911184|NCT00629707|566432759|FG000|Overall Study|Withdrawal by Subject|0|||
156911185|NCT00629707|566432760|FG001|Overall Study|Withdrawal by Subject|1|||
156911186|NCT00629707|566432759|FG000|Overall Study|Physician Decision|0|||
156911187|NCT00629707|566432760|FG001|Overall Study|Physician Decision|1|||
156911188|NCT00751933|566432761|FG000|Overall Study|Withdrawal by Subject|0|||
156911189|NCT00751933|566432762|FG001|Overall Study|Withdrawal by Subject|1|||
156911190|NCT00751933|566432763|FG002|Overall Study|Withdrawal by Subject|0|||
156911191|NCT00751933|566432764|FG003|Overall Study|Withdrawal by Subject|0|||
156911192|NCT00751933|566432761|FG000|Overall Study|Physician Decision|0|||
156911193|NCT00751933|566432762|FG001|Overall Study|Physician Decision|0|||
156911194|NCT00751933|566432763|FG002|Overall Study|Physician Decision|1|||
156911195|NCT00751933|566432764|FG003|Overall Study|Physician Decision|1|||
156911196|NCT03846804|566432765|FG000|Overall Study|Refused blood draw|1|||
156911197|NCT03846804|566432765|FG000|Overall Study|Protocol Violation|1|||
156911198|NCT02657369|566432766|FG000|Overall Study|Death|27|||
156911199|NCT02657369|566432766|FG000|Overall Study|Study terminated by sponsor|7|||
156911200|NCT02605824|566432767|FG000|Overall Study|Physician Decision|1|||
156911201|NCT02605824|566432768|FG001|Overall Study|Physician Decision|0|||
156911202|NCT04875195|566432769|FG000|Overall Study|Death|9|||
156911203|NCT04875195|566432770|FG001|Overall Study|Death|3|||
156911204|NCT04875195|566432769|FG000|Overall Study|Withdrawal by Subject|2|||
156911205|NCT04875195|566432770|FG001|Overall Study|Withdrawal by Subject|1|||
156911206|NCT04875195|566432769|FG000|Overall Study|Ongoing in study|49|||
156911207|NCT04875195|566432770|FG001|Overall Study|Ongoing in study|2|||
156911208|NCT03288129|566432776|FG000|Overall Study|Adverse Event|10|||
156911209|NCT03288129|566432776|FG000|Overall Study|Lost to Follow-up|3|||
156911210|NCT03288129|566432776|FG000|Overall Study|Withdrawal by Subject|3|||
156911211|NCT03288129|566432776|FG000|Overall Study|Withdrawal of consent/assent|1|||
156911212|NCT03288129|566432776|FG000|Overall Study|Other|5|||
156911213|NCT01744197|566432777|FG000|Overall Study|Received 1 patch|2|||
156911214|NCT01744197|566432778|FG001|Overall Study|Received 1 patch|1|||
156911215|NCT01744197|566432777|FG000|Overall Study|No patch received|2|||
156911216|NCT01744197|566432778|FG001|Overall Study|No patch received|2|||
156911217|NCT04706091|566432779|FG000|Treatment 2|Withdrawal by Subject|1|||
156911218|NCT04706091|566432780|FG001|Treatment 2|Withdrawal by Subject|0|||
156911219|NCT03329573|566432781|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156911220|NCT03329573|566432782|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
157027285|NCT03854227|566856072|FG009|Overall Study|Withdrawal by Subject|1|||
157160010|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
156911221|NCT03329573|566432783|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156911222|NCT03329573|566432784|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
156911223|NCT03329573|566432781|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
156911224|NCT03329573|566432782|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
157160011|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
156911225|NCT03329573|566432783|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156911226|NCT03329573|566432784|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
156911227|NCT03329573|566432781|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
156911228|NCT03329573|566432782|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156911229|NCT03329573|566432783|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156911230|NCT03329573|566432784|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
156911231|NCT03329573|566432781|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156911232|NCT03329573|566432782|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
156911233|NCT03329573|566432783|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156911234|NCT03329573|566432784|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
156911235|NCT02777333|566432787|FG000|Overall Study|Withdrawal by Subject|0|||
156911236|NCT02777333|566432788|FG001|Overall Study|Withdrawal by Subject|1|||
156911237|NCT02777333|566432787|FG000|Overall Study|Lost to Follow-up|0|||
156911238|NCT02777333|566432788|FG001|Overall Study|Lost to Follow-up|1|||
156911239|NCT04997304|566432789|FG000|Overall Study|Lost to Follow-up|11|||
156911240|NCT04997304|566432789|FG000|Overall Study|Death|1|||
156911241|NCT04997304|566432789|FG000|Overall Study|Withdrawal by Subject|14|||
156911242|NCT01606800|566434246|FG000|Overall Study|Adverse Event|3|||
156911243|NCT01606800|566434247|FG001|Overall Study|Adverse Event|1|||
156911244|NCT01606800|566434246|FG000|Overall Study|Participant withdrew consent|0|||
156911245|NCT01606800|566434247|FG001|Overall Study|Participant withdrew consent|1|||
156911246|NCT01606800|566434246|FG000|Overall Study|Missing completion status|2|||
156911247|NCT01606800|566434247|FG001|Overall Study|Missing completion status|0|||
156911248|NCT01648101|566434249|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
156911249|NCT01648101|566434250|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
156911250|NCT01648101|566434251|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
156911251|NCT01648101|566434249|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
156911252|NCT01648101|566434250|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
156911253|NCT01648101|566434251|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
156911254|NCT01648101|566434249|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
156911255|NCT01648101|566434250|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
156911256|NCT01648101|566434251|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
156911257|NCT01648101|566434249|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
156911258|NCT01648101|566434250|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
156911259|NCT01648101|566434251|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
156911260|NCT01648101|566434249|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
156911261|NCT01648101|566434250|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
156911262|NCT01648101|566434251|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
156911263|NCT01648101|566434249|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
156911264|NCT01648101|566434250|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
156911265|NCT01648101|566434251|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
156911266|NCT01648101|566434249|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
156911267|NCT01648101|566434250|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
156911268|NCT01648101|566434251|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
156911269|NCT01648101|566434249|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
156911270|NCT01648101|566434250|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
156911271|NCT01648101|566434251|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
156911272|NCT01648101|566434249|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
156911273|NCT01648101|566434250|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
156911274|NCT01648101|566434251|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
156911275|NCT01648101|566434249|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
156911276|NCT01648101|566434250|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
156911277|NCT01648101|566434251|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
156911278|NCT01648101|566434249|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
156911279|NCT01648101|566434250|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
156911280|NCT01648101|566434251|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
156911281|NCT03311724|566434254|FG000|Overall Study|Physician Decision|0|||
156911282|NCT03311724|566434255|FG001|Overall Study|Physician Decision|0|||
156911283|NCT03311724|566434256|FG002|Overall Study|Physician Decision|0|||
156911284|NCT03311724|566434257|FG003|Overall Study|Physician Decision|1|||
156911285|NCT03311724|566434254|FG000|Overall Study|Protocol Violation|1|||
156911286|NCT03311724|566434255|FG001|Overall Study|Protocol Violation|0|||
156911287|NCT03311724|566434256|FG002|Overall Study|Protocol Violation|1|||
156911288|NCT03311724|566434257|FG003|Overall Study|Protocol Violation|0|||
156911289|NCT03311724|566434254|FG000|Overall Study|Withdrawal by Subject|1|||
156911290|NCT03311724|566434255|FG001|Overall Study|Withdrawal by Subject|1|||
156911291|NCT03311724|566434256|FG002|Overall Study|Withdrawal by Subject|0|||
156911292|NCT03311724|566434257|FG003|Overall Study|Withdrawal by Subject|0|||
156911293|NCT03311724|566434254|FG000|Overall Study|Lost to Follow-up|1|||
156911294|NCT03311724|566434255|FG001|Overall Study|Lost to Follow-up|0|||
156911295|NCT03311724|566434256|FG002|Overall Study|Lost to Follow-up|0|||
156911296|NCT03311724|566434257|FG003|Overall Study|Lost to Follow-up|0|||
156911297|NCT03311724|566434254|FG000|Overall Study|Sponsor Decision|0|||
156911298|NCT03311724|566434255|FG001|Overall Study|Sponsor Decision|0|||
156911299|NCT03311724|566434256|FG002|Overall Study|Sponsor Decision|1|||
156911300|NCT03311724|566434257|FG003|Overall Study|Sponsor Decision|0|||
156911301|NCT02370160|566434258|FG000|Overall Study|Death|3|||
156911302|NCT02370160|566434259|FG001|Overall Study|Death|4|||
156911303|NCT02370160|566434260|FG002|Overall Study|Death|1|||
156911304|NCT04487730|566434265|FG000|Overall Study|Withdrawal by Subject|3|||
156911305|NCT04487730|566434266|FG001|Overall Study|Withdrawal by Subject|1|||
156911306|NCT04487730|566434265|FG000|Overall Study|Lost to Follow-up|0|||
156911307|NCT04487730|566434266|FG001|Overall Study|Lost to Follow-up|1|||
156911308|NCT04487730|566434265|FG000|Overall Study|Physician Decision|0|||
156911309|NCT04487730|566434266|FG001|Overall Study|Physician Decision|1|||
156911310|NCT00907777|566434267|FG000|Overall Study|Withdrawal by Subject|0|||
156911311|NCT00907777|566434268|FG001|Overall Study|Withdrawal by Subject|1|||
156911312|NCT03364023|566434271|FG000|Overall Study|Lost to Follow-up|3|||
156911313|NCT03364023|566434271|FG000|Overall Study|Death|14|||
156911314|NCT03797014|566434274|FG000|Overall Study|Withdrawal by Subject|1|||
156911315|NCT03797014|566434274|FG000|Overall Study|Lost to Follow-up|1|||
156911316|NCT03797014|566434274|FG000|Overall Study|Protocol Violation|1|||
156911317|NCT01970397|566434275|FG000|Overall Study|Adverse Event|0|||
156911318|NCT01970397|566434276|FG001|Overall Study|Adverse Event|1|||
156911319|NCT01970397|566434275|FG000|Overall Study|Lost to Follow-up|0|||
156911320|NCT01970397|566434276|FG001|Overall Study|Lost to Follow-up|1|||
156911321|NCT01970397|566434275|FG000|Overall Study|Personal Reasons|1|||
156911322|NCT01970397|566434276|FG001|Overall Study|Personal Reasons|2|||
156911323|NCT01970397|566434275|FG000|Overall Study|Protocol Violation|1|||
156911324|NCT01970397|566434276|FG001|Overall Study|Protocol Violation|1|||
156911325|NCT03305575|566434281|FG000|Overall Study|Physician Decision|1|||
156911326|NCT03305575|566434282|FG001|Overall Study|Physician Decision|0|||
156911327|NCT00105469|566434283|FG000|Overall Study|Adverse Event|9|||
156911328|NCT00105469|566434284|FG001|Overall Study|Adverse Event|8|||
156911329|NCT00105469|566434283|FG000|Overall Study|Protocol Violation|4|||
156911330|NCT00105469|566434284|FG001|Overall Study|Protocol Violation|0|||
156911331|NCT00105469|566434283|FG000|Overall Study|Withdrawal by Subject|2|||
156911332|NCT00105469|566434284|FG001|Overall Study|Withdrawal by Subject|3|||
156911333|NCT00105469|566434283|FG000|Overall Study|Lost to Follow-up|1|||
156911334|NCT00105469|566434284|FG001|Overall Study|Lost to Follow-up|0|||
156911335|NCT00105469|566434283|FG000|Overall Study|Lack of Efficacy|2|||
156911336|NCT00105469|566434284|FG001|Overall Study|Lack of Efficacy|0|||
156911337|NCT00105469|566434283|FG000|Overall Study|Other Reason|4|||
156911338|NCT00105469|566434284|FG001|Overall Study|Other Reason|0|||
156911339|NCT04980040|566434285|FG000|Overall Study|Violated the Inclusion Criteria|260|||
156911340|NCT04980040|566434285|FG000|Overall Study|Violated the Administration & Dosage|225|||
156911341|NCT04980040|566434285|FG000|Overall Study|Lost to Safety-Follow-up|4|||
156911342|NCT04980040|566434285|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
156911343|NCT01408485|566434286|FG000|Overall Study|Withdrawal by Subject|21|||
156911344|NCT01751867|566434287|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
156911345|NCT01751867|566434288|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
156911346|NCT01751867|566434287|FG000|Overall Study|Diease Progression|4|||
156911347|NCT01751867|566434288|FG001|Overall Study|Diease Progression|18|||
156911348|NCT01751867|566434287|FG000|Overall Study|Adverse Event|8|||
156911349|NCT01751867|566434288|FG001|Overall Study|Adverse Event|15|||
156911350|NCT01751867|566434287|FG000|Overall Study|Poor Compliance|0|||
156911351|NCT01751867|566434288|FG001|Overall Study|Poor Compliance|5|||
156911352|NCT01751867|566434287|FG000|Overall Study|Withdrawal by Subject|3|||
156911353|NCT01751867|566434288|FG001|Overall Study|Withdrawal by Subject|1|||
156911354|NCT01751867|566434287|FG000|Overall Study|Physician Decision|4|||
156911355|NCT01751867|566434288|FG001|Overall Study|Physician Decision|7|||
156911356|NCT01751867|566434287|FG000|Overall Study|Protocol Violation|0|||
156911357|NCT01751867|566434288|FG001|Overall Study|Protocol Violation|2|||
156911358|NCT01751867|566434287|FG000|Overall Study|Death|0|||
156911359|NCT01751867|566434288|FG001|Overall Study|Death|5|||
156911360|NCT01751867|566434287|FG000|Overall Study|Other|11|||
156911361|NCT01751867|566434288|FG001|Overall Study|Other|37|||
156911362|NCT01751867|566434287|FG000|Overall Study|Randomized but not treated.|2|||
156911363|NCT01751867|566434288|FG001|Overall Study|Randomized but not treated.|1|||
156911364|NCT01508650|566434289|FG000|Overall Study|Lost to Follow-up|0|||
156911365|NCT01508650|566434290|FG001|Overall Study|Lost to Follow-up|3|||
156911366|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
156911367|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
156911368|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911369|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911370|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911371|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911372|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911373|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
156911374|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
156911375|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
156911376|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911377|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911378|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911379|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911380|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911381|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
156911382|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
156911383|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
156911384|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911385|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911386|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911387|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911388|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911389|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
156911390|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911391|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
156911392|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911393|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911394|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911395|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911396|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911397|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
156911398|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
156911399|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
156911400|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911401|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911402|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911403|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911404|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911405|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
156911406|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
156911407|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911408|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911409|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911410|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911411|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911412|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911413|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
156911414|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
156911415|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
156911416|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911417|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911418|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911419|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911420|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911421|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
156911422|NCT03095066|566434291|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
156911423|NCT03095066|566434292|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
156911424|NCT03095066|566434293|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911425|NCT03095066|566434294|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911426|NCT03095066|566434295|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911427|NCT03095066|566434296|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911428|NCT03095066|566434297|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911429|NCT03095066|566434298|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
156911430|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911431|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911432|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
156911433|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911434|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911435|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911436|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
156911437|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
156911438|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
157160012|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
157160013|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
157160014|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
157160015|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
156911439|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
157160016|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
157160017|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
156911440|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
156911441|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156911442|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156911443|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156911444|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
156911445|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
156911446|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911447|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911448|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
156911449|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911450|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911451|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911452|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
156911453|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
156911454|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911455|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911456|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
156911457|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911458|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911459|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911460|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
156911461|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
156911462|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911463|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911464|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
156911465|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911466|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911467|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911468|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911469|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
156911470|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911471|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911472|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
156911473|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911474|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911475|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911476|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
156911477|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
156911478|NCT03095066|566434291|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911479|NCT03095066|566434292|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911480|NCT03095066|566434293|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911481|NCT03095066|566434294|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911482|NCT03095066|566434295|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911483|NCT03095066|566434296|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911484|NCT03095066|566434297|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
156911485|NCT03095066|566434298|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
156911486|NCT03095066|566434291|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911487|NCT03095066|566434292|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911488|NCT03095066|566434293|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911489|NCT03095066|566434294|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911490|NCT03095066|566434295|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911491|NCT03095066|566434296|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
156911492|NCT03095066|566434297|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911493|NCT03095066|566434298|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
156911494|NCT03095066|566434291|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911495|NCT03095066|566434292|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911496|NCT03095066|566434293|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911497|NCT03095066|566434294|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911498|NCT03095066|566434295|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
156911499|NCT03095066|566434296|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911500|NCT03095066|566434297|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
156911501|NCT03095066|566434298|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
156911502|NCT03095066|566434291|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911503|NCT03095066|566434292|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911504|NCT03095066|566434293|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911505|NCT03095066|566434294|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911506|NCT03095066|566434295|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
156911507|NCT03095066|566434296|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911508|NCT03095066|566434297|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
156911509|NCT03095066|566434298|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
156911510|NCT03095066|566434291|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911511|NCT03095066|566434292|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911512|NCT03095066|566434293|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911513|NCT03095066|566434294|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911514|NCT03095066|566434295|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
156911515|NCT03095066|566434296|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911516|NCT03095066|566434297|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
156911517|NCT03095066|566434298|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
156911518|NCT03095066|566434291|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156911519|NCT03095066|566434292|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156911520|NCT03095066|566434293|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156911521|NCT03095066|566434294|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
157027286|NCT03854227|566856073|FG010|Overall Study|Withdrawal by Subject|1|||
157027287|NCT03854227|566856074|FG011|Overall Study|Withdrawal by Subject|0|||
157027288|NCT03854227|566856063|FG000|Overall Study|Disease relapse|0|||
157027289|NCT03854227|566856064|FG001|Overall Study|Disease relapse|0|||
157027290|NCT03854227|566856065|FG002|Overall Study|Disease relapse|0|||
157027291|NCT03854227|566856066|FG003|Overall Study|Disease relapse|0|||
157027292|NCT03854227|566856067|FG004|Overall Study|Disease relapse|0|||
157027293|NCT03854227|566856068|FG005|Overall Study|Disease relapse|0|||
157027294|NCT03854227|566856069|FG006|Overall Study|Disease relapse|0|||
157027295|NCT03854227|566856070|FG007|Overall Study|Disease relapse|0|||
157027296|NCT03854227|566856071|FG008|Overall Study|Disease relapse|1|||
157027297|NCT03854227|566856072|FG009|Overall Study|Disease relapse|0|||
157027298|NCT03854227|566856073|FG010|Overall Study|Disease relapse|0|||
157027299|NCT03854227|566856074|FG011|Overall Study|Disease relapse|0|||
157027300|NCT03854227|566856063|FG000|Overall Study|Global deterioration of health status|0|||
157027301|NCT03854227|566856064|FG001|Overall Study|Global deterioration of health status|0|||
157027302|NCT03854227|566856065|FG002|Overall Study|Global deterioration of health status|0|||
157027303|NCT03854227|566856066|FG003|Overall Study|Global deterioration of health status|0|||
157027304|NCT03854227|566856067|FG004|Overall Study|Global deterioration of health status|0|||
157027305|NCT03854227|566856068|FG005|Overall Study|Global deterioration of health status|1|||
157027306|NCT03854227|566856069|FG006|Overall Study|Global deterioration of health status|0|||
157027307|NCT03854227|566856070|FG007|Overall Study|Global deterioration of health status|1|||
157027308|NCT03854227|566856071|FG008|Overall Study|Global deterioration of health status|0|||
157027309|NCT03854227|566856072|FG009|Overall Study|Global deterioration of health status|0|||
157027310|NCT03854227|566856073|FG010|Overall Study|Global deterioration of health status|0|||
157027311|NCT03854227|566856074|FG011|Overall Study|Global deterioration of health status|0|||
157027312|NCT03854227|566856063|FG000|Overall Study|Refused further treatment|0|||
157027313|NCT03854227|566856064|FG001|Overall Study|Refused further treatment|0|||
157027314|NCT03854227|566856065|FG002|Overall Study|Refused further treatment|0|||
157027315|NCT03854227|566856066|FG003|Overall Study|Refused further treatment|0|||
157027316|NCT03854227|566856067|FG004|Overall Study|Refused further treatment|0|||
157027317|NCT03854227|566856068|FG005|Overall Study|Refused further treatment|0|||
157027318|NCT03854227|566856069|FG006|Overall Study|Refused further treatment|0|||
157027319|NCT03854227|566856070|FG007|Overall Study|Refused further treatment|0|||
157027320|NCT03854227|566856071|FG008|Overall Study|Refused further treatment|0|||
157027321|NCT03854227|566856072|FG009|Overall Study|Refused further treatment|1|||
157027322|NCT03854227|566856073|FG010|Overall Study|Refused further treatment|0|||
157027323|NCT03854227|566856074|FG011|Overall Study|Refused further treatment|1|||
157027324|NCT03854227|566856063|FG000|Overall Study|Other|0|||
157027325|NCT03854227|566856064|FG001|Overall Study|Other|0|||
157027326|NCT03854227|566856065|FG002|Overall Study|Other|0|||
157027327|NCT03854227|566856066|FG003|Overall Study|Other|0|||
157027328|NCT03854227|566856067|FG004|Overall Study|Other|0|||
157027329|NCT03854227|566856068|FG005|Overall Study|Other|0|||
157027330|NCT03854227|566856069|FG006|Overall Study|Other|0|||
157027331|NCT03854227|566856070|FG007|Overall Study|Other|0|||
157027332|NCT03854227|566856071|FG008|Overall Study|Other|1|||
157027333|NCT03854227|566856072|FG009|Overall Study|Other|1|||
157027334|NCT03854227|566856073|FG010|Overall Study|Other|0|||
157027335|NCT03854227|566856074|FG011|Overall Study|Other|0|||
157027336|NCT01574274|566856075|FG000|Overall Study|Ineligible|0|||
157027337|NCT01574274|566856076|FG001|Overall Study|Ineligible|1|||
157027338|NCT01574274|566856075|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
157027339|NCT01574274|566856076|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
156911522|NCT03095066|566434295|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
157027340|NCT01574274|566856075|FG000|Overall Study|Ph+ B-ALL|3|||
157027341|NCT01574274|566856076|FG001|Overall Study|Ph+ B-ALL|4|||
157027342|NCT01574274|566856075|FG000|Overall Study|Induction Death|2|||
157027343|NCT01574274|566856076|FG001|Overall Study|Induction Death|0|||
157027344|NCT01574274|566856075|FG000|Overall Study|Induction Failure|4|||
157027345|NCT01574274|566856076|FG001|Overall Study|Induction Failure|1|||
157027346|NCT01574274|566856075|FG000|Overall Study|Adverse Event|16|||
156911523|NCT03095066|566434296|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
156911524|NCT03095066|566434297|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156911525|NCT03095066|566434298|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
156911526|NCT00160693|566434299|FG000|Overall Study|Adverse Event|97|||
156911527|NCT00160693|566434299|FG000|Overall Study|Lack of Efficacy|30|||
156911528|NCT00160693|566434299|FG000|Overall Study|Protocol Violation|24|||
156911529|NCT00160693|566434299|FG000|Overall Study|Lost to Follow-up|15|||
156911530|NCT00160693|566434299|FG000|Overall Study|Withdrawal by Subject|54|||
156911531|NCT00160693|566434299|FG000|Overall Study|Study terminated by sponsor|15|||
156911532|NCT01976338|566434300|FG000|Overall Study|Physician Decision|0|||
156911533|NCT01976338|566434301|FG001|Overall Study|Physician Decision|1|||
157160018|NCT02052778|567329531|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
156911534|NCT01976338|566434300|FG000|Overall Study|Lost to Follow-up|3|||
156911535|NCT01976338|566434301|FG001|Overall Study|Lost to Follow-up|0|||
156911536|NCT01976338|566434300|FG000|Overall Study|Withdrawal by Subject|5|||
156911537|NCT01976338|566434301|FG001|Overall Study|Withdrawal by Subject|2|||
156911538|NCT01976338|566434300|FG000|Overall Study|Adverse Event|5|||
156911539|NCT01976338|566434301|FG001|Overall Study|Adverse Event|1|||
156911540|NCT05988619|566434302|FG000|Overall Study|Lost to Follow-up|1|||
156911541|NCT05988619|566434303|FG001|Overall Study|Lost to Follow-up|4|||
156911542|NCT05988619|566434302|FG000|Overall Study|Withdrawal by Subject|2|||
156911543|NCT05988619|566434303|FG001|Overall Study|Withdrawal by Subject|9|||
156911544|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Death|0|||
156911545|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Death|0|||
156911546|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Death|0|||
156911547|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Death|0|||
156911548|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Death|1|||
156911549|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Death|0|||
156911550|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Death|0|||
156911551|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Death|0|||
156911552|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
156911553|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
156911554|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
156911555|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
156911556|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
156911557|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
156911558|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
156911559|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
156911560|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
156911561|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156911562|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156911563|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
157160019|NCT02052778|567329532|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160020|NCT02052778|567329533|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160021|NCT02052778|567329534|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160022|NCT02052778|567329535|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160023|NCT02052778|567329536|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160024|NCT02052778|567329537|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160025|NCT02052778|567329538|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160026|NCT02052778|567329539|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160027|NCT02052778|567329540|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160028|NCT02052778|567329541|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160029|NCT02052778|567329542|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160030|NCT02052778|567329543|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160031|NCT02052778|567329544|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160032|NCT02052778|567329545|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160033|NCT02052778|567329546|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160034|NCT02052778|567329547|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160035|NCT02052778|567329548|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160036|NCT02052778|567329549|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160037|NCT02052778|567329550|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160038|NCT02052778|567329551|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
157160039|NCT02052778|567329552|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
156911564|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156911565|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
156911566|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156911567|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
156911568|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
156911569|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
156911570|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
157160040|NCT02052778|567329553|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
156911571|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
156911572|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
156911573|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
156911574|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
156911575|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
156911576|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
156911577|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156911578|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156911579|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
156911580|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
156911581|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
156911582|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
156911583|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
156911584|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
156911585|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156911586|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156911587|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
156911588|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
156911589|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
156911590|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156911591|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
156911592|NCT00726232|566434307|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
156911593|NCT00726232|566434308|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911594|NCT00726232|566434309|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911595|NCT00726232|566434310|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911596|NCT00726232|566434311|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911597|NCT00726232|566434312|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911598|NCT00726232|566434313|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911599|NCT00726232|566434314|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
156911600|NCT00726232|566434307|FG000|Expansion Phase|Death|0|||
156911601|NCT00726232|566434308|FG001|Expansion Phase|Death|0|||
156911602|NCT00726232|566434309|FG002|Expansion Phase|Death|0|||
156911603|NCT00726232|566434310|FG003|Expansion Phase|Death|0|||
156911604|NCT00726232|566434311|FG004|Expansion Phase|Death|0|||
156911605|NCT00726232|566434312|FG005|Expansion Phase|Death|0|||
156911606|NCT00726232|566434313|FG006|Expansion Phase|Death|0|||
156911607|NCT00726232|566434314|FG007|Expansion Phase|Death|1|||
156911608|NCT00726232|566434307|FG000|Expansion Phase|Adverse Event|0|||
156911609|NCT00726232|566434308|FG001|Expansion Phase|Adverse Event|0|||
156911610|NCT00726232|566434309|FG002|Expansion Phase|Adverse Event|0|||
156911611|NCT00726232|566434310|FG003|Expansion Phase|Adverse Event|0|||
156911612|NCT00726232|566434311|FG004|Expansion Phase|Adverse Event|0|||
156911613|NCT00726232|566434312|FG005|Expansion Phase|Adverse Event|0|||
156911614|NCT00726232|566434313|FG006|Expansion Phase|Adverse Event|6|||
156911615|NCT00726232|566434314|FG007|Expansion Phase|Adverse Event|11|||
156911616|NCT00726232|566434307|FG000|Expansion Phase|Withdrawal by Subject|0|||
156911617|NCT00726232|566434308|FG001|Expansion Phase|Withdrawal by Subject|0|||
156911618|NCT00726232|566434309|FG002|Expansion Phase|Withdrawal by Subject|0|||
156911619|NCT00726232|566434310|FG003|Expansion Phase|Withdrawal by Subject|0|||
156911620|NCT00726232|566434311|FG004|Expansion Phase|Withdrawal by Subject|0|||
156911621|NCT00726232|566434312|FG005|Expansion Phase|Withdrawal by Subject|0|||
156911622|NCT00726232|566434313|FG006|Expansion Phase|Withdrawal by Subject|2|||
156911623|NCT00726232|566434314|FG007|Expansion Phase|Withdrawal by Subject|3|||
156911624|NCT00726232|566434307|FG000|Expansion Phase|Disease progression|0|||
156911625|NCT00726232|566434308|FG001|Expansion Phase|Disease progression|0|||
156911626|NCT00726232|566434309|FG002|Expansion Phase|Disease progression|0|||
156911627|NCT00726232|566434310|FG003|Expansion Phase|Disease progression|0|||
156911628|NCT00726232|566434311|FG004|Expansion Phase|Disease progression|0|||
156911629|NCT00726232|566434312|FG005|Expansion Phase|Disease progression|0|||
156911630|NCT00726232|566434313|FG006|Expansion Phase|Disease progression|4|||
157160041|NCT02345252|567329558|FG000|Double-Blind Phase|Adverse Event|2|||
157160042|NCT02345252|567329559|FG001|Double-Blind Phase|Adverse Event|3|||
157160043|NCT02345252|567329558|FG000|Double-Blind Phase|Death|1|||
157160044|NCT02345252|567329559|FG001|Double-Blind Phase|Death|2|||
157160045|NCT02345252|567329558|FG000|Double-Blind Phase|Lack of Efficacy|1|||
157160046|NCT02345252|567329559|FG001|Double-Blind Phase|Lack of Efficacy|0|||
156911631|NCT00726232|566434314|FG007|Expansion Phase|Disease progression|0|||
156911632|NCT00726232|566434307|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
156911633|NCT00726232|566434308|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
157027347|NCT01574274|566856076|FG001|Overall Study|Adverse Event|13|||
156911634|NCT00726232|566434309|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
157027348|NCT01574274|566856075|FG000|Overall Study|Remission Death|1|||
157160047|NCT02345252|567329558|FG000|Double-Blind Phase|Investigator's Discretion|4|||
156911635|NCT00726232|566434310|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
156911636|NCT00726232|566434311|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
156911637|NCT00726232|566434312|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
156911638|NCT00726232|566434313|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
156911639|NCT00726232|566434314|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
156911640|NCT00726232|566434307|FG000|Expansion Phase|Per Investigator: lack of response|0|||
156911641|NCT00726232|566434308|FG001|Expansion Phase|Per Investigator: lack of response|0|||
156911642|NCT00726232|566434309|FG002|Expansion Phase|Per Investigator: lack of response|0|||
156911643|NCT00726232|566434310|FG003|Expansion Phase|Per Investigator: lack of response|0|||
156911644|NCT00726232|566434311|FG004|Expansion Phase|Per Investigator: lack of response|0|||
156911645|NCT00726232|566434312|FG005|Expansion Phase|Per Investigator: lack of response|0|||
156911646|NCT00726232|566434313|FG006|Expansion Phase|Per Investigator: lack of response|1|||
156911647|NCT00726232|566434314|FG007|Expansion Phase|Per Investigator: lack of response|7|||
156911648|NCT00726232|566434307|FG000|Expansion Phase|Unspecified reason|0|||
156911649|NCT00726232|566434308|FG001|Expansion Phase|Unspecified reason|0|||
156911650|NCT00726232|566434309|FG002|Expansion Phase|Unspecified reason|0|||
156911651|NCT00726232|566434310|FG003|Expansion Phase|Unspecified reason|0|||
156911652|NCT00726232|566434311|FG004|Expansion Phase|Unspecified reason|0|||
156911653|NCT00726232|566434312|FG005|Expansion Phase|Unspecified reason|0|||
156911654|NCT00726232|566434313|FG006|Expansion Phase|Unspecified reason|1|||
156911655|NCT00726232|566434314|FG007|Expansion Phase|Unspecified reason|0|||
156911656|NCT00709761|566434315|FG000|Overall Study|Withdrawal by Subject|8|||
156911657|NCT00709761|566434315|FG000|Overall Study|study closed/terminated|17|||
156911658|NCT00709761|566434315|FG000|Overall Study|Lost to Follow-up|2|||
156911659|NCT01471171|566434316|FG000|Treatment Period 1|Adverse Event|4|||
156911660|NCT01471171|566434317|FG001|Treatment Period 1|Adverse Event|1|||
156911661|NCT01471171|566434316|FG000|Treatment Period 2|Adverse Event|1|||
156911662|NCT01471171|566434317|FG001|Treatment Period 2|Adverse Event|0|||
156911663|NCT02864498|566434318|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
156911664|NCT02864498|566434319|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
156911665|NCT02864498|566434320|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
156911666|NCT02864498|566434318|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
156911667|NCT02864498|566434319|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
156911668|NCT02864498|566434320|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
156911669|NCT02864498|566434318|FG000|Overall Study|Investigator Discretion|0|||
156911670|NCT02864498|566434319|FG001|Overall Study|Investigator Discretion|2|||
156911671|NCT02864498|566434320|FG002|Overall Study|Investigator Discretion|1|||
156911672|NCT02864498|566434318|FG000|Overall Study|Lost to Follow-up|8|||
156911673|NCT02864498|566434319|FG001|Overall Study|Lost to Follow-up|6|||
156911674|NCT02864498|566434320|FG002|Overall Study|Lost to Follow-up|3|||
156911675|NCT02864498|566434318|FG000|Overall Study|Lack of Efficacy|5|||
156911676|NCT02864498|566434319|FG001|Overall Study|Lack of Efficacy|3|||
156911677|NCT02864498|566434320|FG002|Overall Study|Lack of Efficacy|3|||
156911678|NCT02864498|566434318|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
156911679|NCT02864498|566434319|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
156911680|NCT02864498|566434320|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
156911681|NCT02864498|566434318|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
156911682|NCT02864498|566434319|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
156911683|NCT02864498|566434320|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
156911684|NCT02864498|566434318|FG000|Overall Study|Subject moved out of the country.|0|||
156911685|NCT02864498|566434319|FG001|Overall Study|Subject moved out of the country.|0|||
156911686|NCT02864498|566434320|FG002|Overall Study|Subject moved out of the country.|1|||
156911687|NCT03478930|566434321|FG000|Overall Study|Adverse Event|0|||
156911688|NCT03478930|566434322|FG001|Overall Study|Adverse Event|1|||
156911689|NCT03478930|566434321|FG000|Overall Study|Lack of Efficacy|3|||
156911690|NCT03478930|566434322|FG001|Overall Study|Lack of Efficacy|3|||
156911691|NCT03478930|566434321|FG000|Overall Study|Withdrawal by Subject|6|||
156911692|NCT03478930|566434322|FG001|Overall Study|Withdrawal by Subject|5|||
156911693|NCT01812174|566434323|FG000|Overall Study|Death|1|||
156911694|NCT01812174|566434324|FG001|Overall Study|Death|0|||
156911695|NCT01812174|566434323|FG000|Overall Study|Protocol Violation|2|||
156911696|NCT01812174|566434324|FG001|Overall Study|Protocol Violation|0|||
156911697|NCT00553644|566434327|FG000|Overall Study|Adverse Event|17|||
156911698|NCT00553644|566434327|FG000|Overall Study|Withdrawal by Subject|4|||
156911699|NCT00553644|566434327|FG000|Overall Study|Physician Decision|1|||
156911700|NCT00553644|566434327|FG000|Overall Study|Alternative therapy|6|||
156911701|NCT00555971|566434331|FG000|Overall Study|Adverse Event|1|||
156911702|NCT00555971|566434332|FG001|Overall Study|Adverse Event|1|||
156911703|NCT03470441|566434333|FG000|Overall Study|Death|0|||
156911704|NCT03470441|566434334|FG001|Overall Study|Death|1|||
156911705|NCT03470441|566434335|FG002|Overall Study|Death|1|||
156911706|NCT03470441|566434336|FG003|Overall Study|Death|0|||
156911707|NCT03470441|566434333|FG000|Overall Study|Adverse Event|0|||
156911708|NCT03470441|566434334|FG001|Overall Study|Adverse Event|0|||
156911709|NCT03470441|566434335|FG002|Overall Study|Adverse Event|0|||
156911710|NCT03470441|566434336|FG003|Overall Study|Adverse Event|1|||
157160048|NCT02345252|567329559|FG001|Double-Blind Phase|Investigator's Discretion|6|||
157160049|NCT02345252|567329558|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
157160050|NCT02345252|567329559|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
157160051|NCT02345252|567329558|FG000|Double-Blind Phase|Protocol Violation|2|||
156911711|NCT03470441|566434333|FG000|Overall Study|Withdrawal by Subject|1|||
156911712|NCT03470441|566434334|FG001|Overall Study|Withdrawal by Subject|4|||
156911713|NCT03470441|566434335|FG002|Overall Study|Withdrawal by Subject|1|||
156911714|NCT03470441|566434336|FG003|Overall Study|Withdrawal by Subject|3|||
156911715|NCT05393895|566434339|FG000|Overall Study|Adverse Event|2|||
156911716|NCT05393895|566434340|FG001|Overall Study|Adverse Event|3|||
156911717|NCT05393895|566434339|FG000|Overall Study|Lost to Follow-up|4|||
156911718|NCT05393895|566434340|FG001|Overall Study|Lost to Follow-up|3|||
156911719|NCT05393895|566434339|FG000|Overall Study|Protocol Violation|1|||
156911720|NCT05393895|566434340|FG001|Overall Study|Protocol Violation|0|||
156911721|NCT05393895|566434339|FG000|Overall Study|Withdrawal by Subject|1|||
156911722|NCT05393895|566434340|FG001|Overall Study|Withdrawal by Subject|4|||
156911723|NCT01203098|566434343|FG000|Overall Study|Adverse Event|3|||
156911724|NCT01203098|566434344|FG001|Overall Study|Adverse Event|1|||
156911725|NCT01203098|566434345|FG002|Overall Study|Adverse Event|7|||
156911726|NCT01203098|566434343|FG000|Overall Study|Lost to Follow-up|0|||
156911727|NCT01203098|566434344|FG001|Overall Study|Lost to Follow-up|0|||
156911728|NCT01203098|566434345|FG002|Overall Study|Lost to Follow-up|1|||
156911729|NCT01203098|566434343|FG000|Overall Study|Physician Decision|2|||
156911730|NCT01203098|566434344|FG001|Overall Study|Physician Decision|2|||
156911731|NCT01203098|566434345|FG002|Overall Study|Physician Decision|0|||
156911732|NCT01203098|566434343|FG000|Overall Study|Withdrawal by Subject|1|||
156911733|NCT01203098|566434344|FG001|Overall Study|Withdrawal by Subject|1|||
156911734|NCT01203098|566434345|FG002|Overall Study|Withdrawal by Subject|3|||
156911735|NCT02571075|566434350|FG000|Overall Study|Lost to Follow-up|20|||
156911736|NCT02571075|566434351|FG001|Overall Study|Lost to Follow-up|24|||
156911737|NCT04967443|566434359|FG000|Open Label Treatment|Death|1|||
156911738|NCT04967443|566434360|FG001|Open Label Treatment|Death|0|||
156911739|NCT04967443|566434361|FG002|Open Label Treatment|Death|0|||
156911740|NCT04967443|566434362|FG003|Open Label Treatment|Death|0|||
156911741|NCT04967443|566434363|FG004|Open Label Treatment|Death|0|||
156911742|NCT04967443|566434364|FG005|Open Label Treatment|Death|0|||
156911743|NCT04967443|566434365|FG006|Open Label Treatment|Death|0|||
156911744|NCT04967443|566434366|FG007|Open Label Treatment|Death|0|||
156911745|NCT04967443|566434359|FG000|Open Label Treatment|Lost to Follow-up|0|||
156911746|NCT04967443|566434360|FG001|Open Label Treatment|Lost to Follow-up|0|||
156911747|NCT04967443|566434361|FG002|Open Label Treatment|Lost to Follow-up|1|||
156911748|NCT04967443|566434362|FG003|Open Label Treatment|Lost to Follow-up|0|||
156911749|NCT04967443|566434363|FG004|Open Label Treatment|Lost to Follow-up|0|||
156911750|NCT04967443|566434364|FG005|Open Label Treatment|Lost to Follow-up|0|||
156911751|NCT04967443|566434365|FG006|Open Label Treatment|Lost to Follow-up|0|||
156911752|NCT04967443|566434366|FG007|Open Label Treatment|Lost to Follow-up|0|||
156911753|NCT04967443|566434359|FG000|Open Label Treatment|Withdrawal by Subject|0|||
156911754|NCT04967443|566434360|FG001|Open Label Treatment|Withdrawal by Subject|1|||
156911755|NCT04967443|566434361|FG002|Open Label Treatment|Withdrawal by Subject|0|||
156911756|NCT04967443|566434362|FG003|Open Label Treatment|Withdrawal by Subject|1|||
156911757|NCT04967443|566434363|FG004|Open Label Treatment|Withdrawal by Subject|0|||
156911758|NCT04967443|566434364|FG005|Open Label Treatment|Withdrawal by Subject|1|||
156911759|NCT04967443|566434365|FG006|Open Label Treatment|Withdrawal by Subject|2|||
156911760|NCT04967443|566434366|FG007|Open Label Treatment|Withdrawal by Subject|3|||
156911761|NCT04967443|566434359|FG000|Follow-Up|Death|1|||
156911762|NCT04967443|566434360|FG001|Follow-Up|Death|0|||
156911763|NCT04967443|566434361|FG002|Follow-Up|Death|0|||
156911764|NCT04967443|566434362|FG003|Follow-Up|Death|0|||
156911765|NCT04967443|566434363|FG004|Follow-Up|Death|0|||
156911766|NCT04967443|566434364|FG005|Follow-Up|Death|0|||
156911767|NCT04967443|566434365|FG006|Follow-Up|Death|0|||
156911768|NCT04967443|566434366|FG007|Follow-Up|Death|0|||
156911769|NCT04967443|566434359|FG000|Follow-Up|Lost to Follow-up|0|||
156911770|NCT04967443|566434360|FG001|Follow-Up|Lost to Follow-up|0|||
156911771|NCT04967443|566434361|FG002|Follow-Up|Lost to Follow-up|1|||
156911772|NCT04967443|566434362|FG003|Follow-Up|Lost to Follow-up|1|||
156911773|NCT04967443|566434363|FG004|Follow-Up|Lost to Follow-up|0|||
156911774|NCT04967443|566434364|FG005|Follow-Up|Lost to Follow-up|0|||
156911775|NCT04967443|566434365|FG006|Follow-Up|Lost to Follow-up|0|||
156911776|NCT04967443|566434366|FG007|Follow-Up|Lost to Follow-up|0|||
156911777|NCT04967443|566434359|FG000|Follow-Up|Withdrawal by Subject|0|||
156911778|NCT04967443|566434360|FG001|Follow-Up|Withdrawal by Subject|1|||
156911779|NCT04967443|566434361|FG002|Follow-Up|Withdrawal by Subject|0|||
156911780|NCT04967443|566434362|FG003|Follow-Up|Withdrawal by Subject|1|||
156911781|NCT04967443|566434363|FG004|Follow-Up|Withdrawal by Subject|0|||
156911782|NCT04967443|566434364|FG005|Follow-Up|Withdrawal by Subject|1|||
156911783|NCT04967443|566434365|FG006|Follow-Up|Withdrawal by Subject|2|||
156911784|NCT04967443|566434366|FG007|Follow-Up|Withdrawal by Subject|3|||
156911785|NCT02405780|566434368|FG000|Period I|Adverse Event|8|||
156911786|NCT02405780|566434369|FG001|Period I|Adverse Event|0|||
156911787|NCT02405780|566434370|FG002|Period I|Adverse Event|3|||
156911788|NCT02405780|566434371|FG003|Period I|Adverse Event|7|||
156911789|NCT02405780|566434368|FG000|Period I|Medical reasons|1|||
156911790|NCT02405780|566434369|FG001|Period I|Medical reasons|1|||
156911791|NCT02405780|566434370|FG002|Period I|Medical reasons|0|||
156911792|NCT02405780|566434371|FG003|Period I|Medical reasons|1|||
156911793|NCT02405780|566434368|FG000|Period I|Screening Failure|1|||
156911794|NCT02405780|566434369|FG001|Period I|Screening Failure|0|||
156911795|NCT02405780|566434370|FG002|Period I|Screening Failure|1|||
156911796|NCT02405780|566434371|FG003|Period I|Screening Failure|0|||
156911797|NCT02405780|566434368|FG000|Period I|Withdrawal by Subject|9|||
156911798|NCT02405780|566434369|FG001|Period I|Withdrawal by Subject|1|||
156911799|NCT02405780|566434370|FG002|Period I|Withdrawal by Subject|3|||
156911800|NCT02405780|566434371|FG003|Period I|Withdrawal by Subject|4|||
156911801|NCT02405780|566434368|FG000|Period I|Non-compliance with study procedures|8|||
156911802|NCT02405780|566434369|FG001|Period I|Non-compliance with study procedures|6|||
156911803|NCT02405780|566434370|FG002|Period I|Non-compliance with study procedures|8|||
156911804|NCT02405780|566434371|FG003|Period I|Non-compliance with study procedures|11|||
156911805|NCT02405780|566434368|FG000|Period II|Adverse Event|3|||
156911806|NCT02405780|566434369|FG001|Period II|Adverse Event|5|||
156911807|NCT02405780|566434370|FG002|Period II|Adverse Event|4|||
156911808|NCT02405780|566434371|FG003|Period II|Adverse Event|11|||
156911809|NCT02405780|566434368|FG000|Period II|Medical reason|0|||
156911810|NCT02405780|566434369|FG001|Period II|Medical reason|1|||
156911811|NCT02405780|566434370|FG002|Period II|Medical reason|0|||
156911812|NCT02405780|566434371|FG003|Period II|Medical reason|0|||
156911813|NCT02405780|566434368|FG000|Period II|Pregnancy|0|||
156911814|NCT02405780|566434369|FG001|Period II|Pregnancy|0|||
156911815|NCT02405780|566434370|FG002|Period II|Pregnancy|1|||
156911816|NCT02405780|566434371|FG003|Period II|Pregnancy|0|||
156911817|NCT02405780|566434368|FG000|Period II|Withdrawal by Subject|7|||
156911818|NCT02405780|566434369|FG001|Period II|Withdrawal by Subject|4|||
156911819|NCT02405780|566434370|FG002|Period II|Withdrawal by Subject|0|||
156911820|NCT02405780|566434371|FG003|Period II|Withdrawal by Subject|3|||
156911821|NCT02405780|566434368|FG000|Period II|Non-compliance with study procedures|5|||
156911822|NCT02405780|566434369|FG001|Period II|Non-compliance with study procedures|2|||
156911823|NCT02405780|566434370|FG002|Period II|Non-compliance with study procedures|7|||
156911824|NCT02405780|566434371|FG003|Period II|Non-compliance with study procedures|4|||
156911825|NCT01654536|566434372|FG000|Overall Study|Lost to Follow-up|5|||
156911826|NCT01654536|566434373|FG001|Overall Study|Lost to Follow-up|5|||
156911827|NCT01654536|566434372|FG000|Overall Study|Physician Decision|12|||
156911828|NCT01654536|566434373|FG001|Overall Study|Physician Decision|8|||
156911829|NCT01654536|566434372|FG000|Overall Study|Withdrawal by Subject|27|||
156911830|NCT01654536|566434373|FG001|Overall Study|Withdrawal by Subject|25|||
156911831|NCT00668707|566434374|FG000|Overall Study|Cancer Recurrence|58|||
156911832|NCT00668707|566434375|FG001|Overall Study|Cancer Recurrence|58|||
156911833|NCT00668707|566434374|FG000|Overall Study|Withdrawal by Subject|117|||
156911834|NCT00668707|566434375|FG001|Overall Study|Withdrawal by Subject|100|||
156911835|NCT00668707|566434374|FG000|Overall Study|Lost to Follow-up|3|||
156911836|NCT00668707|566434375|FG001|Overall Study|Lost to Follow-up|6|||
157027349|NCT01574274|566856076|FG001|Overall Study|Remission Death|0|||
156911837|NCT00668707|566434374|FG000|Overall Study|Protocol Violation|10|||
156911838|NCT00668707|566434375|FG001|Overall Study|Protocol Violation|12|||
156911839|NCT00668707|566434374|FG000|Overall Study|Death|11|||
156911840|NCT00668707|566434375|FG001|Overall Study|Death|4|||
156911841|NCT02784431|566434382|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
156911842|NCT02784431|566434382|FG000|Overall Study|Early Study Termination|19|||
156911843|NCT00361569|566434383|FG000|Overall Study|Protocol Violation|3|||
156911844|NCT00361569|566434384|FG001|Overall Study|Protocol Violation|2|||
156911845|NCT00361569|566434385|FG002|Overall Study|Protocol Violation|4|||
156911846|NCT00361569|566434386|FG003|Overall Study|Protocol Violation|2|||
156911847|NCT00361569|566434383|FG000|Overall Study|Withdrawal by Subject|2|||
156911848|NCT00361569|566434384|FG001|Overall Study|Withdrawal by Subject|1|||
156911849|NCT00361569|566434385|FG002|Overall Study|Withdrawal by Subject|9|||
156911850|NCT00361569|566434386|FG003|Overall Study|Withdrawal by Subject|14|||
156911851|NCT00361569|566434383|FG000|Overall Study|Adverse Event|3|||
156911852|NCT00361569|566434384|FG001|Overall Study|Adverse Event|5|||
156911853|NCT00361569|566434385|FG002|Overall Study|Adverse Event|2|||
157160052|NCT02345252|567329559|FG001|Double-Blind Phase|Protocol Violation|1|||
156911854|NCT00361569|566434386|FG003|Overall Study|Adverse Event|2|||
156911855|NCT00361569|566434383|FG000|Overall Study|Lost to Follow-up|2|||
156911856|NCT00361569|566434384|FG001|Overall Study|Lost to Follow-up|3|||
156911857|NCT00361569|566434385|FG002|Overall Study|Lost to Follow-up|3|||
156911858|NCT00361569|566434386|FG003|Overall Study|Lost to Follow-up|2|||
156911859|NCT00361569|566434383|FG000|Overall Study|Not specified by investigator|2|||
156911860|NCT00361569|566434384|FG001|Overall Study|Not specified by investigator|0|||
156911861|NCT00361569|566434385|FG002|Overall Study|Not specified by investigator|0|||
156911862|NCT00361569|566434386|FG003|Overall Study|Not specified by investigator|1|||
156911863|NCT00826943|566434387|FG000|Overall Study|Withdrawal by Subject|0|||
156911864|NCT00826943|566434388|FG001|Overall Study|Withdrawal by Subject|0|||
156911865|NCT00826943|566434389|FG002|Overall Study|Withdrawal by Subject|0|||
156911866|NCT00826943|566434390|FG003|Overall Study|Withdrawal by Subject|0|||
156911867|NCT00826943|566434391|FG004|Overall Study|Withdrawal by Subject|1|||
156911868|NCT00826943|566434392|FG005|Overall Study|Withdrawal by Subject|0|||
156911869|NCT00074152|566434393|FG000|Overall Study|Death|21|||
156911870|NCT00074152|566434394|FG001|Overall Study|Death|9|||
156911871|NCT00074152|566434393|FG000|Overall Study|Lack of Efficacy|34|||
156911872|NCT00074152|566434394|FG001|Overall Study|Lack of Efficacy|24|||
156911873|NCT01273597|566434395|FG000|Overall Study|Adverse Event|5|||
156911874|NCT01273597|566434395|FG000|Overall Study|Underwent Kidney Transplantation|2|||
156911875|NCT01273597|566434395|FG000|Overall Study|Reason Not Reported|1|||
156911876|NCT03715530|566434396|FG000|Overall Study|Lost to Follow-up|3|||
156911877|NCT03715530|566434397|FG001|Overall Study|Lost to Follow-up|1|||
156911878|NCT03715530|566434398|FG002|Overall Study|Lost to Follow-up|2|||
156911879|NCT01594762|566434399|FG000|Overall Study|Withdrawal by Subject|1|||
156911880|NCT01594762|566434400|FG001|Overall Study|Withdrawal by Subject|0|||
156911881|NCT01594762|566434399|FG000|Overall Study|Lost to Follow-up|10|||
156911882|NCT01594762|566434400|FG001|Overall Study|Lost to Follow-up|10|||
156911883|NCT03547583|566434401|FG000|Overall Study|Adverse Event|16|||
156911884|NCT03547583|566434402|FG001|Overall Study|Adverse Event|11|||
156911885|NCT03547583|566434403|FG002|Overall Study|Adverse Event|10|||
156911886|NCT03547583|566434401|FG000|Overall Study|Death|11|||
156911887|NCT03547583|566434402|FG001|Overall Study|Death|7|||
156911888|NCT03547583|566434403|FG002|Overall Study|Death|4|||
156911889|NCT03547583|566434401|FG000|Overall Study|Lost to Follow-up|1|||
156911890|NCT03547583|566434402|FG001|Overall Study|Lost to Follow-up|0|||
156911891|NCT03547583|566434403|FG002|Overall Study|Lost to Follow-up|0|||
156911892|NCT03547583|566434401|FG000|Overall Study|Non-compliance with study drug|0|||
156911893|NCT03547583|566434402|FG001|Overall Study|Non-compliance with study drug|0|||
156911894|NCT03547583|566434403|FG002|Overall Study|Non-compliance with study drug|1|||
156911895|NCT03547583|566434401|FG000|Overall Study|Physician Decision|1|||
156911896|NCT03547583|566434402|FG001|Overall Study|Physician Decision|0|||
156911897|NCT03547583|566434403|FG002|Overall Study|Physician Decision|3|||
156911898|NCT03547583|566434401|FG000|Overall Study|Protocol Violation|2|||
156911899|NCT03547583|566434402|FG001|Overall Study|Protocol Violation|1|||
156911900|NCT03547583|566434403|FG002|Overall Study|Protocol Violation|1|||
156911901|NCT03547583|566434401|FG000|Overall Study|Withdrawal by Subject|12|||
156911902|NCT03547583|566434402|FG001|Overall Study|Withdrawal by Subject|19|||
156911903|NCT03547583|566434403|FG002|Overall Study|Withdrawal by Subject|10|||
156911904|NCT03547583|566434401|FG000|Overall Study|Other|2|||
156911905|NCT03547583|566434402|FG001|Overall Study|Other|2|||
156911906|NCT03547583|566434403|FG002|Overall Study|Other|3|||
156911907|NCT01949506|566434411|FG000|Overall Study|Physician Decision|1|||
156911908|NCT01446289|566434412|FG000|Overall Study|Withdrawal by Subject|1|||
156911909|NCT01446289|566434413|FG001|Overall Study|Withdrawal by Subject|0|||
156911910|NCT01446289|566434414|FG002|Overall Study|Withdrawal by Subject|1|||
156911911|NCT01446289|566434415|FG003|Overall Study|Withdrawal by Subject|0|||
156911912|NCT02617628|566434416|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
156911913|NCT02617628|566434417|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
156911914|NCT05372419|566434428|FG000|Overall Study|Protocol Deviation|1|||
156911915|NCT05372419|566434428|FG000|Overall Study|Withdrawal by Subject|5|||
156911916|NCT05372419|566434428|FG000|Overall Study|Lost to Follow-up|7|||
156911917|NCT01397084|566436277|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
156911918|NCT01397084|566436277|FG000|Overall Study|Protocol Violation|2|||
156911919|NCT01397084|566436277|FG000|Overall Study|Adverse Event|2|||
156911920|NCT01397084|566436277|FG000|Overall Study|Withdrawal by Subject|1|||
156911921|NCT01397084|566436277|FG000|Overall Study|Lost to Follow-up|1|||
156911922|NCT01397084|566436277|FG000|Overall Study|Used other proton pump inhibitor|1|||
156911923|NCT00004978|566436278|FG000|Overall Study|Death|107|||
156911924|NCT00004978|566436279|FG001|Overall Study|Death|116|||
156911925|NCT00004978|566436278|FG000|Overall Study|Lost to Follow-up|101|||
156911926|NCT00004978|566436279|FG001|Overall Study|Lost to Follow-up|108|||
156911927|NCT00004978|566436278|FG000|Overall Study|Withdrawal by Subject|17|||
156911928|NCT00004978|566436279|FG001|Overall Study|Withdrawal by Subject|26|||
156911929|NCT00004978|566436278|FG000|Overall Study|site closure - not in analysis cohort|19|||
156911930|NCT00004978|566436279|FG001|Overall Study|site closure - not in analysis cohort|20|||
156911931|NCT01342796|566436280|FG000|Overall Study|Withdrawal by Subject|2|||
156911932|NCT01342796|566436281|FG001|Overall Study|Withdrawal by Subject|0|||
156911933|NCT01342796|566436280|FG000|Overall Study|Lost to Follow-up|0|||
156911934|NCT01342796|566436281|FG001|Overall Study|Lost to Follow-up|3|||
156911935|NCT01342796|566436280|FG000|Overall Study|Inappropriate enrollment|1|||
156911936|NCT01342796|566436281|FG001|Overall Study|Inappropriate enrollment|0|||
156911937|NCT01396148|566436282|FG000|Overall Study|Patient Decision|1|||
156911938|NCT00224042|566436291|FG000|Overall Study|Adverse Event|2|||
156911939|NCT00224042|566436292|FG001|Overall Study|Adverse Event|1|||
156911940|NCT00224042|566436291|FG000|Overall Study|Protocol Violation|0|||
156911941|NCT00224042|566436292|FG001|Overall Study|Protocol Violation|1|||
156911942|NCT00224042|566436291|FG000|Overall Study|Physician Decision|0|||
156911943|NCT00224042|566436292|FG001|Overall Study|Physician Decision|1|||
156911944|NCT00224042|566436291|FG000|Overall Study|Did not meet lab incusion criteria|2|||
156911945|NCT00224042|566436292|FG001|Overall Study|Did not meet lab incusion criteria|3|||
156911946|NCT00224042|566436291|FG000|Overall Study|Other|2|||
156911947|NCT00224042|566436292|FG001|Overall Study|Other|0|||
156911948|NCT03052725|566436295|FG000|Overall Study|Adverse Event|2|||
156911949|NCT03052725|566436296|FG001|Overall Study|Adverse Event|0|||
156911950|NCT03052725|566436295|FG000|Overall Study|Withdrawal by Subject|3|||
156911951|NCT03052725|566436296|FG001|Overall Study|Withdrawal by Subject|4|||
156911952|NCT03052725|566436295|FG000|Overall Study|Pregnancy|0|||
156911953|NCT03052725|566436296|FG001|Overall Study|Pregnancy|1|||
156911954|NCT03052725|566436295|FG000|Overall Study|Site closure|0|||
156911955|NCT03052725|566436296|FG001|Overall Study|Site closure|1|||
156911956|NCT03052725|566436295|FG000|Overall Study|Study terminated by sponsor|143|||
156911957|NCT03052725|566436296|FG001|Overall Study|Study terminated by sponsor|144|||
156911958|NCT04213079|566436297|FG000|Overall Study|Lost to Follow-up|0|||
156911959|NCT04213079|566436298|FG001|Overall Study|Lost to Follow-up|2|||
156911960|NCT01061177|566436303|FG000|Overall Study|Adverse Event|117|||
156911961|NCT01061177|566436303|FG000|Overall Study|Withdrawal by Subject|27|||
156911962|NCT01061177|566436303|FG000|Overall Study|Disease progression|17|||
156911963|NCT01061177|566436303|FG000|Overall Study|Protocol Violation|11|||
156911964|NCT01061177|566436303|FG000|Overall Study|Lost to Follow-up|9|||
156911965|NCT01061177|566436303|FG000|Overall Study|New cancer therapy|9|||
156911966|NCT01061177|566436303|FG000|Overall Study|Abnormal laboratory values|6|||
156911967|NCT01061177|566436303|FG000|Overall Study|Abnormal test procedure results|4|||
156911968|NCT01061177|566436303|FG000|Overall Study|Administratie problems|4|||
156911969|NCT01061177|566436303|FG000|Overall Study|Death|4|||
156911970|NCT03616600|566436304|FG000|Overall Study|Withdrawal by Subject|1|||
156911971|NCT03616600|566436305|FG001|Overall Study|Withdrawal by Subject|0|||
156911972|NCT00587054|566436306|FG000|Overall Study|Patient not treated|9|||
156911973|NCT03984994|566436307|FG000|Overall Study|Withdrawal by Subject|2|||
156911974|NCT03984994|566436308|FG001|Overall Study|Withdrawal by Subject|1|||
156911975|NCT03010176|566436309|FG000|Overall Study|Death|21|||
156911976|NCT03010176|566436310|FG001|Overall Study|Death|35|||
156911977|NCT03010176|566436311|FG002|Overall Study|Death|19|||
156911978|NCT03010176|566436312|FG003|Overall Study|Death|19|||
156911979|NCT03010176|566436313|FG004|Overall Study|Death|14|||
156911980|NCT03010176|566436314|FG005|Overall Study|Death|0|||
156911981|NCT03010176|566436309|FG000|Overall Study|Lost to Follow-up|0|||
156911982|NCT03010176|566436310|FG001|Overall Study|Lost to Follow-up|0|||
156911983|NCT03010176|566436311|FG002|Overall Study|Lost to Follow-up|0|||
156911984|NCT03010176|566436312|FG003|Overall Study|Lost to Follow-up|0|||
156911985|NCT03010176|566436313|FG004|Overall Study|Lost to Follow-up|1|||
156911986|NCT03010176|566436314|FG005|Overall Study|Lost to Follow-up|0|||
156911987|NCT03010176|566436309|FG000|Overall Study|Physician Decision|0|||
156911988|NCT03010176|566436310|FG001|Overall Study|Physician Decision|4|||
156911989|NCT03010176|566436311|FG002|Overall Study|Physician Decision|0|||
156911990|NCT03010176|566436312|FG003|Overall Study|Physician Decision|1|||
156911991|NCT03010176|566436313|FG004|Overall Study|Physician Decision|0|||
156911992|NCT03010176|566436314|FG005|Overall Study|Physician Decision|0|||
156911993|NCT03010176|566436309|FG000|Overall Study|Sponsor Decision|0|||
156911994|NCT03010176|566436310|FG001|Overall Study|Sponsor Decision|4|||
156911995|NCT03010176|566436311|FG002|Overall Study|Sponsor Decision|4|||
156911996|NCT03010176|566436312|FG003|Overall Study|Sponsor Decision|1|||
156911997|NCT03010176|566436313|FG004|Overall Study|Sponsor Decision|6|||
156911998|NCT03010176|566436314|FG005|Overall Study|Sponsor Decision|0|||
156911999|NCT03010176|566436309|FG000|Overall Study|Withdrawal by Subject|11|||
156912000|NCT03010176|566436310|FG001|Overall Study|Withdrawal by Subject|9|||
156912001|NCT03010176|566436311|FG002|Overall Study|Withdrawal by Subject|3|||
156912002|NCT03010176|566436312|FG003|Overall Study|Withdrawal by Subject|0|||
156912003|NCT03010176|566436313|FG004|Overall Study|Withdrawal by Subject|4|||
156912004|NCT03010176|566436314|FG005|Overall Study|Withdrawal by Subject|0|||
156912005|NCT04220866|566436315|FG000|Overall Study|Death|4|||
156912006|NCT04220866|566436316|FG001|Overall Study|Death|5|||
156912007|NCT04220866|566436315|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
156912008|NCT04220866|566436316|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
156912009|NCT04220866|566436315|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
156912010|NCT04220866|566436316|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
156912011|NCT04220866|566436315|FG000|Overall Study|Withdrawal by Subject|0|||
156912012|NCT04220866|566436316|FG001|Overall Study|Withdrawal by Subject|1|||
156912013|NCT00407797|566436319|FG000|Overall Study|Lost to Follow-up|2|||
156912014|NCT00407797|566436319|FG000|Overall Study|Adverse Event|6|||
156912015|NCT00407797|566436319|FG000|Overall Study|Other|7|||
156912016|NCT00407797|566436319|FG000|Overall Study|Withdrawal by Subject|3|||
156912017|NCT05469178|566436321|FG000|Overall Study|Death|1|||
156912018|NCT05469178|566436322|FG001|Overall Study|Death|1|||
156912019|NCT05469178|566436323|FG002|Overall Study|Death|3|||
156912020|NCT05469178|566436324|FG003|Overall Study|Death|6|||
156912021|NCT05469178|566436321|FG000|Overall Study|Lack of Efficacy|2|||
156912022|NCT05469178|566436322|FG001|Overall Study|Lack of Efficacy|2|||
156912023|NCT05469178|566436323|FG002|Overall Study|Lack of Efficacy|1|||
156912024|NCT05469178|566436324|FG003|Overall Study|Lack of Efficacy|10|||
156912025|NCT02801396|566436325|FG000|Period 1|Withdrawal by Subject|0|||
156912026|NCT02801396|566436326|FG001|Period 1|Withdrawal by Subject|0|||
156912027|NCT02801396|566436327|FG002|Period 1|Withdrawal by Subject|0|||
156912028|NCT02801396|566436328|FG003|Period 1|Withdrawal by Subject|0|||
156912029|NCT02801396|566436329|FG004|Period 1|Withdrawal by Subject|1|||
156912030|NCT02801396|566436330|FG005|Period 1|Withdrawal by Subject|0|||
156912031|NCT03208244|566436331|FG000|Overall Study|Death|1|||
156912032|NCT02083783|566436332|FG000|Overall Study|Withdrawal by Subject|1|||
156912033|NCT02083783|566436333|FG001|Overall Study|Withdrawal by Subject|0|||
156912034|NCT02256631|566436336|FG000|Overall Study|Lost to Follow-up|1|||
156912035|NCT02256631|566436337|FG001|Overall Study|Lost to Follow-up|1|||
156912036|NCT02256631|566436338|FG002|Overall Study|Lost to Follow-up|0|||
156912037|NCT02256631|566436339|FG003|Overall Study|Lost to Follow-up|2|||
156912038|NCT02256631|566436340|FG004|Overall Study|Lost to Follow-up|0|||
156912039|NCT02256631|566436341|FG005|Overall Study|Lost to Follow-up|4|||
156912040|NCT02256631|566436342|FG006|Overall Study|Lost to Follow-up|1|||
156912041|NCT02256631|566436336|FG000|Overall Study|Withdrawal by Subject|0|||
156912042|NCT02256631|566436337|FG001|Overall Study|Withdrawal by Subject|0|||
156912043|NCT02256631|566436338|FG002|Overall Study|Withdrawal by Subject|0|||
156912044|NCT02256631|566436339|FG003|Overall Study|Withdrawal by Subject|1|||
156912045|NCT02256631|566436340|FG004|Overall Study|Withdrawal by Subject|1|||
156912046|NCT02256631|566436341|FG005|Overall Study|Withdrawal by Subject|0|||
156912047|NCT02256631|566436342|FG006|Overall Study|Withdrawal by Subject|1|||
156912048|NCT02256631|566436336|FG000|Overall Study|Unable to get to clinic|0|||
156912049|NCT02256631|566436337|FG001|Overall Study|Unable to get to clinic|2|||
156912050|NCT02256631|566436338|FG002|Overall Study|Unable to get to clinic|0|||
156912051|NCT02256631|566436339|FG003|Overall Study|Unable to get to clinic|1|||
156912052|NCT02256631|566436340|FG004|Overall Study|Unable to get to clinic|0|||
156912053|NCT02256631|566436341|FG005|Overall Study|Unable to get to clinic|1|||
156912054|NCT02256631|566436342|FG006|Overall Study|Unable to get to clinic|2|||
156912055|NCT01427972|566436343|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912056|NCT01427972|566436344|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912057|NCT01427972|566436345|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912058|NCT01427972|566436346|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912059|NCT01427972|566436347|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912060|NCT01427972|566436348|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912061|NCT01427972|566436349|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912062|NCT01427972|566436350|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
156912063|NCT01427972|566436351|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912064|NCT01427972|566436352|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912065|NCT01427972|566436353|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912066|NCT01427972|566436354|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
156912067|NCT01427972|566436343|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912068|NCT01427972|566436344|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912069|NCT01427972|566436345|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912070|NCT01427972|566436346|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912071|NCT01427972|566436347|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912072|NCT01427972|566436348|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
156912073|NCT01427972|566436349|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912074|NCT01427972|566436350|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912075|NCT01427972|566436351|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912076|NCT01427972|566436352|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912077|NCT01427972|566436353|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912078|NCT01427972|566436354|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
156912079|NCT01427972|566436343|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912080|NCT01427972|566436344|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
156912081|NCT01427972|566436345|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912082|NCT01427972|566436346|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912083|NCT01427972|566436347|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912084|NCT01427972|566436348|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912085|NCT01427972|566436349|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912086|NCT01427972|566436350|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912087|NCT01427972|566436351|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912088|NCT01427972|566436352|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912089|NCT01427972|566436353|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912090|NCT01427972|566436354|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
156912091|NCT00530946|566436355|FG000|Overall Study|Adverse Event|1|||
156912092|NCT00530946|566436356|FG001|Overall Study|Adverse Event|2|||
157160053|NCT02345252|567329558|FG000|Double-Blind Phase|Withdrew Consent|21|||
157160054|NCT02345252|567329559|FG001|Double-Blind Phase|Withdrew Consent|23|||
157160055|NCT02345252|567329558|FG000|Double-Blind Phase|Lost to Follow-up|8|||
157160056|NCT02345252|567329559|FG001|Double-Blind Phase|Lost to Follow-up|10|||
157160057|NCT02345252|567329558|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
157160058|NCT02345252|567329559|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
157160059|NCT02651194|567329566|FG000|Overall Study|Lost to Follow-up|3|||
157160060|NCT02651194|567329566|FG000|Overall Study|Other|2|||
157160061|NCT01188564|567329567|FG000|Double-blind Phase|randomized not treated|1|||
157160062|NCT01188564|567329568|FG001|Double-blind Phase|randomized not treated|0|||
157160063|NCT04171037|567329569|FG000|Overall Study|Lost to Follow-up|1|||
157160064|NCT04171037|567329570|FG001|Overall Study|Lost to Follow-up|0|||
157160065|NCT04171037|567329569|FG000|Overall Study|Physician Decision|3|||
157160066|NCT04171037|567329570|FG001|Overall Study|Physician Decision|3|||
157160067|NCT02864940|567329571|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
157160068|NCT02864940|567329572|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
157160069|NCT01958125|567329573|FG000|Overall Study|Missing diary data|2|||
157160070|NCT01958125|567329574|FG001|Overall Study|Missing diary data|6|||
157160071|NCT01958125|567329573|FG000|Overall Study|No headache attacks|0|||
157160072|NCT01958125|567329574|FG001|Overall Study|No headache attacks|2|||
157160073|NCT04096326|567329575|FG000|Overall Study|Withdrawal by Subject|0|||
157160074|NCT04096326|567329576|FG001|Overall Study|Withdrawal by Subject|0|||
157160075|NCT04096326|567329577|FG002|Overall Study|Withdrawal by Subject|0|||
157160076|NCT04096326|567329578|FG003|Overall Study|Withdrawal by Subject|0|||
157160077|NCT04096326|567329579|FG004|Overall Study|Withdrawal by Subject|0|||
157160078|NCT04096326|567329580|FG005|Overall Study|Withdrawal by Subject|0|||
157160079|NCT04096326|567329581|FG006|Overall Study|Withdrawal by Subject|1|||
157160080|NCT04096326|567329582|FG007|Overall Study|Withdrawal by Subject|0|||
157160081|NCT04096326|567329583|FG008|Overall Study|Withdrawal by Subject|0|||
157160082|NCT04096326|567329584|FG009|Overall Study|Withdrawal by Subject|0|||
157160083|NCT04096326|567329575|FG000|Overall Study|Lost to Follow-up|0|||
157160084|NCT04096326|567329576|FG001|Overall Study|Lost to Follow-up|1|||
156912093|NCT00530946|566436357|FG002|Overall Study|Adverse Event|1|||
156912094|NCT00530946|566436358|FG003|Overall Study|Adverse Event|1|||
156912095|NCT00530946|566436355|FG000|Overall Study|Protocol Violation|0|||
156912096|NCT00530946|566436356|FG001|Overall Study|Protocol Violation|0|||
156912097|NCT00530946|566436357|FG002|Overall Study|Protocol Violation|0|||
156912098|NCT00530946|566436358|FG003|Overall Study|Protocol Violation|1|||
156912099|NCT00530946|566436355|FG000|Overall Study|Noncompliance|1|||
156912100|NCT00530946|566436356|FG001|Overall Study|Noncompliance|0|||
156912101|NCT00530946|566436357|FG002|Overall Study|Noncompliance|0|||
156912102|NCT00530946|566436358|FG003|Overall Study|Noncompliance|0|||
156912103|NCT01534962|566436359|FG000|Overall Study|Randomized but did not start treatment|2|||
156912104|NCT01534962|566436360|FG001|Overall Study|Randomized but did not start treatment|0|||
156912105|NCT01534962|566436361|FG002|Overall Study|Randomized but did not start treatment|0|||
156912106|NCT01534962|566436362|FG003|Overall Study|Randomized but did not start treatment|1|||
156912107|NCT01534962|566436359|FG000|Overall Study|Discontinued at AF recurrence|35|||
156912108|NCT01534962|566436360|FG001|Overall Study|Discontinued at AF recurrence|26|||
156912109|NCT01534962|566436361|FG002|Overall Study|Discontinued at AF recurrence|24|||
156912110|NCT01534962|566436362|FG003|Overall Study|Discontinued at AF recurrence|31|||
156912111|NCT04545385|566436367|FG000|Overall Study|Withdrawal by Subject|2|||
156912112|NCT04545385|566436368|FG001|Overall Study|Withdrawal by Subject|0|||
156912113|NCT04545385|566436367|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
156912114|NCT04545385|566436368|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
157160085|NCT04096326|567329577|FG002|Overall Study|Lost to Follow-up|0|||
157160086|NCT04096326|567329578|FG003|Overall Study|Lost to Follow-up|0|||
156912115|NCT04545385|566436367|FG000|Overall Study|Study termination|10|||
156912116|NCT04545385|566436368|FG001|Overall Study|Study termination|10|||
156912117|NCT04545385|566436367|FG000|Overall Study|Sponsor decision|2|||
156912118|NCT04545385|566436368|FG001|Overall Study|Sponsor decision|2|||
156912119|NCT04545385|566436367|FG000|Overall Study|Other than specified|1|||
156912120|NCT04545385|566436368|FG001|Overall Study|Other than specified|0|||
156912121|NCT01128842|566436373|FG000|Overall Study|Adverse Event|1|||
156912122|NCT01128842|566436373|FG000|Overall Study|Disease Progression|6|||
156912123|NCT03322631|566436374|FG000|Overall Study|Withdrawal by Subject|0|||
157160087|NCT04096326|567329579|FG004|Overall Study|Lost to Follow-up|0|||
156912124|NCT03322631|566436375|FG001|Overall Study|Withdrawal by Subject|1|||
157160088|NCT04096326|567329580|FG005|Overall Study|Lost to Follow-up|0|||
157160089|NCT04096326|567329581|FG006|Overall Study|Lost to Follow-up|0|||
157160090|NCT04096326|567329582|FG007|Overall Study|Lost to Follow-up|0|||
157160091|NCT04096326|567329583|FG008|Overall Study|Lost to Follow-up|0|||
156912125|NCT03322631|566436376|FG002|Overall Study|Withdrawal by Subject|0|||
156912126|NCT03322631|566436377|FG003|Overall Study|Withdrawal by Subject|0|||
156912127|NCT03322631|566436374|FG000|Overall Study|Adverse Event|0|||
156912128|NCT03322631|566436375|FG001|Overall Study|Adverse Event|0|||
156912129|NCT03322631|566436376|FG002|Overall Study|Adverse Event|1|||
156912130|NCT03322631|566436377|FG003|Overall Study|Adverse Event|0|||
156912131|NCT02378961|566436378|FG000|Overall Study|Lack of Efficacy|4|||
156912132|NCT02378961|566436379|FG001|Overall Study|Lack of Efficacy|2|||
156912133|NCT02378961|566436380|FG002|Overall Study|Lack of Efficacy|0|||
156912134|NCT02378961|566436381|FG003|Overall Study|Lack of Efficacy|1|||
156912135|NCT02378961|566436378|FG000|Overall Study|Death|0|||
156912136|NCT02378961|566436379|FG001|Overall Study|Death|0|||
156912137|NCT02378961|566436380|FG002|Overall Study|Death|1|||
156912138|NCT02378961|566436381|FG003|Overall Study|Death|0|||
156912139|NCT04528732|566436383|FG000|Overall Study|Death|1|||
156912140|NCT04528732|566436384|FG001|Overall Study|Death|0|||
156912141|NCT04528732|566436385|FG002|Overall Study|Death|1|||
156912142|NCT04528732|566436383|FG000|Overall Study|Lost to Follow-up|0|||
156912143|NCT04528732|566436384|FG001|Overall Study|Lost to Follow-up|1|||
156912144|NCT04528732|566436385|FG002|Overall Study|Lost to Follow-up|2|||
156912145|NCT05399641|566436392|FG000|Overall Study|Adverse Event|0|||
156912146|NCT05399641|566436393|FG001|Overall Study|Adverse Event|1|||
156912147|NCT05399641|566436394|FG002|Overall Study|Adverse Event|1|||
156912148|NCT05399641|566436392|FG000|Overall Study|Lost to Follow-up|1|||
156912149|NCT05399641|566436393|FG001|Overall Study|Lost to Follow-up|2|||
156912150|NCT05399641|566436394|FG002|Overall Study|Lost to Follow-up|2|||
156912151|NCT05399641|566436392|FG000|Overall Study|Physician Decision|1|||
156912152|NCT05399641|566436393|FG001|Overall Study|Physician Decision|3|||
156912153|NCT05399641|566436394|FG002|Overall Study|Physician Decision|3|||
156912154|NCT05399641|566436392|FG000|Overall Study|Withdrawal by Subject|4|||
156912155|NCT05399641|566436393|FG001|Overall Study|Withdrawal by Subject|11|||
156912156|NCT05399641|566436394|FG002|Overall Study|Withdrawal by Subject|7|||
156912157|NCT05399641|566436392|FG000|Overall Study|Reason not defined|3|||
156912158|NCT05399641|566436393|FG001|Overall Study|Reason not defined|5|||
156912159|NCT05399641|566436394|FG002|Overall Study|Reason not defined|6|||
156912160|NCT02094677|566436395|FG000|Overall Study|Screening|3|||
156912161|NCT02094677|566436396|FG001|Overall Study|Screening|1|||
156912162|NCT01300650|566436397|FG000|Overall Study|Adverse Event|1|||
156912163|NCT03338998|566436398|FG000|Treatment Period|Withdrawal by Subject|1|||
156912164|NCT03338998|566436399|FG001|Treatment Period|Withdrawal by Subject|1|||
156912165|NCT03338998|566436398|FG000|Treatment Period|Adverse Event|0|||
156912166|NCT03338998|566436399|FG001|Treatment Period|Adverse Event|2|||
156912167|NCT03338998|566436398|FG000|Treatment Period|Protocol deviation|1|||
156912168|NCT03338998|566436399|FG001|Treatment Period|Protocol deviation|0|||
156912169|NCT03338998|566436398|FG000|Treatment Period|Physician Decision|2|||
156912170|NCT03338998|566436399|FG001|Treatment Period|Physician Decision|0|||
156912171|NCT03338998|566436398|FG000|Treatment Period|Subject failed swallow test|4|||
156912172|NCT03338998|566436399|FG001|Treatment Period|Subject failed swallow test|0|||
156912173|NCT03338998|566436398|FG000|Safety Follow-Up Period|Adverse Event|0|||
156912174|NCT03338998|566436399|FG001|Safety Follow-Up Period|Adverse Event|1|||
156912175|NCT03338998|566436398|FG000|Safety Follow-Up Period|Protocol deviation|1|||
156912176|NCT03338998|566436399|FG001|Safety Follow-Up Period|Protocol deviation|0|||
156912177|NCT03338998|566436398|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
156912178|NCT03338998|566436399|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
156912179|NCT03307967|566436400|FG000|Overall Study|Lost to Follow-up|4|||
156912180|NCT02915016|566436401|FG000|Overall Study|Lost to Follow-up|4|||
156912181|NCT02915016|566436402|FG001|Overall Study|Lost to Follow-up|2|||
156912182|NCT02915016|566436403|FG002|Overall Study|Lost to Follow-up|5|||
156912183|NCT02915016|566436404|FG003|Overall Study|Lost to Follow-up|3|||
156912184|NCT02915016|566436405|FG004|Overall Study|Lost to Follow-up|5|||
156912185|NCT02915016|566436406|FG005|Overall Study|Lost to Follow-up|2|||
156912186|NCT02915016|566436407|FG006|Overall Study|Lost to Follow-up|8|||
156912187|NCT02915016|566436408|FG007|Overall Study|Lost to Follow-up|2|||
156912188|NCT02915016|566436401|FG000|Overall Study|Physician Decision|0|||
156912189|NCT02915016|566436402|FG001|Overall Study|Physician Decision|0|||
156912190|NCT02915016|566436403|FG002|Overall Study|Physician Decision|1|||
156912191|NCT02915016|566436404|FG003|Overall Study|Physician Decision|0|||
156912192|NCT02915016|566436405|FG004|Overall Study|Physician Decision|0|||
156912193|NCT02915016|566436406|FG005|Overall Study|Physician Decision|1|||
156912194|NCT02915016|566436407|FG006|Overall Study|Physician Decision|2|||
157225590|NCT00337571|567571477|FG003|Overall Study|Withdrawal by Subject|0|||
156912195|NCT02915016|566436408|FG007|Overall Study|Physician Decision|0|||
156912196|NCT02915016|566436401|FG000|Overall Study|Withdrawal by Subject|2|||
156912197|NCT02915016|566436402|FG001|Overall Study|Withdrawal by Subject|0|||
156912198|NCT02915016|566436403|FG002|Overall Study|Withdrawal by Subject|1|||
156912199|NCT02915016|566436404|FG003|Overall Study|Withdrawal by Subject|0|||
156912200|NCT02915016|566436405|FG004|Overall Study|Withdrawal by Subject|1|||
156912201|NCT02915016|566436406|FG005|Overall Study|Withdrawal by Subject|3|||
156912202|NCT02915016|566436407|FG006|Overall Study|Withdrawal by Subject|1|||
156912203|NCT02915016|566436408|FG007|Overall Study|Withdrawal by Subject|1|||
156912204|NCT02915016|566436401|FG000|Overall Study|Elected not to continue|0|||
156912205|NCT02915016|566436402|FG001|Overall Study|Elected not to continue|0|||
156912206|NCT02915016|566436403|FG002|Overall Study|Elected not to continue|0|||
156912207|NCT02915016|566436404|FG003|Overall Study|Elected not to continue|1|||
156912208|NCT02915016|566436405|FG004|Overall Study|Elected not to continue|0|||
156912209|NCT02915016|566436406|FG005|Overall Study|Elected not to continue|0|||
156912210|NCT02915016|566436407|FG006|Overall Study|Elected not to continue|1|||
156912211|NCT02915016|566436408|FG007|Overall Study|Elected not to continue|0|||
156912212|NCT02915016|566436401|FG000|Overall Study|HIV infection|1|||
156912213|NCT02915016|566436402|FG001|Overall Study|HIV infection|1|||
156912214|NCT02915016|566436403|FG002|Overall Study|HIV infection|1|||
156912215|NCT02915016|566436404|FG003|Overall Study|HIV infection|0|||
156912216|NCT02915016|566436405|FG004|Overall Study|HIV infection|1|||
156912217|NCT02915016|566436406|FG005|Overall Study|HIV infection|0|||
156912218|NCT02915016|566436407|FG006|Overall Study|HIV infection|0|||
156912219|NCT02915016|566436408|FG007|Overall Study|HIV infection|0|||
156912220|NCT02915016|566436401|FG000|Overall Study|Participant unable to adhere|0|||
156912221|NCT02915016|566436402|FG001|Overall Study|Participant unable to adhere|0|||
156912222|NCT02915016|566436403|FG002|Overall Study|Participant unable to adhere|0|||
156912223|NCT02915016|566436404|FG003|Overall Study|Participant unable to adhere|0|||
156912224|NCT02915016|566436405|FG004|Overall Study|Participant unable to adhere|0|||
156912225|NCT02915016|566436406|FG005|Overall Study|Participant unable to adhere|0|||
156912226|NCT02915016|566436407|FG006|Overall Study|Participant unable to adhere|0|||
156912227|NCT02915016|566436408|FG007|Overall Study|Participant unable to adhere|1|||
156912228|NCT02578316|566436409|FG000|Extension Phase|Progression of disease|6|||
156912229|NCT02166905|566436410|FG000|Overall Study|Withdrawal by Subject|1|||
156912230|NCT02166905|566436411|FG001|Overall Study|Withdrawal by Subject|0|||
156912231|NCT02166905|566436412|FG002|Overall Study|Withdrawal by Subject|0|||
156912232|NCT02166905|566436413|FG003|Overall Study|Withdrawal by Subject|0|||
156912233|NCT03278873|566436418|FG000|Overall Study|Withdrawal by Subject|0|||
156912234|NCT03278873|566436419|FG001|Overall Study|Withdrawal by Subject|1|||
156912235|NCT03278873|566436420|FG002|Overall Study|Withdrawal by Subject|0|||
156912236|NCT03278873|566436421|FG003|Overall Study|Withdrawal by Subject|0|||
156912237|NCT03278873|566436418|FG000|Overall Study|Sponsor's decision|0|||
156912238|NCT03278873|566436419|FG001|Overall Study|Sponsor's decision|1|||
156912239|NCT03278873|566436420|FG002|Overall Study|Sponsor's decision|0|||
156912240|NCT03278873|566436421|FG003|Overall Study|Sponsor's decision|0|||
156912241|NCT03278873|566436418|FG000|Overall Study|Early Termination|2|||
156912242|NCT03278873|566436419|FG001|Overall Study|Early Termination|6|||
156912243|NCT03278873|566436420|FG002|Overall Study|Early Termination|0|||
156912244|NCT03278873|566436421|FG003|Overall Study|Early Termination|4|||
156912245|NCT03278873|566436418|FG000|Overall Study|Lost to Follow-up|0|||
156912246|NCT03278873|566436419|FG001|Overall Study|Lost to Follow-up|0|||
156912247|NCT03278873|566436420|FG002|Overall Study|Lost to Follow-up|2|||
156912248|NCT03278873|566436421|FG003|Overall Study|Lost to Follow-up|0|||
156912249|NCT03278873|566436418|FG000|Overall Study|The patient decided to withdraw via email|1|||
156912250|NCT03278873|566436419|FG001|Overall Study|The patient decided to withdraw via email|0|||
156912251|NCT03278873|566436420|FG002|Overall Study|The patient decided to withdraw via email|0|||
156912252|NCT03278873|566436421|FG003|Overall Study|The patient decided to withdraw via email|0|||
156912253|NCT03278873|566436418|FG000|Overall Study|The patient was unresponsive to contact|0|||
156912254|NCT03278873|566436419|FG001|Overall Study|The patient was unresponsive to contact|0|||
156912255|NCT03278873|566436420|FG002|Overall Study|The patient was unresponsive to contact|0|||
156912256|NCT03278873|566436421|FG003|Overall Study|The patient was unresponsive to contact|4|||
156912257|NCT03278873|566436418|FG000|Overall Study|The patient wished to participate no longer|0|||
156912258|NCT03278873|566436419|FG001|Overall Study|The patient wished to participate no longer|1|||
156912259|NCT03278873|566436420|FG002|Overall Study|The patient wished to participate no longer|0|||
156912260|NCT03278873|566436421|FG003|Overall Study|The patient wished to participate no longer|0|||
157027350|NCT01574274|566856075|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
157027351|NCT01574274|566856076|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
157027352|NCT01574274|566856075|FG000|Overall Study|Other, unknown|3|||
157027353|NCT01574274|566856076|FG001|Overall Study|Other, unknown|2|||
156912261|NCT03278873|566436418|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156912262|NCT03278873|566436419|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156912263|NCT03278873|566436420|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
156912264|NCT03278873|566436421|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
156912265|NCT05243641|566436422|FG000|Overall Study|Adverse Event|3|||
156912266|NCT05243641|566436423|FG001|Overall Study|Adverse Event|0|||
157027354|NCT04413708|566856083|FG000|Overall Study|Lost to Follow-up|1|||
157027355|NCT04413708|566856084|FG001|Overall Study|Lost to Follow-up|2|||
157027356|NCT05877976|566856085|FG000|Overall Study|Lost to Follow-up|31|||
157027357|NCT04314713|566856086|FG000|Overall Study|Lost to Follow-up|0|||
157027358|NCT04314713|566856087|FG001|Overall Study|Lost to Follow-up|0|||
156912267|NCT05243641|566436424|FG002|Overall Study|Adverse Event|0|||
156912268|NCT05243641|566436425|FG003|Overall Study|Adverse Event|1|||
156912269|NCT05243641|566436426|FG004|Overall Study|Adverse Event|0|||
156912270|NCT05243641|566436427|FG005|Overall Study|Adverse Event|0|||
156912271|NCT05243641|566436422|FG000|Overall Study|Disease progression|4|||
156912272|NCT05243641|566436423|FG001|Overall Study|Disease progression|0|||
156912273|NCT05243641|566436424|FG002|Overall Study|Disease progression|0|||
156912274|NCT05243641|566436425|FG003|Overall Study|Disease progression|2|||
156912275|NCT05243641|566436426|FG004|Overall Study|Disease progression|0|||
156912276|NCT05243641|566436427|FG005|Overall Study|Disease progression|0|||
156912277|NCT04698187|566436434|FG000|Overall Study|Withdrawal by Subject|7|||
156912278|NCT04698187|566436434|FG000|Overall Study|Death|21|||
156912279|NCT04698187|566436434|FG000|Overall Study|Sponsor Decision|15|||
157160092|NCT04096326|567329584|FG009|Overall Study|Lost to Follow-up|0|||
157160093|NCT04096326|567329575|FG000|Overall Study|COVID-19-related reasons|0|||
157160094|NCT04096326|567329576|FG001|Overall Study|COVID-19-related reasons|0|||
157160095|NCT04096326|567329577|FG002|Overall Study|COVID-19-related reasons|0|||
157160096|NCT04096326|567329578|FG003|Overall Study|COVID-19-related reasons|0|||
157160097|NCT04096326|567329579|FG004|Overall Study|COVID-19-related reasons|1|||
157160098|NCT04096326|567329580|FG005|Overall Study|COVID-19-related reasons|5|||
157160099|NCT04096326|567329581|FG006|Overall Study|COVID-19-related reasons|0|||
157160100|NCT04096326|567329582|FG007|Overall Study|COVID-19-related reasons|0|||
157160101|NCT04096326|567329583|FG008|Overall Study|COVID-19-related reasons|0|||
157160102|NCT04096326|567329584|FG009|Overall Study|COVID-19-related reasons|0|||
157160103|NCT04804033|567329585|FG000|Period 1: DBT Phase|Adverse Event|1|||
157160104|NCT04804033|567329586|FG001|Period 1: DBT Phase|Adverse Event|5|||
157160105|NCT04804033|567329587|FG002|Period 1: DBT Phase|Adverse Event|3|||
157160106|NCT04804033|567329588|FG003|Period 1: DBT Phase|Adverse Event|4|||
157160107|NCT04804033|567329585|FG000|Period 1: DBT Phase|Death|1|||
157160108|NCT04804033|567329586|FG001|Period 1: DBT Phase|Death|0|||
157160109|NCT04804033|567329587|FG002|Period 1: DBT Phase|Death|0|||
157160110|NCT04804033|567329588|FG003|Period 1: DBT Phase|Death|0|||
157160111|NCT04804033|567329585|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
157160112|NCT04804033|567329586|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
157160113|NCT04804033|567329587|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
157160114|NCT04804033|567329588|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
157160115|NCT04804033|567329585|FG000|Period 1: DBT Phase|Non-compliance|1|||
157160116|NCT04804033|567329586|FG001|Period 1: DBT Phase|Non-compliance|0|||
157160117|NCT04804033|567329587|FG002|Period 1: DBT Phase|Non-compliance|1|||
157160118|NCT04804033|567329588|FG003|Period 1: DBT Phase|Non-compliance|2|||
157160119|NCT04804033|567329585|FG000|Period 1: DBT Phase|Other|0|||
157160120|NCT04804033|567329586|FG001|Period 1: DBT Phase|Other|1|||
157160121|NCT04804033|567329587|FG002|Period 1: DBT Phase|Other|0|||
157160122|NCT04804033|567329588|FG003|Period 1: DBT Phase|Other|0|||
157160123|NCT04804033|567329585|FG000|Period 1: DBT Phase|Pregnancy|2|||
157160124|NCT04804033|567329586|FG001|Period 1: DBT Phase|Pregnancy|0|||
157160125|NCT04804033|567329587|FG002|Period 1: DBT Phase|Pregnancy|0|||
157160126|NCT04804033|567329588|FG003|Period 1: DBT Phase|Pregnancy|0|||
157160127|NCT04804033|567329585|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
156912280|NCT04698187|566436434|FG000|Overall Study|In-transit Disease|1|||
156912281|NCT03820986|566436435|FG000|Overall Study|Death|201|||
156912282|NCT03820986|566436436|FG001|Overall Study|Death|175|||
156912283|NCT03820986|566436435|FG000|Overall Study|Lost to Follow-up|1|||
156912284|NCT03820986|566436436|FG001|Overall Study|Lost to Follow-up|1|||
156912285|NCT03820986|566436435|FG000|Overall Study|Physician Decision|1|||
156912286|NCT03820986|566436436|FG001|Overall Study|Physician Decision|0|||
156912287|NCT03820986|566436435|FG000|Overall Study|Sponsor Decision|122|||
157160128|NCT04804033|567329586|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
157160129|NCT04804033|567329587|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
157160130|NCT04804033|567329588|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
157160131|NCT04804033|567329585|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
157160132|NCT04804033|567329586|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
157160133|NCT04804033|567329587|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
157160134|NCT04804033|567329588|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
157160135|NCT04804033|567329585|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
156912288|NCT03820986|566436436|FG001|Overall Study|Sponsor Decision|160|||
156912289|NCT03820986|566436435|FG000|Overall Study|Withdrawal by Subject|9|||
156912290|NCT03820986|566436436|FG001|Overall Study|Withdrawal by Subject|4|||
156912291|NCT03069378|566436437|FG000|Overall Study|Withdrawal by Subject|1|||
156912292|NCT02993146|566436438|FG000|Overall Study|Withdrawal by Subject|0|||
156912293|NCT02993146|566436439|FG001|Overall Study|Withdrawal by Subject|0|||
156912294|NCT02993146|566436440|FG002|Overall Study|Withdrawal by Subject|1|||
157160136|NCT04804033|567329586|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
156912295|NCT02993146|566436441|FG003|Overall Study|Withdrawal by Subject|1|||
157160137|NCT04804033|567329587|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
157160138|NCT04804033|567329588|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
157160139|NCT04804033|567329585|FG000|Period 2: OLE Phase|Adverse Event|3|||
156912296|NCT01397708|566436442|FG000|Overall Study|Withdrawal by Subject|0|||
156912297|NCT01397708|566436443|FG001|Overall Study|Withdrawal by Subject|0|||
156912298|NCT01397708|566436444|FG002|Overall Study|Withdrawal by Subject|1|||
156912299|NCT01397708|566436445|FG003|Overall Study|Withdrawal by Subject|0|||
156912300|NCT01397708|566436446|FG004|Overall Study|Withdrawal by Subject|0|||
156912301|NCT01397708|566436447|FG005|Overall Study|Withdrawal by Subject|0|||
156912302|NCT01397708|566436448|FG006|Overall Study|Withdrawal by Subject|0|||
156912303|NCT01397708|566436449|FG007|Overall Study|Withdrawal by Subject|1|||
156912304|NCT01397708|566436442|FG000|Overall Study|Death|0|||
156912305|NCT01397708|566436443|FG001|Overall Study|Death|0|||
156912306|NCT01397708|566436444|FG002|Overall Study|Death|1|||
156912307|NCT01397708|566436445|FG003|Overall Study|Death|1|||
156912308|NCT01397708|566436446|FG004|Overall Study|Death|0|||
156912309|NCT01397708|566436447|FG005|Overall Study|Death|0|||
156912310|NCT01397708|566436448|FG006|Overall Study|Death|0|||
156912311|NCT01397708|566436449|FG007|Overall Study|Death|0|||
156912312|NCT01397708|566436442|FG000|Overall Study|Lost to Follow-up|0|||
156912313|NCT01397708|566436443|FG001|Overall Study|Lost to Follow-up|0|||
156912314|NCT01397708|566436444|FG002|Overall Study|Lost to Follow-up|0|||
156912315|NCT01397708|566436445|FG003|Overall Study|Lost to Follow-up|0|||
156912316|NCT01397708|566436446|FG004|Overall Study|Lost to Follow-up|1|||
156912317|NCT01397708|566436447|FG005|Overall Study|Lost to Follow-up|0|||
156912318|NCT01397708|566436448|FG006|Overall Study|Lost to Follow-up|0|||
156912319|NCT01397708|566436449|FG007|Overall Study|Lost to Follow-up|0|||
156912320|NCT01397708|566436442|FG000|Overall Study|Other|0|||
156912321|NCT01397708|566436443|FG001|Overall Study|Other|0|||
156912322|NCT01397708|566436444|FG002|Overall Study|Other|0|||
156912323|NCT01397708|566436445|FG003|Overall Study|Other|0|||
156912324|NCT01397708|566436446|FG004|Overall Study|Other|0|||
156912325|NCT01397708|566436447|FG005|Overall Study|Other|0|||
156912326|NCT01397708|566436448|FG006|Overall Study|Other|1|||
156912327|NCT01397708|566436449|FG007|Overall Study|Other|0|||
156912328|NCT04524689|566436452|FG000|Overall Study|Withdrawal by Subject|1|||
156912329|NCT04524689|566436453|FG001|Overall Study|Withdrawal by Subject|1|||
156912330|NCT04524689|566436454|FG002|Overall Study|Withdrawal by Subject|0|||
156912331|NCT04524689|566436455|FG003|Overall Study|Withdrawal by Subject|0|||
156912332|NCT04524689|566436456|FG004|Overall Study|Withdrawal by Subject|2|||
156912333|NCT04524689|566436457|FG005|Overall Study|Withdrawal by Subject|0|||
156912334|NCT04524689|566436452|FG000|Overall Study|Study terminated by Sponsor|6|||
156912335|NCT04524689|566436453|FG001|Overall Study|Study terminated by Sponsor|0|||
156912336|NCT04524689|566436454|FG002|Overall Study|Study terminated by Sponsor|1|||
156912337|NCT04524689|566436455|FG003|Overall Study|Study terminated by Sponsor|0|||
156912338|NCT04524689|566436456|FG004|Overall Study|Study terminated by Sponsor|4|||
156912339|NCT04524689|566436457|FG005|Overall Study|Study terminated by Sponsor|0|||
156912340|NCT04524689|566436452|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
156912341|NCT04524689|566436453|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
156912342|NCT04524689|566436454|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
156912343|NCT04524689|566436455|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
156912344|NCT04524689|566436456|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
156912345|NCT04524689|566436457|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
156912346|NCT02513394|566436460|FG000|Overall Study|Withdrawal by Subject|11|||
156912347|NCT02513394|566436461|FG001|Overall Study|Withdrawal by Subject|23|||
156912348|NCT02513394|566436460|FG000|Overall Study|Ineligible|1|||
156912349|NCT02513394|566436461|FG001|Overall Study|Ineligible|0|||
156912350|NCT05766423|566436462|FG000|Overall Study|Withdrawal by Subject|1|||
156912351|NCT05766423|566436463|FG001|Overall Study|Withdrawal by Subject|0|||
156912352|NCT05766423|566436462|FG000|Overall Study|Consented, not scheduled|3|||
156912353|NCT05766423|566436463|FG001|Overall Study|Consented, not scheduled|5|||
156912354|NCT00612690|566438403|FG000|Overall Study|Lost to Follow-up|72|||
156912355|NCT00612690|566438404|FG001|Overall Study|Lost to Follow-up|98|||
156912356|NCT00612690|566438403|FG000|Overall Study|Withdrawal by Subject|32|||
156912357|NCT00612690|566438404|FG001|Overall Study|Withdrawal by Subject|20|||
156912358|NCT00612690|566438403|FG000|Overall Study|Withdrawal by Site|11|||
156912359|NCT00612690|566438404|FG001|Overall Study|Withdrawal by Site|0|||
156912360|NCT01664533|566438405|FG000|Overall Study|Death|42|||
156912361|NCT01664533|566438405|FG000|Overall Study|Lost to Follow-up|3|||
156912362|NCT01664533|566438405|FG000|Overall Study|Study termination|9|||
156912363|NCT01664533|566438405|FG000|Overall Study|Protocol Violation|3|||
156912364|NCT05255068|566438407|FG000|Overall Study|Lost to Follow-up|0|||
156912365|NCT05255068|566438408|FG001|Overall Study|Lost to Follow-up|1|||
156912366|NCT02397278|566438420|FG000|Overall Study|Withdrawal by Subject|0|||
156912367|NCT02397278|566438421|FG001|Overall Study|Withdrawal by Subject|2|||
156912368|NCT02397278|566438420|FG000|Overall Study|Deemed ineligible following surgery|1|||
156912369|NCT02397278|566438421|FG001|Overall Study|Deemed ineligible following surgery|1|||
156912370|NCT02871297|566438430|FG000|Overall Study|Adverse Event|34|||
156912371|NCT02871297|566438430|FG000|Overall Study|Lack of Efficacy|10|||
156912372|NCT02871297|566438430|FG000|Overall Study|Non-compliance with study drug|15|||
156912373|NCT02871297|566438430|FG000|Overall Study|Protocol Violation|3|||
156912374|NCT02871297|566438430|FG000|Overall Study|Withdrawal by Subject|20|||
156912375|NCT02871297|566438430|FG000|Overall Study|Lost to Follow-up|13|||
156912376|NCT02871297|566438430|FG000|Overall Study|Rolled over to 13546A|2|||
156912377|NCT02871297|566438430|FG000|Overall Study|Other than specified|39|||
156912378|NCT02966028|566438434|FG000|Overall Study|Adverse Event|7|||
156912379|NCT02966028|566438435|FG001|Overall Study|Adverse Event|13|||
156912380|NCT02966028|566438436|FG002|Overall Study|Adverse Event|10|||
156912381|NCT02966028|566438434|FG000|Overall Study|Physician Decision|1|||
156912382|NCT02966028|566438435|FG001|Overall Study|Physician Decision|0|||
156912383|NCT02966028|566438436|FG002|Overall Study|Physician Decision|2|||
156912384|NCT02966028|566438434|FG000|Overall Study|Withdrawal by Subject|7|||
156912385|NCT02966028|566438435|FG001|Overall Study|Withdrawal by Subject|5|||
156912386|NCT02966028|566438436|FG002|Overall Study|Withdrawal by Subject|5|||
156912387|NCT02966028|566438434|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
156912388|NCT02966028|566438435|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
156912389|NCT02966028|566438436|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
156912390|NCT04115839|566438437|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
156912391|NCT04115839|566438438|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
156912392|NCT04115839|566438439|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
156912393|NCT04115839|566438440|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156912394|NCT04115839|566438441|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156912395|NCT04115839|566438442|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156912396|NCT04115839|566438443|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
156912397|NCT04115839|566438437|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
156912398|NCT04115839|566438438|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
156912399|NCT04115839|566438439|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
156912400|NCT04115839|566438440|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156912401|NCT04115839|566438441|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156912402|NCT04115839|566438442|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156912403|NCT04115839|566438443|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
156912404|NCT04115839|566438437|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
156912405|NCT04115839|566438438|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912406|NCT04115839|566438439|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912407|NCT04115839|566438440|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912408|NCT04115839|566438441|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912409|NCT04115839|566438442|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912410|NCT04115839|566438443|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
156912411|NCT04115839|566438437|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912412|NCT04115839|566438438|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912413|NCT04115839|566438439|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
156912414|NCT04115839|566438440|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912415|NCT04115839|566438441|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912416|NCT04115839|566438442|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912417|NCT04115839|566438443|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
156912418|NCT04115839|566438437|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156912419|NCT04115839|566438438|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156912420|NCT04115839|566438439|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
156912421|NCT04115839|566438440|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
156912422|NCT04115839|566438441|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
156912423|NCT04115839|566438442|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
156912424|NCT04115839|566438443|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
156912425|NCT04115839|566438437|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156912426|NCT04115839|566438438|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156912427|NCT04115839|566438439|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156912428|NCT04115839|566438440|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
156912429|NCT04115839|566438441|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
156912430|NCT04115839|566438442|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156912431|NCT04115839|566438443|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
156912432|NCT02820753|566438445|FG000|2 Month|Withdrawal by Subject|3|||
157160140|NCT04804033|567329586|FG001|Period 2: OLE Phase|Adverse Event|4|||
157160141|NCT04804033|567329587|FG002|Period 2: OLE Phase|Adverse Event|2|||
156912433|NCT02820753|566438446|FG001|2 Month|Withdrawal by Subject|3|||
156912434|NCT02820753|566438445|FG000|2 Month|Lost to Follow-up|24|||
156912435|NCT02820753|566438446|FG001|2 Month|Lost to Follow-up|26|||
157027359|NCT04314713|566856088|FG002|Overall Study|Lost to Follow-up|0|||
157027360|NCT04314713|566856089|FG003|Overall Study|Lost to Follow-up|1|||
157027361|NCT04314713|566856090|FG004|Overall Study|Lost to Follow-up|0|||
157027362|NCT04314713|566856091|FG005|Overall Study|Lost to Follow-up|0|||
157027363|NCT04907851|566856092|FG000|Overall Study|Consent withdrawn|1|||
157027364|NCT04907851|566856093|FG001|Overall Study|Consent withdrawn|2|||
157027365|NCT04907851|566856094|FG002|Overall Study|Consent withdrawn|0|||
157160142|NCT04804033|567329588|FG003|Period 2: OLE Phase|Adverse Event|0|||
156912436|NCT02820753|566438445|FG000|2 Month|Stopped per NIH Hold|51|||
156912437|NCT02820753|566438446|FG001|2 Month|Stopped per NIH Hold|13|||
156912438|NCT02820753|566438445|FG000|6 Month|Withdrawal by Subject|2|||
156912439|NCT02820753|566438446|FG001|6 Month|Withdrawal by Subject|2|||
156912440|NCT02820753|566438445|FG000|6 Month|Lost to Follow-up|20|||
156912441|NCT02820753|566438446|FG001|6 Month|Lost to Follow-up|27|||
156912442|NCT02820753|566438445|FG000|6 Month|Stopped per NIH Hold|81|||
156912443|NCT02820753|566438446|FG001|6 Month|Stopped per NIH Hold|81|||
156912444|NCT02820753|566438445|FG000|6 Month|Death|0|||
156912445|NCT02820753|566438446|FG001|6 Month|Death|1|||
156912446|NCT00790023|566438447|FG000|Overall Study|Adverse Event|2|||
156912447|NCT00790023|566438448|FG001|Overall Study|Adverse Event|1|||
156912448|NCT00790023|566438449|FG002|Overall Study|Adverse Event|4|||
156912449|NCT00790023|566438447|FG000|Overall Study|Protocol Violation|2|||
156912450|NCT00790023|566438448|FG001|Overall Study|Protocol Violation|4|||
156912451|NCT00790023|566438449|FG002|Overall Study|Protocol Violation|2|||
156912452|NCT00790023|566438447|FG000|Overall Study|Withdrawal by Subject|2|||
156912453|NCT00790023|566438448|FG001|Overall Study|Withdrawal by Subject|0|||
156912454|NCT00790023|566438449|FG002|Overall Study|Withdrawal by Subject|6|||
156912455|NCT00790023|566438447|FG000|Overall Study|Lost to Follow-up|0|||
156912456|NCT00790023|566438448|FG001|Overall Study|Lost to Follow-up|0|||
156912457|NCT00790023|566438449|FG002|Overall Study|Lost to Follow-up|1|||
156912458|NCT00790023|566438447|FG000|Overall Study|Other|5|||
156912459|NCT00790023|566438448|FG001|Overall Study|Other|5|||
156912460|NCT00790023|566438449|FG002|Overall Study|Other|8|||
156912461|NCT00573469|566438450|FG000|Overall Study|Adverse Event|1|||
156912462|NCT00573469|566438451|FG001|Overall Study|Adverse Event|1|||
156912463|NCT00573469|566438452|FG002|Overall Study|Adverse Event|1|||
156912464|NCT00573469|566438450|FG000|Overall Study|Withdrawal by Subject|0|||
156912465|NCT00573469|566438451|FG001|Overall Study|Withdrawal by Subject|2|||
157027366|NCT04907851|566856092|FG000|Overall Study|Death|5|||
157027367|NCT04907851|566856093|FG001|Overall Study|Death|15|||
156912466|NCT00573469|566438452|FG002|Overall Study|Withdrawal by Subject|0|||
156912467|NCT00573469|566438450|FG000|Overall Study|Other|5|||
156912468|NCT00573469|566438451|FG001|Overall Study|Other|1|||
156912469|NCT00573469|566438452|FG002|Overall Study|Other|3|||
156912470|NCT01338792|566438453|FG000|Overall Study|Adverse Event|2|||
156912471|NCT01338792|566438453|FG000|Overall Study|Death|1|||
156912472|NCT01338792|566438453|FG000|Overall Study|Withdrawal by Subject|1|||
156912473|NCT01652703|566438454|FG000|Overall Study|Withdrawal by Subject|0|||
156912474|NCT01652703|566438455|FG001|Overall Study|Withdrawal by Subject|1|||
156912475|NCT01652703|566438456|FG002|Overall Study|Withdrawal by Subject|3|||
156912476|NCT01652703|566438457|FG003|Overall Study|Withdrawal by Subject|1|||
156912477|NCT01652703|566438458|FG004|Overall Study|Withdrawal by Subject|0|||
156912478|NCT01652703|566438459|FG005|Overall Study|Withdrawal by Subject|1|||
156912479|NCT01652703|566438454|FG000|Overall Study|Other|0|||
156912480|NCT01652703|566438455|FG001|Overall Study|Other|0|||
156912481|NCT01652703|566438456|FG002|Overall Study|Other|0|||
157160143|NCT04804033|567329585|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
157160144|NCT04804033|567329586|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
157160145|NCT04804033|567329587|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
157160146|NCT04804033|567329588|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
157160147|NCT04804033|567329585|FG000|Period 2: OLE Phase|Non-compliance|2|||
157160148|NCT04804033|567329586|FG001|Period 2: OLE Phase|Non-compliance|2|||
156912482|NCT01652703|566438457|FG003|Overall Study|Other|1|||
157027368|NCT04907851|566856094|FG002|Overall Study|Death|10|||
157027369|NCT03656510|566856105|FG000|Overall Study|Lost to Follow-up|1|||
157027370|NCT03656510|566856106|FG001|Overall Study|Lost to Follow-up|0|||
157160149|NCT04804033|567329587|FG002|Period 2: OLE Phase|Non-compliance|0|||
157160150|NCT04804033|567329588|FG003|Period 2: OLE Phase|Non-compliance|1|||
156912483|NCT01652703|566438458|FG004|Overall Study|Other|1|||
156912484|NCT01652703|566438459|FG005|Overall Study|Other|1|||
156912485|NCT00062374|566438463|FG000|Overall Study|Not treated|12|||
157027371|NCT03656510|566856107|FG002|Overall Study|Lost to Follow-up|0|||
157027372|NCT03656510|566856108|FG003|Overall Study|Lost to Follow-up|0|||
156912486|NCT00684593|566438464|FG000|Overall Study|Adverse Event|0|||
157027373|NCT03656510|566856109|FG004|Overall Study|Lost to Follow-up|0|||
156912487|NCT00684593|566438465|FG001|Overall Study|Adverse Event|2|||
156912488|NCT02599129|566438468|FG000|Overall Study|Lack of Efficacy|2|||
156912489|NCT02599129|566438469|FG001|Overall Study|Lack of Efficacy|2|||
156912490|NCT02599129|566438468|FG000|Overall Study|Lost to Follow-up|1|||
156912491|NCT02599129|566438469|FG001|Overall Study|Lost to Follow-up|0|||
156912492|NCT02599129|566438468|FG000|Overall Study|Withdrawal by Subject|2|||
156912493|NCT02599129|566438469|FG001|Overall Study|Withdrawal by Subject|1|||
156912494|NCT00617773|566438470|FG000|Overall Study|Physician Decision|1|||
156912495|NCT00617773|566438470|FG000|Overall Study|Lack of compliance with the protocol|1|||
157027374|NCT03656510|566856110|FG005|Overall Study|Lost to Follow-up|0|||
156912496|NCT00617773|566438470|FG000|Overall Study|Withdrawal by Subject|1|||
157027375|NCT03656510|566856105|FG000|Overall Study|Withdrawal by Subject|1|||
157160151|NCT04804033|567329585|FG000|Period 2: OLE Phase|Other|0|||
157160152|NCT04804033|567329586|FG001|Period 2: OLE Phase|Other|2|||
156912497|NCT00617773|566438470|FG000|Overall Study|Death|1|||
156912498|NCT00617773|566438470|FG000|Overall Study|Progressive disease|19|||
156912499|NCT00617773|566438470|FG000|Overall Study|Protocol Violation|1|||
156912500|NCT01029795|566438471|FG000|Overall Study|Entry Criteria Not Met|2|||
156912501|NCT01029795|566438472|FG001|Overall Study|Entry Criteria Not Met|1|||
156912502|NCT01029795|566438471|FG000|Overall Study|Physician Decision|2|||
156912503|NCT01029795|566438472|FG001|Overall Study|Physician Decision|1|||
156912504|NCT01029795|566438471|FG000|Overall Study|Sponsor Decision|11|||
156912505|NCT01029795|566438472|FG001|Overall Study|Sponsor Decision|17|||
156912506|NCT01029795|566438471|FG000|Overall Study|Withdrawal by Subject|1|||
156912507|NCT01029795|566438472|FG001|Overall Study|Withdrawal by Subject|3|||
156912508|NCT05035550|566438483|FG000|Overall Study|Withdrawal by Subject|3|||
156912509|NCT05035550|566438484|FG001|Overall Study|Withdrawal by Subject|0|||
156912510|NCT00840450|566438485|FG000|Overall Study|Adverse Event|1|||
156912511|NCT00840450|566438485|FG000|Overall Study|Lack of Efficacy|2|||
156912512|NCT00520936|566438486|FG000|Overall Study|Physician Decision|0|||
156912513|NCT00520936|566438487|FG001|Overall Study|Physician Decision|2|||
156912514|NCT00520936|566438488|FG002|Overall Study|Physician Decision|1|||
156912515|NCT00520936|566438489|FG003|Overall Study|Physician Decision|0|||
156912516|NCT00520936|566438490|FG004|Overall Study|Physician Decision|0|||
156912517|NCT00520936|566438491|FG005|Overall Study|Physician Decision|0|||
156912518|NCT00520936|566438492|FG006|Overall Study|Physician Decision|0|||
156912519|NCT00520936|566438493|FG007|Overall Study|Physician Decision|0|||
156912520|NCT00520936|566438486|FG000|Overall Study|Withdrawal by Subject|0|||
156912521|NCT00520936|566438487|FG001|Overall Study|Withdrawal by Subject|0|||
156912522|NCT00520936|566438488|FG002|Overall Study|Withdrawal by Subject|0|||
156912523|NCT00520936|566438489|FG003|Overall Study|Withdrawal by Subject|0|||
156912524|NCT00520936|566438490|FG004|Overall Study|Withdrawal by Subject|0|||
156912525|NCT00520936|566438491|FG005|Overall Study|Withdrawal by Subject|0|||
156912526|NCT00520936|566438492|FG006|Overall Study|Withdrawal by Subject|0|||
156912527|NCT00520936|566438493|FG007|Overall Study|Withdrawal by Subject|1|||
156912528|NCT00520936|566438486|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
156912529|NCT00520936|566438487|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
156912530|NCT00520936|566438488|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
156912531|NCT00520936|566438489|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
156912532|NCT00520936|566438490|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
156912533|NCT00520936|566438491|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
156912534|NCT00520936|566438492|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
156912535|NCT00520936|566438493|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
156912536|NCT00520936|566438486|FG000|Overall Study|Death|0|||
156912537|NCT00520936|566438487|FG001|Overall Study|Death|0|||
156912538|NCT00520936|566438488|FG002|Overall Study|Death|0|||
156912539|NCT00520936|566438489|FG003|Overall Study|Death|0|||
156912540|NCT00520936|566438490|FG004|Overall Study|Death|0|||
156912541|NCT00520936|566438491|FG005|Overall Study|Death|0|||
156912542|NCT00520936|566438492|FG006|Overall Study|Death|1|||
156912543|NCT00520936|566438493|FG007|Overall Study|Death|0|||
156912544|NCT00520936|566438486|FG000|Overall Study|Protocol Violation|0|||
156912545|NCT00520936|566438487|FG001|Overall Study|Protocol Violation|1|||
156912546|NCT00520936|566438488|FG002|Overall Study|Protocol Violation|1|||
156912547|NCT00520936|566438489|FG003|Overall Study|Protocol Violation|0|||
156912548|NCT00520936|566438490|FG004|Overall Study|Protocol Violation|1|||
156912549|NCT00520936|566438491|FG005|Overall Study|Protocol Violation|0|||
156912550|NCT00520936|566438492|FG006|Overall Study|Protocol Violation|1|||
156912551|NCT00520936|566438493|FG007|Overall Study|Protocol Violation|0|||
156912552|NCT03858309|566438500|FG000|Overall Study|Withdrawal by Subject|2|||
156912553|NCT03858309|566438501|FG001|Overall Study|Withdrawal by Subject|3|||
156912554|NCT03897465|566438510|FG000|Overall Study|Lost to Follow-up|2|||
156912555|NCT03897465|566438511|FG001|Overall Study|Lost to Follow-up|1|||
156912556|NCT03897465|566438510|FG000|Overall Study|Adverse Event|2|||
156912557|NCT03897465|566438511|FG001|Overall Study|Adverse Event|0|||
156912558|NCT03897465|566438510|FG000|Overall Study|complete healing by V2|1|||
156912559|NCT03897465|566438511|FG001|Overall Study|complete healing by V2|0|||
156912560|NCT03897465|566438510|FG000|Overall Study|occurence of exclusion criterion|1|||
156912561|NCT03897465|566438511|FG001|Overall Study|occurence of exclusion criterion|1|||
156912562|NCT03897465|566438510|FG000|Overall Study|Other|1|||
156912563|NCT03897465|566438511|FG001|Overall Study|Other|0|||
156912564|NCT00521014|566438512|FG000|Overall Study|Inevaluable, not treated|1|||
156912565|NCT03132220|566438513|FG000|Overall Study|Lost to Follow-up|17|||
156912566|NCT03132220|566438514|FG001|Overall Study|Lost to Follow-up|8|||
156912567|NCT03132220|566438513|FG000|Overall Study|Withdrawal by Subject|1|||
156912568|NCT03132220|566438514|FG001|Overall Study|Withdrawal by Subject|4|||
156912569|NCT00730132|566438515|FG000|Overall Study|Protocol Violation|154|||
156912570|NCT00730132|566438515|FG000|Overall Study|Death|1|||
156912571|NCT00601458|566438516|FG000|Overall Study|Dosing Error|1|||
156912572|NCT00601458|566438517|FG001|Overall Study|Dosing Error|0|||
156912573|NCT00601458|566438518|FG002|Overall Study|Dosing Error|0|||
156912574|NCT00601458|566438516|FG000|Overall Study|Incomplete Data|0|||
156912575|NCT00601458|566438517|FG001|Overall Study|Incomplete Data|2|||
156912576|NCT00601458|566438518|FG002|Overall Study|Incomplete Data|0|||
156912577|NCT00601458|566438516|FG000|Overall Study|Protocol Violation|3|||
156912578|NCT00601458|566438517|FG001|Overall Study|Protocol Violation|2|||
156912579|NCT00601458|566438518|FG002|Overall Study|Protocol Violation|1|||
156912580|NCT00601458|566438516|FG000|Overall Study|Early Termination|0|||
156912581|NCT00601458|566438517|FG001|Overall Study|Early Termination|1|||
156912582|NCT00601458|566438518|FG002|Overall Study|Early Termination|1|||
156912583|NCT00370032|566438519|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
156912584|NCT00370032|566438520|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
156912585|NCT00370032|566438519|FG000|Washout Period|Withdrawal by Subject|0|||
156912586|NCT00370032|566438520|FG001|Washout Period|Withdrawal by Subject|1|||
156912587|NCT00370032|566438519|FG000|Washout Period|Lost to Follow-up|0|||
156912588|NCT00370032|566438520|FG001|Washout Period|Lost to Follow-up|1|||
156912589|NCT00370032|566438519|FG000|Washout Period|Adverse Event|1|||
156912590|NCT00370032|566438520|FG001|Washout Period|Adverse Event|0|||
156912591|NCT00370032|566438519|FG000|Follow-up Period|Withdrawal by Subject|1|||
156912592|NCT00370032|566438520|FG001|Follow-up Period|Withdrawal by Subject|0|||
156912593|NCT00518986|566438521|FG000|Overall Study|Adverse Event|12|||
156912594|NCT00518986|566438522|FG001|Overall Study|Adverse Event|7|||
156912595|NCT00518986|566438521|FG000|Overall Study|Lack of Efficacy|0|||
156912596|NCT00518986|566438522|FG001|Overall Study|Lack of Efficacy|2|||
156912597|NCT00518986|566438521|FG000|Overall Study|Lost to Follow-up|3|||
156912598|NCT00518986|566438522|FG001|Overall Study|Lost to Follow-up|2|||
156912599|NCT00518986|566438521|FG000|Overall Study|Physician Decision|0|||
156912600|NCT00518986|566438522|FG001|Overall Study|Physician Decision|3|||
156912601|NCT00518986|566438521|FG000|Overall Study|Protocol Violation|5|||
156912602|NCT00518986|566438522|FG001|Overall Study|Protocol Violation|7|||
156912603|NCT00518986|566438521|FG000|Overall Study|Withdrawal by Subject|4|||
156912604|NCT00518986|566438522|FG001|Overall Study|Withdrawal by Subject|4|||
156912605|NCT00518986|566438521|FG000|Overall Study|Non-Specific|2|||
156912606|NCT00518986|566438522|FG001|Overall Study|Non-Specific|1|||
156912607|NCT00968513|566438523|FG000|Overall Study|Death|4|||
156912608|NCT00968513|566438524|FG001|Overall Study|Death|10|||
156912609|NCT00968513|566438525|FG002|Overall Study|Death|15|||
156912610|NCT01328431|566438526|FG000|Baseline|Protocol Violation|0|||
156912611|NCT01328431|566438527|FG001|Baseline|Protocol Violation|2|||
156912612|NCT01328431|566438526|FG000|1 Month (1M)|Lost to Follow-up|55|||
156912613|NCT01328431|566438527|FG001|1 Month (1M)|Lost to Follow-up|58|||
156912614|NCT01328431|566438526|FG000|3 Month (3M)|Death|2|||
156912615|NCT01328431|566438527|FG001|3 Month (3M)|Death|2|||
156912616|NCT01328431|566438526|FG000|3 Month (3M)|Lost to Follow-up|75|||
156912617|NCT01328431|566438527|FG001|3 Month (3M)|Lost to Follow-up|70|||
156912618|NCT01328431|566438526|FG000|12 Month (12M)|Death|2|||
156912619|NCT01328431|566438527|FG001|12 Month (12M)|Death|6|||
156912620|NCT01328431|566438526|FG000|12 Month (12M)|Lost to Follow-up|82|||
156912621|NCT01328431|566438527|FG001|12 Month (12M)|Lost to Follow-up|91|||
156912622|NCT05466682|566438531|FG000|Overall Study|Withdrawal by Subject|0|||
156912623|NCT05466682|566438532|FG001|Overall Study|Withdrawal by Subject|2|||
156912624|NCT05466682|566438531|FG000|Overall Study|Lost to Follow-up|2|||
156912625|NCT05466682|566438532|FG001|Overall Study|Lost to Follow-up|1|||
156912626|NCT00390468|566438537|FG000|Overall Study|Protocol Violation|2|||
156912627|NCT00390468|566438537|FG000|Overall Study|Lack of Efficacy|1|||
156912628|NCT03943147|566438538|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
156912629|NCT03943147|566438539|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
156912630|NCT03943147|566438538|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
156912631|NCT03943147|566438539|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
156912632|NCT03943147|566438538|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
156912633|NCT03943147|566438539|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
156912634|NCT03943147|566438538|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
156912635|NCT03943147|566438539|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
156912636|NCT03943147|566438538|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
156912637|NCT03943147|566438539|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
156912638|NCT03943147|566438538|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
156912639|NCT03943147|566438539|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
156912640|NCT02695329|566438542|FG000|Overall Study|Adverse Event|1|||
156912641|NCT02695329|566438543|FG001|Overall Study|Adverse Event|0|||
156912642|NCT02695329|566438542|FG000|Overall Study|Poor X-ray quality for measurement|4|||
156912643|NCT02695329|566438543|FG001|Overall Study|Poor X-ray quality for measurement|5|||
156912644|NCT01382212|566438544|FG000|Overall Study|Kidney transplant|1|||
156912645|NCT01382212|566438544|FG000|Overall Study|Withdrew consent|1|||
156912646|NCT00393029|566438545|FG000|Overall Study|Not treated|0|||
156912647|NCT00393029|566438546|FG001|Overall Study|Not treated|1|||
156912648|NCT00382252|566438547|FG000|Overall Study|Death|4|||
156912649|NCT00382252|566438547|FG000|Overall Study|Protocol Violation|8|||
156912650|NCT00382252|566438547|FG000|Overall Study|Not treated by RFA|1|||
156912651|NCT00039130|566438549|FG000|Overall Study|Adverse Event|11|||
157160153|NCT04804033|567329587|FG002|Period 2: OLE Phase|Other|0|||
157160154|NCT04804033|567329588|FG003|Period 2: OLE Phase|Other|0|||
157160155|NCT04804033|567329585|FG000|Period 2: OLE Phase|Physician Decision|1|||
157160156|NCT04804033|567329586|FG001|Period 2: OLE Phase|Physician Decision|1|||
157160157|NCT04804033|567329587|FG002|Period 2: OLE Phase|Physician Decision|0|||
157160158|NCT04804033|567329588|FG003|Period 2: OLE Phase|Physician Decision|0|||
157160159|NCT04804033|567329585|FG000|Period 2: OLE Phase|Pregnancy|0|||
157160160|NCT04804033|567329586|FG001|Period 2: OLE Phase|Pregnancy|0|||
157160161|NCT04804033|567329587|FG002|Period 2: OLE Phase|Pregnancy|2|||
157160162|NCT04804033|567329588|FG003|Period 2: OLE Phase|Pregnancy|0|||
157160163|NCT04804033|567329585|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
157160164|NCT04804033|567329586|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
157160165|NCT04804033|567329587|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
157160166|NCT04804033|567329588|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
157160167|NCT04804033|567329585|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
157160168|NCT04804033|567329586|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
157160169|NCT04804033|567329587|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
157160170|NCT04804033|567329588|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
157160171|NCT04804033|567329585|FG000|Period 2: OLE Phase|Not reported|0|||
157160172|NCT04804033|567329586|FG001|Period 2: OLE Phase|Not reported|2|||
157160173|NCT04804033|567329587|FG002|Period 2: OLE Phase|Not reported|0|||
157160174|NCT04804033|567329588|FG003|Period 2: OLE Phase|Not reported|0|||
157160175|NCT04804033|567329585|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
157160176|NCT04804033|567329586|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
157160177|NCT04804033|567329587|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
157160178|NCT04804033|567329588|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
157160179|NCT04804033|567329585|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
157160180|NCT04804033|567329586|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
157160181|NCT04804033|567329587|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
157160182|NCT04804033|567329588|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
157160183|NCT04804033|567329585|FG000|Period 3: Follow-up Phase|Other|0|||
157160184|NCT04804033|567329586|FG001|Period 3: Follow-up Phase|Other|1|||
157160185|NCT04804033|567329587|FG002|Period 3: Follow-up Phase|Other|2|||
157160186|NCT04804033|567329588|FG003|Period 3: Follow-up Phase|Other|1|||
157160187|NCT04804033|567329585|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
156912652|NCT00039130|566438549|FG000|Overall Study|Death|9|||
156912653|NCT00039130|566438549|FG000|Overall Study|Withdrawal by Subject|3|||
156912654|NCT00039130|566438549|FG000|Overall Study|Progression|2|||
156912655|NCT00039130|566438549|FG000|Overall Study|Subsequent treatment|2|||
156912656|NCT00039130|566438549|FG000|Overall Study|Physician Decision|3|||
156912657|NCT02612727|566438550|FG000|Overall Study|Parent request|4|||
156912658|NCT02612727|566438551|FG001|Overall Study|Parent request|1|||
156912659|NCT02612727|566438550|FG000|Overall Study|Needed treatment incompatible with PT|1|||
156912660|NCT02612727|566438551|FG001|Overall Study|Needed treatment incompatible with PT|1|||
156912661|NCT02612727|566438550|FG000|Overall Study|Direct hyperbilirubinemia|0|||
156912662|NCT02612727|566438551|FG001|Overall Study|Direct hyperbilirubinemia|2|||
156912663|NCT01063868|566438552|FG000|Overall Study|Adverse Event|9|||
156912664|NCT01063868|566438553|FG001|Overall Study|Adverse Event|7|||
156912665|NCT01063868|566438552|FG000|Overall Study|Withdrawal by Subject|3|||
156912666|NCT01063868|566438553|FG001|Overall Study|Withdrawal by Subject|1|||
156912667|NCT01063868|566438552|FG000|Overall Study|Study Terminated By Sponsor|23|||
156912668|NCT01063868|566438553|FG001|Overall Study|Study Terminated By Sponsor|4|||
156912669|NCT04518306|566438559|FG000|Double-Blind Period|Run in failure|0|||
156912670|NCT04518306|566438560|FG001|Double-Blind Period|Run in failure|0|||
156912671|NCT04518306|566438561|FG002|Double-Blind Period|Run in failure|1|||
156912672|NCT04518306|566438559|FG000|Double-Blind Period|Adverse Event|0|||
156912673|NCT04518306|566438560|FG001|Double-Blind Period|Adverse Event|2|||
156912674|NCT04518306|566438561|FG002|Double-Blind Period|Adverse Event|2|||
156912675|NCT04518306|566438559|FG000|Double-Blind Period|Lost to Follow-up|1|||
156912676|NCT04518306|566438560|FG001|Double-Blind Period|Lost to Follow-up|2|||
157160188|NCT04804033|567329586|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
157160189|NCT04804033|567329587|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
157160190|NCT04804033|567329588|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
156912677|NCT04518306|566438561|FG002|Double-Blind Period|Lost to Follow-up|2|||
157160191|NCT04804033|567329585|FG000|Period 3: Follow-up Phase|Not reported|18|||
157160192|NCT04804033|567329586|FG001|Period 3: Follow-up Phase|Not reported|15|||
157160193|NCT04804033|567329587|FG002|Period 3: Follow-up Phase|Not reported|1|||
157160194|NCT04804033|567329588|FG003|Period 3: Follow-up Phase|Not reported|4|||
157160195|NCT02496585|567329591|FG000|Overall Study|Death|3|||
157160196|NCT02496585|567329592|FG001|Overall Study|Death|0|||
157160197|NCT02496585|567329591|FG000|Overall Study|Lost to Follow-up|2|||
156912678|NCT04518306|566438559|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
156912679|NCT04518306|566438560|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
156912680|NCT04518306|566438561|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
156912681|NCT04518306|566438559|FG000|Double-Blind Period|Other|0|||
157160198|NCT02496585|567329592|FG001|Overall Study|Lost to Follow-up|0|||
157160199|NCT02496585|567329591|FG000|Overall Study|Withdrawal by Subject|1|||
157160200|NCT02496585|567329592|FG001|Overall Study|Withdrawal by Subject|2|||
157160201|NCT02496585|567329591|FG000|Overall Study|Progression of Malignancy|4|||
157160202|NCT02496585|567329592|FG001|Overall Study|Progression of Malignancy|1|||
157160203|NCT01276457|567329593|FG000|Core Study|Adverse Event|6|||
157160204|NCT01276457|567329594|FG001|Core Study|Adverse Event|3|||
157160205|NCT01276457|567329593|FG000|Core Study|Lost to Follow-up|1|||
157160206|NCT01276457|567329594|FG001|Core Study|Lost to Follow-up|2|||
157160207|NCT01276457|567329593|FG000|Core Study|Administrative problems|1|||
157160208|NCT01276457|567329594|FG001|Core Study|Administrative problems|1|||
157160209|NCT01276457|567329593|FG000|Core Study|Death|2|||
157160210|NCT01276457|567329594|FG001|Core Study|Death|2|||
157160211|NCT01276457|567329593|FG000|Core Study|Lack of Efficacy|3|||
157160212|NCT01276457|567329594|FG001|Core Study|Lack of Efficacy|12|||
157160213|NCT01276457|567329593|FG000|Extension Study|Lost to Follow-up|3|||
157160214|NCT01276457|567329594|FG001|Extension Study|Lost to Follow-up|0|||
157160215|NCT01276457|567329593|FG000|Extension Study|Death|0|||
157160216|NCT01276457|567329594|FG001|Extension Study|Death|1|||
157160217|NCT01276457|567329593|FG000|Extension Study|Lack of Efficacy|3|||
157160218|NCT01276457|567329594|FG001|Extension Study|Lack of Efficacy|1|||
157160219|NCT04360187|567329595|FG000|Double-Blind Treatment|Adverse Event|9|||
156912682|NCT04518306|566438560|FG001|Double-Blind Period|Other|2|||
156912683|NCT04518306|566438561|FG002|Double-Blind Period|Other|0|||
156912684|NCT04518306|566438559|FG000|Double-Blind Period|Missing|0|||
156912685|NCT04518306|566438560|FG001|Double-Blind Period|Missing|1|||
156912686|NCT04518306|566438561|FG002|Double-Blind Period|Missing|0|||
156912687|NCT03268954|566438562|FG000|Overall Study|Withdrawal by Subject|27|||
156912688|NCT03268954|566438563|FG001|Overall Study|Withdrawal by Subject|17|||
156912689|NCT03268954|566438562|FG000|Overall Study|Lost to Follow-up|2|||
156912690|NCT03268954|566438563|FG001|Overall Study|Lost to Follow-up|3|||
156912691|NCT03268954|566438562|FG000|Overall Study|Reason Not Specified|3|||
156912692|NCT03268954|566438563|FG001|Overall Study|Reason Not Specified|8|||
156912693|NCT05358444|566438566|FG000|Overall Study|Withdrawal by Subject|0|||
156912694|NCT05358444|566438567|FG001|Overall Study|Withdrawal by Subject|1|||
156912695|NCT05358444|566438566|FG000|Overall Study|Lost to Follow-up|0|||
156912696|NCT05358444|566438567|FG001|Overall Study|Lost to Follow-up|3|||
156912697|NCT02801331|566438568|FG000|Overall Study|Transferred to another hospital|8|||
156912698|NCT02801331|566438569|FG001|Overall Study|Transferred to another hospital|7|||
156912699|NCT02801331|566438568|FG000|Overall Study|Withdrawal by Subject|0|||
156912700|NCT02801331|566438569|FG001|Overall Study|Withdrawal by Subject|4|||
156912701|NCT02801331|566438568|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
156912702|NCT02801331|566438569|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
156912703|NCT02443987|566438570|FG000|Overall Study|Bladder injury|1|||
156912704|NCT02443987|566438571|FG001|Overall Study|Bladder injury|1|||
156912705|NCT02443987|566438570|FG000|Overall Study|Other|0|||
156912706|NCT02443987|566438571|FG001|Overall Study|Other|1|||
156912707|NCT00844831|566440274|FG000|Overall Study|Withdrawal by Subject|4|||
156912708|NCT00844831|566440274|FG000|Overall Study|Adverse Event|1|||
156912709|NCT00844831|566440274|FG000|Overall Study|Physician Decision|1|||
156912710|NCT03156543|566440276|FG000|Overall Study|Withdrawal by Subject|1|||
156912711|NCT03156543|566440277|FG001|Overall Study|Withdrawal by Subject|0|||
156912712|NCT00638378|566440278|FG000|Overall Study|Death|2|||
156912713|NCT00638378|566440278|FG000|Overall Study|Adverse Event|1|||
156912714|NCT00638378|566440278|FG000|Overall Study|Disease progression|15|||
156912715|NCT00638378|566440278|FG000|Overall Study|Physician Decision|4|||
156912716|NCT03291808|566440279|FG000|Overall Study|Lost to Follow-up|6|||
156912717|NCT03291808|566440279|FG000|Overall Study|Research burden|4|||
157160220|NCT04360187|567329596|FG001|Double-Blind Treatment|Adverse Event|11|||
157160221|NCT04360187|567329595|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
157160222|NCT04360187|567329596|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
157160223|NCT04360187|567329595|FG000|Double-Blind Treatment|Physician Decision|1|||
156912718|NCT02601469|566440280|FG000|Overall Study|Enrolled in Error|1|||
156912719|NCT02601469|566440281|FG001|Overall Study|Enrolled in Error|0|||
156912720|NCT02161731|566440282|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
157160224|NCT04360187|567329596|FG001|Double-Blind Treatment|Physician Decision|0|||
157160225|NCT04360187|567329595|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
157160226|NCT04360187|567329596|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
157160227|NCT04360187|567329595|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
156912721|NCT02161731|566440283|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
156912722|NCT02161731|566440282|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
156912723|NCT02161731|566440283|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
156912724|NCT02468414|566440291|FG000|Overall Study|Early Study Termination by Sponsor|1|||
156912725|NCT02468414|566440292|FG001|Overall Study|Early Study Termination by Sponsor|0|||
157160228|NCT04360187|567329596|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
157160229|NCT04360187|567329595|FG000|Follow-Up|Lost to Follow-up|1|||
157160230|NCT04360187|567329596|FG001|Follow-Up|Lost to Follow-up|0|||
157160231|NCT02203838|567329597|FG000|Overall Study|Lack of Efficacy|7|||
157160232|NCT02203838|567329598|FG001|Overall Study|Lack of Efficacy|0|||
157160233|NCT02203838|567329599|FG002|Overall Study|Lack of Efficacy|1|||
157160234|NCT02203838|567329600|FG003|Overall Study|Lack of Efficacy|1|||
157160235|NCT02203838|567329597|FG000|Overall Study|Adverse Event|46|||
157160236|NCT02203838|567329598|FG001|Overall Study|Adverse Event|6|||
157160237|NCT02203838|567329599|FG002|Overall Study|Adverse Event|3|||
157160238|NCT02203838|567329600|FG003|Overall Study|Adverse Event|2|||
157160239|NCT02203838|567329597|FG000|Overall Study|Lost to Follow-up|39|||
157160240|NCT02203838|567329598|FG001|Overall Study|Lost to Follow-up|3|||
157160241|NCT02203838|567329599|FG002|Overall Study|Lost to Follow-up|2|||
157160242|NCT02203838|567329600|FG003|Overall Study|Lost to Follow-up|1|||
157160243|NCT02203838|567329597|FG000|Overall Study|Protocol Violation|7|||
156912726|NCT02468414|566440291|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
156912727|NCT02468414|566440292|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
156912728|NCT02468414|566440291|FG000|Overall Study|Screen Failure|1|||
156912729|NCT02468414|566440292|FG001|Overall Study|Screen Failure|0|||
157225591|NCT00337571|567571474|FG000|Overall Study|Lost to Follow-up|3|||
156912730|NCT02151591|566440294|FG000|Overall Study|Lost to Follow-up|6|||
156912731|NCT02151591|566440295|FG001|Overall Study|Lost to Follow-up|3|||
156912732|NCT02155608|566440298|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
156912733|NCT02155608|566440299|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
156912734|NCT02155608|566440298|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
157225592|NCT00337571|567571475|FG001|Overall Study|Lost to Follow-up|1|||
157225593|NCT00337571|567571476|FG002|Overall Study|Lost to Follow-up|0|||
157225594|NCT00337571|567571477|FG003|Overall Study|Lost to Follow-up|1|||
157225595|NCT00337571|567571474|FG000|Overall Study|Poor/noncompliance|1|||
157225596|NCT00337571|567571475|FG001|Overall Study|Poor/noncompliance|1|||
157225597|NCT00337571|567571476|FG002|Overall Study|Poor/noncompliance|1|||
157225598|NCT00337571|567571477|FG003|Overall Study|Poor/noncompliance|1|||
157225599|NCT00337571|567571474|FG000|Overall Study|No longer met study criteria|1|||
157225600|NCT00337571|567571475|FG001|Overall Study|No longer met study criteria|0|||
156912735|NCT02155608|566440299|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
156912736|NCT03555591|566440300|FG000|Overall Study|Protocol Violation|77|||
156912737|NCT01532414|566440301|FG000|Overall Study|Lost to Follow-up|3|||
156912738|NCT01532414|566440302|FG001|Overall Study|Lost to Follow-up|0|||
156912739|NCT01532414|566440303|FG002|Overall Study|Lost to Follow-up|1|||
156912740|NCT01532414|566440301|FG000|Overall Study|Withdrawal by Subject|3|||
156912741|NCT01532414|566440302|FG001|Overall Study|Withdrawal by Subject|0|||
156912742|NCT01532414|566440303|FG002|Overall Study|Withdrawal by Subject|0|||
156912743|NCT01532414|566440301|FG000|Overall Study|No V6 semen sample|0|||
156912744|NCT01532414|566440302|FG001|Overall Study|No V6 semen sample|1|||
156912745|NCT01532414|566440303|FG002|Overall Study|No V6 semen sample|0|||
156912746|NCT01532414|566440301|FG000|Overall Study|Adverse Event|0|||
156912747|NCT01532414|566440302|FG001|Overall Study|Adverse Event|1|||
156912748|NCT01532414|566440303|FG002|Overall Study|Adverse Event|1|||
156912749|NCT01532414|566440301|FG000|Overall Study|Unable to complete 24 hour PK|0|||
156912750|NCT01532414|566440302|FG001|Overall Study|Unable to complete 24 hour PK|0|||
156912751|NCT01532414|566440303|FG002|Overall Study|Unable to complete 24 hour PK|1|||
156912752|NCT01532414|566440301|FG000|Overall Study|Withdrawn by sponsor|1|||
156912753|NCT01532414|566440302|FG001|Overall Study|Withdrawn by sponsor|0|||
156912754|NCT01532414|566440303|FG002|Overall Study|Withdrawn by sponsor|0|||
156912755|NCT02380677|566440313|FG000|Overall Study|Adverse Event|0|||
156912756|NCT02380677|566440314|FG001|Overall Study|Adverse Event|0|||
156912757|NCT02380677|566440315|FG002|Overall Study|Adverse Event|0|||
156912758|NCT02380677|566440316|FG003|Overall Study|Adverse Event|1|||
156912759|NCT02380677|566440317|FG004|Overall Study|Adverse Event|1|||
156912760|NCT02380677|566440318|FG005|Overall Study|Adverse Event|4|||
156912761|NCT02380677|566440319|FG006|Overall Study|Adverse Event|2|||
156912762|NCT02380677|566440320|FG007|Overall Study|Adverse Event|2|||
156912763|NCT02380677|566440321|FG008|Overall Study|Adverse Event|2|||
156912764|NCT02380677|566440322|FG009|Overall Study|Adverse Event|1|||
156912765|NCT02380677|566440323|FG010|Overall Study|Adverse Event|2|||
156912766|NCT02380677|566440324|FG011|Overall Study|Adverse Event|1|||
156912767|NCT02380677|566440313|FG000|Overall Study|Physician Decision|1|||
156912768|NCT02380677|566440314|FG001|Overall Study|Physician Decision|0|||
156912769|NCT02380677|566440315|FG002|Overall Study|Physician Decision|1|||
156912770|NCT02380677|566440316|FG003|Overall Study|Physician Decision|1|||
156912771|NCT02380677|566440317|FG004|Overall Study|Physician Decision|0|||
156912772|NCT02380677|566440318|FG005|Overall Study|Physician Decision|0|||
156912773|NCT02380677|566440319|FG006|Overall Study|Physician Decision|0|||
156912774|NCT02380677|566440320|FG007|Overall Study|Physician Decision|0|||
156912775|NCT02380677|566440321|FG008|Overall Study|Physician Decision|0|||
156912776|NCT02380677|566440322|FG009|Overall Study|Physician Decision|0|||
156912777|NCT02380677|566440323|FG010|Overall Study|Physician Decision|0|||
157160244|NCT02203838|567329598|FG001|Overall Study|Protocol Violation|3|||
157160245|NCT02203838|567329599|FG002|Overall Study|Protocol Violation|0|||
157160246|NCT02203838|567329600|FG003|Overall Study|Protocol Violation|0|||
157225601|NCT00337571|567571476|FG002|Overall Study|No longer met study criteria|0|||
156912778|NCT02380677|566440324|FG011|Overall Study|Physician Decision|0|||
156912779|NCT02380677|566440313|FG000|Overall Study|Lack of Efficacy|0|||
156912780|NCT02380677|566440314|FG001|Overall Study|Lack of Efficacy|1|||
156912781|NCT02380677|566440315|FG002|Overall Study|Lack of Efficacy|2|||
156912782|NCT02380677|566440316|FG003|Overall Study|Lack of Efficacy|0|||
156912783|NCT02380677|566440317|FG004|Overall Study|Lack of Efficacy|4|||
156912784|NCT02380677|566440318|FG005|Overall Study|Lack of Efficacy|1|||
156912785|NCT02380677|566440319|FG006|Overall Study|Lack of Efficacy|1|||
156912786|NCT02380677|566440320|FG007|Overall Study|Lack of Efficacy|2|||
156912787|NCT02380677|566440321|FG008|Overall Study|Lack of Efficacy|2|||
156912788|NCT02380677|566440322|FG009|Overall Study|Lack of Efficacy|0|||
156912789|NCT02380677|566440323|FG010|Overall Study|Lack of Efficacy|2|||
156912790|NCT02380677|566440324|FG011|Overall Study|Lack of Efficacy|1|||
156912791|NCT02380677|566440313|FG000|Overall Study|Withdrawal by Subject|0|||
156912792|NCT02380677|566440314|FG001|Overall Study|Withdrawal by Subject|0|||
156912793|NCT02380677|566440315|FG002|Overall Study|Withdrawal by Subject|0|||
156912794|NCT02380677|566440316|FG003|Overall Study|Withdrawal by Subject|0|||
156912795|NCT02380677|566440317|FG004|Overall Study|Withdrawal by Subject|0|||
156912796|NCT02380677|566440318|FG005|Overall Study|Withdrawal by Subject|0|||
156912797|NCT02380677|566440319|FG006|Overall Study|Withdrawal by Subject|0|||
156912798|NCT02380677|566440320|FG007|Overall Study|Withdrawal by Subject|0|||
156912799|NCT02380677|566440321|FG008|Overall Study|Withdrawal by Subject|0|||
156912800|NCT02380677|566440322|FG009|Overall Study|Withdrawal by Subject|1|||
156912801|NCT02380677|566440323|FG010|Overall Study|Withdrawal by Subject|0|||
156912802|NCT02380677|566440324|FG011|Overall Study|Withdrawal by Subject|3|||
156912803|NCT02380677|566440313|FG000|Overall Study|Other|0|||
156912804|NCT02380677|566440314|FG001|Overall Study|Other|0|||
156912805|NCT02380677|566440315|FG002|Overall Study|Other|0|||
156912806|NCT02380677|566440316|FG003|Overall Study|Other|1|||
156912807|NCT02380677|566440317|FG004|Overall Study|Other|1|||
156912808|NCT02380677|566440318|FG005|Overall Study|Other|1|||
156912809|NCT02380677|566440319|FG006|Overall Study|Other|0|||
156912810|NCT02380677|566440320|FG007|Overall Study|Other|0|||
156912811|NCT02380677|566440321|FG008|Overall Study|Other|0|||
156912812|NCT02380677|566440322|FG009|Overall Study|Other|0|||
156912813|NCT02380677|566440323|FG010|Overall Study|Other|0|||
156912814|NCT02380677|566440324|FG011|Overall Study|Other|0|||
156912815|NCT03217175|566440328|FG000|Overall Study|Physician Decision|4|||
156912816|NCT03217175|566440329|FG001|Overall Study|Physician Decision|1|||
156912817|NCT05526716|566440331|FG000|Overall Study|Death|1|||
156912818|NCT05526716|566440332|FG001|Overall Study|Death|2|||
156912819|NCT05526716|566440331|FG000|Overall Study|Lost to Follow-up|17|||
156912820|NCT05526716|566440332|FG001|Overall Study|Lost to Follow-up|15|||
156912821|NCT05526716|566440331|FG000|Overall Study|Physician Decision|0|||
156912822|NCT05526716|566440332|FG001|Overall Study|Physician Decision|1|||
156912823|NCT05526716|566440331|FG000|Overall Study|Randomized by mistake without study treatment|0|||
156912824|NCT05526716|566440332|FG001|Overall Study|Randomized by mistake without study treatment|1|||
156912825|NCT05526716|566440331|FG000|Overall Study|Withdrawal by Subject|12|||
156912826|NCT05526716|566440332|FG001|Overall Study|Withdrawal by Subject|12|||
156912827|NCT05526716|566440331|FG000|Overall Study|Not reported|0|||
156912828|NCT05526716|566440332|FG001|Overall Study|Not reported|2|||
156912829|NCT04932096|566440335|FG000|Overall Study|Withdrawal by Subject|1|||
156912830|NCT04932096|566440336|FG001|Overall Study|Withdrawal by Subject|1|||
156912831|NCT04932096|566440335|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
156912832|NCT04932096|566440336|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
156912833|NCT00429273|566440337|FG000|Overall Study|Lost to Follow-up|1|||
156912834|NCT00429273|566440338|FG001|Overall Study|Lost to Follow-up|2|||
156912835|NCT00429273|566440339|FG002|Overall Study|Lost to Follow-up|2|||
156912836|NCT00429273|566440337|FG000|Overall Study|Physician Decision|6|||
156912837|NCT00429273|566440338|FG001|Overall Study|Physician Decision|5|||
156912838|NCT00429273|566440339|FG002|Overall Study|Physician Decision|5|||
156912839|NCT00429273|566440337|FG000|Overall Study|Adverse Event|1|||
156912840|NCT00429273|566440338|FG001|Overall Study|Adverse Event|1|||
156912841|NCT00429273|566440339|FG002|Overall Study|Adverse Event|2|||
156912842|NCT01438957|566440340|FG000|Overall Study|Physician Decision|1|||
156912843|NCT01438957|566440341|FG001|Overall Study|Physician Decision|1|||
156912844|NCT01438957|566440342|FG002|Overall Study|Physician Decision|0|||
156912845|NCT01438957|566440343|FG003|Overall Study|Physician Decision|1|||
156912846|NCT01438957|566440344|FG004|Overall Study|Physician Decision|0|||
156912847|NCT00617123|566440345|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
156912848|NCT00617123|566440346|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
156912849|NCT00617123|566440345|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
156912850|NCT00617123|566440346|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
156912851|NCT00617123|566440345|FG000|Referral Screening Period|Adverse Event|0|||
156912852|NCT00617123|566440346|FG001|Referral Screening Period|Adverse Event|1|||
156912853|NCT00617123|566440345|FG000|Study Treatment Period|Withdrawal by Subject|8|||
156912854|NCT00617123|566440346|FG001|Study Treatment Period|Withdrawal by Subject|12|||
156912855|NCT00617123|566440345|FG000|Study Treatment Period|Adverse Event|7|||
156912856|NCT00617123|566440346|FG001|Study Treatment Period|Adverse Event|3|||
156860109|NCT03448406|566244671|FG000|Overall Study|Withdrawal by Subject|1|||
156860110|NCT03448406|566244672|FG001|Overall Study|Withdrawal by Subject|2|||
156860111|NCT03448406|566244671|FG000|Overall Study|Protocol Violation|1|||
156860112|NCT03448406|566244672|FG001|Overall Study|Protocol Violation|0|||
156860113|NCT03448406|566244671|FG000|Overall Study|Adverse Event|8|||
156860114|NCT03448406|566244672|FG001|Overall Study|Adverse Event|9|||
156860115|NCT04602390|566244673|FG000|Overall Study|Withdrawal by Subject|0|||
156860116|NCT04602390|566244674|FG001|Overall Study|Withdrawal by Subject|0|||
156860117|NCT04602390|566244675|FG002|Overall Study|Withdrawal by Subject|0|||
156860118|NCT04602390|566244676|FG003|Overall Study|Withdrawal by Subject|0|||
156860119|NCT04602390|566244677|FG004|Overall Study|Withdrawal by Subject|1|||
156860120|NCT04602390|566244678|FG005|Overall Study|Withdrawal by Subject|0|||
156860121|NCT04602390|566244673|FG000|Overall Study|Adverse Event|0|||
156860122|NCT04602390|566244674|FG001|Overall Study|Adverse Event|0|||
156860123|NCT04602390|566244675|FG002|Overall Study|Adverse Event|0|||
156860124|NCT04602390|566244676|FG003|Overall Study|Adverse Event|0|||
156860125|NCT04602390|566244677|FG004|Overall Study|Adverse Event|0|||
156860126|NCT04602390|566244678|FG005|Overall Study|Adverse Event|1|||
156860127|NCT01176032|566244679|FG000|Overall Study|Adverse Event|1|||
156860128|NCT01176032|566244680|FG001|Overall Study|Adverse Event|0|||
156860129|NCT01176032|566244679|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156860130|NCT01176032|566244680|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156860131|NCT01176032|566244679|FG000|Overall Study|Protocol Violation|1|||
156860132|NCT01176032|566244680|FG001|Overall Study|Protocol Violation|0|||
156860133|NCT01176032|566244679|FG000|Overall Study|Informed consent withdrawn|3|||
156860134|NCT01176032|566244680|FG001|Overall Study|Informed consent withdrawn|0|||
156860135|NCT01176032|566244679|FG000|Overall Study|Other|1|||
156860136|NCT01176032|566244680|FG001|Overall Study|Other|0|||
156860137|NCT00659061|566244682|FG000|Overall Study|Migration due to political unrest|21|||
156860138|NCT00659061|566244683|FG001|Overall Study|Migration due to political unrest|15|||
156860139|NCT01277744|566244692|FG000|Overall Study|Physician Decision|2|||
156860140|NCT02358473|566244700|FG000|Overall Study|Disease Progession|6|||
156860141|NCT02358473|566244700|FG000|Overall Study|Adverse Event|3|||
156860142|NCT02358473|566244700|FG000|Overall Study|Withdrawal by Subject|2|||
156860143|NCT02358473|566244700|FG000|Overall Study|Physician Decision|2|||
156860144|NCT04038359|566244718|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
156860145|NCT04038359|566244719|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
156860146|NCT04038359|566244718|FG000|Overall Study|Death|8|||
156860147|NCT04038359|566244719|FG001|Overall Study|Death|7|||
156860148|NCT04038359|566244718|FG000|Overall Study|Lost to Follow-up|3|||
156860149|NCT04038359|566244719|FG001|Overall Study|Lost to Follow-up|0|||
156860150|NCT04038359|566244718|FG000|Overall Study|Participant Moved|1|||
156860151|NCT04038359|566244719|FG001|Overall Study|Participant Moved|0|||
156860152|NCT04038359|566244718|FG000|Overall Study|Withdrawal by Subject|4|||
156860153|NCT04038359|566244719|FG001|Overall Study|Withdrawal by Subject|3|||
156860154|NCT04038359|566244718|FG000|Overall Study|Physician Decision|3|||
156860155|NCT04038359|566244719|FG001|Overall Study|Physician Decision|2|||
156860156|NCT04038359|566244718|FG000|Overall Study|Adverse Event|0|||
156860157|NCT04038359|566244719|FG001|Overall Study|Adverse Event|2|||
156860158|NCT04038359|566244718|FG000|Overall Study|Progressive Disease|0|||
156860159|NCT04038359|566244719|FG001|Overall Study|Progressive Disease|1|||
156860160|NCT02004236|566244720|FG000|Overall Study|Lack of Efficacy|0|||
156860161|NCT02004236|566244721|FG001|Overall Study|Lack of Efficacy|0|||
156860162|NCT02004236|566244722|FG002|Overall Study|Lack of Efficacy|16|||
157160247|NCT02203838|567329597|FG000|Overall Study|Withdrawal by Subject|83|||
156860163|NCT01476722|566244724|FG000|Overall Study|Adverse Event|1|||
156860164|NCT00625131|566244730|FG000|Overall Study|Lost to Follow-up|3|||
156860165|NCT00625131|566244731|FG001|Overall Study|Lost to Follow-up|2|||
156860166|NCT00625131|566244732|FG002|Overall Study|Lost to Follow-up|0|||
156860167|NCT00625131|566244730|FG000|Overall Study|Withdrawal by Subject|1|||
156860168|NCT00625131|566244731|FG001|Overall Study|Withdrawal by Subject|0|||
156860169|NCT00625131|566244732|FG002|Overall Study|Withdrawal by Subject|5|||
156860170|NCT00918281|566244736|FG000|Overall Study|Physician Decision|29|||
156860171|NCT02978417|566244739|FG000|Overall Study|Lost to Follow-up|2|||
156912857|NCT00617123|566440345|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
157160248|NCT02203838|567329598|FG001|Overall Study|Withdrawal by Subject|10|||
157160249|NCT02203838|567329599|FG002|Overall Study|Withdrawal by Subject|8|||
156860172|NCT02978417|566244740|FG001|Overall Study|Lost to Follow-up|2|||
156860173|NCT02675907|566244743|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
156860174|NCT02675907|566244744|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
156860175|NCT02675907|566244743|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
157160250|NCT02203838|567329600|FG003|Overall Study|Withdrawal by Subject|11|||
156860176|NCT02675907|566244744|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
156860177|NCT02675907|566244743|FG000|Study Overall|Lack of Efficacy|1|||
156860178|NCT02675907|566244744|FG001|Study Overall|Lack of Efficacy|0|||
156860179|NCT02675907|566244743|FG000|Study Overall|Withdrawal by Subject|2|||
156860180|NCT02675907|566244744|FG001|Study Overall|Withdrawal by Subject|2|||
156860181|NCT02675907|566244743|FG000|Study Overall|Lost to Follow-up|0|||
156860182|NCT02675907|566244744|FG001|Study Overall|Lost to Follow-up|2|||
156860183|NCT03416868|566244748|FG000|Overall Study|Withdrawal by Subject|2|||
156860184|NCT03416868|566244748|FG000|Overall Study|Lost to Follow-up|1|||
156860185|NCT03624881|566244749|FG000|Overall Study|Screen Failure|14|||
156860186|NCT03624881|566244750|FG001|Overall Study|Screen Failure|0|||
156860187|NCT03624881|566244749|FG000|Overall Study|No Catheter Inserted|6|||
156860188|NCT03624881|566244750|FG001|Overall Study|No Catheter Inserted|1|||
156860189|NCT03624881|566244749|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
156860190|NCT03624881|566244750|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
156860191|NCT03624881|566244749|FG000|Overall Study|Death|2|||
156860192|NCT03624881|566244750|FG001|Overall Study|Death|0|||
156860193|NCT03624881|566244749|FG000|Overall Study|Lost to Follow-up|10|||
156860194|NCT03624881|566244750|FG001|Overall Study|Lost to Follow-up|4|||
156860195|NCT03624881|566244749|FG000|Overall Study|Withdrawal by Subject|12|||
156860196|NCT03624881|566244750|FG001|Overall Study|Withdrawal by Subject|1|||
156860197|NCT00168844|566244751|FG000|Overall Study|Adverse Event|31|||
156860198|NCT00168844|566244752|FG001|Overall Study|Adverse Event|32|||
156860199|NCT00168844|566244753|FG002|Overall Study|Adverse Event|48|||
156860200|NCT00168844|566244751|FG000|Overall Study|Lost to Follow-up|4|||
156860201|NCT00168844|566244752|FG001|Overall Study|Lost to Follow-up|5|||
156860202|NCT00168844|566244753|FG002|Overall Study|Lost to Follow-up|11|||
156860203|NCT00168844|566244751|FG000|Overall Study|Withdrawal by Subject|12|||
156860204|NCT00168844|566244752|FG001|Overall Study|Withdrawal by Subject|9|||
156860205|NCT00168844|566244753|FG002|Overall Study|Withdrawal by Subject|19|||
156860206|NCT00168844|566244751|FG000|Overall Study|Protocol Violation|2|||
156860207|NCT00168844|566244752|FG001|Overall Study|Protocol Violation|2|||
156860208|NCT00168844|566244753|FG002|Overall Study|Protocol Violation|4|||
156860209|NCT00168844|566244751|FG000|Overall Study|Other|6|||
156912858|NCT00617123|566440346|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
156912859|NCT00617123|566440345|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
156912860|NCT00617123|566440346|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
156912861|NCT00133952|566440348|FG000|Overall Study|Adverse Event|1|||
156912862|NCT00133952|566440349|FG001|Overall Study|Adverse Event|2|||
156912863|NCT00133952|566440348|FG000|Overall Study|Death|3|||
156912864|NCT00133952|566440349|FG001|Overall Study|Death|2|||
156912865|NCT00133952|566440348|FG000|Overall Study|Lost to Follow-up|9|||
156912866|NCT00133952|566440349|FG001|Overall Study|Lost to Follow-up|14|||
156912867|NCT00133952|566440348|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
156912868|NCT00133952|566440349|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
156912869|NCT00133952|566440348|FG000|Overall Study|Protocol Violation|1|||
156912870|NCT00133952|566440349|FG001|Overall Study|Protocol Violation|1|||
156912871|NCT00133952|566440348|FG000|Overall Study|Withdrawal by Subject|20|||
156912872|NCT00133952|566440349|FG001|Overall Study|Withdrawal by Subject|4|||
156912873|NCT00133952|566440348|FG000|Overall Study|Physician Decision|4|||
156912874|NCT00133952|566440349|FG001|Overall Study|Physician Decision|3|||
156912875|NCT00133952|566440348|FG000|Overall Study|Sponsor Decision|0|||
156912876|NCT00133952|566440349|FG001|Overall Study|Sponsor Decision|1|||
156912877|NCT02170298|566440356|FG000|Overall Study|Withdrawal by Subject|0|||
157027376|NCT03656510|566856106|FG001|Overall Study|Withdrawal by Subject|1|||
156860210|NCT00168844|566244752|FG001|Overall Study|Other|7|||
156860211|NCT00168844|566244753|FG002|Overall Study|Other|9|||
156860212|NCT00112736|566244758|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
156860213|NCT00112736|566244759|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
156860214|NCT00004563|566244767|FG000|Overall Study|Withdrawal by Subject|20|||
156860215|NCT00004563|566244768|FG001|Overall Study|Withdrawal by Subject|16|||
156860216|NCT00004563|566244767|FG000|Overall Study|Lack of Efficacy|3|||
156860217|NCT00004563|566244768|FG001|Overall Study|Lack of Efficacy|5|||
156860218|NCT00004563|566244767|FG000|Overall Study|Death|2|||
156860219|NCT00004563|566244768|FG001|Overall Study|Death|3|||
156860220|NCT00849940|566244776|FG000|Overall Study|Physician Decision|4|||
156860221|NCT04258423|566244777|FG000|Overall Study|Study Closure|2|||
156860222|NCT04258423|566244778|FG001|Overall Study|Study Closure|2|||
156860223|NCT02994108|566246678|FG000|Intervention Messages|Withdrawal by Subject|2|||
156860224|NCT02994108|566246679|FG001|Intervention Messages|Withdrawal by Subject|0|||
156860225|NCT02994108|566246678|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
157027377|NCT03656510|566856107|FG002|Overall Study|Withdrawal by Subject|0|||
157027378|NCT03656510|566856108|FG003|Overall Study|Withdrawal by Subject|1|||
156860226|NCT02994108|566246679|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
156860227|NCT02994108|566246678|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
156860228|NCT02994108|566246679|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
156860229|NCT02994108|566246678|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
156860230|NCT02994108|566246679|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
156860231|NCT00089297|566246680|FG000|Overall Study|Adverse Event|9|||
156860232|NCT00089297|566246680|FG000|Overall Study|Death|1|||
156912878|NCT02170298|566440357|FG001|Overall Study|Withdrawal by Subject|1|||
156860233|NCT00089297|566246680|FG000|Overall Study|Withdrawal by Subject|12|||
156860234|NCT00089297|566246680|FG000|Overall Study|Disease progression|2|||
156860235|NCT00089297|566246680|FG000|Overall Study|Ineligible|11|||
156860236|NCT00089297|566246680|FG000|Overall Study|Secondary malignancy|1|||
156860237|NCT00089297|566246680|FG000|Overall Study|IRB approval not ready|1|||
156860238|NCT00089297|566246680|FG000|Overall Study|Non-compliance|1|||
156860239|NCT00904969|566246681|FG000|Overall Study|Lost to Follow-up|4|||
156860240|NCT00904969|566246681|FG000|Overall Study|Withdrawal by Subject|3|||
156860241|NCT00904969|566246681|FG000|Overall Study|Additional Treatments|11|||
156860242|NCT00904969|566246681|FG000|Overall Study|Case Aborted; Subject Exited|1|||
156860243|NCT01097668|566246682|FG000|Overall Study|Withdrawal by Subject|1|||
156860244|NCT01097668|566246683|FG001|Overall Study|Withdrawal by Subject|2|||
156860245|NCT01097668|566246682|FG000|Overall Study|Lost to Follow-up|1|||
156860246|NCT01097668|566246683|FG001|Overall Study|Lost to Follow-up|0|||
156860247|NCT00385671|566246684|FG000|Overall Study|Adverse Event|14|||
156860248|NCT00385671|566246685|FG001|Overall Study|Adverse Event|27|||
156860249|NCT00385671|566246686|FG002|Overall Study|Adverse Event|18|||
156860250|NCT00385671|566246684|FG000|Overall Study|Lack of Efficacy|5|||
156860251|NCT00385671|566246685|FG001|Overall Study|Lack of Efficacy|9|||
156860252|NCT00385671|566246686|FG002|Overall Study|Lack of Efficacy|5|||
156860253|NCT00385671|566246684|FG000|Overall Study|Lost to Follow-up|6|||
157160251|NCT02203838|567329597|FG000|Overall Study|Physician Decision|27|||
156860254|NCT00385671|566246685|FG001|Overall Study|Lost to Follow-up|6|||
157160252|NCT02203838|567329598|FG001|Overall Study|Physician Decision|0|||
157160253|NCT02203838|567329599|FG002|Overall Study|Physician Decision|2|||
157160254|NCT02203838|567329600|FG003|Overall Study|Physician Decision|3|||
157160255|NCT02203838|567329597|FG000|Overall Study|Other|1|||
157160256|NCT02203838|567329598|FG001|Overall Study|Other|0|||
157160257|NCT02203838|567329599|FG002|Overall Study|Other|0|||
157160258|NCT02203838|567329600|FG003|Overall Study|Other|0|||
157160259|NCT02739594|567329605|FG000|Overall Study|Undesired Event|3|||
157160260|NCT02739594|567329606|FG001|Overall Study|Undesired Event|4|||
157160261|NCT02739594|567329605|FG000|Overall Study|Violation of Eligibility Criteria|1|||
157160262|NCT02739594|567329606|FG001|Overall Study|Violation of Eligibility Criteria|2|||
157160263|NCT02739594|567329605|FG000|Overall Study|Protocol Violation|5|||
157160264|NCT02739594|567329606|FG001|Overall Study|Protocol Violation|6|||
156860255|NCT00385671|566246686|FG002|Overall Study|Lost to Follow-up|5|||
156860256|NCT00385671|566246684|FG000|Overall Study|Physician Decision|2|||
156860257|NCT00385671|566246685|FG001|Overall Study|Physician Decision|1|||
156860258|NCT00385671|566246686|FG002|Overall Study|Physician Decision|2|||
157160265|NCT02739594|567329605|FG000|Overall Study|Death|4|||
157160266|NCT02739594|567329606|FG001|Overall Study|Death|2|||
157160267|NCT02739594|567329605|FG000|Overall Study|Renal Insufficiency|4|||
156860259|NCT00385671|566246684|FG000|Overall Study|Protocol Violation|5|||
156860260|NCT00385671|566246685|FG001|Overall Study|Protocol Violation|2|||
156860261|NCT00385671|566246686|FG002|Overall Study|Protocol Violation|1|||
156860262|NCT00385671|566246684|FG000|Overall Study|Sponsor Decision|2|||
156860263|NCT00385671|566246685|FG001|Overall Study|Sponsor Decision|2|||
156860264|NCT00385671|566246686|FG002|Overall Study|Sponsor Decision|1|||
156860265|NCT00385671|566246684|FG000|Overall Study|Withdrawal by Subject|4|||
156860266|NCT00385671|566246685|FG001|Overall Study|Withdrawal by Subject|4|||
156860267|NCT00385671|566246686|FG002|Overall Study|Withdrawal by Subject|4|||
156860268|NCT01295814|566246687|FG000|Overall Study|Lack of Efficacy|0|||
156860269|NCT01295814|566246688|FG001|Overall Study|Lack of Efficacy|2|||
156860270|NCT01295814|566246687|FG000|Overall Study|Withdrawal by Subject|2|||
156860271|NCT01295814|566246688|FG001|Overall Study|Withdrawal by Subject|0|||
156860272|NCT04515771|566246689|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
157160268|NCT02739594|567329606|FG001|Overall Study|Renal Insufficiency|6|||
156860273|NCT04515771|566246690|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
157027379|NCT03656510|566856109|FG004|Overall Study|Withdrawal by Subject|0|||
157027380|NCT03656510|566856110|FG005|Overall Study|Withdrawal by Subject|0|||
157160269|NCT02739594|567329605|FG000|Overall Study|Administrative Reasons|1|||
157160270|NCT02739594|567329606|FG001|Overall Study|Administrative Reasons|3|||
156860274|NCT04515771|566246689|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
156860275|NCT04515771|566246690|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
156860276|NCT04515771|566246689|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
156860277|NCT04515771|566246690|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
156860278|NCT00948246|566246694|FG000|Overall Study|Lost to Follow-up|11|||
156860279|NCT00948246|566246694|FG000|Overall Study|Adverse Event|11|||
156860280|NCT00948246|566246694|FG000|Overall Study|Death|1|||
156860281|NCT00948246|566246694|FG000|Overall Study|Withdrawal by Subject|1|||
156860282|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
156860283|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
157160271|NCT02739594|567329605|FG000|Overall Study|Withdrawal by Subject|1|||
157160272|NCT02739594|567329606|FG001|Overall Study|Withdrawal by Subject|1|||
157160273|NCT02739594|567329605|FG000|Overall Study|Lost to Follow-up|0|||
157160274|NCT02739594|567329606|FG001|Overall Study|Lost to Follow-up|1|||
157160275|NCT02739594|567329605|FG000|Overall Study|Elevated Serum Creatinine|0|||
157160276|NCT02739594|567329606|FG001|Overall Study|Elevated Serum Creatinine|1|||
157160277|NCT02739594|567329605|FG000|Overall Study|Other|6|||
157160278|NCT02739594|567329606|FG001|Overall Study|Other|2|||
157160279|NCT00527111|567329607|FG000|Overall Study|Adverse Event|14|||
157160280|NCT00527111|567329608|FG001|Overall Study|Adverse Event|13|||
157160281|NCT00527111|567329607|FG000|Overall Study|Death|0|||
157160282|NCT00527111|567329608|FG001|Overall Study|Death|1|||
156860284|NCT00148317|566246695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
156860285|NCT03623243|566246698|FG000|Overall Study|Adverse Event|15|||
156860286|NCT03623243|566246698|FG000|Overall Study|Guardian Decision|1|||
156860287|NCT03623243|566246698|FG000|Overall Study|New Therapy for Study Indication|1|||
156860288|NCT03623243|566246698|FG000|Overall Study|Protocol Deviation|3|||
156860289|NCT03623243|566246698|FG000|Overall Study|Physician Decision|4|||
156860290|NCT03623243|566246698|FG000|Overall Study|Patient Decision|15|||
156860291|NCT00979901|566246702|FG000|Overall Study|Adverse Event|1|||
156860292|NCT00979901|566246703|FG001|Overall Study|Adverse Event|3|||
156860293|NCT00979901|566246704|FG002|Overall Study|Adverse Event|9|||
156860294|NCT00979901|566246705|FG003|Overall Study|Adverse Event|2|||
156860295|NCT00979901|566246702|FG000|Overall Study|Lack of Efficacy|8|||
156860296|NCT00979901|566246703|FG001|Overall Study|Lack of Efficacy|4|||
156860297|NCT00979901|566246704|FG002|Overall Study|Lack of Efficacy|9|||
156860298|NCT00979901|566246705|FG003|Overall Study|Lack of Efficacy|0|||
156860299|NCT00979901|566246702|FG000|Overall Study|Lost to Follow-up|1|||
156860300|NCT00979901|566246703|FG001|Overall Study|Lost to Follow-up|1|||
156860301|NCT00979901|566246704|FG002|Overall Study|Lost to Follow-up|2|||
156860302|NCT00979901|566246705|FG003|Overall Study|Lost to Follow-up|0|||
156860303|NCT00979901|566246702|FG000|Overall Study|Protocol Violation|2|||
156860304|NCT00979901|566246703|FG001|Overall Study|Protocol Violation|2|||
156860305|NCT00979901|566246704|FG002|Overall Study|Protocol Violation|7|||
156860306|NCT00979901|566246705|FG003|Overall Study|Protocol Violation|1|||
156860307|NCT00979901|566246702|FG000|Overall Study|Withdrawal by Subject|2|||
156860308|NCT00979901|566246703|FG001|Overall Study|Withdrawal by Subject|1|||
156860309|NCT00979901|566246704|FG002|Overall Study|Withdrawal by Subject|1|||
156860310|NCT00979901|566246705|FG003|Overall Study|Withdrawal by Subject|1|||
156860311|NCT00979901|566246702|FG000|Overall Study|Noncompliance|1|||
156860312|NCT00979901|566246703|FG001|Overall Study|Noncompliance|0|||
156860313|NCT00979901|566246704|FG002|Overall Study|Noncompliance|0|||
156860314|NCT00979901|566246705|FG003|Overall Study|Noncompliance|0|||
156860315|NCT00979901|566246702|FG000|Overall Study|out-of-state|1|||
156860316|NCT00979901|566246703|FG001|Overall Study|out-of-state|0|||
156860317|NCT00979901|566246704|FG002|Overall Study|out-of-state|0|||
156860318|NCT00979901|566246705|FG003|Overall Study|out-of-state|0|||
156860319|NCT00979901|566246702|FG000|Overall Study|vacation|1|||
156860320|NCT00979901|566246703|FG001|Overall Study|vacation|0|||
156860321|NCT00979901|566246704|FG002|Overall Study|vacation|0|||
156860322|NCT00979901|566246705|FG003|Overall Study|vacation|0|||
156860323|NCT00979901|566246702|FG000|Overall Study|elevated lab values pre-randomization|1|||
156860324|NCT00979901|566246703|FG001|Overall Study|elevated lab values pre-randomization|0|||
156860325|NCT00979901|566246704|FG002|Overall Study|elevated lab values pre-randomization|0|||
156860326|NCT00979901|566246705|FG003|Overall Study|elevated lab values pre-randomization|0|||
156860327|NCT00979901|566246702|FG000|Overall Study|Discontinued in Error|0|||
156860328|NCT00979901|566246703|FG001|Overall Study|Discontinued in Error|1|||
156860329|NCT00979901|566246704|FG002|Overall Study|Discontinued in Error|0|||
156860330|NCT00979901|566246705|FG003|Overall Study|Discontinued in Error|0|||
156860331|NCT00979901|566246702|FG000|Overall Study|Left Country|0|||
156860332|NCT00979901|566246703|FG001|Overall Study|Left Country|0|||
156860333|NCT00979901|566246704|FG002|Overall Study|Left Country|1|||
156860334|NCT00979901|566246705|FG003|Overall Study|Left Country|0|||
156860335|NCT00979901|566246702|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860336|NCT00979901|566246703|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860337|NCT00979901|566246704|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
156860338|NCT00979901|566246705|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
156860339|NCT03924622|566246706|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
156860340|NCT03924622|566246707|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
157027381|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
157160283|NCT00527111|567329607|FG000|Overall Study|Investigator Request|2|||
157160284|NCT00527111|567329608|FG001|Overall Study|Investigator Request|1|||
157160285|NCT00527111|567329607|FG000|Overall Study|Patient Request|2|||
156860341|NCT03924622|566246708|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
157027382|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
157160286|NCT00527111|567329608|FG001|Overall Study|Patient Request|5|||
157160287|NCT00527111|567329607|FG000|Overall Study|Other|2|||
157160288|NCT00527111|567329608|FG001|Overall Study|Other|2|||
157160289|NCT00952289|567329611|FG000|All Participants|Death|9|||
156860342|NCT03924622|566246709|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
156860343|NCT03924622|566246710|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156860344|NCT03924622|566246711|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
156860345|NCT00248625|566246712|FG000|Overall Study|Withdrawal by Subject|0|||
156860346|NCT00248625|566246713|FG001|Overall Study|Withdrawal by Subject|2|||
156860347|NCT03284710|566246718|FG000|Overall Study|Withdrawal by Subject|1|||
156860348|NCT03284710|566246719|FG001|Overall Study|Withdrawal by Subject|0|||
156860349|NCT03284710|566246720|FG002|Overall Study|Withdrawal by Subject|1|||
156860350|NCT03284710|566246721|FG003|Overall Study|Withdrawal by Subject|6|||
156860351|NCT03284710|566246718|FG000|Overall Study|Lost to Follow-up|3|||
156860352|NCT03284710|566246719|FG001|Overall Study|Lost to Follow-up|3|||
156860353|NCT03284710|566246720|FG002|Overall Study|Lost to Follow-up|1|||
156860354|NCT03284710|566246721|FG003|Overall Study|Lost to Follow-up|0|||
156860355|NCT03284710|566246718|FG000|Overall Study|Physician Decision|1|||
156860356|NCT03284710|566246719|FG001|Overall Study|Physician Decision|0|||
156860357|NCT03284710|566246720|FG002|Overall Study|Physician Decision|0|||
156860358|NCT03284710|566246721|FG003|Overall Study|Physician Decision|0|||
156860359|NCT03284710|566246718|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
156860360|NCT03284710|566246719|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156860361|NCT03284710|566246720|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
156860362|NCT03284710|566246721|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
156860363|NCT03284710|566246718|FG000|Overall Study|HIV Infection|0|||
156860364|NCT03284710|566246719|FG001|Overall Study|HIV Infection|2|||
156860365|NCT03284710|566246720|FG002|Overall Study|HIV Infection|2|||
156860366|NCT03284710|566246721|FG003|Overall Study|HIV Infection|1|||
156860367|NCT02814916|566246725|FG000|Overall Study|Withdrawal of consent|0|||
156860368|NCT02814916|566246726|FG001|Overall Study|Withdrawal of consent|2|||
156860369|NCT02814916|566246727|FG002|Overall Study|Withdrawal of consent|0|||
156860370|NCT02814916|566246725|FG000|Overall Study|Lost to Follow-up|0|||
156860371|NCT02814916|566246726|FG001|Overall Study|Lost to Follow-up|1|||
156860372|NCT02814916|566246727|FG002|Overall Study|Lost to Follow-up|0|||
156860373|NCT02814916|566246725|FG000|Overall Study|Other, not specified|0|||
156860374|NCT02814916|566246726|FG001|Overall Study|Other, not specified|1|||
156860375|NCT02814916|566246727|FG002|Overall Study|Other, not specified|0|||
156860376|NCT03547518|566246732|FG000|Overall Study|Lost to Follow-up|2|||
156860377|NCT03547518|566246733|FG001|Overall Study|Lost to Follow-up|0|||
156860378|NCT00286468|566246739|FG000|Overall Study|Hyperglycemic Rescue|28|||
156860379|NCT00286468|566246740|FG001|Overall Study|Hyperglycemic Rescue|30|||
156860380|NCT00286468|566246741|FG002|Overall Study|Hyperglycemic Rescue|31|||
156860381|NCT00286468|566246739|FG000|Overall Study|Adverse Event|2|||
156860382|NCT00286468|566246740|FG001|Overall Study|Adverse Event|6|||
156860383|NCT00286468|566246741|FG002|Overall Study|Adverse Event|4|||
156860384|NCT00286468|566246739|FG000|Overall Study|Protocol Violation|0|||
156860385|NCT00286468|566246740|FG001|Overall Study|Protocol Violation|3|||
156860386|NCT00286468|566246741|FG002|Overall Study|Protocol Violation|1|||
156860387|NCT00286468|566246739|FG000|Overall Study|Lost to Follow-up|1|||
156860388|NCT00286468|566246740|FG001|Overall Study|Lost to Follow-up|1|||
156860389|NCT00286468|566246741|FG002|Overall Study|Lost to Follow-up|2|||
156860390|NCT00286468|566246739|FG000|Overall Study|Withdrawal by Subject|3|||
156860391|NCT00286468|566246740|FG001|Overall Study|Withdrawal by Subject|8|||
156860392|NCT00286468|566246741|FG002|Overall Study|Withdrawal by Subject|11|||
156860393|NCT00286468|566246739|FG000|Overall Study|Physician Decision|3|||
156860394|NCT00286468|566246740|FG001|Overall Study|Physician Decision|2|||
156860395|NCT00286468|566246741|FG002|Overall Study|Physician Decision|1|||
156860396|NCT02953652|566246742|FG000|Overall Study|Adverse Event|18|||
156860397|NCT02953652|566246742|FG000|Overall Study|Withdrawal by Subject|6|||
156860398|NCT02953652|566246742|FG000|Overall Study|Protocol Violation|1|||
156860399|NCT02953652|566246742|FG000|Overall Study|Disease Progression|27|||
156860400|NCT00671658|566246746|FG000|Overall Study|Physician Decision|5|||
156860401|NCT03617172|566246755|FG000|Overall Study|Lost to Follow-up|1|||
156860402|NCT03617172|566246756|FG001|Overall Study|Lost to Follow-up|0|||
156860403|NCT03557970|566246757|FG000|Overall Study|Study closure|1|||
156860404|NCT03557970|566246758|FG001|Overall Study|Study closure|0|||
156860405|NCT03557970|566246757|FG000|Overall Study|Physician Decision|0|||
156860406|NCT03557970|566246758|FG001|Overall Study|Physician Decision|1|||
156860407|NCT03557970|566246757|FG000|Overall Study|Death|0|||
156860408|NCT03557970|566246758|FG001|Overall Study|Death|1|||
156860409|NCT02138890|566246761|FG000|Overall Study|Adverse Event|1|||
156860410|NCT02138890|566246762|FG001|Overall Study|Adverse Event|0|||
156860411|NCT03019406|566246763|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
156860412|NCT03019406|566246764|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
156860413|NCT03019406|566246765|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
156860414|NCT03019406|566246766|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
156860415|NCT01446159|566246767|FG000|Overall Study|Withdrawal by Subject|1|||
156860416|NCT01446159|566246768|FG001|Overall Study|Withdrawal by Subject|0|||
156860417|NCT01446159|566246769|FG002|Overall Study|Withdrawal by Subject|14|||
156860418|NCT01446159|566246770|FG003|Overall Study|Withdrawal by Subject|11|||
156860419|NCT01446159|566246767|FG000|Overall Study|Lost to Follow-up|0|||
156860420|NCT01446159|566246768|FG001|Overall Study|Lost to Follow-up|0|||
156860421|NCT01446159|566246769|FG002|Overall Study|Lost to Follow-up|1|||
157160290|NCT00952289|567329612|FG001|All Participants|Death|9|||
157160291|NCT00952289|567329611|FG000|All Participants|Adverse Event|8|||
157160292|NCT00952289|567329612|FG001|All Participants|Adverse Event|8|||
156860422|NCT01446159|566246770|FG003|Overall Study|Lost to Follow-up|2|||
156860423|NCT01446159|566246767|FG000|Overall Study|Death|2|||
156860424|NCT01446159|566246768|FG001|Overall Study|Death|3|||
156860425|NCT01446159|566246769|FG002|Overall Study|Death|43|||
156860426|NCT01446159|566246770|FG003|Overall Study|Death|36|||
156860427|NCT01446159|566246767|FG000|Overall Study|Other|0|||
156860428|NCT01446159|566246768|FG001|Overall Study|Other|0|||
156860429|NCT01446159|566246769|FG002|Overall Study|Other|13|||
156860430|NCT01446159|566246770|FG003|Overall Study|Other|13|||
156860431|NCT03668873|566246771|FG000|Overall Study|Lost to Follow-up|6|||
156860432|NCT03668873|566246772|FG001|Overall Study|Lost to Follow-up|3|||
156860433|NCT03155724|566246777|FG000|Overall Study|Death|3|||
156860434|NCT03155724|566246777|FG000|Overall Study|Physician Decision|1|||
156860435|NCT03155724|566246777|FG000|Overall Study|Study closure|7|||
156860436|NCT05135871|566246779|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
156860437|NCT05135871|566246780|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860438|NCT05135871|566246781|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860439|NCT05135871|566246782|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
156860440|NCT00525512|566246783|FG000|Double-Blind Phase|Adverse Event|48|||
156860441|NCT00525512|566246784|FG001|Double-Blind Phase|Adverse Event|28|||
156860442|NCT00525512|566246785|FG002|Double-Blind Phase|Adverse Event|0|||
156860443|NCT00525512|566246786|FG003|Double-Blind Phase|Adverse Event|0|||
156860444|NCT00525512|566246783|FG000|Double-Blind Phase|Protocol Violation|3|||
156860445|NCT00525512|566246784|FG001|Double-Blind Phase|Protocol Violation|1|||
156860446|NCT00525512|566246785|FG002|Double-Blind Phase|Protocol Violation|0|||
156860447|NCT00525512|566246786|FG003|Double-Blind Phase|Protocol Violation|0|||
156860448|NCT00525512|566246783|FG000|Double-Blind Phase|Lost to Follow-up|3|||
156860449|NCT00525512|566246784|FG001|Double-Blind Phase|Lost to Follow-up|7|||
156860450|NCT00525512|566246785|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156860451|NCT00525512|566246786|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156860452|NCT00525512|566246783|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
156860453|NCT00525512|566246784|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
156860454|NCT00525512|566246785|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156860455|NCT00525512|566246786|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156860456|NCT00525512|566246783|FG000|Double-Blind Phase|Lack of Efficacy|13|||
156860457|NCT00525512|566246784|FG001|Double-Blind Phase|Lack of Efficacy|5|||
156860458|NCT00525512|566246785|FG002|Double-Blind Phase|Lack of Efficacy|0|||
156860459|NCT00525512|566246786|FG003|Double-Blind Phase|Lack of Efficacy|0|||
156860460|NCT00525512|566246783|FG000|Double-Blind Phase|Other reason (not specified)|12|||
156860461|NCT00525512|566246784|FG001|Double-Blind Phase|Other reason (not specified)|13|||
156860462|NCT00525512|566246785|FG002|Double-Blind Phase|Other reason (not specified)|0|||
156860463|NCT00525512|566246786|FG003|Double-Blind Phase|Other reason (not specified)|0|||
156860464|NCT00525512|566246783|FG000|Open-Label Phase|Adverse Event|0|||
156860465|NCT00525512|566246784|FG001|Open-Label Phase|Adverse Event|0|||
156860466|NCT00525512|566246785|FG002|Open-Label Phase|Adverse Event|1|||
156860467|NCT00525512|566246786|FG003|Open-Label Phase|Adverse Event|0|||
156860468|NCT00525512|566246783|FG000|Open-Label Phase|Lost to Follow-up|0|||
156860469|NCT00525512|566246784|FG001|Open-Label Phase|Lost to Follow-up|0|||
156860470|NCT00525512|566246785|FG002|Open-Label Phase|Lost to Follow-up|1|||
156860471|NCT00525512|566246786|FG003|Open-Label Phase|Lost to Follow-up|0|||
156860472|NCT00525512|566246783|FG000|Open-Label Phase|Other reason (not specified)|0|||
156860473|NCT00525512|566246784|FG001|Open-Label Phase|Other reason (not specified)|0|||
156860474|NCT00525512|566246785|FG002|Open-Label Phase|Other reason (not specified)|4|||
156860475|NCT00525512|566246786|FG003|Open-Label Phase|Other reason (not specified)|5|||
156860476|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
156860477|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
156860478|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
156860479|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
156860480|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
157160293|NCT00952289|567329611|FG000|All Participants|Disease progression|3|||
156860481|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
156860482|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
156860483|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
157160294|NCT00952289|567329612|FG001|All Participants|Disease progression|12|||
157160295|NCT00952289|567329611|FG000|All Participants|Withdrawal by Subject|1|||
157160296|NCT00952289|567329612|FG001|All Participants|Withdrawal by Subject|10|||
156860484|NCT04576988|566246793|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
156860485|NCT04576988|566246794|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
156860486|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
156860487|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
156860488|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
156860489|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
156860490|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
156860491|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
156860492|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Death|2|||
156860493|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Death|1|||
156860494|NCT04576988|566246793|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
156860495|NCT04576988|566246794|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
156860496|NCT03309020|566246795|FG000|Overall Study|Death|1|||
156860497|NCT03309020|566246796|FG001|Overall Study|Death|0|||
156860498|NCT03309020|566246795|FG000|Overall Study|Did not undergo surgery|2|||
156860499|NCT03309020|566246796|FG001|Overall Study|Did not undergo surgery|1|||
156860500|NCT02025179|566246805|FG000|Overall Study|Lost to Follow-up|0|||
156860501|NCT02025179|566246806|FG001|Overall Study|Lost to Follow-up|0|||
156860502|NCT02025179|566246807|FG002|Overall Study|Lost to Follow-up|1|||
156860503|NCT02362724|566246808|FG000|Overall Study|Withdrawal by Subject|3|||
156860504|NCT02362724|566246809|FG001|Overall Study|Withdrawal by Subject|1|||
156860505|NCT02362724|566246808|FG000|Overall Study|Adverse Event|3|||
156860506|NCT02362724|566246809|FG001|Overall Study|Adverse Event|0|||
156860507|NCT00601835|566246815|FG000|Overall Study|Withdrawal by Subject|9|||
156860508|NCT00601835|566246816|FG001|Overall Study|Withdrawal by Subject|6|||
156860509|NCT00601835|566246815|FG000|Overall Study|Physician Decision|1|||
156860510|NCT00601835|566246816|FG001|Overall Study|Physician Decision|0|||
156860511|NCT00601835|566246815|FG000|Overall Study|Lost to Follow-up|37|||
156860512|NCT00601835|566246816|FG001|Overall Study|Lost to Follow-up|5|||
156860513|NCT00601835|566246815|FG000|Overall Study|Adverse Event|1|||
156860514|NCT00601835|566246816|FG001|Overall Study|Adverse Event|1|||
156860515|NCT00601835|566246815|FG000|Overall Study|Relocate|12|||
156860516|NCT00601835|566246816|FG001|Overall Study|Relocate|2|||
156860517|NCT00880620|566246817|FG000|Overall Study|Adverse Event|4|||
156860518|NCT00880620|566246818|FG001|Overall Study|Adverse Event|5|||
156860519|NCT00880620|566246819|FG002|Overall Study|Adverse Event|15|||
156860520|NCT00880620|566246820|FG003|Overall Study|Adverse Event|15|||
156860521|NCT00880620|566246817|FG000|Overall Study|Death|0|||
156860522|NCT00880620|566246818|FG001|Overall Study|Death|0|||
156860523|NCT00880620|566246819|FG002|Overall Study|Death|1|||
156860524|NCT00880620|566246820|FG003|Overall Study|Death|0|||
156860525|NCT00880620|566246817|FG000|Overall Study|Lack of Efficacy|12|||
156860526|NCT00880620|566246818|FG001|Overall Study|Lack of Efficacy|4|||
156860527|NCT00880620|566246819|FG002|Overall Study|Lack of Efficacy|0|||
156860528|NCT00880620|566246820|FG003|Overall Study|Lack of Efficacy|1|||
156860529|NCT00880620|566246817|FG000|Overall Study|Lost to Follow-up|0|||
156860530|NCT00880620|566246818|FG001|Overall Study|Lost to Follow-up|1|||
156860531|NCT00880620|566246819|FG002|Overall Study|Lost to Follow-up|1|||
156860532|NCT00880620|566246820|FG003|Overall Study|Lost to Follow-up|0|||
156860533|NCT00880620|566246817|FG000|Overall Study|Protocol Violation|0|||
156860534|NCT00880620|566246818|FG001|Overall Study|Protocol Violation|1|||
156860535|NCT00880620|566246819|FG002|Overall Study|Protocol Violation|0|||
156860536|NCT00880620|566246820|FG003|Overall Study|Protocol Violation|2|||
156860537|NCT00880620|566246817|FG000|Overall Study|Withdrawal by Subject|4|||
156860538|NCT00880620|566246818|FG001|Overall Study|Withdrawal by Subject|3|||
156860539|NCT00880620|566246819|FG002|Overall Study|Withdrawal by Subject|1|||
156860540|NCT00880620|566246820|FG003|Overall Study|Withdrawal by Subject|3|||
156860541|NCT00880620|566246817|FG000|Overall Study|Noncompliance|0|||
156860542|NCT00880620|566246818|FG001|Overall Study|Noncompliance|0|||
156860543|NCT00880620|566246819|FG002|Overall Study|Noncompliance|1|||
156860544|NCT00880620|566246820|FG003|Overall Study|Noncompliance|1|||
156860545|NCT00880620|566246817|FG000|Overall Study|Other|1|||
156860546|NCT00880620|566246818|FG001|Overall Study|Other|1|||
156860547|NCT00880620|566246819|FG002|Overall Study|Other|2|||
156860548|NCT00880620|566246820|FG003|Overall Study|Other|2|||
156860549|NCT00880698|566246823|FG000|Overall Study|Death|0|||
156860550|NCT00880698|566246824|FG001|Overall Study|Death|0|||
156860551|NCT00880698|566246825|FG002|Overall Study|Death|1|||
156860552|NCT00880698|566246826|FG003|Overall Study|Death|2|||
156860553|NCT00880698|566246823|FG000|Overall Study|Lost to Follow-up|1|||
156860554|NCT00880698|566246824|FG001|Overall Study|Lost to Follow-up|3|||
156860555|NCT00880698|566246825|FG002|Overall Study|Lost to Follow-up|0|||
156860556|NCT00880698|566246826|FG003|Overall Study|Lost to Follow-up|1|||
156860557|NCT04972162|566246829|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
156860558|NCT04972162|566246830|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
156860559|NCT03414983|566248943|FG000|Pre-Treatment|Other reasons|1|||
156860560|NCT03414983|566248944|FG001|Pre-Treatment|Other reasons|0|||
156860561|NCT03414983|566248943|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156860562|NCT03414983|566248944|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
156860563|NCT03414983|566248943|FG000|Pre-Treatment|Participant withdrew consent|1|||
156860564|NCT03414983|566248944|FG001|Pre-Treatment|Participant withdrew consent|3|||
156860565|NCT03414983|566248943|FG000|Treatment|Participant withdrew consent|4|||
156860566|NCT03414983|566248944|FG001|Treatment|Participant withdrew consent|3|||
156860567|NCT03414983|566248943|FG000|Treatment|Participant request to discontinue study treatment|8|||
156860568|NCT03414983|566248944|FG001|Treatment|Participant request to discontinue study treatment|10|||
156860569|NCT03414983|566248943|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
156860570|NCT03414983|566248944|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
156860571|NCT03414983|566248943|FG000|Treatment|Death|0|||
156860572|NCT03414983|566248944|FG001|Treatment|Death|1|||
156860573|NCT03414983|566248943|FG000|Treatment|Study Drug Toxicity|10|||
156860574|NCT03414983|566248944|FG001|Treatment|Study Drug Toxicity|5|||
156860575|NCT03414983|566248943|FG000|Treatment|Disease Progression|75|||
156860576|NCT03414983|566248944|FG001|Treatment|Disease Progression|29|||
156860577|NCT03414983|566248943|FG000|Treatment|Not reported|1|||
156860578|NCT03414983|566248944|FG001|Treatment|Not reported|0|||
156860579|NCT03414983|566248943|FG000|Treatment|Other reasons|3|||
156860580|NCT03414983|566248944|FG001|Treatment|Other reasons|2|||
156860581|NCT03414983|566248943|FG000|Treatment|Poor/non-compliance|2|||
156860582|NCT03414983|566248944|FG001|Treatment|Poor/non-compliance|0|||
156860583|NCT03414983|566248943|FG000|Treatment|Maximum clinical benefit|5|||
156860584|NCT03414983|566248944|FG001|Treatment|Maximum clinical benefit|9|||
156860585|NCT03414983|566248943|FG000|Treatment|Lost to Follow-up|0|||
156860586|NCT03414983|566248944|FG001|Treatment|Lost to Follow-up|1|||
156860587|NCT03414983|566248943|FG000|Treatment|Administrative reasons by sponsor|1|||
156860588|NCT03414983|566248944|FG001|Treatment|Administrative reasons by sponsor|0|||
156860589|NCT02608684|566248945|FG000|Overall Study|Physician Decision|2|||
156860590|NCT02608684|566248945|FG000|Overall Study|Withdrawal by Subject|1|||
156860591|NCT01910298|566248946|FG000|Overall Study|Adverse Event|1|||
156860592|NCT01910298|566248947|FG001|Overall Study|Adverse Event|0|||
156860593|NCT01910298|566248946|FG000|Overall Study|Withdrawal by Subject|2|||
156860594|NCT01910298|566248947|FG001|Overall Study|Withdrawal by Subject|7|||
156860595|NCT01910298|566248946|FG000|Overall Study|Protocol Deviation|0|||
156860596|NCT01910298|566248947|FG001|Overall Study|Protocol Deviation|5|||
156860597|NCT01910298|566248946|FG000|Overall Study|Lost to Follow-up|1|||
156860598|NCT01910298|566248947|FG001|Overall Study|Lost to Follow-up|1|||
156860599|NCT01910298|566248946|FG000|Overall Study|Study Terminated by Sponsor|1|||
156860600|NCT01910298|566248947|FG001|Overall Study|Study Terminated by Sponsor|17|||
156860601|NCT01910298|566248946|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156860602|NCT01910298|566248947|FG001|Overall Study|Other Miscellaneous Reasons|2|||
156860603|NCT01775501|566248948|FG000|Overall Study|Discontinued prior to treatment|1|||
156860604|NCT03037385|566248949|FG000|Overall Study|Adverse Event|0|||
156860605|NCT03037385|566248950|FG001|Overall Study|Adverse Event|0|||
156860606|NCT03037385|566248951|FG002|Overall Study|Adverse Event|1|||
156860607|NCT03037385|566248952|FG003|Overall Study|Adverse Event|0|||
156860608|NCT03037385|566248953|FG004|Overall Study|Adverse Event|0|||
156860609|NCT03037385|566248954|FG005|Overall Study|Adverse Event|0|||
156860610|NCT03037385|566248955|FG006|Overall Study|Adverse Event|0|||
156860611|NCT03037385|566248956|FG007|Overall Study|Adverse Event|0|||
156860612|NCT03037385|566248957|FG008|Overall Study|Adverse Event|0|||
156860613|NCT03037385|566248958|FG009|Overall Study|Adverse Event|6|||
156860614|NCT03037385|566248949|FG000|Overall Study|Death|1|||
156860615|NCT03037385|566248950|FG001|Overall Study|Death|4|||
156860616|NCT03037385|566248951|FG002|Overall Study|Death|2|||
156860617|NCT03037385|566248952|FG003|Overall Study|Death|2|||
156860618|NCT03037385|566248953|FG004|Overall Study|Death|5|||
156860619|NCT03037385|566248954|FG005|Overall Study|Death|2|||
156860620|NCT03037385|566248955|FG006|Overall Study|Death|1|||
156860621|NCT03037385|566248956|FG007|Overall Study|Death|4|||
156860622|NCT03037385|566248957|FG008|Overall Study|Death|3|||
156860623|NCT03037385|566248958|FG009|Overall Study|Death|240|||
156860624|NCT03037385|566248949|FG000|Overall Study|Initiation of Another Therapy|1|||
156912879|NCT02170298|566440356|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
157160297|NCT00952289|567329611|FG000|All Participants|Data lost during site relocation|0|||
157160298|NCT00952289|567329612|FG001|All Participants|Data lost during site relocation|1|||
157160299|NCT00952289|567329611|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
157160300|NCT00952289|567329612|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
156860625|NCT03037385|566248950|FG001|Overall Study|Initiation of Another Therapy|0|||
156860626|NCT03037385|566248951|FG002|Overall Study|Initiation of Another Therapy|0|||
156860627|NCT03037385|566248952|FG003|Overall Study|Initiation of Another Therapy|0|||
156860628|NCT03037385|566248953|FG004|Overall Study|Initiation of Another Therapy|0|||
156860629|NCT03037385|566248954|FG005|Overall Study|Initiation of Another Therapy|0|||
156860630|NCT03037385|566248955|FG006|Overall Study|Initiation of Another Therapy|0|||
156860631|NCT03037385|566248956|FG007|Overall Study|Initiation of Another Therapy|1|||
156860632|NCT03037385|566248957|FG008|Overall Study|Initiation of Another Therapy|0|||
156860633|NCT03037385|566248958|FG009|Overall Study|Initiation of Another Therapy|2|||
156860634|NCT03037385|566248949|FG000|Overall Study|Lost to Follow-up|0|||
156860635|NCT03037385|566248950|FG001|Overall Study|Lost to Follow-up|0|||
156860636|NCT03037385|566248951|FG002|Overall Study|Lost to Follow-up|0|||
156860637|NCT03037385|566248952|FG003|Overall Study|Lost to Follow-up|0|||
156860638|NCT03037385|566248953|FG004|Overall Study|Lost to Follow-up|0|||
156860639|NCT03037385|566248954|FG005|Overall Study|Lost to Follow-up|1|||
156860640|NCT03037385|566248955|FG006|Overall Study|Lost to Follow-up|0|||
156860641|NCT03037385|566248956|FG007|Overall Study|Lost to Follow-up|0|||
156860642|NCT03037385|566248957|FG008|Overall Study|Lost to Follow-up|0|||
156860643|NCT03037385|566248958|FG009|Overall Study|Lost to Follow-up|16|||
156860644|NCT03037385|566248949|FG000|Overall Study|Physician Decision|0|||
156860645|NCT03037385|566248950|FG001|Overall Study|Physician Decision|0|||
156860646|NCT03037385|566248951|FG002|Overall Study|Physician Decision|0|||
156860647|NCT03037385|566248952|FG003|Overall Study|Physician Decision|0|||
156860648|NCT03037385|566248953|FG004|Overall Study|Physician Decision|0|||
156860649|NCT03037385|566248954|FG005|Overall Study|Physician Decision|0|||
156860650|NCT03037385|566248955|FG006|Overall Study|Physician Decision|0|||
156860651|NCT03037385|566248956|FG007|Overall Study|Physician Decision|0|||
156860652|NCT03037385|566248957|FG008|Overall Study|Physician Decision|0|||
156860653|NCT03037385|566248958|FG009|Overall Study|Physician Decision|1|||
156860654|NCT03037385|566248949|FG000|Overall Study|Progressive Disease|0|||
156860655|NCT03037385|566248950|FG001|Overall Study|Progressive Disease|1|||
156860656|NCT03037385|566248951|FG002|Overall Study|Progressive Disease|1|||
156860657|NCT03037385|566248952|FG003|Overall Study|Progressive Disease|5|||
156860658|NCT03037385|566248953|FG004|Overall Study|Progressive Disease|2|||
156860659|NCT03037385|566248954|FG005|Overall Study|Progressive Disease|0|||
156860660|NCT03037385|566248955|FG006|Overall Study|Progressive Disease|1|||
156860661|NCT03037385|566248956|FG007|Overall Study|Progressive Disease|0|||
156860662|NCT03037385|566248957|FG008|Overall Study|Progressive Disease|0|||
156860663|NCT03037385|566248958|FG009|Overall Study|Progressive Disease|30|||
156860664|NCT03037385|566248949|FG000|Overall Study|Withdrawal by Subject|0|||
156860665|NCT03037385|566248950|FG001|Overall Study|Withdrawal by Subject|0|||
156860666|NCT03037385|566248951|FG002|Overall Study|Withdrawal by Subject|1|||
156860667|NCT03037385|566248952|FG003|Overall Study|Withdrawal by Subject|2|||
156860668|NCT03037385|566248953|FG004|Overall Study|Withdrawal by Subject|1|||
156860669|NCT03037385|566248954|FG005|Overall Study|Withdrawal by Subject|3|||
156860670|NCT03037385|566248955|FG006|Overall Study|Withdrawal by Subject|0|||
156860671|NCT03037385|566248956|FG007|Overall Study|Withdrawal by Subject|0|||
156860672|NCT03037385|566248957|FG008|Overall Study|Withdrawal by Subject|0|||
156860673|NCT03037385|566248958|FG009|Overall Study|Withdrawal by Subject|52|||
156860674|NCT03037385|566248949|FG000|Overall Study|Reason Not Specified|0|||
156860675|NCT03037385|566248950|FG001|Overall Study|Reason Not Specified|1|||
156860676|NCT03037385|566248951|FG002|Overall Study|Reason Not Specified|0|||
156860677|NCT03037385|566248952|FG003|Overall Study|Reason Not Specified|4|||
156860678|NCT03037385|566248953|FG004|Overall Study|Reason Not Specified|3|||
156860679|NCT03037385|566248954|FG005|Overall Study|Reason Not Specified|6|||
156860680|NCT03037385|566248955|FG006|Overall Study|Reason Not Specified|2|||
156860681|NCT03037385|566248956|FG007|Overall Study|Reason Not Specified|0|||
156860682|NCT03037385|566248957|FG008|Overall Study|Reason Not Specified|1|||
157027383|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
157027384|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
157027385|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
157027386|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
157027387|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
157027388|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
157027389|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
157027390|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
157027391|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
157027392|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
157027393|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
157027394|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
157027395|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
157027396|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
157027397|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
157027398|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
157027399|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
157027400|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
157027401|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
157027402|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
156860683|NCT03037385|566248958|FG009|Overall Study|Reason Not Specified|181|||
156860684|NCT03007966|566248962|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
156860685|NCT03007966|566248963|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
156860686|NCT00419393|566248964|FG000|Overall Study|Adverse Event|5|||
156860687|NCT00419393|566248964|FG000|Overall Study|Protocol Violation|5|||
156860688|NCT00419393|566248964|FG000|Overall Study|Withdrawal by Subject|7|||
156860689|NCT00419393|566248964|FG000|Overall Study|Other: Sponsor request|3|||
156860690|NCT00419393|566248964|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
156860691|NCT00419393|566248964|FG000|Overall Study|Other: Site closure|1|||
156860692|NCT00419393|566248964|FG000|Overall Study|Other: Other health problems|1|||
157160301|NCT00952289|567329611|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
157160302|NCT00952289|567329612|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
157160303|NCT00952289|567329611|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
156860693|NCT00419393|566248964|FG000|Overall Study|Other: Investigator decision|1|||
156860694|NCT02587221|566248968|FG000|Overall Study|Adverse Event|3|||
156860695|NCT02587221|566248969|FG001|Overall Study|Adverse Event|3|||
156860696|NCT02587221|566248968|FG000|Overall Study|Death|33|||
156860697|NCT02587221|566248969|FG001|Overall Study|Death|34|||
156860698|NCT02587221|566248968|FG000|Overall Study|Withdrawal by Subject|66|||
156860699|NCT02587221|566248969|FG001|Overall Study|Withdrawal by Subject|61|||
156860700|NCT02587221|566248968|FG000|Overall Study|Lost to Follow-up|21|||
156860701|NCT02587221|566248969|FG001|Overall Study|Lost to Follow-up|19|||
156860702|NCT02587221|566248968|FG000|Overall Study|Protocol Violation|6|||
156860703|NCT02587221|566248969|FG001|Overall Study|Protocol Violation|5|||
156860704|NCT02587221|566248968|FG000|Overall Study|Other Reason or Unspecified|2|||
156860705|NCT02587221|566248969|FG001|Overall Study|Other Reason or Unspecified|1|||
156860706|NCT02546609|566248970|FG000|Overall Study|Withdrawal by Subject|0|||
156860707|NCT02546609|566248971|FG001|Overall Study|Withdrawal by Subject|1|||
156860708|NCT02546609|566248972|FG002|Overall Study|Withdrawal by Subject|2|||
156860709|NCT02546609|566248970|FG000|Overall Study|Adverse Event|0|||
156860710|NCT02546609|566248971|FG001|Overall Study|Adverse Event|6|||
156860711|NCT02546609|566248972|FG002|Overall Study|Adverse Event|1|||
156860712|NCT02546609|566248970|FG000|Overall Study|Protocol Violation|0|||
156860713|NCT02546609|566248971|FG001|Overall Study|Protocol Violation|1|||
156860714|NCT02546609|566248972|FG002|Overall Study|Protocol Violation|1|||
156860715|NCT02546609|566248970|FG000|Overall Study|Lost to Follow-up|2|||
156860716|NCT02546609|566248971|FG001|Overall Study|Lost to Follow-up|3|||
156860717|NCT02546609|566248972|FG002|Overall Study|Lost to Follow-up|1|||
156860718|NCT02546609|566248970|FG000|Overall Study|travel or work schedule restriction|0|||
156860719|NCT02546609|566248971|FG001|Overall Study|travel or work schedule restriction|0|||
156860720|NCT02546609|566248972|FG002|Overall Study|travel or work schedule restriction|2|||
156860721|NCT03988400|566248974|FG000|Overall Study|Adverse Event|1|||
156860722|NCT03988400|566248975|FG001|Overall Study|Adverse Event|0|||
156860723|NCT03988400|566248974|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
156860724|NCT03988400|566248975|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
156860725|NCT03988400|566248974|FG000|Overall Study|Lost to Follow-up|0|||
156860726|NCT03988400|566248975|FG001|Overall Study|Lost to Follow-up|1|||
156860727|NCT04913610|566248976|FG000|Randomized Participants|Did Not Receive Treatment|0|||
156860728|NCT04913610|566248977|FG001|Randomized Participants|Did Not Receive Treatment|0|||
156860729|NCT04913610|566248978|FG002|Randomized Participants|Did Not Receive Treatment|1|||
156860730|NCT04913610|566248979|FG003|Randomized Participants|Did Not Receive Treatment|1|||
156860731|NCT04913610|566248980|FG004|Randomized Participants|Did Not Receive Treatment|0|||
156860732|NCT04913610|566248976|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
156860733|NCT04913610|566248977|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860734|NCT04913610|566248978|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860735|NCT04913610|566248979|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
156860736|NCT04913610|566248980|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
156860737|NCT03186209|566248981|FG000|Overall Study|Withdrawal by Subject|11|||
156860738|NCT03186209|566248982|FG001|Overall Study|Withdrawal by Subject|22|||
156860739|NCT03186209|566248981|FG000|Overall Study|Pregnancy|1|||
156860740|NCT03186209|566248982|FG001|Overall Study|Pregnancy|0|||
156860741|NCT03186209|566248981|FG000|Overall Study|Adverse Event|4|||
156860742|NCT03186209|566248982|FG001|Overall Study|Adverse Event|0|||
156860743|NCT03186209|566248981|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
156860744|NCT03186209|566248982|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
156860745|NCT03186209|566248981|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
156860746|NCT03186209|566248982|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
156860747|NCT03186209|566248981|FG000|Overall Study|Fail to meet randomization criteria|0|||
156860748|NCT03186209|566248982|FG001|Overall Study|Fail to meet randomization criteria|1|||
156860749|NCT03186209|566248981|FG000|Overall Study|Lost to Follow-up|0|||
156860750|NCT03186209|566248982|FG001|Overall Study|Lost to Follow-up|1|||
157160304|NCT00952289|567329612|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
157160305|NCT00952289|567329611|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
156860751|NCT00953667|566248983|FG000|Overall Study|Lost to Follow-up|11|||
157160306|NCT00952289|567329612|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
156860752|NCT00953667|566248983|FG000|Overall Study|Physician Decision|35|||
156860753|NCT00953667|566248983|FG000|Overall Study|Withdrawal by Subject|63|||
156860754|NCT00953667|566248983|FG000|Overall Study|Adverse Event|10|||
156860755|NCT00953667|566248983|FG000|Overall Study|poor venous access,unable to draw blood|4|||
156860756|NCT00322881|566248985|FG000|Overall Study|Death|2|||
156860757|NCT00322881|566248985|FG000|Overall Study|Adverse Event|1|||
156860758|NCT00322881|566248985|FG000|Overall Study|Disease Progression|2|||
156860759|NCT05435339|566248993|FG000|Overall Study|Death|1|||
156860760|NCT05435339|566248994|FG001|Overall Study|Death|0|||
156860761|NCT05435339|566248995|FG002|Overall Study|Death|3|||
157160307|NCT00952289|567329611|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
157160308|NCT00952289|567329612|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
156860762|NCT05435339|566248996|FG003|Overall Study|Death|1|||
156860763|NCT05435339|566248997|FG004|Overall Study|Death|3|||
156860764|NCT05435339|566248998|FG005|Overall Study|Death|2|||
156860765|NCT05435339|566248999|FG006|Overall Study|Death|4|||
156860766|NCT05435339|566249000|FG007|Overall Study|Death|6|||
156860767|NCT05435339|566248993|FG000|Overall Study|Sponsor Decision|0|||
156860768|NCT05435339|566248994|FG001|Overall Study|Sponsor Decision|1|||
156860769|NCT05435339|566248995|FG002|Overall Study|Sponsor Decision|0|||
156860770|NCT05435339|566248996|FG003|Overall Study|Sponsor Decision|0|||
156860771|NCT05435339|566248997|FG004|Overall Study|Sponsor Decision|2|||
156860772|NCT05435339|566248998|FG005|Overall Study|Sponsor Decision|1|||
156860773|NCT05435339|566248999|FG006|Overall Study|Sponsor Decision|2|||
156860774|NCT05435339|566249000|FG007|Overall Study|Sponsor Decision|2|||
156860775|NCT05435339|566248993|FG000|Overall Study|Withdrawal by Subject|0|||
156860776|NCT05435339|566248994|FG001|Overall Study|Withdrawal by Subject|0|||
156860777|NCT05435339|566248995|FG002|Overall Study|Withdrawal by Subject|0|||
156860778|NCT05435339|566248996|FG003|Overall Study|Withdrawal by Subject|0|||
156860779|NCT05435339|566248997|FG004|Overall Study|Withdrawal by Subject|1|||
156860780|NCT05435339|566248998|FG005|Overall Study|Withdrawal by Subject|0|||
156860781|NCT05435339|566248999|FG006|Overall Study|Withdrawal by Subject|1|||
156860782|NCT05435339|566249000|FG007|Overall Study|Withdrawal by Subject|1|||
156860783|NCT00537394|566249001|FG000|First Year of Follow-up|Death|7|||
156860784|NCT00537394|566249002|FG001|First Year of Follow-up|Death|0|||
156860785|NCT00537394|566249003|FG002|First Year of Follow-up|Death|0|||
156860786|NCT00537394|566249001|FG000|First Year of Follow-up|Severe debilitation|1|||
156860787|NCT00537394|566249002|FG001|First Year of Follow-up|Severe debilitation|0|||
156860788|NCT00537394|566249003|FG002|First Year of Follow-up|Severe debilitation|1|||
156860789|NCT00537394|566249001|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
156860790|NCT00537394|566249002|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
156860791|NCT00537394|566249003|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
156860792|NCT00537394|566249001|FG000|First Year of Follow-up|Lost to Follow-up|1|||
156860793|NCT00537394|566249002|FG001|First Year of Follow-up|Lost to Follow-up|5|||
156860794|NCT00537394|566249003|FG002|First Year of Follow-up|Lost to Follow-up|1|||
156860795|NCT00537394|566249001|FG000|2nd Year of Follow-up|Death|4|||
156860796|NCT00537394|566249002|FG001|2nd Year of Follow-up|Death|1|||
156860797|NCT00537394|566249003|FG002|2nd Year of Follow-up|Death|2|||
156860798|NCT00537394|566249001|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
156860799|NCT00537394|566249002|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
156860800|NCT00537394|566249003|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
156860801|NCT00537394|566249001|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
156860802|NCT00537394|566249002|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
156860803|NCT00537394|566249003|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
156860804|NCT00537394|566249001|FG000|2nd Year of Follow-up|Clinic site closure|1|||
156860805|NCT00537394|566249002|FG001|2nd Year of Follow-up|Clinic site closure|0|||
156860806|NCT00537394|566249003|FG002|2nd Year of Follow-up|Clinic site closure|0|||
156860807|NCT01283139|566249004|FG000|Overall Study|Lost to Follow-up|5|||
156860808|NCT01283139|566249005|FG001|Overall Study|Lost to Follow-up|2|||
156860809|NCT01283139|566249006|FG002|Overall Study|Lost to Follow-up|3|||
156860810|NCT01283139|566249007|FG003|Overall Study|Lost to Follow-up|1|||
156860811|NCT01283139|566249004|FG000|Overall Study|Withdrawal by Subject|8|||
156860812|NCT01283139|566249005|FG001|Overall Study|Withdrawal by Subject|8|||
156860813|NCT01283139|566249006|FG002|Overall Study|Withdrawal by Subject|6|||
156860814|NCT01283139|566249007|FG003|Overall Study|Withdrawal by Subject|8|||
156860815|NCT01283139|566249004|FG000|Overall Study|Death|2|||
156860816|NCT01283139|566249005|FG001|Overall Study|Death|0|||
156860817|NCT01283139|566249006|FG002|Overall Study|Death|2|||
156860818|NCT01283139|566249007|FG003|Overall Study|Death|2|||
156860819|NCT01283139|566249004|FG000|Overall Study|Lack of Efficacy|1|||
156860820|NCT01283139|566249005|FG001|Overall Study|Lack of Efficacy|2|||
156860821|NCT01283139|566249006|FG002|Overall Study|Lack of Efficacy|2|||
156860822|NCT01283139|566249007|FG003|Overall Study|Lack of Efficacy|1|||
156860823|NCT01283139|566249004|FG000|Overall Study|Early termination due to AE/SAE|1|||
156860824|NCT01283139|566249005|FG001|Overall Study|Early termination due to AE/SAE|1|||
156860825|NCT01283139|566249006|FG002|Overall Study|Early termination due to AE/SAE|0|||
156860826|NCT01283139|566249007|FG003|Overall Study|Early termination due to AE/SAE|0|||
156860827|NCT01283139|566249004|FG000|Overall Study|Participant's refusal to continue|0|||
156860828|NCT01283139|566249005|FG001|Overall Study|Participant's refusal to continue|3|||
156860829|NCT01283139|566249006|FG002|Overall Study|Participant's refusal to continue|1|||
157160309|NCT03259334|567329613|FG000|Overall Study|Adverse Event|3|||
157160310|NCT03259334|567329614|FG001|Overall Study|Adverse Event|8|||
156860830|NCT01283139|566249007|FG003|Overall Study|Participant's refusal to continue|1|||
156860831|NCT01283139|566249004|FG000|Overall Study|Pregnancy|0|||
156860832|NCT01283139|566249005|FG001|Overall Study|Pregnancy|1|||
157160311|NCT03259334|567329615|FG002|Overall Study|Adverse Event|5|||
157160312|NCT03259334|567329613|FG000|Overall Study|Withdrawal by Subject|4|||
157160313|NCT03259334|567329614|FG001|Overall Study|Withdrawal by Subject|2|||
157160314|NCT03259334|567329615|FG002|Overall Study|Withdrawal by Subject|4|||
157160315|NCT03259334|567329613|FG000|Overall Study|Physician Decision|1|||
157160316|NCT03259334|567329614|FG001|Overall Study|Physician Decision|0|||
157160317|NCT03259334|567329615|FG002|Overall Study|Physician Decision|0|||
157160318|NCT03259334|567329613|FG000|Overall Study|Lost to Follow-up|0|||
157160319|NCT03259334|567329614|FG001|Overall Study|Lost to Follow-up|2|||
156860833|NCT01283139|566249006|FG002|Overall Study|Pregnancy|1|||
156860834|NCT01283139|566249007|FG003|Overall Study|Pregnancy|0|||
156860835|NCT01283139|566249004|FG000|Overall Study|Missed follow-up visit|0|||
156860836|NCT01283139|566249005|FG001|Overall Study|Missed follow-up visit|1|||
156860837|NCT01283139|566249006|FG002|Overall Study|Missed follow-up visit|2|||
156860838|NCT01283139|566249007|FG003|Overall Study|Missed follow-up visit|2|||
156860839|NCT01283139|566249004|FG000|Overall Study|Participant randomized in error|0|||
156860840|NCT01283139|566249005|FG001|Overall Study|Participant randomized in error|0|||
156860841|NCT01283139|566249006|FG002|Overall Study|Participant randomized in error|1|||
156860842|NCT01283139|566249007|FG003|Overall Study|Participant randomized in error|0|||
156860843|NCT02183675|566249008|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860844|NCT02183675|566249009|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860845|NCT02183675|566249010|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860846|NCT02183675|566249011|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860847|NCT02183675|566249012|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
156860848|NCT02183675|566249013|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
156860849|NCT01521117|566249014|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
156860850|NCT01521117|566249015|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
156860851|NCT01521117|566249014|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
156860852|NCT01521117|566249015|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
156860853|NCT01521117|566249014|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
156860854|NCT01521117|566249015|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
156860855|NCT01056822|566249016|FG000|Overall Study|Adverse Event|0|||
156860856|NCT01056822|566249017|FG001|Overall Study|Adverse Event|1|||
156860857|NCT01056822|566249016|FG000|Overall Study|Protocol Violation|6|||
156860858|NCT01056822|566249017|FG001|Overall Study|Protocol Violation|5|||
156860859|NCT01056822|566249016|FG000|Overall Study|Withdrawal by Subject|1|||
156860860|NCT01056822|566249017|FG001|Overall Study|Withdrawal by Subject|1|||
156860861|NCT01056822|566249016|FG000|Overall Study|Lost to Follow-up|1|||
157160320|NCT03259334|567329615|FG002|Overall Study|Lost to Follow-up|1|||
157160321|NCT03259334|567329613|FG000|Overall Study|Protocol Deviation|0|||
157160322|NCT03259334|567329614|FG001|Overall Study|Protocol Deviation|3|||
157160323|NCT03259334|567329615|FG002|Overall Study|Protocol Deviation|2|||
157160324|NCT03259334|567329613|FG000|Overall Study|Lack of Efficacy|2|||
157160325|NCT03259334|567329614|FG001|Overall Study|Lack of Efficacy|0|||
157160326|NCT03259334|567329615|FG002|Overall Study|Lack of Efficacy|1|||
157160327|NCT03259334|567329613|FG000|Overall Study|Randomized but never treated|0|||
157160328|NCT03259334|567329614|FG001|Overall Study|Randomized but never treated|2|||
157160329|NCT03259334|567329615|FG002|Overall Study|Randomized but never treated|0|||
157160330|NCT00777491|567329616|FG000|Overall Study|Protocol Violation|0|||
157160331|NCT00777491|567329617|FG001|Overall Study|Protocol Violation|2|||
157160332|NCT00777491|567329616|FG000|Overall Study|Did not receive any protocol treatment|2|||
157160333|NCT00777491|567329617|FG001|Overall Study|Did not receive any protocol treatment|0|||
157160334|NCT01689207|567329618|FG000|Overall Study|Adverse Event|0|||
157160335|NCT01689207|567329619|FG001|Overall Study|Adverse Event|1|||
157160336|NCT01689207|567329620|FG002|Overall Study|Adverse Event|0|||
157160337|NCT01689207|567329621|FG003|Overall Study|Adverse Event|0|||
157160338|NCT01689207|567329622|FG004|Overall Study|Adverse Event|2|||
156860862|NCT01056822|566249017|FG001|Overall Study|Lost to Follow-up|0|||
157160339|NCT01689207|567329623|FG005|Overall Study|Adverse Event|1|||
157160340|NCT01689207|567329624|FG006|Overall Study|Adverse Event|0|||
157160341|NCT01689207|567329625|FG007|Overall Study|Adverse Event|0|||
156860863|NCT01601535|566249030|FG000|Phase 1|Adverse Event|1|||
156860864|NCT01601535|566249031|FG001|Phase 1|Adverse Event|0|||
156860865|NCT01601535|566249032|FG002|Phase 1|Adverse Event|2|||
156860866|NCT01601535|566249033|FG003|Phase 1|Adverse Event|1|||
157160342|NCT01689207|567329626|FG008|Overall Study|Adverse Event|1|||
157160343|NCT01689207|567329627|FG009|Overall Study|Adverse Event|0|||
157160344|NCT01689207|567329628|FG010|Overall Study|Adverse Event|0|||
157160345|NCT01912768|567329629|FG000|Overall Study|Adverse Event|2|||
157160346|NCT01912768|567329630|FG001|Overall Study|Adverse Event|0|||
157160347|NCT01912768|567329629|FG000|Overall Study|Lost to Follow-up|2|||
157160348|NCT01912768|567329630|FG001|Overall Study|Lost to Follow-up|1|||
156860867|NCT01601535|566249034|FG004|Phase 1|Adverse Event|0|||
156860868|NCT01601535|566249035|FG005|Phase 1|Adverse Event|0|||
156860869|NCT01601535|566249030|FG000|Phase 1|Withdrawal by Subject|2|||
156860870|NCT01601535|566249031|FG001|Phase 1|Withdrawal by Subject|1|||
157160349|NCT01912768|567329629|FG000|Overall Study|Withdrawal by Subject|5|||
156860871|NCT01601535|566249032|FG002|Phase 1|Withdrawal by Subject|1|||
156860872|NCT01601535|566249033|FG003|Phase 1|Withdrawal by Subject|2|||
156860873|NCT01601535|566249034|FG004|Phase 1|Withdrawal by Subject|0|||
156860874|NCT01601535|566249035|FG005|Phase 1|Withdrawal by Subject|0|||
156860875|NCT01601535|566249030|FG000|Phase 1|Progressive Disease|2|||
156860876|NCT01601535|566249031|FG001|Phase 1|Progressive Disease|3|||
156860877|NCT01601535|566249032|FG002|Phase 1|Progressive Disease|2|||
156860878|NCT01601535|566249033|FG003|Phase 1|Progressive Disease|1|||
156860879|NCT01601535|566249034|FG004|Phase 1|Progressive Disease|0|||
156860880|NCT01601535|566249035|FG005|Phase 1|Progressive Disease|0|||
156912880|NCT02170298|566440357|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
156912881|NCT00777608|566440359|FG000|Overall Study|Lost to Follow-up|1|||
156912882|NCT00777608|566440360|FG001|Overall Study|Lost to Follow-up|1|||
156912883|NCT00777608|566440359|FG000|Overall Study|Withdrawal by Subject|1|||
156912884|NCT00777608|566440360|FG001|Overall Study|Withdrawal by Subject|3|||
156912885|NCT00777608|566440359|FG000|Overall Study|Protocol Violation|1|||
156912886|NCT00777608|566440360|FG001|Overall Study|Protocol Violation|0|||
156912887|NCT00777608|566440359|FG000|Overall Study|Investigator Decision|1|||
156860881|NCT01601535|566249030|FG000|Phase 1|Started Another Treatment|1|||
156860882|NCT01601535|566249031|FG001|Phase 1|Started Another Treatment|2|||
156912888|NCT00777608|566440360|FG001|Overall Study|Investigator Decision|2|||
156912889|NCT04182763|566440364|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
156912890|NCT04182763|566440365|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
156912891|NCT04182763|566440366|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
156912892|NCT04182763|566440367|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
156912893|NCT04182763|566440368|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
156912894|NCT04182763|566440364|FG000|Double-Blind Period, initial 6 months|Death|0|||
156912895|NCT04182763|566440365|FG001|Double-Blind Period, initial 6 months|Death|1|||
156912896|NCT04182763|566440366|FG002|Double-Blind Period, initial 6 months|Death|0|||
156912897|NCT04182763|566440367|FG003|Double-Blind Period, initial 6 months|Death|0|||
156912898|NCT04182763|566440368|FG004|Double-Blind Period, initial 6 months|Death|0|||
156912899|NCT04182763|566440364|FG000|Open-Label Period, subsequent 18 months|Death|3|||
156860883|NCT01601535|566249032|FG002|Phase 1|Started Another Treatment|0|||
156860884|NCT01601535|566249033|FG003|Phase 1|Started Another Treatment|0|||
156860885|NCT01601535|566249034|FG004|Phase 1|Started Another Treatment|0|||
156860886|NCT01601535|566249035|FG005|Phase 1|Started Another Treatment|0|||
156860887|NCT01601535|566249030|FG000|Phase 2|Adverse Event|0|||
156860888|NCT01601535|566249031|FG001|Phase 2|Adverse Event|0|||
156860889|NCT01601535|566249032|FG002|Phase 2|Adverse Event|0|||
156860890|NCT01601535|566249033|FG003|Phase 2|Adverse Event|0|||
156860891|NCT01601535|566249034|FG004|Phase 2|Adverse Event|5|||
156860892|NCT01601535|566249035|FG005|Phase 2|Adverse Event|1|||
156860893|NCT01601535|566249030|FG000|Phase 2|Withdrawal by Subject|0|||
156860894|NCT01601535|566249031|FG001|Phase 2|Withdrawal by Subject|0|||
156860895|NCT01601535|566249032|FG002|Phase 2|Withdrawal by Subject|0|||
156860896|NCT01601535|566249033|FG003|Phase 2|Withdrawal by Subject|0|||
156860897|NCT01601535|566249034|FG004|Phase 2|Withdrawal by Subject|8|||
156860898|NCT01601535|566249035|FG005|Phase 2|Withdrawal by Subject|2|||
156860899|NCT01601535|566249030|FG000|Phase 2|Progressive Disease|0|||
156860900|NCT01601535|566249031|FG001|Phase 2|Progressive Disease|0|||
156860901|NCT01601535|566249032|FG002|Phase 2|Progressive Disease|0|||
156860902|NCT01601535|566249033|FG003|Phase 2|Progressive Disease|0|||
156860903|NCT01601535|566249034|FG004|Phase 2|Progressive Disease|5|||
156860904|NCT01601535|566249035|FG005|Phase 2|Progressive Disease|7|||
156860905|NCT01601535|566249030|FG000|Phase 2|Started Another Treatment|0|||
156860906|NCT01601535|566249031|FG001|Phase 2|Started Another Treatment|0|||
156860907|NCT01601535|566249032|FG002|Phase 2|Started Another Treatment|0|||
156860908|NCT01601535|566249033|FG003|Phase 2|Started Another Treatment|0|||
156860909|NCT01601535|566249034|FG004|Phase 2|Started Another Treatment|1|||
156860910|NCT01601535|566249035|FG005|Phase 2|Started Another Treatment|2|||
156860911|NCT01576341|566249038|FG000|Overall Study|Withdrawal by Subject|24|||
156860912|NCT01576341|566249038|FG000|Overall Study|Adverse Event|10|||
156860913|NCT01576341|566249038|FG000|Overall Study|Death|21|||
156860914|NCT01576341|566249038|FG000|Overall Study|Physician Decision|2|||
156912900|NCT04182763|566440365|FG001|Open-Label Period, subsequent 18 months|Death|2|||
156912901|NCT04182763|566440366|FG002|Open-Label Period, subsequent 18 months|Death|2|||
156912902|NCT04182763|566440367|FG003|Open-Label Period, subsequent 18 months|Death|0|||
156860915|NCT01576341|566249038|FG000|Overall Study|Lost to Follow-up|2|||
156860916|NCT01576341|566249038|FG000|Overall Study|Kidney transplantation|10|||
156860917|NCT01576341|566249038|FG000|Overall Study|Protocol Violation|12|||
156860918|NCT01576341|566249038|FG000|Overall Study|Other|12|||
156860919|NCT00556075|566249039|FG000|Overall Study|Lost to Follow-up|3|||
156860920|NCT00556075|566249040|FG001|Overall Study|Lost to Follow-up|0|||
156860921|NCT00556075|566249041|FG002|Overall Study|Lost to Follow-up|3|||
156860922|NCT00556075|566249039|FG000|Overall Study|Withdrawal by Subject|3|||
156860923|NCT00556075|566249040|FG001|Overall Study|Withdrawal by Subject|3|||
156912903|NCT04182763|566440368|FG004|Open-Label Period, subsequent 18 months|Death|1|||
156912904|NCT04182763|566440364|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
156912905|NCT04182763|566440365|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
156912906|NCT04182763|566440366|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
156912907|NCT04182763|566440367|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
156912908|NCT04182763|566440368|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
156912909|NCT04182763|566440364|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156912910|NCT04182763|566440365|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
156912911|NCT04182763|566440366|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156912912|NCT04182763|566440367|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
156912913|NCT04182763|566440368|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
156912914|NCT01539538|566440370|FG000|Overall Study|Adverse Event|13|||
156912915|NCT01539538|566440371|FG001|Overall Study|Adverse Event|18|||
156912916|NCT01539538|566440370|FG000|Overall Study|Lack of Efficacy|13|||
156912917|NCT01539538|566440371|FG001|Overall Study|Lack of Efficacy|16|||
156912918|NCT01539538|566440370|FG000|Overall Study|Withdrawal by Subject|2|||
156912919|NCT01539538|566440371|FG001|Overall Study|Withdrawal by Subject|3|||
156912920|NCT01539538|566440370|FG000|Overall Study|PCA no longer required or PCA problem|3|||
156912921|NCT01539538|566440371|FG001|Overall Study|PCA no longer required or PCA problem|7|||
156912922|NCT00847379|566440372|FG000|Overall Study|Study terminated by Sponsor|59|||
156912923|NCT00847379|566440373|FG001|Overall Study|Study terminated by Sponsor|57|||
156912924|NCT00847379|566440374|FG002|Overall Study|Study terminated by Sponsor|57|||
156912925|NCT00378378|566440379|FG000|Overall Study|Withdrawal by Subject|0|||
156912926|NCT00378378|566440380|FG001|Overall Study|Withdrawal by Subject|1|||
156912927|NCT00378378|566440381|FG002|Overall Study|Withdrawal by Subject|0|||
156912928|NCT00378378|566440379|FG000|Overall Study|Treatment Failure|0|||
156912929|NCT00378378|566440380|FG001|Overall Study|Treatment Failure|0|||
156912930|NCT00378378|566440381|FG002|Overall Study|Treatment Failure|1|||
156912931|NCT00378378|566440379|FG000|Overall Study|Non-compliance with protocol|0|||
156912932|NCT00378378|566440380|FG001|Overall Study|Non-compliance with protocol|0|||
157160350|NCT01912768|567329630|FG001|Overall Study|Withdrawal by Subject|3|||
157160351|NCT01912768|567329629|FG000|Overall Study|Randomized in error|1|||
157160352|NCT01912768|567329630|FG001|Overall Study|Randomized in error|0|||
157160353|NCT00524316|567329631|FG000|Overall Study|Withdrawal by Subject|2|||
157160354|NCT00524316|567329631|FG000|Overall Study|Adverse Event|7|||
157160355|NCT00524316|567329631|FG000|Overall Study|Disease Progression|7|||
157160356|NCT01199263|567329632|FG000|Overall Study|Ineligible|0|||
156860924|NCT00556075|566249041|FG002|Overall Study|Withdrawal by Subject|0|||
156860925|NCT00556075|566249039|FG000|Overall Study|Protocol Violation|1|||
156860926|NCT00556075|566249040|FG001|Overall Study|Protocol Violation|1|||
156860927|NCT00556075|566249041|FG002|Overall Study|Protocol Violation|3|||
156860928|NCT00556075|566249039|FG000|Overall Study|Not eligible|1|||
156860929|NCT00556075|566249040|FG001|Overall Study|Not eligible|1|||
156860930|NCT00556075|566249041|FG002|Overall Study|Not eligible|2|||
156860931|NCT00556075|566249039|FG000|Overall Study|Adverse Event|1|||
156860932|NCT00556075|566249040|FG001|Overall Study|Adverse Event|2|||
156860933|NCT00556075|566249041|FG002|Overall Study|Adverse Event|0|||
156860934|NCT00556075|566249039|FG000|Overall Study|Personal issues|4|||
156860935|NCT00556075|566249040|FG001|Overall Study|Personal issues|1|||
156860936|NCT00556075|566249041|FG002|Overall Study|Personal issues|0|||
156860937|NCT00556075|566249039|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
156860938|NCT00556075|566249040|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
156860939|NCT00556075|566249041|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
156860940|NCT01927497|566249042|FG000|Overall Study|Death|0|||
156860941|NCT01927497|566249043|FG001|Overall Study|Death|1|||
156860942|NCT01927497|566249042|FG000|Overall Study|Protocol Violation|2|||
156860943|NCT01927497|566249043|FG001|Overall Study|Protocol Violation|0|||
156860944|NCT00395746|566249044|FG000|Overall Study|Adverse Event|5|||
156860945|NCT00395746|566249045|FG001|Overall Study|Adverse Event|2|||
156860946|NCT00395746|566249046|FG002|Overall Study|Adverse Event|2|||
156860947|NCT00395746|566249044|FG000|Overall Study|Protocol Violation|0|||
156860948|NCT00395746|566249045|FG001|Overall Study|Protocol Violation|1|||
156860949|NCT00395746|566249046|FG002|Overall Study|Protocol Violation|0|||
156860950|NCT00395746|566249044|FG000|Overall Study|Lack of Efficacy|2|||
156860951|NCT00395746|566249045|FG001|Overall Study|Lack of Efficacy|0|||
156860952|NCT00395746|566249046|FG002|Overall Study|Lack of Efficacy|17|||
156860953|NCT00395746|566249044|FG000|Overall Study|Hypoglycaemia|2|||
156860954|NCT00395746|566249045|FG001|Overall Study|Hypoglycaemia|1|||
156860955|NCT00395746|566249046|FG002|Overall Study|Hypoglycaemia|0|||
156860956|NCT00395746|566249044|FG000|Overall Study|Subject decision|0|||
156860957|NCT00395746|566249045|FG001|Overall Study|Subject decision|0|||
156860958|NCT00395746|566249046|FG002|Overall Study|Subject decision|1|||
156912933|NCT00378378|566440381|FG002|Overall Study|Non-compliance with protocol|1|||
157160357|NCT01199263|567329633|FG001|Overall Study|Ineligible|2|||
157160358|NCT01199263|567329632|FG000|Overall Study|Never Treated|6|||
157225602|NCT00337571|567571477|FG003|Overall Study|No longer met study criteria|0|||
157225603|NCT00337571|567571474|FG000|Overall Study|High Potassium level|0|||
156860959|NCT00395746|566249044|FG000|Overall Study|Withdrawal of consent|0|||
156860960|NCT00395746|566249045|FG001|Overall Study|Withdrawal of consent|0|||
156860961|NCT00395746|566249046|FG002|Overall Study|Withdrawal of consent|1|||
156860962|NCT00395746|566249044|FG000|Overall Study|Difficultulty in use of device|0|||
156860963|NCT00395746|566249045|FG001|Overall Study|Difficultulty in use of device|0|||
156860964|NCT00395746|566249046|FG002|Overall Study|Difficultulty in use of device|1|||
156860965|NCT00395746|566249044|FG000|Overall Study|Unable to visit site on schedule|1|||
156860966|NCT00395746|566249045|FG001|Overall Study|Unable to visit site on schedule|0|||
156860967|NCT00395746|566249046|FG002|Overall Study|Unable to visit site on schedule|0|||
156860968|NCT04528641|566249047|FG000|Overall Study|Withdrawal by Subject|0|||
156860969|NCT04528641|566249048|FG001|Overall Study|Withdrawal by Subject|0|||
156860970|NCT04528641|566249049|FG002|Overall Study|Withdrawal by Subject|0|||
156860971|NCT04528641|566249050|FG003|Overall Study|Withdrawal by Subject|1|||
156860972|NCT04528641|566249051|FG004|Overall Study|Withdrawal by Subject|0|||
156860973|NCT04528641|566249052|FG005|Overall Study|Withdrawal by Subject|1|||
156860974|NCT00517296|566249055|FG000|Overall Study|Withdrawal by Subject|1|||
156860975|NCT00517296|566249056|FG001|Overall Study|Withdrawal by Subject|0|||
156860976|NCT04764162|566249057|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
156860977|NCT04764162|566249058|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
156860978|NCT03361137|566249059|FG000|Overall Study|Reason not specified|1|||
156860979|NCT03361137|566249060|FG001|Overall Study|Reason not specified|0|||
156860980|NCT03361137|566249061|FG002|Overall Study|Reason not specified|0|||
156860981|NCT03361137|566249062|FG003|Overall Study|Reason not specified|0|||
156860982|NCT03361137|566249063|FG004|Overall Study|Reason not specified|0|||
156860983|NCT03009058|566249066|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
156860984|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860985|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
156860986|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860987|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860988|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
156860989|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860990|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
156860991|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860992|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860993|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
156860994|NCT05556265|566249067|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860995|NCT05556265|566249068|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
156860996|NCT05556265|566249069|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860997|NCT05556265|566249070|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860998|NCT05556265|566249071|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
156860999|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
156861000|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
156861001|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
156861002|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
156861003|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
156861004|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
156861005|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
156861006|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
156861007|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
156861008|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
156861009|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
156861010|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
156861011|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
156861012|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
156861013|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
156861014|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861015|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
156861016|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861017|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
156861018|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
156912934|NCT00982878|566440392|FG000|Overall Study|Physician Decision|1|||
156912935|NCT01854710|566440393|FG000|Overall Study|Withdrawal by Subject|2|||
157160359|NCT01199263|567329633|FG001|Overall Study|Never Treated|0|||
157160360|NCT00444626|567329636|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
157160361|NCT00444626|567329636|FG000|Initial Treatment Period|Adverse Event|1|||
157160362|NCT00444626|567329636|FG000|Initial Treatment Period|Lost to Follow-up|9|||
156861019|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861020|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861021|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
156861022|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
156861023|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
156861024|NCT05556265|566249067|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861025|NCT05556265|566249068|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861026|NCT05556265|566249069|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
156861027|NCT05556265|566249070|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
156861028|NCT05556265|566249071|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
156861029|NCT03077542|566249074|FG000|Overall Study|Death|4|||
156861030|NCT03077542|566249075|FG001|Overall Study|Death|0|||
156861031|NCT03077542|566249074|FG000|Overall Study|Physician Decision|6|||
156861032|NCT03077542|566249075|FG001|Overall Study|Physician Decision|1|||
156861033|NCT03077542|566249074|FG000|Overall Study|Withdrawal by Subject|0|||
156861034|NCT03077542|566249075|FG001|Overall Study|Withdrawal by Subject|1|||
156861035|NCT00795704|566249076|FG000|Overall Study|Withdrawal by Subject|3|||
156861036|NCT00795704|566249077|FG001|Overall Study|Withdrawal by Subject|2|||
156861037|NCT00795704|566249076|FG000|Overall Study|Adverse Event|1|||
156861038|NCT00795704|566249077|FG001|Overall Study|Adverse Event|1|||
156861039|NCT03980730|566249078|FG000|Overall Study|Study Terminated by Sponsor|0|||
156861040|NCT03980730|566249079|FG001|Overall Study|Study Terminated by Sponsor|3|||
156861041|NCT03980730|566249078|FG000|Overall Study|Adverse Event|2|||
156861042|NCT03980730|566249079|FG001|Overall Study|Adverse Event|0|||
156861043|NCT03980730|566249078|FG000|Overall Study|Sponsor Request|0|||
156861044|NCT03980730|566249079|FG001|Overall Study|Sponsor Request|1|||
156861045|NCT01300728|566249080|FG000|Overall Study|Withdrawal by Subject|1|||
156861046|NCT01300728|566249081|FG001|Overall Study|Withdrawal by Subject|1|||
156861047|NCT01300728|566249080|FG000|Overall Study|Physician Decision|1|||
156861048|NCT01300728|566249081|FG001|Overall Study|Physician Decision|0|||
156861049|NCT03474588|566249089|FG000|Overall Study|Withdrawal by Subject|4|||
156861050|NCT03474588|566249090|FG001|Overall Study|Withdrawal by Subject|3|||
156861051|NCT03474588|566249089|FG000|Overall Study|Death|0|||
156861052|NCT03474588|566249090|FG001|Overall Study|Death|1|||
156861053|NCT00945009|566249094|FG000|Overall Study|Lack of Efficacy|10|||
156861054|NCT00945009|566249095|FG001|Overall Study|Lack of Efficacy|0|||
156861055|NCT00945009|566249096|FG002|Overall Study|Lack of Efficacy|0|||
156861056|NCT00945009|566249094|FG000|Overall Study|Physician Decision|21|||
156861057|NCT00945009|566249095|FG001|Overall Study|Physician Decision|4|||
156861058|NCT00945009|566249096|FG002|Overall Study|Physician Decision|3|||
156861059|NCT00945009|566249094|FG000|Overall Study|Protocol Violation|6|||
156861060|NCT00945009|566249095|FG001|Overall Study|Protocol Violation|1|||
156861061|NCT00945009|566249096|FG002|Overall Study|Protocol Violation|0|||
156861062|NCT00945009|566249094|FG000|Overall Study|Withdrawal by Subject|1|||
156861063|NCT00945009|566249095|FG001|Overall Study|Withdrawal by Subject|0|||
156861064|NCT00945009|566249096|FG002|Overall Study|Withdrawal by Subject|0|||
156861065|NCT00945009|566249094|FG000|Overall Study|Ineligible|6|||
156861066|NCT00945009|566249095|FG001|Overall Study|Ineligible|1|||
156861067|NCT00945009|566249096|FG002|Overall Study|Ineligible|0|||
156861068|NCT00945009|566249094|FG000|Overall Study|Inevaluable|0|||
156861069|NCT00945009|566249095|FG001|Overall Study|Inevaluable|1|||
156861070|NCT00945009|566249096|FG002|Overall Study|Inevaluable|0|||
156861071|NCT00945009|566249094|FG000|Overall Study|Refusal of further protocol|1|||
156861072|NCT00945009|566249095|FG001|Overall Study|Refusal of further protocol|0|||
156861073|NCT00945009|566249096|FG002|Overall Study|Refusal of further protocol|0|||
156861074|NCT03724942|566249097|FG000|Overall Study|Adverse Event|20|||
156861075|NCT03724942|566249098|FG001|Overall Study|Adverse Event|14|||
156861076|NCT03724942|566249097|FG000|Overall Study|Lack of Efficacy|0|||
156861077|NCT03724942|566249098|FG001|Overall Study|Lack of Efficacy|1|||
156861078|NCT03724942|566249097|FG000|Overall Study|Physician Decision|5|||
156861079|NCT03724942|566249098|FG001|Overall Study|Physician Decision|2|||
157160363|NCT00008138|567329639|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
157160364|NCT00008138|567329639|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
157160365|NCT00008138|567329639|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
156861080|NCT03724942|566249097|FG000|Overall Study|Protocol Violation|1|||
156861081|NCT03724942|566249098|FG001|Overall Study|Protocol Violation|0|||
156861082|NCT03724942|566249097|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
157160366|NCT00008138|567329639|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
157160367|NCT00008138|567329639|FG000|Interval Debulking|Withdrawal by Subject|2|||
156861083|NCT03724942|566249098|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
156861084|NCT03724942|566249097|FG000|Overall Study|Withdrawal by Legal Representative|3|||
157160368|NCT00008138|567329639|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
156861085|NCT03724942|566249098|FG001|Overall Study|Withdrawal by Legal Representative|0|||
156861086|NCT04875975|566249099|FG000|Overall Study|Adverse Event|1|||
156861087|NCT04875975|566249100|FG001|Overall Study|Adverse Event|2|||
156861088|NCT04875975|566249099|FG000|Overall Study|Lack of Efficacy|2|||
156861089|NCT04875975|566249100|FG001|Overall Study|Lack of Efficacy|2|||
156861090|NCT04875975|566249099|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
156861091|NCT04875975|566249100|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
156861092|NCT04875975|566249099|FG000|Overall Study|Relapse With Insults|0|||
156861093|NCT04875975|566249100|FG001|Overall Study|Relapse With Insults|1|||
156861094|NCT04875975|566249099|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
156861095|NCT04875975|566249100|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
156861096|NCT02429830|566249101|FG000|Overall Study|Lost to Follow-up|1|||
156861097|NCT02429830|566249101|FG000|Overall Study|Device Explant|2|||
156861098|NCT00474487|566250678|FG000|Overall Study|Withdrawal by Subject|6|||
156861099|NCT00474487|566250679|FG001|Overall Study|Withdrawal by Subject|0|||
156861100|NCT00474487|566250680|FG002|Overall Study|Withdrawal by Subject|0|||
156861101|NCT00474487|566250681|FG003|Overall Study|Withdrawal by Subject|0|||
156861102|NCT00474487|566250678|FG000|Overall Study|Lost to Follow-up|20|||
156861103|NCT00474487|566250679|FG001|Overall Study|Lost to Follow-up|1|||
156861104|NCT00474487|566250680|FG002|Overall Study|Lost to Follow-up|7|||
156861105|NCT00474487|566250681|FG003|Overall Study|Lost to Follow-up|0|||
156861106|NCT00474487|566250678|FG000|Overall Study|Inappropriate enrollment|4|||
156861107|NCT00474487|566250679|FG001|Overall Study|Inappropriate enrollment|0|||
156861108|NCT00474487|566250680|FG002|Overall Study|Inappropriate enrollment|7|||
156861109|NCT00474487|566250681|FG003|Overall Study|Inappropriate enrollment|0|||
156861110|NCT00474487|566250678|FG000|Overall Study|Death|0|||
156861111|NCT00474487|566250679|FG001|Overall Study|Death|1|||
156912936|NCT01854710|566440394|FG001|Overall Study|Withdrawal by Subject|1|||
156912937|NCT01854710|566440395|FG002|Overall Study|Withdrawal by Subject|0|||
156861112|NCT00474487|566250680|FG002|Overall Study|Death|0|||
156861113|NCT00474487|566250681|FG003|Overall Study|Death|0|||
156861114|NCT02220920|566250682|FG000|Overall Study|Adverse Event|1|||
156861115|NCT02220920|566250683|FG001|Overall Study|Adverse Event|0|||
156861116|NCT02220920|566250682|FG000|Overall Study|Lack of Efficacy|0|||
156861117|NCT02220920|566250683|FG001|Overall Study|Lack of Efficacy|1|||
156861118|NCT02220920|566250682|FG000|Overall Study|Withdrawal by Subject|1|||
156861119|NCT02220920|566250683|FG001|Overall Study|Withdrawal by Subject|0|||
156861120|NCT02220920|566250682|FG000|Overall Study|Conflict with the stopping criteria|1|||
156861121|NCT02220920|566250683|FG001|Overall Study|Conflict with the stopping criteria|2|||
156861122|NCT05176314|566250686|FG000|Overall Study|Lost to Follow-up|2|||
156861123|NCT05176314|566250686|FG000|Overall Study|Physician Decision|1|||
156861124|NCT05176314|566250686|FG000|Overall Study|Adverse Event|1|||
156861125|NCT05543265|566250689|FG000|Overall Study|Lost to Follow-up|3|||
156861126|NCT05543265|566250690|FG001|Overall Study|Lost to Follow-up|3|||
156861127|NCT05543265|566250689|FG000|Overall Study|Withdrawal by Subject|0|||
156861128|NCT05543265|566250690|FG001|Overall Study|Withdrawal by Subject|1|||
156861129|NCT05316597|566250691|FG000|First Session|Withdrawal by Subject|0|||
156861130|NCT05316597|566250692|FG001|First Session|Withdrawal by Subject|1|||
156861131|NCT05316597|566250691|FG000|Washout Period|Lost to Follow-up|1|||
156861132|NCT05316597|566250692|FG001|Washout Period|Lost to Follow-up|2|||
156861133|NCT05316597|566250691|FG000|Washout Period|Physician Decision|1|||
156912938|NCT01854710|566440396|FG003|Overall Study|Withdrawal by Subject|0|||
156912939|NCT01854710|566440397|FG004|Overall Study|Withdrawal by Subject|0|||
156912940|NCT01854710|566440398|FG005|Overall Study|Withdrawal by Subject|0|||
157160369|NCT00008138|567329639|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
157160370|NCT00008138|567329639|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
157160371|NCT01575197|567331455|FG000|Overall Study|Migration out of study area|1|||
157160372|NCT01575197|567331456|FG001|Overall Study|Migration out of study area|5|||
157160373|NCT01575197|567331457|FG002|Overall Study|Migration out of study area|4|||
157160374|NCT01575197|567331455|FG000|Overall Study|SAE|0|||
157160375|NCT01575197|567331456|FG001|Overall Study|SAE|1|||
157160376|NCT01575197|567331457|FG002|Overall Study|SAE|0|||
156912941|NCT01854710|566440393|FG000|Overall Study|CRI procedural error|2|||
157160377|NCT01575197|567331455|FG000|Overall Study|Lost to Follow-up|0|||
156861134|NCT05316597|566250692|FG001|Washout Period|Physician Decision|1|||
156861135|NCT05316597|566250691|FG000|Washout Period|Excluded before second session|1|||
157160378|NCT01575197|567331456|FG001|Overall Study|Lost to Follow-up|1|||
156861136|NCT05316597|566250692|FG001|Washout Period|Excluded before second session|1|||
156861137|NCT05316597|566250691|FG000|Washout Period|Withdrawal by Subject|0|||
156861138|NCT05316597|566250692|FG001|Washout Period|Withdrawal by Subject|4|||
156861139|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
156861140|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
156912942|NCT01854710|566440394|FG001|Overall Study|CRI procedural error|2|||
157160379|NCT01575197|567331457|FG002|Overall Study|Lost to Follow-up|0|||
157160380|NCT01575197|567331455|FG000|Overall Study|Withdrawal by Subject|0|||
157160381|NCT01575197|567331456|FG001|Overall Study|Withdrawal by Subject|1|||
157160382|NCT01575197|567331457|FG002|Overall Study|Withdrawal by Subject|1|||
156861141|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
156861142|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Death|9|||
156861143|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Death|0|||
156861144|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Death|0|||
156861145|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
156861146|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
156861147|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
157160383|NCT01575197|567331455|FG000|Overall Study|Protocol Violation|2|||
157160384|NCT01575197|567331456|FG001|Overall Study|Protocol Violation|1|||
157160385|NCT01575197|567331457|FG002|Overall Study|Protocol Violation|1|||
156861148|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
156861149|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
156861150|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
156861151|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Other|135|||
156861152|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Other|0|||
156861153|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Other|0|||
156861154|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
156861155|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
156861156|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
156861157|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
156861158|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
156861159|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
156861160|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
156861161|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
156861162|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
156861163|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Other|3|||
156861164|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Other|0|||
156861165|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Other|0|||
156861166|NCT02118584|566250693|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
156861167|NCT02118584|566250694|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
157160386|NCT02709083|567331458|FG000|Overall Study|Original PI left institution|7|||
157160387|NCT01626352|567331462|FG000|Overall Study|Disease Progression|3|||
157160388|NCT01626352|567331462|FG000|Overall Study|Intercurrent Illness|2|||
156861168|NCT02118584|566250695|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
156861169|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156861170|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
156861171|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
156861172|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
156861173|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
156861174|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
156861175|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
156861176|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
156861177|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
156861178|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156861179|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
156861180|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
156861181|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156861182|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
156861183|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
156861184|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
156861185|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
156861186|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
156861187|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156861188|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
156861189|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
156861190|NCT02118584|566250693|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
156861191|NCT02118584|566250694|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
156861192|NCT02118584|566250695|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
156861193|NCT02182895|566250698|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
157160389|NCT01626352|567331462|FG000|Overall Study|Death|2|||
157160390|NCT01626352|567331462|FG000|Overall Study|Withdrawal by Subject|1|||
157160391|NCT01626352|567331462|FG000|Overall Study|Non-Compliance|1|||
156861194|NCT02182895|566250699|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
156861195|NCT03103542|566250700|FG000|Overall Study|Physician Decision|2|||
156861196|NCT03103542|566250700|FG000|Overall Study|Adverse Event|2|||
156861197|NCT03103542|566250700|FG000|Overall Study|Other|2|||
156861198|NCT03103542|566250700|FG000|Overall Study|Withdrawal by Subject|1|||
156861199|NCT03566511|566250701|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
157160392|NCT01626352|567331462|FG000|Overall Study|Never Treated|1|||
157160393|NCT03583372|567331463|FG000|Overall Study|Withdrawal by Subject|6|||
157160394|NCT03583372|567331464|FG001|Overall Study|Withdrawal by Subject|11|||
157160395|NCT03583372|567331465|FG002|Overall Study|Withdrawal by Subject|7|||
157160396|NCT03583372|567331466|FG003|Overall Study|Withdrawal by Subject|8|||
157160397|NCT03583372|567331463|FG000|Overall Study|Lost to Follow-up|4|||
157160398|NCT03583372|567331464|FG001|Overall Study|Lost to Follow-up|6|||
157160399|NCT03583372|567331465|FG002|Overall Study|Lost to Follow-up|3|||
157160400|NCT03583372|567331466|FG003|Overall Study|Lost to Follow-up|2|||
157160401|NCT03583372|567331463|FG000|Overall Study|Adverse Event|1|||
157225604|NCT00337571|567571475|FG001|Overall Study|High Potassium level|0|||
157225605|NCT00337571|567571476|FG002|Overall Study|High Potassium level|0|||
157225606|NCT00337571|567571477|FG003|Overall Study|High Potassium level|1|||
157225607|NCT01974895|567571483|FG000|Overall Study|Protocol Violation|1|||
157225608|NCT01974895|567571484|FG001|Overall Study|Protocol Violation|0|||
157225609|NCT01974895|567571483|FG000|Overall Study|Lost to Follow-up|4|||
157225610|NCT01974895|567571484|FG001|Overall Study|Lost to Follow-up|6|||
157225611|NCT01974895|567571483|FG000|Overall Study|Withdrawal by Subject|0|||
157225612|NCT01974895|567571484|FG001|Overall Study|Withdrawal by Subject|1|||
157225613|NCT01974895|567571483|FG000|Overall Study|Other (Missed Visit)|1|||
157225614|NCT01974895|567571484|FG001|Overall Study|Other (Missed Visit)|0|||
157225615|NCT01974895|567571483|FG000|Overall Study|Other (Reason unknown)|9|||
157225616|NCT01974895|567571484|FG001|Overall Study|Other (Reason unknown)|8|||
157225617|NCT02192099|567571485|FG000|Overall Study|Adverse Event|1|||
157225618|NCT02192099|567571485|FG000|Overall Study|Lost to Follow-up|2|||
157225619|NCT02192099|567571485|FG000|Overall Study|Physician Decision|1|||
157225620|NCT02192099|567571485|FG000|Overall Study|Pregnancy|1|||
157225621|NCT02192099|567571485|FG000|Overall Study|Protocol Violation|8|||
157225622|NCT02192099|567571485|FG000|Overall Study|Study Terminated by Sponsor|32|||
157225623|NCT02192099|567571485|FG000|Overall Study|Withdrawal by Subject|11|||
157225624|NCT02192099|567571485|FG000|Overall Study|Miscellaneous Reasons|5|||
157225625|NCT00386009|567571486|FG000|Overall Study|Adverse Event|0|||
157225626|NCT00386009|567571487|FG001|Overall Study|Adverse Event|2|||
157225627|NCT00386009|567571486|FG000|Overall Study|Death|1|||
157225628|NCT00386009|567571487|FG001|Overall Study|Death|0|||
156861200|NCT03566511|566250702|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
156861201|NCT02939287|566250706|FG000|Overall Study|met exclusion criteria|1|||
156861202|NCT02939287|566250707|FG001|Overall Study|met exclusion criteria|1|||
156861203|NCT02939287|566250708|FG002|Overall Study|met exclusion criteria|1|||
156861204|NCT02939287|566250706|FG000|Overall Study|Did not complete survey|2|||
156861205|NCT02939287|566250707|FG001|Overall Study|Did not complete survey|2|||
156861206|NCT02939287|566250708|FG002|Overall Study|Did not complete survey|0|||
157225629|NCT00386009|567571486|FG000|Overall Study|Entry Criteria Not Met|0|||
156861207|NCT02939287|566250706|FG000|Overall Study|Withdrawal by Subject|1|||
156861208|NCT02939287|566250707|FG001|Overall Study|Withdrawal by Subject|1|||
156861209|NCT02939287|566250708|FG002|Overall Study|Withdrawal by Subject|0|||
156861210|NCT02927301|566250709|FG000|Overall Study|Death|39|||
156861211|NCT02927301|566250709|FG000|Overall Study|Lost to Follow-up|8|||
156861212|NCT02927301|566250709|FG000|Overall Study|Physician Decision|2|||
156861213|NCT02927301|566250709|FG000|Overall Study|Withdrawal by Subject|12|||
156861214|NCT02927301|566250709|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
156861215|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
156861216|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861217|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861218|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861219|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861220|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
156861221|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
156861222|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861223|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
156861224|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
157160402|NCT03583372|567331464|FG001|Overall Study|Adverse Event|3|||
156861225|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
157225630|NCT00386009|567571487|FG001|Overall Study|Entry Criteria Not Met|2|||
157225631|NCT00386009|567571486|FG000|Overall Study|Lost to Follow-up|1|||
157225632|NCT00386009|567571487|FG001|Overall Study|Lost to Follow-up|1|||
156861226|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861227|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
157160403|NCT03583372|567331465|FG002|Overall Study|Adverse Event|4|||
157225633|NCT00386009|567571486|FG000|Overall Study|Protocol Violation|1|||
157225634|NCT00386009|567571487|FG001|Overall Study|Protocol Violation|0|||
157225635|NCT00386009|567571486|FG000|Overall Study|Sponsor Decision|1|||
157225636|NCT00386009|567571487|FG001|Overall Study|Sponsor Decision|1|||
157225637|NCT00386009|567571486|FG000|Overall Study|Withdrawal by Subject|5|||
157225638|NCT00386009|567571487|FG001|Overall Study|Withdrawal by Subject|4|||
157160404|NCT03583372|567331466|FG003|Overall Study|Adverse Event|4|||
156861228|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
156861229|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861230|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861231|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
156861232|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861233|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861234|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
156861235|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
156861236|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861237|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861238|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861239|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861240|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
156861241|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861242|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
156861243|NCT02903771|566250710|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861244|NCT02903771|566250711|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861245|NCT02903771|566250712|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861246|NCT02903771|566250713|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861247|NCT02903771|566250714|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861248|NCT02903771|566250715|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
157160405|NCT03583372|567331463|FG000|Overall Study|Physician Decision|0|||
157160406|NCT03583372|567331464|FG001|Overall Study|Physician Decision|1|||
157160407|NCT03583372|567331465|FG002|Overall Study|Physician Decision|1|||
157160408|NCT03583372|567331466|FG003|Overall Study|Physician Decision|1|||
157160409|NCT03583372|567331463|FG000|Overall Study|Lack of Efficacy|0|||
157160410|NCT03583372|567331464|FG001|Overall Study|Lack of Efficacy|1|||
157160411|NCT03583372|567331465|FG002|Overall Study|Lack of Efficacy|0|||
157160412|NCT03583372|567331466|FG003|Overall Study|Lack of Efficacy|1|||
157160413|NCT03583372|567331463|FG000|Overall Study|Death|1|||
157160414|NCT03583372|567331464|FG001|Overall Study|Death|0|||
157160415|NCT03583372|567331465|FG002|Overall Study|Death|0|||
157160416|NCT03583372|567331466|FG003|Overall Study|Death|0|||
157160417|NCT03583372|567331463|FG000|Overall Study|Protocol Violation|0|||
157160418|NCT03583372|567331464|FG001|Overall Study|Protocol Violation|1|||
157160419|NCT03583372|567331465|FG002|Overall Study|Protocol Violation|0|||
157160420|NCT03583372|567331466|FG003|Overall Study|Protocol Violation|0|||
157160421|NCT03583372|567331463|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
157160422|NCT03583372|567331464|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
157160423|NCT03583372|567331465|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
157160424|NCT03583372|567331466|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
157160425|NCT03583372|567331463|FG000|Overall Study|Did Not Receive Study Drug|0|||
157160426|NCT03583372|567331464|FG001|Overall Study|Did Not Receive Study Drug|1|||
157160427|NCT03583372|567331465|FG002|Overall Study|Did Not Receive Study Drug|0|||
157160428|NCT03583372|567331466|FG003|Overall Study|Did Not Receive Study Drug|0|||
157160429|NCT03583372|567331463|FG000|Overall Study|Captured as Other in the Database|1|||
157160430|NCT03583372|567331464|FG001|Overall Study|Captured as Other in the Database|2|||
157160431|NCT03583372|567331465|FG002|Overall Study|Captured as Other in the Database|4|||
157160432|NCT03583372|567331466|FG003|Overall Study|Captured as Other in the Database|1|||
157160433|NCT02796391|567331467|FG000|Overall Study|Lost to Follow-up|2|||
157160434|NCT02796391|567331468|FG001|Overall Study|Lost to Follow-up|2|||
157160435|NCT02796391|567331469|FG002|Overall Study|Lost to Follow-up|13|||
157160436|NCT02796391|567331470|FG003|Overall Study|Lost to Follow-up|8|||
157160437|NCT02796391|567331471|FG004|Overall Study|Lost to Follow-up|14|||
157160438|NCT02796391|567331472|FG005|Overall Study|Lost to Follow-up|13|||
157160439|NCT02796391|567331467|FG000|Overall Study|COVID|0|||
157160440|NCT02796391|567331468|FG001|Overall Study|COVID|0|||
157160441|NCT02796391|567331469|FG002|Overall Study|COVID|5|||
157160442|NCT02796391|567331470|FG003|Overall Study|COVID|5|||
156861249|NCT02903771|566250716|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
156861250|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
157027403|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
157027404|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
157160443|NCT02796391|567331471|FG004|Overall Study|COVID|2|||
157160444|NCT02796391|567331472|FG005|Overall Study|COVID|4|||
157160445|NCT02796391|567331467|FG000|Overall Study|Participant did not like study cigarettes|0|||
157160446|NCT02796391|567331468|FG001|Overall Study|Participant did not like study cigarettes|0|||
157160447|NCT02796391|567331469|FG002|Overall Study|Participant did not like study cigarettes|3|||
157160448|NCT02796391|567331470|FG003|Overall Study|Participant did not like study cigarettes|0|||
157160449|NCT02796391|567331471|FG004|Overall Study|Participant did not like study cigarettes|0|||
157160450|NCT02796391|567331472|FG005|Overall Study|Participant did not like study cigarettes|0|||
157160451|NCT02796391|567331467|FG000|Overall Study|Withdrawal by Subject|1|||
157160452|NCT02796391|567331468|FG001|Overall Study|Withdrawal by Subject|1|||
156861251|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861252|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861253|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861254|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
156861255|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861256|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
156861257|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861258|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861259|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861260|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861261|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
156861262|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861263|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
156861264|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861265|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861266|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861267|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861268|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
156861269|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861270|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
156861271|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861272|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861273|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861274|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861275|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
156861276|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861277|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
156861278|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861279|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861280|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861281|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861282|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
156861283|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861284|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
156861285|NCT02903771|566250710|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861286|NCT02903771|566250711|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861287|NCT02903771|566250712|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861288|NCT02903771|566250713|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861289|NCT02903771|566250714|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
156861290|NCT02903771|566250715|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861291|NCT02903771|566250716|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
156861292|NCT02218372|566250717|FG000|Overall Study|Adverse Event|1|||
156861293|NCT02218372|566250718|FG001|Overall Study|Adverse Event|1|||
156861294|NCT02218372|566250717|FG000|Overall Study|Miscellaneous|2|||
156861295|NCT02218372|566250718|FG001|Overall Study|Miscellaneous|1|||
156861296|NCT02218372|566250717|FG000|Overall Study|Randomized but did not receive treatment|2|||
156861297|NCT02218372|566250718|FG001|Overall Study|Randomized but did not receive treatment|3|||
156861298|NCT02218372|566250717|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156861299|NCT02218372|566250718|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156861300|NCT03406780|566250723|FG000|Overall Study|Withdrawal by Subject|1|||
156861301|NCT03406780|566250724|FG001|Overall Study|Withdrawal by Subject|1|||
156861302|NCT03406780|566250723|FG000|Overall Study|Other|0|||
156861303|NCT03406780|566250724|FG001|Overall Study|Other|2|||
156861304|NCT01488045|566250729|FG000|Overall Study|Withdrawal by Subject|6|||
156861305|NCT01488045|566250730|FG001|Overall Study|Withdrawal by Subject|11|||
156861306|NCT01488045|566250729|FG000|Overall Study|Failure to present for colonoscopy|3|||
156861307|NCT01488045|566250730|FG001|Overall Study|Failure to present for colonoscopy|6|||
156861308|NCT01488045|566250729|FG000|Overall Study|Failure to report exclusion criteria|0|||
156861309|NCT01488045|566250730|FG001|Overall Study|Failure to report exclusion criteria|1|||
156861310|NCT05365217|566250732|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156861311|NCT05365217|566250733|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156861312|NCT01680341|566250736|FG000|Overall Study|Adverse Event|3|||
156861313|NCT01680341|566250737|FG001|Overall Study|Adverse Event|2|||
156861314|NCT01680341|566250736|FG000|Overall Study|Unclassified|18|||
156912943|NCT01854710|566440395|FG002|Overall Study|CRI procedural error|2|||
156912944|NCT01854710|566440396|FG003|Overall Study|CRI procedural error|2|||
156912945|NCT01854710|566440397|FG004|Overall Study|CRI procedural error|2|||
156861315|NCT01680341|566250737|FG001|Overall Study|Unclassified|15|||
156861316|NCT03796728|566250739|FG000|Overall Study|Lost to Follow-up|8|||
156861317|NCT03796728|566250739|FG000|Overall Study|Reason not Specified|16|||
156861318|NCT00333775|566250740|FG000|Overall Study|Death|144|||
156861319|NCT00333775|566250741|FG001|Overall Study|Death|149|||
156861320|NCT00333775|566250742|FG002|Overall Study|Death|143|||
156861321|NCT00333775|566250740|FG000|Overall Study|In Follow-up When Study Stopped|87|||
156861322|NCT00333775|566250741|FG001|Overall Study|In Follow-up When Study Stopped|92|||
156861323|NCT00333775|566250742|FG002|Overall Study|In Follow-up When Study Stopped|96|||
156861324|NCT00333775|566250740|FG000|Overall Study|Lost to Follow-up|10|||
156861325|NCT00333775|566250741|FG001|Overall Study|Lost to Follow-up|7|||
156861326|NCT00333775|566250742|FG002|Overall Study|Lost to Follow-up|8|||
156861327|NCT02476617|566250743|FG000|Overall Study|Adverse Event|1|||
156861328|NCT02476617|566250743|FG000|Overall Study|Lost to Follow-up|1|||
156861329|NCT01383928|566250744|FG000|Overall Study|Initiation of ASCT|2|||
156861330|NCT01383928|566250745|FG001|Overall Study|Initiation of ASCT|1|||
156861331|NCT01383928|566250746|FG002|Overall Study|Initiation of ASCT|18|||
156861332|NCT01383928|566250744|FG000|Overall Study|Adverse Event|1|||
156861333|NCT01383928|566250745|FG001|Overall Study|Adverse Event|2|||
156861334|NCT01383928|566250746|FG002|Overall Study|Adverse Event|8|||
156861335|NCT01383928|566250744|FG000|Overall Study|Other|1|||
156861336|NCT01383928|566250745|FG001|Overall Study|Other|3|||
156861337|NCT01383928|566250746|FG002|Overall Study|Other|4|||
156861338|NCT01383928|566250744|FG000|Overall Study|Progressive Disease|1|||
156861339|NCT01383928|566250745|FG001|Overall Study|Progressive Disease|1|||
156861340|NCT01383928|566250746|FG002|Overall Study|Progressive Disease|5|||
156861341|NCT01383928|566250744|FG000|Overall Study|Withdrawal by Subject|0|||
156861342|NCT01383928|566250745|FG001|Overall Study|Withdrawal by Subject|0|||
156861343|NCT01383928|566250746|FG002|Overall Study|Withdrawal by Subject|4|||
156861344|NCT01383928|566250744|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
156861345|NCT01383928|566250745|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156861346|NCT01383928|566250746|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
156861347|NCT02491684|566250747|FG000|Treatment Phase|Adverse Event|2|||
156861348|NCT02491684|566250748|FG001|Treatment Phase|Adverse Event|2|||
156861349|NCT02491684|566250747|FG000|Treatment Phase|Incorrect randomisation|1|||
156861350|NCT02491684|566250748|FG001|Treatment Phase|Incorrect randomisation|0|||
156861351|NCT02491684|566250747|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
156861352|NCT02491684|566250748|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
156861353|NCT01149096|566250749|FG000|Overall Study|Lost to Follow-up|0|||
156861354|NCT01149096|566250750|FG001|Overall Study|Lost to Follow-up|1|||
156861355|NCT04739982|566250752|FG000|Overall Study|Lost to Follow-up|176|||
156861356|NCT04739982|566250753|FG001|Overall Study|Lost to Follow-up|65|||
156861357|NCT04739982|566250752|FG000|Overall Study|Withdrawal by Subject|19|||
156861358|NCT04739982|566250753|FG001|Overall Study|Withdrawal by Subject|0|||
156861359|NCT04739982|566250752|FG000|Overall Study|Protocol Violation|0|||
156861360|NCT04739982|566250753|FG001|Overall Study|Protocol Violation|5|||
156861361|NCT03651765|566250754|FG000|Overall Study|Adverse Event|6|||
156861362|NCT03651765|566250754|FG000|Overall Study|Lack of Efficacy|18|||
156861363|NCT03651765|566250754|FG000|Overall Study|Lost to Follow-up|5|||
156861364|NCT03651765|566250754|FG000|Overall Study|Non-Compliance with Study Drug|4|||
156861365|NCT03651765|566250754|FG000|Overall Study|Physician Decision|6|||
156861366|NCT03651765|566250754|FG000|Overall Study|Pregnancy|1|||
156861367|NCT03651765|566250754|FG000|Overall Study|Discontinued by Sponsor|40|||
156861368|NCT03651765|566250754|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
156861369|NCT03651765|566250754|FG000|Overall Study|Withdrawal by Subject|24|||
156861370|NCT03651765|566250754|FG000|Overall Study|Miscellaneous|6|||
157160453|NCT02796391|567331469|FG002|Overall Study|Withdrawal by Subject|4|||
157160454|NCT02796391|567331470|FG003|Overall Study|Withdrawal by Subject|3|||
157160455|NCT02796391|567331471|FG004|Overall Study|Withdrawal by Subject|4|||
156861371|NCT04914364|566250755|FG000|Overall Study|No longer eligible for study|1|||
156861372|NCT04914364|566250755|FG000|Overall Study|Lost to Follow-up|2|||
156861373|NCT01263769|566250756|FG000|Overall Study|Non-Compliant with treatment|1|||
156861374|NCT03267277|566250757|FG000|Overall Study|Withdrawal by Subject|1|||
156861375|NCT00702702|566250762|FG000|Overall Study|Study prematurely terminated|56|||
156861376|NCT03521570|566250765|FG000|Overall Study|Not eligible|11|||
156861377|NCT01667900|566250766|FG000|Part B|Death|0|||
156861378|NCT01667900|566250767|FG001|Part B|Death|0|||
156861379|NCT01667900|566250768|FG002|Part B|Death|0|||
156861380|NCT01667900|566250769|FG003|Part B|Death|0|||
156861381|NCT01667900|566250770|FG004|Part B|Death|0|||
156861382|NCT01667900|566250771|FG005|Part B|Death|0|||
156861383|NCT01667900|566250772|FG006|Part B|Death|0|||
156861384|NCT01667900|566250773|FG007|Part B|Death|0|||
156861385|NCT01667900|566250774|FG008|Part B|Death|0|||
156861386|NCT01667900|566250775|FG009|Part B|Death|0|||
156861387|NCT01667900|566250776|FG010|Part B|Death|0|||
156861388|NCT01667900|566250777|FG011|Part B|Death|0|||
156861389|NCT01667900|566250778|FG012|Part B|Death|0|||
156861390|NCT01667900|566250779|FG013|Part B|Death|0|||
156861391|NCT01667900|566250780|FG014|Part B|Death|0|||
156861392|NCT01667900|566250781|FG015|Part B|Death|0|||
156861393|NCT01667900|566250782|FG016|Part B|Death|1|||
156861394|NCT01667900|566250783|FG017|Part B|Death|0|||
156861395|NCT01667900|566250784|FG018|Part B|Death|0|||
156861396|NCT01667900|566250785|FG019|Part B|Death|0|||
156861397|NCT00468169|566250788|FG000|Overall Study|Withdrawal by Subject|1|||
156861398|NCT00468169|566250789|FG001|Overall Study|Withdrawal by Subject|0|||
156861399|NCT00784563|566250790|FG000|Years 1 & 2|Withdrawal by Subject|3|||
156861400|NCT00784563|566250791|FG001|Years 1 & 2|Withdrawal by Subject|2|||
156861401|NCT00784563|566250792|FG002|Years 1 & 2|Withdrawal by Subject|0|||
156861402|NCT00784563|566250790|FG000|Years 1 & 2|Adverse Event|0|||
156861403|NCT00784563|566250791|FG001|Years 1 & 2|Adverse Event|3|||
156861404|NCT00784563|566250792|FG002|Years 1 & 2|Adverse Event|0|||
156861405|NCT00784563|566250790|FG000|Year 3|Withdrawal by Subject|0|||
156861406|NCT00784563|566250791|FG001|Year 3|Withdrawal by Subject|0|||
156861407|NCT00784563|566250792|FG002|Year 3|Withdrawal by Subject|2|||
156861408|NCT00784563|566250790|FG000|Year 3|Adverse Event|0|||
156861409|NCT00784563|566250791|FG001|Year 3|Adverse Event|0|||
156861410|NCT00784563|566250792|FG002|Year 3|Adverse Event|1|||
156861411|NCT00762164|566250793|FG000|Overall Study|Lost to Follow-up|1|||
156861412|NCT00762164|566250794|FG001|Overall Study|Lost to Follow-up|1|||
156861413|NCT00762164|566250793|FG000|Overall Study|Discontinued medication|2|||
156861414|NCT00762164|566250794|FG001|Overall Study|Discontinued medication|0|||
156861415|NCT00762164|566250793|FG000|Overall Study|Withdrawal by Subject|0|||
156861416|NCT00762164|566250794|FG001|Overall Study|Withdrawal by Subject|1|||
156861417|NCT03600909|566250795|FG000|Overall Study|Not treated|0|||
156861418|NCT03600909|566250796|FG001|Overall Study|Not treated|3|||
156861419|NCT03600909|566250797|FG002|Overall Study|Not treated|0|||
156861420|NCT01607957|566250805|FG000|Overall Study|Not treated|1|||
156861421|NCT01607957|566250806|FG001|Overall Study|Not treated|1|||
156861422|NCT01607957|566250805|FG000|Overall Study|Death|367|||
156861423|NCT01607957|566250806|FG001|Overall Study|Death|211|||
156861424|NCT01607957|566250805|FG000|Overall Study|Lost to Follow-up|3|||
156861425|NCT01607957|566250806|FG001|Overall Study|Lost to Follow-up|3|||
156861426|NCT01607957|566250805|FG000|Overall Study|Participant refusal|1|||
156861427|NCT01607957|566250806|FG001|Overall Study|Participant refusal|0|||
156861428|NCT01691794|566250807|FG000|Overall Study|Poor/Non-Compliance|1|||
156861429|NCT01691794|566250808|FG001|Overall Study|Poor/Non-Compliance|4|||
156861430|NCT01691794|566250809|FG002|Overall Study|Poor/Non-Compliance|1|||
156861431|NCT01691794|566250807|FG000|Overall Study|Death|0|||
156861432|NCT01691794|566250808|FG001|Overall Study|Death|0|||
156861433|NCT01691794|566250809|FG002|Overall Study|Death|1|||
156861434|NCT01691794|566250807|FG000|Overall Study|Lack of Efficacy|0|||
156861435|NCT01691794|566250808|FG001|Overall Study|Lack of Efficacy|7|||
156861436|NCT01691794|566250809|FG002|Overall Study|Lack of Efficacy|1|||
156861437|NCT01691794|566250807|FG000|Overall Study|Participant request to discontinue|0|||
156861438|NCT01691794|566250808|FG001|Overall Study|Participant request to discontinue|1|||
156861439|NCT01691794|566250809|FG002|Overall Study|Participant request to discontinue|0|||
156861440|NCT01691794|566250807|FG000|Overall Study|Adverse Event|0|||
156861441|NCT01691794|566250808|FG001|Overall Study|Adverse Event|1|||
156861442|NCT01691794|566250809|FG002|Overall Study|Adverse Event|1|||
156861443|NCT01691794|566250807|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
156861444|NCT01691794|566250808|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
156861445|NCT01691794|566250809|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
156861446|NCT01691794|566250807|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
156861447|NCT01691794|566250808|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
156912946|NCT01854710|566440398|FG005|Overall Study|CRI procedural error|2|||
157160456|NCT02796391|567331472|FG005|Overall Study|Withdrawal by Subject|3|||
157160457|NCT02796391|567331467|FG000|Overall Study|Adverse Event|0|||
157160458|NCT02796391|567331468|FG001|Overall Study|Adverse Event|0|||
156912947|NCT01336764|566440403|FG000|Overall Study|Withdrawal by Subject|5|||
156912948|NCT01336764|566440404|FG001|Overall Study|Withdrawal by Subject|5|||
156912949|NCT01626391|566440405|FG000|Overall Study|Physician Decision|1|||
156912950|NCT01626391|566440406|FG001|Overall Study|Physician Decision|0|||
156912951|NCT01626391|566440405|FG000|Overall Study|Withdrawal by Subject|1|||
157160459|NCT02796391|567331469|FG002|Overall Study|Adverse Event|0|||
157160460|NCT02796391|567331470|FG003|Overall Study|Adverse Event|1|||
156861448|NCT01691794|566250809|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
156861449|NCT00844844|566250810|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
156861450|NCT00844844|566250810|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
156861451|NCT00844844|566250810|FG000|Extension Treatment Period|Adverse Event|2|||
156861452|NCT00844844|566250810|FG000|Post Treatment Period|Withdrawal by Subject|1|||
156861453|NCT03905096|566250811|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
156861454|NCT03905096|566250812|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
156861455|NCT02016781|566250813|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
156861456|NCT02016781|566250814|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
156861457|NCT02016781|566250813|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
156861458|NCT02016781|566250814|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
156861459|NCT02016781|566250813|FG000|Final Database Lock|Withdrawal by Subject|2|||
156912952|NCT01626391|566440406|FG001|Overall Study|Withdrawal by Subject|0|||
157160461|NCT02796391|567331471|FG004|Overall Study|Adverse Event|0|||
157160462|NCT02796391|567331472|FG005|Overall Study|Adverse Event|0|||
157160463|NCT02796391|567331467|FG000|Overall Study|Protocol Violation|0|||
157160464|NCT02796391|567331468|FG001|Overall Study|Protocol Violation|0|||
157160465|NCT02796391|567331469|FG002|Overall Study|Protocol Violation|0|||
157160466|NCT02796391|567331470|FG003|Overall Study|Protocol Violation|1|||
157160467|NCT02796391|567331471|FG004|Overall Study|Protocol Violation|0|||
157160468|NCT02796391|567331472|FG005|Overall Study|Protocol Violation|0|||
157160469|NCT00377611|567331475|FG000|Overall Study|Adverse Event|2|||
157160470|NCT00377611|567331476|FG001|Overall Study|Adverse Event|9|||
157160471|NCT00377611|567331475|FG000|Overall Study|Protocol Violation|2|||
157160472|NCT00377611|567331476|FG001|Overall Study|Protocol Violation|0|||
157160473|NCT00377611|567331475|FG000|Overall Study|Withdrawal by Subject|0|||
157160474|NCT00377611|567331476|FG001|Overall Study|Withdrawal by Subject|5|||
157160475|NCT00377611|567331475|FG000|Overall Study|Lost to Follow-up|18|||
157160476|NCT00377611|567331476|FG001|Overall Study|Lost to Follow-up|16|||
157160477|NCT00377611|567331475|FG000|Overall Study|Other|0|||
157160478|NCT00377611|567331476|FG001|Overall Study|Other|3|||
157160479|NCT03446651|567331484|FG000|Overall Study|Lost to Follow-up|4|||
157160480|NCT03446651|567331485|FG001|Overall Study|Lost to Follow-up|0|||
157160481|NCT03446651|567331484|FG000|Overall Study|Open Label Participants|5|||
157160482|NCT03446651|567331485|FG001|Overall Study|Open Label Participants|0|||
157160483|NCT00798655|567331486|FG000|Overall Study|Did not receive at least one dose of pan|2|||
157160484|NCT00343291|567331487|FG000|Overall Study|Adverse Event|13|||
157160485|NCT00343291|567331488|FG001|Overall Study|Adverse Event|13|||
157160486|NCT00343291|567331487|FG000|Overall Study|Death|3|||
157160487|NCT00343291|567331488|FG001|Overall Study|Death|2|||
157160488|NCT00343291|567331487|FG000|Overall Study|Progressive disease|33|||
157160489|NCT00343291|567331488|FG001|Overall Study|Progressive disease|34|||
157160490|NCT00343291|567331487|FG000|Overall Study|Withdrawal by Subject|0|||
157160491|NCT00343291|567331488|FG001|Overall Study|Withdrawal by Subject|2|||
157160492|NCT00343291|567331487|FG000|Overall Study|Other|8|||
157160493|NCT00343291|567331488|FG001|Overall Study|Other|5|||
157160494|NCT03712345|567331491|FG000|Overall Study|Failure to meet randomization criteria|0|||
157160495|NCT03712345|567331492|FG001|Overall Study|Failure to meet randomization criteria|0|||
157160496|NCT03712345|567331493|FG002|Overall Study|Failure to meet randomization criteria|1|||
157160497|NCT00960934|567331494|FG000|Overall Study|Adverse Event|2|||
157160498|NCT00960934|567331495|FG001|Overall Study|Adverse Event|3|||
157160499|NCT00960934|567331496|FG002|Overall Study|Adverse Event|3|||
156861460|NCT02016781|566250814|FG001|Final Database Lock|Withdrawal by Subject|1|||
156861461|NCT02016781|566250813|FG000|Final Database Lock|Lost to Follow-up|11|||
156861462|NCT02016781|566250814|FG001|Final Database Lock|Lost to Follow-up|4|||
156861463|NCT02016781|566250813|FG000|Final Database Lock|Missing data|0|||
156861464|NCT02016781|566250814|FG001|Final Database Lock|Missing data|3|||
156861465|NCT04886154|566250817|FG000|Overall Study|Adverse Event|0|||
156861466|NCT04886154|566250818|FG001|Overall Study|Adverse Event|0|||
156861467|NCT04886154|566250819|FG002|Overall Study|Adverse Event|0|||
156861468|NCT04886154|566250820|FG003|Overall Study|Adverse Event|0|||
156861469|NCT04886154|566250821|FG004|Overall Study|Adverse Event|1|||
156861470|NCT04886154|566250822|FG005|Overall Study|Adverse Event|0|||
156861471|NCT04886154|566250823|FG006|Overall Study|Adverse Event|0|||
156861472|NCT04886154|566250824|FG007|Overall Study|Adverse Event|1|||
156861473|NCT04886154|566250825|FG008|Overall Study|Adverse Event|1|||
156861474|NCT04886154|566250826|FG009|Overall Study|Adverse Event|0|||
156861475|NCT04886154|566250827|FG010|Overall Study|Adverse Event|0|||
156861476|NCT04886154|566250828|FG011|Overall Study|Adverse Event|1|||
156861477|NCT04886154|566250829|FG012|Overall Study|Adverse Event|0|||
156861478|NCT04886154|566250830|FG013|Overall Study|Adverse Event|0|||
156861479|NCT04886154|566250831|FG014|Overall Study|Adverse Event|3|||
156861480|NCT04886154|566250817|FG000|Overall Study|Lost to Follow-up|1|||
156861481|NCT04886154|566250818|FG001|Overall Study|Lost to Follow-up|0|||
156861482|NCT04886154|566250819|FG002|Overall Study|Lost to Follow-up|2|||
156861483|NCT04886154|566250820|FG003|Overall Study|Lost to Follow-up|0|||
157160500|NCT00960934|567331497|FG003|Overall Study|Adverse Event|2|||
157160501|NCT00960934|567331498|FG004|Overall Study|Adverse Event|4|||
157160502|NCT00960934|567331499|FG005|Overall Study|Adverse Event|3|||
157160503|NCT00960934|567331494|FG000|Overall Study|Lack of Efficacy|1|||
157160504|NCT00960934|567331495|FG001|Overall Study|Lack of Efficacy|0|||
157160505|NCT00960934|567331496|FG002|Overall Study|Lack of Efficacy|0|||
157160506|NCT00960934|567331497|FG003|Overall Study|Lack of Efficacy|0|||
156861484|NCT04886154|566250821|FG004|Overall Study|Lost to Follow-up|17|||
156861485|NCT04886154|566250822|FG005|Overall Study|Lost to Follow-up|7|||
156861486|NCT04886154|566250823|FG006|Overall Study|Lost to Follow-up|8|||
156861487|NCT04886154|566250824|FG007|Overall Study|Lost to Follow-up|7|||
156861488|NCT04886154|566250825|FG008|Overall Study|Lost to Follow-up|8|||
156861489|NCT04886154|566250826|FG009|Overall Study|Lost to Follow-up|0|||
156861490|NCT04886154|566250827|FG010|Overall Study|Lost to Follow-up|2|||
156861491|NCT04886154|566250828|FG011|Overall Study|Lost to Follow-up|0|||
156861492|NCT04886154|566250829|FG012|Overall Study|Lost to Follow-up|0|||
157160507|NCT00960934|567331498|FG004|Overall Study|Lack of Efficacy|0|||
156912953|NCT02573311|566440407|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
156912954|NCT02573311|566440408|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
156912955|NCT02573311|566440407|FG000|Disposition for Part 2|Physician Decision|25|||
156912956|NCT02573311|566440408|FG001|Disposition for Part 2|Physician Decision|7|||
156912957|NCT02573311|566440407|FG000|Disposition for Part 2|Adverse Event|36|||
156912958|NCT02573311|566440408|FG001|Disposition for Part 2|Adverse Event|5|||
156912959|NCT02573311|566440407|FG000|Disposition for Part 2|Lost to Follow-up|76|||
156912960|NCT02573311|566440408|FG001|Disposition for Part 2|Lost to Follow-up|7|||
156912961|NCT02573311|566440407|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
156912962|NCT02573311|566440408|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
156912963|NCT02573311|566440407|FG000|Disposition for Part 2|Investigator decision|0|||
156912964|NCT02573311|566440408|FG001|Disposition for Part 2|Investigator decision|1|||
157160508|NCT00960934|567331499|FG005|Overall Study|Lack of Efficacy|0|||
157160509|NCT00960934|567331494|FG000|Overall Study|Lost to Follow-up|0|||
157160510|NCT00960934|567331495|FG001|Overall Study|Lost to Follow-up|1|||
157160511|NCT00960934|567331496|FG002|Overall Study|Lost to Follow-up|0|||
157160512|NCT00960934|567331497|FG003|Overall Study|Lost to Follow-up|0|||
156861493|NCT04886154|566250830|FG013|Overall Study|Lost to Follow-up|0|||
156861494|NCT04886154|566250831|FG014|Overall Study|Lost to Follow-up|0|||
156861495|NCT04886154|566250817|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861496|NCT04886154|566250818|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861497|NCT04886154|566250819|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861498|NCT04886154|566250820|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861499|NCT04886154|566250821|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861500|NCT04886154|566250822|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861501|NCT04886154|566250823|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
156861502|NCT04886154|566250824|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861503|NCT04886154|566250825|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861504|NCT04886154|566250826|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861505|NCT04886154|566250827|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861506|NCT04886154|566250828|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861507|NCT04886154|566250829|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861508|NCT04886154|566250830|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861509|NCT04886154|566250831|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
156861510|NCT04886154|566250817|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861511|NCT04886154|566250818|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861512|NCT04886154|566250819|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861513|NCT04886154|566250820|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861514|NCT04886154|566250821|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157160513|NCT00960934|567331498|FG004|Overall Study|Lost to Follow-up|0|||
156861515|NCT04886154|566250822|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861516|NCT04886154|566250823|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
156861517|NCT04886154|566250824|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156861518|NCT04886154|566250825|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861519|NCT04886154|566250826|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861520|NCT04886154|566250827|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861521|NCT04886154|566250828|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861522|NCT04886154|566250829|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861523|NCT04886154|566250830|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156861524|NCT04886154|566250831|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156861525|NCT04886154|566250817|FG000|Overall Study|Other, Not Specified|0|||
156861526|NCT04886154|566250818|FG001|Overall Study|Other, Not Specified|0|||
156861527|NCT04886154|566250819|FG002|Overall Study|Other, Not Specified|0|||
156861528|NCT04886154|566250820|FG003|Overall Study|Other, Not Specified|0|||
156861529|NCT04886154|566250821|FG004|Overall Study|Other, Not Specified|11|||
156861530|NCT04886154|566250822|FG005|Overall Study|Other, Not Specified|8|||
156861531|NCT04886154|566250823|FG006|Overall Study|Other, Not Specified|9|||
156861532|NCT04886154|566250824|FG007|Overall Study|Other, Not Specified|10|||
157160514|NCT00960934|567331499|FG005|Overall Study|Lost to Follow-up|0|||
157160515|NCT00960934|567331494|FG000|Overall Study|Other|2|||
156861533|NCT04886154|566250825|FG008|Overall Study|Other, Not Specified|6|||
156861534|NCT04886154|566250826|FG009|Overall Study|Other, Not Specified|1|||
156861535|NCT04886154|566250827|FG010|Overall Study|Other, Not Specified|1|||
156861536|NCT04886154|566250828|FG011|Overall Study|Other, Not Specified|2|||
156861537|NCT04886154|566250829|FG012|Overall Study|Other, Not Specified|1|||
156861538|NCT04886154|566250830|FG013|Overall Study|Other, Not Specified|2|||
157160516|NCT00960934|567331495|FG001|Overall Study|Other|1|||
157160517|NCT00960934|567331496|FG002|Overall Study|Other|5|||
156861539|NCT04886154|566250831|FG014|Overall Study|Other, Not Specified|3|||
156861540|NCT03919773|566250840|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
156861541|NCT03919773|566250841|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
156861542|NCT03919773|566250840|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
156861543|NCT03919773|566250841|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
156861544|NCT04659044|566250844|FG000|Induction|Physician Decision|1|||
156861545|NCT04659044|566250844|FG000|Induction|Adverse Event|2|||
156861546|NCT04966013|566250846|FG000|Overall Study|Withdrawal by Subject|0|||
156861547|NCT04966013|566250847|FG001|Overall Study|Withdrawal by Subject|2|||
156861548|NCT04966013|566250848|FG002|Overall Study|Withdrawal by Subject|1|||
156861549|NCT04966013|566250846|FG000|Overall Study|Adverse Event|2|||
156861550|NCT04966013|566250847|FG001|Overall Study|Adverse Event|1|||
156861551|NCT04966013|566250848|FG002|Overall Study|Adverse Event|1|||
156861552|NCT02458313|566253122|FG000|Overall Study|Withdrawal by Subject|6|||
156861553|NCT02458313|566253123|FG001|Overall Study|Withdrawal by Subject|8|||
156861554|NCT02458313|566253122|FG000|Overall Study|Excluded for motion during MRI|1|||
156861555|NCT02458313|566253123|FG001|Overall Study|Excluded for motion during MRI|2|||
156861556|NCT03714672|566253126|FG000|Overall Study|Adverse Event|0|||
156861557|NCT03714672|566253127|FG001|Overall Study|Adverse Event|0|||
156861558|NCT03714672|566253128|FG002|Overall Study|Adverse Event|3|||
156861559|NCT03714672|566253129|FG003|Overall Study|Adverse Event|0|||
156861560|NCT03714672|566253126|FG000|Overall Study|Physician Decision|0|||
156861561|NCT03714672|566253127|FG001|Overall Study|Physician Decision|1|||
156861562|NCT03714672|566253128|FG002|Overall Study|Physician Decision|0|||
156861563|NCT03714672|566253129|FG003|Overall Study|Physician Decision|0|||
156861564|NCT03714672|566253126|FG000|Overall Study|Other Reason|1|||
156861565|NCT03714672|566253127|FG001|Overall Study|Other Reason|2|||
156861566|NCT03714672|566253128|FG002|Overall Study|Other Reason|1|||
156861567|NCT03714672|566253129|FG003|Overall Study|Other Reason|1|||
156861568|NCT03714672|566253126|FG000|Overall Study|Lost to Follow-up|1|||
156861569|NCT03714672|566253127|FG001|Overall Study|Lost to Follow-up|1|||
156861570|NCT03714672|566253128|FG002|Overall Study|Lost to Follow-up|0|||
156861571|NCT03714672|566253129|FG003|Overall Study|Lost to Follow-up|0|||
156861572|NCT01428258|566253135|FG000|Intervention 1|Withdrawal by Subject|2|||
156861573|NCT01428258|566253136|FG001|Intervention 1|Withdrawal by Subject|0|||
156861574|NCT03085095|566253141|FG000|Overall Study|Adverse Event|23|||
156861575|NCT03085095|566253142|FG001|Overall Study|Adverse Event|8|||
156861576|NCT03085095|566253141|FG000|Overall Study|Protocol Violation|0|||
156861577|NCT03085095|566253142|FG001|Overall Study|Protocol Violation|1|||
156861578|NCT03085095|566253141|FG000|Overall Study|Lost to Follow-up|2|||
156861579|NCT03085095|566253142|FG001|Overall Study|Lost to Follow-up|1|||
156861580|NCT03085095|566253141|FG000|Overall Study|Withdrawal by Subject|17|||
156861581|NCT03085095|566253142|FG001|Overall Study|Withdrawal by Subject|6|||
156861582|NCT03085095|566253141|FG000|Overall Study|Physician Decision|9|||
156861583|NCT03085095|566253142|FG001|Overall Study|Physician Decision|3|||
156861584|NCT03085095|566253141|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
156861585|NCT03085095|566253142|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
156861586|NCT03085095|566253141|FG000|Overall Study|Did not Receive Study Drug|2|||
156861587|NCT03085095|566253142|FG001|Overall Study|Did not Receive Study Drug|2|||
156861588|NCT03085095|566253141|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
157160518|NCT00960934|567331497|FG003|Overall Study|Other|4|||
157160519|NCT00960934|567331498|FG004|Overall Study|Other|2|||
157160520|NCT00960934|567331499|FG005|Overall Study|Other|2|||
157160521|NCT00960934|567331494|FG000|Overall Study|Physician Decision|0|||
157160522|NCT00960934|567331495|FG001|Overall Study|Physician Decision|1|||
157160523|NCT00960934|567331496|FG002|Overall Study|Physician Decision|0|||
157160524|NCT00960934|567331497|FG003|Overall Study|Physician Decision|0|||
156861589|NCT03085095|566253142|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
156861590|NCT01074502|566253143|FG000|Overall Study|Withdrawal by Subject|1|||
156861591|NCT00674817|566253151|FG000|Period 1|Withdrawal by Subject|2|||
156861592|NCT00674817|566253151|FG000|Period 1|Protocol Violation|1|||
156861593|NCT00674817|566253151|FG000|Period 3|Adverse Event|1|||
156861594|NCT00674817|566253151|FG000|Period 3|Protocol Violation|1|||
156861595|NCT00674817|566253151|FG000|Period 4|Adverse Event|1|||
156861596|NCT00726063|566253152|FG000|Overall Study|Adverse Event|9|||
156861597|NCT00726063|566253153|FG001|Overall Study|Adverse Event|7|||
157160525|NCT00960934|567331498|FG004|Overall Study|Physician Decision|0|||
157160526|NCT00960934|567331499|FG005|Overall Study|Physician Decision|0|||
157225639|NCT00319449|567571499|FG000|Overall Study|Subject did not wish to continue|1|||
157160527|NCT00960934|567331494|FG000|Overall Study|Progressive Disease|1|||
156861598|NCT01231984|566253154|FG000|Study Period 1|Withdrawal by Subject|0|||
156861599|NCT01231984|566253155|FG001|Study Period 1|Withdrawal by Subject|0|||
156861600|NCT01231984|566253156|FG002|Study Period 1|Withdrawal by Subject|0|||
156861601|NCT01231984|566253157|FG003|Study Period 1|Withdrawal by Subject|1|||
156861602|NCT01231984|566253154|FG000|Study Period 1|Lost to Follow-up|1|||
156861603|NCT01231984|566253155|FG001|Study Period 1|Lost to Follow-up|1|||
156861604|NCT01231984|566253156|FG002|Study Period 1|Lost to Follow-up|1|||
156861605|NCT01231984|566253157|FG003|Study Period 1|Lost to Follow-up|0|||
156861606|NCT01231984|566253154|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861607|NCT01231984|566253155|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
157160528|NCT00960934|567331495|FG001|Overall Study|Progressive Disease|1|||
157160529|NCT00960934|567331496|FG002|Overall Study|Progressive Disease|0|||
157160530|NCT00960934|567331497|FG003|Overall Study|Progressive Disease|0|||
157160531|NCT00960934|567331498|FG004|Overall Study|Progressive Disease|1|||
157160532|NCT00960934|567331499|FG005|Overall Study|Progressive Disease|1|||
157160533|NCT00960934|567331494|FG000|Overall Study|Protocol Violation|3|||
157160534|NCT00960934|567331495|FG001|Overall Study|Protocol Violation|4|||
157160535|NCT00960934|567331496|FG002|Overall Study|Protocol Violation|0|||
157160536|NCT00960934|567331497|FG003|Overall Study|Protocol Violation|3|||
157160537|NCT00960934|567331498|FG004|Overall Study|Protocol Violation|3|||
157160538|NCT00960934|567331499|FG005|Overall Study|Protocol Violation|2|||
157160539|NCT00960934|567331494|FG000|Overall Study|Withdrawal by Subject|5|||
157160540|NCT00960934|567331495|FG001|Overall Study|Withdrawal by Subject|6|||
157160541|NCT00960934|567331496|FG002|Overall Study|Withdrawal by Subject|4|||
156861608|NCT01231984|566253156|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861609|NCT01231984|566253157|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
156861610|NCT01231984|566253154|FG000|Study Period 1|Screen Failure|0|||
157160542|NCT00960934|567331497|FG003|Overall Study|Withdrawal by Subject|5|||
157160543|NCT00960934|567331498|FG004|Overall Study|Withdrawal by Subject|5|||
156861611|NCT01231984|566253155|FG001|Study Period 1|Screen Failure|0|||
156861612|NCT01231984|566253156|FG002|Study Period 1|Screen Failure|0|||
156861613|NCT01231984|566253157|FG003|Study Period 1|Screen Failure|1|||
156861614|NCT01231984|566253154|FG000|Study Period 1|Non-compliance with study requirements|5|||
156861615|NCT01231984|566253155|FG001|Study Period 1|Non-compliance with study requirements|0|||
156861616|NCT01231984|566253156|FG002|Study Period 1|Non-compliance with study requirements|2|||
156861617|NCT01231984|566253157|FG003|Study Period 1|Non-compliance with study requirements|1|||
157160544|NCT00960934|567331499|FG005|Overall Study|Withdrawal by Subject|7|||
156861618|NCT01231984|566253154|FG000|Study Period 1|Protocol Violation|3|||
156861619|NCT01231984|566253155|FG001|Study Period 1|Protocol Violation|4|||
156861620|NCT01231984|566253156|FG002|Study Period 1|Protocol Violation|2|||
156861621|NCT01231984|566253157|FG003|Study Period 1|Protocol Violation|3|||
156861622|NCT01231984|566253154|FG000|Study Period 1|Adverse Event|1|||
156861623|NCT01231984|566253155|FG001|Study Period 1|Adverse Event|0|||
156861624|NCT01231984|566253156|FG002|Study Period 1|Adverse Event|0|||
156861625|NCT01231984|566253157|FG003|Study Period 1|Adverse Event|0|||
156861626|NCT01231984|566253154|FG000|Study Period 1|Other|0|||
156861627|NCT01231984|566253155|FG001|Study Period 1|Other|0|||
156861628|NCT01231984|566253156|FG002|Study Period 1|Other|0|||
156861629|NCT01231984|566253157|FG003|Study Period 1|Other|1|||
156861630|NCT01231984|566253154|FG000|Study Period 2|Withdrawal by Subject|1|||
156861631|NCT01231984|566253155|FG001|Study Period 2|Withdrawal by Subject|1|||
156861632|NCT01231984|566253156|FG002|Study Period 2|Withdrawal by Subject|0|||
156861633|NCT01231984|566253157|FG003|Study Period 2|Withdrawal by Subject|0|||
156861634|NCT01231984|566253154|FG000|Study Period 2|Lost to Follow-up|1|||
156861635|NCT01231984|566253155|FG001|Study Period 2|Lost to Follow-up|0|||
156861636|NCT01231984|566253156|FG002|Study Period 2|Lost to Follow-up|0|||
156861637|NCT01231984|566253157|FG003|Study Period 2|Lost to Follow-up|3|||
156861638|NCT01231984|566253154|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861639|NCT01231984|566253155|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861640|NCT01231984|566253156|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
156861641|NCT01231984|566253157|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
156861642|NCT00981656|566253160|FG000|Overall Study|Protocol Violation|1|||
156861643|NCT00981656|566253160|FG000|Overall Study|Did not start protocol treatment|2|||
156861644|NCT05236270|566253164|FG000|Overall Study|Lost to Follow-up|3|||
156861645|NCT05236270|566253165|FG001|Overall Study|Lost to Follow-up|2|||
156861646|NCT05236270|566253166|FG002|Overall Study|Lost to Follow-up|0|||
156861647|NCT05236270|566253167|FG003|Overall Study|Lost to Follow-up|0|||
156861648|NCT05236270|566253168|FG004|Overall Study|Lost to Follow-up|2|||
156861649|NCT05236270|566253169|FG005|Overall Study|Lost to Follow-up|0|||
156861650|NCT05236270|566253170|FG006|Overall Study|Lost to Follow-up|1|||
156861651|NCT05236270|566253171|FG007|Overall Study|Lost to Follow-up|3|||
156861652|NCT03486912|566253173|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861653|NCT03486912|566253174|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
156861654|NCT03486912|566253175|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861655|NCT03486912|566253176|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
156861656|NCT03486912|566253173|FG000|Treatment Period|Withdrawal by Subject|3|||
156861657|NCT03486912|566253174|FG001|Treatment Period|Withdrawal by Subject|3|||
156861658|NCT03486912|566253175|FG002|Treatment Period|Withdrawal by Subject|3|||
156861659|NCT03486912|566253176|FG003|Treatment Period|Withdrawal by Subject|2|||
157160545|NCT00960934|567331494|FG000|Overall Study|Study Terminated by Sponsor|50|||
157160546|NCT00960934|567331495|FG001|Overall Study|Study Terminated by Sponsor|46|||
156861660|NCT03486912|566253173|FG000|Treatment Period|Other Reasons|0|||
156861661|NCT03486912|566253174|FG001|Treatment Period|Other Reasons|2|||
156861662|NCT03486912|566253175|FG002|Treatment Period|Other Reasons|1|||
156861663|NCT03486912|566253176|FG003|Treatment Period|Other Reasons|1|||
156861664|NCT03486912|566253173|FG000|Treatment Period|Adverse Event|0|||
156861665|NCT03486912|566253174|FG001|Treatment Period|Adverse Event|1|||
156861666|NCT03486912|566253175|FG002|Treatment Period|Adverse Event|1|||
156861667|NCT03486912|566253176|FG003|Treatment Period|Adverse Event|0|||
156861668|NCT03486912|566253173|FG000|Treatment Period|Lost to Follow-up|1|||
156861669|NCT03486912|566253174|FG001|Treatment Period|Lost to Follow-up|0|||
156861670|NCT03486912|566253175|FG002|Treatment Period|Lost to Follow-up|0|||
156861671|NCT03486912|566253176|FG003|Treatment Period|Lost to Follow-up|2|||
156861672|NCT01499940|566253177|FG000|Overall Study|Study was withdrawn before completion.|9|||
156861673|NCT01346358|566253181|FG000|Overall Study|Withdrawal by Subject|1|||
156861674|NCT01346358|566253182|FG001|Overall Study|Withdrawal by Subject|0|||
156861675|NCT01346358|566253183|FG002|Overall Study|Withdrawal by Subject|1|||
156861676|NCT01346358|566253184|FG003|Overall Study|Withdrawal by Subject|1|||
156861677|NCT01346358|566253185|FG004|Overall Study|Withdrawal by Subject|0|||
156861678|NCT01346358|566253186|FG005|Overall Study|Withdrawal by Subject|2|||
156861679|NCT01346358|566253187|FG006|Overall Study|Withdrawal by Subject|1|||
156861680|NCT01346358|566253188|FG007|Overall Study|Withdrawal by Subject|1|||
156861681|NCT01346358|566253189|FG008|Overall Study|Withdrawal by Subject|1|||
156861682|NCT01346358|566253181|FG000|Overall Study|Adverse Event|1|||
156861683|NCT01346358|566253182|FG001|Overall Study|Adverse Event|0|||
156861684|NCT01346358|566253183|FG002|Overall Study|Adverse Event|0|||
156861685|NCT01346358|566253184|FG003|Overall Study|Adverse Event|0|||
156861686|NCT01346358|566253185|FG004|Overall Study|Adverse Event|1|||
156861687|NCT01346358|566253186|FG005|Overall Study|Adverse Event|0|||
156861688|NCT01346358|566253187|FG006|Overall Study|Adverse Event|0|||
156861689|NCT01346358|566253188|FG007|Overall Study|Adverse Event|0|||
156861690|NCT01346358|566253189|FG008|Overall Study|Adverse Event|1|||
156861691|NCT01346358|566253181|FG000|Overall Study|Non-Compliance|0|||
156861692|NCT01346358|566253182|FG001|Overall Study|Non-Compliance|0|||
156861693|NCT01346358|566253183|FG002|Overall Study|Non-Compliance|0|||
156861694|NCT01346358|566253184|FG003|Overall Study|Non-Compliance|0|||
156861695|NCT01346358|566253185|FG004|Overall Study|Non-Compliance|0|||
156861696|NCT01346358|566253186|FG005|Overall Study|Non-Compliance|0|||
156861697|NCT01346358|566253187|FG006|Overall Study|Non-Compliance|0|||
156861698|NCT01346358|566253188|FG007|Overall Study|Non-Compliance|2|||
156861699|NCT01346358|566253189|FG008|Overall Study|Non-Compliance|0|||
156861700|NCT01346358|566253181|FG000|Overall Study|Physician Decision|0|||
156861701|NCT01346358|566253182|FG001|Overall Study|Physician Decision|1|||
156861702|NCT01346358|566253183|FG002|Overall Study|Physician Decision|0|||
156861703|NCT01346358|566253184|FG003|Overall Study|Physician Decision|0|||
156861704|NCT01346358|566253185|FG004|Overall Study|Physician Decision|0|||
156861705|NCT01346358|566253186|FG005|Overall Study|Physician Decision|0|||
156861706|NCT01346358|566253187|FG006|Overall Study|Physician Decision|0|||
156861707|NCT01346358|566253188|FG007|Overall Study|Physician Decision|1|||
156861708|NCT01346358|566253189|FG008|Overall Study|Physician Decision|1|||
156861709|NCT05058365|566253190|FG000|Overall Study|Migration|1|||
156861710|NCT05058365|566253191|FG001|Overall Study|Migration|1|||
156861711|NCT04819945|566253192|FG000|Overall Study|Lost to Follow-up|1|||
156861712|NCT00551759|566253194|FG000|Overall Study|Adverse Event|7|||
156861713|NCT00551759|566253194|FG000|Overall Study|Death|5|||
156861714|NCT00551759|566253194|FG000|Overall Study|Ineligible|1|||
156861715|NCT04531176|566253195|FG000|Overall Study|Study was stopped early|24|||
156861716|NCT04531176|566253196|FG001|Overall Study|Study was stopped early|26|||
156861717|NCT04531176|566253197|FG002|Overall Study|Study was stopped early|24|||
156861718|NCT00561652|566253200|FG000|Overall Study|Withdrawal by Subject|0|||
156861719|NCT00561652|566253201|FG001|Overall Study|Withdrawal by Subject|1|||
156912965|NCT02573311|566440407|FG000|Disposition for Part 2|Other than specified above|13|||
156912966|NCT02573311|566440408|FG001|Disposition for Part 2|Other than specified above|3|||
156912967|NCT05683249|566440409|FG000|Overall Study|Adverse Event|3|||
157160547|NCT00960934|567331496|FG002|Overall Study|Study Terminated by Sponsor|52|||
157160548|NCT00960934|567331497|FG003|Overall Study|Study Terminated by Sponsor|50|||
157160549|NCT00960934|567331498|FG004|Overall Study|Study Terminated by Sponsor|49|||
157160550|NCT00960934|567331499|FG005|Overall Study|Study Terminated by Sponsor|49|||
157160551|NCT00756886|567331502|FG000|Overall Study|Lost to Follow-up|1|||
156912968|NCT05683249|566440410|FG001|Overall Study|Adverse Event|1|||
156912969|NCT05683249|566440409|FG000|Overall Study|Lack of Efficacy|0|||
156912970|NCT05683249|566440410|FG001|Overall Study|Lack of Efficacy|2|||
156912971|NCT05683249|566440409|FG000|Overall Study|Lost to Follow-up|6|||
156912972|NCT05683249|566440410|FG001|Overall Study|Lost to Follow-up|5|||
156912973|NCT05683249|566440409|FG000|Overall Study|Non-compliance with Study Drug|2|||
157160552|NCT00756886|567331503|FG001|Overall Study|Lost to Follow-up|0|||
157160553|NCT00756886|567331502|FG000|Overall Study|Adverse Event|0|||
157160554|NCT00756886|567331503|FG001|Overall Study|Adverse Event|3|||
157160555|NCT00756886|567331502|FG000|Overall Study|Lack of Efficacy|1|||
156861720|NCT01345240|566253207|FG000|Overall Study|Adverse Event|3|||
156861721|NCT01345240|566253208|FG001|Overall Study|Adverse Event|5|||
156861722|NCT01345240|566253209|FG002|Overall Study|Adverse Event|4|||
156861723|NCT01345240|566253210|FG003|Overall Study|Adverse Event|2|||
156861724|NCT01345240|566253211|FG004|Overall Study|Adverse Event|1|||
156861725|NCT01345240|566253207|FG000|Overall Study|Lost to Follow-up|8|||
156861726|NCT01345240|566253208|FG001|Overall Study|Lost to Follow-up|9|||
156912974|NCT05683249|566440410|FG001|Overall Study|Non-compliance with Study Drug|0|||
156912975|NCT05683249|566440409|FG000|Overall Study|Protocol Violation|6|||
156912976|NCT05683249|566440410|FG001|Overall Study|Protocol Violation|3|||
156912977|NCT05683249|566440409|FG000|Overall Study|Withdrawal by Subject|9|||
156912978|NCT05683249|566440410|FG001|Overall Study|Withdrawal by Subject|8|||
156912979|NCT05683249|566440409|FG000|Overall Study|Other|0|||
156912980|NCT05683249|566440410|FG001|Overall Study|Other|2|||
156912981|NCT04862585|566440411|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
156912982|NCT04862585|566440412|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
157225640|NCT00319449|567571500|FG001|Overall Study|Subject did not wish to continue|0|||
156861727|NCT01345240|566253209|FG002|Overall Study|Lost to Follow-up|14|||
156861728|NCT01345240|566253210|FG003|Overall Study|Lost to Follow-up|7|||
156861729|NCT01345240|566253211|FG004|Overall Study|Lost to Follow-up|9|||
156861730|NCT00774046|566253212|FG000|Screening|Not eligible|56|||
156861731|NCT00774046|566253212|FG000|Enrollment|Desired other therapy/refused|28|||
156861732|NCT00774046|566253212|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
156861733|NCT05498649|566253219|FG000|Overall Study|Lost to Follow-up|1|||
156861734|NCT03094416|566253223|FG000|Run-in|Screening failure|8|||
156861735|NCT03094416|566253223|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
156861736|NCT03094416|566253223|FG000|Run-in|Withdrawal by Subject|3|||
156861737|NCT03094416|566253223|FG000|Treatment Period|Withdrawal by Subject|2|||
156861738|NCT00685165|566253224|FG000|Washout Period of 14 Days|Adverse Event|1|||
156861739|NCT00685165|566253225|FG001|Washout Period of 14 Days|Adverse Event|0|||
156861740|NCT00321789|566253226|FG000|Overall Study|Lost to Follow-up|4|||
156861741|NCT00321789|566253227|FG001|Overall Study|Lost to Follow-up|7|||
156861742|NCT00321789|566253226|FG000|Overall Study|Withdrawal by Subject|6|||
156861743|NCT00321789|566253227|FG001|Overall Study|Withdrawal by Subject|6|||
156861744|NCT00321789|566253226|FG000|Overall Study|Protocol Violation|5|||
156861745|NCT00321789|566253227|FG001|Overall Study|Protocol Violation|3|||
156861746|NCT03050801|566253228|FG000|Experiment 1|Lost to Follow-up|0|||
156861747|NCT03050801|566253229|FG001|Experiment 1|Lost to Follow-up|1|||
156861748|NCT03050801|566253230|FG002|Experiment 1|Lost to Follow-up|0|||
156861749|NCT03050801|566253231|FG003|Experiment 1|Lost to Follow-up|0|||
156861750|NCT03050801|566253232|FG004|Experiment 1|Lost to Follow-up|0|||
156861751|NCT03050801|566253233|FG005|Experiment 1|Lost to Follow-up|0|||
156861752|NCT03050801|566253228|FG000|Experiment 1|Physician Decision|0|||
156861753|NCT03050801|566253229|FG001|Experiment 1|Physician Decision|3|||
156861754|NCT03050801|566253230|FG002|Experiment 1|Physician Decision|0|||
156861755|NCT03050801|566253231|FG003|Experiment 1|Physician Decision|0|||
156861756|NCT03050801|566253232|FG004|Experiment 1|Physician Decision|0|||
156861757|NCT03050801|566253233|FG005|Experiment 1|Physician Decision|0|||
156861758|NCT03050801|566253228|FG000|Experiment 1|Change of experimental design|0|||
156861759|NCT03050801|566253229|FG001|Experiment 1|Change of experimental design|3|||
156861760|NCT03050801|566253230|FG002|Experiment 1|Change of experimental design|0|||
156861761|NCT03050801|566253231|FG003|Experiment 1|Change of experimental design|0|||
156861762|NCT03050801|566253232|FG004|Experiment 1|Change of experimental design|0|||
156861763|NCT03050801|566253233|FG005|Experiment 1|Change of experimental design|0|||
156861764|NCT03050801|566253228|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861765|NCT03050801|566253229|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861766|NCT03050801|566253230|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
156861767|NCT03050801|566253231|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861768|NCT03050801|566253232|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861769|NCT03050801|566253233|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
156861770|NCT03050801|566253228|FG000|Experiment 2|Lost to Follow-up|0|||
156861771|NCT03050801|566253229|FG001|Experiment 2|Lost to Follow-up|0|||
156861772|NCT03050801|566253230|FG002|Experiment 2|Lost to Follow-up|0|||
156861773|NCT03050801|566253231|FG003|Experiment 2|Lost to Follow-up|1|||
156861774|NCT03050801|566253232|FG004|Experiment 2|Lost to Follow-up|1|||
156861775|NCT03050801|566253233|FG005|Experiment 2|Lost to Follow-up|0|||
156861776|NCT03050801|566253228|FG000|Experiment 2|Physician Decision|0|||
156861777|NCT03050801|566253229|FG001|Experiment 2|Physician Decision|0|||
156861778|NCT03050801|566253230|FG002|Experiment 2|Physician Decision|0|||
156861779|NCT03050801|566253231|FG003|Experiment 2|Physician Decision|0|||
156861780|NCT03050801|566253232|FG004|Experiment 2|Physician Decision|1|||
156861781|NCT03050801|566253233|FG005|Experiment 2|Physician Decision|0|||
156861782|NCT03050801|566253228|FG000|Experiment 2|Pregnancy|0|||
156861783|NCT03050801|566253229|FG001|Experiment 2|Pregnancy|0|||
156861784|NCT03050801|566253230|FG002|Experiment 2|Pregnancy|0|||
156861785|NCT03050801|566253231|FG003|Experiment 2|Pregnancy|0|||
156861786|NCT03050801|566253232|FG004|Experiment 2|Pregnancy|1|||
156861787|NCT03050801|566253233|FG005|Experiment 2|Pregnancy|0|||
156861788|NCT03050801|566253228|FG000|Experiment 2|Withdrawal by Subject|0|||
156861789|NCT03050801|566253229|FG001|Experiment 2|Withdrawal by Subject|0|||
156861790|NCT03050801|566253230|FG002|Experiment 2|Withdrawal by Subject|0|||
156861791|NCT03050801|566253231|FG003|Experiment 2|Withdrawal by Subject|1|||
156861792|NCT03050801|566253232|FG004|Experiment 2|Withdrawal by Subject|0|||
156977463|NCT04534114|566670717|FG000|Main Treatment Period|Adverse Event|4|||
156861793|NCT03050801|566253233|FG005|Experiment 2|Withdrawal by Subject|0|||
156861794|NCT03050801|566253228|FG000|Experiment 2|Poor data quality|0|||
156861795|NCT03050801|566253229|FG001|Experiment 2|Poor data quality|0|||
156861796|NCT03050801|566253230|FG002|Experiment 2|Poor data quality|0|||
156861797|NCT03050801|566253231|FG003|Experiment 2|Poor data quality|4|||
156861798|NCT03050801|566253232|FG004|Experiment 2|Poor data quality|1|||
156861799|NCT03050801|566253233|FG005|Experiment 2|Poor data quality|0|||
156861800|NCT03050801|566253228|FG000|Experiment 2|Discomfort during stimulation|0|||
156861801|NCT03050801|566253229|FG001|Experiment 2|Discomfort during stimulation|0|||
156861802|NCT03050801|566253230|FG002|Experiment 2|Discomfort during stimulation|0|||
156861803|NCT03050801|566253231|FG003|Experiment 2|Discomfort during stimulation|0|||
156861804|NCT03050801|566253232|FG004|Experiment 2|Discomfort during stimulation|0|||
156861805|NCT03050801|566253233|FG005|Experiment 2|Discomfort during stimulation|2|||
156861806|NCT01844765|566253234|FG000|Overall Study|Adverse Event|6|||
156861807|NCT01844765|566253235|FG001|Overall Study|Adverse Event|8|||
156861808|NCT01844765|566253234|FG000|Overall Study|Withdrawal by Subject|2|||
156861809|NCT01844765|566253235|FG001|Overall Study|Withdrawal by Subject|3|||
156861810|NCT01844765|566253234|FG000|Overall Study|Disease progression|1|||
156861811|NCT01844765|566253235|FG001|Overall Study|Disease progression|0|||
156861812|NCT01844765|566253234|FG000|Overall Study|Administrative problems|3|||
156861813|NCT01844765|566253235|FG001|Overall Study|Administrative problems|4|||
156861814|NCT01844765|566253234|FG000|Overall Study|Protocol deviation|2|||
156861815|NCT01844765|566253235|FG001|Overall Study|Protocol deviation|0|||
156861816|NCT01844765|566253234|FG000|Overall Study|Untreated|1|||
156861817|NCT01844765|566253235|FG001|Overall Study|Untreated|0|||
156861818|NCT00617734|566253236|FG000|Overall Study|Withdrew Consent|2|||
156861819|NCT00617734|566253237|FG001|Overall Study|Withdrew Consent|0|||
156861820|NCT00617734|566253236|FG000|Overall Study|Adverse Event|4|||
156861821|NCT00617734|566253237|FG001|Overall Study|Adverse Event|1|||
156861822|NCT00617734|566253236|FG000|Overall Study|Protocol Violation|1|||
156861823|NCT00617734|566253237|FG001|Overall Study|Protocol Violation|0|||
156861824|NCT00617734|566253236|FG000|Overall Study|Found Ineligible After Randomization|1|||
156861825|NCT00617734|566253237|FG001|Overall Study|Found Ineligible After Randomization|4|||
156861826|NCT00617734|566253236|FG000|Overall Study|Lost to Follow-up|0|||
156861827|NCT00617734|566253237|FG001|Overall Study|Lost to Follow-up|1|||
156861828|NCT02485691|566253238|FG000|Overall Study|Adverse Event|25|||
156861829|NCT02485691|566253239|FG001|Overall Study|Adverse Event|11|||
156861830|NCT02485691|566253238|FG000|Overall Study|Poor compliance to protocol|0|||
156861831|NCT02485691|566253239|FG001|Overall Study|Poor compliance to protocol|1|||
156861832|NCT02485691|566253238|FG000|Overall Study|Disease progression|57|||
156861833|NCT02485691|566253239|FG001|Overall Study|Disease progression|92|||
156861834|NCT02485691|566253238|FG000|Overall Study|Investigator's decision|23|||
156861835|NCT02485691|566253239|FG001|Overall Study|Investigator's decision|5|||
156861836|NCT02485691|566253238|FG000|Overall Study|Participant's request|13|||
156861837|NCT02485691|566253239|FG001|Overall Study|Participant's request|6|||
156861838|NCT02485691|566253238|FG000|Overall Study|Other reason|8|||
156861839|NCT02485691|566253239|FG001|Overall Study|Other reason|9|||
156861840|NCT02485691|566253238|FG000|Overall Study|Randomized and not treated|3|||
156861841|NCT02485691|566253239|FG001|Overall Study|Randomized and not treated|2|||
156861842|NCT04292535|566253240|FG000|Overall Study|Withdrawal by Subject|0|||
156861843|NCT04292535|566253241|FG001|Overall Study|Withdrawal by Subject|0|||
156861844|NCT04292535|566253242|FG002|Overall Study|Withdrawal by Subject|0|||
156861845|NCT04292535|566253243|FG003|Overall Study|Withdrawal by Subject|0|||
156861846|NCT04292535|566253244|FG004|Overall Study|Withdrawal by Subject|0|||
156861847|NCT04292535|566253245|FG005|Overall Study|Withdrawal by Subject|0|||
156861848|NCT04292535|566253246|FG006|Overall Study|Withdrawal by Subject|0|||
156861849|NCT04292535|566253247|FG007|Overall Study|Withdrawal by Subject|1|||
156861850|NCT04292535|566253248|FG008|Overall Study|Withdrawal by Subject|0|||
156861851|NCT04292535|566253249|FG009|Overall Study|Withdrawal by Subject|0|||
156861852|NCT04292535|566253250|FG010|Overall Study|Withdrawal by Subject|0|||
156861853|NCT04292535|566253251|FG011|Overall Study|Withdrawal by Subject|0|||
156861854|NCT04292535|566253252|FG012|Overall Study|Withdrawal by Subject|0|||
156861855|NCT04292535|566253253|FG013|Overall Study|Withdrawal by Subject|0|||
156861856|NCT04292535|566253240|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861857|NCT04292535|566253241|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861858|NCT04292535|566253242|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861859|NCT04292535|566253243|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861860|NCT04292535|566253244|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861861|NCT04292535|566253245|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861862|NCT04292535|566253246|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861863|NCT04292535|566253247|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861864|NCT04292535|566253248|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861865|NCT04292535|566253249|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861866|NCT04292535|566253250|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861867|NCT04292535|566253251|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
156861868|NCT04292535|566253252|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861869|NCT04292535|566253253|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
156861870|NCT04292535|566253240|FG000|Overall Study|Report of Dizziness|0|||
156861871|NCT04292535|566253241|FG001|Overall Study|Report of Dizziness|0|||
156861872|NCT04292535|566253242|FG002|Overall Study|Report of Dizziness|0|||
156861873|NCT04292535|566253243|FG003|Overall Study|Report of Dizziness|0|||
156861874|NCT04292535|566253244|FG004|Overall Study|Report of Dizziness|0|||
156861875|NCT04292535|566253245|FG005|Overall Study|Report of Dizziness|0|||
156861876|NCT04292535|566253246|FG006|Overall Study|Report of Dizziness|0|||
156861877|NCT04292535|566253247|FG007|Overall Study|Report of Dizziness|0|||
156861878|NCT04292535|566253248|FG008|Overall Study|Report of Dizziness|0|||
156861879|NCT04292535|566253249|FG009|Overall Study|Report of Dizziness|0|||
156861880|NCT04292535|566253250|FG010|Overall Study|Report of Dizziness|0|||
156861881|NCT04292535|566253251|FG011|Overall Study|Report of Dizziness|0|||
156861882|NCT04292535|566253252|FG012|Overall Study|Report of Dizziness|0|||
156861883|NCT04292535|566253253|FG013|Overall Study|Report of Dizziness|1|||
156861884|NCT04292535|566253240|FG000|Overall Study|Equipment Failure|0|||
156861885|NCT04292535|566253241|FG001|Overall Study|Equipment Failure|0|||
156861886|NCT04292535|566253242|FG002|Overall Study|Equipment Failure|0|||
156861887|NCT04292535|566253243|FG003|Overall Study|Equipment Failure|0|||
156861888|NCT04292535|566253244|FG004|Overall Study|Equipment Failure|0|||
156861889|NCT04292535|566253245|FG005|Overall Study|Equipment Failure|0|||
156861890|NCT04292535|566253246|FG006|Overall Study|Equipment Failure|0|||
156861891|NCT04292535|566253247|FG007|Overall Study|Equipment Failure|0|||
156861892|NCT04292535|566253248|FG008|Overall Study|Equipment Failure|0|||
156861893|NCT04292535|566253249|FG009|Overall Study|Equipment Failure|0|||
156861894|NCT04292535|566253250|FG010|Overall Study|Equipment Failure|0|||
156861895|NCT04292535|566253251|FG011|Overall Study|Equipment Failure|1|||
156861896|NCT04292535|566253252|FG012|Overall Study|Equipment Failure|0|||
156861897|NCT04292535|566253253|FG013|Overall Study|Equipment Failure|0|||
156861898|NCT03914417|566253254|FG000|Overall Study|Withdrawal by Subject|2|||
156861899|NCT03836625|566253255|FG000|Overall Study|Lost to Follow-up|9|||
156861900|NCT03836625|566253256|FG001|Overall Study|Lost to Follow-up|9|||
156861901|NCT03836625|566253255|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
156861902|NCT03836625|566253256|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
156861903|NCT03836625|566253255|FG000|Overall Study|Death|0|||
156861904|NCT03836625|566253256|FG001|Overall Study|Death|1|||
156861905|NCT03836625|566253255|FG000|Overall Study|Refused follow-up|0|||
156861906|NCT03836625|566253256|FG001|Overall Study|Refused follow-up|1|||
156861907|NCT01420861|566253257|FG000|Overall Study|Adverse Event|2|||
156861908|NCT01420861|566253257|FG000|Overall Study|Study terminated by Sponsor|7|||
156861909|NCT01420861|566253257|FG000|Overall Study|Screen failure|7|||
156861910|NCT01420861|566253257|FG000|Overall Study|Randomized not Treated|2|||
156861911|NCT00791934|566253258|FG000|Overall Study|Withdrawal by Subject|2|||
156861912|NCT00791934|566253258|FG000|Overall Study|Did not consent for extended follow-up|13|||
156861913|NCT03413891|566253260|FG000|Overall Study|Lost to Follow-up|2|||
156861914|NCT03413891|566253261|FG001|Overall Study|Lost to Follow-up|1|||
156861915|NCT03413891|566253260|FG000|Overall Study|Protocol Violation|0|||
156861916|NCT03413891|566253261|FG001|Overall Study|Protocol Violation|1|||
156861917|NCT04905134|566253262|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
156861918|NCT04905134|566253262|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
156861919|NCT03137992|566253263|FG000|Washout Period 1|Adverse Event|1|||
156912983|NCT04862585|566440411|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
156912984|NCT04862585|566440412|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
156912985|NCT04862585|566440411|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
156912986|NCT04862585|566440412|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
156912987|NCT04862585|566440411|FG000|Overall Study|one withdrew without providing a reason|0|||
156912988|NCT04862585|566440412|FG001|Overall Study|one withdrew without providing a reason|1|||
156912989|NCT05229406|566440415|FG000|Overall Study|Withdrawal by Subject|1|||
156912990|NCT05229406|566440416|FG001|Overall Study|Withdrawal by Subject|2|||
156912991|NCT01930123|566440417|FG000|Overall Study|Adverse Event|1|||
156912992|NCT01930123|566440418|FG001|Overall Study|Adverse Event|0|||
156912993|NCT01930123|566440417|FG000|Overall Study|Physician Decision|21|||
156912994|NCT01930123|566440418|FG001|Overall Study|Physician Decision|8|||
156912995|NCT01930123|566440417|FG000|Overall Study|Withdrawal by Subject|1|||
156912996|NCT01930123|566440418|FG001|Overall Study|Withdrawal by Subject|0|||
156912997|NCT03310021|566440422|FG000|Overall Study|Withdrawal by Subject|0|||
156912998|NCT03310021|566440423|FG001|Overall Study|Withdrawal by Subject|0|||
156861920|NCT03137992|566253264|FG001|Washout Period 1|Adverse Event|1|||
156861921|NCT03137992|566253265|FG002|Washout Period 1|Adverse Event|0|||
156861922|NCT03137992|566253266|FG003|Washout Period 1|Adverse Event|0|||
156861923|NCT03137992|566253267|FG004|Washout Period 1|Adverse Event|0|||
156861924|NCT03137992|566253268|FG005|Washout Period 1|Adverse Event|1|||
156861925|NCT03137992|566253263|FG000|Washout Period 1|Withdrawal by Subject|0|||
156912999|NCT03310021|566440424|FG002|Overall Study|Withdrawal by Subject|0|||
156861926|NCT03137992|566253264|FG001|Washout Period 1|Withdrawal by Subject|1|||
156861927|NCT03137992|566253265|FG002|Washout Period 1|Withdrawal by Subject|1|||
156861928|NCT03137992|566253266|FG003|Washout Period 1|Withdrawal by Subject|0|||
156861929|NCT03137992|566253267|FG004|Washout Period 1|Withdrawal by Subject|0|||
156861930|NCT03137992|566253268|FG005|Washout Period 1|Withdrawal by Subject|0|||
156861931|NCT03137992|566253263|FG000|Washout Period 1|Principal Investigator Discretion|0|||
156861932|NCT03137992|566253264|FG001|Washout Period 1|Principal Investigator Discretion|1|||
156861933|NCT03137992|566253265|FG002|Washout Period 1|Principal Investigator Discretion|0|||
156861934|NCT03137992|566253266|FG003|Washout Period 1|Principal Investigator Discretion|0|||
156861935|NCT03137992|566253267|FG004|Washout Period 1|Principal Investigator Discretion|0|||
156861936|NCT03137992|566253268|FG005|Washout Period 1|Principal Investigator Discretion|0|||
156861937|NCT03137992|566253263|FG000|Washout Period 1|COPD Exacerbation|1|||
156861938|NCT03137992|566253264|FG001|Washout Period 1|COPD Exacerbation|1|||
156861939|NCT03137992|566253265|FG002|Washout Period 1|COPD Exacerbation|1|||
156861940|NCT03137992|566253266|FG003|Washout Period 1|COPD Exacerbation|0|||
156861941|NCT03137992|566253267|FG004|Washout Period 1|COPD Exacerbation|1|||
156861942|NCT03137992|566253268|FG005|Washout Period 1|COPD Exacerbation|1|||
156861943|NCT03137992|566253263|FG000|Washout Period 1|Subject Noncompliance|1|||
156861944|NCT03137992|566253264|FG001|Washout Period 1|Subject Noncompliance|0|||
156861945|NCT03137992|566253265|FG002|Washout Period 1|Subject Noncompliance|0|||
156861946|NCT03137992|566253266|FG003|Washout Period 1|Subject Noncompliance|0|||
156861947|NCT03137992|566253267|FG004|Washout Period 1|Subject Noncompliance|1|||
156861948|NCT03137992|566253268|FG005|Washout Period 1|Subject Noncompliance|0|||
156861949|NCT03137992|566253263|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861950|NCT03137992|566253264|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861951|NCT03137992|566253265|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861952|NCT03137992|566253266|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861953|NCT03137992|566253267|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
156861954|NCT03137992|566253268|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
156861955|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
156861956|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861957|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861958|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
156861959|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
156861960|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
156861961|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Adverse Event|0|||
156861962|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Adverse Event|1|||
156861963|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Adverse Event|0|||
156861964|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Adverse Event|0|||
156861965|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Adverse Event|0|||
156861966|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Adverse Event|0|||
156861967|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861968|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861969|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861970|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
156861971|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861972|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
156861973|NCT03137992|566253263|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861974|NCT03137992|566253264|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
156861975|NCT03137992|566253265|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861976|NCT03137992|566253266|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861977|NCT03137992|566253267|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
156861978|NCT03137992|566253268|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
156861979|NCT03137992|566253263|FG000|Washout Period 2|COPD Exacerbation|1|||
156861980|NCT03137992|566253264|FG001|Washout Period 2|COPD Exacerbation|1|||
156861981|NCT03137992|566253265|FG002|Washout Period 2|COPD Exacerbation|0|||
156861982|NCT03137992|566253266|FG003|Washout Period 2|COPD Exacerbation|0|||
156861983|NCT03137992|566253267|FG004|Washout Period 2|COPD Exacerbation|1|||
156861984|NCT03137992|566253268|FG005|Washout Period 2|COPD Exacerbation|0|||
156861985|NCT03137992|566253263|FG000|Washout Period 2|Subject Non-compliance|0|||
156861986|NCT03137992|566253264|FG001|Washout Period 2|Subject Non-compliance|1|||
156861987|NCT03137992|566253265|FG002|Washout Period 2|Subject Non-compliance|0|||
156913000|NCT03310021|566440425|FG003|Overall Study|Withdrawal by Subject|0|||
156913001|NCT03310021|566440426|FG004|Overall Study|Withdrawal by Subject|0|||
156861988|NCT03137992|566253266|FG003|Washout Period 2|Subject Non-compliance|0|||
156861989|NCT03137992|566253267|FG004|Washout Period 2|Subject Non-compliance|0|||
156861990|NCT03137992|566253268|FG005|Washout Period 2|Subject Non-compliance|0|||
156861991|NCT03137992|566253263|FG000|Washout Period 2|Adverse Event|0|||
156861992|NCT03137992|566253264|FG001|Washout Period 2|Adverse Event|0|||
156861993|NCT03137992|566253265|FG002|Washout Period 2|Adverse Event|0|||
157160556|NCT00756886|567331503|FG001|Overall Study|Lack of Efficacy|0|||
157160557|NCT00756886|567331502|FG000|Overall Study|Ineligible|9|||
157160558|NCT00756886|567331503|FG001|Overall Study|Ineligible|4|||
156861994|NCT03137992|566253266|FG003|Washout Period 2|Adverse Event|1|||
156861995|NCT03137992|566253267|FG004|Washout Period 2|Adverse Event|1|||
156861996|NCT03137992|566253268|FG005|Washout Period 2|Adverse Event|0|||
156861997|NCT03137992|566253263|FG000|Washout Period 2|Withdrawal by Subject|1|||
156861998|NCT03137992|566253264|FG001|Washout Period 2|Withdrawal by Subject|0|||
156861999|NCT03137992|566253265|FG002|Washout Period 2|Withdrawal by Subject|0|||
156862000|NCT03137992|566253266|FG003|Washout Period 2|Withdrawal by Subject|0|||
156862001|NCT03137992|566253267|FG004|Washout Period 2|Withdrawal by Subject|1|||
156862002|NCT03137992|566253268|FG005|Washout Period 2|Withdrawal by Subject|0|||
156862003|NCT03137992|566253263|FG000|Washout Period 2|Sponsor Decision|0|||
156862004|NCT03137992|566253264|FG001|Washout Period 2|Sponsor Decision|0|||
156862005|NCT03137992|566253265|FG002|Washout Period 2|Sponsor Decision|0|||
156862006|NCT03137992|566253266|FG003|Washout Period 2|Sponsor Decision|0|||
156862007|NCT03137992|566253267|FG004|Washout Period 2|Sponsor Decision|0|||
156862008|NCT03137992|566253268|FG005|Washout Period 2|Sponsor Decision|1|||
157160559|NCT01395368|567331508|FG000|Overall Study|Physician Decision|14|||
157160560|NCT01395368|567331508|FG000|Overall Study|Withdrawal by Subject|2|||
157160561|NCT00310388|567331509|FG000|Primary Reporting Phase|Adverse Event|101|||
157160562|NCT00310388|567331510|FG001|Primary Reporting Phase|Adverse Event|0|||
157160563|NCT00310388|567331509|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
157160564|NCT00310388|567331510|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
157160565|NCT00310388|567331509|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
157160566|NCT00310388|567331510|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
157160567|NCT00310388|567331509|FG000|Primary Reporting Phase|Protocol Violation|10|||
157160568|NCT00310388|567331510|FG001|Primary Reporting Phase|Protocol Violation|0|||
157160569|NCT00310388|567331509|FG000|Primary Reporting Phase|Pregnancy|3|||
157160570|NCT00310388|567331510|FG001|Primary Reporting Phase|Pregnancy|0|||
157160571|NCT00310388|567331509|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
157160572|NCT00310388|567331510|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
157160573|NCT00310388|567331509|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
157160574|NCT00310388|567331510|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
157160575|NCT00310388|567331509|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
157160576|NCT00310388|567331510|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
157160577|NCT00310388|567331509|FG000|Primary Reporting Phase|Physician Decision|2|||
157160578|NCT00310388|567331510|FG001|Primary Reporting Phase|Physician Decision|0|||
157160579|NCT00310388|567331509|FG000|Primary Reporting Phase|Request of the sponsor|19|||
157160580|NCT00310388|567331510|FG001|Primary Reporting Phase|Request of the sponsor|0|||
157160581|NCT00310388|567331509|FG000|Primary Reporting Phase|Failed to return|8|||
157160582|NCT00310388|567331510|FG001|Primary Reporting Phase|Failed to return|0|||
157160583|NCT00310388|567331509|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
157160584|NCT00310388|567331510|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
157160585|NCT00310388|567331509|FG000|Primary Reporting Phase|Participant request|2|||
157160586|NCT00310388|567331510|FG001|Primary Reporting Phase|Participant request|0|||
157160587|NCT00310388|567331509|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
157160588|NCT00310388|567331510|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
157160589|NCT00310388|567331509|FG000|Primary Reporting Phase|Discontinuation of study|1|||
157160590|NCT00310388|567331510|FG001|Primary Reporting Phase|Discontinuation of study|0|||
157160591|NCT00310388|567331509|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
157160592|NCT00310388|567331510|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
157160593|NCT00310388|567331509|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
157160594|NCT00310388|567331510|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
157160595|NCT00310388|567331509|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
157160596|NCT00310388|567331510|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
157160597|NCT00310388|567331509|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
157160598|NCT00310388|567331510|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
157160599|NCT00310388|567331509|FG000|Primary Reporting Phase|Participant passed away|1|||
157160600|NCT00310388|567331510|FG001|Primary Reporting Phase|Participant passed away|0|||
157160601|NCT00310388|567331509|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
157160602|NCT00310388|567331510|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
157160603|NCT00310388|567331509|FG000|Primary Reporting Phase|Missing|1|||
157225641|NCT00319449|567571499|FG000|Overall Study|Noncompliance with the protocol|1|||
157225642|NCT00319449|567571500|FG001|Overall Study|Noncompliance with the protocol|0|||
156862009|NCT03137992|566253263|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
156862010|NCT03137992|566253264|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
156862011|NCT03137992|566253265|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
156862012|NCT03137992|566253266|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
157160604|NCT00310388|567331510|FG001|Primary Reporting Phase|Missing|0|||
156862013|NCT03137992|566253267|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
156862014|NCT03137992|566253268|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
156862015|NCT03137992|566253263|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862016|NCT03137992|566253264|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
156862017|NCT03137992|566253265|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
156862018|NCT03137992|566253266|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862019|NCT03137992|566253267|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
156862020|NCT03137992|566253268|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
156862021|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
156862022|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862023|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
156862024|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862025|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862026|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
156862027|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862028|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862029|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862030|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
156862031|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862032|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
156862033|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Per study team|1|||
156862034|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Per study team|0|||
156862035|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Per study team|0|||
156862036|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Per study team|0|||
156862037|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Per study team|0|||
156862038|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Per study team|0|||
156862039|NCT03137992|566253263|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862040|NCT03137992|566253264|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862041|NCT03137992|566253265|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862042|NCT03137992|566253266|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862043|NCT03137992|566253267|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
156862044|NCT03137992|566253268|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
156862045|NCT04609319|566253269|FG000|Overall Study|Death|64|||
156862046|NCT04609319|566253270|FG001|Overall Study|Death|49|||
156862047|NCT04609319|566253271|FG002|Overall Study|Death|1|||
156862048|NCT04609319|566253269|FG000|Overall Study|Withdrawal of consent|15|||
156862049|NCT04609319|566253270|FG001|Overall Study|Withdrawal of consent|3|||
156862050|NCT04609319|566253271|FG002|Overall Study|Withdrawal of consent|0|||
156862051|NCT04609319|566253269|FG000|Overall Study|Lost to Follow-up|20|||
156862052|NCT04609319|566253270|FG001|Overall Study|Lost to Follow-up|33|||
156862053|NCT04609319|566253271|FG002|Overall Study|Lost to Follow-up|0|||
156862054|NCT04609319|566253269|FG000|Overall Study|Alive until end of follow-up|60|||
156913002|NCT03310021|566440427|FG005|Overall Study|Withdrawal by Subject|0|||
156913003|NCT03310021|566440428|FG006|Overall Study|Withdrawal by Subject|1|||
156913004|NCT03310021|566440429|FG007|Overall Study|Withdrawal by Subject|0|||
156913005|NCT03310021|566440430|FG008|Overall Study|Withdrawal by Subject|0|||
156913006|NCT03310021|566440431|FG009|Overall Study|Withdrawal by Subject|0|||
156913007|NCT03310021|566440432|FG010|Overall Study|Withdrawal by Subject|0|||
156913008|NCT03310021|566440433|FG011|Overall Study|Withdrawal by Subject|0|||
156913009|NCT03310021|566440434|FG012|Overall Study|Withdrawal by Subject|0|||
156913010|NCT03310021|566440435|FG013|Overall Study|Withdrawal by Subject|0|||
156913011|NCT03310021|566440436|FG014|Overall Study|Withdrawal by Subject|0|||
156913012|NCT03310021|566440437|FG015|Overall Study|Withdrawal by Subject|0|||
156913013|NCT03310021|566440438|FG016|Overall Study|Withdrawal by Subject|0|||
156913014|NCT03310021|566440439|FG017|Overall Study|Withdrawal by Subject|0|||
156913015|NCT03310021|566440440|FG018|Overall Study|Withdrawal by Subject|0|||
156913016|NCT03310021|566440441|FG019|Overall Study|Withdrawal by Subject|0|||
156913017|NCT03310021|566440422|FG000|Overall Study|Lost to Follow-up|0|||
156913018|NCT03310021|566440423|FG001|Overall Study|Lost to Follow-up|0|||
156913019|NCT03310021|566440424|FG002|Overall Study|Lost to Follow-up|0|||
156913020|NCT03310021|566440425|FG003|Overall Study|Lost to Follow-up|0|||
156862055|NCT04609319|566253270|FG001|Overall Study|Alive until end of follow-up|53|||
156862056|NCT04609319|566253271|FG002|Overall Study|Alive until end of follow-up|1|||
156862057|NCT03221556|566253274|FG000|Allocation|post-randomization exclusion|0|||
156862058|NCT03221556|566253275|FG001|Allocation|post-randomization exclusion|1|||
156862059|NCT03221556|566253274|FG000|Follow-Up|Withdrawal by Subject|0|||
156862060|NCT03221556|566253275|FG001|Follow-Up|Withdrawal by Subject|1|||
156913021|NCT03310021|566440426|FG004|Overall Study|Lost to Follow-up|0|||
156862061|NCT01247324|566253278|FG000|Overall Study|Death|6|||
156862062|NCT01247324|566253279|FG001|Overall Study|Death|10|||
156862063|NCT01247324|566253278|FG000|Overall Study|Physician Decision|2|||
156862064|NCT01247324|566253279|FG001|Overall Study|Physician Decision|3|||
156862065|NCT01247324|566253278|FG000|Overall Study|Non-compliance with study drug|3|||
156913022|NCT03310021|566440427|FG005|Overall Study|Lost to Follow-up|0|||
156913023|NCT03310021|566440428|FG006|Overall Study|Lost to Follow-up|0|||
156913024|NCT03310021|566440429|FG007|Overall Study|Lost to Follow-up|0|||
156913025|NCT03310021|566440430|FG008|Overall Study|Lost to Follow-up|0|||
156862066|NCT01247324|566253279|FG001|Overall Study|Non-compliance with study drug|0|||
156862067|NCT01247324|566253278|FG000|Overall Study|Lack of Efficacy|24|||
156862068|NCT01247324|566253279|FG001|Overall Study|Lack of Efficacy|14|||
156862069|NCT01247324|566253278|FG000|Overall Study|Non-compliance|3|||
156862070|NCT01247324|566253279|FG001|Overall Study|Non-compliance|2|||
156862071|NCT01247324|566253278|FG000|Overall Study|Pregnancy|5|||
156862072|NCT01247324|566253279|FG001|Overall Study|Pregnancy|10|||
156862073|NCT01247324|566253278|FG000|Overall Study|Protocol Violation|1|||
156862074|NCT01247324|566253279|FG001|Overall Study|Protocol Violation|1|||
156862075|NCT01247324|566253278|FG000|Overall Study|Reason not specified|42|||
156862076|NCT01247324|566253279|FG001|Overall Study|Reason not specified|32|||
156862077|NCT01247324|566253278|FG000|Overall Study|Consent withdrawn by participant|41|||
156862078|NCT01247324|566253279|FG001|Overall Study|Consent withdrawn by participant|56|||
156862079|NCT01247324|566253278|FG000|Overall Study|Adverse Event|49|||
156862080|NCT01247324|566253279|FG001|Overall Study|Adverse Event|35|||
156862081|NCT01247324|566253278|FG000|Overall Study|Lost to Follow-up|3|||
156862082|NCT01247324|566253279|FG001|Overall Study|Lost to Follow-up|6|||
156862083|NCT01247324|566253278|FG000|Overall Study|Study Terminated by Sponsor|4|||
156862084|NCT01247324|566253279|FG001|Overall Study|Study Terminated by Sponsor|1|||
156862085|NCT01247324|566253278|FG000|Overall Study|Missing|2|||
156862086|NCT01247324|566253279|FG001|Overall Study|Missing|1|||
156862087|NCT01486966|566253280|FG000|Overall Study|Adverse Event|0|||
156913026|NCT03310021|566440431|FG009|Overall Study|Lost to Follow-up|0|||
156913027|NCT03310021|566440432|FG010|Overall Study|Lost to Follow-up|1|||
156913028|NCT03310021|566440433|FG011|Overall Study|Lost to Follow-up|0|||
156913029|NCT03310021|566440434|FG012|Overall Study|Lost to Follow-up|0|||
156913030|NCT03310021|566440435|FG013|Overall Study|Lost to Follow-up|0|||
156913031|NCT03310021|566440436|FG014|Overall Study|Lost to Follow-up|0|||
156913032|NCT03310021|566440437|FG015|Overall Study|Lost to Follow-up|0|||
157160605|NCT00310388|567331509|FG000|Primary Reporting Phase|Other|1|||
157160606|NCT00310388|567331510|FG001|Primary Reporting Phase|Other|0|||
157160607|NCT00310388|567331509|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
157160608|NCT00310388|567331510|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
157160609|NCT00310388|567331509|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
157160610|NCT00310388|567331510|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
157160611|NCT00310388|567331509|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
157160612|NCT00310388|567331510|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
157160613|NCT00310388|567331509|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
157160614|NCT00310388|567331510|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
157160615|NCT02179515|567331513|FG000|Overall Study|switched to alternative treatment|0|||
157160616|NCT02179515|567331514|FG001|Overall Study|switched to alternative treatment|1|||
157160617|NCT02179515|567331515|FG002|Overall Study|switched to alternative treatment|1|||
157160618|NCT02179515|567331513|FG000|Overall Study|Death|0|||
157160619|NCT02179515|567331514|FG001|Overall Study|Death|1|||
157160620|NCT02179515|567331515|FG002|Overall Study|Death|1|||
157160621|NCT02179515|567331513|FG000|Overall Study|refused further treatment|0|||
157160622|NCT02179515|567331514|FG001|Overall Study|refused further treatment|3|||
157160623|NCT02179515|567331515|FG002|Overall Study|refused further treatment|4|||
157160624|NCT02179515|567331513|FG000|Overall Study|Disease progression on study|2|||
157160625|NCT02179515|567331514|FG001|Overall Study|Disease progression on study|11|||
157160626|NCT02179515|567331515|FG002|Overall Study|Disease progression on study|8|||
157160627|NCT00782418|567331520|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
157160628|NCT00782418|567331521|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160629|NCT00782418|567331522|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160630|NCT00782418|567331523|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160631|NCT00782418|567331524|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160632|NCT00782418|567331525|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160633|NCT00782418|567331526|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
157160634|NCT00782418|567331520|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
157160635|NCT00782418|567331521|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
157160636|NCT00782418|567331522|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
157160637|NCT00782418|567331523|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
157160638|NCT00782418|567331524|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
156862088|NCT01486966|566253281|FG001|Overall Study|Adverse Event|1|||
156913033|NCT03310021|566440438|FG016|Overall Study|Lost to Follow-up|0|||
157160639|NCT00782418|567331525|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
157160640|NCT00782418|567331526|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
157160641|NCT00882999|567331527|FG000|Overall Study|Adverse Event|0|||
157160642|NCT00882999|567331528|FG001|Overall Study|Adverse Event|0|||
156862089|NCT01486966|566253280|FG000|Overall Study|Withdrawal by Subject|0|||
156862090|NCT01486966|566253281|FG001|Overall Study|Withdrawal by Subject|1|||
156862091|NCT00301808|566253284|FG000|Overall Study|Adverse Event|5|||
156913034|NCT03310021|566440439|FG017|Overall Study|Lost to Follow-up|0|||
156913035|NCT03310021|566440440|FG018|Overall Study|Lost to Follow-up|0|||
156913036|NCT03310021|566440441|FG019|Overall Study|Lost to Follow-up|0|||
156913037|NCT00702923|566440444|FG000|Overall Study|Adverse Event|1|||
156913038|NCT02002091|566440449|FG000|Screening|Lost to Follow-up|10|||
156913039|NCT02002091|566440450|FG001|Screening|Lost to Follow-up|12|||
156913040|NCT02002091|566440449|FG000|Screening|Death|3|||
156913041|NCT02002091|566440450|FG001|Screening|Death|2|||
156913042|NCT01233258|566440452|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
156913043|NCT01233258|566440453|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
156913044|NCT01233258|566440454|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
156862092|NCT00301808|566253284|FG000|Overall Study|Death|3|||
156862093|NCT00301808|566253284|FG000|Overall Study|Lack of Efficacy|4|||
156862094|NCT00506350|566253285|FG000|Overall Study|Serious Adverse Event|1|||
156862095|NCT00506350|566253286|FG001|Overall Study|Serious Adverse Event|0|||
156862096|NCT00506350|566253287|FG002|Overall Study|Serious Adverse Event|0|||
156862097|NCT00506350|566253288|FG003|Overall Study|Serious Adverse Event|0|||
156862098|NCT00506350|566253289|FG004|Overall Study|Serious Adverse Event|0|||
156862099|NCT00506350|566253290|FG005|Overall Study|Serious Adverse Event|0|||
156862100|NCT00506350|566253291|FG006|Overall Study|Serious Adverse Event|0|||
156862101|NCT00506350|566253292|FG007|Overall Study|Serious Adverse Event|0|||
156862102|NCT00506350|566253293|FG008|Overall Study|Serious Adverse Event|0|||
156862103|NCT00506350|566253285|FG000|Overall Study|Adverse Event|0|||
156862104|NCT00506350|566253286|FG001|Overall Study|Adverse Event|0|||
156862105|NCT00506350|566253287|FG002|Overall Study|Adverse Event|0|||
156862106|NCT00506350|566253288|FG003|Overall Study|Adverse Event|0|||
156862107|NCT00506350|566253289|FG004|Overall Study|Adverse Event|0|||
156862108|NCT00506350|566253290|FG005|Overall Study|Adverse Event|0|||
156862109|NCT00506350|566253291|FG006|Overall Study|Adverse Event|0|||
156862110|NCT00506350|566253292|FG007|Overall Study|Adverse Event|1|||
156862111|NCT00506350|566253293|FG008|Overall Study|Adverse Event|1|||
156862112|NCT00506350|566253285|FG000|Overall Study|Protocol Violation|0|||
156862113|NCT00506350|566253286|FG001|Overall Study|Protocol Violation|0|||
156862114|NCT00506350|566253287|FG002|Overall Study|Protocol Violation|1|||
156862115|NCT00506350|566253288|FG003|Overall Study|Protocol Violation|0|||
156862116|NCT00506350|566253289|FG004|Overall Study|Protocol Violation|0|||
156862117|NCT00506350|566253290|FG005|Overall Study|Protocol Violation|0|||
156862118|NCT00506350|566253291|FG006|Overall Study|Protocol Violation|1|||
156862119|NCT00506350|566253292|FG007|Overall Study|Protocol Violation|0|||
156862120|NCT00506350|566253293|FG008|Overall Study|Protocol Violation|0|||
156862121|NCT00506350|566253285|FG000|Overall Study|Withdrawal by Subject|0|||
156862122|NCT00506350|566253286|FG001|Overall Study|Withdrawal by Subject|1|||
156862123|NCT00506350|566253287|FG002|Overall Study|Withdrawal by Subject|1|||
156862124|NCT00506350|566253288|FG003|Overall Study|Withdrawal by Subject|1|||
156862125|NCT00506350|566253289|FG004|Overall Study|Withdrawal by Subject|4|||
156862126|NCT00506350|566253290|FG005|Overall Study|Withdrawal by Subject|1|||
156862127|NCT00506350|566253291|FG006|Overall Study|Withdrawal by Subject|1|||
156862128|NCT00506350|566253292|FG007|Overall Study|Withdrawal by Subject|2|||
156862129|NCT00506350|566253293|FG008|Overall Study|Withdrawal by Subject|0|||
156862130|NCT00506350|566253285|FG000|Overall Study|Lost to Follow-up|1|||
156862131|NCT00506350|566253286|FG001|Overall Study|Lost to Follow-up|1|||
156862132|NCT00506350|566253287|FG002|Overall Study|Lost to Follow-up|1|||
156862133|NCT00506350|566253288|FG003|Overall Study|Lost to Follow-up|1|||
156862134|NCT00506350|566253289|FG004|Overall Study|Lost to Follow-up|2|||
156862135|NCT00506350|566253290|FG005|Overall Study|Lost to Follow-up|1|||
156862136|NCT00506350|566253291|FG006|Overall Study|Lost to Follow-up|0|||
156862137|NCT00506350|566253292|FG007|Overall Study|Lost to Follow-up|0|||
156862138|NCT00506350|566253293|FG008|Overall Study|Lost to Follow-up|2|||
156862139|NCT00506350|566253285|FG000|Overall Study|Medical Reason|0|||
156862140|NCT00506350|566253286|FG001|Overall Study|Medical Reason|0|||
156862141|NCT00506350|566253287|FG002|Overall Study|Medical Reason|0|||
156862142|NCT00506350|566253288|FG003|Overall Study|Medical Reason|0|||
156862143|NCT00506350|566253289|FG004|Overall Study|Medical Reason|1|||
156862144|NCT00506350|566253290|FG005|Overall Study|Medical Reason|0|||
156862145|NCT00506350|566253291|FG006|Overall Study|Medical Reason|0|||
156862146|NCT00506350|566253292|FG007|Overall Study|Medical Reason|0|||
156862147|NCT00506350|566253293|FG008|Overall Study|Medical Reason|0|||
156862148|NCT00506350|566253285|FG000|Overall Study|Other|1|||
156862149|NCT00506350|566253286|FG001|Overall Study|Other|1|||
156862150|NCT00506350|566253287|FG002|Overall Study|Other|3|||
156862151|NCT00506350|566253288|FG003|Overall Study|Other|0|||
156862152|NCT00506350|566253289|FG004|Overall Study|Other|3|||
156862153|NCT00506350|566253290|FG005|Overall Study|Other|0|||
156913045|NCT01233258|566440455|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
157160643|NCT00882999|567331529|FG002|Overall Study|Adverse Event|0|||
157160644|NCT00882999|567331530|FG003|Overall Study|Adverse Event|0|||
156862154|NCT00506350|566253291|FG006|Overall Study|Other|0|||
156862155|NCT00506350|566253292|FG007|Overall Study|Other|2|||
156862156|NCT00506350|566253293|FG008|Overall Study|Other|2|||
156913046|NCT01233258|566440456|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
157160645|NCT00882999|567331531|FG004|Overall Study|Adverse Event|1|||
157027405|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
157027406|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
157027407|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
157027408|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
157027409|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
157027410|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
157027411|NCT03852472|566856114|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
157027412|NCT03852472|566856115|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
157027413|NCT03852472|566856116|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
157027414|NCT03852472|566856117|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
157027415|NCT03852472|566856118|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
157027416|NCT03852472|566856114|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
156862157|NCT04972786|566253294|FG000|First Intervention (1 Day)|Adverse Event|1|||
156862158|NCT04972786|566253295|FG001|First Intervention (1 Day)|Adverse Event|0|||
156862159|NCT03518086|566253297|FG000|Overall Study|Adverse Event|23|||
156862160|NCT03518086|566253298|FG001|Overall Study|Adverse Event|15|||
156862161|NCT03518086|566253299|FG002|Overall Study|Adverse Event|3|||
156862162|NCT03518086|566253300|FG003|Overall Study|Adverse Event|2|||
156862163|NCT03518086|566253297|FG000|Overall Study|Withdrawal by Subject|8|||
156862164|NCT03518086|566253298|FG001|Overall Study|Withdrawal by Subject|5|||
156862165|NCT03518086|566253299|FG002|Overall Study|Withdrawal by Subject|1|||
156862166|NCT03518086|566253300|FG003|Overall Study|Withdrawal by Subject|0|||
156862167|NCT03518086|566253297|FG000|Overall Study|Lack of Efficacy|5|||
156862168|NCT03518086|566253298|FG001|Overall Study|Lack of Efficacy|5|||
156862169|NCT03518086|566253299|FG002|Overall Study|Lack of Efficacy|0|||
156862170|NCT03518086|566253300|FG003|Overall Study|Lack of Efficacy|2|||
156862171|NCT03518086|566253297|FG000|Overall Study|Protocol Violation|1|||
156862172|NCT03518086|566253298|FG001|Overall Study|Protocol Violation|5|||
156862173|NCT03518086|566253299|FG002|Overall Study|Protocol Violation|1|||
156862174|NCT03518086|566253300|FG003|Overall Study|Protocol Violation|3|||
156862175|NCT03518086|566253297|FG000|Overall Study|Lost to Follow-up|0|||
156862176|NCT03518086|566253298|FG001|Overall Study|Lost to Follow-up|3|||
156862177|NCT03518086|566253299|FG002|Overall Study|Lost to Follow-up|0|||
156862178|NCT03518086|566253300|FG003|Overall Study|Lost to Follow-up|0|||
156862179|NCT03518086|566253297|FG000|Overall Study|Insufficient Diary Data|0|||
156862180|NCT03518086|566253298|FG001|Overall Study|Insufficient Diary Data|2|||
156862181|NCT03518086|566253299|FG002|Overall Study|Insufficient Diary Data|0|||
156862182|NCT03518086|566253300|FG003|Overall Study|Insufficient Diary Data|0|||
156862183|NCT03518086|566253297|FG000|Overall Study|Non- compliance to Protocol|0|||
156862184|NCT03518086|566253298|FG001|Overall Study|Non- compliance to Protocol|1|||
156862185|NCT03518086|566253299|FG002|Overall Study|Non- compliance to Protocol|0|||
156862186|NCT03518086|566253300|FG003|Overall Study|Non- compliance to Protocol|0|||
156862187|NCT03518086|566253297|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
156862188|NCT03518086|566253298|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
156862189|NCT03518086|566253299|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
156862190|NCT03518086|566253300|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
156862191|NCT03518086|566253297|FG000|Overall Study|Site Terminated by Sponsor|0|||
156862192|NCT03518086|566253298|FG001|Overall Study|Site Terminated by Sponsor|1|||
156862193|NCT03518086|566253299|FG002|Overall Study|Site Terminated by Sponsor|0|||
156862194|NCT03518086|566253300|FG003|Overall Study|Site Terminated by Sponsor|0|||
156862195|NCT03518086|566253297|FG000|Overall Study|Pregnancy|0|||
156862196|NCT03518086|566253298|FG001|Overall Study|Pregnancy|0|||
156862197|NCT03518086|566253299|FG002|Overall Study|Pregnancy|0|||
156862198|NCT03518086|566253300|FG003|Overall Study|Pregnancy|2|||
156862199|NCT02336282|566253304|FG000|Overall Study|Unrelated illness|1|||
156862200|NCT02336282|566253304|FG000|Overall Study|Uncomfortable with technology|1|||
156862201|NCT02336282|566253304|FG000|Overall Study|Lost to Follow-up|1|||
157027417|NCT03852472|566856115|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
157027418|NCT03852472|566856116|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
157027419|NCT03852472|566856117|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
157027420|NCT03852472|566856118|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
157027421|NCT03852472|566856114|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
157027422|NCT03852472|566856115|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
157027423|NCT03852472|566856116|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
157027424|NCT03852472|566856117|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
157027425|NCT03852472|566856118|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
157027426|NCT03852472|566856114|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
157160646|NCT00882999|567331532|FG005|Overall Study|Adverse Event|0|||
156862202|NCT02336282|566253304|FG000|Overall Study|Not enough time to complete sessions|2|||
156862203|NCT00668148|566253320|FG000|Overall Study|Adverse Event|5|||
156862204|NCT00668148|566253320|FG000|Overall Study|Subject Non-compliance|1|||
156862205|NCT00668148|566253320|FG000|Overall Study|Progressive Disease Before Treatment|2|||
156862206|NCT00668148|566253320|FG000|Overall Study|Withdrawal of Consent|2|||
156862207|NCT02702492|566253321|FG000|Overall Study|Disease progression|3|||
156862208|NCT02702492|566253322|FG001|Overall Study|Disease progression|3|||
156862209|NCT02702492|566253323|FG002|Overall Study|Disease progression|2|||
156862210|NCT02702492|566253324|FG003|Overall Study|Disease progression|4|||
156862211|NCT02702492|566253325|FG004|Overall Study|Disease progression|4|||
156862212|NCT02702492|566253326|FG005|Overall Study|Disease progression|1|||
156862213|NCT02702492|566253327|FG006|Overall Study|Disease progression|2|||
156862214|NCT02702492|566253328|FG007|Overall Study|Disease progression|8|||
156862215|NCT02702492|566253329|FG008|Overall Study|Disease progression|5|||
156862216|NCT02702492|566253330|FG009|Overall Study|Disease progression|1|||
156862217|NCT02702492|566253331|FG010|Overall Study|Disease progression|0|||
156862218|NCT02702492|566253332|FG011|Overall Study|Disease progression|3|||
156862219|NCT02702492|566253333|FG012|Overall Study|Disease progression|2|||
156862220|NCT02702492|566253321|FG000|Overall Study|Clinical progression|0|||
156862221|NCT02702492|566253322|FG001|Overall Study|Clinical progression|0|||
156862222|NCT02702492|566253323|FG002|Overall Study|Clinical progression|2|||
156862223|NCT02702492|566253324|FG003|Overall Study|Clinical progression|1|||
156862224|NCT02702492|566253325|FG004|Overall Study|Clinical progression|0|||
156862225|NCT02702492|566253326|FG005|Overall Study|Clinical progression|2|||
156862226|NCT02702492|566253327|FG006|Overall Study|Clinical progression|1|||
156862227|NCT02702492|566253328|FG007|Overall Study|Clinical progression|4|||
156862228|NCT02702492|566253329|FG008|Overall Study|Clinical progression|0|||
156862229|NCT02702492|566253330|FG009|Overall Study|Clinical progression|0|||
156862230|NCT02702492|566253331|FG010|Overall Study|Clinical progression|1|||
156913047|NCT01233258|566440457|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
156913048|NCT01233258|566440452|FG000|First Intervention (6 Months)|Protocol Violation|0|||
156913049|NCT01233258|566440453|FG001|First Intervention (6 Months)|Protocol Violation|0|||
156913050|NCT01233258|566440454|FG002|First Intervention (6 Months)|Protocol Violation|1|||
156913051|NCT01233258|566440455|FG003|First Intervention (6 Months)|Protocol Violation|0|||
156913052|NCT01233258|566440456|FG004|First Intervention (6 Months)|Protocol Violation|0|||
156913053|NCT01233258|566440457|FG005|First Intervention (6 Months)|Protocol Violation|0|||
156862231|NCT02702492|566253332|FG011|Overall Study|Clinical progression|2|||
156862232|NCT02702492|566253333|FG012|Overall Study|Clinical progression|0|||
156862233|NCT02702492|566253321|FG000|Overall Study|Adverse Event|0|||
156862234|NCT02702492|566253322|FG001|Overall Study|Adverse Event|0|||
156862235|NCT02702492|566253323|FG002|Overall Study|Adverse Event|1|||
156862236|NCT02702492|566253324|FG003|Overall Study|Adverse Event|2|||
156862237|NCT02702492|566253325|FG004|Overall Study|Adverse Event|1|||
156862238|NCT02702492|566253326|FG005|Overall Study|Adverse Event|0|||
156862239|NCT02702492|566253327|FG006|Overall Study|Adverse Event|1|||
156862240|NCT02702492|566253328|FG007|Overall Study|Adverse Event|0|||
156862241|NCT02702492|566253329|FG008|Overall Study|Adverse Event|2|||
156862242|NCT02702492|566253330|FG009|Overall Study|Adverse Event|0|||
156862243|NCT02702492|566253331|FG010|Overall Study|Adverse Event|0|||
156862244|NCT02702492|566253332|FG011|Overall Study|Adverse Event|0|||
156862245|NCT02702492|566253333|FG012|Overall Study|Adverse Event|1|||
156862246|NCT02702492|566253321|FG000|Overall Study|Other|0|||
156862247|NCT02702492|566253322|FG001|Overall Study|Other|0|||
156862248|NCT02702492|566253323|FG002|Overall Study|Other|0|||
156862249|NCT02702492|566253324|FG003|Overall Study|Other|0|||
156862250|NCT02702492|566253325|FG004|Overall Study|Other|0|||
156862251|NCT02702492|566253326|FG005|Overall Study|Other|0|||
156862252|NCT02702492|566253327|FG006|Overall Study|Other|0|||
156862253|NCT02702492|566253328|FG007|Overall Study|Other|0|||
156862254|NCT02702492|566253329|FG008|Overall Study|Other|0|||
156862255|NCT02702492|566253330|FG009|Overall Study|Other|0|||
156862256|NCT02702492|566253331|FG010|Overall Study|Other|0|||
156862257|NCT02702492|566253332|FG011|Overall Study|Other|0|||
156862258|NCT02702492|566253333|FG012|Overall Study|Other|1|||
156862259|NCT00781768|566254713|FG000|Overall Study|Not transplanted.|0|||
156862260|NCT00781768|566254714|FG001|Overall Study|Not transplanted.|2|||
156862261|NCT00199381|566254717|FG000|Overall Study|Withdrawal by Subject|38|||
156862262|NCT00199381|566254717|FG000|Overall Study|Adverse Event|73|||
156862263|NCT00199381|566254717|FG000|Overall Study|Protocol Violation|6|||
156862264|NCT00199381|566254717|FG000|Overall Study|Lack of Efficacy|27|||
156862265|NCT00199381|566254717|FG000|Overall Study|Not including due to early termination|37|||
156862266|NCT00199381|566254717|FG000|Overall Study|Study termination by Sponsor|323|||
156862267|NCT02892344|566254718|FG000|Overall Study|Protocol deviation|3|||
156862268|NCT02892344|566254719|FG001|Overall Study|Protocol deviation|4|||
156862269|NCT02892344|566254718|FG000|Overall Study|Adverse Event|1|||
156862270|NCT02892344|566254719|FG001|Overall Study|Adverse Event|8|||
156862271|NCT02892344|566254718|FG000|Overall Study|Lost to Follow-up|0|||
156862272|NCT02892344|566254719|FG001|Overall Study|Lost to Follow-up|1|||
157225643|NCT02415959|567571501|FG000|Overall Study|Adverse Event|0|||
156862273|NCT02892344|566254718|FG000|Overall Study|Non-compliance with study treatment|0|||
156862274|NCT02892344|566254719|FG001|Overall Study|Non-compliance with study treatment|1|||
156862275|NCT02892344|566254718|FG000|Overall Study|Physician Decision|0|||
156862276|NCT02892344|566254719|FG001|Overall Study|Physician Decision|2|||
156862277|NCT02892344|566254718|FG000|Overall Study|Subject/guardian decision|0|||
156862278|NCT02892344|566254719|FG001|Overall Study|Subject/guardian decision|4|||
156862279|NCT02892344|566254718|FG000|Overall Study|Technical problems|0|||
156862280|NCT02892344|566254719|FG001|Overall Study|Technical problems|1|||
156862281|NCT00751296|566254720|FG000|Overall Study|Adverse Event|2|||
156862282|NCT02318706|566254723|FG000|Double-blind Phase|Adverse Event|7|||
156862283|NCT02318706|566254724|FG001|Double-blind Phase|Adverse Event|4|||
156862284|NCT02318706|566254725|FG002|Double-blind Phase|Adverse Event|3|||
156862285|NCT02318706|566254726|FG003|Double-blind Phase|Adverse Event|10|||
156862286|NCT02318706|566254727|FG004|Double-blind Phase|Adverse Event|0|||
156862287|NCT02318706|566254723|FG000|Double-blind Phase|Lost to Follow-up|1|||
156862288|NCT02318706|566254724|FG001|Double-blind Phase|Lost to Follow-up|0|||
156862289|NCT02318706|566254725|FG002|Double-blind Phase|Lost to Follow-up|0|||
156862290|NCT02318706|566254726|FG003|Double-blind Phase|Lost to Follow-up|0|||
156862291|NCT02318706|566254727|FG004|Double-blind Phase|Lost to Follow-up|0|||
156862292|NCT02318706|566254723|FG000|Double-blind Phase|Protocol Violation|4|||
156862293|NCT02318706|566254724|FG001|Double-blind Phase|Protocol Violation|2|||
156862294|NCT02318706|566254725|FG002|Double-blind Phase|Protocol Violation|4|||
156862295|NCT02318706|566254726|FG003|Double-blind Phase|Protocol Violation|3|||
156862296|NCT02318706|566254727|FG004|Double-blind Phase|Protocol Violation|0|||
156862297|NCT02318706|566254723|FG000|Double-blind Phase|Withdrawal by Subject|9|||
156862298|NCT02318706|566254724|FG001|Double-blind Phase|Withdrawal by Subject|5|||
156862299|NCT02318706|566254725|FG002|Double-blind Phase|Withdrawal by Subject|7|||
156862300|NCT02318706|566254726|FG003|Double-blind Phase|Withdrawal by Subject|10|||
156862301|NCT02318706|566254727|FG004|Double-blind Phase|Withdrawal by Subject|0|||
156862302|NCT02318706|566254723|FG000|Double-blind Phase|Other|4|||
156862303|NCT02318706|566254724|FG001|Double-blind Phase|Other|1|||
156862304|NCT02318706|566254725|FG002|Double-blind Phase|Other|2|||
156862305|NCT02318706|566254726|FG003|Double-blind Phase|Other|1|||
156862306|NCT02318706|566254727|FG004|Double-blind Phase|Other|0|||
156862307|NCT02318706|566254723|FG000|Double-blind Phase|Death|0|||
156862308|NCT02318706|566254724|FG001|Double-blind Phase|Death|0|||
156862309|NCT02318706|566254725|FG002|Double-blind Phase|Death|2|||
156862310|NCT02318706|566254726|FG003|Double-blind Phase|Death|0|||
156862311|NCT02318706|566254727|FG004|Double-blind Phase|Death|0|||
156862312|NCT02318706|566254723|FG000|Open-label Extension Phase|Adverse Event|0|||
156862313|NCT02318706|566254724|FG001|Open-label Extension Phase|Adverse Event|0|||
156862314|NCT02318706|566254725|FG002|Open-label Extension Phase|Adverse Event|0|||
156862315|NCT02318706|566254726|FG003|Open-label Extension Phase|Adverse Event|0|||
156862316|NCT02318706|566254727|FG004|Open-label Extension Phase|Adverse Event|21|||
156862317|NCT02318706|566254723|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
156862318|NCT02318706|566254724|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
156862319|NCT02318706|566254725|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
156862320|NCT02318706|566254726|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
156862321|NCT02318706|566254727|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
156862322|NCT02318706|566254723|FG000|Open-label Extension Phase|Death|0|||
156862323|NCT02318706|566254724|FG001|Open-label Extension Phase|Death|0|||
156862324|NCT02318706|566254725|FG002|Open-label Extension Phase|Death|0|||
156862325|NCT02318706|566254726|FG003|Open-label Extension Phase|Death|0|||
156862326|NCT02318706|566254727|FG004|Open-label Extension Phase|Death|1|||
156862327|NCT02318706|566254723|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
156862328|NCT02318706|566254724|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
156862329|NCT02318706|566254725|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
156862330|NCT02318706|566254726|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
156862331|NCT02318706|566254727|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
156862332|NCT04328077|566254728|FG000|Overall Study|Lost to Follow-up|0|||
156862333|NCT04328077|566254729|FG001|Overall Study|Lost to Follow-up|1|||
156862334|NCT04328077|566254730|FG002|Overall Study|Lost to Follow-up|0|||
156862335|NCT04328077|566254731|FG003|Overall Study|Lost to Follow-up|0|||
156862336|NCT04328077|566254728|FG000|Overall Study|Withdrawal by Subject|0|||
156862337|NCT04328077|566254729|FG001|Overall Study|Withdrawal by Subject|1|||
156862338|NCT04328077|566254730|FG002|Overall Study|Withdrawal by Subject|1|||
156862339|NCT04328077|566254731|FG003|Overall Study|Withdrawal by Subject|3|||
156862340|NCT01702311|566254732|FG000|Overall Study|Withdrawal by Subject|3|||
156862341|NCT01702311|566254733|FG001|Overall Study|Withdrawal by Subject|2|||
156862342|NCT01702311|566254732|FG000|Overall Study|Discharge less than 24 hours|10|||
156862343|NCT01702311|566254733|FG001|Overall Study|Discharge less than 24 hours|7|||
157225644|NCT02415959|567571502|FG001|Overall Study|Adverse Event|1|||
156862344|NCT01702311|566254732|FG000|Overall Study|Physician Decision|3|||
156862345|NCT01702311|566254733|FG001|Overall Study|Physician Decision|4|||
156862346|NCT00804908|566254734|FG000|Overall Study|Other|115|||
156862347|NCT00804908|566254735|FG001|Overall Study|Other|116|||
156862348|NCT00804908|566254736|FG002|Overall Study|Other|114|||
156862349|NCT04945733|566254740|FG000|Overall Study|Physician Decision|1|||
156862350|NCT04945733|566254741|FG001|Overall Study|Physician Decision|3|||
156862351|NCT04945733|566254742|FG002|Overall Study|Physician Decision|0|||
156862352|NCT04945733|566254740|FG000|Overall Study|Withdrawal by Subject|3|||
156862353|NCT04945733|566254741|FG001|Overall Study|Withdrawal by Subject|3|||
156862354|NCT04945733|566254742|FG002|Overall Study|Withdrawal by Subject|0|||
156862355|NCT02007096|566254743|FG000|Overall Study|medication not available|2|||
156862356|NCT02007096|566254744|FG001|Overall Study|medication not available|0|||
156862357|NCT02007096|566254743|FG000|Overall Study|did not inject saline|0|||
156862358|NCT02007096|566254744|FG001|Overall Study|did not inject saline|3|||
156862359|NCT02007096|566254743|FG000|Overall Study|did not follow postoperative protocol|8|||
156862360|NCT02007096|566254744|FG001|Overall Study|did not follow postoperative protocol|11|||
156862361|NCT02007096|566254743|FG000|Overall Study|converted to open surgery|1|||
156862362|NCT02007096|566254744|FG001|Overall Study|converted to open surgery|1|||
156862363|NCT02007096|566254743|FG000|Overall Study|no mesh placed|0|||
156862364|NCT02007096|566254744|FG001|Overall Study|no mesh placed|1|||
156862365|NCT05660577|566254745|FG000|Overall Study|Discontinued|9|||
156862366|NCT03363841|566254751|FG000|Overall Study|Adverse Event|1|||
156862367|NCT03363841|566254751|FG000|Overall Study|Withdrawal by Subject|1|||
156862368|NCT03363841|566254751|FG000|Overall Study|Death|7|||
156862369|NCT03363841|566254751|FG000|Overall Study|Physician Decision|1|||
156862370|NCT02156076|566254754|FG000|Treatment Period|no longer meets study criteria|0|||
156862371|NCT02156076|566254755|FG001|Treatment Period|no longer meets study criteria|0|||
156862372|NCT02156076|566254756|FG002|Treatment Period|no longer meets study criteria|1|||
156862373|NCT02156076|566254757|FG003|Treatment Period|no longer meets study criteria|0|||
156862374|NCT02156076|566254754|FG000|Treatment Period|Poor/non-compliance|0|||
156862375|NCT02156076|566254755|FG001|Treatment Period|Poor/non-compliance|1|||
156862376|NCT02156076|566254756|FG002|Treatment Period|Poor/non-compliance|0|||
156862377|NCT02156076|566254757|FG003|Treatment Period|Poor/non-compliance|0|||
156862378|NCT02156076|566254754|FG000|Treatment Period|Lost to Follow-up|0|||
156862379|NCT02156076|566254755|FG001|Treatment Period|Lost to Follow-up|0|||
156862380|NCT02156076|566254756|FG002|Treatment Period|Lost to Follow-up|0|||
156862381|NCT02156076|566254757|FG003|Treatment Period|Lost to Follow-up|1|||
156862382|NCT02156076|566254754|FG000|Treatment Period|Withdrawal by Subject|0|||
156862383|NCT02156076|566254755|FG001|Treatment Period|Withdrawal by Subject|0|||
156862384|NCT02156076|566254756|FG002|Treatment Period|Withdrawal by Subject|1|||
156862385|NCT02156076|566254757|FG003|Treatment Period|Withdrawal by Subject|0|||
156862386|NCT02156076|566254754|FG000|Treatment Period|Subject request to discontinue treatment|0|||
156862387|NCT02156076|566254755|FG001|Treatment Period|Subject request to discontinue treatment|1|||
156862388|NCT02156076|566254756|FG002|Treatment Period|Subject request to discontinue treatment|0|||
156862389|NCT02156076|566254757|FG003|Treatment Period|Subject request to discontinue treatment|0|||
156862390|NCT02156076|566254754|FG000|Treatment Period|Adverse Event|0|||
156862391|NCT02156076|566254755|FG001|Treatment Period|Adverse Event|0|||
156862392|NCT02156076|566254756|FG002|Treatment Period|Adverse Event|0|||
156862393|NCT02156076|566254757|FG003|Treatment Period|Adverse Event|1|||
156862394|NCT02156076|566254754|FG000|Follow-up Period|Withdrawal by Subject|1|||
156862395|NCT02156076|566254755|FG001|Follow-up Period|Withdrawal by Subject|0|||
156862396|NCT02156076|566254756|FG002|Follow-up Period|Withdrawal by Subject|0|||
156862397|NCT02156076|566254757|FG003|Follow-up Period|Withdrawal by Subject|0|||
156862398|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
156862399|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
156862400|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
156862401|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
156862402|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
156862403|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156862404|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
156862405|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
156862406|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
156862407|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156862408|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
156862409|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
156862410|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
156862411|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
156862412|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
157160647|NCT00882999|567331533|FG006|Overall Study|Adverse Event|0|||
157160648|NCT00882999|567331527|FG000|Overall Study|Death|0|||
157160649|NCT00882999|567331528|FG001|Overall Study|Death|1|||
157160650|NCT00882999|567331529|FG002|Overall Study|Death|0|||
157160651|NCT00882999|567331530|FG003|Overall Study|Death|0|||
157160652|NCT00882999|567331531|FG004|Overall Study|Death|0|||
157160653|NCT00882999|567331532|FG005|Overall Study|Death|0|||
157160654|NCT00882999|567331533|FG006|Overall Study|Death|0|||
157225645|NCT02415959|567571503|FG002|Overall Study|Adverse Event|0|||
156862413|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
156862414|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
156862415|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
157160655|NCT00882999|567331527|FG000|Overall Study|Withdrawal by Subject|7|||
157160656|NCT00882999|567331528|FG001|Overall Study|Withdrawal by Subject|6|||
157160657|NCT00882999|567331529|FG002|Overall Study|Withdrawal by Subject|3|||
157225646|NCT02415959|567571504|FG003|Overall Study|Adverse Event|0|||
157027427|NCT03852472|566856115|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
157160658|NCT00882999|567331530|FG003|Overall Study|Withdrawal by Subject|3|||
156862416|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
156862417|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
156862418|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156862419|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
156862420|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156862421|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
156862422|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862423|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
156862424|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862425|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
156862426|NCT04026113|566254760|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862427|NCT04026113|566254761|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
156862428|NCT04026113|566254762|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862429|NCT04026113|566254763|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
156862430|NCT04026113|566254760|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
156862431|NCT04026113|566254761|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
156862432|NCT04026113|566254762|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
156862433|NCT04026113|566254763|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
156862434|NCT00687596|566254764|FG000|Overall Study|Adverse Event (AE)|10|||
156862435|NCT00687596|566254765|FG001|Overall Study|Adverse Event (AE)|3|||
156862436|NCT00687596|566254764|FG000|Overall Study|Radiological Disease Progression|6|||
156862437|NCT00687596|566254765|FG001|Overall Study|Radiological Disease Progression|2|||
156862438|NCT00687596|566254764|FG000|Overall Study|Clinical Disease Progression|1|||
156862439|NCT00687596|566254765|FG001|Overall Study|Clinical Disease Progression|3|||
156862440|NCT00687596|566254764|FG000|Overall Study|Investigator Discretion|3|||
156862441|NCT00687596|566254765|FG001|Overall Study|Investigator Discretion|1|||
156862442|NCT00687596|566254764|FG000|Overall Study|Sponsor Terminated Study|6|||
156862443|NCT00687596|566254765|FG001|Overall Study|Sponsor Terminated Study|17|||
156862444|NCT01527149|566254767|FG000|Overall Study|Death|2|||
156862445|NCT00499486|566254770|FG000|Overall Study|Withdrawal by Subject|16|||
156862446|NCT01867671|566254776|FG000|Overall Study|Adverse Event|5|||
156862447|NCT01867671|566254777|FG001|Overall Study|Adverse Event|3|||
156862448|NCT01867671|566254776|FG000|Overall Study|Anaphylaxis|0|||
156862449|NCT01867671|566254777|FG001|Overall Study|Anaphylaxis|1|||
156862450|NCT01867671|566254776|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
156862451|NCT01867671|566254777|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
156862452|NCT01867671|566254776|FG000|Overall Study|Lost to Follow-up|0|||
156862453|NCT01867671|566254777|FG001|Overall Study|Lost to Follow-up|1|||
156862454|NCT01867671|566254776|FG000|Overall Study|Non-compliance with Study Drug|1|||
156862455|NCT01867671|566254777|FG001|Overall Study|Non-compliance with Study Drug|2|||
156862456|NCT01867671|566254776|FG000|Overall Study|Withdrawal by Subject|21|||
156862457|NCT01867671|566254777|FG001|Overall Study|Withdrawal by Subject|21|||
156862458|NCT01451606|566254783|FG000|Overall Study|Withdrawal by Subject|4|||
156862459|NCT01451606|566254784|FG001|Overall Study|Withdrawal by Subject|3|||
156862460|NCT02163538|566254785|FG000|Overall Study|Protocol Violation|1|||
156862461|NCT02163538|566254786|FG001|Overall Study|Protocol Violation|0|||
156862462|NCT02163538|566254785|FG000|Overall Study|Physician Decision|0|||
156862463|NCT02163538|566254786|FG001|Overall Study|Physician Decision|1|||
156862464|NCT04484961|566254787|FG000|Overall Study|Lost to Follow-up|9|||
156862465|NCT04484961|566254788|FG001|Overall Study|Lost to Follow-up|9|||
156862466|NCT00388349|566254789|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
156862467|NCT00388349|566254790|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
157027428|NCT03852472|566856116|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
157160659|NCT00882999|567331531|FG004|Overall Study|Withdrawal by Subject|6|||
157160660|NCT00882999|567331532|FG005|Overall Study|Withdrawal by Subject|5|||
157160661|NCT00882999|567331533|FG006|Overall Study|Withdrawal by Subject|5|||
157160662|NCT00882999|567331527|FG000|Overall Study|Lost to Follow-up|0|||
157160663|NCT00882999|567331528|FG001|Overall Study|Lost to Follow-up|1|||
157160664|NCT00882999|567331529|FG002|Overall Study|Lost to Follow-up|1|||
157160665|NCT00882999|567331530|FG003|Overall Study|Lost to Follow-up|2|||
157160666|NCT00882999|567331531|FG004|Overall Study|Lost to Follow-up|1|||
157160667|NCT00882999|567331532|FG005|Overall Study|Lost to Follow-up|1|||
156862468|NCT01126749|566254793|FG000|Phase 1b|Other|0|||
156862469|NCT01126749|566254794|FG001|Phase 1b|Other|1|||
156862470|NCT01126749|566254795|FG002|Phase 1b|Other|0|||
156862471|NCT01126749|566254796|FG003|Phase 1b|Other|0|||
157160668|NCT00882999|567331533|FG006|Overall Study|Lost to Follow-up|2|||
157160669|NCT00882999|567331527|FG000|Overall Study|Physician Decision|1|||
156862472|NCT01126749|566254793|FG000|Phase 1b|Withdrawal by Subject|0|||
157160670|NCT00882999|567331528|FG001|Overall Study|Physician Decision|0|||
157160671|NCT00882999|567331529|FG002|Overall Study|Physician Decision|0|||
157160672|NCT00882999|567331530|FG003|Overall Study|Physician Decision|0|||
156862473|NCT01126749|566254794|FG001|Phase 1b|Withdrawal by Subject|1|||
156862474|NCT01126749|566254795|FG002|Phase 1b|Withdrawal by Subject|0|||
156862475|NCT01126749|566254796|FG003|Phase 1b|Withdrawal by Subject|0|||
156862476|NCT01126749|566254793|FG000|Phase 1b|Death|3|||
156862477|NCT01126749|566254794|FG001|Phase 1b|Death|4|||
156862478|NCT01126749|566254795|FG002|Phase 1b|Death|0|||
156862479|NCT01126749|566254796|FG003|Phase 1b|Death|0|||
156862480|NCT01126749|566254793|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
156862481|NCT01126749|566254794|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
156862482|NCT01126749|566254795|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
156862483|NCT01126749|566254796|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
156862484|NCT01126749|566254793|FG000|Phase 2|Study Termination by Sponsor|0|||
156862485|NCT01126749|566254794|FG001|Phase 2|Study Termination by Sponsor|0|||
156862486|NCT01126749|566254795|FG002|Phase 2|Study Termination by Sponsor|12|||
156862487|NCT01126749|566254796|FG003|Phase 2|Study Termination by Sponsor|6|||
156862488|NCT01126749|566254793|FG000|Phase 2|Other|0|||
156862489|NCT01126749|566254794|FG001|Phase 2|Other|0|||
156862490|NCT01126749|566254795|FG002|Phase 2|Other|4|||
156862491|NCT01126749|566254796|FG003|Phase 2|Other|2|||
156862492|NCT01126749|566254793|FG000|Phase 2|Withdrawal by Subject|0|||
156862493|NCT01126749|566254794|FG001|Phase 2|Withdrawal by Subject|0|||
156862494|NCT01126749|566254795|FG002|Phase 2|Withdrawal by Subject|0|||
156862495|NCT01126749|566254796|FG003|Phase 2|Withdrawal by Subject|2|||
156862496|NCT01126749|566254793|FG000|Phase 2|Lost to Follow-up|0|||
156862497|NCT01126749|566254794|FG001|Phase 2|Lost to Follow-up|0|||
156862498|NCT01126749|566254795|FG002|Phase 2|Lost to Follow-up|0|||
156862499|NCT01126749|566254796|FG003|Phase 2|Lost to Follow-up|1|||
156862500|NCT01126749|566254793|FG000|Phase 2|Death|0|||
156862501|NCT01126749|566254794|FG001|Phase 2|Death|0|||
156862502|NCT01126749|566254795|FG002|Phase 2|Death|22|||
156862503|NCT01126749|566254796|FG003|Phase 2|Death|22|||
156862504|NCT01126749|566254793|FG000|Phase 2|Adverse Event|0|||
156862505|NCT01126749|566254794|FG001|Phase 2|Adverse Event|0|||
156862506|NCT01126749|566254795|FG002|Phase 2|Adverse Event|0|||
156862507|NCT01126749|566254796|FG003|Phase 2|Adverse Event|1|||
156862508|NCT00976274|566254797|FG000|Overall Study|Lost to Follow-up|5|||
156862509|NCT00976274|566254798|FG001|Overall Study|Lost to Follow-up|5|||
156862510|NCT00976274|566254797|FG000|Overall Study|Withdrawal by Subject|1|||
156862511|NCT00976274|566254798|FG001|Overall Study|Withdrawal by Subject|1|||
156862512|NCT00976274|566254797|FG000|Overall Study|Physician Decision|1|||
156862513|NCT00976274|566254798|FG001|Overall Study|Physician Decision|2|||
156862514|NCT01614249|566254800|FG000|Overall Study|Lost to Follow-up|11|||
156862515|NCT01614249|566254801|FG001|Overall Study|Lost to Follow-up|23|||
156862516|NCT02954536|566254802|FG000|Overall Study|Adverse Event|2|||
156862517|NCT02954536|566254802|FG000|Overall Study|Death|12|||
157027429|NCT03852472|566856117|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
157027430|NCT03852472|566856118|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
157027431|NCT03852472|566856114|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
157027432|NCT03852472|566856115|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
157027433|NCT03852472|566856116|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
157027434|NCT03852472|566856117|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
157027435|NCT03852472|566856118|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
157027436|NCT03852472|566856114|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
157027437|NCT03852472|566856115|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
157027438|NCT03852472|566856116|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
157027439|NCT03852472|566856117|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
157027440|NCT03852472|566856118|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
157027441|NCT03852472|566856114|FG000|Period 2 - Week 44|Adverse Event|0|||
157027442|NCT03852472|566856115|FG001|Period 2 - Week 44|Adverse Event|3|||
157027443|NCT03852472|566856116|FG002|Period 2 - Week 44|Adverse Event|1|||
156862518|NCT02946580|566254803|FG000|Overall Study|Withdrawal by Subject|1|||
156862519|NCT02946580|566254804|FG001|Overall Study|Withdrawal by Subject|2|||
156862520|NCT02946580|566254803|FG000|Overall Study|Adverse Event|0|||
157027444|NCT03852472|566856117|FG003|Period 2 - Week 44|Adverse Event|2|||
157027445|NCT03852472|566856118|FG004|Period 2 - Week 44|Adverse Event|2|||
157027446|NCT03852472|566856114|FG000|Period 2 - Week 44|COVID-19 Related|0|||
156862521|NCT02946580|566254804|FG001|Overall Study|Adverse Event|2|||
156862522|NCT02946580|566254803|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
156862523|NCT02946580|566254804|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
156862524|NCT02158442|566254805|FG000|Overall Study|Withdrawal by Subject|1|||
156862525|NCT02158442|566254806|FG001|Overall Study|Withdrawal by Subject|0|||
156862526|NCT02158442|566254805|FG000|Overall Study|Perfusion staff not available|1|||
156862527|NCT02158442|566254806|FG001|Overall Study|Perfusion staff not available|0|||
156862528|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
156862529|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
156862530|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
156862531|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
156862532|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
156862533|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862534|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862535|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
156862536|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862537|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
156862538|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862539|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
156862540|NCT02657889|566254809|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862541|NCT02657889|566254810|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
156862542|NCT02657889|566254811|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862543|NCT02657889|566254812|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
156862544|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
156862545|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
156862546|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
156862547|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
156862548|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
156862549|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
156862550|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
156862551|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
156862552|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
156862553|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
156862554|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
157027447|NCT03852472|566856115|FG001|Period 2 - Week 44|COVID-19 Related|0|||
157027448|NCT03852472|566856116|FG002|Period 2 - Week 44|COVID-19 Related|0|||
157160673|NCT00882999|567331531|FG004|Overall Study|Physician Decision|0|||
157160674|NCT00882999|567331532|FG005|Overall Study|Physician Decision|1|||
157160675|NCT00882999|567331533|FG006|Overall Study|Physician Decision|1|||
157160676|NCT01757405|567331536|FG000|Overall Study|Lost to Follow-up|1|||
157160677|NCT01757405|567331537|FG001|Overall Study|Lost to Follow-up|1|||
157160678|NCT01757405|567331536|FG000|Overall Study|Withdrawal by Subject|0|||
157160679|NCT01757405|567331537|FG001|Overall Study|Withdrawal by Subject|1|||
157160680|NCT00082758|567331539|FG000|Overall Study|Adverse Event|0|||
157160681|NCT00082758|567331540|FG001|Overall Study|Adverse Event|2|||
157160682|NCT00082758|567331541|FG002|Overall Study|Adverse Event|0|||
157160683|NCT00082758|567331539|FG000|Overall Study|Lack of Efficacy|12|||
157160684|NCT00082758|567331540|FG001|Overall Study|Lack of Efficacy|13|||
157160685|NCT00082758|567331541|FG002|Overall Study|Lack of Efficacy|0|||
157160686|NCT00082758|567331539|FG000|Overall Study|Physician Decision|0|||
157160687|NCT00082758|567331540|FG001|Overall Study|Physician Decision|1|||
157160688|NCT00082758|567331541|FG002|Overall Study|Physician Decision|0|||
157160689|NCT00082758|567331539|FG000|Overall Study|Withdrawal by Subject|3|||
157160690|NCT00082758|567331540|FG001|Overall Study|Withdrawal by Subject|0|||
157160691|NCT00082758|567331541|FG002|Overall Study|Withdrawal by Subject|0|||
157160692|NCT00082758|567331539|FG000|Overall Study|Protocol Violation|0|||
157160693|NCT00082758|567331540|FG001|Overall Study|Protocol Violation|1|||
157160694|NCT00082758|567331541|FG002|Overall Study|Protocol Violation|0|||
157160695|NCT00238303|567331542|FG000|Overall Study|Withdrawal by Subject|11|||
157160696|NCT00238303|567331543|FG001|Overall Study|Withdrawal by Subject|1|||
157160697|NCT00238303|567331544|FG002|Overall Study|Withdrawal by Subject|2|||
157160698|NCT00238303|567331542|FG000|Overall Study|Death|1|||
157160699|NCT00238303|567331543|FG001|Overall Study|Death|0|||
157160700|NCT00238303|567331544|FG002|Overall Study|Death|1|||
157160701|NCT00238303|567331542|FG000|Overall Study|Other Medical Problems|2|||
157160702|NCT00238303|567331543|FG001|Overall Study|Other Medical Problems|0|||
157160703|NCT00238303|567331544|FG002|Overall Study|Other Medical Problems|2|||
157160704|NCT00238303|567331542|FG000|Overall Study|Poor tolerance of study treatment|1|||
156862555|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
156862556|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
156862557|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
156862558|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
156862559|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
156862560|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
156863430|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
157160705|NCT00238303|567331543|FG001|Overall Study|Poor tolerance of study treatment|0|||
157160706|NCT00238303|567331544|FG002|Overall Study|Poor tolerance of study treatment|1|||
157160707|NCT00238303|567331542|FG000|Overall Study|Adverse Event|0|||
157160708|NCT00238303|567331543|FG001|Overall Study|Adverse Event|1|||
157160709|NCT00238303|567331544|FG002|Overall Study|Adverse Event|3|||
157160710|NCT00937560|567331546|FG000|Initial Treatment|Death|6|||
157160711|NCT00937560|567331546|FG000|Initial Treatment|Withdraw consent|3|||
157160712|NCT00937560|567331546|FG000|Initial Treatment|Adverse Event|1|||
157027449|NCT03852472|566856117|FG003|Period 2 - Week 44|COVID-19 Related|1|||
157027450|NCT03852472|566856118|FG004|Period 2 - Week 44|COVID-19 Related|0|||
157027451|NCT03852472|566856114|FG000|Period 2 - Week 44|Reason not stated|0|||
157027452|NCT03852472|566856115|FG001|Period 2 - Week 44|Reason not stated|0|||
157027453|NCT03852472|566856116|FG002|Period 2 - Week 44|Reason not stated|0|||
157027454|NCT03852472|566856117|FG003|Period 2 - Week 44|Reason not stated|0|||
157027455|NCT03852472|566856118|FG004|Period 2 - Week 44|Reason not stated|1|||
156862561|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
156862562|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
156862563|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
156862564|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862565|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862566|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
156862567|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
156862568|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
156862569|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
156862570|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
156862571|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
156862572|NCT02657889|566254809|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862573|NCT02657889|566254810|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862574|NCT02657889|566254811|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
156862575|NCT02657889|566254812|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
156862576|NCT02234843|566254815|FG000|Overall Study|Death|1|||
156862577|NCT02234843|566254816|FG001|Overall Study|Death|0|||
156862578|NCT02234843|566254817|FG002|Overall Study|Death|0|||
156862579|NCT02234843|566254818|FG003|Overall Study|Death|0|||
156862580|NCT02234843|566254819|FG004|Overall Study|Death|0|||
156862581|NCT02234843|566254820|FG005|Overall Study|Death|0|||
156862582|NCT02234843|566254821|FG006|Overall Study|Death|0|||
156862583|NCT02234843|566254822|FG007|Overall Study|Death|0|||
156862584|NCT02234843|566254823|FG008|Overall Study|Death|0|||
156862585|NCT02234843|566254824|FG009|Overall Study|Death|0|||
156862586|NCT02234843|566254815|FG000|Overall Study|Protocol Violation|1|||
156862587|NCT02234843|566254816|FG001|Overall Study|Protocol Violation|0|||
156862588|NCT02234843|566254817|FG002|Overall Study|Protocol Violation|1|||
156862589|NCT02234843|566254818|FG003|Overall Study|Protocol Violation|0|||
156862590|NCT02234843|566254819|FG004|Overall Study|Protocol Violation|0|||
156862591|NCT02234843|566254820|FG005|Overall Study|Protocol Violation|0|||
156862592|NCT02234843|566254821|FG006|Overall Study|Protocol Violation|0|||
156862593|NCT02234843|566254822|FG007|Overall Study|Protocol Violation|0|||
156862594|NCT02234843|566254823|FG008|Overall Study|Protocol Violation|0|||
156862595|NCT02234843|566254824|FG009|Overall Study|Protocol Violation|0|||
156862596|NCT02234843|566254815|FG000|Overall Study|Efficacy outcome reached|2|||
156862597|NCT02234843|566254816|FG001|Overall Study|Efficacy outcome reached|0|||
156862598|NCT02234843|566254817|FG002|Overall Study|Efficacy outcome reached|0|||
156862599|NCT02234843|566254818|FG003|Overall Study|Efficacy outcome reached|0|||
156862600|NCT02234843|566254819|FG004|Overall Study|Efficacy outcome reached|0|||
156862601|NCT02234843|566254820|FG005|Overall Study|Efficacy outcome reached|2|||
156862602|NCT02234843|566254821|FG006|Overall Study|Efficacy outcome reached|0|||
156862603|NCT02234843|566254822|FG007|Overall Study|Efficacy outcome reached|0|||
156862604|NCT02234843|566254823|FG008|Overall Study|Efficacy outcome reached|0|||
156862605|NCT02234843|566254824|FG009|Overall Study|Efficacy outcome reached|0|||
156862606|NCT02234843|566254815|FG000|Overall Study|Patient convenience|2|||
156862607|NCT02234843|566254816|FG001|Overall Study|Patient convenience|0|||
156862608|NCT02234843|566254817|FG002|Overall Study|Patient convenience|0|||
156862609|NCT02234843|566254818|FG003|Overall Study|Patient convenience|0|||
157027456|NCT03819153|566856121|FG000|Overall Study|Withdrawal by Subject|20|||
157027457|NCT03819153|566856122|FG001|Overall Study|Withdrawal by Subject|28|||
157027458|NCT03819153|566856121|FG000|Overall Study|Lost to Follow-up|23|||
157027459|NCT03819153|566856122|FG001|Overall Study|Lost to Follow-up|30|||
157027460|NCT03974178|566856123|FG000|Overall Study|Death|0|||
157027461|NCT03974178|566856124|FG001|Overall Study|Death|1|||
157160713|NCT00937560|567331546|FG000|Initial Treatment|Lost to Follow-up|1|||
156862610|NCT02234843|566254819|FG004|Overall Study|Patient convenience|0|||
156862611|NCT02234843|566254820|FG005|Overall Study|Patient convenience|1|||
156862612|NCT02234843|566254821|FG006|Overall Study|Patient convenience|0|||
156862613|NCT02234843|566254822|FG007|Overall Study|Patient convenience|0|||
156862614|NCT02234843|566254823|FG008|Overall Study|Patient convenience|0|||
156862615|NCT02234843|566254824|FG009|Overall Study|Patient convenience|0|||
156862616|NCT02234843|566254815|FG000|Overall Study|Withdrawal by Subject|5|||
156862617|NCT02234843|566254816|FG001|Overall Study|Withdrawal by Subject|1|||
157160714|NCT00937560|567331546|FG000|Initial Treatment|No end of study page|10|||
157027462|NCT01152450|566856125|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
157027463|NCT01152450|566856126|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
157027464|NCT01152450|566856127|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
157225647|NCT02415959|567571505|FG004|Overall Study|Adverse Event|0|||
157225648|NCT02415959|567571501|FG000|Overall Study|Protocol Violation|0|||
157225649|NCT02415959|567571502|FG001|Overall Study|Protocol Violation|0|||
157225650|NCT02415959|567571503|FG002|Overall Study|Protocol Violation|0|||
157225651|NCT02415959|567571504|FG003|Overall Study|Protocol Violation|1|||
157225652|NCT02415959|567571505|FG004|Overall Study|Protocol Violation|0|||
157225653|NCT02260492|567571506|FG000|Overall Study|Adverse Event|6|||
157225654|NCT02260492|567571507|FG001|Overall Study|Adverse Event|1|||
157225655|NCT02260492|567571508|FG002|Overall Study|Adverse Event|2|||
157225656|NCT02260492|567571506|FG000|Overall Study|Death|0|||
157225657|NCT02260492|567571507|FG001|Overall Study|Death|1|||
157225658|NCT02260492|567571508|FG002|Overall Study|Death|0|||
157225659|NCT02260492|567571506|FG000|Overall Study|Lost to Follow-up|12|||
157225660|NCT02260492|567571507|FG001|Overall Study|Lost to Follow-up|9|||
157225661|NCT02260492|567571508|FG002|Overall Study|Lost to Follow-up|0|||
157225662|NCT02260492|567571506|FG000|Overall Study|Physician Decision|2|||
156862618|NCT02234843|566254817|FG002|Overall Study|Withdrawal by Subject|1|||
156862619|NCT02234843|566254818|FG003|Overall Study|Withdrawal by Subject|0|||
156862620|NCT02234843|566254819|FG004|Overall Study|Withdrawal by Subject|0|||
156862621|NCT02234843|566254820|FG005|Overall Study|Withdrawal by Subject|7|||
156862622|NCT02234843|566254821|FG006|Overall Study|Withdrawal by Subject|0|||
156862623|NCT02234843|566254822|FG007|Overall Study|Withdrawal by Subject|0|||
156862624|NCT02234843|566254823|FG008|Overall Study|Withdrawal by Subject|0|||
156862625|NCT02234843|566254824|FG009|Overall Study|Withdrawal by Subject|0|||
156862626|NCT02234843|566254815|FG000|Overall Study|Recovery|1|||
156862627|NCT02234843|566254816|FG001|Overall Study|Recovery|0|||
156862628|NCT02234843|566254817|FG002|Overall Study|Recovery|0|||
156862629|NCT02234843|566254818|FG003|Overall Study|Recovery|0|||
156862630|NCT02234843|566254819|FG004|Overall Study|Recovery|0|||
156862631|NCT02234843|566254820|FG005|Overall Study|Recovery|0|||
156862632|NCT02234843|566254821|FG006|Overall Study|Recovery|0|||
156862633|NCT02234843|566254822|FG007|Overall Study|Recovery|0|||
156862634|NCT02234843|566254823|FG008|Overall Study|Recovery|0|||
156862635|NCT02234843|566254824|FG009|Overall Study|Recovery|0|||
156862636|NCT02234843|566254815|FG000|Overall Study|Other|0|||
156862637|NCT02234843|566254816|FG001|Overall Study|Other|2|||
156913054|NCT01233258|566440452|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
156913055|NCT01233258|566440453|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
157160715|NCT00937560|567331546|FG000|Maintenance Treatment|Death|12|||
157160716|NCT00937560|567331546|FG000|Maintenance Treatment|Withdraw consent|5|||
157160717|NCT00937560|567331546|FG000|Maintenance Treatment|According to protocol|1|||
157160718|NCT01994226|567331553|FG000|Overall Study|Protocol Violation|13|||
157160719|NCT01994226|567331554|FG001|Overall Study|Protocol Violation|10|||
157160720|NCT01994226|567331553|FG000|Overall Study|Early Cessation of treatment|6|||
157160721|NCT01994226|567331554|FG001|Overall Study|Early Cessation of treatment|11|||
157160722|NCT00501046|567331555|FG000|Overall Study|Adverse Event|21|||
157160723|NCT00501046|567331556|FG001|Overall Study|Adverse Event|25|||
157160724|NCT00501046|567331555|FG000|Overall Study|Death|23|||
157160725|NCT00501046|567331556|FG001|Overall Study|Death|30|||
157160726|NCT00501046|567331555|FG000|Overall Study|Lost to Follow-up|14|||
157160727|NCT00501046|567331556|FG001|Overall Study|Lost to Follow-up|13|||
157160728|NCT00501046|567331555|FG000|Overall Study|Physician Decision|7|||
157160729|NCT00501046|567331556|FG001|Overall Study|Physician Decision|2|||
157160730|NCT00501046|567331555|FG000|Overall Study|Pregnancy|0|||
157160731|NCT00501046|567331556|FG001|Overall Study|Pregnancy|3|||
157160732|NCT00501046|567331555|FG000|Overall Study|Protocol Violation|2|||
157160733|NCT00501046|567331556|FG001|Overall Study|Protocol Violation|1|||
157160734|NCT00501046|567331555|FG000|Overall Study|Withdrawal by Subject|84|||
157160735|NCT00501046|567331556|FG001|Overall Study|Withdrawal by Subject|83|||
157160736|NCT00501046|567331555|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
157160737|NCT00501046|567331556|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
157160738|NCT02488551|567331560|FG000|Overall Study|Lost to Follow-up|4|||
157160739|NCT02488551|567331561|FG001|Overall Study|Lost to Follow-up|7|||
157225663|NCT02260492|567571507|FG001|Overall Study|Physician Decision|0|||
157225664|NCT02260492|567571508|FG002|Overall Study|Physician Decision|1|||
157225665|NCT02260492|567571506|FG000|Overall Study|Withdrawal by Subject|3|||
156862638|NCT02234843|566254817|FG002|Overall Study|Other|0|||
156862639|NCT02234843|566254818|FG003|Overall Study|Other|1|||
156862640|NCT02234843|566254819|FG004|Overall Study|Other|0|||
156862641|NCT02234843|566254820|FG005|Overall Study|Other|1|||
156913056|NCT01233258|566440454|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
156913057|NCT01233258|566440455|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
157160740|NCT02488551|567331562|FG002|Overall Study|Lost to Follow-up|0|||
157160741|NCT02488551|567331563|FG003|Overall Study|Lost to Follow-up|0|||
157160742|NCT02488551|567331560|FG000|Overall Study|Military Deployment|1|||
157160743|NCT02488551|567331561|FG001|Overall Study|Military Deployment|1|||
157160744|NCT02488551|567331562|FG002|Overall Study|Military Deployment|0|||
157225666|NCT02260492|567571507|FG001|Overall Study|Withdrawal by Subject|2|||
156862642|NCT02234843|566254821|FG006|Overall Study|Other|0|||
156862643|NCT02234843|566254822|FG007|Overall Study|Other|1|||
156862644|NCT02234843|566254823|FG008|Overall Study|Other|0|||
156862645|NCT02234843|566254824|FG009|Overall Study|Other|0|||
156862646|NCT02234843|566254815|FG000|Overall Study|Physician Decision|4|||
156862647|NCT02234843|566254816|FG001|Overall Study|Physician Decision|1|||
156862648|NCT02234843|566254817|FG002|Overall Study|Physician Decision|0|||
156862649|NCT02234843|566254818|FG003|Overall Study|Physician Decision|1|||
156862650|NCT02234843|566254819|FG004|Overall Study|Physician Decision|0|||
156862651|NCT02234843|566254820|FG005|Overall Study|Physician Decision|0|||
156862652|NCT02234843|566254821|FG006|Overall Study|Physician Decision|0|||
156862653|NCT02234843|566254822|FG007|Overall Study|Physician Decision|1|||
156862654|NCT02234843|566254823|FG008|Overall Study|Physician Decision|0|||
156862655|NCT02234843|566254824|FG009|Overall Study|Physician Decision|0|||
156862656|NCT02234843|566254815|FG000|Overall Study|Adverse Event|5|||
156862657|NCT02234843|566254816|FG001|Overall Study|Adverse Event|1|||
156862658|NCT02234843|566254817|FG002|Overall Study|Adverse Event|1|||
156862659|NCT02234843|566254818|FG003|Overall Study|Adverse Event|3|||
156862660|NCT02234843|566254819|FG004|Overall Study|Adverse Event|2|||
156862661|NCT02234843|566254820|FG005|Overall Study|Adverse Event|1|||
156862662|NCT02234843|566254821|FG006|Overall Study|Adverse Event|0|||
156862663|NCT02234843|566254822|FG007|Overall Study|Adverse Event|0|||
156862664|NCT02234843|566254823|FG008|Overall Study|Adverse Event|1|||
156862665|NCT02234843|566254824|FG009|Overall Study|Adverse Event|0|||
156862666|NCT02234843|566254815|FG000|Overall Study|Non-compliance with study drug|1|||
156862667|NCT02234843|566254816|FG001|Overall Study|Non-compliance with study drug|0|||
156862668|NCT02234843|566254817|FG002|Overall Study|Non-compliance with study drug|0|||
156862669|NCT02234843|566254818|FG003|Overall Study|Non-compliance with study drug|0|||
156862670|NCT02234843|566254819|FG004|Overall Study|Non-compliance with study drug|0|||
156862671|NCT02234843|566254820|FG005|Overall Study|Non-compliance with study drug|1|||
156862672|NCT02234843|566254821|FG006|Overall Study|Non-compliance with study drug|1|||
156862673|NCT02234843|566254822|FG007|Overall Study|Non-compliance with study drug|0|||
156862674|NCT02234843|566254823|FG008|Overall Study|Non-compliance with study drug|0|||
156862675|NCT02234843|566254824|FG009|Overall Study|Non-compliance with study drug|0|||
156862676|NCT02234843|566254815|FG000|Overall Study|Lost to Follow-up|0|||
156862677|NCT02234843|566254816|FG001|Overall Study|Lost to Follow-up|1|||
156862678|NCT02234843|566254817|FG002|Overall Study|Lost to Follow-up|0|||
156862679|NCT02234843|566254818|FG003|Overall Study|Lost to Follow-up|0|||
156862680|NCT02234843|566254819|FG004|Overall Study|Lost to Follow-up|0|||
156862681|NCT02234843|566254820|FG005|Overall Study|Lost to Follow-up|0|||
156862682|NCT02234843|566254821|FG006|Overall Study|Lost to Follow-up|1|||
156862683|NCT02234843|566254822|FG007|Overall Study|Lost to Follow-up|0|||
156862684|NCT02234843|566254823|FG008|Overall Study|Lost to Follow-up|0|||
156862685|NCT02234843|566254824|FG009|Overall Study|Lost to Follow-up|0|||
156862686|NCT05472090|566254833|FG000|Overall Study|Adverse Event|2|||
156862687|NCT05472090|566254834|FG001|Overall Study|Adverse Event|3|||
156862688|NCT05472090|566254833|FG000|Overall Study|Lack of Efficacy|1|||
156862689|NCT05472090|566254834|FG001|Overall Study|Lack of Efficacy|0|||
156862690|NCT05472090|566254833|FG000|Overall Study|Physician Decision|1|||
156862691|NCT05472090|566254834|FG001|Overall Study|Physician Decision|0|||
156862692|NCT05472090|566254833|FG000|Overall Study|Withdrawal by Subject|2|||
156862693|NCT05472090|566254834|FG001|Overall Study|Withdrawal by Subject|0|||
156862694|NCT05472090|566254833|FG000|Overall Study|Lost to Follow-up|0|||
156862695|NCT05472090|566254834|FG001|Overall Study|Lost to Follow-up|3|||
156862696|NCT00079417|566256524|FG000|Overall Study|Physician Decision|2|||
156862697|NCT00079417|566256524|FG000|Overall Study|Ineligible|7|||
156862698|NCT01456039|566256525|FG000|Phase 1 (First Step)|Disease Progression|1|||
156862699|NCT01456039|566256526|FG001|Phase 1 (First Step)|Disease Progression|1|||
156862700|NCT01456039|566256527|FG002|Phase 1 (First Step)|Disease Progression|0|||
156862701|NCT01456039|566256525|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
156862702|NCT01456039|566256526|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
156862703|NCT01456039|566256527|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
156862704|NCT01456039|566256525|FG000|Phase 1 (First Step)|Adverse Event|0|||
156862705|NCT01456039|566256526|FG001|Phase 1 (First Step)|Adverse Event|3|||
156862706|NCT01456039|566256527|FG002|Phase 1 (First Step)|Adverse Event|0|||
156862707|NCT01456039|566256525|FG000|Phase 1 (First Step)|Other|0|||
156862708|NCT01456039|566256526|FG001|Phase 1 (First Step)|Other|1|||
156862709|NCT01456039|566256527|FG002|Phase 1 (First Step)|Other|0|||
156862710|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Disease Progression|0|||
156862711|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Disease Progression|0|||
156862712|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Disease Progression|17|||
156862713|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Adverse Event|0|||
156862714|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Adverse Event|0|||
156862715|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Adverse Event|10|||
156862716|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
156862717|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
156862718|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
156862719|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
157225667|NCT02260492|567571508|FG002|Overall Study|Withdrawal by Subject|2|||
157225668|NCT03131999|567571509|FG000|Overall Study|Withdrawal by Subject|0|||
157225669|NCT03131999|567571510|FG001|Overall Study|Withdrawal by Subject|1|||
157225670|NCT01497938|567571512|FG000|Overall Study|Adverse Event|0|||
157225671|NCT01497938|567571513|FG001|Overall Study|Adverse Event|1|||
157225672|NCT01497938|567571512|FG000|Overall Study|Physician Decision|0|||
157225673|NCT01497938|567571513|FG001|Overall Study|Physician Decision|1|||
157225674|NCT01497938|567571512|FG000|Overall Study|Withdrawal by Subject|4|||
157225675|NCT01497938|567571513|FG001|Overall Study|Withdrawal by Subject|0|||
157225676|NCT01497938|567571512|FG000|Overall Study|Device Violation|1|||
157225677|NCT01497938|567571513|FG001|Overall Study|Device Violation|0|||
157225678|NCT03708211|567571514|FG000|Overall Study|Progressive Disease|10|||
157225679|NCT03708211|567571515|FG001|Overall Study|Progressive Disease|7|||
157225680|NCT03708211|567571514|FG000|Overall Study|Withdrawal by Subject|0|||
157225681|NCT03708211|567571515|FG001|Overall Study|Withdrawal by Subject|1|||
157225682|NCT03708211|567571514|FG000|Overall Study|Other|2|||
157225683|NCT03708211|567571515|FG001|Overall Study|Other|0|||
157225684|NCT00365352|567571516|FG000|Overall Study|Adverse Event|6|||
157225685|NCT00365352|567571517|FG001|Overall Study|Adverse Event|7|||
157225686|NCT00365352|567571518|FG002|Overall Study|Adverse Event|8|||
157225687|NCT00365352|567571516|FG000|Overall Study|Participant Withdrew Consent|8|||
157225688|NCT00365352|567571517|FG001|Overall Study|Participant Withdrew Consent|3|||
157225689|NCT00365352|567571518|FG002|Overall Study|Participant Withdrew Consent|4|||
157225690|NCT00365352|567571516|FG000|Overall Study|Lack of Efficacy|3|||
157225691|NCT00365352|567571517|FG001|Overall Study|Lack of Efficacy|0|||
157225692|NCT00365352|567571518|FG002|Overall Study|Lack of Efficacy|0|||
157225693|NCT00365352|567571516|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
157225694|NCT00365352|567571517|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
157225695|NCT00365352|567571518|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
157225696|NCT00365352|567571516|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
157225697|NCT00365352|567571517|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
157225698|NCT00365352|567571518|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
157225699|NCT00365352|567571516|FG000|Overall Study|Lost to Follow-up|1|||
157225700|NCT00365352|567571517|FG001|Overall Study|Lost to Follow-up|1|||
157225701|NCT00365352|567571518|FG002|Overall Study|Lost to Follow-up|0|||
157225702|NCT00365352|567571516|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
157225703|NCT00365352|567571517|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
157225704|NCT00365352|567571518|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
157225705|NCT00462982|567571523|FG000|Overall Study|Adverse Event|1|||
157225706|NCT00462982|567571523|FG000|Overall Study|Patient Not Treated|2|||
157225707|NCT02683187|567571526|FG000|Overall Study|Failed IV access|3|||
157225708|NCT02683187|567571526|FG000|Overall Study|Withdrawal by Subject|5|||
157225709|NCT00770315|567571527|FG000|Overall Study|Adverse Event|11|||
157225710|NCT00770315|567571528|FG001|Overall Study|Adverse Event|17|||
157225711|NCT00770315|567571529|FG002|Overall Study|Adverse Event|16|||
157225712|NCT00770315|567571530|FG003|Overall Study|Adverse Event|6|||
157225713|NCT00770315|567571527|FG000|Overall Study|Lost to Follow-up|9|||
156862720|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
156862721|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
156862722|NCT01456039|566256525|FG000|Phase 2 (Second Step)|Other|0|||
156862723|NCT01456039|566256526|FG001|Phase 2 (Second Step)|Other|0|||
156862724|NCT01456039|566256527|FG002|Phase 2 (Second Step)|Other|1|||
156862725|NCT04106557|566256536|FG000|Overall Study|Physician Decision|0|||
157225714|NCT00770315|567571528|FG001|Overall Study|Lost to Follow-up|5|||
157225715|NCT00770315|567571529|FG002|Overall Study|Lost to Follow-up|10|||
157225716|NCT00770315|567571530|FG003|Overall Study|Lost to Follow-up|3|||
157225717|NCT00770315|567571527|FG000|Overall Study|Withdrawal by Subject|13|||
157225718|NCT00770315|567571528|FG001|Overall Study|Withdrawal by Subject|17|||
156862726|NCT04106557|566256537|FG001|Overall Study|Physician Decision|1|||
156862727|NCT04106557|566256538|FG002|Overall Study|Physician Decision|0|||
156862728|NCT04106557|566256536|FG000|Overall Study|Protocol Violation|0|||
156862729|NCT04106557|566256537|FG001|Overall Study|Protocol Violation|1|||
156862730|NCT04106557|566256538|FG002|Overall Study|Protocol Violation|0|||
156862731|NCT02326155|566256539|FG000|Overall Study|Adverse Event|21|||
156862732|NCT02326155|566256540|FG001|Overall Study|Adverse Event|5|||
156913058|NCT01233258|566440456|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
157225719|NCT00770315|567571529|FG002|Overall Study|Withdrawal by Subject|24|||
157225720|NCT00770315|567571530|FG003|Overall Study|Withdrawal by Subject|20|||
157225721|NCT00770315|567571527|FG000|Overall Study|Noncompliance with Protocol|7|||
156913059|NCT01233258|566440457|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
156913060|NCT04502693|566440461|FG000|Overall Study|Adverse Event|7|||
157225722|NCT00770315|567571528|FG001|Overall Study|Noncompliance with Protocol|4|||
156913061|NCT04502693|566440462|FG001|Overall Study|Adverse Event|6|||
157225723|NCT00770315|567571529|FG002|Overall Study|Noncompliance with Protocol|7|||
157225724|NCT00770315|567571530|FG003|Overall Study|Noncompliance with Protocol|9|||
156862733|NCT02326155|566256539|FG000|Overall Study|Death|3|||
156862734|NCT02326155|566256540|FG001|Overall Study|Death|0|||
156862735|NCT02326155|566256539|FG000|Overall Study|Lack of Efficacy|49|||
156862736|NCT02326155|566256540|FG001|Overall Study|Lack of Efficacy|5|||
156862737|NCT02326155|566256539|FG000|Overall Study|Lost to Follow-up|14|||
156862738|NCT02326155|566256540|FG001|Overall Study|Lost to Follow-up|3|||
156862739|NCT02326155|566256539|FG000|Overall Study|Protocol Violation|2|||
156862740|NCT02326155|566256540|FG001|Overall Study|Protocol Violation|0|||
156862741|NCT02326155|566256539|FG000|Overall Study|Withdrawal by Subject|34|||
156862742|NCT02326155|566256540|FG001|Overall Study|Withdrawal by Subject|11|||
156862743|NCT02326155|566256539|FG000|Overall Study|Disease progression|37|||
156862744|NCT02326155|566256540|FG001|Overall Study|Disease progression|4|||
156862745|NCT02326155|566256539|FG000|Overall Study|Study close|188|||
156862746|NCT02326155|566256540|FG001|Overall Study|Study close|21|||
156862747|NCT02326155|566256539|FG000|Overall Study|except for study close|46|||
156862748|NCT02326155|566256540|FG001|Overall Study|except for study close|13|||
156862749|NCT00939393|566256541|FG000|Overall Study|Withdrawal by Subject|1|||
156862750|NCT00939393|566256542|FG001|Overall Study|Withdrawal by Subject|0|||
156862751|NCT00939393|566256541|FG000|Overall Study|Lost to Follow-up|3|||
156862752|NCT00939393|566256542|FG001|Overall Study|Lost to Follow-up|0|||
156862753|NCT00313014|566256543|FG000|Overall Study|Withdrawal by Subject|11|||
156862754|NCT00313014|566256544|FG001|Overall Study|Withdrawal by Subject|7|||
156862755|NCT00313014|566256545|FG002|Overall Study|Withdrawal by Subject|5|||
156862756|NCT00313014|566256543|FG000|Overall Study|Adverse Event|14|||
156862757|NCT00313014|566256544|FG001|Overall Study|Adverse Event|29|||
156862758|NCT00313014|566256545|FG002|Overall Study|Adverse Event|16|||
156862759|NCT00313014|566256543|FG000|Overall Study|Lost to Follow-up|7|||
156862760|NCT00313014|566256544|FG001|Overall Study|Lost to Follow-up|6|||
156862761|NCT00313014|566256545|FG002|Overall Study|Lost to Follow-up|10|||
156862762|NCT00313014|566256543|FG000|Overall Study|Administrative|9|||
156862763|NCT00313014|566256544|FG001|Overall Study|Administrative|6|||
156862764|NCT00313014|566256545|FG002|Overall Study|Administrative|14|||
156862765|NCT00313014|566256543|FG000|Overall Study|Lack of Efficacy|52|||
156862766|NCT00313014|566256544|FG001|Overall Study|Lack of Efficacy|25|||
156862767|NCT00313014|566256545|FG002|Overall Study|Lack of Efficacy|16|||
156862768|NCT01280903|566256546|FG000|Overall Study|Lost to Follow-up|23|||
156862769|NCT01280903|566256547|FG001|Overall Study|Lost to Follow-up|16|||
156862770|NCT03453164|566256548|FG000|Overall Study|Lack of Efficacy|16|||
156862771|NCT03453164|566256548|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
156862772|NCT03829228|566256549|FG000|Overall Study|Protocol Violation|1|||
156862773|NCT02177695|566256550|FG000|ITT Analysis|Ineligible|5|||
156862774|NCT02177695|566256551|FG001|ITT Analysis|Ineligible|5|||
156862775|NCT02177695|566256550|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
156862776|NCT02177695|566256551|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
156862777|NCT02177695|566256550|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
156862778|NCT02177695|566256551|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
156862779|NCT02177695|566256550|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
156862780|NCT02177695|566256551|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
156862781|NCT02443688|566256554|FG000|Overall Study|Adverse Event|2|||
156862782|NCT02443688|566256555|FG001|Overall Study|Adverse Event|3|||
156862783|NCT02443688|566256556|FG002|Overall Study|Adverse Event|2|||
156862784|NCT02443688|566256554|FG000|Overall Study|Lost to Follow-up|1|||
156862785|NCT02443688|566256555|FG001|Overall Study|Lost to Follow-up|0|||
156862786|NCT02443688|566256556|FG002|Overall Study|Lost to Follow-up|0|||
156862787|NCT02443688|566256554|FG000|Overall Study|Physician Decision|3|||
156862788|NCT02443688|566256555|FG001|Overall Study|Physician Decision|0|||
156862789|NCT02443688|566256556|FG002|Overall Study|Physician Decision|1|||
156862790|NCT02443688|566256554|FG000|Overall Study|Pregnancy|0|||
156862791|NCT02443688|566256555|FG001|Overall Study|Pregnancy|0|||
156862792|NCT02443688|566256556|FG002|Overall Study|Pregnancy|1|||
156862793|NCT02443688|566256554|FG000|Overall Study|Withdrawal by Subject|3|||
156862794|NCT02443688|566256555|FG001|Overall Study|Withdrawal by Subject|3|||
156862795|NCT02443688|566256556|FG002|Overall Study|Withdrawal by Subject|4|||
156862796|NCT02443688|566256554|FG000|Overall Study|Non-compliance with study drug|1|||
156862797|NCT02443688|566256555|FG001|Overall Study|Non-compliance with study drug|2|||
156862798|NCT02443688|566256556|FG002|Overall Study|Non-compliance with study drug|4|||
156862799|NCT02443688|566256554|FG000|Overall Study|Sponsor Request|2|||
156862800|NCT02443688|566256555|FG001|Overall Study|Sponsor Request|1|||
156862801|NCT02443688|566256556|FG002|Overall Study|Sponsor Request|0|||
156862802|NCT03459079|566256558|FG000|Overall Study|Adverse Event|4|||
156862803|NCT03459079|566256559|FG001|Overall Study|Adverse Event|2|||
156862804|NCT03459079|566256560|FG002|Overall Study|Adverse Event|0|||
156862805|NCT03459079|566256558|FG000|Overall Study|Withdrawal by Subject|2|||
156862806|NCT03459079|566256559|FG001|Overall Study|Withdrawal by Subject|2|||
156862807|NCT03459079|566256560|FG002|Overall Study|Withdrawal by Subject|0|||
156862808|NCT02379728|566256561|FG000|Overall Study|Lost to Follow-up|1|||
156862809|NCT02379728|566256562|FG001|Overall Study|Lost to Follow-up|0|||
157027465|NCT01152450|566856128|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
157027466|NCT01152450|566856129|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
157027467|NCT01152450|566856130|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
157027468|NCT01152450|566856125|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
157027469|NCT01152450|566856126|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
157027470|NCT01152450|566856127|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
157027471|NCT01152450|566856128|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
157027472|NCT01152450|566856129|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
157027473|NCT01152450|566856130|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
157027474|NCT01152450|566856125|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157027475|NCT01152450|566856126|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
157027476|NCT01152450|566856127|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
157027477|NCT01152450|566856128|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157027478|NCT01152450|566856129|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157027479|NCT01152450|566856130|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157027480|NCT05670587|566856131|FG000|Overall Study|Withdrawal by Subject|3|||
157027481|NCT02305888|566856134|FG000|Overall Study|Lost to Follow-up|0|||
157027482|NCT02305888|566856135|FG001|Overall Study|Lost to Follow-up|0|||
157027483|NCT02305888|566856136|FG002|Overall Study|Lost to Follow-up|1|||
157027484|NCT02305888|566856134|FG000|Overall Study|Adverse Event|0|||
157027485|NCT02305888|566856135|FG001|Overall Study|Adverse Event|1|||
157027486|NCT02305888|566856136|FG002|Overall Study|Adverse Event|0|||
157027487|NCT05139810|566856137|FG000|Overall Study|Voluntary Withdrawal|2|||
157027488|NCT05139810|566856138|FG001|Overall Study|Voluntary Withdrawal|1|||
157027489|NCT05139810|566856139|FG002|Overall Study|Voluntary Withdrawal|0|||
157027490|NCT05139810|566856137|FG000|Overall Study|Pregnancy|1|||
157027491|NCT05139810|566856138|FG001|Overall Study|Pregnancy|0|||
157027492|NCT05139810|566856139|FG002|Overall Study|Pregnancy|0|||
157027493|NCT05139810|566856137|FG000|Overall Study|Roll Over to CS7|19|||
157027494|NCT05139810|566856138|FG001|Overall Study|Roll Over to CS7|44|||
157027495|NCT05139810|566856139|FG002|Overall Study|Roll Over to CS7|20|||
157027496|NCT04914676|566856144|FG000|Overall Study|Study termination|3|||
157027497|NCT04914676|566856145|FG001|Overall Study|Study termination|0|||
157027498|NCT03024437|566856146|FG000|Overall Study|Adverse Event|0|||
157160745|NCT02488551|567331563|FG003|Overall Study|Military Deployment|0|||
157160746|NCT01934894|567331564|FG000|Overall Study|Adverse Event|1|||
157160747|NCT01934894|567331565|FG001|Overall Study|Adverse Event|2|||
157160748|NCT01934894|567331564|FG000|Overall Study|Death|2|||
157160749|NCT01934894|567331565|FG001|Overall Study|Death|0|||
156913062|NCT04502693|566440463|FG002|Overall Study|Adverse Event|11|||
156913063|NCT04502693|566440464|FG003|Overall Study|Adverse Event|1|||
156913064|NCT04502693|566440461|FG000|Overall Study|Lost to Follow-up|32|||
156913065|NCT04502693|566440462|FG001|Overall Study|Lost to Follow-up|36|||
156913066|NCT04502693|566440463|FG002|Overall Study|Lost to Follow-up|69|||
156913067|NCT04502693|566440464|FG003|Overall Study|Lost to Follow-up|4|||
156913068|NCT04502693|566440461|FG000|Overall Study|Protocol Violation|8|||
156913069|NCT04502693|566440462|FG001|Overall Study|Protocol Violation|8|||
156913070|NCT04502693|566440463|FG002|Overall Study|Protocol Violation|16|||
156913071|NCT04502693|566440464|FG003|Overall Study|Protocol Violation|1|||
156913072|NCT04502693|566440461|FG000|Overall Study|Withdrawal by Subject|46|||
156913073|NCT04502693|566440462|FG001|Overall Study|Withdrawal by Subject|38|||
156913074|NCT04502693|566440463|FG002|Overall Study|Withdrawal by Subject|54|||
156913075|NCT04502693|566440464|FG003|Overall Study|Withdrawal by Subject|7|||
156913076|NCT04502693|566440461|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
157160750|NCT01934894|567331564|FG000|Overall Study|Withdrawal by Subject|0|||
157160751|NCT01934894|567331565|FG001|Overall Study|Withdrawal by Subject|1|||
157160752|NCT01934894|567331564|FG000|Overall Study|Progressive Disease|3|||
157160753|NCT01934894|567331565|FG001|Overall Study|Progressive Disease|2|||
157160754|NCT01954251|567331570|FG000|Overall Study|Adverse Event|5|||
157160755|NCT01954251|567331571|FG001|Overall Study|Adverse Event|7|||
157160756|NCT01954251|567331570|FG000|Overall Study|Lost to Follow-up|6|||
157160757|NCT01954251|567331571|FG001|Overall Study|Lost to Follow-up|6|||
157160758|NCT01954251|567331570|FG000|Overall Study|Withdrawal by Subject|2|||
156913077|NCT04502693|566440462|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
157027499|NCT03024437|566856147|FG001|Overall Study|Adverse Event|1|||
157160759|NCT01954251|567331571|FG001|Overall Study|Withdrawal by Subject|6|||
157160760|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
157027500|NCT03024437|566856148|FG002|Overall Study|Adverse Event|3|||
157027501|NCT03024437|566856149|FG003|Overall Study|Adverse Event|5|||
157027502|NCT03024437|566856150|FG004|Overall Study|Adverse Event|0|||
157027503|NCT03024437|566856146|FG000|Overall Study|Physician Decision|1|||
157027504|NCT03024437|566856147|FG001|Overall Study|Physician Decision|0|||
157027505|NCT03024437|566856148|FG002|Overall Study|Physician Decision|0|||
157160761|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156913078|NCT04502693|566440463|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
156913079|NCT04502693|566440464|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157027506|NCT03024437|566856149|FG003|Overall Study|Physician Decision|1|||
157027507|NCT03024437|566856150|FG004|Overall Study|Physician Decision|0|||
157160762|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160763|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160764|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160765|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160766|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160767|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160768|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157160769|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
157160770|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160771|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160772|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160773|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160774|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160775|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160776|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160777|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157160778|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
157160779|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160780|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160781|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160782|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160783|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160784|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160785|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160786|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157160787|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
157160788|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160789|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160790|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160791|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160792|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160793|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160794|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160795|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
157160796|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
157160797|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160798|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160799|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160800|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160801|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160802|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160803|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160804|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157160805|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
157160806|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160807|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160808|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160809|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160810|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160811|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160812|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160813|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157160814|NCT02175771|567331572|FG000|Run-In Period (Pre-assignment)|Other|8|||
157160815|NCT02175771|567331573|FG001|Run-In Period (Pre-assignment)|Other|0|||
156913080|NCT04502693|566440461|FG000|Overall Study|Other|1|||
156913081|NCT04502693|566440462|FG001|Overall Study|Other|0|||
157160816|NCT02175771|567331574|FG002|Run-In Period (Pre-assignment)|Other|0|||
157160817|NCT02175771|567331575|FG003|Run-In Period (Pre-assignment)|Other|0|||
157160818|NCT02175771|567331576|FG004|Run-In Period (Pre-assignment)|Other|0|||
157160819|NCT02175771|567331577|FG005|Run-In Period (Pre-assignment)|Other|0|||
157160820|NCT02175771|567331578|FG006|Run-In Period (Pre-assignment)|Other|0|||
157225725|NCT01402908|567573347|FG000|Overall Study|Withdrawal by Subject|30|||
157225726|NCT01402908|567573348|FG001|Overall Study|Withdrawal by Subject|17|||
156913082|NCT04502693|566440463|FG002|Overall Study|Other|1|||
156913083|NCT04502693|566440464|FG003|Overall Study|Other|1|||
157160821|NCT02175771|567331579|FG007|Run-In Period (Pre-assignment)|Other|0|||
157160822|NCT02175771|567331580|FG008|Run-In Period (Pre-assignment)|Other|0|||
157160823|NCT02175771|567331572|FG000|Treatment Period|Adverse Event|0|||
156913084|NCT00968201|566440468|FG000|Base Study - (Period II)|Adverse Event|8|||
156913085|NCT00968201|566440469|FG001|Base Study - (Period II)|Adverse Event|0|||
156913086|NCT00968201|566440470|FG002|Base Study - (Period II)|Adverse Event|16|||
156913087|NCT00968201|566440468|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
157225727|NCT01402908|567573347|FG000|Overall Study|Lost to Follow-up|3|||
157225728|NCT01402908|567573348|FG001|Overall Study|Lost to Follow-up|1|||
157225729|NCT01402908|567573347|FG000|Overall Study|Physician Decision|1|||
157225730|NCT01402908|567573348|FG001|Overall Study|Physician Decision|0|||
157225731|NCT01739790|567573349|FG000|Overall Study|Early Trial Termination|2|||
157225732|NCT01739790|567573350|FG001|Overall Study|Early Trial Termination|4|||
157225733|NCT02581345|567573351|FG000|Part 1: up to Week 16|Adverse Event|3|||
157225734|NCT02581345|567573352|FG001|Part 1: up to Week 16|Adverse Event|8|||
157225735|NCT02581345|567573353|FG002|Part 1: up to Week 16|Adverse Event|0|||
157225736|NCT02581345|567573354|FG003|Part 1: up to Week 16|Adverse Event|0|||
157225737|NCT02581345|567573351|FG000|Part 1: up to Week 16|Physician Decision|2|||
157225738|NCT02581345|567573352|FG001|Part 1: up to Week 16|Physician Decision|4|||
157225739|NCT02581345|567573353|FG002|Part 1: up to Week 16|Physician Decision|0|||
157225740|NCT02581345|567573354|FG003|Part 1: up to Week 16|Physician Decision|0|||
157225741|NCT02581345|567573351|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
157225742|NCT02581345|567573352|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
157225743|NCT02581345|567573353|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
157225744|NCT02581345|567573354|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
157225745|NCT02581345|567573351|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
157225746|NCT02581345|567573352|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
156913088|NCT00968201|566440469|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
156913089|NCT00968201|566440470|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
156913090|NCT00968201|566440468|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
156913091|NCT00968201|566440469|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
156913092|NCT00968201|566440470|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
156913093|NCT00968201|566440468|FG000|Base Study - (Period II)|Protocol Violation|12|||
156913094|NCT00968201|566440469|FG001|Base Study - (Period II)|Protocol Violation|0|||
157160824|NCT02175771|567331573|FG001|Treatment Period|Adverse Event|2|||
157160825|NCT02175771|567331574|FG002|Treatment Period|Adverse Event|1|||
157160826|NCT02175771|567331575|FG003|Treatment Period|Adverse Event|1|||
157160827|NCT02175771|567331576|FG004|Treatment Period|Adverse Event|1|||
157160828|NCT02175771|567331577|FG005|Treatment Period|Adverse Event|3|||
157160829|NCT02175771|567331578|FG006|Treatment Period|Adverse Event|2|||
157160830|NCT02175771|567331579|FG007|Treatment Period|Adverse Event|0|||
157160831|NCT02175771|567331580|FG008|Treatment Period|Adverse Event|1|||
157160832|NCT02175771|567331572|FG000|Treatment Period|Withdrawal by Subject|0|||
157160833|NCT02175771|567331573|FG001|Treatment Period|Withdrawal by Subject|9|||
157160834|NCT02175771|567331574|FG002|Treatment Period|Withdrawal by Subject|3|||
157160835|NCT02175771|567331575|FG003|Treatment Period|Withdrawal by Subject|6|||
157160836|NCT02175771|567331576|FG004|Treatment Period|Withdrawal by Subject|2|||
157160837|NCT02175771|567331577|FG005|Treatment Period|Withdrawal by Subject|4|||
157160838|NCT02175771|567331578|FG006|Treatment Period|Withdrawal by Subject|2|||
157160839|NCT02175771|567331579|FG007|Treatment Period|Withdrawal by Subject|9|||
157160840|NCT02175771|567331580|FG008|Treatment Period|Withdrawal by Subject|2|||
157160841|NCT02175771|567331572|FG000|Treatment Period|Noncompliance|0|||
157160842|NCT02175771|567331573|FG001|Treatment Period|Noncompliance|1|||
157160843|NCT02175771|567331574|FG002|Treatment Period|Noncompliance|2|||
157160844|NCT02175771|567331575|FG003|Treatment Period|Noncompliance|0|||
157160845|NCT02175771|567331576|FG004|Treatment Period|Noncompliance|0|||
157160846|NCT02175771|567331577|FG005|Treatment Period|Noncompliance|0|||
157160847|NCT02175771|567331578|FG006|Treatment Period|Noncompliance|0|||
157160848|NCT02175771|567331579|FG007|Treatment Period|Noncompliance|0|||
157160849|NCT02175771|567331580|FG008|Treatment Period|Noncompliance|1|||
157160850|NCT02175771|567331572|FG000|Treatment Period|Protocol Violation|0|||
157160851|NCT02175771|567331573|FG001|Treatment Period|Protocol Violation|0|||
157160852|NCT02175771|567331574|FG002|Treatment Period|Protocol Violation|0|||
157160853|NCT02175771|567331575|FG003|Treatment Period|Protocol Violation|0|||
157160854|NCT02175771|567331576|FG004|Treatment Period|Protocol Violation|0|||
156913095|NCT00968201|566440470|FG002|Base Study - (Period II)|Protocol Violation|12|||
156913096|NCT00968201|566440468|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
157160855|NCT02175771|567331577|FG005|Treatment Period|Protocol Violation|0|||
157160856|NCT02175771|567331578|FG006|Treatment Period|Protocol Violation|0|||
157225747|NCT02581345|567573353|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
157225748|NCT02581345|567573354|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
156913097|NCT00968201|566440469|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
157027508|NCT03024437|566856146|FG000|Overall Study|Disease progression, relapse|1|||
157160857|NCT02175771|567331579|FG007|Treatment Period|Protocol Violation|1|||
157160858|NCT02175771|567331580|FG008|Treatment Period|Protocol Violation|0|||
157160859|NCT02175771|567331572|FG000|Treatment Period|Disease progression|0|||
156913098|NCT00968201|566440470|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
157160860|NCT02175771|567331573|FG001|Treatment Period|Disease progression|0|||
157160861|NCT02175771|567331574|FG002|Treatment Period|Disease progression|0|||
156913099|NCT00968201|566440468|FG000|Base Study - (Period II)|Site Error|0|||
157225749|NCT02581345|567573351|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
157225750|NCT02581345|567573352|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
157225751|NCT02581345|567573353|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
157225752|NCT02581345|567573354|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
157225753|NCT02581345|567573351|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
157225754|NCT02581345|567573352|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
157225755|NCT02581345|567573353|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
157225756|NCT02581345|567573354|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
157225757|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
157225758|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
157225759|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
157225760|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
157225761|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
157225762|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
157225763|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
157225764|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
157225765|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
157225766|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
157225767|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
157225768|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
157225769|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
157225770|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
157225771|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
157225772|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
157225773|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
157225774|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
157225775|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
157225776|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
157225777|NCT02581345|567573351|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
157225778|NCT02581345|567573352|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
157225779|NCT02581345|567573353|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
157225780|NCT02581345|567573354|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
157225781|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
157225782|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
157225783|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
157225784|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
157225785|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
157225786|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
157225787|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
157225788|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
157225789|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
157225790|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
157225791|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
157225792|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
157225793|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
157225794|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
157225795|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
157225796|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
157225797|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
157225798|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
157225799|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
157225800|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
157225801|NCT02207231|567573361|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
157225802|NCT02207231|567573362|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
157225803|NCT02207231|567573363|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
157225804|NCT02207231|567573364|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
157225805|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
157225806|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
156862810|NCT02379728|566256563|FG002|Overall Study|Lost to Follow-up|3|||
156862811|NCT02379728|566256564|FG003|Overall Study|Lost to Follow-up|0|||
156862812|NCT02379728|566256561|FG000|Overall Study|Withdrawal by Subject|5|||
156862813|NCT02379728|566256562|FG001|Overall Study|Withdrawal by Subject|0|||
156862814|NCT02379728|566256563|FG002|Overall Study|Withdrawal by Subject|5|||
156862815|NCT02379728|566256564|FG003|Overall Study|Withdrawal by Subject|3|||
156862816|NCT02379728|566256561|FG000|Overall Study|Protocol Violation|0|||
156862817|NCT02379728|566256562|FG001|Overall Study|Protocol Violation|0|||
156862818|NCT02379728|566256563|FG002|Overall Study|Protocol Violation|2|||
156862819|NCT02379728|566256564|FG003|Overall Study|Protocol Violation|0|||
157027509|NCT03024437|566856147|FG001|Overall Study|Disease progression, relapse|0|||
157027510|NCT03024437|566856148|FG002|Overall Study|Disease progression, relapse|0|||
157027511|NCT03024437|566856149|FG003|Overall Study|Disease progression, relapse|3|||
157027512|NCT03024437|566856150|FG004|Overall Study|Disease progression, relapse|0|||
157027513|NCT03024437|566856146|FG000|Overall Study|Disease progression, refractory disease|4|||
157027514|NCT03024437|566856147|FG001|Overall Study|Disease progression, refractory disease|4|||
157027515|NCT03024437|566856148|FG002|Overall Study|Disease progression, refractory disease|2|||
157027516|NCT03024437|566856149|FG003|Overall Study|Disease progression, refractory disease|2|||
157027517|NCT03024437|566856150|FG004|Overall Study|Disease progression, refractory disease|1|||
157027518|NCT03024437|566856146|FG000|Overall Study|Newly diagnosed cancer|0|||
157027519|NCT03024437|566856147|FG001|Overall Study|Newly diagnosed cancer|0|||
157027520|NCT03024437|566856148|FG002|Overall Study|Newly diagnosed cancer|0|||
157027521|NCT03024437|566856149|FG003|Overall Study|Newly diagnosed cancer|1|||
157027522|NCT03024437|566856150|FG004|Overall Study|Newly diagnosed cancer|0|||
157027523|NCT03024437|566856146|FG000|Overall Study|Moved out of state|0|||
157027524|NCT03024437|566856147|FG001|Overall Study|Moved out of state|1|||
157027525|NCT03024437|566856148|FG002|Overall Study|Moved out of state|0|||
157027526|NCT03024437|566856149|FG003|Overall Study|Moved out of state|0|||
157027527|NCT03024437|566856150|FG004|Overall Study|Moved out of state|0|||
157027528|NCT03024437|566856146|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
157027529|NCT03024437|566856147|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
157027530|NCT03024437|566856148|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
157027531|NCT03024437|566856149|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
157027532|NCT03024437|566856150|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
157027533|NCT03240016|566856153|FG000|Overall Study|Adverse Event|9|||
157027534|NCT03240016|566856153|FG000|Overall Study|Withdrawal by Subject|7|||
157027535|NCT03240016|566856153|FG000|Overall Study|Death|1|||
157027536|NCT03240016|566856153|FG000|Overall Study|Physician Decision|2|||
157027537|NCT05200403|566856154|FG000|Overall Study|Withdrawal by Subject|4|||
157027538|NCT05200403|566856155|FG001|Overall Study|Withdrawal by Subject|2|||
157027539|NCT05200403|566856156|FG002|Overall Study|Withdrawal by Subject|6|||
157027540|NCT05546411|566856157|FG000|Overall Study|Progressive Disease|1|||
157027541|NCT05546411|566856158|FG001|Overall Study|Progressive Disease|0|||
157027542|NCT05546411|566856157|FG000|Overall Study|Adverse Event|0|||
157027543|NCT05546411|566856158|FG001|Overall Study|Adverse Event|1|||
157027544|NCT05546411|566856157|FG000|Overall Study|Metastatic disease|1|||
157027545|NCT05546411|566856158|FG001|Overall Study|Metastatic disease|0|||
157027546|NCT04625465|566856159|FG000|Overall Study|Lost to Follow-up|2|||
157027547|NCT04625465|566856160|FG001|Overall Study|Lost to Follow-up|2|||
157027548|NCT04625465|566856161|FG002|Overall Study|Lost to Follow-up|1|||
157027549|NCT04625465|566856162|FG003|Overall Study|Lost to Follow-up|0|||
157027550|NCT04625465|566856163|FG004|Overall Study|Lost to Follow-up|0|||
157027551|NCT04625465|566856164|FG005|Overall Study|Lost to Follow-up|2|||
157027552|NCT04625465|566856165|FG006|Overall Study|Lost to Follow-up|0|||
157027553|NCT04625465|566856166|FG007|Overall Study|Lost to Follow-up|0|||
157027554|NCT04625465|566856159|FG000|Overall Study|Death|1|||
157027555|NCT04625465|566856160|FG001|Overall Study|Death|0|||
156913100|NCT00968201|566440469|FG001|Base Study - (Period II)|Site Error|0|||
156913101|NCT00968201|566440470|FG002|Base Study - (Period II)|Site Error|1|||
156913102|NCT00968201|566440468|FG000|Extension Study - (Period III)|Adverse Event|0|||
156913103|NCT00968201|566440469|FG001|Extension Study - (Period III)|Adverse Event|5|||
156913104|NCT00968201|566440470|FG002|Extension Study - (Period III)|Adverse Event|22|||
156913105|NCT00968201|566440468|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
156913106|NCT00968201|566440469|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
156913107|NCT00968201|566440470|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
156913108|NCT00968201|566440468|FG000|Extension Study - (Period III)|Protocol Violation|0|||
156913109|NCT00968201|566440469|FG001|Extension Study - (Period III)|Protocol Violation|17|||
156913110|NCT00968201|566440470|FG002|Extension Study - (Period III)|Protocol Violation|14|||
156913111|NCT00968201|566440468|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
156913112|NCT00968201|566440469|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
156913113|NCT00968201|566440470|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
156913114|NCT00968201|566440468|FG000|Extension Study - (Period III)|Patient Relocated|0|||
156913115|NCT00968201|566440469|FG001|Extension Study - (Period III)|Patient Relocated|1|||
156913116|NCT00968201|566440470|FG002|Extension Study - (Period III)|Patient Relocated|1|||
156913117|NCT00968201|566440468|FG000|Extension Study - (Period III)|Noncompliance|0|||
156913118|NCT00968201|566440469|FG001|Extension Study - (Period III)|Noncompliance|0|||
156913119|NCT00968201|566440470|FG002|Extension Study - (Period III)|Noncompliance|3|||
156913120|NCT00968201|566440468|FG000|Extension Study - (Period III)|Other|0|||
157027556|NCT04625465|566856161|FG002|Overall Study|Death|0|||
157027557|NCT04625465|566856162|FG003|Overall Study|Death|0|||
157027558|NCT04625465|566856163|FG004|Overall Study|Death|0|||
157027559|NCT04625465|566856164|FG005|Overall Study|Death|0|||
157027560|NCT04625465|566856165|FG006|Overall Study|Death|0|||
157027561|NCT04625465|566856166|FG007|Overall Study|Death|0|||
156862820|NCT01112917|566256566|FG000|Overall Study|Death|2|||
156862821|NCT01112917|566256567|FG001|Overall Study|Death|11|||
156862822|NCT01112917|566256566|FG000|Overall Study|Lost to Follow-up|1|||
156862823|NCT01112917|566256567|FG001|Overall Study|Lost to Follow-up|1|||
156862824|NCT01112917|566256566|FG000|Overall Study|Withdrawal by Subject|1|||
156862825|NCT01112917|566256567|FG001|Overall Study|Withdrawal by Subject|3|||
156862826|NCT01112917|566256566|FG000|Overall Study|Unable to Convert Filter|3|||
156862827|NCT01112917|566256567|FG001|Overall Study|Unable to Convert Filter|0|||
156862828|NCT05101122|566256568|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
156862829|NCT05101122|566256568|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
156862830|NCT05101122|566256568|FG000|AD313 80/5|Withdrawal by Subject|1|||
156862831|NCT05101122|566256568|FG000|AD313 80/10|Physician Decision|1|||
156862832|NCT00837434|566256580|FG000|Overall Study|Physician Decision|3|||
156862833|NCT00837434|566256581|FG001|Overall Study|Physician Decision|0|||
156862834|NCT00837434|566256580|FG000|Overall Study|Lost to Follow-up|1|||
156862835|NCT00837434|566256581|FG001|Overall Study|Lost to Follow-up|1|||
156862836|NCT00837434|566256580|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
156862837|NCT00837434|566256581|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
156862838|NCT00837434|566256580|FG000|Overall Study|Noncompliant|2|||
156862839|NCT00837434|566256581|FG001|Overall Study|Noncompliant|0|||
156862840|NCT00837434|566256580|FG000|Overall Study|Baseline assessments not done in time|1|||
156862841|NCT00837434|566256581|FG001|Overall Study|Baseline assessments not done in time|0|||
156862842|NCT00837434|566256580|FG000|Overall Study|Unable to obtain study drug|1|||
156862843|NCT00837434|566256581|FG001|Overall Study|Unable to obtain study drug|0|||
156862844|NCT01709721|566256582|FG000|Open Label Phase|Withdrawal by Subject|0|||
156862845|NCT01709721|566256583|FG001|Open Label Phase|Withdrawal by Subject|0|||
156862846|NCT01709721|566256584|FG002|Open Label Phase|Withdrawal by Subject|5|||
157160862|NCT02175771|567331575|FG003|Treatment Period|Disease progression|0|||
157160863|NCT02175771|567331576|FG004|Treatment Period|Disease progression|0|||
157160864|NCT02175771|567331577|FG005|Treatment Period|Disease progression|0|||
157160865|NCT02175771|567331578|FG006|Treatment Period|Disease progression|0|||
157160866|NCT02175771|567331579|FG007|Treatment Period|Disease progression|2|||
157160867|NCT02175771|567331580|FG008|Treatment Period|Disease progression|0|||
157160868|NCT02175771|567331572|FG000|Treatment Period|Lost to Follow-up|0|||
157160869|NCT02175771|567331573|FG001|Treatment Period|Lost to Follow-up|3|||
157160870|NCT02175771|567331574|FG002|Treatment Period|Lost to Follow-up|1|||
157160871|NCT02175771|567331575|FG003|Treatment Period|Lost to Follow-up|3|||
157160872|NCT02175771|567331576|FG004|Treatment Period|Lost to Follow-up|1|||
157160873|NCT02175771|567331577|FG005|Treatment Period|Lost to Follow-up|2|||
157160874|NCT02175771|567331578|FG006|Treatment Period|Lost to Follow-up|1|||
157160875|NCT02175771|567331579|FG007|Treatment Period|Lost to Follow-up|2|||
157160876|NCT02175771|567331580|FG008|Treatment Period|Lost to Follow-up|2|||
157160877|NCT02175771|567331572|FG000|Treatment Period|Lack of Efficacy|0|||
157160878|NCT02175771|567331573|FG001|Treatment Period|Lack of Efficacy|0|||
157160879|NCT02175771|567331574|FG002|Treatment Period|Lack of Efficacy|0|||
157160880|NCT02175771|567331575|FG003|Treatment Period|Lack of Efficacy|0|||
157160881|NCT02175771|567331576|FG004|Treatment Period|Lack of Efficacy|0|||
157160882|NCT02175771|567331577|FG005|Treatment Period|Lack of Efficacy|1|||
157160883|NCT02175771|567331578|FG006|Treatment Period|Lack of Efficacy|0|||
157160884|NCT02175771|567331579|FG007|Treatment Period|Lack of Efficacy|1|||
157160885|NCT02175771|567331580|FG008|Treatment Period|Lack of Efficacy|0|||
157160886|NCT02175771|567331572|FG000|Treatment Period|Other|0|||
157160887|NCT02175771|567331573|FG001|Treatment Period|Other|1|||
157160888|NCT02175771|567331574|FG002|Treatment Period|Other|0|||
157160889|NCT02175771|567331575|FG003|Treatment Period|Other|3|||
157160890|NCT02175771|567331576|FG004|Treatment Period|Other|1|||
157160891|NCT02175771|567331577|FG005|Treatment Period|Other|0|||
157160892|NCT02175771|567331578|FG006|Treatment Period|Other|0|||
157160893|NCT02175771|567331579|FG007|Treatment Period|Other|2|||
157160894|NCT02175771|567331580|FG008|Treatment Period|Other|0|||
157160895|NCT03364673|567331581|FG000|Overall Study|Withdrawal by Subject|2|||
157160896|NCT03364673|567331581|FG000|Overall Study|Injury unrelated to study|3|||
157160897|NCT02208024|567331582|FG000|Overall Study|Withdrawal by Subject|1|||
157160898|NCT00779324|567331583|FG000|Overall Study|Lost to Follow-up|2|||
157160899|NCT00779324|567331584|FG001|Overall Study|Lost to Follow-up|1|||
157160900|NCT00779324|567331583|FG000|Overall Study|Withdrawal by Subject|4|||
157160901|NCT00779324|567331584|FG001|Overall Study|Withdrawal by Subject|2|||
157160902|NCT00779324|567331583|FG000|Overall Study|Missed visit|1|||
157160903|NCT00779324|567331584|FG001|Overall Study|Missed visit|1|||
157160904|NCT02207556|567331585|FG000|Overall Study|Physician Decision|1|||
157160905|NCT02207556|567331586|FG001|Overall Study|Physician Decision|0|||
157160906|NCT02207556|567331585|FG000|Overall Study|Withdrawal by Subject|1|||
157160907|NCT02207556|567331586|FG001|Overall Study|Withdrawal by Subject|0|||
157160908|NCT02207556|567331585|FG000|Overall Study|Death|0|||
156862847|NCT01709721|566256582|FG000|Open Label Phase|Adverse Event|0|||
156862848|NCT01709721|566256583|FG001|Open Label Phase|Adverse Event|0|||
156862849|NCT01709721|566256584|FG002|Open Label Phase|Adverse Event|8|||
157160909|NCT02207556|567331586|FG001|Overall Study|Death|5|||
157160910|NCT03558555|567331587|FG000|Overall Study|Lost to Follow-up|2|||
157225807|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
157225808|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
157225809|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
157225810|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
157225811|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
156913121|NCT00968201|566440469|FG001|Extension Study - (Period III)|Other|0|||
156913122|NCT00968201|566440470|FG002|Extension Study - (Period III)|Other|2|||
156913123|NCT00968201|566440468|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
157160911|NCT03558555|567331588|FG001|Overall Study|Lost to Follow-up|1|||
157160912|NCT00496873|567331598|FG000|Overall Study|Ineligible|2|||
157160913|NCT00496873|567331598|FG000|Overall Study|Death|2|||
157160914|NCT00496873|567331598|FG000|Overall Study|Withdrawal by Subject|3|||
157160915|NCT01842620|567331599|FG000|Period 1|Withdrawal by Subject|1|||
157160916|NCT01842620|567331600|FG001|Period 1|Withdrawal by Subject|0|||
157160917|NCT02402218|567331601|FG000|Overall Study|Did not pickup study medication|12|||
157160918|NCT02402218|567331602|FG001|Overall Study|Did not pickup study medication|9|||
157160919|NCT02402218|567331603|FG002|Overall Study|Did not pickup study medication|13|||
157160920|NCT02402218|567331601|FG000|Overall Study|Lack of Efficacy|0|||
157160921|NCT02402218|567331602|FG001|Overall Study|Lack of Efficacy|1|||
157160922|NCT02402218|567331603|FG002|Overall Study|Lack of Efficacy|1|||
157160923|NCT02402218|567331601|FG000|Overall Study|Death|1|||
157160924|NCT02402218|567331602|FG001|Overall Study|Death|0|||
157160925|NCT02402218|567331603|FG002|Overall Study|Death|0|||
157160926|NCT02402218|567331601|FG000|Overall Study|Reinfection|0|||
157160927|NCT02402218|567331602|FG001|Overall Study|Reinfection|0|||
157160928|NCT02402218|567331603|FG002|Overall Study|Reinfection|1|||
157160929|NCT02402218|567331601|FG000|Overall Study|Adverse Event|0|||
157160930|NCT02402218|567331602|FG001|Overall Study|Adverse Event|2|||
157160931|NCT02402218|567331603|FG002|Overall Study|Adverse Event|1|||
157160932|NCT02402218|567331601|FG000|Overall Study|Withdrawal by Subject|1|||
157160933|NCT02402218|567331602|FG001|Overall Study|Withdrawal by Subject|1|||
157160934|NCT02402218|567331603|FG002|Overall Study|Withdrawal by Subject|1|||
157160935|NCT03827473|567331604|FG000|Overall Study|Withdrawal by Subject|1|||
157160936|NCT03827473|567331605|FG001|Overall Study|Withdrawal by Subject|0|||
157160937|NCT03807739|567331606|FG000|Overall Study|Adverse Event|1|||
157160938|NCT03807739|567331607|FG001|Overall Study|Adverse Event|0|||
157160939|NCT03807739|567331608|FG002|Overall Study|Adverse Event|0|||
157160940|NCT03807739|567331609|FG003|Overall Study|Adverse Event|0|||
157160941|NCT03807739|567331606|FG000|Overall Study|Withdrawal by Subject|1|||
157160942|NCT03807739|567331607|FG001|Overall Study|Withdrawal by Subject|0|||
157160943|NCT03807739|567331608|FG002|Overall Study|Withdrawal by Subject|0|||
157160944|NCT03807739|567331609|FG003|Overall Study|Withdrawal by Subject|0|||
157160945|NCT02371759|567331610|FG000|Overall Study|Protocol Violation|3|||
157160946|NCT02371759|567331611|FG001|Overall Study|Protocol Violation|1|||
157160947|NCT02371759|567331612|FG002|Overall Study|Protocol Violation|1|||
157160948|NCT02371759|567331613|FG003|Overall Study|Protocol Violation|0|||
157160949|NCT02371759|567331614|FG004|Overall Study|Protocol Violation|3|||
157160950|NCT02371759|567331615|FG005|Overall Study|Protocol Violation|1|||
157160951|NCT02371759|567331616|FG006|Overall Study|Protocol Violation|0|||
157160952|NCT02371759|567331617|FG007|Overall Study|Protocol Violation|3|||
157160953|NCT02371759|567331610|FG000|Overall Study|Withdrawal by Subject|0|||
157160954|NCT02371759|567331611|FG001|Overall Study|Withdrawal by Subject|0|||
157160955|NCT02371759|567331612|FG002|Overall Study|Withdrawal by Subject|0|||
157160956|NCT02371759|567331613|FG003|Overall Study|Withdrawal by Subject|0|||
157160957|NCT02371759|567331614|FG004|Overall Study|Withdrawal by Subject|0|||
157160958|NCT02371759|567331615|FG005|Overall Study|Withdrawal by Subject|0|||
157160959|NCT02371759|567331616|FG006|Overall Study|Withdrawal by Subject|0|||
157160960|NCT02371759|567331617|FG007|Overall Study|Withdrawal by Subject|1|||
157160961|NCT03599141|567331620|FG000|Overall Study|Lost to Follow-up|3|||
157160962|NCT03599141|567331621|FG001|Overall Study|Lost to Follow-up|1|||
157160963|NCT00488033|567331625|FG000|Overall Study|Withdrawal by Subject|1|||
157160964|NCT00488033|567331626|FG001|Overall Study|Withdrawal by Subject|0|||
157160965|NCT00303108|567331629|FG000|Overall Study|Adverse Event|5|||
157160966|NCT00303108|567331630|FG001|Overall Study|Adverse Event|6|||
157160967|NCT00303108|567331631|FG002|Overall Study|Adverse Event|7|||
157160968|NCT00303108|567331629|FG000|Overall Study|Patient Request|4|||
157160969|NCT00303108|567331630|FG001|Overall Study|Patient Request|2|||
157160970|NCT00303108|567331631|FG002|Overall Study|Patient Request|8|||
157160971|NCT00303108|567331629|FG000|Overall Study|Failed Entry|1|||
157160972|NCT00303108|567331630|FG001|Overall Study|Failed Entry|0|||
157160973|NCT00303108|567331631|FG002|Overall Study|Failed Entry|1|||
157160974|NCT00303108|567331629|FG000|Overall Study|ineligible|2|||
157160975|NCT00303108|567331630|FG001|Overall Study|ineligible|1|||
157160976|NCT00303108|567331631|FG002|Overall Study|ineligible|0|||
157160977|NCT00894413|567331632|FG000|Overall Study|Physician Decision|0|||
157160978|NCT00894413|567331633|FG001|Overall Study|Physician Decision|2|||
157160979|NCT00894413|567331632|FG000|Overall Study|Adverse Event|0|||
157160980|NCT00894413|567331633|FG001|Overall Study|Adverse Event|2|||
157160981|NCT00894413|567331632|FG000|Overall Study|Withdrawal by Subject|0|||
157160982|NCT00894413|567331633|FG001|Overall Study|Withdrawal by Subject|4|||
157160983|NCT02435277|567331638|FG000|Overall Study|Adverse Event|1|||
156913124|NCT00968201|566440469|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
156913125|NCT00968201|566440470|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
156913126|NCT03736447|566440471|FG000|Overall Study|Adverse Event|5|||
156913127|NCT03736447|566440472|FG001|Overall Study|Adverse Event|1|||
156913128|NCT03736447|566440471|FG000|Overall Study|Withdrawal by Subject|5|||
156913129|NCT03736447|566440472|FG001|Overall Study|Withdrawal by Subject|1|||
156913130|NCT03736447|566440471|FG000|Overall Study|Lost to Follow-up|1|||
156913131|NCT03736447|566440472|FG001|Overall Study|Lost to Follow-up|0|||
156913132|NCT03736447|566440471|FG000|Overall Study|Physician Decision|1|||
156913133|NCT03736447|566440472|FG001|Overall Study|Physician Decision|0|||
156913134|NCT03736447|566440471|FG000|Overall Study|Continued commitment to study treatment|3|||
156913135|NCT03736447|566440472|FG001|Overall Study|Continued commitment to study treatment|0|||
156913136|NCT03736447|566440471|FG000|Overall Study|Taste aversion to study product|0|||
156913137|NCT03736447|566440472|FG001|Overall Study|Taste aversion to study product|1|||
156913138|NCT02619175|566440473|FG000|Overall Study|Withdrawal by Subject|1|||
156913139|NCT02619175|566440474|FG001|Overall Study|Withdrawal by Subject|0|||
156913140|NCT02619175|566440473|FG000|Overall Study|foot pain|1|||
156913141|NCT02619175|566440474|FG001|Overall Study|foot pain|0|||
156913142|NCT00540514|566442371|FG000|Overall Study|Still on treatment|3|||
156913143|NCT00540514|566442372|FG001|Overall Study|Still on treatment|0|||
156913144|NCT00540514|566442371|FG000|Overall Study|Unacceptable Toxicity|61|||
156913145|NCT00540514|566442372|FG001|Overall Study|Unacceptable Toxicity|62|||
156913146|NCT00540514|566442371|FG000|Overall Study|Adverse Event|20|||
156913147|NCT00540514|566442372|FG001|Overall Study|Adverse Event|24|||
157027562|NCT04625465|566856159|FG000|Overall Study|Withdrawal by Subject|1|||
156862850|NCT01709721|566256582|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
156862851|NCT01709721|566256583|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
156862852|NCT01709721|566256584|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
156862853|NCT01709721|566256582|FG000|Open Label Phase|Investigator Decision|0|||
156862854|NCT01709721|566256583|FG001|Open Label Phase|Investigator Decision|0|||
156862855|NCT01709721|566256584|FG002|Open Label Phase|Investigator Decision|1|||
156862856|NCT01709721|566256582|FG000|Open Label Phase|Sponsor Decision|0|||
156862857|NCT01709721|566256583|FG001|Open Label Phase|Sponsor Decision|0|||
156862858|NCT01709721|566256584|FG002|Open Label Phase|Sponsor Decision|2|||
156862859|NCT01709721|566256582|FG000|Open Label Phase|Protocol Violation|0|||
156862860|NCT01709721|566256583|FG001|Open Label Phase|Protocol Violation|0|||
156862861|NCT01709721|566256584|FG002|Open Label Phase|Protocol Violation|1|||
156862862|NCT01709721|566256582|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
156862863|NCT01709721|566256583|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
156862864|NCT01709721|566256584|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
156862865|NCT01709721|566256582|FG000|Open Label Phase|Inadequate Pain Control|0|||
156862866|NCT01709721|566256583|FG001|Open Label Phase|Inadequate Pain Control|0|||
156862867|NCT01709721|566256584|FG002|Open Label Phase|Inadequate Pain Control|37|||
156862868|NCT01709721|566256582|FG000|Open Label Phase|Other, Specify in text field in database|0|||
156862869|NCT01709721|566256583|FG001|Open Label Phase|Other, Specify in text field in database|0|||
156862870|NCT01709721|566256584|FG002|Open Label Phase|Other, Specify in text field in database|14|||
156862871|NCT01709721|566256582|FG000|Randomized Phase|Adverse Event|0|||
156862872|NCT01709721|566256583|FG001|Randomized Phase|Adverse Event|1|||
156862873|NCT01709721|566256584|FG002|Randomized Phase|Adverse Event|0|||
156862874|NCT01709721|566256582|FG000|Randomized Phase|Lost to Follow-up|1|||
156862875|NCT01709721|566256583|FG001|Randomized Phase|Lost to Follow-up|0|||
156862876|NCT01709721|566256584|FG002|Randomized Phase|Lost to Follow-up|0|||
156862877|NCT01709721|566256582|FG000|Randomized Phase|Inadequate Pain Control|1|||
156862878|NCT01709721|566256583|FG001|Randomized Phase|Inadequate Pain Control|2|||
156862879|NCT01709721|566256584|FG002|Randomized Phase|Inadequate Pain Control|0|||
156862880|NCT01709721|566256582|FG000|Randomized Phase|Other, Specify text field in database|1|||
156862881|NCT01709721|566256583|FG001|Randomized Phase|Other, Specify text field in database|3|||
156862882|NCT01709721|566256584|FG002|Randomized Phase|Other, Specify text field in database|0|||
156862883|NCT02230410|566256585|FG000|Overall Study|Screen Failure|3|||
156862884|NCT02558894|566256591|FG000|Overall Study|Death; any cause, entire study duration|28|||
156862885|NCT02558894|566256592|FG001|Overall Study|Death; any cause, entire study duration|31|||
156913148|NCT00540514|566442371|FG000|Overall Study|Physician Decision|86|||
156913149|NCT00540514|566442372|FG001|Overall Study|Physician Decision|99|||
156913150|NCT00540514|566442371|FG000|Overall Study|Protocol Deviation|3|||
156913151|NCT00540514|566442372|FG001|Overall Study|Protocol Deviation|4|||
157027563|NCT04625465|566856160|FG001|Overall Study|Withdrawal by Subject|0|||
157027564|NCT04625465|566856161|FG002|Overall Study|Withdrawal by Subject|4|||
157027565|NCT04625465|566856162|FG003|Overall Study|Withdrawal by Subject|4|||
157160984|NCT02435277|567331639|FG001|Overall Study|Adverse Event|1|||
157027566|NCT04625465|566856163|FG004|Overall Study|Withdrawal by Subject|4|||
156862886|NCT02558894|566256591|FG000|Overall Study|Withdrawal by Subject|2|||
156862887|NCT02558894|566256592|FG001|Overall Study|Withdrawal by Subject|1|||
156862888|NCT02558894|566256591|FG000|Overall Study|Closure of Part A|2|||
156862889|NCT02558894|566256592|FG001|Overall Study|Closure of Part A|1|||
156862890|NCT02992288|566256593|FG000|Overall Study|Adverse Event|8|||
156862891|NCT02992288|566256594|FG001|Overall Study|Adverse Event|2|||
156862892|NCT02992288|566256595|FG002|Overall Study|Adverse Event|2|||
156862893|NCT02992288|566256596|FG003|Overall Study|Adverse Event|2|||
156862894|NCT02992288|566256597|FG004|Overall Study|Adverse Event|2|||
156862895|NCT02992288|566256598|FG005|Overall Study|Adverse Event|7|||
156862896|NCT02992288|566256593|FG000|Overall Study|Non-compliance with study drug|0|||
156862897|NCT02992288|566256594|FG001|Overall Study|Non-compliance with study drug|1|||
156862898|NCT02992288|566256595|FG002|Overall Study|Non-compliance with study drug|1|||
156862899|NCT02992288|566256596|FG003|Overall Study|Non-compliance with study drug|0|||
156862900|NCT02992288|566256597|FG004|Overall Study|Non-compliance with study drug|1|||
156862901|NCT02992288|566256598|FG005|Overall Study|Non-compliance with study drug|0|||
156862902|NCT02992288|566256593|FG000|Overall Study|Physician Decision|3|||
156862903|NCT02992288|566256594|FG001|Overall Study|Physician Decision|0|||
156862904|NCT02992288|566256595|FG002|Overall Study|Physician Decision|1|||
156862905|NCT02992288|566256596|FG003|Overall Study|Physician Decision|0|||
156862906|NCT02992288|566256597|FG004|Overall Study|Physician Decision|0|||
156862907|NCT02992288|566256598|FG005|Overall Study|Physician Decision|1|||
156862908|NCT02992288|566256593|FG000|Overall Study|Death|2|||
156862909|NCT02992288|566256594|FG001|Overall Study|Death|0|||
156862910|NCT02992288|566256595|FG002|Overall Study|Death|2|||
156862911|NCT02992288|566256596|FG003|Overall Study|Death|1|||
156862912|NCT02992288|566256597|FG004|Overall Study|Death|2|||
156862913|NCT02992288|566256598|FG005|Overall Study|Death|0|||
156862914|NCT02992288|566256593|FG000|Overall Study|Lost to Follow-up|0|||
156862915|NCT02992288|566256594|FG001|Overall Study|Lost to Follow-up|0|||
156862916|NCT02992288|566256595|FG002|Overall Study|Lost to Follow-up|0|||
156862917|NCT02992288|566256596|FG003|Overall Study|Lost to Follow-up|1|||
156862918|NCT02992288|566256597|FG004|Overall Study|Lost to Follow-up|0|||
156862919|NCT02992288|566256598|FG005|Overall Study|Lost to Follow-up|0|||
156862920|NCT02992288|566256593|FG000|Overall Study|Protocol Violation|0|||
156862921|NCT02992288|566256594|FG001|Overall Study|Protocol Violation|0|||
156862922|NCT02992288|566256595|FG002|Overall Study|Protocol Violation|0|||
156862923|NCT02992288|566256596|FG003|Overall Study|Protocol Violation|0|||
156862924|NCT02992288|566256597|FG004|Overall Study|Protocol Violation|0|||
156862925|NCT02992288|566256598|FG005|Overall Study|Protocol Violation|1|||
156862926|NCT02992288|566256593|FG000|Overall Study|Withdrawal by Subject|4|||
156862927|NCT02992288|566256594|FG001|Overall Study|Withdrawal by Subject|2|||
156862928|NCT02992288|566256595|FG002|Overall Study|Withdrawal by Subject|1|||
156862929|NCT02992288|566256596|FG003|Overall Study|Withdrawal by Subject|5|||
156862930|NCT02992288|566256597|FG004|Overall Study|Withdrawal by Subject|3|||
156862931|NCT02992288|566256598|FG005|Overall Study|Withdrawal by Subject|4|||
156862932|NCT00656513|566256599|FG000|Overall Study|Protocol Violation|1|||
156862933|NCT00656513|566256600|FG001|Overall Study|Protocol Violation|0|||
156862934|NCT00656513|566256601|FG002|Overall Study|Protocol Violation|2|||
156862935|NCT00656513|566256599|FG000|Overall Study|Withdrawal by Subject|0|||
156862936|NCT00656513|566256600|FG001|Overall Study|Withdrawal by Subject|11|||
156862937|NCT00656513|566256601|FG002|Overall Study|Withdrawal by Subject|4|||
156862938|NCT00656513|566256599|FG000|Overall Study|Death|0|||
156862939|NCT00656513|566256600|FG001|Overall Study|Death|0|||
156862940|NCT00656513|566256601|FG002|Overall Study|Death|1|||
156862941|NCT00656513|566256599|FG000|Overall Study|Missing data|0|||
156862942|NCT00656513|566256600|FG001|Overall Study|Missing data|11|||
156862943|NCT00656513|566256601|FG002|Overall Study|Missing data|9|||
156862944|NCT00656513|566256599|FG000|Overall Study|Incomplete treatment|3|||
156862945|NCT00656513|566256600|FG001|Overall Study|Incomplete treatment|0|||
156862946|NCT00656513|566256601|FG002|Overall Study|Incomplete treatment|0|||
156862947|NCT00656513|566256599|FG000|Overall Study|Treatment completed outside of timeframe|0|||
157027567|NCT04625465|566856164|FG005|Overall Study|Withdrawal by Subject|0|||
156862948|NCT00656513|566256600|FG001|Overall Study|Treatment completed outside of timeframe|3|||
156862949|NCT00656513|566256601|FG002|Overall Study|Treatment completed outside of timeframe|1|||
156862950|NCT00656513|566256599|FG000|Overall Study|Missing baseline form|0|||
156862951|NCT00656513|566256600|FG001|Overall Study|Missing baseline form|5|||
156862952|NCT00656513|566256601|FG002|Overall Study|Missing baseline form|5|||
156862953|NCT04558125|566256602|FG000|Overall Study|Death|1|||
156862954|NCT01748292|566256603|FG000|Overall Study|Adverse Event|2|||
156862955|NCT01748292|566256604|FG001|Overall Study|Adverse Event|4|||
156862956|NCT01748292|566256603|FG000|Overall Study|Lost to Follow-up|0|||
156862957|NCT01748292|566256604|FG001|Overall Study|Lost to Follow-up|3|||
156862958|NCT01748292|566256603|FG000|Overall Study|Death|0|||
156862959|NCT01748292|566256604|FG001|Overall Study|Death|3|||
156862960|NCT01748292|566256603|FG000|Overall Study|Withdrawal by Subject|0|||
156862961|NCT01748292|566256604|FG001|Overall Study|Withdrawal by Subject|2|||
156862962|NCT03199976|566256606|FG000|Overall Study|Lack of Efficacy|3|||
156862963|NCT03199976|566256607|FG001|Overall Study|Lack of Efficacy|6|||
156862964|NCT03199976|566256608|FG002|Overall Study|Lack of Efficacy|13|||
156862965|NCT03199976|566256606|FG000|Overall Study|Withdrawal by Subject|1|||
156862966|NCT03199976|566256607|FG001|Overall Study|Withdrawal by Subject|0|||
156862967|NCT03199976|566256608|FG002|Overall Study|Withdrawal by Subject|0|||
156862968|NCT03199976|566256606|FG000|Overall Study|Lost to Follow-up|0|||
156862969|NCT03199976|566256607|FG001|Overall Study|Lost to Follow-up|1|||
156862970|NCT03199976|566256608|FG002|Overall Study|Lost to Follow-up|1|||
156862971|NCT01761877|566256609|FG000|Overall Study|Adverse Event|7|||
156862972|NCT01761877|566256610|FG001|Overall Study|Adverse Event|0|||
156862973|NCT01761877|566256609|FG000|Overall Study|Withdrawal by Subject|6|||
156862974|NCT01761877|566256610|FG001|Overall Study|Withdrawal by Subject|4|||
156862975|NCT01761877|566256609|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
156862976|NCT01761877|566256610|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
156862977|NCT01761877|566256609|FG000|Overall Study|Death|0|||
156862978|NCT01761877|566256610|FG001|Overall Study|Death|1|||
156862979|NCT01761877|566256609|FG000|Overall Study|MRI intolerant|1|||
156862980|NCT01761877|566256610|FG001|Overall Study|MRI intolerant|6|||
156862981|NCT00003475|566256612|FG000|Overall Study|Not evaluable|13|||
156862982|NCT03962491|566256613|FG000|Overall Study|Lost to Follow-up|4|||
156862983|NCT03962491|566256614|FG001|Overall Study|Lost to Follow-up|5|||
156862984|NCT03697252|566256621|FG000|Overall Study|Adverse Event|3|||
156862985|NCT03697252|566256622|FG001|Overall Study|Adverse Event|2|||
156862986|NCT03697252|566256621|FG000|Overall Study|Withdrawal by Subject|14|||
156862987|NCT03697252|566256622|FG001|Overall Study|Withdrawal by Subject|14|||
156862988|NCT03697252|566256621|FG000|Overall Study|Lost to Follow-up|0|||
156862989|NCT03697252|566256622|FG001|Overall Study|Lost to Follow-up|1|||
156862990|NCT03697252|566256621|FG000|Overall Study|Physician Decision|1|||
156862991|NCT03697252|566256622|FG001|Overall Study|Physician Decision|1|||
156862992|NCT03697252|566256621|FG000|Overall Study|Other|0|||
156862993|NCT03697252|566256622|FG001|Overall Study|Other|1|||
156862994|NCT00106704|566256623|FG000|Overall Study|Adverse Event|10|||
156862995|NCT00106704|566256624|FG001|Overall Study|Adverse Event|7|||
156862996|NCT00106704|566256623|FG000|Overall Study|Death|2|||
156862997|NCT00106704|566256624|FG001|Overall Study|Death|1|||
156862998|NCT00106704|566256623|FG000|Overall Study|Lack of Efficacy|67|||
156862999|NCT00106704|566256624|FG001|Overall Study|Lack of Efficacy|69|||
156863000|NCT00106704|566256623|FG000|Overall Study|Lost to Follow-up|7|||
156863001|NCT00106704|566256624|FG001|Overall Study|Lost to Follow-up|3|||
156863002|NCT00106704|566256623|FG000|Overall Study|Pregnancy|1|||
156863003|NCT00106704|566256624|FG001|Overall Study|Pregnancy|0|||
156863004|NCT00106704|566256623|FG000|Overall Study|Protocol Violation|4|||
156863005|NCT00106704|566256624|FG001|Overall Study|Protocol Violation|7|||
156863006|NCT00106704|566256623|FG000|Overall Study|Withdrawal by Subject|14|||
156863007|NCT00106704|566256624|FG001|Overall Study|Withdrawal by Subject|21|||
156863008|NCT00106704|566256623|FG000|Overall Study|Patient moved|1|||
156863009|NCT00106704|566256624|FG001|Overall Study|Patient moved|0|||
156863010|NCT00106704|566256623|FG000|Overall Study|Site terminated|0|||
156863011|NCT00106704|566256624|FG001|Overall Study|Site terminated|1|||
156863012|NCT00106704|566256623|FG000|Overall Study|Planned major surgery|1|||
156863013|NCT00106704|566256624|FG001|Overall Study|Planned major surgery|0|||
156863014|NCT00106704|566256623|FG000|Overall Study|Patient Received Glycemic Medication|22|||
156863015|NCT00106704|566256624|FG001|Overall Study|Patient Received Glycemic Medication|41|||
156863016|NCT00106704|566256623|FG000|Overall Study|Unable to re-enter US|1|||
156863017|NCT00106704|566256624|FG001|Overall Study|Unable to re-enter US|0|||
156863018|NCT00106704|566256623|FG000|Overall Study|Laboratory test|1|||
156863019|NCT00106704|566256624|FG001|Overall Study|Laboratory test|1|||
156863020|NCT01780506|566256625|FG000|Double-Blind Phase|Randomized but not Treated|3|||
156863021|NCT01780506|566256626|FG001|Double-Blind Phase|Randomized but not Treated|2|||
156863022|NCT01780506|566256625|FG000|Double-Blind Phase|Adverse Event|4|||
156863023|NCT01780506|566256626|FG001|Double-Blind Phase|Adverse Event|14|||
156863024|NCT01780506|566256625|FG000|Double-Blind Phase|Death|1|||
156863025|NCT01780506|566256626|FG001|Double-Blind Phase|Death|2|||
157225812|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
156863026|NCT01780506|566256625|FG000|Double-Blind Phase|Pregnancy|2|||
156863027|NCT01780506|566256626|FG001|Double-Blind Phase|Pregnancy|1|||
156863028|NCT01780506|566256625|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156863029|NCT01780506|566256626|FG001|Double-Blind Phase|Lack of Efficacy|1|||
156863030|NCT01780506|566256625|FG000|Double-Blind Phase|Investigator's Discretion|5|||
156863031|NCT01780506|566256626|FG001|Double-Blind Phase|Investigator's Discretion|2|||
156863032|NCT01780506|566256625|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
156863033|NCT01780506|566256626|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
156863034|NCT01780506|566256625|FG000|Double-Blind Phase|Protocol Violation|4|||
156863035|NCT01780506|566256626|FG001|Double-Blind Phase|Protocol Violation|3|||
156863036|NCT01780506|566256625|FG000|Double-Blind Phase|Withdrew Consent|23|||
156863037|NCT01780506|566256626|FG001|Double-Blind Phase|Withdrew Consent|24|||
156863038|NCT01780506|566256625|FG000|Double-Blind Phase|Lost to Follow-up|23|||
156913152|NCT00540514|566442371|FG000|Overall Study|Lost to Follow-up|1|||
156913153|NCT00540514|566442372|FG001|Overall Study|Lost to Follow-up|1|||
156863039|NCT01780506|566256626|FG001|Double-Blind Phase|Lost to Follow-up|26|||
156863040|NCT01780506|566256625|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
156863041|NCT01780506|566256626|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
156863042|NCT00412984|566256631|FG000|Overall Study|Death|331|||
156863043|NCT00412984|566256632|FG001|Overall Study|Death|349|||
156863044|NCT00412984|566256631|FG000|Overall Study|Adverse Event|679|||
157160985|NCT02435277|567331640|FG002|Overall Study|Adverse Event|0|||
157160986|NCT02435277|567331641|FG003|Overall Study|Adverse Event|0|||
157160987|NCT02435277|567331638|FG000|Overall Study|Withdrawal by Subject|1|||
157160988|NCT02435277|567331639|FG001|Overall Study|Withdrawal by Subject|0|||
156863045|NCT00412984|566256632|FG001|Overall Study|Adverse Event|738|||
156863046|NCT00412984|566256631|FG000|Overall Study|Withdrawal by Subject|921|||
156863047|NCT00412984|566256632|FG001|Overall Study|Withdrawal by Subject|989|||
156863048|NCT00412984|566256631|FG000|Overall Study|Lost to Follow-up|51|||
157160989|NCT02435277|567331640|FG002|Overall Study|Withdrawal by Subject|0|||
157160990|NCT02435277|567331641|FG003|Overall Study|Withdrawal by Subject|0|||
157160991|NCT00786032|567332929|FG000|Overall Study|Death|4|||
157160992|NCT00786032|567332929|FG000|Overall Study|Withdrawal by Subject|14|||
157160993|NCT00786032|567332929|FG000|Overall Study|Did not complete in the timeframe|6|||
157160994|NCT02457182|567332930|FG000|Overall Study|Lost to Follow-up|1|||
157160995|NCT02457182|567332931|FG001|Overall Study|Lost to Follow-up|0|||
157160996|NCT00165841|567332934|FG000|Overall Study|Adverse Event|2|||
157160997|NCT00165841|567332935|FG001|Overall Study|Adverse Event|3|||
157160998|NCT00165841|567332934|FG000|Overall Study|Lack of Efficacy|6|||
157160999|NCT00165841|567332935|FG001|Overall Study|Lack of Efficacy|33|||
157161000|NCT00165841|567332934|FG000|Overall Study|Lost to Follow-up|4|||
157161001|NCT00165841|567332935|FG001|Overall Study|Lost to Follow-up|4|||
157161002|NCT00165841|567332934|FG000|Overall Study|Withdrawal by Subject|7|||
157161003|NCT00165841|567332935|FG001|Overall Study|Withdrawal by Subject|8|||
157161004|NCT00165841|567332934|FG000|Overall Study|Physician Decision|1|||
157161005|NCT00165841|567332935|FG001|Overall Study|Physician Decision|0|||
157161006|NCT00165841|567332934|FG000|Overall Study|Protocol Violation|6|||
157161007|NCT00165841|567332935|FG001|Overall Study|Protocol Violation|8|||
157161008|NCT00165841|567332934|FG000|Overall Study|Other|3|||
157161009|NCT00165841|567332935|FG001|Overall Study|Other|5|||
157161010|NCT00165841|567332934|FG000|Overall Study|Medication Noncompliance|1|||
157161011|NCT00165841|567332935|FG001|Overall Study|Medication Noncompliance|1|||
157161012|NCT01000727|567332938|FG000|Overall Study|Lost to Follow-up|41|||
157161013|NCT01000727|567332939|FG001|Overall Study|Lost to Follow-up|43|||
157161014|NCT01000727|567332938|FG000|Overall Study|Withdrawal by Subject|111|||
157161015|NCT01000727|567332939|FG001|Overall Study|Withdrawal by Subject|109|||
156863049|NCT00412984|566256632|FG001|Overall Study|Lost to Follow-up|39|||
156863050|NCT00412984|566256631|FG000|Overall Study|Poor/Noncompliance|57|||
156863051|NCT00412984|566256632|FG001|Overall Study|Poor/Noncompliance|77|||
156863052|NCT00412984|566256631|FG000|Overall Study|Pregnancy|1|||
156863053|NCT00412984|566256632|FG001|Overall Study|Pregnancy|0|||
156863054|NCT00412984|566256631|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
157027568|NCT04625465|566856165|FG006|Overall Study|Withdrawal by Subject|0|||
157027569|NCT04625465|566856166|FG007|Overall Study|Withdrawal by Subject|0|||
157027570|NCT05566639|566856169|FG000|Overall Study|Adverse Event|1|||
157161016|NCT01000727|567332938|FG000|Overall Study|Study closed/terminated|23|||
157225813|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
156863055|NCT00412984|566256632|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
156863056|NCT00412984|566256631|FG000|Overall Study|Administrative Reason by Sponsor|11|||
156863057|NCT00412984|566256632|FG001|Overall Study|Administrative Reason by Sponsor|8|||
156863058|NCT00412984|566256631|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
156863059|NCT00412984|566256632|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
156863060|NCT00412984|566256631|FG000|Overall Study|Other Reason|80|||
156863061|NCT00412984|566256632|FG001|Overall Study|Other Reason|92|||
156863062|NCT00412984|566256631|FG000|Overall Study|Not Reported|11|||
156863063|NCT00412984|566256632|FG001|Overall Study|Not Reported|12|||
156863064|NCT04097678|566256633|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
156863065|NCT04097678|566256634|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
156863066|NCT03694678|566256635|FG000|Overall Study|Withdrawal by Subject|2|||
156863067|NCT03694678|566256636|FG001|Overall Study|Withdrawal by Subject|0|||
156863068|NCT03694678|566256635|FG000|Overall Study|Lost to Follow-up|2|||
156863069|NCT03694678|566256636|FG001|Overall Study|Lost to Follow-up|3|||
157161017|NCT01000727|567332939|FG001|Overall Study|Study closed/terminated|24|||
157161018|NCT03196193|567332940|FG000|Overall Study|Adverse Event|1|||
157161019|NCT03196193|567332941|FG001|Overall Study|Adverse Event|0|||
157161020|NCT03196193|567332940|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
157225814|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
156863070|NCT02435212|566256637|FG000|Core Phase|Adverse Event|8|||
156863071|NCT02435212|566256638|FG001|Core Phase|Adverse Event|5|||
156863072|NCT02435212|566256637|FG000|Core Phase|Withdrawal by Subject|3|||
157027571|NCT05566639|566856170|FG001|Overall Study|Adverse Event|1|||
156863073|NCT02435212|566256638|FG001|Core Phase|Withdrawal by Subject|0|||
156863074|NCT02435212|566256637|FG000|Core Phase|Withdrawal by parent/guardian|9|||
156863075|NCT02435212|566256638|FG001|Core Phase|Withdrawal by parent/guardian|4|||
156863076|NCT02435212|566256637|FG000|Core Phase|Protocol Violation|1|||
156863077|NCT02435212|566256638|FG001|Core Phase|Protocol Violation|2|||
156863078|NCT02435212|566256637|FG000|Core Phase|Physician Decision|3|||
156863079|NCT02435212|566256638|FG001|Core Phase|Physician Decision|0|||
156863080|NCT02435212|566256637|FG000|Core Phase|Lost to Follow-up|0|||
156863081|NCT02435212|566256638|FG001|Core Phase|Lost to Follow-up|1|||
156863082|NCT02435212|566256637|FG000|Core Phase|Lack of Efficacy|0|||
156863083|NCT02435212|566256638|FG001|Core Phase|Lack of Efficacy|1|||
156863084|NCT02435212|566256637|FG000|Core Phase|Recovery|1|||
156863085|NCT02435212|566256638|FG001|Core Phase|Recovery|0|||
156863086|NCT02435212|566256637|FG000|Optional Extension Phase|Adverse Event|3|||
156863087|NCT02435212|566256638|FG001|Optional Extension Phase|Adverse Event|9|||
156863088|NCT02435212|566256637|FG000|Optional Extension Phase|Physician Decision|6|||
156863089|NCT02435212|566256638|FG001|Optional Extension Phase|Physician Decision|8|||
156863090|NCT02435212|566256637|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
156863091|NCT02435212|566256638|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
156863092|NCT02435212|566256637|FG000|Optional Extension Phase|Lack of Efficacy|2|||
156863093|NCT02435212|566256638|FG001|Optional Extension Phase|Lack of Efficacy|3|||
156863094|NCT02435212|566256637|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
156863095|NCT02435212|566256638|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
156863096|NCT02435212|566256637|FG000|Optional Extension Phase|Protocol Violation|0|||
156863097|NCT02435212|566256638|FG001|Optional Extension Phase|Protocol Violation|1|||
156863098|NCT02435212|566256637|FG000|Optional Extension Phase|Recovery|1|||
156863099|NCT02435212|566256638|FG001|Optional Extension Phase|Recovery|1|||
156863100|NCT02435212|566256637|FG000|Optional Extension Phase|Death|1|||
156863101|NCT02435212|566256638|FG001|Optional Extension Phase|Death|0|||
156863102|NCT02435212|566256637|FG000|Optional Extension Phase|Technical problems|2|||
156863103|NCT02435212|566256638|FG001|Optional Extension Phase|Technical problems|0|||
156863104|NCT04852302|566256639|FG000|Overall Study|Withdrawal by Subject|2|||
156863105|NCT04852302|566256639|FG000|Overall Study|Did not complete CALM therapy.|2|||
156863106|NCT04711850|566256640|FG000|Overall Study|Graft loss|2|||
156863107|NCT04711850|566256641|FG001|Overall Study|Graft loss|1|||
156863108|NCT04711850|566256640|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
156863109|NCT04711850|566256641|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
156863110|NCT04711850|566256640|FG000|Overall Study|Study terminated by sponsor|5|||
156863111|NCT04711850|566256641|FG001|Overall Study|Study terminated by sponsor|3|||
156863112|NCT04711850|566256640|FG000|Overall Study|Sponsor decision|0|||
156863113|NCT04711850|566256641|FG001|Overall Study|Sponsor decision|2|||
156863114|NCT05249582|566256642|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
156863115|NCT05249582|566256643|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
156863116|NCT05249582|566256642|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
156863117|NCT05249582|566256643|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
156863118|NCT05249582|566256642|FG000|Overall Study|Declined to use virtual reality headset|1|||
156863119|NCT05249582|566256643|FG001|Overall Study|Declined to use virtual reality headset|0|||
156863120|NCT02718898|566256647|FG000|Blinded Treatment Period|Adverse Event|5|||
156863121|NCT02718898|566256648|FG001|Blinded Treatment Period|Adverse Event|1|||
156863122|NCT02718898|566256649|FG002|Blinded Treatment Period|Adverse Event|0|||
156863123|NCT02718898|566256650|FG003|Blinded Treatment Period|Adverse Event|0|||
156863124|NCT02718898|566256651|FG004|Blinded Treatment Period|Adverse Event|0|||
156863125|NCT02718898|566256652|FG005|Blinded Treatment Period|Adverse Event|0|||
156863126|NCT02718898|566256653|FG006|Blinded Treatment Period|Adverse Event|0|||
156863127|NCT02718898|566256647|FG000|Blinded Treatment Period|Physician Decision|1|||
156863128|NCT02718898|566256648|FG001|Blinded Treatment Period|Physician Decision|0|||
156863129|NCT02718898|566256649|FG002|Blinded Treatment Period|Physician Decision|0|||
156863130|NCT02718898|566256650|FG003|Blinded Treatment Period|Physician Decision|0|||
156863131|NCT02718898|566256651|FG004|Blinded Treatment Period|Physician Decision|0|||
156863132|NCT02718898|566256652|FG005|Blinded Treatment Period|Physician Decision|0|||
156863133|NCT02718898|566256653|FG006|Blinded Treatment Period|Physician Decision|0|||
156863134|NCT02718898|566256647|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
156863135|NCT02718898|566256648|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
156863136|NCT02718898|566256649|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
156863137|NCT02718898|566256650|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
156863138|NCT02718898|566256651|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
156863139|NCT02718898|566256652|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
156863140|NCT02718898|566256653|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
156863141|NCT02718898|566256647|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
156863142|NCT02718898|566256648|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
156863143|NCT02718898|566256649|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
156863144|NCT02718898|566256650|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
156863145|NCT02718898|566256651|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
156863146|NCT02718898|566256652|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
157225815|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
157225816|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
157225817|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
157225818|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
157225819|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
157225820|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
157225821|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
156863147|NCT02718898|566256653|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
156863148|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863149|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863150|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
156863151|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
156863152|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863153|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863154|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
156863155|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156863156|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
157161021|NCT03196193|567332941|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
157161022|NCT01026389|567332945|FG000|Overall Study|Withdrawal by Subject|1|||
157161023|NCT01026389|567332946|FG001|Overall Study|Withdrawal by Subject|3|||
157161024|NCT01026389|567332945|FG000|Overall Study|change of treatment, patient moved|4|||
157161025|NCT01026389|567332946|FG001|Overall Study|change of treatment, patient moved|2|||
157161026|NCT01697267|567332947|FG000|Overall Study|Death|3|||
157161027|NCT01697267|567332948|FG001|Overall Study|Death|1|||
157161028|NCT01697267|567332947|FG000|Overall Study|Withdrawal by Subject|5|||
157161029|NCT01697267|567332948|FG001|Overall Study|Withdrawal by Subject|5|||
157161030|NCT01697267|567332947|FG000|Overall Study|Adverse Event|2|||
157161031|NCT01697267|567332948|FG001|Overall Study|Adverse Event|1|||
157161032|NCT01697267|567332947|FG000|Overall Study|Lost to Follow-up|2|||
157161033|NCT01697267|567332948|FG001|Overall Study|Lost to Follow-up|4|||
157161034|NCT01697267|567332947|FG000|Overall Study|Physician Decision|2|||
157161035|NCT01697267|567332948|FG001|Overall Study|Physician Decision|4|||
157161036|NCT03544268|567332949|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
157161037|NCT03544268|567332950|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
157161038|NCT04410198|567332951|FG000|Overall Study|Death|10|||
157161039|NCT04410198|567332951|FG000|Overall Study|Withdrawal by Subject|7|||
157161040|NCT04410198|567332951|FG000|Overall Study|Transferred/Relocation|4|||
157161041|NCT04410198|567332951|FG000|Overall Study|Kidney Transplant|9|||
157161042|NCT04410198|567332951|FG000|Overall Study|Adverse Event|4|||
157161043|NCT04410198|567332951|FG000|Overall Study|Physician Decision|2|||
157161044|NCT04410198|567332951|FG000|Overall Study|Other than specified|1|||
157161045|NCT02006667|567332952|FG000|Overall Study|Adverse Event|3|||
157161046|NCT02006667|567332952|FG000|Overall Study|Death|2|||
157161047|NCT02006667|567332952|FG000|Overall Study|Withdrawal by Subject|1|||
157161048|NCT04831515|567332955|FG000|First Intervention|Adverse Event|0|||
157161049|NCT04831515|567332956|FG001|First Intervention|Adverse Event|1|||
157161050|NCT02338492|567332966|FG000|Overall Study|Death|32|||
157161051|NCT02338492|567332966|FG000|Overall Study|Adverse Event|3|||
157161052|NCT02338492|567332966|FG000|Overall Study|Lost to Follow-up|4|||
157161053|NCT02338492|567332966|FG000|Overall Study|Reason not captured above|6|||
157161054|NCT00174785|567332967|FG000|Overall Study|Adverse Event|293|||
157161055|NCT00174785|567332968|FG001|Overall Study|Adverse Event|191|||
157161056|NCT00174785|567332967|FG000|Overall Study|Protocol Violation|14|||
157161057|NCT00174785|567332968|FG001|Overall Study|Protocol Violation|14|||
157161058|NCT00174785|567332967|FG000|Overall Study|Withdrawal by Subject|173|||
157161059|NCT00174785|567332968|FG001|Overall Study|Withdrawal by Subject|175|||
157161060|NCT00174785|567332967|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
157161061|NCT00174785|567332968|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
157161062|NCT00174785|567332967|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
157161063|NCT00174785|567332968|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
157161064|NCT00174785|567332967|FG000|Overall Study|Other prohibited medication|5|||
157161065|NCT00174785|567332968|FG001|Overall Study|Other prohibited medication|3|||
157161066|NCT00174785|567332967|FG000|Overall Study|Family request|6|||
157161067|NCT00174785|567332968|FG001|Overall Study|Family request|8|||
157161068|NCT00174785|567332967|FG000|Overall Study|Not pre-specified/Not coded|56|||
156863157|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
157161069|NCT00174785|567332968|FG001|Overall Study|Not pre-specified/Not coded|70|||
157161070|NCT00120289|567332969|FG000|Overall Study|Death|96|||
157161071|NCT00120289|567332970|FG001|Overall Study|Death|82|||
157161072|NCT00120289|567332969|FG000|Overall Study|Lost to Follow-up|11|||
157161073|NCT00120289|567332970|FG001|Overall Study|Lost to Follow-up|14|||
157161074|NCT00120289|567332969|FG000|Overall Study|Withdrawal by Subject|14|||
157161075|NCT00120289|567332970|FG001|Overall Study|Withdrawal by Subject|13|||
157161076|NCT00511342|567332981|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
157225822|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
157225823|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
157225824|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
157225825|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
157225826|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
157225827|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
157225828|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
157225829|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
157225830|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
157225831|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
157225832|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
157225833|NCT02207231|567573361|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
157225834|NCT02207231|567573362|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
157225835|NCT02207231|567573363|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
157225836|NCT02207231|567573364|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
157225837|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
157225838|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
157225839|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
157225840|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
157225841|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
157225842|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
157225843|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
157225844|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
157225845|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
157225846|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
157225847|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
157225848|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
157225849|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
157225850|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
157225851|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
157225852|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
157225853|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
157161077|NCT00511342|567332982|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
157161078|NCT00511342|567332981|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
157161079|NCT00511342|567332982|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
157161080|NCT00511342|567332981|FG000|Overall Study|Pregnancy|0|||
157161081|NCT00511342|567332982|FG001|Overall Study|Pregnancy|1|||
157161082|NCT00511342|567332981|FG000|Overall Study|Pregnancy wish|0|||
157161083|NCT00511342|567332982|FG001|Overall Study|Pregnancy wish|1|||
157161084|NCT00511342|567332981|FG000|Overall Study|Lost to Follow-up|1|||
157161085|NCT00511342|567332982|FG001|Overall Study|Lost to Follow-up|5|||
157161086|NCT00511342|567332981|FG000|Overall Study|Other Reason|2|||
157161087|NCT00511342|567332982|FG001|Overall Study|Other Reason|2|||
157161088|NCT02432040|567332983|FG000|Overall Study|Lack of Efficacy|3|||
157161089|NCT02432040|567332984|FG001|Overall Study|Lack of Efficacy|0|||
157161090|NCT02432040|567332983|FG000|Overall Study|Lost to Follow-up|4|||
157161091|NCT02432040|567332984|FG001|Overall Study|Lost to Follow-up|5|||
157161092|NCT02432040|567332983|FG000|Overall Study|Physician Decision|1|||
157161093|NCT02432040|567332984|FG001|Overall Study|Physician Decision|1|||
157161094|NCT00608530|567332987|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
157161095|NCT00608530|567332988|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
157161096|NCT00608530|567332989|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
157161097|NCT00608530|567332990|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
157161098|NCT00608530|567332987|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
157161099|NCT00608530|567332988|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
157161100|NCT00608530|567332989|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
157161101|NCT00608530|567332990|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
157161102|NCT00608530|567332987|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
157161103|NCT00608530|567332988|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
157161104|NCT00608530|567332989|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
157161105|NCT00608530|567332990|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
157161106|NCT00608530|567332987|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
157225854|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
157225855|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
157225856|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
156863158|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
156863159|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
157161107|NCT00608530|567332988|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
156863160|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156863161|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
156863162|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863163|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863164|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
156863165|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
156863166|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863167|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863168|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
156863169|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863170|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863171|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
156863172|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
156863173|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863174|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863175|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
156863176|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863177|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863178|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863179|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
156863180|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863181|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863182|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
156863183|NCT02718898|566256647|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863184|NCT02718898|566256648|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863185|NCT02718898|566256649|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863186|NCT02718898|566256650|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
156863187|NCT02718898|566256651|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863188|NCT02718898|566256652|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863189|NCT02718898|566256653|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
156863190|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
157027572|NCT05566639|566856169|FG000|Overall Study|Serious Adverse Event|1|||
157027573|NCT05566639|566856170|FG001|Overall Study|Serious Adverse Event|3|||
157027574|NCT05566639|566856169|FG000|Overall Study|Death|44|||
157027575|NCT05566639|566856170|FG001|Overall Study|Death|45|||
157027576|NCT05566639|566856169|FG000|Overall Study|Lost to Follow-up|467|||
157027577|NCT05566639|566856170|FG001|Overall Study|Lost to Follow-up|461|||
157027578|NCT05566639|566856169|FG000|Overall Study|Physician Decision|45|||
157027579|NCT05566639|566856170|FG001|Overall Study|Physician Decision|44|||
157027580|NCT05566639|566856169|FG000|Overall Study|Protocol Deviation|4|||
157027581|NCT05566639|566856170|FG001|Overall Study|Protocol Deviation|4|||
157027582|NCT05566639|566856169|FG000|Overall Study|Withdrawal by Subject|277|||
157027583|NCT05566639|566856170|FG001|Overall Study|Withdrawal by Subject|271|||
157027584|NCT05566639|566856169|FG000|Overall Study|Other Than Specified|52|||
157027585|NCT05566639|566856170|FG001|Overall Study|Other Than Specified|64|||
157027586|NCT04054193|566856178|FG000|Cycle 1|Physician Decision|1|||
157027587|NCT04054193|566856178|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
157027588|NCT04054193|566856178|FG000|Cycle 1|Allocated but not treated|3|||
157027589|NCT04054193|566856178|FG000|Cycles 2-3|Physician Decision|2|||
157027590|NCT04054193|566856178|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
157027591|NCT04054193|566856178|FG000|Cycles 2-3|Various reasons|17|||
157027592|NCT02966873|566856179|FG000|Overall Study|Lost to Follow-up|16|||
157027593|NCT02966873|566856180|FG001|Overall Study|Lost to Follow-up|15|||
157027594|NCT00950742|566856186|FG000|Overall Study|Other Adverse Event|1|||
157027595|NCT00950742|566856187|FG001|Overall Study|Other Adverse Event|0|||
157027596|NCT00950742|566856186|FG000|Overall Study|Withdrawal by Subject|3|||
157027597|NCT00950742|566856187|FG001|Overall Study|Withdrawal by Subject|0|||
157027598|NCT00950742|566856186|FG000|Overall Study|Progressive Disease|6|||
157027599|NCT00950742|566856187|FG001|Overall Study|Progressive Disease|2|||
157027600|NCT00950742|566856186|FG000|Overall Study|Dose limiting toxicity|6|||
157027601|NCT00950742|566856187|FG001|Overall Study|Dose limiting toxicity|0|||
157027602|NCT05436262|566856189|FG000|Pre-Randomization|Withdrawal by Subject|1|||
157027603|NCT05436262|566856190|FG001|Pre-Randomization|Withdrawal by Subject|0|||
157161108|NCT00608530|567332989|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
157161109|NCT00608530|567332990|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
157027604|NCT05436262|566856191|FG002|Pre-Randomization|Withdrawal by Subject|0|||
157027605|NCT05436262|566856189|FG000|Randomization|Withdrawal by Subject|0|||
157027606|NCT05436262|566856190|FG001|Randomization|Withdrawal by Subject|1|||
157027607|NCT05436262|566856191|FG002|Randomization|Withdrawal by Subject|0|||
157027608|NCT01456949|566856192|FG000|Enrollment|PI death- incomplete data|6|||
157027609|NCT01456949|566856192|FG000|Enrollment|Death|1|||
157027610|NCT01456949|566856192|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
157161110|NCT00608530|567332987|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
157161111|NCT00608530|567332988|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
157161112|NCT00608530|567332989|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
157161113|NCT00608530|567332990|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
157161114|NCT00608530|567332987|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
157161115|NCT00608530|567332988|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
156863191|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
156863192|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
156863193|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
156863194|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
156863195|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
156863196|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
156863197|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863198|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863199|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
157027611|NCT01456949|566856192|FG000|Enrollment|Physician Decision|10|||
157027612|NCT01456949|566856192|FG000|Enrollment|Withdrawal by Subject|7|||
157027613|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
157027614|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
157027615|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
157027616|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
157027617|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
157027618|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
157027619|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
157027620|NCT01456949|566856192|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
157027621|NCT04753697|566856193|FG000|Induction Phase|Withdrawal by Subject|12|||
157027622|NCT04753697|566856194|FG001|Induction Phase|Withdrawal by Subject|5|||
157027623|NCT04753697|566856195|FG002|Induction Phase|Withdrawal by Subject|6|||
157027624|NCT04753697|566856193|FG000|Induction Phase|Physician Decision|1|||
157027625|NCT04753697|566856194|FG001|Induction Phase|Physician Decision|0|||
157027626|NCT04753697|566856195|FG002|Induction Phase|Physician Decision|0|||
157027627|NCT04753697|566856193|FG000|Induction Phase|Lost to Follow-up|2|||
157027628|NCT04753697|566856194|FG001|Induction Phase|Lost to Follow-up|2|||
157027629|NCT04753697|566856195|FG002|Induction Phase|Lost to Follow-up|1|||
157027630|NCT04753697|566856193|FG000|Induction Phase|Lack of Efficacy|1|||
157027631|NCT04753697|566856194|FG001|Induction Phase|Lack of Efficacy|0|||
157027632|NCT04753697|566856195|FG002|Induction Phase|Lack of Efficacy|0|||
157027633|NCT04753697|566856193|FG000|Maintenance Phase|Physician Decision|0|||
157027634|NCT04753697|566856194|FG001|Maintenance Phase|Physician Decision|0|||
157027635|NCT04753697|566856195|FG002|Maintenance Phase|Physician Decision|1|||
157027636|NCT04753697|566856193|FG000|Maintenance Phase|Withdrawal by Subject|3|||
157027637|NCT04753697|566856194|FG001|Maintenance Phase|Withdrawal by Subject|4|||
157027638|NCT04753697|566856195|FG002|Maintenance Phase|Withdrawal by Subject|6|||
157027639|NCT04753697|566856193|FG000|Maintenance Phase|Lost to Follow-up|2|||
157027640|NCT04753697|566856194|FG001|Maintenance Phase|Lost to Follow-up|2|||
157027641|NCT04753697|566856195|FG002|Maintenance Phase|Lost to Follow-up|0|||
157027642|NCT04753697|566856193|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
157027643|NCT04753697|566856194|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
157027644|NCT04753697|566856195|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
157027645|NCT04753697|566856193|FG000|Maintenance Phase|Adverse Event|0|||
157027646|NCT04753697|566856194|FG001|Maintenance Phase|Adverse Event|1|||
157027647|NCT04753697|566856195|FG002|Maintenance Phase|Adverse Event|1|||
157027648|NCT04753697|566856193|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
157027649|NCT04753697|566856194|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
157027650|NCT04753697|566856195|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
157027651|NCT04068181|566856198|FG000|Overall Study|Death|17|||
157027652|NCT04068181|566856199|FG001|Overall Study|Death|12|||
157161116|NCT00608530|567332989|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
157161117|NCT00608530|567332990|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
157161118|NCT00077610|567332991|FG000|Overall Study|Adverse Event|9|||
157161119|NCT00077610|567332992|FG001|Overall Study|Adverse Event|7|||
157161120|NCT00077610|567332993|FG002|Overall Study|Adverse Event|1|||
157161121|NCT00077610|567332991|FG000|Overall Study|Lost to Follow-up|0|||
157161122|NCT00077610|567332992|FG001|Overall Study|Lost to Follow-up|1|||
157161123|NCT00077610|567332993|FG002|Overall Study|Lost to Follow-up|2|||
157161124|NCT00077610|567332991|FG000|Overall Study|Withdrawal by Subject|4|||
157161125|NCT00077610|567332992|FG001|Overall Study|Withdrawal by Subject|10|||
157027653|NCT04068181|566856200|FG002|Overall Study|Death|4|||
157027654|NCT04068181|566856201|FG003|Overall Study|Death|7|||
157027655|NCT04068181|566856198|FG000|Overall Study|Lost to Follow-up|1|||
157027656|NCT04068181|566856199|FG001|Overall Study|Lost to Follow-up|0|||
157027657|NCT04068181|566856200|FG002|Overall Study|Lost to Follow-up|0|||
156863200|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
156863201|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
156863202|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
156863203|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
156863204|NCT02718898|566256647|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863205|NCT02718898|566256648|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863206|NCT02718898|566256649|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863207|NCT02718898|566256650|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863208|NCT02718898|566256651|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
156863209|NCT02718898|566256652|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
156863210|NCT02718898|566256653|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
156863211|NCT04011540|566256654|FG000|Overall Study|Lost to Follow-up|9|||
156863212|NCT04011540|566256655|FG001|Overall Study|Lost to Follow-up|6|||
156863213|NCT01339832|566256656|FG000|Overall Study|Lost to Follow-up|3|||
156863214|NCT01339832|566256656|FG000|Overall Study|Death|11|||
156863215|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
156863216|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
156863217|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
156863218|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
156863219|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
156863220|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
156863221|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
156863222|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
156863223|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
156863224|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
156863225|NCT01668784|566256671|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
156863226|NCT01668784|566256672|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
156863227|NCT01668784|566256671|FG000|Treatment Period|Disease Progression|316|||
156863228|NCT01668784|566256672|FG001|Treatment Period|Disease Progression|293|||
156863229|NCT01668784|566256671|FG000|Treatment Period|Study Drug Toxicity|46|||
156863230|NCT01668784|566256672|FG001|Treatment Period|Study Drug Toxicity|53|||
156863231|NCT01668784|566256671|FG000|Treatment Period|Death|1|||
156863232|NCT01668784|566256672|FG001|Treatment Period|Death|1|||
156863233|NCT01668784|566256671|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
156863234|NCT01668784|566256672|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
156863235|NCT01668784|566256671|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
156863236|NCT01668784|566256672|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
156863237|NCT01668784|566256671|FG000|Treatment Period|Withdrawal by Subject|5|||
156863238|NCT01668784|566256672|FG001|Treatment Period|Withdrawal by Subject|3|||
156863239|NCT01668784|566256671|FG000|Treatment Period|Maximal Clinical Benefit|3|||
156863240|NCT01668784|566256672|FG001|Treatment Period|Maximal Clinical Benefit|3|||
156863241|NCT01668784|566256671|FG000|Treatment Period|Other|2|||
156863242|NCT01668784|566256672|FG001|Treatment Period|Other|8|||
156863243|NCT01668784|566256671|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
156863244|NCT01668784|566256672|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
156863245|NCT02761330|566256673|FG000|Treatment Week 1|Withdrawal by Subject|0|||
156863246|NCT02761330|566256674|FG001|Treatment Week 1|Withdrawal by Subject|0|||
156863247|NCT02761330|566256675|FG002|Treatment Week 1|Withdrawal by Subject|0|||
156863248|NCT02761330|566256676|FG003|Treatment Week 1|Withdrawal by Subject|1|||
156863249|NCT02761330|566256677|FG004|Treatment Week 1|Withdrawal by Subject|0|||
156863250|NCT02761330|566256678|FG005|Treatment Week 1|Withdrawal by Subject|1|||
156863251|NCT05386329|566256679|FG000|Overall Study|Lost to Follow-up|3|||
156863252|NCT03341299|566256682|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863253|NCT03341299|566256683|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863254|NCT03341299|566256684|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
156863255|NCT03341299|566256685|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
156863256|NCT05967260|566256686|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
156863257|NCT05967260|566256687|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
156863258|NCT05565742|566256688|FG000|Overall Study|Withdrawal by Subject|0|||
156863259|NCT05565742|566256689|FG001|Overall Study|Withdrawal by Subject|0|||
156863260|NCT05565742|566256690|FG002|Overall Study|Withdrawal by Subject|2|||
156863261|NCT05565742|566256691|FG003|Overall Study|Withdrawal by Subject|2|||
156863262|NCT05565742|566256692|FG004|Overall Study|Withdrawal by Subject|2|||
156913154|NCT00540514|566442371|FG000|Overall Study|Withdrawal by Subject|65|||
156913155|NCT00540514|566442372|FG001|Overall Study|Withdrawal by Subject|67|||
156913156|NCT00540514|566442371|FG000|Overall Study|Excluded prior to treatment|7|||
156913157|NCT00540514|566442372|FG001|Overall Study|Excluded prior to treatment|7|||
156913158|NCT00540514|566442371|FG000|Overall Study|Paclitaxel not available|0|||
156913159|NCT00540514|566442372|FG001|Overall Study|Paclitaxel not available|2|||
156913160|NCT02891850|566442373|FG000|Overall Study|Adverse Event|3|||
157225857|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
157225858|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
157225859|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
157225860|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
157225861|NCT02207231|567573361|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
157225862|NCT02207231|567573362|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
157225863|NCT02207231|567573363|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
157225864|NCT02207231|567573364|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
157225865|NCT01290263|567573367|FG000|Overall Study|Adverse Event|0|||
157225866|NCT01290263|567573368|FG001|Overall Study|Adverse Event|0|||
157225867|NCT01290263|567573369|FG002|Overall Study|Adverse Event|0|||
157225868|NCT01290263|567573370|FG003|Overall Study|Adverse Event|1|||
157225869|NCT01290263|567573371|FG004|Overall Study|Adverse Event|1|||
157225870|NCT01290263|567573367|FG000|Overall Study|Lack of Efficacy|8|||
157225871|NCT01290263|567573368|FG001|Overall Study|Lack of Efficacy|2|||
157225872|NCT01290263|567573369|FG002|Overall Study|Lack of Efficacy|7|||
157225873|NCT01290263|567573370|FG003|Overall Study|Lack of Efficacy|24|||
156863263|NCT05565742|566256688|FG000|Overall Study|Death|1|||
156863264|NCT05565742|566256689|FG001|Overall Study|Death|0|||
156863265|NCT05565742|566256690|FG002|Overall Study|Death|0|||
156863266|NCT05565742|566256691|FG003|Overall Study|Death|0|||
156863267|NCT05565742|566256692|FG004|Overall Study|Death|0|||
156863268|NCT05565742|566256688|FG000|Overall Study|Participant Travelled Abroad|0|||
156863269|NCT05565742|566256689|FG001|Overall Study|Participant Travelled Abroad|0|||
156863270|NCT05565742|566256690|FG002|Overall Study|Participant Travelled Abroad|0|||
156863271|NCT05565742|566256691|FG003|Overall Study|Participant Travelled Abroad|0|||
156863272|NCT05565742|566256692|FG004|Overall Study|Participant Travelled Abroad|1|||
156863273|NCT04163341|566256693|FG000|Overall Study|Withdrawal by Subject|2|||
156863274|NCT04163341|566256694|FG001|Overall Study|Withdrawal by Subject|0|||
156863275|NCT04163341|566256693|FG000|Overall Study|Lost to Follow-up|3|||
156863276|NCT04163341|566256694|FG001|Overall Study|Lost to Follow-up|4|||
156863277|NCT01615939|566258593|FG000|Overall Study|Lost to Follow-up|5|||
156863278|NCT01615939|566258594|FG001|Overall Study|Lost to Follow-up|0|||
156863279|NCT01586364|566258598|FG000|Overall Study|Withdrawal by Subject|40|||
156863280|NCT01586364|566258598|FG000|Overall Study|Adverse Event|37|||
156863281|NCT01586364|566258598|FG000|Overall Study|Lost to Follow-up|17|||
156863282|NCT01586364|566258598|FG000|Overall Study|Protocol Violation|16|||
156863283|NCT01586364|566258598|FG000|Overall Study|Lack of Efficacy|1|||
156863284|NCT01586364|566258598|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
156863285|NCT01586364|566258598|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
156863286|NCT01586364|566258598|FG000|Overall Study|Other-Site closure due to PI illness|1|||
156863287|NCT01586364|566258598|FG000|Overall Study|Other-PI discretion, site closing|2|||
156863288|NCT01586364|566258598|FG000|Overall Study|Other-Not specified|1|||
156863289|NCT02121535|566258599|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
156863290|NCT02121535|566258600|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
156863291|NCT02121535|566258599|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
156863292|NCT02121535|566258600|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
156863293|NCT04944992|566258601|FG000|Overall Study|Lost to Follow-up|1|||
156863294|NCT04944992|566258602|FG001|Overall Study|Lost to Follow-up|1|||
156863295|NCT04944992|566258601|FG000|Overall Study|Physician Decision|1|||
156863296|NCT04944992|566258602|FG001|Overall Study|Physician Decision|0|||
156863297|NCT04944992|566258601|FG000|Overall Study|Withdrawal by Subject|6|||
156863298|NCT04944992|566258602|FG001|Overall Study|Withdrawal by Subject|1|||
156863299|NCT00091949|566258603|FG000|Overall Study|Withdrawal by Subject|117|||
156863300|NCT00091949|566258604|FG001|Overall Study|Withdrawal by Subject|110|||
156863301|NCT00091949|566258603|FG000|Overall Study|Lost to Follow-up|58|||
156863302|NCT00091949|566258604|FG001|Overall Study|Lost to Follow-up|41|||
156863303|NCT05366738|566258606|FG000|Overall Study|Adverse Event|0|||
156863304|NCT05366738|566258607|FG001|Overall Study|Adverse Event|1|||
156863305|NCT05366738|566258608|FG002|Overall Study|Adverse Event|0|||
156863306|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
156863307|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
156863308|NCT00335777|566258609|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
156863309|NCT00335777|566258609|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
156863310|NCT00335777|566258609|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
156863311|NCT00535496|566258616|FG000|Overall Study|Lost to Follow-up|0|||
156863312|NCT00535496|566258617|FG001|Overall Study|Lost to Follow-up|1|||
156863313|NCT00535496|566258618|FG002|Overall Study|Lost to Follow-up|0|||
156863314|NCT00535496|566258619|FG003|Overall Study|Lost to Follow-up|0|||
156863315|NCT00535496|566258616|FG000|Overall Study|Not treated with sugammadex|0|||
157225874|NCT01290263|567573371|FG004|Overall Study|Lack of Efficacy|33|||
157225875|NCT01290263|567573367|FG000|Overall Study|Withdrawal by Subject|3|||
157225876|NCT01290263|567573368|FG001|Overall Study|Withdrawal by Subject|1|||
157225877|NCT01290263|567573369|FG002|Overall Study|Withdrawal by Subject|0|||
157225878|NCT01290263|567573370|FG003|Overall Study|Withdrawal by Subject|1|||
156863316|NCT00535496|566258617|FG001|Overall Study|Not treated with sugammadex|1|||
156863317|NCT00535496|566258618|FG002|Overall Study|Not treated with sugammadex|0|||
156863318|NCT00535496|566258619|FG003|Overall Study|Not treated with sugammadex|0|||
156863319|NCT05024032|566258622|FG000|Overall Study|Withdrawal by Subject|0|||
156863320|NCT05024032|566258623|FG001|Overall Study|Withdrawal by Subject|3|||
156863321|NCT05024032|566258624|FG002|Overall Study|Withdrawal by Subject|4|||
157161126|NCT00077610|567332993|FG002|Overall Study|Withdrawal by Subject|6|||
157161127|NCT00077610|567332991|FG000|Overall Study|Death|17|||
157161128|NCT00077610|567332992|FG001|Overall Study|Death|13|||
157161129|NCT00077610|567332993|FG002|Overall Study|Death|13|||
157161130|NCT00077610|567332991|FG000|Overall Study|Renal transplant|12|||
157161131|NCT00077610|567332992|FG001|Overall Study|Renal transplant|15|||
157161132|NCT00077610|567332993|FG002|Overall Study|Renal transplant|11|||
157161133|NCT00077610|567332991|FG000|Overall Study|Withdrew from dialysis care|5|||
157161134|NCT00077610|567332992|FG001|Overall Study|Withdrew from dialysis care|0|||
157161135|NCT00077610|567332993|FG002|Overall Study|Withdrew from dialysis care|3|||
157161136|NCT00077610|567332991|FG000|Overall Study|Insufficient Therapeutic Response|1|||
157161137|NCT00077610|567332992|FG001|Overall Study|Insufficient Therapeutic Response|0|||
157161138|NCT00077610|567332993|FG002|Overall Study|Insufficient Therapeutic Response|0|||
157161139|NCT00077610|567332991|FG000|Overall Study|Multiple blood transfusions|0|||
157161140|NCT00077610|567332992|FG001|Overall Study|Multiple blood transfusions|0|||
157161141|NCT00077610|567332993|FG002|Overall Study|Multiple blood transfusions|1|||
157161142|NCT00077610|567332991|FG000|Overall Study|Principal Investigator's decision|1|||
157161143|NCT00077610|567332992|FG001|Overall Study|Principal Investigator's decision|0|||
157161144|NCT00077610|567332993|FG002|Overall Study|Principal Investigator's decision|1|||
157161145|NCT00077610|567332991|FG000|Overall Study|Worsening of health condition|1|||
157161146|NCT00077610|567332992|FG001|Overall Study|Worsening of health condition|1|||
157161147|NCT00077610|567332993|FG002|Overall Study|Worsening of health condition|0|||
157161148|NCT00077610|567332991|FG000|Overall Study|Given Epogen in hospital|1|||
157161149|NCT00077610|567332992|FG001|Overall Study|Given Epogen in hospital|0|||
157161150|NCT00077610|567332993|FG002|Overall Study|Given Epogen in hospital|0|||
157161151|NCT00077610|567332991|FG000|Overall Study|Transferred to other unit|0|||
157161152|NCT00077610|567332992|FG001|Overall Study|Transferred to other unit|0|||
157161153|NCT00077610|567332993|FG002|Overall Study|Transferred to other unit|1|||
156863322|NCT05024032|566258622|FG000|Overall Study|Adverse Event|0|||
156863323|NCT05024032|566258623|FG001|Overall Study|Adverse Event|1|||
156863324|NCT05024032|566258624|FG002|Overall Study|Adverse Event|0|||
156863325|NCT05024032|566258622|FG000|Overall Study|Protocol Deviation|1|||
156863326|NCT05024032|566258623|FG001|Overall Study|Protocol Deviation|0|||
156863327|NCT05024032|566258624|FG002|Overall Study|Protocol Deviation|0|||
156863328|NCT01209689|566258625|FG000|Overall Study|Insufficient Therapeutic Response|7|||
156863329|NCT01209689|566258626|FG001|Overall Study|Insufficient Therapeutic Response|2|||
156863330|NCT01209689|566258625|FG000|Overall Study|Refused Treatment|8|||
156863331|NCT01209689|566258626|FG001|Overall Study|Refused Treatment|3|||
156863332|NCT01209689|566258625|FG000|Overall Study|Adverse Event|4|||
156863333|NCT01209689|566258626|FG001|Overall Study|Adverse Event|0|||
156863334|NCT01209689|566258625|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156863335|NCT01209689|566258626|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156863336|NCT01209689|566258625|FG000|Overall Study|Failure to Return|3|||
157161154|NCT00077610|567332991|FG000|Overall Study|Transferred to nursing home|0|||
157161155|NCT00077610|567332992|FG001|Overall Study|Transferred to nursing home|0|||
157161156|NCT00077610|567332993|FG002|Overall Study|Transferred to nursing home|1|||
157161157|NCT00077610|567332991|FG000|Overall Study|Transfer to satellite unit|1|||
157161158|NCT00077610|567332992|FG001|Overall Study|Transfer to satellite unit|0|||
157161159|NCT00077610|567332993|FG002|Overall Study|Transfer to satellite unit|0|||
157161160|NCT00077610|567332991|FG000|Overall Study|Transfer to other center for surgery|1|||
157161161|NCT00077610|567332992|FG001|Overall Study|Transfer to other center for surgery|0|||
157161162|NCT00077610|567332993|FG002|Overall Study|Transfer to other center for surgery|0|||
157161163|NCT00077610|567332991|FG000|Overall Study|Change in dialysis modality|1|||
157161164|NCT00077610|567332992|FG001|Overall Study|Change in dialysis modality|0|||
157161165|NCT00077610|567332993|FG002|Overall Study|Change in dialysis modality|0|||
157161166|NCT00077610|567332991|FG000|Overall Study|Relocation|0|||
157161167|NCT00077610|567332992|FG001|Overall Study|Relocation|8|||
157161168|NCT00077610|567332993|FG002|Overall Study|Relocation|5|||
157161169|NCT00077610|567332991|FG000|Overall Study|Financial issues|0|||
157161170|NCT00077610|567332992|FG001|Overall Study|Financial issues|1|||
157161171|NCT00077610|567332993|FG002|Overall Study|Financial issues|0|||
157161172|NCT00077610|567332991|FG000|Overall Study|Sponsors decision to withdraw|0|||
157161173|NCT00077610|567332992|FG001|Overall Study|Sponsors decision to withdraw|0|||
157161174|NCT00077610|567332993|FG002|Overall Study|Sponsors decision to withdraw|1|||
156863337|NCT01209689|566258626|FG001|Overall Study|Failure to Return|0|||
156863338|NCT01209689|566258625|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
157161175|NCT01153763|567332997|FG000|Overall Study|Study Closed|16|||
157161176|NCT01153763|567332997|FG000|Overall Study|Lost to Follow-up|1|||
157161177|NCT01153763|567332997|FG000|Overall Study|Physician Decision|2|||
157161178|NCT01153763|567332997|FG000|Overall Study|Withdrawal by Subject|2|||
156913161|NCT02891850|566442374|FG001|Overall Study|Adverse Event|0|||
156913162|NCT02891850|566442373|FG000|Overall Study|Death|0|||
156913163|NCT02891850|566442374|FG001|Overall Study|Death|4|||
156913164|NCT02891850|566442373|FG000|Overall Study|Physician Decision|1|||
156913165|NCT02891850|566442374|FG001|Overall Study|Physician Decision|0|||
156913166|NCT02891850|566442373|FG000|Overall Study|Pregnancy|1|||
156913167|NCT02891850|566442374|FG001|Overall Study|Pregnancy|0|||
156913168|NCT02891850|566442373|FG000|Overall Study|Withdrawal by Subject|2|||
156913169|NCT02891850|566442374|FG001|Overall Study|Withdrawal by Subject|3|||
156913170|NCT02674529|566442375|FG000|Overall Study|Lost to Follow-up|1|||
156913171|NCT02674529|566442376|FG001|Overall Study|Lost to Follow-up|2|||
156913172|NCT02674529|566442375|FG000|Overall Study|Withdrawal by Subject|2|||
156913173|NCT02674529|566442376|FG001|Overall Study|Withdrawal by Subject|1|||
156913174|NCT02674529|566442375|FG000|Overall Study|Physician Decision|0|||
156913175|NCT02674529|566442376|FG001|Overall Study|Physician Decision|1|||
156913176|NCT02674529|566442375|FG000|Overall Study|Protocol Violation|0|||
156913177|NCT02674529|566442376|FG001|Overall Study|Protocol Violation|1|||
156913178|NCT01892293|566442383|FG000|Overall Study|Apheresed but not treated|4|||
157161179|NCT02841787|567333000|FG000|Overall Study|Lost to Follow-up|1|||
157161180|NCT02841787|567333001|FG001|Overall Study|Lost to Follow-up|0|||
157161181|NCT02841787|567333002|FG002|Overall Study|Lost to Follow-up|0|||
157161182|NCT02841787|567333000|FG000|Overall Study|Symptoms dropped below threshold|1|||
157161183|NCT02841787|567333001|FG001|Overall Study|Symptoms dropped below threshold|0|||
157161184|NCT02841787|567333002|FG002|Overall Study|Symptoms dropped below threshold|0|||
157161185|NCT02841787|567333000|FG000|Overall Study|Withdrawal by Subject|1|||
157161186|NCT02841787|567333001|FG001|Overall Study|Withdrawal by Subject|4|||
157161187|NCT02841787|567333002|FG002|Overall Study|Withdrawal by Subject|0|||
157161188|NCT01474746|567333003|FG000|Overall Study|Lost to Follow-up|1|||
157161189|NCT01474746|567333004|FG001|Overall Study|Lost to Follow-up|1|||
157161190|NCT01474746|567333003|FG000|Overall Study|Withdrawal by Subject|2|||
157161191|NCT01474746|567333004|FG001|Overall Study|Withdrawal by Subject|1|||
157161192|NCT01766336|567333008|FG000|Overall Study|Adverse Event|11|||
157161193|NCT01766336|567333009|FG001|Overall Study|Adverse Event|8|||
157161194|NCT01766336|567333008|FG000|Overall Study|Death|4|||
156913179|NCT03602482|566442384|FG000|Overall Study|Withdrawal by Subject|6|||
156913180|NCT03602482|566442385|FG001|Overall Study|Withdrawal by Subject|7|||
156913181|NCT03602482|566442386|FG002|Overall Study|Withdrawal by Subject|0|||
156913182|NCT03602482|566442387|FG003|Overall Study|Withdrawal by Subject|0|||
156913183|NCT01411774|566442394|FG000|Overall Study|Withdrawal by Subject|0|||
156913184|NCT01411774|566442395|FG001|Overall Study|Withdrawal by Subject|3|||
156913185|NCT03808545|566442396|FG000|Overall Study|Withdrawal by Subject|1|||
156913186|NCT03808545|566442397|FG001|Overall Study|Withdrawal by Subject|1|||
156913187|NCT00056316|566442398|FG000|Overall Study|Withdrawal by Subject|2|||
156913188|NCT00056316|566442399|FG001|Overall Study|Withdrawal by Subject|2|||
156913189|NCT00056316|566442398|FG000|Overall Study|Death/NH placement of pt|1|||
156913190|NCT00056316|566442399|FG001|Overall Study|Death/NH placement of pt|1|||
156913191|NCT01315678|566442402|FG000|Overall Study|Withdrawal by Subject|7|||
156913192|NCT01315678|566442403|FG001|Overall Study|Withdrawal by Subject|3|||
156913193|NCT01315678|566442402|FG000|Overall Study|Adverse Event|3|||
156913194|NCT01315678|566442403|FG001|Overall Study|Adverse Event|1|||
156913195|NCT01315678|566442402|FG000|Overall Study|Lost to Follow-up|1|||
156913196|NCT01315678|566442403|FG001|Overall Study|Lost to Follow-up|0|||
156913197|NCT01315678|566442402|FG000|Overall Study|similar reason to those listed above|3|||
156913198|NCT01315678|566442403|FG001|Overall Study|similar reason to those listed above|2|||
156913199|NCT00618072|566442412|FG000|Overall Study|Lost to Follow-up|2|||
156913200|NCT00618072|566442413|FG001|Overall Study|Lost to Follow-up|0|||
156913201|NCT00618072|566442414|FG002|Overall Study|Lost to Follow-up|3|||
157027658|NCT04068181|566856201|FG003|Overall Study|Lost to Follow-up|0|||
157027659|NCT04068181|566856198|FG000|Overall Study|Withdrawal of consent from study|3|||
157027660|NCT04068181|566856199|FG001|Overall Study|Withdrawal of consent from study|0|||
157161195|NCT01766336|567333009|FG001|Overall Study|Death|3|||
157161196|NCT01766336|567333008|FG000|Overall Study|Lost to Follow-up|1|||
157161197|NCT01766336|567333009|FG001|Overall Study|Lost to Follow-up|3|||
157161198|NCT01766336|567333008|FG000|Overall Study|Physician Decision|4|||
157161199|NCT01766336|567333009|FG001|Overall Study|Physician Decision|2|||
157161200|NCT01766336|567333008|FG000|Overall Study|Protocol Violation|0|||
157161201|NCT01766336|567333009|FG001|Overall Study|Protocol Violation|1|||
157161202|NCT01766336|567333008|FG000|Overall Study|Sponsor Decision|52|||
157161203|NCT01766336|567333009|FG001|Overall Study|Sponsor Decision|43|||
157161204|NCT01766336|567333008|FG000|Overall Study|Withdrawal by Subject|18|||
157161205|NCT01766336|567333009|FG001|Overall Study|Withdrawal by Subject|15|||
157161206|NCT03029650|567333010|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
156913202|NCT00618072|566442412|FG000|Overall Study|Physician Decision|0|||
156913203|NCT00618072|566442413|FG001|Overall Study|Physician Decision|1|||
156913204|NCT00618072|566442414|FG002|Overall Study|Physician Decision|1|||
157161207|NCT03029650|567333011|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
157161208|NCT03029650|567333010|FG000|Washout (1 Week)|Physician Decision|0|||
156913205|NCT03633695|566442415|FG000|Overall Study|Lost to Follow-up|4|||
157161209|NCT03029650|567333011|FG001|Washout (1 Week)|Physician Decision|1|||
157161210|NCT04544709|567333012|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
157161211|NCT03135028|567333013|FG000|Overall Study|Death|6|||
157161212|NCT03135028|567333013|FG000|Overall Study|Study Terminated by Sponsor|2|||
157161213|NCT03135028|567333013|FG000|Overall Study|Withdrew Consent|1|||
157161214|NCT02065869|567333014|FG000|Overall Study|Death|7|||
157161215|NCT02065869|567333014|FG000|Overall Study|Disease relapse|16|||
157161216|NCT02065869|567333014|FG000|Overall Study|Lost to Follow-up|4|||
157161217|NCT02065869|567333014|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
157161218|NCT02065869|567333014|FG000|Overall Study|Withdrawal by Subject|1|||
157161219|NCT01814800|567333017|FG000|Overall Study|Adverse Event|2|||
157161220|NCT01814800|567333017|FG000|Overall Study|Pregnancy|1|||
157161221|NCT01814800|567333017|FG000|Overall Study|Sponsor decision|1|||
157161222|NCT01814800|567333017|FG000|Overall Study|Subject relocation|1|||
157161223|NCT04436822|567333018|FG000|Overall Study|Physician Decision|2|||
157161224|NCT04436822|567333019|FG001|Overall Study|Physician Decision|0|||
157161225|NCT04436822|567333018|FG000|Overall Study|Sponsor request|1|||
157161226|NCT04436822|567333019|FG001|Overall Study|Sponsor request|0|||
157161227|NCT04436822|567333018|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157161228|NCT04436822|567333019|FG001|Overall Study|Withdrawal by parent/guardian|3|||
157161229|NCT04436822|567333018|FG000|Overall Study|Unsuccessful procedure|0|||
157161230|NCT04436822|567333019|FG001|Overall Study|Unsuccessful procedure|1|||
157161231|NCT04436822|567333018|FG000|Overall Study|Withdrawal due to Covid-19|8|||
157161232|NCT04436822|567333019|FG001|Overall Study|Withdrawal due to Covid-19|1|||
157161233|NCT04436822|567333018|FG000|Overall Study|Withdrawal by Subject|1|||
157161234|NCT04436822|567333019|FG001|Overall Study|Withdrawal by Subject|0|||
157161235|NCT04436822|567333018|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
157161236|NCT04436822|567333019|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
157161237|NCT03375112|567333020|FG000|Overall Study|Withdrawal by Subject|3|||
157161238|NCT03375112|567333021|FG001|Overall Study|Withdrawal by Subject|0|||
157161239|NCT03136185|567333022|FG000|Overall Study|Adverse Event|0|||
157161240|NCT03136185|567333023|FG001|Overall Study|Adverse Event|1|||
157161241|NCT03136185|567333024|FG002|Overall Study|Adverse Event|3|||
157161242|NCT03136185|567333025|FG003|Overall Study|Adverse Event|1|||
157161243|NCT03136185|567333026|FG004|Overall Study|Adverse Event|2|||
157161244|NCT03136185|567333027|FG005|Overall Study|Adverse Event|2|||
157161245|NCT03136185|567333028|FG006|Overall Study|Adverse Event|5|||
157161246|NCT03136185|567333029|FG007|Overall Study|Adverse Event|1|||
157161247|NCT03136185|567333030|FG008|Overall Study|Adverse Event|1|||
157161248|NCT03136185|567333022|FG000|Overall Study|Death|0|||
156913206|NCT03633695|566442416|FG001|Overall Study|Lost to Follow-up|5|||
156913207|NCT03633695|566442415|FG000|Overall Study|Discontinued|8|||
156913208|NCT03633695|566442416|FG001|Overall Study|Discontinued|4|||
156913209|NCT01104493|566442421|FG000|Overall Study|Lost to Follow-up|0|||
156913210|NCT01104493|566442422|FG001|Overall Study|Lost to Follow-up|2|||
156913211|NCT02511184|566442423|FG000|Overall Study|Death|1|||
156913212|NCT02511184|566442424|FG001|Overall Study|Death|0|||
156913213|NCT02511184|566442423|FG000|Overall Study|Lost to Follow-up|0|||
156913214|NCT02511184|566442424|FG001|Overall Study|Lost to Follow-up|1|||
156913215|NCT02511184|566442423|FG000|Overall Study|Study terminated by sponsor|1|||
156913216|NCT02511184|566442424|FG001|Overall Study|Study terminated by sponsor|5|||
156913217|NCT02511184|566442423|FG000|Overall Study|Withdrawal by Subject|0|||
156913218|NCT02511184|566442424|FG001|Overall Study|Withdrawal by Subject|1|||
156913219|NCT03902574|566442427|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
156913220|NCT03902574|566442428|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
156913221|NCT03902574|566442429|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
156913222|NCT05048784|566442439|FG000|Period 1|Adverse Event|3|||
156913223|NCT05048784|566442440|FG001|Period 1|Adverse Event|1|||
156913224|NCT05048784|566442441|FG002|Period 1|Adverse Event|0|||
156913225|NCT05048784|566442442|FG003|Period 1|Adverse Event|0|||
156913226|NCT05048784|566442439|FG000|Period 2|Lost to Follow-up|0|||
156913227|NCT05048784|566442440|FG001|Period 2|Lost to Follow-up|1|||
156913228|NCT05048784|566442441|FG002|Period 2|Lost to Follow-up|0|||
156913229|NCT05048784|566442442|FG003|Period 2|Lost to Follow-up|0|||
156913230|NCT02853604|566442447|FG000|Overall Study|Withdrawal by Subject|12|||
156913231|NCT02853604|566442448|FG001|Overall Study|Withdrawal by Subject|35|||
156913232|NCT02853604|566442447|FG000|Overall Study|Lost to Follow-up|4|||
157161249|NCT03136185|567333023|FG001|Overall Study|Death|0|||
157161250|NCT03136185|567333024|FG002|Overall Study|Death|0|||
157161251|NCT03136185|567333025|FG003|Overall Study|Death|1|||
157161252|NCT03136185|567333026|FG004|Overall Study|Death|1|||
157161253|NCT03136185|567333027|FG005|Overall Study|Death|0|||
157161254|NCT03136185|567333028|FG006|Overall Study|Death|1|||
156913233|NCT02853604|566442448|FG001|Overall Study|Lost to Follow-up|8|||
156913234|NCT02853604|566442447|FG000|Overall Study|Death|1|||
156913235|NCT02853604|566442448|FG001|Overall Study|Death|5|||
157161255|NCT03136185|567333029|FG007|Overall Study|Death|0|||
157161256|NCT03136185|567333030|FG008|Overall Study|Death|0|||
157161257|NCT03136185|567333022|FG000|Overall Study|Physician Decision|3|||
157161258|NCT03136185|567333023|FG001|Overall Study|Physician Decision|1|||
157161259|NCT03136185|567333024|FG002|Overall Study|Physician Decision|1|||
157161260|NCT03136185|567333025|FG003|Overall Study|Physician Decision|2|||
157161261|NCT03136185|567333026|FG004|Overall Study|Physician Decision|1|||
157161262|NCT03136185|567333027|FG005|Overall Study|Physician Decision|2|||
157161263|NCT03136185|567333028|FG006|Overall Study|Physician Decision|1|||
157161264|NCT03136185|567333029|FG007|Overall Study|Physician Decision|0|||
157161265|NCT03136185|567333030|FG008|Overall Study|Physician Decision|1|||
157161266|NCT03136185|567333022|FG000|Overall Study|Protocol Defined Disease Progression|0|||
157161267|NCT03136185|567333023|FG001|Overall Study|Protocol Defined Disease Progression|0|||
157161268|NCT03136185|567333024|FG002|Overall Study|Protocol Defined Disease Progression|1|||
157161269|NCT03136185|567333025|FG003|Overall Study|Protocol Defined Disease Progression|0|||
157161270|NCT03136185|567333026|FG004|Overall Study|Protocol Defined Disease Progression|0|||
157161271|NCT03136185|567333027|FG005|Overall Study|Protocol Defined Disease Progression|1|||
157161272|NCT03136185|567333028|FG006|Overall Study|Protocol Defined Disease Progression|0|||
157161273|NCT03136185|567333029|FG007|Overall Study|Protocol Defined Disease Progression|1|||
157161274|NCT03136185|567333030|FG008|Overall Study|Protocol Defined Disease Progression|1|||
157161275|NCT03136185|567333022|FG000|Overall Study|Withdrawal by Subject|1|||
157161276|NCT03136185|567333023|FG001|Overall Study|Withdrawal by Subject|0|||
157161277|NCT03136185|567333024|FG002|Overall Study|Withdrawal by Subject|1|||
157161278|NCT03136185|567333025|FG003|Overall Study|Withdrawal by Subject|1|||
157161279|NCT03136185|567333026|FG004|Overall Study|Withdrawal by Subject|1|||
157161280|NCT03136185|567333027|FG005|Overall Study|Withdrawal by Subject|1|||
157161281|NCT03136185|567333028|FG006|Overall Study|Withdrawal by Subject|2|||
157161282|NCT03136185|567333029|FG007|Overall Study|Withdrawal by Subject|3|||
157161283|NCT03136185|567333030|FG008|Overall Study|Withdrawal by Subject|3|||
157161284|NCT03136185|567333022|FG000|Overall Study|Not Reported|4|||
157161285|NCT03136185|567333023|FG001|Overall Study|Not Reported|1|||
157161286|NCT03136185|567333024|FG002|Overall Study|Not Reported|0|||
157161287|NCT03136185|567333025|FG003|Overall Study|Not Reported|1|||
157161288|NCT03136185|567333026|FG004|Overall Study|Not Reported|0|||
157161289|NCT03136185|567333027|FG005|Overall Study|Not Reported|2|||
157161290|NCT03136185|567333028|FG006|Overall Study|Not Reported|1|||
157161291|NCT03136185|567333029|FG007|Overall Study|Not Reported|1|||
157161292|NCT03136185|567333030|FG008|Overall Study|Not Reported|0|||
157161293|NCT05118386|567333033|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
157161294|NCT05118386|567333034|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
157161295|NCT05118386|567333035|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
157161296|NCT05118386|567333036|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
157161297|NCT05118386|567333037|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
157161298|NCT05118386|567333038|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
157161299|NCT05118386|567333033|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
157161300|NCT05118386|567333034|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
157161301|NCT05118386|567333035|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
157161302|NCT05118386|567333036|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
157161303|NCT05118386|567333037|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
157161304|NCT05118386|567333038|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
157161305|NCT02427477|567333041|FG000|Period 1|Adverse Event|1|||
157161306|NCT02427477|567333042|FG001|Period 1|Adverse Event|0|||
157161307|NCT01067508|567333043|FG000|Overall Study|Physician Decision|0|||
157161308|NCT01067508|567333044|FG001|Overall Study|Physician Decision|1|||
157225879|NCT01290263|567573371|FG004|Overall Study|Withdrawal by Subject|2|||
157225880|NCT01290263|567573367|FG000|Overall Study|Participant Non-Compliance|0|||
157161309|NCT01067508|567333043|FG000|Overall Study|Withdrawal by Subject|0|||
157161310|NCT01067508|567333044|FG001|Overall Study|Withdrawal by Subject|1|||
157161311|NCT02635737|567333048|FG000|Overall Study|Protocol Violation|1|||
157161312|NCT00632463|567333050|FG000|Overall Study|Adverse Event|0|||
157161313|NCT00632463|567333051|FG001|Overall Study|Adverse Event|1|||
157161314|NCT00632463|567333052|FG002|Overall Study|Adverse Event|0|||
157161315|NCT02065622|567333053|FG000|Induction Study|Adverse Event|13|||
157161316|NCT02065622|567333054|FG001|Induction Study|Adverse Event|19|||
157161317|NCT02065622|567333055|FG002|Induction Study|Adverse Event|0|||
157225881|NCT01290263|567573368|FG001|Overall Study|Participant Non-Compliance|0|||
157225882|NCT01290263|567573369|FG002|Overall Study|Participant Non-Compliance|0|||
157161318|NCT02065622|567333056|FG003|Induction Study|Adverse Event|0|||
157161319|NCT02065622|567333057|FG004|Induction Study|Adverse Event|0|||
157161320|NCT02065622|567333053|FG000|Induction Study|Withdrawal by Subject|3|||
157161321|NCT02065622|567333054|FG001|Induction Study|Withdrawal by Subject|5|||
157161322|NCT02065622|567333055|FG002|Induction Study|Withdrawal by Subject|0|||
157161323|NCT02065622|567333056|FG003|Induction Study|Withdrawal by Subject|0|||
157161324|NCT02065622|567333057|FG004|Induction Study|Withdrawal by Subject|0|||
157225883|NCT01290263|567573370|FG003|Overall Study|Participant Non-Compliance|1|||
156913236|NCT02853604|566442447|FG000|Overall Study|Miscellaneous|11|||
156913237|NCT02853604|566442448|FG001|Overall Study|Miscellaneous|2|||
156913238|NCT02853604|566442447|FG000|Overall Study|Progressive Disease|0|||
156913239|NCT02853604|566442448|FG001|Overall Study|Progressive Disease|2|||
156913240|NCT00727025|566442449|FG000|Overall Study|Physician Decision|23|||
156913241|NCT03020160|566442450|FG000|Overall Study|Withdrawal by Subject|1|||
156913242|NCT03020160|566442451|FG001|Overall Study|Withdrawal by Subject|0|||
156913243|NCT01218204|566442452|FG000|Part B Washout|Adverse Event|0|||
156913244|NCT01218204|566442453|FG001|Part B Washout|Adverse Event|1|||
156913245|NCT01218204|566442454|FG002|Part B Washout|Adverse Event|0|||
156913246|NCT01218204|566442455|FG003|Part B Washout|Adverse Event|0|||
156913247|NCT01218204|566442452|FG000|Part B Washout|Lost to Follow-up|0|||
156913248|NCT01218204|566442453|FG001|Part B Washout|Lost to Follow-up|2|||
156913249|NCT01218204|566442454|FG002|Part B Washout|Lost to Follow-up|0|||
156913250|NCT01218204|566442455|FG003|Part B Washout|Lost to Follow-up|0|||
156913251|NCT01218204|566442452|FG000|Part B Washout|Physician Decision|0|||
156913252|NCT01218204|566442453|FG001|Part B Washout|Physician Decision|14|||
156913253|NCT01218204|566442454|FG002|Part B Washout|Physician Decision|0|||
156913254|NCT01218204|566442455|FG003|Part B Washout|Physician Decision|0|||
156913255|NCT01218204|566442452|FG000|Part B Washout|Withdrawal by Subject|0|||
156913256|NCT01218204|566442453|FG001|Part B Washout|Withdrawal by Subject|14|||
156913257|NCT01218204|566442454|FG002|Part B Washout|Withdrawal by Subject|0|||
156913258|NCT01218204|566442455|FG003|Part B Washout|Withdrawal by Subject|0|||
156913259|NCT01218204|566442452|FG000|Part B Washout|Reached defined stopping criteria|0|||
156913260|NCT01218204|566442453|FG001|Part B Washout|Reached defined stopping criteria|2|||
156913261|NCT01218204|566442454|FG002|Part B Washout|Reached defined stopping criteria|0|||
156913262|NCT01218204|566442455|FG003|Part B Washout|Reached defined stopping criteria|0|||
156913263|NCT01218204|566442452|FG000|Part B Washout|Did not meet continuation criteria|0|||
156913264|NCT01218204|566442453|FG001|Part B Washout|Did not meet continuation criteria|112|||
156913265|NCT01218204|566442454|FG002|Part B Washout|Did not meet continuation criteria|0|||
156913266|NCT01218204|566442455|FG003|Part B Washout|Did not meet continuation criteria|0|||
156913267|NCT01218204|566442452|FG000|Part B Run-in|Adverse Event|0|||
156913268|NCT01218204|566442453|FG001|Part B Run-in|Adverse Event|0|||
156913269|NCT01218204|566442454|FG002|Part B Run-in|Adverse Event|1|||
156913270|NCT01218204|566442455|FG003|Part B Run-in|Adverse Event|0|||
156913271|NCT01218204|566442452|FG000|Part B Run-in|Protocol Violation|0|||
156913272|NCT01218204|566442453|FG001|Part B Run-in|Protocol Violation|0|||
156913273|NCT01218204|566442454|FG002|Part B Run-in|Protocol Violation|2|||
156913274|NCT01218204|566442455|FG003|Part B Run-in|Protocol Violation|0|||
156913275|NCT01218204|566442452|FG000|Part B Run-in|Withdrawal by Subject|0|||
156913276|NCT01218204|566442453|FG001|Part B Run-in|Withdrawal by Subject|0|||
156913277|NCT01218204|566442454|FG002|Part B Run-in|Withdrawal by Subject|3|||
156913278|NCT01218204|566442455|FG003|Part B Run-in|Withdrawal by Subject|0|||
156913279|NCT01218204|566442452|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
156913280|NCT01218204|566442453|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
156913281|NCT01218204|566442454|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
156913282|NCT01218204|566442455|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
156913283|NCT01218204|566442452|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
156913284|NCT01218204|566442453|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
156913285|NCT01218204|566442454|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
156913286|NCT01218204|566442455|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
156913287|NCT00545168|566442456|FG000|Overall Study|Lost to Follow-up|5|||
156913288|NCT00545168|566442457|FG001|Overall Study|Lost to Follow-up|5|||
156913289|NCT00545168|566442458|FG002|Overall Study|Lost to Follow-up|5|||
156913290|NCT00545168|566442456|FG000|Overall Study|Withdrawal by Subject|9|||
156913291|NCT00545168|566442457|FG001|Overall Study|Withdrawal by Subject|0|||
156913292|NCT00545168|566442458|FG002|Overall Study|Withdrawal by Subject|13|||
156913293|NCT00545168|566442456|FG000|Overall Study|Protocol Violation|1|||
157161325|NCT02065622|567333053|FG000|Induction Study|Lost to Follow-up|1|||
157161326|NCT02065622|567333054|FG001|Induction Study|Lost to Follow-up|0|||
157161327|NCT02065622|567333055|FG002|Induction Study|Lost to Follow-up|0|||
157161328|NCT02065622|567333056|FG003|Induction Study|Lost to Follow-up|0|||
157161329|NCT02065622|567333057|FG004|Induction Study|Lost to Follow-up|0|||
157161330|NCT02065622|567333053|FG000|Induction Study|Lack of Efficacy|22|||
157161331|NCT02065622|567333054|FG001|Induction Study|Lack of Efficacy|27|||
156863339|NCT01209689|566258626|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
156863340|NCT03780244|566258627|FG000|Overall Study|Lost to Follow-up|1|||
156863341|NCT03780244|566258628|FG001|Overall Study|Lost to Follow-up|0|||
156863342|NCT02345070|566258629|FG000|Overall Study|Adverse Event|12|||
156863343|NCT02345070|566258630|FG001|Overall Study|Adverse Event|8|||
156863344|NCT02345070|566258631|FG002|Overall Study|Adverse Event|16|||
156863345|NCT02345070|566258629|FG000|Overall Study|Poor compliance to protocol|2|||
156863346|NCT02345070|566258630|FG001|Overall Study|Poor compliance to protocol|0|||
156863347|NCT02345070|566258631|FG002|Overall Study|Poor compliance to protocol|0|||
156863348|NCT02345070|566258629|FG000|Overall Study|Other than specified above|6|||
156863349|NCT02345070|566258630|FG001|Overall Study|Other than specified above|3|||
157161332|NCT02065622|567333055|FG002|Induction Study|Lack of Efficacy|0|||
156913294|NCT00545168|566442457|FG001|Overall Study|Protocol Violation|0|||
156913295|NCT00545168|566442458|FG002|Overall Study|Protocol Violation|1|||
156913296|NCT00545168|566442456|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
156913297|NCT00545168|566442457|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
156913298|NCT00545168|566442458|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
156913299|NCT04390191|566442459|FG000|Overall Study|Withdrawal by Subject|1|||
156913300|NCT04390191|566442460|FG001|Overall Study|Withdrawal by Subject|0|||
156913301|NCT01256008|566442463|FG000|Overall Study|Lost to Follow-up|6|||
156913302|NCT01256008|566442464|FG001|Overall Study|Lost to Follow-up|4|||
156913303|NCT01256008|566442465|FG002|Overall Study|Lost to Follow-up|11|||
156913304|NCT01256008|566442463|FG000|Overall Study|Withdrawal by Subject|2|||
156913305|NCT01256008|566442464|FG001|Overall Study|Withdrawal by Subject|3|||
156913306|NCT01256008|566442465|FG002|Overall Study|Withdrawal by Subject|10|||
156913307|NCT02244606|566442466|FG000|Overall Study|Adverse Event|0|||
156913308|NCT02244606|566442467|FG001|Overall Study|Adverse Event|1|||
156913309|NCT02244606|566442468|FG002|Overall Study|Adverse Event|1|||
156913310|NCT02244606|566442469|FG003|Overall Study|Adverse Event|0|||
156913311|NCT02244606|566442466|FG000|Overall Study|Lost to Follow-up|2|||
156913312|NCT02244606|566442467|FG001|Overall Study|Lost to Follow-up|2|||
156913313|NCT02244606|566442468|FG002|Overall Study|Lost to Follow-up|1|||
156913314|NCT02244606|566442469|FG003|Overall Study|Lost to Follow-up|0|||
156913315|NCT02244606|566442466|FG000|Overall Study|Protocol Violation|0|||
156913316|NCT02244606|566442467|FG001|Overall Study|Protocol Violation|0|||
156913317|NCT02244606|566442468|FG002|Overall Study|Protocol Violation|0|||
156913318|NCT02244606|566442469|FG003|Overall Study|Protocol Violation|1|||
156913319|NCT02244606|566442466|FG000|Overall Study|Withdrawal by Subject|1|||
156913320|NCT02244606|566442467|FG001|Overall Study|Withdrawal by Subject|1|||
156913321|NCT02244606|566442468|FG002|Overall Study|Withdrawal by Subject|0|||
156913322|NCT02244606|566442469|FG003|Overall Study|Withdrawal by Subject|0|||
156913323|NCT02244606|566442466|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
156913324|NCT02244606|566442467|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
156913325|NCT02244606|566442468|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
156913326|NCT02244606|566442469|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
156913327|NCT01402492|566442472|FG000|Overall Study|Withdrawal by Subject|17|||
156913328|NCT01402492|566442473|FG001|Overall Study|Withdrawal by Subject|11|||
156913329|NCT01402492|566442474|FG002|Overall Study|Withdrawal by Subject|11|||
156913330|NCT01402492|566442472|FG000|Overall Study|Adverse Event|2|||
156913331|NCT01402492|566442473|FG001|Overall Study|Adverse Event|3|||
156913332|NCT01402492|566442474|FG002|Overall Study|Adverse Event|4|||
156913333|NCT01402492|566442472|FG000|Overall Study|Physician Decision|0|||
156913334|NCT01402492|566442473|FG001|Overall Study|Physician Decision|3|||
157161333|NCT02065622|567333056|FG003|Induction Study|Lack of Efficacy|0|||
157161334|NCT02065622|567333057|FG004|Induction Study|Lack of Efficacy|0|||
157161335|NCT02065622|567333053|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
157161336|NCT02065622|567333054|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
157161337|NCT02065622|567333055|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
157161338|NCT02065622|567333056|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
157161339|NCT02065622|567333057|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
157161340|NCT02065622|567333053|FG000|Induction Study|Subject Noncompliance|1|||
157161341|NCT02065622|567333054|FG001|Induction Study|Subject Noncompliance|1|||
157161342|NCT02065622|567333055|FG002|Induction Study|Subject Noncompliance|0|||
157161343|NCT02065622|567333056|FG003|Induction Study|Subject Noncompliance|0|||
157161344|NCT02065622|567333057|FG004|Induction Study|Subject Noncompliance|0|||
157161345|NCT02065622|567333053|FG000|Induction Study|Other, Not Specified|3|||
157161346|NCT02065622|567333054|FG001|Induction Study|Other, Not Specified|2|||
157161347|NCT02065622|567333055|FG002|Induction Study|Other, Not Specified|0|||
157161348|NCT02065622|567333056|FG003|Induction Study|Other, Not Specified|0|||
157161349|NCT02065622|567333057|FG004|Induction Study|Other, Not Specified|0|||
157161350|NCT02065622|567333053|FG000|Maintenance Study|Adverse Event|0|||
157161351|NCT02065622|567333054|FG001|Maintenance Study|Adverse Event|0|||
157161352|NCT02065622|567333055|FG002|Maintenance Study|Adverse Event|25|||
157161353|NCT02065622|567333056|FG003|Maintenance Study|Adverse Event|22|||
157161354|NCT02065622|567333057|FG004|Maintenance Study|Adverse Event|11|||
157161355|NCT02065622|567333053|FG000|Maintenance Study|Withdrawal by Subject|0|||
157161356|NCT02065622|567333054|FG001|Maintenance Study|Withdrawal by Subject|0|||
157161357|NCT02065622|567333055|FG002|Maintenance Study|Withdrawal by Subject|11|||
157161358|NCT02065622|567333056|FG003|Maintenance Study|Withdrawal by Subject|5|||
157161359|NCT02065622|567333057|FG004|Maintenance Study|Withdrawal by Subject|7|||
157161360|NCT02065622|567333053|FG000|Maintenance Study|Lost to Follow-up|0|||
157161361|NCT02065622|567333054|FG001|Maintenance Study|Lost to Follow-up|0|||
157161362|NCT02065622|567333055|FG002|Maintenance Study|Lost to Follow-up|4|||
157161363|NCT02065622|567333056|FG003|Maintenance Study|Lost to Follow-up|1|||
157161364|NCT02065622|567333057|FG004|Maintenance Study|Lost to Follow-up|1|||
157161365|NCT02065622|567333053|FG000|Maintenance Study|Lack of Efficacy|0|||
157027661|NCT04068181|566856200|FG002|Overall Study|Withdrawal of consent from study|0|||
157027662|NCT04068181|566856201|FG003|Overall Study|Withdrawal of consent from study|0|||
157027663|NCT05070728|566856202|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
156863350|NCT02345070|566258631|FG002|Overall Study|Other than specified above|7|||
157091563|NCT01323972|567089168|FG002|Overall Study|Withdrawal by Subject|1|||
157091564|NCT01323972|567089169|FG003|Overall Study|Withdrawal by Subject|0|||
156863351|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
156863352|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863353|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863354|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863355|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863356|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863357|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
156863358|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
156863359|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863360|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863361|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863362|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863363|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863364|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
156863365|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
156863366|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863367|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863368|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863369|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863370|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863371|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
156863372|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
156863373|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863374|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863375|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863376|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863377|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863378|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
156863379|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
156863380|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863381|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863382|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863383|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863384|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863385|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
156863386|NCT01054885|566258632|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
156863387|NCT01054885|566258633|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863388|NCT01054885|566258634|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863389|NCT01054885|566258635|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863390|NCT01054885|566258636|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863391|NCT01054885|566258637|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863392|NCT01054885|566258638|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
156863393|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
156863394|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
156863395|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
157091565|NCT01323972|567089166|FG000|Overall Study|Migrated/moved from study area|1|||
157091566|NCT01323972|567089167|FG001|Overall Study|Migrated/moved from study area|2|||
157091567|NCT01323972|567089168|FG002|Overall Study|Migrated/moved from study area|0|||
157091568|NCT01323972|567089169|FG003|Overall Study|Migrated/moved from study area|0|||
157091569|NCT01323972|567089166|FG000|Overall Study|Lost to Follow-up|0|||
157091570|NCT01323972|567089167|FG001|Overall Study|Lost to Follow-up|1|||
157091571|NCT01323972|567089168|FG002|Overall Study|Lost to Follow-up|1|||
157091572|NCT01323972|567089169|FG003|Overall Study|Lost to Follow-up|1|||
157091573|NCT01049217|567089172|FG000|Overall Study|Adverse Event|2|||
157091574|NCT01049217|567089173|FG001|Overall Study|Adverse Event|1|||
157091575|NCT01049217|567089172|FG000|Overall Study|Lack of Efficacy|1|||
157091576|NCT01049217|567089173|FG001|Overall Study|Lack of Efficacy|1|||
157091577|NCT01049217|567089172|FG000|Overall Study|Lost to Follow-up|3|||
157091578|NCT01049217|567089173|FG001|Overall Study|Lost to Follow-up|8|||
157091579|NCT01049217|567089172|FG000|Overall Study|Withdrawal by Subject|4|||
157091580|NCT01049217|567089173|FG001|Overall Study|Withdrawal by Subject|3|||
156913335|NCT01402492|566442474|FG002|Overall Study|Physician Decision|0|||
156913336|NCT01402492|566442472|FG000|Overall Study|Incarcerated (N=3)|2|||
156913337|NCT01402492|566442473|FG001|Overall Study|Incarcerated (N=3)|0|||
156913338|NCT01402492|566442474|FG002|Overall Study|Incarcerated (N=3)|1|||
156913339|NCT02296320|566442477|FG000|Overall Study|Withdrawal by Subject|4|||
156913340|NCT02296320|566442478|FG001|Overall Study|Withdrawal by Subject|0|||
156913341|NCT02296320|566442479|FG002|Overall Study|Withdrawal by Subject|2|||
156913342|NCT02296320|566442477|FG000|Overall Study|Death|24|||
156913343|NCT02296320|566442478|FG001|Overall Study|Death|3|||
156913344|NCT02296320|566442479|FG002|Overall Study|Death|27|||
156913345|NCT02296320|566442477|FG000|Overall Study|Lost to Follow-up|5|||
156913346|NCT02296320|566442478|FG001|Overall Study|Lost to Follow-up|2|||
156913347|NCT02296320|566442479|FG002|Overall Study|Lost to Follow-up|7|||
156913348|NCT02296320|566442477|FG000|Overall Study|Not treated|2|||
156913349|NCT02296320|566442478|FG001|Overall Study|Not treated|0|||
156913350|NCT02296320|566442479|FG002|Overall Study|Not treated|0|||
156913351|NCT02296320|566442477|FG000|Overall Study|Not - specified|0|||
156913352|NCT02296320|566442478|FG001|Overall Study|Not - specified|0|||
156913353|NCT02296320|566442479|FG002|Overall Study|Not - specified|1|||
156913354|NCT03953820|566442480|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
156913355|NCT03953820|566442481|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
156913356|NCT03953820|566442482|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
156913357|NCT03953820|566442480|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
156913358|NCT03953820|566442481|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
156913359|NCT03953820|566442482|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
156913360|NCT00880009|566442483|FG000|Overall Study|Study terminated by sponsor|14|||
156913361|NCT00880009|566442483|FG000|Overall Study|Withdrawal by Subject|1|||
156913362|NCT00880009|566442483|FG000|Overall Study|Protocol Violation|1|||
156913363|NCT01049308|566442484|FG000|Pill Counts|Withdrawal by Subject|83|||
156913364|NCT02795832|566442488|FG000|Overall Study|Adverse Event|0|||
156913365|NCT02795832|566442489|FG001|Overall Study|Adverse Event|0|||
156913366|NCT02795832|566442490|FG002|Overall Study|Adverse Event|0|||
156913367|NCT02795832|566442491|FG003|Overall Study|Adverse Event|0|||
156913368|NCT02795832|566442492|FG004|Overall Study|Adverse Event|0|||
156913369|NCT02795832|566442493|FG005|Overall Study|Adverse Event|3|||
156913370|NCT00221403|566442494|FG000|Overall Study|Protocol Violation|1|||
156913371|NCT00221403|566442495|FG001|Overall Study|Protocol Violation|0|||
156913372|NCT00221403|566442496|FG002|Overall Study|Protocol Violation|0|||
156913373|NCT00221403|566442494|FG000|Overall Study|Physician Decision|1|||
156913374|NCT00221403|566442495|FG001|Overall Study|Physician Decision|0|||
156913375|NCT00221403|566442496|FG002|Overall Study|Physician Decision|0|||
156913376|NCT00221403|566442494|FG000|Overall Study|Withdrawal by Subject|0|||
156913377|NCT00221403|566442495|FG001|Overall Study|Withdrawal by Subject|3|||
156913378|NCT00221403|566442496|FG002|Overall Study|Withdrawal by Subject|0|||
156913379|NCT00221403|566442494|FG000|Overall Study|Lack of Efficacy|0|||
156913380|NCT00221403|566442495|FG001|Overall Study|Lack of Efficacy|1|||
156913381|NCT00221403|566442496|FG002|Overall Study|Lack of Efficacy|0|||
156913382|NCT00221403|566442494|FG000|Overall Study|Adverse Event|0|||
156913383|NCT00221403|566442495|FG001|Overall Study|Adverse Event|1|||
156913384|NCT00221403|566442496|FG002|Overall Study|Adverse Event|0|||
156913385|NCT00256750|566442498|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
156913386|NCT00256750|566442499|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
156913387|NCT00256750|566442500|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
156913388|NCT00256750|566442498|FG000|Transplanted Pre-Treatment|Other|2|||
156913389|NCT00256750|566442499|FG001|Transplanted Pre-Treatment|Other|0|||
156913390|NCT00256750|566442500|FG002|Transplanted Pre-Treatment|Other|0|||
156913391|NCT00256750|566442498|FG000|Transplanted Pre-Treatment|Death|1|||
156913392|NCT00256750|566442499|FG001|Transplanted Pre-Treatment|Death|0|||
156913393|NCT00256750|566442500|FG002|Transplanted Pre-Treatment|Death|0|||
156913394|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
156913395|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
156913396|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
156913397|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Death|3|||
156913398|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Death|2|||
156913399|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Death|4|||
156913400|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
156913401|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
156913402|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
156913403|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
156913404|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
156913405|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
156913406|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Other|5|||
156913407|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Other|4|||
156913408|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Other|2|||
156913409|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
156913410|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
157225884|NCT01290263|567573371|FG004|Overall Study|Participant Non-Compliance|1|||
156913411|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
156913412|NCT00256750|566442498|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
156913413|NCT00256750|566442499|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
156913414|NCT00256750|566442500|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
156913415|NCT00256750|566442498|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
156913416|NCT00256750|566442499|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
156913417|NCT00256750|566442500|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
156913418|NCT00256750|566442498|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
156913419|NCT00256750|566442499|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
157225885|NCT00502775|567573372|FG000|Overall Study|Adverse Event|1|||
156913420|NCT00256750|566442500|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
157091581|NCT01049217|567089172|FG000|Overall Study|Protocol Violation|1|||
157091582|NCT01049217|567089173|FG001|Overall Study|Protocol Violation|3|||
157091583|NCT01049217|567089172|FG000|Overall Study|Pregnancy|1|||
157091584|NCT01049217|567089173|FG001|Overall Study|Pregnancy|0|||
157091585|NCT01049217|567089172|FG000|Overall Study|Study Terminated by Sponsor|43|||
157091586|NCT01049217|567089173|FG001|Overall Study|Study Terminated by Sponsor|43|||
157091587|NCT01049217|567089172|FG000|Overall Study|Other|1|||
157091588|NCT01049217|567089173|FG001|Overall Study|Other|2|||
157091589|NCT01049217|567089172|FG000|Overall Study|Randomized but not Treated|0|||
157091590|NCT01049217|567089173|FG001|Overall Study|Randomized but not Treated|2|||
157091591|NCT01946438|567089174|FG000|Overall Study|Adverse Event|0|||
157091592|NCT01946438|567089175|FG001|Overall Study|Adverse Event|0|||
157091593|NCT01946438|567089176|FG002|Overall Study|Adverse Event|0|||
157091594|NCT01946438|567089177|FG003|Overall Study|Adverse Event|1|||
157091595|NCT01946438|567089174|FG000|Overall Study|Serious Adverse event|1|||
157091596|NCT01946438|567089175|FG001|Overall Study|Serious Adverse event|0|||
157091597|NCT01946438|567089176|FG002|Overall Study|Serious Adverse event|0|||
157091598|NCT01946438|567089177|FG003|Overall Study|Serious Adverse event|0|||
157091599|NCT01946438|567089174|FG000|Overall Study|Protocol Violation|0|||
157091600|NCT01946438|567089175|FG001|Overall Study|Protocol Violation|0|||
157091601|NCT01946438|567089176|FG002|Overall Study|Protocol Violation|1|||
157091602|NCT01946438|567089177|FG003|Overall Study|Protocol Violation|0|||
157091603|NCT01946438|567089174|FG000|Overall Study|Withdrawal by Subject|1|||
157091604|NCT01946438|567089175|FG001|Overall Study|Withdrawal by Subject|0|||
157091605|NCT01946438|567089176|FG002|Overall Study|Withdrawal by Subject|0|||
157091606|NCT01946438|567089177|FG003|Overall Study|Withdrawal by Subject|0|||
157091607|NCT02523599|567089178|FG000|Overall Study|Adverse Event|1|||
157091608|NCT02523599|567089179|FG001|Overall Study|Adverse Event|0|||
157091609|NCT02523599|567089178|FG000|Overall Study|Physician Decision|1|||
157091610|NCT02523599|567089179|FG001|Overall Study|Physician Decision|0|||
157091611|NCT02523599|567089178|FG000|Overall Study|Lost to Follow-up|4|||
157091612|NCT02523599|567089179|FG001|Overall Study|Lost to Follow-up|1|||
157091613|NCT02523599|567089178|FG000|Overall Study|Did not return for Day 30 visit|2|||
157091614|NCT02523599|567089179|FG001|Overall Study|Did not return for Day 30 visit|0|||
157091615|NCT03519971|567089180|FG000|Overall Study|Death|142|||
157091616|NCT03519971|567089181|FG001|Overall Study|Death|69|||
157091617|NCT03519971|567089180|FG000|Overall Study|Lost to Follow-up|0|||
157091618|NCT03519971|567089181|FG001|Overall Study|Lost to Follow-up|1|||
157091619|NCT03519971|567089180|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
157091620|NCT03519971|567089181|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
157091621|NCT03519971|567089180|FG000|Overall Study|Withdrawal by Subject|3|||
157091622|NCT03519971|567089181|FG001|Overall Study|Withdrawal by Subject|2|||
157091623|NCT03519971|567089180|FG000|Overall Study|Other|1|||
157091624|NCT03519971|567089181|FG001|Overall Study|Other|0|||
157091625|NCT03141905|567089182|FG000|Overall Study|Death|3|||
157091626|NCT03141905|567089183|FG001|Overall Study|Death|2|||
157091627|NCT03141905|567089182|FG000|Overall Study|Withdrawal by Subject|1|||
157091628|NCT03141905|567089183|FG001|Overall Study|Withdrawal by Subject|0|||
157091629|NCT03141905|567089182|FG000|Overall Study|Lost to Follow-up|3|||
157091630|NCT03141905|567089183|FG001|Overall Study|Lost to Follow-up|7|||
157091631|NCT03141905|567089182|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
157091632|NCT03141905|567089183|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
157091633|NCT05180500|567089184|FG000|Overall Study|Adverse Event|1|||
157091634|NCT05180500|567089185|FG001|Overall Study|Adverse Event|0|||
157091635|NCT05180500|567089184|FG000|Overall Study|Withdrawal by Subject|2|||
157091636|NCT05180500|567089185|FG001|Overall Study|Withdrawal by Subject|0|||
157091637|NCT04927884|567089186|FG000|Overall Study|Progressive Disease|2|||
157091638|NCT01775124|567089187|FG000|Core Period|Disease Progression|0|||
157091639|NCT01775124|567089188|FG001|Core Period|Disease Progression|1|||
157091640|NCT01775124|567089187|FG000|Core Period|Physician Decision|1|||
157091641|NCT01775124|567089188|FG001|Core Period|Physician Decision|1|||
157091642|NCT01775124|567089187|FG000|Core Period|Death|0|||
156913421|NCT00256750|566442498|FG000|Post-Transplant Treated (24 Months)|Death|3|||
156913422|NCT00256750|566442499|FG001|Post-Transplant Treated (24 Months)|Death|0|||
156913423|NCT00256750|566442500|FG002|Post-Transplant Treated (24 Months)|Death|0|||
156913424|NCT00256750|566442498|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
156913425|NCT00256750|566442499|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
156913426|NCT00256750|566442500|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
156913427|NCT00256750|566442498|FG000|Post-Transplant Treated (24 Months)|Other|2|||
156913428|NCT00256750|566442499|FG001|Post-Transplant Treated (24 Months)|Other|0|||
156913429|NCT00256750|566442500|FG002|Post-Transplant Treated (24 Months)|Other|1|||
156913430|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
156913431|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
156913432|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
156913433|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
156913434|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
156913435|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
156913436|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Death|0|||
156913437|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Death|2|||
156913438|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Death|1|||
156913439|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
156913440|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
156913441|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
156913442|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
156913443|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
156913444|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
156913445|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
156913446|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
156913447|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
156913448|NCT00256750|566442498|FG000|Post-Transplant Treated (36 Months)|Other|0|||
156913449|NCT00256750|566442499|FG001|Post-Transplant Treated (36 Months)|Other|1|||
156913450|NCT00256750|566442500|FG002|Post-Transplant Treated (36 Months)|Other|1|||
156913451|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
156913452|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
156913453|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
156913454|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
157161366|NCT02065622|567333054|FG001|Maintenance Study|Lack of Efficacy|0|||
157161367|NCT02065622|567333055|FG002|Maintenance Study|Lack of Efficacy|70|||
157161368|NCT02065622|567333056|FG003|Maintenance Study|Lack of Efficacy|55|||
157161369|NCT02065622|567333057|FG004|Maintenance Study|Lack of Efficacy|19|||
157161370|NCT02065622|567333053|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
157161371|NCT02065622|567333054|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
157161372|NCT02065622|567333055|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
157161373|NCT02065622|567333056|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
157161374|NCT02065622|567333057|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
157161375|NCT02065622|567333053|FG000|Maintenance Study|Subject Non-Compliance|0|||
157161376|NCT02065622|567333054|FG001|Maintenance Study|Subject Non-Compliance|0|||
157161377|NCT02065622|567333055|FG002|Maintenance Study|Subject Non-Compliance|1|||
157161378|NCT02065622|567333056|FG003|Maintenance Study|Subject Non-Compliance|3|||
157161379|NCT02065622|567333057|FG004|Maintenance Study|Subject Non-Compliance|2|||
157161380|NCT02065622|567333053|FG000|Maintenance Study|Other, Not Specified|0|||
157161381|NCT02065622|567333054|FG001|Maintenance Study|Other, Not Specified|0|||
157161382|NCT02065622|567333055|FG002|Maintenance Study|Other, Not Specified|6|||
157161383|NCT02065622|567333056|FG003|Maintenance Study|Other, Not Specified|14|||
157161384|NCT02065622|567333057|FG004|Maintenance Study|Other, Not Specified|2|||
157161385|NCT02065622|567333053|FG000|Maintenance Study|Unknown Reason|0|||
156913455|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
156913456|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
156913457|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
156913458|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
156913459|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
156913460|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
156913461|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
156913462|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
156913463|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
157161386|NCT02065622|567333054|FG001|Maintenance Study|Unknown Reason|0|||
157161387|NCT02065622|567333055|FG002|Maintenance Study|Unknown Reason|0|||
157161388|NCT02065622|567333056|FG003|Maintenance Study|Unknown Reason|1|||
157161389|NCT02065622|567333057|FG004|Maintenance Study|Unknown Reason|0|||
157161390|NCT02349789|567334596|FG000|Overall Study|Withdrawal by Subject|2|||
157161391|NCT02922634|567334597|FG000|Overall Study|Withdrawal by Subject|5|||
157161392|NCT02922634|567334597|FG000|Overall Study|Did not have their surgery|5|||
157161393|NCT00352755|567334598|FG000|Overall Study|Physician Decision|1|||
157161394|NCT00352755|567334598|FG000|Overall Study|Adverse Event|1|||
157161395|NCT02397694|567334601|FG000|Double-Blinded Phase|Adverse Event|1|||
157161396|NCT02397694|567334602|FG001|Double-Blinded Phase|Adverse Event|0|||
157161397|NCT02397694|567334601|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
157161398|NCT02397694|567334602|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
157161399|NCT02397694|567334601|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
157161400|NCT02397694|567334602|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
157161401|NCT02397694|567334601|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
157161402|NCT02397694|567334602|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
157161403|NCT02397694|567334601|FG000|Open Label Extension Phase|Protocol Violation|1|||
157161404|NCT02397694|567334602|FG001|Open Label Extension Phase|Protocol Violation|0|||
157161405|NCT02397694|567334601|FG000|Open Label Extension Phase|Withdrew Consent|3|||
157161406|NCT02397694|567334602|FG001|Open Label Extension Phase|Withdrew Consent|1|||
157161407|NCT02397694|567334601|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
157161408|NCT02397694|567334602|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
157161409|NCT01116687|567334603|FG000|Overall Study|Withdrawal by Subject|4|||
157161410|NCT00424528|567334604|FG000|Overall Study|Adverse Event|2|||
157161411|NCT00424528|567334605|FG001|Overall Study|Adverse Event|1|||
157161412|NCT00424528|567334606|FG002|Overall Study|Adverse Event|2|||
157161413|NCT00424528|567334604|FG000|Overall Study|Protocol Violation|1|||
157161414|NCT00424528|567334605|FG001|Overall Study|Protocol Violation|1|||
157161415|NCT00424528|567334606|FG002|Overall Study|Protocol Violation|0|||
157161416|NCT00424528|567334604|FG000|Overall Study|Lost to Follow-up|0|||
157161417|NCT00424528|567334605|FG001|Overall Study|Lost to Follow-up|1|||
157161418|NCT00424528|567334606|FG002|Overall Study|Lost to Follow-up|0|||
157161419|NCT00424528|567334604|FG000|Overall Study|noncompliance with study requirements|2|||
157161420|NCT00424528|567334605|FG001|Overall Study|noncompliance with study requirements|1|||
157161421|NCT00424528|567334606|FG002|Overall Study|noncompliance with study requirements|2|||
157161422|NCT01009983|567334608|FG000|Overall Study|necessary scans not completed|1|||
157161423|NCT00296725|567334613|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
157161424|NCT00296725|567334613|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
157161425|NCT00296725|567334613|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
157161426|NCT03137121|567334620|FG000|Overall Study|Withdrawal by Subject|0|||
157161427|NCT03137121|567334621|FG001|Overall Study|Withdrawal by Subject|1|||
157161428|NCT00568958|567334625|FG000|Allocation|Withdrawal by Subject|7|||
157161429|NCT00568958|567334626|FG001|Allocation|Withdrawal by Subject|3|||
157161430|NCT00568958|567334625|FG000|Allocation|Physician Decision|2|||
157161431|NCT00568958|567334626|FG001|Allocation|Physician Decision|0|||
157161432|NCT00568958|567334625|FG000|Follow-Up|Withdrawal by Subject|6|||
157161433|NCT00568958|567334626|FG001|Follow-Up|Withdrawal by Subject|6|||
157161434|NCT00568958|567334625|FG000|Follow-Up|Physician Decision|1|||
157161435|NCT00568958|567334626|FG001|Follow-Up|Physician Decision|1|||
157161436|NCT00568958|567334625|FG000|Follow-Up|Family Emergency|1|||
157161437|NCT00568958|567334626|FG001|Follow-Up|Family Emergency|0|||
157161438|NCT00568958|567334625|FG000|Follow-Up|Adverse Event|1|||
157161439|NCT00568958|567334626|FG001|Follow-Up|Adverse Event|0|||
157161440|NCT05254613|567334638|FG000|Overall Study|Lost to Follow-up|0|||
157161441|NCT05254613|567334639|FG001|Overall Study|Lost to Follow-up|0|||
157161442|NCT05254613|567334640|FG002|Overall Study|Lost to Follow-up|1|||
157161443|NCT02387372|567334641|FG000|Overall Study|Not Treated|1|||
157161444|NCT02387372|567334642|FG001|Overall Study|Not Treated|0|||
157161445|NCT01911845|567334644|FG000|Overall Study|Adverse Event|2|||
157161446|NCT01911845|567334644|FG000|Overall Study|Lost to Follow-up|1|||
157161447|NCT01911845|567334644|FG000|Overall Study|Other (not specified)|3|||
157161448|NCT01576016|567334645|FG000|Lead Safety|Death|132|||
157161449|NCT01576016|567334646|FG001|Lead Safety|Death|0|||
157161450|NCT01576016|567334645|FG000|Lead Safety|Withdrawal by Subject|81|||
157161451|NCT01576016|567334646|FG001|Lead Safety|Withdrawal by Subject|0|||
157161452|NCT01576016|567334645|FG000|Lead Safety|System Explanted without Replacement|24|||
157161453|NCT01576016|567334646|FG001|Lead Safety|System Explanted without Replacement|0|||
156863396|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
156863397|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
156863398|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
156863399|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
157161454|NCT01576016|567334645|FG000|Lead Safety|Physician Decision|14|||
157161455|NCT01576016|567334646|FG001|Lead Safety|Physician Decision|0|||
157161456|NCT01576016|567334645|FG000|Lead Safety|Lost to Follow-up|13|||
157161457|NCT01576016|567334646|FG001|Lead Safety|Lost to Follow-up|0|||
157161458|NCT01576016|567334645|FG000|Lead Safety|Unsuccessful implant|2|||
157161459|NCT01576016|567334646|FG001|Lead Safety|Unsuccessful implant|0|||
157161460|NCT01576016|567334645|FG000|Lead Safety|Sponsor request|1|||
157161461|NCT01576016|567334646|FG001|Lead Safety|Sponsor request|0|||
157161462|NCT01576016|567334645|FG000|Lead Safety|Device replaced with CRT-D|1|||
157161463|NCT01576016|567334646|FG001|Lead Safety|Device replaced with CRT-D|0|||
157161464|NCT01576016|567334645|FG000|Lead Safety|Patient on Palliative Care|1|||
157225886|NCT00502775|567573373|FG001|Overall Study|Adverse Event|2|||
157225887|NCT00502775|567573374|FG002|Overall Study|Adverse Event|1|||
157225888|NCT00502775|567573372|FG000|Overall Study|Protocol Violation|1|||
157225889|NCT00502775|567573373|FG001|Overall Study|Protocol Violation|5|||
157225890|NCT00502775|567573374|FG002|Overall Study|Protocol Violation|2|||
157225891|NCT00502775|567573372|FG000|Overall Study|Withdrawal by Subject|1|||
157225892|NCT00502775|567573373|FG001|Overall Study|Withdrawal by Subject|1|||
157225893|NCT00502775|567573374|FG002|Overall Study|Withdrawal by Subject|2|||
157225894|NCT00502775|567573372|FG000|Overall Study|Sponsor Terminated Study|1|||
157225895|NCT00502775|567573373|FG001|Overall Study|Sponsor Terminated Study|0|||
157225896|NCT00502775|567573374|FG002|Overall Study|Sponsor Terminated Study|1|||
157225897|NCT00502775|567573372|FG000|Overall Study|Non-compliance with eDiary|4|||
157225898|NCT00502775|567573373|FG001|Overall Study|Non-compliance with eDiary|1|||
157225899|NCT00502775|567573374|FG002|Overall Study|Non-compliance with eDiary|1|||
157225900|NCT00502775|567573372|FG000|Overall Study|Subject unable to swallow capsule|1|||
157225901|NCT00502775|567573373|FG001|Overall Study|Subject unable to swallow capsule|0|||
157225902|NCT00502775|567573374|FG002|Overall Study|Subject unable to swallow capsule|1|||
157225903|NCT00502775|567573372|FG000|Overall Study|Logpad compliance <80%|1|||
157225904|NCT00502775|567573373|FG001|Overall Study|Logpad compliance <80%|0|||
157225905|NCT00502775|567573374|FG002|Overall Study|Logpad compliance <80%|0|||
157225906|NCT00502775|567573372|FG000|Overall Study|Randomized in error|0|||
157225907|NCT00502775|567573373|FG001|Overall Study|Randomized in error|1|||
157225908|NCT00502775|567573374|FG002|Overall Study|Randomized in error|1|||
157225909|NCT00502775|567573372|FG000|Overall Study|Non-compliance|0|||
157225910|NCT00502775|567573373|FG001|Overall Study|Non-compliance|2|||
157225911|NCT00502775|567573374|FG002|Overall Study|Non-compliance|2|||
157225912|NCT00502775|567573372|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
157225913|NCT00502775|567573373|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
157225914|NCT00502775|567573374|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
157225915|NCT00502775|567573372|FG000|Overall Study|Declining pollen counts|0|||
157225916|NCT00502775|567573373|FG001|Overall Study|Declining pollen counts|1|||
157225917|NCT00502775|567573374|FG002|Overall Study|Declining pollen counts|1|||
157225918|NCT00502775|567573372|FG000|Overall Study|Subject in jail|0|||
157225919|NCT00502775|567573373|FG001|Overall Study|Subject in jail|1|||
157225920|NCT00502775|567573374|FG002|Overall Study|Subject in jail|0|||
157225921|NCT00502775|567573372|FG000|Overall Study|Subject took disallowed drug|0|||
157225922|NCT00502775|567573373|FG001|Overall Study|Subject took disallowed drug|0|||
157225923|NCT00502775|567573374|FG002|Overall Study|Subject took disallowed drug|1|||
157225924|NCT01545076|567573376|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
157225925|NCT01545076|567573377|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
157225926|NCT01545076|567573378|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
157225927|NCT01545076|567573379|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
157225928|NCT01545076|567573380|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
157225929|NCT01545076|567573376|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
157225930|NCT01545076|567573377|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
157225931|NCT01545076|567573378|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
157225932|NCT01545076|567573379|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
157225933|NCT01545076|567573380|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
157225934|NCT01545076|567573376|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
157225935|NCT01545076|567573377|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
157225936|NCT01545076|567573378|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
157225937|NCT01545076|567573379|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
157225938|NCT01545076|567573380|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
157225939|NCT01545076|567573376|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
157225940|NCT01545076|567573377|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
157225941|NCT01545076|567573378|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
157225942|NCT01545076|567573379|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
157225943|NCT01545076|567573380|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
157225944|NCT01545076|567573376|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
157225945|NCT01545076|567573377|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
157225946|NCT01545076|567573378|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
157225947|NCT01545076|567573379|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
157225948|NCT01545076|567573380|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
157225949|NCT01545076|567573376|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
157225950|NCT01545076|567573377|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
157225951|NCT01545076|567573378|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156913464|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
156913465|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
156913466|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
157091643|NCT01775124|567089188|FG001|Core Period|Death|1|||
157225952|NCT01545076|567573379|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
157027664|NCT05070728|566856203|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
157027665|NCT03924635|566856223|FG000|Overall Study|Withdrawal by Subject|2|||
157027666|NCT03924635|566856224|FG001|Overall Study|Withdrawal by Subject|4|||
157027667|NCT04568434|566856227|FG000|Overall Study|Voluntary Withdrawal|0|||
157027668|NCT04568434|566856228|FG001|Overall Study|Voluntary Withdrawal|1|||
157027669|NCT04568434|566856229|FG002|Overall Study|Voluntary Withdrawal|1|||
157027670|NCT04568434|566856227|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
157027671|NCT04568434|566856228|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
157027672|NCT04568434|566856229|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
157027673|NCT04568434|566856227|FG000|Overall Study|Investigator Judgement|1|||
157027674|NCT04568434|566856228|FG001|Overall Study|Investigator Judgement|0|||
157027675|NCT04568434|566856229|FG002|Overall Study|Investigator Judgement|0|||
157027676|NCT05469464|566856230|FG000|Overall Study|Withdrawal by Subject|8|||
157027677|NCT05469464|566856231|FG001|Overall Study|Withdrawal by Subject|7|||
157027678|NCT05469464|566856232|FG002|Overall Study|Withdrawal by Subject|4|||
157027679|NCT05469464|566856233|FG003|Overall Study|Withdrawal by Subject|5|||
157027680|NCT05469464|566856230|FG000|Overall Study|Adverse Event|8|||
157027681|NCT05469464|566856231|FG001|Overall Study|Adverse Event|14|||
157027682|NCT05469464|566856232|FG002|Overall Study|Adverse Event|13|||
157027683|NCT05469464|566856233|FG003|Overall Study|Adverse Event|2|||
157027684|NCT05469464|566856230|FG000|Overall Study|Lost to Follow-up|2|||
157027685|NCT05469464|566856231|FG001|Overall Study|Lost to Follow-up|5|||
157027686|NCT05469464|566856232|FG002|Overall Study|Lost to Follow-up|3|||
157027687|NCT05469464|566856233|FG003|Overall Study|Lost to Follow-up|3|||
157027688|NCT05469464|566856230|FG000|Overall Study|Lack of Efficacy|4|||
157027689|NCT05469464|566856231|FG001|Overall Study|Lack of Efficacy|1|||
157027690|NCT05469464|566856232|FG002|Overall Study|Lack of Efficacy|2|||
157027691|NCT05469464|566856233|FG003|Overall Study|Lack of Efficacy|2|||
157027692|NCT05469464|566856230|FG000|Overall Study|Physician Decision|0|||
157027693|NCT05469464|566856231|FG001|Overall Study|Physician Decision|0|||
157027694|NCT05469464|566856232|FG002|Overall Study|Physician Decision|0|||
157027695|NCT05469464|566856233|FG003|Overall Study|Physician Decision|1|||
157027696|NCT05374798|566856234|FG000|Overall Study|Lost to Follow-up|2|||
157027697|NCT05374798|566856234|FG000|Overall Study|Withdrawal by Subject|2|||
157027698|NCT05374798|566856234|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
157027699|NCT03463044|566856235|FG000|Overall Study|Lost to Follow-up|0|||
157027700|NCT03463044|566856236|FG001|Overall Study|Lost to Follow-up|0|||
157027701|NCT03463044|566856237|FG002|Overall Study|Lost to Follow-up|0|||
157027702|NCT03463044|566856238|FG003|Overall Study|Lost to Follow-up|0|||
157027703|NCT03463044|566856239|FG004|Overall Study|Lost to Follow-up|0|||
157027704|NCT03463044|566856240|FG005|Overall Study|Lost to Follow-up|0|||
157027705|NCT03463044|566856241|FG006|Overall Study|Lost to Follow-up|0|||
157027706|NCT03463044|566856242|FG007|Overall Study|Lost to Follow-up|1|||
157027707|NCT03463044|566856243|FG008|Overall Study|Lost to Follow-up|0|||
157027708|NCT05093842|566856246|FG000|Overall Study|Pregnancy loss|1|||
157027709|NCT05093842|566856247|FG001|Overall Study|Pregnancy loss|1|||
157027710|NCT05093842|566856246|FG000|Overall Study|Lost to Follow-up|6|||
157027711|NCT05093842|566856247|FG001|Overall Study|Lost to Follow-up|0|||
157027712|NCT05093842|566856246|FG000|Overall Study|Physician Decision|0|||
157027713|NCT05093842|566856247|FG001|Overall Study|Physician Decision|1|||
157027714|NCT03910478|566856253|FG000|Overall Study|Death|13|||
157027715|NCT03910478|566856254|FG001|Overall Study|Death|6|||
157027716|NCT03910478|566856253|FG000|Overall Study|Withdrawal by Subject|23|||
157161465|NCT01576016|567334646|FG001|Lead Safety|Patient on Palliative Care|0|||
157027717|NCT03910478|566856254|FG001|Overall Study|Withdrawal by Subject|2|||
157027718|NCT03910478|566856253|FG000|Overall Study|Physician Decision|5|||
157027719|NCT03910478|566856254|FG001|Overall Study|Physician Decision|0|||
157027720|NCT03910478|566856253|FG000|Overall Study|Protocol Violation|1|||
157027721|NCT03910478|566856254|FG001|Overall Study|Protocol Violation|0|||
157027722|NCT03910478|566856253|FG000|Overall Study|Failure to meet continuation criteria|2|||
157027723|NCT03910478|566856254|FG001|Overall Study|Failure to meet continuation criteria|0|||
157027724|NCT03910478|566856253|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
157027725|NCT03910478|566856254|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
157027726|NCT03478956|566856256|FG000|Randomized Treatment Period|Adverse Event|1|||
157027727|NCT03478956|566856257|FG001|Randomized Treatment Period|Adverse Event|0|||
157161466|NCT01576016|567334645|FG000|Lead Safety|Patient noncompliance|1|||
157027728|NCT03478956|566856258|FG002|Randomized Treatment Period|Adverse Event|0|||
157027729|NCT03478956|566856259|FG003|Randomized Treatment Period|Adverse Event|0|||
157027730|NCT03478956|566856256|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
157027731|NCT03478956|566856257|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
157027732|NCT03478956|566856258|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
157027733|NCT03478956|566856259|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
157027734|NCT03478956|566856256|FG000|Open Label Extension Period|Adverse Event|0|||
157027735|NCT03478956|566856257|FG001|Open Label Extension Period|Adverse Event|0|||
157027736|NCT03478956|566856258|FG002|Open Label Extension Period|Adverse Event|4|||
157161467|NCT01576016|567334646|FG001|Lead Safety|Patient noncompliance|0|||
157161468|NCT01576016|567334645|FG000|Lead Safety|Too far from study site|1|||
157161469|NCT01576016|567334646|FG001|Lead Safety|Too far from study site|0|||
157161470|NCT01576016|567334645|FG000|Lead Safety|System deactivated|1|||
157161471|NCT01576016|567334646|FG001|Lead Safety|System deactivated|0|||
157161472|NCT01576016|567334645|FG000|Lead Safety|Patient no longer followed by study PI|1|||
156913467|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
156913468|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
156913469|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
156913470|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
156913471|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
156913472|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
156913473|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
156913474|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
156913475|NCT00256750|566442498|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
156913476|NCT00256750|566442499|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
156913477|NCT00256750|566442500|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
156913478|NCT01348165|566442501|FG000|Overall Study|Adverse Event|0|||
156913479|NCT01348165|566442502|FG001|Overall Study|Adverse Event|0|||
156913480|NCT01348165|566442503|FG002|Overall Study|Adverse Event|0|||
156913481|NCT01348165|566442504|FG003|Overall Study|Adverse Event|0|||
156913482|NCT01348165|566442505|FG004|Overall Study|Adverse Event|0|||
156913483|NCT01348165|566442506|FG005|Overall Study|Adverse Event|0|||
156913484|NCT01348165|566442507|FG006|Overall Study|Adverse Event|1|||
156913485|NCT03648983|566442513|FG000|Overall Study|Study was terminated due to PI departure|95|||
156913486|NCT01269463|566442516|FG000|First Intervention|Withdrawal by Subject|1|||
156913487|NCT01269463|566442517|FG001|First Intervention|Withdrawal by Subject|0|||
156913488|NCT01269463|566442516|FG000|First Intervention|Adverse Event|1|||
156913489|NCT01269463|566442517|FG001|First Intervention|Adverse Event|0|||
156913490|NCT01269463|566442516|FG000|First Intervention|Lack of Efficacy|0|||
156913491|NCT01269463|566442517|FG001|First Intervention|Lack of Efficacy|1|||
156913492|NCT01269463|566442516|FG000|First Intervention|Physician Decision|0|||
156913493|NCT01269463|566442517|FG001|First Intervention|Physician Decision|1|||
156913494|NCT00279305|566442518|FG000|Overall Study|Pregnancy|1|||
156913495|NCT00279305|566442519|FG001|Overall Study|Pregnancy|0|||
156913496|NCT00279305|566442518|FG000|Overall Study|Withdrawal by Subject|2|||
156913497|NCT00279305|566442519|FG001|Overall Study|Withdrawal by Subject|0|||
156913498|NCT00279305|566442518|FG000|Overall Study|Dificulting establishing IV|1|||
156913499|NCT00279305|566442519|FG001|Overall Study|Dificulting establishing IV|0|||
156913500|NCT00279305|566442518|FG000|Overall Study|FDA Safety Alert|4|||
156913501|NCT00279305|566442519|FG001|Overall Study|FDA Safety Alert|1|||
156913502|NCT04404361|566442520|FG000|Overall Study|Death|12|||
156913503|NCT04404361|566442521|FG001|Overall Study|Death|12|||
156913504|NCT04404361|566442520|FG000|Overall Study|Withdrawal by Subject|13|||
156913505|NCT04404361|566442521|FG001|Overall Study|Withdrawal by Subject|5|||
156913506|NCT04404361|566442520|FG000|Overall Study|Lost to Follow-up|6|||
156913507|NCT04404361|566442521|FG001|Overall Study|Lost to Follow-up|3|||
156913508|NCT04404361|566442520|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
156913509|NCT04404361|566442521|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
156913510|NCT00558558|566442522|FG000|Overall Study|Unable to swallow|1|||
156913511|NCT00558558|566442522|FG000|Overall Study|Withdrawal by Subject|1|||
156913512|NCT00558558|566442522|FG000|Overall Study|Lack of Efficacy|4|||
156913513|NCT02549937|566442524|FG000|Overall Study|Death|0|||
156913514|NCT02549937|566442525|FG001|Overall Study|Death|1|||
156913515|NCT02549937|566442526|FG002|Overall Study|Death|0|||
156913516|NCT02549937|566442527|FG003|Overall Study|Death|1|||
156913517|NCT02549937|566442528|FG004|Overall Study|Death|0|||
156913518|NCT02549937|566442529|FG005|Overall Study|Death|8|||
156913519|NCT02549937|566442530|FG006|Overall Study|Death|0|||
156913520|NCT02549937|566442531|FG007|Overall Study|Death|0|||
156913521|NCT02549937|566442532|FG008|Overall Study|Death|19|||
156913522|NCT02549937|566442524|FG000|Overall Study|No follow up required|3|||
156913523|NCT02549937|566442525|FG001|Overall Study|No follow up required|6|||
156913524|NCT02549937|566442526|FG002|Overall Study|No follow up required|3|||
156913525|NCT02549937|566442527|FG003|Overall Study|No follow up required|8|||
156913526|NCT02549937|566442528|FG004|Overall Study|No follow up required|12|||
156913527|NCT02549937|566442529|FG005|Overall Study|No follow up required|21|||
156913528|NCT02549937|566442530|FG006|Overall Study|No follow up required|9|||
156913529|NCT02549937|566442531|FG007|Overall Study|No follow up required|11|||
156913530|NCT02549937|566442532|FG008|Overall Study|No follow up required|0|||
156913531|NCT02549937|566442524|FG000|Overall Study|Other|0|||
156913532|NCT02549937|566442525|FG001|Overall Study|Other|0|||
156913533|NCT02549937|566442526|FG002|Overall Study|Other|0|||
156913534|NCT02549937|566442527|FG003|Overall Study|Other|0|||
156913535|NCT02549937|566442528|FG004|Overall Study|Other|1|||
156913536|NCT02549937|566442529|FG005|Overall Study|Other|0|||
157161473|NCT01576016|567334646|FG001|Lead Safety|Patient no longer followed by study PI|0|||
156913537|NCT02549937|566442530|FG006|Overall Study|Other|3|||
156913538|NCT02549937|566442531|FG007|Overall Study|Other|2|||
156913539|NCT02549937|566442532|FG008|Overall Study|Other|3|||
157161474|NCT01576016|567334645|FG000|MRI Safety|Withdrawal by Subject|0|||
157161475|NCT01576016|567334646|FG001|MRI Safety|Withdrawal by Subject|10|||
157161476|NCT01576016|567334645|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
157161477|NCT01576016|567334646|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
157161478|NCT01576016|567334645|FG000|MRI Safety|Has not yet completed MRI scan|0|||
157161479|NCT01576016|567334646|FG001|MRI Safety|Has not yet completed MRI scan|56|||
157161480|NCT01576016|567334645|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
157161481|NCT01576016|567334646|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
157161482|NCT01774344|567334647|FG000|Overall Study|Withdrawal by Subject|3|||
157161483|NCT01774344|567334648|FG001|Overall Study|Withdrawal by Subject|10|||
157161484|NCT01774344|567334647|FG000|Overall Study|Protocol Violation|0|||
157161485|NCT01774344|567334648|FG001|Overall Study|Protocol Violation|1|||
157161486|NCT01774344|567334647|FG000|Overall Study|Lost to Follow-up|4|||
157161487|NCT01774344|567334648|FG001|Overall Study|Lost to Follow-up|10|||
157161488|NCT01774344|567334647|FG000|Overall Study|End of survival follow-up not available|2|||
157161489|NCT01774344|567334648|FG001|Overall Study|End of survival follow-up not available|2|||
157161490|NCT01774344|567334647|FG000|Overall Study|Data collection finished|4|||
157161491|NCT01774344|567334648|FG001|Overall Study|Data collection finished|14|||
157161492|NCT01774344|567334647|FG000|Overall Study|Other|0|||
157161493|NCT01774344|567334648|FG001|Overall Study|Other|1|||
157161494|NCT01774344|567334647|FG000|Overall Study|Did not enter Survival Follow up|49|||
157161495|NCT01774344|567334648|FG001|Overall Study|Did not enter Survival Follow up|83|||
157161496|NCT00436566|567334661|FG000|Overall Study|Withdrawal by Subject|2|||
157161497|NCT00436566|567334661|FG000|Overall Study|Protocol Violation|1|||
157161498|NCT04507867|567334662|FG000|Overall Study|Death|7|||
157161499|NCT04507867|567334663|FG001|Overall Study|Death|1|||
157161500|NCT01860534|567334666|FG000|ROP #1|Needed treatment for ROP|0|||
157161501|NCT01860534|567334667|FG001|ROP #1|Needed treatment for ROP|1|||
157161502|NCT01860534|567334666|FG000|ROP #2|discharged prior to ROP #2|1|||
157161503|NCT01860534|567334667|FG001|ROP #2|discharged prior to ROP #2|0|||
157161504|NCT00194025|567334670|FG000|Overall Study|Adverse Event|1|||
157161505|NCT00194025|567334670|FG000|Overall Study|non-adherence with study medication|4|||
157161506|NCT00543569|567334671|FG000|Overall Study|Death|2|||
157161507|NCT00543569|567334672|FG001|Overall Study|Death|2|||
157161508|NCT00543569|567334673|FG002|Overall Study|Death|3|||
157161509|NCT00543569|567334674|FG003|Overall Study|Death|1|||
157161510|NCT00543569|567334671|FG000|Overall Study|Lost to Follow-up|0|||
157161511|NCT00543569|567334672|FG001|Overall Study|Lost to Follow-up|0|||
157161512|NCT00543569|567334673|FG002|Overall Study|Lost to Follow-up|1|||
157161513|NCT00543569|567334674|FG003|Overall Study|Lost to Follow-up|1|||
157161514|NCT00543569|567334671|FG000|Overall Study|Miscellaneous Reasons|7|||
157161515|NCT00543569|567334672|FG001|Overall Study|Miscellaneous Reasons|3|||
157161516|NCT00543569|567334673|FG002|Overall Study|Miscellaneous Reasons|11|||
157161517|NCT00543569|567334674|FG003|Overall Study|Miscellaneous Reasons|4|||
157161518|NCT00543569|567334671|FG000|Overall Study|Randomized but never received study drug|3|||
157161519|NCT00543569|567334672|FG001|Overall Study|Randomized but never received study drug|3|||
157161520|NCT00543569|567334673|FG002|Overall Study|Randomized but never received study drug|5|||
157161521|NCT00543569|567334674|FG003|Overall Study|Randomized but never received study drug|3|||
157161522|NCT00862849|567334675|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
157161523|NCT00862849|567334676|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
157161524|NCT00862849|567334677|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
156913540|NCT02549937|566442524|FG000|Overall Study|Lost to Follow-up|0|||
157161525|NCT00862849|567334678|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
157161526|NCT00862849|567334679|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
157161527|NCT00862849|567334680|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
157161528|NCT00862849|567334675|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
157161529|NCT00862849|567334676|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
157161530|NCT00862849|567334677|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
157161531|NCT00862849|567334678|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
157161532|NCT00862849|567334679|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
157161533|NCT00862849|567334680|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
157161534|NCT00617409|567334681|FG000|Overall Study|Withdrawal by Subject|4|||
157225953|NCT01545076|567573380|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
156913541|NCT02549937|566442525|FG001|Overall Study|Lost to Follow-up|0|||
157161535|NCT00617409|567334682|FG001|Overall Study|Withdrawal by Subject|1|||
157161536|NCT00617409|567334683|FG002|Overall Study|Withdrawal by Subject|2|||
157161537|NCT00617409|567334681|FG000|Overall Study|Adverse Event|0|||
157161538|NCT00617409|567334682|FG001|Overall Study|Adverse Event|2|||
157161539|NCT00617409|567334683|FG002|Overall Study|Adverse Event|3|||
157161540|NCT00617409|567334681|FG000|Overall Study|Disease Progression|8|||
157225954|NCT01545076|567573376|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
157225955|NCT01545076|567573377|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
157161541|NCT00617409|567334682|FG001|Overall Study|Disease Progression|8|||
157161542|NCT00617409|567334683|FG002|Overall Study|Disease Progression|18|||
156913542|NCT02549937|566442526|FG002|Overall Study|Lost to Follow-up|0|||
156913543|NCT02549937|566442527|FG003|Overall Study|Lost to Follow-up|0|||
156913544|NCT02549937|566442528|FG004|Overall Study|Lost to Follow-up|0|||
156913545|NCT02549937|566442529|FG005|Overall Study|Lost to Follow-up|0|||
156913546|NCT02549937|566442530|FG006|Overall Study|Lost to Follow-up|0|||
156913547|NCT02549937|566442531|FG007|Overall Study|Lost to Follow-up|0|||
156913548|NCT02549937|566442532|FG008|Overall Study|Lost to Follow-up|3|||
156913549|NCT02549937|566442524|FG000|Overall Study|Withdrawal by Subject|0|||
157161543|NCT00617409|567334681|FG000|Overall Study|Death|3|||
157161544|NCT00617409|567334682|FG001|Overall Study|Death|5|||
157161545|NCT00617409|567334683|FG002|Overall Study|Death|4|||
157161546|NCT00617409|567334681|FG000|Overall Study|Alternative Therapy|1|||
157161547|NCT00617409|567334682|FG001|Overall Study|Alternative Therapy|2|||
157161548|NCT00617409|567334683|FG002|Overall Study|Alternative Therapy|0|||
157161549|NCT02124707|567334684|FG000|Overall Study|Adverse Event|5|||
157161550|NCT02124707|567334684|FG000|Overall Study|Physician Decision|1|||
157161551|NCT02124707|567334684|FG000|Overall Study|Death|1|||
157161552|NCT03198754|567334691|FG000|Overall Study|Withdrawal by Subject|5|||
157161553|NCT03198754|567334692|FG001|Overall Study|Withdrawal by Subject|4|||
157161554|NCT03198754|567334691|FG000|Overall Study|Lost to Follow-up|4|||
157161555|NCT03198754|567334692|FG001|Overall Study|Lost to Follow-up|3|||
157161556|NCT03198754|567334691|FG000|Overall Study|Ineligible|2|||
157161557|NCT03198754|567334692|FG001|Overall Study|Ineligible|1|||
157161558|NCT03247413|567334698|FG000|Overall Study|Lost to Follow-up|28|||
157161559|NCT00668200|567334699|FG000|Overall Study|Withdrawal by Subject|2|||
157161560|NCT00668200|567334699|FG000|Overall Study|Lost to Follow-up|1|||
157161561|NCT01100307|567334703|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
157161562|NCT01100307|567334704|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
157161563|NCT01100307|567334703|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
157161564|NCT01100307|567334704|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
157161565|NCT01100307|567334703|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
157161566|NCT01100307|567334704|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
157161567|NCT01100307|567334703|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
157161568|NCT01100307|567334704|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
157161569|NCT01100307|567334703|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
157161570|NCT01100307|567334704|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
157161571|NCT01100307|567334703|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
157161572|NCT01100307|567334704|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
156913550|NCT02549937|566442525|FG001|Overall Study|Withdrawal by Subject|0|||
156913551|NCT02549937|566442526|FG002|Overall Study|Withdrawal by Subject|0|||
156913552|NCT02549937|566442527|FG003|Overall Study|Withdrawal by Subject|0|||
156913553|NCT02549937|566442528|FG004|Overall Study|Withdrawal by Subject|0|||
156913554|NCT02549937|566442529|FG005|Overall Study|Withdrawal by Subject|1|||
156913555|NCT02549937|566442530|FG006|Overall Study|Withdrawal by Subject|4|||
156913556|NCT02549937|566442531|FG007|Overall Study|Withdrawal by Subject|3|||
156913557|NCT02549937|566442532|FG008|Overall Study|Withdrawal by Subject|2|||
156913558|NCT02549937|566442524|FG000|Overall Study|Sponsor Decision|0|||
156913559|NCT02549937|566442525|FG001|Overall Study|Sponsor Decision|0|||
156913560|NCT02549937|566442526|FG002|Overall Study|Sponsor Decision|0|||
156913561|NCT02549937|566442527|FG003|Overall Study|Sponsor Decision|0|||
156913562|NCT02549937|566442528|FG004|Overall Study|Sponsor Decision|0|||
156913563|NCT02549937|566442529|FG005|Overall Study|Sponsor Decision|0|||
156913564|NCT02549937|566442530|FG006|Overall Study|Sponsor Decision|0|||
156913565|NCT02549937|566442531|FG007|Overall Study|Sponsor Decision|0|||
156913566|NCT02549937|566442532|FG008|Overall Study|Sponsor Decision|6|||
157161573|NCT01496430|567334705|FG000|Overall Study|Adverse Event|0|||
157161574|NCT01496430|567334706|FG001|Overall Study|Adverse Event|0|||
157161575|NCT01496430|567334707|FG002|Overall Study|Adverse Event|1|||
157161576|NCT01496430|567334705|FG000|Overall Study|Major Protocol Deviation|0|||
157161577|NCT01496430|567334706|FG001|Overall Study|Major Protocol Deviation|0|||
157161578|NCT01496430|567334707|FG002|Overall Study|Major Protocol Deviation|1|||
157161579|NCT01496430|567334705|FG000|Overall Study|Lost to Follow-up|2|||
156913567|NCT01638546|566442544|FG000|Overall Study|Adverse Event|1|||
157027737|NCT03478956|566856259|FG003|Open Label Extension Period|Adverse Event|0|||
157161580|NCT01496430|567334706|FG001|Overall Study|Lost to Follow-up|3|||
157161581|NCT01496430|567334707|FG002|Overall Study|Lost to Follow-up|1|||
157161582|NCT01496430|567334705|FG000|Overall Study|Voluntary Withdrawal|2|||
157161583|NCT01496430|567334706|FG001|Overall Study|Voluntary Withdrawal|1|||
157161584|NCT01496430|567334707|FG002|Overall Study|Voluntary Withdrawal|6|||
157161585|NCT01496430|567334705|FG000|Overall Study|Principal Investigator Discretion|0|||
157161586|NCT01496430|567334706|FG001|Overall Study|Principal Investigator Discretion|1|||
157161587|NCT01496430|567334707|FG002|Overall Study|Principal Investigator Discretion|1|||
156913568|NCT01638546|566442545|FG001|Overall Study|Adverse Event|3|||
156913569|NCT04292743|566442548|FG000|Overall Study|Physician Decision|1|||
156913570|NCT04292743|566442549|FG001|Overall Study|Physician Decision|3|||
156913571|NCT04292743|566442550|FG002|Overall Study|Physician Decision|0|||
156913572|NCT04292743|566442551|FG003|Overall Study|Physician Decision|0|||
156913573|NCT04292743|566442548|FG000|Overall Study|Withdrawal by Subject|0|||
156913574|NCT04292743|566442549|FG001|Overall Study|Withdrawal by Subject|5|||
156913575|NCT04292743|566442550|FG002|Overall Study|Withdrawal by Subject|0|||
156913576|NCT04292743|566442551|FG003|Overall Study|Withdrawal by Subject|0|||
156913577|NCT04292743|566442548|FG000|Overall Study|Death|0|||
156913578|NCT04292743|566442549|FG001|Overall Study|Death|1|||
156913579|NCT04292743|566442550|FG002|Overall Study|Death|0|||
156913580|NCT04292743|566442551|FG003|Overall Study|Death|0|||
156913581|NCT04292743|566442548|FG000|Overall Study|Progression of Disease|2|||
156913582|NCT04292743|566442549|FG001|Overall Study|Progression of Disease|5|||
156913583|NCT04292743|566442550|FG002|Overall Study|Progression of Disease|0|||
156913584|NCT04292743|566442551|FG003|Overall Study|Progression of Disease|0|||
156913585|NCT04292743|566442548|FG000|Overall Study|No Treatment per protocol|0|||
156913586|NCT04292743|566442549|FG001|Overall Study|No Treatment per protocol|2|||
156913587|NCT04292743|566442550|FG002|Overall Study|No Treatment per protocol|0|||
156913588|NCT04292743|566442551|FG003|Overall Study|No Treatment per protocol|0|||
156913589|NCT05330702|566442552|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
156913590|NCT05330702|566442553|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
156913591|NCT05330702|566442554|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
156913592|NCT02881554|566442555|FG000|Overall Study|Withdrawal by Subject|2|||
157161588|NCT01496430|567334705|FG000|Overall Study|Other|2|||
157161589|NCT01496430|567334706|FG001|Overall Study|Other|0|||
157161590|NCT01496430|567334707|FG002|Overall Study|Other|0|||
156913593|NCT02881554|566442556|FG001|Overall Study|Withdrawal by Subject|0|||
156913594|NCT00331682|566444594|FG000|Overall Study|Adverse Event|1|||
156913595|NCT03292588|566444595|FG000|Overall Study|Death|1|||
156913596|NCT03292588|566444596|FG001|Overall Study|Death|0|||
156913597|NCT03292588|566444595|FG000|Overall Study|Lost to Follow-up|12|||
156913598|NCT03292588|566444596|FG001|Overall Study|Lost to Follow-up|16|||
156913599|NCT03292588|566444595|FG000|Overall Study|Physician Decision|0|||
156913600|NCT03292588|566444596|FG001|Overall Study|Physician Decision|1|||
156913601|NCT03292588|566444595|FG000|Overall Study|Withdrawal by Subject|4|||
156913602|NCT03292588|566444596|FG001|Overall Study|Withdrawal by Subject|4|||
156913603|NCT03292588|566444595|FG000|Overall Study|Move out of town|1|||
156913604|NCT03292588|566444596|FG001|Overall Study|Move out of town|0|||
156913605|NCT03292588|566444595|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
156913606|NCT03292588|566444596|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
156913607|NCT00187486|566444597|FG000|Overall Study|Protocol Violation|1|||
156913608|NCT00684307|566444598|FG000|Overall Study|Adverse Event|11|||
156913609|NCT00684307|566444599|FG001|Overall Study|Adverse Event|6|||
156913610|NCT00684307|566444600|FG002|Overall Study|Adverse Event|15|||
156913611|NCT00684307|566444601|FG003|Overall Study|Adverse Event|16|||
156913612|NCT00684307|566444602|FG004|Overall Study|Adverse Event|8|||
156913613|NCT00684307|566444598|FG000|Overall Study|Development of increasing Liver Function|0|||
156913614|NCT00684307|566444599|FG001|Overall Study|Development of increasing Liver Function|2|||
156913615|NCT00684307|566444600|FG002|Overall Study|Development of increasing Liver Function|0|||
156913616|NCT00684307|566444601|FG003|Overall Study|Development of increasing Liver Function|1|||
156913617|NCT00684307|566444602|FG004|Overall Study|Development of increasing Liver Function|0|||
156913618|NCT00684307|566444598|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
156913619|NCT00684307|566444599|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
156913620|NCT00684307|566444600|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
156913621|NCT00684307|566444601|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
156913622|NCT00684307|566444602|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
156913623|NCT00684307|566444598|FG000|Overall Study|Incorrect enrolment or randomization|4|||
156913624|NCT00684307|566444599|FG001|Overall Study|Incorrect enrolment or randomization|0|||
156913625|NCT00684307|566444600|FG002|Overall Study|Incorrect enrolment or randomization|0|||
156913626|NCT00684307|566444601|FG003|Overall Study|Incorrect enrolment or randomization|0|||
156913627|NCT00684307|566444602|FG004|Overall Study|Incorrect enrolment or randomization|0|||
156913628|NCT00684307|566444598|FG000|Overall Study|Interupted IP for more than 7 days|0|||
156913629|NCT00684307|566444599|FG001|Overall Study|Interupted IP for more than 7 days|4|||
156913630|NCT00684307|566444600|FG002|Overall Study|Interupted IP for more than 7 days|1|||
156913631|NCT00684307|566444601|FG003|Overall Study|Interupted IP for more than 7 days|3|||
156913632|NCT00684307|566444602|FG004|Overall Study|Interupted IP for more than 7 days|3|||
156913633|NCT00684307|566444598|FG000|Overall Study|Severe non compliance to protocol|1|||
156913634|NCT00684307|566444599|FG001|Overall Study|Severe non compliance to protocol|0|||
156913635|NCT00684307|566444600|FG002|Overall Study|Severe non compliance to protocol|0|||
156913636|NCT00684307|566444601|FG003|Overall Study|Severe non compliance to protocol|1|||
156913637|NCT00684307|566444602|FG004|Overall Study|Severe non compliance to protocol|2|||
156913638|NCT00684307|566444598|FG000|Overall Study|Participant not willing to continue|7|||
156913639|NCT00684307|566444599|FG001|Overall Study|Participant not willing to continue|10|||
156913640|NCT00684307|566444600|FG002|Overall Study|Participant not willing to continue|11|||
156913641|NCT00684307|566444601|FG003|Overall Study|Participant not willing to continue|5|||
157161591|NCT00997321|567334708|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
157161592|NCT00997321|567334709|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
157161593|NCT02196038|567334712|FG000|Overall Study|Death|16|||
157161594|NCT02196038|567334713|FG001|Overall Study|Death|21|||
157161595|NCT02196038|567334712|FG000|Overall Study|Withdrawal by Subject|0|||
157161596|NCT02196038|567334713|FG001|Overall Study|Withdrawal by Subject|1|||
157161597|NCT02196038|567334712|FG000|Overall Study|Lost to Follow-up|1|||
157161598|NCT02196038|567334713|FG001|Overall Study|Lost to Follow-up|0|||
157161599|NCT01151579|567334727|FG000|Overall Study|Physician Decision|3|||
157161600|NCT01151579|567334728|FG001|Overall Study|Physician Decision|1|||
157161601|NCT01151579|567334727|FG000|Overall Study|Withdrawal by Subject|3|||
157161602|NCT01151579|567334728|FG001|Overall Study|Withdrawal by Subject|2|||
157161603|NCT01151579|567334727|FG000|Overall Study|Not meet inclusion criteria|6|||
157161604|NCT01151579|567334728|FG001|Overall Study|Not meet inclusion criteria|4|||
157161605|NCT00305253|567334729|FG000|Overall Study|Withdrawal by Subject|0|||
157161606|NCT00305253|567334730|FG001|Overall Study|Withdrawal by Subject|1|||
157161607|NCT01357915|567334731|FG000|Overall Study|Lost to Follow-up|3|||
157161608|NCT01357915|567334732|FG001|Overall Study|Lost to Follow-up|0|||
157161609|NCT00369668|567334741|FG000|Overall Study|Lack of Efficacy|4|||
157161610|NCT00369668|567334742|FG001|Overall Study|Lack of Efficacy|5|||
157161611|NCT00369668|567334743|FG002|Overall Study|Lack of Efficacy|7|||
157161612|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
157161613|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
157161614|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
157161615|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
157161616|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
157161617|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
157161618|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
157161619|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
157161620|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
157161621|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
157161622|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
157161623|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
157161624|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
157161625|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
157161626|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
157161627|NCT03855137|567334744|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
157161628|NCT03855137|567334745|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
157161629|NCT03855137|567334746|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
157161630|NCT03855137|567334744|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
157161631|NCT03855137|567334745|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
157161632|NCT03855137|567334746|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
157161633|NCT03855137|567334744|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
157161634|NCT03855137|567334745|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
157161635|NCT03855137|567334746|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
157161636|NCT03855137|567334744|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
157161637|NCT03855137|567334745|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
157161638|NCT03855137|567334746|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
157161639|NCT03855137|567334744|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
157161640|NCT03855137|567334745|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
157161641|NCT03855137|567334746|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
157161642|NCT03213626|567334747|FG000|Overall Study|Adverse Event|1|||
157161643|NCT03213626|567334747|FG000|Overall Study|Progressive Disease|6|||
157161644|NCT01005732|567334748|FG000|Overall Study|Lost to Follow-up|10|||
157161645|NCT01005732|567334748|FG000|Overall Study|Death|1|||
157161646|NCT01552928|567334749|FG000|Period 3|Adverse Event|0|||
157161647|NCT01552928|567334750|FG001|Period 3|Adverse Event|0|||
157161648|NCT01552928|567334751|FG002|Period 3|Adverse Event|1|||
157161649|NCT01552928|567334752|FG003|Period 3|Adverse Event|0|||
157161650|NCT00992446|567334756|FG000|Overall Study|Disease Progression|1|||
157161651|NCT00992446|567334756|FG000|Overall Study|Withdrawal by Subject|2|||
156913642|NCT00684307|566444602|FG004|Overall Study|Participant not willing to continue|8|||
156913643|NCT00684307|566444598|FG000|Overall Study|Criteria from the CSR|0|||
157161652|NCT00992446|567334756|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
157161653|NCT02625324|567336879|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
157161654|NCT02625324|567336879|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
157161655|NCT02625324|567336879|FG000|6-Month Follow-up Subject Accountability|Death|5|||
157161656|NCT02625324|567336879|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
157161657|NCT02625324|567336879|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
157161658|NCT02625324|567336879|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
157161659|NCT02625324|567336879|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
157161660|NCT02625324|567336879|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
157161661|NCT02625324|567336879|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
157161662|NCT02625324|567336879|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
157161663|NCT02625324|567336879|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
157161664|NCT02625324|567336879|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
157161665|NCT02625324|567336879|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
157161666|NCT02625324|567336879|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
157161667|NCT02625324|567336879|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
157161668|NCT02625324|567336879|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
157161669|NCT02625324|567336879|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
157161670|NCT02115113|567336880|FG000|Participants in Run-in Period|Death|0|||
157161671|NCT02115113|567336881|FG001|Participants in Run-in Period|Death|0|||
157161672|NCT02115113|567336882|FG002|Participants in Run-in Period|Death|1|||
157161673|NCT02115113|567336880|FG000|Participants in Run-in Period|Administrative problems|0|||
157161674|NCT02115113|567336881|FG001|Participants in Run-in Period|Administrative problems|0|||
157161675|NCT02115113|567336882|FG002|Participants in Run-in Period|Administrative problems|1|||
157161676|NCT02115113|567336880|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
157161677|NCT02115113|567336881|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
157161678|NCT02115113|567336882|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
157161679|NCT02115113|567336880|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
157161680|NCT02115113|567336881|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
157161681|NCT02115113|567336882|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
157161682|NCT02115113|567336880|FG000|Participants Randomized|Lost to Follow-up|1|||
157161683|NCT02115113|567336881|FG001|Participants Randomized|Lost to Follow-up|0|||
157161684|NCT02115113|567336882|FG002|Participants Randomized|Lost to Follow-up|0|||
157161685|NCT02115113|567336880|FG000|Participants Randomized|Death|1|||
157161686|NCT02115113|567336881|FG001|Participants Randomized|Death|0|||
157161687|NCT02115113|567336882|FG002|Participants Randomized|Death|0|||
157161688|NCT00789191|567336883|FG000|Overall Study|Adverse Event|2|||
157161689|NCT00789191|567336884|FG001|Overall Study|Adverse Event|4|||
157161690|NCT00789191|567336883|FG000|Overall Study|Lack of Efficacy|0|||
157161691|NCT00789191|567336884|FG001|Overall Study|Lack of Efficacy|5|||
157161692|NCT00789191|567336883|FG000|Overall Study|Protocol Violation|5|||
157225956|NCT01545076|567573378|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
157225957|NCT01545076|567573379|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
157225958|NCT01545076|567573380|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
157225959|NCT01545076|567573376|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
156913644|NCT00684307|566444599|FG001|Overall Study|Criteria from the CSR|0|||
156913645|NCT00684307|566444600|FG002|Overall Study|Criteria from the CSR|1|||
156913646|NCT00684307|566444601|FG003|Overall Study|Criteria from the CSR|3|||
156913647|NCT00684307|566444602|FG004|Overall Study|Criteria from the CSR|3|||
156913648|NCT00759031|566444603|FG000|First Intervention (1 Day)|Physician Decision|1|||
156913649|NCT00759031|566444604|FG001|First Intervention (1 Day)|Physician Decision|0|||
156913650|NCT00759031|566444603|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
156913651|NCT00759031|566444604|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
156913652|NCT00759031|566444603|FG000|First Intervention (1 Day)|Screening failure|1|||
156913653|NCT00759031|566444604|FG001|First Intervention (1 Day)|Screening failure|0|||
156913654|NCT00543140|566444605|FG000|Overall Study|Lost to Follow-up|33|||
156913655|NCT00543140|566444605|FG000|Overall Study|Withdrawal by Subject|13|||
156913656|NCT00543140|566444605|FG000|Overall Study|Protocol Violation|10|||
156913657|NCT00543140|566444605|FG000|Overall Study|Insufficient weight loss|10|||
156913658|NCT00543140|566444605|FG000|Overall Study|SAE leading to explant of SAGB|3|||
156913659|NCT00543140|566444605|FG000|Overall Study|Death|1|||
156913660|NCT00543140|566444605|FG000|Overall Study|Subject moved|1|||
156913661|NCT00543140|566444605|FG000|Overall Study|Conversion to different procedure|1|||
156913662|NCT02101060|566444606|FG000|Overall Study|Adverse Event|1|||
156913663|NCT02101060|566444607|FG001|Overall Study|Adverse Event|0|||
156913664|NCT02101060|566444606|FG000|Overall Study|Withdrawal by Subject|1|||
156913665|NCT02101060|566444607|FG001|Overall Study|Withdrawal by Subject|1|||
156913666|NCT02101060|566444606|FG000|Overall Study|Lost to Follow-up|3|||
157161693|NCT00789191|567336884|FG001|Overall Study|Protocol Violation|3|||
157225960|NCT01545076|567573377|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
156913667|NCT02101060|566444607|FG001|Overall Study|Lost to Follow-up|3|||
156913668|NCT02269241|566444608|FG000|Overall Study|Lost to Follow-up|269|||
156913669|NCT02269241|566444608|FG000|Overall Study|Withdrawal by Subject|155|||
156913670|NCT02269241|566444608|FG000|Overall Study|Protocol Violation|1|||
157161694|NCT00789191|567336883|FG000|Overall Study|Withdrawal Criteria|2|||
156913671|NCT02269241|566444608|FG000|Overall Study|Physician Decision|7|||
156913672|NCT02269241|566444608|FG000|Overall Study|Pregnancy|15|||
156913673|NCT02269241|566444608|FG000|Overall Study|Wish for pregnancy|5|||
157161695|NCT00789191|567336884|FG001|Overall Study|Withdrawal Criteria|4|||
156913674|NCT02269241|566444608|FG000|Overall Study|Development of an exclusion criteria|16|||
156913675|NCT02269241|566444608|FG000|Overall Study|Adverse Event|113|||
156913676|NCT02269241|566444608|FG000|Overall Study|At the specific request of the sponsor|20|||
156913677|NCT02269241|566444608|FG000|Overall Study|Several reasons not classified|53|||
156913678|NCT02269241|566444608|FG000|Overall Study|Screening failures|546|||
156913679|NCT02270957|566444609|FG000|Overall Study|Lack of Efficacy|2|||
156913680|NCT02270957|566444610|FG001|Overall Study|Lack of Efficacy|4|||
157161696|NCT00789191|567336883|FG000|Overall Study|Unclassified|5|||
157161697|NCT00789191|567336884|FG001|Overall Study|Unclassified|3|||
157161698|NCT03497429|567336886|FG000|Overall Study|Progressive disease|3|||
157161699|NCT03497429|567336887|FG001|Overall Study|Progressive disease|4|||
157161700|NCT03497429|567336886|FG000|Overall Study|Adverse Event|0|||
157161701|NCT03497429|567336887|FG001|Overall Study|Adverse Event|2|||
157161702|NCT00605722|567336891|FG000|Overall Study|Adverse Event|6|||
157027738|NCT03478956|566856256|FG000|Open Label Extension Period|Lack of Efficacy|0|||
157161703|NCT00605722|567336891|FG000|Overall Study|Insufficient therapeutic response|44|||
157161704|NCT00605722|567336891|FG000|Overall Study|Failure to return|1|||
157161705|NCT00356863|567336894|FG000|Overall Study|Death|16|||
157161706|NCT00356863|567336895|FG001|Overall Study|Death|32|||
157161707|NCT00356863|567336894|FG000|Overall Study|Lost to Follow-up|76|||
157161708|NCT00356863|567336895|FG001|Overall Study|Lost to Follow-up|43|||
157161709|NCT00836277|567336898|FG000|Overall Study|Not evaluable for response|6|||
157161710|NCT00280150|567336899|FG000|Overall Study|Adverse Event|0|||
157161711|NCT00280150|567336900|FG001|Overall Study|Adverse Event|1|||
157161712|NCT00280150|567336901|FG002|Overall Study|Adverse Event|2|||
157161713|NCT00280150|567336902|FG003|Overall Study|Adverse Event|3|||
157161714|NCT00280150|567336899|FG000|Overall Study|Lack of Efficacy|0|||
157161715|NCT00280150|567336900|FG001|Overall Study|Lack of Efficacy|0|||
157161716|NCT00280150|567336901|FG002|Overall Study|Lack of Efficacy|0|||
157161717|NCT00280150|567336902|FG003|Overall Study|Lack of Efficacy|3|||
157161718|NCT00280150|567336899|FG000|Overall Study|Physician Decision|0|||
157161719|NCT00280150|567336900|FG001|Overall Study|Physician Decision|0|||
157161720|NCT00280150|567336901|FG002|Overall Study|Physician Decision|0|||
157161721|NCT00280150|567336902|FG003|Overall Study|Physician Decision|1|||
157161722|NCT00280150|567336899|FG000|Overall Study|Protocol Violation|0|||
157161723|NCT00280150|567336900|FG001|Overall Study|Protocol Violation|0|||
157161724|NCT00280150|567336901|FG002|Overall Study|Protocol Violation|0|||
157161725|NCT00280150|567336902|FG003|Overall Study|Protocol Violation|1|||
157161726|NCT00280150|567336899|FG000|Overall Study|Withdrawal by Subject|0|||
157161727|NCT00280150|567336900|FG001|Overall Study|Withdrawal by Subject|0|||
157161728|NCT00280150|567336901|FG002|Overall Study|Withdrawal by Subject|0|||
157161729|NCT00280150|567336902|FG003|Overall Study|Withdrawal by Subject|1|||
157161730|NCT00280150|567336899|FG000|Overall Study|Did not get consolidation therapy|3|||
157161731|NCT00280150|567336900|FG001|Overall Study|Did not get consolidation therapy|0|||
157161732|NCT00280150|567336901|FG002|Overall Study|Did not get consolidation therapy|3|||
157161733|NCT00280150|567336902|FG003|Overall Study|Did not get consolidation therapy|0|||
157161734|NCT00280150|567336899|FG000|Overall Study|Declining Performance Status|0|||
157161735|NCT00280150|567336900|FG001|Overall Study|Declining Performance Status|0|||
157161736|NCT00280150|567336901|FG002|Overall Study|Declining Performance Status|0|||
157161737|NCT00280150|567336902|FG003|Overall Study|Declining Performance Status|1|||
157161738|NCT02871401|567336910|FG000|Overall Study|Adverse Event|1|||
157161739|NCT02871401|567336911|FG001|Overall Study|Adverse Event|0|||
157161740|NCT04031404|567336912|FG000|Baseline|Lost to Follow-up|0|||
157161741|NCT04031404|567336913|FG001|Baseline|Lost to Follow-up|1|||
157161742|NCT04031404|567336912|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
157161743|NCT04031404|567336913|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
157161744|NCT04031404|567336912|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
157161745|NCT04031404|567336913|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
157161746|NCT04031404|567336912|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
157161747|NCT04031404|567336913|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
157161748|NCT04031404|567336912|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
157161749|NCT04031404|567336913|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
157161750|NCT01993615|567336917|FG000|Overall Study|Death|1|||
157161751|NCT01993615|567336918|FG001|Overall Study|Death|0|||
156913681|NCT02270957|566444609|FG000|Overall Study|Adverse Event|2|||
157161752|NCT02282982|567336919|FG000|Overall Study|Lost to Follow-up|15|||
157161753|NCT02282982|567336919|FG000|Overall Study|Withdrew consent|2|||
157161754|NCT02282982|567336919|FG000|Overall Study|Death|4|||
157161755|NCT02282982|567336919|FG000|Overall Study|Lack of product|156|||
157161756|NCT02282982|567336919|FG000|Overall Study|Palivizumab is ended|11|||
157161757|NCT02282982|567336919|FG000|Overall Study|Other, not specified|18|||
157161758|NCT02939937|567336920|FG000|Overall Study|Adverse Event|5|||
157161759|NCT02939937|567336921|FG001|Overall Study|Adverse Event|0|||
156913682|NCT02270957|566444610|FG001|Overall Study|Adverse Event|0|||
156913683|NCT00284050|566444611|FG000|Overall Study|Adverse Event|1|||
157161760|NCT02939937|567336920|FG000|Overall Study|Lost to Follow-up|1|||
157161761|NCT02939937|567336921|FG001|Overall Study|Lost to Follow-up|3|||
157161762|NCT01354353|567336922|FG000|Overall Study|Adverse Event|1|||
156913684|NCT00284050|566444612|FG001|Overall Study|Adverse Event|1|||
157161763|NCT01354353|567336923|FG001|Overall Study|Adverse Event|0|||
157161764|NCT01354353|567336924|FG002|Overall Study|Adverse Event|0|||
157161765|NCT01354353|567336925|FG003|Overall Study|Adverse Event|4|||
157161766|NCT01354353|567336926|FG004|Overall Study|Adverse Event|0|||
157161767|NCT01354353|567336927|FG005|Overall Study|Adverse Event|5|||
157161768|NCT01354353|567336922|FG000|Overall Study|Entry Criteria Not Met|0|||
157161769|NCT01354353|567336923|FG001|Overall Study|Entry Criteria Not Met|0|||
157161770|NCT01354353|567336924|FG002|Overall Study|Entry Criteria Not Met|0|||
157161771|NCT01354353|567336925|FG003|Overall Study|Entry Criteria Not Met|1|||
157161772|NCT01354353|567336926|FG004|Overall Study|Entry Criteria Not Met|1|||
157161773|NCT01354353|567336927|FG005|Overall Study|Entry Criteria Not Met|0|||
157161774|NCT01354353|567336922|FG000|Overall Study|Physician Decision|0|||
157161775|NCT01354353|567336923|FG001|Overall Study|Physician Decision|1|||
157161776|NCT01354353|567336924|FG002|Overall Study|Physician Decision|1|||
157161777|NCT01354353|567336925|FG003|Overall Study|Physician Decision|0|||
157161778|NCT01354353|567336926|FG004|Overall Study|Physician Decision|0|||
157161779|NCT01354353|567336927|FG005|Overall Study|Physician Decision|0|||
157161780|NCT01354353|567336922|FG000|Overall Study|Withdrawal by Subject|2|||
157161781|NCT01354353|567336923|FG001|Overall Study|Withdrawal by Subject|0|||
157161782|NCT01354353|567336924|FG002|Overall Study|Withdrawal by Subject|1|||
157161783|NCT01354353|567336925|FG003|Overall Study|Withdrawal by Subject|0|||
157161784|NCT01354353|567336926|FG004|Overall Study|Withdrawal by Subject|0|||
157161785|NCT01354353|567336927|FG005|Overall Study|Withdrawal by Subject|1|||
157161786|NCT00502320|567336928|FG000|Overall Study|Lost to Follow-up|1|||
157161787|NCT00502320|567336929|FG001|Overall Study|Lost to Follow-up|1|||
157161788|NCT00502320|567336928|FG000|Overall Study|Withdrew Consent|1|||
157161789|NCT00502320|567336929|FG001|Overall Study|Withdrew Consent|0|||
157161790|NCT00502320|567336928|FG000|Overall Study|No longer met criteria|1|||
157161791|NCT00502320|567336929|FG001|Overall Study|No longer met criteria|0|||
157161792|NCT00502320|567336928|FG000|Overall Study|Screen Failure|0|||
157161793|NCT00502320|567336929|FG001|Overall Study|Screen Failure|1|||
157161794|NCT00502320|567336928|FG000|Overall Study|Adverse Event|3|||
157161795|NCT00502320|567336929|FG001|Overall Study|Adverse Event|5|||
157161796|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
157161797|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
157161798|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Death|2|||
157161799|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Death|1|||
157161800|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
157161801|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
157161802|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
157161803|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
157161804|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
157161805|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
157161806|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
157161807|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
157161808|NCT03633227|567336942|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
157161809|NCT03633227|567336943|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
157161810|NCT03633227|567336942|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
157161811|NCT03633227|567336943|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
157161812|NCT03633227|567336942|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
157161813|NCT03633227|567336943|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
157161814|NCT03633227|567336942|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
157161815|NCT03633227|567336943|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
157161816|NCT03633227|567336942|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
157161817|NCT03633227|567336943|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
157161818|NCT03633227|567336942|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
157161819|NCT03633227|567336943|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
157161820|NCT03491553|567336944|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
157161821|NCT03491553|567336945|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
157161822|NCT03491553|567336946|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
156863400|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863401|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863402|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
156863403|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
156863404|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863405|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
156863406|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
156863407|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
156863408|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
156913685|NCT00284050|566444613|FG002|Overall Study|Adverse Event|1|||
156913686|NCT00284050|566444611|FG000|Overall Study|Lack of Efficacy|0|||
156913687|NCT00284050|566444612|FG001|Overall Study|Lack of Efficacy|1|||
156913688|NCT00284050|566444613|FG002|Overall Study|Lack of Efficacy|3|||
156913689|NCT00284050|566444611|FG000|Overall Study|Protocol Violation|0|||
157161823|NCT03491553|567336947|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
157161824|NCT03491553|567336948|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
157161825|NCT03491553|567336949|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
157161826|NCT03491553|567336944|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
157161827|NCT03491553|567336945|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
157161828|NCT03491553|567336946|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
157161829|NCT03491553|567336947|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
157161830|NCT03491553|567336948|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
157161831|NCT03491553|567336949|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
157161832|NCT01479374|567336957|FG000|Overall Study|Adverse Event|2|||
157161833|NCT01479374|567336958|FG001|Overall Study|Adverse Event|1|||
157161834|NCT01479374|567336959|FG002|Overall Study|Adverse Event|0|||
157161835|NCT01479374|567336957|FG000|Overall Study|Lost to Follow-up|1|||
157161836|NCT01479374|567336958|FG001|Overall Study|Lost to Follow-up|2|||
157161837|NCT01479374|567336959|FG002|Overall Study|Lost to Follow-up|0|||
157161838|NCT01479374|567336957|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
157161839|NCT01479374|567336958|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
157161840|NCT01479374|567336959|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
157161841|NCT01479374|567336957|FG000|Overall Study|Other|0|||
157161842|NCT01479374|567336958|FG001|Overall Study|Other|4|||
157161843|NCT01479374|567336959|FG002|Overall Study|Other|5|||
157161844|NCT01606761|567336960|FG000|Prior to Week 24|Lost to Follow-up|0|||
157161845|NCT01606761|567336961|FG001|Prior to Week 24|Lost to Follow-up|3|||
157161846|NCT01606761|567336962|FG002|Prior to Week 24|Lost to Follow-up|2|||
157161847|NCT01606761|567336963|FG003|Prior to Week 24|Lost to Follow-up|0|||
157161848|NCT01606761|567336964|FG004|Prior to Week 24|Lost to Follow-up|0|||
157161849|NCT01606761|567336960|FG000|Prior to Week 24|Withdrawal by Subject|12|||
157161850|NCT01606761|567336961|FG001|Prior to Week 24|Withdrawal by Subject|10|||
157161851|NCT01606761|567336962|FG002|Prior to Week 24|Withdrawal by Subject|9|||
157161852|NCT01606761|567336963|FG003|Prior to Week 24|Withdrawal by Subject|0|||
157161853|NCT01606761|567336964|FG004|Prior to Week 24|Withdrawal by Subject|0|||
157161854|NCT01606761|567336960|FG000|Prior to Week 24|Adverse Event|11|||
157161855|NCT01606761|567336961|FG001|Prior to Week 24|Adverse Event|18|||
157161856|NCT01606761|567336962|FG002|Prior to Week 24|Adverse Event|22|||
157161857|NCT01606761|567336963|FG003|Prior to Week 24|Adverse Event|0|||
157161858|NCT01606761|567336964|FG004|Prior to Week 24|Adverse Event|0|||
156913690|NCT00284050|566444612|FG001|Overall Study|Protocol Violation|1|||
156913691|NCT00284050|566444613|FG002|Overall Study|Protocol Violation|2|||
156913692|NCT00284050|566444611|FG000|Overall Study|Withdrawal by Subject|2|||
156913693|NCT00284050|566444612|FG001|Overall Study|Withdrawal by Subject|2|||
156913694|NCT00284050|566444613|FG002|Overall Study|Withdrawal by Subject|2|||
156913695|NCT00284050|566444611|FG000|Overall Study|Lost to Follow-up|1|||
156913696|NCT00284050|566444612|FG001|Overall Study|Lost to Follow-up|0|||
156913697|NCT00284050|566444613|FG002|Overall Study|Lost to Follow-up|1|||
156913698|NCT00284050|566444611|FG000|Overall Study|Death|1|||
156913699|NCT00284050|566444612|FG001|Overall Study|Death|0|||
156913700|NCT00284050|566444613|FG002|Overall Study|Death|0|||
156913701|NCT00166114|566444614|FG000|Overall Study|Protocol Violation|2|||
156913702|NCT00166114|566444615|FG001|Overall Study|Protocol Violation|1|||
156913703|NCT00166114|566444614|FG000|Overall Study|Withdrawal by Subject|10|||
156913704|NCT00166114|566444615|FG001|Overall Study|Withdrawal by Subject|4|||
156913705|NCT00166114|566444614|FG000|Overall Study|Adverse Event|2|||
156913706|NCT00166114|566444615|FG001|Overall Study|Adverse Event|1|||
156913707|NCT03978832|566444638|FG000|Overall Study|Adverse Event|1|||
156913708|NCT03978832|566444638|FG000|Overall Study|Lost to Follow-up|1|||
156913709|NCT03978832|566444638|FG000|Overall Study|Withdrawal by Subject|6|||
156913710|NCT03978832|566444638|FG000|Overall Study|Physician Decision|2|||
157161859|NCT01606761|567336960|FG000|Prior to Week 24|Lack of Efficacy|15|||
157161860|NCT01606761|567336961|FG001|Prior to Week 24|Lack of Efficacy|14|||
157161861|NCT01606761|567336962|FG002|Prior to Week 24|Lack of Efficacy|8|||
157161862|NCT01606761|567336963|FG003|Prior to Week 24|Lack of Efficacy|0|||
157161863|NCT01606761|567336964|FG004|Prior to Week 24|Lack of Efficacy|0|||
157161864|NCT01606761|567336960|FG000|Prior to Week 24|Physician Decision|0|||
157161865|NCT01606761|567336961|FG001|Prior to Week 24|Physician Decision|3|||
156913711|NCT03978832|566444638|FG000|Overall Study|did not pass screening criteria|44|||
156913712|NCT00003499|566444639|FG000|Overall Study|Not evaluable|8|||
156913713|NCT02042183|566444640|FG000|Overall Study|Physician Decision|7|||
156913714|NCT02042183|566444641|FG001|Overall Study|Physician Decision|2|||
156913715|NCT02042183|566444640|FG000|Overall Study|Lack of Efficacy|4|||
157161866|NCT01606761|567336962|FG002|Prior to Week 24|Physician Decision|1|||
157161867|NCT01606761|567336963|FG003|Prior to Week 24|Physician Decision|0|||
157161868|NCT01606761|567336964|FG004|Prior to Week 24|Physician Decision|0|||
157161869|NCT01606761|567336960|FG000|Prior to Week 24|Other|4|||
157161870|NCT01606761|567336961|FG001|Prior to Week 24|Other|7|||
157161871|NCT01606761|567336962|FG002|Prior to Week 24|Other|5|||
157161872|NCT01606761|567336963|FG003|Prior to Week 24|Other|0|||
157161873|NCT01606761|567336964|FG004|Prior to Week 24|Other|0|||
157161874|NCT01606761|567336960|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
157161875|NCT01606761|567336961|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
157161876|NCT01606761|567336962|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
157161877|NCT01606761|567336963|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
157161878|NCT01606761|567336964|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
157161879|NCT01606761|567336960|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
157161880|NCT01606761|567336961|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
157161881|NCT01606761|567336962|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
157161882|NCT01606761|567336963|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
157161883|NCT01606761|567336964|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
157161884|NCT01606761|567336960|FG000|Week 24 to Week 52|Adverse Event|0|||
157161885|NCT01606761|567336961|FG001|Week 24 to Week 52|Adverse Event|11|||
157161886|NCT01606761|567336962|FG002|Week 24 to Week 52|Adverse Event|14|||
157161887|NCT01606761|567336963|FG003|Week 24 to Week 52|Adverse Event|3|||
157161888|NCT01606761|567336964|FG004|Week 24 to Week 52|Adverse Event|15|||
157161889|NCT01606761|567336960|FG000|Week 24 to Week 52|Death|0|||
157161890|NCT01606761|567336961|FG001|Week 24 to Week 52|Death|0|||
157161891|NCT01606761|567336962|FG002|Week 24 to Week 52|Death|2|||
157161892|NCT01606761|567336963|FG003|Week 24 to Week 52|Death|1|||
157161893|NCT01606761|567336964|FG004|Week 24 to Week 52|Death|0|||
157161894|NCT01606761|567336960|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
157161895|NCT01606761|567336961|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
157161896|NCT01606761|567336962|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
157161897|NCT01606761|567336963|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
157161898|NCT01606761|567336964|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
157225961|NCT01545076|567573378|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
157225962|NCT01545076|567573379|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
157225963|NCT01545076|567573380|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
157225964|NCT01545076|567573376|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
156913716|NCT02042183|566444641|FG001|Overall Study|Lack of Efficacy|3|||
156913717|NCT02042183|566444640|FG000|Overall Study|Non-compliance with Study Drug|2|||
156913718|NCT02042183|566444641|FG001|Overall Study|Non-compliance with Study Drug|3|||
156913719|NCT02042183|566444640|FG000|Overall Study|Adverse Event|17|||
156913720|NCT02042183|566444641|FG001|Overall Study|Adverse Event|6|||
156913721|NCT02042183|566444640|FG000|Overall Study|Other|3|||
156913722|NCT02042183|566444641|FG001|Overall Study|Other|3|||
156913723|NCT02042183|566444640|FG000|Overall Study|Withdrawal by Subject|21|||
156913724|NCT02042183|566444641|FG001|Overall Study|Withdrawal by Subject|16|||
156913725|NCT02042183|566444640|FG000|Overall Study|Site Terminated by Sponsor|2|||
156913726|NCT02042183|566444641|FG001|Overall Study|Site Terminated by Sponsor|1|||
156913727|NCT02042183|566444640|FG000|Overall Study|Lost to Follow-up|9|||
156913728|NCT02042183|566444641|FG001|Overall Study|Lost to Follow-up|2|||
156913729|NCT02321800|566444647|FG000|Overall Study|Withdrawal by Subject|3|||
156913730|NCT02321800|566444648|FG001|Overall Study|Withdrawal by Subject|3|||
156913731|NCT02321800|566444647|FG000|Overall Study|Death|1|||
156913732|NCT02321800|566444648|FG001|Overall Study|Death|0|||
156913733|NCT02321800|566444647|FG000|Overall Study|Protocol Violation|1|||
156913734|NCT02321800|566444648|FG001|Overall Study|Protocol Violation|0|||
156913735|NCT02321800|566444647|FG000|Overall Study|Lost to Follow-up|10|||
156913736|NCT02321800|566444648|FG001|Overall Study|Lost to Follow-up|4|||
156913737|NCT02321800|566444647|FG000|Overall Study|Adverse Event|2|||
156913738|NCT02321800|566444648|FG001|Overall Study|Adverse Event|3|||
156913739|NCT02321800|566444647|FG000|Overall Study|Other, Miscellaneous|3|||
156913740|NCT02321800|566444648|FG001|Overall Study|Other, Miscellaneous|1|||
156913741|NCT01051323|566444649|FG000|Overall Study|Discontinuation of treatment|103|||
156913742|NCT01051323|566444649|FG000|Overall Study|Transplantation|28|||
156913743|NCT01051323|566444649|FG000|Overall Study|Dialysis dependency|22|||
156913744|NCT01051323|566444649|FG000|Overall Study|Withdrawal by Subject|13|||
156913745|NCT01051323|566444649|FG000|Overall Study|Lost to Follow-up|31|||
156913746|NCT01051323|566444649|FG000|Overall Study|Death|129|||
156913747|NCT01051323|566444649|FG000|Overall Study|Hospitalization|28|||
157161899|NCT01606761|567336960|FG000|Week 24 to Week 52|Physician Decision|0|||
157225965|NCT01545076|567573377|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
157225966|NCT01545076|567573378|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
156913748|NCT01051323|566444649|FG000|Overall Study|Other|148|||
156913749|NCT01051323|566444649|FG000|Overall Study|Missing|37|||
156913750|NCT04171531|566444654|FG000|Overall Study|Lost to Follow-up|4|||
156913751|NCT04171531|566444655|FG001|Overall Study|Lost to Follow-up|5|||
156913752|NCT04171531|566444654|FG000|Overall Study|Consent only through 6 months|1|||
157161900|NCT01606761|567336961|FG001|Week 24 to Week 52|Physician Decision|1|||
157161901|NCT01606761|567336962|FG002|Week 24 to Week 52|Physician Decision|1|||
157161902|NCT01606761|567336963|FG003|Week 24 to Week 52|Physician Decision|0|||
157161903|NCT01606761|567336964|FG004|Week 24 to Week 52|Physician Decision|0|||
157161904|NCT01606761|567336960|FG000|Week 24 to Week 52|Other|0|||
157027739|NCT03478956|566856257|FG001|Open Label Extension Period|Lack of Efficacy|0|||
157027740|NCT03478956|566856258|FG002|Open Label Extension Period|Lack of Efficacy|8|||
157027741|NCT03478956|566856259|FG003|Open Label Extension Period|Lack of Efficacy|0|||
157027742|NCT03478956|566856256|FG000|Open Label Extension Period|Reason Not Provided|0|||
157027743|NCT03478956|566856257|FG001|Open Label Extension Period|Reason Not Provided|0|||
157027744|NCT03478956|566856258|FG002|Open Label Extension Period|Reason Not Provided|1|||
157027745|NCT03478956|566856259|FG003|Open Label Extension Period|Reason Not Provided|0|||
157027746|NCT03478956|566856256|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
157027747|NCT03478956|566856257|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
157027748|NCT03478956|566856258|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
157027749|NCT03478956|566856259|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
157027750|NCT03478956|566856256|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
157027751|NCT03478956|566856257|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
157027752|NCT03478956|566856258|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
157027753|NCT03478956|566856259|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
157027754|NCT03478956|566856256|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
157027755|NCT03478956|566856257|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
157027756|NCT03478956|566856258|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
157027757|NCT03478956|566856259|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
157027758|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
157027759|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
157027760|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
157027761|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
157027762|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
157027763|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
157027764|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
157027765|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
157027766|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
157027767|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
157027768|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
157027769|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
157027770|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
157027771|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
157027772|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
157027773|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
157027774|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
157027775|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
157027776|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
157027777|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
157027778|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
157027779|NCT04800211|566856262|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
157027780|NCT04800211|566856263|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
157027781|NCT04800211|566856264|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
157027782|NCT04800211|566856262|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
157027783|NCT04800211|566856263|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
157027784|NCT04800211|566856264|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
157027785|NCT04800211|566856262|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
157161905|NCT01606761|567336961|FG001|Week 24 to Week 52|Other|1|||
157161906|NCT01606761|567336962|FG002|Week 24 to Week 52|Other|5|||
157161907|NCT01606761|567336963|FG003|Week 24 to Week 52|Other|2|||
157161908|NCT01606761|567336964|FG004|Week 24 to Week 52|Other|2|||
157161909|NCT01606761|567336960|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
157161910|NCT01606761|567336961|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
157161911|NCT01606761|567336962|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
157161912|NCT01606761|567336963|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
157161913|NCT01606761|567336964|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
157161914|NCT01606761|567336960|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
157161915|NCT01606761|567336961|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
157161916|NCT01606761|567336962|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
157027786|NCT04800211|566856263|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
157027787|NCT04800211|566856264|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
157027788|NCT04800211|566856262|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
157027789|NCT04800211|566856263|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
157027790|NCT04800211|566856264|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
157027791|NCT05256017|566858990|FG000|Treatment Period|Withdrawal by Subject|1|||
157027792|NCT05256017|566858991|FG001|Treatment Period|Withdrawal by Subject|1|||
157027793|NCT05256017|566858990|FG000|Follow-up|Lost to Follow-up|7|||
157027794|NCT05256017|566858991|FG001|Follow-up|Lost to Follow-up|1|||
156913753|NCT04171531|566444655|FG001|Overall Study|Consent only through 6 months|1|||
156913754|NCT04171531|566444654|FG000|Overall Study|Insurance did not cover procedure|0|||
156913755|NCT04171531|566444655|FG001|Overall Study|Insurance did not cover procedure|1|||
156913756|NCT04171531|566444654|FG000|Overall Study|Physician Decision|0|||
156913757|NCT04171531|566444655|FG001|Overall Study|Physician Decision|3|||
156913758|NCT04171531|566444654|FG000|Overall Study|Withdrawal by Subject|1|||
156913759|NCT04171531|566444655|FG001|Overall Study|Withdrawal by Subject|5|||
156913760|NCT05537883|566444657|FG000|Overall Study|revisional surgery|4|||
156913761|NCT05537883|566444658|FG001|Overall Study|revisional surgery|2|||
156913762|NCT05537883|566444657|FG000|Overall Study|surgeries were cancelled|0|||
156913763|NCT05537883|566444658|FG001|Overall Study|surgeries were cancelled|2|||
156913764|NCT05537883|566444657|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
156913765|NCT05537883|566444658|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
156913766|NCT02099708|566444659|FG000|Overall Study|Data Not Available|30|||
156913767|NCT02099708|566444659|FG000|Overall Study|Lost to Follow-up|141|||
156913768|NCT02099708|566444659|FG000|Overall Study|Other|29|||
156913769|NCT00040664|566444665|FG000|Overall Study|Adverse Event|12|||
156913770|NCT00040664|566444666|FG001|Overall Study|Adverse Event|3|||
156913771|NCT00040664|566444667|FG002|Overall Study|Adverse Event|2|||
156913772|NCT00040664|566444668|FG003|Overall Study|Adverse Event|7|||
156913773|NCT00040664|566444665|FG000|Overall Study|Lack of Efficacy|9|||
156913774|NCT00040664|566444666|FG001|Overall Study|Lack of Efficacy|2|||
156913775|NCT00040664|566444667|FG002|Overall Study|Lack of Efficacy|3|||
156913776|NCT00040664|566444668|FG003|Overall Study|Lack of Efficacy|4|||
156913777|NCT00040664|566444665|FG000|Overall Study|Insufficient CD4 response|1|||
156913778|NCT00040664|566444666|FG001|Overall Study|Insufficient CD4 response|0|||
156913779|NCT00040664|566444667|FG002|Overall Study|Insufficient CD4 response|1|||
156913780|NCT00040664|566444668|FG003|Overall Study|Insufficient CD4 response|0|||
156913781|NCT00040664|566444665|FG000|Overall Study|Lost to Follow-up|4|||
156913782|NCT00040664|566444666|FG001|Overall Study|Lost to Follow-up|2|||
156913783|NCT00040664|566444667|FG002|Overall Study|Lost to Follow-up|0|||
156913784|NCT00040664|566444668|FG003|Overall Study|Lost to Follow-up|2|||
156913785|NCT00040664|566444665|FG000|Overall Study|Protocol Violation|2|||
156913786|NCT00040664|566444666|FG001|Overall Study|Protocol Violation|1|||
156913787|NCT00040664|566444667|FG002|Overall Study|Protocol Violation|0|||
156913788|NCT00040664|566444668|FG003|Overall Study|Protocol Violation|1|||
156913789|NCT00040664|566444665|FG000|Overall Study|Withdrawal by Subject|7|||
156913790|NCT00040664|566444666|FG001|Overall Study|Withdrawal by Subject|0|||
156913791|NCT00040664|566444667|FG002|Overall Study|Withdrawal by Subject|3|||
156913792|NCT00040664|566444668|FG003|Overall Study|Withdrawal by Subject|4|||
156913793|NCT00040664|566444665|FG000|Overall Study|Pregnancy|3|||
156913794|NCT00040664|566444666|FG001|Overall Study|Pregnancy|0|||
156913795|NCT00040664|566444667|FG002|Overall Study|Pregnancy|0|||
156913796|NCT00040664|566444668|FG003|Overall Study|Pregnancy|3|||
156913797|NCT00040664|566444665|FG000|Overall Study|Medication adherence/compliance problems|8|||
156913798|NCT00040664|566444666|FG001|Overall Study|Medication adherence/compliance problems|2|||
156913799|NCT00040664|566444667|FG002|Overall Study|Medication adherence/compliance problems|1|||
156913800|NCT00040664|566444668|FG003|Overall Study|Medication adherence/compliance problems|5|||
156913801|NCT00040664|566444665|FG000|Overall Study|Poor taste|2|||
156913802|NCT00040664|566444666|FG001|Overall Study|Poor taste|0|||
156913803|NCT00040664|566444667|FG002|Overall Study|Poor taste|2|||
156913804|NCT00040664|566444668|FG003|Overall Study|Poor taste|0|||
156913805|NCT00040664|566444665|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
156913806|NCT00040664|566444666|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
156913807|NCT00040664|566444667|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
156913808|NCT00040664|566444668|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
156913809|NCT00040664|566444665|FG000|Overall Study|Change of formulation|2|||
157161917|NCT01606761|567336963|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
157161918|NCT01606761|567336964|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
157161919|NCT01606761|567336960|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
157161920|NCT01606761|567336961|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
157161921|NCT01606761|567336962|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
157161922|NCT01606761|567336963|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
157161923|NCT01606761|567336964|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
156913810|NCT00040664|566444666|FG001|Overall Study|Change of formulation|2|||
156913811|NCT00040664|566444667|FG002|Overall Study|Change of formulation|0|||
156913812|NCT00040664|566444668|FG003|Overall Study|Change of formulation|0|||
156913813|NCT00040664|566444665|FG000|Overall Study|Non-viability of oral suspension|1|||
156913814|NCT00040664|566444666|FG001|Overall Study|Non-viability of oral suspension|0|||
156913815|NCT00040664|566444667|FG002|Overall Study|Non-viability of oral suspension|1|||
156913816|NCT00040664|566444668|FG003|Overall Study|Non-viability of oral suspension|0|||
156913817|NCT01709162|566444669|FG000|Overall Study|Disease progression|3|||
156913818|NCT01709162|566444670|FG001|Overall Study|Disease progression|3|||
156913819|NCT01709162|566444669|FG000|Overall Study|Study drug toxicity|2|||
156913820|NCT01709162|566444670|FG001|Overall Study|Study drug toxicity|0|||
156913821|NCT01709162|566444669|FG000|Overall Study|Administrative reason by sponsor|0|||
156913822|NCT01709162|566444670|FG001|Overall Study|Administrative reason by sponsor|1|||
157161924|NCT01606761|567336960|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
157161925|NCT01606761|567336961|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
157161926|NCT01606761|567336962|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
157161927|NCT01606761|567336963|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
157161928|NCT01606761|567336964|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
157161929|NCT05086289|567336965|FG000|Overall Study|Adverse Event|4|||
157161930|NCT05086289|567336966|FG001|Overall Study|Adverse Event|2|||
157161931|NCT05086289|567336965|FG000|Overall Study|Lost to Follow-up|2|||
157161932|NCT05086289|567336966|FG001|Overall Study|Lost to Follow-up|0|||
157161933|NCT05086289|567336965|FG000|Overall Study|Non-compliance with study drug|2|||
157161934|NCT05086289|567336966|FG001|Overall Study|Non-compliance with study drug|1|||
157161935|NCT05086289|567336965|FG000|Overall Study|Physician Decision|2|||
157161936|NCT05086289|567336966|FG001|Overall Study|Physician Decision|0|||
157161937|NCT05086289|567336965|FG000|Overall Study|Withdrawal by Subject|5|||
157161938|NCT05086289|567336966|FG001|Overall Study|Withdrawal by Subject|2|||
157161939|NCT03628508|567336972|FG000|Overall Study|Lost to Follow-up|1|||
157161940|NCT01996748|567336973|FG000|Overall Study|Personal reason|1|||
157161941|NCT01996748|567336974|FG001|Overall Study|Personal reason|0|||
157161942|NCT01996748|567336973|FG000|Overall Study|Physician Decision|2|||
157161943|NCT01996748|567336974|FG001|Overall Study|Physician Decision|0|||
157161944|NCT01996748|567336973|FG000|Overall Study|Adverse Event|1|||
157161945|NCT01996748|567336974|FG001|Overall Study|Adverse Event|4|||
157161946|NCT01996748|567336973|FG000|Overall Study|Withdrawal by Subject|0|||
157161947|NCT01996748|567336974|FG001|Overall Study|Withdrawal by Subject|1|||
157161948|NCT01996748|567336973|FG000|Overall Study|Lost to Follow-up|4|||
157161949|NCT01996748|567336974|FG001|Overall Study|Lost to Follow-up|1|||
157161950|NCT00515008|567336975|FG000|Overall Study|Lost to Follow-up|1|||
157161951|NCT00515008|567336976|FG001|Overall Study|Lost to Follow-up|0|||
157161952|NCT00515008|567336975|FG000|Overall Study|Declined|0|||
157161953|NCT00515008|567336976|FG001|Overall Study|Declined|3|||
157161954|NCT00515008|567336975|FG000|Overall Study|Left the Boston Area|1|||
157161955|NCT00515008|567336976|FG001|Overall Study|Left the Boston Area|1|||
157161956|NCT00515008|567336975|FG000|Overall Study|Scheduling conflict|1|||
157161957|NCT00515008|567336976|FG001|Overall Study|Scheduling conflict|0|||
157161958|NCT03238235|567336977|FG000|Overall Study|Adverse Event|2|||
157161959|NCT03238235|567336978|FG001|Overall Study|Adverse Event|0|||
157161960|NCT03238235|567336977|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
157161961|NCT03238235|567336978|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
157161962|NCT00243230|567336983|FG000|Double-Blind Period|Adverse Event|0|||
157161963|NCT00243230|567336984|FG001|Double-Blind Period|Adverse Event|2|||
157161964|NCT00243230|567336985|FG002|Double-Blind Period|Adverse Event|2|||
157161965|NCT00243230|567336986|FG003|Double-Blind Period|Adverse Event|0|||
157161966|NCT00243230|567336983|FG000|Double-Blind Period|Withdrawal by Subject|1|||
157161967|NCT00243230|567336984|FG001|Double-Blind Period|Withdrawal by Subject|0|||
157161968|NCT00243230|567336985|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157161969|NCT00243230|567336986|FG003|Double-Blind Period|Withdrawal by Subject|0|||
157161970|NCT00243230|567336983|FG000|Double-Blind Period|Protocol Violation|0|||
157161971|NCT00243230|567336984|FG001|Double-Blind Period|Protocol Violation|0|||
157161972|NCT00243230|567336985|FG002|Double-Blind Period|Protocol Violation|1|||
157161973|NCT00243230|567336986|FG003|Double-Blind Period|Protocol Violation|0|||
157161974|NCT00243230|567336983|FG000|Double-Blind Period|Randomized but Not Treated|0|||
157161975|NCT00243230|567336984|FG001|Double-Blind Period|Randomized but Not Treated|0|||
157161976|NCT00243230|567336985|FG002|Double-Blind Period|Randomized but Not Treated|2|||
157161977|NCT00243230|567336986|FG003|Double-Blind Period|Randomized but Not Treated|0|||
157161978|NCT00243230|567336983|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
157161979|NCT00243230|567336984|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
157161980|NCT00243230|567336985|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
157161981|NCT00243230|567336986|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
157161982|NCT00243230|567336983|FG000|Open Label Period|Adverse Event|0|||
157161983|NCT00243230|567336984|FG001|Open Label Period|Adverse Event|0|||
157161984|NCT00243230|567336985|FG002|Open Label Period|Adverse Event|0|||
157161985|NCT00243230|567336986|FG003|Open Label Period|Adverse Event|2|||
157161986|NCT00243230|567336983|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
157161987|NCT00243230|567336984|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
156913823|NCT01709162|566444669|FG000|Overall Study|Other|1|||
157161988|NCT00243230|567336985|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
157161989|NCT00243230|567336986|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
157161990|NCT00243230|567336983|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
157161991|NCT00243230|567336984|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
156913824|NCT01709162|566444670|FG001|Overall Study|Other|0|||
156913825|NCT01709162|566444669|FG000|Overall Study|Withdrawal by Subject|0|||
157161992|NCT00243230|567336985|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
157161993|NCT00243230|567336986|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
157161994|NCT00243230|567336983|FG000|Open Label Period|Lost to Follow-up|0|||
157161995|NCT00243230|567336984|FG001|Open Label Period|Lost to Follow-up|0|||
157161996|NCT00243230|567336985|FG002|Open Label Period|Lost to Follow-up|0|||
156913826|NCT01709162|566444670|FG001|Overall Study|Withdrawal by Subject|1|||
156913827|NCT04584645|566444673|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
156913828|NCT04584645|566444674|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
156913829|NCT03845985|566444679|FG000|Overall Study|Lost to Follow-up|2|||
156913830|NCT03845985|566444680|FG001|Overall Study|Lost to Follow-up|1|||
156913831|NCT03845985|566444679|FG000|Overall Study|Physician Decision|1|||
156913832|NCT03845985|566444680|FG001|Overall Study|Physician Decision|0|||
156913833|NCT03845985|566444679|FG000|Overall Study|Withdrawal by Subject|4|||
156913834|NCT03845985|566444680|FG001|Overall Study|Withdrawal by Subject|1|||
156913835|NCT01318993|566444681|FG000|Overall Study|Adverse Event|53|||
156913836|NCT01318993|566444681|FG000|Overall Study|Lack of Efficacy|121|||
156913837|NCT01318993|566444681|FG000|Overall Study|Protocol Violation|3|||
156913838|NCT01318993|566444681|FG000|Overall Study|Protocol based stopping criteria|6|||
156913839|NCT01318993|566444681|FG000|Overall Study|Study closed or terminated|174|||
156913840|NCT01318993|566444681|FG000|Overall Study|Lost to Follow-up|4|||
156913841|NCT01318993|566444681|FG000|Overall Study|Physician Decision|13|||
156913842|NCT01318993|566444681|FG000|Overall Study|Withdrawal by Subject|24|||
156913843|NCT03708328|566444687|FG000|Overall Study|Death|3|||
156913844|NCT03708328|566444688|FG001|Overall Study|Death|3|||
156913845|NCT03708328|566444689|FG002|Overall Study|Death|4|||
156913846|NCT03708328|566444690|FG003|Overall Study|Death|2|||
156913847|NCT03708328|566444691|FG004|Overall Study|Death|2|||
156913848|NCT03708328|566444692|FG005|Overall Study|Death|13|||
156913849|NCT03708328|566444693|FG006|Overall Study|Death|26|||
156913850|NCT03708328|566444694|FG007|Overall Study|Death|18|||
156913851|NCT03708328|566444695|FG008|Overall Study|Death|13|||
156913852|NCT03708328|566444696|FG009|Overall Study|Death|8|||
156913853|NCT03708328|566444687|FG000|Overall Study|Lost to Follow-up|0|||
156913854|NCT03708328|566444688|FG001|Overall Study|Lost to Follow-up|1|||
156913855|NCT03708328|566444689|FG002|Overall Study|Lost to Follow-up|0|||
156913856|NCT03708328|566444690|FG003|Overall Study|Lost to Follow-up|1|||
156913857|NCT03708328|566444691|FG004|Overall Study|Lost to Follow-up|0|||
156913858|NCT03708328|566444692|FG005|Overall Study|Lost to Follow-up|3|||
156913859|NCT03708328|566444693|FG006|Overall Study|Lost to Follow-up|3|||
156913860|NCT03708328|566444694|FG007|Overall Study|Lost to Follow-up|0|||
156913861|NCT03708328|566444695|FG008|Overall Study|Lost to Follow-up|0|||
156913862|NCT03708328|566444696|FG009|Overall Study|Lost to Follow-up|1|||
156913863|NCT03708328|566444687|FG000|Overall Study|Physician Decision|0|||
156913864|NCT03708328|566444688|FG001|Overall Study|Physician Decision|0|||
157161997|NCT00243230|567336986|FG003|Open Label Period|Lost to Follow-up|2|||
157161998|NCT00243230|567336983|FG000|Open Label Period|Withdrawal by Subject|0|||
157161999|NCT00243230|567336984|FG001|Open Label Period|Withdrawal by Subject|0|||
157162000|NCT00243230|567336985|FG002|Open Label Period|Withdrawal by Subject|0|||
157162001|NCT00243230|567336986|FG003|Open Label Period|Withdrawal by Subject|2|||
157162002|NCT00243230|567336983|FG000|Open Label Period|Protocol Violation|0|||
157162003|NCT00243230|567336984|FG001|Open Label Period|Protocol Violation|0|||
157162004|NCT00243230|567336985|FG002|Open Label Period|Protocol Violation|0|||
157162005|NCT00243230|567336986|FG003|Open Label Period|Protocol Violation|2|||
157162006|NCT00243230|567336983|FG000|Open Label Period|Administrative Reason|0|||
156913865|NCT03708328|566444689|FG002|Overall Study|Physician Decision|0|||
156913866|NCT03708328|566444690|FG003|Overall Study|Physician Decision|0|||
156913867|NCT03708328|566444691|FG004|Overall Study|Physician Decision|0|||
156913868|NCT03708328|566444692|FG005|Overall Study|Physician Decision|1|||
156913869|NCT03708328|566444693|FG006|Overall Study|Physician Decision|0|||
156913870|NCT03708328|566444694|FG007|Overall Study|Physician Decision|0|||
157162007|NCT00243230|567336984|FG001|Open Label Period|Administrative Reason|0|||
157162008|NCT00243230|567336985|FG002|Open Label Period|Administrative Reason|0|||
157162009|NCT00243230|567336986|FG003|Open Label Period|Administrative Reason|63|||
157162010|NCT03011840|567336988|FG000|Overall Study|Not received PIL in post PIL phase|0|||
156913871|NCT03708328|566444695|FG008|Overall Study|Physician Decision|0|||
156913872|NCT03708328|566444696|FG009|Overall Study|Physician Decision|0|||
156913873|NCT03708328|566444687|FG000|Overall Study|Withdrawal by Subject|0|||
156913874|NCT03708328|566444688|FG001|Overall Study|Withdrawal by Subject|0|||
156913875|NCT03708328|566444689|FG002|Overall Study|Withdrawal by Subject|0|||
156913876|NCT03708328|566444690|FG003|Overall Study|Withdrawal by Subject|0|||
156913877|NCT03708328|566444691|FG004|Overall Study|Withdrawal by Subject|1|||
156913878|NCT03708328|566444692|FG005|Overall Study|Withdrawal by Subject|0|||
156913879|NCT03708328|566444693|FG006|Overall Study|Withdrawal by Subject|2|||
156913880|NCT03708328|566444694|FG007|Overall Study|Withdrawal by Subject|4|||
156913881|NCT03708328|566444695|FG008|Overall Study|Withdrawal by Subject|1|||
156913882|NCT03708328|566444696|FG009|Overall Study|Withdrawal by Subject|5|||
157162011|NCT03011840|567336989|FG001|Overall Study|Not received PIL in post PIL phase|21|||
157162012|NCT03201198|567336995|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
157027795|NCT05256017|566858990|FG000|Follow-up|Withdrawal by Subject|1|||
157027796|NCT05256017|566858991|FG001|Follow-up|Withdrawal by Subject|0|||
157027797|NCT05256017|566858990|FG000|Follow-up|Death|0|||
157027798|NCT05256017|566858991|FG001|Follow-up|Death|1|||
157027799|NCT03668236|566858994|FG000|90-day Follow-up|Withdrawal by Subject|3|||
157027800|NCT03668236|566858995|FG001|90-day Follow-up|Withdrawal by Subject|2|||
157027801|NCT03668236|566858994|FG000|90-day Follow-up|Lost to Follow-up|3|||
157027802|NCT03668236|566858995|FG001|90-day Follow-up|Lost to Follow-up|1|||
157027803|NCT03668236|566858994|FG000|Baseline Characteristics|Lost to Follow-up|9|||
157027804|NCT03668236|566858995|FG001|Baseline Characteristics|Lost to Follow-up|5|||
157027805|NCT03668236|566858994|FG000|1-year Follow-up|Withdrawal by Subject|17|||
157027806|NCT03668236|566858995|FG001|1-year Follow-up|Withdrawal by Subject|15|||
157027807|NCT06132282|566858996|FG000|Overall Study|Lost to Follow-up|31|||
157027808|NCT03748953|566859000|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
157027809|NCT03748953|566859001|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
157027810|NCT03748953|566859000|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
157027811|NCT03748953|566859001|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
157027812|NCT03748953|566859000|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
157027813|NCT03748953|566859001|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
157027814|NCT03748953|566859000|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
157027815|NCT03748953|566859001|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
157027816|NCT03748953|566859000|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
157027817|NCT03748953|566859001|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
157027818|NCT04676763|566859002|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
157027819|NCT04676763|566859003|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
157027820|NCT04676763|566859004|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
157027821|NCT04676763|566859002|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
157027822|NCT04676763|566859003|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
157027823|NCT04676763|566859004|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
157027824|NCT04676763|566859002|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
157027825|NCT04676763|566859003|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
157027826|NCT04676763|566859004|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
157027827|NCT04858451|566859011|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
157027828|NCT04858451|566859012|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027829|NCT04858451|566859013|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027830|NCT04858451|566859014|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027831|NCT04858451|566859015|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027832|NCT04858451|566859016|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027833|NCT04858451|566859017|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027834|NCT04858451|566859018|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027835|NCT04858451|566859019|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
157027836|NCT04858451|566859011|FG000|Part 2|Discontinued|0|||
157027837|NCT04858451|566859012|FG001|Part 2|Discontinued|0|||
157027838|NCT04858451|566859013|FG002|Part 2|Discontinued|0|||
157027839|NCT04858451|566859014|FG003|Part 2|Discontinued|0|||
157027840|NCT04858451|566859015|FG004|Part 2|Discontinued|0|||
157027841|NCT04858451|566859016|FG005|Part 2|Discontinued|0|||
157027842|NCT04858451|566859017|FG006|Part 2|Discontinued|0|||
157027843|NCT04858451|566859018|FG007|Part 2|Discontinued|0|||
157027844|NCT04858451|566859019|FG008|Part 2|Discontinued|63|||
157027845|NCT03314454|566859020|FG000|Overall Study|Protocol Violation|1|||
157027846|NCT04119843|566859021|FG000|Overall Study|Adverse Event|3|||
157027847|NCT04119843|566859021|FG000|Overall Study|Death|1|||
157027848|NCT04499924|566859022|FG000|Overall Study|Study termination by sponsor|4|||
157027849|NCT04499924|566859023|FG001|Overall Study|Study termination by sponsor|6|||
157027850|NCT04499924|566859022|FG000|Overall Study|Withdrawal by Subject|1|||
157027851|NCT04499924|566859023|FG001|Overall Study|Withdrawal by Subject|3|||
157027852|NCT04233216|566859034|FG000|Overall Study|Lost to Follow-up|1|||
157027853|NCT04233216|566859035|FG001|Overall Study|Lost to Follow-up|0|||
157027854|NCT04233216|566859036|FG002|Overall Study|Lost to Follow-up|2|||
157027855|NCT04233216|566859037|FG003|Overall Study|Lost to Follow-up|0|||
157027856|NCT04233216|566859034|FG000|Overall Study|Physician Decision|0|||
157027857|NCT04233216|566859035|FG001|Overall Study|Physician Decision|3|||
157027858|NCT04233216|566859036|FG002|Overall Study|Physician Decision|0|||
157027859|NCT04233216|566859037|FG003|Overall Study|Physician Decision|2|||
157027860|NCT04233216|566859034|FG000|Overall Study|Withdrawal by Subject|0|||
157027861|NCT04233216|566859035|FG001|Overall Study|Withdrawal by Subject|2|||
157027862|NCT04233216|566859036|FG002|Overall Study|Withdrawal by Subject|1|||
157027863|NCT04233216|566859037|FG003|Overall Study|Withdrawal by Subject|0|||
157027864|NCT04225273|566859038|FG000|Overall Study|Lost to Follow-up|3|||
157027865|NCT03652389|566859039|FG000|Overall Study|Lost to Follow-up|1|||
157027866|NCT03652389|566859040|FG001|Overall Study|Lost to Follow-up|5|||
157027867|NCT03652389|566859039|FG000|Overall Study|Withdrawal by Subject|5|||
157027868|NCT03652389|566859040|FG001|Overall Study|Withdrawal by Subject|1|||
157027869|NCT03652389|566859039|FG000|Overall Study|New diagnosis|2|||
157027870|NCT03652389|566859040|FG001|Overall Study|New diagnosis|0|||
157162013|NCT03201198|567336996|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
157162014|NCT03201198|567336995|FG000|Overall Study|Withdrawal by Subject|2|||
157162015|NCT03201198|567336996|FG001|Overall Study|Withdrawal by Subject|3|||
157162016|NCT00471445|567336997|FG000|Overall Study|Withdrawal by Subject|1|||
157162017|NCT00471445|567336998|FG001|Overall Study|Withdrawal by Subject|1|||
157162018|NCT00471445|567336997|FG000|Overall Study|Ineligible|1|||
157162019|NCT00471445|567336998|FG001|Overall Study|Ineligible|0|||
157162020|NCT00471445|567336997|FG000|Overall Study|Protocol Violation|0|||
157162021|NCT00471445|567336998|FG001|Overall Study|Protocol Violation|1|||
157162022|NCT04715230|567337004|FG000|Overall Study|Withdrawal by Subject|1|||
157162023|NCT04715230|567337005|FG001|Overall Study|Withdrawal by Subject|0|||
157162024|NCT04715230|567337006|FG002|Overall Study|Withdrawal by Subject|0|||
157162025|NCT04715230|567337004|FG000|Overall Study|Lost to Follow-up|0|||
157162026|NCT04715230|567337005|FG001|Overall Study|Lost to Follow-up|5|||
157162027|NCT04715230|567337006|FG002|Overall Study|Lost to Follow-up|1|||
157162028|NCT02596711|567337013|FG000|Overall Study|Lost to Follow-up|1|||
157162029|NCT02596711|567337014|FG001|Overall Study|Lost to Follow-up|2|||
157162030|NCT02596711|567337015|FG002|Overall Study|Lost to Follow-up|3|||
157162031|NCT00586924|567337016|FG000|Overall Study|Adverse event/serious adverse event|0|||
157162032|NCT00586924|567337017|FG001|Overall Study|Adverse event/serious adverse event|0|||
157162033|NCT00586924|567337018|FG002|Overall Study|Adverse event/serious adverse event|0|||
157162034|NCT00586924|567337019|FG003|Overall Study|Adverse event/serious adverse event|1|||
157162035|NCT00586924|567337020|FG004|Overall Study|Adverse event/serious adverse event|0|||
157162036|NCT00586924|567337021|FG005|Overall Study|Adverse event/serious adverse event|2|||
157162037|NCT00586924|567337016|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
157162038|NCT00586924|567337017|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
157162039|NCT00586924|567337018|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
157162040|NCT00586924|567337019|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
157162041|NCT00586924|567337020|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
157162042|NCT00586924|567337021|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
157162043|NCT00586924|567337016|FG000|Overall Study|Disease progression|0|||
157162044|NCT00586924|567337017|FG001|Overall Study|Disease progression|0|||
157162045|NCT00586924|567337018|FG002|Overall Study|Disease progression|0|||
157162046|NCT00586924|567337019|FG003|Overall Study|Disease progression|1|||
157162047|NCT00586924|567337020|FG004|Overall Study|Disease progression|1|||
157162048|NCT00586924|567337021|FG005|Overall Study|Disease progression|0|||
157162049|NCT00586924|567337016|FG000|Overall Study|Development of neutralizing antibodies|2|||
157162050|NCT00586924|567337017|FG001|Overall Study|Development of neutralizing antibodies|2|||
157162051|NCT00586924|567337018|FG002|Overall Study|Development of neutralizing antibodies|2|||
157162052|NCT00586924|567337019|FG003|Overall Study|Development of neutralizing antibodies|0|||
157162053|NCT00586924|567337020|FG004|Overall Study|Development of neutralizing antibodies|0|||
157162054|NCT00586924|567337021|FG005|Overall Study|Development of neutralizing antibodies|22|||
157162055|NCT00586924|567337016|FG000|Overall Study|Complete response|0|||
157162056|NCT00586924|567337017|FG001|Overall Study|Complete response|1|||
157162057|NCT00586924|567337018|FG002|Overall Study|Complete response|0|||
157162058|NCT00586924|567337019|FG003|Overall Study|Complete response|0|||
157162059|NCT00586924|567337020|FG004|Overall Study|Complete response|2|||
157162060|NCT00586924|567337021|FG005|Overall Study|Complete response|2|||
157162061|NCT00586924|567337016|FG000|Overall Study|Other|1|||
157162062|NCT00586924|567337017|FG001|Overall Study|Other|0|||
157162063|NCT00586924|567337018|FG002|Overall Study|Other|1|||
157162064|NCT00586924|567337019|FG003|Overall Study|Other|1|||
157225967|NCT01545076|567573379|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
157225968|NCT01545076|567573380|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
157225969|NCT02710123|567573381|FG000|Overall Study|Lost to Follow-up|3|||
157225970|NCT02710123|567573382|FG001|Overall Study|Lost to Follow-up|4|||
157225971|NCT02710123|567573381|FG000|Overall Study|Withdrawal by Subject|1|||
157162065|NCT00586924|567337020|FG004|Overall Study|Other|1|||
157162066|NCT00586924|567337021|FG005|Overall Study|Other|6|||
157162067|NCT01767194|567337023|FG000|Overall Study|Adverse Event|1|||
157162068|NCT01767194|567337024|FG001|Overall Study|Adverse Event|1|||
157162069|NCT01767194|567337023|FG000|Overall Study|Death|0|||
157162070|NCT01767194|567337024|FG001|Overall Study|Death|1|||
157162071|NCT01767194|567337023|FG000|Overall Study|Lack of Efficacy|12|||
157162072|NCT01767194|567337024|FG001|Overall Study|Lack of Efficacy|11|||
157162073|NCT01767194|567337023|FG000|Overall Study|Physician Decision|2|||
157162074|NCT01767194|567337024|FG001|Overall Study|Physician Decision|23|||
157162075|NCT01767194|567337023|FG000|Overall Study|Withdrawal by Subject|0|||
157162076|NCT01767194|567337024|FG001|Overall Study|Withdrawal by Subject|1|||
157162077|NCT01767194|567337023|FG000|Overall Study|Ineligible|1|||
157162078|NCT01767194|567337024|FG001|Overall Study|Ineligible|1|||
157162079|NCT01767194|567337023|FG000|Overall Study|Refusal by patient/parent|2|||
157162080|NCT01767194|567337024|FG001|Overall Study|Refusal by patient/parent|4|||
157162081|NCT01767194|567337023|FG000|Overall Study|Criteria not met on time for next cycle|0|||
157162082|NCT01767194|567337024|FG001|Overall Study|Criteria not met on time for next cycle|1|||
157162083|NCT02112994|567337025|FG000|Overall Study|Progressive Disease|0|||
157162084|NCT02112994|567337026|FG001|Overall Study|Progressive Disease|0|||
157162085|NCT02112994|567337027|FG002|Overall Study|Progressive Disease|1|||
157162086|NCT02112994|567337025|FG000|Overall Study|Pregnancy|0|||
157162087|NCT02112994|567337026|FG001|Overall Study|Pregnancy|1|||
157162088|NCT02112994|567337027|FG002|Overall Study|Pregnancy|1|||
157162089|NCT02112994|567337025|FG000|Overall Study|Liver Transplant|0|||
157162090|NCT02112994|567337026|FG001|Overall Study|Liver Transplant|1|||
157162091|NCT02112994|567337027|FG002|Overall Study|Liver Transplant|0|||
157162092|NCT02112994|567337025|FG000|Overall Study|Withdrawal by Subject|0|||
157162093|NCT02112994|567337026|FG001|Overall Study|Withdrawal by Subject|0|||
157162094|NCT02112994|567337027|FG002|Overall Study|Withdrawal by Subject|1|||
157162095|NCT01683071|567337031|FG000|Part 1|Lack of Efficacy|1|||
157162096|NCT01683071|567337032|FG001|Part 1|Lack of Efficacy|0|||
157162097|NCT01683071|567337033|FG002|Part 1|Lack of Efficacy|0|||
157162098|NCT01683071|567337034|FG003|Part 1|Lack of Efficacy|3|||
157162099|NCT01683071|567337035|FG004|Part 1|Lack of Efficacy|0|||
157162100|NCT01683071|567337036|FG005|Part 1|Lack of Efficacy|0|||
157162101|NCT01683071|567337031|FG000|Part 1|Withdrawal by Subject|1|||
157162102|NCT01683071|567337032|FG001|Part 1|Withdrawal by Subject|2|||
157162103|NCT01683071|567337033|FG002|Part 1|Withdrawal by Subject|2|||
157162104|NCT01683071|567337034|FG003|Part 1|Withdrawal by Subject|1|||
157162105|NCT01683071|567337035|FG004|Part 1|Withdrawal by Subject|0|||
157162106|NCT01683071|567337036|FG005|Part 1|Withdrawal by Subject|0|||
157162107|NCT01683071|567337031|FG000|Part 1|Surgery Cancelled|1|||
157162108|NCT01683071|567337032|FG001|Part 1|Surgery Cancelled|0|||
157162109|NCT01683071|567337033|FG002|Part 1|Surgery Cancelled|0|||
157162110|NCT01683071|567337034|FG003|Part 1|Surgery Cancelled|0|||
157162111|NCT01683071|567337035|FG004|Part 1|Surgery Cancelled|0|||
157162112|NCT01683071|567337036|FG005|Part 1|Surgery Cancelled|0|||
157162113|NCT01683071|567337031|FG000|Part 1|Did not receive study drug|1|||
157162114|NCT01683071|567337032|FG001|Part 1|Did not receive study drug|0|||
157162115|NCT01683071|567337033|FG002|Part 1|Did not receive study drug|0|||
157162116|NCT01683071|567337034|FG003|Part 1|Did not receive study drug|1|||
157162117|NCT01683071|567337035|FG004|Part 1|Did not receive study drug|0|||
157162118|NCT01683071|567337036|FG005|Part 1|Did not receive study drug|0|||
157162119|NCT01683071|567337031|FG000|Part 1|Early termination; met exclusion criteria|0|||
157162120|NCT01683071|567337032|FG001|Part 1|Early termination; met exclusion criteria|2|||
157162121|NCT01683071|567337033|FG002|Part 1|Early termination; met exclusion criteria|1|||
157162122|NCT01683071|567337034|FG003|Part 1|Early termination; met exclusion criteria|0|||
157162123|NCT01683071|567337035|FG004|Part 1|Early termination; met exclusion criteria|0|||
157162124|NCT01683071|567337036|FG005|Part 1|Early termination; met exclusion criteria|0|||
157162125|NCT01683071|567337031|FG000|Part 2|Lack of Efficacy|0|||
157162126|NCT01683071|567337032|FG001|Part 2|Lack of Efficacy|0|||
157162127|NCT01683071|567337033|FG002|Part 2|Lack of Efficacy|0|||
157162128|NCT01683071|567337034|FG003|Part 2|Lack of Efficacy|0|||
157162129|NCT01683071|567337035|FG004|Part 2|Lack of Efficacy|3|||
157162130|NCT01683071|567337036|FG005|Part 2|Lack of Efficacy|4|||
157162131|NCT01683071|567337031|FG000|Part 2|Lost to Follow-up|0|||
157162132|NCT01683071|567337032|FG001|Part 2|Lost to Follow-up|0|||
157162133|NCT01683071|567337033|FG002|Part 2|Lost to Follow-up|0|||
157162134|NCT01683071|567337034|FG003|Part 2|Lost to Follow-up|0|||
157162135|NCT01683071|567337035|FG004|Part 2|Lost to Follow-up|2|||
157162136|NCT01683071|567337036|FG005|Part 2|Lost to Follow-up|0|||
157162137|NCT01683071|567337031|FG000|Part 2|Withdrawal by Subject|0|||
157162138|NCT01683071|567337032|FG001|Part 2|Withdrawal by Subject|0|||
157162139|NCT01683071|567337033|FG002|Part 2|Withdrawal by Subject|0|||
157162140|NCT01683071|567337034|FG003|Part 2|Withdrawal by Subject|0|||
157162141|NCT01683071|567337035|FG004|Part 2|Withdrawal by Subject|3|||
157162142|NCT01683071|567337036|FG005|Part 2|Withdrawal by Subject|3|||
157162143|NCT01683071|567337031|FG000|Part 2|Surgery cancelled|0|||
157162144|NCT01683071|567337032|FG001|Part 2|Surgery cancelled|0|||
157162145|NCT01683071|567337033|FG002|Part 2|Surgery cancelled|0|||
157162146|NCT01683071|567337034|FG003|Part 2|Surgery cancelled|0|||
157162147|NCT01683071|567337035|FG004|Part 2|Surgery cancelled|4|||
157162148|NCT01683071|567337036|FG005|Part 2|Surgery cancelled|2|||
157162149|NCT01683071|567337031|FG000|Part 2|Did not receive study drug|0|||
157162150|NCT01683071|567337032|FG001|Part 2|Did not receive study drug|0|||
157162151|NCT01683071|567337033|FG002|Part 2|Did not receive study drug|0|||
157162152|NCT01683071|567337034|FG003|Part 2|Did not receive study drug|0|||
157162153|NCT01683071|567337035|FG004|Part 2|Did not receive study drug|2|||
157162154|NCT01683071|567337036|FG005|Part 2|Did not receive study drug|1|||
157027871|NCT04231149|566859041|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
157162155|NCT01683071|567337031|FG000|Part 2|Met exclusion criterion|0|||
157162156|NCT01683071|567337032|FG001|Part 2|Met exclusion criterion|0|||
157162157|NCT01683071|567337033|FG002|Part 2|Met exclusion criterion|0|||
157162158|NCT01683071|567337034|FG003|Part 2|Met exclusion criterion|0|||
157162159|NCT01683071|567337035|FG004|Part 2|Met exclusion criterion|1|||
157162160|NCT01683071|567337036|FG005|Part 2|Met exclusion criterion|1|||
157162161|NCT01683071|567337031|FG000|Part 2|Protocol deviation|0|||
157162162|NCT01683071|567337032|FG001|Part 2|Protocol deviation|0|||
157162163|NCT01683071|567337033|FG002|Part 2|Protocol deviation|0|||
157225972|NCT02710123|567573382|FG001|Overall Study|Withdrawal by Subject|1|||
157225973|NCT02710123|567573381|FG000|Overall Study|Illness unrelated to study intervention|1|||
157225974|NCT02710123|567573382|FG001|Overall Study|Illness unrelated to study intervention|0|||
157225975|NCT02153398|567573383|FG000|Overall Study|Withdrawal by Subject|1|||
157225976|NCT02153398|567573384|FG001|Overall Study|Withdrawal by Subject|0|||
157225977|NCT02153398|567573385|FG002|Overall Study|Withdrawal by Subject|0|||
157225978|NCT02153398|567573386|FG003|Overall Study|Withdrawal by Subject|0|||
157225979|NCT02153398|567573387|FG004|Overall Study|Withdrawal by Subject|0|||
157225980|NCT02153398|567573383|FG000|Overall Study|Adverse Event|0|||
157225981|NCT02153398|567573384|FG001|Overall Study|Adverse Event|0|||
157225982|NCT02153398|567573385|FG002|Overall Study|Adverse Event|1|||
157225983|NCT02153398|567573386|FG003|Overall Study|Adverse Event|1|||
157225984|NCT02153398|567573387|FG004|Overall Study|Adverse Event|0|||
157225985|NCT02374918|567573388|FG000|Overall Study|Protocol Violation|2|||
157225986|NCT02374918|567573389|FG001|Overall Study|Protocol Violation|0|||
157225987|NCT02374918|567573390|FG002|Overall Study|Protocol Violation|2|||
157225988|NCT02374918|567573391|FG003|Overall Study|Protocol Violation|1|||
157225989|NCT02374918|567573388|FG000|Overall Study|Withdrawal by Subject|1|||
157225990|NCT02374918|567573389|FG001|Overall Study|Withdrawal by Subject|1|||
157225991|NCT02374918|567573390|FG002|Overall Study|Withdrawal by Subject|1|||
157225992|NCT02374918|567573391|FG003|Overall Study|Withdrawal by Subject|0|||
157225993|NCT02374918|567573388|FG000|Overall Study|Lack of Efficacy|0|||
157225994|NCT02374918|567573389|FG001|Overall Study|Lack of Efficacy|0|||
157225995|NCT02374918|567573390|FG002|Overall Study|Lack of Efficacy|1|||
157225996|NCT02374918|567573391|FG003|Overall Study|Lack of Efficacy|1|||
157225997|NCT01505530|567573392|FG000|Overall Study|Progressive Disease|19|||
157225998|NCT01505530|567573393|FG001|Overall Study|Progressive Disease|17|||
157225999|NCT01505530|567573394|FG002|Overall Study|Progressive Disease|18|||
156913883|NCT03708328|566444687|FG000|Overall Study|Study Closed Locally|0|||
156913884|NCT03708328|566444688|FG001|Overall Study|Study Closed Locally|0|||
156913885|NCT03708328|566444689|FG002|Overall Study|Study Closed Locally|0|||
156913886|NCT03708328|566444690|FG003|Overall Study|Study Closed Locally|0|||
156913887|NCT03708328|566444691|FG004|Overall Study|Study Closed Locally|0|||
156913888|NCT03708328|566444692|FG005|Overall Study|Study Closed Locally|0|||
156913889|NCT03708328|566444693|FG006|Overall Study|Study Closed Locally|0|||
156913890|NCT03708328|566444694|FG007|Overall Study|Study Closed Locally|1|||
156913891|NCT03708328|566444695|FG008|Overall Study|Study Closed Locally|0|||
156913892|NCT03708328|566444696|FG009|Overall Study|Study Closed Locally|0|||
156913893|NCT03708328|566444687|FG000|Overall Study|Study Ended By Sponsor|0|||
156913894|NCT03708328|566444688|FG001|Overall Study|Study Ended By Sponsor|0|||
156913895|NCT03708328|566444689|FG002|Overall Study|Study Ended By Sponsor|0|||
156913896|NCT03708328|566444690|FG003|Overall Study|Study Ended By Sponsor|0|||
156913897|NCT03708328|566444691|FG004|Overall Study|Study Ended By Sponsor|0|||
156913898|NCT03708328|566444692|FG005|Overall Study|Study Ended By Sponsor|1|||
156913899|NCT03708328|566444693|FG006|Overall Study|Study Ended By Sponsor|0|||
156913900|NCT03708328|566444694|FG007|Overall Study|Study Ended By Sponsor|1|||
156913901|NCT03708328|566444695|FG008|Overall Study|Study Ended By Sponsor|0|||
156913902|NCT03708328|566444696|FG009|Overall Study|Study Ended By Sponsor|0|||
156913903|NCT03708328|566444687|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913904|NCT03708328|566444688|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913905|NCT03708328|566444689|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913906|NCT03708328|566444690|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913907|NCT03708328|566444691|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913908|NCT03708328|566444692|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913909|NCT03708328|566444693|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
157226000|NCT01505530|567573392|FG000|Overall Study|Adverse Event|1|||
156913910|NCT03708328|566444694|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913911|NCT03708328|566444695|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
156913912|NCT03708328|566444696|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
156913913|NCT04523220|566444697|FG000|Main Treatment Period|Physician Decision|1|||
156913914|NCT04523220|566444698|FG001|Main Treatment Period|Physician Decision|1|||
156913915|NCT04523220|566444699|FG002|Main Treatment Period|Physician Decision|0|||
156913916|NCT04523220|566444697|FG000|Main Treatment Period|Other|5|||
156913917|NCT04523220|566444698|FG001|Main Treatment Period|Other|2|||
156913918|NCT04523220|566444699|FG002|Main Treatment Period|Other|4|||
157226001|NCT01505530|567573393|FG001|Overall Study|Adverse Event|1|||
157226002|NCT01505530|567573394|FG002|Overall Study|Adverse Event|0|||
157226003|NCT01505530|567573392|FG000|Overall Study|Withdrawal by Subject|7|||
156913919|NCT04523220|566444697|FG000|Main Treatment Period|Subject Decision|5|||
156913920|NCT04523220|566444698|FG001|Main Treatment Period|Subject Decision|7|||
157226004|NCT01505530|567573393|FG001|Overall Study|Withdrawal by Subject|8|||
157226005|NCT01505530|567573394|FG002|Overall Study|Withdrawal by Subject|6|||
157226006|NCT01505530|567573392|FG000|Overall Study|Physician Decision|6|||
157226007|NCT01505530|567573393|FG001|Overall Study|Physician Decision|2|||
157027872|NCT04231149|566859042|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
157027873|NCT04231149|566859043|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
157027874|NCT04231149|566859044|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
157027875|NCT04231149|566859045|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
157027876|NCT03252847|566859046|FG000|Overall Study|Withdrawal by Subject|0|||
157027877|NCT03252847|566859047|FG001|Overall Study|Withdrawal by Subject|0|||
157027878|NCT03252847|566859048|FG002|Overall Study|Withdrawal by Subject|1|||
157027879|NCT03252847|566859049|FG003|Overall Study|Withdrawal by Subject|0|||
157027880|NCT03252847|566859050|FG004|Overall Study|Withdrawal by Subject|0|||
157027881|NCT03252847|566859051|FG005|Overall Study|Withdrawal by Subject|0|||
157027882|NCT03252847|566859052|FG006|Overall Study|Withdrawal by Subject|0|||
157027883|NCT03252847|566859046|FG000|Overall Study|Other: Patient decision|0|||
157027884|NCT03252847|566859047|FG001|Overall Study|Other: Patient decision|0|||
157027885|NCT03252847|566859048|FG002|Overall Study|Other: Patient decision|0|||
157027886|NCT03252847|566859049|FG003|Overall Study|Other: Patient decision|0|||
157027887|NCT03252847|566859050|FG004|Overall Study|Other: Patient decision|1|||
157027888|NCT03252847|566859051|FG005|Overall Study|Other: Patient decision|0|||
157027889|NCT03252847|566859052|FG006|Overall Study|Other: Patient decision|0|||
157027890|NCT01501955|566859055|FG000|Overall Study|Withdrawal by Subject|1|||
157027891|NCT01501955|566859056|FG001|Overall Study|Withdrawal by Subject|0|||
157027892|NCT01501955|566859055|FG000|Overall Study|Adverse Event|1|||
157027893|NCT01501955|566859056|FG001|Overall Study|Adverse Event|3|||
157027894|NCT04298983|566859059|FG000|Overall Study|Adverse Event|4|||
157027895|NCT04298983|566859059|FG000|Overall Study|Lack of Efficacy|3|||
157027896|NCT05477186|566859060|FG000|Overall Study|Vaccine not administered|0|||
157027897|NCT05477186|566859061|FG001|Overall Study|Vaccine not administered|2|||
157027898|NCT05477186|566859062|FG002|Overall Study|Vaccine not administered|1|||
157027899|NCT05477186|566859063|FG003|Overall Study|Vaccine not administered|0|||
157027900|NCT05477186|566859064|FG004|Overall Study|Vaccine not administered|1|||
157027901|NCT05477186|566859065|FG005|Overall Study|Vaccine not administered|0|||
157027902|NCT05477186|566859066|FG006|Overall Study|Vaccine not administered|0|||
157027903|NCT05477186|566859060|FG000|Overall Study|Withdrawal by Subject|1|||
157027904|NCT05477186|566859061|FG001|Overall Study|Withdrawal by Subject|0|||
157027905|NCT05477186|566859062|FG002|Overall Study|Withdrawal by Subject|0|||
157027906|NCT05477186|566859063|FG003|Overall Study|Withdrawal by Subject|0|||
157027907|NCT05477186|566859064|FG004|Overall Study|Withdrawal by Subject|0|||
157027908|NCT05477186|566859065|FG005|Overall Study|Withdrawal by Subject|1|||
157027909|NCT05477186|566859066|FG006|Overall Study|Withdrawal by Subject|0|||
157027910|NCT05477186|566859060|FG000|Overall Study|Lost to Follow-up|1|||
157027911|NCT05477186|566859061|FG001|Overall Study|Lost to Follow-up|0|||
157027912|NCT05477186|566859062|FG002|Overall Study|Lost to Follow-up|2|||
157027913|NCT05477186|566859063|FG003|Overall Study|Lost to Follow-up|1|||
157027914|NCT05477186|566859064|FG004|Overall Study|Lost to Follow-up|1|||
157027915|NCT05477186|566859065|FG005|Overall Study|Lost to Follow-up|0|||
157027916|NCT05477186|566859066|FG006|Overall Study|Lost to Follow-up|2|||
157027917|NCT01919554|566859068|FG000|Overall Study|Withdrawal by Subject|0|||
157027918|NCT01919554|566859069|FG001|Overall Study|Withdrawal by Subject|0|||
157027919|NCT01919554|566859070|FG002|Overall Study|Withdrawal by Subject|1|||
157027920|NCT01919554|566859071|FG003|Overall Study|Withdrawal by Subject|1|||
157027921|NCT02606422|566859073|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
157027922|NCT02606422|566859074|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
157027923|NCT02606422|566859073|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
157162164|NCT01683071|567337034|FG003|Part 2|Protocol deviation|0|||
157162165|NCT01683071|567337035|FG004|Part 2|Protocol deviation|1|||
157162166|NCT01683071|567337036|FG005|Part 2|Protocol deviation|2|||
157162167|NCT01683071|567337031|FG000|Part 2|Withdrawal by investigator decision|0|||
157162168|NCT01683071|567337032|FG001|Part 2|Withdrawal by investigator decision|0|||
157162169|NCT01683071|567337033|FG002|Part 2|Withdrawal by investigator decision|0|||
157162170|NCT01683071|567337034|FG003|Part 2|Withdrawal by investigator decision|0|||
157162171|NCT01683071|567337035|FG004|Part 2|Withdrawal by investigator decision|1|||
157162172|NCT01683071|567337036|FG005|Part 2|Withdrawal by investigator decision|2|||
157027924|NCT02606422|566859074|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
157027925|NCT02606422|566859073|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
157027926|NCT02606422|566859074|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
157027927|NCT02606422|566859073|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
157027928|NCT02606422|566859074|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
157027929|NCT03235544|566859079|FG000|Overall Study|Death|11|||
157027930|NCT03235544|566859080|FG001|Overall Study|Death|31|||
157027931|NCT03235544|566859081|FG002|Overall Study|Death|19|||
157027932|NCT03235544|566859082|FG003|Overall Study|Death|34|||
157027933|NCT03235544|566859079|FG000|Overall Study|Lost to Follow-up|0|||
157027934|NCT03235544|566859080|FG001|Overall Study|Lost to Follow-up|1|||
157162173|NCT00488618|567337040|FG000|Overall Study|Adverse Event|13|||
157162174|NCT00488618|567337041|FG001|Overall Study|Adverse Event|17|||
157027935|NCT03235544|566859081|FG002|Overall Study|Lost to Follow-up|1|||
157226008|NCT01505530|567573394|FG002|Overall Study|Physician Decision|5|||
157162175|NCT00488618|567337040|FG000|Overall Study|Insufficient Therapeutic Response|18|||
157162176|NCT00488618|567337041|FG001|Overall Study|Insufficient Therapeutic Response|11|||
157162177|NCT00488618|567337040|FG000|Overall Study|Protocol Violation|0|||
157162178|NCT00488618|567337041|FG001|Overall Study|Protocol Violation|2|||
157162179|NCT00488618|567337040|FG000|Overall Study|Withdrawal of Consent|15|||
157162180|NCT00488618|567337041|FG001|Overall Study|Withdrawal of Consent|13|||
157162181|NCT00488618|567337040|FG000|Overall Study|Lost to Follow-up|1|||
156913921|NCT04523220|566444699|FG002|Main Treatment Period|Subject Decision|3|||
156913922|NCT04523220|566444697|FG000|Main Treatment Period|Death|5|||
156913923|NCT04523220|566444698|FG001|Main Treatment Period|Death|11|||
156913924|NCT04523220|566444699|FG002|Main Treatment Period|Death|4|||
156913925|NCT04523220|566444697|FG000|Main Treatment Period|Adverse Event|11|||
156913926|NCT04523220|566444698|FG001|Main Treatment Period|Adverse Event|9|||
157162182|NCT00488618|567337041|FG001|Overall Study|Lost to Follow-up|0|||
156913927|NCT04523220|566444699|FG002|Main Treatment Period|Adverse Event|9|||
156913928|NCT04523220|566444697|FG000|Main Treatment Period|Withdrawal by Subject|3|||
156913929|NCT04523220|566444698|FG001|Main Treatment Period|Withdrawal by Subject|3|||
156913930|NCT04523220|566444699|FG002|Main Treatment Period|Withdrawal by Subject|4|||
156913931|NCT04523220|566444697|FG000|Main Treatment Period|Study drug never adminstered|10|||
156913932|NCT04523220|566444698|FG001|Main Treatment Period|Study drug never adminstered|3|||
156913933|NCT04523220|566444699|FG002|Main Treatment Period|Study drug never adminstered|5|||
156913934|NCT04523220|566444697|FG000|Extension Treatment Period|Physician Decision|1|||
156913935|NCT04523220|566444698|FG001|Extension Treatment Period|Physician Decision|0|||
156913936|NCT04523220|566444699|FG002|Extension Treatment Period|Physician Decision|3|||
156913937|NCT04523220|566444697|FG000|Extension Treatment Period|Other|2|||
156913938|NCT04523220|566444698|FG001|Extension Treatment Period|Other|6|||
156913939|NCT04523220|566444699|FG002|Extension Treatment Period|Other|6|||
156913940|NCT04523220|566444697|FG000|Extension Treatment Period|Subject Decision|5|||
156913941|NCT04523220|566444698|FG001|Extension Treatment Period|Subject Decision|2|||
156913942|NCT04523220|566444699|FG002|Extension Treatment Period|Subject Decision|4|||
156913943|NCT04523220|566444697|FG000|Extension Treatment Period|Death|6|||
156913944|NCT04523220|566444698|FG001|Extension Treatment Period|Death|4|||
156913945|NCT04523220|566444699|FG002|Extension Treatment Period|Death|7|||
156913946|NCT04523220|566444697|FG000|Extension Treatment Period|Adverse Event|6|||
156913947|NCT04523220|566444698|FG001|Extension Treatment Period|Adverse Event|7|||
156913948|NCT04523220|566444699|FG002|Extension Treatment Period|Adverse Event|9|||
156913949|NCT04523220|566444697|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
156913950|NCT04523220|566444698|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
156913951|NCT04523220|566444699|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
156913952|NCT04523220|566444697|FG000|Extension Treatment Period|Study drug never administered|0|||
156913953|NCT04523220|566444698|FG001|Extension Treatment Period|Study drug never administered|1|||
156913954|NCT04523220|566444699|FG002|Extension Treatment Period|Study drug never administered|0|||
156913955|NCT01845831|566444700|FG000|Inpatient Phase|Withdrawal by Subject|1|||
156913956|NCT01845831|566444701|FG001|Inpatient Phase|Withdrawal by Subject|1|||
156913957|NCT01845831|566444702|FG002|Inpatient Phase|Withdrawal by Subject|0|||
156913958|NCT01845831|566444703|FG003|Inpatient Phase|Withdrawal by Subject|0|||
156913959|NCT01845831|566444704|FG004|Inpatient Phase|Withdrawal by Subject|0|||
156913960|NCT02010775|566444706|FG000|Overall Study|Adverse Event|0|||
156913961|NCT02010775|566444707|FG001|Overall Study|Adverse Event|0|||
156913962|NCT02010775|566444708|FG002|Overall Study|Adverse Event|0|||
156913963|NCT02010775|566444709|FG003|Overall Study|Adverse Event|0|||
156913964|NCT02010775|566444710|FG004|Overall Study|Adverse Event|1|||
156913965|NCT02010775|566444706|FG000|Overall Study|Pregnancy|0|||
156913966|NCT02010775|566444707|FG001|Overall Study|Pregnancy|0|||
156913967|NCT02010775|566444708|FG002|Overall Study|Pregnancy|2|||
156913968|NCT02010775|566444709|FG003|Overall Study|Pregnancy|0|||
156913969|NCT02010775|566444710|FG004|Overall Study|Pregnancy|0|||
156913970|NCT02010775|566444706|FG000|Overall Study|Lost to Follow-up|2|||
156913971|NCT02010775|566444707|FG001|Overall Study|Lost to Follow-up|0|||
156913972|NCT02010775|566444708|FG002|Overall Study|Lost to Follow-up|0|||
156913973|NCT02010775|566444709|FG003|Overall Study|Lost to Follow-up|1|||
156913974|NCT02010775|566444710|FG004|Overall Study|Lost to Follow-up|1|||
156913975|NCT02010775|566444706|FG000|Overall Study|Personal Reasons|3|||
156913976|NCT02010775|566444707|FG001|Overall Study|Personal Reasons|3|||
157162183|NCT02198651|567339057|FG000|Lead-in Period|Withdrew consent|13|||
157162184|NCT02198651|567339058|FG001|Lead-in Period|Withdrew consent|0|||
156913977|NCT02010775|566444708|FG002|Overall Study|Personal Reasons|1|||
156913978|NCT02010775|566444709|FG003|Overall Study|Personal Reasons|2|||
156913979|NCT02010775|566444710|FG004|Overall Study|Personal Reasons|4|||
156913980|NCT02439138|566444715|FG000|Overall Study|Adverse Event|1|||
156913981|NCT02439138|566444715|FG000|Overall Study|PI decision to terminate the study|2|||
157162185|NCT02198651|567339059|FG002|Lead-in Period|Withdrew consent|0|||
157162186|NCT02198651|567339060|FG003|Lead-in Period|Withdrew consent|0|||
157162187|NCT02198651|567339061|FG004|Lead-in Period|Withdrew consent|0|||
156913982|NCT04659161|566444716|FG000|Overall Study|Adverse Event|10|||
156913983|NCT04659161|566444717|FG001|Overall Study|Adverse Event|6|||
157162188|NCT02198651|567339057|FG000|Lead-in Period|Adverse Event|2|||
157162189|NCT02198651|567339058|FG001|Lead-in Period|Adverse Event|0|||
157162190|NCT02198651|567339059|FG002|Lead-in Period|Adverse Event|0|||
157162191|NCT02198651|567339060|FG003|Lead-in Period|Adverse Event|0|||
157162192|NCT02198651|567339061|FG004|Lead-in Period|Adverse Event|0|||
157162193|NCT02198651|567339057|FG000|Lead-in Period|Other, not specified|22|||
157162194|NCT02198651|567339058|FG001|Lead-in Period|Other, not specified|0|||
157162195|NCT02198651|567339059|FG002|Lead-in Period|Other, not specified|0|||
157162196|NCT02198651|567339060|FG003|Lead-in Period|Other, not specified|0|||
156913984|NCT04659161|566444716|FG000|Overall Study|Withdrawal by Subject|13|||
156913985|NCT04659161|566444717|FG001|Overall Study|Withdrawal by Subject|12|||
156913986|NCT04659161|566444716|FG000|Overall Study|Other|9|||
156913987|NCT04659161|566444717|FG001|Overall Study|Other|8|||
156913988|NCT01929343|566444720|FG000|Overall Study|Physician Decision|0|||
156913989|NCT01929343|566444721|FG001|Overall Study|Physician Decision|2|||
156913990|NCT01929343|566444722|FG002|Overall Study|Physician Decision|0|||
156913991|NCT01929343|566444720|FG000|Overall Study|Withdrawal by Subject|1|||
157226009|NCT01505530|567573392|FG000|Overall Study|Sponsor Decision|1|||
157226010|NCT01505530|567573393|FG001|Overall Study|Sponsor Decision|8|||
156913992|NCT01929343|566444721|FG001|Overall Study|Withdrawal by Subject|0|||
156913993|NCT01929343|566444722|FG002|Overall Study|Withdrawal by Subject|0|||
156913994|NCT02197130|566444723|FG000|Overall Study|Adverse Event|13|||
156913995|NCT02197130|566444724|FG001|Overall Study|Adverse Event|4|||
156913996|NCT02197130|566444725|FG002|Overall Study|Adverse Event|23|||
156913997|NCT02197130|566444723|FG000|Overall Study|Death|0|||
156913998|NCT02197130|566444724|FG001|Overall Study|Death|1|||
156913999|NCT02197130|566444725|FG002|Overall Study|Death|0|||
156914000|NCT02197130|566444723|FG000|Overall Study|Lost to Follow-up|2|||
156914001|NCT02197130|566444724|FG001|Overall Study|Lost to Follow-up|0|||
156914002|NCT02197130|566444725|FG002|Overall Study|Lost to Follow-up|1|||
156914003|NCT02197130|566444723|FG000|Overall Study|Does not meet entrance criteria|0|||
156914004|NCT02197130|566444724|FG001|Overall Study|Does not meet entrance criteria|0|||
156914005|NCT02197130|566444725|FG002|Overall Study|Does not meet entrance criteria|1|||
156914006|NCT02197130|566444723|FG000|Overall Study|Withdrawal by Subject|0|||
156914007|NCT02197130|566444724|FG001|Overall Study|Withdrawal by Subject|3|||
156914008|NCT02197130|566444725|FG002|Overall Study|Withdrawal by Subject|4|||
156914009|NCT02197130|566444723|FG000|Overall Study|Other|1|||
156914010|NCT02197130|566444724|FG001|Overall Study|Other|0|||
156914011|NCT02197130|566444725|FG002|Overall Study|Other|3|||
156914012|NCT02615145|566444726|FG000|Overall Study|Did Not Start Treatment|0|||
156914013|NCT02615145|566444727|FG001|Overall Study|Did Not Start Treatment|0|||
156914014|NCT02615145|566444728|FG002|Overall Study|Did Not Start Treatment|1|||
156914015|NCT02615145|566444729|FG003|Overall Study|Did Not Start Treatment|1|||
156914016|NCT02615145|566444726|FG000|Overall Study|Failure to Return|20|||
156914017|NCT02615145|566444727|FG001|Overall Study|Failure to Return|10|||
156914018|NCT02615145|566444728|FG002|Overall Study|Failure to Return|7|||
156914019|NCT02615145|566444729|FG003|Overall Study|Failure to Return|0|||
156914020|NCT02615145|566444726|FG000|Overall Study|Death|2|||
156914021|NCT02615145|566444727|FG001|Overall Study|Death|3|||
156914022|NCT02615145|566444728|FG002|Overall Study|Death|0|||
156914023|NCT02615145|566444729|FG003|Overall Study|Death|0|||
156914024|NCT02615145|566444726|FG000|Overall Study|Other, Not Specified|5|||
156914025|NCT02615145|566444727|FG001|Overall Study|Other, Not Specified|2|||
156914026|NCT02615145|566444728|FG002|Overall Study|Other, Not Specified|0|||
156914027|NCT02615145|566444729|FG003|Overall Study|Other, Not Specified|0|||
156914028|NCT00006237|566444732|FG000|Overall Study|Adverse Event|39|||
156914029|NCT00006237|566444733|FG001|Overall Study|Adverse Event|29|||
156914030|NCT00006237|566444732|FG000|Overall Study|Death|1|||
156914031|NCT00006237|566444733|FG001|Overall Study|Death|0|||
156914032|NCT00006237|566444732|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
156914033|NCT00006237|566444733|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
156914034|NCT00006237|566444732|FG000|Overall Study|Progression/relapse|54|||
156914035|NCT00006237|566444733|FG001|Overall Study|Progression/relapse|2|||
156914036|NCT00006237|566444732|FG000|Overall Study|Not eligible|9|||
156914037|NCT00006237|566444733|FG001|Overall Study|Not eligible|20|||
156914038|NCT00006237|566444732|FG000|Overall Study|Withdrawal by Subject|0|||
156914039|NCT00006237|566444733|FG001|Overall Study|Withdrawal by Subject|1|||
156914040|NCT00006237|566444732|FG000|Overall Study|Not protocol specified|14|||
157162197|NCT02198651|567339061|FG004|Lead-in Period|Other, not specified|0|||
157162198|NCT02198651|567339057|FG000|Double-blind Period|Withdrew consent|0|||
156914041|NCT00006237|566444733|FG001|Overall Study|Not protocol specified|5|||
157162199|NCT02198651|567339058|FG001|Double-blind Period|Withdrew consent|4|||
157162200|NCT02198651|567339059|FG002|Double-blind Period|Withdrew consent|0|||
157162201|NCT02198651|567339060|FG003|Double-blind Period|Withdrew consent|0|||
157162202|NCT02198651|567339061|FG004|Double-blind Period|Withdrew consent|0|||
156914042|NCT01846416|566444736|FG000|Treatment Phase|Death|2|||
156914043|NCT01846416|566444737|FG001|Treatment Phase|Death|9|||
156914044|NCT01846416|566444738|FG002|Treatment Phase|Death|1|||
156914045|NCT01846416|566444736|FG000|Treatment Phase|Withdrawal by Subject|2|||
156914046|NCT01846416|566444737|FG001|Treatment Phase|Withdrawal by Subject|4|||
157162203|NCT02198651|567339057|FG000|Double-blind Period|Adverse Event|0|||
157162204|NCT02198651|567339058|FG001|Double-blind Period|Adverse Event|1|||
157162205|NCT02198651|567339059|FG002|Double-blind Period|Adverse Event|0|||
157162206|NCT02198651|567339060|FG003|Double-blind Period|Adverse Event|0|||
157162207|NCT02198651|567339061|FG004|Double-blind Period|Adverse Event|0|||
157162208|NCT02198651|567339057|FG000|Double-blind Period|Other, not specified|0|||
157162209|NCT02198651|567339058|FG001|Double-blind Period|Other, not specified|4|||
157162210|NCT02198651|567339059|FG002|Double-blind Period|Other, not specified|1|||
157162211|NCT02198651|567339060|FG003|Double-blind Period|Other, not specified|0|||
157162212|NCT02198651|567339061|FG004|Double-blind Period|Other, not specified|0|||
157162213|NCT02198651|567339057|FG000|Open-label Rescue Period|Withdrew consent|0|||
157162214|NCT02198651|567339058|FG001|Open-label Rescue Period|Withdrew consent|0|||
157162215|NCT02198651|567339059|FG002|Open-label Rescue Period|Withdrew consent|0|||
157162216|NCT02198651|567339060|FG003|Open-label Rescue Period|Withdrew consent|2|||
157162217|NCT02198651|567339061|FG004|Open-label Rescue Period|Withdrew consent|0|||
157162218|NCT02198651|567339057|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
157162219|NCT02198651|567339058|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
157162220|NCT02198651|567339059|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
157162221|NCT02198651|567339060|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
157162222|NCT02198651|567339061|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
157162223|NCT00333619|567339069|FG000|Overall Study|Death|12|||
157162224|NCT00333619|567339070|FG001|Overall Study|Death|6|||
157162225|NCT00333619|567339069|FG000|Overall Study|Withdrawal by Subject|6|||
157162226|NCT00333619|567339070|FG001|Overall Study|Withdrawal by Subject|1|||
157162227|NCT00333619|567339069|FG000|Overall Study|Lost to Follow-up|3|||
157162228|NCT00333619|567339070|FG001|Overall Study|Lost to Follow-up|3|||
156914047|NCT01846416|566444738|FG002|Treatment Phase|Withdrawal by Subject|2|||
156914048|NCT01846416|566444736|FG000|Treatment Phase|Other|1|||
156914049|NCT01846416|566444737|FG001|Treatment Phase|Other|5|||
156914050|NCT01846416|566444738|FG002|Treatment Phase|Other|1|||
156914051|NCT01846416|566444736|FG000|Treatment Phase|Physician Decision|1|||
156914052|NCT01846416|566444737|FG001|Treatment Phase|Physician Decision|2|||
156914053|NCT01846416|566444738|FG002|Treatment Phase|Physician Decision|0|||
156914054|NCT01846416|566444736|FG000|Treatment Phase|Adverse Event|3|||
156914055|NCT01846416|566444737|FG001|Treatment Phase|Adverse Event|4|||
156914056|NCT01846416|566444738|FG002|Treatment Phase|Adverse Event|0|||
156914057|NCT01846416|566444736|FG000|Treatment Phase|Non-compliance|0|||
156914058|NCT01846416|566444737|FG001|Treatment Phase|Non-compliance|2|||
156914059|NCT01846416|566444738|FG002|Treatment Phase|Non-compliance|0|||
156914060|NCT01846416|566444736|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
156914061|NCT01846416|566444737|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
156914062|NCT01846416|566444738|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
156914063|NCT01846416|566444736|FG000|Treatment Phase|Progressive Disease|21|||
156914064|NCT01846416|566444737|FG001|Treatment Phase|Progressive Disease|63|||
156914065|NCT01846416|566444738|FG002|Treatment Phase|Progressive Disease|9|||
156914066|NCT01846416|566444736|FG000|Survival Follow-up|Death|21|||
156914067|NCT01846416|566444737|FG001|Survival Follow-up|Death|62|||
156914068|NCT01846416|566444738|FG002|Survival Follow-up|Death|9|||
156914069|NCT01846416|566444736|FG000|Survival Follow-up|Lost to Follow-up|0|||
156914070|NCT01846416|566444737|FG001|Survival Follow-up|Lost to Follow-up|2|||
156914071|NCT01846416|566444738|FG002|Survival Follow-up|Lost to Follow-up|2|||
156914072|NCT01846416|566444736|FG000|Survival Follow-up|Withdrawal by Subject|2|||
156914073|NCT01846416|566444737|FG001|Survival Follow-up|Withdrawal by Subject|7|||
156914074|NCT01846416|566444738|FG002|Survival Follow-up|Withdrawal by Subject|0|||
156914075|NCT01846416|566444736|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
156914076|NCT01846416|566444737|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
156914077|NCT01846416|566444738|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
156914078|NCT01846416|566444736|FG000|Survival Follow-up|Other|3|||
156914079|NCT01846416|566444737|FG001|Survival Follow-up|Other|1|||
156914080|NCT01846416|566444738|FG002|Survival Follow-up|Other|1|||
156914081|NCT00833794|566444741|FG000|Open-label Phase|Adverse Event|225|||
156914082|NCT00833794|566444742|FG001|Open-label Phase|Adverse Event|0|||
156914083|NCT00833794|566444741|FG000|Open-label Phase|Lack of Efficacy|28|||
156914084|NCT00833794|566444742|FG001|Open-label Phase|Lack of Efficacy|0|||
156914085|NCT00833794|566444741|FG000|Open-label Phase|Withdrawal by Subject|48|||
156914086|NCT00833794|566444742|FG001|Open-label Phase|Withdrawal by Subject|0|||
156914087|NCT00833794|566444741|FG000|Open-label Phase|Physician Decision|20|||
156914088|NCT00833794|566444742|FG001|Open-label Phase|Physician Decision|0|||
156914089|NCT00833794|566444741|FG000|Open-label Phase|Administrative reason|1|||
156914090|NCT00833794|566444742|FG001|Open-label Phase|Administrative reason|0|||
156914091|NCT00833794|566444741|FG000|Open-label Phase|Protocol Violation|47|||
156914092|NCT00833794|566444742|FG001|Open-label Phase|Protocol Violation|0|||
156914093|NCT00833794|566444741|FG000|Open-label Phase|Did not complete wash-out period|12|||
156914094|NCT00833794|566444742|FG001|Open-label Phase|Did not complete wash-out period|0|||
156914095|NCT00833794|566444741|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
157027936|NCT03235544|566859082|FG003|Overall Study|Lost to Follow-up|1|||
157226011|NCT01505530|567573394|FG002|Overall Study|Sponsor Decision|7|||
157226012|NCT01505530|567573392|FG000|Overall Study|Death|7|||
157226013|NCT01505530|567573393|FG001|Overall Study|Death|6|||
157226014|NCT01505530|567573394|FG002|Overall Study|Death|5|||
157226015|NCT01505530|567573392|FG000|Overall Study|entry criteria not met|0|||
157226016|NCT01505530|567573393|FG001|Overall Study|entry criteria not met|1|||
157226017|NCT01505530|567573394|FG002|Overall Study|entry criteria not met|0|||
157226018|NCT01153984|567573395|FG000|Overall Study|Withdrawal by Subject|1|||
157226019|NCT01153984|567573395|FG000|Overall Study|Adverse Event|1|||
157226020|NCT00973700|567573396|FG000|Overall Study|Withdrawal by Subject|2|||
157226021|NCT00973700|567573397|FG001|Overall Study|Withdrawal by Subject|2|||
157226022|NCT00973700|567573398|FG002|Overall Study|Withdrawal by Subject|8|||
157226023|NCT00973700|567573399|FG003|Overall Study|Withdrawal by Subject|4|||
157226024|NCT00973700|567573400|FG004|Overall Study|Withdrawal by Subject|4|||
157226025|NCT00973700|567573396|FG000|Overall Study|Lost to Follow-up|5|||
157226026|NCT00973700|567573397|FG001|Overall Study|Lost to Follow-up|0|||
157226027|NCT00973700|567573398|FG002|Overall Study|Lost to Follow-up|1|||
157226028|NCT00973700|567573399|FG003|Overall Study|Lost to Follow-up|8|||
157226029|NCT00973700|567573400|FG004|Overall Study|Lost to Follow-up|5|||
157226030|NCT00973700|567573396|FG000|Overall Study|Inappropriate enrolment|0|||
157226031|NCT00973700|567573397|FG001|Overall Study|Inappropriate enrolment|0|||
157226032|NCT00973700|567573398|FG002|Overall Study|Inappropriate enrolment|0|||
157226033|NCT00973700|567573399|FG003|Overall Study|Inappropriate enrolment|4|||
157226034|NCT00973700|567573400|FG004|Overall Study|Inappropriate enrolment|0|||
157226035|NCT00973700|567573396|FG000|Overall Study|Unable to Classify|0|||
157226036|NCT00973700|567573397|FG001|Overall Study|Unable to Classify|0|||
157226037|NCT00973700|567573398|FG002|Overall Study|Unable to Classify|1|||
157226038|NCT00973700|567573399|FG003|Overall Study|Unable to Classify|2|||
157226039|NCT00973700|567573400|FG004|Overall Study|Unable to Classify|1|||
157226040|NCT01618266|567573409|FG000|Overall Study|Lost to Follow-up|9|||
157226041|NCT01618266|567573409|FG000|Overall Study|Treatment satisfaction|10|||
157226042|NCT01618266|567573409|FG000|Overall Study|Other reasons|11|||
157226043|NCT01618266|567573409|FG000|Overall Study|Lack of Efficacy|23|||
157226044|NCT01618266|567573409|FG000|Overall Study|Protocol Violation|43|||
157226045|NCT00626925|567573410|FG000|Overall Study|Lost to Follow-up|1|||
157226046|NCT00626925|567573411|FG001|Overall Study|Lost to Follow-up|2|||
157226047|NCT00626925|567573410|FG000|Overall Study|relapse|1|||
157226048|NCT00626925|567573411|FG001|Overall Study|relapse|0|||
157226049|NCT00626925|567573410|FG000|Overall Study|Adverse effect|6|||
157226050|NCT00626925|567573411|FG001|Overall Study|Adverse effect|2|||
157226051|NCT00626925|567573410|FG000|Overall Study|Lack of Efficacy|1|||
157226052|NCT00626925|567573411|FG001|Overall Study|Lack of Efficacy|4|||
157226053|NCT00626925|567573410|FG000|Overall Study|Time constraints|3|||
157226054|NCT00626925|567573411|FG001|Overall Study|Time constraints|1|||
157226055|NCT00625807|567573412|FG000|Overall Study|schedule conflict|2|||
157226056|NCT00625807|567573413|FG001|Overall Study|schedule conflict|8|||
157226057|NCT01966042|567573414|FG000|Overall Study|Death|2|||
157226058|NCT01946165|567573415|FG000|Overall Study|Physician Decision|2|||
157226059|NCT01946165|567573416|FG001|Overall Study|Physician Decision|0|||
157226060|NCT01946165|567573415|FG000|Overall Study|Withdrawal by Subject|0|||
157226061|NCT01946165|567573416|FG001|Overall Study|Withdrawal by Subject|2|||
157226062|NCT01915732|567573429|FG000|Overall Study|Withdrawal by Subject|18|||
157226063|NCT01915732|567573430|FG001|Overall Study|Withdrawal by Subject|18|||
157226064|NCT01915732|567573429|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
157226065|NCT01915732|567573430|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
157226066|NCT01915732|567573429|FG000|Overall Study|Adverse Event|12|||
157226067|NCT01915732|567573430|FG001|Overall Study|Adverse Event|4|||
157226068|NCT01915732|567573429|FG000|Overall Study|Protocol Violation|5|||
156914096|NCT00833794|566444742|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
156914097|NCT00833794|566444741|FG000|Double-blind Phase|Adverse Event|44|||
156914098|NCT00833794|566444742|FG001|Double-blind Phase|Adverse Event|11|||
156914099|NCT00833794|566444741|FG000|Double-blind Phase|Lack of Efficacy|34|||
156914100|NCT00833794|566444742|FG001|Double-blind Phase|Lack of Efficacy|22|||
156914101|NCT00833794|566444741|FG000|Double-blind Phase|Withdrawal by Subject|23|||
157226069|NCT01915732|567573430|FG001|Overall Study|Protocol Violation|5|||
157226070|NCT01915732|567573429|FG000|Overall Study|Lack of Efficacy|6|||
157226071|NCT01915732|567573430|FG001|Overall Study|Lack of Efficacy|11|||
157226072|NCT01915732|567573429|FG000|Overall Study|Lost to Follow-up|22|||
157226073|NCT01915732|567573430|FG001|Overall Study|Lost to Follow-up|26|||
156914102|NCT00833794|566444742|FG001|Double-blind Phase|Withdrawal by Subject|6|||
157226074|NCT01915732|567573429|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
157226075|NCT01915732|567573430|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
156914103|NCT00833794|566444741|FG000|Double-blind Phase|Physician Decision|4|||
157226076|NCT01915732|567573429|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
157226077|NCT01915732|567573430|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
156914104|NCT00833794|566444742|FG001|Double-blind Phase|Physician Decision|7|||
157226078|NCT01915732|567573429|FG000|Overall Study|Drug Release Error|1|||
157226079|NCT01915732|567573430|FG001|Overall Study|Drug Release Error|0|||
156914105|NCT00833794|566444741|FG000|Double-blind Phase|Administrative reason|1|||
156914106|NCT00833794|566444742|FG001|Double-blind Phase|Administrative reason|3|||
156914107|NCT01866930|566444743|FG000|Treatment Period|Other|1|||
156914108|NCT01866930|566444744|FG001|Treatment Period|Other|0|||
156914109|NCT01866930|566444743|FG000|Treatment Period|Death|0|||
156914110|NCT01866930|566444744|FG001|Treatment Period|Death|2|||
156914111|NCT01866930|566444743|FG000|Treatment Period|Poor/non compliance|0|||
156914112|NCT01866930|566444744|FG001|Treatment Period|Poor/non compliance|2|||
156914113|NCT01866930|566444743|FG000|Treatment Period|No longer meets study criteria|0|||
156914114|NCT01866930|566444744|FG001|Treatment Period|No longer meets study criteria|1|||
156914115|NCT01866930|566444743|FG000|Treatment Period|Withdrawal by Subject|2|||
156914116|NCT01866930|566444744|FG001|Treatment Period|Withdrawal by Subject|8|||
156914117|NCT01866930|566444743|FG000|Treatment Period|Lack of Efficacy|1|||
156914118|NCT01866930|566444744|FG001|Treatment Period|Lack of Efficacy|9|||
156914119|NCT01866930|566444743|FG000|Treatment Period|Adverse Event|4|||
156914120|NCT01866930|566444744|FG001|Treatment Period|Adverse Event|12|||
156914121|NCT01866930|566444743|FG000|Treatment Period|Lost to Follow-up|1|||
156914122|NCT01866930|566444744|FG001|Treatment Period|Lost to Follow-up|1|||
156914123|NCT01866930|566444743|FG000|Follow-up Period|Lost to Follow-up|1|||
156914124|NCT01866930|566444744|FG001|Follow-up Period|Lost to Follow-up|1|||
156914125|NCT01866930|566444743|FG000|Follow-up Period|Other|1|||
156914126|NCT01866930|566444744|FG001|Follow-up Period|Other|5|||
156914127|NCT01866930|566444743|FG000|Follow-up Period|No longer required per protocol|1|||
156914128|NCT01866930|566444744|FG001|Follow-up Period|No longer required per protocol|0|||
156914129|NCT01866930|566444743|FG000|Follow-up Period|Withdrawal by Subject|3|||
156914130|NCT01866930|566444744|FG001|Follow-up Period|Withdrawal by Subject|3|||
156914131|NCT02521870|566444747|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914132|NCT02521870|566444748|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
156914133|NCT02521870|566444749|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914134|NCT02521870|566444750|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914135|NCT02521870|566444751|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914136|NCT02521870|566444752|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914137|NCT02521870|566444753|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914138|NCT02521870|566444754|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914139|NCT02521870|566444755|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914140|NCT02521870|566444756|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914141|NCT02521870|566444757|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914142|NCT02521870|566444758|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156914143|NCT02521870|566444747|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
156914144|NCT02521870|566444748|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
156914145|NCT02521870|566444749|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
156914146|NCT02521870|566444750|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
156914147|NCT02521870|566444751|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
156914148|NCT02521870|566444752|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
156914149|NCT02521870|566444753|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
156914150|NCT02521870|566444754|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
156914151|NCT02521870|566444755|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
156914152|NCT02521870|566444756|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
156914153|NCT02521870|566444757|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
156914154|NCT02521870|566444758|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
156914155|NCT02521870|566444747|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
156914156|NCT02521870|566444748|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
156914157|NCT02521870|566444749|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
156914158|NCT02521870|566444750|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
156914159|NCT02521870|566444751|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
156914160|NCT02521870|566444752|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
156914161|NCT02521870|566444753|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
156914162|NCT02521870|566444754|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
156914163|NCT02521870|566444755|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
156914164|NCT02521870|566444756|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
156914165|NCT02521870|566444757|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
156914166|NCT02521870|566444758|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
156914167|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914168|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914169|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914170|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914171|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
156914172|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156914173|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156914174|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914175|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156914176|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
156914177|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
156914178|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156914179|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
156914180|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
156914181|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
156914182|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
156914183|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
156914184|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
156914185|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
156914186|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
156914187|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
156914188|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
156914189|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
156914190|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
156914191|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
156914192|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
156914193|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
156914194|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
156914195|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
156914196|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
156914197|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
156914198|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
156914199|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
156914200|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
156914201|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
156914202|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
156914203|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Death|0|||
156914204|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Death|0|||
156914205|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Death|0|||
156914206|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Death|0|||
156914207|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Death|1|||
156914208|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Death|1|||
156914209|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Death|3|||
156914210|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Death|1|||
156914211|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Death|1|||
156914212|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Death|5|||
156914213|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Death|2|||
156914214|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Death|2|||
156914215|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Other|0|||
156914216|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Other|0|||
156914217|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Other|0|||
156914218|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Other|0|||
156914219|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Other|10|||
156914220|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Other|3|||
156914221|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Other|2|||
156914222|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Other|0|||
156914223|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Other|10|||
156914224|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Other|5|||
156914225|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Other|1|||
156914226|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Other|7|||
156914227|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914228|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914229|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914230|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914231|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
156914232|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914233|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914234|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914235|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914236|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914237|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914238|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156914239|NCT02521870|566444747|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914240|NCT02521870|566444748|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914241|NCT02521870|566444749|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914242|NCT02521870|566444750|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914243|NCT02521870|566444751|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
156914244|NCT02521870|566444752|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914245|NCT02521870|566444753|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914246|NCT02521870|566444754|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914247|NCT02521870|566444755|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914248|NCT02521870|566444756|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914249|NCT02521870|566444757|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
157162229|NCT01120379|567339079|FG000|One Year Timepoint|Withdrawal by Subject|41|||
157162230|NCT01120379|567339079|FG000|One Year Timepoint|Lost to Follow-up|115|||
156914250|NCT02521870|566444758|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
156914251|NCT00519831|566444759|FG000|Overall Study|Adverse Event|3|||
156914252|NCT02854631|566444760|FG000|Overall Study|Adverse Event|1|||
156914253|NCT02854631|566444761|FG001|Overall Study|Adverse Event|2|||
156914254|NCT02854631|566444760|FG000|Overall Study|Withdrew Consent|3|||
156914255|NCT02854631|566444761|FG001|Overall Study|Withdrew Consent|2|||
156914256|NCT02854631|566444760|FG000|Overall Study|Investigator's Discretion|2|||
156914257|NCT02854631|566444761|FG001|Overall Study|Investigator's Discretion|0|||
157162231|NCT01120379|567339079|FG000|One Year Timepoint|Death|108|||
157162232|NCT01120379|567339079|FG000|One Year Timepoint|Physician Decision|9|||
157162233|NCT01120379|567339079|FG000|One Year Timepoint|Any other reason for early termination|5|||
157162234|NCT01120379|567339079|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
157162235|NCT01120379|567339079|FG000|Two Year Timepoint|Lost to Follow-up|87|||
157162236|NCT01120379|567339079|FG000|Two Year Timepoint|Death|123|||
157162237|NCT01120379|567339079|FG000|Two Year Timepoint|Physician Decision|12|||
157162238|NCT01120379|567339079|FG000|Two Year Timepoint|Any other reason for early termination|4|||
157162239|NCT01120379|567339079|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
157162240|NCT01120379|567339079|FG000|Three Year Timepoint|Lost to Follow-up|43|||
157162241|NCT01120379|567339079|FG000|Three Year Timepoint|Death|120|||
157162242|NCT01120379|567339079|FG000|Three Year Timepoint|Physician Decision|9|||
157162243|NCT01120379|567339079|FG000|Three Year Timepoint|Any other reason for early termination|17|||
157162244|NCT01120379|567339079|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
157162245|NCT01120379|567339079|FG000|Four Year Timepoint|Lost to Follow-up|10|||
157162246|NCT01120379|567339079|FG000|Four Year Timepoint|Death|131|||
157162247|NCT01120379|567339079|FG000|Four Year Timepoint|Physician Decision|5|||
157162248|NCT01120379|567339079|FG000|Four Year Timepoint|Any other reason for early termination|217|||
157162249|NCT03162055|567339080|FG000|Overall Study|Adverse Event|6|||
157162250|NCT03162055|567339081|FG001|Overall Study|Adverse Event|5|||
157162251|NCT03162055|567339080|FG000|Overall Study|Death|3|||
157162252|NCT03162055|567339081|FG001|Overall Study|Death|3|||
157162253|NCT03162055|567339080|FG000|Overall Study|Lost to Follow-up|0|||
157162254|NCT03162055|567339081|FG001|Overall Study|Lost to Follow-up|1|||
157162255|NCT03162055|567339080|FG000|Overall Study|Study-specific withdrawal criteria|22|||
157162256|NCT03162055|567339081|FG001|Overall Study|Study-specific withdrawal criteria|14|||
157162257|NCT03162055|567339080|FG000|Overall Study|Withdrawal by Subject|17|||
157162258|NCT03162055|567339081|FG001|Overall Study|Withdrawal by Subject|2|||
157162259|NCT03162055|567339080|FG000|Overall Study|Did not receive treatment|2|||
157162260|NCT03162055|567339081|FG001|Overall Study|Did not receive treatment|0|||
157162261|NCT03162055|567339080|FG000|Overall Study|Incorrect randomization|4|||
157162262|NCT03162055|567339081|FG001|Overall Study|Incorrect randomization|3|||
157162263|NCT03162055|567339080|FG000|Overall Study|Other|8|||
157162264|NCT03162055|567339081|FG001|Overall Study|Other|15|||
157162265|NCT00831441|567339090|FG000|Randomized|Death|82|||
157162266|NCT00831441|567339091|FG001|Randomized|Death|81|||
157162267|NCT00831441|567339090|FG000|Randomized|Adverse Event|248|||
157162268|NCT00831441|567339091|FG001|Randomized|Adverse Event|321|||
157162269|NCT00831441|567339090|FG000|Randomized|Emergency procedure|2|||
157162270|NCT00831441|567339091|FG001|Randomized|Emergency procedure|2|||
157162271|NCT00831441|567339090|FG000|Randomized|Elective procedure|26|||
157162272|NCT00831441|567339091|FG001|Randomized|Elective procedure|25|||
157162273|NCT00831441|567339090|FG000|Randomized|Physician Decision|26|||
157162274|NCT00831441|567339091|FG001|Randomized|Physician Decision|35|||
157162275|NCT00831441|567339090|FG000|Randomized|No longer met criteria|13|||
157162276|NCT00831441|567339091|FG001|Randomized|No longer met criteria|19|||
157162277|NCT00831441|567339090|FG000|Randomized|Withdrawal by Subject|178|||
157162278|NCT00831441|567339091|FG001|Randomized|Withdrawal by Subject|212|||
157162279|NCT00831441|567339090|FG000|Randomized|Lost to Follow-up|26|||
157162280|NCT00831441|567339091|FG001|Randomized|Lost to Follow-up|35|||
157162281|NCT00831441|567339090|FG000|Randomized|Administrative reason by sponsor|2780|||
157162282|NCT00831441|567339091|FG001|Randomized|Administrative reason by sponsor|2671|||
157162283|NCT00831441|567339090|FG000|Randomized|poor/non-compliance|30|||
157162284|NCT00831441|567339091|FG001|Randomized|poor/non-compliance|38|||
157162285|NCT00831441|567339090|FG000|Randomized|non-specified|276|||
157162286|NCT00831441|567339091|FG001|Randomized|non-specified|266|||
157162287|NCT00831441|567339090|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
157162288|NCT00831441|567339091|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
157162289|NCT00831441|567339090|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
157162290|NCT00831441|567339091|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
157162291|NCT00831441|567339090|FG000|Follow Up (30 Days)|Death|63|||
157162292|NCT00831441|567339091|FG001|Follow Up (30 Days)|Death|86|||
157162293|NCT00831441|567339090|FG000|Follow Up (30 Days)|non-specified|16|||
157162294|NCT00831441|567339091|FG001|Follow Up (30 Days)|non-specified|26|||
157162295|NCT00831441|567339090|FG000|Follow Up (30 Days)|missing end of study status|0|||
157162296|NCT00831441|567339091|FG001|Follow Up (30 Days)|missing end of study status|1|||
157162297|NCT05674344|567339092|FG000|Overall Study|Screen Fail|21|||
157162298|NCT05674344|567339092|FG000|Overall Study|Incomplete study procedures|3|||
157162299|NCT00111917|567339093|FG000|Overall Study|Withdrawal by Subject|1|||
156914258|NCT02854631|566444760|FG000|Overall Study|Death|12|||
156914259|NCT02854631|566444761|FG001|Overall Study|Death|8|||
156914260|NCT02854631|566444760|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
156914261|NCT02854631|566444761|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
156914262|NCT02854631|566444760|FG000|Overall Study|Protocol Violation|0|||
156914263|NCT02854631|566444761|FG001|Overall Study|Protocol Violation|1|||
156914264|NCT02854631|566444760|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
156914265|NCT02854631|566444761|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
156914266|NCT02854631|566444760|FG000|Overall Study|Lost to Follow-up|4|||
156914267|NCT02854631|566444761|FG001|Overall Study|Lost to Follow-up|2|||
156914268|NCT02862171|566444762|FG000|Overall Study|Death|1|||
156914269|NCT02862171|566444762|FG000|Overall Study|Lost to Follow-up|13|||
156914270|NCT02862171|566444762|FG000|Overall Study|Withdrawal by Subject|57|||
156914271|NCT02862171|566444762|FG000|Overall Study|Non-compliance|4|||
156914272|NCT02862171|566444762|FG000|Overall Study|HIV-1 seroconversion|18|||
156914273|NCT03930797|566444763|FG000|Overall Study|Lost to Follow-up|3|||
156914274|NCT03930797|566444764|FG001|Overall Study|Lost to Follow-up|10|||
156914275|NCT00662012|566444765|FG000|Overall Study|Lost to Follow-up|85|||
156914276|NCT00662012|566444765|FG000|Overall Study|Death|1|||
156914277|NCT00662012|566444765|FG000|Overall Study|Withdrawal by Subject|1|||
156914278|NCT02144012|566444768|FG000|Overall Study|Adverse Event|1|||
156914279|NCT02144012|566444769|FG001|Overall Study|Adverse Event|0|||
156914280|NCT02144012|566444768|FG000|Overall Study|Death|1|||
156914281|NCT02144012|566444769|FG001|Overall Study|Death|0|||
156914282|NCT02144012|566444768|FG000|Overall Study|Withdrawal by Subject|11|||
156914283|NCT02144012|566444769|FG001|Overall Study|Withdrawal by Subject|3|||
156914284|NCT02144012|566444768|FG000|Overall Study|Study Terminated by Sponsor|18|||
156914285|NCT02144012|566444769|FG001|Overall Study|Study Terminated by Sponsor|12|||
156914286|NCT02144012|566444768|FG000|Overall Study|Other|3|||
156914287|NCT02144012|566444769|FG001|Overall Study|Other|0|||
156914288|NCT00317356|566444770|FG000|Overall Study|Adverse Event|0|||
156914289|NCT00317356|566444771|FG001|Overall Study|Adverse Event|0|||
156914290|NCT00317356|566444772|FG002|Overall Study|Adverse Event|1|||
156914291|NCT00317356|566444773|FG003|Overall Study|Adverse Event|0|||
156914292|NCT00317356|566444770|FG000|Overall Study|Lack of Efficacy|1|||
156914293|NCT00317356|566444771|FG001|Overall Study|Lack of Efficacy|1|||
156914294|NCT00317356|566444772|FG002|Overall Study|Lack of Efficacy|0|||
156914295|NCT00317356|566444773|FG003|Overall Study|Lack of Efficacy|3|||
156914296|NCT00317356|566444770|FG000|Overall Study|Physician Decision|0|||
156914297|NCT00317356|566444771|FG001|Overall Study|Physician Decision|1|||
156914298|NCT00317356|566444772|FG002|Overall Study|Physician Decision|0|||
156914299|NCT00317356|566444773|FG003|Overall Study|Physician Decision|0|||
156914300|NCT03727347|566444774|FG000|Overall Study|Withdrawal by Subject|2|||
156914301|NCT03727347|566444774|FG000|Overall Study|Lost to Follow-up|1|||
156914302|NCT00963547|566446214|FG000|Overall Study|Adverse Event|0|||
156914303|NCT00963547|566446215|FG001|Overall Study|Adverse Event|1|||
156914304|NCT00963547|566446216|FG002|Overall Study|Adverse Event|0|||
156914305|NCT00963547|566446217|FG003|Overall Study|Adverse Event|1|||
156914306|NCT00963547|566446218|FG004|Overall Study|Adverse Event|0|||
156914307|NCT00963547|566446219|FG005|Overall Study|Adverse Event|0|||
156914308|NCT00963547|566446220|FG006|Overall Study|Adverse Event|0|||
156914309|NCT00963547|566446214|FG000|Overall Study|Physician Decision|1|||
156914310|NCT00963547|566446215|FG001|Overall Study|Physician Decision|1|||
156914311|NCT00963547|566446216|FG002|Overall Study|Physician Decision|0|||
156914312|NCT00963547|566446217|FG003|Overall Study|Physician Decision|0|||
156914313|NCT00963547|566446218|FG004|Overall Study|Physician Decision|0|||
156914314|NCT00963547|566446219|FG005|Overall Study|Physician Decision|0|||
156914315|NCT00963547|566446220|FG006|Overall Study|Physician Decision|0|||
156914316|NCT00963547|566446214|FG000|Overall Study|Progressive Disease|3|||
156914317|NCT00963547|566446215|FG001|Overall Study|Progressive Disease|8|||
156914318|NCT00963547|566446216|FG002|Overall Study|Progressive Disease|9|||
156914319|NCT00963547|566446217|FG003|Overall Study|Progressive Disease|5|||
156914320|NCT00963547|566446218|FG004|Overall Study|Progressive Disease|0|||
156914321|NCT00963547|566446219|FG005|Overall Study|Progressive Disease|0|||
157027937|NCT03235544|566859079|FG000|Overall Study|Withdrawal by Subject|0|||
157162300|NCT00111917|567339094|FG001|Overall Study|Withdrawal by Subject|1|||
156914322|NCT00963547|566446220|FG006|Overall Study|Progressive Disease|0|||
156914323|NCT00963547|566446214|FG000|Overall Study|Withdrawal by Subject|0|||
156914324|NCT00963547|566446215|FG001|Overall Study|Withdrawal by Subject|0|||
156914325|NCT00963547|566446216|FG002|Overall Study|Withdrawal by Subject|3|||
156914326|NCT00963547|566446217|FG003|Overall Study|Withdrawal by Subject|0|||
156914327|NCT00963547|566446218|FG004|Overall Study|Withdrawal by Subject|0|||
156914328|NCT00963547|566446219|FG005|Overall Study|Withdrawal by Subject|0|||
156914329|NCT00963547|566446220|FG006|Overall Study|Withdrawal by Subject|0|||
156914330|NCT00963547|566446214|FG000|Overall Study|Reason Unknown|0|||
156914331|NCT00963547|566446215|FG001|Overall Study|Reason Unknown|1|||
156914332|NCT00963547|566446216|FG002|Overall Study|Reason Unknown|0|||
156914333|NCT00963547|566446217|FG003|Overall Study|Reason Unknown|0|||
156914334|NCT00963547|566446218|FG004|Overall Study|Reason Unknown|0|||
156914335|NCT00963547|566446219|FG005|Overall Study|Reason Unknown|0|||
156914336|NCT00963547|566446220|FG006|Overall Study|Reason Unknown|0|||
156914337|NCT03761277|566446222|FG000|Enrollment to Implant|Screen Failure|17|||
156914338|NCT03761277|566446222|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
156914339|NCT03761277|566446222|FG000|Enrollment to Implant|Physician Decision|2|||
156914340|NCT03761277|566446222|FG000|Enrollment to Implant|Site Closure|3|||
156914341|NCT03761277|566446222|FG000|Enrollment to Implant|Sponsor Request|2|||
156914342|NCT03761277|566446222|FG000|Post-Implant to 6 Months|Adverse Event|2|||
156914343|NCT03761277|566446222|FG000|Post-Implant to 6 Months|Death|1|||
156914344|NCT03761277|566446222|FG000|Post-Implant to 6 Months|Site Closure|2|||
156914345|NCT03761277|566446222|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
156914346|NCT03761277|566446222|FG000|6 Months to 12 Months|Physician Decision|2|||
156914347|NCT03761277|566446222|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
156914348|NCT04532164|566446223|FG000|Overall Study|Adverse Event|1|||
156914349|NCT04532164|566446223|FG000|Overall Study|Protocol Violation|5|||
156914350|NCT04532164|566446223|FG000|Overall Study|Lost to Follow-up|1|||
156914351|NCT04532164|566446223|FG000|Overall Study|Found to be Ineligible|3|||
156914352|NCT04532164|566446223|FG000|Overall Study|Withdrawal by Subject|14|||
156914353|NCT02483520|566446224|FG000|Overall Study|Lost to Follow-up|3|||
156914354|NCT02483520|566446225|FG001|Overall Study|Lost to Follow-up|4|||
156914355|NCT02483520|566446224|FG000|Overall Study|Withdrawal by Subject|4|||
156914356|NCT02483520|566446225|FG001|Overall Study|Withdrawal by Subject|14|||
156914357|NCT02483520|566446224|FG000|Overall Study|Hospitalized|2|||
156914358|NCT02483520|566446225|FG001|Overall Study|Hospitalized|3|||
156914359|NCT02483520|566446224|FG000|Overall Study|Moved to LTC|2|||
156914360|NCT02483520|566446225|FG001|Overall Study|Moved to LTC|3|||
156914361|NCT03489720|566446229|FG000|Overall Study|Withdrawal by Subject|2|||
156914362|NCT03489720|566446230|FG001|Overall Study|Withdrawal by Subject|0|||
156914363|NCT01806545|566446231|FG000|Overall Study|Adverse Event|2|||
156914364|NCT01806545|566446232|FG001|Overall Study|Adverse Event|3|||
156914365|NCT01806545|566446231|FG000|Overall Study|Lost to Follow-up|1|||
156914366|NCT01806545|566446232|FG001|Overall Study|Lost to Follow-up|0|||
156914367|NCT01806545|566446231|FG000|Overall Study|Withdrawal by Subject|3|||
156914368|NCT01806545|566446232|FG001|Overall Study|Withdrawal by Subject|2|||
156914369|NCT00884312|566446233|FG000|Overall Study|Non-fatal Progressive Disease|0|||
156914370|NCT00884312|566446234|FG001|Overall Study|Non-fatal Progressive Disease|8|||
156914371|NCT00884312|566446233|FG000|Overall Study|Fatal Progressive Disease|0|||
156914372|NCT00884312|566446234|FG001|Overall Study|Fatal Progressive Disease|1|||
156914373|NCT00884312|566446233|FG000|Overall Study|Non-fatal Adverse Event|1|||
156914374|NCT00884312|566446234|FG001|Overall Study|Non-fatal Adverse Event|0|||
156914375|NCT00884312|566446233|FG000|Overall Study|Fatal Adverse Event|1|||
156914376|NCT00884312|566446234|FG001|Overall Study|Fatal Adverse Event|4|||
156914377|NCT00884312|566446233|FG000|Overall Study|Withdrawal by Subject|0|||
156914378|NCT00884312|566446234|FG001|Overall Study|Withdrawal by Subject|6|||
156914379|NCT00884312|566446233|FG000|Overall Study|Physician Decision|0|||
156914380|NCT00884312|566446234|FG001|Overall Study|Physician Decision|1|||
156914381|NCT00884312|566446233|FG000|Overall Study|Other|0|||
156914382|NCT00884312|566446234|FG001|Overall Study|Other|4|||
156914383|NCT00884312|566446233|FG000|Overall Study|Did Not Receive Study Drug|0|||
156914384|NCT00884312|566446234|FG001|Overall Study|Did Not Receive Study Drug|1|||
157162301|NCT01640925|567339095|FG000|Overall Study|Withdrawal by Subject|1|||
157162302|NCT01640925|567339096|FG001|Overall Study|Withdrawal by Subject|0|||
157162303|NCT01640925|567339095|FG000|Overall Study|Previously enrolled in this trial|13|||
157162304|NCT01640925|567339096|FG001|Overall Study|Previously enrolled in this trial|11|||
157162305|NCT02156492|567339097|FG000|Period 1|No Reason Given|0|||
157162306|NCT02156492|567339098|FG001|Period 1|No Reason Given|1|||
157162307|NCT02156492|567339099|FG002|Period 1|No Reason Given|0|||
157162308|NCT02156492|567339097|FG000|Period 3|Adverse Event|0|||
157162309|NCT02156492|567339098|FG001|Period 3|Adverse Event|1|||
157162310|NCT02156492|567339099|FG002|Period 3|Adverse Event|0|||
157162311|NCT00485589|567339108|FG000|Overall Study|Death|2|||
156914385|NCT03521934|566446238|FG000|Overall Study|Death|65|||
156914386|NCT03521934|566446239|FG001|Overall Study|Death|73|||
156914387|NCT03521934|566446238|FG000|Overall Study|Withdrawal by Subject|18|||
157162312|NCT00485589|567339109|FG001|Overall Study|Death|2|||
157162313|NCT00485589|567339110|FG002|Overall Study|Death|0|||
157162314|NCT00485589|567339108|FG000|Overall Study|Failure to return|6|||
157162315|NCT00485589|567339109|FG001|Overall Study|Failure to return|5|||
156914388|NCT03521934|566446239|FG001|Overall Study|Withdrawal by Subject|23|||
156914389|NCT03521934|566446238|FG000|Overall Study|Site Terminated by Sponsor|39|||
156914390|NCT03521934|566446239|FG001|Overall Study|Site Terminated by Sponsor|35|||
156914391|NCT03521934|566446238|FG000|Overall Study|Study Terminated by Sponsor|483|||
156914392|NCT03521934|566446239|FG001|Overall Study|Study Terminated by Sponsor|477|||
156914393|NCT03521934|566446238|FG000|Overall Study|Reason not Specified|3|||
156914394|NCT03521934|566446239|FG001|Overall Study|Reason not Specified|6|||
156914395|NCT00489541|566446252|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
156914396|NCT00489541|566446253|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
156914397|NCT00489541|566446252|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
157162316|NCT00485589|567339110|FG002|Overall Study|Failure to return|1|||
156914398|NCT00489541|566446253|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
156914399|NCT00489541|566446252|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
156914400|NCT00489541|566446253|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
156914401|NCT00489541|566446252|FG000|12-Month Clinical Follow-up|Death|3|||
156914402|NCT00489541|566446253|FG001|12-Month Clinical Follow-up|Death|2|||
156914403|NCT00489541|566446252|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
156914404|NCT00489541|566446253|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
156914405|NCT00489541|566446252|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
156914406|NCT00489541|566446253|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
156914407|NCT00299104|566446255|FG000|Treatment Period|Adverse Event|14|||
156914408|NCT00299104|566446256|FG001|Treatment Period|Adverse Event|9|||
156914409|NCT00299104|566446257|FG002|Treatment Period|Adverse Event|7|||
156914410|NCT00299104|566446255|FG000|Treatment Period|Death|1|||
156914411|NCT00299104|566446256|FG001|Treatment Period|Death|1|||
156914412|NCT00299104|566446257|FG002|Treatment Period|Death|1|||
156914413|NCT00299104|566446255|FG000|Treatment Period|Insufficient therapeutic response|34|||
156914414|NCT00299104|566446256|FG001|Treatment Period|Insufficient therapeutic response|13|||
156914415|NCT00299104|566446257|FG002|Treatment Period|Insufficient therapeutic response|8|||
156914416|NCT00299104|566446255|FG000|Treatment Period|Failure to return|9|||
156914417|NCT00299104|566446256|FG001|Treatment Period|Failure to return|8|||
156914418|NCT00299104|566446257|FG002|Treatment Period|Failure to return|8|||
156914419|NCT00299104|566446255|FG000|Treatment Period|Violation of selection criteria|1|||
156914420|NCT00299104|566446256|FG001|Treatment Period|Violation of selection criteria|2|||
156914421|NCT00299104|566446257|FG002|Treatment Period|Violation of selection criteria|0|||
156914422|NCT00299104|566446255|FG000|Treatment Period|Protocol Violation|1|||
156914423|NCT00299104|566446256|FG001|Treatment Period|Protocol Violation|1|||
156914424|NCT00299104|566446257|FG002|Treatment Period|Protocol Violation|0|||
156914425|NCT00299104|566446255|FG000|Treatment Period|Refused treatment|9|||
156914426|NCT00299104|566446256|FG001|Treatment Period|Refused treatment|2|||
156914427|NCT00299104|566446257|FG002|Treatment Period|Refused treatment|2|||
156914428|NCT00299104|566446255|FG000|Treatment Period|Withdrew consent|14|||
156914429|NCT00299104|566446256|FG001|Treatment Period|Withdrew consent|19|||
156914430|NCT00299104|566446257|FG002|Treatment Period|Withdrew consent|9|||
156914431|NCT00299104|566446255|FG000|Treatment Period|Administrative reasons|106|||
156914432|NCT00299104|566446256|FG001|Treatment Period|Administrative reasons|120|||
156914433|NCT00299104|566446257|FG002|Treatment Period|Administrative reasons|137|||
156914434|NCT00299104|566446255|FG000|Safety Follow-Up (SFU) Period|Death|3|||
156914435|NCT00299104|566446256|FG001|Safety Follow-Up (SFU) Period|Death|2|||
156914436|NCT00299104|566446257|FG002|Safety Follow-Up (SFU) Period|Death|1|||
156914437|NCT00299104|566446255|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
156914438|NCT00299104|566446256|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
156914439|NCT00299104|566446257|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
156914440|NCT00299104|566446255|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
156914441|NCT00299104|566446256|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
156914442|NCT00299104|566446257|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
156914443|NCT00299104|566446255|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
156914444|NCT00299104|566446256|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
156914445|NCT00299104|566446257|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
156914446|NCT00299104|566446255|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
156914447|NCT00299104|566446256|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
156914448|NCT00299104|566446257|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
156914449|NCT00299104|566446255|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156914450|NCT00299104|566446256|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156914451|NCT00299104|566446257|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
156914452|NCT00299104|566446255|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
156914453|NCT00299104|566446256|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
157027938|NCT03235544|566859080|FG001|Overall Study|Withdrawal by Subject|3|||
157027939|NCT03235544|566859081|FG002|Overall Study|Withdrawal by Subject|1|||
157027940|NCT03235544|566859082|FG003|Overall Study|Withdrawal by Subject|5|||
156914454|NCT00299104|566446257|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
156914455|NCT00299104|566446255|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
156914456|NCT00299104|566446256|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
156914457|NCT00299104|566446257|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
156914458|NCT04605484|566446264|FG000|Overall Study|Lost to Follow-up|0|||
156914459|NCT04605484|566446265|FG001|Overall Study|Lost to Follow-up|1|||
156914460|NCT04605484|566446266|FG002|Overall Study|Lost to Follow-up|1|||
156914461|NCT04605484|566446264|FG000|Overall Study|Other|0|||
156914462|NCT04605484|566446265|FG001|Overall Study|Other|1|||
156914463|NCT04605484|566446266|FG002|Overall Study|Other|0|||
156914464|NCT03366337|566446267|FG000|Overall Study|Lost to Follow-up|1|||
156914465|NCT03366337|566446268|FG001|Overall Study|Lost to Follow-up|0|||
156914466|NCT03366337|566446269|FG002|Overall Study|Lost to Follow-up|1|||
156914467|NCT03366337|566446270|FG003|Overall Study|Lost to Follow-up|0|||
156914468|NCT03366337|566446267|FG000|Overall Study|Withdrawal by Subject|2|||
156914469|NCT03366337|566446268|FG001|Overall Study|Withdrawal by Subject|0|||
156914470|NCT03366337|566446269|FG002|Overall Study|Withdrawal by Subject|1|||
156914471|NCT03366337|566446270|FG003|Overall Study|Withdrawal by Subject|1|||
156914472|NCT05288062|566446271|FG000|Overall Study|Ineligible|0|||
156914473|NCT05288062|566446272|FG001|Overall Study|Ineligible|0|||
156914474|NCT05288062|566446273|FG002|Overall Study|Ineligible|1|||
156914475|NCT05288062|566446274|FG003|Overall Study|Ineligible|0|||
156914476|NCT05288062|566446271|FG000|Overall Study|Withdrawal by Subject|0|||
156914477|NCT05288062|566446272|FG001|Overall Study|Withdrawal by Subject|0|||
156914478|NCT05288062|566446273|FG002|Overall Study|Withdrawal by Subject|1|||
156914479|NCT05288062|566446274|FG003|Overall Study|Withdrawal by Subject|0|||
156914480|NCT01658072|566446281|FG000|Overall Study|Protocol Violation|4|||
156914481|NCT01658072|566446282|FG001|Overall Study|Protocol Violation|2|||
156914482|NCT00729651|566446285|FG000|Overall Study|Withdrawal by Subject|5|||
156914483|NCT00729651|566446286|FG001|Overall Study|Withdrawal by Subject|6|||
156914484|NCT00729651|566446285|FG000|Overall Study|Lost to Follow-up|5|||
156914485|NCT00729651|566446286|FG001|Overall Study|Lost to Follow-up|4|||
156914486|NCT00729651|566446285|FG000|Overall Study|Protocol Violation|0|||
156914487|NCT00729651|566446286|FG001|Overall Study|Protocol Violation|1|||
156914488|NCT00729651|566446285|FG000|Overall Study|Adverse Event|7|||
156914489|NCT00729651|566446286|FG001|Overall Study|Adverse Event|3|||
156914490|NCT00729651|566446285|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
156914491|NCT00729651|566446286|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
156914492|NCT00729651|566446285|FG000|Overall Study|Subject's private reason|2|||
156914493|NCT00729651|566446286|FG001|Overall Study|Subject's private reason|0|||
156914494|NCT01874054|566446287|FG000|Overall Study|Withdrawal by Subject|3|||
156914495|NCT01874054|566446287|FG000|Overall Study|Study Termination by Sponsor|42|||
156914496|NCT01874054|566446287|FG000|Overall Study|Lost to Follow-up|5|||
156914497|NCT01874054|566446287|FG000|Overall Study|Death|5|||
156914498|NCT00799422|566446293|FG000|First Week of Wear|Lost to Follow-up|0|||
156914499|NCT00799422|566446294|FG001|First Week of Wear|Lost to Follow-up|0|||
156914500|NCT00799422|566446295|FG002|First Week of Wear|Lost to Follow-up|1|||
156914501|NCT00799422|566446296|FG003|First Week of Wear|Lost to Follow-up|0|||
156914502|NCT00799422|566446297|FG004|First Week of Wear|Lost to Follow-up|0|||
156914503|NCT00799422|566446298|FG005|First Week of Wear|Lost to Follow-up|0|||
156914504|NCT00799422|566446293|FG000|First Week of Wear|Adverse Event|0|||
156914505|NCT00799422|566446294|FG001|First Week of Wear|Adverse Event|0|||
156914506|NCT00799422|566446295|FG002|First Week of Wear|Adverse Event|0|||
156914507|NCT00799422|566446296|FG003|First Week of Wear|Adverse Event|1|||
156914508|NCT00799422|566446297|FG004|First Week of Wear|Adverse Event|0|||
156914509|NCT00799422|566446298|FG005|First Week of Wear|Adverse Event|0|||
156914510|NCT01844518|566446301|FG000|Overall Study|Adverse Event|7|||
156914511|NCT01844518|566446302|FG001|Overall Study|Adverse Event|1|||
156914512|NCT01844518|566446301|FG000|Overall Study|Lack of Efficacy|17|||
156914513|NCT01844518|566446302|FG001|Overall Study|Lack of Efficacy|5|||
156914514|NCT01844518|566446301|FG000|Overall Study|Participant's request to discontinue|4|||
156914515|NCT01844518|566446302|FG001|Overall Study|Participant's request to discontinue|1|||
156914516|NCT01844518|566446301|FG000|Overall Study|Poor/Non-compliance|1|||
157162317|NCT00485589|567339108|FG000|Overall Study|Protocol Violation|1|||
157162318|NCT00485589|567339109|FG001|Overall Study|Protocol Violation|0|||
157162319|NCT00485589|567339110|FG002|Overall Study|Protocol Violation|0|||
157162320|NCT00485589|567339108|FG000|Overall Study|Violation of selection criteria at entry|0|||
157162321|NCT00485589|567339109|FG001|Overall Study|Violation of selection criteria at entry|3|||
157162322|NCT00485589|567339110|FG002|Overall Study|Violation of selection criteria at entry|1|||
157162323|NCT00485589|567339108|FG000|Overall Study|Administrative/Other|1|||
157162324|NCT00485589|567339109|FG001|Overall Study|Administrative/Other|2|||
156914517|NCT01844518|566446302|FG001|Overall Study|Poor/Non-compliance|0|||
157027941|NCT03235544|566859079|FG000|Overall Study|Disease Progression|0|||
157162325|NCT00485589|567339110|FG002|Overall Study|Administrative/Other|1|||
157162326|NCT00485589|567339108|FG000|Overall Study|Insufficient therapeutic response|10|||
157162327|NCT00485589|567339109|FG001|Overall Study|Insufficient therapeutic response|3|||
157162328|NCT00485589|567339110|FG002|Overall Study|Insufficient therapeutic response|1|||
157162329|NCT00485589|567339108|FG000|Overall Study|Refused treatment/did not cooperate|1|||
157162330|NCT00485589|567339109|FG001|Overall Study|Refused treatment/did not cooperate|0|||
157162331|NCT00485589|567339110|FG002|Overall Study|Refused treatment/did not cooperate|2|||
157162332|NCT00485589|567339108|FG000|Overall Study|Withdrawal by Subject|3|||
157162333|NCT00485589|567339109|FG001|Overall Study|Withdrawal by Subject|2|||
157162334|NCT00485589|567339110|FG002|Overall Study|Withdrawal by Subject|2|||
156914518|NCT01844518|566446301|FG000|Overall Study|No Longer Met Study Criteria|2|||
156914519|NCT01844518|566446302|FG001|Overall Study|No Longer Met Study Criteria|0|||
156914520|NCT01844518|566446301|FG000|Overall Study|Withdrawal by Subject|9|||
156914521|NCT01844518|566446302|FG001|Overall Study|Withdrawal by Subject|0|||
156914522|NCT01844518|566446301|FG000|Overall Study|Pregnancy|1|||
156914523|NCT01844518|566446302|FG001|Overall Study|Pregnancy|0|||
157162335|NCT00485589|567339108|FG000|Overall Study|Adverse Event|3|||
156914524|NCT01217801|566446303|FG000|Period 1|Protocol Violation|1|||
156914525|NCT01217801|566446304|FG001|Period 1|Protocol Violation|1|||
156914526|NCT01217801|566446303|FG000|Period 1|Withdrawal by Subject|0|||
156914527|NCT01217801|566446304|FG001|Period 1|Withdrawal by Subject|1|||
156914528|NCT03926169|566446307|FG000|Period A|Adverse Event|2|||
156914529|NCT03926169|566446308|FG001|Period A|Adverse Event|2|||
156914530|NCT03926169|566446309|FG002|Period A|Adverse Event|1|||
156914531|NCT03926169|566446307|FG000|Period A|Withdrawal by Subject|2|||
156914532|NCT03926169|566446308|FG001|Period A|Withdrawal by Subject|2|||
156914533|NCT03926169|566446309|FG002|Period A|Withdrawal by Subject|2|||
157027942|NCT03235544|566859080|FG001|Overall Study|Disease Progression|1|||
156914534|NCT03926169|566446307|FG000|Period A|Lost to Follow-up|3|||
157027943|NCT03235544|566859081|FG002|Overall Study|Disease Progression|0|||
157027944|NCT03235544|566859082|FG003|Overall Study|Disease Progression|2|||
157027945|NCT03235544|566859079|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
157027946|NCT03235544|566859080|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
157027947|NCT03235544|566859081|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
157027948|NCT03235544|566859082|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
157027949|NCT03235544|566859079|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
157027950|NCT03235544|566859080|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
157027951|NCT03235544|566859081|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
157027952|NCT03235544|566859082|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
157027953|NCT04200456|566859083|FG000|Overall Study|Physician Decision|0|||
157027954|NCT04200456|566859084|FG001|Overall Study|Physician Decision|1|||
157027955|NCT04200456|566859083|FG000|Overall Study|Withdrawal by Subject|2|||
157027956|NCT04200456|566859084|FG001|Overall Study|Withdrawal by Subject|2|||
157027957|NCT04200456|566859083|FG000|Overall Study|Lack of Efficacy|1|||
157027958|NCT04200456|566859084|FG001|Overall Study|Lack of Efficacy|1|||
157027959|NCT04200456|566859083|FG000|Overall Study|Adverse event, non-fatal|0|||
157027960|NCT04200456|566859084|FG001|Overall Study|Adverse event, non-fatal|1|||
157027961|NCT04200456|566859083|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
157027962|NCT04200456|566859084|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
157027963|NCT05002088|566859086|FG000|Overall Study|Withdrawal by Subject|9|||
157027964|NCT05002088|566859087|FG001|Overall Study|Withdrawal by Subject|0|||
157027965|NCT05002088|566859086|FG000|Overall Study|Lost to Follow-up|0|||
157027966|NCT05002088|566859087|FG001|Overall Study|Lost to Follow-up|1|||
157027967|NCT05002088|566859086|FG000|Overall Study|Death|16|||
157027968|NCT05002088|566859087|FG001|Overall Study|Death|2|||
157027969|NCT05002088|566859086|FG000|Overall Study|Protocol Violation|25|||
157027970|NCT05002088|566859087|FG001|Overall Study|Protocol Violation|7|||
157027971|NCT03785964|566859090|FG000|Overall Study|Adverse Event|14|||
157027972|NCT03785964|566859091|FG001|Overall Study|Adverse Event|1|||
157027973|NCT03785964|566859090|FG000|Overall Study|Unqualified Clinical Progression|1|||
157027974|NCT03785964|566859091|FG001|Overall Study|Unqualified Clinical Progression|1|||
157027975|NCT03785964|566859090|FG000|Overall Study|Participant non-compliance|1|||
157027976|NCT03785964|566859091|FG001|Overall Study|Participant non-compliance|1|||
157027977|NCT03785964|566859090|FG000|Overall Study|Not treated|1|||
157027978|NCT03785964|566859091|FG001|Overall Study|Not treated|0|||
157027979|NCT03785964|566859090|FG000|Overall Study|Other reason|5|||
157027980|NCT03785964|566859091|FG001|Overall Study|Other reason|11|||
157027981|NCT03785964|566859090|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
157027982|NCT03785964|566859091|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
157027983|NCT02723591|566859092|FG000|Overall Study|Adverse Event|48|||
157027984|NCT02723591|566859093|FG001|Overall Study|Adverse Event|40|||
157027985|NCT02723591|566859092|FG000|Overall Study|Death|2|||
157027986|NCT02723591|566859093|FG001|Overall Study|Death|2|||
157027987|NCT02723591|566859092|FG000|Overall Study|Lack of Efficacy|4|||
157027988|NCT02723591|566859093|FG001|Overall Study|Lack of Efficacy|3|||
157027989|NCT02723591|566859092|FG000|Overall Study|Lost to Follow-up|1|||
157027990|NCT02723591|566859093|FG001|Overall Study|Lost to Follow-up|7|||
157027991|NCT02723591|566859092|FG000|Overall Study|Protocol Violation|20|||
157027992|NCT02723591|566859093|FG001|Overall Study|Protocol Violation|23|||
157027993|NCT02723591|566859092|FG000|Overall Study|Withdrawal by Subject|4|||
157027994|NCT02723591|566859093|FG001|Overall Study|Withdrawal by Subject|8|||
157027995|NCT02723591|566859092|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
157027996|NCT02723591|566859093|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
157027997|NCT02723591|566859092|FG000|Overall Study|Miscellaneous|5|||
156914535|NCT03926169|566446308|FG001|Period A|Lost to Follow-up|1|||
156914536|NCT03926169|566446309|FG002|Period A|Lost to Follow-up|0|||
156914537|NCT03926169|566446307|FG000|Period A|Lack of Efficacy|0|||
156914538|NCT03926169|566446308|FG001|Period A|Lack of Efficacy|2|||
156914539|NCT03926169|566446309|FG002|Period A|Lack of Efficacy|2|||
156914540|NCT03926169|566446307|FG000|Period A|COVID-19 Infection|0|||
156914541|NCT03926169|566446308|FG001|Period A|COVID-19 Infection|1|||
156914542|NCT03926169|566446309|FG002|Period A|COVID-19 Infection|0|||
156914543|NCT03926169|566446307|FG000|Period A|COVID-19 Logistical Restrictions|0|||
156914544|NCT03926169|566446308|FG001|Period A|COVID-19 Logistical Restrictions|2|||
156914545|NCT03926169|566446309|FG002|Period A|COVID-19 Logistical Restrictions|1|||
156914546|NCT03926169|566446307|FG000|Period A|Other, Not Specified|1|||
156914547|NCT03926169|566446308|FG001|Period A|Other, Not Specified|0|||
156914548|NCT03926169|566446309|FG002|Period A|Other, Not Specified|0|||
156914549|NCT03926169|566446307|FG000|Period B|Adverse Event|3|||
156914550|NCT03926169|566446308|FG001|Period B|Adverse Event|1|||
156914551|NCT03926169|566446309|FG002|Period B|Adverse Event|1|||
156914552|NCT03926169|566446307|FG000|Period B|Withdrawal by Subject|1|||
156914553|NCT03926169|566446308|FG001|Period B|Withdrawal by Subject|3|||
156914554|NCT03926169|566446309|FG002|Period B|Withdrawal by Subject|0|||
156914555|NCT03926169|566446307|FG000|Period B|Lack of Efficacy|3|||
156914556|NCT03926169|566446308|FG001|Period B|Lack of Efficacy|1|||
156914557|NCT03926169|566446309|FG002|Period B|Lack of Efficacy|1|||
156914558|NCT03926169|566446307|FG000|Period B|Lost to Follow-up|1|||
156914559|NCT03926169|566446308|FG001|Period B|Lost to Follow-up|1|||
156914560|NCT03926169|566446309|FG002|Period B|Lost to Follow-up|4|||
156914561|NCT03926169|566446307|FG000|Period B|Other, Not Specified|62|||
156914562|NCT03926169|566446308|FG001|Period B|Other, Not Specified|57|||
156914563|NCT03926169|566446309|FG002|Period B|Other, Not Specified|65|||
156914564|NCT03334539|566446310|FG000|Overall Study|Adverse Event|3|||
156914565|NCT03334539|566446311|FG001|Overall Study|Adverse Event|5|||
156914566|NCT03334539|566446312|FG002|Overall Study|Adverse Event|0|||
156914567|NCT03334539|566446310|FG000|Overall Study|Withdrawal by Subject|0|||
156914568|NCT03334539|566446311|FG001|Overall Study|Withdrawal by Subject|1|||
156914569|NCT03334539|566446312|FG002|Overall Study|Withdrawal by Subject|1|||
156914570|NCT03334539|566446310|FG000|Overall Study|Administrative Reasons|1|||
156914571|NCT03334539|566446311|FG001|Overall Study|Administrative Reasons|0|||
156914572|NCT03334539|566446312|FG002|Overall Study|Administrative Reasons|0|||
156914573|NCT03334539|566446310|FG000|Overall Study|Hypertension Not Controlled|0|||
156914574|NCT03334539|566446311|FG001|Overall Study|Hypertension Not Controlled|1|||
156914575|NCT03334539|566446312|FG002|Overall Study|Hypertension Not Controlled|0|||
156914576|NCT04974697|566446313|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
156914577|NCT04974697|566446313|FG000|Overall Study|Lens discomfort|1|||
156914578|NCT03706456|566446314|FG000|Overall Study|Adverse Event|1|||
156914579|NCT03706456|566446314|FG000|Overall Study|Lack of Efficacy|2|||
156914580|NCT03302234|566446315|FG000|Overall Study|Death|191|||
156914581|NCT03302234|566446316|FG001|Overall Study|Death|192|||
156914582|NCT03302234|566446315|FG000|Overall Study|Withdrawal by Subject|2|||
156914583|NCT03302234|566446316|FG001|Overall Study|Withdrawal by Subject|2|||
156914584|NCT03302234|566446315|FG000|Overall Study|Sponsor Decision|90|||
156914585|NCT03302234|566446316|FG001|Overall Study|Sponsor Decision|89|||
156914586|NCT03302234|566446315|FG000|Overall Study|Laryngeal carcinoma|0|||
156914587|NCT03302234|566446316|FG001|Overall Study|Laryngeal carcinoma|1|||
157162336|NCT00485589|567339109|FG001|Overall Study|Adverse Event|3|||
157162337|NCT00485589|567339110|FG002|Overall Study|Adverse Event|10|||
157162338|NCT02924688|567339113|FG000|Overall Study|Adverse Event|9|||
157162339|NCT02924688|567339114|FG001|Overall Study|Adverse Event|3|||
157162340|NCT02924688|567339115|FG002|Overall Study|Adverse Event|2|||
157162341|NCT02924688|567339116|FG003|Overall Study|Adverse Event|2|||
157162342|NCT02924688|567339117|FG004|Overall Study|Adverse Event|3|||
157162343|NCT02924688|567339118|FG005|Overall Study|Adverse Event|2|||
157162344|NCT02924688|567339113|FG000|Overall Study|Lack of Efficacy|2|||
157162345|NCT02924688|567339114|FG001|Overall Study|Lack of Efficacy|3|||
157162346|NCT02924688|567339115|FG002|Overall Study|Lack of Efficacy|4|||
157162347|NCT02924688|567339116|FG003|Overall Study|Lack of Efficacy|2|||
157162348|NCT02924688|567339117|FG004|Overall Study|Lack of Efficacy|1|||
157162349|NCT02924688|567339118|FG005|Overall Study|Lack of Efficacy|1|||
157162350|NCT02924688|567339113|FG000|Overall Study|Protocol Violation|3|||
157162351|NCT02924688|567339114|FG001|Overall Study|Protocol Violation|7|||
157162352|NCT02924688|567339115|FG002|Overall Study|Protocol Violation|5|||
157226080|NCT01915732|567573429|FG000|Overall Study|Recovered|1|||
156914588|NCT03302234|566446315|FG000|Overall Study|Not Reported|1|||
156914589|NCT03302234|566446316|FG001|Overall Study|Not Reported|0|||
156914590|NCT04112784|566446317|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
157162353|NCT02924688|567339116|FG003|Overall Study|Protocol Violation|6|||
157162354|NCT02924688|567339117|FG004|Overall Study|Protocol Violation|2|||
157162355|NCT02924688|567339118|FG005|Overall Study|Protocol Violation|2|||
156914591|NCT04112784|566446317|FG000|Overall Study|Screen Failures|4|||
156914592|NCT02006719|566446318|FG000|Overall Study|Withdrawal by Subject|10|||
156914593|NCT02006719|566446319|FG001|Overall Study|Withdrawal by Subject|2|||
156914594|NCT02006719|566446318|FG000|Overall Study|Lost to Follow-up|5|||
156914595|NCT02006719|566446319|FG001|Overall Study|Lost to Follow-up|1|||
156914596|NCT02006719|566446318|FG000|Overall Study|Protocol Violation|2|||
156914597|NCT02006719|566446319|FG001|Overall Study|Protocol Violation|0|||
156914598|NCT02006719|566446318|FG000|Overall Study|Adverse Event|1|||
156914599|NCT02006719|566446319|FG001|Overall Study|Adverse Event|1|||
157162356|NCT02924688|567339113|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
157162357|NCT02924688|567339114|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
157226081|NCT01915732|567573430|FG001|Overall Study|Recovered|0|||
156914600|NCT02006719|566446318|FG000|Overall Study|Other/Unknown|0|||
156914601|NCT02006719|566446319|FG001|Overall Study|Other/Unknown|1|||
156914602|NCT00753415|566446324|FG000|Part A|Disease progression|1|||
156914603|NCT00753415|566446325|FG001|Part A|Disease progression|0|||
156914604|NCT00753415|566446326|FG002|Part A|Disease progression|1|||
156914605|NCT00753415|566446327|FG003|Part A|Disease progression|2|||
156914606|NCT00753415|566446328|FG004|Part A|Disease progression|0|||
156914607|NCT00753415|566446329|FG005|Part A|Disease progression|0|||
156914608|NCT00753415|566446330|FG006|Part A|Disease progression|0|||
156914609|NCT00753415|566446331|FG007|Part A|Disease progression|0|||
156914610|NCT00753415|566446332|FG008|Part A|Disease progression|0|||
156914611|NCT00753415|566446333|FG009|Part A|Disease progression|0|||
156914612|NCT00753415|566446324|FG000|Part A|Withdrawal by Subject|0|||
156914613|NCT00753415|566446325|FG001|Part A|Withdrawal by Subject|0|||
156914614|NCT00753415|566446326|FG002|Part A|Withdrawal by Subject|1|||
156914615|NCT00753415|566446327|FG003|Part A|Withdrawal by Subject|0|||
156914616|NCT00753415|566446328|FG004|Part A|Withdrawal by Subject|0|||
156914617|NCT00753415|566446329|FG005|Part A|Withdrawal by Subject|0|||
156914618|NCT00753415|566446330|FG006|Part A|Withdrawal by Subject|0|||
156914619|NCT00753415|566446331|FG007|Part A|Withdrawal by Subject|0|||
156914620|NCT00753415|566446332|FG008|Part A|Withdrawal by Subject|0|||
156914621|NCT00753415|566446333|FG009|Part A|Withdrawal by Subject|0|||
156914622|NCT00753415|566446324|FG000|Part B|Lost to Follow-up|0|||
156914623|NCT00753415|566446325|FG001|Part B|Lost to Follow-up|0|||
156914624|NCT00753415|566446326|FG002|Part B|Lost to Follow-up|0|||
156914625|NCT00753415|566446327|FG003|Part B|Lost to Follow-up|0|||
156914626|NCT00753415|566446328|FG004|Part B|Lost to Follow-up|0|||
156914627|NCT00753415|566446329|FG005|Part B|Lost to Follow-up|0|||
156914628|NCT00753415|566446330|FG006|Part B|Lost to Follow-up|0|||
156914629|NCT00753415|566446331|FG007|Part B|Lost to Follow-up|1|||
156914630|NCT00753415|566446332|FG008|Part B|Lost to Follow-up|1|||
156914631|NCT00753415|566446333|FG009|Part B|Lost to Follow-up|0|||
156914632|NCT00753415|566446324|FG000|Part B|Disease progression|0|||
156914633|NCT00753415|566446325|FG001|Part B|Disease progression|0|||
156914634|NCT00753415|566446326|FG002|Part B|Disease progression|0|||
156914635|NCT00753415|566446327|FG003|Part B|Disease progression|0|||
156914636|NCT00753415|566446328|FG004|Part B|Disease progression|0|||
156914637|NCT00753415|566446329|FG005|Part B|Disease progression|0|||
156914638|NCT00753415|566446330|FG006|Part B|Disease progression|0|||
156914639|NCT00753415|566446331|FG007|Part B|Disease progression|0|||
156914640|NCT00753415|566446332|FG008|Part B|Disease progression|2|||
156914641|NCT00753415|566446333|FG009|Part B|Disease progression|1|||
156914642|NCT00598832|566446334|FG000|Overall Study|Lack of Efficacy|3|||
156914643|NCT00598832|566446335|FG001|Overall Study|Lack of Efficacy|7|||
156914644|NCT00598832|566446334|FG000|Overall Study|Adverse Event|6|||
156914645|NCT00598832|566446335|FG001|Overall Study|Adverse Event|2|||
156914646|NCT00598832|566446334|FG000|Overall Study|Withdrawal by Subject|25|||
156914647|NCT00598832|566446335|FG001|Overall Study|Withdrawal by Subject|36|||
156914648|NCT00598832|566446334|FG000|Overall Study|Protocol Violation|0|||
156914649|NCT00598832|566446335|FG001|Overall Study|Protocol Violation|2|||
156914650|NCT00598832|566446334|FG000|Overall Study|Lost to Follow-up|24|||
156914651|NCT00598832|566446335|FG001|Overall Study|Lost to Follow-up|29|||
156914652|NCT00598832|566446334|FG000|Overall Study|Pregnancy|2|||
156914653|NCT00598832|566446335|FG001|Overall Study|Pregnancy|2|||
156914654|NCT00598832|566446334|FG000|Overall Study|Physician Decision|1|||
156914655|NCT00598832|566446335|FG001|Overall Study|Physician Decision|4|||
156914656|NCT00598832|566446334|FG000|Overall Study|Non compliance|1|||
157162358|NCT02924688|567339115|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
157162359|NCT02924688|567339116|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
157162360|NCT02924688|567339117|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
157162361|NCT02924688|567339118|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
157162362|NCT02924688|567339113|FG000|Overall Study|Lost to Follow-up|2|||
157162363|NCT02924688|567339114|FG001|Overall Study|Lost to Follow-up|4|||
156914657|NCT00598832|566446335|FG001|Overall Study|Non compliance|0|||
156914658|NCT02142959|566446336|FG000|Overall Study|Adverse Event|1|||
156914659|NCT02142959|566446337|FG001|Overall Study|Adverse Event|0|||
156914660|NCT02142959|566446338|FG002|Overall Study|Adverse Event|0|||
156914661|NCT02142959|566446336|FG000|Overall Study|Death|0|||
156914662|NCT02142959|566446337|FG001|Overall Study|Death|1|||
156914663|NCT02142959|566446338|FG002|Overall Study|Death|0|||
156914664|NCT02142959|566446336|FG000|Overall Study|Withdrawal by Subject|3|||
156914665|NCT02142959|566446337|FG001|Overall Study|Withdrawal by Subject|1|||
156914666|NCT02142959|566446338|FG002|Overall Study|Withdrawal by Subject|3|||
156914667|NCT02142959|566446336|FG000|Overall Study|Administrative Reasons|1|||
156914668|NCT02142959|566446337|FG001|Overall Study|Administrative Reasons|0|||
156914669|NCT02142959|566446338|FG002|Overall Study|Administrative Reasons|1|||
156914670|NCT02142959|566446336|FG000|Overall Study|Missing|0|||
156914671|NCT02142959|566446337|FG001|Overall Study|Missing|1|||
156914672|NCT02142959|566446338|FG002|Overall Study|Missing|0|||
156914673|NCT02142959|566446336|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
157027998|NCT02723591|566859093|FG001|Overall Study|Miscellaneous|6|||
156914674|NCT02142959|566446337|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
156914675|NCT02142959|566446338|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
156914676|NCT02142959|566446336|FG000|Overall Study|Patient didn't complete end of study visit|0|||
156914677|NCT02142959|566446337|FG001|Overall Study|Patient didn't complete end of study visit|0|||
156914678|NCT02142959|566446338|FG002|Overall Study|Patient didn't complete end of study visit|1|||
156914679|NCT01753856|566446344|FG000|Overall Study|Adverse Event|1|||
156914680|NCT01753856|566446345|FG001|Overall Study|Adverse Event|0|||
156914681|NCT01753856|566446344|FG000|Overall Study|Withdrawal by Subject|0|||
156914682|NCT01753856|566446345|FG001|Overall Study|Withdrawal by Subject|2|||
156914683|NCT01753856|566446344|FG000|Overall Study|Sponsor Decision|2|||
156914684|NCT01753856|566446345|FG001|Overall Study|Sponsor Decision|0|||
156914685|NCT05980182|566446346|FG000|Overall Study|Lost to Follow-up|10|||
156914686|NCT02700815|566448539|FG000|Overall Study|Adverse Event|0|||
156914687|NCT02700815|566448540|FG001|Overall Study|Adverse Event|6|||
156914688|NCT02700815|566448541|FG002|Overall Study|Adverse Event|2|||
156914689|NCT02700815|566448542|FG003|Overall Study|Adverse Event|3|||
156914690|NCT02700815|566448539|FG000|Overall Study|Lack of Efficacy|0|||
156914691|NCT02700815|566448540|FG001|Overall Study|Lack of Efficacy|0|||
156914692|NCT02700815|566448541|FG002|Overall Study|Lack of Efficacy|1|||
156914693|NCT02700815|566448542|FG003|Overall Study|Lack of Efficacy|2|||
156914694|NCT02700815|566448539|FG000|Overall Study|Lost to Follow-up|1|||
156914695|NCT02700815|566448540|FG001|Overall Study|Lost to Follow-up|0|||
156914696|NCT02700815|566448541|FG002|Overall Study|Lost to Follow-up|0|||
156914697|NCT02700815|566448542|FG003|Overall Study|Lost to Follow-up|1|||
156914698|NCT02700815|566448539|FG000|Overall Study|Refusal to continue medication|0|||
156914699|NCT02700815|566448540|FG001|Overall Study|Refusal to continue medication|1|||
156914700|NCT02700815|566448541|FG002|Overall Study|Refusal to continue medication|0|||
156914701|NCT02700815|566448542|FG003|Overall Study|Refusal to continue medication|1|||
156914702|NCT02700815|566448539|FG000|Overall Study|Withdrawal by Subject|0|||
156914703|NCT02700815|566448540|FG001|Overall Study|Withdrawal by Subject|0|||
156914704|NCT02700815|566448541|FG002|Overall Study|Withdrawal by Subject|1|||
156914705|NCT02700815|566448542|FG003|Overall Study|Withdrawal by Subject|0|||
156914706|NCT01943292|566448551|FG000|Overall Study|Withdrawal by Subject|1|||
156914707|NCT01943292|566448552|FG001|Overall Study|Withdrawal by Subject|0|||
156914708|NCT01943292|566448553|FG002|Overall Study|Withdrawal by Subject|0|||
156914709|NCT00911820|566448554|FG000|Overall Study|RECIST progression|12|||
156914710|NCT00911820|566448555|FG001|Overall Study|RECIST progression|8|||
156914711|NCT00911820|566448554|FG000|Overall Study|Adverse Event|8|||
156914712|NCT00911820|566448555|FG001|Overall Study|Adverse Event|8|||
156914713|NCT00911820|566448554|FG000|Overall Study|Clinical Progression|7|||
156914714|NCT00911820|566448555|FG001|Overall Study|Clinical Progression|5|||
156914715|NCT00911820|566448554|FG000|Overall Study|Physician Decision|5|||
156914716|NCT00911820|566448555|FG001|Overall Study|Physician Decision|9|||
157162364|NCT02924688|567339115|FG002|Overall Study|Lost to Follow-up|2|||
157162365|NCT02924688|567339116|FG003|Overall Study|Lost to Follow-up|4|||
157162366|NCT02924688|567339117|FG004|Overall Study|Lost to Follow-up|2|||
157162367|NCT02924688|567339118|FG005|Overall Study|Lost to Follow-up|4|||
157162368|NCT02924688|567339113|FG000|Overall Study|Physician Decision|2|||
157162369|NCT02924688|567339114|FG001|Overall Study|Physician Decision|1|||
157162370|NCT02924688|567339115|FG002|Overall Study|Physician Decision|0|||
157162371|NCT02924688|567339116|FG003|Overall Study|Physician Decision|1|||
157162372|NCT02924688|567339117|FG004|Overall Study|Physician Decision|1|||
157162373|NCT02924688|567339118|FG005|Overall Study|Physician Decision|1|||
157162374|NCT02924688|567339113|FG000|Overall Study|Withdrawal by Subject|14|||
157162375|NCT02924688|567339114|FG001|Overall Study|Withdrawal by Subject|13|||
157162376|NCT02924688|567339115|FG002|Overall Study|Withdrawal by Subject|9|||
157162377|NCT02924688|567339116|FG003|Overall Study|Withdrawal by Subject|12|||
157162378|NCT02924688|567339117|FG004|Overall Study|Withdrawal by Subject|13|||
157162379|NCT02924688|567339118|FG005|Overall Study|Withdrawal by Subject|14|||
157162380|NCT01944969|567339121|FG000|Overall Study|Adverse Event|1|||
157226082|NCT01915732|567573429|FG000|Overall Study|Pregnancy|1|||
156914717|NCT00911820|566448554|FG000|Overall Study|Decline in Performance Status|4|||
156914718|NCT00911820|566448555|FG001|Overall Study|Decline in Performance Status|2|||
156914719|NCT00911820|566448554|FG000|Overall Study|Withdrawal by Subject|3|||
156914720|NCT00911820|566448555|FG001|Overall Study|Withdrawal by Subject|4|||
156914721|NCT00911820|566448554|FG000|Overall Study|Death|1|||
156914722|NCT00911820|566448555|FG001|Overall Study|Death|2|||
156914723|NCT00911820|566448554|FG000|Overall Study|Pursue surgery|1|||
156914724|NCT00911820|566448555|FG001|Overall Study|Pursue surgery|1|||
156914725|NCT00911820|566448554|FG000|Overall Study|Pursue Radiation|1|||
156914726|NCT00911820|566448555|FG001|Overall Study|Pursue Radiation|0|||
157226083|NCT01915732|567573430|FG001|Overall Study|Pregnancy|0|||
157226084|NCT01915732|567573429|FG000|Overall Study|Poor Perceived Efficacy|1|||
156914727|NCT00911820|566448554|FG000|Overall Study|Still on Therapy|2|||
156914728|NCT00911820|566448555|FG001|Overall Study|Still on Therapy|2|||
156914729|NCT00911820|566448554|FG000|Overall Study|Pathology Not Confirmed|1|||
157162381|NCT01944969|567339121|FG000|Overall Study|Lack of Efficacy|1|||
157027999|NCT04770402|566859094|FG000|Overall Study|Lost to Follow-up|1|||
157028000|NCT04770402|566859095|FG001|Overall Study|Lost to Follow-up|2|||
157028001|NCT04770402|566859094|FG000|Overall Study|Non-compliance|1|||
157028002|NCT04770402|566859095|FG001|Overall Study|Non-compliance|0|||
157028003|NCT04770402|566859094|FG000|Overall Study|Withdrawal by Subject|0|||
157028004|NCT04770402|566859095|FG001|Overall Study|Withdrawal by Subject|1|||
157028005|NCT03599661|566859096|FG000|Overall Study|Lost to Follow-up|9|||
157028006|NCT04811040|566859097|FG000|Overall Study|Lost to Follow-up|2|||
157028007|NCT04811040|566859098|FG001|Overall Study|Lost to Follow-up|0|||
157028008|NCT04811040|566859099|FG002|Overall Study|Lost to Follow-up|0|||
157028009|NCT04811040|566859100|FG003|Overall Study|Lost to Follow-up|0|||
157028010|NCT04811040|566859097|FG000|Overall Study|Withdrew consent|1|||
157028011|NCT04811040|566859098|FG001|Overall Study|Withdrew consent|1|||
157028012|NCT04811040|566859099|FG002|Overall Study|Withdrew consent|0|||
157028013|NCT04811040|566859100|FG003|Overall Study|Withdrew consent|0|||
157028014|NCT01828099|566859101|FG000|Treatment Period|Adverse Event|24|||
157028015|NCT01828099|566859102|FG001|Treatment Period|Adverse Event|23|||
157028016|NCT01828099|566859101|FG000|Treatment Period|Death|10|||
157028017|NCT01828099|566859102|FG001|Treatment Period|Death|12|||
157028018|NCT01828099|566859101|FG000|Treatment Period|Lost to Follow-up|2|||
157028019|NCT01828099|566859102|FG001|Treatment Period|Lost to Follow-up|1|||
157028020|NCT01828099|566859101|FG000|Treatment Period|Non-compliance with study treatment|1|||
157028021|NCT01828099|566859102|FG001|Treatment Period|Non-compliance with study treatment|0|||
157162382|NCT01944969|567339121|FG000|Overall Study|Non-compliance with IMP|1|||
157162383|NCT01944969|567339121|FG000|Overall Study|Administrative or other reasons|23|||
157162384|NCT03072719|567339122|FG000|Overall Study|Adverse Event|1|||
156914730|NCT00911820|566448555|FG001|Overall Study|Pathology Not Confirmed|0|||
156914731|NCT00911820|566448554|FG000|Overall Study|Withdraw before Receive Treatment|0|||
156914732|NCT00911820|566448555|FG001|Overall Study|Withdraw before Receive Treatment|2|||
156914733|NCT00996216|566448556|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
156914734|NCT00996216|566448556|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
156914735|NCT00996216|566448556|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
156914736|NCT00578812|566448562|FG000|Overall Study|Not treated|6|||
156914737|NCT00578812|566448563|FG001|Overall Study|Not treated|7|||
156914738|NCT00309387|566448565|FG000|Overall Study|Death|72|||
156914739|NCT00309387|566448566|FG001|Overall Study|Death|73|||
156914740|NCT00309387|566448565|FG000|Overall Study|Lost to Follow-up|70|||
156914741|NCT00309387|566448566|FG001|Overall Study|Lost to Follow-up|86|||
156914742|NCT01599234|566448568|FG000|Overall Study|Adverse Event|9|||
156914743|NCT01599234|566448569|FG001|Overall Study|Adverse Event|5|||
156914744|NCT01599234|566448568|FG000|Overall Study|Withdrawal by Subject|2|||
156914745|NCT01599234|566448569|FG001|Overall Study|Withdrawal by Subject|1|||
156914746|NCT01599234|566448568|FG000|Overall Study|Lost to Follow-up|1|||
156914747|NCT01599234|566448569|FG001|Overall Study|Lost to Follow-up|2|||
156914748|NCT01599234|566448568|FG000|Overall Study|Lack of Efficacy|2|||
156914749|NCT01599234|566448569|FG001|Overall Study|Lack of Efficacy|4|||
156914750|NCT01599234|566448568|FG000|Overall Study|Unable to operate spray|1|||
156914751|NCT01599234|566448569|FG001|Overall Study|Unable to operate spray|0|||
156914752|NCT01599234|566448568|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
156914753|NCT01599234|566448569|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
156914754|NCT01599234|566448568|FG000|Overall Study|Death|1|||
156914755|NCT01599234|566448569|FG001|Overall Study|Death|0|||
156914756|NCT01599234|566448568|FG000|Overall Study|Patient would not stop driving|1|||
156914757|NCT01599234|566448569|FG001|Overall Study|Patient would not stop driving|0|||
156914758|NCT01599234|566448568|FG000|Overall Study|Contra-indication discovered|0|||
156914759|NCT01599234|566448569|FG001|Overall Study|Contra-indication discovered|1|||
156914760|NCT01599234|566448568|FG000|Overall Study|Pregnancy|0|||
156914761|NCT01599234|566448569|FG001|Overall Study|Pregnancy|1|||
156914762|NCT04492618|566448580|FG000|Overall Study|Withdrawal by Subject|1|||
156914763|NCT02041286|566448583|FG000|Overall Study|Adverse Event|1|||
157162385|NCT03072719|567339123|FG001|Overall Study|Adverse Event|1|||
157162386|NCT01104584|567339126|FG000|Overall Study|Study drug never administered|21|||
156914764|NCT00085631|566448590|FG000|Overall Study|Missing Data|4|||
156914765|NCT00085631|566448591|FG001|Overall Study|Missing Data|11|||
157028022|NCT01828099|566859101|FG000|Treatment Period|Physician Decision|17|||
157028023|NCT01828099|566859102|FG001|Treatment Period|Physician Decision|16|||
157028024|NCT01828099|566859101|FG000|Treatment Period|Progressive disease|99|||
157028025|NCT01828099|566859102|FG001|Treatment Period|Progressive disease|107|||
157028026|NCT01828099|566859101|FG000|Treatment Period|Subject/guardian decision|22|||
156914766|NCT00085631|566448592|FG002|Overall Study|Missing Data|7|||
157162387|NCT01104584|567339126|FG000|Overall Study|Study prematurely discontinued|2|||
156914767|NCT01349790|566448593|FG000|Overall Study|Investigator Judgement|3|||
156914768|NCT01349790|566448593|FG000|Overall Study|Death|2|||
156914769|NCT01349790|566448593|FG000|Overall Study|Withdrawal by Patient|2|||
156914770|NCT01349790|566448593|FG000|Overall Study|Adverse Event|1|||
156914771|NCT01349790|566448593|FG000|Overall Study|Lost to Follow-up|1|||
157162388|NCT02370498|567339127|FG000|Overall Study|Adverse Event|10|||
156914772|NCT02495168|566448594|FG000|Overall Study|Other than Specified|18|||
156914773|NCT02495168|566448595|FG001|Overall Study|Other than Specified|22|||
156914774|NCT02495168|566448596|FG002|Overall Study|Other than Specified|5|||
156914775|NCT02495168|566448594|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
156914776|NCT02495168|566448595|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
156914777|NCT02495168|566448596|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
156914778|NCT02495168|566448594|FG000|Overall Study|Physician Decision|1|||
156914779|NCT02495168|566448595|FG001|Overall Study|Physician Decision|1|||
156914780|NCT02495168|566448596|FG002|Overall Study|Physician Decision|0|||
156914781|NCT02495168|566448594|FG000|Overall Study|Lost to Follow-up|10|||
156914782|NCT02495168|566448595|FG001|Overall Study|Lost to Follow-up|6|||
156914783|NCT02495168|566448596|FG002|Overall Study|Lost to Follow-up|1|||
156914784|NCT02495168|566448594|FG000|Overall Study|Withdrawal by Subject|1|||
156914785|NCT02495168|566448595|FG001|Overall Study|Withdrawal by Subject|4|||
156914786|NCT02495168|566448596|FG002|Overall Study|Withdrawal by Subject|2|||
156914787|NCT02495168|566448594|FG000|Overall Study|Protocol Violation|0|||
156914788|NCT02495168|566448595|FG001|Overall Study|Protocol Violation|10|||
156914789|NCT02495168|566448596|FG002|Overall Study|Protocol Violation|1|||
156914790|NCT02495168|566448594|FG000|Overall Study|Adverse Event|4|||
156914791|NCT02495168|566448595|FG001|Overall Study|Adverse Event|8|||
156914792|NCT02495168|566448596|FG002|Overall Study|Adverse Event|3|||
156914793|NCT02495168|566448594|FG000|Overall Study|Lack of Efficacy|0|||
156914794|NCT02495168|566448595|FG001|Overall Study|Lack of Efficacy|0|||
156914795|NCT02495168|566448596|FG002|Overall Study|Lack of Efficacy|3|||
156914796|NCT01513473|566448599|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
156914797|NCT01513473|566448600|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
156914798|NCT01513473|566448599|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
156914799|NCT01513473|566448600|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
156914800|NCT01513473|566448599|FG000|Main Trial (26 Weeks)|Unclassified|0|||
156914801|NCT01513473|566448600|FG001|Main Trial (26 Weeks)|Unclassified|2|||
157162389|NCT02370498|567339128|FG001|Overall Study|Adverse Event|8|||
156914802|NCT01513473|566448599|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
156914803|NCT01513473|566448600|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
156914804|NCT01513473|566448599|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
156914805|NCT01513473|566448600|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
156914806|NCT04166435|566448601|FG000|Overall Study|2 patients ineligible for response|2|||
156914807|NCT03462082|566448602|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156914808|NCT03462082|566448603|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156914809|NCT03462082|566448604|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156914810|NCT03462082|566448605|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156914811|NCT03462082|566448606|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
156914812|NCT03462082|566448607|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
157162390|NCT02370498|567339127|FG000|Overall Study|Death|263|||
156914813|NCT03462082|566448608|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
156914814|NCT03462082|566448609|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
156914815|NCT00743340|566448616|FG000|Overall Study|Study medication non-compliance|1|||
156914816|NCT00743340|566448616|FG000|Overall Study|Lost to Follow-up|1|||
156914817|NCT00743340|566448616|FG000|Overall Study|Withdrawal from the Study|5|||
156914818|NCT00743340|566448616|FG000|Overall Study|Protocol Violation|1|||
156914819|NCT00743340|566448616|FG000|Overall Study|Virologic failure|8|||
156914820|NCT00743340|566448616|FG000|Overall Study|Pregnancy|1|||
156914821|NCT00743340|566448616|FG000|Overall Study|Rolled over to other Gilead Study|23|||
156914822|NCT00743340|566448616|FG000|Overall Study|Participant Relocated|1|||
156914823|NCT02708121|566448619|FG000|Overall Study|Withdrawn by Study Team|1|||
156914824|NCT02708121|566448620|FG001|Overall Study|Withdrawn by Study Team|1|||
156914825|NCT02708121|566448619|FG000|Overall Study|Withdrawal by Subject|0|||
156914826|NCT02708121|566448620|FG001|Overall Study|Withdrawal by Subject|4|||
156914827|NCT00127660|566448621|FG000|Overall Study|Protocol Violation|3|||
157162391|NCT02370498|567339128|FG001|Overall Study|Death|265|||
157162392|NCT02370498|567339127|FG000|Overall Study|Protocol Violation|1|||
157162393|NCT02370498|567339128|FG001|Overall Study|Protocol Violation|2|||
157162394|NCT02370498|567339127|FG000|Overall Study|Withdrawal by Subject|7|||
157162395|NCT02370498|567339128|FG001|Overall Study|Withdrawal by Subject|12|||
156914828|NCT00127660|566448622|FG001|Overall Study|Protocol Violation|3|||
156914829|NCT00127660|566448623|FG002|Overall Study|Protocol Violation|5|||
156914830|NCT00127660|566448624|FG003|Overall Study|Protocol Violation|0|||
156914831|NCT01425281|566448625|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
156914832|NCT01425281|566448626|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
156914833|NCT01425281|566448625|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
156914834|NCT01425281|566448626|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
156914835|NCT01425281|566448625|FG000|At 180-day Clinical Follow-up|Death|0|||
156914836|NCT01425281|566448626|FG001|At 180-day Clinical Follow-up|Death|1|||
156914837|NCT01425281|566448625|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
156914838|NCT01425281|566448626|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
157162396|NCT02370498|567339127|FG000|Overall Study|Sponsor's decision|15|||
157162397|NCT02370498|567339128|FG001|Overall Study|Sponsor's decision|9|||
156914839|NCT01425281|566448625|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
156914840|NCT01425281|566448626|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
156914841|NCT01425281|566448625|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
156914842|NCT01425281|566448626|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
156914843|NCT01425281|566448625|FG000|At 2-year Clinical Follow-up|Death|2|||
156914844|NCT01425281|566448626|FG001|At 2-year Clinical Follow-up|Death|0|||
156914845|NCT01425281|566448625|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
156914846|NCT01425281|566448626|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
156914847|NCT01425281|566448625|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
156914848|NCT01425281|566448626|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
156914849|NCT01425281|566448625|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
156914850|NCT01425281|566448626|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
156914851|NCT01425281|566448625|FG000|At 3-year Clinical Follow-up|Death|2|||
156914852|NCT01425281|566448626|FG001|At 3-year Clinical Follow-up|Death|3|||
156914853|NCT01425281|566448625|FG000|At 4-year Clinical Follow-up|Death|7|||
156914854|NCT01425281|566448626|FG001|At 4-year Clinical Follow-up|Death|3|||
156914855|NCT01425281|566448625|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
156914856|NCT01425281|566448626|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
156914857|NCT01425281|566448625|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
156914858|NCT01425281|566448626|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
156914859|NCT01425281|566448625|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
156914860|NCT01425281|566448626|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
156914861|NCT01425281|566448625|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
156914862|NCT01425281|566448626|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
156914863|NCT01425281|566448625|FG000|At 5-year Clinical Follow-up|Death|2|||
156914864|NCT01425281|566448626|FG001|At 5-year Clinical Follow-up|Death|0|||
156914865|NCT01425281|566448625|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
156914866|NCT01425281|566448626|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
156914867|NCT01425281|566448625|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
156914868|NCT01425281|566448626|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
156914869|NCT01425281|566448625|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
156914870|NCT01425281|566448626|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
156914871|NCT01833520|566448627|FG000|Overall Study|Lack of Efficacy|3|||
156914872|NCT01833520|566448628|FG001|Overall Study|Lack of Efficacy|3|||
156914873|NCT01833520|566448629|FG002|Overall Study|Lack of Efficacy|8|||
156914874|NCT01833520|566448630|FG003|Overall Study|Lack of Efficacy|3|||
156914875|NCT01749514|566448631|FG000|Overall Study|Lost to Follow-up|0|||
156914876|NCT01749514|566448632|FG001|Overall Study|Lost to Follow-up|0|||
156914877|NCT01749514|566448633|FG002|Overall Study|Lost to Follow-up|0|||
156914878|NCT01749514|566448634|FG003|Overall Study|Lost to Follow-up|0|||
156914879|NCT01749514|566448635|FG004|Overall Study|Lost to Follow-up|0|||
156914880|NCT01749514|566448636|FG005|Overall Study|Lost to Follow-up|0|||
156914881|NCT01749514|566448637|FG006|Overall Study|Lost to Follow-up|0|||
156914882|NCT01749514|566448638|FG007|Overall Study|Lost to Follow-up|1|||
156914883|NCT01749514|566448631|FG000|Overall Study|Withdrawal by Subject|0|||
156914884|NCT01749514|566448632|FG001|Overall Study|Withdrawal by Subject|0|||
156914885|NCT01749514|566448633|FG002|Overall Study|Withdrawal by Subject|0|||
156914886|NCT01749514|566448634|FG003|Overall Study|Withdrawal by Subject|0|||
156914887|NCT01749514|566448635|FG004|Overall Study|Withdrawal by Subject|0|||
156914888|NCT01749514|566448636|FG005|Overall Study|Withdrawal by Subject|1|||
156914889|NCT01749514|566448637|FG006|Overall Study|Withdrawal by Subject|0|||
156914890|NCT01749514|566448638|FG007|Overall Study|Withdrawal by Subject|1|||
156914891|NCT01749514|566448631|FG000|Overall Study|Not Reported|0|||
156914892|NCT01749514|566448632|FG001|Overall Study|Not Reported|0|||
156914893|NCT01749514|566448633|FG002|Overall Study|Not Reported|0|||
156914894|NCT01749514|566448634|FG003|Overall Study|Not Reported|0|||
156914895|NCT01749514|566448635|FG004|Overall Study|Not Reported|0|||
156914896|NCT01749514|566448636|FG005|Overall Study|Not Reported|0|||
156914897|NCT01749514|566448637|FG006|Overall Study|Not Reported|0|||
156914898|NCT01749514|566448638|FG007|Overall Study|Not Reported|5|||
156914899|NCT05131646|566448639|FG000|Overall Study|Withdrawal by Subject|1|||
156914900|NCT05131646|566448640|FG001|Overall Study|Withdrawal by Subject|0|||
156914901|NCT05131646|566448641|FG002|Overall Study|Withdrawal by Subject|0|||
157162398|NCT04017442|567339129|FG000|Overall Study|Withdrawal by Subject|0|||
157162399|NCT04017442|567339130|FG001|Overall Study|Withdrawal by Subject|3|||
157028027|NCT01828099|566859102|FG001|Treatment Period|Subject/guardian decision|26|||
157162400|NCT04017442|567339129|FG000|Overall Study|Lost to Follow-up|21|||
157162401|NCT04017442|567339130|FG001|Overall Study|Lost to Follow-up|19|||
157162402|NCT02586233|567339134|FG000|Overall Study|Randomized but did not receive treatment|0|||
157162403|NCT02586233|567339135|FG001|Overall Study|Randomized but did not receive treatment|1|||
156914902|NCT03266107|566448642|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
156914903|NCT03266107|566448642|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
156914904|NCT03266107|566448642|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
156914905|NCT03266107|566448642|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
156914906|NCT02548650|566448645|FG000|Triple Therapy|Adverse Event|1|||
156914907|NCT02548650|566448646|FG001|Triple Therapy|Adverse Event|0|||
156914908|NCT02548650|566448645|FG000|Triple Therapy|Withdrawal by Subject|0|||
156914909|NCT02548650|566448646|FG001|Triple Therapy|Withdrawal by Subject|4|||
156914910|NCT02548650|566448645|FG000|Double Therapy|Adverse Event|1|||
156914911|NCT02548650|566448646|FG001|Double Therapy|Adverse Event|1|||
156914912|NCT02548650|566448645|FG000|Double Therapy|Withdrawal by Subject|0|||
156914913|NCT02548650|566448646|FG001|Double Therapy|Withdrawal by Subject|1|||
156914914|NCT01191801|566448647|FG000|Overall Study|Death|36|||
156914915|NCT01191801|566448648|FG001|Overall Study|Death|12|||
156914916|NCT01191801|566448647|FG000|Overall Study|Lack of Efficacy|176|||
156914917|NCT01191801|566448648|FG001|Overall Study|Lack of Efficacy|258|||
156914918|NCT01191801|566448647|FG000|Overall Study|Adverse Event|9|||
156914919|NCT01191801|566448648|FG001|Overall Study|Adverse Event|8|||
156914920|NCT01191801|566448647|FG000|Overall Study|Protocol Violation|2|||
156914921|NCT01191801|566448648|FG001|Overall Study|Protocol Violation|4|||
156914922|NCT01191801|566448647|FG000|Overall Study|Physician Decision|47|||
156914923|NCT01191801|566448648|FG001|Overall Study|Physician Decision|24|||
156914924|NCT01191801|566448647|FG000|Overall Study|Withdrawal by Subject|1|||
156914925|NCT01191801|566448648|FG001|Overall Study|Withdrawal by Subject|4|||
156914926|NCT01191801|566448647|FG000|Overall Study|Not Provided|45|||
156914927|NCT01191801|566448648|FG001|Overall Study|Not Provided|27|||
156914928|NCT00003479|566448649|FG000|Overall Study|Not evaluable|3|||
156914929|NCT02551731|566448650|FG000|Overall Study|Withdrawal by Subject|2|||
156914930|NCT02128113|566448651|FG000|Overall Study|Withdrawal by Subject|3|||
156914931|NCT02128113|566448652|FG001|Overall Study|Withdrawal by Subject|1|||
156914932|NCT02128113|566448653|FG002|Overall Study|Withdrawal by Subject|0|||
156914933|NCT02128113|566448651|FG000|Overall Study|Protocol Violation|0|||
156914934|NCT02128113|566448652|FG001|Overall Study|Protocol Violation|1|||
156914935|NCT02128113|566448653|FG002|Overall Study|Protocol Violation|0|||
156914936|NCT02128113|566448651|FG000|Overall Study|Surgery cancelled|0|||
156914937|NCT02128113|566448652|FG001|Overall Study|Surgery cancelled|1|||
156914938|NCT02128113|566448653|FG002|Overall Study|Surgery cancelled|0|||
156914939|NCT02128113|566448651|FG000|Overall Study|Adverse Event|0|||
156914940|NCT02128113|566448652|FG001|Overall Study|Adverse Event|0|||
156914941|NCT02128113|566448653|FG002|Overall Study|Adverse Event|1|||
156914942|NCT01750242|566448654|FG000|Overall Study|Unreadable Images|3|||
156914943|NCT03765918|566448655|FG000|Overall Study|Death|109|||
156914944|NCT03765918|566448656|FG001|Overall Study|Death|127|||
156914945|NCT03765918|566448655|FG000|Overall Study|Lost to Follow-up|2|||
156914946|NCT03765918|566448656|FG001|Overall Study|Lost to Follow-up|3|||
156914947|NCT03765918|566448655|FG000|Overall Study|Withdrawal by Subject|12|||
156914948|NCT03765918|566448656|FG001|Overall Study|Withdrawal by Subject|16|||
156914949|NCT03765918|566448655|FG000|Overall Study|Participants Ongoing|240|||
156914950|NCT03765918|566448656|FG001|Overall Study|Participants Ongoing|205|||
156914951|NCT02969369|566448657|FG000|Study|Adverse Event|1|||
156914952|NCT02969369|566448658|FG001|Study|Adverse Event|6|||
156914953|NCT02969369|566448657|FG000|Study|Lack of Efficacy|0|||
156914954|NCT02969369|566448658|FG001|Study|Lack of Efficacy|1|||
156914955|NCT02969369|566448657|FG000|Study|Lost to Follow-up|0|||
156914956|NCT02969369|566448658|FG001|Study|Lost to Follow-up|1|||
156914957|NCT02969369|566448657|FG000|Study|Withdrawal by Subject|3|||
156914958|NCT02969369|566448658|FG001|Study|Withdrawal by Subject|5|||
156914959|NCT02969369|566448657|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
156914960|NCT02969369|566448658|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
156914961|NCT02969369|566448657|FG000|Double-blind Period|Adverse Event|1|||
156914962|NCT02969369|566448658|FG001|Double-blind Period|Adverse Event|5|||
156914963|NCT02969369|566448657|FG000|Double-blind Period|Lost to Follow-up|0|||
156914964|NCT02969369|566448658|FG001|Double-blind Period|Lost to Follow-up|1|||
156914965|NCT02969369|566448657|FG000|Double-blind Period|Withdrawal by Subject|2|||
156914966|NCT02969369|566448658|FG001|Double-blind Period|Withdrawal by Subject|3|||
156914967|NCT02969369|566448657|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
156914968|NCT02969369|566448658|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
156914969|NCT02969369|566448657|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
157028028|NCT01828099|566859101|FG000|Treatment Period|Study terminated by Sponsor|13|||
156914970|NCT02969369|566448658|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
156914971|NCT02969369|566448657|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
156914972|NCT02969369|566448658|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
156914973|NCT02969369|566448657|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
156914974|NCT02969369|566448658|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
156914975|NCT01484197|566448666|FG000|Treatment Period 1|Adverse Event|1|||
156914976|NCT01484197|566448667|FG001|Treatment Period 1|Adverse Event|0|||
156914977|NCT01484197|566448668|FG002|Treatment Period 1|Adverse Event|0|||
157162404|NCT02586233|567339136|FG002|Overall Study|Randomized but did not receive treatment|0|||
157162405|NCT02586233|567339137|FG003|Overall Study|Randomized but did not receive treatment|0|||
157162406|NCT02586233|567339138|FG004|Overall Study|Randomized but did not receive treatment|0|||
157162407|NCT02586233|567339139|FG005|Overall Study|Randomized but did not receive treatment|2|||
157162408|NCT02586233|567339140|FG006|Overall Study|Randomized but did not receive treatment|2|||
157162409|NCT02586233|567339134|FG000|Overall Study|Death|0|||
157162410|NCT02586233|567339135|FG001|Overall Study|Death|1|||
157162411|NCT02586233|567339136|FG002|Overall Study|Death|0|||
157162412|NCT02586233|567339137|FG003|Overall Study|Death|0|||
157162413|NCT02586233|567339138|FG004|Overall Study|Death|2|||
157162414|NCT02586233|567339139|FG005|Overall Study|Death|0|||
157162415|NCT02586233|567339140|FG006|Overall Study|Death|0|||
157162416|NCT03225716|567339141|FG000|Overall Study|Withdrawal by Subject|2|||
157162417|NCT03225716|567339142|FG001|Overall Study|Withdrawal by Subject|2|||
157162418|NCT03225716|567339143|FG002|Overall Study|Withdrawal by Subject|0|||
157162419|NCT03225716|567339141|FG000|Overall Study|Lack of Efficacy|1|||
157162420|NCT03225716|567339142|FG001|Overall Study|Lack of Efficacy|0|||
157162421|NCT03225716|567339143|FG002|Overall Study|Lack of Efficacy|0|||
157162422|NCT03225716|567339141|FG000|Overall Study|Adverse Event|2|||
157162423|NCT03225716|567339142|FG001|Overall Study|Adverse Event|0|||
157162424|NCT03225716|567339143|FG002|Overall Study|Adverse Event|1|||
157162425|NCT03225716|567339141|FG000|Overall Study|Study early termination by Sponsor|0|||
157162426|NCT03225716|567339142|FG001|Overall Study|Study early termination by Sponsor|0|||
157162427|NCT03225716|567339143|FG002|Overall Study|Study early termination by Sponsor|2|||
156914978|NCT01484197|566448669|FG003|Treatment Period 1|Adverse Event|0|||
156914979|NCT01484197|566448666|FG000|Treatment Period 2|Subject withdrew consent|0|||
156914980|NCT01484197|566448667|FG001|Treatment Period 2|Subject withdrew consent|0|||
156914981|NCT01484197|566448668|FG002|Treatment Period 2|Subject withdrew consent|0|||
156914982|NCT01484197|566448669|FG003|Treatment Period 2|Subject withdrew consent|1|||
156914983|NCT01727297|566448670|FG000|Overall Study|Death|13|||
156914984|NCT01727297|566448671|FG001|Overall Study|Death|0|||
156914985|NCT01727297|566448670|FG000|Overall Study|Protocol Violation|1|||
156914986|NCT01727297|566448671|FG001|Overall Study|Protocol Violation|10|||
156914987|NCT01727297|566448670|FG000|Overall Study|Adverse Event|3|||
156914988|NCT01727297|566448671|FG001|Overall Study|Adverse Event|1|||
156914989|NCT01727297|566448670|FG000|Overall Study|Lost to Follow-up|11|||
156914990|NCT01727297|566448671|FG001|Overall Study|Lost to Follow-up|0|||
156914991|NCT01727297|566448670|FG000|Overall Study|Withdrawal by Subject|26|||
156914992|NCT01727297|566448671|FG001|Overall Study|Withdrawal by Subject|27|||
156914993|NCT01727297|566448670|FG000|Overall Study|Physician Decision|19|||
156914994|NCT01727297|566448671|FG001|Overall Study|Physician Decision|5|||
156914995|NCT01727297|566448670|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
156914996|NCT01727297|566448671|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
156914997|NCT01192516|566448672|FG000|Overall Study|Lost to Follow-up|7|||
156914998|NCT01192516|566448673|FG001|Overall Study|Lost to Follow-up|10|||
156914999|NCT01192516|566448674|FG002|Overall Study|Lost to Follow-up|7|||
156915000|NCT01192516|566448672|FG000|Overall Study|Withdrawal by Subject|4|||
156915001|NCT01192516|566448673|FG001|Overall Study|Withdrawal by Subject|4|||
156915002|NCT01192516|566448674|FG002|Overall Study|Withdrawal by Subject|1|||
156915003|NCT01192516|566448672|FG000|Overall Study|started new treatment|5|||
156915004|NCT01192516|566448673|FG001|Overall Study|started new treatment|1|||
156915005|NCT01192516|566448674|FG002|Overall Study|started new treatment|0|||
156915006|NCT01192516|566448672|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
156915007|NCT01192516|566448673|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
156915008|NCT01192516|566448674|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
156915009|NCT00814164|566448682|FG000|Overall Study|Progression|7|||
156915010|NCT00814164|566448682|FG000|Overall Study|not stated|7|||
156915011|NCT00814164|566448682|FG000|Overall Study|Death|5|||
156915012|NCT01980992|566448683|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
156915013|NCT01980992|566448684|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
156915014|NCT01980992|566448683|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
156915015|NCT01980992|566448684|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
156915016|NCT01980992|566448683|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
156915017|NCT01980992|566448684|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
157028029|NCT01828099|566859102|FG001|Treatment Period|Study terminated by Sponsor|1|||
156915018|NCT01980992|566448683|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
156915019|NCT01980992|566448684|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
156915020|NCT01980992|566448683|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
156915021|NCT01980992|566448684|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
156915022|NCT01980992|566448683|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
156915023|NCT01980992|566448684|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
156915024|NCT01169493|566448692|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
156915025|NCT01169493|566448693|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
157162428|NCT00848250|567339144|FG000|Overall Study|surgery was completed without cardiopulm|0|||
156915026|NCT01169493|566448694|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
156915027|NCT01169493|566448695|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
156915028|NCT01169493|566448696|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
156915029|NCT01169493|566448697|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
156915030|NCT01169493|566448692|FG000|Period 3 (6 Months)|Adverse Event|0|||
156915031|NCT01169493|566448693|FG001|Period 3 (6 Months)|Adverse Event|1|||
156915032|NCT01169493|566448694|FG002|Period 3 (6 Months)|Adverse Event|0|||
156915033|NCT01169493|566448695|FG003|Period 3 (6 Months)|Adverse Event|0|||
156915034|NCT01169493|566448696|FG004|Period 3 (6 Months)|Adverse Event|0|||
156915035|NCT01169493|566448697|FG005|Period 3 (6 Months)|Adverse Event|0|||
156915036|NCT01169493|566448692|FG000|Period 3 (6 Months)|Physician Decision|0|||
156915037|NCT01169493|566448693|FG001|Period 3 (6 Months)|Physician Decision|1|||
156915038|NCT01169493|566448694|FG002|Period 3 (6 Months)|Physician Decision|1|||
156915039|NCT01169493|566448695|FG003|Period 3 (6 Months)|Physician Decision|0|||
156915040|NCT01169493|566448696|FG004|Period 3 (6 Months)|Physician Decision|0|||
156915041|NCT01169493|566448697|FG005|Period 3 (6 Months)|Physician Decision|0|||
156915042|NCT05228132|566448698|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
156915043|NCT05228132|566448698|FG000|Overall Study|Adverse Event|3|||
156915044|NCT05228132|566448698|FG000|Overall Study|Lost to Follow-up|1|||
156915045|NCT05228132|566448698|FG000|Overall Study|Arteriovenous-fistula mature|1|||
156915046|NCT02627144|566448701|FG000|Overall Study|Serious adverse event|32|||
156915047|NCT02627144|566448701|FG000|Overall Study|Cancer progression|171|||
156915048|NCT02627144|566448701|FG000|Overall Study|Death from cancer|20|||
156915049|NCT02627144|566448701|FG000|Overall Study|Death from other cause|8|||
156915050|NCT02627144|566448701|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
156915051|NCT02627144|566448701|FG000|Overall Study|Administrative reasons|65|||
156915052|NCT02627144|566448701|FG000|Overall Study|Lost to Follow-up|8|||
156915053|NCT02627144|566448701|FG000|Overall Study|Enrolled, not treated|6|||
156915054|NCT02627144|566448701|FG000|Overall Study|Other|17|||
156915055|NCT00642460|566448704|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
156915056|NCT00642460|566448705|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
156915057|NCT00642460|566448706|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
156915058|NCT00642460|566448707|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
156915059|NCT00642460|566448708|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
156915060|NCT00642460|566448709|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
156915061|NCT00642460|566448704|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
156915062|NCT00642460|566448705|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156915063|NCT00642460|566448706|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156915064|NCT00642460|566448707|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156915065|NCT00642460|566448708|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156915066|NCT00642460|566448709|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
156915067|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
156915068|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
156915069|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156915070|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156915071|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156915072|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
156915073|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Death|0|||
156915074|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Death|1|||
156915075|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Death|0|||
157162429|NCT00848250|567339145|FG001|Overall Study|surgery was completed without cardiopulm|1|||
156915076|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Death|2|||
156915077|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Death|0|||
156915078|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Death|0|||
156915079|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
156915080|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
156915081|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156915082|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156915083|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156915084|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
156915085|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
156915086|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
156915087|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156915088|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156915089|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156915090|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
156915091|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
156915092|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
156915093|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
156915094|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
156915095|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
156915096|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
156915097|NCT00642460|566448704|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156915098|NCT00642460|566448705|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156915099|NCT00642460|566448706|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156915100|NCT00642460|566448707|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
156915101|NCT00642460|566448708|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156915102|NCT00642460|566448709|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
156915103|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156915104|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156915105|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156915106|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
156915107|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
156915108|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
156915109|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156915110|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156915111|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156915112|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
156915113|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
156915114|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
156915115|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156915116|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156915117|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156915118|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
156915119|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
156915120|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
156915121|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156915122|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156915123|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156915124|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
156915125|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
156915126|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
156915127|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Other|0|||
156915128|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Other|0|||
156915129|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Other|0|||
156915130|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Other|0|||
156915131|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Other|2|||
156915132|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Other|2|||
156915133|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Death|0|||
156915134|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Death|0|||
156915135|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Death|0|||
156915136|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Death|0|||
156915137|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Death|0|||
156915138|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Death|3|||
156915139|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156915140|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156915141|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156915142|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156915143|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
156915144|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
156915145|NCT00642460|566448704|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156915146|NCT00642460|566448705|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156915147|NCT00642460|566448706|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156915148|NCT00642460|566448707|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
156915149|NCT00642460|566448708|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
156915150|NCT00642460|566448709|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
156915151|NCT02516163|566448714|FG000|Overall Study|Withdrawal by Subject|1|||
156915152|NCT02516163|566448714|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
156915153|NCT02516163|566448714|FG000|Overall Study|Unfit/delay in surgery|3|||
156915154|NCT02516163|566448714|FG000|Overall Study|Use of incorrect measurement technique|5|||
156915155|NCT02516163|566448714|FG000|Overall Study|Data not recorded|2|||
156915156|NCT02516163|566448714|FG000|Overall Study|MRI contraindication exclusion|6|||
156915157|NCT01637272|566448716|FG000|Overall Study|Adverse Event|6|||
156915158|NCT01637272|566448716|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156915159|NCT01637272|566448716|FG000|Overall Study|Withdrawal by Subject|3|||
156915160|NCT01637272|566448716|FG000|Overall Study|Lost to Follow-up|2|||
156915161|NCT01637272|566448716|FG000|Overall Study|completed core, did not enter ext. phase|4|||
156915162|NCT01637272|566448716|FG000|Overall Study|Administrative problems|1|||
156915163|NCT01637272|566448716|FG000|Overall Study|Protocol Violation|2|||
156915164|NCT01496612|566448717|FG000|1st Intervention|Adverse Event|1|||
156915165|NCT01496612|566448718|FG001|1st Intervention|Adverse Event|0|||
156915166|NCT01496612|566448717|FG000|1st Intervention|Withdrawal by Subject|1|||
156915167|NCT01496612|566448718|FG001|1st Intervention|Withdrawal by Subject|0|||
156915168|NCT00291577|566448719|FG000|Overall Study|Adverse Event|1|||
156915169|NCT00291577|566448719|FG000|Overall Study|Other|4|||
156915170|NCT00291577|566448719|FG000|Overall Study|Withdrawal by Subject|2|||
156915171|NCT00291577|566448719|FG000|Overall Study|Lack of Efficacy|14|||
156915172|NCT03129100|566448724|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
156915173|NCT03129100|566448725|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
156915174|NCT03129100|566448726|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
156915175|NCT03129100|566448727|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
156915176|NCT03129100|566448728|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
156915177|NCT03129100|566448729|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
156915178|NCT03129100|566448730|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
156915179|NCT03129100|566448731|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
156915180|NCT03129100|566448732|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
156915181|NCT03129100|566448733|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
156915182|NCT03129100|566448734|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
156915183|NCT03129100|566448735|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
156915184|NCT03129100|566448736|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
156915185|NCT03129100|566448737|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
156915186|NCT03129100|566448738|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
156915187|NCT03129100|566448739|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
156915188|NCT03129100|566448740|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
156915189|NCT03129100|566448741|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
156915190|NCT03129100|566448742|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
156915191|NCT03129100|566448743|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
156915192|NCT03129100|566448744|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
156915193|NCT03129100|566448745|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
156915194|NCT03129100|566448746|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
156915195|NCT03129100|566448747|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
156915196|NCT03129100|566448748|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
156915197|NCT03129100|566448749|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
156915198|NCT03129100|566448724|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
156915199|NCT03129100|566448725|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915200|NCT03129100|566448726|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915201|NCT03129100|566448727|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915202|NCT03129100|566448728|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915203|NCT03129100|566448729|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915204|NCT03129100|566448730|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915205|NCT03129100|566448731|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915206|NCT03129100|566448732|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915207|NCT03129100|566448733|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915208|NCT03129100|566448734|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915209|NCT03129100|566448735|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915210|NCT03129100|566448736|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915211|NCT03129100|566448737|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915212|NCT03129100|566448738|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915213|NCT03129100|566448739|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915214|NCT03129100|566448740|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915215|NCT03129100|566448741|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915216|NCT03129100|566448742|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915217|NCT03129100|566448743|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915218|NCT03129100|566448744|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915219|NCT03129100|566448745|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915220|NCT03129100|566448746|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915221|NCT03129100|566448747|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915222|NCT03129100|566448748|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915223|NCT03129100|566448749|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
156915224|NCT03129100|566448724|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
156915225|NCT03129100|566448725|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
156915226|NCT03129100|566448726|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
157162430|NCT01205451|567339153|FG000|Overall Study|Lost to Follow-up|1|||
157162431|NCT01205451|567339154|FG001|Overall Study|Lost to Follow-up|1|||
157162432|NCT01205451|567339153|FG000|Overall Study|Withdrawal by Subject|5|||
157162433|NCT01205451|567339154|FG001|Overall Study|Withdrawal by Subject|9|||
156915227|NCT03129100|566448727|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915228|NCT03129100|566448728|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915229|NCT03129100|566448729|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915230|NCT03129100|566448730|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915231|NCT03129100|566448731|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
157162434|NCT03421964|567339162|FG000|Overall Study|Lost to Follow-up|11|||
156915232|NCT03129100|566448732|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915233|NCT03129100|566448733|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915234|NCT03129100|566448734|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915235|NCT03129100|566448735|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915236|NCT03129100|566448736|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915237|NCT03129100|566448737|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915238|NCT03129100|566448738|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915239|NCT03129100|566448739|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915240|NCT03129100|566448740|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915241|NCT03129100|566448741|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915242|NCT03129100|566448742|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915243|NCT03129100|566448743|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915244|NCT03129100|566448744|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915245|NCT03129100|566448745|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915246|NCT03129100|566448746|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915247|NCT03129100|566448747|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915248|NCT03129100|566448748|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915249|NCT03129100|566448749|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
156915250|NCT03129100|566448724|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
156915251|NCT03129100|566448725|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
156915252|NCT03129100|566448726|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915253|NCT03129100|566448727|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915254|NCT03129100|566448728|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915255|NCT03129100|566448729|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915256|NCT03129100|566448730|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915257|NCT03129100|566448731|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915258|NCT03129100|566448732|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915259|NCT03129100|566448733|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915260|NCT03129100|566448734|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915261|NCT03129100|566448735|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915262|NCT03129100|566448736|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915263|NCT03129100|566448737|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915264|NCT03129100|566448738|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915265|NCT03129100|566448739|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915266|NCT03129100|566448740|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915267|NCT03129100|566448741|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915268|NCT03129100|566448742|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915269|NCT03129100|566448743|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915270|NCT03129100|566448744|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915271|NCT03129100|566448745|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915272|NCT03129100|566448746|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915273|NCT03129100|566448747|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915274|NCT03129100|566448748|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915275|NCT03129100|566448749|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
156915276|NCT03129100|566448724|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915277|NCT03129100|566448725|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
156915278|NCT03129100|566448726|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915279|NCT03129100|566448727|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915280|NCT03129100|566448728|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915281|NCT03129100|566448729|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915282|NCT03129100|566448730|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915283|NCT03129100|566448731|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915284|NCT03129100|566448732|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915285|NCT03129100|566448733|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915286|NCT03129100|566448734|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915287|NCT03129100|566448735|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915288|NCT03129100|566448736|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915289|NCT03129100|566448737|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915290|NCT03129100|566448738|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915291|NCT03129100|566448739|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915292|NCT03129100|566448740|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915293|NCT03129100|566448741|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915294|NCT03129100|566448742|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915295|NCT03129100|566448743|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915296|NCT03129100|566448744|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915297|NCT03129100|566448745|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915298|NCT03129100|566448746|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915299|NCT03129100|566448747|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915300|NCT03129100|566448748|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
157226085|NCT01915732|567573430|FG001|Overall Study|Poor Perceived Efficacy|0|||
157226086|NCT01915732|567573429|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
157226087|NCT01915732|567573430|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
157226088|NCT01915732|567573429|FG000|Overall Study|Got Well|0|||
157226089|NCT01915732|567573430|FG001|Overall Study|Got Well|1|||
157226090|NCT01915732|567573429|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
157226091|NCT01915732|567573430|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
157226092|NCT01915732|567573429|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
157226093|NCT01915732|567573430|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
157226094|NCT01915732|567573429|FG000|Overall Study|Job Transfer|0|||
157226095|NCT01915732|567573430|FG001|Overall Study|Job Transfer|1|||
157226096|NCT01915732|567573429|FG000|Overall Study|Improper Facial Procedure|0|||
157226097|NCT01915732|567573430|FG001|Overall Study|Improper Facial Procedure|1|||
157226098|NCT01915732|567573429|FG000|Overall Study|Poor Conscious Effect|0|||
157226099|NCT01915732|567573430|FG001|Overall Study|Poor Conscious Effect|1|||
157226100|NCT02114697|567573436|FG000|Overall Study|Study terminated|5|||
157226101|NCT02114697|567573437|FG001|Overall Study|Study terminated|4|||
157226102|NCT00424489|567573438|FG000|Overall Study|Death|3|||
156915301|NCT03129100|566448749|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
156915302|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915303|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915304|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
156915305|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
156915306|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915307|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
156915308|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915309|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915310|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915311|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915312|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915313|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915314|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915315|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915316|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915317|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915318|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915319|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915320|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915321|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915322|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915323|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915324|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915325|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915326|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915327|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
156915328|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Death|0|||
156915329|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Death|0|||
156915330|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Death|1|||
156915331|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Death|0|||
156915332|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Death|0|||
156915333|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Death|0|||
156915334|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Death|0|||
156915335|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Death|0|||
156915336|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Death|0|||
156915337|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Death|0|||
156915338|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Death|0|||
156915339|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Death|0|||
156915340|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Death|0|||
156915341|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Death|0|||
156915342|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Death|0|||
157226103|NCT01984242|567573439|FG000|Overall Study|Death|52|||
157226104|NCT01984242|567573440|FG001|Overall Study|Death|50|||
157226105|NCT01984242|567573441|FG002|Overall Study|Death|52|||
157226106|NCT01984242|567573439|FG000|Overall Study|Withdrawal by Subject|5|||
157226107|NCT01984242|567573440|FG001|Overall Study|Withdrawal by Subject|3|||
157226108|NCT01984242|567573441|FG002|Overall Study|Withdrawal by Subject|10|||
157226109|NCT01984242|567573439|FG000|Overall Study|Physician Decision|0|||
157226110|NCT01984242|567573440|FG001|Overall Study|Physician Decision|0|||
156915343|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Death|0|||
156915344|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Death|0|||
157028030|NCT01828099|566859101|FG000|Treatment Period|Protocol deviation|1|||
157226111|NCT01984242|567573441|FG002|Overall Study|Physician Decision|1|||
156915345|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Death|0|||
156915346|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Death|0|||
156915347|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Death|0|||
156915348|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Death|0|||
156915349|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Death|0|||
156915350|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Death|0|||
156915351|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Death|0|||
156915352|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Death|0|||
156915353|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Death|0|||
156915354|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915355|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915356|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
156915357|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
156915358|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
156915359|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
156915360|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
156915361|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915362|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915363|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915364|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915365|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915366|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915367|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915368|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915369|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915370|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915371|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915372|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915373|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915374|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915375|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915376|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915377|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915378|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915379|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
156915380|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915381|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915382|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
156915383|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915384|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915385|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915386|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915387|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915388|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915389|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915390|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915391|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915392|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915393|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915394|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915395|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915396|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915397|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915398|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915399|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915400|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915401|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915402|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
157028031|NCT01828099|566859102|FG001|Treatment Period|Protocol deviation|0|||
157028032|NCT01828099|566859101|FG000|Treatment Period|No longer requires treatment|0|||
157028033|NCT01828099|566859102|FG001|Treatment Period|No longer requires treatment|1|||
157028034|NCT01828099|566859101|FG000|Extension-treatment Phase|Adverse Event|0|||
157162435|NCT03421964|567339163|FG001|Overall Study|Lost to Follow-up|21|||
157162436|NCT03421964|567339162|FG000|Overall Study|Withdrawal by Subject|9|||
156915403|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915404|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915405|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
156915406|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915407|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915408|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
156915409|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915410|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915411|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915412|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915413|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915414|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915415|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915416|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915417|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915418|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915419|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915420|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915421|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915422|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915423|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915424|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915425|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915426|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915427|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915428|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915429|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915430|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915431|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
156915432|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915433|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915434|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
156915435|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915436|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915437|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915438|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915439|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915440|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915441|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915442|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915443|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915444|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915445|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915446|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915447|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915448|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915449|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915450|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915451|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915452|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915453|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915454|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915455|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915456|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915457|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
156915458|NCT03129100|566448724|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915459|NCT03129100|566448725|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915460|NCT03129100|566448726|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915461|NCT03129100|566448727|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915462|NCT03129100|566448728|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
156915463|NCT03129100|566448729|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
156915464|NCT03129100|566448730|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
157028035|NCT01828099|566859102|FG001|Extension-treatment Phase|Adverse Event|17|||
156915465|NCT03129100|566448731|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915466|NCT03129100|566448732|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915467|NCT03129100|566448733|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915468|NCT03129100|566448734|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915469|NCT03129100|566448735|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915470|NCT03129100|566448736|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915471|NCT03129100|566448737|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915472|NCT03129100|566448738|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915473|NCT03129100|566448739|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915474|NCT03129100|566448740|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915475|NCT03129100|566448741|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915476|NCT03129100|566448742|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915477|NCT03129100|566448743|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915478|NCT03129100|566448744|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915479|NCT03129100|566448745|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915480|NCT03129100|566448746|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915481|NCT03129100|566448747|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915482|NCT03129100|566448748|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915483|NCT03129100|566448749|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
156915484|NCT03129100|566448724|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915485|NCT03129100|566448725|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915486|NCT03129100|566448726|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915487|NCT03129100|566448727|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915488|NCT03129100|566448728|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915489|NCT03129100|566448729|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915490|NCT03129100|566448730|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915491|NCT03129100|566448731|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915492|NCT03129100|566448732|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915493|NCT03129100|566448733|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
156915494|NCT03129100|566448734|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915495|NCT03129100|566448735|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915496|NCT03129100|566448736|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915497|NCT03129100|566448737|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915498|NCT03129100|566448738|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915499|NCT03129100|566448739|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915500|NCT03129100|566448740|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915501|NCT03129100|566448741|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915502|NCT03129100|566448742|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915503|NCT03129100|566448743|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915504|NCT03129100|566448744|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915505|NCT03129100|566448745|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915506|NCT03129100|566448746|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915507|NCT03129100|566448747|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915508|NCT03129100|566448748|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915509|NCT03129100|566448749|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
156915510|NCT03129100|566448724|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915511|NCT03129100|566448725|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915512|NCT03129100|566448726|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915513|NCT03129100|566448727|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915514|NCT03129100|566448728|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915515|NCT03129100|566448729|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
157162437|NCT03421964|567339163|FG001|Overall Study|Withdrawal by Subject|3|||
157162438|NCT03421964|567339162|FG000|Overall Study|Incarcerated|1|||
157162439|NCT03421964|567339163|FG001|Overall Study|Incarcerated|0|||
157162440|NCT03421964|567339162|FG000|Overall Study|Inpt Treatment Facility|1|||
157162441|NCT03421964|567339163|FG001|Overall Study|Inpt Treatment Facility|1|||
157162442|NCT03421964|567339162|FG000|Overall Study|Virtual Platform Issues|1|||
157162443|NCT03421964|567339163|FG001|Overall Study|Virtual Platform Issues|1|||
157162444|NCT02938585|567339164|FG000|Overall Study|Withdrawal by parent or guardian|0|||
157162445|NCT02938585|567339165|FG001|Overall Study|Withdrawal by parent or guardian|1|||
157162446|NCT02938585|567339166|FG002|Overall Study|Withdrawal by parent or guardian|0|||
157162447|NCT02938585|567339167|FG003|Overall Study|Withdrawal by parent or guardian|0|||
157162448|NCT02938585|567339164|FG000|Overall Study|Withdrawal by Subject|0|||
157162449|NCT02938585|567339165|FG001|Overall Study|Withdrawal by Subject|0|||
156915516|NCT03129100|566448730|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915517|NCT03129100|566448731|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915518|NCT03129100|566448732|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915519|NCT03129100|566448733|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915520|NCT03129100|566448734|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915521|NCT03129100|566448735|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
156915522|NCT03129100|566448736|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915523|NCT03129100|566448737|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915524|NCT03129100|566448738|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915525|NCT03129100|566448739|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915526|NCT03129100|566448740|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915527|NCT03129100|566448741|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915528|NCT03129100|566448742|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915529|NCT03129100|566448743|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915530|NCT03129100|566448744|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915531|NCT03129100|566448745|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915532|NCT03129100|566448746|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915533|NCT03129100|566448747|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915534|NCT03129100|566448748|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915535|NCT03129100|566448749|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
156915536|NCT03129100|566448724|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915537|NCT03129100|566448725|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915538|NCT03129100|566448726|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915539|NCT03129100|566448727|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915540|NCT03129100|566448728|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915541|NCT03129100|566448729|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915542|NCT03129100|566448730|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915543|NCT03129100|566448731|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915544|NCT03129100|566448732|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915545|NCT03129100|566448733|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915546|NCT03129100|566448734|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915547|NCT03129100|566448735|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
156915548|NCT03129100|566448736|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
156915549|NCT03129100|566448737|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
156915550|NCT03129100|566448738|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
156915551|NCT03129100|566448739|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915552|NCT03129100|566448740|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915553|NCT03129100|566448741|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915554|NCT03129100|566448742|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915555|NCT03129100|566448743|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915556|NCT03129100|566448744|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915557|NCT03129100|566448745|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915558|NCT03129100|566448746|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915559|NCT03129100|566448747|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915560|NCT03129100|566448748|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915561|NCT03129100|566448749|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
156915562|NCT03129100|566448724|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915563|NCT03129100|566448725|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915564|NCT03129100|566448726|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915565|NCT03129100|566448727|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915566|NCT03129100|566448728|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915567|NCT03129100|566448729|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915568|NCT03129100|566448730|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915569|NCT03129100|566448731|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915570|NCT03129100|566448732|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915571|NCT03129100|566448733|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915572|NCT03129100|566448734|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915573|NCT03129100|566448735|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156915574|NCT03129100|566448736|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915575|NCT03129100|566448737|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156915576|NCT03129100|566448738|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
156915577|NCT03129100|566448739|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915578|NCT03129100|566448740|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
157226112|NCT01984242|567573439|FG000|Overall Study|Lost to Follow-up|4|||
157226113|NCT01984242|567573440|FG001|Overall Study|Lost to Follow-up|0|||
157226114|NCT01984242|567573441|FG002|Overall Study|Lost to Follow-up|3|||
157226115|NCT01984242|567573439|FG000|Overall Study|Sponsor Decision|1|||
157226116|NCT01984242|567573440|FG001|Overall Study|Sponsor Decision|0|||
157226117|NCT01984242|567573441|FG002|Overall Study|Sponsor Decision|0|||
157226118|NCT01984242|567573439|FG000|Overall Study|Non-Compliance|1|||
157226119|NCT01984242|567573440|FG001|Overall Study|Non-Compliance|0|||
157226120|NCT01984242|567573441|FG002|Overall Study|Non-Compliance|0|||
157226121|NCT01984242|567573439|FG000|Overall Study|Study terminated by Sponsor|38|||
157226122|NCT01984242|567573440|FG001|Overall Study|Study terminated by Sponsor|50|||
157226123|NCT01984242|567573441|FG002|Overall Study|Study terminated by Sponsor|34|||
157226124|NCT01984242|567573439|FG000|Overall Study|Disease Progression|0|||
157226125|NCT01984242|567573440|FG001|Overall Study|Disease Progression|0|||
157226126|NCT01984242|567573441|FG002|Overall Study|Disease Progression|1|||
157226127|NCT00449150|567573442|FG000|Overall Study|Adverse Event|11|||
157226128|NCT00449150|567573443|FG001|Overall Study|Adverse Event|18|||
157226129|NCT00449150|567573444|FG002|Overall Study|Adverse Event|9|||
157226130|NCT00449150|567573442|FG000|Overall Study|Lack of Efficacy|1|||
157226131|NCT00449150|567573443|FG001|Overall Study|Lack of Efficacy|2|||
157226132|NCT00449150|567573444|FG002|Overall Study|Lack of Efficacy|2|||
156915579|NCT03129100|566448741|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915580|NCT03129100|566448742|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915581|NCT03129100|566448743|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915582|NCT03129100|566448744|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915583|NCT03129100|566448745|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915584|NCT03129100|566448746|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915585|NCT03129100|566448747|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915586|NCT03129100|566448748|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915587|NCT03129100|566448749|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
156915588|NCT03129100|566448724|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915589|NCT03129100|566448725|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915590|NCT03129100|566448726|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915591|NCT03129100|566448727|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915592|NCT03129100|566448728|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915593|NCT03129100|566448729|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915594|NCT03129100|566448730|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915595|NCT03129100|566448731|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915596|NCT03129100|566448732|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915597|NCT03129100|566448733|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915598|NCT03129100|566448734|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915599|NCT03129100|566448735|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915600|NCT03129100|566448736|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915601|NCT03129100|566448737|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915602|NCT03129100|566448738|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915603|NCT03129100|566448739|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
156915604|NCT03129100|566448740|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915605|NCT03129100|566448741|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915606|NCT03129100|566448742|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915607|NCT03129100|566448743|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915608|NCT03129100|566448744|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915609|NCT03129100|566448745|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915610|NCT03129100|566448746|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915611|NCT03129100|566448747|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915612|NCT03129100|566448748|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915613|NCT03129100|566448749|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
156915614|NCT03129100|566448724|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915615|NCT03129100|566448725|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915616|NCT03129100|566448726|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915617|NCT03129100|566448727|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915618|NCT03129100|566448728|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915619|NCT03129100|566448729|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
157226133|NCT00449150|567573442|FG000|Overall Study|Other|16|||
157226134|NCT00449150|567573443|FG001|Overall Study|Other|13|||
157226135|NCT00449150|567573444|FG002|Overall Study|Other|14|||
157226136|NCT00449150|567573442|FG000|Overall Study|Withdrawal by Subject|17|||
157226137|NCT00449150|567573443|FG001|Overall Study|Withdrawal by Subject|18|||
157226138|NCT00449150|567573444|FG002|Overall Study|Withdrawal by Subject|21|||
157028036|NCT01828099|566859101|FG000|Extension-treatment Phase|Death|0|||
157226139|NCT00449150|567573442|FG000|Overall Study|Protocol Violation|1|||
156915620|NCT03129100|566448730|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915621|NCT03129100|566448731|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915622|NCT03129100|566448732|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915623|NCT03129100|566448733|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915624|NCT03129100|566448734|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915625|NCT03129100|566448735|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915626|NCT03129100|566448736|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
156915627|NCT03129100|566448737|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915628|NCT03129100|566448738|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
156915629|NCT03129100|566448739|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
156915630|NCT03129100|566448740|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915631|NCT03129100|566448741|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915632|NCT03129100|566448742|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915633|NCT03129100|566448743|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915634|NCT03129100|566448744|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915635|NCT03129100|566448745|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915636|NCT03129100|566448746|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915637|NCT03129100|566448747|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915638|NCT03129100|566448748|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915639|NCT03129100|566448749|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
156915640|NCT03129100|566448724|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915641|NCT03129100|566448725|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
157028037|NCT01828099|566859102|FG001|Extension-treatment Phase|Death|11|||
156915642|NCT03129100|566448726|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915643|NCT03129100|566448727|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915644|NCT03129100|566448728|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915645|NCT03129100|566448729|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915646|NCT03129100|566448730|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915647|NCT03129100|566448731|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915648|NCT03129100|566448732|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915649|NCT03129100|566448733|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
157162450|NCT02938585|567339166|FG002|Overall Study|Withdrawal by Subject|0|||
157162451|NCT02938585|567339167|FG003|Overall Study|Withdrawal by Subject|5|||
157162452|NCT02106455|567339175|FG000|Overall Study|Case Report Form Uncollected|6|||
157162453|NCT02106455|567339175|FG000|Overall Study|Protocol Deviation|2|||
157162454|NCT03607838|567339176|FG000|Overall Study|Lack of Efficacy|14|||
157162455|NCT03607838|567339177|FG001|Overall Study|Lack of Efficacy|20|||
157162456|NCT03607838|567339176|FG000|Overall Study|Withdrawal by Subject|13|||
157162457|NCT03607838|567339177|FG001|Overall Study|Withdrawal by Subject|8|||
157162458|NCT03607838|567339176|FG000|Overall Study|Lost to Follow-up|6|||
157162459|NCT03607838|567339177|FG001|Overall Study|Lost to Follow-up|11|||
157162460|NCT03607838|567339176|FG000|Overall Study|Adverse Event|2|||
157162461|NCT03607838|567339177|FG001|Overall Study|Adverse Event|2|||
157162462|NCT03607838|567339176|FG000|Overall Study|Physician Decision|2|||
157162463|NCT03607838|567339177|FG001|Overall Study|Physician Decision|0|||
157162464|NCT03607838|567339176|FG000|Overall Study|Failure to meet randomization criteria|1|||
157162465|NCT03607838|567339177|FG001|Overall Study|Failure to meet randomization criteria|2|||
157162466|NCT03607838|567339176|FG000|Overall Study|Pregnancy|1|||
157162467|NCT03607838|567339177|FG001|Overall Study|Pregnancy|0|||
157162468|NCT03607838|567339176|FG000|Overall Study|Protocol Violation|1|||
157162469|NCT03607838|567339177|FG001|Overall Study|Protocol Violation|0|||
157162470|NCT03607838|567339176|FG000|Overall Study|Due to work|1|||
157162471|NCT03607838|567339177|FG001|Overall Study|Due to work|0|||
157162472|NCT03607838|567339176|FG000|Overall Study|Litigation|0|||
157162473|NCT03607838|567339177|FG001|Overall Study|Litigation|1|||
157162474|NCT03607838|567339176|FG000|Overall Study|Temperature excursion for study drug|0|||
157162475|NCT03607838|567339177|FG001|Overall Study|Temperature excursion for study drug|1|||
157162476|NCT03607838|567339176|FG000|Overall Study|Change of mind|0|||
157226140|NCT00449150|567573443|FG001|Overall Study|Protocol Violation|2|||
156915650|NCT03129100|566448734|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915651|NCT03129100|566448735|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915652|NCT03129100|566448736|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915653|NCT03129100|566448737|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915654|NCT03129100|566448738|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915655|NCT03129100|566448739|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
157162477|NCT03607838|567339177|FG001|Overall Study|Change of mind|1|||
157162478|NCT02411201|567339178|FG000|Overall Study|Adverse Event|2|||
157162479|NCT02411201|567339178|FG000|Overall Study|Withdrawal by Subject|2|||
157162480|NCT02411201|567339178|FG000|Overall Study|Age group completed|2|||
157162481|NCT01260467|567339179|FG000|Overall Study|Withdrawal by Subject|2|||
157162482|NCT00798694|567339180|FG000|Overall Study|Lost to Follow-up|1|||
157162483|NCT00798694|567339181|FG001|Overall Study|Lost to Follow-up|1|||
157028038|NCT01828099|566859101|FG000|Extension-treatment Phase|Physician Decision|0|||
157028039|NCT01828099|566859102|FG001|Extension-treatment Phase|Physician Decision|5|||
157028040|NCT01828099|566859101|FG000|Extension-treatment Phase|Progressive disease|0|||
157028041|NCT01828099|566859102|FG001|Extension-treatment Phase|Progressive disease|54|||
157028042|NCT01828099|566859101|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
157028043|NCT01828099|566859102|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
157028044|NCT01828099|566859101|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
157028045|NCT01828099|566859102|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
157028046|NCT05934942|566859104|FG000|Run-in Period|Not treated|1|||
157028047|NCT05934942|566859104|FG000|Run-in Period|Withdrawal by Subject|1|||
157028048|NCT05645757|566859105|FG000|Overall Study|Enrolled but treatment not administered|0|||
157028049|NCT05645757|566859106|FG001|Overall Study|Enrolled but treatment not administered|0|||
157028050|NCT05645757|566859107|FG002|Overall Study|Enrolled but treatment not administered|0|||
157028051|NCT05645757|566859108|FG003|Overall Study|Enrolled but treatment not administered|0|||
157028052|NCT05645757|566859109|FG004|Overall Study|Enrolled but treatment not administered|1|||
157028053|NCT05645757|566859110|FG005|Overall Study|Enrolled but treatment not administered|1|||
157028054|NCT05645757|566859111|FG006|Overall Study|Enrolled but treatment not administered|0|||
157028055|NCT05645757|566859112|FG007|Overall Study|Enrolled but treatment not administered|0|||
157028056|NCT03905798|566859113|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
157028057|NCT04471246|566859116|FG000|Overall Study|Lost to Follow-up|2|||
157028058|NCT04471246|566859117|FG001|Overall Study|Lost to Follow-up|2|||
157028059|NCT04826471|566859118|FG000|Overall Study|Lost to Follow-up|2|||
157028060|NCT04826471|566859118|FG000|Overall Study|Protocol Violation|3|||
157028061|NCT04826471|566859118|FG000|Overall Study|Withdrawal by Subject|1|||
157028062|NCT05764525|566859119|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
157028063|NCT05764525|566859120|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
157028064|NCT05764525|566859119|FG000|Overall Study|Withdrawal by Subject|4|||
157028065|NCT05764525|566859120|FG001|Overall Study|Withdrawal by Subject|8|||
157028066|NCT05764525|566859119|FG000|Overall Study|Physician Decision|1|||
157028067|NCT05764525|566859120|FG001|Overall Study|Physician Decision|0|||
157028068|NCT03334630|566859121|FG000|Overall Study|Withdrawal by Subject|7|||
157028069|NCT03334630|566859122|FG001|Overall Study|Withdrawal by Subject|7|||
157028070|NCT03334630|566859121|FG000|Overall Study|Lost to Follow-up|3|||
157028071|NCT03334630|566859122|FG001|Overall Study|Lost to Follow-up|1|||
157028072|NCT03334630|566859121|FG000|Overall Study|Adverse Event|0|||
157028073|NCT03334630|566859122|FG001|Overall Study|Adverse Event|1|||
157028074|NCT03334630|566859121|FG000|Overall Study|Physician Decision|1|||
157028075|NCT03334630|566859122|FG001|Overall Study|Physician Decision|1|||
157028076|NCT03334630|566859121|FG000|Overall Study|Enrollment closed|2|||
157028077|NCT03334630|566859122|FG001|Overall Study|Enrollment closed|1|||
156915656|NCT03129100|566448740|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915657|NCT03129100|566448741|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
156915658|NCT03129100|566448742|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915659|NCT03129100|566448743|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
156915660|NCT03129100|566448744|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915661|NCT03129100|566448745|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915662|NCT03129100|566448746|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915663|NCT03129100|566448747|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915664|NCT03129100|566448748|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915665|NCT03129100|566448749|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
156915666|NCT03129100|566448724|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915667|NCT03129100|566448725|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915668|NCT03129100|566448726|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915669|NCT03129100|566448727|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915670|NCT03129100|566448728|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915671|NCT03129100|566448729|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
157028078|NCT03334630|566859121|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
157028079|NCT03334630|566859122|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
156915672|NCT03129100|566448730|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915673|NCT03129100|566448731|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
157028080|NCT03334630|566859121|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
157028081|NCT03334630|566859122|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
157028082|NCT04079218|566859127|FG000|Overall Study|Death|1|||
157028083|NCT04079218|566859128|FG001|Overall Study|Death|0|||
157028084|NCT04079218|566859127|FG000|Overall Study|Withdrawal by Subject|3|||
157028085|NCT04079218|566859128|FG001|Overall Study|Withdrawal by Subject|0|||
157028086|NCT04079218|566859127|FG000|Overall Study|Physician Decision|4|||
156915674|NCT03129100|566448732|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915675|NCT03129100|566448733|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915676|NCT03129100|566448734|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915677|NCT03129100|566448735|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915678|NCT03129100|566448736|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915679|NCT03129100|566448737|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915680|NCT03129100|566448738|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915681|NCT03129100|566448739|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915682|NCT03129100|566448740|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915683|NCT03129100|566448741|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915684|NCT03129100|566448742|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915685|NCT03129100|566448743|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915686|NCT03129100|566448744|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
156915687|NCT03129100|566448745|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915688|NCT03129100|566448746|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915689|NCT03129100|566448747|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915690|NCT03129100|566448748|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915691|NCT03129100|566448749|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
156915692|NCT03129100|566448724|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
156915693|NCT03129100|566448725|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
156915694|NCT03129100|566448726|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
156915695|NCT03129100|566448727|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
156915696|NCT03129100|566448728|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
156915697|NCT03129100|566448729|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
156915698|NCT03129100|566448730|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
156915699|NCT03129100|566448731|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
156915700|NCT03129100|566448732|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
156915701|NCT03129100|566448733|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
156915702|NCT03129100|566448734|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
156915703|NCT03129100|566448735|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
156915704|NCT03129100|566448736|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
156915705|NCT03129100|566448737|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
156915706|NCT03129100|566448738|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
156915707|NCT03129100|566448739|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
156915708|NCT03129100|566448740|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
156915709|NCT03129100|566448741|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
156915710|NCT03129100|566448742|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
156915711|NCT03129100|566448743|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
156915712|NCT03129100|566448744|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
156915713|NCT03129100|566448745|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
156915714|NCT03129100|566448746|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
156915715|NCT03129100|566448747|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
156915716|NCT03129100|566448748|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
156915717|NCT03129100|566448749|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
156915718|NCT03129100|566448724|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915719|NCT03129100|566448725|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915720|NCT03129100|566448726|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915721|NCT03129100|566448727|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915722|NCT03129100|566448728|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915723|NCT03129100|566448729|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915724|NCT03129100|566448730|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915725|NCT03129100|566448731|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915726|NCT03129100|566448732|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915727|NCT03129100|566448733|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915728|NCT03129100|566448734|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915729|NCT03129100|566448735|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915730|NCT03129100|566448736|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915731|NCT03129100|566448737|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915732|NCT03129100|566448738|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915733|NCT03129100|566448739|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915734|NCT03129100|566448740|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915735|NCT03129100|566448741|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915736|NCT03129100|566448742|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915737|NCT03129100|566448743|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915738|NCT03129100|566448744|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
157226141|NCT00449150|567573444|FG002|Overall Study|Protocol Violation|1|||
157226142|NCT02246478|567573445|FG000|Multiple-dose Phase|Protocol Violation|1|||
156915739|NCT03129100|566448745|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915740|NCT03129100|566448746|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915741|NCT03129100|566448747|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915742|NCT03129100|566448748|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915743|NCT03129100|566448749|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
156915744|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
156915745|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
156915746|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
156915747|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
156915748|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
156915749|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
156915750|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
156915751|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
156915752|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
156915753|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
156915754|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
156915755|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
156915756|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
156915757|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
156915758|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
156915759|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
156915760|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
156915761|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
156915762|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
156915763|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
156915764|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
156915765|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
156915766|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
156915767|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
156915768|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
156915769|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
156915770|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915771|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915772|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915773|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915774|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915775|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915776|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915777|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915778|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915779|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915780|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915781|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915782|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915783|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915784|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915785|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915786|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915787|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915788|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915789|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915790|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915791|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915792|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915793|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
156915794|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
156915795|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
156915796|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915797|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915798|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915799|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915800|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915801|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915802|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915803|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915804|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915805|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915806|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915807|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915808|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915809|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915810|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915811|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915812|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915813|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
157028087|NCT04079218|566859128|FG001|Overall Study|Physician Decision|0|||
156915814|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915815|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915816|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915817|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915818|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
156915819|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
156915820|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
156915821|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
156915822|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915823|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915824|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915825|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915826|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915827|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915828|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915829|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915830|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915831|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915832|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915833|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915834|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915835|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915836|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915837|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915838|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915839|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915840|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915841|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915842|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915843|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915844|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915845|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915846|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
156915847|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
156915848|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915849|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915850|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915851|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915852|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915853|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915854|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915855|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915856|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915857|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915858|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915859|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915860|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915861|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915862|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915863|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915864|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915865|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915866|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915867|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915868|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915869|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915870|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915871|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915872|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
156915873|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
156915874|NCT03129100|566448724|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
156915875|NCT03129100|566448725|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
156915876|NCT03129100|566448726|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
156915877|NCT03129100|566448727|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
156915878|NCT03129100|566448728|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
156915879|NCT03129100|566448729|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
156915880|NCT03129100|566448730|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
156915881|NCT03129100|566448731|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
156915882|NCT03129100|566448732|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
156915883|NCT03129100|566448733|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
156915884|NCT03129100|566448734|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
156915885|NCT03129100|566448735|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
156915886|NCT03129100|566448736|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
156915887|NCT03129100|566448737|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
156915888|NCT03129100|566448738|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
156915889|NCT03129100|566448739|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
156915890|NCT03129100|566448740|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
156915891|NCT03129100|566448741|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
156915892|NCT03129100|566448742|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
156915893|NCT03129100|566448743|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
156915894|NCT03129100|566448744|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
156915895|NCT03129100|566448745|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
156915896|NCT03129100|566448746|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
156915897|NCT03129100|566448747|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
156915898|NCT03129100|566448748|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
156915899|NCT03129100|566448749|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
156915900|NCT02030041|566448751|FG000|Overall Study|Withdrawal by Subject|2|||
156915901|NCT02030041|566448752|FG001|Overall Study|Withdrawal by Subject|2|||
156915902|NCT02030041|566448753|FG002|Overall Study|Withdrawal by Subject|1|||
156915903|NCT01032837|566448754|FG000|Overall Study|Adverse event/internal illness|0|||
156915904|NCT01032837|566448755|FG001|Overall Study|Adverse event/internal illness|1|||
156915905|NCT01032837|566448756|FG002|Overall Study|Adverse event/internal illness|0|||
156915906|NCT01032837|566448757|FG003|Overall Study|Adverse event/internal illness|1|||
156915907|NCT01032837|566448754|FG000|Overall Study|Withdrew consent|0|||
156915908|NCT01032837|566448755|FG001|Overall Study|Withdrew consent|2|||
156915909|NCT01032837|566448756|FG002|Overall Study|Withdrew consent|0|||
156915910|NCT01032837|566448757|FG003|Overall Study|Withdrew consent|1|||
156915911|NCT01032837|566448754|FG000|Overall Study|Failed to return|0|||
156915912|NCT01032837|566448755|FG001|Overall Study|Failed to return|0|||
156915913|NCT01032837|566448756|FG002|Overall Study|Failed to return|1|||
156915914|NCT01032837|566448757|FG003|Overall Study|Failed to return|0|||
156915915|NCT01032837|566448754|FG000|Overall Study|Refused treatment|0|||
156915916|NCT01032837|566448755|FG001|Overall Study|Refused treatment|0|||
156915917|NCT01032837|566448756|FG002|Overall Study|Refused treatment|0|||
156915918|NCT01032837|566448757|FG003|Overall Study|Refused treatment|1|||
156915919|NCT01197560|566448758|FG000|Overall Study|Adverse Event|6|||
156915920|NCT01197560|566448759|FG001|Overall Study|Adverse Event|8|||
156915921|NCT01197560|566448758|FG000|Overall Study|Death|3|||
156915922|NCT01197560|566448759|FG001|Overall Study|Death|5|||
156915923|NCT01197560|566448758|FG000|Overall Study|Withdrawal by Subject|1|||
156915924|NCT01197560|566448759|FG001|Overall Study|Withdrawal by Subject|1|||
156915925|NCT01197560|566448758|FG000|Overall Study|Disease progression|40|||
156915926|NCT01197560|566448759|FG001|Overall Study|Disease progression|35|||
156915927|NCT01197560|566448758|FG000|Overall Study|Miscellaneous|4|||
156915928|NCT01197560|566448759|FG001|Overall Study|Miscellaneous|3|||
156915929|NCT01197560|566448758|FG000|Overall Study|Missing|0|||
156915930|NCT01197560|566448759|FG001|Overall Study|Missing|1|||
156915931|NCT02239978|566450335|FG000|Overall Study|Withdrawal by Subject|2|||
156915932|NCT02239978|566450336|FG001|Overall Study|Withdrawal by Subject|0|||
156915933|NCT02324569|566450340|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
156915934|NCT02324569|566450341|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
156915935|NCT02324569|566450340|FG000|Overall Study|Voluntary Withdrawal|3|||
156915936|NCT02324569|566450341|FG001|Overall Study|Voluntary Withdrawal|6|||
156915937|NCT02324569|566450340|FG000|Overall Study|Lack of Efficacy|2|||
157162484|NCT00798694|567339180|FG000|Overall Study|Physician Decision|1|||
157162485|NCT00798694|567339181|FG001|Overall Study|Physician Decision|0|||
157162486|NCT03364608|567339185|FG000|Overall Study|Withdrawal by Subject|4|||
157162487|NCT03364608|567339185|FG000|Overall Study|Protocol Violation|2|||
157162488|NCT03364608|567339185|FG000|Overall Study|Lost to Follow-up|2|||
157162489|NCT03888391|567339188|FG000|Overall Study|Lost to Follow-up|15|||
156915938|NCT02324569|566450341|FG001|Overall Study|Lack of Efficacy|3|||
156915939|NCT02324569|566450340|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
156915940|NCT02324569|566450341|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
156915941|NCT02324569|566450340|FG000|Overall Study|Inconvenient Schedule|2|||
156915942|NCT02324569|566450341|FG001|Overall Study|Inconvenient Schedule|0|||
156915943|NCT00903695|566450349|FG000|Overall Study|medical exclusion after 1st testing|1|||
156915944|NCT00903695|566450350|FG001|Overall Study|medical exclusion after 1st testing|0|||
156915945|NCT00903695|566450349|FG000|Overall Study|lung cancer|1|||
156915946|NCT00903695|566450350|FG001|Overall Study|lung cancer|0|||
156915947|NCT01549860|566450351|FG000|Overall Study|Withdrawal by Subject|1|||
156915948|NCT01549860|566450352|FG001|Overall Study|Withdrawal by Subject|0|||
157162490|NCT02504268|567339191|FG000|Overall Study|Adverse Event|18|||
157162491|NCT02504268|567339192|FG001|Overall Study|Adverse Event|8|||
156915949|NCT01549860|566450351|FG000|Overall Study|Physician Decision|1|||
156915950|NCT01549860|566450352|FG001|Overall Study|Physician Decision|1|||
156915951|NCT01366521|566450354|FG000|Overall Study|Adverse Event|1|||
156915952|NCT01366521|566450355|FG001|Overall Study|Adverse Event|0|||
156915953|NCT01366521|566450356|FG002|Overall Study|Adverse Event|0|||
156915954|NCT01366521|566450357|FG003|Overall Study|Adverse Event|0|||
156915955|NCT01366521|566450354|FG000|Overall Study|Protocol Violation|0|||
156915956|NCT01366521|566450355|FG001|Overall Study|Protocol Violation|0|||
156915957|NCT01366521|566450356|FG002|Overall Study|Protocol Violation|1|||
156915958|NCT01366521|566450357|FG003|Overall Study|Protocol Violation|0|||
156915959|NCT01366521|566450354|FG000|Overall Study|Physician Decision|0|||
156915960|NCT01366521|566450355|FG001|Overall Study|Physician Decision|0|||
156915961|NCT01366521|566450356|FG002|Overall Study|Physician Decision|1|||
156915962|NCT01366521|566450357|FG003|Overall Study|Physician Decision|0|||
156915963|NCT01366521|566450354|FG000|Overall Study|Withdrawal by Subject|0|||
156915964|NCT01366521|566450355|FG001|Overall Study|Withdrawal by Subject|1|||
156915965|NCT01366521|566450356|FG002|Overall Study|Withdrawal by Subject|0|||
156915966|NCT01366521|566450357|FG003|Overall Study|Withdrawal by Subject|0|||
156915967|NCT02430311|566450358|FG000|Part A|Adverse Event|0|||
156915968|NCT02430311|566450359|FG001|Part A|Adverse Event|1|||
156915969|NCT02430311|566450358|FG000|Part A|Withdrawal by Subject|1|||
156915970|NCT02430311|566450359|FG001|Part A|Withdrawal by Subject|0|||
156915971|NCT02430311|566450358|FG000|Part B|Meet study-specific withdrawal criteria|6|||
156915972|NCT02430311|566450359|FG001|Part B|Meet study-specific withdrawal criteria|6|||
156915973|NCT02430311|566450358|FG000|Part B|Withdrawal by Subject|2|||
156915974|NCT02430311|566450359|FG001|Part B|Withdrawal by Subject|2|||
156915975|NCT02430311|566450358|FG000|Part B|Adverse Event|1|||
156915976|NCT02430311|566450359|FG001|Part B|Adverse Event|0|||
156915977|NCT02430311|566450358|FG000|Part B|Death|1|||
156915978|NCT02430311|566450359|FG001|Part B|Death|0|||
156915979|NCT02899988|566450362|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
156915980|NCT02899988|566450363|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
156915981|NCT02899988|566450364|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915982|NCT02899988|566450365|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915983|NCT02899988|566450366|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915984|NCT02899988|566450367|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915985|NCT02899988|566450368|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915986|NCT02899988|566450369|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915987|NCT02899988|566450370|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915988|NCT02899988|566450371|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915989|NCT02899988|566450372|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
156915990|NCT02899988|566450362|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
156915991|NCT02899988|566450363|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
156915992|NCT02899988|566450364|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
156915993|NCT02899988|566450365|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
156915994|NCT02899988|566450366|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
156915995|NCT02899988|566450367|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
156915996|NCT02899988|566450368|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
156915997|NCT02899988|566450369|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
156915998|NCT02899988|566450370|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
156915999|NCT02899988|566450371|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
156916000|NCT02899988|566450372|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
156916001|NCT02899988|566450362|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
156916002|NCT02899988|566450363|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
156916003|NCT02899988|566450364|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
156916004|NCT02899988|566450365|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
156916005|NCT02899988|566450366|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
156916006|NCT02899988|566450367|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
156916007|NCT02899988|566450368|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
156916008|NCT02899988|566450369|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
156916009|NCT02899988|566450370|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
156916010|NCT02899988|566450371|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
156916011|NCT02899988|566450372|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
156916012|NCT02899988|566450362|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
156916013|NCT02899988|566450363|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
156916014|NCT02899988|566450364|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
156916015|NCT02899988|566450365|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
156916016|NCT02899988|566450366|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
156916017|NCT02899988|566450367|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
156916018|NCT02899988|566450368|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
156916019|NCT02899988|566450369|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
156916020|NCT02899988|566450370|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
156916021|NCT02899988|566450371|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
156916022|NCT02899988|566450372|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
156916023|NCT02899988|566450362|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
157226143|NCT02246478|567573446|FG001|Multiple-dose Phase|Protocol Violation|0|||
157226144|NCT02246478|567573447|FG002|Multiple-dose Phase|Protocol Violation|0|||
157226145|NCT02246478|567573448|FG003|Multiple-dose Phase|Protocol Violation|1|||
157226146|NCT00536575|567573449|FG000|Overall Study|Withdrawal by Subject|1|||
157226147|NCT00536575|567573449|FG000|Overall Study|Death|1|||
157226148|NCT00865709|567573459|FG000|Treatment|Adverse Event|9|||
157226149|NCT00865709|567573460|FG001|Treatment|Adverse Event|6|||
157226150|NCT00865709|567573459|FG000|Treatment|Withdrawal by Subject|10|||
157226151|NCT00865709|567573460|FG001|Treatment|Withdrawal by Subject|7|||
157226152|NCT00865709|567573459|FG000|Treatment|Physician Decision|3|||
157226153|NCT00865709|567573460|FG001|Treatment|Physician Decision|2|||
157226154|NCT00865709|567573459|FG000|Treatment|Surgery|8|||
157226155|NCT00865709|567573460|FG001|Treatment|Surgery|3|||
157226156|NCT00429923|567573461|FG000|Overall Study|Adverse Event|0|||
157226157|NCT00429923|567573462|FG001|Overall Study|Adverse Event|2|||
157226158|NCT00429923|567573463|FG002|Overall Study|Adverse Event|3|||
157226159|NCT00429923|567573461|FG000|Overall Study|Lack of Efficacy|4|||
157226160|NCT00429923|567573462|FG001|Overall Study|Lack of Efficacy|1|||
157226161|NCT00429923|567573463|FG002|Overall Study|Lack of Efficacy|33|||
157226162|NCT00429923|567573461|FG000|Overall Study|Lost to Follow-up|0|||
157226163|NCT00429923|567573462|FG001|Overall Study|Lost to Follow-up|0|||
157226164|NCT00429923|567573463|FG002|Overall Study|Lost to Follow-up|2|||
157226165|NCT00429923|567573461|FG000|Overall Study|Withdrew Consent|1|||
157226166|NCT00429923|567573462|FG001|Overall Study|Withdrew Consent|0|||
157226167|NCT00429923|567573463|FG002|Overall Study|Withdrew Consent|1|||
157226168|NCT00429923|567573461|FG000|Overall Study|Early Termination|0|||
157226169|NCT00429923|567573462|FG001|Overall Study|Early Termination|1|||
157226170|NCT00429923|567573463|FG002|Overall Study|Early Termination|0|||
157226171|NCT01265784|567573464|FG000|Overall Study|Lost to Follow-up|5|||
157226172|NCT01265784|567573465|FG001|Overall Study|Lost to Follow-up|3|||
157226173|NCT01265784|567573466|FG002|Overall Study|Lost to Follow-up|2|||
157226174|NCT01265784|567573464|FG000|Overall Study|Withdrawal by Subject|0|||
157226175|NCT01265784|567573465|FG001|Overall Study|Withdrawal by Subject|5|||
157226176|NCT01265784|567573466|FG002|Overall Study|Withdrawal by Subject|0|||
157226177|NCT01265784|567573464|FG000|Overall Study|Physician Decision|1|||
157226178|NCT01265784|567573465|FG001|Overall Study|Physician Decision|0|||
157226179|NCT01265784|567573466|FG002|Overall Study|Physician Decision|1|||
157226180|NCT01265784|567573464|FG000|Overall Study|Adverse Event|1|||
157226181|NCT01265784|567573465|FG001|Overall Study|Adverse Event|0|||
157226182|NCT01265784|567573466|FG002|Overall Study|Adverse Event|0|||
157226183|NCT01265784|567573464|FG000|Overall Study|Death|3|||
157226184|NCT01265784|567573465|FG001|Overall Study|Death|0|||
157226185|NCT01265784|567573466|FG002|Overall Study|Death|0|||
157226186|NCT01265784|567573464|FG000|Overall Study|Protocol Violation|2|||
157226187|NCT01265784|567573465|FG001|Overall Study|Protocol Violation|0|||
157226188|NCT01265784|567573466|FG002|Overall Study|Protocol Violation|0|||
157226189|NCT01265784|567573464|FG000|Overall Study|Incorrectly Randomized|0|||
157226190|NCT01265784|567573465|FG001|Overall Study|Incorrectly Randomized|0|||
157226191|NCT01265784|567573466|FG002|Overall Study|Incorrectly Randomized|1|||
157226192|NCT04333095|567573469|FG000|Overall Study|Protocol Violation|4|||
157226193|NCT04333095|567573470|FG001|Overall Study|Protocol Violation|0|||
157226194|NCT04333095|567573469|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
157226195|NCT04333095|567573470|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
157226196|NCT04333095|567573469|FG000|Overall Study|Mini Sternotomy|4|||
157226197|NCT04333095|567573470|FG001|Overall Study|Mini Sternotomy|5|||
157226198|NCT00984295|567573471|FG000|Overall Study|Lost to Follow-up|31|||
157226199|NCT00984295|567573472|FG001|Overall Study|Lost to Follow-up|12|||
157226200|NCT00984295|567573473|FG002|Overall Study|Lost to Follow-up|13|||
156916024|NCT02899988|566450363|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916025|NCT02899988|566450364|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916026|NCT02899988|566450365|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916027|NCT02899988|566450366|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916028|NCT02899988|566450367|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
156916029|NCT02899988|566450368|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
157226201|NCT00984295|567573471|FG000|Overall Study|Protocol Violation|2|||
157226202|NCT00984295|567573472|FG001|Overall Study|Protocol Violation|1|||
157226203|NCT00984295|567573473|FG002|Overall Study|Protocol Violation|4|||
157226204|NCT00984295|567573471|FG000|Overall Study|Withdrawal by Subject|18|||
157226205|NCT00984295|567573472|FG001|Overall Study|Withdrawal by Subject|9|||
157226206|NCT00984295|567573473|FG002|Overall Study|Withdrawal by Subject|12|||
157226207|NCT00984295|567573471|FG000|Overall Study|CAE - discontinued test vaccine|0|||
157226208|NCT00984295|567573472|FG001|Overall Study|CAE - discontinued test vaccine|1|||
157226209|NCT00984295|567573473|FG002|Overall Study|CAE - discontinued test vaccine|3|||
157226210|NCT00984295|567573471|FG000|Overall Study|Missed one or more blood samplings|3|||
157226211|NCT00984295|567573472|FG001|Overall Study|Missed one or more blood samplings|7|||
156916030|NCT02899988|566450369|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
157226212|NCT00984295|567573473|FG002|Overall Study|Missed one or more blood samplings|2|||
157226213|NCT00984295|567573471|FG000|Overall Study|Incomplete safety follow-up|11|||
156916031|NCT02899988|566450370|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916032|NCT02899988|566450371|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916033|NCT02899988|566450372|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
156916034|NCT02899988|566450362|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916035|NCT02899988|566450363|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916036|NCT02899988|566450364|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916037|NCT02899988|566450365|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916038|NCT02899988|566450366|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
156916039|NCT02899988|566450367|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916040|NCT02899988|566450368|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
156916041|NCT02899988|566450369|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
156916042|NCT02899988|566450370|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
156916043|NCT02899988|566450371|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
156916044|NCT02899988|566450372|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
156916045|NCT04202965|566450377|FG000|Overall Study|Adverse Event|3|||
156916046|NCT04202965|566450377|FG000|Overall Study|Did not meet inclusion criteria|1|||
156916047|NCT00299975|566450378|FG000|Overall Study|Adverse Event|1|||
156916048|NCT00299975|566450379|FG001|Overall Study|Adverse Event|0|||
156916049|NCT00299975|566450380|FG002|Overall Study|Adverse Event|2|||
156916050|NCT00299975|566450378|FG000|Overall Study|Pregnancy|0|||
156916051|NCT00299975|566450379|FG001|Overall Study|Pregnancy|0|||
156916052|NCT00299975|566450380|FG002|Overall Study|Pregnancy|1|||
156916053|NCT00299975|566450378|FG000|Overall Study|Lack of Efficacy|1|||
156916054|NCT00299975|566450379|FG001|Overall Study|Lack of Efficacy|0|||
156916055|NCT00299975|566450380|FG002|Overall Study|Lack of Efficacy|1|||
156916056|NCT00299975|566450378|FG000|Overall Study|Lost to Follow-up|1|||
156916057|NCT00299975|566450379|FG001|Overall Study|Lost to Follow-up|0|||
156916058|NCT00299975|566450380|FG002|Overall Study|Lost to Follow-up|0|||
156916059|NCT00299975|566450378|FG000|Overall Study|Withdrawal by Subject|0|||
156916060|NCT00299975|566450379|FG001|Overall Study|Withdrawal by Subject|1|||
156916061|NCT00299975|566450380|FG002|Overall Study|Withdrawal by Subject|3|||
156916062|NCT00299975|566450378|FG000|Overall Study|Physician Decision|0|||
156916063|NCT00299975|566450379|FG001|Overall Study|Physician Decision|0|||
156916064|NCT00299975|566450380|FG002|Overall Study|Physician Decision|1|||
156916065|NCT02651922|566450382|FG000|Overall Study|due to exclusion criteria|2|||
156916066|NCT01053221|566450383|FG000|Overall Study|The study was closed prematurely|5|||
156916067|NCT01053221|566450384|FG001|Overall Study|The study was closed prematurely|9|||
156916068|NCT03018704|566450385|FG000|Overall Study|Lost to Follow-up|1|||
156916069|NCT03018704|566450386|FG001|Overall Study|Lost to Follow-up|1|||
156916070|NCT04448171|566450387|FG000|Overall Study|Procedure Cancelled|1|||
156916071|NCT04448171|566450388|FG001|Overall Study|Procedure Cancelled|0|||
156916072|NCT04448171|566450387|FG000|Overall Study|Protocol Violation|1|||
156916073|NCT04448171|566450388|FG001|Overall Study|Protocol Violation|0|||
156916074|NCT02088047|566450389|FG000|Overall Study|Withdrawal by Subject|1|||
156916075|NCT02088047|566450390|FG001|Overall Study|Withdrawal by Subject|0|||
156916076|NCT01025752|566450395|FG000|Overall Study|Lost to Follow-up|7|||
156916077|NCT01025752|566450396|FG001|Overall Study|Lost to Follow-up|10|||
156916078|NCT01025752|566450395|FG000|Overall Study|Physician Decision|1|||
156916079|NCT01025752|566450396|FG001|Overall Study|Physician Decision|3|||
156916080|NCT00211809|566450397|FG000|Overall Study|Lack of Efficacy|1|||
156916081|NCT00211809|566450397|FG000|Overall Study|Lost to Follow-up|2|||
156916082|NCT00211809|566450397|FG000|Overall Study|Pregnancy|1|||
156916083|NCT00211809|566450397|FG000|Overall Study|side effects|2|||
156916084|NCT00023764|566450398|FG000|Overall Study|Other|1|||
156916085|NCT00023764|566450398|FG000|Overall Study|Adverse Event|4|||
156916086|NCT00023764|566450398|FG000|Overall Study|Withdrawal by Subject|1|||
156916087|NCT00023764|566450398|FG000|Overall Study|Progression of disease|6|||
156916088|NCT00023764|566450398|FG000|Overall Study|patient received other treatment|1|||
156916089|NCT00023764|566450398|FG000|Overall Study|delay in obtaining staging images|1|||
156916090|NCT01537393|566450402|FG000|Overall Study|Exclude prior to study|32|||
156916091|NCT01537393|566450403|FG001|Overall Study|Exclude prior to study|44|||
156916092|NCT01537393|566450402|FG000|Overall Study|Death|20|||
156916093|NCT01537393|566450403|FG001|Overall Study|Death|32|||
156916094|NCT01537393|566450402|FG000|Overall Study|Withdrawal by Subject|18|||
156916095|NCT01537393|566450403|FG001|Overall Study|Withdrawal by Subject|17|||
156916096|NCT01537393|566450402|FG000|Overall Study|Lost to Follow-up|53|||
156916097|NCT01537393|566450403|FG001|Overall Study|Lost to Follow-up|48|||
156916098|NCT01537393|566450402|FG000|Overall Study|Failure - Regrafted|28|||
156916099|NCT01537393|566450403|FG001|Overall Study|Failure - Regrafted|43|||
156916100|NCT01537393|566450402|FG000|Overall Study|Failure - Not regrafted|2|||
156916101|NCT01537393|566450403|FG001|Overall Study|Failure - Not regrafted|6|||
156916102|NCT01537393|566450402|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
156916103|NCT01537393|566450403|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
156916104|NCT01697566|566450404|FG000|Overall Study|Withdrawal by Subject|0|||
156916105|NCT01697566|566450405|FG001|Overall Study|Withdrawal by Subject|0|||
156916106|NCT01697566|566450406|FG002|Overall Study|Withdrawal by Subject|1|||
156916107|NCT01697566|566450407|FG003|Overall Study|Withdrawal by Subject|1|||
156916108|NCT01697566|566450404|FG000|Overall Study|Final biopsy not obtained|0|||
156916109|NCT01697566|566450405|FG001|Overall Study|Final biopsy not obtained|0|||
156916110|NCT01697566|566450406|FG002|Overall Study|Final biopsy not obtained|1|||
156916111|NCT01697566|566450407|FG003|Overall Study|Final biopsy not obtained|0|||
156916112|NCT00459953|566450409|FG000|Overall Study|not analyzed-household member in study|1|||
156916113|NCT00459953|566450410|FG001|Overall Study|not analyzed-household member in study|1|||
156916114|NCT01447433|566450411|FG000|Overall Study|Lost to Follow-up|0|||
156916115|NCT01447433|566450412|FG001|Overall Study|Lost to Follow-up|2|||
156916116|NCT01447433|566450411|FG000|Overall Study|Withdrawal by Subject|3|||
156916117|NCT01447433|566450412|FG001|Overall Study|Withdrawal by Subject|3|||
156916118|NCT01447433|566450411|FG000|Overall Study|Protocol Violation|1|||
156916119|NCT01447433|566450412|FG001|Overall Study|Protocol Violation|1|||
156916120|NCT00036270|566450413|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
156916121|NCT00036270|566450414|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
156916122|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
156916123|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
156916124|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
156916125|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
156916126|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
156916127|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
156916128|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Other|277|||
156916129|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Other|288|||
156916130|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
156916131|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
156916132|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
156916133|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
156916134|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
156916135|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
156916136|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
156916137|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
156916138|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
156916139|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
156916140|NCT00036270|566450413|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
156916141|NCT00036270|566450414|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
156916142|NCT01578187|566450415|FG000|Usability Phase|Withdrawal by Subject|1|||
156916143|NCT00496470|566450416|FG000|Overall Study|Adverse Event|8|||
156916144|NCT00496470|566450417|FG001|Overall Study|Adverse Event|10|||
156916145|NCT00496470|566450416|FG000|Overall Study|Withdrawal by Subject|5|||
156916146|NCT00496470|566450417|FG001|Overall Study|Withdrawal by Subject|12|||
156916147|NCT00496470|566450416|FG000|Overall Study|Incorrectly enrolled|13|||
156916148|NCT00496470|566450417|FG001|Overall Study|Incorrectly enrolled|5|||
156916149|NCT00496470|566450416|FG000|Overall Study|Other reason|0|||
156916150|NCT00496470|566450417|FG001|Overall Study|Other reason|2|||
156916151|NCT01217814|566450418|FG000|Overall Study|Adverse Event|1|||
156916152|NCT01217814|566450419|FG001|Overall Study|Adverse Event|1|||
156916153|NCT01217814|566450420|FG002|Overall Study|Adverse Event|0|||
156916154|NCT01217814|566450418|FG000|Overall Study|Lack of Efficacy|0|||
156916155|NCT01217814|566450419|FG001|Overall Study|Lack of Efficacy|0|||
156916156|NCT01217814|566450420|FG002|Overall Study|Lack of Efficacy|1|||
156916157|NCT01370356|566450421|FG000|Overall Study|Death|1|||
156916158|NCT01370356|566450422|FG001|Overall Study|Death|0|||
156916159|NCT01370356|566450421|FG000|Overall Study|Lack of Efficacy|6|||
156916160|NCT01370356|566450422|FG001|Overall Study|Lack of Efficacy|28|||
156916161|NCT01370356|566450421|FG000|Overall Study|Lost to Follow-up|76|||
156916162|NCT01370356|566450422|FG001|Overall Study|Lost to Follow-up|81|||
156916163|NCT01370356|566450421|FG000|Overall Study|Withdrawal by Subject|54|||
156916164|NCT01370356|566450422|FG001|Overall Study|Withdrawal by Subject|59|||
156916165|NCT01370356|566450421|FG000|Overall Study|Reason not specified|39|||
156916166|NCT01370356|566450422|FG001|Overall Study|Reason not specified|43|||
156916167|NCT01370356|566450421|FG000|Overall Study|Protocol Violation|3|||
156916168|NCT01370356|566450422|FG001|Overall Study|Protocol Violation|3|||
156916169|NCT01370356|566450421|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
156916170|NCT01370356|566450422|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
156916171|NCT01370356|566450421|FG000|Overall Study|AE Not Related to Study Drug|1|||
156916172|NCT01370356|566450422|FG001|Overall Study|AE Not Related to Study Drug|4|||
156916173|NCT01218243|566450423|FG000|Overall Study|Lack of Efficacy|1|||
156916174|NCT01218243|566450424|FG001|Overall Study|Lack of Efficacy|1|||
156916175|NCT01218243|566450423|FG000|Overall Study|Lost to Follow-up|3|||
156916176|NCT01218243|566450424|FG001|Overall Study|Lost to Follow-up|3|||
156916177|NCT01218243|566450423|FG000|Overall Study|Protocol Violation|5|||
156916178|NCT01218243|566450424|FG001|Overall Study|Protocol Violation|10|||
156916179|NCT02756013|566450425|FG000|Overall Study|Adverse Event|1|||
156916180|NCT02756013|566450425|FG000|Overall Study|Hypersensitivity|1|||
156916181|NCT00571948|566450426|FG000|Overall Study|Lost to Follow-up|2|||
156916182|NCT00571948|566450427|FG001|Overall Study|Lost to Follow-up|0|||
156916183|NCT00571948|566450426|FG000|Overall Study|Withdrawal by Subject|1|||
156916184|NCT00571948|566450427|FG001|Overall Study|Withdrawal by Subject|2|||
156916185|NCT00571948|566450426|FG000|Overall Study|Protocol Violation|3|||
156916186|NCT00571948|566450427|FG001|Overall Study|Protocol Violation|3|||
157226214|NCT00984295|567573472|FG001|Overall Study|Incomplete safety follow-up|2|||
157226215|NCT00984295|567573473|FG002|Overall Study|Incomplete safety follow-up|3|||
157226216|NCT03740165|567573474|FG000|Overall Study|Death|232|||
157226217|NCT03740165|567573475|FG001|Overall Study|Death|242|||
157226218|NCT03740165|567573476|FG002|Overall Study|Death|229|||
156916187|NCT00571948|566450426|FG000|Overall Study|infant refused study meal|3|||
156916188|NCT00571948|566450427|FG001|Overall Study|infant refused study meal|4|||
156916189|NCT00571948|566450426|FG000|Overall Study|Parent were afraid of blood colection|2|||
156916190|NCT00571948|566450427|FG001|Overall Study|Parent were afraid of blood colection|5|||
156916191|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
156916192|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
156916193|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156916194|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156916195|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156916196|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
156916197|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
156916198|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
156916199|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156916200|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156916201|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156916202|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
156916203|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
156916204|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
156916205|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156916206|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156916207|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156916208|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
156916209|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
156916210|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
156916211|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156916212|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156916213|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156916214|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
156916215|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
156916216|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
156916217|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156916218|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156916219|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156916220|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
156916221|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156916222|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
156916223|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156916224|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156916225|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156916226|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
156916227|NCT00843024|566450428|FG000|Single-blind Placebo Run-In Phase|Other|0|||
156916228|NCT00843024|566450429|FG001|Single-blind Placebo Run-In Phase|Other|1|||
156916229|NCT00843024|566450430|FG002|Single-blind Placebo Run-In Phase|Other|0|||
156916230|NCT00843024|566450431|FG003|Single-blind Placebo Run-In Phase|Other|0|||
156916231|NCT00843024|566450432|FG004|Single-blind Placebo Run-In Phase|Other|0|||
156916232|NCT00843024|566450433|FG005|Single-blind Placebo Run-In Phase|Other|0|||
156916233|NCT00843024|566450428|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
156916234|NCT00843024|566450429|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
156916235|NCT00843024|566450430|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
156916236|NCT00843024|566450431|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
156916237|NCT00843024|566450432|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
156916238|NCT00843024|566450433|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
156916239|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156916240|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
156916241|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
157028088|NCT04079218|566859127|FG000|Overall Study|Lost to Follow-up|0|||
157226219|NCT03740165|567573474|FG000|Overall Study|Lost to Follow-up|0|||
156916242|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
156916243|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
156916244|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
156916245|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156916246|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156916247|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156916248|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
156916249|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156916250|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
156916251|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156916252|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
156916253|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
156916254|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
156916255|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
156916256|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
156916257|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Physician Decision|0|||
156916258|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Physician Decision|0|||
156916259|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Physician Decision|0|||
156916260|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Physician Decision|3|||
156916261|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Physician Decision|1|||
156916262|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Physician Decision|1|||
156916263|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156916264|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156916265|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Adverse Event|0|||
156916266|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Adverse Event|0|||
156916267|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Adverse Event|1|||
156916268|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Adverse Event|1|||
156916269|NCT00843024|566450428|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156916270|NCT00843024|566450429|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
156916271|NCT00843024|566450430|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
156916272|NCT00843024|566450431|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
156916273|NCT00843024|566450432|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
156916274|NCT00843024|566450433|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
156916275|NCT05201703|566450434|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
156916276|NCT05201703|566450435|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
156916277|NCT05201703|566450434|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
156916278|NCT05201703|566450435|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
156916279|NCT00211510|566450438|FG000|Overall Study|Physician Decision|3|||
156916280|NCT00211510|566450439|FG001|Overall Study|Physician Decision|1|||
156916281|NCT00211510|566450438|FG000|Overall Study|Withdrawal by Subject|3|||
156916282|NCT00211510|566450439|FG001|Overall Study|Withdrawal by Subject|1|||
156916283|NCT01487200|566450440|FG000|Overall Study|Withdrawal by Subject|0|||
156916284|NCT01487200|566450441|FG001|Overall Study|Withdrawal by Subject|1|||
156916285|NCT01487200|566450442|FG002|Overall Study|Withdrawal by Subject|0|||
156916286|NCT01487200|566450443|FG003|Overall Study|Withdrawal by Subject|0|||
156916287|NCT01950741|566450448|FG000|Overall Study|Lost to Follow-up|1|||
156916288|NCT01950741|566450448|FG000|Overall Study|Death|1|||
156916289|NCT01950741|566450448|FG000|Overall Study|Withdrawal by Subject|1|||
156916290|NCT04051008|566450453|FG000|Overall Study|Withdrawal by Subject|2|||
156916291|NCT04051008|566450454|FG001|Overall Study|Withdrawal by Subject|0|||
156916292|NCT04051008|566450455|FG002|Overall Study|Withdrawal by Subject|1|||
156916293|NCT04342897|566450456|FG000|Overall Study|Death|7|||
156916294|NCT04342897|566450457|FG001|Overall Study|Death|4|||
156916295|NCT04342897|566450456|FG000|Overall Study|Lost to Follow-up|6|||
156916296|NCT04342897|566450457|FG001|Overall Study|Lost to Follow-up|6|||
156916297|NCT04342897|566450456|FG000|Overall Study|Withdrawal by Subject|1|||
156916298|NCT04342897|566450457|FG001|Overall Study|Withdrawal by Subject|2|||
156916299|NCT00621153|566450459|FG000|Overall Study|Safety Reason|8|||
156916300|NCT00621153|566450460|FG001|Overall Study|Safety Reason|7|||
156916301|NCT00621153|566450459|FG000|Overall Study|Adverse Event|3|||
156916302|NCT00621153|566450460|FG001|Overall Study|Adverse Event|2|||
156916303|NCT00621153|566450459|FG000|Overall Study|Lost to Follow-up|5|||
156916304|NCT00621153|566450460|FG001|Overall Study|Lost to Follow-up|1|||
156916305|NCT00621153|566450459|FG000|Overall Study|Withdrawal by Subject|4|||
156916306|NCT00621153|566450460|FG001|Overall Study|Withdrawal by Subject|5|||
156916307|NCT04212650|566450461|FG000|Overall Study|Withdrawal by Subject|1|||
156916308|NCT04212650|566450462|FG001|Overall Study|Withdrawal by Subject|0|||
156916309|NCT00357968|566450467|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
156916310|NCT00357968|566450468|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
156916311|NCT00357968|566450467|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
156916312|NCT00357968|566450468|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
156916313|NCT03547687|566450470|FG000|Overall Study|Withdrawal by Subject|1|||
156916314|NCT03547687|566450470|FG000|Overall Study|Death|1|||
156916315|NCT00679302|566450471|FG000|Overall Study|Lost to Follow-up|8|||
156916316|NCT00679302|566450472|FG001|Overall Study|Lost to Follow-up|4|||
156916317|NCT04656691|566450475|FG000|Overall Study|Adverse Event|1|||
156916318|NCT02846779|566450478|FG000|Overall Study|Lost Enrollment|83|||
156916319|NCT02846779|566450479|FG001|Overall Study|Lost Enrollment|82|||
156916320|NCT02846779|566450480|FG002|Overall Study|Lost Enrollment|86|||
156916321|NCT02846779|566450478|FG000|Overall Study|Less than 31 days of follow-up|56|||
156916322|NCT02846779|566450479|FG001|Overall Study|Less than 31 days of follow-up|45|||
156916323|NCT02846779|566450480|FG002|Overall Study|Less than 31 days of follow-up|52|||
156916324|NCT00887978|566450481|FG000|Overall Study|Adverse Event|18|||
156916325|NCT00887978|566450482|FG001|Overall Study|Adverse Event|5|||
156916326|NCT00887978|566450481|FG000|Overall Study|Clinical Worsening|4|||
156916327|NCT00887978|566450482|FG001|Overall Study|Clinical Worsening|4|||
156916328|NCT00887978|566450481|FG000|Overall Study|Death|2|||
156916329|NCT00887978|566450482|FG001|Overall Study|Death|3|||
156916330|NCT00887978|566450481|FG000|Overall Study|Withdrawal by Subject|1|||
156916331|NCT00887978|566450482|FG001|Overall Study|Withdrawal by Subject|2|||
156916332|NCT00887978|566450481|FG000|Overall Study|Lost to Follow-up|0|||
156916333|NCT00887978|566450482|FG001|Overall Study|Lost to Follow-up|1|||
156916334|NCT04600921|566450483|FG000|Overall Study|Withdrawal by Subject|3|||
156916335|NCT04600921|566450484|FG001|Overall Study|Withdrawal by Subject|5|||
156916336|NCT04600921|566450483|FG000|Overall Study|Death|0|||
156916337|NCT04600921|566450484|FG001|Overall Study|Death|1|||
156916338|NCT04023526|566452299|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
156916339|NCT04023526|566452300|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
156916340|NCT04023526|566452299|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
156916341|NCT04023526|566452300|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
156916342|NCT01955733|566452304|FG000|Period 1|Lost to Follow-up|1|||
156916343|NCT01955733|566452305|FG001|Period 1|Lost to Follow-up|0|||
156916344|NCT01955733|566452306|FG002|Period 1|Lost to Follow-up|0|||
156916345|NCT01955733|566452304|FG000|Period 2|Adverse Event|1|||
156916346|NCT01955733|566452305|FG001|Period 2|Adverse Event|0|||
156916347|NCT01955733|566452306|FG002|Period 2|Adverse Event|0|||
156916348|NCT01955733|566452304|FG000|Period 2|Physician Decision|0|||
156916349|NCT01955733|566452305|FG001|Period 2|Physician Decision|0|||
156916350|NCT01955733|566452306|FG002|Period 2|Physician Decision|1|||
156916351|NCT01955733|566452304|FG000|Period 2|Withdrawal by Subject|1|||
156916352|NCT01955733|566452305|FG001|Period 2|Withdrawal by Subject|3|||
156916353|NCT01955733|566452306|FG002|Period 2|Withdrawal by Subject|2|||
156916354|NCT01955733|566452304|FG000|Period 2|Study terminated by sponsor|8|||
156916355|NCT01955733|566452305|FG001|Period 2|Study terminated by sponsor|14|||
156916356|NCT01955733|566452306|FG002|Period 2|Study terminated by sponsor|16|||
156916357|NCT01955733|566452304|FG000|Period 2|Lost to Follow-up|2|||
156916358|NCT01955733|566452305|FG001|Period 2|Lost to Follow-up|0|||
156916359|NCT01955733|566452306|FG002|Period 2|Lost to Follow-up|0|||
156916360|NCT01955733|566452304|FG000|Period 2|Other not defined above|0|||
156916361|NCT01955733|566452305|FG001|Period 2|Other not defined above|2|||
156916362|NCT01955733|566452306|FG002|Period 2|Other not defined above|2|||
156916363|NCT01852110|566452314|FG000|Overall Study|Adverse Event|12|||
156916364|NCT01852110|566452315|FG001|Overall Study|Adverse Event|5|||
156916365|NCT01852110|566452316|FG002|Overall Study|Adverse Event|0|||
156916366|NCT01852110|566452317|FG003|Overall Study|Adverse Event|0|||
156916367|NCT01852110|566452318|FG004|Overall Study|Adverse Event|0|||
157028089|NCT04079218|566859128|FG001|Overall Study|Lost to Follow-up|1|||
157028090|NCT05907174|566859132|FG000|3-Month Assessment|Withdrawal by Subject|0|||
157028091|NCT05907174|566859133|FG001|3-Month Assessment|Withdrawal by Subject|0|||
157028092|NCT05907174|566859134|FG002|3-Month Assessment|Withdrawal by Subject|0|||
156916368|NCT01852110|566452319|FG005|Overall Study|Adverse Event|0|||
156916369|NCT01852110|566452314|FG000|Overall Study|Lost to Follow-up|1|||
156916370|NCT01852110|566452315|FG001|Overall Study|Lost to Follow-up|3|||
156916371|NCT01852110|566452316|FG002|Overall Study|Lost to Follow-up|0|||
156916372|NCT01852110|566452317|FG003|Overall Study|Lost to Follow-up|0|||
156916373|NCT01852110|566452318|FG004|Overall Study|Lost to Follow-up|0|||
156916374|NCT01852110|566452319|FG005|Overall Study|Lost to Follow-up|0|||
156916375|NCT01852110|566452314|FG000|Overall Study|Non-compliance with Study Drug|2|||
156916376|NCT01852110|566452315|FG001|Overall Study|Non-compliance with Study Drug|1|||
156916377|NCT01852110|566452316|FG002|Overall Study|Non-compliance with Study Drug|0|||
156916378|NCT01852110|566452317|FG003|Overall Study|Non-compliance with Study Drug|0|||
156916379|NCT01852110|566452318|FG004|Overall Study|Non-compliance with Study Drug|0|||
156916380|NCT01852110|566452319|FG005|Overall Study|Non-compliance with Study Drug|0|||
157028093|NCT05907174|566859135|FG003|3-Month Assessment|Withdrawal by Subject|1|||
156916381|NCT01852110|566452314|FG000|Overall Study|Physician Decision|1|||
156916382|NCT01852110|566452315|FG001|Overall Study|Physician Decision|0|||
156916383|NCT01852110|566452316|FG002|Overall Study|Physician Decision|0|||
156916384|NCT01852110|566452317|FG003|Overall Study|Physician Decision|0|||
156916385|NCT01852110|566452318|FG004|Overall Study|Physician Decision|0|||
156916386|NCT01852110|566452319|FG005|Overall Study|Physician Decision|0|||
156916387|NCT01852110|566452314|FG000|Overall Study|Protocol Violation|0|||
156916388|NCT01852110|566452315|FG001|Overall Study|Protocol Violation|1|||
156916389|NCT01852110|566452316|FG002|Overall Study|Protocol Violation|0|||
156916390|NCT01852110|566452317|FG003|Overall Study|Protocol Violation|0|||
156916391|NCT01852110|566452318|FG004|Overall Study|Protocol Violation|0|||
156916392|NCT01852110|566452319|FG005|Overall Study|Protocol Violation|0|||
156916393|NCT01852110|566452314|FG000|Overall Study|Study Terminated by Sponsor|30|||
156916394|NCT01852110|566452315|FG001|Overall Study|Study Terminated by Sponsor|32|||
156916395|NCT01852110|566452316|FG002|Overall Study|Study Terminated by Sponsor|0|||
156916396|NCT01852110|566452317|FG003|Overall Study|Study Terminated by Sponsor|0|||
156916397|NCT01852110|566452318|FG004|Overall Study|Study Terminated by Sponsor|0|||
156916398|NCT01852110|566452319|FG005|Overall Study|Study Terminated by Sponsor|0|||
156916399|NCT01852110|566452314|FG000|Overall Study|Withdrawal by Subject|4|||
156916400|NCT01852110|566452315|FG001|Overall Study|Withdrawal by Subject|4|||
156916401|NCT01852110|566452316|FG002|Overall Study|Withdrawal by Subject|0|||
156916402|NCT01852110|566452317|FG003|Overall Study|Withdrawal by Subject|0|||
156916403|NCT01852110|566452318|FG004|Overall Study|Withdrawal by Subject|0|||
156916404|NCT01852110|566452319|FG005|Overall Study|Withdrawal by Subject|0|||
156916405|NCT00793403|566452320|FG000|Overall Study|Other|73|||
156916406|NCT02961751|566452331|FG000|Overall Study|Lost to Follow-up|11|||
156916407|NCT02961751|566452331|FG000|Overall Study|Physician Decision|2|||
156916408|NCT02961751|566452331|FG000|Overall Study|Not Eligible at Enrollment|1|||
156916409|NCT02961751|566452331|FG000|Overall Study|Protocol Violation|1|||
156916410|NCT00842712|566452332|FG000|Safety Run-in Part|Adverse Event|0|||
156916411|NCT00842712|566452333|FG001|Safety Run-in Part|Adverse Event|1|||
156916412|NCT00842712|566452334|FG002|Safety Run-in Part|Adverse Event|0|||
156916413|NCT00842712|566452335|FG003|Safety Run-in Part|Adverse Event|0|||
156916414|NCT00842712|566452336|FG004|Safety Run-in Part|Adverse Event|0|||
156916415|NCT00842712|566452337|FG005|Safety Run-in Part|Adverse Event|0|||
156916416|NCT00842712|566452338|FG006|Safety Run-in Part|Adverse Event|0|||
156916417|NCT00842712|566452332|FG000|Safety Run-in Part|Progressive disease|3|||
156916418|NCT00842712|566452333|FG001|Safety Run-in Part|Progressive disease|1|||
156916419|NCT00842712|566452334|FG002|Safety Run-in Part|Progressive disease|0|||
156916420|NCT00842712|566452335|FG003|Safety Run-in Part|Progressive disease|1|||
156916421|NCT00842712|566452336|FG004|Safety Run-in Part|Progressive disease|0|||
156916422|NCT00842712|566452337|FG005|Safety Run-in Part|Progressive disease|0|||
156916423|NCT00842712|566452338|FG006|Safety Run-in Part|Progressive disease|0|||
156916424|NCT00842712|566452332|FG000|Randomized Part|Randomized but not treated|0|||
156916425|NCT00842712|566452333|FG001|Randomized Part|Randomized but not treated|0|||
156916426|NCT00842712|566452334|FG002|Randomized Part|Randomized but not treated|0|||
156916427|NCT00842712|566452335|FG003|Randomized Part|Randomized but not treated|0|||
156916428|NCT00842712|566452336|FG004|Randomized Part|Randomized but not treated|0|||
156916429|NCT00842712|566452337|FG005|Randomized Part|Randomized but not treated|1|||
156916430|NCT00842712|566452338|FG006|Randomized Part|Randomized but not treated|4|||
156916431|NCT00842712|566452332|FG000|Randomized Part|Ongoing at cut-off date|0|||
156916432|NCT00842712|566452333|FG001|Randomized Part|Ongoing at cut-off date|0|||
156916433|NCT00842712|566452334|FG002|Randomized Part|Ongoing at cut-off date|0|||
156916434|NCT00842712|566452335|FG003|Randomized Part|Ongoing at cut-off date|0|||
156916435|NCT00842712|566452336|FG004|Randomized Part|Ongoing at cut-off date|0|||
156916436|NCT00842712|566452337|FG005|Randomized Part|Ongoing at cut-off date|0|||
156916437|NCT00842712|566452338|FG006|Randomized Part|Ongoing at cut-off date|2|||
156916438|NCT02373202|566452340|FG000|Overall Study|Adverse Event|2|||
156916439|NCT02373202|566452341|FG001|Overall Study|Adverse Event|5|||
156916440|NCT02373202|566452342|FG002|Overall Study|Adverse Event|2|||
156916441|NCT02373202|566452343|FG003|Overall Study|Adverse Event|1|||
156916442|NCT02373202|566452340|FG000|Overall Study|Lack of Efficacy|0|||
156916443|NCT02373202|566452341|FG001|Overall Study|Lack of Efficacy|0|||
156916444|NCT02373202|566452342|FG002|Overall Study|Lack of Efficacy|1|||
156916445|NCT02373202|566452343|FG003|Overall Study|Lack of Efficacy|0|||
156916446|NCT02373202|566452340|FG000|Overall Study|Other|0|||
156916447|NCT02373202|566452341|FG001|Overall Study|Other|1|||
156916448|NCT02373202|566452342|FG002|Overall Study|Other|0|||
156916449|NCT02373202|566452343|FG003|Overall Study|Other|0|||
156916450|NCT00410046|566452344|FG000|Overall Study|Adverse Event|3|||
156916451|NCT00410046|566452344|FG000|Overall Study|Withdrawal by Subject|1|||
156916452|NCT00410046|566452344|FG000|Overall Study|Lost to Follow-up|1|||
156916453|NCT03010254|566452345|FG000|Overall Study|Adverse Event|0|||
156916454|NCT03010254|566452346|FG001|Overall Study|Adverse Event|1|||
156916455|NCT03010254|566452345|FG000|Overall Study|Lost to Follow-up|4|||
156916456|NCT03010254|566452346|FG001|Overall Study|Lost to Follow-up|0|||
156916457|NCT03010254|566452345|FG000|Overall Study|Withdrawal by Subject|1|||
156916458|NCT03010254|566452346|FG001|Overall Study|Withdrawal by Subject|1|||
156916459|NCT03010254|566452345|FG000|Overall Study|Other|2|||
156916460|NCT03010254|566452346|FG001|Overall Study|Other|3|||
156916461|NCT02141282|566452354|FG000|Overall Study|Adverse event, not related to progression|8|||
156916462|NCT02141282|566452355|FG001|Overall Study|Adverse event, not related to progression|1|||
156916463|NCT02141282|566452356|FG002|Overall Study|Adverse event, not related to progression|3|||
157226220|NCT03740165|567573475|FG001|Overall Study|Lost to Follow-up|0|||
157226221|NCT03740165|567573476|FG002|Overall Study|Lost to Follow-up|1|||
157226222|NCT03740165|567573474|FG000|Overall Study|Withdrawal by Subject|7|||
157226223|NCT03740165|567573475|FG001|Overall Study|Withdrawal by Subject|4|||
157226224|NCT03740165|567573476|FG002|Overall Study|Withdrawal by Subject|3|||
157226225|NCT03740165|567573474|FG000|Overall Study|Ongoing in Study|216|||
157226226|NCT03740165|567573475|FG001|Overall Study|Ongoing in Study|212|||
157226227|NCT03740165|567573476|FG002|Overall Study|Ongoing in Study|221|||
157226228|NCT03049618|567573477|FG000|Overall Study|Death|1|||
157226229|NCT03049618|567573478|FG001|Overall Study|Death|0|||
157226230|NCT03049618|567573477|FG000|Overall Study|Lack of Efficacy|1|||
157226231|NCT03049618|567573478|FG001|Overall Study|Lack of Efficacy|2|||
157226232|NCT00662129|567573482|FG000|Overall Study|Protocol Violation|1|||
157226233|NCT00662129|567573482|FG000|Overall Study|Cancel prior to beginning treatment|1|||
157226234|NCT00662129|567573482|FG000|Overall Study|Ineligible|1|||
157226235|NCT00329602|567573484|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
157226236|NCT00329602|567573485|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
157226237|NCT00329602|567573486|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
157226238|NCT00329602|567573484|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
157226239|NCT00329602|567573485|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
157226240|NCT00329602|567573486|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
157226241|NCT00329602|567573484|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
157226242|NCT00329602|567573485|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
157226243|NCT00329602|567573486|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
157226244|NCT00329602|567573484|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
157226245|NCT00329602|567573485|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
157226246|NCT00329602|567573486|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
157226247|NCT00329602|567573484|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
157226248|NCT00329602|567573485|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
157226249|NCT00329602|567573486|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
157226250|NCT00329602|567573484|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
157226251|NCT00329602|567573485|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
157226252|NCT00329602|567573486|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
157226253|NCT02579096|567573487|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
157226254|NCT02579096|567573488|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
157226255|NCT02579096|567573487|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
157226256|NCT02579096|567573488|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
157226257|NCT02579096|567573487|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
157226258|NCT02579096|567573488|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
157226259|NCT02579096|567573487|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
157226260|NCT02579096|567573488|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
157226261|NCT02579096|567573487|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
156916464|NCT02141282|566452357|FG003|Overall Study|Adverse event, not related to progression|1|||
156916465|NCT02141282|566452354|FG000|Overall Study|Adverse event, related to progression|1|||
156916466|NCT02141282|566452355|FG001|Overall Study|Adverse event, related to progression|0|||
156916467|NCT02141282|566452356|FG002|Overall Study|Adverse event, related to progression|2|||
156916468|NCT02141282|566452357|FG003|Overall Study|Adverse event, related to progression|0|||
156916469|NCT02141282|566452354|FG000|Overall Study|COVID-19 infection|1|||
156916470|NCT02141282|566452355|FG001|Overall Study|COVID-19 infection|0|||
156916471|NCT02141282|566452356|FG002|Overall Study|COVID-19 infection|0|||
156916472|NCT02141282|566452357|FG003|Overall Study|COVID-19 infection|0|||
156916473|NCT02141282|566452354|FG000|Overall Study|Lost to Follow-up|0|||
156916474|NCT02141282|566452355|FG001|Overall Study|Lost to Follow-up|0|||
156916475|NCT02141282|566452356|FG002|Overall Study|Lost to Follow-up|4|||
156916476|NCT02141282|566452357|FG003|Overall Study|Lost to Follow-up|2|||
156916477|NCT02141282|566452354|FG000|Overall Study|Other, not specified|14|||
156916478|NCT02141282|566452355|FG001|Overall Study|Other, not specified|11|||
156916479|NCT02141282|566452356|FG002|Overall Study|Other, not specified|23|||
156916480|NCT02141282|566452357|FG003|Overall Study|Other, not specified|9|||
156916481|NCT02141282|566452354|FG000|Overall Study|Progressive disease, Richter's|4|||
156916482|NCT02141282|566452355|FG001|Overall Study|Progressive disease, Richter's|1|||
157226262|NCT02579096|567573488|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
156916483|NCT02141282|566452356|FG002|Overall Study|Progressive disease, Richter's|1|||
156916484|NCT02141282|566452357|FG003|Overall Study|Progressive disease, Richter's|1|||
156916485|NCT02141282|566452354|FG000|Overall Study|Progressive disease per protocol|12|||
157028094|NCT05907174|566859132|FG000|3-Month Assessment|Lost to Follow-up|1|||
156916486|NCT02141282|566452355|FG001|Overall Study|Progressive disease per protocol|7|||
157028095|NCT05907174|566859133|FG001|3-Month Assessment|Lost to Follow-up|1|||
157226263|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Death|2|||
157226264|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Death|4|||
157226265|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
157226266|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
156916487|NCT02141282|566452356|FG002|Overall Study|Progressive disease per protocol|9|||
156916488|NCT02141282|566452357|FG003|Overall Study|Progressive disease per protocol|2|||
156916489|NCT02141282|566452354|FG000|Overall Study|Stem cell transplant|1|||
156916490|NCT02141282|566452355|FG001|Overall Study|Stem cell transplant|0|||
156916491|NCT02141282|566452356|FG002|Overall Study|Stem cell transplant|1|||
156916492|NCT02141282|566452357|FG003|Overall Study|Stem cell transplant|0|||
156916493|NCT02141282|566452354|FG000|Overall Study|Study terminated by Sponsor|0|||
156916494|NCT02141282|566452355|FG001|Overall Study|Study terminated by Sponsor|1|||
156916495|NCT02141282|566452356|FG002|Overall Study|Study terminated by Sponsor|0|||
156916496|NCT02141282|566452357|FG003|Overall Study|Study terminated by Sponsor|0|||
156916497|NCT02141282|566452354|FG000|Overall Study|Subject non-compliance|0|||
156916498|NCT02141282|566452355|FG001|Overall Study|Subject non-compliance|0|||
156916499|NCT02141282|566452356|FG002|Overall Study|Subject non-compliance|1|||
156916500|NCT02141282|566452357|FG003|Overall Study|Subject non-compliance|0|||
156916501|NCT02141282|566452354|FG000|Overall Study|Withdrew consent|2|||
156916502|NCT02141282|566452355|FG001|Overall Study|Withdrew consent|0|||
156916503|NCT02141282|566452356|FG002|Overall Study|Withdrew consent|4|||
157028096|NCT05907174|566859134|FG002|3-Month Assessment|Lost to Follow-up|1|||
157028097|NCT05907174|566859135|FG003|3-Month Assessment|Lost to Follow-up|1|||
157028098|NCT05907174|566859132|FG000|6-Month Assessment|Death|0|||
157028099|NCT05907174|566859133|FG001|6-Month Assessment|Death|0|||
157028100|NCT05907174|566859134|FG002|6-Month Assessment|Death|3|||
157028101|NCT05907174|566859135|FG003|6-Month Assessment|Death|0|||
157028102|NCT05907174|566859132|FG000|6-Month Assessment|Withdrawal by Subject|0|||
157028103|NCT05907174|566859133|FG001|6-Month Assessment|Withdrawal by Subject|0|||
157028104|NCT05907174|566859134|FG002|6-Month Assessment|Withdrawal by Subject|1|||
157028105|NCT05907174|566859135|FG003|6-Month Assessment|Withdrawal by Subject|1|||
156916504|NCT02141282|566452357|FG003|Overall Study|Withdrew consent|0|||
156916505|NCT03098550|566452358|FG000|Overall Study|Disease Progression|30|||
156916506|NCT03098550|566452359|FG001|Overall Study|Disease Progression|19|||
156916507|NCT03098550|566452360|FG002|Overall Study|Disease Progression|41|||
157028106|NCT05907174|566859132|FG000|6-Month Assessment|Lost to Follow-up|0|||
157028107|NCT05907174|566859133|FG001|6-Month Assessment|Lost to Follow-up|1|||
156916508|NCT03098550|566452358|FG000|Overall Study|Study Drug Toxicity|2|||
156916509|NCT03098550|566452359|FG001|Overall Study|Study Drug Toxicity|1|||
156916510|NCT03098550|566452360|FG002|Overall Study|Study Drug Toxicity|0|||
156916511|NCT03098550|566452358|FG000|Overall Study|Death|1|||
156916512|NCT03098550|566452359|FG001|Overall Study|Death|0|||
156916513|NCT03098550|566452360|FG002|Overall Study|Death|0|||
156916514|NCT03098550|566452358|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
156916515|NCT03098550|566452359|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
156916516|NCT03098550|566452360|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
156916517|NCT03098550|566452358|FG000|Overall Study|Administrative reason by sponsor|0|||
156916518|NCT03098550|566452359|FG001|Overall Study|Administrative reason by sponsor|0|||
156916519|NCT03098550|566452360|FG002|Overall Study|Administrative reason by sponsor|1|||
156916520|NCT03098550|566452358|FG000|Overall Study|Other reasons|2|||
156916521|NCT03098550|566452359|FG001|Overall Study|Other reasons|0|||
156916522|NCT03098550|566452360|FG002|Overall Study|Other reasons|0|||
156916523|NCT00630396|566452361|FG000|Overall Study|Death|4|||
156916524|NCT00630396|566452361|FG000|Overall Study|Lost to Follow-up|3|||
156916525|NCT00856284|566452374|FG000|Overall Study|Hyperglycemic rescue|231|||
156916526|NCT00856284|566452375|FG001|Overall Study|Hyperglycemic rescue|201|||
156916527|NCT00856284|566452376|FG002|Overall Study|Hyperglycemic rescue|235|||
157028108|NCT05907174|566859134|FG002|6-Month Assessment|Lost to Follow-up|1|||
157028109|NCT05907174|566859135|FG003|6-Month Assessment|Lost to Follow-up|1|||
157028110|NCT04498390|566859136|FG000|Overall Study|Adverse Event|0|||
157028111|NCT04498390|566859137|FG001|Overall Study|Adverse Event|0|||
157028112|NCT04498390|566859138|FG002|Overall Study|Adverse Event|1|||
157028113|NCT04498390|566859139|FG003|Overall Study|Adverse Event|0|||
157028114|NCT04498390|566859140|FG004|Overall Study|Adverse Event|0|||
157028115|NCT04498390|566859136|FG000|Overall Study|Withdrawal by Subject|0|||
157028116|NCT04498390|566859137|FG001|Overall Study|Withdrawal by Subject|0|||
156916528|NCT00856284|566452374|FG000|Overall Study|Adverse Event|60|||
156916529|NCT00856284|566452375|FG001|Overall Study|Adverse Event|74|||
157028117|NCT04498390|566859138|FG002|Overall Study|Withdrawal by Subject|0|||
157028118|NCT04498390|566859139|FG003|Overall Study|Withdrawal by Subject|1|||
157028119|NCT04498390|566859140|FG004|Overall Study|Withdrawal by Subject|0|||
157028120|NCT03734679|566859146|FG000|Overall Study|Missed Visit|1|||
157028121|NCT02733159|566859151|FG000|Overall Study|Adverse Event|1|||
156916530|NCT00856284|566452376|FG002|Overall Study|Adverse Event|82|||
156916531|NCT00856284|566452374|FG000|Overall Study|Major protocol deviation|24|||
156916532|NCT00856284|566452375|FG001|Overall Study|Major protocol deviation|16|||
156916533|NCT00856284|566452376|FG002|Overall Study|Major protocol deviation|15|||
157028122|NCT02733159|566859151|FG000|Overall Study|Lack of disease progression|1|||
157028123|NCT03088878|566859161|FG000|Overall Study|Adverse Event|0|||
156916534|NCT00856284|566452374|FG000|Overall Study|Lost to Follow-up|20|||
156916535|NCT00856284|566452375|FG001|Overall Study|Lost to Follow-up|22|||
157028124|NCT03088878|566859162|FG001|Overall Study|Adverse Event|0|||
157162492|NCT02504268|567339193|FG002|Overall Study|Adverse Event|14|||
156916536|NCT00856284|566452376|FG002|Overall Study|Lost to Follow-up|28|||
156916537|NCT00856284|566452374|FG000|Overall Study|Voluntary withdrawal|48|||
156916538|NCT00856284|566452375|FG001|Overall Study|Voluntary withdrawal|52|||
156916539|NCT00856284|566452376|FG002|Overall Study|Voluntary withdrawal|62|||
156916540|NCT00856284|566452374|FG000|Overall Study|Pregnancy|1|||
156916541|NCT00856284|566452375|FG001|Overall Study|Pregnancy|2|||
156916542|NCT00856284|566452376|FG002|Overall Study|Pregnancy|0|||
156916543|NCT00856284|566452374|FG000|Overall Study|Investigator discretion|9|||
156916544|NCT00856284|566452375|FG001|Overall Study|Investigator discretion|8|||
156916545|NCT00856284|566452376|FG002|Overall Study|Investigator discretion|10|||
156916546|NCT00856284|566452374|FG000|Overall Study|Other|15|||
157162493|NCT02504268|567339194|FG003|Overall Study|Adverse Event|0|||
157162494|NCT02504268|567339195|FG004|Overall Study|Adverse Event|0|||
157162495|NCT02504268|567339196|FG005|Overall Study|Adverse Event|0|||
157162496|NCT02504268|567339197|FG006|Overall Study|Adverse Event|0|||
157162497|NCT02504268|567339198|FG007|Overall Study|Adverse Event|0|||
157162498|NCT02504268|567339199|FG008|Overall Study|Adverse Event|0|||
157162499|NCT02504268|567339191|FG000|Overall Study|Withdrawal of Consent|11|||
157162500|NCT02504268|567339192|FG001|Overall Study|Withdrawal of Consent|10|||
157162501|NCT02504268|567339193|FG002|Overall Study|Withdrawal of Consent|3|||
157162502|NCT02504268|567339194|FG003|Overall Study|Withdrawal of Consent|0|||
157162503|NCT02504268|567339195|FG004|Overall Study|Withdrawal of Consent|0|||
157162504|NCT02504268|567339196|FG005|Overall Study|Withdrawal of Consent|0|||
157162505|NCT02504268|567339197|FG006|Overall Study|Withdrawal of Consent|0|||
157162506|NCT02504268|567339198|FG007|Overall Study|Withdrawal of Consent|0|||
157162507|NCT02504268|567339199|FG008|Overall Study|Withdrawal of Consent|0|||
157162508|NCT02504268|567339191|FG000|Overall Study|Pregnancy|2|||
157162509|NCT02504268|567339192|FG001|Overall Study|Pregnancy|0|||
157162510|NCT02504268|567339193|FG002|Overall Study|Pregnancy|0|||
157162511|NCT02504268|567339194|FG003|Overall Study|Pregnancy|0|||
157162512|NCT02504268|567339195|FG004|Overall Study|Pregnancy|0|||
157162513|NCT02504268|567339196|FG005|Overall Study|Pregnancy|0|||
157162514|NCT02504268|567339197|FG006|Overall Study|Pregnancy|0|||
157162515|NCT02504268|567339198|FG007|Overall Study|Pregnancy|0|||
157162516|NCT02504268|567339199|FG008|Overall Study|Pregnancy|0|||
157162517|NCT02504268|567339191|FG000|Overall Study|Lost to Follow-up|3|||
157162518|NCT02504268|567339192|FG001|Overall Study|Lost to Follow-up|6|||
157162519|NCT02504268|567339193|FG002|Overall Study|Lost to Follow-up|4|||
157162520|NCT02504268|567339194|FG003|Overall Study|Lost to Follow-up|0|||
157162521|NCT02504268|567339195|FG004|Overall Study|Lost to Follow-up|0|||
157162522|NCT02504268|567339196|FG005|Overall Study|Lost to Follow-up|0|||
157162523|NCT02504268|567339197|FG006|Overall Study|Lost to Follow-up|0|||
157162524|NCT02504268|567339198|FG007|Overall Study|Lost to Follow-up|0|||
157162525|NCT02504268|567339199|FG008|Overall Study|Lost to Follow-up|0|||
157162526|NCT02504268|567339191|FG000|Overall Study|Death|1|||
157162527|NCT02504268|567339192|FG001|Overall Study|Death|1|||
157162528|NCT02504268|567339193|FG002|Overall Study|Death|0|||
157162529|NCT02504268|567339194|FG003|Overall Study|Death|0|||
157162530|NCT02504268|567339195|FG004|Overall Study|Death|0|||
157162531|NCT02504268|567339196|FG005|Overall Study|Death|0|||
157162532|NCT02504268|567339197|FG006|Overall Study|Death|0|||
157162533|NCT02504268|567339198|FG007|Overall Study|Death|0|||
157162534|NCT02504268|567339199|FG008|Overall Study|Death|0|||
157162535|NCT02504268|567339191|FG000|Overall Study|Subject Request to Discontinue|11|||
157162536|NCT02504268|567339192|FG001|Overall Study|Subject Request to Discontinue|3|||
157162537|NCT02504268|567339193|FG002|Overall Study|Subject Request to Discontinue|6|||
157162538|NCT02504268|567339194|FG003|Overall Study|Subject Request to Discontinue|0|||
157162539|NCT02504268|567339195|FG004|Overall Study|Subject Request to Discontinue|0|||
156916547|NCT00856284|566452375|FG001|Overall Study|Other|17|||
156916548|NCT00856284|566452376|FG002|Overall Study|Other|14|||
157162540|NCT02504268|567339196|FG005|Overall Study|Subject Request to Discontinue|0|||
157162541|NCT02504268|567339197|FG006|Overall Study|Subject Request to Discontinue|0|||
157162542|NCT02504268|567339198|FG007|Overall Study|Subject Request to Discontinue|0|||
157162543|NCT02504268|567339199|FG008|Overall Study|Subject Request to Discontinue|0|||
157162544|NCT02504268|567339191|FG000|Overall Study|No Longer Meets Study Criteria|2|||
157162545|NCT02504268|567339192|FG001|Overall Study|No Longer Meets Study Criteria|3|||
157162546|NCT02504268|567339193|FG002|Overall Study|No Longer Meets Study Criteria|0|||
157162547|NCT02504268|567339194|FG003|Overall Study|No Longer Meets Study Criteria|0|||
157162548|NCT02504268|567339195|FG004|Overall Study|No Longer Meets Study Criteria|0|||
157162549|NCT02504268|567339196|FG005|Overall Study|No Longer Meets Study Criteria|0|||
157162550|NCT02504268|567339197|FG006|Overall Study|No Longer Meets Study Criteria|0|||
157162551|NCT02504268|567339198|FG007|Overall Study|No Longer Meets Study Criteria|0|||
157162552|NCT02504268|567339199|FG008|Overall Study|No Longer Meets Study Criteria|0|||
157162553|NCT02504268|567339191|FG000|Overall Study|Lack of Efficacy|11|||
157162554|NCT02504268|567339192|FG001|Overall Study|Lack of Efficacy|35|||
157162555|NCT02504268|567339193|FG002|Overall Study|Lack of Efficacy|9|||
156916549|NCT00856284|566452374|FG000|Overall Study|Randomized in error|0|||
156916550|NCT00856284|566452375|FG001|Overall Study|Randomized in error|0|||
156916551|NCT00856284|566452376|FG002|Overall Study|Randomized in error|1|||
156916552|NCT01327885|566452377|FG000|Overall Study|Disease progression-according to RECIST|173|||
156916553|NCT01327885|566452378|FG001|Overall Study|Disease progression-according to RECIST|165|||
156916554|NCT01327885|566452377|FG000|Overall Study|Clinical progression|24|||
156916555|NCT01327885|566452378|FG001|Overall Study|Clinical progression|27|||
156916556|NCT01327885|566452377|FG000|Overall Study|Adverse Event|14|||
156916557|NCT01327885|566452378|FG001|Overall Study|Adverse Event|10|||
156916558|NCT01327885|566452377|FG000|Overall Study|Subject choice|5|||
156916559|NCT01327885|566452378|FG001|Overall Study|Subject choice|10|||
156916560|NCT01327885|566452377|FG000|Overall Study|Other|8|||
156916561|NCT01327885|566452378|FG001|Overall Study|Other|6|||
156916562|NCT01327885|566452377|FG000|Overall Study|Withdrawal of consent from study|3|||
156916563|NCT01327885|566452378|FG001|Overall Study|Withdrawal of consent from study|4|||
156916564|NCT01327885|566452377|FG000|Overall Study|Not treated|1|||
156916565|NCT01327885|566452378|FG001|Overall Study|Not treated|1|||
156916566|NCT01327885|566452377|FG000|Overall Study|Administrative decision|0|||
156916567|NCT01327885|566452378|FG001|Overall Study|Administrative decision|1|||
156916568|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916569|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916570|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916571|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916572|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916573|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
156916574|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
156916575|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916576|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916577|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916578|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916579|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916580|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
156916581|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
156916582|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916583|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916584|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916585|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916586|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916587|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
156916588|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
157028125|NCT03088878|566859163|FG002|Overall Study|Adverse Event|0|||
157028126|NCT03088878|566859164|FG003|Overall Study|Adverse Event|0|||
157028127|NCT03088878|566859165|FG004|Overall Study|Adverse Event|4|||
157028128|NCT03088878|566859166|FG005|Overall Study|Adverse Event|2|||
157028129|NCT03088878|566859167|FG006|Overall Study|Adverse Event|1|||
157028130|NCT03088878|566859168|FG007|Overall Study|Adverse Event|0|||
157028131|NCT03088878|566859169|FG008|Overall Study|Adverse Event|0|||
157028132|NCT03088878|566859170|FG009|Overall Study|Adverse Event|0|||
157028133|NCT03088878|566859171|FG010|Overall Study|Adverse Event|0|||
157028134|NCT03088878|566859172|FG011|Overall Study|Adverse Event|0|||
157028135|NCT03088878|566859173|FG012|Overall Study|Adverse Event|5|||
157028136|NCT03088878|566859174|FG013|Overall Study|Adverse Event|3|||
157028137|NCT03088878|566859161|FG000|Overall Study|Clinical Progression|0|||
157028138|NCT03088878|566859162|FG001|Overall Study|Clinical Progression|0|||
157028139|NCT03088878|566859163|FG002|Overall Study|Clinical Progression|0|||
157028140|NCT03088878|566859164|FG003|Overall Study|Clinical Progression|0|||
157028141|NCT03088878|566859165|FG004|Overall Study|Clinical Progression|2|||
157028142|NCT03088878|566859166|FG005|Overall Study|Clinical Progression|0|||
157028143|NCT03088878|566859167|FG006|Overall Study|Clinical Progression|0|||
157028144|NCT03088878|566859168|FG007|Overall Study|Clinical Progression|0|||
157028145|NCT03088878|566859169|FG008|Overall Study|Clinical Progression|0|||
157028146|NCT03088878|566859170|FG009|Overall Study|Clinical Progression|0|||
157028147|NCT03088878|566859171|FG010|Overall Study|Clinical Progression|0|||
157028148|NCT03088878|566859172|FG011|Overall Study|Clinical Progression|0|||
157028149|NCT03088878|566859173|FG012|Overall Study|Clinical Progression|0|||
157028150|NCT03088878|566859174|FG013|Overall Study|Clinical Progression|0|||
157028151|NCT03088878|566859161|FG000|Overall Study|Death|0|||
157028152|NCT03088878|566859162|FG001|Overall Study|Death|0|||
157028153|NCT03088878|566859163|FG002|Overall Study|Death|0|||
157028154|NCT03088878|566859164|FG003|Overall Study|Death|0|||
156916589|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156916590|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156916591|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156916592|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
157028155|NCT03088878|566859165|FG004|Overall Study|Death|2|||
157028156|NCT03088878|566859166|FG005|Overall Study|Death|0|||
157028157|NCT03088878|566859167|FG006|Overall Study|Death|0|||
156916593|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156916594|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
156916595|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
156916596|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
156916597|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
156916598|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
156916599|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
156916600|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
156916601|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
156916602|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
156916603|NCT01059825|566452381|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
156916604|NCT01059825|566452382|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
156916605|NCT01059825|566452383|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
156916606|NCT01059825|566452384|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
156916607|NCT01059825|566452385|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
156916608|NCT01059825|566452386|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
156916609|NCT01059825|566452387|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
156916610|NCT01059825|566452381|FG000|Treatment Period|Lost to Follow-up|2|||
156916611|NCT01059825|566452382|FG001|Treatment Period|Lost to Follow-up|1|||
156916612|NCT01059825|566452383|FG002|Treatment Period|Lost to Follow-up|0|||
156916613|NCT01059825|566452384|FG003|Treatment Period|Lost to Follow-up|1|||
156916614|NCT01059825|566452385|FG004|Treatment Period|Lost to Follow-up|2|||
156916615|NCT01059825|566452386|FG005|Treatment Period|Lost to Follow-up|0|||
156916616|NCT01059825|566452387|FG006|Treatment Period|Lost to Follow-up|0|||
156916617|NCT01059825|566452381|FG000|Treatment Period|Withdrawal by Subject|3|||
156916618|NCT01059825|566452382|FG001|Treatment Period|Withdrawal by Subject|0|||
156916619|NCT01059825|566452383|FG002|Treatment Period|Withdrawal by Subject|1|||
156916620|NCT01059825|566452384|FG003|Treatment Period|Withdrawal by Subject|5|||
156916621|NCT01059825|566452385|FG004|Treatment Period|Withdrawal by Subject|4|||
156916622|NCT01059825|566452386|FG005|Treatment Period|Withdrawal by Subject|1|||
156916623|NCT01059825|566452387|FG006|Treatment Period|Withdrawal by Subject|0|||
156916624|NCT01059825|566452381|FG000|Treatment Period|Other reason not specified|1|||
156916625|NCT01059825|566452382|FG001|Treatment Period|Other reason not specified|2|||
156916626|NCT01059825|566452383|FG002|Treatment Period|Other reason not specified|1|||
156916627|NCT01059825|566452384|FG003|Treatment Period|Other reason not specified|2|||
156916628|NCT01059825|566452385|FG004|Treatment Period|Other reason not specified|0|||
156916629|NCT01059825|566452386|FG005|Treatment Period|Other reason not specified|0|||
156916630|NCT01059825|566452387|FG006|Treatment Period|Other reason not specified|0|||
156916631|NCT01059825|566452381|FG000|Treatment Period|Protocol Violation|0|||
156916632|NCT01059825|566452382|FG001|Treatment Period|Protocol Violation|0|||
156916633|NCT01059825|566452383|FG002|Treatment Period|Protocol Violation|1|||
156916634|NCT01059825|566452384|FG003|Treatment Period|Protocol Violation|1|||
156916635|NCT01059825|566452385|FG004|Treatment Period|Protocol Violation|1|||
156916636|NCT01059825|566452386|FG005|Treatment Period|Protocol Violation|1|||
156916637|NCT01059825|566452387|FG006|Treatment Period|Protocol Violation|0|||
156916638|NCT01059825|566452381|FG000|Treatment Period|Adverse event related to study drug|1|||
156916639|NCT01059825|566452382|FG001|Treatment Period|Adverse event related to study drug|0|||
156916640|NCT01059825|566452383|FG002|Treatment Period|Adverse event related to study drug|1|||
156916641|NCT01059825|566452384|FG003|Treatment Period|Adverse event related to study drug|1|||
156916642|NCT01059825|566452385|FG004|Treatment Period|Adverse event related to study drug|0|||
156916643|NCT01059825|566452386|FG005|Treatment Period|Adverse event related to study drug|0|||
156916644|NCT01059825|566452387|FG006|Treatment Period|Adverse event related to study drug|0|||
156916645|NCT01059825|566452381|FG000|Treatment Period|Insufficient clinical response|3|||
156916646|NCT01059825|566452382|FG001|Treatment Period|Insufficient clinical response|0|||
156916647|NCT01059825|566452383|FG002|Treatment Period|Insufficient clinical response|0|||
156916648|NCT01059825|566452384|FG003|Treatment Period|Insufficient clinical response|0|||
156916649|NCT01059825|566452385|FG004|Treatment Period|Insufficient clinical response|0|||
156916650|NCT01059825|566452386|FG005|Treatment Period|Insufficient clinical response|0|||
156916651|NCT01059825|566452387|FG006|Treatment Period|Insufficient clinical response|0|||
156916652|NCT01059825|566452381|FG000|Treatment Period|Adverse event not related to study drug|0|||
156916653|NCT01059825|566452382|FG001|Treatment Period|Adverse event not related to study drug|1|||
156916654|NCT01059825|566452383|FG002|Treatment Period|Adverse event not related to study drug|2|||
156916655|NCT01059825|566452384|FG003|Treatment Period|Adverse event not related to study drug|1|||
157028158|NCT03088878|566859168|FG007|Overall Study|Death|0|||
156916656|NCT01059825|566452385|FG004|Treatment Period|Adverse event not related to study drug|1|||
156916657|NCT01059825|566452386|FG005|Treatment Period|Adverse event not related to study drug|1|||
156916658|NCT01059825|566452387|FG006|Treatment Period|Adverse event not related to study drug|0|||
156916659|NCT03138889|566452388|FG000|Overall Study|Withdrawal by Subject|5|||
156916660|NCT03138889|566452389|FG001|Overall Study|Withdrawal by Subject|5|||
156916661|NCT03138889|566452390|FG002|Overall Study|Withdrawal by Subject|0|||
157028159|NCT03088878|566859169|FG008|Overall Study|Death|0|||
157226267|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
157226268|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
157226269|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
157226270|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
157226271|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
157226272|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
157226273|NCT02579096|567573487|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
157226274|NCT02579096|567573488|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
157226275|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Death|3|||
157226276|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Death|2|||
157226277|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
157226278|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
157226279|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
157226280|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
157226281|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
157226282|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
157226283|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
157226284|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
157226285|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
157226286|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
157226287|NCT02579096|567573487|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
157226288|NCT02579096|567573488|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
157226289|NCT02275364|567573489|FG000|Period 1|Withdrawal by Subject|1|||
157226290|NCT02275364|567573490|FG001|Period 1|Withdrawal by Subject|0|||
157226291|NCT02275364|567573489|FG000|Period 1|Other reason|1|||
157226292|NCT02275364|567573490|FG001|Period 1|Other reason|0|||
157226293|NCT00510510|567573491|FG000|Overall Study|Adverse Event|4|||
157226294|NCT00510510|567573492|FG001|Overall Study|Adverse Event|3|||
157226295|NCT00510510|567573493|FG002|Overall Study|Adverse Event|6|||
157226296|NCT00510510|567573491|FG000|Overall Study|Lack of Efficacy|0|||
157226297|NCT00510510|567573492|FG001|Overall Study|Lack of Efficacy|1|||
157226298|NCT00510510|567573493|FG002|Overall Study|Lack of Efficacy|1|||
157226299|NCT00510510|567573491|FG000|Overall Study|Subjects no longer requires study drug|0|||
156916662|NCT03138889|566452391|FG003|Overall Study|Withdrawal by Subject|2|||
156916663|NCT03138889|566452392|FG004|Overall Study|Withdrawal by Subject|1|||
156916664|NCT03138889|566452393|FG005|Overall Study|Withdrawal by Subject|3|||
156916665|NCT03138889|566452394|FG006|Overall Study|Withdrawal by Subject|0|||
156916666|NCT03138889|566452395|FG007|Overall Study|Withdrawal by Subject|1|||
156916667|NCT00411645|566452396|FG000|Overall Study|Consent Withdrawn|13|||
156916668|NCT00411645|566452397|FG001|Overall Study|Consent Withdrawn|22|||
156916669|NCT00411645|566452396|FG000|Overall Study|Death|56|||
156916670|NCT00411645|566452397|FG001|Overall Study|Death|135|||
156916671|NCT00411645|566452396|FG000|Overall Study|Investigator/Sponsor Decision|10|||
156916672|NCT00411645|566452397|FG001|Overall Study|Investigator/Sponsor Decision|7|||
156916673|NCT00411645|566452396|FG000|Overall Study|Lost to Follow-up|2|||
156916674|NCT00411645|566452397|FG001|Overall Study|Lost to Follow-up|0|||
156916675|NCT01987505|566452398|FG000|Overall Study|Other|9|||
156916676|NCT01987505|566452398|FG000|Overall Study|Withdrawal by Subject|2|||
156916677|NCT01987505|566452398|FG000|Overall Study|Other Reason|2|||
156916678|NCT01987505|566452398|FG000|Overall Study|Lost to Follow-up|15|||
156916679|NCT01987505|566452398|FG000|Overall Study|Investigator Decision|2|||
156916680|NCT01987505|566452398|FG000|Overall Study|Death|4|||
156916681|NCT02509156|566452399|FG000|Randomized Phase|Death|1|||
156916682|NCT02509156|566452400|FG001|Randomized Phase|Death|0|||
156916683|NCT02509156|566452399|FG000|Randomized Phase|Withdrawal by Subject|1|||
156916684|NCT02509156|566452400|FG001|Randomized Phase|Withdrawal by Subject|1|||
156916685|NCT03042533|566452401|FG000|Overall Study|MD left program|1|||
156916686|NCT03042533|566452402|FG001|Overall Study|MD left program|4|||
156916687|NCT03042533|566452403|FG002|Overall Study|MD left program|1|||
156916688|NCT00496054|566452405|FG000|Overall Study|Adverse Event|1|||
156916689|NCT00496054|566452405|FG000|Overall Study|Lost to Follow-up|7|||
156916690|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916691|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156916692|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916693|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156916694|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
156916695|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916696|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916697|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
157226300|NCT00510510|567573492|FG001|Overall Study|Subjects no longer requires study drug|0|||
157226301|NCT00510510|567573493|FG002|Overall Study|Subjects no longer requires study drug|2|||
157226302|NCT00510510|567573491|FG000|Overall Study|Withdrawal by Subject|1|||
157226303|NCT00510510|567573492|FG001|Overall Study|Withdrawal by Subject|2|||
157226304|NCT00510510|567573493|FG002|Overall Study|Withdrawal by Subject|3|||
157226305|NCT00510510|567573491|FG000|Overall Study|Lost to Follow-up|0|||
156916698|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916699|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916700|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916701|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916702|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916703|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916704|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
156916705|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
156916706|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
156916707|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
156916708|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916709|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916710|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916711|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916712|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916713|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916714|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916715|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916716|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916717|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916718|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916719|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
156916720|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916721|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916722|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916723|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
156916724|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916725|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916726|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916727|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916728|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916729|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916730|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916731|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916732|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916733|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916734|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
156916735|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916736|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
156916737|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916738|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916739|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916740|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916741|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916742|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916743|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916744|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916745|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916746|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916747|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916748|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916749|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
156916750|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916751|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916752|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916753|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916754|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
156916755|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916756|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916757|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916758|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
157162556|NCT02504268|567339194|FG003|Overall Study|Lack of Efficacy|0|||
157162557|NCT02504268|567339195|FG004|Overall Study|Lack of Efficacy|0|||
157162558|NCT02504268|567339196|FG005|Overall Study|Lack of Efficacy|0|||
157162559|NCT02504268|567339197|FG006|Overall Study|Lack of Efficacy|0|||
156916759|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
157162560|NCT02504268|567339198|FG007|Overall Study|Lack of Efficacy|0|||
156916760|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916761|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
157028160|NCT03088878|566859170|FG009|Overall Study|Death|0|||
157162561|NCT02504268|567339199|FG008|Overall Study|Lack of Efficacy|0|||
156916762|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916763|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916764|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
156916765|NCT01737697|566452406|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916766|NCT01737697|566452407|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156916767|NCT01737697|566452408|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156916768|NCT01737697|566452409|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
156916769|NCT01737697|566452410|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
156916770|NCT01737697|566452411|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916771|NCT01737697|566452412|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916772|NCT01737697|566452413|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916773|NCT01737697|566452414|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916774|NCT01737697|566452415|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916775|NCT01737697|566452416|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916776|NCT01737697|566452417|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916777|NCT01737697|566452418|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916778|NCT01737697|566452419|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916779|NCT01737697|566452420|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
156916780|NCT01737697|566452406|FG000|Subacute Phase|Adverse Event|0|||
156916781|NCT01737697|566452407|FG001|Subacute Phase|Adverse Event|0|||
156916782|NCT01737697|566452408|FG002|Subacute Phase|Adverse Event|0|||
156916783|NCT01737697|566452409|FG003|Subacute Phase|Adverse Event|0|||
156916784|NCT01737697|566452410|FG004|Subacute Phase|Adverse Event|0|||
156916785|NCT01737697|566452411|FG005|Subacute Phase|Adverse Event|1|||
156916786|NCT01737697|566452412|FG006|Subacute Phase|Adverse Event|1|||
156916787|NCT01737697|566452413|FG007|Subacute Phase|Adverse Event|1|||
156916788|NCT01737697|566452414|FG008|Subacute Phase|Adverse Event|1|||
156916789|NCT01737697|566452415|FG009|Subacute Phase|Adverse Event|1|||
156916790|NCT01737697|566452416|FG010|Subacute Phase|Adverse Event|4|||
156916791|NCT01737697|566452417|FG011|Subacute Phase|Adverse Event|1|||
156916792|NCT01737697|566452418|FG012|Subacute Phase|Adverse Event|1|||
156916793|NCT01737697|566452419|FG013|Subacute Phase|Adverse Event|0|||
156916794|NCT01737697|566452420|FG014|Subacute Phase|Adverse Event|0|||
156916795|NCT01737697|566452406|FG000|Subacute Phase|Withdrawal by Subject|0|||
156916796|NCT01737697|566452407|FG001|Subacute Phase|Withdrawal by Subject|0|||
156916797|NCT01737697|566452408|FG002|Subacute Phase|Withdrawal by Subject|0|||
156916798|NCT01737697|566452409|FG003|Subacute Phase|Withdrawal by Subject|0|||
156916799|NCT01737697|566452410|FG004|Subacute Phase|Withdrawal by Subject|0|||
156916800|NCT01737697|566452411|FG005|Subacute Phase|Withdrawal by Subject|1|||
156916801|NCT01737697|566452412|FG006|Subacute Phase|Withdrawal by Subject|0|||
156916802|NCT01737697|566452413|FG007|Subacute Phase|Withdrawal by Subject|2|||
156916803|NCT01737697|566452414|FG008|Subacute Phase|Withdrawal by Subject|0|||
156916804|NCT01737697|566452415|FG009|Subacute Phase|Withdrawal by Subject|1|||
156916805|NCT01737697|566452416|FG010|Subacute Phase|Withdrawal by Subject|0|||
156916806|NCT01737697|566452417|FG011|Subacute Phase|Withdrawal by Subject|1|||
156916807|NCT01737697|566452418|FG012|Subacute Phase|Withdrawal by Subject|1|||
156916808|NCT01737697|566452419|FG013|Subacute Phase|Withdrawal by Subject|1|||
156916809|NCT01737697|566452420|FG014|Subacute Phase|Withdrawal by Subject|0|||
156916810|NCT01737697|566452406|FG000|Subacute Phase|Lost to Follow-up|0|||
156916811|NCT01737697|566452407|FG001|Subacute Phase|Lost to Follow-up|0|||
156916812|NCT01737697|566452408|FG002|Subacute Phase|Lost to Follow-up|0|||
156916813|NCT01737697|566452409|FG003|Subacute Phase|Lost to Follow-up|0|||
156916814|NCT01737697|566452410|FG004|Subacute Phase|Lost to Follow-up|0|||
156916815|NCT01737697|566452411|FG005|Subacute Phase|Lost to Follow-up|0|||
156916816|NCT01737697|566452412|FG006|Subacute Phase|Lost to Follow-up|0|||
156916817|NCT01737697|566452413|FG007|Subacute Phase|Lost to Follow-up|0|||
156916818|NCT01737697|566452414|FG008|Subacute Phase|Lost to Follow-up|0|||
156916819|NCT01737697|566452415|FG009|Subacute Phase|Lost to Follow-up|0|||
156916820|NCT01737697|566452416|FG010|Subacute Phase|Lost to Follow-up|0|||
156916821|NCT01737697|566452417|FG011|Subacute Phase|Lost to Follow-up|0|||
156916822|NCT01737697|566452418|FG012|Subacute Phase|Lost to Follow-up|0|||
156916823|NCT01737697|566452419|FG013|Subacute Phase|Lost to Follow-up|0|||
156916824|NCT01737697|566452420|FG014|Subacute Phase|Lost to Follow-up|1|||
156916825|NCT01737697|566452406|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
156916826|NCT01737697|566452407|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
156916827|NCT01737697|566452408|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
156916828|NCT01737697|566452409|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
156916829|NCT01737697|566452410|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
156916830|NCT01737697|566452411|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
156916831|NCT01737697|566452412|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
156916832|NCT01737697|566452413|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
156916833|NCT01737697|566452414|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
156916834|NCT01737697|566452415|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
156916835|NCT01737697|566452416|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
156916836|NCT01737697|566452417|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
156916837|NCT01737697|566452418|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
156916838|NCT01737697|566452419|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
156916839|NCT01737697|566452420|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
156916840|NCT01737697|566452406|FG000|Subacute Phase|Protocol Violation|0|||
156916841|NCT01737697|566452407|FG001|Subacute Phase|Protocol Violation|0|||
156916842|NCT01737697|566452408|FG002|Subacute Phase|Protocol Violation|0|||
156916843|NCT01737697|566452409|FG003|Subacute Phase|Protocol Violation|0|||
156916844|NCT01737697|566452410|FG004|Subacute Phase|Protocol Violation|0|||
156916845|NCT01737697|566452411|FG005|Subacute Phase|Protocol Violation|1|||
156916846|NCT01737697|566452412|FG006|Subacute Phase|Protocol Violation|0|||
156916847|NCT01737697|566452413|FG007|Subacute Phase|Protocol Violation|0|||
156916848|NCT01737697|566452414|FG008|Subacute Phase|Protocol Violation|0|||
156916849|NCT01737697|566452415|FG009|Subacute Phase|Protocol Violation|0|||
156916850|NCT01737697|566452416|FG010|Subacute Phase|Protocol Violation|1|||
156916851|NCT01737697|566452417|FG011|Subacute Phase|Protocol Violation|0|||
156916852|NCT01737697|566452418|FG012|Subacute Phase|Protocol Violation|0|||
156916853|NCT01737697|566452419|FG013|Subacute Phase|Protocol Violation|0|||
156916854|NCT01737697|566452420|FG014|Subacute Phase|Protocol Violation|0|||
156916855|NCT01737697|566452406|FG000|Subacute Phase|Physician Decision|0|||
156916856|NCT01737697|566452407|FG001|Subacute Phase|Physician Decision|0|||
156916857|NCT01737697|566452408|FG002|Subacute Phase|Physician Decision|0|||
156916858|NCT01737697|566452409|FG003|Subacute Phase|Physician Decision|0|||
156916859|NCT01737697|566452410|FG004|Subacute Phase|Physician Decision|0|||
156916860|NCT01737697|566452411|FG005|Subacute Phase|Physician Decision|0|||
156916861|NCT01737697|566452412|FG006|Subacute Phase|Physician Decision|0|||
156916862|NCT01737697|566452413|FG007|Subacute Phase|Physician Decision|0|||
156916863|NCT01737697|566452414|FG008|Subacute Phase|Physician Decision|1|||
156916864|NCT01737697|566452415|FG009|Subacute Phase|Physician Decision|0|||
156916865|NCT01737697|566452416|FG010|Subacute Phase|Physician Decision|0|||
156916866|NCT01737697|566452417|FG011|Subacute Phase|Physician Decision|0|||
156916867|NCT01737697|566452418|FG012|Subacute Phase|Physician Decision|0|||
156916868|NCT01737697|566452419|FG013|Subacute Phase|Physician Decision|0|||
156916869|NCT01737697|566452420|FG014|Subacute Phase|Physician Decision|0|||
156916870|NCT01737697|566452406|FG000|Subacute Phase|Death|0|||
156916871|NCT01737697|566452407|FG001|Subacute Phase|Death|0|||
156916872|NCT01737697|566452408|FG002|Subacute Phase|Death|0|||
156916873|NCT01737697|566452409|FG003|Subacute Phase|Death|0|||
156916874|NCT01737697|566452410|FG004|Subacute Phase|Death|0|||
156916875|NCT01737697|566452411|FG005|Subacute Phase|Death|0|||
156916876|NCT01737697|566452412|FG006|Subacute Phase|Death|0|||
156916877|NCT01737697|566452413|FG007|Subacute Phase|Death|0|||
156916878|NCT01737697|566452414|FG008|Subacute Phase|Death|0|||
156916879|NCT01737697|566452415|FG009|Subacute Phase|Death|0|||
156916880|NCT01737697|566452416|FG010|Subacute Phase|Death|1|||
156916881|NCT01737697|566452417|FG011|Subacute Phase|Death|0|||
156916882|NCT01737697|566452418|FG012|Subacute Phase|Death|0|||
156916883|NCT01737697|566452419|FG013|Subacute Phase|Death|0|||
156916884|NCT01737697|566452420|FG014|Subacute Phase|Death|0|||
156916885|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
156916886|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
156916887|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
156916888|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916889|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916890|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916891|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916892|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916893|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916894|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916895|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
156916896|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
156916897|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916898|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
156916899|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916900|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916901|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916902|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916903|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916904|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916905|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916906|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
156916907|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
156916908|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
156916909|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
156916910|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916911|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
157028161|NCT03088878|566859171|FG010|Overall Study|Death|0|||
156916912|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916913|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916914|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916915|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916916|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916917|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
156916918|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
156916919|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
156916920|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916921|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916922|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916923|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916924|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916925|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916926|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916927|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916928|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
156916929|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
156916930|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
156916931|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
156916932|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916933|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916934|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916935|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916936|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916937|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916938|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916939|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
156916940|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916941|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
156916942|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
156916943|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916944|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916945|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916946|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916947|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916948|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916949|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916950|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
156916951|NCT02207244|566452421|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916952|NCT02207244|566452422|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
156916953|NCT02207244|566452423|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916954|NCT02207244|566452424|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916955|NCT02207244|566452425|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916956|NCT02207244|566452426|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916957|NCT02207244|566452427|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916958|NCT02207244|566452428|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916959|NCT02207244|566452429|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916960|NCT02207244|566452430|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916961|NCT02207244|566452431|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
156916962|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916963|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916964|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916965|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916966|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
156916967|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
156916968|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916969|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916970|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916971|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916972|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
156916973|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916974|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916975|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916976|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
157028162|NCT03088878|566859172|FG011|Overall Study|Death|1|||
157226306|NCT00510510|567573492|FG001|Overall Study|Lost to Follow-up|0|||
157226307|NCT00510510|567573493|FG002|Overall Study|Lost to Follow-up|1|||
157226308|NCT00510510|567573491|FG000|Overall Study|Protocol Violation|0|||
157226309|NCT00510510|567573492|FG001|Overall Study|Protocol Violation|3|||
157226310|NCT00510510|567573493|FG002|Overall Study|Protocol Violation|4|||
157226311|NCT01200394|567573494|FG000|Overall Study|Adverse Event|0|||
157226312|NCT01200394|567573495|FG001|Overall Study|Adverse Event|14|||
157226313|NCT01200394|567573494|FG000|Overall Study|Death|1|||
157226314|NCT01200394|567573495|FG001|Overall Study|Death|0|||
157226315|NCT01200394|567573494|FG000|Overall Study|Lost to Follow-up|0|||
157226316|NCT01200394|567573495|FG001|Overall Study|Lost to Follow-up|1|||
157226317|NCT01200394|567573494|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
157226318|NCT01200394|567573495|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
157226319|NCT01200394|567573494|FG000|Overall Study|Protocol Violation|0|||
157226320|NCT01200394|567573495|FG001|Overall Study|Protocol Violation|3|||
157226321|NCT01200394|567573494|FG000|Overall Study|Withdrawal by Subject|0|||
157226322|NCT01200394|567573495|FG001|Overall Study|Withdrawal by Subject|5|||
157226323|NCT01200394|567573494|FG000|Overall Study|Other|0|||
156916977|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916978|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
156916979|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916980|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916981|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916982|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916983|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
156916984|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916985|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916986|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916987|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
156916988|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
156916989|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
156916990|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916991|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916992|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916993|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916994|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
156916995|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156916996|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156916997|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156916998|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
156916999|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
156917000|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
156917001|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156917002|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156917003|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156917004|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156917005|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
156917006|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917007|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917008|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917009|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
156917010|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917011|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
156917012|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917013|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917014|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
157028163|NCT03088878|566859173|FG012|Overall Study|Death|0|||
157226324|NCT01200394|567573495|FG001|Overall Study|Other|1|||
157226325|NCT02729896|567573498|FG000|Overall Study|Death|0|||
157226326|NCT02729896|567573499|FG001|Overall Study|Death|2|||
157226327|NCT02729896|567573500|FG002|Overall Study|Death|13|||
157226328|NCT02729896|567573498|FG000|Overall Study|Lost to Follow-up|0|||
157226329|NCT02729896|567573499|FG001|Overall Study|Lost to Follow-up|2|||
157028164|NCT03088878|566859174|FG013|Overall Study|Death|0|||
157226330|NCT02729896|567573500|FG002|Overall Study|Lost to Follow-up|3|||
157226331|NCT02729896|567573498|FG000|Overall Study|Other|0|||
157226332|NCT02729896|567573499|FG001|Overall Study|Other|2|||
157226333|NCT02729896|567573500|FG002|Overall Study|Other|0|||
157226334|NCT02729896|567573498|FG000|Overall Study|Physician Decision|1|||
157226335|NCT02729896|567573499|FG001|Overall Study|Physician Decision|2|||
157226336|NCT02729896|567573500|FG002|Overall Study|Physician Decision|3|||
157226337|NCT02729896|567573498|FG000|Overall Study|Progressive Disease|0|||
156917015|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917016|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
156917017|NCT02207244|566452421|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917018|NCT02207244|566452422|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917019|NCT02207244|566452423|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917020|NCT02207244|566452424|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
156917021|NCT02207244|566452425|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917022|NCT02207244|566452426|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917023|NCT02207244|566452427|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917024|NCT02207244|566452428|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917025|NCT02207244|566452429|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917026|NCT02207244|566452430|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917027|NCT02207244|566452431|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
156917028|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917029|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917030|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917031|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917032|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917033|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917034|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
156917035|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
156917036|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
156917037|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
156917038|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
156917039|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917040|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917041|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917042|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917043|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917044|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917045|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917046|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
156917047|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917048|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917049|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
156917050|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917051|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917052|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917053|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917054|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917055|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917056|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
156917057|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
156917058|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
156917059|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
156917060|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
156917061|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917062|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917063|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917064|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917065|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917066|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917067|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
156917068|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
156917069|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917070|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
156917071|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
156917072|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917073|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917074|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917075|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917076|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917077|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917078|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156917079|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
156917080|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156917081|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
156917082|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
156917083|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917084|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917085|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917086|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917087|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917088|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917089|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917090|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
156917091|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
156917092|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917093|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
156917094|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917095|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917096|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917097|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917098|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917099|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917100|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917101|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917102|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
156917103|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917104|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
156917105|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917106|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917107|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917108|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917109|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917110|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917111|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917112|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
156917113|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917114|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917115|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
156917116|NCT02207244|566452421|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917117|NCT02207244|566452422|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917118|NCT02207244|566452423|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917119|NCT02207244|566452424|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917120|NCT02207244|566452425|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917121|NCT02207244|566452426|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917122|NCT02207244|566452427|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
156917123|NCT02207244|566452428|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917124|NCT02207244|566452429|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917125|NCT02207244|566452430|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917126|NCT02207244|566452431|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
156917127|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917128|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917129|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917130|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917131|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917132|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917133|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917134|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
156917135|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
157162562|NCT02504268|567339191|FG000|Overall Study|Poor/Non-Compliance|3|||
157162563|NCT02504268|567339192|FG001|Overall Study|Poor/Non-Compliance|2|||
157162564|NCT02504268|567339193|FG002|Overall Study|Poor/Non-Compliance|3|||
157162565|NCT02504268|567339194|FG003|Overall Study|Poor/Non-Compliance|0|||
157162566|NCT02504268|567339195|FG004|Overall Study|Poor/Non-Compliance|0|||
156917136|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
157162567|NCT02504268|567339196|FG005|Overall Study|Poor/Non-Compliance|0|||
157162568|NCT02504268|567339197|FG006|Overall Study|Poor/Non-Compliance|0|||
157162569|NCT02504268|567339198|FG007|Overall Study|Poor/Non-Compliance|0|||
156917137|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
156917138|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917139|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917140|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917141|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917142|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917143|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917144|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917145|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917146|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
156917147|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
156917148|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
156917149|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917150|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917151|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917152|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917153|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917154|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917155|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917156|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917157|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
156917158|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
156917159|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
156917160|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917161|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917162|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917163|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917164|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917165|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917166|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917167|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917168|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
156917169|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
156917170|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
156917171|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
156917172|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
156917173|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
156917174|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
156917175|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
156917176|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
156917177|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
156917178|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
156917179|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
156917180|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
156917181|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
156917182|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
156917183|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
156917184|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
156917185|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
156917186|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
156917187|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
156917188|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
156917189|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
156917190|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
156917191|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
156917192|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
156917193|NCT02207244|566452421|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917194|NCT02207244|566452422|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917195|NCT02207244|566452423|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917196|NCT02207244|566452424|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917197|NCT02207244|566452425|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917198|NCT02207244|566452426|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917199|NCT02207244|566452427|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917200|NCT02207244|566452428|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917201|NCT02207244|566452429|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917202|NCT02207244|566452430|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
156917203|NCT02207244|566452431|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
156917204|NCT02216591|566452434|FG000|Overall Study|Lost to Follow-up|0|||
156917205|NCT02216591|566452435|FG001|Overall Study|Lost to Follow-up|1|||
156917206|NCT00471328|566452439|FG000|Core Phase|Adverse Event|18|||
156917207|NCT00471328|566452440|FG001|Core Phase|Adverse Event|6|||
157028165|NCT03088878|566859161|FG000|Overall Study|Disease Progression|1|||
156917208|NCT00471328|566452439|FG000|Core Phase|Death|8|||
156917209|NCT00471328|566452440|FG001|Core Phase|Death|4|||
156917210|NCT00471328|566452439|FG000|Core Phase|Withdrawal by Subject|2|||
156917211|NCT00471328|566452440|FG001|Core Phase|Withdrawal by Subject|2|||
156917212|NCT00471328|566452439|FG000|Core Phase|Abnormal laboratory value|1|||
156917213|NCT00471328|566452440|FG001|Core Phase|Abnormal laboratory value|0|||
156917214|NCT00471328|566452439|FG000|Core Phase|Disease Progression|78|||
156917215|NCT00471328|566452440|FG001|Core Phase|Disease Progression|53|||
156917216|NCT00471328|566452439|FG000|Core Phase|Administrative Problem|0|||
156917217|NCT00471328|566452440|FG001|Core Phase|Administrative Problem|1|||
156917218|NCT00471328|566452439|FG000|Core Phase|Protocol Deviation|0|||
156917219|NCT00471328|566452440|FG001|Core Phase|Protocol Deviation|1|||
156917220|NCT00471328|566452439|FG000|Extension Phase|Adverse Event|3|||
156917221|NCT00471328|566452440|FG001|Extension Phase|Adverse Event|12|||
156917222|NCT00471328|566452439|FG000|Extension Phase|Withdrawal by Subject|0|||
156917223|NCT00471328|566452440|FG001|Extension Phase|Withdrawal by Subject|2|||
156917224|NCT00471328|566452439|FG000|Extension Phase|Death|1|||
156917225|NCT00471328|566452440|FG001|Extension Phase|Death|7|||
156917226|NCT00471328|566452439|FG000|Extension Phase|Protocol Deviation|3|||
156917227|NCT00471328|566452440|FG001|Extension Phase|Protocol Deviation|1|||
156917228|NCT00471328|566452439|FG000|Extension Phase|Treatment duration as per protocol|0|||
156917229|NCT00471328|566452440|FG001|Extension Phase|Treatment duration as per protocol|1|||
156917230|NCT00471328|566452439|FG000|Extension Phase|Disease Progression|32|||
156917231|NCT00471328|566452440|FG001|Extension Phase|Disease Progression|44|||
156917232|NCT00471328|566452439|FG000|Extension Phase|New cancer Therapy|1|||
156917233|NCT00471328|566452440|FG001|Extension Phase|New cancer Therapy|0|||
156917234|NCT00471328|566452439|FG000|Extension Phase|Administrative Problem|1|||
156917235|NCT00471328|566452440|FG001|Extension Phase|Administrative Problem|0|||
156917236|NCT01962896|566452441|FG000|Overall Study|Lack of Efficacy|4|||
156917237|NCT02837783|566452442|FG000|Overall Study|Adverse Event|1|||
156917238|NCT02837783|566452443|FG001|Overall Study|Adverse Event|0|||
156917239|NCT02837783|566452442|FG000|Overall Study|Other, Not Specified|1|||
156917240|NCT02837783|566452443|FG001|Overall Study|Other, Not Specified|2|||
156917241|NCT03200860|566452444|FG000|Overall Study|Withdrawal by Subject|1|||
156917242|NCT03200860|566452445|FG001|Overall Study|Withdrawal by Subject|0|||
156917243|NCT00844896|566452446|FG000|Overall Study|Lost to Follow-up|12|||
156917244|NCT00844896|566452447|FG001|Overall Study|Lost to Follow-up|16|||
156917245|NCT00844896|566452446|FG000|Overall Study|Parents did not have time to complete|0|||
156917246|NCT00844896|566452447|FG001|Overall Study|Parents did not have time to complete|1|||
156917247|NCT02233647|566452448|FG000|Overall Study|Adverse Event|1|||
156917248|NCT00458211|566452452|FG000|Overall Study|Lack of Efficacy|12|||
156917249|NCT00458211|566452452|FG000|Overall Study|Withdrawal by Subject|2|||
156917250|NCT00458211|566452452|FG000|Overall Study|Protocol Violation|2|||
156917251|NCT02634320|566452455|FG000|Overall Study|Adverse Event|2|||
156917252|NCT02634320|566452455|FG000|Overall Study|Lost to Follow-up|3|||
156917253|NCT02634320|566452455|FG000|Overall Study|Moved out of area|2|||
156917254|NCT02634320|566452455|FG000|Overall Study|Out of window for study visits|1|||
156917255|NCT02634320|566452455|FG000|Overall Study|Protocol Violation|1|||
156917256|NCT02634320|566452455|FG000|Overall Study|Withdrawal by Subject|5|||
156917257|NCT02634320|566452455|FG000|Overall Study|Lack of Efficacy|2|||
156917258|NCT00838578|566452456|FG000|Overall Study|Protocol Violation|2|||
156917259|NCT03919799|566452464|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
156917260|NCT03919799|566452465|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
156917261|NCT03919799|566452466|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
156917262|NCT03919799|566452467|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
156917263|NCT03919799|566452468|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
156917264|NCT03919799|566452464|FG000|DB Period (28 Weeks)|Adverse Event|1|||
156917265|NCT03919799|566452465|FG001|DB Period (28 Weeks)|Adverse Event|1|||
156917266|NCT03919799|566452466|FG002|DB Period (28 Weeks)|Adverse Event|1|||
157028166|NCT03088878|566859162|FG001|Overall Study|Disease Progression|2|||
157028167|NCT03088878|566859163|FG002|Overall Study|Disease Progression|3|||
156917267|NCT03919799|566452467|FG003|DB Period (28 Weeks)|Adverse Event|0|||
156917268|NCT03919799|566452468|FG004|DB Period (28 Weeks)|Adverse Event|0|||
156917269|NCT03919799|566452464|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156917270|NCT03919799|566452465|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
156917271|NCT03919799|566452466|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156917272|NCT03919799|566452467|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
157028168|NCT03088878|566859164|FG003|Overall Study|Disease Progression|0|||
157028169|NCT03088878|566859165|FG004|Overall Study|Disease Progression|3|||
156917273|NCT03919799|566452468|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
156917274|NCT03919799|566452464|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156917275|NCT03919799|566452465|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
157028170|NCT03088878|566859166|FG005|Overall Study|Disease Progression|0|||
156917276|NCT03919799|566452466|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
157028171|NCT03088878|566859167|FG006|Overall Study|Disease Progression|0|||
157028172|NCT03088878|566859168|FG007|Overall Study|Disease Progression|0|||
157162570|NCT02504268|567339199|FG008|Overall Study|Poor/Non-Compliance|0|||
156917277|NCT03919799|566452467|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156917278|NCT03919799|566452468|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
156917279|NCT03919799|566452464|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
156917280|NCT03919799|566452465|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
156917281|NCT03919799|566452466|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
156917282|NCT03919799|566452467|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
156917283|NCT03919799|566452468|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
156917284|NCT00646776|566452471|FG000|Overall Study|Adverse Event|1|||
156917285|NCT00646776|566452472|FG001|Overall Study|Adverse Event|9|||
156917286|NCT00646776|566452471|FG000|Overall Study|Investigator discretion|0|||
156917287|NCT00646776|566452472|FG001|Overall Study|Investigator discretion|4|||
156917288|NCT05425745|566452475|FG000|Overall Study|Withdrawal of Consent|3|||
156917289|NCT05425745|566452476|FG001|Overall Study|Withdrawal of Consent|3|||
156917290|NCT05425745|566452475|FG000|Overall Study|Death|2|||
156917291|NCT05425745|566452476|FG001|Overall Study|Death|3|||
156917292|NCT05425745|566452475|FG000|Overall Study|Lost to Follow-up|1|||
156917293|NCT05425745|566452476|FG001|Overall Study|Lost to Follow-up|2|||
156917294|NCT05425745|566452475|FG000|Overall Study|Adverse Event|0|||
156917295|NCT05425745|566452476|FG001|Overall Study|Adverse Event|1|||
156917296|NCT05425745|566452475|FG000|Overall Study|Did not return for end of study visit|0|||
156917297|NCT05425745|566452476|FG001|Overall Study|Did not return for end of study visit|1|||
156917298|NCT05425745|566452475|FG000|Overall Study|End of study visit completed by phone|1|||
156917299|NCT05425745|566452476|FG001|Overall Study|End of study visit completed by phone|0|||
156917300|NCT05425745|566452475|FG000|Overall Study|Subject decision|1|||
156917301|NCT05425745|566452476|FG001|Overall Study|Subject decision|0|||
156917302|NCT00524368|566453817|FG000|Overall Study|Adverse Event|10|||
156917303|NCT00524368|566453818|FG001|Overall Study|Adverse Event|12|||
156917304|NCT00524368|566453817|FG000|Overall Study|Lost to Follow-up|9|||
156917305|NCT00524368|566453818|FG001|Overall Study|Lost to Follow-up|13|||
156917306|NCT00524368|566453817|FG000|Overall Study|Withdrawal by Subject|4|||
156917307|NCT00524368|566453818|FG001|Overall Study|Withdrawal by Subject|5|||
156917308|NCT00524368|566453817|FG000|Overall Study|Non-compliant|8|||
156917309|NCT00524368|566453818|FG001|Overall Study|Non-compliant|9|||
156917310|NCT00524368|566453817|FG000|Overall Study|Reached a Virologic Endpoint|3|||
156917311|NCT00524368|566453818|FG001|Overall Study|Reached a Virologic Endpoint|2|||
156917312|NCT00524368|566453817|FG000|Overall Study|Sponsor's Decision|2|||
156917313|NCT00524368|566453818|FG001|Overall Study|Sponsor's Decision|0|||
156917314|NCT00524368|566453817|FG000|Overall Study|Ineligible to Continue the study|2|||
156917315|NCT00524368|566453818|FG001|Overall Study|Ineligible to Continue the study|5|||
156917316|NCT00524368|566453817|FG000|Overall Study|Other|3|||
156917317|NCT00524368|566453818|FG001|Overall Study|Other|2|||
156917318|NCT03312933|566453820|FG000|Overall Study|Protocol Violation|15|||
156917319|NCT03312933|566453820|FG000|Overall Study|Lost to Follow-up|36|||
156917320|NCT03312933|566453820|FG000|Overall Study|Withdrawal by Subject|3|||
156917321|NCT01752907|566453822|FG000|Overall Study|Withdrawal by Subject|4|||
156917322|NCT01752907|566453823|FG001|Overall Study|Withdrawal by Subject|10|||
156917323|NCT01752907|566453822|FG000|Overall Study|Lost to Follow-up|2|||
156917324|NCT01752907|566453823|FG001|Overall Study|Lost to Follow-up|1|||
156917325|NCT01752907|566453822|FG000|Overall Study|Decision by Sponsor|6|||
156917326|NCT01752907|566453823|FG001|Overall Study|Decision by Sponsor|9|||
156917327|NCT01384760|566453824|FG000|Overall Study|Lost to Follow-up|0|||
156917328|NCT01384760|566453825|FG001|Overall Study|Lost to Follow-up|6|||
156917329|NCT01384760|566453824|FG000|Overall Study|Protocol Violation|16|||
156917330|NCT01384760|566453825|FG001|Overall Study|Protocol Violation|0|||
156917331|NCT02990910|566453826|FG000|Overall Study|Lack of Efficacy|6|||
156917332|NCT02990910|566453827|FG001|Overall Study|Lack of Efficacy|10|||
156917333|NCT00381095|566453835|FG000|Overall Study|Death|3|||
156917334|NCT00381095|566453836|FG001|Overall Study|Death|4|||
156917335|NCT00381095|566453835|FG000|Overall Study|Lack of Efficacy|2|||
156917336|NCT00381095|566453836|FG001|Overall Study|Lack of Efficacy|4|||
156917337|NCT00381095|566453835|FG000|Overall Study|Other|2|||
156917338|NCT00381095|566453836|FG001|Overall Study|Other|2|||
156917339|NCT00381095|566453835|FG000|Overall Study|Protocol Violation|1|||
156917340|NCT00381095|566453836|FG001|Overall Study|Protocol Violation|1|||
156917341|NCT00381095|566453835|FG000|Overall Study|Withdrawal by Subject|3|||
156917342|NCT00381095|566453836|FG001|Overall Study|Withdrawal by Subject|3|||
156917343|NCT00381095|566453835|FG000|Overall Study|Adverse Event|2|||
156917344|NCT00381095|566453836|FG001|Overall Study|Adverse Event|7|||
156917345|NCT04271605|566453841|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
156917346|NCT02485301|566453842|FG000|Overall Study|Serious Adverse Events|2|||
157162571|NCT02504268|567339191|FG000|Overall Study|Not Disclosed|1|||
157162572|NCT02504268|567339192|FG001|Overall Study|Not Disclosed|0|||
156917347|NCT02485301|566453843|FG001|Overall Study|Serious Adverse Events|1|||
156917348|NCT02485301|566453842|FG000|Overall Study|Protocol Violation|0|||
156917349|NCT02485301|566453843|FG001|Overall Study|Protocol Violation|1|||
156917350|NCT02485301|566453842|FG000|Overall Study|Withdrawal by Subject|6|||
157162573|NCT02504268|567339193|FG002|Overall Study|Not Disclosed|2|||
156917351|NCT02485301|566453843|FG001|Overall Study|Withdrawal by Subject|7|||
156917352|NCT02485301|566453842|FG000|Overall Study|Migrated/moved from study area|10|||
156917353|NCT02485301|566453843|FG001|Overall Study|Migrated/moved from study area|19|||
156917354|NCT02485301|566453842|FG000|Overall Study|Lost to Follow-up|17|||
156917355|NCT02485301|566453843|FG001|Overall Study|Lost to Follow-up|17|||
156917356|NCT02485301|566453842|FG000|Overall Study|Other|3|||
156917357|NCT02485301|566453843|FG001|Overall Study|Other|4|||
156917358|NCT00105482|566453846|FG000|Overall Study|Adverse Event|1|||
156917359|NCT00105482|566453847|FG001|Overall Study|Adverse Event|1|||
156917360|NCT00105482|566453846|FG000|Overall Study|Lost to Follow-up|26|||
156917361|NCT00105482|566453847|FG001|Overall Study|Lost to Follow-up|17|||
156917362|NCT00105482|566453846|FG000|Overall Study|Withdrawal by Subject|0|||
156917363|NCT00105482|566453847|FG001|Overall Study|Withdrawal by Subject|1|||
156917364|NCT00105482|566453846|FG000|Overall Study|Lost Interest|29|||
156917365|NCT00105482|566453847|FG001|Overall Study|Lost Interest|32|||
156917366|NCT00105482|566453846|FG000|Overall Study|Scheduling Conflict|2|||
156917367|NCT00105482|566453847|FG001|Overall Study|Scheduling Conflict|3|||
156917368|NCT00105482|566453846|FG000|Overall Study|Withdrawn by PI|1|||
156917369|NCT00105482|566453847|FG001|Overall Study|Withdrawn by PI|1|||
156917370|NCT04016285|566453848|FG000|Overall Study|Did not progress to surgery|2|||
156917371|NCT04016285|566453849|FG001|Overall Study|Did not progress to surgery|5|||
156917372|NCT04016285|566453848|FG000|Overall Study|Failed to collect outcome data|5|||
156917373|NCT04016285|566453849|FG001|Overall Study|Failed to collect outcome data|3|||
156917374|NCT02547649|566453851|FG000|Overall Study|Lost to Follow-up|3|||
156917375|NCT02547649|566453852|FG001|Overall Study|Lost to Follow-up|1|||
156917376|NCT02547649|566453853|FG002|Overall Study|Lost to Follow-up|1|||
156917377|NCT02547649|566453851|FG000|Overall Study|Not vaccinated|0|||
156917378|NCT02547649|566453852|FG001|Overall Study|Not vaccinated|0|||
156917379|NCT02547649|566453853|FG002|Overall Study|Not vaccinated|1|||
156917380|NCT02547649|566453851|FG000|Overall Study|Withdrawal by Subject|0|||
156917381|NCT02547649|566453852|FG001|Overall Study|Withdrawal by Subject|4|||
156917382|NCT02547649|566453853|FG002|Overall Study|Withdrawal by Subject|2|||
156917383|NCT01111149|566453858|FG000|Overall Study|Protocol Violation|1|||
156917384|NCT01111149|566453859|FG001|Overall Study|Protocol Violation|1|||
156917385|NCT01111149|566453860|FG002|Overall Study|Protocol Violation|2|||
156917386|NCT01111149|566453858|FG000|Overall Study|Withdrawal by Subject|1|||
156917387|NCT01111149|566453859|FG001|Overall Study|Withdrawal by Subject|0|||
156917388|NCT01111149|566453860|FG002|Overall Study|Withdrawal by Subject|2|||
156917389|NCT01909674|566453870|FG000|Overall Study|Withdrawal by Subject|5|||
156917390|NCT01909674|566453871|FG001|Overall Study|Withdrawal by Subject|2|||
156917391|NCT02794883|566453872|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
156917392|NCT02794883|566453873|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
156917393|NCT02794883|566453874|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
156917394|NCT02794883|566453872|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
156917395|NCT02794883|566453873|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
156917396|NCT02794883|566453874|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
156917397|NCT02794883|566453872|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
156917398|NCT02794883|566453873|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
156917399|NCT02794883|566453874|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
156917400|NCT02794883|566453872|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
156917401|NCT02794883|566453873|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
156917402|NCT02794883|566453874|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
156917403|NCT02794883|566453872|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
156917404|NCT02794883|566453873|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
156917405|NCT02794883|566453874|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
156917406|NCT02794883|566453872|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
156917407|NCT02794883|566453873|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
156917408|NCT02794883|566453874|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
156917409|NCT02794883|566453872|FG000|Follow-up Period (up to 2 Years)|Death|12|||
156917410|NCT02794883|566453873|FG001|Follow-up Period (up to 2 Years)|Death|10|||
156917411|NCT02794883|566453874|FG002|Follow-up Period (up to 2 Years)|Death|10|||
157162574|NCT02504268|567339194|FG003|Overall Study|Not Disclosed|0|||
156917412|NCT03167411|566453877|FG000|Overall Study|Adverse Event|0|||
156917413|NCT03167411|566453878|FG001|Overall Study|Adverse Event|1|||
156917414|NCT01366209|566453881|FG000|Overall Study|Adverse Event|6|||
156917415|NCT01366209|566453882|FG001|Overall Study|Adverse Event|7|||
156917416|NCT01366209|566453881|FG000|Overall Study|Withdrawal by Subject|4|||
156917417|NCT01366209|566453882|FG001|Overall Study|Withdrawal by Subject|4|||
156917418|NCT01366209|566453881|FG000|Overall Study|Death|12|||
156917419|NCT01366209|566453882|FG001|Overall Study|Death|19|||
156917420|NCT01366209|566453881|FG000|Overall Study|Lung transplantation|6|||
156917421|NCT01366209|566453882|FG001|Overall Study|Lung transplantation|1|||
156917422|NCT01366209|566453881|FG000|Overall Study|Lost to Follow-up|2|||
156917423|NCT01366209|566453882|FG001|Overall Study|Lost to Follow-up|1|||
157162575|NCT02504268|567339195|FG004|Overall Study|Not Disclosed|0|||
157162576|NCT02504268|567339196|FG005|Overall Study|Not Disclosed|0|||
157162577|NCT02504268|567339197|FG006|Overall Study|Not Disclosed|0|||
157162578|NCT02504268|567339198|FG007|Overall Study|Not Disclosed|0|||
156917424|NCT01366209|566453881|FG000|Overall Study|Physician Decision|1|||
156917425|NCT01366209|566453882|FG001|Overall Study|Physician Decision|0|||
156917426|NCT01366209|566453881|FG000|Overall Study|Sponsors decision|0|||
156917427|NCT01366209|566453882|FG001|Overall Study|Sponsors decision|1|||
156917428|NCT01366209|566453881|FG000|Overall Study|Withdrew consent|4|||
156917429|NCT01366209|566453882|FG001|Overall Study|Withdrew consent|3|||
156917430|NCT02266225|566453883|FG000|Overall Study|Lost to Follow-up|2|||
156917431|NCT02266225|566453883|FG000|Overall Study|Death|1|||
156917432|NCT02266225|566453883|FG000|Overall Study|Withdrawal by Subject|13|||
156917433|NCT00420927|566453884|FG000|Period 1|Adverse Event|19|||
156917434|NCT00420927|566453885|FG001|Period 1|Adverse Event|15|||
156917435|NCT00420927|566453886|FG002|Period 1|Adverse Event|0|||
156917436|NCT00420927|566453887|FG003|Period 1|Adverse Event|0|||
156917437|NCT00420927|566453888|FG004|Period 1|Adverse Event|0|||
156917438|NCT00420927|566453889|FG005|Period 1|Adverse Event|0|||
156917439|NCT00420927|566453890|FG006|Period 1|Adverse Event|0|||
156917440|NCT00420927|566453884|FG000|Period 1|Withdrawal by Subject|7|||
156917441|NCT00420927|566453885|FG001|Period 1|Withdrawal by Subject|12|||
156917442|NCT00420927|566453886|FG002|Period 1|Withdrawal by Subject|0|||
156917443|NCT00420927|566453887|FG003|Period 1|Withdrawal by Subject|0|||
156917444|NCT00420927|566453888|FG004|Period 1|Withdrawal by Subject|0|||
156917445|NCT00420927|566453889|FG005|Period 1|Withdrawal by Subject|0|||
156917446|NCT00420927|566453890|FG006|Period 1|Withdrawal by Subject|0|||
156917447|NCT00420927|566453884|FG000|Period 1|Lost to Follow-up|8|||
156917448|NCT00420927|566453885|FG001|Period 1|Lost to Follow-up|6|||
156917449|NCT00420927|566453886|FG002|Period 1|Lost to Follow-up|0|||
156917450|NCT00420927|566453887|FG003|Period 1|Lost to Follow-up|0|||
156917451|NCT00420927|566453888|FG004|Period 1|Lost to Follow-up|0|||
156917452|NCT00420927|566453889|FG005|Period 1|Lost to Follow-up|0|||
156917453|NCT00420927|566453890|FG006|Period 1|Lost to Follow-up|0|||
156917454|NCT00420927|566453884|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
156917455|NCT00420927|566453885|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
156917456|NCT00420927|566453886|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
156917457|NCT00420927|566453887|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
156917458|NCT00420927|566453888|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
156917459|NCT00420927|566453889|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
156917460|NCT00420927|566453890|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
156917461|NCT00420927|566453884|FG000|Period 1|Death|2|||
156917462|NCT00420927|566453885|FG001|Period 1|Death|0|||
156917463|NCT00420927|566453886|FG002|Period 1|Death|0|||
156917464|NCT00420927|566453887|FG003|Period 1|Death|0|||
156917465|NCT00420927|566453888|FG004|Period 1|Death|0|||
156917466|NCT00420927|566453889|FG005|Period 1|Death|0|||
156917467|NCT00420927|566453890|FG006|Period 1|Death|0|||
156917468|NCT00420927|566453884|FG000|Period 1|Subject moved/relocated|0|||
156917469|NCT00420927|566453885|FG001|Period 1|Subject moved/relocated|2|||
156917470|NCT00420927|566453886|FG002|Period 1|Subject moved/relocated|0|||
156917471|NCT00420927|566453887|FG003|Period 1|Subject moved/relocated|0|||
156917472|NCT00420927|566453888|FG004|Period 1|Subject moved/relocated|0|||
156917473|NCT00420927|566453889|FG005|Period 1|Subject moved/relocated|0|||
156917474|NCT00420927|566453890|FG006|Period 1|Subject moved/relocated|0|||
156917475|NCT00420927|566453884|FG000|Period 1|Noncompliant with study drug|1|||
156917476|NCT00420927|566453885|FG001|Period 1|Noncompliant with study drug|1|||
156917477|NCT00420927|566453886|FG002|Period 1|Noncompliant with study drug|0|||
156917478|NCT00420927|566453887|FG003|Period 1|Noncompliant with study drug|0|||
156917479|NCT00420927|566453888|FG004|Period 1|Noncompliant with study drug|0|||
156917480|NCT00420927|566453889|FG005|Period 1|Noncompliant with study drug|0|||
156917481|NCT00420927|566453890|FG006|Period 1|Noncompliant with study drug|0|||
156917482|NCT00420927|566453884|FG000|Period 1|Randomization error|1|||
156917483|NCT00420927|566453885|FG001|Period 1|Randomization error|0|||
156917484|NCT00420927|566453886|FG002|Period 1|Randomization error|0|||
156917485|NCT00420927|566453887|FG003|Period 1|Randomization error|0|||
156917486|NCT00420927|566453888|FG004|Period 1|Randomization error|0|||
156917487|NCT00420927|566453889|FG005|Period 1|Randomization error|0|||
156917488|NCT00420927|566453890|FG006|Period 1|Randomization error|0|||
156917489|NCT00420927|566453884|FG000|Period 1|Suspected tuberculosis/positive test|1|||
156917490|NCT00420927|566453885|FG001|Period 1|Suspected tuberculosis/positive test|1|||
156917491|NCT00420927|566453886|FG002|Period 1|Suspected tuberculosis/positive test|0|||
156917492|NCT00420927|566453887|FG003|Period 1|Suspected tuberculosis/positive test|0|||
156917493|NCT00420927|566453888|FG004|Period 1|Suspected tuberculosis/positive test|0|||
156917494|NCT00420927|566453889|FG005|Period 1|Suspected tuberculosis/positive test|0|||
156917495|NCT00420927|566453890|FG006|Period 1|Suspected tuberculosis/positive test|0|||
156917496|NCT00420927|566453884|FG000|Period 1|Study site closure|0|||
156917497|NCT00420927|566453885|FG001|Period 1|Study site closure|1|||
156917498|NCT00420927|566453886|FG002|Period 1|Study site closure|0|||
156917499|NCT00420927|566453887|FG003|Period 1|Study site closure|0|||
156917500|NCT00420927|566453888|FG004|Period 1|Study site closure|0|||
156917501|NCT00420927|566453889|FG005|Period 1|Study site closure|0|||
156917502|NCT00420927|566453890|FG006|Period 1|Study site closure|0|||
156917503|NCT00420927|566453884|FG000|Period 1|Subject received new diagnosis|0|||
156917504|NCT00420927|566453885|FG001|Period 1|Subject received new diagnosis|2|||
156917505|NCT00420927|566453886|FG002|Period 1|Subject received new diagnosis|0|||
156917506|NCT00420927|566453887|FG003|Period 1|Subject received new diagnosis|0|||
156917507|NCT00420927|566453888|FG004|Period 1|Subject received new diagnosis|0|||
156917508|NCT00420927|566453889|FG005|Period 1|Subject received new diagnosis|0|||
156917509|NCT00420927|566453890|FG006|Period 1|Subject received new diagnosis|0|||
156917510|NCT00420927|566453884|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
156917511|NCT00420927|566453885|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
156917512|NCT00420927|566453886|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
156917513|NCT00420927|566453887|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
156917514|NCT00420927|566453888|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
156917515|NCT00420927|566453889|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
156917516|NCT00420927|566453890|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
156917517|NCT00420927|566453884|FG000|Period 1|Failed to meet entry criteria|8|||
156917518|NCT00420927|566453885|FG001|Period 1|Failed to meet entry criteria|7|||
157162579|NCT02504268|567339199|FG008|Overall Study|Not Disclosed|0|||
157162580|NCT03025217|567339200|FG000|Overall Study|Pregnancy|1|||
157162581|NCT03025217|567339200|FG000|Overall Study|Lost to Follow-up|1|||
157162582|NCT03025217|567339200|FG000|Overall Study|Not eligible, poor English|2|||
157162583|NCT03654755|567339206|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
157162584|NCT03654755|567339207|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
157162585|NCT03654755|567339208|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
157162586|NCT03654755|567339206|FG000|Overall Study|Withdrawal by Subject|2|||
157162587|NCT03654755|567339207|FG001|Overall Study|Withdrawal by Subject|4|||
157162588|NCT03654755|567339208|FG002|Overall Study|Withdrawal by Subject|8|||
157162589|NCT03654755|567339206|FG000|Overall Study|Lost to Follow-up|1|||
157162590|NCT03654755|567339207|FG001|Overall Study|Lost to Follow-up|3|||
157162591|NCT03654755|567339208|FG002|Overall Study|Lost to Follow-up|7|||
157162592|NCT03654755|567339206|FG000|Overall Study|Physician Decision|0|||
157162593|NCT03654755|567339207|FG001|Overall Study|Physician Decision|1|||
157162594|NCT03654755|567339208|FG002|Overall Study|Physician Decision|0|||
157162595|NCT03654755|567339206|FG000|Overall Study|Adverse Event|0|||
157162596|NCT03654755|567339207|FG001|Overall Study|Adverse Event|0|||
157162597|NCT03654755|567339208|FG002|Overall Study|Adverse Event|4|||
157162598|NCT03654755|567339206|FG000|Overall Study|Lack of Efficacy|0|||
157162599|NCT03654755|567339207|FG001|Overall Study|Lack of Efficacy|0|||
157162600|NCT03654755|567339208|FG002|Overall Study|Lack of Efficacy|1|||
157162601|NCT00781599|567339210|FG000|Overall Study|Lost to Follow-up|7|||
157162602|NCT00781599|567339211|FG001|Overall Study|Lost to Follow-up|4|||
157162603|NCT01088438|567339212|FG000|Overall Study|Withdrawal by Subject|11|||
157162604|NCT01088438|567339213|FG001|Overall Study|Withdrawal by Subject|6|||
157162605|NCT01088438|567339212|FG000|Overall Study|Lost to Follow-up|18|||
157162606|NCT01088438|567339213|FG001|Overall Study|Lost to Follow-up|30|||
157162607|NCT01363713|567339214|FG000|Overall Study|Adverse Event|1|||
157162608|NCT01363713|567339214|FG000|Overall Study|Protocol Violation|3|||
157162609|NCT01363713|567339214|FG000|Overall Study|Withdrawal by Subject|2|||
157162610|NCT01199055|567339215|FG000|Overall Study|Death|0|||
157162611|NCT01199055|567339216|FG001|Overall Study|Death|1|||
157162612|NCT01199055|567339217|FG002|Overall Study|Death|0|||
157162613|NCT01199055|567339215|FG000|Overall Study|Physician Decision|0|||
157162614|NCT01199055|567339216|FG001|Overall Study|Physician Decision|1|||
157162615|NCT01199055|567339217|FG002|Overall Study|Physician Decision|1|||
157162616|NCT01199055|567339215|FG000|Overall Study|Progressive disease|2|||
157162617|NCT01199055|567339216|FG001|Overall Study|Progressive disease|1|||
157162618|NCT01199055|567339217|FG002|Overall Study|Progressive disease|2|||
157162619|NCT01199055|567339215|FG000|Overall Study|Withdrawal by Subject|0|||
157162620|NCT01199055|567339216|FG001|Overall Study|Withdrawal by Subject|0|||
157162621|NCT01199055|567339217|FG002|Overall Study|Withdrawal by Subject|1|||
157162622|NCT00642746|567339222|FG000|Overall Study|Patient unevaluable|1|||
157162623|NCT00642746|567339223|FG001|Overall Study|Patient unevaluable|0|||
157162624|NCT00424294|567339224|FG000|Overall Study|Adverse Event|4|||
157162625|NCT00424294|567339225|FG001|Overall Study|Adverse Event|10|||
157162626|NCT00424294|567339224|FG000|Overall Study|Lack of Efficacy|2|||
157162627|NCT00424294|567339225|FG001|Overall Study|Lack of Efficacy|1|||
157162628|NCT00424294|567339224|FG000|Overall Study|Withdrawal by Subject|1|||
157162629|NCT00424294|567339225|FG001|Overall Study|Withdrawal by Subject|2|||
157162630|NCT00424294|567339224|FG000|Overall Study|Other|0|||
157162631|NCT00424294|567339225|FG001|Overall Study|Other|2|||
157162632|NCT00424294|567339224|FG000|Overall Study|Randomized but not Treated|1|||
157162633|NCT00424294|567339225|FG001|Overall Study|Randomized but not Treated|0|||
157162634|NCT02108951|567339228|FG000|Overall Study|Lost to Follow-up|1|||
157162635|NCT02108951|567339228|FG000|Overall Study|Patient's/guardian's decision|1|||
156917519|NCT00420927|566453886|FG002|Period 1|Failed to meet entry criteria|0|||
156917520|NCT00420927|566453887|FG003|Period 1|Failed to meet entry criteria|0|||
157162636|NCT02108951|567339228|FG000|Overall Study|Study Terminated by Sponsor|14|||
157162637|NCT03337152|567339229|FG000|Overall Study|Physician Decision|1|||
156917521|NCT00420927|566453888|FG004|Period 1|Failed to meet entry criteria|0|||
156917522|NCT00420927|566453889|FG005|Period 1|Failed to meet entry criteria|0|||
156917523|NCT00420927|566453890|FG006|Period 1|Failed to meet entry criteria|0|||
156917524|NCT00420927|566453884|FG000|Period 1|Took prohibited medication|1|||
156917525|NCT00420927|566453885|FG001|Period 1|Took prohibited medication|3|||
156917526|NCT00420927|566453886|FG002|Period 1|Took prohibited medication|0|||
156917527|NCT00420927|566453887|FG003|Period 1|Took prohibited medication|0|||
156917528|NCT00420927|566453888|FG004|Period 1|Took prohibited medication|0|||
157028173|NCT03088878|566859169|FG008|Overall Study|Disease Progression|0|||
157028174|NCT03088878|566859170|FG009|Overall Study|Disease Progression|0|||
157028175|NCT03088878|566859171|FG010|Overall Study|Disease Progression|0|||
157028176|NCT03088878|566859172|FG011|Overall Study|Disease Progression|0|||
157028177|NCT03088878|566859173|FG012|Overall Study|Disease Progression|1|||
157028178|NCT03088878|566859174|FG013|Overall Study|Disease Progression|1|||
157028179|NCT03088878|566859161|FG000|Overall Study|Initiation of Alternative Treatment|0|||
157028180|NCT03088878|566859162|FG001|Overall Study|Initiation of Alternative Treatment|0|||
157028181|NCT03088878|566859163|FG002|Overall Study|Initiation of Alternative Treatment|0|||
157028182|NCT03088878|566859164|FG003|Overall Study|Initiation of Alternative Treatment|1|||
157028183|NCT03088878|566859165|FG004|Overall Study|Initiation of Alternative Treatment|0|||
157028184|NCT03088878|566859166|FG005|Overall Study|Initiation of Alternative Treatment|0|||
157028185|NCT03088878|566859167|FG006|Overall Study|Initiation of Alternative Treatment|0|||
157028186|NCT03088878|566859168|FG007|Overall Study|Initiation of Alternative Treatment|1|||
157028187|NCT03088878|566859169|FG008|Overall Study|Initiation of Alternative Treatment|1|||
157028188|NCT03088878|566859170|FG009|Overall Study|Initiation of Alternative Treatment|0|||
157028189|NCT03088878|566859171|FG010|Overall Study|Initiation of Alternative Treatment|0|||
157028190|NCT03088878|566859172|FG011|Overall Study|Initiation of Alternative Treatment|0|||
157028191|NCT03088878|566859173|FG012|Overall Study|Initiation of Alternative Treatment|0|||
157028192|NCT03088878|566859174|FG013|Overall Study|Initiation of Alternative Treatment|0|||
157028193|NCT03088878|566859161|FG000|Overall Study|Withdrawal by Subject|0|||
157028194|NCT03088878|566859162|FG001|Overall Study|Withdrawal by Subject|0|||
157028195|NCT03088878|566859163|FG002|Overall Study|Withdrawal by Subject|0|||
157028196|NCT03088878|566859164|FG003|Overall Study|Withdrawal by Subject|1|||
157028197|NCT03088878|566859165|FG004|Overall Study|Withdrawal by Subject|4|||
157028198|NCT03088878|566859166|FG005|Overall Study|Withdrawal by Subject|1|||
157028199|NCT03088878|566859167|FG006|Overall Study|Withdrawal by Subject|1|||
157028200|NCT03088878|566859168|FG007|Overall Study|Withdrawal by Subject|0|||
157028201|NCT03088878|566859169|FG008|Overall Study|Withdrawal by Subject|1|||
157028202|NCT03088878|566859170|FG009|Overall Study|Withdrawal by Subject|2|||
157028203|NCT03088878|566859171|FG010|Overall Study|Withdrawal by Subject|0|||
157028204|NCT03088878|566859172|FG011|Overall Study|Withdrawal by Subject|2|||
157028205|NCT03088878|566859173|FG012|Overall Study|Withdrawal by Subject|1|||
157028206|NCT03088878|566859174|FG013|Overall Study|Withdrawal by Subject|0|||
157028207|NCT03088878|566859161|FG000|Overall Study|Terminated by Sponsor|2|||
157028208|NCT03088878|566859162|FG001|Overall Study|Terminated by Sponsor|1|||
157028209|NCT03088878|566859163|FG002|Overall Study|Terminated by Sponsor|0|||
157028210|NCT03088878|566859164|FG003|Overall Study|Terminated by Sponsor|1|||
157028211|NCT03088878|566859165|FG004|Overall Study|Terminated by Sponsor|6|||
157028212|NCT03088878|566859166|FG005|Overall Study|Terminated by Sponsor|0|||
157028213|NCT03088878|566859167|FG006|Overall Study|Terminated by Sponsor|0|||
157028214|NCT03088878|566859168|FG007|Overall Study|Terminated by Sponsor|0|||
157028215|NCT03088878|566859169|FG008|Overall Study|Terminated by Sponsor|0|||
157028216|NCT03088878|566859170|FG009|Overall Study|Terminated by Sponsor|0|||
157028217|NCT03088878|566859171|FG010|Overall Study|Terminated by Sponsor|3|||
157028218|NCT03088878|566859172|FG011|Overall Study|Terminated by Sponsor|13|||
157028219|NCT03088878|566859173|FG012|Overall Study|Terminated by Sponsor|2|||
157028220|NCT03088878|566859174|FG013|Overall Study|Terminated by Sponsor|1|||
157028221|NCT03088878|566859161|FG000|Overall Study|Completed 2 years of Treatment|0|||
157028222|NCT03088878|566859162|FG001|Overall Study|Completed 2 years of Treatment|0|||
157028223|NCT03088878|566859163|FG002|Overall Study|Completed 2 years of Treatment|0|||
157028224|NCT03088878|566859164|FG003|Overall Study|Completed 2 years of Treatment|0|||
156917529|NCT00420927|566453889|FG005|Period 1|Took prohibited medication|0|||
156917530|NCT00420927|566453890|FG006|Period 1|Took prohibited medication|0|||
156917531|NCT00420927|566453884|FG000|Period 2|Adverse Event|0|||
156917532|NCT00420927|566453885|FG001|Period 2|Adverse Event|0|||
157028225|NCT03088878|566859165|FG004|Overall Study|Completed 2 years of Treatment|0|||
157028226|NCT03088878|566859166|FG005|Overall Study|Completed 2 years of Treatment|0|||
157028227|NCT03088878|566859167|FG006|Overall Study|Completed 2 years of Treatment|1|||
157028228|NCT03088878|566859168|FG007|Overall Study|Completed 2 years of Treatment|0|||
157028229|NCT03088878|566859169|FG008|Overall Study|Completed 2 years of Treatment|0|||
157028230|NCT03088878|566859170|FG009|Overall Study|Completed 2 years of Treatment|1|||
156917533|NCT00420927|566453886|FG002|Period 2|Adverse Event|7|||
157028231|NCT03088878|566859171|FG010|Overall Study|Completed 2 years of Treatment|0|||
157028232|NCT03088878|566859172|FG011|Overall Study|Completed 2 years of Treatment|0|||
156917534|NCT00420927|566453887|FG003|Period 2|Adverse Event|3|||
156917535|NCT00420927|566453888|FG004|Period 2|Adverse Event|17|||
157162638|NCT03337152|567339230|FG001|Overall Study|Physician Decision|0|||
157162639|NCT03337152|567339229|FG000|Overall Study|Lost to Follow-up|1|||
157162640|NCT03337152|567339230|FG001|Overall Study|Lost to Follow-up|3|||
157162641|NCT03337152|567339229|FG000|Overall Study|Adverse Event|3|||
157162642|NCT03337152|567339230|FG001|Overall Study|Adverse Event|1|||
157162643|NCT03337152|567339229|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
157162644|NCT03337152|567339230|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
157162645|NCT00718666|567339231|FG000|Booster Phase Year 5|No active participation request|0|||
156917536|NCT00420927|566453889|FG005|Period 2|Adverse Event|6|||
156917537|NCT00420927|566453890|FG006|Period 2|Adverse Event|20|||
156917538|NCT00420927|566453884|FG000|Period 2|Withdrawal by Subject|0|||
156917539|NCT00420927|566453885|FG001|Period 2|Withdrawal by Subject|0|||
156917540|NCT00420927|566453886|FG002|Period 2|Withdrawal by Subject|1|||
156917541|NCT00420927|566453887|FG003|Period 2|Withdrawal by Subject|3|||
156917542|NCT00420927|566453888|FG004|Period 2|Withdrawal by Subject|11|||
156917543|NCT00420927|566453889|FG005|Period 2|Withdrawal by Subject|2|||
156917544|NCT00420927|566453890|FG006|Period 2|Withdrawal by Subject|12|||
156917545|NCT00420927|566453884|FG000|Period 2|Lost to Follow-up|0|||
156917546|NCT00420927|566453885|FG001|Period 2|Lost to Follow-up|0|||
156917547|NCT00420927|566453886|FG002|Period 2|Lost to Follow-up|2|||
156917548|NCT00420927|566453887|FG003|Period 2|Lost to Follow-up|2|||
157162646|NCT00718666|567339232|FG001|Booster Phase Year 5|No active participation request|0|||
157162647|NCT00718666|567339233|FG002|Booster Phase Year 5|No active participation request|1|||
157162648|NCT00718666|567339231|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
157162649|NCT00718666|567339232|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
157162650|NCT00718666|567339233|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
157162651|NCT00718666|567339231|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
157162652|NCT00718666|567339232|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
157162653|NCT00718666|567339233|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
157162654|NCT00718666|567339231|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
157162655|NCT00718666|567339232|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
157162656|NCT00718666|567339233|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
157162657|NCT01098461|567339238|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
157162658|NCT01098461|567339239|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
157162659|NCT01098461|567339240|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
157162660|NCT01098461|567339241|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
157162661|NCT01098461|567339238|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
157162662|NCT01098461|567339239|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
157162663|NCT01098461|567339240|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
157162664|NCT01098461|567339241|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
157162665|NCT01098461|567339238|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
157162666|NCT01098461|567339239|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
157162667|NCT01098461|567339240|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
157162668|NCT01098461|567339241|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
157162669|NCT01098461|567339238|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
157162670|NCT01098461|567339239|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
157162671|NCT01098461|567339240|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
157162672|NCT01098461|567339241|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
157162673|NCT01098461|567339238|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
156917549|NCT00420927|566453888|FG004|Period 2|Lost to Follow-up|6|||
156917550|NCT00420927|566453889|FG005|Period 2|Lost to Follow-up|3|||
156917551|NCT00420927|566453890|FG006|Period 2|Lost to Follow-up|9|||
156917552|NCT00420927|566453884|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
156917553|NCT00420927|566453885|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
156917554|NCT00420927|566453886|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
156917555|NCT00420927|566453887|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
156917556|NCT00420927|566453888|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
156917557|NCT00420927|566453889|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
156917558|NCT00420927|566453890|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
156917559|NCT00420927|566453884|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
156917560|NCT00420927|566453885|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
156917561|NCT00420927|566453886|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
156917562|NCT00420927|566453887|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
156917563|NCT00420927|566453888|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
156917564|NCT00420927|566453889|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
156917565|NCT00420927|566453890|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
156917566|NCT00420927|566453884|FG000|Period 2|Subject unable to find transportation|0|||
156917567|NCT00420927|566453885|FG001|Period 2|Subject unable to find transportation|0|||
156917568|NCT00420927|566453886|FG002|Period 2|Subject unable to find transportation|0|||
156917569|NCT00420927|566453887|FG003|Period 2|Subject unable to find transportation|0|||
156917570|NCT00420927|566453888|FG004|Period 2|Subject unable to find transportation|0|||
157162674|NCT01098461|567339239|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
157162675|NCT01098461|567339240|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
157162676|NCT01098461|567339241|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
157162677|NCT01098461|567339238|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
157162678|NCT01098461|567339239|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
157162679|NCT01098461|567339240|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
157162680|NCT01098461|567339241|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
157162681|NCT01098461|567339238|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
157162682|NCT01098461|567339239|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
157162683|NCT01098461|567339240|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
157162684|NCT01098461|567339241|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
157162685|NCT02662985|567339242|FG000|Treatment Period 1|Adverse Event|0|||
157162686|NCT02662985|567339243|FG001|Treatment Period 1|Adverse Event|2|||
157162687|NCT02662985|567339242|FG000|Treatment Period 1|Protocol Violation|0|||
157162688|NCT02662985|567339243|FG001|Treatment Period 1|Protocol Violation|1|||
157162689|NCT02662985|567339242|FG000|Treatment Period 1|Physician Decision|1|||
157162690|NCT02662985|567339243|FG001|Treatment Period 1|Physician Decision|0|||
157162691|NCT02662985|567339242|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157162692|NCT02662985|567339243|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157162693|NCT02662985|567339242|FG000|Treatment Period 2|Lack of Efficacy|0|||
157162694|NCT02662985|567339243|FG001|Treatment Period 2|Lack of Efficacy|1|||
157162695|NCT02662985|567339242|FG000|Treatment Period 2|Lost to Follow-up|1|||
157162696|NCT02662985|567339243|FG001|Treatment Period 2|Lost to Follow-up|0|||
157162697|NCT02662985|567339242|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
157162698|NCT02662985|567339243|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
157162699|NCT02662985|567339242|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
157162700|NCT02662985|567339243|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
157162701|NCT02662985|567339242|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
157162702|NCT02662985|567339243|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
157162703|NCT02662985|567339242|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
157162704|NCT02662985|567339243|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
157162705|NCT02662985|567339242|FG000|Treatment Period 3 (Extension Period)|Death|0|||
157162706|NCT02662985|567339243|FG001|Treatment Period 3 (Extension Period)|Death|1|||
157162707|NCT05373706|567339244|FG000|Overall Study|Lost to Follow-up|2|||
157162708|NCT05373706|567339245|FG001|Overall Study|Lost to Follow-up|2|||
157162709|NCT01486784|567339246|FG000|Overall Study|Withdrawal by Subject|0|||
157162710|NCT01486784|567339247|FG001|Overall Study|Withdrawal by Subject|0|||
157162711|NCT01486784|567339248|FG002|Overall Study|Withdrawal by Subject|1|||
157162712|NCT01486784|567339249|FG003|Overall Study|Withdrawal by Subject|0|||
157162713|NCT01486784|567339250|FG004|Overall Study|Withdrawal by Subject|1|||
157162714|NCT01486784|567339251|FG005|Overall Study|Withdrawal by Subject|2|||
157162715|NCT01486784|567339246|FG000|Overall Study|Subject did not meet entry criteria|0|||
157162716|NCT01486784|567339247|FG001|Overall Study|Subject did not meet entry criteria|0|||
157162717|NCT01486784|567339248|FG002|Overall Study|Subject did not meet entry criteria|0|||
157162718|NCT01486784|567339249|FG003|Overall Study|Subject did not meet entry criteria|0|||
157162719|NCT01486784|567339250|FG004|Overall Study|Subject did not meet entry criteria|1|||
157162720|NCT01486784|567339251|FG005|Overall Study|Subject did not meet entry criteria|0|||
157162721|NCT01486784|567339246|FG000|Overall Study|Death|0|||
157162722|NCT01486784|567339247|FG001|Overall Study|Death|0|||
156917571|NCT00420927|566453889|FG005|Period 2|Subject unable to find transportation|0|||
156917572|NCT00420927|566453890|FG006|Period 2|Subject unable to find transportation|1|||
156917573|NCT00420927|566453884|FG000|Period 2|Physician Decision|0|||
156917574|NCT00420927|566453885|FG001|Period 2|Physician Decision|0|||
156917575|NCT00420927|566453886|FG002|Period 2|Physician Decision|0|||
156917576|NCT00420927|566453887|FG003|Period 2|Physician Decision|0|||
156917577|NCT00420927|566453888|FG004|Period 2|Physician Decision|1|||
156917578|NCT00420927|566453889|FG005|Period 2|Physician Decision|1|||
156917579|NCT00420927|566453890|FG006|Period 2|Physician Decision|0|||
156917580|NCT00420927|566453884|FG000|Period 2|Sponsor decision|0|||
157162723|NCT01486784|567339248|FG002|Overall Study|Death|0|||
157162724|NCT01486784|567339249|FG003|Overall Study|Death|0|||
157162725|NCT01486784|567339250|FG004|Overall Study|Death|0|||
157162726|NCT01486784|567339251|FG005|Overall Study|Death|1|||
157162727|NCT00213980|567340522|FG000|Overall Study|Withdrawal by Subject|3|||
157162728|NCT00213980|567340523|FG001|Overall Study|Withdrawal by Subject|1|||
157162729|NCT00213980|567340522|FG000|Overall Study|Adverse Event|1|||
157162730|NCT00213980|567340523|FG001|Overall Study|Adverse Event|1|||
157028233|NCT03088878|566859173|FG012|Overall Study|Completed 2 years of Treatment|8|||
157162731|NCT00213980|567340522|FG000|Overall Study|Disease progression|0|||
157162732|NCT00213980|567340523|FG001|Overall Study|Disease progression|2|||
156917581|NCT00420927|566453885|FG001|Period 2|Sponsor decision|0|||
156917582|NCT00420927|566453886|FG002|Period 2|Sponsor decision|1|||
157226338|NCT02729896|567573499|FG001|Overall Study|Progressive Disease|1|||
157226339|NCT02729896|567573500|FG002|Overall Study|Progressive Disease|0|||
157226340|NCT02729896|567573498|FG000|Overall Study|Withdrawal by Subject|1|||
157226341|NCT02729896|567573499|FG001|Overall Study|Withdrawal by Subject|0|||
157226342|NCT02729896|567573500|FG002|Overall Study|Withdrawal by Subject|3|||
157226343|NCT00996736|567573502|FG000|Overall Study|Death|1|||
157226344|NCT00996736|567573503|FG001|Overall Study|Death|1|||
157226345|NCT00996736|567573502|FG000|Overall Study|Lost to Follow-up|15|||
157226346|NCT00996736|567573503|FG001|Overall Study|Lost to Follow-up|14|||
157226347|NCT00996736|567573502|FG000|Overall Study|Visit not within 3-month window|5|||
157226348|NCT00996736|567573503|FG001|Overall Study|Visit not within 3-month window|3|||
157226349|NCT02346201|567573504|FG000|Overall Study|Adverse Event|3|||
157226350|NCT02346201|567573505|FG001|Overall Study|Adverse Event|2|||
157226351|NCT02346201|567573504|FG000|Overall Study|Lost to Follow-up|1|||
157226352|NCT02346201|567573505|FG001|Overall Study|Lost to Follow-up|0|||
157226353|NCT02346201|567573504|FG000|Overall Study|Withdrawal by Subject|6|||
157226354|NCT02346201|567573505|FG001|Overall Study|Withdrawal by Subject|3|||
157226355|NCT02346201|567573504|FG000|Overall Study|Unavailable for future follow-up|0|||
157226356|NCT02346201|567573505|FG001|Overall Study|Unavailable for future follow-up|1|||
157226357|NCT02346201|567573504|FG000|Overall Study|Physician Decision|0|||
157226358|NCT02346201|567573505|FG001|Overall Study|Physician Decision|1|||
157226359|NCT02346201|567573504|FG000|Overall Study|Missed final visit|0|||
157226360|NCT02346201|567573505|FG001|Overall Study|Missed final visit|2|||
157226361|NCT05200858|567573506|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
157226362|NCT05200858|567573507|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
157226363|NCT05200858|567573508|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
157226364|NCT05200858|567573509|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
157226365|NCT04256421|567573510|FG000|Overall Study|Death|171|||
157226366|NCT04256421|567573511|FG001|Overall Study|Death|180|||
157226367|NCT04256421|567573510|FG000|Overall Study|Lost to Follow-up|1|||
157226368|NCT04256421|567573511|FG001|Overall Study|Lost to Follow-up|1|||
157226369|NCT04256421|567573510|FG000|Overall Study|Withdrawal by Subject|9|||
157226370|NCT04256421|567573511|FG001|Overall Study|Withdrawal by Subject|10|||
157226371|NCT04256421|567573510|FG000|Overall Study|Ongoing in Study|66|||
157226372|NCT04256421|567573511|FG001|Overall Study|Ongoing in Study|52|||
157226373|NCT01052116|567575823|FG000|Overall Study|Lost to Follow-up|11|||
157226374|NCT01052116|567575824|FG001|Overall Study|Lost to Follow-up|17|||
157226375|NCT01052116|567575823|FG000|Overall Study|Withdrawal by Subject|3|||
157226376|NCT01052116|567575824|FG001|Overall Study|Withdrawal by Subject|6|||
157226377|NCT01052116|567575823|FG000|Overall Study|Spirometry not performed|0|||
157226378|NCT01052116|567575824|FG001|Overall Study|Spirometry not performed|4|||
157226379|NCT05301751|567575825|FG000|Overall Study|Withdrawal by Subject|0|||
157226380|NCT05301751|567575826|FG001|Overall Study|Withdrawal by Subject|0|||
157226381|NCT05301751|567575827|FG002|Overall Study|Withdrawal by Subject|1|||
157226382|NCT05301751|567575828|FG003|Overall Study|Withdrawal by Subject|0|||
157226383|NCT06165744|567575831|FG000|Overall Study|Non device-related adverse event|1|||
157226384|NCT01546987|567575832|FG000|Overall Study|Protocol Violation|3|||
157226385|NCT01546987|567575833|FG001|Overall Study|Protocol Violation|4|||
157226386|NCT02270736|567575834|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
157226387|NCT02270736|567575835|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
157226388|NCT02270736|567575836|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
157226389|NCT02270736|567575837|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
157226390|NCT02270736|567575838|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
156917583|NCT00420927|566453887|FG003|Period 2|Sponsor decision|0|||
156917584|NCT00420927|566453888|FG004|Period 2|Sponsor decision|0|||
156917585|NCT00420927|566453889|FG005|Period 2|Sponsor decision|0|||
157226391|NCT02270736|567575834|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
156917586|NCT00420927|566453890|FG006|Period 2|Sponsor decision|1|||
156917587|NCT00420927|566453884|FG000|Period 2|Randomization error|0|||
156917588|NCT00420927|566453885|FG001|Period 2|Randomization error|0|||
156917589|NCT00420927|566453886|FG002|Period 2|Randomization error|0|||
156917590|NCT00420927|566453887|FG003|Period 2|Randomization error|0|||
156917591|NCT00420927|566453888|FG004|Period 2|Randomization error|1|||
156917592|NCT00420927|566453889|FG005|Period 2|Randomization error|1|||
156917593|NCT00420927|566453890|FG006|Period 2|Randomization error|0|||
156917594|NCT00420927|566453884|FG000|Period 2|Noncompliant with study drug|0|||
156917595|NCT00420927|566453885|FG001|Period 2|Noncompliant with study drug|0|||
156917596|NCT00420927|566453886|FG002|Period 2|Noncompliant with study drug|0|||
156917597|NCT00420927|566453887|FG003|Period 2|Noncompliant with study drug|1|||
157226392|NCT02270736|567575835|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
157226393|NCT02270736|567575836|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
157226394|NCT02270736|567575837|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
157226395|NCT02270736|567575838|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
157226396|NCT02270736|567575834|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
157226397|NCT02270736|567575835|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
157226398|NCT02270736|567575836|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
157226399|NCT02270736|567575837|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
157226400|NCT02270736|567575838|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
157226401|NCT02270736|567575834|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
157226402|NCT02270736|567575835|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
157226403|NCT02270736|567575836|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
157226404|NCT02270736|567575837|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
157226405|NCT02270736|567575838|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
157226406|NCT02270736|567575834|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
157226407|NCT02270736|567575835|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
157226408|NCT02270736|567575836|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
157226409|NCT02270736|567575837|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
157226410|NCT02270736|567575838|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
157226411|NCT02270736|567575834|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
157226412|NCT02270736|567575835|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
157226413|NCT02270736|567575836|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
157226414|NCT02270736|567575837|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
157226415|NCT02270736|567575838|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
157226416|NCT02270736|567575834|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
157226417|NCT02270736|567575835|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
157226418|NCT02270736|567575836|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
157226419|NCT02270736|567575837|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
157226420|NCT02270736|567575838|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
157226421|NCT02270736|567575834|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156917598|NCT00420927|566453888|FG004|Period 2|Noncompliant with study drug|0|||
156917599|NCT00420927|566453889|FG005|Period 2|Noncompliant with study drug|0|||
156917600|NCT00420927|566453890|FG006|Period 2|Noncompliant with study drug|2|||
156917601|NCT00420927|566453884|FG000|Period 2|Methotrexate intolerance|0|||
156917602|NCT00420927|566453885|FG001|Period 2|Methotrexate intolerance|0|||
156917603|NCT00420927|566453886|FG002|Period 2|Methotrexate intolerance|0|||
156917604|NCT00420927|566453887|FG003|Period 2|Methotrexate intolerance|0|||
156917605|NCT00420927|566453888|FG004|Period 2|Methotrexate intolerance|0|||
156917606|NCT00420927|566453889|FG005|Period 2|Methotrexate intolerance|0|||
156917607|NCT00420927|566453890|FG006|Period 2|Methotrexate intolerance|1|||
156917608|NCT00420927|566453884|FG000|Period 2|Took prohibited medication|0|||
156917609|NCT00420927|566453885|FG001|Period 2|Took prohibited medication|0|||
156917610|NCT00420927|566453886|FG002|Period 2|Took prohibited medication|0|||
156917611|NCT00420927|566453887|FG003|Period 2|Took prohibited medication|0|||
156917612|NCT00420927|566453888|FG004|Period 2|Took prohibited medication|1|||
156917613|NCT00420927|566453889|FG005|Period 2|Took prohibited medication|0|||
156917614|NCT00420927|566453890|FG006|Period 2|Took prohibited medication|0|||
156917615|NCT00320411|566453891|FG000|Overall Study|No investigational product admin.|4|||
156917616|NCT01417234|566453894|FG000|Overall Study|Subject non-compliant|3|||
156917617|NCT02268084|566453896|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
156917618|NCT02268084|566453897|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
156917619|NCT02268084|566453896|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
156917620|NCT02268084|566453897|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
156917621|NCT05227027|566453898|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
156917622|NCT05227027|566453899|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
156917623|NCT06149247|566453901|FG000|Overall Study|Adverse Event|0|||
156917624|NCT06149247|566453902|FG001|Overall Study|Adverse Event|1|||
156917625|NCT00855920|566453905|FG000|Overall Study|Protocol Violation|0|||
156917626|NCT00855920|566453906|FG001|Overall Study|Protocol Violation|0|||
156917627|NCT00855920|566453907|FG002|Overall Study|Protocol Violation|2|||
156917628|NCT00855920|566453905|FG000|Overall Study|Adverse Event|2|||
156917629|NCT00855920|566453906|FG001|Overall Study|Adverse Event|1|||
156917630|NCT00855920|566453907|FG002|Overall Study|Adverse Event|1|||
156917631|NCT00855920|566453905|FG000|Overall Study|Lack of Efficacy|2|||
156917632|NCT00855920|566453906|FG001|Overall Study|Lack of Efficacy|2|||
156917633|NCT00855920|566453907|FG002|Overall Study|Lack of Efficacy|2|||
156917634|NCT00855920|566453905|FG000|Overall Study|Withdrawal by Subject|2|||
156917635|NCT00855920|566453906|FG001|Overall Study|Withdrawal by Subject|3|||
156917636|NCT00855920|566453907|FG002|Overall Study|Withdrawal by Subject|2|||
157226422|NCT02270736|567575835|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
157226423|NCT02270736|567575836|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156917637|NCT00855920|566453905|FG000|Overall Study|Lost to Follow-up|1|||
156917638|NCT00855920|566453906|FG001|Overall Study|Lost to Follow-up|0|||
156917639|NCT00855920|566453907|FG002|Overall Study|Lost to Follow-up|2|||
156917640|NCT00855920|566453905|FG000|Overall Study|Death|0|||
156917641|NCT00855920|566453906|FG001|Overall Study|Death|1|||
156917642|NCT00855920|566453907|FG002|Overall Study|Death|0|||
156917643|NCT00855920|566453905|FG000|Overall Study|Decision by the sponsor|0|||
156917644|NCT00855920|566453906|FG001|Overall Study|Decision by the sponsor|1|||
156917645|NCT00855920|566453907|FG002|Overall Study|Decision by the sponsor|1|||
156917646|NCT00855920|566453905|FG000|Overall Study|Other than specified above|1|||
156917647|NCT00855920|566453906|FG001|Overall Study|Other than specified above|1|||
156917648|NCT00855920|566453907|FG002|Overall Study|Other than specified above|1|||
156917649|NCT01587001|566453913|FG000|Overall Study|Lost to Follow-up|2|||
156917650|NCT01587001|566453914|FG001|Overall Study|Lost to Follow-up|0|||
156917651|NCT01587001|566453913|FG000|Overall Study|Insufficient samples to complete testing|4|||
156917652|NCT01587001|566453914|FG001|Overall Study|Insufficient samples to complete testing|1|||
156917653|NCT01666782|566453917|FG000|Overall Study|Received 2 doses of vaccine|0|||
156917654|NCT01666782|566453918|FG001|Overall Study|Received 2 doses of vaccine|1|||
156917655|NCT01666782|566453917|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
156917656|NCT01666782|566453918|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
156917657|NCT04786990|566453919|FG000|Overall Study|Withdrawal by Subject|1|||
156917658|NCT04786990|566453919|FG000|Overall Study|Adverse Event|1|||
156917659|NCT04786990|566453919|FG000|Overall Study|Lost to Follow-up|1|||
156917660|NCT04786990|566453919|FG000|Overall Study|Noncompliance|1|||
156917661|NCT04786990|566453919|FG000|Overall Study|Unable to complete site visits|1|||
156917662|NCT04786990|566453919|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
156917663|NCT02007109|566453920|FG000|Overall Study|Diary not returned or excluded|102|||
156917664|NCT02007109|566453920|FG000|Overall Study|Excluded - Age<7yo|9|||
156917665|NCT00687323|566453927|FG000|Overall Study|Death|25|||
156917666|NCT00687323|566453927|FG000|Overall Study|Withdrawal by Subject|1|||
156917667|NCT00687323|566453927|FG000|Overall Study|Excluded from efficacy evaluations|6|||
156917668|NCT00687323|566453927|FG000|Overall Study|Screen failure|148|||
156917669|NCT02132130|566453928|FG000|Overall Study|Lost to Follow-up|0|||
156917670|NCT02132130|566453929|FG001|Overall Study|Lost to Follow-up|2|||
156917671|NCT02132130|566453930|FG002|Overall Study|Lost to Follow-up|0|||
156917672|NCT02132130|566453931|FG003|Overall Study|Lost to Follow-up|0|||
156917673|NCT02132130|566453928|FG000|Overall Study|Withdrawal by Subject|0|||
156917674|NCT02132130|566453929|FG001|Overall Study|Withdrawal by Subject|0|||
156917675|NCT02132130|566453930|FG002|Overall Study|Withdrawal by Subject|0|||
156917676|NCT02132130|566453931|FG003|Overall Study|Withdrawal by Subject|1|||
156917677|NCT02760069|566453932|FG000|Overall Study|Withdrawal by Subject|0|||
156917678|NCT02760069|566453933|FG001|Overall Study|Withdrawal by Subject|1|||
156917679|NCT02760069|566453934|FG002|Overall Study|Withdrawal by Subject|1|||
156917680|NCT03031678|566453942|FG000|Overall Study|Study closed prior to completion|1|||
156917681|NCT00439244|566453943|FG000|Overall Study|Adverse Event|5|||
156917682|NCT00439244|566453944|FG001|Overall Study|Adverse Event|2|||
156917683|NCT00439244|566453945|FG002|Overall Study|Adverse Event|3|||
156917684|NCT00439244|566453943|FG000|Overall Study|Withdrawal by Subject|3|||
156917685|NCT00439244|566453944|FG001|Overall Study|Withdrawal by Subject|1|||
156917686|NCT00439244|566453945|FG002|Overall Study|Withdrawal by Subject|2|||
156917687|NCT00439244|566453943|FG000|Overall Study|Lost to Follow-up|2|||
156917688|NCT00439244|566453944|FG001|Overall Study|Lost to Follow-up|1|||
156917689|NCT00439244|566453945|FG002|Overall Study|Lost to Follow-up|2|||
156917690|NCT00439244|566453943|FG000|Overall Study|Death|0|||
156917691|NCT00439244|566453944|FG001|Overall Study|Death|1|||
156917692|NCT00439244|566453945|FG002|Overall Study|Death|0|||
156917693|NCT00439244|566453943|FG000|Overall Study|Protocol Violation|0|||
156917694|NCT00439244|566453944|FG001|Overall Study|Protocol Violation|1|||
156917695|NCT00439244|566453945|FG002|Overall Study|Protocol Violation|0|||
156917696|NCT00439244|566453943|FG000|Overall Study|Administrative problems|1|||
156917697|NCT00439244|566453944|FG001|Overall Study|Administrative problems|0|||
156917698|NCT00439244|566453945|FG002|Overall Study|Administrative problems|0|||
156917699|NCT04557371|566453948|FG000|Overall Study|Covid-19-related|0|||
156917700|NCT04557371|566453949|FG001|Overall Study|Covid-19-related|1|||
156917701|NCT04557371|566453950|FG002|Overall Study|Covid-19-related|0|||
156917702|NCT04557371|566453948|FG000|Overall Study|Withdrawal by Subject|0|||
156917703|NCT04557371|566453949|FG001|Overall Study|Withdrawal by Subject|1|||
156917704|NCT04557371|566453950|FG002|Overall Study|Withdrawal by Subject|0|||
156917705|NCT04557371|566453948|FG000|Overall Study|Adverse Event|1|||
156917706|NCT04557371|566453949|FG001|Overall Study|Adverse Event|0|||
156917707|NCT04557371|566453950|FG002|Overall Study|Adverse Event|0|||
156917708|NCT01482884|566453953|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
156917709|NCT01482884|566453954|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
156917710|NCT01482884|566453953|FG000|Overall Study|Protocol Violation|1|||
156917711|NCT01482884|566453954|FG001|Overall Study|Protocol Violation|0|||
156917712|NCT01482884|566453953|FG000|Overall Study|Lost to Follow-up|2|||
156917713|NCT01482884|566453954|FG001|Overall Study|Lost to Follow-up|2|||
156917714|NCT01482884|566453953|FG000|Overall Study|Lack of Efficacy|0|||
156917715|NCT01482884|566453954|FG001|Overall Study|Lack of Efficacy|1|||
156917716|NCT01482884|566453953|FG000|Overall Study|Adverse Event|2|||
156917717|NCT01482884|566453954|FG001|Overall Study|Adverse Event|1|||
156917718|NCT01482884|566453953|FG000|Overall Study|Withdrawal by Subject|8|||
156917719|NCT01482884|566453954|FG001|Overall Study|Withdrawal by Subject|13|||
156917720|NCT05353985|566453961|FG000|Overall Study|Adverse Event|5|||
156917721|NCT05353985|566453962|FG001|Overall Study|Adverse Event|7|||
156917722|NCT05353985|566453961|FG000|Overall Study|Lost to Follow-up|1|||
156917723|NCT05353985|566453962|FG001|Overall Study|Lost to Follow-up|1|||
156917724|NCT05353985|566453961|FG000|Overall Study|Protocol Violation|1|||
156917725|NCT05353985|566453962|FG001|Overall Study|Protocol Violation|0|||
156917726|NCT05353985|566453961|FG000|Overall Study|Withdrawal by Subject|13|||
156917727|NCT05353985|566453962|FG001|Overall Study|Withdrawal by Subject|17|||
156917728|NCT05353985|566453961|FG000|Overall Study|Reason Not Specified|1|||
156917729|NCT05353985|566453962|FG001|Overall Study|Reason Not Specified|0|||
156917730|NCT05353985|566453961|FG000|Overall Study|Randomized in Error & Not Treated|0|||
156917731|NCT05353985|566453962|FG001|Overall Study|Randomized in Error & Not Treated|1|||
156917732|NCT04419714|566453963|FG000|Overall Study|Technical Fault|5|||
156917733|NCT04419714|566453963|FG000|Overall Study|Protocol Deviation|2|||
156917734|NCT04419714|566453963|FG000|Overall Study|Withdrawal by Subject|1|||
156917735|NCT02762266|566455637|FG000|Overall Study|Physician Decision|2|||
156917736|NCT02762266|566455638|FG001|Overall Study|Physician Decision|0|||
156917737|NCT03909295|566455644|FG000|Overall Study|Adverse Event|2|||
156917738|NCT03909295|566455644|FG000|Overall Study|Study terminated by sponsor|50|||
156917739|NCT00848081|566455648|FG000|Overall Study|Adverse Event|6|||
156917740|NCT00848081|566455649|FG001|Overall Study|Adverse Event|7|||
156917741|NCT00848081|566455648|FG000|Overall Study|Protocol Violation|8|||
156917742|NCT00848081|566455649|FG001|Overall Study|Protocol Violation|5|||
156917743|NCT00848081|566455648|FG000|Overall Study|Lost to Follow-up|1|||
156917744|NCT00848081|566455649|FG001|Overall Study|Lost to Follow-up|0|||
156917745|NCT00848081|566455648|FG000|Overall Study|Physician Decision|0|||
156917746|NCT00848081|566455649|FG001|Overall Study|Physician Decision|3|||
156917747|NCT00848081|566455648|FG000|Overall Study|Withdrawal by Subject|5|||
156917748|NCT00848081|566455649|FG001|Overall Study|Withdrawal by Subject|3|||
156917749|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156917750|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156917751|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156917752|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
156917753|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
156917754|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
156917755|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156917756|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156917757|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156917758|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
156917759|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|Other|1|||
156917760|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|Other|1|||
156917761|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|Other|0|||
156917762|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|Other|0|||
156917763|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|Other|0|||
156917764|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156917765|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156917766|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
156917767|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
156917768|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
156917769|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156917770|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156917771|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156917772|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
156917773|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
156917774|NCT02310568|566455650|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156917775|NCT02310568|566455651|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156917776|NCT02310568|566455652|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156917777|NCT02310568|566455653|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
156917778|NCT02310568|566455654|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
156917779|NCT02310568|566455650|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
156917780|NCT02310568|566455651|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156917781|NCT02310568|566455652|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156917782|NCT02310568|566455653|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
156917783|NCT02310568|566455654|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
156917784|NCT02310568|566455650|FG000|Stage 2 (4 Weeks)|Other|0|||
156917785|NCT02310568|566455651|FG001|Stage 2 (4 Weeks)|Other|1|||
156917786|NCT02310568|566455652|FG002|Stage 2 (4 Weeks)|Other|1|||
156917787|NCT02310568|566455653|FG003|Stage 2 (4 Weeks)|Other|0|||
157226424|NCT02270736|567575837|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
156917788|NCT02310568|566455654|FG004|Stage 2 (4 Weeks)|Other|0|||
156917789|NCT02310568|566455650|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
156917790|NCT02310568|566455651|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
156917791|NCT02310568|566455652|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
156917792|NCT02310568|566455653|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
156917793|NCT02310568|566455654|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
157028234|NCT03088878|566859174|FG013|Overall Study|Completed 2 years of Treatment|3|||
157028235|NCT03088878|566859161|FG000|Overall Study|Physician Decision|0|||
156917794|NCT02310568|566455650|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
156917795|NCT02310568|566455651|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
156917796|NCT02310568|566455652|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
156917797|NCT02310568|566455653|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
156917798|NCT02310568|566455654|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
156917799|NCT02310568|566455650|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156917800|NCT02310568|566455651|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156917801|NCT02310568|566455652|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156917802|NCT02310568|566455653|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
156917803|NCT02310568|566455654|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
156917804|NCT02989194|566455658|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
156917805|NCT02989194|566455659|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
156917806|NCT02989194|566455660|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
156917807|NCT02989194|566455658|FG000|Overall Study|Lost to Follow-up|0|||
156917808|NCT02989194|566455659|FG001|Overall Study|Lost to Follow-up|1|||
156917809|NCT02989194|566455660|FG002|Overall Study|Lost to Follow-up|0|||
156917810|NCT02989194|566455658|FG000|Overall Study|Withdrawal by Subject|0|||
156917811|NCT02989194|566455659|FG001|Overall Study|Withdrawal by Subject|1|||
156917812|NCT02989194|566455660|FG002|Overall Study|Withdrawal by Subject|0|||
156917813|NCT02064868|566455662|FG000|Overall Study|Lost to Follow-up|14|||
156917814|NCT02064868|566455663|FG001|Overall Study|Lost to Follow-up|8|||
156917815|NCT02064868|566455662|FG000|Overall Study|Physician Decision|1|||
156917816|NCT02064868|566455663|FG001|Overall Study|Physician Decision|0|||
156917817|NCT02064868|566455662|FG000|Overall Study|Withdrawal by Subject|14|||
157028236|NCT03088878|566859162|FG001|Overall Study|Physician Decision|0|||
157162733|NCT00213980|567340522|FG000|Overall Study|Developed ovarian cancer|1|||
157162734|NCT00213980|567340523|FG001|Overall Study|Developed ovarian cancer|0|||
157162735|NCT00213980|567340522|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
157162736|NCT00213980|567340523|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
157162737|NCT04032171|567340524|FG000|Overall Study|Study Termination|1|||
157162738|NCT04032171|567340525|FG001|Overall Study|Study Termination|0|||
157162739|NCT00992784|567340526|FG000|Overall Study|Adverse Event|2|||
157162740|NCT00992784|567340527|FG001|Overall Study|Adverse Event|1|||
157162741|NCT00992784|567340528|FG002|Overall Study|Adverse Event|0|||
157162742|NCT00992784|567340526|FG000|Overall Study|Withdrawal by Subject|1|||
157162743|NCT00992784|567340527|FG001|Overall Study|Withdrawal by Subject|1|||
157162744|NCT00992784|567340528|FG002|Overall Study|Withdrawal by Subject|1|||
157162745|NCT00289185|567340529|FG000|Overall Study|Withdrawal by Subject|4|||
157162746|NCT00289185|567340530|FG001|Overall Study|Withdrawal by Subject|8|||
157162747|NCT00289185|567340529|FG000|Overall Study|Lost to Follow-up|23|||
157162748|NCT00289185|567340530|FG001|Overall Study|Lost to Follow-up|17|||
157162749|NCT00289185|567340529|FG000|Overall Study|Death|1|||
157162750|NCT00289185|567340530|FG001|Overall Study|Death|1|||
157162751|NCT01124448|567340533|FG000|Overall Study|Lost to Follow-up|0|||
157162752|NCT01124448|567340534|FG001|Overall Study|Lost to Follow-up|3|||
157162753|NCT01124448|567340533|FG000|Overall Study|Protocol Violation|2|||
157162754|NCT01124448|567340534|FG001|Overall Study|Protocol Violation|0|||
157162755|NCT00421343|567340535|FG000|Overall Study|Death|1|||
157162756|NCT00421343|567340535|FG000|Overall Study|Withdrawal by Subject|2|||
157162757|NCT00421343|567340535|FG000|Overall Study|Lost to Follow-up|3|||
157162758|NCT03471767|567340536|FG000|Overall Study|Withdrawal by Subject|3|||
157162759|NCT03471767|567340537|FG001|Overall Study|Withdrawal by Subject|1|||
157162760|NCT03471767|567340536|FG000|Overall Study|Adverse Event|1|||
157162761|NCT03471767|567340537|FG001|Overall Study|Adverse Event|0|||
157162762|NCT03471767|567340536|FG000|Overall Study|Lost to Follow-up|1|||
157162763|NCT03471767|567340537|FG001|Overall Study|Lost to Follow-up|0|||
157162764|NCT03471767|567340536|FG000|Overall Study|PI Withdrawal|1|||
157162765|NCT03471767|567340537|FG001|Overall Study|PI Withdrawal|3|||
157162766|NCT00678587|567340538|FG000|Overall Study|Adverse Event|3|||
157162767|NCT00678587|567340539|FG001|Overall Study|Adverse Event|3|||
157162768|NCT00678587|567340538|FG000|Overall Study|Lack of Efficacy|1|||
157162769|NCT00678587|567340539|FG001|Overall Study|Lack of Efficacy|0|||
157162770|NCT00678587|567340538|FG000|Overall Study|Protocol Violation|2|||
157162771|NCT00678587|567340539|FG001|Overall Study|Protocol Violation|1|||
157162772|NCT00678587|567340538|FG000|Overall Study|Study Closed/Terminated|1|||
157162773|NCT00678587|567340539|FG001|Overall Study|Study Closed/Terminated|0|||
157162774|NCT00678587|567340538|FG000|Overall Study|Lost to Follow-up|3|||
157162775|NCT00678587|567340539|FG001|Overall Study|Lost to Follow-up|5|||
157162776|NCT00678587|567340538|FG000|Overall Study|Investigator Discretion|2|||
157162777|NCT00678587|567340539|FG001|Overall Study|Investigator Discretion|6|||
157162778|NCT00678587|567340538|FG000|Overall Study|Withdrew Consent|8|||
156917818|NCT02064868|566455663|FG001|Overall Study|Withdrawal by Subject|3|||
156917819|NCT02064868|566455662|FG000|Overall Study|Technical Problems or Missing|5|||
156917820|NCT02064868|566455663|FG001|Overall Study|Technical Problems or Missing|2|||
156917821|NCT00482612|566455666|FG000|In-treatment Period|No study medication administered|0|||
156917822|NCT00482612|566455667|FG001|In-treatment Period|No study medication administered|0|||
157162779|NCT00678587|567340539|FG001|Overall Study|Withdrew Consent|3|||
157162780|NCT03806179|567340540|FG000|Overall Study|Progressive disease|0|||
156917823|NCT00482612|566455668|FG002|In-treatment Period|No study medication administered|1|||
156917824|NCT00482612|566455669|FG003|In-treatment Period|No study medication administered|0|||
156917825|NCT00482612|566455666|FG000|Follow-up Period|Other|4|||
156917826|NCT00482612|566455667|FG001|Follow-up Period|Other|2|||
156917827|NCT00482612|566455668|FG002|Follow-up Period|Other|1|||
156917828|NCT00482612|566455669|FG003|Follow-up Period|Other|2|||
156917829|NCT00482612|566455666|FG000|Follow-up Period|Lack of compliance|0|||
156917830|NCT00482612|566455667|FG001|Follow-up Period|Lack of compliance|0|||
156917831|NCT00482612|566455668|FG002|Follow-up Period|Lack of compliance|1|||
156917832|NCT00482612|566455669|FG003|Follow-up Period|Lack of compliance|0|||
156917833|NCT00482612|566455666|FG000|Follow-up Period|Lost to Follow-up|0|||
156917834|NCT00482612|566455667|FG001|Follow-up Period|Lost to Follow-up|4|||
156917835|NCT00482612|566455668|FG002|Follow-up Period|Lost to Follow-up|2|||
156917836|NCT00482612|566455669|FG003|Follow-up Period|Lost to Follow-up|1|||
156917837|NCT00482612|566455666|FG000|Follow-up Period|Adverse Event|4|||
156917838|NCT00482612|566455667|FG001|Follow-up Period|Adverse Event|7|||
156917839|NCT00482612|566455668|FG002|Follow-up Period|Adverse Event|9|||
156917840|NCT00482612|566455669|FG003|Follow-up Period|Adverse Event|0|||
156917841|NCT00482612|566455666|FG000|Follow-up Period|Lack of Efficacy|2|||
156917842|NCT00482612|566455667|FG001|Follow-up Period|Lack of Efficacy|0|||
156917843|NCT00482612|566455668|FG002|Follow-up Period|Lack of Efficacy|1|||
156917844|NCT00482612|566455669|FG003|Follow-up Period|Lack of Efficacy|0|||
156917845|NCT00482612|566455666|FG000|Follow-up Period|Withdrawal by Subject|3|||
156917846|NCT00482612|566455667|FG001|Follow-up Period|Withdrawal by Subject|5|||
156917847|NCT00482612|566455668|FG002|Follow-up Period|Withdrawal by Subject|7|||
156917848|NCT00482612|566455669|FG003|Follow-up Period|Withdrawal by Subject|2|||
156917849|NCT00482612|566455666|FG000|Follow-up Period|Reasons not related to trial|1|||
156917850|NCT00482612|566455667|FG001|Follow-up Period|Reasons not related to trial|0|||
156917851|NCT00482612|566455668|FG002|Follow-up Period|Reasons not related to trial|1|||
156917852|NCT00482612|566455669|FG003|Follow-up Period|Reasons not related to trial|3|||
156917853|NCT03506815|566455670|FG000|Overall Study|Adverse Event|8|||
156917854|NCT03506815|566455671|FG001|Overall Study|Adverse Event|0|||
156917855|NCT03506815|566455670|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
156917856|NCT03506815|566455671|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
156917857|NCT03506815|566455670|FG000|Overall Study|Protocol Violation|1|||
156917858|NCT03506815|566455671|FG001|Overall Study|Protocol Violation|0|||
156917859|NCT03506815|566455670|FG000|Overall Study|Elective Surgery|1|||
156917860|NCT03506815|566455671|FG001|Overall Study|Elective Surgery|0|||
156917861|NCT04160091|566455674|FG000|Overall Study|Terminated by Sponsor|7|||
156917862|NCT04160091|566455675|FG001|Overall Study|Terminated by Sponsor|3|||
156917863|NCT04160091|566455676|FG002|Overall Study|Terminated by Sponsor|5|||
156917864|NCT04160091|566455677|FG003|Overall Study|Terminated by Sponsor|2|||
156917865|NCT04160091|566455674|FG000|Overall Study|Noncompliance|0|||
156917866|NCT04160091|566455675|FG001|Overall Study|Noncompliance|0|||
156917867|NCT04160091|566455676|FG002|Overall Study|Noncompliance|0|||
156917868|NCT04160091|566455677|FG003|Overall Study|Noncompliance|1|||
156917869|NCT04160091|566455674|FG000|Overall Study|Withdrawal by Subject|0|||
156917870|NCT04160091|566455675|FG001|Overall Study|Withdrawal by Subject|0|||
156917871|NCT04160091|566455676|FG002|Overall Study|Withdrawal by Subject|0|||
156917872|NCT04160091|566455677|FG003|Overall Study|Withdrawal by Subject|1|||
156917873|NCT01224431|566455680|FG000|Overall Study|not randomized|0|||
156917874|NCT01224431|566455681|FG001|Overall Study|not randomized|4|||
156917875|NCT01224431|566455680|FG000|Overall Study|no video record|0|||
156917876|NCT01224431|566455681|FG001|Overall Study|no video record|1|||
156917877|NCT02057406|566455682|FG000|Overall Study|Physician Decision|0|||
156917878|NCT02057406|566455683|FG001|Overall Study|Physician Decision|0|||
156917879|NCT02057406|566455684|FG002|Overall Study|Physician Decision|2|||
156917880|NCT02057406|566455682|FG000|Overall Study|Withdrawal by Subject|0|||
156917881|NCT02057406|566455683|FG001|Overall Study|Withdrawal by Subject|2|||
156917882|NCT02057406|566455684|FG002|Overall Study|Withdrawal by Subject|0|||
157226425|NCT02270736|567575838|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
156917883|NCT02057406|566455682|FG000|Overall Study|Lost to Follow-up|0|||
157226426|NCT02270736|567575834|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
157226427|NCT02270736|567575835|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
157226428|NCT02270736|567575836|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
157226429|NCT02270736|567575837|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
156917884|NCT02057406|566455683|FG001|Overall Study|Lost to Follow-up|0|||
156917885|NCT02057406|566455684|FG002|Overall Study|Lost to Follow-up|1|||
156917886|NCT02057406|566455682|FG000|Overall Study|Death|1|||
156917887|NCT02057406|566455683|FG001|Overall Study|Death|0|||
157226430|NCT02270736|567575838|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
156917888|NCT02057406|566455684|FG002|Overall Study|Death|0|||
156917889|NCT02057406|566455682|FG000|Overall Study|Protocol Violation|0|||
156917890|NCT02057406|566455683|FG001|Overall Study|Protocol Violation|1|||
156917891|NCT02057406|566455684|FG002|Overall Study|Protocol Violation|0|||
156917892|NCT02057406|566455682|FG000|Overall Study|Patient transportation issues|0|||
156917893|NCT02057406|566455683|FG001|Overall Study|Patient transportation issues|0|||
156917894|NCT02057406|566455684|FG002|Overall Study|Patient transportation issues|1|||
156917895|NCT02692716|566455685|FG000|Overall Study|Lost to Follow-up|2|||
156917896|NCT02692716|566455686|FG001|Overall Study|Lost to Follow-up|5|||
156917897|NCT02692716|566455685|FG000|Overall Study|Withdrawal by Subject|3|||
156917898|NCT02692716|566455686|FG001|Overall Study|Withdrawal by Subject|1|||
156917899|NCT03562481|566455691|FG000|First Intervention|Lost to Follow-up|1|||
156917900|NCT03562481|566455692|FG001|First Intervention|Lost to Follow-up|0|||
156917901|NCT03654651|566455694|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
156917902|NCT03654651|566455695|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
156917903|NCT01401283|566455696|FG000|Overall Study|surgery cancelled|5|||
156917904|NCT01401283|566455697|FG001|Overall Study|surgery cancelled|8|||
156917905|NCT01401283|566455696|FG000|Overall Study|preoperative arrhythmia|5|||
156917906|NCT01401283|566455697|FG001|Overall Study|preoperative arrhythmia|0|||
156917907|NCT01401283|566455696|FG000|Overall Study|no central venous access|0|||
156917908|NCT01401283|566455697|FG001|Overall Study|no central venous access|1|||
156917909|NCT01401283|566455696|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
156917910|NCT01401283|566455697|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
156917911|NCT02433483|566455698|FG000|Overall Study|Unacceptable toxicity|1|||
156917912|NCT02433483|566455698|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
156917913|NCT03824912|566455702|FG000|Overall Study|Lost to Follow-up|18|||
156917914|NCT03824912|566455703|FG001|Overall Study|Lost to Follow-up|15|||
156917915|NCT03824912|566455704|FG002|Overall Study|Lost to Follow-up|8|||
156917916|NCT03824912|566455702|FG000|Overall Study|Negative Baseline Culture Result|118|||
156917917|NCT03824912|566455703|FG001|Overall Study|Negative Baseline Culture Result|112|||
156917918|NCT03824912|566455704|FG002|Overall Study|Negative Baseline Culture Result|57|||
156917919|NCT03824912|566455702|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156917920|NCT03824912|566455703|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156917921|NCT03824912|566455704|FG002|Overall Study|Non-Compliance with Study Drug|1|||
156917922|NCT03824912|566455702|FG000|Overall Study|Protocol Violation|1|||
156917923|NCT03824912|566455703|FG001|Overall Study|Protocol Violation|4|||
156917924|NCT03824912|566455704|FG002|Overall Study|Protocol Violation|1|||
156917925|NCT03824912|566455702|FG000|Overall Study|Withdrawal by Subject|3|||
156917926|NCT03824912|566455703|FG001|Overall Study|Withdrawal by Subject|2|||
156917927|NCT03824912|566455704|FG002|Overall Study|Withdrawal by Subject|1|||
156917928|NCT03824912|566455702|FG000|Overall Study|Participation in another study|0|||
156917929|NCT03824912|566455703|FG001|Overall Study|Participation in another study|1|||
156917930|NCT03824912|566455704|FG002|Overall Study|Participation in another study|0|||
156917931|NCT03342690|566455709|FG000|Overall Study|Missing Information|9|||
156917932|NCT03342690|566455709|FG000|Overall Study|Protocol Violation|16|||
156917933|NCT00549302|566455717|FG000|Double-Blind|Death|2|||
156917934|NCT00549302|566455718|FG001|Double-Blind|Death|9|||
156917935|NCT00549302|566455719|FG002|Double-Blind|Death|0|||
156917936|NCT00549302|566455717|FG000|Double-Blind|Adverse Event|3|||
156917937|NCT00549302|566455718|FG001|Double-Blind|Adverse Event|16|||
156917938|NCT00549302|566455719|FG002|Double-Blind|Adverse Event|0|||
156917939|NCT00549302|566455717|FG000|Double-Blind|Withdrawal by Subject|3|||
156917940|NCT00549302|566455718|FG001|Double-Blind|Withdrawal by Subject|8|||
156917941|NCT00549302|566455719|FG002|Double-Blind|Withdrawal by Subject|0|||
156917942|NCT00549302|566455717|FG000|Double-Blind|Investigator Decision|1|||
156917943|NCT00549302|566455718|FG001|Double-Blind|Investigator Decision|5|||
156917944|NCT00549302|566455719|FG002|Double-Blind|Investigator Decision|0|||
156917945|NCT00549302|566455717|FG000|Double-Blind|Sponsor Decision|0|||
156917946|NCT00549302|566455718|FG001|Double-Blind|Sponsor Decision|1|||
156917947|NCT00549302|566455719|FG002|Double-Blind|Sponsor Decision|0|||
156917948|NCT00549302|566455717|FG000|Double-Blind|Lost to Follow-up|1|||
156917949|NCT00549302|566455718|FG001|Double-Blind|Lost to Follow-up|2|||
156917950|NCT00549302|566455719|FG002|Double-Blind|Lost to Follow-up|0|||
156917951|NCT00549302|566455717|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
156917952|NCT00549302|566455718|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
156917953|NCT00549302|566455719|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
156917954|NCT00549302|566455717|FG000|Double-Blind|New condition or starts new therapy|0|||
156917955|NCT00549302|566455718|FG001|Double-Blind|New condition or starts new therapy|2|||
156917956|NCT00549302|566455719|FG002|Double-Blind|New condition or starts new therapy|0|||
156917957|NCT00549302|566455717|FG000|Open-Label|Adverse Event|0|||
156917958|NCT00549302|566455718|FG001|Open-Label|Adverse Event|0|||
156917959|NCT00549302|566455719|FG002|Open-Label|Adverse Event|11|||
156917960|NCT00549302|566455717|FG000|Open-Label|Death|0|||
156917961|NCT00549302|566455718|FG001|Open-Label|Death|0|||
156917962|NCT00549302|566455719|FG002|Open-Label|Death|40|||
156917963|NCT00549302|566455717|FG000|Open-Label|Investigator Decision|0|||
156917964|NCT00549302|566455718|FG001|Open-Label|Investigator Decision|0|||
156917965|NCT00549302|566455719|FG002|Open-Label|Investigator Decision|5|||
156917966|NCT00549302|566455717|FG000|Open-Label|Lost to Follow-up|0|||
156917967|NCT00549302|566455718|FG001|Open-Label|Lost to Follow-up|0|||
156917968|NCT00549302|566455719|FG002|Open-Label|Lost to Follow-up|2|||
156917969|NCT00549302|566455717|FG000|Open-Label|Other|0|||
156917970|NCT00549302|566455718|FG001|Open-Label|Other|0|||
156917971|NCT00549302|566455719|FG002|Open-Label|Other|3|||
156917972|NCT00549302|566455717|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
156917973|NCT00549302|566455718|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
156917974|NCT00549302|566455719|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
156917975|NCT00549302|566455717|FG000|Open-Label|Withdrawal by Subject|0|||
156917976|NCT00549302|566455718|FG001|Open-Label|Withdrawal by Subject|0|||
156917977|NCT00549302|566455719|FG002|Open-Label|Withdrawal by Subject|6|||
156917978|NCT01414114|566455720|FG000|Overall Study|Adverse Event|2|||
156917979|NCT01414114|566455720|FG000|Overall Study|Withdrawal by Subject|1|||
156917980|NCT01414114|566455720|FG000|Overall Study|Other|2|||
156917981|NCT05620563|566455725|FG000|Overall Study|Adverse Event|3|||
156917982|NCT05620563|566455726|FG001|Overall Study|Adverse Event|1|||
156917983|NCT05620563|566455725|FG000|Overall Study|Lost to Follow-up|0|||
156917984|NCT05620563|566455726|FG001|Overall Study|Lost to Follow-up|2|||
156917985|NCT05620563|566455725|FG000|Overall Study|Protocol Deviation|1|||
156917986|NCT05620563|566455726|FG001|Overall Study|Protocol Deviation|2|||
156917987|NCT05620563|566455725|FG000|Overall Study|Withdrawal by Subject|3|||
156917988|NCT05620563|566455726|FG001|Overall Study|Withdrawal by Subject|3|||
156917989|NCT05620563|566455725|FG000|Overall Study|Physician Decision|0|||
156917990|NCT05620563|566455726|FG001|Overall Study|Physician Decision|1|||
156917991|NCT02289690|566455732|FG000|Overall Study|Adverse Event Related to Progression|0|||
156917992|NCT02289690|566455733|FG001|Overall Study|Adverse Event Related to Progression|1|||
156917993|NCT02289690|566455734|FG002|Overall Study|Adverse Event Related to Progression|1|||
156917994|NCT02289690|566455735|FG003|Overall Study|Adverse Event Related to Progression|0|||
156917995|NCT02289690|566455736|FG004|Overall Study|Adverse Event Related to Progression|1|||
156917996|NCT02289690|566455737|FG005|Overall Study|Adverse Event Related to Progression|0|||
156917997|NCT02289690|566455738|FG006|Overall Study|Adverse Event Related to Progression|1|||
156917998|NCT02289690|566455739|FG007|Overall Study|Adverse Event Related to Progression|0|||
156917999|NCT02289690|566455740|FG008|Overall Study|Adverse Event Related to Progression|0|||
156918000|NCT02289690|566455741|FG009|Overall Study|Adverse Event Related to Progression|0|||
156918001|NCT02289690|566455732|FG000|Overall Study|Withdrawal by Subject|1|||
156918002|NCT02289690|566455733|FG001|Overall Study|Withdrawal by Subject|0|||
156918003|NCT02289690|566455734|FG002|Overall Study|Withdrawal by Subject|0|||
156918004|NCT02289690|566455735|FG003|Overall Study|Withdrawal by Subject|0|||
156918005|NCT02289690|566455736|FG004|Overall Study|Withdrawal by Subject|1|||
156918006|NCT02289690|566455737|FG005|Overall Study|Withdrawal by Subject|1|||
156918007|NCT02289690|566455738|FG006|Overall Study|Withdrawal by Subject|0|||
156918008|NCT02289690|566455739|FG007|Overall Study|Withdrawal by Subject|0|||
156918009|NCT02289690|566455740|FG008|Overall Study|Withdrawal by Subject|4|||
156918010|NCT02289690|566455741|FG009|Overall Study|Withdrawal by Subject|2|||
156918011|NCT02289690|566455732|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
156918012|NCT02289690|566455733|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
156918013|NCT02289690|566455734|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
156918014|NCT02289690|566455735|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
156918015|NCT02289690|566455736|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
156918016|NCT02289690|566455737|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
156918017|NCT02289690|566455738|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
156918018|NCT02289690|566455739|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
156918019|NCT02289690|566455740|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
156918020|NCT02289690|566455741|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
156918021|NCT02289690|566455732|FG000|Overall Study|Lost to Follow-up|0|||
156918022|NCT02289690|566455733|FG001|Overall Study|Lost to Follow-up|0|||
156918023|NCT02289690|566455734|FG002|Overall Study|Lost to Follow-up|0|||
156918024|NCT02289690|566455735|FG003|Overall Study|Lost to Follow-up|0|||
156918025|NCT02289690|566455736|FG004|Overall Study|Lost to Follow-up|0|||
156918026|NCT02289690|566455737|FG005|Overall Study|Lost to Follow-up|0|||
156918027|NCT02289690|566455738|FG006|Overall Study|Lost to Follow-up|0|||
156918028|NCT02289690|566455739|FG007|Overall Study|Lost to Follow-up|1|||
156918029|NCT02289690|566455740|FG008|Overall Study|Lost to Follow-up|0|||
156918030|NCT02289690|566455741|FG009|Overall Study|Lost to Follow-up|2|||
156918031|NCT02289690|566455732|FG000|Overall Study|Death|0|||
156918032|NCT02289690|566455733|FG001|Overall Study|Death|0|||
156918033|NCT02289690|566455734|FG002|Overall Study|Death|0|||
156918034|NCT02289690|566455735|FG003|Overall Study|Death|0|||
156918035|NCT02289690|566455736|FG004|Overall Study|Death|0|||
156918036|NCT02289690|566455737|FG005|Overall Study|Death|0|||
156918037|NCT02289690|566455738|FG006|Overall Study|Death|0|||
156918038|NCT02289690|566455739|FG007|Overall Study|Death|49|||
156918039|NCT02289690|566455740|FG008|Overall Study|Death|45|||
156918040|NCT02289690|566455741|FG009|Overall Study|Death|41|||
156918041|NCT02289690|566455732|FG000|Overall Study|Sponsor Discontinued Study|0|||
156918042|NCT02289690|566455733|FG001|Overall Study|Sponsor Discontinued Study|0|||
156918043|NCT02289690|566455734|FG002|Overall Study|Sponsor Discontinued Study|0|||
156918044|NCT02289690|566455735|FG003|Overall Study|Sponsor Discontinued Study|0|||
156918045|NCT02289690|566455736|FG004|Overall Study|Sponsor Discontinued Study|0|||
156918046|NCT02289690|566455737|FG005|Overall Study|Sponsor Discontinued Study|0|||
156918047|NCT02289690|566455738|FG006|Overall Study|Sponsor Discontinued Study|0|||
156918048|NCT02289690|566455739|FG007|Overall Study|Sponsor Discontinued Study|9|||
156918049|NCT02289690|566455740|FG008|Overall Study|Sponsor Discontinued Study|7|||
156918050|NCT02289690|566455741|FG009|Overall Study|Sponsor Discontinued Study|15|||
156918051|NCT02289690|566455732|FG000|Overall Study|Other|0|||
156918052|NCT02289690|566455733|FG001|Overall Study|Other|0|||
156918053|NCT02289690|566455734|FG002|Overall Study|Other|0|||
156918054|NCT02289690|566455735|FG003|Overall Study|Other|1|||
156918055|NCT02289690|566455736|FG004|Overall Study|Other|1|||
156918056|NCT02289690|566455737|FG005|Overall Study|Other|0|||
156918057|NCT02289690|566455738|FG006|Overall Study|Other|1|||
156918058|NCT02289690|566455739|FG007|Overall Study|Other|2|||
156918059|NCT02289690|566455740|FG008|Overall Study|Other|3|||
156918060|NCT02289690|566455741|FG009|Overall Study|Other|1|||
156918061|NCT02085785|566455744|FG000|Overall Study|Withdrawal by Subject|2|||
156918062|NCT02085785|566455745|FG001|Overall Study|Withdrawal by Subject|1|||
156918063|NCT02085785|566455744|FG000|Overall Study|Lost to Follow-up|0|||
156918064|NCT02085785|566455745|FG001|Overall Study|Lost to Follow-up|1|||
156918065|NCT00779467|566455746|FG000|Overall Study|Lack of Efficacy|11|||
156918066|NCT00779467|566455747|FG001|Overall Study|Lack of Efficacy|2|||
156918067|NCT00779467|566455748|FG002|Overall Study|Lack of Efficacy|6|||
156918068|NCT00779467|566455749|FG003|Overall Study|Lack of Efficacy|11|||
156918069|NCT00779467|566455746|FG000|Overall Study|failed inclusion criteria|3|||
156918070|NCT00779467|566455747|FG001|Overall Study|failed inclusion criteria|3|||
156918071|NCT00779467|566455748|FG002|Overall Study|failed inclusion criteria|1|||
156918072|NCT00779467|566455749|FG003|Overall Study|failed inclusion criteria|2|||
156918073|NCT00779467|566455746|FG000|Overall Study|missing data|1|||
156918074|NCT00779467|566455747|FG001|Overall Study|missing data|0|||
156918075|NCT00779467|566455748|FG002|Overall Study|missing data|1|||
156918076|NCT00779467|566455749|FG003|Overall Study|missing data|4|||
156918077|NCT00779467|566455746|FG000|Overall Study|technical issue|0|||
156918078|NCT00779467|566455747|FG001|Overall Study|technical issue|0|||
156918079|NCT00779467|566455748|FG002|Overall Study|technical issue|2|||
156918080|NCT00779467|566455749|FG003|Overall Study|technical issue|1|||
156918081|NCT00779467|566455746|FG000|Overall Study|unavailable research staff|0|||
156918082|NCT00779467|566455747|FG001|Overall Study|unavailable research staff|0|||
156918083|NCT00779467|566455748|FG002|Overall Study|unavailable research staff|0|||
156918084|NCT00779467|566455749|FG003|Overall Study|unavailable research staff|1|||
156918085|NCT02692703|566455750|FG000|Overall Study|Lost to Follow-up|1|||
156918086|NCT02692703|566455750|FG000|Overall Study|Other|1|||
156918087|NCT00644995|566455751|FG000|Overall Study|Lost to Follow-up|1|||
156918088|NCT00644995|566455752|FG001|Overall Study|Lost to Follow-up|4|||
156918089|NCT00644995|566455751|FG000|Overall Study|Refused|1|||
156918090|NCT00644995|566455752|FG001|Overall Study|Refused|0|||
156918091|NCT00865124|566455759|FG000|Overall Study|Physician Decision|2|||
156918092|NCT00865124|566455760|FG001|Overall Study|Physician Decision|1|||
156918093|NCT00865124|566455761|FG002|Overall Study|Physician Decision|0|||
156918094|NCT00865124|566455759|FG000|Overall Study|Withdrawn consent|2|||
156918095|NCT00865124|566455760|FG001|Overall Study|Withdrawn consent|0|||
156918096|NCT00865124|566455761|FG002|Overall Study|Withdrawn consent|0|||
156918097|NCT02573350|566455762|FG000|Overall Study|Lost to Follow-up|2|||
156918098|NCT02573350|566455763|FG001|Overall Study|Lost to Follow-up|1|||
156918099|NCT02573350|566455762|FG000|Overall Study|Adverse Event|3|||
156918100|NCT02573350|566455763|FG001|Overall Study|Adverse Event|4|||
156918101|NCT02573350|566455762|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
156918102|NCT02573350|566455763|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
156918103|NCT02573350|566455762|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
156918104|NCT02573350|566455763|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
156918105|NCT02573350|566455762|FG000|Overall Study|Subject withdrew consent to participate|6|||
156918106|NCT02573350|566455763|FG001|Overall Study|Subject withdrew consent to participate|1|||
156918107|NCT02573350|566455762|FG000|Overall Study|Protocol Deviation|1|||
156918108|NCT02573350|566455763|FG001|Overall Study|Protocol Deviation|1|||
156918109|NCT02743520|566455764|FG000|Overall Study|Withdrawal by Subject|1|||
157162781|NCT03806179|567340541|FG001|Overall Study|Progressive disease|2|||
156918110|NCT03247530|566455765|FG000|Overall Study|Withdrawal by caregiver|19|||
156918111|NCT03247530|566455766|FG001|Overall Study|Withdrawal by caregiver|8|||
157162782|NCT01952730|567340544|FG000|Overall Study|FDA shut down core lab used by study|1|||
157162783|NCT00976950|567340548|FG000|Overall Study|Adverse Event|3|||
157162784|NCT00976950|567340548|FG000|Overall Study|Events with no relationship to Aptivus|3|||
156918112|NCT03247530|566455767|FG002|Overall Study|Withdrawal by caregiver|10|||
156918113|NCT03247530|566455765|FG000|Overall Study|Lost to Follow-up|3|||
156918114|NCT03247530|566455766|FG001|Overall Study|Lost to Follow-up|9|||
156918115|NCT03247530|566455767|FG002|Overall Study|Lost to Follow-up|6|||
156918116|NCT03247530|566455765|FG000|Overall Study|Adverse Event|2|||
156918117|NCT03247530|566455766|FG001|Overall Study|Adverse Event|5|||
156918118|NCT03247530|566455767|FG002|Overall Study|Adverse Event|2|||
156918119|NCT03247530|566455765|FG000|Overall Study|Failure to follow procedure|1|||
157226431|NCT00262600|567575839|FG000|Overall Study|Lost to Follow-up|17|||
157226432|NCT00262600|567575840|FG001|Overall Study|Lost to Follow-up|31|||
156918120|NCT03247530|566455766|FG001|Overall Study|Failure to follow procedure|1|||
156918121|NCT03247530|566455767|FG002|Overall Study|Failure to follow procedure|1|||
156918122|NCT03247530|566455765|FG000|Overall Study|Withdrawal by Subject|1|||
156918123|NCT03247530|566455766|FG001|Overall Study|Withdrawal by Subject|1|||
156918124|NCT03247530|566455767|FG002|Overall Study|Withdrawal by Subject|0|||
156918125|NCT03247530|566455765|FG000|Overall Study|Study medication misuse|0|||
156918126|NCT03247530|566455766|FG001|Overall Study|Study medication misuse|1|||
156918127|NCT03247530|566455767|FG002|Overall Study|Study medication misuse|0|||
156918128|NCT03247530|566455765|FG000|Overall Study|Other, multiple categories|1|||
156918129|NCT03247530|566455766|FG001|Overall Study|Other, multiple categories|3|||
156918130|NCT03247530|566455767|FG002|Overall Study|Other, multiple categories|1|||
156918131|NCT03454997|566455770|FG000|Overall Study|Staff Coach - Left Oranization|1|||
156918132|NCT03454997|566455771|FG001|Overall Study|Staff Coach - Left Oranization|1|||
156918133|NCT03454997|566455770|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
156918134|NCT03454997|566455771|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
156918135|NCT03454997|566455770|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
156918136|NCT03454997|566455771|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
156918137|NCT03454997|566455770|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
156918138|NCT03454997|566455771|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
156918139|NCT03454997|566455770|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
156918140|NCT03454997|566455771|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
156918141|NCT03454997|566455770|FG000|Overall Study|Client with SMI - Left organization|0|||
156918142|NCT03454997|566455771|FG001|Overall Study|Client with SMI - Left organization|1|||
156918143|NCT03454997|566455770|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
156918144|NCT03454997|566455771|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
156918145|NCT00006903|566455772|FG000|Overall Study|Still receiving treatment|0|||
156918146|NCT00006903|566455773|FG001|Overall Study|Still receiving treatment|0|||
156918147|NCT00006903|566455774|FG002|Overall Study|Still receiving treatment|1|||
156918148|NCT00006903|566455772|FG000|Overall Study|Refused further treatment|0|||
156918149|NCT00006903|566455773|FG001|Overall Study|Refused further treatment|2|||
156918150|NCT00006903|566455774|FG002|Overall Study|Refused further treatment|1|||
156918151|NCT00006903|566455772|FG000|Overall Study|Adverse Event|0|||
156918152|NCT00006903|566455773|FG001|Overall Study|Adverse Event|0|||
156918153|NCT00006903|566455774|FG002|Overall Study|Adverse Event|1|||
156918154|NCT00006903|566455772|FG000|Overall Study|Death|0|||
156918155|NCT00006903|566455773|FG001|Overall Study|Death|1|||
156918156|NCT00006903|566455774|FG002|Overall Study|Death|0|||
156918157|NCT00006903|566455772|FG000|Overall Study|Patient never treated|0|||
156918158|NCT00006903|566455773|FG001|Overall Study|Patient never treated|0|||
156918159|NCT00006903|566455774|FG002|Overall Study|Patient never treated|1|||
156918160|NCT00006903|566455772|FG000|Overall Study|Ineligible|10|||
156918161|NCT00006903|566455773|FG001|Overall Study|Ineligible|1|||
156918162|NCT00006903|566455774|FG002|Overall Study|Ineligible|2|||
156918163|NCT01678911|566455776|FG000|Second Intervention|Lost to Follow-up|2|||
156918164|NCT01678911|566455777|FG001|Second Intervention|Lost to Follow-up|0|||
156918165|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
156918166|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
156918167|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
156918168|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
156918169|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
156918170|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
156918171|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
156918172|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
156918173|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Patient Request|1|||
156918174|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Patient Request|0|||
156918175|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
156918176|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
156918177|NCT04649060|566455778|FG000|Arm A/Arm B Treatment|Other|1|||
156918178|NCT04649060|566455779|FG001|Arm A/Arm B Treatment|Other|0|||
156918179|NCT04649060|566455778|FG000|Crossover (Arm B)|Adverse Event|0|||
156918180|NCT04649060|566455779|FG001|Crossover (Arm B)|Adverse Event|1|||
156918181|NCT04649060|566455778|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
156918182|NCT04649060|566455779|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
156918183|NCT01906008|566455783|FG000|Overall Study|Lost to Follow-up|2|||
156918184|NCT01906008|566455784|FG001|Overall Study|Lost to Follow-up|0|||
156918185|NCT01906008|566455783|FG000|Overall Study|Oxaliplatin toxicity|2|||
156918186|NCT01906008|566455784|FG001|Overall Study|Oxaliplatin toxicity|0|||
156918187|NCT01906008|566455783|FG000|Overall Study|Protocol Violation|0|||
156918188|NCT01906008|566455784|FG001|Overall Study|Protocol Violation|1|||
156918189|NCT01906008|566455783|FG000|Overall Study|Withdrawal by Subject|1|||
156918190|NCT01906008|566455784|FG001|Overall Study|Withdrawal by Subject|5|||
156918191|NCT01906008|566455783|FG000|Overall Study|Did not start study med|3|||
157028237|NCT03088878|566859163|FG002|Overall Study|Physician Decision|0|||
157162785|NCT01514188|567340550|FG000|Overall Study|Adverse Event|3|||
156918192|NCT01906008|566455784|FG001|Overall Study|Did not start study med|4|||
156918193|NCT01906008|566455783|FG000|Overall Study|Oxaliplatin stops|10|||
156918194|NCT01906008|566455784|FG001|Overall Study|Oxaliplatin stops|8|||
156918195|NCT01906008|566455783|FG000|Overall Study|Hospice|1|||
156918196|NCT01906008|566455784|FG001|Overall Study|Hospice|0|||
156918197|NCT01906008|566455783|FG000|Overall Study|Physician Decision|3|||
156918198|NCT01906008|566455784|FG001|Overall Study|Physician Decision|3|||
156918199|NCT01906008|566455783|FG000|Overall Study|Lack of compliance of study med|5|||
156918200|NCT01906008|566455784|FG001|Overall Study|Lack of compliance of study med|3|||
156918201|NCT01906008|566455783|FG000|Overall Study|Adverse Event|0|||
156918202|NCT01906008|566455784|FG001|Overall Study|Adverse Event|3|||
156918203|NCT02117648|566455785|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
156918204|NCT02117648|566455785|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
156918205|NCT02117648|566455785|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
156918206|NCT02117648|566455785|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
156918207|NCT02117648|566455785|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
156918208|NCT02117648|566455785|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
156918209|NCT02117648|566455785|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
156918210|NCT02117648|566455785|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
156918211|NCT02117648|566455785|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
156918212|NCT02117648|566455785|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
156918213|NCT02117648|566455785|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
156918214|NCT00171730|566455787|FG000|Overall Study|Adverse Event|3|||
156918215|NCT00171730|566455787|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
156918216|NCT00171730|566455787|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
156918217|NCT00171730|566455787|FG000|Overall Study|Withdrawal by Subject|3|||
156918218|NCT05025241|566455788|FG000|Screening|Failed Screening|5|||
156918219|NCT05025241|566455788|FG000|Treatment and Follow Up|Adverse Event|3|||
156918220|NCT01985867|566455789|FG000|Overall Study|Lost to Follow-up|3|||
156918221|NCT01985867|566455790|FG001|Overall Study|Lost to Follow-up|4|||
156918222|NCT01985867|566455789|FG000|Overall Study|Adverse Event|3|||
156918223|NCT01985867|566455790|FG001|Overall Study|Adverse Event|2|||
156918224|NCT01985867|566455789|FG000|Overall Study|Lack of Efficacy|1|||
156918225|NCT01985867|566455790|FG001|Overall Study|Lack of Efficacy|0|||
156918226|NCT02670837|566455791|FG000|Overall Study|Death|2|||
156918227|NCT02670837|566455792|FG001|Overall Study|Death|0|||
156918228|NCT02670837|566455793|FG002|Overall Study|Death|0|||
156918229|NCT02220205|566455794|FG000|Overall Study|Withdrawal by Subject|1|||
156918230|NCT02220205|566455795|FG001|Overall Study|Withdrawal by Subject|0|||
156918231|NCT01465997|566455796|FG000|Overall Study|Adverse Event|12|||
157162786|NCT01514188|567340551|FG001|Overall Study|Adverse Event|5|||
157162787|NCT01514188|567340550|FG000|Overall Study|Withdrawal by Subject|2|||
157162788|NCT01514188|567340551|FG001|Overall Study|Withdrawal by Subject|4|||
157162789|NCT01514188|567340550|FG000|Overall Study|Protocol Violation|2|||
157162790|NCT01514188|567340551|FG001|Overall Study|Protocol Violation|4|||
157162791|NCT01514188|567340550|FG000|Overall Study|Physician Decision|0|||
157162792|NCT01514188|567340551|FG001|Overall Study|Physician Decision|2|||
157162793|NCT01514188|567340550|FG000|Overall Study|Disease Progression|13|||
157162794|NCT01514188|567340551|FG001|Overall Study|Disease Progression|14|||
157162795|NCT01514188|567340550|FG000|Overall Study|Death|1|||
157162796|NCT01514188|567340551|FG001|Overall Study|Death|3|||
157162797|NCT01514188|567340550|FG000|Overall Study|Other|2|||
157162798|NCT01514188|567340551|FG001|Overall Study|Other|1|||
157162799|NCT02932332|567340552|FG000|Overall Study|Withdrawal by Subject|1|||
157162800|NCT02932332|567340553|FG001|Overall Study|Withdrawal by Subject|1|||
157162801|NCT02932332|567340554|FG002|Overall Study|Withdrawal by Subject|0|||
157162802|NCT02932332|567340555|FG003|Overall Study|Withdrawal by Subject|1|||
157162803|NCT02932332|567340552|FG000|Overall Study|Chest pain|0|||
156918232|NCT01465997|566455797|FG001|Overall Study|Adverse Event|22|||
156918233|NCT01465997|566455796|FG000|Overall Study|Lack of Efficacy|13|||
156918234|NCT01465997|566455797|FG001|Overall Study|Lack of Efficacy|1|||
156918235|NCT01465997|566455796|FG000|Overall Study|Protocol Violation|1|||
156918236|NCT01465997|566455797|FG001|Overall Study|Protocol Violation|4|||
156918237|NCT01465997|566455796|FG000|Overall Study|Lost to Follow-up|6|||
156918238|NCT01465997|566455797|FG001|Overall Study|Lost to Follow-up|9|||
156918239|NCT01465997|566455796|FG000|Overall Study|Withdrawal by Subject|32|||
156918240|NCT01465997|566455797|FG001|Overall Study|Withdrawal by Subject|35|||
156918241|NCT01465997|566455796|FG000|Overall Study|investigator's decision|1|||
156918242|NCT01465997|566455797|FG001|Overall Study|investigator's decision|1|||
156918243|NCT01465997|566455796|FG000|Overall Study|Death|0|||
157162804|NCT02932332|567340553|FG001|Overall Study|Chest pain|0|||
157162805|NCT02932332|567340554|FG002|Overall Study|Chest pain|0|||
157162806|NCT02932332|567340555|FG003|Overall Study|Chest pain|1|||
157162807|NCT02932332|567340552|FG000|Overall Study|Not Dyspneic cough|1|||
156918244|NCT01465997|566455797|FG001|Overall Study|Death|1|||
156918245|NCT01465997|566455796|FG000|Overall Study|sponsor's decision|1|||
157162808|NCT02932332|567340553|FG001|Overall Study|Not Dyspneic cough|2|||
157226433|NCT00262600|567575841|FG002|Overall Study|Lost to Follow-up|41|||
157226434|NCT00262600|567575839|FG000|Overall Study|Withdrawal by Subject|128|||
157226435|NCT00262600|567575840|FG001|Overall Study|Withdrawal by Subject|145|||
157226436|NCT00262600|567575841|FG002|Overall Study|Withdrawal by Subject|139|||
157226437|NCT00262600|567575839|FG000|Overall Study|Not Treated|32|||
157226438|NCT00262600|567575840|FG001|Overall Study|Not Treated|17|||
157226439|NCT00262600|567575841|FG002|Overall Study|Not Treated|24|||
157226440|NCT00262600|567575839|FG000|Overall Study|Other|58|||
157226441|NCT00262600|567575840|FG001|Overall Study|Other|59|||
157226442|NCT00262600|567575841|FG002|Overall Study|Other|62|||
157226443|NCT05381948|567575846|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
157226444|NCT05381948|567575847|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
157226445|NCT05381948|567575848|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
157226446|NCT05381948|567575846|FG000|Overall Study|Adverse Event: Non-ocular|0|||
157226447|NCT05381948|567575847|FG001|Overall Study|Adverse Event: Non-ocular|1|||
157226448|NCT05381948|567575848|FG002|Overall Study|Adverse Event: Non-ocular|0|||
157226449|NCT05381948|567575846|FG000|Overall Study|Lost to Follow-up|1|||
157226450|NCT05381948|567575847|FG001|Overall Study|Lost to Follow-up|0|||
157226451|NCT05381948|567575848|FG002|Overall Study|Lost to Follow-up|0|||
157226452|NCT05381948|567575846|FG000|Overall Study|Protocol Deviation|0|||
157226453|NCT05381948|567575847|FG001|Overall Study|Protocol Deviation|2|||
157226454|NCT05381948|567575848|FG002|Overall Study|Protocol Deviation|0|||
157226455|NCT05381948|567575846|FG000|Overall Study|Withdrawal by Subject|1|||
157226456|NCT05381948|567575847|FG001|Overall Study|Withdrawal by Subject|0|||
157226457|NCT05381948|567575848|FG002|Overall Study|Withdrawal by Subject|1|||
157226458|NCT05381948|567575846|FG000|Overall Study|Death|0|||
157226459|NCT05381948|567575847|FG001|Overall Study|Death|2|||
157226460|NCT05381948|567575848|FG002|Overall Study|Death|0|||
157226461|NCT05381948|567575846|FG000|Overall Study|Discontinued study without receiving study drug|0|||
157226462|NCT05381948|567575847|FG001|Overall Study|Discontinued study without receiving study drug|0|||
157226463|NCT05381948|567575848|FG002|Overall Study|Discontinued study without receiving study drug|1|||
157226464|NCT04471207|567575849|FG000|Overall Study|Lost to Follow-up|4|||
156918246|NCT01465997|566455797|FG001|Overall Study|sponsor's decision|1|||
156918247|NCT01465997|566455796|FG000|Overall Study|subject withdrew consent|1|||
156918248|NCT01465997|566455797|FG001|Overall Study|subject withdrew consent|0|||
156918249|NCT01465997|566455796|FG000|Overall Study|local lab unblinded site|1|||
156918250|NCT01465997|566455797|FG001|Overall Study|local lab unblinded site|0|||
157226465|NCT04471207|567575850|FG001|Overall Study|Lost to Follow-up|1|||
157226466|NCT04471207|567575849|FG000|Overall Study|Medication Contraindication|0|||
157226467|NCT04471207|567575850|FG001|Overall Study|Medication Contraindication|1|||
157226468|NCT04471207|567575849|FG000|Overall Study|Loss of Interest|2|||
157226469|NCT04471207|567575850|FG001|Overall Study|Loss of Interest|1|||
156918251|NCT01465997|566455796|FG000|Overall Study|withdrew before follow-up|0|||
156918252|NCT01465997|566455797|FG001|Overall Study|withdrew before follow-up|13|||
156918253|NCT01465997|566455796|FG000|Overall Study|decision by site staff|0|||
156918254|NCT01465997|566455797|FG001|Overall Study|decision by site staff|1|||
156918255|NCT01465997|566455796|FG000|Overall Study|subject left participation SP0993|0|||
156918256|NCT01465997|566455797|FG001|Overall Study|subject left participation SP0993|1|||
156918257|NCT04221009|566458093|FG000|Overall Study|Withdrawal by Subject|4|||
156918258|NCT00793598|566458094|FG000|Overall Study|Patient Request|0|||
156918259|NCT00793598|566458095|FG001|Overall Study|Patient Request|1|||
156918260|NCT00793598|566458096|FG002|Overall Study|Patient Request|0|||
156918261|NCT00793598|566458097|FG003|Overall Study|Patient Request|0|||
156918262|NCT00793598|566458098|FG004|Overall Study|Patient Request|0|||
156918263|NCT00793598|566458099|FG005|Overall Study|Patient Request|0|||
156918264|NCT00793598|566458100|FG006|Overall Study|Patient Request|0|||
156918265|NCT00793598|566458101|FG007|Overall Study|Patient Request|0|||
156918266|NCT00793598|566458094|FG000|Overall Study|Protocol Violation|0|||
156918267|NCT00793598|566458095|FG001|Overall Study|Protocol Violation|0|||
157226470|NCT04471207|567575849|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
157226471|NCT04471207|567575850|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
157226472|NCT04471207|567575849|FG000|Overall Study|Scheduling Conflicts|3|||
157226473|NCT04471207|567575850|FG001|Overall Study|Scheduling Conflicts|1|||
156918268|NCT00793598|566458096|FG002|Overall Study|Protocol Violation|0|||
156918269|NCT00793598|566458097|FG003|Overall Study|Protocol Violation|0|||
157226474|NCT04471207|567575849|FG000|Overall Study|Physician Decision|1|||
157226475|NCT04471207|567575850|FG001|Overall Study|Physician Decision|0|||
157226476|NCT04471207|567575849|FG000|Overall Study|Unwilling to Use System|0|||
157226477|NCT04471207|567575850|FG001|Overall Study|Unwilling to Use System|1|||
157226478|NCT02132247|567575851|FG000|Overall Study|Protocol Violation|1|||
157226479|NCT02132247|567575852|FG001|Overall Study|Protocol Violation|0|||
157226480|NCT00561730|567575855|FG000|Overall Study|Adverse Event|2|||
156918270|NCT00793598|566458098|FG004|Overall Study|Protocol Violation|0|||
156918271|NCT00793598|566458099|FG005|Overall Study|Protocol Violation|0|||
156918272|NCT00793598|566458100|FG006|Overall Study|Protocol Violation|0|||
156918273|NCT00793598|566458101|FG007|Overall Study|Protocol Violation|1|||
157226481|NCT00561730|567575855|FG000|Overall Study|Handling of the drug|1|||
157226482|NCT00561730|567575855|FG000|Overall Study|Lost to Follow-up|5|||
156918274|NCT00793598|566458094|FG000|Overall Study|Subject not dosed|0|||
156918275|NCT00793598|566458095|FG001|Overall Study|Subject not dosed|0|||
156918276|NCT00793598|566458096|FG002|Overall Study|Subject not dosed|0|||
156918277|NCT00793598|566458097|FG003|Overall Study|Subject not dosed|0|||
156918278|NCT00793598|566458098|FG004|Overall Study|Subject not dosed|0|||
156918279|NCT00793598|566458099|FG005|Overall Study|Subject not dosed|1|||
156918280|NCT00793598|566458100|FG006|Overall Study|Subject not dosed|0|||
156918281|NCT00793598|566458101|FG007|Overall Study|Subject not dosed|0|||
156918282|NCT01404325|566458102|FG000|Overall Study|Lost to Follow-up|1|||
156918283|NCT01404325|566458103|FG001|Overall Study|Lost to Follow-up|0|||
156918284|NCT01404325|566458102|FG000|Overall Study|Death|2|||
156918285|NCT01404325|566458103|FG001|Overall Study|Death|0|||
156918286|NCT01404325|566458102|FG000|Overall Study|Graft loss/Retransplantation|1|||
156918287|NCT01404325|566458103|FG001|Overall Study|Graft loss/Retransplantation|0|||
156918288|NCT01404325|566458102|FG000|Overall Study|non-specified reason|0|||
156918289|NCT01404325|566458103|FG001|Overall Study|non-specified reason|2|||
156918290|NCT00660023|566458108|FG000|Overall Study|Adverse Event|2|||
156918291|NCT00660023|566458108|FG000|Overall Study|Death|8|||
156918292|NCT00660023|566458108|FG000|Overall Study|Blood Transfusion|5|||
156918293|NCT00660023|566458108|FG000|Overall Study|Renal Transplantation|3|||
156918294|NCT00660023|566458108|FG000|Overall Study|Withdrawal by Subject|1|||
156918295|NCT00660023|566458108|FG000|Overall Study|Missed Pregnancy Test|1|||
156918296|NCT00660023|566458108|FG000|Overall Study|Other Screening Failure|9|||
156918297|NCT04180488|566458110|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156918298|NCT04180488|566458111|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
156918299|NCT04180488|566458112|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
156918300|NCT04180488|566458113|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
156918301|NCT04180488|566458114|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156918302|NCT04180488|566458115|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
156918303|NCT04180488|566458110|FG000|Overall Study|Withdrawal by Subject|8|||
156918304|NCT04180488|566458111|FG001|Overall Study|Withdrawal by Subject|4|||
156918305|NCT04180488|566458112|FG002|Overall Study|Withdrawal by Subject|5|||
157028238|NCT03088878|566859164|FG003|Overall Study|Physician Decision|0|||
157028239|NCT03088878|566859165|FG004|Overall Study|Physician Decision|0|||
157028240|NCT03088878|566859166|FG005|Overall Study|Physician Decision|0|||
157028241|NCT03088878|566859167|FG006|Overall Study|Physician Decision|0|||
157028242|NCT03088878|566859168|FG007|Overall Study|Physician Decision|2|||
157028243|NCT03088878|566859169|FG008|Overall Study|Physician Decision|1|||
157028244|NCT03088878|566859170|FG009|Overall Study|Physician Decision|0|||
157028245|NCT03088878|566859171|FG010|Overall Study|Physician Decision|0|||
157162809|NCT02932332|567340554|FG002|Overall Study|Not Dyspneic cough|1|||
157162810|NCT02932332|567340555|FG003|Overall Study|Not Dyspneic cough|0|||
157162811|NCT03442829|567340557|FG000|Overall Study|Scheduling clash|3|||
157162812|NCT03442829|567340558|FG001|Overall Study|Scheduling clash|1|||
157162813|NCT03442829|567340557|FG000|Overall Study|Illness unrelated to study|1|||
157162814|NCT03442829|567340558|FG001|Overall Study|Illness unrelated to study|1|||
157162815|NCT01069523|567340559|FG000|Overall Study|Withdrawal by Subject|4|||
157162816|NCT01069523|567340560|FG001|Overall Study|Withdrawal by Subject|7|||
157162817|NCT01875367|567340563|FG000|Overall Study|Not complete at least 2 questionaries|4|||
157162818|NCT01875367|567340564|FG001|Overall Study|Not complete at least 2 questionaries|2|||
157162819|NCT01875367|567340563|FG000|Overall Study|Not receive study treatment|1|||
157162820|NCT01875367|567340564|FG001|Overall Study|Not receive study treatment|0|||
157162821|NCT02605447|567340567|FG000|Overall Study|Death|66|||
157162822|NCT02605447|567340567|FG000|Overall Study|Physician Decision|1|||
157162823|NCT02605447|567340567|FG000|Overall Study|Lost to Follow-up|24|||
157162824|NCT02605447|567340567|FG000|Overall Study|Withdrawal by Subject|10|||
157162825|NCT02605447|567340567|FG000|Overall Study|Not disclosed|1|||
157162826|NCT02237157|567340568|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
157162827|NCT02237157|567340569|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
157162828|NCT02237157|567340570|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
157162829|NCT02237157|567340571|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
157162830|NCT02237157|567340568|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
157162831|NCT02237157|567340569|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
157162832|NCT02237157|567340570|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
157162833|NCT02237157|567340571|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
157162834|NCT04533815|567340576|FG000|Overall Study|Adverse Event|2|||
157162835|NCT04533815|567340576|FG000|Overall Study|Site withdrew|5|||
157162836|NCT02045212|567340577|FG000|Overall Study|Adverse Event|0|||
157162837|NCT02045212|567340578|FG001|Overall Study|Adverse Event|1|||
157162838|NCT02045212|567340577|FG000|Overall Study|Withdrawal by Subject|1|||
157162839|NCT02045212|567340578|FG001|Overall Study|Withdrawal by Subject|0|||
157162840|NCT02045212|567340577|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
157162841|NCT02045212|567340578|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
156918306|NCT04180488|566458113|FG003|Overall Study|Withdrawal by Subject|2|||
157028246|NCT03088878|566859172|FG011|Overall Study|Physician Decision|0|||
156918307|NCT04180488|566458114|FG004|Overall Study|Withdrawal by Subject|8|||
156918308|NCT04180488|566458115|FG005|Overall Study|Withdrawal by Subject|6|||
156918309|NCT04180488|566458110|FG000|Overall Study|Adverse Event|3|||
156918310|NCT04180488|566458111|FG001|Overall Study|Adverse Event|2|||
156918311|NCT04180488|566458112|FG002|Overall Study|Adverse Event|0|||
156918312|NCT04180488|566458113|FG003|Overall Study|Adverse Event|0|||
156918313|NCT04180488|566458114|FG004|Overall Study|Adverse Event|0|||
156918314|NCT04180488|566458115|FG005|Overall Study|Adverse Event|0|||
156918315|NCT04180488|566458110|FG000|Overall Study|Poor compliance to protocol|0|||
156918316|NCT04180488|566458111|FG001|Overall Study|Poor compliance to protocol|0|||
156918317|NCT04180488|566458112|FG002|Overall Study|Poor compliance to protocol|1|||
157028247|NCT03088878|566859173|FG012|Overall Study|Physician Decision|0|||
157028248|NCT03088878|566859174|FG013|Overall Study|Physician Decision|1|||
156918318|NCT04180488|566458113|FG003|Overall Study|Poor compliance to protocol|0|||
156918319|NCT04180488|566458114|FG004|Overall Study|Poor compliance to protocol|0|||
156918320|NCT04180488|566458115|FG005|Overall Study|Poor compliance to protocol|0|||
156918321|NCT00609492|566458119|FG000|Overall Study|Withdrawal by Subject|0|||
156918322|NCT00609492|566458120|FG001|Overall Study|Withdrawal by Subject|2|||
156918323|NCT00609492|566458121|FG002|Overall Study|Withdrawal by Subject|3|||
156918324|NCT00609492|566458119|FG000|Overall Study|Lost to Follow-up|1|||
156918325|NCT00609492|566458120|FG001|Overall Study|Lost to Follow-up|1|||
156918326|NCT00609492|566458121|FG002|Overall Study|Lost to Follow-up|4|||
156918327|NCT03585504|566458126|FG000|Overall Study|Lost to Follow-up|26|||
156918328|NCT03585504|566458127|FG001|Overall Study|Lost to Follow-up|29|||
156918329|NCT04626297|566458128|FG000|Overall Study|Adverse Event|5|||
156918330|NCT04626297|566458129|FG001|Overall Study|Adverse Event|3|||
156918331|NCT04626297|566458128|FG000|Overall Study|Lost to Follow-up|7|||
156918332|NCT04626297|566458129|FG001|Overall Study|Lost to Follow-up|3|||
156918333|NCT04626297|566458128|FG000|Overall Study|Protocol Violation|5|||
156918334|NCT04626297|566458129|FG001|Overall Study|Protocol Violation|1|||
156918335|NCT04626297|566458128|FG000|Overall Study|Withdrawal by Subject|20|||
156918336|NCT04626297|566458129|FG001|Overall Study|Withdrawal by Subject|6|||
156918337|NCT04626297|566458128|FG000|Overall Study|Sponsor decision|2|||
156918338|NCT04626297|566458129|FG001|Overall Study|Sponsor decision|1|||
156918339|NCT04118166|566458130|FG000|Overall Study|Adverse Event|1|||
156918340|NCT02557646|566458135|FG000|Overall Study|Adverse Event|40|||
156918341|NCT02557646|566458135|FG000|Overall Study|Death|1|||
156918342|NCT02557646|566458135|FG000|Overall Study|Lack of Efficacy|186|||
156918343|NCT02557646|566458135|FG000|Overall Study|Withdrawal by Subject|18|||
156918344|NCT02557646|566458135|FG000|Overall Study|Lost to Follow-up|17|||
156918345|NCT02557646|566458135|FG000|Overall Study|Other|14|||
156918346|NCT00660309|566458136|FG000|Overall Study|Adverse Event|2|||
156918347|NCT00660309|566458137|FG001|Overall Study|Adverse Event|0|||
156918348|NCT00660309|566458136|FG000|Overall Study|Withdrawal by Subject|0|||
156918349|NCT00660309|566458137|FG001|Overall Study|Withdrawal by Subject|3|||
156918350|NCT00137046|566458138|FG000|Overall Study|Death|2|||
156918351|NCT00137046|566458139|FG001|Overall Study|Death|1|||
156918352|NCT00137046|566458138|FG000|Overall Study|Adverse Event|16|||
156918353|NCT00137046|566458139|FG001|Overall Study|Adverse Event|5|||
156918354|NCT00137046|566458138|FG000|Overall Study|Laboratory Abnormality|2|||
156918355|NCT00137046|566458139|FG001|Overall Study|Laboratory Abnormality|0|||
156918356|NCT00137046|566458138|FG000|Overall Study|Lack of Efficacy|13|||
156918357|NCT00137046|566458139|FG001|Overall Study|Lack of Efficacy|1|||
156918358|NCT00137046|566458138|FG000|Overall Study|Lost to Follow-up|8|||
156918359|NCT00137046|566458139|FG001|Overall Study|Lost to Follow-up|24|||
156918360|NCT00137046|566458138|FG000|Overall Study|Other|23|||
156918361|NCT00137046|566458139|FG001|Overall Study|Other|19|||
156918362|NCT00137046|566458138|FG000|Overall Study|Withdrawal by Subject|33|||
156918363|NCT00137046|566458139|FG001|Overall Study|Withdrawal by Subject|42|||
156918364|NCT00137046|566458138|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
156918365|NCT00137046|566458139|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
156918366|NCT00137046|566458138|FG000|Overall Study|Withdrew prior to study treatment|1|||
156918367|NCT00137046|566458139|FG001|Overall Study|Withdrew prior to study treatment|1|||
156918368|NCT02532972|566458140|FG000|Overall Study|Withdrawal by Subject|1|||
156918369|NCT00110149|566458141|FG000|Overall Study|Physician Decision|3|||
156918370|NCT00748033|566458144|FG000|Overall Study|Adverse Event|0|||
157028249|NCT03088878|566859161|FG000|Overall Study|COVID Related noncompliance|0|||
157028250|NCT03088878|566859162|FG001|Overall Study|COVID Related noncompliance|0|||
157028251|NCT03088878|566859163|FG002|Overall Study|COVID Related noncompliance|0|||
157028252|NCT03088878|566859164|FG003|Overall Study|COVID Related noncompliance|0|||
156918371|NCT00748033|566458145|FG001|Overall Study|Adverse Event|1|||
156918372|NCT01018186|566458146|FG000|2-week Run-in Period|Protocol Violation|1|||
156918373|NCT01018186|566458147|FG001|2-week Run-in Period|Protocol Violation|0|||
156918374|NCT01018186|566458148|FG002|2-week Run-in Period|Protocol Violation|0|||
156918375|NCT01018186|566458149|FG003|2-week Run-in Period|Protocol Violation|0|||
157028253|NCT03088878|566859165|FG004|Overall Study|COVID Related noncompliance|0|||
156918376|NCT01018186|566458146|FG000|2-week Run-in Period|Lost to Follow-up|2|||
156918377|NCT01018186|566458147|FG001|2-week Run-in Period|Lost to Follow-up|0|||
156918378|NCT01018186|566458148|FG002|2-week Run-in Period|Lost to Follow-up|0|||
156918379|NCT01018186|566458149|FG003|2-week Run-in Period|Lost to Follow-up|0|||
156918380|NCT01018186|566458146|FG000|2-week Run-in Period|Physician Decision|3|||
156918381|NCT01018186|566458147|FG001|2-week Run-in Period|Physician Decision|0|||
156918382|NCT01018186|566458148|FG002|2-week Run-in Period|Physician Decision|0|||
156918383|NCT01018186|566458149|FG003|2-week Run-in Period|Physician Decision|0|||
156918384|NCT01018186|566458146|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
156918385|NCT01018186|566458147|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
156918386|NCT01018186|566458148|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
156918387|NCT01018186|566458149|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
156918388|NCT01018186|566458146|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
156918389|NCT01018186|566458147|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156918390|NCT01018186|566458148|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156918391|NCT01018186|566458149|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
156918392|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
156918393|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
156918394|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
156918395|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
156918396|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
156918397|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
156918398|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
156918399|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
156918400|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
156918401|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
156918402|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
156918403|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
156918404|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
156918405|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
156918406|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
156918407|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
156918408|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
156918409|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
156918410|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
156918411|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
156918412|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
156918413|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
156918414|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
156918415|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
156918416|NCT01018186|566458146|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
156918417|NCT01018186|566458147|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
156918418|NCT01018186|566458148|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
156918419|NCT01018186|566458149|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
156918420|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156918421|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
156918422|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156918423|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156918424|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156918425|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
156918426|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
156918427|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
156918428|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
156918429|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
156918430|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
156918431|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
156918432|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
156918433|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
156918434|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
156918435|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
156918436|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
156918437|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
157162842|NCT00488592|567340579|FG000|Overall Study|Withdrawal by Subject|1|||
157162843|NCT00488592|567340579|FG000|Overall Study|Disease progression|1|||
157162844|NCT00488592|567340579|FG000|Overall Study|Enrolled but not treated|1|||
157162845|NCT00441103|567340580|FG000|Overall Study|Adverse Event|2|||
156918438|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
157162846|NCT00441103|567340581|FG001|Overall Study|Adverse Event|1|||
157162847|NCT00441103|567340580|FG000|Overall Study|Death|1|||
157226483|NCT00561730|567575855|FG000|Overall Study|Not specified reasons|1|||
157226484|NCT00520741|567575860|FG000|Overall Study|Adverse Event|16|||
157226485|NCT00520741|567575861|FG001|Overall Study|Adverse Event|56|||
157226486|NCT00520741|567575860|FG000|Overall Study|Lack of Efficacy|11|||
157226487|NCT00520741|567575861|FG001|Overall Study|Lack of Efficacy|30|||
157226488|NCT00520741|567575860|FG000|Overall Study|Withdrawal by Subject|0|||
157226489|NCT00520741|567575861|FG001|Overall Study|Withdrawal by Subject|11|||
156918439|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156918440|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156918441|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156918442|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
156918443|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
156918444|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156918445|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
156918446|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156918447|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156918448|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156918449|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
156918450|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
156918451|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156918452|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156918453|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
156918454|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
156918455|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
156918456|NCT02603419|566458150|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156918457|NCT02603419|566458151|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156918458|NCT02603419|566458152|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156918459|NCT02603419|566458153|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
156918460|NCT02603419|566458154|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156918461|NCT02603419|566458155|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
156918462|NCT02603419|566458150|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156918463|NCT02603419|566458151|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156918464|NCT02603419|566458152|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156918465|NCT02603419|566458153|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156918466|NCT02603419|566458154|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
156918467|NCT02603419|566458155|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
156918468|NCT02603419|566458150|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156918469|NCT02603419|566458151|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156918470|NCT02603419|566458152|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156918471|NCT02603419|566458153|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156918472|NCT02603419|566458154|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
156918473|NCT02603419|566458155|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
156918474|NCT02603419|566458150|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156918475|NCT02603419|566458151|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156918476|NCT02603419|566458152|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156918477|NCT02603419|566458153|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156918478|NCT02603419|566458154|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
156918479|NCT02603419|566458155|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
156918480|NCT03552198|566458156|FG000|Overall Study|Lost to Follow-up|42|||
156918481|NCT03552198|566458157|FG001|Overall Study|Lost to Follow-up|48|||
156918482|NCT03552198|566458158|FG002|Overall Study|Lost to Follow-up|15|||
156918483|NCT03552198|566458159|FG003|Overall Study|Lost to Follow-up|19|||
156918484|NCT03552198|566458156|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
156918485|NCT03552198|566458157|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
156918486|NCT03552198|566458158|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
156918487|NCT03552198|566458159|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
156918488|NCT03552198|566458156|FG000|Overall Study|Did not receive air alerts|1|||
156918489|NCT03552198|566458157|FG001|Overall Study|Did not receive air alerts|0|||
156918490|NCT03552198|566458158|FG002|Overall Study|Did not receive air alerts|0|||
156918491|NCT03552198|566458159|FG003|Overall Study|Did not receive air alerts|1|||
156918492|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156918493|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
157226490|NCT00520741|567575860|FG000|Overall Study|Protocol Violation|2|||
157226491|NCT00520741|567575861|FG001|Overall Study|Protocol Violation|15|||
157226492|NCT00520741|567575860|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
157226493|NCT00520741|567575861|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
157226494|NCT00520741|567575860|FG000|Overall Study|Lost to Follow-up|4|||
156918494|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
156918495|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
156918496|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
156918497|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156918498|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
156918499|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
157162848|NCT00441103|567340581|FG001|Overall Study|Death|0|||
157162849|NCT00441103|567340580|FG000|Overall Study|Disease Progression|2|||
157162850|NCT00441103|567340581|FG001|Overall Study|Disease Progression|0|||
157162851|NCT00441103|567340580|FG000|Overall Study|Lost to Follow-up|1|||
157162852|NCT00441103|567340581|FG001|Overall Study|Lost to Follow-up|0|||
157162853|NCT00441103|567340580|FG000|Overall Study|Protocol Violation|1|||
157162854|NCT00441103|567340581|FG001|Overall Study|Protocol Violation|0|||
157162855|NCT00441103|567340580|FG000|Overall Study|Participant unable to use Rebiject II|1|||
157162856|NCT00441103|567340581|FG001|Overall Study|Participant unable to use Rebiject II|0|||
157162857|NCT00441103|567340580|FG000|Overall Study|Participant refused MRI|1|||
157162858|NCT00441103|567340581|FG001|Overall Study|Participant refused MRI|0|||
157162859|NCT00441103|567340580|FG000|Overall Study|Inclusion criteria absent|1|||
157162860|NCT00441103|567340581|FG001|Overall Study|Inclusion criteria absent|0|||
157162861|NCT00441103|567340580|FG000|Overall Study|Non-compliant|0|||
157162862|NCT00441103|567340581|FG001|Overall Study|Non-compliant|1|||
157162863|NCT00441103|567340580|FG000|Overall Study|Participant decided to withdraw|1|||
157162864|NCT00441103|567340581|FG001|Overall Study|Participant decided to withdraw|0|||
157162865|NCT00441103|567340580|FG000|Overall Study|Participant's reason|0|||
157162866|NCT00441103|567340581|FG001|Overall Study|Participant's reason|1|||
157162867|NCT00441103|567340580|FG000|Overall Study|Participant decided to stop|0|||
157162868|NCT00441103|567340581|FG001|Overall Study|Participant decided to stop|1|||
157162869|NCT05836818|567340582|FG000|Overall Study|Physician Decision|1|||
157162870|NCT05836818|567340583|FG001|Overall Study|Physician Decision|1|||
157162871|NCT05836818|567340584|FG002|Overall Study|Physician Decision|0|||
157162872|NCT05836818|567340582|FG000|Overall Study|Withdrawal by Subject|0|||
157162873|NCT05836818|567340583|FG001|Overall Study|Withdrawal by Subject|0|||
157162874|NCT05836818|567340584|FG002|Overall Study|Withdrawal by Subject|1|||
157162875|NCT05836818|567340582|FG000|Overall Study|Later found to be previously vaccinated|0|||
157162876|NCT05836818|567340583|FG001|Overall Study|Later found to be previously vaccinated|1|||
156918500|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Other|1|||
156918501|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Other|4|||
156918502|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Other|3|||
156918503|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Other|6|||
156918504|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
156918505|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
156918506|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
156918507|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
156918508|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
156918509|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
156918510|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
156918511|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
156918512|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156918513|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
156918514|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
156918515|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
156918516|NCT02925494|566458160|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
156918517|NCT02925494|566458161|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
156918518|NCT02925494|566458162|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
156918519|NCT02925494|566458163|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
156918520|NCT03334448|566458169|FG000|Washout|Personal Reason|0|||
156918521|NCT03334448|566458170|FG001|Washout|Personal Reason|1|||
156918522|NCT03334448|566458171|FG002|Washout|Personal Reason|0|||
156918523|NCT03334448|566458172|FG003|Washout|Personal Reason|0|||
156918524|NCT03334448|566458169|FG000|Washout|Protocol Violation|0|||
156918525|NCT03334448|566458170|FG001|Washout|Protocol Violation|0|||
156918526|NCT03334448|566458171|FG002|Washout|Protocol Violation|0|||
156918527|NCT03334448|566458172|FG003|Washout|Protocol Violation|1|||
156918528|NCT01365910|566458173|FG000|Overall Study|Withdrawal by Subject|7|||
156918529|NCT01365910|566458173|FG000|Overall Study|disease progression|18|||
156918530|NCT01365910|566458173|FG000|Overall Study|Adverse Event|3|||
156918531|NCT01365910|566458173|FG000|Overall Study|other complicating disease|1|||
156918532|NCT01365910|566458173|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
156918533|NCT00371137|566458174|FG000|Overall Study|Adverse Event|20|||
156918534|NCT00371137|566458175|FG001|Overall Study|Adverse Event|35|||
156918535|NCT00371137|566458176|FG002|Overall Study|Adverse Event|42|||
157162877|NCT05836818|567340584|FG002|Overall Study|Later found to be previously vaccinated|3|||
157162878|NCT05836818|567340582|FG000|Overall Study|Pregnancy|0|||
157162879|NCT05836818|567340583|FG001|Overall Study|Pregnancy|1|||
157028254|NCT03088878|566859166|FG005|Overall Study|COVID Related noncompliance|0|||
157028255|NCT03088878|566859167|FG006|Overall Study|COVID Related noncompliance|0|||
157028256|NCT03088878|566859168|FG007|Overall Study|COVID Related noncompliance|0|||
157028257|NCT03088878|566859169|FG008|Overall Study|COVID Related noncompliance|0|||
157028258|NCT03088878|566859170|FG009|Overall Study|COVID Related noncompliance|0|||
157028259|NCT03088878|566859171|FG010|Overall Study|COVID Related noncompliance|0|||
157028260|NCT03088878|566859172|FG011|Overall Study|COVID Related noncompliance|0|||
157028261|NCT03088878|566859173|FG012|Overall Study|COVID Related noncompliance|0|||
157028262|NCT03088878|566859174|FG013|Overall Study|COVID Related noncompliance|1|||
157028263|NCT03088878|566859161|FG000|Overall Study|Drug or Study Noncompliance|0|||
157028264|NCT03088878|566859162|FG001|Overall Study|Drug or Study Noncompliance|0|||
157028265|NCT03088878|566859163|FG002|Overall Study|Drug or Study Noncompliance|0|||
157028266|NCT03088878|566859164|FG003|Overall Study|Drug or Study Noncompliance|0|||
157028267|NCT03088878|566859165|FG004|Overall Study|Drug or Study Noncompliance|0|||
157028268|NCT03088878|566859166|FG005|Overall Study|Drug or Study Noncompliance|0|||
157028269|NCT03088878|566859167|FG006|Overall Study|Drug or Study Noncompliance|0|||
157028270|NCT03088878|566859168|FG007|Overall Study|Drug or Study Noncompliance|0|||
157028271|NCT03088878|566859169|FG008|Overall Study|Drug or Study Noncompliance|0|||
157028272|NCT03088878|566859170|FG009|Overall Study|Drug or Study Noncompliance|0|||
157028273|NCT03088878|566859171|FG010|Overall Study|Drug or Study Noncompliance|0|||
157162880|NCT05836818|567340584|FG002|Overall Study|Pregnancy|0|||
157162881|NCT05836818|567340582|FG000|Overall Study|Allergic to vaccines|0|||
157162882|NCT05836818|567340583|FG001|Overall Study|Allergic to vaccines|1|||
156918536|NCT00371137|566458174|FG000|Overall Study|Withdrawal by Subject|11|||
156918537|NCT00371137|566458175|FG001|Overall Study|Withdrawal by Subject|10|||
156918538|NCT00371137|566458176|FG002|Overall Study|Withdrawal by Subject|15|||
156918539|NCT00371137|566458174|FG000|Overall Study|Lost to Follow-up|6|||
156918540|NCT00371137|566458175|FG001|Overall Study|Lost to Follow-up|3|||
156918541|NCT00371137|566458176|FG002|Overall Study|Lost to Follow-up|5|||
156918542|NCT00371137|566458174|FG000|Overall Study|Lack of Efficacy|30|||
156918543|NCT00371137|566458175|FG001|Overall Study|Lack of Efficacy|12|||
156918544|NCT00371137|566458176|FG002|Overall Study|Lack of Efficacy|13|||
156918545|NCT00371137|566458174|FG000|Overall Study|Sponsor Decision|2|||
156918546|NCT00371137|566458175|FG001|Overall Study|Sponsor Decision|1|||
156918547|NCT00371137|566458176|FG002|Overall Study|Sponsor Decision|2|||
156918548|NCT00371137|566458174|FG000|Overall Study|Physician Decision|1|||
156918549|NCT00371137|566458175|FG001|Overall Study|Physician Decision|1|||
156918550|NCT00371137|566458176|FG002|Overall Study|Physician Decision|1|||
156918551|NCT00371137|566458174|FG000|Overall Study|Protocol Violation|2|||
156918552|NCT00371137|566458175|FG001|Overall Study|Protocol Violation|1|||
156918553|NCT00371137|566458176|FG002|Overall Study|Protocol Violation|1|||
156918554|NCT02013791|566458177|FG000|Period 1|Lost to Follow-up|0|||
156918555|NCT02013791|566458178|FG001|Period 1|Lost to Follow-up|0|||
157028274|NCT03088878|566859172|FG011|Overall Study|Drug or Study Noncompliance|0|||
157028275|NCT03088878|566859173|FG012|Overall Study|Drug or Study Noncompliance|1|||
157028276|NCT03088878|566859174|FG013|Overall Study|Drug or Study Noncompliance|0|||
157028277|NCT04690582|566859175|FG000|Overall Study|Withdrawal by Subject|6|||
157028278|NCT04690582|566859176|FG001|Overall Study|Withdrawal by Subject|4|||
157162883|NCT05836818|567340584|FG002|Overall Study|Allergic to vaccines|0|||
157162884|NCT03738566|567340585|FG000|Initial Study Phase|Withdrawal by Subject|1|||
157162885|NCT03738566|567340586|FG001|Initial Study Phase|Withdrawal by Subject|1|||
157162886|NCT03738566|567340587|FG002|Initial Study Phase|Withdrawal by Subject|2|||
157162887|NCT03738566|567340588|FG003|Initial Study Phase|Withdrawal by Subject|0|||
157162888|NCT03738566|567340585|FG000|Initial Study Phase|Death|0|||
157162889|NCT03738566|567340586|FG001|Initial Study Phase|Death|1|||
157162890|NCT03738566|567340587|FG002|Initial Study Phase|Death|0|||
157162891|NCT03738566|567340588|FG003|Initial Study Phase|Death|0|||
157162892|NCT03738566|567340585|FG000|Initial Study Phase|Treatment failure|5|||
157162893|NCT03738566|567340586|FG001|Initial Study Phase|Treatment failure|0|||
157162894|NCT03738566|567340587|FG002|Initial Study Phase|Treatment failure|0|||
157162895|NCT03738566|567340588|FG003|Initial Study Phase|Treatment failure|0|||
157028279|NCT04032847|566859182|FG000|Overall Study|Study termination by sponsor|8|||
157028280|NCT04032847|566859183|FG001|Overall Study|Study termination by sponsor|0|||
157028281|NCT04032847|566859184|FG002|Overall Study|Study termination by sponsor|4|||
157028282|NCT04032847|566859182|FG000|Overall Study|Death|12|||
157162896|NCT03738566|567340585|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
157162897|NCT03738566|567340586|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
157226495|NCT00520741|567575861|FG001|Overall Study|Lost to Follow-up|4|||
156918556|NCT02013791|566458179|FG002|Period 1|Lost to Follow-up|0|||
156918557|NCT02013791|566458180|FG003|Period 1|Lost to Follow-up|1|||
156918558|NCT02013791|566458181|FG004|Period 1|Lost to Follow-up|0|||
156918559|NCT02013791|566458182|FG005|Period 1|Lost to Follow-up|0|||
156918560|NCT02013791|566458183|FG006|Period 1|Lost to Follow-up|1|||
157028283|NCT04032847|566859183|FG001|Overall Study|Death|0|||
157028284|NCT04032847|566859184|FG002|Overall Study|Death|0|||
157028285|NCT04032847|566859182|FG000|Overall Study|Progressive disease|2|||
157028286|NCT04032847|566859183|FG001|Overall Study|Progressive disease|0|||
157028287|NCT04032847|566859184|FG002|Overall Study|Progressive disease|1|||
157162898|NCT03738566|567340587|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
157162899|NCT03738566|567340588|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
157162900|NCT03126539|567340592|FG000|Overall Study|Lost to Follow-up|1|||
156918561|NCT02013791|566458184|FG007|Period 1|Lost to Follow-up|1|||
156918562|NCT02013791|566458185|FG008|Period 1|Lost to Follow-up|0|||
156918563|NCT02013791|566458177|FG000|Period 1|Other Miscellaneous Reasons|0|||
156918564|NCT02013791|566458178|FG001|Period 1|Other Miscellaneous Reasons|2|||
156918565|NCT02013791|566458179|FG002|Period 1|Other Miscellaneous Reasons|0|||
156918566|NCT02013791|566458180|FG003|Period 1|Other Miscellaneous Reasons|0|||
156918567|NCT02013791|566458181|FG004|Period 1|Other Miscellaneous Reasons|0|||
156918568|NCT02013791|566458182|FG005|Period 1|Other Miscellaneous Reasons|0|||
156918569|NCT02013791|566458183|FG006|Period 1|Other Miscellaneous Reasons|0|||
156918570|NCT02013791|566458184|FG007|Period 1|Other Miscellaneous Reasons|0|||
156918571|NCT02013791|566458185|FG008|Period 1|Other Miscellaneous Reasons|0|||
156918572|NCT02289417|566458186|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
156918573|NCT02289417|566458187|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918574|NCT02289417|566458188|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
156918575|NCT02289417|566458189|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918576|NCT02289417|566458190|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918577|NCT02289417|566458191|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918578|NCT02289417|566458192|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918579|NCT02289417|566458193|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918580|NCT02289417|566458194|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
156918581|NCT02289417|566458186|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
156918582|NCT02289417|566458187|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
156918583|NCT02289417|566458188|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
156918584|NCT02289417|566458189|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918585|NCT02289417|566458190|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918586|NCT02289417|566458191|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918587|NCT02289417|566458192|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918588|NCT02289417|566458193|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918589|NCT02289417|566458194|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
156918590|NCT02289417|566458186|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918591|NCT02289417|566458187|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
156918592|NCT02289417|566458188|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918593|NCT02289417|566458189|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918594|NCT02289417|566458190|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918595|NCT02289417|566458191|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918596|NCT02289417|566458192|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918597|NCT02289417|566458193|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918598|NCT02289417|566458194|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
156918599|NCT02289417|566458186|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
156918600|NCT02289417|566458187|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918601|NCT02289417|566458188|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918602|NCT02289417|566458189|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918603|NCT02289417|566458190|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918604|NCT02289417|566458191|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918605|NCT02289417|566458192|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918606|NCT02289417|566458193|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918607|NCT02289417|566458194|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
156918608|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156918609|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
156918610|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
156918611|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
156918612|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
156918613|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
156918614|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156918615|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156918616|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
156918617|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918618|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918619|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
156918620|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918621|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918622|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918623|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918624|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918625|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
156918626|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156918627|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
156918628|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
156918629|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
156918630|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
156918631|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
156918632|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156918633|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
156918634|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
157162901|NCT03126539|567340593|FG001|Overall Study|Lost to Follow-up|1|||
156918635|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918636|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918637|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156918638|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918639|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156918640|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
156918641|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918642|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918643|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
156918644|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918645|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918646|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918647|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918648|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918649|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918650|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
156918651|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918652|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
156918653|NCT02289417|566458186|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918654|NCT02289417|566458187|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918655|NCT02289417|566458188|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918656|NCT02289417|566458189|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
156918657|NCT02289417|566458190|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918658|NCT02289417|566458191|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918659|NCT02289417|566458192|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
156918660|NCT02289417|566458193|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918661|NCT02289417|566458194|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
156918662|NCT02289417|566458186|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
156918663|NCT02289417|566458187|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
156918664|NCT02289417|566458188|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
156918665|NCT02289417|566458189|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
156918666|NCT02289417|566458190|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
156918667|NCT02289417|566458191|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
156918668|NCT02289417|566458192|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
156918669|NCT02289417|566458193|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
156918670|NCT02289417|566458194|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
156918671|NCT02289417|566458186|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918672|NCT02289417|566458187|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918673|NCT02289417|566458188|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918674|NCT02289417|566458189|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918675|NCT02289417|566458190|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918676|NCT02289417|566458191|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918677|NCT02289417|566458192|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
156918678|NCT02289417|566458193|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
156918679|NCT02289417|566458194|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
156918680|NCT02289417|566458186|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918681|NCT02289417|566458187|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918682|NCT02289417|566458188|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918683|NCT02289417|566458189|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918684|NCT02289417|566458190|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918685|NCT02289417|566458191|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918686|NCT02289417|566458192|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
156918687|NCT02289417|566458193|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
156918688|NCT02289417|566458194|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
156918689|NCT02289417|566458186|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918690|NCT02289417|566458187|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
157028288|NCT03056573|566859185|FG000|Overall Study|Death|2|||
157162902|NCT03126539|567340594|FG002|Overall Study|Lost to Follow-up|1|||
157162903|NCT03126539|567340595|FG003|Overall Study|Lost to Follow-up|0|||
156918691|NCT02289417|566458188|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
157162904|NCT03126539|567340596|FG004|Overall Study|Lost to Follow-up|0|||
157162905|NCT01627067|567340597|FG000|Overall Study|Screen Failure|1|||
157162906|NCT00926796|567340598|FG000|Overall Study|Did not receive randomized treatment|4|||
157162907|NCT00926796|567340599|FG001|Overall Study|Did not receive randomized treatment|7|||
157162908|NCT00926796|567340598|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
157162909|NCT00926796|567340599|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
157162910|NCT00926796|567340598|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
157162911|NCT00926796|567340599|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
157162912|NCT00926796|567340598|FG000|Overall Study|Adverse Event|7|||
157162913|NCT00926796|567340599|FG001|Overall Study|Adverse Event|14|||
157162914|NCT00926796|567340598|FG000|Overall Study|Lost to Follow-up|22|||
157162915|NCT00926796|567340599|FG001|Overall Study|Lost to Follow-up|13|||
157162916|NCT00926796|567340598|FG000|Overall Study|Protocol Violation|15|||
157162917|NCT00926796|567340599|FG001|Overall Study|Protocol Violation|11|||
157162918|NCT00926796|567340598|FG000|Overall Study|Withdrawal by Subject|1|||
157162919|NCT00926796|567340599|FG001|Overall Study|Withdrawal by Subject|0|||
157162920|NCT01072539|567340605|FG000|Overall Study|Treated prior to the Site Initiation|1|||
157162921|NCT01072539|567340605|FG000|Overall Study|Protocol Violation|2|||
157162922|NCT00946530|567340606|FG000|Overall Study|Withdrawal by Subject|0|||
157162923|NCT00946530|567340607|FG001|Overall Study|Withdrawal by Subject|3|||
157162924|NCT00946530|567340608|FG002|Overall Study|Withdrawal by Subject|0|||
156918692|NCT02289417|566458189|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918693|NCT02289417|566458190|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918694|NCT02289417|566458191|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918695|NCT02289417|566458192|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918696|NCT02289417|566458193|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
156918697|NCT02289417|566458194|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
156918698|NCT02725710|566458195|FG000|Overall Study|Lost to Follow-up|1|||
156918699|NCT02725710|566458196|FG001|Overall Study|Lost to Follow-up|0|||
156918700|NCT01782222|566458210|FG000|Overall Study|Adverse Event|4|||
156918701|NCT01782222|566458211|FG001|Overall Study|Adverse Event|5|||
156918702|NCT01782222|566458212|FG002|Overall Study|Adverse Event|3|||
156918703|NCT01782222|566458210|FG000|Overall Study|Lack of Efficacy|2|||
156918704|NCT01782222|566458211|FG001|Overall Study|Lack of Efficacy|1|||
156918705|NCT01782222|566458212|FG002|Overall Study|Lack of Efficacy|0|||
156918706|NCT01782222|566458210|FG000|Overall Study|Protocol Violation|1|||
156918707|NCT01782222|566458211|FG001|Overall Study|Protocol Violation|0|||
156918708|NCT01782222|566458212|FG002|Overall Study|Protocol Violation|0|||
156918709|NCT01782222|566458210|FG000|Overall Study|Withdrawal by Subject|1|||
156918710|NCT01782222|566458211|FG001|Overall Study|Withdrawal by Subject|4|||
156918711|NCT01782222|566458212|FG002|Overall Study|Withdrawal by Subject|1|||
156918712|NCT01782222|566458210|FG000|Overall Study|Moved to other state|0|||
156918713|NCT01782222|566458211|FG001|Overall Study|Moved to other state|1|||
156918714|NCT01782222|566458212|FG002|Overall Study|Moved to other state|0|||
156918715|NCT01756898|566458216|FG000|Overall Study|Adverse Event|7|||
156918716|NCT01756898|566458217|FG001|Overall Study|Adverse Event|1|||
156918717|NCT01756898|566458218|FG002|Overall Study|Adverse Event|0|||
156918718|NCT01756898|566458219|FG003|Overall Study|Adverse Event|0|||
156918719|NCT01756898|566458216|FG000|Overall Study|Lack of Efficacy|4|||
156918720|NCT01756898|566458217|FG001|Overall Study|Lack of Efficacy|7|||
156918721|NCT01756898|566458218|FG002|Overall Study|Lack of Efficacy|6|||
156918722|NCT01756898|566458219|FG003|Overall Study|Lack of Efficacy|6|||
156918723|NCT01756898|566458216|FG000|Overall Study|Lost to Follow-up|2|||
156918724|NCT01756898|566458217|FG001|Overall Study|Lost to Follow-up|4|||
156918725|NCT01756898|566458218|FG002|Overall Study|Lost to Follow-up|2|||
156918726|NCT01756898|566458219|FG003|Overall Study|Lost to Follow-up|3|||
156918727|NCT01756898|566458216|FG000|Overall Study|Protocol Violation|1|||
156918728|NCT01756898|566458217|FG001|Overall Study|Protocol Violation|2|||
156918729|NCT01756898|566458218|FG002|Overall Study|Protocol Violation|2|||
156918730|NCT01756898|566458219|FG003|Overall Study|Protocol Violation|1|||
156918731|NCT01756898|566458216|FG000|Overall Study|Withdrew Consent|5|||
156918732|NCT01756898|566458217|FG001|Overall Study|Withdrew Consent|3|||
156918733|NCT01756898|566458218|FG002|Overall Study|Withdrew Consent|5|||
156918734|NCT01756898|566458219|FG003|Overall Study|Withdrew Consent|6|||
156918735|NCT01756898|566458216|FG000|Overall Study|Other|0|||
156918736|NCT01756898|566458217|FG001|Overall Study|Other|2|||
156918737|NCT01756898|566458218|FG002|Overall Study|Other|2|||
156918738|NCT01756898|566458219|FG003|Overall Study|Other|0|||
156918739|NCT01500694|566458220|FG000|Overall Study|Adverse Event|4|||
156918740|NCT01500694|566458221|FG001|Overall Study|Adverse Event|3|||
156918741|NCT01500694|566458220|FG000|Overall Study|Protocol Violation|0|||
157162925|NCT00946530|567340609|FG003|Overall Study|Withdrawal by Subject|3|||
157162926|NCT00946530|567340606|FG000|Overall Study|Physician Decision|1|||
157162927|NCT00946530|567340607|FG001|Overall Study|Physician Decision|1|||
157162928|NCT00946530|567340608|FG002|Overall Study|Physician Decision|1|||
156918742|NCT01500694|566458221|FG001|Overall Study|Protocol Violation|1|||
156918743|NCT01500694|566458220|FG000|Overall Study|Withdrawal by Subject|23|||
156918744|NCT01500694|566458221|FG001|Overall Study|Withdrawal by Subject|14|||
156918745|NCT01500694|566458220|FG000|Overall Study|Lost to Follow-up|2|||
156918746|NCT01500694|566458221|FG001|Overall Study|Lost to Follow-up|3|||
157028289|NCT03056573|566859186|FG001|Overall Study|Death|4|||
157028290|NCT03056573|566859185|FG000|Overall Study|Withdrawal by Subject|2|||
157028291|NCT03056573|566859186|FG001|Overall Study|Withdrawal by Subject|0|||
156918747|NCT01500694|566458220|FG000|Overall Study|Lack of Efficacy|14|||
156918748|NCT01500694|566458221|FG001|Overall Study|Lack of Efficacy|5|||
156918749|NCT01500694|566458220|FG000|Overall Study|Other|9|||
156918750|NCT01500694|566458221|FG001|Overall Study|Other|3|||
156918751|NCT01858389|566458222|FG000|Overall Study|Death|1|||
157028292|NCT03056573|566859185|FG000|Overall Study|Lost to Follow-up|1|||
157028293|NCT03056573|566859186|FG001|Overall Study|Lost to Follow-up|1|||
157028294|NCT05104463|566859187|FG000|Overall Study|Adverse Event|1|||
157028295|NCT05104463|566859188|FG001|Overall Study|Adverse Event|1|||
157028296|NCT05104463|566859187|FG000|Overall Study|Lost to Follow-up|1|||
157028297|NCT05104463|566859188|FG001|Overall Study|Lost to Follow-up|1|||
157028298|NCT05104463|566859187|FG000|Overall Study|Physician Decision|1|||
157028299|NCT05104463|566859188|FG001|Overall Study|Physician Decision|0|||
157028300|NCT05104463|566859187|FG000|Overall Study|Protocol Violation|0|||
157028301|NCT05104463|566859188|FG001|Overall Study|Protocol Violation|2|||
157028302|NCT05104463|566859187|FG000|Overall Study|Withdrawal by Subject|1|||
157028303|NCT05104463|566859188|FG001|Overall Study|Withdrawal by Subject|1|||
157028304|NCT05267470|566859189|FG000|Overall Study|Decision by sponsor|0|||
157028305|NCT05267470|566859190|FG001|Overall Study|Decision by sponsor|3|||
157028306|NCT05267470|566859191|FG002|Overall Study|Decision by sponsor|19|||
157028307|NCT05267470|566859192|FG003|Overall Study|Decision by sponsor|7|||
157028308|NCT05267470|566859193|FG004|Overall Study|Decision by sponsor|3|||
157028309|NCT05267470|566859189|FG000|Overall Study|Withdrawal by Subject|1|||
157028310|NCT05267470|566859190|FG001|Overall Study|Withdrawal by Subject|1|||
157028311|NCT05267470|566859191|FG002|Overall Study|Withdrawal by Subject|2|||
157028312|NCT05267470|566859192|FG003|Overall Study|Withdrawal by Subject|2|||
157028313|NCT05267470|566859193|FG004|Overall Study|Withdrawal by Subject|0|||
157028314|NCT05267470|566859189|FG000|Overall Study|Death|3|||
157028315|NCT05267470|566859190|FG001|Overall Study|Death|5|||
157028316|NCT05267470|566859191|FG002|Overall Study|Death|8|||
157028317|NCT05267470|566859192|FG003|Overall Study|Death|18|||
157028318|NCT05267470|566859193|FG004|Overall Study|Death|1|||
157028319|NCT05267470|566859189|FG000|Overall Study|Lost to Follow-up|0|||
157028320|NCT05267470|566859190|FG001|Overall Study|Lost to Follow-up|0|||
157028321|NCT05267470|566859191|FG002|Overall Study|Lost to Follow-up|0|||
157028322|NCT05267470|566859192|FG003|Overall Study|Lost to Follow-up|1|||
157028323|NCT05267470|566859193|FG004|Overall Study|Lost to Follow-up|0|||
157028324|NCT04428203|566859194|FG000|Overall Study|Adverse Event|1|||
157028325|NCT04428203|566859195|FG001|Overall Study|Adverse Event|0|||
157028326|NCT04428203|566859196|FG002|Overall Study|Adverse Event|0|||
157028327|NCT04428203|566859194|FG000|Overall Study|Withdrawal by Subject|1|||
157028328|NCT04428203|566859195|FG001|Overall Study|Withdrawal by Subject|0|||
157028329|NCT04428203|566859196|FG002|Overall Study|Withdrawal by Subject|1|||
157028330|NCT02823145|566859197|FG000|Enrollment|Other|1|||
157028331|NCT02823145|566859198|FG001|Enrollment|Other|0|||
157028332|NCT02823145|566859197|FG000|Treatment|Adverse Event|0|||
157028333|NCT02823145|566859198|FG001|Treatment|Adverse Event|11|||
157028334|NCT02823145|566859197|FG000|Treatment|Death|0|||
157028335|NCT02823145|566859198|FG001|Treatment|Death|3|||
157028336|NCT02823145|566859197|FG000|Treatment|Family Decision|0|||
157028337|NCT02823145|566859198|FG001|Treatment|Family Decision|1|||
157028338|NCT02823145|566859197|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
157028339|NCT02823145|566859198|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
157028340|NCT02823145|566859197|FG000|Treatment|Lack of Efficacy|0|||
157028341|NCT02823145|566859198|FG001|Treatment|Lack of Efficacy|48|||
157028342|NCT02823145|566859197|FG000|Treatment|Non-Compliance With E-Diary|0|||
157028343|NCT02823145|566859198|FG001|Treatment|Non-Compliance With E-Diary|1|||
157162929|NCT00946530|567340609|FG003|Overall Study|Physician Decision|1|||
157028344|NCT02823145|566859197|FG000|Treatment|Physician Decision|0|||
157028345|NCT02823145|566859198|FG001|Treatment|Physician Decision|2|||
157028346|NCT02823145|566859197|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
157028347|NCT02823145|566859198|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
156918752|NCT01858389|566458223|FG001|Overall Study|Death|3|||
156918753|NCT01858389|566458222|FG000|Overall Study|Study terminated by sponsor|0|||
157028348|NCT02823145|566859197|FG000|Treatment|Subject needed to take prohibited medication|0|||
157028349|NCT02823145|566859198|FG001|Treatment|Subject needed to take prohibited medication|1|||
157028350|NCT02823145|566859197|FG000|Treatment|Subject transferred to direct access programme|0|||
157028351|NCT02823145|566859198|FG001|Treatment|Subject transferred to direct access programme|1|||
157028352|NCT02823145|566859197|FG000|Treatment|Switching to commercially available drug|0|||
157028353|NCT02823145|566859198|FG001|Treatment|Switching to commercially available drug|11|||
157028354|NCT02823145|566859197|FG000|Treatment|Transitioned to commercial supply of medication|0|||
157028355|NCT02823145|566859198|FG001|Treatment|Transitioned to commercial supply of medication|1|||
156918754|NCT01858389|566458223|FG001|Overall Study|Study terminated by sponsor|2|||
156918755|NCT01858389|566458222|FG000|Overall Study|Withdrawal by Subject|0|||
156918756|NCT01858389|566458223|FG001|Overall Study|Withdrawal by Subject|1|||
156918757|NCT01858389|566458222|FG000|Overall Study|Progressive disease|10|||
156918758|NCT01858389|566458223|FG001|Overall Study|Progressive disease|11|||
156918759|NCT01858389|566458222|FG000|Overall Study|Other|2|||
156918760|NCT01858389|566458223|FG001|Overall Study|Other|4|||
156918761|NCT01858389|566458222|FG000|Overall Study|Adverse Event|3|||
157162930|NCT00115804|567340610|FG000|Overall Study|Adverse Event|2|||
156918762|NCT01858389|566458223|FG001|Overall Study|Adverse Event|1|||
156918763|NCT01858389|566458222|FG000|Overall Study|Did not receive treatment|0|||
156918764|NCT01858389|566458223|FG001|Overall Study|Did not receive treatment|3|||
156918765|NCT03572062|566458224|FG000|Overall Study|Adverse Event|0|||
156918766|NCT03572062|566458225|FG001|Overall Study|Adverse Event|0|||
156918767|NCT03572062|566458226|FG002|Overall Study|Adverse Event|0|||
156918768|NCT03572062|566458227|FG003|Overall Study|Adverse Event|0|||
156918769|NCT03572062|566458228|FG004|Overall Study|Adverse Event|0|||
156918770|NCT03572062|566458229|FG005|Overall Study|Adverse Event|0|||
156918771|NCT03572062|566458230|FG006|Overall Study|Adverse Event|0|||
156918772|NCT03572062|566458231|FG007|Overall Study|Adverse Event|0|||
156918773|NCT03572062|566458232|FG008|Overall Study|Adverse Event|1|||
156918774|NCT03572062|566458233|FG009|Overall Study|Adverse Event|3|||
156918775|NCT03572062|566458224|FG000|Overall Study|Death|0|||
157162931|NCT00621855|567340611|FG000|Overall Study|Adverse Event|32|||
157162932|NCT00621855|567340612|FG001|Overall Study|Adverse Event|31|||
157162933|NCT00621855|567340613|FG002|Overall Study|Adverse Event|48|||
157162934|NCT00621855|567340614|FG003|Overall Study|Adverse Event|34|||
157162935|NCT00621855|567340615|FG004|Overall Study|Adverse Event|31|||
157162936|NCT00621855|567340611|FG000|Overall Study|Lost to Follow-up|0|||
157162937|NCT00621855|567340612|FG001|Overall Study|Lost to Follow-up|1|||
157162938|NCT00621855|567340613|FG002|Overall Study|Lost to Follow-up|3|||
157162939|NCT00621855|567340614|FG003|Overall Study|Lost to Follow-up|4|||
157162940|NCT00621855|567340615|FG004|Overall Study|Lost to Follow-up|1|||
157162941|NCT00621855|567340611|FG000|Overall Study|Protocol Violation|16|||
157162942|NCT00621855|567340612|FG001|Overall Study|Protocol Violation|8|||
157162943|NCT00621855|567340613|FG002|Overall Study|Protocol Violation|6|||
157162944|NCT00621855|567340614|FG003|Overall Study|Protocol Violation|7|||
157162945|NCT00621855|567340615|FG004|Overall Study|Protocol Violation|8|||
157162946|NCT00621855|567340611|FG000|Overall Study|Withdrawal by Subject|16|||
157162947|NCT00621855|567340612|FG001|Overall Study|Withdrawal by Subject|11|||
157162948|NCT00621855|567340613|FG002|Overall Study|Withdrawal by Subject|13|||
157162949|NCT00621855|567340614|FG003|Overall Study|Withdrawal by Subject|13|||
157162950|NCT00621855|567340615|FG004|Overall Study|Withdrawal by Subject|9|||
157162951|NCT00621855|567340611|FG000|Overall Study|Other|9|||
157162952|NCT00621855|567340612|FG001|Overall Study|Other|7|||
157162953|NCT00621855|567340613|FG002|Overall Study|Other|6|||
157162954|NCT00621855|567340614|FG003|Overall Study|Other|5|||
157162955|NCT00621855|567340615|FG004|Overall Study|Other|4|||
157162956|NCT00621855|567340611|FG000|Overall Study|Patients did not receive study drug|3|||
157162957|NCT00621855|567340612|FG001|Overall Study|Patients did not receive study drug|3|||
157162958|NCT00621855|567340613|FG002|Overall Study|Patients did not receive study drug|5|||
157162959|NCT00621855|567340614|FG003|Overall Study|Patients did not receive study drug|4|||
157162960|NCT00621855|567340615|FG004|Overall Study|Patients did not receive study drug|2|||
157162961|NCT04387136|567340616|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
157162962|NCT04387136|567340617|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
157162963|NCT01029886|567340620|FG000|Overall Study|Adverse Event|12|||
157162964|NCT01029886|567340621|FG001|Overall Study|Adverse Event|25|||
157162965|NCT01029886|567340620|FG000|Overall Study|Lost to Follow-up|1|||
157162966|NCT01029886|567340621|FG001|Overall Study|Lost to Follow-up|0|||
157162967|NCT01029886|567340620|FG000|Overall Study|Physician Decision|2|||
157162968|NCT01029886|567340621|FG001|Overall Study|Physician Decision|6|||
157162969|NCT01029886|567340620|FG000|Overall Study|Protocol Violation|17|||
157162970|NCT01029886|567340621|FG001|Overall Study|Protocol Violation|5|||
157162971|NCT01029886|567340620|FG000|Overall Study|Withdrawal by Subject|8|||
156918776|NCT03572062|566458225|FG001|Overall Study|Death|0|||
156918777|NCT03572062|566458226|FG002|Overall Study|Death|0|||
156918778|NCT03572062|566458227|FG003|Overall Study|Death|0|||
157162972|NCT01029886|567340621|FG001|Overall Study|Withdrawal by Subject|18|||
157162973|NCT01029886|567340620|FG000|Overall Study|Entry Criteria Not Met|13|||
156918779|NCT03572062|566458228|FG004|Overall Study|Death|0|||
156918780|NCT03572062|566458229|FG005|Overall Study|Death|1|||
156918781|NCT03572062|566458230|FG006|Overall Study|Death|0|||
157162974|NCT01029886|567340621|FG001|Overall Study|Entry Criteria Not Met|5|||
157162975|NCT01029886|567340620|FG000|Overall Study|Sponsor Decision|1|||
157162976|NCT01029886|567340621|FG001|Overall Study|Sponsor Decision|0|||
157162977|NCT01029886|567340620|FG000|Overall Study|Loss Glucose Control|7|||
157162978|NCT01029886|567340621|FG001|Overall Study|Loss Glucose Control|1|||
157162979|NCT03294681|567340622|FG000|Overall Study|Withdrawal by Subject|1|||
157162980|NCT00417976|567340623|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
157162981|NCT00417976|567340623|FG000|Overall Study|Treatment -related toxicity|2|||
156918782|NCT03572062|566458231|FG007|Overall Study|Death|0|||
156918783|NCT03572062|566458232|FG008|Overall Study|Death|0|||
156918784|NCT03572062|566458233|FG009|Overall Study|Death|0|||
156918785|NCT03572062|566458224|FG000|Overall Study|Lost to Follow-up|0|||
156918786|NCT03572062|566458225|FG001|Overall Study|Lost to Follow-up|0|||
156918787|NCT03572062|566458226|FG002|Overall Study|Lost to Follow-up|0|||
156918788|NCT03572062|566458227|FG003|Overall Study|Lost to Follow-up|0|||
156918789|NCT03572062|566458228|FG004|Overall Study|Lost to Follow-up|0|||
156918790|NCT03572062|566458229|FG005|Overall Study|Lost to Follow-up|1|||
156918791|NCT03572062|566458230|FG006|Overall Study|Lost to Follow-up|1|||
156918792|NCT03572062|566458231|FG007|Overall Study|Lost to Follow-up|0|||
156918793|NCT03572062|566458232|FG008|Overall Study|Lost to Follow-up|0|||
156918794|NCT03572062|566458233|FG009|Overall Study|Lost to Follow-up|0|||
156918795|NCT03572062|566458224|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918796|NCT03572062|566458225|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918797|NCT03572062|566458226|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918798|NCT03572062|566458227|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918799|NCT03572062|566458228|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918800|NCT03572062|566458229|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918801|NCT03572062|566458230|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918802|NCT03572062|566458231|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918803|NCT03572062|566458232|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
156918804|NCT03572062|566458233|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
156918805|NCT03572062|566458224|FG000|Overall Study|Study Terminated By Sponsor|0|||
156918806|NCT03572062|566458225|FG001|Overall Study|Study Terminated By Sponsor|0|||
156918807|NCT03572062|566458226|FG002|Overall Study|Study Terminated By Sponsor|0|||
156918808|NCT03572062|566458227|FG003|Overall Study|Study Terminated By Sponsor|0|||
156918809|NCT03572062|566458228|FG004|Overall Study|Study Terminated By Sponsor|0|||
156918810|NCT03572062|566458229|FG005|Overall Study|Study Terminated By Sponsor|0|||
156918811|NCT03572062|566458230|FG006|Overall Study|Study Terminated By Sponsor|0|||
156918812|NCT03572062|566458231|FG007|Overall Study|Study Terminated By Sponsor|0|||
156918813|NCT03572062|566458232|FG008|Overall Study|Study Terminated By Sponsor|29|||
156918814|NCT03572062|566458233|FG009|Overall Study|Study Terminated By Sponsor|27|||
156918815|NCT03572062|566458224|FG000|Overall Study|Physician Decision|0|||
156918816|NCT03572062|566458225|FG001|Overall Study|Physician Decision|0|||
156918817|NCT03572062|566458226|FG002|Overall Study|Physician Decision|0|||
156918818|NCT03572062|566458227|FG003|Overall Study|Physician Decision|0|||
156918819|NCT03572062|566458228|FG004|Overall Study|Physician Decision|0|||
156918820|NCT03572062|566458229|FG005|Overall Study|Physician Decision|0|||
156918821|NCT03572062|566458230|FG006|Overall Study|Physician Decision|0|||
156918822|NCT03572062|566458231|FG007|Overall Study|Physician Decision|0|||
156918823|NCT03572062|566458232|FG008|Overall Study|Physician Decision|1|||
156918824|NCT03572062|566458233|FG009|Overall Study|Physician Decision|0|||
156918825|NCT03572062|566458224|FG000|Overall Study|Withdrawal by Subject|0|||
156918826|NCT03572062|566458225|FG001|Overall Study|Withdrawal by Subject|0|||
156918827|NCT03572062|566458226|FG002|Overall Study|Withdrawal by Subject|0|||
156918828|NCT03572062|566458227|FG003|Overall Study|Withdrawal by Subject|0|||
156918829|NCT03572062|566458228|FG004|Overall Study|Withdrawal by Subject|0|||
156918830|NCT03572062|566458229|FG005|Overall Study|Withdrawal by Subject|0|||
156918831|NCT03572062|566458230|FG006|Overall Study|Withdrawal by Subject|0|||
156918832|NCT03572062|566458231|FG007|Overall Study|Withdrawal by Subject|0|||
156918833|NCT03572062|566458232|FG008|Overall Study|Withdrawal by Subject|0|||
156918834|NCT03572062|566458233|FG009|Overall Study|Withdrawal by Subject|1|||
156918835|NCT03572062|566458224|FG000|Overall Study|Randomized But Not Treated|0|||
156918836|NCT03572062|566458225|FG001|Overall Study|Randomized But Not Treated|0|||
156918837|NCT03572062|566458226|FG002|Overall Study|Randomized But Not Treated|0|||
156918838|NCT03572062|566458227|FG003|Overall Study|Randomized But Not Treated|0|||
156918839|NCT03572062|566458228|FG004|Overall Study|Randomized But Not Treated|1|||
156918840|NCT03572062|566458229|FG005|Overall Study|Randomized But Not Treated|2|||
157226496|NCT00520741|567575860|FG000|Overall Study|Other reasons for premature termination|0|||
156918841|NCT03572062|566458230|FG006|Overall Study|Randomized But Not Treated|0|||
156918842|NCT03572062|566458231|FG007|Overall Study|Randomized But Not Treated|1|||
156918843|NCT03572062|566458232|FG008|Overall Study|Randomized But Not Treated|0|||
156918844|NCT03572062|566458233|FG009|Overall Study|Randomized But Not Treated|0|||
157226497|NCT00520741|567575861|FG001|Overall Study|Other reasons for premature termination|6|||
156918845|NCT01691781|566458234|FG000|Overall Study|Withdrawal by Subject|4|||
156918846|NCT01691781|566458235|FG001|Overall Study|Withdrawal by Subject|3|||
156918847|NCT01691781|566458234|FG000|Overall Study|Physician Decision|1|||
156918848|NCT01691781|566458235|FG001|Overall Study|Physician Decision|1|||
156918849|NCT01691781|566458234|FG000|Overall Study|Protocol Violation|2|||
157226498|NCT04373434|567575862|FG000|Overall Study|Lost to Follow-up|37|||
156918850|NCT01691781|566458235|FG001|Overall Study|Protocol Violation|2|||
156918851|NCT01691781|566458234|FG000|Overall Study|Adverse Event|0|||
156918852|NCT01691781|566458235|FG001|Overall Study|Adverse Event|1|||
156918853|NCT03978520|566458236|FG000|Overall Study|Adverse Event|2|||
156918854|NCT03978520|566458237|FG001|Overall Study|Adverse Event|5|||
157226499|NCT04373434|567575863|FG001|Overall Study|Lost to Follow-up|32|||
157226500|NCT04373434|567575862|FG000|Overall Study|Refused at 9 months|1|||
157226501|NCT04373434|567575863|FG001|Overall Study|Refused at 9 months|2|||
157226502|NCT04373434|567575862|FG000|Overall Study|Refused at 4 months|7|||
157226503|NCT04373434|567575863|FG001|Overall Study|Refused at 4 months|3|||
157226504|NCT04373434|567575862|FG000|Overall Study|Excluded|2|||
157226505|NCT04373434|567575863|FG001|Overall Study|Excluded|0|||
157226506|NCT03702621|567575864|FG000|Overall Study|Physician Decision|6|||
157226507|NCT03702621|567575865|FG001|Overall Study|Physician Decision|6|||
157226508|NCT00527423|567575866|FG000|Overall Study|Protocol Violation|1|||
157226509|NCT00527423|567575866|FG000|Overall Study|Adverse Event|5|||
157226510|NCT00527423|567575866|FG000|Overall Study|Physician Decision|4|||
157226511|NCT00527423|567575866|FG000|Overall Study|Withdrawal by Subject|10|||
157226512|NCT00527423|567575866|FG000|Overall Study|Lost to Follow-up|4|||
157226513|NCT00527423|567575866|FG000|Overall Study|OTHER|4|||
157226514|NCT00527423|567575866|FG000|Overall Study|Death|9|||
157226515|NCT03194464|567575867|FG000|Overall Study|data not usable|2|||
157226516|NCT02446132|567575868|FG000|Overall Study|Adverse Event|10|||
157226517|NCT02446132|567575869|FG001|Overall Study|Adverse Event|27|||
157226518|NCT02446132|567575870|FG002|Overall Study|Adverse Event|27|||
157226519|NCT02446132|567575868|FG000|Overall Study|Death|2|||
157226520|NCT02446132|567575869|FG001|Overall Study|Death|13|||
157226521|NCT02446132|567575870|FG002|Overall Study|Death|10|||
157226522|NCT02446132|567575868|FG000|Overall Study|Lack of Efficacy|1|||
157226523|NCT02446132|567575869|FG001|Overall Study|Lack of Efficacy|10|||
157226524|NCT02446132|567575870|FG002|Overall Study|Lack of Efficacy|6|||
157226525|NCT02446132|567575868|FG000|Overall Study|Lost to Follow-up|2|||
157226526|NCT02446132|567575869|FG001|Overall Study|Lost to Follow-up|4|||
157226527|NCT02446132|567575870|FG002|Overall Study|Lost to Follow-up|5|||
157226528|NCT02446132|567575868|FG000|Overall Study|Non-compliance With Study Drug|2|||
157226529|NCT02446132|567575869|FG001|Overall Study|Non-compliance With Study Drug|2|||
157226530|NCT02446132|567575870|FG002|Overall Study|Non-compliance With Study Drug|3|||
157226531|NCT02446132|567575868|FG000|Overall Study|Physician Decision|1|||
157226532|NCT02446132|567575869|FG001|Overall Study|Physician Decision|8|||
157226533|NCT02446132|567575870|FG002|Overall Study|Physician Decision|13|||
157226534|NCT02446132|567575868|FG000|Overall Study|Protocol Deviation|0|||
157226535|NCT02446132|567575869|FG001|Overall Study|Protocol Deviation|0|||
157226536|NCT02446132|567575870|FG002|Overall Study|Protocol Deviation|1|||
157226537|NCT02446132|567575868|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
157226538|NCT02446132|567575869|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
157226539|NCT02446132|567575870|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
157226540|NCT02446132|567575868|FG000|Overall Study|Study Terminated by Sponsor|4|||
157226541|NCT02446132|567575869|FG001|Overall Study|Study Terminated by Sponsor|35|||
157226542|NCT02446132|567575870|FG002|Overall Study|Study Terminated by Sponsor|58|||
157226543|NCT02446132|567575868|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
157226544|NCT02446132|567575869|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
157226545|NCT02446132|567575870|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
157226546|NCT02446132|567575868|FG000|Overall Study|Withdrawal by Subject|11|||
157226547|NCT02446132|567575869|FG001|Overall Study|Withdrawal by Subject|29|||
157226548|NCT02446132|567575870|FG002|Overall Study|Withdrawal by Subject|25|||
157226549|NCT02446132|567575868|FG000|Overall Study|Reason not Specified|4|||
157226550|NCT02446132|567575869|FG001|Overall Study|Reason not Specified|16|||
157226551|NCT02446132|567575870|FG002|Overall Study|Reason not Specified|10|||
157226552|NCT02446132|567575868|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
157226553|NCT02446132|567575869|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
157226554|NCT02446132|567575870|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
157028356|NCT02823145|566859197|FG000|Treatment|Withdrawal By Caregiver|0|||
157028357|NCT02823145|566859198|FG001|Treatment|Withdrawal By Caregiver|1|||
157028358|NCT02823145|566859197|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
157226555|NCT03444038|567575871|FG000|Overall Study|Adverse Event|12|||
157226556|NCT03444038|567575871|FG000|Overall Study|Withdrawal by Subject|7|||
157226557|NCT03444038|567575871|FG000|Overall Study|Lost to Follow-up|1|||
157028359|NCT02823145|566859198|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
157028360|NCT02823145|566859197|FG000|Treatment|Withdrawal by Subject|0|||
157028361|NCT02823145|566859198|FG001|Treatment|Withdrawal by Subject|16|||
157226558|NCT03444038|567575871|FG000|Overall Study|Physician Decision|2|||
157226559|NCT03444038|567575871|FG000|Overall Study|Lack of Efficacy|7|||
157226560|NCT02354586|567575872|FG000|Overall Study|Death|230|||
157226561|NCT02354586|567575872|FG000|Overall Study|Withdrawal by Subject|59|||
157226562|NCT02354586|567575872|FG000|Overall Study|Lost to Follow-up|11|||
157226563|NCT02354586|567575872|FG000|Overall Study|Sponsor decision|51|||
157226564|NCT02354586|567575872|FG000|Overall Study|Site closure|2|||
157226565|NCT02354586|567575872|FG000|Overall Study|Intercurrent illness|1|||
157226566|NCT02354586|567575872|FG000|Overall Study|Protocol Violation|3|||
157226567|NCT02354586|567575872|FG000|Overall Study|Physician Decision|13|||
157226568|NCT02354586|567575872|FG000|Overall Study|Lack of Efficacy|86|||
157226569|NCT02354586|567575872|FG000|Overall Study|Adverse Event|7|||
157028362|NCT02823145|566859197|FG000|Treatment|Reason unknown|0|||
157028363|NCT02823145|566859198|FG001|Treatment|Reason unknown|1|||
157028364|NCT02841579|566860580|FG000|Overall Study|Death|1|||
157028365|NCT02841579|566860580|FG000|Overall Study|Adverse Event|1|||
157028366|NCT02841579|566860580|FG000|Overall Study|Lack of Efficacy|9|||
157028367|NCT03011333|566860581|FG000|Overall Study|Lost to Follow-up|0|||
157028368|NCT03011333|566860582|FG001|Overall Study|Lost to Follow-up|1|||
157028369|NCT03011333|566860583|FG002|Overall Study|Lost to Follow-up|0|||
157028370|NCT03011333|566860584|FG003|Overall Study|Lost to Follow-up|1|||
157028371|NCT03011333|566860585|FG004|Overall Study|Lost to Follow-up|4|||
157028372|NCT03011333|566860586|FG005|Overall Study|Lost to Follow-up|4|||
157028373|NCT03011333|566860587|FG006|Overall Study|Lost to Follow-up|5|||
157028374|NCT02998268|566860588|FG000|Overall Study|Adverse Event|0|||
157028375|NCT02998268|566860589|FG001|Overall Study|Adverse Event|2|||
157028376|NCT02998268|566860588|FG000|Overall Study|Withdrawal by Subject|0|||
157028377|NCT02998268|566860589|FG001|Overall Study|Withdrawal by Subject|1|||
157028378|NCT05622812|566860590|FG000|Overall Study|Withdrawal by Subject|1|||
157028379|NCT05622812|566860591|FG001|Overall Study|Withdrawal by Subject|4|||
157028380|NCT05622812|566860590|FG000|Overall Study|Lost to Follow-up|2|||
157028381|NCT05622812|566860591|FG001|Overall Study|Lost to Follow-up|1|||
157028382|NCT02116530|566860592|FG000|Overall Study|Withdrawal by Subject|1|||
157028383|NCT02116530|566860593|FG001|Overall Study|Withdrawal by Subject|2|||
157028384|NCT02116530|566860592|FG000|Overall Study|Adverse Event|4|||
157028385|NCT02116530|566860593|FG001|Overall Study|Adverse Event|0|||
157028386|NCT02116530|566860592|FG000|Overall Study|Physician Decision|1|||
157028387|NCT02116530|566860593|FG001|Overall Study|Physician Decision|0|||
157028388|NCT02116530|566860592|FG000|Overall Study|Lost to Follow-up|1|||
157028389|NCT02116530|566860593|FG001|Overall Study|Lost to Follow-up|0|||
157028390|NCT02116530|566860592|FG000|Overall Study|Other Medical Problems|2|||
157028391|NCT02116530|566860593|FG001|Overall Study|Other Medical Problems|2|||
157028392|NCT02927236|566860594|FG000|Characterization Phase|Physician Decision|0|||
157028393|NCT02927236|566860595|FG001|Characterization Phase|Physician Decision|3|||
157028394|NCT02927236|566860596|FG002|Characterization Phase|Physician Decision|0|||
157028395|NCT02927236|566860597|FG003|Characterization Phase|Physician Decision|2|||
157028396|NCT02927236|566860594|FG000|Characterization Phase|Lost to Follow-up|0|||
157028397|NCT02927236|566860595|FG001|Characterization Phase|Lost to Follow-up|0|||
157028398|NCT02927236|566860596|FG002|Characterization Phase|Lost to Follow-up|0|||
157028399|NCT02927236|566860597|FG003|Characterization Phase|Lost to Follow-up|3|||
157028400|NCT02927236|566860594|FG000|Characterization Phase|Withdrawal by Subject|1|||
157028401|NCT02927236|566860595|FG001|Characterization Phase|Withdrawal by Subject|0|||
157028402|NCT02927236|566860596|FG002|Characterization Phase|Withdrawal by Subject|0|||
157028403|NCT02927236|566860597|FG003|Characterization Phase|Withdrawal by Subject|1|||
157028404|NCT02927236|566860594|FG000|Treatment Phase|Adverse Event|1|||
157028405|NCT02927236|566860595|FG001|Treatment Phase|Adverse Event|0|||
157028406|NCT02927236|566860596|FG002|Treatment Phase|Adverse Event|1|||
157028407|NCT02927236|566860597|FG003|Treatment Phase|Adverse Event|1|||
157028408|NCT02927236|566860594|FG000|Treatment Phase|Protocol Violation|3|||
157028409|NCT02927236|566860595|FG001|Treatment Phase|Protocol Violation|0|||
157028410|NCT02927236|566860596|FG002|Treatment Phase|Protocol Violation|0|||
157028411|NCT02927236|566860597|FG003|Treatment Phase|Protocol Violation|1|||
157028412|NCT02927236|566860594|FG000|Treatment Phase|Lost to Follow-up|1|||
157028413|NCT02927236|566860595|FG001|Treatment Phase|Lost to Follow-up|0|||
157028414|NCT02927236|566860596|FG002|Treatment Phase|Lost to Follow-up|0|||
157028415|NCT02927236|566860597|FG003|Treatment Phase|Lost to Follow-up|0|||
157028416|NCT02927236|566860594|FG000|Follow-up Phase|Lost to Follow-up|1|||
157028417|NCT02927236|566860595|FG001|Follow-up Phase|Lost to Follow-up|0|||
157028418|NCT02927236|566860596|FG002|Follow-up Phase|Lost to Follow-up|1|||
157028419|NCT02927236|566860597|FG003|Follow-up Phase|Lost to Follow-up|0|||
157028420|NCT05297565|566860598|FG000|Overall Study|Other Reasons|0|||
157028421|NCT05297565|566860599|FG001|Overall Study|Other Reasons|1|||
157028422|NCT05297565|566860598|FG000|Overall Study|Physician Decision|0|||
157028423|NCT05297565|566860599|FG001|Overall Study|Physician Decision|1|||
157028424|NCT05297565|566860598|FG000|Overall Study|Disease recurrence|1|||
157028425|NCT05297565|566860599|FG001|Overall Study|Disease recurrence|0|||
157028426|NCT01959607|566860600|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
157028427|NCT01959607|566860601|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
157028428|NCT01959607|566860602|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
157028429|NCT01959607|566860603|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
157028430|NCT03913442|566860604|FG000|Overall Study|Adverse Event|0|||
157028431|NCT03913442|566860605|FG001|Overall Study|Adverse Event|3|||
157028432|NCT03913442|566860604|FG000|Overall Study|Withdrawal by Subject|5|||
157162982|NCT04501679|567340624|FG000|Overall Study|Pregnancy|0|||
157028433|NCT03913442|566860605|FG001|Overall Study|Withdrawal by Subject|5|||
157028434|NCT03913442|566860604|FG000|Overall Study|Terminations|2|||
157028435|NCT03913442|566860605|FG001|Overall Study|Terminations|1|||
157028436|NCT03913442|566860604|FG000|Overall Study|Lost to Follow-up|2|||
157028437|NCT03913442|566860605|FG001|Overall Study|Lost to Follow-up|2|||
157028438|NCT02433379|566860609|FG000|Overall Study|Screen Failures|55|||
157162983|NCT04501679|567340625|FG001|Overall Study|Pregnancy|1|||
157028439|NCT02433379|566860609|FG000|Overall Study|Death|57|||
157028440|NCT02433379|566860609|FG000|Overall Study|Total Withdrawals|209|||
157028441|NCT03952338|566860610|FG000|Overall Study|Lost to Follow-up|11|||
157028442|NCT03952338|566860611|FG001|Overall Study|Lost to Follow-up|17|||
157028443|NCT03952338|566860610|FG000|Overall Study|Withdrawal by Subject|1|||
157028444|NCT03952338|566860611|FG001|Overall Study|Withdrawal by Subject|1|||
157028445|NCT03952338|566860610|FG000|Overall Study|Protocol Violation|1|||
157028446|NCT03952338|566860611|FG001|Overall Study|Protocol Violation|0|||
157028447|NCT03710603|566860612|FG000|Overall Study|Adverse Event|1|||
157028448|NCT03710603|566860613|FG001|Overall Study|Adverse Event|0|||
157028449|NCT03710603|566860612|FG000|Overall Study|Death|44|||
157028450|NCT03710603|566860613|FG001|Overall Study|Death|34|||
157028451|NCT03710603|566860612|FG000|Overall Study|Lost to Follow-up|3|||
157028452|NCT03710603|566860613|FG001|Overall Study|Lost to Follow-up|5|||
157028453|NCT03710603|566860612|FG000|Overall Study|Withdrawal by Subject|11|||
157028454|NCT03710603|566860613|FG001|Overall Study|Withdrawal by Subject|10|||
157028455|NCT02589795|566860616|FG000|Overall Study|Lost to Follow-up|1|||
157028456|NCT02589795|566860617|FG001|Overall Study|Lost to Follow-up|0|||
157028457|NCT02589795|566860618|FG002|Overall Study|Lost to Follow-up|0|||
157028458|NCT02589795|566860616|FG000|Overall Study|Withdrawal by Subject|0|||
157028459|NCT02589795|566860617|FG001|Overall Study|Withdrawal by Subject|0|||
157028460|NCT02589795|566860618|FG002|Overall Study|Withdrawal by Subject|2|||
157028461|NCT02589795|566860616|FG000|Overall Study|Protocol Violation|0|||
157028462|NCT02589795|566860617|FG001|Overall Study|Protocol Violation|0|||
157028463|NCT02589795|566860618|FG002|Overall Study|Protocol Violation|1|||
156918855|NCT03978520|566458238|FG002|Overall Study|Adverse Event|3|||
156918856|NCT03978520|566458239|FG003|Overall Study|Adverse Event|5|||
156918857|NCT03978520|566458240|FG004|Overall Study|Adverse Event|6|||
156918858|NCT03978520|566458236|FG000|Overall Study|Withdrawal by Subject|10|||
156918859|NCT03978520|566458237|FG001|Overall Study|Withdrawal by Subject|4|||
156918860|NCT03978520|566458238|FG002|Overall Study|Withdrawal by Subject|5|||
156918861|NCT03978520|566458239|FG003|Overall Study|Withdrawal by Subject|6|||
156918862|NCT03978520|566458240|FG004|Overall Study|Withdrawal by Subject|5|||
156918863|NCT03978520|566458236|FG000|Overall Study|Lost to Follow-up|2|||
156918864|NCT03978520|566458237|FG001|Overall Study|Lost to Follow-up|2|||
156918865|NCT03978520|566458238|FG002|Overall Study|Lost to Follow-up|2|||
156918866|NCT03978520|566458239|FG003|Overall Study|Lost to Follow-up|0|||
156918867|NCT03978520|566458240|FG004|Overall Study|Lost to Follow-up|1|||
156918868|NCT03978520|566458236|FG000|Overall Study|COVID-19 infection|0|||
156918869|NCT03978520|566458237|FG001|Overall Study|COVID-19 infection|1|||
156918870|NCT03978520|566458238|FG002|Overall Study|COVID-19 infection|0|||
156918871|NCT03978520|566458239|FG003|Overall Study|COVID-19 infection|0|||
156918872|NCT03978520|566458240|FG004|Overall Study|COVID-19 infection|0|||
156918873|NCT03978520|566458236|FG000|Overall Study|Other, not specified|9|||
156918874|NCT03978520|566458237|FG001|Overall Study|Other, not specified|4|||
156918875|NCT03978520|566458238|FG002|Overall Study|Other, not specified|1|||
156918876|NCT03978520|566458239|FG003|Overall Study|Other, not specified|1|||
156918877|NCT03978520|566458240|FG004|Overall Study|Other, not specified|2|||
156918878|NCT03978520|566458236|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
156918879|NCT03978520|566458237|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
156918880|NCT03978520|566458238|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
156918881|NCT03978520|566458239|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
156918882|NCT03978520|566458240|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
156918883|NCT01918085|566458243|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
156918884|NCT01918085|566458244|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
156918885|NCT00600483|566458247|FG000|Overall Study|Lost to Follow-up|26|||
156918886|NCT00600483|566458248|FG001|Overall Study|Lost to Follow-up|47|||
156918887|NCT00600483|566458247|FG000|Overall Study|Randomized but not treated|10|||
156918888|NCT00600483|566458248|FG001|Overall Study|Randomized but not treated|0|||
156918889|NCT03655691|566458259|FG000|Overall Study|Adverse Event|0|||
156918890|NCT03655691|566458260|FG001|Overall Study|Adverse Event|0|||
156918891|NCT03655691|566458261|FG002|Overall Study|Adverse Event|1|||
156918892|NCT03655691|566458259|FG000|Overall Study|Lost to Follow-up|1|||
156918893|NCT03655691|566458260|FG001|Overall Study|Lost to Follow-up|1|||
156918894|NCT03655691|566458261|FG002|Overall Study|Lost to Follow-up|2|||
156918895|NCT03655691|566458259|FG000|Overall Study|Protocol Violation|0|||
156918896|NCT03655691|566458260|FG001|Overall Study|Protocol Violation|1|||
157028464|NCT00321048|566860620|FG000|Overall Study|Withdrawal by Subject|6|||
157028465|NCT00321048|566860621|FG001|Overall Study|Withdrawal by Subject|8|||
157028466|NCT06473662|566860622|FG000|Overall Study|Withdrawal by Subject|1|||
156918897|NCT03655691|566458261|FG002|Overall Study|Protocol Violation|0|||
156918898|NCT03655691|566458259|FG000|Overall Study|Withdrawal by Subject|1|||
156918899|NCT03655691|566458260|FG001|Overall Study|Withdrawal by Subject|1|||
157028467|NCT06473662|566860623|FG001|Overall Study|Withdrawal by Subject|6|||
157028468|NCT06473662|566860624|FG002|Overall Study|Withdrawal by Subject|5|||
157028469|NCT06473662|566860622|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
157028470|NCT06473662|566860623|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
156918900|NCT03655691|566458261|FG002|Overall Study|Withdrawal by Subject|0|||
156918901|NCT03694821|566458262|FG000|Overall Study|Study terminated|4|||
156918902|NCT03694821|566458263|FG001|Overall Study|Study terminated|8|||
156918903|NCT03694821|566458264|FG002|Overall Study|Study terminated|4|||
156918904|NCT04102020|566458269|FG000|Overall Study|Adverse Event|1|||
156918905|NCT04102020|566458270|FG001|Overall Study|Adverse Event|0|||
156918906|NCT04102020|566458271|FG002|Overall Study|Adverse Event|0|||
156918907|NCT04102020|566458272|FG003|Overall Study|Adverse Event|1|||
156918908|NCT04102020|566458273|FG004|Overall Study|Adverse Event|0|||
156918909|NCT04102020|566458269|FG000|Overall Study|Withdrawal by Subject|0|||
156918910|NCT04102020|566458270|FG001|Overall Study|Withdrawal by Subject|1|||
156918911|NCT04102020|566458271|FG002|Overall Study|Withdrawal by Subject|1|||
156918912|NCT04102020|566458272|FG003|Overall Study|Withdrawal by Subject|1|||
156918913|NCT04102020|566458273|FG004|Overall Study|Withdrawal by Subject|1|||
156918914|NCT04102020|566458269|FG000|Overall Study|Death|1|||
156918915|NCT04102020|566458270|FG001|Overall Study|Death|4|||
156918916|NCT04102020|566458271|FG002|Overall Study|Death|1|||
156918917|NCT04102020|566458272|FG003|Overall Study|Death|1|||
156918918|NCT04102020|566458273|FG004|Overall Study|Death|0|||
156918919|NCT04102020|566458269|FG000|Overall Study|Physician Decision|1|||
156918920|NCT04102020|566458270|FG001|Overall Study|Physician Decision|2|||
156918921|NCT04102020|566458271|FG002|Overall Study|Physician Decision|2|||
156918922|NCT04102020|566458272|FG003|Overall Study|Physician Decision|0|||
156918923|NCT04102020|566458273|FG004|Overall Study|Physician Decision|1|||
156918924|NCT04102020|566458269|FG000|Overall Study|COVID-19 Infection|1|||
156918925|NCT04102020|566458270|FG001|Overall Study|COVID-19 Infection|0|||
156918926|NCT04102020|566458271|FG002|Overall Study|COVID-19 Infection|0|||
156918927|NCT04102020|566458272|FG003|Overall Study|COVID-19 Infection|0|||
156918928|NCT04102020|566458273|FG004|Overall Study|COVID-19 Infection|0|||
156918929|NCT04102020|566458269|FG000|Overall Study|Not disclosed|5|||
156918930|NCT04102020|566458270|FG001|Overall Study|Not disclosed|3|||
156918931|NCT04102020|566458271|FG002|Overall Study|Not disclosed|8|||
156918932|NCT04102020|566458272|FG003|Overall Study|Not disclosed|0|||
156918933|NCT04102020|566458273|FG004|Overall Study|Not disclosed|1|||
156918934|NCT04102020|566458269|FG000|Overall Study|MIssing|1|||
156918935|NCT04102020|566458270|FG001|Overall Study|MIssing|0|||
156918936|NCT04102020|566458271|FG002|Overall Study|MIssing|1|||
156918937|NCT04102020|566458272|FG003|Overall Study|MIssing|1|||
157028471|NCT06473662|566860624|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
157028472|NCT06473662|566860622|FG000|Overall Study|Starting HbA1c below 7%|0|||
157028473|NCT06473662|566860623|FG001|Overall Study|Starting HbA1c below 7%|1|||
157028474|NCT06473662|566860624|FG002|Overall Study|Starting HbA1c below 7%|1|||
157028475|NCT06473662|566860622|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
157028476|NCT06473662|566860623|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
157028477|NCT06473662|566860624|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
157028478|NCT06473662|566860622|FG000|Overall Study|Did not take medication|2|||
157028479|NCT06473662|566860623|FG001|Overall Study|Did not take medication|3|||
157028480|NCT06473662|566860624|FG002|Overall Study|Did not take medication|2|||
157028481|NCT02038777|566860627|FG000|Overall Study|Death|0|||
157028482|NCT02038777|566860628|FG001|Overall Study|Death|2|||
157028483|NCT02038777|566860629|FG002|Overall Study|Death|0|||
157028484|NCT02038777|566860630|FG003|Overall Study|Death|1|||
157028485|NCT02038777|566860631|FG004|Overall Study|Death|2|||
157028486|NCT02038777|566860632|FG005|Overall Study|Death|4|||
157028487|NCT02038777|566860633|FG006|Overall Study|Death|0|||
157028488|NCT02038777|566860634|FG007|Overall Study|Death|11|||
157028489|NCT02038777|566860627|FG000|Overall Study|Lost to Follow-up|0|||
157028490|NCT02038777|566860628|FG001|Overall Study|Lost to Follow-up|0|||
157028491|NCT02038777|566860629|FG002|Overall Study|Lost to Follow-up|0|||
157028492|NCT02038777|566860630|FG003|Overall Study|Lost to Follow-up|1|||
157028493|NCT02038777|566860631|FG004|Overall Study|Lost to Follow-up|0|||
157028494|NCT02038777|566860632|FG005|Overall Study|Lost to Follow-up|0|||
157028495|NCT02038777|566860633|FG006|Overall Study|Lost to Follow-up|0|||
157028496|NCT02038777|566860634|FG007|Overall Study|Lost to Follow-up|0|||
157028497|NCT02038777|566860627|FG000|Overall Study|Other|0|||
157028498|NCT02038777|566860628|FG001|Overall Study|Other|1|||
157028499|NCT02038777|566860629|FG002|Overall Study|Other|0|||
157028500|NCT02038777|566860630|FG003|Overall Study|Other|2|||
157028501|NCT02038777|566860631|FG004|Overall Study|Other|1|||
157028502|NCT02038777|566860632|FG005|Overall Study|Other|0|||
157162984|NCT04501679|567340624|FG000|Overall Study|Adverse Event|4|||
156918938|NCT04102020|566458273|FG004|Overall Study|MIssing|1|||
156918939|NCT04102020|566458269|FG000|Overall Study|Continuing in ongoing study|13|||
156918940|NCT04102020|566458270|FG001|Overall Study|Continuing in ongoing study|13|||
156918941|NCT04102020|566458271|FG002|Overall Study|Continuing in ongoing study|7|||
156918942|NCT04102020|566458272|FG003|Overall Study|Continuing in ongoing study|26|||
157028503|NCT02038777|566860633|FG006|Overall Study|Other|0|||
157028504|NCT02038777|566860634|FG007|Overall Study|Other|0|||
157028505|NCT02038777|566860627|FG000|Overall Study|Randomized but not treated|0|||
157028506|NCT02038777|566860628|FG001|Overall Study|Randomized but not treated|1|||
157162985|NCT04501679|567340625|FG001|Overall Study|Adverse Event|2|||
156918943|NCT04102020|566458273|FG004|Overall Study|Continuing in ongoing study|12|||
156918944|NCT05109442|566458274|FG000|Overall Study|Withdrawal by Subject|0|||
156918945|NCT05109442|566458275|FG001|Overall Study|Withdrawal by Subject|0|||
156918946|NCT05109442|566458276|FG002|Overall Study|Withdrawal by Subject|1|||
156918947|NCT05109442|566458277|FG003|Overall Study|Withdrawal by Subject|0|||
156918948|NCT05109442|566458278|FG004|Overall Study|Withdrawal by Subject|0|||
156918949|NCT05109442|566458279|FG005|Overall Study|Withdrawal by Subject|0|||
156918950|NCT05109442|566458274|FG000|Overall Study|Adverse Event|0|||
156918951|NCT05109442|566458275|FG001|Overall Study|Adverse Event|1|||
156918952|NCT05109442|566458276|FG002|Overall Study|Adverse Event|5|||
156918953|NCT05109442|566458277|FG003|Overall Study|Adverse Event|0|||
156918954|NCT05109442|566458278|FG004|Overall Study|Adverse Event|0|||
156918955|NCT05109442|566458279|FG005|Overall Study|Adverse Event|2|||
156918956|NCT05109442|566458274|FG000|Overall Study|Death|0|||
156918957|NCT05109442|566458275|FG001|Overall Study|Death|0|||
156918958|NCT05109442|566458276|FG002|Overall Study|Death|4|||
156918959|NCT05109442|566458277|FG003|Overall Study|Death|0|||
156918960|NCT05109442|566458278|FG004|Overall Study|Death|0|||
156918961|NCT05109442|566458279|FG005|Overall Study|Death|1|||
156918962|NCT05109442|566458274|FG000|Overall Study|Physician Decision|1|||
156918963|NCT05109442|566458275|FG001|Overall Study|Physician Decision|0|||
156918964|NCT05109442|566458276|FG002|Overall Study|Physician Decision|1|||
156918965|NCT05109442|566458277|FG003|Overall Study|Physician Decision|0|||
156918966|NCT05109442|566458278|FG004|Overall Study|Physician Decision|0|||
156918967|NCT05109442|566458279|FG005|Overall Study|Physician Decision|2|||
156918968|NCT05109442|566458274|FG000|Overall Study|Other than listed|0|||
156918969|NCT05109442|566458275|FG001|Overall Study|Other than listed|0|||
156918970|NCT05109442|566458276|FG002|Overall Study|Other than listed|9|||
156918971|NCT05109442|566458277|FG003|Overall Study|Other than listed|2|||
156918972|NCT05109442|566458278|FG004|Overall Study|Other than listed|0|||
156918973|NCT05109442|566458279|FG005|Overall Study|Other than listed|8|||
156918974|NCT05109442|566458274|FG000|Overall Study|Lack of Efficacy|3|||
156918975|NCT05109442|566458275|FG001|Overall Study|Lack of Efficacy|5|||
156918976|NCT05109442|566458276|FG002|Overall Study|Lack of Efficacy|29|||
156918977|NCT05109442|566458277|FG003|Overall Study|Lack of Efficacy|10|||
156918978|NCT05109442|566458278|FG004|Overall Study|Lack of Efficacy|11|||
156918979|NCT05109442|566458279|FG005|Overall Study|Lack of Efficacy|17|||
156918980|NCT04853225|566458284|FG000|Overall Study|Withdrawal by Subject|81|||
156918981|NCT04853225|566458285|FG001|Overall Study|Withdrawal by Subject|4|||
156918982|NCT04853225|566458286|FG002|Overall Study|Withdrawal by Subject|1|||
156918983|NCT04853225|566458284|FG000|Overall Study|Physician Decision|12|||
156918984|NCT04853225|566458285|FG001|Overall Study|Physician Decision|4|||
156918985|NCT04853225|566458286|FG002|Overall Study|Physician Decision|1|||
156918986|NCT04853225|566458284|FG000|Overall Study|Lost to Follow-up|50|||
156918987|NCT04853225|566458285|FG001|Overall Study|Lost to Follow-up|0|||
156918988|NCT04853225|566458286|FG002|Overall Study|Lost to Follow-up|0|||
156918989|NCT04853225|566458284|FG000|Overall Study|Other|102|||
156918990|NCT04853225|566458285|FG001|Overall Study|Other|11|||
156918991|NCT04853225|566458286|FG002|Overall Study|Other|5|||
156918992|NCT04853225|566458284|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
156918993|NCT04853225|566458285|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
156918994|NCT04853225|566458286|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
156918995|NCT04853225|566458284|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
156918996|NCT04853225|566458285|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
156918997|NCT04853225|566458286|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
156918998|NCT03918447|566458287|FG000|Overall Study|Death|1|||
156918999|NCT03918447|566458288|FG001|Overall Study|Death|0|||
157028507|NCT02038777|566860629|FG002|Overall Study|Randomized but not treated|0|||
157028508|NCT02038777|566860630|FG003|Overall Study|Randomized but not treated|0|||
157028509|NCT02038777|566860631|FG004|Overall Study|Randomized but not treated|0|||
156919000|NCT03918447|566458287|FG000|Overall Study|Lost to Follow-up|13|||
156919001|NCT03918447|566458288|FG001|Overall Study|Lost to Follow-up|6|||
156919002|NCT03918447|566458287|FG000|Overall Study|Withdrawal by Subject|19|||
156919003|NCT03918447|566458288|FG001|Overall Study|Withdrawal by Subject|17|||
156919004|NCT03918447|566458287|FG000|Overall Study|Study Terminated by Sponsor|195|||
156919005|NCT03918447|566458288|FG001|Overall Study|Study Terminated by Sponsor|197|||
156919006|NCT03918447|566458287|FG000|Overall Study|Reason not Specified|0|||
156919007|NCT03918447|566458288|FG001|Overall Study|Reason not Specified|1|||
156919008|NCT03278613|566458289|FG000|Overall Study|Lost to Follow-up|3|||
156919009|NCT03278613|566458290|FG001|Overall Study|Lost to Follow-up|1|||
156919010|NCT01405456|566458291|FG000|Overall Study|Lost to Follow-up|2|||
156919011|NCT01405456|566458292|FG001|Overall Study|Lost to Follow-up|1|||
156919012|NCT01405456|566458291|FG000|Overall Study|Physician Decision|1|||
156919013|NCT01405456|566458292|FG001|Overall Study|Physician Decision|0|||
156919014|NCT05475236|566458293|FG000|Overall Study|Withdrawal by Subject|0|||
156919015|NCT05475236|566458294|FG001|Overall Study|Withdrawal by Subject|1|||
156919016|NCT01774968|566458295|FG000|Overall Study|Adverse Event|4|||
156919017|NCT01774968|566458296|FG001|Overall Study|Adverse Event|4|||
156919018|NCT01774968|566458295|FG000|Overall Study|Death|0|||
156919019|NCT01774968|566458296|FG001|Overall Study|Death|1|||
156919020|NCT01774968|566458295|FG000|Overall Study|Lost to Follow-up|1|||
156919021|NCT01774968|566458296|FG001|Overall Study|Lost to Follow-up|3|||
156919022|NCT01774968|566458295|FG000|Overall Study|Physician Decision|5|||
156919023|NCT01774968|566458296|FG001|Overall Study|Physician Decision|1|||
156919024|NCT01774968|566458295|FG000|Overall Study|Protocol Violation|14|||
156919025|NCT01774968|566458296|FG001|Overall Study|Protocol Violation|13|||
156919026|NCT01774968|566458295|FG000|Overall Study|Sponsor Decision|0|||
156919027|NCT01774968|566458296|FG001|Overall Study|Sponsor Decision|2|||
156919028|NCT01774968|566458295|FG000|Overall Study|Withdrawal by Subject|6|||
156919029|NCT01774968|566458296|FG001|Overall Study|Withdrawal by Subject|11|||
156919030|NCT05355805|566458299|FG000|Overall Study|Lost to Follow-up|6|||
156919031|NCT05355805|566458300|FG001|Overall Study|Lost to Follow-up|11|||
156919032|NCT05355805|566458301|FG002|Overall Study|Lost to Follow-up|10|||
156919033|NCT05355805|566458302|FG003|Overall Study|Lost to Follow-up|6|||
156919034|NCT05355805|566458299|FG000|Overall Study|Decision by Sponsor|0|||
156919035|NCT05355805|566458300|FG001|Overall Study|Decision by Sponsor|0|||
156919036|NCT05355805|566458301|FG002|Overall Study|Decision by Sponsor|1|||
156919037|NCT05355805|566458302|FG003|Overall Study|Decision by Sponsor|0|||
156919038|NCT05355805|566458299|FG000|Overall Study|Withdrawal by Subject|7|||
156919039|NCT05355805|566458300|FG001|Overall Study|Withdrawal by Subject|14|||
156919040|NCT05355805|566458301|FG002|Overall Study|Withdrawal by Subject|15|||
156919041|NCT05355805|566458302|FG003|Overall Study|Withdrawal by Subject|13|||
156919042|NCT04847557|566458304|FG000|Overall Study|Adverse Event|1|||
156919043|NCT04847557|566458305|FG001|Overall Study|Adverse Event|0|||
156919044|NCT04847557|566458304|FG000|Overall Study|Death|19|||
156919045|NCT04847557|566458305|FG001|Overall Study|Death|15|||
156919046|NCT04847557|566458304|FG000|Overall Study|Lost to Follow-up|3|||
156919047|NCT04847557|566458305|FG001|Overall Study|Lost to Follow-up|6|||
156919048|NCT04847557|566458304|FG000|Overall Study|Physician Decision|1|||
156919049|NCT04847557|566458305|FG001|Overall Study|Physician Decision|0|||
156919050|NCT04847557|566458304|FG000|Overall Study|Protocol Violation|0|||
156919051|NCT04847557|566458305|FG001|Overall Study|Protocol Violation|1|||
156919052|NCT04847557|566458304|FG000|Overall Study|Withdrawal by Subject|8|||
156919053|NCT04847557|566458305|FG001|Overall Study|Withdrawal by Subject|14|||
156919054|NCT01325584|566458306|FG000|Overall Study|Death|1|||
156919055|NCT02154490|566460142|FG000|Overall Study|No tissue submitted|23|||
156919056|NCT02154490|566460142|FG000|Overall Study|No biomarker results|167|||
156919057|NCT02154490|566460142|FG000|Overall Study|Not assigned to a sub-study|270|||
156919058|NCT02154490|566460142|FG000|Overall Study|Did not register to a sub-study|749|||
156919059|NCT01411228|566460144|FG000|Overall Study|Lost to Follow-up|0|||
156919060|NCT01411228|566460145|FG001|Overall Study|Lost to Follow-up|0|||
156919061|NCT01411228|566460146|FG002|Overall Study|Lost to Follow-up|1|||
156919062|NCT01411228|566460144|FG000|Overall Study|Withdrawal by Subject|1|||
156919063|NCT01411228|566460145|FG001|Overall Study|Withdrawal by Subject|0|||
156919064|NCT01411228|566460146|FG002|Overall Study|Withdrawal by Subject|0|||
156919065|NCT00664742|566460147|FG000|Overall Study|Withdrawn due to adverse events|3|||
156919066|NCT00664742|566460147|FG000|Overall Study|Withdrawal by Subject|31|||
156919067|NCT00664742|566460147|FG000|Overall Study|Lost to Follow-up|92|||
156919068|NCT01986855|566460148|FG000|Overall Study|Adverse Event|1|||
156919069|NCT01986855|566460149|FG001|Overall Study|Adverse Event|0|||
156919070|NCT01986855|566460150|FG002|Overall Study|Adverse Event|0|||
156919071|NCT01986855|566460148|FG000|Overall Study|Death|3|||
156919072|NCT01986855|566460149|FG001|Overall Study|Death|4|||
156919073|NCT01986855|566460150|FG002|Overall Study|Death|4|||
156919074|NCT01986855|566460148|FG000|Overall Study|Lost to Follow-up|2|||
156919075|NCT01986855|566460149|FG001|Overall Study|Lost to Follow-up|1|||
156919076|NCT01986855|566460150|FG002|Overall Study|Lost to Follow-up|0|||
156919077|NCT01986855|566460148|FG000|Overall Study|Screen Failure|0|||
156919078|NCT01986855|566460149|FG001|Overall Study|Screen Failure|1|||
156919079|NCT01986855|566460150|FG002|Overall Study|Screen Failure|0|||
156919080|NCT01986855|566460148|FG000|Overall Study|Participant Moved|0|||
156919081|NCT01986855|566460149|FG001|Overall Study|Participant Moved|0|||
156919082|NCT01986855|566460150|FG002|Overall Study|Participant Moved|2|||
156919083|NCT01986855|566460148|FG000|Overall Study|Withdrawal by Subject|7|||
156919084|NCT01986855|566460149|FG001|Overall Study|Withdrawal by Subject|8|||
156919085|NCT01986855|566460150|FG002|Overall Study|Withdrawal by Subject|5|||
156919086|NCT04317066|566460151|FG000|Overall Study|Sponsor decision|5|||
156919087|NCT04317066|566460151|FG000|Overall Study|Death|2|||
156919088|NCT02670083|566460155|FG000|Overall Study|Adverse Event|16|||
156919089|NCT02670083|566460156|FG001|Overall Study|Adverse Event|13|||
156919090|NCT02670083|566460155|FG000|Overall Study|Death|4|||
156919091|NCT02670083|566460156|FG001|Overall Study|Death|6|||
156919092|NCT02670083|566460155|FG000|Overall Study|Lost to Follow-up|2|||
156919093|NCT02670083|566460156|FG001|Overall Study|Lost to Follow-up|2|||
156919094|NCT02670083|566460155|FG000|Overall Study|Multiple Reasons|9|||
156919095|NCT02670083|566460156|FG001|Overall Study|Multiple Reasons|9|||
156919096|NCT02670083|566460155|FG000|Overall Study|Physician Decision|0|||
156919097|NCT02670083|566460156|FG001|Overall Study|Physician Decision|2|||
157226570|NCT00721409|567575873|FG000|Overall Study|Global deterioration of health status|2|||
157226571|NCT00721409|567575874|FG001|Overall Study|Global deterioration of health status|6|||
157226572|NCT00721409|567575875|FG002|Overall Study|Global deterioration of health status|3|||
157226573|NCT00721409|567575873|FG000|Overall Study|Death|0|||
157226574|NCT00721409|567575874|FG001|Overall Study|Death|1|||
157226575|NCT00721409|567575875|FG002|Overall Study|Death|0|||
157226576|NCT00721409|567575873|FG000|Overall Study|Randomized not Treated|0|||
157226577|NCT00721409|567575874|FG001|Overall Study|Randomized not Treated|1|||
157226578|NCT00721409|567575875|FG002|Overall Study|Randomized not Treated|4|||
157226579|NCT00721409|567575873|FG000|Overall Study|Reason not specified|1|||
157226580|NCT00721409|567575874|FG001|Overall Study|Reason not specified|0|||
157226581|NCT00721409|567575875|FG002|Overall Study|Reason not specified|2|||
157226582|NCT00721409|567575873|FG000|Overall Study|Adverse Event|0|||
157226583|NCT00721409|567575874|FG001|Overall Study|Adverse Event|13|||
157226584|NCT00721409|567575875|FG002|Overall Study|Adverse Event|2|||
157226585|NCT00721409|567575873|FG000|Overall Study|Lost to Follow-up|0|||
157226586|NCT00721409|567575874|FG001|Overall Study|Lost to Follow-up|0|||
156919098|NCT02670083|566460155|FG000|Overall Study|Study Terminated By Sponsor|257|||
156919099|NCT02670083|566460156|FG001|Overall Study|Study Terminated By Sponsor|254|||
156919100|NCT02670083|566460155|FG000|Overall Study|Symptomatic Deterioration|0|||
156919101|NCT02670083|566460156|FG001|Overall Study|Symptomatic Deterioration|2|||
156919102|NCT02670083|566460155|FG000|Overall Study|Withdrawal by Subject|32|||
156919103|NCT02670083|566460156|FG001|Overall Study|Withdrawal by Subject|31|||
156919104|NCT02670083|566460155|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156919105|NCT02670083|566460156|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156919106|NCT02825992|566460157|FG000|Overall Study|Withdrawal by Subject|4|||
156919107|NCT02825992|566460157|FG000|Overall Study|Lost to Follow-up|2|||
156919108|NCT02825992|566460157|FG000|Overall Study|Procedure terminated|2|||
156919109|NCT02279173|566460159|FG000|Overall Study|Protocol-specified Criteria|67|||
156919110|NCT02279173|566460159|FG000|Overall Study|Withdrawal by Subject|20|||
156919111|NCT02279173|566460159|FG000|Overall Study|Decision by Sponsor|4|||
156919112|NCT02279173|566460159|FG000|Overall Study|Lost to Follow-up|3|||
156919113|NCT00464087|566460160|FG000|Overall Study|No PCI per inclusion criteria|0|||
156919114|NCT00464087|566460161|FG001|Overall Study|No PCI per inclusion criteria|0|||
156919115|NCT00464087|566460162|FG002|Overall Study|No PCI per inclusion criteria|29|||
156919116|NCT01164956|566460163|FG000|Overall Study|Side Effects|1|||
156919117|NCT01164956|566460164|FG001|Overall Study|Side Effects|0|||
156919118|NCT01164956|566460165|FG002|Overall Study|Side Effects|1|||
156919119|NCT00720434|566460166|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156919120|NCT00720434|566460167|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
156919121|NCT00720434|566460168|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156919122|NCT00720434|566460169|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
156919123|NCT00720434|566460166|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
156919124|NCT00720434|566460167|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
156919125|NCT00720434|566460168|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
156919126|NCT00720434|566460169|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
156919127|NCT00720434|566460166|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
156919128|NCT00720434|566460167|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156919129|NCT00720434|566460168|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156919130|NCT00720434|566460169|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
156919131|NCT00720434|566460166|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
156919132|NCT00720434|566460167|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
156919133|NCT00720434|566460168|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
156919134|NCT00720434|566460169|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
156919135|NCT00720434|566460166|FG000|Open-Label Period (Week 5-72)|Other|4|||
156919136|NCT00720434|566460167|FG001|Open-Label Period (Week 5-72)|Other|3|||
156919137|NCT00720434|566460168|FG002|Open-Label Period (Week 5-72)|Other|3|||
156919138|NCT00720434|566460169|FG003|Open-Label Period (Week 5-72)|Other|2|||
156919139|NCT00418314|566460170|FG000|Overall Study|Withdrawal by Subject|1|||
157226587|NCT00721409|567575875|FG002|Overall Study|Lost to Follow-up|1|||
157226588|NCT00721409|567575873|FG000|Overall Study|Withdrawal by Subject|1|||
156919140|NCT00418314|566460171|FG001|Overall Study|Withdrawal by Subject|2|||
156919141|NCT02425046|566460172|FG000|Overall Study|Lost to Follow-up|52|||
156919142|NCT02425046|566460173|FG001|Overall Study|Lost to Follow-up|50|||
156919143|NCT02425046|566460174|FG002|Overall Study|Lost to Follow-up|56|||
156919144|NCT02425046|566460172|FG000|Overall Study|Withdrawal by Subject|16|||
156919145|NCT02425046|566460173|FG001|Overall Study|Withdrawal by Subject|12|||
157226589|NCT00721409|567575874|FG001|Overall Study|Withdrawal by Subject|6|||
157226590|NCT00721409|567575875|FG002|Overall Study|Withdrawal by Subject|5|||
157226591|NCT00721409|567575873|FG000|Overall Study|Objective progression or relapse|8|||
157226592|NCT00721409|567575874|FG001|Overall Study|Objective progression or relapse|55|||
157226593|NCT00721409|567575875|FG002|Overall Study|Objective progression or relapse|62|||
156919146|NCT02425046|566460174|FG002|Overall Study|Withdrawal by Subject|0|||
156919147|NCT02782780|566460175|FG000|Overall Study|dropped out after randomization.|7|||
157162986|NCT04501679|567340624|FG000|Overall Study|Withdrawal by Subject|2|||
157162987|NCT04501679|567340625|FG001|Overall Study|Withdrawal by Subject|0|||
157162988|NCT04501679|567340624|FG000|Overall Study|Physician Decision|1|||
157162989|NCT04501679|567340625|FG001|Overall Study|Physician Decision|0|||
157162990|NCT04501679|567340624|FG000|Overall Study|Lost to Follow-up|2|||
157162991|NCT04501679|567340625|FG001|Overall Study|Lost to Follow-up|0|||
157162992|NCT02358369|567340628|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
157162993|NCT02358369|567340629|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
157162994|NCT02358369|567340630|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
157162995|NCT02358369|567340631|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
157162996|NCT02358369|567340632|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
157162997|NCT02358369|567340628|FG000|Treatment Period A/B|Adverse Event|0|||
157162998|NCT02358369|567340629|FG001|Treatment Period A/B|Adverse Event|0|||
157162999|NCT02358369|567340630|FG002|Treatment Period A/B|Adverse Event|1|||
156919148|NCT02782780|566460176|FG001|Overall Study|dropped out after randomization.|5|||
156919149|NCT02782780|566460175|FG000|Overall Study|Protocol Violation|0|||
156919150|NCT02782780|566460176|FG001|Overall Study|Protocol Violation|2|||
156919151|NCT01413191|566460177|FG000|Overall Study|Lost to Follow-up|5|||
156919152|NCT01413191|566460177|FG000|Overall Study|Disease Progression|5|||
156919153|NCT01413191|566460177|FG000|Overall Study|Death|1|||
156919154|NCT01963403|566460188|FG000|Overall Study|Lost to Follow-up|2|||
156919155|NCT01963403|566460189|FG001|Overall Study|Lost to Follow-up|3|||
156919156|NCT01963403|566460188|FG000|Overall Study|Implant removal|0|||
156919157|NCT01963403|566460189|FG001|Overall Study|Implant removal|1|||
156919158|NCT03590041|566460193|FG000|Overall Study|Protocol Violation|4|||
156919159|NCT03590041|566460194|FG001|Overall Study|Protocol Violation|3|||
156919160|NCT03590041|566460193|FG000|Overall Study|No session data recorded|14|||
156919161|NCT03590041|566460194|FG001|Overall Study|No session data recorded|2|||
156919162|NCT00103142|566460195|FG000|Overall Study|Adverse Event|1|||
156919163|NCT00103142|566460196|FG001|Overall Study|Adverse Event|0|||
156919164|NCT00103142|566460195|FG000|Overall Study|Progression of disease|2|||
156919165|NCT00103142|566460196|FG001|Overall Study|Progression of disease|1|||
156919166|NCT01979016|566460203|FG000|Overall Study|Withdrawal by Subject|2|||
156919167|NCT01979016|566460204|FG001|Overall Study|Withdrawal by Subject|0|||
156919168|NCT01979016|566460203|FG000|Overall Study|Adverse Event|0|||
156919169|NCT01979016|566460204|FG001|Overall Study|Adverse Event|1|||
156919170|NCT01442493|566460205|FG000|Overall Study|withdrawn from study|3|||
156919171|NCT01442493|566460206|FG001|Overall Study|withdrawn from study|2|||
156919172|NCT00938639|566460207|FG000|Overall Study|Moved away from study area|0|||
156919173|NCT00938639|566460208|FG001|Overall Study|Moved away from study area|1|||
156919174|NCT00938639|566460207|FG000|Overall Study|Lost to Follow-up|1|||
156919175|NCT00938639|566460208|FG001|Overall Study|Lost to Follow-up|2|||
156919176|NCT00938639|566460207|FG000|Overall Study|Family issues|1|||
156919177|NCT00938639|566460208|FG001|Overall Study|Family issues|1|||
156919178|NCT00938639|566460207|FG000|Overall Study|Participant noncompliance|1|||
156919179|NCT00938639|566460208|FG001|Overall Study|Participant noncompliance|0|||
156919180|NCT04326231|566460212|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
156919181|NCT03303079|566460213|FG000|Overall Study|Adverse Event|0|||
156919182|NCT03303079|566460214|FG001|Overall Study|Adverse Event|1|||
156919183|NCT03303079|566460215|FG002|Overall Study|Adverse Event|3|||
156919184|NCT03303079|566460213|FG000|Overall Study|Protocol Violation|5|||
156919185|NCT03303079|566460214|FG001|Overall Study|Protocol Violation|4|||
156919186|NCT03303079|566460215|FG002|Overall Study|Protocol Violation|7|||
156919187|NCT03303079|566460213|FG000|Overall Study|Withdrawal by Subject|2|||
156919188|NCT03303079|566460214|FG001|Overall Study|Withdrawal by Subject|4|||
156919189|NCT03303079|566460215|FG002|Overall Study|Withdrawal by Subject|2|||
156919190|NCT03303079|566460213|FG000|Overall Study|Other than specified|0|||
156919191|NCT03303079|566460214|FG001|Overall Study|Other than specified|2|||
156919192|NCT03303079|566460215|FG002|Overall Study|Other than specified|0|||
156919193|NCT00759954|566460216|FG000|Overall Study|Personal reason|1|||
156919194|NCT00759954|566460217|FG001|Overall Study|Personal reason|0|||
157163000|NCT02358369|567340631|FG003|Treatment Period A/B|Adverse Event|2|||
157163001|NCT02358369|567340632|FG004|Treatment Period A/B|Adverse Event|0|||
157226594|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
157226595|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
157226596|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
156919195|NCT00759954|566460216|FG000|Overall Study|Adverse Event|1|||
156919196|NCT00759954|566460217|FG001|Overall Study|Adverse Event|2|||
156919197|NCT00372112|566460221|FG000|Overall Study|Adverse Event|0|||
156919198|NCT00372112|566460222|FG001|Overall Study|Adverse Event|1|||
156919199|NCT00372112|566460223|FG002|Overall Study|Adverse Event|1|||
156919200|NCT00372112|566460224|FG003|Overall Study|Adverse Event|1|||
156919201|NCT00372112|566460221|FG000|Overall Study|Withdrawal by Subject|0|||
156919202|NCT00372112|566460222|FG001|Overall Study|Withdrawal by Subject|0|||
156919203|NCT00372112|566460223|FG002|Overall Study|Withdrawal by Subject|2|||
156919204|NCT00372112|566460224|FG003|Overall Study|Withdrawal by Subject|1|||
156919205|NCT00372112|566460221|FG000|Overall Study|Exacerbation|0|||
156919206|NCT00372112|566460222|FG001|Overall Study|Exacerbation|0|||
156919207|NCT00372112|566460223|FG002|Overall Study|Exacerbation|0|||
156919208|NCT00372112|566460224|FG003|Overall Study|Exacerbation|1|||
156919209|NCT00372112|566460221|FG000|Overall Study|PR >240 at Visit 3|0|||
157163002|NCT02358369|567340628|FG000|Treatment Period A/B|Death|0|||
157163003|NCT02358369|567340629|FG001|Treatment Period A/B|Death|0|||
157163004|NCT02358369|567340630|FG002|Treatment Period A/B|Death|1|||
157163005|NCT02358369|567340631|FG003|Treatment Period A/B|Death|0|||
157163006|NCT02358369|567340632|FG004|Treatment Period A/B|Death|0|||
157163007|NCT02358369|567340628|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
157163008|NCT02358369|567340629|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
157163009|NCT02358369|567340630|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
157163010|NCT02358369|567340631|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
157163011|NCT02358369|567340632|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
157163012|NCT02358369|567340628|FG000|Treatment Period C|Adverse Event|0|||
157163013|NCT02358369|567340629|FG001|Treatment Period C|Adverse Event|0|||
157163014|NCT02358369|567340630|FG002|Treatment Period C|Adverse Event|0|||
157163015|NCT02358369|567340631|FG003|Treatment Period C|Adverse Event|0|||
157163016|NCT02358369|567340632|FG004|Treatment Period C|Adverse Event|7|||
157163017|NCT03095521|567340633|FG000|Overall Study|Withdrawal by Subject|0|||
157163018|NCT03095521|567340634|FG001|Overall Study|Withdrawal by Subject|1|||
157163019|NCT03095521|567340633|FG000|Overall Study|Lost to Follow-up|0|||
157163020|NCT03095521|567340634|FG001|Overall Study|Lost to Follow-up|1|||
157163021|NCT01536119|567340637|FG000|Overall Study|Lost to Follow-up|17|||
157163022|NCT01536119|567340638|FG001|Overall Study|Lost to Follow-up|14|||
157163023|NCT04191577|567340639|FG000|Overall Study|Withdrawal by Subject|2|||
157163024|NCT04191577|567340640|FG001|Overall Study|Withdrawal by Subject|2|||
157163025|NCT04191577|567340641|FG002|Overall Study|Withdrawal by Subject|1|||
157163026|NCT04191577|567340639|FG000|Overall Study|Physician Decision|1|||
157163027|NCT04191577|567340640|FG001|Overall Study|Physician Decision|1|||
157163028|NCT04191577|567340641|FG002|Overall Study|Physician Decision|0|||
157163029|NCT04191577|567340639|FG000|Overall Study|Adverse Event|0|||
157163030|NCT04191577|567340640|FG001|Overall Study|Adverse Event|0|||
157163031|NCT04191577|567340641|FG002|Overall Study|Adverse Event|1|||
157163032|NCT04191577|567340639|FG000|Overall Study|Death|0|||
157163033|NCT04191577|567340640|FG001|Overall Study|Death|0|||
157163034|NCT04191577|567340641|FG002|Overall Study|Death|1|||
157163035|NCT00430521|567340644|FG000|Overall Study|Adverse Event|0|||
157163036|NCT00430521|567340645|FG001|Overall Study|Adverse Event|0|||
157163037|NCT00430521|567340646|FG002|Overall Study|Adverse Event|0|||
157163038|NCT00430521|567340647|FG003|Overall Study|Adverse Event|0|||
157163039|NCT00430521|567340648|FG004|Overall Study|Adverse Event|0|||
157163040|NCT00430521|567340649|FG005|Overall Study|Adverse Event|2|||
157163041|NCT00430521|567340650|FG006|Overall Study|Adverse Event|1|||
157163042|NCT00430521|567340651|FG007|Overall Study|Adverse Event|0|||
157163043|NCT00430521|567340644|FG000|Overall Study|Lost to Follow-up|7|||
157163044|NCT00430521|567340645|FG001|Overall Study|Lost to Follow-up|8|||
157163045|NCT00430521|567340646|FG002|Overall Study|Lost to Follow-up|3|||
157163046|NCT00430521|567340647|FG003|Overall Study|Lost to Follow-up|5|||
157163047|NCT00430521|567340648|FG004|Overall Study|Lost to Follow-up|5|||
157163048|NCT00430521|567340649|FG005|Overall Study|Lost to Follow-up|2|||
157163049|NCT00430521|567340650|FG006|Overall Study|Lost to Follow-up|8|||
157163050|NCT00430521|567340651|FG007|Overall Study|Lost to Follow-up|10|||
157163051|NCT00430521|567340644|FG000|Overall Study|Pregnancy|0|||
157163052|NCT00430521|567340645|FG001|Overall Study|Pregnancy|0|||
157163053|NCT00430521|567340646|FG002|Overall Study|Pregnancy|0|||
157163054|NCT00430521|567340647|FG003|Overall Study|Pregnancy|0|||
157163055|NCT00430521|567340648|FG004|Overall Study|Pregnancy|0|||
157163056|NCT00430521|567340649|FG005|Overall Study|Pregnancy|0|||
157163057|NCT00430521|567340650|FG006|Overall Study|Pregnancy|1|||
157163058|NCT00430521|567340651|FG007|Overall Study|Pregnancy|0|||
157163059|NCT00430521|567340644|FG000|Overall Study|Vaccine Expired|0|||
157163060|NCT00430521|567340645|FG001|Overall Study|Vaccine Expired|0|||
157163061|NCT00430521|567340646|FG002|Overall Study|Vaccine Expired|0|||
157163062|NCT00430521|567340647|FG003|Overall Study|Vaccine Expired|0|||
157163063|NCT00430521|567340648|FG004|Overall Study|Vaccine Expired|0|||
157163064|NCT00430521|567340649|FG005|Overall Study|Vaccine Expired|1|||
157163065|NCT00430521|567340650|FG006|Overall Study|Vaccine Expired|0|||
157163066|NCT00430521|567340651|FG007|Overall Study|Vaccine Expired|0|||
157163067|NCT00430521|567340644|FG000|Overall Study|Protocol Violation|1|||
157163068|NCT00430521|567340645|FG001|Overall Study|Protocol Violation|0|||
157163069|NCT00430521|567340646|FG002|Overall Study|Protocol Violation|0|||
157163070|NCT00430521|567340647|FG003|Overall Study|Protocol Violation|0|||
157163071|NCT00430521|567340648|FG004|Overall Study|Protocol Violation|0|||
157163072|NCT00430521|567340649|FG005|Overall Study|Protocol Violation|0|||
156919210|NCT00372112|566460222|FG001|Overall Study|PR >240 at Visit 3|0|||
157163073|NCT00430521|567340650|FG006|Overall Study|Protocol Violation|0|||
157163074|NCT00430521|567340651|FG007|Overall Study|Protocol Violation|0|||
157163075|NCT00430521|567340644|FG000|Overall Study|Withdrawal by Subject|3|||
157163076|NCT00430521|567340645|FG001|Overall Study|Withdrawal by Subject|1|||
156919211|NCT00372112|566460223|FG002|Overall Study|PR >240 at Visit 3|0|||
156919212|NCT00372112|566460224|FG003|Overall Study|PR >240 at Visit 3|1|||
156919213|NCT00372112|566460221|FG000|Overall Study|Hepatitis B|1|||
156919214|NCT00372112|566460222|FG001|Overall Study|Hepatitis B|0|||
156919215|NCT00372112|566460223|FG002|Overall Study|Hepatitis B|0|||
156919216|NCT00372112|566460224|FG003|Overall Study|Hepatitis B|0|||
156919217|NCT00372112|566460221|FG000|Overall Study|Other-protocol violation|0|||
156919218|NCT00372112|566460222|FG001|Overall Study|Other-protocol violation|0|||
156919219|NCT00372112|566460223|FG002|Overall Study|Other-protocol violation|1|||
156919220|NCT00372112|566460224|FG003|Overall Study|Other-protocol violation|0|||
156919221|NCT02706691|566460225|FG000|Overall Study|Adverse Event|1|||
156919222|NCT02927431|566460226|FG000|Overall Study|Withdrawal by Subject|0|||
156919223|NCT02927431|566460227|FG001|Overall Study|Withdrawal by Subject|0|||
156919224|NCT02927431|566460228|FG002|Overall Study|Withdrawal by Subject|1|||
156919225|NCT01830972|566460229|FG000|Part II|Withdrawal by Subject|2|||
156919226|NCT01830972|566460230|FG001|Part II|Withdrawal by Subject|2|||
156919227|NCT01830972|566460229|FG000|Part III|Withdrawal by Subject|1|||
156919228|NCT01830972|566460230|FG001|Part III|Withdrawal by Subject|0|||
156919229|NCT01830972|566460229|FG000|Part III|Noncompliance|1|||
156919230|NCT01830972|566460230|FG001|Part III|Noncompliance|0|||
156919231|NCT01830972|566460229|FG000|Part IV|Withdrawal by Subject|2|||
156919232|NCT01830972|566460230|FG001|Part IV|Withdrawal by Subject|1|||
156919233|NCT01830972|566460229|FG000|Part IV|Non-Compliance|1|||
156919234|NCT01830972|566460230|FG001|Part IV|Non-Compliance|0|||
156919235|NCT01829191|566460231|FG000|Overall Study|Relocation|0|||
156919236|NCT01829191|566460232|FG001|Overall Study|Relocation|1|||
156919237|NCT01829191|566460231|FG000|Overall Study|Lens discomfort|0|||
156919238|NCT01829191|566460232|FG001|Overall Study|Lens discomfort|3|||
156919239|NCT01829191|566460231|FG000|Overall Study|Lens handling difficulty|1|||
156919240|NCT01829191|566460232|FG001|Overall Study|Lens handling difficulty|4|||
156919241|NCT01829191|566460231|FG000|Overall Study|Protocol Violation|4|||
156919242|NCT01829191|566460232|FG001|Overall Study|Protocol Violation|1|||
156919243|NCT01829191|566460231|FG000|Overall Study|Withdrawal by Subject|2|||
156919244|NCT01829191|566460232|FG001|Overall Study|Withdrawal by Subject|3|||
156919245|NCT01829191|566460231|FG000|Overall Study|Lost to Follow-up|0|||
156919246|NCT01829191|566460232|FG001|Overall Study|Lost to Follow-up|1|||
156919247|NCT01829191|566460231|FG000|Overall Study|Subject was fit for ortho - k|0|||
156919248|NCT01829191|566460232|FG001|Overall Study|Subject was fit for ortho - k|1|||
156919249|NCT01276353|566460235|FG000|Double-blind|Adverse Event|2|||
156919250|NCT01276353|566460236|FG001|Double-blind|Adverse Event|0|||
156919251|NCT01276353|566460235|FG000|Double-blind|Withdrawal by Subject|1|||
156919252|NCT01276353|566460236|FG001|Double-blind|Withdrawal by Subject|0|||
156919253|NCT01276353|566460235|FG000|Extension|Adverse Event|2|||
156919254|NCT01276353|566460236|FG001|Extension|Adverse Event|5|||
156919255|NCT01276353|566460235|FG000|Extension|Withdrawal by Subject|1|||
156919256|NCT01276353|566460236|FG001|Extension|Withdrawal by Subject|2|||
156919257|NCT01276353|566460235|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
156919258|NCT01276353|566460236|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
156919259|NCT01276353|566460235|FG000|Extension|Physician Decision|1|||
156919260|NCT01276353|566460236|FG001|Extension|Physician Decision|0|||
156919261|NCT01276353|566460235|FG000|Extension|Prohibited concomitant medications|0|||
156919262|NCT01276353|566460236|FG001|Extension|Prohibited concomitant medications|1|||
156919263|NCT00553514|566460239|FG000|Overall Study|Protocol deviation|0|||
156919264|NCT00553514|566460240|FG001|Overall Study|Protocol deviation|0|||
156919265|NCT00553514|566460241|FG002|Overall Study|Protocol deviation|0|||
156919266|NCT00553514|566460242|FG003|Overall Study|Protocol deviation|1|||
156919267|NCT00553514|566460243|FG004|Overall Study|Protocol deviation|0|||
156919268|NCT00553514|566460239|FG000|Overall Study|Lack of ovarian response|4|||
156919269|NCT00553514|566460240|FG001|Overall Study|Lack of ovarian response|5|||
156919270|NCT00553514|566460241|FG002|Overall Study|Lack of ovarian response|5|||
156919271|NCT00553514|566460242|FG003|Overall Study|Lack of ovarian response|5|||
156919272|NCT00553514|566460243|FG004|Overall Study|Lack of ovarian response|6|||
156919273|NCT00553514|566460239|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
156919274|NCT00553514|566460240|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156919275|NCT00553514|566460241|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156919276|NCT00553514|566460242|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156919277|NCT00553514|566460243|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
156919278|NCT00553514|566460239|FG000|Overall Study|Risk of multiple pregnancy|0|||
156919279|NCT00553514|566460240|FG001|Overall Study|Risk of multiple pregnancy|2|||
156919280|NCT00553514|566460241|FG002|Overall Study|Risk of multiple pregnancy|0|||
156919281|NCT00553514|566460242|FG003|Overall Study|Risk of multiple pregnancy|1|||
156919282|NCT00553514|566460243|FG004|Overall Study|Risk of multiple pregnancy|0|||
156919283|NCT00553514|566460239|FG000|Overall Study|Other|1|||
156919284|NCT00553514|566460240|FG001|Overall Study|Other|1|||
156919285|NCT00553514|566460241|FG002|Overall Study|Other|0|||
156919286|NCT00553514|566460242|FG003|Overall Study|Other|0|||
156919287|NCT00553514|566460243|FG004|Overall Study|Other|1|||
156919288|NCT02205814|566460245|FG000|Overall Study|Lost to Follow-up|0|||
156919289|NCT02205814|566460246|FG001|Overall Study|Lost to Follow-up|0|||
156919290|NCT02205814|566460247|FG002|Overall Study|Lost to Follow-up|0|||
156919291|NCT02205814|566460248|FG003|Overall Study|Lost to Follow-up|1|||
156919292|NCT02205814|566460245|FG000|Overall Study|Lack of Efficacy|1|||
156919293|NCT02205814|566460246|FG001|Overall Study|Lack of Efficacy|0|||
156919294|NCT02205814|566460247|FG002|Overall Study|Lack of Efficacy|1|||
156919295|NCT02205814|566460248|FG003|Overall Study|Lack of Efficacy|1|||
156919296|NCT02205814|566460245|FG000|Overall Study|Physician Decision|0|||
156919297|NCT02205814|566460246|FG001|Overall Study|Physician Decision|0|||
156919298|NCT02205814|566460247|FG002|Overall Study|Physician Decision|1|||
156919299|NCT02205814|566460248|FG003|Overall Study|Physician Decision|0|||
156919300|NCT02205814|566460245|FG000|Overall Study|Protocol Violation|1|||
156919301|NCT02205814|566460246|FG001|Overall Study|Protocol Violation|0|||
156919302|NCT02205814|566460247|FG002|Overall Study|Protocol Violation|0|||
156919303|NCT02205814|566460248|FG003|Overall Study|Protocol Violation|1|||
156919304|NCT02205814|566460245|FG000|Overall Study|Withdrawal by Subject|0|||
156919305|NCT02205814|566460246|FG001|Overall Study|Withdrawal by Subject|1|||
156919306|NCT02205814|566460247|FG002|Overall Study|Withdrawal by Subject|2|||
156919307|NCT02205814|566460248|FG003|Overall Study|Withdrawal by Subject|1|||
156919308|NCT02205814|566460245|FG000|Overall Study|not compliant with study procedures|0|||
156919309|NCT02205814|566460246|FG001|Overall Study|not compliant with study procedures|0|||
156919310|NCT02205814|566460247|FG002|Overall Study|not compliant with study procedures|1|||
156919311|NCT02205814|566460248|FG003|Overall Study|not compliant with study procedures|0|||
156919312|NCT01426373|566460249|FG000|Overall Study|Adverse Event|6|||
156919313|NCT01426373|566460249|FG000|Overall Study|Lost to Follow-up|14|||
156919314|NCT01426373|566460249|FG000|Overall Study|Participant Convenience|10|||
156919315|NCT01426373|566460249|FG000|Overall Study|Miscellaneous Reasons|4|||
156919316|NCT02246660|566460250|FG000|Overall Study|Withdrawal by Subject|0|||
156919317|NCT02246660|566460251|FG001|Overall Study|Withdrawal by Subject|1|||
156919318|NCT02246660|566460252|FG002|Overall Study|Withdrawal by Subject|0|||
156919319|NCT02246660|566460250|FG000|Overall Study|Death|0|||
156919320|NCT02246660|566460251|FG001|Overall Study|Death|0|||
156919321|NCT02246660|566460252|FG002|Overall Study|Death|1|||
156919322|NCT00726661|566460253|FG000|Overall Study|Lost to Follow-up|36|||
156919323|NCT00726661|566460254|FG001|Overall Study|Lost to Follow-up|11|||
156919324|NCT00726661|566460253|FG000|Overall Study|Withdrawal by Subject|17|||
156919325|NCT00726661|566460254|FG001|Overall Study|Withdrawal by Subject|13|||
156919326|NCT00726661|566460253|FG000|Overall Study|Trial terminated by sponsor|214|||
156919327|NCT00726661|566460254|FG001|Overall Study|Trial terminated by sponsor|187|||
156919328|NCT00726661|566460253|FG000|Overall Study|Death|475|||
156919329|NCT00726661|566460254|FG001|Overall Study|Death|159|||
156919330|NCT00726661|566460253|FG000|Overall Study|Physician Decision|25|||
156919331|NCT00726661|566460254|FG001|Overall Study|Physician Decision|13|||
156919332|NCT00726661|566460253|FG000|Overall Study|Other|47|||
156919333|NCT00726661|566460254|FG001|Overall Study|Other|35|||
156919334|NCT00587639|566460257|FG000|Overall Study|Withdrawal by Subject|1|||
156919335|NCT01574326|566460258|FG000|Overall Study|Randomized but not treated|0|||
156919336|NCT01574326|566460259|FG001|Overall Study|Randomized but not treated|1|||
156919337|NCT01574326|566460258|FG000|Overall Study|Withdrawal by Participant|2|||
156919338|NCT01574326|566460259|FG001|Overall Study|Withdrawal by Participant|4|||
156919339|NCT01574326|566460258|FG000|Overall Study|Physician Decision|5|||
156919340|NCT01574326|566460259|FG001|Overall Study|Physician Decision|3|||
156919341|NCT01574326|566460258|FG000|Overall Study|Adverse Event|1|||
156919342|NCT01574326|566460259|FG001|Overall Study|Adverse Event|3|||
156919343|NCT01574326|566460258|FG000|Overall Study|Other: Mainly kidney transplant|8|||
156919344|NCT01574326|566460259|FG001|Overall Study|Other: Mainly kidney transplant|8|||
156919345|NCT00005937|566460271|FG000|Overall Study|Lack of Efficacy|5|||
157028510|NCT02038777|566860632|FG005|Overall Study|Randomized but not treated|0|||
157028511|NCT02038777|566860633|FG006|Overall Study|Randomized but not treated|0|||
157028512|NCT02038777|566860634|FG007|Overall Study|Randomized but not treated|0|||
157028513|NCT02038777|566860627|FG000|Overall Study|Started Chemotherapy|1|||
157028514|NCT02038777|566860628|FG001|Overall Study|Started Chemotherapy|0|||
157028515|NCT02038777|566860629|FG002|Overall Study|Started Chemotherapy|3|||
157028516|NCT02038777|566860630|FG003|Overall Study|Started Chemotherapy|0|||
157028517|NCT02038777|566860631|FG004|Overall Study|Started Chemotherapy|0|||
156919346|NCT01288469|566460272|FG000|Overall Study|Adverse Event|4|||
156919347|NCT01288469|566460273|FG001|Overall Study|Adverse Event|1|||
156919348|NCT01288469|566460274|FG002|Overall Study|Adverse Event|1|||
156919349|NCT01288469|566460272|FG000|Overall Study|Poor compliance to protocol|0|||
156919350|NCT01288469|566460273|FG001|Overall Study|Poor compliance to protocol|1|||
156919351|NCT01288469|566460274|FG002|Overall Study|Poor compliance to protocol|0|||
156919352|NCT01288469|566460272|FG000|Overall Study|Participant Moved|1|||
156919353|NCT01288469|566460273|FG001|Overall Study|Participant Moved|0|||
156919354|NCT01288469|566460274|FG002|Overall Study|Participant Moved|0|||
156919355|NCT01288469|566460272|FG000|Overall Study|Consent withdrawn by subject|1|||
156919356|NCT01288469|566460273|FG001|Overall Study|Consent withdrawn by subject|1|||
156919357|NCT01288469|566460274|FG002|Overall Study|Consent withdrawn by subject|1|||
157028518|NCT02038777|566860632|FG005|Overall Study|Started Chemotherapy|0|||
156919358|NCT01288469|566460272|FG000|Overall Study|Exclusion criteria finally met|1|||
156919359|NCT01288469|566460273|FG001|Overall Study|Exclusion criteria finally met|0|||
156919360|NCT01288469|566460274|FG002|Overall Study|Exclusion criteria finally met|0|||
156919361|NCT00582166|566460277|FG000|Overall Study|Death|1|||
156919362|NCT00582166|566460277|FG000|Overall Study|Ineligible pathology|1|||
156919363|NCT01606436|566460278|FG000|Overall Study|Withdrawal by Subject|0|||
156919364|NCT01606436|566460279|FG001|Overall Study|Withdrawal by Subject|0|||
156919365|NCT01606436|566460280|FG002|Overall Study|Withdrawal by Subject|1|||
156919366|NCT01606436|566460281|FG003|Overall Study|Withdrawal by Subject|1|||
156919367|NCT01606436|566460282|FG004|Overall Study|Withdrawal by Subject|1|||
156919368|NCT01606436|566460283|FG005|Overall Study|Withdrawal by Subject|0|||
156919369|NCT01606436|566460278|FG000|Overall Study|Adverse Event|0|||
156919370|NCT01606436|566460279|FG001|Overall Study|Adverse Event|0|||
156919371|NCT01606436|566460280|FG002|Overall Study|Adverse Event|1|||
156919372|NCT01606436|566460281|FG003|Overall Study|Adverse Event|0|||
156919373|NCT01606436|566460282|FG004|Overall Study|Adverse Event|0|||
156919374|NCT01606436|566460283|FG005|Overall Study|Adverse Event|0|||
156919375|NCT01606436|566460278|FG000|Overall Study|Sponsor Decision|0|||
156919376|NCT01606436|566460279|FG001|Overall Study|Sponsor Decision|0|||
156919377|NCT01606436|566460280|FG002|Overall Study|Sponsor Decision|0|||
156919378|NCT01606436|566460281|FG003|Overall Study|Sponsor Decision|1|||
156919379|NCT01606436|566460282|FG004|Overall Study|Sponsor Decision|0|||
156919380|NCT01606436|566460283|FG005|Overall Study|Sponsor Decision|0|||
156919381|NCT02859454|566460284|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
156919382|NCT04294472|566460285|FG000|Overall Study|Adverse Event|0|||
156919383|NCT04294472|566460286|FG001|Overall Study|Adverse Event|1|||
156919384|NCT04294472|566460287|FG002|Overall Study|Adverse Event|1|||
156919385|NCT04294472|566460285|FG000|Overall Study|Randomized but not treated|0|||
156919386|NCT04294472|566460286|FG001|Overall Study|Randomized but not treated|1|||
156919387|NCT04294472|566460287|FG002|Overall Study|Randomized but not treated|1|||
156919388|NCT02452398|566460290|FG000|Overall Study|Adverse Event|1|||
156919389|NCT02452398|566460290|FG000|Overall Study|Lost to Follow-up|28|||
156919390|NCT02452398|566460290|FG000|Overall Study|Physician Decision|2|||
156919391|NCT02452398|566460290|FG000|Overall Study|Withdrawal by Subject|6|||
156919392|NCT02452398|566460290|FG000|Overall Study|Moved away|4|||
156919393|NCT03944954|566460291|FG000|Overall Study|Withdrawal by Subject|22|||
156919394|NCT03944954|566460292|FG001|Overall Study|Withdrawal by Subject|4|||
156919395|NCT03944954|566460291|FG000|Overall Study|Lost to Follow-up|18|||
156919396|NCT03944954|566460292|FG001|Overall Study|Lost to Follow-up|0|||
156919397|NCT03944954|566460291|FG000|Overall Study|Failed Medical Screening|7|||
156919398|NCT03944954|566460292|FG001|Overall Study|Failed Medical Screening|0|||
156919399|NCT03798483|566460293|FG000|Overall Study|Lost to Follow-up|2|||
156919400|NCT02547454|566460294|FG000|Overall Study|Due to hemodialysis|53|||
156919401|NCT02547454|566460294|FG000|Overall Study|Due to transplantation|1|||
156919402|NCT02547454|566460294|FG000|Overall Study|Due to no further need to treat|4|||
156919403|NCT02547454|566460294|FG000|Overall Study|Death|38|||
156919404|NCT02547454|566460294|FG000|Overall Study|Lost to Follow-up|26|||
156919405|NCT02547454|566460294|FG000|Overall Study|Other|39|||
156919406|NCT02547454|566460294|FG000|Overall Study|No data|11|||
156919407|NCT01438424|566461374|FG000|Overall Study|Continuing treatment|29|||
156919408|NCT01438424|566461374|FG000|Overall Study|Minimal virologic response|95|||
156919409|NCT01438424|566461374|FG000|Overall Study|Not identified|55|||
156919410|NCT01438424|566461374|FG000|Overall Study|Withdrawal by Subject|104|||
156919411|NCT01438424|566461374|FG000|Overall Study|Progression of chronic hepatitis B|22|||
156919412|NCT01438424|566461374|FG000|Overall Study|Death|22|||
156919413|NCT01438424|566461374|FG000|Overall Study|Adverse Event|17|||
156919414|NCT01438424|566461374|FG000|Overall Study|Lost to Follow-up|17|||
156919415|NCT01438424|566461374|FG000|Overall Study|Abnormal laboratory test result|14|||
157163077|NCT00430521|567340646|FG002|Overall Study|Withdrawal by Subject|0|||
157163078|NCT00430521|567340647|FG003|Overall Study|Withdrawal by Subject|3|||
157163079|NCT00430521|567340648|FG004|Overall Study|Withdrawal by Subject|0|||
157163080|NCT00430521|567340649|FG005|Overall Study|Withdrawal by Subject|0|||
157163081|NCT00430521|567340650|FG006|Overall Study|Withdrawal by Subject|0|||
157163082|NCT00430521|567340651|FG007|Overall Study|Withdrawal by Subject|2|||
157163083|NCT01274338|567341900|FG000|Overall Study|Lack of Efficacy|72|||
157163084|NCT01274338|567341901|FG001|Overall Study|Lack of Efficacy|108|||
156919416|NCT01438424|566461374|FG000|Overall Study|Need for drug prohibited by protocol|14|||
156919417|NCT01438424|566461374|FG000|Overall Study|Pregnancy|7|||
156919418|NCT01438424|566461374|FG000|Overall Study|No longer met inclusion criteria|1|||
156919419|NCT01438424|566461374|FG000|Overall Study|Participant noncompliance|20|||
156919420|NCT02927080|566461375|FG000|Overall Study|Withdrawal by Subject|0|||
156919421|NCT02927080|566461376|FG001|Overall Study|Withdrawal by Subject|0|||
156919422|NCT02927080|566461377|FG002|Overall Study|Withdrawal by Subject|0|||
156919423|NCT02927080|566461378|FG003|Overall Study|Withdrawal by Subject|0|||
156919424|NCT02927080|566461379|FG004|Overall Study|Withdrawal by Subject|1|||
157163085|NCT01274338|567341902|FG002|Overall Study|Lack of Efficacy|116|||
156919425|NCT02927080|566461380|FG005|Overall Study|Withdrawal by Subject|0|||
157163086|NCT01274338|567341903|FG003|Overall Study|Lack of Efficacy|0|||
156919426|NCT02927080|566461381|FG006|Overall Study|Withdrawal by Subject|1|||
156919427|NCT02927080|566461382|FG007|Overall Study|Withdrawal by Subject|1|||
156919428|NCT02927080|566461383|FG008|Overall Study|Withdrawal by Subject|0|||
156919429|NCT02927080|566461384|FG009|Overall Study|Withdrawal by Subject|2|||
156919430|NCT02927080|566461375|FG000|Overall Study|Willingness to comply with protocol|0|||
156919431|NCT02927080|566461376|FG001|Overall Study|Willingness to comply with protocol|0|||
156919432|NCT02927080|566461377|FG002|Overall Study|Willingness to comply with protocol|0|||
156919433|NCT02927080|566461378|FG003|Overall Study|Willingness to comply with protocol|0|||
156919434|NCT02927080|566461379|FG004|Overall Study|Willingness to comply with protocol|0|||
156919435|NCT02927080|566461380|FG005|Overall Study|Willingness to comply with protocol|0|||
156919436|NCT02927080|566461381|FG006|Overall Study|Willingness to comply with protocol|0|||
156919437|NCT02927080|566461382|FG007|Overall Study|Willingness to comply with protocol|0|||
156919438|NCT02927080|566461383|FG008|Overall Study|Willingness to comply with protocol|0|||
156919439|NCT02927080|566461384|FG009|Overall Study|Willingness to comply with protocol|1|||
156919440|NCT02927080|566461375|FG000|Overall Study|Study terminated by Sponsor|0|||
156919441|NCT02927080|566461376|FG001|Overall Study|Study terminated by Sponsor|0|||
156919442|NCT02927080|566461377|FG002|Overall Study|Study terminated by Sponsor|0|||
156919443|NCT02927080|566461378|FG003|Overall Study|Study terminated by Sponsor|0|||
156919444|NCT02927080|566461379|FG004|Overall Study|Study terminated by Sponsor|0|||
156919445|NCT02927080|566461380|FG005|Overall Study|Study terminated by Sponsor|0|||
156919446|NCT02927080|566461381|FG006|Overall Study|Study terminated by Sponsor|6|||
156919447|NCT02927080|566461382|FG007|Overall Study|Study terminated by Sponsor|7|||
156919448|NCT02927080|566461383|FG008|Overall Study|Study terminated by Sponsor|2|||
156919449|NCT02927080|566461384|FG009|Overall Study|Study terminated by Sponsor|3|||
156919450|NCT02927080|566461375|FG000|Overall Study|Adverse Event|0|||
156919451|NCT02927080|566461376|FG001|Overall Study|Adverse Event|1|||
156919452|NCT02927080|566461377|FG002|Overall Study|Adverse Event|0|||
156919453|NCT02927080|566461378|FG003|Overall Study|Adverse Event|0|||
156919454|NCT02927080|566461379|FG004|Overall Study|Adverse Event|0|||
156919455|NCT02927080|566461380|FG005|Overall Study|Adverse Event|0|||
156919456|NCT02927080|566461381|FG006|Overall Study|Adverse Event|0|||
156919457|NCT02927080|566461382|FG007|Overall Study|Adverse Event|1|||
156919458|NCT02927080|566461383|FG008|Overall Study|Adverse Event|0|||
156919459|NCT02927080|566461384|FG009|Overall Study|Adverse Event|1|||
156919460|NCT02927080|566461375|FG000|Overall Study|Other|0|||
156919461|NCT02927080|566461376|FG001|Overall Study|Other|0|||
156919462|NCT02927080|566461377|FG002|Overall Study|Other|0|||
156919463|NCT02927080|566461378|FG003|Overall Study|Other|0|||
156919464|NCT02927080|566461379|FG004|Overall Study|Other|0|||
156919465|NCT02927080|566461380|FG005|Overall Study|Other|0|||
156919466|NCT02927080|566461381|FG006|Overall Study|Other|1|||
156919467|NCT02927080|566461382|FG007|Overall Study|Other|0|||
156919468|NCT02927080|566461383|FG008|Overall Study|Other|1|||
156919469|NCT02927080|566461384|FG009|Overall Study|Other|0|||
156919470|NCT02904512|566461386|FG000|Overall Study|Withdrawal by Subject|1|||
156919471|NCT02904512|566461387|FG001|Overall Study|Withdrawal by Subject|0|||
156919472|NCT02904512|566461386|FG000|Overall Study|Transferred to ICU|1|||
156919473|NCT02904512|566461387|FG001|Overall Study|Transferred to ICU|0|||
156919474|NCT02904512|566461386|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
156919475|NCT02904512|566461387|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
156919476|NCT00589914|566461390|FG000|Overall Study|Adverse Event|19|||
156919477|NCT00589914|566461391|FG001|Overall Study|Adverse Event|10|||
156919478|NCT00589914|566461390|FG000|Overall Study|Death|2|||
156919479|NCT00589914|566461391|FG001|Overall Study|Death|0|||
156919480|NCT00589914|566461390|FG000|Overall Study|Lack of Efficacy|40|||
156919481|NCT00589914|566461391|FG001|Overall Study|Lack of Efficacy|43|||
156919482|NCT00589914|566461390|FG000|Overall Study|Lost to Follow-up|11|||
156919483|NCT00589914|566461391|FG001|Overall Study|Lost to Follow-up|18|||
156919484|NCT00589914|566461390|FG000|Overall Study|Pregnancy|1|||
156919485|NCT00589914|566461391|FG001|Overall Study|Pregnancy|0|||
156919486|NCT00589914|566461390|FG000|Overall Study|Withdrawal by Subject|55|||
156919487|NCT00589914|566461391|FG001|Overall Study|Withdrawal by Subject|49|||
156919488|NCT00589914|566461390|FG000|Overall Study|Other|22|||
156919489|NCT00589914|566461391|FG001|Overall Study|Other|17|||
156919490|NCT01356966|566461392|FG000|Overall Study|Withdrawal by Subject|1|||
156919491|NCT01356966|566461393|FG001|Overall Study|Withdrawal by Subject|2|||
156919492|NCT01356966|566461392|FG000|Overall Study|Physician Decision|1|||
156919493|NCT01356966|566461393|FG001|Overall Study|Physician Decision|0|||
156919494|NCT02743806|566461394|FG000|Overall Study|Adverse Event|9|||
156919495|NCT02743806|566461394|FG000|Overall Study|Lost to Follow-up|8|||
156919496|NCT02743806|566461394|FG000|Overall Study|Voluntary Withdrawal|54|||
156919497|NCT02743806|566461394|FG000|Overall Study|Study Termination|65|||
156919498|NCT02743806|566461394|FG000|Overall Study|Pregnancy|6|||
156919499|NCT02743806|566461394|FG000|Overall Study|No Longer Clinically Benefiting|27|||
156919500|NCT02743806|566461394|FG000|Overall Study|Reason Not Specified|12|||
156919501|NCT00849381|566461395|FG000|Overall Study|Adverse Event|1|||
156919502|NCT00849381|566461395|FG000|Overall Study|Lost to Follow-up|129|||
156919503|NCT00849381|566461395|FG000|Overall Study|Protocol Violation|5|||
157163087|NCT01274338|567341904|FG004|Overall Study|Lack of Efficacy|0|||
157163088|NCT01274338|567341905|FG005|Overall Study|Lack of Efficacy|0|||
157163089|NCT01274338|567341900|FG000|Overall Study|Adverse Event|272|||
157163090|NCT01274338|567341901|FG001|Overall Study|Adverse Event|105|||
157163091|NCT01274338|567341902|FG002|Overall Study|Adverse Event|180|||
157163092|NCT01274338|567341903|FG003|Overall Study|Adverse Event|1|||
157163093|NCT01274338|567341904|FG004|Overall Study|Adverse Event|0|||
157163094|NCT01274338|567341905|FG005|Overall Study|Adverse Event|0|||
157163095|NCT01274338|567341900|FG000|Overall Study|Death|8|||
157163096|NCT01274338|567341901|FG001|Overall Study|Death|1|||
157163097|NCT01274338|567341902|FG002|Overall Study|Death|0|||
157163098|NCT01274338|567341903|FG003|Overall Study|Death|0|||
157163099|NCT01274338|567341904|FG004|Overall Study|Death|0|||
157163100|NCT01274338|567341905|FG005|Overall Study|Death|0|||
157163101|NCT01274338|567341900|FG000|Overall Study|Withdrawal by Subject|27|||
157163102|NCT01274338|567341901|FG001|Overall Study|Withdrawal by Subject|99|||
157163103|NCT01274338|567341902|FG002|Overall Study|Withdrawal by Subject|17|||
157163104|NCT01274338|567341903|FG003|Overall Study|Withdrawal by Subject|0|||
157163105|NCT01274338|567341904|FG004|Overall Study|Withdrawal by Subject|0|||
157163106|NCT01274338|567341905|FG005|Overall Study|Withdrawal by Subject|0|||
157163107|NCT01274338|567341900|FG000|Overall Study|Did not start treatment|8|||
157163108|NCT01274338|567341901|FG001|Overall Study|Did not start treatment|116|||
157163109|NCT01274338|567341902|FG002|Overall Study|Did not start treatment|7|||
157163110|NCT01274338|567341903|FG003|Overall Study|Did not start treatment|0|||
157163111|NCT01274338|567341904|FG004|Overall Study|Did not start treatment|0|||
157163112|NCT01274338|567341905|FG005|Overall Study|Did not start treatment|0|||
157163113|NCT01274338|567341900|FG000|Overall Study|Alternative therapy|0|||
157163114|NCT01274338|567341901|FG001|Overall Study|Alternative therapy|1|||
157163115|NCT01274338|567341902|FG002|Overall Study|Alternative therapy|0|||
157163116|NCT01274338|567341903|FG003|Overall Study|Alternative therapy|0|||
157163117|NCT01274338|567341904|FG004|Overall Study|Alternative therapy|0|||
157163118|NCT01274338|567341905|FG005|Overall Study|Alternative therapy|0|||
157163119|NCT01274338|567341900|FG000|Overall Study|Other complicating diseases|0|||
157163120|NCT01274338|567341901|FG001|Overall Study|Other complicating diseases|3|||
157163121|NCT01274338|567341902|FG002|Overall Study|Other complicating diseases|1|||
157163122|NCT01274338|567341903|FG003|Overall Study|Other complicating diseases|0|||
157163123|NCT01274338|567341904|FG004|Overall Study|Other complicating diseases|0|||
157163124|NCT01274338|567341905|FG005|Overall Study|Other complicating diseases|0|||
157163125|NCT01274338|567341900|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
157163126|NCT01274338|567341901|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
157163127|NCT01274338|567341902|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
157163128|NCT01274338|567341903|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
157163129|NCT01274338|567341904|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
157163130|NCT01274338|567341905|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
157163131|NCT01274338|567341900|FG000|Overall Study|Pregnancy|0|||
157163132|NCT01274338|567341901|FG001|Overall Study|Pregnancy|0|||
157163133|NCT01274338|567341902|FG002|Overall Study|Pregnancy|1|||
157163134|NCT01274338|567341903|FG003|Overall Study|Pregnancy|0|||
156919504|NCT00849381|566461395|FG000|Overall Study|Withdrawal by Subject|6|||
156919505|NCT00849381|566461395|FG000|Overall Study|Other|4|||
156919506|NCT04429061|566461397|FG000|Overall Study|Lost to Follow-up|62|||
156919507|NCT04429061|566461398|FG001|Overall Study|Lost to Follow-up|87|||
156919508|NCT04429061|566461397|FG000|Overall Study|Withdrawal by Subject|3|||
156919509|NCT04429061|566461398|FG001|Overall Study|Withdrawal by Subject|4|||
156919510|NCT02618434|566461403|FG000|Overall Study|Withdrawal by Subject|0|||
156919511|NCT02618434|566461404|FG001|Overall Study|Withdrawal by Subject|2|||
156919512|NCT02618434|566461405|FG002|Overall Study|Withdrawal by Subject|3|||
156919513|NCT02618434|566461403|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
156919514|NCT02618434|566461404|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
156919515|NCT02618434|566461405|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
156919516|NCT02618434|566461403|FG000|Overall Study|Lost to Follow-up|3|||
156919517|NCT02618434|566461404|FG001|Overall Study|Lost to Follow-up|1|||
156919518|NCT02618434|566461405|FG002|Overall Study|Lost to Follow-up|3|||
156919519|NCT02618434|566461403|FG000|Overall Study|Adverse Event|1|||
157163135|NCT01274338|567341904|FG004|Overall Study|Pregnancy|0|||
157163136|NCT01274338|567341905|FG005|Overall Study|Pregnancy|0|||
157163137|NCT01274338|567341900|FG000|Overall Study|Reason not reported|12|||
157163138|NCT01274338|567341901|FG001|Overall Study|Reason not reported|21|||
157163139|NCT01274338|567341902|FG002|Overall Study|Reason not reported|3|||
157163140|NCT01274338|567341903|FG003|Overall Study|Reason not reported|0|||
157163141|NCT01274338|567341904|FG004|Overall Study|Reason not reported|1|||
156919520|NCT02618434|566461404|FG001|Overall Study|Adverse Event|0|||
156919521|NCT02618434|566461405|FG002|Overall Study|Adverse Event|12|||
156919522|NCT02618434|566461403|FG000|Overall Study|Physician Decision|0|||
156919523|NCT02618434|566461404|FG001|Overall Study|Physician Decision|1|||
157163142|NCT01274338|567341905|FG005|Overall Study|Reason not reported|0|||
157163143|NCT01927744|567341906|FG000|Overall Study|Death|2|||
157163144|NCT01927744|567341907|FG001|Overall Study|Death|9|||
157163145|NCT00369967|567341908|FG000|Overall Study|Lost to Follow-up|23|||
157163146|NCT00369967|567341909|FG001|Overall Study|Lost to Follow-up|12|||
156919524|NCT02618434|566461405|FG002|Overall Study|Physician Decision|0|||
156919525|NCT02618434|566461403|FG000|Overall Study|Protocol Violation|0|||
156919526|NCT02618434|566461404|FG001|Overall Study|Protocol Violation|0|||
156919527|NCT02618434|566461405|FG002|Overall Study|Protocol Violation|1|||
156919528|NCT02618434|566461403|FG000|Overall Study|Other, Multiple categories|1|||
156919529|NCT02618434|566461404|FG001|Overall Study|Other, Multiple categories|1|||
156919530|NCT02618434|566461405|FG002|Overall Study|Other, Multiple categories|1|||
156919531|NCT02289898|566461411|FG000|Overall Study|Death|5|||
156919532|NCT02289898|566461412|FG001|Overall Study|Death|4|||
156919533|NCT02289898|566461413|FG002|Overall Study|Death|3|||
156919534|NCT02289898|566461411|FG000|Overall Study|Physician Decision|2|||
156919535|NCT02289898|566461412|FG001|Overall Study|Physician Decision|5|||
156919536|NCT02289898|566461413|FG002|Overall Study|Physician Decision|2|||
156919537|NCT02289898|566461411|FG000|Overall Study|Withdrawal by Subject|0|||
156919538|NCT02289898|566461412|FG001|Overall Study|Withdrawal by Subject|4|||
156919539|NCT02289898|566461413|FG002|Overall Study|Withdrawal by Subject|1|||
156919540|NCT02289898|566461411|FG000|Overall Study|Adverse Event|3|||
156919541|NCT02289898|566461412|FG001|Overall Study|Adverse Event|5|||
156919542|NCT02289898|566461413|FG002|Overall Study|Adverse Event|5|||
156919543|NCT02289898|566461411|FG000|Overall Study|Disease progression|34|||
156919544|NCT02289898|566461412|FG001|Overall Study|Disease progression|28|||
156919545|NCT02289898|566461413|FG002|Overall Study|Disease progression|34|||
156919546|NCT02289898|566461411|FG000|Overall Study|Use of another anticancer therapy|0|||
156919547|NCT02289898|566461412|FG001|Overall Study|Use of another anticancer therapy|0|||
156919548|NCT02289898|566461413|FG002|Overall Study|Use of another anticancer therapy|1|||
156919549|NCT02289898|566461411|FG000|Overall Study|Other|8|||
156919550|NCT02289898|566461412|FG001|Overall Study|Other|7|||
156919551|NCT02289898|566461413|FG002|Overall Study|Other|10|||
156919552|NCT00885105|566461414|FG000|Overall Study|Withdrawal by Subject|0|||
156919553|NCT00885105|566461415|FG001|Overall Study|Withdrawal by Subject|8|||
156919554|NCT00885105|566461414|FG000|Overall Study|Adverse Event|1|||
156919555|NCT00885105|566461415|FG001|Overall Study|Adverse Event|0|||
156919556|NCT00885105|566461414|FG000|Overall Study|Protocol Violation|0|||
156919557|NCT00885105|566461415|FG001|Overall Study|Protocol Violation|2|||
156919558|NCT03519932|566461416|FG000|First Intervention|Adverse Event|1|||
156919559|NCT03519932|566461417|FG001|First Intervention|Adverse Event|3|||
156919560|NCT02254486|566461418|FG000|Overall Study|Adverse Event|1|||
156919561|NCT02254486|566461419|FG001|Overall Study|Adverse Event|1|||
156919562|NCT02254486|566461418|FG000|Overall Study|Lack of Efficacy|1|||
156919563|NCT02254486|566461419|FG001|Overall Study|Lack of Efficacy|0|||
156919564|NCT02254486|566461418|FG000|Overall Study|Lost to Follow-up|2|||
156919565|NCT02254486|566461419|FG001|Overall Study|Lost to Follow-up|4|||
156919566|NCT02254486|566461418|FG000|Overall Study|Protocol Violation|1|||
156919567|NCT02254486|566461419|FG001|Overall Study|Protocol Violation|2|||
156919568|NCT02254486|566461418|FG000|Overall Study|Withdrawal by Subject|17|||
156919569|NCT02254486|566461419|FG001|Overall Study|Withdrawal by Subject|15|||
156919570|NCT02254486|566461418|FG000|Overall Study|GFR<60mL/min|16|||
156919571|NCT02254486|566461419|FG001|Overall Study|GFR<60mL/min|21|||
156919572|NCT02254486|566461418|FG000|Overall Study|Various|12|||
156919573|NCT02254486|566461419|FG001|Overall Study|Various|12|||
156919574|NCT01350414|566461420|FG000|Overall Study|Lost to Follow-up|13|||
156919575|NCT01350414|566461420|FG000|Overall Study|Withdrawal by Subject|4|||
156919576|NCT01350414|566461420|FG000|Overall Study|Physician Decision|2|||
156919577|NCT00267046|566461426|FG000|Overall Study|Disease progression|4|||
156919578|NCT00267046|566461427|FG001|Overall Study|Disease progression|2|||
156919579|NCT00267046|566461426|FG000|Overall Study|Chemotoxicity|2|||
156919580|NCT00267046|566461427|FG001|Overall Study|Chemotoxicity|0|||
156919581|NCT00267046|566461426|FG000|Overall Study|Open-label palifermin|2|||
156919582|NCT00267046|566461427|FG001|Overall Study|Open-label palifermin|7|||
156919583|NCT00267046|566461426|FG000|Overall Study|Surgery|3|||
157163147|NCT03073213|567341910|FG000|Multiple Dose Period|Protocol Violation|0|||
157163148|NCT03073213|567341911|FG001|Multiple Dose Period|Protocol Violation|0|||
157163149|NCT03073213|567341912|FG002|Multiple Dose Period|Protocol Violation|1|||
157163150|NCT02064205|567341913|FG000|Overall Study|Withdrawal by Subject|1|||
157163151|NCT01708941|567341915|FG000|Overall Study|Adverse Event|4|||
156919584|NCT00267046|566461427|FG001|Overall Study|Surgery|1|||
156919585|NCT00267046|566461426|FG000|Overall Study|Withdrawal by Subject|1|||
156919586|NCT00267046|566461427|FG001|Overall Study|Withdrawal by Subject|0|||
156919587|NCT00267046|566461426|FG000|Overall Study|Radiation|0|||
157028519|NCT02038777|566860633|FG006|Overall Study|Started Chemotherapy|0|||
157163152|NCT01708941|567341916|FG001|Overall Study|Adverse Event|6|||
157163153|NCT01708941|567341917|FG002|Overall Study|Adverse Event|1|||
156919588|NCT00267046|566461427|FG001|Overall Study|Radiation|1|||
156919589|NCT00460408|566461428|FG000|Overall Study|Adverse Event|1|||
156919590|NCT00460408|566461429|FG001|Overall Study|Adverse Event|0|||
156919591|NCT00460408|566461430|FG002|Overall Study|Adverse Event|0|||
156919592|NCT00460408|566461431|FG003|Overall Study|Adverse Event|0|||
156919593|NCT00460408|566461428|FG000|Overall Study|Death|7|||
156919594|NCT00460408|566461429|FG001|Overall Study|Death|0|||
156919595|NCT00460408|566461430|FG002|Overall Study|Death|0|||
156919596|NCT00460408|566461431|FG003|Overall Study|Death|0|||
156919597|NCT00460408|566461428|FG000|Overall Study|Lost to Follow-up|11|||
156919598|NCT00460408|566461429|FG001|Overall Study|Lost to Follow-up|0|||
156919599|NCT00460408|566461430|FG002|Overall Study|Lost to Follow-up|1|||
156919600|NCT00460408|566461431|FG003|Overall Study|Lost to Follow-up|0|||
156919601|NCT00460408|566461428|FG000|Overall Study|Withdrawal by Subject|31|||
156919602|NCT00460408|566461429|FG001|Overall Study|Withdrawal by Subject|0|||
156919603|NCT00460408|566461430|FG002|Overall Study|Withdrawal by Subject|0|||
156919604|NCT00460408|566461431|FG003|Overall Study|Withdrawal by Subject|0|||
156919605|NCT00460408|566461428|FG000|Overall Study|Insufficient clinical response|5|||
156919606|NCT00460408|566461429|FG001|Overall Study|Insufficient clinical response|1|||
156919607|NCT00460408|566461430|FG002|Overall Study|Insufficient clinical response|5|||
156919608|NCT00460408|566461431|FG003|Overall Study|Insufficient clinical response|0|||
156919609|NCT00460408|566461428|FG000|Overall Study|Other|12|||
156919610|NCT00460408|566461429|FG001|Overall Study|Other|2|||
156919611|NCT00460408|566461430|FG002|Overall Study|Other|0|||
156919612|NCT00460408|566461431|FG003|Overall Study|Other|0|||
156919613|NCT02066233|566461432|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
156919614|NCT02066233|566461433|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
156919615|NCT02772081|566461434|FG000|Overall Study|Physician Decision|1|||
156919616|NCT02772081|566461435|FG001|Overall Study|Physician Decision|1|||
156919617|NCT02772081|566461434|FG000|Overall Study|Death|1|||
156919618|NCT02772081|566461435|FG001|Overall Study|Death|1|||
156919619|NCT01741701|566461444|FG000|Overall Study|Adverse Event|5|||
156919620|NCT01741701|566461445|FG001|Overall Study|Adverse Event|1|||
156919621|NCT01741701|566461444|FG000|Overall Study|Withdrawal by Subject|0|||
156919622|NCT01741701|566461445|FG001|Overall Study|Withdrawal by Subject|1|||
156919623|NCT02850965|566461449|FG000|Overall Study|Other than listed|3|||
156919624|NCT02850965|566461450|FG001|Overall Study|Other than listed|4|||
156919625|NCT02850965|566461449|FG000|Overall Study|Protocol Violation|0|||
156919626|NCT02850965|566461450|FG001|Overall Study|Protocol Violation|2|||
156919627|NCT02850965|566461449|FG000|Overall Study|Lost to Follow-up|5|||
156919628|NCT02850965|566461450|FG001|Overall Study|Lost to Follow-up|3|||
156919629|NCT02850965|566461449|FG000|Overall Study|Lack of Efficacy|4|||
156919630|NCT02850965|566461450|FG001|Overall Study|Lack of Efficacy|8|||
156919631|NCT02850965|566461449|FG000|Overall Study|Adverse Event|3|||
156919632|NCT02850965|566461450|FG001|Overall Study|Adverse Event|2|||
156919633|NCT02850965|566461449|FG000|Overall Study|Withdrawal by Subject|3|||
156919634|NCT02850965|566461450|FG001|Overall Study|Withdrawal by Subject|4|||
156919635|NCT02850965|566461449|FG000|Overall Study|Physician Decision|0|||
156919636|NCT02850965|566461450|FG001|Overall Study|Physician Decision|1|||
156919637|NCT02850965|566461449|FG000|Overall Study|Randomized but not treated|0|||
156919638|NCT02850965|566461450|FG001|Overall Study|Randomized but not treated|1|||
156919639|NCT02326025|566461451|FG000|Overall Study|Adverse Event|3|||
156919640|NCT02326025|566461452|FG001|Overall Study|Adverse Event|0|||
156919641|NCT02326025|566461451|FG000|Overall Study|Physician Decision|1|||
156919642|NCT02326025|566461452|FG001|Overall Study|Physician Decision|2|||
156919643|NCT02326025|566461451|FG000|Overall Study|Physician and Participant Decision|1|||
156919644|NCT02326025|566461452|FG001|Overall Study|Physician and Participant Decision|0|||
156919645|NCT02326025|566461451|FG000|Overall Study|Withdrawal by Subject|0|||
156919646|NCT02326025|566461452|FG001|Overall Study|Withdrawal by Subject|2|||
156919647|NCT02326025|566461451|FG000|Overall Study|Protocol Violation|0|||
156919648|NCT02326025|566461452|FG001|Overall Study|Protocol Violation|1|||
156919649|NCT00536198|566461453|FG000|Overall Study|Lost to Follow-up|15|||
156919650|NCT00536198|566461454|FG001|Overall Study|Lost to Follow-up|14|||
156919651|NCT00536198|566461453|FG000|Overall Study|Withdrawal by Subject|16|||
156919652|NCT00536198|566461454|FG001|Overall Study|Withdrawal by Subject|12|||
156919653|NCT00536198|566461453|FG000|Overall Study|Adverse Event|2|||
156919654|NCT00536198|566461454|FG001|Overall Study|Adverse Event|2|||
156919655|NCT00536198|566461453|FG000|Overall Study|Rescue|3|||
157163154|NCT01708941|567341918|FG003|Overall Study|Adverse Event|0|||
157163155|NCT01708941|567341915|FG000|Overall Study|Death|1|||
156919656|NCT00536198|566461454|FG001|Overall Study|Rescue|9|||
156919657|NCT00536198|566461453|FG000|Overall Study|Pregnancy|1|||
156919658|NCT00536198|566461454|FG001|Overall Study|Pregnancy|1|||
156919659|NCT00536198|566461453|FG000|Overall Study|Protocol Violation|0|||
156919660|NCT00536198|566461454|FG001|Overall Study|Protocol Violation|1|||
157163156|NCT01708941|567341916|FG001|Overall Study|Death|1|||
156919661|NCT02643082|566461455|FG000|Period 1|Adverse Event|1|||
156919662|NCT02643082|566461456|FG001|Period 1|Adverse Event|0|||
156919663|NCT00881712|566461457|FG000|Overall Study|Death|1|||
156919664|NCT00881712|566461458|FG001|Overall Study|Death|0|||
156919665|NCT00881712|566461459|FG002|Overall Study|Death|0|||
156919666|NCT00881712|566461457|FG000|Overall Study|Withdrawal by Subject|1|||
156919667|NCT00881712|566461458|FG001|Overall Study|Withdrawal by Subject|0|||
156919668|NCT00881712|566461459|FG002|Overall Study|Withdrawal by Subject|0|||
156919669|NCT00276744|566461460|FG000|PART A|Reason unknown|98|||
156919670|NCT02505867|566461463|FG000|Overall Study|Lack of Efficacy|6|||
156919671|NCT02505867|566461464|FG001|Overall Study|Lack of Efficacy|6|||
157163157|NCT01708941|567341917|FG002|Overall Study|Death|2|||
157163158|NCT01708941|567341918|FG003|Overall Study|Death|14|||
157163159|NCT01708941|567341915|FG000|Overall Study|Withdrawal by Subject|1|||
157163160|NCT01708941|567341916|FG001|Overall Study|Withdrawal by Subject|0|||
156919672|NCT01605877|566461466|FG000|Overall Study|Withdrawal by Subject|1|||
156919673|NCT03310775|566461470|FG000|Overall Study|Lost to Follow-up|2|||
156919674|NCT03310775|566461471|FG001|Overall Study|Lost to Follow-up|3|||
156919675|NCT03310775|566461470|FG000|Overall Study|aggravation of depression|0|||
156919676|NCT03310775|566461471|FG001|Overall Study|aggravation of depression|1|||
156919677|NCT00580606|566461481|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
156919678|NCT00580606|566461482|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
156919679|NCT00580606|566461481|FG000|Open Label (OL)|Withdrawal by Subject|4|||
156919680|NCT00580606|566461482|FG001|Open Label (OL)|Withdrawal by Subject|6|||
156919681|NCT00580606|566461481|FG000|Open Label (OL)|Dosing Symptoms|0|||
156919682|NCT00580606|566461482|FG001|Open Label (OL)|Dosing Symptoms|1|||
156919683|NCT00580606|566461481|FG000|Open Label (OL)|Lost to Follow-up|0|||
156919684|NCT00580606|566461482|FG001|Open Label (OL)|Lost to Follow-up|1|||
156919685|NCT00580606|566461481|FG000|Open Label (OL)|Pregnancy|0|||
156919686|NCT00580606|566461482|FG001|Open Label (OL)|Pregnancy|1|||
156919687|NCT00580606|566461481|FG000|Open Label (OL)|Non-compliance|2|||
156919688|NCT00580606|566461482|FG001|Open Label (OL)|Non-compliance|0|||
156919689|NCT00580606|566461481|FG000|Open Label (OL)|Physician Decision|1|||
156919690|NCT00580606|566461482|FG001|Open Label (OL)|Physician Decision|1|||
156919691|NCT00580606|566461481|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
156919692|NCT00580606|566461482|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
156919693|NCT03064451|566461484|FG000|Overall Study|Lost to Follow-up|1|||
156919694|NCT03064451|566461484|FG000|Overall Study|Mapping Failure|4|||
156919695|NCT03064451|566461484|FG000|Overall Study|Exited prior to procedure|8|||
156919696|NCT03064451|566461484|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
156919697|NCT00750204|566461487|FG000|Overall Study|study halted prematurely|1|||
156919698|NCT00750204|566461488|FG001|Overall Study|study halted prematurely|1|||
156919699|NCT01428453|566461489|FG000|Overall Study|Adverse Event|2|||
156919700|NCT01428453|566461490|FG001|Overall Study|Adverse Event|7|||
156919701|NCT01428453|566461489|FG000|Overall Study|Protocol Violation|1|||
156919702|NCT01428453|566461490|FG001|Overall Study|Protocol Violation|0|||
156919703|NCT01428453|566461489|FG000|Overall Study|Lost to Follow-up|0|||
156919704|NCT01428453|566461490|FG001|Overall Study|Lost to Follow-up|1|||
156919705|NCT01428453|566461489|FG000|Overall Study|Withdrawal by Subject|3|||
156919706|NCT01428453|566461490|FG001|Overall Study|Withdrawal by Subject|1|||
156919707|NCT01996709|566461491|FG000|Overall Study|Withdrawal by Subject|1|||
156919708|NCT01996709|566461492|FG001|Overall Study|Withdrawal by Subject|0|||
156919709|NCT01996709|566461491|FG000|Overall Study|Lost to Follow-up|3|||
156919710|NCT01996709|566461492|FG001|Overall Study|Lost to Follow-up|0|||
156919711|NCT01996709|566461491|FG000|Overall Study|Subject Non-Compliant|1|||
156919712|NCT01996709|566461492|FG001|Overall Study|Subject Non-Compliant|0|||
156919713|NCT01996709|566461491|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
156919714|NCT01996709|566461492|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
156919715|NCT00477971|566461493|FG000|Overall Study|Disease progression|6|||
156919716|NCT00477971|566461494|FG001|Overall Study|Disease progression|0|||
156919717|NCT00477971|566461493|FG000|Overall Study|Withdrawal by Subject|3|||
156919718|NCT00477971|566461494|FG001|Overall Study|Withdrawal by Subject|1|||
156919719|NCT00477971|566461493|FG000|Overall Study|Adverse Event|3|||
156919720|NCT00477971|566461494|FG001|Overall Study|Adverse Event|0|||
156919721|NCT00477971|566461493|FG000|Overall Study|Death|2|||
156919722|NCT00477971|566461494|FG001|Overall Study|Death|4|||
156919723|NCT00477971|566461493|FG000|Overall Study|Alternative treatment|3|||
156919724|NCT00477971|566461494|FG001|Overall Study|Alternative treatment|1|||
156919725|NCT02167893|566461495|FG000|Overall Study|Investigator transferred|85|||
156919726|NCT02167893|566461495|FG000|Overall Study|Investigator health reasons|10|||
156919727|NCT02167893|566461495|FG000|Overall Study|Case report forms not collected|68|||
156919728|NCT04232124|566463008|FG000|Overall Study|Lost to Follow-up|3|||
156919729|NCT00967798|566463012|FG000|Overall Study|Withdrawal by Subject|5|||
156919730|NCT00967798|566463013|FG001|Overall Study|Withdrawal by Subject|2|||
156919731|NCT00967798|566463012|FG000|Overall Study|Lost to Follow-up|4|||
156919732|NCT00967798|566463013|FG001|Overall Study|Lost to Follow-up|1|||
156919733|NCT03045328|566463019|FG000|Overall Study|Withdrawal by Subject|2|||
156919734|NCT02564042|566463022|FG000|Overall Study|Adverse Event|4|||
156919735|NCT02564042|566463023|FG001|Overall Study|Adverse Event|4|||
156919736|NCT02564042|566463024|FG002|Overall Study|Adverse Event|3|||
156919737|NCT02564042|566463025|FG003|Overall Study|Adverse Event|0|||
156919738|NCT02564042|566463026|FG004|Overall Study|Adverse Event|0|||
156919739|NCT02564042|566463027|FG005|Overall Study|Adverse Event|1|||
157163161|NCT01708941|567341917|FG002|Overall Study|Withdrawal by Subject|3|||
156919740|NCT02564042|566463022|FG000|Overall Study|Lost to Follow-up|1|||
157163162|NCT01708941|567341918|FG003|Overall Study|Withdrawal by Subject|4|||
156919741|NCT02564042|566463023|FG001|Overall Study|Lost to Follow-up|1|||
156919742|NCT02564042|566463024|FG002|Overall Study|Lost to Follow-up|1|||
156919743|NCT02564042|566463025|FG003|Overall Study|Lost to Follow-up|0|||
156919744|NCT02564042|566463026|FG004|Overall Study|Lost to Follow-up|1|||
156919745|NCT02564042|566463027|FG005|Overall Study|Lost to Follow-up|1|||
156919746|NCT02564042|566463022|FG000|Overall Study|Physician Decision|1|||
156919747|NCT02564042|566463023|FG001|Overall Study|Physician Decision|0|||
156919748|NCT02564042|566463024|FG002|Overall Study|Physician Decision|0|||
156919749|NCT02564042|566463025|FG003|Overall Study|Physician Decision|1|||
156919750|NCT02564042|566463026|FG004|Overall Study|Physician Decision|0|||
156919751|NCT02564042|566463027|FG005|Overall Study|Physician Decision|0|||
156919752|NCT02564042|566463022|FG000|Overall Study|Withdrawal by Subject|5|||
156919753|NCT02564042|566463023|FG001|Overall Study|Withdrawal by Subject|3|||
156919754|NCT02564042|566463024|FG002|Overall Study|Withdrawal by Subject|2|||
156919755|NCT02564042|566463025|FG003|Overall Study|Withdrawal by Subject|2|||
156919756|NCT02564042|566463026|FG004|Overall Study|Withdrawal by Subject|10|||
156919757|NCT02564042|566463027|FG005|Overall Study|Withdrawal by Subject|12|||
156919758|NCT02598076|566463030|FG000|Overall Study|Lost to Follow-up|2|||
156919759|NCT02598076|566463031|FG001|Overall Study|Lost to Follow-up|3|||
156919760|NCT04983264|566463032|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
156919761|NCT04983264|566463033|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
156919762|NCT04983264|566463034|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
156919763|NCT04983264|566463032|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
156919764|NCT04983264|566463033|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
156919765|NCT04983264|566463034|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
156919766|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Death|3|||
156919767|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Death|3|||
156919768|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Death|0|||
156919769|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Death|0|||
156919770|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
156919771|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
156919772|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
156919773|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
156919774|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
156919775|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
156919776|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
157163163|NCT01708941|567341915|FG000|Overall Study|Disease progression|9|||
157163164|NCT01708941|567341916|FG001|Overall Study|Disease progression|10|||
157163165|NCT01708941|567341917|FG002|Overall Study|Disease progression|8|||
157163166|NCT01708941|567341918|FG003|Overall Study|Disease progression|0|||
157163167|NCT01708941|567341915|FG000|Overall Study|Alternative therapy|0|||
157163168|NCT01708941|567341916|FG001|Overall Study|Alternative therapy|0|||
157163169|NCT01708941|567341917|FG002|Overall Study|Alternative therapy|2|||
157163170|NCT01708941|567341918|FG003|Overall Study|Alternative therapy|0|||
157163171|NCT01708941|567341915|FG000|Overall Study|Ineligible and never started treatment|1|||
157163172|NCT01708941|567341916|FG001|Overall Study|Ineligible and never started treatment|0|||
157163173|NCT01708941|567341917|FG002|Overall Study|Ineligible and never started treatment|1|||
157163174|NCT01708941|567341918|FG003|Overall Study|Ineligible and never started treatment|0|||
157163175|NCT01708941|567341915|FG000|Overall Study|Never started treatment|2|||
157163176|NCT01708941|567341916|FG001|Overall Study|Never started treatment|1|||
157163177|NCT01708941|567341917|FG002|Overall Study|Never started treatment|0|||
157163178|NCT01708941|567341918|FG003|Overall Study|Never started treatment|0|||
157163179|NCT01708941|567341915|FG000|Overall Study|Ineligible|0|||
157163180|NCT01708941|567341916|FG001|Overall Study|Ineligible|0|||
157163181|NCT01708941|567341917|FG002|Overall Study|Ineligible|2|||
157163182|NCT01708941|567341918|FG003|Overall Study|Ineligible|0|||
157163183|NCT02226146|567341919|FG000|Overall Study|Received rescue therapy|1|||
157163184|NCT02226146|567341919|FG000|Overall Study|Withdrawal by Subject|2|||
157163185|NCT05464836|567341920|FG000|Overall Study|Progression of Disease|1|||
157163186|NCT05464836|567341920|FG000|Overall Study|Physician Decision|1|||
157163187|NCT01522976|567341921|FG000|Overall Study|Ineligible|4|||
157163188|NCT01522976|567341922|FG001|Overall Study|Ineligible|0|||
157163189|NCT01522976|567341923|FG002|Overall Study|Ineligible|1|||
157163190|NCT01522976|567341921|FG000|Overall Study|Death|7|||
157163191|NCT01522976|567341922|FG001|Overall Study|Death|6|||
157163192|NCT01522976|567341923|FG002|Overall Study|Death|2|||
157163193|NCT01522976|567341921|FG000|Overall Study|Still on treatment|9|||
157163194|NCT01522976|567341922|FG001|Overall Study|Still on treatment|9|||
157163195|NCT01522976|567341923|FG002|Overall Study|Still on treatment|6|||
157163196|NCT01522976|567341921|FG000|Overall Study|Disease progression|28|||
157163197|NCT01522976|567341922|FG001|Overall Study|Disease progression|30|||
157163198|NCT01522976|567341923|FG002|Overall Study|Disease progression|25|||
157163199|NCT01522976|567341921|FG000|Overall Study|Adverse Event|17|||
157163200|NCT01522976|567341922|FG001|Overall Study|Adverse Event|7|||
157163201|NCT01522976|567341923|FG002|Overall Study|Adverse Event|18|||
157163202|NCT01522976|567341921|FG000|Overall Study|Refusal unrelated to adverse event|10|||
157163203|NCT01522976|567341922|FG001|Overall Study|Refusal unrelated to adverse event|13|||
157163204|NCT01522976|567341923|FG002|Overall Study|Refusal unrelated to adverse event|14|||
157163205|NCT01522976|567341921|FG000|Overall Study|Not protocol specified|22|||
157163206|NCT01522976|567341922|FG001|Overall Study|Not protocol specified|27|||
156919777|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
156919778|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
156919779|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
156919780|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
156919781|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
156919782|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
156919783|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
156919784|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
156919785|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
156919786|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
156919787|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
156919788|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
156919789|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
156919790|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
156919791|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
156919792|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
156919793|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
156919794|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Other|6|||
156919795|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Other|3|||
156919796|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Other|0|||
156919797|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Other|0|||
156919798|NCT02051608|566463035|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
156919799|NCT02051608|566463036|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
156919800|NCT02051608|566463037|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
156919801|NCT02051608|566463038|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
156919802|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Adverse Event|0|||
156919803|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Adverse Event|0|||
156919804|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Adverse Event|6|||
156919805|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Adverse Event|8|||
156919806|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Death|0|||
156919807|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Death|0|||
156919808|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Death|7|||
156919809|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Death|4|||
156919810|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
156919811|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
156919812|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
156919813|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
156919814|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
156919815|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
156919816|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
156919817|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
156919818|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156919819|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
156919820|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
156919821|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
156919822|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156919823|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156919824|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
156919825|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
156919826|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Physician Decision|0|||
156919827|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Physician Decision|0|||
156919828|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Physician Decision|8|||
156919829|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Physician Decision|5|||
156919830|NCT02051608|566463035|FG000|Part 2: Open-label Extension|Other|0|||
156919831|NCT02051608|566463036|FG001|Part 2: Open-label Extension|Other|0|||
156919832|NCT02051608|566463037|FG002|Part 2: Open-label Extension|Other|9|||
156919833|NCT02051608|566463038|FG003|Part 2: Open-label Extension|Other|9|||
156919834|NCT02709785|566463045|FG000|Overall Study|Withdrawal by Subject|1|||
156919835|NCT02709785|566463046|FG001|Overall Study|Withdrawal by Subject|2|||
156919836|NCT02709785|566463047|FG002|Overall Study|Withdrawal by Subject|1|||
156919837|NCT00010374|566463048|FG000|Overall Study|False positive phrenic nerve test|1|||
156919838|NCT03315208|566463049|FG000|Overall Study|Lost to Follow-up|11|||
156919839|NCT03315208|566463050|FG001|Overall Study|Lost to Follow-up|6|||
156919840|NCT03315208|566463049|FG000|Overall Study|Withdrawal by Subject|2|||
156919841|NCT03315208|566463050|FG001|Overall Study|Withdrawal by Subject|0|||
156919842|NCT02875860|566463054|FG000|Overall Study|Withdrawal by Subject|0|||
156919843|NCT02875860|566463055|FG001|Overall Study|Withdrawal by Subject|1|||
157163207|NCT01522976|567341923|FG002|Overall Study|Not protocol specified|27|||
157163208|NCT02883049|567341924|FG000|Induction|Adverse Event|52|||
157163209|NCT02883049|567341925|FG001|Induction|Adverse Event|2|||
156919844|NCT01881776|566463056|FG000|Overall Study|Lost to Follow-up|1|||
156919845|NCT01881776|566463057|FG001|Overall Study|Lost to Follow-up|2|||
157163210|NCT02883049|567341926|FG002|Induction|Adverse Event|0|||
157163211|NCT02883049|567341927|FG003|Induction|Adverse Event|0|||
157163212|NCT02883049|567341928|FG004|Induction|Adverse Event|0|||
157163213|NCT02883049|567341929|FG005|Induction|Adverse Event|0|||
157163214|NCT02883049|567341930|FG006|Induction|Adverse Event|0|||
157163215|NCT02883049|567341931|FG007|Induction|Adverse Event|0|||
157163216|NCT02883049|567341932|FG008|Induction|Adverse Event|0|||
157163217|NCT02883049|567341933|FG009|Induction|Adverse Event|0|||
157163218|NCT02883049|567341934|FG010|Induction|Adverse Event|0|||
157163219|NCT02883049|567341935|FG011|Induction|Adverse Event|0|||
157163220|NCT02883049|567341936|FG012|Induction|Adverse Event|0|||
157163221|NCT02883049|567341937|FG013|Induction|Adverse Event|0|||
157163222|NCT02883049|567341938|FG014|Induction|Adverse Event|0|||
157163223|NCT02883049|567341939|FG015|Induction|Adverse Event|0|||
157163224|NCT02883049|567341924|FG000|Induction|Death|76|||
157163225|NCT02883049|567341925|FG001|Induction|Death|8|||
157163226|NCT02883049|567341926|FG002|Induction|Death|0|||
157163227|NCT02883049|567341927|FG003|Induction|Death|0|||
157163228|NCT02883049|567341928|FG004|Induction|Death|0|||
157163229|NCT02883049|567341929|FG005|Induction|Death|0|||
157163230|NCT02883049|567341930|FG006|Induction|Death|0|||
157163231|NCT02883049|567341931|FG007|Induction|Death|0|||
157163232|NCT02883049|567341932|FG008|Induction|Death|0|||
157163233|NCT02883049|567341933|FG009|Induction|Death|0|||
157163234|NCT02883049|567341934|FG010|Induction|Death|0|||
157163235|NCT02883049|567341935|FG011|Induction|Death|0|||
157163236|NCT02883049|567341936|FG012|Induction|Death|0|||
157163237|NCT02883049|567341937|FG013|Induction|Death|0|||
156919846|NCT01881776|566463058|FG002|Overall Study|Lost to Follow-up|1|||
156919847|NCT01881776|566463056|FG000|Overall Study|Protocol Violation|0|||
156919848|NCT01881776|566463057|FG001|Overall Study|Protocol Violation|2|||
156919849|NCT01881776|566463058|FG002|Overall Study|Protocol Violation|1|||
156919850|NCT03033394|566463070|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
156919851|NCT03033394|566463070|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
156919852|NCT03033394|566463070|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
156919853|NCT03033394|566463070|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
156919854|NCT03033394|566463070|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
156919855|NCT02036294|566463071|FG000|Overall Study|Death|7|||
156919856|NCT02036294|566463072|FG001|Overall Study|Death|8|||
156919857|NCT02036294|566463071|FG000|Overall Study|Withdrawal by Subject|2|||
156919858|NCT02036294|566463072|FG001|Overall Study|Withdrawal by Subject|3|||
156919859|NCT00356369|566463073|FG000|Active Phase|Withdrawal by Subject|2|||
156919860|NCT00356369|566463074|FG001|Active Phase|Withdrawal by Subject|1|||
156919861|NCT00673465|566463078|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919862|NCT00673465|566463079|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919863|NCT00673465|566463080|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919864|NCT00673465|566463081|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919865|NCT00673465|566463082|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
156919866|NCT00673465|566463083|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
156919867|NCT00673465|566463084|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919868|NCT00673465|566463085|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919869|NCT00673465|566463086|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919870|NCT00673465|566463087|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919871|NCT00673465|566463088|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919872|NCT00673465|566463089|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
156919873|NCT00673465|566463078|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919874|NCT00673465|566463079|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919875|NCT00673465|566463080|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919876|NCT00673465|566463081|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919877|NCT00673465|566463082|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
156919878|NCT00673465|566463083|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919879|NCT00673465|566463084|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919880|NCT00673465|566463085|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919881|NCT00673465|566463086|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919882|NCT00673465|566463087|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919883|NCT00673465|566463088|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
157163238|NCT02883049|567341938|FG014|Induction|Death|0|||
157163239|NCT02883049|567341939|FG015|Induction|Death|0|||
157163240|NCT02883049|567341924|FG000|Induction|Lost to Follow-up|2|||
157163241|NCT02883049|567341925|FG001|Induction|Lost to Follow-up|0|||
157163242|NCT02883049|567341926|FG002|Induction|Lost to Follow-up|0|||
157163243|NCT02883049|567341927|FG003|Induction|Lost to Follow-up|0|||
157163244|NCT02883049|567341928|FG004|Induction|Lost to Follow-up|0|||
157163245|NCT02883049|567341929|FG005|Induction|Lost to Follow-up|0|||
157163246|NCT02883049|567341930|FG006|Induction|Lost to Follow-up|0|||
157163247|NCT02883049|567341931|FG007|Induction|Lost to Follow-up|0|||
156919884|NCT00673465|566463089|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
156919885|NCT04952402|566463090|FG000|Overall Study|Lost to Follow-up|1|||
156919886|NCT04952402|566463091|FG001|Overall Study|Lost to Follow-up|3|||
156919887|NCT04952402|566463090|FG000|Overall Study|Lack Of Venous Access|0|||
156919888|NCT04952402|566463091|FG001|Overall Study|Lack Of Venous Access|1|||
156919889|NCT00143403|566463092|FG000|Overall Study|Adverse Event|3|||
156919890|NCT00143403|566463093|FG001|Overall Study|Adverse Event|8|||
156919891|NCT00143403|566463092|FG000|Overall Study|Death|1|||
156919892|NCT00143403|566463093|FG001|Overall Study|Death|0|||
156919893|NCT00143403|566463092|FG000|Overall Study|Withdrawal by Subject|3|||
156919894|NCT00143403|566463093|FG001|Overall Study|Withdrawal by Subject|12|||
156919895|NCT00143403|566463092|FG000|Overall Study|Relapse|15|||
156919896|NCT00143403|566463093|FG001|Overall Study|Relapse|7|||
156919897|NCT00143403|566463092|FG000|Overall Study|Protocol Violation|2|||
156919898|NCT00143403|566463093|FG001|Overall Study|Protocol Violation|2|||
156919899|NCT00143403|566463092|FG000|Overall Study|specified by site|4|||
156919900|NCT00143403|566463093|FG001|Overall Study|specified by site|9|||
156919901|NCT00143403|566463092|FG000|Overall Study|Randomized Not Treated|7|||
156919902|NCT00143403|566463093|FG001|Overall Study|Randomized Not Treated|8|||
156919903|NCT01996982|566463094|FG000|Overall Study|PI/team left institution|7|||
156919904|NCT01442675|566463099|FG000|Overall Study|Protocol Violation|6|||
156919905|NCT01442675|566463099|FG000|Overall Study|Lost to Follow-up|2|||
156919906|NCT01442675|566463099|FG000|Overall Study|Withdrawal by Subject|4|||
156919907|NCT01919723|566463100|FG000|Overall Study|Blood Samples Hemolyzed|2|||
156919908|NCT01919723|566463101|FG001|Overall Study|Blood Samples Hemolyzed|2|||
156919909|NCT04502589|566463102|FG000|Overall Study|Physician Decision|1|||
156919910|NCT04502589|566463103|FG001|Overall Study|Physician Decision|0|||
156919911|NCT00160251|566463104|FG000|Prior to Amendment 2|Adverse Event|2|||
156919912|NCT00160251|566463105|FG001|Prior to Amendment 2|Adverse Event|1|||
156919913|NCT00160251|566463106|FG002|Prior to Amendment 2|Adverse Event|3|||
156919914|NCT00160251|566463107|FG003|Prior to Amendment 2|Adverse Event|1|||
156919915|NCT00160251|566463108|FG004|Prior to Amendment 2|Adverse Event|1|||
156919916|NCT00160251|566463109|FG005|Prior to Amendment 2|Adverse Event|1|||
156919917|NCT00160251|566463110|FG006|Prior to Amendment 2|Adverse Event|1|||
156919918|NCT00160251|566463111|FG007|Prior to Amendment 2|Adverse Event|0|||
156919919|NCT00160251|566463104|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
156919920|NCT00160251|566463105|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
156919921|NCT00160251|566463106|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
156919922|NCT00160251|566463107|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
156919923|NCT00160251|566463108|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
156919924|NCT00160251|566463109|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
156919925|NCT00160251|566463110|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
156919926|NCT00160251|566463111|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
156919927|NCT00160251|566463104|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
156919928|NCT00160251|566463105|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
156919929|NCT00160251|566463106|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
156919930|NCT00160251|566463107|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
156919931|NCT00160251|566463108|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
156919932|NCT00160251|566463109|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
156919933|NCT00160251|566463110|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
156919934|NCT00160251|566463111|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
156919935|NCT00160251|566463104|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
156919936|NCT00160251|566463105|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
156919937|NCT00160251|566463106|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
156919938|NCT00160251|566463107|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
156919939|NCT00160251|566463108|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
156919940|NCT00160251|566463109|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
156919941|NCT00160251|566463110|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
156919942|NCT00160251|566463111|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
156919943|NCT00160251|566463104|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
156919944|NCT00160251|566463105|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
156919945|NCT00160251|566463106|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
156919946|NCT00160251|566463107|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
156919947|NCT00160251|566463108|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
156919948|NCT00160251|566463109|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
156919949|NCT00160251|566463110|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
156919950|NCT00160251|566463111|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
156919951|NCT00160251|566463104|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
156919952|NCT00160251|566463105|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
156919953|NCT00160251|566463106|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
156919954|NCT00160251|566463107|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
156919955|NCT00160251|566463108|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
156919956|NCT00160251|566463109|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
156919957|NCT00160251|566463110|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
156919958|NCT00160251|566463111|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
156919959|NCT00160251|566463104|FG000|Post-amendment 2|Adverse Event|0|||
156919960|NCT00160251|566463105|FG001|Post-amendment 2|Adverse Event|0|||
156919961|NCT00160251|566463106|FG002|Post-amendment 2|Adverse Event|0|||
156919962|NCT00160251|566463107|FG003|Post-amendment 2|Adverse Event|0|||
156919963|NCT00160251|566463108|FG004|Post-amendment 2|Adverse Event|0|||
156919964|NCT00160251|566463109|FG005|Post-amendment 2|Adverse Event|0|||
156919965|NCT00160251|566463110|FG006|Post-amendment 2|Adverse Event|0|||
156919966|NCT00160251|566463111|FG007|Post-amendment 2|Adverse Event|20|||
156919967|NCT00160251|566463104|FG000|Post-amendment 2|Lack of Efficacy|0|||
156919968|NCT00160251|566463105|FG001|Post-amendment 2|Lack of Efficacy|0|||
156919969|NCT00160251|566463106|FG002|Post-amendment 2|Lack of Efficacy|0|||
156919970|NCT00160251|566463107|FG003|Post-amendment 2|Lack of Efficacy|0|||
156919971|NCT00160251|566463108|FG004|Post-amendment 2|Lack of Efficacy|0|||
156919972|NCT00160251|566463109|FG005|Post-amendment 2|Lack of Efficacy|0|||
156919973|NCT00160251|566463110|FG006|Post-amendment 2|Lack of Efficacy|0|||
156919974|NCT00160251|566463111|FG007|Post-amendment 2|Lack of Efficacy|24|||
156919975|NCT00160251|566463104|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919976|NCT00160251|566463105|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919977|NCT00160251|566463106|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919978|NCT00160251|566463107|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919979|NCT00160251|566463108|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919980|NCT00160251|566463109|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919981|NCT00160251|566463110|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
156919982|NCT00160251|566463111|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
156919983|NCT01574612|566463112|FG000|Overall Study|Adverse Event|3|||
156919984|NCT01574612|566463112|FG000|Overall Study|non compliant with drug|2|||
156919985|NCT01574612|566463112|FG000|Overall Study|Withdrawal by Subject|1|||
156919986|NCT01574612|566463112|FG000|Overall Study|Lost to Follow-up|2|||
156919987|NCT03235154|566463118|FG000|Overall Study|Withdrawal by Subject|1|||
156919988|NCT03235154|566463118|FG000|Overall Study|Adverse Event|1|||
156919989|NCT03235154|566463118|FG000|Overall Study|Lost to Follow-up|2|||
156919990|NCT01683383|566463123|FG000|Overall Study|Infant was not transported|1|||
156919991|NCT01683383|566463124|FG001|Overall Study|Infant was not transported|0|||
156919992|NCT02496611|566463125|FG000|Overall Study|Lost to Follow-up|2|||
156919993|NCT02496611|566463126|FG001|Overall Study|Lost to Follow-up|1|||
156919994|NCT02496611|566463125|FG000|Overall Study|Withdrawal by Subject|5|||
156919995|NCT02496611|566463126|FG001|Overall Study|Withdrawal by Subject|2|||
156919996|NCT01129960|566463127|FG000|Overall Study|Withdrawal by Subject|3|||
156919997|NCT01129960|566463128|FG001|Overall Study|Withdrawal by Subject|0|||
156919998|NCT01129960|566463129|FG002|Overall Study|Withdrawal by Subject|3|||
156919999|NCT01129960|566463130|FG003|Overall Study|Withdrawal by Subject|2|||
156920000|NCT01129960|566463127|FG000|Overall Study|Lack of Efficacy|1|||
156920001|NCT01129960|566463128|FG001|Overall Study|Lack of Efficacy|1|||
156920002|NCT01129960|566463129|FG002|Overall Study|Lack of Efficacy|1|||
156920003|NCT01129960|566463130|FG003|Overall Study|Lack of Efficacy|1|||
156920004|NCT01129960|566463127|FG000|Overall Study|Adverse Event|23|||
156920005|NCT01129960|566463128|FG001|Overall Study|Adverse Event|16|||
156920006|NCT01129960|566463129|FG002|Overall Study|Adverse Event|16|||
156920007|NCT01129960|566463130|FG003|Overall Study|Adverse Event|7|||
156920008|NCT01129960|566463127|FG000|Overall Study|Protocol Violation|1|||
156920009|NCT01129960|566463128|FG001|Overall Study|Protocol Violation|2|||
156920010|NCT01129960|566463129|FG002|Overall Study|Protocol Violation|3|||
156920011|NCT01129960|566463130|FG003|Overall Study|Protocol Violation|0|||
156920012|NCT01129960|566463127|FG000|Overall Study|Lost to Follow-up|0|||
156920013|NCT01129960|566463128|FG001|Overall Study|Lost to Follow-up|2|||
156920014|NCT01129960|566463129|FG002|Overall Study|Lost to Follow-up|3|||
156920015|NCT01129960|566463130|FG003|Overall Study|Lost to Follow-up|3|||
156920016|NCT01129960|566463127|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
156920017|NCT01129960|566463128|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
157028520|NCT02038777|566860634|FG007|Overall Study|Started Chemotherapy|0|||
157028521|NCT02038777|566860627|FG000|Overall Study|participation terminated by sponsor|0|||
157028522|NCT02038777|566860628|FG001|Overall Study|participation terminated by sponsor|0|||
156920018|NCT01129960|566463129|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
156920019|NCT01129960|566463130|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
156920020|NCT01129960|566463127|FG000|Overall Study|Physician Decision|1|||
156920021|NCT01129960|566463128|FG001|Overall Study|Physician Decision|0|||
156920022|NCT01129960|566463129|FG002|Overall Study|Physician Decision|0|||
156920023|NCT01129960|566463130|FG003|Overall Study|Physician Decision|0|||
157163248|NCT02883049|567341932|FG008|Induction|Lost to Follow-up|0|||
156920024|NCT01129960|566463127|FG000|Overall Study|Pregnancy|1|||
156920025|NCT01129960|566463128|FG001|Overall Study|Pregnancy|0|||
156920026|NCT01129960|566463129|FG002|Overall Study|Pregnancy|0|||
156920027|NCT01129960|566463130|FG003|Overall Study|Pregnancy|0|||
156920028|NCT03672747|566463131|FG000|Overall Study|Lost to Follow-up|1|||
156920029|NCT03672747|566463132|FG001|Overall Study|Lost to Follow-up|1|||
156920030|NCT03672747|566463133|FG002|Overall Study|Lost to Follow-up|2|||
157163249|NCT02883049|567341933|FG009|Induction|Lost to Follow-up|0|||
156920031|NCT03672747|566463134|FG003|Overall Study|Lost to Follow-up|2|||
156920032|NCT03672747|566463135|FG004|Overall Study|Lost to Follow-up|2|||
156920033|NCT03672747|566463136|FG005|Overall Study|Lost to Follow-up|1|||
156920034|NCT00165776|566463138|FG000|Overall Study|Lack of Efficacy|0|||
156920035|NCT00165776|566463139|FG001|Overall Study|Lack of Efficacy|0|||
156920036|NCT00165776|566463140|FG002|Overall Study|Lack of Efficacy|0|||
156920037|NCT00165776|566463141|FG003|Overall Study|Lack of Efficacy|1|||
156920038|NCT00165776|566463138|FG000|Overall Study|Withdrawal by Subject|4|||
156920039|NCT00165776|566463139|FG001|Overall Study|Withdrawal by Subject|1|||
156920040|NCT00165776|566463140|FG002|Overall Study|Withdrawal by Subject|2|||
156920041|NCT00165776|566463141|FG003|Overall Study|Withdrawal by Subject|0|||
156920042|NCT00165776|566463138|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
156920043|NCT00165776|566463139|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
156920044|NCT00165776|566463140|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
156920045|NCT00165776|566463141|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
156920046|NCT00126568|566463142|FG000|Overall Study|Death|2|||
156920047|NCT03358290|566463143|FG000|Overall Study|Study discontinued by Sponsor|0|||
156920048|NCT03358290|566463144|FG001|Overall Study|Study discontinued by Sponsor|1|||
156920049|NCT03358290|566463145|FG002|Overall Study|Study discontinued by Sponsor|1|||
156920050|NCT03358290|566463146|FG003|Overall Study|Study discontinued by Sponsor|0|||
156920051|NCT03358290|566463147|FG004|Overall Study|Study discontinued by Sponsor|0|||
156920052|NCT03358290|566463143|FG000|Overall Study|Adverse Event|0|||
156920053|NCT03358290|566463144|FG001|Overall Study|Adverse Event|0|||
156920054|NCT03358290|566463145|FG002|Overall Study|Adverse Event|1|||
156920055|NCT03358290|566463146|FG003|Overall Study|Adverse Event|2|||
156920056|NCT03358290|566463147|FG004|Overall Study|Adverse Event|0|||
156920057|NCT03358290|566463143|FG000|Overall Study|Withdrawal by Subject|0|||
156920058|NCT03358290|566463144|FG001|Overall Study|Withdrawal by Subject|0|||
156920059|NCT03358290|566463145|FG002|Overall Study|Withdrawal by Subject|0|||
156920060|NCT03358290|566463146|FG003|Overall Study|Withdrawal by Subject|0|||
156920061|NCT03358290|566463147|FG004|Overall Study|Withdrawal by Subject|1|||
156920062|NCT00203996|566463148|FG000|Overall Study|Lost to Follow-up|0|||
156920063|NCT00203996|566463149|FG001|Overall Study|Lost to Follow-up|0|||
156920064|NCT00203996|566463150|FG002|Overall Study|Lost to Follow-up|0|||
156920065|NCT00203996|566463151|FG003|Overall Study|Lost to Follow-up|1|||
156920066|NCT00203996|566463152|FG004|Overall Study|Lost to Follow-up|0|||
156920067|NCT00203996|566463153|FG005|Overall Study|Lost to Follow-up|0|||
156920068|NCT00203996|566463154|FG006|Overall Study|Lost to Follow-up|0|||
156920069|NCT00203996|566463155|FG007|Overall Study|Lost to Follow-up|0|||
156920070|NCT00203996|566463156|FG008|Overall Study|Lost to Follow-up|0|||
156920071|NCT00203996|566463157|FG009|Overall Study|Lost to Follow-up|0|||
156920072|NCT00203996|566463148|FG000|Overall Study|Protocol Violation|0|||
156920073|NCT00203996|566463149|FG001|Overall Study|Protocol Violation|0|||
156920074|NCT00203996|566463150|FG002|Overall Study|Protocol Violation|0|||
156920075|NCT00203996|566463151|FG003|Overall Study|Protocol Violation|6|||
156920076|NCT00203996|566463152|FG004|Overall Study|Protocol Violation|1|||
156920077|NCT00203996|566463153|FG005|Overall Study|Protocol Violation|0|||
156920078|NCT00203996|566463154|FG006|Overall Study|Protocol Violation|0|||
156920079|NCT00203996|566463155|FG007|Overall Study|Protocol Violation|0|||
156920080|NCT00203996|566463156|FG008|Overall Study|Protocol Violation|0|||
156920081|NCT00203996|566463157|FG009|Overall Study|Protocol Violation|0|||
156920082|NCT00203996|566463148|FG000|Overall Study|Physician Decision|0|||
156920083|NCT00203996|566463149|FG001|Overall Study|Physician Decision|0|||
156920084|NCT00203996|566463150|FG002|Overall Study|Physician Decision|0|||
156920085|NCT00203996|566463151|FG003|Overall Study|Physician Decision|2|||
156920086|NCT00203996|566463152|FG004|Overall Study|Physician Decision|0|||
156920087|NCT00203996|566463153|FG005|Overall Study|Physician Decision|0|||
156920088|NCT00203996|566463154|FG006|Overall Study|Physician Decision|0|||
156920089|NCT00203996|566463155|FG007|Overall Study|Physician Decision|0|||
156920090|NCT00203996|566463156|FG008|Overall Study|Physician Decision|0|||
157163250|NCT02883049|567341934|FG010|Induction|Lost to Follow-up|0|||
157163251|NCT02883049|567341935|FG011|Induction|Lost to Follow-up|0|||
156920091|NCT00203996|566463157|FG009|Overall Study|Physician Decision|1|||
156920092|NCT00203996|566463148|FG000|Overall Study|CPAP machine malfunction|0|||
156920093|NCT00203996|566463149|FG001|Overall Study|CPAP machine malfunction|0|||
156920094|NCT00203996|566463150|FG002|Overall Study|CPAP machine malfunction|0|||
156920095|NCT00203996|566463151|FG003|Overall Study|CPAP machine malfunction|1|||
157028523|NCT02038777|566860629|FG002|Overall Study|participation terminated by sponsor|0|||
157163252|NCT02883049|567341936|FG012|Induction|Lost to Follow-up|0|||
156920096|NCT00203996|566463152|FG004|Overall Study|CPAP machine malfunction|0|||
156920097|NCT00203996|566463153|FG005|Overall Study|CPAP machine malfunction|0|||
156920098|NCT00203996|566463154|FG006|Overall Study|CPAP machine malfunction|0|||
156920099|NCT00203996|566463155|FG007|Overall Study|CPAP machine malfunction|0|||
156920100|NCT00203996|566463156|FG008|Overall Study|CPAP machine malfunction|0|||
156920101|NCT00203996|566463157|FG009|Overall Study|CPAP machine malfunction|0|||
157028524|NCT02038777|566860630|FG003|Overall Study|participation terminated by sponsor|0|||
156920102|NCT00203996|566463148|FG000|Overall Study|Scheduling issue|0|||
156920103|NCT00203996|566463149|FG001|Overall Study|Scheduling issue|0|||
157163253|NCT02883049|567341937|FG013|Induction|Lost to Follow-up|0|||
157163254|NCT02883049|567341938|FG014|Induction|Lost to Follow-up|0|||
157163255|NCT02883049|567341939|FG015|Induction|Lost to Follow-up|0|||
157163256|NCT02883049|567341924|FG000|Induction|Physician Decision|1407|||
157163257|NCT02883049|567341925|FG001|Induction|Physician Decision|8|||
157163258|NCT02883049|567341926|FG002|Induction|Physician Decision|0|||
157163259|NCT02883049|567341927|FG003|Induction|Physician Decision|0|||
157163260|NCT02883049|567341928|FG004|Induction|Physician Decision|0|||
157163261|NCT02883049|567341929|FG005|Induction|Physician Decision|0|||
157163262|NCT02883049|567341930|FG006|Induction|Physician Decision|0|||
157163263|NCT02883049|567341931|FG007|Induction|Physician Decision|0|||
157163264|NCT02883049|567341932|FG008|Induction|Physician Decision|0|||
157163265|NCT02883049|567341933|FG009|Induction|Physician Decision|0|||
157163266|NCT02883049|567341934|FG010|Induction|Physician Decision|0|||
157163267|NCT02883049|567341935|FG011|Induction|Physician Decision|0|||
157163268|NCT02883049|567341936|FG012|Induction|Physician Decision|0|||
157163269|NCT02883049|567341937|FG013|Induction|Physician Decision|0|||
157163270|NCT02883049|567341938|FG014|Induction|Physician Decision|0|||
157163271|NCT02883049|567341939|FG015|Induction|Physician Decision|0|||
157163272|NCT02883049|567341924|FG000|Induction|Protocol Violation|6|||
157163273|NCT02883049|567341925|FG001|Induction|Protocol Violation|0|||
157163274|NCT02883049|567341926|FG002|Induction|Protocol Violation|0|||
157163275|NCT02883049|567341927|FG003|Induction|Protocol Violation|0|||
157163276|NCT02883049|567341928|FG004|Induction|Protocol Violation|0|||
157163277|NCT02883049|567341929|FG005|Induction|Protocol Violation|0|||
157163278|NCT02883049|567341930|FG006|Induction|Protocol Violation|0|||
157163279|NCT02883049|567341931|FG007|Induction|Protocol Violation|0|||
157163280|NCT02883049|567341932|FG008|Induction|Protocol Violation|0|||
157163281|NCT02883049|567341933|FG009|Induction|Protocol Violation|0|||
157163282|NCT02883049|567341934|FG010|Induction|Protocol Violation|0|||
157163283|NCT02883049|567341935|FG011|Induction|Protocol Violation|0|||
157163284|NCT02883049|567341936|FG012|Induction|Protocol Violation|0|||
157163285|NCT02883049|567341937|FG013|Induction|Protocol Violation|0|||
157163286|NCT02883049|567341938|FG014|Induction|Protocol Violation|0|||
157163287|NCT02883049|567341939|FG015|Induction|Protocol Violation|0|||
157163288|NCT02883049|567341924|FG000|Induction|Withdrawal by Subject|6|||
157163289|NCT02883049|567341925|FG001|Induction|Withdrawal by Subject|0|||
157163290|NCT02883049|567341926|FG002|Induction|Withdrawal by Subject|0|||
157163291|NCT02883049|567341927|FG003|Induction|Withdrawal by Subject|0|||
157163292|NCT02883049|567341928|FG004|Induction|Withdrawal by Subject|0|||
157163293|NCT02883049|567341929|FG005|Induction|Withdrawal by Subject|0|||
157163294|NCT02883049|567341930|FG006|Induction|Withdrawal by Subject|0|||
157163295|NCT02883049|567341931|FG007|Induction|Withdrawal by Subject|0|||
157163296|NCT02883049|567341932|FG008|Induction|Withdrawal by Subject|0|||
157163297|NCT02883049|567341933|FG009|Induction|Withdrawal by Subject|0|||
157163298|NCT02883049|567341934|FG010|Induction|Withdrawal by Subject|0|||
157163299|NCT02883049|567341935|FG011|Induction|Withdrawal by Subject|0|||
157163300|NCT02883049|567341936|FG012|Induction|Withdrawal by Subject|0|||
157163301|NCT02883049|567341937|FG013|Induction|Withdrawal by Subject|0|||
157163302|NCT02883049|567341938|FG014|Induction|Withdrawal by Subject|0|||
157163303|NCT02883049|567341939|FG015|Induction|Withdrawal by Subject|0|||
157163304|NCT02883049|567341924|FG000|Induction|Ineligible|35|||
157163305|NCT02883049|567341925|FG001|Induction|Ineligible|1|||
157163306|NCT02883049|567341926|FG002|Induction|Ineligible|0|||
157163307|NCT02883049|567341927|FG003|Induction|Ineligible|0|||
157163308|NCT02883049|567341928|FG004|Induction|Ineligible|0|||
157163309|NCT02883049|567341929|FG005|Induction|Ineligible|0|||
157163310|NCT02883049|567341930|FG006|Induction|Ineligible|0|||
157163311|NCT02883049|567341931|FG007|Induction|Ineligible|0|||
157163312|NCT02883049|567341932|FG008|Induction|Ineligible|0|||
157163313|NCT02883049|567341933|FG009|Induction|Ineligible|0|||
157163314|NCT02883049|567341934|FG010|Induction|Ineligible|0|||
157163315|NCT02883049|567341935|FG011|Induction|Ineligible|0|||
157163316|NCT02883049|567341936|FG012|Induction|Ineligible|0|||
157163317|NCT02883049|567341937|FG013|Induction|Ineligible|0|||
157163318|NCT02883049|567341938|FG014|Induction|Ineligible|0|||
157163319|NCT02883049|567341939|FG015|Induction|Ineligible|0|||
157163320|NCT02883049|567341924|FG000|Induction|Refusal of further protocol therapy|466|||
157163321|NCT02883049|567341925|FG001|Induction|Refusal of further protocol therapy|2|||
157163322|NCT02883049|567341926|FG002|Induction|Refusal of further protocol therapy|0|||
157163323|NCT02883049|567341927|FG003|Induction|Refusal of further protocol therapy|0|||
157163324|NCT02883049|567341928|FG004|Induction|Refusal of further protocol therapy|0|||
157163325|NCT02883049|567341929|FG005|Induction|Refusal of further protocol therapy|0|||
157163326|NCT02883049|567341930|FG006|Induction|Refusal of further protocol therapy|0|||
157226597|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
157163327|NCT02883049|567341931|FG007|Induction|Refusal of further protocol therapy|0|||
157163328|NCT02883049|567341932|FG008|Induction|Refusal of further protocol therapy|0|||
157163329|NCT02883049|567341933|FG009|Induction|Refusal of further protocol therapy|0|||
157163330|NCT02883049|567341934|FG010|Induction|Refusal of further protocol therapy|0|||
157226598|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
157226599|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
157226600|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
157226601|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
157226602|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
157226603|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
157226604|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
157226605|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
157226606|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
157226607|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
157226608|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
157226609|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
157226610|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
157226611|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
157226612|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
157226613|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
157226614|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
157226615|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
157226616|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
157226617|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
157226618|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
157226619|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
157226620|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
157226621|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
157226622|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
157226623|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
157226624|NCT01957488|567575876|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
157226625|NCT01957488|567575877|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
157226626|NCT01957488|567575878|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
157226627|NCT01957488|567575879|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
157226628|NCT01957488|567575880|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
157226629|NCT01957488|567575881|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
157226630|NCT01957488|567575876|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
157226631|NCT01957488|567575877|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
157226632|NCT01957488|567575878|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
156920104|NCT00203996|566463150|FG002|Overall Study|Scheduling issue|0|||
156920105|NCT00203996|566463151|FG003|Overall Study|Scheduling issue|0|||
156920106|NCT00203996|566463152|FG004|Overall Study|Scheduling issue|0|||
156920107|NCT00203996|566463153|FG005|Overall Study|Scheduling issue|0|||
156920108|NCT00203996|566463154|FG006|Overall Study|Scheduling issue|0|||
156920109|NCT00203996|566463155|FG007|Overall Study|Scheduling issue|2|||
156920110|NCT00203996|566463156|FG008|Overall Study|Scheduling issue|0|||
156920111|NCT00203996|566463157|FG009|Overall Study|Scheduling issue|0|||
156920112|NCT00434330|566463160|FG000|Overall Study|Adverse Event|0|||
156920113|NCT00434330|566463161|FG001|Overall Study|Adverse Event|0|||
156920114|NCT00434330|566463162|FG002|Overall Study|Adverse Event|1|||
156920115|NCT00434330|566463163|FG003|Overall Study|Adverse Event|0|||
156920116|NCT00434330|566463164|FG004|Overall Study|Adverse Event|0|||
156920117|NCT00434330|566463165|FG005|Overall Study|Adverse Event|0|||
156920118|NCT00434330|566463160|FG000|Overall Study|Death|1|||
156920119|NCT00434330|566463161|FG001|Overall Study|Death|0|||
156920120|NCT00434330|566463162|FG002|Overall Study|Death|0|||
156920121|NCT00434330|566463163|FG003|Overall Study|Death|0|||
156920122|NCT00434330|566463164|FG004|Overall Study|Death|1|||
156920123|NCT00434330|566463165|FG005|Overall Study|Death|1|||
156920124|NCT00434330|566463160|FG000|Overall Study|Withdrawal by Subject|0|||
156920125|NCT00434330|566463161|FG001|Overall Study|Withdrawal by Subject|0|||
156920126|NCT00434330|566463162|FG002|Overall Study|Withdrawal by Subject|1|||
156920127|NCT00434330|566463163|FG003|Overall Study|Withdrawal by Subject|1|||
156920128|NCT00434330|566463164|FG004|Overall Study|Withdrawal by Subject|0|||
156920129|NCT00434330|566463165|FG005|Overall Study|Withdrawal by Subject|0|||
156920130|NCT00434330|566463160|FG000|Overall Study|Renal transplant|0|||
156920131|NCT00434330|566463161|FG001|Overall Study|Renal transplant|0|||
156920132|NCT00434330|566463162|FG002|Overall Study|Renal transplant|0|||
156920133|NCT00434330|566463163|FG003|Overall Study|Renal transplant|1|||
156920134|NCT00434330|566463164|FG004|Overall Study|Renal transplant|0|||
156920135|NCT00434330|566463165|FG005|Overall Study|Renal transplant|0|||
156920136|NCT00434330|566463160|FG000|Overall Study|Subject Not Compliant With Study|0|||
156920137|NCT00434330|566463161|FG001|Overall Study|Subject Not Compliant With Study|0|||
156920138|NCT00434330|566463162|FG002|Overall Study|Subject Not Compliant With Study|1|||
156920139|NCT00434330|566463163|FG003|Overall Study|Subject Not Compliant With Study|0|||
156920140|NCT00434330|566463164|FG004|Overall Study|Subject Not Compliant With Study|0|||
156920141|NCT00434330|566463165|FG005|Overall Study|Subject Not Compliant With Study|0|||
157226633|NCT01957488|567575879|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
157226634|NCT01957488|567575880|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
156920142|NCT03789318|566463166|FG000|Overall Study|Adverse Event|0|||
156920143|NCT03789318|566463167|FG001|Overall Study|Adverse Event|0|||
156920144|NCT03789318|566463168|FG002|Overall Study|Adverse Event|1|||
156920145|NCT03789318|566463169|FG003|Overall Study|Adverse Event|1|||
156920146|NCT03789318|566463170|FG004|Overall Study|Adverse Event|0|||
156920147|NCT03789318|566463166|FG000|Overall Study|Lost to Follow-up|0|||
156920148|NCT03789318|566463167|FG001|Overall Study|Lost to Follow-up|0|||
156920149|NCT03789318|566463168|FG002|Overall Study|Lost to Follow-up|1|||
157163331|NCT02883049|567341935|FG011|Induction|Refusal of further protocol therapy|0|||
157163332|NCT02883049|567341936|FG012|Induction|Refusal of further protocol therapy|0|||
157163333|NCT02883049|567341937|FG013|Induction|Refusal of further protocol therapy|0|||
157163334|NCT02883049|567341938|FG014|Induction|Refusal of further protocol therapy|0|||
157163335|NCT02883049|567341939|FG015|Induction|Refusal of further protocol therapy|0|||
157163336|NCT02883049|567341924|FG000|Induction|Identified as Ph+ patients|279|||
157163337|NCT02883049|567341925|FG001|Induction|Identified as Ph+ patients|1|||
157163338|NCT02883049|567341926|FG002|Induction|Identified as Ph+ patients|0|||
157163339|NCT02883049|567341927|FG003|Induction|Identified as Ph+ patients|0|||
157163340|NCT02883049|567341928|FG004|Induction|Identified as Ph+ patients|0|||
157163341|NCT02883049|567341929|FG005|Induction|Identified as Ph+ patients|0|||
157163342|NCT02883049|567341930|FG006|Induction|Identified as Ph+ patients|0|||
157163343|NCT02883049|567341931|FG007|Induction|Identified as Ph+ patients|0|||
157163344|NCT02883049|567341932|FG008|Induction|Identified as Ph+ patients|0|||
157163345|NCT02883049|567341933|FG009|Induction|Identified as Ph+ patients|0|||
157163346|NCT02883049|567341934|FG010|Induction|Identified as Ph+ patients|0|||
157163347|NCT02883049|567341935|FG011|Induction|Identified as Ph+ patients|0|||
157163348|NCT02883049|567341936|FG012|Induction|Identified as Ph+ patients|0|||
157163349|NCT02883049|567341937|FG013|Induction|Identified as Ph+ patients|0|||
157163350|NCT02883049|567341938|FG014|Induction|Identified as Ph+ patients|0|||
157163351|NCT02883049|567341939|FG015|Induction|Identified as Ph+ patients|0|||
157163352|NCT02883049|567341924|FG000|Induction|M3 Marrow at Day29|8|||
157163353|NCT02883049|567341925|FG001|Induction|M3 Marrow at Day29|1|||
157163354|NCT02883049|567341926|FG002|Induction|M3 Marrow at Day29|0|||
157163355|NCT02883049|567341927|FG003|Induction|M3 Marrow at Day29|0|||
157163356|NCT02883049|567341928|FG004|Induction|M3 Marrow at Day29|0|||
157163357|NCT02883049|567341929|FG005|Induction|M3 Marrow at Day29|0|||
157163358|NCT02883049|567341930|FG006|Induction|M3 Marrow at Day29|0|||
157163359|NCT02883049|567341931|FG007|Induction|M3 Marrow at Day29|0|||
157163360|NCT02883049|567341932|FG008|Induction|M3 Marrow at Day29|0|||
157163361|NCT02883049|567341933|FG009|Induction|M3 Marrow at Day29|0|||
157163362|NCT02883049|567341934|FG010|Induction|M3 Marrow at Day29|0|||
157163363|NCT02883049|567341935|FG011|Induction|M3 Marrow at Day29|0|||
157163364|NCT02883049|567341936|FG012|Induction|M3 Marrow at Day29|0|||
157163365|NCT02883049|567341937|FG013|Induction|M3 Marrow at Day29|0|||
157163366|NCT02883049|567341938|FG014|Induction|M3 Marrow at Day29|0|||
157163367|NCT02883049|567341939|FG015|Induction|M3 Marrow at Day29|0|||
157163368|NCT02883049|567341924|FG000|Induction|Inevaluable|33|||
157163369|NCT02883049|567341925|FG001|Induction|Inevaluable|1|||
157163370|NCT02883049|567341926|FG002|Induction|Inevaluable|0|||
157163371|NCT02883049|567341927|FG003|Induction|Inevaluable|0|||
157163372|NCT02883049|567341928|FG004|Induction|Inevaluable|0|||
157163373|NCT02883049|567341929|FG005|Induction|Inevaluable|0|||
157163374|NCT02883049|567341930|FG006|Induction|Inevaluable|0|||
157163375|NCT02883049|567341931|FG007|Induction|Inevaluable|0|||
157163376|NCT02883049|567341932|FG008|Induction|Inevaluable|0|||
157163377|NCT02883049|567341933|FG009|Induction|Inevaluable|0|||
157163378|NCT02883049|567341934|FG010|Induction|Inevaluable|0|||
157163379|NCT02883049|567341935|FG011|Induction|Inevaluable|0|||
157163380|NCT02883049|567341936|FG012|Induction|Inevaluable|0|||
157163381|NCT02883049|567341937|FG013|Induction|Inevaluable|0|||
157163382|NCT02883049|567341938|FG014|Induction|Inevaluable|0|||
157163383|NCT02883049|567341939|FG015|Induction|Inevaluable|0|||
157163384|NCT02883049|567341924|FG000|Induction|Identified as VHR at end of Induction|244|||
157163385|NCT02883049|567341925|FG001|Induction|Identified as VHR at end of Induction|0|||
157163386|NCT02883049|567341926|FG002|Induction|Identified as VHR at end of Induction|0|||
157163387|NCT02883049|567341927|FG003|Induction|Identified as VHR at end of Induction|0|||
157163388|NCT02883049|567341928|FG004|Induction|Identified as VHR at end of Induction|0|||
157163389|NCT02883049|567341929|FG005|Induction|Identified as VHR at end of Induction|0|||
157163390|NCT02883049|567341930|FG006|Induction|Identified as VHR at end of Induction|0|||
157163391|NCT02883049|567341931|FG007|Induction|Identified as VHR at end of Induction|0|||
157163392|NCT02883049|567341932|FG008|Induction|Identified as VHR at end of Induction|0|||
157163393|NCT02883049|567341933|FG009|Induction|Identified as VHR at end of Induction|0|||
157163394|NCT02883049|567341934|FG010|Induction|Identified as VHR at end of Induction|0|||
157163395|NCT02883049|567341935|FG011|Induction|Identified as VHR at end of Induction|0|||
157163396|NCT02883049|567341936|FG012|Induction|Identified as VHR at end of Induction|0|||
157163397|NCT02883049|567341937|FG013|Induction|Identified as VHR at end of Induction|0|||
157163398|NCT02883049|567341938|FG014|Induction|Identified as VHR at end of Induction|0|||
157163399|NCT02883049|567341939|FG015|Induction|Identified as VHR at end of Induction|0|||
157163400|NCT02883049|567341924|FG000|Induction|Moved to another non-COG institution|3|||
156920150|NCT03789318|566463169|FG003|Overall Study|Lost to Follow-up|0|||
156920151|NCT03789318|566463170|FG004|Overall Study|Lost to Follow-up|0|||
156920152|NCT03789318|566463166|FG000|Overall Study|Withdrawal by Subject|0|||
156920153|NCT03789318|566463167|FG001|Overall Study|Withdrawal by Subject|0|||
157163401|NCT02883049|567341925|FG001|Induction|Moved to another non-COG institution|0|||
157163402|NCT02883049|567341926|FG002|Induction|Moved to another non-COG institution|0|||
157163403|NCT02883049|567341927|FG003|Induction|Moved to another non-COG institution|0|||
157163404|NCT02883049|567341928|FG004|Induction|Moved to another non-COG institution|0|||
157163405|NCT02883049|567341929|FG005|Induction|Moved to another non-COG institution|0|||
157163406|NCT02883049|567341930|FG006|Induction|Moved to another non-COG institution|0|||
157163407|NCT02883049|567341931|FG007|Induction|Moved to another non-COG institution|0|||
157163408|NCT02883049|567341932|FG008|Induction|Moved to another non-COG institution|0|||
157163409|NCT02883049|567341933|FG009|Induction|Moved to another non-COG institution|0|||
157163410|NCT02883049|567341934|FG010|Induction|Moved to another non-COG institution|0|||
157163411|NCT02883049|567341935|FG011|Induction|Moved to another non-COG institution|0|||
157163412|NCT02883049|567341936|FG012|Induction|Moved to another non-COG institution|0|||
157163413|NCT02883049|567341937|FG013|Induction|Moved to another non-COG institution|0|||
157163414|NCT02883049|567341938|FG014|Induction|Moved to another non-COG institution|0|||
157163415|NCT02883049|567341939|FG015|Induction|Moved to another non-COG institution|0|||
157163416|NCT02883049|567341924|FG000|Induction|Randomization closed|41|||
157163417|NCT02883049|567341925|FG001|Induction|Randomization closed|0|||
157163418|NCT02883049|567341926|FG002|Induction|Randomization closed|0|||
157163419|NCT02883049|567341927|FG003|Induction|Randomization closed|0|||
157163420|NCT02883049|567341928|FG004|Induction|Randomization closed|0|||
157163421|NCT02883049|567341929|FG005|Induction|Randomization closed|0|||
157163422|NCT02883049|567341930|FG006|Induction|Randomization closed|0|||
157163423|NCT02883049|567341931|FG007|Induction|Randomization closed|0|||
157163424|NCT02883049|567341932|FG008|Induction|Randomization closed|0|||
157163425|NCT02883049|567341933|FG009|Induction|Randomization closed|0|||
157163426|NCT02883049|567341934|FG010|Induction|Randomization closed|0|||
157163427|NCT02883049|567341935|FG011|Induction|Randomization closed|0|||
157163428|NCT02883049|567341936|FG012|Induction|Randomization closed|0|||
157163429|NCT02883049|567341937|FG013|Induction|Randomization closed|0|||
157163430|NCT02883049|567341938|FG014|Induction|Randomization closed|0|||
157163431|NCT02883049|567341939|FG015|Induction|Randomization closed|0|||
157163432|NCT02883049|567341924|FG000|Induction|MRD negative|36|||
157163433|NCT02883049|567341925|FG001|Induction|MRD negative|0|||
157163434|NCT02883049|567341926|FG002|Induction|MRD negative|0|||
157163435|NCT02883049|567341927|FG003|Induction|MRD negative|0|||
157163436|NCT02883049|567341928|FG004|Induction|MRD negative|0|||
157163437|NCT02883049|567341929|FG005|Induction|MRD negative|0|||
157163438|NCT02883049|567341930|FG006|Induction|MRD negative|0|||
157163439|NCT02883049|567341931|FG007|Induction|MRD negative|0|||
157163440|NCT02883049|567341932|FG008|Induction|MRD negative|0|||
157163441|NCT02883049|567341933|FG009|Induction|MRD negative|0|||
157163442|NCT02883049|567341934|FG010|Induction|MRD negative|0|||
157163443|NCT02883049|567341935|FG011|Induction|MRD negative|0|||
157163444|NCT02883049|567341936|FG012|Induction|MRD negative|0|||
157163445|NCT02883049|567341937|FG013|Induction|MRD negative|0|||
157163446|NCT02883049|567341938|FG014|Induction|MRD negative|0|||
157163447|NCT02883049|567341939|FG015|Induction|MRD negative|0|||
157163448|NCT02883049|567341924|FG000|Induction|Identified as HR patients|165|||
157163449|NCT02883049|567341925|FG001|Induction|Identified as HR patients|0|||
157163450|NCT02883049|567341926|FG002|Induction|Identified as HR patients|0|||
157163451|NCT02883049|567341927|FG003|Induction|Identified as HR patients|0|||
157163452|NCT02883049|567341928|FG004|Induction|Identified as HR patients|0|||
157163453|NCT02883049|567341929|FG005|Induction|Identified as HR patients|0|||
157163454|NCT02883049|567341930|FG006|Induction|Identified as HR patients|0|||
157163455|NCT02883049|567341931|FG007|Induction|Identified as HR patients|0|||
157163456|NCT02883049|567341932|FG008|Induction|Identified as HR patients|0|||
157163457|NCT02883049|567341933|FG009|Induction|Identified as HR patients|0|||
156920154|NCT03789318|566463168|FG002|Overall Study|Withdrawal by Subject|1|||
156920155|NCT03789318|566463169|FG003|Overall Study|Withdrawal by Subject|0|||
157163458|NCT02883049|567341934|FG010|Induction|Identified as HR patients|0|||
157163459|NCT02883049|567341935|FG011|Induction|Identified as HR patients|0|||
157163460|NCT02883049|567341936|FG012|Induction|Identified as HR patients|0|||
157163461|NCT02883049|567341937|FG013|Induction|Identified as HR patients|0|||
157163462|NCT02883049|567341938|FG014|Induction|Identified as HR patients|0|||
157163463|NCT02883049|567341939|FG015|Induction|Identified as HR patients|0|||
157163464|NCT02883049|567341924|FG000|Induction|Developed SMN|0|||
157163465|NCT02883049|567341925|FG001|Induction|Developed SMN|1|||
157163466|NCT02883049|567341926|FG002|Induction|Developed SMN|0|||
156920156|NCT03789318|566463170|FG004|Overall Study|Withdrawal by Subject|0|||
157163467|NCT02883049|567341927|FG003|Induction|Developed SMN|0|||
156920157|NCT00850564|566463171|FG000|Overall Study|Withdrawal by Subject|2|||
157163468|NCT02883049|567341928|FG004|Induction|Developed SMN|0|||
157163469|NCT02883049|567341929|FG005|Induction|Developed SMN|0|||
157163470|NCT02883049|567341930|FG006|Induction|Developed SMN|0|||
157163471|NCT02883049|567341931|FG007|Induction|Developed SMN|0|||
156920158|NCT00531232|566465752|FG000|Overall Study|Investigator decision|0|||
156920159|NCT00531232|566465753|FG001|Overall Study|Investigator decision|0|||
156920160|NCT00531232|566465754|FG002|Overall Study|Investigator decision|4|||
156920161|NCT00531232|566465752|FG000|Overall Study|Participants refused further treatment|0|||
156920162|NCT00531232|566465753|FG001|Overall Study|Participants refused further treatment|1|||
156920163|NCT00531232|566465754|FG002|Overall Study|Participants refused further treatment|2|||
156920164|NCT00531232|566465752|FG000|Overall Study|Adverse events (AEs)|1|||
156920165|NCT00531232|566465753|FG001|Overall Study|Adverse events (AEs)|2|||
156920166|NCT00531232|566465754|FG002|Overall Study|Adverse events (AEs)|2|||
156920167|NCT00531232|566465752|FG000|Overall Study|Treatment failure|1|||
156920168|NCT00531232|566465753|FG001|Overall Study|Treatment failure|3|||
156920169|NCT00531232|566465754|FG002|Overall Study|Treatment failure|7|||
156920170|NCT00531232|566465752|FG000|Overall Study|Disease recurrence|0|||
156920171|NCT00531232|566465753|FG001|Overall Study|Disease recurrence|0|||
156920172|NCT00531232|566465754|FG002|Overall Study|Disease recurrence|1|||
156920173|NCT00531232|566465752|FG000|Overall Study|Deceased|2|||
156920174|NCT00531232|566465753|FG001|Overall Study|Deceased|2|||
156920175|NCT00531232|566465754|FG002|Overall Study|Deceased|2|||
156920176|NCT00531232|566465752|FG000|Overall Study|Withdrawal by Subject|0|||
156920177|NCT00531232|566465753|FG001|Overall Study|Withdrawal by Subject|1|||
156920178|NCT00531232|566465754|FG002|Overall Study|Withdrawal by Subject|2|||
156920179|NCT00531232|566465752|FG000|Overall Study|Other|0|||
156920180|NCT00531232|566465753|FG001|Overall Study|Other|0|||
156920181|NCT00531232|566465754|FG002|Overall Study|Other|5|||
156920182|NCT00397982|566465755|FG000|Overall Study|Withdrawal by Subject|1|||
156920183|NCT00397982|566465755|FG000|Overall Study|Adverse Event|1|||
156920184|NCT00397982|566465755|FG000|Overall Study|noncompliance|1|||
156920185|NCT00397982|566465755|FG000|Overall Study|Unrelated health issues|1|||
156920186|NCT02345850|566465758|FG000|Overall Study|Not transplanted|10|||
156920187|NCT02345850|566465759|FG001|Overall Study|Not transplanted|5|||
156920188|NCT02345850|566465760|FG002|Overall Study|Not transplanted|4|||
156920189|NCT02345850|566465758|FG000|Overall Study|Lost to Follow-up|2|||
156920190|NCT02345850|566465759|FG001|Overall Study|Lost to Follow-up|3|||
156920191|NCT02345850|566465760|FG002|Overall Study|Lost to Follow-up|2|||
156920192|NCT02345850|566465758|FG000|Overall Study|Withdrawal by Subject|1|||
156920193|NCT02345850|566465759|FG001|Overall Study|Withdrawal by Subject|0|||
156920194|NCT02345850|566465760|FG002|Overall Study|Withdrawal by Subject|0|||
156920195|NCT02392247|566465763|FG000|Overall Study|Withdrawal by Subject|1|||
156920196|NCT02392247|566465763|FG000|Overall Study|Surgery cancelled; no data|1|||
156920197|NCT02014597|566465764|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
156920198|NCT02014597|566465765|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
156920199|NCT00754624|566465766|FG000|Overall Study|Adverse Event|16|||
156920200|NCT00754624|566465766|FG000|Overall Study|Death|1|||
156920201|NCT00754624|566465766|FG000|Overall Study|Physician Decision|8|||
156920202|NCT00754624|566465766|FG000|Overall Study|Protocol Violation|1|||
156920203|NCT00754624|566465766|FG000|Overall Study|Withdrawal by Subject|28|||
156920204|NCT00754624|566465766|FG000|Overall Study|Various|12|||
156920205|NCT00754624|566465766|FG000|Overall Study|Lost to Follow-up|3|||
156920206|NCT04067544|566465767|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
156920207|NCT01409564|566465768|FG000|Overall Study|low medication compliance|4|||
156920208|NCT01409564|566465769|FG001|Overall Study|low medication compliance|3|||
156920209|NCT01409564|566465768|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
156920210|NCT01409564|566465769|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
156920211|NCT00592839|566465772|FG000|Overall Study|Withdrawal by Subject|1|||
156920212|NCT00592839|566465773|FG001|Overall Study|Withdrawal by Subject|1|||
156920213|NCT00592839|566465774|FG002|Overall Study|Withdrawal by Subject|3|||
156920214|NCT00592839|566465772|FG000|Overall Study|Protocol Violation|1|||
156920215|NCT00592839|566465773|FG001|Overall Study|Protocol Violation|1|||
156920216|NCT00592839|566465774|FG002|Overall Study|Protocol Violation|2|||
156920217|NCT00592839|566465772|FG000|Overall Study|Adverse Event|0|||
156920218|NCT00592839|566465773|FG001|Overall Study|Adverse Event|1|||
156920219|NCT00592839|566465774|FG002|Overall Study|Adverse Event|0|||
156920220|NCT00592839|566465772|FG000|Overall Study|Lost to Follow-up|0|||
156920221|NCT00592839|566465773|FG001|Overall Study|Lost to Follow-up|1|||
157028525|NCT02038777|566860631|FG004|Overall Study|participation terminated by sponsor|0|||
156920222|NCT00592839|566465774|FG002|Overall Study|Lost to Follow-up|1|||
156920223|NCT01828281|566465775|FG000|Overall Study|Withdrawal by Subject|1|||
157028526|NCT02038777|566860632|FG005|Overall Study|participation terminated by sponsor|0|||
157028527|NCT02038777|566860633|FG006|Overall Study|participation terminated by sponsor|1|||
156920224|NCT01828281|566465776|FG001|Overall Study|Withdrawal by Subject|0|||
156920225|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
156920226|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
156920227|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
156920228|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
156920229|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
156920230|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
156920231|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
156920232|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
156920233|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
156920234|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
156920235|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
156920236|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
156920237|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
156920238|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
156920239|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
156920240|NCT01124422|566465777|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
156920241|NCT01124422|566465778|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
156920242|NCT01124422|566465779|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
156920243|NCT01124422|566465777|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
156920244|NCT01124422|566465778|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
156920245|NCT01124422|566465779|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
156920246|NCT01124422|566465777|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
156920247|NCT01124422|566465778|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
156920248|NCT01124422|566465779|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
156920249|NCT01124422|566465777|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
156920250|NCT01124422|566465778|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
156920251|NCT01124422|566465779|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
156920252|NCT01124422|566465777|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
156920253|NCT01124422|566465778|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
156920254|NCT01124422|566465779|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
156920255|NCT00142584|566465782|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
156920256|NCT00142584|566465783|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
156920257|NCT00142584|566465782|FG000|Overall Study|Withdrawal by Subject|30|||
156920258|NCT00142584|566465783|FG001|Overall Study|Withdrawal by Subject|16|||
156920259|NCT00142584|566465782|FG000|Overall Study|Lost to Follow-up|22|||
156920260|NCT00142584|566465783|FG001|Overall Study|Lost to Follow-up|12|||
156920261|NCT00142584|566465782|FG000|Overall Study|Adverse Event|14|||
156920262|NCT00142584|566465783|FG001|Overall Study|Adverse Event|5|||
156920263|NCT00142584|566465782|FG000|Overall Study|Protocol Violation|4|||
156920264|NCT00142584|566465783|FG001|Overall Study|Protocol Violation|7|||
156920265|NCT00142584|566465782|FG000|Overall Study|Treatment Failure|2|||
156920266|NCT00142584|566465783|FG001|Overall Study|Treatment Failure|0|||
156920267|NCT03070782|566465784|FG000|Overall Study|Adverse Event|3|||
156920268|NCT03070782|566465785|FG001|Overall Study|Adverse Event|0|||
156920269|NCT03070782|566465786|FG002|Overall Study|Adverse Event|3|||
156920270|NCT03070782|566465787|FG003|Overall Study|Adverse Event|1|||
156920271|NCT03070782|566465788|FG004|Overall Study|Adverse Event|6|||
156920272|NCT03070782|566465789|FG005|Overall Study|Adverse Event|2|||
156920273|NCT03070782|566465784|FG000|Overall Study|Withdrawal by Subject|2|||
156920274|NCT03070782|566465785|FG001|Overall Study|Withdrawal by Subject|1|||
157163472|NCT02883049|567341932|FG008|Induction|Developed SMN|0|||
157163473|NCT02883049|567341933|FG009|Induction|Developed SMN|0|||
157163474|NCT02883049|567341934|FG010|Induction|Developed SMN|0|||
157163475|NCT02883049|567341935|FG011|Induction|Developed SMN|0|||
157163476|NCT02883049|567341936|FG012|Induction|Developed SMN|0|||
157163477|NCT02883049|567341937|FG013|Induction|Developed SMN|0|||
157163478|NCT02883049|567341938|FG014|Induction|Developed SMN|0|||
157163479|NCT02883049|567341939|FG015|Induction|Developed SMN|0|||
157163480|NCT02883049|567341924|FG000|Induction|Enrolled onto another COG study|72|||
157163481|NCT02883049|567341925|FG001|Induction|Enrolled onto another COG study|0|||
157163482|NCT02883049|567341926|FG002|Induction|Enrolled onto another COG study|0|||
157163483|NCT02883049|567341927|FG003|Induction|Enrolled onto another COG study|0|||
157163484|NCT02883049|567341928|FG004|Induction|Enrolled onto another COG study|0|||
157163485|NCT02883049|567341929|FG005|Induction|Enrolled onto another COG study|0|||
157163486|NCT02883049|567341930|FG006|Induction|Enrolled onto another COG study|0|||
157163487|NCT02883049|567341931|FG007|Induction|Enrolled onto another COG study|0|||
157163488|NCT02883049|567341932|FG008|Induction|Enrolled onto another COG study|0|||
157163489|NCT02883049|567341933|FG009|Induction|Enrolled onto another COG study|0|||
157163490|NCT02883049|567341934|FG010|Induction|Enrolled onto another COG study|0|||
157163491|NCT02883049|567341935|FG011|Induction|Enrolled onto another COG study|0|||
157163492|NCT02883049|567341936|FG012|Induction|Enrolled onto another COG study|0|||
157163493|NCT02883049|567341937|FG013|Induction|Enrolled onto another COG study|0|||
157163494|NCT02883049|567341938|FG014|Induction|Enrolled onto another COG study|0|||
157226635|NCT01957488|567575881|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
156920275|NCT03070782|566465786|FG002|Overall Study|Withdrawal by Subject|1|||
156920276|NCT03070782|566465787|FG003|Overall Study|Withdrawal by Subject|0|||
156920277|NCT03070782|566465788|FG004|Overall Study|Withdrawal by Subject|4|||
156920278|NCT03070782|566465789|FG005|Overall Study|Withdrawal by Subject|3|||
156920279|NCT03070782|566465784|FG000|Overall Study|Reason Not Specified|2|||
157163495|NCT02883049|567341939|FG015|Induction|Enrolled onto another COG study|0|||
156920280|NCT03070782|566465785|FG001|Overall Study|Reason Not Specified|0|||
156920281|NCT03070782|566465786|FG002|Overall Study|Reason Not Specified|0|||
156920282|NCT03070782|566465787|FG003|Overall Study|Reason Not Specified|1|||
156920283|NCT03070782|566465788|FG004|Overall Study|Reason Not Specified|2|||
156920284|NCT03070782|566465789|FG005|Overall Study|Reason Not Specified|1|||
156920285|NCT03070782|566465784|FG000|Overall Study|Ineligibility|0|||
156920286|NCT03070782|566465785|FG001|Overall Study|Ineligibility|0|||
156920287|NCT03070782|566465786|FG002|Overall Study|Ineligibility|0|||
156920288|NCT03070782|566465787|FG003|Overall Study|Ineligibility|1|||
156920289|NCT03070782|566465788|FG004|Overall Study|Ineligibility|0|||
157163496|NCT02883049|567341924|FG000|Induction|Incomplete induction data|17|||
157163497|NCT02883049|567341925|FG001|Induction|Incomplete induction data|0|||
157163498|NCT02883049|567341926|FG002|Induction|Incomplete induction data|0|||
157163499|NCT02883049|567341927|FG003|Induction|Incomplete induction data|0|||
156920290|NCT03070782|566465789|FG005|Overall Study|Ineligibility|1|||
156920291|NCT03070782|566465784|FG000|Overall Study|Pregnancy|0|||
156920292|NCT03070782|566465785|FG001|Overall Study|Pregnancy|0|||
156920293|NCT03070782|566465786|FG002|Overall Study|Pregnancy|0|||
156920294|NCT03070782|566465787|FG003|Overall Study|Pregnancy|1|||
156920295|NCT03070782|566465788|FG004|Overall Study|Pregnancy|0|||
156920296|NCT03070782|566465789|FG005|Overall Study|Pregnancy|0|||
156920297|NCT03070782|566465784|FG000|Overall Study|Investigator Judgement|0|||
156920298|NCT03070782|566465785|FG001|Overall Study|Investigator Judgement|0|||
156920299|NCT03070782|566465786|FG002|Overall Study|Investigator Judgement|0|||
156920300|NCT03070782|566465787|FG003|Overall Study|Investigator Judgement|1|||
156920301|NCT03070782|566465788|FG004|Overall Study|Investigator Judgement|0|||
156920302|NCT03070782|566465789|FG005|Overall Study|Investigator Judgement|0|||
156920303|NCT00449540|566465790|FG000|Pretreatment Phase|No migraine experienced|66|||
156920304|NCT00449540|566465791|FG001|Pretreatment Phase|No migraine experienced|0|||
156920305|NCT00449540|566465792|FG002|Pretreatment Phase|No migraine experienced|0|||
156920306|NCT00449540|566465790|FG000|Treatment Phase|did not experience or treat migraine|0|||
156920307|NCT00449540|566465791|FG001|Treatment Phase|did not experience or treat migraine|20|||
156920308|NCT00449540|566465792|FG002|Treatment Phase|did not experience or treat migraine|17|||
156920309|NCT01961323|566465793|FG000|Overall Study|Withdrawal by Subject|7|||
156920310|NCT01961323|566465793|FG000|Overall Study|Lost to Follow-up|8|||
156920311|NCT01961323|566465793|FG000|Overall Study|screen failure|34|||
156920312|NCT02320149|566465794|FG000|Overall Study|Adverse Event|3|||
156920313|NCT02320149|566465795|FG001|Overall Study|Adverse Event|7|||
156920314|NCT02320149|566465794|FG000|Overall Study|Withdrawal of Consent|28|||
156920315|NCT02320149|566465795|FG001|Overall Study|Withdrawal of Consent|32|||
156920316|NCT02320149|566465794|FG000|Overall Study|Lost to Follow-up|21|||
156920317|NCT02320149|566465795|FG001|Overall Study|Lost to Follow-up|34|||
156920318|NCT02320149|566465794|FG000|Overall Study|Protocol Violation|2|||
156920319|NCT02320149|566465795|FG001|Overall Study|Protocol Violation|1|||
156920320|NCT02320149|566465794|FG000|Overall Study|Noncompliance with Study Treatment|7|||
156920321|NCT02320149|566465795|FG001|Overall Study|Noncompliance with Study Treatment|2|||
156920322|NCT02320149|566465794|FG000|Overall Study|Lack of Efficacy|0|||
156920323|NCT02320149|566465795|FG001|Overall Study|Lack of Efficacy|1|||
156920324|NCT02320149|566465794|FG000|Overall Study|Other Miscellaneous Reasons|2|||
157163500|NCT02883049|567341928|FG004|Induction|Incomplete induction data|0|||
157163501|NCT02883049|567341929|FG005|Induction|Incomplete induction data|0|||
157163502|NCT02883049|567341930|FG006|Induction|Incomplete induction data|0|||
157163503|NCT02883049|567341931|FG007|Induction|Incomplete induction data|0|||
157163504|NCT02883049|567341932|FG008|Induction|Incomplete induction data|0|||
157163505|NCT02883049|567341933|FG009|Induction|Incomplete induction data|0|||
157163506|NCT02883049|567341934|FG010|Induction|Incomplete induction data|0|||
157163507|NCT02883049|567341935|FG011|Induction|Incomplete induction data|0|||
157163508|NCT02883049|567341936|FG012|Induction|Incomplete induction data|0|||
157163509|NCT02883049|567341937|FG013|Induction|Incomplete induction data|0|||
157163510|NCT02883049|567341938|FG014|Induction|Incomplete induction data|0|||
156920325|NCT02320149|566465795|FG001|Overall Study|Other Miscellaneous Reasons|3|||
156920326|NCT01156311|566465796|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
156920327|NCT01156311|566465797|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
156920328|NCT01156311|566465798|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
156920329|NCT01156311|566465799|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
156920330|NCT01156311|566465796|FG000|2-Month Monotherapy Period|Physician Decision|0|||
157163511|NCT02883049|567341939|FG015|Induction|Incomplete induction data|0|||
157163512|NCT02883049|567341924|FG000|Post Induction|Adverse Event|0|||
156920331|NCT01156311|566465797|FG001|2-Month Monotherapy Period|Physician Decision|1|||
156920332|NCT01156311|566465798|FG002|2-Month Monotherapy Period|Physician Decision|0|||
156920333|NCT01156311|566465799|FG003|2-Month Monotherapy Period|Physician Decision|0|||
156920334|NCT01156311|566465796|FG000|2-Month Monotherapy Period|Other|1|||
156920335|NCT01156311|566465797|FG001|2-Month Monotherapy Period|Other|0|||
156920336|NCT01156311|566465798|FG002|2-Month Monotherapy Period|Other|0|||
156920337|NCT01156311|566465799|FG003|2-Month Monotherapy Period|Other|0|||
156920338|NCT01156311|566465796|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
156920339|NCT01156311|566465797|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
156920340|NCT01156311|566465798|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
156920341|NCT01156311|566465799|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
156920342|NCT01156311|566465796|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
157163513|NCT02883049|567341925|FG001|Post Induction|Adverse Event|0|||
157163514|NCT02883049|567341926|FG002|Post Induction|Adverse Event|0|||
157163515|NCT02883049|567341927|FG003|Post Induction|Adverse Event|7|||
157163516|NCT02883049|567341928|FG004|Post Induction|Adverse Event|8|||
157163517|NCT02883049|567341929|FG005|Post Induction|Adverse Event|3|||
157163518|NCT02883049|567341930|FG006|Post Induction|Adverse Event|4|||
157163519|NCT02883049|567341931|FG007|Post Induction|Adverse Event|5|||
157163520|NCT02883049|567341932|FG008|Post Induction|Adverse Event|6|||
157163521|NCT02883049|567341933|FG009|Post Induction|Adverse Event|7|||
157163522|NCT02883049|567341934|FG010|Post Induction|Adverse Event|2|||
157163523|NCT02883049|567341935|FG011|Post Induction|Adverse Event|2|||
157163524|NCT02883049|567341936|FG012|Post Induction|Adverse Event|0|||
157163525|NCT02883049|567341937|FG013|Post Induction|Adverse Event|0|||
157163526|NCT02883049|567341938|FG014|Post Induction|Adverse Event|5|||
157163527|NCT02883049|567341939|FG015|Post Induction|Adverse Event|2|||
157163528|NCT02883049|567341924|FG000|Post Induction|Death|0|||
157163529|NCT02883049|567341925|FG001|Post Induction|Death|0|||
157163530|NCT02883049|567341926|FG002|Post Induction|Death|0|||
157163531|NCT02883049|567341927|FG003|Post Induction|Death|9|||
157163532|NCT02883049|567341928|FG004|Post Induction|Death|9|||
157163533|NCT02883049|567341929|FG005|Post Induction|Death|0|||
157163534|NCT02883049|567341930|FG006|Post Induction|Death|1|||
157163535|NCT02883049|567341931|FG007|Post Induction|Death|6|||
157163536|NCT02883049|567341932|FG008|Post Induction|Death|5|||
157163537|NCT02883049|567341933|FG009|Post Induction|Death|3|||
157163538|NCT02883049|567341934|FG010|Post Induction|Death|1|||
157163539|NCT02883049|567341935|FG011|Post Induction|Death|0|||
157163540|NCT02883049|567341936|FG012|Post Induction|Death|1|||
157163541|NCT02883049|567341937|FG013|Post Induction|Death|1|||
157163542|NCT02883049|567341938|FG014|Post Induction|Death|10|||
157163543|NCT02883049|567341939|FG015|Post Induction|Death|2|||
157163544|NCT02883049|567341924|FG000|Post Induction|Lost to Follow-up|0|||
157163545|NCT02883049|567341925|FG001|Post Induction|Lost to Follow-up|0|||
157163546|NCT02883049|567341926|FG002|Post Induction|Lost to Follow-up|0|||
157163547|NCT02883049|567341927|FG003|Post Induction|Lost to Follow-up|0|||
157163548|NCT02883049|567341928|FG004|Post Induction|Lost to Follow-up|1|||
157163549|NCT02883049|567341929|FG005|Post Induction|Lost to Follow-up|1|||
157163550|NCT02883049|567341930|FG006|Post Induction|Lost to Follow-up|0|||
157163551|NCT02883049|567341931|FG007|Post Induction|Lost to Follow-up|0|||
157163552|NCT02883049|567341932|FG008|Post Induction|Lost to Follow-up|3|||
157163553|NCT02883049|567341933|FG009|Post Induction|Lost to Follow-up|0|||
157163554|NCT02883049|567341934|FG010|Post Induction|Lost to Follow-up|1|||
157163555|NCT02883049|567341935|FG011|Post Induction|Lost to Follow-up|0|||
157163556|NCT02883049|567341936|FG012|Post Induction|Lost to Follow-up|0|||
157163557|NCT02883049|567341937|FG013|Post Induction|Lost to Follow-up|0|||
157163558|NCT02883049|567341938|FG014|Post Induction|Lost to Follow-up|0|||
157163559|NCT02883049|567341939|FG015|Post Induction|Lost to Follow-up|0|||
157163560|NCT02883049|567341924|FG000|Post Induction|Physician Decision|0|||
157163561|NCT02883049|567341925|FG001|Post Induction|Physician Decision|0|||
157163562|NCT02883049|567341926|FG002|Post Induction|Physician Decision|0|||
157163563|NCT02883049|567341927|FG003|Post Induction|Physician Decision|27|||
156920343|NCT01156311|566465797|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
156920344|NCT01156311|566465798|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
156920345|NCT01156311|566465799|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
157163564|NCT02883049|567341928|FG004|Post Induction|Physician Decision|27|||
157163565|NCT02883049|567341929|FG005|Post Induction|Physician Decision|23|||
157163566|NCT02883049|567341930|FG006|Post Induction|Physician Decision|30|||
157163567|NCT02883049|567341931|FG007|Post Induction|Physician Decision|56|||
157163568|NCT02883049|567341932|FG008|Post Induction|Physician Decision|85|||
157163569|NCT02883049|567341933|FG009|Post Induction|Physician Decision|12|||
157163570|NCT02883049|567341934|FG010|Post Induction|Physician Decision|5|||
157163571|NCT02883049|567341935|FG011|Post Induction|Physician Decision|14|||
156920346|NCT01156311|566465796|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
157163572|NCT02883049|567341936|FG012|Post Induction|Physician Decision|1|||
157163573|NCT02883049|567341937|FG013|Post Induction|Physician Decision|11|||
157163574|NCT02883049|567341938|FG014|Post Induction|Physician Decision|19|||
157163575|NCT02883049|567341939|FG015|Post Induction|Physician Decision|5|||
157163576|NCT02883049|567341924|FG000|Post Induction|Protocol Violation|0|||
157163577|NCT02883049|567341925|FG001|Post Induction|Protocol Violation|0|||
157163578|NCT02883049|567341926|FG002|Post Induction|Protocol Violation|0|||
157163579|NCT02883049|567341927|FG003|Post Induction|Protocol Violation|0|||
157163580|NCT02883049|567341928|FG004|Post Induction|Protocol Violation|0|||
157163581|NCT02883049|567341929|FG005|Post Induction|Protocol Violation|0|||
157163582|NCT02883049|567341930|FG006|Post Induction|Protocol Violation|0|||
157163583|NCT02883049|567341931|FG007|Post Induction|Protocol Violation|1|||
157163584|NCT02883049|567341932|FG008|Post Induction|Protocol Violation|0|||
157163585|NCT02883049|567341933|FG009|Post Induction|Protocol Violation|0|||
156920347|NCT01156311|566465797|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
156920348|NCT01156311|566465798|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
156920349|NCT01156311|566465799|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
156920350|NCT01156311|566465796|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
156920351|NCT01156311|566465797|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
156920352|NCT01156311|566465798|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
156920353|NCT01156311|566465799|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
156920354|NCT01156311|566465796|FG000|6-month Add-on Therapy Period|Other|0|||
156920355|NCT01156311|566465797|FG001|6-month Add-on Therapy Period|Other|0|||
156920356|NCT01156311|566465798|FG002|6-month Add-on Therapy Period|Other|1|||
156920357|NCT01156311|566465799|FG003|6-month Add-on Therapy Period|Other|2|||
156920358|NCT00022633|566465802|FG000|Overall Study|Adverse Event|11|||
156920359|NCT00022633|566465803|FG001|Overall Study|Adverse Event|1|||
156920360|NCT00022633|566465802|FG000|Overall Study|Refusal unrelated to adverse event|1|||
156920361|NCT00022633|566465803|FG001|Overall Study|Refusal unrelated to adverse event|0|||
156920362|NCT00022633|566465802|FG000|Overall Study|Progression/relapse|9|||
156920363|NCT00022633|566465803|FG001|Overall Study|Progression/relapse|2|||
156920364|NCT00022633|566465802|FG000|Overall Study|Death|4|||
156920365|NCT00022633|566465803|FG001|Overall Study|Death|0|||
156920366|NCT00022633|566465802|FG000|Overall Study|Other - not protocol specified|3|||
156920367|NCT00022633|566465803|FG001|Overall Study|Other - not protocol specified|2|||
156920368|NCT00022633|566465802|FG000|Overall Study|Ineligible|4|||
156920369|NCT00022633|566465803|FG001|Overall Study|Ineligible|0|||
156920370|NCT06133348|566465804|FG000|Overall Study|Death|3|||
156920371|NCT06133348|566465804|FG000|Overall Study|Lost to Follow-up|1|||
156920372|NCT06133348|566465804|FG000|Overall Study|Physician Decision|1|||
156920373|NCT06133348|566465804|FG000|Overall Study|Withdrawal by Subject|5|||
156920374|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
156920375|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
156920376|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
156920377|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
156920378|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
156920379|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
156920380|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
156920381|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
156920382|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
156920383|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
156920384|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
156920385|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156920386|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
156920387|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156920388|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
156920389|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
156920390|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
156920391|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
156920392|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
156920393|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
156920394|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156920395|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
156920396|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
156920397|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156920398|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
156920399|NCT01285310|566465807|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
156920400|NCT01285310|566465808|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156920401|NCT01285310|566465809|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
156920402|NCT01285310|566465810|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156920403|NCT01285310|566465811|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
156920404|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
156920405|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
156920406|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
156920407|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
156920408|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
156920409|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
156920410|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
156920411|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
156920412|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
156920413|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
156920414|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
156920415|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
156920416|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
157163586|NCT02883049|567341934|FG010|Post Induction|Protocol Violation|0|||
157163587|NCT02883049|567341935|FG011|Post Induction|Protocol Violation|0|||
157163588|NCT02883049|567341936|FG012|Post Induction|Protocol Violation|0|||
157163589|NCT02883049|567341937|FG013|Post Induction|Protocol Violation|0|||
157163590|NCT02883049|567341938|FG014|Post Induction|Protocol Violation|0|||
157163591|NCT02883049|567341939|FG015|Post Induction|Protocol Violation|0|||
157163592|NCT02883049|567341924|FG000|Post Induction|Withdrawal by Subject|0|||
157163593|NCT02883049|567341925|FG001|Post Induction|Withdrawal by Subject|0|||
157163594|NCT02883049|567341926|FG002|Post Induction|Withdrawal by Subject|0|||
157163595|NCT02883049|567341927|FG003|Post Induction|Withdrawal by Subject|5|||
157163596|NCT02883049|567341928|FG004|Post Induction|Withdrawal by Subject|2|||
157163597|NCT02883049|567341929|FG005|Post Induction|Withdrawal by Subject|1|||
157163598|NCT02883049|567341930|FG006|Post Induction|Withdrawal by Subject|0|||
157163599|NCT02883049|567341931|FG007|Post Induction|Withdrawal by Subject|0|||
157163600|NCT02883049|567341932|FG008|Post Induction|Withdrawal by Subject|2|||
157163601|NCT02883049|567341933|FG009|Post Induction|Withdrawal by Subject|0|||
157163602|NCT02883049|567341934|FG010|Post Induction|Withdrawal by Subject|1|||
157163603|NCT02883049|567341935|FG011|Post Induction|Withdrawal by Subject|1|||
157163604|NCT02883049|567341936|FG012|Post Induction|Withdrawal by Subject|0|||
156920417|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
156920418|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
156920419|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
156920420|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
156920421|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
156920422|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
156920423|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
156920424|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
156920425|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
156920426|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
156920427|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
156920428|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
156920429|NCT01285310|566465807|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
156920430|NCT01285310|566465808|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156920431|NCT01285310|566465809|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156920432|NCT01285310|566465810|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
156920433|NCT01285310|566465811|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
156920434|NCT01195415|566465832|FG000|Overall Study|No repeat biopsy due to progression|2|||
156920435|NCT00533845|566465833|FG000|Overall Study|Physician Decision|1|||
156920436|NCT00533845|566465834|FG001|Overall Study|Physician Decision|0|||
156920437|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
156920438|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
156920439|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
156920440|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
156920441|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
156920442|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
156920443|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156920444|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
156920445|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156920446|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
156920447|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Death|2|||
156920448|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Death|1|||
156920449|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Death|4|||
156920450|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Death|0|||
156920451|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Death|0|||
156920452|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
156920453|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
156920454|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
156920455|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
156920456|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
156920457|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Other Reason|1|||
156920458|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Other Reason|3|||
156920459|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Other Reason|2|||
157028528|NCT02038777|566860634|FG007|Overall Study|participation terminated by sponsor|1|||
156920460|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Other Reason|0|||
157028529|NCT05293171|566860645|FG000|Washout 5 to 7 Days|Adverse Event|1|||
157028530|NCT05293171|566860646|FG001|Washout 5 to 7 Days|Adverse Event|1|||
157163605|NCT02883049|567341937|FG013|Post Induction|Withdrawal by Subject|0|||
157163606|NCT02883049|567341938|FG014|Post Induction|Withdrawal by Subject|1|||
157226636|NCT01957488|567575876|FG000|Test Period 2 (2 Weeks)|Other|1|||
157163607|NCT02883049|567341939|FG015|Post Induction|Withdrawal by Subject|0|||
157163608|NCT02883049|567341924|FG000|Post Induction|Ineligible|0|||
157163609|NCT02883049|567341925|FG001|Post Induction|Ineligible|0|||
157163610|NCT02883049|567341926|FG002|Post Induction|Ineligible|2|||
157163611|NCT02883049|567341927|FG003|Post Induction|Ineligible|0|||
156920461|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Other Reason|0|||
156920462|NCT00555321|566465835|FG000|Treatment Phase up to 12-months|Never treated|2|||
156920463|NCT00555321|566465836|FG001|Treatment Phase up to 12-months|Never treated|3|||
156920464|NCT00555321|566465837|FG002|Treatment Phase up to 12-months|Never treated|1|||
156920465|NCT00555321|566465838|FG003|Treatment Phase up to 12-months|Never treated|0|||
156920466|NCT00555321|566465839|FG004|Treatment Phase up to 12-months|Never treated|4|||
156920467|NCT00555321|566465835|FG000|Long-term Extension Phase|Adverse Event|2|||
156920468|NCT00555321|566465836|FG001|Long-term Extension Phase|Adverse Event|5|||
156920469|NCT00555321|566465837|FG002|Long-term Extension Phase|Adverse Event|2|||
156920470|NCT00555321|566465838|FG003|Long-term Extension Phase|Adverse Event|1|||
156920471|NCT00555321|566465839|FG004|Long-term Extension Phase|Adverse Event|0|||
156920472|NCT00555321|566465835|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
156920473|NCT00555321|566465836|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
156920474|NCT00555321|566465837|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
156920475|NCT00555321|566465838|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
156920476|NCT00555321|566465839|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
156920477|NCT00555321|566465835|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
156920478|NCT00555321|566465836|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
156920479|NCT00555321|566465837|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
156920480|NCT00555321|566465838|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
156920481|NCT00555321|566465839|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
156920482|NCT00555321|566465835|FG000|Long-term Extension Phase|Death|2|||
156920483|NCT00555321|566465836|FG001|Long-term Extension Phase|Death|0|||
156920484|NCT00555321|566465837|FG002|Long-term Extension Phase|Death|0|||
156920485|NCT00555321|566465838|FG003|Long-term Extension Phase|Death|3|||
156920486|NCT00555321|566465839|FG004|Long-term Extension Phase|Death|0|||
156920487|NCT00555321|566465835|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
156920488|NCT00555321|566465836|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
156920489|NCT00555321|566465837|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
156920490|NCT00555321|566465838|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
156920491|NCT00555321|566465839|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
156920492|NCT00555321|566465835|FG000|Long-term Extension Phase|Other Reason|1|||
156920493|NCT00555321|566465836|FG001|Long-term Extension Phase|Other Reason|0|||
156920494|NCT00555321|566465837|FG002|Long-term Extension Phase|Other Reason|2|||
156920495|NCT00555321|566465838|FG003|Long-term Extension Phase|Other Reason|0|||
156920496|NCT00555321|566465839|FG004|Long-term Extension Phase|Other Reason|0|||
156920497|NCT00563381|566465845|FG000|Overall Study|Adverse Event|264|||
156920498|NCT00563381|566465846|FG001|Overall Study|Adverse Event|292|||
156920499|NCT00563381|566465845|FG000|Overall Study|Protocol Violation|66|||
156920500|NCT00563381|566465846|FG001|Overall Study|Protocol Violation|74|||
156920501|NCT00563381|566465845|FG000|Overall Study|Lost to Follow-up|7|||
156920502|NCT00563381|566465846|FG001|Overall Study|Lost to Follow-up|15|||
156920503|NCT00563381|566465845|FG000|Overall Study|Withdrawal by Subject|192|||
156920504|NCT00563381|566465846|FG001|Overall Study|Withdrawal by Subject|209|||
156920505|NCT00563381|566465845|FG000|Overall Study|Lack of Efficacy|32|||
156920506|NCT00563381|566465846|FG001|Overall Study|Lack of Efficacy|24|||
156920507|NCT00563381|566465845|FG000|Overall Study|Individual different reasons|24|||
156920508|NCT00563381|566465846|FG001|Overall Study|Individual different reasons|34|||
156920509|NCT00667368|566465847|FG000|Overall Study|Lost to Follow-up|176|||
156920510|NCT00667368|566465848|FG001|Overall Study|Lost to Follow-up|155|||
156920511|NCT00667368|566465847|FG000|Overall Study|Discontinued early|24|||
156920512|NCT00667368|566465848|FG001|Overall Study|Discontinued early|17|||
156920513|NCT02407704|566465849|FG000|Overall Study|Lost to Follow-up|0|||
156920514|NCT02407704|566465850|FG001|Overall Study|Lost to Follow-up|0|||
156920515|NCT02407704|566465851|FG002|Overall Study|Lost to Follow-up|0|||
156920516|NCT02407704|566465852|FG003|Overall Study|Lost to Follow-up|2|||
156920517|NCT02407704|566465849|FG000|Overall Study|Protocol Violation|0|||
156920518|NCT02407704|566465850|FG001|Overall Study|Protocol Violation|0|||
156920519|NCT02407704|566465851|FG002|Overall Study|Protocol Violation|0|||
156920520|NCT02407704|566465852|FG003|Overall Study|Protocol Violation|1|||
157028531|NCT05293171|566860647|FG002|Washout 5 to 7 Days|Adverse Event|0|||
157163612|NCT02883049|567341928|FG004|Post Induction|Ineligible|0|||
156920521|NCT02407704|566465849|FG000|Overall Study|Withdrawal by Subject|0|||
156920522|NCT02407704|566465850|FG001|Overall Study|Withdrawal by Subject|0|||
157028532|NCT05293171|566860648|FG003|Washout 5 to 7 Days|Adverse Event|0|||
156920523|NCT02407704|566465851|FG002|Overall Study|Withdrawal by Subject|1|||
156920524|NCT02407704|566465852|FG003|Overall Study|Withdrawal by Subject|0|||
156920525|NCT01957644|566465853|FG000|Overall Study|Adverse Event|4|||
156920526|NCT01957644|566465854|FG001|Overall Study|Adverse Event|2|||
156920527|NCT01957644|566465855|FG002|Overall Study|Adverse Event|0|||
156920528|NCT01957644|566465856|FG003|Overall Study|Adverse Event|0|||
157028533|NCT05293171|566860649|FG004|Washout 5 to 7 Days|Adverse Event|0|||
157163613|NCT02883049|567341929|FG005|Post Induction|Ineligible|0|||
156920529|NCT01957644|566465857|FG004|Overall Study|Adverse Event|1|||
156920530|NCT01957644|566465853|FG000|Overall Study|Progressive disease / relapse|0|||
156920531|NCT01957644|566465854|FG001|Overall Study|Progressive disease / relapse|1|||
156920532|NCT01957644|566465855|FG002|Overall Study|Progressive disease / relapse|0|||
156920533|NCT01957644|566465856|FG003|Overall Study|Progressive disease / relapse|1|||
156920534|NCT01957644|566465857|FG004|Overall Study|Progressive disease / relapse|0|||
156920535|NCT01957644|566465853|FG000|Overall Study|Other reason|1|||
156920536|NCT01957644|566465854|FG001|Overall Study|Other reason|2|||
156920537|NCT01957644|566465855|FG002|Overall Study|Other reason|1|||
156920538|NCT01957644|566465856|FG003|Overall Study|Other reason|1|||
156920539|NCT01957644|566465857|FG004|Overall Study|Other reason|0|||
156920540|NCT01957644|566465853|FG000|Overall Study|Withdrawal by Subject|1|||
156920541|NCT01957644|566465854|FG001|Overall Study|Withdrawal by Subject|0|||
156920542|NCT01957644|566465855|FG002|Overall Study|Withdrawal by Subject|0|||
156920543|NCT01957644|566465856|FG003|Overall Study|Withdrawal by Subject|0|||
156920544|NCT01957644|566465857|FG004|Overall Study|Withdrawal by Subject|0|||
156920545|NCT01957644|566465853|FG000|Overall Study|Protocol Violation|0|||
156920546|NCT01957644|566465854|FG001|Overall Study|Protocol Violation|1|||
156920547|NCT01957644|566465855|FG002|Overall Study|Protocol Violation|0|||
156920548|NCT01957644|566465856|FG003|Overall Study|Protocol Violation|0|||
156920549|NCT01957644|566465857|FG004|Overall Study|Protocol Violation|0|||
156920550|NCT01957553|566465858|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
156920551|NCT01957553|566465859|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
156920552|NCT01957553|566465858|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
156920553|NCT01957553|566465859|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
156920554|NCT01957553|566465858|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
156920555|NCT01957553|566465859|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
156920556|NCT01957553|566465858|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
156920557|NCT01957553|566465859|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
156920558|NCT01957553|566465858|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
156920559|NCT01957553|566465859|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
156920560|NCT01957553|566465858|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
156920561|NCT01957553|566465859|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
156920562|NCT01957553|566465858|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
156920563|NCT01957553|566465859|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
156920564|NCT01957553|566465858|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
156920565|NCT01957553|566465859|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
156920566|NCT01957553|566465858|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
156920567|NCT01957553|566465859|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
156920568|NCT04044716|566465860|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
156920569|NCT04044716|566465861|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
156920570|NCT04044716|566465862|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
156920571|NCT04044716|566465860|FG000|Overall Study|Lost to Follow-up|2|||
156920572|NCT04044716|566465861|FG001|Overall Study|Lost to Follow-up|3|||
156920573|NCT04044716|566465862|FG002|Overall Study|Lost to Follow-up|0|||
156920574|NCT02788357|566465863|FG000|Overall Study|Lost to Follow-up|3|||
156920575|NCT02788357|566465864|FG001|Overall Study|Lost to Follow-up|0|||
156920576|NCT02170051|566465865|FG000|Overall Study|Withdrawal by Subject|10|||
156920577|NCT02170051|566465866|FG001|Overall Study|Withdrawal by Subject|10|||
156920578|NCT02170051|566465865|FG000|Overall Study|Lost to Follow-up|1|||
156920579|NCT02170051|566465866|FG001|Overall Study|Lost to Follow-up|3|||
156920580|NCT00640601|566465872|FG000|Overall Study|Adverse Event|43|||
156920581|NCT00640601|566465872|FG000|Overall Study|Withdrawal by Subject|20|||
156920582|NCT00640601|566465872|FG000|Overall Study|Protocol Violation|6|||
156920583|NCT00640601|566465872|FG000|Overall Study|Lack of Efficacy|16|||
156920584|NCT00640601|566465872|FG000|Overall Study|Lost to Follow-up|9|||
156920585|NCT00640601|566465872|FG000|Overall Study|Physician Decision|8|||
156920586|NCT00640601|566465872|FG000|Overall Study|treatment naive, combination therapy|10|||
156920587|NCT01714635|566465875|FG000|Overall Study|Discontinued|1|||
156920588|NCT01714635|566465876|FG001|Overall Study|Discontinued|0|||
156920589|NCT01714635|566465877|FG002|Overall Study|Discontinued|2|||
156920590|NCT01714635|566465875|FG000|Overall Study|Missed 6-month exam|1|||
157028534|NCT05293171|566860650|FG005|Washout 5 to 7 Days|Adverse Event|0|||
157028535|NCT05293171|566860651|FG006|Washout 5 to 7 Days|Adverse Event|0|||
157163614|NCT02883049|567341930|FG006|Post Induction|Ineligible|1|||
157163615|NCT02883049|567341931|FG007|Post Induction|Ineligible|0|||
157163616|NCT02883049|567341932|FG008|Post Induction|Ineligible|0|||
157163617|NCT02883049|567341933|FG009|Post Induction|Ineligible|0|||
157163618|NCT02883049|567341934|FG010|Post Induction|Ineligible|1|||
157163619|NCT02883049|567341935|FG011|Post Induction|Ineligible|0|||
156920591|NCT01714635|566465876|FG001|Overall Study|Missed 6-month exam|0|||
156920592|NCT01714635|566465877|FG002|Overall Study|Missed 6-month exam|0|||
156920593|NCT00230607|566465878|FG000|Overall Study|Other|3|||
157163620|NCT02883049|567341936|FG012|Post Induction|Ineligible|0|||
157163621|NCT02883049|567341937|FG013|Post Induction|Ineligible|0|||
157163622|NCT02883049|567341938|FG014|Post Induction|Ineligible|0|||
156920594|NCT02860169|566465879|FG000|Part A|Withdrawal by Subject|1|||
156920595|NCT02860169|566465879|FG000|Part A|Other (Screening failure)|6|||
156920596|NCT02860169|566465879|FG000|Part A|Other (Survey not completed)|3|||
156920597|NCT02860169|566465879|FG000|Part A|Other (did not completed consent)|1|||
156920598|NCT02860169|566465879|FG000|Part B|Other (Screening failure)|10|||
156920599|NCT02860169|566465879|FG000|Part B|Withdrawal by Subject|1|||
156920600|NCT02860169|566465879|FG000|Part C|Other (Screening failure)|1|||
156920601|NCT03198234|566465880|FG000|Overall Study|Relapse of primary disease|0|||
156920602|NCT03198234|566465881|FG001|Overall Study|Relapse of primary disease|1|||
156920603|NCT03198234|566465882|FG002|Overall Study|Relapse of primary disease|0|||
156920604|NCT04285879|566465883|FG000|Overall Study|Lost to Follow-up|1|||
156920605|NCT04285879|566465884|FG001|Overall Study|Lost to Follow-up|8|||
156920606|NCT04285879|566465883|FG000|Overall Study|medical/surgical exclusion|16|||
156920607|NCT04285879|566465884|FG001|Overall Study|medical/surgical exclusion|0|||
156920608|NCT01835587|566465887|FG000|Overall Study|Disease Recurrence or Relapse|0|||
156920609|NCT01835587|566465888|FG001|Overall Study|Disease Recurrence or Relapse|3|||
156920610|NCT01835587|566465889|FG002|Overall Study|Disease Recurrence or Relapse|0|||
156920611|NCT01835587|566465890|FG003|Overall Study|Disease Recurrence or Relapse|3|||
156920612|NCT01835587|566465887|FG000|Overall Study|Withdrawal by Subject|2|||
156920613|NCT01835587|566465888|FG001|Overall Study|Withdrawal by Subject|0|||
156920614|NCT01835587|566465889|FG002|Overall Study|Withdrawal by Subject|0|||
156920615|NCT01835587|566465890|FG003|Overall Study|Withdrawal by Subject|3|||
156920616|NCT01835587|566465887|FG000|Overall Study|Adverse Event|0|||
156920617|NCT01835587|566465888|FG001|Overall Study|Adverse Event|0|||
156920618|NCT01835587|566465889|FG002|Overall Study|Adverse Event|2|||
156920619|NCT01835587|566465890|FG003|Overall Study|Adverse Event|2|||
156920620|NCT01835587|566465887|FG000|Overall Study|Death|0|||
156920621|NCT01835587|566465888|FG001|Overall Study|Death|0|||
156920622|NCT01835587|566465889|FG002|Overall Study|Death|0|||
156920623|NCT01835587|566465890|FG003|Overall Study|Death|1|||
156920624|NCT01835587|566465887|FG000|Overall Study|Miscellaneous|0|||
156920625|NCT01835587|566465888|FG001|Overall Study|Miscellaneous|1|||
156920626|NCT01835587|566465889|FG002|Overall Study|Miscellaneous|0|||
156920627|NCT01835587|566465890|FG003|Overall Study|Miscellaneous|0|||
156920628|NCT00071513|566465901|FG000|Intervention Component|Withdrawal by Subject|2|||
156920629|NCT00071513|566465902|FG001|Intervention Component|Withdrawal by Subject|3|||
156920630|NCT00071513|566465901|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
156920631|NCT00071513|566465902|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
156920632|NCT02622321|566465903|FG000|Overall Study|Withdrawal by Subject|2|||
156920633|NCT02622321|566465904|FG001|Overall Study|Withdrawal by Subject|0|||
156920634|NCT02622321|566465905|FG002|Overall Study|Withdrawal by Subject|0|||
156920635|NCT02622321|566465906|FG003|Overall Study|Withdrawal by Subject|0|||
156920636|NCT02622321|566465903|FG000|Overall Study|Death|0|||
156920637|NCT02622321|566465904|FG001|Overall Study|Death|0|||
156920638|NCT02622321|566465905|FG002|Overall Study|Death|1|||
156920639|NCT02622321|566465906|FG003|Overall Study|Death|0|||
156920640|NCT02622321|566465903|FG000|Overall Study|Physician Decision|1|||
156920641|NCT02622321|566465904|FG001|Overall Study|Physician Decision|0|||
156920642|NCT02622321|566465905|FG002|Overall Study|Physician Decision|0|||
156920643|NCT02622321|566465906|FG003|Overall Study|Physician Decision|0|||
156920644|NCT00965718|566465909|FG000|Overall Study|Withdrawal by Subject|4|||
156920645|NCT01634360|566465910|FG000|Overall Study|Adverse Event|10|||
156920646|NCT01634360|566465911|FG001|Overall Study|Adverse Event|34|||
156920647|NCT01634360|566465910|FG000|Overall Study|subject withdrew consent|13|||
156920648|NCT01634360|566465911|FG001|Overall Study|subject withdrew consent|23|||
156920649|NCT01634360|566465910|FG000|Overall Study|Protocol Violation|1|||
156920650|NCT01634360|566465911|FG001|Overall Study|Protocol Violation|1|||
156920651|NCT01634360|566465910|FG000|Overall Study|Lack of Efficacy|4|||
156920652|NCT01634360|566465911|FG001|Overall Study|Lack of Efficacy|14|||
156920653|NCT01634360|566465910|FG000|Overall Study|Other|3|||
156920654|NCT01634360|566465911|FG001|Overall Study|Other|20|||
156920655|NCT01634360|566465910|FG000|Overall Study|Study termination by sponsor|18|||
156920656|NCT01634360|566465911|FG001|Overall Study|Study termination by sponsor|44|||
156920657|NCT03667924|566465912|FG000|Baseline Completed|Lost to Follow-up|0|||
156920658|NCT03667924|566465913|FG001|Baseline Completed|Lost to Follow-up|2|||
156920659|NCT03667924|566465914|FG002|Baseline Completed|Lost to Follow-up|0|||
156920660|NCT03667924|566465912|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
156920661|NCT03667924|566465913|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
156920662|NCT03667924|566465914|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
157163623|NCT02883049|567341939|FG015|Post Induction|Ineligible|1|||
157163624|NCT02883049|567341924|FG000|Post Induction|Refusal of further protocol therapy|0|||
157163625|NCT02883049|567341925|FG001|Post Induction|Refusal of further protocol therapy|0|||
156920663|NCT03667924|566465912|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
156920664|NCT03667924|566465913|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
156920665|NCT03667924|566465914|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
156920666|NCT03667924|566465912|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
156920667|NCT03667924|566465913|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
156920668|NCT03667924|566465914|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
156920669|NCT03667924|566465912|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
156920670|NCT03667924|566465913|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
156920671|NCT03667924|566465914|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
156920672|NCT03667924|566465912|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
156920673|NCT03667924|566465913|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
156920674|NCT03667924|566465914|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
156920675|NCT03667924|566465912|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
156920676|NCT03667924|566465913|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
156920677|NCT03667924|566465914|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
156920678|NCT02260921|566465921|FG000|Overall Study|Adverse Event|1|||
156920679|NCT02260921|566465922|FG001|Overall Study|Adverse Event|0|||
156920680|NCT02260921|566465921|FG000|Overall Study|Lost to Follow-up|4|||
156920681|NCT02260921|566465922|FG001|Overall Study|Lost to Follow-up|3|||
156920682|NCT02260921|566465921|FG000|Overall Study|Withdraw Consent|4|||
156920683|NCT02260921|566465922|FG001|Overall Study|Withdraw Consent|1|||
156920684|NCT02260921|566465921|FG000|Overall Study|Death|1|||
156920685|NCT02260921|566465922|FG001|Overall Study|Death|0|||
156920686|NCT02260921|566465921|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
156920687|NCT02260921|566465922|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
156920688|NCT01244425|566465923|FG000|Overall Study|Withdrawal by Subject|2|||
156920689|NCT01244425|566465924|FG001|Overall Study|Withdrawal by Subject|2|||
156920690|NCT01244425|566465923|FG000|Overall Study|Adverse Event|1|||
156920691|NCT01244425|566465924|FG001|Overall Study|Adverse Event|1|||
156920692|NCT02999854|566465925|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
156920693|NCT02999854|566465926|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
156920694|NCT02999854|566465925|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
156920695|NCT02999854|566465926|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
156920696|NCT02999854|566465925|FG000|Active Study Phase (up to 18 Months)|Death|7|||
156920697|NCT02999854|566465926|FG001|Active Study Phase (up to 18 Months)|Death|5|||
156920698|NCT02999854|566465925|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
156920699|NCT02999854|566465926|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
156920700|NCT02999854|566465925|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
156920701|NCT02999854|566465926|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
156920702|NCT02999854|566465925|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
156920703|NCT02999854|566465926|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
156920704|NCT02999854|566465925|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
156920705|NCT02999854|566465926|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
156920706|NCT02999854|566465925|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
156920707|NCT02999854|566465926|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
156920708|NCT00897104|566465927|FG000|Overall Study|Lost to Follow-up|12|||
156920709|NCT00897104|566465928|FG001|Overall Study|Lost to Follow-up|17|||
156920710|NCT00897104|566465929|FG002|Overall Study|Lost to Follow-up|2|||
156920711|NCT00897104|566465927|FG000|Overall Study|Pregnancy|0|||
156920712|NCT00897104|566465928|FG001|Overall Study|Pregnancy|1|||
156920713|NCT00897104|566465929|FG002|Overall Study|Pregnancy|0|||
156920714|NCT00897104|566465927|FG000|Overall Study|Protocol Violation|0|||
156920715|NCT00897104|566465928|FG001|Overall Study|Protocol Violation|1|||
156920716|NCT00897104|566465929|FG002|Overall Study|Protocol Violation|0|||
156920717|NCT00897104|566465927|FG000|Overall Study|Withdrawal by Subject|23|||
156920718|NCT00897104|566465928|FG001|Overall Study|Withdrawal by Subject|27|||
156920719|NCT00897104|566465929|FG002|Overall Study|Withdrawal by Subject|3|||
156920720|NCT00897104|566465927|FG000|Overall Study|Abnormal Prestudy Labs|2|||
156920721|NCT00897104|566465928|FG001|Overall Study|Abnormal Prestudy Labs|0|||
156920722|NCT00897104|566465929|FG002|Overall Study|Abnormal Prestudy Labs|0|||
156920723|NCT00897104|566465927|FG000|Overall Study|Abnormal Baseline ECG|2|||
156920724|NCT00897104|566465928|FG001|Overall Study|Abnormal Baseline ECG|2|||
156920725|NCT00897104|566465929|FG002|Overall Study|Abnormal Baseline ECG|0|||
156920726|NCT00897104|566465927|FG000|Overall Study|Need for Concom. Med.|0|||
156920727|NCT00897104|566465928|FG001|Overall Study|Need for Concom. Med.|1|||
156920728|NCT00897104|566465929|FG002|Overall Study|Need for Concom. Med.|1|||
156920729|NCT00897104|566465927|FG000|Overall Study|Lack of Migraine Attack|20|||
156920730|NCT00897104|566465928|FG001|Overall Study|Lack of Migraine Attack|22|||
156920731|NCT00897104|566465929|FG002|Overall Study|Lack of Migraine Attack|1|||
156920732|NCT00897104|566465927|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
156920733|NCT00897104|566465928|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156920734|NCT00897104|566465929|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
156920735|NCT00897104|566465927|FG000|Overall Study|Other|3|||
156920736|NCT00897104|566465928|FG001|Overall Study|Other|0|||
156920737|NCT00897104|566465929|FG002|Overall Study|Other|0|||
157226637|NCT01957488|567575877|FG001|Test Period 2 (2 Weeks)|Other|0|||
157226638|NCT01957488|567575878|FG002|Test Period 2 (2 Weeks)|Other|0|||
157226639|NCT01957488|567575879|FG003|Test Period 2 (2 Weeks)|Other|0|||
157226640|NCT01957488|567575880|FG004|Test Period 2 (2 Weeks)|Other|0|||
157226641|NCT01957488|567575881|FG005|Test Period 2 (2 Weeks)|Other|0|||
157226642|NCT01957488|567575876|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
157226643|NCT01957488|567575877|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
157226644|NCT01957488|567575878|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
157226645|NCT01957488|567575879|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
157226646|NCT01957488|567575880|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
157226647|NCT01957488|567575881|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
157226648|NCT01957488|567575876|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
157226649|NCT01957488|567575877|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
157226650|NCT01957488|567575878|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
157226651|NCT01957488|567575879|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
157226652|NCT01957488|567575880|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
157226653|NCT01957488|567575881|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
157226654|NCT01957488|567575876|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
157226655|NCT01957488|567575877|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
157226656|NCT01957488|567575878|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
157226657|NCT01957488|567575879|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
157226658|NCT01957488|567575880|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
157226659|NCT01957488|567575881|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
157226660|NCT01957488|567575876|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
157226661|NCT01957488|567575877|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
157226662|NCT01957488|567575878|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
157226663|NCT01957488|567575879|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
157226664|NCT01957488|567575880|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
157226665|NCT01957488|567575881|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
157226666|NCT01957488|567575876|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
157226667|NCT01957488|567575877|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
157226668|NCT01957488|567575878|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
157226669|NCT01957488|567575879|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
157226670|NCT01957488|567575880|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
157226671|NCT01957488|567575881|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
157226672|NCT02402166|567575882|FG000|Overall Study|Adverse Event|2|||
157226673|NCT02402166|567575882|FG000|Overall Study|Withdrawal by Subject|2|||
157226674|NCT02402166|567575882|FG000|Overall Study|Lost to Follow-up|1|||
157226675|NCT00810368|567575884|FG000|Overall Study|Lost to Follow-up|4|||
157226676|NCT00810368|567575885|FG001|Overall Study|Lost to Follow-up|2|||
157226677|NCT00810368|567575884|FG000|Overall Study|Lack of Efficacy|2|||
157226678|NCT00810368|567575885|FG001|Overall Study|Lack of Efficacy|0|||
157226679|NCT00623103|567575886|FG000|Overall Study|Adverse Event|70|||
157226680|NCT00623103|567575887|FG001|Overall Study|Adverse Event|60|||
157226681|NCT00623103|567575886|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157226682|NCT00623103|567575887|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
157226683|NCT00623103|567575886|FG000|Overall Study|Withdrawal by Subject|18|||
157226684|NCT00623103|567575887|FG001|Overall Study|Withdrawal by Subject|24|||
157163626|NCT02883049|567341926|FG002|Post Induction|Refusal of further protocol therapy|0|||
157163627|NCT02883049|567341927|FG003|Post Induction|Refusal of further protocol therapy|11|||
157163628|NCT02883049|567341928|FG004|Post Induction|Refusal of further protocol therapy|15|||
157163629|NCT02883049|567341929|FG005|Post Induction|Refusal of further protocol therapy|9|||
157163630|NCT02883049|567341930|FG006|Post Induction|Refusal of further protocol therapy|13|||
157163631|NCT02883049|567341931|FG007|Post Induction|Refusal of further protocol therapy|5|||
157163632|NCT02883049|567341932|FG008|Post Induction|Refusal of further protocol therapy|21|||
157163633|NCT02883049|567341933|FG009|Post Induction|Refusal of further protocol therapy|7|||
157163634|NCT02883049|567341934|FG010|Post Induction|Refusal of further protocol therapy|0|||
157163635|NCT02883049|567341935|FG011|Post Induction|Refusal of further protocol therapy|7|||
157163636|NCT02883049|567341936|FG012|Post Induction|Refusal of further protocol therapy|3|||
157226685|NCT00623103|567575886|FG000|Overall Study|Lost to Follow-up|4|||
157226686|NCT00623103|567575887|FG001|Overall Study|Lost to Follow-up|1|||
157163637|NCT02883049|567341937|FG013|Post Induction|Refusal of further protocol therapy|0|||
157226687|NCT00623103|567575886|FG000|Overall Study|Administrative problems|2|||
157226688|NCT00623103|567575887|FG001|Overall Study|Administrative problems|4|||
157226689|NCT00623103|567575886|FG000|Overall Study|Death|11|||
157226690|NCT00623103|567575887|FG001|Overall Study|Death|11|||
157226691|NCT00623103|567575886|FG000|Overall Study|Protocol deviation|2|||
157226692|NCT00623103|567575887|FG001|Overall Study|Protocol deviation|1|||
157226693|NCT03803943|567575896|FG000|Overall Study|Withdrawal by Subject|2|||
157226694|NCT03803943|567575897|FG001|Overall Study|Withdrawal by Subject|2|||
157226695|NCT03803943|567575898|FG002|Overall Study|Withdrawal by Subject|2|||
157226696|NCT03803943|567575899|FG003|Overall Study|Withdrawal by Subject|2|||
156920738|NCT00897104|566465927|FG000|Overall Study|Protocol Violation|1|||
156920739|NCT00897104|566465928|FG001|Overall Study|Protocol Violation|0|||
156920740|NCT00897104|566465929|FG002|Overall Study|Protocol Violation|0|||
156920741|NCT00897104|566465927|FG000|Overall Study|Withdrawal by Subject|0|||
156920742|NCT00897104|566465928|FG001|Overall Study|Withdrawal by Subject|0|||
156920743|NCT00897104|566465929|FG002|Overall Study|Withdrawal by Subject|1|||
156920744|NCT03032705|566465930|FG000|Overall Study|Lost to Follow-up|16|||
156920745|NCT03032705|566465931|FG001|Overall Study|Lost to Follow-up|17|||
156920746|NCT03032705|566465930|FG000|Overall Study|did not quality|6|||
156920747|NCT03032705|566465931|FG001|Overall Study|did not quality|6|||
156920748|NCT00733408|566468017|FG000|Overall Study|Adverse Event|4|||
156920749|NCT01134783|566468018|FG000|Overall Study|Pregnancy|16|||
156920750|NCT01134783|566468019|FG001|Overall Study|Pregnancy|8|||
156920751|NCT01134783|566468018|FG000|Overall Study|Withdrawal by Subject|15|||
156920752|NCT01134783|566468019|FG001|Overall Study|Withdrawal by Subject|9|||
156920753|NCT01134783|566468018|FG000|Overall Study|Lost to Follow-up|5|||
156920754|NCT01134783|566468019|FG001|Overall Study|Lost to Follow-up|20|||
156920755|NCT02329730|566468025|FG000|Overall Study|Protocol Violation|0|||
156920756|NCT02329730|566468026|FG001|Overall Study|Protocol Violation|0|||
156920757|NCT02329730|566468027|FG002|Overall Study|Protocol Violation|0|||
156920758|NCT02329730|566468028|FG003|Overall Study|Protocol Violation|0|||
156920759|NCT02329730|566468029|FG004|Overall Study|Protocol Violation|2|||
156920760|NCT02329730|566468030|FG005|Overall Study|Protocol Violation|2|||
156920761|NCT02329730|566468031|FG006|Overall Study|Protocol Violation|0|||
156920762|NCT02329730|566468032|FG007|Overall Study|Protocol Violation|0|||
156920763|NCT02329730|566468033|FG008|Overall Study|Protocol Violation|0|||
156920764|NCT02329730|566468034|FG009|Overall Study|Protocol Violation|0|||
156920765|NCT02329730|566468035|FG010|Overall Study|Protocol Violation|0|||
156920766|NCT02329730|566468036|FG011|Overall Study|Protocol Violation|0|||
156920767|NCT02329730|566468025|FG000|Overall Study|Withdrawal by Subject|0|||
156920768|NCT02329730|566468026|FG001|Overall Study|Withdrawal by Subject|0|||
156920769|NCT02329730|566468027|FG002|Overall Study|Withdrawal by Subject|0|||
156920770|NCT02329730|566468028|FG003|Overall Study|Withdrawal by Subject|0|||
156920771|NCT02329730|566468029|FG004|Overall Study|Withdrawal by Subject|1|||
156920772|NCT02329730|566468030|FG005|Overall Study|Withdrawal by Subject|0|||
156920773|NCT02329730|566468031|FG006|Overall Study|Withdrawal by Subject|1|||
156920774|NCT02329730|566468032|FG007|Overall Study|Withdrawal by Subject|1|||
156920775|NCT02329730|566468033|FG008|Overall Study|Withdrawal by Subject|1|||
156920776|NCT02329730|566468034|FG009|Overall Study|Withdrawal by Subject|1|||
156920777|NCT02329730|566468035|FG010|Overall Study|Withdrawal by Subject|0|||
156920778|NCT02329730|566468036|FG011|Overall Study|Withdrawal by Subject|0|||
156920779|NCT00463346|566468037|FG000|Overall Study|Withdrawal by Subject|3|||
156920780|NCT00463346|566468038|FG001|Overall Study|Withdrawal by Subject|3|||
156920781|NCT03641651|566468040|FG000|Overall Study|organizational issues at one study site|1|||
156920782|NCT01991067|566468042|FG000|Overall Study|Lost to Follow-up|6|||
156920783|NCT01991067|566468043|FG001|Overall Study|Lost to Follow-up|5|||
156920784|NCT00951665|566468045|FG000|Phase 1b|Adverse Event|2|||
156920785|NCT00951665|566468046|FG001|Phase 1b|Adverse Event|1|||
156920786|NCT00951665|566468047|FG002|Phase 1b|Adverse Event|0|||
156920787|NCT00951665|566468048|FG003|Phase 1b|Adverse Event|1|||
156920788|NCT00951665|566468049|FG004|Phase 1b|Adverse Event|0|||
156920789|NCT00951665|566468050|FG005|Phase 1b|Adverse Event|0|||
156920790|NCT00951665|566468045|FG000|Phase 1b|Death|1|||
156920791|NCT00951665|566468046|FG001|Phase 1b|Death|0|||
156920792|NCT00951665|566468047|FG002|Phase 1b|Death|2|||
156920793|NCT00951665|566468048|FG003|Phase 1b|Death|0|||
156920794|NCT00951665|566468049|FG004|Phase 1b|Death|0|||
156920795|NCT00951665|566468050|FG005|Phase 1b|Death|0|||
156920796|NCT00951665|566468045|FG000|Phase 1b|Physician Decision|4|||
156920797|NCT00951665|566468046|FG001|Phase 1b|Physician Decision|0|||
156920798|NCT00951665|566468047|FG002|Phase 1b|Physician Decision|1|||
156920799|NCT00951665|566468048|FG003|Phase 1b|Physician Decision|0|||
156920800|NCT00951665|566468049|FG004|Phase 1b|Physician Decision|0|||
156920801|NCT00951665|566468050|FG005|Phase 1b|Physician Decision|0|||
156920802|NCT00951665|566468045|FG000|Phase 1b|Withdrawal by Subject|0|||
156920803|NCT00951665|566468046|FG001|Phase 1b|Withdrawal by Subject|1|||
156920804|NCT00951665|566468047|FG002|Phase 1b|Withdrawal by Subject|0|||
157163638|NCT02883049|567341938|FG014|Post Induction|Refusal of further protocol therapy|4|||
156920805|NCT00951665|566468048|FG003|Phase 1b|Withdrawal by Subject|0|||
156920806|NCT00951665|566468049|FG004|Phase 1b|Withdrawal by Subject|0|||
156920807|NCT00951665|566468050|FG005|Phase 1b|Withdrawal by Subject|0|||
156920808|NCT00951665|566468045|FG000|Phase 1b|Disease Progression|13|||
156920809|NCT00951665|566468046|FG001|Phase 1b|Disease Progression|2|||
156920810|NCT00951665|566468047|FG002|Phase 1b|Disease Progression|14|||
156920811|NCT00951665|566468048|FG003|Phase 1b|Disease Progression|0|||
156920812|NCT00951665|566468049|FG004|Phase 1b|Disease Progression|0|||
156920813|NCT00951665|566468050|FG005|Phase 1b|Disease Progression|0|||
156920814|NCT00951665|566468045|FG000|Phase 1b|Protocol Violation|2|||
156920815|NCT00951665|566468046|FG001|Phase 1b|Protocol Violation|0|||
156920816|NCT00951665|566468047|FG002|Phase 1b|Protocol Violation|0|||
156920817|NCT00951665|566468048|FG003|Phase 1b|Protocol Violation|0|||
157163639|NCT02883049|567341939|FG015|Post Induction|Refusal of further protocol therapy|1|||
157163640|NCT02883049|567341924|FG000|Post Induction|Inevaluable|0|||
157163641|NCT02883049|567341925|FG001|Post Induction|Inevaluable|0|||
157163642|NCT02883049|567341926|FG002|Post Induction|Inevaluable|0|||
157163643|NCT02883049|567341927|FG003|Post Induction|Inevaluable|1|||
157163644|NCT02883049|567341928|FG004|Post Induction|Inevaluable|1|||
157163645|NCT02883049|567341929|FG005|Post Induction|Inevaluable|2|||
157163646|NCT02883049|567341930|FG006|Post Induction|Inevaluable|7|||
157163647|NCT02883049|567341931|FG007|Post Induction|Inevaluable|6|||
157163648|NCT02883049|567341932|FG008|Post Induction|Inevaluable|4|||
157163649|NCT02883049|567341933|FG009|Post Induction|Inevaluable|4|||
157163650|NCT02883049|567341934|FG010|Post Induction|Inevaluable|1|||
157163651|NCT02883049|567341935|FG011|Post Induction|Inevaluable|1|||
157163652|NCT02883049|567341936|FG012|Post Induction|Inevaluable|2|||
157163653|NCT02883049|567341937|FG013|Post Induction|Inevaluable|0|||
157163654|NCT02883049|567341938|FG014|Post Induction|Inevaluable|0|||
157163655|NCT02883049|567341939|FG015|Post Induction|Inevaluable|1|||
157163656|NCT02883049|567341924|FG000|Post Induction|Moved to another non-COG institution|0|||
157163657|NCT02883049|567341925|FG001|Post Induction|Moved to another non-COG institution|0|||
157163658|NCT02883049|567341926|FG002|Post Induction|Moved to another non-COG institution|0|||
157163659|NCT02883049|567341927|FG003|Post Induction|Moved to another non-COG institution|0|||
157163660|NCT02883049|567341928|FG004|Post Induction|Moved to another non-COG institution|0|||
157163661|NCT02883049|567341929|FG005|Post Induction|Moved to another non-COG institution|0|||
157163662|NCT02883049|567341930|FG006|Post Induction|Moved to another non-COG institution|0|||
157163663|NCT02883049|567341931|FG007|Post Induction|Moved to another non-COG institution|2|||
157163664|NCT02883049|567341932|FG008|Post Induction|Moved to another non-COG institution|2|||
157163665|NCT02883049|567341933|FG009|Post Induction|Moved to another non-COG institution|0|||
157163666|NCT02883049|567341934|FG010|Post Induction|Moved to another non-COG institution|0|||
157163667|NCT02883049|567341935|FG011|Post Induction|Moved to another non-COG institution|1|||
157163668|NCT02883049|567341936|FG012|Post Induction|Moved to another non-COG institution|0|||
157163669|NCT02883049|567341937|FG013|Post Induction|Moved to another non-COG institution|0|||
157163670|NCT02883049|567341938|FG014|Post Induction|Moved to another non-COG institution|0|||
157163671|NCT02883049|567341939|FG015|Post Induction|Moved to another non-COG institution|0|||
157163672|NCT02883049|567341924|FG000|Post Induction|Randomization closed|0|||
157163673|NCT02883049|567341925|FG001|Post Induction|Randomization closed|0|||
157163674|NCT02883049|567341926|FG002|Post Induction|Randomization closed|0|||
157163675|NCT02883049|567341927|FG003|Post Induction|Randomization closed|0|||
157163676|NCT02883049|567341928|FG004|Post Induction|Randomization closed|0|||
157163677|NCT02883049|567341929|FG005|Post Induction|Randomization closed|0|||
157163678|NCT02883049|567341930|FG006|Post Induction|Randomization closed|0|||
157163679|NCT02883049|567341931|FG007|Post Induction|Randomization closed|20|||
157163680|NCT02883049|567341932|FG008|Post Induction|Randomization closed|0|||
157163681|NCT02883049|567341933|FG009|Post Induction|Randomization closed|0|||
157163682|NCT02883049|567341934|FG010|Post Induction|Randomization closed|0|||
157163683|NCT02883049|567341935|FG011|Post Induction|Randomization closed|0|||
157163684|NCT02883049|567341936|FG012|Post Induction|Randomization closed|0|||
157163685|NCT02883049|567341937|FG013|Post Induction|Randomization closed|0|||
157163686|NCT02883049|567341938|FG014|Post Induction|Randomization closed|0|||
157163687|NCT02883049|567341939|FG015|Post Induction|Randomization closed|0|||
157163688|NCT02883049|567341924|FG000|Post Induction|MRD negative|0|||
157163689|NCT02883049|567341925|FG001|Post Induction|MRD negative|0|||
157163690|NCT02883049|567341926|FG002|Post Induction|MRD negative|0|||
157163691|NCT02883049|567341927|FG003|Post Induction|MRD negative|0|||
157163692|NCT02883049|567341928|FG004|Post Induction|MRD negative|0|||
157163693|NCT02883049|567341929|FG005|Post Induction|MRD negative|0|||
157163694|NCT02883049|567341930|FG006|Post Induction|MRD negative|0|||
157163695|NCT02883049|567341931|FG007|Post Induction|MRD negative|11|||
157163696|NCT02883049|567341932|FG008|Post Induction|MRD negative|0|||
157163697|NCT02883049|567341933|FG009|Post Induction|MRD negative|0|||
157163698|NCT02883049|567341934|FG010|Post Induction|MRD negative|0|||
157163699|NCT02883049|567341935|FG011|Post Induction|MRD negative|0|||
156920818|NCT00951665|566468049|FG004|Phase 1b|Protocol Violation|0|||
156920819|NCT00951665|566468050|FG005|Phase 1b|Protocol Violation|0|||
156920820|NCT00951665|566468045|FG000|Phase 2a|Adverse Event|0|||
157163700|NCT02883049|567341936|FG012|Post Induction|MRD negative|0|||
157163701|NCT02883049|567341937|FG013|Post Induction|MRD negative|0|||
157163702|NCT02883049|567341938|FG014|Post Induction|MRD negative|0|||
157163703|NCT02883049|567341939|FG015|Post Induction|MRD negative|0|||
157163704|NCT02883049|567341924|FG000|Post Induction|Developed SMN|0|||
157163705|NCT02883049|567341925|FG001|Post Induction|Developed SMN|0|||
157163706|NCT02883049|567341926|FG002|Post Induction|Developed SMN|0|||
157163707|NCT02883049|567341927|FG003|Post Induction|Developed SMN|0|||
157163708|NCT02883049|567341928|FG004|Post Induction|Developed SMN|1|||
157163709|NCT02883049|567341929|FG005|Post Induction|Developed SMN|0|||
157163710|NCT02883049|567341930|FG006|Post Induction|Developed SMN|1|||
157163711|NCT02883049|567341931|FG007|Post Induction|Developed SMN|0|||
157163712|NCT02883049|567341932|FG008|Post Induction|Developed SMN|0|||
157163713|NCT02883049|567341933|FG009|Post Induction|Developed SMN|0|||
157163714|NCT02883049|567341934|FG010|Post Induction|Developed SMN|1|||
157163715|NCT02883049|567341935|FG011|Post Induction|Developed SMN|1|||
157163716|NCT02883049|567341936|FG012|Post Induction|Developed SMN|0|||
157163717|NCT02883049|567341937|FG013|Post Induction|Developed SMN|0|||
157163718|NCT02883049|567341938|FG014|Post Induction|Developed SMN|1|||
157163719|NCT02883049|567341939|FG015|Post Induction|Developed SMN|0|||
157163720|NCT02883049|567341924|FG000|Post Induction|Enrolled onto another COG study|0|||
157163721|NCT02883049|567341925|FG001|Post Induction|Enrolled onto another COG study|0|||
157163722|NCT02883049|567341926|FG002|Post Induction|Enrolled onto another COG study|0|||
157163723|NCT02883049|567341927|FG003|Post Induction|Enrolled onto another COG study|1|||
157163724|NCT02883049|567341928|FG004|Post Induction|Enrolled onto another COG study|1|||
157163725|NCT02883049|567341929|FG005|Post Induction|Enrolled onto another COG study|0|||
157163726|NCT02883049|567341930|FG006|Post Induction|Enrolled onto another COG study|0|||
157163727|NCT02883049|567341931|FG007|Post Induction|Enrolled onto another COG study|4|||
157163728|NCT02883049|567341932|FG008|Post Induction|Enrolled onto another COG study|0|||
157163729|NCT02883049|567341933|FG009|Post Induction|Enrolled onto another COG study|0|||
157163730|NCT02883049|567341934|FG010|Post Induction|Enrolled onto another COG study|0|||
157163731|NCT02883049|567341935|FG011|Post Induction|Enrolled onto another COG study|2|||
157163732|NCT02883049|567341936|FG012|Post Induction|Enrolled onto another COG study|0|||
157163733|NCT02883049|567341937|FG013|Post Induction|Enrolled onto another COG study|1|||
157163734|NCT02883049|567341938|FG014|Post Induction|Enrolled onto another COG study|0|||
157163735|NCT02883049|567341939|FG015|Post Induction|Enrolled onto another COG study|0|||
157163736|NCT02883049|567341924|FG000|Post Induction|Recurrent leukemia|0|||
157163737|NCT02883049|567341925|FG001|Post Induction|Recurrent leukemia|0|||
157163738|NCT02883049|567341926|FG002|Post Induction|Recurrent leukemia|0|||
157163739|NCT02883049|567341927|FG003|Post Induction|Recurrent leukemia|17|||
157163740|NCT02883049|567341928|FG004|Post Induction|Recurrent leukemia|12|||
157163741|NCT02883049|567341929|FG005|Post Induction|Recurrent leukemia|4|||
157163742|NCT02883049|567341930|FG006|Post Induction|Recurrent leukemia|1|||
157163743|NCT02883049|567341931|FG007|Post Induction|Recurrent leukemia|13|||
157163744|NCT02883049|567341932|FG008|Post Induction|Recurrent leukemia|27|||
157163745|NCT02883049|567341933|FG009|Post Induction|Recurrent leukemia|5|||
157163746|NCT02883049|567341934|FG010|Post Induction|Recurrent leukemia|3|||
157163747|NCT02883049|567341935|FG011|Post Induction|Recurrent leukemia|12|||
157163748|NCT02883049|567341936|FG012|Post Induction|Recurrent leukemia|1|||
157163749|NCT02883049|567341937|FG013|Post Induction|Recurrent leukemia|1|||
157163750|NCT02883049|567341938|FG014|Post Induction|Recurrent leukemia|9|||
157163751|NCT02883049|567341939|FG015|Post Induction|Recurrent leukemia|3|||
157163752|NCT02883049|567341924|FG000|Post Induction|Induction Failure|0|||
157163753|NCT02883049|567341925|FG001|Post Induction|Induction Failure|0|||
157163754|NCT02883049|567341926|FG002|Post Induction|Induction Failure|0|||
157163755|NCT02883049|567341927|FG003|Post Induction|Induction Failure|0|||
157163756|NCT02883049|567341928|FG004|Post Induction|Induction Failure|0|||
157226697|NCT01424722|567575900|FG000|Overall Study|Sponsor terminated investigation|2258|||
156920821|NCT00951665|566468046|FG001|Phase 2a|Adverse Event|0|||
156920822|NCT00951665|566468047|FG002|Phase 2a|Adverse Event|0|||
156920823|NCT00951665|566468048|FG003|Phase 2a|Adverse Event|0|||
156920824|NCT00951665|566468049|FG004|Phase 2a|Adverse Event|2|||
156920825|NCT00951665|566468050|FG005|Phase 2a|Adverse Event|0|||
156920826|NCT00951665|566468045|FG000|Phase 2a|Death|0|||
156920827|NCT00951665|566468046|FG001|Phase 2a|Death|0|||
156920828|NCT00951665|566468047|FG002|Phase 2a|Death|0|||
156920829|NCT00951665|566468048|FG003|Phase 2a|Death|0|||
156920830|NCT00951665|566468049|FG004|Phase 2a|Death|1|||
156920831|NCT00951665|566468050|FG005|Phase 2a|Death|1|||
156920832|NCT00951665|566468045|FG000|Phase 2a|Lost to Follow-up|0|||
156920833|NCT00951665|566468046|FG001|Phase 2a|Lost to Follow-up|0|||
156920834|NCT00951665|566468047|FG002|Phase 2a|Lost to Follow-up|0|||
156920835|NCT00951665|566468048|FG003|Phase 2a|Lost to Follow-up|0|||
156920836|NCT00951665|566468049|FG004|Phase 2a|Lost to Follow-up|1|||
157163757|NCT02883049|567341929|FG005|Post Induction|Induction Failure|0|||
157163758|NCT02883049|567341930|FG006|Post Induction|Induction Failure|0|||
157163759|NCT02883049|567341931|FG007|Post Induction|Induction Failure|2|||
157163760|NCT02883049|567341932|FG008|Post Induction|Induction Failure|2|||
157163761|NCT02883049|567341933|FG009|Post Induction|Induction Failure|0|||
156920837|NCT00951665|566468050|FG005|Phase 2a|Lost to Follow-up|0|||
157163762|NCT02883049|567341934|FG010|Post Induction|Induction Failure|0|||
157163763|NCT02883049|567341935|FG011|Post Induction|Induction Failure|0|||
157163764|NCT02883049|567341936|FG012|Post Induction|Induction Failure|0|||
156920838|NCT00951665|566468045|FG000|Phase 2a|Physician Decision|0|||
156920839|NCT00951665|566468046|FG001|Phase 2a|Physician Decision|0|||
156920840|NCT00951665|566468047|FG002|Phase 2a|Physician Decision|0|||
156920841|NCT00951665|566468048|FG003|Phase 2a|Physician Decision|0|||
157163765|NCT02883049|567341937|FG013|Post Induction|Induction Failure|2|||
156920842|NCT00951665|566468049|FG004|Phase 2a|Physician Decision|0|||
156920843|NCT00951665|566468050|FG005|Phase 2a|Physician Decision|1|||
156920844|NCT00951665|566468045|FG000|Phase 2a|Withdrawal by Subject|0|||
156920845|NCT00951665|566468046|FG001|Phase 2a|Withdrawal by Subject|0|||
157163766|NCT02883049|567341938|FG014|Post Induction|Induction Failure|0|||
157163767|NCT02883049|567341939|FG015|Post Induction|Induction Failure|0|||
157163768|NCT00229203|567341940|FG000|Overall Study|Progressive disease|18|||
157163769|NCT00229203|567341941|FG001|Overall Study|Progressive disease|9|||
157163770|NCT00229203|567341940|FG000|Overall Study|Toxicity|6|||
157163771|NCT00229203|567341941|FG001|Overall Study|Toxicity|1|||
157163772|NCT00229203|567341940|FG000|Overall Study|Death|4|||
157163773|NCT00229203|567341941|FG001|Overall Study|Death|2|||
157163774|NCT00229203|567341940|FG000|Overall Study|Other|3|||
157163775|NCT00229203|567341941|FG001|Overall Study|Other|3|||
157163776|NCT00229203|567341940|FG000|Overall Study|Withdrawal by Subject|1|||
157163777|NCT00229203|567341941|FG001|Overall Study|Withdrawal by Subject|4|||
157163778|NCT03457103|567341942|FG000|Overall Study|illness/hospitalization|4|||
157163779|NCT03457103|567341943|FG001|Overall Study|illness/hospitalization|2|||
157163780|NCT03457103|567341942|FG000|Overall Study|Lost to Follow-up|2|||
157163781|NCT03457103|567341943|FG001|Overall Study|Lost to Follow-up|1|||
157163782|NCT03457103|567341942|FG000|Overall Study|Withdrawal by Subject|1|||
157163783|NCT03457103|567341943|FG001|Overall Study|Withdrawal by Subject|2|||
157163784|NCT03457103|567341942|FG000|Overall Study|financial/ insurance issues|1|||
157163785|NCT03457103|567341943|FG001|Overall Study|financial/ insurance issues|1|||
157163786|NCT03004469|567341946|FG000|Overall Study|Adverse Event|6|||
157163787|NCT03004469|567341947|FG001|Overall Study|Adverse Event|4|||
157163788|NCT03004469|567341948|FG002|Overall Study|Adverse Event|6|||
157163789|NCT03004469|567341946|FG000|Overall Study|Lack of Efficacy|1|||
157163790|NCT03004469|567341947|FG001|Overall Study|Lack of Efficacy|0|||
157163791|NCT03004469|567341948|FG002|Overall Study|Lack of Efficacy|1|||
157163792|NCT03004469|567341946|FG000|Overall Study|Lost to Follow-up|23|||
157163793|NCT03004469|567341947|FG001|Overall Study|Lost to Follow-up|14|||
157163794|NCT03004469|567341948|FG002|Overall Study|Lost to Follow-up|6|||
157163795|NCT03004469|567341946|FG000|Overall Study|Non-Compliance with Study Drug|2|||
157163796|NCT03004469|567341947|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157163797|NCT03004469|567341948|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157163798|NCT03004469|567341946|FG000|Overall Study|Protocol Violation|0|||
157163799|NCT03004469|567341947|FG001|Overall Study|Protocol Violation|0|||
157163800|NCT03004469|567341948|FG002|Overall Study|Protocol Violation|1|||
157163801|NCT03004469|567341946|FG000|Overall Study|Withdrawal by Subject|29|||
157163802|NCT03004469|567341947|FG001|Overall Study|Withdrawal by Subject|27|||
157163803|NCT03004469|567341948|FG002|Overall Study|Withdrawal by Subject|10|||
157163804|NCT03004469|567341946|FG000|Overall Study|Other unspecified reason|0|||
157163805|NCT03004469|567341947|FG001|Overall Study|Other unspecified reason|4|||
157163806|NCT03004469|567341948|FG002|Overall Study|Other unspecified reason|1|||
157163807|NCT01163253|567341949|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
157163808|NCT01163253|567341950|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
157163809|NCT01163253|567341949|FG000|Overall Study|Study Terminated by Sponsor|978|||
157163810|NCT01163253|567341950|FG001|Overall Study|Study Terminated by Sponsor|349|||
157163811|NCT01163253|567341949|FG000|Overall Study|Protocol Violation|43|||
157163812|NCT01163253|567341950|FG001|Overall Study|Protocol Violation|12|||
157163813|NCT01163253|567341949|FG000|Overall Study|Withdrawal by Subject|199|||
157163814|NCT01163253|567341950|FG001|Overall Study|Withdrawal by Subject|50|||
157163815|NCT01163253|567341949|FG000|Overall Study|Medication Error|1|||
157163816|NCT01163253|567341950|FG001|Overall Study|Medication Error|0|||
157163817|NCT01163253|567341949|FG000|Overall Study|Lost to Follow-up|125|||
157163818|NCT01163253|567341950|FG001|Overall Study|Lost to Follow-up|23|||
157163819|NCT01163253|567341949|FG000|Overall Study|Insufficient Clinical Response|423|||
157163820|NCT01163253|567341950|FG001|Overall Study|Insufficient Clinical Response|29|||
157163821|NCT01163253|567341949|FG000|Overall Study|Adverse Event|300|||
156920846|NCT00951665|566468047|FG002|Phase 2a|Withdrawal by Subject|0|||
156920847|NCT00951665|566468048|FG003|Phase 2a|Withdrawal by Subject|0|||
156920848|NCT00951665|566468049|FG004|Phase 2a|Withdrawal by Subject|2|||
156920849|NCT00951665|566468050|FG005|Phase 2a|Withdrawal by Subject|0|||
156920850|NCT00951665|566468045|FG000|Phase 2a|Disease Progression|0|||
156920851|NCT00951665|566468046|FG001|Phase 2a|Disease Progression|0|||
157163822|NCT01163253|567341950|FG001|Overall Study|Adverse Event|78|||
157163823|NCT01163253|567341949|FG000|Overall Study|Death|17|||
157163824|NCT01163253|567341950|FG001|Overall Study|Death|5|||
157163825|NCT01163253|567341949|FG000|Overall Study|Ongoing|13|||
157163826|NCT01163253|567341950|FG001|Overall Study|Ongoing|4|||
157163827|NCT01163253|567341949|FG000|Overall Study|Other Unspecified|170|||
157163828|NCT01163253|567341950|FG001|Overall Study|Other Unspecified|34|||
157163829|NCT01397552|567341951|FG000|Overall Study|Adverse Event|1|||
157163830|NCT01397552|567341952|FG001|Overall Study|Adverse Event|0|||
157163831|NCT01397552|567341951|FG000|Overall Study|Withdrawal by Subject|2|||
157163832|NCT01397552|567341952|FG001|Overall Study|Withdrawal by Subject|1|||
156920852|NCT00951665|566468047|FG002|Phase 2a|Disease Progression|0|||
157163833|NCT00423735|567341953|FG000|Overall Study|Ineligible / No protocol treatment|8|||
157163834|NCT00423735|567341954|FG001|Overall Study|Ineligible / No protocol treatment|6|||
157163835|NCT00423735|567341955|FG002|Overall Study|Ineligible / No protocol treatment|0|||
157163836|NCT00579501|567341961|FG000|Overall Study|Death|1|||
157163837|NCT00579501|567341961|FG000|Overall Study|End of neoadjuvant therapy|25|||
156920853|NCT00951665|566468048|FG003|Phase 2a|Disease Progression|0|||
156920854|NCT00951665|566468049|FG004|Phase 2a|Disease Progression|6|||
156920855|NCT00951665|566468050|FG005|Phase 2a|Disease Progression|5|||
156920856|NCT00224055|566468051|FG000|Overall Study|Adverse Event|9|||
156920857|NCT00224055|566468052|FG001|Overall Study|Adverse Event|3|||
156920858|NCT00224055|566468051|FG000|Overall Study|Lost to Follow-up|1|||
156920859|NCT00224055|566468052|FG001|Overall Study|Lost to Follow-up|2|||
156920860|NCT00224055|566468051|FG000|Overall Study|Protocol Violation|1|||
156920861|NCT00224055|566468052|FG001|Overall Study|Protocol Violation|1|||
156920862|NCT00224055|566468051|FG000|Overall Study|Inclusion Violation|3|||
156920863|NCT00224055|566468052|FG001|Overall Study|Inclusion Violation|6|||
156920864|NCT00224055|566468051|FG000|Overall Study|Withdrawal by Subject|0|||
156920865|NCT00224055|566468052|FG001|Overall Study|Withdrawal by Subject|2|||
156920866|NCT00224055|566468051|FG000|Overall Study|Other|1|||
156920867|NCT00224055|566468052|FG001|Overall Study|Other|0|||
156920868|NCT02068443|566468053|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156920869|NCT02068443|566468054|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
156920870|NCT02068443|566468055|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
156920871|NCT02068443|566468053|FG000|Overall Study|Voluntary Withdrawal|4|||
156920872|NCT02068443|566468054|FG001|Overall Study|Voluntary Withdrawal|0|||
156920873|NCT02068443|566468055|FG002|Overall Study|Voluntary Withdrawal|1|||
156920874|NCT02068443|566468053|FG000|Overall Study|Lack of Efficacy|2|||
156920875|NCT02068443|566468054|FG001|Overall Study|Lack of Efficacy|1|||
156920876|NCT02068443|566468055|FG002|Overall Study|Lack of Efficacy|0|||
156920877|NCT02068443|566468053|FG000|Overall Study|Other Reason Not Specified|1|||
156920878|NCT02068443|566468054|FG001|Overall Study|Other Reason Not Specified|0|||
156920879|NCT02068443|566468055|FG002|Overall Study|Other Reason Not Specified|0|||
156920880|NCT00127712|566468058|FG000|Overall Study|Adverse Event|3|||
156920881|NCT00127712|566468059|FG001|Overall Study|Adverse Event|0|||
156920882|NCT00127712|566468058|FG000|Overall Study|Lack of GI access to continue|2|||
156920883|NCT00127712|566468059|FG001|Overall Study|Lack of GI access to continue|0|||
156920884|NCT00407563|566468062|FG000|Overall Study|Patient continues on treatment|1|||
156920885|NCT02450903|566468063|FG000|Overall Study|Adverse Event|3|||
156920886|NCT02450903|566468063|FG000|Overall Study|Progressive disease|15|||
156920887|NCT02450903|566468063|FG000|Overall Study|Switched to commercial drug|1|||
156920888|NCT02450903|566468063|FG000|Overall Study|Subject/guardian decision|1|||
156920889|NCT05126901|566468064|FG000|Overall Study|Withdrawal by Subject|1|||
156920890|NCT05126901|566468065|FG001|Overall Study|Withdrawal by Subject|1|||
156920891|NCT05126901|566468066|FG002|Overall Study|Withdrawal by Subject|4|||
156920892|NCT05126901|566468064|FG000|Overall Study|Adverse Event|0|||
156920893|NCT05126901|566468065|FG001|Overall Study|Adverse Event|0|||
156920894|NCT05126901|566468066|FG002|Overall Study|Adverse Event|1|||
156920895|NCT05126901|566468064|FG000|Overall Study|Lost to Follow-up|0|||
156920896|NCT05126901|566468065|FG001|Overall Study|Lost to Follow-up|2|||
156920897|NCT05126901|566468066|FG002|Overall Study|Lost to Follow-up|0|||
156920898|NCT01320085|566468067|FG000|Overall Study|Disease Progression|26|||
156920899|NCT01320085|566468068|FG001|Overall Study|Disease Progression|93|||
156920900|NCT01320085|566468069|FG002|Overall Study|Disease Progression|17|||
156920901|NCT01320085|566468067|FG000|Overall Study|Adverse Event|12|||
156920902|NCT01320085|566468068|FG001|Overall Study|Adverse Event|20|||
156920903|NCT01320085|566468069|FG002|Overall Study|Adverse Event|5|||
156920904|NCT01320085|566468067|FG000|Overall Study|Withdrawal by Subject|2|||
156920905|NCT01320085|566468068|FG001|Overall Study|Withdrawal by Subject|4|||
156920906|NCT01320085|566468069|FG002|Overall Study|Withdrawal by Subject|1|||
156920907|NCT01320085|566468067|FG000|Overall Study|Protocol Deviation|1|||
156920908|NCT01320085|566468068|FG001|Overall Study|Protocol Deviation|0|||
156920909|NCT01320085|566468069|FG002|Overall Study|Protocol Deviation|1|||
156920910|NCT01320085|566468067|FG000|Overall Study|Administrative problems|0|||
156920911|NCT01320085|566468068|FG001|Overall Study|Administrative problems|0|||
156920912|NCT01320085|566468069|FG002|Overall Study|Administrative problems|1|||
156920913|NCT05040386|566468070|FG000|Overall Study|Withdrawal by Subject|1|||
156920914|NCT05040386|566468071|FG001|Overall Study|Withdrawal by Subject|0|||
156920915|NCT05040386|566468072|FG002|Overall Study|Withdrawal by Subject|1|||
156920916|NCT05040386|566468073|FG003|Overall Study|Withdrawal by Subject|0|||
156920917|NCT05040386|566468070|FG000|Overall Study|Lost to Follow-up|0|||
156920918|NCT05040386|566468071|FG001|Overall Study|Lost to Follow-up|0|||
156920919|NCT05040386|566468072|FG002|Overall Study|Lost to Follow-up|1|||
156920920|NCT05040386|566468073|FG003|Overall Study|Lost to Follow-up|0|||
156920921|NCT01702454|566468074|FG000|Overall Study|Consent withdrawal|0|||
156920922|NCT01702454|566468075|FG001|Overall Study|Consent withdrawal|1|||
156920923|NCT01702454|566468074|FG000|Overall Study|Migrated/moved from study area|0|||
156920924|NCT01702454|566468075|FG001|Overall Study|Migrated/moved from study area|1|||
156920925|NCT01702454|566468074|FG000|Overall Study|Lost to Follow-up|3|||
156920926|NCT01702454|566468075|FG001|Overall Study|Lost to Follow-up|6|||
156920927|NCT00715078|566468076|FG000|Overall Study|Death|29|||
156920928|NCT00715078|566468077|FG001|Overall Study|Death|36|||
156920929|NCT00715078|566468078|FG002|Overall Study|Death|36|||
156920930|NCT00715078|566468076|FG000|Overall Study|Withdrawal by Subject|1|||
156920931|NCT00715078|566468077|FG001|Overall Study|Withdrawal by Subject|0|||
156920932|NCT00715078|566468078|FG002|Overall Study|Withdrawal by Subject|1|||
156920933|NCT00715078|566468076|FG000|Overall Study|Unable to start due to disease prog.|0|||
156920934|NCT00715078|566468077|FG001|Overall Study|Unable to start due to disease prog.|0|||
156920935|NCT00715078|566468078|FG002|Overall Study|Unable to start due to disease prog.|1|||
157163838|NCT00579501|567341961|FG000|Overall Study|toxicity|1|||
157163839|NCT00579501|567341961|FG000|Overall Study|Secondary lesion|1|||
157163840|NCT00579501|567341961|FG000|Overall Study|Radiation therapy before surgery|1|||
157163841|NCT00190983|567341962|FG000|Overall Study|Inevaluable (never treated)|2|||
157163842|NCT02287402|567341963|FG000|Treatment Period|Adverse Event|17|||
157163843|NCT02287402|567341963|FG000|Treatment Period|Voluntary Withdrawal|10|||
157163844|NCT02287402|567341963|FG000|Follow-up|Lost to Follow-up|1|||
157163845|NCT02287402|567341963|FG000|Follow-up|Voluntary Withdrawal|2|||
157163846|NCT04247815|567341964|FG000|Overall Study|Adverse Event|1|||
157163847|NCT04247815|567341965|FG001|Overall Study|Adverse Event|0|||
157163848|NCT04247815|567341964|FG000|Overall Study|Withdrawal by Subject|1|||
157163849|NCT04247815|567341965|FG001|Overall Study|Withdrawal by Subject|0|||
157163850|NCT04247815|567341964|FG000|Overall Study|Protocol Violation|0|||
157163851|NCT04247815|567341965|FG001|Overall Study|Protocol Violation|1|||
157163852|NCT02394808|567341966|FG000|Period 1|Unsatisfactory lens fitting|0|||
157163853|NCT02394808|567341967|FG001|Period 1|Unsatisfactory lens fitting|1|||
157163854|NCT02394808|567341966|FG000|Period 2|Lost to Follow-up|1|||
157163855|NCT02394808|567341967|FG001|Period 2|Lost to Follow-up|0|||
157163856|NCT05025787|567341968|FG000|Overall Study|Lack of Efficacy|0|||
157163857|NCT05025787|567341969|FG001|Overall Study|Lack of Efficacy|1|||
157163858|NCT05025787|567341968|FG000|Overall Study|Adverse Event|2|||
157163859|NCT05025787|567341969|FG001|Overall Study|Adverse Event|4|||
157163860|NCT05025787|567341968|FG000|Overall Study|Non compliance|0|||
157163861|NCT05025787|567341969|FG001|Overall Study|Non compliance|1|||
157163862|NCT05025787|567341968|FG000|Overall Study|Protocol Violation|3|||
157163863|NCT05025787|567341969|FG001|Overall Study|Protocol Violation|1|||
157163864|NCT05025787|567341968|FG000|Overall Study|Stopping criteria met|1|||
157163865|NCT05025787|567341969|FG001|Overall Study|Stopping criteria met|1|||
157163866|NCT05025787|567341968|FG000|Overall Study|Withdrawal by Subject|3|||
157163867|NCT05025787|567341969|FG001|Overall Study|Withdrawal by Subject|1|||
157163868|NCT01019486|567341972|FG000|Overall Study|Withdrawal by Subject|1|||
157163869|NCT01019486|567341973|FG001|Overall Study|Withdrawal by Subject|1|||
157163870|NCT01019486|567341974|FG002|Overall Study|Withdrawal by Subject|1|||
157163871|NCT02493426|567341975|FG000|Overall Study|Withdrawal by Subject|0|||
157163872|NCT02493426|567341976|FG001|Overall Study|Withdrawal by Subject|1|||
157163873|NCT02951988|567341977|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
157163874|NCT02951988|567341978|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
157163875|NCT02951988|567341979|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
157163876|NCT02951988|567341980|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
157163877|NCT02951988|567341977|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
157163878|NCT02951988|567341978|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
157163879|NCT02951988|567341979|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
157163880|NCT02951988|567341980|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
157163881|NCT02951988|567341977|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
157163882|NCT02951988|567341978|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
157163883|NCT02951988|567341979|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
157163884|NCT02951988|567341980|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
157163885|NCT02951988|567341977|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
157163886|NCT02951988|567341978|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
157163887|NCT02951988|567341979|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
157163888|NCT02951988|567341980|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
157163889|NCT02951988|567341977|FG000|Open-Label Treatment Period|Protocol Violation|22|||
157163890|NCT02951988|567341978|FG001|Open-Label Treatment Period|Protocol Violation|0|||
157163891|NCT02951988|567341979|FG002|Open-Label Treatment Period|Protocol Violation|0|||
157163892|NCT02951988|567341980|FG003|Open-Label Treatment Period|Protocol Violation|0|||
157163893|NCT02951988|567341977|FG000|Open-Label Treatment Period|Pregnancy|2|||
157163894|NCT02951988|567341978|FG001|Open-Label Treatment Period|Pregnancy|0|||
157163895|NCT02951988|567341979|FG002|Open-Label Treatment Period|Pregnancy|0|||
157163896|NCT02951988|567341980|FG003|Open-Label Treatment Period|Pregnancy|0|||
157163897|NCT02951988|567341977|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
157163898|NCT02951988|567341978|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
157163899|NCT02951988|567341979|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
157163900|NCT02951988|567341980|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
157163901|NCT02951988|567341977|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
157163902|NCT02951988|567341978|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
156920936|NCT01500629|566468079|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
156920937|NCT01500629|566468080|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
157163903|NCT02951988|567341979|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
157163904|NCT02951988|567341980|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
157163905|NCT02951988|567341977|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
157163906|NCT02951988|567341978|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
157163907|NCT02951988|567341979|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
157163908|NCT02951988|567341980|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
157163909|NCT02951988|567341977|FG000|Open-Label Treatment Period|Adverse Event|45|||
157163910|NCT02951988|567341978|FG001|Open-Label Treatment Period|Adverse Event|0|||
157163911|NCT02951988|567341979|FG002|Open-Label Treatment Period|Adverse Event|0|||
157163912|NCT02951988|567341980|FG003|Open-Label Treatment Period|Adverse Event|0|||
157163913|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
157163914|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
157163915|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
157163916|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
157163917|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
157163918|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
157163919|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
157163920|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
157163921|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
157163922|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
157163923|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
156920938|NCT03998189|566468081|FG000|Overall Study|Lack of Efficacy|0|||
156920939|NCT03998189|566468082|FG001|Overall Study|Lack of Efficacy|1|||
156920940|NCT03454893|566468087|FG000|Overall Study|Study Terminated by the Sponsor|5|||
156920941|NCT03454893|566468087|FG000|Overall Study|Did not pass screening|4|||
156920942|NCT01986985|566468088|FG000|Overall Study|Withdrawal by Subject|4|||
156920943|NCT01986985|566468088|FG000|Overall Study|Scan not completed due to malfunction|3|||
156920944|NCT00558025|566468089|FG000|Overall Study|Adverse Event|1|||
156920945|NCT00558025|566468090|FG001|Overall Study|Adverse Event|1|||
156920946|NCT00558025|566468089|FG000|Overall Study|Withdrawal by Subject|2|||
156920947|NCT00558025|566468090|FG001|Overall Study|Withdrawal by Subject|2|||
156920948|NCT00558025|566468089|FG000|Overall Study|Protocol Violation|1|||
156920949|NCT00558025|566468090|FG001|Overall Study|Protocol Violation|0|||
156920950|NCT02288559|566468091|FG000|Overall Study|Adverse Event|1|||
156920951|NCT02288559|566468092|FG001|Overall Study|Adverse Event|1|||
156920952|NCT02288559|566468093|FG002|Overall Study|Adverse Event|5|||
156920953|NCT02288559|566468094|FG003|Overall Study|Adverse Event|0|||
156920954|NCT02288559|566468091|FG000|Overall Study|Death|0|||
156920955|NCT02288559|566468092|FG001|Overall Study|Death|0|||
156920956|NCT02288559|566468093|FG002|Overall Study|Death|1|||
156920957|NCT02288559|566468094|FG003|Overall Study|Death|0|||
156920958|NCT02288559|566468091|FG000|Overall Study|Lost to Follow-up|0|||
156920959|NCT02288559|566468092|FG001|Overall Study|Lost to Follow-up|0|||
156920960|NCT02288559|566468093|FG002|Overall Study|Lost to Follow-up|0|||
156920961|NCT02288559|566468094|FG003|Overall Study|Lost to Follow-up|1|||
156920962|NCT02288559|566468091|FG000|Overall Study|Withdrawal by Subject|0|||
156920963|NCT02288559|566468092|FG001|Overall Study|Withdrawal by Subject|0|||
156920964|NCT02288559|566468093|FG002|Overall Study|Withdrawal by Subject|2|||
156920965|NCT02288559|566468094|FG003|Overall Study|Withdrawal by Subject|1|||
156920966|NCT02288559|566468091|FG000|Overall Study|Reason Not Specified|0|||
156920967|NCT02288559|566468092|FG001|Overall Study|Reason Not Specified|0|||
156920968|NCT02288559|566468093|FG002|Overall Study|Reason Not Specified|3|||
156920969|NCT02288559|566468094|FG003|Overall Study|Reason Not Specified|0|||
156920970|NCT02393547|566468109|FG000|Overall Study|Adverse Event|2|||
156920971|NCT02393547|566468109|FG000|Overall Study|Withdrawal by Subject|3|||
156920972|NCT02393547|566468109|FG000|Overall Study|Lost to Follow-up|1|||
156920973|NCT01907815|566468110|FG000|Overall Study|Withdrawal by Subject|1|||
156920974|NCT01907815|566468111|FG001|Overall Study|Withdrawal by Subject|0|||
156920975|NCT00514540|566468112|FG000|First-Line Chemo|Withdrawal by Subject|1|||
156920976|NCT00514540|566468112|FG000|First-Line Chemo|Protocol Violation|7|||
156920977|NCT00514540|566468112|FG000|Second-Line|Physician/Patient Decision|31|||
156920978|NCT05185089|566468117|FG000|First Intervention (4 weeks)|Adverse Event|0|||
156920979|NCT05185089|566468118|FG001|First Intervention (4 weeks)|Adverse Event|0|||
156920980|NCT05185089|566468119|FG002|First Intervention (4 weeks)|Adverse Event|0|||
157163924|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
157163925|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
157163926|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
157163927|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
157163928|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
157163929|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Pregnancy|0|||
156920981|NCT05185089|566468120|FG003|First Intervention (4 weeks)|Adverse Event|1|||
156920982|NCT05185089|566468117|FG000|Second Intervention (4 weeks)|Death|0|||
156920983|NCT05185089|566468118|FG001|Second Intervention (4 weeks)|Death|1|||
156920984|NCT05185089|566468119|FG002|Second Intervention (4 weeks)|Death|0|||
156920985|NCT05185089|566468120|FG003|Second Intervention (4 weeks)|Death|0|||
156920986|NCT05185089|566468117|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
156920987|NCT05185089|566468118|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
156920988|NCT05185089|566468119|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
156920989|NCT05185089|566468120|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
156920990|NCT04997161|566468133|FG000|Overall Study|Study terminated by sponsor|3|||
156920991|NCT00752232|566468134|FG000|Overall Study|Protocol Violation|0|||
156920992|NCT00752232|566468135|FG001|Overall Study|Protocol Violation|0|||
156920993|NCT00752232|566468136|FG002|Overall Study|Protocol Violation|0|||
156920994|NCT00752232|566468137|FG003|Overall Study|Protocol Violation|0|||
156920995|NCT00752232|566468138|FG004|Overall Study|Protocol Violation|0|||
156920996|NCT00752232|566468139|FG005|Overall Study|Protocol Violation|1|||
156920997|NCT00752232|566468140|FG006|Overall Study|Protocol Violation|0|||
156920998|NCT00752232|566468134|FG000|Overall Study|Caregiver request|2|||
156920999|NCT00752232|566468135|FG001|Overall Study|Caregiver request|0|||
156921000|NCT00752232|566468136|FG002|Overall Study|Caregiver request|0|||
156921001|NCT00752232|566468137|FG003|Overall Study|Caregiver request|0|||
156921002|NCT00752232|566468138|FG004|Overall Study|Caregiver request|1|||
156921003|NCT00752232|566468139|FG005|Overall Study|Caregiver request|0|||
156921004|NCT00752232|566468140|FG006|Overall Study|Caregiver request|0|||
156921005|NCT00752232|566468134|FG000|Overall Study|Investigator request|0|||
156921006|NCT00752232|566468135|FG001|Overall Study|Investigator request|0|||
156921007|NCT00752232|566468136|FG002|Overall Study|Investigator request|0|||
156921008|NCT00752232|566468137|FG003|Overall Study|Investigator request|0|||
156921009|NCT00752232|566468138|FG004|Overall Study|Investigator request|1|||
156921010|NCT00752232|566468139|FG005|Overall Study|Investigator request|0|||
156921011|NCT00752232|566468140|FG006|Overall Study|Investigator request|0|||
156921012|NCT00752232|566468134|FG000|Overall Study|Subject request|0|||
156921013|NCT00752232|566468135|FG001|Overall Study|Subject request|0|||
156921014|NCT00752232|566468136|FG002|Overall Study|Subject request|1|||
156921015|NCT00752232|566468137|FG003|Overall Study|Subject request|0|||
156921016|NCT00752232|566468138|FG004|Overall Study|Subject request|0|||
156921017|NCT00752232|566468139|FG005|Overall Study|Subject request|0|||
156921018|NCT00752232|566468140|FG006|Overall Study|Subject request|0|||
156921019|NCT00752232|566468134|FG000|Overall Study|Group home admission|0|||
156921020|NCT00752232|566468135|FG001|Overall Study|Group home admission|0|||
156921021|NCT00752232|566468136|FG002|Overall Study|Group home admission|0|||
156921022|NCT00752232|566468137|FG003|Overall Study|Group home admission|1|||
156921023|NCT00752232|566468138|FG004|Overall Study|Group home admission|0|||
156921024|NCT00752232|566468139|FG005|Overall Study|Group home admission|0|||
156921025|NCT00752232|566468140|FG006|Overall Study|Group home admission|0|||
156921026|NCT00752232|566468134|FG000|Overall Study|Caregiver could not attend the subject|0|||
156921027|NCT00752232|566468135|FG001|Overall Study|Caregiver could not attend the subject|0|||
156921028|NCT00752232|566468136|FG002|Overall Study|Caregiver could not attend the subject|0|||
156921029|NCT00752232|566468137|FG003|Overall Study|Caregiver could not attend the subject|0|||
156921030|NCT00752232|566468138|FG004|Overall Study|Caregiver could not attend the subject|1|||
156921031|NCT00752232|566468139|FG005|Overall Study|Caregiver could not attend the subject|0|||
156921032|NCT00752232|566468140|FG006|Overall Study|Caregiver could not attend the subject|0|||
156921033|NCT02730455|566468141|FG000|Overall Study|Death|5|||
156921034|NCT02730455|566468142|FG001|Overall Study|Death|6|||
156921035|NCT02730455|566468143|FG002|Overall Study|Death|4|||
156921036|NCT02730455|566468141|FG000|Overall Study|Consent withdrawn|2|||
156921037|NCT02730455|566468142|FG001|Overall Study|Consent withdrawn|4|||
156921038|NCT02730455|566468143|FG002|Overall Study|Consent withdrawn|1|||
156921039|NCT02730455|566468141|FG000|Overall Study|Lost to Follow-up|3|||
156921040|NCT02730455|566468142|FG001|Overall Study|Lost to Follow-up|1|||
156921041|NCT02730455|566468143|FG002|Overall Study|Lost to Follow-up|4|||
156921042|NCT02730455|566468141|FG000|Overall Study|Other|1|||
156921043|NCT02730455|566468142|FG001|Overall Study|Other|1|||
156921044|NCT02730455|566468143|FG002|Overall Study|Other|2|||
156921045|NCT02730455|566468141|FG000|Overall Study|Other|2|||
156921046|NCT02730455|566468142|FG001|Overall Study|Other|2|||
156921047|NCT02730455|566468143|FG002|Overall Study|Other|0|||
157163930|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Pregnancy|1|||
157163931|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Pregnancy|1|||
157163932|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Pregnancy|0|||
156921048|NCT02733367|566468144|FG000|Overall Study|Withdrawal by Subject|6|||
156921049|NCT01348347|566468145|FG000|Overall Study|Withdrawal by Subject|1|||
156921050|NCT01348347|566468146|FG001|Overall Study|Withdrawal by Subject|1|||
156921051|NCT01348347|566468147|FG002|Overall Study|Withdrawal by Subject|1|||
157163933|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156921052|NCT01348347|566468145|FG000|Overall Study|Progressive disease|2|||
156921053|NCT01348347|566468146|FG001|Overall Study|Progressive disease|5|||
156921054|NCT01348347|566468147|FG002|Overall Study|Progressive disease|5|||
156921055|NCT01922089|566468153|FG000|Overall Study|Adverse Event|18|||
156921056|NCT01922089|566468154|FG001|Overall Study|Adverse Event|13|||
156921057|NCT01922089|566468153|FG000|Overall Study|Protocol Deviation|10|||
156921058|NCT01922089|566468154|FG001|Overall Study|Protocol Deviation|7|||
156921059|NCT01922089|566468153|FG000|Overall Study|Withdrawal by Subject|3|||
156921060|NCT01922089|566468154|FG001|Overall Study|Withdrawal by Subject|4|||
156921061|NCT01922089|566468153|FG000|Overall Study|administrative problems|4|||
156921062|NCT01922089|566468154|FG001|Overall Study|administrative problems|1|||
156921063|NCT01922089|566468153|FG000|Overall Study|Physician Decision|2|||
156921064|NCT01922089|566468154|FG001|Overall Study|Physician Decision|3|||
156921065|NCT01922089|566468153|FG000|Overall Study|Death|2|||
156921066|NCT01922089|566468154|FG001|Overall Study|Death|1|||
156921067|NCT01922089|566468153|FG000|Overall Study|Lost to Follow-up|0|||
156921068|NCT01922089|566468154|FG001|Overall Study|Lost to Follow-up|1|||
156921069|NCT01324999|566468156|FG000|Overall Study|Adverse Event|3|||
156921070|NCT01324999|566468156|FG000|Overall Study|Withdrawal by Subject|2|||
156921071|NCT03681405|566468157|FG000|Overall Study|Found to be ineligible after randomized|1|||
156921072|NCT03681405|566468158|FG001|Overall Study|Found to be ineligible after randomized|0|||
156921073|NCT03228537|566468164|FG000|Neoadjuvant|Adverse Event|2|||
156921074|NCT03228537|566468164|FG000|Neoadjuvant|Progression/Relapse|4|||
156921075|NCT03228537|566468164|FG000|Neoadjuvant|Death|1|||
156921076|NCT03228537|566468164|FG000|Surgery|Death|1|||
156921077|NCT03228537|566468164|FG000|Surgery|Other - Not Protocol Specified|2|||
156921078|NCT03228537|566468164|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
156921079|NCT03228537|566468164|FG000|Maintenance|Progression/Relapse|10|||
156921080|NCT01927367|566468165|FG000|Overall Study|Withdrawal by Subject|7|||
156921081|NCT01927367|566468166|FG001|Overall Study|Withdrawal by Subject|4|||
156921082|NCT01927367|566468165|FG000|Overall Study|No baseline data|0|||
156921083|NCT01927367|566468166|FG001|Overall Study|No baseline data|1|||
156921084|NCT01648205|566468167|FG000|Placebo|Pregnancy|1|||
156921085|NCT01648205|566468167|FG000|Placebo|Withdrawal by Subject|1|||
156921086|NCT01648205|566468167|FG000|Placebo|Protocol Violation|2|||
156921087|NCT01648205|566468167|FG000|Ranolazine|Death|1|||
156921088|NCT01648205|566468167|FG000|Ranolazine|Withdrawal by Subject|1|||
156921089|NCT01648205|566468167|FG000|Ranolazine|Protocol Violation|3|||
156921090|NCT01958008|566468169|FG000|Overall Study|Worsening of disease under study|0|||
156921091|NCT01958008|566468170|FG001|Overall Study|Worsening of disease under study|0|||
156921092|NCT01958008|566468171|FG002|Overall Study|Worsening of disease under study|1|||
156921093|NCT01958008|566468172|FG003|Overall Study|Worsening of disease under study|0|||
156921094|NCT01958008|566468169|FG000|Overall Study|Other adverse event|1|||
156921095|NCT01958008|566468170|FG001|Overall Study|Other adverse event|0|||
156921096|NCT01958008|566468171|FG002|Overall Study|Other adverse event|0|||
156921097|NCT01958008|566468172|FG003|Overall Study|Other adverse event|0|||
156921098|NCT01414855|566468173|FG000|Overall Study|Death|17|||
156921099|NCT01414855|566468173|FG000|Overall Study|Lost to Follow-up|5|||
156921100|NCT01414855|566468173|FG000|Overall Study|Withdrawal by Subject|7|||
156921101|NCT02743871|566468174|FG000|Overall Study|Lost to Follow-up|0|||
156921102|NCT02743871|566468175|FG001|Overall Study|Lost to Follow-up|0|||
156921103|NCT02743871|566468176|FG002|Overall Study|Lost to Follow-up|0|||
156921104|NCT02743871|566468177|FG003|Overall Study|Lost to Follow-up|1|||
156921105|NCT02743871|566468178|FG004|Overall Study|Lost to Follow-up|0|||
156921106|NCT02743871|566468179|FG005|Overall Study|Lost to Follow-up|0|||
156921107|NCT02743871|566468180|FG006|Overall Study|Lost to Follow-up|1|||
156921108|NCT02743871|566468181|FG007|Overall Study|Lost to Follow-up|0|||
156921109|NCT02743871|566468182|FG008|Overall Study|Lost to Follow-up|0|||
156921110|NCT02743871|566468183|FG009|Overall Study|Lost to Follow-up|0|||
156921111|NCT02743871|566468184|FG010|Overall Study|Lost to Follow-up|0|||
156921112|NCT02743871|566468185|FG011|Overall Study|Lost to Follow-up|2|||
156921113|NCT02743871|566468186|FG012|Overall Study|Lost to Follow-up|0|||
156921114|NCT02743871|566468187|FG013|Overall Study|Lost to Follow-up|0|||
156921115|NCT02743871|566468174|FG000|Overall Study|Withdrawal by Subject|0|||
156921116|NCT02743871|566468175|FG001|Overall Study|Withdrawal by Subject|0|||
156921117|NCT02743871|566468176|FG002|Overall Study|Withdrawal by Subject|0|||
156921118|NCT02743871|566468177|FG003|Overall Study|Withdrawal by Subject|0|||
156921119|NCT02743871|566468178|FG004|Overall Study|Withdrawal by Subject|0|||
156921120|NCT02743871|566468179|FG005|Overall Study|Withdrawal by Subject|0|||
156921121|NCT02743871|566468180|FG006|Overall Study|Withdrawal by Subject|0|||
156921122|NCT02743871|566468181|FG007|Overall Study|Withdrawal by Subject|0|||
156921123|NCT02743871|566468182|FG008|Overall Study|Withdrawal by Subject|0|||
156921124|NCT02743871|566468183|FG009|Overall Study|Withdrawal by Subject|0|||
156921125|NCT02743871|566468184|FG010|Overall Study|Withdrawal by Subject|1|||
156921126|NCT02743871|566468185|FG011|Overall Study|Withdrawal by Subject|0|||
156921127|NCT02743871|566468186|FG012|Overall Study|Withdrawal by Subject|12|||
157028536|NCT05293171|566860652|FG007|Washout 5 to 7 Days|Adverse Event|0|||
156921128|NCT02743871|566468187|FG013|Overall Study|Withdrawal by Subject|6|||
156921129|NCT02743871|566468174|FG000|Overall Study|Adverse Event|1|||
156921130|NCT02743871|566468175|FG001|Overall Study|Adverse Event|0|||
156921131|NCT02743871|566468176|FG002|Overall Study|Adverse Event|0|||
157028537|NCT05293171|566860653|FG008|Washout 5 to 7 Days|Adverse Event|0|||
156921132|NCT02743871|566468177|FG003|Overall Study|Adverse Event|0|||
156921133|NCT02743871|566468178|FG004|Overall Study|Adverse Event|0|||
156921134|NCT02743871|566468179|FG005|Overall Study|Adverse Event|0|||
156921135|NCT02743871|566468180|FG006|Overall Study|Adverse Event|0|||
156921136|NCT02743871|566468181|FG007|Overall Study|Adverse Event|0|||
157163934|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
157163935|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
157163936|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
157163937|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157163938|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
157163939|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
157163940|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
157163941|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157163942|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Adverse Event|8|||
157163943|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Adverse Event|3|||
157163944|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Adverse Event|6|||
157163945|NCT02951988|567341977|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
157163946|NCT02951988|567341978|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
157163947|NCT02951988|567341979|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
157163948|NCT02951988|567341980|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
157163949|NCT00516269|567341981|FG000|Overall Study|Adverse Event|2|||
157163950|NCT00516269|567341982|FG001|Overall Study|Adverse Event|1|||
157163951|NCT00516269|567341981|FG000|Overall Study|Lost to Follow-up|0|||
157163952|NCT00516269|567341982|FG001|Overall Study|Lost to Follow-up|1|||
157163953|NCT00516269|567341981|FG000|Overall Study|Protocol Violation|0|||
157163954|NCT00516269|567341982|FG001|Overall Study|Protocol Violation|1|||
157163955|NCT04570657|567341984|FG000|Overall Study|Adverse Event|0|||
157163956|NCT04570657|567341985|FG001|Overall Study|Adverse Event|0|||
157163957|NCT04570657|567341986|FG002|Overall Study|Adverse Event|1|||
157163958|NCT04570657|567341984|FG000|Overall Study|Lost to Follow-up|0|||
157163959|NCT04570657|567341985|FG001|Overall Study|Lost to Follow-up|0|||
157163960|NCT04570657|567341986|FG002|Overall Study|Lost to Follow-up|1|||
157163961|NCT04570657|567341984|FG000|Overall Study|Physician Decision|0|||
157163962|NCT04570657|567341985|FG001|Overall Study|Physician Decision|1|||
157163963|NCT04570657|567341986|FG002|Overall Study|Physician Decision|0|||
157163964|NCT04570657|567341984|FG000|Overall Study|Withdrawal by Subject|1|||
157163965|NCT04570657|567341985|FG001|Overall Study|Withdrawal by Subject|2|||
157163966|NCT04570657|567341986|FG002|Overall Study|Withdrawal by Subject|2|||
157163967|NCT01079962|567341987|FG000|Overall Study|Adverse Event|2|||
157163968|NCT01079962|567341988|FG001|Overall Study|Adverse Event|2|||
157163969|NCT01079962|567341987|FG000|Overall Study|Withdrawal by Subject|5|||
157163970|NCT01079962|567341988|FG001|Overall Study|Withdrawal by Subject|7|||
157163971|NCT01079962|567341987|FG000|Overall Study|Protocol Violation|2|||
157163972|NCT01079962|567341988|FG001|Overall Study|Protocol Violation|2|||
157163973|NCT01079962|567341987|FG000|Overall Study|No blood pressure (BP) control|3|||
157163974|NCT01079962|567341988|FG001|Overall Study|No blood pressure (BP) control|0|||
157163975|NCT01079962|567341987|FG000|Overall Study|Inclusion/exclusion criteria|1|||
157163976|NCT01079962|567341988|FG001|Overall Study|Inclusion/exclusion criteria|3|||
156921137|NCT02743871|566468182|FG008|Overall Study|Adverse Event|0|||
156921138|NCT02743871|566468183|FG009|Overall Study|Adverse Event|0|||
156921139|NCT02743871|566468184|FG010|Overall Study|Adverse Event|0|||
156921140|NCT02743871|566468185|FG011|Overall Study|Adverse Event|0|||
156921141|NCT02743871|566468186|FG012|Overall Study|Adverse Event|0|||
156921142|NCT02743871|566468187|FG013|Overall Study|Adverse Event|0|||
156921143|NCT02743871|566468174|FG000|Overall Study|Other|0|||
156921144|NCT02743871|566468175|FG001|Overall Study|Other|0|||
156921145|NCT02743871|566468176|FG002|Overall Study|Other|0|||
156921146|NCT02743871|566468177|FG003|Overall Study|Other|0|||
156921147|NCT02743871|566468178|FG004|Overall Study|Other|0|||
156921148|NCT02743871|566468179|FG005|Overall Study|Other|0|||
156921149|NCT02743871|566468180|FG006|Overall Study|Other|0|||
156921150|NCT02743871|566468181|FG007|Overall Study|Other|0|||
156921151|NCT02743871|566468182|FG008|Overall Study|Other|0|||
156921152|NCT02743871|566468183|FG009|Overall Study|Other|0|||
156921153|NCT02743871|566468184|FG010|Overall Study|Other|0|||
156921154|NCT02743871|566468185|FG011|Overall Study|Other|1|||
156921155|NCT02743871|566468186|FG012|Overall Study|Other|1|||
156921156|NCT02743871|566468187|FG013|Overall Study|Other|1|||
156921157|NCT02743871|566468174|FG000|Overall Study|Protocol Violation|0|||
156921158|NCT02743871|566468175|FG001|Overall Study|Protocol Violation|0|||
156921159|NCT02743871|566468176|FG002|Overall Study|Protocol Violation|0|||
156921160|NCT02743871|566468177|FG003|Overall Study|Protocol Violation|0|||
156921161|NCT02743871|566468178|FG004|Overall Study|Protocol Violation|0|||
156921162|NCT02743871|566468179|FG005|Overall Study|Protocol Violation|0|||
156921163|NCT02743871|566468180|FG006|Overall Study|Protocol Violation|0|||
156921164|NCT02743871|566468181|FG007|Overall Study|Protocol Violation|0|||
156921165|NCT02743871|566468182|FG008|Overall Study|Protocol Violation|0|||
156921166|NCT02743871|566468183|FG009|Overall Study|Protocol Violation|0|||
156921167|NCT02743871|566468184|FG010|Overall Study|Protocol Violation|0|||
156921168|NCT02743871|566468185|FG011|Overall Study|Protocol Violation|0|||
157163977|NCT01079962|567341987|FG000|Overall Study|Participant not returning for next visit|1|||
157163978|NCT01079962|567341988|FG001|Overall Study|Participant not returning for next visit|0|||
157163979|NCT01079962|567341987|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
156921169|NCT02743871|566468186|FG012|Overall Study|Protocol Violation|2|||
156921170|NCT02743871|566468187|FG013|Overall Study|Protocol Violation|0|||
156921171|NCT01937559|566468190|FG000|Overall Study|Physician Decision|3|||
156921172|NCT01937559|566468191|FG001|Overall Study|Physician Decision|3|||
156921173|NCT01937559|566468192|FG002|Overall Study|Physician Decision|0|||
156921174|NCT01937559|566468190|FG000|Overall Study|Withdrawal by Subject|6|||
156921175|NCT01937559|566468191|FG001|Overall Study|Withdrawal by Subject|4|||
156921176|NCT01937559|566468192|FG002|Overall Study|Withdrawal by Subject|0|||
156921177|NCT01937559|566468190|FG000|Overall Study|screen fail|2|||
156921178|NCT01937559|566468191|FG001|Overall Study|screen fail|4|||
156921179|NCT01937559|566468192|FG002|Overall Study|screen fail|0|||
156921180|NCT04818840|566468193|FG000|Overall Study|Lost to Follow-up|0|||
156921181|NCT04818840|566468194|FG001|Overall Study|Lost to Follow-up|5|||
156921182|NCT04818840|566468193|FG000|Overall Study|Physician Decision|1|||
156921183|NCT04818840|566468194|FG001|Overall Study|Physician Decision|0|||
156921184|NCT04818840|566468193|FG000|Overall Study|Site Terminated by Sponsor|0|||
156921185|NCT04818840|566468194|FG001|Overall Study|Site Terminated by Sponsor|3|||
156921186|NCT04818840|566468193|FG000|Overall Study|Study Terminated by Sponsor|43|||
156921187|NCT04818840|566468194|FG001|Overall Study|Study Terminated by Sponsor|7|||
156921188|NCT04818840|566468193|FG000|Overall Study|Withdrawal by Subject|0|||
156921189|NCT04818840|566468194|FG001|Overall Study|Withdrawal by Subject|1|||
156921190|NCT03653637|566469981|FG000|Overall Study|Death|1|||
156921191|NCT03653637|566469982|FG001|Overall Study|Death|3|||
156921192|NCT03653637|566469981|FG000|Overall Study|Lost to Follow-up|29|||
156921193|NCT03653637|566469982|FG001|Overall Study|Lost to Follow-up|30|||
156921194|NCT03653637|566469981|FG000|Overall Study|Physician Decision|1|||
156921195|NCT03653637|566469982|FG001|Overall Study|Physician Decision|1|||
156921196|NCT03653637|566469981|FG000|Overall Study|Withdrawal by Subject|7|||
156921197|NCT03653637|566469982|FG001|Overall Study|Withdrawal by Subject|4|||
156921198|NCT04779489|566469985|FG000|Overall Study|Physician Decision|1|||
156921199|NCT00157950|566469988|FG000|Overall Study|Death|1|||
156921200|NCT00157950|566469989|FG001|Overall Study|Death|0|||
156921201|NCT02282020|566469990|FG000|Overall Study|Objective Disease Progression|128|||
156921202|NCT02282020|566469991|FG001|Overall Study|Objective Disease Progression|30|||
156921203|NCT02282020|566469990|FG000|Overall Study|Adverse Event|18|||
156921204|NCT02282020|566469991|FG001|Overall Study|Adverse Event|15|||
156921205|NCT02282020|566469990|FG000|Overall Study|Withdrawal by Subject|7|||
156921206|NCT02282020|566469991|FG001|Overall Study|Withdrawal by Subject|10|||
156921207|NCT02282020|566469990|FG000|Overall Study|Miscellaneous|5|||
156921208|NCT02282020|566469991|FG001|Overall Study|Miscellaneous|19|||
156921209|NCT02282020|566469990|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
156921210|NCT02282020|566469991|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
156921211|NCT02282020|566469990|FG000|Overall Study|Developed Discontinuation Criteria|0|||
156921212|NCT02282020|566469991|FG001|Overall Study|Developed Discontinuation Criteria|2|||
156921213|NCT02282020|566469990|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
156921214|NCT02282020|566469991|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
156921215|NCT00249444|566469992|FG000|Overall Study|Lost to Follow-up|2|||
156921216|NCT00249444|566469993|FG001|Overall Study|Lost to Follow-up|2|||
156921217|NCT00249444|566469992|FG000|Overall Study|non-compliant|9|||
156921218|NCT00249444|566469993|FG001|Overall Study|non-compliant|11|||
156921219|NCT00249444|566469992|FG000|Overall Study|Adverse Event|1|||
156921220|NCT00249444|566469993|FG001|Overall Study|Adverse Event|1|||
156921221|NCT00249444|566469992|FG000|Overall Study|life event|0|||
156921222|NCT00249444|566469993|FG001|Overall Study|life event|1|||
156921223|NCT01499667|566469994|FG000|Overall Study|administrative problems|4|||
156921224|NCT01499667|566469995|FG001|Overall Study|administrative problems|5|||
156921225|NCT01499667|566469996|FG002|Overall Study|administrative problems|5|||
156921226|NCT01499667|566469994|FG000|Overall Study|Protocol Violation|1|||
156921227|NCT01499667|566469995|FG001|Overall Study|Protocol Violation|3|||
156921228|NCT01499667|566469996|FG002|Overall Study|Protocol Violation|2|||
156921229|NCT01499667|566469994|FG000|Overall Study|Adverse Event|0|||
157163980|NCT01079962|567341988|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
156921230|NCT01499667|566469995|FG001|Overall Study|Adverse Event|2|||
156921231|NCT01499667|566469996|FG002|Overall Study|Adverse Event|2|||
157163981|NCT01331239|567341989|FG000|Part II: Core Study|Adverse Event|0|||
156921232|NCT01499667|566469994|FG000|Overall Study|Withdrawal by Subject|2|||
156921233|NCT01499667|566469995|FG001|Overall Study|Withdrawal by Subject|1|||
156921234|NCT01499667|566469996|FG002|Overall Study|Withdrawal by Subject|1|||
156921235|NCT01499667|566469994|FG000|Overall Study|Lack of Efficacy|2|||
156921236|NCT01499667|566469995|FG001|Overall Study|Lack of Efficacy|0|||
156921237|NCT01499667|566469996|FG002|Overall Study|Lack of Efficacy|0|||
156921238|NCT00759863|566469997|FG000|Overall Study|Death, moved, or lost contact|20|||
156921239|NCT00759863|566469998|FG001|Overall Study|Death, moved, or lost contact|18|||
156921240|NCT00531050|566469999|FG000|Part 1: Period 1|Adverse Event|0|||
156921241|NCT00531050|566470000|FG001|Part 1: Period 1|Adverse Event|1|||
156921242|NCT00531050|566470001|FG002|Part 1: Period 1|Adverse Event|0|||
156921243|NCT00531050|566470002|FG003|Part 1: Period 1|Adverse Event|0|||
156921244|NCT00531050|566470003|FG004|Part 1: Period 1|Adverse Event|0|||
156921245|NCT00531050|566470004|FG005|Part 1: Period 1|Adverse Event|0|||
157226698|NCT01781286|567575901|FG000|Overall Study|Lost to Follow-up|0|||
157226699|NCT01781286|567575902|FG001|Overall Study|Lost to Follow-up|0|||
157226700|NCT01781286|567575903|FG002|Overall Study|Lost to Follow-up|0|||
157226701|NCT01781286|567575904|FG003|Overall Study|Lost to Follow-up|0|||
157226702|NCT01781286|567575905|FG004|Overall Study|Lost to Follow-up|0|||
157226703|NCT01781286|567575906|FG005|Overall Study|Lost to Follow-up|1|||
157226704|NCT01781286|567575901|FG000|Overall Study|Time Constraints|2|||
157226705|NCT01781286|567575902|FG001|Overall Study|Time Constraints|0|||
157226706|NCT01781286|567575903|FG002|Overall Study|Time Constraints|2|||
157226707|NCT01781286|567575904|FG003|Overall Study|Time Constraints|0|||
157226708|NCT01781286|567575905|FG004|Overall Study|Time Constraints|0|||
157226709|NCT01781286|567575906|FG005|Overall Study|Time Constraints|0|||
157226710|NCT01781286|567575901|FG000|Overall Study|Noncompliance|0|||
157226711|NCT01781286|567575902|FG001|Overall Study|Noncompliance|0|||
157226712|NCT01781286|567575903|FG002|Overall Study|Noncompliance|0|||
157226713|NCT01781286|567575904|FG003|Overall Study|Noncompliance|1|||
157226714|NCT01781286|567575905|FG004|Overall Study|Noncompliance|0|||
157226715|NCT01781286|567575906|FG005|Overall Study|Noncompliance|0|||
157226716|NCT00995410|567575907|FG000|Overall Study|Adverse Event|51|||
157226717|NCT00995410|567575907|FG000|Overall Study|Withdrawal by Subject|7|||
157226718|NCT00995410|567575907|FG000|Overall Study|Lost to Follow-up|2|||
157226719|NCT00995410|567575907|FG000|Overall Study|Misc|28|||
157226720|NCT02166697|567575908|FG000|Overall Study|Protocol Violation|347|||
157226721|NCT02684578|567575909|FG000|Overall Study|Withdrawal by Subject|10|||
157226722|NCT02684578|567575910|FG001|Overall Study|Withdrawal by Subject|7|||
157226723|NCT02684578|567575909|FG000|Overall Study|Lost to Follow-up|0|||
157226724|NCT02684578|567575910|FG001|Overall Study|Lost to Follow-up|3|||
157226725|NCT02684578|567575909|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
157226726|NCT02684578|567575910|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
157226727|NCT02684578|567575909|FG000|Overall Study|Missing follow-up data|0|||
157226728|NCT02684578|567575910|FG001|Overall Study|Missing follow-up data|1|||
157226729|NCT03267264|567575913|FG000|Overall Study|Withdrawal by Subject|1|||
157226730|NCT03267264|567575914|FG001|Overall Study|Withdrawal by Subject|0|||
157226731|NCT03267264|567575915|FG002|Overall Study|Withdrawal by Subject|2|||
157226732|NCT03267264|567575916|FG003|Overall Study|Withdrawal by Subject|4|||
157226733|NCT02224391|567575917|FG000|Overall Study|Lost to Follow-up|26|||
157226734|NCT02224391|567575918|FG001|Overall Study|Lost to Follow-up|19|||
157226735|NCT02224391|567575917|FG000|Overall Study|Withdrawal by Subject|6|||
157226736|NCT02224391|567575918|FG001|Overall Study|Withdrawal by Subject|5|||
157226737|NCT02492958|567575919|FG000|Overall Study|Withdrawal by Subject|0|||
157226738|NCT02492958|567575920|FG001|Overall Study|Withdrawal by Subject|0|||
157226739|NCT02492958|567575921|FG002|Overall Study|Withdrawal by Subject|1|||
157226740|NCT02492958|567575922|FG003|Overall Study|Withdrawal by Subject|0|||
157226741|NCT02492958|567575919|FG000|Overall Study|Adverse Event|1|||
157226742|NCT02492958|567575920|FG001|Overall Study|Adverse Event|0|||
157226743|NCT02492958|567575921|FG002|Overall Study|Adverse Event|1|||
157226744|NCT02492958|567575922|FG003|Overall Study|Adverse Event|0|||
157226745|NCT03522948|567575923|FG000|Overall Study|Lost to Follow-up|1|||
157226746|NCT00084084|567575925|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
157226747|NCT00084084|567575925|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
157226748|NCT02236130|567575933|FG000|Overall Study|Lost to Follow-up|7|||
157226749|NCT02236130|567575934|FG001|Overall Study|Lost to Follow-up|12|||
157226750|NCT00712010|567575935|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
157226751|NCT02660242|567575942|FG000|Glucose Tabs|Lost to Follow-up|1|||
157226752|NCT02660242|567575942|FG000|Glucagon Injection|Lost to Follow-up|1|||
157226753|NCT00770510|567575944|FG000|Overall Study|Lost to Follow-up|2|||
157226754|NCT00770510|567575944|FG000|Overall Study|Pregnancy|1|||
157226755|NCT00770510|567575944|FG000|Overall Study|Withdrawal by Subject|2|||
157226756|NCT01089647|567575946|FG000|Overall Study|Lost to Follow-up|2|||
157226757|NCT01089647|567575947|FG001|Overall Study|Lost to Follow-up|2|||
157226758|NCT01089647|567575946|FG000|Overall Study|Withdrawal by Subject|2|||
157226759|NCT01089647|567575947|FG001|Overall Study|Withdrawal by Subject|1|||
157226760|NCT01089647|567575946|FG000|Overall Study|Adverse Event|0|||
157226761|NCT01089647|567575947|FG001|Overall Study|Adverse Event|1|||
157226762|NCT01531205|567575948|FG000|Overall Study|Did not proceed to surgery|1|||
157226763|NCT00995553|567575949|FG000|Overall Study|Withdrawal by Subject|2|||
157028538|NCT05293171|566860654|FG009|Washout 5 to 7 Days|Adverse Event|0|||
157226764|NCT00995553|567575950|FG001|Overall Study|Withdrawal by Subject|6|||
157226765|NCT00198029|567575953|FG000|Overall Study|Withdrawal by Subject|4|||
157226766|NCT02465567|567575954|FG000|Overall Study|Adverse Event|118|||
157028539|NCT05293171|566860655|FG010|Washout 5 to 7 Days|Adverse Event|0|||
157226767|NCT02465567|567575955|FG001|Overall Study|Adverse Event|113|||
157226768|NCT02465567|567575956|FG002|Overall Study|Adverse Event|147|||
157226769|NCT02465567|567575957|FG003|Overall Study|Adverse Event|138|||
157226770|NCT02465567|567575954|FG000|Overall Study|Lack of Efficacy|103|||
157226771|NCT02465567|567575955|FG001|Overall Study|Lack of Efficacy|102|||
157226772|NCT02465567|567575956|FG002|Overall Study|Lack of Efficacy|171|||
157226773|NCT02465567|567575957|FG003|Overall Study|Lack of Efficacy|135|||
156921246|NCT00531050|566469999|FG000|Part 1: Period 1|Protocol Deviation|0|||
156921247|NCT00531050|566470000|FG001|Part 1: Period 1|Protocol Deviation|0|||
156921248|NCT00531050|566470001|FG002|Part 1: Period 1|Protocol Deviation|0|||
156921249|NCT00531050|566470002|FG003|Part 1: Period 1|Protocol Deviation|1|||
156921250|NCT00531050|566470003|FG004|Part 1: Period 1|Protocol Deviation|0|||
156921251|NCT00531050|566470004|FG005|Part 1: Period 1|Protocol Deviation|0|||
156921252|NCT00531050|566469999|FG000|Part 1: Period 3|Adverse Event|1|||
156921253|NCT00531050|566470000|FG001|Part 1: Period 3|Adverse Event|0|||
156921254|NCT00531050|566470001|FG002|Part 1: Period 3|Adverse Event|0|||
156921255|NCT00531050|566470002|FG003|Part 1: Period 3|Adverse Event|0|||
156921256|NCT00531050|566470003|FG004|Part 1: Period 3|Adverse Event|0|||
156921257|NCT00531050|566470004|FG005|Part 1: Period 3|Adverse Event|0|||
156921258|NCT00531050|566469999|FG000|Part 2: Period 1|Adverse Event|0|||
156921259|NCT00531050|566470000|FG001|Part 2: Period 1|Adverse Event|0|||
156921260|NCT00531050|566470001|FG002|Part 2: Period 1|Adverse Event|0|||
156921261|NCT00531050|566470002|FG003|Part 2: Period 1|Adverse Event|0|||
156921262|NCT00531050|566470003|FG004|Part 2: Period 1|Adverse Event|0|||
156921263|NCT00531050|566470004|FG005|Part 2: Period 1|Adverse Event|1|||
156921264|NCT00531050|566469999|FG000|Part 2: Period 3|Abnormal test procedure|1|||
156921265|NCT00531050|566470000|FG001|Part 2: Period 3|Abnormal test procedure|0|||
156921266|NCT00531050|566470001|FG002|Part 2: Period 3|Abnormal test procedure|0|||
156921267|NCT00531050|566470002|FG003|Part 2: Period 3|Abnormal test procedure|0|||
156921268|NCT00531050|566470003|FG004|Part 2: Period 3|Abnormal test procedure|0|||
156921269|NCT00531050|566470004|FG005|Part 2: Period 3|Abnormal test procedure|1|||
156921270|NCT02233309|566470009|FG000|Overall Study|Physician Decision|5|||
156921271|NCT00799487|566470010|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
156921272|NCT00799487|566470011|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
156921273|NCT00799487|566470012|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
156921274|NCT00799487|566470010|FG000|Dose Adjustment Period|Adverse Event|2|||
156921275|NCT00799487|566470011|FG001|Dose Adjustment Period|Adverse Event|0|||
156921276|NCT00799487|566470012|FG002|Dose Adjustment Period|Adverse Event|0|||
156921277|NCT00799487|566470010|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
156921278|NCT00799487|566470011|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
156921279|NCT00799487|566470012|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
156921280|NCT00799487|566470010|FG000|Dose Adjustment Period|Investigator Discretion|2|||
156921281|NCT00799487|566470011|FG001|Dose Adjustment Period|Investigator Discretion|0|||
156921282|NCT00799487|566470012|FG002|Dose Adjustment Period|Investigator Discretion|0|||
156921283|NCT00799487|566470010|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
156921284|NCT00799487|566470011|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
156921285|NCT00799487|566470012|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
156921286|NCT00799487|566470010|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
156921287|NCT00799487|566470011|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
156921288|NCT00799487|566470012|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
156921289|NCT00799487|566470010|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
156921290|NCT00799487|566470011|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
156921291|NCT00799487|566470012|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
156921292|NCT00799487|566470010|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
156921293|NCT00799487|566470011|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
156921294|NCT00799487|566470012|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
156921295|NCT00799487|566470010|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
156921296|NCT00799487|566470011|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
156921297|NCT00799487|566470012|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
156921298|NCT00799487|566470010|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
156921299|NCT00799487|566470011|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
156921300|NCT00799487|566470012|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
156921301|NCT00799487|566470010|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
156921302|NCT00799487|566470011|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
156921303|NCT00799487|566470012|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
156921304|NCT00799487|566470010|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
156921305|NCT00799487|566470011|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
156921306|NCT00799487|566470012|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
156921307|NCT00232817|566470013|FG000|Overall Study|Protocol Violation|2|||
156921308|NCT00232817|566470014|FG001|Overall Study|Protocol Violation|1|||
156921309|NCT01484873|566470015|FG000|Overall Study|Withdrawal by Subject|2|||
156921310|NCT01549392|566470016|FG000|Overall Study|Withdrawal by Subject|1|||
156921311|NCT01549392|566470017|FG001|Overall Study|Withdrawal by Subject|0|||
156921312|NCT04273217|566470018|FG000|Overall Study|Lost to Follow-up|0|||
156921313|NCT04273217|566470019|FG001|Overall Study|Lost to Follow-up|0|||
156921314|NCT04273217|566470020|FG002|Overall Study|Lost to Follow-up|0|||
156921315|NCT04273217|566470021|FG003|Overall Study|Lost to Follow-up|0|||
156921316|NCT04273217|566470022|FG004|Overall Study|Lost to Follow-up|0|||
156921317|NCT04273217|566470023|FG005|Overall Study|Lost to Follow-up|1|||
157028540|NCT05293171|566860656|FG011|Washout 5 to 7 Days|Adverse Event|0|||
156921318|NCT04273217|566470018|FG000|Overall Study|Participant non-compliance|0|||
156921319|NCT04273217|566470019|FG001|Overall Study|Participant non-compliance|0|||
156921320|NCT04273217|566470020|FG002|Overall Study|Participant non-compliance|0|||
156921321|NCT04273217|566470021|FG003|Overall Study|Participant non-compliance|0|||
156921322|NCT04273217|566470022|FG004|Overall Study|Participant non-compliance|1|||
156921323|NCT04273217|566470023|FG005|Overall Study|Participant non-compliance|0|||
156921324|NCT04273217|566470018|FG000|Overall Study|Positive urine drug screen|1|||
156921325|NCT04273217|566470019|FG001|Overall Study|Positive urine drug screen|0|||
156921326|NCT04273217|566470020|FG002|Overall Study|Positive urine drug screen|1|||
156921327|NCT04273217|566470021|FG003|Overall Study|Positive urine drug screen|0|||
156921328|NCT04273217|566470022|FG004|Overall Study|Positive urine drug screen|0|||
156921329|NCT04273217|566470023|FG005|Overall Study|Positive urine drug screen|1|||
156921330|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
156921331|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
156921332|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
156921333|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
156921334|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
156921335|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
156921336|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156921337|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156921338|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156921339|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
156921340|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
156921341|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
156921342|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
156921343|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
156921344|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
156921345|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
156921346|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
156921347|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
156921348|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156921349|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156921350|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156921351|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
156921352|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
156921353|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
156921354|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156921355|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
156921356|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
156921357|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156921358|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
156921359|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
156921360|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
156921361|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
156921362|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
156921363|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
156921364|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
156921365|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
156921366|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156921367|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156921368|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156921369|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
156921370|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
156921371|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
156921372|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
156921373|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
156921374|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
156921375|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
156921376|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
156921377|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
156921378|NCT03720470|566470026|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156921379|NCT03720470|566470027|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156921380|NCT03720470|566470028|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156921381|NCT03720470|566470029|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
156921382|NCT03720470|566470030|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
157028541|NCT05293171|566860645|FG000|Washout 5 to 7 Days|Adverse Event|0|||
157163982|NCT01331239|567341990|FG001|Part II: Core Study|Adverse Event|3|||
157163983|NCT01331239|567341991|FG002|Part II: Core Study|Adverse Event|0|||
157163984|NCT01331239|567341989|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
157163985|NCT01331239|567341990|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
157163986|NCT01331239|567341991|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
157163987|NCT01331239|567341989|FG000|Part II: Core Study|Withdrawal by Subject|0|||
157163988|NCT01331239|567341990|FG001|Part II: Core Study|Withdrawal by Subject|2|||
157163989|NCT01331239|567341991|FG002|Part II: Core Study|Withdrawal by Subject|0|||
157163990|NCT01331239|567341989|FG000|Part II: Core Study|Administrative problems|0|||
157163991|NCT01331239|567341990|FG001|Part II: Core Study|Administrative problems|1|||
157163992|NCT01331239|567341991|FG002|Part II: Core Study|Administrative problems|0|||
157163993|NCT01008995|567341992|FG000|Controlled Period|Adverse Event|1|||
157163994|NCT01008995|567341993|FG001|Controlled Period|Adverse Event|2|||
157163995|NCT01008995|567341994|FG002|Controlled Period|Adverse Event|0|||
157163996|NCT01008995|567341995|FG003|Controlled Period|Adverse Event|0|||
157163997|NCT01008995|567341992|FG000|Controlled Period|Other|2|||
157163998|NCT01008995|567341993|FG001|Controlled Period|Other|1|||
157163999|NCT01008995|567341994|FG002|Controlled Period|Other|0|||
157164000|NCT01008995|567341995|FG003|Controlled Period|Other|0|||
157164001|NCT01008995|567341992|FG000|After Controlled Period|Adverse Event|0|||
157164002|NCT01008995|567341993|FG001|After Controlled Period|Adverse Event|0|||
157164003|NCT01008995|567341994|FG002|After Controlled Period|Adverse Event|1|||
157164004|NCT01008995|567341995|FG003|After Controlled Period|Adverse Event|1|||
157164005|NCT01008995|567341992|FG000|After Controlled Period|Other|0|||
157164006|NCT01008995|567341993|FG001|After Controlled Period|Other|0|||
157164007|NCT01008995|567341994|FG002|After Controlled Period|Other|1|||
157164008|NCT01008995|567341995|FG003|After Controlled Period|Other|0|||
157164009|NCT04167306|567341996|FG000|Overall Study|Lost to Follow-up|2|||
157164010|NCT04167306|567341997|FG001|Overall Study|Lost to Follow-up|2|||
157164011|NCT04167306|567341998|FG002|Overall Study|Lost to Follow-up|5|||
157164012|NCT04167306|567341999|FG003|Overall Study|Lost to Follow-up|5|||
157164013|NCT04167306|567341996|FG000|Overall Study|Adverse Event|13|||
157164014|NCT04167306|567341997|FG001|Overall Study|Adverse Event|14|||
156921383|NCT03720470|566470031|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
156921384|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156921385|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156921386|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
156921387|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
156921388|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
156921389|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
156921390|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156921391|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156921392|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
156921393|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156921394|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156921395|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
156921396|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156921397|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156921398|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156921399|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
156921400|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
156921401|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
156921402|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156921403|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156921404|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156921405|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156921406|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
156921407|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
156921408|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156921409|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156921410|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
156921411|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
157028542|NCT05293171|566860646|FG001|Washout 5 to 7 Days|Adverse Event|0|||
157028543|NCT05293171|566860647|FG002|Washout 5 to 7 Days|Adverse Event|0|||
157164015|NCT04167306|567341998|FG002|Overall Study|Adverse Event|5|||
157164016|NCT04167306|567341999|FG003|Overall Study|Adverse Event|4|||
156921412|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156921413|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
156921414|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
157028544|NCT05293171|566860648|FG003|Washout 5 to 7 Days|Adverse Event|0|||
157164017|NCT04167306|567341996|FG000|Overall Study|Withdrawal by Subject|4|||
157164018|NCT04167306|567341997|FG001|Overall Study|Withdrawal by Subject|6|||
157164019|NCT04167306|567341998|FG002|Overall Study|Withdrawal by Subject|8|||
157164020|NCT04167306|567341999|FG003|Overall Study|Withdrawal by Subject|3|||
156921415|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
156921416|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
156921417|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156921418|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156921419|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
156921420|NCT03720470|566470026|FG000|Treatment Period: Final 4 Weeks|Other|0|||
156921421|NCT03720470|566470027|FG001|Treatment Period: Final 4 Weeks|Other|1|||
156921422|NCT03720470|566470028|FG002|Treatment Period: Final 4 Weeks|Other|0|||
156921423|NCT03720470|566470029|FG003|Treatment Period: Final 4 Weeks|Other|2|||
156921424|NCT03720470|566470030|FG004|Treatment Period: Final 4 Weeks|Other|1|||
156921425|NCT03720470|566470031|FG005|Treatment Period: Final 4 Weeks|Other|0|||
156921426|NCT04532099|566470032|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
156921427|NCT04532099|566470033|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
156921428|NCT04532099|566470034|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
156921429|NCT01988103|566470039|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
156921430|NCT01988103|566470040|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
156921431|NCT01988103|566470041|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
156921432|NCT01988103|566470042|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
156921433|NCT01988103|566470043|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
156921434|NCT01988103|566470039|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
156921435|NCT01988103|566470040|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
156921436|NCT01988103|566470041|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
156921437|NCT01988103|566470042|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
156921438|NCT01988103|566470043|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
156921439|NCT01988103|566470039|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
156921440|NCT01988103|566470040|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
156921441|NCT01988103|566470041|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
156921442|NCT01988103|566470042|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156921443|NCT01988103|566470043|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
156921444|NCT01988103|566470039|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
156921445|NCT01988103|566470040|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
156921446|NCT01988103|566470041|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
156921447|NCT01988103|566470042|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
156921448|NCT01988103|566470043|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
156921449|NCT01988103|566470039|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156921450|NCT01988103|566470040|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
156921451|NCT01988103|566470041|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
156921452|NCT01988103|566470042|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156921453|NCT01988103|566470043|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
156921454|NCT01988103|566470039|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
156921455|NCT01988103|566470040|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
156921456|NCT01988103|566470041|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
156921457|NCT01988103|566470042|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
156921458|NCT01988103|566470043|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
156921459|NCT01988103|566470039|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
156921460|NCT01988103|566470040|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
156921461|NCT01988103|566470041|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
156921462|NCT01988103|566470042|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
156921463|NCT01988103|566470043|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
156921464|NCT05492942|566470044|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
156921465|NCT05492942|566470045|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
156921466|NCT05492942|566470046|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
156921467|NCT05492942|566470047|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
156921468|NCT02506153|566470048|FG000|Overall Study|Adverse Event|359|||
156921469|NCT02506153|566470049|FG001|Overall Study|Adverse Event|114|||
156921470|NCT02506153|566470048|FG000|Overall Study|Refused unrelated to adverse event|127|||
156921471|NCT02506153|566470049|FG001|Overall Study|Refused unrelated to adverse event|18|||
156921472|NCT02506153|566470048|FG000|Overall Study|Progression/relapse|91|||
156921473|NCT02506153|566470049|FG001|Overall Study|Progression/relapse|136|||
156921474|NCT02506153|566470048|FG000|Overall Study|Death|2|||
156921475|NCT02506153|566470049|FG001|Overall Study|Death|1|||
156921476|NCT02506153|566470048|FG000|Overall Study|Other - not protocol specified|23|||
156921477|NCT02506153|566470049|FG001|Overall Study|Other - not protocol specified|12|||
156921478|NCT00311623|566470052|FG000|Overall Study|Physician Decision|0|||
156921479|NCT00311623|566470053|FG001|Overall Study|Physician Decision|0|||
156921480|NCT00311623|566470054|FG002|Overall Study|Physician Decision|2|||
156921481|NCT03103919|566470055|FG000|Overall Study|Adverse Event|2|||
157164021|NCT04167306|567341996|FG000|Overall Study|covid|1|||
156921482|NCT03103919|566470056|FG001|Overall Study|Adverse Event|2|||
156921483|NCT04876274|566470057|FG000|Overall Study|Lost to Follow-up|9|||
156921484|NCT04876274|566470058|FG001|Overall Study|Lost to Follow-up|12|||
156921485|NCT01083576|566470059|FG000|Overall Study|Treatment Failure|6|||
156921486|NCT01083576|566470060|FG001|Overall Study|Treatment Failure|1|||
156921487|NCT03527966|566470061|FG000|Overall Study|Lost to Follow-up|3|||
156921488|NCT03527966|566470062|FG001|Overall Study|Lost to Follow-up|0|||
156921489|NCT01948050|566470063|FG000|Overall Study|Withdrawal by Subject|0|||
156921490|NCT01948050|566470064|FG001|Overall Study|Withdrawal by Subject|1|||
156921491|NCT02005445|566470065|FG000|Overall Study|Dual study enrollment|0|||
156921492|NCT02005445|566470066|FG001|Overall Study|Dual study enrollment|1|||
156921493|NCT04577118|566470069|FG000|Overall Study|Withdrawal by Subject|4|||
156921494|NCT00276159|566470070|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
156921495|NCT00333866|566470073|FG000|Overall Study|Adverse Event|23|||
156921496|NCT00333866|566470074|FG001|Overall Study|Adverse Event|37|||
156921497|NCT00333866|566470075|FG002|Overall Study|Adverse Event|38|||
156921498|NCT00333866|566470076|FG003|Overall Study|Adverse Event|47|||
156921499|NCT00333866|566470073|FG000|Overall Study|Other|3|||
156921500|NCT00333866|566470074|FG001|Overall Study|Other|2|||
156921501|NCT00333866|566470075|FG002|Overall Study|Other|2|||
156921502|NCT00333866|566470076|FG003|Overall Study|Other|2|||
156921503|NCT00333866|566470073|FG000|Overall Study|Lack of Efficacy|8|||
156921504|NCT00333866|566470074|FG001|Overall Study|Lack of Efficacy|6|||
156921505|NCT00333866|566470075|FG002|Overall Study|Lack of Efficacy|3|||
156921506|NCT00333866|566470076|FG003|Overall Study|Lack of Efficacy|5|||
156921507|NCT00333866|566470073|FG000|Overall Study|Lost to Follow-up|1|||
156921508|NCT00333866|566470074|FG001|Overall Study|Lost to Follow-up|2|||
156921509|NCT00333866|566470075|FG002|Overall Study|Lost to Follow-up|2|||
156921510|NCT00333866|566470076|FG003|Overall Study|Lost to Follow-up|2|||
156921511|NCT00333866|566470073|FG000|Overall Study|Withdrawal by Subject|8|||
156921512|NCT00333866|566470074|FG001|Overall Study|Withdrawal by Subject|14|||
156921513|NCT00333866|566470075|FG002|Overall Study|Withdrawal by Subject|4|||
156921514|NCT00333866|566470076|FG003|Overall Study|Withdrawal by Subject|9|||
156921515|NCT00333866|566470073|FG000|Overall Study|Randomized but not Treated|5|||
156921516|NCT00333866|566470074|FG001|Overall Study|Randomized but not Treated|3|||
156921517|NCT00333866|566470075|FG002|Overall Study|Randomized but not Treated|2|||
156921518|NCT00333866|566470076|FG003|Overall Study|Randomized but not Treated|1|||
156921519|NCT06073119|566470077|FG000|Overall Study|Adverse Event|1|||
156921520|NCT06073119|566470078|FG001|Overall Study|Adverse Event|3|||
156921521|NCT06073119|566470079|FG002|Overall Study|Adverse Event|0|||
156921522|NCT06073119|566470080|FG003|Overall Study|Adverse Event|0|||
156921523|NCT06073119|566470081|FG004|Overall Study|Adverse Event|1|||
157164022|NCT04167306|567341997|FG001|Overall Study|covid|1|||
157164023|NCT04167306|567341998|FG002|Overall Study|covid|2|||
157164024|NCT04167306|567341999|FG003|Overall Study|covid|1|||
157164025|NCT04167306|567341996|FG000|Overall Study|concomitant medication|0|||
157164026|NCT04167306|567341997|FG001|Overall Study|concomitant medication|0|||
157164027|NCT04167306|567341998|FG002|Overall Study|concomitant medication|0|||
157164028|NCT04167306|567341999|FG003|Overall Study|concomitant medication|1|||
157164029|NCT04167306|567341996|FG000|Overall Study|Alcohol treatment|0|||
157164030|NCT04167306|567341997|FG001|Overall Study|Alcohol treatment|4|||
157164031|NCT04167306|567341998|FG002|Overall Study|Alcohol treatment|3|||
157164032|NCT04167306|567341999|FG003|Overall Study|Alcohol treatment|2|||
157164033|NCT04167306|567341996|FG000|Overall Study|non-compliance|0|||
157164034|NCT04167306|567341997|FG001|Overall Study|non-compliance|0|||
157164035|NCT04167306|567341998|FG002|Overall Study|non-compliance|1|||
157164036|NCT04167306|567341999|FG003|Overall Study|non-compliance|0|||
157164037|NCT04167306|567341996|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
157164038|NCT04167306|567341997|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
157164039|NCT04167306|567341998|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
157164040|NCT04167306|567341999|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
157164041|NCT03731364|567342002|FG000|Overall Study|Adverse Event|0|||
157164042|NCT03731364|567342003|FG001|Overall Study|Adverse Event|0|||
157164043|NCT03731364|567342004|FG002|Overall Study|Adverse Event|1|||
156921524|NCT06073119|566470082|FG005|Overall Study|Adverse Event|0|||
156921525|NCT06073119|566470077|FG000|Overall Study|Non-compliance with study schedule|1|||
156921526|NCT06073119|566470078|FG001|Overall Study|Non-compliance with study schedule|0|||
156921527|NCT06073119|566470079|FG002|Overall Study|Non-compliance with study schedule|0|||
156921528|NCT06073119|566470080|FG003|Overall Study|Non-compliance with study schedule|0|||
156921529|NCT06073119|566470081|FG004|Overall Study|Non-compliance with study schedule|1|||
156921530|NCT06073119|566470082|FG005|Overall Study|Non-compliance with study schedule|0|||
156921531|NCT06073119|566470077|FG000|Overall Study|Withdrawal by Subject|4|||
156921532|NCT06073119|566470078|FG001|Overall Study|Withdrawal by Subject|4|||
156921533|NCT06073119|566470079|FG002|Overall Study|Withdrawal by Subject|3|||
156921534|NCT06073119|566470080|FG003|Overall Study|Withdrawal by Subject|5|||
157164044|NCT03731364|567342005|FG003|Overall Study|Adverse Event|2|||
157164045|NCT03731364|567342006|FG004|Overall Study|Adverse Event|1|||
157164046|NCT00547378|567342009|FG000|Randomized Cohort|Withdrawal by Subject|7|||
157164047|NCT00547378|567342010|FG001|Randomized Cohort|Withdrawal by Subject|5|||
157164048|NCT00547378|567342011|FG002|Randomized Cohort|Withdrawal by Subject|0|||
157164049|NCT00547378|567342009|FG000|Randomized Cohort|Death|0|||
157164050|NCT00547378|567342010|FG001|Randomized Cohort|Death|1|||
157164051|NCT00547378|567342011|FG002|Randomized Cohort|Death|0|||
157164052|NCT00547378|567342009|FG000|Randomized Cohort|Lost to Follow-up|1|||
157164053|NCT00547378|567342010|FG001|Randomized Cohort|Lost to Follow-up|0|||
157164054|NCT00547378|567342011|FG002|Randomized Cohort|Lost to Follow-up|0|||
157164055|NCT00547378|567342009|FG000|Randomized Cohort|Adverse Event|1|||
157164056|NCT00547378|567342010|FG001|Randomized Cohort|Adverse Event|0|||
157164057|NCT00547378|567342011|FG002|Randomized Cohort|Adverse Event|0|||
157164058|NCT00547378|567342009|FG000|Randomized Cohort|Other reasons|2|||
157164059|NCT00547378|567342010|FG001|Randomized Cohort|Other reasons|0|||
157164060|NCT00547378|567342011|FG002|Randomized Cohort|Other reasons|0|||
157164061|NCT00547378|567342009|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
157164062|NCT00547378|567342010|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
157164063|NCT00547378|567342011|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
157164064|NCT00547378|567342009|FG000|All Implanted Cohort|Adverse Event|4|||
157164065|NCT00547378|567342010|FG001|All Implanted Cohort|Adverse Event|10|||
157164066|NCT00547378|567342011|FG002|All Implanted Cohort|Adverse Event|17|||
157164067|NCT00547378|567342009|FG000|All Implanted Cohort|Lost to Follow-up|0|||
157164068|NCT00547378|567342010|FG001|All Implanted Cohort|Lost to Follow-up|1|||
157164069|NCT00547378|567342011|FG002|All Implanted Cohort|Lost to Follow-up|14|||
157164070|NCT00547378|567342009|FG000|All Implanted Cohort|Death|3|||
157164071|NCT00547378|567342010|FG001|All Implanted Cohort|Death|1|||
157164072|NCT00547378|567342011|FG002|All Implanted Cohort|Death|4|||
157164073|NCT00547378|567342009|FG000|All Implanted Cohort|Physician Decision|0|||
157164074|NCT00547378|567342010|FG001|All Implanted Cohort|Physician Decision|2|||
157164075|NCT00547378|567342011|FG002|All Implanted Cohort|Physician Decision|6|||
157164076|NCT00547378|567342009|FG000|All Implanted Cohort|Site closure|2|||
157164077|NCT00547378|567342010|FG001|All Implanted Cohort|Site closure|0|||
157164078|NCT00547378|567342011|FG002|All Implanted Cohort|Site closure|1|||
157164079|NCT00547378|567342009|FG000|All Implanted Cohort|Other reasons|1|||
157164080|NCT00547378|567342010|FG001|All Implanted Cohort|Other reasons|0|||
157164081|NCT00547378|567342011|FG002|All Implanted Cohort|Other reasons|1|||
157164082|NCT02768194|567342012|FG000|Period 1|Adverse Event|0|||
157164083|NCT02768194|567342013|FG001|Period 1|Adverse Event|0|||
157164084|NCT02768194|567342014|FG002|Period 1|Adverse Event|0|||
157164085|NCT02768194|567342015|FG003|Period 1|Adverse Event|1|||
157164086|NCT02768194|567342016|FG004|Period 1|Adverse Event|0|||
157164087|NCT02768194|567342017|FG005|Period 1|Adverse Event|0|||
157164088|NCT02768194|567342012|FG000|Period 2|Other (Reason not specified)|1|||
156921535|NCT06073119|566470081|FG004|Overall Study|Withdrawal by Subject|3|||
156921536|NCT06073119|566470082|FG005|Overall Study|Withdrawal by Subject|1|||
156921537|NCT06073119|566470077|FG000|Overall Study|Other|2|||
156921538|NCT06073119|566470078|FG001|Overall Study|Other|4|||
156921539|NCT06073119|566470079|FG002|Overall Study|Other|1|||
156921540|NCT06073119|566470080|FG003|Overall Study|Other|0|||
156921541|NCT06073119|566470081|FG004|Overall Study|Other|1|||
156921542|NCT06073119|566470082|FG005|Overall Study|Other|0|||
156921543|NCT01359449|566470083|FG000|Overall Study|Lost to Follow-up|1|||
156921544|NCT01359449|566470084|FG001|Overall Study|Lost to Follow-up|0|||
156921545|NCT01359449|566470083|FG000|Overall Study|Protocol Violation|0|||
156921546|NCT01359449|566470084|FG001|Overall Study|Protocol Violation|2|||
156921547|NCT01359449|566470083|FG000|Overall Study|Withdrawal by Subject|3|||
156921548|NCT01359449|566470084|FG001|Overall Study|Withdrawal by Subject|2|||
156921549|NCT00191789|566470092|FG000|Overall Study|Adverse Event|5|||
156921550|NCT00191789|566470092|FG000|Overall Study|Patient: Satisfactory Response|5|||
156921551|NCT00191789|566470092|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
156921552|NCT00191789|566470092|FG000|Overall Study|Withdrawal by Subject|4|||
157164089|NCT02768194|567342013|FG001|Period 2|Other (Reason not specified)|0|||
157164090|NCT02768194|567342014|FG002|Period 2|Other (Reason not specified)|0|||
157164091|NCT02768194|567342015|FG003|Period 2|Other (Reason not specified)|0|||
157164092|NCT02768194|567342016|FG004|Period 2|Other (Reason not specified)|0|||
157164093|NCT02768194|567342017|FG005|Period 2|Other (Reason not specified)|0|||
157164094|NCT02768194|567342012|FG000|Period 3|Other (Reason not specified)|0|||
157164095|NCT02768194|567342013|FG001|Period 3|Other (Reason not specified)|1|||
157164096|NCT02768194|567342014|FG002|Period 3|Other (Reason not specified)|0|||
156921553|NCT00191789|566470092|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
156921554|NCT00191789|566470092|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
156921555|NCT00191789|566470092|FG000|Overall Study|Death - Not Study-Drug Related|1|||
156921556|NCT00996307|566470095|FG000|Overall Study|Adverse Event|0|||
156921557|NCT00996307|566470096|FG001|Overall Study|Adverse Event|1|||
156921558|NCT00996307|566470097|FG002|Overall Study|Adverse Event|0|||
157164097|NCT02768194|567342015|FG003|Period 3|Other (Reason not specified)|0|||
156921559|NCT00996307|566470098|FG003|Overall Study|Adverse Event|0|||
156921560|NCT00996307|566470095|FG000|Overall Study|Withdrawal by Subject|3|||
156921561|NCT00996307|566470096|FG001|Overall Study|Withdrawal by Subject|2|||
156921562|NCT00996307|566470097|FG002|Overall Study|Withdrawal by Subject|5|||
156921563|NCT00996307|566470098|FG003|Overall Study|Withdrawal by Subject|5|||
156921564|NCT00996307|566470095|FG000|Overall Study|Lost to Follow-up|13|||
156921565|NCT00996307|566470096|FG001|Overall Study|Lost to Follow-up|13|||
156921566|NCT00996307|566470097|FG002|Overall Study|Lost to Follow-up|7|||
156921567|NCT00996307|566470098|FG003|Overall Study|Lost to Follow-up|15|||
156921568|NCT00996307|566470095|FG000|Overall Study|Administrative reason|0|||
156921569|NCT00996307|566470096|FG001|Overall Study|Administrative reason|1|||
156921570|NCT00996307|566470097|FG002|Overall Study|Administrative reason|0|||
156921571|NCT00996307|566470098|FG003|Overall Study|Administrative reason|0|||
156921572|NCT00996307|566470095|FG000|Overall Study|Unable to classify|4|||
156921573|NCT00996307|566470096|FG001|Overall Study|Unable to classify|0|||
156921574|NCT00996307|566470097|FG002|Overall Study|Unable to classify|2|||
156921575|NCT00996307|566470098|FG003|Overall Study|Unable to classify|1|||
156921576|NCT00001723|566470099|FG000|Overall Study|Lack of Efficacy|6|||
156921577|NCT00001723|566470100|FG001|Overall Study|Lack of Efficacy|7|||
156921578|NCT00001723|566470099|FG000|Overall Study|Lack of family interest|4|||
156921579|NCT00001723|566470100|FG001|Overall Study|Lack of family interest|5|||
156921580|NCT00001723|566470099|FG000|Overall Study|Lost to Follow-up|2|||
156921581|NCT00001723|566470100|FG001|Overall Study|Lost to Follow-up|2|||
156921582|NCT00001723|566470099|FG000|Overall Study|medication intolerance|1|||
156921583|NCT00001723|566470100|FG001|Overall Study|medication intolerance|2|||
156921584|NCT01867021|566470101|FG000|Overall Study|Adverse Event|0|||
156921585|NCT01867021|566470102|FG001|Overall Study|Adverse Event|1|||
156921586|NCT01867021|566470101|FG000|Overall Study|Not Eligible|0|||
156921587|NCT01867021|566470102|FG001|Overall Study|Not Eligible|1|||
156921588|NCT01867021|566470101|FG000|Overall Study|Death|1|||
156921589|NCT01867021|566470102|FG001|Overall Study|Death|0|||
156921590|NCT01867021|566470101|FG000|Overall Study|Lost to Follow-up|0|||
156921591|NCT01867021|566470102|FG001|Overall Study|Lost to Follow-up|2|||
156921592|NCT01867021|566470101|FG000|Overall Study|Withdrawal by Subject|1|||
156921593|NCT01867021|566470102|FG001|Overall Study|Withdrawal by Subject|6|||
156921594|NCT01712490|566470103|FG000|Overall Study|Ongoing|601|||
156921595|NCT01712490|566470104|FG001|Overall Study|Ongoing|586|||
156921596|NCT01712490|566470103|FG000|Overall Study|Other|11|||
156921597|NCT01712490|566470104|FG001|Overall Study|Other|11|||
156921598|NCT01712490|566470103|FG000|Overall Study|Withdrawal by Subject|36|||
156921599|NCT01712490|566470104|FG001|Overall Study|Withdrawal by Subject|44|||
156921600|NCT01712490|566470103|FG000|Overall Study|Lost to Follow-up|16|||
156921601|NCT01712490|566470104|FG001|Overall Study|Lost to Follow-up|29|||
156921602|NCT01862874|566470107|FG000|Overall Study|Randomized not treated|1|||
156921603|NCT01862874|566470108|FG001|Overall Study|Randomized not treated|0|||
156921604|NCT01862874|566470107|FG000|Overall Study|Adverse Event|0|||
156921605|NCT01862874|566470108|FG001|Overall Study|Adverse Event|3|||
156921606|NCT01862874|566470107|FG000|Overall Study|Lost to Follow-up|26|||
156921607|NCT01862874|566470108|FG001|Overall Study|Lost to Follow-up|29|||
156921608|NCT01862874|566470107|FG000|Overall Study|Physician Decision|5|||
156921609|NCT01862874|566470108|FG001|Overall Study|Physician Decision|3|||
156921610|NCT01862874|566470107|FG000|Overall Study|Withdrawn by parent/guardian|1|||
156921611|NCT01862874|566470108|FG001|Overall Study|Withdrawn by parent/guardian|1|||
156921612|NCT01862874|566470107|FG000|Overall Study|Withdrawal by Subject|46|||
156921613|NCT01862874|566470108|FG001|Overall Study|Withdrawal by Subject|40|||
156921614|NCT01862874|566470107|FG000|Overall Study|Death|0|||
156921615|NCT01862874|566470108|FG001|Overall Study|Death|1|||
156921616|NCT01782495|566470116|FG000|Overall Study|Adverse Event|0|||
156921617|NCT01782495|566470117|FG001|Overall Study|Adverse Event|0|||
157226774|NCT02465567|567575954|FG000|Overall Study|Withdrawal by Subject|104|||
156921618|NCT01782495|566470118|FG002|Overall Study|Adverse Event|0|||
156921619|NCT01782495|566470119|FG003|Overall Study|Adverse Event|0|||
156921620|NCT01782495|566470120|FG004|Overall Study|Adverse Event|0|||
156921621|NCT01782495|566470121|FG005|Overall Study|Adverse Event|0|||
156921622|NCT01782495|566470122|FG006|Overall Study|Adverse Event|0|||
156921623|NCT01782495|566470123|FG007|Overall Study|Adverse Event|2|||
156921624|NCT01782495|566470124|FG008|Overall Study|Adverse Event|0|||
156921625|NCT01782495|566470125|FG009|Overall Study|Adverse Event|0|||
156921626|NCT01782495|566470126|FG010|Overall Study|Adverse Event|0|||
156921627|NCT01782495|566470116|FG000|Overall Study|Withdrew Consent|0|||
156921628|NCT01782495|566470117|FG001|Overall Study|Withdrew Consent|1|||
156921629|NCT01782495|566470118|FG002|Overall Study|Withdrew Consent|0|||
156921630|NCT01782495|566470119|FG003|Overall Study|Withdrew Consent|0|||
156921631|NCT01782495|566470120|FG004|Overall Study|Withdrew Consent|0|||
156921632|NCT01782495|566470121|FG005|Overall Study|Withdrew Consent|0|||
156921633|NCT01782495|566470122|FG006|Overall Study|Withdrew Consent|0|||
156921634|NCT01782495|566470123|FG007|Overall Study|Withdrew Consent|1|||
156921635|NCT01782495|566470124|FG008|Overall Study|Withdrew Consent|0|||
156921636|NCT01782495|566470125|FG009|Overall Study|Withdrew Consent|0|||
156921637|NCT01782495|566470126|FG010|Overall Study|Withdrew Consent|0|||
156921638|NCT00241280|566470127|FG000|Overall Study|Adverse Event|2|||
156921639|NCT00241280|566470128|FG001|Overall Study|Adverse Event|6|||
156921640|NCT00241280|566470127|FG000|Overall Study|Discomfort|11|||
156921641|NCT00241280|566470128|FG001|Overall Study|Discomfort|16|||
156921642|NCT00241280|566470127|FG000|Overall Study|Pregnancy|1|||
156921643|NCT00241280|566470128|FG001|Overall Study|Pregnancy|5|||
156921644|NCT00241280|566470127|FG000|Overall Study|Lost to Follow-up|5|||
156921645|NCT00241280|566470128|FG001|Overall Study|Lost to Follow-up|8|||
156921646|NCT00241280|566470127|FG000|Overall Study|Withdrawal by Subject|7|||
156921647|NCT00241280|566470128|FG001|Overall Study|Withdrawal by Subject|4|||
156921648|NCT00241280|566470127|FG000|Overall Study|Protocol Violation|4|||
156921649|NCT00241280|566470128|FG001|Overall Study|Protocol Violation|10|||
156921650|NCT00241280|566470127|FG000|Overall Study|Relocation|4|||
156921651|NCT00241280|566470128|FG001|Overall Study|Relocation|4|||
156921652|NCT00241280|566470127|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
156921653|NCT00241280|566470128|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
156921654|NCT00241280|566470127|FG000|Overall Study|Unsatisfactory Visual Response|1|||
156921655|NCT00241280|566470128|FG001|Overall Study|Unsatisfactory Visual Response|1|||
156921656|NCT00241280|566470127|FG000|Overall Study|Diabetic|1|||
156921657|NCT00241280|566470128|FG001|Overall Study|Diabetic|0|||
156921658|NCT00241280|566470127|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
156921659|NCT00241280|566470128|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
156921660|NCT00241280|566470127|FG000|Overall Study|Dispensed incorrect test article|1|||
156921661|NCT00241280|566470128|FG001|Overall Study|Dispensed incorrect test article|2|||
156921662|NCT00241280|566470127|FG000|Overall Study|Unacceptable Fit|0|||
156921663|NCT00241280|566470128|FG001|Overall Study|Unacceptable Fit|1|||
156921664|NCT00241280|566470127|FG000|Overall Study|Scheduling Conflict|0|||
156921665|NCT00241280|566470128|FG001|Overall Study|Scheduling Conflict|2|||
156921666|NCT00241280|566470127|FG000|Overall Study|History of Ocular Surgery|0|||
156921667|NCT00241280|566470128|FG001|Overall Study|History of Ocular Surgery|1|||
156921668|NCT00241280|566470127|FG000|Overall Study|Coating on Lens|1|||
156921669|NCT00241280|566470128|FG001|Overall Study|Coating on Lens|0|||
156921670|NCT00241280|566470127|FG000|Overall Study|Excessive Dryness|0|||
156921671|NCT00241280|566470128|FG001|Overall Study|Excessive Dryness|1|||
157164098|NCT02768194|567342016|FG004|Period 3|Other (Reason not specified)|0|||
157164099|NCT02768194|567342017|FG005|Period 3|Other (Reason not specified)|0|||
157164100|NCT01982773|567342018|FG000|Overall Study|Withdrawal by Subject|1|||
156921672|NCT02848651|566470130|FG000|Overall Study|Death|85|||
156921673|NCT02848651|566470130|FG000|Overall Study|Lost to Follow-up|1|||
157164101|NCT01982773|567342019|FG001|Overall Study|Withdrawal by Subject|3|||
157164102|NCT01982773|567342018|FG000|Overall Study|Lost to Follow-up|7|||
156921674|NCT02848651|566470130|FG000|Overall Study|Non-Compliance|1|||
156921675|NCT02848651|566470130|FG000|Overall Study|Symptomatic Deterioration|1|||
156921676|NCT02848651|566470130|FG000|Overall Study|Physician Decision|4|||
156921677|NCT02848651|566470130|FG000|Overall Study|Withdrawal by Subject|14|||
156921678|NCT04140292|566470135|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
156921679|NCT04140292|566470136|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
156921680|NCT00396591|566470137|FG000|Overall Study|Disease Progression|13|||
156921681|NCT00396591|566470137|FG000|Overall Study|Adverse Event|2|||
156921682|NCT00396591|566470137|FG000|Overall Study|Participant request|1|||
156921683|NCT02480114|566470142|FG000|Overall Study|Not completing surveys|3|||
156921684|NCT02480114|566470143|FG001|Overall Study|Not completing surveys|2|||
156921685|NCT02480114|566470142|FG000|Overall Study|Withdrawal by Subject|2|||
156921686|NCT02480114|566470143|FG001|Overall Study|Withdrawal by Subject|4|||
157164103|NCT01982773|567342019|FG001|Overall Study|Lost to Follow-up|1|||
157164104|NCT03089216|567342022|FG000|Overall Study|Adverse Event|0|||
157164105|NCT03089216|567342023|FG001|Overall Study|Adverse Event|0|||
157164106|NCT03089216|567342024|FG002|Overall Study|Adverse Event|0|||
157164107|NCT03089216|567342025|FG003|Overall Study|Adverse Event|1|||
157164108|NCT02121756|567342026|FG000|Overall Study|Adverse Event|3|||
157164109|NCT02121756|567342027|FG001|Overall Study|Adverse Event|0|||
157164110|NCT02121756|567342026|FG000|Overall Study|Protocol Violation|1|||
157164111|NCT02121756|567342027|FG001|Overall Study|Protocol Violation|1|||
157164112|NCT02121756|567342026|FG000|Overall Study|Physician Decision|2|||
157226775|NCT02465567|567575955|FG001|Overall Study|Withdrawal by Subject|94|||
157226776|NCT02465567|567575956|FG002|Overall Study|Withdrawal by Subject|123|||
156921687|NCT02480114|566470142|FG000|Overall Study|Disease progression|3|||
156921688|NCT02480114|566470143|FG001|Overall Study|Disease progression|0|||
157164113|NCT02121756|567342027|FG001|Overall Study|Physician Decision|1|||
156921689|NCT02480114|566470142|FG000|Overall Study|Improper completion of survey|1|||
157164114|NCT00751114|567342028|FG000|Overall Study|Adverse Event|2|||
156921690|NCT02480114|566470143|FG001|Overall Study|Improper completion of survey|1|||
156921691|NCT02480114|566470142|FG000|Overall Study|Not eligible|0|||
156921692|NCT02480114|566470143|FG001|Overall Study|Not eligible|1|||
156921693|NCT01535053|566470144|FG000|Overall Study|Ineligible|1|||
156921694|NCT01535053|566470145|FG001|Overall Study|Ineligible|2|||
156921695|NCT01031069|566470146|FG000|Overall Study|Serious Adverse Event|0|||
157164115|NCT00751114|567342029|FG001|Overall Study|Adverse Event|4|||
156921696|NCT01031069|566470147|FG001|Overall Study|Serious Adverse Event|1|||
156921697|NCT01031069|566470148|FG002|Overall Study|Serious Adverse Event|0|||
156921698|NCT01031069|566470149|FG003|Overall Study|Serious Adverse Event|0|||
156921699|NCT01031069|566470146|FG000|Overall Study|Withdrawal by Subject|2|||
156921700|NCT01031069|566470147|FG001|Overall Study|Withdrawal by Subject|3|||
156921701|NCT01031069|566470148|FG002|Overall Study|Withdrawal by Subject|18|||
156921702|NCT01031069|566470149|FG003|Overall Study|Withdrawal by Subject|18|||
156921703|NCT01031069|566470146|FG000|Overall Study|Migrated/moved from study area|1|||
156921704|NCT01031069|566470147|FG001|Overall Study|Migrated/moved from study area|2|||
156921705|NCT01031069|566470148|FG002|Overall Study|Migrated/moved from study area|1|||
156921706|NCT01031069|566470149|FG003|Overall Study|Migrated/moved from study area|1|||
156921707|NCT01031069|566470146|FG000|Overall Study|Lost to Follow-up|9|||
156921708|NCT01031069|566470147|FG001|Overall Study|Lost to Follow-up|5|||
156921709|NCT01031069|566470148|FG002|Overall Study|Lost to Follow-up|21|||
156921710|NCT01031069|566470149|FG003|Overall Study|Lost to Follow-up|15|||
156921711|NCT01031069|566470146|FG000|Overall Study|Other|0|||
156921712|NCT01031069|566470147|FG001|Overall Study|Other|0|||
156921713|NCT01031069|566470148|FG002|Overall Study|Other|1|||
156921714|NCT01031069|566470149|FG003|Overall Study|Other|0|||
156921715|NCT00512707|566470150|FG000|Overall Study|Lost to Follow-up|5|||
156921716|NCT00512707|566470151|FG001|Overall Study|Lost to Follow-up|11|||
156921717|NCT00512707|566470150|FG000|Overall Study|Developed skin irritation|2|||
156921718|NCT00512707|566470151|FG001|Overall Study|Developed skin irritation|1|||
156921719|NCT00512707|566470150|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
156921720|NCT00512707|566470151|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
156921721|NCT00512707|566470150|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
156921722|NCT00512707|566470151|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
156921723|NCT01317160|566470152|FG000|Overall Study|Incorrect inclusion|1|||
156921724|NCT01317160|566470153|FG001|Overall Study|Incorrect inclusion|1|||
156921725|NCT01317160|566470152|FG000|Overall Study|Lost to Follow-up|3|||
156921726|NCT01317160|566470153|FG001|Overall Study|Lost to Follow-up|3|||
156921727|NCT01317160|566470152|FG000|Overall Study|Withdrawal by Subject|0|||
156921728|NCT01317160|566470153|FG001|Overall Study|Withdrawal by Subject|2|||
156921729|NCT04405037|566470155|FG000|Overall Study|Withdrawal by Subject|1|||
156921730|NCT04405037|566470156|FG001|Overall Study|Withdrawal by Subject|0|||
156921731|NCT04405037|566470155|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
156921732|NCT04405037|566470156|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
156977464|NCT04534114|566670718|FG001|Main Treatment Period|Adverse Event|2|||
156977465|NCT04534114|566670719|FG002|Main Treatment Period|Adverse Event|1|||
156977466|NCT04534114|566670720|FG003|Main Treatment Period|Adverse Event|2|||
156977467|NCT04534114|566670717|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156977468|NCT04534114|566670718|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156977469|NCT04534114|566670719|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
156977470|NCT04534114|566670720|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
156977471|NCT04534114|566670717|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
156977472|NCT04534114|566670718|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156977473|NCT04534114|566670719|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156977474|NCT04534114|566670720|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
156977475|NCT04534114|566670717|FG000|Extension Treatment Period|Other reason|0|||
156977476|NCT04534114|566670718|FG001|Extension Treatment Period|Other reason|1|||
156977477|NCT04534114|566670719|FG002|Extension Treatment Period|Other reason|0|||
156977478|NCT04534114|566670720|FG003|Extension Treatment Period|Other reason|0|||
156977479|NCT04534114|566670717|FG000|Extension Treatment Period|Death|0|||
156977480|NCT04534114|566670718|FG001|Extension Treatment Period|Death|0|||
156977481|NCT04534114|566670719|FG002|Extension Treatment Period|Death|1|||
156977482|NCT04534114|566670720|FG003|Extension Treatment Period|Death|2|||
156977483|NCT04534114|566670717|FG000|Extension Treatment Period|Adverse Event|0|||
156977484|NCT04534114|566670718|FG001|Extension Treatment Period|Adverse Event|1|||
157028545|NCT05293171|566860649|FG004|Washout 5 to 7 Days|Adverse Event|0|||
157028546|NCT05293171|566860650|FG005|Washout 5 to 7 Days|Adverse Event|1|||
157028547|NCT05293171|566860651|FG006|Washout 5 to 7 Days|Adverse Event|0|||
157028548|NCT05293171|566860652|FG007|Washout 5 to 7 Days|Adverse Event|0|||
157028549|NCT05293171|566860653|FG008|Washout 5 to 7 Days|Adverse Event|0|||
157028550|NCT05293171|566860654|FG009|Washout 5 to 7 Days|Adverse Event|0|||
157028551|NCT05293171|566860655|FG010|Washout 5 to 7 Days|Adverse Event|0|||
156977485|NCT04534114|566670719|FG002|Extension Treatment Period|Adverse Event|0|||
156977486|NCT04534114|566670720|FG003|Extension Treatment Period|Adverse Event|1|||
156977487|NCT04534114|566670717|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
156977488|NCT04534114|566670718|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
156977489|NCT04534114|566670719|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
156977490|NCT04534114|566670720|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
156977491|NCT02223754|566670721|FG000|Period 1|Adverse Event|1|||
157028552|NCT05293171|566860656|FG011|Washout 5 to 7 Days|Adverse Event|0|||
157164116|NCT00751114|567342028|FG000|Overall Study|Protocol Violation|8|||
157164117|NCT00751114|567342029|FG001|Overall Study|Protocol Violation|9|||
157164118|NCT00751114|567342028|FG000|Overall Study|Withdrawal by Subject|9|||
157164119|NCT00751114|567342029|FG001|Overall Study|Withdrawal by Subject|4|||
157164120|NCT00751114|567342028|FG000|Overall Study|Lost to Follow-up|4|||
157164121|NCT00751114|567342029|FG001|Overall Study|Lost to Follow-up|7|||
157164122|NCT00751114|567342028|FG000|Overall Study|Lack of Efficacy|0|||
157164123|NCT00751114|567342029|FG001|Overall Study|Lack of Efficacy|7|||
157164124|NCT00751114|567342028|FG000|Overall Study|Not Treated|13|||
157164125|NCT00751114|567342029|FG001|Overall Study|Not Treated|1|||
157164126|NCT00751114|567342028|FG000|Overall Study|Out of country for 2 months|1|||
157164127|NCT00751114|567342029|FG001|Overall Study|Out of country for 2 months|0|||
157164128|NCT00751114|567342028|FG000|Overall Study|Move to another city|1|||
157164129|NCT00751114|567342029|FG001|Overall Study|Move to another city|0|||
157164130|NCT03655717|567342030|FG000|Overall Study|Withdrawal by Subject|4|||
156921733|NCT01853826|566472260|FG000|Overall Study|Patients who switched to commercial drug|11|||
156921734|NCT01853826|566472260|FG000|Overall Study|Patient refused to continue medication|21|||
156921735|NCT01853826|566472260|FG000|Overall Study|Lost to Follow-up|2|||
156921736|NCT01853826|566472260|FG000|Overall Study|Non-compliant with protocol|4|||
156921737|NCT01853826|566472260|FG000|Overall Study|Other adverse events (AE)|62|||
156921738|NCT01853826|566472260|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
156921739|NCT01853826|566472260|FG000|Overall Study|Progressive disease|342|||
156921740|NCT01853826|566472260|FG000|Overall Study|Other than listed|13|||
156921741|NCT01853826|566472260|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
156921742|NCT05661942|566472261|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
156921743|NCT05661942|566472262|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
156921744|NCT01572909|566472279|FG000|Overall Study|Adverse Event|7|||
156921745|NCT01572909|566472280|FG001|Overall Study|Adverse Event|2|||
156921746|NCT01572909|566472279|FG000|Overall Study|Death|3|||
156921747|NCT01572909|566472280|FG001|Overall Study|Death|1|||
156921748|NCT01572909|566472279|FG000|Overall Study|Lost to Follow-up|8|||
156921749|NCT01572909|566472280|FG001|Overall Study|Lost to Follow-up|7|||
156921750|NCT01572909|566472279|FG000|Overall Study|Physician Decision|1|||
156921751|NCT01572909|566472280|FG001|Overall Study|Physician Decision|1|||
156921752|NCT01572909|566472279|FG000|Overall Study|Technical Issues|1|||
156921753|NCT01572909|566472280|FG001|Overall Study|Technical Issues|0|||
156921754|NCT01572909|566472279|FG000|Overall Study|Withdrawal by Subject|12|||
156921755|NCT01572909|566472280|FG001|Overall Study|Withdrawal by Subject|11|||
156921756|NCT01572909|566472279|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
156921757|NCT01572909|566472280|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
156921758|NCT02723084|566472282|FG000|Overall Study|Withdrawal by Subject|1|||
156921759|NCT02723084|566472283|FG001|Overall Study|Withdrawal by Subject|1|||
156921760|NCT02723084|566472282|FG000|Overall Study|Lost to Follow-up|3|||
156921761|NCT02723084|566472283|FG001|Overall Study|Lost to Follow-up|0|||
156921762|NCT05024058|566472286|FG000|Treatment|Study terminated by sponsor|5|||
156921763|NCT05024058|566472287|FG001|Treatment|Study terminated by sponsor|6|||
157164131|NCT03655717|567342031|FG001|Overall Study|Withdrawal by Subject|8|||
157164132|NCT03655717|567342032|FG002|Overall Study|Withdrawal by Subject|1|||
157164133|NCT03655717|567342033|FG003|Overall Study|Withdrawal by Subject|0|||
157164134|NCT03655717|567342034|FG004|Overall Study|Withdrawal by Subject|0|||
157164135|NCT03655717|567342035|FG005|Overall Study|Withdrawal by Subject|1|||
157164136|NCT03655717|567342036|FG006|Overall Study|Withdrawal by Subject|3|||
157164137|NCT03655717|567342037|FG007|Overall Study|Withdrawal by Subject|1|||
156921764|NCT05024058|566472288|FG002|Treatment|Study terminated by sponsor|4|||
156921765|NCT05024058|566472289|FG003|Treatment|Study terminated by sponsor|2|||
156921766|NCT05024058|566472290|FG004|Treatment|Study terminated by sponsor|3|||
156921767|NCT05024058|566472291|FG005|Treatment|Study terminated by sponsor|3|||
156921768|NCT05024058|566472292|FG006|Treatment|Study terminated by sponsor|1|||
156921769|NCT05024058|566472293|FG007|Treatment|Study terminated by sponsor|3|||
156921770|NCT05024058|566472294|FG008|Treatment|Study terminated by sponsor|6|||
156921771|NCT05024058|566472295|FG009|Treatment|Study terminated by sponsor|6|||
156921772|NCT05024058|566472286|FG000|Follow-up|Withdrawal by Subject|1|||
156921773|NCT05024058|566472287|FG001|Follow-up|Withdrawal by Subject|0|||
156921774|NCT05024058|566472288|FG002|Follow-up|Withdrawal by Subject|1|||
156921775|NCT05024058|566472289|FG003|Follow-up|Withdrawal by Subject|0|||
156921776|NCT05024058|566472290|FG004|Follow-up|Withdrawal by Subject|0|||
156921777|NCT05024058|566472291|FG005|Follow-up|Withdrawal by Subject|0|||
156921778|NCT05024058|566472292|FG006|Follow-up|Withdrawal by Subject|0|||
156921779|NCT05024058|566472293|FG007|Follow-up|Withdrawal by Subject|1|||
156921780|NCT05024058|566472294|FG008|Follow-up|Withdrawal by Subject|0|||
156921781|NCT05024058|566472295|FG009|Follow-up|Withdrawal by Subject|1|||
156921782|NCT03055260|566472299|FG000|Overall Study|Withdrawal by Subject|1|||
156921783|NCT03055260|566472300|FG001|Overall Study|Withdrawal by Subject|0|||
156921784|NCT00931762|566472301|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
156921785|NCT00931762|566472301|FG000|Overall Study|Administrative Problems|5|||
157164138|NCT03655717|567342038|FG008|Overall Study|Withdrawal by Subject|2|||
157028553|NCT04066205|566860657|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
157028554|NCT04066205|566860658|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
157028555|NCT04066205|566860657|FG000|T2 Immediate Post-Intervention|did not respond|5|||
157028556|NCT04066205|566860658|FG001|T2 Immediate Post-Intervention|did not respond|3|||
157028557|NCT02052882|566860659|FG000|Overall Study|Not treated|11|||
157028558|NCT02052882|566860659|FG000|Overall Study|Protocol Violation|1|||
157028559|NCT02052882|566860659|FG000|Overall Study|Inadequate testing|1|||
157028560|NCT01275677|566860666|FG000|Overall Study|Not at risk for recurrence.|1|||
157028561|NCT01275677|566860667|FG001|Overall Study|Not at risk for recurrence.|1|||
157028562|NCT01275677|566860666|FG000|Overall Study|No follow-up|26|||
157028563|NCT01275677|566860667|FG001|Overall Study|No follow-up|37|||
157028564|NCT01275677|566860666|FG000|Overall Study|No clinical follow up.|1|||
157028565|NCT01275677|566860667|FG001|Overall Study|No clinical follow up.|4|||
157028566|NCT05170841|566860671|FG000|Single Dose Phase|Adverse Event|1|||
157028567|NCT05170841|566860672|FG001|Single Dose Phase|Adverse Event|2|||
157028568|NCT05170841|566860673|FG002|Single Dose Phase|Adverse Event|0|||
157028569|NCT05170841|566860674|FG003|Single Dose Phase|Adverse Event|2|||
157028570|NCT05170841|566860671|FG000|Multiple Dose Phase|Adverse Event|1|||
157028571|NCT05170841|566860672|FG001|Multiple Dose Phase|Adverse Event|2|||
157028572|NCT05170841|566860673|FG002|Multiple Dose Phase|Adverse Event|1|||
157028573|NCT05170841|566860674|FG003|Multiple Dose Phase|Adverse Event|4|||
157028574|NCT05170841|566860671|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
157028575|NCT05170841|566860672|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
157028576|NCT05170841|566860673|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
157028577|NCT05170841|566860674|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
157028578|NCT05123586|566860677|FG000|Overall Study|Physician Decision|1|||
157028579|NCT05123586|566860678|FG001|Overall Study|Physician Decision|1|||
157028580|NCT05123586|566860677|FG000|Overall Study|Withdrawal by Subject|0|||
157028581|NCT05123586|566860678|FG001|Overall Study|Withdrawal by Subject|3|||
157028582|NCT06122194|566860694|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
157028583|NCT06122194|566860695|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
157028584|NCT06122194|566860696|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
157028585|NCT06122194|566860697|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
157028586|NCT05218096|566860698|FG000|Primary Evaluation|Withdrawal by Subject|0|||
157028587|NCT05218096|566860699|FG001|Primary Evaluation|Withdrawal by Subject|0|||
157028588|NCT05218096|566860700|FG002|Primary Evaluation|Withdrawal by Subject|2|||
157028589|NCT05218096|566860701|FG003|Primary Evaluation|Withdrawal by Subject|0|||
157028590|NCT05218096|566860702|FG004|Primary Evaluation|Withdrawal by Subject|0|||
156921786|NCT00931762|566472301|FG000|Overall Study|Death|1|||
156921787|NCT00931762|566472301|FG000|Overall Study|Disease Progression|3|||
156921788|NCT00931762|566472301|FG000|Overall Study|Adverse Event (s)|11|||
156921789|NCT00931762|566472301|FG000|Overall Study|Subject withdrew consent|13|||
156921790|NCT00225251|566472302|FG000|Overall Study|Withdrawal by Subject|1|||
156921791|NCT00225251|566472303|FG001|Overall Study|Withdrawal by Subject|1|||
156921792|NCT02664441|566472304|FG000|Randomization|Withdrawal by Subject|0|||
156921793|NCT02664441|566472305|FG001|Randomization|Withdrawal by Subject|1|||
156921794|NCT02664441|566472304|FG000|36-week Randomized Trial|Adverse Event|2|||
156921795|NCT02664441|566472305|FG001|36-week Randomized Trial|Adverse Event|0|||
156921796|NCT02664441|566472304|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
156921797|NCT02664441|566472305|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
156921798|NCT02664441|566472304|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
156921799|NCT02664441|566472305|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
156921800|NCT02664441|566472304|FG000|18-week Open Label Extension|Adverse Event|1|||
156921801|NCT02664441|566472305|FG001|18-week Open Label Extension|Adverse Event|0|||
156921802|NCT02664441|566472304|FG000|18-week Open Label Extension|Physician Decision|1|||
156921803|NCT02664441|566472305|FG001|18-week Open Label Extension|Physician Decision|0|||
156921804|NCT02664441|566472304|FG000|18-week Open Label Extension|Death|1|||
156921805|NCT02664441|566472305|FG001|18-week Open Label Extension|Death|0|||
156921806|NCT02664441|566472304|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
156921807|NCT02664441|566472305|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
156921808|NCT00710710|566472306|FG000|Overall Study|Consent withdrawn|2|||
156921809|NCT00710710|566472307|FG001|Overall Study|Consent withdrawn|2|||
157028591|NCT05218096|566860698|FG000|Primary Evaluation|Physician Decision|1|||
157028592|NCT05218096|566860699|FG001|Primary Evaluation|Physician Decision|0|||
157028593|NCT05218096|566860700|FG002|Primary Evaluation|Physician Decision|0|||
156921810|NCT00710710|566472306|FG000|Overall Study|Protocol Violation|0|||
156921811|NCT00710710|566472307|FG001|Overall Study|Protocol Violation|1|||
156921812|NCT00710710|566472306|FG000|Overall Study|Adverse Event|3|||
157028594|NCT05218096|566860701|FG003|Primary Evaluation|Physician Decision|0|||
157028595|NCT05218096|566860702|FG004|Primary Evaluation|Physician Decision|0|||
157028596|NCT05218096|566860698|FG000|Extended Treatment|Clinical Deterioration|1|||
157028597|NCT05218096|566860699|FG001|Extended Treatment|Clinical Deterioration|1|||
157028598|NCT05218096|566860700|FG002|Extended Treatment|Clinical Deterioration|0|||
157028599|NCT05218096|566860701|FG003|Extended Treatment|Clinical Deterioration|0|||
157028600|NCT05218096|566860702|FG004|Extended Treatment|Clinical Deterioration|0|||
156921813|NCT00710710|566472307|FG001|Overall Study|Adverse Event|3|||
156921814|NCT00710710|566472306|FG000|Overall Study|Progressive disease|40|||
156921815|NCT00710710|566472307|FG001|Overall Study|Progressive disease|38|||
156921816|NCT03510884|566472308|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
156921817|NCT03510884|566472309|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
157226777|NCT02465567|567575957|FG003|Overall Study|Withdrawal by Subject|130|||
157226778|NCT02465567|567575954|FG000|Overall Study|Physician Decision|23|||
157226779|NCT02465567|567575955|FG001|Overall Study|Physician Decision|33|||
157226780|NCT02465567|567575956|FG002|Overall Study|Physician Decision|38|||
157226781|NCT02465567|567575957|FG003|Overall Study|Physician Decision|28|||
157226782|NCT02465567|567575954|FG000|Overall Study|Major Protocol Deviation|24|||
157226783|NCT02465567|567575955|FG001|Overall Study|Major Protocol Deviation|26|||
157226784|NCT02465567|567575956|FG002|Overall Study|Major Protocol Deviation|22|||
157226785|NCT02465567|567575957|FG003|Overall Study|Major Protocol Deviation|25|||
156921818|NCT03510884|566472310|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
156921819|NCT03510884|566472311|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
156921820|NCT03510884|566472308|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
156921821|NCT03510884|566472309|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
156921822|NCT03510884|566472310|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
156921823|NCT03510884|566472311|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
156921824|NCT03510884|566472308|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156921825|NCT03510884|566472309|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
156921826|NCT03510884|566472310|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156921827|NCT03510884|566472311|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
156921828|NCT03510884|566472308|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156921829|NCT03510884|566472309|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
156921830|NCT03510884|566472310|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156921831|NCT03510884|566472311|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
156921832|NCT03510884|566472308|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
156921833|NCT03510884|566472309|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
156921834|NCT03510884|566472310|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
156921835|NCT03510884|566472311|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
156921836|NCT03510884|566472308|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
156921837|NCT03510884|566472309|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
156921838|NCT03510884|566472310|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
156921839|NCT03510884|566472311|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
156921840|NCT03510884|566472308|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156921841|NCT03510884|566472309|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
156921842|NCT03510884|566472310|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156921843|NCT03510884|566472311|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
156921844|NCT03510884|566472308|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
156921845|NCT03510884|566472309|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
156921846|NCT03510884|566472310|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
156921847|NCT03510884|566472311|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
156921848|NCT03510884|566472308|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156921849|NCT03510884|566472309|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
156921850|NCT03510884|566472310|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156921851|NCT03510884|566472311|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
156921852|NCT03510884|566472308|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
156921853|NCT03510884|566472309|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
156921854|NCT03510884|566472310|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
156921855|NCT03510884|566472311|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
156921856|NCT01313767|566472313|FG000|Overall Study|Adverse Event|1|||
156921857|NCT01313767|566472314|FG001|Overall Study|Adverse Event|0|||
156921858|NCT01313767|566472313|FG000|Overall Study|Lost to Follow-up|1|||
156921859|NCT01313767|566472314|FG001|Overall Study|Lost to Follow-up|0|||
156921860|NCT01313767|566472313|FG000|Overall Study|Withdrawal by Subject|2|||
156921861|NCT01313767|566472314|FG001|Overall Study|Withdrawal by Subject|1|||
156921862|NCT01313767|566472313|FG000|Overall Study|Protocol Violation|3|||
156921863|NCT01313767|566472314|FG001|Overall Study|Protocol Violation|1|||
156921864|NCT01529346|566472318|FG000|Overall Study|Lost to Follow-up|2|||
156921865|NCT01529346|566472319|FG001|Overall Study|Lost to Follow-up|0|||
156921866|NCT01529346|566472320|FG002|Overall Study|Lost to Follow-up|1|||
156921867|NCT01529346|566472321|FG003|Overall Study|Lost to Follow-up|0|||
156921868|NCT01529346|566472322|FG004|Overall Study|Lost to Follow-up|0|||
157226786|NCT02465567|567575954|FG000|Overall Study|Lost to Follow-up|25|||
157226787|NCT02465567|567575955|FG001|Overall Study|Lost to Follow-up|21|||
156921869|NCT01529346|566472318|FG000|Overall Study|Other|0|||
156921870|NCT01529346|566472319|FG001|Overall Study|Other|1|||
156921871|NCT01529346|566472320|FG002|Overall Study|Other|1|||
156921872|NCT01529346|566472321|FG003|Overall Study|Other|0|||
156921873|NCT01529346|566472322|FG004|Overall Study|Other|0|||
156921874|NCT01287897|566472323|FG000|Overall Study|Adverse Event|5|||
156921875|NCT01287897|566472324|FG001|Overall Study|Adverse Event|3|||
156921876|NCT01287897|566472325|FG002|Overall Study|Adverse Event|6|||
156921877|NCT01287897|566472326|FG003|Overall Study|Adverse Event|4|||
156921878|NCT01287897|566472323|FG000|Overall Study|Lack of Efficacy|2|||
156921879|NCT01287897|566472324|FG001|Overall Study|Lack of Efficacy|0|||
156921880|NCT01287897|566472325|FG002|Overall Study|Lack of Efficacy|0|||
156921881|NCT01287897|566472326|FG003|Overall Study|Lack of Efficacy|0|||
156921882|NCT01287897|566472323|FG000|Overall Study|Protocol Violation|1|||
156921883|NCT01287897|566472324|FG001|Overall Study|Protocol Violation|1|||
156921884|NCT01287897|566472325|FG002|Overall Study|Protocol Violation|0|||
156921885|NCT01287897|566472326|FG003|Overall Study|Protocol Violation|1|||
156921886|NCT01287897|566472323|FG000|Overall Study|Lost to Follow-up|0|||
156921887|NCT01287897|566472324|FG001|Overall Study|Lost to Follow-up|0|||
156921888|NCT01287897|566472325|FG002|Overall Study|Lost to Follow-up|2|||
156921889|NCT01287897|566472326|FG003|Overall Study|Lost to Follow-up|0|||
156921890|NCT01287897|566472323|FG000|Overall Study|Withdrawal by Subject|1|||
156921891|NCT01287897|566472324|FG001|Overall Study|Withdrawal by Subject|5|||
156921892|NCT01287897|566472325|FG002|Overall Study|Withdrawal by Subject|3|||
156921893|NCT01287897|566472326|FG003|Overall Study|Withdrawal by Subject|2|||
156921894|NCT01287897|566472323|FG000|Overall Study|Not consented properly|0|||
156921895|NCT01287897|566472324|FG001|Overall Study|Not consented properly|1|||
156921896|NCT01287897|566472325|FG002|Overall Study|Not consented properly|0|||
156921897|NCT01287897|566472326|FG003|Overall Study|Not consented properly|0|||
156921898|NCT01287897|566472323|FG000|Overall Study|Not meeting entrance criteria|1|||
156921899|NCT01287897|566472324|FG001|Overall Study|Not meeting entrance criteria|1|||
156921900|NCT01287897|566472325|FG002|Overall Study|Not meeting entrance criteria|0|||
156921901|NCT01287897|566472326|FG003|Overall Study|Not meeting entrance criteria|0|||
156921902|NCT01287897|566472323|FG000|Overall Study|Other|1|||
156921903|NCT01287897|566472324|FG001|Overall Study|Other|0|||
156921904|NCT01287897|566472325|FG002|Overall Study|Other|1|||
156921905|NCT01287897|566472326|FG003|Overall Study|Other|0|||
156921906|NCT02892760|566472327|FG000|Overall Study|Withdrawal by Subject|3|||
156921907|NCT00386776|566472334|FG000|Overall Study|Withdrawal by Subject|8|||
156921908|NCT00588848|566472335|FG000|Overall Study|Physician Decision|0|||
156921909|NCT00588848|566472336|FG001|Overall Study|Physician Decision|3|||
156921910|NCT02902965|566472337|FG000|Overall Study|Withdrawal by Subject|10|||
156921911|NCT02673489|566472338|FG000|Treatment Period|Lost to Follow-up|3|||
156921912|NCT02673489|566472339|FG001|Treatment Period|Lost to Follow-up|0|||
156921913|NCT02673489|566472338|FG000|Treatment Period|Participant request to discontinue|1|||
156921914|NCT02673489|566472339|FG001|Treatment Period|Participant request to discontinue|1|||
156921915|NCT02673489|566472338|FG000|Treatment Period|Participant moved to another province|1|||
156921916|NCT02673489|566472339|FG001|Treatment Period|Participant moved to another province|0|||
156921917|NCT02673489|566472338|FG000|Treatment Period|Participant was incarcerated|0|||
156921918|NCT02673489|566472339|FG001|Treatment Period|Participant was incarcerated|1|||
156921919|NCT02673489|566472338|FG000|Treatment Period|Adverse Event|0|||
156921920|NCT02673489|566472339|FG001|Treatment Period|Adverse Event|1|||
156921921|NCT02673489|566472338|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
156921922|NCT02673489|566472339|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
156921923|NCT02673489|566472338|FG000|Follow Up Period|Unable to return for follow-up|0|||
156921924|NCT02673489|566472339|FG001|Follow Up Period|Unable to return for follow-up|1|||
156921925|NCT00082355|566472340|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
156921926|NCT00082355|566472340|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
156921927|NCT00082355|566472340|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
156921928|NCT02335489|566472341|FG000|Overall Study|Sponsor terminated study|4|||
156921929|NCT02335489|566472341|FG000|Overall Study|Lost to Follow-up|1|||
156921930|NCT02335489|566472341|FG000|Overall Study|Withdrawal by Subject|2|||
156921931|NCT02335489|566472341|FG000|Overall Study|Physician Decision|2|||
156921932|NCT02335489|566472341|FG000|Overall Study|Lack of Efficacy|1|||
156921933|NCT00412854|566472348|FG000|Overall Study|Withdrawn due to adverse events|1|||
156921934|NCT00412854|566472349|FG001|Overall Study|Withdrawn due to adverse events|5|||
156921935|NCT00412854|566472348|FG000|Overall Study|Withdrawn for other reasons|13|||
156921936|NCT00412854|566472349|FG001|Overall Study|Withdrawn for other reasons|11|||
156921937|NCT00708643|566472353|FG000|Overall Study|Adverse Event|0|||
156921938|NCT00708643|566472354|FG001|Overall Study|Adverse Event|1|||
156921939|NCT01402544|566472355|FG000|Overall Study|Withdrawal by Subject|6|||
156921940|NCT01506479|566472356|FG000|Overall Study|Lost to Follow-up|1|||
156921941|NCT01506479|566472357|FG001|Overall Study|Lost to Follow-up|2|||
156921942|NCT01506479|566472358|FG002|Overall Study|Lost to Follow-up|2|||
156921943|NCT01506479|566472356|FG000|Overall Study|Withdrawal by Subject|1|||
156921944|NCT01506479|566472357|FG001|Overall Study|Withdrawal by Subject|2|||
156921945|NCT01506479|566472358|FG002|Overall Study|Withdrawal by Subject|1|||
156921946|NCT01506479|566472356|FG000|Overall Study|Missing assessment|1|||
156921947|NCT01506479|566472357|FG001|Overall Study|Missing assessment|0|||
156921948|NCT01506479|566472358|FG002|Overall Study|Missing assessment|0|||
156921949|NCT01506479|566472356|FG000|Overall Study|Adverse Event|0|||
156921950|NCT01506479|566472357|FG001|Overall Study|Adverse Event|1|||
156921951|NCT01506479|566472358|FG002|Overall Study|Adverse Event|0|||
156921952|NCT01846507|566472359|FG000|Overall Study|Lost to Follow-up|4|||
156921953|NCT01846507|566472359|FG000|Overall Study|Protocol Violation|1|||
156921954|NCT01846507|566472359|FG000|Overall Study|Missing data|2|||
156921955|NCT01314443|566472360|FG000|Overall Study|Withdrawal by Subject|2|||
156921956|NCT01314443|566472361|FG001|Overall Study|Withdrawal by Subject|1|||
156921957|NCT01314443|566472362|FG002|Overall Study|Withdrawal by Subject|1|||
156921958|NCT01314443|566472363|FG003|Overall Study|Withdrawal by Subject|1|||
156921959|NCT01314443|566472360|FG000|Overall Study|Protocol Violation|2|||
156921960|NCT01314443|566472361|FG001|Overall Study|Protocol Violation|2|||
156921961|NCT01314443|566472362|FG002|Overall Study|Protocol Violation|1|||
156921962|NCT01314443|566472363|FG003|Overall Study|Protocol Violation|1|||
156921963|NCT04545866|566472365|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
156921964|NCT04545866|566472366|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
156921965|NCT04545866|566472365|FG000|Overall Study|Withdrawal by Physician|1|||
156921966|NCT04545866|566472366|FG001|Overall Study|Withdrawal by Physician|0|||
156921967|NCT05247866|566472367|FG000|Overall Study|Adverse Event|2|||
156921968|NCT05247866|566472367|FG000|Overall Study|Lack of Efficacy|1|||
156921969|NCT05247866|566472367|FG000|Overall Study|Protocol Violation|1|||
156921970|NCT05247866|566472367|FG000|Overall Study|Withdrawal by Subject|3|||
156921971|NCT04463719|566472372|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
156921972|NCT04463719|566472373|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
156921973|NCT04463719|566472374|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
156921974|NCT02436356|566472375|FG000|Overall Study|Excluded by MRI Screening|0|||
156921975|NCT02436356|566472376|FG001|Overall Study|Excluded by MRI Screening|0|||
156921976|NCT02436356|566472377|FG002|Overall Study|Excluded by MRI Screening|2|||
156921977|NCT02436356|566472375|FG000|Overall Study|Lost to Follow-up|0|||
156921978|NCT02436356|566472376|FG001|Overall Study|Lost to Follow-up|1|||
156921979|NCT02436356|566472377|FG002|Overall Study|Lost to Follow-up|0|||
156921980|NCT02436356|566472375|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
156921981|NCT02436356|566472376|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
156921982|NCT02436356|566472377|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
156921983|NCT02436356|566472375|FG000|Overall Study|Excluded due to other medical conditions|3|||
156921984|NCT02436356|566472376|FG001|Overall Study|Excluded due to other medical conditions|0|||
156921985|NCT02436356|566472377|FG002|Overall Study|Excluded due to other medical conditions|0|||
156921986|NCT02436356|566472375|FG000|Overall Study|Withdrawal by Subject|1|||
156921987|NCT02436356|566472376|FG001|Overall Study|Withdrawal by Subject|0|||
156921988|NCT02436356|566472377|FG002|Overall Study|Withdrawal by Subject|0|||
156921989|NCT00810407|566472378|FG000|Overall Study|Protocol Violation|3|||
156921990|NCT00810407|566472378|FG000|Overall Study|No Visit After First Day of Treatment|3|||
156921991|NCT02746874|566472379|FG000|Overall Study|Withdrawal by Subject|0|||
156921992|NCT02746874|566472380|FG001|Overall Study|Withdrawal by Subject|1|||
156921993|NCT02746874|566472379|FG000|Overall Study|Surgery Date Changed|0|||
156921994|NCT02746874|566472380|FG001|Overall Study|Surgery Date Changed|2|||
156921995|NCT00487747|566472381|FG000|Overall Study|Adverse Event|1|||
156921996|NCT00487747|566472381|FG000|Overall Study|Lost to Follow-up|9|||
156921997|NCT00487747|566472381|FG000|Overall Study|Lack of Efficacy|1|||
156921998|NCT02979522|566472385|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
156921999|NCT02979522|566472386|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
156922000|NCT02979522|566472385|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
156922001|NCT02979522|566472386|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
156922002|NCT03049280|566472389|FG000|Overall Study|Physician Decision|1|||
156922003|NCT05582889|566472390|FG000|Overall Study|Health event|3|||
156922004|NCT05582889|566472391|FG001|Overall Study|Health event|2|||
156922005|NCT05582889|566472390|FG000|Overall Study|Lost to Follow-up|2|||
156922006|NCT05582889|566472391|FG001|Overall Study|Lost to Follow-up|4|||
157164139|NCT03655717|567342039|FG009|Overall Study|Withdrawal by Subject|0|||
157164140|NCT03655717|567342040|FG010|Overall Study|Withdrawal by Subject|0|||
156922007|NCT06112756|566472392|FG000|Overall Study|Withdrawal by Subject|0|||
156922008|NCT06112756|566472393|FG001|Overall Study|Withdrawal by Subject|2|||
156922009|NCT06112756|566472392|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
156922010|NCT06112756|566472393|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
156922011|NCT06112756|566472392|FG000|Overall Study|Adverse Event|2|||
156922012|NCT06112756|566472393|FG001|Overall Study|Adverse Event|2|||
156922013|NCT04551092|566472394|FG000|Overall Study|Lost to Follow-up|7|||
156922014|NCT04551092|566472394|FG000|Overall Study|Withdrawal by Subject|4|||
156922015|NCT03060629|566472397|FG000|Overall Study|Death|4|||
156922016|NCT03060629|566472398|FG001|Overall Study|Death|5|||
157226788|NCT02465567|567575956|FG002|Overall Study|Lost to Follow-up|19|||
156922017|NCT03060629|566472397|FG000|Overall Study|Withdrawal by Subject|50|||
156922018|NCT03060629|566472398|FG001|Overall Study|Withdrawal by Subject|35|||
156922019|NCT03060629|566472397|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
156922020|NCT03060629|566472398|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
156922021|NCT03060629|566472397|FG000|Overall Study|Participant Relocate|15|||
156922022|NCT03060629|566472398|FG001|Overall Study|Participant Relocate|15|||
156922023|NCT03060629|566472397|FG000|Overall Study|Unable to Contact Participant|34|||
156922024|NCT03060629|566472398|FG001|Overall Study|Unable to Contact Participant|23|||
156922025|NCT03060629|566472397|FG000|Overall Study|Investigator Decision|7|||
156922026|NCT03060629|566472398|FG001|Overall Study|Investigator Decision|7|||
156922027|NCT03060629|566472397|FG000|Overall Study|Study Terminated by Sponsor|1100|||
156922028|NCT03060629|566472398|FG001|Overall Study|Study Terminated by Sponsor|1123|||
156922029|NCT03060629|566472397|FG000|Overall Study|Other|4|||
156922030|NCT03060629|566472398|FG001|Overall Study|Other|4|||
156922031|NCT02056340|566472399|FG000|Overall Study|Lost to Follow-up|5|||
156922032|NCT02056340|566472400|FG001|Overall Study|Lost to Follow-up|5|||
156922033|NCT02056340|566472399|FG000|Overall Study|Withdrawal by Subject|2|||
156922034|NCT02056340|566472400|FG001|Overall Study|Withdrawal by Subject|6|||
156922035|NCT00541034|566472404|FG000|Overall Study|Non-Compliance|3|||
156922036|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
156922037|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
156922038|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
156922039|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
156922040|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
156922041|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
156922042|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
156922043|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
156922044|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
156922045|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
156922046|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
156922047|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
156922048|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
156922049|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
156922050|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
156922051|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
156922052|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
156922053|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
156922054|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
156922055|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
156922056|NCT01962207|566472406|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
156922057|NCT01962207|566472407|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
156922058|NCT01962207|566472408|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
156922059|NCT01962207|566472409|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
156922060|NCT00847704|566472410|FG000|Overall Study|Withdrawal by Subject|1|||
156922061|NCT03036072|566472414|FG000|Overall Study|Death|0|||
156922062|NCT03036072|566472415|FG001|Overall Study|Death|1|||
156922063|NCT03036072|566472414|FG000|Overall Study|Withdrawal by Subject|0|||
156922064|NCT03036072|566472415|FG001|Overall Study|Withdrawal by Subject|1|||
156922065|NCT03036072|566472414|FG000|Overall Study|Physician Decision|0|||
156922066|NCT03036072|566472415|FG001|Overall Study|Physician Decision|1|||
156922067|NCT00680043|566472416|FG000|Overall Study|Withdrawal by Subject|1|||
156922068|NCT00680043|566472417|FG001|Overall Study|Withdrawal by Subject|0|||
156922069|NCT00680043|566472418|FG002|Overall Study|Withdrawal by Subject|0|||
156922070|NCT00680043|566472416|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
156922071|NCT00680043|566472417|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
156922072|NCT00680043|566472418|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
156922073|NCT00680043|566472416|FG000|Overall Study|Renal Transplant|1|||
156922074|NCT00680043|566472417|FG001|Overall Study|Renal Transplant|0|||
156922075|NCT00680043|566472418|FG002|Overall Study|Renal Transplant|4|||
156922076|NCT02484729|566472419|FG000|Overall Study|Failure of IntelliCap Error|0|||
156922077|NCT02484729|566472420|FG001|Overall Study|Failure of IntelliCap Error|0|||
156922078|NCT02484729|566472421|FG002|Overall Study|Failure of IntelliCap Error|0|||
156922079|NCT02484729|566472422|FG003|Overall Study|Failure of IntelliCap Error|0|||
156922080|NCT02484729|566472423|FG004|Overall Study|Failure of IntelliCap Error|0|||
156922081|NCT02484729|566472424|FG005|Overall Study|Failure of IntelliCap Error|0|||
156922082|NCT02484729|566472425|FG006|Overall Study|Failure of IntelliCap Error|0|||
156922083|NCT02484729|566472426|FG007|Overall Study|Failure of IntelliCap Error|0|||
156922084|NCT02484729|566472427|FG008|Overall Study|Failure of IntelliCap Error|0|||
156922085|NCT02484729|566472428|FG009|Overall Study|Failure of IntelliCap Error|1|||
156922086|NCT03334903|566472429|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
157226789|NCT02465567|567575957|FG003|Overall Study|Lost to Follow-up|15|||
156922087|NCT03334903|566472430|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
156922088|NCT03334903|566472429|FG000|Overall Study|Protocol Violation|1|||
156922089|NCT03334903|566472430|FG001|Overall Study|Protocol Violation|3|||
156922090|NCT03334903|566472429|FG000|Overall Study|Surgery postponed|1|||
156922091|NCT03334903|566472430|FG001|Overall Study|Surgery postponed|0|||
156922092|NCT03334903|566472429|FG000|Overall Study|Adverse Event|1|||
156922093|NCT03334903|566472430|FG001|Overall Study|Adverse Event|1|||
156922094|NCT03334903|566472429|FG000|Overall Study|Withdrawal by Subject|0|||
156922095|NCT03334903|566472430|FG001|Overall Study|Withdrawal by Subject|1|||
156922096|NCT02734810|566473901|FG000|Overall Study|Adverse Event|1|||
156922097|NCT02734810|566473902|FG001|Overall Study|Adverse Event|0|||
156922098|NCT02734810|566473901|FG000|Overall Study|Lack of Efficacy|1|||
156922099|NCT02734810|566473902|FG001|Overall Study|Lack of Efficacy|0|||
156922100|NCT00254540|566473903|FG000|Overall Study|Adverse Event|6|||
156922101|NCT00254540|566473904|FG001|Overall Study|Adverse Event|7|||
156922102|NCT00254540|566473903|FG000|Overall Study|Lack of Efficacy|13|||
156922103|NCT00254540|566473904|FG001|Overall Study|Lack of Efficacy|13|||
156922104|NCT00254540|566473903|FG000|Overall Study|Death|0|||
156922105|NCT00254540|566473904|FG001|Overall Study|Death|1|||
156922106|NCT00254540|566473903|FG000|Overall Study|Laboratory Test Abnormality|0|||
156922107|NCT00254540|566473904|FG001|Overall Study|Laboratory Test Abnormality|1|||
156922108|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
156922109|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
156922110|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
156922111|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156922112|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
156922113|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
156922114|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156922115|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156922116|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
156922117|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156922118|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
156922119|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156922120|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
156922121|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
156922122|NCT00293254|566473905|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
156922123|NCT00293254|566473906|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
156922124|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
156922125|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
156922126|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Death|4|||
156922127|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Death|1|||
156922128|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
156922129|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
156922130|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
156922131|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
156922132|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
156922133|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
156922134|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
156922135|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
156922136|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
156922137|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
156922138|NCT00293254|566473905|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
156922139|NCT00293254|566473906|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
156922140|NCT00293254|566473905|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
156922141|NCT00293254|566473906|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
156922142|NCT00293254|566473905|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
156922143|NCT00293254|566473906|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
156922144|NCT00293254|566473905|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
156922145|NCT00293254|566473906|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
157164141|NCT03655717|567342041|FG011|Overall Study|Withdrawal by Subject|1|||
157164142|NCT03655717|567342042|FG012|Overall Study|Withdrawal by Subject|0|||
157164143|NCT03655717|567342043|FG013|Overall Study|Withdrawal by Subject|3|||
157164144|NCT03655717|567342044|FG014|Overall Study|Withdrawal by Subject|0|||
157164145|NCT03655717|567342045|FG015|Overall Study|Withdrawal by Subject|1|||
157164146|NCT03655717|567342046|FG016|Overall Study|Withdrawal by Subject|0|||
157164147|NCT03655717|567342047|FG017|Overall Study|Withdrawal by Subject|0|||
157164148|NCT03655717|567342048|FG018|Overall Study|Withdrawal by Subject|1|||
157164149|NCT03655717|567342049|FG019|Overall Study|Withdrawal by Subject|0|||
157164150|NCT03655717|567342050|FG020|Overall Study|Withdrawal by Subject|0|||
157164151|NCT03655717|567342051|FG021|Overall Study|Withdrawal by Subject|1|||
156922146|NCT00293254|566473905|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
156922147|NCT00293254|566473906|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
156922148|NCT00293254|566473905|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
156922149|NCT00293254|566473906|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
156922150|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
156922151|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
156922152|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
156922153|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
156922154|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
156922155|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
156922156|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
156922157|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
156922158|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
156922159|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
156922160|NCT00293254|566473905|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
156922161|NCT00293254|566473906|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
156922162|NCT00503308|566473907|FG000|Overall Study|Protocol Violation|2|||
156922163|NCT00503308|566473908|FG001|Overall Study|Protocol Violation|1|||
156922164|NCT04481750|566473909|FG000|Period 1 (Fasted)|Adverse Event|0|||
156922165|NCT04481750|566473910|FG001|Period 1 (Fasted)|Adverse Event|0|||
156922166|NCT04481750|566473911|FG002|Period 1 (Fasted)|Adverse Event|1|||
156922167|NCT04481750|566473912|FG003|Period 1 (Fasted)|Adverse Event|0|||
156922168|NCT04481750|566473913|FG004|Period 1 (Fasted)|Adverse Event|0|||
156922169|NCT04481750|566473914|FG005|Period 1 (Fasted)|Adverse Event|0|||
156922170|NCT04481750|566473915|FG006|Period 1 (Fasted)|Adverse Event|0|||
156922171|NCT04481750|566473916|FG007|Period 1 (Fasted)|Adverse Event|0|||
156922172|NCT04481750|566473917|FG008|Period 1 (Fasted)|Adverse Event|0|||
156922173|NCT04481750|566473918|FG009|Period 1 (Fasted)|Adverse Event|0|||
156922174|NCT04481750|566473919|FG010|Period 1 (Fasted)|Adverse Event|0|||
156922175|NCT03263442|566473920|FG000|Inpatient Phase|Death|1|||
157028601|NCT05218096|566860698|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
157028602|NCT05218096|566860699|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
157028603|NCT05218096|566860700|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
157028604|NCT05218096|566860701|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
157028605|NCT05218096|566860702|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
157028606|NCT05218096|566860698|FG000|Extended Treatment|Withdrawal by Subject|1|||
157028607|NCT05218096|566860699|FG001|Extended Treatment|Withdrawal by Subject|3|||
157028608|NCT05218096|566860700|FG002|Extended Treatment|Withdrawal by Subject|0|||
157028609|NCT05218096|566860701|FG003|Extended Treatment|Withdrawal by Subject|2|||
157164152|NCT03655717|567342052|FG022|Overall Study|Withdrawal by Subject|2|||
156922176|NCT03263442|566473921|FG001|Inpatient Phase|Death|0|||
156922177|NCT03263442|566473920|FG000|Inpatient Phase|Withdrawal by Subject|1|||
156922178|NCT03263442|566473921|FG001|Inpatient Phase|Withdrawal by Subject|0|||
156922179|NCT03263442|566473920|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
156922180|NCT03263442|566473921|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
156922181|NCT03263442|566473920|FG000|1-month Follow-Up|Lost to Follow-up|1|||
156922182|NCT03263442|566473921|FG001|1-month Follow-Up|Lost to Follow-up|0|||
156922183|NCT03263442|566473920|FG000|3-month Follow-Up|Lost to Follow-up|1|||
156922184|NCT03263442|566473921|FG001|3-month Follow-Up|Lost to Follow-up|3|||
156922185|NCT03263442|566473920|FG000|6-month Follow-Up|Lost to Follow-up|2|||
156922186|NCT03263442|566473921|FG001|6-month Follow-Up|Lost to Follow-up|2|||
156922187|NCT00475176|566473922|FG000|Overall Study|Adverse Event|2|||
156922188|NCT00475176|566473922|FG000|Overall Study|Withdrawal by Subject|1|||
156922189|NCT00475176|566473922|FG000|Overall Study|Protocol Violation|1|||
156922190|NCT01463878|566473926|FG000|Overall Study|no longer met criteria for tube feed|2|||
156922191|NCT01463878|566473927|FG001|Overall Study|no longer met criteria for tube feed|2|||
156922192|NCT02436889|566473928|FG000|Overall Study|No improvement in symptoms|1|||
156922193|NCT02436889|566473929|FG001|Overall Study|No improvement in symptoms|0|||
156922194|NCT02436889|566473928|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
156922195|NCT02436889|566473929|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
156922196|NCT01084174|566473930|FG000|Overall Study|gastrointestinal symptoms|1|||
156922197|NCT01084174|566473931|FG001|Overall Study|gastrointestinal symptoms|1|||
156922198|NCT01084174|566473930|FG000|Overall Study|Eosinophilic esophagitis|0|||
156922199|NCT01084174|566473931|FG001|Overall Study|Eosinophilic esophagitis|1|||
156922200|NCT01084174|566473930|FG000|Overall Study|Anaphylaxis|0|||
156922201|NCT01084174|566473931|FG001|Overall Study|Anaphylaxis|1|||
156922202|NCT01084174|566473930|FG000|Overall Study|Participant noncompliance|0|||
157028610|NCT05218096|566860702|FG004|Extended Treatment|Withdrawal by Subject|2|||
157164153|NCT03655717|567342053|FG023|Overall Study|Withdrawal by Subject|1|||
157164154|NCT03655717|567342054|FG024|Overall Study|Withdrawal by Subject|1|||
156922203|NCT01084174|566473931|FG001|Overall Study|Participant noncompliance|1|||
157028611|NCT05218096|566860698|FG000|Extended Treatment|Lack of Efficacy|3|||
157028612|NCT05218096|566860699|FG001|Extended Treatment|Lack of Efficacy|0|||
156922204|NCT01034462|566473932|FG000|Overall Study|Adverse Event|7|||
156922205|NCT01034462|566473933|FG001|Overall Study|Adverse Event|17|||
156922206|NCT01034462|566473932|FG000|Overall Study|Lack of Efficacy|4|||
156922207|NCT01034462|566473933|FG001|Overall Study|Lack of Efficacy|4|||
156922208|NCT01034462|566473932|FG000|Overall Study|Protocol Violation|10|||
156922209|NCT01034462|566473933|FG001|Overall Study|Protocol Violation|7|||
156922210|NCT01034462|566473932|FG000|Overall Study|Withdrawal by Subject|9|||
156922211|NCT01034462|566473933|FG001|Overall Study|Withdrawal by Subject|8|||
156922212|NCT01034462|566473932|FG000|Overall Study|Lost to Follow-up|14|||
156922213|NCT01034462|566473933|FG001|Overall Study|Lost to Follow-up|16|||
156922214|NCT01034462|566473932|FG000|Overall Study|Other reasons|1|||
156922215|NCT01034462|566473933|FG001|Overall Study|Other reasons|2|||
156922216|NCT01594125|566473934|FG000|Overall Study|Withdrawal by Subject|1|||
156922217|NCT01594125|566473935|FG001|Overall Study|Withdrawal by Subject|0|||
156922218|NCT01594125|566473936|FG002|Overall Study|Withdrawal by Subject|0|||
156922219|NCT01594125|566473937|FG003|Overall Study|Withdrawal by Subject|1|||
156922220|NCT01594125|566473938|FG004|Overall Study|Withdrawal by Subject|0|||
156922221|NCT01594125|566473934|FG000|Overall Study|Progressive Disease|3|||
156922222|NCT01594125|566473935|FG001|Overall Study|Progressive Disease|12|||
156922223|NCT01594125|566473936|FG002|Overall Study|Progressive Disease|3|||
156922224|NCT01594125|566473937|FG003|Overall Study|Progressive Disease|3|||
156922225|NCT01594125|566473938|FG004|Overall Study|Progressive Disease|7|||
156922226|NCT00227903|566473941|FG000|Overall Study|Withdrawal by Subject|2|||
156922227|NCT00227903|566473942|FG001|Overall Study|Withdrawal by Subject|5|||
156922228|NCT00227903|566473941|FG000|Overall Study|Subject moved out of area|1|||
156922229|NCT00227903|566473942|FG001|Overall Study|Subject moved out of area|2|||
156922230|NCT00227903|566473941|FG000|Overall Study|Lost to Follow-up|1|||
156922231|NCT00227903|566473942|FG001|Overall Study|Lost to Follow-up|3|||
156922232|NCT00227903|566473941|FG000|Overall Study|Miscarriage|1|||
156922233|NCT00227903|566473942|FG001|Overall Study|Miscarriage|0|||
156922234|NCT01475331|566473943|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
156922235|NCT01475331|566473944|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
156922236|NCT01475331|566473943|FG000|Overall Study|excessive main duct communication|1|||
156922237|NCT01475331|566473944|FG001|Overall Study|excessive main duct communication|1|||
156922238|NCT01475331|566473943|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
156922239|NCT01475331|566473944|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
156922240|NCT01475331|566473943|FG000|Overall Study|Sign of malignancy during the procedure|2|||
156922241|NCT01475331|566473944|FG001|Overall Study|Sign of malignancy during the procedure|0|||
156922242|NCT01475331|566473943|FG000|Overall Study|cyst found to be prohibitively small|0|||
156922243|NCT01475331|566473944|FG001|Overall Study|cyst found to be prohibitively small|1|||
156922244|NCT00462761|566473945|FG000|Overall Study|Adverse Event|6|||
156922245|NCT00462761|566473945|FG000|Overall Study|Withdrawal by Subject|9|||
156922246|NCT00462761|566473945|FG000|Overall Study|Physician Decision|5|||
156922247|NCT00462761|566473945|FG000|Overall Study|Disease progression|43|||
156922248|NCT00462761|566473945|FG000|Overall Study|Death|12|||
156922249|NCT00462761|566473945|FG000|Overall Study|Other|1|||
156922250|NCT02877082|566473946|FG000|Overall Study|Trial was closed early|5|||
156922251|NCT00460031|566473949|FG000|Overall Study|Adverse Event|5|||
156922252|NCT00460031|566473949|FG000|Overall Study|Withdrawal by Subject|5|||
157226790|NCT02465567|567575954|FG000|Overall Study|Protocol Specified Criteria|20|||
157226791|NCT02465567|567575955|FG001|Overall Study|Protocol Specified Criteria|10|||
157226792|NCT02465567|567575956|FG002|Overall Study|Protocol Specified Criteria|9|||
157226793|NCT02465567|567575957|FG003|Overall Study|Protocol Specified Criteria|12|||
157226794|NCT02465567|567575954|FG000|Overall Study|Administrative Reasons|12|||
157226795|NCT02465567|567575955|FG001|Overall Study|Administrative Reasons|9|||
157226796|NCT02465567|567575956|FG002|Overall Study|Administrative Reasons|11|||
157226797|NCT02465567|567575957|FG003|Overall Study|Administrative Reasons|5|||
157226798|NCT02465567|567575954|FG000|Overall Study|Randomized but not treated|1|||
157226799|NCT02465567|567575955|FG001|Overall Study|Randomized but not treated|5|||
157226800|NCT02465567|567575956|FG002|Overall Study|Randomized but not treated|4|||
157226801|NCT02465567|567575957|FG003|Overall Study|Randomized but not treated|5|||
157226802|NCT02465567|567575954|FG000|Overall Study|enrolled in >1 studies|18|||
156922253|NCT00460031|566473949|FG000|Overall Study|Death|1|||
156922254|NCT01946425|566473951|FG000|Overall Study|Protocol Violation|1|||
156922255|NCT01946425|566473952|FG001|Overall Study|Protocol Violation|0|||
157226803|NCT02465567|567575955|FG001|Overall Study|enrolled in >1 studies|11|||
156922256|NCT01946425|566473951|FG000|Overall Study|Withdrawal by Subject|1|||
156922257|NCT01946425|566473952|FG001|Overall Study|Withdrawal by Subject|0|||
156922258|NCT05682326|566473958|FG000|Overall Study|Withdrawal by Subject|1|||
156922259|NCT05682326|566473959|FG001|Overall Study|Withdrawal by Subject|0|||
156922260|NCT01113801|566473960|FG000|Overall Study|Adverse Event|4|||
157226804|NCT02465567|567575956|FG002|Overall Study|enrolled in >1 studies|19|||
157226805|NCT02465567|567575957|FG003|Overall Study|enrolled in >1 studies|15|||
157226806|NCT02465567|567575954|FG000|Overall Study|missing PI Signature|1|||
156922261|NCT01113801|566473961|FG001|Overall Study|Adverse Event|0|||
156922262|NCT01113801|566473962|FG002|Overall Study|Adverse Event|2|||
156922263|NCT01113801|566473963|FG003|Overall Study|Adverse Event|6|||
156922264|NCT01113801|566473960|FG000|Overall Study|Death|4|||
156922265|NCT01113801|566473961|FG001|Overall Study|Death|5|||
156922266|NCT01113801|566473962|FG002|Overall Study|Death|3|||
156922267|NCT01113801|566473963|FG003|Overall Study|Death|4|||
156922268|NCT01113801|566473960|FG000|Overall Study|Protocol Violation|0|||
156922269|NCT01113801|566473961|FG001|Overall Study|Protocol Violation|1|||
156922270|NCT01113801|566473962|FG002|Overall Study|Protocol Violation|0|||
156922271|NCT01113801|566473963|FG003|Overall Study|Protocol Violation|0|||
156922272|NCT01113801|566473960|FG000|Overall Study|Withdrawal by Subject|9|||
156922273|NCT01113801|566473961|FG001|Overall Study|Withdrawal by Subject|7|||
156922274|NCT01113801|566473962|FG002|Overall Study|Withdrawal by Subject|7|||
156922275|NCT01113801|566473963|FG003|Overall Study|Withdrawal by Subject|8|||
156922276|NCT01113801|566473960|FG000|Overall Study|Physician Decision|2|||
156922277|NCT01113801|566473961|FG001|Overall Study|Physician Decision|2|||
156922278|NCT01113801|566473962|FG002|Overall Study|Physician Decision|3|||
156922279|NCT01113801|566473963|FG003|Overall Study|Physician Decision|3|||
156922280|NCT01113801|566473960|FG000|Overall Study|Sponsor Decision|15|||
156922281|NCT01113801|566473961|FG001|Overall Study|Sponsor Decision|21|||
156922282|NCT01113801|566473962|FG002|Overall Study|Sponsor Decision|20|||
156922283|NCT01113801|566473963|FG003|Overall Study|Sponsor Decision|15|||
156922284|NCT01113801|566473960|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
156922285|NCT01113801|566473961|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
156922286|NCT01113801|566473962|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
156922287|NCT01113801|566473963|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
156922288|NCT03414424|566473964|FG000|Overall Study|Screened out after consent|0|||
156922289|NCT03414424|566473965|FG001|Overall Study|Screened out after consent|2|||
156922290|NCT03414424|566473964|FG000|Overall Study|Lost to Follow-up|0|||
156922291|NCT03414424|566473965|FG001|Overall Study|Lost to Follow-up|1|||
156922292|NCT01949051|566473969|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
156922293|NCT01949051|566473970|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156922294|NCT01949051|566473971|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156922295|NCT01949051|566473972|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
156922296|NCT01949051|566473973|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156922297|NCT01949051|566473974|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
156922298|NCT01949051|566473969|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
156922299|NCT01949051|566473970|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156922300|NCT01949051|566473971|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156922301|NCT01949051|566473972|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156922302|NCT01949051|566473973|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156922303|NCT01949051|566473974|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
156922304|NCT01949051|566473969|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156922305|NCT01949051|566473970|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156922306|NCT01949051|566473971|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156922307|NCT01949051|566473972|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156922308|NCT01949051|566473973|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
156922309|NCT01949051|566473974|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
156922310|NCT01949051|566473969|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156922311|NCT01949051|566473970|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
156922312|NCT01949051|566473971|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156922313|NCT01949051|566473972|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156922314|NCT01949051|566473973|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156922315|NCT01949051|566473974|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
156922316|NCT01949051|566473969|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156922317|NCT01949051|566473970|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156922318|NCT01949051|566473971|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
156922319|NCT01949051|566473972|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156922320|NCT01949051|566473973|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156922321|NCT01949051|566473974|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
156922322|NCT01782859|566473976|FG000|Overall Study|Protocol Violation|6|||
156922323|NCT01782859|566473977|FG001|Overall Study|Protocol Violation|6|||
156922324|NCT01782859|566473976|FG000|Overall Study|Withdrawal by Subject|0|||
156922325|NCT01782859|566473977|FG001|Overall Study|Withdrawal by Subject|1|||
156922326|NCT04483011|566473980|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
156922327|NCT04483011|566473981|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
156922328|NCT00429104|566473992|FG000|Overall Study|Protocol Violation|1|||
156922329|NCT01896531|566473993|FG000|Overall Study|Death|57|||
156922330|NCT01896531|566473994|FG001|Overall Study|Death|59|||
156922331|NCT01896531|566473993|FG000|Overall Study|Lost to Follow-up|3|||
156922332|NCT01896531|566473994|FG001|Overall Study|Lost to Follow-up|0|||
157164155|NCT03655717|567342055|FG025|Overall Study|Withdrawal by Subject|0|||
156922333|NCT01896531|566473993|FG000|Overall Study|Non-compliance|0|||
156922334|NCT01896531|566473994|FG001|Overall Study|Non-compliance|1|||
156922335|NCT01896531|566473993|FG000|Overall Study|Study Ended by Sponsor|7|||
157164156|NCT03655717|567342030|FG000|Overall Study|Physician Decision|3|||
157164157|NCT03655717|567342031|FG001|Overall Study|Physician Decision|3|||
157164158|NCT03655717|567342032|FG002|Overall Study|Physician Decision|0|||
156922336|NCT01896531|566473994|FG001|Overall Study|Study Ended by Sponsor|20|||
156922337|NCT01896531|566473993|FG000|Overall Study|Withdrawal by Subject|3|||
156922338|NCT01896531|566473994|FG001|Overall Study|Withdrawal by Subject|2|||
156922339|NCT01896531|566473993|FG000|Overall Study|Death Prior to Treatment|1|||
156922340|NCT01896531|566473994|FG001|Overall Study|Death Prior to Treatment|0|||
156922341|NCT00770289|566473995|FG000|Overall Study|Other|6|||
156922342|NCT02956486|566473996|FG000|Core Phase|Adverse Event|51|||
156922343|NCT02956486|566473997|FG001|Core Phase|Adverse Event|88|||
156922344|NCT02956486|566473998|FG002|Core Phase|Adverse Event|0|||
156922345|NCT02956486|566473996|FG000|Core Phase|Lost to Follow-up|8|||
156922346|NCT02956486|566473997|FG001|Core Phase|Lost to Follow-up|6|||
156922347|NCT02956486|566473998|FG002|Core Phase|Lost to Follow-up|0|||
156922348|NCT02956486|566473996|FG000|Core Phase|Inadequate therapeutic effect|4|||
156922349|NCT02956486|566473997|FG001|Core Phase|Inadequate therapeutic effect|5|||
156922350|NCT02956486|566473998|FG002|Core Phase|Inadequate therapeutic effect|0|||
156922351|NCT02956486|566473996|FG000|Core Phase|Withdrawal by Subject|101|||
156922352|NCT02956486|566473997|FG001|Core Phase|Withdrawal by Subject|104|||
156922353|NCT02956486|566473998|FG002|Core Phase|Withdrawal by Subject|0|||
156922354|NCT02956486|566473996|FG000|Core Phase|Study terminated by sponsor|888|||
156922355|NCT02956486|566473997|FG001|Core Phase|Study terminated by sponsor|848|||
156922356|NCT02956486|566473998|FG002|Core Phase|Study terminated by sponsor|0|||
156922357|NCT02956486|566473996|FG000|Core Phase|Other|27|||
156922358|NCT02956486|566473997|FG001|Core Phase|Other|18|||
156922359|NCT02956486|566473998|FG002|Core Phase|Other|0|||
156922360|NCT02956486|566473996|FG000|Core Phase|Not treated|0|||
156922361|NCT02956486|566473997|FG001|Core Phase|Not treated|3|||
156922362|NCT02956486|566473998|FG002|Core Phase|Not treated|0|||
156922363|NCT02956486|566473996|FG000|Extension Phase|Adverse Event|0|||
156922364|NCT02956486|566473997|FG001|Extension Phase|Adverse Event|0|||
156922365|NCT02956486|566473998|FG002|Extension Phase|Adverse Event|2|||
156922366|NCT02956486|566473996|FG000|Extension Phase|Study terminated by sponsor|0|||
156922367|NCT02956486|566473997|FG001|Extension Phase|Study terminated by sponsor|0|||
156922368|NCT02956486|566473998|FG002|Extension Phase|Study terminated by sponsor|16|||
156922369|NCT02956486|566473996|FG000|Extension Phase|Not Treated|0|||
156922370|NCT02956486|566473997|FG001|Extension Phase|Not Treated|0|||
156922371|NCT02956486|566473998|FG002|Extension Phase|Not Treated|1|||
156922372|NCT00680745|566474002|FG000|Overall Study|Withdrawal by Subject|8|||
156922373|NCT00680745|566474003|FG001|Overall Study|Withdrawal by Subject|3|||
156922374|NCT00680745|566474004|FG002|Overall Study|Withdrawal by Subject|2|||
156922375|NCT00680745|566474005|FG003|Overall Study|Withdrawal by Subject|8|||
156922376|NCT00680745|566474002|FG000|Overall Study|Lost to Follow-up|0|||
156922377|NCT00680745|566474003|FG001|Overall Study|Lost to Follow-up|1|||
156922378|NCT00680745|566474004|FG002|Overall Study|Lost to Follow-up|1|||
156922379|NCT00680745|566474005|FG003|Overall Study|Lost to Follow-up|0|||
156922380|NCT00680745|566474002|FG000|Overall Study|Death|1|||
156922381|NCT00680745|566474003|FG001|Overall Study|Death|0|||
156922382|NCT00680745|566474004|FG002|Overall Study|Death|1|||
156922383|NCT00680745|566474005|FG003|Overall Study|Death|0|||
156922384|NCT00680745|566474002|FG000|Overall Study|Adverse Event|5|||
156922385|NCT00680745|566474003|FG001|Overall Study|Adverse Event|3|||
156922386|NCT00680745|566474004|FG002|Overall Study|Adverse Event|3|||
156922387|NCT00680745|566474005|FG003|Overall Study|Adverse Event|3|||
156922388|NCT00680745|566474002|FG000|Overall Study|Poor/Non-compliance|0|||
156922389|NCT00680745|566474003|FG001|Overall Study|Poor/Non-compliance|3|||
156922390|NCT00680745|566474004|FG002|Overall Study|Poor/Non-compliance|0|||
156922391|NCT00680745|566474005|FG003|Overall Study|Poor/Non-compliance|0|||
156922392|NCT00680745|566474002|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
156922393|NCT00680745|566474003|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
156922394|NCT00680745|566474004|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
156922395|NCT00680745|566474005|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
156922396|NCT00680745|566474002|FG000|Overall Study|False Treatment|0|||
156922397|NCT00680745|566474003|FG001|Overall Study|False Treatment|1|||
156922398|NCT00680745|566474004|FG002|Overall Study|False Treatment|3|||
156922399|NCT00680745|566474005|FG003|Overall Study|False Treatment|0|||
156922400|NCT02485574|566474010|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
156922401|NCT01408914|566474012|FG000|Overall Study|Could not complete tx in protocol period|5|||
156922402|NCT01408914|566474013|FG001|Overall Study|Could not complete tx in protocol period|5|||
157164159|NCT03655717|567342033|FG003|Overall Study|Physician Decision|0|||
156922403|NCT01408914|566474014|FG002|Overall Study|Could not complete tx in protocol period|6|||
156922404|NCT01408914|566474012|FG000|Overall Study|Lost to Follow-up|4|||
156922405|NCT01408914|566474013|FG001|Overall Study|Lost to Follow-up|1|||
156922406|NCT01408914|566474014|FG002|Overall Study|Lost to Follow-up|2|||
156922407|NCT01408914|566474012|FG000|Overall Study|Physician Decision|1|||
156922408|NCT01408914|566474013|FG001|Overall Study|Physician Decision|1|||
156922409|NCT01408914|566474014|FG002|Overall Study|Physician Decision|0|||
156922410|NCT01408914|566474012|FG000|Overall Study|Withdrawal by Subject|1|||
156922411|NCT01408914|566474013|FG001|Overall Study|Withdrawal by Subject|0|||
156922412|NCT01408914|566474014|FG002|Overall Study|Withdrawal by Subject|1|||
157226807|NCT02465567|567575955|FG001|Overall Study|missing PI Signature|0|||
157226808|NCT02465567|567575956|FG002|Overall Study|missing PI Signature|0|||
157226809|NCT02465567|567575957|FG003|Overall Study|missing PI Signature|0|||
157226810|NCT02001558|567575958|FG000|Overall Study|Lost to Follow-up|8|||
157226811|NCT02001558|567575959|FG001|Overall Study|Lost to Follow-up|14|||
157226812|NCT04117607|567575960|FG000|Overall Study|Early Termination|0|||
156922413|NCT01408914|566474012|FG000|Overall Study|Moved out of study jurisdiction|1|||
156922414|NCT01408914|566474013|FG001|Overall Study|Moved out of study jurisdiction|1|||
156922415|NCT01408914|566474014|FG002|Overall Study|Moved out of study jurisdiction|0|||
156922416|NCT01408914|566474012|FG000|Overall Study|Late exclusion|0|||
156922417|NCT01408914|566474013|FG001|Overall Study|Late exclusion|3|||
156922418|NCT01408914|566474014|FG002|Overall Study|Late exclusion|3|||
156922419|NCT01408914|566474012|FG000|Overall Study|Change in local TB/HIV norms|0|||
156922420|NCT01408914|566474013|FG001|Overall Study|Change in local TB/HIV norms|1|||
156922421|NCT01408914|566474014|FG002|Overall Study|Change in local TB/HIV norms|1|||
156922422|NCT01187043|566474024|FG000|Overall Study|Adverse Event|0|||
156922423|NCT01187043|566474025|FG001|Overall Study|Adverse Event|0|||
156922424|NCT01187043|566474026|FG002|Overall Study|Adverse Event|0|||
156922425|NCT01187043|566474027|FG003|Overall Study|Adverse Event|0|||
156922426|NCT01187043|566474028|FG004|Overall Study|Adverse Event|1|||
156922427|NCT01187043|566474024|FG000|Overall Study|Unable to make scheduled visits|1|||
156922428|NCT01187043|566474025|FG001|Overall Study|Unable to make scheduled visits|0|||
156922429|NCT01187043|566474026|FG002|Overall Study|Unable to make scheduled visits|4|||
156922430|NCT01187043|566474027|FG003|Overall Study|Unable to make scheduled visits|0|||
156922431|NCT01187043|566474028|FG004|Overall Study|Unable to make scheduled visits|1|||
156922432|NCT04903626|566474029|FG000|Overall Study|Lost to Follow-up|6|||
156922433|NCT04903626|566474029|FG000|Overall Study|Withdrawal by Subject|1|||
156922434|NCT04903626|566474029|FG000|Overall Study|Other, Not Specified|1|||
156922435|NCT00573534|566474030|FG000|Overall Study|oppositional behavior|3|||
157028613|NCT05218096|566860700|FG002|Extended Treatment|Lack of Efficacy|0|||
157028614|NCT05218096|566860701|FG003|Extended Treatment|Lack of Efficacy|0|||
157028615|NCT05218096|566860702|FG004|Extended Treatment|Lack of Efficacy|0|||
157028616|NCT05218096|566860698|FG000|Extended Treatment|Physician Decision|0|||
157028617|NCT05218096|566860699|FG001|Extended Treatment|Physician Decision|1|||
157028618|NCT05218096|566860700|FG002|Extended Treatment|Physician Decision|0|||
157028619|NCT05218096|566860701|FG003|Extended Treatment|Physician Decision|0|||
157028620|NCT05218096|566860702|FG004|Extended Treatment|Physician Decision|0|||
157028621|NCT05218096|566860698|FG000|Open-label Extension|Adverse Event|1|||
157028622|NCT05218096|566860699|FG001|Open-label Extension|Adverse Event|0|||
157028623|NCT05218096|566860700|FG002|Open-label Extension|Adverse Event|0|||
157028624|NCT05218096|566860701|FG003|Open-label Extension|Adverse Event|0|||
157028625|NCT05218096|566860702|FG004|Open-label Extension|Adverse Event|1|||
157028626|NCT05218096|566860698|FG000|Open-label Extension|Pregnancy|0|||
157028627|NCT05218096|566860699|FG001|Open-label Extension|Pregnancy|0|||
157028628|NCT05218096|566860700|FG002|Open-label Extension|Pregnancy|0|||
157028629|NCT05218096|566860701|FG003|Open-label Extension|Pregnancy|0|||
157028630|NCT05218096|566860702|FG004|Open-label Extension|Pregnancy|1|||
157028631|NCT05218096|566860698|FG000|Open-label Extension|Lack of Efficacy|1|||
157028632|NCT05218096|566860699|FG001|Open-label Extension|Lack of Efficacy|2|||
157028633|NCT05218096|566860700|FG002|Open-label Extension|Lack of Efficacy|0|||
157028634|NCT05218096|566860701|FG003|Open-label Extension|Lack of Efficacy|0|||
157028635|NCT05218096|566860702|FG004|Open-label Extension|Lack of Efficacy|0|||
157028636|NCT05218096|566860698|FG000|Open-label Extension|Lost to Follow-up|1|||
157028637|NCT05218096|566860699|FG001|Open-label Extension|Lost to Follow-up|0|||
157028638|NCT05218096|566860700|FG002|Open-label Extension|Lost to Follow-up|0|||
157028639|NCT05218096|566860701|FG003|Open-label Extension|Lost to Follow-up|0|||
157028640|NCT05218096|566860702|FG004|Open-label Extension|Lost to Follow-up|0|||
157164160|NCT03655717|567342034|FG004|Overall Study|Physician Decision|0|||
157164161|NCT03655717|567342035|FG005|Overall Study|Physician Decision|0|||
157164162|NCT03655717|567342036|FG006|Overall Study|Physician Decision|0|||
157164163|NCT03655717|567342037|FG007|Overall Study|Physician Decision|0|||
157164164|NCT03655717|567342038|FG008|Overall Study|Physician Decision|0|||
157164165|NCT03655717|567342039|FG009|Overall Study|Physician Decision|1|||
157164166|NCT03655717|567342040|FG010|Overall Study|Physician Decision|0|||
157164167|NCT03655717|567342041|FG011|Overall Study|Physician Decision|0|||
157164168|NCT03655717|567342042|FG012|Overall Study|Physician Decision|0|||
157164169|NCT03655717|567342043|FG013|Overall Study|Physician Decision|0|||
157164170|NCT03655717|567342044|FG014|Overall Study|Physician Decision|0|||
157226813|NCT04117607|567575961|FG001|Overall Study|Early Termination|1|||
157226814|NCT04117607|567575962|FG002|Overall Study|Early Termination|0|||
157028641|NCT05218096|566860698|FG000|Open-label Extension|Death|0|||
157028642|NCT05218096|566860699|FG001|Open-label Extension|Death|0|||
157028643|NCT05218096|566860700|FG002|Open-label Extension|Death|0|||
157028644|NCT05218096|566860701|FG003|Open-label Extension|Death|1|||
157028645|NCT05218096|566860702|FG004|Open-label Extension|Death|0|||
157164171|NCT03655717|567342045|FG015|Overall Study|Physician Decision|0|||
157164172|NCT03655717|567342046|FG016|Overall Study|Physician Decision|0|||
157028646|NCT05218096|566860698|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
157028647|NCT05218096|566860699|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
157028648|NCT05218096|566860700|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
157028649|NCT05218096|566860701|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
157028650|NCT05218096|566860702|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
157028651|NCT04741776|566860715|FG000|Overall Study|Withdrawal by Subject|7|||
157028652|NCT04741776|566860716|FG001|Overall Study|Withdrawal by Subject|10|||
157028653|NCT04741776|566860717|FG002|Overall Study|Withdrawal by Subject|10|||
157028654|NCT04741776|566860718|FG003|Overall Study|Withdrawal by Subject|17|||
157028655|NCT04741776|566860715|FG000|Overall Study|Death|0|||
157028656|NCT04741776|566860716|FG001|Overall Study|Death|0|||
157028657|NCT04741776|566860717|FG002|Overall Study|Death|1|||
157028658|NCT04741776|566860718|FG003|Overall Study|Death|0|||
157028659|NCT02852655|566860734|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
157028660|NCT02852655|566860735|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
157028661|NCT02852655|566860736|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
157028662|NCT02852655|566860734|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
157028663|NCT02852655|566860735|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
157028664|NCT02852655|566860736|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
157028665|NCT02852655|566860734|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
157028666|NCT02852655|566860735|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
157028667|NCT02852655|566860736|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
157028668|NCT02852655|566860734|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
157028669|NCT02852655|566860735|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
157028670|NCT02852655|566860736|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
157028671|NCT02852655|566860734|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
157028672|NCT02852655|566860735|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
157028673|NCT02852655|566860736|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
157028674|NCT02852655|566860734|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
157028675|NCT02852655|566860735|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
157028676|NCT02852655|566860736|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
156922436|NCT03035409|566474031|FG000|Overall Study|Adverse Event|5|||
156922437|NCT03035409|566474031|FG000|Overall Study|Death|2|||
156922438|NCT03035409|566474031|FG000|Overall Study|Withdrawal by Subject|2|||
156922439|NCT03035409|566474031|FG000|Overall Study|Non compliance|4|||
156922440|NCT03035409|566474031|FG000|Overall Study|Patient was jittery|1|||
156922441|NCT03035409|566474031|FG000|Overall Study|Did not like Questionnaire|1|||
156922442|NCT03035409|566474031|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
156922443|NCT03035409|566474031|FG000|Overall Study|Did not like taking drugs|1|||
156922444|NCT00927784|566474036|FG000|Overall Study|Death|1|||
156922445|NCT00927784|566474037|FG001|Overall Study|Death|0|||
156922446|NCT00927784|566474036|FG000|Overall Study|Withdrawal by Subject|1|||
156922447|NCT00927784|566474037|FG001|Overall Study|Withdrawal by Subject|0|||
156922448|NCT02457910|566474038|FG000|Overall Study|Withdrawal by Subject|0|||
156922449|NCT02457910|566474039|FG001|Overall Study|Withdrawal by Subject|0|||
156922450|NCT02457910|566474040|FG002|Overall Study|Withdrawal by Subject|0|||
156922451|NCT02457910|566474041|FG003|Overall Study|Withdrawal by Subject|0|||
156922452|NCT02457910|566474042|FG004|Overall Study|Withdrawal by Subject|0|||
156922453|NCT02457910|566474043|FG005|Overall Study|Withdrawal by Subject|1|||
156922454|NCT02457910|566474038|FG000|Overall Study|Adverse Event|0|||
156922455|NCT02457910|566474039|FG001|Overall Study|Adverse Event|2|||
156922456|NCT02457910|566474040|FG002|Overall Study|Adverse Event|1|||
156922457|NCT02457910|566474041|FG003|Overall Study|Adverse Event|1|||
156922458|NCT02457910|566474042|FG004|Overall Study|Adverse Event|1|||
157028677|NCT02852655|566860734|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
157028678|NCT02852655|566860735|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
157028679|NCT02852655|566860736|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
157028680|NCT02852655|566860734|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
157028681|NCT02852655|566860735|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
157028682|NCT02852655|566860736|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
157028683|NCT02852655|566860734|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
157028684|NCT02852655|566860735|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
157028685|NCT02852655|566860736|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
157028686|NCT03257410|566862774|FG000|Overall Study|Adverse Event|2|||
156922459|NCT02457910|566474043|FG005|Overall Study|Adverse Event|3|||
156922460|NCT02457910|566474038|FG000|Overall Study|Disease progression|3|||
156922461|NCT02457910|566474039|FG001|Overall Study|Disease progression|3|||
156922462|NCT02457910|566474040|FG002|Overall Study|Disease progression|1|||
157028687|NCT03257410|566862775|FG001|Overall Study|Adverse Event|3|||
157028688|NCT03257410|566862774|FG000|Overall Study|Protocol Violation|1|||
157028689|NCT03257410|566862775|FG001|Overall Study|Protocol Violation|2|||
157028690|NCT03257410|566862774|FG000|Overall Study|Lost to Follow-up|1|||
156922463|NCT02457910|566474041|FG003|Overall Study|Disease progression|1|||
156922464|NCT02457910|566474042|FG004|Overall Study|Disease progression|4|||
156922465|NCT02457910|566474043|FG005|Overall Study|Disease progression|6|||
156922466|NCT02457910|566474038|FG000|Overall Study|Other complicating illness|0|||
156922467|NCT02457910|566474039|FG001|Overall Study|Other complicating illness|0|||
156922468|NCT02457910|566474040|FG002|Overall Study|Other complicating illness|0|||
156922469|NCT02457910|566474041|FG003|Overall Study|Other complicating illness|0|||
156922470|NCT02457910|566474042|FG004|Overall Study|Other complicating illness|0|||
156922471|NCT02457910|566474043|FG005|Overall Study|Other complicating illness|1|||
156922472|NCT02457910|566474038|FG000|Overall Study|Death|0|||
156922473|NCT02457910|566474039|FG001|Overall Study|Death|0|||
156922474|NCT02457910|566474040|FG002|Overall Study|Death|1|||
156922475|NCT02457910|566474041|FG003|Overall Study|Death|0|||
156922476|NCT02457910|566474042|FG004|Overall Study|Death|0|||
156922477|NCT02457910|566474043|FG005|Overall Study|Death|0|||
156922478|NCT00467259|566474044|FG000|Overall Study|Adverse Event|24|||
156922479|NCT00467259|566474045|FG001|Overall Study|Adverse Event|90|||
156922480|NCT00467259|566474044|FG000|Overall Study|Protocol Violation|1|||
156922481|NCT00467259|566474045|FG001|Overall Study|Protocol Violation|7|||
156922482|NCT00467259|566474044|FG000|Overall Study|Withdrawal by Subject|34|||
156922483|NCT00467259|566474045|FG001|Overall Study|Withdrawal by Subject|108|||
156922484|NCT00467259|566474044|FG000|Overall Study|Physician Decision|0|||
156922485|NCT00467259|566474045|FG001|Overall Study|Physician Decision|2|||
156922486|NCT00467259|566474044|FG000|Overall Study|Lost to Follow-up|14|||
156922487|NCT00467259|566474045|FG001|Overall Study|Lost to Follow-up|34|||
156922488|NCT00467259|566474044|FG000|Overall Study|Site Closed|2|||
156922489|NCT00467259|566474045|FG001|Overall Study|Site Closed|1|||
156922490|NCT04851314|566474049|FG000|Overall Study|Unable to complete research set-up procedures|0|||
156922491|NCT04851314|566474050|FG001|Overall Study|Unable to complete research set-up procedures|2|||
156922492|NCT04851314|566474049|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
156922493|NCT04851314|566474050|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
156922494|NCT03578367|566474055|FG000|Overall Study|Adverse Event|0|||
156922495|NCT03578367|566474056|FG001|Overall Study|Adverse Event|3|||
156922496|NCT03578367|566474057|FG002|Overall Study|Adverse Event|0|||
156922497|NCT03578367|566474058|FG003|Overall Study|Adverse Event|5|||
156922498|NCT03578367|566474055|FG000|Overall Study|Withdrawal by Subject|2|||
156922499|NCT03578367|566474056|FG001|Overall Study|Withdrawal by Subject|2|||
156922500|NCT03578367|566474057|FG002|Overall Study|Withdrawal by Subject|1|||
156922501|NCT03578367|566474058|FG003|Overall Study|Withdrawal by Subject|3|||
156922502|NCT03578367|566474055|FG000|Overall Study|Physician Decision|0|||
156922503|NCT03578367|566474056|FG001|Overall Study|Physician Decision|0|||
156922504|NCT03578367|566474057|FG002|Overall Study|Physician Decision|14|||
156922505|NCT03578367|566474058|FG003|Overall Study|Physician Decision|0|||
156922506|NCT03578367|566474055|FG000|Overall Study|Death|1|||
156922507|NCT03578367|566474056|FG001|Overall Study|Death|0|||
156922508|NCT03578367|566474057|FG002|Overall Study|Death|0|||
156922509|NCT03578367|566474058|FG003|Overall Study|Death|0|||
156922510|NCT03578367|566474055|FG000|Overall Study|Not treated|0|||
156922511|NCT03578367|566474056|FG001|Overall Study|Not treated|0|||
156922512|NCT03578367|566474057|FG002|Overall Study|Not treated|1|||
156922513|NCT03578367|566474058|FG003|Overall Study|Not treated|0|||
156922514|NCT00587561|566475448|FG000|Overall Study|Lost to Follow-up|6|||
156922515|NCT00587561|566475449|FG001|Overall Study|Lost to Follow-up|4|||
156922516|NCT02081690|566475452|FG000|Overall Study|Death|3|||
156922517|NCT02081690|566475452|FG000|Overall Study|Physician Decision|3|||
156922518|NCT02081690|566475452|FG000|Overall Study|Withdrawal by Subject|1|||
156922519|NCT03204981|566475454|FG000|Overall Study|Physician Decision|2|||
156922520|NCT03204981|566475454|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
156922521|NCT04203238|566475455|FG000|Overall Study|Withdrawal by Subject|1|||
156922522|NCT04203238|566475456|FG001|Overall Study|Withdrawal by Subject|1|||
156922523|NCT04203238|566475455|FG000|Overall Study|Covid-19|3|||
156922524|NCT04203238|566475456|FG001|Overall Study|Covid-19|0|||
156922525|NCT01199289|566475459|FG000|Overall Study|Ineligibility determined|2|||
156922526|NCT01199289|566475460|FG001|Overall Study|Ineligibility determined|1|||
156922527|NCT01199289|566475461|FG002|Overall Study|Ineligibility determined|0|||
156922528|NCT01199289|566475462|FG003|Overall Study|Ineligibility determined|0|||
156922529|NCT01199289|566475459|FG000|Overall Study|Protocol Violation|1|||
156922530|NCT01199289|566475460|FG001|Overall Study|Protocol Violation|0|||
156922531|NCT01199289|566475461|FG002|Overall Study|Protocol Violation|0|||
156922532|NCT01199289|566475462|FG003|Overall Study|Protocol Violation|1|||
156922533|NCT01199289|566475459|FG000|Overall Study|Noncompliance|1|||
156922534|NCT01199289|566475460|FG001|Overall Study|Noncompliance|0|||
156922535|NCT01199289|566475461|FG002|Overall Study|Noncompliance|2|||
156922536|NCT01199289|566475462|FG003|Overall Study|Noncompliance|0|||
156922537|NCT01199289|566475459|FG000|Overall Study|Adverse Event|0|||
156922538|NCT01199289|566475460|FG001|Overall Study|Adverse Event|3|||
156922539|NCT01199289|566475461|FG002|Overall Study|Adverse Event|1|||
156922540|NCT01199289|566475462|FG003|Overall Study|Adverse Event|4|||
156922541|NCT01199289|566475459|FG000|Overall Study|Full consent withdrawn|2|||
156922542|NCT01199289|566475460|FG001|Overall Study|Full consent withdrawn|2|||
156922543|NCT01199289|566475461|FG002|Overall Study|Full consent withdrawn|2|||
156922544|NCT01199289|566475462|FG003|Overall Study|Full consent withdrawn|3|||
156922545|NCT01199289|566475459|FG000|Overall Study|Administrative decision|0|||
156922546|NCT01199289|566475460|FG001|Overall Study|Administrative decision|0|||
156922547|NCT01199289|566475461|FG002|Overall Study|Administrative decision|0|||
156922548|NCT01199289|566475462|FG003|Overall Study|Administrative decision|1|||
156922549|NCT01199289|566475459|FG000|Overall Study|Lost to Follow-up|0|||
156922550|NCT01199289|566475460|FG001|Overall Study|Lost to Follow-up|0|||
156922551|NCT01199289|566475461|FG002|Overall Study|Lost to Follow-up|0|||
156922552|NCT01199289|566475462|FG003|Overall Study|Lost to Follow-up|1|||
156922553|NCT01199289|566475459|FG000|Overall Study|Protocol-specified criteria|3|||
156922554|NCT01199289|566475460|FG001|Overall Study|Protocol-specified criteria|0|||
156922555|NCT01199289|566475461|FG002|Overall Study|Protocol-specified criteria|0|||
156922556|NCT01199289|566475462|FG003|Overall Study|Protocol-specified criteria|1|||
156922557|NCT01199289|566475459|FG000|Overall Study|Pregnancy|0|||
156922558|NCT01199289|566475460|FG001|Overall Study|Pregnancy|1|||
156922559|NCT01199289|566475461|FG002|Overall Study|Pregnancy|0|||
156922560|NCT01199289|566475462|FG003|Overall Study|Pregnancy|1|||
156922561|NCT00415909|566475464|FG000|Overall Study|Withdrawal by Subject|2|||
156922562|NCT00415909|566475464|FG000|Overall Study|Death|1|||
156922563|NCT01104636|566475466|FG000|Overall Study|Lack of Efficacy|43|||
156922564|NCT01104636|566475466|FG000|Overall Study|Lost to Follow-up|24|||
156922565|NCT01104636|566475466|FG000|Overall Study|Withdrawal by Subject|4|||
156922566|NCT01104636|566475466|FG000|Overall Study|Other|43|||
156922567|NCT01104636|566475466|FG000|Overall Study|Study terminated by sponsor|1|||
156922568|NCT01104636|566475466|FG000|Overall Study|Pregnancy|2|||
156922569|NCT01104636|566475466|FG000|Overall Study|Adverse Event|40|||
156922570|NCT01104636|566475466|FG000|Overall Study|Ongoing|21|||
156922571|NCT01706003|566475467|FG000|Overall Study|Withdrawal by Subject|2|||
156922572|NCT01706003|566475468|FG001|Overall Study|Withdrawal by Subject|0|||
156922573|NCT01706003|566475467|FG000|Overall Study|Not scheduled|3|||
156922574|NCT01706003|566475468|FG001|Overall Study|Not scheduled|0|||
156922575|NCT01706003|566475467|FG000|Overall Study|Lost to Follow-up|6|||
156922576|NCT01706003|566475468|FG001|Overall Study|Lost to Follow-up|4|||
156922577|NCT02507505|566475469|FG000|Overall Study|Withdrawal by Subject|13|||
156922578|NCT02507505|566475470|FG001|Overall Study|Withdrawal by Subject|11|||
156922579|NCT02507505|566475469|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
156922580|NCT02507505|566475470|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
156922581|NCT02507505|566475469|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
156922582|NCT02507505|566475470|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
156922583|NCT02507505|566475469|FG000|Overall Study|Death before receipt of anesthesia|0|||
156922584|NCT02507505|566475470|FG001|Overall Study|Death before receipt of anesthesia|1|||
156922585|NCT03182829|566475471|FG000|Overall Study|Protocol Violation|12|||
156922586|NCT03182829|566475472|FG001|Overall Study|Protocol Violation|12|||
156922587|NCT03182829|566475471|FG000|Overall Study|Other|4|||
156922588|NCT03182829|566475472|FG001|Overall Study|Other|3|||
156922589|NCT03518073|566475473|FG000|Overall Study|Adverse Event|2|||
156922590|NCT03518073|566475474|FG001|Overall Study|Adverse Event|4|||
156922591|NCT03518073|566475475|FG002|Overall Study|Adverse Event|2|||
156922592|NCT03518073|566475473|FG000|Overall Study|Death|2|||
156922593|NCT03518073|566475474|FG001|Overall Study|Death|1|||
156922594|NCT03518073|566475475|FG002|Overall Study|Death|3|||
156922595|NCT03518073|566475473|FG000|Overall Study|Lost to Follow-up|1|||
156922596|NCT03518073|566475474|FG001|Overall Study|Lost to Follow-up|0|||
156922597|NCT03518073|566475475|FG002|Overall Study|Lost to Follow-up|1|||
156922598|NCT03518073|566475473|FG000|Overall Study|Physician Decision|5|||
156922599|NCT03518073|566475474|FG001|Overall Study|Physician Decision|0|||
156922600|NCT03518073|566475475|FG002|Overall Study|Physician Decision|2|||
156922601|NCT03518073|566475473|FG000|Overall Study|Progressive disease|1|||
156922602|NCT03518073|566475474|FG001|Overall Study|Progressive disease|1|||
156922603|NCT03518073|566475475|FG002|Overall Study|Progressive disease|1|||
156922604|NCT03518073|566475473|FG000|Overall Study|Protocol Violation|1|||
156922605|NCT03518073|566475474|FG001|Overall Study|Protocol Violation|0|||
156922606|NCT03518073|566475475|FG002|Overall Study|Protocol Violation|0|||
156922607|NCT03518073|566475473|FG000|Overall Study|Withdrawal by Subject|30|||
156922608|NCT03518073|566475474|FG001|Overall Study|Withdrawal by Subject|34|||
156922609|NCT03518073|566475475|FG002|Overall Study|Withdrawal by Subject|29|||
156922610|NCT03518073|566475473|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
156922611|NCT03518073|566475474|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
156922612|NCT03518073|566475475|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
156922613|NCT03518073|566475473|FG000|Overall Study|Covid-19|1|||
156922614|NCT03518073|566475474|FG001|Overall Study|Covid-19|2|||
156922615|NCT03518073|566475475|FG002|Overall Study|Covid-19|1|||
156922616|NCT01710033|566475476|FG000|Stage 2|Adverse Event|0|||
156922617|NCT01710033|566475477|FG001|Stage 2|Adverse Event|0|||
156922618|NCT01710033|566475478|FG002|Stage 2|Adverse Event|0|||
156922619|NCT01710033|566475479|FG003|Stage 2|Adverse Event|0|||
156922620|NCT01710033|566475480|FG004|Stage 2|Adverse Event|1|||
156922621|NCT01525550|566475482|FG000|Overall Study|Lost to Follow-up|8|||
156922622|NCT01525550|566475483|FG001|Overall Study|Lost to Follow-up|2|||
156922623|NCT01525550|566475482|FG000|Overall Study|Death|19|||
156922624|NCT01525550|566475483|FG001|Overall Study|Death|28|||
156922625|NCT01525550|566475482|FG000|Overall Study|Other|0|||
156922626|NCT01525550|566475483|FG001|Overall Study|Other|4|||
156922627|NCT01525550|566475482|FG000|Overall Study|Sponsor's Decision|30|||
156922628|NCT01525550|566475483|FG001|Overall Study|Sponsor's Decision|11|||
156922629|NCT01525550|566475482|FG000|Overall Study|Withdrawal by Subject|4|||
156922630|NCT01525550|566475483|FG001|Overall Study|Withdrawal by Subject|0|||
156922631|NCT03287804|566475486|FG000|Overall Study|Death|1|||
156922632|NCT03287804|566475486|FG000|Overall Study|Physician Decision|2|||
156922633|NCT03287804|566475486|FG000|Overall Study|Progressive disease|8|||
156922634|NCT03402386|566475487|FG000|Overall Study|Adverse Event|3|||
156922635|NCT03402386|566475487|FG000|Overall Study|Physician Decision|1|||
156922636|NCT03402386|566475487|FG000|Overall Study|Difficult to control Hb|2|||
156922637|NCT02733991|566475488|FG000|Overall Study|Adverse Event|1|||
156922638|NCT02733991|566475489|FG001|Overall Study|Adverse Event|0|||
156922639|NCT02733991|566475488|FG000|Overall Study|Withdrawal by Subject|0|||
156922640|NCT02733991|566475489|FG001|Overall Study|Withdrawal by Subject|5|||
156922641|NCT00255047|566475490|FG000|Overall Study|Serious Adverse Events|2|||
156922642|NCT00255047|566475491|FG001|Overall Study|Serious Adverse Events|1|||
156922643|NCT00255047|566475492|FG002|Overall Study|Serious Adverse Events|2|||
156922644|NCT00255047|566475493|FG003|Overall Study|Serious Adverse Events|1|||
156922645|NCT00255047|566475490|FG000|Overall Study|Adverse Event|0|||
156922646|NCT00255047|566475491|FG001|Overall Study|Adverse Event|3|||
156922647|NCT00255047|566475492|FG002|Overall Study|Adverse Event|2|||
156922648|NCT00255047|566475493|FG003|Overall Study|Adverse Event|1|||
156922649|NCT00255047|566475490|FG000|Overall Study|Protocol Violation|13|||
156922650|NCT00255047|566475491|FG001|Overall Study|Protocol Violation|13|||
156922651|NCT00255047|566475492|FG002|Overall Study|Protocol Violation|16|||
156922652|NCT00255047|566475493|FG003|Overall Study|Protocol Violation|20|||
156922653|NCT00255047|566475490|FG000|Overall Study|Lost to Follow-up|9|||
156922654|NCT00255047|566475491|FG001|Overall Study|Lost to Follow-up|8|||
156922655|NCT00255047|566475492|FG002|Overall Study|Lost to Follow-up|5|||
156922656|NCT00255047|566475493|FG003|Overall Study|Lost to Follow-up|6|||
156922657|NCT00255047|566475490|FG000|Overall Study|Withdrawal by Subject|24|||
156922658|NCT00255047|566475491|FG001|Overall Study|Withdrawal by Subject|23|||
156922659|NCT00255047|566475492|FG002|Overall Study|Withdrawal by Subject|25|||
156922660|NCT00255047|566475493|FG003|Overall Study|Withdrawal by Subject|18|||
156922661|NCT01585194|566475496|FG000|Overall Study|Withdrawal by Subject|1|||
156922662|NCT01585194|566475496|FG000|Overall Study|Physician Decision|2|||
156922663|NCT01585194|566475496|FG000|Overall Study|Lack of insurance|1|||
156922664|NCT00993291|566475497|FG000|Overall Study|Withdrawal by Subject|1|||
156922665|NCT00003492|566475498|FG000|Overall Study|Not evaluable|6|||
156922666|NCT04446377|566475499|FG000|Overall Study|Withdrawal by Subject|6|||
156922667|NCT04446377|566475500|FG001|Overall Study|Withdrawal by Subject|1|||
156922668|NCT04446377|566475499|FG000|Overall Study|Physician Decision|1|||
156922669|NCT04446377|566475500|FG001|Overall Study|Physician Decision|1|||
156922670|NCT04446377|566475499|FG000|Overall Study|Lost to Follow-up|0|||
156922671|NCT04446377|566475500|FG001|Overall Study|Lost to Follow-up|2|||
156922672|NCT04446377|566475499|FG000|Overall Study|Not eligible|0|||
156922673|NCT04446377|566475500|FG001|Overall Study|Not eligible|1|||
156922674|NCT01414075|566475508|FG000|Overall Study|Adverse Event|1|||
156922675|NCT01414075|566475509|FG001|Overall Study|Adverse Event|0|||
156922676|NCT01414075|566475510|FG002|Overall Study|Adverse Event|1|||
156922677|NCT01414075|566475511|FG003|Overall Study|Adverse Event|0|||
156922678|NCT01414075|566475508|FG000|Overall Study|Death|1|||
156922679|NCT01414075|566475509|FG001|Overall Study|Death|0|||
156922680|NCT01414075|566475510|FG002|Overall Study|Death|0|||
156922681|NCT01414075|566475511|FG003|Overall Study|Death|1|||
156922682|NCT01414075|566475508|FG000|Overall Study|Withdrawal by Subject|0|||
156922683|NCT01414075|566475509|FG001|Overall Study|Withdrawal by Subject|0|||
156922684|NCT01414075|566475510|FG002|Overall Study|Withdrawal by Subject|0|||
156922685|NCT01414075|566475511|FG003|Overall Study|Withdrawal by Subject|1|||
156922686|NCT01414075|566475508|FG000|Overall Study|Other than specified|1|||
156922687|NCT01414075|566475509|FG001|Overall Study|Other than specified|0|||
156922688|NCT01414075|566475510|FG002|Overall Study|Other than specified|1|||
156922689|NCT01414075|566475511|FG003|Overall Study|Other than specified|0|||
156922690|NCT00867009|566475514|FG000|Induction Period|Nonserious Adverse Event|5|||
156922691|NCT00867009|566475514|FG000|Induction Period|Serious Adverse Event|10|||
156922692|NCT00867009|566475514|FG000|Induction Period|Death due to serious adverse event|6|||
156922693|NCT00867009|566475514|FG000|Induction Period|Death due to Study Disease|4|||
156922694|NCT00867009|566475514|FG000|Induction Period|Protocol Violation|1|||
156922695|NCT00867009|566475514|FG000|Induction Period|Withdrawal by Subject|8|||
156922696|NCT00867009|566475514|FG000|Induction Period|Physician Decision|3|||
156922697|NCT00867009|566475514|FG000|Induction Period|Progressive Disease (PD)|25|||
157028691|NCT03257410|566862775|FG001|Overall Study|Lost to Follow-up|0|||
157028692|NCT03257410|566862774|FG000|Overall Study|Withdrawal by Subject|1|||
157028693|NCT03257410|566862775|FG001|Overall Study|Withdrawal by Subject|2|||
157028694|NCT03257410|566862774|FG000|Overall Study|Physician Decision|1|||
157028695|NCT03257410|566862775|FG001|Overall Study|Physician Decision|1|||
157028696|NCT03257410|566862774|FG000|Overall Study|Renal transplantation|2|||
157028697|NCT03257410|566862775|FG001|Overall Study|Renal transplantation|0|||
157028698|NCT03257410|566862774|FG000|Overall Study|Switch to peritoneal dialysis|1|||
157028699|NCT03257410|566862775|FG001|Overall Study|Switch to peritoneal dialysis|0|||
157028700|NCT03257410|566862774|FG000|Overall Study|Death|3|||
157028701|NCT03257410|566862775|FG001|Overall Study|Death|2|||
157028702|NCT03257410|566862774|FG000|Overall Study|Change to another dialysis center|2|||
157028703|NCT03257410|566862775|FG001|Overall Study|Change to another dialysis center|2|||
157028704|NCT03257410|566862774|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
157028705|NCT03257410|566862775|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
157028706|NCT03257410|566862774|FG000|Overall Study|Miscellaneous|2|||
157028707|NCT03257410|566862775|FG001|Overall Study|Miscellaneous|2|||
157028708|NCT03257410|566862774|FG000|Overall Study|Other|0|||
157028709|NCT03257410|566862775|FG001|Overall Study|Other|1|||
157028710|NCT02598388|566862776|FG000|Overall Study|Lost to Follow-up|1|||
157028711|NCT02598388|566862777|FG001|Overall Study|Lost to Follow-up|0|||
157028712|NCT02598388|566862778|FG002|Overall Study|Lost to Follow-up|1|||
157028713|NCT02598388|566862779|FG003|Overall Study|Lost to Follow-up|0|||
157028714|NCT02598388|566862780|FG004|Overall Study|Lost to Follow-up|5|||
157028715|NCT02598388|566862781|FG005|Overall Study|Lost to Follow-up|1|||
157028716|NCT02598388|566862782|FG006|Overall Study|Lost to Follow-up|2|||
157028717|NCT02598388|566862783|FG007|Overall Study|Lost to Follow-up|1|||
157028718|NCT02598388|566862784|FG008|Overall Study|Lost to Follow-up|0|||
157028719|NCT02598388|566862785|FG009|Overall Study|Lost to Follow-up|0|||
157028720|NCT02598388|566862786|FG010|Overall Study|Lost to Follow-up|1|||
157028721|NCT02598388|566862787|FG011|Overall Study|Lost to Follow-up|0|||
157028722|NCT02598388|566862776|FG000|Overall Study|Withdrawal by Subject|0|||
157028723|NCT02598388|566862777|FG001|Overall Study|Withdrawal by Subject|0|||
157028724|NCT02598388|566862778|FG002|Overall Study|Withdrawal by Subject|0|||
157028725|NCT02598388|566862779|FG003|Overall Study|Withdrawal by Subject|0|||
157028726|NCT02598388|566862780|FG004|Overall Study|Withdrawal by Subject|2|||
157028727|NCT02598388|566862781|FG005|Overall Study|Withdrawal by Subject|0|||
157028728|NCT02598388|566862782|FG006|Overall Study|Withdrawal by Subject|2|||
157028729|NCT02598388|566862783|FG007|Overall Study|Withdrawal by Subject|0|||
157028730|NCT02598388|566862784|FG008|Overall Study|Withdrawal by Subject|0|||
157028731|NCT02598388|566862785|FG009|Overall Study|Withdrawal by Subject|1|||
157028732|NCT02598388|566862786|FG010|Overall Study|Withdrawal by Subject|0|||
157028733|NCT02598388|566862787|FG011|Overall Study|Withdrawal by Subject|0|||
157028734|NCT02598388|566862776|FG000|Overall Study|Other|0|||
157028735|NCT02598388|566862777|FG001|Overall Study|Other|0|||
157028736|NCT02598388|566862778|FG002|Overall Study|Other|1|||
157028737|NCT02598388|566862779|FG003|Overall Study|Other|0|||
157028738|NCT02598388|566862780|FG004|Overall Study|Other|3|||
157028739|NCT02598388|566862781|FG005|Overall Study|Other|0|||
157028740|NCT02598388|566862782|FG006|Overall Study|Other|1|||
157028741|NCT02598388|566862783|FG007|Overall Study|Other|0|||
157028742|NCT02598388|566862784|FG008|Overall Study|Other|0|||
157028743|NCT02598388|566862785|FG009|Overall Study|Other|0|||
157028744|NCT02598388|566862786|FG010|Overall Study|Other|0|||
157028745|NCT02598388|566862787|FG011|Overall Study|Other|0|||
157028746|NCT04171141|566862790|FG000|Overall Study|Adverse Event|0|||
157164173|NCT03655717|567342047|FG017|Overall Study|Physician Decision|0|||
157164174|NCT03655717|567342048|FG018|Overall Study|Physician Decision|0|||
157164175|NCT03655717|567342049|FG019|Overall Study|Physician Decision|1|||
157164176|NCT03655717|567342050|FG020|Overall Study|Physician Decision|0|||
157164177|NCT03655717|567342051|FG021|Overall Study|Physician Decision|0|||
157164178|NCT03655717|567342052|FG022|Overall Study|Physician Decision|0|||
157164179|NCT03655717|567342053|FG023|Overall Study|Physician Decision|1|||
157164180|NCT03655717|567342054|FG024|Overall Study|Physician Decision|0|||
157028747|NCT04171141|566862791|FG001|Overall Study|Adverse Event|0|||
157028748|NCT04171141|566862792|FG002|Overall Study|Adverse Event|2|||
157028749|NCT04171141|566862793|FG003|Overall Study|Adverse Event|0|||
157028750|NCT04171141|566862794|FG004|Overall Study|Adverse Event|0|||
157028751|NCT04171141|566862795|FG005|Overall Study|Adverse Event|0|||
157028752|NCT04171141|566862796|FG006|Overall Study|Adverse Event|0|||
157028753|NCT04171141|566862797|FG007|Overall Study|Adverse Event|0|||
157028754|NCT04171141|566862798|FG008|Overall Study|Adverse Event|0|||
157028755|NCT04171141|566862799|FG009|Overall Study|Adverse Event|0|||
157028756|NCT04171141|566862800|FG010|Overall Study|Adverse Event|0|||
157028757|NCT04171141|566862801|FG011|Overall Study|Adverse Event|0|||
157028758|NCT04171141|566862802|FG012|Overall Study|Adverse Event|0|||
157028759|NCT04171141|566862803|FG013|Overall Study|Adverse Event|2|||
157028760|NCT04171141|566862804|FG014|Overall Study|Adverse Event|0|||
157028761|NCT04171141|566862805|FG015|Overall Study|Adverse Event|0|||
157164181|NCT03655717|567342055|FG025|Overall Study|Physician Decision|0|||
157226815|NCT04117607|567575963|FG003|Overall Study|Early Termination|0|||
156922698|NCT00867009|566475514|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
156922699|NCT03266094|566475515|FG000|Overall Study|Lost to Follow-up|1|||
156922700|NCT03266094|566475515|FG000|Overall Study|Withdrawal by Subject|1|||
156922701|NCT03171415|566475516|FG000|Overall Study|Lost to Follow-up|0|||
156922702|NCT03171415|566475517|FG001|Overall Study|Lost to Follow-up|0|||
156922703|NCT03171415|566475518|FG002|Overall Study|Lost to Follow-up|0|||
156922704|NCT03171415|566475519|FG003|Overall Study|Lost to Follow-up|0|||
156922705|NCT03171415|566475520|FG004|Overall Study|Lost to Follow-up|2|||
156922706|NCT01339429|566475521|FG000|Overall Study|Withdrawal by Subject|1|||
156922707|NCT01339429|566475521|FG000|Overall Study|Physician Decision|3|||
156922708|NCT01085591|566475524|FG000|Overall Study|Adverse Event|0|||
156922709|NCT01085591|566475525|FG001|Overall Study|Adverse Event|1|||
156922710|NCT01085591|566475526|FG002|Overall Study|Adverse Event|3|||
156922711|NCT01085591|566475524|FG000|Overall Study|Physician Decision|1|||
157226816|NCT04117607|567575964|FG004|Overall Study|Early Termination|0|||
157226817|NCT04117607|567575965|FG005|Overall Study|Early Termination|0|||
157226818|NCT04117607|567575966|FG006|Overall Study|Early Termination|1|||
157226819|NCT04117607|567575967|FG007|Overall Study|Early Termination|0|||
157226820|NCT04117607|567575968|FG008|Overall Study|Early Termination|0|||
157226821|NCT04117607|567575969|FG009|Overall Study|Early Termination|0|||
157226822|NCT04117607|567575970|FG010|Overall Study|Early Termination|0|||
157226823|NCT04117607|567575971|FG011|Overall Study|Early Termination|0|||
157226824|NCT04117607|567575972|FG012|Overall Study|Early Termination|0|||
157226825|NCT04117607|567575973|FG013|Overall Study|Early Termination|0|||
157226826|NCT04582539|567575975|FG000|Overall Study|Death|1|||
157226827|NCT04582539|567575976|FG001|Overall Study|Death|1|||
157226828|NCT04582539|567575977|FG002|Overall Study|Death|0|||
157226829|NCT04582539|567575978|FG003|Overall Study|Death|1|||
157226830|NCT04582539|567575979|FG004|Overall Study|Death|0|||
157226831|NCT04582539|567575975|FG000|Overall Study|Lost to Follow-up|1|||
157226832|NCT04582539|567575976|FG001|Overall Study|Lost to Follow-up|0|||
157226833|NCT04582539|567575977|FG002|Overall Study|Lost to Follow-up|0|||
157226834|NCT04582539|567575978|FG003|Overall Study|Lost to Follow-up|0|||
156922712|NCT01085591|566475525|FG001|Overall Study|Physician Decision|0|||
156922713|NCT01085591|566475526|FG002|Overall Study|Physician Decision|1|||
156922714|NCT01085591|566475524|FG000|Overall Study|Withdrawal by Subject|0|||
156922715|NCT01085591|566475525|FG001|Overall Study|Withdrawal by Subject|2|||
156922716|NCT01085591|566475526|FG002|Overall Study|Withdrawal by Subject|1|||
156922717|NCT01085591|566475524|FG000|Overall Study|Lost to Follow-up|0|||
156922718|NCT01085591|566475525|FG001|Overall Study|Lost to Follow-up|1|||
156922719|NCT01085591|566475526|FG002|Overall Study|Lost to Follow-up|1|||
156922720|NCT01085591|566475524|FG000|Overall Study|Protocol Violation|1|||
156922721|NCT01085591|566475525|FG001|Overall Study|Protocol Violation|1|||
156922722|NCT01085591|566475526|FG002|Overall Study|Protocol Violation|1|||
156922723|NCT01085591|566475524|FG000|Overall Study|Other|0|||
156922724|NCT01085591|566475525|FG001|Overall Study|Other|1|||
156922725|NCT01085591|566475526|FG002|Overall Study|Other|0|||
156922726|NCT01085591|566475524|FG000|Overall Study|Not Properly Consented|1|||
156922727|NCT01085591|566475525|FG001|Overall Study|Not Properly Consented|0|||
156922728|NCT01085591|566475526|FG002|Overall Study|Not Properly Consented|0|||
156922729|NCT00883116|566475529|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156922730|NCT00883116|566475530|FG001|Overall Study|Adverse event unrelated to study drug|10|||
156922731|NCT00883116|566475529|FG000|Overall Study|Death|6|||
156922732|NCT00883116|566475530|FG001|Overall Study|Death|2|||
156922733|NCT00883116|566475529|FG000|Overall Study|Disease progression|130|||
156922734|NCT00883116|566475530|FG001|Overall Study|Disease progression|128|||
156922735|NCT00883116|566475529|FG000|Overall Study|Lost to Follow-up|0|||
156922736|NCT00883116|566475530|FG001|Overall Study|Lost to Follow-up|1|||
156922737|NCT00883116|566475529|FG000|Overall Study|Maximum clinical benefit|13|||
156922738|NCT00883116|566475530|FG001|Overall Study|Maximum clinical benefit|46|||
156922739|NCT00883116|566475529|FG000|Overall Study|Not identified|3|||
156922740|NCT00883116|566475530|FG001|Overall Study|Not identified|6|||
156922741|NCT00883116|566475529|FG000|Overall Study|Study drug toxicity|36|||
156922742|NCT00883116|566475530|FG001|Overall Study|Study drug toxicity|16|||
156922743|NCT00883116|566475529|FG000|Overall Study|Withdrawal by Subject|14|||
156922744|NCT00883116|566475530|FG001|Overall Study|Withdrawal by Subject|8|||
157226835|NCT04582539|567575979|FG004|Overall Study|Lost to Follow-up|0|||
157226836|NCT04582539|567575975|FG000|Overall Study|Study Terminated by Sponsor|1|||
157226837|NCT04582539|567575976|FG001|Overall Study|Study Terminated by Sponsor|3|||
157226838|NCT04582539|567575977|FG002|Overall Study|Study Terminated by Sponsor|2|||
156922745|NCT00883116|566475529|FG000|Overall Study|No longer meets study criteria|2|||
156922746|NCT00883116|566475530|FG001|Overall Study|No longer meets study criteria|2|||
156922747|NCT03241342|566475534|FG000|Overall Study|Adverse Event|5|||
156922748|NCT03241342|566475535|FG001|Overall Study|Adverse Event|8|||
156922749|NCT03241342|566475536|FG002|Overall Study|Adverse Event|4|||
156922750|NCT03241342|566475534|FG000|Overall Study|Lack of Efficacy|0|||
157226839|NCT04582539|567575978|FG003|Overall Study|Study Terminated by Sponsor|2|||
157226840|NCT04582539|567575979|FG004|Overall Study|Study Terminated by Sponsor|3|||
157226841|NCT04582539|567575975|FG000|Overall Study|Physician Decision|0|||
156922751|NCT03241342|566475535|FG001|Overall Study|Lack of Efficacy|0|||
156922752|NCT03241342|566475536|FG002|Overall Study|Lack of Efficacy|1|||
156922753|NCT03241342|566475534|FG000|Overall Study|noncompliance with study drug|2|||
156922754|NCT03241342|566475535|FG001|Overall Study|noncompliance with study drug|1|||
156922755|NCT03241342|566475536|FG002|Overall Study|noncompliance with study drug|1|||
156922756|NCT03241342|566475534|FG000|Overall Study|sponsor decision|0|||
157028762|NCT04171141|566862790|FG000|Overall Study|Physician Decision|0|||
157028763|NCT04171141|566862791|FG001|Overall Study|Physician Decision|0|||
157028764|NCT04171141|566862792|FG002|Overall Study|Physician Decision|0|||
157028765|NCT04171141|566862793|FG003|Overall Study|Physician Decision|0|||
157028766|NCT04171141|566862794|FG004|Overall Study|Physician Decision|1|||
156922757|NCT03241342|566475535|FG001|Overall Study|sponsor decision|1|||
156922758|NCT03241342|566475536|FG002|Overall Study|sponsor decision|2|||
156922759|NCT03241342|566475534|FG000|Overall Study|not reported|15|||
156922760|NCT03241342|566475535|FG001|Overall Study|not reported|21|||
156922761|NCT03241342|566475536|FG002|Overall Study|not reported|19|||
156922762|NCT01846611|566475542|FG000|Overall Study|Lost to Follow-up|4|||
156922763|NCT01846611|566475543|FG001|Overall Study|Lost to Follow-up|6|||
156922764|NCT01846611|566475542|FG000|Overall Study|Withdrawal by Subject|15|||
156922765|NCT01846611|566475543|FG001|Overall Study|Withdrawal by Subject|19|||
156922766|NCT01846611|566475542|FG000|Overall Study|Other|19|||
156922767|NCT01846611|566475543|FG001|Overall Study|Other|18|||
156922768|NCT02671422|566475544|FG000|Overall Study|Lost to Follow-up|1|||
156922769|NCT02671422|566475544|FG000|Overall Study|Adverse Event|68|||
156922770|NCT02671422|566475544|FG000|Overall Study|Lack of Efficacy|1|||
156922771|NCT02671422|566475544|FG000|Overall Study|Lost to Follow-up|4|||
156922772|NCT02671422|566475544|FG000|Overall Study|Withdrawal by Subject|7|||
156922773|NCT02671422|566475544|FG000|Overall Study|Progressive Disease|156|||
156922774|NCT02671422|566475544|FG000|Overall Study|Worsening of Disease|4|||
156922775|NCT02671422|566475544|FG000|Overall Study|Sponsor decision|5|||
156922776|NCT02671422|566475544|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
156922777|NCT02671422|566475544|FG000|Overall Study|Not treated with Vargatef®|3|||
156922778|NCT02671422|566475544|FG000|Overall Study|Other not defined above|3|||
156922779|NCT02289079|566475545|FG000|Overall Study|Physician Decision|2|||
156922780|NCT02289079|566475546|FG001|Overall Study|Physician Decision|0|||
156922781|NCT02289079|566475545|FG000|Overall Study|Lost to Follow-up|0|||
156922782|NCT02289079|566475546|FG001|Overall Study|Lost to Follow-up|1|||
156922783|NCT02111850|566475547|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922784|NCT02111850|566475548|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922785|NCT02111850|566475549|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922786|NCT02111850|566475550|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922787|NCT02111850|566475551|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
156922788|NCT02111850|566475552|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922789|NCT02111850|566475553|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922790|NCT02111850|566475554|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922791|NCT02111850|566475555|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922792|NCT02111850|566475556|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922793|NCT02111850|566475557|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
156922794|NCT03061331|566475558|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
156922795|NCT03061331|566475559|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
156922796|NCT02625259|566475560|FG000|First Intervention (Day 1)|Other|0|||
156922797|NCT02625259|566475561|FG001|First Intervention (Day 1)|Other|0|||
156922798|NCT02625259|566475562|FG002|First Intervention (Day 1)|Other|1|||
156922799|NCT02625259|566475563|FG003|First Intervention (Day 1)|Other|0|||
156922800|NCT02625259|566475564|FG004|First Intervention (Day 1)|Other|0|||
156922801|NCT02625259|566475560|FG000|First Intervention (Day 1)|Adverse Event|2|||
156922802|NCT02625259|566475561|FG001|First Intervention (Day 1)|Adverse Event|1|||
156922803|NCT02625259|566475562|FG002|First Intervention (Day 1)|Adverse Event|0|||
156922804|NCT02625259|566475563|FG003|First Intervention (Day 1)|Adverse Event|0|||
156922805|NCT02625259|566475564|FG004|First Intervention (Day 1)|Adverse Event|0|||
156922806|NCT02625259|566475560|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
156922807|NCT02625259|566475561|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
156922808|NCT02625259|566475562|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
156922809|NCT02625259|566475563|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
156922810|NCT02625259|566475564|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
156922811|NCT00513474|566475565|FG000|Overall Study|Death|6|||
157028767|NCT04171141|566862795|FG005|Overall Study|Physician Decision|0|||
156922812|NCT00513474|566475566|FG001|Overall Study|Death|9|||
156922813|NCT00513474|566475565|FG000|Overall Study|Participant Withdrew Consent|1|||
156922814|NCT00513474|566475566|FG001|Overall Study|Participant Withdrew Consent|0|||
156922815|NCT04772755|566475567|FG000|Overall Study|Withdrawal by Subject|1|||
156922816|NCT04772755|566475568|FG001|Overall Study|Withdrawal by Subject|0|||
157028768|NCT04171141|566862796|FG006|Overall Study|Physician Decision|0|||
157226842|NCT04582539|567575976|FG001|Overall Study|Physician Decision|1|||
157226843|NCT04582539|567575977|FG002|Overall Study|Physician Decision|0|||
157226844|NCT04582539|567575978|FG003|Overall Study|Physician Decision|0|||
157226845|NCT04582539|567575979|FG004|Overall Study|Physician Decision|0|||
157226846|NCT04582539|567575975|FG000|Overall Study|Withdrawal by Subject|1|||
157226847|NCT04582539|567575976|FG001|Overall Study|Withdrawal by Subject|0|||
157226848|NCT04582539|567575977|FG002|Overall Study|Withdrawal by Subject|2|||
157226849|NCT04582539|567575978|FG003|Overall Study|Withdrawal by Subject|1|||
157226850|NCT04582539|567575979|FG004|Overall Study|Withdrawal by Subject|0|||
157226851|NCT04582539|567575975|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
157226852|NCT04582539|567575976|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
157226853|NCT04582539|567575977|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
157226854|NCT04582539|567575978|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
157226855|NCT04582539|567575979|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
157226856|NCT00788957|567575980|FG000|Part 1|Death|8|||
157226857|NCT00788957|567575981|FG001|Part 1|Death|0|||
157226858|NCT00788957|567575982|FG002|Part 1|Death|0|||
157226859|NCT00788957|567575983|FG003|Part 1|Death|0|||
157226860|NCT00788957|567575984|FG004|Part 1|Death|0|||
157226861|NCT00788957|567575985|FG005|Part 1|Death|0|||
157226862|NCT00788957|567575980|FG000|Part 1|Lost to Follow-up|1|||
157226863|NCT00788957|567575981|FG001|Part 1|Lost to Follow-up|0|||
157226864|NCT00788957|567575982|FG002|Part 1|Lost to Follow-up|0|||
156922817|NCT04772755|566475567|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
156922818|NCT04772755|566475568|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
156922819|NCT00662363|566475569|FG000|Overall Study|Withdrawal by Subject|6|||
156922820|NCT00662363|566475570|FG001|Overall Study|Withdrawal by Subject|5|||
157164182|NCT03655717|567342030|FG000|Overall Study|Lost to Follow-up|3|||
157164183|NCT03655717|567342031|FG001|Overall Study|Lost to Follow-up|1|||
157164184|NCT03655717|567342032|FG002|Overall Study|Lost to Follow-up|0|||
157164185|NCT03655717|567342033|FG003|Overall Study|Lost to Follow-up|1|||
157164186|NCT03655717|567342034|FG004|Overall Study|Lost to Follow-up|0|||
157164187|NCT03655717|567342035|FG005|Overall Study|Lost to Follow-up|1|||
157164188|NCT03655717|567342036|FG006|Overall Study|Lost to Follow-up|0|||
157164189|NCT03655717|567342037|FG007|Overall Study|Lost to Follow-up|0|||
157164190|NCT03655717|567342038|FG008|Overall Study|Lost to Follow-up|0|||
157164191|NCT03655717|567342039|FG009|Overall Study|Lost to Follow-up|0|||
157164192|NCT03655717|567342040|FG010|Overall Study|Lost to Follow-up|0|||
157164193|NCT03655717|567342041|FG011|Overall Study|Lost to Follow-up|1|||
157164194|NCT03655717|567342042|FG012|Overall Study|Lost to Follow-up|0|||
157164195|NCT03655717|567342043|FG013|Overall Study|Lost to Follow-up|0|||
157164196|NCT03655717|567342044|FG014|Overall Study|Lost to Follow-up|0|||
157164197|NCT03655717|567342045|FG015|Overall Study|Lost to Follow-up|0|||
157164198|NCT03655717|567342046|FG016|Overall Study|Lost to Follow-up|0|||
157164199|NCT03655717|567342047|FG017|Overall Study|Lost to Follow-up|0|||
157164200|NCT03655717|567342048|FG018|Overall Study|Lost to Follow-up|0|||
157164201|NCT03655717|567342049|FG019|Overall Study|Lost to Follow-up|0|||
157164202|NCT03655717|567342050|FG020|Overall Study|Lost to Follow-up|0|||
157164203|NCT03655717|567342051|FG021|Overall Study|Lost to Follow-up|0|||
157164204|NCT03655717|567342052|FG022|Overall Study|Lost to Follow-up|0|||
157164205|NCT03655717|567342053|FG023|Overall Study|Lost to Follow-up|0|||
157164206|NCT03655717|567342054|FG024|Overall Study|Lost to Follow-up|0|||
157164207|NCT03655717|567342055|FG025|Overall Study|Lost to Follow-up|0|||
157164208|NCT01185249|567342056|FG000|Overall Study|Patients discharged or change in status|42|||
157164209|NCT02365584|567342057|FG000|Overall Study|Adverse Event|2|||
157164210|NCT02365584|567342058|FG001|Overall Study|Adverse Event|2|||
157164211|NCT02365584|567342057|FG000|Overall Study|Withdrawal by Subject|1|||
157164212|NCT02365584|567342058|FG001|Overall Study|Withdrawal by Subject|0|||
157164213|NCT02365584|567342057|FG000|Overall Study|Disease Progression|9|||
157226865|NCT00788957|567575983|FG003|Part 1|Lost to Follow-up|0|||
157226866|NCT00788957|567575984|FG004|Part 1|Lost to Follow-up|0|||
157226867|NCT00788957|567575985|FG005|Part 1|Lost to Follow-up|0|||
156922821|NCT00662363|566475569|FG000|Overall Study|Adverse Event|0|||
156922822|NCT00662363|566475570|FG001|Overall Study|Adverse Event|3|||
156922823|NCT00662363|566475569|FG000|Overall Study|Discharged early from rehab|4|||
157164214|NCT02365584|567342058|FG001|Overall Study|Disease Progression|12|||
157164215|NCT01973452|567342059|FG000|Overall Study|Lack of Efficacy|0|||
157164216|NCT01973452|567342060|FG001|Overall Study|Lack of Efficacy|1|||
157164217|NCT01973452|567342059|FG000|Overall Study|Lost to Follow-up|1|||
157226868|NCT00788957|567575980|FG000|Part 2|Withdrawal by Subject|0|||
157226869|NCT00788957|567575981|FG001|Part 2|Withdrawal by Subject|9|||
157226870|NCT00788957|567575982|FG002|Part 2|Withdrawal by Subject|5|||
157226871|NCT00788957|567575983|FG003|Part 2|Withdrawal by Subject|3|||
156922824|NCT00662363|566475570|FG001|Overall Study|Discharged early from rehab|1|||
157164218|NCT01973452|567342060|FG001|Overall Study|Lost to Follow-up|0|||
157164219|NCT01973452|567342059|FG000|Overall Study|Withdrawal by Subject|10|||
157164220|NCT01973452|567342060|FG001|Overall Study|Withdrawal by Subject|9|||
157164221|NCT01973452|567342059|FG000|Overall Study|Ineligible|1|||
157164222|NCT01973452|567342060|FG001|Overall Study|Ineligible|1|||
156922825|NCT00662363|566475569|FG000|Overall Study|Protocol Violation|1|||
156922826|NCT00662363|566475570|FG001|Overall Study|Protocol Violation|1|||
156922827|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Adverse Event|82|||
156922828|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Death|6|||
156922829|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
156922830|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
156922831|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
156922832|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
156922833|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
156922834|NCT00195676|566475571|FG000|Period O - Open-label Treatment|Other reasons|68|||
156922835|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
156922836|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
156922837|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
156922838|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
156922839|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
156922840|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
156922841|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
156922842|NCT00195676|566475571|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
156922843|NCT00195676|566475571|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
156922844|NCT00195676|566475571|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
156922845|NCT00195676|566475571|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
156922846|NCT00195676|566475571|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
156922847|NCT00195676|566475571|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
156922848|NCT01189812|566475572|FG000|Overall Study|Withdrawal by Subject|2|||
156922849|NCT01189812|566475573|FG001|Overall Study|Withdrawal by Subject|3|||
156922850|NCT01189812|566475572|FG000|Overall Study|Adverse Event|1|||
156922851|NCT01189812|566475573|FG001|Overall Study|Adverse Event|0|||
156922852|NCT01189812|566475572|FG000|Overall Study|Out of Window|4|||
156922853|NCT01189812|566475573|FG001|Overall Study|Out of Window|3|||
156922854|NCT01189812|566475572|FG000|Overall Study|Moved out of State|1|||
156922855|NCT01189812|566475573|FG001|Overall Study|Moved out of State|2|||
156922856|NCT01905657|566475574|FG000|Overall Study|Adverse Event|23|||
156922857|NCT01905657|566475575|FG001|Overall Study|Adverse Event|17|||
156922858|NCT01905657|566475576|FG002|Overall Study|Adverse Event|18|||
156922859|NCT01905657|566475574|FG000|Overall Study|Clinical Progression|103|||
156922860|NCT01905657|566475575|FG001|Overall Study|Clinical Progression|78|||
156922861|NCT01905657|566475576|FG002|Overall Study|Clinical Progression|59|||
156922862|NCT01905657|566475574|FG000|Overall Study|Death|40|||
156922863|NCT01905657|566475575|FG001|Overall Study|Death|43|||
156922864|NCT01905657|566475576|FG002|Overall Study|Death|47|||
156922865|NCT01905657|566475574|FG000|Overall Study|Excluded Medication|13|||
156922866|NCT01905657|566475575|FG001|Overall Study|Excluded Medication|16|||
156922867|NCT01905657|566475576|FG002|Overall Study|Excluded Medication|9|||
156922868|NCT01905657|566475574|FG000|Overall Study|Lost to Follow-up|1|||
156922869|NCT01905657|566475575|FG001|Overall Study|Lost to Follow-up|2|||
156922870|NCT01905657|566475576|FG002|Overall Study|Lost to Follow-up|1|||
156922871|NCT01905657|566475574|FG000|Overall Study|Physician Decision|5|||
156922872|NCT01905657|566475575|FG001|Overall Study|Physician Decision|8|||
156922873|NCT01905657|566475576|FG002|Overall Study|Physician Decision|12|||
156922874|NCT01905657|566475574|FG000|Overall Study|Protocol Violation|2|||
156922875|NCT01905657|566475575|FG001|Overall Study|Protocol Violation|1|||
156922876|NCT01905657|566475576|FG002|Overall Study|Protocol Violation|1|||
156922877|NCT01905657|566475574|FG000|Overall Study|Screen Failure|0|||
156922878|NCT01905657|566475575|FG001|Overall Study|Screen Failure|1|||
156922879|NCT01905657|566475576|FG002|Overall Study|Screen Failure|0|||
156922880|NCT01905657|566475574|FG000|Overall Study|Withdrawal by Subject|15|||
156922881|NCT01905657|566475575|FG001|Overall Study|Withdrawal by Subject|21|||
156922882|NCT01905657|566475576|FG002|Overall Study|Withdrawal by Subject|53|||
156922883|NCT01905657|566475574|FG000|Overall Study|Sponsor Decision|1|||
156922884|NCT01905657|566475575|FG001|Overall Study|Sponsor Decision|0|||
156922885|NCT01905657|566475576|FG002|Overall Study|Sponsor Decision|0|||
156922886|NCT05838742|566475577|FG000|Overall Study|Adverse Event|2|||
156922887|NCT05838742|566475578|FG001|Overall Study|Adverse Event|0|||
156922888|NCT05838742|566475579|FG002|Overall Study|Adverse Event|1|||
157226872|NCT00788957|567575984|FG004|Part 2|Withdrawal by Subject|0|||
157226873|NCT00788957|567575985|FG005|Part 2|Withdrawal by Subject|0|||
157226874|NCT00788957|567575980|FG000|Part 2|Death|0|||
157226875|NCT00788957|567575981|FG001|Part 2|Death|32|||
157226876|NCT00788957|567575982|FG002|Part 2|Death|35|||
157226877|NCT00788957|567575983|FG003|Part 2|Death|37|||
156922889|NCT05838742|566475580|FG003|Overall Study|Adverse Event|0|||
156922890|NCT05838742|566475581|FG004|Overall Study|Adverse Event|1|||
156922891|NCT05838742|566475577|FG000|Overall Study|Lost to Follow-up|1|||
156922892|NCT05838742|566475578|FG001|Overall Study|Lost to Follow-up|1|||
156922893|NCT05838742|566475579|FG002|Overall Study|Lost to Follow-up|1|||
156922894|NCT05838742|566475580|FG003|Overall Study|Lost to Follow-up|0|||
157226878|NCT00788957|567575984|FG004|Part 2|Death|0|||
156922895|NCT05838742|566475581|FG004|Overall Study|Lost to Follow-up|0|||
156922896|NCT05838742|566475577|FG000|Overall Study|Physician Decision|0|||
156922897|NCT05838742|566475578|FG001|Overall Study|Physician Decision|0|||
156922898|NCT05838742|566475579|FG002|Overall Study|Physician Decision|0|||
156922899|NCT05838742|566475580|FG003|Overall Study|Physician Decision|0|||
156922900|NCT05838742|566475581|FG004|Overall Study|Physician Decision|1|||
156922901|NCT05838742|566475577|FG000|Overall Study|Withdrawal by Subject|8|||
156922902|NCT05838742|566475578|FG001|Overall Study|Withdrawal by Subject|3|||
156922903|NCT05838742|566475579|FG002|Overall Study|Withdrawal by Subject|3|||
156922904|NCT05838742|566475580|FG003|Overall Study|Withdrawal by Subject|1|||
156922905|NCT05838742|566475581|FG004|Overall Study|Withdrawal by Subject|4|||
156922906|NCT05838742|566475577|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
156922907|NCT05838742|566475578|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
156922908|NCT05838742|566475579|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
156922909|NCT05838742|566475580|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
156922910|NCT05838742|566475581|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
156922911|NCT05838742|566475577|FG000|Overall Study|Lack of Efficacy|0|||
156922912|NCT05838742|566475578|FG001|Overall Study|Lack of Efficacy|0|||
156922913|NCT05838742|566475579|FG002|Overall Study|Lack of Efficacy|0|||
156922914|NCT05838742|566475580|FG003|Overall Study|Lack of Efficacy|1|||
156922915|NCT05838742|566475581|FG004|Overall Study|Lack of Efficacy|0|||
156922916|NCT05838742|566475577|FG000|Overall Study|Randomized, not treated|2|||
156922917|NCT05838742|566475578|FG001|Overall Study|Randomized, not treated|1|||
156922918|NCT05838742|566475579|FG002|Overall Study|Randomized, not treated|0|||
156922919|NCT05838742|566475580|FG003|Overall Study|Randomized, not treated|1|||
156922920|NCT05838742|566475581|FG004|Overall Study|Randomized, not treated|0|||
156922921|NCT05119569|566475584|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
156922922|NCT05119569|566475585|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
156922923|NCT05119569|566475586|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156922924|NCT05119569|566475587|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
156922925|NCT05119569|566475584|FG000|Double Blind Treatment Phase|Adverse Event|6|||
156922926|NCT05119569|566475585|FG001|Double Blind Treatment Phase|Adverse Event|0|||
156922927|NCT05119569|566475586|FG002|Double Blind Treatment Phase|Adverse Event|0|||
156922928|NCT05119569|566475587|FG003|Double Blind Treatment Phase|Adverse Event|0|||
156922929|NCT05119569|566475584|FG000|Open Label Extension Phase|Ongoing in the study|0|||
156922930|NCT05119569|566475585|FG001|Open Label Extension Phase|Ongoing in the study|0|||
156922931|NCT05119569|566475586|FG002|Open Label Extension Phase|Ongoing in the study|65|||
156922932|NCT05119569|566475587|FG003|Open Label Extension Phase|Ongoing in the study|34|||
156922933|NCT02623439|566475590|FG000|Overall Study|Withdrawal by Subject|1|||
156922934|NCT02623439|566475590|FG000|Overall Study|Screen Failure|1|||
156922935|NCT02200445|566475594|FG000|Overall Study|Lack of Efficacy|1|||
156922936|NCT02200445|566475595|FG001|Overall Study|Lack of Efficacy|2|||
156922937|NCT02200445|566475596|FG002|Overall Study|Lack of Efficacy|2|||
156922938|NCT02200445|566475594|FG000|Overall Study|Adverse Event|0|||
156922939|NCT02200445|566475595|FG001|Overall Study|Adverse Event|2|||
156922940|NCT02200445|566475596|FG002|Overall Study|Adverse Event|0|||
156922941|NCT04484142|566475597|FG000|Overall Study|Adverse Event|13|||
156922942|NCT04484142|566475597|FG000|Overall Study|Progressive Disease|87|||
156922943|NCT04484142|566475597|FG000|Overall Study|Clinical Progression|10|||
156922944|NCT04484142|566475597|FG000|Overall Study|Withdrawal by Subject|6|||
156922945|NCT04484142|566475597|FG000|Overall Study|Physician Decision|1|||
156922946|NCT03700671|566475598|FG000|Overall Study|Lack of Efficacy|1|||
156922947|NCT03700671|566475599|FG001|Overall Study|Lack of Efficacy|2|||
156922948|NCT05371509|566475600|FG000|Overall Study|Physician Decision|1|||
156922949|NCT05371509|566475601|FG001|Overall Study|Physician Decision|0|||
156922950|NCT03851302|566475608|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
156922951|NCT03851302|566475609|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
156922952|NCT03851302|566475610|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
156922953|NCT03851302|566475611|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
156922954|NCT03851302|566475612|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
156922955|NCT03851302|566475613|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
156922956|NCT03851302|566475608|FG000|Screening (1 Day)|Screened out|0|||
156922957|NCT03851302|566475609|FG001|Screening (1 Day)|Screened out|0|||
156922958|NCT03851302|566475610|FG002|Screening (1 Day)|Screened out|1|||
156922959|NCT03851302|566475611|FG003|Screening (1 Day)|Screened out|1|||
156922960|NCT03851302|566475612|FG004|Screening (1 Day)|Screened out|0|||
156922961|NCT03851302|566475613|FG005|Screening (1 Day)|Screened out|0|||
156922962|NCT03851302|566475608|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
156922963|NCT03851302|566475609|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
156922964|NCT03851302|566475610|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
156922965|NCT03851302|566475611|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
156922966|NCT03851302|566475612|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
156922967|NCT03851302|566475613|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
156922968|NCT00982488|566478117|FG000|Overall Study|Administrative reason by sponsor|81|||
156922969|NCT00982488|566478118|FG001|Overall Study|Administrative reason by sponsor|3|||
156922970|NCT00982488|566478119|FG002|Overall Study|Administrative reason by sponsor|11|||
157164223|NCT01973452|567342059|FG000|Overall Study|Surgery canceled by participant|5|||
157164224|NCT01973452|567342060|FG001|Overall Study|Surgery canceled by participant|3|||
157164225|NCT03521193|567342061|FG000|Overall Study|Withdrawal by Subject|8|||
157164226|NCT03521193|567342062|FG001|Overall Study|Withdrawal by Subject|0|||
157028769|NCT04171141|566862797|FG007|Overall Study|Physician Decision|0|||
157028770|NCT04171141|566862798|FG008|Overall Study|Physician Decision|0|||
157028771|NCT04171141|566862799|FG009|Overall Study|Physician Decision|0|||
157028772|NCT04171141|566862800|FG010|Overall Study|Physician Decision|0|||
157028773|NCT04171141|566862801|FG011|Overall Study|Physician Decision|0|||
157028774|NCT04171141|566862802|FG012|Overall Study|Physician Decision|0|||
157028775|NCT04171141|566862803|FG013|Overall Study|Physician Decision|0|||
157028776|NCT04171141|566862804|FG014|Overall Study|Physician Decision|0|||
157028777|NCT04171141|566862805|FG015|Overall Study|Physician Decision|1|||
157028778|NCT04171141|566862790|FG000|Overall Study|Progressive disease|2|||
157028779|NCT04171141|566862791|FG001|Overall Study|Progressive disease|3|||
157164227|NCT03521193|567342061|FG000|Overall Study|non compliant to ASA treatment|8|||
157164228|NCT03521193|567342062|FG001|Overall Study|non compliant to ASA treatment|0|||
156922971|NCT00982488|566478120|FG003|Overall Study|Administrative reason by sponsor|0|||
156922972|NCT00982488|566478121|FG004|Overall Study|Administrative reason by sponsor|0|||
156922973|NCT00982488|566478117|FG000|Overall Study|Adverse event unrelated to study drug|5|||
156922974|NCT00982488|566478118|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156922975|NCT00982488|566478119|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156922976|NCT00982488|566478120|FG003|Overall Study|Adverse event unrelated to study drug|0|||
156922977|NCT00982488|566478121|FG004|Overall Study|Adverse event unrelated to study drug|0|||
156922978|NCT00982488|566478117|FG000|Overall Study|Death|11|||
156922979|NCT00982488|566478118|FG001|Overall Study|Death|0|||
156922980|NCT00982488|566478119|FG002|Overall Study|Death|2|||
156922981|NCT00982488|566478120|FG003|Overall Study|Death|0|||
156922982|NCT00982488|566478121|FG004|Overall Study|Death|0|||
156922983|NCT00982488|566478117|FG000|Overall Study|Disease progression|30|||
156922984|NCT00982488|566478118|FG001|Overall Study|Disease progression|5|||
156922985|NCT00982488|566478119|FG002|Overall Study|Disease progression|10|||
156922986|NCT00982488|566478120|FG003|Overall Study|Disease progression|1|||
156922987|NCT00982488|566478121|FG004|Overall Study|Disease progression|1|||
156922988|NCT00982488|566478117|FG000|Overall Study|Lost to Follow-up|1|||
156922989|NCT00982488|566478118|FG001|Overall Study|Lost to Follow-up|0|||
156922990|NCT00982488|566478119|FG002|Overall Study|Lost to Follow-up|0|||
156922991|NCT00982488|566478120|FG003|Overall Study|Lost to Follow-up|0|||
156922992|NCT00982488|566478121|FG004|Overall Study|Lost to Follow-up|0|||
156922993|NCT00982488|566478117|FG000|Overall Study|Maximum clinical benefit|1|||
156922994|NCT00982488|566478118|FG001|Overall Study|Maximum clinical benefit|1|||
156922995|NCT00982488|566478119|FG002|Overall Study|Maximum clinical benefit|1|||
156922996|NCT00982488|566478120|FG003|Overall Study|Maximum clinical benefit|0|||
156922997|NCT00982488|566478121|FG004|Overall Study|Maximum clinical benefit|0|||
156922998|NCT00982488|566478117|FG000|Overall Study|Other|15|||
156922999|NCT00982488|566478118|FG001|Overall Study|Other|1|||
156923000|NCT00982488|566478119|FG002|Overall Study|Other|3|||
156923001|NCT00982488|566478120|FG003|Overall Study|Other|1|||
157164229|NCT03675737|567342065|FG000|Overall Study|Death|593|||
157164230|NCT03675737|567342066|FG001|Overall Study|Death|660|||
157164231|NCT03675737|567342065|FG000|Overall Study|Lost to Follow-up|1|||
157164232|NCT03675737|567342066|FG001|Overall Study|Lost to Follow-up|5|||
157164233|NCT03675737|567342065|FG000|Overall Study|Physician Decision|1|||
157164234|NCT03675737|567342066|FG001|Overall Study|Physician Decision|0|||
157164235|NCT03675737|567342065|FG000|Overall Study|Withdrawal by Subject|14|||
157164236|NCT03675737|567342066|FG001|Overall Study|Withdrawal by Subject|12|||
157164237|NCT03675737|567342065|FG000|Overall Study|Ongoing in Study|181|||
157164238|NCT03675737|567342066|FG001|Overall Study|Ongoing in Study|112|||
157164239|NCT01089582|567343923|FG000|Overall Study|Death|2|||
157164240|NCT01089582|567343923|FG000|Overall Study|Adverse Event|15|||
157164241|NCT01089582|567343923|FG000|Overall Study|Lost to Follow-up|8|||
157164242|NCT01089582|567343923|FG000|Overall Study|Other|4|||
157164243|NCT01089582|567343923|FG000|Overall Study|Withdrawal by Subject|1|||
157164244|NCT04069156|567343924|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
156923002|NCT00982488|566478121|FG004|Overall Study|Other|0|||
156923003|NCT00982488|566478117|FG000|Overall Study|Poor compliance/noncompliance|0|||
156923004|NCT00982488|566478118|FG001|Overall Study|Poor compliance/noncompliance|1|||
156923005|NCT00982488|566478119|FG002|Overall Study|Poor compliance/noncompliance|0|||
156923006|NCT00982488|566478120|FG003|Overall Study|Poor compliance/noncompliance|0|||
156923007|NCT00982488|566478121|FG004|Overall Study|Poor compliance/noncompliance|0|||
156923008|NCT00982488|566478117|FG000|Overall Study|Stem cell transplant|2|||
156923009|NCT00982488|566478118|FG001|Overall Study|Stem cell transplant|0|||
157028780|NCT04171141|566862792|FG002|Overall Study|Progressive disease|4|||
157028781|NCT04171141|566862793|FG003|Overall Study|Progressive disease|7|||
157028782|NCT04171141|566862794|FG004|Overall Study|Progressive disease|1|||
157028783|NCT04171141|566862795|FG005|Overall Study|Progressive disease|8|||
157164245|NCT04069156|567343925|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
157164246|NCT04069156|567343924|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
156923010|NCT00982488|566478119|FG002|Overall Study|Stem cell transplant|0|||
156923011|NCT00982488|566478120|FG003|Overall Study|Stem cell transplant|1|||
156923012|NCT00982488|566478121|FG004|Overall Study|Stem cell transplant|0|||
156923013|NCT00982488|566478117|FG000|Overall Study|Study drug toxicity|34|||
156923014|NCT00982488|566478118|FG001|Overall Study|Study drug toxicity|1|||
156923015|NCT00982488|566478119|FG002|Overall Study|Study drug toxicity|6|||
156923016|NCT00982488|566478120|FG003|Overall Study|Study drug toxicity|0|||
156923017|NCT00982488|566478121|FG004|Overall Study|Study drug toxicity|0|||
156923018|NCT00982488|566478117|FG000|Overall Study|Withdrawal by Subject|5|||
156923019|NCT00982488|566478118|FG001|Overall Study|Withdrawal by Subject|1|||
156923020|NCT00982488|566478119|FG002|Overall Study|Withdrawal by Subject|1|||
156923021|NCT00982488|566478120|FG003|Overall Study|Withdrawal by Subject|0|||
156923022|NCT00982488|566478121|FG004|Overall Study|Withdrawal by Subject|0|||
156923023|NCT04244786|566478122|FG000|Overall Study|Adverse Event|0|||
156923024|NCT04244786|566478123|FG001|Overall Study|Adverse Event|0|||
156923025|NCT04244786|566478124|FG002|Overall Study|Adverse Event|2|||
156923026|NCT04244786|566478122|FG000|Overall Study|Withdrawal by Subject|0|||
156923027|NCT04244786|566478123|FG001|Overall Study|Withdrawal by Subject|0|||
156923028|NCT04244786|566478124|FG002|Overall Study|Withdrawal by Subject|5|||
156923029|NCT00001596|566478125|FG000|Overall Study|Death|1|||
156923030|NCT00001596|566478126|FG001|Overall Study|Death|0|||
156923031|NCT00001596|566478125|FG000|Overall Study|Withdrawal by Subject|3|||
156923032|NCT00001596|566478126|FG001|Overall Study|Withdrawal by Subject|1|||
156923033|NCT00001596|566478125|FG000|Overall Study|Study Termination|12|||
156923034|NCT00001596|566478126|FG001|Overall Study|Study Termination|9|||
156923035|NCT00001596|566478125|FG000|Overall Study|Adverse Event|1|||
156923036|NCT00001596|566478126|FG001|Overall Study|Adverse Event|0|||
156923037|NCT03274687|566478127|FG000|Overall Study|Protocol Violation|1|||
156923038|NCT03274687|566478128|FG001|Overall Study|Protocol Violation|1|||
156923039|NCT02636868|566478130|FG000|Overall Study|Death|0|||
156923040|NCT02636868|566478131|FG001|Overall Study|Death|1|||
156923041|NCT02636868|566478132|FG002|Overall Study|Death|2|||
156923042|NCT00903617|566478135|FG000|Overall Study|Adverse Event|0|||
156923043|NCT00903617|566478136|FG001|Overall Study|Adverse Event|1|||
156923044|NCT00903617|566478137|FG002|Overall Study|Adverse Event|1|||
156923045|NCT00903617|566478138|FG003|Overall Study|Adverse Event|0|||
156923046|NCT00903617|566478135|FG000|Overall Study|Protocol-defined stopping criteria|0|||
156923047|NCT00903617|566478136|FG001|Overall Study|Protocol-defined stopping criteria|2|||
156923048|NCT00903617|566478137|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156923049|NCT00903617|566478138|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156923050|NCT00903617|566478135|FG000|Overall Study|Lost to Follow-up|2|||
156923051|NCT00903617|566478136|FG001|Overall Study|Lost to Follow-up|0|||
156923052|NCT00903617|566478137|FG002|Overall Study|Lost to Follow-up|1|||
156923053|NCT00903617|566478138|FG003|Overall Study|Lost to Follow-up|1|||
156923054|NCT00903617|566478135|FG000|Overall Study|Withdrawal by Subject|1|||
157164247|NCT04069156|567343925|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
157164248|NCT04069156|567343924|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
157164249|NCT04069156|567343925|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
157164250|NCT04069156|567343924|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
157164251|NCT04069156|567343925|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
157164252|NCT02108600|567343926|FG000|Overall Study|Withdrawal by Subject|2|||
157164253|NCT02108600|567343927|FG001|Overall Study|Withdrawal by Subject|0|||
157164254|NCT02108600|567343926|FG000|Overall Study|Lost to Follow-up|1|||
157164255|NCT02108600|567343927|FG001|Overall Study|Lost to Follow-up|1|||
157164256|NCT03150095|567343928|FG000|Overall Study|Death|0|||
157164257|NCT03150095|567343929|FG001|Overall Study|Death|1|||
157164258|NCT03150095|567343928|FG000|Overall Study|Lost to Follow-up|1|||
157164259|NCT03150095|567343929|FG001|Overall Study|Lost to Follow-up|1|||
157164260|NCT03150095|567343928|FG000|Overall Study|Withdrawal by Subject|4|||
157164261|NCT03150095|567343929|FG001|Overall Study|Withdrawal by Subject|0|||
157164262|NCT03150095|567343928|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
157164263|NCT03150095|567343929|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
157164264|NCT00089479|567343940|FG000|Overall Study|Death|108|||
157164265|NCT00089479|567343941|FG001|Overall Study|Death|75|||
157164266|NCT00089479|567343940|FG000|Overall Study|Withdrawal by Subject|86|||
156923055|NCT00903617|566478136|FG001|Overall Study|Withdrawal by Subject|2|||
156923056|NCT00903617|566478137|FG002|Overall Study|Withdrawal by Subject|3|||
156923057|NCT00903617|566478138|FG003|Overall Study|Withdrawal by Subject|0|||
156923058|NCT03316131|566478141|FG000|Treatment Period 2|Protocol deviation|1|||
156923059|NCT03316131|566478142|FG001|Treatment Period 2|Protocol deviation|0|||
156923060|NCT05608005|566478143|FG000|Overall Study|Adverse Event|2|||
156923061|NCT05608005|566478144|FG001|Overall Study|Adverse Event|1|||
156923062|NCT05608005|566478145|FG002|Overall Study|Adverse Event|3|||
156923063|NCT05608005|566478143|FG000|Overall Study|Protocol Violation|2|||
156923064|NCT05608005|566478144|FG001|Overall Study|Protocol Violation|3|||
156923065|NCT05608005|566478145|FG002|Overall Study|Protocol Violation|0|||
156923066|NCT05608005|566478143|FG000|Overall Study|Withdrawal by Subject|10|||
157164267|NCT00089479|567343941|FG001|Overall Study|Withdrawal by Subject|107|||
157164268|NCT00089479|567343940|FG000|Overall Study|Lost to Follow-up|137|||
157164269|NCT00089479|567343941|FG001|Overall Study|Lost to Follow-up|107|||
157164270|NCT03943953|567343942|FG000|Trial of ITG 1|Lost to Follow-up|19|||
157164271|NCT03943953|567343943|FG001|Trial of ITG 1|Lost to Follow-up|1|||
157164272|NCT03943953|567343942|FG000|Trial of ITG 2|Lost to Follow-up|8|||
157164273|NCT03943953|567343943|FG001|Trial of ITG 2|Lost to Follow-up|0|||
157164274|NCT03943953|567343942|FG000|Trial of ITG 3|Lost to Follow-up|2|||
157164275|NCT03943953|567343943|FG001|Trial of ITG 3|Lost to Follow-up|0|||
157164276|NCT03943953|567343942|FG000|Trial of ITG 4|Lost to Follow-up|2|||
157164277|NCT03943953|567343943|FG001|Trial of ITG 4|Lost to Follow-up|0|||
157164278|NCT01742078|567343946|FG000|Overall Study|Withdrawal by Subject|0|||
157164279|NCT01742078|567343947|FG001|Overall Study|Withdrawal by Subject|0|||
157164280|NCT01742078|567343948|FG002|Overall Study|Withdrawal by Subject|0|||
157164281|NCT01742078|567343949|FG003|Overall Study|Withdrawal by Subject|1|||
157164282|NCT01742078|567343950|FG004|Overall Study|Withdrawal by Subject|0|||
157164283|NCT01742078|567343951|FG005|Overall Study|Withdrawal by Subject|0|||
157164284|NCT01742078|567343952|FG006|Overall Study|Withdrawal by Subject|0|||
157164285|NCT01742078|567343953|FG007|Overall Study|Withdrawal by Subject|0|||
157164286|NCT01742078|567343954|FG008|Overall Study|Withdrawal by Subject|0|||
157164287|NCT05600309|567343957|FG000|Overall Study|Death|41|||
157164288|NCT05600309|567343958|FG001|Overall Study|Death|38|||
157164289|NCT05600309|567343957|FG000|Overall Study|Sponsor Decision|9|||
157164290|NCT05600309|567343958|FG001|Overall Study|Sponsor Decision|6|||
157164291|NCT05822830|567343959|FG000|Overall Study|Adverse Event|6|||
157164292|NCT05822830|567343960|FG001|Overall Study|Adverse Event|6|||
157164293|NCT05822830|567343959|FG000|Overall Study|Assigned Treatment by Mistake|5|||
157164294|NCT05822830|567343960|FG001|Overall Study|Assigned Treatment by Mistake|3|||
157164295|NCT05822830|567343959|FG000|Overall Study|Lost to Follow-up|16|||
157164296|NCT05822830|567343960|FG001|Overall Study|Lost to Follow-up|18|||
157164297|NCT05822830|567343959|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157164298|NCT05822830|567343960|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157164299|NCT05822830|567343959|FG000|Overall Study|Participant was Out of the Country|0|||
157164300|NCT05822830|567343960|FG001|Overall Study|Participant was Out of the Country|1|||
157164301|NCT05822830|567343959|FG000|Overall Study|Pregnancy|1|||
157164302|NCT05822830|567343960|FG001|Overall Study|Pregnancy|2|||
157164303|NCT05822830|567343959|FG000|Overall Study|Withdrawal by Subject|27|||
157164304|NCT05822830|567343960|FG001|Overall Study|Withdrawal by Subject|26|||
157164305|NCT03368664|567343967|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
157164306|NCT03368664|567343967|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
157164307|NCT03368664|567343967|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
157164308|NCT03368664|567343967|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
157164309|NCT01025817|567343969|FG000|Completed Study Medication|Adverse Event|66|||
157164310|NCT01025817|567343970|FG001|Completed Study Medication|Adverse Event|39|||
157164311|NCT01025817|567343969|FG000|Completed Study Medication|Protocol Deviation|9|||
157164312|NCT01025817|567343970|FG001|Completed Study Medication|Protocol Deviation|8|||
157164313|NCT01025817|567343969|FG000|Completed Study Medication|Withdrawal by Subject|8|||
157164314|NCT01025817|567343970|FG001|Completed Study Medication|Withdrawal by Subject|9|||
157164315|NCT01025817|567343969|FG000|Completed Study Medication|Administrative problems|7|||
157164316|NCT01025817|567343970|FG001|Completed Study Medication|Administrative problems|5|||
157164317|NCT01025817|567343969|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
157164318|NCT01025817|567343970|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
157164319|NCT01025817|567343969|FG000|Completed Study Medication|Abnormal test procedure|4|||
157164320|NCT01025817|567343970|FG001|Completed Study Medication|Abnormal test procedure|0|||
157164321|NCT01025817|567343969|FG000|Completed Study Medication|Graft loss|2|||
157164322|NCT01025817|567343970|FG001|Completed Study Medication|Graft loss|5|||
157164323|NCT01025817|567343969|FG000|Completed Study Medication|Death|2|||
157164324|NCT01025817|567343970|FG001|Completed Study Medication|Death|2|||
157164325|NCT01025817|567343969|FG000|Completed Study Medication|Abnormal lab values|0|||
157164326|NCT01025817|567343970|FG001|Completed Study Medication|Abnormal lab values|2|||
157164327|NCT01025817|567343969|FG000|Completed Study Medication|Subject no longer required study drug|0|||
157164328|NCT01025817|567343970|FG001|Completed Study Medication|Subject no longer required study drug|1|||
157164329|NCT01025817|567343969|FG000|Completed Study Medication|Lost to Follow-up|0|||
157164330|NCT01025817|567343970|FG001|Completed Study Medication|Lost to Follow-up|1|||
157164331|NCT01025817|567343969|FG000|Completed Study|Withdrawal by Subject|8|||
157164332|NCT01025817|567343970|FG001|Completed Study|Withdrawal by Subject|16|||
157164333|NCT01025817|567343969|FG000|Completed Study|Death|6|||
157164334|NCT01025817|567343970|FG001|Completed Study|Death|5|||
157164335|NCT01025817|567343969|FG000|Completed Study|Missing|2|||
157164336|NCT01025817|567343970|FG001|Completed Study|Missing|0|||
157164337|NCT01025817|567343969|FG000|Completed Study|Lost to Follow-up|0|||
157164338|NCT01025817|567343970|FG001|Completed Study|Lost to Follow-up|1|||
157164339|NCT00807846|567343973|FG000|Overall Study|Adverse Event|5|||
157164340|NCT00807846|567343974|FG001|Overall Study|Adverse Event|0|||
156923067|NCT05608005|566478144|FG001|Overall Study|Withdrawal by Subject|12|||
156923068|NCT05608005|566478145|FG002|Overall Study|Withdrawal by Subject|4|||
156923069|NCT05608005|566478143|FG000|Overall Study|Lost to Follow-up|25|||
156923070|NCT05608005|566478144|FG001|Overall Study|Lost to Follow-up|27|||
156923071|NCT05608005|566478145|FG002|Overall Study|Lost to Follow-up|15|||
156923072|NCT05608005|566478143|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
156923073|NCT05608005|566478144|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
156923074|NCT05608005|566478145|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
156923075|NCT02259582|566478152|FG000|Overall Study|Physician Decision|0|||
156923076|NCT02259582|566478153|FG001|Overall Study|Physician Decision|1|||
156923077|NCT02259582|566478154|FG002|Overall Study|Physician Decision|0|||
156923078|NCT02259582|566478152|FG000|Overall Study|Death|0|||
157164341|NCT00807846|567343973|FG000|Overall Study|Lack of Efficacy|2|||
157164342|NCT00807846|567343974|FG001|Overall Study|Lack of Efficacy|0|||
157164343|NCT00807846|567343973|FG000|Overall Study|Protocol Violation|2|||
157164344|NCT00807846|567343974|FG001|Overall Study|Protocol Violation|1|||
157164345|NCT00807846|567343973|FG000|Overall Study|Withdrawal by Subject|2|||
157164346|NCT00807846|567343974|FG001|Overall Study|Withdrawal by Subject|1|||
157164347|NCT00807846|567343973|FG000|Overall Study|Other|1|||
157164348|NCT00807846|567343974|FG001|Overall Study|Other|2|||
157164349|NCT01081873|567343975|FG000|Overall Study|Death|86|||
157164350|NCT01081873|567343975|FG000|Overall Study|Withdrawal by Subject|10|||
156923079|NCT02259582|566478153|FG001|Overall Study|Death|0|||
156923080|NCT02259582|566478154|FG002|Overall Study|Death|1|||
156923081|NCT02259582|566478152|FG000|Overall Study|Adverse Event|1|||
156923082|NCT02259582|566478153|FG001|Overall Study|Adverse Event|0|||
157164351|NCT01081873|567343975|FG000|Overall Study|Lost to Follow-up|142|||
157164352|NCT01081873|567343975|FG000|Overall Study|Progression of prostate cancer|13|||
157164353|NCT01081873|567343975|FG000|Overall Study|Other|47|||
157164354|NCT01165021|567343977|FG000|Overall Study|Death|1|||
157164355|NCT02491073|567343978|FG000|Overall Study|screen failure|1|||
157164356|NCT02491073|567343979|FG001|Overall Study|screen failure|0|||
156923083|NCT02259582|566478154|FG002|Overall Study|Adverse Event|1|||
156923084|NCT02259582|566478152|FG000|Overall Study|Withdrawal by Subject|0|||
157164357|NCT03977727|567343980|FG000|Second Treatment|Lost to Follow-up|0|||
157164358|NCT03977727|567343981|FG001|Second Treatment|Lost to Follow-up|3|||
157164359|NCT01419665|567343982|FG000|Combination Treatment|Adverse Event|7|||
157164360|NCT01419665|567343983|FG001|Combination Treatment|Adverse Event|10|||
157164361|NCT01419665|567343982|FG000|Combination Treatment|Physician Decision|5|||
156923085|NCT02259582|566478153|FG001|Overall Study|Withdrawal by Subject|0|||
156923086|NCT02259582|566478154|FG002|Overall Study|Withdrawal by Subject|1|||
156923087|NCT02259582|566478152|FG000|Overall Study|Disease progression|14|||
156923088|NCT02259582|566478153|FG001|Overall Study|Disease progression|15|||
156923089|NCT02259582|566478154|FG002|Overall Study|Disease progression|17|||
156923090|NCT02259582|566478152|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
156923091|NCT02259582|566478153|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
156923092|NCT02259582|566478154|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
157164362|NCT01419665|567343983|FG001|Combination Treatment|Physician Decision|8|||
157164363|NCT01419665|567343982|FG000|Combination Treatment|Protocol Violation|6|||
157164364|NCT01419665|567343983|FG001|Combination Treatment|Protocol Violation|2|||
157164365|NCT01419665|567343982|FG000|Combination Treatment|disease progression|10|||
156923093|NCT03045081|566478155|FG000|Overall Study|Withdrawal by Subject|6|||
156923094|NCT03045081|566478156|FG001|Overall Study|Withdrawal by Subject|11|||
156923095|NCT03804879|566478157|FG000|Overall Study|Adverse Event|3|||
156923096|NCT03804879|566478158|FG001|Overall Study|Adverse Event|0|||
156923097|NCT03804879|566478157|FG000|Overall Study|Study Terminated By Sponsor|10|||
156923098|NCT03804879|566478158|FG001|Overall Study|Study Terminated By Sponsor|12|||
156923099|NCT03804879|566478157|FG000|Overall Study|Withdrawal by Subject|3|||
156923100|NCT03804879|566478158|FG001|Overall Study|Withdrawal by Subject|1|||
156923101|NCT02169739|566478160|FG000|Overall Study|Lost to Follow-up|0|||
156923102|NCT02169739|566478161|FG001|Overall Study|Lost to Follow-up|4|||
156923103|NCT03635957|566478162|FG000|Run-In Period|Lost to Follow-up|1|||
156923104|NCT03635957|566478162|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
156923105|NCT00100815|566478163|FG000|Overall Study|Progression|24|||
156923106|NCT00100815|566478163|FG000|Overall Study|Adverse Event|18|||
156923107|NCT00100815|566478163|FG000|Overall Study|Death|4|||
156923108|NCT00100815|566478163|FG000|Overall Study|Other|3|||
156923109|NCT03683758|566478169|FG000|Overall Study|Non-study commitment conflict|1|||
156923110|NCT03683758|566478170|FG001|Overall Study|Non-study commitment conflict|3|||
156923111|NCT03683758|566478169|FG000|Overall Study|Illness preventing participation|1|||
157164366|NCT01419665|567343983|FG001|Combination Treatment|disease progression|9|||
157164367|NCT01419665|567343982|FG000|Combination Treatment|Death|5|||
157164368|NCT01419665|567343983|FG001|Combination Treatment|Death|7|||
157164369|NCT01419665|567343982|FG000|Combination Treatment|administrative problems|0|||
157164370|NCT01419665|567343983|FG001|Combination Treatment|administrative problems|1|||
157164371|NCT01419665|567343982|FG000|Combination Treatment|Withdrawal by Subject|5|||
157164372|NCT01419665|567343983|FG001|Combination Treatment|Withdrawal by Subject|4|||
157164373|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
157164374|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
157164375|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
157164376|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
157164377|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
157164378|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
157164379|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
157164380|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
157164381|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
157164382|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
157164383|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
157164384|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
157164385|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Death|1|||
157164386|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Death|2|||
157164387|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
157164388|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
157164389|NCT01419665|567343982|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
157164390|NCT01419665|567343983|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
157164391|NCT01419665|567343982|FG000|Open Label Phase|Death|1|||
157164392|NCT01419665|567343983|FG001|Open Label Phase|Death|0|||
157164393|NCT01419665|567343982|FG000|Open Label Phase|disease progression|0|||
157164394|NCT01419665|567343983|FG001|Open Label Phase|disease progression|1|||
157164395|NCT02683525|567343985|FG000|Overall Study|Lost to Follow-up|1|||
157164396|NCT02683525|567343985|FG000|Overall Study|Physician Decision|1|||
157164397|NCT02683525|567343985|FG000|Overall Study|Disease Progression|6|||
157164398|NCT03352414|567343989|FG000|Overall Study|Ineligible by operative criteria|12|||
157164399|NCT03352414|567343990|FG001|Overall Study|Ineligible by operative criteria|10|||
157164400|NCT01341652|567343991|FG000|Overall Study|Incorrect Random Assignment|0|||
157164401|NCT01341652|567343992|FG001|Overall Study|Incorrect Random Assignment|1|||
157164402|NCT01341652|567343991|FG000|Overall Study|ineligible; presence metastatic disease|0|||
157164403|NCT01341652|567343992|FG001|Overall Study|ineligible; presence metastatic disease|1|||
157164404|NCT02998554|567343996|FG000|Overall Study|Adverse Event|8|||
157164405|NCT02998554|567343997|FG001|Overall Study|Adverse Event|3|||
157164406|NCT02998554|567343996|FG000|Overall Study|Protocol deviation|1|||
157164407|NCT02998554|567343997|FG001|Overall Study|Protocol deviation|0|||
157164408|NCT02998554|567343996|FG000|Overall Study|Withdrawal by Subject|2|||
157164409|NCT02998554|567343997|FG001|Overall Study|Withdrawal by Subject|6|||
157164410|NCT02998554|567343996|FG000|Overall Study|Lost to Follow-up|0|||
157164411|NCT02998554|567343997|FG001|Overall Study|Lost to Follow-up|1|||
157164412|NCT02998554|567343996|FG000|Overall Study|Lack of Efficacy|0|||
157164413|NCT02998554|567343997|FG001|Overall Study|Lack of Efficacy|1|||
157164414|NCT02953782|567343998|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
157164415|NCT02953782|567343999|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
157164416|NCT02953782|567344000|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
157164417|NCT02953782|567344001|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
157164418|NCT02953782|567344002|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
157164419|NCT02953782|567344003|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
157164420|NCT02953782|567344004|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
157164421|NCT02953782|567344005|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
157164422|NCT02953782|567343998|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
157164423|NCT02953782|567343999|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
157164424|NCT02953782|567344000|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
157164425|NCT02953782|567344001|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
157164426|NCT02953782|567344002|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
157164427|NCT02953782|567344003|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
157164428|NCT02953782|567344004|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
157164429|NCT02953782|567344005|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
157164430|NCT02953782|567343998|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
157164431|NCT02953782|567343999|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
157164432|NCT02953782|567344000|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
157164433|NCT02953782|567344001|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
157164434|NCT02953782|567344002|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
157164435|NCT02953782|567344003|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
157164436|NCT02953782|567344004|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
157164437|NCT02953782|567344005|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
157164438|NCT02953782|567343998|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157164439|NCT02953782|567343999|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157205207|NCT03669640|567496073|FG000|Overall Study|Study Terminated by Sponsor|0|||
157226879|NCT00788957|567575985|FG005|Part 2|Death|0|||
157226880|NCT00788957|567575980|FG000|Part 2|Lost to Follow-up|0|||
157226881|NCT00788957|567575981|FG001|Part 2|Lost to Follow-up|0|||
157226882|NCT00788957|567575982|FG002|Part 2|Lost to Follow-up|3|||
157226883|NCT00788957|567575983|FG003|Part 2|Lost to Follow-up|0|||
157226884|NCT00788957|567575984|FG004|Part 2|Lost to Follow-up|0|||
157226885|NCT00788957|567575985|FG005|Part 2|Lost to Follow-up|0|||
157226886|NCT00788957|567575980|FG000|Part 2|On-study at time of data cut-off|0|||
157226887|NCT00788957|567575981|FG001|Part 2|On-study at time of data cut-off|1|||
157226888|NCT00788957|567575982|FG002|Part 2|On-study at time of data cut-off|1|||
157226889|NCT00788957|567575983|FG003|Part 2|On-study at time of data cut-off|1|||
157226890|NCT00788957|567575984|FG004|Part 2|On-study at time of data cut-off|0|||
157226891|NCT00788957|567575985|FG005|Part 2|On-study at time of data cut-off|0|||
157226892|NCT00788957|567575980|FG000|Part 3|Withdrawal by Subject|0|||
157226893|NCT00788957|567575981|FG001|Part 3|Withdrawal by Subject|0|||
157226894|NCT00788957|567575982|FG002|Part 3|Withdrawal by Subject|0|||
157226895|NCT00788957|567575983|FG003|Part 3|Withdrawal by Subject|0|||
157226896|NCT00788957|567575984|FG004|Part 3|Withdrawal by Subject|0|||
157226897|NCT00788957|567575985|FG005|Part 3|Withdrawal by Subject|2|||
157226898|NCT00788957|567575980|FG000|Part 3|Death|0|||
157226899|NCT00788957|567575981|FG001|Part 3|Death|0|||
157226900|NCT00788957|567575982|FG002|Part 3|Death|0|||
157226901|NCT00788957|567575983|FG003|Part 3|Death|0|||
157226902|NCT00788957|567575984|FG004|Part 3|Death|8|||
157226903|NCT00788957|567575985|FG005|Part 3|Death|8|||
157226904|NCT00788957|567575980|FG000|Part 3|On-study at time of data cut-off|0|||
157226905|NCT00788957|567575981|FG001|Part 3|On-study at time of data cut-off|0|||
157226906|NCT00788957|567575982|FG002|Part 3|On-study at time of data cut-off|0|||
157226907|NCT00788957|567575983|FG003|Part 3|On-study at time of data cut-off|0|||
157226908|NCT00788957|567575984|FG004|Part 3|On-study at time of data cut-off|1|||
157226909|NCT00788957|567575985|FG005|Part 3|On-study at time of data cut-off|0|||
157226910|NCT05030753|567575986|FG000|9-week|Lost to Follow-up|10|||
157226911|NCT05030753|567575987|FG001|9-week|Lost to Follow-up|7|||
157226912|NCT05030753|567575986|FG000|9-week|Withdrawal by Subject|1|||
157226913|NCT05030753|567575987|FG001|9-week|Withdrawal by Subject|0|||
157226914|NCT05030753|567575986|FG000|9-week|Excluded from analysis due to missing covariates|2|||
157226915|NCT05030753|567575987|FG001|9-week|Excluded from analysis due to missing covariates|1|||
157226916|NCT05030753|567575986|FG000|6-month post intervention|Lost to Follow-up|5|||
157226917|NCT05030753|567575987|FG001|6-month post intervention|Lost to Follow-up|4|||
157226918|NCT05030753|567575986|FG000|6-month post intervention|Withdrawal by Subject|4|||
157226919|NCT05030753|567575987|FG001|6-month post intervention|Withdrawal by Subject|0|||
157226920|NCT05030753|567575986|FG000|18-month post intervention|Lost to Follow-up|3|||
157226921|NCT05030753|567575987|FG001|18-month post intervention|Lost to Follow-up|1|||
157226922|NCT03072459|567575988|FG000|Overall Study|Device revised/removed|1|||
157226923|NCT03072459|567575988|FG000|Overall Study|Subject not able to return|1|||
157226924|NCT02097121|567575993|FG000|Overall Study|Other, not specified|4|||
157226925|NCT02097121|567575994|FG001|Overall Study|Other, not specified|2|||
157226926|NCT02097121|567575995|FG002|Overall Study|Other, not specified|3|||
157164440|NCT02953782|567344000|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
157164441|NCT02953782|567344001|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
157164442|NCT02953782|567344002|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157164443|NCT02953782|567344003|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157164444|NCT02953782|567344004|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157164445|NCT02953782|567344005|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
157164446|NCT02953782|567343998|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
157164447|NCT02953782|567343999|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
157164448|NCT02953782|567344000|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
157226927|NCT02097121|567575993|FG000|Overall Study|Lack of Efficacy|2|||
157226928|NCT02097121|567575994|FG001|Overall Study|Lack of Efficacy|1|||
157226929|NCT02097121|567575995|FG002|Overall Study|Lack of Efficacy|3|||
157226930|NCT02097121|567575993|FG000|Overall Study|Withdrawal by Subject|0|||
157226931|NCT02097121|567575994|FG001|Overall Study|Withdrawal by Subject|1|||
156923112|NCT03683758|566478170|FG001|Overall Study|Illness preventing participation|0|||
157164449|NCT02953782|567344001|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
157164450|NCT02953782|567344002|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
157226932|NCT02097121|567575995|FG002|Overall Study|Withdrawal by Subject|2|||
157226933|NCT02097121|567575993|FG000|Overall Study|Adverse Event|0|||
157226934|NCT02097121|567575994|FG001|Overall Study|Adverse Event|1|||
157226935|NCT02097121|567575995|FG002|Overall Study|Adverse Event|0|||
157226936|NCT02097121|567575993|FG000|Overall Study|Lost to Follow-up|1|||
157226937|NCT02097121|567575994|FG001|Overall Study|Lost to Follow-up|1|||
157226938|NCT02097121|567575995|FG002|Overall Study|Lost to Follow-up|2|||
157226939|NCT03595657|567575996|FG000|Overall Study|Adverse Event|14|||
157226940|NCT03595657|567575996|FG000|Overall Study|Death|1|||
156923113|NCT03683758|566478169|FG000|Overall Study|Adverse Event|1|||
157226941|NCT03595657|567575996|FG000|Overall Study|Lack of Efficacy|40|||
156923114|NCT03683758|566478170|FG001|Overall Study|Adverse Event|0|||
156923115|NCT00723892|566478171|FG000|Overall Study|Participant not tracked|33|||
156923116|NCT00723892|566478172|FG001|Overall Study|Participant not tracked|35|||
156923117|NCT00723892|566478171|FG000|Overall Study|Virological criterion|24|||
156923118|NCT00723892|566478172|FG001|Overall Study|Virological criterion|9|||
156923119|NCT00723892|566478171|FG000|Overall Study|Withdrawal by Subject|6|||
156923120|NCT00723892|566478172|FG001|Overall Study|Withdrawal by Subject|9|||
156923121|NCT00723892|566478171|FG000|Overall Study|End planned|11|||
156923122|NCT00723892|566478172|FG001|Overall Study|End planned|7|||
156923123|NCT00723892|566478171|FG000|Overall Study|Bad tolerance|5|||
156923124|NCT00723892|566478172|FG001|Overall Study|Bad tolerance|5|||
156923125|NCT00723892|566478171|FG000|Overall Study|Multiple reasons|17|||
156923126|NCT00723892|566478172|FG001|Overall Study|Multiple reasons|12|||
156923127|NCT00723892|566478171|FG000|Overall Study|Other|6|||
156923128|NCT00723892|566478172|FG001|Overall Study|Other|3|||
156923129|NCT00723892|566478171|FG000|Overall Study|Study end|1|||
156923130|NCT00723892|566478172|FG001|Overall Study|Study end|3|||
156923131|NCT00723892|566478171|FG000|Overall Study|Weight loss|1|||
156923132|NCT00723892|566478172|FG001|Overall Study|Weight loss|3|||
156923133|NCT00723892|566478171|FG000|Overall Study|Alcohol abuse|0|||
156923134|NCT00723892|566478172|FG001|Overall Study|Alcohol abuse|1|||
156923135|NCT00723892|566478171|FG000|Overall Study|Intercurrent infection|2|||
156923136|NCT00723892|566478172|FG001|Overall Study|Intercurrent infection|0|||
156923137|NCT00723892|566478171|FG000|Overall Study|Drug addiction|1|||
156923138|NCT00723892|566478172|FG001|Overall Study|Drug addiction|0|||
156923139|NCT02411292|566478173|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
156923140|NCT02411292|566478173|FG000|Overall Study|Death|2|||
156923141|NCT02411292|566478173|FG000|Overall Study|Lost to Follow-up|3|||
156923142|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
156923143|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
156923144|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
156923145|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
156923146|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
156923147|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
156923148|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
156923149|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
156923150|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Other|4|||
156923151|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Other|1|||
156923152|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
156923153|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
156923154|NCT00303498|566478174|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
156923155|NCT00303498|566478175|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
156923156|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
156923157|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
156923158|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Death|1|||
156923159|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Death|0|||
156923160|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
156923161|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
156923162|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
156923163|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
156923164|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
156923165|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
156923166|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
156923167|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
156923168|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Other|1|||
156923169|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Other|0|||
156923170|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
156923171|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
156923172|NCT00303498|566478174|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
156923173|NCT00303498|566478175|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
156923174|NCT00453921|566478176|FG000|Overall Study|Withdrawal by Subject|1|||
156923175|NCT00453921|566478177|FG001|Overall Study|Withdrawal by Subject|1|||
156923176|NCT00453921|566478178|FG002|Overall Study|Withdrawal by Subject|1|||
156923177|NCT00453921|566478179|FG003|Overall Study|Withdrawal by Subject|1|||
156923178|NCT00453921|566478176|FG000|Overall Study|Lost to Follow-up|0|||
156923179|NCT00453921|566478177|FG001|Overall Study|Lost to Follow-up|0|||
156923180|NCT00453921|566478178|FG002|Overall Study|Lost to Follow-up|1|||
156923181|NCT00453921|566478179|FG003|Overall Study|Lost to Follow-up|0|||
156923182|NCT03060447|566478180|FG000|Overall Study|Withdrawal by Subject|2|||
156923183|NCT03060447|566478181|FG001|Overall Study|Withdrawal by Subject|0|||
156923184|NCT01601626|566478184|FG000|Overall Study|Death|1|||
156923185|NCT01601626|566478185|FG001|Overall Study|Death|1|||
156923186|NCT01601626|566478186|FG002|Overall Study|Death|1|||
156923187|NCT01601626|566478184|FG000|Overall Study|Lost to Follow-up|1|||
156923188|NCT01601626|566478185|FG001|Overall Study|Lost to Follow-up|2|||
156923189|NCT01601626|566478186|FG002|Overall Study|Lost to Follow-up|0|||
156923190|NCT01601626|566478184|FG000|Overall Study|Unable to Get to Clinic|0|||
156923191|NCT01601626|566478185|FG001|Overall Study|Unable to Get to Clinic|1|||
156923192|NCT01601626|566478186|FG002|Overall Study|Unable to Get to Clinic|0|||
156923193|NCT01601626|566478184|FG000|Overall Study|Withdrawal by Subject|0|||
156923194|NCT01601626|566478185|FG001|Overall Study|Withdrawal by Subject|1|||
156923195|NCT01601626|566478186|FG002|Overall Study|Withdrawal by Subject|1|||
156923196|NCT01601626|566478184|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
156923197|NCT01601626|566478185|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
156923198|NCT01601626|566478186|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
156923199|NCT03045887|566478187|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
156923200|NCT03045887|566478188|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923201|NCT03045887|566478189|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923202|NCT03045887|566478190|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923203|NCT03045887|566478191|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923204|NCT03045887|566478192|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923205|NCT03045887|566478193|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923206|NCT03045887|566478194|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923207|NCT03045887|566478195|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923208|NCT03045887|566478196|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
156923209|NCT03045887|566478187|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923210|NCT03045887|566478188|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923211|NCT03045887|566478189|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923212|NCT03045887|566478190|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
156923213|NCT03045887|566478191|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923214|NCT03045887|566478192|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923215|NCT03045887|566478193|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923216|NCT03045887|566478194|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923217|NCT03045887|566478195|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923218|NCT03045887|566478196|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
156923219|NCT03045887|566478187|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
156923220|NCT03045887|566478188|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923221|NCT03045887|566478189|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923222|NCT03045887|566478190|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923223|NCT03045887|566478191|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923224|NCT03045887|566478192|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923225|NCT03045887|566478193|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923226|NCT03045887|566478194|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923227|NCT03045887|566478195|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923228|NCT03045887|566478196|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
156923229|NCT03045887|566478187|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923230|NCT03045887|566478188|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923231|NCT03045887|566478189|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
156923232|NCT03045887|566478190|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
156923233|NCT03045887|566478191|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923234|NCT03045887|566478192|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923235|NCT03045887|566478193|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923236|NCT03045887|566478194|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923237|NCT03045887|566478195|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923238|NCT03045887|566478196|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
156923239|NCT03045887|566478187|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923240|NCT03045887|566478188|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923241|NCT03045887|566478189|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923242|NCT03045887|566478190|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
156923243|NCT03045887|566478191|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923244|NCT03045887|566478192|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157164451|NCT02953782|567344003|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
157164452|NCT02953782|567344004|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
157164453|NCT02953782|567344005|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
157164454|NCT02953782|567343998|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
157164455|NCT02953782|567343999|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
157164456|NCT02953782|567344000|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
157164457|NCT02953782|567344001|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
156923245|NCT03045887|566478193|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923246|NCT03045887|566478194|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923247|NCT03045887|566478195|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157164458|NCT02953782|567344002|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
157164459|NCT02953782|567344003|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
157164460|NCT02953782|567344004|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
157164461|NCT02953782|567344005|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
157164462|NCT02953782|567343998|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
157164463|NCT02953782|567343999|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
157164464|NCT02953782|567344000|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
157164465|NCT02953782|567344001|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
157164466|NCT02953782|567344002|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
157164467|NCT02953782|567344003|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
157164468|NCT02953782|567344004|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
157164469|NCT02953782|567344005|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
157164470|NCT02953782|567343998|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164471|NCT02953782|567343999|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164472|NCT02953782|567344000|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164473|NCT02953782|567344001|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164474|NCT02953782|567344002|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164475|NCT02953782|567344003|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164476|NCT02953782|567344004|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
157164477|NCT02953782|567344005|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
157164478|NCT01934192|567344006|FG000|Overall Study|Protocol Violation|0|||
157164479|NCT01934192|567344007|FG001|Overall Study|Protocol Violation|0|||
157164480|NCT01934192|567344008|FG002|Overall Study|Protocol Violation|0|||
157164481|NCT01934192|567344009|FG003|Overall Study|Protocol Violation|1|||
157164482|NCT01934192|567344006|FG000|Overall Study|Other: reached stopping criteria|6|||
157164483|NCT01934192|567344007|FG001|Overall Study|Other: reached stopping criteria|5|||
157164484|NCT01934192|567344008|FG002|Overall Study|Other: reached stopping criteria|1|||
157164485|NCT01934192|567344009|FG003|Overall Study|Other: reached stopping criteria|0|||
157164486|NCT01934192|567344006|FG000|Overall Study|Physician Decision|3|||
157164487|NCT01934192|567344007|FG001|Overall Study|Physician Decision|2|||
157164488|NCT01934192|567344008|FG002|Overall Study|Physician Decision|0|||
157164489|NCT01934192|567344009|FG003|Overall Study|Physician Decision|0|||
157164490|NCT01737840|567344010|FG000|Overall Study|Diagnosed with an other pathology|2|||
157164491|NCT01737840|567344011|FG001|Overall Study|Diagnosed with an other pathology|2|||
157164492|NCT01189435|567344012|FG000|Overall Study|Withdrawal by Subject|1|||
157164493|NCT01189435|567344012|FG000|Overall Study|Physician Decision|1|||
157164494|NCT03105700|567344013|FG000|Overall Study|screen fail|3|||
157164495|NCT03105700|567344013|FG000|Overall Study|Lost to Follow-up|4|||
157164496|NCT00403559|567344014|FG000|Overall Study|Adverse Event|0|||
157164497|NCT00403559|567344015|FG001|Overall Study|Adverse Event|1|||
157164498|NCT00403559|567344014|FG000|Overall Study|Lost to Follow-up|3|||
157164499|NCT00403559|567344015|FG001|Overall Study|Lost to Follow-up|3|||
157164500|NCT00403559|567344014|FG000|Overall Study|Withdrawal by Subject|1|||
157164501|NCT00403559|567344015|FG001|Overall Study|Withdrawal by Subject|0|||
156923248|NCT03045887|566478196|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
156923249|NCT02426892|566478197|FG000|Overall Study|Adverse Event|2|||
156923250|NCT02426892|566478197|FG000|Overall Study|Lack of Efficacy|17|||
156923251|NCT02426892|566478197|FG000|Overall Study|Withdrawal by Subject|1|||
156923252|NCT03178773|566478198|FG000|Overall Study|Death|0|||
156923253|NCT03178773|566478199|FG001|Overall Study|Death|1|||
156923254|NCT03178773|566478198|FG000|Overall Study|Lost to Follow-up|29|||
156923255|NCT03178773|566478199|FG001|Overall Study|Lost to Follow-up|25|||
156923256|NCT03178773|566478198|FG000|Overall Study|Withdrawal by Subject|10|||
156923257|NCT03178773|566478199|FG001|Overall Study|Withdrawal by Subject|14|||
156923258|NCT01382446|566478200|FG000|Overall Study|Withdrawal by Subject|0|||
156923259|NCT01382446|566478201|FG001|Overall Study|Withdrawal by Subject|1|||
156923260|NCT01382446|566478200|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
156923261|NCT01382446|566478201|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
157164502|NCT01449682|567344018|FG000|Overall Study|Death|0|||
156923262|NCT02617511|566478206|FG000|Overall Study|Withdrawal by Subject|1|||
157164503|NCT01449682|567344019|FG001|Overall Study|Death|1|||
157164504|NCT01449682|567344018|FG000|Overall Study|Adverse Event|1|||
157164505|NCT01449682|567344019|FG001|Overall Study|Adverse Event|0|||
157164506|NCT04105244|567344020|FG000|Overall Study|Withdrawal by Subject|10|||
157164507|NCT04105244|567344021|FG001|Overall Study|Withdrawal by Subject|12|||
157164508|NCT04105244|567344020|FG000|Overall Study|Lost to Follow-up|20|||
157164509|NCT04105244|567344021|FG001|Overall Study|Lost to Follow-up|15|||
157164510|NCT04105244|567344020|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
157164511|NCT04105244|567344021|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
157164512|NCT04105244|567344020|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
156923263|NCT02617511|566478207|FG001|Overall Study|Withdrawal by Subject|0|||
156923264|NCT00811473|566478208|FG000|Overall Study|Adverse Event|3|||
156923265|NCT00811473|566478209|FG001|Overall Study|Adverse Event|12|||
157226942|NCT03595657|567575996|FG000|Overall Study|Withdrawal by Subject|10|||
157226943|NCT03595657|567575996|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
157226944|NCT03595657|567575996|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
157226945|NCT01066052|567575997|FG000|Overall Study|Enrolled But Not Treated|3|||
157226946|NCT01066052|567575998|FG001|Overall Study|Enrolled But Not Treated|0|||
157226947|NCT01835145|567575999|FG000|Overall Study|Ineligible prior to treatment|1|||
157226948|NCT01835145|567576000|FG001|Overall Study|Ineligible prior to treatment|0|||
157226949|NCT04094870|567576001|FG000|Overall Study|Lost to Follow-up|1|||
156923266|NCT00811473|566478208|FG000|Overall Study|Lost to Follow-up|5|||
157164513|NCT04105244|567344021|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
157164514|NCT04863014|567344022|FG000|Overall Study|Lost to Follow-up|3|||
157164515|NCT04863014|567344023|FG001|Overall Study|Lost to Follow-up|2|||
157164516|NCT04863014|567344022|FG000|Overall Study|Subject Decision|0|||
157164517|NCT04863014|567344023|FG001|Overall Study|Subject Decision|4|||
157164518|NCT02720016|567344028|FG000|Overall Study|Separation of couple|6|||
157164519|NCT02720016|567344029|FG001|Overall Study|Separation of couple|8|||
157164520|NCT02720016|567344030|FG002|Overall Study|Separation of couple|2|||
157164521|NCT02720016|567344028|FG000|Overall Study|Withdrawal by Subject|6|||
157164522|NCT02720016|567344029|FG001|Overall Study|Withdrawal by Subject|6|||
157164523|NCT02720016|567344030|FG002|Overall Study|Withdrawal by Subject|4|||
157164524|NCT02720016|567344028|FG000|Overall Study|Scheduling issues|2|||
157164525|NCT02720016|567344029|FG001|Overall Study|Scheduling issues|4|||
157164526|NCT02720016|567344030|FG002|Overall Study|Scheduling issues|7|||
157164527|NCT02720016|567344028|FG000|Overall Study|Childcare|2|||
157164528|NCT02720016|567344029|FG001|Overall Study|Childcare|0|||
157164529|NCT02720016|567344030|FG002|Overall Study|Childcare|2|||
157164530|NCT02720016|567344028|FG000|Overall Study|Withdrawal by PI|2|||
157164531|NCT02720016|567344029|FG001|Overall Study|Withdrawal by PI|2|||
157164532|NCT02720016|567344030|FG002|Overall Study|Withdrawal by PI|0|||
157164533|NCT02720016|567344028|FG000|Overall Study|Moved away|2|||
157164534|NCT02720016|567344029|FG001|Overall Study|Moved away|0|||
157164535|NCT02720016|567344030|FG002|Overall Study|Moved away|0|||
157164536|NCT02720016|567344028|FG000|Overall Study|Not Primary Health Concern|0|||
157164537|NCT02720016|567344029|FG001|Overall Study|Not Primary Health Concern|0|||
157164538|NCT02720016|567344030|FG002|Overall Study|Not Primary Health Concern|2|||
157226950|NCT04094870|567576002|FG001|Overall Study|Lost to Follow-up|1|||
156923267|NCT00811473|566478209|FG001|Overall Study|Lost to Follow-up|1|||
156923268|NCT00811473|566478208|FG000|Overall Study|Withdrawal by Subject|2|||
156923269|NCT00811473|566478209|FG001|Overall Study|Withdrawal by Subject|4|||
156923270|NCT00811473|566478208|FG000|Overall Study|Severe non-compliance to protocol|2|||
156923271|NCT00811473|566478209|FG001|Overall Study|Severe non-compliance to protocol|4|||
156923272|NCT00811473|566478208|FG000|Overall Study|Lack of therapeutic response|4|||
156923273|NCT00811473|566478209|FG001|Overall Study|Lack of therapeutic response|1|||
156923274|NCT00811473|566478208|FG000|Overall Study|Condition under investigation worsened|1|||
156923275|NCT00811473|566478209|FG001|Overall Study|Condition under investigation worsened|3|||
156923276|NCT00811473|566478208|FG000|Overall Study|Other 2|4|||
156923277|NCT00811473|566478209|FG001|Overall Study|Other 2|1|||
156923278|NCT00811473|566478208|FG000|Overall Study|Incorrect Enrollment|1|||
156923279|NCT00811473|566478209|FG001|Overall Study|Incorrect Enrollment|0|||
156923280|NCT00811473|566478208|FG000|Overall Study|Safety Reasons|1|||
156923281|NCT00811473|566478209|FG001|Overall Study|Safety Reasons|0|||
156923282|NCT01119131|566478213|FG000|Overall Study|Adverse Event|1|||
156923283|NCT01119131|566478214|FG001|Overall Study|Adverse Event|1|||
156923284|NCT01119131|566478215|FG002|Overall Study|Adverse Event|1|||
156923285|NCT01119131|566478213|FG000|Overall Study|Non-Compliance|1|||
156923286|NCT01119131|566478214|FG001|Overall Study|Non-Compliance|0|||
156923287|NCT01119131|566478215|FG002|Overall Study|Non-Compliance|4|||
156923288|NCT01119131|566478213|FG000|Overall Study|Physician Decision|0|||
157226951|NCT02708277|567576003|FG000|Overall Study|Lost to Follow-up|7|||
157164539|NCT02720016|567344028|FG000|Overall Study|Transportation issues|0|||
157164540|NCT02720016|567344029|FG001|Overall Study|Transportation issues|0|||
157164541|NCT02720016|567344030|FG002|Overall Study|Transportation issues|1|||
157164542|NCT02720016|567344028|FG000|Overall Study|Other|0|||
157164543|NCT02720016|567344029|FG001|Overall Study|Other|0|||
157226952|NCT02708277|567576004|FG001|Overall Study|Lost to Follow-up|4|||
156923289|NCT01119131|566478214|FG001|Overall Study|Physician Decision|0|||
156923290|NCT01119131|566478215|FG002|Overall Study|Physician Decision|1|||
156923291|NCT00732615|566478216|FG000|Overall Study|Withdrawal by Subject|3|||
156923292|NCT00732615|566478217|FG001|Overall Study|Withdrawal by Subject|1|||
156923293|NCT00732615|566478216|FG000|Overall Study|Lost to Follow-up|0|||
157164544|NCT02720016|567344030|FG002|Overall Study|Other|2|||
157164545|NCT05319080|567344032|FG000|Overall Study|Withdrawal by Subject|2|||
157164546|NCT05319080|567344032|FG000|Overall Study|Physician Decision|4|||
157164547|NCT00448916|567344033|FG000|Overall Study|Adverse Event|2|||
157164548|NCT00448916|567344034|FG001|Overall Study|Adverse Event|2|||
157164549|NCT00448916|567344035|FG002|Overall Study|Adverse Event|3|||
157164550|NCT00448916|567344036|FG003|Overall Study|Adverse Event|2|||
157164551|NCT00448916|567344033|FG000|Overall Study|Lack of Efficacy|1|||
157226953|NCT01592370|567576007|FG000|Overall Study|Disease Progression|62|||
157226954|NCT01592370|567576008|FG001|Overall Study|Disease Progression|16|||
157226955|NCT01592370|567576009|FG002|Overall Study|Disease Progression|52|||
157226956|NCT01592370|567576010|FG003|Overall Study|Disease Progression|3|||
157226957|NCT01592370|567576011|FG004|Overall Study|Disease Progression|3|||
157226958|NCT01592370|567576012|FG005|Overall Study|Disease Progression|31|||
157226959|NCT01592370|567576013|FG006|Overall Study|Disease Progression|14|||
157226960|NCT01592370|567576007|FG000|Overall Study|Study Drug Toxicity|14|||
157226961|NCT01592370|567576008|FG001|Overall Study|Study Drug Toxicity|3|||
157226962|NCT01592370|567576009|FG002|Overall Study|Study Drug Toxicity|0|||
157226963|NCT01592370|567576010|FG003|Overall Study|Study Drug Toxicity|0|||
157226964|NCT01592370|567576011|FG004|Overall Study|Study Drug Toxicity|0|||
157226965|NCT01592370|567576012|FG005|Overall Study|Study Drug Toxicity|0|||
157226966|NCT01592370|567576013|FG006|Overall Study|Study Drug Toxicity|1|||
157226967|NCT01592370|567576007|FG000|Overall Study|AE unrelated to study drug|4|||
157226968|NCT01592370|567576008|FG001|Overall Study|AE unrelated to study drug|3|||
157226969|NCT01592370|567576009|FG002|Overall Study|AE unrelated to study drug|0|||
157226970|NCT01592370|567576010|FG003|Overall Study|AE unrelated to study drug|0|||
157226971|NCT01592370|567576011|FG004|Overall Study|AE unrelated to study drug|0|||
157226972|NCT01592370|567576012|FG005|Overall Study|AE unrelated to study drug|0|||
157226973|NCT01592370|567576013|FG006|Overall Study|AE unrelated to study drug|1|||
157226974|NCT01592370|567576007|FG000|Overall Study|Request to discontinue study treatment|5|||
157226975|NCT01592370|567576008|FG001|Overall Study|Request to discontinue study treatment|0|||
157226976|NCT01592370|567576009|FG002|Overall Study|Request to discontinue study treatment|2|||
157226977|NCT01592370|567576010|FG003|Overall Study|Request to discontinue study treatment|0|||
157226978|NCT01592370|567576011|FG004|Overall Study|Request to discontinue study treatment|1|||
157226979|NCT01592370|567576012|FG005|Overall Study|Request to discontinue study treatment|2|||
157226980|NCT01592370|567576013|FG006|Overall Study|Request to discontinue study treatment|0|||
157226981|NCT01592370|567576007|FG000|Overall Study|Withdrew consent|1|||
157226982|NCT01592370|567576008|FG001|Overall Study|Withdrew consent|2|||
157226983|NCT01592370|567576009|FG002|Overall Study|Withdrew consent|1|||
157226984|NCT01592370|567576010|FG003|Overall Study|Withdrew consent|1|||
157226985|NCT01592370|567576011|FG004|Overall Study|Withdrew consent|0|||
157226986|NCT01592370|567576012|FG005|Overall Study|Withdrew consent|0|||
157226987|NCT01592370|567576013|FG006|Overall Study|Withdrew consent|0|||
157226988|NCT01592370|567576007|FG000|Overall Study|Maximum clinical benefit|11|||
157226989|NCT01592370|567576008|FG001|Overall Study|Maximum clinical benefit|1|||
157226990|NCT01592370|567576009|FG002|Overall Study|Maximum clinical benefit|7|||
157226991|NCT01592370|567576010|FG003|Overall Study|Maximum clinical benefit|1|||
156923294|NCT00732615|566478217|FG001|Overall Study|Lost to Follow-up|1|||
156923295|NCT00732615|566478216|FG000|Overall Study|Adverse Event|0|||
156923296|NCT00732615|566478217|FG001|Overall Study|Adverse Event|2|||
156923297|NCT00732615|566478216|FG000|Overall Study|Physician Decision|3|||
156923298|NCT00732615|566478217|FG001|Overall Study|Physician Decision|0|||
156923299|NCT00732615|566478216|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
156923300|NCT00732615|566478217|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
156923301|NCT01333059|566478218|FG000|Overall Study|Physician Decision|3|||
156923302|NCT01333059|566478219|FG001|Overall Study|Physician Decision|3|||
156923303|NCT01333059|566478218|FG000|Overall Study|Protocol Violation|3|||
156923304|NCT01333059|566478219|FG001|Overall Study|Protocol Violation|0|||
156923305|NCT03566823|566478220|FG000|Overall Study|Lack of Efficacy|0|||
156923306|NCT03566823|566478221|FG001|Overall Study|Lack of Efficacy|1|||
156923307|NCT03566823|566478222|FG002|Overall Study|Lack of Efficacy|0|||
156923308|NCT03566823|566478220|FG000|Overall Study|Withdrawal by Subject|1|||
156923309|NCT03566823|566478221|FG001|Overall Study|Withdrawal by Subject|2|||
156923310|NCT03566823|566478222|FG002|Overall Study|Withdrawal by Subject|0|||
156923311|NCT03566823|566478220|FG000|Overall Study|Adverse Event|1|||
156923312|NCT03566823|566478221|FG001|Overall Study|Adverse Event|0|||
156923313|NCT03566823|566478222|FG002|Overall Study|Adverse Event|2|||
156923314|NCT06079320|566478225|FG000|Follow up Phase|Lost to Follow-up|1|||
156923315|NCT06079320|566478226|FG001|Follow up Phase|Lost to Follow-up|0|||
157226992|NCT01592370|567576011|FG004|Overall Study|Maximum clinical benefit|0|||
157226993|NCT01592370|567576012|FG005|Overall Study|Maximum clinical benefit|0|||
156923316|NCT01405742|566478227|FG000|Overall Study|Lost to Follow-up|1|||
156923317|NCT01405742|566478228|FG001|Overall Study|Lost to Follow-up|0|||
156923318|NCT02196558|566478229|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
156923319|NCT02196558|566478230|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
157028784|NCT04171141|566862796|FG006|Overall Study|Progressive disease|4|||
156923320|NCT02196558|566478231|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
156923321|NCT02196558|566478229|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
156923322|NCT02196558|566478230|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
157028785|NCT04171141|566862797|FG007|Overall Study|Progressive disease|6|||
157226994|NCT01592370|567576013|FG006|Overall Study|Maximum clinical benefit|0|||
157226995|NCT01592370|567576007|FG000|Overall Study|No longer meets study criteria|1|||
157226996|NCT01592370|567576008|FG001|Overall Study|No longer meets study criteria|0|||
157226997|NCT01592370|567576009|FG002|Overall Study|No longer meets study criteria|0|||
156923323|NCT02196558|566478231|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
156923324|NCT02196558|566478229|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
156923325|NCT02196558|566478230|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
156923326|NCT02196558|566478231|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
156923327|NCT02196558|566478229|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
156923328|NCT02196558|566478230|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
156923329|NCT02196558|566478231|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
156923330|NCT02196558|566478229|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
156923331|NCT02196558|566478230|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
157164552|NCT00448916|567344034|FG001|Overall Study|Lack of Efficacy|0|||
157164553|NCT00448916|567344035|FG002|Overall Study|Lack of Efficacy|2|||
157164554|NCT00448916|567344036|FG003|Overall Study|Lack of Efficacy|1|||
157164555|NCT00448916|567344033|FG000|Overall Study|Withdrawal by Subject|3|||
157164556|NCT00448916|567344034|FG001|Overall Study|Withdrawal by Subject|3|||
157164557|NCT00448916|567344035|FG002|Overall Study|Withdrawal by Subject|1|||
157164558|NCT00448916|567344036|FG003|Overall Study|Withdrawal by Subject|1|||
157164559|NCT00448916|567344033|FG000|Overall Study|Other|1|||
157164560|NCT00448916|567344034|FG001|Overall Study|Other|0|||
157164561|NCT00448916|567344035|FG002|Overall Study|Other|0|||
157164562|NCT00448916|567344036|FG003|Overall Study|Other|0|||
157164563|NCT00448916|567344033|FG000|Overall Study|Lost to Follow-up|0|||
157164564|NCT00448916|567344034|FG001|Overall Study|Lost to Follow-up|1|||
157164565|NCT00448916|567344035|FG002|Overall Study|Lost to Follow-up|0|||
157164566|NCT00448916|567344036|FG003|Overall Study|Lost to Follow-up|1|||
157164567|NCT00448916|567344033|FG000|Overall Study|Protocol Violation|0|||
157164568|NCT00448916|567344034|FG001|Overall Study|Protocol Violation|0|||
157164569|NCT00448916|567344035|FG002|Overall Study|Protocol Violation|0|||
157164570|NCT00448916|567344036|FG003|Overall Study|Protocol Violation|1|||
156923332|NCT02196558|566478231|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
156923333|NCT03428360|566478232|FG000|Overall Study|Informed consent withdrawn|5|||
156923334|NCT03428360|566478232|FG000|Overall Study|Withdrawal by Subject|4|||
156923335|NCT03428360|566478232|FG000|Overall Study|Lost to Follow-up|5|||
156923336|NCT03428360|566478232|FG000|Overall Study|Physician Decision|2|||
156923337|NCT03428360|566478232|FG000|Overall Study|Informed consent withdrawn|5|||
156923338|NCT03428360|566478232|FG000|Overall Study|Study terminated by sponsor|10|||
156923339|NCT03428360|566478232|FG000|Overall Study|Non-compliant with study|1|||
156923340|NCT03428360|566478232|FG000|Overall Study|Non-compliant with study drug|3|||
156923341|NCT03428360|566478232|FG000|Overall Study|Death|3|||
156923342|NCT03428360|566478232|FG000|Overall Study|Adverse Event|1|||
156923343|NCT03428360|566478232|FG000|Overall Study|Not on antiepileptic drug|1|||
156923344|NCT02107482|566478236|FG000|Overall Study|inconveinence|2|||
156923345|NCT02107482|566478236|FG000|Overall Study|Lost to Follow-up|1|||
156923346|NCT02107482|566478236|FG000|Overall Study|Lack of Efficacy|1|||
156923347|NCT02669433|566478239|FG000|Overall Study|Protocol Violation|0|||
156923348|NCT02669433|566478240|FG001|Overall Study|Protocol Violation|4|||
156923349|NCT02669433|566478241|FG002|Overall Study|Protocol Violation|1|||
156923350|NCT02669433|566478239|FG000|Overall Study|Disease Progression|1|||
156923351|NCT02669433|566478240|FG001|Overall Study|Disease Progression|0|||
156923352|NCT02669433|566478241|FG002|Overall Study|Disease Progression|0|||
156923353|NCT02669433|566478239|FG000|Overall Study|Physician Decision|1|||
156923354|NCT02669433|566478240|FG001|Overall Study|Physician Decision|1|||
156923355|NCT02669433|566478241|FG002|Overall Study|Physician Decision|0|||
156923356|NCT02669433|566478239|FG000|Overall Study|Adverse Event|6|||
156923357|NCT02669433|566478240|FG001|Overall Study|Adverse Event|7|||
156923358|NCT02669433|566478241|FG002|Overall Study|Adverse Event|10|||
156923359|NCT02669433|566478239|FG000|Overall Study|Sponsor Termination|1|||
156923360|NCT02669433|566478240|FG001|Overall Study|Sponsor Termination|0|||
156923361|NCT02669433|566478241|FG002|Overall Study|Sponsor Termination|1|||
156923362|NCT02669433|566478239|FG000|Overall Study|Withdrawal by Subject|5|||
156923363|NCT02669433|566478240|FG001|Overall Study|Withdrawal by Subject|1|||
157164571|NCT00406783|567344037|FG000|Overall Study|Adverse Event|4|||
157164572|NCT00406783|567344038|FG001|Overall Study|Adverse Event|4|||
157164573|NCT00406783|567344037|FG000|Overall Study|Treatment Failure|2|||
157164574|NCT00406783|567344038|FG001|Overall Study|Treatment Failure|3|||
157164575|NCT00406783|567344037|FG000|Overall Study|Lost to Follow-up|3|||
156923364|NCT02669433|566478241|FG002|Overall Study|Withdrawal by Subject|0|||
156923365|NCT02669433|566478239|FG000|Overall Study|Withdrawal by Caregiver|1|||
156923366|NCT02669433|566478240|FG001|Overall Study|Withdrawal by Caregiver|0|||
156923367|NCT02669433|566478241|FG002|Overall Study|Withdrawal by Caregiver|2|||
156923368|NCT02669433|566478239|FG000|Overall Study|Death|0|||
156923369|NCT02669433|566478240|FG001|Overall Study|Death|1|||
156923370|NCT02669433|566478241|FG002|Overall Study|Death|1|||
156923371|NCT00576927|566478242|FG000|Clinical Assessment|Lack of Efficacy|24|||
157164576|NCT00406783|567344038|FG001|Overall Study|Lost to Follow-up|0|||
157164577|NCT00406783|567344037|FG000|Overall Study|Withdrawal by Subject|1|||
157164578|NCT00406783|567344038|FG001|Overall Study|Withdrawal by Subject|4|||
157164579|NCT00406783|567344037|FG000|Overall Study|Protocol Violation|4|||
157164580|NCT00406783|567344038|FG001|Overall Study|Protocol Violation|4|||
156923372|NCT00576927|566478242|FG000|Clinical Assessment|Death|1|||
156923373|NCT00576927|566478242|FG000|Clinical Assessment|Withdrawal by Subject|10|||
156923374|NCT00576927|566478242|FG000|Clinical Assessment|Physician Decision|1|||
157164581|NCT00064350|567344039|FG000|Induction Treatment|Disease Progression|5|||
157164582|NCT00064350|567344040|FG001|Induction Treatment|Disease Progression|1|||
157164583|NCT00064350|567344041|FG002|Induction Treatment|Disease Progression|110|||
156923375|NCT00576927|566478242|FG000|Baseline|Physician Decision|9|||
156923376|NCT00576927|566478242|FG000|Baseline|Medication Change by PCP of subject|1|||
156923377|NCT00576927|566478242|FG000|Baseline|Withdrawal by Subject|3|||
156923378|NCT00576927|566478242|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
156923379|NCT00576927|566478242|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
157164584|NCT00064350|567344039|FG000|Induction Treatment|Adverse Event|0|||
157164585|NCT00064350|567344040|FG001|Induction Treatment|Adverse Event|2|||
157164586|NCT00064350|567344041|FG002|Induction Treatment|Adverse Event|49|||
157164587|NCT00064350|567344039|FG000|Induction Treatment|Death|0|||
156923380|NCT00576927|566478242|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
156923381|NCT00576927|566478242|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
156923382|NCT00576927|566478242|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
156923383|NCT03128892|566478243|FG000|Overall Study|Withdrawal by Subject|2|||
156923384|NCT03128892|566478243|FG000|Overall Study|Physician Decision|1|||
156923385|NCT01850524|566478246|FG000|Overall Study|Lost to Follow-up|5|||
156923386|NCT01850524|566478247|FG001|Overall Study|Lost to Follow-up|10|||
157164588|NCT00064350|567344040|FG001|Induction Treatment|Death|0|||
157164589|NCT00064350|567344041|FG002|Induction Treatment|Death|9|||
157164590|NCT00064350|567344039|FG000|Induction Treatment|Withdrawal by Subject|0|||
157164591|NCT00064350|567344040|FG001|Induction Treatment|Withdrawal by Subject|0|||
157164592|NCT00064350|567344041|FG002|Induction Treatment|Withdrawal by Subject|21|||
157164593|NCT00064350|567344039|FG000|Induction Treatment|Ineligible or never started treatment|3|||
157164594|NCT00064350|567344040|FG001|Induction Treatment|Ineligible or never started treatment|6|||
157164595|NCT00064350|567344041|FG002|Induction Treatment|Ineligible or never started treatment|34|||
157164596|NCT00064350|567344039|FG000|Induction Treatment|Other|0|||
157164597|NCT00064350|567344040|FG001|Induction Treatment|Other|0|||
157164598|NCT00064350|567344041|FG002|Induction Treatment|Other|13|||
157164599|NCT00064350|567344039|FG000|Randomization|Adverse Event|8|||
157164600|NCT00064350|567344040|FG001|Randomization|Adverse Event|3|||
157164601|NCT00064350|567344041|FG002|Randomization|Adverse Event|0|||
157164602|NCT00064350|567344039|FG000|Randomization|Death|3|||
157164603|NCT00064350|567344040|FG001|Randomization|Death|0|||
157164604|NCT00064350|567344041|FG002|Randomization|Death|0|||
157164605|NCT00064350|567344039|FG000|Randomization|Withdrawal by Subject|1|||
156923387|NCT01850524|566478246|FG000|Overall Study|Withdrawal by Subject|24|||
156923388|NCT01850524|566478247|FG001|Overall Study|Withdrawal by Subject|22|||
156923389|NCT01850524|566478246|FG000|Overall Study|Reason not Specified|142|||
156923390|NCT01850524|566478247|FG001|Overall Study|Reason not Specified|141|||
156923391|NCT00368355|566478248|FG000|Overall Study|Adverse Event|1|||
156923392|NCT00368355|566478249|FG001|Overall Study|Adverse Event|0|||
156923393|NCT00368355|566478248|FG000|Overall Study|Death|2|||
157028786|NCT04171141|566862798|FG008|Overall Study|Progressive disease|7|||
157028787|NCT04171141|566862799|FG009|Overall Study|Progressive disease|3|||
157028788|NCT04171141|566862800|FG010|Overall Study|Progressive disease|4|||
157028789|NCT04171141|566862801|FG011|Overall Study|Progressive disease|3|||
157028790|NCT04171141|566862802|FG012|Overall Study|Progressive disease|4|||
157028791|NCT04171141|566862803|FG013|Overall Study|Progressive disease|2|||
157028792|NCT04171141|566862804|FG014|Overall Study|Progressive disease|4|||
157028793|NCT04171141|566862805|FG015|Overall Study|Progressive disease|1|||
157028794|NCT04171141|566862790|FG000|Overall Study|Withdrawal by Subject|0|||
157028795|NCT04171141|566862791|FG001|Overall Study|Withdrawal by Subject|0|||
157028796|NCT04171141|566862792|FG002|Overall Study|Withdrawal by Subject|0|||
157164606|NCT00064350|567344040|FG001|Randomization|Withdrawal by Subject|0|||
157164607|NCT00064350|567344041|FG002|Randomization|Withdrawal by Subject|0|||
157164608|NCT00064350|567344039|FG000|Randomization|Ineligible or never started treatment|9|||
157164609|NCT00064350|567344040|FG001|Randomization|Ineligible or never started treatment|15|||
156923394|NCT00368355|566478249|FG001|Overall Study|Death|4|||
156923395|NCT00368355|566478248|FG000|Overall Study|Relapse|6|||
156923396|NCT00368355|566478249|FG001|Overall Study|Relapse|10|||
156923397|NCT00368355|566478248|FG000|Overall Study|Subsequent transplant|0|||
156923398|NCT00368355|566478249|FG001|Overall Study|Subsequent transplant|3|||
156923399|NCT00368355|566478248|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
157164610|NCT00064350|567344041|FG002|Randomization|Ineligible or never started treatment|0|||
156923400|NCT00368355|566478249|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
157028797|NCT04171141|566862793|FG003|Overall Study|Withdrawal by Subject|1|||
157028798|NCT04171141|566862794|FG004|Overall Study|Withdrawal by Subject|0|||
157028799|NCT04171141|566862795|FG005|Overall Study|Withdrawal by Subject|0|||
157164611|NCT00064350|567344039|FG000|Randomization|Other|5|||
157164612|NCT00064350|567344040|FG001|Randomization|Other|0|||
157164613|NCT00064350|567344041|FG002|Randomization|Other|0|||
157164614|NCT00064350|567344039|FG000|Cross-Over|Adverse Event|0|||
156923401|NCT03473808|566478259|FG000|Overall Study|Withdrawal by Subject|1|||
156923402|NCT04059094|566478262|FG000|Overall Study|Adverse Event|0|||
156923403|NCT04059094|566478263|FG001|Overall Study|Adverse Event|0|||
156923404|NCT04059094|566478264|FG002|Overall Study|Adverse Event|0|||
156923405|NCT04059094|566478265|FG003|Overall Study|Adverse Event|0|||
156923406|NCT04059094|566478266|FG004|Overall Study|Adverse Event|1|||
156923407|NCT04059094|566478262|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156923408|NCT04059094|566478263|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
156923409|NCT04059094|566478264|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156923410|NCT04059094|566478265|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156923411|NCT04059094|566478266|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
156923412|NCT00459667|566478269|FG000|Overall Study|Adverse Event|9|||
156923413|NCT00459667|566478270|FG001|Overall Study|Adverse Event|12|||
156923414|NCT00459667|566478271|FG002|Overall Study|Adverse Event|8|||
156923415|NCT00459667|566478269|FG000|Overall Study|Lost to Follow-up|5|||
156923416|NCT00459667|566478270|FG001|Overall Study|Lost to Follow-up|9|||
156923417|NCT00459667|566478271|FG002|Overall Study|Lost to Follow-up|3|||
156923418|NCT00459667|566478269|FG000|Overall Study|Pregnancy|1|||
156923419|NCT00459667|566478270|FG001|Overall Study|Pregnancy|1|||
156923420|NCT00459667|566478271|FG002|Overall Study|Pregnancy|1|||
156923421|NCT00459667|566478269|FG000|Overall Study|Protocol Violation|1|||
156923422|NCT00459667|566478270|FG001|Overall Study|Protocol Violation|0|||
156923423|NCT00459667|566478271|FG002|Overall Study|Protocol Violation|0|||
156923424|NCT00459667|566478269|FG000|Overall Study|Withdrawal by Subject|3|||
156923425|NCT00459667|566478270|FG001|Overall Study|Withdrawal by Subject|5|||
156923426|NCT00459667|566478271|FG002|Overall Study|Withdrawal by Subject|5|||
156923427|NCT00459667|566478269|FG000|Overall Study|Other disease modifying treatment|1|||
156923428|NCT00459667|566478270|FG001|Overall Study|Other disease modifying treatment|2|||
156923429|NCT00459667|566478271|FG002|Overall Study|Other disease modifying treatment|1|||
156923430|NCT00459667|566478269|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
156923431|NCT00459667|566478270|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
156923432|NCT00459667|566478271|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
156923433|NCT00459667|566478269|FG000|Overall Study|No treatment administered|6|||
156923434|NCT00459667|566478270|FG001|Overall Study|No treatment administered|3|||
156923435|NCT00459667|566478271|FG002|Overall Study|No treatment administered|1|||
156923436|NCT01013701|566478272|FG000|Overall Study|study prematurely terminated|7|||
156923437|NCT00556712|566478273|FG000|Overall Study|Adverse Event|7|||
156923438|NCT00556712|566478274|FG001|Overall Study|Adverse Event|19|||
156923439|NCT00556712|566478273|FG000|Overall Study|Death|5|||
156923440|NCT00556712|566478274|FG001|Overall Study|Death|10|||
156923441|NCT00556712|566478273|FG000|Overall Study|Progressive Disease|383|||
156923442|NCT00556712|566478274|FG001|Overall Study|Progressive Disease|320|||
156923443|NCT00556712|566478273|FG000|Overall Study|Protocol Violation|3|||
156923444|NCT00556712|566478274|FG001|Overall Study|Protocol Violation|2|||
156923445|NCT00556712|566478273|FG000|Overall Study|Refused Treatment|17|||
156923446|NCT00556712|566478274|FG001|Overall Study|Refused Treatment|16|||
156923447|NCT00556712|566478273|FG000|Overall Study|Failure to Return|2|||
156923448|NCT00556712|566478274|FG001|Overall Study|Failure to Return|3|||
156923449|NCT00556712|566478273|FG000|Overall Study|Other|2|||
156923450|NCT00556712|566478274|FG001|Overall Study|Other|2|||
156923451|NCT00556712|566478273|FG000|Overall Study|Ongoing at Data Cutoff|32|||
156923452|NCT00556712|566478274|FG001|Overall Study|Ongoing at Data Cutoff|66|||
156923453|NCT01059799|566478275|FG000|Overall Study|Adverse Event|2|||
156923454|NCT01059799|566478276|FG001|Overall Study|Adverse Event|3|||
156923455|NCT01059799|566478275|FG000|Overall Study|Lack of Efficacy|1|||
156923456|NCT01059799|566478276|FG001|Overall Study|Lack of Efficacy|0|||
156923457|NCT01059799|566478275|FG000|Overall Study|Protocol Violation|3|||
156923458|NCT01059799|566478276|FG001|Overall Study|Protocol Violation|2|||
156923459|NCT01059799|566478275|FG000|Overall Study|Withdrawal criteria|13|||
156923460|NCT01059799|566478276|FG001|Overall Study|Withdrawal criteria|2|||
156923461|NCT01059799|566478275|FG000|Overall Study|Other|12|||
156923462|NCT01059799|566478276|FG001|Overall Study|Other|3|||
156923463|NCT01980875|566478277|FG000|Overall Study|Withdrew Consent|1|||
156923464|NCT01980875|566478278|FG001|Overall Study|Withdrew Consent|1|||
156923465|NCT01980875|566478279|FG002|Overall Study|Withdrew Consent|1|||
156923466|NCT01980875|566478277|FG000|Overall Study|Study Terminated by Sponsor|7|||
156923467|NCT01980875|566478278|FG001|Overall Study|Study Terminated by Sponsor|24|||
156923468|NCT01980875|566478279|FG002|Overall Study|Study Terminated by Sponsor|22|||
156923469|NCT01980875|566478277|FG000|Overall Study|Lost to Follow-up|0|||
156923470|NCT01980875|566478278|FG001|Overall Study|Lost to Follow-up|0|||
156923471|NCT01980875|566478279|FG002|Overall Study|Lost to Follow-up|1|||
156923472|NCT03761147|566478281|FG000|Overall Study|Withdrawal by Subject|6|||
156923473|NCT03761147|566478282|FG001|Overall Study|Withdrawal by Subject|1|||
156923474|NCT03761147|566478281|FG000|Overall Study|Adverse Event|1|||
156923475|NCT03761147|566478282|FG001|Overall Study|Adverse Event|3|||
156923476|NCT04080297|566478283|FG000|Overall Study|Adverse Event|1|||
156923477|NCT04080297|566478284|FG001|Overall Study|Adverse Event|3|||
156923478|NCT04080297|566478283|FG000|Overall Study|concurrent illness|1|||
156923479|NCT04080297|566478284|FG001|Overall Study|concurrent illness|0|||
156923480|NCT02744391|566478286|FG000|Overall Study|Lost to Follow-up|9|||
156923481|NCT02744391|566478286|FG000|Overall Study|Physician Decision|2|||
156923482|NCT02744391|566478286|FG000|Overall Study|Withdrawal by Subject|3|||
156923483|NCT02045797|566478287|FG000|Overall Study|Adverse Event|3|||
156923484|NCT02045797|566478288|FG001|Overall Study|Adverse Event|1|||
156923485|NCT02045797|566478289|FG002|Overall Study|Adverse Event|0|||
156923486|NCT02045797|566478287|FG000|Overall Study|Lack of Efficacy|1|||
156923487|NCT02045797|566478288|FG001|Overall Study|Lack of Efficacy|0|||
156923488|NCT02045797|566478289|FG002|Overall Study|Lack of Efficacy|0|||
156923489|NCT02045797|566478287|FG000|Overall Study|Lost to Follow-up|2|||
156923490|NCT02045797|566478288|FG001|Overall Study|Lost to Follow-up|3|||
156923491|NCT02045797|566478289|FG002|Overall Study|Lost to Follow-up|1|||
156923492|NCT02045797|566478287|FG000|Overall Study|Physician Decision|0|||
156923493|NCT02045797|566478288|FG001|Overall Study|Physician Decision|1|||
156923494|NCT02045797|566478289|FG002|Overall Study|Physician Decision|0|||
156923495|NCT02045797|566478287|FG000|Overall Study|Withdrawal by Subject|1|||
156923496|NCT02045797|566478288|FG001|Overall Study|Withdrawal by Subject|2|||
156923497|NCT02045797|566478289|FG002|Overall Study|Withdrawal by Subject|0|||
156923498|NCT04434092|566478290|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
156923499|NCT04434092|566478291|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
156923500|NCT04434092|566478292|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
156923501|NCT04434092|566478290|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
156923502|NCT04434092|566478291|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
156923503|NCT04434092|566478292|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
156923504|NCT04434092|566478290|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
156923505|NCT04434092|566478291|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
156923506|NCT04434092|566478292|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
156923507|NCT04434092|566478290|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
156923508|NCT04434092|566478291|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
156923509|NCT04434092|566478292|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
156923510|NCT04434092|566478290|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
156923511|NCT04434092|566478291|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
156923512|NCT04434092|566478292|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
156923513|NCT04434092|566478290|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
156923514|NCT04434092|566478291|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
156923515|NCT04434092|566478292|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
156923516|NCT04434092|566478290|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
156923517|NCT04434092|566478291|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
156923518|NCT04434092|566478292|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
156923519|NCT02554812|566478293|FG000|Overall Study|Adverse Event|2|||
156923520|NCT02554812|566478294|FG001|Overall Study|Adverse Event|5|||
156923521|NCT02554812|566478295|FG002|Overall Study|Adverse Event|3|||
156923522|NCT02554812|566478296|FG003|Overall Study|Adverse Event|0|||
156923523|NCT02554812|566478297|FG004|Overall Study|Adverse Event|5|||
156923524|NCT02554812|566478298|FG005|Overall Study|Adverse Event|0|||
156923525|NCT02554812|566478299|FG006|Overall Study|Adverse Event|1|||
157028800|NCT04171141|566862796|FG006|Overall Study|Withdrawal by Subject|1|||
157028801|NCT04171141|566862797|FG007|Overall Study|Withdrawal by Subject|0|||
157028802|NCT04171141|566862798|FG008|Overall Study|Withdrawal by Subject|0|||
157028803|NCT04171141|566862799|FG009|Overall Study|Withdrawal by Subject|1|||
157028804|NCT04171141|566862800|FG010|Overall Study|Withdrawal by Subject|0|||
157028805|NCT04171141|566862801|FG011|Overall Study|Withdrawal by Subject|0|||
157028806|NCT04171141|566862802|FG012|Overall Study|Withdrawal by Subject|0|||
157028807|NCT04171141|566862803|FG013|Overall Study|Withdrawal by Subject|0|||
157028808|NCT04171141|566862804|FG014|Overall Study|Withdrawal by Subject|0|||
157028809|NCT04171141|566862805|FG015|Overall Study|Withdrawal by Subject|0|||
157028810|NCT04171141|566862790|FG000|Overall Study|Global deterioration of health status|0|||
157028811|NCT04171141|566862791|FG001|Overall Study|Global deterioration of health status|0|||
156923526|NCT02554812|566478300|FG007|Overall Study|Adverse Event|6|||
156923527|NCT02554812|566478301|FG008|Overall Study|Adverse Event|2|||
157028812|NCT04171141|566862792|FG002|Overall Study|Global deterioration of health status|0|||
157226998|NCT01592370|567576010|FG003|Overall Study|No longer meets study criteria|0|||
157226999|NCT01592370|567576011|FG004|Overall Study|No longer meets study criteria|0|||
157227000|NCT01592370|567576012|FG005|Overall Study|No longer meets study criteria|0|||
156923528|NCT02554812|566478302|FG009|Overall Study|Adverse Event|2|||
156923529|NCT02554812|566478303|FG010|Overall Study|Adverse Event|1|||
156923530|NCT02554812|566478304|FG011|Overall Study|Adverse Event|2|||
156923531|NCT02554812|566478305|FG012|Overall Study|Adverse Event|0|||
156923532|NCT02554812|566478306|FG013|Overall Study|Adverse Event|3|||
157028813|NCT04171141|566862793|FG003|Overall Study|Global deterioration of health status|1|||
157028814|NCT04171141|566862794|FG004|Overall Study|Global deterioration of health status|0|||
156923533|NCT02554812|566478307|FG014|Overall Study|Adverse Event|2|||
156923534|NCT02554812|566478308|FG015|Overall Study|Adverse Event|1|||
156923535|NCT02554812|566478309|FG016|Overall Study|Adverse Event|0|||
156923536|NCT02554812|566478310|FG017|Overall Study|Adverse Event|1|||
156923537|NCT02554812|566478311|FG018|Overall Study|Adverse Event|0|||
156923538|NCT02554812|566478312|FG019|Overall Study|Adverse Event|0|||
156923539|NCT02554812|566478313|FG020|Overall Study|Adverse Event|0|||
156923540|NCT02554812|566478314|FG021|Overall Study|Adverse Event|2|||
156923541|NCT02554812|566478315|FG022|Overall Study|Adverse Event|1|||
156923542|NCT02554812|566478316|FG023|Overall Study|Adverse Event|1|||
156923543|NCT02554812|566478317|FG024|Overall Study|Adverse Event|1|||
156923544|NCT02554812|566478318|FG025|Overall Study|Adverse Event|2|||
156923545|NCT02554812|566478319|FG026|Overall Study|Adverse Event|1|||
156923546|NCT02554812|566478293|FG000|Overall Study|Death|1|||
156923547|NCT02554812|566478294|FG001|Overall Study|Death|2|||
156923548|NCT02554812|566478295|FG002|Overall Study|Death|2|||
156923549|NCT02554812|566478296|FG003|Overall Study|Death|2|||
156923550|NCT02554812|566478297|FG004|Overall Study|Death|0|||
156923551|NCT02554812|566478298|FG005|Overall Study|Death|1|||
156923552|NCT02554812|566478299|FG006|Overall Study|Death|1|||
156923553|NCT02554812|566478300|FG007|Overall Study|Death|1|||
156923554|NCT02554812|566478301|FG008|Overall Study|Death|0|||
156923555|NCT02554812|566478302|FG009|Overall Study|Death|0|||
156923556|NCT02554812|566478303|FG010|Overall Study|Death|0|||
156923557|NCT02554812|566478304|FG011|Overall Study|Death|0|||
156923558|NCT02554812|566478305|FG012|Overall Study|Death|0|||
156923559|NCT02554812|566478306|FG013|Overall Study|Death|0|||
156923560|NCT02554812|566478307|FG014|Overall Study|Death|1|||
156923561|NCT02554812|566478308|FG015|Overall Study|Death|1|||
156923562|NCT02554812|566478309|FG016|Overall Study|Death|1|||
156923563|NCT02554812|566478310|FG017|Overall Study|Death|0|||
156923564|NCT02554812|566478311|FG018|Overall Study|Death|1|||
156923565|NCT02554812|566478312|FG019|Overall Study|Death|2|||
156923566|NCT02554812|566478313|FG020|Overall Study|Death|0|||
156923567|NCT02554812|566478314|FG021|Overall Study|Death|1|||
156923568|NCT02554812|566478315|FG022|Overall Study|Death|1|||
156923569|NCT02554812|566478316|FG023|Overall Study|Death|0|||
156923570|NCT02554812|566478317|FG024|Overall Study|Death|0|||
156923571|NCT02554812|566478318|FG025|Overall Study|Death|0|||
156923572|NCT02554812|566478319|FG026|Overall Study|Death|0|||
156923573|NCT02554812|566478293|FG000|Overall Study|Lost to Follow-up|0|||
156923574|NCT02554812|566478294|FG001|Overall Study|Lost to Follow-up|1|||
156923575|NCT02554812|566478295|FG002|Overall Study|Lost to Follow-up|0|||
156923576|NCT02554812|566478296|FG003|Overall Study|Lost to Follow-up|0|||
156923577|NCT02554812|566478297|FG004|Overall Study|Lost to Follow-up|0|||
156923578|NCT02554812|566478298|FG005|Overall Study|Lost to Follow-up|0|||
156923579|NCT02554812|566478299|FG006|Overall Study|Lost to Follow-up|0|||
156923580|NCT02554812|566478300|FG007|Overall Study|Lost to Follow-up|0|||
156923581|NCT02554812|566478301|FG008|Overall Study|Lost to Follow-up|0|||
156923582|NCT02554812|566478302|FG009|Overall Study|Lost to Follow-up|0|||
156923583|NCT02554812|566478303|FG010|Overall Study|Lost to Follow-up|0|||
156923584|NCT02554812|566478304|FG011|Overall Study|Lost to Follow-up|0|||
156923585|NCT02554812|566478305|FG012|Overall Study|Lost to Follow-up|0|||
156923586|NCT02554812|566478306|FG013|Overall Study|Lost to Follow-up|0|||
156923587|NCT02554812|566478307|FG014|Overall Study|Lost to Follow-up|0|||
156923588|NCT02554812|566478308|FG015|Overall Study|Lost to Follow-up|0|||
156923589|NCT02554812|566478309|FG016|Overall Study|Lost to Follow-up|0|||
156923590|NCT02554812|566478310|FG017|Overall Study|Lost to Follow-up|0|||
156923591|NCT02554812|566478311|FG018|Overall Study|Lost to Follow-up|0|||
156923592|NCT02554812|566478312|FG019|Overall Study|Lost to Follow-up|0|||
156923593|NCT02554812|566478313|FG020|Overall Study|Lost to Follow-up|0|||
156923594|NCT02554812|566478314|FG021|Overall Study|Lost to Follow-up|0|||
156923595|NCT02554812|566478315|FG022|Overall Study|Lost to Follow-up|0|||
156923596|NCT02554812|566478316|FG023|Overall Study|Lost to Follow-up|0|||
156923597|NCT02554812|566478317|FG024|Overall Study|Lost to Follow-up|0|||
156923598|NCT02554812|566478318|FG025|Overall Study|Lost to Follow-up|0|||
156923599|NCT02554812|566478319|FG026|Overall Study|Lost to Follow-up|0|||
156923600|NCT02554812|566478293|FG000|Overall Study|Global deterioration of health status|4|||
156923601|NCT02554812|566478294|FG001|Overall Study|Global deterioration of health status|3|||
156923602|NCT02554812|566478295|FG002|Overall Study|Global deterioration of health status|3|||
156923603|NCT02554812|566478296|FG003|Overall Study|Global deterioration of health status|2|||
156923604|NCT02554812|566478297|FG004|Overall Study|Global deterioration of health status|5|||
156923605|NCT02554812|566478298|FG005|Overall Study|Global deterioration of health status|0|||
156923606|NCT02554812|566478299|FG006|Overall Study|Global deterioration of health status|2|||
156923607|NCT02554812|566478300|FG007|Overall Study|Global deterioration of health status|1|||
156923608|NCT02554812|566478301|FG008|Overall Study|Global deterioration of health status|1|||
156923609|NCT02554812|566478302|FG009|Overall Study|Global deterioration of health status|1|||
157028815|NCT04171141|566862795|FG005|Overall Study|Global deterioration of health status|2|||
156923610|NCT02554812|566478303|FG010|Overall Study|Global deterioration of health status|2|||
156923611|NCT02554812|566478304|FG011|Overall Study|Global deterioration of health status|1|||
156923612|NCT02554812|566478305|FG012|Overall Study|Global deterioration of health status|0|||
156923613|NCT02554812|566478306|FG013|Overall Study|Global deterioration of health status|0|||
156923614|NCT02554812|566478307|FG014|Overall Study|Global deterioration of health status|0|||
156923615|NCT02554812|566478308|FG015|Overall Study|Global deterioration of health status|1|||
156923616|NCT02554812|566478309|FG016|Overall Study|Global deterioration of health status|0|||
156923617|NCT02554812|566478310|FG017|Overall Study|Global deterioration of health status|0|||
156923618|NCT02554812|566478311|FG018|Overall Study|Global deterioration of health status|0|||
156923619|NCT02554812|566478312|FG019|Overall Study|Global deterioration of health status|0|||
156923620|NCT02554812|566478313|FG020|Overall Study|Global deterioration of health status|0|||
156923621|NCT02554812|566478314|FG021|Overall Study|Global deterioration of health status|0|||
156923622|NCT02554812|566478315|FG022|Overall Study|Global deterioration of health status|0|||
156923623|NCT02554812|566478316|FG023|Overall Study|Global deterioration of health status|0|||
156923624|NCT02554812|566478317|FG024|Overall Study|Global deterioration of health status|0|||
156923625|NCT02554812|566478318|FG025|Overall Study|Global deterioration of health status|0|||
156923626|NCT02554812|566478319|FG026|Overall Study|Global deterioration of health status|0|||
156923627|NCT02554812|566478293|FG000|Overall Study|Progressive disease|20|||
156923628|NCT02554812|566478294|FG001|Overall Study|Progressive disease|16|||
156923629|NCT02554812|566478295|FG002|Overall Study|Progressive disease|19|||
156923630|NCT02554812|566478296|FG003|Overall Study|Progressive disease|18|||
156923631|NCT02554812|566478297|FG004|Overall Study|Progressive disease|21|||
156923632|NCT02554812|566478298|FG005|Overall Study|Progressive disease|15|||
156923633|NCT02554812|566478299|FG006|Overall Study|Progressive disease|6|||
156923634|NCT02554812|566478300|FG007|Overall Study|Progressive disease|13|||
156923635|NCT02554812|566478301|FG008|Overall Study|Progressive disease|6|||
156923636|NCT02554812|566478302|FG009|Overall Study|Progressive disease|6|||
156923637|NCT02554812|566478303|FG010|Overall Study|Progressive disease|8|||
156923638|NCT02554812|566478304|FG011|Overall Study|Progressive disease|8|||
156923639|NCT02554812|566478305|FG012|Overall Study|Progressive disease|6|||
156923640|NCT02554812|566478306|FG013|Overall Study|Progressive disease|10|||
156923641|NCT02554812|566478307|FG014|Overall Study|Progressive disease|20|||
156923642|NCT02554812|566478308|FG015|Overall Study|Progressive disease|6|||
156923643|NCT02554812|566478309|FG016|Overall Study|Progressive disease|3|||
156923644|NCT02554812|566478310|FG017|Overall Study|Progressive disease|3|||
156923645|NCT02554812|566478311|FG018|Overall Study|Progressive disease|11|||
156923646|NCT02554812|566478312|FG019|Overall Study|Progressive disease|7|||
156923647|NCT02554812|566478313|FG020|Overall Study|Progressive disease|11|||
156923648|NCT02554812|566478314|FG021|Overall Study|Progressive disease|6|||
156923649|NCT02554812|566478315|FG022|Overall Study|Progressive disease|9|||
156923650|NCT02554812|566478316|FG023|Overall Study|Progressive disease|9|||
156923651|NCT02554812|566478317|FG024|Overall Study|Progressive disease|4|||
156923652|NCT02554812|566478318|FG025|Overall Study|Progressive disease|5|||
156923653|NCT02554812|566478319|FG026|Overall Study|Progressive disease|5|||
156923654|NCT02554812|566478293|FG000|Overall Study|Other|0|||
156923655|NCT02554812|566478294|FG001|Overall Study|Other|0|||
156923656|NCT02554812|566478295|FG002|Overall Study|Other|2|||
156923657|NCT02554812|566478296|FG003|Overall Study|Other|3|||
156923658|NCT02554812|566478297|FG004|Overall Study|Other|2|||
156923659|NCT02554812|566478298|FG005|Overall Study|Other|1|||
156923660|NCT02554812|566478299|FG006|Overall Study|Other|0|||
156923661|NCT02554812|566478300|FG007|Overall Study|Other|0|||
156923662|NCT02554812|566478301|FG008|Overall Study|Other|1|||
156923663|NCT02554812|566478302|FG009|Overall Study|Other|1|||
156923664|NCT02554812|566478303|FG010|Overall Study|Other|0|||
156923665|NCT02554812|566478304|FG011|Overall Study|Other|0|||
156923666|NCT02554812|566478305|FG012|Overall Study|Other|1|||
156923667|NCT02554812|566478306|FG013|Overall Study|Other|0|||
156923668|NCT02554812|566478307|FG014|Overall Study|Other|1|||
156923669|NCT02554812|566478308|FG015|Overall Study|Other|0|||
156923670|NCT02554812|566478309|FG016|Overall Study|Other|0|||
156923671|NCT02554812|566478310|FG017|Overall Study|Other|0|||
156923672|NCT02554812|566478311|FG018|Overall Study|Other|0|||
156923673|NCT02554812|566478312|FG019|Overall Study|Other|0|||
156923674|NCT02554812|566478313|FG020|Overall Study|Other|0|||
156923675|NCT02554812|566478314|FG021|Overall Study|Other|2|||
156923676|NCT02554812|566478315|FG022|Overall Study|Other|0|||
156923677|NCT02554812|566478316|FG023|Overall Study|Other|0|||
156923678|NCT02554812|566478317|FG024|Overall Study|Other|0|||
156923679|NCT02554812|566478318|FG025|Overall Study|Other|0|||
156923680|NCT02554812|566478319|FG026|Overall Study|Other|0|||
156923681|NCT02554812|566478293|FG000|Overall Study|Withdrawal by Subject|1|||
156923682|NCT02554812|566478294|FG001|Overall Study|Withdrawal by Subject|0|||
156923683|NCT02554812|566478295|FG002|Overall Study|Withdrawal by Subject|0|||
156923684|NCT02554812|566478296|FG003|Overall Study|Withdrawal by Subject|2|||
156923685|NCT02554812|566478297|FG004|Overall Study|Withdrawal by Subject|2|||
156923686|NCT02554812|566478298|FG005|Overall Study|Withdrawal by Subject|3|||
156923687|NCT02554812|566478299|FG006|Overall Study|Withdrawal by Subject|0|||
156923688|NCT02554812|566478300|FG007|Overall Study|Withdrawal by Subject|0|||
156923689|NCT02554812|566478301|FG008|Overall Study|Withdrawal by Subject|1|||
156923690|NCT02554812|566478302|FG009|Overall Study|Withdrawal by Subject|1|||
156923691|NCT02554812|566478303|FG010|Overall Study|Withdrawal by Subject|0|||
156923692|NCT02554812|566478304|FG011|Overall Study|Withdrawal by Subject|1|||
156923693|NCT02554812|566478305|FG012|Overall Study|Withdrawal by Subject|1|||
156923694|NCT02554812|566478306|FG013|Overall Study|Withdrawal by Subject|1|||
156923695|NCT02554812|566478307|FG014|Overall Study|Withdrawal by Subject|1|||
156923696|NCT02554812|566478308|FG015|Overall Study|Withdrawal by Subject|1|||
156923697|NCT02554812|566478309|FG016|Overall Study|Withdrawal by Subject|3|||
156923698|NCT02554812|566478310|FG017|Overall Study|Withdrawal by Subject|1|||
156923699|NCT02554812|566478311|FG018|Overall Study|Withdrawal by Subject|0|||
156923700|NCT02554812|566478312|FG019|Overall Study|Withdrawal by Subject|2|||
156923701|NCT02554812|566478313|FG020|Overall Study|Withdrawal by Subject|0|||
156923702|NCT02554812|566478314|FG021|Overall Study|Withdrawal by Subject|1|||
156923703|NCT02554812|566478315|FG022|Overall Study|Withdrawal by Subject|0|||
157164615|NCT00064350|567344040|FG001|Cross-Over|Adverse Event|1|||
157164616|NCT00064350|567344041|FG002|Cross-Over|Adverse Event|0|||
157164617|NCT00064350|567344039|FG000|Cross-Over|Death|1|||
157164618|NCT00064350|567344040|FG001|Cross-Over|Death|3|||
157164619|NCT00064350|567344041|FG002|Cross-Over|Death|0|||
157164620|NCT00064350|567344039|FG000|Cross-Over|Withdrawal by Subject|2|||
157164621|NCT00064350|567344040|FG001|Cross-Over|Withdrawal by Subject|2|||
157164622|NCT00064350|567344041|FG002|Cross-Over|Withdrawal by Subject|0|||
157164623|NCT00064350|567344039|FG000|Cross-Over|Ineligible or never started treatment|3|||
157164624|NCT00064350|567344040|FG001|Cross-Over|Ineligible or never started treatment|6|||
157164625|NCT00064350|567344041|FG002|Cross-Over|Ineligible or never started treatment|0|||
157164626|NCT00064350|567344039|FG000|Cross-Over|Other|0|||
157164627|NCT00064350|567344040|FG001|Cross-Over|Other|2|||
157164628|NCT00064350|567344041|FG002|Cross-Over|Other|0|||
157164629|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
157164630|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
157164631|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
157164632|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
157164633|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
157164634|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
157164635|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
157164636|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
157164637|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
157164638|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
157164639|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
157164640|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
157164641|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
157164642|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
157164643|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
157164644|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
157164645|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Missing|3|||
157164646|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Missing|1|||
157164647|NCT00838916|567344042|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
157164648|NCT00838916|567344043|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
157164649|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
157164650|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
157164651|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
157164652|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
157164653|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
157164654|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
157164655|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
157164656|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
157164657|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
157164658|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
157164659|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
157164660|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
157164661|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
157164662|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
157227001|NCT01592370|567576013|FG006|Overall Study|No longer meets study criteria|0|||
157227002|NCT01592370|567576007|FG000|Overall Study|Other Reasons|6|||
157227003|NCT01592370|567576008|FG001|Overall Study|Other Reasons|0|||
157227004|NCT01592370|567576009|FG002|Overall Study|Other Reasons|10|||
156923704|NCT02554812|566478316|FG023|Overall Study|Withdrawal by Subject|1|||
157164663|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
157164664|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
157164665|NCT00838916|567344042|FG000|Follow-up Period (8 Weeks)|Missing|3|||
157164666|NCT00838916|567344043|FG001|Follow-up Period (8 Weeks)|Missing|0|||
157164667|NCT01927419|567344044|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
157164668|NCT01927419|567344045|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
157227005|NCT01592370|567576010|FG003|Overall Study|Other Reasons|0|||
156923705|NCT02554812|566478317|FG024|Overall Study|Withdrawal by Subject|0|||
156923706|NCT02554812|566478318|FG025|Overall Study|Withdrawal by Subject|0|||
156923707|NCT02554812|566478319|FG026|Overall Study|Withdrawal by Subject|1|||
156923708|NCT02554812|566478293|FG000|Overall Study|Physician Decision|1|||
156923709|NCT02554812|566478294|FG001|Overall Study|Physician Decision|0|||
156923710|NCT02554812|566478295|FG002|Overall Study|Physician Decision|0|||
156923711|NCT02554812|566478296|FG003|Overall Study|Physician Decision|1|||
156923712|NCT02554812|566478297|FG004|Overall Study|Physician Decision|0|||
156923713|NCT02554812|566478298|FG005|Overall Study|Physician Decision|1|||
156923714|NCT02554812|566478299|FG006|Overall Study|Physician Decision|0|||
156923715|NCT02554812|566478300|FG007|Overall Study|Physician Decision|0|||
156923716|NCT02554812|566478301|FG008|Overall Study|Physician Decision|0|||
156923717|NCT02554812|566478302|FG009|Overall Study|Physician Decision|0|||
156923718|NCT02554812|566478303|FG010|Overall Study|Physician Decision|1|||
156923719|NCT02554812|566478304|FG011|Overall Study|Physician Decision|0|||
156923720|NCT02554812|566478305|FG012|Overall Study|Physician Decision|0|||
156923721|NCT02554812|566478306|FG013|Overall Study|Physician Decision|0|||
156923722|NCT02554812|566478307|FG014|Overall Study|Physician Decision|0|||
156923723|NCT02554812|566478308|FG015|Overall Study|Physician Decision|0|||
156923724|NCT02554812|566478309|FG016|Overall Study|Physician Decision|1|||
156923725|NCT02554812|566478310|FG017|Overall Study|Physician Decision|1|||
156923726|NCT02554812|566478311|FG018|Overall Study|Physician Decision|0|||
156923727|NCT02554812|566478312|FG019|Overall Study|Physician Decision|1|||
156923728|NCT02554812|566478313|FG020|Overall Study|Physician Decision|1|||
156923729|NCT02554812|566478314|FG021|Overall Study|Physician Decision|0|||
156923730|NCT02554812|566478315|FG022|Overall Study|Physician Decision|1|||
156923731|NCT02554812|566478316|FG023|Overall Study|Physician Decision|0|||
156923732|NCT02554812|566478317|FG024|Overall Study|Physician Decision|0|||
156923733|NCT02554812|566478318|FG025|Overall Study|Physician Decision|0|||
156923734|NCT02554812|566478319|FG026|Overall Study|Physician Decision|0|||
156923735|NCT02554812|566478293|FG000|Overall Study|Study terminated by sponsor|0|||
156923736|NCT02554812|566478294|FG001|Overall Study|Study terminated by sponsor|0|||
156923737|NCT02554812|566478295|FG002|Overall Study|Study terminated by sponsor|0|||
156923738|NCT02554812|566478296|FG003|Overall Study|Study terminated by sponsor|0|||
156923739|NCT02554812|566478297|FG004|Overall Study|Study terminated by sponsor|0|||
156923740|NCT02554812|566478298|FG005|Overall Study|Study terminated by sponsor|0|||
156923741|NCT02554812|566478299|FG006|Overall Study|Study terminated by sponsor|0|||
156923742|NCT02554812|566478300|FG007|Overall Study|Study terminated by sponsor|0|||
156923743|NCT02554812|566478301|FG008|Overall Study|Study terminated by sponsor|0|||
156923744|NCT02554812|566478302|FG009|Overall Study|Study terminated by sponsor|0|||
156923745|NCT02554812|566478303|FG010|Overall Study|Study terminated by sponsor|0|||
156923746|NCT02554812|566478304|FG011|Overall Study|Study terminated by sponsor|0|||
156923747|NCT02554812|566478305|FG012|Overall Study|Study terminated by sponsor|0|||
156923748|NCT02554812|566478306|FG013|Overall Study|Study terminated by sponsor|0|||
156923749|NCT02554812|566478307|FG014|Overall Study|Study terminated by sponsor|0|||
156923750|NCT02554812|566478308|FG015|Overall Study|Study terminated by sponsor|0|||
156923751|NCT02554812|566478309|FG016|Overall Study|Study terminated by sponsor|0|||
156923752|NCT02554812|566478310|FG017|Overall Study|Study terminated by sponsor|0|||
156923753|NCT02554812|566478311|FG018|Overall Study|Study terminated by sponsor|0|||
156923754|NCT02554812|566478312|FG019|Overall Study|Study terminated by sponsor|0|||
156923755|NCT02554812|566478313|FG020|Overall Study|Study terminated by sponsor|0|||
156923756|NCT02554812|566478314|FG021|Overall Study|Study terminated by sponsor|0|||
156923757|NCT02554812|566478315|FG022|Overall Study|Study terminated by sponsor|0|||
156923758|NCT02554812|566478316|FG023|Overall Study|Study terminated by sponsor|0|||
156923759|NCT02554812|566478317|FG024|Overall Study|Study terminated by sponsor|1|||
156923760|NCT02554812|566478318|FG025|Overall Study|Study terminated by sponsor|0|||
156923761|NCT02554812|566478319|FG026|Overall Study|Study terminated by sponsor|0|||
156923762|NCT02554812|566478293|FG000|Overall Study|No longer meets eligibility criteria|0|||
156923763|NCT02554812|566478294|FG001|Overall Study|No longer meets eligibility criteria|1|||
156923764|NCT02554812|566478295|FG002|Overall Study|No longer meets eligibility criteria|0|||
156923765|NCT02554812|566478296|FG003|Overall Study|No longer meets eligibility criteria|0|||
156923766|NCT02554812|566478297|FG004|Overall Study|No longer meets eligibility criteria|0|||
157164669|NCT01927419|567344044|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
156923767|NCT02554812|566478298|FG005|Overall Study|No longer meets eligibility criteria|0|||
156923768|NCT02554812|566478299|FG006|Overall Study|No longer meets eligibility criteria|0|||
156923769|NCT02554812|566478300|FG007|Overall Study|No longer meets eligibility criteria|0|||
156923770|NCT02554812|566478301|FG008|Overall Study|No longer meets eligibility criteria|0|||
156923771|NCT02554812|566478302|FG009|Overall Study|No longer meets eligibility criteria|0|||
156923772|NCT02554812|566478303|FG010|Overall Study|No longer meets eligibility criteria|0|||
156923773|NCT02554812|566478304|FG011|Overall Study|No longer meets eligibility criteria|0|||
156923774|NCT02554812|566478305|FG012|Overall Study|No longer meets eligibility criteria|0|||
156923775|NCT02554812|566478306|FG013|Overall Study|No longer meets eligibility criteria|0|||
156923776|NCT02554812|566478307|FG014|Overall Study|No longer meets eligibility criteria|0|||
156977492|NCT02223754|566670722|FG001|Period 1|Adverse Event|0|||
156977493|NCT02223754|566670721|FG000|Period 1|Lost to Follow-up|0|||
157164670|NCT01927419|567344045|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
157164671|NCT01927419|567344044|FG000|Treatment Period|Disease progression|17|||
157164672|NCT01927419|567344045|FG001|Treatment Period|Disease progression|20|||
157164673|NCT01927419|567344044|FG000|Treatment Period|Study drug toxicity|48|||
157164674|NCT01927419|567344045|FG001|Treatment Period|Study drug toxicity|10|||
157164675|NCT01927419|567344044|FG000|Treatment Period|Death|0|||
157164676|NCT01927419|567344045|FG001|Treatment Period|Death|1|||
157164677|NCT01927419|567344044|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
157164678|NCT01927419|567344045|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
157164679|NCT01927419|567344044|FG000|Treatment Period|Participant request to discontinue|12|||
157164680|NCT01927419|567344045|FG001|Treatment Period|Participant request to discontinue|4|||
157164681|NCT01927419|567344044|FG000|Treatment Period|Withdrawal by Subject|1|||
157164682|NCT01927419|567344045|FG001|Treatment Period|Withdrawal by Subject|1|||
157164683|NCT01927419|567344044|FG000|Treatment Period|Maximum Clinical Benefit|6|||
157164684|NCT01927419|567344045|FG001|Treatment Period|Maximum Clinical Benefit|2|||
157164685|NCT01927419|567344044|FG000|Treatment Period|Other reasons|3|||
157164686|NCT01927419|567344045|FG001|Treatment Period|Other reasons|4|||
157164687|NCT01927419|567344044|FG000|Treatment Period|Not Reported|1|||
157164688|NCT01927419|567344045|FG001|Treatment Period|Not Reported|1|||
157164689|NCT00115765|567344048|FG000|Overall Study|Withdrawal by Subject|22|||
157164690|NCT00115765|567344049|FG001|Overall Study|Withdrawal by Subject|53|||
157164691|NCT00115765|567344050|FG002|Overall Study|Withdrawal by Subject|76|||
157164692|NCT00115765|567344051|FG003|Overall Study|Withdrawal by Subject|15|||
157164693|NCT00115765|567344048|FG000|Overall Study|Physician Decision|4|||
157164694|NCT00115765|567344049|FG001|Overall Study|Physician Decision|15|||
157164695|NCT00115765|567344050|FG002|Overall Study|Physician Decision|18|||
157164696|NCT00115765|567344051|FG003|Overall Study|Physician Decision|13|||
157164697|NCT00115765|567344048|FG000|Overall Study|Lost to Follow-up|3|||
157164698|NCT00115765|567344049|FG001|Overall Study|Lost to Follow-up|20|||
157164699|NCT00115765|567344050|FG002|Overall Study|Lost to Follow-up|18|||
157164700|NCT00115765|567344051|FG003|Overall Study|Lost to Follow-up|1|||
157164701|NCT00115765|567344048|FG000|Overall Study|Other|6|||
157164702|NCT00115765|567344049|FG001|Overall Study|Other|12|||
157164703|NCT00115765|567344050|FG002|Overall Study|Other|9|||
157164704|NCT00115765|567344051|FG003|Overall Study|Other|2|||
157164705|NCT03600714|567344052|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
157164706|NCT01935336|567344055|FG000|Overall Study|Adverse Event|1|||
157164707|NCT01935336|567344056|FG001|Overall Study|Adverse Event|0|||
157164708|NCT01935336|567344057|FG002|Overall Study|Adverse Event|0|||
157164709|NCT01935336|567344058|FG003|Overall Study|Adverse Event|0|||
157164710|NCT01935336|567344055|FG000|Overall Study|Progressive disease|5|||
157164711|NCT01935336|567344056|FG001|Overall Study|Progressive disease|3|||
157164712|NCT01935336|567344057|FG002|Overall Study|Progressive disease|47|||
157164713|NCT01935336|567344058|FG003|Overall Study|Progressive disease|66|||
157164714|NCT01810042|567344061|FG000|Overall Study|Lost to Follow-up|10|||
157164715|NCT03707158|567344062|FG000|Midtreatment|Lost to Follow-up|16|||
157164716|NCT03707158|567344063|FG001|Midtreatment|Lost to Follow-up|7|||
157164717|NCT03707158|567344062|FG000|Midtreatment|Withdrawal by Subject|28|||
157164718|NCT03707158|567344063|FG001|Midtreatment|Withdrawal by Subject|19|||
157227006|NCT01592370|567576011|FG004|Overall Study|Other Reasons|0|||
157227007|NCT01592370|567576012|FG005|Overall Study|Other Reasons|1|||
157227008|NCT01592370|567576013|FG006|Overall Study|Other Reasons|0|||
157227009|NCT01592370|567576007|FG000|Overall Study|Not Treated|0|||
157227010|NCT01592370|567576008|FG001|Overall Study|Not Treated|0|||
157227011|NCT01592370|567576009|FG002|Overall Study|Not Treated|0|||
157227012|NCT01592370|567576010|FG003|Overall Study|Not Treated|0|||
157227013|NCT01592370|567576011|FG004|Overall Study|Not Treated|2|||
157164719|NCT03707158|567344062|FG000|Posttreatment|Lost to Follow-up|0|||
157164720|NCT03707158|567344063|FG001|Posttreatment|Lost to Follow-up|5|||
157164721|NCT03707158|567344062|FG000|Follow-up|Lost to Follow-up|19|||
157164722|NCT03707158|567344063|FG001|Follow-up|Lost to Follow-up|18|||
157227014|NCT01592370|567576012|FG005|Overall Study|Not Treated|2|||
157164723|NCT03707158|567344062|FG000|Follow-up|Withdrawal by Subject|13|||
157227015|NCT01592370|567576013|FG006|Overall Study|Not Treated|0|||
157164724|NCT03707158|567344063|FG001|Follow-up|Withdrawal by Subject|6|||
157164725|NCT01454401|567344065|FG000|Overall Study|Death|1|||
157164726|NCT01454401|567344065|FG000|Overall Study|hospitalised|1|||
157164727|NCT01454401|567344065|FG000|Overall Study|osteomyelitis|2|||
157164728|NCT01454401|567344065|FG000|Overall Study|non-adherence|1|||
157164729|NCT01968187|567344066|FG000|Overall Study|Adverse Event|0|||
157164730|NCT01968187|567344067|FG001|Overall Study|Adverse Event|1|||
157164731|NCT01968187|567344066|FG000|Overall Study|Randomized but not treated|1|||
157164732|NCT01968187|567344067|FG001|Overall Study|Randomized but not treated|0|||
157164733|NCT01877382|567344068|FG000|Dose Escalation|Progressive disease|2|||
157164734|NCT01877382|567344069|FG001|Dose Escalation|Progressive disease|0|||
157227016|NCT02742181|567576014|FG000|Overall Study|Physician Decision|1|||
157227017|NCT02742181|567576015|FG001|Overall Study|Physician Decision|0|||
157227018|NCT02739984|567576016|FG000|Overall Study|Sponsor Decision|1|||
157227019|NCT02739984|567576017|FG001|Overall Study|Sponsor Decision|0|||
156923777|NCT02554812|566478308|FG015|Overall Study|No longer meets eligibility criteria|0|||
156923778|NCT02554812|566478309|FG016|Overall Study|No longer meets eligibility criteria|0|||
156923779|NCT02554812|566478310|FG017|Overall Study|No longer meets eligibility criteria|0|||
156923780|NCT02554812|566478311|FG018|Overall Study|No longer meets eligibility criteria|0|||
156923781|NCT02554812|566478312|FG019|Overall Study|No longer meets eligibility criteria|0|||
156923782|NCT02554812|566478313|FG020|Overall Study|No longer meets eligibility criteria|0|||
156923783|NCT02554812|566478314|FG021|Overall Study|No longer meets eligibility criteria|0|||
156923784|NCT02554812|566478315|FG022|Overall Study|No longer meets eligibility criteria|0|||
156923785|NCT02554812|566478316|FG023|Overall Study|No longer meets eligibility criteria|0|||
156923786|NCT02554812|566478317|FG024|Overall Study|No longer meets eligibility criteria|0|||
156923787|NCT02554812|566478318|FG025|Overall Study|No longer meets eligibility criteria|0|||
156923788|NCT02554812|566478319|FG026|Overall Study|No longer meets eligibility criteria|0|||
156923789|NCT02879305|566478320|FG000|Overall Study|Investigator Site Closed|55|||
156923790|NCT02879305|566478321|FG001|Overall Study|Investigator Site Closed|57|||
156923791|NCT02879305|566478320|FG000|Overall Study|Withdrawal by Subject|44|||
156923792|NCT02879305|566478321|FG001|Overall Study|Withdrawal by Subject|42|||
156923793|NCT02879305|566478320|FG000|Overall Study|Lost to Follow-up|17|||
156923794|NCT02879305|566478321|FG001|Overall Study|Lost to Follow-up|12|||
156923795|NCT02879305|566478320|FG000|Overall Study|Other|1|||
156923796|NCT02879305|566478321|FG001|Overall Study|Other|0|||
156923797|NCT00670800|566480211|FG000|Overall Study|2 controls were insulin resistant|0|||
156923798|NCT00670800|566480212|FG001|Overall Study|2 controls were insulin resistant|2|||
156923799|NCT00180414|566480216|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
156923800|NCT00180414|566480217|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
156923801|NCT00613938|566480222|FG000|Overall Study|Withdrawal by Subject|2|||
156923802|NCT00613938|566480223|FG001|Overall Study|Withdrawal by Subject|4|||
156923803|NCT00613938|566480224|FG002|Overall Study|Withdrawal by Subject|9|||
156923804|NCT00613938|566480225|FG003|Overall Study|Withdrawal by Subject|9|||
156923805|NCT00613938|566480222|FG000|Overall Study|Adverse Event|1|||
156923806|NCT00613938|566480223|FG001|Overall Study|Adverse Event|4|||
156923807|NCT00613938|566480224|FG002|Overall Study|Adverse Event|8|||
156923808|NCT00613938|566480225|FG003|Overall Study|Adverse Event|5|||
156923809|NCT00613938|566480222|FG000|Overall Study|Lack of Efficacy|16|||
156923810|NCT00613938|566480223|FG001|Overall Study|Lack of Efficacy|18|||
156923811|NCT00613938|566480224|FG002|Overall Study|Lack of Efficacy|5|||
156923812|NCT00613938|566480225|FG003|Overall Study|Lack of Efficacy|9|||
156923813|NCT00613938|566480222|FG000|Overall Study|Other|1|||
156923814|NCT00613938|566480223|FG001|Overall Study|Other|2|||
156923815|NCT00613938|566480224|FG002|Overall Study|Other|1|||
156923816|NCT00613938|566480225|FG003|Overall Study|Other|3|||
156923817|NCT00623727|566480226|FG000|Double Blind (DB)|Adverse Event|1|||
156923818|NCT00623727|566480227|FG001|Double Blind (DB)|Adverse Event|3|||
156923819|NCT00623727|566480226|FG000|Double Blind (DB)|Physician Decision|0|||
156923820|NCT00623727|566480227|FG001|Double Blind (DB)|Physician Decision|1|||
156923821|NCT00623727|566480226|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
156923822|NCT00623727|566480227|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
156923823|NCT00623727|566480226|FG000|Double Blind (DB)|Lack of Efficacy|2|||
156923824|NCT00623727|566480227|FG001|Double Blind (DB)|Lack of Efficacy|2|||
156923825|NCT00623727|566480226|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
156923826|NCT00623727|566480227|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
156923827|NCT00623727|566480226|FG000|Double Blind (DB)|Lost to Follow-up|1|||
156923828|NCT00623727|566480227|FG001|Double Blind (DB)|Lost to Follow-up|1|||
156923829|NCT00623727|566480226|FG000|Double Blind (DB)|Protocol Violation|2|||
156923830|NCT00623727|566480227|FG001|Double Blind (DB)|Protocol Violation|2|||
156923831|NCT00623727|566480226|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
156923832|NCT00623727|566480227|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
156923833|NCT00623727|566480226|FG000|Open Label Follow-up|Study termination|0|||
156923834|NCT00623727|566480227|FG001|Open Label Follow-up|Study termination|6|||
156923835|NCT00623727|566480226|FG000|Open Label Follow-up|Participant convenience|0|||
156923836|NCT00623727|566480227|FG001|Open Label Follow-up|Participant convenience|1|||
156923837|NCT03220217|566480228|FG000|Overall Study|Withdrawal by Subject|0|||
156923838|NCT03220217|566480229|FG001|Overall Study|Withdrawal by Subject|1|||
156923839|NCT03220217|566480230|FG002|Overall Study|Withdrawal by Subject|0|||
156923840|NCT03220217|566480228|FG000|Overall Study|Subject Missed Procedure|0|||
156923841|NCT03220217|566480229|FG001|Overall Study|Subject Missed Procedure|0|||
156923842|NCT03220217|566480230|FG002|Overall Study|Subject Missed Procedure|1|||
156923843|NCT03025542|566480231|FG000|Overall Study|Adverse Event|0|||
156923844|NCT03025542|566480232|FG001|Overall Study|Adverse Event|2|||
156923845|NCT03025542|566480231|FG000|Overall Study|Lost to Follow-up|1|||
156923846|NCT03025542|566480232|FG001|Overall Study|Lost to Follow-up|0|||
156923847|NCT03025542|566480231|FG000|Overall Study|Withdrawal by Subject|1|||
156923848|NCT03025542|566480232|FG001|Overall Study|Withdrawal by Subject|0|||
156923849|NCT03745937|566480233|FG000|Overall Study|Withdrawal by Subject|0|||
156923850|NCT03745937|566480234|FG001|Overall Study|Withdrawal by Subject|0|||
156923851|NCT03745937|566480235|FG002|Overall Study|Withdrawal by Subject|0|||
156923852|NCT03745937|566480236|FG003|Overall Study|Withdrawal by Subject|1|||
156923853|NCT03745937|566480233|FG000|Overall Study|Not-specifed|0|||
156923854|NCT03745937|566480234|FG001|Overall Study|Not-specifed|1|||
156923855|NCT03745937|566480235|FG002|Overall Study|Not-specifed|0|||
156923856|NCT03745937|566480236|FG003|Overall Study|Not-specifed|1|||
156923857|NCT00501293|566480237|FG000|Optimization Period|Enrolled in error|1|||
156923858|NCT00501293|566480238|FG001|Optimization Period|Enrolled in error|0|||
156923859|NCT00501293|566480237|FG000|Maintenance Period|Withdrawal by Subject|14|||
156923860|NCT00501293|566480238|FG001|Maintenance Period|Withdrawal by Subject|13|||
156923861|NCT00501293|566480237|FG000|Maintenance Period|Lost to Follow-up|12|||
156923862|NCT00501293|566480238|FG001|Maintenance Period|Lost to Follow-up|7|||
156923863|NCT00501293|566480237|FG000|Maintenance Period|Adverse Event|6|||
156923864|NCT00501293|566480238|FG001|Maintenance Period|Adverse Event|6|||
156923865|NCT00501293|566480237|FG000|Maintenance Period|Protocol Violation|2|||
156923866|NCT00501293|566480238|FG001|Maintenance Period|Protocol Violation|1|||
156923867|NCT00501293|566480237|FG000|Maintenance Period|Lack of Efficacy|4|||
156923868|NCT00501293|566480238|FG001|Maintenance Period|Lack of Efficacy|1|||
156923869|NCT00501293|566480237|FG000|Maintenance Period|Noncompliant with study medication|5|||
156923870|NCT00501293|566480238|FG001|Maintenance Period|Noncompliant with study medication|0|||
156923871|NCT00501293|566480237|FG000|Maintenance Period|Went into rehabilitation|1|||
156923872|NCT00501293|566480238|FG001|Maintenance Period|Went into rehabilitation|0|||
156923873|NCT00501293|566480237|FG000|Maintenance Period|Would not wear patch|1|||
156923874|NCT00501293|566480238|FG001|Maintenance Period|Would not wear patch|0|||
156923875|NCT00501293|566480237|FG000|Maintenance Period|Application site reaction|1|||
156923876|NCT00501293|566480238|FG001|Maintenance Period|Application site reaction|0|||
156923877|NCT00488345|566480240|FG000|Overall Study|Adverse Event|0|||
156923878|NCT00488345|566480241|FG001|Overall Study|Adverse Event|1|||
156923879|NCT00488345|566480242|FG002|Overall Study|Adverse Event|1|||
156923880|NCT00488345|566480240|FG000|Overall Study|Unable to administer antibiotics at home|0|||
156923881|NCT00488345|566480241|FG001|Overall Study|Unable to administer antibiotics at home|1|||
156923882|NCT00488345|566480242|FG002|Overall Study|Unable to administer antibiotics at home|0|||
156923883|NCT00488345|566480240|FG000|Overall Study|Institutional Review Board review|0|||
156923884|NCT00488345|566480241|FG001|Overall Study|Institutional Review Board review|0|||
156923885|NCT00488345|566480242|FG002|Overall Study|Institutional Review Board review|1|||
156923886|NCT00488345|566480240|FG000|Overall Study|Surgical team recommendation|0|||
156923887|NCT00488345|566480241|FG001|Overall Study|Surgical team recommendation|1|||
156923888|NCT00488345|566480242|FG002|Overall Study|Surgical team recommendation|0|||
156923889|NCT00488345|566480240|FG000|Overall Study|Parent/legal guardian request|0|||
156923890|NCT00488345|566480241|FG001|Overall Study|Parent/legal guardian request|1|||
156923891|NCT00488345|566480242|FG002|Overall Study|Parent/legal guardian request|1|||
156923892|NCT01853046|566480243|FG000|Overall Study|Withdrawal by Subject|1|||
156923893|NCT01853046|566480244|FG001|Overall Study|Withdrawal by Subject|1|||
156923894|NCT01853046|566480243|FG000|Overall Study|Adverse Event|4|||
156923895|NCT01853046|566480244|FG001|Overall Study|Adverse Event|2|||
156923896|NCT01853046|566480243|FG000|Overall Study|Disease progression|13|||
156923897|NCT01853046|566480244|FG001|Overall Study|Disease progression|3|||
156923898|NCT03020407|566480246|FG000|Overall Study|Withdrawal by Subject|2|||
156923899|NCT03020407|566480247|FG001|Overall Study|Withdrawal by Subject|1|||
157164735|NCT01877382|567344070|FG002|Dose Escalation|Progressive disease|1|||
157164736|NCT01877382|567344071|FG003|Dose Escalation|Progressive disease|6|||
157164737|NCT01877382|567344072|FG004|Dose Escalation|Progressive disease|1|||
157164738|NCT01877382|567344073|FG005|Dose Escalation|Progressive disease|0|||
157164739|NCT01877382|567344074|FG006|Dose Escalation|Progressive disease|3|||
156923900|NCT03020407|566480246|FG000|Overall Study|Lost to Follow-up|2|||
156923901|NCT03020407|566480247|FG001|Overall Study|Lost to Follow-up|3|||
156923902|NCT03020407|566480246|FG000|Overall Study|Protocol Violation|0|||
156923903|NCT03020407|566480247|FG001|Overall Study|Protocol Violation|1|||
156923904|NCT01585428|566480248|FG000|Overall Study|Death during treatment|1|||
156923905|NCT01585428|566480249|FG001|Overall Study|Death during treatment|0|||
157028816|NCT04171141|566862796|FG006|Overall Study|Global deterioration of health status|1|||
157028817|NCT04171141|566862797|FG007|Overall Study|Global deterioration of health status|0|||
157028818|NCT04171141|566862798|FG008|Overall Study|Global deterioration of health status|1|||
157164740|NCT01877382|567344075|FG007|Dose Escalation|Progressive disease|10|||
156923906|NCT00708162|566480250|FG000|Randomized Phase|Randomized but Not Treated|7|||
156923907|NCT00708162|566480251|FG001|Randomized Phase|Randomized but Not Treated|5|||
157028819|NCT04171141|566862799|FG009|Overall Study|Global deterioration of health status|0|||
157164741|NCT01877382|567344076|FG008|Dose Escalation|Progressive disease|4|||
156923908|NCT00708162|566480250|FG000|Randomized Phase|Participant Noncompliance|40|||
156923909|NCT00708162|566480251|FG001|Randomized Phase|Participant Noncompliance|32|||
156923910|NCT00708162|566480250|FG000|Randomized Phase|Lost to Follow-up|34|||
156923911|NCT00708162|566480251|FG001|Randomized Phase|Lost to Follow-up|34|||
157164742|NCT01877382|567344077|FG009|Dose Escalation|Progressive disease|2|||
157164743|NCT01877382|567344078|FG010|Dose Escalation|Progressive disease|3|||
157164744|NCT01877382|567344079|FG011|Dose Escalation|Progressive disease|3|||
157164745|NCT01877382|567344080|FG012|Dose Escalation|Progressive disease|13|||
157164746|NCT01877382|567344081|FG013|Dose Escalation|Progressive disease|1|||
157164747|NCT01877382|567344082|FG014|Dose Escalation|Progressive disease|0|||
157164748|NCT01877382|567344068|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
157164749|NCT01877382|567344069|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164750|NCT01877382|567344070|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164751|NCT01877382|567344071|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
157164752|NCT01877382|567344072|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164753|NCT01877382|567344073|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164754|NCT01877382|567344074|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
157164755|NCT01877382|567344075|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164756|NCT01877382|567344076|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164757|NCT01877382|567344077|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164758|NCT01877382|567344078|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164759|NCT01877382|567344079|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164760|NCT01877382|567344080|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164761|NCT01877382|567344081|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164762|NCT01877382|567344082|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164763|NCT01877382|567344068|FG000|Dose Escalation|Clinical progression|0|||
157164764|NCT01877382|567344069|FG001|Dose Escalation|Clinical progression|1|||
157164765|NCT01877382|567344070|FG002|Dose Escalation|Clinical progression|0|||
157164766|NCT01877382|567344071|FG003|Dose Escalation|Clinical progression|2|||
157164767|NCT01877382|567344072|FG004|Dose Escalation|Clinical progression|0|||
157164768|NCT01877382|567344073|FG005|Dose Escalation|Clinical progression|0|||
157164769|NCT01877382|567344074|FG006|Dose Escalation|Clinical progression|1|||
157164770|NCT01877382|567344075|FG007|Dose Escalation|Clinical progression|0|||
157164771|NCT01877382|567344076|FG008|Dose Escalation|Clinical progression|0|||
157164772|NCT01877382|567344077|FG009|Dose Escalation|Clinical progression|1|||
157164773|NCT01877382|567344078|FG010|Dose Escalation|Clinical progression|0|||
157164774|NCT01877382|567344079|FG011|Dose Escalation|Clinical progression|0|||
157164775|NCT01877382|567344080|FG012|Dose Escalation|Clinical progression|2|||
157164776|NCT01877382|567344081|FG013|Dose Escalation|Clinical progression|1|||
157164777|NCT01877382|567344082|FG014|Dose Escalation|Clinical progression|0|||
157164778|NCT01877382|567344068|FG000|Dose Escalation|Adverse Event|0|||
157164779|NCT01877382|567344069|FG001|Dose Escalation|Adverse Event|0|||
157164780|NCT01877382|567344070|FG002|Dose Escalation|Adverse Event|0|||
157164781|NCT01877382|567344071|FG003|Dose Escalation|Adverse Event|4|||
157164782|NCT01877382|567344072|FG004|Dose Escalation|Adverse Event|1|||
157164783|NCT01877382|567344073|FG005|Dose Escalation|Adverse Event|2|||
157164784|NCT01877382|567344074|FG006|Dose Escalation|Adverse Event|1|||
157164785|NCT01877382|567344075|FG007|Dose Escalation|Adverse Event|2|||
157164786|NCT01877382|567344076|FG008|Dose Escalation|Adverse Event|0|||
157164787|NCT01877382|567344077|FG009|Dose Escalation|Adverse Event|0|||
157164788|NCT01877382|567344078|FG010|Dose Escalation|Adverse Event|0|||
157164789|NCT01877382|567344079|FG011|Dose Escalation|Adverse Event|0|||
156923912|NCT00708162|566480250|FG000|Randomized Phase|Withdrew Consent|31|||
156923913|NCT00708162|566480251|FG001|Randomized Phase|Withdrew Consent|22|||
156923914|NCT00708162|566480250|FG000|Randomized Phase|Lack of Efficacy|14|||
156923915|NCT00708162|566480251|FG001|Randomized Phase|Lack of Efficacy|19|||
156923916|NCT00708162|566480250|FG000|Randomized Phase|Protocol Violation|10|||
156923917|NCT00708162|566480251|FG001|Randomized Phase|Protocol Violation|11|||
156923918|NCT00708162|566480250|FG000|Randomized Phase|Adverse Event|8|||
156923919|NCT00708162|566480251|FG001|Randomized Phase|Adverse Event|12|||
156923920|NCT00708162|566480250|FG000|Randomized Phase|Investigator's Discretion|7|||
156923921|NCT00708162|566480251|FG001|Randomized Phase|Investigator's Discretion|10|||
156923922|NCT00708162|566480250|FG000|Randomized Phase|Death|2|||
156923923|NCT00708162|566480251|FG001|Randomized Phase|Death|9|||
156923924|NCT00708162|566480250|FG000|Randomized Phase|Pregnancy|3|||
157028820|NCT04171141|566862800|FG010|Overall Study|Global deterioration of health status|0|||
157164790|NCT01877382|567344080|FG012|Dose Escalation|Adverse Event|1|||
157164791|NCT01877382|567344081|FG013|Dose Escalation|Adverse Event|0|||
157164792|NCT01877382|567344082|FG014|Dose Escalation|Adverse Event|0|||
157028821|NCT04171141|566862801|FG011|Overall Study|Global deterioration of health status|0|||
157164793|NCT01877382|567344068|FG000|Dose Escalation|Withdrawal by Subject|0|||
157164794|NCT01877382|567344069|FG001|Dose Escalation|Withdrawal by Subject|0|||
156923925|NCT00708162|566480251|FG001|Randomized Phase|Pregnancy|0|||
156923926|NCT00708162|566480250|FG000|Open-Label Phase|Lost to Follow-up|10|||
156923927|NCT00708162|566480251|FG001|Open-Label Phase|Lost to Follow-up|8|||
157164795|NCT01877382|567344070|FG002|Dose Escalation|Withdrawal by Subject|0|||
157164796|NCT01877382|567344071|FG003|Dose Escalation|Withdrawal by Subject|0|||
156923928|NCT00708162|566480250|FG000|Open-Label Phase|Withdrew Consent|12|||
156923929|NCT00708162|566480251|FG001|Open-Label Phase|Withdrew Consent|6|||
156923930|NCT00708162|566480250|FG000|Open-Label Phase|Participant Noncompliance|7|||
156923931|NCT00708162|566480251|FG001|Open-Label Phase|Participant Noncompliance|7|||
156923932|NCT00708162|566480250|FG000|Open-Label Phase|Lack of Efficacy|7|||
156923933|NCT00708162|566480251|FG001|Open-Label Phase|Lack of Efficacy|4|||
156923934|NCT00708162|566480250|FG000|Open-Label Phase|Investigator's Discretion|3|||
156923935|NCT00708162|566480251|FG001|Open-Label Phase|Investigator's Discretion|2|||
156923936|NCT00708162|566480250|FG000|Open-Label Phase|Death|3|||
156923937|NCT00708162|566480251|FG001|Open-Label Phase|Death|1|||
156923938|NCT00708162|566480250|FG000|Open-Label Phase|Adverse Event|1|||
156923939|NCT00708162|566480251|FG001|Open-Label Phase|Adverse Event|2|||
156923940|NCT00708162|566480250|FG000|Open-Label Phase|Other|1|||
156923941|NCT00708162|566480251|FG001|Open-Label Phase|Other|0|||
156923942|NCT02699554|566480252|FG000|Overall Study|Lost to Follow-up|9|||
156923943|NCT00788151|566480253|FG000|Overall Study|Other adverse event|0|||
156923944|NCT00788151|566480254|FG001|Overall Study|Other adverse event|2|||
156923945|NCT00788151|566480253|FG000|Overall Study|Protocol Violation|0|||
156923946|NCT00788151|566480254|FG001|Overall Study|Protocol Violation|1|||
156923947|NCT00788151|566480253|FG000|Overall Study|Withdrawal by Subject|13|||
156923948|NCT00788151|566480254|FG001|Overall Study|Withdrawal by Subject|6|||
156923949|NCT00788151|566480253|FG000|Overall Study|Enrolled but not treated|1|||
156923950|NCT00788151|566480254|FG001|Overall Study|Enrolled but not treated|1|||
156923951|NCT00503009|566480257|FG000|Overall Study|Protocol Violation|1|||
156923952|NCT00503009|566480258|FG001|Overall Study|Protocol Violation|0|||
156923953|NCT00503009|566480259|FG002|Overall Study|Protocol Violation|1|||
156923954|NCT00503009|566480257|FG000|Overall Study|Withdrawal by Subject|0|||
156923955|NCT00503009|566480258|FG001|Overall Study|Withdrawal by Subject|1|||
156923956|NCT00503009|566480259|FG002|Overall Study|Withdrawal by Subject|1|||
156923957|NCT00503009|566480257|FG000|Overall Study|Physician Decision|0|||
156923958|NCT00503009|566480258|FG001|Overall Study|Physician Decision|1|||
156923959|NCT00503009|566480259|FG002|Overall Study|Physician Decision|1|||
156923960|NCT02057198|566480260|FG000|Overall Study|Death|0|||
156923961|NCT02057198|566480261|FG001|Overall Study|Death|0|||
156923962|NCT02057198|566480262|FG002|Overall Study|Death|1|||
156923963|NCT02057198|566480260|FG000|Overall Study|Discharged early; lost to followup|0|||
156923964|NCT02057198|566480261|FG001|Overall Study|Discharged early; lost to followup|1|||
156923965|NCT02057198|566480262|FG002|Overall Study|Discharged early; lost to followup|0|||
156923966|NCT00065507|566480263|FG000|Overall Study|Death|16|||
156923967|NCT00065507|566480264|FG001|Overall Study|Death|17|||
156923968|NCT00065507|566480263|FG000|Overall Study|Adverse Event|4|||
156923969|NCT00065507|566480264|FG001|Overall Study|Adverse Event|3|||
156923970|NCT00065507|566480263|FG000|Overall Study|Lack of Efficacy|0|||
156923971|NCT00065507|566480264|FG001|Overall Study|Lack of Efficacy|6|||
156923972|NCT00065507|566480263|FG000|Overall Study|Poor/Non-compliance|3|||
156923973|NCT00065507|566480264|FG001|Overall Study|Poor/Non-compliance|2|||
156923974|NCT00065507|566480263|FG000|Overall Study|Lost to Follow-up|3|||
156923975|NCT00065507|566480264|FG001|Overall Study|Lost to Follow-up|0|||
156923976|NCT00065507|566480263|FG000|Overall Study|Subject Withdrew Consent|2|||
156923977|NCT00065507|566480264|FG001|Overall Study|Subject Withdrew Consent|1|||
156923978|NCT00065507|566480263|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
156923979|NCT00065507|566480264|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
156923980|NCT00350636|566480265|FG000|Overall Study|Adverse Event|19|||
156923981|NCT00350636|566480266|FG001|Overall Study|Adverse Event|13|||
156923982|NCT00350636|566480265|FG000|Overall Study|Protocol Violation|1|||
156923983|NCT00350636|566480266|FG001|Overall Study|Protocol Violation|3|||
156923984|NCT00350636|566480265|FG000|Overall Study|Withdrawal by Subject|13|||
156923985|NCT00350636|566480266|FG001|Overall Study|Withdrawal by Subject|17|||
156923986|NCT00350636|566480265|FG000|Overall Study|Lost to Follow-up|9|||
156923987|NCT00350636|566480266|FG001|Overall Study|Lost to Follow-up|8|||
156923988|NCT00350636|566480265|FG000|Overall Study|Physician Decision|0|||
156923989|NCT00350636|566480266|FG001|Overall Study|Physician Decision|2|||
157164797|NCT01877382|567344072|FG004|Dose Escalation|Withdrawal by Subject|0|||
157164798|NCT01877382|567344073|FG005|Dose Escalation|Withdrawal by Subject|3|||
157164799|NCT01877382|567344074|FG006|Dose Escalation|Withdrawal by Subject|2|||
156923990|NCT00350636|566480265|FG000|Overall Study|Other|1|||
156923991|NCT00350636|566480266|FG001|Overall Study|Other|2|||
157164800|NCT01877382|567344075|FG007|Dose Escalation|Withdrawal by Subject|1|||
156923992|NCT01647282|566480269|FG000|Overall Study|Physician Decision|7|||
156923993|NCT01647282|566480270|FG001|Overall Study|Physician Decision|5|||
156923994|NCT01042236|566480271|FG000|Treatment Period 1|Adverse Event|0|||
156923995|NCT01042236|566480272|FG001|Treatment Period 1|Adverse Event|1|||
156923996|NCT01042236|566480273|FG002|Treatment Period 1|Adverse Event|0|||
156923997|NCT01042236|566480274|FG003|Treatment Period 1|Adverse Event|0|||
156923998|NCT01042236|566480275|FG004|Treatment Period 1|Adverse Event|1|||
157164801|NCT01877382|567344076|FG008|Dose Escalation|Withdrawal by Subject|1|||
156923999|NCT01042236|566480276|FG005|Treatment Period 1|Adverse Event|0|||
156924000|NCT01042236|566480271|FG000|Treatment Period 3|Adverse Event|0|||
156924001|NCT01042236|566480272|FG001|Treatment Period 3|Adverse Event|0|||
156924002|NCT01042236|566480273|FG002|Treatment Period 3|Adverse Event|0|||
156924003|NCT01042236|566480274|FG003|Treatment Period 3|Adverse Event|1|||
156924004|NCT01042236|566480275|FG004|Treatment Period 3|Adverse Event|0|||
157164802|NCT01877382|567344077|FG009|Dose Escalation|Withdrawal by Subject|0|||
157164803|NCT01877382|567344078|FG010|Dose Escalation|Withdrawal by Subject|0|||
157164804|NCT01877382|567344079|FG011|Dose Escalation|Withdrawal by Subject|0|||
157164805|NCT01877382|567344080|FG012|Dose Escalation|Withdrawal by Subject|0|||
157164806|NCT01877382|567344081|FG013|Dose Escalation|Withdrawal by Subject|0|||
157164807|NCT01877382|567344082|FG014|Dose Escalation|Withdrawal by Subject|0|||
157164808|NCT01877382|567344068|FG000|Dose Escalation|Protocol Violation|0|||
157164809|NCT01877382|567344069|FG001|Dose Escalation|Protocol Violation|0|||
157164810|NCT01877382|567344070|FG002|Dose Escalation|Protocol Violation|0|||
157164811|NCT01877382|567344071|FG003|Dose Escalation|Protocol Violation|0|||
157164812|NCT01877382|567344072|FG004|Dose Escalation|Protocol Violation|0|||
157164813|NCT01877382|567344073|FG005|Dose Escalation|Protocol Violation|0|||
157164814|NCT01877382|567344074|FG006|Dose Escalation|Protocol Violation|1|||
157164815|NCT01877382|567344075|FG007|Dose Escalation|Protocol Violation|0|||
157164816|NCT01877382|567344076|FG008|Dose Escalation|Protocol Violation|0|||
157164817|NCT01877382|567344077|FG009|Dose Escalation|Protocol Violation|0|||
157164818|NCT01877382|567344078|FG010|Dose Escalation|Protocol Violation|0|||
157164819|NCT01877382|567344079|FG011|Dose Escalation|Protocol Violation|0|||
157164820|NCT01877382|567344080|FG012|Dose Escalation|Protocol Violation|0|||
157164821|NCT01877382|567344081|FG013|Dose Escalation|Protocol Violation|0|||
157164822|NCT01877382|567344082|FG014|Dose Escalation|Protocol Violation|0|||
157164823|NCT01877382|567344068|FG000|Dose Escalation|Study terminated by sponsor|0|||
157164824|NCT01877382|567344069|FG001|Dose Escalation|Study terminated by sponsor|0|||
157164825|NCT01877382|567344070|FG002|Dose Escalation|Study terminated by sponsor|0|||
157164826|NCT01877382|567344071|FG003|Dose Escalation|Study terminated by sponsor|0|||
157164827|NCT01877382|567344072|FG004|Dose Escalation|Study terminated by sponsor|0|||
157164828|NCT01877382|567344073|FG005|Dose Escalation|Study terminated by sponsor|0|||
157164829|NCT01877382|567344074|FG006|Dose Escalation|Study terminated by sponsor|0|||
157164830|NCT01877382|567344075|FG007|Dose Escalation|Study terminated by sponsor|1|||
157164831|NCT01877382|567344076|FG008|Dose Escalation|Study terminated by sponsor|1|||
157164832|NCT01877382|567344077|FG009|Dose Escalation|Study terminated by sponsor|0|||
157164833|NCT01877382|567344078|FG010|Dose Escalation|Study terminated by sponsor|0|||
157164834|NCT01877382|567344079|FG011|Dose Escalation|Study terminated by sponsor|0|||
157164835|NCT01877382|567344080|FG012|Dose Escalation|Study terminated by sponsor|3|||
157164836|NCT01877382|567344081|FG013|Dose Escalation|Study terminated by sponsor|0|||
157164837|NCT01877382|567344082|FG014|Dose Escalation|Study terminated by sponsor|0|||
157164838|NCT01877382|567344068|FG000|Dose Escalation|Death|0|||
157164839|NCT01877382|567344069|FG001|Dose Escalation|Death|0|||
157164840|NCT01877382|567344070|FG002|Dose Escalation|Death|0|||
157164841|NCT01877382|567344071|FG003|Dose Escalation|Death|0|||
157164842|NCT01877382|567344072|FG004|Dose Escalation|Death|0|||
157164843|NCT01877382|567344073|FG005|Dose Escalation|Death|0|||
157164844|NCT01877382|567344074|FG006|Dose Escalation|Death|0|||
157164845|NCT01877382|567344075|FG007|Dose Escalation|Death|1|||
157164846|NCT01877382|567344076|FG008|Dose Escalation|Death|0|||
157164847|NCT01877382|567344077|FG009|Dose Escalation|Death|0|||
157164848|NCT01877382|567344078|FG010|Dose Escalation|Death|0|||
157164849|NCT01877382|567344079|FG011|Dose Escalation|Death|0|||
157164850|NCT01877382|567344080|FG012|Dose Escalation|Death|1|||
157164851|NCT01877382|567344081|FG013|Dose Escalation|Death|1|||
157164852|NCT01877382|567344082|FG014|Dose Escalation|Death|0|||
157164853|NCT01877382|567344068|FG000|Dose Expansion|Progressive disease|0|||
157164854|NCT01877382|567344069|FG001|Dose Expansion|Progressive disease|0|||
157164855|NCT01877382|567344070|FG002|Dose Expansion|Progressive disease|0|||
157164856|NCT01877382|567344071|FG003|Dose Expansion|Progressive disease|0|||
157164857|NCT01877382|567344072|FG004|Dose Expansion|Progressive disease|0|||
157164858|NCT01877382|567344073|FG005|Dose Expansion|Progressive disease|0|||
157164859|NCT01877382|567344074|FG006|Dose Expansion|Progressive disease|0|||
156924005|NCT01042236|566480276|FG005|Treatment Period 3|Adverse Event|0|||
156924006|NCT01042236|566480271|FG000|Treatment Period 3|Protocol Violation|0|||
156924007|NCT01042236|566480272|FG001|Treatment Period 3|Protocol Violation|0|||
157164860|NCT01877382|567344075|FG007|Dose Expansion|Progressive disease|0|||
157164861|NCT01877382|567344076|FG008|Dose Expansion|Progressive disease|0|||
157164862|NCT01877382|567344077|FG009|Dose Expansion|Progressive disease|0|||
157164863|NCT01877382|567344078|FG010|Dose Expansion|Progressive disease|0|||
157164864|NCT01877382|567344079|FG011|Dose Expansion|Progressive disease|0|||
157164865|NCT01877382|567344080|FG012|Dose Expansion|Progressive disease|0|||
157164866|NCT01877382|567344081|FG013|Dose Expansion|Progressive disease|0|||
157164867|NCT01877382|567344082|FG014|Dose Expansion|Progressive disease|11|||
157164868|NCT01877382|567344068|FG000|Dose Expansion|Clinical progression|0|||
157164869|NCT01877382|567344069|FG001|Dose Expansion|Clinical progression|0|||
156924008|NCT01042236|566480273|FG002|Treatment Period 3|Protocol Violation|0|||
157164870|NCT01877382|567344070|FG002|Dose Expansion|Clinical progression|0|||
157164871|NCT01877382|567344071|FG003|Dose Expansion|Clinical progression|0|||
157028822|NCT04171141|566862802|FG012|Overall Study|Global deterioration of health status|0|||
156924009|NCT01042236|566480274|FG003|Treatment Period 3|Protocol Violation|1|||
156924010|NCT01042236|566480275|FG004|Treatment Period 3|Protocol Violation|0|||
156924011|NCT01042236|566480276|FG005|Treatment Period 3|Protocol Violation|0|||
156924012|NCT02522286|566480278|FG000|Overall Study|Withdrawal by Subject|3|||
156924013|NCT02522286|566480279|FG001|Overall Study|Withdrawal by Subject|0|||
156924014|NCT02522286|566480280|FG002|Overall Study|Withdrawal by Subject|0|||
156924015|NCT02522286|566480281|FG003|Overall Study|Withdrawal by Subject|3|||
156924016|NCT01244906|566480282|FG000|Overall Study|Death|2|||
156924017|NCT01244906|566480282|FG000|Overall Study|Progression of disease post treatment|6|||
156924018|NCT03480750|566480283|FG000|Overall Study|Withdrawal by Subject|0|||
156924019|NCT03480750|566480284|FG001|Overall Study|Withdrawal by Subject|1|||
156924020|NCT03480750|566480285|FG002|Overall Study|Withdrawal by Subject|0|||
156924021|NCT03480750|566480286|FG003|Overall Study|Withdrawal by Subject|0|||
156924022|NCT03480750|566480287|FG004|Overall Study|Withdrawal by Subject|0|||
156924023|NCT03480750|566480288|FG005|Overall Study|Withdrawal by Subject|0|||
156924024|NCT03480750|566480283|FG000|Overall Study|The interruption in Trientine shippment|0|||
156924025|NCT03480750|566480284|FG001|Overall Study|The interruption in Trientine shippment|0|||
156924026|NCT03480750|566480285|FG002|Overall Study|The interruption in Trientine shippment|0|||
156924027|NCT03480750|566480286|FG003|Overall Study|The interruption in Trientine shippment|0|||
156924028|NCT03480750|566480287|FG004|Overall Study|The interruption in Trientine shippment|0|||
156924029|NCT03480750|566480288|FG005|Overall Study|The interruption in Trientine shippment|1|||
156924030|NCT00174915|566480295|FG000|Overall Study|Lost to Follow-up|19|||
156924031|NCT00174915|566480296|FG001|Overall Study|Lost to Follow-up|17|||
156924032|NCT00174915|566480297|FG002|Overall Study|Lost to Follow-up|9|||
156924033|NCT00174915|566480298|FG003|Overall Study|Lost to Follow-up|17|||
156924034|NCT00174915|566480299|FG004|Overall Study|Lost to Follow-up|10|||
156924035|NCT00174915|566480295|FG000|Overall Study|Adverse Event|18|||
156924036|NCT00174915|566480296|FG001|Overall Study|Adverse Event|16|||
157028823|NCT04171141|566862803|FG013|Overall Study|Global deterioration of health status|0|||
157028824|NCT04171141|566862804|FG014|Overall Study|Global deterioration of health status|1|||
157028825|NCT04171141|566862805|FG015|Overall Study|Global deterioration of health status|1|||
157028826|NCT03663569|566862808|FG000|Overall Study|Discontinuation of study|11|||
157164872|NCT01877382|567344072|FG004|Dose Expansion|Clinical progression|0|||
157164873|NCT01877382|567344073|FG005|Dose Expansion|Clinical progression|0|||
157164874|NCT01877382|567344074|FG006|Dose Expansion|Clinical progression|0|||
157164875|NCT01877382|567344075|FG007|Dose Expansion|Clinical progression|0|||
157164876|NCT01877382|567344076|FG008|Dose Expansion|Clinical progression|0|||
157164877|NCT01877382|567344077|FG009|Dose Expansion|Clinical progression|0|||
157164878|NCT01877382|567344078|FG010|Dose Expansion|Clinical progression|0|||
157164879|NCT01877382|567344079|FG011|Dose Expansion|Clinical progression|0|||
157164880|NCT01877382|567344080|FG012|Dose Expansion|Clinical progression|0|||
157164881|NCT01877382|567344081|FG013|Dose Expansion|Clinical progression|0|||
157164882|NCT01877382|567344082|FG014|Dose Expansion|Clinical progression|6|||
157164883|NCT01877382|567344068|FG000|Dose Expansion|Adverse Event|0|||
157164884|NCT01877382|567344069|FG001|Dose Expansion|Adverse Event|0|||
157164885|NCT01877382|567344070|FG002|Dose Expansion|Adverse Event|0|||
157164886|NCT01877382|567344071|FG003|Dose Expansion|Adverse Event|0|||
157164887|NCT01877382|567344072|FG004|Dose Expansion|Adverse Event|0|||
157164888|NCT01877382|567344073|FG005|Dose Expansion|Adverse Event|0|||
157164889|NCT01877382|567344074|FG006|Dose Expansion|Adverse Event|0|||
157164890|NCT01877382|567344075|FG007|Dose Expansion|Adverse Event|0|||
157164891|NCT01877382|567344076|FG008|Dose Expansion|Adverse Event|0|||
157164892|NCT01877382|567344077|FG009|Dose Expansion|Adverse Event|0|||
157164893|NCT01877382|567344078|FG010|Dose Expansion|Adverse Event|0|||
157164894|NCT01877382|567344079|FG011|Dose Expansion|Adverse Event|0|||
157164895|NCT01877382|567344080|FG012|Dose Expansion|Adverse Event|0|||
157164896|NCT01877382|567344081|FG013|Dose Expansion|Adverse Event|0|||
157164897|NCT01877382|567344082|FG014|Dose Expansion|Adverse Event|1|||
157164898|NCT01877382|567344068|FG000|Dose Expansion|Death|0|||
157164899|NCT01877382|567344069|FG001|Dose Expansion|Death|0|||
157164900|NCT01877382|567344070|FG002|Dose Expansion|Death|0|||
157164901|NCT01877382|567344071|FG003|Dose Expansion|Death|0|||
156924037|NCT00174915|566480297|FG002|Overall Study|Adverse Event|11|||
156924038|NCT00174915|566480298|FG003|Overall Study|Adverse Event|18|||
156924039|NCT00174915|566480299|FG004|Overall Study|Adverse Event|5|||
157164902|NCT01877382|567344072|FG004|Dose Expansion|Death|0|||
157164903|NCT01877382|567344073|FG005|Dose Expansion|Death|0|||
157164904|NCT01877382|567344074|FG006|Dose Expansion|Death|0|||
157164905|NCT01877382|567344075|FG007|Dose Expansion|Death|0|||
157164906|NCT01877382|567344076|FG008|Dose Expansion|Death|0|||
157164907|NCT01877382|567344077|FG009|Dose Expansion|Death|0|||
157164908|NCT01877382|567344078|FG010|Dose Expansion|Death|0|||
156924040|NCT00174915|566480295|FG000|Overall Study|Personal Reason(s)|16|||
156924041|NCT00174915|566480296|FG001|Overall Study|Personal Reason(s)|16|||
157028827|NCT03663569|566862808|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
157164909|NCT01877382|567344079|FG011|Dose Expansion|Death|0|||
157164910|NCT01877382|567344080|FG012|Dose Expansion|Death|0|||
156924042|NCT00174915|566480297|FG002|Overall Study|Personal Reason(s)|9|||
156924043|NCT00174915|566480298|FG003|Overall Study|Personal Reason(s)|9|||
156924044|NCT00174915|566480299|FG004|Overall Study|Personal Reason(s)|9|||
156924045|NCT00174915|566480295|FG000|Overall Study|Other|15|||
156924046|NCT00174915|566480296|FG001|Overall Study|Other|8|||
156924047|NCT00174915|566480297|FG002|Overall Study|Other|6|||
156924048|NCT00174915|566480298|FG003|Overall Study|Other|5|||
156924049|NCT00174915|566480299|FG004|Overall Study|Other|3|||
156924050|NCT00174915|566480295|FG000|Overall Study|Gout Flare|13|||
156924051|NCT00174915|566480296|FG001|Overall Study|Gout Flare|6|||
156924052|NCT00174915|566480297|FG002|Overall Study|Gout Flare|8|||
156924053|NCT00174915|566480298|FG003|Overall Study|Gout Flare|1|||
156924054|NCT00174915|566480299|FG004|Overall Study|Gout Flare|0|||
156924055|NCT00174915|566480295|FG000|Overall Study|Protocol Violation|6|||
156924056|NCT00174915|566480296|FG001|Overall Study|Protocol Violation|3|||
156924057|NCT00174915|566480297|FG002|Overall Study|Protocol Violation|3|||
156924058|NCT00174915|566480298|FG003|Overall Study|Protocol Violation|6|||
156924059|NCT00174915|566480299|FG004|Overall Study|Protocol Violation|3|||
156924060|NCT00174915|566480295|FG000|Overall Study|Therapeutic Failure|6|||
156924061|NCT00174915|566480296|FG001|Overall Study|Therapeutic Failure|3|||
156924062|NCT00174915|566480297|FG002|Overall Study|Therapeutic Failure|2|||
156924063|NCT00174915|566480298|FG003|Overall Study|Therapeutic Failure|1|||
156924064|NCT00174915|566480299|FG004|Overall Study|Therapeutic Failure|3|||
156924065|NCT02232425|566480300|FG000|Overall Study|Lost to Follow-up|6|||
156924066|NCT02232425|566480301|FG001|Overall Study|Lost to Follow-up|2|||
156924067|NCT02232425|566480300|FG000|Overall Study|Adverse Event|2|||
156924068|NCT02232425|566480301|FG001|Overall Study|Adverse Event|0|||
156924069|NCT02232425|566480300|FG000|Overall Study|Withdrawal by Subject|5|||
156924070|NCT02232425|566480301|FG001|Overall Study|Withdrawal by Subject|6|||
156924071|NCT02232425|566480300|FG000|Overall Study|Lack of Efficacy|1|||
156924072|NCT02232425|566480301|FG001|Overall Study|Lack of Efficacy|0|||
156924073|NCT00498602|566480302|FG000|Overall Study|Death|0|||
156924074|NCT00498602|566480303|FG001|Overall Study|Death|0|||
156924075|NCT00498602|566480304|FG002|Overall Study|Death|0|||
156924076|NCT00498602|566480305|FG003|Overall Study|Death|0|||
156924077|NCT00498602|566480306|FG004|Overall Study|Death|0|||
156924078|NCT00498602|566480307|FG005|Overall Study|Death|1|||
156924079|NCT00498602|566480308|FG006|Overall Study|Death|0|||
156924080|NCT00498602|566480302|FG000|Overall Study|Lack of Efficacy|1|||
156924081|NCT00498602|566480303|FG001|Overall Study|Lack of Efficacy|0|||
156924082|NCT00498602|566480304|FG002|Overall Study|Lack of Efficacy|0|||
156924083|NCT00498602|566480305|FG003|Overall Study|Lack of Efficacy|0|||
156924084|NCT00498602|566480306|FG004|Overall Study|Lack of Efficacy|0|||
156924085|NCT00498602|566480307|FG005|Overall Study|Lack of Efficacy|0|||
157164911|NCT01877382|567344081|FG013|Dose Expansion|Death|0|||
157164912|NCT01877382|567344082|FG014|Dose Expansion|Death|1|||
157164913|NCT01877382|567344068|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164914|NCT01877382|567344069|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164915|NCT01877382|567344070|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164916|NCT01877382|567344071|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164917|NCT01877382|567344072|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164918|NCT01877382|567344073|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164919|NCT01877382|567344074|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164920|NCT01877382|567344075|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164921|NCT01877382|567344076|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164922|NCT01877382|567344077|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164923|NCT01877382|567344078|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164924|NCT01877382|567344079|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164925|NCT01877382|567344080|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
157164926|NCT01877382|567344081|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
156924086|NCT00498602|566480308|FG006|Overall Study|Lack of Efficacy|0|||
156924087|NCT00498602|566480302|FG000|Overall Study|Lost to Follow-up|0|||
157227020|NCT02739984|567576016|FG000|Overall Study|Withdrawal by Subject|1|||
157227021|NCT02739984|567576017|FG001|Overall Study|Withdrawal by Subject|1|||
157227022|NCT02739984|567576016|FG000|Overall Study|Death|0|||
157227023|NCT02739984|567576017|FG001|Overall Study|Death|1|||
156924088|NCT00498602|566480303|FG001|Overall Study|Lost to Follow-up|2|||
156924089|NCT00498602|566480304|FG002|Overall Study|Lost to Follow-up|0|||
156924090|NCT00498602|566480305|FG003|Overall Study|Lost to Follow-up|2|||
156924091|NCT00498602|566480306|FG004|Overall Study|Lost to Follow-up|0|||
156924092|NCT00498602|566480307|FG005|Overall Study|Lost to Follow-up|0|||
156924093|NCT00498602|566480308|FG006|Overall Study|Lost to Follow-up|0|||
156924094|NCT00498602|566480302|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156924095|NCT00498602|566480303|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156924096|NCT00498602|566480304|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
156924097|NCT00498602|566480305|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
156924098|NCT00498602|566480306|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156924099|NCT00498602|566480307|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
156924100|NCT00498602|566480308|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
156924101|NCT00498602|566480302|FG000|Overall Study|AE not related to Study Drug|1|||
156924102|NCT00498602|566480303|FG001|Overall Study|AE not related to Study Drug|3|||
156924103|NCT00498602|566480304|FG002|Overall Study|AE not related to Study Drug|0|||
156924104|NCT00498602|566480305|FG003|Overall Study|AE not related to Study Drug|0|||
156924105|NCT00498602|566480306|FG004|Overall Study|AE not related to Study Drug|2|||
156924106|NCT00498602|566480307|FG005|Overall Study|AE not related to Study Drug|2|||
156924107|NCT00498602|566480308|FG006|Overall Study|AE not related to Study Drug|1|||
156924108|NCT00498602|566480302|FG000|Overall Study|Caregiver Request|2|||
156924109|NCT00498602|566480303|FG001|Overall Study|Caregiver Request|2|||
156924110|NCT00498602|566480304|FG002|Overall Study|Caregiver Request|2|||
156924111|NCT00498602|566480305|FG003|Overall Study|Caregiver Request|0|||
156924112|NCT00498602|566480306|FG004|Overall Study|Caregiver Request|1|||
156924113|NCT00498602|566480307|FG005|Overall Study|Caregiver Request|2|||
156924114|NCT00498602|566480308|FG006|Overall Study|Caregiver Request|0|||
156924115|NCT00498602|566480302|FG000|Overall Study|Investigator Request|0|||
156924116|NCT00498602|566480303|FG001|Overall Study|Investigator Request|0|||
156924117|NCT00498602|566480304|FG002|Overall Study|Investigator Request|1|||
156924118|NCT00498602|566480305|FG003|Overall Study|Investigator Request|0|||
156924119|NCT00498602|566480306|FG004|Overall Study|Investigator Request|0|||
156924120|NCT00498602|566480307|FG005|Overall Study|Investigator Request|0|||
156924121|NCT00498602|566480308|FG006|Overall Study|Investigator Request|0|||
156924122|NCT00498602|566480302|FG000|Overall Study|Subject Request|3|||
156924123|NCT00498602|566480303|FG001|Overall Study|Subject Request|0|||
156924124|NCT00498602|566480304|FG002|Overall Study|Subject Request|1|||
156924125|NCT00498602|566480305|FG003|Overall Study|Subject Request|1|||
156924126|NCT00498602|566480306|FG004|Overall Study|Subject Request|1|||
156924127|NCT00498602|566480307|FG005|Overall Study|Subject Request|4|||
156924128|NCT00498602|566480308|FG006|Overall Study|Subject Request|1|||
156924129|NCT00498602|566480302|FG000|Overall Study|Other|2|||
156924130|NCT00498602|566480303|FG001|Overall Study|Other|3|||
156924131|NCT00498602|566480304|FG002|Overall Study|Other|1|||
156924132|NCT00498602|566480305|FG003|Overall Study|Other|0|||
156924133|NCT00498602|566480306|FG004|Overall Study|Other|0|||
156924134|NCT00498602|566480307|FG005|Overall Study|Other|3|||
156924135|NCT00498602|566480308|FG006|Overall Study|Other|0|||
156924136|NCT02632552|566480309|FG000|Overall Study|Lost to Follow-up|14|||
156924137|NCT02632552|566480310|FG001|Overall Study|Lost to Follow-up|8|||
156924138|NCT02632552|566480309|FG000|Overall Study|Withdrawal by Subject|2|||
156924139|NCT02632552|566480310|FG001|Overall Study|Withdrawal by Subject|0|||
156924140|NCT02632552|566480309|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
156924141|NCT02632552|566480310|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
156924142|NCT00546637|566480313|FG000|Overall Study|Adverse Event|46|||
156924143|NCT00546637|566480314|FG001|Overall Study|Adverse Event|20|||
156924144|NCT00546637|566480313|FG000|Overall Study|Lack of Efficacy|5|||
156924145|NCT00546637|566480314|FG001|Overall Study|Lack of Efficacy|5|||
156924146|NCT00546637|566480313|FG000|Overall Study|Lost to Follow-up|2|||
156924147|NCT00546637|566480314|FG001|Overall Study|Lost to Follow-up|2|||
156924148|NCT00546637|566480313|FG000|Overall Study|Other|10|||
156924149|NCT00546637|566480314|FG001|Overall Study|Other|12|||
156924150|NCT00546637|566480313|FG000|Overall Study|Withdrawal by Subject|7|||
156924151|NCT00546637|566480314|FG001|Overall Study|Withdrawal by Subject|9|||
156924152|NCT00546637|566480313|FG000|Overall Study|Randomized, but not treated|3|||
156924153|NCT00546637|566480314|FG001|Overall Study|Randomized, but not treated|1|||
156924154|NCT02611778|566480318|FG000|Overall Study|Withdrawal by Subject|2|||
156924155|NCT02611778|566480319|FG001|Overall Study|Withdrawal by Subject|8|||
156924156|NCT02611778|566480318|FG000|Overall Study|Adverse Event|1|||
156924157|NCT02611778|566480319|FG001|Overall Study|Adverse Event|2|||
156924158|NCT02611778|566480318|FG000|Overall Study|Death|2|||
156924159|NCT02611778|566480319|FG001|Overall Study|Death|1|||
156924160|NCT02611778|566480318|FG000|Overall Study|Protocol Violation|1|||
156924161|NCT02611778|566480319|FG001|Overall Study|Protocol Violation|0|||
156924162|NCT02611778|566480318|FG000|Overall Study|Lost to Follow-up|3|||
156924163|NCT02611778|566480319|FG001|Overall Study|Lost to Follow-up|1|||
156924164|NCT02611778|566480318|FG000|Overall Study|Need for alternative treatment|1|||
156924165|NCT02611778|566480319|FG001|Overall Study|Need for alternative treatment|0|||
156924166|NCT02611778|566480318|FG000|Overall Study|Other Reason|2|||
156924167|NCT02611778|566480319|FG001|Overall Study|Other Reason|1|||
156924168|NCT02968563|566480320|FG000|Overall Study|Adverse Event|0|||
156924169|NCT02968563|566480321|FG001|Overall Study|Adverse Event|6|||
156924170|NCT02968563|566480320|FG000|Overall Study|Death|1|||
156924171|NCT02968563|566480321|FG001|Overall Study|Death|1|||
156924172|NCT02968563|566480320|FG000|Overall Study|Lost to Follow-up|0|||
156924173|NCT02968563|566480321|FG001|Overall Study|Lost to Follow-up|1|||
156977494|NCT02223754|566670722|FG001|Period 1|Lost to Follow-up|1|||
156924174|NCT03108027|566480330|FG000|Period 1|Subject/Guardian Decision|0|||
156924175|NCT03108027|566480331|FG001|Period 1|Subject/Guardian Decision|0|||
156924176|NCT03108027|566480332|FG002|Period 1|Subject/Guardian Decision|0|||
156924177|NCT03108027|566480333|FG003|Period 1|Subject/Guardian Decision|2|||
156924178|NCT03108027|566480334|FG004|Period 1|Subject/Guardian Decision|0|||
156924179|NCT03108027|566480335|FG005|Period 1|Subject/Guardian Decision|0|||
156924180|NCT03108027|566480330|FG000|Period 3|Adverse Event|0|||
156924181|NCT03108027|566480331|FG001|Period 3|Adverse Event|1|||
156924182|NCT03108027|566480332|FG002|Period 3|Adverse Event|0|||
156924183|NCT03108027|566480333|FG003|Period 3|Adverse Event|0|||
156924184|NCT03108027|566480334|FG004|Period 3|Adverse Event|0|||
156924185|NCT03108027|566480335|FG005|Period 3|Adverse Event|0|||
156924186|NCT00003901|566480336|FG000|Overall Study|Adverse Event|1|||
156924187|NCT00003901|566480336|FG000|Overall Study|Withdrawal by Subject|1|||
156924188|NCT00003901|566480336|FG000|Overall Study|Ineligible|6|||
156924189|NCT00003901|566480336|FG000|Overall Study|CT Scan not within protocol requirement|2|||
156924190|NCT00003901|566480336|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
156924191|NCT00003901|566480336|FG000|Overall Study|Medical problems|6|||
156924192|NCT00268996|566480339|FG000|Overall Study|Adverse Event|11|||
156924193|NCT00268996|566480340|FG001|Overall Study|Adverse Event|7|||
156924194|NCT00268996|566480339|FG000|Overall Study|Lost to Follow-up|3|||
156924195|NCT00268996|566480340|FG001|Overall Study|Lost to Follow-up|1|||
156924196|NCT00268996|566480339|FG000|Overall Study|Withdrawal by Subject|5|||
156924197|NCT00268996|566480340|FG001|Overall Study|Withdrawal by Subject|11|||
156924198|NCT00268996|566480339|FG000|Overall Study|Non-compliance|1|||
156924199|NCT00268996|566480340|FG001|Overall Study|Non-compliance|0|||
156924200|NCT00268996|566480339|FG000|Overall Study|Other|1|||
157164927|NCT01877382|567344082|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
157164928|NCT05108805|567344087|FG000|Overall Study|T-cell expansion was not successful.|5|||
157164929|NCT00479557|567344088|FG000|Overall Study|Death|0|||
157164930|NCT00479557|567344089|FG001|Overall Study|Death|0|||
157164931|NCT00479557|567344090|FG002|Overall Study|Death|0|||
157164932|NCT00479557|567344091|FG003|Overall Study|Death|0|||
157164933|NCT00479557|567344092|FG004|Overall Study|Death|0|||
157164934|NCT00479557|567344093|FG005|Overall Study|Death|1|||
157164935|NCT00479557|567344094|FG006|Overall Study|Death|0|||
157164936|NCT00479557|567344088|FG000|Overall Study|Lack of Efficacy|1|||
157164937|NCT00479557|567344089|FG001|Overall Study|Lack of Efficacy|0|||
157164938|NCT00479557|567344090|FG002|Overall Study|Lack of Efficacy|0|||
157164939|NCT00479557|567344091|FG003|Overall Study|Lack of Efficacy|0|||
157164940|NCT00479557|567344092|FG004|Overall Study|Lack of Efficacy|0|||
157164941|NCT00479557|567344093|FG005|Overall Study|Lack of Efficacy|0|||
157164942|NCT00479557|567344094|FG006|Overall Study|Lack of Efficacy|0|||
157164943|NCT00479557|567344088|FG000|Overall Study|Lost to Follow-up|0|||
157164944|NCT00479557|567344089|FG001|Overall Study|Lost to Follow-up|2|||
157164945|NCT00479557|567344090|FG002|Overall Study|Lost to Follow-up|0|||
157164946|NCT00479557|567344091|FG003|Overall Study|Lost to Follow-up|2|||
157164947|NCT00479557|567344092|FG004|Overall Study|Lost to Follow-up|0|||
157164948|NCT00479557|567344093|FG005|Overall Study|Lost to Follow-up|0|||
157164949|NCT00479557|567344094|FG006|Overall Study|Lost to Follow-up|0|||
157164950|NCT00479557|567344088|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
157164951|NCT00479557|567344089|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
157164952|NCT00479557|567344090|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
157164953|NCT00479557|567344091|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
157164954|NCT00479557|567344092|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
157164955|NCT00479557|567344093|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
157164956|NCT00479557|567344094|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
157164957|NCT00479557|567344088|FG000|Overall Study|AE not related to Study Drug|1|||
157164958|NCT00479557|567344089|FG001|Overall Study|AE not related to Study Drug|3|||
156924201|NCT00268996|566480340|FG001|Overall Study|Other|1|||
156924202|NCT03325075|566480342|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
156924203|NCT03325075|566480343|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156924204|NCT03325075|566480344|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156924205|NCT03325075|566480345|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
156924206|NCT03325075|566480342|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
157164959|NCT00479557|567344090|FG002|Overall Study|AE not related to Study Drug|0|||
157164960|NCT00479557|567344091|FG003|Overall Study|AE not related to Study Drug|0|||
157164961|NCT00479557|567344092|FG004|Overall Study|AE not related to Study Drug|2|||
157164962|NCT00479557|567344093|FG005|Overall Study|AE not related to Study Drug|2|||
157164963|NCT00479557|567344094|FG006|Overall Study|AE not related to Study Drug|1|||
157164964|NCT00479557|567344088|FG000|Overall Study|Caregiver Request|2|||
156924207|NCT03325075|566480343|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
156924208|NCT03325075|566480344|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
156924209|NCT03325075|566480345|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
157164965|NCT00479557|567344089|FG001|Overall Study|Caregiver Request|2|||
157164966|NCT00479557|567344090|FG002|Overall Study|Caregiver Request|2|||
157164967|NCT00479557|567344091|FG003|Overall Study|Caregiver Request|0|||
157164968|NCT00479557|567344092|FG004|Overall Study|Caregiver Request|1|||
157164969|NCT00479557|567344093|FG005|Overall Study|Caregiver Request|2|||
157164970|NCT00479557|567344094|FG006|Overall Study|Caregiver Request|0|||
157164971|NCT00479557|567344088|FG000|Overall Study|Investigator Request|0|||
157164972|NCT00479557|567344089|FG001|Overall Study|Investigator Request|0|||
157164973|NCT00479557|567344090|FG002|Overall Study|Investigator Request|1|||
157164974|NCT00479557|567344091|FG003|Overall Study|Investigator Request|0|||
157164975|NCT00479557|567344092|FG004|Overall Study|Investigator Request|0|||
157164976|NCT00479557|567344093|FG005|Overall Study|Investigator Request|0|||
157164977|NCT00479557|567344094|FG006|Overall Study|Investigator Request|0|||
157164978|NCT00479557|567344088|FG000|Overall Study|Subject Request|3|||
157164979|NCT00479557|567344089|FG001|Overall Study|Subject Request|0|||
157164980|NCT00479557|567344090|FG002|Overall Study|Subject Request|1|||
157164981|NCT00479557|567344091|FG003|Overall Study|Subject Request|1|||
157164982|NCT00479557|567344092|FG004|Overall Study|Subject Request|1|||
157164983|NCT00479557|567344093|FG005|Overall Study|Subject Request|4|||
157164984|NCT00479557|567344094|FG006|Overall Study|Subject Request|1|||
157164985|NCT00479557|567344088|FG000|Overall Study|Other|2|||
157164986|NCT00479557|567344089|FG001|Overall Study|Other|3|||
157164987|NCT00479557|567344090|FG002|Overall Study|Other|1|||
157164988|NCT00479557|567344091|FG003|Overall Study|Other|0|||
157164989|NCT00479557|567344092|FG004|Overall Study|Other|0|||
157164990|NCT00479557|567344093|FG005|Overall Study|Other|3|||
157164991|NCT00479557|567344094|FG006|Overall Study|Other|0|||
157164992|NCT01511107|567344097|FG000|Overall Study|Ineligible|3|||
157164993|NCT01511107|567344098|FG001|Overall Study|Ineligible|2|||
157164994|NCT01511107|567344097|FG000|Overall Study|Lost to Follow-up|10|||
157164995|NCT01511107|567344098|FG001|Overall Study|Lost to Follow-up|19|||
157164996|NCT01511107|567344097|FG000|Overall Study|Withdrawal by Subject|9|||
157164997|NCT01511107|567344098|FG001|Overall Study|Withdrawal by Subject|20|||
157164998|NCT03422133|567344099|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
157164999|NCT03422133|567344100|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
157165000|NCT05195359|567345982|FG000|Overall Study|Lost to Follow-up|124|||
157165001|NCT05195359|567345983|FG001|Overall Study|Lost to Follow-up|34|||
157165002|NCT01146951|567345984|FG000|Overall Study|Adverse Event|4|||
157165003|NCT01146951|567345985|FG001|Overall Study|Adverse Event|1|||
157165004|NCT01747811|567345990|FG000|Overall Study|Lack of Efficacy|2|||
157165005|NCT01747811|567345991|FG001|Overall Study|Lack of Efficacy|4|||
157165006|NCT01617655|567345992|FG000|Overall Study|Adverse Event|2|||
157165007|NCT01617655|567345993|FG001|Overall Study|Adverse Event|3|||
157165008|NCT01617655|567345992|FG000|Overall Study|Poor compliance to protocol|1|||
157165009|NCT01617655|567345993|FG001|Overall Study|Poor compliance to protocol|4|||
157165010|NCT01617655|567345992|FG000|Overall Study|Participants moved|0|||
157165011|NCT01617655|567345993|FG001|Overall Study|Participants moved|4|||
157165012|NCT01617655|567345992|FG000|Overall Study|Consent withdrawn by participant|1|||
157165013|NCT01617655|567345993|FG001|Overall Study|Consent withdrawn by participant|1|||
157165014|NCT01617655|567345992|FG000|Overall Study|Last visit outside protocol visit window|1|||
157165015|NCT01617655|567345993|FG001|Overall Study|Last visit outside protocol visit window|10|||
157165016|NCT01617655|567345992|FG000|Overall Study|Site closure|3|||
157165017|NCT01617655|567345993|FG001|Overall Study|Site closure|5|||
157165018|NCT01617655|567345992|FG000|Overall Study|Other than specified above|1|||
157165019|NCT01617655|567345993|FG001|Overall Study|Other than specified above|2|||
157165020|NCT01175213|567345996|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
157165021|NCT01175213|567345997|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
157165022|NCT01175213|567345996|FG000|IGSC, 10%/rHuPH20|Death|1|||
157165023|NCT01175213|567345997|FG001|IGSC, 10%/rHuPH20|Death|0|||
157165024|NCT01175213|567345996|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
157165025|NCT01175213|567345997|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
157165026|NCT01175213|567345996|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
157165027|NCT01175213|567345997|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
157028828|NCT03663569|566862808|FG000|Overall Study|Deceased patient|6|||
157028829|NCT03663569|566862808|FG000|Overall Study|Lost to Follow-up|18|||
157165028|NCT01175213|567345996|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
157165029|NCT01175213|567345997|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
157165030|NCT01175213|567345996|FG000|Safety Follow-up|Adverse Event|1|||
157165031|NCT01175213|567345997|FG001|Safety Follow-up|Adverse Event|0|||
157165032|NCT02492997|567346002|FG000|Overall Study|Withdrawal by Subject|1|||
157165033|NCT02492997|567346003|FG001|Overall Study|Withdrawal by Subject|0|||
157165034|NCT02492997|567346002|FG000|Overall Study|Gained Weight|1|||
157165035|NCT02492997|567346003|FG001|Overall Study|Gained Weight|0|||
157165036|NCT02492997|567346002|FG000|Overall Study|Lost to Follow-up|0|||
157165037|NCT02492997|567346003|FG001|Overall Study|Lost to Follow-up|1|||
157165038|NCT01844830|567346008|FG000|Overall Study|Withdrawal by Subject|1|||
157165039|NCT01844830|567346009|FG001|Overall Study|Withdrawal by Subject|0|||
157165040|NCT04735393|567346015|FG000|Overall Study|Lost to Follow-up|46|||
157227024|NCT02739984|567576016|FG000|Overall Study|Lost to Follow-up|3|||
157227025|NCT02739984|567576017|FG001|Overall Study|Lost to Follow-up|0|||
156924210|NCT03325075|566480342|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
156924211|NCT03325075|566480343|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
156924212|NCT03325075|566480344|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
156924213|NCT03325075|566480345|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
156924214|NCT00422591|566480346|FG000|Overall Study|Physician Decision|4|||
156924215|NCT00422591|566480346|FG000|Overall Study|Withdrawal by Subject|2|||
156924216|NCT04191499|566480349|FG000|Overall Study|Adverse Event|1|||
156924217|NCT04191499|566480350|FG001|Overall Study|Adverse Event|0|||
156924218|NCT04191499|566480349|FG000|Overall Study|Death|42|||
156924219|NCT04191499|566480350|FG001|Overall Study|Death|55|||
156924220|NCT04191499|566480349|FG000|Overall Study|Lost to Follow-up|4|||
157165041|NCT04735393|567346016|FG001|Overall Study|Lost to Follow-up|24|||
157165042|NCT04735393|567346015|FG000|Overall Study|Physician Decision|2|||
157165043|NCT04735393|567346016|FG001|Overall Study|Physician Decision|1|||
157165044|NCT04735393|567346015|FG000|Overall Study|Not Detailed|1|||
157165045|NCT04735393|567346016|FG001|Overall Study|Not Detailed|2|||
157165046|NCT04735393|567346015|FG000|Overall Study|Withdrawal by Subject|71|||
157165047|NCT04735393|567346016|FG001|Overall Study|Withdrawal by Subject|28|||
157165048|NCT04735393|567346015|FG000|Overall Study|Adverse Event|56|||
157165049|NCT04735393|567346016|FG001|Overall Study|Adverse Event|7|||
157165050|NCT04735393|567346015|FG000|Overall Study|Protocol Violation|6|||
157165051|NCT04735393|567346016|FG001|Overall Study|Protocol Violation|1|||
157165052|NCT04735393|567346015|FG000|Overall Study|Trial terminated by Sponsor|49|||
157165053|NCT04735393|567346016|FG001|Overall Study|Trial terminated by Sponsor|29|||
157165054|NCT00209170|567346017|FG000|Overall Study|Adverse Event|0|||
157165055|NCT00209170|567346018|FG001|Overall Study|Adverse Event|1|||
157165056|NCT00209170|567346017|FG000|Overall Study|Withdrawal by Subject|2|||
157165057|NCT00209170|567346018|FG001|Overall Study|Withdrawal by Subject|1|||
157165058|NCT00209170|567346017|FG000|Overall Study|Lack of Efficacy|0|||
157165059|NCT00209170|567346018|FG001|Overall Study|Lack of Efficacy|1|||
157165060|NCT02130427|567346019|FG000|Overall Study|Imaging results not interpretable|30|||
157165061|NCT01295580|567346026|FG000|Overall Study|Protocol Violation|4|||
157165062|NCT01295580|567346027|FG001|Overall Study|Protocol Violation|2|||
157165063|NCT01295580|567346026|FG000|Overall Study|Withdrawal by Subject|1|||
157165064|NCT01295580|567346027|FG001|Overall Study|Withdrawal by Subject|4|||
157165065|NCT01295580|567346026|FG000|Overall Study|Adverse Event|2|||
157165066|NCT01295580|567346027|FG001|Overall Study|Adverse Event|1|||
157165067|NCT01295580|567346026|FG000|Overall Study|Lost to Follow-up|1|||
156924221|NCT04191499|566480350|FG001|Overall Study|Lost to Follow-up|1|||
156924222|NCT04191499|566480349|FG000|Overall Study|Physician Decision|1|||
156924223|NCT04191499|566480350|FG001|Overall Study|Physician Decision|0|||
157165068|NCT01295580|567346027|FG001|Overall Study|Lost to Follow-up|0|||
157165069|NCT01295580|567346026|FG000|Overall Study|Lack of Efficacy|1|||
157165070|NCT01295580|567346027|FG001|Overall Study|Lack of Efficacy|0|||
157165071|NCT01295580|567346026|FG000|Overall Study|Other: inconvenience|1|||
157165072|NCT01295580|567346027|FG001|Overall Study|Other: inconvenience|0|||
157165073|NCT01295580|567346026|FG000|Overall Study|Other: family objection|0|||
157165074|NCT01295580|567346027|FG001|Overall Study|Other: family objection|1|||
156924224|NCT04191499|566480349|FG000|Overall Study|Progressive Disease|1|||
156924225|NCT04191499|566480350|FG001|Overall Study|Progressive Disease|0|||
156924226|NCT04191499|566480349|FG000|Overall Study|Symptomatic Deterioration|1|||
156924227|NCT04191499|566480350|FG001|Overall Study|Symptomatic Deterioration|0|||
156924228|NCT04191499|566480349|FG000|Overall Study|Withdrawal by Subject|7|||
156924229|NCT04191499|566480350|FG001|Overall Study|Withdrawal by Subject|11|||
156924230|NCT04191499|566480349|FG000|Overall Study|Ongoing in the study|104|||
156924231|NCT04191499|566480350|FG001|Overall Study|Ongoing in the study|97|||
156924232|NCT04900220|566480351|FG000|Overall Study|Lost to Follow-up|1|||
157165075|NCT05441592|567346028|FG000|Overall Study|Lost to Follow-up|1|||
157165076|NCT05441592|567346029|FG001|Overall Study|Lost to Follow-up|5|||
157165077|NCT01021852|567346030|FG000|Treatment Period 1|Adverse Event|3|||
157165078|NCT01021852|567346031|FG001|Treatment Period 1|Adverse Event|1|||
157165079|NCT01021852|567346032|FG002|Treatment Period 1|Adverse Event|1|||
157165080|NCT01021852|567346033|FG003|Treatment Period 1|Adverse Event|0|||
157165081|NCT01021852|567346034|FG004|Treatment Period 1|Adverse Event|2|||
157165082|NCT01021852|567346035|FG005|Treatment Period 1|Adverse Event|2|||
157165083|NCT01021852|567346036|FG006|Treatment Period 1|Adverse Event|0|||
157227026|NCT01048333|567576022|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156924233|NCT04900220|566480352|FG001|Overall Study|Lost to Follow-up|1|||
156924234|NCT03021265|566480353|FG000|Overall Study|Adverse Event|29|||
156924235|NCT03021265|566480353|FG000|Overall Study|Lack of Efficacy|3|||
156924236|NCT03021265|566480353|FG000|Overall Study|Improved|17|||
156924237|NCT03021265|566480353|FG000|Overall Study|Lost to Follow-up|67|||
156924238|NCT03021265|566480353|FG000|Overall Study|No reason given|2|||
156924239|NCT03021265|566480353|FG000|Overall Study|No visit since the first visit|4|||
157165084|NCT01021852|567346037|FG007|Treatment Period 1|Adverse Event|0|||
157165085|NCT01021852|567346030|FG000|Treatment Period 1|Pregnancy|0|||
157165086|NCT01021852|567346031|FG001|Treatment Period 1|Pregnancy|0|||
157165087|NCT01021852|567346032|FG002|Treatment Period 1|Pregnancy|1|||
156924240|NCT01338493|566480354|FG000|Enrolled|Withdrawal by Subject|1|||
156924241|NCT01338493|566480354|FG000|Enrolled|Patient not implanted|4|||
156924242|NCT01338493|566480354|FG000|Discharge|Death|1|||
156924243|NCT01338493|566480354|FG000|Discharge|Missed visit|1|||
156924244|NCT01338493|566480354|FG000|6 Months Follow up|Lost to Follow-up|11|||
156924245|NCT01338493|566480354|FG000|6 Months Follow up|Missed visit|8|||
156924246|NCT01338493|566480354|FG000|12 Months Follow up|Lost to Follow-up|9|||
156924247|NCT01614067|566480355|FG000|Overall Study|Pregnancy|1|||
156924248|NCT01614067|566480356|FG001|Overall Study|Pregnancy|0|||
156924249|NCT01614067|566480355|FG000|Overall Study|Physician Decision|6|||
156924250|NCT01614067|566480356|FG001|Overall Study|Physician Decision|5|||
156924251|NCT01614067|566480355|FG000|Overall Study|Withdrawal by Subject|0|||
156924252|NCT01614067|566480356|FG001|Overall Study|Withdrawal by Subject|1|||
156924253|NCT01614067|566480355|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
156924254|NCT01614067|566480356|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
156924255|NCT02062879|566480359|FG000|Overall Study|Withdrawal by Subject|4|||
156924256|NCT02062879|566480360|FG001|Overall Study|Withdrawal by Subject|1|||
156924257|NCT00665847|566480361|FG000|Overall Study|Adverse Event|8|||
156924258|NCT00665847|566480361|FG000|Overall Study|Withdrawal by Subject|2|||
156924259|NCT00665847|566480361|FG000|Overall Study|Subject non-compliant|8|||
156924260|NCT00665847|566480361|FG000|Overall Study|Subject reached a virologic endpoint|4|||
156924261|NCT00665847|566480361|FG000|Overall Study|Resistance to TMC125|1|||
156924262|NCT00665847|566480361|FG000|Overall Study|Subject ineligible to continue the trial|1|||
156924263|NCT00665847|566480361|FG000|Overall Study|Switch to Commercial Medication|1|||
156924264|NCT00511667|566480363|FG000|Overall Study|Adverse Event|1|||
156924265|NCT00511667|566480364|FG001|Overall Study|Adverse Event|0|||
156924266|NCT00511667|566480363|FG000|Overall Study|Protocol Violation|1|||
156924267|NCT00511667|566480364|FG001|Overall Study|Protocol Violation|1|||
156924268|NCT00511667|566480363|FG000|Overall Study|Withdrawal by Subject|2|||
156924269|NCT00511667|566480364|FG001|Overall Study|Withdrawal by Subject|0|||
156924270|NCT00511667|566480363|FG000|Overall Study|Site terminated|6|||
156924271|NCT00511667|566480364|FG001|Overall Study|Site terminated|1|||
156924272|NCT00511667|566480363|FG000|Overall Study|Other|2|||
156924273|NCT00511667|566480364|FG001|Overall Study|Other|1|||
156924274|NCT03564145|566480365|FG000|Overall Study|Adverse Event|4|||
156924275|NCT03564145|566480365|FG000|Overall Study|Lost to Follow-up|21|||
156924276|NCT03564145|566480365|FG000|Overall Study|Protocol Violation|2|||
156924277|NCT03564145|566480365|FG000|Overall Study|Withdrawal by Subject|48|||
156924278|NCT03564145|566480365|FG000|Overall Study|Study Terminated by Sponsor|146|||
156924279|NCT03564145|566480365|FG000|Overall Study|Physician Decision|1|||
156924280|NCT03564145|566480365|FG000|Overall Study|Other Than Specified|1|||
156924281|NCT03564145|566480365|FG000|Overall Study|Pregnancy|1|||
156924282|NCT00936910|566481642|FG000|Overall Study|Lack of Efficacy|3|||
156924283|NCT02355691|566481644|FG000|Overall Study|Loss of Research Personnel|7|||
156924284|NCT02355691|566481645|FG001|Overall Study|Loss of Research Personnel|9|||
156924285|NCT02345811|566481646|FG000|First Intervention|Withdrawal by Subject|1|||
156924286|NCT02345811|566481647|FG001|First Intervention|Withdrawal by Subject|1|||
157165088|NCT01021852|567346033|FG003|Treatment Period 1|Pregnancy|0|||
156924287|NCT01172847|566481648|FG000|Overall Study|Withdrawal by Subject|3|||
156924288|NCT01163279|566481649|FG000|Overall Study|Withdrawal by Subject|2|||
156924289|NCT01163279|566481650|FG001|Overall Study|Withdrawal by Subject|0|||
156924290|NCT02132767|566481651|FG000|Overall Study|Death|3|||
156924291|NCT02132767|566481652|FG001|Overall Study|Death|2|||
156924292|NCT02132767|566481651|FG000|Overall Study|Withdrawal by Subject|10|||
156924293|NCT02132767|566481652|FG001|Overall Study|Withdrawal by Subject|9|||
156924294|NCT02132767|566481651|FG000|Overall Study|Lost to Follow-up|4|||
156924295|NCT02132767|566481652|FG001|Overall Study|Lost to Follow-up|4|||
156924296|NCT00390858|566481653|FG000|Overall Study|Adverse Event|6|||
156924297|NCT00390858|566481654|FG001|Overall Study|Adverse Event|2|||
156924298|NCT00390858|566481653|FG000|Overall Study|Lack of Efficacy|0|||
157165089|NCT01021852|567346034|FG004|Treatment Period 1|Pregnancy|0|||
157165090|NCT01021852|567346035|FG005|Treatment Period 1|Pregnancy|0|||
157165091|NCT01021852|567346036|FG006|Treatment Period 1|Pregnancy|0|||
156924299|NCT00390858|566481654|FG001|Overall Study|Lack of Efficacy|1|||
156924300|NCT00390858|566481653|FG000|Overall Study|Withdrawal by Subject|3|||
156924301|NCT00390858|566481654|FG001|Overall Study|Withdrawal by Subject|4|||
156924302|NCT00450450|566481661|FG000|Overall Study|Death|1|||
156924303|NCT00450450|566481662|FG001|Overall Study|Death|3|||
157165092|NCT01021852|567346037|FG007|Treatment Period 1|Pregnancy|0|||
157165093|NCT01021852|567346030|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157165094|NCT01021852|567346031|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156924304|NCT00450450|566481661|FG000|Overall Study|Relapse|2|||
156924305|NCT00450450|566481662|FG001|Overall Study|Relapse|0|||
156924306|NCT00450450|566481661|FG000|Overall Study|Missing Data|2|||
157165095|NCT01021852|567346032|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157165096|NCT01021852|567346033|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156924307|NCT00450450|566481662|FG001|Overall Study|Missing Data|0|||
157165097|NCT01021852|567346034|FG004|Treatment Period 1|Withdrawal by Subject|1|||
156924308|NCT04984993|566481663|FG000|Overall Study|Withdrawal by Subject|8|||
156924309|NCT04984993|566481664|FG001|Overall Study|Withdrawal by Subject|2|||
156924310|NCT04984993|566481663|FG000|Overall Study|Lost to Follow-up|2|||
156924311|NCT04984993|566481664|FG001|Overall Study|Lost to Follow-up|2|||
156924312|NCT04984993|566481663|FG000|Overall Study|Both patients moved to another country|4|||
156924313|NCT04984993|566481664|FG001|Overall Study|Both patients moved to another country|0|||
156924314|NCT01110707|566481665|FG000|Overall Study|Protocol Violation|0|||
156924315|NCT01110707|566481666|FG001|Overall Study|Protocol Violation|3|||
156924316|NCT03318315|566481667|FG000|Overall Study|Lost to Follow-up|3|||
156924317|NCT03318315|566481668|FG001|Overall Study|Lost to Follow-up|2|||
156924318|NCT03318315|566481669|FG002|Overall Study|Lost to Follow-up|1|||
156924319|NCT03318315|566481667|FG000|Overall Study|Protocol Violation|1|||
156924320|NCT03318315|566481668|FG001|Overall Study|Protocol Violation|1|||
156924321|NCT03318315|566481669|FG002|Overall Study|Protocol Violation|1|||
156924322|NCT03318315|566481667|FG000|Overall Study|Withdrawal by Subject|0|||
156924323|NCT03318315|566481668|FG001|Overall Study|Withdrawal by Subject|0|||
156924324|NCT03318315|566481669|FG002|Overall Study|Withdrawal by Subject|2|||
156924325|NCT00495170|566481674|FG000|Overall Study|Lost to Follow-up|9|||
156924326|NCT00495170|566481674|FG000|Overall Study|Withdrawal by Subject|3|||
156924327|NCT00495170|566481674|FG000|Overall Study|Inappropriate staging|8|||
156924328|NCT04210310|566481675|FG000|Overall Study|Lost to Follow-up|32|||
156924329|NCT04210310|566481676|FG001|Overall Study|Lost to Follow-up|1|||
156924330|NCT01928329|566481677|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
156924331|NCT01928329|566481678|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
156924332|NCT01928329|566481677|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
156924333|NCT01928329|566481678|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
156924334|NCT01928329|566481677|FG000|Overall Study|Adverse Event|5|||
156924335|NCT01928329|566481678|FG001|Overall Study|Adverse Event|3|||
156924336|NCT01928329|566481677|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
156924337|NCT01928329|566481678|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
156924338|NCT01928329|566481677|FG000|Overall Study|Withdrawal by Subject|1|||
156924339|NCT01928329|566481678|FG001|Overall Study|Withdrawal by Subject|5|||
156924340|NCT01928329|566481677|FG000|Overall Study|Physician Decision|1|||
156924341|NCT01928329|566481678|FG001|Overall Study|Physician Decision|1|||
156924342|NCT00330616|566481679|FG000|Overall Study|Adverse Event|13|||
156924343|NCT00330616|566481679|FG000|Overall Study|Lack of Efficacy|1|||
156924344|NCT00330616|566481679|FG000|Overall Study|Lost to Follow-up|2|||
156924345|NCT00330616|566481679|FG000|Overall Study|Withdrawal by Subject|4|||
156924346|NCT00330616|566481679|FG000|Overall Study|Other|1|||
156924347|NCT02141997|566481684|FG000|Overall Study|Adverse Event|0|||
156924348|NCT02141997|566481685|FG001|Overall Study|Adverse Event|2|||
156924349|NCT02141997|566481686|FG002|Overall Study|Adverse Event|0|||
156924350|NCT02141997|566481687|FG003|Overall Study|Adverse Event|1|||
156924351|NCT02141997|566481684|FG000|Overall Study|Participant noncompliance|1|||
156924352|NCT02141997|566481685|FG001|Overall Study|Participant noncompliance|0|||
156924353|NCT02141997|566481686|FG002|Overall Study|Participant noncompliance|0|||
156924354|NCT02141997|566481687|FG003|Overall Study|Participant noncompliance|0|||
156924355|NCT02141997|566481684|FG000|Overall Study|Withdrew consent|1|||
156924356|NCT02141997|566481685|FG001|Overall Study|Withdrew consent|0|||
156924357|NCT02141997|566481686|FG002|Overall Study|Withdrew consent|3|||
156924358|NCT02141997|566481687|FG003|Overall Study|Withdrew consent|0|||
156924359|NCT02141997|566481684|FG000|Overall Study|Other|1|||
156924360|NCT02141997|566481685|FG001|Overall Study|Other|4|||
156924361|NCT02141997|566481686|FG002|Overall Study|Other|0|||
156924362|NCT02141997|566481687|FG003|Overall Study|Other|0|||
156924363|NCT00909389|566481696|FG000|Overall Study|Adverse Event|6|||
156924364|NCT00909389|566481696|FG000|Overall Study|Death|4|||
157028830|NCT03663569|566862808|FG000|Overall Study|Withdrawal of consent|5|||
157028831|NCT03663569|566862808|FG000|Overall Study|Patient's request|11|||
157028832|NCT03663569|566862808|FG000|Overall Study|Adverse Event|4|||
157028833|NCT03663569|566862808|FG000|Overall Study|Not come to second visit|3|||
157028834|NCT03663569|566862808|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
157028835|NCT03663569|566862808|FG000|Overall Study|Serious adverse event|1|||
157028836|NCT04979442|566862809|FG000|Overall Study|Death|43|||
156924365|NCT00909389|566481696|FG000|Overall Study|Poor Compliance|16|||
156924366|NCT00909389|566481696|FG000|Overall Study|Lost to Follow-up|4|||
156924367|NCT00909389|566481696|FG000|Overall Study|No Information|103|||
156924368|NCT00597766|566481699|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
156924369|NCT00597766|566481700|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
156924370|NCT00597766|566481701|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
156924371|NCT00597766|566481699|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
156924372|NCT00597766|566481700|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
156924373|NCT00597766|566481701|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
156924374|NCT01166763|566481703|FG000|Overall Study|Withdrawal by Subject|3|||
156924375|NCT01528254|566481704|FG000|Overall Study|Administrative problems|96|||
156924376|NCT01528254|566481705|FG001|Overall Study|Administrative problems|94|||
157028837|NCT04979442|566862810|FG001|Overall Study|Death|30|||
157028838|NCT04979442|566862809|FG000|Overall Study|Withdrawal by Subject|8|||
157165098|NCT01021852|567346035|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157165099|NCT01021852|567346036|FG006|Treatment Period 1|Withdrawal by Subject|0|||
157165100|NCT01021852|567346037|FG007|Treatment Period 1|Withdrawal by Subject|1|||
157165101|NCT01021852|567346030|FG000|Treatment Period 1|Not Treated|0|||
157165102|NCT01021852|567346031|FG001|Treatment Period 1|Not Treated|0|||
157165103|NCT01021852|567346032|FG002|Treatment Period 1|Not Treated|0|||
157165104|NCT01021852|567346033|FG003|Treatment Period 1|Not Treated|2|||
157165105|NCT01021852|567346034|FG004|Treatment Period 1|Not Treated|0|||
157165106|NCT01021852|567346035|FG005|Treatment Period 1|Not Treated|0|||
157165107|NCT01021852|567346036|FG006|Treatment Period 1|Not Treated|0|||
157165108|NCT01021852|567346037|FG007|Treatment Period 1|Not Treated|0|||
157165109|NCT01021852|567346030|FG000|Washout Period-Placebo|Adverse Event|0|||
157165110|NCT01021852|567346031|FG001|Washout Period-Placebo|Adverse Event|0|||
157165111|NCT01021852|567346032|FG002|Washout Period-Placebo|Adverse Event|0|||
157165112|NCT01021852|567346033|FG003|Washout Period-Placebo|Adverse Event|1|||
157165113|NCT01021852|567346034|FG004|Washout Period-Placebo|Adverse Event|0|||
157165114|NCT01021852|567346035|FG005|Washout Period-Placebo|Adverse Event|1|||
157165115|NCT01021852|567346036|FG006|Washout Period-Placebo|Adverse Event|0|||
157165116|NCT01021852|567346037|FG007|Washout Period-Placebo|Adverse Event|0|||
157165117|NCT01021852|567346030|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
157165118|NCT01021852|567346031|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
157165119|NCT01021852|567346032|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
157165120|NCT01021852|567346033|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
157165121|NCT01021852|567346034|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
157165122|NCT01021852|567346035|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
157165123|NCT01021852|567346036|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
157165124|NCT01021852|567346037|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
157165125|NCT01021852|567346030|FG000|Washout Period-Placebo|Protocol Violation|0|||
157165126|NCT01021852|567346031|FG001|Washout Period-Placebo|Protocol Violation|0|||
157165127|NCT01021852|567346032|FG002|Washout Period-Placebo|Protocol Violation|0|||
157165128|NCT01021852|567346033|FG003|Washout Period-Placebo|Protocol Violation|0|||
157165129|NCT01021852|567346034|FG004|Washout Period-Placebo|Protocol Violation|0|||
157165130|NCT01021852|567346035|FG005|Washout Period-Placebo|Protocol Violation|0|||
157165131|NCT01021852|567346036|FG006|Washout Period-Placebo|Protocol Violation|1|||
157165132|NCT01021852|567346037|FG007|Washout Period-Placebo|Protocol Violation|0|||
157165133|NCT01021852|567346030|FG000|Washout Period-No Drug|Adverse Event|1|||
157165134|NCT01021852|567346031|FG001|Washout Period-No Drug|Adverse Event|0|||
157165135|NCT01021852|567346032|FG002|Washout Period-No Drug|Adverse Event|0|||
157165136|NCT01021852|567346033|FG003|Washout Period-No Drug|Adverse Event|0|||
157165137|NCT01021852|567346034|FG004|Washout Period-No Drug|Adverse Event|0|||
157165138|NCT01021852|567346035|FG005|Washout Period-No Drug|Adverse Event|1|||
157165139|NCT01021852|567346036|FG006|Washout Period-No Drug|Adverse Event|0|||
157165140|NCT01021852|567346037|FG007|Washout Period-No Drug|Adverse Event|0|||
157165141|NCT01021852|567346030|FG000|Treatment Period 2|Adverse Event|0|||
157165142|NCT01021852|567346031|FG001|Treatment Period 2|Adverse Event|1|||
157165143|NCT01021852|567346032|FG002|Treatment Period 2|Adverse Event|0|||
157165144|NCT01021852|567346033|FG003|Treatment Period 2|Adverse Event|0|||
156924377|NCT01528254|566481704|FG000|Overall Study|Adverse Event|28|||
156924378|NCT01528254|566481705|FG001|Overall Study|Adverse Event|44|||
156924379|NCT01528254|566481704|FG000|Overall Study|Lost to Follow-up|17|||
156924380|NCT01528254|566481705|FG001|Overall Study|Lost to Follow-up|24|||
156924381|NCT01528254|566481704|FG000|Overall Study|Death|13|||
156924382|NCT01528254|566481705|FG001|Overall Study|Death|9|||
156924383|NCT01528254|566481704|FG000|Overall Study|Protocol deviation|9|||
156924384|NCT01528254|566481705|FG001|Overall Study|Protocol deviation|19|||
156924385|NCT01528254|566481704|FG000|Overall Study|New therapy for study indication|8|||
156924386|NCT01528254|566481705|FG001|Overall Study|New therapy for study indication|6|||
156924387|NCT01528254|566481704|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
156924388|NCT01528254|566481705|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
156924389|NCT01528254|566481704|FG000|Overall Study|Withdrawal by Subject|5|||
157165145|NCT01021852|567346034|FG004|Treatment Period 2|Adverse Event|1|||
157165146|NCT01021852|567346035|FG005|Treatment Period 2|Adverse Event|0|||
157165147|NCT01021852|567346036|FG006|Treatment Period 2|Adverse Event|1|||
157165148|NCT01021852|567346037|FG007|Treatment Period 2|Adverse Event|0|||
157165149|NCT01021852|567346030|FG000|Treatment Period 2|Lack of Efficacy|0|||
156924390|NCT01528254|566481705|FG001|Overall Study|Withdrawal by Subject|4|||
156924391|NCT01528254|566481704|FG000|Overall Study|Abnormal laboratory value(s)|3|||
156924392|NCT01528254|566481705|FG001|Overall Study|Abnormal laboratory value(s)|7|||
156924393|NCT01528254|566481704|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157165150|NCT01021852|567346031|FG001|Treatment Period 2|Lack of Efficacy|0|||
157165151|NCT01021852|567346032|FG002|Treatment Period 2|Lack of Efficacy|0|||
157165152|NCT01021852|567346033|FG003|Treatment Period 2|Lack of Efficacy|0|||
157165153|NCT01021852|567346034|FG004|Treatment Period 2|Lack of Efficacy|0|||
157165154|NCT01021852|567346035|FG005|Treatment Period 2|Lack of Efficacy|1|||
157165155|NCT01021852|567346036|FG006|Treatment Period 2|Lack of Efficacy|0|||
157165156|NCT01021852|567346037|FG007|Treatment Period 2|Lack of Efficacy|0|||
157165157|NCT01021852|567346030|FG000|Treatment Period 2|Physician Decision|0|||
156924394|NCT01528254|566481705|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156924395|NCT01528254|566481704|FG000|Overall Study|No longer requires study drug|1|||
156924396|NCT01528254|566481705|FG001|Overall Study|No longer requires study drug|1|||
156924397|NCT01909479|566481706|FG000|From Baseline to Week 26|Adverse Event|3|||
156924398|NCT01909479|566481707|FG001|From Baseline to Week 26|Adverse Event|2|||
156924399|NCT01909479|566481706|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
156924400|NCT01909479|566481707|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
156924401|NCT01909479|566481706|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
156924402|NCT01909479|566481707|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
156924403|NCT01909479|566481706|FG000|26 - 52 Weeks|Adverse Event|0|||
156924404|NCT01909479|566481707|FG001|26 - 52 Weeks|Adverse Event|1|||
156924405|NCT01909479|566481706|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
156924406|NCT01909479|566481707|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
156924407|NCT01909479|566481706|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
156924408|NCT01909479|566481707|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
156924409|NCT01909479|566481706|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
156924410|NCT01909479|566481707|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
156924411|NCT01909479|566481706|FG000|52 Weeks to End of Study|Adverse Event|2|||
156924412|NCT01909479|566481707|FG001|52 Weeks to End of Study|Adverse Event|1|||
156924413|NCT01909479|566481706|FG000|52 Weeks to End of Study|Death|0|||
156924414|NCT01909479|566481707|FG001|52 Weeks to End of Study|Death|1|||
156924415|NCT01909479|566481706|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
156924416|NCT01909479|566481707|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
156924417|NCT01909479|566481706|FG000|52 Weeks to End of Study|Protocol Violation|1|||
156924418|NCT01909479|566481707|FG001|52 Weeks to End of Study|Protocol Violation|0|||
156924419|NCT01909479|566481706|FG000|52 Weeks to End of Study|Progressive disease|1|||
156924420|NCT01909479|566481707|FG001|52 Weeks to End of Study|Progressive disease|1|||
156924421|NCT01909479|566481706|FG000|52 Weeks to End of Study|Personal reasons|2|||
156924422|NCT01909479|566481707|FG001|52 Weeks to End of Study|Personal reasons|1|||
156924423|NCT01909479|566481706|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
156924424|NCT01909479|566481707|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
156924425|NCT01909479|566481706|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
156924426|NCT01909479|566481707|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
156924427|NCT01909479|566481706|FG000|52 Weeks to End of Study|Lack of contact|1|||
156924428|NCT01909479|566481707|FG001|52 Weeks to End of Study|Lack of contact|0|||
156924429|NCT01909479|566481706|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
156924430|NCT01909479|566481707|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
156924431|NCT01909479|566481706|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
156924432|NCT01909479|566481707|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
156924433|NCT00737282|566481709|FG000|Overall Study|Study prematurely terminated|175|||
156924434|NCT02763189|566481710|FG000|Overall Study|Device failure|0|||
156924435|NCT02763189|566481711|FG001|Overall Study|Device failure|2|||
156924436|NCT02049957|566481716|FG000|Overall Study|Progressive Disease|5|||
156924437|NCT02049957|566481717|FG001|Overall Study|Progressive Disease|4|||
156924438|NCT02049957|566481718|FG002|Overall Study|Progressive Disease|2|||
156924439|NCT02049957|566481719|FG003|Overall Study|Progressive Disease|2|||
156924440|NCT02049957|566481720|FG004|Overall Study|Progressive Disease|6|||
156924441|NCT02049957|566481721|FG005|Overall Study|Progressive Disease|35|||
156924442|NCT02049957|566481722|FG006|Overall Study|Progressive Disease|7|||
157165158|NCT01021852|567346031|FG001|Treatment Period 2|Physician Decision|0|||
157165159|NCT01021852|567346032|FG002|Treatment Period 2|Physician Decision|1|||
157165160|NCT01021852|567346033|FG003|Treatment Period 2|Physician Decision|0|||
157165161|NCT01021852|567346034|FG004|Treatment Period 2|Physician Decision|0|||
156924443|NCT02049957|566481723|FG007|Overall Study|Progressive Disease|26|||
156924444|NCT02049957|566481724|FG008|Overall Study|Progressive Disease|6|||
156924445|NCT02049957|566481716|FG000|Overall Study|Adverse Event|1|||
156924446|NCT02049957|566481717|FG001|Overall Study|Adverse Event|1|||
156924447|NCT02049957|566481718|FG002|Overall Study|Adverse Event|1|||
156924448|NCT02049957|566481719|FG003|Overall Study|Adverse Event|0|||
156924449|NCT02049957|566481720|FG004|Overall Study|Adverse Event|0|||
156924450|NCT02049957|566481721|FG005|Overall Study|Adverse Event|5|||
156924451|NCT02049957|566481722|FG006|Overall Study|Adverse Event|0|||
156924452|NCT02049957|566481723|FG007|Overall Study|Adverse Event|6|||
157165162|NCT01021852|567346035|FG005|Treatment Period 2|Physician Decision|0|||
157165163|NCT01021852|567346036|FG006|Treatment Period 2|Physician Decision|0|||
156924453|NCT02049957|566481724|FG008|Overall Study|Adverse Event|1|||
156924454|NCT02049957|566481716|FG000|Overall Study|Study Terminated by Sponsor|0|||
156924455|NCT02049957|566481717|FG001|Overall Study|Study Terminated by Sponsor|1|||
157165164|NCT01021852|567346037|FG007|Treatment Period 2|Physician Decision|0|||
156924456|NCT02049957|566481718|FG002|Overall Study|Study Terminated by Sponsor|0|||
156924457|NCT02049957|566481719|FG003|Overall Study|Study Terminated by Sponsor|0|||
156924458|NCT02049957|566481720|FG004|Overall Study|Study Terminated by Sponsor|0|||
156924459|NCT02049957|566481721|FG005|Overall Study|Study Terminated by Sponsor|0|||
156924460|NCT02049957|566481722|FG006|Overall Study|Study Terminated by Sponsor|1|||
156924461|NCT02049957|566481723|FG007|Overall Study|Study Terminated by Sponsor|0|||
156924462|NCT02049957|566481724|FG008|Overall Study|Study Terminated by Sponsor|0|||
156924463|NCT02049957|566481716|FG000|Overall Study|Withdrawal by Subject|0|||
156924464|NCT02049957|566481717|FG001|Overall Study|Withdrawal by Subject|0|||
156924465|NCT02049957|566481718|FG002|Overall Study|Withdrawal by Subject|0|||
156924466|NCT02049957|566481719|FG003|Overall Study|Withdrawal by Subject|1|||
156924467|NCT02049957|566481720|FG004|Overall Study|Withdrawal by Subject|0|||
156924468|NCT02049957|566481721|FG005|Overall Study|Withdrawal by Subject|2|||
157165165|NCT01021852|567346030|FG000|Treatment Period 2|Protocol Violation|0|||
157165166|NCT01021852|567346031|FG001|Treatment Period 2|Protocol Violation|0|||
157165167|NCT01021852|567346032|FG002|Treatment Period 2|Protocol Violation|0|||
157165168|NCT01021852|567346033|FG003|Treatment Period 2|Protocol Violation|0|||
157165169|NCT01021852|567346034|FG004|Treatment Period 2|Protocol Violation|1|||
157165170|NCT01021852|567346035|FG005|Treatment Period 2|Protocol Violation|0|||
157165171|NCT01021852|567346036|FG006|Treatment Period 2|Protocol Violation|1|||
157165172|NCT01021852|567346037|FG007|Treatment Period 2|Protocol Violation|0|||
157165173|NCT01021852|567346030|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157165174|NCT01021852|567346031|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157165175|NCT01021852|567346032|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157165176|NCT01021852|567346033|FG003|Treatment Period 2|Withdrawal by Subject|0|||
157165177|NCT01021852|567346034|FG004|Treatment Period 2|Withdrawal by Subject|0|||
157165178|NCT01021852|567346035|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157165179|NCT01021852|567346036|FG006|Treatment Period 2|Withdrawal by Subject|1|||
157165180|NCT01021852|567346037|FG007|Treatment Period 2|Withdrawal by Subject|2|||
157165181|NCT01371981|567346038|FG000|Overall Study|Adverse Event|12|||
157165182|NCT01371981|567346039|FG001|Overall Study|Adverse Event|17|||
157165183|NCT01371981|567346040|FG002|Overall Study|Adverse Event|0|||
157165184|NCT01371981|567346041|FG003|Overall Study|Adverse Event|4|||
157165185|NCT01371981|567346042|FG004|Overall Study|Adverse Event|1|||
157165186|NCT01371981|567346043|FG005|Overall Study|Adverse Event|0|||
157165187|NCT01371981|567346038|FG000|Overall Study|Death|22|||
157165188|NCT01371981|567346039|FG001|Overall Study|Death|16|||
157165189|NCT01371981|567346040|FG002|Overall Study|Death|0|||
157165190|NCT01371981|567346041|FG003|Overall Study|Death|0|||
157165191|NCT01371981|567346042|FG004|Overall Study|Death|2|||
157165192|NCT01371981|567346043|FG005|Overall Study|Death|2|||
157165193|NCT01371981|567346038|FG000|Overall Study|Lack of Efficacy|69|||
157165194|NCT01371981|567346039|FG001|Overall Study|Lack of Efficacy|61|||
157165195|NCT01371981|567346040|FG002|Overall Study|Lack of Efficacy|4|||
157165196|NCT01371981|567346041|FG003|Overall Study|Lack of Efficacy|8|||
157165197|NCT01371981|567346042|FG004|Overall Study|Lack of Efficacy|5|||
157165198|NCT01371981|567346043|FG005|Overall Study|Lack of Efficacy|0|||
157165199|NCT01371981|567346038|FG000|Overall Study|Physician Decision|48|||
157165200|NCT01371981|567346039|FG001|Overall Study|Physician Decision|63|||
157165201|NCT01371981|567346040|FG002|Overall Study|Physician Decision|1|||
157165202|NCT01371981|567346041|FG003|Overall Study|Physician Decision|7|||
157165203|NCT01371981|567346042|FG004|Overall Study|Physician Decision|14|||
157165204|NCT01371981|567346043|FG005|Overall Study|Physician Decision|3|||
157165205|NCT01371981|567346038|FG000|Overall Study|Withdrawal by Subject|12|||
157165206|NCT01371981|567346039|FG001|Overall Study|Withdrawal by Subject|19|||
157165207|NCT01371981|567346040|FG002|Overall Study|Withdrawal by Subject|1|||
157165208|NCT01371981|567346041|FG003|Overall Study|Withdrawal by Subject|2|||
157165209|NCT01371981|567346042|FG004|Overall Study|Withdrawal by Subject|10|||
157165210|NCT01371981|567346043|FG005|Overall Study|Withdrawal by Subject|3|||
157165211|NCT01371981|567346038|FG000|Overall Study|Ineligible|19|||
157165212|NCT01371981|567346039|FG001|Overall Study|Ineligible|13|||
157165213|NCT01371981|567346040|FG002|Overall Study|Ineligible|0|||
157165214|NCT01371981|567346041|FG003|Overall Study|Ineligible|0|||
157165215|NCT01371981|567346042|FG004|Overall Study|Ineligible|0|||
157028839|NCT04979442|566862810|FG001|Overall Study|Withdrawal by Subject|13|||
157165216|NCT01371981|567346043|FG005|Overall Study|Ineligible|4|||
157165217|NCT01371981|567346038|FG000|Overall Study|Did not start treatment|2|||
157165218|NCT01371981|567346039|FG001|Overall Study|Did not start treatment|3|||
157165219|NCT01371981|567346040|FG002|Overall Study|Did not start treatment|0|||
157165220|NCT01371981|567346041|FG003|Overall Study|Did not start treatment|0|||
157165221|NCT01371981|567346042|FG004|Overall Study|Did not start treatment|0|||
157165222|NCT01371981|567346043|FG005|Overall Study|Did not start treatment|2|||
157165223|NCT01655823|567346044|FG000|Overall Study|Lost to Follow-up|0|||
157165224|NCT01655823|567346045|FG001|Overall Study|Lost to Follow-up|1|||
157165225|NCT01655823|567346046|FG002|Overall Study|Lost to Follow-up|0|||
157165226|NCT01655823|567346047|FG003|Overall Study|Lost to Follow-up|0|||
157165227|NCT01655823|567346048|FG004|Overall Study|Lost to Follow-up|1|||
156924469|NCT02049957|566481722|FG006|Overall Study|Withdrawal by Subject|0|||
156924470|NCT02049957|566481723|FG007|Overall Study|Withdrawal by Subject|3|||
157165228|NCT01655823|567346044|FG000|Overall Study|Withdrawal by Subject|0|||
157165229|NCT01655823|567346045|FG001|Overall Study|Withdrawal by Subject|1|||
157165230|NCT01655823|567346046|FG002|Overall Study|Withdrawal by Subject|0|||
156924471|NCT02049957|566481724|FG008|Overall Study|Withdrawal by Subject|1|||
156924472|NCT02049957|566481716|FG000|Overall Study|Physician Decision|0|||
157165231|NCT01655823|567346047|FG003|Overall Study|Withdrawal by Subject|1|||
157165232|NCT01655823|567346048|FG004|Overall Study|Withdrawal by Subject|0|||
157165233|NCT00603980|567346049|FG000|Study Qualification|Protocol Violation|3|||
156924473|NCT02049957|566481717|FG001|Overall Study|Physician Decision|0|||
156924474|NCT02049957|566481718|FG002|Overall Study|Physician Decision|0|||
156924475|NCT02049957|566481719|FG003|Overall Study|Physician Decision|0|||
156924476|NCT02049957|566481720|FG004|Overall Study|Physician Decision|0|||
156924477|NCT02049957|566481721|FG005|Overall Study|Physician Decision|1|||
156924478|NCT02049957|566481722|FG006|Overall Study|Physician Decision|0|||
156924479|NCT02049957|566481723|FG007|Overall Study|Physician Decision|0|||
156924480|NCT02049957|566481724|FG008|Overall Study|Physician Decision|0|||
156924481|NCT03557151|566481725|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
156924482|NCT03557151|566481726|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
156924483|NCT03557151|566481725|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
156924484|NCT03557151|566481726|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
156924485|NCT03557151|566481725|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
156924486|NCT03557151|566481726|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
156924487|NCT02810392|566481727|FG000|Overall Study|Subject too ill to continue|1|||
156924488|NCT02810392|566481728|FG001|Overall Study|Subject too ill to continue|0|||
156924489|NCT02810392|566481727|FG000|Overall Study|COVID 19 research restrictions|0|||
156924490|NCT02810392|566481728|FG001|Overall Study|COVID 19 research restrictions|1|||
156924491|NCT00840294|566481729|FG000|Overall Study|Withdrawal by Subject|2|||
156924492|NCT00840294|566481730|FG001|Overall Study|Withdrawal by Subject|1|||
156924493|NCT00840294|566481729|FG000|Overall Study|Protocol Violation|1|||
156924494|NCT00840294|566481730|FG001|Overall Study|Protocol Violation|3|||
156924495|NCT00840294|566481729|FG000|Overall Study|Illness|0|||
156924496|NCT00840294|566481730|FG001|Overall Study|Illness|1|||
156924497|NCT02028065|566481735|FG000|Randomization Through Start Treatment|Not treated|1|||
156924498|NCT02028065|566481736|FG001|Randomization Through Start Treatment|Not treated|3|||
156924499|NCT02028065|566481737|FG002|Randomization Through Start Treatment|Not treated|3|||
156924500|NCT02028065|566481735|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
156924501|NCT02028065|566481736|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
156924502|NCT02028065|566481737|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
156924503|NCT02028065|566481735|FG000|Treatment Through Study Completion|Physician Decision|1|||
156924504|NCT02028065|566481736|FG001|Treatment Through Study Completion|Physician Decision|0|||
156924505|NCT02028065|566481737|FG002|Treatment Through Study Completion|Physician Decision|0|||
156924506|NCT02028065|566481735|FG000|Treatment Through Study Completion|Protocol Violation|1|||
156924507|NCT02028065|566481736|FG001|Treatment Through Study Completion|Protocol Violation|4|||
156924508|NCT02028065|566481737|FG002|Treatment Through Study Completion|Protocol Violation|0|||
156924509|NCT02028065|566481735|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
156924510|NCT02028065|566481736|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
156924511|NCT02028065|566481737|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
156924512|NCT02028065|566481735|FG000|Treatment Through Study Completion|Adverse Event|3|||
156924513|NCT02028065|566481736|FG001|Treatment Through Study Completion|Adverse Event|3|||
156924514|NCT02028065|566481737|FG002|Treatment Through Study Completion|Adverse Event|5|||
156924515|NCT04868890|566481738|FG000|Overall Study|Death|2|||
156924516|NCT04868890|566481739|FG001|Overall Study|Death|1|||
156924517|NCT04868890|566481738|FG000|Overall Study|Withdrawal by Subject|1|||
156924518|NCT04868890|566481739|FG001|Overall Study|Withdrawal by Subject|5|||
156924519|NCT02157298|566481747|FG000|Overall Study|Adverse Event|1|||
156924520|NCT02157298|566481748|FG001|Overall Study|Adverse Event|0|||
156924521|NCT02157298|566481747|FG000|Overall Study|Subject no longer meets study criteria|1|||
156924522|NCT02157298|566481748|FG001|Overall Study|Subject no longer meets study criteria|2|||
156924523|NCT02157298|566481747|FG000|Overall Study|Poor/Non-compliance|1|||
156924524|NCT02157298|566481748|FG001|Overall Study|Poor/Non-compliance|0|||
156924525|NCT02157298|566481747|FG000|Overall Study|Withdrawal by Subject|1|||
157165234|NCT00603980|567346049|FG000|Study Qualification|Inconsistent data reporting|13|||
157165235|NCT00603980|567346049|FG000|Main Study|14th subject completed trial|1|||
157165236|NCT01029002|567346050|FG000|Overall Study|Lost to Follow-up|2|||
157165237|NCT01029002|567346051|FG001|Overall Study|Lost to Follow-up|4|||
157165238|NCT02632110|567346056|FG000|Overall Study|Withdrawal by Subject|1|||
157165239|NCT02632110|567346057|FG001|Overall Study|Withdrawal by Subject|1|||
157165240|NCT02632110|567346058|FG002|Overall Study|Withdrawal by Subject|0|||
157165241|NCT02632110|567346059|FG003|Overall Study|Withdrawal by Subject|0|||
156924526|NCT02157298|566481748|FG001|Overall Study|Withdrawal by Subject|0|||
156924527|NCT03715764|566481749|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
156924528|NCT03715764|566481750|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
156924529|NCT03715764|566481749|FG000|3 Month Follow-up|Lost to Follow-up|2|||
156924530|NCT03715764|566481750|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156924531|NCT03715764|566481749|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
156924532|NCT03715764|566481750|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
156924533|NCT03715764|566481749|FG000|6 Month Follow-up|Lost to Follow-up|3|||
156924534|NCT03715764|566481750|FG001|6 Month Follow-up|Lost to Follow-up|0|||
156924535|NCT03715764|566481749|FG000|12 Month Follow-up|Lost to Follow-up|2|||
156924536|NCT03715764|566481750|FG001|12 Month Follow-up|Lost to Follow-up|3|||
156924537|NCT03715764|566481749|FG000|12 Month Follow-up|Pregnancy|0|||
156924538|NCT03715764|566481750|FG001|12 Month Follow-up|Pregnancy|1|||
156924539|NCT03715764|566481749|FG000|12 Month Follow-up|Surgery|2|||
156924540|NCT03715764|566481750|FG001|12 Month Follow-up|Surgery|0|||
156924541|NCT03715764|566481749|FG000|12 Month Follow-up|Wrong address|1|||
156924542|NCT03715764|566481750|FG001|12 Month Follow-up|Wrong address|0|||
156924543|NCT03715764|566481749|FG000|12 Month Follow-up|No symptoms|1|||
156924544|NCT03715764|566481750|FG001|12 Month Follow-up|No symptoms|0|||
156924545|NCT03715764|566481749|FG000|12 Month Follow-up|Changed primary care centre|0|||
156924546|NCT03715764|566481750|FG001|12 Month Follow-up|Changed primary care centre|1|||
156924547|NCT01361464|566481754|FG000|Overall Study|Death|1|||
156924548|NCT01361464|566481754|FG000|Overall Study|Withdrawal by Subject|2|||
156924549|NCT01722071|566481755|FG000|Overall Study|Protocol Violation|1|||
156924550|NCT01722071|566481756|FG001|Overall Study|Protocol Violation|0|||
156924551|NCT00818662|566481757|FG000|Overall Study|Adverse Event|5|||
156924552|NCT00818662|566481758|FG001|Overall Study|Adverse Event|14|||
156924553|NCT00818662|566481759|FG002|Overall Study|Adverse Event|4|||
156924554|NCT00818662|566481760|FG003|Overall Study|Adverse Event|3|||
156924555|NCT00818662|566481757|FG000|Overall Study|Withdrawal by Subject|5|||
156924556|NCT00818662|566481758|FG001|Overall Study|Withdrawal by Subject|4|||
156924557|NCT00818662|566481759|FG002|Overall Study|Withdrawal by Subject|2|||
156924558|NCT00818662|566481760|FG003|Overall Study|Withdrawal by Subject|2|||
156924559|NCT00818662|566481757|FG000|Overall Study|Death|1|||
156924560|NCT00818662|566481758|FG001|Overall Study|Death|3|||
156924561|NCT00818662|566481759|FG002|Overall Study|Death|0|||
156924562|NCT00818662|566481760|FG003|Overall Study|Death|0|||
156924563|NCT00818662|566481757|FG000|Overall Study|Physician Decision|1|||
156924564|NCT00818662|566481758|FG001|Overall Study|Physician Decision|0|||
156924565|NCT00818662|566481759|FG002|Overall Study|Physician Decision|0|||
156924566|NCT00818662|566481760|FG003|Overall Study|Physician Decision|0|||
156924567|NCT00818662|566481757|FG000|Overall Study|Lost to Follow-up|0|||
156924568|NCT00818662|566481758|FG001|Overall Study|Lost to Follow-up|0|||
156924569|NCT00818662|566481759|FG002|Overall Study|Lost to Follow-up|0|||
156924570|NCT00818662|566481760|FG003|Overall Study|Lost to Follow-up|1|||
156924571|NCT00818662|566481757|FG000|Overall Study|Unwilling or Unable to Participate|4|||
156924572|NCT00818662|566481758|FG001|Overall Study|Unwilling or Unable to Participate|6|||
156924573|NCT00818662|566481759|FG002|Overall Study|Unwilling or Unable to Participate|2|||
156924574|NCT00818662|566481760|FG003|Overall Study|Unwilling or Unable to Participate|4|||
156924575|NCT00818662|566481757|FG000|Overall Study|Protocol Violation|1|||
156924576|NCT00818662|566481758|FG001|Overall Study|Protocol Violation|1|||
156924577|NCT00818662|566481759|FG002|Overall Study|Protocol Violation|0|||
156924578|NCT00818662|566481760|FG003|Overall Study|Protocol Violation|0|||
156924579|NCT00818662|566481757|FG000|Overall Study|Requires a Prohibited Medication|1|||
156924580|NCT00818662|566481758|FG001|Overall Study|Requires a Prohibited Medication|0|||
156924581|NCT00818662|566481759|FG002|Overall Study|Requires a Prohibited Medication|0|||
156924582|NCT00818662|566481760|FG003|Overall Study|Requires a Prohibited Medication|0|||
156924583|NCT00818662|566481757|FG000|Overall Study|Safety Risk|1|||
156924584|NCT00818662|566481758|FG001|Overall Study|Safety Risk|1|||
156924585|NCT00818662|566481759|FG002|Overall Study|Safety Risk|0|||
156924586|NCT00818662|566481760|FG003|Overall Study|Safety Risk|1|||
156924587|NCT00818662|566481757|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
156924588|NCT00818662|566481758|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
156924589|NCT00818662|566481759|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
157028840|NCT04979442|566862809|FG000|Overall Study|Physician Decision|1|||
156924590|NCT00818662|566481760|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
157028841|NCT04979442|566862810|FG001|Overall Study|Physician Decision|1|||
157028842|NCT04979442|566862809|FG000|Overall Study|Lost to Follow-up|0|||
157028843|NCT04979442|566862810|FG001|Overall Study|Lost to Follow-up|2|||
157028844|NCT04979442|566862809|FG000|Overall Study|do not want to continue|0|||
157165242|NCT02632110|567346060|FG004|Overall Study|Withdrawal by Subject|1|||
156924591|NCT00818662|566481757|FG000|Overall Study|Participant's health declined|0|||
156924592|NCT00818662|566481758|FG001|Overall Study|Participant's health declined|0|||
156924593|NCT00818662|566481759|FG002|Overall Study|Participant's health declined|0|||
156924594|NCT00818662|566481760|FG003|Overall Study|Participant's health declined|1|||
156924595|NCT00818662|566481757|FG000|Overall Study|Caregiver to pursue other treatment|0|||
157165243|NCT02632110|567346061|FG005|Overall Study|Withdrawal by Subject|1|||
156924596|NCT00818662|566481758|FG001|Overall Study|Caregiver to pursue other treatment|1|||
156924597|NCT00818662|566481759|FG002|Overall Study|Caregiver to pursue other treatment|0|||
156924598|NCT00818662|566481760|FG003|Overall Study|Caregiver to pursue other treatment|0|||
156924599|NCT00818662|566481757|FG000|Overall Study|Moving out of state|0|||
156924600|NCT00818662|566481758|FG001|Overall Study|Moving out of state|0|||
156924601|NCT00818662|566481759|FG002|Overall Study|Moving out of state|0|||
156924602|NCT00818662|566481760|FG003|Overall Study|Moving out of state|1|||
156924603|NCT00818662|566481757|FG000|Overall Study|Declined move to another study site|1|||
156924604|NCT00818662|566481758|FG001|Overall Study|Declined move to another study site|0|||
157028845|NCT04979442|566862810|FG001|Overall Study|do not want to continue|1|||
156924605|NCT00818662|566481759|FG002|Overall Study|Declined move to another study site|0|||
156924606|NCT00818662|566481760|FG003|Overall Study|Declined move to another study site|0|||
156924607|NCT00818662|566481757|FG000|Overall Study|Change in living situation|0|||
156924608|NCT00818662|566481758|FG001|Overall Study|Change in living situation|0|||
156924609|NCT00818662|566481759|FG002|Overall Study|Change in living situation|0|||
156924610|NCT00818662|566481760|FG003|Overall Study|Change in living situation|1|||
156924611|NCT00818662|566481757|FG000|Overall Study|Study partner decision|0|||
156924612|NCT00818662|566481758|FG001|Overall Study|Study partner decision|0|||
156924613|NCT00818662|566481759|FG002|Overall Study|Study partner decision|0|||
156924614|NCT00818662|566481760|FG003|Overall Study|Study partner decision|1|||
156924615|NCT00818662|566481757|FG000|Overall Study|Admitted to long term nursing care|0|||
156924616|NCT00818662|566481758|FG001|Overall Study|Admitted to long term nursing care|1|||
156924617|NCT00818662|566481759|FG002|Overall Study|Admitted to long term nursing care|0|||
156924618|NCT00818662|566481760|FG003|Overall Study|Admitted to long term nursing care|0|||
156924619|NCT01106898|566481761|FG000|Overall Study|Adverse Event|6|||
156924620|NCT01705652|566481762|FG000|Overall Study|Adverse Event|1|||
156924621|NCT01705652|566481763|FG001|Overall Study|Adverse Event|0|||
156924622|NCT01705652|566481762|FG000|Overall Study|Withdrawal by Subject|1|||
156924623|NCT01705652|566481763|FG001|Overall Study|Withdrawal by Subject|2|||
156924624|NCT01705652|566481762|FG000|Overall Study|non-compliance|1|||
156924625|NCT01705652|566481763|FG001|Overall Study|non-compliance|1|||
156924626|NCT01698801|566481764|FG000|Treatment Phase|Adverse Event|4|||
156924627|NCT01698801|566481764|FG000|Treatment Phase|Protocol Violation|1|||
156924628|NCT01698801|566481764|FG000|Treatment Phase|Other|4|||
156924629|NCT01698801|566481764|FG000|Treatment Phase|Withdrawal by Subject|1|||
156924630|NCT01698801|566481764|FG000|Treatment Phase|Disease progression|1|||
156924631|NCT01698801|566481764|FG000|Follow Up Phase|Withdrawal by Subject|1|||
156924632|NCT01698801|566481764|FG000|Follow Up Phase|Death|4|||
156924633|NCT00656474|566481765|FG000|Overall Study|Other Reason|1|||
156924634|NCT02998840|566481769|FG000|Overall Study|Lost to Follow-up|1|||
156924635|NCT02998840|566481770|FG001|Overall Study|Lost to Follow-up|1|||
156924636|NCT02998840|566481771|FG002|Overall Study|Lost to Follow-up|2|||
156924637|NCT02998840|566481772|FG003|Overall Study|Lost to Follow-up|3|||
156924638|NCT02998840|566481769|FG000|Overall Study|Withdrawal by Subject|1|||
156924639|NCT02998840|566481770|FG001|Overall Study|Withdrawal by Subject|1|||
156924640|NCT02998840|566481771|FG002|Overall Study|Withdrawal by Subject|0|||
156924641|NCT02998840|566481772|FG003|Overall Study|Withdrawal by Subject|1|||
156924642|NCT02998840|566481769|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
156924643|NCT02998840|566481770|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
156924644|NCT02998840|566481771|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
156924645|NCT02998840|566481772|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
156924646|NCT01686633|566481773|FG000|Overall Study|Lack of Efficacy|33|||
156924647|NCT01686633|566481774|FG001|Overall Study|Lack of Efficacy|13|||
156924648|NCT01686633|566481775|FG002|Overall Study|Lack of Efficacy|11|||
156924649|NCT01686633|566481773|FG000|Overall Study|Withdrawal by Subject|8|||
156924650|NCT01686633|566481774|FG001|Overall Study|Withdrawal by Subject|8|||
156924651|NCT01686633|566481775|FG002|Overall Study|Withdrawal by Subject|5|||
156924652|NCT01686633|566481773|FG000|Overall Study|Physician Decision|3|||
156924653|NCT01686633|566481774|FG001|Overall Study|Physician Decision|4|||
156924654|NCT01686633|566481775|FG002|Overall Study|Physician Decision|4|||
156924655|NCT01686633|566481773|FG000|Overall Study|Adverse Event|4|||
156924656|NCT01686633|566481774|FG001|Overall Study|Adverse Event|3|||
156924657|NCT01686633|566481775|FG002|Overall Study|Adverse Event|3|||
156924658|NCT01686633|566481773|FG000|Overall Study|Protocol Violation|2|||
156924659|NCT01686633|566481774|FG001|Overall Study|Protocol Violation|3|||
156924660|NCT01686633|566481775|FG002|Overall Study|Protocol Violation|0|||
156924661|NCT01686633|566481773|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
156924662|NCT01686633|566481774|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
156924663|NCT01686633|566481775|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
156924664|NCT01686633|566481773|FG000|Overall Study|Lost to Follow-up|0|||
156924665|NCT01686633|566481774|FG001|Overall Study|Lost to Follow-up|1|||
156924666|NCT01686633|566481775|FG002|Overall Study|Lost to Follow-up|1|||
156924667|NCT00056407|566481780|FG000|Overall Study|Adverse Event|282|||
156924668|NCT00056407|566481781|FG001|Overall Study|Adverse Event|364|||
156924669|NCT00056407|566481780|FG000|Overall Study|Withdrawal by Subject|377|||
156924670|NCT00056407|566481781|FG001|Overall Study|Withdrawal by Subject|361|||
156924671|NCT00056407|566481780|FG000|Overall Study|Lost to Follow-up|123|||
156924672|NCT00056407|566481781|FG001|Overall Study|Lost to Follow-up|113|||
156924673|NCT00056407|566481780|FG000|Overall Study|Protocol Violation|104|||
156924674|NCT00056407|566481781|FG001|Overall Study|Protocol Violation|95|||
156924675|NCT00056407|566481780|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
156924676|NCT00056407|566481781|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
156924677|NCT00056407|566481780|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
156924678|NCT00056407|566481781|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
156924679|NCT00056407|566481780|FG000|Overall Study|Missing|25|||
156924680|NCT00056407|566481781|FG001|Overall Study|Missing|34|||
157165244|NCT02632110|567346062|FG006|Overall Study|Withdrawal by Subject|3|||
157165245|NCT02632110|567346063|FG007|Overall Study|Withdrawal by Subject|3|||
157165246|NCT02632110|567346064|FG008|Overall Study|Withdrawal by Subject|1|||
157165247|NCT02632110|567346065|FG009|Overall Study|Withdrawal by Subject|1|||
157165248|NCT01096849|567346068|FG000|Overall Study|Consent Withdrawn|1|||
157165249|NCT01096849|567346069|FG001|Overall Study|Consent Withdrawn|4|||
157165250|NCT01096849|567346070|FG002|Overall Study|Consent Withdrawn|2|||
157165251|NCT01096849|567346068|FG000|Overall Study|Lack of Efficacy|0|||
157165252|NCT01096849|567346069|FG001|Overall Study|Lack of Efficacy|2|||
157165253|NCT01096849|567346070|FG002|Overall Study|Lack of Efficacy|0|||
157165254|NCT01096849|567346068|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
157165255|NCT01096849|567346069|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
157165256|NCT01096849|567346070|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
156924681|NCT00616655|566481782|FG000|Overall Study|Adverse Event|10|||
156924682|NCT00616655|566481783|FG001|Overall Study|Adverse Event|7|||
156924683|NCT00616655|566481784|FG002|Overall Study|Adverse Event|12|||
156924684|NCT00616655|566481782|FG000|Overall Study|Lack of Efficacy|5|||
156924685|NCT00616655|566481783|FG001|Overall Study|Lack of Efficacy|5|||
156924686|NCT00616655|566481784|FG002|Overall Study|Lack of Efficacy|5|||
156924687|NCT00616655|566481782|FG000|Overall Study|Lost to Follow-up|3|||
156924688|NCT00616655|566481783|FG001|Overall Study|Lost to Follow-up|12|||
156924689|NCT00616655|566481784|FG002|Overall Study|Lost to Follow-up|10|||
156924690|NCT00616655|566481782|FG000|Overall Study|Protocol Violation|2|||
156924691|NCT00616655|566481783|FG001|Overall Study|Protocol Violation|4|||
156924692|NCT00616655|566481784|FG002|Overall Study|Protocol Violation|3|||
156924693|NCT00616655|566481782|FG000|Overall Study|Withdrawal by Subject|9|||
156924694|NCT00616655|566481783|FG001|Overall Study|Withdrawal by Subject|7|||
156924695|NCT00616655|566481784|FG002|Overall Study|Withdrawal by Subject|11|||
156924696|NCT00616655|566481782|FG000|Overall Study|Does not meet in/ex criteria|0|||
156924697|NCT00616655|566481783|FG001|Overall Study|Does not meet in/ex criteria|0|||
156924698|NCT00616655|566481784|FG002|Overall Study|Does not meet in/ex criteria|2|||
156924699|NCT00616655|566481782|FG000|Overall Study|Other|6|||
156924700|NCT00616655|566481783|FG001|Overall Study|Other|6|||
156924701|NCT00616655|566481784|FG002|Overall Study|Other|5|||
156924702|NCT01786629|566483516|FG000|Overall Study|Lack of Efficacy|0|||
156924703|NCT01786629|566483517|FG001|Overall Study|Lack of Efficacy|4|||
156924704|NCT01786629|566483516|FG000|Overall Study|Adverse Event|0|||
156924705|NCT01786629|566483517|FG001|Overall Study|Adverse Event|1|||
156924706|NCT00410761|566483518|FG000|Randomized Treatment Period|Adverse Event|34|||
156924707|NCT00410761|566483519|FG001|Randomized Treatment Period|Adverse Event|3|||
156924708|NCT00410761|566483518|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
156924709|NCT00410761|566483519|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
156924710|NCT00410761|566483518|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
156924711|NCT00410761|566483519|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
156924712|NCT00410761|566483518|FG000|Randomized Treatment Period|Other|69|||
156924713|NCT00410761|566483519|FG001|Randomized Treatment Period|Other|21|||
156924714|NCT00410761|566483518|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
156924715|NCT00410761|566483519|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
156924716|NCT00410761|566483518|FG000|Open-Label Treatment Period|Adverse Event|13|||
156924717|NCT00410761|566483519|FG001|Open-Label Treatment Period|Adverse Event|15|||
156924718|NCT00410761|566483518|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
156924719|NCT00410761|566483519|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
156924720|NCT00410761|566483518|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
157165257|NCT01096849|567346068|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
157165258|NCT01096849|567346069|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
156924721|NCT00410761|566483519|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
156924722|NCT00410761|566483518|FG000|Open-Label Treatment Period|Other|18|||
156924723|NCT00410761|566483519|FG001|Open-Label Treatment Period|Other|9|||
156924724|NCT00312494|566483520|FG000|Overall Study|Randomized; not treated with study drug|9|||
156924725|NCT00312494|566483521|FG001|Overall Study|Randomized; not treated with study drug|10|||
156924726|NCT00312494|566483522|FG002|Overall Study|Randomized; not treated with study drug|5|||
156924727|NCT00312494|566483520|FG000|Overall Study|Adverse Event|33|||
156924728|NCT00312494|566483521|FG001|Overall Study|Adverse Event|15|||
156924729|NCT00312494|566483522|FG002|Overall Study|Adverse Event|11|||
156924730|NCT00312494|566483520|FG000|Overall Study|Lack of Efficacy|4|||
156924731|NCT00312494|566483521|FG001|Overall Study|Lack of Efficacy|6|||
156924732|NCT00312494|566483522|FG002|Overall Study|Lack of Efficacy|8|||
157165259|NCT01096849|567346070|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
157165260|NCT01096849|567346068|FG000|Overall Study|Administrative Reasons|0|||
157165261|NCT01096849|567346069|FG001|Overall Study|Administrative Reasons|1|||
157165262|NCT01096849|567346070|FG002|Overall Study|Administrative Reasons|2|||
156924733|NCT00312494|566483520|FG000|Overall Study|Laboratory abnormality|1|||
156924734|NCT00312494|566483521|FG001|Overall Study|Laboratory abnormality|0|||
156924735|NCT00312494|566483522|FG002|Overall Study|Laboratory abnormality|0|||
156924736|NCT00312494|566483520|FG000|Overall Study|Lost to Follow-up|8|||
157165263|NCT01096849|567346068|FG000|Overall Study|Lost to Follow-up|1|||
157165264|NCT01096849|567346069|FG001|Overall Study|Lost to Follow-up|3|||
157165265|NCT01096849|567346070|FG002|Overall Study|Lost to Follow-up|1|||
157165266|NCT02357849|567346076|FG000|Overall Study|Withdrawal by Subject|2|||
156924737|NCT00312494|566483521|FG001|Overall Study|Lost to Follow-up|8|||
156924738|NCT00312494|566483522|FG002|Overall Study|Lost to Follow-up|8|||
156924739|NCT00312494|566483520|FG000|Overall Study|Withdrawal by Subject|6|||
156924740|NCT00312494|566483521|FG001|Overall Study|Withdrawal by Subject|9|||
157165267|NCT02357849|567346077|FG001|Overall Study|Withdrawal by Subject|3|||
157165268|NCT01822691|567346079|FG000|Overall Study|Withdrawal by Subject|2|||
157165269|NCT01778127|567346082|FG000|Overall Study|Lost to Follow-up|5|||
157165270|NCT01778127|567346083|FG001|Overall Study|Lost to Follow-up|1|||
157165271|NCT01778127|567346084|FG002|Overall Study|Lost to Follow-up|2|||
157165272|NCT01778127|567346082|FG000|Overall Study|Withdrawal by Subject|3|||
157165273|NCT01778127|567346083|FG001|Overall Study|Withdrawal by Subject|1|||
157165274|NCT01778127|567346084|FG002|Overall Study|Withdrawal by Subject|4|||
157165275|NCT01348425|567346085|FG000|Overall Study|Imaging was not taken.|1|||
157165276|NCT01348425|567346086|FG001|Overall Study|Imaging was not taken.|1|||
157165277|NCT03488251|567346094|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
157165278|NCT03488251|567346095|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
157165279|NCT03488251|567346096|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
157165280|NCT03488251|567346097|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
157165281|NCT03488251|567346094|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
157165282|NCT03488251|567346095|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
157165283|NCT03488251|567346096|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
157165284|NCT03488251|567346097|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
157165285|NCT03488251|567346094|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
157165286|NCT03488251|567346095|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
157165287|NCT03488251|567346096|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
157165288|NCT03488251|567346097|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
157165289|NCT03488251|567346094|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
157165290|NCT03488251|567346095|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
157165291|NCT03488251|567346096|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
157165292|NCT03488251|567346097|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
157165293|NCT03488251|567346094|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
157165294|NCT03488251|567346095|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
157165295|NCT03488251|567346096|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
157165296|NCT03488251|567346097|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
157165297|NCT00995670|567346098|FG000|Overall Study|Failed arterial cannulation|1|||
157165298|NCT00995670|567346099|FG001|Overall Study|Failed arterial cannulation|0|||
156924741|NCT00312494|566483522|FG002|Overall Study|Withdrawal by Subject|10|||
156924742|NCT00312494|566483520|FG000|Overall Study|Other|10|||
156924743|NCT00312494|566483521|FG001|Overall Study|Other|10|||
156924744|NCT00312494|566483522|FG002|Overall Study|Other|1|||
156924745|NCT00696696|566483523|FG000|Overall Study|Adverse Event|5|||
156924746|NCT00696696|566483523|FG000|Overall Study|Withdrawal by Subject|8|||
156924747|NCT00696696|566483523|FG000|Overall Study|Physician Decision|2|||
156924748|NCT00696696|566483523|FG000|Overall Study|Death|3|||
156924749|NCT01349803|566483525|FG000|Overall Study|Adverse Event|0|||
156924750|NCT01349803|566483526|FG001|Overall Study|Adverse Event|0|||
156924751|NCT01349803|566483527|FG002|Overall Study|Adverse Event|0|||
156924752|NCT01349803|566483528|FG003|Overall Study|Adverse Event|2|||
156924753|NCT01349803|566483525|FG000|Overall Study|Withdrawal by Subject|1|||
157165299|NCT00995670|567346100|FG002|Overall Study|Failed arterial cannulation|3|||
157165300|NCT00675103|567346101|FG000|Overall Study|Lack of Efficacy|2|||
157165301|NCT00675103|567346101|FG000|Overall Study|Adverse Event|1|||
156924754|NCT01349803|566483526|FG001|Overall Study|Withdrawal by Subject|0|||
156924755|NCT01349803|566483527|FG002|Overall Study|Withdrawal by Subject|0|||
156924756|NCT01349803|566483528|FG003|Overall Study|Withdrawal by Subject|0|||
157165302|NCT00592553|567346102|FG000|Overall Study|Protocol Noncompliance|1|||
157165303|NCT00592553|567346103|FG001|Overall Study|Protocol Noncompliance|0|||
157165304|NCT00592553|567346104|FG002|Overall Study|Protocol Noncompliance|0|||
157165305|NCT02773238|567346107|FG000|Overall Study|Lack of Efficacy|4|||
157165306|NCT01208038|567346108|FG000|Overall Study|Withdrawal by Subject|1|||
157165307|NCT03260205|567346113|FG000|Overall Study|Adverse Event|2|||
157165308|NCT03260205|567346114|FG001|Overall Study|Adverse Event|0|||
157165309|NCT03260205|567346115|FG002|Overall Study|Adverse Event|2|||
157227027|NCT01048333|567576023|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
156924757|NCT01349803|566483525|FG000|Overall Study|Protocol-specified criteria|0|||
156924758|NCT01349803|566483526|FG001|Overall Study|Protocol-specified criteria|1|||
156977495|NCT02223754|566670721|FG000|Period 1|Protocol Violation|2|||
156977496|NCT02223754|566670722|FG001|Period 1|Protocol Violation|4|||
156977497|NCT02223754|566670721|FG000|Period 1|Withdrawal by Subject|0|||
156924759|NCT01349803|566483527|FG002|Overall Study|Protocol-specified criteria|3|||
156924760|NCT01349803|566483528|FG003|Overall Study|Protocol-specified criteria|0|||
156924761|NCT00605813|566483530|FG000|Overall Study|Protocol Violation|25|||
156924762|NCT00665353|566483535|FG000|Study Step 1|Adverse Event|1|||
156924763|NCT00665353|566483535|FG000|Study Step 1|Withdrawal by Subject|2|||
156924764|NCT00665353|566483535|FG000|Study Step 2|Lost to Follow-up|2|||
156924765|NCT00665353|566483535|FG000|Study Step 2|Lack of Efficacy|12|||
156924766|NCT00573755|566483536|FG000|Overall Study|Still receiving treatment|1|||
156924767|NCT00573755|566483537|FG001|Overall Study|Still receiving treatment|0|||
156924768|NCT03724812|566483538|FG000|Overall Study|Missed Visit|1|||
156924769|NCT03724812|566483538|FG000|Overall Study|Death|2|||
156924770|NCT03724812|566483538|FG000|Overall Study|Withdrawal by Subject|1|||
156924771|NCT01851720|566483539|FG000|Overall Study|Lost to Follow-up|0|||
156924772|NCT01851720|566483540|FG001|Overall Study|Lost to Follow-up|1|||
156924773|NCT01770379|566483545|FG000|Overall Study|Technical issues|1|||
156924774|NCT01770379|566483546|FG001|Overall Study|Technical issues|0|||
156924775|NCT01770379|566483547|FG002|Overall Study|Technical issues|0|||
156924776|NCT01770379|566483545|FG000|Overall Study|Withdrawal by Subject|7|||
156924777|NCT01770379|566483546|FG001|Overall Study|Withdrawal by Subject|10|||
156924778|NCT01770379|566483547|FG002|Overall Study|Withdrawal by Subject|7|||
156924779|NCT01770379|566483545|FG000|Overall Study|study terminated by sponsor|22|||
156924780|NCT01770379|566483546|FG001|Overall Study|study terminated by sponsor|23|||
156924781|NCT01770379|566483547|FG002|Overall Study|study terminated by sponsor|22|||
156924782|NCT01770379|566483545|FG000|Overall Study|Protocol Violation|0|||
156924783|NCT01770379|566483546|FG001|Overall Study|Protocol Violation|1|||
156924784|NCT01770379|566483547|FG002|Overall Study|Protocol Violation|1|||
156924785|NCT01770379|566483545|FG000|Overall Study|Physician Decision|0|||
156924786|NCT01770379|566483546|FG001|Overall Study|Physician Decision|1|||
156924787|NCT01770379|566483547|FG002|Overall Study|Physician Decision|2|||
156924788|NCT01770379|566483545|FG000|Overall Study|Lost to Follow-up|0|||
156924789|NCT01770379|566483546|FG001|Overall Study|Lost to Follow-up|0|||
156924790|NCT01770379|566483547|FG002|Overall Study|Lost to Follow-up|2|||
156924791|NCT01770379|566483545|FG000|Overall Study|Lack of Efficacy|8|||
156924792|NCT01770379|566483546|FG001|Overall Study|Lack of Efficacy|6|||
156924793|NCT01770379|566483547|FG002|Overall Study|Lack of Efficacy|6|||
156924794|NCT01770379|566483545|FG000|Overall Study|Adverse Event|1|||
156924795|NCT01770379|566483546|FG001|Overall Study|Adverse Event|3|||
156924796|NCT01770379|566483547|FG002|Overall Study|Adverse Event|2|||
156924797|NCT01291173|566483548|FG000|Overall Study|Adverse Event|0|||
156924798|NCT01291173|566483549|FG001|Overall Study|Adverse Event|3|||
156924799|NCT01291173|566483550|FG002|Overall Study|Adverse Event|1|||
156924800|NCT01291173|566483551|FG003|Overall Study|Adverse Event|3|||
156924801|NCT01291173|566483548|FG000|Overall Study|Protocol Violation|7|||
156924802|NCT01291173|566483549|FG001|Overall Study|Protocol Violation|2|||
156924803|NCT01291173|566483550|FG002|Overall Study|Protocol Violation|2|||
156924804|NCT01291173|566483551|FG003|Overall Study|Protocol Violation|5|||
156924805|NCT01291173|566483548|FG000|Overall Study|Withdrawal by Subject|6|||
156924806|NCT01291173|566483549|FG001|Overall Study|Withdrawal by Subject|4|||
156924807|NCT01291173|566483550|FG002|Overall Study|Withdrawal by Subject|4|||
156924808|NCT01291173|566483551|FG003|Overall Study|Withdrawal by Subject|2|||
156924809|NCT01291173|566483548|FG000|Overall Study|Lost to Follow-up|4|||
156924810|NCT01291173|566483549|FG001|Overall Study|Lost to Follow-up|6|||
156924811|NCT01291173|566483550|FG002|Overall Study|Lost to Follow-up|3|||
156924812|NCT01291173|566483551|FG003|Overall Study|Lost to Follow-up|2|||
156924813|NCT01291173|566483548|FG000|Overall Study|Unable to meet visit schedule|0|||
156924814|NCT01291173|566483549|FG001|Overall Study|Unable to meet visit schedule|0|||
156924815|NCT01291173|566483550|FG002|Overall Study|Unable to meet visit schedule|1|||
156924816|NCT01291173|566483551|FG003|Overall Study|Unable to meet visit schedule|0|||
156924817|NCT01291173|566483548|FG000|Overall Study|Lack of compliance|0|||
156924818|NCT01291173|566483549|FG001|Overall Study|Lack of compliance|0|||
156924819|NCT01291173|566483550|FG002|Overall Study|Lack of compliance|0|||
156924820|NCT01291173|566483551|FG003|Overall Study|Lack of compliance|1|||
156924821|NCT01291173|566483548|FG000|Overall Study|Subject was unblinded|0|||
156924822|NCT01291173|566483549|FG001|Overall Study|Subject was unblinded|0|||
156924823|NCT01291173|566483550|FG002|Overall Study|Subject was unblinded|1|||
156924824|NCT01291173|566483551|FG003|Overall Study|Subject was unblinded|0|||
156924825|NCT01291173|566483548|FG000|Overall Study|Excluded therapy|0|||
156924826|NCT01291173|566483549|FG001|Overall Study|Excluded therapy|0|||
156924827|NCT01291173|566483550|FG002|Overall Study|Excluded therapy|1|||
156924828|NCT01291173|566483551|FG003|Overall Study|Excluded therapy|0|||
156924829|NCT00937157|566483552|FG000|Overall Study|Pregnancy|1|||
156924830|NCT00937157|566483552|FG000|Overall Study|Lost to Follow-up|3|||
156924831|NCT02865187|566483553|FG000|Overall Study|Lost to Follow-up|12|||
156924832|NCT02865187|566483554|FG001|Overall Study|Lost to Follow-up|7|||
156924833|NCT02865187|566483553|FG000|Overall Study|Adverse Event|1|||
156924834|NCT02865187|566483554|FG001|Overall Study|Adverse Event|0|||
156924835|NCT04267133|566483555|FG000|Overall Study|Withdrawal by Subject|1|||
156924836|NCT04267133|566483555|FG000|Overall Study|Adverse Event|4|||
156924837|NCT04008030|566483559|FG000|Pre-Treatment|Withdrawal by Subject|0|||
156924838|NCT04008030|566483560|FG001|Pre-Treatment|Withdrawal by Subject|0|||
156924839|NCT04008030|566483561|FG002|Pre-Treatment|Withdrawal by Subject|9|||
156924840|NCT04008030|566483559|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
156924841|NCT04008030|566483560|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
156924842|NCT04008030|566483561|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
156924843|NCT04008030|566483559|FG000|Pre-Treatment|Other reasons|0|||
156924844|NCT04008030|566483560|FG001|Pre-Treatment|Other reasons|1|||
156924845|NCT04008030|566483561|FG002|Pre-Treatment|Other reasons|6|||
156924846|NCT04008030|566483559|FG000|Treatment|Withdrawal by Subject|1|||
156924847|NCT04008030|566483560|FG001|Treatment|Withdrawal by Subject|1|||
156924848|NCT04008030|566483561|FG002|Treatment|Withdrawal by Subject|1|||
156924849|NCT04008030|566483559|FG000|Treatment|Death|2|||
156924850|NCT04008030|566483560|FG001|Treatment|Death|4|||
156924851|NCT04008030|566483561|FG002|Treatment|Death|0|||
156924852|NCT04008030|566483559|FG000|Treatment|Pregnancy|0|||
156924853|NCT04008030|566483560|FG001|Treatment|Pregnancy|1|||
156924854|NCT04008030|566483561|FG002|Treatment|Pregnancy|0|||
156924855|NCT04008030|566483559|FG000|Treatment|Participant no longer meets study criteria|0|||
156924856|NCT04008030|566483560|FG001|Treatment|Participant no longer meets study criteria|1|||
156924857|NCT04008030|566483561|FG002|Treatment|Participant no longer meets study criteria|0|||
156924858|NCT04008030|566483559|FG000|Treatment|Other reasons|5|||
156924859|NCT04008030|566483560|FG001|Treatment|Other reasons|13|||
156924860|NCT04008030|566483561|FG002|Treatment|Other reasons|6|||
156924861|NCT04008030|566483559|FG000|Treatment|Disease Progression|137|||
156924862|NCT04008030|566483560|FG001|Treatment|Disease Progression|82|||
156924863|NCT04008030|566483561|FG002|Treatment|Disease Progression|85|||
156924864|NCT04008030|566483559|FG000|Treatment|Study drug toxicity|28|||
156924865|NCT04008030|566483560|FG001|Treatment|Study drug toxicity|48|||
156924866|NCT04008030|566483561|FG002|Treatment|Study drug toxicity|8|||
156924867|NCT04008030|566483559|FG000|Treatment|Adverse Event unrelated to study drug|28|||
156924868|NCT04008030|566483560|FG001|Treatment|Adverse Event unrelated to study drug|22|||
156924869|NCT04008030|566483561|FG002|Treatment|Adverse Event unrelated to study drug|6|||
156924870|NCT04008030|566483559|FG000|Treatment|Maximum Clinical Benefit|0|||
156924871|NCT04008030|566483560|FG001|Treatment|Maximum Clinical Benefit|1|||
156924872|NCT04008030|566483561|FG002|Treatment|Maximum Clinical Benefit|9|||
156924873|NCT04008030|566483559|FG000|Treatment|On-going treatment|13|||
156924874|NCT04008030|566483560|FG001|Treatment|On-going treatment|20|||
156924875|NCT04008030|566483561|FG002|Treatment|On-going treatment|0|||
156924876|NCT00674661|566483562|FG000|Overall Study|Other|5|||
156924877|NCT00674661|566483563|FG001|Overall Study|Other|7|||
156924878|NCT00674661|566483562|FG000|Overall Study|Lost to Follow-up|6|||
156924879|NCT00674661|566483563|FG001|Overall Study|Lost to Follow-up|3|||
156924880|NCT00674661|566483562|FG000|Overall Study|Withdrawal by Subject|0|||
156924881|NCT00674661|566483563|FG001|Overall Study|Withdrawal by Subject|5|||
156924882|NCT02574247|566483566|FG000|Overall Study|Withdrawal by Subject|1|||
156924883|NCT02574247|566483567|FG001|Overall Study|Withdrawal by Subject|0|||
156924884|NCT02574247|566483568|FG002|Overall Study|Withdrawal by Subject|0|||
156924885|NCT02574247|566483566|FG000|Overall Study|Did not meet inclusion criteria|4|||
156924886|NCT02574247|566483567|FG001|Overall Study|Did not meet inclusion criteria|3|||
156924887|NCT02574247|566483568|FG002|Overall Study|Did not meet inclusion criteria|5|||
156924888|NCT02659631|566483572|FG000|Overall Study|Lost to Follow-up|0|||
156924889|NCT02659631|566483573|FG001|Overall Study|Lost to Follow-up|0|||
156924890|NCT02659631|566483574|FG002|Overall Study|Lost to Follow-up|2|||
156924891|NCT02659631|566483575|FG003|Overall Study|Lost to Follow-up|0|||
156924892|NCT02659631|566483576|FG004|Overall Study|Lost to Follow-up|0|||
156924893|NCT02659631|566483577|FG005|Overall Study|Lost to Follow-up|1|||
156924894|NCT02659631|566483578|FG006|Overall Study|Lost to Follow-up|0|||
156924895|NCT02659631|566483579|FG007|Overall Study|Lost to Follow-up|0|||
156924896|NCT02659631|566483580|FG008|Overall Study|Lost to Follow-up|0|||
156924897|NCT02659631|566483581|FG009|Overall Study|Lost to Follow-up|0|||
156924898|NCT02659631|566483572|FG000|Overall Study|Withdrawal prior to treatment|0|||
156924899|NCT02659631|566483573|FG001|Overall Study|Withdrawal prior to treatment|0|||
156924900|NCT02659631|566483574|FG002|Overall Study|Withdrawal prior to treatment|0|||
156924901|NCT02659631|566483575|FG003|Overall Study|Withdrawal prior to treatment|0|||
156924902|NCT02659631|566483576|FG004|Overall Study|Withdrawal prior to treatment|1|||
156924903|NCT02659631|566483577|FG005|Overall Study|Withdrawal prior to treatment|0|||
156924904|NCT02659631|566483578|FG006|Overall Study|Withdrawal prior to treatment|0|||
156924905|NCT02659631|566483579|FG007|Overall Study|Withdrawal prior to treatment|0|||
156924906|NCT02659631|566483580|FG008|Overall Study|Withdrawal prior to treatment|0|||
156924907|NCT02659631|566483581|FG009|Overall Study|Withdrawal prior to treatment|0|||
156924908|NCT02659631|566483572|FG000|Overall Study|Participant refused further follow-up|0|||
156924909|NCT02659631|566483573|FG001|Overall Study|Participant refused further follow-up|0|||
156924910|NCT02659631|566483574|FG002|Overall Study|Participant refused further follow-up|0|||
156924911|NCT02659631|566483575|FG003|Overall Study|Participant refused further follow-up|1|||
156924912|NCT02659631|566483576|FG004|Overall Study|Participant refused further follow-up|0|||
156924913|NCT02659631|566483577|FG005|Overall Study|Participant refused further follow-up|0|||
156924914|NCT02659631|566483578|FG006|Overall Study|Participant refused further follow-up|0|||
156924915|NCT02659631|566483579|FG007|Overall Study|Participant refused further follow-up|0|||
156924916|NCT02659631|566483580|FG008|Overall Study|Participant refused further follow-up|1|||
156924917|NCT02659631|566483581|FG009|Overall Study|Participant refused further follow-up|0|||
156924918|NCT02659631|566483572|FG000|Overall Study|Death (follow-up phase)|1|||
156924919|NCT02659631|566483573|FG001|Overall Study|Death (follow-up phase)|2|||
156924920|NCT02659631|566483574|FG002|Overall Study|Death (follow-up phase)|1|||
156924921|NCT02659631|566483575|FG003|Overall Study|Death (follow-up phase)|1|||
156924922|NCT02659631|566483576|FG004|Overall Study|Death (follow-up phase)|3|||
156924923|NCT02659631|566483577|FG005|Overall Study|Death (follow-up phase)|2|||
156924924|NCT02659631|566483578|FG006|Overall Study|Death (follow-up phase)|0|||
156924925|NCT02659631|566483579|FG007|Overall Study|Death (follow-up phase)|3|||
156924926|NCT02659631|566483580|FG008|Overall Study|Death (follow-up phase)|1|||
156924927|NCT02659631|566483581|FG009|Overall Study|Death (follow-up phase)|0|||
156924928|NCT02659631|566483572|FG000|Overall Study|Death (treatment phase)|0|||
156924929|NCT02659631|566483573|FG001|Overall Study|Death (treatment phase)|0|||
156924930|NCT02659631|566483574|FG002|Overall Study|Death (treatment phase)|0|||
156924931|NCT02659631|566483575|FG003|Overall Study|Death (treatment phase)|0|||
156924932|NCT02659631|566483576|FG004|Overall Study|Death (treatment phase)|1|||
156924933|NCT02659631|566483577|FG005|Overall Study|Death (treatment phase)|0|||
156924934|NCT02659631|566483578|FG006|Overall Study|Death (treatment phase)|1|||
156924935|NCT02659631|566483579|FG007|Overall Study|Death (treatment phase)|0|||
156924936|NCT02659631|566483580|FG008|Overall Study|Death (treatment phase)|0|||
156924937|NCT02659631|566483581|FG009|Overall Study|Death (treatment phase)|0|||
156924938|NCT02377466|566483582|FG000|Overall Study|Other: Randomized and not treated|0|||
156924939|NCT02377466|566483583|FG001|Overall Study|Other: Randomized and not treated|2|||
156924940|NCT00857220|566483584|FG000|Overall Study|Adverse Event|35|||
156924941|NCT00857220|566483584|FG000|Overall Study|Death|1|||
156924942|NCT00857220|566483584|FG000|Overall Study|Lack of Efficacy|11|||
156924943|NCT00857220|566483584|FG000|Overall Study|Lost to Follow-up|30|||
156924944|NCT00857220|566483584|FG000|Overall Study|Physician Decision|4|||
156924945|NCT00857220|566483584|FG000|Overall Study|Protocol Violation|16|||
156924946|NCT00857220|566483584|FG000|Overall Study|Withdrawal by Subject|67|||
156924947|NCT00857220|566483584|FG000|Overall Study|Clinical Hold|6|||
156924948|NCT00857220|566483584|FG000|Overall Study|Site Closed|5|||
156924949|NCT00857220|566483584|FG000|Overall Study|Miscellaneous|8|||
156924950|NCT02612428|566483585|FG000|VTL-308|Death|14|||
156924951|NCT02612428|566483586|FG001|VTL-308|Death|16|||
156924952|NCT02612428|566483585|FG000|VTL-308|Withdrawal by Subject|0|||
156924953|NCT02612428|566483586|FG001|VTL-308|Withdrawal by Subject|1|||
156924954|NCT02612428|566483585|FG000|VTL-308E|Death|9|||
156924955|NCT02612428|566483586|FG001|VTL-308E|Death|7|||
156924956|NCT02612428|566483585|FG000|VTL-308E|Lost to Follow-up|2|||
156924957|NCT02612428|566483586|FG001|VTL-308E|Lost to Follow-up|0|||
156924958|NCT00742001|566483589|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
156924959|NCT00742001|566483590|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
156924960|NCT00742001|566483591|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
156924961|NCT00137423|566483592|FG000|Overall Study|Adverse Event|7|||
156924962|NCT00137423|566483593|FG001|Overall Study|Adverse Event|9|||
156924963|NCT00137423|566483592|FG000|Overall Study|consent withdrawn|1|||
156924964|NCT00137423|566483593|FG001|Overall Study|consent withdrawn|1|||
156924965|NCT00137423|566483592|FG000|Overall Study|Lack of Efficacy|31|||
156924966|NCT00137423|566483593|FG001|Overall Study|Lack of Efficacy|33|||
156924967|NCT00137423|566483592|FG000|Overall Study|Death|0|||
156924968|NCT00137423|566483593|FG001|Overall Study|Death|1|||
156924969|NCT03187262|566483595|FG000|Induction|Lack of Efficacy|2|||
156924970|NCT03187262|566483595|FG000|Induction|Progressive Disease|4|||
156924971|NCT03187262|566483595|FG000|Consolidation|Progressive Disease|5|||
156924972|NCT01496313|566483596|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
156924973|NCT01496313|566483597|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
156924974|NCT01496313|566483598|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
156924975|NCT01496313|566483599|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
156924976|NCT01496313|566483600|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
156924977|NCT01496313|566483601|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
157227028|NCT01048333|567576024|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156924978|NCT01496313|566483596|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
156924979|NCT01496313|566483597|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
156924980|NCT01496313|566483598|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156924981|NCT01496313|566483599|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156924982|NCT01496313|566483600|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156924983|NCT01496313|566483601|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
156924984|NCT01496313|566483596|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
157227029|NCT01048333|567576025|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
157227030|NCT01048333|567576026|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
156924985|NCT01496313|566483597|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
156924986|NCT01496313|566483598|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156924987|NCT01496313|566483599|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156924988|NCT01496313|566483600|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156924989|NCT01496313|566483601|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
156924990|NCT01496313|566483596|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
156924991|NCT01496313|566483597|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
156924992|NCT01496313|566483598|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
156924993|NCT01496313|566483599|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
156924994|NCT01496313|566483600|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
156924995|NCT01496313|566483601|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
156924996|NCT01496313|566483596|FG000|Randomized Period (up to 14 Months)|Other|1|||
156924997|NCT01496313|566483597|FG001|Randomized Period (up to 14 Months)|Other|2|||
156924998|NCT01496313|566483598|FG002|Randomized Period (up to 14 Months)|Other|0|||
156924999|NCT01496313|566483599|FG003|Randomized Period (up to 14 Months)|Other|0|||
156925000|NCT01496313|566483600|FG004|Randomized Period (up to 14 Months)|Other|0|||
156925001|NCT01496313|566483601|FG005|Randomized Period (up to 14 Months)|Other|0|||
156925002|NCT01496313|566483596|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156925003|NCT01496313|566483597|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156925004|NCT01496313|566483598|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156925005|NCT01496313|566483599|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156925006|NCT01496313|566483600|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
156925007|NCT01496313|566483601|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
156925008|NCT01496313|566483596|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156925009|NCT01496313|566483597|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156925010|NCT01496313|566483598|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156925011|NCT01496313|566483599|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156925012|NCT01496313|566483600|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
156925013|NCT01496313|566483601|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
156925014|NCT01496313|566483596|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
156925015|NCT01496313|566483597|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
156925016|NCT01496313|566483598|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
156925017|NCT01496313|566483599|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
156925018|NCT01496313|566483600|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
156925019|NCT01496313|566483601|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
156925020|NCT00451321|566483606|FG000|Overall Study|Lost to Follow-up|3|||
156925021|NCT00451321|566483607|FG001|Overall Study|Lost to Follow-up|3|||
156925022|NCT00451321|566483608|FG002|Overall Study|Lost to Follow-up|1|||
156925023|NCT00451321|566483609|FG003|Overall Study|Lost to Follow-up|3|||
156925024|NCT00451321|566483610|FG004|Overall Study|Lost to Follow-up|0|||
156925025|NCT00451321|566483611|FG005|Overall Study|Lost to Follow-up|1|||
156925026|NCT00451321|566483612|FG006|Overall Study|Lost to Follow-up|0|||
156925027|NCT00451321|566483613|FG007|Overall Study|Lost to Follow-up|0|||
156925028|NCT00451321|566483606|FG000|Overall Study|Withdrawal by Subject|3|||
156925029|NCT00451321|566483607|FG001|Overall Study|Withdrawal by Subject|1|||
156925030|NCT00451321|566483608|FG002|Overall Study|Withdrawal by Subject|0|||
156925031|NCT00451321|566483609|FG003|Overall Study|Withdrawal by Subject|4|||
156925032|NCT00451321|566483610|FG004|Overall Study|Withdrawal by Subject|0|||
156925033|NCT00451321|566483611|FG005|Overall Study|Withdrawal by Subject|0|||
156925034|NCT00451321|566483612|FG006|Overall Study|Withdrawal by Subject|0|||
156925035|NCT00451321|566483613|FG007|Overall Study|Withdrawal by Subject|0|||
156925036|NCT00451321|566483606|FG000|Overall Study|Study closed/terminated|1|||
156925037|NCT00451321|566483607|FG001|Overall Study|Study closed/terminated|1|||
156925038|NCT00451321|566483608|FG002|Overall Study|Study closed/terminated|17|||
156925039|NCT00451321|566483609|FG003|Overall Study|Study closed/terminated|5|||
156925040|NCT00451321|566483610|FG004|Overall Study|Study closed/terminated|7|||
156925041|NCT00451321|566483611|FG005|Overall Study|Study closed/terminated|7|||
156925042|NCT00451321|566483612|FG006|Overall Study|Study closed/terminated|5|||
156925043|NCT00451321|566483613|FG007|Overall Study|Study closed/terminated|3|||
156925044|NCT00451321|566483606|FG000|Overall Study|Sponsor decision to amend protocol|0|||
157165310|NCT03260205|567346116|FG003|Overall Study|Adverse Event|2|||
157165311|NCT03260205|567346117|FG004|Overall Study|Adverse Event|4|||
157165312|NCT03260205|567346113|FG000|Overall Study|Lost to Follow-up|2|||
156925045|NCT00451321|566483607|FG001|Overall Study|Sponsor decision to amend protocol|0|||
156925046|NCT00451321|566483608|FG002|Overall Study|Sponsor decision to amend protocol|0|||
156925047|NCT00451321|566483609|FG003|Overall Study|Sponsor decision to amend protocol|0|||
156925048|NCT00451321|566483610|FG004|Overall Study|Sponsor decision to amend protocol|0|||
156925049|NCT00451321|566483611|FG005|Overall Study|Sponsor decision to amend protocol|1|||
157165313|NCT03260205|567346114|FG001|Overall Study|Lost to Follow-up|2|||
156925050|NCT00451321|566483612|FG006|Overall Study|Sponsor decision to amend protocol|1|||
156925051|NCT00451321|566483613|FG007|Overall Study|Sponsor decision to amend protocol|3|||
156925052|NCT00383149|566483616|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
156925053|NCT00383149|566483616|FG000|Overall Study|Death|2|||
156925054|NCT00383149|566483616|FG000|Overall Study|Disease Progression|38|||
156925055|NCT00383149|566483616|FG000|Overall Study|Lost to Follow-up|1|||
156925056|NCT00383149|566483616|FG000|Overall Study|Other|1|||
156925057|NCT00383149|566483616|FG000|Overall Study|Study Drug Toxicity|4|||
156925058|NCT00383149|566483616|FG000|Overall Study|Request to Discontinue Treatment|4|||
156925059|NCT00383149|566483616|FG000|Overall Study|Participant Withdrew Consent|1|||
156925060|NCT03721276|566483617|FG000|Overall Study|Lost to Follow-up|5|||
156925061|NCT03721276|566483618|FG001|Overall Study|Lost to Follow-up|3|||
156925062|NCT03721276|566483617|FG000|Overall Study|Adverse Event|0|||
156925063|NCT03721276|566483618|FG001|Overall Study|Adverse Event|1|||
156925064|NCT01340898|566483621|FG000|Primary Phase|Serious Adverse Events|0|||
156925065|NCT01340898|566483622|FG001|Primary Phase|Serious Adverse Events|0|||
156925066|NCT01340898|566483623|FG002|Primary Phase|Serious Adverse Events|1|||
156925067|NCT01340898|566483621|FG000|Primary Phase|Withdrawal by Subject|8|||
156925068|NCT01340898|566483622|FG001|Primary Phase|Withdrawal by Subject|7|||
156925069|NCT01340898|566483623|FG002|Primary Phase|Withdrawal by Subject|5|||
156925070|NCT01340898|566483621|FG000|Primary Phase|Migrated/moved from study area|4|||
156925071|NCT01340898|566483622|FG001|Primary Phase|Migrated/moved from study area|1|||
156925072|NCT01340898|566483623|FG002|Primary Phase|Migrated/moved from study area|0|||
156925073|NCT01340898|566483621|FG000|Primary Phase|Lost to Follow-up|4|||
156925074|NCT01340898|566483622|FG001|Primary Phase|Lost to Follow-up|1|||
156925075|NCT01340898|566483623|FG002|Primary Phase|Lost to Follow-up|0|||
156925076|NCT01340898|566483621|FG000|Booster Phase|Withdrawal by Subject|3|||
156925077|NCT01340898|566483622|FG001|Booster Phase|Withdrawal by Subject|0|||
156925078|NCT01340898|566483623|FG002|Booster Phase|Withdrawal by Subject|4|||
156925079|NCT01340898|566483621|FG000|Booster Phase|Migrated/moved from study area|3|||
156925080|NCT01340898|566483622|FG001|Booster Phase|Migrated/moved from study area|0|||
156925081|NCT01340898|566483623|FG002|Booster Phase|Migrated/moved from study area|0|||
156925082|NCT01340898|566483621|FG000|Booster Phase|Lost to Follow-up|4|||
156925083|NCT01340898|566483622|FG001|Booster Phase|Lost to Follow-up|2|||
156925084|NCT01340898|566483623|FG002|Booster Phase|Lost to Follow-up|3|||
156925085|NCT00416078|566483628|FG000|Overall Study|Death|3|||
156925086|NCT00416078|566483629|FG001|Overall Study|Death|4|||
156925087|NCT00416078|566483628|FG000|Overall Study|Withdrawal by Subject|3|||
156925088|NCT00416078|566483629|FG001|Overall Study|Withdrawal by Subject|2|||
156925089|NCT00416078|566483628|FG000|Overall Study|Physician Decision|1|||
156925090|NCT00416078|566483629|FG001|Overall Study|Physician Decision|0|||
156925091|NCT00416078|566483628|FG000|Overall Study|Lost to Follow-up|4|||
156925092|NCT00416078|566483629|FG001|Overall Study|Lost to Follow-up|2|||
156925093|NCT00969150|566483634|FG000|Overall Study|Adverse Event|4|||
156925094|NCT00969150|566483635|FG001|Overall Study|Adverse Event|14|||
156925095|NCT00969150|566483634|FG000|Overall Study|Lack of Efficacy|1|||
156925096|NCT00969150|566483635|FG001|Overall Study|Lack of Efficacy|1|||
156925097|NCT00969150|566483634|FG000|Overall Study|Protocol Violation|9|||
156925098|NCT00969150|566483635|FG001|Overall Study|Protocol Violation|12|||
156925099|NCT00969150|566483634|FG000|Overall Study|Withdrawal by Subject|13|||
156925100|NCT00969150|566483635|FG001|Overall Study|Withdrawal by Subject|9|||
156925101|NCT00969150|566483634|FG000|Overall Study|Lost to Follow-up|5|||
156925102|NCT00969150|566483635|FG001|Overall Study|Lost to Follow-up|4|||
156925103|NCT00969150|566483634|FG000|Overall Study|Other reasons|1|||
156925104|NCT00969150|566483635|FG001|Overall Study|Other reasons|0|||
156925105|NCT03605303|566483638|FG000|Period 1|Study Terminated|2|||
156925106|NCT03605303|566483639|FG001|Period 1|Study Terminated|1|||
156925107|NCT01026792|566483640|FG000|Overall Study|Protocol Violation|1|||
156925108|NCT00309842|566483641|FG000|Overall Study|Lost to Follow-up|1|||
156925109|NCT01472081|566483648|FG000|Overall Study|Continuing treatment at time of analysis|1|||
156925110|NCT01472081|566483649|FG001|Overall Study|Continuing treatment at time of analysis|4|||
156925111|NCT01472081|566483650|FG002|Overall Study|Continuing treatment at time of analysis|1|||
156925112|NCT01472081|566483651|FG003|Overall Study|Continuing treatment at time of analysis|8|||
156925113|NCT01472081|566483652|FG004|Overall Study|Continuing treatment at time of analysis|9|||
156925114|NCT01472081|566483653|FG005|Overall Study|Continuing treatment at time of analysis|0|||
156925115|NCT01472081|566483648|FG000|Overall Study|Disease Progression|4|||
156925116|NCT01472081|566483649|FG001|Overall Study|Disease Progression|10|||
156925117|NCT01472081|566483650|FG002|Overall Study|Disease Progression|12|||
157165314|NCT03260205|567346115|FG002|Overall Study|Lost to Follow-up|1|||
156925118|NCT01472081|566483651|FG003|Overall Study|Disease Progression|31|||
156925119|NCT01472081|566483652|FG004|Overall Study|Disease Progression|22|||
156925120|NCT01472081|566483653|FG005|Overall Study|Disease Progression|3|||
156925121|NCT01472081|566483648|FG000|Overall Study|Study drug toxicity|2|||
156925122|NCT01472081|566483649|FG001|Overall Study|Study drug toxicity|9|||
156925123|NCT01472081|566483650|FG002|Overall Study|Study drug toxicity|4|||
156925124|NCT01472081|566483651|FG003|Overall Study|Study drug toxicity|6|||
156925125|NCT01472081|566483652|FG004|Overall Study|Study drug toxicity|13|||
156925126|NCT01472081|566483653|FG005|Overall Study|Study drug toxicity|2|||
156925127|NCT01472081|566483648|FG000|Overall Study|Death|0|||
156925128|NCT01472081|566483649|FG001|Overall Study|Death|0|||
156925129|NCT01472081|566483650|FG002|Overall Study|Death|0|||
156925130|NCT01472081|566483651|FG003|Overall Study|Death|0|||
156925131|NCT01472081|566483652|FG004|Overall Study|Death|1|||
156925132|NCT01472081|566483653|FG005|Overall Study|Death|0|||
156925133|NCT01472081|566483648|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156925134|NCT01472081|566483649|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156925135|NCT01472081|566483650|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156925136|NCT01472081|566483651|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
156925137|NCT01472081|566483652|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
156925138|NCT01472081|566483653|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
156925139|NCT01472081|566483648|FG000|Overall Study|Withdrawal by Subject|0|||
156925140|NCT01472081|566483649|FG001|Overall Study|Withdrawal by Subject|0|||
156925141|NCT01472081|566483650|FG002|Overall Study|Withdrawal by Subject|0|||
156925142|NCT01472081|566483651|FG003|Overall Study|Withdrawal by Subject|0|||
156925143|NCT01472081|566483652|FG004|Overall Study|Withdrawal by Subject|0|||
156925144|NCT01472081|566483653|FG005|Overall Study|Withdrawal by Subject|1|||
156925145|NCT01472081|566483648|FG000|Overall Study|Poor/non-compliance|0|||
156925146|NCT01472081|566483649|FG001|Overall Study|Poor/non-compliance|0|||
156925147|NCT01472081|566483650|FG002|Overall Study|Poor/non-compliance|1|||
156925148|NCT01472081|566483651|FG003|Overall Study|Poor/non-compliance|0|||
156925149|NCT01472081|566483652|FG004|Overall Study|Poor/non-compliance|1|||
156925150|NCT01472081|566483653|FG005|Overall Study|Poor/non-compliance|0|||
156925151|NCT01472081|566483648|FG000|Overall Study|No longer meets study criteria|0|||
156925152|NCT01472081|566483649|FG001|Overall Study|No longer meets study criteria|0|||
156925153|NCT01472081|566483650|FG002|Overall Study|No longer meets study criteria|1|||
156925154|NCT01472081|566483651|FG003|Overall Study|No longer meets study criteria|0|||
156925155|NCT01472081|566483652|FG004|Overall Study|No longer meets study criteria|0|||
156925156|NCT01472081|566483653|FG005|Overall Study|No longer meets study criteria|0|||
156925157|NCT01472081|566483648|FG000|Overall Study|Subject request to discontinue treatment|0|||
156925158|NCT01472081|566483649|FG001|Overall Study|Subject request to discontinue treatment|3|||
156925159|NCT01472081|566483650|FG002|Overall Study|Subject request to discontinue treatment|1|||
156925160|NCT01472081|566483651|FG003|Overall Study|Subject request to discontinue treatment|1|||
156925161|NCT01472081|566483652|FG004|Overall Study|Subject request to discontinue treatment|0|||
156925162|NCT01472081|566483653|FG005|Overall Study|Subject request to discontinue treatment|0|||
156925163|NCT04702997|566483654|FG000|Overall Study|Withdrawal by Subject|1|||
156925164|NCT04702997|566483655|FG001|Overall Study|Withdrawal by Subject|1|||
156925165|NCT01386554|566483658|FG000|Overall Study|Lost to Follow-up|0|||
156925166|NCT01386554|566483659|FG001|Overall Study|Lost to Follow-up|0|||
156925167|NCT01386554|566483660|FG002|Overall Study|Lost to Follow-up|1|||
156925168|NCT01386554|566483658|FG000|Overall Study|Adverse Event|2|||
156925169|NCT01386554|566483659|FG001|Overall Study|Adverse Event|5|||
156925170|NCT01386554|566483660|FG002|Overall Study|Adverse Event|2|||
156925171|NCT01386554|566483658|FG000|Overall Study|Progressive disease|1|||
156925172|NCT01386554|566483659|FG001|Overall Study|Progressive disease|2|||
156925173|NCT01386554|566483660|FG002|Overall Study|Progressive disease|2|||
156925174|NCT01386554|566483658|FG000|Overall Study|Administration of live vaccines|0|||
156925175|NCT01386554|566483659|FG001|Overall Study|Administration of live vaccines|1|||
156925176|NCT01386554|566483660|FG002|Overall Study|Administration of live vaccines|0|||
156925177|NCT01386554|566483658|FG000|Overall Study|Investigator discretion|0|||
156925178|NCT01386554|566483659|FG001|Overall Study|Investigator discretion|0|||
156925179|NCT01386554|566483660|FG002|Overall Study|Investigator discretion|1|||
157028846|NCT04005794|566862812|FG000|Overall Study|Lost to Follow-up|0|||
157028847|NCT04005794|566862813|FG001|Overall Study|Lost to Follow-up|4|||
157165315|NCT03260205|567346116|FG003|Overall Study|Lost to Follow-up|1|||
156925180|NCT01386554|566483658|FG000|Overall Study|Reason not collected|0|||
156925181|NCT01386554|566483659|FG001|Overall Study|Reason not collected|1|||
156925182|NCT01386554|566483660|FG002|Overall Study|Reason not collected|0|||
156925183|NCT00353262|566483661|FG000|Overall Study|Adverse Event|8|||
156925184|NCT00353262|566483661|FG000|Overall Study|Withdrawal by Subject|2|||
156925185|NCT00353262|566483661|FG000|Overall Study|Insufficient Therapeutic Response|13|||
156925186|NCT00353262|566483661|FG000|Overall Study|Progression|1|||
156925187|NCT00353262|566483661|FG000|Overall Study|Surgery|4|||
156925188|NCT00353262|566483661|FG000|Overall Study|Break from Chemotherapy|1|||
156925189|NCT04166513|566483662|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
156925190|NCT04166513|566483663|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
156925191|NCT04166513|566483664|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
156925192|NCT04166513|566483665|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
156925193|NCT04166513|566483662|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
156925194|NCT04166513|566483663|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
156925195|NCT04166513|566483664|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
157165316|NCT03260205|567346117|FG004|Overall Study|Lost to Follow-up|5|||
157165317|NCT03260205|567346113|FG000|Overall Study|Protocol Violation|0|||
156925196|NCT04166513|566483665|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
156925197|NCT04166513|566483662|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
156925198|NCT04166513|566483663|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
156925199|NCT04166513|566483664|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
156925200|NCT04166513|566483665|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
156925201|NCT04166513|566483662|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
156925202|NCT04166513|566483663|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
156925203|NCT04166513|566483664|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
156925204|NCT04166513|566483665|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
156925205|NCT04166513|566483662|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
156925206|NCT04166513|566483663|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
156925207|NCT04166513|566483664|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
156925208|NCT04166513|566483665|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
156925209|NCT05286307|566483666|FG000|Overall Study|Incomplete outcome assessments|2|||
156925210|NCT05286307|566483667|FG001|Overall Study|Incomplete outcome assessments|1|||
156925211|NCT05286307|566483666|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
156925212|NCT05286307|566483667|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
156925213|NCT05286307|566483666|FG000|Overall Study|Lost to follow up at 6 months|25|||
156925214|NCT05286307|566483667|FG001|Overall Study|Lost to follow up at 6 months|35|||
156925215|NCT05286307|566483666|FG000|Overall Study|Study medication not available|1|||
156925216|NCT05286307|566483667|FG001|Overall Study|Study medication not available|1|||
156925217|NCT02759471|566483669|FG000|Overall Study|discomfort|2|||
156925218|NCT04219891|566483672|FG000|Overall Study|Lost to Follow-up|3|||
156925219|NCT04219891|566483672|FG000|Overall Study|Withdrawal by Subject|2|||
156925220|NCT00597012|566483673|FG000|Overall Study|Death|1|||
156925221|NCT00597012|566483674|FG001|Overall Study|Death|1|||
156925222|NCT00597012|566483673|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
156925223|NCT00597012|566483674|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
156925224|NCT00597012|566483673|FG000|Overall Study|Withdrawal by Subject|7|||
156925225|NCT00597012|566483674|FG001|Overall Study|Withdrawal by Subject|4|||
156925226|NCT00597012|566483673|FG000|Overall Study|Ineligible|2|||
156925227|NCT00597012|566483674|FG001|Overall Study|Ineligible|0|||
156925228|NCT00597012|566483673|FG000|Overall Study|Lost to Follow-up|0|||
156925229|NCT00597012|566483674|FG001|Overall Study|Lost to Follow-up|2|||
156925230|NCT01103284|566483676|FG000|Overall Study|Death|2|||
156925231|NCT01103284|566483677|FG001|Overall Study|Death|0|||
156925232|NCT01103284|566483676|FG000|Overall Study|Lost to Follow-up|9|||
156925233|NCT01103284|566483677|FG001|Overall Study|Lost to Follow-up|10|||
156925234|NCT01103284|566483676|FG000|Overall Study|Pregnancy|3|||
156925235|NCT01103284|566483677|FG001|Overall Study|Pregnancy|1|||
156925236|NCT01103284|566483676|FG000|Overall Study|Protocol Violation|12|||
156925237|NCT01103284|566483677|FG001|Overall Study|Protocol Violation|5|||
156925238|NCT01103284|566483676|FG000|Overall Study|Adverse Event|0|||
156925239|NCT01103284|566483677|FG001|Overall Study|Adverse Event|5|||
156925240|NCT01103284|566483676|FG000|Overall Study|Withdrawal by Subject|14|||
156925241|NCT01103284|566483677|FG001|Overall Study|Withdrawal by Subject|18|||
157028848|NCT04005794|566862814|FG002|Overall Study|Lost to Follow-up|0|||
157028849|NCT00104676|566862818|FG000|Overall Study|Death|3|||
157028850|NCT00104676|566862819|FG001|Overall Study|Death|2|||
157028851|NCT00104676|566862818|FG000|Overall Study|Withdrawal by Subject|0|||
157028852|NCT00104676|566862819|FG001|Overall Study|Withdrawal by Subject|2|||
157028853|NCT00104676|566862818|FG000|Overall Study|treatment interruption|4|||
157028854|NCT00104676|566862819|FG001|Overall Study|treatment interruption|10|||
156925242|NCT01103284|566483676|FG000|Overall Study|Dermal Hypersensitivity|0|||
156925243|NCT01103284|566483677|FG001|Overall Study|Dermal Hypersensitivity|1|||
156925244|NCT01103284|566483676|FG000|Overall Study|Termination by the Sponsor|0|||
156925245|NCT01103284|566483677|FG001|Overall Study|Termination by the Sponsor|1|||
156925246|NCT01103284|566483676|FG000|Overall Study|Not described|2|||
156925247|NCT01103284|566483677|FG001|Overall Study|Not described|1|||
156925248|NCT01103284|566483676|FG000|Overall Study|Missing CRF entries for study completion|0|||
156925249|NCT01103284|566483677|FG001|Overall Study|Missing CRF entries for study completion|2|||
156925250|NCT01852942|566485349|FG000|Overall Study|Physician Decision|1|||
156925251|NCT01852942|566485350|FG001|Overall Study|Physician Decision|0|||
156925252|NCT01852942|566485349|FG000|Overall Study|Death|1|||
156925253|NCT01852942|566485350|FG001|Overall Study|Death|1|||
156925254|NCT01852942|566485349|FG000|Overall Study|Withdrawal by Subject|2|||
156925255|NCT01852942|566485350|FG001|Overall Study|Withdrawal by Subject|3|||
156925256|NCT01852942|566485349|FG000|Overall Study|Lost to Follow-up|1|||
157028855|NCT03916185|566862820|FG000|Overall Study|Lost to Follow-up|0|||
157028856|NCT03916185|566862821|FG001|Overall Study|Lost to Follow-up|1|||
157028857|NCT03916185|566862822|FG002|Overall Study|Lost to Follow-up|0|||
156925257|NCT01852942|566485350|FG001|Overall Study|Lost to Follow-up|2|||
156925258|NCT02642614|566485356|FG000|Overall Study|Adverse Event|1|||
156925259|NCT02642614|566485357|FG001|Overall Study|Adverse Event|1|||
157028858|NCT03916185|566862823|FG003|Overall Study|Lost to Follow-up|0|||
157028859|NCT03916185|566862820|FG000|Overall Study|Moved|1|||
157028860|NCT03916185|566862821|FG001|Overall Study|Moved|0|||
157028861|NCT03916185|566862822|FG002|Overall Study|Moved|0|||
157028862|NCT03916185|566862823|FG003|Overall Study|Moved|1|||
157028863|NCT03916185|566862820|FG000|Overall Study|Not Able to Get to Clinic|1|||
157028864|NCT03916185|566862821|FG001|Overall Study|Not Able to Get to Clinic|0|||
157028865|NCT03916185|566862822|FG002|Overall Study|Not Able to Get to Clinic|0|||
157028866|NCT03916185|566862823|FG003|Overall Study|Not Able to Get to Clinic|0|||
157028867|NCT03766685|566862824|FG000|Overall Study|Lost to Follow-up|1|||
157028868|NCT03766685|566862825|FG001|Overall Study|Lost to Follow-up|1|||
157028869|NCT03766685|566862826|FG002|Overall Study|Lost to Follow-up|0|||
157028870|NCT03766685|566862827|FG003|Overall Study|Lost to Follow-up|0|||
157028871|NCT03766685|566862824|FG000|Overall Study|Adverse Event, not fatal|0|||
157028872|NCT03766685|566862825|FG001|Overall Study|Adverse Event, not fatal|1|||
157028873|NCT03766685|566862826|FG002|Overall Study|Adverse Event, not fatal|0|||
157028874|NCT03766685|566862827|FG003|Overall Study|Adverse Event, not fatal|1|||
157028875|NCT03766685|566862824|FG000|Overall Study|Withdrawal by Subject|0|||
157165318|NCT03260205|567346114|FG001|Overall Study|Protocol Violation|0|||
157165319|NCT03260205|567346115|FG002|Overall Study|Protocol Violation|2|||
157165320|NCT03260205|567346116|FG003|Overall Study|Protocol Violation|0|||
157165321|NCT03260205|567346117|FG004|Overall Study|Protocol Violation|1|||
157165322|NCT03260205|567346113|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
157165323|NCT03260205|567346114|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
157165324|NCT03260205|567346115|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
157165325|NCT03260205|567346116|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
157165326|NCT03260205|567346117|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
157165327|NCT03260205|567346113|FG000|Overall Study|Other: Unspecified|0|||
157165328|NCT03260205|567346114|FG001|Overall Study|Other: Unspecified|0|||
157165329|NCT03260205|567346115|FG002|Overall Study|Other: Unspecified|3|||
157165330|NCT03260205|567346116|FG003|Overall Study|Other: Unspecified|1|||
157165331|NCT03260205|567346117|FG004|Overall Study|Other: Unspecified|1|||
157165332|NCT03260205|567346113|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
157165333|NCT03260205|567346114|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
157165334|NCT03260205|567346115|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
157165335|NCT03260205|567346116|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
157165336|NCT03260205|567346117|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
157165337|NCT03423979|567346118|FG000|Overall Study|Death|5|||
157165338|NCT03423979|567346118|FG000|Overall Study|Adverse Event|4|||
156925260|NCT02642614|566485358|FG002|Overall Study|Adverse Event|2|||
156925261|NCT02642614|566485359|FG003|Overall Study|Adverse Event|2|||
156925262|NCT02642614|566485356|FG000|Overall Study|Lost to Follow-up|1|||
156925263|NCT02642614|566485357|FG001|Overall Study|Lost to Follow-up|0|||
156925264|NCT02642614|566485358|FG002|Overall Study|Lost to Follow-up|0|||
156925265|NCT02642614|566485359|FG003|Overall Study|Lost to Follow-up|0|||
156925266|NCT02642614|566485356|FG000|Overall Study|Withdrawal by Subject|1|||
156925267|NCT02642614|566485357|FG001|Overall Study|Withdrawal by Subject|1|||
156925268|NCT02642614|566485358|FG002|Overall Study|Withdrawal by Subject|0|||
156925269|NCT02642614|566485359|FG003|Overall Study|Withdrawal by Subject|0|||
156925270|NCT04708886|566485362|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
156925271|NCT04708886|566485362|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
156925272|NCT01729754|566485363|FG000|Part 1|Adverse Event|2|||
156925273|NCT01729754|566485364|FG001|Part 1|Adverse Event|0|||
156925274|NCT01729754|566485365|FG002|Part 1|Adverse Event|0|||
156925275|NCT01729754|566485366|FG003|Part 1|Adverse Event|1|||
156925276|NCT01729754|566485367|FG004|Part 1|Adverse Event|0|||
156925277|NCT01729754|566485368|FG005|Part 1|Adverse Event|0|||
156925278|NCT01729754|566485369|FG006|Part 1|Adverse Event|2|||
156925279|NCT01729754|566485370|FG007|Part 1|Adverse Event|0|||
156925280|NCT01729754|566485371|FG008|Part 1|Adverse Event|0|||
157165339|NCT03423979|567346118|FG000|Overall Study|Withdrawal by Subject|3|||
157165340|NCT03423979|567346118|FG000|Overall Study|Lost to Follow-up|16|||
156925281|NCT01729754|566485372|FG009|Part 1|Adverse Event|5|||
156925282|NCT01729754|566485363|FG000|Part 1|Lack of Efficacy|1|||
156925283|NCT01729754|566485364|FG001|Part 1|Lack of Efficacy|0|||
157165341|NCT00808249|567346119|FG000|Overall Study|Adverse Event|4|||
157165342|NCT00808249|567346120|FG001|Overall Study|Adverse Event|7|||
157165343|NCT00808249|567346121|FG002|Overall Study|Adverse Event|10|||
157165344|NCT00808249|567346122|FG003|Overall Study|Adverse Event|6|||
157165345|NCT00808249|567346119|FG000|Overall Study|Lost to Follow-up|2|||
157165346|NCT00808249|567346120|FG001|Overall Study|Lost to Follow-up|3|||
156925284|NCT01729754|566485365|FG002|Part 1|Lack of Efficacy|0|||
156925285|NCT01729754|566485366|FG003|Part 1|Lack of Efficacy|0|||
156925286|NCT01729754|566485367|FG004|Part 1|Lack of Efficacy|0|||
156925287|NCT01729754|566485368|FG005|Part 1|Lack of Efficacy|0|||
156925288|NCT01729754|566485369|FG006|Part 1|Lack of Efficacy|2|||
156925289|NCT01729754|566485370|FG007|Part 1|Lack of Efficacy|0|||
157028876|NCT03766685|566862825|FG001|Overall Study|Withdrawal by Subject|2|||
157028877|NCT03766685|566862826|FG002|Overall Study|Withdrawal by Subject|0|||
157028878|NCT03766685|566862827|FG003|Overall Study|Withdrawal by Subject|0|||
157028879|NCT03766685|566862824|FG000|Overall Study|Protocol Violation|0|||
157028880|NCT03766685|566862825|FG001|Overall Study|Protocol Violation|1|||
156925290|NCT01729754|566485371|FG008|Part 1|Lack of Efficacy|0|||
156925291|NCT01729754|566485372|FG009|Part 1|Lack of Efficacy|0|||
156925292|NCT01729754|566485363|FG000|Part 1|Lost to Follow-up|1|||
156925293|NCT01729754|566485364|FG001|Part 1|Lost to Follow-up|0|||
156925294|NCT01729754|566485365|FG002|Part 1|Lost to Follow-up|0|||
156925295|NCT01729754|566485366|FG003|Part 1|Lost to Follow-up|2|||
156925296|NCT01729754|566485367|FG004|Part 1|Lost to Follow-up|0|||
156925297|NCT01729754|566485368|FG005|Part 1|Lost to Follow-up|0|||
156925298|NCT01729754|566485369|FG006|Part 1|Lost to Follow-up|3|||
156925299|NCT01729754|566485370|FG007|Part 1|Lost to Follow-up|0|||
156925300|NCT01729754|566485371|FG008|Part 1|Lost to Follow-up|0|||
156925301|NCT01729754|566485372|FG009|Part 1|Lost to Follow-up|3|||
156925302|NCT01729754|566485363|FG000|Part 1|Non-compliance with Study Drug|1|||
156925303|NCT01729754|566485364|FG001|Part 1|Non-compliance with Study Drug|0|||
156925304|NCT01729754|566485365|FG002|Part 1|Non-compliance with Study Drug|0|||
156925305|NCT01729754|566485366|FG003|Part 1|Non-compliance with Study Drug|0|||
156925306|NCT01729754|566485367|FG004|Part 1|Non-compliance with Study Drug|0|||
156925307|NCT01729754|566485368|FG005|Part 1|Non-compliance with Study Drug|0|||
156925308|NCT01729754|566485369|FG006|Part 1|Non-compliance with Study Drug|0|||
156925309|NCT01729754|566485370|FG007|Part 1|Non-compliance with Study Drug|0|||
156925310|NCT01729754|566485371|FG008|Part 1|Non-compliance with Study Drug|0|||
156925311|NCT01729754|566485372|FG009|Part 1|Non-compliance with Study Drug|0|||
156925312|NCT01729754|566485363|FG000|Part 1|Physician Decision|0|||
156925313|NCT01729754|566485364|FG001|Part 1|Physician Decision|0|||
156925314|NCT01729754|566485365|FG002|Part 1|Physician Decision|0|||
156925315|NCT01729754|566485366|FG003|Part 1|Physician Decision|0|||
156925316|NCT01729754|566485367|FG004|Part 1|Physician Decision|0|||
156925317|NCT01729754|566485368|FG005|Part 1|Physician Decision|0|||
156925318|NCT01729754|566485369|FG006|Part 1|Physician Decision|0|||
156925319|NCT01729754|566485370|FG007|Part 1|Physician Decision|0|||
156925320|NCT01729754|566485371|FG008|Part 1|Physician Decision|0|||
156925321|NCT01729754|566485372|FG009|Part 1|Physician Decision|4|||
156925322|NCT01729754|566485363|FG000|Part 1|Pregnancy|0|||
156925323|NCT01729754|566485364|FG001|Part 1|Pregnancy|0|||
156925324|NCT01729754|566485365|FG002|Part 1|Pregnancy|0|||
156925325|NCT01729754|566485366|FG003|Part 1|Pregnancy|1|||
156925326|NCT01729754|566485367|FG004|Part 1|Pregnancy|0|||
156925327|NCT01729754|566485368|FG005|Part 1|Pregnancy|0|||
156925328|NCT01729754|566485369|FG006|Part 1|Pregnancy|0|||
156925329|NCT01729754|566485370|FG007|Part 1|Pregnancy|0|||
156925330|NCT01729754|566485371|FG008|Part 1|Pregnancy|0|||
156925331|NCT01729754|566485372|FG009|Part 1|Pregnancy|1|||
156925332|NCT01729754|566485363|FG000|Part 1|Progressive Disease|0|||
156925333|NCT01729754|566485364|FG001|Part 1|Progressive Disease|0|||
156925334|NCT01729754|566485365|FG002|Part 1|Progressive Disease|0|||
156925335|NCT01729754|566485366|FG003|Part 1|Progressive Disease|0|||
156925336|NCT01729754|566485367|FG004|Part 1|Progressive Disease|0|||
156925337|NCT01729754|566485368|FG005|Part 1|Progressive Disease|0|||
156925338|NCT01729754|566485369|FG006|Part 1|Progressive Disease|0|||
156925339|NCT01729754|566485370|FG007|Part 1|Progressive Disease|0|||
157028881|NCT03766685|566862826|FG002|Overall Study|Protocol Violation|0|||
157028882|NCT03766685|566862827|FG003|Overall Study|Protocol Violation|0|||
157028883|NCT03766685|566862824|FG000|Overall Study|Non-compliance|0|||
157028884|NCT03766685|566862825|FG001|Overall Study|Non-compliance|2|||
157028885|NCT03766685|566862826|FG002|Overall Study|Non-compliance|0|||
157028886|NCT03766685|566862827|FG003|Overall Study|Non-compliance|0|||
157028887|NCT02844465|566862833|FG000|Overall Study|Screen Failure|36|||
157028888|NCT02844465|566862833|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
157028889|NCT02844465|566862833|FG000|Overall Study|Withdrawal by Subject|5|||
157028890|NCT02844465|566862833|FG000|Overall Study|Lost to Follow-up|1|||
157028891|NCT02844465|566862833|FG000|Overall Study|Retreatment|1|||
157028892|NCT05029622|566862835|FG000|Overall Study|Lost to Follow-up|1|||
157028893|NCT06232590|566862836|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
157028894|NCT06232590|566862837|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
156925340|NCT01729754|566485371|FG008|Part 1|Progressive Disease|0|||
156925341|NCT01729754|566485372|FG009|Part 1|Progressive Disease|1|||
156925342|NCT01729754|566485363|FG000|Part 1|Protocol Violation|2|||
156925343|NCT01729754|566485364|FG001|Part 1|Protocol Violation|0|||
157028895|NCT05299723|566862838|FG000|Overall Study|Withdrawal by Subject|0|||
156925344|NCT01729754|566485365|FG002|Part 1|Protocol Violation|0|||
156925345|NCT01729754|566485366|FG003|Part 1|Protocol Violation|1|||
156925346|NCT01729754|566485367|FG004|Part 1|Protocol Violation|0|||
156925347|NCT01729754|566485368|FG005|Part 1|Protocol Violation|0|||
156925348|NCT01729754|566485369|FG006|Part 1|Protocol Violation|1|||
157028896|NCT05299723|566862839|FG001|Overall Study|Withdrawal by Subject|2|||
157028897|NCT05299723|566862840|FG002|Overall Study|Withdrawal by Subject|0|||
156925349|NCT01729754|566485370|FG007|Part 1|Protocol Violation|0|||
156925350|NCT01729754|566485371|FG008|Part 1|Protocol Violation|0|||
156925351|NCT01729754|566485372|FG009|Part 1|Protocol Violation|0|||
156925352|NCT01729754|566485363|FG000|Part 1|Withdrawal by Subject|5|||
156925353|NCT01729754|566485364|FG001|Part 1|Withdrawal by Subject|0|||
157028898|NCT02460458|566862841|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
157028899|NCT02460458|566862841|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
157165347|NCT00808249|567346121|FG002|Overall Study|Lost to Follow-up|3|||
157165348|NCT00808249|567346122|FG003|Overall Study|Lost to Follow-up|5|||
157165349|NCT00808249|567346119|FG000|Overall Study|Withdrawal by Subject|4|||
157165350|NCT00808249|567346120|FG001|Overall Study|Withdrawal by Subject|0|||
157165351|NCT00808249|567346121|FG002|Overall Study|Withdrawal by Subject|2|||
157165352|NCT00808249|567346122|FG003|Overall Study|Withdrawal by Subject|4|||
157165353|NCT00808249|567346119|FG000|Overall Study|Protocol Violation|3|||
157165354|NCT00808249|567346120|FG001|Overall Study|Protocol Violation|3|||
157165355|NCT00808249|567346121|FG002|Overall Study|Protocol Violation|3|||
157165356|NCT00808249|567346122|FG003|Overall Study|Protocol Violation|0|||
157165357|NCT00808249|567346119|FG000|Overall Study|Lack of Efficacy|1|||
157165358|NCT00808249|567346120|FG001|Overall Study|Lack of Efficacy|1|||
157165359|NCT00808249|567346121|FG002|Overall Study|Lack of Efficacy|0|||
157165360|NCT00808249|567346122|FG003|Overall Study|Lack of Efficacy|0|||
157165361|NCT00808249|567346119|FG000|Overall Study|study specific discontinuation criteria|1|||
157165362|NCT00808249|567346120|FG001|Overall Study|study specific discontinuation criteria|0|||
157165363|NCT00808249|567346121|FG002|Overall Study|study specific discontinuation criteria|1|||
157165364|NCT00808249|567346122|FG003|Overall Study|study specific discontinuation criteria|0|||
157165365|NCT00808249|567346119|FG000|Overall Study|All other reasons|2|||
157165366|NCT00808249|567346120|FG001|Overall Study|All other reasons|1|||
157165367|NCT00808249|567346121|FG002|Overall Study|All other reasons|3|||
157165368|NCT00808249|567346122|FG003|Overall Study|All other reasons|1|||
157165369|NCT04095286|567346123|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165370|NCT04095286|567346124|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
157165371|NCT04095286|567346125|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165372|NCT04095286|567346126|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165373|NCT04095286|567346127|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165374|NCT04095286|567346128|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165375|NCT04095286|567346123|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
157165376|NCT04095286|567346124|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
157165377|NCT04095286|567346125|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
157165378|NCT04095286|567346126|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
157165379|NCT04095286|567346127|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
157165380|NCT04095286|567346128|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
157165381|NCT04095286|567346123|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
157165382|NCT04095286|567346124|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
157165383|NCT04095286|567346125|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
157165384|NCT04095286|567346126|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
157165385|NCT04095286|567346127|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
157165386|NCT04095286|567346128|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
156925354|NCT01729754|566485365|FG002|Part 1|Withdrawal by Subject|0|||
156925355|NCT01729754|566485366|FG003|Part 1|Withdrawal by Subject|7|||
156925356|NCT01729754|566485367|FG004|Part 1|Withdrawal by Subject|0|||
156925357|NCT01729754|566485368|FG005|Part 1|Withdrawal by Subject|0|||
156925358|NCT01729754|566485369|FG006|Part 1|Withdrawal by Subject|5|||
156925359|NCT01729754|566485370|FG007|Part 1|Withdrawal by Subject|0|||
156925360|NCT01729754|566485371|FG008|Part 1|Withdrawal by Subject|0|||
156925361|NCT01729754|566485372|FG009|Part 1|Withdrawal by Subject|6|||
156925362|NCT01729754|566485363|FG000|Part 1|Other Protocol Specified Criteria|2|||
156925363|NCT01729754|566485364|FG001|Part 1|Other Protocol Specified Criteria|0|||
156925364|NCT01729754|566485365|FG002|Part 1|Other Protocol Specified Criteria|0|||
156925365|NCT01729754|566485366|FG003|Part 1|Other Protocol Specified Criteria|0|||
156925366|NCT01729754|566485367|FG004|Part 1|Other Protocol Specified Criteria|0|||
156925367|NCT01729754|566485368|FG005|Part 1|Other Protocol Specified Criteria|0|||
157165387|NCT04095286|567346123|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165388|NCT04095286|567346124|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165389|NCT04095286|567346125|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
157165390|NCT04095286|567346126|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165391|NCT04095286|567346127|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165392|NCT04095286|567346128|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
157165393|NCT04095286|567346123|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
157165394|NCT04095286|567346124|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
157165395|NCT04095286|567346125|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
157165396|NCT04095286|567346126|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
157165397|NCT04095286|567346127|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
157227031|NCT01048333|567576027|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
157227032|NCT00409578|567576031|FG000|Overall Study|Adverse Event|27|||
156925368|NCT01729754|566485369|FG006|Part 1|Other Protocol Specified Criteria|1|||
156925369|NCT01729754|566485370|FG007|Part 1|Other Protocol Specified Criteria|0|||
156925370|NCT01729754|566485371|FG008|Part 1|Other Protocol Specified Criteria|0|||
156925371|NCT01729754|566485372|FG009|Part 1|Other Protocol Specified Criteria|4|||
156925372|NCT01729754|566485363|FG000|Part 2|Adverse Event|2|||
156925373|NCT01729754|566485364|FG001|Part 2|Adverse Event|0|||
156925374|NCT01729754|566485365|FG002|Part 2|Adverse Event|0|||
156925375|NCT01729754|566485366|FG003|Part 2|Adverse Event|0|||
156925376|NCT01729754|566485367|FG004|Part 2|Adverse Event|0|||
156925377|NCT01729754|566485368|FG005|Part 2|Adverse Event|0|||
156925378|NCT01729754|566485369|FG006|Part 2|Adverse Event|0|||
156925379|NCT01729754|566485370|FG007|Part 2|Adverse Event|0|||
156925380|NCT01729754|566485371|FG008|Part 2|Adverse Event|1|||
156925381|NCT01729754|566485372|FG009|Part 2|Adverse Event|2|||
156925382|NCT01729754|566485363|FG000|Part 2|Lack of Efficacy|0|||
156925383|NCT01729754|566485364|FG001|Part 2|Lack of Efficacy|0|||
156925384|NCT01729754|566485365|FG002|Part 2|Lack of Efficacy|0|||
156925385|NCT01729754|566485366|FG003|Part 2|Lack of Efficacy|0|||
156925386|NCT01729754|566485367|FG004|Part 2|Lack of Efficacy|0|||
156925387|NCT01729754|566485368|FG005|Part 2|Lack of Efficacy|0|||
157165398|NCT04095286|567346128|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
157165399|NCT02598661|567346133|FG000|Overall Study|Death|27|||
157165400|NCT02598661|567346134|FG001|Overall Study|Death|34|||
157165401|NCT02598661|567346135|FG002|Overall Study|Death|14|||
157165402|NCT02598661|567346136|FG003|Overall Study|Death|1|||
157165403|NCT02598661|567346137|FG004|Overall Study|Death|0|||
157165404|NCT02598661|567346133|FG000|Overall Study|Lost to Follow-up|2|||
157165405|NCT02598661|567346134|FG001|Overall Study|Lost to Follow-up|3|||
157165406|NCT02598661|567346135|FG002|Overall Study|Lost to Follow-up|2|||
157165407|NCT02598661|567346136|FG003|Overall Study|Lost to Follow-up|0|||
157165408|NCT02598661|567346137|FG004|Overall Study|Lost to Follow-up|0|||
157165409|NCT02598661|567346133|FG000|Overall Study|Withdrawal by Subject|13|||
157165410|NCT02598661|567346134|FG001|Overall Study|Withdrawal by Subject|24|||
157165411|NCT02598661|567346135|FG002|Overall Study|Withdrawal by Subject|14|||
157165412|NCT02598661|567346136|FG003|Overall Study|Withdrawal by Subject|1|||
157165413|NCT02598661|567346137|FG004|Overall Study|Withdrawal by Subject|1|||
157165414|NCT02598661|567346133|FG000|Overall Study|Adverse Event|0|||
157165415|NCT02598661|567346134|FG001|Overall Study|Adverse Event|0|||
157165416|NCT02598661|567346135|FG002|Overall Study|Adverse Event|1|||
157165417|NCT02598661|567346136|FG003|Overall Study|Adverse Event|0|||
157165418|NCT02598661|567346137|FG004|Overall Study|Adverse Event|0|||
157165419|NCT02598661|567346133|FG000|Overall Study|Randomized, Never Treated|0|||
157165420|NCT02598661|567346134|FG001|Overall Study|Randomized, Never Treated|0|||
157165421|NCT02598661|567346135|FG002|Overall Study|Randomized, Never Treated|0|||
157165422|NCT02598661|567346136|FG003|Overall Study|Randomized, Never Treated|0|||
157165423|NCT02598661|567346137|FG004|Overall Study|Randomized, Never Treated|1|||
157165424|NCT03003403|567346138|FG000|Overall Study|Ineligible|8|||
157165425|NCT03003403|567346139|FG001|Overall Study|Ineligible|7|||
157165426|NCT03003403|567346138|FG000|Overall Study|Withdrawal by Subject|3|||
157165427|NCT03003403|567346139|FG001|Overall Study|Withdrawal by Subject|1|||
157165428|NCT04092816|567347989|FG000|Overall Study|Lost to Follow-up|1|||
157165429|NCT04092816|567347990|FG001|Overall Study|Lost to Follow-up|2|||
157165430|NCT02700919|567347996|FG000|Overall Study|Physician Decision|1|||
157165431|NCT02700919|567347997|FG001|Overall Study|Physician Decision|0|||
157165432|NCT02700919|567347998|FG002|Overall Study|Physician Decision|0|||
157165433|NCT02700919|567347996|FG000|Overall Study|Protocol Violation|1|||
157165434|NCT02700919|567347997|FG001|Overall Study|Protocol Violation|0|||
157165435|NCT02700919|567347998|FG002|Overall Study|Protocol Violation|0|||
157165436|NCT02700919|567347996|FG000|Overall Study|Adverse Event|1|||
157165437|NCT02700919|567347997|FG001|Overall Study|Adverse Event|3|||
157165438|NCT02700919|567347998|FG002|Overall Study|Adverse Event|1|||
156925388|NCT01729754|566485369|FG006|Part 2|Lack of Efficacy|0|||
157165439|NCT02700919|567347996|FG000|Overall Study|Withdrawal by Subject|5|||
157165440|NCT02700919|567347997|FG001|Overall Study|Withdrawal by Subject|8|||
157165441|NCT02700919|567347998|FG002|Overall Study|Withdrawal by Subject|2|||
157165442|NCT02700919|567347996|FG000|Overall Study|Lost to Follow-up|2|||
157165443|NCT02700919|567347997|FG001|Overall Study|Lost to Follow-up|0|||
156925389|NCT01729754|566485370|FG007|Part 2|Lack of Efficacy|0|||
156925390|NCT01729754|566485371|FG008|Part 2|Lack of Efficacy|2|||
156925391|NCT01729754|566485372|FG009|Part 2|Lack of Efficacy|2|||
156925392|NCT01729754|566485363|FG000|Part 2|Lost to Follow-up|0|||
156925393|NCT01729754|566485364|FG001|Part 2|Lost to Follow-up|0|||
157227033|NCT00409578|567576032|FG001|Overall Study|Adverse Event|37|||
157165444|NCT02700919|567347998|FG002|Overall Study|Lost to Follow-up|0|||
157165445|NCT02700919|567347996|FG000|Overall Study|Other|2|||
157165446|NCT02700919|567347997|FG001|Overall Study|Other|1|||
157165447|NCT02700919|567347998|FG002|Overall Study|Other|1|||
157165448|NCT03569449|567347999|FG000|Overall Study|Lost to Follow-up|0|||
156925394|NCT01729754|566485365|FG002|Part 2|Lost to Follow-up|0|||
156925395|NCT01729754|566485366|FG003|Part 2|Lost to Follow-up|2|||
156925396|NCT01729754|566485367|FG004|Part 2|Lost to Follow-up|0|||
157165449|NCT03569449|567348000|FG001|Overall Study|Lost to Follow-up|1|||
157165450|NCT03569449|567348001|FG002|Overall Study|Lost to Follow-up|0|||
157165451|NCT03569449|567348002|FG003|Overall Study|Lost to Follow-up|2|||
157165452|NCT03569449|567348003|FG004|Overall Study|Lost to Follow-up|0|||
157165453|NCT03569449|567348004|FG005|Overall Study|Lost to Follow-up|0|||
157165454|NCT03569449|567348005|FG006|Overall Study|Lost to Follow-up|0|||
156925397|NCT01729754|566485368|FG005|Part 2|Lost to Follow-up|0|||
156925398|NCT01729754|566485369|FG006|Part 2|Lost to Follow-up|0|||
156925399|NCT01729754|566485370|FG007|Part 2|Lost to Follow-up|1|||
156925400|NCT01729754|566485371|FG008|Part 2|Lost to Follow-up|0|||
156925401|NCT01729754|566485372|FG009|Part 2|Lost to Follow-up|2|||
156925402|NCT01729754|566485363|FG000|Part 2|Non-Compliance with Study Drug|0|||
156925403|NCT01729754|566485364|FG001|Part 2|Non-Compliance with Study Drug|0|||
156925404|NCT01729754|566485365|FG002|Part 2|Non-Compliance with Study Drug|0|||
156925405|NCT01729754|566485366|FG003|Part 2|Non-Compliance with Study Drug|0|||
156925406|NCT01729754|566485367|FG004|Part 2|Non-Compliance with Study Drug|0|||
156925407|NCT01729754|566485368|FG005|Part 2|Non-Compliance with Study Drug|0|||
156925408|NCT01729754|566485369|FG006|Part 2|Non-Compliance with Study Drug|0|||
156925409|NCT01729754|566485370|FG007|Part 2|Non-Compliance with Study Drug|0|||
156925410|NCT01729754|566485371|FG008|Part 2|Non-Compliance with Study Drug|0|||
156925411|NCT01729754|566485372|FG009|Part 2|Non-Compliance with Study Drug|1|||
156925412|NCT01729754|566485363|FG000|Part 2|Pregnancy|0|||
156925413|NCT01729754|566485364|FG001|Part 2|Pregnancy|0|||
156925414|NCT01729754|566485365|FG002|Part 2|Pregnancy|0|||
156925415|NCT01729754|566485366|FG003|Part 2|Pregnancy|1|||
156925416|NCT01729754|566485367|FG004|Part 2|Pregnancy|0|||
156925417|NCT01729754|566485368|FG005|Part 2|Pregnancy|0|||
156925418|NCT01729754|566485369|FG006|Part 2|Pregnancy|0|||
156925419|NCT01729754|566485370|FG007|Part 2|Pregnancy|0|||
156925420|NCT01729754|566485371|FG008|Part 2|Pregnancy|0|||
156925421|NCT01729754|566485372|FG009|Part 2|Pregnancy|1|||
156925422|NCT01729754|566485363|FG000|Part 2|Withdrawal by Subject|3|||
156925423|NCT01729754|566485364|FG001|Part 2|Withdrawal by Subject|0|||
156925424|NCT01729754|566485365|FG002|Part 2|Withdrawal by Subject|0|||
156925425|NCT01729754|566485366|FG003|Part 2|Withdrawal by Subject|2|||
156925426|NCT01729754|566485367|FG004|Part 2|Withdrawal by Subject|0|||
156925427|NCT01729754|566485368|FG005|Part 2|Withdrawal by Subject|0|||
156925428|NCT01729754|566485369|FG006|Part 2|Withdrawal by Subject|0|||
156925429|NCT01729754|566485370|FG007|Part 2|Withdrawal by Subject|1|||
156925430|NCT01729754|566485371|FG008|Part 2|Withdrawal by Subject|1|||
156925431|NCT01729754|566485372|FG009|Part 2|Withdrawal by Subject|4|||
156925432|NCT01729754|566485363|FG000|Part 2|Other Protocol Specified Criteria|1|||
156925433|NCT01729754|566485364|FG001|Part 2|Other Protocol Specified Criteria|0|||
156925434|NCT01729754|566485365|FG002|Part 2|Other Protocol Specified Criteria|0|||
156925435|NCT01729754|566485366|FG003|Part 2|Other Protocol Specified Criteria|0|||
156925436|NCT01729754|566485367|FG004|Part 2|Other Protocol Specified Criteria|0|||
156925437|NCT01729754|566485368|FG005|Part 2|Other Protocol Specified Criteria|0|||
156925438|NCT01729754|566485369|FG006|Part 2|Other Protocol Specified Criteria|0|||
156925439|NCT01729754|566485370|FG007|Part 2|Other Protocol Specified Criteria|1|||
156925440|NCT01729754|566485371|FG008|Part 2|Other Protocol Specified Criteria|0|||
156925441|NCT01729754|566485372|FG009|Part 2|Other Protocol Specified Criteria|0|||
156925442|NCT01729754|566485363|FG000|Part 3|Adverse Event|0|||
156925443|NCT01729754|566485364|FG001|Part 3|Adverse Event|0|||
156925444|NCT01729754|566485365|FG002|Part 3|Adverse Event|1|||
156925445|NCT01729754|566485366|FG003|Part 3|Adverse Event|0|||
156925446|NCT01729754|566485367|FG004|Part 3|Adverse Event|0|||
156925447|NCT01729754|566485368|FG005|Part 3|Adverse Event|5|||
156925448|NCT01729754|566485369|FG006|Part 3|Adverse Event|0|||
156925449|NCT01729754|566485370|FG007|Part 3|Adverse Event|0|||
156925450|NCT01729754|566485371|FG008|Part 3|Adverse Event|0|||
156925451|NCT01729754|566485372|FG009|Part 3|Adverse Event|3|||
156925452|NCT01729754|566485363|FG000|Part 3|Death|0|||
157165455|NCT03569449|567348006|FG007|Overall Study|Lost to Follow-up|0|||
157165456|NCT03569449|567348007|FG008|Overall Study|Lost to Follow-up|0|||
157165457|NCT03569449|567348008|FG009|Overall Study|Lost to Follow-up|0|||
157165458|NCT03569449|567348009|FG010|Overall Study|Lost to Follow-up|0|||
157165459|NCT03569449|567348010|FG011|Overall Study|Lost to Follow-up|0|||
157165460|NCT03569449|567348011|FG012|Overall Study|Lost to Follow-up|0|||
157165461|NCT03569449|567348012|FG013|Overall Study|Lost to Follow-up|0|||
156925453|NCT01729754|566485364|FG001|Part 3|Death|0|||
156925454|NCT01729754|566485365|FG002|Part 3|Death|0|||
156925455|NCT01729754|566485366|FG003|Part 3|Death|0|||
156925456|NCT01729754|566485367|FG004|Part 3|Death|0|||
156925457|NCT01729754|566485368|FG005|Part 3|Death|2|||
156925458|NCT01729754|566485369|FG006|Part 3|Death|0|||
156925459|NCT01729754|566485370|FG007|Part 3|Death|0|||
156925460|NCT01729754|566485371|FG008|Part 3|Death|0|||
156925461|NCT01729754|566485372|FG009|Part 3|Death|0|||
157165462|NCT03569449|567348013|FG014|Overall Study|Lost to Follow-up|1|||
156925462|NCT01729754|566485363|FG000|Part 3|Lack of Efficacy|0|||
156925463|NCT01729754|566485364|FG001|Part 3|Lack of Efficacy|0|||
156925464|NCT01729754|566485365|FG002|Part 3|Lack of Efficacy|0|||
156925465|NCT01729754|566485366|FG003|Part 3|Lack of Efficacy|0|||
156925466|NCT01729754|566485367|FG004|Part 3|Lack of Efficacy|2|||
156925467|NCT01729754|566485368|FG005|Part 3|Lack of Efficacy|0|||
156925468|NCT01729754|566485369|FG006|Part 3|Lack of Efficacy|0|||
156925469|NCT01729754|566485370|FG007|Part 3|Lack of Efficacy|0|||
156925470|NCT01729754|566485371|FG008|Part 3|Lack of Efficacy|0|||
156925471|NCT01729754|566485372|FG009|Part 3|Lack of Efficacy|4|||
157165463|NCT03569449|567348014|FG015|Overall Study|Lost to Follow-up|0|||
156925472|NCT01729754|566485363|FG000|Part 3|Lost to Follow-up|0|||
156925473|NCT01729754|566485364|FG001|Part 3|Lost to Follow-up|1|||
156925474|NCT01729754|566485365|FG002|Part 3|Lost to Follow-up|2|||
156925475|NCT01729754|566485366|FG003|Part 3|Lost to Follow-up|0|||
156925476|NCT01729754|566485367|FG004|Part 3|Lost to Follow-up|0|||
156925477|NCT01729754|566485368|FG005|Part 3|Lost to Follow-up|3|||
156925478|NCT01729754|566485369|FG006|Part 3|Lost to Follow-up|0|||
156925479|NCT01729754|566485370|FG007|Part 3|Lost to Follow-up|0|||
156925480|NCT01729754|566485371|FG008|Part 3|Lost to Follow-up|1|||
156925481|NCT01729754|566485372|FG009|Part 3|Lost to Follow-up|0|||
156925482|NCT01729754|566485363|FG000|Part 3|Physician Decision|0|||
156925483|NCT01729754|566485364|FG001|Part 3|Physician Decision|0|||
156925484|NCT01729754|566485365|FG002|Part 3|Physician Decision|1|||
156925485|NCT01729754|566485366|FG003|Part 3|Physician Decision|0|||
156925486|NCT01729754|566485367|FG004|Part 3|Physician Decision|0|||
156925487|NCT01729754|566485368|FG005|Part 3|Physician Decision|0|||
156925488|NCT01729754|566485369|FG006|Part 3|Physician Decision|0|||
156925489|NCT01729754|566485370|FG007|Part 3|Physician Decision|0|||
156925490|NCT01729754|566485371|FG008|Part 3|Physician Decision|0|||
156925491|NCT01729754|566485372|FG009|Part 3|Physician Decision|0|||
156925492|NCT01729754|566485363|FG000|Part 3|Withdrawal by Subject|0|||
156925493|NCT01729754|566485364|FG001|Part 3|Withdrawal by Subject|4|||
156925494|NCT01729754|566485365|FG002|Part 3|Withdrawal by Subject|1|||
156925495|NCT01729754|566485366|FG003|Part 3|Withdrawal by Subject|0|||
156925496|NCT01729754|566485367|FG004|Part 3|Withdrawal by Subject|2|||
156925497|NCT01729754|566485368|FG005|Part 3|Withdrawal by Subject|1|||
156925498|NCT01729754|566485369|FG006|Part 3|Withdrawal by Subject|0|||
156925499|NCT01729754|566485370|FG007|Part 3|Withdrawal by Subject|2|||
156925500|NCT01729754|566485371|FG008|Part 3|Withdrawal by Subject|0|||
156925501|NCT01729754|566485372|FG009|Part 3|Withdrawal by Subject|0|||
156925502|NCT01729754|566485363|FG000|Part 3|Other Protocol Specified Criteria|0|||
156925503|NCT01729754|566485364|FG001|Part 3|Other Protocol Specified Criteria|0|||
156925504|NCT01729754|566485365|FG002|Part 3|Other Protocol Specified Criteria|0|||
156925505|NCT01729754|566485366|FG003|Part 3|Other Protocol Specified Criteria|0|||
156925506|NCT01729754|566485367|FG004|Part 3|Other Protocol Specified Criteria|0|||
156925507|NCT01729754|566485368|FG005|Part 3|Other Protocol Specified Criteria|2|||
156925508|NCT01729754|566485369|FG006|Part 3|Other Protocol Specified Criteria|0|||
156925509|NCT01729754|566485370|FG007|Part 3|Other Protocol Specified Criteria|1|||
156925510|NCT01729754|566485371|FG008|Part 3|Other Protocol Specified Criteria|0|||
156925511|NCT01729754|566485372|FG009|Part 3|Other Protocol Specified Criteria|0|||
156925512|NCT01485640|566485373|FG000|Overall Study|Adverse Event|10|||
156925513|NCT01485640|566485373|FG000|Overall Study|Lack of Efficacy|2|||
156925514|NCT01485640|566485373|FG000|Overall Study|Protocol Violation|1|||
156925515|NCT01485640|566485373|FG000|Overall Study|Withdrawal by Subject|14|||
156925516|NCT01485640|566485373|FG000|Overall Study|Terminated by Sponsor|95|||
156925517|NCT03232281|566485377|FG000|Overall Study|Adverse Event|1|||
156925518|NCT03232281|566485378|FG001|Overall Study|Adverse Event|1|||
156925519|NCT03232281|566485377|FG000|Overall Study|Withdrawal by Subject|5|||
156925520|NCT03232281|566485378|FG001|Overall Study|Withdrawal by Subject|4|||
156925521|NCT03232281|566485377|FG000|Overall Study|Protocol Deviation|1|||
156925522|NCT03232281|566485378|FG001|Overall Study|Protocol Deviation|1|||
156925523|NCT01132482|566485380|FG000|Overall Study|Adverse Event|1|||
156925524|NCT01132482|566485381|FG001|Overall Study|Adverse Event|0|||
156925525|NCT05333900|566485383|FG000|Overall Study|Protocol Violation|0|||
156925526|NCT05333900|566485384|FG001|Overall Study|Protocol Violation|1|||
156925527|NCT05333900|566485383|FG000|Overall Study|Withdrawal by Subject|0|||
156925528|NCT05333900|566485384|FG001|Overall Study|Withdrawal by Subject|1|||
156925529|NCT05333900|566485383|FG000|Overall Study|COVID-19 Pandemic|1|||
156925530|NCT05333900|566485384|FG001|Overall Study|COVID-19 Pandemic|1|||
156925531|NCT01870583|566485385|FG000|Overall Study|Protocol Violation|0|||
156925532|NCT01870583|566485386|FG001|Overall Study|Protocol Violation|5|||
157028900|NCT02460458|566862841|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
156925533|NCT01870583|566485387|FG002|Overall Study|Protocol Violation|3|||
156925534|NCT01870583|566485385|FG000|Overall Study|Lost to Follow-up|11|||
156925535|NCT01870583|566485386|FG001|Overall Study|Lost to Follow-up|13|||
156925536|NCT01870583|566485387|FG002|Overall Study|Lost to Follow-up|5|||
156925537|NCT01394523|566485388|FG000|Overall Study|Unable to place block|1|||
156925538|NCT01394523|566485389|FG001|Overall Study|Unable to place block|0|||
156925539|NCT01394523|566485390|FG002|Overall Study|Unable to place block|0|||
156925540|NCT02389998|566485394|FG000|Overall Study|car accident|1|||
156925541|NCT02389998|566485395|FG001|Overall Study|car accident|0|||
156925542|NCT04741074|566485398|FG000|Overall Study|Withdrawal by Subject|1|||
156925543|NCT04741074|566485399|FG001|Overall Study|Withdrawal by Subject|1|||
156925544|NCT04741074|566485398|FG000|Overall Study|Study terminated prematurely|1|||
156925545|NCT04741074|566485399|FG001|Overall Study|Study terminated prematurely|0|||
156925546|NCT00778700|566485407|FG000|Overall Study|Adverse Event|6|||
156925547|NCT00778700|566485408|FG001|Overall Study|Adverse Event|1|||
156925548|NCT00778700|566485409|FG002|Overall Study|Adverse Event|3|||
156925549|NCT00778700|566485410|FG003|Overall Study|Adverse Event|5|||
156925550|NCT00778700|566485407|FG000|Overall Study|Protocol Violation|1|||
156925551|NCT00778700|566485408|FG001|Overall Study|Protocol Violation|1|||
156925552|NCT00778700|566485409|FG002|Overall Study|Protocol Violation|0|||
156925553|NCT00778700|566485410|FG003|Overall Study|Protocol Violation|0|||
156925554|NCT00778700|566485407|FG000|Overall Study|Subject Withdrew Consent|6|||
156925555|NCT00778700|566485408|FG001|Overall Study|Subject Withdrew Consent|4|||
156925556|NCT00778700|566485409|FG002|Overall Study|Subject Withdrew Consent|1|||
156925557|NCT00778700|566485410|FG003|Overall Study|Subject Withdrew Consent|4|||
156925558|NCT00778700|566485407|FG000|Overall Study|Lost to Follow-up|3|||
156925559|NCT00778700|566485408|FG001|Overall Study|Lost to Follow-up|1|||
156925560|NCT00778700|566485409|FG002|Overall Study|Lost to Follow-up|0|||
156925561|NCT00778700|566485410|FG003|Overall Study|Lost to Follow-up|1|||
156925562|NCT00778700|566485407|FG000|Overall Study|Reason not Specified|2|||
156925563|NCT00778700|566485408|FG001|Overall Study|Reason not Specified|0|||
156925564|NCT00778700|566485409|FG002|Overall Study|Reason not Specified|1|||
156925565|NCT00778700|566485410|FG003|Overall Study|Reason not Specified|3|||
156925566|NCT00778700|566485407|FG000|Overall Study|Other|0|||
156925567|NCT00778700|566485408|FG001|Overall Study|Other|0|||
156925568|NCT00778700|566485409|FG002|Overall Study|Other|1|||
156925569|NCT00778700|566485410|FG003|Overall Study|Other|0|||
156925570|NCT03227029|566485414|FG000|Overall Study|Child Wheezed (no treatment)|0|||
157028901|NCT02460458|566862841|FG000|First Prospective Phase|Lost to Follow-up|84|||
157028902|NCT02460458|566862841|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
157028903|NCT05299073|566862842|FG000|Overall Study|Withdrawal by Subject|0|||
157028904|NCT05299073|566862843|FG001|Overall Study|Withdrawal by Subject|0|||
157028905|NCT05299073|566862844|FG002|Overall Study|Withdrawal by Subject|1|||
157028906|NCT05299073|566862842|FG000|Overall Study|Adverse Event|0|||
157028907|NCT05299073|566862843|FG001|Overall Study|Adverse Event|1|||
157028908|NCT05299073|566862844|FG002|Overall Study|Adverse Event|0|||
157028909|NCT05299073|566862842|FG000|Overall Study|Lost to Follow-up|0|||
157028910|NCT05299073|566862843|FG001|Overall Study|Lost to Follow-up|1|||
157028911|NCT05299073|566862844|FG002|Overall Study|Lost to Follow-up|0|||
157028912|NCT00592852|566862845|FG000|Overall Study|Non-compliance|1|||
157028913|NCT00592852|566862845|FG000|Overall Study|Adverse Event|3|||
157028914|NCT00592852|566862845|FG000|Overall Study|Found ineligible|1|||
157028915|NCT00592852|566862845|FG000|Overall Study|Withdrawal by Subject|1|||
157028916|NCT02505984|566862849|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
157028917|NCT02505984|566862850|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
157028918|NCT02505984|566862849|FG000|Overall Study|Unreliable self-report data|1|||
157028919|NCT02505984|566862850|FG001|Overall Study|Unreliable self-report data|0|||
157028920|NCT02505984|566862849|FG000|Overall Study|Study blind opened during assessment|0|||
157028921|NCT02505984|566862850|FG001|Overall Study|Study blind opened during assessment|1|||
157028922|NCT02505984|566862849|FG000|Overall Study|Noncompliance with study protocol|0|||
157028923|NCT02505984|566862850|FG001|Overall Study|Noncompliance with study protocol|1|||
157028924|NCT03691935|566862855|FG000|Overall Study|Physician Decision|2|||
157028925|NCT03691935|566862856|FG001|Overall Study|Physician Decision|1|||
157028926|NCT03691935|566862855|FG000|Overall Study|Adverse Event|3|||
157028927|NCT03691935|566862856|FG001|Overall Study|Adverse Event|0|||
157028928|NCT03511664|566862868|FG000|Overall Study|Death|457|||
157028929|NCT03511664|566862869|FG001|Overall Study|Death|201|||
157028930|NCT03511664|566862870|FG002|Overall Study|Death|21|||
157028931|NCT03511664|566862868|FG000|Overall Study|Withdrew consent|40|||
157028932|NCT03511664|566862869|FG001|Overall Study|Withdrew consent|63|||
157028933|NCT03511664|566862870|FG002|Overall Study|Withdrew consent|3|||
157028934|NCT03511664|566862868|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
157028935|NCT03511664|566862869|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
157028936|NCT03511664|566862870|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
157028937|NCT03511664|566862868|FG000|Overall Study|Lost to Follow-up|8|||
157028938|NCT03511664|566862869|FG001|Overall Study|Lost to Follow-up|5|||
157028939|NCT03511664|566862870|FG002|Overall Study|Lost to Follow-up|0|||
157028940|NCT03511664|566862868|FG000|Overall Study|Physician Decision|2|||
157165464|NCT03569449|567347999|FG000|Overall Study|Withdrawal by Subject|0|||
156925571|NCT03227029|566485415|FG001|Overall Study|Child Wheezed (no treatment)|1|||
156925572|NCT03227029|566485416|FG002|Overall Study|Child Wheezed (no treatment)|0|||
156925573|NCT03227029|566485414|FG000|Overall Study|No post RSV season visit due to COVID|3|||
156925574|NCT03227029|566485415|FG001|Overall Study|No post RSV season visit due to COVID|3|||
157028941|NCT03511664|566862869|FG001|Overall Study|Physician Decision|1|||
157028942|NCT03511664|566862870|FG002|Overall Study|Physician Decision|0|||
157028943|NCT03511664|566862868|FG000|Overall Study|Patient non-compliance|1|||
157028944|NCT03511664|566862869|FG001|Overall Study|Patient non-compliance|0|||
157028945|NCT03511664|566862870|FG002|Overall Study|Patient non-compliance|0|||
157165465|NCT03569449|567348000|FG001|Overall Study|Withdrawal by Subject|1|||
157165466|NCT03569449|567348001|FG002|Overall Study|Withdrawal by Subject|0|||
156925575|NCT03227029|566485416|FG002|Overall Study|No post RSV season visit due to COVID|2|||
156925576|NCT03227029|566485414|FG000|Overall Study|Not able to get to clinic|0|||
157028946|NCT01946789|566862871|FG000|Overall Study|Death|0|||
156925577|NCT03227029|566485415|FG001|Overall Study|Not able to get to clinic|0|||
156925578|NCT03227029|566485416|FG002|Overall Study|Not able to get to clinic|1|||
156925579|NCT03227029|566485414|FG000|Overall Study|Withdrawal by Subject|1|||
156925580|NCT03227029|566485415|FG001|Overall Study|Withdrawal by Subject|0|||
156925581|NCT03227029|566485416|FG002|Overall Study|Withdrawal by Subject|0|||
156925582|NCT03227029|566485414|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
156925583|NCT03227029|566485415|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
156925584|NCT03227029|566485416|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
156925585|NCT03274440|566485417|FG000|Overall Study|Time commitment too great|1|||
156925586|NCT03274440|566485418|FG001|Overall Study|Time commitment too great|0|||
156925587|NCT03274440|566485419|FG002|Overall Study|Time commitment too great|0|||
156925588|NCT03274440|566485420|FG003|Overall Study|Time commitment too great|1|||
156925589|NCT03274440|566485421|FG004|Overall Study|Time commitment too great|0|||
156925590|NCT03274440|566485422|FG005|Overall Study|Time commitment too great|0|||
156925591|NCT01074450|566485427|FG000|First Intervention|Emesis in Dosing Interval|0|||
156925592|NCT01074450|566485428|FG001|First Intervention|Emesis in Dosing Interval|2|||
156925593|NCT01074450|566485427|FG000|Second Intervention|Protocol Violation|1|||
156925594|NCT01074450|566485428|FG001|Second Intervention|Protocol Violation|0|||
156925595|NCT01074450|566485427|FG000|Second Intervention|Physician Decision|0|||
157165467|NCT03569449|567348002|FG003|Overall Study|Withdrawal by Subject|0|||
156925596|NCT01074450|566485428|FG001|Second Intervention|Physician Decision|1|||
156925597|NCT03226392|566485429|FG000|Overall Study|Protocol Deviation|1|||
156925598|NCT03226392|566485430|FG001|Overall Study|Protocol Deviation|0|||
156925599|NCT03226392|566485429|FG000|Overall Study|Physician Decision|1|||
156925600|NCT03226392|566485430|FG001|Overall Study|Physician Decision|0|||
156925601|NCT03226392|566485429|FG000|Overall Study|Lost to Follow-up|1|||
156925602|NCT03226392|566485430|FG001|Overall Study|Lost to Follow-up|0|||
156925603|NCT03226392|566485429|FG000|Overall Study|Adverse Event|1|||
156925604|NCT03226392|566485430|FG001|Overall Study|Adverse Event|0|||
156925605|NCT03226392|566485429|FG000|Overall Study|Technical Problems|0|||
156925606|NCT03226392|566485430|FG001|Overall Study|Technical Problems|2|||
156925607|NCT03226392|566485429|FG000|Overall Study|Subject/Guardian Decision|7|||
156925608|NCT03226392|566485430|FG001|Overall Study|Subject/Guardian Decision|6|||
156925609|NCT02728895|566485431|FG000|Overall Study|Other|1|||
156925610|NCT02728895|566485432|FG001|Overall Study|Other|2|||
157165468|NCT03569449|567348003|FG004|Overall Study|Withdrawal by Subject|1|||
157028947|NCT01946789|566862872|FG001|Overall Study|Death|2|||
157165469|NCT03569449|567348004|FG005|Overall Study|Withdrawal by Subject|0|||
157165470|NCT03569449|567348005|FG006|Overall Study|Withdrawal by Subject|0|||
157165471|NCT03569449|567348006|FG007|Overall Study|Withdrawal by Subject|0|||
157165472|NCT03569449|567348007|FG008|Overall Study|Withdrawal by Subject|0|||
157165473|NCT03569449|567348008|FG009|Overall Study|Withdrawal by Subject|0|||
157165474|NCT03569449|567348009|FG010|Overall Study|Withdrawal by Subject|0|||
157165475|NCT03569449|567348010|FG011|Overall Study|Withdrawal by Subject|0|||
156925611|NCT02728895|566485431|FG000|Overall Study|Withdrawal by Subject|0|||
156925612|NCT02728895|566485432|FG001|Overall Study|Withdrawal by Subject|3|||
156925613|NCT04788953|566485433|FG000|Overall Study|Adverse Event|1|||
156925614|NCT04788953|566485434|FG001|Overall Study|Adverse Event|1|||
156925615|NCT04788953|566485433|FG000|Overall Study|Withdrawal by Subject|1|||
156925616|NCT04788953|566485434|FG001|Overall Study|Withdrawal by Subject|0|||
156925617|NCT04788953|566485433|FG000|Overall Study|Protocol Violation|0|||
156925618|NCT04788953|566485434|FG001|Overall Study|Protocol Violation|1|||
156925619|NCT02024867|566485435|FG000|Overall Study|Protocol Violation|3|||
157165476|NCT03569449|567348011|FG012|Overall Study|Withdrawal by Subject|0|||
157165477|NCT03569449|567348012|FG013|Overall Study|Withdrawal by Subject|0|||
157165478|NCT03569449|567348013|FG014|Overall Study|Withdrawal by Subject|0|||
156925620|NCT02024867|566485436|FG001|Overall Study|Protocol Violation|3|||
156925621|NCT02024867|566485435|FG000|Overall Study|Lost to Follow-up|6|||
156925622|NCT02024867|566485436|FG001|Overall Study|Lost to Follow-up|4|||
156925623|NCT02369341|566485442|FG000|Overall Study|Migrated/moved from study area|1|||
156925624|NCT02369341|566485443|FG001|Overall Study|Migrated/moved from study area|0|||
156925625|NCT01086540|566485444|FG000|Overall Study|Death|3|||
157165479|NCT03569449|567348014|FG015|Overall Study|Withdrawal by Subject|0|||
157165480|NCT05279898|567348026|FG000|Overall Study|Withdrawal by Subject|1|||
157165481|NCT05279898|567348027|FG001|Overall Study|Withdrawal by Subject|0|||
157165482|NCT05279898|567348026|FG000|Overall Study|Physician Decision|1|||
157165483|NCT05279898|567348027|FG001|Overall Study|Physician Decision|1|||
157165484|NCT05136170|567348028|FG000|Overall Study|Withdrawal by Subject|2|||
157165485|NCT05136170|567348029|FG001|Overall Study|Withdrawal by Subject|2|||
157227034|NCT00409578|567576033|FG002|Overall Study|Adverse Event|25|||
156925626|NCT01086540|566485445|FG001|Overall Study|Death|1|||
156925627|NCT01086540|566485444|FG000|Overall Study|Physician Decision|2|||
156925628|NCT01086540|566485445|FG001|Overall Study|Physician Decision|1|||
156925629|NCT01086540|566485444|FG000|Overall Study|Addition of new therapy for PAH|1|||
156925630|NCT01086540|566485445|FG001|Overall Study|Addition of new therapy for PAH|0|||
156925631|NCT02707991|566485450|FG000|Overall Study|Protocol Violation|1|||
156925632|NCT02707991|566485451|FG001|Overall Study|Protocol Violation|0|||
156925633|NCT02707991|566485450|FG000|Overall Study|Became ineligible|0|||
156925634|NCT02707991|566485451|FG001|Overall Study|Became ineligible|1|||
156925635|NCT05407675|566485454|FG000|Overall Study|Withdrawal by Subject|0|||
156925636|NCT05407675|566485455|FG001|Overall Study|Withdrawal by Subject|2|||
156925637|NCT05407675|566485456|FG002|Overall Study|Withdrawal by Subject|3|||
156925638|NCT05407675|566485457|FG003|Overall Study|Withdrawal by Subject|5|||
156925639|NCT05407675|566485458|FG004|Overall Study|Withdrawal by Subject|0|||
156925640|NCT05407675|566485459|FG005|Overall Study|Withdrawal by Subject|2|||
156925641|NCT05407675|566485460|FG006|Overall Study|Withdrawal by Subject|0|||
156925642|NCT05407675|566485461|FG007|Overall Study|Withdrawal by Subject|0|||
156925643|NCT05407675|566485462|FG008|Overall Study|Withdrawal by Subject|2|||
156925644|NCT05407675|566485463|FG009|Overall Study|Withdrawal by Subject|0|||
156925645|NCT05407675|566485464|FG010|Overall Study|Withdrawal by Subject|1|||
156925646|NCT05407675|566485465|FG011|Overall Study|Withdrawal by Subject|0|||
156925647|NCT05407675|566485466|FG012|Overall Study|Withdrawal by Subject|0|||
156925648|NCT05407675|566485454|FG000|Overall Study|Site terminated by sponsor|0|||
156925649|NCT05407675|566485455|FG001|Overall Study|Site terminated by sponsor|0|||
156925650|NCT05407675|566485456|FG002|Overall Study|Site terminated by sponsor|1|||
156925651|NCT05407675|566485457|FG003|Overall Study|Site terminated by sponsor|0|||
156925652|NCT05407675|566485458|FG004|Overall Study|Site terminated by sponsor|2|||
156925653|NCT05407675|566485459|FG005|Overall Study|Site terminated by sponsor|0|||
156925654|NCT05407675|566485460|FG006|Overall Study|Site terminated by sponsor|1|||
156925655|NCT05407675|566485461|FG007|Overall Study|Site terminated by sponsor|0|||
156925656|NCT05407675|566485462|FG008|Overall Study|Site terminated by sponsor|0|||
156925657|NCT05407675|566485463|FG009|Overall Study|Site terminated by sponsor|2|||
156925658|NCT05407675|566485464|FG010|Overall Study|Site terminated by sponsor|2|||
156925659|NCT05407675|566485465|FG011|Overall Study|Site terminated by sponsor|2|||
156925660|NCT05407675|566485466|FG012|Overall Study|Site terminated by sponsor|1|||
156925661|NCT05407675|566485454|FG000|Overall Study|Disease Progression|0|||
156925662|NCT05407675|566485455|FG001|Overall Study|Disease Progression|0|||
156925663|NCT05407675|566485456|FG002|Overall Study|Disease Progression|0|||
156925664|NCT05407675|566485457|FG003|Overall Study|Disease Progression|0|||
156925665|NCT05407675|566485458|FG004|Overall Study|Disease Progression|0|||
156925666|NCT05407675|566485459|FG005|Overall Study|Disease Progression|0|||
156925667|NCT05407675|566485460|FG006|Overall Study|Disease Progression|0|||
156925668|NCT05407675|566485461|FG007|Overall Study|Disease Progression|0|||
156925669|NCT05407675|566485462|FG008|Overall Study|Disease Progression|0|||
156925670|NCT05407675|566485463|FG009|Overall Study|Disease Progression|0|||
156925671|NCT05407675|566485464|FG010|Overall Study|Disease Progression|1|||
156925672|NCT05407675|566485465|FG011|Overall Study|Disease Progression|0|||
156925673|NCT05407675|566485466|FG012|Overall Study|Disease Progression|0|||
156925674|NCT05407675|566485454|FG000|Overall Study|Physician Decision|0|||
156925675|NCT05407675|566485455|FG001|Overall Study|Physician Decision|0|||
156925676|NCT05407675|566485456|FG002|Overall Study|Physician Decision|0|||
156925677|NCT05407675|566485457|FG003|Overall Study|Physician Decision|0|||
156925678|NCT05407675|566485458|FG004|Overall Study|Physician Decision|0|||
156925679|NCT05407675|566485459|FG005|Overall Study|Physician Decision|0|||
156925680|NCT05407675|566485460|FG006|Overall Study|Physician Decision|0|||
156925681|NCT05407675|566485461|FG007|Overall Study|Physician Decision|0|||
156925682|NCT05407675|566485462|FG008|Overall Study|Physician Decision|0|||
156925683|NCT05407675|566485463|FG009|Overall Study|Physician Decision|0|||
156925684|NCT05407675|566485464|FG010|Overall Study|Physician Decision|1|||
156925685|NCT05407675|566485465|FG011|Overall Study|Physician Decision|0|||
156925686|NCT05407675|566485466|FG012|Overall Study|Physician Decision|0|||
156925687|NCT05407675|566485454|FG000|Overall Study|Other reasons|0|||
156925688|NCT05407675|566485455|FG001|Overall Study|Other reasons|0|||
156925689|NCT05407675|566485456|FG002|Overall Study|Other reasons|0|||
156925690|NCT05407675|566485457|FG003|Overall Study|Other reasons|0|||
156925691|NCT05407675|566485458|FG004|Overall Study|Other reasons|0|||
156925692|NCT05407675|566485459|FG005|Overall Study|Other reasons|0|||
156925693|NCT05407675|566485460|FG006|Overall Study|Other reasons|0|||
156925694|NCT05407675|566485461|FG007|Overall Study|Other reasons|0|||
156925695|NCT05407675|566485462|FG008|Overall Study|Other reasons|1|||
156925696|NCT05407675|566485463|FG009|Overall Study|Other reasons|1|||
156925697|NCT05407675|566485464|FG010|Overall Study|Other reasons|1|||
156925698|NCT05407675|566485465|FG011|Overall Study|Other reasons|1|||
156925699|NCT05407675|566485466|FG012|Overall Study|Other reasons|0|||
156925700|NCT05407675|566485454|FG000|Overall Study|Death|3|||
156925701|NCT05407675|566485455|FG001|Overall Study|Death|4|||
156925702|NCT05407675|566485456|FG002|Overall Study|Death|3|||
156925703|NCT05407675|566485457|FG003|Overall Study|Death|6|||
156925704|NCT05407675|566485458|FG004|Overall Study|Death|0|||
156925705|NCT05407675|566485459|FG005|Overall Study|Death|2|||
156925706|NCT05407675|566485460|FG006|Overall Study|Death|4|||
156925707|NCT05407675|566485461|FG007|Overall Study|Death|2|||
156925708|NCT05407675|566485462|FG008|Overall Study|Death|2|||
156925709|NCT05407675|566485463|FG009|Overall Study|Death|4|||
156925710|NCT05407675|566485464|FG010|Overall Study|Death|2|||
156925711|NCT05407675|566485465|FG011|Overall Study|Death|1|||
156925712|NCT05407675|566485466|FG012|Overall Study|Death|0|||
156925713|NCT05407675|566485454|FG000|Overall Study|Adverse Event|0|||
156925714|NCT05407675|566485455|FG001|Overall Study|Adverse Event|0|||
156925715|NCT05407675|566485456|FG002|Overall Study|Adverse Event|0|||
156925716|NCT05407675|566485457|FG003|Overall Study|Adverse Event|0|||
156925717|NCT05407675|566485458|FG004|Overall Study|Adverse Event|1|||
156925718|NCT05407675|566485459|FG005|Overall Study|Adverse Event|0|||
156925719|NCT05407675|566485460|FG006|Overall Study|Adverse Event|0|||
156925720|NCT05407675|566485461|FG007|Overall Study|Adverse Event|0|||
156925721|NCT05407675|566485462|FG008|Overall Study|Adverse Event|0|||
156925722|NCT05407675|566485463|FG009|Overall Study|Adverse Event|0|||
156925723|NCT05407675|566485464|FG010|Overall Study|Adverse Event|0|||
156925724|NCT05407675|566485465|FG011|Overall Study|Adverse Event|1|||
156925725|NCT05407675|566485466|FG012|Overall Study|Adverse Event|0|||
156925726|NCT05407675|566485454|FG000|Overall Study|Ongoing Treatment|0|||
156925727|NCT05407675|566485455|FG001|Overall Study|Ongoing Treatment|0|||
156925728|NCT05407675|566485456|FG002|Overall Study|Ongoing Treatment|0|||
156925729|NCT05407675|566485457|FG003|Overall Study|Ongoing Treatment|0|||
156925730|NCT05407675|566485458|FG004|Overall Study|Ongoing Treatment|0|||
156925731|NCT05407675|566485459|FG005|Overall Study|Ongoing Treatment|0|||
156925732|NCT05407675|566485460|FG006|Overall Study|Ongoing Treatment|0|||
156925733|NCT05407675|566485461|FG007|Overall Study|Ongoing Treatment|0|||
156925734|NCT05407675|566485462|FG008|Overall Study|Ongoing Treatment|1|||
156925735|NCT05407675|566485463|FG009|Overall Study|Ongoing Treatment|0|||
156925736|NCT05407675|566485464|FG010|Overall Study|Ongoing Treatment|0|||
156925737|NCT05407675|566485465|FG011|Overall Study|Ongoing Treatment|0|||
156925738|NCT05407675|566485466|FG012|Overall Study|Ongoing Treatment|0|||
156925739|NCT04128267|566485472|FG000|Overall Study|Withdrawal by Subject|6|||
156925740|NCT04128267|566485472|FG000|Overall Study|Death|2|||
156925741|NCT04128267|566485472|FG000|Overall Study|Disease progression|1|||
156925742|NCT04128267|566485472|FG000|Overall Study|Participant had other medical issues|4|||
156925743|NCT04128267|566485472|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
156925744|NCT04501666|566485473|FG000|Overall Study|Physician Decision|0|||
156925745|NCT04501666|566485474|FG001|Overall Study|Physician Decision|1|||
156925746|NCT04501666|566485473|FG000|Overall Study|Adverse Event|12|||
156925747|NCT04501666|566485474|FG001|Overall Study|Adverse Event|4|||
156925748|NCT04501666|566485473|FG000|Overall Study|Subject's request|10|||
156925749|NCT04501666|566485474|FG001|Overall Study|Subject's request|6|||
156925750|NCT04501666|566485473|FG000|Overall Study|Protocol Deviation|2|||
156925751|NCT04501666|566485474|FG001|Overall Study|Protocol Deviation|1|||
156925752|NCT04501666|566485473|FG000|Overall Study|Other-- site permanently closing|0|||
156925753|NCT04501666|566485474|FG001|Overall Study|Other-- site permanently closing|1|||
156925754|NCT00642941|566485477|FG000|Overall Study|Physician Decision|3|||
156925755|NCT00642941|566485478|FG001|Overall Study|Physician Decision|1|||
156925756|NCT00642941|566485479|FG002|Overall Study|Physician Decision|0|||
156925757|NCT00642941|566485480|FG003|Overall Study|Physician Decision|0|||
156925758|NCT00642941|566485481|FG004|Overall Study|Physician Decision|0|||
156925759|NCT00642941|566485482|FG005|Overall Study|Physician Decision|0|||
156925760|NCT00642941|566485483|FG006|Overall Study|Physician Decision|1|||
156925761|NCT00642941|566485484|FG007|Overall Study|Physician Decision|0|||
156925762|NCT00642941|566485485|FG008|Overall Study|Physician Decision|0|||
156925763|NCT00642941|566485486|FG009|Overall Study|Physician Decision|1|||
156925764|NCT00642941|566485487|FG010|Overall Study|Physician Decision|0|||
156925765|NCT00642941|566485488|FG011|Overall Study|Physician Decision|1|||
156925766|NCT00642941|566485477|FG000|Overall Study|Death|4|||
156925767|NCT00642941|566485478|FG001|Overall Study|Death|0|||
156925768|NCT00642941|566485479|FG002|Overall Study|Death|1|||
156925769|NCT00642941|566485480|FG003|Overall Study|Death|1|||
156925770|NCT00642941|566485481|FG004|Overall Study|Death|2|||
156925771|NCT00642941|566485482|FG005|Overall Study|Death|1|||
156925772|NCT00642941|566485483|FG006|Overall Study|Death|0|||
156925773|NCT00642941|566485484|FG007|Overall Study|Death|0|||
156925774|NCT00642941|566485485|FG008|Overall Study|Death|0|||
156925775|NCT00642941|566485486|FG009|Overall Study|Death|0|||
156925776|NCT00642941|566485487|FG010|Overall Study|Death|0|||
156925777|NCT00642941|566485488|FG011|Overall Study|Death|1|||
156925778|NCT00642941|566485477|FG000|Overall Study|Study closed by Sponsor|0|||
156925779|NCT00642941|566485478|FG001|Overall Study|Study closed by Sponsor|1|||
156925780|NCT00642941|566485479|FG002|Overall Study|Study closed by Sponsor|0|||
156925781|NCT00642941|566485480|FG003|Overall Study|Study closed by Sponsor|0|||
156925782|NCT00642941|566485481|FG004|Overall Study|Study closed by Sponsor|0|||
156925783|NCT00642941|566485482|FG005|Overall Study|Study closed by Sponsor|0|||
156925784|NCT00642941|566485483|FG006|Overall Study|Study closed by Sponsor|0|||
156925785|NCT00642941|566485484|FG007|Overall Study|Study closed by Sponsor|0|||
156925786|NCT00642941|566485485|FG008|Overall Study|Study closed by Sponsor|0|||
156925787|NCT00642941|566485486|FG009|Overall Study|Study closed by Sponsor|0|||
156925788|NCT00642941|566485487|FG010|Overall Study|Study closed by Sponsor|0|||
156925789|NCT00642941|566485488|FG011|Overall Study|Study closed by Sponsor|0|||
156925790|NCT00642941|566485477|FG000|Overall Study|Withdrawal by Subject|1|||
156925791|NCT00642941|566485478|FG001|Overall Study|Withdrawal by Subject|0|||
156925792|NCT00642941|566485479|FG002|Overall Study|Withdrawal by Subject|0|||
156925793|NCT00642941|566485480|FG003|Overall Study|Withdrawal by Subject|2|||
156925794|NCT00642941|566485481|FG004|Overall Study|Withdrawal by Subject|0|||
156925795|NCT00642941|566485482|FG005|Overall Study|Withdrawal by Subject|0|||
156925796|NCT00642941|566485483|FG006|Overall Study|Withdrawal by Subject|2|||
156925797|NCT00642941|566485484|FG007|Overall Study|Withdrawal by Subject|0|||
156925798|NCT00642941|566485485|FG008|Overall Study|Withdrawal by Subject|1|||
156925799|NCT00642941|566485486|FG009|Overall Study|Withdrawal by Subject|0|||
157165486|NCT05136170|567348028|FG000|Overall Study|Can no longer make office visits|1|||
157165487|NCT05136170|567348029|FG001|Overall Study|Can no longer make office visits|0|||
157165488|NCT04393038|567348030|FG000|Overall Study|Adverse Event|11|||
157165489|NCT04393038|567348031|FG001|Overall Study|Adverse Event|2|||
156925800|NCT00642941|566485487|FG010|Overall Study|Withdrawal by Subject|0|||
156925801|NCT00642941|566485488|FG011|Overall Study|Withdrawal by Subject|1|||
156925802|NCT00642941|566485477|FG000|Overall Study|Protocol Violation|0|||
156925803|NCT00642941|566485478|FG001|Overall Study|Protocol Violation|0|||
156925804|NCT00642941|566485479|FG002|Overall Study|Protocol Violation|0|||
156925805|NCT00642941|566485480|FG003|Overall Study|Protocol Violation|0|||
156925806|NCT00642941|566485481|FG004|Overall Study|Protocol Violation|0|||
156925807|NCT00642941|566485482|FG005|Overall Study|Protocol Violation|0|||
156925808|NCT00642941|566485483|FG006|Overall Study|Protocol Violation|1|||
156925809|NCT00642941|566485484|FG007|Overall Study|Protocol Violation|0|||
156925810|NCT00642941|566485485|FG008|Overall Study|Protocol Violation|0|||
156925811|NCT00642941|566485486|FG009|Overall Study|Protocol Violation|0|||
156925812|NCT00642941|566485487|FG010|Overall Study|Protocol Violation|0|||
156925813|NCT00642941|566485488|FG011|Overall Study|Protocol Violation|0|||
156925814|NCT00642941|566485477|FG000|Overall Study|Adverse Event|1|||
156925815|NCT00642941|566485478|FG001|Overall Study|Adverse Event|1|||
156925816|NCT00642941|566485479|FG002|Overall Study|Adverse Event|0|||
156925817|NCT00642941|566485480|FG003|Overall Study|Adverse Event|0|||
156925818|NCT00642941|566485481|FG004|Overall Study|Adverse Event|0|||
156925819|NCT00642941|566485482|FG005|Overall Study|Adverse Event|0|||
156925820|NCT00642941|566485483|FG006|Overall Study|Adverse Event|1|||
156925821|NCT00642941|566485484|FG007|Overall Study|Adverse Event|1|||
156925822|NCT00642941|566485485|FG008|Overall Study|Adverse Event|0|||
156925823|NCT00642941|566485486|FG009|Overall Study|Adverse Event|1|||
156925824|NCT00642941|566485487|FG010|Overall Study|Adverse Event|0|||
156925825|NCT00642941|566485488|FG011|Overall Study|Adverse Event|0|||
156925826|NCT00642941|566485477|FG000|Overall Study|Other|1|||
156925827|NCT00642941|566485478|FG001|Overall Study|Other|1|||
156925828|NCT00642941|566485479|FG002|Overall Study|Other|1|||
156925829|NCT00642941|566485480|FG003|Overall Study|Other|1|||
156925830|NCT00642941|566485481|FG004|Overall Study|Other|0|||
156925831|NCT00642941|566485482|FG005|Overall Study|Other|1|||
156925832|NCT00642941|566485483|FG006|Overall Study|Other|0|||
156925833|NCT00642941|566485484|FG007|Overall Study|Other|1|||
156925834|NCT00642941|566485485|FG008|Overall Study|Other|0|||
156925835|NCT00642941|566485486|FG009|Overall Study|Other|0|||
156925836|NCT00642941|566485487|FG010|Overall Study|Other|0|||
156925837|NCT00642941|566485488|FG011|Overall Study|Other|1|||
157165490|NCT04393038|567348030|FG000|Overall Study|Protocol Violation|1|||
157165491|NCT04393038|567348031|FG001|Overall Study|Protocol Violation|0|||
157165492|NCT04393038|567348030|FG000|Overall Study|Death|6|||
157165493|NCT04393038|567348031|FG001|Overall Study|Death|4|||
157165494|NCT04393038|567348030|FG000|Overall Study|Withdrawal by Subject|24|||
157165495|NCT04393038|567348031|FG001|Overall Study|Withdrawal by Subject|8|||
157165496|NCT04393038|567348030|FG000|Overall Study|Lost to Follow-up|5|||
156925838|NCT00642941|566485477|FG000|Overall Study|Disease progression|60|||
157165497|NCT04393038|567348031|FG001|Overall Study|Lost to Follow-up|4|||
157165498|NCT04393038|567348030|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
157165499|NCT04393038|567348031|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
157165500|NCT04393038|567348030|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
157165501|NCT04393038|567348031|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
157165502|NCT05168813|567348032|FG000|Part A (Open-label)|Lost to Follow-up|21|||
156925839|NCT00642941|566485478|FG001|Overall Study|Disease progression|50|||
156925840|NCT00642941|566485479|FG002|Overall Study|Disease progression|5|||
156925841|NCT00642941|566485480|FG003|Overall Study|Disease progression|36|||
156925842|NCT00642941|566485481|FG004|Overall Study|Disease progression|23|||
156925843|NCT00642941|566485482|FG005|Overall Study|Disease progression|39|||
157165503|NCT05168813|567348033|FG001|Part A (Open-label)|Lost to Follow-up|39|||
156925844|NCT00642941|566485483|FG006|Overall Study|Disease progression|18|||
156925845|NCT00642941|566485484|FG007|Overall Study|Disease progression|12|||
156925846|NCT00642941|566485485|FG008|Overall Study|Disease progression|10|||
156925847|NCT00642941|566485486|FG009|Overall Study|Disease progression|7|||
156925848|NCT00642941|566485487|FG010|Overall Study|Disease progression|12|||
156925849|NCT00642941|566485488|FG011|Overall Study|Disease progression|7|||
156925850|NCT00553150|566485490|FG000|Overall Study|Withdrawal by Subject|0|||
156925851|NCT00553150|566485491|FG001|Overall Study|Withdrawal by Subject|0|||
156925852|NCT00553150|566485492|FG002|Overall Study|Withdrawal by Subject|0|||
156925853|NCT00553150|566485493|FG003|Overall Study|Withdrawal by Subject|2|||
156925854|NCT00553150|566485490|FG000|Overall Study|Protocol Violation|0|||
156925855|NCT00553150|566485491|FG001|Overall Study|Protocol Violation|0|||
156925856|NCT00553150|566485492|FG002|Overall Study|Protocol Violation|0|||
156925857|NCT00553150|566485493|FG003|Overall Study|Protocol Violation|1|||
156925858|NCT00553150|566485490|FG000|Overall Study|Ineligible|0|||
156925859|NCT00553150|566485491|FG001|Overall Study|Ineligible|0|||
156925860|NCT00553150|566485492|FG002|Overall Study|Ineligible|0|||
156925861|NCT00553150|566485493|FG003|Overall Study|Ineligible|1|||
156925862|NCT03251079|566485495|FG000|Overall Study|Withdrawal by Subject|1|||
156925863|NCT02626520|566485508|FG000|Overall Study|Physician Decision|1|||
156925864|NCT02626520|566485509|FG001|Overall Study|Physician Decision|1|||
156925865|NCT02626520|566485508|FG000|Overall Study|Adverse Event|0|||
156925866|NCT02626520|566485509|FG001|Overall Study|Adverse Event|4|||
156925867|NCT02626520|566485508|FG000|Overall Study|Lack of Efficacy|0|||
156925868|NCT02626520|566485509|FG001|Overall Study|Lack of Efficacy|2|||
156925869|NCT02626520|566485508|FG000|Overall Study|Did not start protocol therapy|0|||
156925870|NCT02626520|566485509|FG001|Overall Study|Did not start protocol therapy|2|||
156925871|NCT02626520|566485508|FG000|Overall Study|Study terminated|0|||
156925872|NCT02626520|566485509|FG001|Overall Study|Study terminated|1|||
156925873|NCT00492115|566485510|FG000|Overall Study|Withdrawal by Subject|3|||
156925874|NCT00492115|566485511|FG001|Overall Study|Withdrawal by Subject|4|||
156925875|NCT03915496|566485514|FG000|Overall Study|Adverse Event|2|||
156925876|NCT03915496|566485515|FG001|Overall Study|Adverse Event|1|||
156925877|NCT03915496|566485516|FG002|Overall Study|Adverse Event|2|||
156925878|NCT02472795|566485517|FG000|Overall Study|Adverse Event|0|||
156925879|NCT02472795|566485518|FG001|Overall Study|Adverse Event|1|||
156925880|NCT02472795|566485519|FG002|Overall Study|Adverse Event|0|||
156925881|NCT02472795|566485520|FG003|Overall Study|Adverse Event|0|||
156925882|NCT02472795|566485521|FG004|Overall Study|Adverse Event|2|||
156925883|NCT02472795|566485517|FG000|Overall Study|Withdrawal by Subject|0|||
156925884|NCT02472795|566485518|FG001|Overall Study|Withdrawal by Subject|0|||
156925885|NCT02472795|566485519|FG002|Overall Study|Withdrawal by Subject|0|||
156925886|NCT02472795|566485520|FG003|Overall Study|Withdrawal by Subject|0|||
156925887|NCT02472795|566485521|FG004|Overall Study|Withdrawal by Subject|1|||
156925888|NCT03712904|566486676|FG000|Overall Study|Death|0|||
156925889|NCT03712904|566486677|FG001|Overall Study|Death|1|||
156925890|NCT03712904|566486676|FG000|Overall Study|Withdrawal by Subject|0|||
156925891|NCT03712904|566486677|FG001|Overall Study|Withdrawal by Subject|1|||
156925892|NCT03712904|566486676|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
156925893|NCT03712904|566486677|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
156925894|NCT00773292|566486679|FG000|Treatment 48 Weeks|Adverse Event|1|||
156925895|NCT00773292|566486679|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
156925896|NCT03525574|566486680|FG000|Overall Study|Adverse Event|15|||
156925897|NCT03525574|566486681|FG001|Overall Study|Adverse Event|0|||
156925898|NCT03525574|566486680|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
156925899|NCT03525574|566486681|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
156925900|NCT03525574|566486680|FG000|Overall Study|Lost to Follow-up|4|||
156925901|NCT03525574|566486681|FG001|Overall Study|Lost to Follow-up|0|||
156925902|NCT03525574|566486680|FG000|Overall Study|Commercial drug is Available for participant|48|||
156925903|NCT03525574|566486681|FG001|Overall Study|Commercial drug is Available for participant|0|||
156925904|NCT03525574|566486680|FG000|Overall Study|Death|1|||
156925905|NCT03525574|566486681|FG001|Overall Study|Death|0|||
156925906|NCT03525574|566486680|FG000|Overall Study|Other non-compliance|2|||
156925907|NCT03525574|566486681|FG001|Overall Study|Other non-compliance|0|||
156925908|NCT03525574|566486680|FG000|Overall Study|Physician Decision|6|||
156925909|NCT03525574|566486681|FG001|Overall Study|Physician Decision|0|||
156925910|NCT03525574|566486680|FG000|Overall Study|Other|58|||
156925911|NCT03525574|566486681|FG001|Overall Study|Other|0|||
156925912|NCT03525574|566486680|FG000|Overall Study|Enrolled but never dosed|1|||
156925913|NCT03525574|566486681|FG001|Overall Study|Enrolled but never dosed|0|||
156925914|NCT03525574|566486680|FG000|Overall Study|Not enrolled in 105 study|0|||
156925915|NCT03525574|566486681|FG001|Overall Study|Not enrolled in 105 study|3|||
156925916|NCT02769247|566486685|FG000|Overall Study|Withdrawal by Subject|1|||
156925917|NCT02769247|566486686|FG001|Overall Study|Withdrawal by Subject|0|||
156925918|NCT02769247|566486687|FG002|Overall Study|Withdrawal by Subject|0|||
156925919|NCT02769247|566486688|FG003|Overall Study|Withdrawal by Subject|1|||
156925920|NCT02769247|566486685|FG000|Overall Study|Protocol Violation|0|||
157165504|NCT05168813|567348034|FG002|Part A (Open-label)|Lost to Follow-up|8|||
156925921|NCT02769247|566486686|FG001|Overall Study|Protocol Violation|0|||
156925922|NCT02769247|566486687|FG002|Overall Study|Protocol Violation|1|||
156925923|NCT02769247|566486688|FG003|Overall Study|Protocol Violation|0|||
156925924|NCT02769247|566486685|FG000|Overall Study|Physician Decision|1|||
156925925|NCT02769247|566486686|FG001|Overall Study|Physician Decision|0|||
156925926|NCT02769247|566486687|FG002|Overall Study|Physician Decision|0|||
156925927|NCT02769247|566486688|FG003|Overall Study|Physician Decision|0|||
156925928|NCT00469092|566486689|FG000|Overall Study|Adverse Event|5|||
156925929|NCT00469092|566486690|FG001|Overall Study|Adverse Event|4|||
156925930|NCT00469092|566486689|FG000|Overall Study|Lack of Efficacy|1|||
156925931|NCT00469092|566486690|FG001|Overall Study|Lack of Efficacy|0|||
156925932|NCT00469092|566486689|FG000|Overall Study|Lost to Follow-up|1|||
156925933|NCT00469092|566486690|FG001|Overall Study|Lost to Follow-up|2|||
156925934|NCT00469092|566486689|FG000|Overall Study|Protocol Violation|3|||
156925935|NCT00469092|566486690|FG001|Overall Study|Protocol Violation|3|||
156925936|NCT00469092|566486689|FG000|Overall Study|Withdrawal by Subject|4|||
156925937|NCT00469092|566486690|FG001|Overall Study|Withdrawal by Subject|4|||
156925938|NCT00469092|566486689|FG000|Overall Study|Withdrawal Criteria|3|||
156925939|NCT00469092|566486690|FG001|Overall Study|Withdrawal Criteria|4|||
156925940|NCT00469092|566486689|FG000|Overall Study|Incorrectly Randomised|4|||
156925941|NCT00469092|566486690|FG001|Overall Study|Incorrectly Randomised|3|||
156925942|NCT00469092|566486689|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
156925943|NCT00469092|566486690|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
156925944|NCT00469092|566486689|FG000|Overall Study|Use of lipid lowering drug|1|||
156925945|NCT00469092|566486690|FG001|Overall Study|Use of lipid lowering drug|0|||
156925946|NCT00469092|566486689|FG000|Overall Study|Hypoglycaemic Episodes|1|||
156925947|NCT00469092|566486690|FG001|Overall Study|Hypoglycaemic Episodes|1|||
156925948|NCT00469092|566486689|FG000|Overall Study|Abnormal lab value|1|||
156925949|NCT00469092|566486690|FG001|Overall Study|Abnormal lab value|0|||
156925950|NCT00469092|566486689|FG000|Overall Study|Use of Corticosteroid|1|||
156925951|NCT00469092|566486690|FG001|Overall Study|Use of Corticosteroid|0|||
156925952|NCT02150954|566486691|FG000|Overall Study|Protocol Violation|1|||
156925953|NCT02150954|566486692|FG001|Overall Study|Protocol Violation|0|||
156925954|NCT01998737|566486697|FG000|Overall Study|Corrupted database|23|||
156925955|NCT01998737|566486698|FG001|Overall Study|Corrupted database|0|||
156925956|NCT02092662|566486699|FG000|Overall Study|Lost to Follow-up|13|||
156925957|NCT02092662|566486700|FG001|Overall Study|Lost to Follow-up|0|||
156925958|NCT02268864|566486702|FG000|Overall Study|Withdrawal by Subject|2|||
156925959|NCT02268864|566486703|FG001|Overall Study|Withdrawal by Subject|0|||
156925960|NCT02268864|566486704|FG002|Overall Study|Withdrawal by Subject|0|||
156925961|NCT02268864|566486702|FG000|Overall Study|Death|0|||
156925962|NCT02268864|566486703|FG001|Overall Study|Death|1|||
156925963|NCT02268864|566486704|FG002|Overall Study|Death|0|||
156925964|NCT01050257|566486705|FG000|Overall Study|Adverse Event|4|||
156925965|NCT01050257|566486706|FG001|Overall Study|Adverse Event|4|||
156925966|NCT01050257|566486707|FG002|Overall Study|Adverse Event|2|||
156925967|NCT01050257|566486705|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
156925968|NCT01050257|566486706|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
156925969|NCT01050257|566486707|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
156925970|NCT01050257|566486705|FG000|Overall Study|Withdrawal by Subject|0|||
156925971|NCT01050257|566486706|FG001|Overall Study|Withdrawal by Subject|3|||
156925972|NCT01050257|566486707|FG002|Overall Study|Withdrawal by Subject|0|||
156925973|NCT01050257|566486705|FG000|Overall Study|No reason specified|0|||
156925974|NCT01050257|566486706|FG001|Overall Study|No reason specified|0|||
156925975|NCT01050257|566486707|FG002|Overall Study|No reason specified|2|||
156925976|NCT01050257|566486705|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
156925977|NCT01050257|566486706|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
156925978|NCT01050257|566486707|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
156925979|NCT01050257|566486705|FG000|Overall Study|Violation criteria|0|||
156925980|NCT01050257|566486706|FG001|Overall Study|Violation criteria|1|||
156925981|NCT01050257|566486707|FG002|Overall Study|Violation criteria|0|||
156925982|NCT01050257|566486705|FG000|Overall Study|Failure to return|0|||
156925983|NCT01050257|566486706|FG001|Overall Study|Failure to return|2|||
156925984|NCT01050257|566486707|FG002|Overall Study|Failure to return|0|||
156925985|NCT01050257|566486705|FG000|Overall Study|Death|0|||
156925986|NCT01050257|566486706|FG001|Overall Study|Death|0|||
156925987|NCT01050257|566486707|FG002|Overall Study|Death|1|||
156925988|NCT00171223|566486708|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
156925989|NCT00171223|566486709|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
156925990|NCT00171223|566486710|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
156925991|NCT00171223|566486708|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
156925992|NCT00171223|566486709|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
156925993|NCT00171223|566486710|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
156925994|NCT00171223|566486708|FG000|Overall Study|Abnormal Procedure|1|||
156925995|NCT00171223|566486709|FG001|Overall Study|Abnormal Procedure|0|||
156925996|NCT00171223|566486710|FG002|Overall Study|Abnormal Procedure|0|||
157165505|NCT05168813|567348035|FG003|Part A (Open-label)|Lost to Follow-up|26|||
157165506|NCT05168813|567348036|FG004|Part A (Open-label)|Lost to Follow-up|0|||
156925997|NCT00171223|566486708|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
156925998|NCT00171223|566486709|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
156925999|NCT00171223|566486710|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
156926000|NCT00171223|566486708|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
156926001|NCT00171223|566486709|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
156926002|NCT00171223|566486710|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
156926003|NCT00171223|566486708|FG000|Overall Study|Protocol Violation|2|||
156926004|NCT00171223|566486709|FG001|Overall Study|Protocol Violation|2|||
157165507|NCT05168813|567348037|FG005|Part A (Open-label)|Lost to Follow-up|0|||
157165508|NCT05168813|567348032|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
157165509|NCT05168813|567348033|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
157165510|NCT05168813|567348034|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
157165511|NCT05168813|567348035|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
157165512|NCT05168813|567348036|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
157165513|NCT05168813|567348037|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
157165514|NCT05168813|567348032|FG000|Part A (Open-label)|Death|23|||
157165515|NCT05168813|567348033|FG001|Part A (Open-label)|Death|28|||
157165516|NCT05168813|567348034|FG002|Part A (Open-label)|Death|1|||
157165517|NCT05168813|567348035|FG003|Part A (Open-label)|Death|9|||
157165518|NCT05168813|567348036|FG004|Part A (Open-label)|Death|0|||
157165519|NCT05168813|567348037|FG005|Part A (Open-label)|Death|0|||
157165520|NCT05168813|567348032|FG000|Part A (Open-label)|Physician Decision|0|||
157165521|NCT05168813|567348033|FG001|Part A (Open-label)|Physician Decision|1|||
157165522|NCT05168813|567348034|FG002|Part A (Open-label)|Physician Decision|0|||
157165523|NCT05168813|567348035|FG003|Part A (Open-label)|Physician Decision|2|||
157165524|NCT05168813|567348036|FG004|Part A (Open-label)|Physician Decision|0|||
157165525|NCT05168813|567348037|FG005|Part A (Open-label)|Physician Decision|0|||
157165526|NCT05168813|567348032|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
157165527|NCT05168813|567348033|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
157165528|NCT05168813|567348034|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
157165529|NCT05168813|567348035|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
157165530|NCT05168813|567348036|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
157165531|NCT05168813|567348037|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
157165532|NCT05168813|567348032|FG000|Part A (Open-label)|Protocol Violation|0|||
157165533|NCT05168813|567348033|FG001|Part A (Open-label)|Protocol Violation|1|||
157165534|NCT05168813|567348034|FG002|Part A (Open-label)|Protocol Violation|0|||
157165535|NCT05168813|567348035|FG003|Part A (Open-label)|Protocol Violation|0|||
157165536|NCT05168813|567348036|FG004|Part A (Open-label)|Protocol Violation|0|||
157165537|NCT05168813|567348037|FG005|Part A (Open-label)|Protocol Violation|0|||
157028948|NCT01946789|566862873|FG002|Overall Study|Death|1|||
157028949|NCT01946789|566862874|FG003|Overall Study|Death|1|||
157028950|NCT01946789|566862875|FG004|Overall Study|Death|1|||
157028951|NCT01946789|566862876|FG005|Overall Study|Death|1|||
157028952|NCT01946789|566862877|FG006|Overall Study|Death|3|||
157028953|NCT01946789|566862878|FG007|Overall Study|Death|1|||
157165538|NCT05168813|567348032|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
157165539|NCT05168813|567348033|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
157165540|NCT05168813|567348034|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
157165541|NCT05168813|567348035|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
157165542|NCT05168813|567348036|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
157165543|NCT05168813|567348037|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
157165544|NCT05168813|567348032|FG000|Part A (Open-label)|Other|0|||
157165545|NCT05168813|567348033|FG001|Part A (Open-label)|Other|1|||
157165546|NCT05168813|567348034|FG002|Part A (Open-label)|Other|0|||
157165547|NCT05168813|567348035|FG003|Part A (Open-label)|Other|0|||
157165548|NCT05168813|567348036|FG004|Part A (Open-label)|Other|0|||
157165549|NCT05168813|567348037|FG005|Part A (Open-label)|Other|0|||
157165550|NCT05168813|567348032|FG000|Part B (Blinded)|Lost to Follow-up|0|||
157165551|NCT05168813|567348033|FG001|Part B (Blinded)|Lost to Follow-up|0|||
157165552|NCT05168813|567348034|FG002|Part B (Blinded)|Lost to Follow-up|0|||
157165553|NCT05168813|567348035|FG003|Part B (Blinded)|Lost to Follow-up|0|||
157165554|NCT05168813|567348036|FG004|Part B (Blinded)|Lost to Follow-up|219|||
157165555|NCT05168813|567348037|FG005|Part B (Blinded)|Lost to Follow-up|88|||
157165556|NCT05168813|567348032|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
157165557|NCT05168813|567348033|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
157165558|NCT05168813|567348034|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
157165559|NCT05168813|567348035|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
157165560|NCT05168813|567348036|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
157165561|NCT05168813|567348037|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
157028954|NCT01946789|566862879|FG008|Overall Study|Death|2|||
157028955|NCT01946789|566862871|FG000|Overall Study|Progressive Disease|0|||
157165562|NCT05168813|567348032|FG000|Part B (Blinded)|Death|0|||
157165563|NCT05168813|567348033|FG001|Part B (Blinded)|Death|0|||
157165564|NCT05168813|567348034|FG002|Part B (Blinded)|Death|0|||
157165565|NCT05168813|567348035|FG003|Part B (Blinded)|Death|0|||
157165566|NCT05168813|567348036|FG004|Part B (Blinded)|Death|63|||
157028956|NCT01946789|566862872|FG001|Overall Study|Progressive Disease|0|||
157165567|NCT05168813|567348037|FG005|Part B (Blinded)|Death|19|||
157165568|NCT05168813|567348032|FG000|Part B (Blinded)|Physician Decision|0|||
157165569|NCT05168813|567348033|FG001|Part B (Blinded)|Physician Decision|0|||
157165570|NCT05168813|567348034|FG002|Part B (Blinded)|Physician Decision|0|||
157165571|NCT05168813|567348035|FG003|Part B (Blinded)|Physician Decision|0|||
157227035|NCT00409578|567576034|FG003|Overall Study|Adverse Event|33|||
157028957|NCT01946789|566862873|FG002|Overall Study|Progressive Disease|1|||
157028958|NCT01946789|566862874|FG003|Overall Study|Progressive Disease|0|||
157165572|NCT05168813|567348036|FG004|Part B (Blinded)|Physician Decision|6|||
157165573|NCT05168813|567348037|FG005|Part B (Blinded)|Physician Decision|1|||
157165574|NCT05168813|567348032|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
157165575|NCT05168813|567348033|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
157165576|NCT05168813|567348034|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
157165577|NCT05168813|567348035|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
157165578|NCT05168813|567348036|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
157165579|NCT05168813|567348037|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
157165580|NCT05168813|567348032|FG000|Part B (Blinded)|Pregnancy|0|||
157165581|NCT05168813|567348033|FG001|Part B (Blinded)|Pregnancy|0|||
157165582|NCT05168813|567348034|FG002|Part B (Blinded)|Pregnancy|0|||
157165583|NCT05168813|567348035|FG003|Part B (Blinded)|Pregnancy|0|||
157165584|NCT05168813|567348036|FG004|Part B (Blinded)|Pregnancy|1|||
157165585|NCT05168813|567348037|FG005|Part B (Blinded)|Pregnancy|0|||
157165586|NCT05168813|567348032|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
157165587|NCT05168813|567348033|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
157165588|NCT05168813|567348034|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
157165589|NCT05168813|567348035|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
157165590|NCT05168813|567348036|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
157165591|NCT05168813|567348037|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
157165592|NCT05168813|567348032|FG000|Part B (Blinded)|Other|0|||
157165593|NCT05168813|567348033|FG001|Part B (Blinded)|Other|0|||
156926005|NCT00171223|566486710|FG002|Overall Study|Protocol Violation|3|||
156926006|NCT00171223|566486708|FG000|Overall Study|Participant Withdrew Consent|12|||
156926007|NCT00171223|566486709|FG001|Overall Study|Participant Withdrew Consent|21|||
156926008|NCT00171223|566486710|FG002|Overall Study|Participant Withdrew Consent|15|||
156926009|NCT00171223|566486708|FG000|Overall Study|Lost to Follow-up|5|||
156926010|NCT00171223|566486709|FG001|Overall Study|Lost to Follow-up|2|||
156926011|NCT00171223|566486710|FG002|Overall Study|Lost to Follow-up|3|||
156926012|NCT00171223|566486708|FG000|Overall Study|Administrative Problems|4|||
156926013|NCT00171223|566486709|FG001|Overall Study|Administrative Problems|7|||
156926014|NCT00171223|566486710|FG002|Overall Study|Administrative Problems|6|||
156926015|NCT00171223|566486708|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
156926016|NCT00171223|566486709|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
156926017|NCT00171223|566486710|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
156926018|NCT00171223|566486708|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
156926019|NCT00171223|566486709|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
156926020|NCT00171223|566486710|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
156926021|NCT00278109|566486712|FG000|Overall Study|Adverse Event|3|||
156926022|NCT00278109|566486712|FG000|Overall Study|social circumstances|1|||
156926023|NCT02580357|566486713|FG000|Overall Study|Lost to Follow-up|2|||
156926024|NCT02580357|566486714|FG001|Overall Study|Lost to Follow-up|0|||
156926025|NCT02580357|566486715|FG002|Overall Study|Lost to Follow-up|0|||
156926026|NCT02580357|566486713|FG000|Overall Study|Protocol Violation|1|||
156926027|NCT02580357|566486714|FG001|Overall Study|Protocol Violation|0|||
156926028|NCT02580357|566486715|FG002|Overall Study|Protocol Violation|0|||
156926029|NCT02064166|566486716|FG000|Overall Study|Adverse Event|1|||
156926030|NCT02064166|566486717|FG001|Overall Study|Adverse Event|0|||
156926031|NCT04339296|566486723|FG000|Overall Study|Refuse to participate after allocation|1|||
156926032|NCT04339296|566486724|FG001|Overall Study|Refuse to participate after allocation|1|||
156926033|NCT04339296|566486723|FG000|Overall Study|Withdrew after completion of baseline|2|||
156926034|NCT04339296|566486724|FG001|Overall Study|Withdrew after completion of baseline|1|||
156926035|NCT04339296|566486723|FG000|Overall Study|Lost to Follow-up|0|||
156926036|NCT04339296|566486724|FG001|Overall Study|Lost to Follow-up|4|||
156926037|NCT04339296|566486723|FG000|Overall Study|Discontinued intervention|5|||
156926038|NCT04339296|566486724|FG001|Overall Study|Discontinued intervention|3|||
156926039|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156926040|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
156926041|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156926042|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
157165594|NCT05168813|567348034|FG002|Part B (Blinded)|Other|0|||
157165595|NCT05168813|567348035|FG003|Part B (Blinded)|Other|0|||
157165596|NCT05168813|567348036|FG004|Part B (Blinded)|Other|41|||
156926043|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
157165597|NCT05168813|567348037|FG005|Part B (Blinded)|Other|27|||
157165598|NCT01754922|567348039|FG000|Overall Study|Adverse Event|0|||
157165599|NCT01754922|567348040|FG001|Overall Study|Adverse Event|1|||
157165600|NCT01207388|567348041|FG000|Overall Study|Death|67|||
157165601|NCT01207388|567348041|FG000|Overall Study|Withdrawal by Subject|1|||
157165602|NCT02680587|567348042|FG000|Overall Study|Withdrawal by Subject|1|||
157165603|NCT02680587|567348043|FG001|Overall Study|Withdrawal by Subject|0|||
156926044|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156926045|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
156926046|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156926047|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
156926048|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
156926049|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156926050|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
156926051|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
156926052|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
156926053|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
156926054|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
156926055|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
156926056|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
156926057|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
156926058|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
156926059|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
156926060|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156926061|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
156926062|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156926063|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
157028959|NCT01946789|566862875|FG004|Overall Study|Progressive Disease|0|||
157028960|NCT01946789|566862876|FG005|Overall Study|Progressive Disease|2|||
157028961|NCT01946789|566862877|FG006|Overall Study|Progressive Disease|0|||
157028962|NCT01946789|566862878|FG007|Overall Study|Progressive Disease|0|||
157028963|NCT01946789|566862879|FG008|Overall Study|Progressive Disease|0|||
157165604|NCT00259740|567348047|FG000|Overall Study|Physician Decision|1|||
157165605|NCT00259740|567348048|FG001|Overall Study|Physician Decision|1|||
157165606|NCT00259740|567348047|FG000|Overall Study|Adverse Event|0|||
157165607|NCT00259740|567348048|FG001|Overall Study|Adverse Event|2|||
157165608|NCT00259740|567348047|FG000|Overall Study|Withdrawal by Subject|2|||
157165609|NCT00259740|567348048|FG001|Overall Study|Withdrawal by Subject|6|||
157165610|NCT00259740|567348047|FG000|Overall Study|Death|1|||
157165611|NCT00259740|567348048|FG001|Overall Study|Death|1|||
157165612|NCT00259740|567348047|FG000|Overall Study|Disease progression|19|||
157165613|NCT00259740|567348048|FG001|Overall Study|Disease progression|36|||
157165614|NCT00259740|567348047|FG000|Overall Study|Ongoing|17|||
157165615|NCT00259740|567348048|FG001|Overall Study|Ongoing|3|||
157165616|NCT00259740|567348047|FG000|Overall Study|Other|3|||
157165617|NCT00259740|567348048|FG001|Overall Study|Other|0|||
157165618|NCT00259740|567348047|FG000|Overall Study|Requirement for alternative therapy|0|||
157165619|NCT00259740|567348048|FG001|Overall Study|Requirement for alternative therapy|4|||
157165620|NCT04580394|567348049|FG000|First Intervention|Incorrectly Randomized|1|||
157165621|NCT04580394|567348049|FG000|First Intervention|Physician Decision|1|||
157165622|NCT04580394|567348049|FG000|First Intervention|Lost to Follow-up|1|||
157165623|NCT04580394|567348049|FG000|Washout (One Week)|Withdrawal by Subject|1|||
157165624|NCT04580394|567348049|FG000|Washout (One Week)|Adverse Event|1|||
157165625|NCT04580394|567348049|FG000|Washout (One Week)|Withdrawal by Subject|2|||
157165626|NCT04580394|567348049|FG000|Third Intervention|Adverse Event|1|||
157165627|NCT04580394|567348049|FG000|Third Intervention|Withdrawal by Subject|1|||
157028964|NCT01946789|566862871|FG000|Overall Study|Withdrawal by Subject|0|||
157028965|NCT01946789|566862872|FG001|Overall Study|Withdrawal by Subject|0|||
157028966|NCT01946789|566862873|FG002|Overall Study|Withdrawal by Subject|0|||
157028967|NCT01946789|566862874|FG003|Overall Study|Withdrawal by Subject|2|||
157028968|NCT01946789|566862875|FG004|Overall Study|Withdrawal by Subject|1|||
157028969|NCT01946789|566862876|FG005|Overall Study|Withdrawal by Subject|0|||
157028970|NCT01946789|566862877|FG006|Overall Study|Withdrawal by Subject|1|||
157028971|NCT01946789|566862878|FG007|Overall Study|Withdrawal by Subject|0|||
157028972|NCT01946789|566862879|FG008|Overall Study|Withdrawal by Subject|0|||
157165628|NCT04580394|567348049|FG000|Washout (One Week)|Withdrawal by Subject|2|||
157028973|NCT04362254|566862883|FG000|Overall Study|Adverse Event|1|||
157028974|NCT04362254|566862883|FG000|Overall Study|Protocol Violation|1|||
157028975|NCT04362254|566862883|FG000|Overall Study|Due to early termination of the trial|10|||
157028976|NCT04076618|566862884|FG000|Overall Study|Lost to Follow-up|2|||
157028977|NCT04076618|566862885|FG001|Overall Study|Lost to Follow-up|1|||
157028978|NCT04076618|566862886|FG002|Overall Study|Lost to Follow-up|3|||
157165629|NCT04397718|567348052|FG000|Overall Study|Death|7|||
157165630|NCT04397718|567348053|FG001|Overall Study|Death|11|||
157165631|NCT04397718|567348052|FG000|Overall Study|Lost to Follow-up|0|||
157165632|NCT04397718|567348053|FG001|Overall Study|Lost to Follow-up|4|||
157227036|NCT00409578|567576031|FG000|Overall Study|Abnormal laboratory value(s)|2|||
157227037|NCT00409578|567576032|FG001|Overall Study|Abnormal laboratory value(s)|2|||
157028979|NCT04076618|566862884|FG000|Overall Study|Withdrawal by Subject|3|||
157165633|NCT06087328|567348054|FG000|28-Day Treatment|Lost to Follow-up|7|||
157165634|NCT06087328|567348055|FG001|28-Day Treatment|Lost to Follow-up|3|||
157028980|NCT04076618|566862885|FG001|Overall Study|Withdrawal by Subject|1|||
157028981|NCT04076618|566862886|FG002|Overall Study|Withdrawal by Subject|2|||
157165635|NCT06087328|567348056|FG002|28-Day Treatment|Lost to Follow-up|4|||
156926064|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156926065|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
156926066|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
156926067|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
156926068|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
156926069|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
156926070|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
156926071|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
156926072|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
156926073|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
156926074|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926075|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926076|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926077|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926078|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926079|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
156926080|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
156926081|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156926082|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156926083|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156926084|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156926085|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
156926086|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
156926087|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
156926088|NCT03742037|566486726|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926089|NCT03742037|566486727|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926090|NCT03742037|566486728|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926091|NCT03742037|566486729|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926092|NCT03742037|566486730|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926093|NCT03742037|566486731|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
156926094|NCT03742037|566486732|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
156926095|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
156926096|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
156926097|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
156926098|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
156926099|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
156926100|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
156926101|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
156926102|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156926103|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156926104|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
156926105|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
156926106|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156926107|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
156926108|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
156926109|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156926110|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
156926111|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
156926112|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156926113|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156926114|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156926115|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
156926116|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
156926117|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156926118|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156926119|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156926120|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156926121|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
156926122|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
156926123|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156926124|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
156926125|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
156926126|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
157028982|NCT04076618|566862884|FG000|Overall Study|Relocated out of state|0|||
157028983|NCT04076618|566862885|FG001|Overall Study|Relocated out of state|2|||
157028984|NCT04076618|566862886|FG002|Overall Study|Relocated out of state|0|||
157028985|NCT04076618|566862884|FG000|Overall Study|COVID concerns|0|||
157028986|NCT04076618|566862885|FG001|Overall Study|COVID concerns|1|||
157028987|NCT04076618|566862886|FG002|Overall Study|COVID concerns|0|||
157028988|NCT04076618|566862884|FG000|Overall Study|Adverse Event|0|||
157028989|NCT04076618|566862885|FG001|Overall Study|Adverse Event|0|||
157028990|NCT04076618|566862886|FG002|Overall Study|Adverse Event|2|||
157028991|NCT01928394|566862887|FG000|Treatment Period|Disease progression|17|||
157028992|NCT01928394|566862888|FG001|Treatment Period|Disease progression|2|||
157028993|NCT01928394|566862889|FG002|Treatment Period|Disease progression|12|||
157028994|NCT01928394|566862890|FG003|Treatment Period|Disease progression|48|||
157028995|NCT01928394|566862891|FG004|Treatment Period|Disease progression|3|||
157028996|NCT01928394|566862892|FG005|Treatment Period|Disease progression|25|||
157028997|NCT01928394|566862893|FG006|Treatment Period|Disease progression|38|||
157028998|NCT01928394|566862894|FG007|Treatment Period|Disease progression|16|||
157028999|NCT01928394|566862895|FG008|Treatment Period|Disease progression|3|||
157029000|NCT01928394|566862896|FG009|Treatment Period|Disease progression|11|||
157029001|NCT01928394|566862897|FG010|Treatment Period|Disease progression|22|||
157029002|NCT01928394|566862898|FG011|Treatment Period|Disease progression|73|||
157029003|NCT01928394|566862899|FG012|Treatment Period|Disease progression|38|||
157029004|NCT01928394|566862900|FG013|Treatment Period|Disease progression|118|||
156926127|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156926128|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
156926129|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
156926130|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
156926131|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156926132|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
156926133|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156926134|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156926135|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
156926136|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
156926137|NCT03742037|566486726|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926138|NCT03742037|566486727|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926139|NCT03742037|566486728|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
156926140|NCT03742037|566486729|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926141|NCT03742037|566486730|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926142|NCT03742037|566486731|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926143|NCT03742037|566486732|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
156926144|NCT04447755|566486733|FG000|Overall Study|Death|9|||
156926145|NCT04447755|566486734|FG001|Overall Study|Death|16|||
156926146|NCT04447755|566486735|FG002|Overall Study|Death|8|||
156926147|NCT04447755|566486736|FG003|Overall Study|Death|9|||
156926148|NCT04447755|566486737|FG004|Overall Study|Death|8|||
156926149|NCT04447755|566486738|FG005|Overall Study|Death|9|||
156926150|NCT04447755|566486739|FG006|Overall Study|Death|55|||
156926151|NCT04447755|566486733|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156926152|NCT04447755|566486734|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156926153|NCT04447755|566486735|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
156926154|NCT04447755|566486736|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
156926155|NCT04447755|566486737|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
156926156|NCT04447755|566486738|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
156926157|NCT04447755|566486739|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
156926158|NCT04447755|566486733|FG000|Overall Study|Sponsor Decision|0|||
156926159|NCT04447755|566486734|FG001|Overall Study|Sponsor Decision|0|||
156926160|NCT04447755|566486735|FG002|Overall Study|Sponsor Decision|0|||
156926161|NCT04447755|566486736|FG003|Overall Study|Sponsor Decision|0|||
156926162|NCT04447755|566486737|FG004|Overall Study|Sponsor Decision|1|||
156926163|NCT04447755|566486738|FG005|Overall Study|Sponsor Decision|0|||
157029005|NCT01928394|566862901|FG014|Treatment Period|Disease progression|59|||
157029006|NCT01928394|566862902|FG015|Treatment Period|Disease progression|1|||
157029007|NCT01928394|566862903|FG016|Treatment Period|Disease progression|43|||
157029008|NCT01928394|566862904|FG017|Treatment Period|Disease progression|56|||
157029009|NCT01928394|566862905|FG018|Treatment Period|Disease progression|50|||
157029010|NCT01928394|566862906|FG019|Treatment Period|Disease progression|71|||
157029011|NCT01928394|566862907|FG020|Treatment Period|Disease progression|30|||
157029012|NCT01928394|566862908|FG021|Treatment Period|Disease progression|31|||
157165636|NCT06087328|567348054|FG000|1-month Follow-up|Lost to Follow-up|0|||
157165637|NCT06087328|567348055|FG001|1-month Follow-up|Lost to Follow-up|1|||
157029013|NCT01928394|566862909|FG022|Treatment Period|Disease progression|31|||
157029014|NCT01928394|566862887|FG000|Treatment Period|Study drug toxicity|1|||
157029015|NCT01928394|566862888|FG001|Treatment Period|Study drug toxicity|1|||
157029016|NCT01928394|566862889|FG002|Treatment Period|Study drug toxicity|3|||
157029017|NCT01928394|566862890|FG003|Treatment Period|Study drug toxicity|3|||
157029018|NCT01928394|566862891|FG004|Treatment Period|Study drug toxicity|0|||
157029019|NCT01928394|566862892|FG005|Treatment Period|Study drug toxicity|9|||
157029020|NCT01928394|566862893|FG006|Treatment Period|Study drug toxicity|7|||
157029021|NCT01928394|566862894|FG007|Treatment Period|Study drug toxicity|1|||
157029022|NCT01928394|566862895|FG008|Treatment Period|Study drug toxicity|0|||
157029023|NCT01928394|566862896|FG009|Treatment Period|Study drug toxicity|5|||
157029024|NCT01928394|566862897|FG010|Treatment Period|Study drug toxicity|2|||
157029025|NCT01928394|566862898|FG011|Treatment Period|Study drug toxicity|3|||
156926164|NCT04447755|566486739|FG006|Overall Study|Sponsor Decision|10|||
156926165|NCT04447755|566486733|FG000|Overall Study|Lost to Follow-up|0|||
156926166|NCT04447755|566486734|FG001|Overall Study|Lost to Follow-up|0|||
156926167|NCT04447755|566486735|FG002|Overall Study|Lost to Follow-up|0|||
156926168|NCT04447755|566486736|FG003|Overall Study|Lost to Follow-up|0|||
156926169|NCT04447755|566486737|FG004|Overall Study|Lost to Follow-up|0|||
156926170|NCT04447755|566486738|FG005|Overall Study|Lost to Follow-up|0|||
156926171|NCT04447755|566486739|FG006|Overall Study|Lost to Follow-up|1|||
156926172|NCT00071760|566486740|FG000|Overall Study|Adverse Event|2|||
156926173|NCT00071760|566486741|FG001|Overall Study|Adverse Event|1|||
156926174|NCT00071760|566486740|FG000|Overall Study|Lost to Follow-up|0|||
156926175|NCT00071760|566486741|FG001|Overall Study|Lost to Follow-up|3|||
156926176|NCT00071760|566486740|FG000|Overall Study|Protocol Violation|1|||
156926177|NCT00071760|566486741|FG001|Overall Study|Protocol Violation|0|||
156926178|NCT00071760|566486740|FG000|Overall Study|Withdrawal by Subject|0|||
156926179|NCT00071760|566486741|FG001|Overall Study|Withdrawal by Subject|1|||
156926180|NCT00071760|566486740|FG000|Overall Study|Insufficient Viral Load Response|1|||
157029026|NCT01928394|566862899|FG012|Treatment Period|Study drug toxicity|7|||
157029027|NCT01928394|566862900|FG013|Treatment Period|Study drug toxicity|5|||
157029028|NCT01928394|566862901|FG014|Treatment Period|Study drug toxicity|12|||
157029029|NCT01928394|566862902|FG015|Treatment Period|Study drug toxicity|0|||
157029030|NCT01928394|566862903|FG016|Treatment Period|Study drug toxicity|3|||
157029031|NCT01928394|566862904|FG017|Treatment Period|Study drug toxicity|3|||
157029032|NCT01928394|566862905|FG018|Treatment Period|Study drug toxicity|12|||
157029033|NCT01928394|566862906|FG019|Treatment Period|Study drug toxicity|15|||
157029034|NCT01928394|566862907|FG020|Treatment Period|Study drug toxicity|4|||
157029035|NCT01928394|566862908|FG021|Treatment Period|Study drug toxicity|7|||
157029036|NCT01928394|566862909|FG022|Treatment Period|Study drug toxicity|4|||
157029037|NCT01928394|566862887|FG000|Treatment Period|AE unrelated to study drug|0|||
157029038|NCT01928394|566862888|FG001|Treatment Period|AE unrelated to study drug|0|||
157029039|NCT01928394|566862889|FG002|Treatment Period|AE unrelated to study drug|2|||
157029040|NCT01928394|566862890|FG003|Treatment Period|AE unrelated to study drug|3|||
157029041|NCT01928394|566862891|FG004|Treatment Period|AE unrelated to study drug|0|||
157029042|NCT01928394|566862892|FG005|Treatment Period|AE unrelated to study drug|5|||
157029043|NCT01928394|566862893|FG006|Treatment Period|AE unrelated to study drug|1|||
157029044|NCT01928394|566862894|FG007|Treatment Period|AE unrelated to study drug|0|||
157029045|NCT01928394|566862895|FG008|Treatment Period|AE unrelated to study drug|0|||
157029046|NCT01928394|566862896|FG009|Treatment Period|AE unrelated to study drug|2|||
157029047|NCT01928394|566862897|FG010|Treatment Period|AE unrelated to study drug|0|||
157029048|NCT01928394|566862898|FG011|Treatment Period|AE unrelated to study drug|12|||
157165638|NCT06087328|567348056|FG002|1-month Follow-up|Lost to Follow-up|1|||
157165639|NCT03201965|567348057|FG000|Overall Study|Death|5|||
157029049|NCT01928394|566862899|FG012|Treatment Period|AE unrelated to study drug|6|||
157029050|NCT01928394|566862900|FG013|Treatment Period|AE unrelated to study drug|13|||
157029051|NCT01928394|566862901|FG014|Treatment Period|AE unrelated to study drug|6|||
157029052|NCT01928394|566862902|FG015|Treatment Period|AE unrelated to study drug|1|||
157029053|NCT01928394|566862903|FG016|Treatment Period|AE unrelated to study drug|1|||
157029054|NCT01928394|566862904|FG017|Treatment Period|AE unrelated to study drug|6|||
157029055|NCT01928394|566862905|FG018|Treatment Period|AE unrelated to study drug|3|||
157029056|NCT01928394|566862906|FG019|Treatment Period|AE unrelated to study drug|5|||
157165640|NCT03201965|567348058|FG001|Overall Study|Death|65|||
157165641|NCT03201965|567348059|FG002|Overall Study|Death|47|||
157165642|NCT03201965|567348057|FG000|Overall Study|Lost to Follow-up|0|||
156926181|NCT00071760|566486741|FG001|Overall Study|Insufficient Viral Load Response|1|||
156926182|NCT00071760|566486740|FG000|Overall Study|Lack of availability of RTV|1|||
157165643|NCT03201965|567348058|FG001|Overall Study|Lost to Follow-up|6|||
156926183|NCT00071760|566486741|FG001|Overall Study|Lack of availability of RTV|0|||
156926184|NCT00071760|566486740|FG000|Overall Study|Physician Decision|2|||
156926185|NCT00071760|566486741|FG001|Overall Study|Physician Decision|1|||
157029057|NCT01928394|566862907|FG020|Treatment Period|AE unrelated to study drug|1|||
157029058|NCT01928394|566862908|FG021|Treatment Period|AE unrelated to study drug|1|||
157029059|NCT01928394|566862909|FG022|Treatment Period|AE unrelated to study drug|0|||
157165644|NCT03201965|567348059|FG002|Overall Study|Lost to Follow-up|0|||
157165645|NCT03201965|567348057|FG000|Overall Study|Withdrawal by Subject|3|||
157165646|NCT03201965|567348058|FG001|Overall Study|Withdrawal by Subject|23|||
157165647|NCT03201965|567348059|FG002|Overall Study|Withdrawal by Subject|8|||
157165648|NCT03201965|567348057|FG000|Overall Study|Sponsor's Decision|20|||
157165649|NCT03201965|567348058|FG001|Overall Study|Sponsor's Decision|99|||
157165650|NCT03201965|567348059|FG002|Overall Study|Sponsor's Decision|140|||
157165651|NCT03589326|567348060|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
157165652|NCT03589326|567348061|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
157165653|NCT03589326|567348060|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
157165654|NCT03589326|567348061|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
157165655|NCT03589326|567348060|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
157165656|NCT03589326|567348061|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
157165657|NCT03589326|567348060|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
157165658|NCT03589326|567348061|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
157165659|NCT03589326|567348060|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
156926186|NCT00071760|566486740|FG000|Overall Study|Relocation|0|||
156926187|NCT00071760|566486741|FG001|Overall Study|Relocation|1|||
156926188|NCT03424265|566486755|FG000|Overall Study|screening failure|1|||
156926189|NCT03424265|566486756|FG001|Overall Study|screening failure|0|||
156926190|NCT03424265|566486755|FG000|Overall Study|Withdrawal by Subject|0|||
156926191|NCT03424265|566486756|FG001|Overall Study|Withdrawal by Subject|2|||
156926192|NCT00619801|566486760|FG000|Overall Study|Lack of Efficacy|0|||
156926193|NCT00619801|566486761|FG001|Overall Study|Lack of Efficacy|1|||
156926194|NCT00619801|566486760|FG000|Overall Study|Withdrawal by Subject|1|||
156926195|NCT00619801|566486761|FG001|Overall Study|Withdrawal by Subject|1|||
156926196|NCT00619801|566486760|FG000|Overall Study|Loss of efficacy|0|||
156926197|NCT00619801|566486761|FG001|Overall Study|Loss of efficacy|1|||
156926198|NCT02375113|566486772|FG000|Overall Study|Undisclosed Reason(s).|1|||
156926199|NCT02375113|566486773|FG001|Overall Study|Undisclosed Reason(s).|1|||
156926200|NCT02375113|566486772|FG000|Overall Study|Poor adherence (<70%).|1|||
156926201|NCT02375113|566486773|FG001|Overall Study|Poor adherence (<70%).|0|||
156926202|NCT02375113|566486772|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
156926203|NCT02375113|566486773|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
156926204|NCT01214629|566486774|FG000|Overall Study|Progressive Disease|1|||
156926205|NCT01214629|566486775|FG001|Overall Study|Progressive Disease|1|||
156926206|NCT01214629|566486776|FG002|Overall Study|Progressive Disease|0|||
156926207|NCT01214629|566486777|FG003|Overall Study|Progressive Disease|1|||
156926208|NCT01214629|566486778|FG004|Overall Study|Progressive Disease|2|||
156926209|NCT01214629|566486779|FG005|Overall Study|Progressive Disease|3|||
156926210|NCT01214629|566486780|FG006|Overall Study|Progressive Disease|1|||
156926211|NCT01214629|566486781|FG007|Overall Study|Progressive Disease|1|||
156926212|NCT01214629|566486782|FG008|Overall Study|Progressive Disease|1|||
156926213|NCT01214629|566486783|FG009|Overall Study|Progressive Disease|5|||
156926214|NCT01214629|566486784|FG010|Overall Study|Progressive Disease|1|||
156926215|NCT01214629|566486774|FG000|Overall Study|Adverse Event|0|||
156926216|NCT01214629|566486775|FG001|Overall Study|Adverse Event|0|||
156926217|NCT01214629|566486776|FG002|Overall Study|Adverse Event|0|||
156926218|NCT01214629|566486777|FG003|Overall Study|Adverse Event|1|||
156926219|NCT01214629|566486778|FG004|Overall Study|Adverse Event|0|||
156926220|NCT01214629|566486779|FG005|Overall Study|Adverse Event|1|||
156926221|NCT01214629|566486780|FG006|Overall Study|Adverse Event|0|||
156926222|NCT01214629|566486781|FG007|Overall Study|Adverse Event|0|||
156926223|NCT01214629|566486782|FG008|Overall Study|Adverse Event|0|||
156926224|NCT01214629|566486783|FG009|Overall Study|Adverse Event|1|||
156926225|NCT01214629|566486784|FG010|Overall Study|Adverse Event|0|||
156926226|NCT01214629|566486774|FG000|Overall Study|Physician Decision|0|||
156926227|NCT01214629|566486775|FG001|Overall Study|Physician Decision|0|||
156926228|NCT01214629|566486776|FG002|Overall Study|Physician Decision|0|||
156926229|NCT01214629|566486777|FG003|Overall Study|Physician Decision|0|||
156926230|NCT01214629|566486778|FG004|Overall Study|Physician Decision|0|||
156926231|NCT01214629|566486779|FG005|Overall Study|Physician Decision|0|||
156926232|NCT01214629|566486780|FG006|Overall Study|Physician Decision|0|||
156926233|NCT01214629|566486781|FG007|Overall Study|Physician Decision|0|||
157165660|NCT03589326|567348061|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
157165661|NCT02618928|567348064|FG000|Overall Study|Failure to Return|28|||
157165662|NCT02618928|567348064|FG000|Overall Study|Insufficient Virological Response|1|||
157165663|NCT02618928|567348064|FG000|Overall Study|Withdrawal by Subject|2|||
157165664|NCT02618928|567348064|FG000|Overall Study|Death|3|||
157165665|NCT02618928|567348064|FG000|Overall Study|Other|11|||
157165666|NCT02618928|567348064|FG000|Overall Study|Missing|6|||
156926234|NCT01214629|566486782|FG008|Overall Study|Physician Decision|0|||
156926235|NCT01214629|566486783|FG009|Overall Study|Physician Decision|0|||
156926236|NCT01214629|566486784|FG010|Overall Study|Physician Decision|1|||
156926237|NCT01214629|566486774|FG000|Overall Study|Withdrawal by Subject|0|||
156926238|NCT01214629|566486775|FG001|Overall Study|Withdrawal by Subject|0|||
156926239|NCT01214629|566486776|FG002|Overall Study|Withdrawal by Subject|0|||
157165667|NCT02618928|567348064|FG000|Overall Study|Treatment Never Started|7|||
157165668|NCT00118482|567348069|FG000|Overall Study|Lost to Follow-up|7|||
157165669|NCT00118482|567348070|FG001|Overall Study|Lost to Follow-up|7|||
156926240|NCT01214629|566486777|FG003|Overall Study|Withdrawal by Subject|0|||
156926241|NCT01214629|566486778|FG004|Overall Study|Withdrawal by Subject|0|||
156926242|NCT01214629|566486779|FG005|Overall Study|Withdrawal by Subject|0|||
156926243|NCT01214629|566486780|FG006|Overall Study|Withdrawal by Subject|0|||
156926244|NCT01214629|566486781|FG007|Overall Study|Withdrawal by Subject|0|||
156926245|NCT01214629|566486782|FG008|Overall Study|Withdrawal by Subject|0|||
156926246|NCT01214629|566486783|FG009|Overall Study|Withdrawal by Subject|1|||
156926247|NCT01214629|566486784|FG010|Overall Study|Withdrawal by Subject|0|||
156926248|NCT00877383|566486787|FG000|Overall Study|Adverse Event|13|||
156926249|NCT00877383|566486788|FG001|Overall Study|Adverse Event|14|||
156926250|NCT00877383|566486787|FG000|Overall Study|Lost to Follow-up|5|||
156926251|NCT00877383|566486788|FG001|Overall Study|Lost to Follow-up|3|||
156926252|NCT00877383|566486787|FG000|Overall Study|Subject withdrew consent|3|||
156926253|NCT00877383|566486788|FG001|Overall Study|Subject withdrew consent|12|||
156926254|NCT00877383|566486787|FG000|Overall Study|Subject no longer requires study drug|2|||
156926255|NCT00877383|566486788|FG001|Overall Study|Subject no longer requires study drug|0|||
156926256|NCT00877383|566486787|FG000|Overall Study|Administrative problems|2|||
156926257|NCT00877383|566486788|FG001|Overall Study|Administrative problems|0|||
156926258|NCT00877383|566486787|FG000|Overall Study|Protocol deviation|2|||
156926259|NCT00877383|566486788|FG001|Overall Study|Protocol deviation|6|||
156926260|NCT00877383|566486787|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
156926261|NCT00877383|566486788|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156926262|NCT00877383|566486787|FG000|Overall Study|Death|1|||
156926263|NCT00877383|566486788|FG001|Overall Study|Death|2|||
156926264|NCT00459108|566486789|FG000|Overall Study|Withdrawal by Subject|5|||
156926265|NCT00459108|566486789|FG000|Overall Study|Adverse Event|3|||
156926266|NCT00459108|566486789|FG000|Overall Study|Death|2|||
156926267|NCT00459108|566486789|FG000|Overall Study|Progression|1|||
156926268|NCT00461682|566486796|FG000|Overall Study|Protocol Violation|1|||
156926269|NCT03051607|566486798|FG000|Overall Study|Adverse Event|66|||
156926270|NCT00399360|566486801|FG000|Overall Study|Lost to Follow-up|2|||
156926271|NCT00399360|566486802|FG001|Overall Study|Lost to Follow-up|1|||
156926272|NCT00399360|566486803|FG002|Overall Study|Lost to Follow-up|2|||
156926273|NCT00399360|566486804|FG003|Overall Study|Lost to Follow-up|4|||
156926274|NCT00399360|566486801|FG000|Overall Study|Adverse Event|0|||
156926275|NCT00399360|566486802|FG001|Overall Study|Adverse Event|0|||
156926276|NCT00399360|566486803|FG002|Overall Study|Adverse Event|1|||
156926277|NCT00399360|566486804|FG003|Overall Study|Adverse Event|0|||
156926278|NCT00399360|566486801|FG000|Overall Study|Withdrawal by Subject|0|||
156926279|NCT00399360|566486802|FG001|Overall Study|Withdrawal by Subject|2|||
156926280|NCT00399360|566486803|FG002|Overall Study|Withdrawal by Subject|0|||
156926281|NCT00399360|566486804|FG003|Overall Study|Withdrawal by Subject|2|||
156926282|NCT01190254|566488869|FG000|Overall Study|Adverse Event|3|||
156926283|NCT01190254|566488870|FG001|Overall Study|Adverse Event|6|||
156926284|NCT01190254|566488871|FG002|Overall Study|Adverse Event|8|||
156926285|NCT01190254|566488869|FG000|Overall Study|Lack of Efficacy|7|||
156926286|NCT01190254|566488870|FG001|Overall Study|Lack of Efficacy|4|||
156926287|NCT01190254|566488871|FG002|Overall Study|Lack of Efficacy|5|||
156926288|NCT01190254|566488869|FG000|Overall Study|Lost to Follow-up|4|||
156926289|NCT01190254|566488870|FG001|Overall Study|Lost to Follow-up|2|||
156926290|NCT01190254|566488871|FG002|Overall Study|Lost to Follow-up|0|||
156926291|NCT01190254|566488869|FG000|Overall Study|Withdrawal by Subject|4|||
156926292|NCT01190254|566488870|FG001|Overall Study|Withdrawal by Subject|5|||
156926293|NCT01190254|566488871|FG002|Overall Study|Withdrawal by Subject|7|||
156926294|NCT01190254|566488869|FG000|Overall Study|Protocol Violation|2|||
156926295|NCT01190254|566488870|FG001|Overall Study|Protocol Violation|0|||
156926296|NCT01190254|566488871|FG002|Overall Study|Protocol Violation|2|||
156926297|NCT01190254|566488869|FG000|Overall Study|Did not meet protocol eligibility|1|||
157029060|NCT01928394|566862887|FG000|Treatment Period|Participant request to stop therapy|0|||
157165670|NCT00118482|567348069|FG000|Overall Study|Withdrawal by Subject|23|||
157165671|NCT00118482|567348070|FG001|Overall Study|Withdrawal by Subject|22|||
156926298|NCT01190254|566488870|FG001|Overall Study|Did not meet protocol eligibility|0|||
156926299|NCT01190254|566488871|FG002|Overall Study|Did not meet protocol eligibility|0|||
156926300|NCT02489344|566488878|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
156926301|NCT02489344|566488878|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
156926302|NCT02489344|566488878|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
156926303|NCT02489344|566488878|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
156926304|NCT01275833|566488879|FG000|Overall Study|Study terminated|1|||
156926305|NCT01275833|566488880|FG001|Overall Study|Study terminated|1|||
157165672|NCT04146467|567348073|FG000|Overall Study|Adverse Event|0|||
156926306|NCT00227305|566488885|FG000|Overall Study|Adverse Event|40|||
156926307|NCT00227305|566488885|FG000|Overall Study|Withdrawal by Subject|42|||
156926308|NCT00227305|566488885|FG000|Overall Study|Lost to Follow-up|33|||
156926309|NCT00227305|566488885|FG000|Overall Study|Study specific discontinuation|13|||
156926310|NCT00227305|566488885|FG000|Overall Study|MOVED OUT OF AREA|3|||
156926311|NCT00227305|566488885|FG000|Overall Study|Lack of Efficacy|7|||
156926312|NCT00227305|566488885|FG000|Overall Study|Physician Decision|3|||
156926313|NCT00227305|566488885|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
156926314|NCT00227305|566488885|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
156926315|NCT00227305|566488885|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
156926316|NCT04105998|566488888|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
156926317|NCT04105998|566488889|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
156926318|NCT02604212|566488890|FG000|Overall Study|Study Terminated by Sponsor|2|||
156926319|NCT02604212|566488891|FG001|Overall Study|Study Terminated by Sponsor|1|||
156926320|NCT02604212|566488892|FG002|Overall Study|Study Terminated by Sponsor|3|||
157165673|NCT04146467|567348074|FG001|Overall Study|Adverse Event|1|||
157165674|NCT04146467|567348073|FG000|Overall Study|Lost to Follow-up|0|||
157165675|NCT04146467|567348074|FG001|Overall Study|Lost to Follow-up|2|||
157165676|NCT02128763|567348076|FG000|Overall Study|Death|1|||
157165677|NCT02128763|567348077|FG001|Overall Study|Death|0|||
157165678|NCT02128763|567348076|FG000|Overall Study|Lost to Follow-up|19|||
157165679|NCT02128763|567348077|FG001|Overall Study|Lost to Follow-up|16|||
157165680|NCT01608724|567348078|FG000|Overall Study|Withdrawal by Subject|131|||
157165681|NCT01608724|567348078|FG000|Overall Study|Lost to Follow-up|41|||
157165682|NCT01608724|567348078|FG000|Overall Study|Study-specific discontinuation criteria|32|||
157165683|NCT01608724|567348078|FG000|Overall Study|Adverse Event|29|||
157165684|NCT01608724|567348078|FG000|Overall Study|Protocol Violation|6|||
157165685|NCT01608724|567348078|FG000|Overall Study|bood sugar too high, etc.|3|||
157165686|NCT01608724|567348078|FG000|Overall Study|Safety reasons|1|||
157165687|NCT04633473|567348079|FG000|Overall Study|Withdrawal by Subject|6|||
157165688|NCT01553916|567348080|FG000|Overall Study|Withdrawal by Subject|2|||
157165689|NCT01553916|567348080|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
157165690|NCT02104804|567348083|FG000|Overall Study|Did not take study medication|0|||
157165691|NCT02104804|567348084|FG001|Overall Study|Did not take study medication|1|||
157165692|NCT02104804|567348083|FG000|Overall Study|Study specific discontinuation criteria|6|||
157165693|NCT02104804|567348084|FG001|Overall Study|Study specific discontinuation criteria|1|||
157165694|NCT02104804|567348083|FG000|Overall Study|Other listed|2|||
157165695|NCT02104804|567348084|FG001|Overall Study|Other listed|1|||
157165696|NCT02104804|567348083|FG000|Overall Study|Protocol Violation|0|||
157165697|NCT02104804|567348084|FG001|Overall Study|Protocol Violation|1|||
157165698|NCT02104804|567348083|FG000|Overall Study|Adverse Event|4|||
157165699|NCT02104804|567348084|FG001|Overall Study|Adverse Event|3|||
157165700|NCT02104804|567348083|FG000|Overall Study|Withdrawal by Subject|4|||
157165701|NCT02104804|567348084|FG001|Overall Study|Withdrawal by Subject|12|||
157165702|NCT01968954|567348088|FG000|Overall Study|Adverse Event|6|||
157165703|NCT01968954|567348089|FG001|Overall Study|Adverse Event|3|||
157165704|NCT01968954|567348088|FG000|Overall Study|Death|1|||
157165705|NCT01968954|567348089|FG001|Overall Study|Death|2|||
157165706|NCT01968954|567348088|FG000|Overall Study|Lost to Follow-up|6|||
157165707|NCT01968954|567348089|FG001|Overall Study|Lost to Follow-up|4|||
157165708|NCT01968954|567348088|FG000|Overall Study|Withdrawal by Subject|20|||
156926321|NCT02604212|566488893|FG003|Overall Study|Study Terminated by Sponsor|3|||
156926322|NCT02604212|566488890|FG000|Overall Study|Withdrawal by Subject|0|||
156926323|NCT02604212|566488891|FG001|Overall Study|Withdrawal by Subject|0|||
156926324|NCT02604212|566488892|FG002|Overall Study|Withdrawal by Subject|1|||
156926325|NCT02604212|566488893|FG003|Overall Study|Withdrawal by Subject|0|||
156926326|NCT02073279|566488894|FG000|Double-blind Period|Adverse Event|1|||
156926327|NCT02073279|566488895|FG001|Double-blind Period|Adverse Event|1|||
156926328|NCT02073279|566488894|FG000|Double-blind Period|Switched to another treatment|1|||
156926329|NCT02073279|566488895|FG001|Double-blind Period|Switched to another treatment|2|||
156926330|NCT02073279|566488894|FG000|Double-blind Period|Protocol Violation|0|||
156926331|NCT02073279|566488895|FG001|Double-blind Period|Protocol Violation|1|||
156926332|NCT02073279|566488894|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
157165709|NCT01968954|567348089|FG001|Overall Study|Withdrawal by Subject|23|||
157165710|NCT01968954|567348088|FG000|Overall Study|Other|7|||
157165711|NCT01968954|567348089|FG001|Overall Study|Other|8|||
157165712|NCT01968954|567348088|FG000|Overall Study|Protocol Violation|0|||
157165713|NCT01968954|567348089|FG001|Overall Study|Protocol Violation|1|||
157227038|NCT00409578|567576033|FG002|Overall Study|Abnormal laboratory value(s)|2|||
156926333|NCT02073279|566488895|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
156926334|NCT02073279|566488894|FG000|Double-blind Period|Withdrawal by Subject|2|||
156926335|NCT02073279|566488895|FG001|Double-blind Period|Withdrawal by Subject|2|||
156977498|NCT02223754|566670722|FG001|Period 1|Withdrawal by Subject|4|||
157165714|NCT01968954|567348088|FG000|Overall Study|Did not met inclusion criteria|0|||
157165715|NCT01968954|567348089|FG001|Overall Study|Did not met inclusion criteria|2|||
157165716|NCT00645567|567348092|FG000|Overall Study|Adverse Event|1|||
157165717|NCT03259490|567348093|FG000|Period 1|Withdrawal by Subject|0|||
157165718|NCT03259490|567348094|FG001|Period 1|Withdrawal by Subject|1|||
157165719|NCT03259490|567348093|FG000|Period 2|Protocol Violation|1|||
157165720|NCT03259490|567348094|FG001|Period 2|Protocol Violation|0|||
156926336|NCT02073279|566488894|FG000|Open-label Extension Period|Adverse Event|1|||
156926337|NCT02073279|566488895|FG001|Open-label Extension Period|Adverse Event|0|||
156926338|NCT02073279|566488894|FG000|Open-label Extension Period|Lack of Efficacy|1|||
156926339|NCT02073279|566488895|FG001|Open-label Extension Period|Lack of Efficacy|0|||
156926340|NCT02073279|566488894|FG000|Open-label Extension Period|Lost to Follow-up|0|||
156926341|NCT02073279|566488895|FG001|Open-label Extension Period|Lost to Follow-up|4|||
156926342|NCT02073279|566488894|FG000|Open-label Extension Period|Switched to another treatment|1|||
156926343|NCT02073279|566488895|FG001|Open-label Extension Period|Switched to another treatment|4|||
156926344|NCT02073279|566488894|FG000|Open-label Extension Period|Protocol Violation|0|||
156926345|NCT02073279|566488895|FG001|Open-label Extension Period|Protocol Violation|1|||
156926346|NCT02073279|566488894|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
156926347|NCT02073279|566488895|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
156926348|NCT02073279|566488894|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
156926349|NCT02073279|566488895|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
156926350|NCT01994629|566488896|FG000|Overall Study|Withdrawal by Subject|1|||
156926351|NCT01994629|566488897|FG001|Overall Study|Withdrawal by Subject|0|||
156926352|NCT01994629|566488896|FG000|Overall Study|Lost to Follow-up|0|||
156926353|NCT01994629|566488897|FG001|Overall Study|Lost to Follow-up|3|||
156926354|NCT03338062|566488900|FG000|Overall Study|Alternative Therapy|1|||
156926355|NCT03338062|566488901|FG001|Overall Study|Alternative Therapy|0|||
156926356|NCT00453544|566488904|FG000|Overall Study|Withdrawal by Subject|1|||
156926357|NCT00453544|566488905|FG001|Overall Study|Withdrawal by Subject|0|||
156926358|NCT00453544|566488906|FG002|Overall Study|Withdrawal by Subject|0|||
156926359|NCT00453544|566488907|FG003|Overall Study|Withdrawal by Subject|0|||
156926360|NCT00453544|566488904|FG000|Overall Study|Primary outcome measure not completed|1|||
156926361|NCT00453544|566488905|FG001|Overall Study|Primary outcome measure not completed|1|||
156926362|NCT00453544|566488906|FG002|Overall Study|Primary outcome measure not completed|0|||
156926363|NCT00453544|566488907|FG003|Overall Study|Primary outcome measure not completed|1|||
156926364|NCT01558752|566488908|FG000|Overall Study|Physician Decision|2|||
156926365|NCT01558752|566488909|FG001|Overall Study|Physician Decision|0|||
156926366|NCT00450333|566488912|FG000|Overall Study|Study terminated|47|||
156926367|NCT00450333|566488913|FG001|Overall Study|Study terminated|54|||
156926368|NCT00450333|566488914|FG002|Overall Study|Study terminated|16|||
156926369|NCT00450333|566488915|FG003|Overall Study|Study terminated|21|||
156926370|NCT00450333|566488912|FG000|Overall Study|Adverse Event|1|||
156926371|NCT00450333|566488913|FG001|Overall Study|Adverse Event|7|||
156926372|NCT00450333|566488914|FG002|Overall Study|Adverse Event|2|||
156926373|NCT00450333|566488915|FG003|Overall Study|Adverse Event|2|||
156926374|NCT00450333|566488912|FG000|Overall Study|Protocol Violation|1|||
156926375|NCT00450333|566488913|FG001|Overall Study|Protocol Violation|0|||
156926376|NCT00450333|566488914|FG002|Overall Study|Protocol Violation|1|||
156926377|NCT00450333|566488915|FG003|Overall Study|Protocol Violation|0|||
156926378|NCT00450333|566488912|FG000|Overall Study|Withdrawal by Subject|1|||
156926379|NCT00450333|566488913|FG001|Overall Study|Withdrawal by Subject|0|||
156926380|NCT00450333|566488914|FG002|Overall Study|Withdrawal by Subject|3|||
156926381|NCT00450333|566488915|FG003|Overall Study|Withdrawal by Subject|0|||
156926382|NCT00450333|566488912|FG000|Overall Study|Kidney transplant|1|||
156926383|NCT00450333|566488913|FG001|Overall Study|Kidney transplant|0|||
156926384|NCT00450333|566488914|FG002|Overall Study|Kidney transplant|1|||
156926385|NCT00450333|566488915|FG003|Overall Study|Kidney transplant|3|||
156926386|NCT00450333|566488912|FG000|Overall Study|Death|3|||
156926387|NCT00450333|566488913|FG001|Overall Study|Death|2|||
156926388|NCT00450333|566488914|FG002|Overall Study|Death|2|||
156926389|NCT00450333|566488915|FG003|Overall Study|Death|2|||
156926390|NCT04340362|566488916|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
156926391|NCT01829230|566488923|FG000|Overall Study|Protocol Violation|0|||
156926392|NCT01829230|566488924|FG001|Overall Study|Protocol Violation|2|||
156926393|NCT01829230|566488923|FG000|Overall Study|Withdrawal by Subject|0|||
156926394|NCT01829230|566488924|FG001|Overall Study|Withdrawal by Subject|1|||
156926395|NCT01829230|566488923|FG000|Overall Study|Lost to Follow-up|1|||
156926396|NCT01829230|566488924|FG001|Overall Study|Lost to Follow-up|1|||
156926397|NCT00391274|566488925|FG000|Overall Study|Death Due to Study Disease|55|||
156926398|NCT00391274|566488926|FG001|Overall Study|Death Due to Study Disease|45|||
156926399|NCT00391274|566488925|FG000|Overall Study|Lost to Follow-up|0|||
156926400|NCT00391274|566488926|FG001|Overall Study|Lost to Follow-up|3|||
156926401|NCT00391274|566488925|FG000|Overall Study|Physician Decision|4|||
156926402|NCT00391274|566488926|FG001|Overall Study|Physician Decision|2|||
156926403|NCT00391274|566488925|FG000|Overall Study|Withdrawal by Subject|0|||
156926404|NCT00391274|566488926|FG001|Overall Study|Withdrawal by Subject|3|||
156926405|NCT00391274|566488925|FG000|Overall Study|Death Due to Adverse Event|1|||
156926406|NCT00391274|566488926|FG001|Overall Study|Death Due to Adverse Event|3|||
156926407|NCT00391274|566488925|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
156926408|NCT00391274|566488926|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
156926409|NCT00391274|566488925|FG000|Overall Study|Death Not Study Related|0|||
156926410|NCT00391274|566488926|FG001|Overall Study|Death Not Study Related|1|||
157165721|NCT00434122|567348095|FG000|Overall Study|Non-compliance with protocol|0|||
157165722|NCT00434122|567348096|FG001|Overall Study|Non-compliance with protocol|1|||
157165723|NCT00434122|567348095|FG000|Overall Study|loss of subject contact|1|||
157165724|NCT00434122|567348096|FG001|Overall Study|loss of subject contact|1|||
157165725|NCT00434122|567348095|FG000|Overall Study|Personal reasons|1|||
157165726|NCT00434122|567348096|FG001|Overall Study|Personal reasons|1|||
157165727|NCT00434122|567348095|FG000|Overall Study|Large follicle size|2|||
157165728|NCT00434122|567348096|FG001|Overall Study|Large follicle size|2|||
157165729|NCT00434122|567348095|FG000|Overall Study|Low follicular response.|1|||
157165730|NCT00434122|567348096|FG001|Overall Study|Low follicular response.|2|||
157165731|NCT00434122|567348095|FG000|Overall Study|Travelling of subject.|1|||
157165732|NCT00434122|567348096|FG001|Overall Study|Travelling of subject.|0|||
157165733|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
157165734|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
157165735|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
157165736|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
157165737|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
157165738|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
157165739|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
157165740|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
157165741|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
157165742|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
157165743|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
157165744|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
157165745|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
157165746|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156926411|NCT01505868|566488928|FG000|Overall Study|Withdrawal by Subject|1|||
156926412|NCT01505868|566488929|FG001|Overall Study|Withdrawal by Subject|0|||
156926413|NCT01505868|566488930|FG002|Overall Study|Withdrawal by Subject|0|||
156926414|NCT01505868|566488931|FG003|Overall Study|Withdrawal by Subject|0|||
156926415|NCT01505868|566488932|FG004|Overall Study|Withdrawal by Subject|0|||
156926416|NCT00894322|566488933|FG000|Overall Study|Withdrawal by Subject|1|||
156926417|NCT00894322|566488934|FG001|Overall Study|Withdrawal by Subject|0|||
156926418|NCT00894322|566488935|FG002|Overall Study|Withdrawal by Subject|0|||
156926419|NCT03204305|566488945|FG000|Overall Study|Lost to Follow-up|6|||
156926420|NCT03204305|566488946|FG001|Overall Study|Lost to Follow-up|4|||
156926421|NCT03204305|566488947|FG002|Overall Study|Lost to Follow-up|0|||
156926422|NCT03204305|566488948|FG003|Overall Study|Lost to Follow-up|0|||
156926423|NCT03204305|566488945|FG000|Overall Study|Physician Decision|1|||
156926424|NCT03204305|566488946|FG001|Overall Study|Physician Decision|0|||
156926425|NCT03204305|566488947|FG002|Overall Study|Physician Decision|0|||
156926426|NCT03204305|566488948|FG003|Overall Study|Physician Decision|0|||
156926427|NCT03204305|566488945|FG000|Overall Study|failure to place arterial line|2|||
156926428|NCT03204305|566488946|FG001|Overall Study|failure to place arterial line|1|||
156926429|NCT03204305|566488947|FG002|Overall Study|failure to place arterial line|0|||
156926430|NCT03204305|566488948|FG003|Overall Study|failure to place arterial line|0|||
156926431|NCT03204305|566488945|FG000|Overall Study|Withdrawal by Subject|2|||
156926432|NCT03204305|566488946|FG001|Overall Study|Withdrawal by Subject|0|||
156926433|NCT03204305|566488947|FG002|Overall Study|Withdrawal by Subject|0|||
156926434|NCT03204305|566488948|FG003|Overall Study|Withdrawal by Subject|0|||
156926435|NCT01603459|566488949|FG000|Overall Study|Adverse Event|5|||
156926436|NCT01603459|566488949|FG000|Overall Study|Withdrawal by Subject|5|||
156926437|NCT01603459|566488949|FG000|Overall Study|Lost to Follow-up|3|||
156926438|NCT01603459|566488949|FG000|Overall Study|Predefined discontinuation criteria|3|||
156926439|NCT01603459|566488949|FG000|Overall Study|Non-compliance|1|||
156926440|NCT01603459|566488949|FG000|Overall Study|Administrative reason|1|||
156926441|NCT00535223|566488951|FG000|Overall Study|Withdrawal by Subject|4|||
156926442|NCT00535223|566488952|FG001|Overall Study|Withdrawal by Subject|1|||
156926443|NCT02953314|566488953|FG000|Overall Study|Adverse Event|0|||
156926444|NCT02953314|566488954|FG001|Overall Study|Adverse Event|1|||
157165747|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
157165748|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
157165749|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
156926445|NCT02953314|566488953|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
156926446|NCT02953314|566488954|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
156926447|NCT02335099|566488955|FG000|Treatment|Withdrawal by Subject|1|||
156926448|NCT02335099|566488956|FG001|Treatment|Withdrawal by Subject|3|||
156926449|NCT02335099|566488955|FG000|Treatment|Lost to Follow-up|2|||
156926450|NCT02335099|566488956|FG001|Treatment|Lost to Follow-up|0|||
156926451|NCT02335099|566488955|FG000|Treatment|Death|1|||
157165750|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
157165751|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
157165752|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
157165753|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
156926452|NCT02335099|566488956|FG001|Treatment|Death|0|||
156926453|NCT02335099|566488955|FG000|Treatment|Adverse Event|1|||
156926454|NCT02335099|566488956|FG001|Treatment|Adverse Event|2|||
156926455|NCT02335099|566488955|FG000|Follow-up|Death|0|||
156926456|NCT02335099|566488956|FG001|Follow-up|Death|1|||
156926457|NCT01288287|566488957|FG000|Overall Study|Lost to Follow-up|8|||
156926458|NCT01288287|566488957|FG000|Overall Study|Withdrawal by Subject|4|||
156926459|NCT01288287|566488957|FG000|Overall Study|Lack of Efficacy|13|||
156926460|NCT01288287|566488957|FG000|Overall Study|Other Reason|13|||
156926461|NCT01288287|566488957|FG000|Overall Study|Unknown Reason|1|||
156926462|NCT01288287|566488957|FG000|Overall Study|Unknown Status|7|||
156926463|NCT04948450|566488968|FG000|Overall Study|Return home|1|||
156926464|NCT04948450|566488969|FG001|Overall Study|Return home|3|||
156926465|NCT00101907|566488972|FG000|Overall Study|Adverse Event|1|||
156926466|NCT00101907|566488973|FG001|Overall Study|Adverse Event|0|||
156926467|NCT00101907|566488974|FG002|Overall Study|Adverse Event|0|||
156926468|NCT00101907|566488975|FG003|Overall Study|Adverse Event|0|||
156926469|NCT00101907|566488976|FG004|Overall Study|Adverse Event|0|||
156926470|NCT00101907|566488977|FG005|Overall Study|Adverse Event|0|||
156926471|NCT00101907|566488972|FG000|Overall Study|Death|0|||
156926472|NCT00101907|566488973|FG001|Overall Study|Death|1|||
156926473|NCT00101907|566488974|FG002|Overall Study|Death|0|||
156926474|NCT00101907|566488975|FG003|Overall Study|Death|0|||
156926475|NCT00101907|566488976|FG004|Overall Study|Death|3|||
156926476|NCT00101907|566488977|FG005|Overall Study|Death|0|||
156926477|NCT00101907|566488972|FG000|Overall Study|Physician Decision|0|||
156926478|NCT00101907|566488973|FG001|Overall Study|Physician Decision|0|||
156926479|NCT00101907|566488974|FG002|Overall Study|Physician Decision|0|||
156926480|NCT00101907|566488975|FG003|Overall Study|Physician Decision|1|||
156926481|NCT00101907|566488976|FG004|Overall Study|Physician Decision|1|||
156926482|NCT00101907|566488977|FG005|Overall Study|Physician Decision|0|||
156926483|NCT00101907|566488972|FG000|Overall Study|Withdrawal by Subject|1|||
156926484|NCT00101907|566488973|FG001|Overall Study|Withdrawal by Subject|0|||
156926485|NCT00101907|566488974|FG002|Overall Study|Withdrawal by Subject|1|||
156926486|NCT00101907|566488975|FG003|Overall Study|Withdrawal by Subject|0|||
156926487|NCT00101907|566488976|FG004|Overall Study|Withdrawal by Subject|1|||
156926488|NCT00101907|566488977|FG005|Overall Study|Withdrawal by Subject|0|||
156926489|NCT00624052|566488978|FG000|Overall Study|Adverse Event|7|||
156926490|NCT00624052|566488979|FG001|Overall Study|Adverse Event|6|||
156926491|NCT00624052|566488980|FG002|Overall Study|Adverse Event|0|||
156926492|NCT00624052|566488981|FG003|Overall Study|Adverse Event|3|||
156926493|NCT00624052|566488978|FG000|Overall Study|Lack of Efficacy|1|||
156926494|NCT00624052|566488979|FG001|Overall Study|Lack of Efficacy|1|||
156926495|NCT00624052|566488980|FG002|Overall Study|Lack of Efficacy|0|||
156926496|NCT00624052|566488981|FG003|Overall Study|Lack of Efficacy|0|||
156926497|NCT00624052|566488978|FG000|Overall Study|Lost to Follow-up|2|||
156926498|NCT00624052|566488979|FG001|Overall Study|Lost to Follow-up|3|||
156926499|NCT00624052|566488980|FG002|Overall Study|Lost to Follow-up|1|||
156926500|NCT00624052|566488981|FG003|Overall Study|Lost to Follow-up|0|||
156926501|NCT00624052|566488978|FG000|Overall Study|Non compliant with the protocol|2|||
156926502|NCT00624052|566488979|FG001|Overall Study|Non compliant with the protocol|1|||
156926503|NCT00624052|566488980|FG002|Overall Study|Non compliant with the protocol|1|||
156926504|NCT00624052|566488981|FG003|Overall Study|Non compliant with the protocol|1|||
156926505|NCT00624052|566488978|FG000|Overall Study|Consent withdrawn|3|||
156926506|NCT00624052|566488979|FG001|Overall Study|Consent withdrawn|1|||
156926507|NCT00624052|566488980|FG002|Overall Study|Consent withdrawn|1|||
156926508|NCT00624052|566488981|FG003|Overall Study|Consent withdrawn|0|||
156926509|NCT00624052|566488978|FG000|Overall Study|Changed job/ran out if meds|0|||
156926510|NCT00624052|566488979|FG001|Overall Study|Changed job/ran out if meds|2|||
156926511|NCT00624052|566488980|FG002|Overall Study|Changed job/ran out if meds|0|||
156926512|NCT00624052|566488981|FG003|Overall Study|Changed job/ran out if meds|0|||
156926513|NCT01367158|566488991|FG000|Overall Study|Withdrew consent|0|||
157165754|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
157165755|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
157165756|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
156926514|NCT01367158|566488992|FG001|Overall Study|Withdrew consent|2|||
156926515|NCT01367158|566488993|FG002|Overall Study|Withdrew consent|1|||
156926516|NCT01367158|566488994|FG003|Overall Study|Withdrew consent|0|||
157029061|NCT01928394|566862888|FG001|Treatment Period|Participant request to stop therapy|0|||
156926517|NCT01367158|566488995|FG004|Overall Study|Withdrew consent|2|||
156926518|NCT01367158|566488996|FG005|Overall Study|Withdrew consent|0|||
156926519|NCT01367158|566488997|FG006|Overall Study|Withdrew consent|0|||
156926520|NCT01367158|566488998|FG007|Overall Study|Withdrew consent|1|||
156926521|NCT01367158|566488999|FG008|Overall Study|Withdrew consent|0|||
156926522|NCT01367158|566489000|FG009|Overall Study|Withdrew consent|0|||
156926523|NCT01367158|566489001|FG010|Overall Study|Withdrew consent|0|||
156926524|NCT01367158|566488991|FG000|Overall Study|Lost to Follow-up|0|||
156926525|NCT01367158|566488992|FG001|Overall Study|Lost to Follow-up|0|||
156926526|NCT01367158|566488993|FG002|Overall Study|Lost to Follow-up|0|||
156926527|NCT01367158|566488994|FG003|Overall Study|Lost to Follow-up|1|||
156926528|NCT01367158|566488995|FG004|Overall Study|Lost to Follow-up|0|||
156926529|NCT01367158|566488996|FG005|Overall Study|Lost to Follow-up|2|||
156926530|NCT01367158|566488997|FG006|Overall Study|Lost to Follow-up|0|||
156926531|NCT01367158|566488998|FG007|Overall Study|Lost to Follow-up|1|||
156926532|NCT01367158|566488999|FG008|Overall Study|Lost to Follow-up|0|||
156926533|NCT01367158|566489000|FG009|Overall Study|Lost to Follow-up|0|||
156926534|NCT01367158|566489001|FG010|Overall Study|Lost to Follow-up|1|||
156926535|NCT01367158|566488991|FG000|Overall Study|Protocol Violation|0|||
156926536|NCT01367158|566488992|FG001|Overall Study|Protocol Violation|1|||
156926537|NCT01367158|566488993|FG002|Overall Study|Protocol Violation|0|||
156926538|NCT01367158|566488994|FG003|Overall Study|Protocol Violation|0|||
156926539|NCT01367158|566488995|FG004|Overall Study|Protocol Violation|0|||
156926540|NCT01367158|566488996|FG005|Overall Study|Protocol Violation|0|||
156926541|NCT01367158|566488997|FG006|Overall Study|Protocol Violation|0|||
156926542|NCT01367158|566488998|FG007|Overall Study|Protocol Violation|0|||
156926543|NCT01367158|566488999|FG008|Overall Study|Protocol Violation|0|||
156926544|NCT01367158|566489000|FG009|Overall Study|Protocol Violation|0|||
156926545|NCT01367158|566489001|FG010|Overall Study|Protocol Violation|0|||
156926546|NCT01765153|566489002|FG000|Training Phase 1|Format of intervention differed|1|||
156926547|NCT01765153|566489003|FG001|Training Phase 1|Format of intervention differed|0|||
156926548|NCT01765153|566489002|FG000|Training Phase 1|Poor participation in intervention|0|||
156926549|NCT01765153|566489003|FG001|Training Phase 1|Poor participation in intervention|1|||
156926550|NCT01765153|566489002|FG000|Rest Phase 1|Withdrawal by Subject|0|||
156926551|NCT01765153|566489003|FG001|Rest Phase 1|Withdrawal by Subject|1|||
156926552|NCT01765153|566489002|FG000|Training Phase 2|Withdrawal by Subject|0|||
156926553|NCT01765153|566489003|FG001|Training Phase 2|Withdrawal by Subject|1|||
156926554|NCT01765153|566489002|FG000|Rest Phase 2|Lost to Follow-up|2|||
156926555|NCT01765153|566489003|FG001|Rest Phase 2|Lost to Follow-up|1|||
156926556|NCT02663674|566489004|FG000|Overall Study|Lost to Follow-up|5|||
156926557|NCT02663674|566489005|FG001|Overall Study|Lost to Follow-up|4|||
156926558|NCT02663674|566489004|FG000|Overall Study|Withdrawal by Subject|1|||
156926559|NCT02663674|566489005|FG001|Overall Study|Withdrawal by Subject|4|||
156926560|NCT02663674|566489004|FG000|Overall Study|Physician Decision|1|||
156926561|NCT02663674|566489005|FG001|Overall Study|Physician Decision|1|||
156926562|NCT02663674|566489004|FG000|Overall Study|Other Event (Health Related)|0|||
156926563|NCT02663674|566489005|FG001|Overall Study|Other Event (Health Related)|1|||
156926564|NCT04568590|566490711|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
156926565|NCT00202644|566490714|FG000|Overall Study|Adverse Event|12|||
156926566|NCT00202644|566490715|FG001|Overall Study|Adverse Event|13|||
156926567|NCT00202644|566490714|FG000|Overall Study|Withdrawal by Subject|8|||
156926568|NCT00202644|566490715|FG001|Overall Study|Withdrawal by Subject|6|||
156926569|NCT00202644|566490714|FG000|Overall Study|Lack of Efficacy|6|||
156926570|NCT00202644|566490715|FG001|Overall Study|Lack of Efficacy|6|||
156926571|NCT00202644|566490714|FG000|Overall Study|Lost to Follow-up|0|||
156926572|NCT00202644|566490715|FG001|Overall Study|Lost to Follow-up|1|||
156926573|NCT00202644|566490714|FG000|Overall Study|Other|9|||
156926574|NCT00202644|566490715|FG001|Overall Study|Other|1|||
157029062|NCT01928394|566862889|FG002|Treatment Period|Participant request to stop therapy|0|||
157029063|NCT01928394|566862890|FG003|Treatment Period|Participant request to stop therapy|0|||
157029064|NCT01928394|566862891|FG004|Treatment Period|Participant request to stop therapy|0|||
157029065|NCT01928394|566862892|FG005|Treatment Period|Participant request to stop therapy|3|||
157029066|NCT01928394|566862893|FG006|Treatment Period|Participant request to stop therapy|3|||
157029067|NCT01928394|566862894|FG007|Treatment Period|Participant request to stop therapy|0|||
157029068|NCT01928394|566862895|FG008|Treatment Period|Participant request to stop therapy|0|||
157029069|NCT01928394|566862896|FG009|Treatment Period|Participant request to stop therapy|0|||
157029070|NCT01928394|566862897|FG010|Treatment Period|Participant request to stop therapy|3|||
157029071|NCT01928394|566862898|FG011|Treatment Period|Participant request to stop therapy|2|||
157029072|NCT01928394|566862899|FG012|Treatment Period|Participant request to stop therapy|1|||
157029073|NCT01928394|566862900|FG013|Treatment Period|Participant request to stop therapy|2|||
157029074|NCT01928394|566862901|FG014|Treatment Period|Participant request to stop therapy|4|||
156926575|NCT02750592|566490716|FG000|Overall Study|Adverse Event|3|||
156926576|NCT02750592|566490716|FG000|Overall Study|Lack of Efficacy|2|||
156926577|NCT01372501|566490717|FG000|Overall Study|Adverse Event|4|||
156926578|NCT01372501|566490717|FG000|Overall Study|Device migration|1|||
156926579|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Death|3|||
156926580|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Death|2|||
156926581|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Death|4|||
156926582|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Death|3|||
156926583|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Death|0|||
156926584|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Death|0|||
156926585|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156926586|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
156926587|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
156926588|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156926589|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156926590|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
156926591|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
156926592|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156926593|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156926594|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156926595|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156926596|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
156926597|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
156926598|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156926599|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
156926600|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
156926601|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156926602|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
156926603|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156926604|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156926605|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
156926606|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
156926607|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156926608|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
156926609|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
156926610|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
156926611|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
156926612|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
156926613|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
156926614|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
156926615|NCT02432846|566490723|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156926616|NCT02432846|566490724|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156926617|NCT02432846|566490725|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
156926618|NCT02432846|566490726|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156926619|NCT02432846|566490727|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156926620|NCT02432846|566490728|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
156926621|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
156926622|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
156926623|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
156926624|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
156926625|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
157165757|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
157165758|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
156926626|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
156926627|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156926628|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
157165759|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
157165760|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
157165761|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
157165762|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
157165763|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
157165764|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
157165765|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
157165766|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
157165767|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
157165768|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
156926629|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156926630|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
156926631|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
156926632|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
157165769|NCT01963208|567348098|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
157165770|NCT01963208|567348099|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
157165771|NCT01963208|567348100|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
157165772|NCT01963208|567348101|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
157165773|NCT01963208|567348102|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
157165774|NCT01963208|567348103|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
157165775|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
157227039|NCT00409578|567576034|FG003|Overall Study|Abnormal laboratory value(s)|4|||
156926633|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156926634|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156926635|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
157165776|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156926636|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156926637|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
156926638|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
156926639|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156926640|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156926641|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156926642|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
156926643|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
156926644|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
156926645|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156926646|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156926647|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156926648|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
156926649|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
156926650|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
156926651|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156926652|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156926653|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156926654|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
156926655|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
156926656|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
156926657|NCT02432846|566490723|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156926658|NCT02432846|566490724|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156926659|NCT02432846|566490725|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156926660|NCT02432846|566490726|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156926661|NCT02432846|566490727|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
156926662|NCT02432846|566490728|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
156926663|NCT01912287|566490729|FG000|Overall Study|Ineligible|1|||
156926664|NCT01912287|566490730|FG001|Overall Study|Ineligible|0|||
156926665|NCT01912287|566490731|FG002|Overall Study|Ineligible|1|||
156926666|NCT01912287|566490729|FG000|Overall Study|No-show|0|||
156926667|NCT01912287|566490730|FG001|Overall Study|No-show|0|||
156926668|NCT01912287|566490731|FG002|Overall Study|No-show|1|||
156926669|NCT01912287|566490729|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
156926670|NCT01912287|566490730|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
156926671|NCT01912287|566490731|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
156926672|NCT01912287|566490729|FG000|Overall Study|Felt treatment no longer needed|0|||
156926673|NCT01912287|566490730|FG001|Overall Study|Felt treatment no longer needed|1|||
156926674|NCT01912287|566490731|FG002|Overall Study|Felt treatment no longer needed|0|||
156926675|NCT01912287|566490729|FG000|Overall Study|Life circumstances|4|||
156926676|NCT01912287|566490730|FG001|Overall Study|Life circumstances|2|||
156926677|NCT01912287|566490731|FG002|Overall Study|Life circumstances|0|||
156926678|NCT01912287|566490729|FG000|Overall Study|Lost Interest|1|||
156926679|NCT01912287|566490730|FG001|Overall Study|Lost Interest|0|||
156926680|NCT01912287|566490731|FG002|Overall Study|Lost Interest|0|||
156926681|NCT01912287|566490729|FG000|Overall Study|Uknown reason - subject drop out|5|||
156926682|NCT01912287|566490730|FG001|Overall Study|Uknown reason - subject drop out|7|||
156926683|NCT01912287|566490731|FG002|Overall Study|Uknown reason - subject drop out|3|||
156926684|NCT01912287|566490729|FG000|Overall Study|Missed Assesment|1|||
156926685|NCT01912287|566490730|FG001|Overall Study|Missed Assesment|1|||
156926686|NCT01912287|566490731|FG002|Overall Study|Missed Assesment|1|||
156926687|NCT01912287|566490729|FG000|Overall Study|Scheduling/change in availability|17|||
156926688|NCT01912287|566490730|FG001|Overall Study|Scheduling/change in availability|10|||
156926689|NCT01912287|566490731|FG002|Overall Study|Scheduling/change in availability|8|||
156926690|NCT02631850|566490732|FG000|Treatment Period|Lost to Follow-up|0|||
156926691|NCT02631850|566490733|FG001|Treatment Period|Lost to Follow-up|1|||
156926692|NCT02631850|566490734|FG002|Treatment Period|Lost to Follow-up|0|||
156926693|NCT02631850|566490735|FG003|Treatment Period|Lost to Follow-up|0|||
156926694|NCT02631850|566490732|FG000|Treatment Period|Protocol Violation|1|||
156926695|NCT02631850|566490733|FG001|Treatment Period|Protocol Violation|0|||
156926696|NCT02631850|566490734|FG002|Treatment Period|Protocol Violation|0|||
156926697|NCT02631850|566490735|FG003|Treatment Period|Protocol Violation|0|||
156926698|NCT02631850|566490732|FG000|Treatment Period|Withdrawal by Subject|0|||
156926699|NCT02631850|566490733|FG001|Treatment Period|Withdrawal by Subject|5|||
156926700|NCT02631850|566490734|FG002|Treatment Period|Withdrawal by Subject|2|||
157165777|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
156926701|NCT02631850|566490735|FG003|Treatment Period|Withdrawal by Subject|2|||
156926702|NCT02631850|566490732|FG000|Treatment Period|Adverse Event|1|||
156926703|NCT02631850|566490733|FG001|Treatment Period|Adverse Event|0|||
156926704|NCT02631850|566490734|FG002|Treatment Period|Adverse Event|2|||
156926705|NCT02631850|566490735|FG003|Treatment Period|Adverse Event|3|||
157165778|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
157165779|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
157165780|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
157165781|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
157165782|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
157165783|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
157165784|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
157165785|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
157165786|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
157165787|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
157165788|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
157165789|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
157165790|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
157165791|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
157165792|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
157165793|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
157165794|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
157165795|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
157165796|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
157165797|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
156926706|NCT02631850|566490732|FG000|Treatment Period|Family medical issue|1|||
156926707|NCT02631850|566490733|FG001|Treatment Period|Family medical issue|0|||
156926708|NCT02631850|566490734|FG002|Treatment Period|Family medical issue|0|||
156926709|NCT02631850|566490735|FG003|Treatment Period|Family medical issue|0|||
156926710|NCT02631850|566490732|FG000|6 Month Follow up|Lost to Follow-up|5|||
156926711|NCT02631850|566490733|FG001|6 Month Follow up|Lost to Follow-up|8|||
156926712|NCT02631850|566490734|FG002|6 Month Follow up|Lost to Follow-up|3|||
156926713|NCT02631850|566490735|FG003|6 Month Follow up|Lost to Follow-up|5|||
157165798|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
157165799|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
157165800|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
157165801|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
157165802|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
157165803|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
157165804|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
157165805|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
157165806|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
157165807|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
156926714|NCT02631850|566490732|FG000|6 Month Follow up|Withdrawal by Subject|1|||
156926715|NCT02631850|566490733|FG001|6 Month Follow up|Withdrawal by Subject|0|||
156926716|NCT02631850|566490734|FG002|6 Month Follow up|Withdrawal by Subject|0|||
156926717|NCT02631850|566490735|FG003|6 Month Follow up|Withdrawal by Subject|2|||
156926718|NCT02631850|566490732|FG000|6 Month Follow up|Adverse Event|1|||
156926719|NCT02631850|566490733|FG001|6 Month Follow up|Adverse Event|4|||
156926720|NCT02631850|566490734|FG002|6 Month Follow up|Adverse Event|1|||
156926721|NCT02631850|566490735|FG003|6 Month Follow up|Adverse Event|3|||
156926722|NCT02631850|566490732|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
156926723|NCT02631850|566490733|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
156926724|NCT02631850|566490734|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
156926725|NCT02631850|566490735|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
156926726|NCT01462084|566490736|FG000|Overall Study|Withdrawal by Subject|1|||
156926727|NCT01462084|566490737|FG001|Overall Study|Withdrawal by Subject|0|||
156926728|NCT01462084|566490736|FG000|Overall Study|Protocol Violation|1|||
156926729|NCT01462084|566490737|FG001|Overall Study|Protocol Violation|1|||
156926730|NCT02278263|566490738|FG000|Overall Study|Protocol Violation|7|||
156926731|NCT02278263|566490739|FG001|Overall Study|Protocol Violation|0|||
156926732|NCT02278263|566490740|FG002|Overall Study|Protocol Violation|9|||
157165808|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
157165809|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
157165810|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
157165811|NCT01963208|567348098|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
157165812|NCT01963208|567348099|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
157165813|NCT01963208|567348100|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
157165814|NCT01963208|567348101|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
157165815|NCT01963208|567348102|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
156926733|NCT01514760|566490741|FG000|Overall Study|Lost to Follow-up|2|||
156926734|NCT01266460|566490743|FG000|Overall Study|Adverse Event|3|||
156926735|NCT01266460|566490743|FG000|Overall Study|Withdrawal by Subject|5|||
157165816|NCT01963208|567348103|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
157165817|NCT00438399|567348104|FG000|Overall Study|Lost to Follow-up|2|||
156926736|NCT01266460|566490743|FG000|Overall Study|Disease Progression|18|||
156926737|NCT01266460|566490743|FG000|Overall Study|Not otherwise specified|8|||
156926738|NCT01132547|566490744|FG000|Overall Study|Withdrawal by Subject|3|||
156926739|NCT01132547|566490745|FG001|Overall Study|Withdrawal by Subject|1|||
156926740|NCT01132547|566490744|FG000|Overall Study|Death|1|||
156926741|NCT01132547|566490745|FG001|Overall Study|Death|0|||
156926742|NCT05811234|566490746|FG000|Overall Study|Loss of Effectiveness|2|||
156926743|NCT05811234|566490746|FG000|Overall Study|Adverse Event|4|||
156926744|NCT05811234|566490746|FG000|Overall Study|Pregnancy|1|||
156926745|NCT05811234|566490746|FG000|Overall Study|Disease progression|1|||
156926746|NCT05811234|566490746|FG000|Overall Study|Withdrawal by Subject|4|||
156926747|NCT05811234|566490746|FG000|Overall Study|Lost to Follow-up|13|||
156926748|NCT05811234|566490746|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
156926749|NCT02710045|566490747|FG000|Overall Study|Death|1|||
156926750|NCT02710045|566490748|FG001|Overall Study|Death|2|||
156926751|NCT02710045|566490749|FG002|Overall Study|Death|0|||
156926752|NCT02710045|566490747|FG000|Overall Study|Withdrawal by Subject|6|||
156926753|NCT02710045|566490748|FG001|Overall Study|Withdrawal by Subject|6|||
156926754|NCT02710045|566490749|FG002|Overall Study|Withdrawal by Subject|2|||
156926755|NCT02710045|566490747|FG000|Overall Study|Protocol Violation|1|||
156926756|NCT02710045|566490748|FG001|Overall Study|Protocol Violation|2|||
156926757|NCT02710045|566490749|FG002|Overall Study|Protocol Violation|3|||
156926758|NCT02710045|566490747|FG000|Overall Study|Lost to Follow-up|3|||
156926759|NCT02710045|566490748|FG001|Overall Study|Lost to Follow-up|6|||
156926760|NCT02710045|566490749|FG002|Overall Study|Lost to Follow-up|7|||
156926761|NCT02710045|566490747|FG000|Overall Study|Physician Decision|0|||
156926762|NCT02710045|566490748|FG001|Overall Study|Physician Decision|0|||
156926763|NCT02710045|566490749|FG002|Overall Study|Physician Decision|1|||
156926764|NCT02710045|566490747|FG000|Overall Study|Poor Attendance|0|||
156926765|NCT02710045|566490748|FG001|Overall Study|Poor Attendance|1|||
156926766|NCT02710045|566490749|FG002|Overall Study|Poor Attendance|0|||
156926767|NCT02118012|566490750|FG000|Overall Study|Adverse Event|0|||
156926768|NCT02118012|566490751|FG001|Overall Study|Adverse Event|1|||
156926769|NCT02118012|566490750|FG000|Overall Study|Physician Decision|0|||
156926770|NCT02118012|566490751|FG001|Overall Study|Physician Decision|1|||
156926771|NCT00536107|566490755|FG000|Overall Study|Death|5|||
156926772|NCT00536107|566490756|FG001|Overall Study|Death|1|||
156926773|NCT00536107|566490755|FG000|Overall Study|Incorrect enrolment|1|||
156926774|NCT00536107|566490756|FG001|Overall Study|Incorrect enrolment|0|||
156926775|NCT00536107|566490755|FG000|Overall Study|Withdrawal by Subject|0|||
156926776|NCT00536107|566490756|FG001|Overall Study|Withdrawal by Subject|1|||
156926777|NCT00536107|566490755|FG000|Overall Study|Study Termination|2|||
156926778|NCT00536107|566490756|FG001|Overall Study|Study Termination|4|||
156926779|NCT00613015|566490761|FG000|Overall Study|Lost to Follow-up|0|||
156926780|NCT00613015|566490762|FG001|Overall Study|Lost to Follow-up|1|||
156926781|NCT00613015|566490763|FG002|Overall Study|Lost to Follow-up|3|||
156926782|NCT00613015|566490764|FG003|Overall Study|Lost to Follow-up|3|||
156926783|NCT00613015|566490765|FG004|Overall Study|Lost to Follow-up|2|||
156926784|NCT00613015|566490766|FG005|Overall Study|Lost to Follow-up|3|||
156926785|NCT04327388|566490769|FG000|Overall Study|Adverse Event|17|||
156926786|NCT04327388|566490770|FG001|Overall Study|Adverse Event|18|||
156926787|NCT04327388|566490771|FG002|Overall Study|Adverse Event|9|||
156926788|NCT04327388|566490769|FG000|Overall Study|Other|1|||
156926789|NCT04327388|566490770|FG001|Overall Study|Other|2|||
156926790|NCT04327388|566490771|FG002|Overall Study|Other|0|||
156926791|NCT04327388|566490769|FG000|Overall Study|Randomized and not treated|2|||
156926792|NCT04327388|566490770|FG001|Overall Study|Randomized and not treated|0|||
156926793|NCT04327388|566490771|FG002|Overall Study|Randomized and not treated|2|||
156926794|NCT04387435|566490778|FG000|Overall Study|Physician Decision|1|||
156926795|NCT03855280|566490779|FG000|Treatment Phase|Adverse Event|1|||
156926796|NCT03855280|566490779|FG000|Treatment Phase|Withdrawal by Subject|1|||
156926797|NCT03855280|566490779|FG000|Continuation Phase|Protocol Violation|1|||
156926798|NCT03855280|566490779|FG000|Continuation Phase|Adverse Event|1|||
156926799|NCT03855280|566490779|FG000|Continuation Phase|Sponsor Concluded Study|1|||
156926800|NCT03338855|566490781|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
156926801|NCT03338855|566490782|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
156926802|NCT00975481|566490783|FG000|Second Intervention Period|Adverse Event|2|||
156926803|NCT00975481|566490784|FG001|Second Intervention Period|Adverse Event|1|||
156926804|NCT00975481|566490785|FG002|Second Intervention Period|Adverse Event|0|||
156926805|NCT00975481|566490786|FG003|Second Intervention Period|Adverse Event|0|||
156926806|NCT00975481|566490787|FG004|Second Intervention Period|Adverse Event|0|||
156926807|NCT00975481|566490788|FG005|Second Intervention Period|Adverse Event|0|||
156926808|NCT00975481|566490783|FG000|Second Intervention Period|Withdrawal by Subject|0|||
156926809|NCT00975481|566490784|FG001|Second Intervention Period|Withdrawal by Subject|0|||
156926810|NCT00975481|566490785|FG002|Second Intervention Period|Withdrawal by Subject|1|||
156926811|NCT00975481|566490786|FG003|Second Intervention Period|Withdrawal by Subject|0|||
157165818|NCT00438399|567348105|FG001|Overall Study|Lost to Follow-up|2|||
157165819|NCT00438399|567348106|FG002|Overall Study|Lost to Follow-up|1|||
157165820|NCT00438399|567348107|FG003|Overall Study|Lost to Follow-up|1|||
156926812|NCT00975481|566490787|FG004|Second Intervention Period|Withdrawal by Subject|0|||
156926813|NCT00975481|566490788|FG005|Second Intervention Period|Withdrawal by Subject|0|||
156926814|NCT00975481|566490783|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
156926815|NCT00975481|566490784|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
156926816|NCT00975481|566490785|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
156926817|NCT00975481|566490786|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
156926818|NCT00975481|566490787|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
156926819|NCT00975481|566490788|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
156926820|NCT00975481|566490783|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
156926821|NCT00975481|566490784|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
156926822|NCT00975481|566490785|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
156926823|NCT00975481|566490786|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
156926824|NCT00975481|566490787|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
156926825|NCT00975481|566490788|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
156926826|NCT02738450|566490792|FG000|Overall Study|Withdrawal by Subject|0|||
156926827|NCT02738450|566490793|FG001|Overall Study|Withdrawal by Subject|2|||
156926828|NCT02738450|566490794|FG002|Overall Study|Withdrawal by Subject|0|||
156926829|NCT03559257|566490795|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
156926830|NCT03559257|566490796|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
156926831|NCT03559257|566490795|FG000|Double Blind Treatment Period|Protocol Violation|1|||
156926832|NCT03559257|566490796|FG001|Double Blind Treatment Period|Protocol Violation|4|||
156926833|NCT03559257|566490795|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
157165821|NCT00438399|567348108|FG004|Overall Study|Lost to Follow-up|1|||
156926834|NCT03559257|566490796|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
156926835|NCT03559257|566490795|FG000|Double Blind Treatment Period|Adverse Event|0|||
156926836|NCT03559257|566490796|FG001|Double Blind Treatment Period|Adverse Event|1|||
156926837|NCT03559257|566490795|FG000|Double Blind Treatment Period|Screen Failure|0|||
156926838|NCT03559257|566490796|FG001|Double Blind Treatment Period|Screen Failure|1|||
156926839|NCT03559257|566490795|FG000|Open-label Treatment Period|Adverse Event|1|||
156926840|NCT03559257|566490796|FG001|Open-label Treatment Period|Adverse Event|4|||
156926841|NCT03559257|566490795|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
156926842|NCT03559257|566490796|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
156926843|NCT03559257|566490795|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
156926844|NCT03559257|566490796|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
156926845|NCT03559257|566490795|FG000|Open-label Treatment Period|Protocol Violation|2|||
156926846|NCT03559257|566490796|FG001|Open-label Treatment Period|Protocol Violation|0|||
156926847|NCT03559257|566490795|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
156926848|NCT03559257|566490796|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
156926849|NCT03559257|566490795|FG000|Open-label Treatment Period|Physician Decision|0|||
156926850|NCT03559257|566490796|FG001|Open-label Treatment Period|Physician Decision|1|||
156926851|NCT03630120|566490797|FG000|Overall Study|Disease progression|0|||
156926852|NCT03630120|566490798|FG001|Overall Study|Disease progression|1|||
156926853|NCT03630120|566490799|FG002|Overall Study|Disease progression|1|||
156926854|NCT03630120|566490800|FG003|Overall Study|Disease progression|1|||
157165822|NCT00438399|567348109|FG005|Overall Study|Lost to Follow-up|1|||
157165823|NCT00438399|567348104|FG000|Overall Study|Adverse Event|0|||
157165824|NCT00438399|567348105|FG001|Overall Study|Adverse Event|0|||
157165825|NCT00438399|567348106|FG002|Overall Study|Adverse Event|1|||
157165826|NCT00438399|567348107|FG003|Overall Study|Adverse Event|1|||
157165827|NCT00438399|567348108|FG004|Overall Study|Adverse Event|0|||
157165828|NCT00438399|567348109|FG005|Overall Study|Adverse Event|1|||
157165829|NCT00438399|567348104|FG000|Overall Study|Withdrawal by Subject|5|||
157165830|NCT00438399|567348105|FG001|Overall Study|Withdrawal by Subject|6|||
157165831|NCT00438399|567348106|FG002|Overall Study|Withdrawal by Subject|3|||
157165832|NCT00438399|567348107|FG003|Overall Study|Withdrawal by Subject|2|||
157165833|NCT00438399|567348108|FG004|Overall Study|Withdrawal by Subject|2|||
157165834|NCT00438399|567348109|FG005|Overall Study|Withdrawal by Subject|2|||
157165835|NCT00438399|567348104|FG000|Overall Study|Protocol Violation|0|||
157165836|NCT00438399|567348105|FG001|Overall Study|Protocol Violation|0|||
157165837|NCT00438399|567348106|FG002|Overall Study|Protocol Violation|1|||
157165838|NCT00438399|567348107|FG003|Overall Study|Protocol Violation|0|||
157165839|NCT00438399|567348108|FG004|Overall Study|Protocol Violation|0|||
157165840|NCT00438399|567348109|FG005|Overall Study|Protocol Violation|1|||
156926855|NCT01519960|566490801|FG000|Overall Study|Withdrawal from the study|26|||
157165841|NCT00438399|567348104|FG000|Overall Study|Subje stopped study|0|||
157165842|NCT00438399|567348105|FG001|Overall Study|Subje stopped study|0|||
157165843|NCT00438399|567348106|FG002|Overall Study|Subje stopped study|1|||
157165844|NCT00438399|567348107|FG003|Overall Study|Subje stopped study|0|||
157165845|NCT00438399|567348108|FG004|Overall Study|Subje stopped study|0|||
157165846|NCT00438399|567348109|FG005|Overall Study|Subje stopped study|0|||
157165847|NCT00438399|567348104|FG000|Overall Study|Pregnancy|0|||
157165848|NCT00438399|567348105|FG001|Overall Study|Pregnancy|0|||
157165849|NCT00438399|567348106|FG002|Overall Study|Pregnancy|0|||
157165850|NCT00438399|567348107|FG003|Overall Study|Pregnancy|0|||
157165851|NCT00438399|567348108|FG004|Overall Study|Pregnancy|0|||
156926856|NCT01519960|566490802|FG001|Overall Study|Withdrawal from the study|22|||
156926857|NCT01519960|566490803|FG002|Overall Study|Withdrawal from the study|5|||
156926858|NCT01387347|566490804|FG000|Overall Study|Lost to Follow-up|2|||
156926859|NCT01387347|566490805|FG001|Overall Study|Lost to Follow-up|1|||
156926860|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
156926861|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
156926862|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
156926863|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
156926864|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
156926865|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
156926866|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
156926867|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
156926868|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
156926869|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
156926870|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
156926871|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
156926872|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
156926873|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
156926874|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
156926875|NCT00561080|566490809|FG000|Vaccination Period (up to Month 4)|Other|0|||
156926876|NCT00561080|566490810|FG001|Vaccination Period (up to Month 4)|Other|2|||
156926877|NCT00561080|566490811|FG002|Vaccination Period (up to Month 4)|Other|1|||
156926878|NCT00561080|566490809|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
156926879|NCT00561080|566490810|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
156926880|NCT00561080|566490811|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
156926881|NCT00561080|566490809|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
156926882|NCT00561080|566490810|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
156926883|NCT00561080|566490811|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
157029075|NCT01928394|566862902|FG015|Treatment Period|Participant request to stop therapy|0|||
157029076|NCT01928394|566862903|FG016|Treatment Period|Participant request to stop therapy|1|||
157029077|NCT01928394|566862904|FG017|Treatment Period|Participant request to stop therapy|3|||
157029078|NCT01928394|566862905|FG018|Treatment Period|Participant request to stop therapy|1|||
157029079|NCT01928394|566862906|FG019|Treatment Period|Participant request to stop therapy|1|||
157029080|NCT01928394|566862907|FG020|Treatment Period|Participant request to stop therapy|3|||
157029081|NCT01928394|566862908|FG021|Treatment Period|Participant request to stop therapy|1|||
157029082|NCT01928394|566862909|FG022|Treatment Period|Participant request to stop therapy|3|||
157029083|NCT01928394|566862887|FG000|Treatment Period|Participant withdrew consent|0|||
157029084|NCT01928394|566862888|FG001|Treatment Period|Participant withdrew consent|0|||
157029085|NCT01928394|566862889|FG002|Treatment Period|Participant withdrew consent|1|||
157029086|NCT01928394|566862890|FG003|Treatment Period|Participant withdrew consent|1|||
157029087|NCT01928394|566862891|FG004|Treatment Period|Participant withdrew consent|0|||
157029088|NCT01928394|566862892|FG005|Treatment Period|Participant withdrew consent|1|||
157029089|NCT01928394|566862893|FG006|Treatment Period|Participant withdrew consent|0|||
157029090|NCT01928394|566862894|FG007|Treatment Period|Participant withdrew consent|1|||
157029091|NCT01928394|566862895|FG008|Treatment Period|Participant withdrew consent|0|||
157029092|NCT01928394|566862896|FG009|Treatment Period|Participant withdrew consent|0|||
157029093|NCT01928394|566862897|FG010|Treatment Period|Participant withdrew consent|1|||
157029094|NCT01928394|566862898|FG011|Treatment Period|Participant withdrew consent|1|||
157029095|NCT01928394|566862899|FG012|Treatment Period|Participant withdrew consent|1|||
157029096|NCT01928394|566862900|FG013|Treatment Period|Participant withdrew consent|0|||
157029097|NCT01928394|566862901|FG014|Treatment Period|Participant withdrew consent|2|||
157029098|NCT01928394|566862902|FG015|Treatment Period|Participant withdrew consent|0|||
157029099|NCT01928394|566862903|FG016|Treatment Period|Participant withdrew consent|2|||
157029100|NCT01928394|566862904|FG017|Treatment Period|Participant withdrew consent|1|||
157029101|NCT01928394|566862905|FG018|Treatment Period|Participant withdrew consent|1|||
157029102|NCT01928394|566862906|FG019|Treatment Period|Participant withdrew consent|1|||
157029103|NCT01928394|566862907|FG020|Treatment Period|Participant withdrew consent|0|||
157029104|NCT01928394|566862908|FG021|Treatment Period|Participant withdrew consent|2|||
157029105|NCT01928394|566862909|FG022|Treatment Period|Participant withdrew consent|0|||
157029106|NCT01928394|566862887|FG000|Treatment Period|Poor/non-compliance|0|||
157029107|NCT01928394|566862888|FG001|Treatment Period|Poor/non-compliance|0|||
157029108|NCT01928394|566862889|FG002|Treatment Period|Poor/non-compliance|0|||
157029109|NCT01928394|566862890|FG003|Treatment Period|Poor/non-compliance|1|||
157029110|NCT01928394|566862891|FG004|Treatment Period|Poor/non-compliance|0|||
156926884|NCT00561080|566490809|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
156926885|NCT00561080|566490810|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
156926886|NCT00561080|566490811|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
157029111|NCT01928394|566862892|FG005|Treatment Period|Poor/non-compliance|0|||
157029112|NCT01928394|566862893|FG006|Treatment Period|Poor/non-compliance|0|||
157029113|NCT01928394|566862894|FG007|Treatment Period|Poor/non-compliance|0|||
156926887|NCT00561080|566490809|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
156926888|NCT00561080|566490810|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
156926889|NCT00561080|566490811|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
156926890|NCT01165554|566490812|FG000|Overall Study|Withdrawal by Subject|23|||
156926891|NCT02113956|566490821|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
156926892|NCT02113956|566490822|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
156926893|NCT02113956|566490821|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
156926894|NCT02113956|566490822|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
156926895|NCT02113956|566490821|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
156926896|NCT02113956|566490822|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
156926897|NCT01499563|566490825|FG000|Overall Study|Withdrawal by Subject|10|||
156926898|NCT01499563|566490826|FG001|Overall Study|Withdrawal by Subject|11|||
156926899|NCT01499563|566490827|FG002|Overall Study|Withdrawal by Subject|7|||
156926900|NCT01499563|566490828|FG003|Overall Study|Withdrawal by Subject|8|||
156926901|NCT01499563|566490825|FG000|Overall Study|Physician Decision|2|||
156926902|NCT01499563|566490826|FG001|Overall Study|Physician Decision|1|||
156926903|NCT01499563|566490827|FG002|Overall Study|Physician Decision|3|||
156926904|NCT01499563|566490828|FG003|Overall Study|Physician Decision|0|||
156926905|NCT01499563|566490825|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
156926906|NCT01499563|566490826|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
156926907|NCT01499563|566490827|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
156926908|NCT01499563|566490828|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
156926909|NCT01499563|566490825|FG000|Overall Study|Adverse Event|2|||
156926910|NCT01499563|566490826|FG001|Overall Study|Adverse Event|0|||
156926911|NCT01499563|566490827|FG002|Overall Study|Adverse Event|1|||
157029114|NCT01928394|566862895|FG008|Treatment Period|Poor/non-compliance|0|||
157029115|NCT01928394|566862896|FG009|Treatment Period|Poor/non-compliance|0|||
157029116|NCT01928394|566862897|FG010|Treatment Period|Poor/non-compliance|0|||
157029117|NCT01928394|566862898|FG011|Treatment Period|Poor/non-compliance|0|||
157029118|NCT01928394|566862899|FG012|Treatment Period|Poor/non-compliance|1|||
157029119|NCT01928394|566862900|FG013|Treatment Period|Poor/non-compliance|0|||
157029120|NCT01928394|566862901|FG014|Treatment Period|Poor/non-compliance|1|||
157029121|NCT01928394|566862902|FG015|Treatment Period|Poor/non-compliance|0|||
157029122|NCT01928394|566862903|FG016|Treatment Period|Poor/non-compliance|0|||
157029123|NCT01928394|566862904|FG017|Treatment Period|Poor/non-compliance|1|||
157029124|NCT01928394|566862905|FG018|Treatment Period|Poor/non-compliance|0|||
157029125|NCT01928394|566862906|FG019|Treatment Period|Poor/non-compliance|1|||
157029126|NCT01928394|566862907|FG020|Treatment Period|Poor/non-compliance|0|||
157029127|NCT01928394|566862908|FG021|Treatment Period|Poor/non-compliance|0|||
157029128|NCT01928394|566862909|FG022|Treatment Period|Poor/non-compliance|0|||
157029129|NCT01928394|566862887|FG000|Treatment Period|other reason|0|||
157029130|NCT01928394|566862888|FG001|Treatment Period|other reason|0|||
157029131|NCT01928394|566862889|FG002|Treatment Period|other reason|0|||
157029132|NCT01928394|566862890|FG003|Treatment Period|other reason|0|||
157029133|NCT01928394|566862891|FG004|Treatment Period|other reason|0|||
157029134|NCT01928394|566862892|FG005|Treatment Period|other reason|0|||
157029135|NCT01928394|566862893|FG006|Treatment Period|other reason|0|||
157029136|NCT01928394|566862894|FG007|Treatment Period|other reason|0|||
157029137|NCT01928394|566862895|FG008|Treatment Period|other reason|0|||
157029138|NCT01928394|566862896|FG009|Treatment Period|other reason|0|||
157029139|NCT01928394|566862897|FG010|Treatment Period|other reason|1|||
157029140|NCT01928394|566862898|FG011|Treatment Period|other reason|1|||
157029141|NCT01928394|566862899|FG012|Treatment Period|other reason|1|||
157029142|NCT01928394|566862900|FG013|Treatment Period|other reason|0|||
157029143|NCT01928394|566862901|FG014|Treatment Period|other reason|1|||
157029144|NCT01928394|566862902|FG015|Treatment Period|other reason|0|||
156926912|NCT01499563|566490828|FG003|Overall Study|Adverse Event|3|||
156926913|NCT01499563|566490825|FG000|Overall Study|Lack of Efficacy|0|||
156926914|NCT01499563|566490826|FG001|Overall Study|Lack of Efficacy|1|||
156926915|NCT01499563|566490827|FG002|Overall Study|Lack of Efficacy|6|||
156926916|NCT01499563|566490828|FG003|Overall Study|Lack of Efficacy|3|||
156926917|NCT01499563|566490825|FG000|Overall Study|Other|8|||
157029145|NCT01928394|566862903|FG016|Treatment Period|other reason|0|||
157029146|NCT01928394|566862904|FG017|Treatment Period|other reason|0|||
157029147|NCT01928394|566862905|FG018|Treatment Period|other reason|2|||
157029148|NCT01928394|566862906|FG019|Treatment Period|other reason|2|||
156926918|NCT01499563|566490826|FG001|Overall Study|Other|6|||
156926919|NCT01499563|566490827|FG002|Overall Study|Other|6|||
156926920|NCT01499563|566490828|FG003|Overall Study|Other|4|||
156926921|NCT03658538|566490829|FG000|Overall Study|Death|2|||
157029149|NCT01928394|566862907|FG020|Treatment Period|other reason|0|||
157029150|NCT01928394|566862908|FG021|Treatment Period|other reason|0|||
157029151|NCT01928394|566862909|FG022|Treatment Period|other reason|0|||
157029152|NCT01928394|566862887|FG000|Treatment Period|Maximum clinical benefit|0|||
157029153|NCT01928394|566862888|FG001|Treatment Period|Maximum clinical benefit|0|||
157165852|NCT00438399|567348109|FG005|Overall Study|Pregnancy|1|||
157165853|NCT00438399|567348104|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
157165854|NCT00438399|567348105|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
157165855|NCT00438399|567348106|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
157165856|NCT00438399|567348107|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
157165857|NCT00438399|567348108|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
157165858|NCT00438399|567348109|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
157165859|NCT01364233|567348110|FG000|Overall Study|Lost to Follow-up|1|||
157165860|NCT00349752|567348115|FG000|Overall Study|Adverse Event|8|||
157165861|NCT00349752|567348116|FG001|Overall Study|Adverse Event|12|||
157165862|NCT00349752|567348115|FG000|Overall Study|Lack of Efficacy|37|||
157165863|NCT00349752|567348116|FG001|Overall Study|Lack of Efficacy|42|||
157165864|NCT00349752|567348115|FG000|Overall Study|Lost to Follow-up|4|||
157165865|NCT00349752|567348116|FG001|Overall Study|Lost to Follow-up|2|||
157165866|NCT00349752|567348115|FG000|Overall Study|Personal reasons|6|||
157165867|NCT00349752|567348116|FG001|Overall Study|Personal reasons|5|||
157165868|NCT00349752|567348115|FG000|Overall Study|Other: Required exclusionary medication|0|||
157165869|NCT00349752|567348116|FG001|Overall Study|Other: Required exclusionary medication|1|||
157165870|NCT00349752|567348115|FG000|Overall Study|Other: Non compliance|0|||
157165871|NCT00349752|567348116|FG001|Overall Study|Other: Non compliance|1|||
157165872|NCT00349752|567348115|FG000|Overall Study|Other: Patient stopped steroids|0|||
157165873|NCT00349752|567348116|FG001|Overall Study|Other: Patient stopped steroids|1|||
157165874|NCT00349752|567348115|FG000|Overall Study|Other: Patient's steroid use|1|||
157165875|NCT00349752|567348116|FG001|Overall Study|Other: Patient's steroid use|0|||
157165876|NCT00349752|567348115|FG000|Overall Study|Other: Ineligible|1|||
157165877|NCT00349752|567348116|FG001|Overall Study|Other: Ineligible|0|||
157165878|NCT00349752|567348115|FG000|Overall Study|Other: Inadvertently unblinded|1|||
157165879|NCT00349752|567348116|FG001|Overall Study|Other: Inadvertently unblinded|0|||
157165880|NCT00349752|567348115|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
157165881|NCT00349752|567348116|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
157165882|NCT00819585|567348117|FG000|Core Study|Adverse Event|2|||
157165883|NCT00819585|567348118|FG001|Core Study|Adverse Event|1|||
157165884|NCT00819585|567348119|FG002|Core Study|Adverse Event|1|||
157165885|NCT00819585|567348120|FG003|Core Study|Adverse Event|4|||
157165886|NCT00819585|567348121|FG004|Core Study|Adverse Event|1|||
157165887|NCT00819585|567348122|FG005|Core Study|Adverse Event|0|||
157165888|NCT00819585|567348123|FG006|Core Study|Adverse Event|2|||
157165889|NCT00819585|567348124|FG007|Core Study|Adverse Event|0|||
157165890|NCT00819585|567348125|FG008|Core Study|Adverse Event|0|||
157165891|NCT00819585|567348126|FG009|Core Study|Adverse Event|0|||
157165892|NCT00819585|567348127|FG010|Core Study|Adverse Event|0|||
157165893|NCT00819585|567348117|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
157165894|NCT00819585|567348118|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
157165895|NCT00819585|567348119|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
156926922|NCT03658538|566490830|FG001|Overall Study|Death|1|||
156926923|NCT03658538|566490829|FG000|Overall Study|Cancer diagnosis|1|||
156926924|NCT03658538|566490830|FG001|Overall Study|Cancer diagnosis|0|||
156926925|NCT03658538|566490829|FG000|Overall Study|Change residence|1|||
156926926|NCT03658538|566490830|FG001|Overall Study|Change residence|2|||
156926927|NCT03658538|566490829|FG000|Overall Study|Lost to Follow-up|3|||
156926928|NCT03658538|566490830|FG001|Overall Study|Lost to Follow-up|3|||
156926929|NCT03658538|566490829|FG000|Overall Study|Unblinded|2|||
156926930|NCT03658538|566490830|FG001|Overall Study|Unblinded|3|||
156926931|NCT03658538|566490829|FG000|Overall Study|Physician Decision|0|||
156926932|NCT03658538|566490830|FG001|Overall Study|Physician Decision|1|||
157029154|NCT01928394|566862889|FG002|Treatment Period|Maximum clinical benefit|0|||
157029155|NCT01928394|566862890|FG003|Treatment Period|Maximum clinical benefit|0|||
157029156|NCT01928394|566862891|FG004|Treatment Period|Maximum clinical benefit|0|||
157029157|NCT01928394|566862892|FG005|Treatment Period|Maximum clinical benefit|0|||
157029158|NCT01928394|566862893|FG006|Treatment Period|Maximum clinical benefit|0|||
157029159|NCT01928394|566862894|FG007|Treatment Period|Maximum clinical benefit|0|||
157165896|NCT00819585|567348120|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
157165897|NCT00819585|567348121|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
157165898|NCT00819585|567348122|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
157165899|NCT00819585|567348123|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
157165900|NCT00819585|567348124|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
157165901|NCT00819585|567348125|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
157165902|NCT00819585|567348126|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
157165903|NCT00819585|567348127|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
157165904|NCT00819585|567348117|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165905|NCT00819585|567348118|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
157165906|NCT00819585|567348119|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165907|NCT00819585|567348120|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165908|NCT00819585|567348121|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165909|NCT00819585|567348122|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
156926933|NCT03658538|566490829|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
156926934|NCT03658538|566490830|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
156926935|NCT03658538|566490829|FG000|Overall Study|Evicted from home|1|||
156926936|NCT03658538|566490830|FG001|Overall Study|Evicted from home|0|||
156926937|NCT03333044|566490832|FG000|Overall Study|Pregnancy|1|||
156926938|NCT03333044|566490833|FG001|Overall Study|Pregnancy|0|||
156926939|NCT03333044|566490834|FG002|Overall Study|Pregnancy|0|||
156926940|NCT03333044|566490832|FG000|Overall Study|Lost to Follow-up|0|||
156926941|NCT03333044|566490833|FG001|Overall Study|Lost to Follow-up|14|||
156926942|NCT03333044|566490834|FG002|Overall Study|Lost to Follow-up|6|||
156926943|NCT02921776|566490835|FG000|Overall Study|patient deterioration, fatigue|2|||
156926944|NCT02921776|566490836|FG001|Overall Study|patient deterioration, fatigue|6|||
156926945|NCT02921776|566490837|FG002|Overall Study|patient deterioration, fatigue|0|||
156926946|NCT02921776|566490838|FG003|Overall Study|patient deterioration, fatigue|0|||
156926947|NCT02921776|566490839|FG004|Overall Study|patient deterioration, fatigue|0|||
156926948|NCT02921776|566490840|FG005|Overall Study|patient deterioration, fatigue|0|||
156926949|NCT02921776|566490841|FG006|Overall Study|patient deterioration, fatigue|0|||
156926950|NCT02921776|566490842|FG007|Overall Study|patient deterioration, fatigue|0|||
156926951|NCT02921776|566490835|FG000|Overall Study|Withdrawal by Subject|0|||
156926952|NCT02921776|566490836|FG001|Overall Study|Withdrawal by Subject|2|||
156926953|NCT02921776|566490837|FG002|Overall Study|Withdrawal by Subject|0|||
156926954|NCT02921776|566490838|FG003|Overall Study|Withdrawal by Subject|1|||
156926955|NCT02921776|566490839|FG004|Overall Study|Withdrawal by Subject|1|||
156926956|NCT02921776|566490840|FG005|Overall Study|Withdrawal by Subject|0|||
156926957|NCT02921776|566490841|FG006|Overall Study|Withdrawal by Subject|8|||
156926958|NCT02921776|566490842|FG007|Overall Study|Withdrawal by Subject|1|||
156926959|NCT02921776|566490835|FG000|Overall Study|Death|0|||
156926960|NCT02921776|566490836|FG001|Overall Study|Death|0|||
156926961|NCT02921776|566490837|FG002|Overall Study|Death|0|||
156926962|NCT02921776|566490838|FG003|Overall Study|Death|2|||
156926963|NCT02921776|566490839|FG004|Overall Study|Death|0|||
156926964|NCT02921776|566490840|FG005|Overall Study|Death|0|||
156926965|NCT02921776|566490841|FG006|Overall Study|Death|0|||
156926966|NCT02921776|566490842|FG007|Overall Study|Death|0|||
156926967|NCT02921776|566490835|FG000|Overall Study|extubation or early discharge|0|||
156926968|NCT02921776|566490836|FG001|Overall Study|extubation or early discharge|0|||
156926969|NCT02921776|566490837|FG002|Overall Study|extubation or early discharge|0|||
156926970|NCT02921776|566490838|FG003|Overall Study|extubation or early discharge|5|||
156926971|NCT02921776|566490839|FG004|Overall Study|extubation or early discharge|5|||
156926972|NCT02921776|566490840|FG005|Overall Study|extubation or early discharge|0|||
156926973|NCT02921776|566490841|FG006|Overall Study|extubation or early discharge|0|||
156926974|NCT02921776|566490842|FG007|Overall Study|extubation or early discharge|0|||
156926975|NCT02921776|566490835|FG000|Overall Study|Lost to Follow-up|0|||
156926976|NCT02921776|566490836|FG001|Overall Study|Lost to Follow-up|0|||
156926977|NCT02921776|566490837|FG002|Overall Study|Lost to Follow-up|0|||
156926978|NCT02921776|566490838|FG003|Overall Study|Lost to Follow-up|0|||
156926979|NCT02921776|566490839|FG004|Overall Study|Lost to Follow-up|0|||
156926980|NCT02921776|566490840|FG005|Overall Study|Lost to Follow-up|2|||
156926981|NCT02921776|566490841|FG006|Overall Study|Lost to Follow-up|3|||
156926982|NCT02921776|566490842|FG007|Overall Study|Lost to Follow-up|6|||
156926983|NCT04537234|566490844|FG000|Overall Study|Withdrawal by Subject|2|||
156926984|NCT04537234|566490845|FG001|Overall Study|Withdrawal by Subject|0|||
156926985|NCT02070744|566490846|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156926986|NCT02070744|566490847|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156926987|NCT02070744|566490848|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
157165910|NCT00819585|567348123|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
157165911|NCT00819585|567348124|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165912|NCT00819585|567348125|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165913|NCT00819585|567348126|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
156926988|NCT02070744|566490849|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
156926989|NCT02070744|566490850|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
156926990|NCT02070744|566490846|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156926991|NCT02070744|566490847|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156926992|NCT02070744|566490848|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156926993|NCT02070744|566490849|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
156926994|NCT02070744|566490850|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
157165914|NCT00819585|567348127|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
157165915|NCT00819585|567348117|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
157165916|NCT00819585|567348118|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
157227040|NCT00409578|567576031|FG000|Overall Study|Lack of Efficacy|0|||
156926995|NCT02070744|566490846|FG000|OLE Phase (48 Weeks)|Other|0|||
156926996|NCT02070744|566490847|FG001|OLE Phase (48 Weeks)|Other|0|||
156926997|NCT02070744|566490848|FG002|OLE Phase (48 Weeks)|Other|0|||
156926998|NCT02070744|566490849|FG003|OLE Phase (48 Weeks)|Other|0|||
156926999|NCT02070744|566490850|FG004|OLE Phase (48 Weeks)|Other|1|||
156927000|NCT07114198|566490851|FG000|Overall Study|Protocol Violation|1|||
156927001|NCT07114198|566490852|FG001|Overall Study|Protocol Violation|1|||
157165917|NCT00819585|567348119|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
157165918|NCT00819585|567348120|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
157165919|NCT00819585|567348121|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
157165920|NCT00819585|567348122|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
157165921|NCT00819585|567348123|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
157165922|NCT00819585|567348124|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
157165923|NCT00819585|567348125|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
157165924|NCT00819585|567348126|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
157165925|NCT00819585|567348127|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
157165926|NCT00819585|567348117|FG000|Core Study|Subject Withdrew Consent|0|||
157165927|NCT00819585|567348118|FG001|Core Study|Subject Withdrew Consent|3|||
157165928|NCT00819585|567348119|FG002|Core Study|Subject Withdrew Consent|2|||
157165929|NCT00819585|567348120|FG003|Core Study|Subject Withdrew Consent|1|||
157165930|NCT00819585|567348121|FG004|Core Study|Subject Withdrew Consent|0|||
157165931|NCT00819585|567348122|FG005|Core Study|Subject Withdrew Consent|0|||
157165932|NCT00819585|567348123|FG006|Core Study|Subject Withdrew Consent|3|||
157165933|NCT00819585|567348124|FG007|Core Study|Subject Withdrew Consent|0|||
157165934|NCT00819585|567348125|FG008|Core Study|Subject Withdrew Consent|0|||
157165935|NCT00819585|567348126|FG009|Core Study|Subject Withdrew Consent|0|||
157165936|NCT00819585|567348127|FG010|Core Study|Subject Withdrew Consent|0|||
157165937|NCT00819585|567348117|FG000|Core Study|Lost to Follow-up|2|||
157165938|NCT00819585|567348118|FG001|Core Study|Lost to Follow-up|1|||
157165939|NCT00819585|567348119|FG002|Core Study|Lost to Follow-up|2|||
157165940|NCT00819585|567348120|FG003|Core Study|Lost to Follow-up|0|||
157165941|NCT00819585|567348121|FG004|Core Study|Lost to Follow-up|1|||
157165942|NCT00819585|567348122|FG005|Core Study|Lost to Follow-up|1|||
157165943|NCT00819585|567348123|FG006|Core Study|Lost to Follow-up|1|||
157165944|NCT00819585|567348124|FG007|Core Study|Lost to Follow-up|0|||
157165945|NCT00819585|567348125|FG008|Core Study|Lost to Follow-up|0|||
157165946|NCT00819585|567348126|FG009|Core Study|Lost to Follow-up|0|||
157165947|NCT00819585|567348127|FG010|Core Study|Lost to Follow-up|0|||
157165948|NCT00819585|567348117|FG000|Core Study|Administrative Problems|0|||
157165949|NCT00819585|567348118|FG001|Core Study|Administrative Problems|0|||
157165950|NCT00819585|567348119|FG002|Core Study|Administrative Problems|0|||
157165951|NCT00819585|567348120|FG003|Core Study|Administrative Problems|0|||
157165952|NCT00819585|567348121|FG004|Core Study|Administrative Problems|0|||
157165953|NCT00819585|567348122|FG005|Core Study|Administrative Problems|0|||
157165954|NCT00819585|567348123|FG006|Core Study|Administrative Problems|2|||
157165955|NCT00819585|567348124|FG007|Core Study|Administrative Problems|0|||
157165956|NCT00819585|567348125|FG008|Core Study|Administrative Problems|0|||
157165957|NCT00819585|567348126|FG009|Core Study|Administrative Problems|0|||
157165958|NCT00819585|567348127|FG010|Core Study|Administrative Problems|0|||
157165959|NCT00819585|567348117|FG000|Core Study|Death|0|||
157165960|NCT00819585|567348118|FG001|Core Study|Death|0|||
157165961|NCT00819585|567348119|FG002|Core Study|Death|0|||
157165962|NCT00819585|567348120|FG003|Core Study|Death|0|||
157165963|NCT00819585|567348121|FG004|Core Study|Death|0|||
157165964|NCT00819585|567348122|FG005|Core Study|Death|0|||
157165965|NCT00819585|567348123|FG006|Core Study|Death|1|||
157165966|NCT00819585|567348124|FG007|Core Study|Death|0|||
157165967|NCT00819585|567348125|FG008|Core Study|Death|0|||
157165968|NCT00819585|567348126|FG009|Core Study|Death|0|||
157165969|NCT00819585|567348127|FG010|Core Study|Death|0|||
157165970|NCT00819585|567348117|FG000|Core Study|Protocol Violation|0|||
157165971|NCT00819585|567348118|FG001|Core Study|Protocol Violation|0|||
156927002|NCT04318080|566493433|FG000|Overall Study|Study closed by sponsor|10|||
156927003|NCT04318080|566493434|FG001|Overall Study|Study closed by sponsor|22|||
156927004|NCT04318080|566493433|FG000|Overall Study|Death|3|||
157165972|NCT00819585|567348119|FG002|Core Study|Protocol Violation|1|||
157165973|NCT00819585|567348120|FG003|Core Study|Protocol Violation|0|||
157165974|NCT00819585|567348121|FG004|Core Study|Protocol Violation|0|||
157165975|NCT00819585|567348122|FG005|Core Study|Protocol Violation|1|||
157165976|NCT00819585|567348123|FG006|Core Study|Protocol Violation|3|||
157165977|NCT00819585|567348124|FG007|Core Study|Protocol Violation|0|||
157165978|NCT00819585|567348125|FG008|Core Study|Protocol Violation|0|||
157165979|NCT00819585|567348126|FG009|Core Study|Protocol Violation|0|||
157165980|NCT00819585|567348127|FG010|Core Study|Protocol Violation|0|||
157165981|NCT00819585|567348117|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
157165982|NCT00819585|567348118|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
156927005|NCT04318080|566493434|FG001|Overall Study|Death|9|||
157165983|NCT00819585|567348119|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
156927006|NCT04318080|566493433|FG000|Overall Study|Withdrawal by Subject|1|||
157165984|NCT00819585|567348120|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
157165985|NCT00819585|567348121|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
157165986|NCT00819585|567348122|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
157165987|NCT00819585|567348123|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
157165988|NCT00819585|567348124|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
156927007|NCT04318080|566493434|FG001|Overall Study|Withdrawal by Subject|0|||
156927008|NCT04318080|566493433|FG000|Overall Study|Protocol Deviation|1|||
156927009|NCT04318080|566493434|FG001|Overall Study|Protocol Deviation|0|||
156927010|NCT06308822|566493435|FG000|Overall Study|Mutation Status Not Confirmed|17|||
156927011|NCT06308822|566493435|FG000|Overall Study|Adverse Event|1|||
156927012|NCT06308822|566493435|FG000|Overall Study|Death|5|||
156927013|NCT06308822|566493435|FG000|Overall Study|Disease progression|8|||
156927014|NCT06308822|566493435|FG000|Overall Study|Withdrawal by Subject|1|||
156927015|NCT06308822|566493435|FG000|Overall Study|Physician Decision|3|||
156927016|NCT01536379|566493436|FG000|Overall Study|Adverse Event|1|||
156927017|NCT01536379|566493437|FG001|Overall Study|Adverse Event|2|||
156927018|NCT01536379|566493436|FG000|Overall Study|Withdrawal by Subject|1|||
156927019|NCT01536379|566493437|FG001|Overall Study|Withdrawal by Subject|1|||
156927020|NCT04734652|566493450|FG000|Overall Study|Withdrawal by Subject|2|||
156927021|NCT04734652|566493451|FG001|Overall Study|Withdrawal by Subject|0|||
156927022|NCT04734652|566493450|FG000|Overall Study|Death|0|||
156927023|NCT04734652|566493451|FG001|Overall Study|Death|1|||
156927024|NCT00939809|566493452|FG000|Overall Study|Adverse Event|2|||
156927025|NCT00939809|566493452|FG000|Overall Study|Death|1|||
156927026|NCT01921179|566493453|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
156927027|NCT01921179|566493454|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
156927028|NCT01921179|566493453|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
156927029|NCT01921179|566493454|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
156927030|NCT02356783|566493455|FG000|Overall Study|Lost to Follow-up|1|||
156927031|NCT02356783|566493456|FG001|Overall Study|Lost to Follow-up|3|||
156927032|NCT02603809|566493457|FG000|Overall Study|Withdrawal by Subject|4|||
156927033|NCT02603809|566493458|FG001|Overall Study|Withdrawal by Subject|1|||
156927034|NCT02603809|566493459|FG002|Overall Study|Withdrawal by Subject|2|||
156927035|NCT02603809|566493460|FG003|Overall Study|Withdrawal by Subject|3|||
156927036|NCT02603809|566493461|FG004|Overall Study|Withdrawal by Subject|3|||
156927037|NCT02603809|566493462|FG005|Overall Study|Withdrawal by Subject|4|||
156927038|NCT02603809|566493457|FG000|Overall Study|Lost to Follow-up|2|||
156927039|NCT02603809|566493458|FG001|Overall Study|Lost to Follow-up|3|||
156927040|NCT02603809|566493459|FG002|Overall Study|Lost to Follow-up|1|||
156927041|NCT02603809|566493460|FG003|Overall Study|Lost to Follow-up|4|||
156927042|NCT02603809|566493461|FG004|Overall Study|Lost to Follow-up|2|||
156927043|NCT02603809|566493462|FG005|Overall Study|Lost to Follow-up|2|||
156927044|NCT02603809|566493457|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
156927045|NCT02603809|566493458|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
156927046|NCT02603809|566493459|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
156927047|NCT02603809|566493460|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
156927048|NCT02603809|566493461|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
156927049|NCT02603809|566493462|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
156927050|NCT02603809|566493457|FG000|Overall Study|Physician Decision|0|||
156927051|NCT02603809|566493458|FG001|Overall Study|Physician Decision|0|||
156927052|NCT02603809|566493459|FG002|Overall Study|Physician Decision|0|||
156927053|NCT02603809|566493460|FG003|Overall Study|Physician Decision|1|||
156927054|NCT02603809|566493461|FG004|Overall Study|Physician Decision|2|||
156927055|NCT02603809|566493462|FG005|Overall Study|Physician Decision|1|||
156927056|NCT02603809|566493457|FG000|Overall Study|Adverse Event|3|||
156927057|NCT02603809|566493458|FG001|Overall Study|Adverse Event|0|||
156927058|NCT02603809|566493459|FG002|Overall Study|Adverse Event|2|||
156927059|NCT02603809|566493460|FG003|Overall Study|Adverse Event|2|||
156927060|NCT02603809|566493461|FG004|Overall Study|Adverse Event|1|||
156927061|NCT02603809|566493462|FG005|Overall Study|Adverse Event|1|||
156927062|NCT02603809|566493457|FG000|Overall Study|Lack of Efficacy|0|||
156927063|NCT02603809|566493458|FG001|Overall Study|Lack of Efficacy|1|||
157165989|NCT00819585|567348125|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
156927064|NCT02603809|566493459|FG002|Overall Study|Lack of Efficacy|0|||
156927065|NCT02603809|566493460|FG003|Overall Study|Lack of Efficacy|0|||
156927066|NCT02603809|566493461|FG004|Overall Study|Lack of Efficacy|0|||
156927067|NCT02603809|566493462|FG005|Overall Study|Lack of Efficacy|1|||
156927068|NCT00380978|566493463|FG000|Overall Study|Refused allocated intervention|0|||
156927069|NCT00380978|566493464|FG001|Overall Study|Refused allocated intervention|6|||
156927070|NCT00380978|566493463|FG000|Overall Study|Wrong study envelope|0|||
156927071|NCT00380978|566493464|FG001|Overall Study|Wrong study envelope|2|||
156927072|NCT00380978|566493463|FG000|Overall Study|Allocation prior to analgesia request|1|||
156927073|NCT00380978|566493464|FG001|Overall Study|Allocation prior to analgesia request|2|||
156927074|NCT00380978|566493463|FG000|Overall Study|Parous patient|1|||
156927075|NCT00380978|566493464|FG001|Overall Study|Parous patient|0|||
156927076|NCT04146545|566493465|FG000|Overall Study|deemed ineligible after randomization|1|||
156927077|NCT04146545|566493466|FG001|Overall Study|deemed ineligible after randomization|0|||
156927078|NCT04729127|566493467|FG000|Overall Study|Suspended/Terminated EI Services|4|||
156927079|NCT04729127|566493468|FG001|Overall Study|Suspended/Terminated EI Services|0|||
156927080|NCT04729127|566493469|FG002|Overall Study|Suspended/Terminated EI Services|4|||
156927081|NCT04729127|566493470|FG003|Overall Study|Suspended/Terminated EI Services|6|||
156927082|NCT04729127|566493471|FG004|Overall Study|Suspended/Terminated EI Services|0|||
156927083|NCT04729127|566493472|FG005|Overall Study|Suspended/Terminated EI Services|6|||
156927084|NCT04729127|566493473|FG006|Overall Study|Suspended/Terminated EI Services|2|||
156927085|NCT04729127|566493474|FG007|Overall Study|Suspended/Terminated EI Services|0|||
156927086|NCT04729127|566493475|FG008|Overall Study|Suspended/Terminated EI Services|2|||
156927087|NCT04729127|566493467|FG000|Overall Study|Withdrawal by Subject|1|||
156927088|NCT04729127|566493468|FG001|Overall Study|Withdrawal by Subject|0|||
156927089|NCT04729127|566493469|FG002|Overall Study|Withdrawal by Subject|1|||
156927090|NCT04729127|566493470|FG003|Overall Study|Withdrawal by Subject|0|||
156927091|NCT04729127|566493471|FG004|Overall Study|Withdrawal by Subject|0|||
156927092|NCT04729127|566493472|FG005|Overall Study|Withdrawal by Subject|0|||
156927093|NCT04729127|566493473|FG006|Overall Study|Withdrawal by Subject|0|||
156927094|NCT04729127|566493474|FG007|Overall Study|Withdrawal by Subject|0|||
156927095|NCT04729127|566493475|FG008|Overall Study|Withdrawal by Subject|0|||
156927096|NCT04729127|566493467|FG000|Overall Study|Switched Agency/Setting|1|||
156927097|NCT04729127|566493468|FG001|Overall Study|Switched Agency/Setting|0|||
156927098|NCT04729127|566493469|FG002|Overall Study|Switched Agency/Setting|1|||
156927099|NCT04729127|566493470|FG003|Overall Study|Switched Agency/Setting|1|||
156927100|NCT04729127|566493471|FG004|Overall Study|Switched Agency/Setting|0|||
156927101|NCT04729127|566493472|FG005|Overall Study|Switched Agency/Setting|1|||
156927102|NCT04729127|566493473|FG006|Overall Study|Switched Agency/Setting|1|||
156927103|NCT04729127|566493474|FG007|Overall Study|Switched Agency/Setting|0|||
156927104|NCT04729127|566493475|FG008|Overall Study|Switched Agency/Setting|1|||
156927105|NCT02981342|566493476|FG000|Overall Study|Adverse Event|0|||
156927106|NCT02981342|566493477|FG001|Overall Study|Adverse Event|0|||
156927107|NCT02981342|566493478|FG002|Overall Study|Adverse Event|0|||
156927108|NCT02981342|566493479|FG003|Overall Study|Adverse Event|1|||
156927109|NCT02981342|566493476|FG000|Overall Study|Death|0|||
156927110|NCT02981342|566493477|FG001|Overall Study|Death|9|||
156927111|NCT02981342|566493478|FG002|Overall Study|Death|9|||
156927112|NCT02981342|566493479|FG003|Overall Study|Death|4|||
156927113|NCT02981342|566493476|FG000|Overall Study|Withdrawal by Subject|0|||
156927114|NCT02981342|566493477|FG001|Overall Study|Withdrawal by Subject|0|||
156927115|NCT02981342|566493478|FG002|Overall Study|Withdrawal by Subject|3|||
156927116|NCT02981342|566493479|FG003|Overall Study|Withdrawal by Subject|1|||
156927117|NCT02981342|566493476|FG000|Overall Study|Study closed by sponsor|0|||
156927118|NCT02981342|566493477|FG001|Overall Study|Study closed by sponsor|0|||
156927119|NCT02981342|566493478|FG002|Overall Study|Study closed by sponsor|1|||
156927120|NCT02981342|566493479|FG003|Overall Study|Study closed by sponsor|1|||
156927121|NCT02981342|566493476|FG000|Overall Study|Randomized, Never Treated|0|||
156927122|NCT02981342|566493477|FG001|Overall Study|Randomized, Never Treated|1|||
156927123|NCT02981342|566493478|FG002|Overall Study|Randomized, Never Treated|0|||
156927124|NCT02981342|566493479|FG003|Overall Study|Randomized, Never Treated|7|||
156927125|NCT02981342|566493476|FG000|Overall Study|Lost to Follow-up|0|||
156927126|NCT02981342|566493477|FG001|Overall Study|Lost to Follow-up|1|||
156927127|NCT02981342|566493478|FG002|Overall Study|Lost to Follow-up|0|||
156927128|NCT02981342|566493479|FG003|Overall Study|Lost to Follow-up|0|||
156927129|NCT01277523|566493482|FG000|Overall Study|Adverse Event|1|||
156927130|NCT01277523|566493483|FG001|Overall Study|Adverse Event|0|||
156927131|NCT01277523|566493484|FG002|Overall Study|Adverse Event|0|||
156927132|NCT01277523|566493482|FG000|Overall Study|Protocol Violation|2|||
156927133|NCT01277523|566493483|FG001|Overall Study|Protocol Violation|0|||
156927134|NCT01277523|566493484|FG002|Overall Study|Protocol Violation|0|||
156927135|NCT01277523|566493482|FG000|Overall Study|Other Reason not Defined|0|||
156927136|NCT01277523|566493483|FG001|Overall Study|Other Reason not Defined|1|||
156927137|NCT01277523|566493484|FG002|Overall Study|Other Reason not Defined|0|||
156927138|NCT00112502|566493485|FG000|Overall Study|Withdrawal by Subject|0|||
156927139|NCT00112502|566493486|FG001|Overall Study|Withdrawal by Subject|1|||
156927140|NCT00112502|566493487|FG002|Overall Study|Withdrawal by Subject|1|||
157029160|NCT01928394|566862895|FG008|Treatment Period|Maximum clinical benefit|0|||
157029161|NCT01928394|566862896|FG009|Treatment Period|Maximum clinical benefit|0|||
156927141|NCT00112502|566493488|FG003|Overall Study|Withdrawal by Subject|4|||
156927142|NCT00112502|566493489|FG004|Overall Study|Withdrawal by Subject|2|||
156927143|NCT00112502|566493490|FG005|Overall Study|Withdrawal by Subject|5|||
156927144|NCT00112502|566493491|FG006|Overall Study|Withdrawal by Subject|3|||
157165990|NCT00819585|567348126|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
156927145|NCT00112502|566493492|FG007|Overall Study|Withdrawal by Subject|7|||
156927146|NCT00265343|566493493|FG000|Overall Study|Adverse Event|10|||
156927147|NCT00265343|566493494|FG001|Overall Study|Adverse Event|7|||
156927148|NCT00265343|566493493|FG000|Overall Study|Withdrawal by Subject|3|||
156927149|NCT00265343|566493494|FG001|Overall Study|Withdrawal by Subject|9|||
156927150|NCT00265343|566493493|FG000|Overall Study|Other|8|||
156927151|NCT00265343|566493494|FG001|Overall Study|Other|3|||
156927152|NCT02608268|566493495|FG000|Overall Study|Adverse Event|0|||
156927153|NCT02608268|566493496|FG001|Overall Study|Adverse Event|0|||
156927154|NCT02608268|566493497|FG002|Overall Study|Adverse Event|1|||
156927155|NCT02608268|566493498|FG003|Overall Study|Adverse Event|0|||
157165991|NCT00819585|567348127|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
157165992|NCT00819585|567348117|FG000|Extension Study|Subject Withdrew Consent|0|||
157165993|NCT00819585|567348118|FG001|Extension Study|Subject Withdrew Consent|0|||
157165994|NCT00819585|567348119|FG002|Extension Study|Subject Withdrew Consent|0|||
157165995|NCT00819585|567348120|FG003|Extension Study|Subject Withdrew Consent|0|||
157165996|NCT00819585|567348121|FG004|Extension Study|Subject Withdrew Consent|0|||
157165997|NCT00819585|567348122|FG005|Extension Study|Subject Withdrew Consent|0|||
157165998|NCT00819585|567348123|FG006|Extension Study|Subject Withdrew Consent|0|||
157165999|NCT00819585|567348124|FG007|Extension Study|Subject Withdrew Consent|0|||
157166000|NCT00819585|567348125|FG008|Extension Study|Subject Withdrew Consent|3|||
157166001|NCT00819585|567348126|FG009|Extension Study|Subject Withdrew Consent|0|||
157166002|NCT00819585|567348127|FG010|Extension Study|Subject Withdrew Consent|1|||
157166003|NCT00819585|567348117|FG000|Extension Study|Lost to Follow-up|0|||
157166004|NCT00819585|567348118|FG001|Extension Study|Lost to Follow-up|0|||
157166005|NCT00819585|567348119|FG002|Extension Study|Lost to Follow-up|0|||
157166006|NCT00819585|567348120|FG003|Extension Study|Lost to Follow-up|0|||
157166007|NCT00819585|567348121|FG004|Extension Study|Lost to Follow-up|0|||
157166008|NCT00819585|567348122|FG005|Extension Study|Lost to Follow-up|0|||
157166009|NCT00819585|567348123|FG006|Extension Study|Lost to Follow-up|0|||
157166010|NCT00819585|567348124|FG007|Extension Study|Lost to Follow-up|0|||
156927156|NCT02608268|566493499|FG004|Overall Study|Adverse Event|0|||
156927157|NCT02608268|566493500|FG005|Overall Study|Adverse Event|0|||
156927158|NCT02608268|566493501|FG006|Overall Study|Adverse Event|0|||
156927159|NCT02608268|566493502|FG007|Overall Study|Adverse Event|0|||
156927160|NCT02608268|566493503|FG008|Overall Study|Adverse Event|0|||
156927161|NCT02608268|566493504|FG009|Overall Study|Adverse Event|0|||
156927162|NCT02608268|566493505|FG010|Overall Study|Adverse Event|0|||
156927163|NCT02608268|566493506|FG011|Overall Study|Adverse Event|0|||
156927164|NCT02608268|566493507|FG012|Overall Study|Adverse Event|2|||
156927165|NCT02608268|566493508|FG013|Overall Study|Adverse Event|0|||
156927166|NCT02608268|566493509|FG014|Overall Study|Adverse Event|0|||
156927167|NCT02608268|566493510|FG015|Overall Study|Adverse Event|0|||
156927168|NCT02608268|566493511|FG016|Overall Study|Adverse Event|0|||
156927169|NCT02608268|566493512|FG017|Overall Study|Adverse Event|0|||
156927170|NCT02608268|566493513|FG018|Overall Study|Adverse Event|0|||
156927171|NCT02608268|566493514|FG019|Overall Study|Adverse Event|0|||
156927172|NCT02608268|566493515|FG020|Overall Study|Adverse Event|1|||
157029162|NCT01928394|566862897|FG010|Treatment Period|Maximum clinical benefit|1|||
157029163|NCT01928394|566862898|FG011|Treatment Period|Maximum clinical benefit|1|||
157029164|NCT01928394|566862899|FG012|Treatment Period|Maximum clinical benefit|0|||
157029165|NCT01928394|566862900|FG013|Treatment Period|Maximum clinical benefit|0|||
157029166|NCT01928394|566862901|FG014|Treatment Period|Maximum clinical benefit|1|||
157029167|NCT01928394|566862902|FG015|Treatment Period|Maximum clinical benefit|0|||
157029168|NCT01928394|566862903|FG016|Treatment Period|Maximum clinical benefit|0|||
157029169|NCT01928394|566862904|FG017|Treatment Period|Maximum clinical benefit|1|||
157029170|NCT01928394|566862905|FG018|Treatment Period|Maximum clinical benefit|1|||
157029171|NCT01928394|566862906|FG019|Treatment Period|Maximum clinical benefit|0|||
157029172|NCT01928394|566862907|FG020|Treatment Period|Maximum clinical benefit|2|||
157029173|NCT01928394|566862908|FG021|Treatment Period|Maximum clinical benefit|0|||
157029174|NCT01928394|566862909|FG022|Treatment Period|Maximum clinical benefit|0|||
157029175|NCT01928394|566862887|FG000|Treatment Period|Lost to Follow-up|0|||
157029176|NCT01928394|566862888|FG001|Treatment Period|Lost to Follow-up|0|||
157029177|NCT01928394|566862889|FG002|Treatment Period|Lost to Follow-up|0|||
157029178|NCT01928394|566862890|FG003|Treatment Period|Lost to Follow-up|0|||
157029179|NCT01928394|566862891|FG004|Treatment Period|Lost to Follow-up|0|||
157029180|NCT01928394|566862892|FG005|Treatment Period|Lost to Follow-up|0|||
157029181|NCT01928394|566862893|FG006|Treatment Period|Lost to Follow-up|0|||
157029182|NCT01928394|566862894|FG007|Treatment Period|Lost to Follow-up|0|||
157029183|NCT01928394|566862895|FG008|Treatment Period|Lost to Follow-up|0|||
157029184|NCT01928394|566862896|FG009|Treatment Period|Lost to Follow-up|0|||
157029185|NCT01928394|566862897|FG010|Treatment Period|Lost to Follow-up|0|||
157029186|NCT01928394|566862898|FG011|Treatment Period|Lost to Follow-up|0|||
157029187|NCT01928394|566862899|FG012|Treatment Period|Lost to Follow-up|0|||
157029188|NCT01928394|566862900|FG013|Treatment Period|Lost to Follow-up|0|||
157029189|NCT01928394|566862901|FG014|Treatment Period|Lost to Follow-up|0|||
157029190|NCT01928394|566862902|FG015|Treatment Period|Lost to Follow-up|0|||
157029191|NCT01928394|566862903|FG016|Treatment Period|Lost to Follow-up|0|||
157029192|NCT01928394|566862904|FG017|Treatment Period|Lost to Follow-up|0|||
157029193|NCT01928394|566862905|FG018|Treatment Period|Lost to Follow-up|0|||
157029194|NCT01928394|566862906|FG019|Treatment Period|Lost to Follow-up|0|||
157029195|NCT01928394|566862907|FG020|Treatment Period|Lost to Follow-up|0|||
157166011|NCT00819585|567348125|FG008|Extension Study|Lost to Follow-up|2|||
157227041|NCT00409578|567576032|FG001|Overall Study|Lack of Efficacy|0|||
156927173|NCT02608268|566493516|FG021|Overall Study|Adverse Event|1|||
156927174|NCT02608268|566493517|FG022|Overall Study|Adverse Event|0|||
156927175|NCT02608268|566493518|FG023|Overall Study|Adverse Event|0|||
156927176|NCT02608268|566493519|FG024|Overall Study|Adverse Event|1|||
157166012|NCT00819585|567348126|FG009|Extension Study|Lost to Follow-up|1|||
157166013|NCT00819585|567348127|FG010|Extension Study|Lost to Follow-up|1|||
157166014|NCT00819585|567348117|FG000|Extension Study|Death|0|||
157166015|NCT00819585|567348118|FG001|Extension Study|Death|0|||
157166016|NCT00819585|567348119|FG002|Extension Study|Death|0|||
157166017|NCT00819585|567348120|FG003|Extension Study|Death|0|||
157166018|NCT00819585|567348121|FG004|Extension Study|Death|0|||
157166019|NCT00819585|567348122|FG005|Extension Study|Death|0|||
157166020|NCT00819585|567348123|FG006|Extension Study|Death|0|||
157166021|NCT00819585|567348124|FG007|Extension Study|Death|0|||
157166022|NCT00819585|567348125|FG008|Extension Study|Death|2|||
157166023|NCT00819585|567348126|FG009|Extension Study|Death|0|||
157166024|NCT00819585|567348127|FG010|Extension Study|Death|0|||
157166025|NCT03334396|567348128|FG000|Overall Study|Adverse Event|1|||
157166026|NCT03334396|567348129|FG001|Overall Study|Adverse Event|0|||
157166027|NCT03334396|567348130|FG002|Overall Study|Adverse Event|1|||
157166028|NCT03334396|567348131|FG003|Overall Study|Adverse Event|0|||
157166029|NCT03334396|567348132|FG004|Overall Study|Adverse Event|0|||
157166030|NCT03334396|567348133|FG005|Overall Study|Adverse Event|0|||
157166031|NCT03334396|567348134|FG006|Overall Study|Adverse Event|0|||
157166032|NCT03334396|567348135|FG007|Overall Study|Adverse Event|0|||
157166033|NCT03334396|567348128|FG000|Overall Study|Lack of Efficacy|10|||
157166034|NCT03334396|567348129|FG001|Overall Study|Lack of Efficacy|4|||
157166035|NCT03334396|567348130|FG002|Overall Study|Lack of Efficacy|1|||
157166036|NCT03334396|567348131|FG003|Overall Study|Lack of Efficacy|3|||
157166037|NCT03334396|567348132|FG004|Overall Study|Lack of Efficacy|1|||
157166038|NCT03334396|567348133|FG005|Overall Study|Lack of Efficacy|0|||
157166039|NCT03334396|567348134|FG006|Overall Study|Lack of Efficacy|0|||
157166040|NCT03334396|567348135|FG007|Overall Study|Lack of Efficacy|1|||
157166041|NCT03334396|567348128|FG000|Overall Study|Lost to Follow-up|0|||
157166042|NCT03334396|567348129|FG001|Overall Study|Lost to Follow-up|0|||
157166043|NCT03334396|567348130|FG002|Overall Study|Lost to Follow-up|1|||
157166044|NCT03334396|567348131|FG003|Overall Study|Lost to Follow-up|0|||
157166045|NCT03334396|567348132|FG004|Overall Study|Lost to Follow-up|0|||
157166046|NCT03334396|567348133|FG005|Overall Study|Lost to Follow-up|0|||
157166047|NCT03334396|567348134|FG006|Overall Study|Lost to Follow-up|1|||
157166048|NCT03334396|567348135|FG007|Overall Study|Lost to Follow-up|0|||
157166049|NCT03334396|567348128|FG000|Overall Study|Physician Decision|1|||
157166050|NCT03334396|567348129|FG001|Overall Study|Physician Decision|0|||
156927177|NCT02608268|566493520|FG025|Overall Study|Adverse Event|0|||
156927178|NCT02608268|566493521|FG026|Overall Study|Adverse Event|0|||
156927179|NCT02608268|566493522|FG027|Overall Study|Adverse Event|0|||
156927180|NCT02608268|566493523|FG028|Overall Study|Adverse Event|1|||
156927181|NCT02608268|566493524|FG029|Overall Study|Adverse Event|0|||
156927182|NCT02608268|566493495|FG000|Overall Study|Death|1|||
156927183|NCT02608268|566493496|FG001|Overall Study|Death|0|||
156927184|NCT02608268|566493497|FG002|Overall Study|Death|0|||
156927185|NCT02608268|566493498|FG003|Overall Study|Death|0|||
156927186|NCT02608268|566493499|FG004|Overall Study|Death|0|||
157166051|NCT03334396|567348130|FG002|Overall Study|Physician Decision|0|||
157166052|NCT03334396|567348131|FG003|Overall Study|Physician Decision|0|||
157166053|NCT03334396|567348132|FG004|Overall Study|Physician Decision|0|||
157166054|NCT03334396|567348133|FG005|Overall Study|Physician Decision|0|||
157166055|NCT03334396|567348134|FG006|Overall Study|Physician Decision|0|||
157166056|NCT03334396|567348135|FG007|Overall Study|Physician Decision|0|||
157166057|NCT03334396|567348128|FG000|Overall Study|Withdrawal by Subject|10|||
157166058|NCT03334396|567348129|FG001|Overall Study|Withdrawal by Subject|5|||
157166059|NCT03334396|567348130|FG002|Overall Study|Withdrawal by Subject|7|||
157166060|NCT03334396|567348131|FG003|Overall Study|Withdrawal by Subject|2|||
157166061|NCT03334396|567348132|FG004|Overall Study|Withdrawal by Subject|2|||
157166062|NCT03334396|567348133|FG005|Overall Study|Withdrawal by Subject|1|||
157166063|NCT03334396|567348134|FG006|Overall Study|Withdrawal by Subject|2|||
156927187|NCT02608268|566493500|FG005|Overall Study|Death|0|||
156927188|NCT02608268|566493501|FG006|Overall Study|Death|0|||
157029196|NCT01928394|566862908|FG021|Treatment Period|Lost to Follow-up|0|||
157166064|NCT03334396|567348135|FG007|Overall Study|Withdrawal by Subject|0|||
157166065|NCT03334396|567348128|FG000|Overall Study|Pregnancy|0|||
157166066|NCT03334396|567348129|FG001|Overall Study|Pregnancy|1|||
157166067|NCT03334396|567348130|FG002|Overall Study|Pregnancy|0|||
156927189|NCT02608268|566493502|FG007|Overall Study|Death|0|||
156927190|NCT02608268|566493503|FG008|Overall Study|Death|1|||
156927191|NCT02608268|566493504|FG009|Overall Study|Death|1|||
156927192|NCT02608268|566493505|FG010|Overall Study|Death|0|||
156927193|NCT02608268|566493506|FG011|Overall Study|Death|0|||
156927194|NCT02608268|566493507|FG012|Overall Study|Death|0|||
157166068|NCT03334396|567348131|FG003|Overall Study|Pregnancy|0|||
157166069|NCT03334396|567348132|FG004|Overall Study|Pregnancy|0|||
157166070|NCT03334396|567348133|FG005|Overall Study|Pregnancy|0|||
157166071|NCT03334396|567348134|FG006|Overall Study|Pregnancy|0|||
157166072|NCT03334396|567348135|FG007|Overall Study|Pregnancy|0|||
157166073|NCT03334396|567348128|FG000|Overall Study|Ineligible|0|||
157166074|NCT03334396|567348129|FG001|Overall Study|Ineligible|1|||
157166075|NCT03334396|567348130|FG002|Overall Study|Ineligible|0|||
157166076|NCT03334396|567348131|FG003|Overall Study|Ineligible|0|||
157166077|NCT03334396|567348132|FG004|Overall Study|Ineligible|0|||
157166078|NCT03334396|567348133|FG005|Overall Study|Ineligible|0|||
157166079|NCT03334396|567348134|FG006|Overall Study|Ineligible|0|||
157166080|NCT03334396|567348135|FG007|Overall Study|Ineligible|0|||
157166081|NCT03334396|567348128|FG000|Overall Study|Started New Job|1|||
157166082|NCT03334396|567348129|FG001|Overall Study|Started New Job|0|||
157166083|NCT03334396|567348130|FG002|Overall Study|Started New Job|0|||
157166084|NCT03334396|567348131|FG003|Overall Study|Started New Job|0|||
157166085|NCT03334396|567348132|FG004|Overall Study|Started New Job|0|||
157166086|NCT03334396|567348133|FG005|Overall Study|Started New Job|0|||
157166087|NCT03334396|567348134|FG006|Overall Study|Started New Job|0|||
157166088|NCT03334396|567348135|FG007|Overall Study|Started New Job|0|||
157166089|NCT03829332|567348137|FG000|Overall Study|Death|225|||
157166090|NCT03829332|567348138|FG001|Overall Study|Death|230|||
157166091|NCT03829332|567348137|FG000|Overall Study|Lost to Follow-up|1|||
157166092|NCT03829332|567348138|FG001|Overall Study|Lost to Follow-up|3|||
157166093|NCT03829332|567348137|FG000|Overall Study|Physician Decision|1|||
157166094|NCT03829332|567348138|FG001|Overall Study|Physician Decision|0|||
157166095|NCT03829332|567348137|FG000|Overall Study|Sponsor Decision|71|||
157166096|NCT03829332|567348138|FG001|Overall Study|Sponsor Decision|72|||
157166097|NCT03829332|567348137|FG000|Overall Study|Withdrawal by Subject|11|||
157166098|NCT03829332|567348138|FG001|Overall Study|Withdrawal by Subject|9|||
157166099|NCT02509494|567348139|FG000|Overall Study|Lost to Follow-up|8|||
157166100|NCT02509494|567348140|FG001|Overall Study|Lost to Follow-up|47|||
157166101|NCT02509494|567348141|FG002|Overall Study|Lost to Follow-up|19|||
157166102|NCT02509494|567348142|FG003|Overall Study|Lost to Follow-up|6|||
157166103|NCT02509494|567348143|FG004|Overall Study|Lost to Follow-up|3|||
157166104|NCT02509494|567348144|FG005|Overall Study|Lost to Follow-up|3|||
157166105|NCT02509494|567348145|FG006|Overall Study|Lost to Follow-up|1|||
157166106|NCT02509494|567348146|FG007|Overall Study|Lost to Follow-up|3|||
157166107|NCT02509494|567348147|FG008|Overall Study|Lost to Follow-up|1|||
157166108|NCT02509494|567348139|FG000|Overall Study|Physician Decision|2|||
156927195|NCT02608268|566493508|FG013|Overall Study|Death|0|||
156927196|NCT02608268|566493509|FG014|Overall Study|Death|0|||
156927197|NCT02608268|566493510|FG015|Overall Study|Death|1|||
156927198|NCT02608268|566493511|FG016|Overall Study|Death|0|||
156927199|NCT02608268|566493512|FG017|Overall Study|Death|1|||
156927200|NCT02608268|566493513|FG018|Overall Study|Death|0|||
156927201|NCT02608268|566493514|FG019|Overall Study|Death|1|||
156927202|NCT02608268|566493515|FG020|Overall Study|Death|1|||
156927203|NCT02608268|566493516|FG021|Overall Study|Death|0|||
156927204|NCT02608268|566493517|FG022|Overall Study|Death|0|||
156927205|NCT02608268|566493518|FG023|Overall Study|Death|0|||
156927206|NCT02608268|566493519|FG024|Overall Study|Death|1|||
156927207|NCT02608268|566493520|FG025|Overall Study|Death|2|||
156927208|NCT02608268|566493521|FG026|Overall Study|Death|0|||
156927209|NCT02608268|566493522|FG027|Overall Study|Death|1|||
156927210|NCT02608268|566493523|FG028|Overall Study|Death|4|||
156927211|NCT02608268|566493524|FG029|Overall Study|Death|0|||
156927212|NCT02608268|566493495|FG000|Overall Study|Physician Decision|0|||
157166109|NCT02509494|567348140|FG001|Overall Study|Physician Decision|1|||
157166110|NCT02509494|567348141|FG002|Overall Study|Physician Decision|0|||
157166111|NCT02509494|567348142|FG003|Overall Study|Physician Decision|0|||
157166112|NCT02509494|567348143|FG004|Overall Study|Physician Decision|0|||
157166113|NCT02509494|567348144|FG005|Overall Study|Physician Decision|0|||
157166114|NCT02509494|567348145|FG006|Overall Study|Physician Decision|0|||
157166115|NCT02509494|567348146|FG007|Overall Study|Physician Decision|0|||
157166116|NCT02509494|567348147|FG008|Overall Study|Physician Decision|0|||
157166117|NCT02509494|567348139|FG000|Overall Study|Withdrawal by Subject|4|||
156927213|NCT02608268|566493496|FG001|Overall Study|Physician Decision|0|||
156927214|NCT02608268|566493497|FG002|Overall Study|Physician Decision|0|||
156927215|NCT02608268|566493498|FG003|Overall Study|Physician Decision|0|||
156927216|NCT02608268|566493499|FG004|Overall Study|Physician Decision|0|||
157166118|NCT02509494|567348140|FG001|Overall Study|Withdrawal by Subject|17|||
157166119|NCT02509494|567348141|FG002|Overall Study|Withdrawal by Subject|7|||
157166120|NCT02509494|567348142|FG003|Overall Study|Withdrawal by Subject|5|||
157166121|NCT02509494|567348143|FG004|Overall Study|Withdrawal by Subject|0|||
157166122|NCT02509494|567348144|FG005|Overall Study|Withdrawal by Subject|6|||
157227042|NCT00409578|567576033|FG002|Overall Study|Lack of Efficacy|0|||
156927217|NCT02608268|566493500|FG005|Overall Study|Physician Decision|0|||
156927218|NCT02608268|566493501|FG006|Overall Study|Physician Decision|0|||
156927219|NCT02608268|566493502|FG007|Overall Study|Physician Decision|0|||
156927220|NCT02608268|566493503|FG008|Overall Study|Physician Decision|0|||
156927221|NCT02608268|566493504|FG009|Overall Study|Physician Decision|0|||
156927222|NCT02608268|566493505|FG010|Overall Study|Physician Decision|1|||
156927223|NCT02608268|566493506|FG011|Overall Study|Physician Decision|0|||
156927224|NCT02608268|566493507|FG012|Overall Study|Physician Decision|0|||
157166123|NCT02509494|567348145|FG006|Overall Study|Withdrawal by Subject|1|||
157166124|NCT02509494|567348146|FG007|Overall Study|Withdrawal by Subject|2|||
157166125|NCT02509494|567348147|FG008|Overall Study|Withdrawal by Subject|1|||
157166126|NCT02509494|567348139|FG000|Overall Study|Death|0|||
157166127|NCT02509494|567348140|FG001|Overall Study|Death|1|||
157166128|NCT02509494|567348141|FG002|Overall Study|Death|0|||
157166129|NCT02509494|567348142|FG003|Overall Study|Death|0|||
157166130|NCT02509494|567348143|FG004|Overall Study|Death|1|||
157166131|NCT02509494|567348144|FG005|Overall Study|Death|0|||
157166132|NCT02509494|567348145|FG006|Overall Study|Death|0|||
157166133|NCT02509494|567348146|FG007|Overall Study|Death|1|||
157166134|NCT02509494|567348147|FG008|Overall Study|Death|0|||
157166135|NCT02509494|567348139|FG000|Overall Study|Other|0|||
157166136|NCT02509494|567348140|FG001|Overall Study|Other|4|||
157166137|NCT02509494|567348141|FG002|Overall Study|Other|5|||
157166138|NCT02509494|567348142|FG003|Overall Study|Other|0|||
157166139|NCT02509494|567348143|FG004|Overall Study|Other|0|||
157166140|NCT02509494|567348144|FG005|Overall Study|Other|0|||
157166141|NCT02509494|567348145|FG006|Overall Study|Other|0|||
157166142|NCT02509494|567348146|FG007|Overall Study|Other|0|||
157166143|NCT02509494|567348147|FG008|Overall Study|Other|0|||
157166144|NCT02509494|567348139|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157166145|NCT02509494|567348140|FG001|Overall Study|Non-Compliance With Study Drug|11|||
157166146|NCT02509494|567348141|FG002|Overall Study|Non-Compliance With Study Drug|7|||
157166147|NCT02509494|567348142|FG003|Overall Study|Non-Compliance With Study Drug|0|||
157166148|NCT02509494|567348143|FG004|Overall Study|Non-Compliance With Study Drug|1|||
157166149|NCT02509494|567348144|FG005|Overall Study|Non-Compliance With Study Drug|2|||
157166150|NCT02509494|567348145|FG006|Overall Study|Non-Compliance With Study Drug|1|||
157166151|NCT02509494|567348146|FG007|Overall Study|Non-Compliance With Study Drug|1|||
157166152|NCT02509494|567348147|FG008|Overall Study|Non-Compliance With Study Drug|0|||
157166153|NCT05371912|567348148|FG000|Overall Study|Lost to Follow-up|3|||
157166154|NCT05371912|567348149|FG001|Overall Study|Lost to Follow-up|2|||
157166155|NCT04752189|567348150|FG000|Overall Study|Withdrawal by Subject|0|||
157166156|NCT04752189|567348151|FG001|Overall Study|Withdrawal by Subject|150|||
157166157|NCT04752189|567348150|FG000|Overall Study|Lost to Follow-up|261|||
157166158|NCT04752189|567348151|FG001|Overall Study|Lost to Follow-up|126|||
157166159|NCT00975195|567348152|FG000|Overall Study|Adverse Event|108|||
157166160|NCT00975195|567348153|FG001|Overall Study|Adverse Event|101|||
157166161|NCT00975195|567348152|FG000|Overall Study|Lack of Efficacy|6|||
157166162|NCT00975195|567348153|FG001|Overall Study|Lack of Efficacy|6|||
157166163|NCT00975195|567348152|FG000|Overall Study|Protocol Violation|27|||
157166164|NCT00975195|567348153|FG001|Overall Study|Protocol Violation|23|||
157166165|NCT00975195|567348152|FG000|Overall Study|Lost to Follow-up|9|||
157166166|NCT00975195|567348153|FG001|Overall Study|Lost to Follow-up|7|||
157166167|NCT00975195|567348152|FG000|Overall Study|Withdrawal by Subject|48|||
157166168|NCT00975195|567348153|FG001|Overall Study|Withdrawal by Subject|61|||
157166169|NCT00975195|567348152|FG000|Overall Study|Other reason not defined above|29|||
156927225|NCT02608268|566493508|FG013|Overall Study|Physician Decision|1|||
156927226|NCT02608268|566493509|FG014|Overall Study|Physician Decision|0|||
156927227|NCT02608268|566493510|FG015|Overall Study|Physician Decision|0|||
156927228|NCT02608268|566493511|FG016|Overall Study|Physician Decision|0|||
156927229|NCT02608268|566493512|FG017|Overall Study|Physician Decision|0|||
156927230|NCT02608268|566493513|FG018|Overall Study|Physician Decision|0|||
156927231|NCT02608268|566493514|FG019|Overall Study|Physician Decision|0|||
156927232|NCT02608268|566493515|FG020|Overall Study|Physician Decision|0|||
156927233|NCT02608268|566493516|FG021|Overall Study|Physician Decision|0|||
156927234|NCT02608268|566493517|FG022|Overall Study|Physician Decision|1|||
156927235|NCT02608268|566493518|FG023|Overall Study|Physician Decision|1|||
156927236|NCT02608268|566493519|FG024|Overall Study|Physician Decision|1|||
156927237|NCT02608268|566493520|FG025|Overall Study|Physician Decision|0|||
156927238|NCT02608268|566493521|FG026|Overall Study|Physician Decision|0|||
156927239|NCT02608268|566493522|FG027|Overall Study|Physician Decision|2|||
156927240|NCT02608268|566493523|FG028|Overall Study|Physician Decision|1|||
156927241|NCT02608268|566493524|FG029|Overall Study|Physician Decision|1|||
156927242|NCT02608268|566493495|FG000|Overall Study|Progressive disease|12|||
156927243|NCT02608268|566493496|FG001|Overall Study|Progressive disease|8|||
156927244|NCT02608268|566493497|FG002|Overall Study|Progressive disease|13|||
156927245|NCT02608268|566493498|FG003|Overall Study|Progressive disease|5|||
157166170|NCT00975195|567348153|FG001|Overall Study|Other reason not defined above|33|||
156927246|NCT02608268|566493499|FG004|Overall Study|Progressive disease|2|||
157029197|NCT01928394|566862909|FG022|Treatment Period|Lost to Follow-up|1|||
157166171|NCT00975195|567348152|FG000|Overall Study|Not treated|1|||
157166172|NCT00975195|567348153|FG001|Overall Study|Not treated|2|||
157166173|NCT05084053|567350438|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
157166174|NCT05084053|567350439|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
157166175|NCT05084053|567350440|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
157166176|NCT05084053|567350441|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
157166177|NCT05084053|567350438|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
157166178|NCT05084053|567350439|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
157227043|NCT00409578|567576034|FG003|Overall Study|Lack of Efficacy|2|||
156927247|NCT02608268|566493500|FG005|Overall Study|Progressive disease|4|||
156927248|NCT02608268|566493501|FG006|Overall Study|Progressive disease|6|||
156927249|NCT02608268|566493502|FG007|Overall Study|Progressive disease|2|||
156927250|NCT02608268|566493503|FG008|Overall Study|Progressive disease|5|||
156927251|NCT02608268|566493504|FG009|Overall Study|Progressive disease|6|||
156927252|NCT02608268|566493505|FG010|Overall Study|Progressive disease|5|||
156927253|NCT02608268|566493506|FG011|Overall Study|Progressive disease|5|||
156927254|NCT02608268|566493507|FG012|Overall Study|Progressive disease|4|||
156927255|NCT02608268|566493508|FG013|Overall Study|Progressive disease|11|||
156927256|NCT02608268|566493509|FG014|Overall Study|Progressive disease|6|||
156927257|NCT02608268|566493510|FG015|Overall Study|Progressive disease|3|||
156927258|NCT02608268|566493511|FG016|Overall Study|Progressive disease|5|||
156927259|NCT02608268|566493512|FG017|Overall Study|Progressive disease|5|||
157166179|NCT05084053|567350440|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
157166180|NCT05084053|567350441|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
157166181|NCT05084053|567350438|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
157166182|NCT05084053|567350439|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
156927260|NCT02608268|566493513|FG018|Overall Study|Progressive disease|5|||
156927261|NCT02608268|566493514|FG019|Overall Study|Progressive disease|2|||
156927262|NCT02608268|566493515|FG020|Overall Study|Progressive disease|10|||
156927263|NCT02608268|566493516|FG021|Overall Study|Progressive disease|4|||
156927264|NCT02608268|566493517|FG022|Overall Study|Progressive disease|5|||
156927265|NCT02608268|566493518|FG023|Overall Study|Progressive disease|5|||
156927266|NCT02608268|566493519|FG024|Overall Study|Progressive disease|3|||
156927267|NCT02608268|566493520|FG025|Overall Study|Progressive disease|11|||
156927268|NCT02608268|566493521|FG026|Overall Study|Progressive disease|16|||
156927269|NCT02608268|566493522|FG027|Overall Study|Progressive disease|11|||
156927270|NCT02608268|566493523|FG028|Overall Study|Progressive disease|10|||
156927271|NCT02608268|566493524|FG029|Overall Study|Progressive disease|15|||
156927272|NCT02608268|566493495|FG000|Overall Study|Subject/guardian decision|1|||
156927273|NCT02608268|566493496|FG001|Overall Study|Subject/guardian decision|1|||
156927274|NCT02608268|566493497|FG002|Overall Study|Subject/guardian decision|2|||
156927275|NCT02608268|566493498|FG003|Overall Study|Subject/guardian decision|0|||
156927276|NCT02608268|566493499|FG004|Overall Study|Subject/guardian decision|0|||
156927277|NCT02608268|566493500|FG005|Overall Study|Subject/guardian decision|0|||
156927278|NCT02608268|566493501|FG006|Overall Study|Subject/guardian decision|0|||
156927279|NCT02608268|566493502|FG007|Overall Study|Subject/guardian decision|0|||
156927280|NCT02608268|566493503|FG008|Overall Study|Subject/guardian decision|2|||
156927281|NCT02608268|566493504|FG009|Overall Study|Subject/guardian decision|2|||
156927282|NCT02608268|566493505|FG010|Overall Study|Subject/guardian decision|0|||
156927283|NCT02608268|566493506|FG011|Overall Study|Subject/guardian decision|1|||
156927284|NCT02608268|566493507|FG012|Overall Study|Subject/guardian decision|0|||
156927285|NCT02608268|566493508|FG013|Overall Study|Subject/guardian decision|1|||
156927286|NCT02608268|566493509|FG014|Overall Study|Subject/guardian decision|0|||
156927287|NCT02608268|566493510|FG015|Overall Study|Subject/guardian decision|1|||
156927288|NCT02608268|566493511|FG016|Overall Study|Subject/guardian decision|0|||
156927289|NCT02608268|566493512|FG017|Overall Study|Subject/guardian decision|0|||
156927290|NCT02608268|566493513|FG018|Overall Study|Subject/guardian decision|1|||
156927291|NCT02608268|566493514|FG019|Overall Study|Subject/guardian decision|0|||
156927292|NCT02608268|566493515|FG020|Overall Study|Subject/guardian decision|0|||
156927293|NCT02608268|566493516|FG021|Overall Study|Subject/guardian decision|0|||
156927294|NCT02608268|566493517|FG022|Overall Study|Subject/guardian decision|1|||
156927295|NCT02608268|566493518|FG023|Overall Study|Subject/guardian decision|0|||
156927296|NCT02608268|566493519|FG024|Overall Study|Subject/guardian decision|0|||
156927297|NCT02608268|566493520|FG025|Overall Study|Subject/guardian decision|1|||
156927298|NCT02608268|566493521|FG026|Overall Study|Subject/guardian decision|1|||
156927299|NCT02608268|566493522|FG027|Overall Study|Subject/guardian decision|1|||
156927300|NCT02608268|566493523|FG028|Overall Study|Subject/guardian decision|1|||
156927301|NCT02608268|566493524|FG029|Overall Study|Subject/guardian decision|0|||
156927302|NCT03662542|566493528|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
156927303|NCT03662542|566493529|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927304|NCT03662542|566493530|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
157166183|NCT05084053|567350440|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
157166184|NCT05084053|567350441|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
157166185|NCT02180724|567350442|FG000|Overall Study|Death|26|||
157166186|NCT02180724|567350443|FG001|Overall Study|Death|1|||
157227044|NCT00409578|567576031|FG000|Overall Study|Subject no longer requires study drug|0|||
157227045|NCT00409578|567576032|FG001|Overall Study|Subject no longer requires study drug|0|||
156927305|NCT03662542|566493531|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927306|NCT03662542|566493532|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927307|NCT03662542|566493533|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927308|NCT03662542|566493534|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927309|NCT03662542|566493535|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927310|NCT03662542|566493536|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
156927311|NCT03662542|566493528|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927312|NCT03662542|566493529|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
156927313|NCT03662542|566493530|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927314|NCT03662542|566493531|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927315|NCT03662542|566493532|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927316|NCT03662542|566493533|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927317|NCT03662542|566493534|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927318|NCT03662542|566493535|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927319|NCT03662542|566493536|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
156927320|NCT03662542|566493528|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
156927321|NCT03662542|566493529|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
156927322|NCT03662542|566493530|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
156927323|NCT03662542|566493531|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
156927324|NCT03662542|566493532|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
156927325|NCT03662542|566493533|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
156927326|NCT03662542|566493534|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
156927327|NCT03662542|566493535|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
156927328|NCT03662542|566493536|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
156927329|NCT03662542|566493528|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
156927330|NCT03662542|566493529|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927331|NCT03662542|566493530|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927332|NCT03662542|566493531|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927333|NCT03662542|566493532|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927334|NCT03662542|566493533|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927335|NCT03662542|566493534|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927336|NCT03662542|566493535|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927337|NCT03662542|566493536|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
156927338|NCT03662542|566493528|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927339|NCT03662542|566493529|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927340|NCT03662542|566493530|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927341|NCT03662542|566493531|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927342|NCT03662542|566493532|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927343|NCT03662542|566493533|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
156927344|NCT03662542|566493534|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927345|NCT03662542|566493535|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927346|NCT03662542|566493536|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
156927347|NCT03662542|566493528|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927348|NCT03662542|566493529|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927349|NCT03662542|566493530|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927350|NCT03662542|566493531|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
156927351|NCT03662542|566493532|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
156927352|NCT03662542|566493533|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927353|NCT03662542|566493534|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927354|NCT03662542|566493535|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927355|NCT03662542|566493536|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
156927356|NCT03662542|566493528|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927357|NCT03662542|566493529|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927358|NCT03662542|566493530|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927359|NCT03662542|566493531|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
156927360|NCT03662542|566493532|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
156927361|NCT03662542|566493533|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
156927362|NCT03662542|566493534|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927363|NCT03662542|566493535|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927364|NCT03662542|566493536|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
156927365|NCT03662542|566493528|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927366|NCT03662542|566493529|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927367|NCT03662542|566493530|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927368|NCT03662542|566493531|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927369|NCT03662542|566493532|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
156927370|NCT03662542|566493533|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
156927371|NCT03662542|566493534|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927372|NCT03662542|566493535|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927373|NCT03662542|566493536|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
156927374|NCT03662542|566493528|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927375|NCT03662542|566493529|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927376|NCT03662542|566493530|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927377|NCT03662542|566493531|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927378|NCT03662542|566493532|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927379|NCT03662542|566493533|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
156927380|NCT03662542|566493534|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927381|NCT03662542|566493535|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927382|NCT03662542|566493536|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
156927383|NCT03662542|566493528|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927384|NCT03662542|566493529|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927385|NCT03662542|566493530|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927386|NCT03662542|566493531|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927387|NCT03662542|566493532|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927388|NCT03662542|566493533|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927389|NCT03662542|566493534|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927390|NCT03662542|566493535|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
156927391|NCT03662542|566493536|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
156927392|NCT03662542|566493528|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927393|NCT03662542|566493529|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927394|NCT03662542|566493530|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927395|NCT03662542|566493531|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927396|NCT03662542|566493532|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927397|NCT03662542|566493533|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927398|NCT03662542|566493534|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
156927399|NCT03662542|566493535|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
156927400|NCT03662542|566493536|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
156927401|NCT03662542|566493528|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927402|NCT03662542|566493529|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927403|NCT03662542|566493530|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927404|NCT03662542|566493531|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927405|NCT03662542|566493532|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927406|NCT03662542|566493533|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927407|NCT03662542|566493534|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
156927408|NCT03662542|566493535|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
156927409|NCT03662542|566493536|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
156927410|NCT03662542|566493528|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927411|NCT03662542|566493529|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927412|NCT03662542|566493530|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927413|NCT03662542|566493531|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927414|NCT03662542|566493532|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927415|NCT03662542|566493533|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
156927416|NCT03662542|566493534|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
156927417|NCT03662542|566493535|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
156927418|NCT03662542|566493536|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
156927419|NCT01217060|566493537|FG000|Overall Study|Withdrawal by Subject|1|||
156927420|NCT01859494|566493549|FG000|Overall Study|Adverse Event|1|||
156927421|NCT04014075|566493550|FG000|Overall Study|Progressive Disease|53|||
156927422|NCT04014075|566493550|FG000|Overall Study|Adverse Event|15|||
156927423|NCT04014075|566493550|FG000|Overall Study|Clinical Progression|4|||
156927424|NCT04014075|566493550|FG000|Overall Study|Death|2|||
156927425|NCT04014075|566493550|FG000|Overall Study|Withdrawal by Subject|2|||
156927426|NCT04014075|566493550|FG000|Overall Study|Miscellaneous|2|||
156927427|NCT04014075|566493550|FG000|Overall Study|Physician Decision|1|||
156927428|NCT02584504|566493553|FG000|Double-blind Treatment|Participant withdrew consent|0|||
156927429|NCT02584504|566493554|FG001|Double-blind Treatment|Participant withdrew consent|0|||
156927430|NCT02584504|566493555|FG002|Double-blind Treatment|Participant withdrew consent|1|||
156927431|NCT02584504|566493553|FG000|Double-blind Treatment|Adverse Event|0|||
156927432|NCT02584504|566493554|FG001|Double-blind Treatment|Adverse Event|1|||
156927433|NCT02584504|566493555|FG002|Double-blind Treatment|Adverse Event|0|||
156927434|NCT02584504|566493553|FG000|Double-blind Treatment|Family Matter|0|||
156927435|NCT02584504|566493554|FG001|Double-blind Treatment|Family Matter|1|||
156927436|NCT02584504|566493555|FG002|Double-blind Treatment|Family Matter|0|||
156927437|NCT02584504|566493553|FG000|Open-label Treatment|Participant withdrew consent|0|||
156927438|NCT02584504|566493554|FG001|Open-label Treatment|Participant withdrew consent|0|||
156927439|NCT02584504|566493555|FG002|Open-label Treatment|Participant withdrew consent|4|||
156927440|NCT02584504|566493553|FG000|Open-label Treatment|Adverse Event|2|||
156927441|NCT02584504|566493554|FG001|Open-label Treatment|Adverse Event|2|||
156927442|NCT02584504|566493555|FG002|Open-label Treatment|Adverse Event|3|||
156927443|NCT02584504|566493553|FG000|Open-label Treatment|Physician Decision|0|||
156927444|NCT02584504|566493554|FG001|Open-label Treatment|Physician Decision|1|||
156927445|NCT02584504|566493555|FG002|Open-label Treatment|Physician Decision|0|||
156927446|NCT02584504|566493553|FG000|Open-label Treatment|Entered but not treated|0|||
156927447|NCT02584504|566493554|FG001|Open-label Treatment|Entered but not treated|1|||
157166187|NCT02180724|567350442|FG000|Overall Study|Lost to Follow-up|3|||
157166188|NCT02180724|567350443|FG001|Overall Study|Lost to Follow-up|1|||
156927448|NCT02584504|566493555|FG002|Open-label Treatment|Entered but not treated|1|||
156927449|NCT00413192|566493559|FG000|Overall Study|Disease progression|26|||
156927450|NCT00413192|566493560|FG001|Overall Study|Disease progression|31|||
156927451|NCT00413192|566493561|FG002|Overall Study|Disease progression|16|||
156927452|NCT00413192|566493562|FG003|Overall Study|Disease progression|25|||
156927453|NCT00413192|566493559|FG000|Overall Study|Toxicity|3|||
156927454|NCT00413192|566493560|FG001|Overall Study|Toxicity|2|||
157166189|NCT02180724|567350442|FG000|Overall Study|Withdrawal by Subject|4|||
157166190|NCT02180724|567350443|FG001|Overall Study|Withdrawal by Subject|2|||
156927455|NCT00413192|566493561|FG002|Overall Study|Toxicity|2|||
156927456|NCT00413192|566493562|FG003|Overall Study|Toxicity|2|||
156927457|NCT00413192|566493559|FG000|Overall Study|Withdrawal by Subject|3|||
156927458|NCT00413192|566493560|FG001|Overall Study|Withdrawal by Subject|5|||
156927459|NCT00413192|566493561|FG002|Overall Study|Withdrawal by Subject|0|||
156927460|NCT00413192|566493562|FG003|Overall Study|Withdrawal by Subject|1|||
156927461|NCT00413192|566493559|FG000|Overall Study|Intercurrent illness|0|||
156927462|NCT00413192|566493560|FG001|Overall Study|Intercurrent illness|0|||
156927463|NCT00413192|566493561|FG002|Overall Study|Intercurrent illness|0|||
156927464|NCT00413192|566493562|FG003|Overall Study|Intercurrent illness|1|||
156927465|NCT00413192|566493559|FG000|Overall Study|Intercurrent death|0|||
156927466|NCT00413192|566493560|FG001|Overall Study|Intercurrent death|1|||
156927467|NCT00413192|566493561|FG002|Overall Study|Intercurrent death|0|||
156927468|NCT00413192|566493562|FG003|Overall Study|Intercurrent death|0|||
156927469|NCT00413192|566493559|FG000|Overall Study|Other|5|||
156927470|NCT00413192|566493560|FG001|Overall Study|Other|1|||
156927471|NCT00413192|566493561|FG002|Overall Study|Other|1|||
156927472|NCT00413192|566493562|FG003|Overall Study|Other|2|||
156927473|NCT00413192|566493559|FG000|Overall Study|Not treated|0|||
156927474|NCT00413192|566493560|FG001|Overall Study|Not treated|0|||
156927475|NCT00413192|566493561|FG002|Overall Study|Not treated|0|||
156927476|NCT00413192|566493562|FG003|Overall Study|Not treated|1|||
156927477|NCT01998633|566493563|FG000|Overall Study|Death|1|||
156927478|NCT03814746|566493564|FG000|Overall Study|Participant decision|9|||
156927479|NCT03814746|566493565|FG001|Overall Study|Participant decision|6|||
156927480|NCT03814746|566493566|FG002|Overall Study|Participant decision|15|||
156927481|NCT03814746|566493564|FG000|Overall Study|Physician Decision|2|||
156927482|NCT03814746|566493565|FG001|Overall Study|Physician Decision|2|||
156927483|NCT03814746|566493566|FG002|Overall Study|Physician Decision|4|||
156927484|NCT03814746|566493564|FG000|Overall Study|Death|2|||
156927485|NCT03814746|566493565|FG001|Overall Study|Death|2|||
156927486|NCT03814746|566493566|FG002|Overall Study|Death|2|||
156927487|NCT03814746|566493564|FG000|Overall Study|Adverse Event|2|||
156927488|NCT03814746|566493565|FG001|Overall Study|Adverse Event|2|||
156927489|NCT03814746|566493566|FG002|Overall Study|Adverse Event|1|||
156927490|NCT03814746|566493564|FG000|Overall Study|Lost to Follow-up|2|||
156927491|NCT03814746|566493565|FG001|Overall Study|Lost to Follow-up|1|||
156927492|NCT03814746|566493566|FG002|Overall Study|Lost to Follow-up|2|||
156927493|NCT03814746|566493564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
156927494|NCT03814746|566493565|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
156927495|NCT03814746|566493566|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
156927496|NCT03814746|566493564|FG000|Overall Study|Pregnancy|0|||
156927497|NCT03814746|566493565|FG001|Overall Study|Pregnancy|1|||
156927498|NCT03814746|566493566|FG002|Overall Study|Pregnancy|1|||
156927499|NCT03814746|566493564|FG000|Overall Study|Protocol Violation|1|||
156927500|NCT03814746|566493565|FG001|Overall Study|Protocol Violation|0|||
156927501|NCT03814746|566493566|FG002|Overall Study|Protocol Violation|0|||
156927502|NCT05089682|566493567|FG000|Overall Study|Withdrawal by Subject|2|||
156927503|NCT03992781|566493568|FG000|Overall Study|Lost to Follow-up|5|||
156927504|NCT03992781|566493568|FG000|Overall Study|Adverse Event|1|||
156927505|NCT03992781|566493568|FG000|Overall Study|Lack of Efficacy|5|||
156927506|NCT01996826|566493569|FG000|Overall Study|Lost to Follow-up|6|||
156927507|NCT01996826|566493570|FG001|Overall Study|Lost to Follow-up|2|||
156927508|NCT01996826|566493569|FG000|Overall Study|Physician Decision|1|||
156927509|NCT01996826|566493570|FG001|Overall Study|Physician Decision|1|||
157166191|NCT02180724|567350442|FG000|Overall Study|PI Decision|5|||
156927510|NCT00695396|566493571|FG000|Overall Study|Study Closed Prematurely|5|||
156927511|NCT00695396|566493572|FG001|Overall Study|Study Closed Prematurely|6|||
156927512|NCT00695396|566493573|FG002|Overall Study|Study Closed Prematurely|8|||
156927513|NCT00695396|566493571|FG000|Overall Study|Withdrawal by Subject|2|||
156927514|NCT00695396|566493572|FG001|Overall Study|Withdrawal by Subject|2|||
156927515|NCT00695396|566493573|FG002|Overall Study|Withdrawal by Subject|0|||
156927516|NCT00518323|566493575|FG000|Overall Study|Lack of Efficacy|14|||
156927517|NCT00518323|566493576|FG001|Overall Study|Lack of Efficacy|2|||
156927518|NCT00518323|566493577|FG002|Overall Study|Lack of Efficacy|4|||
156927519|NCT00518323|566493578|FG003|Overall Study|Lack of Efficacy|20|||
156927520|NCT00518323|566493575|FG000|Overall Study|Withdrawal by Subject|1|||
156927521|NCT00518323|566493576|FG001|Overall Study|Withdrawal by Subject|2|||
156927522|NCT00518323|566493577|FG002|Overall Study|Withdrawal by Subject|4|||
156927523|NCT00518323|566493578|FG003|Overall Study|Withdrawal by Subject|2|||
156927524|NCT00518323|566493575|FG000|Overall Study|Lost to Follow-up|0|||
156927525|NCT00518323|566493576|FG001|Overall Study|Lost to Follow-up|2|||
156927526|NCT00518323|566493577|FG002|Overall Study|Lost to Follow-up|1|||
156927527|NCT00518323|566493578|FG003|Overall Study|Lost to Follow-up|3|||
157166192|NCT02180724|567350443|FG001|Overall Study|PI Decision|2|||
156927528|NCT00518323|566493575|FG000|Overall Study|Adverse Event|1|||
156927529|NCT00518323|566493576|FG001|Overall Study|Adverse Event|1|||
156927530|NCT00518323|566493577|FG002|Overall Study|Adverse Event|1|||
156927531|NCT00518323|566493578|FG003|Overall Study|Adverse Event|0|||
156927532|NCT00518323|566493575|FG000|Overall Study|Prohibited medication and others|3|||
156927533|NCT00518323|566493576|FG001|Overall Study|Prohibited medication and others|1|||
156927534|NCT00518323|566493577|FG002|Overall Study|Prohibited medication and others|1|||
156927535|NCT00518323|566493578|FG003|Overall Study|Prohibited medication and others|0|||
156927536|NCT03164928|566493580|FG000|Overall Study|Lost to Follow-up|1|||
156927537|NCT03164928|566493581|FG001|Overall Study|Lost to Follow-up|0|||
156927538|NCT00326950|566493585|FG000|Overall Study|Progressive Disease|1|||
156927539|NCT00772707|566493587|FG000|Overall Study|Withdrawn|3|||
156927540|NCT04499781|566493588|FG000|Overall Study|Lost to Follow-up|2|||
156927541|NCT04499781|566493589|FG001|Overall Study|Lost to Follow-up|3|||
156927542|NCT04499781|566493588|FG000|Overall Study|Withdrawal by Subject|2|||
156927543|NCT04499781|566493589|FG001|Overall Study|Withdrawal by Subject|0|||
156927544|NCT00483379|566493590|FG000|Treatment Period|Adverse Event|1|||
156927545|NCT00483379|566493591|FG001|Treatment Period|Adverse Event|0|||
156927546|NCT00483379|566493590|FG000|Treatment Period|Withdrawal by Subject|1|||
156927547|NCT00483379|566493591|FG001|Treatment Period|Withdrawal by Subject|0|||
156927548|NCT00371254|566493593|FG000|Overall Study|Disease progression|13|||
156927549|NCT00371254|566493594|FG001|Overall Study|Disease progression|13|||
156927550|NCT00371254|566493593|FG000|Overall Study|Study drug toxicity|3|||
156927551|NCT00371254|566493594|FG001|Overall Study|Study drug toxicity|5|||
156927552|NCT00371254|566493593|FG000|Overall Study|Subject request|5|||
156927553|NCT00371254|566493594|FG001|Overall Study|Subject request|0|||
156927554|NCT00371254|566493593|FG000|Overall Study|Investigator Decision|2|||
156927555|NCT00371254|566493594|FG001|Overall Study|Investigator Decision|0|||
156927556|NCT00371254|566493593|FG000|Overall Study|Adverse event unrelated to study drug|0|||
156927557|NCT00371254|566493594|FG001|Overall Study|Adverse event unrelated to study drug|1|||
156927558|NCT00371254|566493593|FG000|Overall Study|Lost to Follow-up|0|||
156927559|NCT00371254|566493594|FG001|Overall Study|Lost to Follow-up|1|||
156927560|NCT00371254|566493593|FG000|Overall Study|Withdrawal by Subject|0|||
156927561|NCT00371254|566493594|FG001|Overall Study|Withdrawal by Subject|1|||
156927562|NCT02951156|566493595|FG000|Overall Study|Death|3|||
156927563|NCT02951156|566493596|FG001|Overall Study|Death|8|||
156927564|NCT02951156|566493597|FG002|Overall Study|Death|5|||
156927565|NCT02951156|566493595|FG000|Overall Study|Progressive disease|1|||
156927566|NCT02951156|566493596|FG001|Overall Study|Progressive disease|0|||
156927567|NCT02951156|566493597|FG002|Overall Study|Progressive disease|1|||
156927568|NCT02951156|566493595|FG000|Overall Study|Withdrawal by Subject|0|||
156927569|NCT02951156|566493596|FG001|Overall Study|Withdrawal by Subject|0|||
156927570|NCT02951156|566493597|FG002|Overall Study|Withdrawal by Subject|1|||
156927571|NCT02951156|566493595|FG000|Overall Study|Study terminated by sponsor|0|||
156927572|NCT02951156|566493596|FG001|Overall Study|Study terminated by sponsor|0|||
156927573|NCT02951156|566493597|FG002|Overall Study|Study terminated by sponsor|1|||
156927574|NCT02951156|566493595|FG000|Overall Study|Other|5|||
156927575|NCT02951156|566493596|FG001|Overall Study|Other|1|||
156927576|NCT02951156|566493597|FG002|Overall Study|Other|2|||
156927577|NCT01641692|566493598|FG000|Treatment Period 1|Adverse Event|1|||
156927578|NCT01641692|566493599|FG001|Treatment Period 1|Adverse Event|0|||
156927579|NCT01641692|566493600|FG002|Treatment Period 1|Adverse Event|0|||
156927580|NCT01641692|566493601|FG003|Treatment Period 1|Adverse Event|0|||
156927581|NCT01641692|566493602|FG004|Treatment Period 1|Adverse Event|0|||
156927582|NCT01641692|566493603|FG005|Treatment Period 1|Adverse Event|0|||
156927583|NCT01641692|566493604|FG006|Treatment Period 1|Adverse Event|0|||
156927584|NCT01641692|566493605|FG007|Treatment Period 1|Adverse Event|0|||
156927585|NCT01641692|566493598|FG000|Treatment Period 1|Lack of Efficacy|0|||
156927586|NCT01641692|566493599|FG001|Treatment Period 1|Lack of Efficacy|0|||
156927587|NCT01641692|566493600|FG002|Treatment Period 1|Lack of Efficacy|0|||
156927588|NCT01641692|566493601|FG003|Treatment Period 1|Lack of Efficacy|0|||
156927589|NCT01641692|566493602|FG004|Treatment Period 1|Lack of Efficacy|0|||
156927590|NCT01641692|566493603|FG005|Treatment Period 1|Lack of Efficacy|0|||
156927591|NCT01641692|566493604|FG006|Treatment Period 1|Lack of Efficacy|0|||
156927592|NCT01641692|566493605|FG007|Treatment Period 1|Lack of Efficacy|1|||
156927593|NCT01641692|566493598|FG000|Treatment Period 1|Protocol Violation|1|||
156927594|NCT01641692|566493599|FG001|Treatment Period 1|Protocol Violation|0|||
156927595|NCT01641692|566493600|FG002|Treatment Period 1|Protocol Violation|0|||
156927596|NCT01641692|566493601|FG003|Treatment Period 1|Protocol Violation|0|||
156927597|NCT01641692|566493602|FG004|Treatment Period 1|Protocol Violation|2|||
156927598|NCT01641692|566493603|FG005|Treatment Period 1|Protocol Violation|0|||
156927599|NCT01641692|566493604|FG006|Treatment Period 1|Protocol Violation|0|||
156927600|NCT01641692|566493605|FG007|Treatment Period 1|Protocol Violation|0|||
156927601|NCT01641692|566493598|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156927602|NCT01641692|566493599|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156927603|NCT01641692|566493600|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156927604|NCT01641692|566493601|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156927605|NCT01641692|566493602|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
156927606|NCT01641692|566493603|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
156927607|NCT01641692|566493604|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
157029198|NCT01928394|566862887|FG000|Treatment Period|Death|0|||
156927608|NCT01641692|566493605|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
156927609|NCT01641692|566493598|FG000|Treatment Period 1|Lost to Follow-up|0|||
156927610|NCT01641692|566493599|FG001|Treatment Period 1|Lost to Follow-up|0|||
156927611|NCT01641692|566493600|FG002|Treatment Period 1|Lost to Follow-up|1|||
156927612|NCT01641692|566493601|FG003|Treatment Period 1|Lost to Follow-up|0|||
156927613|NCT01641692|566493602|FG004|Treatment Period 1|Lost to Follow-up|0|||
156927614|NCT01641692|566493603|FG005|Treatment Period 1|Lost to Follow-up|0|||
157166193|NCT02180724|567350442|FG000|Overall Study|Study terminated by sponsor|54|||
157166194|NCT02180724|567350443|FG001|Overall Study|Study terminated by sponsor|8|||
157166195|NCT01255306|567350444|FG000|Overall Study|Physician Decision|1|||
157166196|NCT01255306|567350445|FG001|Overall Study|Physician Decision|1|||
157166197|NCT01677624|567350446|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
157166198|NCT03363919|567350450|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
157166199|NCT03363919|567350451|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
157166200|NCT03363919|567350450|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
157166201|NCT03363919|567350451|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
157166202|NCT01975246|567350452|FG000|Overall Study|Adverse Event|2|||
157166203|NCT01975246|567350453|FG001|Overall Study|Adverse Event|1|||
157166204|NCT01975246|567350452|FG000|Overall Study|Lack of Efficacy|1|||
157166205|NCT01975246|567350453|FG001|Overall Study|Lack of Efficacy|0|||
157166206|NCT01975246|567350452|FG000|Overall Study|Protocol Violation|1|||
157166207|NCT01975246|567350453|FG001|Overall Study|Protocol Violation|0|||
157166208|NCT01975246|567350452|FG000|Overall Study|Other than stated|0|||
156927615|NCT01641692|566493604|FG006|Treatment Period 1|Lost to Follow-up|0|||
156927616|NCT01641692|566493605|FG007|Treatment Period 1|Lost to Follow-up|0|||
156927617|NCT01641692|566493598|FG000|Treatment Period 1|Physician Decision|0|||
156927618|NCT01641692|566493599|FG001|Treatment Period 1|Physician Decision|0|||
156927619|NCT01641692|566493600|FG002|Treatment Period 1|Physician Decision|0|||
156927620|NCT01641692|566493601|FG003|Treatment Period 1|Physician Decision|0|||
156927621|NCT01641692|566493602|FG004|Treatment Period 1|Physician Decision|1|||
156927622|NCT01641692|566493603|FG005|Treatment Period 1|Physician Decision|0|||
156927623|NCT01641692|566493604|FG006|Treatment Period 1|Physician Decision|0|||
156927624|NCT01641692|566493605|FG007|Treatment Period 1|Physician Decision|0|||
156927625|NCT01641692|566493598|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156927626|NCT01641692|566493599|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156927627|NCT01641692|566493600|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156927628|NCT01641692|566493601|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156927629|NCT01641692|566493602|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156927630|NCT01641692|566493603|FG005|Treatment Period 1|Withdrawal by Subject|2|||
156927631|NCT01641692|566493604|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156927632|NCT01641692|566493605|FG007|Treatment Period 1|Withdrawal by Subject|1|||
156927633|NCT01641692|566493598|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
156927634|NCT01641692|566493599|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927635|NCT01641692|566493600|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927636|NCT01641692|566493601|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927637|NCT01641692|566493602|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927638|NCT01641692|566493603|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927639|NCT01641692|566493604|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927640|NCT01641692|566493605|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
156927641|NCT01641692|566493598|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927642|NCT01641692|566493599|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927643|NCT01641692|566493600|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927644|NCT01641692|566493601|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927645|NCT01641692|566493602|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927646|NCT01641692|566493603|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156927647|NCT01641692|566493604|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156927648|NCT01641692|566493605|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
157166209|NCT01975246|567350453|FG001|Overall Study|Other than stated|1|||
156927649|NCT01641692|566493598|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156927650|NCT01641692|566493599|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927651|NCT01641692|566493600|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156927652|NCT01641692|566493601|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156927653|NCT01641692|566493602|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156927654|NCT01641692|566493603|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927655|NCT01641692|566493604|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927656|NCT01641692|566493605|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
157166210|NCT01646398|567350454|FG000|Overall Study|Withdrawal by Subject|1|||
156927657|NCT01641692|566493598|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
157166211|NCT01646398|567350455|FG001|Overall Study|Withdrawal by Subject|0|||
157166212|NCT01263093|567350456|FG000|Washout|Physician Decision|1|||
157166213|NCT01263093|567350457|FG001|Washout|Physician Decision|0|||
156927658|NCT01641692|566493599|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156927659|NCT01641692|566493600|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156927660|NCT01641692|566493601|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156927661|NCT01641692|566493602|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156927662|NCT01641692|566493603|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156927663|NCT01641692|566493604|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156927664|NCT01641692|566493605|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156927665|NCT01641692|566493598|FG000|Treatment Period 2|Lack of Efficacy|1|||
156927666|NCT01641692|566493599|FG001|Treatment Period 2|Lack of Efficacy|0|||
156927667|NCT01641692|566493600|FG002|Treatment Period 2|Lack of Efficacy|0|||
156927668|NCT01641692|566493601|FG003|Treatment Period 2|Lack of Efficacy|0|||
156927669|NCT01641692|566493602|FG004|Treatment Period 2|Lack of Efficacy|0|||
156927670|NCT01641692|566493603|FG005|Treatment Period 2|Lack of Efficacy|0|||
156927671|NCT01641692|566493604|FG006|Treatment Period 2|Lack of Efficacy|0|||
156927672|NCT01641692|566493605|FG007|Treatment Period 2|Lack of Efficacy|0|||
156927673|NCT01641692|566493598|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
156927674|NCT01641692|566493599|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927675|NCT01641692|566493600|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927676|NCT01641692|566493601|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927677|NCT01641692|566493602|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927678|NCT01641692|566493603|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927679|NCT01641692|566493604|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927680|NCT01641692|566493605|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156927681|NCT01641692|566493598|FG000|Treatment Period 2|Lost to Follow-up|0|||
156927682|NCT01641692|566493599|FG001|Treatment Period 2|Lost to Follow-up|0|||
156927683|NCT01641692|566493600|FG002|Treatment Period 2|Lost to Follow-up|0|||
156927684|NCT01641692|566493601|FG003|Treatment Period 2|Lost to Follow-up|0|||
156927685|NCT01641692|566493602|FG004|Treatment Period 2|Lost to Follow-up|0|||
156927686|NCT01641692|566493603|FG005|Treatment Period 2|Lost to Follow-up|1|||
156927687|NCT01641692|566493604|FG006|Treatment Period 2|Lost to Follow-up|0|||
156927688|NCT01641692|566493605|FG007|Treatment Period 2|Lost to Follow-up|0|||
156927689|NCT01641692|566493598|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156927690|NCT01641692|566493599|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156927691|NCT01641692|566493600|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156927692|NCT01641692|566493601|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156927693|NCT01641692|566493602|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156927694|NCT01641692|566493603|FG005|Treatment Period 2|Withdrawal by Subject|1|||
156927695|NCT01641692|566493604|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156927696|NCT01641692|566493605|FG007|Treatment Period 2|Withdrawal by Subject|1|||
156927697|NCT01641692|566493598|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927698|NCT01641692|566493599|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927699|NCT01641692|566493600|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927700|NCT01641692|566493601|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927701|NCT01641692|566493602|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
156927702|NCT01641692|566493603|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927703|NCT01641692|566493604|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
156927704|NCT01641692|566493605|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
156927705|NCT01641692|566493598|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156927706|NCT01641692|566493599|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156927707|NCT01641692|566493600|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156927708|NCT01641692|566493601|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156927709|NCT01641692|566493602|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156927710|NCT01641692|566493603|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156927711|NCT01641692|566493604|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156927712|NCT01641692|566493605|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156927713|NCT01641692|566493598|FG000|Treatment Period 3|Adverse Event|0|||
156927714|NCT01641692|566493599|FG001|Treatment Period 3|Adverse Event|0|||
156927715|NCT01641692|566493600|FG002|Treatment Period 3|Adverse Event|0|||
156927716|NCT01641692|566493601|FG003|Treatment Period 3|Adverse Event|0|||
156927717|NCT01641692|566493602|FG004|Treatment Period 3|Adverse Event|0|||
156927718|NCT01641692|566493603|FG005|Treatment Period 3|Adverse Event|0|||
156927719|NCT01641692|566493604|FG006|Treatment Period 3|Adverse Event|1|||
156927720|NCT01641692|566493605|FG007|Treatment Period 3|Adverse Event|0|||
156927721|NCT01641692|566493598|FG000|Treatment Period 3|Protocol Violation|0|||
156927722|NCT01641692|566493599|FG001|Treatment Period 3|Protocol Violation|0|||
156927723|NCT01641692|566493600|FG002|Treatment Period 3|Protocol Violation|1|||
156927724|NCT01641692|566493601|FG003|Treatment Period 3|Protocol Violation|0|||
156927725|NCT01641692|566493602|FG004|Treatment Period 3|Protocol Violation|0|||
156927726|NCT01641692|566493603|FG005|Treatment Period 3|Protocol Violation|0|||
157029199|NCT01928394|566862888|FG001|Treatment Period|Death|0|||
156927727|NCT01641692|566493604|FG006|Treatment Period 3|Protocol Violation|0|||
157166214|NCT01263093|567350456|FG000|Period 2|Adverse Event|1|||
157166215|NCT01263093|567350457|FG001|Period 2|Adverse Event|0|||
157166216|NCT00571519|567350458|FG000|Overall Study|Subject withdrew consent|0|||
157166217|NCT00571519|567350459|FG001|Overall Study|Subject withdrew consent|1|||
157166218|NCT00571519|567350460|FG002|Overall Study|Subject withdrew consent|0|||
157166219|NCT00571519|567350461|FG003|Overall Study|Subject withdrew consent|2|||
157166220|NCT00571519|567350462|FG004|Overall Study|Subject withdrew consent|1|||
157166221|NCT00571519|567350463|FG005|Overall Study|Subject withdrew consent|1|||
157166222|NCT00571519|567350464|FG006|Overall Study|Subject withdrew consent|2|||
157166223|NCT00571519|567350458|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
157166224|NCT00571519|567350459|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
157166225|NCT00571519|567350460|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
157166226|NCT00571519|567350461|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
157166227|NCT00571519|567350462|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
157166228|NCT00571519|567350463|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
157166229|NCT00571519|567350464|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
157166230|NCT00571519|567350458|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166231|NCT00571519|567350459|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
157166232|NCT00571519|567350460|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166233|NCT00571519|567350461|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166234|NCT00571519|567350462|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166235|NCT00571519|567350463|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166236|NCT00571519|567350464|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
157166237|NCT00571519|567350458|FG000|Overall Study|Termination of study by Sponsor|2|||
157166238|NCT00571519|567350459|FG001|Overall Study|Termination of study by Sponsor|7|||
157166239|NCT00571519|567350460|FG002|Overall Study|Termination of study by Sponsor|10|||
157166240|NCT00571519|567350461|FG003|Overall Study|Termination of study by Sponsor|24|||
157166241|NCT00571519|567350462|FG004|Overall Study|Termination of study by Sponsor|8|||
157166242|NCT00571519|567350463|FG005|Overall Study|Termination of study by Sponsor|9|||
157166243|NCT00571519|567350464|FG006|Overall Study|Termination of study by Sponsor|22|||
157166244|NCT00571519|567350458|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166245|NCT00571519|567350459|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166246|NCT00571519|567350460|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
157166247|NCT00571519|567350461|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166248|NCT00571519|567350462|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166249|NCT00571519|567350463|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166250|NCT00571519|567350464|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
157166251|NCT05458011|567350465|FG000|DB Period (12 Weeks)|Adverse Event|2|||
157166252|NCT05458011|567350466|FG001|DB Period (12 Weeks)|Adverse Event|1|||
157166253|NCT05458011|567350467|FG002|DB Period (12 Weeks)|Adverse Event|1|||
157166254|NCT05458011|567350465|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
157166255|NCT05458011|567350466|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
156927728|NCT01641692|566493605|FG007|Treatment Period 3|Protocol Violation|0|||
156927729|NCT01641692|566493598|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927730|NCT01641692|566493599|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927731|NCT01641692|566493600|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927732|NCT01641692|566493601|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927733|NCT01641692|566493602|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927734|NCT01641692|566493603|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927735|NCT01641692|566493604|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
156927736|NCT01641692|566493605|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
156927737|NCT01641692|566493598|FG000|Treatment Period 3|Lost to Follow-up|0|||
156927738|NCT01641692|566493599|FG001|Treatment Period 3|Lost to Follow-up|1|||
156927739|NCT01641692|566493600|FG002|Treatment Period 3|Lost to Follow-up|0|||
156927740|NCT01641692|566493601|FG003|Treatment Period 3|Lost to Follow-up|0|||
156927741|NCT01641692|566493602|FG004|Treatment Period 3|Lost to Follow-up|0|||
156927742|NCT01641692|566493603|FG005|Treatment Period 3|Lost to Follow-up|0|||
156927743|NCT01641692|566493604|FG006|Treatment Period 3|Lost to Follow-up|0|||
156927744|NCT01641692|566493605|FG007|Treatment Period 3|Lost to Follow-up|0|||
156927745|NCT01641692|566493598|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927746|NCT01641692|566493599|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
157166256|NCT05458011|567350467|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
157166257|NCT05458011|567350465|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
157166258|NCT05458011|567350466|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
157166259|NCT05458011|567350467|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
157166260|NCT05458011|567350465|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
157166261|NCT05458011|567350466|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
157166262|NCT05458011|567350467|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
156927747|NCT01641692|566493600|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927748|NCT01641692|566493601|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927749|NCT01641692|566493602|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927750|NCT01641692|566493603|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
156927751|NCT01641692|566493604|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927752|NCT01641692|566493605|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
156927753|NCT01641692|566493598|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156927754|NCT01641692|566493599|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156927755|NCT01641692|566493600|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156927756|NCT01641692|566493601|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156927757|NCT01641692|566493602|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156927758|NCT01641692|566493603|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156927759|NCT01641692|566493604|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
156927760|NCT01641692|566493605|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
156927761|NCT01166178|566493606|FG000|Overall Study|Withdrawal by Subject|1|||
156927762|NCT01166178|566493607|FG001|Overall Study|Withdrawal by Subject|0|||
156927763|NCT01166178|566493606|FG000|Overall Study|Study was terminated|20|||
156927764|NCT01166178|566493607|FG001|Overall Study|Study was terminated|8|||
156927765|NCT01474876|566493612|FG000|Overall Study|Adverse Event|11|||
156927766|NCT01474876|566493613|FG001|Overall Study|Adverse Event|5|||
156927767|NCT01474876|566493614|FG002|Overall Study|Adverse Event|0|||
156927768|NCT01474876|566493612|FG000|Overall Study|Serious Adverse Event|2|||
156927769|NCT01474876|566493613|FG001|Overall Study|Serious Adverse Event|3|||
156927770|NCT01474876|566493614|FG002|Overall Study|Serious Adverse Event|0|||
156927771|NCT01474876|566493612|FG000|Overall Study|Lost to Follow-up|5|||
156927772|NCT01474876|566493613|FG001|Overall Study|Lost to Follow-up|4|||
156927773|NCT01474876|566493614|FG002|Overall Study|Lost to Follow-up|0|||
156927774|NCT01474876|566493612|FG000|Overall Study|Investigator's decision|28|||
156927775|NCT01474876|566493613|FG001|Overall Study|Investigator's decision|6|||
156927776|NCT01474876|566493614|FG002|Overall Study|Investigator's decision|0|||
156927777|NCT01474876|566493612|FG000|Overall Study|Patient's request|19|||
156927778|NCT01474876|566493613|FG001|Overall Study|Patient's request|5|||
156927779|NCT01474876|566493614|FG002|Overall Study|Patient's request|0|||
156927780|NCT01474876|566493612|FG000|Overall Study|Investigator's decision and pt request|1|||
156927781|NCT01474876|566493613|FG001|Overall Study|Investigator's decision and pt request|0|||
156927782|NCT01474876|566493614|FG002|Overall Study|Investigator's decision and pt request|0|||
156927783|NCT02291055|566493615|FG000|Overall Study|Death|2|||
156927784|NCT02291055|566493616|FG001|Overall Study|Death|2|||
156927785|NCT02291055|566493617|FG002|Overall Study|Death|5|||
156927786|NCT02291055|566493618|FG003|Overall Study|Death|8|||
156927787|NCT02291055|566493619|FG004|Overall Study|Death|12|||
156927788|NCT02291055|566493615|FG000|Overall Study|Lost to Follow-up|0|||
156927789|NCT02291055|566493616|FG001|Overall Study|Lost to Follow-up|0|||
156927790|NCT02291055|566493617|FG002|Overall Study|Lost to Follow-up|0|||
156927791|NCT02291055|566493618|FG003|Overall Study|Lost to Follow-up|1|||
156927792|NCT02291055|566493619|FG004|Overall Study|Lost to Follow-up|2|||
156927793|NCT02291055|566493615|FG000|Overall Study|Withdrawal by Subject|3|||
156927794|NCT02291055|566493616|FG001|Overall Study|Withdrawal by Subject|1|||
156927795|NCT02291055|566493617|FG002|Overall Study|Withdrawal by Subject|1|||
156927796|NCT02291055|566493618|FG003|Overall Study|Withdrawal by Subject|5|||
156927797|NCT02291055|566493619|FG004|Overall Study|Withdrawal by Subject|10|||
156927798|NCT02291055|566493615|FG000|Overall Study|Progressive Disease|0|||
156927799|NCT02291055|566493616|FG001|Overall Study|Progressive Disease|0|||
156927800|NCT02291055|566493617|FG002|Overall Study|Progressive Disease|1|||
156927801|NCT02291055|566493618|FG003|Overall Study|Progressive Disease|4|||
156927802|NCT02291055|566493619|FG004|Overall Study|Progressive Disease|2|||
156927803|NCT02291055|566493615|FG000|Overall Study|Study Terminated by Sponsor|0|||
156927804|NCT02291055|566493616|FG001|Overall Study|Study Terminated by Sponsor|0|||
157166263|NCT05458011|567350465|FG000|OL Period (12 Weeks)|Adverse Event|1|||
156927805|NCT02291055|566493617|FG002|Overall Study|Study Terminated by Sponsor|0|||
156927806|NCT02291055|566493618|FG003|Overall Study|Study Terminated by Sponsor|5|||
156927807|NCT02291055|566493619|FG004|Overall Study|Study Terminated by Sponsor|1|||
156927808|NCT02291055|566493615|FG000|Overall Study|Other|0|||
156927809|NCT02291055|566493616|FG001|Overall Study|Other|2|||
156927810|NCT02291055|566493617|FG002|Overall Study|Other|1|||
156927811|NCT02291055|566493618|FG003|Overall Study|Other|4|||
156927812|NCT02291055|566493619|FG004|Overall Study|Other|0|||
156927813|NCT01523886|566493620|FG000|Overall Study|surgery cancelled|0|||
156927814|NCT01523886|566493621|FG001|Overall Study|surgery cancelled|1|||
156927815|NCT01239368|566495559|FG000|Overall Study|Principal investigator discretion|1|||
156927816|NCT01239368|566495560|FG001|Overall Study|Principal investigator discretion|0|||
156927817|NCT01239368|566495561|FG002|Overall Study|Principal investigator discretion|0|||
156927818|NCT01239368|566495562|FG003|Overall Study|Principal investigator discretion|0|||
156927819|NCT01239368|566495563|FG004|Overall Study|Principal investigator discretion|1|||
156927820|NCT01239368|566495564|FG005|Overall Study|Principal investigator discretion|2|||
156927821|NCT01239368|566495565|FG006|Overall Study|Principal investigator discretion|0|||
156927822|NCT01239368|566495566|FG007|Overall Study|Principal investigator discretion|0|||
156927823|NCT01239368|566495567|FG008|Overall Study|Principal investigator discretion|0|||
156927824|NCT01239368|566495568|FG009|Overall Study|Principal investigator discretion|1|||
156927825|NCT01239368|566495559|FG000|Overall Study|Disease progression on study|1|||
156927826|NCT01239368|566495560|FG001|Overall Study|Disease progression on study|1|||
156927827|NCT01239368|566495561|FG002|Overall Study|Disease progression on study|1|||
156927828|NCT01239368|566495562|FG003|Overall Study|Disease progression on study|1|||
156927829|NCT01239368|566495563|FG004|Overall Study|Disease progression on study|4|||
156927830|NCT01239368|566495564|FG005|Overall Study|Disease progression on study|2|||
156927831|NCT01239368|566495565|FG006|Overall Study|Disease progression on study|5|||
156927832|NCT01239368|566495566|FG007|Overall Study|Disease progression on study|0|||
156927833|NCT01239368|566495567|FG008|Overall Study|Disease progression on study|0|||
156927834|NCT01239368|566495568|FG009|Overall Study|Disease progression on study|2|||
156927835|NCT01239368|566495559|FG000|Overall Study|Refused further treatment|0|||
156927836|NCT01239368|566495560|FG001|Overall Study|Refused further treatment|0|||
156927837|NCT01239368|566495561|FG002|Overall Study|Refused further treatment|0|||
156927838|NCT01239368|566495562|FG003|Overall Study|Refused further treatment|0|||
156927839|NCT01239368|566495563|FG004|Overall Study|Refused further treatment|0|||
156927840|NCT01239368|566495564|FG005|Overall Study|Refused further treatment|0|||
156927841|NCT01239368|566495565|FG006|Overall Study|Refused further treatment|0|||
156927842|NCT01239368|566495566|FG007|Overall Study|Refused further treatment|0|||
156927843|NCT01239368|566495567|FG008|Overall Study|Refused further treatment|0|||
156927844|NCT01239368|566495568|FG009|Overall Study|Refused further treatment|1|||
156927845|NCT01239368|566495559|FG000|Overall Study|Death|0|||
156927846|NCT01239368|566495560|FG001|Overall Study|Death|0|||
156927847|NCT01239368|566495561|FG002|Overall Study|Death|0|||
156927848|NCT01239368|566495562|FG003|Overall Study|Death|0|||
156927849|NCT01239368|566495563|FG004|Overall Study|Death|0|||
156927850|NCT01239368|566495564|FG005|Overall Study|Death|0|||
156927851|NCT01239368|566495565|FG006|Overall Study|Death|1|||
156927852|NCT01239368|566495566|FG007|Overall Study|Death|0|||
156927853|NCT01239368|566495567|FG008|Overall Study|Death|0|||
156927854|NCT01239368|566495568|FG009|Overall Study|Death|0|||
156927855|NCT03181399|566495570|FG000|6 Months on Treatment|Protocol non-compliance|7|||
156927856|NCT03181399|566495570|FG000|6 Months on Treatment|Adverse Event|4|||
156927857|NCT03181399|566495570|FG000|6 Months on Treatment|Tried alternative treatment|2|||
156927858|NCT03181399|566495570|FG000|6 Months on Treatment|Lost to Follow-up|2|||
156927859|NCT03181399|566495570|FG000|6 Months on Treatment|Personal reasons|1|||
156927860|NCT03181399|566495570|FG000|3 Months Off-treatment|Parent unable to travel|1|||
156927861|NCT03329690|566495571|FG000|Overall Study|Progressive disease per RECIST|85|||
156927862|NCT03329690|566495572|FG001|Overall Study|Progressive disease per RECIST|44|||
156927863|NCT03329690|566495573|FG002|Overall Study|Progressive disease per RECIST|6|||
156927864|NCT03329690|566495574|FG003|Overall Study|Progressive disease per RECIST|16|||
156927865|NCT03329690|566495575|FG004|Overall Study|Progressive disease per RECIST|20|||
156927866|NCT03329690|566495571|FG000|Overall Study|Clinical progression|7|||
156927867|NCT03329690|566495572|FG001|Overall Study|Clinical progression|4|||
156927868|NCT03329690|566495573|FG002|Overall Study|Clinical progression|1|||
156927869|NCT03329690|566495574|FG003|Overall Study|Clinical progression|1|||
156927870|NCT03329690|566495575|FG004|Overall Study|Clinical progression|1|||
156927871|NCT03329690|566495571|FG000|Overall Study|Adverse Event|22|||
156927872|NCT03329690|566495572|FG001|Overall Study|Adverse Event|4|||
156927873|NCT03329690|566495573|FG002|Overall Study|Adverse Event|0|||
156927874|NCT03329690|566495574|FG003|Overall Study|Adverse Event|1|||
156927875|NCT03329690|566495575|FG004|Overall Study|Adverse Event|2|||
156927876|NCT03329690|566495571|FG000|Overall Study|Death|2|||
156927877|NCT03329690|566495572|FG001|Overall Study|Death|0|||
156927878|NCT03329690|566495573|FG002|Overall Study|Death|0|||
157166264|NCT05458011|567350466|FG001|OL Period (12 Weeks)|Adverse Event|2|||
156927879|NCT03329690|566495574|FG003|Overall Study|Death|1|||
156927880|NCT03329690|566495575|FG004|Overall Study|Death|0|||
156927881|NCT03329690|566495571|FG000|Overall Study|Withdrawal by Subject|2|||
156927882|NCT03329690|566495572|FG001|Overall Study|Withdrawal by Subject|3|||
156927883|NCT03329690|566495573|FG002|Overall Study|Withdrawal by Subject|0|||
156927884|NCT03329690|566495574|FG003|Overall Study|Withdrawal by Subject|1|||
156927885|NCT03329690|566495575|FG004|Overall Study|Withdrawal by Subject|0|||
156927886|NCT03329690|566495571|FG000|Overall Study|Physician Decision|1|||
156927887|NCT03329690|566495572|FG001|Overall Study|Physician Decision|0|||
156927888|NCT03329690|566495573|FG002|Overall Study|Physician Decision|0|||
156927889|NCT03329690|566495574|FG003|Overall Study|Physician Decision|0|||
156927890|NCT03329690|566495575|FG004|Overall Study|Physician Decision|1|||
156927891|NCT03329690|566495571|FG000|Overall Study|Miscellaneous|6|||
156927892|NCT03329690|566495572|FG001|Overall Study|Miscellaneous|0|||
156927893|NCT03329690|566495573|FG002|Overall Study|Miscellaneous|0|||
156927894|NCT03329690|566495574|FG003|Overall Study|Miscellaneous|0|||
156927895|NCT03329690|566495575|FG004|Overall Study|Miscellaneous|0|||
157166265|NCT05458011|567350467|FG002|OL Period (12 Weeks)|Adverse Event|1|||
156927896|NCT03329690|566495571|FG000|Overall Study|Did not receive treatment|1|||
156927897|NCT03329690|566495572|FG001|Overall Study|Did not receive treatment|0|||
156927898|NCT03329690|566495573|FG002|Overall Study|Did not receive treatment|0|||
156927899|NCT03329690|566495574|FG003|Overall Study|Did not receive treatment|1|||
156927900|NCT03329690|566495575|FG004|Overall Study|Did not receive treatment|0|||
156927901|NCT01817725|566495576|FG000|Overall Study|Withdrawal by Subject|1|||
156927902|NCT02337907|566495579|FG000|Overall Study|Other than listed|1|||
156927903|NCT02337907|566495580|FG001|Overall Study|Other than listed|0|||
156927904|NCT02337907|566495581|FG002|Overall Study|Other than listed|0|||
156927905|NCT02337907|566495582|FG003|Overall Study|Other than listed|1|||
156927906|NCT02337907|566495583|FG004|Overall Study|Other than listed|1|||
157029200|NCT01928394|566862889|FG002|Treatment Period|Death|0|||
157029201|NCT01928394|566862890|FG003|Treatment Period|Death|0|||
157029202|NCT01928394|566862891|FG004|Treatment Period|Death|0|||
157166266|NCT05458011|567350465|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
157166267|NCT05458011|567350466|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
157166268|NCT05458011|567350467|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
157166269|NCT00574119|567350468|FG000|Overall Study|Adverse Event|1|||
157166270|NCT00574119|567350468|FG000|Overall Study|Protocol Violation|1|||
157166271|NCT00574119|567350468|FG000|Overall Study|Withdrawal by Subject|1|||
157166272|NCT00574119|567350468|FG000|Overall Study|Physician Decision|1|||
157166273|NCT02690207|567350472|FG000|Overall Study|Lost to Follow-up|48|||
157166274|NCT02690207|567350472|FG000|Overall Study|Withdrawal by Subject|46|||
157166275|NCT02690207|567350472|FG000|Overall Study|Protocol Violation|2|||
157166276|NCT02690207|567350472|FG000|Overall Study|Serious adverse event|110|||
157166277|NCT02690207|567350472|FG000|Overall Study|Non-serious Adverse Event|18|||
157166278|NCT02690207|567350472|FG000|Overall Study|Migrated/moved from study area|5|||
157166279|NCT02690207|567350472|FG000|Overall Study|Suspected HZ Episode|1|||
157166280|NCT02690207|567350472|FG000|Overall Study|Other reasons for withdrawal|23|||
157166281|NCT04656418|567350473|FG000|Overall Study|Withdrawal by Subject|1|||
157166282|NCT04656418|567350474|FG001|Overall Study|Withdrawal by Subject|3|||
157166283|NCT02586077|567350475|FG000|Overall Study|Withdrawal by Subject|1|||
157166284|NCT02586077|567350475|FG000|Overall Study|Physician Decision|4|||
157166285|NCT02586077|567350475|FG000|Overall Study|Lost to Follow-up|3|||
157029203|NCT01928394|566862892|FG005|Treatment Period|Death|0|||
157029204|NCT01928394|566862893|FG006|Treatment Period|Death|0|||
157029205|NCT01928394|566862894|FG007|Treatment Period|Death|0|||
157166286|NCT00880763|567350476|FG000|Extension Period (Part 2)|Adverse Event|0|||
157166287|NCT00880763|567350477|FG001|Extension Period (Part 2)|Adverse Event|0|||
157166288|NCT00880763|567350478|FG002|Extension Period (Part 2)|Adverse Event|1|||
157166289|NCT00880763|567350479|FG003|Extension Period (Part 2)|Adverse Event|1|||
157166290|NCT00880763|567350476|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
157166291|NCT00880763|567350477|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
157166292|NCT00880763|567350478|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
157166293|NCT00880763|567350479|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
157166294|NCT00880763|567350476|FG000|Extension Period (Part 2)|Physician Decision|0|||
157166295|NCT00880763|567350477|FG001|Extension Period (Part 2)|Physician Decision|1|||
157166296|NCT00880763|567350478|FG002|Extension Period (Part 2)|Physician Decision|1|||
157166297|NCT00880763|567350479|FG003|Extension Period (Part 2)|Physician Decision|0|||
157166298|NCT00880763|567350476|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
157166299|NCT00880763|567350477|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
157166300|NCT00880763|567350478|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
157166301|NCT00880763|567350479|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
157166302|NCT02475850|567350480|FG000|Overall Study|Death|155|||
157166303|NCT02475850|567350481|FG001|Overall Study|Death|141|||
157166304|NCT02475850|567350480|FG000|Overall Study|Lost to Follow-up|217|||
157166305|NCT02475850|567350481|FG001|Overall Study|Lost to Follow-up|188|||
157166306|NCT02475850|567350480|FG000|Overall Study|Withdrawal by Subject|221|||
157166307|NCT02475850|567350481|FG001|Overall Study|Withdrawal by Subject|155|||
157029206|NCT01928394|566862895|FG008|Treatment Period|Death|0|||
157029207|NCT01928394|566862896|FG009|Treatment Period|Death|0|||
157166308|NCT03057951|567350486|FG000|Overall Study|Adverse Event|553|||
157166309|NCT03057951|567350487|FG001|Overall Study|Adverse Event|575|||
157166310|NCT03057951|567350486|FG000|Overall Study|Protocol Violation|30|||
156927907|NCT02337907|566495584|FG005|Overall Study|Other than listed|0|||
157029208|NCT01928394|566862897|FG010|Treatment Period|Death|0|||
157029209|NCT01928394|566862898|FG011|Treatment Period|Death|0|||
157166311|NCT03057951|567350487|FG001|Overall Study|Protocol Violation|24|||
157166312|NCT03057951|567350486|FG000|Overall Study|Lost to Follow-up|6|||
157166313|NCT03057951|567350487|FG001|Overall Study|Lost to Follow-up|16|||
157166314|NCT03057951|567350486|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
157166315|NCT03057951|567350487|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
157166316|NCT03057951|567350486|FG000|Overall Study|Study drug stopped, reason missing|6|||
156927908|NCT02337907|566495579|FG000|Overall Study|Withdrawal by Subject|2|||
156927909|NCT02337907|566495580|FG001|Overall Study|Withdrawal by Subject|3|||
156927910|NCT02337907|566495581|FG002|Overall Study|Withdrawal by Subject|0|||
157029210|NCT01928394|566862899|FG012|Treatment Period|Death|0|||
156927911|NCT02337907|566495582|FG003|Overall Study|Withdrawal by Subject|2|||
156927912|NCT02337907|566495583|FG004|Overall Study|Withdrawal by Subject|5|||
156927913|NCT02337907|566495584|FG005|Overall Study|Withdrawal by Subject|0|||
156927914|NCT02337907|566495579|FG000|Overall Study|Lost to Follow-up|0|||
156927915|NCT02337907|566495580|FG001|Overall Study|Lost to Follow-up|0|||
156927916|NCT02337907|566495581|FG002|Overall Study|Lost to Follow-up|0|||
156927917|NCT02337907|566495582|FG003|Overall Study|Lost to Follow-up|0|||
156927918|NCT02337907|566495583|FG004|Overall Study|Lost to Follow-up|0|||
156927919|NCT02337907|566495584|FG005|Overall Study|Lost to Follow-up|1|||
156927920|NCT02337907|566495579|FG000|Overall Study|Adverse Event|1|||
156927921|NCT02337907|566495580|FG001|Overall Study|Adverse Event|1|||
156927922|NCT02337907|566495581|FG002|Overall Study|Adverse Event|1|||
156927923|NCT02337907|566495582|FG003|Overall Study|Adverse Event|1|||
156927924|NCT02337907|566495583|FG004|Overall Study|Adverse Event|4|||
156927925|NCT02337907|566495584|FG005|Overall Study|Adverse Event|0|||
156927926|NCT00099437|566495585|FG000|Overall Study|Lost to Follow-up|30|||
156927927|NCT00099437|566495586|FG001|Overall Study|Lost to Follow-up|33|||
156927928|NCT00099437|566495585|FG000|Overall Study|Death|293|||
156927929|NCT00099437|566495586|FG001|Overall Study|Death|261|||
156927930|NCT00099437|566495585|FG000|Overall Study|Withdrawal by Subject|6|||
156927931|NCT00099437|566495586|FG001|Overall Study|Withdrawal by Subject|10|||
156927932|NCT00099437|566495585|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
156927933|NCT00099437|566495586|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
156927934|NCT00949325|566495587|FG000|Overall Study|Adverse Event|0|||
156927935|NCT00949325|566495588|FG001|Overall Study|Adverse Event|2|||
156927936|NCT00949325|566495589|FG002|Overall Study|Adverse Event|0|||
156927937|NCT04519645|566495590|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
156927938|NCT04519645|566495591|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
156927939|NCT04519645|566495592|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
156927940|NCT04519645|566495590|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
156927941|NCT04519645|566495591|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
156927942|NCT04519645|566495592|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
156927943|NCT04519645|566495590|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
156927944|NCT04519645|566495591|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
156927945|NCT04519645|566495592|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
156927946|NCT04519645|566495590|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
156927947|NCT04519645|566495591|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
156927948|NCT04519645|566495592|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
156927949|NCT01679002|566495593|FG000|Overall Study|Adverse Event|1|||
156927950|NCT01679002|566495594|FG001|Overall Study|Adverse Event|1|||
156927951|NCT01679002|566495595|FG002|Overall Study|Adverse Event|0|||
156927952|NCT05172544|566495598|FG000|Overall Study|Withdrawal by Subject|1|||
156927953|NCT05172544|566495599|FG001|Overall Study|Withdrawal by Subject|0|||
156927954|NCT05172544|566495600|FG002|Overall Study|Withdrawal by Subject|0|||
156927955|NCT05172544|566495598|FG000|Overall Study|Physician Decision|0|||
157166317|NCT03057951|567350487|FG001|Overall Study|Study drug stopped, reason missing|1|||
157166318|NCT03057951|567350486|FG000|Overall Study|Medical advice|6|||
157166319|NCT03057951|567350487|FG001|Overall Study|Medical advice|2|||
157166320|NCT03057951|567350486|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
157166321|NCT03057951|567350487|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
157166322|NCT03057951|567350486|FG000|Overall Study|Investigator decision|2|||
157166323|NCT03057951|567350487|FG001|Overall Study|Investigator decision|0|||
157166324|NCT03057951|567350486|FG000|Overall Study|Patient decision|5|||
157166325|NCT03057951|567350487|FG001|Overall Study|Patient decision|2|||
157166326|NCT03057951|567350486|FG000|Overall Study|Not attending study visits|3|||
157166327|NCT03057951|567350487|FG001|Overall Study|Not attending study visits|0|||
157166328|NCT03057951|567350486|FG000|Overall Study|Patient moved away|3|||
157166329|NCT03057951|567350487|FG001|Overall Study|Patient moved away|4|||
157166330|NCT03057951|567350486|FG000|Overall Study|Other reason than stated above|23|||
157166331|NCT03057951|567350487|FG001|Overall Study|Other reason than stated above|29|||
157166332|NCT03057951|567350486|FG000|Overall Study|Not treated|2|||
156927956|NCT05172544|566495599|FG001|Overall Study|Physician Decision|0|||
156927957|NCT05172544|566495600|FG002|Overall Study|Physician Decision|1|||
156927958|NCT00730912|566495603|FG000|Overall Study|Discontinued|0|||
157166333|NCT03057951|567350487|FG001|Overall Study|Not treated|1|||
157166334|NCT03434418|567350488|FG000|Overall Study|Disease Progression|11|||
157166335|NCT03434418|567350488|FG000|Overall Study|Adverse Event|2|||
157166336|NCT03434418|567350488|FG000|Overall Study|Physician Decision|1|||
157166337|NCT03434418|567350488|FG000|Overall Study|Decline in Performance Status (PS)|1|||
157166338|NCT01293006|567350491|FG000|Period 2|Lost to Follow-up|1|||
156927959|NCT00730912|566495604|FG001|Overall Study|Discontinued|0|||
156927960|NCT00730912|566495605|FG002|Overall Study|Discontinued|1|||
156927961|NCT03311659|566495611|FG000|Overall Study|Protocol Violation|1|||
156927962|NCT01176266|566495614|FG000|Overall Study|Death|6|||
156927963|NCT01176266|566495614|FG000|Overall Study|Withdrawal by Subject|3|||
157166339|NCT01293006|567350492|FG001|Period 2|Lost to Follow-up|0|||
156927964|NCT01179477|566495615|FG000|Overall Study|Death|542|||
156927965|NCT01179477|566495615|FG000|Overall Study|Unsuccessful implant|80|||
156927966|NCT01179477|566495615|FG000|Overall Study|Non-death withdrawal|438|||
156927967|NCT01179477|566495615|FG000|Overall Study|Did not complete final visit|27|||
156927968|NCT04829318|566495617|FG000|Overall Study|Adverse Event|6|||
156927969|NCT04829318|566495617|FG000|Overall Study|Death|1|||
156927970|NCT04829318|566495617|FG000|Overall Study|Lost to Follow-up|1|||
156927971|NCT04829318|566495617|FG000|Overall Study|Physician Decision|1|||
156927972|NCT04829318|566495617|FG000|Overall Study|Withdrawal by Subject|19|||
156927973|NCT04829318|566495617|FG000|Overall Study|Site terminated by sponsor|1|||
156927974|NCT04829318|566495617|FG000|Overall Study|Sponsor decision|5|||
156927975|NCT04829318|566495617|FG000|Overall Study|Other|1|||
156927976|NCT00728130|566495618|FG000|Overall Study|Withdrawal by Subject|1|||
156927977|NCT00728130|566495618|FG000|Overall Study|Paperwork not completed in time|1|||
156927978|NCT00728130|566495618|FG000|Overall Study|Physician Decision|1|||
156927979|NCT04053023|566495621|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
156927980|NCT04053023|566495622|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
156927981|NCT03447990|566495632|FG000|Overall Study|Withdrawal by Subject|0|||
156927982|NCT03447990|566495633|FG001|Overall Study|Withdrawal by Subject|0|||
156927983|NCT03447990|566495634|FG002|Overall Study|Withdrawal by Subject|0|||
156927984|NCT03447990|566495635|FG003|Overall Study|Withdrawal by Subject|0|||
156927985|NCT03447990|566495636|FG004|Overall Study|Withdrawal by Subject|0|||
156927986|NCT03447990|566495637|FG005|Overall Study|Withdrawal by Subject|0|||
156927987|NCT03447990|566495638|FG006|Overall Study|Withdrawal by Subject|1|||
156927988|NCT00423150|566495639|FG000|Overall Study|Adverse Event|11|||
156927989|NCT00423150|566495639|FG000|Overall Study|Progression of disease being studied|69|||
156927990|NCT00423150|566495639|FG000|Overall Study|Withdrawal by Subject|1|||
156927991|NCT00423150|566495639|FG000|Overall Study|Non-compliance with protocol|1|||
156927992|NCT00423150|566495639|FG000|Overall Study|Administrative|4|||
156927993|NCT00455429|566495640|FG000|Overall Study|Study Terminated by Sponsor|0|||
156927994|NCT00455429|566495641|FG001|Overall Study|Study Terminated by Sponsor|0|||
156927995|NCT00455429|566495642|FG002|Overall Study|Study Terminated by Sponsor|0|||
156927996|NCT00455429|566495643|FG003|Overall Study|Study Terminated by Sponsor|3|||
156927997|NCT00455429|566495640|FG000|Overall Study|Lost to Follow-up|1|||
156927998|NCT00455429|566495641|FG001|Overall Study|Lost to Follow-up|0|||
156927999|NCT00455429|566495642|FG002|Overall Study|Lost to Follow-up|0|||
156928000|NCT00455429|566495643|FG003|Overall Study|Lost to Follow-up|3|||
156928001|NCT00455429|566495640|FG000|Overall Study|Withdrawal by Subject|0|||
156928002|NCT00455429|566495641|FG001|Overall Study|Withdrawal by Subject|1|||
156928003|NCT00455429|566495642|FG002|Overall Study|Withdrawal by Subject|1|||
156928004|NCT00455429|566495643|FG003|Overall Study|Withdrawal by Subject|0|||
156928005|NCT00455429|566495640|FG000|Overall Study|Lack of Efficacy|0|||
156928006|NCT00455429|566495641|FG001|Overall Study|Lack of Efficacy|1|||
156928007|NCT00455429|566495642|FG002|Overall Study|Lack of Efficacy|0|||
156928008|NCT00455429|566495643|FG003|Overall Study|Lack of Efficacy|1|||
156928009|NCT00455429|566495640|FG000|Overall Study|Adverse Event|0|||
156928010|NCT00455429|566495641|FG001|Overall Study|Adverse Event|1|||
156928011|NCT00455429|566495642|FG002|Overall Study|Adverse Event|0|||
156928012|NCT00455429|566495643|FG003|Overall Study|Adverse Event|3|||
156928013|NCT00455429|566495640|FG000|Overall Study|Randomly assigned but not treated|0|||
156928014|NCT00455429|566495641|FG001|Overall Study|Randomly assigned but not treated|0|||
156928015|NCT00455429|566495642|FG002|Overall Study|Randomly assigned but not treated|0|||
156928016|NCT00455429|566495643|FG003|Overall Study|Randomly assigned but not treated|2|||
156928017|NCT00455429|566495640|FG000|Overall Study|Personal Reason|1|||
156928018|NCT00455429|566495641|FG001|Overall Study|Personal Reason|0|||
157166340|NCT01293006|567350493|FG002|Period 2|Lost to Follow-up|0|||
157166341|NCT01293006|567350494|FG003|Period 2|Lost to Follow-up|0|||
157166342|NCT02254551|567350497|FG000|Dose Escalation|Physician Decision|1|||
157166343|NCT02254551|567350497|FG000|Dose Escalation|Dose-limiting toxicity|2|||
157166344|NCT04124692|567350498|FG000|Overall Study|Medical reason|0|||
157166345|NCT04124692|567350499|FG001|Overall Study|Medical reason|1|||
156928019|NCT00455429|566495642|FG002|Overall Study|Personal Reason|0|||
156928020|NCT00455429|566495643|FG003|Overall Study|Personal Reason|0|||
156928021|NCT00455429|566495640|FG000|Overall Study|Non-compliance|0|||
156928022|NCT00455429|566495641|FG001|Overall Study|Non-compliance|0|||
156928023|NCT00455429|566495642|FG002|Overall Study|Non-compliance|0|||
156928024|NCT00455429|566495643|FG003|Overall Study|Non-compliance|1|||
156928025|NCT00455429|566495640|FG000|Overall Study|Other|0|||
156928026|NCT00455429|566495641|FG001|Overall Study|Other|2|||
156928027|NCT00455429|566495642|FG002|Overall Study|Other|0|||
156928028|NCT00455429|566495643|FG003|Overall Study|Other|1|||
156928029|NCT03519347|566495644|FG000|Interventional Crossover Period 1|Death|0|||
156928030|NCT03519347|566495645|FG001|Interventional Crossover Period 1|Death|0|||
156928031|NCT03519347|566495646|FG002|Interventional Crossover Period 1|Death|0|||
157205208|NCT03669640|567496074|FG001|Overall Study|Study Terminated by Sponsor|0|||
156928032|NCT03519347|566495647|FG003|Interventional Crossover Period 1|Death|1|||
156928033|NCT01092182|566495648|FG000|Overall Study|Death|0|||
156928034|NCT01092182|566495649|FG001|Overall Study|Death|5|||
156928035|NCT01092182|566495650|FG002|Overall Study|Death|3|||
156928036|NCT01092182|566495648|FG000|Overall Study|participant safety|1|||
156928037|NCT01092182|566495649|FG001|Overall Study|participant safety|2|||
156928038|NCT01092182|566495650|FG002|Overall Study|participant safety|0|||
156928039|NCT01092182|566495648|FG000|Overall Study|Physician Decision|0|||
156928040|NCT01092182|566495649|FG001|Overall Study|Physician Decision|6|||
156928041|NCT01092182|566495650|FG002|Overall Study|Physician Decision|0|||
156928042|NCT01092182|566495648|FG000|Overall Study|Did not meet criteria|0|||
156928043|NCT01092182|566495649|FG001|Overall Study|Did not meet criteria|0|||
156928044|NCT01092182|566495650|FG002|Overall Study|Did not meet criteria|25|||
156928045|NCT01092182|566495648|FG000|Overall Study|Non-compliance|0|||
156928046|NCT01092182|566495649|FG001|Overall Study|Non-compliance|3|||
156928047|NCT01092182|566495650|FG002|Overall Study|Non-compliance|0|||
156928048|NCT01092182|566495648|FG000|Overall Study|Participant refused follow-up|0|||
156928049|NCT01092182|566495649|FG001|Overall Study|Participant refused follow-up|2|||
156928050|NCT01092182|566495650|FG002|Overall Study|Participant refused follow-up|0|||
156928051|NCT02515045|566495651|FG000|Overall Study|Adverse Event|0|||
156928052|NCT02515045|566495652|FG001|Overall Study|Adverse Event|3|||
156928053|NCT02515045|566495653|FG002|Overall Study|Adverse Event|3|||
157166346|NCT04124692|567350498|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
156928054|NCT02515045|566495651|FG000|Overall Study|Lost to Follow-up|0|||
156928055|NCT02515045|566495652|FG001|Overall Study|Lost to Follow-up|1|||
156928056|NCT02515045|566495653|FG002|Overall Study|Lost to Follow-up|1|||
156928057|NCT01412021|566495654|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
156928058|NCT01412021|566495654|FG000|Overall Study|Treatment Prior to Approval|3|||
157166347|NCT04124692|567350499|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
157166348|NCT04124692|567350498|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
157166349|NCT04124692|567350499|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
157166350|NCT04124692|567350498|FG000|Overall Study|Lost to Follow-up|2|||
157166351|NCT04124692|567350499|FG001|Overall Study|Lost to Follow-up|4|||
157166352|NCT04124692|567350498|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
157166353|NCT04124692|567350499|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
156928059|NCT01412021|566495654|FG000|Overall Study|Transferred to Other Hospital|9|||
156928060|NCT00238121|566495657|FG000|Overall Study|Withdrawal by Subject|1|||
156928061|NCT00238121|566495658|FG001|Overall Study|Withdrawal by Subject|1|||
156928062|NCT00238121|566495657|FG000|Overall Study|Adverse Event|2|||
156928063|NCT00238121|566495658|FG001|Overall Study|Adverse Event|1|||
156928064|NCT03255382|566495659|FG000|Overall Study|Adverse Event|3|||
156928065|NCT03255382|566495660|FG001|Overall Study|Adverse Event|0|||
156928066|NCT03255382|566495659|FG000|Overall Study|Lost to Follow-up|2|||
156928067|NCT03255382|566495660|FG001|Overall Study|Lost to Follow-up|0|||
156928068|NCT03255382|566495659|FG000|Overall Study|Withdrawal by Subject|2|||
156928069|NCT03255382|566495660|FG001|Overall Study|Withdrawal by Subject|0|||
156928070|NCT03255382|566495659|FG000|Overall Study|Other|6|||
156928071|NCT03255382|566495660|FG001|Overall Study|Other|0|||
156928072|NCT02221284|566495661|FG000|Overall Study|Case Report Forms Uncollected|56|||
156928073|NCT02221284|566495661|FG000|Overall Study|Protocol Deviation|5|||
156928074|NCT00484939|566495662|FG000|Overall Study|Death|9|||
156928075|NCT00484939|566495663|FG001|Overall Study|Death|13|||
156928076|NCT00484939|566495662|FG000|Overall Study|Adverse Event|22|||
156928077|NCT00484939|566495663|FG001|Overall Study|Adverse Event|12|||
156928078|NCT00484939|566495662|FG000|Overall Study|Patient Withdrew Consent|19|||
156928079|NCT00484939|566495663|FG001|Overall Study|Patient Withdrew Consent|10|||
156928080|NCT00484939|566495662|FG000|Overall Study|Protocol Violation|3|||
156928081|NCT00484939|566495663|FG001|Overall Study|Protocol Violation|3|||
156928082|NCT00484939|566495662|FG000|Overall Study|Lost to Follow-up|0|||
156928083|NCT00484939|566495663|FG001|Overall Study|Lost to Follow-up|3|||
156928084|NCT00484939|566495662|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
157227046|NCT00409578|567576033|FG002|Overall Study|Subject no longer requires study drug|0|||
157227047|NCT00409578|567576034|FG003|Overall Study|Subject no longer requires study drug|1|||
157227048|NCT00409578|567576031|FG000|Overall Study|Withdrawal by Subject|8|||
156928085|NCT00484939|566495663|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
156928086|NCT00484939|566495662|FG000|Overall Study|Disease progression|67|||
156928087|NCT00484939|566495663|FG001|Overall Study|Disease progression|88|||
156928088|NCT00484939|566495662|FG000|Overall Study|Screen Failure|2|||
156928089|NCT00484939|566495663|FG001|Overall Study|Screen Failure|2|||
156928090|NCT00484939|566495662|FG000|Overall Study|Reason Not Specified|11|||
157029211|NCT01928394|566862900|FG013|Treatment Period|Death|1|||
156928091|NCT00484939|566495663|FG001|Overall Study|Reason Not Specified|6|||
156928092|NCT02466555|566495664|FG000|Overall Study|Lost to Follow-up|2|||
156928093|NCT00529542|566495667|FG000|Overall Study|Withdrawal by Subject|1|||
156928094|NCT00529542|566495668|FG001|Overall Study|Withdrawal by Subject|0|||
156928095|NCT00529542|566495667|FG000|Overall Study|Lost to Follow-up|0|||
157029212|NCT01928394|566862901|FG014|Treatment Period|Death|2|||
157029213|NCT01928394|566862902|FG015|Treatment Period|Death|0|||
157029214|NCT01928394|566862903|FG016|Treatment Period|Death|0|||
157166354|NCT00205699|567350502|FG000|Overall Study|Lost to Follow-up|1|||
157166355|NCT00205699|567350503|FG001|Overall Study|Lost to Follow-up|3|||
157166356|NCT00205699|567350504|FG002|Overall Study|Lost to Follow-up|5|||
157166357|NCT00205699|567350502|FG000|Overall Study|Adverse Event|1|||
157166358|NCT00205699|567350503|FG001|Overall Study|Adverse Event|0|||
157166359|NCT00205699|567350504|FG002|Overall Study|Adverse Event|0|||
157166360|NCT00205699|567350502|FG000|Overall Study|Withdrawal by Subject|1|||
157166361|NCT00205699|567350503|FG001|Overall Study|Withdrawal by Subject|2|||
157166362|NCT00205699|567350504|FG002|Overall Study|Withdrawal by Subject|1|||
157166363|NCT00205699|567350502|FG000|Overall Study|Lack of Efficacy|0|||
157166364|NCT00205699|567350503|FG001|Overall Study|Lack of Efficacy|1|||
157166365|NCT00205699|567350504|FG002|Overall Study|Lack of Efficacy|0|||
157166366|NCT01885078|567350505|FG000|Treatment Period|Adverse Event|52|||
157166367|NCT01885078|567350506|FG001|Treatment Period|Adverse Event|136|||
157166368|NCT01885078|567350507|FG002|Treatment Period|Adverse Event|30|||
157166369|NCT01885078|567350508|FG003|Treatment Period|Adverse Event|73|||
157166370|NCT01885078|567350509|FG004|Treatment Period|Adverse Event|17|||
157166371|NCT01885078|567350510|FG005|Treatment Period|Adverse Event|72|||
157166372|NCT01885078|567350511|FG006|Treatment Period|Adverse Event|24|||
157166373|NCT01885078|567350512|FG007|Treatment Period|Adverse Event|5|||
157166374|NCT01885078|567350513|FG008|Treatment Period|Adverse Event|0|||
157166375|NCT01885078|567350514|FG009|Treatment Period|Adverse Event|0|||
157166376|NCT01885078|567350505|FG000|Treatment Period|Death|13|||
157166377|NCT01885078|567350506|FG001|Treatment Period|Death|33|||
157166378|NCT01885078|567350507|FG002|Treatment Period|Death|5|||
157166379|NCT01885078|567350508|FG003|Treatment Period|Death|9|||
157166380|NCT01885078|567350509|FG004|Treatment Period|Death|2|||
157166381|NCT01885078|567350510|FG005|Treatment Period|Death|10|||
157166382|NCT01885078|567350511|FG006|Treatment Period|Death|3|||
157166383|NCT01885078|567350512|FG007|Treatment Period|Death|2|||
157166384|NCT01885078|567350513|FG008|Treatment Period|Death|0|||
157166385|NCT01885078|567350514|FG009|Treatment Period|Death|0|||
157166386|NCT01885078|567350505|FG000|Treatment Period|Lack of Efficacy|12|||
157166387|NCT01885078|567350506|FG001|Treatment Period|Lack of Efficacy|33|||
157166388|NCT01885078|567350507|FG002|Treatment Period|Lack of Efficacy|10|||
157166389|NCT01885078|567350508|FG003|Treatment Period|Lack of Efficacy|23|||
157166390|NCT01885078|567350509|FG004|Treatment Period|Lack of Efficacy|24|||
157166391|NCT01885078|567350510|FG005|Treatment Period|Lack of Efficacy|58|||
157166392|NCT01885078|567350511|FG006|Treatment Period|Lack of Efficacy|9|||
157166393|NCT01885078|567350512|FG007|Treatment Period|Lack of Efficacy|5|||
157166394|NCT01885078|567350513|FG008|Treatment Period|Lack of Efficacy|0|||
157166395|NCT01885078|567350514|FG009|Treatment Period|Lack of Efficacy|0|||
157166396|NCT01885078|567350505|FG000|Treatment Period|Lost to Follow-up|16|||
157166397|NCT01885078|567350506|FG001|Treatment Period|Lost to Follow-up|19|||
157166398|NCT01885078|567350507|FG002|Treatment Period|Lost to Follow-up|7|||
157166399|NCT01885078|567350508|FG003|Treatment Period|Lost to Follow-up|9|||
157166400|NCT01885078|567350509|FG004|Treatment Period|Lost to Follow-up|2|||
157166401|NCT01885078|567350510|FG005|Treatment Period|Lost to Follow-up|8|||
157166402|NCT01885078|567350511|FG006|Treatment Period|Lost to Follow-up|2|||
157166403|NCT01885078|567350512|FG007|Treatment Period|Lost to Follow-up|0|||
157166404|NCT01885078|567350513|FG008|Treatment Period|Lost to Follow-up|0|||
157166405|NCT01885078|567350514|FG009|Treatment Period|Lost to Follow-up|0|||
157166406|NCT01885078|567350505|FG000|Treatment Period|Physician Decision|19|||
157166407|NCT01885078|567350506|FG001|Treatment Period|Physician Decision|21|||
156928096|NCT00529542|566495668|FG001|Overall Study|Lost to Follow-up|1|||
156928097|NCT03839212|566495675|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
156928098|NCT00679263|566495680|FG000|Visit 2/Dose 1|Adverse Event|1|||
156928099|NCT00679263|566495681|FG001|Visit 2/Dose 1|Adverse Event|0|||
156928100|NCT00679263|566495682|FG002|Visit 2/Dose 1|Adverse Event|0|||
156928101|NCT00679263|566495680|FG000|Visit 2/Dose 1|subject not compliance|1|||
157166408|NCT01885078|567350507|FG002|Treatment Period|Physician Decision|5|||
157166409|NCT01885078|567350508|FG003|Treatment Period|Physician Decision|12|||
157166410|NCT01885078|567350509|FG004|Treatment Period|Physician Decision|9|||
157166411|NCT01885078|567350510|FG005|Treatment Period|Physician Decision|24|||
157166412|NCT01885078|567350511|FG006|Treatment Period|Physician Decision|4|||
157166413|NCT01885078|567350512|FG007|Treatment Period|Physician Decision|3|||
156928102|NCT00679263|566495681|FG001|Visit 2/Dose 1|subject not compliance|1|||
157166414|NCT01885078|567350513|FG008|Treatment Period|Physician Decision|0|||
157166415|NCT01885078|567350514|FG009|Treatment Period|Physician Decision|0|||
157166416|NCT01885078|567350505|FG000|Treatment Period|Protocol Violation|3|||
157166417|NCT01885078|567350506|FG001|Treatment Period|Protocol Violation|5|||
157166418|NCT01885078|567350507|FG002|Treatment Period|Protocol Violation|0|||
156928103|NCT00679263|566495682|FG002|Visit 2/Dose 1|subject not compliance|0|||
157166419|NCT01885078|567350508|FG003|Treatment Period|Protocol Violation|3|||
157166420|NCT01885078|567350509|FG004|Treatment Period|Protocol Violation|1|||
157166421|NCT01885078|567350510|FG005|Treatment Period|Protocol Violation|6|||
157166422|NCT01885078|567350511|FG006|Treatment Period|Protocol Violation|0|||
157166423|NCT01885078|567350512|FG007|Treatment Period|Protocol Violation|0|||
157166424|NCT01885078|567350513|FG008|Treatment Period|Protocol Violation|0|||
157166425|NCT01885078|567350514|FG009|Treatment Period|Protocol Violation|0|||
157166426|NCT01885078|567350505|FG000|Treatment Period|Sponsor Decision|245|||
156928104|NCT05104567|566495684|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928105|NCT05104567|566495685|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
156928106|NCT05104567|566495686|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928107|NCT05104567|566495687|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928108|NCT05104567|566495688|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928109|NCT05104567|566495689|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928110|NCT05104567|566495690|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
156928111|NCT05104567|566495684|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
156928112|NCT05104567|566495685|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
156928113|NCT05104567|566495686|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
156928114|NCT05104567|566495687|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
156928115|NCT05104567|566495688|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
156928116|NCT05104567|566495689|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
156928117|NCT05104567|566495690|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
156928118|NCT05104567|566495684|FG000|Overall Study|Progressive disease|3|||
156928119|NCT05104567|566495685|FG001|Overall Study|Progressive disease|13|||
156928120|NCT05104567|566495686|FG002|Overall Study|Progressive disease|13|||
156928121|NCT05104567|566495687|FG003|Overall Study|Progressive disease|17|||
156928122|NCT05104567|566495688|FG004|Overall Study|Progressive disease|17|||
156928123|NCT05104567|566495689|FG005|Overall Study|Progressive disease|28|||
156928124|NCT05104567|566495690|FG006|Overall Study|Progressive disease|24|||
156928125|NCT05104567|566495684|FG000|Overall Study|Withdrawal by Subject|1|||
156928126|NCT05104567|566495685|FG001|Overall Study|Withdrawal by Subject|1|||
156928127|NCT05104567|566495686|FG002|Overall Study|Withdrawal by Subject|2|||
156928128|NCT05104567|566495687|FG003|Overall Study|Withdrawal by Subject|0|||
156928129|NCT05104567|566495688|FG004|Overall Study|Withdrawal by Subject|0|||
156928130|NCT05104567|566495689|FG005|Overall Study|Withdrawal by Subject|0|||
156928131|NCT05104567|566495690|FG006|Overall Study|Withdrawal by Subject|0|||
156928132|NCT05104567|566495684|FG000|Overall Study|Other|1|||
156928133|NCT05104567|566495685|FG001|Overall Study|Other|1|||
156928134|NCT05104567|566495686|FG002|Overall Study|Other|1|||
156928135|NCT05104567|566495687|FG003|Overall Study|Other|0|||
156928136|NCT05104567|566495688|FG004|Overall Study|Other|0|||
156928137|NCT05104567|566495689|FG005|Overall Study|Other|0|||
156928138|NCT05104567|566495690|FG006|Overall Study|Other|0|||
156928139|NCT01464346|566495694|FG000|Overall Study|Withdrawal by Subject|0|||
156928140|NCT01464346|566495695|FG001|Overall Study|Withdrawal by Subject|0|||
156928141|NCT01464346|566495696|FG002|Overall Study|Withdrawal by Subject|1|||
156928142|NCT00733746|566495697|FG000|Overall Study|Ineligible|5|||
156928143|NCT02295995|566495698|FG000|Overall Study|Lost to Follow-up|5|||
156928144|NCT02295995|566495699|FG001|Overall Study|Lost to Follow-up|1|||
156928145|NCT01173718|566495700|FG000|Overall Study|Death|17|||
156928146|NCT01173718|566495700|FG000|Overall Study|Abandonment of study graft|27|||
156928147|NCT02738151|566495701|FG000|Overall Study|Randomized but not treated|4|||
156928148|NCT02738151|566495702|FG001|Overall Study|Randomized but not treated|1|||
156928149|NCT02738151|566495701|FG000|Overall Study|Adverse Event|4|||
156928150|NCT02738151|566495702|FG001|Overall Study|Adverse Event|5|||
156928151|NCT02738151|566495701|FG000|Overall Study|Hypoglycemia|0|||
156928152|NCT02738151|566495702|FG001|Overall Study|Hypoglycemia|1|||
156928153|NCT02738151|566495701|FG000|Overall Study|Poor Compliance to Protocol|4|||
156928154|NCT02738151|566495702|FG001|Overall Study|Poor Compliance to Protocol|3|||
156928155|NCT02738151|566495701|FG000|Overall Study|Other than specified above|11|||
156928156|NCT02738151|566495702|FG001|Overall Study|Other than specified above|21|||
156928157|NCT02588833|566495703|FG000|Part 1|Withdrawal by Subject|1|||
156928158|NCT02588833|566495704|FG001|Part 1|Withdrawal by Subject|0|||
156928159|NCT02588833|566495703|FG000|Part 2A|Physician Decision|0|||
156928160|NCT02588833|566495704|FG001|Part 2A|Physician Decision|1|||
156928161|NCT02588833|566495703|FG000|Part 2A|Withdrawal by Subject|0|||
156928162|NCT02588833|566495704|FG001|Part 2A|Withdrawal by Subject|1|||
156928163|NCT02588833|566495703|FG000|Part 2B|Adverse Event|0|||
156928164|NCT02588833|566495704|FG001|Part 2B|Adverse Event|1|||
156928165|NCT02588833|566495703|FG000|Part 2C|Adverse Event|0|||
156928166|NCT02588833|566495704|FG001|Part 2C|Adverse Event|1|||
156928167|NCT02588833|566495703|FG000|Part 2C|Withdrawal by Subject|0|||
157029215|NCT01928394|566862904|FG017|Treatment Period|Death|0|||
157029216|NCT01928394|566862905|FG018|Treatment Period|Death|0|||
157029217|NCT01928394|566862906|FG019|Treatment Period|Death|0|||
157029218|NCT01928394|566862907|FG020|Treatment Period|Death|0|||
157166427|NCT01885078|567350506|FG001|Treatment Period|Sponsor Decision|648|||
156928168|NCT02588833|566495704|FG001|Part 2C|Withdrawal by Subject|1|||
156928169|NCT02588833|566495703|FG000|Part 3 (Safety Follow-up)|Other|0|||
156928170|NCT02588833|566495704|FG001|Part 3 (Safety Follow-up)|Other|2|||
157029219|NCT01928394|566862908|FG021|Treatment Period|Death|0|||
157029220|NCT01928394|566862909|FG022|Treatment Period|Death|0|||
157166428|NCT01885078|567350507|FG002|Treatment Period|Sponsor Decision|49|||
157166429|NCT01885078|567350508|FG003|Treatment Period|Sponsor Decision|90|||
157166430|NCT01885078|567350509|FG004|Treatment Period|Sponsor Decision|20|||
157166431|NCT01885078|567350510|FG005|Treatment Period|Sponsor Decision|38|||
157166432|NCT01885078|567350511|FG006|Treatment Period|Sponsor Decision|162|||
157166433|NCT01885078|567350512|FG007|Treatment Period|Sponsor Decision|3|||
157166434|NCT01885078|567350513|FG008|Treatment Period|Sponsor Decision|0|||
157166435|NCT01885078|567350514|FG009|Treatment Period|Sponsor Decision|0|||
157166436|NCT01885078|567350505|FG000|Treatment Period|Withdrawal by Subject|72|||
157166437|NCT01885078|567350506|FG001|Treatment Period|Withdrawal by Subject|132|||
157166438|NCT01885078|567350507|FG002|Treatment Period|Withdrawal by Subject|25|||
157166439|NCT01885078|567350508|FG003|Treatment Period|Withdrawal by Subject|63|||
157166440|NCT01885078|567350509|FG004|Treatment Period|Withdrawal by Subject|15|||
157166441|NCT01885078|567350510|FG005|Treatment Period|Withdrawal by Subject|34|||
157166442|NCT01885078|567350511|FG006|Treatment Period|Withdrawal by Subject|17|||
156928171|NCT02005250|566495705|FG000|Overall Study|Lost to Follow-up|15|||
157166443|NCT01885078|567350512|FG007|Treatment Period|Withdrawal by Subject|10|||
157166444|NCT01885078|567350513|FG008|Treatment Period|Withdrawal by Subject|0|||
157166445|NCT01885078|567350514|FG009|Treatment Period|Withdrawal by Subject|0|||
157166446|NCT01885078|567350505|FG000|Treatment Period|Other|0|||
157166447|NCT01885078|567350506|FG001|Treatment Period|Other|0|||
157166448|NCT01885078|567350507|FG002|Treatment Period|Other|0|||
157166449|NCT01885078|567350508|FG003|Treatment Period|Other|1|||
157166450|NCT01885078|567350509|FG004|Treatment Period|Other|0|||
156928172|NCT02005250|566495706|FG001|Overall Study|Lost to Follow-up|5|||
156928173|NCT03649711|566495712|FG000|Overall Study|Adverse Event|0|||
156928174|NCT03649711|566495713|FG001|Overall Study|Adverse Event|1|||
157166451|NCT01885078|567350510|FG005|Treatment Period|Other|0|||
157166452|NCT01885078|567350511|FG006|Treatment Period|Other|0|||
157166453|NCT01885078|567350512|FG007|Treatment Period|Other|0|||
157166454|NCT01885078|567350513|FG008|Treatment Period|Other|0|||
157166455|NCT01885078|567350514|FG009|Treatment Period|Other|0|||
157166456|NCT01885078|567350505|FG000|Step-down Period|Sponsor Decision|0|||
157166457|NCT01885078|567350506|FG001|Step-down Period|Sponsor Decision|0|||
157166458|NCT01885078|567350507|FG002|Step-down Period|Sponsor Decision|0|||
157166459|NCT01885078|567350508|FG003|Step-down Period|Sponsor Decision|0|||
157166460|NCT01885078|567350509|FG004|Step-down Period|Sponsor Decision|0|||
157166461|NCT01885078|567350510|FG005|Step-down Period|Sponsor Decision|0|||
157166462|NCT01885078|567350511|FG006|Step-down Period|Sponsor Decision|0|||
157166463|NCT01885078|567350512|FG007|Step-down Period|Sponsor Decision|0|||
157166464|NCT01885078|567350513|FG008|Step-down Period|Sponsor Decision|1|||
157166465|NCT01885078|567350514|FG009|Step-down Period|Sponsor Decision|1|||
157166466|NCT01885078|567350505|FG000|Step-down Period|Adverse Event|0|||
157166467|NCT01885078|567350506|FG001|Step-down Period|Adverse Event|0|||
157166468|NCT01885078|567350507|FG002|Step-down Period|Adverse Event|0|||
157166469|NCT01885078|567350508|FG003|Step-down Period|Adverse Event|0|||
156928175|NCT03649711|566495714|FG002|Overall Study|Adverse Event|0|||
156928176|NCT03649711|566495712|FG000|Overall Study|Kidney Transplant|1|||
156928177|NCT03649711|566495713|FG001|Overall Study|Kidney Transplant|0|||
156928178|NCT03649711|566495714|FG002|Overall Study|Kidney Transplant|0|||
156928179|NCT04007094|566495719|FG000|Overall Study|Lost to Follow-up|1|||
156928180|NCT04007094|566495720|FG001|Overall Study|Lost to Follow-up|1|||
156928181|NCT04350788|566495733|FG000|Overall Study|Lost to Follow-up|6|||
156928182|NCT04350788|566495734|FG001|Overall Study|Lost to Follow-up|2|||
156928183|NCT04350788|566495733|FG000|Overall Study|Withdrawal by Subject|2|||
156928184|NCT04350788|566495734|FG001|Overall Study|Withdrawal by Subject|4|||
156928185|NCT04350788|566495733|FG000|Overall Study|Protocol Violation|4|||
156928186|NCT04350788|566495734|FG001|Overall Study|Protocol Violation|0|||
156928187|NCT01581307|566495735|FG000|Overall Study|Withdrawal by Subject|1|||
156928188|NCT00378209|566495738|FG000|Overall Study|Progressive disease|11|||
156928189|NCT00378209|566495738|FG000|Overall Study|Adverse Event|3|||
156928190|NCT00378209|566495738|FG000|Overall Study|Initiation of non-protocol therapy|3|||
156928191|NCT00378209|566495738|FG000|Overall Study|Physician Decision|3|||
156928192|NCT00378209|566495738|FG000|Overall Study|Death|1|||
156928193|NCT00378209|566495738|FG000|Overall Study|Treatment delay|1|||
156928194|NCT04709575|566497537|FG000|Overall Study|Withdrawal by Subject|6|||
156928195|NCT04709575|566497538|FG001|Overall Study|Withdrawal by Subject|2|||
156928196|NCT04709575|566497537|FG000|Overall Study|Lost to Follow-up|2|||
156928197|NCT04709575|566497538|FG001|Overall Study|Lost to Follow-up|2|||
157166470|NCT01885078|567350509|FG004|Step-down Period|Adverse Event|0|||
157166471|NCT01885078|567350510|FG005|Step-down Period|Adverse Event|0|||
157166472|NCT01885078|567350511|FG006|Step-down Period|Adverse Event|0|||
157166473|NCT01885078|567350512|FG007|Step-down Period|Adverse Event|0|||
156928198|NCT04709575|566497537|FG000|Overall Study|Adverse Event|1|||
156928199|NCT04709575|566497538|FG001|Overall Study|Adverse Event|0|||
156928200|NCT04709575|566497537|FG000|Overall Study|Protocol Violation|1|||
157166474|NCT01885078|567350513|FG008|Step-down Period|Adverse Event|29|||
157166475|NCT01885078|567350514|FG009|Step-down Period|Adverse Event|38|||
157166476|NCT01885078|567350505|FG000|Step-down Period|Withdrawal by Subject|0|||
157166477|NCT01885078|567350506|FG001|Step-down Period|Withdrawal by Subject|0|||
156928201|NCT04709575|566497538|FG001|Overall Study|Protocol Violation|1|||
156928202|NCT02926924|566497539|FG000|Overall Study|withdrawal - reason unknown|0|||
156928203|NCT02926924|566497540|FG001|Overall Study|withdrawal - reason unknown|1|||
156928204|NCT04762680|566497545|FG000|Phase 2|Adverse Event|0|||
156928205|NCT04762680|566497546|FG001|Phase 2|Adverse Event|1|||
156928206|NCT04762680|566497547|FG002|Phase 2|Adverse Event|0|||
156928207|NCT04762680|566497548|FG003|Phase 2|Adverse Event|0|||
156928208|NCT04762680|566497549|FG004|Phase 2|Adverse Event|0|||
156928209|NCT04762680|566497550|FG005|Phase 2|Adverse Event|0|||
156928210|NCT04762680|566497551|FG006|Phase 2|Adverse Event|0|||
156928211|NCT04762680|566497552|FG007|Phase 2|Adverse Event|0|||
156928212|NCT04762680|566497553|FG008|Phase 2|Adverse Event|0|||
156928213|NCT04762680|566497554|FG009|Phase 2|Adverse Event|0|||
156928214|NCT04762680|566497555|FG010|Phase 2|Adverse Event|0|||
156928215|NCT04762680|566497556|FG011|Phase 2|Adverse Event|0|||
156928216|NCT04762680|566497557|FG012|Phase 2|Adverse Event|0|||
156928217|NCT04762680|566497558|FG013|Phase 2|Adverse Event|0|||
156928218|NCT04762680|566497559|FG014|Phase 2|Adverse Event|0|||
156928219|NCT04762680|566497560|FG015|Phase 2|Adverse Event|0|||
156928220|NCT04762680|566497561|FG016|Phase 2|Adverse Event|0|||
156928221|NCT04762680|566497562|FG017|Phase 2|Adverse Event|0|||
156928222|NCT04762680|566497563|FG018|Phase 2|Adverse Event|0|||
156928223|NCT04762680|566497564|FG019|Phase 2|Adverse Event|0|||
156928224|NCT04762680|566497565|FG020|Phase 2|Adverse Event|0|||
156928225|NCT04762680|566497566|FG021|Phase 2|Adverse Event|0|||
156928226|NCT04762680|566497545|FG000|Phase 2|Protocol Violation|5|||
156928227|NCT04762680|566497546|FG001|Phase 2|Protocol Violation|5|||
156928228|NCT04762680|566497547|FG002|Phase 2|Protocol Violation|1|||
156928229|NCT04762680|566497548|FG003|Phase 2|Protocol Violation|0|||
156928230|NCT04762680|566497549|FG004|Phase 2|Protocol Violation|0|||
156928231|NCT04762680|566497550|FG005|Phase 2|Protocol Violation|0|||
156928232|NCT04762680|566497551|FG006|Phase 2|Protocol Violation|0|||
156928233|NCT04762680|566497552|FG007|Phase 2|Protocol Violation|0|||
156928234|NCT04762680|566497553|FG008|Phase 2|Protocol Violation|0|||
156928235|NCT04762680|566497554|FG009|Phase 2|Protocol Violation|0|||
156928236|NCT04762680|566497555|FG010|Phase 2|Protocol Violation|0|||
156928237|NCT04762680|566497556|FG011|Phase 2|Protocol Violation|0|||
156928238|NCT04762680|566497557|FG012|Phase 2|Protocol Violation|0|||
156928239|NCT04762680|566497558|FG013|Phase 2|Protocol Violation|0|||
156928240|NCT04762680|566497559|FG014|Phase 2|Protocol Violation|0|||
156928241|NCT04762680|566497560|FG015|Phase 2|Protocol Violation|0|||
156928242|NCT04762680|566497561|FG016|Phase 2|Protocol Violation|0|||
156928243|NCT04762680|566497562|FG017|Phase 2|Protocol Violation|0|||
156928244|NCT04762680|566497563|FG018|Phase 2|Protocol Violation|0|||
156928245|NCT04762680|566497564|FG019|Phase 2|Protocol Violation|0|||
156928246|NCT04762680|566497565|FG020|Phase 2|Protocol Violation|0|||
156928247|NCT04762680|566497566|FG021|Phase 2|Protocol Violation|0|||
156928248|NCT04762680|566497545|FG000|Phase 2|Withdrawal by Subject|23|||
157166478|NCT01885078|567350507|FG002|Step-down Period|Withdrawal by Subject|0|||
157166479|NCT01885078|567350508|FG003|Step-down Period|Withdrawal by Subject|0|||
157166480|NCT01885078|567350509|FG004|Step-down Period|Withdrawal by Subject|0|||
157166481|NCT01885078|567350510|FG005|Step-down Period|Withdrawal by Subject|0|||
157166482|NCT01885078|567350511|FG006|Step-down Period|Withdrawal by Subject|0|||
157166483|NCT01885078|567350512|FG007|Step-down Period|Withdrawal by Subject|0|||
157166484|NCT01885078|567350513|FG008|Step-down Period|Withdrawal by Subject|25|||
157166485|NCT01885078|567350514|FG009|Step-down Period|Withdrawal by Subject|15|||
157166486|NCT01885078|567350505|FG000|Step-down Period|Physician Decision|0|||
157166487|NCT01885078|567350506|FG001|Step-down Period|Physician Decision|0|||
157166488|NCT01885078|567350507|FG002|Step-down Period|Physician Decision|0|||
157166489|NCT01885078|567350508|FG003|Step-down Period|Physician Decision|0|||
157166490|NCT01885078|567350509|FG004|Step-down Period|Physician Decision|0|||
156928249|NCT04762680|566497546|FG001|Phase 2|Withdrawal by Subject|21|||
156928250|NCT04762680|566497547|FG002|Phase 2|Withdrawal by Subject|28|||
156928251|NCT04762680|566497548|FG003|Phase 2|Withdrawal by Subject|0|||
156928252|NCT04762680|566497549|FG004|Phase 2|Withdrawal by Subject|0|||
156928253|NCT04762680|566497550|FG005|Phase 2|Withdrawal by Subject|0|||
156928254|NCT04762680|566497551|FG006|Phase 2|Withdrawal by Subject|0|||
156928255|NCT04762680|566497552|FG007|Phase 2|Withdrawal by Subject|0|||
156928256|NCT04762680|566497553|FG008|Phase 2|Withdrawal by Subject|0|||
156928257|NCT04762680|566497554|FG009|Phase 2|Withdrawal by Subject|0|||
156928258|NCT04762680|566497555|FG010|Phase 2|Withdrawal by Subject|0|||
156928259|NCT04762680|566497556|FG011|Phase 2|Withdrawal by Subject|0|||
156928260|NCT04762680|566497557|FG012|Phase 2|Withdrawal by Subject|0|||
157029221|NCT01928394|566862887|FG000|Follow-up Period|Participant withdrew consent|3|||
157029222|NCT01928394|566862888|FG001|Follow-up Period|Participant withdrew consent|0|||
157166491|NCT01885078|567350510|FG005|Step-down Period|Physician Decision|0|||
156928261|NCT04762680|566497558|FG013|Phase 2|Withdrawal by Subject|0|||
156928262|NCT04762680|566497559|FG014|Phase 2|Withdrawal by Subject|0|||
156928263|NCT04762680|566497560|FG015|Phase 2|Withdrawal by Subject|0|||
156928264|NCT04762680|566497561|FG016|Phase 2|Withdrawal by Subject|0|||
156928265|NCT04762680|566497562|FG017|Phase 2|Withdrawal by Subject|0|||
156928266|NCT04762680|566497563|FG018|Phase 2|Withdrawal by Subject|0|||
156928267|NCT04762680|566497564|FG019|Phase 2|Withdrawal by Subject|0|||
156928268|NCT04762680|566497565|FG020|Phase 2|Withdrawal by Subject|0|||
156928269|NCT04762680|566497566|FG021|Phase 2|Withdrawal by Subject|0|||
156928270|NCT04762680|566497545|FG000|Phase 2|Lost to Follow-up|14|||
156928271|NCT04762680|566497546|FG001|Phase 2|Lost to Follow-up|8|||
156928272|NCT04762680|566497547|FG002|Phase 2|Lost to Follow-up|9|||
156928273|NCT04762680|566497548|FG003|Phase 2|Lost to Follow-up|0|||
156928274|NCT04762680|566497549|FG004|Phase 2|Lost to Follow-up|0|||
157166492|NCT01885078|567350511|FG006|Step-down Period|Physician Decision|0|||
157166493|NCT01885078|567350512|FG007|Step-down Period|Physician Decision|0|||
157166494|NCT01885078|567350513|FG008|Step-down Period|Physician Decision|7|||
157166495|NCT01885078|567350514|FG009|Step-down Period|Physician Decision|2|||
157166496|NCT01885078|567350505|FG000|Step-down Period|Death|0|||
157166497|NCT01885078|567350506|FG001|Step-down Period|Death|0|||
157166498|NCT01885078|567350507|FG002|Step-down Period|Death|0|||
157166499|NCT01885078|567350508|FG003|Step-down Period|Death|0|||
157166500|NCT01885078|567350509|FG004|Step-down Period|Death|0|||
157166501|NCT01885078|567350510|FG005|Step-down Period|Death|0|||
157166502|NCT01885078|567350511|FG006|Step-down Period|Death|0|||
157166503|NCT01885078|567350512|FG007|Step-down Period|Death|0|||
157166504|NCT01885078|567350513|FG008|Step-down Period|Death|4|||
157166505|NCT01885078|567350514|FG009|Step-down Period|Death|3|||
157166506|NCT01885078|567350505|FG000|Step-down Period|Lost to Follow-up|0|||
157166507|NCT01885078|567350506|FG001|Step-down Period|Lost to Follow-up|0|||
157166508|NCT01885078|567350507|FG002|Step-down Period|Lost to Follow-up|0|||
157166509|NCT01885078|567350508|FG003|Step-down Period|Lost to Follow-up|0|||
157166510|NCT01885078|567350509|FG004|Step-down Period|Lost to Follow-up|0|||
157166511|NCT01885078|567350510|FG005|Step-down Period|Lost to Follow-up|0|||
157166512|NCT01885078|567350511|FG006|Step-down Period|Lost to Follow-up|0|||
157166513|NCT01885078|567350512|FG007|Step-down Period|Lost to Follow-up|0|||
157166514|NCT01885078|567350513|FG008|Step-down Period|Lost to Follow-up|1|||
157166515|NCT01885078|567350514|FG009|Step-down Period|Lost to Follow-up|1|||
157166516|NCT01885078|567350505|FG000|Step-down Period|Lack of Efficacy|0|||
157166517|NCT01885078|567350506|FG001|Step-down Period|Lack of Efficacy|0|||
157166518|NCT01885078|567350507|FG002|Step-down Period|Lack of Efficacy|0|||
157166519|NCT01885078|567350508|FG003|Step-down Period|Lack of Efficacy|0|||
157166520|NCT01885078|567350509|FG004|Step-down Period|Lack of Efficacy|0|||
157166521|NCT01885078|567350510|FG005|Step-down Period|Lack of Efficacy|0|||
157166522|NCT01885078|567350511|FG006|Step-down Period|Lack of Efficacy|0|||
157166523|NCT01885078|567350512|FG007|Step-down Period|Lack of Efficacy|0|||
157166524|NCT01885078|567350513|FG008|Step-down Period|Lack of Efficacy|1|||
157166525|NCT01885078|567350514|FG009|Step-down Period|Lack of Efficacy|0|||
157166526|NCT01885078|567350505|FG000|Step-down Period|Protocol Violation|0|||
157166527|NCT01885078|567350506|FG001|Step-down Period|Protocol Violation|0|||
156928275|NCT04762680|566497550|FG005|Phase 2|Lost to Follow-up|0|||
156928276|NCT04762680|566497551|FG006|Phase 2|Lost to Follow-up|0|||
156928277|NCT04762680|566497552|FG007|Phase 2|Lost to Follow-up|0|||
156928278|NCT04762680|566497553|FG008|Phase 2|Lost to Follow-up|0|||
156928279|NCT04762680|566497554|FG009|Phase 2|Lost to Follow-up|0|||
156928280|NCT04762680|566497555|FG010|Phase 2|Lost to Follow-up|0|||
156928281|NCT04762680|566497556|FG011|Phase 2|Lost to Follow-up|0|||
156928282|NCT04762680|566497557|FG012|Phase 2|Lost to Follow-up|0|||
156928283|NCT04762680|566497558|FG013|Phase 2|Lost to Follow-up|0|||
156928284|NCT04762680|566497559|FG014|Phase 2|Lost to Follow-up|0|||
156928285|NCT04762680|566497560|FG015|Phase 2|Lost to Follow-up|0|||
156928286|NCT04762680|566497561|FG016|Phase 2|Lost to Follow-up|0|||
156928287|NCT04762680|566497562|FG017|Phase 2|Lost to Follow-up|0|||
156928288|NCT04762680|566497563|FG018|Phase 2|Lost to Follow-up|0|||
156928289|NCT04762680|566497564|FG019|Phase 2|Lost to Follow-up|0|||
156928290|NCT04762680|566497565|FG020|Phase 2|Lost to Follow-up|0|||
156928291|NCT04762680|566497566|FG021|Phase 2|Lost to Follow-up|0|||
157166528|NCT01885078|567350507|FG002|Step-down Period|Protocol Violation|0|||
157166529|NCT01885078|567350508|FG003|Step-down Period|Protocol Violation|0|||
156928292|NCT04762680|566497545|FG000|Phase 3|Adverse Event|0|||
156928293|NCT04762680|566497546|FG001|Phase 3|Adverse Event|0|||
157166530|NCT01885078|567350509|FG004|Step-down Period|Protocol Violation|0|||
157166531|NCT01885078|567350510|FG005|Step-down Period|Protocol Violation|0|||
156928294|NCT04762680|566497547|FG002|Phase 3|Adverse Event|0|||
157166532|NCT01885078|567350511|FG006|Step-down Period|Protocol Violation|0|||
157166533|NCT01885078|567350512|FG007|Step-down Period|Protocol Violation|0|||
157166534|NCT01885078|567350513|FG008|Step-down Period|Protocol Violation|1|||
156928295|NCT04762680|566497548|FG003|Phase 3|Adverse Event|1|||
156928296|NCT04762680|566497549|FG004|Phase 3|Adverse Event|0|||
156928297|NCT04762680|566497550|FG005|Phase 3|Adverse Event|0|||
156928298|NCT04762680|566497551|FG006|Phase 3|Adverse Event|0|||
156928299|NCT04762680|566497552|FG007|Phase 3|Adverse Event|0|||
156928300|NCT04762680|566497553|FG008|Phase 3|Adverse Event|0|||
156928301|NCT04762680|566497554|FG009|Phase 3|Adverse Event|0|||
157166535|NCT01885078|567350514|FG009|Step-down Period|Protocol Violation|1|||
157166536|NCT00571688|567350518|FG000|Overall Study|Lost to Follow-up|3|||
157166537|NCT00571688|567350519|FG001|Overall Study|Lost to Follow-up|6|||
156928302|NCT04762680|566497555|FG010|Phase 3|Adverse Event|0|||
156928303|NCT04762680|566497556|FG011|Phase 3|Adverse Event|0|||
156928304|NCT04762680|566497557|FG012|Phase 3|Adverse Event|0|||
156928305|NCT04762680|566497558|FG013|Phase 3|Adverse Event|0|||
156928306|NCT04762680|566497559|FG014|Phase 3|Adverse Event|0|||
156928307|NCT04762680|566497560|FG015|Phase 3|Adverse Event|0|||
156928308|NCT04762680|566497561|FG016|Phase 3|Adverse Event|0|||
156928309|NCT04762680|566497562|FG017|Phase 3|Adverse Event|3|||
156928310|NCT04762680|566497563|FG018|Phase 3|Adverse Event|0|||
156928311|NCT04762680|566497564|FG019|Phase 3|Adverse Event|0|||
156928312|NCT04762680|566497565|FG020|Phase 3|Adverse Event|0|||
156928313|NCT04762680|566497566|FG021|Phase 3|Adverse Event|0|||
156928314|NCT04762680|566497545|FG000|Phase 3|Protocol Violation|0|||
156928315|NCT04762680|566497546|FG001|Phase 3|Protocol Violation|0|||
156928316|NCT04762680|566497547|FG002|Phase 3|Protocol Violation|0|||
156928317|NCT04762680|566497548|FG003|Phase 3|Protocol Violation|4|||
156928318|NCT04762680|566497549|FG004|Phase 3|Protocol Violation|1|||
156928319|NCT04762680|566497550|FG005|Phase 3|Protocol Violation|5|||
156928320|NCT04762680|566497551|FG006|Phase 3|Protocol Violation|1|||
156928321|NCT04762680|566497552|FG007|Phase 3|Protocol Violation|0|||
156928322|NCT04762680|566497553|FG008|Phase 3|Protocol Violation|0|||
156928323|NCT04762680|566497554|FG009|Phase 3|Protocol Violation|0|||
156928324|NCT04762680|566497555|FG010|Phase 3|Protocol Violation|0|||
156928325|NCT04762680|566497556|FG011|Phase 3|Protocol Violation|2|||
156928326|NCT04762680|566497557|FG012|Phase 3|Protocol Violation|3|||
156928327|NCT04762680|566497558|FG013|Phase 3|Protocol Violation|0|||
156928328|NCT04762680|566497559|FG014|Phase 3|Protocol Violation|0|||
156928329|NCT04762680|566497560|FG015|Phase 3|Protocol Violation|1|||
156928330|NCT04762680|566497561|FG016|Phase 3|Protocol Violation|0|||
156928331|NCT04762680|566497562|FG017|Phase 3|Protocol Violation|10|||
156928332|NCT04762680|566497563|FG018|Phase 3|Protocol Violation|0|||
156928333|NCT04762680|566497564|FG019|Phase 3|Protocol Violation|0|||
156928334|NCT04762680|566497565|FG020|Phase 3|Protocol Violation|0|||
156928335|NCT04762680|566497566|FG021|Phase 3|Protocol Violation|0|||
156928336|NCT04762680|566497545|FG000|Phase 3|Withdrawal by Subject|0|||
156928337|NCT04762680|566497546|FG001|Phase 3|Withdrawal by Subject|0|||
156928338|NCT04762680|566497547|FG002|Phase 3|Withdrawal by Subject|0|||
156928339|NCT04762680|566497548|FG003|Phase 3|Withdrawal by Subject|13|||
156928340|NCT04762680|566497549|FG004|Phase 3|Withdrawal by Subject|17|||
156928341|NCT04762680|566497550|FG005|Phase 3|Withdrawal by Subject|12|||
156928342|NCT04762680|566497551|FG006|Phase 3|Withdrawal by Subject|8|||
156928343|NCT04762680|566497552|FG007|Phase 3|Withdrawal by Subject|3|||
156928344|NCT04762680|566497553|FG008|Phase 3|Withdrawal by Subject|2|||
156928345|NCT04762680|566497554|FG009|Phase 3|Withdrawal by Subject|4|||
156928346|NCT04762680|566497555|FG010|Phase 3|Withdrawal by Subject|3|||
156928347|NCT04762680|566497556|FG011|Phase 3|Withdrawal by Subject|1|||
156928348|NCT04762680|566497557|FG012|Phase 3|Withdrawal by Subject|3|||
156928349|NCT04762680|566497558|FG013|Phase 3|Withdrawal by Subject|2|||
156928350|NCT04762680|566497559|FG014|Phase 3|Withdrawal by Subject|1|||
156928351|NCT04762680|566497560|FG015|Phase 3|Withdrawal by Subject|4|||
156928352|NCT04762680|566497561|FG016|Phase 3|Withdrawal by Subject|6|||
156928353|NCT04762680|566497562|FG017|Phase 3|Withdrawal by Subject|32|||
156928354|NCT04762680|566497563|FG018|Phase 3|Withdrawal by Subject|0|||
156928355|NCT04762680|566497564|FG019|Phase 3|Withdrawal by Subject|0|||
156928356|NCT04762680|566497565|FG020|Phase 3|Withdrawal by Subject|0|||
156928357|NCT04762680|566497566|FG021|Phase 3|Withdrawal by Subject|0|||
156928358|NCT04762680|566497545|FG000|Phase 3|Lost to Follow-up|0|||
156928359|NCT04762680|566497546|FG001|Phase 3|Lost to Follow-up|0|||
156928360|NCT04762680|566497547|FG002|Phase 3|Lost to Follow-up|0|||
156928361|NCT04762680|566497548|FG003|Phase 3|Lost to Follow-up|9|||
157166538|NCT00571688|567350518|FG000|Overall Study|subject did not tolerate Consta|1|||
157166539|NCT00571688|567350519|FG001|Overall Study|subject did not tolerate Consta|0|||
157166540|NCT00571688|567350518|FG000|Overall Study|subject moved out of the area|1|||
157166541|NCT00571688|567350519|FG001|Overall Study|subject moved out of the area|0|||
157166542|NCT01194869|567350520|FG000|Overall Study|Disease Progression|2|||
157166543|NCT01194869|567350520|FG000|Overall Study|Toxicity|2|||
157166544|NCT01048853|567350521|FG000|Overall Study|Death|1|||
156928362|NCT04762680|566497549|FG004|Phase 3|Lost to Follow-up|22|||
156928363|NCT04762680|566497550|FG005|Phase 3|Lost to Follow-up|24|||
156928364|NCT04762680|566497551|FG006|Phase 3|Lost to Follow-up|2|||
156928365|NCT04762680|566497552|FG007|Phase 3|Lost to Follow-up|4|||
156928366|NCT04762680|566497553|FG008|Phase 3|Lost to Follow-up|6|||
156928367|NCT04762680|566497554|FG009|Phase 3|Lost to Follow-up|4|||
156928368|NCT04762680|566497555|FG010|Phase 3|Lost to Follow-up|3|||
156928369|NCT04762680|566497556|FG011|Phase 3|Lost to Follow-up|0|||
157166545|NCT01048853|567350522|FG001|Overall Study|Death|0|||
156928370|NCT04762680|566497557|FG012|Phase 3|Lost to Follow-up|5|||
156928371|NCT04762680|566497558|FG013|Phase 3|Lost to Follow-up|4|||
156928372|NCT04762680|566497559|FG014|Phase 3|Lost to Follow-up|6|||
156928373|NCT04762680|566497560|FG015|Phase 3|Lost to Follow-up|1|||
156928374|NCT04762680|566497561|FG016|Phase 3|Lost to Follow-up|1|||
156928375|NCT04762680|566497562|FG017|Phase 3|Lost to Follow-up|66|||
157166546|NCT01048853|567350523|FG002|Overall Study|Death|0|||
156928376|NCT04762680|566497563|FG018|Phase 3|Lost to Follow-up|0|||
156928377|NCT04762680|566497564|FG019|Phase 3|Lost to Follow-up|0|||
156928378|NCT04762680|566497565|FG020|Phase 3|Lost to Follow-up|0|||
156928379|NCT04762680|566497566|FG021|Phase 3|Lost to Follow-up|0|||
156928380|NCT04762680|566497545|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928381|NCT04762680|566497546|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928382|NCT04762680|566497547|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928383|NCT04762680|566497548|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928384|NCT04762680|566497549|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928385|NCT04762680|566497550|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928386|NCT04762680|566497551|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928387|NCT04762680|566497552|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928388|NCT04762680|566497553|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928389|NCT04762680|566497554|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928390|NCT04762680|566497555|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928391|NCT04762680|566497556|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928392|NCT04762680|566497557|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928393|NCT04762680|566497558|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928394|NCT04762680|566497559|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928395|NCT04762680|566497560|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928396|NCT04762680|566497561|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928397|NCT04762680|566497562|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928398|NCT04762680|566497563|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928399|NCT04762680|566497564|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928400|NCT04762680|566497565|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
156928401|NCT04762680|566497566|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
156928402|NCT04762680|566497545|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928403|NCT04762680|566497546|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928404|NCT04762680|566497547|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928405|NCT04762680|566497548|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928406|NCT04762680|566497549|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928407|NCT04762680|566497550|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928408|NCT04762680|566497551|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928409|NCT04762680|566497552|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928410|NCT04762680|566497553|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928411|NCT04762680|566497554|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928412|NCT04762680|566497555|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928413|NCT04762680|566497556|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928414|NCT04762680|566497557|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928415|NCT04762680|566497558|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928416|NCT04762680|566497559|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928417|NCT04762680|566497560|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928418|NCT04762680|566497561|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928419|NCT04762680|566497562|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928420|NCT04762680|566497563|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928421|NCT04762680|566497564|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
156928422|NCT04762680|566497565|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928423|NCT04762680|566497566|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
156928424|NCT02082210|566497567|FG000|Overall Study|Death|0|||
156928425|NCT02082210|566497568|FG001|Overall Study|Death|0|||
156928426|NCT02082210|566497569|FG002|Overall Study|Death|1|||
156928427|NCT02082210|566497570|FG003|Overall Study|Death|1|||
156928428|NCT02082210|566497571|FG004|Overall Study|Death|1|||
156928429|NCT02082210|566497572|FG005|Overall Study|Death|0|||
156928430|NCT02082210|566497567|FG000|Overall Study|Withdrawal by Subject|0|||
156928431|NCT02082210|566497568|FG001|Overall Study|Withdrawal by Subject|0|||
156928432|NCT02082210|566497569|FG002|Overall Study|Withdrawal by Subject|0|||
156928433|NCT02082210|566497570|FG003|Overall Study|Withdrawal by Subject|1|||
156928434|NCT02082210|566497571|FG004|Overall Study|Withdrawal by Subject|2|||
156928435|NCT02082210|566497572|FG005|Overall Study|Withdrawal by Subject|2|||
156928436|NCT02082210|566497567|FG000|Overall Study|Clinical Progression|0|||
156928437|NCT02082210|566497568|FG001|Overall Study|Clinical Progression|0|||
156928438|NCT02082210|566497569|FG002|Overall Study|Clinical Progression|0|||
156928439|NCT02082210|566497570|FG003|Overall Study|Clinical Progression|1|||
156928440|NCT02082210|566497571|FG004|Overall Study|Clinical Progression|0|||
156928441|NCT02082210|566497572|FG005|Overall Study|Clinical Progression|0|||
156928442|NCT02082210|566497567|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
156928443|NCT02082210|566497568|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
156928444|NCT02082210|566497569|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
156928445|NCT02082210|566497570|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
156928446|NCT02082210|566497571|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
156928447|NCT02082210|566497572|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
156928448|NCT02082210|566497567|FG000|Overall Study|Physician Decision|0|||
156928449|NCT02082210|566497568|FG001|Overall Study|Physician Decision|0|||
156928450|NCT02082210|566497569|FG002|Overall Study|Physician Decision|1|||
156928451|NCT02082210|566497570|FG003|Overall Study|Physician Decision|1|||
156928452|NCT02082210|566497571|FG004|Overall Study|Physician Decision|0|||
156928453|NCT02082210|566497572|FG005|Overall Study|Physician Decision|0|||
156928454|NCT03388138|566497573|FG000|Overall Study|Protocol Violation|1|||
156928455|NCT03388138|566497574|FG001|Overall Study|Protocol Violation|0|||
156928456|NCT01528072|566497577|FG000|Overall Study|Withdrawal by Subject|5|||
156928457|NCT01528072|566497577|FG000|Overall Study|Physician Decision|1|||
156928458|NCT01528072|566497577|FG000|Overall Study|Determined not eligible by AEAC|1|||
156928459|NCT01528072|566497577|FG000|Overall Study|Missed Visit|2|||
156928460|NCT01528072|566497577|FG000|Overall Study|Lost to Follow-up|5|||
156928461|NCT01528072|566497577|FG000|Overall Study|Explanted|2|||
156928462|NCT01528072|566497577|FG000|Overall Study|Site Closure|4|||
156928463|NCT01528072|566497577|FG000|Overall Study|Death|2|||
156928464|NCT01528072|566497577|FG000|Overall Study|Early Termination of Study|52|||
156928465|NCT02436759|566497591|FG000|Overall Study|Adverse Event|3|||
156928466|NCT02436759|566497592|FG001|Overall Study|Adverse Event|0|||
156928467|NCT02436759|566497591|FG000|Overall Study|Protocol Violation|1|||
156928468|NCT02436759|566497592|FG001|Overall Study|Protocol Violation|0|||
156928469|NCT02436759|566497591|FG000|Overall Study|Withdrawal by Subject|0|||
156928470|NCT02436759|566497592|FG001|Overall Study|Withdrawal by Subject|1|||
156928471|NCT01290666|566497594|FG000|Overall Study|Lost to Follow-up|11|||
156928472|NCT01290666|566497594|FG000|Overall Study|Withdrawal by Subject|23|||
156928473|NCT01290666|566497594|FG000|Overall Study|Early Termination of Study|4|||
156928474|NCT01652664|566497597|FG000|Overall Study|Treatment Failure|5|||
156928475|NCT01652664|566497598|FG001|Overall Study|Treatment Failure|1|||
156928476|NCT01652664|566497597|FG000|Overall Study|Inadequate IOP control|1|||
156928477|NCT01652664|566497598|FG001|Overall Study|Inadequate IOP control|0|||
156928478|NCT00297037|566497599|FG000|Overall Study|Withdrawal by Subject|2|||
156928479|NCT00297037|566497600|FG001|Overall Study|Withdrawal by Subject|0|||
156928480|NCT00581776|566497601|FG000|Overall Study|Disease progression or no response|3|||
156928481|NCT02357901|566497602|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
156928482|NCT02357901|566497603|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156928483|NCT02357901|566497604|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156928484|NCT02357901|566497605|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
156928485|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
156928486|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
156928487|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
156928488|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
156928489|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
156928490|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
156928491|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
156928492|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
156928493|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
156928494|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
156928495|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
156928496|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
156928497|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
156928498|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
156928499|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
156928500|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
156928501|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
156928502|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
156928503|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
156928504|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
156928505|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
156928506|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
156928507|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
156928508|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
157029223|NCT01928394|566862889|FG002|Follow-up Period|Participant withdrew consent|1|||
157166547|NCT01048853|567350521|FG000|Overall Study|Lost to Follow-up|1|||
157166548|NCT01048853|567350522|FG001|Overall Study|Lost to Follow-up|4|||
156928509|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
156928510|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
156928511|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
156928512|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
156928513|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
156928514|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
156928515|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
156928516|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
156928517|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
156928518|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
156928519|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
156928520|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
156928521|NCT02357901|566497602|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
156928522|NCT02357901|566497603|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
156928523|NCT02357901|566497604|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
156928524|NCT02357901|566497605|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
156928525|NCT02418468|566497612|FG000|Overall Study|Adverse Event|1|||
156928526|NCT02418468|566497613|FG001|Overall Study|Adverse Event|0|||
156928527|NCT02418468|566497612|FG000|Overall Study|Withdrawal of informed consent|1|||
156928528|NCT02418468|566497613|FG001|Overall Study|Withdrawal of informed consent|1|||
156928529|NCT00909779|566497614|FG000|Overall Study|Adverse Event|53|||
156928530|NCT00909779|566497615|FG001|Overall Study|Adverse Event|55|||
156928531|NCT00909779|566497614|FG000|Overall Study|Lack of Efficacy|7|||
156928532|NCT00909779|566497615|FG001|Overall Study|Lack of Efficacy|4|||
156928533|NCT00909779|566497614|FG000|Overall Study|Lost to Follow-up|19|||
156928534|NCT00909779|566497615|FG001|Overall Study|Lost to Follow-up|15|||
156928535|NCT00909779|566497614|FG000|Overall Study|Physician Decision|8|||
156928536|NCT00909779|566497615|FG001|Overall Study|Physician Decision|2|||
156928537|NCT00909779|566497614|FG000|Overall Study|Protocol Violation|2|||
156928538|NCT00909779|566497615|FG001|Overall Study|Protocol Violation|5|||
156928539|NCT00909779|566497614|FG000|Overall Study|Withdrawal by Subject|116|||
156928540|NCT00909779|566497615|FG001|Overall Study|Withdrawal by Subject|80|||
156928541|NCT00909779|566497614|FG000|Overall Study|Site Ceasing Operation|2|||
156928542|NCT00909779|566497615|FG001|Overall Study|Site Ceasing Operation|2|||
156928543|NCT00909779|566497614|FG000|Overall Study|Medical Monitor Decision|1|||
156928544|NCT00909779|566497615|FG001|Overall Study|Medical Monitor Decision|0|||
156928545|NCT00909779|566497614|FG000|Overall Study|Noncompliance|1|||
156928546|NCT00909779|566497615|FG001|Overall Study|Noncompliance|1|||
156928547|NCT00909779|566497614|FG000|Overall Study|Randomized in error|1|||
156928548|NCT00909779|566497615|FG001|Overall Study|Randomized in error|1|||
156928549|NCT01592344|566497616|FG000|Overall Study|Adverse Event|1|||
156928550|NCT01592344|566497617|FG001|Overall Study|Adverse Event|1|||
156928551|NCT01592344|566497616|FG000|Overall Study|Lack of Efficacy|1|||
156928552|NCT01592344|566497617|FG001|Overall Study|Lack of Efficacy|0|||
156928553|NCT01592344|566497616|FG000|Overall Study|not available at primary outcome visit|2|||
156928554|NCT01592344|566497617|FG001|Overall Study|not available at primary outcome visit|4|||
156928555|NCT02809677|566497618|FG000|Overall Study|Withdrawal by Subject|8|||
156928556|NCT02205333|566497619|FG000|Overall Study|Death|5|||
156928557|NCT02205333|566497620|FG001|Overall Study|Death|6|||
156928558|NCT02205333|566497621|FG002|Overall Study|Death|2|||
156928559|NCT02205333|566497622|FG003|Overall Study|Death|6|||
156928560|NCT02205333|566497623|FG004|Overall Study|Death|5|||
156928561|NCT02205333|566497624|FG005|Overall Study|Death|3|||
157166549|NCT01048853|567350523|FG002|Overall Study|Lost to Follow-up|0|||
157166550|NCT06964165|567350527|FG000|Overall Study|Death|4|||
156928562|NCT02205333|566497625|FG006|Overall Study|Death|3|||
156928563|NCT02205333|566497626|FG007|Overall Study|Death|2|||
156928564|NCT02205333|566497627|FG008|Overall Study|Death|0|||
156928565|NCT02205333|566497619|FG000|Overall Study|Withdrawal by Subject|1|||
156928566|NCT02205333|566497620|FG001|Overall Study|Withdrawal by Subject|0|||
156928567|NCT02205333|566497621|FG002|Overall Study|Withdrawal by Subject|0|||
156928568|NCT02205333|566497622|FG003|Overall Study|Withdrawal by Subject|1|||
156928569|NCT02205333|566497623|FG004|Overall Study|Withdrawal by Subject|0|||
156928570|NCT02205333|566497624|FG005|Overall Study|Withdrawal by Subject|0|||
156928571|NCT02205333|566497625|FG006|Overall Study|Withdrawal by Subject|2|||
156928572|NCT02205333|566497626|FG007|Overall Study|Withdrawal by Subject|0|||
156928573|NCT02205333|566497627|FG008|Overall Study|Withdrawal by Subject|0|||
156928574|NCT01120756|566497630|FG000|Overall Study|Withdrawal by Subject|1|||
156928575|NCT01120756|566497631|FG001|Overall Study|Withdrawal by Subject|1|||
156928576|NCT00698581|566497632|FG000|Overall Study|Lack of Efficacy|23|||
156928577|NCT00698581|566497633|FG001|Overall Study|Lack of Efficacy|11|||
156928578|NCT00698581|566497632|FG000|Overall Study|Withdrawal by Subject|6|||
156928579|NCT00698581|566497633|FG001|Overall Study|Withdrawal by Subject|0|||
156928580|NCT00698581|566497632|FG000|Overall Study|Other reason|9|||
156928581|NCT00698581|566497633|FG001|Overall Study|Other reason|1|||
156928582|NCT00698581|566497632|FG000|Overall Study|SAE, non-fatal|1|||
156928583|NCT00698581|566497633|FG001|Overall Study|SAE, non-fatal|0|||
156928584|NCT00698581|566497632|FG000|Overall Study|AE, non-serious non-fatal|4|||
156928585|NCT00698581|566497633|FG001|Overall Study|AE, non-serious non-fatal|0|||
157166551|NCT06964165|567350528|FG001|Overall Study|Death|4|||
156928586|NCT00698581|566497632|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156928587|NCT00698581|566497633|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156928588|NCT00698581|566497632|FG000|Overall Study|AE of unknown type|1|||
156928589|NCT00698581|566497633|FG001|Overall Study|AE of unknown type|0|||
156928590|NCT03760146|566497634|FG000|Overall Study|Adverse Event|11|||
156928591|NCT03760146|566497635|FG001|Overall Study|Adverse Event|8|||
156928592|NCT03760146|566497636|FG002|Overall Study|Adverse Event|0|||
156928593|NCT03760146|566497637|FG003|Overall Study|Adverse Event|0|||
156928594|NCT03760146|566497638|FG004|Overall Study|Adverse Event|0|||
156928595|NCT03760146|566497639|FG005|Overall Study|Adverse Event|0|||
156928596|NCT03760146|566497634|FG000|Overall Study|Death|1|||
156928597|NCT03760146|566497635|FG001|Overall Study|Death|0|||
156928598|NCT03760146|566497636|FG002|Overall Study|Death|0|||
156928599|NCT03760146|566497637|FG003|Overall Study|Death|0|||
156928600|NCT03760146|566497638|FG004|Overall Study|Death|0|||
156928601|NCT03760146|566497639|FG005|Overall Study|Death|0|||
156928602|NCT03760146|566497634|FG000|Overall Study|Lost to Follow-up|41|||
156928603|NCT03760146|566497635|FG001|Overall Study|Lost to Follow-up|28|||
156928604|NCT03760146|566497636|FG002|Overall Study|Lost to Follow-up|9|||
156928605|NCT03760146|566497637|FG003|Overall Study|Lost to Follow-up|2|||
156928606|NCT03760146|566497638|FG004|Overall Study|Lost to Follow-up|14|||
156928607|NCT03760146|566497639|FG005|Overall Study|Lost to Follow-up|8|||
156928608|NCT03760146|566497634|FG000|Overall Study|No longer met eligibility criteria|3|||
156928609|NCT03760146|566497635|FG001|Overall Study|No longer met eligibility criteria|9|||
156928610|NCT03760146|566497636|FG002|Overall Study|No longer met eligibility criteria|0|||
156928611|NCT03760146|566497637|FG003|Overall Study|No longer met eligibility criteria|0|||
156928612|NCT03760146|566497638|FG004|Overall Study|No longer met eligibility criteria|1|||
156928613|NCT03760146|566497639|FG005|Overall Study|No longer met eligibility criteria|0|||
156928614|NCT03760146|566497634|FG000|Overall Study|Protocol Violation|21|||
156928615|NCT03760146|566497635|FG001|Overall Study|Protocol Violation|13|||
156928616|NCT03760146|566497636|FG002|Overall Study|Protocol Violation|1|||
156928617|NCT03760146|566497637|FG003|Overall Study|Protocol Violation|0|||
156928618|NCT03760146|566497638|FG004|Overall Study|Protocol Violation|1|||
156928619|NCT03760146|566497639|FG005|Overall Study|Protocol Violation|0|||
156928620|NCT03760146|566497634|FG000|Overall Study|Withdrawal by Subject|19|||
156928621|NCT03760146|566497635|FG001|Overall Study|Withdrawal by Subject|20|||
156928622|NCT03760146|566497636|FG002|Overall Study|Withdrawal by Subject|1|||
156928623|NCT03760146|566497637|FG003|Overall Study|Withdrawal by Subject|0|||
156928624|NCT03760146|566497638|FG004|Overall Study|Withdrawal by Subject|1|||
156928625|NCT03760146|566497639|FG005|Overall Study|Withdrawal by Subject|0|||
156928626|NCT00449644|566497640|FG000|Overall Study|Adverse Event|0|||
156928627|NCT00449644|566497641|FG001|Overall Study|Adverse Event|0|||
156928628|NCT00449644|566497642|FG002|Overall Study|Adverse Event|3|||
156928629|NCT00449644|566497643|FG003|Overall Study|Adverse Event|5|||
156928630|NCT00449644|566497640|FG000|Overall Study|Death|1|||
156928631|NCT00449644|566497641|FG001|Overall Study|Death|0|||
156928632|NCT00449644|566497642|FG002|Overall Study|Death|6|||
156928633|NCT00449644|566497643|FG003|Overall Study|Death|1|||
156928634|NCT00449644|566497640|FG000|Overall Study|Lost to Follow-up|1|||
156928635|NCT00449644|566497641|FG001|Overall Study|Lost to Follow-up|1|||
156928636|NCT00449644|566497642|FG002|Overall Study|Lost to Follow-up|5|||
156928637|NCT00449644|566497643|FG003|Overall Study|Lost to Follow-up|3|||
156928638|NCT00449644|566497640|FG000|Overall Study|Pregnancy|0|||
156928639|NCT00449644|566497641|FG001|Overall Study|Pregnancy|0|||
156928640|NCT00449644|566497642|FG002|Overall Study|Pregnancy|3|||
156928641|NCT00449644|566497643|FG003|Overall Study|Pregnancy|2|||
156928642|NCT00449644|566497640|FG000|Overall Study|Protocol Violation|4|||
156928643|NCT00449644|566497641|FG001|Overall Study|Protocol Violation|4|||
156928644|NCT00449644|566497642|FG002|Overall Study|Protocol Violation|3|||
156928645|NCT00449644|566497643|FG003|Overall Study|Protocol Violation|7|||
156928646|NCT00449644|566497640|FG000|Overall Study|Withdrawal by Subject|3|||
156928647|NCT00449644|566497641|FG001|Overall Study|Withdrawal by Subject|4|||
156928648|NCT00449644|566497642|FG002|Overall Study|Withdrawal by Subject|6|||
156928649|NCT00449644|566497643|FG003|Overall Study|Withdrawal by Subject|7|||
156928650|NCT00449644|566497640|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156928651|NCT00449644|566497641|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
156928652|NCT00449644|566497642|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
156928653|NCT00449644|566497643|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
156928654|NCT00449644|566497640|FG000|Overall Study|Other|1|||
156928655|NCT00449644|566497641|FG001|Overall Study|Other|4|||
156928656|NCT00449644|566497642|FG002|Overall Study|Other|1|||
156928657|NCT00449644|566497643|FG003|Overall Study|Other|0|||
156928658|NCT00449644|566497640|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
156928659|NCT00449644|566497641|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
156928660|NCT00449644|566497642|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
156928661|NCT00449644|566497643|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
156928662|NCT03999892|566497644|FG000|Overall Study|Lost to Follow-up|1|||
156928663|NCT01848756|566497645|FG000|Overall Study|Adverse Event|1|||
156928664|NCT01848756|566497645|FG000|Overall Study|Withdrawal by Subject|1|||
156928665|NCT01848756|566497645|FG000|Overall Study|Enrolled in Error|1|||
156928666|NCT03245008|566497646|FG000|Overall Study|Adverse Event|15|||
156928667|NCT03245008|566497647|FG001|Overall Study|Adverse Event|18|||
156928668|NCT03245008|566497648|FG002|Overall Study|Adverse Event|15|||
156928669|NCT03245008|566497649|FG003|Overall Study|Adverse Event|0|||
156928670|NCT03245008|566497650|FG004|Overall Study|Adverse Event|1|||
156928671|NCT03245008|566497646|FG000|Overall Study|Lack of Efficacy|0|||
156928672|NCT03245008|566497647|FG001|Overall Study|Lack of Efficacy|1|||
156928673|NCT03245008|566497648|FG002|Overall Study|Lack of Efficacy|0|||
156928674|NCT03245008|566497649|FG003|Overall Study|Lack of Efficacy|0|||
156928675|NCT03245008|566497650|FG004|Overall Study|Lack of Efficacy|0|||
156928676|NCT03245008|566497646|FG000|Overall Study|Lost to Follow-up|4|||
156928677|NCT03245008|566497647|FG001|Overall Study|Lost to Follow-up|1|||
156928678|NCT03245008|566497648|FG002|Overall Study|Lost to Follow-up|0|||
156928679|NCT03245008|566497649|FG003|Overall Study|Lost to Follow-up|0|||
156928680|NCT03245008|566497650|FG004|Overall Study|Lost to Follow-up|1|||
156928681|NCT03245008|566497646|FG000|Overall Study|Physician Decision|1|||
156928682|NCT03245008|566497647|FG001|Overall Study|Physician Decision|3|||
156928683|NCT03245008|566497648|FG002|Overall Study|Physician Decision|4|||
156928684|NCT03245008|566497649|FG003|Overall Study|Physician Decision|0|||
156928685|NCT03245008|566497650|FG004|Overall Study|Physician Decision|0|||
156928686|NCT03245008|566497646|FG000|Overall Study|Protocol Violation|0|||
156928687|NCT03245008|566497647|FG001|Overall Study|Protocol Violation|1|||
156928688|NCT03245008|566497648|FG002|Overall Study|Protocol Violation|0|||
156928689|NCT03245008|566497649|FG003|Overall Study|Protocol Violation|0|||
156928690|NCT03245008|566497650|FG004|Overall Study|Protocol Violation|0|||
156928691|NCT03245008|566497646|FG000|Overall Study|Withdrawal by Subject|20|||
156928692|NCT03245008|566497647|FG001|Overall Study|Withdrawal by Subject|19|||
156928693|NCT03245008|566497648|FG002|Overall Study|Withdrawal by Subject|11|||
156928694|NCT03245008|566497649|FG003|Overall Study|Withdrawal by Subject|0|||
156928695|NCT03245008|566497650|FG004|Overall Study|Withdrawal by Subject|0|||
156928696|NCT03245008|566497646|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156928697|NCT03245008|566497647|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156928698|NCT03245008|566497648|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
156928699|NCT03245008|566497649|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
156928700|NCT03245008|566497650|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
156928701|NCT03245008|566497646|FG000|Overall Study|Failure to meet randomization criteria|0|||
156928702|NCT03245008|566497647|FG001|Overall Study|Failure to meet randomization criteria|1|||
156928703|NCT03245008|566497648|FG002|Overall Study|Failure to meet randomization criteria|0|||
156928704|NCT03245008|566497649|FG003|Overall Study|Failure to meet randomization criteria|1|||
156928705|NCT03245008|566497650|FG004|Overall Study|Failure to meet randomization criteria|0|||
156928706|NCT02075658|566497651|FG000|Overall Study|Physician Decision|2|||
156928707|NCT02075658|566497652|FG001|Overall Study|Physician Decision|2|||
156928708|NCT01286012|566497653|FG000|Overall Study|Adverse Event|3|||
156928709|NCT01286012|566497654|FG001|Overall Study|Adverse Event|3|||
156928710|NCT01286012|566497653|FG000|Overall Study|Death|2|||
156928711|NCT01286012|566497654|FG001|Overall Study|Death|3|||
156928712|NCT01286012|566497653|FG000|Overall Study|Protocol Violation|1|||
156928713|NCT01286012|566497654|FG001|Overall Study|Protocol Violation|1|||
156928714|NCT01286012|566497653|FG000|Overall Study|Withdrawal by Subject|4|||
156928715|NCT01286012|566497654|FG001|Overall Study|Withdrawal by Subject|4|||
156928716|NCT01286012|566497653|FG000|Overall Study|Physician Decision|2|||
156928717|NCT01286012|566497654|FG001|Overall Study|Physician Decision|0|||
156928718|NCT01286012|566497653|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
156928719|NCT01286012|566497654|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
156928720|NCT04056195|566497658|FG000|Overall Study|Adverse Event|1|||
156928721|NCT04056195|566497659|FG001|Overall Study|Adverse Event|0|||
156928722|NCT04056195|566497660|FG002|Overall Study|Adverse Event|0|||
156928723|NCT04056195|566497658|FG000|Overall Study|Withdrawal by Subject|0|||
156928724|NCT04056195|566497659|FG001|Overall Study|Withdrawal by Subject|1|||
156928725|NCT04056195|566497660|FG002|Overall Study|Withdrawal by Subject|1|||
156928726|NCT04056195|566497658|FG000|Overall Study|Physician Decision|1|||
156928727|NCT04056195|566497659|FG001|Overall Study|Physician Decision|1|||
156928728|NCT04056195|566497660|FG002|Overall Study|Physician Decision|1|||
156928729|NCT01498458|566497661|FG000|Overall Study|Adverse Event|4|||
156928730|NCT01498458|566497661|FG000|Overall Study|Physician Decision|3|||
156928731|NCT02406651|566497662|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
157166552|NCT06964165|567350527|FG000|Overall Study|Physician Decision|1|||
156928732|NCT02226003|566497666|FG000|Overall Study|Lost to Follow-up|2|||
157166553|NCT06964165|567350528|FG001|Overall Study|Physician Decision|1|||
157166554|NCT06964165|567350527|FG000|Overall Study|Withdrawal by Subject|0|||
156928733|NCT02226003|566497667|FG001|Overall Study|Lost to Follow-up|1|||
156928734|NCT02226003|566497668|FG002|Overall Study|Lost to Follow-up|3|||
156928735|NCT02226003|566497666|FG000|Overall Study|Withdrawal by Subject|0|||
156928736|NCT02226003|566497667|FG001|Overall Study|Withdrawal by Subject|0|||
156928737|NCT02226003|566497668|FG002|Overall Study|Withdrawal by Subject|3|||
156928738|NCT00718328|566497669|FG000|Overall Study|Lost to Follow-up|1|||
156928739|NCT00718328|566497670|FG001|Overall Study|Lost to Follow-up|0|||
156928740|NCT02865915|566497671|FG000|Overall Study|Pregnancy|1|||
156928741|NCT02865915|566497672|FG001|Overall Study|Pregnancy|0|||
156928742|NCT02865915|566497671|FG000|Overall Study|Withdrawal by Subject|1|||
156928743|NCT02865915|566497672|FG001|Overall Study|Withdrawal by Subject|1|||
156928744|NCT02865915|566497671|FG000|Overall Study|Adverse Event|0|||
156928745|NCT02865915|566497672|FG001|Overall Study|Adverse Event|4|||
156928746|NCT02865915|566497671|FG000|Overall Study|Lost to Follow-up|0|||
156928747|NCT02865915|566497672|FG001|Overall Study|Lost to Follow-up|1|||
156928748|NCT02865915|566497671|FG000|Overall Study|Protocol Violation|0|||
156928749|NCT02865915|566497672|FG001|Overall Study|Protocol Violation|1|||
156928750|NCT02865915|566497671|FG000|Overall Study|Study terminated by sponsor|23|||
156928751|NCT02865915|566497672|FG001|Overall Study|Study terminated by sponsor|18|||
156928752|NCT02865915|566497671|FG000|Overall Study|Dosing group discontinued|0|||
156928753|NCT02865915|566497672|FG001|Overall Study|Dosing group discontinued|5|||
156928754|NCT00663052|566497675|FG000|Overall Study|Adverse Event|6|||
156928755|NCT00663052|566497676|FG001|Overall Study|Adverse Event|3|||
156928756|NCT00663052|566497675|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
156928757|NCT00663052|566497676|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
156928758|NCT00663052|566497675|FG000|Overall Study|Protocol Violation|1|||
156928759|NCT00663052|566497676|FG001|Overall Study|Protocol Violation|0|||
156928760|NCT00663052|566497675|FG000|Overall Study|Withdrawal by Subject|2|||
156928761|NCT00663052|566497676|FG001|Overall Study|Withdrawal by Subject|5|||
156928762|NCT00663052|566497675|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
156928763|NCT00663052|566497676|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
156928764|NCT00663052|566497675|FG000|Overall Study|Other|0|||
156928765|NCT00663052|566497676|FG001|Overall Study|Other|1|||
156928766|NCT03279692|566497683|FG000|Overall Study|Withdrawal by Subject|1|||
156928767|NCT05198843|566497686|FG000|Overall Study|Lack of Efficacy|1|||
156928768|NCT02446990|566497687|FG000|Overall Study|Death|485|||
156928769|NCT02446990|566497688|FG001|Overall Study|Death|458|||
156928770|NCT02446990|566497687|FG000|Overall Study|Lost to Follow-up|3|||
156928771|NCT02446990|566497688|FG001|Overall Study|Lost to Follow-up|1|||
156928772|NCT02446990|566497687|FG000|Overall Study|Physician Decision|1|||
156928773|NCT02446990|566497688|FG001|Overall Study|Physician Decision|0|||
156928774|NCT02446990|566497687|FG000|Overall Study|Withdrawal by Subject|231|||
156928775|NCT02446990|566497688|FG001|Overall Study|Withdrawal by Subject|199|||
156928776|NCT01064401|566497689|FG000|Overall Study|Adverse Event|47|||
156928777|NCT01064401|566497690|FG001|Overall Study|Adverse Event|56|||
156928778|NCT01064401|566497689|FG000|Overall Study|Lack of Efficacy|46|||
156928779|NCT01064401|566497690|FG001|Overall Study|Lack of Efficacy|23|||
156928780|NCT01064401|566497689|FG000|Overall Study|Lost to Follow-up|12|||
156928781|NCT01064401|566497690|FG001|Overall Study|Lost to Follow-up|9|||
156928782|NCT01064401|566497689|FG000|Overall Study|Consent Withdrawn|98|||
156928783|NCT01064401|566497690|FG001|Overall Study|Consent Withdrawn|80|||
156928784|NCT01064401|566497689|FG000|Overall Study|Investigator Decision|4|||
156928785|NCT01064401|566497690|FG001|Overall Study|Investigator Decision|6|||
156928786|NCT01064401|566497689|FG000|Overall Study|Death|4|||
156928787|NCT01064401|566497690|FG001|Overall Study|Death|0|||
156928788|NCT01064401|566497689|FG000|Overall Study|Pregnancy|4|||
156928789|NCT01064401|566497690|FG001|Overall Study|Pregnancy|7|||
156928790|NCT01064401|566497689|FG000|Overall Study|Noncompliance|7|||
156928791|NCT01064401|566497690|FG001|Overall Study|Noncompliance|8|||
156928792|NCT01064401|566497689|FG000|Overall Study|Site Closure|4|||
156928793|NCT01064401|566497690|FG001|Overall Study|Site Closure|5|||
156928794|NCT01064401|566497689|FG000|Overall Study|Other|2|||
156928795|NCT01064401|566497690|FG001|Overall Study|Other|1|||
156928796|NCT03158051|566497691|FG000|Overall Study|Lost to Follow-up|41|||
156928797|NCT03158051|566497692|FG001|Overall Study|Lost to Follow-up|47|||
156928798|NCT03158051|566497691|FG000|Overall Study|Physician Decision|6|||
156928799|NCT03158051|566497692|FG001|Overall Study|Physician Decision|7|||
157227049|NCT00409578|567576032|FG001|Overall Study|Withdrawal by Subject|15|||
156928800|NCT03158051|566497691|FG000|Overall Study|Withdrawal by Subject|24|||
156928801|NCT03158051|566497692|FG001|Overall Study|Withdrawal by Subject|15|||
156928802|NCT03158051|566497691|FG000|Overall Study|Death|0|||
156928803|NCT03158051|566497692|FG001|Overall Study|Death|1|||
157227050|NCT00409578|567576033|FG002|Overall Study|Withdrawal by Subject|16|||
156928804|NCT00296374|566497696|FG000|Overall Study|Adverse Event|14|||
156928805|NCT00296374|566497697|FG001|Overall Study|Adverse Event|10|||
156928806|NCT00296374|566497698|FG002|Overall Study|Adverse Event|7|||
156928807|NCT00296374|566497696|FG000|Overall Study|Withdrawal by Subject|3|||
156928808|NCT00296374|566497697|FG001|Overall Study|Withdrawal by Subject|5|||
156928809|NCT00296374|566497698|FG002|Overall Study|Withdrawal by Subject|11|||
156928810|NCT00296374|566497696|FG000|Overall Study|Incorrect enrollment|3|||
156928811|NCT00296374|566497697|FG001|Overall Study|Incorrect enrollment|3|||
156928812|NCT00296374|566497698|FG002|Overall Study|Incorrect enrollment|4|||
156928813|NCT00296374|566497696|FG000|Overall Study|Protocol Violation|1|||
156928814|NCT00296374|566497697|FG001|Overall Study|Protocol Violation|2|||
156928815|NCT00296374|566497698|FG002|Overall Study|Protocol Violation|3|||
156928816|NCT00296374|566497696|FG000|Overall Study|Lost to Follow-up|3|||
156928817|NCT00296374|566497697|FG001|Overall Study|Lost to Follow-up|1|||
156928818|NCT00296374|566497698|FG002|Overall Study|Lost to Follow-up|1|||
156928819|NCT00296374|566497696|FG000|Overall Study|Relocated to another state|1|||
156928820|NCT00296374|566497697|FG001|Overall Study|Relocated to another state|0|||
156928821|NCT00296374|566497698|FG002|Overall Study|Relocated to another state|0|||
156928822|NCT00296374|566497696|FG000|Overall Study|Stopped drug before end of study visit|0|||
156928823|NCT00296374|566497697|FG001|Overall Study|Stopped drug before end of study visit|1|||
156928824|NCT00296374|566497698|FG002|Overall Study|Stopped drug before end of study visit|0|||
156928825|NCT00296374|566497696|FG000|Overall Study|Nephrologist introduced ACE|0|||
156928826|NCT00296374|566497697|FG001|Overall Study|Nephrologist introduced ACE|1|||
156928827|NCT00296374|566497698|FG002|Overall Study|Nephrologist introduced ACE|0|||
156928828|NCT00296374|566497696|FG000|Overall Study|Pregnancy|0|||
156928829|NCT00296374|566497697|FG001|Overall Study|Pregnancy|0|||
156928830|NCT00296374|566497698|FG002|Overall Study|Pregnancy|2|||
156928831|NCT00296374|566497696|FG000|Overall Study|Other|0|||
156928832|NCT00296374|566497697|FG001|Overall Study|Other|0|||
156928833|NCT00296374|566497698|FG002|Overall Study|Other|1|||
156928834|NCT01721330|566497699|FG000|Overall Study|Withdrawal by Subject|0|||
156928835|NCT01721330|566497700|FG001|Overall Study|Withdrawal by Subject|1|||
156928836|NCT01816893|566497701|FG000|Washout Period|Withdrawal by Subject|2|||
156928837|NCT01816893|566497702|FG001|Washout Period|Withdrawal by Subject|0|||
156928838|NCT00858442|566499368|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
156928839|NCT00858442|566499369|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
156928840|NCT02016625|566499372|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
156928841|NCT02016625|566499373|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
156928842|NCT02016625|566499372|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
156928843|NCT02016625|566499373|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
156928844|NCT02016625|566499372|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
156928845|NCT02016625|566499373|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
156928846|NCT02155738|566499374|FG000|Overall Study|Missing critical information|1|||
156928847|NCT02155738|566499375|FG001|Overall Study|Missing critical information|0|||
156928848|NCT02155738|566499376|FG002|Overall Study|Missing critical information|0|||
156928849|NCT02155738|566499377|FG003|Overall Study|Missing critical information|1|||
156928850|NCT01254227|566499382|FG000|Overall Study|Withdrawal by Subject|6|||
156928851|NCT01254227|566499382|FG000|Overall Study|Lost to Follow-up|6|||
156928852|NCT01254227|566499382|FG000|Overall Study|Adverse Event|5|||
156928853|NCT01254227|566499382|FG000|Overall Study|Abnormal test procedure result|5|||
156928854|NCT01254227|566499382|FG000|Overall Study|Administrative problems|2|||
156928855|NCT01254227|566499382|FG000|Overall Study|Death|1|||
156928856|NCT01254227|566499382|FG000|Overall Study|Protocol deviation|1|||
156928857|NCT03970733|566499383|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156928858|NCT03970733|566499384|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
156928859|NCT03970733|566499385|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
156928860|NCT03970733|566499386|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156928861|NCT03970733|566499387|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
156928862|NCT03970733|566499383|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
156928863|NCT03970733|566499384|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
156928864|NCT03970733|566499385|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
157029224|NCT01928394|566862890|FG003|Follow-up Period|Participant withdrew consent|4|||
157166555|NCT06964165|567350528|FG001|Overall Study|Withdrawal by Subject|2|||
157166556|NCT06964165|567350527|FG000|Overall Study|Study terminated by sponsor|12|||
157166557|NCT06964165|567350528|FG001|Overall Study|Study terminated by sponsor|10|||
157166558|NCT06964165|567350527|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
157166559|NCT06964165|567350528|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
157166560|NCT06964165|567350527|FG000|Overall Study|Participant removed due to non-compliance|0|||
157166561|NCT06964165|567350528|FG001|Overall Study|Participant removed due to non-compliance|1|||
157166562|NCT03224104|567350535|FG000|Overall Study|Lack of Efficacy|2|||
157166563|NCT03224104|567350536|FG001|Overall Study|Lack of Efficacy|6|||
157166564|NCT03224104|567350537|FG002|Overall Study|Lack of Efficacy|3|||
157166565|NCT03224104|567350538|FG003|Overall Study|Lack of Efficacy|4|||
157166566|NCT03224104|567350539|FG004|Overall Study|Lack of Efficacy|42|||
157166567|NCT03224104|567350535|FG000|Overall Study|Withdrawal by Subject|0|||
157166568|NCT03224104|567350536|FG001|Overall Study|Withdrawal by Subject|2|||
157166569|NCT03224104|567350537|FG002|Overall Study|Withdrawal by Subject|0|||
157166570|NCT03224104|567350538|FG003|Overall Study|Withdrawal by Subject|1|||
156928865|NCT03970733|566499386|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
156928866|NCT03970733|566499387|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
157029225|NCT01928394|566862891|FG004|Follow-up Period|Participant withdrew consent|0|||
157029226|NCT01928394|566862892|FG005|Follow-up Period|Participant withdrew consent|2|||
157029227|NCT01928394|566862893|FG006|Follow-up Period|Participant withdrew consent|5|||
157166571|NCT03224104|567350539|FG004|Overall Study|Withdrawal by Subject|3|||
157166572|NCT03224104|567350535|FG000|Overall Study|Death|0|||
156928867|NCT03970733|566499383|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
156928868|NCT03970733|566499384|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
156928869|NCT03970733|566499385|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
157166573|NCT03224104|567350536|FG001|Overall Study|Death|1|||
156928870|NCT03970733|566499386|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
156928871|NCT03970733|566499387|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
156928872|NCT03970733|566499383|FG000|Main Study Phase (18 Months)|Other|1|||
156928873|NCT03970733|566499384|FG001|Main Study Phase (18 Months)|Other|1|||
156928874|NCT03970733|566499385|FG002|Main Study Phase (18 Months)|Other|0|||
156928875|NCT03970733|566499386|FG003|Main Study Phase (18 Months)|Other|0|||
156928876|NCT03970733|566499387|FG004|Main Study Phase (18 Months)|Other|0|||
156928877|NCT03970733|566499383|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156928878|NCT03970733|566499384|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156928879|NCT03970733|566499385|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156928880|NCT03970733|566499386|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
156928881|NCT03970733|566499387|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
156928882|NCT02189473|566499391|FG000|Overall Study|Death|22|||
156928883|NCT02189473|566499392|FG001|Overall Study|Death|23|||
156928884|NCT02189473|566499391|FG000|Overall Study|Lost to Follow-up|1|||
156928885|NCT02189473|566499392|FG001|Overall Study|Lost to Follow-up|2|||
156928886|NCT02784821|566499393|FG000|Overall Study|Death|0|||
156928887|NCT02784821|566499394|FG001|Overall Study|Death|5|||
156928888|NCT02784821|566499395|FG002|Overall Study|Death|4|||
156928889|NCT02784821|566499396|FG003|Overall Study|Death|5|||
156928890|NCT02794103|566499397|FG000|Overall Study|Loss to follow up due to high sedation|3|||
156928891|NCT01139450|566499398|FG000|Overall Study|Withdrawal by Subject|7|||
156928892|NCT01139450|566499399|FG001|Overall Study|Withdrawal by Subject|10|||
156928893|NCT01139450|566499400|FG002|Overall Study|Withdrawal by Subject|13|||
156928894|NCT01139450|566499398|FG000|Overall Study|Lack of Efficacy|3|||
156928895|NCT01139450|566499399|FG001|Overall Study|Lack of Efficacy|1|||
156928896|NCT01139450|566499400|FG002|Overall Study|Lack of Efficacy|8|||
156928897|NCT01139450|566499398|FG000|Overall Study|Protocol Violation|6|||
156928898|NCT01139450|566499399|FG001|Overall Study|Protocol Violation|5|||
156928899|NCT01139450|566499400|FG002|Overall Study|Protocol Violation|2|||
156928900|NCT01139450|566499398|FG000|Overall Study|Lost to Follow-up|9|||
156928901|NCT01139450|566499399|FG001|Overall Study|Lost to Follow-up|7|||
156928902|NCT01139450|566499400|FG002|Overall Study|Lost to Follow-up|11|||
156928903|NCT01139450|566499398|FG000|Overall Study|Administrative|0|||
156928904|NCT01139450|566499399|FG001|Overall Study|Administrative|0|||
156928905|NCT01139450|566499400|FG002|Overall Study|Administrative|1|||
156928906|NCT01139450|566499398|FG000|Overall Study|Adverse Event|2|||
156928907|NCT01139450|566499399|FG001|Overall Study|Adverse Event|2|||
156928908|NCT01139450|566499400|FG002|Overall Study|Adverse Event|3|||
156928909|NCT05123222|566499401|FG000|Overall Study|Lost to Follow-up|2|||
156928910|NCT05123222|566499402|FG001|Overall Study|Lost to Follow-up|0|||
156928911|NCT05123222|566499403|FG002|Overall Study|Lost to Follow-up|0|||
156928912|NCT05123222|566499404|FG003|Overall Study|Lost to Follow-up|0|||
156928913|NCT05123222|566499401|FG000|Overall Study|Protocol Violation|0|||
156928914|NCT05123222|566499402|FG001|Overall Study|Protocol Violation|0|||
156928915|NCT05123222|566499403|FG002|Overall Study|Protocol Violation|1|||
156928916|NCT05123222|566499404|FG003|Overall Study|Protocol Violation|0|||
156928917|NCT02535741|566499409|FG000|Overall Study|Adverse Event|3|||
156928918|NCT02535741|566499409|FG000|Overall Study|Withdrawal by Subject|9|||
156928919|NCT02535741|566499409|FG000|Overall Study|Lost to Follow-up|10|||
156928920|NCT02535741|566499409|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
156928921|NCT02535741|566499409|FG000|Overall Study|Missing data|6|||
156928922|NCT00491387|566499417|FG000|Overall Study|study terminated|20|||
156928923|NCT03538158|566499420|FG000|Overall Study|Lost to Follow-up|13|||
156928924|NCT03538158|566499421|FG001|Overall Study|Lost to Follow-up|7|||
156928925|NCT03538158|566499420|FG000|Overall Study|Withdrawal by Subject|2|||
156928926|NCT03538158|566499421|FG001|Overall Study|Withdrawal by Subject|1|||
156928927|NCT01413360|566499430|FG000|Overall Study|Lost to Follow-up|2|||
156928928|NCT01413360|566499430|FG000|Overall Study|Adverse Event|1|||
156928929|NCT02246673|566499435|FG000|Overall Study|Sponsor Decision|1|||
156928930|NCT02246673|566499436|FG001|Overall Study|Sponsor Decision|0|||
156928931|NCT02246673|566499437|FG002|Overall Study|Sponsor Decision|0|||
156928932|NCT02246673|566499438|FG003|Overall Study|Sponsor Decision|0|||
156928933|NCT02246673|566499439|FG004|Overall Study|Sponsor Decision|0|||
156928934|NCT02246673|566499435|FG000|Overall Study|Withdrawal by Subject|0|||
156928935|NCT02246673|566499436|FG001|Overall Study|Withdrawal by Subject|0|||
156928936|NCT02246673|566499437|FG002|Overall Study|Withdrawal by Subject|0|||
156928937|NCT02246673|566499438|FG003|Overall Study|Withdrawal by Subject|0|||
156928938|NCT02246673|566499439|FG004|Overall Study|Withdrawal by Subject|1|||
156928939|NCT02246673|566499435|FG000|Overall Study|Lost to Follow-up|0|||
156928940|NCT02246673|566499436|FG001|Overall Study|Lost to Follow-up|0|||
156928941|NCT02246673|566499437|FG002|Overall Study|Lost to Follow-up|0|||
156928942|NCT02246673|566499438|FG003|Overall Study|Lost to Follow-up|1|||
156928943|NCT02246673|566499439|FG004|Overall Study|Lost to Follow-up|0|||
156928944|NCT02246673|566499435|FG000|Overall Study|Protocol Violation|0|||
156928945|NCT02246673|566499436|FG001|Overall Study|Protocol Violation|0|||
156928946|NCT02246673|566499437|FG002|Overall Study|Protocol Violation|0|||
156928947|NCT02246673|566499438|FG003|Overall Study|Protocol Violation|1|||
156928948|NCT02246673|566499439|FG004|Overall Study|Protocol Violation|0|||
156928949|NCT02914769|566499440|FG000|Overall Study|Protocol Violation|3|||
156928950|NCT02914769|566499441|FG001|Overall Study|Protocol Violation|2|||
156928951|NCT02914769|566499440|FG000|Overall Study|Withdrawal by Subject|0|||
156928952|NCT02914769|566499441|FG001|Overall Study|Withdrawal by Subject|1|||
156928953|NCT04356963|566499442|FG000|First Session|Withdrawal by Subject|1|||
156928954|NCT04356963|566499442|FG000|Second Session|Withdrawal by Subject|3|||
156928955|NCT04356963|566499442|FG000|Second Session|Lost to Follow-up|1|||
156928956|NCT04356963|566499442|FG000|Third Session|Lost to Follow-up|6|||
156928957|NCT04356963|566499442|FG000|Third Session|Withdrawal by Subject|1|||
156928958|NCT02410954|566499444|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
156928959|NCT02410954|566499445|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
156928960|NCT02410954|566499444|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
156928961|NCT02410954|566499445|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
156928962|NCT02738333|566499446|FG000|Overall Study|Death|1|||
156928963|NCT02738333|566499447|FG001|Overall Study|Death|0|||
156928964|NCT02738333|566499448|FG002|Overall Study|Death|0|||
156928965|NCT02738333|566499446|FG000|Overall Study|Lost to Follow-up|1|||
156928966|NCT02738333|566499447|FG001|Overall Study|Lost to Follow-up|0|||
156928967|NCT02738333|566499448|FG002|Overall Study|Lost to Follow-up|0|||
156928968|NCT03755414|566499455|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
156928969|NCT03755414|566499456|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
156928970|NCT03755414|566499457|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
156928971|NCT03755414|566499455|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
156928972|NCT03755414|566499456|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
156928973|NCT03755414|566499457|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
156928974|NCT03755414|566499455|FG000|Overall Study|Non-compliance|0|||
156928975|NCT03755414|566499456|FG001|Overall Study|Non-compliance|1|||
156928976|NCT03755414|566499457|FG002|Overall Study|Non-compliance|0|||
156928977|NCT02153112|566499458|FG000|Overall Study|Adverse Event|0|||
156928978|NCT02153112|566499459|FG001|Overall Study|Adverse Event|0|||
156928979|NCT02153112|566499460|FG002|Overall Study|Adverse Event|1|||
156928980|NCT02153112|566499461|FG003|Overall Study|Adverse Event|0|||
156928981|NCT02153112|566499462|FG004|Overall Study|Adverse Event|0|||
156928982|NCT02153112|566499463|FG005|Overall Study|Adverse Event|0|||
156928983|NCT02153112|566499464|FG006|Overall Study|Adverse Event|0|||
156928984|NCT02153112|566499465|FG007|Overall Study|Adverse Event|0|||
156928985|NCT02153112|566499466|FG008|Overall Study|Adverse Event|0|||
156928986|NCT02153112|566499467|FG009|Overall Study|Adverse Event|0|||
156928987|NCT02153112|566499458|FG000|Overall Study|Lost to Follow-up|1|||
156928988|NCT02153112|566499459|FG001|Overall Study|Lost to Follow-up|1|||
156928989|NCT02153112|566499460|FG002|Overall Study|Lost to Follow-up|0|||
156928990|NCT02153112|566499461|FG003|Overall Study|Lost to Follow-up|0|||
156928991|NCT02153112|566499462|FG004|Overall Study|Lost to Follow-up|2|||
156928992|NCT02153112|566499463|FG005|Overall Study|Lost to Follow-up|1|||
156928993|NCT02153112|566499464|FG006|Overall Study|Lost to Follow-up|1|||
156928994|NCT02153112|566499465|FG007|Overall Study|Lost to Follow-up|0|||
156928995|NCT02153112|566499466|FG008|Overall Study|Lost to Follow-up|1|||
156928996|NCT02153112|566499467|FG009|Overall Study|Lost to Follow-up|1|||
156928997|NCT02153112|566499458|FG000|Overall Study|Withdrawal by Subject|3|||
156928998|NCT02153112|566499459|FG001|Overall Study|Withdrawal by Subject|1|||
156928999|NCT02153112|566499460|FG002|Overall Study|Withdrawal by Subject|2|||
156929000|NCT02153112|566499461|FG003|Overall Study|Withdrawal by Subject|2|||
156929001|NCT02153112|566499462|FG004|Overall Study|Withdrawal by Subject|1|||
156929002|NCT02153112|566499463|FG005|Overall Study|Withdrawal by Subject|1|||
156929003|NCT02153112|566499464|FG006|Overall Study|Withdrawal by Subject|7|||
156929004|NCT02153112|566499465|FG007|Overall Study|Withdrawal by Subject|2|||
156929005|NCT02153112|566499466|FG008|Overall Study|Withdrawal by Subject|13|||
156929006|NCT02153112|566499467|FG009|Overall Study|Withdrawal by Subject|12|||
156929007|NCT02153112|566499458|FG000|Overall Study|Reason not Specified|0|||
156929008|NCT02153112|566499459|FG001|Overall Study|Reason not Specified|0|||
157166574|NCT03224104|567350537|FG002|Overall Study|Death|0|||
157166575|NCT03224104|567350538|FG003|Overall Study|Death|0|||
157166576|NCT03224104|567350539|FG004|Overall Study|Death|0|||
157166577|NCT03224104|567350535|FG000|Overall Study|Adverse Event|1|||
157166578|NCT03224104|567350536|FG001|Overall Study|Adverse Event|0|||
157166579|NCT03224104|567350537|FG002|Overall Study|Adverse Event|0|||
157166580|NCT03224104|567350538|FG003|Overall Study|Adverse Event|1|||
157166581|NCT03224104|567350539|FG004|Overall Study|Adverse Event|3|||
157166582|NCT03224104|567350535|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
157166583|NCT03224104|567350536|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
157166584|NCT03224104|567350537|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
157166585|NCT03224104|567350538|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
157166586|NCT03224104|567350539|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
156929009|NCT02153112|566499460|FG002|Overall Study|Reason not Specified|0|||
156929010|NCT02153112|566499461|FG003|Overall Study|Reason not Specified|0|||
156929011|NCT02153112|566499462|FG004|Overall Study|Reason not Specified|0|||
156929012|NCT02153112|566499463|FG005|Overall Study|Reason not Specified|0|||
156929013|NCT02153112|566499464|FG006|Overall Study|Reason not Specified|0|||
156929014|NCT02153112|566499465|FG007|Overall Study|Reason not Specified|0|||
156929015|NCT02153112|566499466|FG008|Overall Study|Reason not Specified|1|||
156929016|NCT02153112|566499467|FG009|Overall Study|Reason not Specified|1|||
156929017|NCT04351087|566499468|FG000|Overall Study|Lost to Follow-up|7|||
156929018|NCT04351087|566499469|FG001|Overall Study|Lost to Follow-up|3|||
156929019|NCT04351087|566499468|FG000|Overall Study|Withdrawal by Subject|3|||
156929020|NCT04351087|566499469|FG001|Overall Study|Withdrawal by Subject|4|||
156929021|NCT04351087|566499468|FG000|Overall Study|Lack of Efficacy|3|||
156929022|NCT04351087|566499469|FG001|Overall Study|Lack of Efficacy|2|||
156929023|NCT05517382|566499470|FG000|Overall Study|Lost to Follow-up|0|||
156929024|NCT05517382|566499471|FG001|Overall Study|Lost to Follow-up|1|||
156929025|NCT01374087|566499474|FG000|Overall Study|Adverse Event|1|||
156929026|NCT01374087|566499475|FG001|Overall Study|Adverse Event|0|||
156929027|NCT01374087|566499474|FG000|Overall Study|Disease progression|2|||
156929028|NCT01374087|566499475|FG001|Overall Study|Disease progression|2|||
156929029|NCT01374087|566499474|FG000|Overall Study|Study discontinued|13|||
156929030|NCT01374087|566499475|FG001|Overall Study|Study discontinued|13|||
156929031|NCT00271947|566499478|FG000|Overall Study|Lost to Follow-up|1|||
156929032|NCT01522365|566499481|FG000|Overall Study|Withdrawal by Subject|1|||
156929033|NCT01522365|566499482|FG001|Overall Study|Withdrawal by Subject|1|||
156929034|NCT01522365|566499481|FG000|Overall Study|Lost to Follow-up|1|||
156929035|NCT01522365|566499482|FG001|Overall Study|Lost to Follow-up|1|||
156929036|NCT00651755|566499483|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
156929037|NCT00651755|566499484|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
156929038|NCT00651755|566499483|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
156929039|NCT00651755|566499484|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
156929040|NCT04170348|566499487|FG000|Overall Study|Lost to Follow-up|2|||
156929041|NCT04170348|566499488|FG001|Overall Study|Lost to Follow-up|2|||
156929042|NCT04170348|566499487|FG000|Overall Study|Withdrawal by Subject|1|||
156929043|NCT04170348|566499488|FG001|Overall Study|Withdrawal by Subject|5|||
156929044|NCT04170348|566499487|FG000|Overall Study|Non-adherence|1|||
156929045|NCT04170348|566499488|FG001|Overall Study|Non-adherence|1|||
156929046|NCT04170348|566499487|FG000|Overall Study|Adverse Event|1|||
156929047|NCT04170348|566499488|FG001|Overall Study|Adverse Event|0|||
156929048|NCT01602380|566499489|FG000|Overall Study|Death|147|||
156929049|NCT01602380|566499490|FG001|Overall Study|Death|145|||
156929050|NCT01602380|566499489|FG000|Overall Study|Withdrawal by Subject|39|||
156929051|NCT01602380|566499490|FG001|Overall Study|Withdrawal by Subject|41|||
156929052|NCT01602380|566499489|FG000|Overall Study|Lost to Follow-up|15|||
156929053|NCT01602380|566499490|FG001|Overall Study|Lost to Follow-up|12|||
156929054|NCT01602380|566499489|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156929055|NCT01602380|566499490|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
156929056|NCT01602380|566499489|FG000|Overall Study|Other|2|||
156929057|NCT01602380|566499490|FG001|Overall Study|Other|0|||
156929058|NCT05760300|566499493|FG000|Overall Study|Adverse Event|0|||
156929059|NCT05760300|566499494|FG001|Overall Study|Adverse Event|0|||
156929060|NCT05760300|566499495|FG002|Overall Study|Adverse Event|1|||
156929061|NCT05760300|566499496|FG003|Overall Study|Adverse Event|0|||
156929062|NCT05760300|566499493|FG000|Overall Study|Participant Decision|1|||
156929063|NCT05760300|566499494|FG001|Overall Study|Participant Decision|0|||
156929064|NCT05760300|566499495|FG002|Overall Study|Participant Decision|0|||
156929065|NCT05760300|566499496|FG003|Overall Study|Participant Decision|0|||
156929066|NCT01894581|566499497|FG000|Overall Study|Withdrawal by Subject|2|||
156929067|NCT01894581|566499498|FG001|Overall Study|Withdrawal by Subject|3|||
156929068|NCT01894581|566499497|FG000|Overall Study|Screen Failure|3|||
156929069|NCT01894581|566499498|FG001|Overall Study|Screen Failure|4|||
156929070|NCT03795298|566499502|FG000|Overall Study|Death|34|||
156929071|NCT03795298|566499503|FG001|Overall Study|Death|29|||
157166587|NCT03224104|567350535|FG000|Overall Study|Treatment ongoing|0|||
157166588|NCT03224104|567350536|FG001|Overall Study|Treatment ongoing|0|||
156929072|NCT03795298|566499502|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
156929073|NCT03795298|566499503|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
156929074|NCT03795298|566499502|FG000|Overall Study|Lost to Follow-up|28|||
156929075|NCT03795298|566499503|FG001|Overall Study|Lost to Follow-up|17|||
156929076|NCT03795298|566499502|FG000|Overall Study|Physician Decision|5|||
156929077|NCT03795298|566499503|FG001|Overall Study|Physician Decision|4|||
156929078|NCT03795298|566499502|FG000|Overall Study|Withdrawal by Subject|43|||
156929079|NCT03795298|566499503|FG001|Overall Study|Withdrawal by Subject|28|||
156929080|NCT03795298|566499502|FG000|Overall Study|Reason not reported|7|||
156929081|NCT03795298|566499503|FG001|Overall Study|Reason not reported|9|||
156929082|NCT01252940|566499504|FG000|Main Study Phase|Randomized but not treated|4|||
156929083|NCT01252940|566499505|FG001|Main Study Phase|Randomized but not treated|2|||
157166589|NCT03224104|567350537|FG002|Overall Study|Treatment ongoing|0|||
156929084|NCT01252940|566499504|FG000|Main Study Phase|Adverse Event|3|||
156929085|NCT01252940|566499505|FG001|Main Study Phase|Adverse Event|1|||
156929086|NCT01252940|566499504|FG000|Main Study Phase|Lack of Efficacy|1|||
156929087|NCT01252940|566499505|FG001|Main Study Phase|Lack of Efficacy|0|||
156929088|NCT01252940|566499504|FG000|Main Study Phase|Lost to Follow-up|6|||
156929089|NCT01252940|566499505|FG001|Main Study Phase|Lost to Follow-up|1|||
156929090|NCT01252940|566499504|FG000|Main Study Phase|Physician Decision|1|||
156929091|NCT01252940|566499505|FG001|Main Study Phase|Physician Decision|0|||
156929092|NCT01252940|566499504|FG000|Main Study Phase|Protocol Violation|4|||
156929093|NCT01252940|566499505|FG001|Main Study Phase|Protocol Violation|2|||
156929094|NCT01252940|566499504|FG000|Main Study Phase|Withdrawal by Subject|6|||
156929095|NCT01252940|566499505|FG001|Main Study Phase|Withdrawal by Subject|5|||
156929096|NCT01252940|566499504|FG000|Main Study Phase|Subject Non-compliance|1|||
157029228|NCT01928394|566862894|FG007|Follow-up Period|Participant withdrew consent|1|||
157029229|NCT01928394|566862895|FG008|Follow-up Period|Participant withdrew consent|0|||
157029230|NCT01928394|566862896|FG009|Follow-up Period|Participant withdrew consent|0|||
156929097|NCT01252940|566499505|FG001|Main Study Phase|Subject Non-compliance|1|||
156929098|NCT01252940|566499504|FG000|Extension Phase|Adverse Event|2|||
156929099|NCT01252940|566499505|FG001|Extension Phase|Adverse Event|1|||
156929100|NCT01252940|566499504|FG000|Extension Phase|Lack of Efficacy|1|||
156929101|NCT01252940|566499505|FG001|Extension Phase|Lack of Efficacy|0|||
156929102|NCT01252940|566499504|FG000|Extension Phase|Lost to Follow-up|5|||
156929103|NCT01252940|566499505|FG001|Extension Phase|Lost to Follow-up|0|||
156929104|NCT01252940|566499504|FG000|Extension Phase|Physician Decision|0|||
156929105|NCT01252940|566499505|FG001|Extension Phase|Physician Decision|1|||
156929106|NCT01252940|566499504|FG000|Extension Phase|Subject Non-compliance|1|||
156929107|NCT01252940|566499505|FG001|Extension Phase|Subject Non-compliance|0|||
156929108|NCT01252940|566499504|FG000|Extension Phase|Withdrawal by Subject|1|||
156929109|NCT01252940|566499505|FG001|Extension Phase|Withdrawal by Subject|1|||
156929110|NCT04199117|566499506|FG000|Overall Study|Withdrawal by Subject|3|||
156929111|NCT04199117|566499507|FG001|Overall Study|Withdrawal by Subject|0|||
156929112|NCT04199117|566499508|FG002|Overall Study|Withdrawal by Subject|0|||
156929113|NCT04199117|566499509|FG003|Overall Study|Withdrawal by Subject|1|||
156929114|NCT04199117|566499510|FG004|Overall Study|Withdrawal by Subject|1|||
156929115|NCT04199117|566499511|FG005|Overall Study|Withdrawal by Subject|0|||
156929116|NCT04199117|566499512|FG006|Overall Study|Withdrawal by Subject|0|||
156929117|NCT04199117|566499513|FG007|Overall Study|Withdrawal by Subject|2|||
157029231|NCT01928394|566862897|FG010|Follow-up Period|Participant withdrew consent|5|||
157029232|NCT01928394|566862898|FG011|Follow-up Period|Participant withdrew consent|8|||
157029233|NCT01928394|566862899|FG012|Follow-up Period|Participant withdrew consent|2|||
157029234|NCT01928394|566862900|FG013|Follow-up Period|Participant withdrew consent|12|||
157029235|NCT01928394|566862901|FG014|Follow-up Period|Participant withdrew consent|7|||
157029236|NCT01928394|566862902|FG015|Follow-up Period|Participant withdrew consent|0|||
157029237|NCT01928394|566862903|FG016|Follow-up Period|Participant withdrew consent|5|||
157029238|NCT01928394|566862904|FG017|Follow-up Period|Participant withdrew consent|3|||
157029239|NCT01928394|566862905|FG018|Follow-up Period|Participant withdrew consent|2|||
157029240|NCT01928394|566862906|FG019|Follow-up Period|Participant withdrew consent|7|||
157029241|NCT01928394|566862907|FG020|Follow-up Period|Participant withdrew consent|4|||
157029242|NCT01928394|566862908|FG021|Follow-up Period|Participant withdrew consent|6|||
157029243|NCT01928394|566862909|FG022|Follow-up Period|Participant withdrew consent|2|||
157029244|NCT01928394|566862887|FG000|Follow-up Period|Death|0|||
157029245|NCT01928394|566862888|FG001|Follow-up Period|Death|0|||
157029246|NCT01928394|566862889|FG002|Follow-up Period|Death|2|||
157029247|NCT01928394|566862890|FG003|Follow-up Period|Death|6|||
157029248|NCT01928394|566862891|FG004|Follow-up Period|Death|0|||
157029249|NCT01928394|566862892|FG005|Follow-up Period|Death|6|||
157029250|NCT01928394|566862893|FG006|Follow-up Period|Death|6|||
157029251|NCT01928394|566862894|FG007|Follow-up Period|Death|2|||
157029252|NCT01928394|566862895|FG008|Follow-up Period|Death|1|||
157029253|NCT01928394|566862896|FG009|Follow-up Period|Death|2|||
157029254|NCT01928394|566862897|FG010|Follow-up Period|Death|4|||
157029255|NCT01928394|566862898|FG011|Follow-up Period|Death|12|||
157029256|NCT01928394|566862899|FG012|Follow-up Period|Death|11|||
157029257|NCT01928394|566862900|FG013|Follow-up Period|Death|25|||
157029258|NCT01928394|566862901|FG014|Follow-up Period|Death|18|||
157029259|NCT01928394|566862902|FG015|Follow-up Period|Death|0|||
157029260|NCT01928394|566862903|FG016|Follow-up Period|Death|6|||
157029261|NCT01928394|566862904|FG017|Follow-up Period|Death|5|||
157029262|NCT01928394|566862905|FG018|Follow-up Period|Death|13|||
157029263|NCT01928394|566862906|FG019|Follow-up Period|Death|13|||
156929118|NCT04199117|566499514|FG008|Overall Study|Withdrawal by Subject|0|||
156929119|NCT04199117|566499515|FG009|Overall Study|Withdrawal by Subject|0|||
156929120|NCT04199117|566499516|FG010|Overall Study|Withdrawal by Subject|1|||
156929121|NCT04199117|566499517|FG011|Overall Study|Withdrawal by Subject|1|||
156929122|NCT04199117|566499518|FG012|Overall Study|Withdrawal by Subject|2|||
156929123|NCT04199117|566499519|FG013|Overall Study|Withdrawal by Subject|1|||
156929124|NCT04199117|566499520|FG014|Overall Study|Withdrawal by Subject|1|||
156929125|NCT04199117|566499521|FG015|Overall Study|Withdrawal by Subject|1|||
156929126|NCT04199117|566499506|FG000|Overall Study|Death|1|||
156929127|NCT04199117|566499507|FG001|Overall Study|Death|1|||
156929128|NCT04199117|566499508|FG002|Overall Study|Death|0|||
156929129|NCT04199117|566499509|FG003|Overall Study|Death|0|||
156929130|NCT04199117|566499510|FG004|Overall Study|Death|0|||
156929131|NCT04199117|566499511|FG005|Overall Study|Death|0|||
156929132|NCT04199117|566499512|FG006|Overall Study|Death|0|||
156929133|NCT04199117|566499513|FG007|Overall Study|Death|0|||
156929134|NCT04199117|566499514|FG008|Overall Study|Death|0|||
156929135|NCT04199117|566499515|FG009|Overall Study|Death|0|||
156929136|NCT04199117|566499516|FG010|Overall Study|Death|0|||
156929137|NCT04199117|566499517|FG011|Overall Study|Death|1|||
156929138|NCT04199117|566499518|FG012|Overall Study|Death|0|||
156929139|NCT04199117|566499519|FG013|Overall Study|Death|1|||
156929140|NCT04199117|566499520|FG014|Overall Study|Death|0|||
156929141|NCT04199117|566499521|FG015|Overall Study|Death|0|||
156929142|NCT04199117|566499506|FG000|Overall Study|Withdrawal by PI|0|||
156929143|NCT04199117|566499507|FG001|Overall Study|Withdrawal by PI|0|||
156929144|NCT04199117|566499508|FG002|Overall Study|Withdrawal by PI|0|||
156929145|NCT04199117|566499509|FG003|Overall Study|Withdrawal by PI|0|||
156929146|NCT04199117|566499510|FG004|Overall Study|Withdrawal by PI|0|||
156929147|NCT04199117|566499511|FG005|Overall Study|Withdrawal by PI|0|||
156929148|NCT04199117|566499512|FG006|Overall Study|Withdrawal by PI|0|||
156929149|NCT04199117|566499513|FG007|Overall Study|Withdrawal by PI|0|||
156929150|NCT04199117|566499514|FG008|Overall Study|Withdrawal by PI|0|||
156929151|NCT04199117|566499515|FG009|Overall Study|Withdrawal by PI|0|||
156929152|NCT04199117|566499516|FG010|Overall Study|Withdrawal by PI|0|||
156929153|NCT04199117|566499517|FG011|Overall Study|Withdrawal by PI|0|||
156929154|NCT04199117|566499518|FG012|Overall Study|Withdrawal by PI|1|||
156929155|NCT04199117|566499519|FG013|Overall Study|Withdrawal by PI|0|||
156929156|NCT04199117|566499520|FG014|Overall Study|Withdrawal by PI|0|||
156929157|NCT04199117|566499521|FG015|Overall Study|Withdrawal by PI|0|||
156929158|NCT04383743|566499522|FG000|Overall Study|Withdrawal by Subject|1|||
156929159|NCT04383743|566499522|FG000|Overall Study|Adverse Event|1|||
156929160|NCT03482791|566499529|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
156929161|NCT03482791|566499530|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
156929162|NCT04439253|566501010|FG000|Overall Study|Adverse Event|1|||
156929163|NCT04439253|566501010|FG000|Overall Study|Disease progression|2|||
156929164|NCT04439253|566501010|FG000|Overall Study|Complicating disease|1|||
156929165|NCT03971695|566501011|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929166|NCT03971695|566501012|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929167|NCT03971695|566501013|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929168|NCT03971695|566501014|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
156929169|NCT03971695|566501015|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
156929170|NCT03971695|566501016|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929171|NCT03971695|566501017|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929172|NCT03971695|566501018|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929173|NCT03971695|566501019|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
156929174|NCT03971695|566501020|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
156929175|NCT03971695|566501021|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156929176|NCT03971695|566501022|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156929177|NCT03971695|566501023|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
156929178|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
156929179|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
156929180|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
156929181|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
156929182|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
156929183|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
156929184|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
156929185|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
156929186|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
156929187|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
157166590|NCT03224104|567350538|FG003|Overall Study|Treatment ongoing|0|||
157166591|NCT03224104|567350539|FG004|Overall Study|Treatment ongoing|1|||
157166592|NCT01153893|567350542|FG000|Overall Study|Adverse Event|1|||
156929188|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
156929189|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
156929190|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
156929191|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
156929192|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
156929193|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
157166593|NCT01153893|567350543|FG001|Overall Study|Adverse Event|0|||
156929194|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
156929195|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
156929196|NCT00887354|566501029|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
156929197|NCT00887354|566501030|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
156929198|NCT00887354|566501029|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
156929199|NCT00887354|566501030|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
156929200|NCT00887354|566501029|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
156929201|NCT00887354|566501030|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
156929202|NCT00887354|566501029|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
156929203|NCT00887354|566501030|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
156929204|NCT00887354|566501029|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
156929205|NCT00887354|566501030|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
156929206|NCT00887354|566501029|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
156929207|NCT00887354|566501030|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
156929208|NCT01466348|566501033|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
156929209|NCT01466348|566501034|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
156929210|NCT00192504|566501037|FG000|Overall Study|Lost to Follow-up|1|||
156929211|NCT00192504|566501038|FG001|Overall Study|Lost to Follow-up|0|||
156929212|NCT00192504|566501039|FG002|Overall Study|Lost to Follow-up|0|||
156929213|NCT00192504|566501040|FG003|Overall Study|Lost to Follow-up|0|||
156929214|NCT00192504|566501037|FG000|Overall Study|Dosing window missed|0|||
156929215|NCT00192504|566501038|FG001|Overall Study|Dosing window missed|0|||
156929216|NCT00192504|566501039|FG002|Overall Study|Dosing window missed|1|||
156929217|NCT00192504|566501040|FG003|Overall Study|Dosing window missed|0|||
156929218|NCT03989440|566501041|FG000|Overall Study|COVID-19 travel restrictions|0|||
156929219|NCT03989440|566501042|FG001|Overall Study|COVID-19 travel restrictions|0|||
156929220|NCT03989440|566501043|FG002|Overall Study|COVID-19 travel restrictions|1|||
156929221|NCT03989440|566501044|FG003|Overall Study|COVID-19 travel restrictions|0|||
156929222|NCT03989440|566501045|FG004|Overall Study|COVID-19 travel restrictions|0|||
156929223|NCT03989440|566501046|FG005|Overall Study|COVID-19 travel restrictions|0|||
156929224|NCT03989440|566501041|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
156929225|NCT03989440|566501042|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
156929226|NCT03989440|566501043|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
156929227|NCT03989440|566501044|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
156929228|NCT03989440|566501045|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
156929229|NCT03989440|566501046|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
156929230|NCT01955161|566501049|FG000|Overall Study|Withdrawal before treatment|2|||
156929231|NCT01955161|566501050|FG001|Overall Study|Withdrawal before treatment|0|||
156929232|NCT01955161|566501051|FG002|Overall Study|Withdrawal before treatment|1|||
156929233|NCT01955161|566501049|FG000|Overall Study|Adverse Event|10|||
156929234|NCT01955161|566501050|FG001|Overall Study|Adverse Event|14|||
156929235|NCT01955161|566501051|FG002|Overall Study|Adverse Event|15|||
156929236|NCT01955161|566501049|FG000|Overall Study|Death|1|||
156929237|NCT01955161|566501050|FG001|Overall Study|Death|1|||
156929238|NCT01955161|566501051|FG002|Overall Study|Death|3|||
156929239|NCT01955161|566501049|FG000|Overall Study|Withdrawal by Subject|9|||
156929240|NCT01955161|566501050|FG001|Overall Study|Withdrawal by Subject|8|||
156929241|NCT01955161|566501051|FG002|Overall Study|Withdrawal by Subject|12|||
157166594|NCT04799405|567350544|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
156929242|NCT01955161|566501049|FG000|Overall Study|Protocol Violation|2|||
156929243|NCT01955161|566501050|FG001|Overall Study|Protocol Violation|0|||
156929244|NCT01955161|566501051|FG002|Overall Study|Protocol Violation|0|||
156929245|NCT01955161|566501049|FG000|Overall Study|Other reason: physician decision|0|||
156929246|NCT01955161|566501050|FG001|Overall Study|Other reason: physician decision|1|||
156929247|NCT01955161|566501051|FG002|Overall Study|Other reason: physician decision|1|||
156929248|NCT01955161|566501049|FG000|Overall Study|Other reason: disallowed medication|1|||
156929249|NCT01955161|566501050|FG001|Overall Study|Other reason: disallowed medication|0|||
156929250|NCT01955161|566501051|FG002|Overall Study|Other reason: disallowed medication|1|||
156929251|NCT01955161|566501049|FG000|Overall Study|Other reason: caregiver unavailable|1|||
156929252|NCT01955161|566501050|FG001|Overall Study|Other reason: caregiver unavailable|0|||
156929253|NCT01955161|566501051|FG002|Overall Study|Other reason: caregiver unavailable|0|||
156929254|NCT01955161|566501049|FG000|Overall Study|Other reason: moved to nursing home|0|||
156929255|NCT01955161|566501050|FG001|Overall Study|Other reason: moved to nursing home|1|||
156929256|NCT01955161|566501051|FG002|Overall Study|Other reason: moved to nursing home|0|||
157029264|NCT01928394|566862907|FG020|Follow-up Period|Death|5|||
157029265|NCT01928394|566862908|FG021|Follow-up Period|Death|3|||
156929257|NCT01955161|566501049|FG000|Overall Study|Other reason: insufficient compliance|0|||
156929258|NCT01955161|566501050|FG001|Overall Study|Other reason: insufficient compliance|0|||
156929259|NCT01955161|566501051|FG002|Overall Study|Other reason: insufficient compliance|1|||
156929260|NCT01955161|566501049|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
156929261|NCT01955161|566501050|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
157029266|NCT01928394|566862909|FG022|Follow-up Period|Death|2|||
156929262|NCT01955161|566501051|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
156929263|NCT01955161|566501049|FG000|Overall Study|Other reason: patient's will|0|||
156929264|NCT01955161|566501050|FG001|Overall Study|Other reason: patient's will|0|||
156929265|NCT01955161|566501051|FG002|Overall Study|Other reason: patient's will|1|||
156929266|NCT04608500|566501052|FG000|Overall Study|Adverse Event|2|||
156929267|NCT04608500|566501053|FG001|Overall Study|Adverse Event|0|||
156929268|NCT04608500|566501052|FG000|Overall Study|Lost to Follow-up|15|||
156929269|NCT04608500|566501053|FG001|Overall Study|Lost to Follow-up|9|||
156929270|NCT04608500|566501052|FG000|Overall Study|Participant request|11|||
156929271|NCT04608500|566501053|FG001|Overall Study|Participant request|7|||
156929272|NCT04608500|566501052|FG000|Overall Study|Protocol Violation|1|||
156929273|NCT04608500|566501053|FG001|Overall Study|Protocol Violation|0|||
156929274|NCT04608500|566501052|FG000|Overall Study|Other|6|||
156929275|NCT04608500|566501053|FG001|Overall Study|Other|2|||
156929276|NCT00542919|566501065|FG000|Overall Study|Adverse Event|1|||
156929277|NCT00542919|566501066|FG001|Overall Study|Adverse Event|5|||
156929278|NCT00542919|566501067|FG002|Overall Study|Adverse Event|1|||
156929279|NCT00542919|566501065|FG000|Overall Study|Withdrawal by Subject|1|||
156929280|NCT00542919|566501066|FG001|Overall Study|Withdrawal by Subject|0|||
156929281|NCT00542919|566501067|FG002|Overall Study|Withdrawal by Subject|3|||
156929282|NCT00542919|566501065|FG000|Overall Study|Physician Decision|2|||
156929283|NCT00542919|566501066|FG001|Overall Study|Physician Decision|2|||
156929284|NCT00542919|566501067|FG002|Overall Study|Physician Decision|1|||
156929285|NCT00542919|566501065|FG000|Overall Study|Sponsor Decision|1|||
156929286|NCT00542919|566501066|FG001|Overall Study|Sponsor Decision|0|||
156929287|NCT00542919|566501067|FG002|Overall Study|Sponsor Decision|0|||
156929288|NCT00542919|566501065|FG000|Overall Study|Lost to Follow-up|2|||
156929289|NCT00542919|566501066|FG001|Overall Study|Lost to Follow-up|0|||
156929290|NCT00542919|566501067|FG002|Overall Study|Lost to Follow-up|1|||
156929291|NCT02385266|566501068|FG000|Overall Study|Withdrawal by Subject|1|||
156929292|NCT02385266|566501069|FG001|Overall Study|Withdrawal by Subject|3|||
156929293|NCT00914810|566501070|FG000|Overall Study|Withdrawal by Subject|1|||
156929294|NCT00914810|566501071|FG001|Overall Study|Withdrawal by Subject|0|||
156929295|NCT00914810|566501070|FG000|Overall Study|Relocated out of state|1|||
156929296|NCT00914810|566501071|FG001|Overall Study|Relocated out of state|0|||
156929297|NCT00914810|566501070|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
156929298|NCT00914810|566501071|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
156929299|NCT02747420|566501072|FG000|Overall Study|Lost to Follow-up|4|||
156929300|NCT02747420|566501073|FG001|Overall Study|Lost to Follow-up|2|||
156929301|NCT02747420|566501072|FG000|Overall Study|Withdrawal by Subject|3|||
156929302|NCT02747420|566501073|FG001|Overall Study|Withdrawal by Subject|2|||
156929303|NCT03020823|566501074|FG000|Overall Study|Physician Decision|4|||
156929304|NCT03020823|566501074|FG000|Overall Study|Lack of Efficacy|4|||
157166595|NCT01253421|567350545|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
157166596|NCT01253421|567350546|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
157166597|NCT01253421|567350547|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
157166598|NCT01253421|567350548|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
157166599|NCT01253421|567350549|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
157166600|NCT01253421|567350545|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
157166601|NCT01253421|567350546|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
157166602|NCT01253421|567350547|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
157166603|NCT01253421|567350548|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
157166604|NCT01253421|567350549|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
156929305|NCT03020823|566501074|FG000|Overall Study|Adverse Event|2|||
156929306|NCT03739112|566501075|FG000|Overall Study|Adverse Event|2|||
156929307|NCT03739112|566501076|FG001|Overall Study|Adverse Event|2|||
156929308|NCT03739112|566501075|FG000|Overall Study|Withdrawal by Subject|38|||
156929309|NCT03739112|566501076|FG001|Overall Study|Withdrawal by Subject|19|||
156929310|NCT03739112|566501075|FG000|Overall Study|Lost to Follow-up|31|||
156929311|NCT03739112|566501076|FG001|Overall Study|Lost to Follow-up|33|||
156929312|NCT03739112|566501075|FG000|Overall Study|Protocol Deviation|12|||
156929313|NCT03739112|566501076|FG001|Overall Study|Protocol Deviation|9|||
156929314|NCT03739112|566501075|FG000|Overall Study|Physician Decision|1|||
156929315|NCT03739112|566501076|FG001|Overall Study|Physician Decision|0|||
157166605|NCT01253421|567350545|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
157166606|NCT01253421|567350546|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
156929316|NCT03739112|566501075|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
156929317|NCT03739112|566501076|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
156929318|NCT03739112|566501075|FG000|Overall Study|Site went on hold|65|||
156929319|NCT03739112|566501076|FG001|Overall Study|Site went on hold|67|||
156929320|NCT03739112|566501075|FG000|Overall Study|Other than specified|8|||
156929321|NCT03739112|566501076|FG001|Overall Study|Other than specified|5|||
156929322|NCT03739112|566501075|FG000|Overall Study|Randomized but not vaccinated|31|||
156929323|NCT03739112|566501076|FG001|Overall Study|Randomized but not vaccinated|25|||
156929324|NCT00588822|566501077|FG000|Overall Study|progression of disease|8|||
156929325|NCT01727141|566501080|FG000|Overall Study|Physician Decision|0|||
156929326|NCT01727141|566501081|FG001|Overall Study|Physician Decision|1|||
156929327|NCT01727141|566501082|FG002|Overall Study|Physician Decision|0|||
156929328|NCT01727141|566501083|FG003|Overall Study|Physician Decision|2|||
156929329|NCT01727141|566501080|FG000|Overall Study|Lost to Follow-up|0|||
156929330|NCT01727141|566501081|FG001|Overall Study|Lost to Follow-up|2|||
156929331|NCT01727141|566501082|FG002|Overall Study|Lost to Follow-up|0|||
156929332|NCT01727141|566501083|FG003|Overall Study|Lost to Follow-up|0|||
156929333|NCT01727141|566501080|FG000|Overall Study|Death|0|||
156929334|NCT01727141|566501081|FG001|Overall Study|Death|1|||
156929335|NCT01727141|566501082|FG002|Overall Study|Death|1|||
156929336|NCT01727141|566501083|FG003|Overall Study|Death|1|||
156929337|NCT01727141|566501080|FG000|Overall Study|Protocol deviation|1|||
156929338|NCT01727141|566501081|FG001|Overall Study|Protocol deviation|1|||
156929339|NCT01727141|566501082|FG002|Overall Study|Protocol deviation|0|||
156929340|NCT01727141|566501083|FG003|Overall Study|Protocol deviation|1|||
156929341|NCT01727141|566501080|FG000|Overall Study|Withdrawal by Subject|4|||
156929342|NCT01727141|566501081|FG001|Overall Study|Withdrawal by Subject|4|||
156929343|NCT01727141|566501082|FG002|Overall Study|Withdrawal by Subject|2|||
156929344|NCT01727141|566501083|FG003|Overall Study|Withdrawal by Subject|11|||
156929345|NCT02529137|566501084|FG000|Overall Study|Discontinuation for different reasons|8|||
156929346|NCT02731729|566501087|FG000|Overall Study|Death|2|||
156929347|NCT02731729|566501088|FG001|Overall Study|Death|2|||
156929348|NCT02731729|566501087|FG000|Overall Study|Study terminated by Sponsor|6|||
156929349|NCT02731729|566501088|FG001|Overall Study|Study terminated by Sponsor|6|||
156929350|NCT02731729|566501087|FG000|Overall Study|Withdrawal by Subject|1|||
156929351|NCT02731729|566501088|FG001|Overall Study|Withdrawal by Subject|0|||
156929352|NCT01344447|566501089|FG000|Overall Study|Adverse Event|1|||
156929353|NCT01344447|566501089|FG000|Overall Study|Protocol Violation|1|||
156929354|NCT01344447|566501089|FG000|Overall Study|Withdrawal by Subject|1|||
156929355|NCT01344447|566501089|FG000|Overall Study|The contrast was not seen|1|||
156929356|NCT01344447|566501089|FG000|Overall Study|Physician Decision|1|||
156929357|NCT01344447|566501089|FG000|Overall Study|MRA unsuccessful|1|||
156929358|NCT01344447|566501089|FG000|Overall Study|Bolus tracking failed|1|||
156929359|NCT01344447|566501089|FG000|Overall Study|Error of power injector|1|||
156929360|NCT01660711|566501090|FG000|Overall Study|Adverse Event|7|||
156929361|NCT01660711|566501090|FG000|Overall Study|Withdrawal by Subject|1|||
156929362|NCT00952341|566501092|FG000|Cycle 1|Adverse Event|4|||
156929363|NCT00952341|566501093|FG001|Cycle 1|Adverse Event|1|||
156929364|NCT00952341|566501092|FG000|Cycle 1|Withdrawal by Subject|3|||
156929365|NCT00952341|566501093|FG001|Cycle 1|Withdrawal by Subject|8|||
156929366|NCT00952341|566501092|FG000|Cycle 1|Protocol Violation|2|||
156929367|NCT00952341|566501093|FG001|Cycle 1|Protocol Violation|1|||
156929368|NCT00952341|566501092|FG000|Cycle 1|Lost to Follow-up|11|||
156929369|NCT00952341|566501093|FG001|Cycle 1|Lost to Follow-up|2|||
156929370|NCT00952341|566501092|FG000|Cycle 1|Physician Decision|0|||
156929371|NCT00952341|566501093|FG001|Cycle 1|Physician Decision|1|||
156929372|NCT00952341|566501092|FG000|Cycle 2|Withdrawal by Subject|1|||
156929373|NCT00952341|566501093|FG001|Cycle 2|Withdrawal by Subject|1|||
156929374|NCT00952341|566501092|FG000|Cycle 2|Protocol Violation|1|||
156929375|NCT00952341|566501093|FG001|Cycle 2|Protocol Violation|0|||
156929376|NCT00952341|566501092|FG000|Cycle 2|Lost to Follow-up|6|||
156929377|NCT00952341|566501093|FG001|Cycle 2|Lost to Follow-up|9|||
156929378|NCT00952341|566501092|FG000|Cycle 2|Physician Decision|1|||
156929379|NCT00952341|566501093|FG001|Cycle 2|Physician Decision|1|||
156929380|NCT00952341|566501092|FG000|Cycle 2|Progressive Disease|0|||
156929381|NCT00952341|566501093|FG001|Cycle 2|Progressive Disease|1|||
156929382|NCT02066467|566501098|FG000|Overall Study|Did not undergo implant procedure|24|||
156929383|NCT02066467|566501098|FG000|Overall Study|Attempted to implant withoput success|43|||
156929384|NCT02066467|566501098|FG000|Overall Study|Consent ineligible|1|||
157227051|NCT00409578|567576034|FG003|Overall Study|Withdrawal by Subject|17|||
157227052|NCT00409578|567576031|FG000|Overall Study|Lost to Follow-up|2|||
156929385|NCT02066467|566501098|FG000|Overall Study|Death|54|||
156929386|NCT02066467|566501098|FG000|Overall Study|Lost to Follow-up|51|||
156929387|NCT02066467|566501098|FG000|Overall Study|Adverse Event|20|||
156929388|NCT02066467|566501098|FG000|Overall Study|Withdrawal by Subject|16|||
156929389|NCT02066467|566501098|FG000|Overall Study|Physician Decision|2|||
156929390|NCT02066467|566501098|FG000|Overall Study|Not defined|4|||
156929391|NCT02759120|566501104|FG000|Overall Study|Death|34|||
156929392|NCT02759120|566501105|FG001|Overall Study|Death|36|||
156929393|NCT02759120|566501104|FG000|Overall Study|Lost to Follow-up|4|||
156929394|NCT02759120|566501105|FG001|Overall Study|Lost to Follow-up|7|||
156929395|NCT02759120|566501104|FG000|Overall Study|Physician Decision|3|||
156929396|NCT02759120|566501105|FG001|Overall Study|Physician Decision|0|||
156929397|NCT02759120|566501104|FG000|Overall Study|Withdrawal by Subject|28|||
156929398|NCT02759120|566501105|FG001|Overall Study|Withdrawal by Subject|15|||
156929399|NCT02759120|566501104|FG000|Overall Study|Moved out of area|3|||
156929400|NCT02759120|566501105|FG001|Overall Study|Moved out of area|4|||
156929401|NCT02759120|566501104|FG000|Overall Study|Lung transplant|3|||
156929402|NCT02759120|566501105|FG001|Overall Study|Lung transplant|5|||
156929403|NCT02759120|566501104|FG000|Overall Study|Other reason not completed|10|||
156929404|NCT02759120|566501105|FG001|Overall Study|Other reason not completed|12|||
156929405|NCT04461015|566501107|FG000|Overall Study|IV access lost during the study|0|||
156929406|NCT04461015|566501108|FG001|Overall Study|IV access lost during the study|1|||
156929407|NCT04461015|566501107|FG000|Overall Study|Withdrawal by Subject|0|||
156929408|NCT04461015|566501108|FG001|Overall Study|Withdrawal by Subject|1|||
156929409|NCT02063854|566501115|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
156929410|NCT02063854|566501116|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
156929411|NCT02063854|566501117|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
156929412|NCT02063854|566501118|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
156929413|NCT02063854|566501119|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
156929414|NCT02063854|566501120|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
156929415|NCT02063854|566501121|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
156929416|NCT02063854|566501115|FG000|Overall Study|Major Protocol Deviation|0|||
156929417|NCT02063854|566501116|FG001|Overall Study|Major Protocol Deviation|0|||
156929418|NCT02063854|566501117|FG002|Overall Study|Major Protocol Deviation|3|||
156929419|NCT02063854|566501118|FG003|Overall Study|Major Protocol Deviation|0|||
156929420|NCT02063854|566501119|FG004|Overall Study|Major Protocol Deviation|0|||
156929421|NCT02063854|566501120|FG005|Overall Study|Major Protocol Deviation|0|||
156929422|NCT02063854|566501121|FG006|Overall Study|Major Protocol Deviation|0|||
156929423|NCT02063854|566501115|FG000|Overall Study|Voluntary Withdrawal|2|||
156929424|NCT02063854|566501116|FG001|Overall Study|Voluntary Withdrawal|0|||
156929425|NCT02063854|566501117|FG002|Overall Study|Voluntary Withdrawal|8|||
156929426|NCT02063854|566501118|FG003|Overall Study|Voluntary Withdrawal|1|||
156929427|NCT02063854|566501119|FG004|Overall Study|Voluntary Withdrawal|3|||
156929428|NCT02063854|566501120|FG005|Overall Study|Voluntary Withdrawal|6|||
156929429|NCT02063854|566501121|FG006|Overall Study|Voluntary Withdrawal|1|||
156929430|NCT02063854|566501115|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
156929431|NCT02063854|566501116|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
156929432|NCT02063854|566501117|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
156929433|NCT02063854|566501118|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
156929434|NCT02063854|566501119|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
156929435|NCT02063854|566501120|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
156929436|NCT02063854|566501121|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
156929437|NCT02063854|566501115|FG000|Overall Study|Reason Not Specified|1|||
156929438|NCT02063854|566501116|FG001|Overall Study|Reason Not Specified|0|||
156929439|NCT02063854|566501117|FG002|Overall Study|Reason Not Specified|0|||
156929440|NCT02063854|566501118|FG003|Overall Study|Reason Not Specified|0|||
156929441|NCT02063854|566501119|FG004|Overall Study|Reason Not Specified|0|||
156929442|NCT02063854|566501120|FG005|Overall Study|Reason Not Specified|0|||
156929443|NCT02063854|566501121|FG006|Overall Study|Reason Not Specified|0|||
156929444|NCT02063854|566501115|FG000|Overall Study|Did Not Receive Study Drug|0|||
156929445|NCT02063854|566501116|FG001|Overall Study|Did Not Receive Study Drug|0|||
156929446|NCT02063854|566501117|FG002|Overall Study|Did Not Receive Study Drug|0|||
156929447|NCT02063854|566501118|FG003|Overall Study|Did Not Receive Study Drug|0|||
156929448|NCT02063854|566501119|FG004|Overall Study|Did Not Receive Study Drug|0|||
156929449|NCT02063854|566501120|FG005|Overall Study|Did Not Receive Study Drug|1|||
156929450|NCT02063854|566501121|FG006|Overall Study|Did Not Receive Study Drug|0|||
156929451|NCT00791518|566501122|FG000|Overall Study|Protocol Violation|93|||
156929452|NCT05413369|566501123|FG000|Overall Study|Adverse Event|1|||
156929453|NCT05413369|566501124|FG001|Overall Study|Adverse Event|1|||
156929454|NCT05413369|566501123|FG000|Overall Study|Withdrawal by Subject|13|||
156929455|NCT05413369|566501124|FG001|Overall Study|Withdrawal by Subject|4|||
156929456|NCT05413369|566501123|FG000|Overall Study|Non-compliance with study schedule|2|||
156929457|NCT05413369|566501124|FG001|Overall Study|Non-compliance with study schedule|1|||
156929458|NCT05413369|566501123|FG000|Overall Study|Other|1|||
156929459|NCT05413369|566501124|FG001|Overall Study|Other|1|||
156929460|NCT03165110|566501128|FG000|Overall Study|Anroid phone software incompatibility|1|||
156929461|NCT00454987|566501133|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
156929462|NCT00454987|566501134|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
156929463|NCT00454987|566501135|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
156929464|NCT00454987|566501133|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
157029267|NCT01928394|566862887|FG000|Follow-up Period|other reason|0|||
156929465|NCT00454987|566501134|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
156929466|NCT00454987|566501135|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
156929467|NCT00454987|566501133|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
157029268|NCT01928394|566862888|FG001|Follow-up Period|other reason|0|||
156929468|NCT00454987|566501134|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
156929469|NCT00454987|566501135|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
156929470|NCT00973479|566501136|FG000|Overall Study|Lost to Follow-up|0|||
156929471|NCT00973479|566501137|FG001|Overall Study|Lost to Follow-up|3|||
156929472|NCT00973479|566501136|FG000|Overall Study|Death|2|||
156929473|NCT00973479|566501137|FG001|Overall Study|Death|2|||
156929474|NCT00973479|566501136|FG000|Overall Study|Withdrawal by Subject|15|||
156929475|NCT00973479|566501137|FG001|Overall Study|Withdrawal by Subject|16|||
156929476|NCT00973479|566501136|FG000|Overall Study|Lack of Efficacy|5|||
156929477|NCT00973479|566501137|FG001|Overall Study|Lack of Efficacy|7|||
156929478|NCT00973479|566501136|FG000|Overall Study|Adverse Event|12|||
156929479|NCT00973479|566501137|FG001|Overall Study|Adverse Event|32|||
156929480|NCT00973479|566501136|FG000|Overall Study|Protocol Violation|2|||
156929481|NCT00973479|566501137|FG001|Overall Study|Protocol Violation|2|||
156929482|NCT00973479|566501136|FG000|Overall Study|Other|1|||
156929483|NCT00973479|566501137|FG001|Overall Study|Other|7|||
156929484|NCT05075850|566501138|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
156929485|NCT04256785|566501139|FG000|Overall Study|Adverse Event|8|||
156929486|NCT04256785|566501140|FG001|Overall Study|Adverse Event|6|||
156929487|NCT04256785|566501139|FG000|Overall Study|Lack of Efficacy|3|||
156929488|NCT04256785|566501140|FG001|Overall Study|Lack of Efficacy|4|||
156929489|NCT04256785|566501139|FG000|Overall Study|Lost to Follow-up|7|||
156929490|NCT04256785|566501140|FG001|Overall Study|Lost to Follow-up|7|||
156929491|NCT04256785|566501139|FG000|Overall Study|Protocol Violation|1|||
156929492|NCT04256785|566501140|FG001|Overall Study|Protocol Violation|0|||
156929493|NCT04256785|566501139|FG000|Overall Study|Withdrawal by Subject|4|||
156929494|NCT04256785|566501140|FG001|Overall Study|Withdrawal by Subject|1|||
156929495|NCT04256785|566501139|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
156929496|NCT04256785|566501140|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
156929497|NCT00643682|566501142|FG000|Overall Study|did not keep appointment|522|||
156929498|NCT00643682|566501143|FG001|Overall Study|did not keep appointment|509|||
156929499|NCT02642432|566501144|FG000|Overall Study|Adverse Event|2|||
156929500|NCT02642432|566501144|FG000|Overall Study|Withdrew Consent|1|||
156929501|NCT02642432|566501144|FG000|Overall Study|Lost to Follow-up|2|||
156929502|NCT02642432|566501144|FG000|Overall Study|Other|3|||
156929503|NCT04814433|566501145|FG000|Overall Study|Survey not returned|4|||
156929504|NCT04814433|566501146|FG001|Overall Study|Survey not returned|8|||
156929505|NCT04814433|566501147|FG002|Overall Study|Survey not returned|4|||
156929506|NCT04814433|566501148|FG003|Overall Study|Survey not returned|5|||
156929507|NCT01545817|566502770|FG000|Pazopanib|Disease progression|51|||
156929508|NCT01545817|566502771|FG001|Pazopanib|Disease progression|0|||
156929509|NCT01545817|566502770|FG000|Pazopanib|Adverse Event|19|||
156929510|NCT01545817|566502771|FG001|Pazopanib|Adverse Event|0|||
156929511|NCT01545817|566502770|FG000|Pazopanib|Other reason|4|||
156929512|NCT01545817|566502771|FG001|Pazopanib|Other reason|0|||
156929513|NCT01545817|566502770|FG000|Everolimus|Other reason|0|||
156929514|NCT01545817|566502771|FG001|Everolimus|Other reason|7|||
156929515|NCT01545817|566502770|FG000|Everolimus|Disease progression|0|||
156929516|NCT01545817|566502771|FG001|Everolimus|Disease progression|25|||
156929517|NCT01545817|566502770|FG000|Everolimus|Adverse Event|0|||
156929518|NCT01545817|566502771|FG001|Everolimus|Adverse Event|6|||
156929519|NCT02967692|566502772|FG000|Overall Study|Progressive disease|3|||
156929520|NCT02967692|566502773|FG001|Overall Study|Progressive disease|15|||
156929521|NCT02967692|566502774|FG002|Overall Study|Progressive disease|114|||
156929522|NCT02967692|566502775|FG003|Overall Study|Progressive disease|151|||
156929523|NCT02967692|566502772|FG000|Overall Study|Subject/guardian decision|1|||
156929524|NCT02967692|566502773|FG001|Overall Study|Subject/guardian decision|1|||
156929525|NCT02967692|566502774|FG002|Overall Study|Subject/guardian decision|14|||
156929526|NCT02967692|566502775|FG003|Overall Study|Subject/guardian decision|22|||
156929527|NCT02967692|566502772|FG000|Overall Study|Death|0|||
156929528|NCT02967692|566502773|FG001|Overall Study|Death|1|||
156929529|NCT02967692|566502774|FG002|Overall Study|Death|13|||
156929530|NCT02967692|566502775|FG003|Overall Study|Death|13|||
156929531|NCT02967692|566502772|FG000|Overall Study|Protocol deviation|1|||
156929532|NCT02967692|566502773|FG001|Overall Study|Protocol deviation|0|||
156929533|NCT02967692|566502774|FG002|Overall Study|Protocol deviation|1|||
156929534|NCT02967692|566502775|FG003|Overall Study|Protocol deviation|1|||
156929535|NCT02967692|566502772|FG000|Overall Study|Lost to Follow-up|0|||
156929536|NCT02967692|566502773|FG001|Overall Study|Lost to Follow-up|0|||
156929537|NCT02967692|566502774|FG002|Overall Study|Lost to Follow-up|1|||
156929538|NCT02967692|566502775|FG003|Overall Study|Lost to Follow-up|0|||
156929539|NCT02967692|566502772|FG000|Overall Study|Physician Decision|0|||
156929540|NCT02967692|566502773|FG001|Overall Study|Physician Decision|0|||
156929541|NCT02967692|566502774|FG002|Overall Study|Physician Decision|22|||
156929542|NCT02967692|566502775|FG003|Overall Study|Physician Decision|13|||
156929543|NCT02967692|566502772|FG000|Overall Study|Adverse Event|2|||
156929544|NCT02967692|566502773|FG001|Overall Study|Adverse Event|9|||
156929545|NCT02967692|566502774|FG002|Overall Study|Adverse Event|60|||
156929546|NCT02967692|566502775|FG003|Overall Study|Adverse Event|28|||
156929547|NCT02967692|566502772|FG000|Overall Study|Study terminated by sponsor|2|||
156929548|NCT02967692|566502773|FG001|Overall Study|Study terminated by sponsor|1|||
156929549|NCT02967692|566502774|FG002|Overall Study|Study terminated by sponsor|42|||
156929550|NCT02967692|566502775|FG003|Overall Study|Study terminated by sponsor|37|||
156929551|NCT04447417|566502776|FG000|Overall Study|Withdrawal by Subject|1|||
156929552|NCT04447417|566502777|FG001|Overall Study|Withdrawal by Subject|0|||
156929553|NCT04447417|566502776|FG000|Overall Study|Failure to meet inclusion criteria|1|||
156929554|NCT04447417|566502777|FG001|Overall Study|Failure to meet inclusion criteria|0|||
156929555|NCT04447417|566502776|FG000|Overall Study|Lost to Follow-up|1|||
156929556|NCT04447417|566502777|FG001|Overall Study|Lost to Follow-up|0|||
156929557|NCT00702403|566502778|FG000|From Consent to Engraftment|Progressive leukemia|6|||
156929558|NCT00702403|566502778|FG000|From Consent to Engraftment|Critically ill|2|||
156929559|NCT00702403|566502778|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
156929560|NCT00702403|566502778|FG000|From Consent to Engraftment|Myocardial infarction|1|||
156929561|NCT00702403|566502778|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
156929562|NCT00702403|566502778|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
156929563|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
156929564|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
156929565|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Non-compliance|2|||
156929566|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
156929567|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
156929568|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Suicide|1|||
156929569|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
156929570|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
156929571|NCT00702403|566502778|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
156929572|NCT00066066|566502779|FG000|Overall Study|Lost to Follow-up|6|||
156929573|NCT00066066|566502780|FG001|Overall Study|Lost to Follow-up|4|||
156929574|NCT00066066|566502781|FG002|Overall Study|Lost to Follow-up|7|||
156929575|NCT00066066|566502782|FG003|Overall Study|Lost to Follow-up|4|||
156929576|NCT00066066|566502783|FG004|Overall Study|Lost to Follow-up|3|||
156929577|NCT00066066|566502784|FG005|Overall Study|Lost to Follow-up|5|||
156929578|NCT01881230|566502789|FG000|Overall Study|Death|2|||
156929579|NCT01881230|566502790|FG001|Overall Study|Death|0|||
156929580|NCT01881230|566502791|FG002|Overall Study|Death|1|||
156929581|NCT01881230|566502789|FG000|Overall Study|Adverse Event|9|||
156929582|NCT01881230|566502790|FG001|Overall Study|Adverse Event|13|||
156929583|NCT01881230|566502791|FG002|Overall Study|Adverse Event|12|||
156929584|NCT01881230|566502789|FG000|Overall Study|Progressive Disease|31|||
156929585|NCT01881230|566502790|FG001|Overall Study|Progressive Disease|35|||
156929586|NCT01881230|566502791|FG002|Overall Study|Progressive Disease|36|||
156929587|NCT01881230|566502789|FG000|Overall Study|Symptomatic Deterioration|3|||
156929588|NCT01881230|566502790|FG001|Overall Study|Symptomatic Deterioration|3|||
156929589|NCT01881230|566502791|FG002|Overall Study|Symptomatic Deterioration|1|||
156929590|NCT01881230|566502789|FG000|Overall Study|Withdrawal by Subject|6|||
156929591|NCT01881230|566502790|FG001|Overall Study|Withdrawal by Subject|4|||
156929592|NCT01881230|566502791|FG002|Overall Study|Withdrawal by Subject|6|||
156929593|NCT01881230|566502789|FG000|Overall Study|Physician Decision|4|||
156929594|NCT01881230|566502790|FG001|Overall Study|Physician Decision|3|||
156929595|NCT01881230|566502791|FG002|Overall Study|Physician Decision|6|||
156929596|NCT01881230|566502789|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156929597|NCT01881230|566502790|FG001|Overall Study|Non-Compliance with Study Drug|2|||
156929598|NCT01881230|566502791|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156929599|NCT01881230|566502789|FG000|Overall Study|Given Commercially Available Drug|0|||
156929600|NCT01881230|566502790|FG001|Overall Study|Given Commercially Available Drug|0|||
156929601|NCT01881230|566502791|FG002|Overall Study|Given Commercially Available Drug|2|||
156929602|NCT01881230|566502789|FG000|Overall Study|Protocol Violation|1|||
156929603|NCT01881230|566502790|FG001|Overall Study|Protocol Violation|1|||
156929604|NCT01881230|566502791|FG002|Overall Study|Protocol Violation|0|||
156929605|NCT01881230|566502789|FG000|Overall Study|Miscellaneous|3|||
156929606|NCT01881230|566502790|FG001|Overall Study|Miscellaneous|3|||
156929607|NCT01881230|566502791|FG002|Overall Study|Miscellaneous|0|||
157029269|NCT01928394|566862889|FG002|Follow-up Period|other reason|0|||
156929608|NCT01881230|566502789|FG000|Overall Study|Untreated: Other|0|||
156929609|NCT01881230|566502790|FG001|Overall Study|Untreated: Other|0|||
156929610|NCT01881230|566502791|FG002|Overall Study|Untreated: Other|1|||
156929611|NCT01881230|566502789|FG000|Overall Study|Untreated: Death|0|||
156929612|NCT01881230|566502790|FG001|Overall Study|Untreated: Death|0|||
156929613|NCT01881230|566502791|FG002|Overall Study|Untreated: Death|1|||
156929614|NCT01881230|566502789|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
156929615|NCT01881230|566502790|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
156929616|NCT01881230|566502791|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
156929617|NCT05129488|566502792|FG000|Overall Study|Protocol Violation|3|||
156929618|NCT00706641|566502797|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
156929619|NCT00706641|566502797|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
157029270|NCT01928394|566862890|FG003|Follow-up Period|other reason|0|||
156929620|NCT00706641|566502797|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
156929621|NCT04782856|566502798|FG000|Overall Study|Withdrawal by Subject|0|||
157029271|NCT01928394|566862891|FG004|Follow-up Period|other reason|0|||
156929622|NCT04782856|566502799|FG001|Overall Study|Withdrawal by Subject|1|||
156929623|NCT01030523|566502800|FG000|Initial Study (5 Years)|Death|1|||
157029272|NCT01928394|566862892|FG005|Follow-up Period|other reason|0|||
156929624|NCT01030523|566502801|FG001|Initial Study (5 Years)|Death|0|||
156929625|NCT01030523|566502800|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
156929626|NCT01030523|566502801|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
156929627|NCT01030523|566502800|FG000|Initial Study (5 Years)|Implant failure|1|||
156929628|NCT01030523|566502801|FG001|Initial Study (5 Years)|Implant failure|0|||
156929629|NCT01030523|566502800|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
156929630|NCT01030523|566502801|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
156929631|NCT01030523|566502800|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
156929632|NCT01030523|566502801|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
156929633|NCT01030523|566502800|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
156929634|NCT01030523|566502801|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
156929635|NCT00798369|566502804|FG000|Overall Study|Subject withdrew consent|0|||
156929636|NCT00798369|566502805|FG001|Overall Study|Subject withdrew consent|0|||
156929637|NCT00798369|566502806|FG002|Overall Study|Subject withdrew consent|1|||
156929638|NCT00798369|566502807|FG003|Overall Study|Subject withdrew consent|1|||
156929639|NCT00798369|566502808|FG004|Overall Study|Subject withdrew consent|0|||
156929640|NCT00798369|566502809|FG005|Overall Study|Subject withdrew consent|2|||
156929641|NCT00798369|566502804|FG000|Overall Study|Lost to Follow-up|1|||
156929642|NCT00798369|566502805|FG001|Overall Study|Lost to Follow-up|1|||
156929643|NCT00798369|566502806|FG002|Overall Study|Lost to Follow-up|1|||
156929644|NCT00798369|566502807|FG003|Overall Study|Lost to Follow-up|0|||
156929645|NCT00798369|566502808|FG004|Overall Study|Lost to Follow-up|1|||
156929646|NCT00798369|566502809|FG005|Overall Study|Lost to Follow-up|0|||
156929647|NCT00798369|566502804|FG000|Overall Study|Adminstrative problems|0|||
156929648|NCT00798369|566502805|FG001|Overall Study|Adminstrative problems|0|||
156929649|NCT00798369|566502806|FG002|Overall Study|Adminstrative problems|0|||
156929650|NCT00798369|566502807|FG003|Overall Study|Adminstrative problems|0|||
156929651|NCT00798369|566502808|FG004|Overall Study|Adminstrative problems|0|||
156929652|NCT00798369|566502809|FG005|Overall Study|Adminstrative problems|1|||
156929653|NCT04475588|566502810|FG000|Overall Study|Adverse Event|2|||
156929654|NCT04475588|566502811|FG001|Overall Study|Adverse Event|0|||
156929655|NCT01327300|566502812|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
156929656|NCT01327300|566502813|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
156929657|NCT04307446|566502815|FG000|Overall Study|Lost to Follow-up|2|||
156929658|NCT04307446|566502816|FG001|Overall Study|Lost to Follow-up|0|||
156929659|NCT02515942|566502817|FG000|Overall Study|Adverse Event|5|||
156929660|NCT02515942|566502818|FG001|Overall Study|Adverse Event|0|||
156929661|NCT02515942|566502819|FG002|Overall Study|Adverse Event|0|||
156929662|NCT02515942|566502817|FG000|Overall Study|Death|0|||
156929663|NCT02515942|566502818|FG001|Overall Study|Death|0|||
156929664|NCT02515942|566502819|FG002|Overall Study|Death|1|||
156929665|NCT02515942|566502817|FG000|Overall Study|Lack of Efficacy|0|||
156929666|NCT02515942|566502818|FG001|Overall Study|Lack of Efficacy|0|||
156929667|NCT02515942|566502819|FG002|Overall Study|Lack of Efficacy|1|||
156929668|NCT02515942|566502817|FG000|Overall Study|Lost to Follow-up|2|||
156929669|NCT02515942|566502818|FG001|Overall Study|Lost to Follow-up|0|||
156929670|NCT02515942|566502819|FG002|Overall Study|Lost to Follow-up|0|||
156929671|NCT02515942|566502817|FG000|Overall Study|Withdrawal by Subject|0|||
156929672|NCT02515942|566502818|FG001|Overall Study|Withdrawal by Subject|3|||
156929673|NCT02515942|566502819|FG002|Overall Study|Withdrawal by Subject|2|||
156929674|NCT01063764|566502820|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
156929675|NCT01063764|566502820|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
156929676|NCT01063764|566502820|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
156929677|NCT01063764|566502820|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
156929678|NCT01063764|566502820|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
156929679|NCT01063764|566502820|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
156929680|NCT01063764|566502820|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
156929681|NCT00697515|566502821|FG000|Dose Optimization Period|Adverse Event|4|||
156929682|NCT00697515|566502822|FG001|Dose Optimization Period|Adverse Event|0|||
156929683|NCT00697515|566502821|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
156929684|NCT00697515|566502822|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
156929685|NCT00697515|566502821|FG000|Dose Optimization Period|Lost to Follow-up|2|||
157166607|NCT01253421|567350547|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
156929686|NCT00697515|566502822|FG001|Dose Optimization Period|Lost to Follow-up|0|||
156929687|NCT00697515|566502821|FG000|Dose Optimization Period|sponsor request|2|||
156929688|NCT00697515|566502822|FG001|Dose Optimization Period|sponsor request|0|||
156929689|NCT00697515|566502821|FG000|Dose Optimization Period|called to active duty|1|||
156929690|NCT00697515|566502822|FG001|Dose Optimization Period|called to active duty|0|||
156929691|NCT00697515|566502821|FG000|Dose Optimization Period|elevated QTc|1|||
156929692|NCT00697515|566502822|FG001|Dose Optimization Period|elevated QTc|0|||
156929693|NCT00697515|566502821|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
156929694|NCT00697515|566502822|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
156929695|NCT00697515|566502821|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
156929696|NCT00697515|566502822|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
156929697|NCT00697515|566502821|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
156929698|NCT00697515|566502822|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
156929699|NCT00697515|566502821|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
156929700|NCT00697515|566502822|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
156929701|NCT02603432|566502823|FG000|Overall Study|Adverse Event|1|||
156929702|NCT02603432|566502824|FG001|Overall Study|Adverse Event|0|||
156929703|NCT02603432|566502823|FG000|Overall Study|Death|221|||
156929704|NCT02603432|566502824|FG001|Overall Study|Death|242|||
156929705|NCT02603432|566502823|FG000|Overall Study|Lost to Follow-up|3|||
156929706|NCT02603432|566502824|FG001|Overall Study|Lost to Follow-up|9|||
156929707|NCT02603432|566502823|FG000|Overall Study|Progressive Disease|7|||
156929708|NCT02603432|566502824|FG001|Overall Study|Progressive Disease|5|||
156929709|NCT02603432|566502823|FG000|Overall Study|Withdrawal by Subject|12|||
156929710|NCT02603432|566502824|FG001|Overall Study|Withdrawal by Subject|18|||
156929711|NCT02603432|566502823|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
156929712|NCT02603432|566502824|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
156929713|NCT02603432|566502823|FG000|Overall Study|Study terminated by sponsor|74|||
156929714|NCT02603432|566502824|FG001|Overall Study|Study terminated by sponsor|75|||
156929715|NCT02603432|566502823|FG000|Overall Study|Other|13|||
156929716|NCT02603432|566502824|FG001|Overall Study|Other|0|||
156929717|NCT00666757|566502825|FG000|Overall Study|Lost to Follow-up|39|||
156929718|NCT00666757|566502826|FG001|Overall Study|Lost to Follow-up|35|||
156929719|NCT00666757|566502825|FG000|Overall Study|Protocol Violation|23|||
156929720|NCT00666757|566502826|FG001|Overall Study|Protocol Violation|24|||
156929721|NCT00666757|566502825|FG000|Overall Study|Adverse Event|22|||
156929722|NCT00666757|566502826|FG001|Overall Study|Adverse Event|12|||
156929723|NCT00666757|566502825|FG000|Overall Study|Withdrawal by Subject|13|||
156929724|NCT00666757|566502826|FG001|Overall Study|Withdrawal by Subject|17|||
156929725|NCT00666757|566502825|FG000|Overall Study|Lack of Efficacy|3|||
156929726|NCT00666757|566502826|FG001|Overall Study|Lack of Efficacy|6|||
156929727|NCT00666757|566502825|FG000|Overall Study|Physician Decision|0|||
156929728|NCT00666757|566502826|FG001|Overall Study|Physician Decision|2|||
156929729|NCT00666757|566502825|FG000|Overall Study|Sponsor decision|0|||
156929730|NCT00666757|566502826|FG001|Overall Study|Sponsor decision|1|||
156929731|NCT05954052|566502827|FG000|Overall Study|Adverse Event|1|||
156929732|NCT01957462|566502828|FG000|Test Period 1|Withdrawal by Subject|1|||
156929733|NCT01957462|566502829|FG001|Test Period 1|Withdrawal by Subject|0|||
156929734|NCT01957462|566502828|FG000|Test Period 1|Adverse Event|1|||
156929735|NCT01957462|566502829|FG001|Test Period 1|Adverse Event|0|||
156929736|NCT02419742|566502834|FG000|Overall Study|Adverse Event|2|||
156929737|NCT02419742|566502835|FG001|Overall Study|Adverse Event|0|||
156929738|NCT02419742|566502834|FG000|Overall Study|Disease Progression|0|||
156929739|NCT02419742|566502835|FG001|Overall Study|Disease Progression|1|||
156929740|NCT02419742|566502834|FG000|Overall Study|Withdrew Consent|2|||
156929741|NCT02419742|566502835|FG001|Overall Study|Withdrew Consent|1|||
156929742|NCT02419742|566502834|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
156929743|NCT02419742|566502835|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
156929744|NCT02255981|566502836|FG000|Overall Study|Lost to Follow-up|3|||
156929745|NCT02255981|566502836|FG000|Overall Study|Withdrawal by Subject|1|||
156929746|NCT03425331|566502839|FG000|Overall Study|Withdrawal by Subject|1|||
156929747|NCT03425331|566502839|FG000|Overall Study|Death|1|||
156929748|NCT03425331|566502839|FG000|Overall Study|Adverse Event|1|||
156929749|NCT03425331|566502839|FG000|Overall Study|Disease Progression|2|||
156929750|NCT01454570|566502842|FG000|Overall Study|Withdrawal by Subject|2|||
156929751|NCT01454570|566502842|FG000|Overall Study|Screen Failure|7|||
156929752|NCT02488681|566502843|FG000|Overall Study|Implant unsuccessful|7|||
156929753|NCT00720057|566502844|FG000|Overall Study|Lost to Follow-up|0|||
156929754|NCT00720057|566502845|FG001|Overall Study|Lost to Follow-up|2|||
156929755|NCT00720057|566502844|FG000|Overall Study|Protocol Violation|1|||
156929756|NCT00720057|566502845|FG001|Overall Study|Protocol Violation|0|||
156929757|NCT00720057|566502844|FG000|Overall Study|Withdrawal by Subject|0|||
156929758|NCT00720057|566502845|FG001|Overall Study|Withdrawal by Subject|1|||
156929759|NCT04969224|566502848|FG000|Overall Study|Adverse Event|1|||
156929760|NCT04969224|566502848|FG000|Overall Study|Enrolled but never dosed|1|||
156929761|NCT01498952|566502849|FG000|Overall Study|Death|2|||
156929762|NCT01498952|566502850|FG001|Overall Study|Death|2|||
156929763|NCT01498952|566502851|FG002|Overall Study|Death|0|||
156929764|NCT01498952|566502852|FG003|Overall Study|Death|0|||
156929765|NCT01498952|566502853|FG004|Overall Study|Death|0|||
156929766|NCT02726074|566502854|FG000|Overall Study|Withdrawal by Subject|4|||
156929767|NCT02726074|566502854|FG000|Overall Study|Adverse Event|14|||
156929768|NCT02726074|566502854|FG000|Overall Study|Protocol Violation|3|||
156929769|NCT02726074|566502854|FG000|Overall Study|Lost to Follow-up|2|||
156929770|NCT02726074|566502854|FG000|Overall Study|Others|3|||
156929771|NCT05533632|566502855|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
156929772|NCT05533632|566502855|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
156929773|NCT05533632|566502855|FG000|Overall Study|Lost to Follow-up|1|||
156929774|NCT05533632|566502855|FG000|Overall Study|Withdrawal by Subject|4|||
156929775|NCT05533632|566502855|FG000|Overall Study|Adverse Event|4|||
156929776|NCT00579826|566502856|FG000|Overall Study|Withdrawal by Subject|5|||
156929777|NCT00579826|566502857|FG001|Overall Study|Withdrawal by Subject|3|||
156929778|NCT03054870|566502862|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
156929779|NCT03054870|566502862|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
156929780|NCT02009046|566502863|FG000|Overall Study|Lost to Follow-up|256|||
156929781|NCT02009046|566502864|FG001|Overall Study|Lost to Follow-up|206|||
156929782|NCT03194321|566502869|FG000|Overall Study|Withdrawal by Subject|1|||
156929783|NCT03194321|566502869|FG000|Overall Study|Lost to Follow-up|1|||
156929784|NCT03194321|566502869|FG000|Overall Study|Travel for Follow-up|1|||
156929785|NCT00271609|566502870|FG000|Overall Study|Adverse Event|11|||
156929786|NCT00271609|566502871|FG001|Overall Study|Adverse Event|3|||
156929787|NCT00271609|566502870|FG000|Overall Study|Withdrawal by Subject|2|||
156929788|NCT00271609|566502871|FG001|Overall Study|Withdrawal by Subject|0|||
156929789|NCT03341533|566502872|FG000|Overall Study|Withdrawal by Subject|1|||
156929790|NCT03341533|566502873|FG001|Overall Study|Withdrawal by Subject|1|||
156929791|NCT03341533|566502872|FG000|Overall Study|Not eligible after randomization|2|||
156929792|NCT03341533|566502873|FG001|Overall Study|Not eligible after randomization|1|||
156929793|NCT03886220|566502876|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
156929794|NCT03886220|566502877|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
156929795|NCT03886220|566502876|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
156929796|NCT03886220|566502877|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
156929797|NCT03886220|566502876|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
156929798|NCT03886220|566502877|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
156929799|NCT01675128|566502882|FG000|Overall Study|Disease progression on study|1|||
156929800|NCT01675128|566502883|FG001|Overall Study|Disease progression on study|1|||
156929801|NCT01675128|566502884|FG002|Overall Study|Disease progression on study|1|||
156929802|NCT01675128|566502882|FG000|Overall Study|Refused further treatment|1|||
156929803|NCT01675128|566502883|FG001|Overall Study|Refused further treatment|0|||
156929804|NCT01675128|566502884|FG002|Overall Study|Refused further treatment|0|||
156929805|NCT01675128|566502882|FG000|Overall Study|Pulmonary complication; off study|0|||
156929806|NCT01675128|566502883|FG001|Overall Study|Pulmonary complication; off study|1|||
156929807|NCT01675128|566502884|FG002|Overall Study|Pulmonary complication; off study|0|||
156929808|NCT03526458|566502888|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
156929809|NCT03526458|566502889|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
156929810|NCT03526458|566502888|FG000|Overall Study|Stone passed, surgery cancelled|2|||
156929811|NCT03526458|566502889|FG001|Overall Study|Stone passed, surgery cancelled|1|||
156929812|NCT03526458|566502888|FG000|Overall Study|Withdrawal by Subject|1|||
156929813|NCT03526458|566502889|FG001|Overall Study|Withdrawal by Subject|0|||
156929814|NCT03526458|566502888|FG000|Overall Study|Physician Decision|2|||
156929815|NCT03526458|566502889|FG001|Overall Study|Physician Decision|1|||
156929816|NCT03526458|566502888|FG000|Overall Study|Lack of equipment|1|||
156929817|NCT03526458|566502889|FG001|Overall Study|Lack of equipment|1|||
156929818|NCT03011307|566502890|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
156929819|NCT03011307|566502891|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
156929820|NCT03011307|566502890|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
156929821|NCT03011307|566502891|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
156929822|NCT03011307|566502890|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
156929823|NCT03011307|566502891|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
156929824|NCT01782664|566502892|FG000|Overall Study|Adverse Event|2|||
156929825|NCT01782664|566502893|FG001|Overall Study|Adverse Event|2|||
156929826|NCT01782664|566502894|FG002|Overall Study|Adverse Event|2|||
156929827|NCT01782664|566502895|FG003|Overall Study|Adverse Event|2|||
156929828|NCT01782664|566502896|FG004|Overall Study|Adverse Event|0|||
156929829|NCT01782664|566502897|FG005|Overall Study|Adverse Event|0|||
156929830|NCT01782664|566502892|FG000|Overall Study|Lack of Efficacy|2|||
156929831|NCT01782664|566502893|FG001|Overall Study|Lack of Efficacy|0|||
156929832|NCT01782664|566502894|FG002|Overall Study|Lack of Efficacy|2|||
156929833|NCT01782664|566502895|FG003|Overall Study|Lack of Efficacy|2|||
156929834|NCT01782664|566502896|FG004|Overall Study|Lack of Efficacy|0|||
156929835|NCT01782664|566502897|FG005|Overall Study|Lack of Efficacy|0|||
156929836|NCT01782664|566502892|FG000|Overall Study|Protocol Violation|0|||
156929837|NCT01782664|566502893|FG001|Overall Study|Protocol Violation|1|||
156929838|NCT01782664|566502894|FG002|Overall Study|Protocol Violation|0|||
156929839|NCT01782664|566502895|FG003|Overall Study|Protocol Violation|1|||
156929840|NCT01782664|566502896|FG004|Overall Study|Protocol Violation|0|||
156929841|NCT01782664|566502897|FG005|Overall Study|Protocol Violation|0|||
156929842|NCT01782664|566502892|FG000|Overall Study|Withdrawal by Subject|2|||
156929843|NCT01782664|566502893|FG001|Overall Study|Withdrawal by Subject|2|||
157166608|NCT01253421|567350548|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
156929844|NCT01782664|566502894|FG002|Overall Study|Withdrawal by Subject|0|||
156929845|NCT01782664|566502895|FG003|Overall Study|Withdrawal by Subject|0|||
156929846|NCT01782664|566502896|FG004|Overall Study|Withdrawal by Subject|0|||
156929847|NCT01782664|566502897|FG005|Overall Study|Withdrawal by Subject|0|||
156929848|NCT04404855|566502898|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
156929849|NCT04404855|566502899|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
156929850|NCT01082965|566502903|FG000|Overall Study|Protocol Violation|0|||
156929851|NCT01082965|566502904|FG001|Overall Study|Protocol Violation|1|||
156929852|NCT01082965|566502903|FG000|Overall Study|Other|1|||
156929853|NCT01082965|566502904|FG001|Overall Study|Other|1|||
156929854|NCT03642717|566502905|FG000|Overall Study|Lost to Follow-up|2|||
156929855|NCT03642717|566502905|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
156929856|NCT03642717|566502905|FG000|Overall Study|Taken study drug prior to contract date|3|||
156929857|NCT02587065|566502906|FG000|Overall Study|Adverse Event|14|||
156929858|NCT02587065|566502906|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
156929859|NCT02587065|566502906|FG000|Overall Study|Non-adherence to the Protocol|3|||
156929860|NCT02587065|566502906|FG000|Overall Study|Discontinuation of Study Medication|2|||
156929861|NCT02587065|566502906|FG000|Overall Study|Reason not Specified|3|||
156929862|NCT01559012|566502907|FG000|Overall Study|Withdrawal by Subject|0|||
156929863|NCT01559012|566502908|FG001|Overall Study|Withdrawal by Subject|1|||
156929864|NCT00946712|566502911|FG000|Overall Study|Adverse Event|118|||
156929865|NCT00946712|566502912|FG001|Overall Study|Adverse Event|124|||
156929866|NCT00946712|566502911|FG000|Overall Study|Disease progression|308|||
156929867|NCT00946712|566502912|FG001|Overall Study|Disease progression|404|||
156929868|NCT00946712|566502911|FG000|Overall Study|Death|21|||
156929869|NCT00946712|566502912|FG001|Overall Study|Death|22|||
156929870|NCT00946712|566502911|FG000|Overall Study|No treatment given|25|||
156929871|NCT00946712|566502912|FG001|Overall Study|No treatment given|29|||
156929872|NCT00946712|566502911|FG000|Overall Study|Other reasons|61|||
156929873|NCT00946712|566502912|FG001|Overall Study|Other reasons|73|||
156929874|NCT00946712|566502911|FG000|Overall Study|On Treatment|0|||
156929875|NCT00946712|566502912|FG001|Overall Study|On Treatment|4|||
156929876|NCT00946712|566502911|FG000|Overall Study|Ineligible|14|||
156929877|NCT00946712|566502912|FG001|Overall Study|Ineligible|6|||
156929878|NCT00302458|566502913|FG000|Overall Study|Lost to Follow-up|1|||
156929879|NCT00302458|566502913|FG000|Overall Study|Ineligible after screening|1|||
156929880|NCT00302458|566502913|FG000|Overall Study|Withdrawal by Subject|1|||
156929881|NCT00853723|566502915|FG000|Overall Study|Adverse Event|3|||
156929882|NCT00853723|566502916|FG001|Overall Study|Adverse Event|4|||
156929883|NCT00853723|566502917|FG002|Overall Study|Adverse Event|1|||
156929884|NCT00853723|566502915|FG000|Overall Study|Withdrawal by Subject|2|||
156929885|NCT00853723|566502916|FG001|Overall Study|Withdrawal by Subject|1|||
156929886|NCT00853723|566502917|FG002|Overall Study|Withdrawal by Subject|0|||
156929887|NCT00853723|566502915|FG000|Overall Study|Protocol Violation|1|||
156929888|NCT00853723|566502916|FG001|Overall Study|Protocol Violation|2|||
156929889|NCT00853723|566502917|FG002|Overall Study|Protocol Violation|1|||
156929890|NCT04248933|566502918|FG000|Overall Study|Lost to Follow-up|9|||
156929891|NCT04248933|566502918|FG000|Overall Study|Withdrawal by Subject|2|||
156929892|NCT02447081|566502921|FG000|Overall Study|Death|161|||
156929893|NCT02447081|566502921|FG000|Overall Study|Lost to Follow-up|36|||
156929894|NCT02447081|566502921|FG000|Overall Study|Visit not completed|17|||
156929895|NCT02447081|566502921|FG000|Overall Study|unsuccessful implant procedure|10|||
156929896|NCT05778786|566502924|FG000|Period 1|COVID-19 Related|3|||
156929897|NCT05778786|566502925|FG001|Period 1|COVID-19 Related|3|||
156929898|NCT05778786|566502924|FG000|Period 1|Withdrew Consent during Study|1|||
156929899|NCT05778786|566502925|FG001|Period 1|Withdrew Consent during Study|0|||
156929900|NCT05778786|566502924|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
156929901|NCT05778786|566502925|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
156929902|NCT05778786|566502924|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
156929903|NCT05778786|566502925|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
156929904|NCT05497284|566502927|FG000|Overall Study|Adverse Event|1|||
156929905|NCT05497284|566502928|FG001|Overall Study|Adverse Event|0|||
157029273|NCT01928394|566862893|FG006|Follow-up Period|other reason|1|||
157029274|NCT01928394|566862894|FG007|Follow-up Period|other reason|3|||
157029275|NCT01928394|566862895|FG008|Follow-up Period|other reason|0|||
157029276|NCT01928394|566862896|FG009|Follow-up Period|other reason|0|||
157029277|NCT01928394|566862897|FG010|Follow-up Period|other reason|2|||
157029278|NCT01928394|566862898|FG011|Follow-up Period|other reason|1|||
156929906|NCT05497284|566502927|FG000|Overall Study|Physician Decision|0|||
156929907|NCT05497284|566502928|FG001|Overall Study|Physician Decision|1|||
156929908|NCT05497284|566502927|FG000|Overall Study|Study terminated by sponsor|7|||
156929909|NCT05497284|566502928|FG001|Overall Study|Study terminated by sponsor|4|||
156929910|NCT05497284|566502927|FG000|Overall Study|Subject Decision|0|||
156929911|NCT05497284|566502928|FG001|Overall Study|Subject Decision|1|||
156929912|NCT03313804|566502929|FG000|Treatment|Death|5|||
156929913|NCT03313804|566502929|FG000|Treatment|still on treatment|2|||
157029279|NCT01928394|566862899|FG012|Follow-up Period|other reason|0|||
157166609|NCT01253421|567350549|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
157166610|NCT01253421|567350545|FG000|Assessment and Scheduling|Physician Decision|1|||
157166611|NCT01253421|567350546|FG001|Assessment and Scheduling|Physician Decision|0|||
157166612|NCT01253421|567350547|FG002|Assessment and Scheduling|Physician Decision|0|||
157166613|NCT01253421|567350548|FG003|Assessment and Scheduling|Physician Decision|0|||
157166614|NCT01253421|567350549|FG004|Assessment and Scheduling|Physician Decision|0|||
157166615|NCT01253421|567350545|FG000|Drug+Scanning Visit|Physician Decision|0|||
157166616|NCT01253421|567350546|FG001|Drug+Scanning Visit|Physician Decision|0|||
157166617|NCT01253421|567350547|FG002|Drug+Scanning Visit|Physician Decision|0|||
157166618|NCT01253421|567350548|FG003|Drug+Scanning Visit|Physician Decision|0|||
157166619|NCT01253421|567350549|FG004|Drug+Scanning Visit|Physician Decision|1|||
157166620|NCT00099359|567350551|FG000|Overall Study|Death|11|||
157166621|NCT00099359|567350552|FG001|Overall Study|Death|15|||
157166622|NCT00099359|567350553|FG002|Overall Study|Death|17|||
157166623|NCT00099359|567350551|FG000|Overall Study|Withdrawal by Subject|19|||
157166624|NCT00099359|567350552|FG001|Overall Study|Withdrawal by Subject|19|||
157166625|NCT00099359|567350553|FG002|Overall Study|Withdrawal by Subject|23|||
157166626|NCT00099359|567350551|FG000|Overall Study|Lost to Follow-up|15|||
157166627|NCT00099359|567350552|FG001|Overall Study|Lost to Follow-up|24|||
157166628|NCT00099359|567350553|FG002|Overall Study|Lost to Follow-up|24|||
157166629|NCT00099359|567350551|FG000|Overall Study|moved out of area|9|||
157166630|NCT00099359|567350552|FG001|Overall Study|moved out of area|7|||
157166631|NCT00099359|567350553|FG002|Overall Study|moved out of area|4|||
157166632|NCT00717366|567350554|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
157166633|NCT00717366|567350555|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
157166634|NCT00717366|567350554|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
157166635|NCT00717366|567350555|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
157166636|NCT00717366|567350554|FG000|Core Study Period (20 Weeks)|Death|0|||
157166637|NCT00717366|567350555|FG001|Core Study Period (20 Weeks)|Death|1|||
157166638|NCT00717366|567350554|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
157166639|NCT00717366|567350555|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
157166640|NCT00717366|567350554|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
157166641|NCT00717366|567350555|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
157166642|NCT00717366|567350554|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
157166643|NCT00717366|567350555|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
157166644|NCT00717366|567350554|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
157166645|NCT00717366|567350555|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
157166646|NCT00255086|567350559|FG000|Overall Study|Adverse Event|1|||
157166647|NCT00255086|567350560|FG001|Overall Study|Adverse Event|1|||
157166648|NCT00255086|567350559|FG000|Overall Study|Protocol Violation|1|||
157166649|NCT00255086|567350560|FG001|Overall Study|Protocol Violation|1|||
157166650|NCT05294211|567350561|FG000|Overall Study|Withdrawal by Subject|3|||
157166651|NCT05294211|567350561|FG000|Overall Study|Physician Decision|2|||
157166652|NCT05294211|567350561|FG000|Overall Study|Progressed to active labor|1|||
157166653|NCT05294211|567350561|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
157166654|NCT05294211|567350561|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
157166655|NCT01842607|567350563|FG000|Overall Study|Adverse Event|11|||
157166656|NCT01842607|567350563|FG000|Overall Study|Lack of Efficacy|19|||
157166657|NCT01842607|567350563|FG000|Overall Study|Protocol Violation|8|||
157166658|NCT01842607|567350563|FG000|Overall Study|Protocol defined stopping criteria|2|||
157166659|NCT01842607|567350563|FG000|Overall Study|Lost to Follow-up|3|||
157166660|NCT01842607|567350563|FG000|Overall Study|Physician Decision|9|||
157166661|NCT01842607|567350563|FG000|Overall Study|Withdrawal by Subject|14|||
157166662|NCT00012012|567350566|FG000|Overall Study|Protocol Violation|1|||
157166663|NCT00012012|567350567|FG001|Overall Study|Protocol Violation|1|||
157166664|NCT00012012|567350566|FG000|Overall Study|Withdrawal by Subject|0|||
157166665|NCT00012012|567350567|FG001|Overall Study|Withdrawal by Subject|2|||
157166666|NCT02159469|567350568|FG000|Overall Study|Missing Completion status|1|||
157166667|NCT02159469|567350568|FG000|Overall Study|Adverse Event|5|||
157166668|NCT02159469|567350568|FG000|Overall Study|Non-compliance|2|||
157166669|NCT02159469|567350568|FG000|Overall Study|Withdrawal by Subject|9|||
157166670|NCT02159469|567350568|FG000|Overall Study|Lost to Follow-up|1|||
157166671|NCT02159469|567350568|FG000|Overall Study|Sponsor's request|2|||
157166672|NCT02159469|567350568|FG000|Overall Study|Met Stopping Criteria|3|||
157166673|NCT02159469|567350568|FG000|Overall Study|Other|1|||
157166674|NCT02159469|567350568|FG000|Overall Study|Multiple|29|||
157166675|NCT02034474|567350569|FG000|Overall Study|Adverse Event|3|||
157166676|NCT02034474|567350570|FG001|Overall Study|Adverse Event|2|||
157166677|NCT02034474|567350569|FG000|Overall Study|Withdrawal by Subject|1|||
157166678|NCT02034474|567350570|FG001|Overall Study|Withdrawal by Subject|2|||
157166679|NCT03629041|567350576|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
157166680|NCT03629041|567350577|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
157166681|NCT03629041|567350578|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
157166682|NCT03629041|567350579|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
157166683|NCT01391819|567350580|FG000|Overall Study|Withdrawal by Subject|56|||
157166684|NCT01391819|567350580|FG000|Overall Study|Migrated/moved from study area|82|||
157166685|NCT01391819|567350580|FG000|Overall Study|Lost to Follow-up|252|||
157166686|NCT01391819|567350580|FG000|Overall Study|Death|3|||
157166687|NCT01391819|567350580|FG000|Overall Study|Other|9|||
157166688|NCT03730194|567350582|FG000|First Stage Treatment|Withdrawal by Subject|1|||
157166689|NCT03730194|567350583|FG001|First Stage Treatment|Withdrawal by Subject|1|||
157166690|NCT03730194|567350584|FG002|First Stage Treatment|Withdrawal by Subject|0|||
157166691|NCT03730194|567350585|FG003|First Stage Treatment|Withdrawal by Subject|0|||
157166692|NCT03730194|567350586|FG004|First Stage Treatment|Withdrawal by Subject|0|||
157166693|NCT03730194|567350587|FG005|First Stage Treatment|Withdrawal by Subject|0|||
157166694|NCT03730194|567350582|FG000|First Stage Treatment|Protocol Violation|3|||
157166695|NCT03730194|567350583|FG001|First Stage Treatment|Protocol Violation|3|||
157166696|NCT03730194|567350584|FG002|First Stage Treatment|Protocol Violation|0|||
157166697|NCT03730194|567350585|FG003|First Stage Treatment|Protocol Violation|0|||
157166698|NCT03730194|567350586|FG004|First Stage Treatment|Protocol Violation|0|||
157166699|NCT03730194|567350587|FG005|First Stage Treatment|Protocol Violation|0|||
157166700|NCT03814590|567350592|FG000|Overall Study|Adverse Event|0|||
157166701|NCT03814590|567350593|FG001|Overall Study|Adverse Event|0|||
157166702|NCT03814590|567350594|FG002|Overall Study|Adverse Event|0|||
157166703|NCT03814590|567350595|FG003|Overall Study|Adverse Event|0|||
157166704|NCT03814590|567350596|FG004|Overall Study|Adverse Event|0|||
157166705|NCT03814590|567350597|FG005|Overall Study|Adverse Event|1|||
157166706|NCT03814590|567350598|FG006|Overall Study|Adverse Event|1|||
157166707|NCT03814590|567350599|FG007|Overall Study|Adverse Event|1|||
157166708|NCT03814590|567350600|FG008|Overall Study|Adverse Event|0|||
157166709|NCT03814590|567350601|FG009|Overall Study|Adverse Event|0|||
157166710|NCT03814590|567350602|FG010|Overall Study|Adverse Event|1|||
156929914|NCT03313804|566502929|FG000|Follow Up|still on follow up|3|||
156929915|NCT01502423|566502930|FG000|Overall Study|Withdrawal by Subject|0|||
156929916|NCT01502423|566502931|FG001|Overall Study|Withdrawal by Subject|1|||
156929917|NCT00567892|566502932|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156929918|NCT00567892|566502933|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156929919|NCT00567892|566502934|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
156929920|NCT00567892|566502935|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
156929921|NCT00567892|566502932|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156929922|NCT00567892|566502933|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156929923|NCT00567892|566502934|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
156929924|NCT00567892|566502935|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
156929925|NCT01723163|566504182|FG000|Treatment Phase|Withdrawal by Subject|14|||
156929926|NCT01723163|566504183|FG001|Treatment Phase|Withdrawal by Subject|6|||
156929927|NCT01723163|566504182|FG000|Treatment Phase|Withdrawal by PI|5|||
156929928|NCT01723163|566504183|FG001|Treatment Phase|Withdrawal by PI|1|||
156929929|NCT01723163|566504182|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
156929930|NCT01723163|566504183|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
156929931|NCT01723163|566504182|FG000|3-Month Follow-up|Unable to Contact|12|||
156929932|NCT01723163|566504183|FG001|3-Month Follow-up|Unable to Contact|19|||
156929933|NCT01723163|566504182|FG000|6-Month Follow-up|Death|1|||
156929934|NCT01723163|566504183|FG001|6-Month Follow-up|Death|0|||
156929935|NCT01723163|566504182|FG000|6-Month Follow-up|Unable to Contact|17|||
156929936|NCT01723163|566504183|FG001|6-Month Follow-up|Unable to Contact|15|||
156929937|NCT01723163|566504182|FG000|12-Month Follow-up|Death|1|||
156929938|NCT01723163|566504183|FG001|12-Month Follow-up|Death|0|||
156929939|NCT01723163|566504182|FG000|12-Month Follow-up|Unable to Contact|23|||
156929940|NCT01723163|566504183|FG001|12-Month Follow-up|Unable to Contact|28|||
156929941|NCT02510794|566504184|FG000|Overall Study|Adverse Event|0|||
156929942|NCT02510794|566504185|FG001|Overall Study|Adverse Event|1|||
156929943|NCT02510794|566504186|FG002|Overall Study|Adverse Event|0|||
157166711|NCT03814590|567350603|FG011|Overall Study|Adverse Event|0|||
157166712|NCT03814590|567350604|FG012|Overall Study|Adverse Event|3|||
157166713|NCT03814590|567350605|FG013|Overall Study|Adverse Event|0|||
157166714|NCT03814590|567350592|FG000|Overall Study|Lost to Follow-up|0|||
157166715|NCT03814590|567350593|FG001|Overall Study|Lost to Follow-up|2|||
157166716|NCT03814590|567350594|FG002|Overall Study|Lost to Follow-up|1|||
156929944|NCT02510794|566504187|FG003|Overall Study|Adverse Event|0|||
156929945|NCT02510794|566504184|FG000|Overall Study|Death|1|||
156929946|NCT02510794|566504185|FG001|Overall Study|Death|2|||
156929947|NCT02510794|566504186|FG002|Overall Study|Death|1|||
156929948|NCT02510794|566504187|FG003|Overall Study|Death|1|||
156929949|NCT02510794|566504184|FG000|Overall Study|Lack of Efficacy|3|||
156929950|NCT02510794|566504185|FG001|Overall Study|Lack of Efficacy|1|||
157166717|NCT03814590|567350595|FG003|Overall Study|Lost to Follow-up|0|||
157166718|NCT03814590|567350596|FG004|Overall Study|Lost to Follow-up|1|||
157166719|NCT03814590|567350597|FG005|Overall Study|Lost to Follow-up|1|||
156929951|NCT02510794|566504186|FG002|Overall Study|Lack of Efficacy|1|||
157166720|NCT03814590|567350598|FG006|Overall Study|Lost to Follow-up|1|||
157166721|NCT03814590|567350599|FG007|Overall Study|Lost to Follow-up|1|||
156929952|NCT02510794|566504187|FG003|Overall Study|Lack of Efficacy|0|||
156929953|NCT02510794|566504184|FG000|Overall Study|Participant moved out of the area|0|||
156929954|NCT02510794|566504185|FG001|Overall Study|Participant moved out of the area|0|||
156929955|NCT02510794|566504186|FG002|Overall Study|Participant moved out of the area|0|||
156929956|NCT02510794|566504187|FG003|Overall Study|Participant moved out of the area|1|||
156929957|NCT02510794|566504184|FG000|Overall Study|Physician Decision|3|||
156929958|NCT02510794|566504185|FG001|Overall Study|Physician Decision|0|||
156929959|NCT02510794|566504186|FG002|Overall Study|Physician Decision|0|||
156929960|NCT02510794|566504187|FG003|Overall Study|Physician Decision|0|||
156929961|NCT02510794|566504184|FG000|Overall Study|Protocol Violation|0|||
156929962|NCT02510794|566504185|FG001|Overall Study|Protocol Violation|0|||
156929963|NCT02510794|566504186|FG002|Overall Study|Protocol Violation|1|||
156929964|NCT02510794|566504187|FG003|Overall Study|Protocol Violation|0|||
156929965|NCT02510794|566504184|FG000|Overall Study|Withdrawal by Subject|1|||
156929966|NCT02510794|566504185|FG001|Overall Study|Withdrawal by Subject|2|||
156929967|NCT02510794|566504186|FG002|Overall Study|Withdrawal by Subject|4|||
156929968|NCT02510794|566504187|FG003|Overall Study|Withdrawal by Subject|3|||
156929969|NCT01649375|566504188|FG000|Up to Week 16|Adverse Event|2|||
156929970|NCT01649375|566504189|FG001|Up to Week 16|Adverse Event|5|||
156929971|NCT01649375|566504190|FG002|Up to Week 16|Adverse Event|4|||
156929972|NCT01649375|566504191|FG003|Up to Week 16|Adverse Event|0|||
156929973|NCT01649375|566504192|FG004|Up to Week 16|Adverse Event|0|||
156929974|NCT01649375|566504188|FG000|Up to Week 16|Lack of Efficacy|0|||
156929975|NCT01649375|566504189|FG001|Up to Week 16|Lack of Efficacy|0|||
156929976|NCT01649375|566504190|FG002|Up to Week 16|Lack of Efficacy|1|||
156929977|NCT01649375|566504191|FG003|Up to Week 16|Lack of Efficacy|0|||
156929978|NCT01649375|566504192|FG004|Up to Week 16|Lack of Efficacy|0|||
156929979|NCT01649375|566504188|FG000|Up to Week 16|Physician Decision|0|||
156929980|NCT01649375|566504189|FG001|Up to Week 16|Physician Decision|0|||
156929981|NCT01649375|566504190|FG002|Up to Week 16|Physician Decision|1|||
156929982|NCT01649375|566504191|FG003|Up to Week 16|Physician Decision|0|||
156929983|NCT01649375|566504192|FG004|Up to Week 16|Physician Decision|0|||
156929984|NCT01649375|566504188|FG000|Up to Week 16|Withdrawal by Subject|2|||
156929985|NCT01649375|566504189|FG001|Up to Week 16|Withdrawal by Subject|1|||
156929986|NCT01649375|566504190|FG002|Up to Week 16|Withdrawal by Subject|2|||
156929987|NCT01649375|566504191|FG003|Up to Week 16|Withdrawal by Subject|0|||
156929988|NCT01649375|566504192|FG004|Up to Week 16|Withdrawal by Subject|0|||
156929989|NCT01649375|566504188|FG000|Up to Week 16|Death|1|||
156929990|NCT01649375|566504189|FG001|Up to Week 16|Death|0|||
156929991|NCT01649375|566504190|FG002|Up to Week 16|Death|0|||
156929992|NCT01649375|566504191|FG003|Up to Week 16|Death|0|||
156929993|NCT01649375|566504192|FG004|Up to Week 16|Death|0|||
156929994|NCT01649375|566504188|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
156929995|NCT01649375|566504189|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
156929996|NCT01649375|566504190|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
156929997|NCT01649375|566504191|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
156929998|NCT01649375|566504192|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
156929999|NCT01649375|566504188|FG000|Week 16 up to Week 260|Non-compliance|0|||
156930000|NCT01649375|566504189|FG001|Week 16 up to Week 260|Non-compliance|1|||
156930001|NCT01649375|566504190|FG002|Week 16 up to Week 260|Non-compliance|0|||
156930002|NCT01649375|566504191|FG003|Week 16 up to Week 260|Non-compliance|1|||
156930003|NCT01649375|566504192|FG004|Week 16 up to Week 260|Non-compliance|0|||
156930004|NCT01649375|566504188|FG000|Week 16 up to Week 260|Physician Decision|0|||
156930005|NCT01649375|566504189|FG001|Week 16 up to Week 260|Physician Decision|2|||
156930006|NCT01649375|566504190|FG002|Week 16 up to Week 260|Physician Decision|0|||
156930007|NCT01649375|566504191|FG003|Week 16 up to Week 260|Physician Decision|0|||
156930008|NCT01649375|566504192|FG004|Week 16 up to Week 260|Physician Decision|0|||
156930009|NCT01649375|566504188|FG000|Week 16 up to Week 260|Technical issues|0|||
156930010|NCT01649375|566504189|FG001|Week 16 up to Week 260|Technical issues|1|||
157166722|NCT03814590|567350600|FG008|Overall Study|Lost to Follow-up|0|||
157166723|NCT03814590|567350601|FG009|Overall Study|Lost to Follow-up|0|||
157166724|NCT03814590|567350602|FG010|Overall Study|Lost to Follow-up|1|||
157166725|NCT03814590|567350603|FG011|Overall Study|Lost to Follow-up|0|||
157166726|NCT03814590|567350604|FG012|Overall Study|Lost to Follow-up|0|||
157166727|NCT03814590|567350605|FG013|Overall Study|Lost to Follow-up|1|||
157227053|NCT00409578|567576032|FG001|Overall Study|Lost to Follow-up|0|||
156930011|NCT01649375|566504190|FG002|Week 16 up to Week 260|Technical issues|0|||
156930012|NCT01649375|566504191|FG003|Week 16 up to Week 260|Technical issues|1|||
156930013|NCT01649375|566504192|FG004|Week 16 up to Week 260|Technical issues|0|||
156930014|NCT01649375|566504188|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
156930015|NCT01649375|566504189|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
156930016|NCT01649375|566504190|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
156930017|NCT01649375|566504191|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
156930018|NCT01649375|566504192|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
156930019|NCT01649375|566504188|FG000|Week 16 up to Week 260|Death|1|||
156930020|NCT01649375|566504189|FG001|Week 16 up to Week 260|Death|1|||
156930021|NCT01649375|566504190|FG002|Week 16 up to Week 260|Death|0|||
156930022|NCT01649375|566504191|FG003|Week 16 up to Week 260|Death|0|||
156930023|NCT01649375|566504192|FG004|Week 16 up to Week 260|Death|0|||
156930024|NCT01649375|566504188|FG000|Week 16 up to Week 260|Adverse Event|5|||
156930025|NCT01649375|566504189|FG001|Week 16 up to Week 260|Adverse Event|2|||
156930026|NCT01649375|566504190|FG002|Week 16 up to Week 260|Adverse Event|0|||
156930027|NCT01649375|566504191|FG003|Week 16 up to Week 260|Adverse Event|3|||
156930028|NCT01649375|566504192|FG004|Week 16 up to Week 260|Adverse Event|2|||
156930029|NCT01856790|566504195|FG000|Closed Loop Control|Withdrawal by Subject|2|||
156930030|NCT01856790|566504195|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
156930031|NCT04091646|566504196|FG000|Overall Study|Adverse Event|2|||
156930032|NCT04091646|566504197|FG001|Overall Study|Adverse Event|1|||
156930033|NCT04091646|566504196|FG000|Overall Study|Lost to Follow-up|6|||
156930034|NCT04091646|566504197|FG001|Overall Study|Lost to Follow-up|2|||
156930035|NCT04091646|566504196|FG000|Overall Study|Protocol Violation|0|||
156930036|NCT04091646|566504197|FG001|Overall Study|Protocol Violation|1|||
156930037|NCT04091646|566504196|FG000|Overall Study|Withdrawal by Subject|4|||
156930038|NCT04091646|566504197|FG001|Overall Study|Withdrawal by Subject|1|||
156930039|NCT04091646|566504196|FG000|Overall Study|Participant Incarcerated|1|||
156930040|NCT04091646|566504197|FG001|Overall Study|Participant Incarcerated|0|||
156930041|NCT01921829|566504198|FG000|Overall Study|Withdrawal by Subject|0|||
156930042|NCT01921829|566504199|FG001|Overall Study|Withdrawal by Subject|1|||
156930043|NCT03102918|566504202|FG000|Overall Study|Protocol Violation|1|||
156930044|NCT03102918|566504203|FG001|Overall Study|Protocol Violation|0|||
156930045|NCT04765358|566504206|FG000|Overall Study|Withdrawal by Subject|1|||
156930046|NCT00885755|566504213|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
156930047|NCT00885755|566504214|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
156930048|NCT00885755|566504215|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
156930049|NCT00885755|566504213|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
156930050|NCT00885755|566504214|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
156930051|NCT00885755|566504215|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
156930052|NCT00885755|566504213|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
156930053|NCT00885755|566504214|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
156930054|NCT00885755|566504215|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
156930055|NCT00885755|566504213|FG000|Part I: Trastuzumab+Taxane|Death|0|||
156930056|NCT00885755|566504214|FG001|Part I: Trastuzumab+Taxane|Death|0|||
156930057|NCT00885755|566504215|FG002|Part I: Trastuzumab+Taxane|Death|1|||
156930058|NCT00885755|566504213|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
156930059|NCT00885755|566504214|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
156930060|NCT00885755|566504215|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
156930061|NCT01852812|566504218|FG000|Overall Study|Adverse Event|0|||
156930062|NCT01852812|566504219|FG001|Overall Study|Adverse Event|0|||
156930063|NCT01852812|566504220|FG002|Overall Study|Adverse Event|1|||
156930064|NCT01852812|566504218|FG000|Overall Study|Non-compliance With Study Drug|0|||
156930065|NCT01852812|566504219|FG001|Overall Study|Non-compliance With Study Drug|1|||
156930066|NCT01852812|566504220|FG002|Overall Study|Non-compliance With Study Drug|0|||
156930067|NCT02625090|566504221|FG000|Overall Study|Participant wants to be pregnant|2|||
156930068|NCT02625090|566504221|FG000|Overall Study|For the Promoter|1|||
156930069|NCT02625090|566504221|FG000|Overall Study|Sponsor's Decision|9|||
156930070|NCT02625090|566504221|FG000|Overall Study|Somnolence|1|||
156930071|NCT02625090|566504221|FG000|Overall Study|Study terminated by Sponsor|7|||
156930072|NCT02625090|566504221|FG000|Overall Study|Negative Benefit/Risk|1|||
156930073|NCT02625090|566504221|FG000|Overall Study|Protocol Deviation|2|||
156930074|NCT02625090|566504221|FG000|Overall Study|Lack of Efficacy|16|||
156930075|NCT02625090|566504221|FG000|Overall Study|Adverse Event|3|||
156930076|NCT04649164|566504222|FG000|Overall Study|Withdrawal by Subject|1|||
156930077|NCT04649164|566504223|FG001|Overall Study|Withdrawal by Subject|1|||
156930078|NCT04649164|566504224|FG002|Overall Study|Withdrawal by Subject|2|||
156930079|NCT04649164|566504222|FG000|Overall Study|Participant's care recipient expired|0|||
156930080|NCT04649164|566504223|FG001|Overall Study|Participant's care recipient expired|0|||
156930081|NCT04649164|566504224|FG002|Overall Study|Participant's care recipient expired|2|||
156930082|NCT02250443|566504225|FG000|Overall Study|Administrative problems|7|||
156930083|NCT02250443|566504225|FG000|Overall Study|Adverse Event|3|||
156930084|NCT03168464|566504226|FG000|Overall Study|Death|9|||
156930085|NCT03168464|566504226|FG000|Overall Study|Progression of disease|6|||
156930086|NCT00634088|566504227|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
157166728|NCT03814590|567350592|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166729|NCT03814590|567350593|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156930087|NCT00634088|566504228|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
156930088|NCT00634088|566504229|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
156930089|NCT00634088|566504230|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
156930090|NCT00634088|566504227|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
156930091|NCT00634088|566504228|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
156930092|NCT00634088|566504229|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
157029280|NCT01928394|566862900|FG013|Follow-up Period|other reason|1|||
156930093|NCT00634088|566504230|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
157166730|NCT03814590|567350594|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
156930094|NCT00634088|566504227|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
156930095|NCT00634088|566504228|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
156930096|NCT00634088|566504229|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
156930097|NCT00634088|566504230|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
156930098|NCT00634088|566504227|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
156930099|NCT00634088|566504228|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
156930100|NCT00634088|566504229|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
156930101|NCT00634088|566504230|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
156930102|NCT00634088|566504227|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
156930103|NCT00634088|566504228|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
156930104|NCT00634088|566504229|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
156930105|NCT00634088|566504230|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
156930106|NCT00634088|566504227|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
156930107|NCT00634088|566504228|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
156930108|NCT00634088|566504229|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
156930109|NCT00634088|566504230|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
156930110|NCT01520363|566504241|FG000|Overall Study|Withdrawal by Subject|2|||
156930111|NCT01520363|566504242|FG001|Overall Study|Withdrawal by Subject|0|||
156930112|NCT01265849|566504246|FG000|Overall Study|Randomized//Treatment not initiated|1|||
156930113|NCT01265849|566504247|FG001|Overall Study|Randomized//Treatment not initiated|4|||
156930114|NCT01265849|566504248|FG002|Overall Study|Randomized//Treatment not initiated|0|||
156930115|NCT01265849|566504246|FG000|Overall Study|Physician Decision|1|||
156930116|NCT01265849|566504247|FG001|Overall Study|Physician Decision|2|||
156930117|NCT01265849|566504248|FG002|Overall Study|Physician Decision|0|||
156930118|NCT01265849|566504246|FG000|Overall Study|Lost to Follow-up|18|||
156930119|NCT01265849|566504247|FG001|Overall Study|Lost to Follow-up|15|||
156930120|NCT01265849|566504248|FG002|Overall Study|Lost to Follow-up|5|||
156930121|NCT01265849|566504246|FG000|Overall Study|Not otherwise specified|1|||
156930122|NCT01265849|566504247|FG001|Overall Study|Not otherwise specified|6|||
156930123|NCT01265849|566504248|FG002|Overall Study|Not otherwise specified|1|||
156930124|NCT01265849|566504246|FG000|Overall Study|Withdrawal by Subject|25|||
156930125|NCT01265849|566504247|FG001|Overall Study|Withdrawal by Subject|34|||
156930126|NCT01265849|566504248|FG002|Overall Study|Withdrawal by Subject|13|||
156930127|NCT01154218|566504249|FG000|Third Intervention Period|Adverse Event|0|||
156930128|NCT01154218|566504250|FG001|Third Intervention Period|Adverse Event|1|||
156930129|NCT01154218|566504251|FG002|Third Intervention Period|Adverse Event|0|||
156930130|NCT01154218|566504252|FG003|Third Intervention Period|Adverse Event|0|||
156930131|NCT01154218|566504249|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156930132|NCT01154218|566504250|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156930133|NCT01154218|566504251|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
156930134|NCT01154218|566504252|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
156930135|NCT01154218|566504249|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
156930136|NCT01154218|566504250|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
156930137|NCT01154218|566504251|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
156930138|NCT01154218|566504252|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
156930139|NCT00362115|566504253|FG000|Overall Study|Adverse Event|0|||
156930140|NCT00362115|566504254|FG001|Overall Study|Adverse Event|1|||
156930141|NCT00362115|566504255|FG002|Overall Study|Adverse Event|1|||
156930142|NCT00362115|566504256|FG003|Overall Study|Adverse Event|1|||
156930143|NCT00362115|566504257|FG004|Overall Study|Adverse Event|2|||
156930144|NCT00362115|566504258|FG005|Overall Study|Adverse Event|2|||
156930145|NCT00362115|566504259|FG006|Overall Study|Adverse Event|1|||
157166731|NCT03814590|567350595|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166732|NCT03814590|567350596|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166733|NCT03814590|567350597|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166734|NCT03814590|567350598|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166735|NCT03814590|567350599|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166736|NCT03814590|567350600|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166737|NCT03814590|567350601|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
157166738|NCT03814590|567350602|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157205209|NCT03669640|567496075|FG002|Overall Study|Study Terminated by Sponsor|0|||
156930146|NCT00362115|566504253|FG000|Overall Study|Protocol Violation|0|||
156930147|NCT00362115|566504254|FG001|Overall Study|Protocol Violation|0|||
156930148|NCT00362115|566504255|FG002|Overall Study|Protocol Violation|0|||
156930149|NCT00362115|566504256|FG003|Overall Study|Protocol Violation|0|||
156930150|NCT00362115|566504257|FG004|Overall Study|Protocol Violation|0|||
156930151|NCT00362115|566504258|FG005|Overall Study|Protocol Violation|1|||
156930152|NCT00362115|566504259|FG006|Overall Study|Protocol Violation|0|||
156930153|NCT00362115|566504253|FG000|Overall Study|Lost to Follow-up|0|||
156930154|NCT00362115|566504254|FG001|Overall Study|Lost to Follow-up|1|||
156930155|NCT00362115|566504255|FG002|Overall Study|Lost to Follow-up|0|||
156930156|NCT00362115|566504256|FG003|Overall Study|Lost to Follow-up|0|||
157166739|NCT03814590|567350603|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166740|NCT03814590|567350604|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166741|NCT03814590|567350605|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
157166742|NCT03814590|567350592|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166743|NCT03814590|567350593|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166744|NCT03814590|567350594|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166745|NCT03814590|567350595|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157029281|NCT01928394|566862901|FG014|Follow-up Period|other reason|4|||
157029282|NCT01928394|566862902|FG015|Follow-up Period|other reason|0|||
157029283|NCT01928394|566862903|FG016|Follow-up Period|other reason|2|||
157029284|NCT01928394|566862904|FG017|Follow-up Period|other reason|0|||
157166746|NCT03814590|567350596|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166747|NCT03814590|567350597|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
157166748|NCT03814590|567350598|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
157166749|NCT03814590|567350599|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
157166750|NCT03814590|567350600|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166751|NCT03814590|567350601|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
157166752|NCT03814590|567350602|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
157166753|NCT03814590|567350603|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
157166754|NCT03814590|567350604|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
157166755|NCT03814590|567350605|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
157166756|NCT03814590|567350592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166757|NCT03814590|567350593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166758|NCT03814590|567350594|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166759|NCT03814590|567350595|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166760|NCT03814590|567350596|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166761|NCT03814590|567350597|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166762|NCT03814590|567350598|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156930157|NCT00362115|566504257|FG004|Overall Study|Lost to Follow-up|2|||
156930158|NCT00362115|566504258|FG005|Overall Study|Lost to Follow-up|0|||
156930159|NCT00362115|566504259|FG006|Overall Study|Lost to Follow-up|1|||
156930160|NCT00362115|566504253|FG000|Overall Study|Withdrawal by Subject|1|||
156930161|NCT00362115|566504254|FG001|Overall Study|Withdrawal by Subject|3|||
156930162|NCT00362115|566504255|FG002|Overall Study|Withdrawal by Subject|1|||
156930163|NCT00362115|566504256|FG003|Overall Study|Withdrawal by Subject|0|||
156930164|NCT00362115|566504257|FG004|Overall Study|Withdrawal by Subject|1|||
156930165|NCT00362115|566504258|FG005|Overall Study|Withdrawal by Subject|3|||
156930166|NCT00362115|566504259|FG006|Overall Study|Withdrawal by Subject|4|||
156930167|NCT00362115|566504253|FG000|Overall Study|Lack of Efficacy|1|||
156930168|NCT00362115|566504254|FG001|Overall Study|Lack of Efficacy|0|||
156930169|NCT00362115|566504255|FG002|Overall Study|Lack of Efficacy|5|||
156930170|NCT00362115|566504256|FG003|Overall Study|Lack of Efficacy|2|||
156930171|NCT00362115|566504257|FG004|Overall Study|Lack of Efficacy|2|||
156930172|NCT00362115|566504258|FG005|Overall Study|Lack of Efficacy|0|||
156930173|NCT00362115|566504259|FG006|Overall Study|Lack of Efficacy|3|||
156930174|NCT00362115|566504253|FG000|Overall Study|Physician Decision|0|||
156930175|NCT00362115|566504254|FG001|Overall Study|Physician Decision|0|||
156930176|NCT00362115|566504255|FG002|Overall Study|Physician Decision|0|||
156930177|NCT00362115|566504256|FG003|Overall Study|Physician Decision|0|||
156930178|NCT00362115|566504257|FG004|Overall Study|Physician Decision|0|||
156930179|NCT00362115|566504258|FG005|Overall Study|Physician Decision|0|||
156930180|NCT00362115|566504259|FG006|Overall Study|Physician Decision|3|||
156930181|NCT00362115|566504253|FG000|Overall Study|Other|0|||
156930182|NCT00362115|566504254|FG001|Overall Study|Other|1|||
156930183|NCT00362115|566504255|FG002|Overall Study|Other|0|||
156930184|NCT00362115|566504256|FG003|Overall Study|Other|1|||
157029285|NCT01928394|566862905|FG018|Follow-up Period|other reason|1|||
156930185|NCT00362115|566504257|FG004|Overall Study|Other|0|||
156930186|NCT00362115|566504258|FG005|Overall Study|Other|1|||
156930187|NCT00362115|566504259|FG006|Overall Study|Other|0|||
156930188|NCT01170091|566504260|FG000|Overall Study|Missing efficacy evaluation|3|||
156930189|NCT01170091|566504260|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
156930190|NCT02188589|566504261|FG000|Overall Study|Withdrawal by Subject|5|||
156930191|NCT00003641|566504269|FG000|Overall Study|Withdrawal by Subject|0|||
156930192|NCT00003641|566504270|FG001|Overall Study|Withdrawal by Subject|100|||
156930193|NCT00003641|566504269|FG000|Overall Study|Adverse Event|0|||
156930194|NCT00003641|566504270|FG001|Overall Study|Adverse Event|38|||
157029286|NCT01928394|566862906|FG019|Follow-up Period|other reason|1|||
157166763|NCT03814590|567350599|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157166764|NCT03814590|567350600|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166765|NCT03814590|567350601|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157166766|NCT03814590|567350602|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166767|NCT03814590|567350603|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166768|NCT03814590|567350604|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166769|NCT03814590|567350605|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157166770|NCT03814590|567350592|FG000|Overall Study|UNKNOWN REASON|0|||
157166771|NCT03814590|567350593|FG001|Overall Study|UNKNOWN REASON|0|||
157166772|NCT03814590|567350594|FG002|Overall Study|UNKNOWN REASON|0|||
157166773|NCT03814590|567350595|FG003|Overall Study|UNKNOWN REASON|0|||
157166774|NCT03814590|567350596|FG004|Overall Study|UNKNOWN REASON|0|||
157166775|NCT03814590|567350597|FG005|Overall Study|UNKNOWN REASON|0|||
157166776|NCT03814590|567350598|FG006|Overall Study|UNKNOWN REASON|0|||
157166777|NCT03814590|567350599|FG007|Overall Study|UNKNOWN REASON|1|||
157166778|NCT03814590|567350600|FG008|Overall Study|UNKNOWN REASON|0|||
157166779|NCT03814590|567350601|FG009|Overall Study|UNKNOWN REASON|0|||
157166780|NCT03814590|567350602|FG010|Overall Study|UNKNOWN REASON|0|||
157166781|NCT03814590|567350603|FG011|Overall Study|UNKNOWN REASON|0|||
157166782|NCT03814590|567350604|FG012|Overall Study|UNKNOWN REASON|0|||
157166783|NCT03814590|567350605|FG013|Overall Study|UNKNOWN REASON|0|||
157166784|NCT02164513|567350606|FG000|Overall Study|Adverse Event|162|||
157166785|NCT02164513|567350607|FG001|Overall Study|Adverse Event|180|||
157166786|NCT02164513|567350608|FG002|Overall Study|Adverse Event|111|||
157166787|NCT02164513|567350606|FG000|Overall Study|Other: Study Closed or terminated|5|||
157166788|NCT02164513|567350607|FG001|Overall Study|Other: Study Closed or terminated|2|||
157166789|NCT02164513|567350608|FG002|Overall Study|Other: Study Closed or terminated|4|||
157166790|NCT02164513|567350606|FG000|Overall Study|Lost to Follow-up|30|||
157166791|NCT02164513|567350607|FG001|Overall Study|Lost to Follow-up|36|||
157166792|NCT02164513|567350608|FG002|Overall Study|Lost to Follow-up|22|||
157166793|NCT02164513|567350606|FG000|Overall Study|Physician Decision|47|||
157166794|NCT02164513|567350607|FG001|Overall Study|Physician Decision|57|||
157166795|NCT02164513|567350608|FG002|Overall Study|Physician Decision|28|||
157166796|NCT02164513|567350606|FG000|Overall Study|Withdrawal by Subject|192|||
157166797|NCT02164513|567350607|FG001|Overall Study|Withdrawal by Subject|261|||
157166798|NCT02164513|567350608|FG002|Overall Study|Withdrawal by Subject|130|||
157166799|NCT02164513|567350606|FG000|Overall Study|Other: Reason not provided by site|1|||
157166800|NCT02164513|567350607|FG001|Overall Study|Other: Reason not provided by site|0|||
157166801|NCT02164513|567350608|FG002|Overall Study|Other: Reason not provided by site|0|||
157166802|NCT05301322|567350609|FG000|Overall Study|Adverse Event|7|||
157166803|NCT05301322|567350610|FG001|Overall Study|Adverse Event|3|||
157166804|NCT05301322|567350609|FG000|Overall Study|Death|0|||
157166805|NCT05301322|567350610|FG001|Overall Study|Death|1|||
157166806|NCT05301322|567350609|FG000|Overall Study|Lost to Follow-up|2|||
157166807|NCT05301322|567350610|FG001|Overall Study|Lost to Follow-up|1|||
157166808|NCT05301322|567350609|FG000|Overall Study|Protocol Violation|3|||
156930195|NCT00003641|566504269|FG000|Overall Study|Disease progression|0|||
156930196|NCT00003641|566504270|FG001|Overall Study|Disease progression|2|||
156930197|NCT00003641|566504269|FG000|Overall Study|Unknown/missing|0|||
156930198|NCT00003641|566504270|FG001|Overall Study|Unknown/missing|22|||
156930199|NCT00003641|566504269|FG000|Overall Study|Should not receive interferon therapy|2|||
157166809|NCT05301322|567350610|FG001|Overall Study|Protocol Violation|1|||
157166810|NCT05301322|567350609|FG000|Overall Study|Withdrawal by Subject|3|||
157166811|NCT05301322|567350610|FG001|Overall Study|Withdrawal by Subject|0|||
157166812|NCT05301322|567350609|FG000|Overall Study|Other|4|||
157166813|NCT05301322|567350610|FG001|Overall Study|Other|0|||
157166814|NCT04971785|567350611|FG000|Overall Study|Withdrew Consent|5|||
157166815|NCT04971785|567350612|FG001|Overall Study|Withdrew Consent|5|||
157166816|NCT04971785|567350613|FG002|Overall Study|Withdrew Consent|17|||
157166817|NCT04971785|567350614|FG003|Overall Study|Withdrew Consent|7|||
157166818|NCT04971785|567350611|FG000|Overall Study|Adverse Event|7|||
157166819|NCT04971785|567350612|FG001|Overall Study|Adverse Event|8|||
157166820|NCT04971785|567350613|FG002|Overall Study|Adverse Event|6|||
156930200|NCT00003641|566504270|FG001|Overall Study|Should not receive interferon therapy|0|||
157166821|NCT04971785|567350614|FG003|Overall Study|Adverse Event|3|||
157166822|NCT04971785|567350611|FG000|Overall Study|Lost to Follow-up|2|||
157166823|NCT04971785|567350612|FG001|Overall Study|Lost to Follow-up|1|||
156930201|NCT00003641|566504269|FG000|Overall Study|Never started interferon|567|||
157166824|NCT04971785|567350613|FG002|Overall Study|Lost to Follow-up|6|||
157166825|NCT04971785|567350614|FG003|Overall Study|Lost to Follow-up|7|||
157166826|NCT04971785|567350611|FG000|Overall Study|Protocol Violation|3|||
156930202|NCT00003641|566504270|FG001|Overall Study|Never started interferon|12|||
156930203|NCT02154581|566504273|FG000|Overall Study|Lost to Follow-up|7|||
156930204|NCT02154581|566504274|FG001|Overall Study|Lost to Follow-up|8|||
157166827|NCT04971785|567350612|FG001|Overall Study|Protocol Violation|1|||
157166828|NCT04971785|567350613|FG002|Overall Study|Protocol Violation|1|||
157166829|NCT04971785|567350614|FG003|Overall Study|Protocol Violation|2|||
157166830|NCT04971785|567350611|FG000|Overall Study|Investigator's Discretion|3|||
156930205|NCT03082599|566504277|FG000|Overall Study|Lost to Follow-up|1|||
156930206|NCT03082599|566504278|FG001|Overall Study|Lost to Follow-up|0|||
156930207|NCT00832585|566504279|FG000|Overall Study|Withdrawal by Subject|1|||
156930208|NCT00832585|566504279|FG000|Overall Study|Lost to Follow-up|1|||
156930209|NCT00735878|566504280|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
156930210|NCT00735878|566504281|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
156930211|NCT00735878|566504282|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
156930212|NCT02946047|566504290|FG000|Overall Study|Adverse Event|1|||
156930213|NCT02946047|566504291|FG001|Overall Study|Adverse Event|0|||
156930214|NCT02946047|566504292|FG002|Overall Study|Adverse Event|0|||
156930215|NCT02946047|566504293|FG003|Overall Study|Adverse Event|0|||
156930216|NCT03615105|566504294|FG000|Overall Study|Protocol Violation|1|||
156930217|NCT03615105|566504295|FG001|Overall Study|Protocol Violation|0|||
156930218|NCT03615105|566504296|FG002|Overall Study|Protocol Violation|0|||
156930219|NCT03615105|566504294|FG000|Overall Study|Death|0|||
156930220|NCT03615105|566504295|FG001|Overall Study|Death|2|||
156930221|NCT03615105|566504296|FG002|Overall Study|Death|0|||
156930222|NCT05041322|566504297|FG000|Baseline|Withdrawal by Subject|1|||
156930223|NCT05041322|566504298|FG001|Baseline|Withdrawal by Subject|0|||
156930224|NCT05041322|566504297|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
156930225|NCT05041322|566504298|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
156930226|NCT05041322|566504297|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
156930227|NCT05041322|566504298|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
156930228|NCT04690751|566504300|FG000|Overall Study|Protocol Violation|0|||
156930229|NCT04690751|566504301|FG001|Overall Study|Protocol Violation|1|||
156930230|NCT04690751|566504302|FG002|Overall Study|Protocol Violation|0|||
156930231|NCT04690751|566504303|FG003|Overall Study|Protocol Violation|1|||
156930232|NCT04690751|566504304|FG004|Overall Study|Protocol Violation|2|||
156930233|NCT04690751|566504305|FG005|Overall Study|Protocol Violation|0|||
156930234|NCT04690751|566504300|FG000|Overall Study|Adverse Event|0|||
156930235|NCT04690751|566504301|FG001|Overall Study|Adverse Event|0|||
156930236|NCT04690751|566504302|FG002|Overall Study|Adverse Event|1|||
156930237|NCT04690751|566504303|FG003|Overall Study|Adverse Event|0|||
156930238|NCT04690751|566504304|FG004|Overall Study|Adverse Event|0|||
156930239|NCT04690751|566504305|FG005|Overall Study|Adverse Event|0|||
156930240|NCT04690751|566504300|FG000|Overall Study|Positive urine drug screen test|0|||
156930241|NCT04690751|566504301|FG001|Overall Study|Positive urine drug screen test|0|||
156930242|NCT04690751|566504302|FG002|Overall Study|Positive urine drug screen test|0|||
156930243|NCT04690751|566504303|FG003|Overall Study|Positive urine drug screen test|0|||
156930244|NCT04690751|566504304|FG004|Overall Study|Positive urine drug screen test|1|||
156930245|NCT04690751|566504305|FG005|Overall Study|Positive urine drug screen test|0|||
156930246|NCT01344161|566504306|FG000|Overall Study|Lost to Follow-up|4|||
156930247|NCT01344161|566504307|FG001|Overall Study|Lost to Follow-up|1|||
156930248|NCT01344161|566504306|FG000|Overall Study|Pregnancy|0|||
156930249|NCT01344161|566504307|FG001|Overall Study|Pregnancy|1|||
156930250|NCT01344161|566504306|FG000|Overall Study|Protocol Violation|1|||
156930251|NCT01344161|566504307|FG001|Overall Study|Protocol Violation|1|||
156930252|NCT04364620|566504308|FG000|Overall Study|Disease Progression|20|||
156930253|NCT04364620|566504308|FG000|Overall Study|Adverse Event|5|||
156930254|NCT04364620|566504308|FG000|Overall Study|Physician Decision|4|||
156930255|NCT04364620|566504308|FG000|Overall Study|Death|3|||
156930256|NCT04364620|566504308|FG000|Overall Study|Other|2|||
156930257|NCT04364620|566504308|FG000|Overall Study|Withdrawal by Subject|1|||
156930258|NCT00699972|566506621|FG000|Overall Study|Adverse Event|7|||
156930259|NCT00699972|566506622|FG001|Overall Study|Adverse Event|9|||
156930260|NCT00699972|566506623|FG002|Overall Study|Adverse Event|24|||
156930261|NCT00699972|566506621|FG000|Overall Study|Lost to Follow-up|0|||
156930262|NCT00699972|566506622|FG001|Overall Study|Lost to Follow-up|2|||
156930263|NCT00699972|566506623|FG002|Overall Study|Lost to Follow-up|0|||
156930264|NCT00699972|566506621|FG000|Overall Study|Withdrawal by Subject|3|||
156930265|NCT00699972|566506622|FG001|Overall Study|Withdrawal by Subject|7|||
156930266|NCT00699972|566506623|FG002|Overall Study|Withdrawal by Subject|4|||
156930267|NCT00699972|566506621|FG000|Overall Study|Lack of Efficacy|2|||
156930268|NCT00699972|566506622|FG001|Overall Study|Lack of Efficacy|0|||
156930269|NCT00699972|566506623|FG002|Overall Study|Lack of Efficacy|2|||
156930270|NCT00699972|566506621|FG000|Overall Study|Administrative/Other|3|||
156930271|NCT00699972|566506622|FG001|Overall Study|Administrative/Other|1|||
156930272|NCT00699972|566506623|FG002|Overall Study|Administrative/Other|4|||
156930273|NCT00699972|566506621|FG000|Overall Study|Randomized, Not Treated|1|||
156930274|NCT00699972|566506622|FG001|Overall Study|Randomized, Not Treated|0|||
156930275|NCT00699972|566506623|FG002|Overall Study|Randomized, Not Treated|1|||
156930276|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
156930277|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
156930278|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
156930279|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
156930280|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
156930281|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
156930282|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
156930283|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
156930284|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
156930285|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
156930286|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
156930287|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
156930288|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
156930289|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
156930290|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
156930291|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
156930292|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
156930293|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
156930294|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
156930295|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
156930296|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
156930297|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
156930298|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
156930299|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
156930300|NCT00277212|566506627|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
156930301|NCT00277212|566506628|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
156930302|NCT00277212|566506629|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
156930303|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
156930304|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
156930305|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
156930306|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
156930307|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
156930308|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
156930309|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
156930310|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
156930311|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
156930312|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
156930313|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
156930314|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
156930315|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
156930316|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
156930317|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
156930318|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
156930319|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
156930320|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
156930321|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
156930322|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
156930323|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
156930324|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
156930325|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
156930326|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
156930327|NCT00277212|566506627|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
156930328|NCT00277212|566506628|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
156930329|NCT00277212|566506629|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
156930330|NCT00902564|566506630|FG000|Overall Study|Withdrawal by Subject|2|||
156930331|NCT05620576|566506631|FG000|Overall Study|Adverse Event|1|||
156930332|NCT05620576|566506632|FG001|Overall Study|Adverse Event|1|||
156930333|NCT05620576|566506631|FG000|Overall Study|Lost to Follow-up|3|||
156930334|NCT05620576|566506632|FG001|Overall Study|Lost to Follow-up|1|||
156930335|NCT05620576|566506631|FG000|Overall Study|Physician Decision|0|||
156930336|NCT05620576|566506632|FG001|Overall Study|Physician Decision|1|||
156930337|NCT05620576|566506631|FG000|Overall Study|Protocol Deviation|1|||
156930338|NCT05620576|566506632|FG001|Overall Study|Protocol Deviation|1|||
156930339|NCT05620576|566506631|FG000|Overall Study|Withdrawal by Subject|2|||
156930340|NCT05620576|566506632|FG001|Overall Study|Withdrawal by Subject|3|||
156930341|NCT03336216|566506633|FG000|Randomization|Not reported|2|||
156930342|NCT03336216|566506634|FG001|Randomization|Not reported|0|||
156930343|NCT03336216|566506635|FG002|Randomization|Not reported|1|||
156930344|NCT03336216|566506636|FG003|Randomization|Not reported|0|||
156930345|NCT03336216|566506633|FG000|Randomization|Other reasons|1|||
156930346|NCT03336216|566506634|FG001|Randomization|Other reasons|1|||
156930347|NCT03336216|566506635|FG002|Randomization|Other reasons|1|||
156930348|NCT03336216|566506636|FG003|Randomization|Other reasons|0|||
156930349|NCT03336216|566506633|FG000|Randomization|Participant no longer meets study criteria|0|||
156930350|NCT03336216|566506634|FG001|Randomization|Participant no longer meets study criteria|2|||
156930351|NCT03336216|566506635|FG002|Randomization|Participant no longer meets study criteria|4|||
157166831|NCT04971785|567350612|FG001|Overall Study|Investigator's Discretion|1|||
157166832|NCT04971785|567350613|FG002|Overall Study|Investigator's Discretion|1|||
157166833|NCT04971785|567350614|FG003|Overall Study|Investigator's Discretion|0|||
157166834|NCT04971785|567350611|FG000|Overall Study|Randomized but Never Treated|1|||
157166835|NCT04971785|567350612|FG001|Overall Study|Randomized but Never Treated|2|||
157166836|NCT04971785|567350613|FG002|Overall Study|Randomized but Never Treated|0|||
157166837|NCT04971785|567350614|FG003|Overall Study|Randomized but Never Treated|1|||
157166838|NCT04971785|567350611|FG000|Overall Study|Death|0|||
157166839|NCT04971785|567350612|FG001|Overall Study|Death|1|||
157166840|NCT04971785|567350613|FG002|Overall Study|Death|1|||
157166841|NCT04971785|567350614|FG003|Overall Study|Death|0|||
157166842|NCT04971785|567350611|FG000|Overall Study|Site Terminated by Sponsor|1|||
157166843|NCT04971785|567350612|FG001|Overall Study|Site Terminated by Sponsor|1|||
157166844|NCT04971785|567350613|FG002|Overall Study|Site Terminated by Sponsor|0|||
157166845|NCT04971785|567350614|FG003|Overall Study|Site Terminated by Sponsor|0|||
157166846|NCT01179347|567352589|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
157166847|NCT01179347|567352590|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
157166848|NCT01179347|567352589|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
157166849|NCT01179347|567352590|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
157166850|NCT01179347|567352589|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
156930352|NCT03336216|566506636|FG003|Randomization|Participant no longer meets study criteria|1|||
156930353|NCT03336216|566506633|FG000|Randomization|Lost to Follow-up|1|||
156930354|NCT03336216|566506634|FG001|Randomization|Lost to Follow-up|0|||
156930355|NCT03336216|566506635|FG002|Randomization|Lost to Follow-up|0|||
156930356|NCT03336216|566506636|FG003|Randomization|Lost to Follow-up|0|||
156930357|NCT03336216|566506633|FG000|Randomization|Participant withdrew consent|9|||
156930358|NCT03336216|566506634|FG001|Randomization|Participant withdrew consent|1|||
156930359|NCT03336216|566506635|FG002|Randomization|Participant withdrew consent|0|||
156930360|NCT03336216|566506636|FG003|Randomization|Participant withdrew consent|0|||
156930361|NCT03336216|566506633|FG000|Randomization|Adverse Event|1|||
156930362|NCT03336216|566506634|FG001|Randomization|Adverse Event|1|||
156930363|NCT03336216|566506635|FG002|Randomization|Adverse Event|0|||
156930364|NCT03336216|566506636|FG003|Randomization|Adverse Event|0|||
156930365|NCT03336216|566506633|FG000|Treatment|Adverse Event|2|||
156930366|NCT03336216|566506634|FG001|Treatment|Adverse Event|3|||
156930367|NCT03336216|566506635|FG002|Treatment|Adverse Event|4|||
156930368|NCT03336216|566506636|FG003|Treatment|Adverse Event|4|||
156930369|NCT03336216|566506633|FG000|Treatment|Participant request to discontinue treatment|2|||
156930370|NCT03336216|566506634|FG001|Treatment|Participant request to discontinue treatment|1|||
156930371|NCT03336216|566506635|FG002|Treatment|Participant request to discontinue treatment|2|||
156930372|NCT03336216|566506636|FG003|Treatment|Participant request to discontinue treatment|2|||
156930373|NCT03336216|566506633|FG000|Treatment|Participant withdrew consent|7|||
156930374|NCT03336216|566506634|FG001|Treatment|Participant withdrew consent|2|||
156930375|NCT03336216|566506635|FG002|Treatment|Participant withdrew consent|3|||
156930376|NCT03336216|566506636|FG003|Treatment|Participant withdrew consent|2|||
156930377|NCT03336216|566506633|FG000|Treatment|Death|2|||
156930378|NCT03336216|566506634|FG001|Treatment|Death|3|||
156930379|NCT03336216|566506635|FG002|Treatment|Death|3|||
156930380|NCT03336216|566506636|FG003|Treatment|Death|4|||
157166851|NCT01179347|567352590|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
156930381|NCT03336216|566506633|FG000|Treatment|Participant no longer meets study criteria|0|||
156930382|NCT03336216|566506634|FG001|Treatment|Participant no longer meets study criteria|1|||
156930383|NCT03336216|566506635|FG002|Treatment|Participant no longer meets study criteria|0|||
156930384|NCT03336216|566506636|FG003|Treatment|Participant no longer meets study criteria|0|||
156930385|NCT03336216|566506633|FG000|Treatment|Other reasons|2|||
156930386|NCT03336216|566506634|FG001|Treatment|Other reasons|0|||
156930387|NCT03336216|566506635|FG002|Treatment|Other reasons|0|||
156930388|NCT03336216|566506636|FG003|Treatment|Other reasons|3|||
156930389|NCT03336216|566506633|FG000|Treatment|Disease progression|23|||
156930390|NCT03336216|566506634|FG001|Treatment|Disease progression|34|||
156930391|NCT03336216|566506635|FG002|Treatment|Disease progression|33|||
156930392|NCT03336216|566506636|FG003|Treatment|Disease progression|26|||
156930393|NCT03336216|566506633|FG000|Treatment|Study drug toxicity|0|||
156930394|NCT03336216|566506634|FG001|Treatment|Study drug toxicity|3|||
156930395|NCT03336216|566506635|FG002|Treatment|Study drug toxicity|2|||
156930396|NCT03336216|566506636|FG003|Treatment|Study drug toxicity|0|||
156930397|NCT03336216|566506633|FG000|Treatment|Adverse Event unrelated to study drug|1|||
156930398|NCT03336216|566506634|FG001|Treatment|Adverse Event unrelated to study drug|1|||
156930399|NCT03336216|566506635|FG002|Treatment|Adverse Event unrelated to study drug|1|||
156930400|NCT03336216|566506636|FG003|Treatment|Adverse Event unrelated to study drug|0|||
156930401|NCT03336216|566506633|FG000|Treatment|Disease Recurrence|1|||
156930402|NCT03336216|566506634|FG001|Treatment|Disease Recurrence|0|||
157166852|NCT01179347|567352589|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
157166853|NCT01179347|567352590|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
156930403|NCT03336216|566506635|FG002|Treatment|Disease Recurrence|0|||
156930404|NCT03336216|566506636|FG003|Treatment|Disease Recurrence|0|||
157029287|NCT01928394|566862907|FG020|Follow-up Period|other reason|0|||
157029288|NCT01928394|566862908|FG021|Follow-up Period|other reason|0|||
157029289|NCT01928394|566862909|FG022|Follow-up Period|other reason|1|||
157029290|NCT01928394|566862887|FG000|Follow-up Period|Lost to Follow-up|0|||
157029291|NCT01928394|566862888|FG001|Follow-up Period|Lost to Follow-up|0|||
157029292|NCT01928394|566862889|FG002|Follow-up Period|Lost to Follow-up|0|||
157029293|NCT01928394|566862890|FG003|Follow-up Period|Lost to Follow-up|0|||
157029294|NCT01928394|566862891|FG004|Follow-up Period|Lost to Follow-up|0|||
157029295|NCT01928394|566862892|FG005|Follow-up Period|Lost to Follow-up|0|||
157029296|NCT01928394|566862893|FG006|Follow-up Period|Lost to Follow-up|0|||
157029297|NCT01928394|566862894|FG007|Follow-up Period|Lost to Follow-up|0|||
157029298|NCT01928394|566862895|FG008|Follow-up Period|Lost to Follow-up|0|||
157029299|NCT01928394|566862896|FG009|Follow-up Period|Lost to Follow-up|0|||
157029300|NCT01928394|566862897|FG010|Follow-up Period|Lost to Follow-up|0|||
157029301|NCT01928394|566862898|FG011|Follow-up Period|Lost to Follow-up|1|||
157029302|NCT01928394|566862899|FG012|Follow-up Period|Lost to Follow-up|1|||
157029303|NCT01928394|566862900|FG013|Follow-up Period|Lost to Follow-up|0|||
157029304|NCT01928394|566862901|FG014|Follow-up Period|Lost to Follow-up|1|||
157029305|NCT01928394|566862902|FG015|Follow-up Period|Lost to Follow-up|0|||
157029306|NCT01928394|566862903|FG016|Follow-up Period|Lost to Follow-up|1|||
157029307|NCT01928394|566862904|FG017|Follow-up Period|Lost to Follow-up|0|||
157029308|NCT01928394|566862905|FG018|Follow-up Period|Lost to Follow-up|0|||
157029309|NCT01928394|566862906|FG019|Follow-up Period|Lost to Follow-up|0|||
157029310|NCT01928394|566862907|FG020|Follow-up Period|Lost to Follow-up|0|||
157029311|NCT01928394|566862908|FG021|Follow-up Period|Lost to Follow-up|0|||
157029312|NCT01928394|566862909|FG022|Follow-up Period|Lost to Follow-up|1|||
157029313|NCT04707625|566862910|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
157029314|NCT05485779|566862911|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029315|NCT05485779|566862912|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029316|NCT05485779|566862913|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029317|NCT05485779|566862914|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029318|NCT05485779|566862915|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029319|NCT05485779|566862916|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029320|NCT05485779|566862917|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029321|NCT05485779|566862918|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
157029322|NCT05485779|566862919|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
157029323|NCT05485779|566862920|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029324|NCT05485779|566862921|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
157029325|NCT05485779|566862911|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029326|NCT05485779|566862912|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029327|NCT05485779|566862913|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029328|NCT05485779|566862914|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029329|NCT05485779|566862915|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029330|NCT05485779|566862916|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029331|NCT05485779|566862917|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029332|NCT05485779|566862918|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
156930405|NCT00539838|566506639|FG000|Overall Study|Fail to return|2|||
156930406|NCT00539838|566506640|FG001|Overall Study|Fail to return|0|||
156930407|NCT00539838|566506641|FG002|Overall Study|Fail to return|0|||
156930408|NCT00539838|566506639|FG000|Overall Study|Withdrawal by Subject|0|||
156930409|NCT00539838|566506640|FG001|Overall Study|Withdrawal by Subject|4|||
156930410|NCT00539838|566506641|FG002|Overall Study|Withdrawal by Subject|0|||
156930411|NCT00539838|566506639|FG000|Overall Study|Death|0|||
156930412|NCT00539838|566506640|FG001|Overall Study|Death|2|||
156930413|NCT00539838|566506641|FG002|Overall Study|Death|0|||
157029333|NCT05485779|566862919|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029334|NCT05485779|566862920|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
157029335|NCT05485779|566862921|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
157029336|NCT05485779|566862911|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029337|NCT05485779|566862912|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029338|NCT05485779|566862913|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029339|NCT05485779|566862914|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
157029340|NCT05485779|566862915|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029341|NCT05485779|566862916|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029342|NCT05485779|566862917|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029343|NCT05485779|566862918|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
156930414|NCT00539838|566506639|FG000|Overall Study|Did not cooperate|1|||
156930415|NCT00539838|566506640|FG001|Overall Study|Did not cooperate|0|||
156930416|NCT00539838|566506641|FG002|Overall Study|Did not cooperate|1|||
156930417|NCT00539838|566506639|FG000|Overall Study|Administrative|4|||
156930418|NCT00539838|566506640|FG001|Overall Study|Administrative|0|||
156930419|NCT00539838|566506641|FG002|Overall Study|Administrative|8|||
156930420|NCT02658890|566506647|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930421|NCT02658890|566506648|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930422|NCT02658890|566506649|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930423|NCT02658890|566506650|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930424|NCT02658890|566506651|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930425|NCT02658890|566506652|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930426|NCT02658890|566506653|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930427|NCT02658890|566506654|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930428|NCT02658890|566506655|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156930429|NCT02658890|566506656|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930430|NCT02658890|566506657|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930431|NCT02658890|566506658|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930432|NCT02658890|566506659|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930433|NCT02658890|566506660|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930434|NCT02658890|566506661|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930435|NCT02658890|566506662|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930436|NCT02658890|566506663|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930437|NCT02658890|566506664|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930438|NCT02658890|566506665|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930439|NCT02658890|566506666|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930440|NCT02658890|566506667|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930441|NCT02658890|566506668|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930442|NCT02658890|566506669|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930443|NCT02658890|566506670|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930444|NCT02658890|566506671|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930445|NCT02658890|566506672|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930446|NCT02658890|566506673|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930447|NCT02658890|566506647|FG000|Treatment Phase|Adverse Event|0|||
156930448|NCT02658890|566506648|FG001|Treatment Phase|Adverse Event|1|||
156930449|NCT02658890|566506649|FG002|Treatment Phase|Adverse Event|2|||
156930450|NCT02658890|566506650|FG003|Treatment Phase|Adverse Event|2|||
156930451|NCT02658890|566506651|FG004|Treatment Phase|Adverse Event|1|||
156930452|NCT02658890|566506652|FG005|Treatment Phase|Adverse Event|0|||
156930453|NCT02658890|566506653|FG006|Treatment Phase|Adverse Event|0|||
156930454|NCT02658890|566506654|FG007|Treatment Phase|Adverse Event|2|||
156930455|NCT02658890|566506655|FG008|Treatment Phase|Adverse Event|1|||
156930456|NCT02658890|566506656|FG009|Treatment Phase|Adverse Event|2|||
156930457|NCT02658890|566506657|FG010|Treatment Phase|Adverse Event|3|||
156930458|NCT02658890|566506658|FG011|Treatment Phase|Adverse Event|0|||
156930459|NCT02658890|566506659|FG012|Treatment Phase|Adverse Event|1|||
156930460|NCT02658890|566506660|FG013|Treatment Phase|Adverse Event|4|||
156930461|NCT02658890|566506661|FG014|Treatment Phase|Adverse Event|0|||
156930462|NCT02658890|566506662|FG015|Treatment Phase|Adverse Event|0|||
156930463|NCT02658890|566506663|FG016|Treatment Phase|Adverse Event|0|||
156930464|NCT02658890|566506664|FG017|Treatment Phase|Adverse Event|0|||
156930465|NCT02658890|566506665|FG018|Treatment Phase|Adverse Event|5|||
156930466|NCT02658890|566506666|FG019|Treatment Phase|Adverse Event|1|||
156930467|NCT02658890|566506667|FG020|Treatment Phase|Adverse Event|3|||
156930468|NCT02658890|566506668|FG021|Treatment Phase|Adverse Event|0|||
156930469|NCT02658890|566506669|FG022|Treatment Phase|Adverse Event|5|||
156930470|NCT02658890|566506670|FG023|Treatment Phase|Adverse Event|0|||
156930471|NCT02658890|566506671|FG024|Treatment Phase|Adverse Event|0|||
156930472|NCT02658890|566506672|FG025|Treatment Phase|Adverse Event|2|||
156930473|NCT02658890|566506673|FG026|Treatment Phase|Adverse Event|1|||
156930474|NCT02658890|566506647|FG000|Treatment Phase|Death|0|||
156930475|NCT02658890|566506648|FG001|Treatment Phase|Death|0|||
156930476|NCT02658890|566506649|FG002|Treatment Phase|Death|0|||
156930477|NCT02658890|566506650|FG003|Treatment Phase|Death|0|||
156930478|NCT02658890|566506651|FG004|Treatment Phase|Death|0|||
156930479|NCT02658890|566506652|FG005|Treatment Phase|Death|0|||
156930480|NCT02658890|566506653|FG006|Treatment Phase|Death|0|||
156930481|NCT02658890|566506654|FG007|Treatment Phase|Death|0|||
156930482|NCT02658890|566506655|FG008|Treatment Phase|Death|0|||
156930483|NCT02658890|566506656|FG009|Treatment Phase|Death|0|||
156930484|NCT02658890|566506657|FG010|Treatment Phase|Death|0|||
156930485|NCT02658890|566506658|FG011|Treatment Phase|Death|0|||
156930486|NCT02658890|566506659|FG012|Treatment Phase|Death|0|||
156930487|NCT02658890|566506660|FG013|Treatment Phase|Death|0|||
156930488|NCT02658890|566506661|FG014|Treatment Phase|Death|0|||
156930489|NCT02658890|566506662|FG015|Treatment Phase|Death|0|||
156930490|NCT02658890|566506663|FG016|Treatment Phase|Death|0|||
156930491|NCT02658890|566506664|FG017|Treatment Phase|Death|0|||
156930492|NCT02658890|566506665|FG018|Treatment Phase|Death|1|||
156930493|NCT02658890|566506666|FG019|Treatment Phase|Death|0|||
156930494|NCT02658890|566506667|FG020|Treatment Phase|Death|0|||
156930495|NCT02658890|566506668|FG021|Treatment Phase|Death|0|||
156930496|NCT02658890|566506669|FG022|Treatment Phase|Death|0|||
157029344|NCT05485779|566862919|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029345|NCT05485779|566862920|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029346|NCT05485779|566862921|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
157029347|NCT04299464|566862922|FG000|Overall Study|Adverse Event|1|||
157029348|NCT04299464|566862923|FG001|Overall Study|Adverse Event|0|||
157029349|NCT04299464|566862924|FG002|Overall Study|Adverse Event|2|||
157029350|NCT04299464|566862922|FG000|Overall Study|Non-compliance with Study Drug|1|||
157029351|NCT04299464|566862923|FG001|Overall Study|Non-compliance with Study Drug|0|||
157029352|NCT04299464|566862924|FG002|Overall Study|Non-compliance with Study Drug|0|||
157029353|NCT04299464|566862922|FG000|Overall Study|Reason not Specified|0|||
157029354|NCT04299464|566862923|FG001|Overall Study|Reason not Specified|1|||
157029355|NCT04299464|566862924|FG002|Overall Study|Reason not Specified|3|||
157029356|NCT04299464|566862922|FG000|Overall Study|Physician Decision|0|||
157029357|NCT04299464|566862923|FG001|Overall Study|Physician Decision|1|||
157029358|NCT04299464|566862924|FG002|Overall Study|Physician Decision|1|||
157029359|NCT04299464|566862922|FG000|Overall Study|Withdrawal by Subject|0|||
157029360|NCT04299464|566862923|FG001|Overall Study|Withdrawal by Subject|2|||
157029361|NCT04299464|566862924|FG002|Overall Study|Withdrawal by Subject|1|||
157029362|NCT03030261|566862925|FG000|Overall Study|Still receiving continuation therapy|5|||
157029363|NCT03209973|566862931|FG000|Overall Study|Withdrawal by Subject|7|||
157029364|NCT03209973|566862931|FG000|Overall Study|Lost to Follow-up|2|||
157029365|NCT03209973|566862931|FG000|Overall Study|Death|8|||
156930497|NCT02658890|566506670|FG023|Treatment Phase|Death|0|||
156930498|NCT02658890|566506671|FG024|Treatment Phase|Death|0|||
156930499|NCT02658890|566506672|FG025|Treatment Phase|Death|0|||
156930500|NCT02658890|566506673|FG026|Treatment Phase|Death|0|||
156930501|NCT02658890|566506647|FG000|Treatment Phase|Lost to Follow-up|0|||
156930502|NCT02658890|566506648|FG001|Treatment Phase|Lost to Follow-up|0|||
156930503|NCT02658890|566506649|FG002|Treatment Phase|Lost to Follow-up|0|||
156930504|NCT02658890|566506650|FG003|Treatment Phase|Lost to Follow-up|0|||
156930505|NCT02658890|566506651|FG004|Treatment Phase|Lost to Follow-up|0|||
156930506|NCT02658890|566506652|FG005|Treatment Phase|Lost to Follow-up|0|||
156930507|NCT02658890|566506653|FG006|Treatment Phase|Lost to Follow-up|1|||
156930508|NCT02658890|566506654|FG007|Treatment Phase|Lost to Follow-up|0|||
156930509|NCT02658890|566506655|FG008|Treatment Phase|Lost to Follow-up|0|||
156930510|NCT02658890|566506656|FG009|Treatment Phase|Lost to Follow-up|0|||
156930511|NCT02658890|566506657|FG010|Treatment Phase|Lost to Follow-up|0|||
156930512|NCT02658890|566506658|FG011|Treatment Phase|Lost to Follow-up|0|||
156930513|NCT02658890|566506659|FG012|Treatment Phase|Lost to Follow-up|0|||
156930514|NCT02658890|566506660|FG013|Treatment Phase|Lost to Follow-up|0|||
156930515|NCT02658890|566506661|FG014|Treatment Phase|Lost to Follow-up|0|||
156930516|NCT02658890|566506662|FG015|Treatment Phase|Lost to Follow-up|0|||
156930517|NCT02658890|566506663|FG016|Treatment Phase|Lost to Follow-up|0|||
156930518|NCT02658890|566506664|FG017|Treatment Phase|Lost to Follow-up|0|||
157029366|NCT03209973|566862931|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
157029367|NCT03209973|566862931|FG000|Overall Study|Sponsor Decision|18|||
157029368|NCT03209973|566862931|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
157029369|NCT03209973|566862931|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
157166854|NCT01179347|567352589|FG000|Double-blind Period (12 Weeks)|Other|2|||
157166855|NCT01179347|567352590|FG001|Double-blind Period (12 Weeks)|Other|4|||
157166856|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
157166857|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
157166858|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
157166859|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
157166860|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
157166861|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
157166862|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
157166863|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
157166864|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
157166865|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
157166866|NCT01179347|567352589|FG000|Open-label Period (12 Weeks)|Other|7|||
157166867|NCT01179347|567352590|FG001|Open-label Period (12 Weeks)|Other|4|||
157166868|NCT01283997|567352591|FG000|Overall Study|Physician Decision|8|||
157166869|NCT01283997|567352592|FG001|Overall Study|Physician Decision|10|||
156930519|NCT02658890|566506665|FG018|Treatment Phase|Lost to Follow-up|0|||
156930520|NCT02658890|566506666|FG019|Treatment Phase|Lost to Follow-up|0|||
156930521|NCT02658890|566506667|FG020|Treatment Phase|Lost to Follow-up|0|||
156930522|NCT02658890|566506668|FG021|Treatment Phase|Lost to Follow-up|0|||
156930523|NCT02658890|566506669|FG022|Treatment Phase|Lost to Follow-up|0|||
157029370|NCT03987022|566862934|FG000|Overall Study|Lost to Follow-up|2|||
157029371|NCT03987022|566862935|FG001|Overall Study|Lost to Follow-up|2|||
157029372|NCT03987022|566862934|FG000|Overall Study|Withdrawal by Subject|1|||
157029373|NCT03987022|566862935|FG001|Overall Study|Withdrawal by Subject|0|||
157029374|NCT01346540|566862936|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
157029375|NCT01346540|566862937|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
157029376|NCT01346540|566862936|FG000|Overall Study|Adverse Event|0|||
157029377|NCT01346540|566862937|FG001|Overall Study|Adverse Event|4|||
157029378|NCT05863156|566862938|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
157029379|NCT05863156|566862939|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
157029380|NCT05863156|566862940|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
157029381|NCT03362476|566862941|FG000|Overall Study|Withdrawal by Subject|0|||
157029382|NCT03362476|566862942|FG001|Overall Study|Withdrawal by Subject|1|||
157029383|NCT05216406|566862945|FG000|Overall Study|Lost to Follow-up|8|||
157029384|NCT05216406|566862946|FG001|Overall Study|Lost to Follow-up|9|||
157029385|NCT04270942|566862947|FG000|Overall Study|Death|1|||
157029386|NCT04797195|566862953|FG000|Overall Study|Death|8|||
157029387|NCT04797195|566862954|FG001|Overall Study|Death|15|||
157029388|NCT04797195|566862953|FG000|Overall Study|Change from PD|15|||
157029389|NCT04797195|566862954|FG001|Overall Study|Change from PD|15|||
157029390|NCT04797195|566862953|FG000|Overall Study|Withdrawal by Subject|3|||
157029391|NCT04797195|566862954|FG001|Overall Study|Withdrawal by Subject|2|||
157029392|NCT01236781|566862956|FG000|Overall Study|Ineligible|2|||
157029393|NCT01236781|566862957|FG001|Overall Study|Ineligible|1|||
157029394|NCT01236781|566862956|FG000|Overall Study|Did not complete study imaging|5|||
157029395|NCT01236781|566862957|FG001|Overall Study|Did not complete study imaging|0|||
157029396|NCT04577963|566862958|FG000|Part 2|Death|0|||
157029397|NCT04577963|566862959|FG001|Part 2|Death|1|||
157029398|NCT04577963|566862960|FG002|Part 2|Death|8|||
157029399|NCT04577963|566862961|FG003|Part 2|Death|0|||
157029400|NCT04577963|566862962|FG004|Part 2|Death|20|||
157029401|NCT04577963|566862958|FG000|Part 2|Lost to Follow-up|0|||
157029402|NCT04577963|566862959|FG001|Part 2|Lost to Follow-up|0|||
157029403|NCT04577963|566862960|FG002|Part 2|Lost to Follow-up|0|||
157029404|NCT04577963|566862961|FG003|Part 2|Lost to Follow-up|0|||
157029405|NCT04577963|566862962|FG004|Part 2|Lost to Follow-up|2|||
157029406|NCT04577963|566862958|FG000|Part 2|Withdrawal by Subject|0|||
157029407|NCT04577963|566862959|FG001|Part 2|Withdrawal by Subject|0|||
157029408|NCT04577963|566862960|FG002|Part 2|Withdrawal by Subject|0|||
157029409|NCT04577963|566862961|FG003|Part 2|Withdrawal by Subject|0|||
157029410|NCT04577963|566862962|FG004|Part 2|Withdrawal by Subject|10|||
157029411|NCT04577963|566862958|FG000|Part 2|Progressive disease|0|||
157029412|NCT04577963|566862959|FG001|Part 2|Progressive disease|0|||
157029413|NCT04577963|566862960|FG002|Part 2|Progressive disease|0|||
157029414|NCT04577963|566862961|FG003|Part 2|Progressive disease|0|||
157029415|NCT04577963|566862962|FG004|Part 2|Progressive disease|2|||
157029416|NCT04577963|566862958|FG000|Part 2|Investigator decision|0|||
157029417|NCT04577963|566862959|FG001|Part 2|Investigator decision|0|||
157029418|NCT04577963|566862960|FG002|Part 2|Investigator decision|0|||
157029419|NCT04577963|566862961|FG003|Part 2|Investigator decision|0|||
157029420|NCT04577963|566862962|FG004|Part 2|Investigator decision|1|||
157029421|NCT04577963|566862958|FG000|Part 2|Sponsor terminated study|0|||
157029422|NCT04577963|566862959|FG001|Part 2|Sponsor terminated study|0|||
157029423|NCT04577963|566862960|FG002|Part 2|Sponsor terminated study|3|||
157029424|NCT04577963|566862961|FG003|Part 2|Sponsor terminated study|1|||
157029425|NCT04577963|566862962|FG004|Part 2|Sponsor terminated study|4|||
157029426|NCT03571581|566862967|FG000|Overall Study|Death|2|||
157029427|NCT03571581|566862967|FG000|Overall Study|Withdrawal by Subject|2|||
157029428|NCT04737330|566862970|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
157029429|NCT04737330|566862971|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
157166870|NCT01283997|567352591|FG000|Overall Study|Withdrawal by Subject|3|||
157166871|NCT01283997|567352592|FG001|Overall Study|Withdrawal by Subject|2|||
157166872|NCT01283997|567352591|FG000|Overall Study|Physically unable to continue|0|||
157166873|NCT01283997|567352592|FG001|Overall Study|Physically unable to continue|1|||
157166874|NCT01283997|567352591|FG000|Overall Study|Progressive disease|1|||
157166875|NCT01283997|567352592|FG001|Overall Study|Progressive disease|0|||
157166876|NCT01283997|567352591|FG000|Overall Study|Other|4|||
157166877|NCT01283997|567352592|FG001|Overall Study|Other|4|||
157029430|NCT04737330|566862970|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
157029431|NCT04737330|566862971|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
157029432|NCT04737330|566862970|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
157029433|NCT04737330|566862971|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
157029434|NCT04737330|566862970|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
157029435|NCT04737330|566862971|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
157029436|NCT04737330|566862970|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
157029437|NCT04737330|566862971|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
156930524|NCT02658890|566506670|FG023|Treatment Phase|Lost to Follow-up|0|||
156930525|NCT02658890|566506671|FG024|Treatment Phase|Lost to Follow-up|0|||
156930526|NCT02658890|566506672|FG025|Treatment Phase|Lost to Follow-up|0|||
156930527|NCT02658890|566506673|FG026|Treatment Phase|Lost to Follow-up|0|||
157166878|NCT02109744|567352593|FG000|Overall Study|Death|1|||
157166879|NCT02109744|567352594|FG001|Overall Study|Death|1|||
157166880|NCT02109744|567352593|FG000|Overall Study|no marrow exam|1|||
156930528|NCT02658890|566506647|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
156930529|NCT02658890|566506648|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
156930530|NCT02658890|566506649|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
156930531|NCT02658890|566506650|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
156930532|NCT02658890|566506651|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
156930533|NCT02658890|566506652|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
156930534|NCT02658890|566506653|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
156930535|NCT02658890|566506654|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
156930536|NCT02658890|566506655|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
156930537|NCT02658890|566506656|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
156930538|NCT02658890|566506657|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
156930539|NCT02658890|566506658|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
156930540|NCT02658890|566506659|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
156930541|NCT02658890|566506660|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
156930542|NCT02658890|566506661|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
156930543|NCT02658890|566506662|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
156930544|NCT02658890|566506663|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
156930545|NCT02658890|566506664|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
156930546|NCT02658890|566506665|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
156930547|NCT02658890|566506666|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
156930548|NCT02658890|566506667|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
156930549|NCT02658890|566506668|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
156930550|NCT02658890|566506669|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
156930551|NCT02658890|566506670|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
156930552|NCT02658890|566506671|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
156930553|NCT02658890|566506672|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
156930554|NCT02658890|566506673|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
156930555|NCT02658890|566506647|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
156930556|NCT02658890|566506648|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
156930557|NCT02658890|566506649|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
156930558|NCT02658890|566506650|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
156930559|NCT02658890|566506651|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
156930560|NCT02658890|566506652|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
156930561|NCT02658890|566506653|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
156930562|NCT02658890|566506654|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
156930563|NCT02658890|566506655|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
156930564|NCT02658890|566506656|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
156930565|NCT02658890|566506657|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
156930566|NCT02658890|566506658|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
156930567|NCT02658890|566506659|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
156930568|NCT02658890|566506660|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
156930569|NCT02658890|566506661|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
156930570|NCT02658890|566506662|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
156930571|NCT02658890|566506663|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
156930572|NCT02658890|566506664|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
156930573|NCT02658890|566506665|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
156930574|NCT02658890|566506666|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
156930575|NCT02658890|566506667|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
156930576|NCT02658890|566506668|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
156930577|NCT02658890|566506669|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
156930578|NCT02658890|566506670|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
156930579|NCT02658890|566506671|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
156930580|NCT02658890|566506672|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
156930581|NCT02658890|566506673|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
156930582|NCT02658890|566506647|FG000|Treatment Phase|Other Reasons|0|||
156930583|NCT02658890|566506648|FG001|Treatment Phase|Other Reasons|0|||
156930584|NCT02658890|566506649|FG002|Treatment Phase|Other Reasons|0|||
156930585|NCT02658890|566506650|FG003|Treatment Phase|Other Reasons|0|||
156930586|NCT02658890|566506651|FG004|Treatment Phase|Other Reasons|0|||
156930587|NCT02658890|566506652|FG005|Treatment Phase|Other Reasons|0|||
157166881|NCT02109744|567352594|FG001|Overall Study|no marrow exam|0|||
156930588|NCT02658890|566506653|FG006|Treatment Phase|Other Reasons|1|||
156930589|NCT02658890|566506654|FG007|Treatment Phase|Other Reasons|0|||
156930590|NCT02658890|566506655|FG008|Treatment Phase|Other Reasons|1|||
156930591|NCT02658890|566506656|FG009|Treatment Phase|Other Reasons|0|||
156930592|NCT02658890|566506657|FG010|Treatment Phase|Other Reasons|0|||
156930593|NCT02658890|566506658|FG011|Treatment Phase|Other Reasons|0|||
157166882|NCT04095442|567352598|FG000|Overall Study|Lost to Follow-up|0|||
156930594|NCT02658890|566506659|FG012|Treatment Phase|Other Reasons|0|||
156930595|NCT02658890|566506660|FG013|Treatment Phase|Other Reasons|2|||
156930596|NCT02658890|566506661|FG014|Treatment Phase|Other Reasons|0|||
156930597|NCT02658890|566506662|FG015|Treatment Phase|Other Reasons|0|||
156930598|NCT02658890|566506663|FG016|Treatment Phase|Other Reasons|0|||
156930599|NCT02658890|566506664|FG017|Treatment Phase|Other Reasons|0|||
156930600|NCT02658890|566506665|FG018|Treatment Phase|Other Reasons|1|||
156930601|NCT02658890|566506666|FG019|Treatment Phase|Other Reasons|0|||
156930602|NCT02658890|566506667|FG020|Treatment Phase|Other Reasons|0|||
156930603|NCT02658890|566506668|FG021|Treatment Phase|Other Reasons|0|||
156930604|NCT02658890|566506669|FG022|Treatment Phase|Other Reasons|0|||
156930605|NCT02658890|566506670|FG023|Treatment Phase|Other Reasons|0|||
156930606|NCT02658890|566506671|FG024|Treatment Phase|Other Reasons|1|||
156930607|NCT02658890|566506672|FG025|Treatment Phase|Other Reasons|0|||
156930608|NCT02658890|566506673|FG026|Treatment Phase|Other Reasons|1|||
156930609|NCT02658890|566506647|FG000|Treatment Phase|Progressive Disease|6|||
156930610|NCT02658890|566506648|FG001|Treatment Phase|Progressive Disease|7|||
156930611|NCT02658890|566506649|FG002|Treatment Phase|Progressive Disease|6|||
156930612|NCT02658890|566506650|FG003|Treatment Phase|Progressive Disease|12|||
156930613|NCT02658890|566506651|FG004|Treatment Phase|Progressive Disease|6|||
156930614|NCT02658890|566506652|FG005|Treatment Phase|Progressive Disease|18|||
156930615|NCT02658890|566506653|FG006|Treatment Phase|Progressive Disease|12|||
156930616|NCT02658890|566506654|FG007|Treatment Phase|Progressive Disease|19|||
156930617|NCT02658890|566506655|FG008|Treatment Phase|Progressive Disease|26|||
156930618|NCT02658890|566506656|FG009|Treatment Phase|Progressive Disease|8|||
156930619|NCT02658890|566506657|FG010|Treatment Phase|Progressive Disease|7|||
156930620|NCT02658890|566506658|FG011|Treatment Phase|Progressive Disease|9|||
156930621|NCT02658890|566506659|FG012|Treatment Phase|Progressive Disease|8|||
156930622|NCT02658890|566506660|FG013|Treatment Phase|Progressive Disease|29|||
156930623|NCT02658890|566506661|FG014|Treatment Phase|Progressive Disease|6|||
156930624|NCT02658890|566506662|FG015|Treatment Phase|Progressive Disease|2|||
156930625|NCT02658890|566506663|FG016|Treatment Phase|Progressive Disease|32|||
156930626|NCT02658890|566506664|FG017|Treatment Phase|Progressive Disease|14|||
156930627|NCT02658890|566506665|FG018|Treatment Phase|Progressive Disease|40|||
156930628|NCT02658890|566506666|FG019|Treatment Phase|Progressive Disease|32|||
156930629|NCT02658890|566506667|FG020|Treatment Phase|Progressive Disease|19|||
156930630|NCT02658890|566506668|FG021|Treatment Phase|Progressive Disease|30|||
156930631|NCT02658890|566506669|FG022|Treatment Phase|Progressive Disease|15|||
156930632|NCT02658890|566506670|FG023|Treatment Phase|Progressive Disease|0|||
156930633|NCT02658890|566506671|FG024|Treatment Phase|Progressive Disease|0|||
157029438|NCT04737330|566862970|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
157029439|NCT04737330|566862971|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
157029440|NCT03034356|566862975|FG000|Baseline|Lost to Follow-up|2|||
157029441|NCT03034356|566862976|FG001|Baseline|Lost to Follow-up|4|||
157029442|NCT03034356|566862975|FG000|Baseline|Withdrawal by Subject|2|||
157029443|NCT03034356|566862976|FG001|Baseline|Withdrawal by Subject|0|||
157029444|NCT03034356|566862975|FG000|Baseline|Physician Decision|0|||
157029445|NCT03034356|566862976|FG001|Baseline|Physician Decision|1|||
157029446|NCT03034356|566862975|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
157029447|NCT03034356|566862976|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
157029448|NCT03034356|566862975|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
157029449|NCT03034356|566862976|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
157029450|NCT03034356|566862975|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
157029451|NCT03034356|566862976|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
157029452|NCT03034356|566862975|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
157029453|NCT03034356|566862976|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
157029454|NCT05671653|566864862|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
156930634|NCT02658890|566506672|FG025|Treatment Phase|Progressive Disease|14|||
156930635|NCT02658890|566506673|FG026|Treatment Phase|Progressive Disease|11|||
157029455|NCT05671653|566864863|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
156930636|NCT02658890|566506647|FG000|Treatment Phase|Study Drug Toxicity|0|||
157029456|NCT05671653|566864864|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
157166883|NCT04095442|567352599|FG001|Overall Study|Lost to Follow-up|1|||
156930637|NCT02658890|566506648|FG001|Treatment Phase|Study Drug Toxicity|0|||
156930638|NCT02658890|566506649|FG002|Treatment Phase|Study Drug Toxicity|2|||
156930639|NCT02658890|566506650|FG003|Treatment Phase|Study Drug Toxicity|0|||
156930640|NCT02658890|566506651|FG004|Treatment Phase|Study Drug Toxicity|0|||
156930641|NCT02658890|566506652|FG005|Treatment Phase|Study Drug Toxicity|0|||
156930642|NCT02658890|566506653|FG006|Treatment Phase|Study Drug Toxicity|0|||
156930643|NCT02658890|566506654|FG007|Treatment Phase|Study Drug Toxicity|0|||
156930644|NCT02658890|566506655|FG008|Treatment Phase|Study Drug Toxicity|3|||
157029457|NCT05671653|566864865|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
157029458|NCT05671653|566864866|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
157029459|NCT05671653|566864867|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
157029460|NCT05671653|566864868|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
156930645|NCT02658890|566506656|FG009|Treatment Phase|Study Drug Toxicity|0|||
156930646|NCT02658890|566506657|FG010|Treatment Phase|Study Drug Toxicity|1|||
156930647|NCT02658890|566506658|FG011|Treatment Phase|Study Drug Toxicity|1|||
156930648|NCT02658890|566506659|FG012|Treatment Phase|Study Drug Toxicity|2|||
156930649|NCT02658890|566506660|FG013|Treatment Phase|Study Drug Toxicity|9|||
156930650|NCT02658890|566506661|FG014|Treatment Phase|Study Drug Toxicity|0|||
156930651|NCT02658890|566506662|FG015|Treatment Phase|Study Drug Toxicity|1|||
156930652|NCT02658890|566506663|FG016|Treatment Phase|Study Drug Toxicity|1|||
156930653|NCT02658890|566506664|FG017|Treatment Phase|Study Drug Toxicity|0|||
156930654|NCT02658890|566506665|FG018|Treatment Phase|Study Drug Toxicity|8|||
156930655|NCT02658890|566506666|FG019|Treatment Phase|Study Drug Toxicity|3|||
156930656|NCT02658890|566506667|FG020|Treatment Phase|Study Drug Toxicity|2|||
156930657|NCT02658890|566506668|FG021|Treatment Phase|Study Drug Toxicity|0|||
156930658|NCT02658890|566506669|FG022|Treatment Phase|Study Drug Toxicity|8|||
156930659|NCT02658890|566506670|FG023|Treatment Phase|Study Drug Toxicity|0|||
156930660|NCT02658890|566506671|FG024|Treatment Phase|Study Drug Toxicity|0|||
156930661|NCT02658890|566506672|FG025|Treatment Phase|Study Drug Toxicity|2|||
156930662|NCT02658890|566506673|FG026|Treatment Phase|Study Drug Toxicity|0|||
156930663|NCT02658890|566506647|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930664|NCT02658890|566506648|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930665|NCT02658890|566506649|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930666|NCT02658890|566506650|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156930667|NCT02658890|566506651|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930668|NCT02658890|566506652|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930669|NCT02658890|566506653|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930670|NCT02658890|566506654|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930671|NCT02658890|566506655|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930672|NCT02658890|566506656|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156930673|NCT02658890|566506657|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930674|NCT02658890|566506658|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930675|NCT02658890|566506659|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930676|NCT02658890|566506660|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930677|NCT02658890|566506661|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930678|NCT02658890|566506662|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930679|NCT02658890|566506663|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930680|NCT02658890|566506664|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930681|NCT02658890|566506665|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156930682|NCT02658890|566506666|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930683|NCT02658890|566506667|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930684|NCT02658890|566506668|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930685|NCT02658890|566506669|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
156930686|NCT02658890|566506670|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930687|NCT02658890|566506671|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930688|NCT02658890|566506672|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930689|NCT02658890|566506673|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
156930690|NCT02658890|566506647|FG000|Treatment Phase|Withdrawal by Subject|0|||
156930691|NCT02658890|566506648|FG001|Treatment Phase|Withdrawal by Subject|1|||
156930692|NCT02658890|566506649|FG002|Treatment Phase|Withdrawal by Subject|0|||
156930693|NCT02658890|566506650|FG003|Treatment Phase|Withdrawal by Subject|0|||
156930694|NCT02658890|566506651|FG004|Treatment Phase|Withdrawal by Subject|0|||
156930695|NCT02658890|566506652|FG005|Treatment Phase|Withdrawal by Subject|0|||
156930696|NCT02658890|566506653|FG006|Treatment Phase|Withdrawal by Subject|1|||
156930697|NCT02658890|566506654|FG007|Treatment Phase|Withdrawal by Subject|0|||
156930698|NCT02658890|566506655|FG008|Treatment Phase|Withdrawal by Subject|0|||
156930699|NCT02658890|566506656|FG009|Treatment Phase|Withdrawal by Subject|1|||
156930700|NCT02658890|566506657|FG010|Treatment Phase|Withdrawal by Subject|0|||
156930701|NCT02658890|566506658|FG011|Treatment Phase|Withdrawal by Subject|0|||
156930702|NCT02658890|566506659|FG012|Treatment Phase|Withdrawal by Subject|1|||
156930703|NCT02658890|566506660|FG013|Treatment Phase|Withdrawal by Subject|3|||
156930704|NCT02658890|566506661|FG014|Treatment Phase|Withdrawal by Subject|0|||
156930705|NCT02658890|566506662|FG015|Treatment Phase|Withdrawal by Subject|0|||
156930706|NCT02658890|566506663|FG016|Treatment Phase|Withdrawal by Subject|1|||
156930707|NCT02658890|566506664|FG017|Treatment Phase|Withdrawal by Subject|0|||
156930708|NCT02658890|566506665|FG018|Treatment Phase|Withdrawal by Subject|4|||
156930709|NCT02658890|566506666|FG019|Treatment Phase|Withdrawal by Subject|3|||
156930710|NCT02658890|566506667|FG020|Treatment Phase|Withdrawal by Subject|0|||
156930711|NCT02658890|566506668|FG021|Treatment Phase|Withdrawal by Subject|4|||
156930712|NCT02658890|566506669|FG022|Treatment Phase|Withdrawal by Subject|1|||
156930713|NCT02658890|566506670|FG023|Treatment Phase|Withdrawal by Subject|1|||
156930714|NCT02658890|566506671|FG024|Treatment Phase|Withdrawal by Subject|0|||
156930715|NCT02658890|566506672|FG025|Treatment Phase|Withdrawal by Subject|0|||
156930716|NCT02658890|566506673|FG026|Treatment Phase|Withdrawal by Subject|0|||
156930717|NCT02474199|566506674|FG000|Overall Study|Lost to Follow-up|1|||
156930718|NCT02474199|566506675|FG001|Overall Study|Lost to Follow-up|0|||
156930719|NCT02474199|566506676|FG002|Overall Study|Lost to Follow-up|0|||
156930720|NCT02474199|566506677|FG003|Overall Study|Lost to Follow-up|0|||
156930721|NCT02474199|566506674|FG000|Overall Study|Withdrawal by Subject|1|||
156930722|NCT02474199|566506675|FG001|Overall Study|Withdrawal by Subject|2|||
156930723|NCT02474199|566506676|FG002|Overall Study|Withdrawal by Subject|0|||
156930724|NCT02474199|566506677|FG003|Overall Study|Withdrawal by Subject|1|||
156930725|NCT02474199|566506674|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156930726|NCT02474199|566506675|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
156930727|NCT02474199|566506676|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156930728|NCT02474199|566506677|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
156930729|NCT02474199|566506674|FG000|Overall Study|Did not meet eligibility criteria|0|||
156930730|NCT02474199|566506675|FG001|Overall Study|Did not meet eligibility criteria|0|||
156930731|NCT02474199|566506676|FG002|Overall Study|Did not meet eligibility criteria|2|||
156930732|NCT02474199|566506677|FG003|Overall Study|Did not meet eligibility criteria|2|||
156930733|NCT03090100|566506678|FG000|Overall Study|Adverse Event|9|||
156930734|NCT03090100|566506679|FG001|Overall Study|Adverse Event|11|||
156930735|NCT03090100|566506678|FG000|Overall Study|Pregnancy|1|||
156930736|NCT03090100|566506679|FG001|Overall Study|Pregnancy|1|||
156930737|NCT03090100|566506678|FG000|Overall Study|Lack of Efficacy|2|||
156930738|NCT03090100|566506679|FG001|Overall Study|Lack of Efficacy|7|||
156930739|NCT03090100|566506678|FG000|Overall Study|Lost to Follow-up|2|||
156930740|NCT03090100|566506679|FG001|Overall Study|Lost to Follow-up|2|||
156930741|NCT03090100|566506678|FG000|Overall Study|Withdrawal by Subject|7|||
156930742|NCT03090100|566506679|FG001|Overall Study|Withdrawal by Subject|19|||
156930743|NCT03090100|566506678|FG000|Overall Study|Protocol Violation|2|||
156930744|NCT03090100|566506679|FG001|Overall Study|Protocol Violation|6|||
156930745|NCT03090100|566506678|FG000|Overall Study|Non-compliance|2|||
156930746|NCT03090100|566506679|FG001|Overall Study|Non-compliance|0|||
156930747|NCT03090100|566506678|FG000|Overall Study|Other|2|||
156930748|NCT03090100|566506679|FG001|Overall Study|Other|2|||
156930749|NCT00159588|566506682|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
156930750|NCT00159588|566506683|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
156930751|NCT00159588|566506684|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
156930752|NCT03446040|566506685|FG000|Overall Study|Disease progression|3|||
156930753|NCT03446040|566506686|FG001|Overall Study|Disease progression|3|||
156930754|NCT03446040|566506687|FG002|Overall Study|Disease progression|3|||
156930755|NCT03446040|566506688|FG003|Overall Study|Disease progression|4|||
156930756|NCT03446040|566506689|FG004|Overall Study|Disease progression|4|||
156930757|NCT03446040|566506690|FG005|Overall Study|Disease progression|6|||
156930758|NCT03446040|566506691|FG006|Overall Study|Disease progression|3|||
156930759|NCT03446040|566506692|FG007|Overall Study|Disease progression|4|||
156930760|NCT03446040|566506693|FG008|Overall Study|Disease progression|2|||
156930761|NCT03446040|566506694|FG009|Overall Study|Disease progression|4|||
156930762|NCT03446040|566506695|FG010|Overall Study|Disease progression|9|||
157029461|NCT05671653|566864869|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
156930763|NCT03446040|566506696|FG011|Overall Study|Disease progression|3|||
156930764|NCT03446040|566506697|FG012|Overall Study|Disease progression|7|||
156930765|NCT03446040|566506698|FG013|Overall Study|Disease progression|7|||
156930766|NCT03446040|566506685|FG000|Overall Study|Study drug toxicity|0|||
156930767|NCT03446040|566506686|FG001|Overall Study|Study drug toxicity|0|||
156930768|NCT03446040|566506687|FG002|Overall Study|Study drug toxicity|0|||
156930769|NCT03446040|566506688|FG003|Overall Study|Study drug toxicity|0|||
156930770|NCT03446040|566506689|FG004|Overall Study|Study drug toxicity|0|||
156930771|NCT03446040|566506690|FG005|Overall Study|Study drug toxicity|0|||
156930772|NCT03446040|566506691|FG006|Overall Study|Study drug toxicity|0|||
156930773|NCT03446040|566506692|FG007|Overall Study|Study drug toxicity|0|||
156930774|NCT03446040|566506693|FG008|Overall Study|Study drug toxicity|1|||
156930775|NCT03446040|566506694|FG009|Overall Study|Study drug toxicity|0|||
156930776|NCT03446040|566506695|FG010|Overall Study|Study drug toxicity|0|||
156930777|NCT03446040|566506696|FG011|Overall Study|Study drug toxicity|0|||
156930778|NCT03446040|566506697|FG012|Overall Study|Study drug toxicity|0|||
156930779|NCT03446040|566506698|FG013|Overall Study|Study drug toxicity|0|||
156930780|NCT03446040|566506685|FG000|Overall Study|Adverse Event|0|||
156930781|NCT03446040|566506686|FG001|Overall Study|Adverse Event|0|||
156930782|NCT03446040|566506687|FG002|Overall Study|Adverse Event|0|||
156930783|NCT03446040|566506688|FG003|Overall Study|Adverse Event|0|||
157029462|NCT05671653|566864870|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
157029463|NCT05671653|566864871|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
156930784|NCT03446040|566506689|FG004|Overall Study|Adverse Event|0|||
156930785|NCT03446040|566506690|FG005|Overall Study|Adverse Event|2|||
156930786|NCT03446040|566506691|FG006|Overall Study|Adverse Event|0|||
156930787|NCT03446040|566506692|FG007|Overall Study|Adverse Event|0|||
156930788|NCT03446040|566506693|FG008|Overall Study|Adverse Event|1|||
156930789|NCT03446040|566506694|FG009|Overall Study|Adverse Event|0|||
156930790|NCT03446040|566506695|FG010|Overall Study|Adverse Event|0|||
156930791|NCT03446040|566506696|FG011|Overall Study|Adverse Event|0|||
156930792|NCT03446040|566506697|FG012|Overall Study|Adverse Event|0|||
156930793|NCT03446040|566506698|FG013|Overall Study|Adverse Event|0|||
156930794|NCT03446040|566506685|FG000|Overall Study|Death|0|||
156930795|NCT03446040|566506686|FG001|Overall Study|Death|0|||
156930796|NCT03446040|566506687|FG002|Overall Study|Death|0|||
156930797|NCT03446040|566506688|FG003|Overall Study|Death|0|||
156930798|NCT03446040|566506689|FG004|Overall Study|Death|0|||
156930799|NCT03446040|566506690|FG005|Overall Study|Death|0|||
156930800|NCT03446040|566506691|FG006|Overall Study|Death|0|||
156930801|NCT03446040|566506692|FG007|Overall Study|Death|0|||
156930802|NCT03446040|566506693|FG008|Overall Study|Death|0|||
156930803|NCT03446040|566506694|FG009|Overall Study|Death|0|||
156930804|NCT03446040|566506695|FG010|Overall Study|Death|1|||
156930805|NCT03446040|566506696|FG011|Overall Study|Death|0|||
156930806|NCT03446040|566506697|FG012|Overall Study|Death|0|||
156930807|NCT03446040|566506698|FG013|Overall Study|Death|2|||
156930808|NCT03446040|566506685|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156930809|NCT03446040|566506686|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
156930810|NCT03446040|566506687|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156930811|NCT03446040|566506688|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
156930812|NCT03446040|566506689|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
156930813|NCT03446040|566506690|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
156930814|NCT03446040|566506691|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
156930815|NCT03446040|566506692|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
156930816|NCT03446040|566506693|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
156930817|NCT03446040|566506694|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
156930818|NCT03446040|566506695|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
156930819|NCT03446040|566506696|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
156930820|NCT03446040|566506697|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
156930821|NCT03446040|566506698|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
156930822|NCT03446040|566506685|FG000|Overall Study|Participant withdrew consent|0|||
156930823|NCT03446040|566506686|FG001|Overall Study|Participant withdrew consent|0|||
156930824|NCT03446040|566506687|FG002|Overall Study|Participant withdrew consent|0|||
156930825|NCT03446040|566506688|FG003|Overall Study|Participant withdrew consent|0|||
156930826|NCT03446040|566506689|FG004|Overall Study|Participant withdrew consent|0|||
156930827|NCT03446040|566506690|FG005|Overall Study|Participant withdrew consent|1|||
156930828|NCT03446040|566506691|FG006|Overall Study|Participant withdrew consent|0|||
156930829|NCT03446040|566506692|FG007|Overall Study|Participant withdrew consent|1|||
156930830|NCT03446040|566506693|FG008|Overall Study|Participant withdrew consent|0|||
156930831|NCT03446040|566506694|FG009|Overall Study|Participant withdrew consent|0|||
156930832|NCT03446040|566506695|FG010|Overall Study|Participant withdrew consent|0|||
156930833|NCT03446040|566506696|FG011|Overall Study|Participant withdrew consent|0|||
156930834|NCT03446040|566506697|FG012|Overall Study|Participant withdrew consent|0|||
156930835|NCT03446040|566506698|FG013|Overall Study|Participant withdrew consent|0|||
156930836|NCT03446040|566506685|FG000|Overall Study|Not reported|0|||
156930837|NCT03446040|566506686|FG001|Overall Study|Not reported|0|||
156930838|NCT03446040|566506687|FG002|Overall Study|Not reported|1|||
156930839|NCT03446040|566506688|FG003|Overall Study|Not reported|0|||
157029464|NCT05671653|566864872|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
157029465|NCT05671653|566864873|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
157029466|NCT05671653|566864874|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
157029467|NCT05671653|566864862|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156930840|NCT03446040|566506689|FG004|Overall Study|Not reported|0|||
156930841|NCT03446040|566506690|FG005|Overall Study|Not reported|0|||
156930842|NCT03446040|566506691|FG006|Overall Study|Not reported|0|||
156930843|NCT03446040|566506692|FG007|Overall Study|Not reported|0|||
156930844|NCT03446040|566506693|FG008|Overall Study|Not reported|0|||
156930845|NCT03446040|566506694|FG009|Overall Study|Not reported|0|||
156930846|NCT03446040|566506695|FG010|Overall Study|Not reported|0|||
156930847|NCT03446040|566506696|FG011|Overall Study|Not reported|0|||
156930848|NCT03446040|566506697|FG012|Overall Study|Not reported|0|||
156930849|NCT03446040|566506698|FG013|Overall Study|Not reported|0|||
156930850|NCT00456521|566506699|FG000|Overall Study|Adverse Event|150|||
156930851|NCT00456521|566506700|FG001|Overall Study|Adverse Event|25|||
156930852|NCT00456521|566506699|FG000|Overall Study|Withdrawal by Subject|43|||
156930853|NCT00456521|566506700|FG001|Overall Study|Withdrawal by Subject|24|||
156930854|NCT00456521|566506699|FG000|Overall Study|Lost to Follow-up|22|||
156930855|NCT00456521|566506700|FG001|Overall Study|Lost to Follow-up|17|||
156930856|NCT00456521|566506699|FG000|Overall Study|Lack of Efficacy|3|||
156930857|NCT00456521|566506700|FG001|Overall Study|Lack of Efficacy|6|||
157029468|NCT05671653|566864863|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156930858|NCT00456521|566506699|FG000|Overall Study|Protocol Violation|4|||
156930859|NCT00456521|566506700|FG001|Overall Study|Protocol Violation|0|||
156930860|NCT00456521|566506699|FG000|Overall Study|Pregnancy|1|||
156930861|NCT00456521|566506700|FG001|Overall Study|Pregnancy|1|||
156930862|NCT00456521|566506699|FG000|Overall Study|Drug non-compliance, moved, other|26|||
156930863|NCT00456521|566506700|FG001|Overall Study|Drug non-compliance, moved, other|11|||
156930864|NCT01316276|566506701|FG000|Overall Study|Death|1|||
156930865|NCT01316276|566506701|FG000|Overall Study|Adverse Event|19|||
156930866|NCT01316276|566506701|FG000|Overall Study|Withdrawal of consent|24|||
156930867|NCT01316276|566506701|FG000|Overall Study|Lost to Follow-up|1|||
156930868|NCT01316276|566506701|FG000|Overall Study|Other|22|||
156930869|NCT00605475|566506702|FG000|Overall Study|Abnormal Laboratory Values|0|||
156930870|NCT00605475|566506703|FG001|Overall Study|Abnormal Laboratory Values|0|||
156930871|NCT00605475|566506704|FG002|Overall Study|Abnormal Laboratory Values|0|||
156930872|NCT00605475|566506705|FG003|Overall Study|Abnormal Laboratory Values|0|||
156930873|NCT00605475|566506706|FG004|Overall Study|Abnormal Laboratory Values|0|||
156930874|NCT00605475|566506707|FG005|Overall Study|Abnormal Laboratory Values|0|||
156930875|NCT00605475|566506708|FG006|Overall Study|Abnormal Laboratory Values|0|||
156930876|NCT00605475|566506709|FG007|Overall Study|Abnormal Laboratory Values|0|||
156930877|NCT00605475|566506710|FG008|Overall Study|Abnormal Laboratory Values|1|||
156930878|NCT00605475|566506711|FG009|Overall Study|Abnormal Laboratory Values|0|||
156930879|NCT00605475|566506702|FG000|Overall Study|Administrative problems|0|||
156930880|NCT00605475|566506703|FG001|Overall Study|Administrative problems|0|||
156930881|NCT00605475|566506704|FG002|Overall Study|Administrative problems|0|||
156930882|NCT00605475|566506705|FG003|Overall Study|Administrative problems|0|||
156930883|NCT00605475|566506706|FG004|Overall Study|Administrative problems|0|||
156930884|NCT00605475|566506707|FG005|Overall Study|Administrative problems|0|||
156930885|NCT00605475|566506708|FG006|Overall Study|Administrative problems|1|||
156930886|NCT00605475|566506709|FG007|Overall Study|Administrative problems|0|||
156930887|NCT00605475|566506710|FG008|Overall Study|Administrative problems|0|||
156930888|NCT00605475|566506711|FG009|Overall Study|Administrative problems|0|||
156930889|NCT00605475|566506702|FG000|Overall Study|Lost to Follow-up|0|||
156930890|NCT00605475|566506703|FG001|Overall Study|Lost to Follow-up|0|||
156930891|NCT00605475|566506704|FG002|Overall Study|Lost to Follow-up|0|||
156930892|NCT00605475|566506705|FG003|Overall Study|Lost to Follow-up|0|||
156930893|NCT00605475|566506706|FG004|Overall Study|Lost to Follow-up|0|||
156930894|NCT00605475|566506707|FG005|Overall Study|Lost to Follow-up|0|||
156930895|NCT00605475|566506708|FG006|Overall Study|Lost to Follow-up|0|||
156930896|NCT00605475|566506709|FG007|Overall Study|Lost to Follow-up|0|||
156930897|NCT00605475|566506710|FG008|Overall Study|Lost to Follow-up|1|||
156930898|NCT00605475|566506711|FG009|Overall Study|Lost to Follow-up|1|||
156930899|NCT00605475|566506702|FG000|Overall Study|Protocol Violation|0|||
156930900|NCT00605475|566506703|FG001|Overall Study|Protocol Violation|0|||
156930901|NCT00605475|566506704|FG002|Overall Study|Protocol Violation|0|||
156930902|NCT00605475|566506705|FG003|Overall Study|Protocol Violation|0|||
156930903|NCT00605475|566506706|FG004|Overall Study|Protocol Violation|1|||
156930904|NCT00605475|566506707|FG005|Overall Study|Protocol Violation|0|||
156930905|NCT00605475|566506708|FG006|Overall Study|Protocol Violation|0|||
156930906|NCT00605475|566506709|FG007|Overall Study|Protocol Violation|0|||
156930907|NCT00605475|566506710|FG008|Overall Study|Protocol Violation|0|||
156930908|NCT00605475|566506711|FG009|Overall Study|Protocol Violation|0|||
156930909|NCT00605475|566506702|FG000|Overall Study|Withdrawal by Subject|0|||
156930910|NCT00605475|566506703|FG001|Overall Study|Withdrawal by Subject|0|||
156930911|NCT00605475|566506704|FG002|Overall Study|Withdrawal by Subject|0|||
156930912|NCT00605475|566506705|FG003|Overall Study|Withdrawal by Subject|0|||
156930913|NCT00605475|566506706|FG004|Overall Study|Withdrawal by Subject|0|||
156930914|NCT00605475|566506707|FG005|Overall Study|Withdrawal by Subject|2|||
156930915|NCT00605475|566506708|FG006|Overall Study|Withdrawal by Subject|0|||
156930916|NCT00605475|566506709|FG007|Overall Study|Withdrawal by Subject|0|||
156930917|NCT00605475|566506710|FG008|Overall Study|Withdrawal by Subject|0|||
156930918|NCT00605475|566506711|FG009|Overall Study|Withdrawal by Subject|1|||
156930919|NCT02596854|566506712|FG000|Overall Study|Withdrawn|8|||
156930920|NCT00464568|566506719|FG000|Overall Study|Adverse Event|2|||
156930921|NCT03406858|566506720|FG000|Overall Study|Failure to receive treatment drug.|1|||
156930922|NCT03406858|566506720|FG000|Overall Study|ineligible|1|||
156930923|NCT00405587|566506721|FG000|Overall Study|Death|0|||
157029469|NCT05671653|566864864|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157166884|NCT04095442|567352598|FG000|Overall Study|Screen failure|1|||
157166885|NCT04095442|567352599|FG001|Overall Study|Screen failure|0|||
157166886|NCT01337167|567352600|FG000|Infant Series|Adverse Event|1|||
156930924|NCT00405587|566506722|FG001|Overall Study|Death|0|||
157166887|NCT01337167|567352601|FG001|Infant Series|Adverse Event|1|||
156930925|NCT00405587|566506723|FG002|Overall Study|Death|0|||
156930926|NCT00405587|566506724|FG003|Overall Study|Death|1|||
157166888|NCT01337167|567352600|FG000|Infant Series|Death|1|||
156930927|NCT00405587|566506721|FG000|Overall Study|Disease Progression|22|||
156930928|NCT00405587|566506722|FG001|Overall Study|Disease Progression|23|||
156930929|NCT00405587|566506723|FG002|Overall Study|Disease Progression|21|||
156930930|NCT00405587|566506724|FG003|Overall Study|Disease Progression|17|||
156930931|NCT00405587|566506721|FG000|Overall Study|Physician Decision|3|||
156930932|NCT00405587|566506722|FG001|Overall Study|Physician Decision|2|||
156930933|NCT00405587|566506723|FG002|Overall Study|Physician Decision|0|||
156930934|NCT00405587|566506724|FG003|Overall Study|Physician Decision|0|||
156930935|NCT00405587|566506721|FG000|Overall Study|Adverse Event|1|||
156930936|NCT00405587|566506722|FG001|Overall Study|Adverse Event|0|||
156930937|NCT00405587|566506723|FG002|Overall Study|Adverse Event|0|||
156930938|NCT00405587|566506724|FG003|Overall Study|Adverse Event|0|||
156930939|NCT00405587|566506721|FG000|Overall Study|Lost to Follow-up|0|||
156930940|NCT00405587|566506722|FG001|Overall Study|Lost to Follow-up|1|||
156930941|NCT00405587|566506723|FG002|Overall Study|Lost to Follow-up|1|||
156930942|NCT00405587|566506724|FG003|Overall Study|Lost to Follow-up|0|||
156930943|NCT00405587|566506721|FG000|Overall Study|Radiation induced necrosis|0|||
156930944|NCT00405587|566506722|FG001|Overall Study|Radiation induced necrosis|1|||
156930945|NCT00405587|566506723|FG002|Overall Study|Radiation induced necrosis|0|||
156930946|NCT00405587|566506724|FG003|Overall Study|Radiation induced necrosis|0|||
156930947|NCT00405587|566506721|FG000|Overall Study|Withdrawal by Subject|0|||
156930948|NCT00405587|566506722|FG001|Overall Study|Withdrawal by Subject|0|||
156930949|NCT00405587|566506723|FG002|Overall Study|Withdrawal by Subject|0|||
156930950|NCT00405587|566506724|FG003|Overall Study|Withdrawal by Subject|2|||
156930951|NCT00405587|566506721|FG000|Overall Study|Participant not dosed|0|||
156930952|NCT00405587|566506722|FG001|Overall Study|Participant not dosed|1|||
156930953|NCT00405587|566506723|FG002|Overall Study|Participant not dosed|0|||
156930954|NCT00405587|566506724|FG003|Overall Study|Participant not dosed|0|||
156930955|NCT06027866|566506725|FG000|Overall Study|Withdrawal by Subject|2|||
156930956|NCT00507442|566506728|FG000|Overall Study|Adverse Event|8|||
156930957|NCT00507442|566506729|FG001|Overall Study|Adverse Event|11|||
156930958|NCT00507442|566506730|FG002|Overall Study|Adverse Event|4|||
156930959|NCT00507442|566506731|FG003|Overall Study|Adverse Event|1|||
156930960|NCT00507442|566506728|FG000|Overall Study|Protocol Violation|0|||
156930961|NCT00507442|566506729|FG001|Overall Study|Protocol Violation|1|||
156930962|NCT00507442|566506730|FG002|Overall Study|Protocol Violation|0|||
156930963|NCT00507442|566506731|FG003|Overall Study|Protocol Violation|0|||
156930964|NCT00507442|566506728|FG000|Overall Study|Lost to Follow-up|0|||
156930965|NCT00507442|566506729|FG001|Overall Study|Lost to Follow-up|0|||
156930966|NCT00507442|566506730|FG002|Overall Study|Lost to Follow-up|1|||
156930967|NCT00507442|566506731|FG003|Overall Study|Lost to Follow-up|0|||
156930968|NCT00507442|566506728|FG000|Overall Study|Physician Decision|0|||
156930969|NCT00507442|566506729|FG001|Overall Study|Physician Decision|2|||
156930970|NCT00507442|566506730|FG002|Overall Study|Physician Decision|4|||
156930971|NCT00507442|566506731|FG003|Overall Study|Physician Decision|1|||
156930972|NCT00507442|566506728|FG000|Overall Study|Progressive Disease|2|||
156930973|NCT00507442|566506729|FG001|Overall Study|Progressive Disease|4|||
156930974|NCT00507442|566506730|FG002|Overall Study|Progressive Disease|2|||
156930975|NCT00507442|566506731|FG003|Overall Study|Progressive Disease|0|||
156930976|NCT00507442|566506728|FG000|Overall Study|Withdrawal by Subject|4|||
156930977|NCT00507442|566506729|FG001|Overall Study|Withdrawal by Subject|4|||
156930978|NCT00507442|566506730|FG002|Overall Study|Withdrawal by Subject|2|||
156930979|NCT00507442|566506731|FG003|Overall Study|Withdrawal by Subject|1|||
156930980|NCT00507442|566506728|FG000|Overall Study|Other|2|||
156930981|NCT00507442|566506729|FG001|Overall Study|Other|5|||
157166889|NCT01337167|567352601|FG001|Infant Series|Death|1|||
157166890|NCT01337167|567352600|FG000|Infant Series|Lost to Follow-up|13|||
157166891|NCT01337167|567352601|FG001|Infant Series|Lost to Follow-up|7|||
156930982|NCT00507442|566506730|FG002|Overall Study|Other|2|||
156930983|NCT00507442|566506731|FG003|Overall Study|Other|2|||
156930984|NCT02672423|566506733|FG000|Period 1|Adverse Event|0|||
156930985|NCT02672423|566506734|FG001|Period 1|Adverse Event|0|||
156930986|NCT02672423|566506735|FG002|Period 1|Adverse Event|0|||
156930987|NCT02672423|566506736|FG003|Period 1|Adverse Event|0|||
156930988|NCT02672423|566506737|FG004|Period 1|Adverse Event|1|||
156930989|NCT02672423|566506738|FG005|Period 1|Adverse Event|0|||
156930990|NCT02672423|566506739|FG006|Period 1|Adverse Event|0|||
156930991|NCT02672423|566506740|FG007|Period 1|Adverse Event|0|||
156930992|NCT02672423|566506741|FG008|Period 1|Adverse Event|0|||
156930993|NCT02672423|566506742|FG009|Period 1|Adverse Event|0|||
156930994|NCT02672423|566506733|FG000|Period 2|Withdrawal by Subject|0|||
156930995|NCT02672423|566506734|FG001|Period 2|Withdrawal by Subject|0|||
156930996|NCT02672423|566506735|FG002|Period 2|Withdrawal by Subject|1|||
156930997|NCT02672423|566506736|FG003|Period 2|Withdrawal by Subject|0|||
156930998|NCT02672423|566506737|FG004|Period 2|Withdrawal by Subject|0|||
156930999|NCT02672423|566506738|FG005|Period 2|Withdrawal by Subject|0|||
156931000|NCT02672423|566506739|FG006|Period 2|Withdrawal by Subject|0|||
156931001|NCT02672423|566506740|FG007|Period 2|Withdrawal by Subject|0|||
156931002|NCT02672423|566506741|FG008|Period 2|Withdrawal by Subject|0|||
156931003|NCT02672423|566506742|FG009|Period 2|Withdrawal by Subject|0|||
156931004|NCT02672423|566506733|FG000|Period 3|Withdrawal by Subject|0|||
156931005|NCT02672423|566506734|FG001|Period 3|Withdrawal by Subject|0|||
156931006|NCT02672423|566506735|FG002|Period 3|Withdrawal by Subject|0|||
156931007|NCT02672423|566506736|FG003|Period 3|Withdrawal by Subject|0|||
156931008|NCT02672423|566506737|FG004|Period 3|Withdrawal by Subject|0|||
156931009|NCT02672423|566506738|FG005|Period 3|Withdrawal by Subject|0|||
156931010|NCT02672423|566506739|FG006|Period 3|Withdrawal by Subject|0|||
156931011|NCT02672423|566506740|FG007|Period 3|Withdrawal by Subject|1|||
156931012|NCT02672423|566506741|FG008|Period 3|Withdrawal by Subject|0|||
156931013|NCT02672423|566506742|FG009|Period 3|Withdrawal by Subject|0|||
156931014|NCT02672423|566506733|FG000|Period 3|Physician Decision|0|||
156931015|NCT02672423|566506734|FG001|Period 3|Physician Decision|0|||
156931016|NCT02672423|566506735|FG002|Period 3|Physician Decision|0|||
156931017|NCT02672423|566506736|FG003|Period 3|Physician Decision|0|||
156931018|NCT02672423|566506737|FG004|Period 3|Physician Decision|0|||
156931019|NCT02672423|566506738|FG005|Period 3|Physician Decision|1|||
156931020|NCT02672423|566506739|FG006|Period 3|Physician Decision|0|||
156931021|NCT02672423|566506740|FG007|Period 3|Physician Decision|0|||
156931022|NCT02672423|566506741|FG008|Period 3|Physician Decision|0|||
156931023|NCT02672423|566506742|FG009|Period 3|Physician Decision|0|||
156931024|NCT02046148|566506745|FG000|Overall Study|Lost to Follow-up|1|||
156931025|NCT02046148|566506746|FG001|Overall Study|Lost to Follow-up|1|||
156931026|NCT02046148|566506745|FG000|Overall Study|Withdrawal by Subject|0|||
156931027|NCT02046148|566506746|FG001|Overall Study|Withdrawal by Subject|2|||
156931028|NCT03506373|566506748|FG000|Overall Study|Adverse Event|6|||
156931029|NCT03506373|566506748|FG000|Overall Study|Withdrawal by Subject|2|||
156931030|NCT03506373|566506748|FG000|Overall Study|Disease progression|5|||
156931031|NCT03506373|566506748|FG000|Overall Study|Other|3|||
156931032|NCT00107198|566506750|FG000|Overall Study|Lack of Efficacy|28|||
156931033|NCT00107198|566506750|FG000|Overall Study|Lost to Follow-up|12|||
156931034|NCT00107198|566506750|FG000|Overall Study|Protocol Violation|1|||
156931035|NCT00107198|566506750|FG000|Overall Study|Withdrawal by Subject|6|||
156931036|NCT00107198|566506750|FG000|Overall Study|Ineligible|5|||
156931037|NCT02939560|566506754|FG000|Overall Study|Withdrawal by Subject|2|||
156931038|NCT02939560|566506754|FG000|Overall Study|Protocol Violation|1|||
156931039|NCT03340025|566506755|FG000|Overall Study|Lost to Follow-up|2|||
156931040|NCT03340025|566506756|FG001|Overall Study|Lost to Follow-up|2|||
156931041|NCT02420691|566506761|FG000|Overall Study|Adverse Event|3|||
156931042|NCT02420691|566506761|FG000|Overall Study|Withdrawal by Subject|3|||
156931043|NCT01480076|566506762|FG000|Overall Study|Run-in Failure|52|||
156931044|NCT01480076|566506762|FG000|Overall Study|Adverse Event|39|||
156931045|NCT01480076|566506762|FG000|Overall Study|Death|2|||
156931046|NCT01480076|566506762|FG000|Overall Study|Disease Progression|5|||
156931047|NCT01480076|566506762|FG000|Overall Study|Non-compliance With Study Protocol|15|||
156931048|NCT01480076|566506762|FG000|Overall Study|Withdrawal by Subject|105|||
156931049|NCT01480076|566506762|FG000|Overall Study|Lost to Follow-up|7|||
156931050|NCT01480076|566506762|FG000|Overall Study|Investigator Decision|13|||
156931051|NCT01480076|566506762|FG000|Overall Study|Other|52|||
156931052|NCT05694546|566506763|FG000|Overall Study|Lost to Follow-up|11|||
156931053|NCT00325754|566506764|FG000|Overall Study|Adverse Event|4|||
156931054|NCT00325754|566506765|FG001|Overall Study|Adverse Event|1|||
156931055|NCT01549964|566506771|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
156931056|NCT01549964|566506772|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
156931057|NCT01549964|566506773|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
156931058|NCT01549964|566506774|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
156931059|NCT01549964|566506771|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
156931060|NCT01549964|566506772|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
156931061|NCT01549964|566506773|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
156931062|NCT01549964|566506774|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
156931063|NCT01549964|566506771|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
156931064|NCT01549964|566506772|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156931065|NCT01549964|566506773|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156931066|NCT01549964|566506774|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
156931067|NCT01549964|566506771|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
156931068|NCT01549964|566506772|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
156931069|NCT01549964|566506773|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
156931070|NCT01549964|566506774|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
156931071|NCT01549964|566506771|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
156931072|NCT01549964|566506772|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
156931073|NCT01549964|566506773|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
156931074|NCT01549964|566506774|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
156931075|NCT01549964|566506771|FG000|24-Week Treatment Period|Other|1|||
156931076|NCT01549964|566506772|FG001|24-Week Treatment Period|Other|0|||
157227054|NCT00409578|567576033|FG002|Overall Study|Lost to Follow-up|2|||
156931077|NCT01549964|566506773|FG002|24-Week Treatment Period|Other|1|||
156931078|NCT01549964|566506774|FG003|24-Week Treatment Period|Other|0|||
156931079|NCT01549964|566506771|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
156931080|NCT01549964|566506772|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
156931081|NCT01549964|566506773|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
156931082|NCT01549964|566506774|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
157227055|NCT00409578|567576034|FG003|Overall Study|Lost to Follow-up|2|||
157166892|NCT01337167|567352600|FG000|Infant Series|Non-compliance with study drug|2|||
157166893|NCT01337167|567352601|FG001|Infant Series|Non-compliance with study drug|1|||
157166894|NCT01337167|567352600|FG000|Infant Series|Physician Decision|3|||
157166895|NCT01337167|567352601|FG001|Infant Series|Physician Decision|1|||
156931083|NCT01549964|566506771|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
156931084|NCT01549964|566506772|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
156931085|NCT01549964|566506773|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
156931086|NCT01549964|566506774|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
156931087|NCT01549964|566506771|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
156931088|NCT01549964|566506772|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
156931089|NCT01549964|566506773|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
156931090|NCT01549964|566506774|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
156931091|NCT01549964|566506771|FG000|80-Week Extension Period|Pregnancy|0|||
156931092|NCT01549964|566506772|FG001|80-Week Extension Period|Pregnancy|0|||
156931093|NCT01549964|566506773|FG002|80-Week Extension Period|Pregnancy|1|||
156931094|NCT01549964|566506774|FG003|80-Week Extension Period|Pregnancy|0|||
156931095|NCT01549964|566506771|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
156931096|NCT01549964|566506772|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
156931097|NCT01549964|566506773|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
156931098|NCT01549964|566506774|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
156931099|NCT01549964|566506771|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
156931100|NCT01549964|566506772|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
156931101|NCT01549964|566506773|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
156931102|NCT01549964|566506774|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
156931103|NCT01549964|566506771|FG000|80-Week Extension Period|Lost to Follow-up|1|||
156931104|NCT01549964|566506772|FG001|80-Week Extension Period|Lost to Follow-up|0|||
156931105|NCT01549964|566506773|FG002|80-Week Extension Period|Lost to Follow-up|2|||
156931106|NCT01549964|566506774|FG003|80-Week Extension Period|Lost to Follow-up|1|||
156931107|NCT01549964|566506771|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
156931108|NCT01549964|566506772|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
156931109|NCT01549964|566506773|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
156931110|NCT01549964|566506774|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
156931111|NCT02290821|566506775|FG000|Overall Study|Withdrawal by Subject|1|||
156931112|NCT02290821|566506776|FG001|Overall Study|Withdrawal by Subject|1|||
156931113|NCT02290821|566506775|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
156931114|NCT02290821|566506776|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
156931115|NCT02290821|566506775|FG000|Overall Study|Lost to Follow-up|3|||
156931116|NCT02290821|566506776|FG001|Overall Study|Lost to Follow-up|2|||
157166896|NCT01337167|567352600|FG000|Infant Series|Protocol Violation|22|||
157166897|NCT01337167|567352601|FG001|Infant Series|Protocol Violation|9|||
157166898|NCT01337167|567352600|FG000|Infant Series|Withdrawal by Subject|15|||
157166899|NCT01337167|567352601|FG001|Infant Series|Withdrawal by Subject|4|||
157166900|NCT01337167|567352600|FG000|Infant Series|Randomized but not vaccinated|5|||
157166901|NCT01337167|567352601|FG001|Infant Series|Randomized but not vaccinated|3|||
157166902|NCT01337167|567352600|FG000|Interim Period|Lost to Follow-up|51|||
157166903|NCT01337167|567352601|FG001|Interim Period|Lost to Follow-up|23|||
157166904|NCT01337167|567352600|FG000|Interim Period|Non-compliance with study drug|1|||
157166905|NCT01337167|567352601|FG001|Interim Period|Non-compliance with study drug|0|||
157166906|NCT01337167|567352600|FG000|Interim Period|Physician Decision|6|||
157166907|NCT01337167|567352601|FG001|Interim Period|Physician Decision|3|||
157166908|NCT01337167|567352600|FG000|Interim Period|Protocol Violation|5|||
157166909|NCT01337167|567352601|FG001|Interim Period|Protocol Violation|3|||
157166910|NCT01337167|567352600|FG000|Interim Period|Withdrawal by Subject|18|||
157166911|NCT01337167|567352601|FG001|Interim Period|Withdrawal by Subject|10|||
157166912|NCT01337167|567352600|FG000|Interim Period|Other protocol criterion not met|0|||
157166913|NCT01337167|567352601|FG001|Interim Period|Other protocol criterion not met|1|||
157166914|NCT01337167|567352600|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
157166915|NCT01337167|567352601|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
157166916|NCT01337167|567352600|FG000|Toddler Vaccinations|Protocol Violation|0|||
156931117|NCT02439320|566506779|FG000|Overall Study|Adverse Event|0|||
156931118|NCT02439320|566506780|FG001|Overall Study|Adverse Event|2|||
156931119|NCT02439320|566506781|FG002|Overall Study|Adverse Event|0|||
156931120|NCT02439320|566506779|FG000|Overall Study|Lost to Follow-up|37|||
156931121|NCT02439320|566506780|FG001|Overall Study|Lost to Follow-up|34|||
156931122|NCT02439320|566506781|FG002|Overall Study|Lost to Follow-up|42|||
156931123|NCT02439320|566506779|FG000|Overall Study|Death|0|||
156931124|NCT02439320|566506780|FG001|Overall Study|Death|1|||
156931125|NCT02439320|566506781|FG002|Overall Study|Death|0|||
156931126|NCT02439320|566506779|FG000|Overall Study|Noncompliance with Protocol|10|||
156931127|NCT02439320|566506780|FG001|Overall Study|Noncompliance with Protocol|11|||
156931128|NCT02439320|566506781|FG002|Overall Study|Noncompliance with Protocol|7|||
156931129|NCT02439320|566506779|FG000|Overall Study|Pregnancy|0|||
157166917|NCT01337167|567352601|FG001|Toddler Vaccinations|Protocol Violation|1|||
156931130|NCT02439320|566506780|FG001|Overall Study|Pregnancy|1|||
156931131|NCT02439320|566506781|FG002|Overall Study|Pregnancy|1|||
156931132|NCT02439320|566506779|FG000|Overall Study|Withdrawal by Subject|12|||
156931133|NCT02439320|566506780|FG001|Overall Study|Withdrawal by Subject|16|||
156931134|NCT02439320|566506781|FG002|Overall Study|Withdrawal by Subject|14|||
156931135|NCT02439320|566506779|FG000|Overall Study|Physician Decision|2|||
156931136|NCT02439320|566506780|FG001|Overall Study|Physician Decision|1|||
156931137|NCT02439320|566506781|FG002|Overall Study|Physician Decision|0|||
156931138|NCT02439320|566506779|FG000|Overall Study|Sponsor Request|0|||
156931139|NCT02439320|566506780|FG001|Overall Study|Sponsor Request|2|||
156931140|NCT02439320|566506781|FG002|Overall Study|Sponsor Request|1|||
156931141|NCT02439320|566506779|FG000|Overall Study|Randomization Failure|35|||
156931142|NCT02439320|566506780|FG001|Overall Study|Randomization Failure|46|||
156931143|NCT02439320|566506781|FG002|Overall Study|Randomization Failure|34|||
156931144|NCT02438722|566506782|FG000|Overall Study|Adverse Event|12|||
156931145|NCT02438722|566506783|FG001|Overall Study|Adverse Event|9|||
156931146|NCT02438722|566506782|FG000|Overall Study|Refusal unrelated to AE|2|||
156931147|NCT02438722|566506783|FG001|Overall Study|Refusal unrelated to AE|5|||
156931148|NCT02438722|566506782|FG000|Overall Study|Disease progression/relapse|46|||
156931149|NCT02438722|566506783|FG001|Overall Study|Disease progression/relapse|51|||
156931150|NCT02438722|566506782|FG000|Overall Study|Death|0|||
156931151|NCT02438722|566506783|FG001|Overall Study|Death|3|||
156931152|NCT02438722|566506782|FG000|Overall Study|Physician Decision|2|||
156931153|NCT02438722|566506783|FG001|Overall Study|Physician Decision|2|||
156931154|NCT02438722|566506782|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
156931155|NCT02438722|566506783|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
156931156|NCT02438722|566506782|FG000|Overall Study|Withdrawal by Subject|0|||
156931157|NCT02438722|566506783|FG001|Overall Study|Withdrawal by Subject|1|||
156931158|NCT02438722|566506782|FG000|Overall Study|On protocol treatment|15|||
156931159|NCT02438722|566506783|FG001|Overall Study|On protocol treatment|14|||
156931160|NCT02438722|566506782|FG000|Overall Study|Did not receive protocol treatment|5|||
156931161|NCT02438722|566506783|FG001|Overall Study|Did not receive protocol treatment|0|||
156931162|NCT04191382|566506784|FG000|Overall Study|Withdrawal by Subject|1|||
156931163|NCT04191382|566506785|FG001|Overall Study|Withdrawal by Subject|0|||
156931164|NCT04191382|566506786|FG002|Overall Study|Withdrawal by Subject|0|||
156931165|NCT00304356|566506789|FG000|Nitazoxanide|Physician Decision|5|||
156931166|NCT00304356|566506789|FG000|Nitazoxanide|Physician Decision|1|||
156931167|NCT00304356|566506789|FG000|Nitazoxanide|number is 0|1|||
156931168|NCT00304356|566506789|FG000|Nitazoxanide|Physician Decision|1|||
156931169|NCT00304356|566506789|FG000|Nitazoxanide|Physician Decision|1|||
156931170|NCT00304356|566506789|FG000|Nitazoxanide|Physician Decision|1|||
156931171|NCT04120974|566506790|FG000|Overall Study|Death|1|||
156931172|NCT04120974|566506790|FG000|Overall Study|Physician Decision|1|||
156931173|NCT04120974|566506790|FG000|Overall Study|Lost to Follow-up|6|||
156931174|NCT00741039|566506796|FG000|Overall Study|Patient non-compliance|2|||
156931175|NCT00741039|566506797|FG001|Overall Study|Patient non-compliance|0|||
156931176|NCT00878709|566506798|FG000|Overall Study|Withdrawal by Subject|197|||
156931177|NCT00878709|566506799|FG001|Overall Study|Withdrawal by Subject|120|||
156931178|NCT00878709|566506798|FG000|Overall Study|Lost to Follow-up|35|||
156931179|NCT00878709|566506799|FG001|Overall Study|Lost to Follow-up|33|||
156931180|NCT00878709|566506798|FG000|Overall Study|Other Reasons|93|||
156931181|NCT00878709|566506799|FG001|Overall Study|Other Reasons|84|||
156931182|NCT00768300|566506800|FG000|Overall Study|Randomized but not treated|1|||
156931183|NCT00768300|566506801|FG001|Overall Study|Randomized but not treated|1|||
156931184|NCT00768300|566506800|FG000|Overall Study|Adverse Event|10|||
156931185|NCT00768300|566506801|FG001|Overall Study|Adverse Event|2|||
156931186|NCT00768300|566506800|FG000|Overall Study|Protocol Violation|6|||
156931187|NCT00768300|566506801|FG001|Overall Study|Protocol Violation|1|||
156931188|NCT00768300|566506800|FG000|Overall Study|Withdrawal by Subject|13|||
156931189|NCT00768300|566506801|FG001|Overall Study|Withdrawal by Subject|7|||
156931190|NCT00768300|566506800|FG000|Overall Study|Physician Decision|2|||
156931191|NCT00768300|566506801|FG001|Overall Study|Physician Decision|3|||
156931192|NCT00768300|566506800|FG000|Overall Study|Study discontinued by Sponsor|271|||
156931193|NCT00768300|566506801|FG001|Overall Study|Study discontinued by Sponsor|140|||
156931194|NCT00768300|566506800|FG000|Overall Study|Death|21|||
156931195|NCT00768300|566506801|FG001|Overall Study|Death|5|||
156931196|NCT00768300|566506800|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
156931197|NCT00768300|566506801|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
156931198|NCT00768300|566506800|FG000|Overall Study|Screen failure following randomization|1|||
156931199|NCT00768300|566506801|FG001|Overall Study|Screen failure following randomization|0|||
156931200|NCT00768300|566506800|FG000|Overall Study|Received lung transplant|1|||
156931201|NCT00768300|566506801|FG001|Overall Study|Received lung transplant|1|||
156931202|NCT00768300|566506800|FG000|Overall Study|Lost to Follow-up|0|||
156931203|NCT00768300|566506801|FG001|Overall Study|Lost to Follow-up|1|||
156931204|NCT00768300|566506800|FG000|Overall Study|Began prohibited concomitant medication|0|||
156931205|NCT00768300|566506801|FG001|Overall Study|Began prohibited concomitant medication|1|||
156931206|NCT00768300|566506800|FG000|Overall Study|Treated but never dosed with Study drug|1|||
156931207|NCT00768300|566506801|FG001|Overall Study|Treated but never dosed with Study drug|0|||
156931208|NCT00768300|566506800|FG000|Overall Study|Missing data|1|||
156931209|NCT00768300|566506801|FG001|Overall Study|Missing data|0|||
156931210|NCT02068222|566506802|FG000|Overall Study|Lost to Follow-up|1|||
156931211|NCT00445965|566506803|FG000|Overall Study|Adverse Event|2|||
156931212|NCT00445965|566506803|FG000|Overall Study|Physician Decision|1|||
156931213|NCT00445965|566506803|FG000|Overall Study|Enrolled but not treated|1|||
156931214|NCT00445965|566506803|FG000|Overall Study|Removed due to progressive disease|29|||
156931215|NCT02867709|566506804|FG000|Treatment Period|Adverse Event|1|||
156931216|NCT02867709|566506805|FG001|Treatment Period|Adverse Event|1|||
156931217|NCT02867709|566506806|FG002|Treatment Period|Adverse Event|2|||
156931218|NCT02867709|566506804|FG000|Treatment Period|Withdrawal of Consent|7|||
156931219|NCT02867709|566506805|FG001|Treatment Period|Withdrawal of Consent|9|||
156931220|NCT02867709|566506806|FG002|Treatment Period|Withdrawal of Consent|8|||
156931221|NCT02867709|566506804|FG000|Treatment Period|Lost to Follow-up|17|||
156931222|NCT02867709|566506805|FG001|Treatment Period|Lost to Follow-up|20|||
156931223|NCT02867709|566506806|FG002|Treatment Period|Lost to Follow-up|20|||
156931224|NCT02867709|566506804|FG000|Treatment Period|Lack of Qualifying Event|42|||
156931225|NCT02867709|566506805|FG001|Treatment Period|Lack of Qualifying Event|55|||
156931226|NCT02867709|566506806|FG002|Treatment Period|Lack of Qualifying Event|42|||
156931227|NCT02867709|566506804|FG000|Treatment Period|Protocol Violation|3|||
156931228|NCT02867709|566506805|FG001|Treatment Period|Protocol Violation|2|||
156931229|NCT02867709|566506806|FG002|Treatment Period|Protocol Violation|3|||
156931230|NCT02867709|566506804|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
156931231|NCT02867709|566506805|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
156931232|NCT02867709|566506806|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
156931233|NCT02867709|566506804|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
156931234|NCT02867709|566506805|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
156931235|NCT02867709|566506806|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
156931236|NCT02867709|566506804|FG000|Safety Follow-up Period|Pregnancy|0|||
156931237|NCT02867709|566506805|FG001|Safety Follow-up Period|Pregnancy|1|||
156931238|NCT02867709|566506806|FG002|Safety Follow-up Period|Pregnancy|0|||
156931239|NCT02867709|566506804|FG000|Safety Follow-up Period|Protocol Violation|0|||
156931240|NCT02867709|566506805|FG001|Safety Follow-up Period|Protocol Violation|1|||
156931241|NCT02867709|566506806|FG002|Safety Follow-up Period|Protocol Violation|1|||
156931242|NCT03188094|566506807|FG000|Overall Study|Screen failure|1|||
156931243|NCT03188094|566506808|FG001|Overall Study|Screen failure|0|||
156931244|NCT03188094|566506809|FG002|Overall Study|Screen failure|0|||
156931245|NCT03188094|566506807|FG000|Overall Study|Pregnancy|3|||
156931246|NCT03188094|566506808|FG001|Overall Study|Pregnancy|0|||
156931247|NCT03188094|566506809|FG002|Overall Study|Pregnancy|0|||
156931248|NCT03188094|566506807|FG000|Overall Study|Ineligible|1|||
156931249|NCT03188094|566506808|FG001|Overall Study|Ineligible|0|||
156931250|NCT03188094|566506809|FG002|Overall Study|Ineligible|0|||
156931251|NCT03188094|566506807|FG000|Overall Study|Lost to Follow-up|0|||
156931252|NCT03188094|566506808|FG001|Overall Study|Lost to Follow-up|0|||
156931253|NCT03188094|566506809|FG002|Overall Study|Lost to Follow-up|17|||
156931254|NCT00156533|566508347|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
156931255|NCT00156533|566508348|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
156931256|NCT00156533|566508349|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
156931257|NCT00156533|566508350|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
156931258|NCT00156533|566508347|FG000|Overall Study|Withdrawal by Subject|1|||
156931259|NCT00156533|566508348|FG001|Overall Study|Withdrawal by Subject|0|||
156931260|NCT00156533|566508349|FG002|Overall Study|Withdrawal by Subject|0|||
156931261|NCT00156533|566508350|FG003|Overall Study|Withdrawal by Subject|1|||
156931262|NCT00156533|566508347|FG000|Overall Study|Failed Screening|1|||
156931263|NCT00156533|566508348|FG001|Overall Study|Failed Screening|0|||
156931264|NCT00156533|566508349|FG002|Overall Study|Failed Screening|1|||
156931265|NCT00156533|566508350|FG003|Overall Study|Failed Screening|1|||
156931266|NCT04254978|566508351|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
156931267|NCT04254978|566508351|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
156931268|NCT04254978|566508351|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
156931269|NCT04254978|566508351|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
156931270|NCT04254978|566508351|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
156931271|NCT04254978|566508351|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
156931272|NCT03257631|566508352|FG000|Overall Study|Death|1|||
157166918|NCT01337167|567352600|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
157166919|NCT01337167|567352601|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
157166920|NCT03833817|567352606|FG000|Overall Study|Withdrawal by Subject|3|||
156931273|NCT03257631|566508353|FG001|Overall Study|Death|0|||
156931274|NCT03257631|566508354|FG002|Overall Study|Death|1|||
156931275|NCT03257631|566508355|FG003|Overall Study|Death|1|||
156931276|NCT03257631|566508352|FG000|Overall Study|Progressive Disease|10|||
156931277|NCT03257631|566508353|FG001|Overall Study|Progressive Disease|9|||
156931278|NCT03257631|566508354|FG002|Overall Study|Progressive Disease|17|||
156931279|NCT03257631|566508355|FG003|Overall Study|Progressive Disease|8|||
156931280|NCT03257631|566508352|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156931281|NCT03257631|566508353|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156931282|NCT03257631|566508354|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
156931283|NCT03257631|566508355|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
156931284|NCT03257631|566508352|FG000|Overall Study|Adverse Event|0|||
156931285|NCT03257631|566508353|FG001|Overall Study|Adverse Event|0|||
156931286|NCT03257631|566508354|FG002|Overall Study|Adverse Event|2|||
156931287|NCT03257631|566508355|FG003|Overall Study|Adverse Event|0|||
156931288|NCT03509675|566508357|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
156931289|NCT03509675|566508358|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
156931290|NCT03509675|566508357|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
156931291|NCT03509675|566508358|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
156931292|NCT03509675|566508357|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
156931293|NCT03509675|566508358|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
156931294|NCT03509675|566508357|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
156931295|NCT03509675|566508358|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
156931296|NCT00922766|566508361|FG000|Overall Study|Death|3|||
156931297|NCT00922766|566508361|FG000|Overall Study|Withdrawal by Subject|2|||
156931298|NCT00922766|566508361|FG000|Overall Study|Other|1|||
156931299|NCT00922766|566508361|FG000|Overall Study|Adverse Event|1|||
156931300|NCT02622828|566508362|FG000|Overall Study|participant withdrew|3|||
156931301|NCT01231581|566508368|FG000|Overall Study|Lost to Follow-up|2|||
156931302|NCT01231581|566508369|FG001|Overall Study|Lost to Follow-up|2|||
156931303|NCT01231581|566508368|FG000|Overall Study|Withdrawal by Subject|6|||
156931304|NCT01231581|566508369|FG001|Overall Study|Withdrawal by Subject|9|||
156931305|NCT01231581|566508368|FG000|Overall Study|Study Closed/Terminated|6|||
156931306|NCT01231581|566508369|FG001|Overall Study|Study Closed/Terminated|5|||
156931307|NCT01231581|566508368|FG000|Overall Study|Death|65|||
156931308|NCT01231581|566508369|FG001|Overall Study|Death|64|||
156931309|NCT01231581|566508368|FG000|Overall Study|Ongoing|1|||
156931310|NCT01231581|566508369|FG001|Overall Study|Ongoing|0|||
156931311|NCT03616912|566508370|FG000|Overall Study|Adverse Event|17|||
156931312|NCT03616912|566508371|FG001|Overall Study|Adverse Event|21|||
156931313|NCT03616912|566508372|FG002|Overall Study|Adverse Event|9|||
156931314|NCT03616912|566508373|FG003|Overall Study|Adverse Event|0|||
156931315|NCT03616912|566508374|FG004|Overall Study|Adverse Event|0|||
156931316|NCT03616912|566508375|FG005|Overall Study|Adverse Event|0|||
156931317|NCT03616912|566508370|FG000|Overall Study|Death|1|||
156931318|NCT03616912|566508371|FG001|Overall Study|Death|1|||
156931319|NCT03616912|566508372|FG002|Overall Study|Death|0|||
156931320|NCT03616912|566508373|FG003|Overall Study|Death|0|||
156931321|NCT03616912|566508374|FG004|Overall Study|Death|0|||
156931322|NCT03616912|566508375|FG005|Overall Study|Death|0|||
156931323|NCT03616912|566508370|FG000|Overall Study|Lack of Efficacy|13|||
156931324|NCT03616912|566508371|FG001|Overall Study|Lack of Efficacy|6|||
156931325|NCT03616912|566508372|FG002|Overall Study|Lack of Efficacy|8|||
156931326|NCT03616912|566508373|FG003|Overall Study|Lack of Efficacy|4|||
156931327|NCT03616912|566508374|FG004|Overall Study|Lack of Efficacy|5|||
156931328|NCT03616912|566508375|FG005|Overall Study|Lack of Efficacy|1|||
156931329|NCT03616912|566508370|FG000|Overall Study|Lost to Follow-up|1|||
156931330|NCT03616912|566508371|FG001|Overall Study|Lost to Follow-up|2|||
156931331|NCT03616912|566508372|FG002|Overall Study|Lost to Follow-up|3|||
156931332|NCT03616912|566508373|FG003|Overall Study|Lost to Follow-up|0|||
156931333|NCT03616912|566508374|FG004|Overall Study|Lost to Follow-up|0|||
156931334|NCT03616912|566508375|FG005|Overall Study|Lost to Follow-up|0|||
156931335|NCT03616912|566508370|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
156931336|NCT03616912|566508371|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
156931337|NCT03616912|566508372|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
156931338|NCT03616912|566508373|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
156931339|NCT03616912|566508374|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
156931340|NCT03616912|566508375|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
156931341|NCT03616912|566508370|FG000|Overall Study|Withdrawal by Subject|12|||
156931342|NCT03616912|566508371|FG001|Overall Study|Withdrawal by Subject|12|||
156931343|NCT03616912|566508372|FG002|Overall Study|Withdrawal by Subject|15|||
156931344|NCT03616912|566508373|FG003|Overall Study|Withdrawal by Subject|2|||
156931345|NCT03616912|566508374|FG004|Overall Study|Withdrawal by Subject|0|||
156931346|NCT03616912|566508375|FG005|Overall Study|Withdrawal by Subject|2|||
156931347|NCT03616912|566508370|FG000|Overall Study|Study Terminated by Sponsor|0|||
156931348|NCT03616912|566508371|FG001|Overall Study|Study Terminated by Sponsor|0|||
156931349|NCT03616912|566508372|FG002|Overall Study|Study Terminated by Sponsor|0|||
156931350|NCT03616912|566508373|FG003|Overall Study|Study Terminated by Sponsor|10|||
156931351|NCT03616912|566508374|FG004|Overall Study|Study Terminated by Sponsor|9|||
156931352|NCT03616912|566508375|FG005|Overall Study|Study Terminated by Sponsor|11|||
156931353|NCT03616912|566508370|FG000|Overall Study|Protocol Deviation|1|||
156931354|NCT03616912|566508371|FG001|Overall Study|Protocol Deviation|1|||
156931355|NCT03616912|566508372|FG002|Overall Study|Protocol Deviation|0|||
156931356|NCT03616912|566508373|FG003|Overall Study|Protocol Deviation|0|||
156931357|NCT03616912|566508374|FG004|Overall Study|Protocol Deviation|0|||
156931358|NCT03616912|566508375|FG005|Overall Study|Protocol Deviation|0|||
156931359|NCT03616912|566508370|FG000|Overall Study|Pregnancy|1|||
156931360|NCT03616912|566508371|FG001|Overall Study|Pregnancy|0|||
156931361|NCT03616912|566508372|FG002|Overall Study|Pregnancy|4|||
156931362|NCT03616912|566508373|FG003|Overall Study|Pregnancy|0|||
156931363|NCT03616912|566508374|FG004|Overall Study|Pregnancy|0|||
156931364|NCT03616912|566508375|FG005|Overall Study|Pregnancy|0|||
156931365|NCT03616912|566508370|FG000|Overall Study|Protocol Violation|1|||
156931366|NCT03616912|566508371|FG001|Overall Study|Protocol Violation|0|||
156931367|NCT03616912|566508372|FG002|Overall Study|Protocol Violation|2|||
156931368|NCT03616912|566508373|FG003|Overall Study|Protocol Violation|0|||
156931369|NCT03616912|566508374|FG004|Overall Study|Protocol Violation|0|||
156931370|NCT03616912|566508375|FG005|Overall Study|Protocol Violation|0|||
156931371|NCT03616912|566508370|FG000|Overall Study|Physician Decision|2|||
156931372|NCT03616912|566508371|FG001|Overall Study|Physician Decision|0|||
156931373|NCT03616912|566508372|FG002|Overall Study|Physician Decision|0|||
156931374|NCT03616912|566508373|FG003|Overall Study|Physician Decision|0|||
156931375|NCT03616912|566508374|FG004|Overall Study|Physician Decision|1|||
156931376|NCT03616912|566508375|FG005|Overall Study|Physician Decision|0|||
156931377|NCT03616912|566508370|FG000|Overall Study|Randomized But Never Treated|0|||
156931378|NCT03616912|566508371|FG001|Overall Study|Randomized But Never Treated|2|||
156931379|NCT03616912|566508372|FG002|Overall Study|Randomized But Never Treated|0|||
156931380|NCT03616912|566508373|FG003|Overall Study|Randomized But Never Treated|0|||
156931381|NCT03616912|566508374|FG004|Overall Study|Randomized But Never Treated|0|||
156931382|NCT03616912|566508375|FG005|Overall Study|Randomized But Never Treated|0|||
156931383|NCT01124604|566508376|FG000|Overall Study|Adverse Event|10|||
156931384|NCT01124604|566508377|FG001|Overall Study|Adverse Event|1|||
156931385|NCT01124604|566508376|FG000|Overall Study|Lack of Efficacy|1|||
156931386|NCT01124604|566508377|FG001|Overall Study|Lack of Efficacy|0|||
156931387|NCT01124604|566508376|FG000|Overall Study|Withdrawal by Subject|4|||
156931388|NCT01124604|566508377|FG001|Overall Study|Withdrawal by Subject|0|||
156931389|NCT01124604|566508376|FG000|Overall Study|Disease Progression|0|||
156931390|NCT01124604|566508377|FG001|Overall Study|Disease Progression|1|||
156931391|NCT01859507|566508378|FG000|Overall Study|left the country|4|||
156931392|NCT01762943|566508379|FG000|Overall Study|Physician Decision|1|||
156931393|NCT01762943|566508380|FG001|Overall Study|Physician Decision|1|||
156931394|NCT01762943|566508379|FG000|Overall Study|Protocol Violation|1|||
156931395|NCT01762943|566508380|FG001|Overall Study|Protocol Violation|0|||
156931396|NCT01762943|566508379|FG000|Overall Study|Withdrawal by Subject|2|||
156931397|NCT01762943|566508380|FG001|Overall Study|Withdrawal by Subject|1|||
156931398|NCT02404311|566508381|FG000|Part A: Month 0-18|Death|2|||
156931399|NCT02404311|566508382|FG001|Part A: Month 0-18|Death|0|||
156931400|NCT02404311|566508383|FG002|Part A: Month 0-18|Death|0|||
156931401|NCT02404311|566508384|FG003|Part A: Month 0-18|Death|0|||
156931402|NCT02404311|566508385|FG004|Part A: Month 0-18|Death|0|||
156931403|NCT02404311|566508381|FG000|Part A: Month 0-18|Physician Decision|1|||
156931404|NCT02404311|566508382|FG001|Part A: Month 0-18|Physician Decision|0|||
156931405|NCT02404311|566508383|FG002|Part A: Month 0-18|Physician Decision|0|||
156931406|NCT02404311|566508384|FG003|Part A: Month 0-18|Physician Decision|0|||
156931407|NCT02404311|566508385|FG004|Part A: Month 0-18|Physician Decision|0|||
156931408|NCT02404311|566508381|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
156931409|NCT02404311|566508382|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
156931410|NCT02404311|566508383|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
156931411|NCT02404311|566508384|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
156931412|NCT02404311|566508385|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
156931413|NCT02404311|566508381|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
156931414|NCT02404311|566508382|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
156931415|NCT02404311|566508383|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
156931416|NCT02404311|566508384|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
156931417|NCT02404311|566508385|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
156931418|NCT02404311|566508381|FG000|Part A: Month 0-18|HIV Infection|6|||
156931419|NCT02404311|566508382|FG001|Part A: Month 0-18|HIV Infection|2|||
156931420|NCT02404311|566508383|FG002|Part A: Month 0-18|HIV Infection|0|||
156931421|NCT02404311|566508384|FG003|Part A: Month 0-18|HIV Infection|0|||
156931422|NCT02404311|566508385|FG004|Part A: Month 0-18|HIV Infection|0|||
156931423|NCT02404311|566508381|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
156931424|NCT02404311|566508382|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
156931425|NCT02404311|566508383|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
156931426|NCT02404311|566508384|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
156931427|NCT02404311|566508385|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
156931428|NCT00930579|566508396|FG000|Overall Study|Withdrawal by Subject|1|||
156931429|NCT00930579|566508396|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
156931430|NCT01046682|566508401|FG000|Overall Study|Adverse Event|2|||
156931431|NCT01046682|566508402|FG001|Overall Study|Adverse Event|0|||
156931432|NCT05071183|566508403|FG000|Overall Study|Death|1|||
156931433|NCT05071183|566508404|FG001|Overall Study|Death|2|||
156931434|NCT05071183|566508405|FG002|Overall Study|Death|0|||
156931435|NCT05071183|566508403|FG000|Overall Study|Other Reasons|1|||
156931436|NCT05071183|566508404|FG001|Overall Study|Other Reasons|3|||
156931437|NCT05071183|566508405|FG002|Overall Study|Other Reasons|2|||
156931438|NCT02864251|566508406|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
156931439|NCT02864251|566508407|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
156931440|NCT02864251|566508408|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
156931441|NCT02864251|566508406|FG000|Pre-Treatment|Withdrawal by Participant|0|||
156931442|NCT02864251|566508407|FG001|Pre-Treatment|Withdrawal by Participant|0|||
156931443|NCT02864251|566508408|FG002|Pre-Treatment|Withdrawal by Participant|4|||
156931444|NCT02864251|566508406|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
156931445|NCT02864251|566508407|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
156931446|NCT02864251|566508408|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
156931447|NCT02864251|566508406|FG000|Pre-Treatment|Other Reasons|0|||
156931448|NCT02864251|566508407|FG001|Pre-Treatment|Other Reasons|1|||
156931449|NCT02864251|566508408|FG002|Pre-Treatment|Other Reasons|1|||
156931450|NCT02864251|566508406|FG000|Treatment|Disease Progression|109|||
156931451|NCT02864251|566508407|FG001|Treatment|Disease Progression|52|||
156931452|NCT02864251|566508408|FG002|Treatment|Disease Progression|101|||
156931453|NCT02864251|566508406|FG000|Treatment|Study Drug Toxicity|9|||
156931454|NCT02864251|566508407|FG001|Treatment|Study Drug Toxicity|4|||
156931455|NCT02864251|566508408|FG002|Treatment|Study Drug Toxicity|10|||
156931456|NCT02864251|566508406|FG000|Treatment|Death|0|||
156931457|NCT02864251|566508407|FG001|Treatment|Death|2|||
156931458|NCT02864251|566508408|FG002|Treatment|Death|3|||
156931459|NCT02864251|566508406|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
156931460|NCT02864251|566508407|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
156931461|NCT02864251|566508408|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
156931462|NCT02864251|566508406|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
156931463|NCT02864251|566508407|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
156931464|NCT02864251|566508408|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
156931465|NCT02864251|566508406|FG000|Treatment|Withdrawal by Participant|8|||
156931466|NCT02864251|566508407|FG001|Treatment|Withdrawal by Participant|5|||
156931467|NCT02864251|566508408|FG002|Treatment|Withdrawal by Participant|13|||
156931468|NCT02864251|566508406|FG000|Treatment|Maximum Clinical Benefit|1|||
156931469|NCT02864251|566508407|FG001|Treatment|Maximum Clinical Benefit|0|||
156931470|NCT02864251|566508408|FG002|Treatment|Maximum Clinical Benefit|1|||
156931471|NCT02864251|566508406|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
156931472|NCT02864251|566508407|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
156931473|NCT02864251|566508408|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
156931474|NCT02864251|566508406|FG000|Treatment|Other Reasons|1|||
156931475|NCT02864251|566508407|FG001|Treatment|Other Reasons|1|||
156931476|NCT02864251|566508408|FG002|Treatment|Other Reasons|4|||
156931477|NCT02864251|566508406|FG000|Treatment|Administrative Reason by Sponsor|1|||
156931478|NCT02864251|566508407|FG001|Treatment|Administrative Reason by Sponsor|0|||
156931479|NCT02864251|566508408|FG002|Treatment|Administrative Reason by Sponsor|0|||
156931480|NCT01752855|566508413|FG000|Overall Study|Adverse Event|1|||
156931481|NCT01752855|566508414|FG001|Overall Study|Adverse Event|0|||
156931482|NCT01752855|566508413|FG000|Overall Study|Withdrew Consent|0|||
156931483|NCT01752855|566508414|FG001|Overall Study|Withdrew Consent|2|||
156931484|NCT01752855|566508413|FG000|Overall Study|Lack of Efficacy|0|||
156931485|NCT01752855|566508414|FG001|Overall Study|Lack of Efficacy|2|||
156931486|NCT03343483|566508421|FG000|Overall Study|Death|0|||
156931487|NCT03343483|566508422|FG001|Overall Study|Death|3|||
156931488|NCT03343483|566508421|FG000|Overall Study|Lost to Follow-up|9|||
156931489|NCT03343483|566508422|FG001|Overall Study|Lost to Follow-up|13|||
156931490|NCT03343483|566508421|FG000|Overall Study|Withdrawal by Subject|8|||
156931491|NCT03343483|566508422|FG001|Overall Study|Withdrawal by Subject|17|||
156931492|NCT01488097|566508425|FG000|Overall Study|Lost to Follow-up|1|||
156931493|NCT01577758|566508426|FG000|Dose Escalation Phase|Adverse Event|0|||
156931494|NCT01577758|566508427|FG001|Dose Escalation Phase|Adverse Event|0|||
156931495|NCT01577758|566508428|FG002|Dose Escalation Phase|Adverse Event|0|||
156931496|NCT01577758|566508429|FG003|Dose Escalation Phase|Adverse Event|0|||
156931497|NCT01577758|566508430|FG004|Dose Escalation Phase|Adverse Event|0|||
156931498|NCT01577758|566508431|FG005|Dose Escalation Phase|Adverse Event|2|||
156931499|NCT01577758|566508432|FG006|Dose Escalation Phase|Adverse Event|1|||
156931500|NCT01577758|566508433|FG007|Dose Escalation Phase|Adverse Event|0|||
156931501|NCT01577758|566508426|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
156931502|NCT01577758|566508427|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
156931503|NCT01577758|566508428|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
156931504|NCT01577758|566508429|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
156931505|NCT01577758|566508430|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
156931506|NCT01577758|566508431|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
156931507|NCT01577758|566508432|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
156931508|NCT01577758|566508433|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
156931509|NCT01577758|566508426|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
156931510|NCT01577758|566508427|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
157029470|NCT05671653|566864865|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
156931511|NCT01577758|566508428|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
156931512|NCT01577758|566508429|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
156931513|NCT01577758|566508430|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
156931514|NCT01577758|566508431|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
156931515|NCT01577758|566508432|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
156931516|NCT01577758|566508433|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
156931517|NCT01577758|566508426|FG000|Dose Escalation Phase|Progression Disease|2|||
156931518|NCT01577758|566508427|FG001|Dose Escalation Phase|Progression Disease|2|||
156931519|NCT01577758|566508428|FG002|Dose Escalation Phase|Progression Disease|1|||
156931520|NCT01577758|566508429|FG003|Dose Escalation Phase|Progression Disease|2|||
156931521|NCT01577758|566508430|FG004|Dose Escalation Phase|Progression Disease|5|||
156931522|NCT01577758|566508431|FG005|Dose Escalation Phase|Progression Disease|0|||
156931523|NCT01577758|566508432|FG006|Dose Escalation Phase|Progression Disease|0|||
156931524|NCT01577758|566508433|FG007|Dose Escalation Phase|Progression Disease|0|||
156931525|NCT01577758|566508426|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931526|NCT01577758|566508427|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931527|NCT01577758|566508428|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931528|NCT01577758|566508429|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931529|NCT01577758|566508430|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931530|NCT01577758|566508431|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931531|NCT01577758|566508432|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
156931532|NCT01577758|566508433|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
156931533|NCT01577758|566508426|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931534|NCT01577758|566508427|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931535|NCT01577758|566508428|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931536|NCT01577758|566508429|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931537|NCT01577758|566508430|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931538|NCT01577758|566508431|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931539|NCT01577758|566508432|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
156931540|NCT01577758|566508433|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
156931541|NCT01577758|566508426|FG000|mCRC Expansion Phase|Progression Disease|0|||
156931542|NCT01577758|566508427|FG001|mCRC Expansion Phase|Progression Disease|0|||
156931543|NCT01577758|566508428|FG002|mCRC Expansion Phase|Progression Disease|0|||
156931544|NCT01577758|566508429|FG003|mCRC Expansion Phase|Progression Disease|0|||
156931545|NCT01577758|566508430|FG004|mCRC Expansion Phase|Progression Disease|0|||
156931546|NCT01577758|566508431|FG005|mCRC Expansion Phase|Progression Disease|0|||
156931547|NCT01577758|566508432|FG006|mCRC Expansion Phase|Progression Disease|0|||
156931548|NCT01577758|566508433|FG007|mCRC Expansion Phase|Progression Disease|19|||
156931549|NCT01293240|566508436|FG000|Overall Study|Noncompliance|2|||
156931550|NCT01251380|566508441|FG000|Overall Study|Other (Not otherwise specified)|12|||
156931551|NCT01251380|566508441|FG000|Overall Study|Withdrawal by Subject|6|||
156931552|NCT01251380|566508441|FG000|Overall Study|Lack of Efficacy|1|||
156931553|NCT01251380|566508441|FG000|Overall Study|Adverse Event|1|||
156931554|NCT01251380|566508441|FG000|Overall Study|Lost to Follow-up|2|||
156931555|NCT02404350|566508445|FG000|Overall Study|Adverse Event|2|||
156931556|NCT02404350|566508446|FG001|Overall Study|Adverse Event|2|||
156931557|NCT02404350|566508447|FG002|Overall Study|Adverse Event|3|||
156931558|NCT02404350|566508448|FG003|Overall Study|Adverse Event|9|||
156931559|NCT02404350|566508445|FG000|Overall Study|Lack of Efficacy|3|||
156931560|NCT02404350|566508446|FG001|Overall Study|Lack of Efficacy|1|||
156931561|NCT02404350|566508447|FG002|Overall Study|Lack of Efficacy|0|||
156931562|NCT02404350|566508448|FG003|Overall Study|Lack of Efficacy|3|||
156931563|NCT02404350|566508445|FG000|Overall Study|Lost to Follow-up|2|||
156931564|NCT02404350|566508446|FG001|Overall Study|Lost to Follow-up|0|||
156931565|NCT02404350|566508447|FG002|Overall Study|Lost to Follow-up|0|||
156931566|NCT02404350|566508448|FG003|Overall Study|Lost to Follow-up|1|||
156931567|NCT02404350|566508445|FG000|Overall Study|Physician Decision|1|||
156931568|NCT02404350|566508446|FG001|Overall Study|Physician Decision|0|||
157029471|NCT05671653|566864866|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029472|NCT05671653|566864867|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
156931569|NCT02404350|566508447|FG002|Overall Study|Physician Decision|0|||
156931570|NCT02404350|566508448|FG003|Overall Study|Physician Decision|2|||
156931571|NCT02404350|566508445|FG000|Overall Study|Pregnancy|0|||
156931572|NCT02404350|566508446|FG001|Overall Study|Pregnancy|0|||
156931573|NCT02404350|566508447|FG002|Overall Study|Pregnancy|0|||
156931574|NCT02404350|566508448|FG003|Overall Study|Pregnancy|1|||
156931575|NCT02404350|566508445|FG000|Overall Study|Withdrawal by Subject|7|||
156931576|NCT02404350|566508446|FG001|Overall Study|Withdrawal by Subject|3|||
156931577|NCT02404350|566508447|FG002|Overall Study|Withdrawal by Subject|3|||
156931578|NCT02404350|566508448|FG003|Overall Study|Withdrawal by Subject|19|||
156931579|NCT02404350|566508445|FG000|Overall Study|Due to Non-compliance with treatment|0|||
156931580|NCT02404350|566508446|FG001|Overall Study|Due to Non-compliance with treatment|0|||
156931581|NCT02404350|566508447|FG002|Overall Study|Due to Non-compliance with treatment|0|||
156931582|NCT02404350|566508448|FG003|Overall Study|Due to Non-compliance with treatment|1|||
156931583|NCT02404350|566508445|FG000|Overall Study|Due to Technical problems|0|||
156931584|NCT02404350|566508446|FG001|Overall Study|Due to Technical problems|0|||
156931585|NCT02404350|566508447|FG002|Overall Study|Due to Technical problems|0|||
156931586|NCT02404350|566508448|FG003|Overall Study|Due to Technical problems|1|||
156931587|NCT05389657|566508449|FG000|Overall Study|Lost to Follow-up|7|||
156931588|NCT05389657|566508450|FG001|Overall Study|Lost to Follow-up|8|||
156931589|NCT05237206|566508452|FG000|Overall Study|screen failure-did not receive treatment|8|||
156931590|NCT05237206|566508452|FG000|Overall Study|did not receive treatment|3|||
156931591|NCT03261947|566508453|FG000|Overall Study|Death|10|||
156931592|NCT03261947|566508454|FG001|Overall Study|Death|13|||
156931593|NCT03261947|566508455|FG002|Overall Study|Death|17|||
156931594|NCT03261947|566508456|FG003|Overall Study|Death|12|||
156931595|NCT03261947|566508457|FG004|Overall Study|Death|8|||
156931596|NCT03261947|566508453|FG000|Overall Study|Lost to Follow-up|0|||
156931597|NCT03261947|566508454|FG001|Overall Study|Lost to Follow-up|0|||
156931598|NCT03261947|566508455|FG002|Overall Study|Lost to Follow-up|2|||
156931599|NCT03261947|566508456|FG003|Overall Study|Lost to Follow-up|1|||
156931600|NCT03261947|566508457|FG004|Overall Study|Lost to Follow-up|0|||
156931601|NCT03261947|566508453|FG000|Overall Study|Withdrawal by Subject|0|||
156931602|NCT03261947|566508454|FG001|Overall Study|Withdrawal by Subject|0|||
156931603|NCT03261947|566508455|FG002|Overall Study|Withdrawal by Subject|3|||
156931604|NCT03261947|566508456|FG003|Overall Study|Withdrawal by Subject|0|||
156931605|NCT03261947|566508457|FG004|Overall Study|Withdrawal by Subject|1|||
156931606|NCT03261947|566508453|FG000|Overall Study|Site Terminated by Sponsor|0|||
156931607|NCT03261947|566508454|FG001|Overall Study|Site Terminated by Sponsor|0|||
156931608|NCT03261947|566508455|FG002|Overall Study|Site Terminated by Sponsor|4|||
156931609|NCT03261947|566508456|FG003|Overall Study|Site Terminated by Sponsor|7|||
156931610|NCT03261947|566508457|FG004|Overall Study|Site Terminated by Sponsor|5|||
156931611|NCT03261947|566508453|FG000|Overall Study|Reason not Specified|2|||
156931612|NCT03261947|566508454|FG001|Overall Study|Reason not Specified|0|||
156931613|NCT03261947|566508455|FG002|Overall Study|Reason not Specified|4|||
156931614|NCT03261947|566508456|FG003|Overall Study|Reason not Specified|1|||
156931615|NCT03261947|566508457|FG004|Overall Study|Reason not Specified|3|||
156931616|NCT03969992|566508458|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
156931617|NCT03969992|566508459|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
156931618|NCT03969992|566508460|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
156931619|NCT03969992|566508458|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
156931620|NCT03969992|566508459|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
156931621|NCT03969992|566508460|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
156931622|NCT03969992|566508458|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
156931623|NCT03969992|566508459|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
156931624|NCT03969992|566508460|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
156931625|NCT03969992|566508458|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
156931626|NCT03969992|566508459|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
156931627|NCT03969992|566508460|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
156931628|NCT03969992|566508458|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
156931629|NCT03969992|566508459|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
156931630|NCT03969992|566508460|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
156931631|NCT01476696|566508463|FG000|Overall Study|Sponsor decision|2|||
156931632|NCT01476696|566508464|FG001|Overall Study|Sponsor decision|1|||
156931633|NCT01476696|566508465|FG002|Overall Study|Sponsor decision|0|||
156931634|NCT01476696|566508463|FG000|Overall Study|Withdrawal by Subject|1|||
156931635|NCT01476696|566508464|FG001|Overall Study|Withdrawal by Subject|0|||
156931636|NCT01476696|566508465|FG002|Overall Study|Withdrawal by Subject|0|||
156931637|NCT03965962|566508471|FG000|Overall Study|Adverse Event|1|||
156931638|NCT03965962|566508472|FG001|Overall Study|Adverse Event|0|||
156931639|NCT03965962|566508473|FG002|Overall Study|Adverse Event|0|||
156931640|NCT03965962|566508474|FG003|Overall Study|Adverse Event|0|||
156931641|NCT03965962|566508471|FG000|Overall Study|Protocol Violation|21|||
156931642|NCT03965962|566508472|FG001|Overall Study|Protocol Violation|4|||
156931643|NCT03965962|566508473|FG002|Overall Study|Protocol Violation|10|||
156931644|NCT03965962|566508474|FG003|Overall Study|Protocol Violation|5|||
156931645|NCT03965962|566508471|FG000|Overall Study|Lost to Follow-up|0|||
156931646|NCT03965962|566508472|FG001|Overall Study|Lost to Follow-up|1|||
156931647|NCT03965962|566508473|FG002|Overall Study|Lost to Follow-up|0|||
156931648|NCT03965962|566508474|FG003|Overall Study|Lost to Follow-up|0|||
156931649|NCT03965962|566508471|FG000|Overall Study|Withdrawal by Subject|3|||
156931650|NCT03965962|566508472|FG001|Overall Study|Withdrawal by Subject|0|||
156931651|NCT03965962|566508473|FG002|Overall Study|Withdrawal by Subject|0|||
156931652|NCT03965962|566508474|FG003|Overall Study|Withdrawal by Subject|1|||
156931653|NCT02225743|566508475|FG000|Overall Study|Withdrawal by Subject|18|||
156931654|NCT00322842|566508478|FG000|Overall Study|Withdrawal by Subject|0|||
156931655|NCT00322842|566508479|FG001|Overall Study|Withdrawal by Subject|1|||
156931656|NCT00322842|566508478|FG000|Overall Study|Lost to Follow-up|0|||
157029473|NCT05671653|566864868|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029474|NCT05671653|566864869|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029475|NCT05671653|566864870|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029476|NCT05671653|566864871|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029477|NCT05671653|566864872|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029478|NCT05671653|566864873|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029479|NCT05671653|566864874|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
157029480|NCT05671653|566864862|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029481|NCT05671653|566864863|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029482|NCT05671653|566864864|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029483|NCT05671653|566864865|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029484|NCT05671653|566864866|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029485|NCT05671653|566864867|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
157029486|NCT05671653|566864868|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029487|NCT05671653|566864869|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029488|NCT05671653|566864870|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029489|NCT05671653|566864871|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029490|NCT05671653|566864872|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029491|NCT05671653|566864873|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029492|NCT05671653|566864874|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
157029493|NCT05671653|566864862|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029494|NCT05671653|566864863|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029495|NCT05671653|566864864|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029496|NCT05671653|566864865|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029497|NCT05671653|566864866|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029498|NCT05671653|566864867|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029499|NCT05671653|566864868|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029500|NCT05671653|566864869|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029501|NCT05671653|566864870|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
157029502|NCT05671653|566864871|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029503|NCT05671653|566864872|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029504|NCT05671653|566864873|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029505|NCT05671653|566864874|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
157029506|NCT05671653|566864862|FG000|Cohort 2 Period 2|Adverse Event|0|||
157029507|NCT05671653|566864863|FG001|Cohort 2 Period 2|Adverse Event|0|||
157029508|NCT05671653|566864864|FG002|Cohort 2 Period 2|Adverse Event|0|||
157029509|NCT05671653|566864865|FG003|Cohort 2 Period 2|Adverse Event|0|||
157029510|NCT05671653|566864866|FG004|Cohort 2 Period 2|Adverse Event|0|||
157029511|NCT05671653|566864867|FG005|Cohort 2 Period 2|Adverse Event|0|||
157029512|NCT05671653|566864868|FG006|Cohort 2 Period 2|Adverse Event|0|||
157029513|NCT05671653|566864869|FG007|Cohort 2 Period 2|Adverse Event|0|||
157029514|NCT05671653|566864870|FG008|Cohort 2 Period 2|Adverse Event|0|||
157029515|NCT05671653|566864871|FG009|Cohort 2 Period 2|Adverse Event|0|||
157029516|NCT05671653|566864872|FG010|Cohort 2 Period 2|Adverse Event|1|||
157029517|NCT05671653|566864873|FG011|Cohort 2 Period 2|Adverse Event|0|||
157029518|NCT05671653|566864874|FG012|Cohort 2 Period 2|Adverse Event|0|||
157029519|NCT05671653|566864862|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
157029520|NCT05671653|566864863|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
157029521|NCT05671653|566864864|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
157029522|NCT05671653|566864865|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
157029523|NCT05671653|566864866|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
157029524|NCT05671653|566864867|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
157029525|NCT05671653|566864868|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
157029526|NCT05671653|566864869|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
157029527|NCT05671653|566864870|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
157029528|NCT05671653|566864871|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
157029529|NCT05671653|566864872|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
157029530|NCT05671653|566864873|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
157029531|NCT05671653|566864874|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
157029532|NCT05671653|566864862|FG000|Cohort 2 Period 2|Pregnancy|0|||
157029533|NCT05671653|566864863|FG001|Cohort 2 Period 2|Pregnancy|0|||
157029534|NCT05671653|566864864|FG002|Cohort 2 Period 2|Pregnancy|0|||
157029535|NCT05671653|566864865|FG003|Cohort 2 Period 2|Pregnancy|0|||
157029536|NCT05671653|566864866|FG004|Cohort 2 Period 2|Pregnancy|0|||
157029537|NCT05671653|566864867|FG005|Cohort 2 Period 2|Pregnancy|0|||
157166921|NCT03833817|567352607|FG001|Overall Study|Withdrawal by Subject|3|||
157029538|NCT05671653|566864868|FG006|Cohort 2 Period 2|Pregnancy|0|||
157029539|NCT05671653|566864869|FG007|Cohort 2 Period 2|Pregnancy|0|||
157029540|NCT05671653|566864870|FG008|Cohort 2 Period 2|Pregnancy|0|||
157029541|NCT05671653|566864871|FG009|Cohort 2 Period 2|Pregnancy|0|||
157029542|NCT05671653|566864872|FG010|Cohort 2 Period 2|Pregnancy|1|||
157029543|NCT05671653|566864873|FG011|Cohort 2 Period 2|Pregnancy|0|||
157029544|NCT05671653|566864874|FG012|Cohort 2 Period 2|Pregnancy|0|||
157029545|NCT05671653|566864862|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029546|NCT05671653|566864863|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029547|NCT05671653|566864864|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029548|NCT05671653|566864865|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029549|NCT05671653|566864866|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029550|NCT05671653|566864867|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029551|NCT05671653|566864868|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029552|NCT05671653|566864869|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029553|NCT05671653|566864870|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029554|NCT05671653|566864871|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029555|NCT05671653|566864872|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
157029556|NCT05671653|566864873|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029557|NCT05671653|566864874|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
157029558|NCT05671653|566864862|FG000|Cohort 2 Period 2|Other|0|||
157029559|NCT05671653|566864863|FG001|Cohort 2 Period 2|Other|0|||
157029560|NCT05671653|566864864|FG002|Cohort 2 Period 2|Other|0|||
157029561|NCT05671653|566864865|FG003|Cohort 2 Period 2|Other|0|||
157029562|NCT05671653|566864866|FG004|Cohort 2 Period 2|Other|0|||
157029563|NCT05671653|566864867|FG005|Cohort 2 Period 2|Other|0|||
157029564|NCT05671653|566864868|FG006|Cohort 2 Period 2|Other|0|||
157029565|NCT05671653|566864869|FG007|Cohort 2 Period 2|Other|0|||
157029566|NCT05671653|566864870|FG008|Cohort 2 Period 2|Other|0|||
157029567|NCT05671653|566864871|FG009|Cohort 2 Period 2|Other|0|||
157029568|NCT05671653|566864872|FG010|Cohort 2 Period 2|Other|1|||
157029569|NCT05671653|566864873|FG011|Cohort 2 Period 2|Other|0|||
157029570|NCT05671653|566864874|FG012|Cohort 2 Period 2|Other|0|||
157029571|NCT05671653|566864862|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029572|NCT05671653|566864863|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029573|NCT05671653|566864864|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029574|NCT05671653|566864865|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029575|NCT05671653|566864866|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029576|NCT05671653|566864867|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029577|NCT05671653|566864868|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029578|NCT05671653|566864869|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029579|NCT05671653|566864870|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029580|NCT05671653|566864871|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029581|NCT05671653|566864872|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029582|NCT05671653|566864873|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
157029583|NCT05671653|566864874|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
157029584|NCT01197378|566864878|FG000|Overall Study|Adverse Event|3|||
157029585|NCT01197378|566864878|FG000|Overall Study|Withdrawal by Subject|1|||
157029586|NCT01197378|566864878|FG000|Overall Study|Physician Decision|1|||
157029587|NCT01197378|566864878|FG000|Overall Study|Other|2|||
157029588|NCT05274074|566864896|FG000|Overall Study|Lost to Follow-up|2|||
157029589|NCT05274074|566864897|FG001|Overall Study|Lost to Follow-up|3|||
157029590|NCT05274074|566864896|FG000|Overall Study|Withdrawal by Subject|1|||
157029591|NCT05274074|566864897|FG001|Overall Study|Withdrawal by Subject|2|||
157029592|NCT04117347|566864898|FG000|Overall Study|Adverse Event|0|||
157029593|NCT04117347|566864899|FG001|Overall Study|Adverse Event|0|||
157029594|NCT04117347|566864900|FG002|Overall Study|Adverse Event|1|||
157029595|NCT04117347|566864898|FG000|Overall Study|No time for study|0|||
157029596|NCT04117347|566864899|FG001|Overall Study|No time for study|2|||
157029597|NCT04117347|566864900|FG002|Overall Study|No time for study|0|||
157029598|NCT04117347|566864898|FG000|Overall Study|Family emergency|1|||
157029599|NCT04117347|566864899|FG001|Overall Study|Family emergency|0|||
157029600|NCT04117347|566864900|FG002|Overall Study|Family emergency|0|||
157029601|NCT03687086|566864901|FG000|Overall Study|Withdrawal by Subject|3|||
157029602|NCT03687086|566864902|FG001|Overall Study|Withdrawal by Subject|4|||
157029603|NCT03687086|566864901|FG000|Overall Study|Lost to Follow-up|1|||
157029604|NCT03687086|566864902|FG001|Overall Study|Lost to Follow-up|1|||
157029605|NCT03687086|566864901|FG000|Overall Study|Death|1|||
157029606|NCT03687086|566864902|FG001|Overall Study|Death|0|||
157029607|NCT03687086|566864901|FG000|Overall Study|Incomplete assessment|0|||
157029608|NCT03687086|566864902|FG001|Overall Study|Incomplete assessment|2|||
157029609|NCT05194956|566864903|FG000|Washout Period|Withdrawal by Subject|0|||
157029610|NCT05194956|566864904|FG001|Washout Period|Withdrawal by Subject|2|||
157029611|NCT02593773|566864905|FG000|Overall Study|Voluntary Withdrawal|3|||
157166922|NCT03833817|567352606|FG000|Overall Study|Lost to Follow-up|3|||
157029612|NCT02593773|566864905|FG000|Overall Study|Study Terminated by Sponsor|31|||
157029613|NCT02593773|566864905|FG000|Overall Study|Death|1|||
157029614|NCT04294641|566864906|FG000|Overall Study|Screen failure|4|||
157029615|NCT01627574|566864907|FG000|Overall Study|Withdrawal by Subject|8|||
157029616|NCT01627574|566864908|FG001|Overall Study|Withdrawal by Subject|5|||
157029617|NCT01627574|566864907|FG000|Overall Study|Lost to Follow-up|13|||
157029618|NCT01627574|566864908|FG001|Overall Study|Lost to Follow-up|13|||
157029619|NCT04314778|566864929|FG000|Overall Study|Lost to Follow-up|5|||
157029620|NCT04314778|566864930|FG001|Overall Study|Lost to Follow-up|3|||
157029621|NCT05646355|566864931|FG000|Overall Study|Lost to Follow-up|1|||
157029622|NCT05646355|566864932|FG001|Overall Study|Lost to Follow-up|0|||
156931657|NCT00322842|566508479|FG001|Overall Study|Lost to Follow-up|1|||
156931658|NCT00322842|566508478|FG000|Overall Study|Refused transplant|1|||
156931659|NCT00322842|566508479|FG001|Overall Study|Refused transplant|0|||
156931660|NCT00322842|566508478|FG000|Overall Study|Death|1|||
156931661|NCT00322842|566508479|FG001|Overall Study|Death|0|||
156931662|NCT00323492|566508480|FG000|Study Phase 1|Adverse Event|2|||
156931663|NCT00323492|566508481|FG001|Study Phase 1|Adverse Event|0|||
156931664|NCT00323492|566508482|FG002|Study Phase 1|Adverse Event|0|||
156931665|NCT00323492|566508480|FG000|Study Phase 2|Adverse Event|1|||
156931666|NCT00323492|566508481|FG001|Study Phase 2|Adverse Event|0|||
156931667|NCT00323492|566508482|FG002|Study Phase 2|Adverse Event|0|||
156931668|NCT00323492|566508480|FG000|Study Phase 2|Physician Decision|1|||
156931669|NCT00323492|566508481|FG001|Study Phase 2|Physician Decision|0|||
156931670|NCT00323492|566508482|FG002|Study Phase 2|Physician Decision|0|||
156931671|NCT00323492|566508480|FG000|Study Phase 2|Lost to Follow-up|1|||
156931672|NCT00323492|566508481|FG001|Study Phase 2|Lost to Follow-up|0|||
156931673|NCT00323492|566508482|FG002|Study Phase 2|Lost to Follow-up|0|||
156931674|NCT00323492|566508480|FG000|Study Phase 2|Withdrawal by Subject|0|||
156931675|NCT00323492|566508481|FG001|Study Phase 2|Withdrawal by Subject|1|||
156931676|NCT00323492|566508482|FG002|Study Phase 2|Withdrawal by Subject|0|||
156931677|NCT00323492|566508480|FG000|Study Phase 2|Noncompliance with study schedule|0|||
156931678|NCT00323492|566508481|FG001|Study Phase 2|Noncompliance with study schedule|0|||
156931679|NCT00323492|566508482|FG002|Study Phase 2|Noncompliance with study schedule|1|||
156931680|NCT00323492|566508480|FG000|Study Phase 2|Protocol Violation|1|||
156931681|NCT00323492|566508481|FG001|Study Phase 2|Protocol Violation|0|||
156931682|NCT00323492|566508482|FG002|Study Phase 2|Protocol Violation|0|||
156931683|NCT02486042|566508483|FG000|Overall Study|Physician Decision|1|||
156931684|NCT02486042|566508484|FG001|Overall Study|Physician Decision|7|||
156931685|NCT02486042|566508483|FG000|Overall Study|Hospital transfer|2|||
156931686|NCT02486042|566508484|FG001|Overall Study|Hospital transfer|2|||
156931687|NCT02486042|566508483|FG000|Overall Study|Withdrawal by Subject|0|||
156931688|NCT02486042|566508484|FG001|Overall Study|Withdrawal by Subject|2|||
156931689|NCT00281684|566508498|FG000|Overall Study|Lost to Follow-up|0|||
156931690|NCT00281684|566508499|FG001|Overall Study|Lost to Follow-up|0|||
156931691|NCT00281684|566508500|FG002|Overall Study|Lost to Follow-up|1|||
156931692|NCT00281684|566508501|FG003|Overall Study|Lost to Follow-up|0|||
156931693|NCT00281684|566508498|FG000|Overall Study|Withdrawal by Subject|1|||
156931694|NCT00281684|566508499|FG001|Overall Study|Withdrawal by Subject|0|||
156931695|NCT00281684|566508500|FG002|Overall Study|Withdrawal by Subject|0|||
156931696|NCT00281684|566508501|FG003|Overall Study|Withdrawal by Subject|0|||
156931697|NCT03979638|566508504|FG000|Period 1|Physician Decision|1|||
156931698|NCT03979638|566508505|FG001|Period 1|Physician Decision|1|||
156931699|NCT03979638|566508504|FG000|Period 1|Withdrawal by Subject|4|||
156931700|NCT03979638|566508505|FG001|Period 1|Withdrawal by Subject|3|||
156931701|NCT03979638|566508504|FG000|Period 1|Study terminated by Sponsor|1|||
156931702|NCT03979638|566508505|FG001|Period 1|Study terminated by Sponsor|3|||
156931703|NCT03979638|566508504|FG000|Period 1|Protocol Violation|1|||
156931704|NCT03979638|566508505|FG001|Period 1|Protocol Violation|0|||
156931705|NCT03979638|566508504|FG000|Period 2|Study terminated by Sponsor|1|||
156931706|NCT03979638|566508505|FG001|Period 2|Study terminated by Sponsor|1|||
156931707|NCT00578942|566508506|FG000|Overall Study|Lost to Follow-up|1|||
156931708|NCT03200899|566508507|FG000|Overall Study|Lost to Follow-up|10|||
156931709|NCT03200899|566508508|FG001|Overall Study|Lost to Follow-up|23|||
156931710|NCT01400516|566508517|FG000|Primary Trial|Withdrawal by Subject|0|||
156931711|NCT01400516|566508518|FG001|Primary Trial|Withdrawal by Subject|2|||
156931712|NCT00549562|566508519|FG000|Overall Study|Adverse Event|1|||
156931713|NCT00549562|566508519|FG000|Overall Study|Lack of Efficacy|1|||
156931714|NCT05756790|566508520|FG000|Overall Study|Withdrawal by Subject|1|||
156931715|NCT05756790|566508521|FG001|Overall Study|Withdrawal by Subject|1|||
156931716|NCT05756790|566508522|FG002|Overall Study|Withdrawal by Subject|1|||
156931717|NCT05756790|566508523|FG003|Overall Study|Withdrawal by Subject|1|||
156931718|NCT05756790|566508524|FG004|Overall Study|Withdrawal by Subject|0|||
156931719|NCT05756790|566508525|FG005|Overall Study|Withdrawal by Subject|0|||
156931720|NCT05756790|566508520|FG000|Overall Study|Protocol Violation|0|||
156931721|NCT05756790|566508521|FG001|Overall Study|Protocol Violation|0|||
156931722|NCT05756790|566508522|FG002|Overall Study|Protocol Violation|1|||
156931723|NCT05756790|566508523|FG003|Overall Study|Protocol Violation|1|||
156931724|NCT05756790|566508524|FG004|Overall Study|Protocol Violation|0|||
156931725|NCT05756790|566508525|FG005|Overall Study|Protocol Violation|0|||
156931726|NCT05756790|566508520|FG000|Overall Study|Ineligible|0|||
156931727|NCT05756790|566508521|FG001|Overall Study|Ineligible|0|||
156931728|NCT05756790|566508522|FG002|Overall Study|Ineligible|0|||
156931729|NCT05756790|566508523|FG003|Overall Study|Ineligible|0|||
156931730|NCT05756790|566508524|FG004|Overall Study|Ineligible|2|||
156931731|NCT05756790|566508525|FG005|Overall Study|Ineligible|2|||
156931732|NCT01541969|566509742|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
156931733|NCT01541969|566509743|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
156931734|NCT01541969|566509742|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
157166923|NCT03833817|567352607|FG001|Overall Study|Lost to Follow-up|3|||
157166924|NCT00884221|567352608|FG000|Overall Study|Withdrawal by Subject|0|||
157166925|NCT00884221|567352609|FG001|Overall Study|Withdrawal by Subject|3|||
157166926|NCT00884221|567352608|FG000|Overall Study|Adverse Event|6|||
157166927|NCT00884221|567352609|FG001|Overall Study|Adverse Event|3|||
156931735|NCT01541969|566509743|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
156931736|NCT01541969|566509742|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
156931737|NCT01541969|566509743|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
156931738|NCT01541969|566509742|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
156931739|NCT01541969|566509743|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
156931740|NCT01541969|566509742|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
156931741|NCT01541969|566509743|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
156931742|NCT01541969|566509742|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
156931743|NCT01541969|566509743|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
156931744|NCT01541969|566509742|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
156931745|NCT01541969|566509743|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
156931746|NCT01541969|566509742|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
156931747|NCT01541969|566509743|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
156931748|NCT01541969|566509742|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
156931749|NCT01541969|566509743|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
156931750|NCT01541969|566509742|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
156931751|NCT01541969|566509743|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
156931752|NCT01365507|566509744|FG000|Overall Study|Withdrawal Criteria|8|||
156931753|NCT01365507|566509745|FG001|Overall Study|Withdrawal Criteria|5|||
156931754|NCT01365507|566509744|FG000|Overall Study|Unclassified|1|||
156931755|NCT01365507|566509745|FG001|Overall Study|Unclassified|4|||
156931756|NCT03265249|566509748|FG000|Overall Study|Withdrawal by Subject|0|||
156931757|NCT03265249|566509749|FG001|Overall Study|Withdrawal by Subject|1|||
156931758|NCT01614990|566509750|FG000|Overall Study|Protocol Violation|1|||
156931759|NCT01614990|566509751|FG001|Overall Study|Protocol Violation|1|||
156931760|NCT02255500|566509758|FG000|Overall Study|Withdrawal by Subject|1|||
156931761|NCT02255500|566509759|FG001|Overall Study|Withdrawal by Subject|0|||
156931762|NCT01012622|566509760|FG000|Overall Study|Withdrawal by Subject|6|||
156931763|NCT01012622|566509760|FG000|Overall Study|Lost to Follow-up|5|||
156931764|NCT01012622|566509760|FG000|Overall Study|Adverse Event|7|||
156931765|NCT01012622|566509760|FG000|Overall Study|non-compliance with the drug|9|||
156931766|NCT01012622|566509760|FG000|Overall Study|Other|1|||
156931767|NCT01012622|566509760|FG000|Overall Study|screening failure|1|||
156931768|NCT01012622|566509760|FG000|Overall Study|withdrawal of consent by a parent|2|||
156931769|NCT00076011|566509764|FG000|Overall Study|Death|1|||
156931770|NCT00076011|566509764|FG000|Overall Study|Adverse Event|10|||
156931771|NCT00076011|566509764|FG000|Overall Study|Lack of Efficacy|25|||
156931772|NCT00076011|566509764|FG000|Overall Study|Withdrawal by Subject|1|||
156931773|NCT00076011|566509764|FG000|Overall Study|Study terminated by sponsor|3|||
156931774|NCT00076011|566509764|FG000|Overall Study|Other|11|||
156931775|NCT00076011|566509764|FG000|Overall Study|Ongoing|1|||
156931776|NCT03314584|566509766|FG000|Overall Study|Withdrawal by Subject|3|||
156931777|NCT03314584|566509767|FG001|Overall Study|Withdrawal by Subject|3|||
156931778|NCT03314584|566509766|FG000|Overall Study|Lost to Follow-up|4|||
156931779|NCT03314584|566509767|FG001|Overall Study|Lost to Follow-up|0|||
156931780|NCT06134817|566509768|FG000|Overall Study|Physician Departure - termination of study|1|||
156931781|NCT04343521|566509778|FG000|Overall Study|Adverse Event|0|||
156931782|NCT04343521|566509779|FG001|Overall Study|Adverse Event|2|||
156931783|NCT04343521|566509778|FG000|Overall Study|Death|1|||
156931784|NCT04343521|566509779|FG001|Overall Study|Death|2|||
156931785|NCT04343521|566509778|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
156931786|NCT04343521|566509779|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
156931787|NCT04343521|566509778|FG000|Overall Study|Withdrawal by Subject|70|||
156931788|NCT04343521|566509779|FG001|Overall Study|Withdrawal by Subject|95|||
156931789|NCT04343521|566509778|FG000|Overall Study|Withdrawal by study team|6|||
156931790|NCT04343521|566509779|FG001|Overall Study|Withdrawal by study team|12|||
156931791|NCT02532647|566509782|FG000|Overall Study|Did not receive trial medication|1|||
156931792|NCT02532647|566509783|FG001|Overall Study|Did not receive trial medication|0|||
156931793|NCT02532647|566509784|FG002|Overall Study|Did not receive trial medication|1|||
156931794|NCT03897179|566509788|FG000|Overall Study|Withdrawal by Subject|1|||
156931795|NCT00704535|566509789|FG000|Overall Study|Adverse Event|2|||
156931796|NCT00704535|566509789|FG000|Overall Study|Death|2|||
156931797|NCT00704535|566509789|FG000|Overall Study|Lost to Follow-up|8|||
156931798|NCT00704535|566509789|FG000|Overall Study|Protocol Violation|10|||
156931799|NCT00704535|566509789|FG000|Overall Study|Completed status not on Case Report Form|124|||
156931800|NCT02503332|566509791|FG000|Overall Study|Adverse Event|17|||
156931801|NCT02503332|566509792|FG001|Overall Study|Adverse Event|5|||
156931802|NCT02503332|566509793|FG002|Overall Study|Adverse Event|3|||
156931803|NCT02503332|566509794|FG003|Overall Study|Adverse Event|1|||
156931804|NCT02503332|566509791|FG000|Overall Study|Investigator's Decision|5|||
157029623|NCT05646355|566864931|FG000|Overall Study|translated materials not available for pilot|2|||
157029624|NCT05646355|566864932|FG001|Overall Study|translated materials not available for pilot|0|||
157029625|NCT05646355|566864931|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
157029626|NCT05646355|566864932|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
157029627|NCT04685135|566864933|FG000|Overall Study|Death|126|||
157029628|NCT04685135|566864934|FG001|Overall Study|Death|53|||
156931805|NCT02503332|566509792|FG001|Overall Study|Investigator's Decision|1|||
156931806|NCT02503332|566509793|FG002|Overall Study|Investigator's Decision|0|||
156931807|NCT02503332|566509794|FG003|Overall Study|Investigator's Decision|0|||
156931808|NCT02503332|566509791|FG000|Overall Study|Sponsor's Decision|1|||
156931809|NCT02503332|566509792|FG001|Overall Study|Sponsor's Decision|0|||
156931810|NCT02503332|566509793|FG002|Overall Study|Sponsor's Decision|0|||
156931811|NCT02503332|566509794|FG003|Overall Study|Sponsor's Decision|1|||
156931812|NCT02503332|566509791|FG000|Overall Study|Subject Request|6|||
156931813|NCT02503332|566509792|FG001|Overall Study|Subject Request|5|||
156931814|NCT02503332|566509793|FG002|Overall Study|Subject Request|2|||
156931815|NCT02503332|566509794|FG003|Overall Study|Subject Request|1|||
156931816|NCT02503332|566509791|FG000|Overall Study|Death|0|||
156931817|NCT02503332|566509792|FG001|Overall Study|Death|2|||
156931818|NCT02503332|566509793|FG002|Overall Study|Death|2|||
156931819|NCT02503332|566509794|FG003|Overall Study|Death|0|||
156931820|NCT02503332|566509791|FG000|Overall Study|Other|5|||
156931821|NCT02503332|566509792|FG001|Overall Study|Other|6|||
156931822|NCT02503332|566509793|FG002|Overall Study|Other|1|||
156931823|NCT02503332|566509794|FG003|Overall Study|Other|1|||
156931824|NCT02120950|566509795|FG000|Overall Study|Adverse Event|5|||
156931825|NCT02120950|566509796|FG001|Overall Study|Adverse Event|4|||
156931826|NCT02120950|566509797|FG002|Overall Study|Adverse Event|3|||
156931827|NCT02120950|566509795|FG000|Overall Study|Death|3|||
156931828|NCT02120950|566509796|FG001|Overall Study|Death|0|||
156931829|NCT02120950|566509797|FG002|Overall Study|Death|1|||
156931830|NCT02120950|566509795|FG000|Overall Study|Withdrawal by Subject|6|||
156931831|NCT02120950|566509796|FG001|Overall Study|Withdrawal by Subject|3|||
157029629|NCT04685135|566864933|FG000|Overall Study|Withdrawal by Subject|12|||
157029630|NCT04685135|566864934|FG001|Overall Study|Withdrawal by Subject|16|||
157029631|NCT02240238|566864937|FG000|Phase 1|Adverse Event|0|||
157029632|NCT02240238|566864938|FG001|Phase 1|Adverse Event|0|||
157029633|NCT02240238|566864939|FG002|Phase 1|Adverse Event|0|||
157029634|NCT02240238|566864940|FG003|Phase 1|Adverse Event|0|||
157029635|NCT02240238|566864941|FG004|Phase 1|Adverse Event|0|||
157029636|NCT02240238|566864942|FG005|Phase 1|Adverse Event|0|||
157029637|NCT02240238|566864943|FG006|Phase 1|Adverse Event|3|||
157029638|NCT02240238|566864944|FG007|Phase 1|Adverse Event|1|||
157029639|NCT02240238|566864945|FG008|Phase 1|Adverse Event|0|||
157029640|NCT02240238|566864946|FG009|Phase 1|Adverse Event|0|||
157029641|NCT02240238|566864947|FG010|Phase 1|Adverse Event|0|||
157029642|NCT02240238|566864948|FG011|Phase 1|Adverse Event|0|||
157029643|NCT02240238|566864937|FG000|Phase 1|Death|0|||
157029644|NCT02240238|566864938|FG001|Phase 1|Death|0|||
157029645|NCT02240238|566864939|FG002|Phase 1|Death|0|||
157029646|NCT02240238|566864940|FG003|Phase 1|Death|0|||
157029647|NCT02240238|566864941|FG004|Phase 1|Death|0|||
157029648|NCT02240238|566864942|FG005|Phase 1|Death|1|||
157029649|NCT02240238|566864943|FG006|Phase 1|Death|0|||
157029650|NCT02240238|566864944|FG007|Phase 1|Death|0|||
157029651|NCT02240238|566864945|FG008|Phase 1|Death|0|||
157029652|NCT02240238|566864946|FG009|Phase 1|Death|0|||
157029653|NCT02240238|566864947|FG010|Phase 1|Death|0|||
157029654|NCT02240238|566864948|FG011|Phase 1|Death|0|||
156931832|NCT02120950|566509797|FG002|Overall Study|Withdrawal by Subject|2|||
156931833|NCT02120950|566509795|FG000|Overall Study|Protocol Violation|1|||
156931834|NCT02120950|566509796|FG001|Overall Study|Protocol Violation|1|||
156931835|NCT02120950|566509797|FG002|Overall Study|Protocol Violation|7|||
156931836|NCT02120950|566509795|FG000|Overall Study|Other reasons|5|||
156931837|NCT02120950|566509796|FG001|Overall Study|Other reasons|4|||
156931838|NCT02120950|566509797|FG002|Overall Study|Other reasons|1|||
156931839|NCT02120950|566509795|FG000|Overall Study|Lost to Follow-up|0|||
156931840|NCT02120950|566509796|FG001|Overall Study|Lost to Follow-up|2|||
156931841|NCT02120950|566509797|FG002|Overall Study|Lost to Follow-up|1|||
156931842|NCT02424383|566509798|FG000|Overall Study|Withdrawal by Subject|32|||
156931843|NCT02424383|566509798|FG000|Overall Study|Death|170|||
156931844|NCT02424383|566509798|FG000|Overall Study|Sponsor's decision|3|||
156931845|NCT02424383|566509798|FG000|Overall Study|Investigator's decision|44|||
156931846|NCT02424383|566509798|FG000|Overall Study|Lost to Follow-up|81|||
156931847|NCT02424383|566509798|FG000|Overall Study|Other|7|||
156931848|NCT02424383|566509798|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
157029655|NCT02240238|566864937|FG000|Phase 1|Sponsor termination|0|||
157029656|NCT02240238|566864938|FG001|Phase 1|Sponsor termination|0|||
157029657|NCT02240238|566864939|FG002|Phase 1|Sponsor termination|0|||
157029658|NCT02240238|566864940|FG003|Phase 1|Sponsor termination|0|||
157029659|NCT02240238|566864941|FG004|Phase 1|Sponsor termination|0|||
157029660|NCT02240238|566864942|FG005|Phase 1|Sponsor termination|1|||
157166928|NCT00884221|567352608|FG000|Overall Study|Protocol Violation|16|||
157166929|NCT00884221|567352609|FG001|Overall Study|Protocol Violation|13|||
156931849|NCT01505608|566509802|FG000|Phase I|Lack of Efficacy|0|||
156931850|NCT01505608|566509803|FG001|Phase I|Lack of Efficacy|4|||
156931851|NCT01505608|566509802|FG000|Phase I|Adverse Event|0|||
156931852|NCT01505608|566509803|FG001|Phase I|Adverse Event|1|||
156931853|NCT01505608|566509802|FG000|Phase I|Withdrawal by Subject|0|||
156931854|NCT01505608|566509803|FG001|Phase I|Withdrawal by Subject|1|||
156931855|NCT01505608|566509802|FG000|Phase II|Lack of Efficacy|2|||
156931856|NCT01505608|566509803|FG001|Phase II|Lack of Efficacy|1|||
156931857|NCT01505608|566509802|FG000|Phase II|Protocol Violation|0|||
156931858|NCT01505608|566509803|FG001|Phase II|Protocol Violation|1|||
156931859|NCT00751348|566509806|FG000|Overall Study|Withdrawal by Subject|5|||
156931860|NCT00751348|566509807|FG001|Overall Study|Withdrawal by Subject|2|||
156931861|NCT00751348|566509806|FG000|Overall Study|Migration from study area|1|||
156931862|NCT00751348|566509807|FG001|Overall Study|Migration from study area|0|||
156931863|NCT01085097|566509810|FG000|Overall Study|Adverse Event|0|||
156931864|NCT01085097|566509811|FG001|Overall Study|Adverse Event|0|||
156931865|NCT01085097|566509812|FG002|Overall Study|Adverse Event|2|||
156931866|NCT01085097|566509810|FG000|Overall Study|Treatment failure|2|||
156931867|NCT01085097|566509811|FG001|Overall Study|Treatment failure|0|||
156931868|NCT01085097|566509812|FG002|Overall Study|Treatment failure|0|||
156931869|NCT01737047|566509815|FG000|Overall Study|Death|10|||
156931870|NCT01737047|566509816|FG001|Overall Study|Death|0|||
156931871|NCT01737047|566509817|FG002|Overall Study|Death|1|||
156931872|NCT01737047|566509815|FG000|Overall Study|Withdrawal by Subject|17|||
156931873|NCT01737047|566509816|FG001|Overall Study|Withdrawal by Subject|11|||
156931874|NCT01737047|566509817|FG002|Overall Study|Withdrawal by Subject|4|||
156931875|NCT06049043|566509818|FG000|Overall Study|Lost to Follow-up|11|||
156931876|NCT06049043|566509819|FG001|Overall Study|Lost to Follow-up|9|||
156931877|NCT03089606|566509820|FG000|Overall Study|Progression after Cycle 1|1|||
156931878|NCT01358357|566509821|FG000|Open Label Phase|Adverse Event|0|||
156931879|NCT01358357|566509822|FG001|Open Label Phase|Adverse Event|0|||
156931880|NCT01358357|566509823|FG002|Open Label Phase|Adverse Event|59|||
156931881|NCT01358357|566509821|FG000|Open Label Phase|Lack of Efficacy|0|||
156931882|NCT01358357|566509822|FG001|Open Label Phase|Lack of Efficacy|0|||
156931883|NCT01358357|566509823|FG002|Open Label Phase|Lack of Efficacy|107|||
156931884|NCT01358357|566509821|FG000|Open Label Phase|Lost to Follow-up|0|||
156931885|NCT01358357|566509822|FG001|Open Label Phase|Lost to Follow-up|0|||
156931886|NCT01358357|566509823|FG002|Open Label Phase|Lost to Follow-up|76|||
156931887|NCT01358357|566509821|FG000|Open Label Phase|Protocol Violation|0|||
156931888|NCT01358357|566509822|FG001|Open Label Phase|Protocol Violation|0|||
156931889|NCT01358357|566509823|FG002|Open Label Phase|Protocol Violation|45|||
156931890|NCT01358357|566509821|FG000|Open Label Phase|Withdrawal by Subject|0|||
156931891|NCT01358357|566509822|FG001|Open Label Phase|Withdrawal by Subject|0|||
156931892|NCT01358357|566509823|FG002|Open Label Phase|Withdrawal by Subject|112|||
156931893|NCT01358357|566509821|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
156931894|NCT01358357|566509822|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
156931895|NCT01358357|566509823|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
156931896|NCT01358357|566509821|FG000|Open Label Phase|Terminated at study completion|0|||
156931897|NCT01358357|566509822|FG001|Open Label Phase|Terminated at study completion|0|||
156931898|NCT01358357|566509823|FG002|Open Label Phase|Terminated at study completion|5|||
156931899|NCT01358357|566509821|FG000|Open Label Phase|Mood episode|0|||
156931900|NCT01358357|566509822|FG001|Open Label Phase|Mood episode|0|||
156931901|NCT01358357|566509823|FG002|Open Label Phase|Mood episode|42|||
156931902|NCT01358357|566509821|FG000|Double-Blind Phase|Adverse Event|8|||
156931903|NCT01358357|566509822|FG001|Double-Blind Phase|Adverse Event|5|||
156931904|NCT01358357|566509823|FG002|Double-Blind Phase|Adverse Event|0|||
156931905|NCT01358357|566509821|FG000|Double-Blind Phase|Lost to Follow-up|5|||
156931906|NCT01358357|566509822|FG001|Double-Blind Phase|Lost to Follow-up|7|||
156931907|NCT01358357|566509823|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156931908|NCT01358357|566509821|FG000|Double-Blind Phase|Protocol Violation|1|||
156931909|NCT01358357|566509822|FG001|Double-Blind Phase|Protocol Violation|11|||
156931910|NCT01358357|566509823|FG002|Double-Blind Phase|Protocol Violation|0|||
156931911|NCT01358357|566509821|FG000|Double-Blind Phase|Protocol Violation|16|||
156931912|NCT01358357|566509822|FG001|Double-Blind Phase|Protocol Violation|12|||
156931913|NCT01358357|566509823|FG002|Double-Blind Phase|Protocol Violation|0|||
156931914|NCT01358357|566509821|FG000|Double-Blind Phase|Terminated at study completion|2|||
156931915|NCT01358357|566509822|FG001|Double-Blind Phase|Terminated at study completion|0|||
156931916|NCT01358357|566509823|FG002|Double-Blind Phase|Terminated at study completion|0|||
156931917|NCT01358357|566509821|FG000|Double-Blind Phase|Recurrence of mood event|48|||
156931918|NCT01358357|566509822|FG001|Double-Blind Phase|Recurrence of mood event|64|||
156931919|NCT01358357|566509823|FG002|Double-Blind Phase|Recurrence of mood event|0|||
156931920|NCT01358357|566509821|FG000|Double-Blind Phase|Administrative|0|||
156931921|NCT01358357|566509822|FG001|Double-Blind Phase|Administrative|1|||
156931922|NCT01358357|566509823|FG002|Double-Blind Phase|Administrative|0|||
156931923|NCT02590939|566509824|FG000|Overall Study|Withdrawal by Subject|3|||
156931924|NCT02590939|566509825|FG001|Overall Study|Withdrawal by Subject|1|||
156931925|NCT02590939|566509824|FG000|Overall Study|Failed the nociceptive test|2|||
156931926|NCT02590939|566509825|FG001|Overall Study|Failed the nociceptive test|1|||
156931927|NCT00768144|566509831|FG000|Overall Study|Adverse Event|13|||
156931928|NCT00768144|566509831|FG000|Overall Study|Progressive Disease|21|||
156931929|NCT00768144|566509831|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
156931930|NCT00768144|566509831|FG000|Overall Study|Pt Withdrew Consent|1|||
156931931|NCT01712854|566509832|FG000|Overall Study|Physician Decision|1|||
156931932|NCT01150123|566509833|FG000|Overall Study|Withdrawal by Subject|1|||
156931933|NCT01150123|566509834|FG001|Overall Study|Withdrawal by Subject|1|||
156931934|NCT01150123|566509835|FG002|Overall Study|Withdrawal by Subject|2|||
156931935|NCT01150123|566509836|FG003|Overall Study|Withdrawal by Subject|1|||
156931936|NCT01150123|566509837|FG004|Overall Study|Withdrawal by Subject|1|||
156931937|NCT01150123|566509838|FG005|Overall Study|Withdrawal by Subject|1|||
156931938|NCT01150123|566509839|FG006|Overall Study|Withdrawal by Subject|0|||
156931939|NCT01150123|566509840|FG007|Overall Study|Withdrawal by Subject|3|||
156931940|NCT01150123|566509841|FG008|Overall Study|Withdrawal by Subject|2|||
156931941|NCT01150123|566509842|FG009|Overall Study|Withdrawal by Subject|0|||
156931942|NCT01150123|566509843|FG010|Overall Study|Withdrawal by Subject|1|||
156931943|NCT01150123|566509844|FG011|Overall Study|Withdrawal by Subject|0|||
156931944|NCT01150123|566509845|FG012|Overall Study|Withdrawal by Subject|1|||
156931945|NCT01150123|566509846|FG013|Overall Study|Withdrawal by Subject|0|||
156931946|NCT01150123|566509847|FG014|Overall Study|Withdrawal by Subject|0|||
156931947|NCT01150123|566509848|FG015|Overall Study|Withdrawal by Subject|1|||
156931948|NCT01150123|566509849|FG016|Overall Study|Withdrawal by Subject|0|||
156931949|NCT01150123|566509850|FG017|Overall Study|Withdrawal by Subject|1|||
156931950|NCT01150123|566509833|FG000|Overall Study|Lost to Follow-up|2|||
156931951|NCT01150123|566509834|FG001|Overall Study|Lost to Follow-up|1|||
156931952|NCT01150123|566509835|FG002|Overall Study|Lost to Follow-up|2|||
156931953|NCT01150123|566509836|FG003|Overall Study|Lost to Follow-up|2|||
156931954|NCT01150123|566509837|FG004|Overall Study|Lost to Follow-up|2|||
156931955|NCT01150123|566509838|FG005|Overall Study|Lost to Follow-up|5|||
156931956|NCT01150123|566509839|FG006|Overall Study|Lost to Follow-up|0|||
156931957|NCT01150123|566509840|FG007|Overall Study|Lost to Follow-up|0|||
156931958|NCT01150123|566509841|FG008|Overall Study|Lost to Follow-up|3|||
156931959|NCT01150123|566509842|FG009|Overall Study|Lost to Follow-up|1|||
156931960|NCT01150123|566509843|FG010|Overall Study|Lost to Follow-up|1|||
156931961|NCT01150123|566509844|FG011|Overall Study|Lost to Follow-up|1|||
156931962|NCT01150123|566509845|FG012|Overall Study|Lost to Follow-up|2|||
156931963|NCT01150123|566509846|FG013|Overall Study|Lost to Follow-up|0|||
156931964|NCT01150123|566509847|FG014|Overall Study|Lost to Follow-up|0|||
156931965|NCT01150123|566509848|FG015|Overall Study|Lost to Follow-up|0|||
156931966|NCT01150123|566509849|FG016|Overall Study|Lost to Follow-up|0|||
156931967|NCT01150123|566509850|FG017|Overall Study|Lost to Follow-up|0|||
156931968|NCT03320564|566509851|FG000|Overall Study|Protocol Violation|1|||
156931969|NCT00600938|566509854|FG000|Core Study|Abnormal test procedure result(s)|3|||
156931970|NCT00600938|566509855|FG001|Core Study|Abnormal test procedure result(s)|2|||
156931971|NCT00600938|566509856|FG002|Core Study|Abnormal test procedure result(s)|0|||
156931972|NCT00600938|566509857|FG003|Core Study|Abnormal test procedure result(s)|0|||
156931973|NCT00600938|566509854|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
156931974|NCT00600938|566509855|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
156931975|NCT00600938|566509856|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
156931976|NCT00600938|566509857|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
156931977|NCT00600938|566509854|FG000|Core Study|Patient withdrew consent|7|||
156931978|NCT00600938|566509855|FG001|Core Study|Patient withdrew consent|12|||
156931979|NCT00600938|566509856|FG002|Core Study|Patient withdrew consent|0|||
156931980|NCT00600938|566509857|FG003|Core Study|Patient withdrew consent|0|||
156931981|NCT00600938|566509854|FG000|Core Study|Lost to Follow-up|3|||
156931982|NCT00600938|566509855|FG001|Core Study|Lost to Follow-up|2|||
156931983|NCT00600938|566509856|FG002|Core Study|Lost to Follow-up|0|||
156931984|NCT00600938|566509857|FG003|Core Study|Lost to Follow-up|0|||
156931985|NCT00600938|566509854|FG000|Core Study|Death|1|||
156931986|NCT00600938|566509855|FG001|Core Study|Death|1|||
156931987|NCT00600938|566509856|FG002|Core Study|Death|0|||
156931988|NCT00600938|566509857|FG003|Core Study|Death|0|||
156931989|NCT00600938|566509854|FG000|Core Study|Protocol Violation|1|||
156931990|NCT00600938|566509855|FG001|Core Study|Protocol Violation|2|||
156931991|NCT00600938|566509856|FG002|Core Study|Protocol Violation|0|||
156931992|NCT00600938|566509857|FG003|Core Study|Protocol Violation|0|||
156931993|NCT00600938|566509854|FG000|Extension Study|Adverse Event|1|||
156931994|NCT00600938|566509855|FG001|Extension Study|Adverse Event|0|||
156931995|NCT00600938|566509856|FG002|Extension Study|Adverse Event|2|||
156931996|NCT00600938|566509857|FG003|Extension Study|Adverse Event|0|||
156931997|NCT00600938|566509854|FG000|Extension Study|Abnormal test procedure results|0|||
156931998|NCT00600938|566509855|FG001|Extension Study|Abnormal test procedure results|1|||
156931999|NCT00600938|566509856|FG002|Extension Study|Abnormal test procedure results|1|||
156932000|NCT00600938|566509857|FG003|Extension Study|Abnormal test procedure results|1|||
156932001|NCT00600938|566509854|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
156932002|NCT00600938|566509855|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
156932003|NCT00600938|566509856|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
156932004|NCT00600938|566509857|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
156932005|NCT00600938|566509854|FG000|Extension Study|Withdrawal by Subject|2|||
156932006|NCT00600938|566509855|FG001|Extension Study|Withdrawal by Subject|2|||
156932007|NCT00600938|566509856|FG002|Extension Study|Withdrawal by Subject|3|||
156932008|NCT00600938|566509857|FG003|Extension Study|Withdrawal by Subject|0|||
156932009|NCT00600938|566509854|FG000|Extension Study|Lost to Follow-up|1|||
156932010|NCT00600938|566509855|FG001|Extension Study|Lost to Follow-up|1|||
156932011|NCT00600938|566509856|FG002|Extension Study|Lost to Follow-up|2|||
156932012|NCT00600938|566509857|FG003|Extension Study|Lost to Follow-up|0|||
156932013|NCT00600938|566509854|FG000|Extension Study|Death|1|||
156932014|NCT00600938|566509855|FG001|Extension Study|Death|0|||
156932015|NCT00600938|566509856|FG002|Extension Study|Death|0|||
156932016|NCT00600938|566509857|FG003|Extension Study|Death|0|||
156932017|NCT02496533|566509866|FG000|Overall Study|Lack of data on outcome|3|||
156932018|NCT02496533|566509867|FG001|Overall Study|Lack of data on outcome|0|||
156932019|NCT02496533|566509866|FG000|Overall Study|Patient did not complete all measures|0|||
156932020|NCT02496533|566509867|FG001|Overall Study|Patient did not complete all measures|4|||
156932021|NCT02496533|566509866|FG000|Overall Study|Late for radiologic testing|0|||
156932022|NCT02496533|566509867|FG001|Overall Study|Late for radiologic testing|2|||
156932023|NCT02449239|566511247|FG000|Induction Phase|Lack of Efficacy|64|||
156932024|NCT02449239|566511247|FG000|Induction Phase|Adverse Event|1|||
156932025|NCT02449239|566511247|FG000|Induction Phase|Lost to Follow-up|1|||
156932026|NCT02449239|566511247|FG000|Induction Phase|Protocol Violation|1|||
156932027|NCT02449239|566511247|FG000|Induction Phase|Physician Decision|1|||
156932028|NCT02449239|566511247|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
156932029|NCT02449239|566511247|FG000|Induction Phase|Withdrawal by Subject|1|||
156932030|NCT02449239|566511247|FG000|Maintenance Month 3|Lack of Efficacy|14|||
156932031|NCT02449239|566511247|FG000|Maintenance Month 6|Lack of Efficacy|10|||
156932032|NCT02449239|566511247|FG000|Maintenance Month 6|Adverse Event|2|||
156932033|NCT02449239|566511247|FG000|Maintenance Month 6|Physician Decision|1|||
156932034|NCT02449239|566511247|FG000|Maintenance Month 9|Lack of Efficacy|2|||
156932035|NCT02449239|566511247|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
156932036|NCT02449239|566511247|FG000|Maintenance Month 12|Lack of Efficacy|5|||
156932037|NCT02449239|566511247|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
156932038|NCT02449239|566511247|FG000|Maintenance Month 12|Subject moved from area|1|||
156932039|NCT02449239|566511247|FG000|Maintenance Month 15|Lack of Efficacy|1|||
156932040|NCT02449239|566511247|FG000|Maintenance Month 21|Lack of Efficacy|1|||
156932041|NCT02449239|566511247|FG000|Maintenance Month 21|Sponsor decision|1|||
156932042|NCT03239470|566511255|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
156932043|NCT03239470|566511256|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
157029661|NCT02240238|566864943|FG006|Phase 1|Sponsor termination|0|||
157029662|NCT02240238|566864944|FG007|Phase 1|Sponsor termination|0|||
157029663|NCT02240238|566864945|FG008|Phase 1|Sponsor termination|0|||
157029664|NCT02240238|566864946|FG009|Phase 1|Sponsor termination|0|||
157029665|NCT02240238|566864947|FG010|Phase 1|Sponsor termination|0|||
157029666|NCT02240238|566864948|FG011|Phase 1|Sponsor termination|0|||
157029667|NCT02240238|566864937|FG000|Phase 1|Withdrawal by Subject|0|||
157029668|NCT02240238|566864938|FG001|Phase 1|Withdrawal by Subject|0|||
156932044|NCT01023581|566511257|FG000|Overall Study|Adverse Event|4|||
157029669|NCT02240238|566864939|FG002|Phase 1|Withdrawal by Subject|0|||
157029670|NCT02240238|566864940|FG003|Phase 1|Withdrawal by Subject|0|||
157166930|NCT00884221|567352608|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
157166931|NCT00884221|567352609|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
157166932|NCT02126670|567352612|FG000|Overall Study|Withdrawal by Subject|1|||
157166933|NCT02126670|567352613|FG001|Overall Study|Withdrawal by Subject|0|||
157166934|NCT02126670|567352614|FG002|Overall Study|Withdrawal by Subject|0|||
157166935|NCT02126670|567352615|FG003|Overall Study|Withdrawal by Subject|1|||
157166936|NCT00255034|567352620|FG000|Overall Study|Withdrawal by Subject|15|||
157166937|NCT00255034|567352621|FG001|Overall Study|Withdrawal by Subject|38|||
157166938|NCT00424346|567352622|FG000|Core Study|Adverse Event|5|||
157166939|NCT00424346|567352623|FG001|Core Study|Adverse Event|3|||
157166940|NCT00424346|567352624|FG002|Core Study|Adverse Event|1|||
157166941|NCT00424346|567352625|FG003|Core Study|Adverse Event|1|||
157166942|NCT00424346|567352622|FG000|Core Study|Abnormal Laboratory Values|0|||
157166943|NCT00424346|567352623|FG001|Core Study|Abnormal Laboratory Values|1|||
157166944|NCT00424346|567352624|FG002|Core Study|Abnormal Laboratory Values|0|||
157166945|NCT00424346|567352625|FG003|Core Study|Abnormal Laboratory Values|0|||
157166946|NCT00424346|567352622|FG000|Core Study|Lack of Efficacy|1|||
157166947|NCT00424346|567352623|FG001|Core Study|Lack of Efficacy|3|||
157166948|NCT00424346|567352624|FG002|Core Study|Lack of Efficacy|0|||
156932045|NCT01023581|566511258|FG001|Overall Study|Adverse Event|4|||
157029671|NCT02240238|566864941|FG004|Phase 1|Withdrawal by Subject|0|||
157029672|NCT02240238|566864942|FG005|Phase 1|Withdrawal by Subject|2|||
156932046|NCT01023581|566511259|FG002|Overall Study|Adverse Event|7|||
156932047|NCT01023581|566511260|FG003|Overall Study|Adverse Event|3|||
156932048|NCT01023581|566511261|FG004|Overall Study|Adverse Event|2|||
156932049|NCT01023581|566511262|FG005|Overall Study|Adverse Event|5|||
156932050|NCT01023581|566511263|FG006|Overall Study|Adverse Event|11|||
156932051|NCT01023581|566511257|FG000|Overall Study|Major protocol deviation|2|||
156932052|NCT01023581|566511258|FG001|Overall Study|Major protocol deviation|0|||
156932053|NCT01023581|566511259|FG002|Overall Study|Major protocol deviation|3|||
156932054|NCT01023581|566511260|FG003|Overall Study|Major protocol deviation|0|||
156932055|NCT01023581|566511261|FG004|Overall Study|Major protocol deviation|0|||
156932056|NCT01023581|566511262|FG005|Overall Study|Major protocol deviation|0|||
156932057|NCT01023581|566511263|FG006|Overall Study|Major protocol deviation|0|||
156932058|NCT01023581|566511257|FG000|Overall Study|Lost to Follow-up|4|||
156932059|NCT01023581|566511258|FG001|Overall Study|Lost to Follow-up|8|||
156932060|NCT01023581|566511259|FG002|Overall Study|Lost to Follow-up|7|||
156932061|NCT01023581|566511260|FG003|Overall Study|Lost to Follow-up|2|||
156932062|NCT01023581|566511261|FG004|Overall Study|Lost to Follow-up|5|||
156932063|NCT01023581|566511262|FG005|Overall Study|Lost to Follow-up|2|||
156932064|NCT01023581|566511263|FG006|Overall Study|Lost to Follow-up|2|||
156932065|NCT01023581|566511257|FG000|Overall Study|Withdrawal by Subject|13|||
156932066|NCT01023581|566511258|FG001|Overall Study|Withdrawal by Subject|8|||
156932067|NCT01023581|566511259|FG002|Overall Study|Withdrawal by Subject|16|||
156932068|NCT01023581|566511260|FG003|Overall Study|Withdrawal by Subject|10|||
156932069|NCT01023581|566511261|FG004|Overall Study|Withdrawal by Subject|6|||
156932070|NCT01023581|566511262|FG005|Overall Study|Withdrawal by Subject|8|||
156932071|NCT01023581|566511263|FG006|Overall Study|Withdrawal by Subject|5|||
156932072|NCT01023581|566511257|FG000|Overall Study|Pregnancy|0|||
156932073|NCT01023581|566511258|FG001|Overall Study|Pregnancy|0|||
156932074|NCT01023581|566511259|FG002|Overall Study|Pregnancy|0|||
156932075|NCT01023581|566511260|FG003|Overall Study|Pregnancy|2|||
156932076|NCT01023581|566511261|FG004|Overall Study|Pregnancy|0|||
156932077|NCT01023581|566511262|FG005|Overall Study|Pregnancy|1|||
156932078|NCT01023581|566511263|FG006|Overall Study|Pregnancy|0|||
156932079|NCT01023581|566511257|FG000|Overall Study|Lack of Efficacy|9|||
156932080|NCT01023581|566511258|FG001|Overall Study|Lack of Efficacy|3|||
156932081|NCT01023581|566511259|FG002|Overall Study|Lack of Efficacy|6|||
156932082|NCT01023581|566511260|FG003|Overall Study|Lack of Efficacy|2|||
156932083|NCT01023581|566511261|FG004|Overall Study|Lack of Efficacy|1|||
156932084|NCT01023581|566511262|FG005|Overall Study|Lack of Efficacy|2|||
156932085|NCT01023581|566511263|FG006|Overall Study|Lack of Efficacy|1|||
156932086|NCT01023581|566511257|FG000|Overall Study|Physician Decision|2|||
156932087|NCT01023581|566511258|FG001|Overall Study|Physician Decision|0|||
156932088|NCT01023581|566511259|FG002|Overall Study|Physician Decision|2|||
156932089|NCT01023581|566511260|FG003|Overall Study|Physician Decision|1|||
156932090|NCT01023581|566511261|FG004|Overall Study|Physician Decision|1|||
156932091|NCT01023581|566511262|FG005|Overall Study|Physician Decision|1|||
156932092|NCT01023581|566511263|FG006|Overall Study|Physician Decision|1|||
156932093|NCT01023581|566511257|FG000|Overall Study|Other|1|||
156932094|NCT01023581|566511258|FG001|Overall Study|Other|0|||
156932095|NCT01023581|566511259|FG002|Overall Study|Other|1|||
156932096|NCT01023581|566511260|FG003|Overall Study|Other|0|||
156932097|NCT01023581|566511261|FG004|Overall Study|Other|1|||
156932098|NCT01023581|566511262|FG005|Overall Study|Other|0|||
156932099|NCT01023581|566511263|FG006|Overall Study|Other|0|||
156932100|NCT01176292|566511267|FG000|Overall Study|Lost to Follow-up|2|||
156932101|NCT01176292|566511268|FG001|Overall Study|Lost to Follow-up|4|||
156932102|NCT01176292|566511267|FG000|Overall Study|Adverse Event|1|||
156932103|NCT01176292|566511268|FG001|Overall Study|Adverse Event|1|||
156932104|NCT01176292|566511267|FG000|Overall Study|Physician Decision|0|||
156932105|NCT01176292|566511268|FG001|Overall Study|Physician Decision|2|||
156932106|NCT01176292|566511267|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
156932107|NCT01176292|566511268|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
156932108|NCT00380393|566511269|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
156932109|NCT00380393|566511270|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
156932110|NCT00380393|566511269|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
156932111|NCT00380393|566511270|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
156932112|NCT00380393|566511269|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
156932113|NCT00380393|566511270|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
156932114|NCT00380393|566511269|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
156932115|NCT00380393|566511270|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
156932116|NCT00380393|566511269|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
156932117|NCT00380393|566511270|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
156932118|NCT00380393|566511269|FG000|Month 14|Withdrawal by Subject|9|||
156932119|NCT00380393|566511270|FG001|Month 14|Withdrawal by Subject|7|||
156932120|NCT00380393|566511269|FG000|Month 14|Death|1|||
156932121|NCT00380393|566511270|FG001|Month 14|Death|0|||
156932122|NCT00380393|566511269|FG000|Month 14|Lost to Follow-up|0|||
156932123|NCT00380393|566511270|FG001|Month 14|Lost to Follow-up|1|||
156932124|NCT00380393|566511269|FG000|Month 14|Migrated/moved from study area|39|||
156932125|NCT00380393|566511270|FG001|Month 14|Migrated/moved from study area|42|||
156932126|NCT00380393|566511269|FG000|Month 14|Protocol Violation|2|||
156932127|NCT00380393|566511270|FG001|Month 14|Protocol Violation|0|||
156932128|NCT00380393|566511269|FG000|Month 14|Others|6|||
156932129|NCT00380393|566511270|FG001|Month 14|Others|6|||
156932130|NCT02780804|566511271|FG000|Overall Study|Death|1|||
156932131|NCT02780804|566511272|FG001|Overall Study|Death|0|||
156932132|NCT02780804|566511273|FG002|Overall Study|Death|0|||
156932133|NCT02780804|566511271|FG000|Overall Study|Lack of Efficacy|5|||
156932134|NCT02780804|566511272|FG001|Overall Study|Lack of Efficacy|8|||
156932135|NCT02780804|566511273|FG002|Overall Study|Lack of Efficacy|4|||
156932136|NCT02780804|566511271|FG000|Overall Study|Physician Decision|0|||
156932137|NCT02780804|566511272|FG001|Overall Study|Physician Decision|0|||
156932138|NCT02780804|566511273|FG002|Overall Study|Physician Decision|2|||
156932139|NCT02780804|566511271|FG000|Overall Study|Withdrawal by Subject|0|||
156932140|NCT02780804|566511272|FG001|Overall Study|Withdrawal by Subject|1|||
156932141|NCT02780804|566511273|FG002|Overall Study|Withdrawal by Subject|0|||
156932142|NCT02476968|566511274|FG000|Overall Study|Other|0|||
156932143|NCT02476968|566511275|FG001|Overall Study|Other|2|||
156932144|NCT02476968|566511276|FG002|Overall Study|Other|0|||
156932145|NCT02476968|566511274|FG000|Overall Study|Lost to Follow-up|10|||
156932146|NCT02476968|566511275|FG001|Overall Study|Lost to Follow-up|0|||
156932147|NCT02476968|566511276|FG002|Overall Study|Lost to Follow-up|1|||
156932148|NCT02476968|566511274|FG000|Overall Study|Death|48|||
156932149|NCT02476968|566511275|FG001|Overall Study|Death|8|||
156932150|NCT02476968|566511276|FG002|Overall Study|Death|1|||
156932151|NCT02476968|566511274|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156932152|NCT02476968|566511275|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156932153|NCT02476968|566511276|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
156932154|NCT02476968|566511274|FG000|Overall Study|Patient decision|37|||
156932155|NCT02476968|566511275|FG001|Overall Study|Patient decision|8|||
156932156|NCT02476968|566511276|FG002|Overall Study|Patient decision|0|||
156932157|NCT04171414|566511279|FG000|Overall Study|Death|1|||
156932158|NCT04171414|566511279|FG000|Overall Study|Withdrawal by Subject|1|||
156932159|NCT02586493|566511282|FG000|Overall Study|Adverse Event|4|||
156932160|NCT02586493|566511282|FG000|Overall Study|Protocol Violation|6|||
156932161|NCT02586493|566511282|FG000|Overall Study|Lost to Follow-up|1|||
156932162|NCT02586493|566511282|FG000|Overall Study|Withdrawal by Subject|1|||
156932163|NCT02211131|566511289|FG000|Overall Study|Death|26|||
156932164|NCT02211131|566511290|FG001|Overall Study|Death|16|||
156932165|NCT02211131|566511289|FG000|Overall Study|Lost to Follow-up|4|||
156932166|NCT02211131|566511290|FG001|Overall Study|Lost to Follow-up|3|||
156932167|NCT02211131|566511289|FG000|Overall Study|Decision by Sponsor|1|||
156932168|NCT02211131|566511290|FG001|Overall Study|Decision by Sponsor|1|||
156932169|NCT02211131|566511289|FG000|Overall Study|Withdrawal by Subject|3|||
156932170|NCT02211131|566511290|FG001|Overall Study|Withdrawal by Subject|8|||
156932171|NCT05664490|566511291|FG000|Overall Study|Withdrawal by Subject|0|||
156932172|NCT05664490|566511292|FG001|Overall Study|Withdrawal by Subject|1|||
156932173|NCT05664490|566511291|FG000|Overall Study|Lost to Follow-up|14|||
156932174|NCT05664490|566511292|FG001|Overall Study|Lost to Follow-up|22|||
156932175|NCT01928862|566511297|FG000|Overall Study|Lost to Follow-up|1|||
156932176|NCT01928862|566511298|FG001|Overall Study|Lost to Follow-up|0|||
156932177|NCT01928862|566511299|FG002|Overall Study|Lost to Follow-up|0|||
156932178|NCT01928862|566511300|FG003|Overall Study|Lost to Follow-up|0|||
156932179|NCT01928862|566511301|FG004|Overall Study|Lost to Follow-up|1|||
156932180|NCT01478321|566511305|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
156932181|NCT01478321|566511305|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
156932182|NCT01478321|566511305|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
156932183|NCT01478321|566511305|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
156932184|NCT01478321|566511305|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
156932185|NCT01478321|566511305|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
156932186|NCT01478321|566511305|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
156932187|NCT01478321|566511305|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
156932188|NCT02063737|566511312|FG000|Overall Study|Lost to Follow-up|11|||
156932189|NCT02063737|566511313|FG001|Overall Study|Lost to Follow-up|4|||
157029673|NCT02240238|566864943|FG006|Phase 1|Withdrawal by Subject|0|||
156932190|NCT00850395|566511320|FG000|Overall Study|Death|1|||
156932191|NCT00850395|566511320|FG000|Overall Study|Adverse Event|1|||
156932192|NCT00850395|566511320|FG000|Overall Study|Insufficient clinical response|3|||
156932193|NCT00850395|566511320|FG000|Overall Study|Other|5|||
156932194|NCT00129129|566511321|FG000|Primary Phase|Adverse Event|2|||
156932195|NCT00129129|566511322|FG001|Primary Phase|Adverse Event|1|||
156932196|NCT00129129|566511323|FG002|Primary Phase|Adverse Event|0|||
156932197|NCT00129129|566511324|FG003|Primary Phase|Adverse Event|0|||
156932198|NCT00129129|566511325|FG004|Primary Phase|Adverse Event|0|||
156932199|NCT00129129|566511321|FG000|Primary Phase|Withdrawal by Subject|12|||
156932200|NCT00129129|566511322|FG001|Primary Phase|Withdrawal by Subject|10|||
156932201|NCT00129129|566511323|FG002|Primary Phase|Withdrawal by Subject|0|||
156932202|NCT00129129|566511324|FG003|Primary Phase|Withdrawal by Subject|0|||
156932203|NCT00129129|566511325|FG004|Primary Phase|Withdrawal by Subject|0|||
156932204|NCT00129129|566511321|FG000|Primary Phase|Migration from study area|1|||
156932205|NCT00129129|566511322|FG001|Primary Phase|Migration from study area|3|||
156932206|NCT00129129|566511323|FG002|Primary Phase|Migration from study area|0|||
156932207|NCT00129129|566511324|FG003|Primary Phase|Migration from study area|0|||
156932208|NCT00129129|566511325|FG004|Primary Phase|Migration from study area|0|||
156932209|NCT00129129|566511321|FG000|Primary Phase|Lost to Follow-up|8|||
156932210|NCT00129129|566511322|FG001|Primary Phase|Lost to Follow-up|6|||
156932211|NCT00129129|566511323|FG002|Primary Phase|Lost to Follow-up|0|||
156932212|NCT00129129|566511324|FG003|Primary Phase|Lost to Follow-up|0|||
156932213|NCT00129129|566511325|FG004|Primary Phase|Lost to Follow-up|0|||
156932214|NCT00129129|566511321|FG000|Primary Phase|Other|2|||
156932215|NCT00129129|566511322|FG001|Primary Phase|Other|5|||
156932216|NCT00129129|566511323|FG002|Primary Phase|Other|0|||
156932217|NCT00129129|566511324|FG003|Primary Phase|Other|0|||
156932218|NCT00129129|566511325|FG004|Primary Phase|Other|0|||
156932219|NCT00129129|566511321|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
156932220|NCT00129129|566511322|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
156932221|NCT00129129|566511323|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
156932222|NCT00129129|566511324|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
156932223|NCT00129129|566511325|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
156932224|NCT00129129|566511321|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
156932225|NCT00129129|566511322|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
156932226|NCT00129129|566511323|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
156932227|NCT00129129|566511324|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
156932228|NCT00129129|566511325|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
156932229|NCT00129129|566511321|FG000|Fourth Dose Phase|Migration from study area|0|||
156932230|NCT00129129|566511322|FG001|Fourth Dose Phase|Migration from study area|0|||
156932231|NCT00129129|566511323|FG002|Fourth Dose Phase|Migration from study area|0|||
156932232|NCT00129129|566511324|FG003|Fourth Dose Phase|Migration from study area|0|||
156932233|NCT00129129|566511325|FG004|Fourth Dose Phase|Migration from study area|2|||
156932234|NCT00129129|566511321|FG000|Fourth Dose Phase|Other|0|||
156932235|NCT00129129|566511322|FG001|Fourth Dose Phase|Other|0|||
156932236|NCT00129129|566511323|FG002|Fourth Dose Phase|Other|0|||
156932237|NCT00129129|566511324|FG003|Fourth Dose Phase|Other|1|||
156932238|NCT00129129|566511325|FG004|Fourth Dose Phase|Other|1|||
156932239|NCT00129129|566511321|FG000|Fourth Dose Phase|Protocol Violation|0|||
156932240|NCT00129129|566511322|FG001|Fourth Dose Phase|Protocol Violation|0|||
156932241|NCT00129129|566511323|FG002|Fourth Dose Phase|Protocol Violation|0|||
156932242|NCT00129129|566511324|FG003|Fourth Dose Phase|Protocol Violation|1|||
156932243|NCT00129129|566511325|FG004|Fourth Dose Phase|Protocol Violation|0|||
156932244|NCT00335972|566511326|FG000|Overall Study|not given treatments|0|||
156932245|NCT00335972|566511327|FG001|Overall Study|not given treatments|3|||
156932246|NCT02140567|566511333|FG000|Overall Study|Problems with recording equipment|6|||
156932247|NCT02802592|566511334|FG000|Overall Study|Study terminated due to loss of funding|4|||
156932248|NCT02882854|566511335|FG000|Overall Study|Lost to Follow-up|1|||
156932249|NCT02882854|566511336|FG001|Overall Study|Lost to Follow-up|2|||
156932250|NCT02882854|566511335|FG000|Overall Study|Physician Decision|0|||
156932251|NCT02882854|566511336|FG001|Overall Study|Physician Decision|1|||
156932252|NCT03774433|566511337|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
156932253|NCT00108160|566511338|FG000|Overall Study|Lost to Follow-up|25|||
156932254|NCT00108160|566511339|FG001|Overall Study|Lost to Follow-up|12|||
156932255|NCT00108160|566511338|FG000|Overall Study|Death|1|||
156932256|NCT00108160|566511339|FG001|Overall Study|Death|2|||
156932257|NCT00108160|566511338|FG000|Overall Study|Withdrawal by Subject|4|||
156932258|NCT00108160|566511339|FG001|Overall Study|Withdrawal by Subject|2|||
156932259|NCT00108160|566511338|FG000|Overall Study|Protocol Violation|9|||
156932260|NCT00108160|566511339|FG001|Overall Study|Protocol Violation|5|||
156932261|NCT02171260|566511340|FG000|Overall Study|Death|0|||
156932262|NCT02171260|566511341|FG001|Overall Study|Death|0|||
156932263|NCT02171260|566511342|FG002|Overall Study|Death|0|||
156932264|NCT02171260|566511343|FG003|Overall Study|Death|1|||
156932265|NCT02171260|566511340|FG000|Overall Study|Physician Decision|1|||
156932266|NCT02171260|566511341|FG001|Overall Study|Physician Decision|0|||
156932267|NCT02171260|566511342|FG002|Overall Study|Physician Decision|1|||
156932268|NCT02171260|566511343|FG003|Overall Study|Physician Decision|0|||
156932269|NCT02171260|566511340|FG000|Overall Study|Withdrawal by Subject|1|||
156932270|NCT02171260|566511341|FG001|Overall Study|Withdrawal by Subject|0|||
156932271|NCT02171260|566511342|FG002|Overall Study|Withdrawal by Subject|0|||
156932272|NCT02171260|566511343|FG003|Overall Study|Withdrawal by Subject|0|||
156932273|NCT02171260|566511340|FG000|Overall Study|Evidence of progressive disease|4|||
156932274|NCT02171260|566511341|FG001|Overall Study|Evidence of progressive disease|6|||
156932275|NCT02171260|566511342|FG002|Overall Study|Evidence of progressive disease|4|||
156932276|NCT02171260|566511343|FG003|Overall Study|Evidence of progressive disease|4|||
156932277|NCT01466387|566511346|FG000|Overall Study|Adverse Event|0|||
156932278|NCT01466387|566511347|FG001|Overall Study|Adverse Event|0|||
156932279|NCT01466387|566511348|FG002|Overall Study|Adverse Event|1|||
156932280|NCT01466387|566511349|FG003|Overall Study|Adverse Event|1|||
156932281|NCT01466387|566511350|FG004|Overall Study|Adverse Event|0|||
156932282|NCT01466387|566511351|FG005|Overall Study|Adverse Event|0|||
156932283|NCT01466387|566511346|FG000|Overall Study|Lost to Follow-up|0|||
156932284|NCT01466387|566511347|FG001|Overall Study|Lost to Follow-up|0|||
156932285|NCT01466387|566511348|FG002|Overall Study|Lost to Follow-up|0|||
156932286|NCT01466387|566511349|FG003|Overall Study|Lost to Follow-up|0|||
156932287|NCT01466387|566511350|FG004|Overall Study|Lost to Follow-up|0|||
156932288|NCT01466387|566511351|FG005|Overall Study|Lost to Follow-up|1|||
156932289|NCT01466387|566511346|FG000|Overall Study|Protocol Violation|1|||
156932290|NCT01466387|566511347|FG001|Overall Study|Protocol Violation|0|||
156932291|NCT01466387|566511348|FG002|Overall Study|Protocol Violation|0|||
156932292|NCT01466387|566511349|FG003|Overall Study|Protocol Violation|1|||
156932293|NCT01466387|566511350|FG004|Overall Study|Protocol Violation|0|||
156932294|NCT01466387|566511351|FG005|Overall Study|Protocol Violation|0|||
156932295|NCT01319877|566511352|FG000|Overall Study|Lost to Follow-up|100|||
156932296|NCT01319877|566511353|FG001|Overall Study|Lost to Follow-up|37|||
156932297|NCT01319877|566511352|FG000|Overall Study|Physician Decision|2|||
156932298|NCT01319877|566511353|FG001|Overall Study|Physician Decision|0|||
156932299|NCT01319877|566511352|FG000|Overall Study|Disease Progression|2|||
156932300|NCT01319877|566511353|FG001|Overall Study|Disease Progression|2|||
156932301|NCT01319877|566511352|FG000|Overall Study|Withdrawal by Subject|0|||
156932302|NCT01319877|566511353|FG001|Overall Study|Withdrawal by Subject|1|||
156932303|NCT01319877|566511352|FG000|Overall Study|Reason Not Specified|4|||
156932304|NCT01319877|566511353|FG001|Overall Study|Reason Not Specified|5|||
156932305|NCT02347189|566511356|FG000|Overall Study|No implant attempted of study device|9|||
156932306|NCT02347189|566511356|FG000|Overall Study|No primary outcome data available|2|||
156932307|NCT02677987|566511358|FG000|Overall Study|Withdrawal by Subject|3|||
156932308|NCT02677987|566511359|FG001|Overall Study|Withdrawal by Subject|0|||
156932309|NCT02677987|566511358|FG000|Overall Study|Lost to Follow-up|1|||
156932310|NCT02677987|566511359|FG001|Overall Study|Lost to Follow-up|0|||
156932311|NCT00673179|566511360|FG000|Overall Study|Toxicity/Complications|3|||
156932312|NCT00673179|566511361|FG001|Overall Study|Toxicity/Complications|0|||
156932313|NCT00352846|566511362|FG000|Overall Study|Disease progression|0|||
156932314|NCT00352846|566511363|FG001|Overall Study|Disease progression|2|||
156932315|NCT00352846|566511362|FG000|Overall Study|Withdrawal by Subject|3|||
156932316|NCT00352846|566511363|FG001|Overall Study|Withdrawal by Subject|8|||
156932317|NCT00352846|566511362|FG000|Overall Study|Ineligible|3|||
156932318|NCT00352846|566511363|FG001|Overall Study|Ineligible|2|||
156932319|NCT00352846|566511362|FG000|Overall Study|Non-compliance|2|||
156932320|NCT00352846|566511363|FG001|Overall Study|Non-compliance|0|||
156932321|NCT00352846|566511362|FG000|Overall Study|Death|0|||
156932322|NCT00352846|566511363|FG001|Overall Study|Death|1|||
156932323|NCT01527682|566511364|FG000|Overall Study|Protocol Violation|8|||
156932324|NCT04668950|566511366|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
156932325|NCT04668950|566511367|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
156932326|NCT04668950|566511366|FG000|Overall Study|Could not confirm started study medication|15|||
156932327|NCT04668950|566511367|FG001|Overall Study|Could not confirm started study medication|15|||
156932328|NCT04668950|566511366|FG000|Overall Study|Could not confirm baseline status|6|||
156932329|NCT04668950|566511367|FG001|Overall Study|Could not confirm baseline status|2|||
156932330|NCT04668950|566511366|FG000|Overall Study|Drop out and did not start medication|15|||
156932331|NCT04668950|566511367|FG001|Overall Study|Drop out and did not start medication|17|||
156932332|NCT04668950|566511366|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
156932333|NCT04668950|566511367|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
156932334|NCT04668950|566511366|FG000|Overall Study|Other|2|||
156932335|NCT04668950|566511367|FG001|Overall Study|Other|4|||
156932336|NCT01531387|566511368|FG000|Overall Study|Early termination of study|11|||
156932337|NCT01531387|566511369|FG001|Overall Study|Early termination of study|11|||
156932338|NCT01124643|566511370|FG000|Overall Study|Death|1|||
156932339|NCT04220411|566511371|FG000|Overall Study|Adverse Event|0|||
156932340|NCT04220411|566511372|FG001|Overall Study|Adverse Event|0|||
156932341|NCT04220411|566511373|FG002|Overall Study|Adverse Event|0|||
156932342|NCT04220411|566511374|FG003|Overall Study|Adverse Event|1|||
156932343|NCT02680639|566511375|FG000|Screening Period|Screen Failure|7|||
156932344|NCT02680639|566511376|FG001|Screening Period|Screen Failure|0|||
156932345|NCT02680639|566511377|FG002|Screening Period|Screen Failure|0|||
156932346|NCT02678676|566511378|FG000|Overall Study|Death|619|||
156932347|NCT02678676|566511379|FG001|Overall Study|Death|649|||
156932348|NCT02678676|566511378|FG000|Overall Study|Withdrawal by Subject|13|||
156932349|NCT02678676|566511379|FG001|Overall Study|Withdrawal by Subject|5|||
156932350|NCT02678676|566511378|FG000|Overall Study|Lost to Follow-up|171|||
156932351|NCT02678676|566511379|FG001|Overall Study|Lost to Follow-up|151|||
156932352|NCT02678676|566511378|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
156932353|NCT02678676|566511379|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
156932354|NCT00323115|566511383|FG000|Vaccine Administration|Adverse Event|1|||
156932355|NCT00323115|566511383|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
156932356|NCT04365556|566511384|FG000|Overall Study|No longer eligible due to treatment plan|1|||
156932357|NCT04365556|566511385|FG001|Overall Study|No longer eligible due to treatment plan|0|||
156932358|NCT04365556|566511384|FG000|Overall Study|Lost to Follow-up|3|||
156932359|NCT04365556|566511385|FG001|Overall Study|Lost to Follow-up|2|||
156932360|NCT04837131|566511386|FG000|Overall Study|Death|1|||
156932361|NCT04837131|566511386|FG000|Overall Study|Withdrawal by Subject|1|||
156932362|NCT04837131|566511386|FG000|Overall Study|Adverse Event|1|||
156932363|NCT04837131|566511386|FG000|Overall Study|Protocol Violation|1|||
156932364|NCT04439318|566511387|FG000|Overall Study|Ineligible|1|||
156932365|NCT04439318|566511387|FG000|Overall Study|Never Started Treatment|3|||
156932366|NCT04439318|566511387|FG000|Overall Study|Adverse Event|10|||
156932367|NCT04439318|566511387|FG000|Overall Study|Death|2|||
156932368|NCT04439318|566511387|FG000|Overall Study|Disease Progression|25|||
156932369|NCT04439318|566511387|FG000|Overall Study|Other Complicating Disease|2|||
156932370|NCT04439318|566511387|FG000|Overall Study|Withdrawal by Subject|4|||
156932371|NCT04439318|566511387|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
156932372|NCT04439318|566511387|FG000|Overall Study|Non-Compliance|1|||
156932373|NCT04439318|566511387|FG000|Overall Study|Still on Treatment|1|||
156932374|NCT03256552|566512956|FG000|Overall Study|Protocol Violation|1|||
156932375|NCT03256552|566512956|FG000|Overall Study|Physician Decision|1|||
156932376|NCT03256552|566512956|FG000|Overall Study|Adverse Event|1|||
156932377|NCT03256552|566512956|FG000|Overall Study|Withdrawal by Subject|2|||
156932378|NCT02268409|566512961|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
156932379|NCT02268409|566512961|FG000|Overall Study|Death|1|||
156932380|NCT02268409|566512961|FG000|Overall Study|Lost to Follow-up|1|||
156932381|NCT02268409|566512961|FG000|Overall Study|Protocol Violation|3|||
156932382|NCT02268409|566512961|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
156932383|NCT02268409|566512961|FG000|Overall Study|Withdrawal by Subject|5|||
156932384|NCT00427635|566512962|FG000|Treatment Phase|Withdrawal by Subject|1|||
156932385|NCT00427635|566512963|FG001|Treatment Phase|Withdrawal by Subject|0|||
156932386|NCT00427635|566512962|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
156932387|NCT00427635|566512963|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
156932388|NCT00838201|566512966|FG000|Overall Study|Investigator decision, or other reasons|2|||
156932389|NCT00838201|566512967|FG001|Overall Study|Investigator decision, or other reasons|3|||
156932390|NCT00838201|566512966|FG000|Overall Study|Noncompliance|0|||
156932391|NCT00838201|566512967|FG001|Overall Study|Noncompliance|1|||
156932392|NCT00838201|566512966|FG000|Overall Study|Administrative decision|1|||
156932393|NCT00838201|566512967|FG001|Overall Study|Administrative decision|2|||
156932394|NCT00838201|566512966|FG000|Overall Study|Disease progression|3|||
156932395|NCT00838201|566512967|FG001|Overall Study|Disease progression|3|||
156932396|NCT00838201|566512966|FG000|Overall Study|Consent withdrawn|16|||
156932397|NCT00838201|566512967|FG001|Overall Study|Consent withdrawn|19|||
156932398|NCT00838201|566512966|FG000|Overall Study|Lost to Follow-up|4|||
156932399|NCT00838201|566512967|FG001|Overall Study|Lost to Follow-up|3|||
156932400|NCT00838201|566512966|FG000|Overall Study|Adverse Event|5|||
156932401|NCT00838201|566512967|FG001|Overall Study|Adverse Event|9|||
156932402|NCT00838201|566512966|FG000|Overall Study|Death|11|||
156932403|NCT00838201|566512967|FG001|Overall Study|Death|13|||
156932404|NCT00489853|566512968|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
156932405|NCT00489853|566512969|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
156932406|NCT00489853|566512970|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
156932407|NCT00489853|566512968|FG000|Wash-out Period 1|Adverse Event|0|||
156932408|NCT00489853|566512969|FG001|Wash-out Period 1|Adverse Event|1|||
156932409|NCT00489853|566512970|FG002|Wash-out Period 1|Adverse Event|1|||
156932410|NCT00489853|566512968|FG000|Wash-out Period 1|Protocol Violation|0|||
156932411|NCT00489853|566512969|FG001|Wash-out Period 1|Protocol Violation|1|||
156932412|NCT00489853|566512970|FG002|Wash-out Period 1|Protocol Violation|1|||
156932413|NCT00489853|566512968|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
156932414|NCT00489853|566512969|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
156932415|NCT00489853|566512970|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
156932416|NCT00489853|566512968|FG000|Wash-out Period 2|Adverse Event|1|||
157166949|NCT00424346|567352625|FG003|Core Study|Lack of Efficacy|4|||
157166950|NCT00424346|567352622|FG000|Core Study|Withdrawal by Subject|1|||
157166951|NCT00424346|567352623|FG001|Core Study|Withdrawal by Subject|0|||
156932417|NCT00489853|566512969|FG001|Wash-out Period 2|Adverse Event|1|||
156932418|NCT00489853|566512970|FG002|Wash-out Period 2|Adverse Event|0|||
156932419|NCT00489853|566512968|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
156932420|NCT00489853|566512969|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
156932421|NCT00489853|566512970|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
156932422|NCT00489853|566512968|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
156932423|NCT00489853|566512969|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
156932424|NCT00489853|566512970|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
156932425|NCT00136084|566512971|FG000|Overall Study|Death|12|||
156932426|NCT00136084|566512972|FG001|Overall Study|Death|5|||
156932427|NCT00136084|566512971|FG000|Overall Study|Unacceptable toxicity|8|||
156932428|NCT00136084|566512972|FG001|Overall Study|Unacceptable toxicity|11|||
156932429|NCT00136084|566512971|FG000|Overall Study|Relapse|20|||
156932430|NCT00136084|566512972|FG001|Overall Study|Relapse|23|||
156932431|NCT00136084|566512971|FG000|Overall Study|Lost to Follow-up|2|||
156932432|NCT00136084|566512972|FG001|Overall Study|Lost to Follow-up|0|||
156932433|NCT00136084|566512971|FG000|Overall Study|No Response|1|||
156932434|NCT00136084|566512972|FG001|Overall Study|No Response|2|||
156932435|NCT00136084|566512971|FG000|Overall Study|Withdrawal by Subject|5|||
156932436|NCT00136084|566512972|FG001|Overall Study|Withdrawal by Subject|1|||
156932437|NCT00997503|566512973|FG000|Overall Study|Death|53|||
156932438|NCT00997503|566512973|FG000|Overall Study|Withdrawal by Subject|76|||
156932439|NCT00997503|566512973|FG000|Overall Study|Lost to Follow-up|33|||
156932440|NCT00997503|566512973|FG000|Overall Study|Adverse Event|3|||
156932441|NCT00997503|566512973|FG000|Overall Study|Physician Decision|10|||
156932442|NCT00997503|566512973|FG000|Overall Study|Missed 12-month follow-up|85|||
156932443|NCT00997503|566512973|FG000|Overall Study|Other reason|13|||
156932444|NCT01933048|566512974|FG000|Overall Study|Lost to Follow-up|15|||
156932445|NCT01933048|566512975|FG001|Overall Study|Lost to Follow-up|18|||
156932446|NCT01933048|566512974|FG000|Overall Study|personal reasons|1|||
156932447|NCT01933048|566512975|FG001|Overall Study|personal reasons|1|||
156932448|NCT01933048|566512974|FG000|Overall Study|Protocol Violation|7|||
156932449|NCT01933048|566512975|FG001|Overall Study|Protocol Violation|8|||
156932450|NCT01933048|566512974|FG000|Overall Study|Physician Decision|1|||
156932451|NCT01933048|566512975|FG001|Overall Study|Physician Decision|0|||
156932452|NCT01933048|566512974|FG000|Overall Study|unknown reasons|1|||
156932453|NCT01933048|566512975|FG001|Overall Study|unknown reasons|1|||
156932454|NCT02487394|566512979|FG000|Phase 1|Withdrawal by Subject|0|||
156932455|NCT02487394|566512980|FG001|Phase 1|Withdrawal by Subject|1|||
156932456|NCT00218296|566512983|FG000|Overall Study|Lost to Follow-up|9|||
156932457|NCT00218296|566512984|FG001|Overall Study|Lost to Follow-up|7|||
156932458|NCT00218296|566512983|FG000|Overall Study|Withdrawal by Subject|36|||
156932459|NCT00218296|566512984|FG001|Overall Study|Withdrawal by Subject|47|||
156932460|NCT00218296|566512983|FG000|Overall Study|Randomized but did not enter treatment|66|||
156932461|NCT00218296|566512984|FG001|Overall Study|Randomized but did not enter treatment|67|||
156932462|NCT00278954|566512995|FG000|Overall Study|Adverse Event|3|||
156932463|NCT00278954|566512995|FG000|Overall Study|Lost to Follow-up|1|||
156932464|NCT00278954|566512995|FG000|Overall Study|Withdrawal by Subject|1|||
156932465|NCT01589445|566512999|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
156932466|NCT01589445|566512999|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
156932467|NCT01589445|566512999|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
156932468|NCT01589445|566512999|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
156932469|NCT01589445|566512999|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
156932470|NCT01589445|566512999|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
156932471|NCT01589445|566512999|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
156932472|NCT01589445|566512999|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
156932473|NCT01589445|566512999|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
156932474|NCT01589445|566512999|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
156932475|NCT01990495|566513000|FG000|Overall Study|Physician Decision|5|||
156932476|NCT01990495|566513001|FG001|Overall Study|Physician Decision|4|||
156932477|NCT03412084|566513002|FG000|Overall Study|Withdrawal by Subject|2|||
156932478|NCT03412084|566513003|FG001|Overall Study|Withdrawal by Subject|0|||
156932479|NCT03412084|566513002|FG000|Overall Study|Participant moved|1|||
156932480|NCT03412084|566513003|FG001|Overall Study|Participant moved|0|||
156932481|NCT03412084|566513002|FG000|Overall Study|Lost to Follow-up|1|||
156932482|NCT03412084|566513003|FG001|Overall Study|Lost to Follow-up|1|||
156932483|NCT00314574|566513008|FG000|Overall Study|Death|3|||
156932484|NCT00314574|566513009|FG001|Overall Study|Death|0|||
156932485|NCT00314574|566513008|FG000|Overall Study|Adverse Event|11|||
156932486|NCT00314574|566513009|FG001|Overall Study|Adverse Event|16|||
156932487|NCT00314574|566513008|FG000|Overall Study|Lost to Follow-up|19|||
156932488|NCT00314574|566513009|FG001|Overall Study|Lost to Follow-up|25|||
156932489|NCT00314574|566513008|FG000|Overall Study|Withdrawal by Subject|33|||
156932490|NCT00314574|566513009|FG001|Overall Study|Withdrawal by Subject|22|||
156932491|NCT00314574|566513008|FG000|Overall Study|Physician Decision|22|||
156932492|NCT00314574|566513009|FG001|Overall Study|Physician Decision|15|||
156932493|NCT00314574|566513008|FG000|Overall Study|Pregnancy|6|||
156932494|NCT00314574|566513009|FG001|Overall Study|Pregnancy|4|||
156932495|NCT00314574|566513008|FG000|Overall Study|Data unknown at database lock|0|||
157166952|NCT00424346|567352624|FG002|Core Study|Withdrawal by Subject|0|||
156932496|NCT00314574|566513009|FG001|Overall Study|Data unknown at database lock|1|||
156932497|NCT02053753|566513010|FG000|Overall Study|Withdrawal by Subject|2|||
156932498|NCT02053753|566513011|FG001|Overall Study|Withdrawal by Subject|4|||
156932499|NCT02053753|566513010|FG000|Overall Study|Decision by Sponsor|1|||
156932500|NCT02053753|566513011|FG001|Overall Study|Decision by Sponsor|1|||
156932501|NCT02053753|566513010|FG000|Overall Study|Lost to Follow-up|4|||
156932502|NCT02053753|566513011|FG001|Overall Study|Lost to Follow-up|3|||
156932503|NCT00449956|566513012|FG000|Overall Study|Adverse Event|7|||
156932504|NCT00449956|566513013|FG001|Overall Study|Adverse Event|1|||
156932505|NCT00449956|566513014|FG002|Overall Study|Adverse Event|6|||
156932506|NCT00449956|566513012|FG000|Overall Study|Lack of Efficacy|0|||
156932507|NCT00449956|566513013|FG001|Overall Study|Lack of Efficacy|0|||
156932508|NCT00449956|566513014|FG002|Overall Study|Lack of Efficacy|1|||
156932509|NCT00449956|566513012|FG000|Overall Study|Protocol Violation|1|||
156932510|NCT00449956|566513013|FG001|Overall Study|Protocol Violation|1|||
156932511|NCT00449956|566513014|FG002|Overall Study|Protocol Violation|1|||
156932512|NCT00449956|566513012|FG000|Overall Study|Withdrawal by Subject|0|||
156932513|NCT00449956|566513013|FG001|Overall Study|Withdrawal by Subject|1|||
156932514|NCT00449956|566513014|FG002|Overall Study|Withdrawal by Subject|0|||
156932515|NCT00449956|566513012|FG000|Overall Study|Physician Decision|2|||
156932516|NCT00449956|566513013|FG001|Overall Study|Physician Decision|1|||
156932517|NCT00449956|566513014|FG002|Overall Study|Physician Decision|1|||
156932518|NCT01828034|566513026|FG000|Overall Study|Withdrawal by Subject|0|||
156932519|NCT01828034|566513027|FG001|Overall Study|Withdrawal by Subject|0|||
156932520|NCT01828034|566513028|FG002|Overall Study|Withdrawal by Subject|0|||
156932521|NCT01828034|566513029|FG003|Overall Study|Withdrawal by Subject|1|||
156932522|NCT04064294|566513030|FG000|Overall Study|Adverse Event|1|||
156932523|NCT04064294|566513031|FG001|Overall Study|Adverse Event|0|||
156932524|NCT04064294|566513032|FG002|Overall Study|Adverse Event|0|||
156932525|NCT01988571|566513033|FG000|Overall Study|Death|3|||
156932526|NCT01988571|566513034|FG001|Overall Study|Death|1|||
156932527|NCT01988571|566513033|FG000|Overall Study|Physician Decision|2|||
156932528|NCT01988571|566513034|FG001|Overall Study|Physician Decision|1|||
156932529|NCT01988571|566513033|FG000|Overall Study|Lost to Follow-up|3|||
156932530|NCT01988571|566513034|FG001|Overall Study|Lost to Follow-up|0|||
156932531|NCT01988571|566513033|FG000|Overall Study|Withdrawal by Subject|31|||
156932532|NCT01988571|566513034|FG001|Overall Study|Withdrawal by Subject|33|||
156932533|NCT00481195|566513035|FG000|Overall Study|Adverse Event|16|||
156932534|NCT00481195|566513036|FG001|Overall Study|Adverse Event|11|||
156932535|NCT00481195|566513035|FG000|Overall Study|Lack of Efficacy|1|||
156932536|NCT00481195|566513036|FG001|Overall Study|Lack of Efficacy|3|||
156932537|NCT00481195|566513035|FG000|Overall Study|Lost to Follow-up|4|||
156932538|NCT00481195|566513036|FG001|Overall Study|Lost to Follow-up|6|||
156932539|NCT00481195|566513035|FG000|Overall Study|Physician Decision|3|||
156932540|NCT00481195|566513036|FG001|Overall Study|Physician Decision|1|||
156932541|NCT00481195|566513035|FG000|Overall Study|Protocol Violation|10|||
156932542|NCT00481195|566513036|FG001|Overall Study|Protocol Violation|7|||
156932543|NCT00481195|566513035|FG000|Overall Study|Withdrawal by Subject|3|||
156932544|NCT00481195|566513036|FG001|Overall Study|Withdrawal by Subject|9|||
156932545|NCT00481195|566513035|FG000|Overall Study|Miscellaneous|2|||
156932546|NCT00481195|566513036|FG001|Overall Study|Miscellaneous|2|||
156932547|NCT02932904|566513038|FG000|Overall Study|Reason not Specified|1|||
156932548|NCT02932904|566513039|FG001|Overall Study|Reason not Specified|0|||
156932549|NCT02932904|566513040|FG002|Overall Study|Reason not Specified|2|||
156932550|NCT02932904|566513041|FG003|Overall Study|Reason not Specified|2|||
156932551|NCT02932904|566513038|FG000|Overall Study|Noncompliance with Study Drug|2|||
156932552|NCT02932904|566513039|FG001|Overall Study|Noncompliance with Study Drug|3|||
156932553|NCT02932904|566513040|FG002|Overall Study|Noncompliance with Study Drug|3|||
156932554|NCT02932904|566513041|FG003|Overall Study|Noncompliance with Study Drug|4|||
156932555|NCT02932904|566513038|FG000|Overall Study|Pregnancy|0|||
156932556|NCT02932904|566513039|FG001|Overall Study|Pregnancy|1|||
156932557|NCT02932904|566513040|FG002|Overall Study|Pregnancy|1|||
156932558|NCT02932904|566513041|FG003|Overall Study|Pregnancy|0|||
156932559|NCT02932904|566513038|FG000|Overall Study|Study Termination|0|||
156932560|NCT02932904|566513039|FG001|Overall Study|Study Termination|1|||
156932561|NCT02932904|566513040|FG002|Overall Study|Study Termination|0|||
156932562|NCT02932904|566513041|FG003|Overall Study|Study Termination|0|||
156932563|NCT02932904|566513038|FG000|Overall Study|Voluntary Withdrawal|2|||
156932564|NCT02932904|566513039|FG001|Overall Study|Voluntary Withdrawal|1|||
156932565|NCT02932904|566513040|FG002|Overall Study|Voluntary Withdrawal|4|||
156932566|NCT02932904|566513041|FG003|Overall Study|Voluntary Withdrawal|2|||
156932567|NCT02932904|566513038|FG000|Overall Study|Lost to Follow-up|5|||
156932568|NCT02932904|566513039|FG001|Overall Study|Lost to Follow-up|3|||
156932569|NCT02932904|566513040|FG002|Overall Study|Lost to Follow-up|6|||
156932570|NCT02932904|566513041|FG003|Overall Study|Lost to Follow-up|0|||
156932571|NCT02932904|566513038|FG000|Overall Study|Significant Protocol Deviation|2|||
156932572|NCT02932904|566513039|FG001|Overall Study|Significant Protocol Deviation|3|||
156932573|NCT02932904|566513040|FG002|Overall Study|Significant Protocol Deviation|6|||
156932574|NCT02932904|566513041|FG003|Overall Study|Significant Protocol Deviation|1|||
156932575|NCT02932904|566513038|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156932576|NCT02932904|566513039|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
156932577|NCT02932904|566513040|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
156932578|NCT02932904|566513041|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
156932579|NCT02932904|566513038|FG000|Overall Study|Randomized But Not Treated|1|||
156932580|NCT02932904|566513039|FG001|Overall Study|Randomized But Not Treated|1|||
156932581|NCT02932904|566513040|FG002|Overall Study|Randomized But Not Treated|0|||
156932582|NCT02932904|566513041|FG003|Overall Study|Randomized But Not Treated|2|||
156932583|NCT03144180|566513045|FG000|Overall Study|STAT Delivery|1|||
156932584|NCT03144180|566513046|FG001|Overall Study|STAT Delivery|1|||
156932585|NCT03144180|566513045|FG000|Overall Study|Provider forgot to fill out forms|1|||
156932586|NCT03144180|566513046|FG001|Overall Study|Provider forgot to fill out forms|3|||
156932587|NCT03144180|566513045|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
156932588|NCT03144180|566513046|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
156932589|NCT03144180|566513045|FG000|Overall Study|Scrub tech removed tube cap|0|||
156932590|NCT03144180|566513046|FG001|Overall Study|Scrub tech removed tube cap|1|||
156932591|NCT00337103|566513047|FG000|Overall Study|Progressive Disease|414|||
156932592|NCT00337103|566513048|FG001|Overall Study|Progressive Disease|410|||
156932593|NCT00337103|566513047|FG000|Overall Study|Adverse Event|45|||
156932594|NCT00337103|566513048|FG001|Overall Study|Adverse Event|59|||
156932595|NCT00337103|566513047|FG000|Overall Study|Subject Choice|34|||
156932596|NCT00337103|566513048|FG001|Overall Study|Subject Choice|27|||
156932597|NCT00337103|566513047|FG000|Overall Study|Clinical Progression|27|||
156932598|NCT00337103|566513048|FG001|Overall Study|Clinical Progression|24|||
156932599|NCT00337103|566513047|FG000|Overall Study|Physician Decision|15|||
156932600|NCT00337103|566513048|FG001|Overall Study|Physician Decision|14|||
156932601|NCT00337103|566513047|FG000|Overall Study|Withdrawal by Subject|8|||
156932602|NCT00337103|566513048|FG001|Overall Study|Withdrawal by Subject|5|||
156932603|NCT00337103|566513047|FG000|Overall Study|Other|5|||
156932604|NCT00337103|566513048|FG001|Overall Study|Other|6|||
156932605|NCT00337103|566513047|FG000|Overall Study|Entry Criteria Not Met|4|||
156932606|NCT00337103|566513048|FG001|Overall Study|Entry Criteria Not Met|1|||
156932607|NCT00337103|566513047|FG000|Overall Study|Lost to Follow-up|1|||
156932608|NCT00337103|566513048|FG001|Overall Study|Lost to Follow-up|2|||
156932609|NCT00337103|566513047|FG000|Overall Study|Death|1|||
156932610|NCT00337103|566513048|FG001|Overall Study|Death|0|||
156932611|NCT01289847|566513051|FG000|Overall Study|Patient could not comply with visits|1|||
156932612|NCT00600756|566513065|FG000|Analysis After 6 Months|Adverse Event|43|||
156932613|NCT00600756|566513066|FG001|Analysis After 6 Months|Adverse Event|33|||
156932614|NCT00600756|566513065|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
156932615|NCT00600756|566513066|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
156932616|NCT00600756|566513065|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
156932617|NCT00600756|566513066|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
156932618|NCT00600756|566513065|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
156932619|NCT00600756|566513066|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
156932620|NCT00600756|566513065|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
156932621|NCT00600756|566513066|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
156932622|NCT00600756|566513065|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
156932623|NCT00600756|566513066|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
156932624|NCT00600756|566513065|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
156932625|NCT00600756|566513066|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
156932626|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
156932627|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
156932628|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
156932629|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
156932630|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
156932631|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
156932632|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
156932633|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
156932634|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
156932635|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
156932636|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
156932637|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
156932638|NCT00600756|566513065|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
156932639|NCT00600756|566513066|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
156932640|NCT01826487|566513069|FG000|Overall Study|Adverse Event|1|||
156932641|NCT01826487|566513070|FG001|Overall Study|Adverse Event|1|||
156932642|NCT01826487|566513069|FG000|Overall Study|Lost to Follow-up|1|||
156932643|NCT01826487|566513070|FG001|Overall Study|Lost to Follow-up|0|||
156932644|NCT01826487|566513069|FG000|Overall Study|Withdrawal by Subject|1|||
156932645|NCT01826487|566513070|FG001|Overall Study|Withdrawal by Subject|3|||
156932646|NCT01826487|566513069|FG000|Overall Study|Protocol Violation|1|||
156932647|NCT01826487|566513070|FG001|Overall Study|Protocol Violation|1|||
156932648|NCT01062555|566513071|FG000|Phase 1|Death|10|||
156932649|NCT01062555|566513072|FG001|Phase 1|Death|17|||
157166953|NCT00424346|567352625|FG003|Core Study|Withdrawal by Subject|2|||
157166954|NCT00424346|567352622|FG000|Core Study|Lost to Follow-up|1|||
156932650|NCT01062555|566513073|FG002|Phase 1|Death|0|||
156932651|NCT01062555|566513074|FG003|Phase 1|Death|0|||
156932652|NCT01062555|566513071|FG000|Phase 1|Graft Failure|12|||
156932653|NCT01062555|566513072|FG001|Phase 1|Graft Failure|8|||
156932654|NCT01062555|566513073|FG002|Phase 1|Graft Failure|0|||
156932655|NCT01062555|566513074|FG003|Phase 1|Graft Failure|0|||
156932656|NCT01062555|566513071|FG000|Phase 1|Withdrawal by Subject|1|||
156932657|NCT01062555|566513072|FG001|Phase 1|Withdrawal by Subject|1|||
156932658|NCT01062555|566513073|FG002|Phase 1|Withdrawal by Subject|0|||
156932659|NCT01062555|566513074|FG003|Phase 1|Withdrawal by Subject|0|||
156932660|NCT01062555|566513071|FG000|Phase 2|Death|0|||
156932661|NCT01062555|566513072|FG001|Phase 2|Death|0|||
156932662|NCT01062555|566513073|FG002|Phase 2|Death|8|||
156932663|NCT01062555|566513074|FG003|Phase 2|Death|3|||
156932664|NCT01062555|566513071|FG000|Phase 2|Graft failure|0|||
156932665|NCT01062555|566513072|FG001|Phase 2|Graft failure|0|||
156932666|NCT01062555|566513073|FG002|Phase 2|Graft failure|7|||
156932667|NCT01062555|566513074|FG003|Phase 2|Graft failure|4|||
156932668|NCT01062555|566513071|FG000|Phase 2|Withdrawal by Subject|0|||
156932669|NCT01062555|566513072|FG001|Phase 2|Withdrawal by Subject|0|||
156932670|NCT01062555|566513073|FG002|Phase 2|Withdrawal by Subject|0|||
156932671|NCT01062555|566513074|FG003|Phase 2|Withdrawal by Subject|7|||
156932672|NCT01062555|566513071|FG000|Phase 2|Protocol Violation|0|||
156932673|NCT01062555|566513072|FG001|Phase 2|Protocol Violation|0|||
156932674|NCT01062555|566513073|FG002|Phase 2|Protocol Violation|0|||
156932675|NCT01062555|566513074|FG003|Phase 2|Protocol Violation|3|||
156932676|NCT01062555|566513071|FG000|Phase 2|Physician Decision|0|||
156932677|NCT01062555|566513072|FG001|Phase 2|Physician Decision|0|||
156932678|NCT01062555|566513073|FG002|Phase 2|Physician Decision|0|||
156932679|NCT01062555|566513074|FG003|Phase 2|Physician Decision|17|||
156932680|NCT00788827|566513075|FG000|Overall Study|Lack of Efficacy|2|||
156932681|NCT00729183|566513076|FG000|Overall Study|Adverse Event|11|||
156932682|NCT00729183|566513077|FG001|Overall Study|Adverse Event|5|||
156932683|NCT00729183|566513076|FG000|Overall Study|Lack of Efficacy|0|||
156932684|NCT00729183|566513077|FG001|Overall Study|Lack of Efficacy|1|||
156932685|NCT00729183|566513076|FG000|Overall Study|Lost to Follow-up|3|||
156932686|NCT00729183|566513077|FG001|Overall Study|Lost to Follow-up|1|||
156932687|NCT00729183|566513076|FG000|Overall Study|Physician Decision|1|||
156932688|NCT00729183|566513077|FG001|Overall Study|Physician Decision|1|||
156932689|NCT00729183|566513076|FG000|Overall Study|Protocol Violation|1|||
156932690|NCT00729183|566513077|FG001|Overall Study|Protocol Violation|0|||
156932691|NCT00729183|566513076|FG000|Overall Study|Withdrawal by Subject|9|||
156932692|NCT00729183|566513077|FG001|Overall Study|Withdrawal by Subject|7|||
156932693|NCT01200797|566513084|FG000|Overall Study|symptomatic deterioration|2|||
156932694|NCT01200797|566513084|FG000|Overall Study|Adverse Event|4|||
156932695|NCT01200797|566513084|FG000|Overall Study|Disease Progression|13|||
156932696|NCT03608774|566513087|FG000|Overall Study|Lost to Follow-up|5|||
156932697|NCT03608774|566513088|FG001|Overall Study|Lost to Follow-up|5|||
156932698|NCT03608774|566513087|FG000|Overall Study|Withdrawal by Subject|1|||
156932699|NCT03608774|566513088|FG001|Overall Study|Withdrawal by Subject|0|||
156932700|NCT03608774|566513087|FG000|Overall Study|Protocol Violation|1|||
156932701|NCT03608774|566513088|FG001|Overall Study|Protocol Violation|0|||
156932702|NCT03608774|566513087|FG000|Overall Study|Not eligible at enrollment|0|||
156932703|NCT03608774|566513088|FG001|Overall Study|Not eligible at enrollment|1|||
156932704|NCT03608774|566513087|FG000|Overall Study|Health related event|0|||
156932705|NCT03608774|566513088|FG001|Overall Study|Health related event|1|||
156932706|NCT01359254|566513089|FG000|Overall Study|Death|1|||
156932707|NCT01359254|566513090|FG001|Overall Study|Death|0|||
156932708|NCT02028988|566513096|FG000|Overall Study|Withdrawal by Subject|2|||
156932709|NCT00851799|566513101|FG000|Overall Study|Death|1|||
156932710|NCT00851799|566513102|FG001|Overall Study|Death|0|||
156932711|NCT00851799|566513103|FG002|Overall Study|Death|1|||
156932712|NCT00851799|566513101|FG000|Overall Study|Lost to Follow-up|5|||
156932713|NCT00851799|566513102|FG001|Overall Study|Lost to Follow-up|3|||
156932714|NCT00851799|566513103|FG002|Overall Study|Lost to Follow-up|10|||
156932715|NCT00851799|566513101|FG000|Overall Study|Not able to get to clinic|8|||
156932716|NCT00851799|566513102|FG001|Overall Study|Not able to get to clinic|5|||
156932717|NCT00851799|566513103|FG002|Overall Study|Not able to get to clinic|9|||
156932718|NCT00851799|566513101|FG000|Overall Study|Not willing to adhere to requirements|1|||
157029674|NCT02240238|566864944|FG007|Phase 1|Withdrawal by Subject|0|||
157029675|NCT02240238|566864945|FG008|Phase 1|Withdrawal by Subject|0|||
157029676|NCT02240238|566864946|FG009|Phase 1|Withdrawal by Subject|0|||
156932719|NCT00851799|566513102|FG001|Overall Study|Not willing to adhere to requirements|2|||
156932720|NCT00851799|566513103|FG002|Overall Study|Not willing to adhere to requirements|2|||
156932721|NCT00851799|566513101|FG000|Overall Study|Withdrew consent prior study completion|1|||
156932722|NCT00851799|566513102|FG001|Overall Study|Withdrew consent prior study completion|2|||
156932723|NCT00851799|566513103|FG002|Overall Study|Withdrew consent prior study completion|1|||
156932724|NCT00851799|566513101|FG000|Overall Study|Severe Debilitation|0|||
156932725|NCT00851799|566513102|FG001|Overall Study|Severe Debilitation|1|||
156932726|NCT00851799|566513103|FG002|Overall Study|Severe Debilitation|0|||
156932727|NCT00851799|566513101|FG000|Overall Study|Completed protocol due to pregnancy|0|||
156932728|NCT00851799|566513102|FG001|Overall Study|Completed protocol due to pregnancy|0|||
156932729|NCT00851799|566513103|FG002|Overall Study|Completed protocol due to pregnancy|1|||
156932730|NCT01342510|566513106|FG000|Overall Study|Protocol Violation|12|||
156932731|NCT01342510|566513107|FG001|Overall Study|Protocol Violation|6|||
156932732|NCT01342510|566513108|FG002|Overall Study|Protocol Violation|13|||
157029677|NCT02240238|566864947|FG010|Phase 1|Withdrawal by Subject|0|||
156932733|NCT01342510|566513109|FG003|Overall Study|Protocol Violation|11|||
156932734|NCT00403273|566514778|FG000|Overall Study|Lost to Follow-up|3|||
156932735|NCT00403273|566514779|FG001|Overall Study|Lost to Follow-up|2|||
156932736|NCT00403273|566514778|FG000|Overall Study|Physician Decision|0|||
156932737|NCT00403273|566514779|FG001|Overall Study|Physician Decision|1|||
156932738|NCT00403273|566514778|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
156932739|NCT00403273|566514779|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
156932740|NCT00502697|566514785|FG000|Overall Study|Withdrawal by Subject|3|||
156932741|NCT00502697|566514786|FG001|Overall Study|Withdrawal by Subject|1|||
156932742|NCT00502697|566514785|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
156932743|NCT00502697|566514786|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
156932744|NCT00502697|566514785|FG000|Overall Study|found not to meet eligibility criteria|3|||
156932745|NCT00502697|566514786|FG001|Overall Study|found not to meet eligibility criteria|4|||
156932746|NCT00502697|566514785|FG000|Overall Study|did not meet assignment criteria|4|||
156932747|NCT00502697|566514786|FG001|Overall Study|did not meet assignment criteria|2|||
156932748|NCT02181556|566514792|FG000|Overall Study|Withdrawal by Subject|1|||
156932749|NCT04380857|566514793|FG000|Overall Study|Lost to Follow-up|3|||
156932750|NCT04380857|566514794|FG001|Overall Study|Lost to Follow-up|3|||
156932751|NCT02558790|566514795|FG000|Overall Study|Lost to Follow-up|2|||
156932752|NCT02558790|566514795|FG000|Overall Study|Physician Decision|1|||
156932753|NCT02558790|566514795|FG000|Overall Study|Withdrawal by Subject|1|||
156932754|NCT02558790|566514795|FG000|Overall Study|Screen Fail|3|||
156932755|NCT05083442|566514796|FG000|Overall Study|Lost to Follow-up|1|||
156932756|NCT05083442|566514797|FG001|Overall Study|Lost to Follow-up|0|||
156932757|NCT05083442|566514796|FG000|Overall Study|Lack of Efficacy|0|||
156932758|NCT05083442|566514797|FG001|Overall Study|Lack of Efficacy|1|||
156932759|NCT05083442|566514796|FG000|Overall Study|Withdrawal by Subject|1|||
156932760|NCT05083442|566514797|FG001|Overall Study|Withdrawal by Subject|3|||
156932761|NCT05083442|566514796|FG000|Overall Study|scheduling difficulties|1|||
156932762|NCT05083442|566514797|FG001|Overall Study|scheduling difficulties|2|||
156932763|NCT04865354|566514803|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
156932764|NCT04865354|566514804|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
156932765|NCT04865354|566514803|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
156932766|NCT04865354|566514804|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
156932767|NCT04865354|566514803|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
156932768|NCT04865354|566514804|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
156932769|NCT03873987|566514810|FG000|Overall Study|Adverse Event|1|||
156932770|NCT03873987|566514811|FG001|Overall Study|Adverse Event|0|||
156932771|NCT03873987|566514810|FG000|Overall Study|staff was unable to start a new IV line|1|||
156932772|NCT03873987|566514811|FG001|Overall Study|staff was unable to start a new IV line|0|||
156932773|NCT03873987|566514810|FG000|Overall Study|Lost to Follow-up|0|||
156932774|NCT03873987|566514811|FG001|Overall Study|Lost to Follow-up|1|||
156932775|NCT01465022|566514812|FG000|Overall Study|Lost to Follow-up|15|||
156932776|NCT01465022|566514813|FG001|Overall Study|Lost to Follow-up|14|||
156932777|NCT01465022|566514814|FG002|Overall Study|Lost to Follow-up|0|||
156932778|NCT01465022|566514812|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
156932779|NCT01465022|566514813|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
156932780|NCT01465022|566514814|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
156932781|NCT01465022|566514812|FG000|Overall Study|Not Randomized|0|||
156932782|NCT01465022|566514813|FG001|Overall Study|Not Randomized|0|||
156932783|NCT01465022|566514814|FG002|Overall Study|Not Randomized|70|||
156932784|NCT00004888|566514815|FG000|Overall Study|Adverse Event|5|||
156932785|NCT00004888|566514816|FG001|Overall Study|Adverse Event|10|||
156932786|NCT00004888|566514815|FG000|Overall Study|Withdrawal by Subject|0|||
156932787|NCT00004888|566514816|FG001|Overall Study|Withdrawal by Subject|3|||
156932788|NCT00004888|566514815|FG000|Overall Study|Physician Decision|1|||
156932789|NCT00004888|566514816|FG001|Overall Study|Physician Decision|1|||
156932790|NCT00004888|566514815|FG000|Overall Study|Progressive Disease|4|||
156932791|NCT00004888|566514816|FG001|Overall Study|Progressive Disease|9|||
156932792|NCT00004888|566514815|FG000|Overall Study|Death without progressive disease|0|||
156932793|NCT00004888|566514816|FG001|Overall Study|Death without progressive disease|1|||
156932794|NCT00004888|566514815|FG000|Overall Study|Toxic death|1|||
156932795|NCT00004888|566514816|FG001|Overall Study|Toxic death|0|||
157166955|NCT00424346|567352623|FG001|Core Study|Lost to Follow-up|1|||
157166956|NCT00424346|567352624|FG002|Core Study|Lost to Follow-up|0|||
156932796|NCT02579265|566514817|FG000|Overall Study|Weaned off earlier than 28 days|44|||
156932797|NCT02579265|566514818|FG001|Overall Study|Weaned off earlier than 28 days|43|||
156932798|NCT02579265|566514817|FG000|Overall Study|Adverse Event|2|||
156932799|NCT02579265|566514818|FG001|Overall Study|Adverse Event|0|||
156932800|NCT02579265|566514817|FG000|Overall Study|Any other reason not specified|0|||
156932801|NCT02579265|566514818|FG001|Overall Study|Any other reason not specified|2|||
156932802|NCT02579265|566514817|FG000|Overall Study|Withdrawal by Subject|2|||
156932803|NCT02579265|566514818|FG001|Overall Study|Withdrawal by Subject|0|||
157166957|NCT00424346|567352625|FG003|Core Study|Lost to Follow-up|0|||
157166958|NCT00424346|567352622|FG000|Core Study|Administrative Problems|1|||
157166959|NCT00424346|567352623|FG001|Core Study|Administrative Problems|0|||
157166960|NCT00424346|567352624|FG002|Core Study|Administrative Problems|1|||
157166961|NCT00424346|567352625|FG003|Core Study|Administrative Problems|0|||
157166962|NCT00424346|567352622|FG000|Core Study|Protocol Violation|0|||
157166963|NCT00424346|567352623|FG001|Core Study|Protocol Violation|0|||
156932804|NCT02579265|566514817|FG000|Overall Study|Physician Decision|1|||
156932805|NCT02579265|566514818|FG001|Overall Study|Physician Decision|0|||
156932806|NCT02579265|566514817|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
156932807|NCT02579265|566514818|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
156932808|NCT02174848|566514819|FG000|Overall Study|Adverse Event|2|||
156932809|NCT02174848|566514820|FG001|Overall Study|Adverse Event|1|||
156932810|NCT02174848|566514819|FG000|Overall Study|Withdrawal by Subject|3|||
156932811|NCT02174848|566514820|FG001|Overall Study|Withdrawal by Subject|3|||
156932812|NCT02174848|566514819|FG000|Overall Study|Lost to Follow-up|0|||
157029678|NCT02240238|566864948|FG011|Phase 1|Withdrawal by Subject|0|||
157029679|NCT02240238|566864937|FG000|Phase 1|Physician Decision|0|||
157029680|NCT02240238|566864938|FG001|Phase 1|Physician Decision|0|||
157029681|NCT02240238|566864939|FG002|Phase 1|Physician Decision|0|||
157029682|NCT02240238|566864940|FG003|Phase 1|Physician Decision|0|||
157029683|NCT02240238|566864941|FG004|Phase 1|Physician Decision|0|||
157029684|NCT02240238|566864942|FG005|Phase 1|Physician Decision|2|||
157029685|NCT02240238|566864943|FG006|Phase 1|Physician Decision|0|||
157029686|NCT02240238|566864944|FG007|Phase 1|Physician Decision|0|||
157029687|NCT02240238|566864945|FG008|Phase 1|Physician Decision|0|||
157029688|NCT02240238|566864946|FG009|Phase 1|Physician Decision|0|||
157029689|NCT02240238|566864947|FG010|Phase 1|Physician Decision|0|||
157029690|NCT02240238|566864948|FG011|Phase 1|Physician Decision|0|||
157029691|NCT02240238|566864937|FG000|Phase 2|Adverse Event|0|||
157029692|NCT02240238|566864938|FG001|Phase 2|Adverse Event|0|||
157029693|NCT02240238|566864939|FG002|Phase 2|Adverse Event|0|||
157029694|NCT02240238|566864940|FG003|Phase 2|Adverse Event|0|||
157029695|NCT02240238|566864941|FG004|Phase 2|Adverse Event|0|||
157029696|NCT02240238|566864942|FG005|Phase 2|Adverse Event|0|||
157029697|NCT02240238|566864943|FG006|Phase 2|Adverse Event|0|||
157029698|NCT02240238|566864944|FG007|Phase 2|Adverse Event|0|||
157029699|NCT02240238|566864945|FG008|Phase 2|Adverse Event|0|||
157029700|NCT02240238|566864946|FG009|Phase 2|Adverse Event|7|||
157029701|NCT02240238|566864947|FG010|Phase 2|Adverse Event|14|||
157029702|NCT02240238|566864948|FG011|Phase 2|Adverse Event|2|||
157029703|NCT02240238|566864937|FG000|Phase 2|Death|0|||
157029704|NCT02240238|566864938|FG001|Phase 2|Death|0|||
157029705|NCT02240238|566864939|FG002|Phase 2|Death|0|||
157029706|NCT02240238|566864940|FG003|Phase 2|Death|0|||
157029707|NCT02240238|566864941|FG004|Phase 2|Death|0|||
157029708|NCT02240238|566864942|FG005|Phase 2|Death|0|||
157029709|NCT02240238|566864943|FG006|Phase 2|Death|0|||
157029710|NCT02240238|566864944|FG007|Phase 2|Death|0|||
157029711|NCT02240238|566864945|FG008|Phase 2|Death|0|||
157029712|NCT02240238|566864946|FG009|Phase 2|Death|3|||
157029713|NCT02240238|566864947|FG010|Phase 2|Death|2|||
157029714|NCT02240238|566864948|FG011|Phase 2|Death|1|||
157029715|NCT02240238|566864937|FG000|Phase 2|Disease progression|0|||
157029716|NCT02240238|566864938|FG001|Phase 2|Disease progression|0|||
157029717|NCT02240238|566864939|FG002|Phase 2|Disease progression|0|||
157029718|NCT02240238|566864940|FG003|Phase 2|Disease progression|0|||
157029719|NCT02240238|566864941|FG004|Phase 2|Disease progression|0|||
157029720|NCT02240238|566864942|FG005|Phase 2|Disease progression|0|||
157029721|NCT02240238|566864943|FG006|Phase 2|Disease progression|0|||
157029722|NCT02240238|566864944|FG007|Phase 2|Disease progression|0|||
157029723|NCT02240238|566864945|FG008|Phase 2|Disease progression|0|||
157029724|NCT02240238|566864946|FG009|Phase 2|Disease progression|5|||
157029725|NCT02240238|566864947|FG010|Phase 2|Disease progression|11|||
157029726|NCT02240238|566864948|FG011|Phase 2|Disease progression|1|||
157029727|NCT02240238|566864937|FG000|Phase 2|Withdrawal by Subject|0|||
157166964|NCT00424346|567352624|FG002|Core Study|Protocol Violation|2|||
157029728|NCT02240238|566864938|FG001|Phase 2|Withdrawal by Subject|0|||
157029729|NCT02240238|566864939|FG002|Phase 2|Withdrawal by Subject|0|||
156932813|NCT02174848|566514820|FG001|Overall Study|Lost to Follow-up|1|||
156932814|NCT02174848|566514819|FG000|Overall Study|Worsening of disease|1|||
157029730|NCT02240238|566864940|FG003|Phase 2|Withdrawal by Subject|0|||
157029731|NCT02240238|566864941|FG004|Phase 2|Withdrawal by Subject|0|||
157029732|NCT02240238|566864942|FG005|Phase 2|Withdrawal by Subject|0|||
157029733|NCT02240238|566864943|FG006|Phase 2|Withdrawal by Subject|0|||
157029734|NCT02240238|566864944|FG007|Phase 2|Withdrawal by Subject|0|||
157166965|NCT00424346|567352625|FG003|Core Study|Protocol Violation|0|||
157166966|NCT00424346|567352622|FG000|Extension Phase|Adverse Event|0|||
157029735|NCT02240238|566864945|FG008|Phase 2|Withdrawal by Subject|0|||
157029736|NCT02240238|566864946|FG009|Phase 2|Withdrawal by Subject|1|||
157029737|NCT02240238|566864947|FG010|Phase 2|Withdrawal by Subject|1|||
157029738|NCT02240238|566864948|FG011|Phase 2|Withdrawal by Subject|0|||
157029739|NCT02240238|566864937|FG000|Phase 2|Physician Decision|0|||
157029740|NCT02240238|566864938|FG001|Phase 2|Physician Decision|0|||
157029741|NCT02240238|566864939|FG002|Phase 2|Physician Decision|0|||
157029742|NCT02240238|566864940|FG003|Phase 2|Physician Decision|0|||
157029743|NCT02240238|566864941|FG004|Phase 2|Physician Decision|0|||
157029744|NCT02240238|566864942|FG005|Phase 2|Physician Decision|0|||
157029745|NCT02240238|566864943|FG006|Phase 2|Physician Decision|0|||
157029746|NCT02240238|566864944|FG007|Phase 2|Physician Decision|0|||
157029747|NCT02240238|566864945|FG008|Phase 2|Physician Decision|0|||
157029748|NCT02240238|566864946|FG009|Phase 2|Physician Decision|1|||
157029749|NCT02240238|566864947|FG010|Phase 2|Physician Decision|3|||
157029750|NCT02240238|566864948|FG011|Phase 2|Physician Decision|0|||
157029751|NCT02240238|566864937|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029752|NCT02240238|566864938|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029753|NCT02240238|566864939|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029754|NCT02240238|566864940|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029755|NCT02240238|566864941|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029756|NCT02240238|566864942|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029757|NCT02240238|566864943|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029758|NCT02240238|566864944|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029759|NCT02240238|566864945|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029760|NCT02240238|566864946|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
157029761|NCT02240238|566864947|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029762|NCT02240238|566864948|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
157029763|NCT02240238|566864937|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029764|NCT02240238|566864938|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029765|NCT02240238|566864939|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029766|NCT02240238|566864940|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029767|NCT02240238|566864941|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029768|NCT02240238|566864942|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029769|NCT02240238|566864943|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029770|NCT02240238|566864944|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029771|NCT02240238|566864945|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029772|NCT02240238|566864946|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
157029773|NCT02240238|566864947|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029774|NCT02240238|566864948|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
157029775|NCT02240238|566864937|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029776|NCT02240238|566864938|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029777|NCT02240238|566864939|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029778|NCT02240238|566864940|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029779|NCT02240238|566864941|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029780|NCT02240238|566864942|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029781|NCT02240238|566864943|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029782|NCT02240238|566864944|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029783|NCT02240238|566864945|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029784|NCT02240238|566864946|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029785|NCT02240238|566864947|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
157029786|NCT02240238|566864948|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
157029787|NCT02240238|566864937|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029788|NCT02240238|566864938|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029789|NCT02240238|566864939|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029790|NCT02240238|566864940|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029791|NCT02240238|566864941|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029792|NCT02240238|566864942|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029793|NCT02240238|566864943|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029794|NCT02240238|566864944|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029795|NCT02240238|566864945|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029796|NCT02240238|566864946|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029797|NCT02240238|566864947|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
157029798|NCT02240238|566864948|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
157029799|NCT02240238|566864937|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029800|NCT02240238|566864938|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029801|NCT02240238|566864939|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029802|NCT02240238|566864940|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029803|NCT02240238|566864941|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029804|NCT02240238|566864942|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029805|NCT02240238|566864943|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029806|NCT02240238|566864944|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029807|NCT02240238|566864945|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029808|NCT02240238|566864946|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029809|NCT02240238|566864947|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
157029810|NCT02240238|566864948|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
157029811|NCT02240238|566864937|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029812|NCT02240238|566864938|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029813|NCT02240238|566864939|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029814|NCT02240238|566864940|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029815|NCT02240238|566864941|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029816|NCT02240238|566864942|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029817|NCT02240238|566864943|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029818|NCT02240238|566864944|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
156932815|NCT02174848|566514820|FG001|Overall Study|Worsening of disease|1|||
156932816|NCT02174848|566514819|FG000|Overall Study|Unable to comply with study requirements|1|||
156932817|NCT02174848|566514820|FG001|Overall Study|Unable to comply with study requirements|0|||
156932818|NCT02520011|566514822|FG000|Overall Study|Adverse Event|0|||
156932819|NCT02520011|566514823|FG001|Overall Study|Adverse Event|1|||
156932820|NCT02520011|566514824|FG002|Overall Study|Adverse Event|2|||
156932821|NCT02520011|566514822|FG000|Overall Study|Death|0|||
156932822|NCT02520011|566514823|FG001|Overall Study|Death|8|||
156932823|NCT02520011|566514824|FG002|Overall Study|Death|1|||
156932824|NCT02520011|566514822|FG000|Overall Study|Lack of Efficacy|4|||
156932825|NCT02520011|566514823|FG001|Overall Study|Lack of Efficacy|26|||
156932826|NCT02520011|566514824|FG002|Overall Study|Lack of Efficacy|4|||
156932827|NCT02520011|566514822|FG000|Overall Study|Physician Decision|0|||
156932828|NCT02520011|566514823|FG001|Overall Study|Physician Decision|2|||
156932829|NCT02520011|566514824|FG002|Overall Study|Physician Decision|0|||
156932830|NCT02520011|566514822|FG000|Overall Study|Withdrawal by Subject|1|||
156932831|NCT02520011|566514823|FG001|Overall Study|Withdrawal by Subject|3|||
156932832|NCT02520011|566514824|FG002|Overall Study|Withdrawal by Subject|0|||
156932833|NCT02520011|566514822|FG000|Overall Study|Protocol Deviation|0|||
156932834|NCT02520011|566514823|FG001|Overall Study|Protocol Deviation|1|||
156932835|NCT02520011|566514824|FG002|Overall Study|Protocol Deviation|0|||
156932836|NCT02520011|566514822|FG000|Overall Study|Patient went to hospice|0|||
156932837|NCT02520011|566514823|FG001|Overall Study|Patient went to hospice|1|||
156932838|NCT02520011|566514824|FG002|Overall Study|Patient went to hospice|0|||
156932839|NCT02520011|566514822|FG000|Overall Study|Progressive disease following response|0|||
156932840|NCT02520011|566514823|FG001|Overall Study|Progressive disease following response|4|||
156932841|NCT02520011|566514824|FG002|Overall Study|Progressive disease following response|2|||
156932842|NCT00644969|566514825|FG000|Treatment Phase|Randomized, not treated|1|||
156932843|NCT00644969|566514826|FG001|Treatment Phase|Randomized, not treated|0|||
156932844|NCT00644969|566514825|FG000|Treatment Phase|Adverse Event|3|||
156932845|NCT00644969|566514826|FG001|Treatment Phase|Adverse Event|0|||
156932846|NCT00644969|566514825|FG000|Treatment Phase|Withdrawal by Subject|4|||
156932847|NCT00644969|566514826|FG001|Treatment Phase|Withdrawal by Subject|0|||
156932848|NCT00644969|566514825|FG000|Treatment Phase|Lost to Follow-up|2|||
156932849|NCT00644969|566514826|FG001|Treatment Phase|Lost to Follow-up|2|||
156932850|NCT00644969|566514825|FG000|Treatment Phase|Other|4|||
156932851|NCT00644969|566514826|FG001|Treatment Phase|Other|1|||
156932852|NCT00644969|566514825|FG000|Post Treatment Phase|Death|1|||
156932853|NCT00644969|566514826|FG001|Post Treatment Phase|Death|0|||
156932854|NCT00644969|566514825|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
156932855|NCT00644969|566514826|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
156932856|NCT00644969|566514825|FG000|Post Treatment Phase|Lost to Follow-up|4|||
156932857|NCT00644969|566514826|FG001|Post Treatment Phase|Lost to Follow-up|1|||
156932858|NCT00644969|566514825|FG000|Post Treatment Phase|Other|1|||
156932859|NCT00644969|566514826|FG001|Post Treatment Phase|Other|0|||
156932860|NCT04476030|566514827|FG000|Overall Study|Withdrawal by Subject|20|||
156932861|NCT04476030|566514828|FG001|Overall Study|Withdrawal by Subject|16|||
156932862|NCT04476030|566514827|FG000|Overall Study|Adverse Event|10|||
156932863|NCT04476030|566514828|FG001|Overall Study|Adverse Event|11|||
156932864|NCT04476030|566514827|FG000|Overall Study|Lost to Follow-up|7|||
156932865|NCT04476030|566514828|FG001|Overall Study|Lost to Follow-up|4|||
156932866|NCT04476030|566514827|FG000|Overall Study|Physician Decision|1|||
156932867|NCT04476030|566514828|FG001|Overall Study|Physician Decision|1|||
156932868|NCT04476030|566514827|FG000|Overall Study|Protocol Deviation|2|||
156932869|NCT04476030|566514828|FG001|Overall Study|Protocol Deviation|0|||
156932870|NCT04476030|566514827|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
156932871|NCT04476030|566514828|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
157029819|NCT02240238|566864945|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029820|NCT02240238|566864946|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029821|NCT02240238|566864947|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
157029822|NCT02240238|566864948|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
157029823|NCT02240238|566864937|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029824|NCT02240238|566864938|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029825|NCT02240238|566864939|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029826|NCT02240238|566864940|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029827|NCT02240238|566864941|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029828|NCT02240238|566864942|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029829|NCT02240238|566864943|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029830|NCT02240238|566864944|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029831|NCT02240238|566864945|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029832|NCT02240238|566864946|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029833|NCT02240238|566864947|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
157029834|NCT02240238|566864948|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
157029835|NCT02240238|566864937|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029836|NCT02240238|566864938|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029837|NCT02240238|566864939|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029838|NCT02240238|566864940|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029839|NCT02240238|566864941|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029840|NCT02240238|566864942|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029841|NCT02240238|566864943|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029842|NCT02240238|566864944|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029843|NCT02240238|566864945|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029844|NCT02240238|566864946|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029845|NCT02240238|566864947|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
157029846|NCT02240238|566864948|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
157029847|NCT02724969|566864961|FG000|Overall Study|Lost to Follow-up|12|||
156932872|NCT04476030|566514827|FG000|Overall Study|Randomized but not Dosed|2|||
156932873|NCT04476030|566514828|FG001|Overall Study|Randomized but not Dosed|8|||
156932874|NCT02042924|566514829|FG000|Overall Study|Early Death|1|||
156932875|NCT02256891|566514830|FG000|Overall Study|Death|0|||
156932876|NCT02256891|566514831|FG001|Overall Study|Death|2|||
156932877|NCT02256891|566514830|FG000|Overall Study|Lost to Follow-up|0|||
156932878|NCT02256891|566514831|FG001|Overall Study|Lost to Follow-up|3|||
156932879|NCT02256891|566514830|FG000|Overall Study|Physician Decision|7|||
156932880|NCT02256891|566514831|FG001|Overall Study|Physician Decision|3|||
157029848|NCT02724969|566864962|FG001|Overall Study|Lost to Follow-up|6|||
157029849|NCT02724969|566864961|FG000|Overall Study|Withdrawal by Subject|3|||
157029850|NCT02724969|566864962|FG001|Overall Study|Withdrawal by Subject|3|||
157029851|NCT02724969|566864961|FG000|Overall Study|Infant demise|0|||
157029852|NCT02724969|566864962|FG001|Overall Study|Infant demise|2|||
157029853|NCT05868382|566864964|FG000|Overall Study|Lost to Follow-up|5|||
157029854|NCT05868382|566864965|FG001|Overall Study|Lost to Follow-up|0|||
157029855|NCT05868382|566864966|FG002|Overall Study|Lost to Follow-up|6|||
157029856|NCT05868382|566864967|FG003|Overall Study|Lost to Follow-up|4|||
157029857|NCT05868382|566864968|FG004|Overall Study|Lost to Follow-up|2|||
157029858|NCT05868382|566864969|FG005|Overall Study|Lost to Follow-up|6|||
157029859|NCT05868382|566864964|FG000|Overall Study|Withdrawal by Subject|1|||
157029860|NCT05868382|566864965|FG001|Overall Study|Withdrawal by Subject|0|||
157029861|NCT05868382|566864966|FG002|Overall Study|Withdrawal by Subject|0|||
157029862|NCT05868382|566864967|FG003|Overall Study|Withdrawal by Subject|0|||
157029863|NCT05868382|566864968|FG004|Overall Study|Withdrawal by Subject|1|||
157029864|NCT05868382|566864969|FG005|Overall Study|Withdrawal by Subject|0|||
157029865|NCT03513302|566864972|FG000|First Intervention (14 Days)|Screen failure|15|||
157029866|NCT03513302|566864973|FG001|First Intervention (14 Days)|Screen failure|16|||
157166967|NCT00424346|567352623|FG001|Extension Phase|Adverse Event|9|||
156932881|NCT02256891|566514830|FG000|Overall Study|Screen Fail|5|||
156932882|NCT02256891|566514831|FG001|Overall Study|Screen Fail|4|||
156932883|NCT02256891|566514830|FG000|Overall Study|Equipment Malfunction|0|||
156932884|NCT02256891|566514831|FG001|Overall Study|Equipment Malfunction|1|||
156932885|NCT04920123|566514841|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156932886|NCT04920123|566514842|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
157029867|NCT05256654|566864974|FG000|Overall Study|Adverse Event|0|||
157029868|NCT05256654|566864975|FG001|Overall Study|Adverse Event|0|||
157029869|NCT05256654|566864976|FG002|Overall Study|Adverse Event|1|||
157029870|NCT05256654|566864977|FG003|Overall Study|Adverse Event|0|||
157029871|NCT05256654|566864974|FG000|Overall Study|Lost to Follow-up|0|||
157029872|NCT05256654|566864975|FG001|Overall Study|Lost to Follow-up|0|||
156932887|NCT04920123|566514843|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
156932888|NCT02711800|566514861|FG000|Overall Study|Lost to Follow-up|1|||
156932889|NCT02711800|566514861|FG000|Overall Study|Withdrawal by Subject|1|||
156932890|NCT00006478|566514866|FG000|Overall Study|Vaccine could not be produced|1|||
156932891|NCT00006478|566514866|FG000|Overall Study|Physician Decision|6|||
156932892|NCT00743652|566514869|FG000|Overall Study|Parent/Legal Guardian Request|3|||
156932893|NCT00743652|566514870|FG001|Overall Study|Parent/Legal Guardian Request|2|||
156932894|NCT00743652|566514871|FG002|Overall Study|Parent/Legal Guardian Request|2|||
156932895|NCT00743652|566514872|FG003|Overall Study|Parent/Legal Guardian Request|2|||
156932896|NCT00743652|566514873|FG004|Overall Study|Parent/Legal Guardian Request|0|||
157029873|NCT05256654|566864976|FG002|Overall Study|Lost to Follow-up|0|||
157029874|NCT05256654|566864977|FG003|Overall Study|Lost to Follow-up|1|||
157029875|NCT05256654|566864974|FG000|Overall Study|Withdrawal by Subject|1|||
157029876|NCT05256654|566864975|FG001|Overall Study|Withdrawal by Subject|2|||
157029877|NCT05256654|566864976|FG002|Overall Study|Withdrawal by Subject|1|||
157029878|NCT05256654|566864977|FG003|Overall Study|Withdrawal by Subject|3|||
157029879|NCT05256654|566864974|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
157029880|NCT05256654|566864975|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
157029881|NCT05256654|566864976|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
157029882|NCT05256654|566864977|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
157029883|NCT05256654|566864974|FG000|Overall Study|Other|0|||
157029884|NCT05256654|566864975|FG001|Overall Study|Other|0|||
157029885|NCT05256654|566864976|FG002|Overall Study|Other|0|||
157029886|NCT05256654|566864977|FG003|Overall Study|Other|1|||
157029887|NCT02709161|566864982|FG000|Overall Study|Withdrawal by Subject|1|||
157029888|NCT02709161|566864983|FG001|Overall Study|Withdrawal by Subject|0|||
157029889|NCT05167864|566864986|FG000|Overall Study|Lost to Follow-up|7|||
157029890|NCT05167864|566864987|FG001|Overall Study|Lost to Follow-up|6|||
157029891|NCT05167864|566864988|FG002|Overall Study|Lost to Follow-up|7|||
157029892|NCT05167864|566864989|FG003|Overall Study|Lost to Follow-up|9|||
157029893|NCT04862416|566864990|FG000|Overall Study|Withdrawal by Subject|0|||
157029894|NCT04862416|566864991|FG001|Overall Study|Withdrawal by Subject|1|||
157029895|NCT04862416|566864992|FG002|Overall Study|Withdrawal by Subject|0|||
157029896|NCT04862416|566864993|FG003|Overall Study|Withdrawal by Subject|1|||
157029897|NCT04862416|566864994|FG004|Overall Study|Withdrawal by Subject|0|||
157029898|NCT04862416|566864995|FG005|Overall Study|Withdrawal by Subject|0|||
157029899|NCT04862416|566864996|FG006|Overall Study|Withdrawal by Subject|0|||
157029900|NCT04862416|566864997|FG007|Overall Study|Withdrawal by Subject|0|||
157029901|NCT00746096|566865000|FG000|Overall Study|Adverse Event|1|||
157029902|NCT00746096|566865001|FG001|Overall Study|Adverse Event|0|||
157029903|NCT00746096|566865000|FG000|Overall Study|Withdrawal by Subject|5|||
157029904|NCT00746096|566865001|FG001|Overall Study|Withdrawal by Subject|1|||
157029905|NCT00746096|566865000|FG000|Overall Study|Lost to Follow-up|2|||
157029906|NCT00746096|566865001|FG001|Overall Study|Lost to Follow-up|1|||
157029907|NCT00746096|566865000|FG000|Overall Study|Protocol Violation|1|||
157029908|NCT00746096|566865001|FG001|Overall Study|Protocol Violation|0|||
157029909|NCT00746096|566865000|FG000|Overall Study|No study drug treatment|1|||
157029910|NCT00746096|566865001|FG001|Overall Study|No study drug treatment|1|||
157029911|NCT04059185|566865002|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
157029912|NCT04059185|566865003|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
157029913|NCT04059185|566865004|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
157029914|NCT04059185|566865002|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
157029915|NCT04059185|566865003|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
157029916|NCT04059185|566865004|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
157029917|NCT04059185|566865002|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
157029918|NCT04059185|566865003|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
157029919|NCT04059185|566865004|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
157029920|NCT04059185|566865002|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
157029921|NCT04059185|566865003|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
157029922|NCT04059185|566865004|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
157029923|NCT04059185|566865002|FG000|Longitudinal Assessment-Adults Only|Death|4|||
157029924|NCT04059185|566865003|FG001|Longitudinal Assessment-Adults Only|Death|4|||
157029925|NCT04059185|566865004|FG002|Longitudinal Assessment-Adults Only|Death|3|||
157029926|NCT04295512|566865012|FG000|Overall Study|Lack of family response to schedule assessment|0|||
156932897|NCT00743652|566514869|FG000|Overall Study|Adverse Event|3|||
156932898|NCT00743652|566514870|FG001|Overall Study|Adverse Event|0|||
156932899|NCT00743652|566514871|FG002|Overall Study|Adverse Event|0|||
157029927|NCT04295512|566865013|FG001|Overall Study|Lack of family response to schedule assessment|0|||
157029928|NCT04295512|566865014|FG002|Overall Study|Lack of family response to schedule assessment|0|||
157029929|NCT04295512|566865015|FG003|Overall Study|Lack of family response to schedule assessment|2|||
157029930|NCT04295512|566865012|FG000|Overall Study|Therapist did not refer eligible family|7|||
157029931|NCT04295512|566865013|FG001|Overall Study|Therapist did not refer eligible family|7|||
156932900|NCT00743652|566514872|FG003|Overall Study|Adverse Event|0|||
156932901|NCT00743652|566514873|FG004|Overall Study|Adverse Event|0|||
156932902|NCT00743652|566514869|FG000|Overall Study|Death|2|||
156932903|NCT00743652|566514870|FG001|Overall Study|Death|0|||
156932904|NCT00743652|566514871|FG002|Overall Study|Death|0|||
156932905|NCT00743652|566514872|FG003|Overall Study|Death|0|||
156932906|NCT00743652|566514873|FG004|Overall Study|Death|0|||
156932907|NCT00743652|566514869|FG000|Overall Study|Investigator Request|0|||
156932908|NCT00743652|566514870|FG001|Overall Study|Investigator Request|0|||
156932909|NCT00743652|566514871|FG002|Overall Study|Investigator Request|0|||
156932910|NCT00743652|566514872|FG003|Overall Study|Investigator Request|2|||
156932911|NCT00743652|566514873|FG004|Overall Study|Investigator Request|0|||
156932912|NCT00743652|566514869|FG000|Overall Study|Other|1|||
156932913|NCT00743652|566514870|FG001|Overall Study|Other|1|||
156932914|NCT00743652|566514871|FG002|Overall Study|Other|0|||
156932915|NCT00743652|566514872|FG003|Overall Study|Other|0|||
156932916|NCT00743652|566514873|FG004|Overall Study|Other|0|||
156932917|NCT00743652|566514869|FG000|Overall Study|Lost to Follow-up|1|||
156932918|NCT00743652|566514870|FG001|Overall Study|Lost to Follow-up|0|||
156932919|NCT00743652|566514871|FG002|Overall Study|Lost to Follow-up|0|||
156932920|NCT00743652|566514872|FG003|Overall Study|Lost to Follow-up|0|||
156932921|NCT00743652|566514873|FG004|Overall Study|Lost to Follow-up|0|||
156932922|NCT00228917|566514876|FG000|Overall Study|Migrated/moved from study area|0|||
156932923|NCT00228917|566514877|FG001|Overall Study|Migrated/moved from study area|0|||
156932924|NCT00228917|566514878|FG002|Overall Study|Migrated/moved from study area|0|||
156932925|NCT00228917|566514879|FG003|Overall Study|Migrated/moved from study area|0|||
156932926|NCT00228917|566514880|FG004|Overall Study|Migrated/moved from study area|0|||
156932927|NCT00228917|566514881|FG005|Overall Study|Migrated/moved from study area|2|||
156932928|NCT00228917|566514882|FG006|Overall Study|Migrated/moved from study area|0|||
156932929|NCT00228917|566514883|FG007|Overall Study|Migrated/moved from study area|0|||
156932930|NCT00694369|566514891|FG000|Overall Study|Adverse Event|0|||
156932931|NCT00694369|566514892|FG001|Overall Study|Adverse Event|1|||
156932932|NCT00694369|566514893|FG002|Overall Study|Adverse Event|0|||
156932933|NCT00694369|566514894|FG003|Overall Study|Adverse Event|1|||
156932934|NCT00694369|566514895|FG004|Overall Study|Adverse Event|3|||
156932935|NCT00694369|566514891|FG000|Overall Study|Lost to Follow-up|0|||
156932936|NCT00694369|566514892|FG001|Overall Study|Lost to Follow-up|0|||
156932937|NCT00694369|566514893|FG002|Overall Study|Lost to Follow-up|1|||
156932938|NCT00694369|566514894|FG003|Overall Study|Lost to Follow-up|1|||
156932939|NCT00694369|566514895|FG004|Overall Study|Lost to Follow-up|0|||
156932940|NCT00694369|566514891|FG000|Overall Study|Physician Decision|0|||
156932941|NCT00694369|566514892|FG001|Overall Study|Physician Decision|0|||
156932942|NCT00694369|566514893|FG002|Overall Study|Physician Decision|0|||
156932943|NCT00694369|566514894|FG003|Overall Study|Physician Decision|0|||
156932944|NCT00694369|566514895|FG004|Overall Study|Physician Decision|1|||
156932945|NCT00694369|566514891|FG000|Overall Study|Protocol Violation|0|||
156932946|NCT00694369|566514892|FG001|Overall Study|Protocol Violation|1|||
156932947|NCT00694369|566514893|FG002|Overall Study|Protocol Violation|0|||
156932948|NCT00694369|566514894|FG003|Overall Study|Protocol Violation|0|||
156932949|NCT00694369|566514895|FG004|Overall Study|Protocol Violation|0|||
156932950|NCT00694369|566514891|FG000|Overall Study|Withdrawal by Subject|1|||
156932951|NCT00694369|566514892|FG001|Overall Study|Withdrawal by Subject|1|||
156932952|NCT00694369|566514893|FG002|Overall Study|Withdrawal by Subject|1|||
156932953|NCT00694369|566514894|FG003|Overall Study|Withdrawal by Subject|1|||
156932954|NCT00694369|566514895|FG004|Overall Study|Withdrawal by Subject|2|||
156932955|NCT00907374|566514896|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
156932956|NCT00907374|566514897|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
156932957|NCT00439556|566514898|FG000|Overall Study|Patient was taken off study for non-comp|0|||
157029932|NCT04295512|566865014|FG002|Overall Study|Therapist did not refer eligible family|0|||
156932958|NCT00439556|566514899|FG001|Overall Study|Patient was taken off study for non-comp|1|||
156932959|NCT00439556|566514900|FG002|Overall Study|Patient was taken off study for non-comp|0|||
156932960|NCT03818516|566514901|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
156932961|NCT04372602|566514904|FG000|Overall Study|Withdrawal by Subject|1|||
156932962|NCT04372602|566514905|FG001|Overall Study|Withdrawal by Subject|1|||
156932963|NCT04372602|566514904|FG000|Overall Study|Adverse Event|0|||
156932964|NCT04372602|566514905|FG001|Overall Study|Adverse Event|1|||
156932965|NCT04372602|566514904|FG000|Overall Study|Transitioned to comfort care|0|||
156932966|NCT04372602|566514905|FG001|Overall Study|Transitioned to comfort care|1|||
156932967|NCT01324388|566514906|FG000|Part 1 of Study|Adverse Event|2|||
156932968|NCT01324388|566514907|FG001|Part 1 of Study|Adverse Event|0|||
156932969|NCT01324388|566514908|FG002|Part 1 of Study|Adverse Event|0|||
156932970|NCT01324388|566514909|FG003|Part 1 of Study|Adverse Event|0|||
156932971|NCT01324388|566514906|FG000|Part 1 of Study|Protocol Violation|1|||
156932972|NCT01324388|566514907|FG001|Part 1 of Study|Protocol Violation|2|||
156932973|NCT01324388|566514908|FG002|Part 1 of Study|Protocol Violation|0|||
156932974|NCT01324388|566514909|FG003|Part 1 of Study|Protocol Violation|0|||
156932975|NCT01324388|566514906|FG000|Part 1 of Study|Physician Decision|1|||
157166968|NCT00424346|567352624|FG002|Extension Phase|Adverse Event|5|||
157166969|NCT00424346|567352625|FG003|Extension Phase|Adverse Event|4|||
157166970|NCT00424346|567352622|FG000|Extension Phase|Lack of Efficacy|0|||
156932976|NCT01324388|566514907|FG001|Part 1 of Study|Physician Decision|0|||
156932977|NCT01324388|566514908|FG002|Part 1 of Study|Physician Decision|0|||
156932978|NCT01324388|566514909|FG003|Part 1 of Study|Physician Decision|0|||
156932979|NCT01324388|566514906|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
156932980|NCT01324388|566514907|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
156932981|NCT01324388|566514908|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
156932982|NCT01324388|566514909|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
156932983|NCT01324388|566514906|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156932984|NCT01324388|566514907|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156932985|NCT01324388|566514908|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
156932986|NCT01324388|566514909|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
156932987|NCT01405963|566514910|FG000|Overall Study|Moved Away|2|||
156932988|NCT01405963|566514911|FG001|Overall Study|Moved Away|0|||
156932989|NCT01405963|566514910|FG000|Overall Study|Adverse Event|0|||
156932990|NCT01405963|566514911|FG001|Overall Study|Adverse Event|1|||
156932991|NCT01405963|566514910|FG000|Overall Study|Lost to Follow-up|0|||
156932992|NCT01405963|566514911|FG001|Overall Study|Lost to Follow-up|1|||
156932993|NCT03742141|566514917|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
156932994|NCT01498640|566514918|FG000|Overall Study|Lost to Follow-up|1|||
156932995|NCT01498640|566514918|FG000|Overall Study|Death|1|||
156932996|NCT01498640|566514918|FG000|Overall Study|Other|3|||
156932997|NCT01524692|566514921|FG000|Overall Study|Withdrawal by Subject|3|||
156932998|NCT03190889|566514922|FG000|Overall Study|Lost to Follow-up|7|||
156932999|NCT03190889|566514923|FG001|Overall Study|Lost to Follow-up|7|||
156933000|NCT03190889|566514924|FG002|Overall Study|Lost to Follow-up|3|||
156933001|NCT03190889|566514922|FG000|Overall Study|Withdrawal by Subject|1|||
156933002|NCT03190889|566514923|FG001|Overall Study|Withdrawal by Subject|1|||
156933003|NCT03190889|566514924|FG002|Overall Study|Withdrawal by Subject|2|||
156933004|NCT03190889|566514922|FG000|Overall Study|Did not complete protocol|4|||
156933005|NCT03190889|566514923|FG001|Overall Study|Did not complete protocol|9|||
156933006|NCT03190889|566514924|FG002|Overall Study|Did not complete protocol|0|||
156933007|NCT03190889|566514922|FG000|Overall Study|COVID-19|1|||
156933008|NCT03190889|566514923|FG001|Overall Study|COVID-19|0|||
156933009|NCT03190889|566514924|FG002|Overall Study|COVID-19|2|||
156933010|NCT01709695|566514925|FG000|Overall Study|Withdrawal by Subject|1|||
156933011|NCT01709695|566514926|FG001|Overall Study|Withdrawal by Subject|1|||
156933012|NCT04007523|566514927|FG000|Overall Study|Withdrawal by Subject|0|||
156933013|NCT04007523|566514928|FG001|Overall Study|Withdrawal by Subject|1|||
156933014|NCT04007523|566514929|FG002|Overall Study|Withdrawal by Subject|1|||
156933015|NCT04007523|566514930|FG003|Overall Study|Withdrawal by Subject|0|||
156933016|NCT04007523|566514927|FG000|Overall Study|ICU Transfer|0|||
156933017|NCT04007523|566514928|FG001|Overall Study|ICU Transfer|1|||
156933018|NCT04007523|566514929|FG002|Overall Study|ICU Transfer|0|||
156933019|NCT04007523|566514930|FG003|Overall Study|ICU Transfer|0|||
156933020|NCT04007523|566514927|FG000|Overall Study|COVID hospital closure|0|||
156933021|NCT04007523|566514928|FG001|Overall Study|COVID hospital closure|0|||
156933022|NCT04007523|566514929|FG002|Overall Study|COVID hospital closure|1|||
156933023|NCT04007523|566514930|FG003|Overall Study|COVID hospital closure|2|||
156933024|NCT04007523|566514927|FG000|Overall Study|Surgery cancelled|0|||
156933025|NCT04007523|566514928|FG001|Overall Study|Surgery cancelled|0|||
156933026|NCT04007523|566514929|FG002|Overall Study|Surgery cancelled|1|||
156933027|NCT04007523|566514930|FG003|Overall Study|Surgery cancelled|1|||
156933028|NCT02039674|566514934|FG000|Overall Study|Adverse Event|0|||
156933029|NCT02039674|566514935|FG001|Overall Study|Adverse Event|0|||
156933030|NCT02039674|566514936|FG002|Overall Study|Adverse Event|0|||
156933031|NCT02039674|566514937|FG003|Overall Study|Adverse Event|1|||
156933032|NCT02039674|566514938|FG004|Overall Study|Adverse Event|0|||
156933033|NCT02039674|566514939|FG005|Overall Study|Adverse Event|0|||
157166971|NCT00424346|567352623|FG001|Extension Phase|Lack of Efficacy|16|||
157166972|NCT00424346|567352624|FG002|Extension Phase|Lack of Efficacy|14|||
156933034|NCT02039674|566514940|FG006|Overall Study|Adverse Event|0|||
156933035|NCT02039674|566514941|FG007|Overall Study|Adverse Event|0|||
156933036|NCT02039674|566514942|FG008|Overall Study|Adverse Event|2|||
156933037|NCT02039674|566514943|FG009|Overall Study|Adverse Event|1|||
156933038|NCT02039674|566514944|FG010|Overall Study|Adverse Event|0|||
156933039|NCT02039674|566514945|FG011|Overall Study|Adverse Event|2|||
156933040|NCT02039674|566514946|FG012|Overall Study|Adverse Event|3|||
156933041|NCT02039674|566514947|FG013|Overall Study|Adverse Event|1|||
156933042|NCT02039674|566514934|FG000|Overall Study|Death|2|||
156933043|NCT02039674|566514935|FG001|Overall Study|Death|0|||
156933044|NCT02039674|566514936|FG002|Overall Study|Death|2|||
156933045|NCT02039674|566514937|FG003|Overall Study|Death|3|||
157166973|NCT00424346|567352625|FG003|Extension Phase|Lack of Efficacy|11|||
156933046|NCT02039674|566514938|FG004|Overall Study|Death|0|||
156933047|NCT02039674|566514939|FG005|Overall Study|Death|0|||
156933048|NCT02039674|566514940|FG006|Overall Study|Death|1|||
156933049|NCT02039674|566514941|FG007|Overall Study|Death|0|||
156933050|NCT02039674|566514942|FG008|Overall Study|Death|2|||
156933051|NCT02039674|566514943|FG009|Overall Study|Death|0|||
156933052|NCT02039674|566514944|FG010|Overall Study|Death|1|||
156933053|NCT02039674|566514945|FG011|Overall Study|Death|3|||
156933054|NCT02039674|566514946|FG012|Overall Study|Death|2|||
156933055|NCT02039674|566514947|FG013|Overall Study|Death|8|||
156933056|NCT02039674|566514934|FG000|Overall Study|Excluded Medication|1|||
156933057|NCT02039674|566514935|FG001|Overall Study|Excluded Medication|1|||
156933058|NCT02039674|566514936|FG002|Overall Study|Excluded Medication|0|||
156933059|NCT02039674|566514937|FG003|Overall Study|Excluded Medication|1|||
156933060|NCT02039674|566514938|FG004|Overall Study|Excluded Medication|0|||
156933061|NCT02039674|566514939|FG005|Overall Study|Excluded Medication|1|||
156933062|NCT02039674|566514940|FG006|Overall Study|Excluded Medication|0|||
156933063|NCT02039674|566514941|FG007|Overall Study|Excluded Medication|0|||
156933064|NCT02039674|566514942|FG008|Overall Study|Excluded Medication|2|||
156933065|NCT02039674|566514943|FG009|Overall Study|Excluded Medication|3|||
156933066|NCT02039674|566514944|FG010|Overall Study|Excluded Medication|5|||
156933067|NCT02039674|566514945|FG011|Overall Study|Excluded Medication|6|||
156933068|NCT02039674|566514946|FG012|Overall Study|Excluded Medication|8|||
156933069|NCT02039674|566514947|FG013|Overall Study|Excluded Medication|3|||
156933070|NCT02039674|566514934|FG000|Overall Study|Lost to Follow-up|0|||
156933071|NCT02039674|566514935|FG001|Overall Study|Lost to Follow-up|0|||
156933072|NCT02039674|566514936|FG002|Overall Study|Lost to Follow-up|0|||
156933073|NCT02039674|566514937|FG003|Overall Study|Lost to Follow-up|0|||
156933074|NCT02039674|566514938|FG004|Overall Study|Lost to Follow-up|1|||
156933075|NCT02039674|566514939|FG005|Overall Study|Lost to Follow-up|1|||
156933076|NCT02039674|566514940|FG006|Overall Study|Lost to Follow-up|0|||
156933077|NCT02039674|566514941|FG007|Overall Study|Lost to Follow-up|0|||
156933078|NCT02039674|566514942|FG008|Overall Study|Lost to Follow-up|0|||
156933079|NCT02039674|566514943|FG009|Overall Study|Lost to Follow-up|0|||
156933080|NCT02039674|566514944|FG010|Overall Study|Lost to Follow-up|0|||
156933081|NCT02039674|566514945|FG011|Overall Study|Lost to Follow-up|2|||
156933082|NCT02039674|566514946|FG012|Overall Study|Lost to Follow-up|2|||
156933083|NCT02039674|566514947|FG013|Overall Study|Lost to Follow-up|1|||
156933084|NCT02039674|566514934|FG000|Overall Study|Physician Decision|0|||
156933085|NCT02039674|566514935|FG001|Overall Study|Physician Decision|0|||
156933086|NCT02039674|566514936|FG002|Overall Study|Physician Decision|0|||
156933087|NCT02039674|566514937|FG003|Overall Study|Physician Decision|0|||
156933088|NCT02039674|566514938|FG004|Overall Study|Physician Decision|0|||
156933089|NCT02039674|566514939|FG005|Overall Study|Physician Decision|0|||
156933090|NCT02039674|566514940|FG006|Overall Study|Physician Decision|0|||
156933091|NCT02039674|566514941|FG007|Overall Study|Physician Decision|0|||
156933092|NCT02039674|566514942|FG008|Overall Study|Physician Decision|0|||
156933093|NCT02039674|566514943|FG009|Overall Study|Physician Decision|0|||
156933094|NCT02039674|566514944|FG010|Overall Study|Physician Decision|0|||
156933095|NCT02039674|566514945|FG011|Overall Study|Physician Decision|1|||
156933096|NCT02039674|566514946|FG012|Overall Study|Physician Decision|1|||
156933097|NCT02039674|566514947|FG013|Overall Study|Physician Decision|0|||
156933098|NCT02039674|566514934|FG000|Overall Study|Progressive Disease|8|||
156933099|NCT02039674|566514935|FG001|Overall Study|Progressive Disease|8|||
156933100|NCT02039674|566514936|FG002|Overall Study|Progressive Disease|6|||
156933101|NCT02039674|566514937|FG003|Overall Study|Progressive Disease|7|||
156933102|NCT02039674|566514938|FG004|Overall Study|Progressive Disease|9|||
156933103|NCT02039674|566514939|FG005|Overall Study|Progressive Disease|10|||
156933104|NCT02039674|566514940|FG006|Overall Study|Progressive Disease|1|||
156933105|NCT02039674|566514941|FG007|Overall Study|Progressive Disease|3|||
156933106|NCT02039674|566514942|FG008|Overall Study|Progressive Disease|6|||
156933107|NCT02039674|566514943|FG009|Overall Study|Progressive Disease|4|||
156933108|NCT02039674|566514944|FG010|Overall Study|Progressive Disease|0|||
156933109|NCT02039674|566514945|FG011|Overall Study|Progressive Disease|34|||
156933110|NCT02039674|566514946|FG012|Overall Study|Progressive Disease|34|||
156933111|NCT02039674|566514947|FG013|Overall Study|Progressive Disease|18|||
156933112|NCT02039674|566514934|FG000|Overall Study|Withdrawal by Subject|1|||
156933113|NCT02039674|566514935|FG001|Overall Study|Withdrawal by Subject|2|||
156933114|NCT02039674|566514936|FG002|Overall Study|Withdrawal by Subject|3|||
156933115|NCT02039674|566514937|FG003|Overall Study|Withdrawal by Subject|0|||
156933116|NCT02039674|566514938|FG004|Overall Study|Withdrawal by Subject|1|||
156933117|NCT02039674|566514939|FG005|Overall Study|Withdrawal by Subject|0|||
156933118|NCT02039674|566514940|FG006|Overall Study|Withdrawal by Subject|0|||
156933119|NCT02039674|566514941|FG007|Overall Study|Withdrawal by Subject|0|||
156933120|NCT02039674|566514942|FG008|Overall Study|Withdrawal by Subject|0|||
156933121|NCT02039674|566514943|FG009|Overall Study|Withdrawal by Subject|1|||
156933122|NCT02039674|566514944|FG010|Overall Study|Withdrawal by Subject|1|||
156933123|NCT02039674|566514945|FG011|Overall Study|Withdrawal by Subject|4|||
156933124|NCT02039674|566514946|FG012|Overall Study|Withdrawal by Subject|6|||
156933125|NCT02039674|566514947|FG013|Overall Study|Withdrawal by Subject|2|||
156933126|NCT02039674|566514934|FG000|Overall Study|Clinical Progression|0|||
156933127|NCT02039674|566514935|FG001|Overall Study|Clinical Progression|0|||
157166974|NCT00424346|567352622|FG000|Extension Phase|Withdrawal by Subject|0|||
157166975|NCT00424346|567352623|FG001|Extension Phase|Withdrawal by Subject|5|||
156933128|NCT02039674|566514936|FG002|Overall Study|Clinical Progression|0|||
156933129|NCT02039674|566514937|FG003|Overall Study|Clinical Progression|0|||
156933130|NCT02039674|566514938|FG004|Overall Study|Clinical Progression|0|||
156933131|NCT02039674|566514939|FG005|Overall Study|Clinical Progression|0|||
156933132|NCT02039674|566514940|FG006|Overall Study|Clinical Progression|1|||
156933133|NCT02039674|566514941|FG007|Overall Study|Clinical Progression|0|||
156933134|NCT02039674|566514942|FG008|Overall Study|Clinical Progression|0|||
156933135|NCT02039674|566514943|FG009|Overall Study|Clinical Progression|0|||
156933136|NCT02039674|566514944|FG010|Overall Study|Clinical Progression|0|||
156933137|NCT02039674|566514945|FG011|Overall Study|Clinical Progression|0|||
156933138|NCT02039674|566514946|FG012|Overall Study|Clinical Progression|1|||
156933139|NCT02039674|566514947|FG013|Overall Study|Clinical Progression|0|||
156933140|NCT02039674|566514934|FG000|Overall Study|Sponsor Decision|1|||
156933141|NCT02039674|566514935|FG001|Overall Study|Sponsor Decision|1|||
156933142|NCT02039674|566514936|FG002|Overall Study|Sponsor Decision|1|||
156933143|NCT02039674|566514937|FG003|Overall Study|Sponsor Decision|1|||
156933144|NCT02039674|566514938|FG004|Overall Study|Sponsor Decision|1|||
156933145|NCT02039674|566514939|FG005|Overall Study|Sponsor Decision|0|||
156933146|NCT02039674|566514940|FG006|Overall Study|Sponsor Decision|0|||
156933147|NCT02039674|566514941|FG007|Overall Study|Sponsor Decision|0|||
156933148|NCT02039674|566514942|FG008|Overall Study|Sponsor Decision|0|||
156933149|NCT02039674|566514943|FG009|Overall Study|Sponsor Decision|3|||
156933150|NCT02039674|566514944|FG010|Overall Study|Sponsor Decision|0|||
156933151|NCT02039674|566514945|FG011|Overall Study|Sponsor Decision|8|||
156933152|NCT02039674|566514946|FG012|Overall Study|Sponsor Decision|5|||
156933153|NCT02039674|566514947|FG013|Overall Study|Sponsor Decision|0|||
156933154|NCT02039674|566514934|FG000|Overall Study|Other|0|||
156933155|NCT02039674|566514935|FG001|Overall Study|Other|0|||
156933156|NCT02039674|566514936|FG002|Overall Study|Other|0|||
156933157|NCT02039674|566514937|FG003|Overall Study|Other|0|||
156933158|NCT02039674|566514938|FG004|Overall Study|Other|0|||
156933159|NCT02039674|566514939|FG005|Overall Study|Other|0|||
156933160|NCT02039674|566514940|FG006|Overall Study|Other|0|||
156933161|NCT02039674|566514941|FG007|Overall Study|Other|0|||
156933162|NCT02039674|566514942|FG008|Overall Study|Other|0|||
156933163|NCT02039674|566514943|FG009|Overall Study|Other|0|||
156933164|NCT02039674|566514944|FG010|Overall Study|Other|0|||
156933165|NCT02039674|566514945|FG011|Overall Study|Other|0|||
156933166|NCT02039674|566514946|FG012|Overall Study|Other|1|||
156933167|NCT02039674|566514947|FG013|Overall Study|Other|0|||
156933168|NCT01408030|566514948|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
156933169|NCT01408030|566514949|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
156933170|NCT01408030|566514950|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
156933171|NCT01408030|566514951|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
156933172|NCT01408030|566514948|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
156933173|NCT01408030|566514949|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
156933174|NCT01408030|566514950|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
156933175|NCT01408030|566514951|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
156933176|NCT01408030|566514948|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
156933177|NCT01408030|566514949|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
156933178|NCT01408030|566514950|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
156933179|NCT01408030|566514951|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
156933180|NCT01408030|566514948|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
156933181|NCT01408030|566514949|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
156933182|NCT01408030|566514950|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
156933183|NCT01408030|566514951|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
156933184|NCT01408030|566514948|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
156933185|NCT01408030|566514949|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
156933186|NCT01408030|566514950|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
156933187|NCT01408030|566514951|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
157166976|NCT00424346|567352624|FG002|Extension Phase|Withdrawal by Subject|3|||
156933188|NCT01408030|566514948|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
156933189|NCT01408030|566514949|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
156933190|NCT01408030|566514950|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
157166977|NCT00424346|567352625|FG003|Extension Phase|Withdrawal by Subject|4|||
156933191|NCT01408030|566514951|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
156933192|NCT01408030|566514948|FG000|Observation Phase (Off Drug)|Other|1|||
156933193|NCT01408030|566514949|FG001|Observation Phase (Off Drug)|Other|1|||
156933194|NCT01408030|566514950|FG002|Observation Phase (Off Drug)|Other|1|||
156933195|NCT01408030|566514951|FG003|Observation Phase (Off Drug)|Other|1|||
156933196|NCT03717480|566514952|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
156933197|NCT01894152|566514953|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
156933198|NCT01774786|566514954|FG000|Overall Study|Death|300|||
156933199|NCT01774786|566514955|FG001|Overall Study|Death|319|||
156933200|NCT01774786|566514954|FG000|Overall Study|Lost to Follow-up|6|||
156933201|NCT01774786|566514955|FG001|Overall Study|Lost to Follow-up|7|||
156933202|NCT01774786|566514954|FG000|Overall Study|Withdrawal by Subject|18|||
156933203|NCT01774786|566514955|FG001|Overall Study|Withdrawal by Subject|14|||
156933204|NCT01774786|566514954|FG000|Overall Study|Physician Decision|2|||
156933205|NCT01774786|566514955|FG001|Overall Study|Physician Decision|0|||
156933206|NCT01774786|566514954|FG000|Overall Study|Non-compliance|0|||
156933207|NCT01774786|566514955|FG001|Overall Study|Non-compliance|1|||
156933208|NCT01774786|566514954|FG000|Overall Study|Reason Not Specified|2|||
156933209|NCT01774786|566514955|FG001|Overall Study|Reason Not Specified|5|||
156933210|NCT02965703|566514960|FG000|Overall Study|Withdrawal by Subject|6|||
156933211|NCT02965703|566514961|FG001|Overall Study|Withdrawal by Subject|3|||
156933212|NCT02965703|566514962|FG002|Overall Study|Withdrawal by Subject|1|||
156933213|NCT02965703|566514960|FG000|Overall Study|Protocol Violation|1|||
156933214|NCT02965703|566514961|FG001|Overall Study|Protocol Violation|0|||
156933215|NCT02965703|566514962|FG002|Overall Study|Protocol Violation|0|||
156933216|NCT02965703|566514960|FG000|Overall Study|Adverse Event|1|||
156933217|NCT02965703|566514961|FG001|Overall Study|Adverse Event|1|||
156933218|NCT02965703|566514962|FG002|Overall Study|Adverse Event|0|||
156933219|NCT02965703|566514960|FG000|Overall Study|Lost to Follow-up|2|||
156933220|NCT02965703|566514961|FG001|Overall Study|Lost to Follow-up|1|||
156933221|NCT02965703|566514962|FG002|Overall Study|Lost to Follow-up|1|||
156933222|NCT02081079|566514963|FG000|Overall Study|Lack of Efficacy|3|||
156933223|NCT02081079|566514964|FG001|Overall Study|Lack of Efficacy|2|||
156933224|NCT02081079|566514963|FG000|Overall Study|Lost to Follow-up|1|||
156933225|NCT02081079|566514964|FG001|Overall Study|Lost to Follow-up|0|||
156933226|NCT02968979|566514970|FG000|Overall Study|Protocol Violation|7|||
156933227|NCT02968979|566514970|FG000|Overall Study|Withdrawal by Subject|1|||
156933228|NCT01471379|566514971|FG000|Overall Study|Adverse Event|1|||
156933229|NCT01471379|566514972|FG001|Overall Study|Adverse Event|0|||
156933230|NCT01471379|566514973|FG002|Overall Study|Adverse Event|0|||
156933231|NCT01471379|566514971|FG000|Overall Study|Study terminated|0|||
156933232|NCT01471379|566514972|FG001|Overall Study|Study terminated|1|||
156933233|NCT01471379|566514973|FG002|Overall Study|Study terminated|0|||
156933234|NCT00589108|566516939|FG000|Overall Study|Lost to Follow-up|1|||
156933235|NCT00589108|566516940|FG001|Overall Study|Lost to Follow-up|1|||
156933236|NCT00589108|566516941|FG002|Overall Study|Lost to Follow-up|1|||
156933237|NCT00589108|566516939|FG000|Overall Study|Death|3|||
156933238|NCT00589108|566516940|FG001|Overall Study|Death|3|||
156933239|NCT00589108|566516941|FG002|Overall Study|Death|4|||
156933240|NCT03026257|566516942|FG000|Overall Study|Adverse Event|3|||
156933241|NCT03026257|566516943|FG001|Overall Study|Adverse Event|0|||
156933242|NCT03026257|566516944|FG002|Overall Study|Adverse Event|0|||
156933243|NCT03026257|566516945|FG003|Overall Study|Adverse Event|0|||
156933244|NCT03026257|566516946|FG004|Overall Study|Adverse Event|0|||
156933245|NCT03026257|566516947|FG005|Overall Study|Adverse Event|0|||
156933246|NCT03026257|566516942|FG000|Overall Study|Lost to Follow-up|1|||
156933247|NCT03026257|566516943|FG001|Overall Study|Lost to Follow-up|0|||
156933248|NCT03026257|566516944|FG002|Overall Study|Lost to Follow-up|0|||
156933249|NCT03026257|566516945|FG003|Overall Study|Lost to Follow-up|0|||
156933250|NCT03026257|566516946|FG004|Overall Study|Lost to Follow-up|0|||
156933251|NCT03026257|566516947|FG005|Overall Study|Lost to Follow-up|0|||
156933252|NCT03026257|566516942|FG000|Overall Study|Protocol Violation|1|||
156933253|NCT03026257|566516943|FG001|Overall Study|Protocol Violation|0|||
156933254|NCT03026257|566516944|FG002|Overall Study|Protocol Violation|0|||
156933255|NCT03026257|566516945|FG003|Overall Study|Protocol Violation|1|||
156933256|NCT03026257|566516946|FG004|Overall Study|Protocol Violation|1|||
156933257|NCT03026257|566516947|FG005|Overall Study|Protocol Violation|0|||
156933258|NCT03026257|566516942|FG000|Overall Study|Withdrawal by Subject|1|||
156933259|NCT03026257|566516943|FG001|Overall Study|Withdrawal by Subject|1|||
156933260|NCT03026257|566516944|FG002|Overall Study|Withdrawal by Subject|0|||
156933261|NCT03026257|566516945|FG003|Overall Study|Withdrawal by Subject|0|||
156933262|NCT03026257|566516946|FG004|Overall Study|Withdrawal by Subject|0|||
156933263|NCT03026257|566516947|FG005|Overall Study|Withdrawal by Subject|0|||
156933264|NCT01886833|566516951|FG000|Overall Study|IgA not available from both periods|204|||
156933265|NCT01454726|566516952|FG000|Overall Study|Withdrawal by Subject|0|||
156933266|NCT01454726|566516953|FG001|Overall Study|Withdrawal by Subject|1|||
156933267|NCT04033003|566516956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
156933268|NCT04033003|566516957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
156933269|NCT04033003|566516956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
156933270|NCT04033003|566516957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
156933271|NCT04033003|566516956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
156933272|NCT04033003|566516957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
156933273|NCT04033003|566516956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
156933274|NCT04033003|566516957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
156933275|NCT04033003|566516956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
156933276|NCT04033003|566516957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
157029933|NCT04295512|566865015|FG003|Overall Study|Therapist did not refer eligible family|0|||
157029934|NCT05207956|566865023|FG000|Overall Study|Lost to follow up|1|||
157029935|NCT05207956|566865024|FG001|Overall Study|Lost to follow up|2|||
157029936|NCT01009788|566865027|FG000|Overall Study|Withdrawal by Subject|1|||
157029937|NCT01009788|566865028|FG001|Overall Study|Withdrawal by Subject|0|||
157029938|NCT04587453|566865029|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
157029939|NCT04587453|566865030|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
157029940|NCT01309672|566865031|FG000|Overall Study|Lack of Efficacy|20|||
157029941|NCT01309672|566865031|FG000|Overall Study|Other|9|||
157029942|NCT01309672|566865031|FG000|Overall Study|Adverse Event|5|||
157029943|NCT01309672|566865031|FG000|Overall Study|Withdrawal by Subject|3|||
157029944|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
157029945|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
157029946|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
157029947|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
157029948|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
157029949|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
157029950|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
157029951|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
157029952|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
157029953|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
157029954|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
157029955|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
157029956|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
157029957|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
157029958|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
157029959|NCT01254864|566865034|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
157029960|NCT01254864|566865035|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
157029961|NCT01254864|566865036|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
157029962|NCT01254864|566865034|FG000|Randomization Phase|Adverse Event|0|||
157029963|NCT01254864|566865035|FG001|Randomization Phase|Adverse Event|5|||
157029964|NCT01254864|566865036|FG002|Randomization Phase|Adverse Event|17|||
157029965|NCT01254864|566865034|FG000|Randomization Phase|Death|0|||
157029966|NCT01254864|566865035|FG001|Randomization Phase|Death|1|||
157029967|NCT01254864|566865036|FG002|Randomization Phase|Death|0|||
157029968|NCT01254864|566865034|FG000|Randomization Phase|Lost to Follow-up|0|||
157029969|NCT01254864|566865035|FG001|Randomization Phase|Lost to Follow-up|0|||
157029970|NCT01254864|566865036|FG002|Randomization Phase|Lost to Follow-up|1|||
157029971|NCT01254864|566865034|FG000|Randomization Phase|Physician Decision|0|||
157029972|NCT01254864|566865035|FG001|Randomization Phase|Physician Decision|20|||
157029973|NCT01254864|566865036|FG002|Randomization Phase|Physician Decision|25|||
157029974|NCT01254864|566865034|FG000|Randomization Phase|Withdrawal by Subject|0|||
157029975|NCT01254864|566865035|FG001|Randomization Phase|Withdrawal by Subject|4|||
157029976|NCT01254864|566865036|FG002|Randomization Phase|Withdrawal by Subject|2|||
157029977|NCT01254864|566865034|FG000|Randomization Phase|Non-Compliance|0|||
157029978|NCT01254864|566865035|FG001|Randomization Phase|Non-Compliance|1|||
157029979|NCT01254864|566865036|FG002|Randomization Phase|Non-Compliance|0|||
157029980|NCT01254864|566865034|FG000|Randomization Phase|Comorbidities|0|||
157029981|NCT01254864|566865035|FG001|Randomization Phase|Comorbidities|2|||
157029982|NCT01254864|566865036|FG002|Randomization Phase|Comorbidities|1|||
157029983|NCT04141891|566865037|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
157029984|NCT04141891|566865038|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
157029985|NCT04141891|566865037|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
157029986|NCT04141891|566865038|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
157029987|NCT04141891|566865037|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
157029988|NCT04141891|566865038|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
157029989|NCT04141891|566865037|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
157029990|NCT04141891|566865038|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
157029991|NCT04141891|566865037|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
157029992|NCT04141891|566865038|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
157029993|NCT04141891|566865037|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
157029994|NCT04141891|566865038|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
157029995|NCT04141891|566865037|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
157029996|NCT04141891|566865038|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
157029997|NCT04141891|566865037|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
157029998|NCT04141891|566865038|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
157029999|NCT04141891|566865037|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
157030000|NCT04141891|566865038|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
157030001|NCT04141891|566865037|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
157091644|NCT01775124|567089187|FG000|Core Period|Administrative problems|1|||
157030002|NCT04141891|566865038|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
157030003|NCT04141891|566865037|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
157030004|NCT04141891|566865038|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
157030005|NCT04141891|566865037|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
157030006|NCT04141891|566865038|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
157030007|NCT04141891|566865037|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
157030008|NCT04141891|566865038|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
157030009|NCT04141891|566865037|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
157030010|NCT04141891|566865038|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
157030011|NCT03295721|566865041|FG000|Overall Study|Adverse Event|1|||
157030012|NCT03295721|566865042|FG001|Overall Study|Adverse Event|0|||
157030013|NCT03295721|566865043|FG002|Overall Study|Adverse Event|0|||
157030014|NCT03295721|566865041|FG000|Overall Study|Lost to Follow-up|1|||
157030015|NCT03295721|566865042|FG001|Overall Study|Lost to Follow-up|1|||
157030016|NCT03295721|566865043|FG002|Overall Study|Lost to Follow-up|1|||
157030017|NCT03295721|566865041|FG000|Overall Study|Withdrawal by Subject|1|||
157030018|NCT03295721|566865042|FG001|Overall Study|Withdrawal by Subject|0|||
157030019|NCT03295721|566865043|FG002|Overall Study|Withdrawal by Subject|1|||
157030020|NCT03295721|566865041|FG000|Overall Study|Death|0|||
157030021|NCT03295721|566865042|FG001|Overall Study|Death|0|||
157030022|NCT03295721|566865043|FG002|Overall Study|Death|1|||
157030023|NCT01651403|566865049|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
157030024|NCT01651403|566865050|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
157030025|NCT01651403|566865049|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
157030026|NCT01651403|566865050|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
157030027|NCT01651403|566865049|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
157030028|NCT01651403|566865050|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
157030029|NCT01651403|566865049|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
157030030|NCT01651403|566865050|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
157030031|NCT01651403|566865049|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
157030032|NCT01651403|566865050|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
157030033|NCT01651403|566865049|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
157030034|NCT01651403|566865050|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
157030035|NCT05090683|566865051|FG000|Overall Study|Lost to Follow-up|10|||
157030036|NCT05090683|566865052|FG001|Overall Study|Lost to Follow-up|2|||
157030037|NCT05090683|566865051|FG000|Overall Study|Withdrawal by Subject|15|||
157030038|NCT05090683|566865052|FG001|Overall Study|Withdrawal by Subject|0|||
157030039|NCT03325985|566865053|FG000|Overall Study|Lost to Follow-up|122|||
157030040|NCT03325985|566865054|FG001|Overall Study|Lost to Follow-up|26|||
157030041|NCT03325985|566865055|FG002|Overall Study|Lost to Follow-up|141|||
157030042|NCT03325985|566865056|FG003|Overall Study|Lost to Follow-up|28|||
157030043|NCT03325985|566865053|FG000|Overall Study|Death|99|||
157030044|NCT03325985|566865054|FG001|Overall Study|Death|36|||
157030045|NCT03325985|566865055|FG002|Overall Study|Death|94|||
157030046|NCT03325985|566865056|FG003|Overall Study|Death|32|||
157030047|NCT03213665|566865057|FG000|Overall Study|Adverse Event|1|||
157030048|NCT03213665|566865057|FG000|Overall Study|Physician Decision|2|||
157030049|NCT03213665|566865057|FG000|Overall Study|Withdrawal by Subject|3|||
157030050|NCT03213665|566865057|FG000|Overall Study|Progressive Disease|13|||
157030051|NCT02684227|566865058|FG000|Overall Study|Adverse Event|1|||
157030052|NCT02684227|566865059|FG001|Overall Study|Adverse Event|7|||
157030053|NCT02684227|566865058|FG000|Overall Study|Death|0|||
157030054|NCT02684227|566865059|FG001|Overall Study|Death|2|||
157166978|NCT00424346|567352622|FG000|Extension Phase|Lost to Follow-up|0|||
157166979|NCT00424346|567352623|FG001|Extension Phase|Lost to Follow-up|2|||
157166980|NCT00424346|567352624|FG002|Extension Phase|Lost to Follow-up|0|||
157166981|NCT00424346|567352625|FG003|Extension Phase|Lost to Follow-up|0|||
157166982|NCT00424346|567352622|FG000|Extension Phase|Administrative Problems|0|||
157166983|NCT00424346|567352623|FG001|Extension Phase|Administrative Problems|69|||
157166984|NCT00424346|567352624|FG002|Extension Phase|Administrative Problems|32|||
157166985|NCT00424346|567352625|FG003|Extension Phase|Administrative Problems|35|||
157166986|NCT00424346|567352622|FG000|Extension Phase|Death|0|||
157227056|NCT00409578|567576031|FG000|Overall Study|Administrative problems|8|||
157166987|NCT00424346|567352623|FG001|Extension Phase|Death|0|||
157227057|NCT00409578|567576032|FG001|Overall Study|Administrative problems|9|||
157030055|NCT02684227|566865058|FG000|Overall Study|Withdrawal by Subject|0|||
157030056|NCT02684227|566865059|FG001|Overall Study|Withdrawal by Subject|1|||
157030057|NCT02684227|566865058|FG000|Overall Study|Progressive Disease|0|||
157030058|NCT02684227|566865059|FG001|Overall Study|Progressive Disease|2|||
157030059|NCT04571619|566865062|FG000|Phase 1|Death|22|||
157030060|NCT04571619|566865063|FG001|Phase 1|Death|18|||
157030061|NCT04571619|566865062|FG000|Phase 1|Withdrawal by Subject|7|||
157030062|NCT04571619|566865063|FG001|Phase 1|Withdrawal by Subject|2|||
157030063|NCT04571619|566865062|FG000|Phase 2|Death|13|||
157227058|NCT00409578|567576033|FG002|Overall Study|Administrative problems|2|||
157227059|NCT00409578|567576034|FG003|Overall Study|Administrative problems|4|||
157227060|NCT00409578|567576031|FG000|Overall Study|Death|2|||
157227061|NCT00409578|567576032|FG001|Overall Study|Death|4|||
157227062|NCT00409578|567576033|FG002|Overall Study|Death|4|||
157227063|NCT00409578|567576034|FG003|Overall Study|Death|2|||
156933277|NCT04033003|566516956|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
156933278|NCT04033003|566516957|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
156933279|NCT04033003|566516956|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
156933280|NCT04033003|566516957|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
156933281|NCT04033003|566516956|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
156933282|NCT04033003|566516957|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
156933283|NCT04033003|566516956|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
156933284|NCT04033003|566516957|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
156933285|NCT04033003|566516956|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
156933286|NCT04033003|566516957|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
156933287|NCT04033003|566516956|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
156933288|NCT04033003|566516957|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
156933289|NCT04033003|566516956|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
156933290|NCT04033003|566516957|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
156933291|NCT04033003|566516956|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
156933292|NCT04033003|566516957|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
156933293|NCT02919670|566516958|FG000|Overall Study|Only 17 participants met compliance|43|||
156933294|NCT02919670|566516959|FG001|Overall Study|Only 17 participants met compliance|39|||
156933295|NCT01714310|566516960|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
156933296|NCT01714310|566516961|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
156933297|NCT01714310|566516962|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
156933298|NCT01714310|566516960|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
156933299|NCT01714310|566516961|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
156933300|NCT01714310|566516962|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
156933301|NCT01714310|566516960|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
156933302|NCT01714310|566516961|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
156933303|NCT01714310|566516962|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
156933304|NCT01714310|566516960|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
156933305|NCT01714310|566516961|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
156933306|NCT01714310|566516962|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
156933307|NCT01641367|566516963|FG000|Cohorts|Death|18|||
156933308|NCT01641367|566516964|FG001|Cohorts|Death|1|||
156933309|NCT01641367|566516965|FG002|Cohorts|Death|2|||
156933310|NCT01641367|566516966|FG003|Cohorts|Death|0|||
156933311|NCT01641367|566516967|FG004|Cohorts|Death|1|||
156933312|NCT01641367|566516968|FG005|Cohorts|Death|1|||
156933313|NCT01641367|566516969|FG006|Cohorts|Death|0|||
156933314|NCT01641367|566516970|FG007|Cohorts|Death|0|||
156933315|NCT01641367|566516963|FG000|Cohorts|Lost to Follow-up|16|||
156933316|NCT01641367|566516964|FG001|Cohorts|Lost to Follow-up|0|||
156933317|NCT01641367|566516965|FG002|Cohorts|Lost to Follow-up|2|||
156933318|NCT01641367|566516966|FG003|Cohorts|Lost to Follow-up|0|||
156933319|NCT01641367|566516967|FG004|Cohorts|Lost to Follow-up|2|||
156933320|NCT01641367|566516968|FG005|Cohorts|Lost to Follow-up|0|||
156933321|NCT01641367|566516969|FG006|Cohorts|Lost to Follow-up|0|||
156933322|NCT01641367|566516970|FG007|Cohorts|Lost to Follow-up|0|||
156933323|NCT01641367|566516963|FG000|Randomized Adherence Intervention|Death|0|||
156933324|NCT01641367|566516964|FG001|Randomized Adherence Intervention|Death|0|||
156933325|NCT01641367|566516965|FG002|Randomized Adherence Intervention|Death|0|||
156933326|NCT01641367|566516966|FG003|Randomized Adherence Intervention|Death|0|||
156933327|NCT01641367|566516967|FG004|Randomized Adherence Intervention|Death|0|||
156933328|NCT01641367|566516968|FG005|Randomized Adherence Intervention|Death|0|||
156933329|NCT01641367|566516969|FG006|Randomized Adherence Intervention|Death|11|||
156933330|NCT01641367|566516970|FG007|Randomized Adherence Intervention|Death|12|||
156933331|NCT01641367|566516963|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
156933332|NCT01641367|566516964|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
157030064|NCT04571619|566865063|FG001|Phase 2|Death|16|||
157030065|NCT04571619|566865062|FG000|Phase 2|Withdrawal by Subject|6|||
156933333|NCT01641367|566516965|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
156933334|NCT01641367|566516966|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
156933335|NCT01641367|566516967|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
156933336|NCT01641367|566516968|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
156933337|NCT01641367|566516969|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
156933338|NCT01641367|566516970|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
157227064|NCT00409578|567576031|FG000|Overall Study|Protocol Violation|3|||
156933339|NCT00826267|566516971|FG000|Overall Study|Other Adverse Event|1|||
156933340|NCT00826267|566516972|FG001|Overall Study|Other Adverse Event|0|||
156933341|NCT00826267|566516973|FG002|Overall Study|Other Adverse Event|0|||
157030066|NCT04571619|566865063|FG001|Phase 2|Withdrawal by Subject|4|||
157227065|NCT00409578|567576032|FG001|Overall Study|Protocol Violation|2|||
157227066|NCT00409578|567576033|FG002|Overall Study|Protocol Violation|3|||
156933342|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
156933343|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
156933344|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
156933345|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
156933346|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
156933347|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
156933348|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
156933349|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
156933350|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
156933351|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
156933352|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
156933353|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
156933354|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
156933355|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
156933356|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
156933357|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Death|5|||
156933358|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Death|0|||
156933359|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Death|2|||
156933360|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Death|0|||
156933361|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Death|4|||
156933362|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
156933363|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
156933364|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
156933365|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
156933366|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
156933367|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
156933368|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
156933369|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
156933370|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
156933371|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
156933372|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
156933373|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156933374|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
156933375|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156933376|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
156933377|NCT01604343|566516974|FG000|Prior to W52 Administration(Through W52)|Other|15|||
156933378|NCT01604343|566516975|FG001|Prior to W52 Administration(Through W52)|Other|0|||
156933379|NCT01604343|566516976|FG002|Prior to W52 Administration(Through W52)|Other|10|||
156933380|NCT01604343|566516977|FG003|Prior to W52 Administration(Through W52)|Other|0|||
156933381|NCT01604343|566516978|FG004|Prior to W52 Administration(Through W52)|Other|6|||
156933382|NCT01604343|566516974|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
156933383|NCT01604343|566516975|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
156933384|NCT01604343|566516976|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
156933385|NCT01604343|566516977|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
156933386|NCT01604343|566516978|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
156933387|NCT01604343|566516974|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
156933388|NCT01604343|566516975|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
156933389|NCT01604343|566516976|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
156933390|NCT01604343|566516977|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
156933391|NCT01604343|566516978|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
156933392|NCT01604343|566516974|FG000|Week 52 to Week 104|Adverse Event|0|||
156933393|NCT01604343|566516975|FG001|Week 52 to Week 104|Adverse Event|12|||
156933394|NCT01604343|566516976|FG002|Week 52 to Week 104|Adverse Event|26|||
156933395|NCT01604343|566516977|FG003|Week 52 to Week 104|Adverse Event|21|||
156933396|NCT01604343|566516978|FG004|Week 52 to Week 104|Adverse Event|27|||
156933397|NCT01604343|566516974|FG000|Week 52 to Week 104|Death|0|||
156933398|NCT01604343|566516975|FG001|Week 52 to Week 104|Death|4|||
156933399|NCT01604343|566516976|FG002|Week 52 to Week 104|Death|2|||
156933400|NCT01604343|566516977|FG003|Week 52 to Week 104|Death|5|||
156933401|NCT01604343|566516978|FG004|Week 52 to Week 104|Death|0|||
156933402|NCT01604343|566516974|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
156933403|NCT01604343|566516975|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
156933404|NCT01604343|566516976|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
156933405|NCT01604343|566516977|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
156933406|NCT01604343|566516978|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
156933407|NCT01604343|566516974|FG000|Week 52 to Week 104|Physician Decision|0|||
156933408|NCT01604343|566516975|FG001|Week 52 to Week 104|Physician Decision|1|||
156933409|NCT01604343|566516976|FG002|Week 52 to Week 104|Physician Decision|0|||
156933410|NCT01604343|566516977|FG003|Week 52 to Week 104|Physician Decision|0|||
156933411|NCT01604343|566516978|FG004|Week 52 to Week 104|Physician Decision|2|||
156933412|NCT01604343|566516974|FG000|Week 52 to Week 104|Pregnancy|0|||
156933413|NCT01604343|566516975|FG001|Week 52 to Week 104|Pregnancy|0|||
156933414|NCT01604343|566516976|FG002|Week 52 to Week 104|Pregnancy|1|||
156933415|NCT01604343|566516977|FG003|Week 52 to Week 104|Pregnancy|2|||
156933416|NCT01604343|566516978|FG004|Week 52 to Week 104|Pregnancy|1|||
156933417|NCT01604343|566516974|FG000|Week 52 to Week 104|Other|0|||
156933418|NCT01604343|566516975|FG001|Week 52 to Week 104|Other|11|||
156933419|NCT01604343|566516976|FG002|Week 52 to Week 104|Other|11|||
156933420|NCT01604343|566516977|FG003|Week 52 to Week 104|Other|6|||
156933421|NCT01604343|566516978|FG004|Week 52 to Week 104|Other|3|||
156933422|NCT01604343|566516974|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
156933423|NCT01604343|566516975|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156933424|NCT01604343|566516976|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
156933425|NCT01604343|566516977|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156933426|NCT01604343|566516978|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
156933427|NCT01604343|566516974|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
156933428|NCT01604343|566516975|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
156933429|NCT01604343|566516976|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
156933430|NCT01604343|566516977|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
156933431|NCT01604343|566516978|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
156933432|NCT01604343|566516974|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
156933433|NCT01604343|566516975|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
156933434|NCT01604343|566516976|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
156933435|NCT01604343|566516977|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
156933436|NCT01604343|566516978|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
156933437|NCT05442554|566516979|FG000|Overall Study|Adverse Event|1|||
156933438|NCT02972632|566516981|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156933439|NCT02972632|566516981|FG000|Overall Study|Lost to Follow-up|4|||
156933440|NCT02972632|566516981|FG000|Overall Study|Voluntary Withdrawal|10|||
156933441|NCT01446965|566516982|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
156933442|NCT01446965|566516983|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
156933443|NCT01446965|566516982|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
156933444|NCT01446965|566516983|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
156933445|NCT02023151|566516984|FG000|Overall Study|Lost to Follow-up|4|||
156933446|NCT03450707|566516985|FG000|Overall Study|Outside enrollment window|4|||
156933447|NCT03450707|566516986|FG001|Overall Study|Outside enrollment window|1|||
156933448|NCT03450707|566516985|FG000|Overall Study|Death|1|||
156933449|NCT03450707|566516986|FG001|Overall Study|Death|0|||
156933450|NCT03450707|566516985|FG000|Overall Study|Indication for thiamine|1|||
156933451|NCT03450707|566516986|FG001|Overall Study|Indication for thiamine|1|||
156933452|NCT03450707|566516985|FG000|Overall Study|Evidence of traumatic brain injury|1|||
156933453|NCT03450707|566516986|FG001|Overall Study|Evidence of traumatic brain injury|0|||
156933454|NCT03450707|566516985|FG000|Overall Study|Following commands|0|||
156933455|NCT03450707|566516986|FG001|Overall Study|Following commands|3|||
156933456|NCT03450707|566516985|FG000|Overall Study|Lactate < 3.5|0|||
156933457|NCT03450707|566516986|FG001|Overall Study|Lactate < 3.5|2|||
156933458|NCT03450707|566516985|FG000|Overall Study|Rearrest with ECMO|0|||
156933459|NCT03450707|566516986|FG001|Overall Study|Rearrest with ECMO|1|||
156933460|NCT03450707|566516985|FG000|Overall Study|Indication for thiamine + head CT results|0|||
156933461|NCT03450707|566516986|FG001|Overall Study|Indication for thiamine + head CT results|1|||
156933462|NCT03450707|566516985|FG000|Overall Study|Family/patient goals of care|0|||
156933463|NCT03450707|566516986|FG001|Overall Study|Family/patient goals of care|1|||
156933464|NCT00004412|566516987|FG000|Randomized Period|Moved to Crossover Period|3|||
156933465|NCT00004412|566516988|FG001|Randomized Period|Moved to Crossover Period|0|||
156933466|NCT00004412|566516989|FG002|Randomized Period|Moved to Crossover Period|0|||
156933467|NCT02016482|566516999|FG000|Period A|Adverse Event|3|||
156933468|NCT02016482|566517000|FG001|Period A|Adverse Event|5|||
156933469|NCT02016482|566516999|FG000|Period A|Withdrawal by Subject|3|||
156933470|NCT02016482|566517000|FG001|Period A|Withdrawal by Subject|4|||
156933471|NCT02016482|566516999|FG000|Period A|Lost to Follow-up|3|||
156933472|NCT02016482|566517000|FG001|Period A|Lost to Follow-up|3|||
156933473|NCT02016482|566516999|FG000|Period A|Lack of Efficacy|2|||
156933474|NCT02016482|566517000|FG001|Period A|Lack of Efficacy|1|||
156933475|NCT02016482|566516999|FG000|Period A|Other|3|||
156933476|NCT02016482|566517000|FG001|Period A|Other|0|||
156933477|NCT02016482|566516999|FG000|Period A|Protocol Violation|0|||
156933478|NCT02016482|566517000|FG001|Period A|Protocol Violation|1|||
156933479|NCT02016482|566516999|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
156933480|NCT02016482|566517000|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
156933481|NCT02016482|566516999|FG000|Period B|Withdrawal by Subject|1|||
156933482|NCT02016482|566517000|FG001|Period B|Withdrawal by Subject|1|||
156933483|NCT02016482|566516999|FG000|Period B|Lost to Follow-up|2|||
156933484|NCT02016482|566517000|FG001|Period B|Lost to Follow-up|0|||
156933485|NCT02016482|566516999|FG000|Period B|Lack of Efficacy|6|||
156933486|NCT02016482|566517000|FG001|Period B|Lack of Efficacy|4|||
156933487|NCT02016482|566516999|FG000|Period B|Other|4|||
157030067|NCT03221426|566865067|FG000|Overall Study|Ongoing in study|212|||
157030068|NCT03221426|566865068|FG001|Overall Study|Ongoing in study|193|||
156933488|NCT02016482|566517000|FG001|Period B|Other|0|||
156933489|NCT02016482|566516999|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
156933490|NCT02016482|566517000|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
156933491|NCT03387813|566517001|FG000|Overall Study|Death|40|||
156933492|NCT03387813|566517002|FG001|Overall Study|Death|37|||
156933493|NCT03387813|566517003|FG002|Overall Study|Death|190|||
156933494|NCT03387813|566517001|FG000|Overall Study|Withdrawal by Subject|9|||
156933495|NCT03387813|566517002|FG001|Overall Study|Withdrawal by Subject|19|||
156933496|NCT03387813|566517003|FG002|Overall Study|Withdrawal by Subject|32|||
156933497|NCT03387813|566517001|FG000|Overall Study|Lost to Follow-up|3|||
156933498|NCT03387813|566517002|FG001|Overall Study|Lost to Follow-up|9|||
156933499|NCT03387813|566517003|FG002|Overall Study|Lost to Follow-up|15|||
156933500|NCT03387813|566517001|FG000|Overall Study|Non-Compliance|6|||
156933501|NCT03387813|566517002|FG001|Overall Study|Non-Compliance|6|||
156933502|NCT03387813|566517003|FG002|Overall Study|Non-Compliance|31|||
156933503|NCT03387813|566517001|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
156933504|NCT03387813|566517002|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
156933505|NCT03387813|566517003|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
156933506|NCT03161483|566517006|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156933507|NCT03161483|566517007|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
156933508|NCT03161483|566517008|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156933509|NCT03161483|566517009|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
156933510|NCT03161483|566517006|FG000|Treatment Period|Death|1|||
156933511|NCT03161483|566517007|FG001|Treatment Period|Death|0|||
156933512|NCT03161483|566517008|FG002|Treatment Period|Death|0|||
156933513|NCT03161483|566517009|FG003|Treatment Period|Death|0|||
156933514|NCT03161483|566517006|FG000|Treatment Period|Adverse Event|5|||
156933515|NCT03161483|566517007|FG001|Treatment Period|Adverse Event|2|||
156933516|NCT03161483|566517008|FG002|Treatment Period|Adverse Event|1|||
156933517|NCT03161483|566517009|FG003|Treatment Period|Adverse Event|11|||
156933518|NCT03161483|566517006|FG000|Treatment Period|Pregnancy|1|||
156933519|NCT03161483|566517007|FG001|Treatment Period|Pregnancy|0|||
156933520|NCT03161483|566517008|FG002|Treatment Period|Pregnancy|0|||
156933521|NCT03161483|566517009|FG003|Treatment Period|Pregnancy|0|||
156933522|NCT03161483|566517006|FG000|Treatment Period|Lack of Efficacy|0|||
156933523|NCT03161483|566517007|FG001|Treatment Period|Lack of Efficacy|0|||
156933524|NCT03161483|566517008|FG002|Treatment Period|Lack of Efficacy|0|||
156933525|NCT03161483|566517009|FG003|Treatment Period|Lack of Efficacy|1|||
156933526|NCT03161483|566517006|FG000|Treatment Period|Withdrawal by Subject|2|||
156933527|NCT03161483|566517007|FG001|Treatment Period|Withdrawal by Subject|5|||
156933528|NCT03161483|566517008|FG002|Treatment Period|Withdrawal by Subject|2|||
156933529|NCT03161483|566517009|FG003|Treatment Period|Withdrawal by Subject|6|||
156933530|NCT03161483|566517006|FG000|Treatment Period|Lost to Follow-up|0|||
157030069|NCT03221426|566865069|FG002|Overall Study|Ongoing in study|61|||
157030070|NCT03221426|566865070|FG003|Overall Study|Ongoing in study|55|||
157030071|NCT03221426|566865067|FG000|Overall Study|Withdrawal by Subject|12|||
157030072|NCT03221426|566865068|FG001|Overall Study|Withdrawal by Subject|4|||
157030073|NCT03221426|566865069|FG002|Overall Study|Withdrawal by Subject|2|||
157030074|NCT03221426|566865070|FG003|Overall Study|Withdrawal by Subject|3|||
157030075|NCT03221426|566865067|FG000|Overall Study|Lost to Follow-up|4|||
157030076|NCT03221426|566865068|FG001|Overall Study|Lost to Follow-up|1|||
157030077|NCT03221426|566865069|FG002|Overall Study|Lost to Follow-up|1|||
157030078|NCT03221426|566865070|FG003|Overall Study|Lost to Follow-up|0|||
157030079|NCT03221426|566865067|FG000|Overall Study|Death|174|||
157166988|NCT00424346|567352624|FG002|Extension Phase|Death|0|||
157166989|NCT00424346|567352625|FG003|Extension Phase|Death|1|||
157166990|NCT00424346|567352622|FG000|Extension Phase|Protocol Violation|0|||
157166991|NCT00424346|567352623|FG001|Extension Phase|Protocol Violation|1|||
157166992|NCT00424346|567352624|FG002|Extension Phase|Protocol Violation|1|||
156933531|NCT03161483|566517007|FG001|Treatment Period|Lost to Follow-up|0|||
156933532|NCT03161483|566517008|FG002|Treatment Period|Lost to Follow-up|0|||
156933533|NCT03161483|566517009|FG003|Treatment Period|Lost to Follow-up|1|||
156933534|NCT03161483|566517006|FG000|Treatment Period|Protocol Violation|0|||
156933535|NCT03161483|566517007|FG001|Treatment Period|Protocol Violation|0|||
156933536|NCT03161483|566517008|FG002|Treatment Period|Protocol Violation|0|||
156933537|NCT03161483|566517009|FG003|Treatment Period|Protocol Violation|1|||
156933538|NCT03161483|566517006|FG000|Treatment Period|Other reasons|1|||
156933539|NCT03161483|566517007|FG001|Treatment Period|Other reasons|1|||
157030080|NCT03221426|566865068|FG001|Overall Study|Death|204|||
157166993|NCT00424346|567352625|FG003|Extension Phase|Protocol Violation|0|||
156933540|NCT03161483|566517008|FG002|Treatment Period|Other reasons|0|||
156933541|NCT03161483|566517009|FG003|Treatment Period|Other reasons|0|||
157030081|NCT03221426|566865069|FG002|Overall Study|Death|36|||
157030082|NCT03221426|566865070|FG003|Overall Study|Death|45|||
157030083|NCT00696111|566866729|FG000|Overall Study|Withdrawal by Subject|17|||
156933542|NCT00805766|566517015|FG000|Screening Period|Adverse Event|1|||
156933543|NCT00805766|566517015|FG000|Screening Period|Lack of Efficacy|2|||
156933544|NCT00805766|566517015|FG000|Screening Period|Pregnancy|1|||
156933545|NCT00805766|566517015|FG000|Screening Period|Responder|2|||
156933546|NCT00805766|566517015|FG000|Increased Dose Period|Adverse Event|4|||
156933547|NCT00805766|566517015|FG000|Increased Dose Period|Lack of Efficacy|7|||
156933548|NCT00805766|566517015|FG000|Increased Dose Period|Pregnancy|1|||
156933549|NCT00805766|566517015|FG000|Increased Dose Period|Withdrawal by Subject|1|||
156933550|NCT00409617|566517020|FG000|Overall Study|Adverse Event|57|||
156933551|NCT00409617|566517020|FG000|Overall Study|Lack of Efficacy|54|||
156933552|NCT00409617|566517020|FG000|Overall Study|Lost to Follow-up|2|||
156933553|NCT00409617|566517020|FG000|Overall Study|Protocol Violation|24|||
156933554|NCT00409617|566517020|FG000|Overall Study|Withdrawal by Subject|8|||
156933555|NCT00409617|566517020|FG000|Overall Study|Administrative reasons|1|||
156933556|NCT00409617|566517020|FG000|Overall Study|Not described|14|||
156933557|NCT00149747|566517021|FG000|Overall Study|Death|1|||
156933558|NCT00149747|566517022|FG001|Overall Study|Death|0|||
156933559|NCT00149747|566517021|FG000|Overall Study|Withdrawal by Subject|3|||
156933560|NCT00149747|566517022|FG001|Overall Study|Withdrawal by Subject|3|||
156933561|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
156933562|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
156933563|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
156933564|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
156933565|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
156933566|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
157030084|NCT03676192|566866733|FG000|Induction Study Period|Adverse Event|21|||
157030085|NCT03676192|566866734|FG001|Induction Study Period|Adverse Event|20|||
157030086|NCT03676192|566866733|FG000|Induction Study Period|Death|23|||
157030087|NCT03676192|566866734|FG001|Induction Study Period|Death|20|||
157030088|NCT03676192|566866733|FG000|Induction Study Period|Lost to Follow-up|3|||
157030089|NCT03676192|566866734|FG001|Induction Study Period|Lost to Follow-up|3|||
157030090|NCT03676192|566866733|FG000|Induction Study Period|Physician Decision|6|||
157030091|NCT03676192|566866734|FG001|Induction Study Period|Physician Decision|3|||
157030092|NCT03676192|566866733|FG000|Induction Study Period|Progressive Disease|32|||
157030093|NCT03676192|566866734|FG001|Induction Study Period|Progressive Disease|21|||
157030094|NCT03676192|566866733|FG000|Induction Study Period|Protocol Violation|1|||
157030095|NCT03676192|566866734|FG001|Induction Study Period|Protocol Violation|2|||
157030096|NCT03676192|566866733|FG000|Induction Study Period|Withdrawal by Subject|20|||
157030097|NCT03676192|566866734|FG001|Induction Study Period|Withdrawal by Subject|15|||
157030098|NCT03386578|566866736|FG000|PK Component|Lost to Follow-up|0|||
157030099|NCT03386578|566866737|FG001|PK Component|Lost to Follow-up|1|||
157030100|NCT03386578|566866738|FG002|PK Component|Lost to Follow-up|0|||
157030101|NCT03386578|566866739|FG003|PK Component|Lost to Follow-up|0|||
157030102|NCT03386578|566866740|FG004|PK Component|Lost to Follow-up|0|||
157030103|NCT03386578|566866741|FG005|PK Component|Lost to Follow-up|0|||
157030104|NCT03386578|566866742|FG006|PK Component|Lost to Follow-up|1|||
157030105|NCT03386578|566866743|FG007|PK Component|Lost to Follow-up|0|||
157030106|NCT03386578|566866744|FG008|PK Component|Lost to Follow-up|0|||
157030107|NCT03386578|566866745|FG009|PK Component|Lost to Follow-up|0|||
157030108|NCT03386578|566866736|FG000|PK Component|Stillbirth/Abortion|0|||
157030109|NCT03386578|566866737|FG001|PK Component|Stillbirth/Abortion|0|||
157030110|NCT03386578|566866738|FG002|PK Component|Stillbirth/Abortion|0|||
157030111|NCT03386578|566866739|FG003|PK Component|Stillbirth/Abortion|0|||
157030112|NCT03386578|566866740|FG004|PK Component|Stillbirth/Abortion|0|||
157166994|NCT03947255|567352627|FG000|Overall Study|Study Closure by Sponsor|2|||
157166995|NCT03947255|567352628|FG001|Overall Study|Study Closure by Sponsor|2|||
157166996|NCT03947255|567352627|FG000|Overall Study|Withdrawal by Subject|2|||
156933567|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
156933568|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156933569|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156933570|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
156933571|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
156933572|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
156933573|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
156933574|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
156933575|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
156933576|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
157166997|NCT03947255|567352628|FG001|Overall Study|Withdrawal by Subject|2|||
156933577|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156933578|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156933579|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
156933580|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
157030113|NCT03386578|566866741|FG005|PK Component|Stillbirth/Abortion|2|||
157030114|NCT03386578|566866742|FG006|PK Component|Stillbirth/Abortion|0|||
157166998|NCT03947255|567352627|FG000|Overall Study|Lost to Follow-up|2|||
157030115|NCT03386578|566866743|FG007|PK Component|Stillbirth/Abortion|0|||
157030116|NCT03386578|566866744|FG008|PK Component|Stillbirth/Abortion|0|||
157166999|NCT03947255|567352628|FG001|Overall Study|Lost to Follow-up|0|||
157167000|NCT03947255|567352627|FG000|Overall Study|Death|0|||
157167001|NCT03947255|567352628|FG001|Overall Study|Death|2|||
157167002|NCT02499575|567352629|FG000|Overall Study|Protocol Violation|0|||
157167003|NCT02499575|567352630|FG001|Overall Study|Protocol Violation|1|||
156933581|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
156933582|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156933583|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
156933584|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156933585|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
156933586|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156933587|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
156933588|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156933589|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156933590|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
156933591|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
156933592|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
156933593|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
156933594|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
156933595|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
156933596|NCT03373383|566517023|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
156933597|NCT03373383|566517024|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
156933598|NCT03373383|566517025|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
156933599|NCT03373383|566517026|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
156933600|NCT03373383|566517027|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
156933601|NCT03373383|566517023|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
156933602|NCT03373383|566517024|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156933603|NCT03373383|566517025|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156933604|NCT03373383|566517026|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156933605|NCT03373383|566517027|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
156933606|NCT02159521|566517028|FG000|Overall Study|Enrolled but not treated|3|||
156933607|NCT02159521|566517028|FG000|Overall Study|Withdrawal by Subject|7|||
156933608|NCT02159521|566517028|FG000|Overall Study|Lost to Follow-up|6|||
156933609|NCT02159521|566517028|FG000|Overall Study|Death|1|||
156933610|NCT02159521|566517028|FG000|Overall Study|Other than specified|1|||
156933611|NCT04753164|566517031|FG000|Overall Study|Adverse Event|0|||
156933612|NCT04753164|566517032|FG001|Overall Study|Adverse Event|2|||
156933613|NCT04753164|566517031|FG000|Overall Study|Withdrawal by Subject|9|||
156933614|NCT04753164|566517032|FG001|Overall Study|Withdrawal by Subject|7|||
156933615|NCT04753164|566517031|FG000|Overall Study|Lost to Follow-up|6|||
156933616|NCT04753164|566517032|FG001|Overall Study|Lost to Follow-up|6|||
156933617|NCT04753164|566517031|FG000|Overall Study|Other|12|||
156933618|NCT04753164|566517032|FG001|Overall Study|Other|5|||
156933619|NCT02871739|566517033|FG000|Overall Study|Lost to Follow-up|3|||
156933620|NCT02871739|566517034|FG001|Overall Study|Lost to Follow-up|2|||
156933621|NCT02871739|566517035|FG002|Overall Study|Lost to Follow-up|0|||
156933622|NCT02871739|566517036|FG003|Overall Study|Lost to Follow-up|2|||
156933623|NCT02907359|566517037|FG000|Overall Study|Death|234|||
156933624|NCT02907359|566517038|FG001|Overall Study|Death|117|||
156933625|NCT02907359|566517037|FG000|Overall Study|Withdrawal by Subject|6|||
156933626|NCT02907359|566517038|FG001|Overall Study|Withdrawal by Subject|11|||
156933627|NCT02907359|566517037|FG000|Overall Study|Lost to Follow-up|1|||
156933628|NCT02907359|566517038|FG001|Overall Study|Lost to Follow-up|0|||
156933629|NCT01354496|566517045|FG000|Period 1|Adverse Event|0|||
156933630|NCT01354496|566517046|FG001|Period 1|Adverse Event|0|||
156933631|NCT01354496|566517047|FG002|Period 1|Adverse Event|1|||
156933632|NCT01354496|566517048|FG003|Period 1|Adverse Event|0|||
156933633|NCT01354496|566517049|FG004|Period 1|Adverse Event|0|||
156933634|NCT01354496|566517050|FG005|Period 1|Adverse Event|0|||
156933635|NCT01354496|566517045|FG000|Period 1|Physician Decision|0|||
156933636|NCT01354496|566517046|FG001|Period 1|Physician Decision|0|||
156933637|NCT01354496|566517047|FG002|Period 1|Physician Decision|1|||
156933638|NCT01354496|566517048|FG003|Period 1|Physician Decision|0|||
156933639|NCT01354496|566517049|FG004|Period 1|Physician Decision|0|||
156933640|NCT01354496|566517050|FG005|Period 1|Physician Decision|0|||
156933641|NCT01354496|566517045|FG000|Period 2|Adverse Event|0|||
156933642|NCT01354496|566517046|FG001|Period 2|Adverse Event|0|||
156933643|NCT01354496|566517047|FG002|Period 2|Adverse Event|0|||
156933644|NCT01354496|566517048|FG003|Period 2|Adverse Event|1|||
156933645|NCT01354496|566517049|FG004|Period 2|Adverse Event|0|||
156933646|NCT01354496|566517050|FG005|Period 2|Adverse Event|0|||
156933647|NCT01354496|566517045|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156933648|NCT01354496|566517046|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
156933649|NCT01354496|566517047|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156933650|NCT01354496|566517048|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
157167004|NCT03287245|567352632|FG000|Overall Study|Study terminated by sponsor|3|||
157030117|NCT03386578|566866745|FG009|PK Component|Stillbirth/Abortion|0|||
157030118|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030119|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030120|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
157030121|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
157030122|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030123|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030124|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030125|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
157030126|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
157030127|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
157030128|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030129|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030130|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
157030131|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
157030132|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030133|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030134|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030135|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
157030136|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
157030137|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
157030138|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Death|0|||
157030139|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Death|0|||
157030140|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Death|1|||
157030141|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Death|0|||
157030142|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Death|0|||
157030143|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Death|0|||
157030144|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Death|0|||
157030145|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Death|9|||
157030146|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Death|5|||
157030147|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Death|0|||
157030148|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157167005|NCT03287245|567352633|FG001|Overall Study|Study terminated by sponsor|0|||
157167006|NCT03287245|567352634|FG002|Overall Study|Study terminated by sponsor|3|||
156933651|NCT01354496|566517049|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156933652|NCT01354496|566517050|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
156933653|NCT02136576|566517051|FG000|Overall Study|Lost to Follow-up|2|||
156933654|NCT02136576|566517052|FG001|Overall Study|Lost to Follow-up|0|||
156933655|NCT02136576|566517053|FG002|Overall Study|Lost to Follow-up|0|||
156933656|NCT03065244|566517060|FG000|Overall Study|Lost to Follow-up|1|||
156933657|NCT03065244|566517061|FG001|Overall Study|Lost to Follow-up|1|||
156933658|NCT03065244|566517060|FG000|Overall Study|Diagnosed with a different disease|1|||
156933659|NCT03065244|566517061|FG001|Overall Study|Diagnosed with a different disease|1|||
156933660|NCT03065244|566517060|FG000|Overall Study|Protocol Violation|0|||
156933661|NCT03065244|566517061|FG001|Overall Study|Protocol Violation|1|||
156933662|NCT03065244|566517060|FG000|Overall Study|Withdrawal by Subject|1|||
156933663|NCT03065244|566517061|FG001|Overall Study|Withdrawal by Subject|1|||
156933664|NCT02268812|566517062|FG000|Overall Study|Adverse Event|8|||
156933665|NCT02268812|566517063|FG001|Overall Study|Adverse Event|26|||
156933666|NCT02268812|566517064|FG002|Overall Study|Adverse Event|7|||
156933667|NCT02268812|566517065|FG003|Overall Study|Adverse Event|10|||
156933668|NCT02268812|566517062|FG000|Overall Study|Protocol deviation|0|||
156933669|NCT02268812|566517063|FG001|Overall Study|Protocol deviation|0|||
156933670|NCT02268812|566517064|FG002|Overall Study|Protocol deviation|1|||
156933671|NCT02268812|566517065|FG003|Overall Study|Protocol deviation|0|||
156933672|NCT02268812|566517062|FG000|Overall Study|Withdrawal by Subject|0|||
156933673|NCT02268812|566517063|FG001|Overall Study|Withdrawal by Subject|1|||
157030149|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030150|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030151|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
157030152|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030153|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030154|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030155|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157167007|NCT03287245|567352635|FG003|Overall Study|Study terminated by sponsor|1|||
157167008|NCT03287245|567352632|FG000|Overall Study|Adverse Event|1|||
156933674|NCT02268812|566517064|FG002|Overall Study|Withdrawal by Subject|0|||
156933675|NCT02268812|566517065|FG003|Overall Study|Withdrawal by Subject|0|||
156933676|NCT02268812|566517062|FG000|Overall Study|Physician Decision|3|||
156933677|NCT02268812|566517063|FG001|Overall Study|Physician Decision|1|||
156933678|NCT02268812|566517064|FG002|Overall Study|Physician Decision|0|||
156933679|NCT02268812|566517065|FG003|Overall Study|Physician Decision|1|||
156933680|NCT02268812|566517062|FG000|Overall Study|Other|5|||
156933681|NCT02268812|566517063|FG001|Overall Study|Other|4|||
156933682|NCT02268812|566517064|FG002|Overall Study|Other|1|||
156933683|NCT02268812|566517065|FG003|Overall Study|Other|3|||
156933684|NCT00075582|566517066|FG000|Overall Study|Adverse Event|3|||
156933685|NCT00075582|566517067|FG001|Overall Study|Adverse Event|1|||
156933686|NCT00075582|566517066|FG000|Overall Study|Lack of Efficacy|4|||
156933687|NCT00075582|566517067|FG001|Overall Study|Lack of Efficacy|8|||
156933688|NCT00075582|566517066|FG000|Overall Study|Physician Decision|5|||
156933689|NCT00075582|566517067|FG001|Overall Study|Physician Decision|8|||
156933690|NCT00075582|566517066|FG000|Overall Study|Withdrawal by Subject|2|||
156933691|NCT00075582|566517067|FG001|Overall Study|Withdrawal by Subject|2|||
156933692|NCT00075582|566517066|FG000|Overall Study|Ineligible for study|36|||
156933693|NCT00075582|566517067|FG001|Overall Study|Ineligible for study|16|||
156933694|NCT01951157|566517069|FG000|Overall Study|Progressive Disease|12|||
156933695|NCT01951157|566517070|FG001|Overall Study|Progressive Disease|13|||
156933696|NCT01951157|566517071|FG002|Overall Study|Progressive Disease|10|||
156933697|NCT01951157|566517069|FG000|Overall Study|Treatment-unrelated AE|1|||
156933698|NCT01951157|566517070|FG001|Overall Study|Treatment-unrelated AE|0|||
156933699|NCT01951157|566517071|FG002|Overall Study|Treatment-unrelated AE|3|||
156933700|NCT01951157|566517069|FG000|Overall Study|Study Termination|0|||
156933701|NCT01951157|566517070|FG001|Overall Study|Study Termination|0|||
156933702|NCT01951157|566517071|FG002|Overall Study|Study Termination|1|||
156933703|NCT01951157|566517069|FG000|Overall Study|Physician Decision|5|||
156933704|NCT01951157|566517070|FG001|Overall Study|Physician Decision|3|||
156933705|NCT01951157|566517071|FG002|Overall Study|Physician Decision|2|||
156933706|NCT01951157|566517069|FG000|Overall Study|Non-treatmentrelated death|2|||
156933707|NCT01951157|566517070|FG001|Overall Study|Non-treatmentrelated death|2|||
156933708|NCT01951157|566517071|FG002|Overall Study|Non-treatmentrelated death|2|||
156933709|NCT01951157|566517069|FG000|Overall Study|No treated|0|||
156933710|NCT01951157|566517070|FG001|Overall Study|No treated|1|||
156933711|NCT01951157|566517071|FG002|Overall Study|No treated|0|||
156933712|NCT01951157|566517069|FG000|Overall Study|Treatment-related AE|2|||
156933713|NCT01951157|566517070|FG001|Overall Study|Treatment-related AE|0|||
156933714|NCT01951157|566517071|FG002|Overall Study|Treatment-related AE|4|||
156933715|NCT01951157|566517069|FG000|Overall Study|Consent withdrawn by subject|0|||
156933716|NCT01951157|566517070|FG001|Overall Study|Consent withdrawn by subject|1|||
156933717|NCT01951157|566517071|FG002|Overall Study|Consent withdrawn by subject|3|||
156933718|NCT01951157|566517069|FG000|Overall Study|Treatment-related death|0|||
156933719|NCT01951157|566517070|FG001|Overall Study|Treatment-related death|2|||
156933720|NCT01951157|566517071|FG002|Overall Study|Treatment-related death|0|||
156933721|NCT04809220|566517072|FG000|Overall Study|Adverse Event|4|||
156933722|NCT04809220|566517073|FG001|Overall Study|Adverse Event|0|||
156933723|NCT04809220|566517072|FG000|Overall Study|Death|1|||
156933724|NCT04809220|566517073|FG001|Overall Study|Death|0|||
156933725|NCT04809220|566517072|FG000|Overall Study|Lost to Follow-up|3|||
156933726|NCT04809220|566517073|FG001|Overall Study|Lost to Follow-up|0|||
156933727|NCT04809220|566517072|FG000|Overall Study|Physician Decision|0|||
156933728|NCT04809220|566517073|FG001|Overall Study|Physician Decision|1|||
156933729|NCT04809220|566517072|FG000|Overall Study|Withdrawal by Subject|9|||
156933730|NCT04809220|566517073|FG001|Overall Study|Withdrawal by Subject|5|||
156933731|NCT04809220|566517072|FG000|Overall Study|Due to long-term overseas business trips|1|||
156933732|NCT04809220|566517073|FG001|Overall Study|Due to long-term overseas business trips|0|||
156933733|NCT00642668|566517084|FG000|Overall Study|Lost to Follow-up|1|||
156933734|NCT00642668|566517084|FG000|Overall Study|Adverse Event|2|||
156933735|NCT00642668|566517084|FG000|Overall Study|Death|2|||
156933736|NCT00642668|566517084|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156933737|NCT00642668|566517084|FG000|Overall Study|Failure to Return|1|||
156933738|NCT00642668|566517084|FG000|Overall Study|Dialysis Initiation|5|||
156933739|NCT00642668|566517084|FG000|Overall Study|Blood Transfusion|2|||
156933740|NCT00896337|566517085|FG000|Overall Study|Death|7|||
156933741|NCT00896337|566517085|FG000|Overall Study|Withdrawal by Subject|7|||
156933742|NCT00896337|566517085|FG000|Overall Study|Lost to Follow-up|11|||
156933743|NCT01586819|566517086|FG000|Overall Study|Withdrawal by Subject|1|||
156933744|NCT01586819|566517087|FG001|Overall Study|Withdrawal by Subject|0|||
156933745|NCT01675882|566518904|FG000|Overall Study|Adverse Event|0|||
156933746|NCT01675882|566518905|FG001|Overall Study|Adverse Event|2|||
156933747|NCT01675882|566518906|FG002|Overall Study|Adverse Event|1|||
156933748|NCT01675882|566518907|FG003|Overall Study|Adverse Event|0|||
156933749|NCT01675882|566518904|FG000|Overall Study|Participant unwilling to continue|2|||
156933750|NCT01675882|566518905|FG001|Overall Study|Participant unwilling to continue|4|||
156933751|NCT01675882|566518906|FG002|Overall Study|Participant unwilling to continue|2|||
156933752|NCT01675882|566518907|FG003|Overall Study|Participant unwilling to continue|1|||
156933753|NCT01675882|566518904|FG000|Overall Study|Lost to Follow-up|0|||
156933754|NCT01675882|566518905|FG001|Overall Study|Lost to Follow-up|1|||
156933755|NCT01675882|566518906|FG002|Overall Study|Lost to Follow-up|0|||
156933756|NCT01675882|566518907|FG003|Overall Study|Lost to Follow-up|0|||
156933757|NCT01675882|566518904|FG000|Overall Study|Non-compliance|0|||
157167009|NCT03287245|567352633|FG001|Overall Study|Adverse Event|0|||
157167010|NCT03287245|567352634|FG002|Overall Study|Adverse Event|0|||
156933758|NCT01675882|566518905|FG001|Overall Study|Non-compliance|0|||
156933759|NCT01675882|566518906|FG002|Overall Study|Non-compliance|0|||
156933760|NCT01675882|566518907|FG003|Overall Study|Non-compliance|1|||
156933761|NCT00850200|566518908|FG000|Overall Study|Physician Decision|2|||
156933762|NCT00850200|566518908|FG000|Overall Study|Did not recieve treatment|2|||
156933763|NCT00850200|566518908|FG000|Overall Study|Withdrawal by Subject|1|||
156933764|NCT04238728|566518923|FG000|Overall Study|Withdrawal by Subject|1|||
156933765|NCT04238728|566518923|FG000|Overall Study|Lost to Follow-up|2|||
156933766|NCT00829296|566518925|FG000|Overall Study|Adverse Event|5|||
156933767|NCT00829296|566518926|FG001|Overall Study|Adverse Event|4|||
156933768|NCT04960228|566518928|FG000|Overall Study|Withdrawal by Subject|216|||
156933769|NCT04960228|566518929|FG001|Overall Study|Withdrawal by Subject|35|||
156933770|NCT04960228|566518928|FG000|Overall Study|Failed attention check|69|||
156933771|NCT04960228|566518929|FG001|Overall Study|Failed attention check|148|||
156933772|NCT04960228|566518928|FG000|Overall Study|Flagged for response quality by Dynata|3|||
156933773|NCT04960228|566518929|FG001|Overall Study|Flagged for response quality by Dynata|3|||
156933774|NCT01987427|566518930|FG000|Overall Study|Adverse Event|4|||
156933775|NCT01987427|566518931|FG001|Overall Study|Adverse Event|2|||
156933776|NCT01987427|566518932|FG002|Overall Study|Adverse Event|8|||
156933777|NCT01987427|566518930|FG000|Overall Study|Lost to Follow-up|6|||
156933778|NCT01987427|566518931|FG001|Overall Study|Lost to Follow-up|6|||
156933779|NCT01987427|566518932|FG002|Overall Study|Lost to Follow-up|9|||
156933780|NCT01987427|566518930|FG000|Overall Study|Withdrawal by Subject|2|||
156933781|NCT01987427|566518931|FG001|Overall Study|Withdrawal by Subject|1|||
156933782|NCT01987427|566518932|FG002|Overall Study|Withdrawal by Subject|3|||
156933783|NCT01987427|566518930|FG000|Overall Study|Lack of Efficacy|1|||
156933784|NCT01987427|566518931|FG001|Overall Study|Lack of Efficacy|0|||
156933785|NCT01987427|566518932|FG002|Overall Study|Lack of Efficacy|0|||
156933786|NCT01987427|566518930|FG000|Overall Study|Other|1|||
156933787|NCT01987427|566518931|FG001|Overall Study|Other|1|||
156933788|NCT01987427|566518932|FG002|Overall Study|Other|0|||
156933789|NCT02129803|566518938|FG000|Overall Study|Protocol Violation|4|||
156933790|NCT02129803|566518939|FG001|Overall Study|Protocol Violation|0|||
156933791|NCT02129803|566518938|FG000|Overall Study|Physician Decision|0|||
156933792|NCT02129803|566518939|FG001|Overall Study|Physician Decision|1|||
156933793|NCT02129803|566518938|FG000|Overall Study|Difficulty sleeping|1|||
156933794|NCT02129803|566518939|FG001|Overall Study|Difficulty sleeping|0|||
156933795|NCT02129803|566518938|FG000|Overall Study|Morning headache|0|||
156933796|NCT02129803|566518939|FG001|Overall Study|Morning headache|1|||
156933797|NCT02129803|566518938|FG000|Overall Study|Withdrawal by Subject|1|||
156933798|NCT02129803|566518939|FG001|Overall Study|Withdrawal by Subject|1|||
156933799|NCT02689258|566518943|FG000|Overall Study|Subject Non-Compliance|0|||
156933800|NCT02689258|566518944|FG001|Overall Study|Subject Non-Compliance|1|||
156933801|NCT02689258|566518945|FG002|Overall Study|Subject Non-Compliance|0|||
156933802|NCT02689258|566518946|FG003|Overall Study|Subject Non-Compliance|0|||
156933803|NCT02689258|566518947|FG004|Overall Study|Subject Non-Compliance|0|||
156933804|NCT02689258|566518948|FG005|Overall Study|Subject Non-Compliance|0|||
156933805|NCT02689258|566518949|FG006|Overall Study|Subject Non-Compliance|0|||
156933806|NCT02689258|566518950|FG007|Overall Study|Subject Non-Compliance|0|||
156933807|NCT02689258|566518951|FG008|Overall Study|Subject Non-Compliance|0|||
156933808|NCT02689258|566518952|FG009|Overall Study|Subject Non-Compliance|0|||
156933809|NCT02689258|566518953|FG010|Overall Study|Subject Non-Compliance|0|||
156933810|NCT02689258|566518954|FG011|Overall Study|Subject Non-Compliance|0|||
156933811|NCT02689258|566518943|FG000|Overall Study|Subject Refusal to Continue|0|||
156933812|NCT02689258|566518944|FG001|Overall Study|Subject Refusal to Continue|1|||
156933813|NCT02689258|566518945|FG002|Overall Study|Subject Refusal to Continue|0|||
156933814|NCT02689258|566518946|FG003|Overall Study|Subject Refusal to Continue|0|||
156933815|NCT02689258|566518947|FG004|Overall Study|Subject Refusal to Continue|0|||
156933816|NCT02689258|566518948|FG005|Overall Study|Subject Refusal to Continue|0|||
157167011|NCT03287245|567352635|FG003|Overall Study|Adverse Event|0|||
157167012|NCT03287245|567352632|FG000|Overall Study|Withdrawal by Subject|8|||
157167013|NCT03287245|567352633|FG001|Overall Study|Withdrawal by Subject|3|||
157167014|NCT03287245|567352634|FG002|Overall Study|Withdrawal by Subject|3|||
157167015|NCT03287245|567352635|FG003|Overall Study|Withdrawal by Subject|0|||
156933817|NCT02689258|566518949|FG006|Overall Study|Subject Refusal to Continue|0|||
156933818|NCT02689258|566518950|FG007|Overall Study|Subject Refusal to Continue|0|||
156933819|NCT02689258|566518951|FG008|Overall Study|Subject Refusal to Continue|1|||
156933820|NCT02689258|566518952|FG009|Overall Study|Subject Refusal to Continue|0|||
157167016|NCT03287245|567352632|FG000|Overall Study|Physician Decision|3|||
157167017|NCT03287245|567352633|FG001|Overall Study|Physician Decision|2|||
157167018|NCT03287245|567352634|FG002|Overall Study|Physician Decision|0|||
156933821|NCT02689258|566518953|FG010|Overall Study|Subject Refusal to Continue|0|||
156933822|NCT02689258|566518954|FG011|Overall Study|Subject Refusal to Continue|1|||
156933823|NCT02689258|566518943|FG000|Overall Study|Other|0|||
156933824|NCT02689258|566518944|FG001|Overall Study|Other|2|||
156933825|NCT02689258|566518945|FG002|Overall Study|Other|0|||
156933826|NCT02689258|566518946|FG003|Overall Study|Other|0|||
156933827|NCT02689258|566518947|FG004|Overall Study|Other|1|||
156933828|NCT02689258|566518948|FG005|Overall Study|Other|0|||
156933829|NCT02689258|566518949|FG006|Overall Study|Other|0|||
156933830|NCT02689258|566518950|FG007|Overall Study|Other|0|||
156933831|NCT02689258|566518951|FG008|Overall Study|Other|1|||
156933832|NCT02689258|566518952|FG009|Overall Study|Other|0|||
156933833|NCT02689258|566518953|FG010|Overall Study|Other|0|||
156933834|NCT02689258|566518954|FG011|Overall Study|Other|0|||
156933835|NCT00594464|566518956|FG000|Overall Study|Withdrawal by Subject|1|||
156933836|NCT00594464|566518956|FG000|Overall Study|Delay in operation|2|||
156933837|NCT00785486|566518957|FG000|Midazolam Alone|Withdrawal by Subject|1|||
156933838|NCT03131440|566518962|FG000|Overall Study|Withdrawal by Subject|1|||
156933839|NCT03131440|566518963|FG001|Overall Study|Withdrawal by Subject|3|||
156933840|NCT03131440|566518964|FG002|Overall Study|Withdrawal by Subject|0|||
156933841|NCT03131440|566518965|FG003|Overall Study|Withdrawal by Subject|0|||
156933842|NCT03131440|566518966|FG004|Overall Study|Withdrawal by Subject|1|||
156933843|NCT03131440|566518967|FG005|Overall Study|Withdrawal by Subject|0|||
156933844|NCT03131440|566518968|FG006|Overall Study|Withdrawal by Subject|0|||
156933845|NCT03131440|566518969|FG007|Overall Study|Withdrawal by Subject|1|||
156933846|NCT03131440|566518970|FG008|Overall Study|Withdrawal by Subject|1|||
156933847|NCT03131440|566518971|FG009|Overall Study|Withdrawal by Subject|1|||
156933848|NCT03131440|566518972|FG010|Overall Study|Withdrawal by Subject|0|||
156933849|NCT03131440|566518973|FG011|Overall Study|Withdrawal by Subject|1|||
156933850|NCT03131440|566518974|FG012|Overall Study|Withdrawal by Subject|1|||
156933851|NCT03131440|566518975|FG013|Overall Study|Withdrawal by Subject|0|||
156933852|NCT03131440|566518976|FG014|Overall Study|Withdrawal by Subject|1|||
156933853|NCT03131440|566518977|FG015|Overall Study|Withdrawal by Subject|0|||
156933854|NCT03131440|566518978|FG016|Overall Study|Withdrawal by Subject|0|||
156933855|NCT03131440|566518979|FG017|Overall Study|Withdrawal by Subject|0|||
156933856|NCT03131440|566518980|FG018|Overall Study|Withdrawal by Subject|1|||
156933857|NCT03131440|566518981|FG019|Overall Study|Withdrawal by Subject|0|||
156933858|NCT03131440|566518982|FG020|Overall Study|Withdrawal by Subject|1|||
156933859|NCT03131440|566518983|FG021|Overall Study|Withdrawal by Subject|1|||
156933860|NCT03131440|566518984|FG022|Overall Study|Withdrawal by Subject|1|||
156933861|NCT03131440|566518985|FG023|Overall Study|Withdrawal by Subject|0|||
156933862|NCT03131440|566518986|FG024|Overall Study|Withdrawal by Subject|0|||
156933863|NCT03131440|566518987|FG025|Overall Study|Withdrawal by Subject|0|||
156933864|NCT03131440|566518988|FG026|Overall Study|Withdrawal by Subject|0|||
156933865|NCT03131440|566518989|FG027|Overall Study|Withdrawal by Subject|0|||
156933866|NCT03131440|566518990|FG028|Overall Study|Withdrawal by Subject|0|||
156933867|NCT03131440|566518991|FG029|Overall Study|Withdrawal by Subject|0|||
156933868|NCT03131440|566518992|FG030|Overall Study|Withdrawal by Subject|1|||
156933869|NCT03131440|566518993|FG031|Overall Study|Withdrawal by Subject|0|||
156933870|NCT03131440|566518962|FG000|Overall Study|Lost to Follow-up|0|||
156933871|NCT03131440|566518963|FG001|Overall Study|Lost to Follow-up|0|||
156933872|NCT03131440|566518964|FG002|Overall Study|Lost to Follow-up|0|||
156933873|NCT03131440|566518965|FG003|Overall Study|Lost to Follow-up|0|||
156933874|NCT03131440|566518966|FG004|Overall Study|Lost to Follow-up|0|||
156933875|NCT03131440|566518967|FG005|Overall Study|Lost to Follow-up|1|||
156933876|NCT03131440|566518968|FG006|Overall Study|Lost to Follow-up|0|||
156933877|NCT03131440|566518969|FG007|Overall Study|Lost to Follow-up|0|||
156933878|NCT03131440|566518970|FG008|Overall Study|Lost to Follow-up|0|||
156933879|NCT03131440|566518971|FG009|Overall Study|Lost to Follow-up|0|||
156933880|NCT03131440|566518972|FG010|Overall Study|Lost to Follow-up|0|||
156933881|NCT03131440|566518973|FG011|Overall Study|Lost to Follow-up|0|||
156933882|NCT03131440|566518974|FG012|Overall Study|Lost to Follow-up|0|||
156933883|NCT03131440|566518975|FG013|Overall Study|Lost to Follow-up|0|||
156933884|NCT03131440|566518976|FG014|Overall Study|Lost to Follow-up|0|||
156933885|NCT03131440|566518977|FG015|Overall Study|Lost to Follow-up|0|||
156933886|NCT03131440|566518978|FG016|Overall Study|Lost to Follow-up|0|||
156933887|NCT03131440|566518979|FG017|Overall Study|Lost to Follow-up|0|||
156933888|NCT03131440|566518980|FG018|Overall Study|Lost to Follow-up|0|||
156933889|NCT03131440|566518981|FG019|Overall Study|Lost to Follow-up|2|||
156933890|NCT03131440|566518982|FG020|Overall Study|Lost to Follow-up|1|||
156933891|NCT03131440|566518983|FG021|Overall Study|Lost to Follow-up|0|||
156933892|NCT03131440|566518984|FG022|Overall Study|Lost to Follow-up|1|||
156933893|NCT03131440|566518985|FG023|Overall Study|Lost to Follow-up|0|||
156933894|NCT03131440|566518986|FG024|Overall Study|Lost to Follow-up|1|||
156933895|NCT03131440|566518987|FG025|Overall Study|Lost to Follow-up|0|||
156933896|NCT03131440|566518988|FG026|Overall Study|Lost to Follow-up|0|||
156933897|NCT03131440|566518989|FG027|Overall Study|Lost to Follow-up|2|||
156933898|NCT03131440|566518990|FG028|Overall Study|Lost to Follow-up|0|||
156933899|NCT03131440|566518991|FG029|Overall Study|Lost to Follow-up|2|||
156933900|NCT03131440|566518992|FG030|Overall Study|Lost to Follow-up|0|||
157030156|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
156933901|NCT03131440|566518993|FG031|Overall Study|Lost to Follow-up|0|||
156933902|NCT03131440|566518962|FG000|Overall Study|Death|0|||
156933903|NCT03131440|566518963|FG001|Overall Study|Death|0|||
157030157|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
157030158|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030159|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030160|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030161|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030162|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030163|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030164|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030165|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
157030166|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
157030167|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
157030168|NCT03386578|566866736|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030169|NCT03386578|566866737|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030170|NCT03386578|566866738|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030171|NCT03386578|566866739|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030172|NCT03386578|566866740|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030173|NCT03386578|566866741|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030174|NCT03386578|566866742|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030175|NCT03386578|566866743|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
157030176|NCT03386578|566866744|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
157030177|NCT03386578|566866745|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
157030178|NCT02694822|566866748|FG000|Phase 1|Death|2|||
157030179|NCT02694822|566866749|FG001|Phase 1|Death|1|||
157030180|NCT02694822|566866750|FG002|Phase 1|Death|6|||
157030181|NCT02694822|566866751|FG003|Phase 1|Death|6|||
157030182|NCT02694822|566866752|FG004|Phase 1|Death|3|||
157030183|NCT02694822|566866753|FG005|Phase 1|Death|0|||
157030184|NCT02694822|566866748|FG000|Phase 1|Withdrawal by Subject|2|||
157030185|NCT02694822|566866749|FG001|Phase 1|Withdrawal by Subject|2|||
157030186|NCT02694822|566866750|FG002|Phase 1|Withdrawal by Subject|4|||
157030187|NCT02694822|566866751|FG003|Phase 1|Withdrawal by Subject|8|||
157030188|NCT02694822|566866752|FG004|Phase 1|Withdrawal by Subject|1|||
157030189|NCT02694822|566866753|FG005|Phase 1|Withdrawal by Subject|0|||
157030190|NCT02694822|566866748|FG000|Phase 2|Death|0|||
157030191|NCT02694822|566866749|FG001|Phase 2|Death|0|||
157030192|NCT02694822|566866750|FG002|Phase 2|Death|0|||
157030193|NCT02694822|566866751|FG003|Phase 2|Death|0|||
157030194|NCT02694822|566866752|FG004|Phase 2|Death|0|||
157030195|NCT02694822|566866753|FG005|Phase 2|Death|26|||
157030196|NCT02694822|566866748|FG000|Phase 2|Withdrawal by Subject|0|||
157030197|NCT02694822|566866749|FG001|Phase 2|Withdrawal by Subject|0|||
157030198|NCT02694822|566866750|FG002|Phase 2|Withdrawal by Subject|0|||
157030199|NCT02694822|566866751|FG003|Phase 2|Withdrawal by Subject|0|||
157030200|NCT02694822|566866752|FG004|Phase 2|Withdrawal by Subject|0|||
157030201|NCT02694822|566866753|FG005|Phase 2|Withdrawal by Subject|13|||
157030202|NCT02694822|566866748|FG000|Phase 2|Administrative Study Closure|0|||
157227067|NCT00409578|567576034|FG003|Overall Study|Protocol Violation|1|||
157227068|NCT00409578|567576031|FG000|Overall Study|Missing|0|||
157030203|NCT02694822|566866749|FG001|Phase 2|Administrative Study Closure|0|||
157030204|NCT02694822|566866750|FG002|Phase 2|Administrative Study Closure|0|||
157030205|NCT02694822|566866751|FG003|Phase 2|Administrative Study Closure|0|||
157030206|NCT02694822|566866752|FG004|Phase 2|Administrative Study Closure|0|||
157030207|NCT02694822|566866753|FG005|Phase 2|Administrative Study Closure|2|||
157030208|NCT02694822|566866748|FG000|Phase 2|Lost to Follow-up|0|||
157030209|NCT02694822|566866749|FG001|Phase 2|Lost to Follow-up|0|||
157030210|NCT02694822|566866750|FG002|Phase 2|Lost to Follow-up|0|||
157030211|NCT02694822|566866751|FG003|Phase 2|Lost to Follow-up|0|||
157030212|NCT02694822|566866752|FG004|Phase 2|Lost to Follow-up|0|||
157030213|NCT02694822|566866753|FG005|Phase 2|Lost to Follow-up|1|||
157030214|NCT02694822|566866748|FG000|Phase 2|Participant Transferred to Another Site|0|||
157030215|NCT02694822|566866749|FG001|Phase 2|Participant Transferred to Another Site|0|||
157227069|NCT00409578|567576032|FG001|Overall Study|Missing|1|||
157227070|NCT00409578|567576033|FG002|Overall Study|Missing|0|||
157227071|NCT00409578|567576034|FG003|Overall Study|Missing|1|||
157030216|NCT02694822|566866750|FG002|Phase 2|Participant Transferred to Another Site|0|||
157030217|NCT02694822|566866751|FG003|Phase 2|Participant Transferred to Another Site|0|||
157030218|NCT02694822|566866752|FG004|Phase 2|Participant Transferred to Another Site|0|||
157030219|NCT02694822|566866753|FG005|Phase 2|Participant Transferred to Another Site|1|||
157030220|NCT01868997|566866754|FG000|Overall Study|Adverse Event|2|||
157030221|NCT01868997|566866755|FG001|Overall Study|Adverse Event|5|||
157030222|NCT01868997|566866754|FG000|Overall Study|Lack of Efficacy|2|||
157030223|NCT01868997|566866755|FG001|Overall Study|Lack of Efficacy|0|||
157030224|NCT01868997|566866754|FG000|Overall Study|Other|3|||
157030225|NCT01868997|566866755|FG001|Overall Study|Other|1|||
157030226|NCT05370040|566866756|FG000|Overall Study|Lost to Follow-up|0|||
157227072|NCT02109133|567576035|FG000|Overall Study|Lost to Follow-up|1|||
157030227|NCT05370040|566866757|FG001|Overall Study|Lost to Follow-up|0|||
157030228|NCT05370040|566866758|FG002|Overall Study|Lost to Follow-up|1|||
157030229|NCT05370040|566866759|FG003|Overall Study|Lost to Follow-up|0|||
157030230|NCT05370040|566866760|FG004|Overall Study|Lost to Follow-up|1|||
157030231|NCT05370040|566866761|FG005|Overall Study|Lost to Follow-up|0|||
157030232|NCT04730739|566866765|FG000|Overall Study|Death|1|||
157030233|NCT03308877|566866766|FG000|Overall Study|Lost to Follow-up|32|||
157030234|NCT03308877|566866767|FG001|Overall Study|Lost to Follow-up|28|||
157030235|NCT03249090|566866768|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
157030236|NCT03249090|566866769|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
157030237|NCT03249090|566866768|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
157030238|NCT03249090|566866769|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
157030239|NCT03249090|566866768|FG000|3 Month Time Point|Voluntary withdrawal|6|||
157030240|NCT03249090|566866769|FG001|3 Month Time Point|Voluntary withdrawal|3|||
157030241|NCT03249090|566866768|FG000|3 Month Time Point|Changed oncology practice|4|||
157030242|NCT03249090|566866769|FG001|3 Month Time Point|Changed oncology practice|2|||
157030243|NCT03249090|566866768|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
157030244|NCT03249090|566866769|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
157030245|NCT03249090|566866768|FG000|12 Month Time Point|Voluntary withdrawal|35|||
157030246|NCT03249090|566866769|FG001|12 Month Time Point|Voluntary withdrawal|4|||
157030247|NCT03249090|566866768|FG000|12 Month Time Point|Changed oncology practice|20|||
157030248|NCT03249090|566866769|FG001|12 Month Time Point|Changed oncology practice|9|||
157030249|NCT03523572|566866771|FG000|Dose Escalation|Progressive disease|1|||
157030250|NCT03523572|566866772|FG001|Dose Escalation|Progressive disease|0|||
157030251|NCT03523572|566866773|FG002|Dose Escalation|Progressive disease|0|||
157030252|NCT03523572|566866774|FG003|Dose Escalation|Progressive disease|0|||
157030253|NCT03523572|566866775|FG004|Dose Escalation|Progressive disease|0|||
157030254|NCT03523572|566866776|FG005|Dose Escalation|Progressive disease|0|||
157030255|NCT03523572|566866771|FG000|Dose Escalation|Clinical Progression|0|||
157030256|NCT03523572|566866772|FG001|Dose Escalation|Clinical Progression|1|||
157030257|NCT03523572|566866773|FG002|Dose Escalation|Clinical Progression|0|||
156933904|NCT03131440|566518964|FG002|Overall Study|Death|0|||
156933905|NCT03131440|566518965|FG003|Overall Study|Death|0|||
156933906|NCT03131440|566518966|FG004|Overall Study|Death|0|||
156933907|NCT03131440|566518967|FG005|Overall Study|Death|0|||
156933908|NCT03131440|566518968|FG006|Overall Study|Death|0|||
156933909|NCT03131440|566518969|FG007|Overall Study|Death|0|||
156933910|NCT03131440|566518970|FG008|Overall Study|Death|0|||
156933911|NCT03131440|566518971|FG009|Overall Study|Death|0|||
156933912|NCT03131440|566518972|FG010|Overall Study|Death|0|||
156933913|NCT03131440|566518973|FG011|Overall Study|Death|0|||
156933914|NCT03131440|566518974|FG012|Overall Study|Death|0|||
156933915|NCT03131440|566518975|FG013|Overall Study|Death|0|||
156933916|NCT03131440|566518976|FG014|Overall Study|Death|0|||
156933917|NCT03131440|566518977|FG015|Overall Study|Death|0|||
156933918|NCT03131440|566518978|FG016|Overall Study|Death|0|||
156933919|NCT03131440|566518979|FG017|Overall Study|Death|0|||
156933920|NCT03131440|566518980|FG018|Overall Study|Death|0|||
156933921|NCT03131440|566518981|FG019|Overall Study|Death|0|||
156933922|NCT03131440|566518982|FG020|Overall Study|Death|0|||
156933923|NCT03131440|566518983|FG021|Overall Study|Death|0|||
156933924|NCT03131440|566518984|FG022|Overall Study|Death|0|||
156933925|NCT03131440|566518985|FG023|Overall Study|Death|0|||
156933926|NCT03131440|566518986|FG024|Overall Study|Death|0|||
156933927|NCT03131440|566518987|FG025|Overall Study|Death|1|||
156933928|NCT03131440|566518988|FG026|Overall Study|Death|0|||
156933929|NCT03131440|566518989|FG027|Overall Study|Death|0|||
156933930|NCT03131440|566518990|FG028|Overall Study|Death|0|||
157030258|NCT03523572|566866774|FG003|Dose Escalation|Clinical Progression|0|||
157030259|NCT03523572|566866775|FG004|Dose Escalation|Clinical Progression|0|||
157030260|NCT03523572|566866776|FG005|Dose Escalation|Clinical Progression|0|||
157030261|NCT03523572|566866771|FG000|Dose Escalation|Adverse Event|2|||
157030262|NCT03523572|566866772|FG001|Dose Escalation|Adverse Event|0|||
157030263|NCT03523572|566866773|FG002|Dose Escalation|Adverse Event|0|||
157030264|NCT03523572|566866774|FG003|Dose Escalation|Adverse Event|0|||
157030265|NCT03523572|566866775|FG004|Dose Escalation|Adverse Event|0|||
157030266|NCT03523572|566866776|FG005|Dose Escalation|Adverse Event|0|||
157030267|NCT03523572|566866771|FG000|Dose Escalation|Physician Decision|1|||
157030268|NCT03523572|566866772|FG001|Dose Escalation|Physician Decision|1|||
156933931|NCT03131440|566518991|FG029|Overall Study|Death|0|||
156933932|NCT03131440|566518992|FG030|Overall Study|Death|0|||
156933933|NCT03131440|566518993|FG031|Overall Study|Death|0|||
157030269|NCT03523572|566866773|FG002|Dose Escalation|Physician Decision|0|||
157030270|NCT03523572|566866774|FG003|Dose Escalation|Physician Decision|0|||
156933934|NCT00746941|566518996|FG000|Overall Study|Death|2|||
156933935|NCT00746941|566518997|FG001|Overall Study|Death|0|||
156933936|NCT00746941|566518998|FG002|Overall Study|Death|0|||
156933937|NCT00746941|566518999|FG003|Overall Study|Death|6|||
156933938|NCT00746941|566518996|FG000|Overall Study|Physician Decision|0|||
156933939|NCT00746941|566518997|FG001|Overall Study|Physician Decision|0|||
157030271|NCT03523572|566866775|FG004|Dose Escalation|Physician Decision|0|||
157030272|NCT03523572|566866776|FG005|Dose Escalation|Physician Decision|0|||
157030273|NCT03523572|566866771|FG000|Dose Expansion|Progressive Disease|0|||
157030274|NCT03523572|566866772|FG001|Dose Expansion|Progressive Disease|0|||
157030275|NCT03523572|566866773|FG002|Dose Expansion|Progressive Disease|9|||
157030276|NCT03523572|566866774|FG003|Dose Expansion|Progressive Disease|11|||
157030277|NCT03523572|566866775|FG004|Dose Expansion|Progressive Disease|15|||
157030278|NCT03523572|566866776|FG005|Dose Expansion|Progressive Disease|2|||
157030279|NCT03523572|566866771|FG000|Dose Expansion|Clinical Progression|0|||
157030280|NCT03523572|566866772|FG001|Dose Expansion|Clinical Progression|0|||
157030281|NCT03523572|566866773|FG002|Dose Expansion|Clinical Progression|2|||
157030282|NCT03523572|566866774|FG003|Dose Expansion|Clinical Progression|2|||
157030283|NCT03523572|566866775|FG004|Dose Expansion|Clinical Progression|2|||
157030284|NCT03523572|566866776|FG005|Dose Expansion|Clinical Progression|0|||
157030285|NCT03523572|566866771|FG000|Dose Expansion|Adverse Event|0|||
157030286|NCT03523572|566866772|FG001|Dose Expansion|Adverse Event|0|||
157030287|NCT03523572|566866773|FG002|Dose Expansion|Adverse Event|10|||
157030288|NCT03523572|566866774|FG003|Dose Expansion|Adverse Event|1|||
157030289|NCT03523572|566866775|FG004|Dose Expansion|Adverse Event|5|||
157030290|NCT03523572|566866776|FG005|Dose Expansion|Adverse Event|2|||
157030291|NCT03523572|566866771|FG000|Dose Expansion|Withdrawal by Subject|0|||
157030292|NCT03523572|566866772|FG001|Dose Expansion|Withdrawal by Subject|0|||
157030293|NCT03523572|566866773|FG002|Dose Expansion|Withdrawal by Subject|1|||
157030294|NCT03523572|566866774|FG003|Dose Expansion|Withdrawal by Subject|1|||
157030295|NCT03523572|566866775|FG004|Dose Expansion|Withdrawal by Subject|0|||
157030296|NCT03523572|566866776|FG005|Dose Expansion|Withdrawal by Subject|0|||
157030297|NCT03523572|566866771|FG000|Dose Expansion|Physician Decision|0|||
157030298|NCT03523572|566866772|FG001|Dose Expansion|Physician Decision|0|||
157030299|NCT03523572|566866773|FG002|Dose Expansion|Physician Decision|1|||
157030300|NCT03523572|566866774|FG003|Dose Expansion|Physician Decision|0|||
157030301|NCT03523572|566866775|FG004|Dose Expansion|Physician Decision|1|||
157030302|NCT03523572|566866776|FG005|Dose Expansion|Physician Decision|0|||
157030303|NCT03523572|566866771|FG000|Dose Expansion|Miscellaneous|0|||
157030304|NCT03523572|566866772|FG001|Dose Expansion|Miscellaneous|0|||
157030305|NCT03523572|566866773|FG002|Dose Expansion|Miscellaneous|0|||
157030306|NCT03523572|566866774|FG003|Dose Expansion|Miscellaneous|0|||
157030307|NCT03523572|566866775|FG004|Dose Expansion|Miscellaneous|3|||
157030308|NCT03523572|566866776|FG005|Dose Expansion|Miscellaneous|0|||
157030309|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
157030310|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
157030311|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
157030312|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
157030313|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
157030314|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
157030315|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
157030316|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
157030317|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
157030318|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
157030319|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
157030320|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
156933940|NCT00746941|566518998|FG002|Overall Study|Physician Decision|2|||
156933941|NCT00746941|566518999|FG003|Overall Study|Physician Decision|0|||
156933942|NCT00746941|566518996|FG000|Overall Study|Withdrawal by Subject|3|||
156933943|NCT00746941|566518997|FG001|Overall Study|Withdrawal by Subject|0|||
156933944|NCT00746941|566518998|FG002|Overall Study|Withdrawal by Subject|0|||
156933945|NCT00746941|566518999|FG003|Overall Study|Withdrawal by Subject|2|||
156933946|NCT00746941|566518996|FG000|Overall Study|Other, reason not provided|2|||
156933947|NCT00746941|566518997|FG001|Overall Study|Other, reason not provided|4|||
156933948|NCT00746941|566518998|FG002|Overall Study|Other, reason not provided|0|||
156933949|NCT00746941|566518999|FG003|Overall Study|Other, reason not provided|4|||
156933950|NCT00746941|566518996|FG000|Overall Study|Adverse Event|0|||
156933951|NCT00746941|566518997|FG001|Overall Study|Adverse Event|0|||
156933952|NCT00746941|566518998|FG002|Overall Study|Adverse Event|0|||
157030321|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
157030322|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
157030323|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
157030324|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
157030325|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
157030326|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
157030327|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
157030328|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
157030329|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
156933953|NCT00746941|566518999|FG003|Overall Study|Adverse Event|1|||
156933954|NCT02197806|566519001|FG000|Overall Study|Adverse Event|0|||
156933955|NCT02197806|566519002|FG001|Overall Study|Adverse Event|1|||
156933956|NCT02197806|566519003|FG002|Overall Study|Adverse Event|0|||
156933957|NCT02197806|566519004|FG003|Overall Study|Adverse Event|1|||
156933958|NCT00537381|566519005|FG000|Overall Study|Adverse Event|13|||
156933959|NCT00537381|566519006|FG001|Overall Study|Adverse Event|9|||
156933960|NCT00537381|566519005|FG000|Overall Study|Death|3|||
156933961|NCT00537381|566519006|FG001|Overall Study|Death|3|||
156933962|NCT00537381|566519005|FG000|Overall Study|Withdrawal by Subject|5|||
156933963|NCT00537381|566519006|FG001|Overall Study|Withdrawal by Subject|14|||
156933964|NCT00537381|566519005|FG000|Overall Study|Physician Decision|7|||
156933965|NCT00537381|566519006|FG001|Overall Study|Physician Decision|6|||
156933966|NCT00537381|566519005|FG000|Overall Study|Disease Progression|9|||
156933967|NCT00537381|566519006|FG001|Overall Study|Disease Progression|18|||
156933968|NCT00537381|566519005|FG000|Overall Study|Sponsor decision|14|||
156933969|NCT00537381|566519006|FG001|Overall Study|Sponsor decision|9|||
156933970|NCT00537381|566519005|FG000|Overall Study|Other|5|||
156933971|NCT00537381|566519006|FG001|Overall Study|Other|3|||
156933972|NCT00680901|566519007|FG000|Overall Study|Ongoing: On Study Treatment|1|||
156933973|NCT00680901|566519008|FG001|Overall Study|Ongoing: On Study Treatment|0|||
156933974|NCT00680901|566519007|FG000|Overall Study|Ongoing: In Follow Up|1|||
156933975|NCT00680901|566519008|FG001|Overall Study|Ongoing: In Follow Up|0|||
157167019|NCT03287245|567352635|FG003|Overall Study|Physician Decision|0|||
157167020|NCT02701192|567352636|FG000|Overall Study|Protocol Violation|2|||
157167021|NCT02701192|567352636|FG000|Overall Study|Lost to Follow-up|4|||
157167022|NCT02862548|567352637|FG000|Randomized Phase (Up to Week 48)|Death|0|||
157167023|NCT02862548|567352638|FG001|Randomized Phase (Up to Week 48)|Death|1|||
157167024|NCT02862548|567352637|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
157167025|NCT02862548|567352638|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
157167026|NCT02862548|567352637|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
157167027|NCT02862548|567352638|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
157167028|NCT02862548|567352637|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
157167029|NCT02862548|567352638|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
157167030|NCT01245764|567352639|FG000|Study Phase A|Other|3|||
157167031|NCT01245764|567352640|FG001|Study Phase A|Other|2|||
157167032|NCT01245764|567352641|FG002|Study Phase A|Other|3|||
157167033|NCT01245764|567352642|FG003|Study Phase A|Other|1|||
157227073|NCT02109133|567576036|FG001|Overall Study|Lost to Follow-up|0|||
156933976|NCT00680901|566519007|FG000|Overall Study|Adverse Event|1|||
156933977|NCT00680901|566519008|FG001|Overall Study|Adverse Event|1|||
156933978|NCT00680901|566519007|FG000|Overall Study|Lost to Follow-up|3|||
156933979|NCT00680901|566519008|FG001|Overall Study|Lost to Follow-up|5|||
156933980|NCT00680901|566519007|FG000|Overall Study|Subject decided to withdraw from the study|4|||
156933981|NCT00680901|566519008|FG001|Overall Study|Subject decided to withdraw from the study|15|||
156933982|NCT00680901|566519007|FG000|Overall Study|Sponsor decision|1|||
156933983|NCT00680901|566519008|FG001|Overall Study|Sponsor decision|0|||
156933984|NCT00680901|566519007|FG000|Overall Study|Physician Decision|0|||
156933985|NCT00680901|566519008|FG001|Overall Study|Physician Decision|2|||
156933986|NCT00680901|566519007|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
156933987|NCT00680901|566519008|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
156933988|NCT00680901|566519007|FG000|Overall Study|Other protocol defined stopping criteria|17|||
156933989|NCT00680901|566519008|FG001|Overall Study|Other protocol defined stopping criteria|17|||
156933990|NCT00500292|566519009|FG000|Overall Study|Adverse Event|3|||
156933991|NCT00500292|566519010|FG001|Overall Study|Adverse Event|6|||
156933992|NCT00500292|566519011|FG002|Overall Study|Adverse Event|4|||
156933993|NCT00500292|566519009|FG000|Overall Study|Condition under investigation worsened|21|||
156933994|NCT00500292|566519010|FG001|Overall Study|Condition under investigation worsened|23|||
156933995|NCT00500292|566519011|FG002|Overall Study|Condition under investigation worsened|19|||
156933996|NCT00500292|566519009|FG000|Overall Study|Withdrawal by Subject|0|||
156933997|NCT00500292|566519010|FG001|Overall Study|Withdrawal by Subject|1|||
156933998|NCT00500292|566519011|FG002|Overall Study|Withdrawal by Subject|0|||
156933999|NCT00500292|566519009|FG000|Overall Study|Other|1|||
156934000|NCT00500292|566519010|FG001|Overall Study|Other|1|||
157167034|NCT01245764|567352639|FG000|Study Phase A|Protocol Violation|6|||
157227074|NCT02448771|567576037|FG000|Overall Study|Disease Progression|30|||
156934001|NCT00500292|566519011|FG002|Overall Study|Other|4|||
156934002|NCT01708174|566519012|FG000|Treatment Period|Withdrawal by Subject|1|||
156934003|NCT01708174|566519013|FG001|Treatment Period|Withdrawal by Subject|0|||
157167035|NCT01245764|567352640|FG001|Study Phase A|Protocol Violation|3|||
157227075|NCT02448771|567576037|FG000|Overall Study|Unacceptable Toxicity|1|||
156934004|NCT01708174|566519014|FG002|Treatment Period|Withdrawal by Subject|0|||
157167036|NCT01245764|567352641|FG002|Study Phase A|Protocol Violation|2|||
157167037|NCT01245764|567352642|FG003|Study Phase A|Protocol Violation|2|||
156934005|NCT01708174|566519012|FG000|Treatment Period|Progressive disease|0|||
156934006|NCT01708174|566519013|FG001|Treatment Period|Progressive disease|1|||
156934007|NCT01708174|566519014|FG002|Treatment Period|Progressive disease|0|||
156934008|NCT01708174|566519012|FG000|Treatment Period|Death|0|||
156934009|NCT01708174|566519013|FG001|Treatment Period|Death|0|||
157167038|NCT01245764|567352639|FG000|Study Phase A|Lost to Follow-up|0|||
156934010|NCT01708174|566519014|FG002|Treatment Period|Death|1|||
156934011|NCT01708174|566519012|FG000|Treatment Period|Adverse Event|0|||
156934012|NCT01708174|566519013|FG001|Treatment Period|Adverse Event|1|||
156934013|NCT01708174|566519014|FG002|Treatment Period|Adverse Event|0|||
156934014|NCT02741700|566519015|FG000|Overall Study|Lost to Follow-up|17|||
156934015|NCT02741700|566519016|FG001|Overall Study|Lost to Follow-up|8|||
156934016|NCT02741700|566519015|FG000|Overall Study|Withdrawal by Subject|2|||
156934017|NCT02741700|566519016|FG001|Overall Study|Withdrawal by Subject|5|||
156934018|NCT02741700|566519015|FG000|Overall Study|Physician Decision|3|||
156934019|NCT02741700|566519016|FG001|Overall Study|Physician Decision|0|||
156934020|NCT02741700|566519015|FG000|Overall Study|Moved out of State|0|||
156934021|NCT02741700|566519016|FG001|Overall Study|Moved out of State|1|||
156934022|NCT02741700|566519015|FG000|Overall Study|Death|4|||
156934023|NCT02741700|566519016|FG001|Overall Study|Death|5|||
156934024|NCT00923559|566519017|FG000|Overall Study|Lost to Follow-up|2|||
156934025|NCT00923559|566519018|FG001|Overall Study|Lost to Follow-up|3|||
156934026|NCT05045144|566519020|FG000|Overall Study|Lost to Follow-up|3|||
156934027|NCT05045144|566519021|FG001|Overall Study|Lost to Follow-up|2|||
156934028|NCT05045144|566519022|FG002|Overall Study|Lost to Follow-up|3|||
156934029|NCT05045144|566519023|FG003|Overall Study|Lost to Follow-up|5|||
156934030|NCT05045144|566519024|FG004|Overall Study|Lost to Follow-up|13|||
156934031|NCT05045144|566519020|FG000|Overall Study|Withdrawal by Subject|0|||
156934032|NCT05045144|566519021|FG001|Overall Study|Withdrawal by Subject|1|||
156934033|NCT05045144|566519022|FG002|Overall Study|Withdrawal by Subject|0|||
156934034|NCT05045144|566519023|FG003|Overall Study|Withdrawal by Subject|0|||
156934035|NCT05045144|566519024|FG004|Overall Study|Withdrawal by Subject|0|||
156934036|NCT05045144|566519020|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156934037|NCT05045144|566519021|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156934038|NCT05045144|566519022|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156934039|NCT05045144|566519023|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156934040|NCT05045144|566519024|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
156934041|NCT04544293|566519025|FG000|Double-blind|Adverse Event|2|||
156934042|NCT04544293|566519026|FG001|Double-blind|Adverse Event|1|||
156934043|NCT04544293|566519025|FG000|Double-blind|Pregnancy|0|||
156934044|NCT04544293|566519026|FG001|Double-blind|Pregnancy|1|||
156934045|NCT04544293|566519025|FG000|Double-blind|Lost to Follow-up|0|||
156934046|NCT04544293|566519026|FG001|Double-blind|Lost to Follow-up|1|||
156934047|NCT04544293|566519025|FG000|Open-Label Extension|Study ongoing|79|||
156934048|NCT04544293|566519026|FG001|Open-Label Extension|Study ongoing|81|||
156934049|NCT02385084|566519027|FG000|Period 2|Protocol Violation|0|||
156934050|NCT02385084|566519028|FG001|Period 2|Protocol Violation|0|||
156934051|NCT02385084|566519029|FG002|Period 2|Protocol Violation|1|||
156934052|NCT02385084|566519030|FG003|Period 2|Protocol Violation|0|||
156934053|NCT02385084|566519031|FG004|Period 2|Protocol Violation|0|||
156934054|NCT02385084|566519032|FG005|Period 2|Protocol Violation|0|||
156934055|NCT02268786|566519034|FG000|Overall Study|No Euploid Embryos available|42|||
156934056|NCT02268786|566519035|FG001|Overall Study|No Euploid Embryos available|0|||
156934057|NCT02268786|566519034|FG000|Overall Study|Withdrawal by Subject|7|||
156934058|NCT02268786|566519035|FG001|Overall Study|Withdrawal by Subject|14|||
156934059|NCT02268786|566519034|FG000|Overall Study|Thaw Failure|6|||
156934060|NCT02268786|566519035|FG001|Overall Study|Thaw Failure|4|||
156934061|NCT02268786|566519034|FG000|Overall Study|Protocol Violation|1|||
156934062|NCT02268786|566519035|FG001|Overall Study|Protocol Violation|0|||
156934063|NCT00744627|566519036|FG000|Overall Study|Adverse Event|6|||
156934064|NCT00744627|566519037|FG001|Overall Study|Adverse Event|9|||
156934065|NCT00744627|566519036|FG000|Overall Study|Lack of Efficacy|7|||
156934066|NCT00744627|566519037|FG001|Overall Study|Lack of Efficacy|3|||
156934067|NCT00744627|566519036|FG000|Overall Study|Noncompliance|0|||
156934068|NCT00744627|566519037|FG001|Overall Study|Noncompliance|1|||
156934069|NCT00744627|566519036|FG000|Overall Study|Protocol Deviations|0|||
156934070|NCT00744627|566519037|FG001|Overall Study|Protocol Deviations|2|||
156934071|NCT00744627|566519036|FG000|Overall Study|Voluntary Withdrawal|9|||
156934072|NCT00744627|566519037|FG001|Overall Study|Voluntary Withdrawal|6|||
156934073|NCT00744627|566519036|FG000|Overall Study|Lost to Follow-up|2|||
156934074|NCT00744627|566519037|FG001|Overall Study|Lost to Follow-up|1|||
156934075|NCT00744627|566519036|FG000|Overall Study|Other|1|||
156934076|NCT00744627|566519037|FG001|Overall Study|Other|0|||
156934077|NCT03560531|566519040|FG000|Overall Study|Death|4|||
156934078|NCT03560531|566519041|FG001|Overall Study|Death|1|||
156934079|NCT03560531|566519042|FG002|Overall Study|Death|1|||
156934080|NCT03560531|566519043|FG003|Overall Study|Death|2|||
156934081|NCT03560531|566519044|FG004|Overall Study|Death|6|||
156934082|NCT03560531|566519045|FG005|Overall Study|Death|1|||
156934083|NCT03560531|566519046|FG006|Overall Study|Death|4|||
156934084|NCT03560531|566519047|FG007|Overall Study|Death|8|||
156934085|NCT03560531|566519048|FG008|Overall Study|Death|1|||
156934086|NCT03560531|566519049|FG009|Overall Study|Death|3|||
156934087|NCT03560531|566519050|FG010|Overall Study|Death|2|||
156934088|NCT03560531|566519051|FG011|Overall Study|Death|0|||
156934089|NCT03560531|566519052|FG012|Overall Study|Death|4|||
156934090|NCT03560531|566519053|FG013|Overall Study|Death|1|||
156934091|NCT03560531|566519040|FG000|Overall Study|Lost to Follow-up|1|||
156934092|NCT03560531|566519041|FG001|Overall Study|Lost to Follow-up|1|||
156934093|NCT03560531|566519042|FG002|Overall Study|Lost to Follow-up|0|||
156934094|NCT03560531|566519043|FG003|Overall Study|Lost to Follow-up|0|||
156934095|NCT03560531|566519044|FG004|Overall Study|Lost to Follow-up|0|||
156934096|NCT03560531|566519045|FG005|Overall Study|Lost to Follow-up|0|||
156934097|NCT03560531|566519046|FG006|Overall Study|Lost to Follow-up|1|||
156934098|NCT03560531|566519047|FG007|Overall Study|Lost to Follow-up|0|||
156934099|NCT03560531|566519048|FG008|Overall Study|Lost to Follow-up|0|||
156934100|NCT03560531|566519049|FG009|Overall Study|Lost to Follow-up|0|||
156934101|NCT03560531|566519050|FG010|Overall Study|Lost to Follow-up|0|||
156934102|NCT03560531|566519051|FG011|Overall Study|Lost to Follow-up|0|||
156934103|NCT03560531|566519052|FG012|Overall Study|Lost to Follow-up|0|||
156934104|NCT03560531|566519053|FG013|Overall Study|Lost to Follow-up|0|||
156934105|NCT03560531|566519040|FG000|Overall Study|Withdrawal by Subject|1|||
156934106|NCT03560531|566519041|FG001|Overall Study|Withdrawal by Subject|0|||
156934107|NCT03560531|566519042|FG002|Overall Study|Withdrawal by Subject|0|||
156934108|NCT03560531|566519043|FG003|Overall Study|Withdrawal by Subject|0|||
156934109|NCT03560531|566519044|FG004|Overall Study|Withdrawal by Subject|0|||
156934110|NCT03560531|566519045|FG005|Overall Study|Withdrawal by Subject|0|||
156934111|NCT03560531|566519046|FG006|Overall Study|Withdrawal by Subject|0|||
156934112|NCT03560531|566519047|FG007|Overall Study|Withdrawal by Subject|3|||
156934113|NCT03560531|566519048|FG008|Overall Study|Withdrawal by Subject|2|||
156934114|NCT03560531|566519049|FG009|Overall Study|Withdrawal by Subject|0|||
156934115|NCT03560531|566519050|FG010|Overall Study|Withdrawal by Subject|0|||
156934116|NCT03560531|566519051|FG011|Overall Study|Withdrawal by Subject|0|||
156934117|NCT03560531|566519052|FG012|Overall Study|Withdrawal by Subject|2|||
156934118|NCT03560531|566519053|FG013|Overall Study|Withdrawal by Subject|0|||
156934119|NCT03560531|566519040|FG000|Overall Study|Study end per-protocol|1|||
156934120|NCT03560531|566519041|FG001|Overall Study|Study end per-protocol|1|||
156934121|NCT03560531|566519042|FG002|Overall Study|Study end per-protocol|2|||
156934122|NCT03560531|566519043|FG003|Overall Study|Study end per-protocol|0|||
156934123|NCT03560531|566519044|FG004|Overall Study|Study end per-protocol|1|||
156934124|NCT03560531|566519045|FG005|Overall Study|Study end per-protocol|0|||
156934125|NCT03560531|566519046|FG006|Overall Study|Study end per-protocol|0|||
156934126|NCT03560531|566519047|FG007|Overall Study|Study end per-protocol|0|||
156934127|NCT03560531|566519048|FG008|Overall Study|Study end per-protocol|0|||
156934128|NCT03560531|566519049|FG009|Overall Study|Study end per-protocol|0|||
156934129|NCT03560531|566519050|FG010|Overall Study|Study end per-protocol|0|||
156934130|NCT03560531|566519051|FG011|Overall Study|Study end per-protocol|0|||
157030330|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
157030331|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
157030332|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
157030333|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030334|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030335|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030336|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030337|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030338|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030339|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
157030340|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
157030341|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
157030342|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
157030343|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
157030344|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
157030345|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
157030346|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
157030347|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
157030348|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
157030349|NCT02315703|566866782|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
157030350|NCT02315703|566866783|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
157030351|NCT02315703|566866784|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
157030352|NCT02315703|566866785|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
157030353|NCT02315703|566866786|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
157030354|NCT02315703|566866787|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
156934131|NCT03560531|566519052|FG012|Overall Study|Study end per-protocol|0|||
156934132|NCT03560531|566519053|FG013|Overall Study|Study end per-protocol|0|||
156934133|NCT03560531|566519040|FG000|Overall Study|Early study termination by sponsor|9|||
156934134|NCT03560531|566519041|FG001|Overall Study|Early study termination by sponsor|0|||
156934135|NCT03560531|566519042|FG002|Overall Study|Early study termination by sponsor|0|||
156934136|NCT03560531|566519043|FG003|Overall Study|Early study termination by sponsor|4|||
156934137|NCT03560531|566519044|FG004|Overall Study|Early study termination by sponsor|8|||
156934138|NCT03560531|566519045|FG005|Overall Study|Early study termination by sponsor|2|||
156934139|NCT03560531|566519046|FG006|Overall Study|Early study termination by sponsor|5|||
156934140|NCT03560531|566519047|FG007|Overall Study|Early study termination by sponsor|64|||
156934141|NCT03560531|566519048|FG008|Overall Study|Early study termination by sponsor|7|||
156934142|NCT03560531|566519049|FG009|Overall Study|Early study termination by sponsor|2|||
156934143|NCT03560531|566519050|FG010|Overall Study|Early study termination by sponsor|16|||
156934144|NCT03560531|566519051|FG011|Overall Study|Early study termination by sponsor|2|||
156934145|NCT03560531|566519052|FG012|Overall Study|Early study termination by sponsor|6|||
156934146|NCT03560531|566519053|FG013|Overall Study|Early study termination by sponsor|2|||
156934147|NCT03745144|566519054|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
156934148|NCT03745144|566519055|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
156934149|NCT03745144|566519056|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
156934150|NCT03745144|566519054|FG000|Period 1|Other|0|||
156934151|NCT03745144|566519055|FG001|Period 1|Other|0|||
156934152|NCT03745144|566519056|FG002|Period 1|Other|1|||
156934153|NCT01177540|566519057|FG000|Overall Study|Adverse Event|1|||
156934154|NCT01177540|566519058|FG001|Overall Study|Adverse Event|0|||
156934155|NCT00747435|566519072|FG000|Overall Study|Lost to Follow-up|2|||
156934156|NCT00747435|566519072|FG000|Overall Study|Withdrawal by Subject|3|||
156934157|NCT00747435|566519072|FG000|Overall Study|Still undergoing follow up|1|||
156934158|NCT02013167|566519073|FG000|Overall Study|Withdrawal by Subject|15|||
156934159|NCT02013167|566519074|FG001|Overall Study|Withdrawal by Subject|14|||
156934160|NCT02013167|566519073|FG000|Overall Study|Sponsor Decision|1|||
156934161|NCT02013167|566519074|FG001|Overall Study|Sponsor Decision|3|||
156934162|NCT02013167|566519073|FG000|Overall Study|Lost to Follow-up|0|||
156934163|NCT02013167|566519074|FG001|Overall Study|Lost to Follow-up|1|||
156934164|NCT02013167|566519073|FG000|Overall Study|Death|85|||
156934165|NCT02013167|566519074|FG001|Overall Study|Death|160|||
156934166|NCT01113879|566519079|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
156934167|NCT01113879|566519080|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
156934168|NCT04151290|566519081|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
156934169|NCT01449526|566519082|FG000|Overall Study|Lost to Follow-up|1|||
156934170|NCT01449526|566519083|FG001|Overall Study|Lost to Follow-up|2|||
156934171|NCT01449526|566519082|FG000|Overall Study|Withdrawal by Subject|1|||
156934172|NCT01449526|566519083|FG001|Overall Study|Withdrawal by Subject|1|||
156934173|NCT01449526|566519082|FG000|Overall Study|Symptoms/complaints|0|||
156934174|NCT01449526|566519083|FG001|Overall Study|Symptoms/complaints|1|||
156934175|NCT01449526|566519082|FG000|Overall Study|Lack of Motivation|0|||
156934176|NCT01449526|566519083|FG001|Overall Study|Lack of Motivation|1|||
156934177|NCT01449526|566519082|FG000|Overall Study|Cannot maintain visits|0|||
156934178|NCT01449526|566519083|FG001|Overall Study|Cannot maintain visits|1|||
156934179|NCT01132495|566519084|FG000|Overall Study|Various reasons|40|||
156934180|NCT01132495|566519085|FG001|Overall Study|Various reasons|38|||
156934181|NCT01132495|566519086|FG002|Overall Study|Various reasons|20|||
156934182|NCT01132495|566519087|FG003|Overall Study|Various reasons|12|||
156934183|NCT00082433|566519091|FG000|Overall Study|Adverse Event|12|||
156934184|NCT00082433|566519092|FG001|Overall Study|Adverse Event|17|||
156934185|NCT00082433|566519091|FG000|Overall Study|Death|8|||
156934186|NCT00082433|566519092|FG001|Overall Study|Death|18|||
156934187|NCT00082433|566519091|FG000|Overall Study|Disease Progression/Relapse|270|||
156934188|NCT00082433|566519092|FG001|Overall Study|Disease Progression/Relapse|388|||
156934189|NCT00082433|566519091|FG000|Overall Study|Physician Decision|50|||
156934190|NCT00082433|566519092|FG001|Overall Study|Physician Decision|61|||
156934191|NCT00082433|566519091|FG000|Overall Study|Lost to Follow-up|1|||
156934192|NCT00082433|566519092|FG001|Overall Study|Lost to Follow-up|2|||
156934193|NCT00082433|566519091|FG000|Overall Study|Study Drug Toxicity|179|||
156934194|NCT00082433|566519092|FG001|Overall Study|Study Drug Toxicity|66|||
156934195|NCT00082433|566519091|FG000|Overall Study|Withdrawal by Subject|55|||
156934196|NCT00082433|566519092|FG001|Overall Study|Withdrawal by Subject|30|||
156934197|NCT00082433|566519091|FG000|Overall Study|Still On Treatment|2|||
156934198|NCT00082433|566519092|FG001|Overall Study|Still On Treatment|1|||
156934199|NCT00082433|566519091|FG000|Overall Study|Not Treated|12|||
156934200|NCT00082433|566519092|FG001|Overall Study|Not Treated|11|||
156934201|NCT00082433|566519091|FG000|Overall Study|Ineligible|2|||
156934202|NCT00082433|566519092|FG001|Overall Study|Ineligible|1|||
156934203|NCT00082433|566519091|FG000|Overall Study|Noncompliance|2|||
156934204|NCT00082433|566519092|FG001|Overall Study|Noncompliance|1|||
156934205|NCT00082433|566519091|FG000|Overall Study|New primary cancer|1|||
156934206|NCT00082433|566519092|FG001|Overall Study|New primary cancer|0|||
156934207|NCT00082433|566519091|FG000|Overall Study|Impending surgery|0|||
156934208|NCT00082433|566519092|FG001|Overall Study|Impending surgery|1|||
156934209|NCT02276612|566519095|FG000|Overall Study|Death|1|||
156934210|NCT02276612|566519096|FG001|Overall Study|Death|0|||
156934211|NCT02276612|566519095|FG000|Overall Study|Pregnancy|1|||
156934212|NCT02276612|566519096|FG001|Overall Study|Pregnancy|0|||
156934213|NCT02276612|566519095|FG000|Overall Study|Withdrew Consent|1|||
156934214|NCT02276612|566519096|FG001|Overall Study|Withdrew Consent|0|||
156934215|NCT02276612|566519095|FG000|Overall Study|Lost to Follow-up|1|||
156934216|NCT02276612|566519096|FG001|Overall Study|Lost to Follow-up|0|||
156934217|NCT01796197|566519097|FG000|Overall Study|Lost to Follow-up|1|||
156934218|NCT01796197|566519097|FG000|Overall Study|Lack of Efficacy|1|||
156934219|NCT04097821|566519098|FG000|Overall Study|Subject Decision|0|||
156934220|NCT04097821|566519099|FG001|Overall Study|Subject Decision|0|||
156934221|NCT04097821|566519100|FG002|Overall Study|Subject Decision|0|||
156934222|NCT04097821|566519101|FG003|Overall Study|Subject Decision|1|||
156934223|NCT04097821|566519102|FG004|Overall Study|Subject Decision|2|||
156934224|NCT04097821|566519103|FG005|Overall Study|Subject Decision|2|||
156934225|NCT04097821|566519104|FG006|Overall Study|Subject Decision|0|||
156934226|NCT04097821|566519105|FG007|Overall Study|Subject Decision|1|||
156934227|NCT04097821|566519098|FG000|Overall Study|Death|0|||
156934228|NCT04097821|566519099|FG001|Overall Study|Death|0|||
156934229|NCT04097821|566519100|FG002|Overall Study|Death|3|||
156934230|NCT04097821|566519101|FG003|Overall Study|Death|1|||
156934231|NCT04097821|566519102|FG004|Overall Study|Death|0|||
156934232|NCT04097821|566519103|FG005|Overall Study|Death|0|||
156934233|NCT04097821|566519104|FG006|Overall Study|Death|0|||
156934234|NCT04097821|566519105|FG007|Overall Study|Death|0|||
156934235|NCT04097821|566519098|FG000|Overall Study|Physician Decision|1|||
156934236|NCT04097821|566519099|FG001|Overall Study|Physician Decision|2|||
156934237|NCT04097821|566519100|FG002|Overall Study|Physician Decision|0|||
156934238|NCT04097821|566519101|FG003|Overall Study|Physician Decision|0|||
156934239|NCT04097821|566519102|FG004|Overall Study|Physician Decision|0|||
156934240|NCT04097821|566519103|FG005|Overall Study|Physician Decision|0|||
156934241|NCT04097821|566519104|FG006|Overall Study|Physician Decision|0|||
156934242|NCT04097821|566519105|FG007|Overall Study|Physician Decision|0|||
156934243|NCT04097821|566519098|FG000|Overall Study|Adverse Event|0|||
156934244|NCT04097821|566519099|FG001|Overall Study|Adverse Event|0|||
156934245|NCT04097821|566519100|FG002|Overall Study|Adverse Event|1|||
156934246|NCT04097821|566519101|FG003|Overall Study|Adverse Event|1|||
156934247|NCT04097821|566519102|FG004|Overall Study|Adverse Event|0|||
156934248|NCT04097821|566519103|FG005|Overall Study|Adverse Event|0|||
156934249|NCT04097821|566519104|FG006|Overall Study|Adverse Event|0|||
156934250|NCT04097821|566519105|FG007|Overall Study|Adverse Event|0|||
156934251|NCT04097821|566519098|FG000|Overall Study|New Therapy For Study Indication|0|||
156934252|NCT04097821|566519099|FG001|Overall Study|New Therapy For Study Indication|0|||
156934253|NCT04097821|566519100|FG002|Overall Study|New Therapy For Study Indication|0|||
156934254|NCT04097821|566519101|FG003|Overall Study|New Therapy For Study Indication|0|||
156934255|NCT04097821|566519102|FG004|Overall Study|New Therapy For Study Indication|0|||
156934256|NCT04097821|566519103|FG005|Overall Study|New Therapy For Study Indication|0|||
156934257|NCT04097821|566519104|FG006|Overall Study|New Therapy For Study Indication|1|||
156934258|NCT04097821|566519105|FG007|Overall Study|New Therapy For Study Indication|0|||
156934259|NCT00244712|566519106|FG000|Overall Study|Adverse Event|20|||
156934260|NCT00244712|566519107|FG001|Overall Study|Adverse Event|21|||
156934261|NCT00244712|566519106|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
156934262|NCT00244712|566519107|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
156934263|NCT00244712|566519106|FG000|Overall Study|Lack of Compliance|10|||
156934264|NCT00244712|566519107|FG001|Overall Study|Lack of Compliance|11|||
156934265|NCT00244712|566519106|FG000|Overall Study|Lost to Follow-up|45|||
156934266|NCT00244712|566519107|FG001|Overall Study|Lost to Follow-up|52|||
156934267|NCT00244712|566519106|FG000|Overall Study|Withdrawal by Subject|13|||
156934268|NCT00244712|566519107|FG001|Overall Study|Withdrawal by Subject|23|||
156934269|NCT00244712|566519106|FG000|Overall Study|Protocol Violation, disease progression|13|||
156934270|NCT00244712|566519107|FG001|Overall Study|Protocol Violation, disease progression|11|||
156934271|NCT01077804|566519110|FG000|Overall Study|Unreachable|102|||
156934272|NCT01077804|566519110|FG000|Overall Study|Refused to continue|79|||
156934273|NCT01077804|566519110|FG000|Overall Study|Other|18|||
156934274|NCT02776917|566519111|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
156934275|NCT00574405|566520393|FG000|Overall Study|Withdrawal by Subject|3|||
156934276|NCT00574405|566520394|FG001|Overall Study|Withdrawal by Subject|2|||
156934277|NCT01336738|566520395|FG000|Overall Study|Adverse Event|0|||
156934278|NCT01336738|566520396|FG001|Overall Study|Adverse Event|3|||
157167039|NCT01245764|567352640|FG001|Study Phase A|Lost to Follow-up|0|||
156934279|NCT01336738|566520397|FG002|Overall Study|Adverse Event|2|||
156934280|NCT01336738|566520398|FG003|Overall Study|Adverse Event|1|||
156934281|NCT01336738|566520399|FG004|Overall Study|Adverse Event|3|||
156934282|NCT01336738|566520395|FG000|Overall Study|Lost to Follow-up|2|||
156934283|NCT01336738|566520396|FG001|Overall Study|Lost to Follow-up|1|||
156934284|NCT01336738|566520397|FG002|Overall Study|Lost to Follow-up|2|||
156934285|NCT01336738|566520398|FG003|Overall Study|Lost to Follow-up|2|||
156934286|NCT01336738|566520399|FG004|Overall Study|Lost to Follow-up|2|||
156934287|NCT01336738|566520395|FG000|Overall Study|Did not meet entrance criteria|0|||
156934288|NCT01336738|566520396|FG001|Overall Study|Did not meet entrance criteria|1|||
156934289|NCT01336738|566520397|FG002|Overall Study|Did not meet entrance criteria|0|||
156934290|NCT01336738|566520398|FG003|Overall Study|Did not meet entrance criteria|0|||
156934291|NCT01336738|566520399|FG004|Overall Study|Did not meet entrance criteria|0|||
156934292|NCT01336738|566520395|FG000|Overall Study|Protocol Violation|0|||
156934293|NCT01336738|566520396|FG001|Overall Study|Protocol Violation|1|||
156934294|NCT01336738|566520397|FG002|Overall Study|Protocol Violation|0|||
156934295|NCT01336738|566520398|FG003|Overall Study|Protocol Violation|0|||
156934296|NCT01336738|566520399|FG004|Overall Study|Protocol Violation|0|||
156934297|NCT01336738|566520395|FG000|Overall Study|Withdrawal by Subject|2|||
156934298|NCT01336738|566520396|FG001|Overall Study|Withdrawal by Subject|0|||
156934299|NCT01336738|566520397|FG002|Overall Study|Withdrawal by Subject|2|||
156934300|NCT01336738|566520398|FG003|Overall Study|Withdrawal by Subject|1|||
156934301|NCT01336738|566520399|FG004|Overall Study|Withdrawal by Subject|1|||
156934302|NCT01336738|566520395|FG000|Overall Study|Other|3|||
156934303|NCT01336738|566520396|FG001|Overall Study|Other|3|||
156934304|NCT01336738|566520397|FG002|Overall Study|Other|2|||
156934305|NCT01336738|566520398|FG003|Overall Study|Other|3|||
156934306|NCT01336738|566520399|FG004|Overall Study|Other|4|||
156934307|NCT01083433|566520400|FG000|Overall Study|Lost to Follow-up|2|||
156934308|NCT01083433|566520401|FG001|Overall Study|Lost to Follow-up|1|||
156934309|NCT01083433|566520402|FG002|Overall Study|Lost to Follow-up|1|||
156934310|NCT01083433|566520400|FG000|Overall Study|Withdrawal by Subject|0|||
156934311|NCT01083433|566520401|FG001|Overall Study|Withdrawal by Subject|5|||
156934312|NCT01083433|566520402|FG002|Overall Study|Withdrawal by Subject|3|||
156934313|NCT01083433|566520400|FG000|Overall Study|Pregnancy|0|||
156934314|NCT01083433|566520401|FG001|Overall Study|Pregnancy|0|||
156934315|NCT01083433|566520402|FG002|Overall Study|Pregnancy|1|||
156934316|NCT03003520|566520404|FG000|Overall Study|Adverse Event|9|||
156934317|NCT03003520|566520405|FG001|Overall Study|Adverse Event|0|||
156934318|NCT03003520|566520404|FG000|Overall Study|Death|1|||
156934319|NCT03003520|566520405|FG001|Overall Study|Death|0|||
156934320|NCT03003520|566520404|FG000|Overall Study|Other reasons|4|||
156934321|NCT03003520|566520405|FG001|Overall Study|Other reasons|0|||
156934322|NCT03003520|566520404|FG000|Overall Study|Withdrawal by Subject|6|||
156934323|NCT03003520|566520405|FG001|Overall Study|Withdrawal by Subject|0|||
156934324|NCT03003520|566520404|FG000|Overall Study|Progressive disease|9|||
156934325|NCT03003520|566520405|FG001|Overall Study|Progressive disease|1|||
156934326|NCT01332149|566520406|FG000|Overall Study|Adverse Event|11|||
156934327|NCT01332149|566520407|FG001|Overall Study|Adverse Event|9|||
156934328|NCT01332149|566520406|FG000|Overall Study|Other unspecified|5|||
156934329|NCT01332149|566520407|FG001|Overall Study|Other unspecified|7|||
156934330|NCT01332149|566520406|FG000|Overall Study|Protocol Violation|1|||
156934331|NCT01332149|566520407|FG001|Overall Study|Protocol Violation|3|||
156934332|NCT01332149|566520406|FG000|Overall Study|Withdrawal by Subject|4|||
156934333|NCT01332149|566520407|FG001|Overall Study|Withdrawal by Subject|5|||
156934334|NCT01332149|566520406|FG000|Overall Study|Lost to Follow-up|1|||
156934335|NCT01332149|566520407|FG001|Overall Study|Lost to Follow-up|1|||
156934336|NCT01332149|566520406|FG000|Overall Study|Insufficient clinical response|4|||
156934337|NCT01332149|566520407|FG001|Overall Study|Insufficient clinical response|7|||
156934338|NCT01332149|566520406|FG000|Overall Study|Did not meet entrance criteria|3|||
156934339|NCT01332149|566520407|FG001|Overall Study|Did not meet entrance criteria|4|||
156934340|NCT01332149|566520406|FG000|Overall Study|Randomized but not treated|1|||
156934341|NCT01332149|566520407|FG001|Overall Study|Randomized but not treated|2|||
156934342|NCT04982029|566520408|FG000|Overall Study|Lost to Follow-up|2|||
156934343|NCT04982029|566520409|FG001|Overall Study|Lost to Follow-up|3|||
156934344|NCT04615949|566520412|FG000|Overall Study|Withdrawal by Subject|2|||
156934345|NCT04615949|566520413|FG001|Overall Study|Withdrawal by Subject|4|||
156934346|NCT04615949|566520412|FG000|Overall Study|Lost to Follow-up|2|||
156934347|NCT04615949|566520413|FG001|Overall Study|Lost to Follow-up|2|||
156934348|NCT04615949|566520412|FG000|Overall Study|Death|0|||
156934349|NCT04615949|566520413|FG001|Overall Study|Death|2|||
156934350|NCT03036566|566520414|FG000|Overall Study|Lost to Follow-up|3|||
156934351|NCT05458856|566520415|FG000|Overall Study|Withdrawal by Subject|5|||
156934352|NCT05458856|566520415|FG000|Overall Study|Death|4|||
156934353|NCT05458856|566520415|FG000|Overall Study|Protocol Deviation|3|||
156934354|NCT05458856|566520415|FG000|Overall Study|Physician Decision|1|||
156934355|NCT01852292|566520419|FG000|Overall Study|Untreated - did not receive study drug|3|||
156934356|NCT01852292|566520420|FG001|Overall Study|Untreated - did not receive study drug|1|||
156934357|NCT01852292|566520419|FG000|Overall Study|Death|9|||
157167040|NCT01245764|567352641|FG002|Study Phase A|Lost to Follow-up|5|||
157167041|NCT01245764|567352642|FG003|Study Phase A|Lost to Follow-up|0|||
156934358|NCT01852292|566520420|FG001|Overall Study|Death|8|||
156934359|NCT01852292|566520419|FG000|Overall Study|Patient/guardian decision|8|||
156934360|NCT01852292|566520420|FG001|Overall Study|Patient/guardian decision|4|||
156934361|NCT01852292|566520419|FG000|Overall Study|Adverse Event|8|||
156934362|NCT01852292|566520420|FG001|Overall Study|Adverse Event|11|||
156934363|NCT01852292|566520419|FG000|Overall Study|Physician Decision|6|||
156934364|NCT01852292|566520420|FG001|Overall Study|Physician Decision|2|||
156934365|NCT01852292|566520419|FG000|Overall Study|Protocol Violation|2|||
156934366|NCT01852292|566520420|FG001|Overall Study|Protocol Violation|0|||
156934367|NCT01852292|566520419|FG000|Overall Study|Non-compliance with study treatment|1|||
156934368|NCT01852292|566520420|FG001|Overall Study|Non-compliance with study treatment|0|||
156934369|NCT01852292|566520419|FG000|Overall Study|Study terminated by Sponsor|0|||
156934370|NCT01852292|566520420|FG001|Overall Study|Study terminated by Sponsor|1|||
157030355|NCT02315703|566866788|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
156934371|NCT01852292|566520419|FG000|Overall Study|Progressive disease|42|||
156934372|NCT01852292|566520420|FG001|Overall Study|Progressive disease|52|||
156934373|NCT01914666|566520423|FG000|Treatment Period|Lack of Efficacy|0|||
156934374|NCT01914666|566520424|FG001|Treatment Period|Lack of Efficacy|0|||
156934375|NCT01914666|566520425|FG002|Treatment Period|Lack of Efficacy|2|||
156934376|NCT01914666|566520423|FG000|Treatment Period|Adverse Event|10|||
156934377|NCT01914666|566520424|FG001|Treatment Period|Adverse Event|4|||
156934378|NCT01914666|566520425|FG002|Treatment Period|Adverse Event|2|||
156934379|NCT01914666|566520423|FG000|Treatment Period|Withdrawal by Subject|3|||
156934380|NCT01914666|566520424|FG001|Treatment Period|Withdrawal by Subject|2|||
156934381|NCT01914666|566520425|FG002|Treatment Period|Withdrawal by Subject|2|||
156934382|NCT01914666|566520423|FG000|Treatment Period|Physician Decision|0|||
156934383|NCT01914666|566520424|FG001|Treatment Period|Physician Decision|0|||
156934384|NCT01914666|566520425|FG002|Treatment Period|Physician Decision|2|||
156934385|NCT03240133|566520426|FG000|Overall Study|Withdrawal by Subject|0|||
156934386|NCT03240133|566520427|FG001|Overall Study|Withdrawal by Subject|1|||
156934387|NCT03240133|566520428|FG002|Overall Study|Withdrawal by Subject|0|||
156934388|NCT03240133|566520426|FG000|Overall Study|Adverse Event|1|||
156934389|NCT03240133|566520427|FG001|Overall Study|Adverse Event|1|||
156934390|NCT03240133|566520428|FG002|Overall Study|Adverse Event|0|||
156934391|NCT03240133|566520426|FG000|Overall Study|Rash|1|||
156934392|NCT03240133|566520427|FG001|Overall Study|Rash|0|||
156934393|NCT03240133|566520428|FG002|Overall Study|Rash|0|||
156934394|NCT03240133|566520426|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
156934395|NCT03240133|566520427|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
156934396|NCT03240133|566520428|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
156934397|NCT03240133|566520426|FG000|Overall Study|Intercurrent illness.|0|||
156934398|NCT03240133|566520427|FG001|Overall Study|Intercurrent illness.|1|||
156934399|NCT03240133|566520428|FG002|Overall Study|Intercurrent illness.|0|||
156934400|NCT03240133|566520426|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
156934401|NCT03240133|566520427|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
156934402|NCT03240133|566520428|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
156934403|NCT00116831|566520429|FG000|Overall Study|Adverse Event|14|||
156934404|NCT00116831|566520430|FG001|Overall Study|Adverse Event|16|||
156934405|NCT00116831|566520429|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
156934406|NCT00116831|566520430|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
156934407|NCT00116831|566520429|FG000|Overall Study|Lost to Follow-up|8|||
156934408|NCT00116831|566520430|FG001|Overall Study|Lost to Follow-up|6|||
156934409|NCT00116831|566520429|FG000|Overall Study|Protocol Violation|3|||
156934410|NCT00116831|566520430|FG001|Overall Study|Protocol Violation|6|||
156934411|NCT00116831|566520429|FG000|Overall Study|Hypoglycaemic events|1|||
156934412|NCT00116831|566520430|FG001|Overall Study|Hypoglycaemic events|0|||
156934413|NCT00116831|566520429|FG000|Overall Study|Low haemoglobin on screening|1|||
156934414|NCT00116831|566520430|FG001|Overall Study|Low haemoglobin on screening|0|||
156934415|NCT00116831|566520429|FG000|Overall Study|Withdrawn investigational product|1|||
156934416|NCT00116831|566520430|FG001|Overall Study|Withdrawn investigational product|0|||
156934417|NCT00116831|566520429|FG000|Overall Study|Withdrawal by Subject|32|||
156934418|NCT00116831|566520430|FG001|Overall Study|Withdrawal by Subject|32|||
156934419|NCT00116831|566520429|FG000|Overall Study|Insufficient therapeutic effect|0|||
156934420|NCT00116831|566520430|FG001|Overall Study|Insufficient therapeutic effect|1|||
156934421|NCT00116831|566520429|FG000|Overall Study|Missing data for participant|1|||
156934422|NCT00116831|566520430|FG001|Overall Study|Missing data for participant|0|||
156934423|NCT04200248|566520437|FG000|Overall Study|Personal reasons|0|||
156934424|NCT04200248|566520438|FG001|Overall Study|Personal reasons|0|||
156934425|NCT04200248|566520439|FG002|Overall Study|Personal reasons|1|||
156934426|NCT04200248|566520437|FG000|Overall Study|Discontinued prior to treatment|3|||
157030356|NCT02315703|566866789|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
157030357|NCT02315703|566866782|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
157030358|NCT02315703|566866783|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
156934427|NCT04200248|566520438|FG001|Overall Study|Discontinued prior to treatment|3|||
156934428|NCT04200248|566520439|FG002|Overall Study|Discontinued prior to treatment|2|||
156934429|NCT00302003|566520440|FG000|Overall Study|Lack of Efficacy|62|||
156934430|NCT00302003|566520440|FG000|Overall Study|Lost to Follow-up|1|||
157030359|NCT02315703|566866784|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
156934431|NCT00302003|566520440|FG000|Overall Study|Physician Decision|2|||
156934432|NCT00302003|566520440|FG000|Overall Study|Withdrawal by Subject|5|||
157030360|NCT02315703|566866785|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
157030361|NCT02315703|566866786|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
157030362|NCT02315703|566866787|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
157227076|NCT02448771|567576037|FG000|Overall Study|Physician Decision|3|||
156934433|NCT00302003|566520440|FG000|Overall Study|Ineligible|9|||
156934434|NCT00302003|566520440|FG000|Overall Study|Protocol Violation|1|||
156934435|NCT00735371|566520453|FG000|Overall Study|Adverse Event|3|||
157227077|NCT02448771|567576037|FG000|Overall Study|Started new therapy|2|||
157227078|NCT03968224|567576038|FG000|Overall Study|Lost to Follow-up|11|||
157227079|NCT03968224|567576039|FG001|Overall Study|Lost to Follow-up|18|||
157227080|NCT05665595|567577705|FG000|Overall Study|Ongoing|692|||
156934436|NCT00735371|566520454|FG001|Overall Study|Adverse Event|3|||
156934437|NCT00735371|566520455|FG002|Overall Study|Adverse Event|4|||
156934438|NCT00735371|566520456|FG003|Overall Study|Adverse Event|1|||
156934439|NCT00735371|566520453|FG000|Overall Study|Protocol Violation|2|||
156934440|NCT00735371|566520454|FG001|Overall Study|Protocol Violation|2|||
156934441|NCT00735371|566520455|FG002|Overall Study|Protocol Violation|0|||
156934442|NCT00735371|566520456|FG003|Overall Study|Protocol Violation|3|||
156934443|NCT00735371|566520453|FG000|Overall Study|Withdrawal by Subject|0|||
156934444|NCT00735371|566520454|FG001|Overall Study|Withdrawal by Subject|2|||
156934445|NCT00735371|566520455|FG002|Overall Study|Withdrawal by Subject|2|||
156934446|NCT00735371|566520456|FG003|Overall Study|Withdrawal by Subject|0|||
156934447|NCT00735371|566520453|FG000|Overall Study|Lost to Follow-up|1|||
156934448|NCT00735371|566520454|FG001|Overall Study|Lost to Follow-up|1|||
156934449|NCT00735371|566520455|FG002|Overall Study|Lost to Follow-up|3|||
156934450|NCT00735371|566520456|FG003|Overall Study|Lost to Follow-up|1|||
156934451|NCT00735371|566520453|FG000|Overall Study|Lack of Efficacy|4|||
156934452|NCT00735371|566520454|FG001|Overall Study|Lack of Efficacy|2|||
156934453|NCT00735371|566520455|FG002|Overall Study|Lack of Efficacy|0|||
156934454|NCT00735371|566520456|FG003|Overall Study|Lack of Efficacy|4|||
156934455|NCT00735371|566520453|FG000|Overall Study|Sponsor Decision|3|||
156934456|NCT00735371|566520454|FG001|Overall Study|Sponsor Decision|1|||
156934457|NCT00735371|566520455|FG002|Overall Study|Sponsor Decision|0|||
156934458|NCT00735371|566520456|FG003|Overall Study|Sponsor Decision|1|||
156934459|NCT00735371|566520453|FG000|Overall Study|Protocol Violation|0|||
156934460|NCT00735371|566520454|FG001|Overall Study|Protocol Violation|1|||
156934461|NCT00735371|566520455|FG002|Overall Study|Protocol Violation|2|||
156934462|NCT00735371|566520456|FG003|Overall Study|Protocol Violation|0|||
156934463|NCT00735371|566520453|FG000|Overall Study|Prior Vyvanse Exposure|1|||
156934464|NCT00735371|566520454|FG001|Overall Study|Prior Vyvanse Exposure|1|||
156934465|NCT00735371|566520455|FG002|Overall Study|Prior Vyvanse Exposure|0|||
156934466|NCT00735371|566520456|FG003|Overall Study|Prior Vyvanse Exposure|0|||
156934467|NCT00735371|566520453|FG000|Overall Study|Exclusion criteria|1|||
156934468|NCT00735371|566520454|FG001|Overall Study|Exclusion criteria|0|||
156934469|NCT00735371|566520455|FG002|Overall Study|Exclusion criteria|0|||
156934470|NCT00735371|566520456|FG003|Overall Study|Exclusion criteria|0|||
156934471|NCT00436748|566520459|FG000|Overall Study|Ineligibility Determined|1|||
156934472|NCT00436748|566520460|FG001|Overall Study|Ineligibility Determined|1|||
156934473|NCT00436748|566520459|FG000|Overall Study|Adverse Event|0|||
156934474|NCT00436748|566520460|FG001|Overall Study|Adverse Event|2|||
156934475|NCT00436748|566520459|FG000|Overall Study|Consent Withdrawn|1|||
156934476|NCT00436748|566520460|FG001|Overall Study|Consent Withdrawn|4|||
156934477|NCT00436748|566520459|FG000|Overall Study|Administrative Decision|1|||
156934478|NCT00436748|566520460|FG001|Overall Study|Administrative Decision|0|||
156934479|NCT00436748|566520459|FG000|Overall Study|Lost to Follow-up|0|||
156934480|NCT00436748|566520460|FG001|Overall Study|Lost to Follow-up|1|||
156934481|NCT00436748|566520459|FG000|Overall Study|Protocol-specified Criteria|5|||
156934482|NCT00436748|566520460|FG001|Overall Study|Protocol-specified Criteria|4|||
156934483|NCT00436748|566520459|FG000|Overall Study|Other|3|||
156934484|NCT00436748|566520460|FG001|Overall Study|Other|0|||
156934485|NCT01610791|566520461|FG000|Overall Study|Lost to Follow-up|7|||
156934486|NCT01610791|566520461|FG000|Overall Study|Adverse Event|6|||
157227081|NCT05665595|567577706|FG001|Overall Study|Ongoing|698|||
156934487|NCT01610791|566520461|FG000|Overall Study|Physician Decision|1|||
156934488|NCT01610791|566520461|FG000|Overall Study|Adverse event and Investigator decision|1|||
156934489|NCT01610791|566520461|FG000|Overall Study|Death|1|||
156934490|NCT01610791|566520461|FG000|Overall Study|Not determined|5|||
156934491|NCT04627064|566520464|FG000|Overall Study|Progressive disease|8|||
156934492|NCT04627064|566520465|FG001|Overall Study|Progressive disease|0|||
156934493|NCT04627064|566520464|FG000|Overall Study|Withdrawal by Subject|2|||
156934494|NCT04627064|566520465|FG001|Overall Study|Withdrawal by Subject|0|||
156934495|NCT04627064|566520464|FG000|Overall Study|Physician Decision|1|||
156934496|NCT04627064|566520465|FG001|Overall Study|Physician Decision|0|||
156934497|NCT00097721|566520466|FG000|Overall Study|Adverse Event|8|||
156934498|NCT00097721|566520467|FG001|Overall Study|Adverse Event|1|||
156934499|NCT00097721|566520466|FG000|Overall Study|Withdrawal by Subject|6|||
157227082|NCT05665595|567577705|FG000|Overall Study|Withdrawal by Subject|2|||
157227083|NCT05665595|567577706|FG001|Overall Study|Withdrawal by Subject|2|||
156934500|NCT00097721|566520467|FG001|Overall Study|Withdrawal by Subject|1|||
156934501|NCT00097721|566520466|FG000|Overall Study|Progressive Disease|55|||
156934502|NCT00097721|566520467|FG001|Overall Study|Progressive Disease|27|||
156934503|NCT00097721|566520466|FG000|Overall Study|Physician Decision|1|||
156934504|NCT00097721|566520467|FG001|Overall Study|Physician Decision|3|||
156934505|NCT00097721|566520466|FG000|Overall Study|Reason not given|1|||
156934506|NCT00097721|566520467|FG001|Overall Study|Reason not given|1|||
156934507|NCT02126969|566520470|FG000|Overall Study|Withdrawal by Subject|1|||
157227084|NCT05665595|567577705|FG000|Overall Study|Lost to Follow-up|1|||
157167042|NCT00003476|567352643|FG000|Overall Study|Not evaluable|1|||
157167043|NCT02667457|567352646|FG000|Overall Study|Withdrawal by Subject|1|||
157167044|NCT02667457|567352647|FG001|Overall Study|Withdrawal by Subject|0|||
157167045|NCT02667457|567352646|FG000|Overall Study|Other Reason|0|||
157167046|NCT02667457|567352647|FG001|Overall Study|Other Reason|2|||
157167047|NCT00696436|567352649|FG000|Overall Study|Adverse Event|7|||
157167048|NCT00696436|567352650|FG001|Overall Study|Adverse Event|9|||
156934508|NCT02126969|566520471|FG001|Overall Study|Withdrawal by Subject|2|||
156934509|NCT01533246|566520474|FG000|Overall Study|Adverse Event|1|||
156934510|NCT01533246|566520474|FG000|Overall Study|Withdrawal by Subject|1|||
156934511|NCT00354172|566520475|FG000|Overall Study|Did not receive transplant|1|||
156934512|NCT03792672|566520482|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
156934513|NCT03792672|566520483|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156934514|NCT03792672|566520484|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156934515|NCT03792672|566520485|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
156934516|NCT03792672|566520486|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156934517|NCT03792672|566520487|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
156934518|NCT03792672|566520482|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
156934519|NCT03792672|566520483|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
156934520|NCT03792672|566520484|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
156934521|NCT03792672|566520485|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
156934522|NCT03792672|566520486|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
156934523|NCT03792672|566520487|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
156934524|NCT03792672|566520482|FG000|Treatment Period 4 (2 Days)|Other|1|||
156934525|NCT03792672|566520483|FG001|Treatment Period 4 (2 Days)|Other|0|||
156934526|NCT03792672|566520484|FG002|Treatment Period 4 (2 Days)|Other|0|||
156934527|NCT03792672|566520485|FG003|Treatment Period 4 (2 Days)|Other|0|||
156934528|NCT03792672|566520486|FG004|Treatment Period 4 (2 Days)|Other|0|||
156934529|NCT03792672|566520487|FG005|Treatment Period 4 (2 Days)|Other|0|||
156934530|NCT00453999|566520488|FG000|Overall Study|Adverse Event|1|||
156934531|NCT00453999|566520489|FG001|Overall Study|Adverse Event|2|||
156934532|NCT00453999|566520490|FG002|Overall Study|Adverse Event|1|||
156934533|NCT00453999|566520488|FG000|Overall Study|Lost to Follow-up|0|||
156934534|NCT00453999|566520489|FG001|Overall Study|Lost to Follow-up|1|||
156934535|NCT00453999|566520490|FG002|Overall Study|Lost to Follow-up|1|||
156934536|NCT00453999|566520488|FG000|Overall Study|Withdrawal by Subject|2|||
156934537|NCT00453999|566520489|FG001|Overall Study|Withdrawal by Subject|1|||
156934538|NCT00453999|566520490|FG002|Overall Study|Withdrawal by Subject|1|||
156934539|NCT00453999|566520488|FG000|Overall Study|Subject Request|2|||
156934540|NCT00453999|566520489|FG001|Overall Study|Subject Request|1|||
156934541|NCT00453999|566520490|FG002|Overall Study|Subject Request|0|||
156934542|NCT00606892|566520491|FG000|First Intervention|Protocol Violation|1|||
156934543|NCT00606892|566520492|FG001|First Intervention|Protocol Violation|4|||
156934544|NCT04225923|566520493|FG000|Overall Study|Protocol Violation|1|||
156934545|NCT04225923|566520494|FG001|Overall Study|Protocol Violation|0|||
156934546|NCT04225923|566520495|FG002|Overall Study|Protocol Violation|1|||
156934547|NCT04225923|566520493|FG000|Overall Study|Withdrawal by Subject|4|||
156934548|NCT04225923|566520494|FG001|Overall Study|Withdrawal by Subject|1|||
156934549|NCT04225923|566520495|FG002|Overall Study|Withdrawal by Subject|3|||
156934550|NCT04225923|566520493|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
156934551|NCT04225923|566520494|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
156934552|NCT04225923|566520495|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
156934553|NCT00855309|566520501|FG000|Overall Study|patient never recieved drug|1|||
156934554|NCT00855309|566520502|FG001|Overall Study|patient never recieved drug|0|||
156934555|NCT02547129|566520507|FG000|Overall Study|Difficulty with ongoing infection|1|||
156934556|NCT02547129|566520508|FG001|Overall Study|Difficulty with ongoing infection|0|||
156934557|NCT00794196|566520509|FG000|Overall Study|Lost to Follow-up|5|||
156934558|NCT00794196|566520510|FG001|Overall Study|Lost to Follow-up|23|||
156934559|NCT02319031|566520511|FG000|Treatment Period|Death|1|||
156934560|NCT02319031|566520512|FG001|Treatment Period|Death|0|||
156934561|NCT02244580|566520522|FG000|Overall Study|No cancer tissues available|241|||
156934562|NCT04964128|566520525|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
156934563|NCT04964128|566520525|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
156934564|NCT02120794|566520526|FG000|Overall Study|Withdrawal by Subject|43|||
157030363|NCT02315703|566866788|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
157167049|NCT00696436|567352651|FG002|Overall Study|Adverse Event|8|||
157167050|NCT00696436|567352652|FG003|Overall Study|Adverse Event|6|||
157167051|NCT00696436|567352653|FG004|Overall Study|Adverse Event|4|||
157227085|NCT05665595|567577706|FG001|Overall Study|Lost to Follow-up|0|||
157227086|NCT05665595|567577705|FG000|Overall Study|Death|6|||
156934565|NCT02120794|566520526|FG000|Overall Study|Adverse Event|10|||
156934566|NCT02120794|566520526|FG000|Overall Study|Physician Decision|4|||
156934567|NCT02120794|566520526|FG000|Overall Study|Due to insurance coverage|1|||
156934568|NCT00994240|566520529|FG000|Overall Study|Lost to Follow-up|3|||
156934569|NCT00994240|566520530|FG001|Overall Study|Lost to Follow-up|2|||
156934570|NCT00994240|566520529|FG000|Overall Study|Withdrawal by Subject|1|||
156934571|NCT00994240|566520530|FG001|Overall Study|Withdrawal by Subject|0|||
156934572|NCT00994240|566520529|FG000|Overall Study|study termination|2|||
156934573|NCT00994240|566520530|FG001|Overall Study|study termination|3|||
156934574|NCT02818777|566520536|FG000|Overall Study|Adverse Event|3|||
156934575|NCT01324349|566520540|FG000|Overall Study|Death|1|||
156934576|NCT01324349|566520541|FG001|Overall Study|Death|1|||
156934577|NCT01324349|566520540|FG000|Overall Study|Withdrawal by Subject|0|||
156934578|NCT01324349|566520541|FG001|Overall Study|Withdrawal by Subject|1|||
156934579|NCT00748215|566520542|FG000|Overall Study|Withdrawal by Subject|7|||
156934580|NCT00748215|566520543|FG001|Overall Study|Withdrawal by Subject|7|||
156934581|NCT00748215|566520542|FG000|Overall Study|Treatment change|2|||
156934582|NCT00748215|566520543|FG001|Overall Study|Treatment change|1|||
156934583|NCT00748215|566520542|FG000|Overall Study|Change in patient condition|0|||
156934584|NCT00748215|566520543|FG001|Overall Study|Change in patient condition|3|||
156934585|NCT00748215|566520542|FG000|Overall Study|Non-compliant|0|||
156934586|NCT00748215|566520543|FG001|Overall Study|Non-compliant|2|||
156934587|NCT00748215|566520542|FG000|Overall Study|Adverse Event|0|||
156934588|NCT00748215|566520543|FG001|Overall Study|Adverse Event|5|||
156934589|NCT03264404|566522265|FG000|Overall Study|Death|2|||
156934590|NCT03264404|566522265|FG000|Overall Study|Physician Decision|1|||
156934591|NCT03264404|566522265|FG000|Overall Study|Disease Progression|28|||
156934592|NCT03264404|566522265|FG000|Overall Study|Adverse Event|1|||
156934593|NCT03264404|566522265|FG000|Overall Study|Off study prior to treatment|2|||
156934594|NCT02388737|566522267|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
156934595|NCT02388737|566522268|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
156934596|NCT02388737|566522269|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
156934597|NCT02388737|566522267|FG000|Overall Study|Major Protocol Deviation|18|||
156934598|NCT02388737|566522268|FG001|Overall Study|Major Protocol Deviation|25|||
156934599|NCT02388737|566522269|FG002|Overall Study|Major Protocol Deviation|22|||
156934600|NCT02388737|566522267|FG000|Overall Study|Lost to Follow-up|5|||
156934601|NCT02388737|566522268|FG001|Overall Study|Lost to Follow-up|1|||
156934602|NCT02388737|566522269|FG002|Overall Study|Lost to Follow-up|4|||
156934603|NCT02388737|566522267|FG000|Overall Study|Voluntary Withdrawal|10|||
156934604|NCT02388737|566522268|FG001|Overall Study|Voluntary Withdrawal|18|||
156934605|NCT02388737|566522269|FG002|Overall Study|Voluntary Withdrawal|17|||
156934606|NCT02388737|566522267|FG000|Overall Study|Lack of Efficacy|3|||
156934607|NCT02388737|566522268|FG001|Overall Study|Lack of Efficacy|0|||
156934608|NCT02388737|566522269|FG002|Overall Study|Lack of Efficacy|3|||
156934609|NCT02388737|566522267|FG000|Overall Study|Reason Not Specified|5|||
156934610|NCT02388737|566522268|FG001|Overall Study|Reason Not Specified|5|||
156934611|NCT02388737|566522269|FG002|Overall Study|Reason Not Specified|4|||
156934612|NCT03252522|566522270|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
156934613|NCT03252522|566522271|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
156934614|NCT03252522|566522272|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
156934615|NCT03252522|566522270|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
156934616|NCT03252522|566522271|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
156934617|NCT03252522|566522272|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
156934618|NCT03252522|566522270|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
156934619|NCT03252522|566522271|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
156934620|NCT03252522|566522272|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
156934621|NCT03252522|566522270|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
156934622|NCT03252522|566522271|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
156934623|NCT03252522|566522272|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
156934624|NCT03252522|566522270|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
156934625|NCT03252522|566522271|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
156934626|NCT03252522|566522272|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
156934627|NCT03252522|566522270|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
156934628|NCT03252522|566522271|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
156934629|NCT03252522|566522272|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
156934630|NCT03252522|566522270|FG000|Phase 2: Open Label|Adverse Event|0|||
156934631|NCT03252522|566522271|FG001|Phase 2: Open Label|Adverse Event|0|||
157227087|NCT05665595|567577706|FG001|Overall Study|Death|1|||
156934632|NCT03252522|566522272|FG002|Phase 2: Open Label|Adverse Event|2|||
156934633|NCT03252522|566522270|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
156934634|NCT03252522|566522271|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
156934635|NCT03252522|566522272|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
156934636|NCT03299842|566522274|FG000|Overall Study|Caregiver withdrew consent|2|||
156934637|NCT03299842|566522274|FG000|Overall Study|Child would not keep the watch on|3|||
156934638|NCT01572038|566522276|FG000|Overall Study|Death|648|||
156934639|NCT01572038|566522276|FG000|Overall Study|Withdrawal by Subject|204|||
156934640|NCT01572038|566522276|FG000|Overall Study|Lost to Follow-up|81|||
157030364|NCT02315703|566866789|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
157030365|NCT02315703|566866782|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156934641|NCT01572038|566522276|FG000|Overall Study|Physician Decision|20|||
156934642|NCT01572038|566522276|FG000|Overall Study|Patient Decision|14|||
156934643|NCT01572038|566522276|FG000|Overall Study|Progressive Disease|8|||
156934644|NCT01572038|566522276|FG000|Overall Study|Site Closed Before Completing Form|6|||
156934645|NCT01572038|566522276|FG000|Overall Study|Enrolled into Another Trial|3|||
156934646|NCT01572038|566522276|FG000|Overall Study|Participated in Another Trial|3|||
156934647|NCT01572038|566522276|FG000|Overall Study|Termination by Sponsor|2|||
156934648|NCT01572038|566522276|FG000|Overall Study|Patient Deterioration|1|||
156934649|NCT01572038|566522276|FG000|Overall Study|Sponsor Decision|1|||
156934650|NCT03711162|566522277|FG000|Overall Study|Adverse Event|5|||
156934651|NCT03711162|566522278|FG001|Overall Study|Adverse Event|2|||
156934652|NCT03711162|566522279|FG002|Overall Study|Adverse Event|4|||
156934653|NCT03711162|566522277|FG000|Overall Study|Death|11|||
156934654|NCT03711162|566522278|FG001|Overall Study|Death|7|||
156934655|NCT03711162|566522279|FG002|Overall Study|Death|8|||
156934656|NCT03711162|566522277|FG000|Overall Study|Lost to Follow-up|1|||
156934657|NCT03711162|566522278|FG001|Overall Study|Lost to Follow-up|0|||
156934658|NCT03711162|566522279|FG002|Overall Study|Lost to Follow-up|1|||
156934659|NCT03711162|566522277|FG000|Overall Study|Study Terminated by Sponsor|139|||
156934660|NCT03711162|566522278|FG001|Overall Study|Study Terminated by Sponsor|152|||
156934661|NCT03711162|566522279|FG002|Overall Study|Study Terminated by Sponsor|146|||
156934662|NCT03711162|566522277|FG000|Overall Study|Withdrawal by Subject|17|||
156934663|NCT03711162|566522278|FG001|Overall Study|Withdrawal by Subject|10|||
156934664|NCT03711162|566522279|FG002|Overall Study|Withdrawal by Subject|10|||
156934665|NCT03711162|566522277|FG000|Overall Study|Miscellaneous|1|||
156934666|NCT03711162|566522278|FG001|Overall Study|Miscellaneous|2|||
156934667|NCT03711162|566522279|FG002|Overall Study|Miscellaneous|2|||
156934668|NCT03711162|566522277|FG000|Overall Study|Not Treated|1|||
156934669|NCT03711162|566522278|FG001|Overall Study|Not Treated|0|||
156934670|NCT03711162|566522279|FG002|Overall Study|Not Treated|1|||
156934671|NCT03711162|566522277|FG000|Overall Study|Physician Decision|0|||
156934672|NCT03711162|566522278|FG001|Overall Study|Physician Decision|2|||
156934673|NCT03711162|566522279|FG002|Overall Study|Physician Decision|0|||
156934674|NCT03711162|566522277|FG000|Overall Study|Lack of Efficacy|0|||
156934675|NCT03711162|566522278|FG001|Overall Study|Lack of Efficacy|0|||
156934676|NCT03711162|566522279|FG002|Overall Study|Lack of Efficacy|2|||
156934677|NCT03711162|566522277|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
156934678|NCT03711162|566522278|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
156934679|NCT03711162|566522279|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
156934680|NCT03034954|566522282|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
156934681|NCT03034954|566522283|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
156934682|NCT03568942|566522288|FG000|Overall Study|Family emergency|1|||
156934683|NCT03568942|566522288|FG000|Overall Study|Lost to Follow-up|1|||
156934684|NCT01275066|566522291|FG000|Overall Study|Withdrawal by Subject|0|||
156934685|NCT01275066|566522292|FG001|Overall Study|Withdrawal by Subject|0|||
156934686|NCT01275066|566522293|FG002|Overall Study|Withdrawal by Subject|1|||
156934687|NCT01275066|566522291|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
156934688|NCT01275066|566522292|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
156934689|NCT01275066|566522293|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
156934690|NCT00394212|566522296|FG000|Overall Study|Lost to Follow-up|3|||
156934691|NCT00394212|566522297|FG001|Overall Study|Lost to Follow-up|0|||
157167052|NCT00696436|567352649|FG000|Overall Study|Protocol Violation|3|||
157167053|NCT00696436|567352650|FG001|Overall Study|Protocol Violation|2|||
157167054|NCT00696436|567352651|FG002|Overall Study|Protocol Violation|2|||
157167055|NCT00696436|567352652|FG003|Overall Study|Protocol Violation|0|||
157167056|NCT00696436|567352653|FG004|Overall Study|Protocol Violation|1|||
157167057|NCT00696436|567352649|FG000|Overall Study|Lost to Follow-up|1|||
157167058|NCT00696436|567352650|FG001|Overall Study|Lost to Follow-up|6|||
157167059|NCT00696436|567352651|FG002|Overall Study|Lost to Follow-up|2|||
157227088|NCT02785913|567577707|FG000|Overall Study|Adverse Event|5|||
157227089|NCT02785913|567577707|FG000|Overall Study|Death|2|||
156934692|NCT00394212|566522296|FG000|Overall Study|Withdrawal by Subject|4|||
156934693|NCT00394212|566522297|FG001|Overall Study|Withdrawal by Subject|1|||
156934694|NCT00588445|566522298|FG000|Overall Study|Protocol Violation|1|||
156934695|NCT00588445|566522298|FG000|Overall Study|Withdrawal by Subject|3|||
156934696|NCT00588445|566522298|FG000|Overall Study|Disease Progression|1|||
156934697|NCT00588445|566522298|FG000|Overall Study|Not Treated|10|||
157227090|NCT02785913|567577707|FG000|Overall Study|Progression|18|||
156934698|NCT00358527|566522299|FG000|Overall Study|Adverse Event|4|||
156934699|NCT00358527|566522300|FG001|Overall Study|Adverse Event|0|||
156934700|NCT00358527|566522299|FG000|Overall Study|Withdrawal by Subject|1|||
156934701|NCT00358527|566522300|FG001|Overall Study|Withdrawal by Subject|1|||
156934702|NCT00358527|566522299|FG000|Overall Study|Non-compliance with protocol|6|||
156934703|NCT00358527|566522300|FG001|Overall Study|Non-compliance with protocol|1|||
156934704|NCT00358527|566522299|FG000|Overall Study|Administrative|2|||
156934705|NCT00358527|566522300|FG001|Overall Study|Administrative|1|||
156934706|NCT04144166|566522301|FG000|Overall Study|Discharged before study start|1|||
157167060|NCT00696436|567352652|FG003|Overall Study|Lost to Follow-up|4|||
157167061|NCT00696436|567352653|FG004|Overall Study|Lost to Follow-up|3|||
156934707|NCT04144166|566522301|FG000|Overall Study|Pregnancy|1|||
156934708|NCT04144166|566522301|FG000|Overall Study|Nail polish could not be removed from finger|1|||
156934709|NCT00749463|566522302|FG000|Overall Study|Adverse Event|0|||
156934710|NCT00749463|566522303|FG001|Overall Study|Adverse Event|4|||
156934711|NCT00749463|566522304|FG002|Overall Study|Adverse Event|1|||
156934712|NCT00749463|566522302|FG000|Overall Study|Withdrawal by Subject|1|||
156934713|NCT00749463|566522303|FG001|Overall Study|Withdrawal by Subject|0|||
156934714|NCT00749463|566522304|FG002|Overall Study|Withdrawal by Subject|0|||
156934715|NCT00913744|566522309|FG000|Overall Study|Adverse Event|2|||
156934716|NCT00913744|566522310|FG001|Overall Study|Adverse Event|0|||
156934717|NCT00913744|566522309|FG000|Overall Study|Withdrawal by Subject|2|||
156934718|NCT00913744|566522310|FG001|Overall Study|Withdrawal by Subject|1|||
156934719|NCT00913744|566522309|FG000|Overall Study|Death|1|||
156934720|NCT00913744|566522310|FG001|Overall Study|Death|0|||
156934721|NCT00805935|566522311|FG000|Overall Study|Stimulation Failure|1|||
156934722|NCT00805935|566522312|FG001|Overall Study|Stimulation Failure|5|||
156934723|NCT00805935|566522313|FG002|Overall Study|Stimulation Failure|2|||
156934724|NCT00805935|566522314|FG003|Overall Study|Stimulation Failure|2|||
156934725|NCT00805935|566522311|FG000|Overall Study|Cycle cancelled|0|||
156934726|NCT00805935|566522312|FG001|Overall Study|Cycle cancelled|0|||
156934727|NCT00805935|566522313|FG002|Overall Study|Cycle cancelled|2|||
156934728|NCT00805935|566522314|FG003|Overall Study|Cycle cancelled|0|||
156934729|NCT00805935|566522311|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
156934730|NCT00805935|566522312|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
156934731|NCT00805935|566522313|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
156934732|NCT00805935|566522314|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
156934733|NCT00805935|566522311|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156934734|NCT00805935|566522312|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156934735|NCT00805935|566522313|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
156934736|NCT00805935|566522314|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
156934737|NCT00805935|566522311|FG000|Overall Study|Lost to Follow-up|1|||
156934738|NCT00805935|566522312|FG001|Overall Study|Lost to Follow-up|0|||
156934739|NCT00805935|566522313|FG002|Overall Study|Lost to Follow-up|0|||
156934740|NCT00805935|566522314|FG003|Overall Study|Lost to Follow-up|0|||
156934741|NCT00805935|566522311|FG000|Overall Study|No positive serum pregnancy|8|||
156934742|NCT00805935|566522312|FG001|Overall Study|No positive serum pregnancy|7|||
156934743|NCT00805935|566522313|FG002|Overall Study|No positive serum pregnancy|6|||
156934744|NCT00805935|566522314|FG003|Overall Study|No positive serum pregnancy|5|||
156934745|NCT00805935|566522311|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156934746|NCT00805935|566522312|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156934747|NCT00805935|566522313|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
156934748|NCT00805935|566522314|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
156934749|NCT00805935|566522311|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
156934750|NCT00805935|566522312|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
156934751|NCT00805935|566522313|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
156934752|NCT00805935|566522314|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
156934753|NCT00805935|566522311|FG000|Overall Study|Biochemical pregnancy|0|||
156934754|NCT00805935|566522312|FG001|Overall Study|Biochemical pregnancy|1|||
156934755|NCT00805935|566522313|FG002|Overall Study|Biochemical pregnancy|0|||
156934756|NCT00805935|566522314|FG003|Overall Study|Biochemical pregnancy|0|||
156934757|NCT00805935|566522311|FG000|Overall Study|Chemical pregnancy|0|||
156934758|NCT00805935|566522312|FG001|Overall Study|Chemical pregnancy|5|||
156934759|NCT00805935|566522313|FG002|Overall Study|Chemical pregnancy|3|||
156934760|NCT00805935|566522314|FG003|Overall Study|Chemical pregnancy|2|||
156934761|NCT00805935|566522311|FG000|Overall Study|Ectopic pregnancy|0|||
156934762|NCT00805935|566522312|FG001|Overall Study|Ectopic pregnancy|0|||
156934763|NCT00805935|566522313|FG002|Overall Study|Ectopic pregnancy|1|||
156934764|NCT00805935|566522314|FG003|Overall Study|Ectopic pregnancy|0|||
156934765|NCT00805935|566522311|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
156934766|NCT00805935|566522312|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
156934767|NCT00805935|566522313|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
156934768|NCT00805935|566522314|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
157030366|NCT02315703|566866783|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
156934769|NCT04904185|566522315|FG000|Overall Study|Expansion failure|1|||
156934770|NCT04904185|566522316|FG001|Overall Study|Expansion failure|0|||
156934771|NCT04904185|566522315|FG000|Overall Study|Late response on prior treatment|1|||
156934772|NCT04904185|566522316|FG001|Overall Study|Late response on prior treatment|0|||
156934773|NCT02945410|566522317|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156934774|NCT02945410|566522318|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
156934775|NCT02945410|566522319|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156934776|NCT02945410|566522320|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156934777|NCT02945410|566522321|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156934778|NCT02945410|566522322|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156934779|NCT02945410|566522317|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
156934780|NCT02945410|566522318|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
156934781|NCT02945410|566522319|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
156934782|NCT02945410|566522320|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
156934783|NCT02945410|566522321|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
156934784|NCT02945410|566522322|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
156934785|NCT02945410|566522317|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156934786|NCT02945410|566522318|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156934787|NCT02945410|566522319|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
156934788|NCT02945410|566522320|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156934789|NCT02945410|566522321|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
156934790|NCT02945410|566522322|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
156934791|NCT00110812|566522323|FG000|Main Study|Death|0|||
156934792|NCT00110812|566522324|FG001|Main Study|Death|0|||
156934793|NCT00110812|566522325|FG002|Main Study|Death|2|||
156934794|NCT00110812|566522323|FG000|Main Study|Withdrawal by Subject|0|||
156934795|NCT00110812|566522324|FG001|Main Study|Withdrawal by Subject|0|||
156934796|NCT00110812|566522325|FG002|Main Study|Withdrawal by Subject|1|||
156934797|NCT00110812|566522323|FG000|Main Study|Lost to Follow-up|8|||
156934798|NCT00110812|566522324|FG001|Main Study|Lost to Follow-up|11|||
156934799|NCT00110812|566522325|FG002|Main Study|Lost to Follow-up|10|||
156934800|NCT00110812|566522323|FG000|Extended Follow-up|Death|1|||
156934801|NCT00110812|566522324|FG001|Extended Follow-up|Death|0|||
156934802|NCT00110812|566522325|FG002|Extended Follow-up|Death|3|||
156934803|NCT00110812|566522323|FG000|Extended Follow-up|Withdrawal by Subject|0|||
156934804|NCT00110812|566522324|FG001|Extended Follow-up|Withdrawal by Subject|1|||
156934805|NCT00110812|566522325|FG002|Extended Follow-up|Withdrawal by Subject|0|||
156934806|NCT00110812|566522323|FG000|Extended Follow-up|Lost to Follow-up|1|||
156934807|NCT00110812|566522324|FG001|Extended Follow-up|Lost to Follow-up|3|||
156934808|NCT00110812|566522325|FG002|Extended Follow-up|Lost to Follow-up|1|||
156934809|NCT01344369|566522326|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
156934810|NCT01344369|566522327|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
156934811|NCT01344369|566522326|FG000|Washout of 28 Days|Physician Decision|0|||
156934812|NCT01344369|566522327|FG001|Washout of 28 Days|Physician Decision|1|||
156934813|NCT01344369|566522326|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
156934814|NCT01344369|566522327|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
156934815|NCT02342704|566522330|FG000|Overall Study|Physician Decision|0|||
156934816|NCT02342704|566522331|FG001|Overall Study|Physician Decision|3|||
156934817|NCT02342704|566522330|FG000|Overall Study|Sponsor Termination|49|||
156934818|NCT02342704|566522331|FG001|Overall Study|Sponsor Termination|43|||
156934819|NCT02342704|566522330|FG000|Overall Study|Other|0|||
156934820|NCT02342704|566522331|FG001|Overall Study|Other|1|||
156934821|NCT02342704|566522330|FG000|Overall Study|Withdrawal by Subject|1|||
156934822|NCT02342704|566522331|FG001|Overall Study|Withdrawal by Subject|0|||
156934823|NCT02342704|566522330|FG000|Overall Study|Lost to Follow-up|2|||
156934824|NCT02342704|566522331|FG001|Overall Study|Lost to Follow-up|1|||
156934825|NCT02342704|566522330|FG000|Overall Study|Adverse Event|1|||
156934826|NCT02342704|566522331|FG001|Overall Study|Adverse Event|3|||
156934827|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
156934828|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
156934829|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
156934830|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
156934831|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156934832|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
156934833|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156934834|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
156934835|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
156934836|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
156934837|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
156934838|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
156934839|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
156934840|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
156934841|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
157030367|NCT02315703|566866784|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
157030368|NCT02315703|566866785|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
157167062|NCT00696436|567352649|FG000|Overall Study|Withdrawal by Subject|4|||
156934842|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
156934843|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
156934844|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
156934845|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
156934846|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
156934847|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156934848|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
156934849|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156934850|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
156934851|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156934852|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
156934853|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156934854|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
156934855|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156934856|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
156934857|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156934858|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
156934859|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
156934860|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
156934861|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
156934862|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
156934863|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156934864|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
156934865|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156934866|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
156934867|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
156934868|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
156934869|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
156934870|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
156934871|NCT01218516|566522333|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
156934872|NCT01218516|566522334|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
156934873|NCT01218516|566522335|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
156934874|NCT01218516|566522336|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
156934875|NCT01539226|566522337|FG000|Overall Study|Withdrawal by Subject|24|||
156934876|NCT01539226|566522338|FG001|Overall Study|Withdrawal by Subject|54|||
156934877|NCT01539226|566522337|FG000|Overall Study|Lost to Follow-up|20|||
156934878|NCT01539226|566522338|FG001|Overall Study|Lost to Follow-up|54|||
156934879|NCT01539226|566522337|FG000|Overall Study|Death|1|||
156934880|NCT01539226|566522338|FG001|Overall Study|Death|2|||
156934881|NCT01539226|566522337|FG000|Overall Study|Adverse Event|2|||
156934882|NCT01539226|566522338|FG001|Overall Study|Adverse Event|0|||
156934883|NCT01539226|566522337|FG000|Overall Study|Pregnancy|13|||
156934884|NCT01539226|566522338|FG001|Overall Study|Pregnancy|29|||
156934885|NCT01539226|566522337|FG000|Overall Study|inappropriate enrollment|0|||
156934886|NCT01539226|566522338|FG001|Overall Study|inappropriate enrollment|1|||
156934887|NCT01539226|566522337|FG000|Overall Study|Multiple Reasons|3|||
156934888|NCT01539226|566522338|FG001|Overall Study|Multiple Reasons|1|||
156934889|NCT01539226|566522337|FG000|Overall Study|not HIV seroconversion-related|93|||
156934890|NCT01539226|566522338|FG001|Overall Study|not HIV seroconversion-related|176|||
156934891|NCT01539226|566522337|FG000|Overall Study|HIV seroconversion-related|55|||
156934892|NCT01539226|566522338|FG001|Overall Study|HIV seroconversion-related|80|||
156934893|NCT01539226|566522337|FG000|Overall Study|Non-compliance|6|||
156934894|NCT01539226|566522338|FG001|Overall Study|Non-compliance|8|||
156934895|NCT01632891|566522339|FG000|Overall Study|Lost to Follow-up|0|||
156934896|NCT01632891|566522340|FG001|Overall Study|Lost to Follow-up|1|||
156934897|NCT01632891|566522339|FG000|Overall Study|Withdrawal by Subject|1|||
156934898|NCT01632891|566522340|FG001|Overall Study|Withdrawal by Subject|0|||
156934899|NCT02118428|566522341|FG000|Overall Study|Physician Decision|0|||
156934900|NCT02118428|566522342|FG001|Overall Study|Physician Decision|1|||
156934901|NCT02118428|566522343|FG002|Overall Study|Physician Decision|0|||
156934902|NCT02118428|566522341|FG000|Overall Study|Withdrawal by Subject|2|||
156934903|NCT02118428|566522342|FG001|Overall Study|Withdrawal by Subject|2|||
156934904|NCT02118428|566522343|FG002|Overall Study|Withdrawal by Subject|0|||
156934905|NCT02118428|566522341|FG000|Overall Study|Death|7|||
156934906|NCT02118428|566522342|FG001|Overall Study|Death|5|||
156934907|NCT02118428|566522343|FG002|Overall Study|Death|0|||
156934908|NCT02118428|566522341|FG000|Overall Study|Lost to Follow-up|3|||
156934909|NCT02118428|566522342|FG001|Overall Study|Lost to Follow-up|1|||
156934910|NCT02118428|566522343|FG002|Overall Study|Lost to Follow-up|0|||
156934911|NCT02118428|566522341|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
157167063|NCT00696436|567352650|FG001|Overall Study|Withdrawal by Subject|11|||
156934912|NCT02118428|566522342|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
156934913|NCT02118428|566522343|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
156934914|NCT02286193|566522347|FG000|Overall Study|Referred: CRS unable to make contact|62|||
156934915|NCT02286193|566522347|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
156934916|NCT02286193|566522347|FG000|Overall Study|Referred: Declined service|38|||
156934917|NCT02871375|566522348|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
156934918|NCT02871375|566522349|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
156934919|NCT04327999|566522354|FG000|Overall Study|Protocol Violation|1|||
156934920|NCT02872116|566522355|FG000|Pre-Treatment|Disease Progression|0|||
156934921|NCT02872116|566522356|FG001|Pre-Treatment|Disease Progression|1|||
156934922|NCT02872116|566522357|FG002|Pre-Treatment|Disease Progression|0|||
156934923|NCT02872116|566522355|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
156934924|NCT02872116|566522356|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
156934925|NCT02872116|566522357|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
156934926|NCT02872116|566522355|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
156934927|NCT02872116|566522356|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
156934928|NCT02872116|566522357|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
156934929|NCT02872116|566522355|FG000|Pre-Treatment|Participant withdrew consent|2|||
156934930|NCT02872116|566522356|FG001|Pre-Treatment|Participant withdrew consent|20|||
156934931|NCT02872116|566522357|FG002|Pre-Treatment|Participant withdrew consent|3|||
156934932|NCT02872116|566522355|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
156934933|NCT02872116|566522356|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
156934934|NCT02872116|566522357|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
156934935|NCT02872116|566522355|FG000|Pre-Treatment|Other reasons|1|||
156934936|NCT02872116|566522356|FG001|Pre-Treatment|Other reasons|2|||
156934937|NCT02872116|566522357|FG002|Pre-Treatment|Other reasons|2|||
156934938|NCT02872116|566522355|FG000|Treatment|Death|121|||
156934939|NCT02872116|566522356|FG001|Treatment|Death|94|||
156934940|NCT02872116|566522357|FG002|Treatment|Death|68|||
156934941|NCT02872116|566522355|FG000|Treatment|Lost to Follow-up|5|||
156934942|NCT02872116|566522356|FG001|Treatment|Lost to Follow-up|7|||
156934943|NCT02872116|566522357|FG002|Treatment|Lost to Follow-up|3|||
156934944|NCT02872116|566522355|FG000|Treatment|Participant withdrew consent|20|||
156934945|NCT02872116|566522356|FG001|Treatment|Participant withdrew consent|40|||
156934946|NCT02872116|566522357|FG002|Treatment|Participant withdrew consent|8|||
156934947|NCT02872116|566522355|FG000|Treatment|Other reasons|13|||
156934948|NCT02872116|566522356|FG001|Treatment|Other reasons|12|||
156934949|NCT02872116|566522357|FG002|Treatment|Other reasons|5|||
156934950|NCT01907828|566522369|FG000|Overall Study|Exclusion criteria not met|0|||
156934951|NCT01907828|566522370|FG001|Overall Study|Exclusion criteria not met|1|||
156934952|NCT01907828|566522369|FG000|Overall Study|Withdrawal by Subject|3|||
156934953|NCT01907828|566522370|FG001|Overall Study|Withdrawal by Subject|4|||
156934954|NCT01907828|566522369|FG000|Overall Study|Lost to Follow-up|3|||
156934955|NCT01907828|566522370|FG001|Overall Study|Lost to Follow-up|0|||
156934956|NCT01907828|566522369|FG000|Overall Study|Participant refused 24-month follow-up|1|||
156934957|NCT01907828|566522370|FG001|Overall Study|Participant refused 24-month follow-up|0|||
156934958|NCT01907828|566522369|FG000|Overall Study|Participant met exclusion criteria|0|||
156934959|NCT01907828|566522370|FG001|Overall Study|Participant met exclusion criteria|1|||
156934960|NCT01364428|566522371|FG000|Overall Study|Adverse Event|1|||
156934961|NCT01364428|566522372|FG001|Overall Study|Adverse Event|2|||
156934962|NCT01364428|566522371|FG000|Overall Study|Protocol Violation|2|||
156934963|NCT01364428|566522372|FG001|Overall Study|Protocol Violation|0|||
156934964|NCT01364428|566522371|FG000|Overall Study|Withdrawal Criteria|14|||
156934965|NCT01364428|566522372|FG001|Overall Study|Withdrawal Criteria|10|||
156934966|NCT01364428|566522371|FG000|Overall Study|Other|3|||
156934967|NCT01364428|566522372|FG001|Overall Study|Other|3|||
156934968|NCT01585766|566522373|FG000|Overall Study|Withdrawal by Subject|0|||
156934969|NCT01585766|566522374|FG001|Overall Study|Withdrawal by Subject|1|||
156934970|NCT01585766|566522375|FG002|Overall Study|Withdrawal by Subject|1|||
156934971|NCT01585766|566522376|FG003|Overall Study|Withdrawal by Subject|0|||
156934972|NCT01585766|566522377|FG004|Overall Study|Withdrawal by Subject|0|||
156934973|NCT01585766|566522378|FG005|Overall Study|Withdrawal by Subject|0|||
156934974|NCT01585766|566522373|FG000|Overall Study|Death|0|||
156934975|NCT01585766|566522374|FG001|Overall Study|Death|1|||
156934976|NCT01585766|566522375|FG002|Overall Study|Death|0|||
156934977|NCT01585766|566522376|FG003|Overall Study|Death|0|||
156934978|NCT01585766|566522377|FG004|Overall Study|Death|0|||
157030369|NCT02315703|566866786|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
157030370|NCT02315703|566866787|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
156934979|NCT01585766|566522378|FG005|Overall Study|Death|0|||
156934980|NCT01585766|566522373|FG000|Overall Study|Physician Decision|0|||
156934981|NCT01585766|566522374|FG001|Overall Study|Physician Decision|0|||
156934982|NCT01585766|566522375|FG002|Overall Study|Physician Decision|1|||
156934983|NCT01585766|566522376|FG003|Overall Study|Physician Decision|0|||
156934984|NCT01585766|566522377|FG004|Overall Study|Physician Decision|0|||
156934985|NCT01585766|566522378|FG005|Overall Study|Physician Decision|0|||
156934986|NCT01073865|566522379|FG000|Overall Study|Reasons other than below|19|||
156934987|NCT01073865|566522380|FG001|Overall Study|Reasons other than below|31|||
156934988|NCT01073865|566522379|FG000|Overall Study|Lost to Follow-up|1|||
156934989|NCT01073865|566522380|FG001|Overall Study|Lost to Follow-up|1|||
156934990|NCT01073865|566522379|FG000|Overall Study|Death|3|||
156934991|NCT01073865|566522380|FG001|Overall Study|Death|2|||
156934992|NCT01073865|566522379|FG000|Overall Study|Withdrawal by Subject|5|||
157030371|NCT02315703|566866788|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
157030372|NCT02315703|566866789|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
157030373|NCT02315703|566866782|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
157030374|NCT02315703|566866783|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
157030375|NCT02315703|566866784|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
157030376|NCT02315703|566866785|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
157030377|NCT02315703|566866786|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
157030378|NCT02315703|566866787|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
157227091|NCT02785913|567577707|FG000|Overall Study|Not protocol specified|1|||
157227092|NCT02016300|567577714|FG000|Overall Study|Lost to Follow-up|0|||
157227093|NCT02016300|567577715|FG001|Overall Study|Lost to Follow-up|3|||
156934993|NCT01073865|566522380|FG001|Overall Study|Withdrawal by Subject|5|||
156934994|NCT03925324|566522381|FG000|Overall Study|Death|1|||
156934995|NCT03925324|566522382|FG001|Overall Study|Death|1|||
156934996|NCT04414553|566522383|FG000|Overall Study|Lost to Follow-up|20|||
156934997|NCT00696137|566522389|FG000|Overall Study|Withdrawal by Subject|2|||
156934998|NCT00775437|566522405|FG000|Overall Study|Loss of efficacy|2|||
156934999|NCT00775437|566522405|FG000|Overall Study|Withdrawal by Subject|3|||
156935000|NCT00775437|566522405|FG000|Overall Study|Lost to Follow-up|1|||
156935001|NCT01183975|566522406|FG000|Overall Study|Lost to Follow-up|73|||
156935002|NCT04371380|566522408|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
156935003|NCT04371380|566522409|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
156935004|NCT04371380|566522410|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
156935005|NCT01148511|566522415|FG000|Exposed to Study Drug|Protocol Violation|2|||
156935006|NCT01148511|566522416|FG001|Exposed to Study Drug|Protocol Violation|0|||
156935007|NCT01148511|566522417|FG002|Exposed to Study Drug|Protocol Violation|0|||
156935008|NCT01148511|566522415|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
156935009|NCT01148511|566522416|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
156935010|NCT01148511|566522417|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
156935011|NCT01148511|566522415|FG000|Randomized|Adverse Event|0|||
156935012|NCT01148511|566522416|FG001|Randomized|Adverse Event|1|||
156935013|NCT01148511|566522417|FG002|Randomized|Adverse Event|0|||
156935014|NCT01148511|566522415|FG000|Randomized|Protocol Violation|0|||
156935015|NCT01148511|566522416|FG001|Randomized|Protocol Violation|2|||
156935016|NCT01148511|566522417|FG002|Randomized|Protocol Violation|1|||
156935017|NCT01148511|566522415|FG000|Randomized|Lost to Follow-up|0|||
156935018|NCT01148511|566522416|FG001|Randomized|Lost to Follow-up|1|||
156935019|NCT01148511|566522417|FG002|Randomized|Lost to Follow-up|1|||
156935020|NCT01148511|566522415|FG000|Randomized|Consent withdrawal|0|||
156935021|NCT01148511|566522416|FG001|Randomized|Consent withdrawal|5|||
156935022|NCT01148511|566522417|FG002|Randomized|Consent withdrawal|3|||
156935023|NCT01148511|566522415|FG000|Randomized|Other|0|||
156935024|NCT01148511|566522416|FG001|Randomized|Other|1|||
156935025|NCT01148511|566522417|FG002|Randomized|Other|1|||
156935026|NCT01418937|566522418|FG000|Overall Study|Lost to Follow-up|5|||
156935027|NCT01418937|566522418|FG000|Overall Study|Protocol Violation|1|||
156935028|NCT01418937|566522418|FG000|Overall Study|Pregnancy|1|||
156935029|NCT01418937|566522418|FG000|Overall Study|Withdrawal by Subject|1|||
156935030|NCT00856908|566522422|FG000|Overall Study|Lost to Follow-up|1|||
156935031|NCT00856908|566522423|FG001|Overall Study|Lost to Follow-up|0|||
156935032|NCT01623596|566522426|FG000|Overall Study|Abnormal laboratory values|2|||
156935033|NCT01623596|566522427|FG001|Overall Study|Abnormal laboratory values|0|||
156935034|NCT01623596|566522426|FG000|Overall Study|Administrative problems|9|||
156935035|NCT01623596|566522427|FG001|Overall Study|Administrative problems|13|||
156935036|NCT01623596|566522426|FG000|Overall Study|Adverse Event|20|||
156935037|NCT01623596|566522427|FG001|Overall Study|Adverse Event|29|||
156935038|NCT01623596|566522426|FG000|Overall Study|Death|0|||
156935039|NCT01623596|566522427|FG001|Overall Study|Death|2|||
156935040|NCT01623596|566522426|FG000|Overall Study|Lost to Follow-up|12|||
156935041|NCT01623596|566522427|FG001|Overall Study|Lost to Follow-up|16|||
156935042|NCT01623596|566522426|FG000|Overall Study|Withdrawal by Subject|13|||
156935043|NCT01623596|566522427|FG001|Overall Study|Withdrawal by Subject|31|||
156935044|NCT01623596|566522426|FG000|Overall Study|Patient no longer requires study drug|1|||
156935045|NCT01623596|566522427|FG001|Overall Study|Patient no longer requires study drug|0|||
156935046|NCT01623596|566522426|FG000|Overall Study|Protocol Violation|0|||
156935047|NCT01623596|566522427|FG001|Overall Study|Protocol Violation|6|||
156935048|NCT01623596|566522426|FG000|Overall Study|Lack of Efficacy|5|||
156935049|NCT01623596|566522427|FG001|Overall Study|Lack of Efficacy|3|||
156935050|NCT04059146|566522428|FG000|Overall Study|Withdrawal by Subject|0|||
156935051|NCT04059146|566522429|FG001|Overall Study|Withdrawal by Subject|1|||
156935052|NCT01070316|566522430|FG000|Extension Phase|Lack of Efficacy|3|||
156935053|NCT01070316|566522430|FG000|Extension Phase|Withdrawal by Subject|1|||
156935054|NCT00026793|566522431|FG000|Overall Study|Death on study due to underlying disease|4|||
156935055|NCT00026793|566522431|FG000|Overall Study|Physician Decision|2|||
156935056|NCT00026793|566522431|FG000|Overall Study|Off study|2|||
156935057|NCT04243538|566522432|FG000|Overall Study|Withdrawal by Subject|0|||
156935058|NCT04243538|566522433|FG001|Overall Study|Withdrawal by Subject|2|||
156935059|NCT04243538|566522432|FG000|Overall Study|Lost to Follow-up|0|||
157030379|NCT02315703|566866788|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
157030380|NCT02315703|566866789|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
156935060|NCT04243538|566522433|FG001|Overall Study|Lost to Follow-up|3|||
156935061|NCT00655564|566522434|FG000|Overall Study|Adverse Event|1|||
156935062|NCT00655564|566522434|FG000|Overall Study|Lost to Follow-up|1|||
156935063|NCT00655564|566522434|FG000|Overall Study|Desired Alternate Therapy|1|||
156935064|NCT04536727|566522435|FG000|Overall Study|Lost to Follow-up|1|||
156935065|NCT04536727|566522436|FG001|Overall Study|Lost to Follow-up|1|||
156935066|NCT04536727|566522435|FG000|Overall Study|Death|0|||
156935067|NCT04536727|566522436|FG001|Overall Study|Death|1|||
156935068|NCT05627518|566522437|FG000|Treatment Period 1|Adverse Event|0|||
156935069|NCT05627518|566522438|FG001|Treatment Period 1|Adverse Event|0|||
156935070|NCT05627518|566522439|FG002|Treatment Period 1|Adverse Event|1|||
156935071|NCT05627518|566522440|FG003|Treatment Period 1|Adverse Event|0|||
156935072|NCT05627518|566522441|FG004|Treatment Period 1|Adverse Event|0|||
156935073|NCT05627518|566522442|FG005|Treatment Period 1|Adverse Event|0|||
156935074|NCT05627518|566522443|FG006|Treatment Period 1|Adverse Event|0|||
156935075|NCT05627518|566522444|FG007|Treatment Period 1|Adverse Event|1|||
156935076|NCT05627518|566522437|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156935077|NCT05627518|566522438|FG001|Treatment Period 1|Withdrawal by Subject|0|||
156935078|NCT05627518|566522439|FG002|Treatment Period 1|Withdrawal by Subject|1|||
156935079|NCT05627518|566522440|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156935080|NCT05627518|566522441|FG004|Treatment Period 1|Withdrawal by Subject|0|||
156935081|NCT05627518|566522442|FG005|Treatment Period 1|Withdrawal by Subject|1|||
156935082|NCT05627518|566522443|FG006|Treatment Period 1|Withdrawal by Subject|0|||
156935083|NCT05627518|566522444|FG007|Treatment Period 1|Withdrawal by Subject|0|||
156935084|NCT05627518|566522437|FG000|Treatment Period 1|Protocol Violation|0|||
156935085|NCT05627518|566522438|FG001|Treatment Period 1|Protocol Violation|0|||
156935086|NCT05627518|566522439|FG002|Treatment Period 1|Protocol Violation|0|||
156935087|NCT05627518|566522440|FG003|Treatment Period 1|Protocol Violation|0|||
156935088|NCT05627518|566522441|FG004|Treatment Period 1|Protocol Violation|0|||
156935089|NCT05627518|566522442|FG005|Treatment Period 1|Protocol Violation|0|||
156935090|NCT05627518|566522443|FG006|Treatment Period 1|Protocol Violation|6|||
156935091|NCT05627518|566522444|FG007|Treatment Period 1|Protocol Violation|6|||
156935092|NCT05627518|566522437|FG000|Treatment Period 2|Adverse Event|1|||
156935093|NCT05627518|566522438|FG001|Treatment Period 2|Adverse Event|0|||
156935094|NCT05627518|566522439|FG002|Treatment Period 2|Adverse Event|0|||
156935095|NCT05627518|566522440|FG003|Treatment Period 2|Adverse Event|0|||
156935096|NCT05627518|566522441|FG004|Treatment Period 2|Adverse Event|0|||
156935097|NCT05627518|566522442|FG005|Treatment Period 2|Adverse Event|0|||
156935098|NCT05627518|566522443|FG006|Treatment Period 2|Adverse Event|0|||
156935099|NCT05627518|566522444|FG007|Treatment Period 2|Adverse Event|0|||
156935100|NCT05627518|566522437|FG000|Treatment Period 2|Withdrawal by Subject|1|||
156935101|NCT05627518|566522438|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156935102|NCT05627518|566522439|FG002|Treatment Period 2|Withdrawal by Subject|0|||
156935103|NCT05627518|566522440|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156935104|NCT05627518|566522441|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156935105|NCT05627518|566522442|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156935106|NCT05627518|566522443|FG006|Treatment Period 2|Withdrawal by Subject|0|||
156935107|NCT05627518|566522444|FG007|Treatment Period 2|Withdrawal by Subject|0|||
156935108|NCT01940120|566524034|FG000|Overall Study|Death|40|||
156935109|NCT01940120|566524034|FG000|Overall Study|Withdrawal by Subject|8|||
156935110|NCT01888497|566524035|FG000|Washout Period 1|Withdrawal by Subject|0|||
156935111|NCT01888497|566524036|FG001|Washout Period 1|Withdrawal by Subject|0|||
156935112|NCT01888497|566524037|FG002|Washout Period 1|Withdrawal by Subject|1|||
156935113|NCT01888497|566524038|FG003|Washout Period 1|Withdrawal by Subject|1|||
156935114|NCT01888497|566524035|FG000|Washout Period 2|Adverse Event|0|||
156935115|NCT01888497|566524036|FG001|Washout Period 2|Adverse Event|0|||
156935116|NCT01888497|566524037|FG002|Washout Period 2|Adverse Event|0|||
156935117|NCT01888497|566524038|FG003|Washout Period 2|Adverse Event|1|||
157227094|NCT03331042|567577727|FG000|Overall Study|Protocol Violation|1|||
157227095|NCT03331042|567577728|FG001|Overall Study|Protocol Violation|0|||
156935118|NCT01888497|566524035|FG000|Washout Period 2|Withdrawal by Subject|0|||
156935119|NCT01888497|566524036|FG001|Washout Period 2|Withdrawal by Subject|0|||
156935120|NCT01888497|566524037|FG002|Washout Period 2|Withdrawal by Subject|0|||
156935121|NCT01888497|566524038|FG003|Washout Period 2|Withdrawal by Subject|1|||
156935122|NCT04482179|566524041|FG000|Overall Study|Death|1|||
156935123|NCT04482179|566524042|FG001|Overall Study|Death|0|||
156935124|NCT04482179|566524041|FG000|Overall Study|Withdrawal by Subject|1|||
156935125|NCT04482179|566524042|FG001|Overall Study|Withdrawal by Subject|0|||
156935126|NCT00283439|566524043|FG000|Overall Study|Adverse Event|0|||
156935127|NCT00283439|566524044|FG001|Overall Study|Adverse Event|0|||
156935128|NCT00283439|566524045|FG002|Overall Study|Adverse Event|0|||
156935129|NCT00283439|566524046|FG003|Overall Study|Adverse Event|1|||
156935130|NCT00283439|566524043|FG000|Overall Study|Death|0|||
156935131|NCT00283439|566524044|FG001|Overall Study|Death|0|||
156935132|NCT00283439|566524045|FG002|Overall Study|Death|1|||
156935133|NCT00283439|566524046|FG003|Overall Study|Death|0|||
156935134|NCT00283439|566524043|FG000|Overall Study|Disease progression|0|||
156935135|NCT00283439|566524044|FG001|Overall Study|Disease progression|1|||
156935136|NCT00283439|566524045|FG002|Overall Study|Disease progression|0|||
156935137|NCT00283439|566524046|FG003|Overall Study|Disease progression|0|||
156935138|NCT00283439|566524043|FG000|Overall Study|Requirement for alternative therapy|1|||
156935139|NCT00283439|566524044|FG001|Overall Study|Requirement for alternative therapy|2|||
156935140|NCT00283439|566524045|FG002|Overall Study|Requirement for alternative therapy|5|||
156935141|NCT00283439|566524046|FG003|Overall Study|Requirement for alternative therapy|2|||
156935142|NCT00283439|566524043|FG000|Overall Study|Stem cell transplant|6|||
156935143|NCT00283439|566524044|FG001|Overall Study|Stem cell transplant|6|||
156935144|NCT00283439|566524045|FG002|Overall Study|Stem cell transplant|4|||
156935145|NCT00283439|566524046|FG003|Overall Study|Stem cell transplant|3|||
156935146|NCT00283439|566524043|FG000|Overall Study|Treatment discontinued|0|||
156935147|NCT00283439|566524044|FG001|Overall Study|Treatment discontinued|2|||
156935148|NCT00283439|566524045|FG002|Overall Study|Treatment discontinued|1|||
156935149|NCT00283439|566524046|FG003|Overall Study|Treatment discontinued|3|||
156935150|NCT00283439|566524043|FG000|Overall Study|Other|1|||
156935151|NCT00283439|566524044|FG001|Overall Study|Other|0|||
156935152|NCT00283439|566524045|FG002|Overall Study|Other|0|||
156935153|NCT00283439|566524046|FG003|Overall Study|Other|0|||
156935154|NCT00333229|566524047|FG000|Overall Study|Lack of Efficacy|0|||
156935155|NCT00333229|566524048|FG001|Overall Study|Lack of Efficacy|1|||
156935156|NCT00782210|566524051|FG000|Overall Study|Adverse Event|21|||
156935157|NCT00782210|566524052|FG001|Overall Study|Adverse Event|17|||
156935158|NCT00782210|566524053|FG002|Overall Study|Adverse Event|16|||
156935159|NCT00782210|566524051|FG000|Overall Study|Lost to Follow-up|2|||
156935160|NCT00782210|566524052|FG001|Overall Study|Lost to Follow-up|1|||
156935161|NCT00782210|566524053|FG002|Overall Study|Lost to Follow-up|2|||
156935162|NCT00782210|566524051|FG000|Overall Study|Withdrawal by Subject|11|||
156935163|NCT00782210|566524052|FG001|Overall Study|Withdrawal by Subject|8|||
156935164|NCT00782210|566524053|FG002|Overall Study|Withdrawal by Subject|11|||
156935165|NCT00782210|566524051|FG000|Overall Study|Non compliance with protocol|0|||
156935166|NCT00782210|566524052|FG001|Overall Study|Non compliance with protocol|3|||
156935167|NCT00782210|566524053|FG002|Overall Study|Non compliance with protocol|2|||
156935168|NCT00782210|566524051|FG000|Overall Study|Lack of Efficacy|13|||
156935169|NCT00782210|566524052|FG001|Overall Study|Lack of Efficacy|4|||
156935170|NCT00782210|566524053|FG002|Overall Study|Lack of Efficacy|1|||
156935171|NCT00782210|566524051|FG000|Overall Study|Other reason not described above|3|||
156935172|NCT00782210|566524052|FG001|Overall Study|Other reason not described above|2|||
156935173|NCT00782210|566524053|FG002|Overall Study|Other reason not described above|3|||
156935174|NCT05358821|566524056|FG000|Overall Study|Withdrawal by Subject|0|||
156935175|NCT05358821|566524057|FG001|Overall Study|Withdrawal by Subject|1|||
156935176|NCT05358821|566524058|FG002|Overall Study|Withdrawal by Subject|0|||
156935177|NCT05358821|566524056|FG000|Overall Study|Withdrawal of Consent|0|||
156935178|NCT05358821|566524057|FG001|Overall Study|Withdrawal of Consent|0|||
156935179|NCT05358821|566524058|FG002|Overall Study|Withdrawal of Consent|1|||
156935180|NCT02704364|566524059|FG000|Overall Study|Adverse Event|1|||
156935181|NCT02704364|566524060|FG001|Overall Study|Adverse Event|1|||
156935182|NCT02704364|566524061|FG002|Overall Study|Adverse Event|0|||
156935183|NCT02704364|566524059|FG000|Overall Study|Noncompliance with study drug|1|||
156935184|NCT02704364|566524060|FG001|Overall Study|Noncompliance with study drug|1|||
156935185|NCT02704364|566524061|FG002|Overall Study|Noncompliance with study drug|0|||
156935186|NCT02704364|566524059|FG000|Overall Study|Other|0|||
156935187|NCT02704364|566524060|FG001|Overall Study|Other|1|||
156935188|NCT02704364|566524061|FG002|Overall Study|Other|1|||
156935189|NCT02086110|566524064|FG000|Overall Study|Withdrawal by Subject|1|||
156935190|NCT02086110|566524065|FG001|Overall Study|Withdrawal by Subject|1|||
156935191|NCT01869192|566524066|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
156935192|NCT01869192|566524067|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
156935193|NCT01869192|566524066|FG000|Postoperative Chemotherapy|Physician Decision|0|||
156935194|NCT01869192|566524067|FG001|Postoperative Chemotherapy|Physician Decision|2|||
156935195|NCT01203072|566524071|FG000|Overall Study|Adverse Event|5|||
156935196|NCT01203072|566524072|FG001|Overall Study|Adverse Event|3|||
156935197|NCT01203072|566524073|FG002|Overall Study|Adverse Event|2|||
156935198|NCT01203072|566524074|FG003|Overall Study|Adverse Event|4|||
156935199|NCT01203072|566524075|FG004|Overall Study|Adverse Event|2|||
156935200|NCT01203072|566524071|FG000|Overall Study|Lack of Efficacy|1|||
156935201|NCT01203072|566524072|FG001|Overall Study|Lack of Efficacy|0|||
156935202|NCT01203072|566524073|FG002|Overall Study|Lack of Efficacy|0|||
156935203|NCT01203072|566524074|FG003|Overall Study|Lack of Efficacy|0|||
156935204|NCT01203072|566524075|FG004|Overall Study|Lack of Efficacy|0|||
156935205|NCT01203072|566524071|FG000|Overall Study|Lost to Follow-up|0|||
156935206|NCT01203072|566524072|FG001|Overall Study|Lost to Follow-up|1|||
156935207|NCT01203072|566524073|FG002|Overall Study|Lost to Follow-up|0|||
156935208|NCT01203072|566524074|FG003|Overall Study|Lost to Follow-up|0|||
156935209|NCT01203072|566524075|FG004|Overall Study|Lost to Follow-up|0|||
156935210|NCT01203072|566524071|FG000|Overall Study|Protocol Violation|2|||
156935211|NCT01203072|566524072|FG001|Overall Study|Protocol Violation|0|||
157030381|NCT03625115|566866790|FG000|Overall Study|Withdrawal by Subject|4|||
157030382|NCT03625115|566866791|FG001|Overall Study|Withdrawal by Subject|7|||
157030383|NCT03625115|566866790|FG000|Overall Study|Lost to Follow-up|17|||
157030384|NCT03625115|566866791|FG001|Overall Study|Lost to Follow-up|24|||
157030385|NCT03672916|566866792|FG000|Overall Study|Death|6|||
157030386|NCT03672916|566866792|FG000|Overall Study|Lost to Follow-up|29|||
157030387|NCT03672916|566866792|FG000|Overall Study|Adverse Event|6|||
157030388|NCT03672916|566866792|FG000|Overall Study|Withdrawal by Subject|11|||
157030389|NCT04197336|566866793|FG000|Overall Study|Withdrawal by Subject|1|||
157030390|NCT01221948|566866803|FG000|Overall Study|Physician Decision|5|||
157030391|NCT01221948|566866803|FG000|Overall Study|Withdrawal by Subject|2|||
157030392|NCT01221948|566866803|FG000|Overall Study|not disclosed|2|||
157030393|NCT01221948|566866803|FG000|Overall Study|Death|1|||
157030394|NCT01221948|566866803|FG000|Overall Study|Protocol Violation|4|||
157030395|NCT03756662|566866804|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
157030396|NCT03626220|566866805|FG000|Overall Study|Withdrawal by Subject|2|||
157030397|NCT03626220|566866806|FG001|Overall Study|Withdrawal by Subject|0|||
157030398|NCT01828112|566866807|FG000|Treatment Phase|Adverse Event|7|||
157030399|NCT01828112|566866808|FG001|Treatment Phase|Adverse Event|8|||
157030400|NCT01828112|566866809|FG002|Treatment Phase|Adverse Event|0|||
157030401|NCT01828112|566866807|FG000|Treatment Phase|Death|9|||
157030402|NCT01828112|566866808|FG001|Treatment Phase|Death|5|||
157030403|NCT01828112|566866809|FG002|Treatment Phase|Death|0|||
157030404|NCT01828112|566866807|FG000|Treatment Phase|No longer required treatment|0|||
157030405|NCT01828112|566866808|FG001|Treatment Phase|No longer required treatment|1|||
157030406|NCT01828112|566866809|FG002|Treatment Phase|No longer required treatment|0|||
157030407|NCT01828112|566866807|FG000|Treatment Phase|Physician Decision|6|||
157030408|NCT01828112|566866808|FG001|Treatment Phase|Physician Decision|7|||
157030409|NCT01828112|566866809|FG002|Treatment Phase|Physician Decision|0|||
157030410|NCT01828112|566866807|FG000|Treatment Phase|Pregnancy|1|||
157030411|NCT01828112|566866808|FG001|Treatment Phase|Pregnancy|0|||
157030412|NCT01828112|566866809|FG002|Treatment Phase|Pregnancy|0|||
157030413|NCT01828112|566866807|FG000|Treatment Phase|Progressive disease|79|||
157030414|NCT01828112|566866808|FG001|Treatment Phase|Progressive disease|87|||
157030415|NCT01828112|566866809|FG002|Treatment Phase|Progressive disease|0|||
156935212|NCT01203072|566524073|FG002|Overall Study|Protocol Violation|0|||
156935213|NCT01203072|566524074|FG003|Overall Study|Protocol Violation|0|||
156935214|NCT01203072|566524075|FG004|Overall Study|Protocol Violation|1|||
156935215|NCT01203072|566524071|FG000|Overall Study|Withdrawal by Subject|2|||
156935216|NCT01203072|566524072|FG001|Overall Study|Withdrawal by Subject|2|||
156935217|NCT01203072|566524073|FG002|Overall Study|Withdrawal by Subject|1|||
156935218|NCT01203072|566524074|FG003|Overall Study|Withdrawal by Subject|2|||
156935219|NCT01203072|566524075|FG004|Overall Study|Withdrawal by Subject|3|||
156935220|NCT02272413|566524077|FG000|Randomized Through Treatment Start|Not treated|3|||
156935221|NCT02272413|566524078|FG001|Randomized Through Treatment Start|Not treated|5|||
156935222|NCT02272413|566524077|FG000|Pre-switch Period|Adverse Event|38|||
156935223|NCT02272413|566524078|FG001|Pre-switch Period|Adverse Event|37|||
156935224|NCT02272413|566524077|FG000|Pre-switch Period|Death|26|||
156935225|NCT02272413|566524078|FG001|Pre-switch Period|Death|26|||
156935226|NCT02272413|566524077|FG000|Pre-switch Period|Withdrawal by Subject|27|||
156935227|NCT02272413|566524078|FG001|Pre-switch Period|Withdrawal by Subject|15|||
156935228|NCT02272413|566524077|FG000|Pre-switch Period|Physician Decision|6|||
156935229|NCT02272413|566524078|FG001|Pre-switch Period|Physician Decision|18|||
157030416|NCT01828112|566866807|FG000|Treatment Phase|Study terminated by sponsor|1|||
157030417|NCT01828112|566866808|FG001|Treatment Phase|Study terminated by sponsor|0|||
157030418|NCT01828112|566866809|FG002|Treatment Phase|Study terminated by sponsor|0|||
157030419|NCT01828112|566866807|FG000|Treatment Phase|Subject/guardian decision|12|||
157030420|NCT01828112|566866808|FG001|Treatment Phase|Subject/guardian decision|8|||
156935230|NCT02272413|566524077|FG000|Pre-switch Period|Progressive disease|185|||
156935231|NCT02272413|566524078|FG001|Pre-switch Period|Progressive disease|173|||
157030421|NCT01828112|566866809|FG002|Treatment Phase|Subject/guardian decision|0|||
157030422|NCT01828112|566866807|FG000|Extension Treatment Phase|Adverse Event|0|||
157030423|NCT01828112|566866808|FG001|Extension Treatment Phase|Adverse Event|0|||
157030424|NCT01828112|566866809|FG002|Extension Treatment Phase|Adverse Event|6|||
157030425|NCT01828112|566866807|FG000|Extension Treatment Phase|Death|0|||
156935232|NCT02272413|566524077|FG000|Pre-switch Period|Lost to Follow-up|0|||
156935233|NCT02272413|566524078|FG001|Pre-switch Period|Lost to Follow-up|2|||
157030426|NCT01828112|566866808|FG001|Extension Treatment Phase|Death|0|||
157030427|NCT01828112|566866809|FG002|Extension Treatment Phase|Death|17|||
157030428|NCT01828112|566866807|FG000|Extension Treatment Phase|Physician Decision|0|||
157030429|NCT01828112|566866808|FG001|Extension Treatment Phase|Physician Decision|0|||
157030430|NCT01828112|566866809|FG002|Extension Treatment Phase|Physician Decision|5|||
157030431|NCT01828112|566866807|FG000|Extension Treatment Phase|Progressive disease|0|||
157227096|NCT03331042|567577729|FG002|Overall Study|Protocol Violation|0|||
156935234|NCT02272413|566524077|FG000|Pre-switch Period|Protocol Violation|1|||
156935235|NCT02272413|566524078|FG001|Pre-switch Period|Protocol Violation|0|||
156935236|NCT02272413|566524077|FG000|Pre-switch Period|Other than listed|10|||
156935237|NCT02272413|566524078|FG001|Pre-switch Period|Other than listed|11|||
156935238|NCT02272413|566524077|FG000|Post-switch Period|Adverse Event|4|||
156935239|NCT02272413|566524078|FG001|Post-switch Period|Adverse Event|4|||
156935240|NCT02272413|566524077|FG000|Post-switch Period|Death|3|||
156935241|NCT02272413|566524078|FG001|Post-switch Period|Death|2|||
156935242|NCT02272413|566524077|FG000|Post-switch Period|Withdrawal by Subject|1|||
156935243|NCT02272413|566524078|FG001|Post-switch Period|Withdrawal by Subject|2|||
156935244|NCT02272413|566524077|FG000|Post-switch Period|Physician Decision|1|||
156935245|NCT02272413|566524078|FG001|Post-switch Period|Physician Decision|1|||
156935246|NCT02272413|566524077|FG000|Post-switch Period|Progressive disease|21|||
156935247|NCT02272413|566524078|FG001|Post-switch Period|Progressive disease|21|||
156935248|NCT02272413|566524077|FG000|Post-switch Period|Study terminated by sponsor|8|||
156935249|NCT02272413|566524078|FG001|Post-switch Period|Study terminated by sponsor|11|||
156935250|NCT02272413|566524077|FG000|Post-switch Period|Other than listed|4|||
156935251|NCT02272413|566524078|FG001|Post-switch Period|Other than listed|5|||
156935252|NCT00423891|566524084|FG000|Enrolled|Withdrawal by Subject|0|||
156935253|NCT00423891|566524085|FG001|Enrolled|Withdrawal by Subject|0|||
156935254|NCT00423891|566524086|FG002|Enrolled|Withdrawal by Subject|1|||
156935255|NCT00423891|566524084|FG000|Enrolled|Lost to Follow-up|0|||
156935256|NCT00423891|566524085|FG001|Enrolled|Lost to Follow-up|0|||
156935257|NCT00423891|566524086|FG002|Enrolled|Lost to Follow-up|1|||
156935258|NCT00423891|566524084|FG000|Enrolled|No longer met criteria|11|||
156935259|NCT00423891|566524085|FG001|Enrolled|No longer met criteria|2|||
156935260|NCT00423891|566524086|FG002|Enrolled|No longer met criteria|1|||
156935261|NCT00423891|566524084|FG000|Treatment|Withdrawal by Subject|1|||
156935262|NCT00423891|566524085|FG001|Treatment|Withdrawal by Subject|0|||
156935263|NCT00423891|566524086|FG002|Treatment|Withdrawal by Subject|0|||
156935264|NCT00423891|566524084|FG000|Treatment|Lost to Follow-up|1|||
156935265|NCT00423891|566524085|FG001|Treatment|Lost to Follow-up|0|||
156935266|NCT00423891|566524086|FG002|Treatment|Lost to Follow-up|0|||
156935267|NCT00423891|566524084|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
156935268|NCT00423891|566524085|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
156935269|NCT00423891|566524086|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
156935270|NCT00423891|566524084|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
156935271|NCT00423891|566524085|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
156935272|NCT00423891|566524086|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
156935273|NCT02346136|566524094|FG000|Overall Study|Withdrawal by Subject|7|||
156935274|NCT02346136|566524095|FG001|Overall Study|Withdrawal by Subject|5|||
156935275|NCT02346136|566524094|FG000|Overall Study|Death|1|||
156935276|NCT02346136|566524095|FG001|Overall Study|Death|0|||
156935277|NCT02346136|566524094|FG000|Overall Study|Study termination|14|||
156935278|NCT02346136|566524095|FG001|Overall Study|Study termination|18|||
156935279|NCT03029624|566524100|FG000|Overall Study|Adverse Event|1|||
156935280|NCT03029624|566524100|FG000|Overall Study|Withdrawal by Subject|1|||
156935281|NCT03029624|566524100|FG000|Overall Study|Lack of Efficacy|1|||
156935282|NCT03029624|566524100|FG000|Overall Study|MRI need|2|||
156935283|NCT00582933|566524101|FG000|Overall Study|Physician Decision|3|||
156935284|NCT01371656|566524105|FG000|Overall Study|Death|7|||
156935285|NCT01371656|566524106|FG001|Overall Study|Death|4|||
156935286|NCT01371656|566524105|FG000|Overall Study|Physician Decision|46|||
156935287|NCT01371656|566524106|FG001|Overall Study|Physician Decision|7|||
156935288|NCT01371656|566524105|FG000|Overall Study|Withdrawal by Subject|7|||
156935289|NCT01371656|566524106|FG001|Overall Study|Withdrawal by Subject|0|||
156935290|NCT01371656|566524105|FG000|Overall Study|Ineligible|4|||
156935291|NCT01371656|566524106|FG001|Overall Study|Ineligible|3|||
156935292|NCT04334460|566524114|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
156935293|NCT04334460|566524115|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
156935294|NCT04334460|566524114|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
156935295|NCT04334460|566524115|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
156935296|NCT01465464|566524116|FG000|Overall Study|Adverse Event|96|||
156935297|NCT01465464|566524117|FG001|Overall Study|Adverse Event|49|||
156935298|NCT01465464|566524116|FG000|Overall Study|Lack of Efficacy|139|||
156935299|NCT01465464|566524117|FG001|Overall Study|Lack of Efficacy|190|||
156935300|NCT01465464|566524116|FG000|Overall Study|Physician Decision|13|||
156935301|NCT01465464|566524117|FG001|Overall Study|Physician Decision|5|||
156935302|NCT01465464|566524116|FG000|Overall Study|Protocol Violation|1|||
156935303|NCT01465464|566524117|FG001|Overall Study|Protocol Violation|1|||
156935304|NCT01465464|566524116|FG000|Overall Study|Withdrawal by Subject|46|||
156935305|NCT01465464|566524117|FG001|Overall Study|Withdrawal by Subject|30|||
156935306|NCT01465464|566524116|FG000|Overall Study|Other|9|||
156935307|NCT01465464|566524117|FG001|Overall Study|Other|3|||
156935308|NCT01465464|566524116|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
156935309|NCT01465464|566524117|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
156935310|NCT03316885|566524118|FG000|Overall Study|Adverse Event|1|||
156935311|NCT03316885|566524118|FG000|Overall Study|Death|10|||
156935312|NCT03316885|566524118|FG000|Overall Study|Lost to Follow-up|4|||
156935313|NCT03316885|566524118|FG000|Overall Study|Withdrawal by Subject|9|||
156935314|NCT03316885|566524118|FG000|Overall Study|COVID related|8|||
156935315|NCT02376166|566524121|FG000|Overall Study|Adverse Event|1|||
156935316|NCT02376166|566524121|FG000|Overall Study|Discontinued metformin early|2|||
156935317|NCT04180020|566524122|FG000|Overall Study|missed visit|18|||
156935318|NCT04180020|566524123|FG001|Overall Study|missed visit|16|||
156935319|NCT04180020|566524122|FG000|Overall Study|Death|2|||
156935320|NCT04180020|566524123|FG001|Overall Study|Death|3|||
156935321|NCT04180020|566524122|FG000|Overall Study|Withdrawal by Subject|1|||
156935322|NCT04180020|566524123|FG001|Overall Study|Withdrawal by Subject|5|||
156935323|NCT04180020|566524122|FG000|Overall Study|incarcerated|1|||
156935324|NCT04180020|566524123|FG001|Overall Study|incarcerated|1|||
156935325|NCT04180020|566524122|FG000|Overall Study|Physician Decision|0|||
156935326|NCT04180020|566524123|FG001|Overall Study|Physician Decision|2|||
156935327|NCT01640366|566524125|FG000|Overall Study|Withdrawal by Subject|1|||
156935328|NCT01640366|566524125|FG000|Overall Study|Protocol Violation|16|||
156935329|NCT01640366|566524125|FG000|Overall Study|Lost to Follow-up|5|||
156935330|NCT02739269|566524128|FG000|Overall Study|Protocol Violation|5|||
156935331|NCT02739269|566524129|FG001|Overall Study|Protocol Violation|0|||
156935332|NCT02739269|566524128|FG000|Overall Study|Cycle cancellation|2|||
156935333|NCT02739269|566524129|FG001|Overall Study|Cycle cancellation|2|||
156935334|NCT02739269|566524128|FG000|Overall Study|Withdrawal by Subject|0|||
156935335|NCT02739269|566524129|FG001|Overall Study|Withdrawal by Subject|2|||
156935336|NCT03554291|566524132|FG000|Overall Study|Death|2|||
156935337|NCT03554291|566524133|FG001|Overall Study|Death|1|||
156935338|NCT03554291|566524132|FG000|Overall Study|Lost to Follow-up|1|||
156935339|NCT03554291|566524133|FG001|Overall Study|Lost to Follow-up|0|||
156935340|NCT03554291|566524132|FG000|Overall Study|Withdrawal by Subject|1|||
156935341|NCT03554291|566524133|FG001|Overall Study|Withdrawal by Subject|0|||
156935342|NCT03554291|566524132|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
156935343|NCT03554291|566524133|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
156935344|NCT01228747|566524134|FG000|Overall Study|Adverse Event|8|||
156935345|NCT01228747|566524135|FG001|Overall Study|Adverse Event|4|||
156935346|NCT01228747|566524134|FG000|Overall Study|Lack of Efficacy|40|||
156935347|NCT01228747|566524135|FG001|Overall Study|Lack of Efficacy|27|||
156935348|NCT01228747|566524134|FG000|Overall Study|Protocol Violation|6|||
156935349|NCT01228747|566524135|FG001|Overall Study|Protocol Violation|5|||
156935350|NCT01228747|566524134|FG000|Overall Study|Lost to Follow-up|4|||
156935351|NCT01228747|566524135|FG001|Overall Study|Lost to Follow-up|3|||
156935352|NCT01228747|566524134|FG000|Overall Study|Withdrawal by Subject|5|||
156935353|NCT01228747|566524135|FG001|Overall Study|Withdrawal by Subject|1|||
156935354|NCT01228747|566524134|FG000|Overall Study|Other Reason|2|||
156935355|NCT01228747|566524135|FG001|Overall Study|Other Reason|5|||
156935356|NCT04251221|566524141|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
156935357|NCT04251221|566524142|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
156935358|NCT04258605|566524144|FG000|Overall Study|Death|1|||
156935359|NCT04258605|566524145|FG001|Overall Study|Death|0|||
156935360|NCT04258605|566524144|FG000|Overall Study|Early study termination|21|||
156935361|NCT04258605|566524145|FG001|Overall Study|Early study termination|2|||
156935362|NCT02910167|566524146|FG000|Overall Study|Adverse Event|1|||
156935363|NCT02910167|566524146|FG000|Overall Study|Lost to Follow-up|18|||
156935364|NCT01063595|566524159|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
156935365|NCT01063595|566524160|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
156935366|NCT01063595|566524159|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
156935367|NCT01063595|566524160|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
156935368|NCT01063595|566524159|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
156935369|NCT01063595|566524160|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
156935370|NCT01063595|566524159|FG000|First Intervention|Adverse Event|1|||
156935371|NCT01063595|566524160|FG001|First Intervention|Adverse Event|4|||
156935372|NCT01063595|566524159|FG000|First Intervention|Withdrawal by Subject|1|||
156935373|NCT01063595|566524160|FG001|First Intervention|Withdrawal by Subject|0|||
156935374|NCT01063595|566524159|FG000|First Intervention|Reason not Specified|0|||
156935375|NCT01063595|566524160|FG001|First Intervention|Reason not Specified|1|||
156935376|NCT00842348|566524166|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
156935377|NCT00842348|566524167|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
156935378|NCT00842348|566524166|FG000|Study 729|Disease progression/death|19|||
156935379|NCT00842348|566524167|FG001|Study 729|Disease progression/death|30|||
156935380|NCT00842348|566524166|FG000|Study 729|Adverse Event|1|||
156935381|NCT00842348|566524167|FG001|Study 729|Adverse Event|1|||
156935382|NCT00842348|566524166|FG000|Study 729|Protocol Violation|1|||
156935383|NCT00842348|566524167|FG001|Study 729|Protocol Violation|1|||
156935384|NCT00842348|566524166|FG000|Study 729|Withdrawal by Subject|2|||
156935385|NCT00842348|566524167|FG001|Study 729|Withdrawal by Subject|4|||
156935386|NCT00842348|566524166|FG000|Study 729|Due to Sponsor stopping the study|1|||
156935387|NCT00842348|566524167|FG001|Study 729|Due to Sponsor stopping the study|1|||
156935388|NCT00842348|566524166|FG000|Study 729|Due to non-availability of IP|0|||
156935389|NCT00842348|566524167|FG001|Study 729|Due to non-availability of IP|1|||
156935390|NCT00842348|566524166|FG000|Study 729|Sponsor's decision|1|||
156935391|NCT00842348|566524167|FG001|Study 729|Sponsor's decision|0|||
156935392|NCT00842348|566524166|FG000|Study 729|Surgical resection|1|||
156935393|NCT00842348|566524167|FG001|Study 729|Surgical resection|0|||
156935394|NCT01524627|566524176|FG000|Overall Study|Physician Decision|0|||
156935395|NCT01524627|566524177|FG001|Overall Study|Physician Decision|1|||
156935396|NCT01524627|566524176|FG000|Overall Study|Lost to Follow-up|1|||
156935397|NCT01524627|566524177|FG001|Overall Study|Lost to Follow-up|1|||
156935398|NCT00500370|566524181|FG000|Overall Study|Adverse Event|9|||
156935399|NCT00500370|566524182|FG001|Overall Study|Adverse Event|3|||
156935400|NCT00500370|566524181|FG000|Overall Study|Lost to Follow-up|10|||
156935401|NCT00500370|566524182|FG001|Overall Study|Lost to Follow-up|10|||
156935402|NCT00500370|566524181|FG000|Overall Study|Protocol Violation|2|||
156935403|NCT00500370|566524182|FG001|Overall Study|Protocol Violation|4|||
156935404|NCT00500370|566524181|FG000|Overall Study|Sponsor Decision|2|||
156935405|NCT00500370|566524182|FG001|Overall Study|Sponsor Decision|0|||
156935406|NCT00500370|566524181|FG000|Overall Study|Subject Decision|10|||
156935407|NCT00500370|566524182|FG001|Overall Study|Subject Decision|17|||
156935408|NCT02620046|566524184|FG000|Overall Study|Adverse Event|22|||
156935409|NCT02620046|566524185|FG001|Overall Study|Adverse Event|42|||
156935410|NCT02620046|566524184|FG000|Overall Study|Lost to Follow-up|4|||
156935411|NCT02620046|566524185|FG001|Overall Study|Lost to Follow-up|10|||
156935412|NCT02620046|566524184|FG000|Overall Study|Withdrawal by Subject|36|||
156935413|NCT02620046|566524185|FG001|Overall Study|Withdrawal by Subject|66|||
156935414|NCT02620046|566524184|FG000|Overall Study|Site Termination|3|||
156935415|NCT02620046|566524185|FG001|Overall Study|Site Termination|3|||
156935416|NCT02620046|566524184|FG000|Overall Study|Pregnancy|3|||
156935417|NCT02620046|566524185|FG001|Overall Study|Pregnancy|7|||
156935418|NCT02620046|566524184|FG000|Overall Study|Lack of Efficacy|81|||
156935419|NCT02620046|566524185|FG001|Overall Study|Lack of Efficacy|146|||
156935420|NCT02620046|566524184|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
156935421|NCT02620046|566524185|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
156935422|NCT02620046|566524184|FG000|Overall Study|Reason Not Specified|13|||
156935423|NCT02620046|566524185|FG001|Overall Study|Reason Not Specified|21|||
156935424|NCT02620046|566524184|FG000|Overall Study|Significant Protocol Deviation|0|||
156935425|NCT02620046|566524185|FG001|Overall Study|Significant Protocol Deviation|1|||
156935426|NCT00560950|566524188|FG000|Overall Study|Lost to Follow-up|1|||
156935427|NCT00560950|566524189|FG001|Overall Study|Lost to Follow-up|0|||
156935428|NCT02970968|566526313|FG000|Overall Study|Withdrawal by Subject|3|||
156935429|NCT02970968|566526314|FG001|Overall Study|Withdrawal by Subject|3|||
156935430|NCT02970968|566526313|FG000|Overall Study|Adverse Event|1|||
156935431|NCT02970968|566526314|FG001|Overall Study|Adverse Event|2|||
156935432|NCT02970968|566526313|FG000|Overall Study|Lost to Follow-up|1|||
156935433|NCT02970968|566526314|FG001|Overall Study|Lost to Follow-up|1|||
156935434|NCT02970968|566526313|FG000|Overall Study|Non-Compliance|0|||
156935435|NCT02970968|566526314|FG001|Overall Study|Non-Compliance|1|||
156935436|NCT02565381|566526315|FG000|Overall Study|Lost to Follow-up|1|||
156935437|NCT02565381|566526316|FG001|Overall Study|Lost to Follow-up|0|||
156935438|NCT02565381|566526317|FG002|Overall Study|Lost to Follow-up|1|||
156935439|NCT00071812|566526318|FG000|24-Week Double-Blind Period|Adverse Event|2|||
156935440|NCT00071812|566526319|FG001|24-Week Double-Blind Period|Adverse Event|3|||
156935441|NCT00071812|566526320|FG002|24-Week Double-Blind Period|Adverse Event|4|||
156935442|NCT00071812|566526321|FG003|24-Week Double-Blind Period|Adverse Event|4|||
156935443|NCT00071812|566526318|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
156935444|NCT00071812|566526319|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
156935445|NCT00071812|566526320|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
156935446|NCT00071812|566526321|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
156935447|NCT00071812|566526318|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
156935448|NCT00071812|566526319|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
156935449|NCT00071812|566526320|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
156935450|NCT00071812|566526321|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
156935451|NCT00071812|566526318|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
156935452|NCT00071812|566526319|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
156935453|NCT00071812|566526320|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
156935454|NCT00071812|566526321|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
156935455|NCT00071812|566526318|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
156935456|NCT00071812|566526319|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
156935457|NCT00071812|566526320|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
156935458|NCT00071812|566526321|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
156935459|NCT00071812|566526318|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
156935460|NCT00071812|566526319|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
156935461|NCT00071812|566526320|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
156935462|NCT00071812|566526321|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
156935463|NCT00071812|566526318|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156935464|NCT00071812|566526319|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
157227097|NCT03331042|567577730|FG003|Overall Study|Protocol Violation|0|||
157227098|NCT03331042|567577727|FG000|Overall Study|Physician Decision|0|||
157227099|NCT03331042|567577728|FG001|Overall Study|Physician Decision|0|||
157227100|NCT03331042|567577729|FG002|Overall Study|Physician Decision|1|||
157227101|NCT03331042|567577730|FG003|Overall Study|Physician Decision|0|||
157227102|NCT03331042|567577727|FG000|Overall Study|Lost to Follow-up|0|||
157227103|NCT03331042|567577728|FG001|Overall Study|Lost to Follow-up|0|||
157227104|NCT03331042|567577729|FG002|Overall Study|Lost to Follow-up|0|||
156935465|NCT00071812|566526320|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156935466|NCT00071812|566526321|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
156935467|NCT00071812|566526318|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156935468|NCT00071812|566526319|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156935469|NCT00071812|566526320|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156935470|NCT00071812|566526321|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
156935471|NCT00071812|566526318|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156935472|NCT00071812|566526319|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156935473|NCT00071812|566526320|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156935474|NCT00071812|566526321|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
156935475|NCT00071812|566526318|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156935476|NCT00071812|566526319|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156935477|NCT00071812|566526320|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
156935478|NCT00071812|566526321|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
156935479|NCT01816139|566526324|FG000|Overall Study|Adverse Event|6|||
156935480|NCT01816139|566526325|FG001|Overall Study|Adverse Event|8|||
156935481|NCT01816139|566526324|FG000|Overall Study|Lack of Efficacy|1|||
156935482|NCT01816139|566526325|FG001|Overall Study|Lack of Efficacy|2|||
156935483|NCT01816139|566526324|FG000|Overall Study|Lost to Follow-up|5|||
156935484|NCT01816139|566526325|FG001|Overall Study|Lost to Follow-up|3|||
156935485|NCT01816139|566526324|FG000|Overall Study|Withdrew Consent|6|||
156935486|NCT01816139|566526325|FG001|Overall Study|Withdrew Consent|4|||
156935487|NCT01816139|566526324|FG000|Overall Study|Protocol Violation|6|||
156935488|NCT01816139|566526325|FG001|Overall Study|Protocol Violation|3|||
156935489|NCT01816139|566526324|FG000|Overall Study|Reason not Specified|4|||
156935490|NCT01816139|566526325|FG001|Overall Study|Reason not Specified|2|||
156935491|NCT02554656|566526326|FG000|Overall Study|Protocol Violation|3|||
156935492|NCT04152447|566526327|FG000|Overall Study|Lost to Follow-up|1|||
156935493|NCT04152447|566526328|FG001|Overall Study|Lost to Follow-up|0|||
156935494|NCT04152447|566526327|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
156935495|NCT04152447|566526328|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
156935496|NCT04152447|566526327|FG000|Overall Study|Withdrawal by Subject|0|||
156935497|NCT04152447|566526328|FG001|Overall Study|Withdrawal by Subject|1|||
156935498|NCT04152447|566526327|FG000|Overall Study|Found ineligible after enrolling|1|||
156935499|NCT04152447|566526328|FG001|Overall Study|Found ineligible after enrolling|1|||
156935500|NCT04152447|566526327|FG000|Overall Study|Did not receive VR headset in time.|0|||
156935501|NCT04152447|566526328|FG001|Overall Study|Did not receive VR headset in time.|2|||
156935502|NCT03240575|566526329|FG000|Overall Study|Adverse Event|0|||
156935503|NCT03240575|566526330|FG001|Overall Study|Adverse Event|2|||
156935504|NCT03240575|566526331|FG002|Overall Study|Adverse Event|0|||
156935505|NCT03240575|566526332|FG003|Overall Study|Adverse Event|1|||
156935506|NCT03240575|566526329|FG000|Overall Study|Withdrawal by Subject|2|||
156935507|NCT03240575|566526330|FG001|Overall Study|Withdrawal by Subject|11|||
156935508|NCT03240575|566526331|FG002|Overall Study|Withdrawal by Subject|0|||
156935509|NCT03240575|566526332|FG003|Overall Study|Withdrawal by Subject|1|||
156935510|NCT03240575|566526329|FG000|Overall Study|Other|0|||
156935511|NCT03240575|566526330|FG001|Overall Study|Other|1|||
156935512|NCT03240575|566526331|FG002|Overall Study|Other|0|||
156935513|NCT03240575|566526332|FG003|Overall Study|Other|0|||
156935514|NCT01140477|566526333|FG000|Overall Study|Lost to Follow-up|4|||
156935515|NCT01140477|566526334|FG001|Overall Study|Lost to Follow-up|0|||
156935516|NCT01140477|566526333|FG000|Overall Study|Withdrawal by Subject|1|||
156935517|NCT01140477|566526334|FG001|Overall Study|Withdrawal by Subject|4|||
156935518|NCT01140477|566526333|FG000|Overall Study|Surgical complication preventing implant|2|||
156935519|NCT01140477|566526334|FG001|Overall Study|Surgical complication preventing implant|0|||
156935520|NCT01140477|566526333|FG000|Overall Study|Death|1|||
156935521|NCT01140477|566526334|FG001|Overall Study|Death|1|||
156935522|NCT01140477|566526333|FG000|Overall Study|Subject explanted|0|||
156935523|NCT01140477|566526334|FG001|Overall Study|Subject explanted|1|||
156935524|NCT04013191|566526335|FG000|Overall Study|Adverse Event|1|||
156935525|NCT04013191|566526336|FG001|Overall Study|Adverse Event|0|||
156935526|NCT04127786|566526349|FG000|Primary Series|Adverse Event|1|||
156935527|NCT04127786|566526350|FG001|Primary Series|Adverse Event|0|||
156935528|NCT04127786|566526351|FG002|Primary Series|Adverse Event|0|||
156935529|NCT04127786|566526352|FG003|Primary Series|Adverse Event|1|||
156935530|NCT04127786|566526353|FG004|Primary Series|Adverse Event|0|||
157227105|NCT03331042|567577730|FG003|Overall Study|Lost to Follow-up|1|||
157227106|NCT02433678|567577734|FG000|Overall Study|Lost to Follow-up|1|||
157030432|NCT01828112|566866808|FG001|Extension Treatment Phase|Progressive disease|0|||
157030433|NCT01828112|566866809|FG002|Extension Treatment Phase|Progressive disease|46|||
157030434|NCT01828112|566866807|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
157030435|NCT01828112|566866808|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
157030436|NCT01828112|566866809|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
157030437|NCT01828112|566866807|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
157030438|NCT01828112|566866808|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
157030439|NCT01828112|566866809|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
157030440|NCT04308681|566866814|FG000|Pre-Treatment|Not reported|1|||
157030441|NCT04308681|566866815|FG001|Pre-Treatment|Not reported|1|||
157030442|NCT04308681|566866816|FG002|Pre-Treatment|Not reported|0|||
157030443|NCT04308681|566866817|FG003|Pre-Treatment|Not reported|0|||
157030444|NCT04308681|566866818|FG004|Pre-Treatment|Not reported|0|||
157030445|NCT04308681|566866819|FG005|Pre-Treatment|Not reported|2|||
157030446|NCT04308681|566866820|FG006|Pre-Treatment|Not reported|0|||
157030447|NCT04308681|566866821|FG007|Pre-Treatment|Not reported|0|||
157030448|NCT04308681|566866814|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
157030449|NCT04308681|566866815|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
157030450|NCT04308681|566866816|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
157030451|NCT04308681|566866817|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
157030452|NCT04308681|566866818|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
157030453|NCT04308681|566866819|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
157030454|NCT04308681|566866820|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
157030455|NCT04308681|566866821|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
157030456|NCT04308681|566866814|FG000|Treatment up to Week 26|Other reasons|2|||
157030457|NCT04308681|566866815|FG001|Treatment up to Week 26|Other reasons|0|||
157030458|NCT04308681|566866816|FG002|Treatment up to Week 26|Other reasons|0|||
157030459|NCT04308681|566866817|FG003|Treatment up to Week 26|Other reasons|0|||
157030460|NCT04308681|566866818|FG004|Treatment up to Week 26|Other reasons|1|||
157030461|NCT04308681|566866819|FG005|Treatment up to Week 26|Other reasons|1|||
157030462|NCT04308681|566866820|FG006|Treatment up to Week 26|Other reasons|0|||
157030463|NCT04308681|566866821|FG007|Treatment up to Week 26|Other reasons|0|||
157030464|NCT04308681|566866814|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
157030465|NCT04308681|566866815|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
157030466|NCT04308681|566866816|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
157030467|NCT04308681|566866817|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
157030468|NCT04308681|566866818|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
157030469|NCT04308681|566866819|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
156935531|NCT04127786|566526354|FG005|Primary Series|Adverse Event|1|||
156935532|NCT04127786|566526349|FG000|Primary Series|Protocol Violation|5|||
156935533|NCT04127786|566526350|FG001|Primary Series|Protocol Violation|3|||
156935534|NCT04127786|566526351|FG002|Primary Series|Protocol Violation|4|||
156935535|NCT04127786|566526352|FG003|Primary Series|Protocol Violation|3|||
156935536|NCT04127786|566526353|FG004|Primary Series|Protocol Violation|2|||
156935537|NCT04127786|566526354|FG005|Primary Series|Protocol Violation|0|||
156935538|NCT04127786|566526349|FG000|Primary Series|Withdrawal by Subject|0|||
156935539|NCT04127786|566526350|FG001|Primary Series|Withdrawal by Subject|0|||
156935540|NCT04127786|566526351|FG002|Primary Series|Withdrawal by Subject|0|||
156935541|NCT04127786|566526352|FG003|Primary Series|Withdrawal by Subject|1|||
156935542|NCT04127786|566526353|FG004|Primary Series|Withdrawal by Subject|0|||
156935543|NCT04127786|566526354|FG005|Primary Series|Withdrawal by Subject|0|||
156935544|NCT04127786|566526349|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
156935545|NCT04127786|566526350|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
156935546|NCT04127786|566526351|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
156935547|NCT04127786|566526352|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
156935548|NCT04127786|566526353|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
156935549|NCT04127786|566526354|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
156935550|NCT04127786|566526349|FG000|Booster Phase|Withdrawal by Subject|2|||
156935551|NCT04127786|566526350|FG001|Booster Phase|Withdrawal by Subject|0|||
156935552|NCT04127786|566526351|FG002|Booster Phase|Withdrawal by Subject|0|||
157030470|NCT04308681|566866820|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
157030471|NCT04308681|566866821|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
157030472|NCT04308681|566866814|FG000|Treatment up to Week 26|Adverse Event|6|||
157030473|NCT04308681|566866815|FG001|Treatment up to Week 26|Adverse Event|5|||
157030474|NCT04308681|566866816|FG002|Treatment up to Week 26|Adverse Event|5|||
156935553|NCT04127786|566526352|FG003|Booster Phase|Withdrawal by Subject|0|||
156935554|NCT04127786|566526353|FG004|Booster Phase|Withdrawal by Subject|0|||
156935555|NCT04127786|566526354|FG005|Booster Phase|Withdrawal by Subject|0|||
156935556|NCT01904604|566526355|FG000|Overall Study|Withdrew before receiving dosing|0|||
156935557|NCT01904604|566526356|FG001|Overall Study|Withdrew before receiving dosing|1|||
157030475|NCT04308681|566866817|FG003|Treatment up to Week 26|Adverse Event|0|||
157030476|NCT04308681|566866818|FG004|Treatment up to Week 26|Adverse Event|6|||
157030477|NCT04308681|566866819|FG005|Treatment up to Week 26|Adverse Event|1|||
157030478|NCT04308681|566866820|FG006|Treatment up to Week 26|Adverse Event|0|||
157030479|NCT04308681|566866821|FG007|Treatment up to Week 26|Adverse Event|0|||
157030480|NCT04308681|566866814|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030481|NCT04308681|566866815|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
157030482|NCT04308681|566866816|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
157030483|NCT04308681|566866817|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030484|NCT04308681|566866818|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030485|NCT04308681|566866819|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030486|NCT04308681|566866820|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030487|NCT04308681|566866821|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
157030488|NCT04308681|566866814|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
157030489|NCT04308681|566866815|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
157030490|NCT04308681|566866816|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
157030491|NCT04308681|566866817|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
157030492|NCT04308681|566866818|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
157030493|NCT04308681|566866819|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
157030494|NCT04308681|566866820|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
157030495|NCT04308681|566866821|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
157030496|NCT04308681|566866814|FG000|OTE - 26 Weeks|Death|0|||
157030497|NCT04308681|566866815|FG001|OTE - 26 Weeks|Death|1|||
157030498|NCT04308681|566866816|FG002|OTE - 26 Weeks|Death|0|||
157030499|NCT04308681|566866817|FG003|OTE - 26 Weeks|Death|0|||
157030500|NCT04308681|566866818|FG004|OTE - 26 Weeks|Death|0|||
157030501|NCT04308681|566866819|FG005|OTE - 26 Weeks|Death|0|||
157030502|NCT04308681|566866820|FG006|OTE - 26 Weeks|Death|1|||
157030503|NCT04308681|566866821|FG007|OTE - 26 Weeks|Death|0|||
157030504|NCT04308681|566866814|FG000|OTE - 26 Weeks|Adverse Event|0|||
157030505|NCT04308681|566866815|FG001|OTE - 26 Weeks|Adverse Event|2|||
157030506|NCT04308681|566866816|FG002|OTE - 26 Weeks|Adverse Event|8|||
157030507|NCT04308681|566866817|FG003|OTE - 26 Weeks|Adverse Event|3|||
157030508|NCT04308681|566866818|FG004|OTE - 26 Weeks|Adverse Event|0|||
157030509|NCT04308681|566866819|FG005|OTE - 26 Weeks|Adverse Event|1|||
157030510|NCT04308681|566866820|FG006|OTE - 26 Weeks|Adverse Event|2|||
157030511|NCT04308681|566866821|FG007|OTE - 26 Weeks|Adverse Event|0|||
157030512|NCT04308681|566866814|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
157030513|NCT04308681|566866815|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
157030514|NCT04308681|566866816|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
157030515|NCT04308681|566866817|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
157030516|NCT04308681|566866818|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
157030517|NCT04308681|566866819|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
157030518|NCT04308681|566866820|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
157030519|NCT04308681|566866821|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
156935558|NCT01904604|566526357|FG002|Overall Study|Withdrew before receiving dosing|0|||
156935559|NCT01904604|566526355|FG000|Overall Study|Non-compliance|1|||
156935560|NCT01904604|566526356|FG001|Overall Study|Non-compliance|0|||
156935561|NCT01904604|566526357|FG002|Overall Study|Non-compliance|0|||
156935562|NCT01904604|566526355|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
156935563|NCT01904604|566526356|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
156935564|NCT01904604|566526357|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
156935565|NCT01904604|566526355|FG000|Overall Study|Patch site reactions|1|||
156935566|NCT01904604|566526356|FG001|Overall Study|Patch site reactions|1|||
156935567|NCT01904604|566526357|FG002|Overall Study|Patch site reactions|0|||
156935568|NCT01904604|566526355|FG000|Overall Study|Increased syncope|0|||
156935569|NCT01904604|566526356|FG001|Overall Study|Increased syncope|1|||
156935570|NCT01904604|566526357|FG002|Overall Study|Increased syncope|0|||
156935571|NCT01904604|566526355|FG000|Overall Study|Unrelated illness|0|||
156935572|NCT01904604|566526356|FG001|Overall Study|Unrelated illness|1|||
156935573|NCT01904604|566526357|FG002|Overall Study|Unrelated illness|0|||
156935574|NCT01904604|566526355|FG000|Overall Study|Passed Week 52 OFC|1|||
157030520|NCT04132518|566866822|FG000|Overall Study|Prematurely withdrawn from the study|0|||
157030521|NCT04132518|566866823|FG001|Overall Study|Prematurely withdrawn from the study|9|||
157030522|NCT04132518|566866824|FG002|Overall Study|Prematurely withdrawn from the study|1|||
157030523|NCT05425420|566866826|FG000|Overall Study|Physician Decision|1|||
157030524|NCT05425420|566866826|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
157030525|NCT03673501|566866827|FG000|Overall Study|Participants ongoing.|36|||
157030526|NCT03673501|566866828|FG001|Overall Study|Participants ongoing.|24|||
156935575|NCT01904604|566526356|FG001|Overall Study|Passed Week 52 OFC|0|||
157030527|NCT03714815|566866829|FG000|Overall Study|Physician Decision|2|||
156935576|NCT01904604|566526357|FG002|Overall Study|Passed Week 52 OFC|0|||
156935577|NCT01904604|566526355|FG000|Overall Study|Withdrawal by Subject|1|||
156935578|NCT01904604|566526356|FG001|Overall Study|Withdrawal by Subject|2|||
157030528|NCT03714815|566866829|FG000|Overall Study|Withdrawal by Subject|2|||
157030529|NCT03714815|566866829|FG000|Overall Study|Death|11|||
156935579|NCT01904604|566526357|FG002|Overall Study|Withdrawal by Subject|0|||
156935580|NCT01904604|566526355|FG000|Overall Study|Participant Relocated|1|||
156935581|NCT01904604|566526356|FG001|Overall Study|Participant Relocated|1|||
157030530|NCT02631746|566866835|FG000|Overall Study|Lack of Efficacy|3|||
157030531|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
157030532|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
157030533|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
157030534|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
157030535|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
157030536|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
157030537|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
157030538|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
157030539|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
157030540|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
157030541|NCT02361216|566866836|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
157030542|NCT02361216|566866837|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
157030543|NCT00323856|566866838|FG000|Overall Study|Withdrawal by Subject|1|||
157030544|NCT00323856|566866838|FG000|Overall Study|Was uncooperative and noncompliant|1|||
157030545|NCT00323856|566866838|FG000|Overall Study|Reason not specified|1|||
157030546|NCT00323856|566866838|FG000|Overall Study|Missing|2|||
157030547|NCT04086121|566866843|FG000|Overall Study|Other than listed|8|||
157030548|NCT04086121|566866843|FG000|Overall Study|Withdrawal by Subject|3|||
157030549|NCT04086121|566866843|FG000|Overall Study|Lost to Follow-up|2|||
157030550|NCT04086121|566866843|FG000|Overall Study|Adverse Event|1|||
157030551|NCT04167553|566866844|FG000|Overall Study|Withdrawal by Subject|1|||
157030552|NCT04167553|566866845|FG001|Overall Study|Withdrawal by Subject|0|||
157030553|NCT04167553|566866846|FG002|Overall Study|Withdrawal by Subject|1|||
157030554|NCT04167553|566866847|FG003|Overall Study|Withdrawal by Subject|2|||
157030555|NCT04167553|566866848|FG004|Overall Study|Withdrawal by Subject|1|||
157030556|NCT04167553|566866849|FG005|Overall Study|Withdrawal by Subject|0|||
157030557|NCT04167553|566866850|FG006|Overall Study|Withdrawal by Subject|0|||
157030558|NCT04167553|566866844|FG000|Overall Study|Physician Decision|0|||
157030559|NCT04167553|566866845|FG001|Overall Study|Physician Decision|0|||
157030560|NCT04167553|566866846|FG002|Overall Study|Physician Decision|0|||
157030561|NCT04167553|566866847|FG003|Overall Study|Physician Decision|0|||
157030562|NCT04167553|566866848|FG004|Overall Study|Physician Decision|2|||
157030563|NCT04167553|566866849|FG005|Overall Study|Physician Decision|2|||
157030564|NCT04167553|566866850|FG006|Overall Study|Physician Decision|0|||
157030565|NCT04167553|566866844|FG000|Overall Study|Lost to Follow-up|0|||
157030566|NCT04167553|566866845|FG001|Overall Study|Lost to Follow-up|0|||
157030567|NCT04167553|566866846|FG002|Overall Study|Lost to Follow-up|2|||
157030568|NCT04167553|566866847|FG003|Overall Study|Lost to Follow-up|0|||
157030569|NCT04167553|566866848|FG004|Overall Study|Lost to Follow-up|0|||
157030570|NCT04167553|566866849|FG005|Overall Study|Lost to Follow-up|0|||
157030571|NCT04167553|566866850|FG006|Overall Study|Lost to Follow-up|0|||
157030572|NCT05285137|566866853|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
157030573|NCT05285137|566866854|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
157030574|NCT05285137|566866855|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
157030575|NCT05285137|566866856|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
157030576|NCT05285137|566866857|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
157030577|NCT05285137|566866858|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
157030578|NCT05285137|566866859|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
157030579|NCT05285137|566866860|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
157030580|NCT05285137|566866861|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
157030581|NCT05285137|566866853|FG000|Overall Study|Lost to Follow-up|0|||
157030582|NCT05285137|566866854|FG001|Overall Study|Lost to Follow-up|0|||
157030583|NCT05285137|566866855|FG002|Overall Study|Lost to Follow-up|1|||
157030584|NCT05285137|566866856|FG003|Overall Study|Lost to Follow-up|3|||
157030585|NCT05285137|566866857|FG004|Overall Study|Lost to Follow-up|0|||
157030586|NCT05285137|566866858|FG005|Overall Study|Lost to Follow-up|0|||
157030587|NCT05285137|566866859|FG006|Overall Study|Lost to Follow-up|1|||
156935582|NCT01904604|566526357|FG002|Overall Study|Participant Relocated|1|||
156935583|NCT01904604|566526355|FG000|Overall Study|Lost to Follow-up|0|||
156935584|NCT01904604|566526356|FG001|Overall Study|Lost to Follow-up|0|||
156935585|NCT01904604|566526357|FG002|Overall Study|Lost to Follow-up|1|||
157030588|NCT05285137|566866860|FG007|Overall Study|Lost to Follow-up|0|||
157030589|NCT05285137|566866861|FG008|Overall Study|Lost to Follow-up|0|||
157030590|NCT05285137|566866853|FG000|Overall Study|Physician Decision|0|||
157030591|NCT05285137|566866854|FG001|Overall Study|Physician Decision|1|||
157030592|NCT05285137|566866855|FG002|Overall Study|Physician Decision|0|||
157030593|NCT05285137|566866856|FG003|Overall Study|Physician Decision|0|||
156935586|NCT01481116|566526360|FG000|Overall Study|Adverse Event|26|||
157030594|NCT05285137|566866857|FG004|Overall Study|Physician Decision|0|||
157030595|NCT05285137|566866858|FG005|Overall Study|Physician Decision|0|||
156935587|NCT01481116|566526361|FG001|Overall Study|Adverse Event|26|||
156935588|NCT01481116|566526362|FG002|Overall Study|Adverse Event|42|||
156935589|NCT01481116|566526360|FG000|Overall Study|Major Protocol Deviation|3|||
156935590|NCT01481116|566526361|FG001|Overall Study|Major Protocol Deviation|7|||
156935591|NCT01481116|566526362|FG002|Overall Study|Major Protocol Deviation|1|||
156935592|NCT01481116|566526360|FG000|Overall Study|Lost to Follow-up|8|||
156935593|NCT01481116|566526361|FG001|Overall Study|Lost to Follow-up|12|||
156935594|NCT01481116|566526362|FG002|Overall Study|Lost to Follow-up|11|||
156935595|NCT01481116|566526360|FG000|Overall Study|Withdrawal by Subject|37|||
156935596|NCT01481116|566526361|FG001|Overall Study|Withdrawal by Subject|33|||
156935597|NCT01481116|566526362|FG002|Overall Study|Withdrawal by Subject|37|||
156935598|NCT01481116|566526360|FG000|Overall Study|Study Termination|730|||
156935599|NCT01481116|566526361|FG001|Overall Study|Study Termination|729|||
156935600|NCT01481116|566526362|FG002|Overall Study|Study Termination|713|||
156935601|NCT01481116|566526360|FG000|Overall Study|Pregnancy|0|||
156935602|NCT01481116|566526361|FG001|Overall Study|Pregnancy|0|||
156935603|NCT01481116|566526362|FG002|Overall Study|Pregnancy|1|||
156935604|NCT01481116|566526360|FG000|Overall Study|Lack of Efficacy|3|||
156935605|NCT01481116|566526361|FG001|Overall Study|Lack of Efficacy|3|||
156935606|NCT01481116|566526362|FG002|Overall Study|Lack of Efficacy|1|||
156935607|NCT01481116|566526360|FG000|Overall Study|Contraindications|1|||
156935608|NCT01481116|566526361|FG001|Overall Study|Contraindications|1|||
156935609|NCT01481116|566526362|FG002|Overall Study|Contraindications|0|||
156935610|NCT01481116|566526360|FG000|Overall Study|Other|1|||
156935611|NCT01481116|566526361|FG001|Overall Study|Other|1|||
156935612|NCT01481116|566526362|FG002|Overall Study|Other|0|||
156935613|NCT01481116|566526360|FG000|Overall Study|Participant Started Taking Glipizide|1|||
156935614|NCT01481116|566526361|FG001|Overall Study|Participant Started Taking Glipizide|0|||
156935615|NCT01481116|566526362|FG002|Overall Study|Participant Started Taking Glipizide|0|||
156935616|NCT01481116|566526360|FG000|Overall Study|Participant Moved Out of Area|2|||
156935617|NCT01481116|566526361|FG001|Overall Study|Participant Moved Out of Area|0|||
156935618|NCT01481116|566526362|FG002|Overall Study|Participant Moved Out of Area|1|||
156935619|NCT01481116|566526360|FG000|Overall Study|Participant Moved Out of Country|1|||
156935620|NCT01481116|566526361|FG001|Overall Study|Participant Moved Out of Country|0|||
156935621|NCT01481116|566526362|FG002|Overall Study|Participant Moved Out of Country|1|||
156935622|NCT01481116|566526360|FG000|Overall Study|Investigator Decision|3|||
156935623|NCT01481116|566526361|FG001|Overall Study|Investigator Decision|2|||
156935624|NCT01481116|566526362|FG002|Overall Study|Investigator Decision|1|||
156935625|NCT01481116|566526360|FG000|Overall Study|Sponsor Decision|0|||
156935626|NCT01481116|566526361|FG001|Overall Study|Sponsor Decision|1|||
156935627|NCT01481116|566526362|FG002|Overall Study|Sponsor Decision|3|||
156935628|NCT01481116|566526360|FG000|Overall Study|Non-Compliant With Study Drug|0|||
156935629|NCT01481116|566526361|FG001|Overall Study|Non-Compliant With Study Drug|1|||
156935630|NCT01481116|566526362|FG002|Overall Study|Non-Compliant With Study Drug|1|||
156935631|NCT01481116|566526360|FG000|Overall Study|Investigator's Discretion|2|||
156935632|NCT01481116|566526361|FG001|Overall Study|Investigator's Discretion|0|||
156935633|NCT01481116|566526362|FG002|Overall Study|Investigator's Discretion|0|||
156935634|NCT01481116|566526360|FG000|Overall Study|Death|2|||
156935635|NCT01481116|566526361|FG001|Overall Study|Death|1|||
156935636|NCT01481116|566526362|FG002|Overall Study|Death|0|||
156935637|NCT01481116|566526360|FG000|Overall Study|Hypoglycemic Event|4|||
156935638|NCT01481116|566526361|FG001|Overall Study|Hypoglycemic Event|0|||
156935639|NCT01481116|566526362|FG002|Overall Study|Hypoglycemic Event|0|||
156935640|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
156935641|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
156935642|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
156935643|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
156935644|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
156935645|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
156935646|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
156935647|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
156935648|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
156935649|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
156935650|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
156935651|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
156935652|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
156935653|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
156935654|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
156935655|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
156935656|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
156935657|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
156935658|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
157030596|NCT05285137|566866859|FG006|Overall Study|Physician Decision|0|||
157030597|NCT05285137|566866860|FG007|Overall Study|Physician Decision|0|||
156935659|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
156935660|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
156935661|NCT00934544|566526363|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
156935662|NCT00934544|566526364|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
156935663|NCT00934544|566526365|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
156935664|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
156935665|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
156935666|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
156935667|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
156935668|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
156935669|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
156935670|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
156935671|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
156935672|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
156935673|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
156935674|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
156935675|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
156935676|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
156935677|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
156935678|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
156935679|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
156935680|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
156935681|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
156935682|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
156935683|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
156935684|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
156935685|NCT00934544|566526363|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
156935686|NCT00934544|566526364|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
156935687|NCT00934544|566526365|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
156935688|NCT02643251|566526366|FG000|Overall Study|Adverse Event|3|||
156935689|NCT02643251|566526367|FG001|Overall Study|Adverse Event|1|||
156935690|NCT02643251|566526366|FG000|Overall Study|Withdrawal by Subject|2|||
156935691|NCT02643251|566526367|FG001|Overall Study|Withdrawal by Subject|0|||
156935692|NCT02643251|566526366|FG000|Overall Study|Lost to Follow-up|4|||
156935693|NCT02643251|566526367|FG001|Overall Study|Lost to Follow-up|1|||
156935694|NCT02643251|566526366|FG000|Overall Study|Protocol Violation|1|||
156935695|NCT02643251|566526367|FG001|Overall Study|Protocol Violation|0|||
156935696|NCT02643251|566526366|FG000|Overall Study|PI Decision to terminate patient|1|||
156935697|NCT02643251|566526367|FG001|Overall Study|PI Decision to terminate patient|0|||
156935698|NCT00348556|566526368|FG000|Overall Study|Adverse Event|1|||
156935699|NCT00240071|566526369|FG000|Overall Study|Withdrawal by Subject|3|||
156935700|NCT01466270|566526370|FG000|Overall Study|Withdrawal by Subject|4|||
156935701|NCT01466270|566526371|FG001|Overall Study|Withdrawal by Subject|1|||
156935702|NCT01466270|566526370|FG000|Overall Study|Physician Decision|1|||
156935703|NCT01466270|566526371|FG001|Overall Study|Physician Decision|0|||
156935704|NCT01466270|566526370|FG000|Overall Study|Lost to Follow-up|1|||
156935705|NCT01466270|566526371|FG001|Overall Study|Lost to Follow-up|3|||
156935706|NCT01466270|566526370|FG000|Overall Study|Progression|1|||
156935707|NCT01466270|566526371|FG001|Overall Study|Progression|0|||
156935708|NCT01466270|566526370|FG000|Overall Study|Toxicity|4|||
156935709|NCT01466270|566526371|FG001|Overall Study|Toxicity|1|||
156935710|NCT01466270|566526370|FG000|Overall Study|Multiple|1|||
156935711|NCT01466270|566526371|FG001|Overall Study|Multiple|1|||
156935712|NCT01944059|566526372|FG000|Overall Study|Lost to Follow-up|1|||
156935713|NCT01944059|566526372|FG000|Overall Study|Physician Decision|3|||
156935714|NCT01944059|566526372|FG000|Overall Study|Withdrawal by Subject|1|||
156935715|NCT01944059|566526372|FG000|Overall Study|Adverse Event|2|||
156935716|NCT02821962|566526373|FG000|Overall Study|Lost to Follow-up|2|||
156935717|NCT02821962|566526374|FG001|Overall Study|Lost to Follow-up|0|||
156935718|NCT04206293|566526386|FG000|Overall Study|Consent withdrawal|1|||
156935719|NCT01956110|566526392|FG000|Overall Study|Protocol Violation|25|||
156935720|NCT01956110|566526393|FG001|Overall Study|Protocol Violation|11|||
156935721|NCT01956110|566526392|FG000|Overall Study|Adverse Event|9|||
156935722|NCT01956110|566526393|FG001|Overall Study|Adverse Event|10|||
156935723|NCT01956110|566526392|FG000|Overall Study|Personal reasons|1|||
156935724|NCT01956110|566526393|FG001|Overall Study|Personal reasons|1|||
156935725|NCT00430092|566526394|FG000|Overall Study|Adverse Event|0|||
156935726|NCT00430092|566526395|FG001|Overall Study|Adverse Event|0|||
156935727|NCT00430092|566526396|FG002|Overall Study|Adverse Event|1|||
156935728|NCT00430092|566526394|FG000|Overall Study|Lack of Efficacy|5|||
156935729|NCT00430092|566526395|FG001|Overall Study|Lack of Efficacy|2|||
157167064|NCT00696436|567352651|FG002|Overall Study|Withdrawal by Subject|5|||
156935730|NCT00430092|566526396|FG002|Overall Study|Lack of Efficacy|54|||
156935731|NCT00430092|566526394|FG000|Overall Study|Lost to Follow-up|1|||
156935732|NCT00430092|566526395|FG001|Overall Study|Lost to Follow-up|0|||
156935733|NCT00430092|566526396|FG002|Overall Study|Lost to Follow-up|0|||
156935734|NCT00430092|566526394|FG000|Overall Study|Protocol Violation|0|||
156935735|NCT00430092|566526395|FG001|Overall Study|Protocol Violation|1|||
156935736|NCT00430092|566526396|FG002|Overall Study|Protocol Violation|1|||
156935737|NCT00430092|566526394|FG000|Overall Study|Withdrawal by Subject|0|||
156935738|NCT00430092|566526395|FG001|Overall Study|Withdrawal by Subject|1|||
156935739|NCT00430092|566526396|FG002|Overall Study|Withdrawal by Subject|1|||
156935740|NCT00006489|566526406|FG000|Overall Study|Adverse Event|3|||
156935741|NCT00006489|566526407|FG001|Overall Study|Adverse Event|2|||
156935742|NCT00006489|566526408|FG002|Overall Study|Adverse Event|4|||
156935743|NCT00006489|566526409|FG003|Overall Study|Adverse Event|3|||
156935744|NCT00006489|566526406|FG000|Overall Study|Withdrawal by Subject|10|||
156935745|NCT00006489|566526407|FG001|Overall Study|Withdrawal by Subject|9|||
156935746|NCT00006489|566526408|FG002|Overall Study|Withdrawal by Subject|9|||
156935747|NCT00006489|566526409|FG003|Overall Study|Withdrawal by Subject|6|||
156935748|NCT00006489|566526406|FG000|Overall Study|Scheduling Conflict|0|||
156935749|NCT00006489|566526407|FG001|Overall Study|Scheduling Conflict|3|||
156935750|NCT00006489|566526408|FG002|Overall Study|Scheduling Conflict|2|||
156935751|NCT00006489|566526409|FG003|Overall Study|Scheduling Conflict|1|||
156935752|NCT00006489|566526406|FG000|Overall Study|Death|0|||
156935753|NCT00006489|566526407|FG001|Overall Study|Death|0|||
156935754|NCT00006489|566526408|FG002|Overall Study|Death|0|||
156935755|NCT00006489|566526409|FG003|Overall Study|Death|1|||
156935756|NCT04889625|566526411|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
156935757|NCT04889625|566526412|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
156935758|NCT04889625|566526411|FG000|Period 1|Subject out of window|0|||
156935759|NCT04889625|566526412|FG001|Period 1|Subject out of window|1|||
156935760|NCT04889625|566526411|FG000|Period 1|Wrong add power dispensed|0|||
156935761|NCT04889625|566526412|FG001|Period 1|Wrong add power dispensed|1|||
156935762|NCT04889625|566526411|FG000|Period 1|Discontinued due to fitting guide error|1|||
156935763|NCT04889625|566526412|FG001|Period 1|Discontinued due to fitting guide error|1|||
156935764|NCT04889625|566526411|FG000|Period 2|Test article no longer available|1|||
156935765|NCT04889625|566526412|FG001|Period 2|Test article no longer available|0|||
156935766|NCT04889625|566526411|FG000|Period 2|Incorrect lens dispensed|1|||
156935767|NCT04889625|566526412|FG001|Period 2|Incorrect lens dispensed|0|||
156935768|NCT04889625|566526411|FG000|Period 2|Wrong add power dispensed|0|||
156935769|NCT04889625|566526412|FG001|Period 2|Wrong add power dispensed|1|||
156935770|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
156935771|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
156935772|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
156935773|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
156935774|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
156935775|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
156935776|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
156935777|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
156935778|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
156935779|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
156935780|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
156935781|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
156935782|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
156935783|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
156935784|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
156935785|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
156935786|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
156935787|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
156935788|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Death|0|||
156935789|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Death|0|||
156935790|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Death|1|||
156935791|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Death|0|||
156935792|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Death|0|||
157167065|NCT00696436|567352652|FG003|Overall Study|Withdrawal by Subject|7|||
157167066|NCT00696436|567352653|FG004|Overall Study|Withdrawal by Subject|1|||
156935793|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Death|0|||
156935794|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Death|0|||
156935795|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Death|0|||
156935796|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Death|0|||
156935797|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
156935798|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
156935799|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
157030598|NCT05285137|566866861|FG008|Overall Study|Physician Decision|0|||
156935800|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935801|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935802|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935803|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935804|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935805|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
156935806|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
156935807|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
156935808|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
156935809|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935810|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935811|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935812|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935813|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935814|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
156935815|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
156935816|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
156935817|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
156935818|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
156935819|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
156935820|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
156935821|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
156935822|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
156935823|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
156935824|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
156935825|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
156935826|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
156935827|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
156935828|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
156935829|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
156935830|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
156935831|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
156935832|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
156935833|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
156935834|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
156935835|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
156935836|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935837|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935838|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935839|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935840|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935841|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
156935842|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935843|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
156935844|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935845|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935846|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935847|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935848|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935849|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935850|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
156935851|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
156935852|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
156935853|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
156935854|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
156935855|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
156935856|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
156935857|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
156935858|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
156935859|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
156935860|NCT00404352|566526413|FG000|Double Blind (up to 24 Month)|Other|0|||
156935861|NCT00404352|566526414|FG001|Double Blind (up to 24 Month)|Other|1|||
156935862|NCT00404352|566526415|FG002|Double Blind (up to 24 Month)|Other|0|||
156935863|NCT00404352|566526416|FG003|Double Blind (up to 24 Month)|Other|0|||
156935864|NCT00404352|566526417|FG004|Double Blind (up to 24 Month)|Other|0|||
156935865|NCT00404352|566526418|FG005|Double Blind (up to 24 Month)|Other|0|||
157167067|NCT00696436|567352649|FG000|Overall Study|Lack of Efficacy|3|||
157167068|NCT00696436|567352650|FG001|Overall Study|Lack of Efficacy|1|||
157167069|NCT00696436|567352651|FG002|Overall Study|Lack of Efficacy|5|||
157030599|NCT05285137|566866853|FG000|Overall Study|Pregnancy|0|||
157030600|NCT05285137|566866854|FG001|Overall Study|Pregnancy|0|||
157030601|NCT05285137|566866855|FG002|Overall Study|Pregnancy|0|||
157030602|NCT05285137|566866856|FG003|Overall Study|Pregnancy|0|||
157030603|NCT05285137|566866857|FG004|Overall Study|Pregnancy|0|||
157030604|NCT05285137|566866858|FG005|Overall Study|Pregnancy|0|||
157030605|NCT05285137|566866859|FG006|Overall Study|Pregnancy|1|||
157030606|NCT05285137|566866860|FG007|Overall Study|Pregnancy|0|||
157030607|NCT05285137|566866861|FG008|Overall Study|Pregnancy|0|||
157030608|NCT05285137|566866853|FG000|Overall Study|Withdrawal by Subject|0|||
157030609|NCT05285137|566866854|FG001|Overall Study|Withdrawal by Subject|1|||
157030610|NCT05285137|566866855|FG002|Overall Study|Withdrawal by Subject|2|||
157030611|NCT05285137|566866856|FG003|Overall Study|Withdrawal by Subject|1|||
157030612|NCT05285137|566866857|FG004|Overall Study|Withdrawal by Subject|0|||
157030613|NCT05285137|566866858|FG005|Overall Study|Withdrawal by Subject|0|||
157030614|NCT05285137|566866859|FG006|Overall Study|Withdrawal by Subject|0|||
157030615|NCT05285137|566866860|FG007|Overall Study|Withdrawal by Subject|0|||
157030616|NCT05285137|566866861|FG008|Overall Study|Withdrawal by Subject|1|||
157030617|NCT04479761|566866862|FG000|Overall Study|could not perform the balance tasks|1|||
157030618|NCT04479761|566866863|FG001|Overall Study|could not perform the balance tasks|0|||
157030619|NCT04479761|566866864|FG002|Overall Study|could not perform the balance tasks|0|||
157030620|NCT04479761|566866862|FG000|Overall Study|Adverse Event|1|||
157030621|NCT04479761|566866863|FG001|Overall Study|Adverse Event|0|||
157030622|NCT04479761|566866864|FG002|Overall Study|Adverse Event|0|||
157030623|NCT04479761|566866862|FG000|Overall Study|one control did not meet screening criteria|0|||
157030624|NCT04479761|566866863|FG001|Overall Study|one control did not meet screening criteria|0|||
157030625|NCT04479761|566866864|FG002|Overall Study|one control did not meet screening criteria|1|||
157030626|NCT04479761|566866862|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
157030627|NCT04479761|566866863|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
157030628|NCT04479761|566866864|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
157030629|NCT05309291|566866865|FG000|Overall Study|Adverse Event|0|||
157030630|NCT05309291|566866866|FG001|Overall Study|Adverse Event|1|||
157030631|NCT05209152|566866867|FG000|Overall Study|Sponsor decision|1|||
157030632|NCT05209152|566866868|FG001|Overall Study|Sponsor decision|2|||
157030633|NCT05209152|566866867|FG000|Overall Study|Death|3|||
157030634|NCT05209152|566866868|FG001|Overall Study|Death|1|||
157030635|NCT05292391|566866871|FG000|Overall Study|Lost to Follow-up|0|||
157030636|NCT05292391|566866872|FG001|Overall Study|Lost to Follow-up|0|||
157030637|NCT05292391|566866873|FG002|Overall Study|Lost to Follow-up|0|||
157030638|NCT05292391|566866874|FG003|Overall Study|Lost to Follow-up|1|||
157030639|NCT05292391|566866875|FG004|Overall Study|Lost to Follow-up|0|||
157030640|NCT04857723|566866878|FG000|Overall Study|Withdrawal by Subject|2|||
157030641|NCT04909801|566868269|FG000|Overall Study|Lack of Efficacy|2|||
157030642|NCT04909801|566868270|FG001|Overall Study|Lack of Efficacy|1|||
157030643|NCT04909801|566868269|FG000|Overall Study|Adverse Event|1|||
157030644|NCT04909801|566868270|FG001|Overall Study|Adverse Event|2|||
157030645|NCT04909801|566868269|FG000|Overall Study|Participant request to discontinue study treatment|1|||
157030646|NCT04909801|566868270|FG001|Overall Study|Participant request to discontinue study treatment|2|||
157030647|NCT04909801|566868269|FG000|Overall Study|Withdrawal by Subject|2|||
157030648|NCT04909801|566868270|FG001|Overall Study|Withdrawal by Subject|1|||
157030649|NCT04909801|566868269|FG000|Overall Study|other reasons|1|||
157030650|NCT04909801|566868270|FG001|Overall Study|other reasons|1|||
157030651|NCT04447040|566868271|FG000|Overall Study|Lost to Follow-up|2|||
157030652|NCT04447040|566868272|FG001|Overall Study|Lost to Follow-up|1|||
157030653|NCT04447040|566868273|FG002|Overall Study|Lost to Follow-up|3|||
157030654|NCT04447040|566868274|FG003|Overall Study|Lost to Follow-up|3|||
157030655|NCT04447040|566868275|FG004|Overall Study|Lost to Follow-up|1|||
157030656|NCT04447040|566868276|FG005|Overall Study|Lost to Follow-up|3|||
157030657|NCT04447040|566868271|FG000|Overall Study|Withdrawal by Subject|0|||
157030658|NCT04447040|566868272|FG001|Overall Study|Withdrawal by Subject|1|||
157030659|NCT04447040|566868273|FG002|Overall Study|Withdrawal by Subject|1|||
157030660|NCT04447040|566868274|FG003|Overall Study|Withdrawal by Subject|1|||
157030661|NCT04447040|566868275|FG004|Overall Study|Withdrawal by Subject|0|||
157030662|NCT04447040|566868276|FG005|Overall Study|Withdrawal by Subject|0|||
157030663|NCT01208662|566868277|FG000|Induction and Consolidation|Disease Progression|23|||
157030664|NCT01208662|566868278|FG001|Induction and Consolidation|Disease Progression|13|||
157030665|NCT01208662|566868279|FG002|Induction and Consolidation|Disease Progression|0|||
157030666|NCT01208662|566868277|FG000|Induction and Consolidation|Adverse Event|16|||
157030667|NCT01208662|566868278|FG001|Induction and Consolidation|Adverse Event|18|||
157030668|NCT01208662|566868279|FG002|Induction and Consolidation|Adverse Event|2|||
157030669|NCT01208662|566868277|FG000|Induction and Consolidation|MD or Participant Decision|16|||
157030670|NCT01208662|566868278|FG001|Induction and Consolidation|MD or Participant Decision|34|||
157030671|NCT01208662|566868279|FG002|Induction and Consolidation|MD or Participant Decision|4|||
157030672|NCT01208662|566868277|FG000|Induction and Consolidation|Death|1|||
157030673|NCT01208662|566868278|FG001|Induction and Consolidation|Death|3|||
156935866|NCT00404352|566526419|FG006|Double Blind (up to 24 Month)|Other|0|||
156935867|NCT00404352|566526420|FG007|Double Blind (up to 24 Month)|Other|0|||
156935868|NCT00404352|566526421|FG008|Double Blind (up to 24 Month)|Other|0|||
156935869|NCT00404352|566526413|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
156935870|NCT00404352|566526414|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
156935871|NCT00404352|566526415|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
156935872|NCT00404352|566526416|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
156935873|NCT00404352|566526417|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
156935874|NCT00404352|566526418|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
156935875|NCT00404352|566526419|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
156935876|NCT00404352|566526420|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
156935877|NCT00404352|566526421|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
156935878|NCT00404352|566526413|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
156935879|NCT00404352|566526414|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
156935880|NCT00404352|566526415|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
156935881|NCT00404352|566526416|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
156935882|NCT00404352|566526417|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
156935883|NCT00404352|566526418|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
156935884|NCT00404352|566526419|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
156935885|NCT00404352|566526420|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
156935886|NCT00404352|566526421|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
156935887|NCT00404352|566526413|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935888|NCT00404352|566526414|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935889|NCT00404352|566526415|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935890|NCT00404352|566526416|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935891|NCT00404352|566526417|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
156935892|NCT00404352|566526418|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935893|NCT00404352|566526419|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935894|NCT00404352|566526420|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935895|NCT00404352|566526421|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
156935896|NCT00404352|566526413|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935897|NCT00404352|566526414|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935898|NCT00404352|566526415|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935899|NCT00404352|566526416|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935900|NCT00404352|566526417|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935901|NCT00404352|566526418|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
156935902|NCT00404352|566526419|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935903|NCT00404352|566526420|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935904|NCT00404352|566526421|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
156935905|NCT00404352|566526413|FG000|Open Label (up to 24 Month)|Disease progression|0|||
156935906|NCT00404352|566526414|FG001|Open Label (up to 24 Month)|Disease progression|0|||
156935907|NCT00404352|566526415|FG002|Open Label (up to 24 Month)|Disease progression|0|||
156935908|NCT00404352|566526416|FG003|Open Label (up to 24 Month)|Disease progression|1|||
156935909|NCT00404352|566526417|FG004|Open Label (up to 24 Month)|Disease progression|0|||
156935910|NCT00404352|566526418|FG005|Open Label (up to 24 Month)|Disease progression|0|||
156935911|NCT00404352|566526419|FG006|Open Label (up to 24 Month)|Disease progression|0|||
156935912|NCT00404352|566526420|FG007|Open Label (up to 24 Month)|Disease progression|0|||
156935913|NCT00404352|566526421|FG008|Open Label (up to 24 Month)|Disease progression|0|||
156935914|NCT00404352|566526413|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935915|NCT00404352|566526414|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935916|NCT00404352|566526415|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935917|NCT00404352|566526416|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935918|NCT00404352|566526417|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935919|NCT00404352|566526418|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935920|NCT00404352|566526419|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
156935921|NCT00404352|566526420|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
156935922|NCT00404352|566526421|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
156935923|NCT00404352|566526413|FG000|Open Label Extension (up to 36 Months)|Other|0|||
156935924|NCT00404352|566526414|FG001|Open Label Extension (up to 36 Months)|Other|0|||
156935925|NCT00404352|566526415|FG002|Open Label Extension (up to 36 Months)|Other|0|||
156935926|NCT00404352|566526416|FG003|Open Label Extension (up to 36 Months)|Other|0|||
156935927|NCT00404352|566526417|FG004|Open Label Extension (up to 36 Months)|Other|0|||
157030674|NCT01208662|566868279|FG002|Induction and Consolidation|Death|1|||
156935928|NCT00404352|566526418|FG005|Open Label Extension (up to 36 Months)|Other|0|||
156935929|NCT00404352|566526419|FG006|Open Label Extension (up to 36 Months)|Other|0|||
156935930|NCT00404352|566526420|FG007|Open Label Extension (up to 36 Months)|Other|0|||
156935931|NCT00404352|566526421|FG008|Open Label Extension (up to 36 Months)|Other|2|||
156935932|NCT01479621|566526424|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
156935933|NCT01479621|566526425|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
157030675|NCT01208662|566868277|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
156935934|NCT01479621|566526426|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156935935|NCT01479621|566526427|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156935936|NCT01479621|566526428|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156935937|NCT01479621|566526429|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156935938|NCT01479621|566526430|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156935939|NCT01479621|566526424|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
156935940|NCT01479621|566526425|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935941|NCT01479621|566526426|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935942|NCT01479621|566526427|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935943|NCT01479621|566526428|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935944|NCT01479621|566526429|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935945|NCT01479621|566526430|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156935946|NCT01479621|566526424|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
156935947|NCT01479621|566526425|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935948|NCT01479621|566526426|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935949|NCT01479621|566526427|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935950|NCT01479621|566526428|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935951|NCT01479621|566526429|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935952|NCT01479621|566526430|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156935953|NCT01479621|566526424|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
156935954|NCT01479621|566526425|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935955|NCT01479621|566526426|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935956|NCT01479621|566526427|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935957|NCT01479621|566526428|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935958|NCT01479621|566526429|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935959|NCT01479621|566526430|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156935960|NCT01479621|566526424|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
156935961|NCT01479621|566526425|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935962|NCT01479621|566526426|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935963|NCT01479621|566526427|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935964|NCT01479621|566526428|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935965|NCT01479621|566526429|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935966|NCT01479621|566526430|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156935967|NCT01479621|566526424|FG000|Treatment Period|Adverse Event|0|||
156935968|NCT01479621|566526425|FG001|Treatment Period|Adverse Event|0|||
156935969|NCT01479621|566526426|FG002|Treatment Period|Adverse Event|0|||
156935970|NCT01479621|566526427|FG003|Treatment Period|Adverse Event|0|||
156935971|NCT01479621|566526428|FG004|Treatment Period|Adverse Event|1|||
156935972|NCT01479621|566526429|FG005|Treatment Period|Adverse Event|2|||
156935973|NCT01479621|566526430|FG006|Treatment Period|Adverse Event|2|||
156935974|NCT01479621|566526424|FG000|Treatment Period|Withdrawal by Subject|0|||
156935975|NCT01479621|566526425|FG001|Treatment Period|Withdrawal by Subject|4|||
156935976|NCT01479621|566526426|FG002|Treatment Period|Withdrawal by Subject|2|||
156935977|NCT01479621|566526427|FG003|Treatment Period|Withdrawal by Subject|2|||
156935978|NCT01479621|566526428|FG004|Treatment Period|Withdrawal by Subject|5|||
156935979|NCT01479621|566526429|FG005|Treatment Period|Withdrawal by Subject|5|||
156935980|NCT01479621|566526430|FG006|Treatment Period|Withdrawal by Subject|1|||
156935981|NCT01479621|566526424|FG000|Treatment Period|Physician Decision|0|||
156935982|NCT01479621|566526425|FG001|Treatment Period|Physician Decision|0|||
156935983|NCT01479621|566526426|FG002|Treatment Period|Physician Decision|0|||
156935984|NCT01479621|566526427|FG003|Treatment Period|Physician Decision|0|||
156935985|NCT01479621|566526428|FG004|Treatment Period|Physician Decision|1|||
156935986|NCT01479621|566526429|FG005|Treatment Period|Physician Decision|1|||
156935987|NCT01479621|566526430|FG006|Treatment Period|Physician Decision|0|||
156935988|NCT01479621|566526424|FG000|Treatment Period|Non-compliance to study drug|0|||
156935989|NCT01479621|566526425|FG001|Treatment Period|Non-compliance to study drug|1|||
156935990|NCT01479621|566526426|FG002|Treatment Period|Non-compliance to study drug|0|||
156935991|NCT01479621|566526427|FG003|Treatment Period|Non-compliance to study drug|0|||
156935992|NCT01479621|566526428|FG004|Treatment Period|Non-compliance to study drug|0|||
156935993|NCT01479621|566526429|FG005|Treatment Period|Non-compliance to study drug|0|||
157030676|NCT01208662|566868278|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
157030677|NCT01208662|566868279|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
156935994|NCT01479621|566526430|FG006|Treatment Period|Non-compliance to study drug|1|||
156935995|NCT01479621|566526424|FG000|Treatment Period|Protocol Violation|0|||
156935996|NCT01479621|566526425|FG001|Treatment Period|Protocol Violation|9|||
156935997|NCT01479621|566526426|FG002|Treatment Period|Protocol Violation|6|||
156935998|NCT01479621|566526427|FG003|Treatment Period|Protocol Violation|5|||
157030678|NCT01208662|566868277|FG000|Maintenance|Disease Progression|156|||
157030679|NCT01208662|566868278|FG001|Maintenance|Disease Progression|102|||
157030680|NCT01208662|566868279|FG002|Maintenance|Disease Progression|0|||
157030681|NCT01208662|566868277|FG000|Maintenance|Adverse Event|12|||
157030682|NCT01208662|566868278|FG001|Maintenance|Adverse Event|28|||
157030683|NCT01208662|566868279|FG002|Maintenance|Adverse Event|0|||
157030684|NCT01208662|566868277|FG000|Maintenance|MD or Participant Decision|24|||
157030685|NCT01208662|566868278|FG001|Maintenance|MD or Participant Decision|36|||
157030686|NCT01208662|566868279|FG002|Maintenance|MD or Participant Decision|0|||
157030687|NCT01208662|566868277|FG000|Maintenance|Death|0|||
157030688|NCT01208662|566868278|FG001|Maintenance|Death|3|||
157030689|NCT01208662|566868279|FG002|Maintenance|Death|0|||
157030690|NCT01208662|566868277|FG000|Maintenance|Discontinued for other reasons|21|||
157030691|NCT01208662|566868278|FG001|Maintenance|Discontinued for other reasons|31|||
157030692|NCT01208662|566868279|FG002|Maintenance|Discontinued for other reasons|0|||
157030693|NCT01208662|566868277|FG000|Maintenance|Still on Treatment|78|||
157030694|NCT01208662|566868278|FG001|Maintenance|Still on Treatment|89|||
157030695|NCT01208662|566868279|FG002|Maintenance|Still on Treatment|0|||
157030696|NCT04971109|566868280|FG000|Overall Study|Adverse Event|4|||
157030697|NCT04971109|566868281|FG001|Overall Study|Adverse Event|3|||
157030698|NCT04971109|566868280|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
157030699|NCT04971109|566868281|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
157030700|NCT04971109|566868280|FG000|Overall Study|Lost to Follow-up|8|||
157030701|NCT04971109|566868281|FG001|Overall Study|Lost to Follow-up|2|||
157030702|NCT04971109|566868280|FG000|Overall Study|Physician Decision|5|||
157030703|NCT04971109|566868281|FG001|Overall Study|Physician Decision|0|||
157030704|NCT04971109|566868280|FG000|Overall Study|Protocol Violation|0|||
156935999|NCT01479621|566526428|FG004|Treatment Period|Protocol Violation|2|||
156936000|NCT01479621|566526429|FG005|Treatment Period|Protocol Violation|10|||
156936001|NCT01479621|566526430|FG006|Treatment Period|Protocol Violation|6|||
156936002|NCT01479621|566526424|FG000|Treatment Period|Pregnancy|0|||
156936003|NCT01479621|566526425|FG001|Treatment Period|Pregnancy|0|||
156936004|NCT01479621|566526426|FG002|Treatment Period|Pregnancy|2|||
156936005|NCT01479621|566526427|FG003|Treatment Period|Pregnancy|0|||
156936006|NCT01479621|566526428|FG004|Treatment Period|Pregnancy|0|||
156936007|NCT01479621|566526429|FG005|Treatment Period|Pregnancy|0|||
156936008|NCT01479621|566526430|FG006|Treatment Period|Pregnancy|0|||
156936009|NCT01479621|566526424|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
156936010|NCT01479621|566526425|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
157030705|NCT04971109|566868281|FG001|Overall Study|Protocol Violation|1|||
157030706|NCT04971109|566868280|FG000|Overall Study|Withdrawal by Subject|18|||
157030707|NCT04971109|566868281|FG001|Overall Study|Withdrawal by Subject|3|||
157030708|NCT04971109|566868280|FG000|Overall Study|Subject was randomized in error|1|||
157030709|NCT04971109|566868281|FG001|Overall Study|Subject was randomized in error|0|||
157030710|NCT04778397|566868284|FG000|Overall Study|Death|59|||
157030711|NCT04778397|566868285|FG001|Overall Study|Death|54|||
157030712|NCT04778397|566868286|FG002|Overall Study|Death|11|||
157030713|NCT04778397|566868287|FG003|Overall Study|Death|9|||
157030714|NCT04778397|566868284|FG000|Overall Study|Study Terminated by Sponsor|34|||
157030715|NCT04778397|566868285|FG001|Overall Study|Study Terminated by Sponsor|42|||
157030716|NCT04778397|566868286|FG002|Overall Study|Study Terminated by Sponsor|15|||
157030717|NCT04778397|566868287|FG003|Overall Study|Study Terminated by Sponsor|12|||
157030718|NCT04778397|566868284|FG000|Overall Study|Withdrew Consent|5|||
157030719|NCT04778397|566868285|FG001|Overall Study|Withdrew Consent|4|||
157030720|NCT04778397|566868286|FG002|Overall Study|Withdrew Consent|1|||
157030721|NCT04778397|566868287|FG003|Overall Study|Withdrew Consent|1|||
157030722|NCT04778397|566868284|FG000|Overall Study|Reason Not Specified|1|||
157030723|NCT04778397|566868285|FG001|Overall Study|Reason Not Specified|3|||
157030724|NCT04778397|566868286|FG002|Overall Study|Reason Not Specified|0|||
157167070|NCT00696436|567352652|FG003|Overall Study|Lack of Efficacy|2|||
156936011|NCT01479621|566526426|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
156936012|NCT01479621|566526427|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
156936013|NCT01479621|566526428|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
156936014|NCT01479621|566526429|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
156936015|NCT01479621|566526430|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
156936016|NCT01479621|566526424|FG000|Treatment Period|Lost to Follow-up|0|||
156936017|NCT01479621|566526425|FG001|Treatment Period|Lost to Follow-up|0|||
157030725|NCT04778397|566868287|FG003|Overall Study|Reason Not Specified|2|||
157030726|NCT04778397|566868284|FG000|Overall Study|Lost to Follow-up|2|||
157030727|NCT04778397|566868285|FG001|Overall Study|Lost to Follow-up|1|||
157030728|NCT04778397|566868286|FG002|Overall Study|Lost to Follow-up|0|||
157167071|NCT00696436|567352653|FG004|Overall Study|Lack of Efficacy|4|||
157030729|NCT04778397|566868287|FG003|Overall Study|Lost to Follow-up|1|||
157030730|NCT05906784|566868289|FG000|Overall Study|Lost to Follow-up|2|||
157030731|NCT05906784|566868290|FG001|Overall Study|Lost to Follow-up|1|||
157030732|NCT05906784|566868291|FG002|Overall Study|Lost to Follow-up|1|||
157030733|NCT05906784|566868292|FG003|Overall Study|Lost to Follow-up|1|||
157030734|NCT05147116|566868294|FG000|Overall Study|Withdrawal by Subject|0|||
157030735|NCT05147116|566868295|FG001|Overall Study|Withdrawal by Subject|1|||
156936018|NCT01479621|566526426|FG002|Treatment Period|Lost to Follow-up|1|||
156936019|NCT01479621|566526427|FG003|Treatment Period|Lost to Follow-up|0|||
156936020|NCT01479621|566526428|FG004|Treatment Period|Lost to Follow-up|2|||
156936021|NCT01479621|566526429|FG005|Treatment Period|Lost to Follow-up|2|||
156936022|NCT01479621|566526430|FG006|Treatment Period|Lost to Follow-up|1|||
156936023|NCT01479621|566526424|FG000|Treatment Period|Met stopping criteria|0|||
156936024|NCT01479621|566526425|FG001|Treatment Period|Met stopping criteria|8|||
156936025|NCT01479621|566526426|FG002|Treatment Period|Met stopping criteria|7|||
156936026|NCT01479621|566526427|FG003|Treatment Period|Met stopping criteria|4|||
156936027|NCT01479621|566526428|FG004|Treatment Period|Met stopping criteria|9|||
156936028|NCT01479621|566526429|FG005|Treatment Period|Met stopping criteria|20|||
156936029|NCT01479621|566526430|FG006|Treatment Period|Met stopping criteria|6|||
156936030|NCT02308735|566526431|FG000|Overall Study|Physician Decision|2|||
156936031|NCT02308735|566526432|FG001|Overall Study|Physician Decision|0|||
156936032|NCT02308735|566526433|FG002|Overall Study|Physician Decision|0|||
156936033|NCT02308735|566526434|FG003|Overall Study|Physician Decision|2|||
156936034|NCT01417481|566526438|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
156936035|NCT01417481|566526439|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156936036|NCT03216850|566526450|FG000|Overall Study|Pre-analytical error|6|||
156936037|NCT02641379|566526451|FG000|Overall Study|Exclusion criterion during screening|1|||
156936038|NCT02641379|566526452|FG001|Overall Study|Exclusion criterion during screening|0|||
156936039|NCT02641379|566526453|FG002|Overall Study|Exclusion criterion during screening|0|||
156936040|NCT02641379|566526454|FG003|Overall Study|Exclusion criterion during screening|1|||
156936041|NCT02641379|566526455|FG004|Overall Study|Exclusion criterion during screening|2|||
156936042|NCT02641379|566526456|FG005|Overall Study|Exclusion criterion during screening|0|||
156936043|NCT02641379|566526457|FG006|Overall Study|Exclusion criterion during screening|0|||
156936044|NCT02641379|566526458|FG007|Overall Study|Exclusion criterion during screening|0|||
156936045|NCT02641379|566526459|FG008|Overall Study|Exclusion criterion during screening|0|||
156936046|NCT02641379|566526460|FG009|Overall Study|Exclusion criterion during screening|0|||
156936047|NCT02641379|566526461|FG010|Overall Study|Exclusion criterion during screening|0|||
156936048|NCT02641379|566526451|FG000|Overall Study|Withdrawal of informed consent|0|||
156936049|NCT02641379|566526452|FG001|Overall Study|Withdrawal of informed consent|1|||
156936050|NCT02641379|566526453|FG002|Overall Study|Withdrawal of informed consent|0|||
156936051|NCT02641379|566526454|FG003|Overall Study|Withdrawal of informed consent|0|||
156936052|NCT02641379|566526455|FG004|Overall Study|Withdrawal of informed consent|0|||
156936053|NCT02641379|566526456|FG005|Overall Study|Withdrawal of informed consent|0|||
156936054|NCT02641379|566526457|FG006|Overall Study|Withdrawal of informed consent|0|||
156936055|NCT02641379|566526458|FG007|Overall Study|Withdrawal of informed consent|1|||
156936056|NCT02641379|566526459|FG008|Overall Study|Withdrawal of informed consent|0|||
156936057|NCT02641379|566526460|FG009|Overall Study|Withdrawal of informed consent|0|||
156936058|NCT02641379|566526461|FG010|Overall Study|Withdrawal of informed consent|0|||
156936059|NCT02641379|566526451|FG000|Overall Study|Adverse Event|7|||
156936060|NCT02641379|566526452|FG001|Overall Study|Adverse Event|8|||
156936061|NCT02641379|566526453|FG002|Overall Study|Adverse Event|2|||
156936062|NCT02641379|566526454|FG003|Overall Study|Adverse Event|2|||
156936063|NCT02641379|566526455|FG004|Overall Study|Adverse Event|5|||
156936064|NCT02641379|566526456|FG005|Overall Study|Adverse Event|1|||
156936065|NCT02641379|566526457|FG006|Overall Study|Adverse Event|5|||
156936066|NCT02641379|566526458|FG007|Overall Study|Adverse Event|0|||
156936067|NCT02641379|566526459|FG008|Overall Study|Adverse Event|1|||
156936068|NCT02641379|566526460|FG009|Overall Study|Adverse Event|1|||
156936069|NCT02641379|566526461|FG010|Overall Study|Adverse Event|5|||
156936070|NCT02641379|566526451|FG000|Overall Study|Lack of Efficacy|0|||
156936071|NCT02641379|566526452|FG001|Overall Study|Lack of Efficacy|0|||
156936072|NCT02641379|566526453|FG002|Overall Study|Lack of Efficacy|2|||
156936073|NCT02641379|566526454|FG003|Overall Study|Lack of Efficacy|0|||
156936074|NCT02641379|566526455|FG004|Overall Study|Lack of Efficacy|0|||
156936075|NCT02641379|566526456|FG005|Overall Study|Lack of Efficacy|2|||
156936076|NCT02641379|566526457|FG006|Overall Study|Lack of Efficacy|0|||
156936077|NCT02641379|566526458|FG007|Overall Study|Lack of Efficacy|5|||
156936078|NCT02641379|566526459|FG008|Overall Study|Lack of Efficacy|0|||
156936079|NCT02641379|566526460|FG009|Overall Study|Lack of Efficacy|0|||
156936080|NCT02641379|566526461|FG010|Overall Study|Lack of Efficacy|0|||
156936081|NCT02641379|566526451|FG000|Overall Study|Participant unable to attend study visit|4|||
156936082|NCT02641379|566526452|FG001|Overall Study|Participant unable to attend study visit|10|||
156936083|NCT02641379|566526453|FG002|Overall Study|Participant unable to attend study visit|1|||
156936084|NCT02641379|566526454|FG003|Overall Study|Participant unable to attend study visit|2|||
156936085|NCT02641379|566526455|FG004|Overall Study|Participant unable to attend study visit|5|||
156936086|NCT02641379|566526456|FG005|Overall Study|Participant unable to attend study visit|1|||
156936087|NCT02641379|566526457|FG006|Overall Study|Participant unable to attend study visit|1|||
156936088|NCT02641379|566526458|FG007|Overall Study|Participant unable to attend study visit|1|||
156936089|NCT02641379|566526459|FG008|Overall Study|Participant unable to attend study visit|0|||
156936090|NCT02641379|566526460|FG009|Overall Study|Participant unable to attend study visit|2|||
156936091|NCT02641379|566526461|FG010|Overall Study|Participant unable to attend study visit|0|||
156936092|NCT02641379|566526451|FG000|Overall Study|Participant's compliance|0|||
156936093|NCT02641379|566526452|FG001|Overall Study|Participant's compliance|1|||
156936094|NCT02641379|566526453|FG002|Overall Study|Participant's compliance|0|||
156936095|NCT02641379|566526454|FG003|Overall Study|Participant's compliance|1|||
156936096|NCT02641379|566526455|FG004|Overall Study|Participant's compliance|0|||
156936097|NCT02641379|566526456|FG005|Overall Study|Participant's compliance|2|||
156936098|NCT02641379|566526457|FG006|Overall Study|Participant's compliance|0|||
156936099|NCT02641379|566526458|FG007|Overall Study|Participant's compliance|0|||
156936100|NCT02641379|566526459|FG008|Overall Study|Participant's compliance|1|||
156936101|NCT02641379|566526460|FG009|Overall Study|Participant's compliance|1|||
156936102|NCT02641379|566526461|FG010|Overall Study|Participant's compliance|1|||
156936103|NCT02641379|566526451|FG000|Overall Study|Participant cannot be reached|4|||
156936104|NCT02641379|566526452|FG001|Overall Study|Participant cannot be reached|4|||
156936105|NCT02641379|566526453|FG002|Overall Study|Participant cannot be reached|0|||
156936106|NCT02641379|566526454|FG003|Overall Study|Participant cannot be reached|8|||
156936107|NCT02641379|566526455|FG004|Overall Study|Participant cannot be reached|2|||
156936108|NCT02641379|566526456|FG005|Overall Study|Participant cannot be reached|1|||
156936109|NCT02641379|566526457|FG006|Overall Study|Participant cannot be reached|0|||
156936110|NCT02641379|566526458|FG007|Overall Study|Participant cannot be reached|1|||
156936111|NCT02641379|566526459|FG008|Overall Study|Participant cannot be reached|0|||
156936112|NCT02641379|566526460|FG009|Overall Study|Participant cannot be reached|2|||
156936113|NCT02641379|566526461|FG010|Overall Study|Participant cannot be reached|1|||
156936114|NCT02641379|566526451|FG000|Overall Study|PCR positive at Week 24|15|||
156936115|NCT02641379|566526452|FG001|Overall Study|PCR positive at Week 24|21|||
156936116|NCT02641379|566526453|FG002|Overall Study|PCR positive at Week 24|62|||
156936117|NCT02641379|566526454|FG003|Overall Study|PCR positive at Week 24|0|||
156936118|NCT02641379|566526455|FG004|Overall Study|PCR positive at Week 24|0|||
156936119|NCT02641379|566526456|FG005|Overall Study|PCR positive at Week 24|6|||
156936120|NCT02641379|566526457|FG006|Overall Study|PCR positive at Week 24|3|||
156936121|NCT02641379|566526458|FG007|Overall Study|PCR positive at Week 24|8|||
156936122|NCT02641379|566526459|FG008|Overall Study|PCR positive at Week 24|0|||
156936123|NCT02641379|566526460|FG009|Overall Study|PCR positive at Week 24|1|||
156936124|NCT02641379|566526461|FG010|Overall Study|PCR positive at Week 24|0|||
156936125|NCT02641379|566526451|FG000|Overall Study|PCR positive at follow up 2|1|||
156936126|NCT02641379|566526452|FG001|Overall Study|PCR positive at follow up 2|0|||
156936127|NCT02641379|566526453|FG002|Overall Study|PCR positive at follow up 2|0|||
156936128|NCT02641379|566526454|FG003|Overall Study|PCR positive at follow up 2|0|||
156936129|NCT02641379|566526455|FG004|Overall Study|PCR positive at follow up 2|0|||
156936130|NCT02641379|566526456|FG005|Overall Study|PCR positive at follow up 2|0|||
156936131|NCT02641379|566526457|FG006|Overall Study|PCR positive at follow up 2|0|||
156936132|NCT02641379|566526458|FG007|Overall Study|PCR positive at follow up 2|0|||
156936133|NCT02641379|566526459|FG008|Overall Study|PCR positive at follow up 2|0|||
156936134|NCT02641379|566526460|FG009|Overall Study|PCR positive at follow up 2|0|||
156936135|NCT02641379|566526461|FG010|Overall Study|PCR positive at follow up 2|0|||
156936136|NCT02641379|566526451|FG000|Overall Study|Participant showed relapse|1|||
156936137|NCT02641379|566526452|FG001|Overall Study|Participant showed relapse|0|||
156936138|NCT02641379|566526453|FG002|Overall Study|Participant showed relapse|0|||
156936139|NCT02641379|566526454|FG003|Overall Study|Participant showed relapse|0|||
156936140|NCT02641379|566526455|FG004|Overall Study|Participant showed relapse|0|||
156936141|NCT02641379|566526456|FG005|Overall Study|Participant showed relapse|0|||
156936142|NCT02641379|566526457|FG006|Overall Study|Participant showed relapse|1|||
156936143|NCT02641379|566526458|FG007|Overall Study|Participant showed relapse|0|||
156936144|NCT02641379|566526459|FG008|Overall Study|Participant showed relapse|0|||
156936145|NCT02641379|566526460|FG009|Overall Study|Participant showed relapse|0|||
156936146|NCT02641379|566526461|FG010|Overall Study|Participant showed relapse|0|||
156936147|NCT02641379|566526451|FG000|Overall Study|Participant stopped study/treatment|1|||
156936148|NCT02641379|566526452|FG001|Overall Study|Participant stopped study/treatment|3|||
156936149|NCT02641379|566526453|FG002|Overall Study|Participant stopped study/treatment|1|||
156936150|NCT02641379|566526454|FG003|Overall Study|Participant stopped study/treatment|0|||
156936151|NCT02641379|566526455|FG004|Overall Study|Participant stopped study/treatment|0|||
156936152|NCT02641379|566526456|FG005|Overall Study|Participant stopped study/treatment|1|||
156936153|NCT02641379|566526457|FG006|Overall Study|Participant stopped study/treatment|2|||
156936154|NCT02641379|566526458|FG007|Overall Study|Participant stopped study/treatment|0|||
156936155|NCT02641379|566526459|FG008|Overall Study|Participant stopped study/treatment|1|||
156936156|NCT02641379|566526460|FG009|Overall Study|Participant stopped study/treatment|0|||
156936157|NCT02641379|566526461|FG010|Overall Study|Participant stopped study/treatment|0|||
156936158|NCT02641379|566526451|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
156936159|NCT02641379|566526452|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
156936160|NCT02641379|566526453|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
156936161|NCT02641379|566526454|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
156936162|NCT02641379|566526455|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
157030736|NCT04101357|566868296|FG000|Overall Study|Death|1|||
157030737|NCT04101357|566868297|FG001|Overall Study|Death|1|||
157030738|NCT04101357|566868298|FG002|Overall Study|Death|1|||
157030739|NCT04101357|566868299|FG003|Overall Study|Death|2|||
157030740|NCT04101357|566868300|FG004|Overall Study|Death|4|||
157030741|NCT04101357|566868301|FG005|Overall Study|Death|11|||
157030742|NCT04101357|566868302|FG006|Overall Study|Death|4|||
157030743|NCT04101357|566868303|FG007|Overall Study|Death|4|||
157030744|NCT04101357|566868304|FG008|Overall Study|Death|5|||
157030745|NCT04101357|566868305|FG009|Overall Study|Death|2|||
157030746|NCT04101357|566868306|FG010|Overall Study|Death|3|||
157030747|NCT04101357|566868296|FG000|Overall Study|Trial closure|0|||
157030748|NCT04101357|566868297|FG001|Overall Study|Trial closure|0|||
157030749|NCT04101357|566868298|FG002|Overall Study|Trial closure|0|||
157030750|NCT04101357|566868299|FG003|Overall Study|Trial closure|0|||
157030751|NCT04101357|566868300|FG004|Overall Study|Trial closure|0|||
157030752|NCT04101357|566868301|FG005|Overall Study|Trial closure|2|||
157030753|NCT04101357|566868302|FG006|Overall Study|Trial closure|2|||
157030754|NCT04101357|566868303|FG007|Overall Study|Trial closure|0|||
157030755|NCT04101357|566868304|FG008|Overall Study|Trial closure|0|||
157030756|NCT04101357|566868305|FG009|Overall Study|Trial closure|0|||
157030757|NCT04101357|566868306|FG010|Overall Study|Trial closure|1|||
157030758|NCT04101357|566868296|FG000|Overall Study|Lost to Follow-up|0|||
157030759|NCT04101357|566868297|FG001|Overall Study|Lost to Follow-up|0|||
157030760|NCT04101357|566868298|FG002|Overall Study|Lost to Follow-up|0|||
157030761|NCT04101357|566868299|FG003|Overall Study|Lost to Follow-up|1|||
157030762|NCT04101357|566868300|FG004|Overall Study|Lost to Follow-up|0|||
157030763|NCT04101357|566868301|FG005|Overall Study|Lost to Follow-up|0|||
157030764|NCT04101357|566868302|FG006|Overall Study|Lost to Follow-up|0|||
157030765|NCT04101357|566868303|FG007|Overall Study|Lost to Follow-up|1|||
157030766|NCT04101357|566868304|FG008|Overall Study|Lost to Follow-up|0|||
157030767|NCT04101357|566868305|FG009|Overall Study|Lost to Follow-up|0|||
157030768|NCT04101357|566868306|FG010|Overall Study|Lost to Follow-up|0|||
157030769|NCT04101357|566868296|FG000|Overall Study|Withdrawal by Subject|1|||
157030770|NCT04101357|566868297|FG001|Overall Study|Withdrawal by Subject|0|||
157030771|NCT04101357|566868298|FG002|Overall Study|Withdrawal by Subject|0|||
157030772|NCT04101357|566868299|FG003|Overall Study|Withdrawal by Subject|0|||
157030773|NCT04101357|566868300|FG004|Overall Study|Withdrawal by Subject|0|||
157030774|NCT04101357|566868301|FG005|Overall Study|Withdrawal by Subject|0|||
157030775|NCT04101357|566868302|FG006|Overall Study|Withdrawal by Subject|0|||
157030776|NCT04101357|566868303|FG007|Overall Study|Withdrawal by Subject|0|||
157030777|NCT04101357|566868304|FG008|Overall Study|Withdrawal by Subject|1|||
157030778|NCT04101357|566868305|FG009|Overall Study|Withdrawal by Subject|1|||
157030779|NCT04101357|566868306|FG010|Overall Study|Withdrawal by Subject|0|||
157030780|NCT04101357|566868296|FG000|Overall Study|Other|0|||
157030781|NCT04101357|566868297|FG001|Overall Study|Other|0|||
157030782|NCT04101357|566868298|FG002|Overall Study|Other|0|||
157030783|NCT04101357|566868299|FG003|Overall Study|Other|0|||
157030784|NCT04101357|566868300|FG004|Overall Study|Other|0|||
157030785|NCT04101357|566868301|FG005|Overall Study|Other|1|||
157167072|NCT00696436|567352649|FG000|Overall Study|Participant Unavailability|2|||
157167073|NCT00696436|567352650|FG001|Overall Study|Participant Unavailability|0|||
157167074|NCT00696436|567352651|FG002|Overall Study|Participant Unavailability|2|||
157167075|NCT00696436|567352652|FG003|Overall Study|Participant Unavailability|1|||
157167076|NCT00696436|567352653|FG004|Overall Study|Participant Unavailability|0|||
157167077|NCT00696436|567352649|FG000|Overall Study|Administrative Error|2|||
157167078|NCT00696436|567352650|FG001|Overall Study|Administrative Error|0|||
157167079|NCT00696436|567352651|FG002|Overall Study|Administrative Error|2|||
157167080|NCT00696436|567352652|FG003|Overall Study|Administrative Error|0|||
157167081|NCT00696436|567352653|FG004|Overall Study|Administrative Error|0|||
157167082|NCT00696436|567352649|FG000|Overall Study|Participant Non-compliance|0|||
157167083|NCT00696436|567352650|FG001|Overall Study|Participant Non-compliance|0|||
157167084|NCT00696436|567352651|FG002|Overall Study|Participant Non-compliance|1|||
157167085|NCT00696436|567352652|FG003|Overall Study|Participant Non-compliance|2|||
157167086|NCT00696436|567352653|FG004|Overall Study|Participant Non-compliance|0|||
157167087|NCT00696436|567352649|FG000|Overall Study|Administrative Decision|1|||
157167088|NCT00696436|567352650|FG001|Overall Study|Administrative Decision|0|||
157167089|NCT00696436|567352651|FG002|Overall Study|Administrative Decision|0|||
157167090|NCT00696436|567352652|FG003|Overall Study|Administrative Decision|0|||
157167091|NCT00696436|567352653|FG004|Overall Study|Administrative Decision|0|||
157167092|NCT00696436|567352649|FG000|Overall Study|Missing|0|||
157167093|NCT00696436|567352650|FG001|Overall Study|Missing|1|||
157030786|NCT04101357|566868302|FG006|Overall Study|Other|2|||
157030787|NCT04101357|566868303|FG007|Overall Study|Other|1|||
157030788|NCT04101357|566868304|FG008|Overall Study|Other|0|||
157030789|NCT04101357|566868305|FG009|Overall Study|Other|0|||
157030790|NCT04101357|566868306|FG010|Overall Study|Other|0|||
157030791|NCT04101357|566868296|FG000|Overall Study|Enrolled but not treated|0|||
157030792|NCT04101357|566868297|FG001|Overall Study|Enrolled but not treated|0|||
157030793|NCT04101357|566868298|FG002|Overall Study|Enrolled but not treated|0|||
157030794|NCT04101357|566868299|FG003|Overall Study|Enrolled but not treated|0|||
156936163|NCT02641379|566526456|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
156936164|NCT02641379|566526457|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
156936165|NCT02641379|566526458|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
156936166|NCT02641379|566526459|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
156936167|NCT02641379|566526460|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
156936168|NCT02641379|566526461|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
156936169|NCT02641379|566526451|FG000|Overall Study|Financial problems|0|||
156936170|NCT02641379|566526452|FG001|Overall Study|Financial problems|1|||
156936171|NCT02641379|566526453|FG002|Overall Study|Financial problems|0|||
156936172|NCT02641379|566526454|FG003|Overall Study|Financial problems|0|||
156936173|NCT02641379|566526455|FG004|Overall Study|Financial problems|0|||
156936174|NCT02641379|566526456|FG005|Overall Study|Financial problems|0|||
156936175|NCT02641379|566526457|FG006|Overall Study|Financial problems|0|||
156936176|NCT02641379|566526458|FG007|Overall Study|Financial problems|0|||
156936177|NCT02641379|566526459|FG008|Overall Study|Financial problems|0|||
156936178|NCT02641379|566526460|FG009|Overall Study|Financial problems|0|||
156936179|NCT02641379|566526461|FG010|Overall Study|Financial problems|0|||
156936180|NCT02641379|566526451|FG000|Overall Study|PCR positive at Week 68|0|||
156936181|NCT02641379|566526452|FG001|Overall Study|PCR positive at Week 68|1|||
156936182|NCT02641379|566526453|FG002|Overall Study|PCR positive at Week 68|0|||
156936183|NCT02641379|566526454|FG003|Overall Study|PCR positive at Week 68|0|||
156936184|NCT02641379|566526455|FG004|Overall Study|PCR positive at Week 68|0|||
156936185|NCT02641379|566526456|FG005|Overall Study|PCR positive at Week 68|0|||
156936186|NCT02641379|566526457|FG006|Overall Study|PCR positive at Week 68|0|||
156936187|NCT02641379|566526458|FG007|Overall Study|PCR positive at Week 68|0|||
156936188|NCT02641379|566526459|FG008|Overall Study|PCR positive at Week 68|0|||
156936189|NCT02641379|566526460|FG009|Overall Study|PCR positive at Week 68|0|||
156936190|NCT02641379|566526461|FG010|Overall Study|PCR positive at Week 68|0|||
156936191|NCT02641379|566526451|FG000|Overall Study|PCR positive at Week 48|0|||
156936192|NCT02641379|566526452|FG001|Overall Study|PCR positive at Week 48|1|||
156936193|NCT02641379|566526453|FG002|Overall Study|PCR positive at Week 48|0|||
156936194|NCT02641379|566526454|FG003|Overall Study|PCR positive at Week 48|0|||
156936195|NCT02641379|566526455|FG004|Overall Study|PCR positive at Week 48|0|||
156936196|NCT02641379|566526456|FG005|Overall Study|PCR positive at Week 48|0|||
156936197|NCT02641379|566526457|FG006|Overall Study|PCR positive at Week 48|0|||
156936198|NCT02641379|566526458|FG007|Overall Study|PCR positive at Week 48|0|||
156936199|NCT02641379|566526459|FG008|Overall Study|PCR positive at Week 48|0|||
156936200|NCT02641379|566526460|FG009|Overall Study|PCR positive at Week 48|0|||
156936201|NCT02641379|566526461|FG010|Overall Study|PCR positive at Week 48|0|||
156936202|NCT02641379|566526451|FG000|Overall Study|PCR not performed at Week 12|0|||
157030795|NCT04101357|566868300|FG004|Overall Study|Enrolled but not treated|0|||
157030796|NCT04101357|566868301|FG005|Overall Study|Enrolled but not treated|1|||
157030797|NCT04101357|566868302|FG006|Overall Study|Enrolled but not treated|1|||
157030798|NCT04101357|566868303|FG007|Overall Study|Enrolled but not treated|0|||
157030799|NCT04101357|566868304|FG008|Overall Study|Enrolled but not treated|0|||
157030800|NCT04101357|566868305|FG009|Overall Study|Enrolled but not treated|0|||
157030801|NCT04101357|566868306|FG010|Overall Study|Enrolled but not treated|0|||
157030802|NCT03655028|566868307|FG000|12-weeks Follow up|Death|1|||
157030803|NCT03655028|566868308|FG001|12-weeks Follow up|Death|0|||
157030804|NCT03655028|566868307|FG000|12-weeks Follow up|Physician Decision|3|||
157030805|NCT03655028|566868308|FG001|12-weeks Follow up|Physician Decision|3|||
157167094|NCT00696436|567352651|FG002|Overall Study|Missing|1|||
157167095|NCT00696436|567352652|FG003|Overall Study|Missing|0|||
157167096|NCT00696436|567352653|FG004|Overall Study|Missing|0|||
157167097|NCT03039738|567352658|FG000|Overall Study|Incomplete data sets|54|||
157167098|NCT03039738|567352659|FG001|Overall Study|Incomplete data sets|0|||
157167099|NCT00912340|567352660|FG000|Overall Study|Adverse Event|2|||
157167100|NCT00912340|567352661|FG001|Overall Study|Adverse Event|4|||
157167101|NCT00912340|567352662|FG002|Overall Study|Adverse Event|0|||
157167102|NCT00912340|567352660|FG000|Overall Study|Protocol revised to remove arm|0|||
157167103|NCT00912340|567352661|FG001|Overall Study|Protocol revised to remove arm|0|||
157167104|NCT00912340|567352662|FG002|Overall Study|Protocol revised to remove arm|4|||
157167105|NCT01517412|567352665|FG000|Overall Study|Adverse Event|10|||
157167106|NCT01517412|567352666|FG001|Overall Study|Adverse Event|11|||
157167107|NCT01517412|567352665|FG000|Overall Study|Lack of Efficacy|10|||
157167108|NCT01517412|567352666|FG001|Overall Study|Lack of Efficacy|5|||
157167109|NCT01517412|567352665|FG000|Overall Study|Poor compliance to protocol|8|||
157167110|NCT01517412|567352666|FG001|Overall Study|Poor compliance to protocol|3|||
157167111|NCT01517412|567352665|FG000|Overall Study|Other than specified above|8|||
157167112|NCT01517412|567352666|FG001|Overall Study|Other than specified above|5|||
157167113|NCT01253187|567352669|FG000|Period 2|Withdrawal by Subject|0|||
157167114|NCT01253187|567352670|FG001|Period 2|Withdrawal by Subject|0|||
157167115|NCT01253187|567352671|FG002|Period 2|Withdrawal by Subject|0|||
157167116|NCT01253187|567352672|FG003|Period 2|Withdrawal by Subject|0|||
157227107|NCT02433678|567577735|FG001|Overall Study|Lost to Follow-up|2|||
157167117|NCT01253187|567352673|FG004|Period 2|Withdrawal by Subject|1|||
157167118|NCT01253187|567352674|FG005|Period 2|Withdrawal by Subject|0|||
157030806|NCT03655028|566868307|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
157030807|NCT03655028|566868308|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
157030808|NCT03655028|566868307|FG000|12-weeks Follow up|Lost to Follow-up|4|||
157030809|NCT03655028|566868308|FG001|12-weeks Follow up|Lost to Follow-up|4|||
157030810|NCT03655028|566868307|FG000|24-weeks|Lost to Follow-up|1|||
157030811|NCT03655028|566868308|FG001|24-weeks|Lost to Follow-up|1|||
157030812|NCT03655028|566868307|FG000|24-weeks|Death|0|||
157030813|NCT03655028|566868308|FG001|24-weeks|Death|1|||
157030814|NCT03852550|566868309|FG000|Overall Study|Lost to Follow-up|4|||
157030815|NCT03852550|566868310|FG001|Overall Study|Lost to Follow-up|3|||
157030816|NCT03852550|566868309|FG000|Overall Study|Only parent outcomes completed|0|||
157030817|NCT03852550|566868310|FG001|Overall Study|Only parent outcomes completed|1|||
157030818|NCT03852550|566868309|FG000|Overall Study|Withdrawal by Subject|1|||
157030819|NCT03852550|566868310|FG001|Overall Study|Withdrawal by Subject|0|||
157030820|NCT05204654|566868311|FG000|Overall Study|Study terminated due to time restraint|2|||
157030821|NCT05204654|566868312|FG001|Overall Study|Study terminated due to time restraint|2|||
157030822|NCT04625725|566868316|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
157030823|NCT04625725|566868317|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
157030824|NCT04625725|566868318|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
157030825|NCT04625725|566868319|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
157030826|NCT04625725|566868320|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
157030827|NCT04625725|566868321|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
157030828|NCT04625725|566868316|FG000|Provent Main Study|Withdrawal by Subject|242|||
157030829|NCT04625725|566868317|FG001|Provent Main Study|Withdrawal by Subject|144|||
157030830|NCT04625725|566868318|FG002|Provent Main Study|Withdrawal by Subject|0|||
157030831|NCT04625725|566868319|FG003|Provent Main Study|Withdrawal by Subject|0|||
157030832|NCT04625725|566868320|FG004|Provent Main Study|Withdrawal by Subject|0|||
157030833|NCT04625725|566868321|FG005|Provent Main Study|Withdrawal by Subject|0|||
157030834|NCT04625725|566868316|FG000|Provent Main Study|Physician Decision|5|||
157030835|NCT04625725|566868317|FG001|Provent Main Study|Physician Decision|0|||
157030836|NCT04625725|566868318|FG002|Provent Main Study|Physician Decision|0|||
157030837|NCT04625725|566868319|FG003|Provent Main Study|Physician Decision|0|||
157030838|NCT04625725|566868320|FG004|Provent Main Study|Physician Decision|0|||
157030839|NCT04625725|566868321|FG005|Provent Main Study|Physician Decision|0|||
157030840|NCT04625725|566868316|FG000|Provent Main Study|Protocol Violation|1|||
157030841|NCT04625725|566868317|FG001|Provent Main Study|Protocol Violation|0|||
157030842|NCT04625725|566868318|FG002|Provent Main Study|Protocol Violation|0|||
157030843|NCT04625725|566868319|FG003|Provent Main Study|Protocol Violation|0|||
157030844|NCT04625725|566868320|FG004|Provent Main Study|Protocol Violation|0|||
157030845|NCT04625725|566868321|FG005|Provent Main Study|Protocol Violation|0|||
157030846|NCT04625725|566868316|FG000|Provent Main Study|Lost to Follow-up|357|||
157030847|NCT04625725|566868317|FG001|Provent Main Study|Lost to Follow-up|200|||
157030848|NCT04625725|566868318|FG002|Provent Main Study|Lost to Follow-up|0|||
157030849|NCT04625725|566868319|FG003|Provent Main Study|Lost to Follow-up|0|||
157030850|NCT04625725|566868320|FG004|Provent Main Study|Lost to Follow-up|0|||
157030851|NCT04625725|566868321|FG005|Provent Main Study|Lost to Follow-up|0|||
157030852|NCT04625725|566868316|FG000|Provent Main Study|Death|22|||
157030853|NCT04625725|566868317|FG001|Provent Main Study|Death|10|||
157030854|NCT04625725|566868318|FG002|Provent Main Study|Death|0|||
157030855|NCT04625725|566868319|FG003|Provent Main Study|Death|0|||
157030856|NCT04625725|566868320|FG004|Provent Main Study|Death|0|||
157030857|NCT04625725|566868321|FG005|Provent Main Study|Death|0|||
157030858|NCT04625725|566868316|FG000|Provent Main Study|Adverse Event|2|||
157030859|NCT04625725|566868317|FG001|Provent Main Study|Adverse Event|1|||
157030860|NCT04625725|566868318|FG002|Provent Main Study|Adverse Event|0|||
157030861|NCT04625725|566868319|FG003|Provent Main Study|Adverse Event|0|||
157030862|NCT04625725|566868320|FG004|Provent Main Study|Adverse Event|0|||
157030863|NCT04625725|566868321|FG005|Provent Main Study|Adverse Event|0|||
157030864|NCT04625725|566868316|FG000|Provent Main Study|Participants dosed in sub-study|310|||
157030865|NCT04625725|566868317|FG001|Provent Main Study|Participants dosed in sub-study|193|||
157030866|NCT04625725|566868318|FG002|Provent Main Study|Participants dosed in sub-study|0|||
157030867|NCT04625725|566868319|FG003|Provent Main Study|Participants dosed in sub-study|0|||
157030868|NCT04625725|566868320|FG004|Provent Main Study|Participants dosed in sub-study|0|||
157030869|NCT04625725|566868321|FG005|Provent Main Study|Participants dosed in sub-study|0|||
157030870|NCT04625725|566868316|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
157030871|NCT04625725|566868317|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
157030872|NCT04625725|566868318|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
157030873|NCT04625725|566868319|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
157030874|NCT04625725|566868320|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
157030875|NCT04625725|566868321|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
157030876|NCT04625725|566868316|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
157030877|NCT04625725|566868317|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
157030878|NCT04625725|566868318|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
157167119|NCT01253187|567352669|FG000|Period 3|Pregnancy|1|||
156936203|NCT02641379|566526452|FG001|Overall Study|PCR not performed at Week 12|0|||
156936204|NCT02641379|566526453|FG002|Overall Study|PCR not performed at Week 12|1|||
156936205|NCT02641379|566526454|FG003|Overall Study|PCR not performed at Week 12|0|||
156936206|NCT02641379|566526455|FG004|Overall Study|PCR not performed at Week 12|0|||
156936207|NCT02641379|566526456|FG005|Overall Study|PCR not performed at Week 12|0|||
156936208|NCT02641379|566526457|FG006|Overall Study|PCR not performed at Week 12|0|||
156936209|NCT02641379|566526458|FG007|Overall Study|PCR not performed at Week 12|0|||
156936210|NCT02641379|566526459|FG008|Overall Study|PCR not performed at Week 12|0|||
156936211|NCT02641379|566526460|FG009|Overall Study|PCR not performed at Week 12|0|||
156936212|NCT02641379|566526461|FG010|Overall Study|PCR not performed at Week 12|0|||
156936213|NCT02641379|566526451|FG000|Overall Study|No PCR at baseline|0|||
156936214|NCT02641379|566526452|FG001|Overall Study|No PCR at baseline|0|||
156936215|NCT02641379|566526453|FG002|Overall Study|No PCR at baseline|1|||
156936216|NCT02641379|566526454|FG003|Overall Study|No PCR at baseline|0|||
156936217|NCT02641379|566526455|FG004|Overall Study|No PCR at baseline|0|||
156936218|NCT02641379|566526456|FG005|Overall Study|No PCR at baseline|0|||
156936219|NCT02641379|566526457|FG006|Overall Study|No PCR at baseline|0|||
156936220|NCT02641379|566526458|FG007|Overall Study|No PCR at baseline|0|||
156936221|NCT02641379|566526459|FG008|Overall Study|No PCR at baseline|0|||
156936222|NCT02641379|566526460|FG009|Overall Study|No PCR at baseline|0|||
156936223|NCT02641379|566526461|FG010|Overall Study|No PCR at baseline|0|||
156936224|NCT02641379|566526451|FG000|Overall Study|PCR positive at Week 28|0|||
156936225|NCT02641379|566526452|FG001|Overall Study|PCR positive at Week 28|0|||
156936226|NCT02641379|566526453|FG002|Overall Study|PCR positive at Week 28|1|||
156936227|NCT02641379|566526454|FG003|Overall Study|PCR positive at Week 28|0|||
156936228|NCT02641379|566526455|FG004|Overall Study|PCR positive at Week 28|0|||
156936229|NCT02641379|566526456|FG005|Overall Study|PCR positive at Week 28|0|||
156936230|NCT02641379|566526457|FG006|Overall Study|PCR positive at Week 28|0|||
156936231|NCT02641379|566526458|FG007|Overall Study|PCR positive at Week 28|0|||
156936232|NCT02641379|566526459|FG008|Overall Study|PCR positive at Week 28|0|||
156936233|NCT02641379|566526460|FG009|Overall Study|PCR positive at Week 28|0|||
156936234|NCT02641379|566526461|FG010|Overall Study|PCR positive at Week 28|0|||
156936235|NCT02641379|566526451|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
156936236|NCT02641379|566526452|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
156936237|NCT02641379|566526453|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
156936238|NCT02641379|566526454|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
156936239|NCT02641379|566526455|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
156936240|NCT02641379|566526456|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
156936241|NCT02641379|566526457|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
156936242|NCT02641379|566526458|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
156936243|NCT02641379|566526459|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
156936244|NCT02641379|566526460|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
156936245|NCT02641379|566526461|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
156936246|NCT02641379|566526451|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
156936247|NCT02641379|566526452|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
156936248|NCT02641379|566526453|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
156936249|NCT02641379|566526454|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
156936250|NCT02641379|566526455|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
156936251|NCT02641379|566526456|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
156936252|NCT02641379|566526457|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
156936253|NCT02641379|566526458|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
156936254|NCT02641379|566526459|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
156936255|NCT02641379|566526460|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
156936256|NCT02641379|566526461|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
156936257|NCT02641379|566526451|FG000|Overall Study|Baseline viral load unavailable|0|||
156936258|NCT02641379|566526452|FG001|Overall Study|Baseline viral load unavailable|0|||
156936259|NCT02641379|566526453|FG002|Overall Study|Baseline viral load unavailable|0|||
156936260|NCT02641379|566526454|FG003|Overall Study|Baseline viral load unavailable|1|||
156936261|NCT02641379|566526455|FG004|Overall Study|Baseline viral load unavailable|0|||
156936262|NCT02641379|566526456|FG005|Overall Study|Baseline viral load unavailable|0|||
156936263|NCT02641379|566526457|FG006|Overall Study|Baseline viral load unavailable|0|||
156936264|NCT02641379|566526458|FG007|Overall Study|Baseline viral load unavailable|0|||
156936265|NCT02641379|566526459|FG008|Overall Study|Baseline viral load unavailable|0|||
156936266|NCT02641379|566526460|FG009|Overall Study|Baseline viral load unavailable|0|||
156936267|NCT02641379|566526461|FG010|Overall Study|Baseline viral load unavailable|0|||
156936268|NCT02641379|566526451|FG000|Overall Study|Blood could not be drawn|0|||
156936269|NCT02641379|566526452|FG001|Overall Study|Blood could not be drawn|0|||
156936270|NCT02641379|566526453|FG002|Overall Study|Blood could not be drawn|0|||
156936271|NCT02641379|566526454|FG003|Overall Study|Blood could not be drawn|0|||
156936272|NCT02641379|566526455|FG004|Overall Study|Blood could not be drawn|1|||
156936273|NCT02641379|566526456|FG005|Overall Study|Blood could not be drawn|0|||
156936274|NCT02641379|566526457|FG006|Overall Study|Blood could not be drawn|0|||
156936275|NCT02641379|566526458|FG007|Overall Study|Blood could not be drawn|0|||
157030879|NCT04625725|566868319|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
157030880|NCT04625725|566868320|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
157030881|NCT04625725|566868321|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
157030882|NCT04625725|566868316|FG000|Provent Main Study|INCARCERATION|3|||
157030883|NCT04625725|566868317|FG001|Provent Main Study|INCARCERATION|0|||
157030884|NCT04625725|566868318|FG002|Provent Main Study|INCARCERATION|0|||
157030885|NCT04625725|566868319|FG003|Provent Main Study|INCARCERATION|0|||
157030886|NCT04625725|566868320|FG004|Provent Main Study|INCARCERATION|0|||
157030887|NCT04625725|566868321|FG005|Provent Main Study|INCARCERATION|0|||
157030888|NCT04625725|566868316|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
157030889|NCT04625725|566868317|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
156936276|NCT02641379|566526459|FG008|Overall Study|Blood could not be drawn|0|||
156936277|NCT02641379|566526460|FG009|Overall Study|Blood could not be drawn|0|||
156936278|NCT02641379|566526461|FG010|Overall Study|Blood could not be drawn|0|||
156936279|NCT02641379|566526451|FG000|Overall Study|Protocol Violation|0|||
156936280|NCT02641379|566526452|FG001|Overall Study|Protocol Violation|0|||
156936281|NCT02641379|566526453|FG002|Overall Study|Protocol Violation|0|||
156936282|NCT02641379|566526454|FG003|Overall Study|Protocol Violation|0|||
156936283|NCT02641379|566526455|FG004|Overall Study|Protocol Violation|2|||
156936284|NCT02641379|566526456|FG005|Overall Study|Protocol Violation|0|||
156936285|NCT02641379|566526457|FG006|Overall Study|Protocol Violation|0|||
156936286|NCT02641379|566526458|FG007|Overall Study|Protocol Violation|0|||
156936287|NCT02641379|566526459|FG008|Overall Study|Protocol Violation|1|||
156936288|NCT02641379|566526460|FG009|Overall Study|Protocol Violation|0|||
156936289|NCT02641379|566526461|FG010|Overall Study|Protocol Violation|0|||
156936290|NCT02641379|566526451|FG000|Overall Study|Participation in sili rescue study|0|||
156936291|NCT02641379|566526452|FG001|Overall Study|Participation in sili rescue study|0|||
156936292|NCT02641379|566526453|FG002|Overall Study|Participation in sili rescue study|0|||
156936293|NCT02641379|566526454|FG003|Overall Study|Participation in sili rescue study|0|||
156936294|NCT02641379|566526455|FG004|Overall Study|Participation in sili rescue study|0|||
156936295|NCT02641379|566526456|FG005|Overall Study|Participation in sili rescue study|1|||
156936296|NCT02641379|566526457|FG006|Overall Study|Participation in sili rescue study|0|||
156936297|NCT02641379|566526458|FG007|Overall Study|Participation in sili rescue study|0|||
156936298|NCT02641379|566526459|FG008|Overall Study|Participation in sili rescue study|0|||
156936299|NCT02641379|566526460|FG009|Overall Study|Participation in sili rescue study|0|||
156936300|NCT02641379|566526461|FG010|Overall Study|Participation in sili rescue study|0|||
156936301|NCT02641379|566526451|FG000|Overall Study|Lost to Follow-up|0|||
156936302|NCT02641379|566526452|FG001|Overall Study|Lost to Follow-up|0|||
156936303|NCT02641379|566526453|FG002|Overall Study|Lost to Follow-up|0|||
156936304|NCT02641379|566526454|FG003|Overall Study|Lost to Follow-up|0|||
156936305|NCT02641379|566526455|FG004|Overall Study|Lost to Follow-up|0|||
156936306|NCT02641379|566526456|FG005|Overall Study|Lost to Follow-up|0|||
156936307|NCT02641379|566526457|FG006|Overall Study|Lost to Follow-up|0|||
156936308|NCT02641379|566526458|FG007|Overall Study|Lost to Follow-up|0|||
156936309|NCT02641379|566526459|FG008|Overall Study|Lost to Follow-up|1|||
156936310|NCT02641379|566526460|FG009|Overall Study|Lost to Follow-up|0|||
156936311|NCT02641379|566526461|FG010|Overall Study|Lost to Follow-up|0|||
156936312|NCT02641379|566526451|FG000|Overall Study|Source data not found|0|||
156936313|NCT02641379|566526452|FG001|Overall Study|Source data not found|0|||
156936314|NCT02641379|566526453|FG002|Overall Study|Source data not found|0|||
156936315|NCT02641379|566526454|FG003|Overall Study|Source data not found|0|||
156936316|NCT02641379|566526455|FG004|Overall Study|Source data not found|0|||
156936317|NCT02641379|566526456|FG005|Overall Study|Source data not found|1|||
156936318|NCT02641379|566526457|FG006|Overall Study|Source data not found|0|||
156936319|NCT02641379|566526458|FG007|Overall Study|Source data not found|0|||
157030890|NCT04625725|566868318|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
157030891|NCT04625725|566868319|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
157030892|NCT04625725|566868320|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
157030893|NCT04625725|566868321|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
157030894|NCT04625725|566868316|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
157030895|NCT04625725|566868317|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
157030896|NCT04625725|566868318|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
157030897|NCT04625725|566868319|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156936320|NCT02641379|566526459|FG008|Overall Study|Source data not found|0|||
156936321|NCT02641379|566526460|FG009|Overall Study|Source data not found|0|||
156936322|NCT02641379|566526461|FG010|Overall Study|Source data not found|0|||
156936323|NCT02641379|566526451|FG000|Overall Study|Participant showed weight reduction|0|||
156936324|NCT02641379|566526452|FG001|Overall Study|Participant showed weight reduction|0|||
156936325|NCT02641379|566526453|FG002|Overall Study|Participant showed weight reduction|0|||
156936326|NCT02641379|566526454|FG003|Overall Study|Participant showed weight reduction|0|||
157030898|NCT04625725|566868320|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
157030899|NCT04625725|566868321|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
156936327|NCT02641379|566526455|FG004|Overall Study|Participant showed weight reduction|0|||
156936328|NCT02641379|566526456|FG005|Overall Study|Participant showed weight reduction|0|||
156936329|NCT02641379|566526457|FG006|Overall Study|Participant showed weight reduction|0|||
156936330|NCT02641379|566526458|FG007|Overall Study|Participant showed weight reduction|1|||
156936331|NCT02641379|566526459|FG008|Overall Study|Participant showed weight reduction|0|||
156936332|NCT02641379|566526460|FG009|Overall Study|Participant showed weight reduction|0|||
156936333|NCT02641379|566526461|FG010|Overall Study|Participant showed weight reduction|0|||
156936334|NCT02641379|566526451|FG000|Overall Study|Non-response Week 12|0|||
156936335|NCT02641379|566526452|FG001|Overall Study|Non-response Week 12|0|||
156936336|NCT02641379|566526453|FG002|Overall Study|Non-response Week 12|0|||
156936337|NCT02641379|566526454|FG003|Overall Study|Non-response Week 12|0|||
156936338|NCT02641379|566526455|FG004|Overall Study|Non-response Week 12|0|||
156936339|NCT02641379|566526456|FG005|Overall Study|Non-response Week 12|0|||
156936340|NCT02641379|566526457|FG006|Overall Study|Non-response Week 12|0|||
156936341|NCT02641379|566526458|FG007|Overall Study|Non-response Week 12|1|||
156936342|NCT02641379|566526459|FG008|Overall Study|Non-response Week 12|0|||
156936343|NCT02641379|566526460|FG009|Overall Study|Non-response Week 12|0|||
156936344|NCT02641379|566526461|FG010|Overall Study|Non-response Week 12|0|||
156936345|NCT02641379|566526451|FG000|Overall Study|No 2 Log drop at Week 12|0|||
156936346|NCT02641379|566526452|FG001|Overall Study|No 2 Log drop at Week 12|0|||
156936347|NCT02641379|566526453|FG002|Overall Study|No 2 Log drop at Week 12|0|||
156936348|NCT02641379|566526454|FG003|Overall Study|No 2 Log drop at Week 12|0|||
156936349|NCT02641379|566526455|FG004|Overall Study|No 2 Log drop at Week 12|0|||
156936350|NCT02641379|566526456|FG005|Overall Study|No 2 Log drop at Week 12|0|||
156936351|NCT02641379|566526457|FG006|Overall Study|No 2 Log drop at Week 12|0|||
156936352|NCT02641379|566526458|FG007|Overall Study|No 2 Log drop at Week 12|0|||
156936353|NCT02641379|566526459|FG008|Overall Study|No 2 Log drop at Week 12|0|||
156936354|NCT02641379|566526460|FG009|Overall Study|No 2 Log drop at Week 12|0|||
156936355|NCT02641379|566526461|FG010|Overall Study|No 2 Log drop at Week 12|1|||
156936356|NCT02641379|566526451|FG000|Overall Study|Negative PCR result|0|||
156936357|NCT02641379|566526452|FG001|Overall Study|Negative PCR result|0|||
156936358|NCT02641379|566526453|FG002|Overall Study|Negative PCR result|0|||
156936359|NCT02641379|566526454|FG003|Overall Study|Negative PCR result|0|||
156936360|NCT02641379|566526455|FG004|Overall Study|Negative PCR result|0|||
156936361|NCT02641379|566526456|FG005|Overall Study|Negative PCR result|0|||
156936362|NCT02641379|566526457|FG006|Overall Study|Negative PCR result|0|||
156936363|NCT02641379|566526458|FG007|Overall Study|Negative PCR result|0|||
156936364|NCT02641379|566526459|FG008|Overall Study|Negative PCR result|0|||
156936365|NCT02641379|566526460|FG009|Overall Study|Negative PCR result|1|||
156936366|NCT02641379|566526461|FG010|Overall Study|Negative PCR result|0|||
156936367|NCT02641379|566526451|FG000|Overall Study|Participant's PCR high|0|||
156936368|NCT02641379|566526452|FG001|Overall Study|Participant's PCR high|0|||
156936369|NCT02641379|566526453|FG002|Overall Study|Participant's PCR high|0|||
156936370|NCT02641379|566526454|FG003|Overall Study|Participant's PCR high|0|||
156936371|NCT02641379|566526455|FG004|Overall Study|Participant's PCR high|0|||
156936372|NCT02641379|566526456|FG005|Overall Study|Participant's PCR high|0|||
156936373|NCT02641379|566526457|FG006|Overall Study|Participant's PCR high|0|||
156936374|NCT02641379|566526458|FG007|Overall Study|Participant's PCR high|1|||
156936375|NCT02641379|566526459|FG008|Overall Study|Participant's PCR high|0|||
156936376|NCT02641379|566526460|FG009|Overall Study|Participant's PCR high|0|||
156936377|NCT02641379|566526461|FG010|Overall Study|Participant's PCR high|0|||
156936378|NCT02641379|566526451|FG000|Overall Study|Participant treated after Week 24|0|||
156936379|NCT02641379|566526452|FG001|Overall Study|Participant treated after Week 24|0|||
156936380|NCT02641379|566526453|FG002|Overall Study|Participant treated after Week 24|0|||
156936381|NCT02641379|566526454|FG003|Overall Study|Participant treated after Week 24|0|||
156936382|NCT02641379|566526455|FG004|Overall Study|Participant treated after Week 24|0|||
156936383|NCT02641379|566526456|FG005|Overall Study|Participant treated after Week 24|0|||
156936384|NCT02641379|566526457|FG006|Overall Study|Participant treated after Week 24|0|||
156936385|NCT02641379|566526458|FG007|Overall Study|Participant treated after Week 24|0|||
156936386|NCT02641379|566526459|FG008|Overall Study|Participant treated after Week 24|1|||
156936387|NCT02641379|566526460|FG009|Overall Study|Participant treated after Week 24|0|||
156936388|NCT02641379|566526461|FG010|Overall Study|Participant treated after Week 24|0|||
156936389|NCT02641379|566526451|FG000|Overall Study|Missing PCR result at Week 8|0|||
156936390|NCT02641379|566526452|FG001|Overall Study|Missing PCR result at Week 8|0|||
156936391|NCT02641379|566526453|FG002|Overall Study|Missing PCR result at Week 8|0|||
156936392|NCT02641379|566526454|FG003|Overall Study|Missing PCR result at Week 8|0|||
156936393|NCT02641379|566526455|FG004|Overall Study|Missing PCR result at Week 8|0|||
157167120|NCT01253187|567352670|FG001|Period 3|Pregnancy|0|||
157167121|NCT01253187|567352671|FG002|Period 3|Pregnancy|0|||
157167122|NCT01253187|567352672|FG003|Period 3|Pregnancy|0|||
156936394|NCT02641379|566526456|FG005|Overall Study|Missing PCR result at Week 8|0|||
156936395|NCT02641379|566526457|FG006|Overall Study|Missing PCR result at Week 8|0|||
156936396|NCT02641379|566526458|FG007|Overall Study|Missing PCR result at Week 8|0|||
157167123|NCT01253187|567352673|FG004|Period 3|Pregnancy|0|||
156936397|NCT02641379|566526459|FG008|Overall Study|Missing PCR result at Week 8|0|||
156936398|NCT02641379|566526460|FG009|Overall Study|Missing PCR result at Week 8|1|||
156936399|NCT02641379|566526461|FG010|Overall Study|Missing PCR result at Week 8|0|||
157167124|NCT01253187|567352674|FG005|Period 3|Pregnancy|0|||
157030900|NCT04625725|566868316|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
157030901|NCT04625725|566868317|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
157030902|NCT04625725|566868318|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
157030903|NCT04625725|566868319|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
157030904|NCT04625725|566868320|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
157030905|NCT04625725|566868321|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
157030906|NCT04625725|566868316|FG000|Provent Main Study|MISSING REASON|0|||
157030907|NCT04625725|566868317|FG001|Provent Main Study|MISSING REASON|1|||
157030908|NCT04625725|566868318|FG002|Provent Main Study|MISSING REASON|0|||
157030909|NCT04625725|566868319|FG003|Provent Main Study|MISSING REASON|0|||
157030910|NCT04625725|566868320|FG004|Provent Main Study|MISSING REASON|0|||
157030911|NCT04625725|566868321|FG005|Provent Main Study|MISSING REASON|0|||
157030912|NCT04625725|566868316|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
157030913|NCT04625725|566868317|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
157030914|NCT04625725|566868318|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
157030915|NCT04625725|566868319|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
157030916|NCT04625725|566868320|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
157030917|NCT04625725|566868321|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
157030918|NCT04625725|566868316|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
157030919|NCT04625725|566868317|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
157030920|NCT04625725|566868318|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
157030921|NCT04625725|566868319|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
157030922|NCT04625725|566868320|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
157030923|NCT04625725|566868321|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
157030924|NCT04625725|566868316|FG000|Provent Sub Study|Lost to Follow-up|0|||
157030925|NCT04625725|566868317|FG001|Provent Sub Study|Lost to Follow-up|0|||
157030926|NCT04625725|566868318|FG002|Provent Sub Study|Lost to Follow-up|20|||
157030927|NCT04625725|566868319|FG003|Provent Sub Study|Lost to Follow-up|10|||
157030928|NCT04625725|566868320|FG004|Provent Sub Study|Lost to Follow-up|6|||
157030929|NCT04625725|566868321|FG005|Provent Sub Study|Lost to Follow-up|4|||
157030930|NCT04625725|566868316|FG000|Provent Sub Study|Death|0|||
157030931|NCT04625725|566868317|FG001|Provent Sub Study|Death|0|||
157030932|NCT04625725|566868318|FG002|Provent Sub Study|Death|8|||
157030933|NCT04625725|566868319|FG003|Provent Sub Study|Death|5|||
157030934|NCT04625725|566868320|FG004|Provent Sub Study|Death|0|||
157030935|NCT04625725|566868321|FG005|Provent Sub Study|Death|1|||
157030936|NCT04625725|566868316|FG000|Provent Sub Study|Adverse Event|0|||
157030937|NCT04625725|566868317|FG001|Provent Sub Study|Adverse Event|0|||
157030938|NCT04625725|566868318|FG002|Provent Sub Study|Adverse Event|0|||
157030939|NCT04625725|566868319|FG003|Provent Sub Study|Adverse Event|0|||
157030940|NCT04625725|566868320|FG004|Provent Sub Study|Adverse Event|0|||
157227108|NCT02720510|567577738|FG000|Overall Study|Study Terminated by the sponsor|2|||
157227109|NCT02720510|567577739|FG001|Overall Study|Study Terminated by the sponsor|0|||
157227110|NCT02720510|567577738|FG000|Overall Study|Adverse Event|0|||
157227111|NCT02720510|567577739|FG001|Overall Study|Adverse Event|1|||
157227112|NCT02720510|567577738|FG000|Overall Study|Physician Decision|1|||
157227113|NCT02720510|567577739|FG001|Overall Study|Physician Decision|2|||
157227114|NCT03499964|567577740|FG000|Overall Study|Lack of Efficacy|6|||
157227115|NCT03499964|567577741|FG001|Overall Study|Lack of Efficacy|26|||
157227116|NCT03499964|567577740|FG000|Overall Study|Adverse Event|1|||
157227117|NCT03499964|567577741|FG001|Overall Study|Adverse Event|0|||
157030941|NCT04625725|566868321|FG005|Provent Sub Study|Adverse Event|1|||
157030942|NCT04625725|566868316|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
157030943|NCT04625725|566868317|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
157030944|NCT04625725|566868318|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
157030945|NCT04625725|566868319|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
157030946|NCT04625725|566868320|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
157030947|NCT04625725|566868321|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
157030948|NCT04625725|566868316|FG000|Provent Sub Study|Withdrawal by Subject|0|||
157030949|NCT04625725|566868317|FG001|Provent Sub Study|Withdrawal by Subject|0|||
157030950|NCT04625725|566868318|FG002|Provent Sub Study|Withdrawal by Subject|11|||
157030951|NCT04625725|566868319|FG003|Provent Sub Study|Withdrawal by Subject|13|||
157227118|NCT03499964|567577740|FG000|Overall Study|Death|1|||
157030952|NCT04625725|566868320|FG004|Provent Sub Study|Withdrawal by Subject|5|||
157030953|NCT04625725|566868321|FG005|Provent Sub Study|Withdrawal by Subject|6|||
157030954|NCT04625725|566868316|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
157227119|NCT03499964|567577741|FG001|Overall Study|Death|0|||
157227120|NCT03499964|567577740|FG000|Overall Study|Withdrawal by Subject|2|||
157227121|NCT03499964|567577741|FG001|Overall Study|Withdrawal by Subject|1|||
157227122|NCT03499964|567577740|FG000|Overall Study|Lost to Follow-up|1|||
157227123|NCT03499964|567577741|FG001|Overall Study|Lost to Follow-up|0|||
156936400|NCT02641379|566526451|FG000|Overall Study|PCR positive|0|||
156936401|NCT02641379|566526452|FG001|Overall Study|PCR positive|0|||
156936402|NCT02641379|566526453|FG002|Overall Study|PCR positive|0|||
156936403|NCT02641379|566526454|FG003|Overall Study|PCR positive|0|||
156936404|NCT02641379|566526455|FG004|Overall Study|PCR positive|0|||
156936405|NCT02641379|566526456|FG005|Overall Study|PCR positive|0|||
156936406|NCT02641379|566526457|FG006|Overall Study|PCR positive|1|||
156936407|NCT02641379|566526458|FG007|Overall Study|PCR positive|0|||
156936408|NCT02641379|566526459|FG008|Overall Study|PCR positive|0|||
156936409|NCT02641379|566526460|FG009|Overall Study|PCR positive|0|||
156936410|NCT02641379|566526461|FG010|Overall Study|PCR positive|0|||
156936411|NCT01165138|566526462|FG000|Overall Study|Adverse Event|0|||
156936412|NCT01165138|566526463|FG001|Overall Study|Adverse Event|1|||
156936413|NCT01165138|566526464|FG002|Overall Study|Adverse Event|0|||
156936414|NCT01165138|566526465|FG003|Overall Study|Adverse Event|2|||
156936415|NCT01165138|566526462|FG000|Overall Study|Lack of Efficacy|0|||
156936416|NCT01165138|566526463|FG001|Overall Study|Lack of Efficacy|32|||
156936417|NCT01165138|566526464|FG002|Overall Study|Lack of Efficacy|6|||
156936418|NCT01165138|566526465|FG003|Overall Study|Lack of Efficacy|7|||
156936419|NCT01165138|566526462|FG000|Overall Study|Protocol Violation|0|||
156936420|NCT01165138|566526463|FG001|Overall Study|Protocol Violation|7|||
156936421|NCT01165138|566526464|FG002|Overall Study|Protocol Violation|0|||
156936422|NCT01165138|566526465|FG003|Overall Study|Protocol Violation|2|||
156936423|NCT01165138|566526462|FG000|Overall Study|Lost to Follow-up|0|||
156936424|NCT01165138|566526463|FG001|Overall Study|Lost to Follow-up|0|||
156936425|NCT01165138|566526464|FG002|Overall Study|Lost to Follow-up|1|||
156936426|NCT01165138|566526465|FG003|Overall Study|Lost to Follow-up|2|||
156936427|NCT01165138|566526462|FG000|Overall Study|Physician Decision|0|||
156936428|NCT01165138|566526463|FG001|Overall Study|Physician Decision|6|||
156936429|NCT01165138|566526464|FG002|Overall Study|Physician Decision|7|||
156936430|NCT01165138|566526465|FG003|Overall Study|Physician Decision|6|||
156936431|NCT01165138|566526462|FG000|Overall Study|Withdrawal by Subject|0|||
156936432|NCT01165138|566526463|FG001|Overall Study|Withdrawal by Subject|6|||
156936433|NCT01165138|566526464|FG002|Overall Study|Withdrawal by Subject|6|||
156936434|NCT01165138|566526465|FG003|Overall Study|Withdrawal by Subject|3|||
156936435|NCT01398956|566526466|FG000|Overall Study|Withdrawal by Subject|4|||
156936436|NCT01398956|566526466|FG000|Overall Study|AE, non-serious non-fatal|4|||
156936437|NCT01398956|566526466|FG000|Overall Study|Withdrawal Criteria No.3|1|||
156936438|NCT01398956|566526466|FG000|Overall Study|Subject moved a long distance|1|||
156936439|NCT00962104|566526469|FG000|Overall Study|Adverse Event|10|||
156936440|NCT00962104|566526470|FG001|Overall Study|Adverse Event|3|||
156936441|NCT00962104|566526469|FG000|Overall Study|Entry Criteria Not Met|1|||
156936442|NCT00962104|566526470|FG001|Overall Study|Entry Criteria Not Met|2|||
156936443|NCT00962104|566526469|FG000|Overall Study|Lack of Efficacy|0|||
156936444|NCT00962104|566526470|FG001|Overall Study|Lack of Efficacy|1|||
156936445|NCT00962104|566526469|FG000|Overall Study|Lost to Follow-up|10|||
156936446|NCT00962104|566526470|FG001|Overall Study|Lost to Follow-up|4|||
156936447|NCT00962104|566526469|FG000|Overall Study|Physician Decision|1|||
156936448|NCT00962104|566526470|FG001|Overall Study|Physician Decision|0|||
156936449|NCT00962104|566526469|FG000|Overall Study|Protocol Violation|6|||
156936450|NCT00962104|566526470|FG001|Overall Study|Protocol Violation|8|||
156936451|NCT00962104|566526469|FG000|Overall Study|Sponsor Decision|0|||
156936452|NCT00962104|566526470|FG001|Overall Study|Sponsor Decision|1|||
156936453|NCT00962104|566526469|FG000|Overall Study|Withdrawal by Subject|10|||
156936454|NCT00962104|566526470|FG001|Overall Study|Withdrawal by Subject|6|||
156936455|NCT00962104|566526469|FG000|Overall Study|Other|2|||
156936456|NCT00962104|566526470|FG001|Overall Study|Other|0|||
156936457|NCT03274986|566526473|FG000|Overall Study|Withdrawal by Subject|0|||
156936458|NCT03274986|566526474|FG001|Overall Study|Withdrawal by Subject|1|||
156936459|NCT03274986|566526473|FG000|Overall Study|Lost to Follow-up|0|||
157167125|NCT01253187|567352669|FG000|Period 3|difficulty with blood sampling|0|||
157167126|NCT01253187|567352670|FG001|Period 3|difficulty with blood sampling|1|||
157167127|NCT01253187|567352671|FG002|Period 3|difficulty with blood sampling|0|||
156936460|NCT03274986|566526474|FG001|Overall Study|Lost to Follow-up|1|||
156936461|NCT00603746|566526475|FG000|Overall Study|Adverse Event|2|||
156936462|NCT00603746|566526476|FG001|Overall Study|Adverse Event|3|||
156936463|NCT00603746|566526477|FG002|Overall Study|Adverse Event|0|||
157167128|NCT01253187|567352672|FG003|Period 3|difficulty with blood sampling|0|||
156936464|NCT00603746|566526478|FG003|Overall Study|Adverse Event|1|||
156936465|NCT00603746|566526479|FG004|Overall Study|Adverse Event|0|||
156936466|NCT00603746|566526480|FG005|Overall Study|Adverse Event|4|||
157167129|NCT01253187|567352673|FG004|Period 3|difficulty with blood sampling|0|||
156936467|NCT00603746|566526475|FG000|Overall Study|Lack of Efficacy|34|||
156936468|NCT00603746|566526476|FG001|Overall Study|Lack of Efficacy|11|||
156936469|NCT00603746|566526477|FG002|Overall Study|Lack of Efficacy|6|||
156936470|NCT00603746|566526478|FG003|Overall Study|Lack of Efficacy|11|||
156936471|NCT00603746|566526479|FG004|Overall Study|Lack of Efficacy|12|||
156936472|NCT00603746|566526480|FG005|Overall Study|Lack of Efficacy|8|||
156936473|NCT00603746|566526475|FG000|Overall Study|Protocol Violation|0|||
156936474|NCT00603746|566526476|FG001|Overall Study|Protocol Violation|3|||
157030955|NCT04625725|566868317|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
157030956|NCT04625725|566868318|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
157030957|NCT04625725|566868319|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
157030958|NCT04625725|566868320|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
157030959|NCT04625725|566868321|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
157030960|NCT05565820|566868334|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
157030961|NCT05565820|566868335|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
157030962|NCT05565820|566868334|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
157030963|NCT05565820|566868335|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
157030964|NCT04871529|566868337|FG000|Overall Study|Withdrawal by Subject|0|||
157030965|NCT04871529|566868338|FG001|Overall Study|Withdrawal by Subject|1|||
157030966|NCT04871529|566868337|FG000|Overall Study|Death|0|||
157030967|NCT04871529|566868338|FG001|Overall Study|Death|1|||
157030968|NCT04871529|566868337|FG000|Overall Study|Not protocol specified|0|||
157030969|NCT04871529|566868338|FG001|Overall Study|Not protocol specified|1|||
157030970|NCT05184452|566868339|FG000|Overall Study|Lost to Follow-up|0|||
157030971|NCT05184452|566868340|FG001|Overall Study|Lost to Follow-up|0|||
157030972|NCT05184452|566868341|FG002|Overall Study|Lost to Follow-up|0|||
157030973|NCT05184452|566868342|FG003|Overall Study|Lost to Follow-up|0|||
157030974|NCT05184452|566868343|FG004|Overall Study|Lost to Follow-up|0|||
157030975|NCT05184452|566868344|FG005|Overall Study|Lost to Follow-up|2|||
157030976|NCT05184452|566868345|FG006|Overall Study|Lost to Follow-up|0|||
157030977|NCT05184452|566868346|FG007|Overall Study|Lost to Follow-up|0|||
157030978|NCT05184452|566868347|FG008|Overall Study|Lost to Follow-up|0|||
157030979|NCT05184452|566868348|FG009|Overall Study|Lost to Follow-up|1|||
157030980|NCT05184452|566868339|FG000|Overall Study|Withdrawal by Subject|0|||
157030981|NCT05184452|566868340|FG001|Overall Study|Withdrawal by Subject|0|||
157030982|NCT05184452|566868341|FG002|Overall Study|Withdrawal by Subject|0|||
157030983|NCT05184452|566868342|FG003|Overall Study|Withdrawal by Subject|0|||
157030984|NCT05184452|566868343|FG004|Overall Study|Withdrawal by Subject|0|||
157030985|NCT05184452|566868344|FG005|Overall Study|Withdrawal by Subject|1|||
157030986|NCT05184452|566868345|FG006|Overall Study|Withdrawal by Subject|0|||
157030987|NCT05184452|566868346|FG007|Overall Study|Withdrawal by Subject|0|||
157030988|NCT05184452|566868347|FG008|Overall Study|Withdrawal by Subject|0|||
157030989|NCT05184452|566868348|FG009|Overall Study|Withdrawal by Subject|1|||
157030990|NCT05586490|566868349|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
157030991|NCT05586490|566868350|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
157030992|NCT05586490|566868351|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
157030993|NCT05586490|566868352|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
157030994|NCT05586490|566868353|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
157030995|NCT05586490|566868349|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
157030996|NCT05586490|566868350|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
157030997|NCT05586490|566868351|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
157030998|NCT05586490|566868352|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
157030999|NCT05586490|566868353|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
157031000|NCT05586490|566868349|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
157031001|NCT05586490|566868350|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
157031002|NCT05586490|566868351|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
157031003|NCT05586490|566868352|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
157031004|NCT05586490|566868353|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
157031005|NCT05873556|566868354|FG000|Overall Study|Lost to Follow-up|4|||
157031006|NCT05873556|566868355|FG001|Overall Study|Lost to Follow-up|1|||
157031007|NCT03606408|566868357|FG000|Overall Study|Adverse Event|13|||
157031008|NCT03606408|566868357|FG000|Overall Study|Withdrawal by Subject|7|||
157031009|NCT03606408|566868357|FG000|Overall Study|Physician Decision|4|||
157031010|NCT03606408|566868357|FG000|Overall Study|Lack of Efficacy|2|||
157031011|NCT03606408|566868357|FG000|Overall Study|Death|1|||
157031012|NCT03606408|566868357|FG000|Overall Study|new therapy for study indication|1|||
157031013|NCT04689256|566868358|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
157031014|NCT04689256|566868359|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
157031015|NCT05828017|566868365|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
157031016|NCT05012163|566868369|FG000|Overall Study|Protocol Violation|0|||
157031017|NCT05012163|566868370|FG001|Overall Study|Protocol Violation|0|||
157031018|NCT05012163|566868371|FG002|Overall Study|Protocol Violation|1|||
157031019|NCT05012163|566868372|FG003|Overall Study|Protocol Violation|1|||
157031020|NCT04599634|566868383|FG000|Overall Study|Dose limiting toxicity|0|||
157031021|NCT04599634|566868384|FG001|Overall Study|Dose limiting toxicity|0|||
157031022|NCT04599634|566868385|FG002|Overall Study|Dose limiting toxicity|2|||
157031023|NCT04599634|566868386|FG003|Overall Study|Dose limiting toxicity|0|||
157031024|NCT03733925|566868389|FG000|Overall Study|Lost to Follow-up|1|||
157031025|NCT03733925|566868389|FG000|Overall Study|Withdrawal by Subject|2|||
156936475|NCT00603746|566526477|FG002|Overall Study|Protocol Violation|1|||
156936476|NCT00603746|566526478|FG003|Overall Study|Protocol Violation|0|||
156936477|NCT00603746|566526479|FG004|Overall Study|Protocol Violation|1|||
156936478|NCT00603746|566526480|FG005|Overall Study|Protocol Violation|0|||
156936479|NCT00603746|566526475|FG000|Overall Study|Lost to Follow-up|0|||
156936480|NCT00603746|566526476|FG001|Overall Study|Lost to Follow-up|1|||
156936481|NCT00603746|566526477|FG002|Overall Study|Lost to Follow-up|1|||
156936482|NCT00603746|566526478|FG003|Overall Study|Lost to Follow-up|0|||
156936483|NCT00603746|566526479|FG004|Overall Study|Lost to Follow-up|0|||
156936484|NCT00603746|566526480|FG005|Overall Study|Lost to Follow-up|0|||
156936485|NCT00603746|566526475|FG000|Overall Study|Physician Decision|1|||
156936486|NCT00603746|566526476|FG001|Overall Study|Physician Decision|0|||
156936487|NCT00603746|566526477|FG002|Overall Study|Physician Decision|0|||
156936488|NCT00603746|566526478|FG003|Overall Study|Physician Decision|0|||
156936489|NCT00603746|566526479|FG004|Overall Study|Physician Decision|1|||
156936490|NCT00603746|566526480|FG005|Overall Study|Physician Decision|0|||
156936491|NCT00603746|566526475|FG000|Overall Study|Withdrawal by Subject|1|||
156936492|NCT00603746|566526476|FG001|Overall Study|Withdrawal by Subject|0|||
156936493|NCT00603746|566526477|FG002|Overall Study|Withdrawal by Subject|0|||
156936494|NCT00603746|566526478|FG003|Overall Study|Withdrawal by Subject|1|||
156936495|NCT00603746|566526479|FG004|Overall Study|Withdrawal by Subject|3|||
156936496|NCT00603746|566526480|FG005|Overall Study|Withdrawal by Subject|1|||
156936497|NCT03323658|566526481|FG000|Overall Study|Adverse Event|0|||
156936498|NCT03323658|566526482|FG001|Overall Study|Adverse Event|1|||
156936499|NCT03323658|566526483|FG002|Overall Study|Adverse Event|0|||
156936500|NCT03913091|566526484|FG000|Overall Study|Lost to Follow-up|18|||
156936501|NCT03913091|566526485|FG001|Overall Study|Lost to Follow-up|11|||
156936502|NCT03913091|566526484|FG000|Overall Study|Required additional meds/surgery|1|||
156936503|NCT03913091|566526485|FG001|Overall Study|Required additional meds/surgery|2|||
156936504|NCT03913091|566526484|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
156936505|NCT03913091|566526485|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
156936506|NCT00969553|566526486|FG000|Overall Study|Progressive disease (PD)|2|||
156936507|NCT00969553|566526487|FG001|Overall Study|Progressive disease (PD)|2|||
156936508|NCT00969553|566526488|FG002|Overall Study|Progressive disease (PD)|6|||
156936509|NCT00969553|566526489|FG003|Overall Study|Progressive disease (PD)|9|||
156936510|NCT00969553|566526490|FG004|Overall Study|Progressive disease (PD)|2|||
156936511|NCT00969553|566526491|FG005|Overall Study|Progressive disease (PD)|4|||
156936512|NCT00969553|566526492|FG006|Overall Study|Progressive disease (PD)|2|||
156936513|NCT00969553|566526493|FG007|Overall Study|Progressive disease (PD)|12|||
156936514|NCT00969553|566526494|FG008|Overall Study|Progressive disease (PD)|3|||
156936515|NCT00969553|566526486|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936516|NCT00969553|566526487|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936517|NCT00969553|566526488|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936518|NCT00969553|566526489|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936519|NCT00969553|566526490|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
156936520|NCT00969553|566526491|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936521|NCT00969553|566526492|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936522|NCT00969553|566526493|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936523|NCT00969553|566526494|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
156936524|NCT00969553|566526486|FG000|Overall Study|Other Adverse Event|0|||
156936525|NCT00969553|566526487|FG001|Overall Study|Other Adverse Event|0|||
156936526|NCT00969553|566526488|FG002|Overall Study|Other Adverse Event|0|||
156936527|NCT00969553|566526489|FG003|Overall Study|Other Adverse Event|1|||
156936528|NCT00969553|566526490|FG004|Overall Study|Other Adverse Event|0|||
156936529|NCT00969553|566526491|FG005|Overall Study|Other Adverse Event|0|||
156936530|NCT00969553|566526492|FG006|Overall Study|Other Adverse Event|1|||
156936531|NCT00969553|566526493|FG007|Overall Study|Other Adverse Event|0|||
156936532|NCT00969553|566526494|FG008|Overall Study|Other Adverse Event|0|||
156936533|NCT00969553|566526486|FG000|Overall Study|Refused cont. medication|1|||
156936534|NCT00969553|566526487|FG001|Overall Study|Refused cont. medication|1|||
156936535|NCT00969553|566526488|FG002|Overall Study|Refused cont. medication|0|||
156936536|NCT00969553|566526489|FG003|Overall Study|Refused cont. medication|2|||
156936537|NCT00969553|566526490|FG004|Overall Study|Refused cont. medication|0|||
156936538|NCT00969553|566526491|FG005|Overall Study|Refused cont. medication|0|||
157031026|NCT03733925|566868389|FG000|Overall Study|Adverse Event|2|||
156936539|NCT00969553|566526492|FG006|Overall Study|Refused cont. medication|0|||
156936540|NCT00969553|566526493|FG007|Overall Study|Refused cont. medication|1|||
156936541|NCT00969553|566526494|FG008|Overall Study|Refused cont. medication|0|||
156936542|NCT00969553|566526486|FG000|Overall Study|Not specified above|0|||
156936543|NCT00969553|566526487|FG001|Overall Study|Not specified above|0|||
156936544|NCT00969553|566526488|FG002|Overall Study|Not specified above|0|||
156936545|NCT00969553|566526489|FG003|Overall Study|Not specified above|4|||
156936546|NCT00969553|566526490|FG004|Overall Study|Not specified above|0|||
156936547|NCT00969553|566526491|FG005|Overall Study|Not specified above|0|||
156936548|NCT00969553|566526492|FG006|Overall Study|Not specified above|1|||
156936549|NCT00969553|566526493|FG007|Overall Study|Not specified above|1|||
156936550|NCT00969553|566526494|FG008|Overall Study|Not specified above|0|||
156936551|NCT00615056|566526495|FG000|Overall Study|Death|31|||
156936552|NCT00615056|566526496|FG001|Overall Study|Death|31|||
156936553|NCT00615056|566526497|FG002|Overall Study|Death|21|||
156936554|NCT00615056|566526498|FG003|Overall Study|Death|23|||
156936555|NCT00615056|566526495|FG000|Overall Study|Lost to Follow-up|1|||
156936556|NCT00615056|566526496|FG001|Overall Study|Lost to Follow-up|2|||
156936557|NCT00615056|566526497|FG002|Overall Study|Lost to Follow-up|4|||
156936558|NCT00615056|566526498|FG003|Overall Study|Lost to Follow-up|5|||
156936559|NCT00615056|566526495|FG000|Overall Study|Other|13|||
156936560|NCT00615056|566526496|FG001|Overall Study|Other|15|||
156936561|NCT00615056|566526497|FG002|Overall Study|Other|10|||
156936562|NCT00615056|566526498|FG003|Overall Study|Other|7|||
156936563|NCT00615056|566526495|FG000|Overall Study|Objective progression or relapse|0|||
156936564|NCT00615056|566526496|FG001|Overall Study|Objective progression or relapse|2|||
156936565|NCT00615056|566526497|FG002|Overall Study|Objective progression or relapse|0|||
156936566|NCT00615056|566526498|FG003|Overall Study|Objective progression or relapse|0|||
156936567|NCT00615056|566526495|FG000|Overall Study|Withdrawal by Subject|0|||
156936568|NCT00615056|566526496|FG001|Overall Study|Withdrawal by Subject|1|||
156936569|NCT00615056|566526497|FG002|Overall Study|Withdrawal by Subject|1|||
156936570|NCT00615056|566526498|FG003|Overall Study|Withdrawal by Subject|0|||
156936571|NCT00615056|566526495|FG000|Overall Study|Discontinued by Sponsor|1|||
156936572|NCT00615056|566526496|FG001|Overall Study|Discontinued by Sponsor|0|||
156936573|NCT00615056|566526497|FG002|Overall Study|Discontinued by Sponsor|0|||
156936574|NCT00615056|566526498|FG003|Overall Study|Discontinued by Sponsor|0|||
156936575|NCT00615056|566526495|FG000|Overall Study|Randomized but not treated|3|||
156936576|NCT00615056|566526496|FG001|Overall Study|Randomized but not treated|0|||
156936577|NCT00615056|566526497|FG002|Overall Study|Randomized but not treated|0|||
156936578|NCT00615056|566526498|FG003|Overall Study|Randomized but not treated|0|||
156936579|NCT02196324|566526502|FG000|Overall Study|Withdrawal by Subject|8|||
156936580|NCT02196324|566526503|FG001|Overall Study|Withdrawal by Subject|4|||
156936581|NCT02196324|566526502|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
156936582|NCT02196324|566526503|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
156936583|NCT02196324|566526502|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
156936584|NCT02196324|566526503|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
156936585|NCT02196324|566526502|FG000|Overall Study|Other|1|||
156936586|NCT02196324|566526503|FG001|Overall Study|Other|0|||
156936587|NCT01380184|566526504|FG000|Part 1 (19 Days)|Adverse Event|1|||
156936588|NCT01380184|566526504|FG000|Part 2|Adverse Event|5|||
156936589|NCT01380184|566526504|FG000|Part 2|Disease Progression|8|||
156936590|NCT01380184|566526504|FG000|Part 2|Lost to Follow-up|1|||
156936591|NCT04248816|566526508|FG000|Overall Study|Ineligible post-randomization|7|||
156936592|NCT04248816|566526509|FG001|Overall Study|Ineligible post-randomization|21|||
156936593|NCT04248816|566526510|FG002|Overall Study|Ineligible post-randomization|25|||
156936594|NCT03350503|566526513|FG000|Overall Study|Adverse Event|5|||
156936595|NCT03350503|566526513|FG000|Overall Study|Withdrawal by Subject|5|||
156936596|NCT03350503|566526513|FG000|Overall Study|Continuation impossible due to move|4|||
156936597|NCT03350503|566526513|FG000|Overall Study|Physician Decision|3|||
156936598|NCT03829046|566526519|FG000|Overall Study|Withdrawal by Subject|1|||
156936599|NCT03829046|566526520|FG001|Overall Study|Withdrawal by Subject|0|||
156936600|NCT00262067|566526521|FG000|Overall Study|Death|190|||
156936601|NCT00262067|566526522|FG001|Overall Study|Death|89|||
156936602|NCT00262067|566526523|FG002|Overall Study|Death|186|||
156936603|NCT00262067|566526524|FG003|Overall Study|Death|99|||
156936604|NCT00262067|566526521|FG000|Overall Study|Lost to Follow-up|5|||
156936605|NCT00262067|566526522|FG001|Overall Study|Lost to Follow-up|4|||
156936606|NCT00262067|566526523|FG002|Overall Study|Lost to Follow-up|7|||
156936607|NCT00262067|566526524|FG003|Overall Study|Lost to Follow-up|5|||
156936608|NCT00262067|566526521|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
156936609|NCT00262067|566526522|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
156936610|NCT00262067|566526523|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
156936611|NCT00262067|566526524|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
156936612|NCT00262067|566526521|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
156936613|NCT00262067|566526522|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
156936614|NCT00262067|566526523|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
156936615|NCT00262067|566526524|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
156936616|NCT01399593|566526526|FG000|Overall Study|Physician Decision|1|||
156936617|NCT01399593|566526527|FG001|Overall Study|Physician Decision|0|||
156936618|NCT01399593|566526526|FG000|Overall Study|Adverse Event|1|||
156936619|NCT01399593|566526527|FG001|Overall Study|Adverse Event|0|||
156936620|NCT01399593|566526526|FG000|Overall Study|Death|1|||
156936621|NCT01399593|566526527|FG001|Overall Study|Death|1|||
156936622|NCT01399593|566526526|FG000|Overall Study|Transplantectomy|0|||
156936623|NCT01399593|566526527|FG001|Overall Study|Transplantectomy|1|||
156936624|NCT01581593|566528666|FG000|Overall Study|Withdrawal by Subject|1|||
156936625|NCT05308901|566528669|FG000|Overall Study|Death|6|||
156936626|NCT00697346|566528671|FG000|Overall Study|Adverse Event|4|||
156936627|NCT00697346|566528672|FG001|Overall Study|Adverse Event|5|||
156936628|NCT00697346|566528673|FG002|Overall Study|Adverse Event|0|||
156936629|NCT00697346|566528671|FG000|Overall Study|Progressive Disease|19|||
156936630|NCT00697346|566528672|FG001|Overall Study|Progressive Disease|18|||
156936631|NCT00697346|566528673|FG002|Overall Study|Progressive Disease|0|||
156936632|NCT00697346|566528671|FG000|Overall Study|Symptomatic Deterioration|0|||
156936633|NCT00697346|566528672|FG001|Overall Study|Symptomatic Deterioration|1|||
156936634|NCT00697346|566528673|FG002|Overall Study|Symptomatic Deterioration|0|||
156936635|NCT00697346|566528671|FG000|Overall Study|Withdrawal by Subject|2|||
156936636|NCT00697346|566528672|FG001|Overall Study|Withdrawal by Subject|2|||
156936637|NCT00697346|566528673|FG002|Overall Study|Withdrawal by Subject|0|||
156936638|NCT00697346|566528671|FG000|Overall Study|Reason not Specified|3|||
156936639|NCT00697346|566528672|FG001|Overall Study|Reason not Specified|0|||
156936640|NCT00697346|566528673|FG002|Overall Study|Reason not Specified|1|||
156936641|NCT03569371|566528674|FG000|Overall Study|Lack of Efficacy|1|||
156936642|NCT03569371|566528674|FG000|Overall Study|Lost to Follow-up|1|||
156936643|NCT03569371|566528674|FG000|Overall Study|Adverse Event|1|||
156936644|NCT03643562|566528675|FG000|Overall Study|Adverse Event|1|||
156936645|NCT03643562|566528676|FG001|Overall Study|Adverse Event|0|||
156936646|NCT03643562|566528675|FG000|Overall Study|Lack of Efficacy|0|||
156936647|NCT03643562|566528676|FG001|Overall Study|Lack of Efficacy|1|||
156936648|NCT03643562|566528675|FG000|Overall Study|Physician Decision|0|||
156936649|NCT03643562|566528676|FG001|Overall Study|Physician Decision|1|||
156936650|NCT03643562|566528675|FG000|Overall Study|Study Terminated by Sponsor|2|||
156936651|NCT03643562|566528676|FG001|Overall Study|Study Terminated by Sponsor|10|||
156936652|NCT03643562|566528675|FG000|Overall Study|Withdrawal by Subject|2|||
156936653|NCT03643562|566528676|FG001|Overall Study|Withdrawal by Subject|2|||
156936654|NCT03643562|566528675|FG000|Overall Study|Other than specified|3|||
156936655|NCT03643562|566528676|FG001|Overall Study|Other than specified|2|||
156936656|NCT04145895|566528677|FG000|Overall Study|Physician Decision|2|||
156936657|NCT04145895|566528678|FG001|Overall Study|Physician Decision|0|||
156936658|NCT04145895|566528677|FG000|Overall Study|Withdrawal by Subject|0|||
156936659|NCT04145895|566528678|FG001|Overall Study|Withdrawal by Subject|2|||
156936660|NCT01236755|566528679|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
156936661|NCT01236755|566528679|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
156936662|NCT01236755|566528679|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
156936663|NCT01236755|566528679|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
156936664|NCT03848845|566528680|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156936665|NCT03848845|566528681|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
156936666|NCT03848845|566528682|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156936667|NCT03848845|566528683|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
156936668|NCT03848845|566528680|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156936669|NCT03848845|566528681|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156936670|NCT03848845|566528682|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
156936671|NCT03848845|566528683|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
156936672|NCT03848845|566528680|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
156936673|NCT03848845|566528681|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
156936674|NCT03848845|566528682|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
156936675|NCT03848845|566528683|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
156936676|NCT03848845|566528680|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156936677|NCT03848845|566528681|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156936678|NCT03848845|566528682|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
156936679|NCT03848845|566528683|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
156936680|NCT02433834|566528685|FG000|Overall Study|Protocol-specified criteria|7|||
156936681|NCT02433834|566528685|FG000|Overall Study|Protocol Violation|3|||
156936682|NCT02433834|566528685|FG000|Overall Study|Lost to Follow-up|6|||
156936683|NCT02433834|566528685|FG000|Overall Study|Withdrawal by Subject|14|||
156936684|NCT02433834|566528685|FG000|Overall Study|Adverse Event|6|||
156936685|NCT02433834|566528685|FG000|Overall Study|Physician Decision|1|||
156936686|NCT03325166|566528688|FG000|Overall Study|Adverse Event|1|||
156936687|NCT00706966|566528690|FG000|Overall Study|Adverse Event|1|||
156936688|NCT01631474|566528695|FG000|Overall Study|Lost to Follow-up|8|||
156936689|NCT01631474|566528696|FG001|Overall Study|Lost to Follow-up|5|||
157031027|NCT03733925|566868389|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157227124|NCT01047345|567577742|FG000|Base Study|Adverse Event|3|||
157031028|NCT02224144|566868394|FG000|Overall Study|Lost to Follow-up|3|||
156936690|NCT01631474|566528697|FG002|Overall Study|Lost to Follow-up|7|||
156936691|NCT01631474|566528698|FG003|Overall Study|Lost to Follow-up|5|||
156936692|NCT01631474|566528699|FG004|Overall Study|Lost to Follow-up|5|||
156936693|NCT01631474|566528695|FG000|Overall Study|Withdrawal by Subject|4|||
156936694|NCT01631474|566528696|FG001|Overall Study|Withdrawal by Subject|4|||
156936695|NCT01631474|566528697|FG002|Overall Study|Withdrawal by Subject|2|||
156936696|NCT01631474|566528698|FG003|Overall Study|Withdrawal by Subject|6|||
156936697|NCT01631474|566528699|FG004|Overall Study|Withdrawal by Subject|5|||
156936698|NCT01631474|566528695|FG000|Overall Study|Lack of Efficacy|2|||
156936699|NCT01631474|566528696|FG001|Overall Study|Lack of Efficacy|2|||
156936700|NCT01631474|566528697|FG002|Overall Study|Lack of Efficacy|0|||
156936701|NCT01631474|566528698|FG003|Overall Study|Lack of Efficacy|0|||
156936702|NCT01631474|566528699|FG004|Overall Study|Lack of Efficacy|2|||
156936703|NCT01631474|566528695|FG000|Overall Study|Noncompliance with Study Drug|0|||
156936704|NCT01631474|566528696|FG001|Overall Study|Noncompliance with Study Drug|0|||
156936705|NCT01631474|566528697|FG002|Overall Study|Noncompliance with Study Drug|0|||
156936706|NCT01631474|566528698|FG003|Overall Study|Noncompliance with Study Drug|0|||
156936707|NCT01631474|566528699|FG004|Overall Study|Noncompliance with Study Drug|1|||
156936708|NCT01631474|566528695|FG000|Overall Study|Adverse Event|0|||
156936709|NCT01631474|566528696|FG001|Overall Study|Adverse Event|1|||
156936710|NCT01631474|566528697|FG002|Overall Study|Adverse Event|0|||
156936711|NCT01631474|566528698|FG003|Overall Study|Adverse Event|0|||
156936712|NCT01631474|566528699|FG004|Overall Study|Adverse Event|0|||
156936713|NCT01467076|566528700|FG000|Overall Study|Lost to Follow-up|1|||
156936714|NCT01467076|566528701|FG001|Overall Study|Lost to Follow-up|0|||
156936715|NCT01467076|566528702|FG002|Overall Study|Lost to Follow-up|0|||
156936716|NCT03354429|566528703|FG000|Overall Study|Withdrawal by Subject|8|||
156936717|NCT03354429|566528704|FG001|Overall Study|Withdrawal by Subject|7|||
156936718|NCT03354429|566528703|FG000|Overall Study|Lost to Follow-up|1|||
156936719|NCT03354429|566528704|FG001|Overall Study|Lost to Follow-up|0|||
156936720|NCT00654381|566528705|FG000|1st Stage|Adverse Event|3|||
156936721|NCT00654381|566528706|FG001|1st Stage|Adverse Event|3|||
156936722|NCT00654381|566528707|FG002|1st Stage|Adverse Event|3|||
156936723|NCT00654381|566528708|FG003|1st Stage|Adverse Event|3|||
156936724|NCT00654381|566528709|FG004|1st Stage|Adverse Event|2|||
156936725|NCT00654381|566528710|FG005|1st Stage|Adverse Event|1|||
156936726|NCT00654381|566528705|FG000|1st Stage|Withdrawal by Subject|0|||
156936727|NCT00654381|566528706|FG001|1st Stage|Withdrawal by Subject|0|||
156936728|NCT00654381|566528707|FG002|1st Stage|Withdrawal by Subject|0|||
156936729|NCT00654381|566528708|FG003|1st Stage|Withdrawal by Subject|1|||
156936730|NCT00654381|566528709|FG004|1st Stage|Withdrawal by Subject|0|||
156936731|NCT00654381|566528710|FG005|1st Stage|Withdrawal by Subject|1|||
156936732|NCT00654381|566528705|FG000|1st Stage|Investigator's decision|0|||
156936733|NCT00654381|566528706|FG001|1st Stage|Investigator's decision|0|||
156936734|NCT00654381|566528707|FG002|1st Stage|Investigator's decision|0|||
156936735|NCT00654381|566528708|FG003|1st Stage|Investigator's decision|1|||
156936736|NCT00654381|566528709|FG004|1st Stage|Investigator's decision|0|||
156936737|NCT00654381|566528710|FG005|1st Stage|Investigator's decision|0|||
156936738|NCT00654381|566528705|FG000|2nd Stage|Adverse Event|2|||
156936739|NCT00654381|566528706|FG001|2nd Stage|Adverse Event|0|||
156936740|NCT00654381|566528707|FG002|2nd Stage|Adverse Event|2|||
156936741|NCT00654381|566528708|FG003|2nd Stage|Adverse Event|3|||
156936742|NCT00654381|566528709|FG004|2nd Stage|Adverse Event|7|||
156936743|NCT00654381|566528710|FG005|2nd Stage|Adverse Event|2|||
156936744|NCT00654381|566528705|FG000|2nd Stage|Withdrawal by Subject|0|||
156936745|NCT00654381|566528706|FG001|2nd Stage|Withdrawal by Subject|0|||
156936746|NCT00654381|566528707|FG002|2nd Stage|Withdrawal by Subject|0|||
156936747|NCT00654381|566528708|FG003|2nd Stage|Withdrawal by Subject|0|||
156936748|NCT00654381|566528709|FG004|2nd Stage|Withdrawal by Subject|1|||
156936749|NCT00654381|566528710|FG005|2nd Stage|Withdrawal by Subject|1|||
156936750|NCT00654381|566528705|FG000|2nd Stage|Investigator's decision|0|||
156936751|NCT00654381|566528706|FG001|2nd Stage|Investigator's decision|0|||
156936752|NCT00654381|566528707|FG002|2nd Stage|Investigator's decision|1|||
156936753|NCT00654381|566528708|FG003|2nd Stage|Investigator's decision|1|||
156936754|NCT00654381|566528709|FG004|2nd Stage|Investigator's decision|0|||
156936755|NCT00654381|566528710|FG005|2nd Stage|Investigator's decision|0|||
156936756|NCT00654381|566528705|FG000|Extension Stage|Adverse Event|1|||
156936757|NCT00654381|566528706|FG001|Extension Stage|Adverse Event|2|||
156936758|NCT00654381|566528707|FG002|Extension Stage|Adverse Event|9|||
156936759|NCT00654381|566528708|FG003|Extension Stage|Adverse Event|7|||
156936760|NCT00654381|566528709|FG004|Extension Stage|Adverse Event|1|||
156936761|NCT00654381|566528710|FG005|Extension Stage|Adverse Event|1|||
156936762|NCT00654381|566528705|FG000|Extension Stage|Protocol Violation|0|||
156936763|NCT00654381|566528706|FG001|Extension Stage|Protocol Violation|0|||
156936764|NCT00654381|566528707|FG002|Extension Stage|Protocol Violation|0|||
156936765|NCT00654381|566528708|FG003|Extension Stage|Protocol Violation|1|||
156936766|NCT00654381|566528709|FG004|Extension Stage|Protocol Violation|0|||
156936767|NCT00654381|566528710|FG005|Extension Stage|Protocol Violation|0|||
156936768|NCT00654381|566528705|FG000|Extension Stage|Lack of Efficacy|0|||
156936769|NCT00654381|566528706|FG001|Extension Stage|Lack of Efficacy|0|||
156936770|NCT00654381|566528707|FG002|Extension Stage|Lack of Efficacy|1|||
156936771|NCT00654381|566528708|FG003|Extension Stage|Lack of Efficacy|0|||
156936772|NCT00654381|566528709|FG004|Extension Stage|Lack of Efficacy|0|||
156936773|NCT00654381|566528710|FG005|Extension Stage|Lack of Efficacy|0|||
156936774|NCT00654381|566528705|FG000|Extension Stage|Withdrawal by Subject|0|||
156936775|NCT00654381|566528706|FG001|Extension Stage|Withdrawal by Subject|0|||
156936776|NCT00654381|566528707|FG002|Extension Stage|Withdrawal by Subject|1|||
156936777|NCT00654381|566528708|FG003|Extension Stage|Withdrawal by Subject|1|||
156936778|NCT00654381|566528709|FG004|Extension Stage|Withdrawal by Subject|1|||
157167130|NCT01253187|567352674|FG005|Period 3|difficulty with blood sampling|0|||
156936779|NCT00654381|566528710|FG005|Extension Stage|Withdrawal by Subject|1|||
156936780|NCT00654381|566528705|FG000|Extension Stage|Closure of the trial site|0|||
156936781|NCT00654381|566528706|FG001|Extension Stage|Closure of the trial site|0|||
156936782|NCT00654381|566528707|FG002|Extension Stage|Closure of the trial site|0|||
156936783|NCT00654381|566528708|FG003|Extension Stage|Closure of the trial site|0|||
156936784|NCT00654381|566528709|FG004|Extension Stage|Closure of the trial site|1|||
156936785|NCT00654381|566528710|FG005|Extension Stage|Closure of the trial site|1|||
156936786|NCT03100825|566528711|FG000|Overall Study|Participant/Guardian Decision|7|||
156936787|NCT03100825|566528711|FG000|Overall Study|Physician Decision|1|||
156936788|NCT00994448|566528713|FG000|Overall Study|Adverse Event|1|||
156936789|NCT00994448|566528714|FG001|Overall Study|Adverse Event|0|||
156936790|NCT00994448|566528713|FG000|Overall Study|Lost to Follow-up|5|||
156936791|NCT00994448|566528714|FG001|Overall Study|Lost to Follow-up|1|||
156936792|NCT00994448|566528713|FG000|Overall Study|Withdrawal by Subject|1|||
156936793|NCT00994448|566528714|FG001|Overall Study|Withdrawal by Subject|1|||
156936794|NCT00994448|566528713|FG000|Overall Study|Physician Decision|1|||
156936795|NCT00994448|566528714|FG001|Overall Study|Physician Decision|0|||
156936796|NCT05923229|566528718|FG000|Overall Study|Withdrawal by Subject|3|||
156936797|NCT05923229|566528719|FG001|Overall Study|Withdrawal by Subject|0|||
156936798|NCT05923229|566528718|FG000|Overall Study|Health related|2|||
156936799|NCT05923229|566528719|FG001|Overall Study|Health related|1|||
156936800|NCT04164901|566528720|FG000|Overall Study|Withdrawal by Subject|4|||
156936801|NCT04164901|566528721|FG001|Overall Study|Withdrawal by Subject|4|||
156936802|NCT05288556|566528722|FG000|Overall Study|Protocol Violation|1|||
156936803|NCT05288556|566528722|FG000|Overall Study|Withdrawal by Subject|1|||
156936804|NCT02465528|566528723|FG000|Overall Study|Progressive disease|0|||
156936805|NCT02465528|566528724|FG001|Overall Study|Progressive disease|2|||
156936806|NCT02465528|566528725|FG002|Overall Study|Progressive disease|9|||
156936807|NCT02465528|566528726|FG003|Overall Study|Progressive disease|4|||
156936808|NCT02465528|566528723|FG000|Overall Study|Study terminated by sponsor|1|||
156936809|NCT02465528|566528724|FG001|Overall Study|Study terminated by sponsor|2|||
156936810|NCT02465528|566528725|FG002|Overall Study|Study terminated by sponsor|0|||
156936811|NCT02465528|566528726|FG003|Overall Study|Study terminated by sponsor|0|||
156936812|NCT02465528|566528723|FG000|Overall Study|Withdrawal by Subject|0|||
156936813|NCT02465528|566528724|FG001|Overall Study|Withdrawal by Subject|0|||
156936814|NCT02465528|566528725|FG002|Overall Study|Withdrawal by Subject|2|||
156936815|NCT02465528|566528726|FG003|Overall Study|Withdrawal by Subject|0|||
156936816|NCT02465528|566528723|FG000|Overall Study|Adverse Event|0|||
156936817|NCT02465528|566528724|FG001|Overall Study|Adverse Event|0|||
156936818|NCT02465528|566528725|FG002|Overall Study|Adverse Event|0|||
156936819|NCT02465528|566528726|FG003|Overall Study|Adverse Event|1|||
156936820|NCT02465528|566528723|FG000|Overall Study|Physician Decision|0|||
156936821|NCT02465528|566528724|FG001|Overall Study|Physician Decision|0|||
156936822|NCT02465528|566528725|FG002|Overall Study|Physician Decision|1|||
156936823|NCT02465528|566528726|FG003|Overall Study|Physician Decision|0|||
156936824|NCT05040152|566528729|FG000|Overall Study|Withdrawal by Subject|5|||
156936825|NCT05040152|566528730|FG001|Overall Study|Withdrawal by Subject|0|||
156936826|NCT05040152|566528729|FG000|Overall Study|Lost to Follow-up|0|||
156936827|NCT05040152|566528730|FG001|Overall Study|Lost to Follow-up|2|||
156936828|NCT00048542|566528737|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156936829|NCT00048542|566528738|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
156936830|NCT00048542|566528739|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
156936831|NCT00048542|566528740|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156936832|NCT00048542|566528741|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156936833|NCT00048542|566528742|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
156936834|NCT00048542|566528743|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
156936835|NCT00048542|566528744|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
156936836|NCT00048542|566528737|FG000|Double-Blind Phase|Protocol Violation|0|||
156936837|NCT00048542|566528738|FG001|Double-Blind Phase|Protocol Violation|0|||
156936838|NCT00048542|566528739|FG002|Double-Blind Phase|Protocol Violation|1|||
156936839|NCT00048542|566528740|FG003|Double-Blind Phase|Protocol Violation|0|||
156936840|NCT00048542|566528741|FG004|Double-Blind Phase|Protocol Violation|0|||
156936841|NCT00048542|566528742|FG005|Double-Blind Phase|Protocol Violation|0|||
156936842|NCT00048542|566528743|FG006|Double-Blind Phase|Protocol Violation|0|||
156936843|NCT00048542|566528744|FG007|Double-Blind Phase|Protocol Violation|0|||
156936844|NCT00048542|566528737|FG000|Double-Blind Phase|Sponsor request or decision|2|||
156936845|NCT00048542|566528738|FG001|Double-Blind Phase|Sponsor request or decision|0|||
156936846|NCT00048542|566528739|FG002|Double-Blind Phase|Sponsor request or decision|0|||
156936847|NCT00048542|566528740|FG003|Double-Blind Phase|Sponsor request or decision|0|||
156936848|NCT00048542|566528741|FG004|Double-Blind Phase|Sponsor request or decision|0|||
156936849|NCT00048542|566528742|FG005|Double-Blind Phase|Sponsor request or decision|0|||
156936850|NCT00048542|566528743|FG006|Double-Blind Phase|Sponsor request or decision|0|||
156936851|NCT00048542|566528744|FG007|Double-Blind Phase|Sponsor request or decision|0|||
156936852|NCT00048542|566528737|FG000|Double-Blind Phase|Randomized in error|1|||
156936853|NCT00048542|566528738|FG001|Double-Blind Phase|Randomized in error|0|||
156936854|NCT00048542|566528739|FG002|Double-Blind Phase|Randomized in error|0|||
156936855|NCT00048542|566528740|FG003|Double-Blind Phase|Randomized in error|0|||
156936856|NCT00048542|566528741|FG004|Double-Blind Phase|Randomized in error|0|||
156936857|NCT00048542|566528742|FG005|Double-Blind Phase|Randomized in error|0|||
156936858|NCT00048542|566528743|FG006|Double-Blind Phase|Randomized in error|0|||
156936859|NCT00048542|566528744|FG007|Double-Blind Phase|Randomized in error|0|||
156936860|NCT00048542|566528737|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936861|NCT00048542|566528738|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936862|NCT00048542|566528739|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936863|NCT00048542|566528740|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936864|NCT00048542|566528741|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
156936865|NCT00048542|566528742|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
156936866|NCT00048542|566528743|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936867|NCT00048542|566528744|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
156936868|NCT00048542|566528737|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936869|NCT00048542|566528738|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936870|NCT00048542|566528739|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936871|NCT00048542|566528740|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936872|NCT00048542|566528741|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936873|NCT00048542|566528742|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
156936874|NCT00048542|566528743|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936875|NCT00048542|566528744|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
156936876|NCT00048542|566528737|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936877|NCT00048542|566528738|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936878|NCT00048542|566528739|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936879|NCT00048542|566528740|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936880|NCT00048542|566528741|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
156936881|NCT00048542|566528742|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
156936882|NCT00048542|566528743|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936883|NCT00048542|566528744|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
156936884|NCT00048542|566528737|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
156936885|NCT00048542|566528738|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
156936886|NCT00048542|566528739|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
156936887|NCT00048542|566528740|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
156936888|NCT00048542|566528741|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
156936889|NCT00048542|566528742|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
156936890|NCT00048542|566528743|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
156936891|NCT00048542|566528744|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
156936892|NCT00048542|566528737|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936893|NCT00048542|566528738|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936894|NCT00048542|566528739|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936895|NCT00048542|566528740|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936896|NCT00048542|566528741|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
156936897|NCT00048542|566528742|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
156936898|NCT00048542|566528743|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936899|NCT00048542|566528744|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
156936900|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936901|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936902|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936903|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936904|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936905|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
156936906|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
156936907|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
156936908|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936909|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936910|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936911|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936912|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936913|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
156936914|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
156936915|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
156936916|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156936917|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156936918|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156936919|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
157031029|NCT02224144|566868395|FG001|Overall Study|Lost to Follow-up|1|||
156936920|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156936921|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
156936922|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
156936923|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
156936924|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936925|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936926|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936927|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936928|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936929|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
156936930|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
156936931|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
156936932|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936933|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936934|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936935|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936936|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936937|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
156936938|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
156936939|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
156936940|NCT00048542|566528737|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936941|NCT00048542|566528738|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936942|NCT00048542|566528739|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936943|NCT00048542|566528740|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936944|NCT00048542|566528741|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936945|NCT00048542|566528742|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
156936946|NCT00048542|566528743|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
156936947|NCT00048542|566528744|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
156936948|NCT04098458|566528745|FG000|Overall Study|Death|1|||
156936949|NCT04098458|566528745|FG000|Overall Study|did not meet study inclusion criteria|3|||
156936950|NCT00578175|566528746|FG000|Overall Study|Adverse Event|0|||
156936951|NCT00578175|566528747|FG001|Overall Study|Adverse Event|1|||
156936952|NCT00578175|566528748|FG002|Overall Study|Adverse Event|1|||
156936953|NCT00578175|566528746|FG000|Overall Study|Other reasons|70|||
156936954|NCT00578175|566528747|FG001|Overall Study|Other reasons|42|||
156936955|NCT00578175|566528748|FG002|Overall Study|Other reasons|23|||
156936956|NCT01232296|566528749|FG000|Overall Study|Adverse Event|24|||
156936957|NCT01232296|566528750|FG001|Overall Study|Adverse Event|12|||
156936958|NCT01232296|566528749|FG000|Overall Study|Physician Decision|1|||
156936959|NCT01232296|566528750|FG001|Overall Study|Physician Decision|1|||
156936960|NCT01232296|566528749|FG000|Overall Study|Progressive disease|43|||
156936961|NCT01232296|566528750|FG001|Overall Study|Progressive disease|61|||
156936962|NCT01232296|566528749|FG000|Overall Study|Study terminated by sponsor|0|||
156936963|NCT01232296|566528750|FG001|Overall Study|Study terminated by sponsor|1|||
156936964|NCT01232296|566528749|FG000|Overall Study|Technical problems|3|||
156936965|NCT01232296|566528750|FG001|Overall Study|Technical problems|0|||
156936966|NCT01232296|566528749|FG000|Overall Study|Subject/guardian decision|10|||
156936967|NCT01232296|566528750|FG001|Overall Study|Subject/guardian decision|2|||
156936968|NCT01232296|566528749|FG000|Overall Study|Death|1|||
156936969|NCT01232296|566528750|FG001|Overall Study|Death|6|||
156936970|NCT00559962|566528751|FG000|Overall Study|Adverse Event|1|||
156936971|NCT00559962|566528752|FG001|Overall Study|Adverse Event|7|||
156936972|NCT00559962|566528753|FG002|Overall Study|Adverse Event|8|||
156936973|NCT00559962|566528754|FG003|Overall Study|Adverse Event|5|||
156936974|NCT00559962|566528755|FG004|Overall Study|Adverse Event|11|||
156936975|NCT00559962|566528756|FG005|Overall Study|Adverse Event|4|||
156936976|NCT00559962|566528757|FG006|Overall Study|Adverse Event|4|||
156936977|NCT00559962|566528758|FG007|Overall Study|Adverse Event|2|||
156936978|NCT00559962|566528751|FG000|Overall Study|Lost to Follow-up|0|||
156936979|NCT00559962|566528752|FG001|Overall Study|Lost to Follow-up|1|||
156936980|NCT00559962|566528753|FG002|Overall Study|Lost to Follow-up|0|||
156936981|NCT00559962|566528754|FG003|Overall Study|Lost to Follow-up|0|||
156936982|NCT00559962|566528755|FG004|Overall Study|Lost to Follow-up|0|||
156936983|NCT00559962|566528756|FG005|Overall Study|Lost to Follow-up|0|||
156936984|NCT00559962|566528757|FG006|Overall Study|Lost to Follow-up|0|||
156936985|NCT00559962|566528758|FG007|Overall Study|Lost to Follow-up|0|||
156936986|NCT00559962|566528751|FG000|Overall Study|Withdrawal by Subject|1|||
156936987|NCT00559962|566528752|FG001|Overall Study|Withdrawal by Subject|1|||
156936988|NCT00559962|566528753|FG002|Overall Study|Withdrawal by Subject|2|||
156936989|NCT00559962|566528754|FG003|Overall Study|Withdrawal by Subject|0|||
156936990|NCT00559962|566528755|FG004|Overall Study|Withdrawal by Subject|3|||
156936991|NCT00559962|566528756|FG005|Overall Study|Withdrawal by Subject|1|||
156936992|NCT00559962|566528757|FG006|Overall Study|Withdrawal by Subject|0|||
157031030|NCT02224144|566868394|FG000|Overall Study|Death|2|||
157031031|NCT02224144|566868395|FG001|Overall Study|Death|0|||
157031032|NCT02224144|566868394|FG000|Overall Study|Withdrawal by Subject|0|||
157031033|NCT02224144|566868395|FG001|Overall Study|Withdrawal by Subject|1|||
157031034|NCT03505008|566868396|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
157031035|NCT03505008|566868397|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
157031036|NCT03505008|566868398|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
157031037|NCT03505008|566868399|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
157031038|NCT03505008|566868396|FG000|Before Week 24 Randomization|Adverse Event|10|||
157031039|NCT03505008|566868397|FG001|Before Week 24 Randomization|Adverse Event|0|||
157031040|NCT03505008|566868398|FG002|Before Week 24 Randomization|Adverse Event|0|||
157031041|NCT03505008|566868399|FG003|Before Week 24 Randomization|Adverse Event|0|||
157031042|NCT03505008|566868396|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
157031043|NCT03505008|566868397|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
157031044|NCT03505008|566868398|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
157031045|NCT03505008|566868399|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
157031046|NCT03505008|566868396|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
157031047|NCT03505008|566868397|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
157031048|NCT03505008|566868398|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
157031049|NCT03505008|566868399|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
157031050|NCT03505008|566868396|FG000|Before Week 24 Randomization|Physician Decision|2|||
157031051|NCT03505008|566868397|FG001|Before Week 24 Randomization|Physician Decision|0|||
157031052|NCT03505008|566868398|FG002|Before Week 24 Randomization|Physician Decision|0|||
157031053|NCT03505008|566868399|FG003|Before Week 24 Randomization|Physician Decision|0|||
157031054|NCT03505008|566868396|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
157031055|NCT03505008|566868397|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
157031056|NCT03505008|566868398|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
157031057|NCT03505008|566868399|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
157031058|NCT03505008|566868396|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
157031059|NCT03505008|566868397|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
157031060|NCT03505008|566868398|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
157031061|NCT03505008|566868399|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
157031062|NCT03505008|566868396|FG000|Before Week 24 Randomization|Complication|1|||
157031063|NCT03505008|566868397|FG001|Before Week 24 Randomization|Complication|0|||
157031064|NCT03505008|566868398|FG002|Before Week 24 Randomization|Complication|0|||
157031065|NCT03505008|566868399|FG003|Before Week 24 Randomization|Complication|0|||
157031066|NCT03505008|566868396|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
157031067|NCT03505008|566868397|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
157031068|NCT03505008|566868398|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
157031069|NCT03505008|566868399|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
157031070|NCT03505008|566868396|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
157031071|NCT03505008|566868397|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
157031072|NCT03505008|566868398|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
157031073|NCT03505008|566868399|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
157031074|NCT03505008|566868396|FG000|After Week 24 Randomization|Adverse Event|0|||
157031075|NCT03505008|566868397|FG001|After Week 24 Randomization|Adverse Event|1|||
157031076|NCT03505008|566868398|FG002|After Week 24 Randomization|Adverse Event|2|||
157031077|NCT03505008|566868399|FG003|After Week 24 Randomization|Adverse Event|2|||
157031078|NCT03505008|566868396|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
157031079|NCT03505008|566868397|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
157031080|NCT03505008|566868398|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
157031081|NCT03505008|566868399|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
157031082|NCT03505008|566868396|FG000|After Week 24 Randomization|Protocol Violation|0|||
157031083|NCT03505008|566868397|FG001|After Week 24 Randomization|Protocol Violation|0|||
157031084|NCT03505008|566868398|FG002|After Week 24 Randomization|Protocol Violation|1|||
157031085|NCT03505008|566868399|FG003|After Week 24 Randomization|Protocol Violation|0|||
157031086|NCT02962076|566868400|FG000|Overall Study|MHED tracer not available|5|||
157031087|NCT02962076|566868400|FG000|Overall Study|Protocol Violation|1|||
157031088|NCT02962076|566868400|FG000|Overall Study|Physician Decision|1|||
157031089|NCT02780700|566868401|FG000|Overall Study|Progressive disease|1|||
157031090|NCT04580914|566868405|FG000|Overall Study|Withdrawal by Subject|6|||
157031091|NCT04580914|566868405|FG000|Overall Study|Lost to Follow-up|2|||
157031092|NCT02998528|566868407|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
157031093|NCT02998528|566868408|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
157031094|NCT02998528|566868409|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
157031095|NCT02998528|566868407|FG000|Randomization Period|Participant withdrew consent|0|||
157031096|NCT02998528|566868408|FG001|Randomization Period|Participant withdrew consent|3|||
157031097|NCT02998528|566868409|FG002|Randomization Period|Participant withdrew consent|0|||
157031098|NCT02998528|566868407|FG000|Randomization Period|Participant no longer meets study criteria|1|||
157031099|NCT02998528|566868408|FG001|Randomization Period|Participant no longer meets study criteria|3|||
157031100|NCT02998528|566868409|FG002|Randomization Period|Participant no longer meets study criteria|2|||
157031101|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
157031102|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
157031103|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
157031104|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
157031105|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
157031106|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
157031107|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
157031108|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
157031109|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
157031110|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
157031111|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
157031112|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
157031113|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
157031114|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
157031115|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
157031116|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Death|1|||
157031117|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Death|0|||
157031118|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Death|0|||
157031119|NCT02998528|566868407|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
157031120|NCT02998528|566868408|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
157031121|NCT02998528|566868409|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
157031122|NCT02998528|566868407|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
157031123|NCT02998528|566868408|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
157031124|NCT02998528|566868409|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
157031125|NCT02998528|566868407|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
157031126|NCT02998528|566868408|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
157031127|NCT02998528|566868409|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
157031128|NCT02998528|566868407|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
157031129|NCT02998528|566868408|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
157031130|NCT02998528|566868409|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
157031131|NCT02998528|566868407|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
157031132|NCT02998528|566868408|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
157031133|NCT02998528|566868409|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
157031134|NCT02998528|566868407|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
157031135|NCT02998528|566868408|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
157031136|NCT02998528|566868409|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
157031137|NCT02828358|566868412|FG000|Overall Study|Physician Decision|7|||
157031138|NCT02828358|566868413|FG001|Overall Study|Physician Decision|1|||
157031139|NCT02828358|566868412|FG000|Overall Study|Treatment Failure|6|||
157031140|NCT02828358|566868413|FG001|Overall Study|Treatment Failure|0|||
157031141|NCT02828358|566868412|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
157031142|NCT02828358|566868413|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
157031143|NCT02828358|566868412|FG000|Overall Study|Refusal of further protocol therapy|2|||
157031144|NCT02828358|566868413|FG001|Overall Study|Refusal of further protocol therapy|0|||
157031145|NCT02828358|566868412|FG000|Overall Study|Relapse|25|||
157031146|NCT02828358|566868413|FG001|Overall Study|Relapse|0|||
157031147|NCT02828358|566868412|FG000|Overall Study|Still on therapy|5|||
157031148|NCT02828358|566868413|FG001|Overall Study|Still on therapy|0|||
157031149|NCT03993392|566868427|FG000|Overall Study|Withdrawal by Subject|3|||
157031150|NCT03993392|566868427|FG000|Overall Study|Lost to Follow-up|2|||
157031151|NCT03993392|566868427|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
157031152|NCT05809453|566870071|FG000|Overall Study|Withdrawal by Subject|1|||
157031153|NCT05809453|566870072|FG001|Overall Study|Withdrawal by Subject|0|||
157031154|NCT05809453|566870073|FG002|Overall Study|Withdrawal by Subject|0|||
157031155|NCT05809453|566870074|FG003|Overall Study|Withdrawal by Subject|0|||
157031156|NCT04183283|566870076|FG000|Period 1|Withdrawal by Subject|0|||
157031157|NCT04183283|566870077|FG001|Period 1|Withdrawal by Subject|1|||
157031158|NCT04183283|566870078|FG002|Period 1|Withdrawal by Subject|0|||
157031159|NCT04183283|566870079|FG003|Period 1|Withdrawal by Subject|0|||
157031160|NCT04183283|566870076|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
157031161|NCT04183283|566870077|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
157031162|NCT04183283|566870078|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
157031163|NCT04183283|566870079|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
157031164|NCT03220035|566870081|FG000|Overall Study|Adverse Event|1|||
157031165|NCT03220035|566870081|FG000|Overall Study|Protocol Violation|1|||
157031166|NCT03220035|566870081|FG000|Overall Study|Progressive Disease|2|||
157167131|NCT01253187|567352669|FG000|Period 3|non-compliance|0|||
157167132|NCT01253187|567352670|FG001|Period 3|non-compliance|0|||
156936993|NCT00559962|566528758|FG007|Overall Study|Withdrawal by Subject|2|||
156936994|NCT00559962|566528751|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
156936995|NCT00559962|566528752|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
156936996|NCT00559962|566528753|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
156936997|NCT00559962|566528754|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
156936998|NCT00559962|566528755|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
156936999|NCT00559962|566528756|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
156937000|NCT00559962|566528757|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
156937001|NCT00559962|566528758|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
156937002|NCT01461096|566528759|FG000|Overall Study|Death|3|||
156937003|NCT01461096|566528760|FG001|Overall Study|Death|6|||
156937004|NCT01461096|566528759|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156937005|NCT01461096|566528760|FG001|Overall Study|Severe debilitation, unable to continue|1|||
156937006|NCT01461096|566528759|FG000|Overall Study|Subj not able to get to clinic|15|||
156937007|NCT01461096|566528760|FG001|Overall Study|Subj not able to get to clinic|13|||
156937008|NCT01461096|566528759|FG000|Overall Study|Site is closing|27|||
156937009|NCT01461096|566528760|FG001|Overall Study|Site is closing|30|||
156937010|NCT01461096|566528759|FG000|Overall Study|Withdrawal by Subject|5|||
156937011|NCT01461096|566528760|FG001|Overall Study|Withdrawal by Subject|3|||
156937012|NCT01461096|566528759|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
156937013|NCT01461096|566528760|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
156937014|NCT01461096|566528759|FG000|Overall Study|Lost to Follow-up|8|||
156937015|NCT01461096|566528760|FG001|Overall Study|Lost to Follow-up|4|||
156937016|NCT03047135|566528773|FG000|Overall Study|Still being treated|3|||
156937017|NCT01256593|566528776|FG000|Overall Study|Protocol Violation|26|||
156937018|NCT01256593|566528776|FG000|Overall Study|No Drug Administration Information|2|||
156937019|NCT01256593|566528776|FG000|Overall Study|No Visit After Treatment|186|||
156937020|NCT05619692|566528777|FG000|Overall Study|Adverse Event|2|||
156937021|NCT05619692|566528778|FG001|Overall Study|Adverse Event|2|||
156937022|NCT05619692|566528777|FG000|Overall Study|Withdrawal by Participant|3|||
156937023|NCT05619692|566528778|FG001|Overall Study|Withdrawal by Participant|4|||
156937024|NCT05619692|566528777|FG000|Overall Study|Lost to Follow-up|2|||
156937025|NCT05619692|566528778|FG001|Overall Study|Lost to Follow-up|1|||
156937026|NCT05619692|566528777|FG000|Overall Study|Randomized but not treated|1|||
156937027|NCT05619692|566528778|FG001|Overall Study|Randomized but not treated|3|||
156937028|NCT00405548|566528779|FG000|Overall Study|Cognitive Memory problems on study day|1|||
156937029|NCT00405548|566528780|FG001|Overall Study|Cognitive Memory problems on study day|0|||
156937030|NCT00405548|566528779|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
156937031|NCT00405548|566528780|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
156937032|NCT00405548|566528779|FG000|Overall Study|Unable to self-administer shots|1|||
156937033|NCT00405548|566528780|FG001|Overall Study|Unable to self-administer shots|0|||
156937034|NCT00405548|566528779|FG000|Overall Study|Venous access failed during study day|1|||
156937035|NCT00405548|566528780|FG001|Overall Study|Venous access failed during study day|0|||
156937036|NCT00405548|566528779|FG000|Overall Study|Withdrawal by Subject|1|||
156937037|NCT00405548|566528780|FG001|Overall Study|Withdrawal by Subject|0|||
156937038|NCT01116232|566528781|FG000|Overall Study|Progressive diease|4|||
156937039|NCT02036502|566528782|FG000|Part 1:Dose Determination/Escalation|Death|3|||
156937040|NCT02036502|566528783|FG001|Part 1:Dose Determination/Escalation|Death|2|||
156937041|NCT02036502|566528784|FG002|Part 1:Dose Determination/Escalation|Death|0|||
156937042|NCT02036502|566528785|FG003|Part 1:Dose Determination/Escalation|Death|0|||
156937043|NCT02036502|566528786|FG004|Part 1:Dose Determination/Escalation|Death|0|||
156937044|NCT02036502|566528787|FG005|Part 1:Dose Determination/Escalation|Death|0|||
156937045|NCT02036502|566528788|FG006|Part 1:Dose Determination/Escalation|Death|0|||
156937046|NCT02036502|566528789|FG007|Part 1:Dose Determination/Escalation|Death|0|||
156937047|NCT02036502|566528782|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
156937048|NCT02036502|566528783|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937049|NCT02036502|566528784|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937050|NCT02036502|566528785|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937051|NCT02036502|566528786|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937052|NCT02036502|566528787|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937053|NCT02036502|566528788|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937054|NCT02036502|566528789|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
156937055|NCT02036502|566528782|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937056|NCT02036502|566528783|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
156937057|NCT02036502|566528784|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937058|NCT02036502|566528785|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937059|NCT02036502|566528786|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937060|NCT02036502|566528787|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937061|NCT02036502|566528788|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937062|NCT02036502|566528789|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
156937063|NCT02036502|566528782|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
156937064|NCT02036502|566528783|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
156937065|NCT02036502|566528784|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
156937066|NCT02036502|566528785|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
156937067|NCT02036502|566528786|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
156937068|NCT02036502|566528787|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
156937069|NCT02036502|566528788|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
156937070|NCT02036502|566528789|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
156937071|NCT02036502|566528782|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156937072|NCT02036502|566528783|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156937073|NCT02036502|566528784|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
156937074|NCT02036502|566528785|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
157031167|NCT04850898|566870082|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
157031168|NCT04850898|566870083|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
157031169|NCT04550221|566870084|FG000|Overall Study|Lost to Follow-up|0|||
157031170|NCT04550221|566870085|FG001|Overall Study|Lost to Follow-up|4|||
157031171|NCT04550221|566870084|FG000|Overall Study|Withdrawn|3|||
157031172|NCT04550221|566870085|FG001|Overall Study|Withdrawn|0|||
157031173|NCT04550221|566870084|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
157031174|NCT04550221|566870085|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
157031175|NCT05452460|566870086|FG000|Overall Study|Lost to Follow-up|3|||
157031176|NCT05452460|566870087|FG001|Overall Study|Lost to Follow-up|3|||
157031177|NCT05452460|566870086|FG000|Overall Study|Did not receive intervention|1|||
157031178|NCT05452460|566870087|FG001|Overall Study|Did not receive intervention|0|||
157031179|NCT04433208|566870088|FG000|Overall Study|Withdrawal by Subject|0|||
157031180|NCT04433208|566870089|FG001|Overall Study|Withdrawal by Subject|1|||
157031181|NCT04433208|566870090|FG002|Overall Study|Withdrawal by Subject|1|||
157031182|NCT04433208|566870091|FG003|Overall Study|Withdrawal by Subject|0|||
157031183|NCT04433208|566870092|FG004|Overall Study|Withdrawal by Subject|2|||
157031184|NCT04433208|566870093|FG005|Overall Study|Withdrawal by Subject|1|||
157031185|NCT04433208|566870088|FG000|Overall Study|Lost to Follow-up|0|||
157031186|NCT04433208|566870089|FG001|Overall Study|Lost to Follow-up|0|||
157031187|NCT04433208|566870090|FG002|Overall Study|Lost to Follow-up|0|||
157031188|NCT04433208|566870091|FG003|Overall Study|Lost to Follow-up|0|||
157031189|NCT04433208|566870092|FG004|Overall Study|Lost to Follow-up|0|||
157031190|NCT04433208|566870093|FG005|Overall Study|Lost to Follow-up|1|||
157031191|NCT02424617|566870096|FG000|Overall Study|Adverse Event|0|||
157031192|NCT02424617|566870097|FG001|Overall Study|Adverse Event|1|||
157031193|NCT02424617|566870098|FG002|Overall Study|Adverse Event|0|||
157031194|NCT02424617|566870099|FG003|Overall Study|Adverse Event|0|||
157031195|NCT02424617|566870096|FG000|Overall Study|Investigator Decision|0|||
157031196|NCT02424617|566870097|FG001|Overall Study|Investigator Decision|0|||
157031197|NCT02424617|566870098|FG002|Overall Study|Investigator Decision|0|||
157031198|NCT02424617|566870099|FG003|Overall Study|Investigator Decision|1|||
157031199|NCT02424617|566870096|FG000|Overall Study|Withdrawal by Subject|1|||
157031200|NCT02424617|566870097|FG001|Overall Study|Withdrawal by Subject|1|||
157031201|NCT02424617|566870098|FG002|Overall Study|Withdrawal by Subject|0|||
157031202|NCT02424617|566870099|FG003|Overall Study|Withdrawal by Subject|1|||
157031203|NCT02424617|566870096|FG000|Overall Study|Progressive Disease|7|||
157031204|NCT02424617|566870097|FG001|Overall Study|Progressive Disease|6|||
157031205|NCT02424617|566870098|FG002|Overall Study|Progressive Disease|11|||
157031206|NCT02424617|566870099|FG003|Overall Study|Progressive Disease|10|||
157031207|NCT02424617|566870096|FG000|Overall Study|Other|0|||
157031208|NCT02424617|566870097|FG001|Overall Study|Other|0|||
157031209|NCT02424617|566870098|FG002|Overall Study|Other|0|||
157031210|NCT02424617|566870099|FG003|Overall Study|Other|1|||
157031211|NCT05269966|566870101|FG000|Overall Study|Adverse Event|4|||
157227125|NCT01047345|567577743|FG001|Base Study|Adverse Event|0|||
157227126|NCT01047345|567577744|FG002|Base Study|Adverse Event|0|||
157227127|NCT01047345|567577742|FG000|Base Study|Lost to Follow-up|4|||
157227128|NCT01047345|567577743|FG001|Base Study|Lost to Follow-up|1|||
156937075|NCT02036502|566528786|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
156937076|NCT02036502|566528787|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156937077|NCT02036502|566528788|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
156937078|NCT02036502|566528789|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
157031212|NCT05269966|566870101|FG000|Overall Study|Withdrawal by Subject|1|||
157031213|NCT05269966|566870101|FG000|Overall Study|Lost to Follow-up|4|||
157031214|NCT05269966|566870101|FG000|Overall Study|Physician Decision|1|||
157031215|NCT06262347|566870104|FG000|Overall Study|Lost to Follow-up|4|||
157031216|NCT06262347|566870105|FG001|Overall Study|Lost to Follow-up|3|||
157031217|NCT06262347|566870104|FG000|Overall Study|Withdrawal by Subject|0|||
157031218|NCT06262347|566870105|FG001|Overall Study|Withdrawal by Subject|1|||
157031219|NCT03476343|566870106|FG000|Overall Study|Clinical exam moved to another scanner|7|||
156937079|NCT02036502|566528782|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
157227129|NCT01047345|567577744|FG002|Base Study|Lost to Follow-up|0|||
157031220|NCT03476343|566870106|FG000|Overall Study|Clinical order cancelled|4|||
157031221|NCT03476343|566870106|FG000|Overall Study|Neonate did not settle down for the scan|1|||
157031222|NCT05974501|566870107|FG000|Overall Study|Physician Decision|0|||
157031223|NCT05974501|566870108|FG001|Overall Study|Physician Decision|1|||
157031224|NCT04304144|566870109|FG000|DLT Observation Period|Physician Decision|0|||
157031225|NCT04304144|566870110|FG001|DLT Observation Period|Physician Decision|1|||
157031226|NCT04304144|566870111|FG002|DLT Observation Period|Physician Decision|0|||
157031227|NCT04304144|566870112|FG003|DLT Observation Period|Physician Decision|0|||
157031228|NCT04304144|566870109|FG000|Continued Treatment Period|Adverse Event|0|||
157031229|NCT04304144|566870110|FG001|Continued Treatment Period|Adverse Event|1|||
157031230|NCT04304144|566870111|FG002|Continued Treatment Period|Adverse Event|0|||
157031231|NCT04304144|566870112|FG003|Continued Treatment Period|Adverse Event|0|||
157031232|NCT04304144|566870109|FG000|Continued Treatment Period|Death|0|||
157031233|NCT04304144|566870110|FG001|Continued Treatment Period|Death|0|||
157031234|NCT04304144|566870111|FG002|Continued Treatment Period|Death|1|||
157031235|NCT04304144|566870112|FG003|Continued Treatment Period|Death|2|||
157031236|NCT04304144|566870109|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
157031237|NCT04304144|566870110|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
157031238|NCT04304144|566870111|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
157031239|NCT04304144|566870112|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
157031240|NCT04304144|566870109|FG000|Continued Treatment Period|Other than specified|2|||
157031241|NCT04304144|566870110|FG001|Continued Treatment Period|Other than specified|0|||
157031242|NCT04304144|566870111|FG002|Continued Treatment Period|Other than specified|1|||
157031243|NCT04304144|566870112|FG003|Continued Treatment Period|Other than specified|1|||
157031244|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
157031245|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
157031246|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
157031247|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
157031248|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
157031249|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
157031250|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
157031251|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Death|0|||
157031252|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Death|1|||
157031253|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Death|0|||
157031254|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Death|0|||
157031255|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Death|0|||
157031256|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Death|0|||
157031257|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Death|0|||
157031258|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
157031259|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031260|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031261|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031262|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031263|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031264|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
157031265|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
157031266|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
157167133|NCT01253187|567352671|FG002|Period 3|non-compliance|0|||
157167134|NCT01253187|567352672|FG003|Period 3|non-compliance|0|||
157167135|NCT01253187|567352673|FG004|Period 3|non-compliance|1|||
157167136|NCT01253187|567352674|FG005|Period 3|non-compliance|0|||
157167137|NCT01494987|567352676|FG000|Overall Study|Adverse Event|6|||
157167138|NCT01494987|567352677|FG001|Overall Study|Adverse Event|5|||
157167139|NCT01494987|567352676|FG000|Overall Study|Hyperglycemia|6|||
157167140|NCT01494987|567352677|FG001|Overall Study|Hyperglycemia|4|||
157167141|NCT01494987|567352676|FG000|Overall Study|Investigator's Discretion|1|||
157167142|NCT01494987|567352677|FG001|Overall Study|Investigator's Discretion|2|||
157167143|NCT01494987|567352676|FG000|Overall Study|Lost to Follow-up|1|||
157167144|NCT01494987|567352677|FG001|Overall Study|Lost to Follow-up|1|||
157167145|NCT01494987|567352676|FG000|Overall Study|Protocol Violation|3|||
157167146|NCT01494987|567352677|FG001|Overall Study|Protocol Violation|3|||
157167147|NCT01494987|567352676|FG000|Overall Study|Subject Non-Compliance|9|||
157167148|NCT01494987|567352677|FG001|Overall Study|Subject Non-Compliance|10|||
157167149|NCT01494987|567352676|FG000|Overall Study|Subject Withdrew Consent|2|||
157031267|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
157167150|NCT01494987|567352677|FG001|Overall Study|Subject Withdrew Consent|3|||
157167151|NCT04999969|567352681|FG000|Overall Study|Death|76|||
157167152|NCT04999969|567352681|FG000|Overall Study|Progressive Disease|1|||
157167153|NCT04999969|567352681|FG000|Overall Study|Withdrawal by Subject|8|||
157167154|NCT04321252|567352683|FG000|Overall Study|Withdrawal by Subject|0|||
157031268|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
157031269|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
157167155|NCT04321252|567352684|FG001|Overall Study|Withdrawal by Subject|0|||
156937080|NCT02036502|566528783|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937081|NCT02036502|566528784|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
156937082|NCT02036502|566528785|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937083|NCT02036502|566528786|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937084|NCT02036502|566528787|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937085|NCT02036502|566528788|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937086|NCT02036502|566528789|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
156937087|NCT02036502|566528782|FG000|Part 2:Dose Confirmation|Death|0|||
156937088|NCT02036502|566528783|FG001|Part 2:Dose Confirmation|Death|0|||
156937089|NCT02036502|566528784|FG002|Part 2:Dose Confirmation|Death|1|||
156937090|NCT02036502|566528785|FG003|Part 2:Dose Confirmation|Death|0|||
156937091|NCT02036502|566528786|FG004|Part 2:Dose Confirmation|Death|0|||
156937092|NCT02036502|566528787|FG005|Part 2:Dose Confirmation|Death|0|||
156937093|NCT02036502|566528788|FG006|Part 2:Dose Confirmation|Death|0|||
156937094|NCT02036502|566528789|FG007|Part 2:Dose Confirmation|Death|0|||
156937095|NCT02036502|566528782|FG000|Part 2:Dose Confirmation|Not treated|0|||
156937096|NCT02036502|566528783|FG001|Part 2:Dose Confirmation|Not treated|0|||
156937097|NCT02036502|566528784|FG002|Part 2:Dose Confirmation|Not treated|0|||
156937098|NCT02036502|566528785|FG003|Part 2:Dose Confirmation|Not treated|1|||
156937099|NCT02036502|566528786|FG004|Part 2:Dose Confirmation|Not treated|0|||
156937100|NCT02036502|566528787|FG005|Part 2:Dose Confirmation|Not treated|0|||
156937101|NCT02036502|566528788|FG006|Part 2:Dose Confirmation|Not treated|0|||
156937102|NCT02036502|566528789|FG007|Part 2:Dose Confirmation|Not treated|0|||
156937103|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Adverse Event|0|||
156937104|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Adverse Event|0|||
156937105|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Adverse Event|0|||
156937106|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Adverse Event|0|||
156937107|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Adverse Event|0|||
156937108|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Adverse Event|4|||
156937109|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Adverse Event|0|||
156937110|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Adverse Event|2|||
156937111|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Death|0|||
156937112|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Death|0|||
156937113|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Death|0|||
156937114|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Death|0|||
156937115|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Death|0|||
156937116|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Death|24|||
156937117|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Death|0|||
156937118|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Death|3|||
156937119|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937120|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937121|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937122|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937123|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937124|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937125|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
156937126|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
156937127|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Physician Decision|0|||
156937128|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Physician Decision|0|||
156937129|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Physician Decision|0|||
156937130|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Physician Decision|0|||
156937131|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Physician Decision|0|||
156937132|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Physician Decision|1|||
156937133|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Physician Decision|0|||
156937134|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Physician Decision|0|||
156937135|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
156937136|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
156937137|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
156937138|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
156937139|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
156937140|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
156937141|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
156937142|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
157031270|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156937143|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
157031271|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
156937144|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
157031272|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Other|1|||
156937145|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156937146|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156937147|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156937148|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
156937149|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
156937150|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
156937151|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156937152|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156937153|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156937154|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156937155|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
156937156|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
156937157|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
156937158|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
156937159|NCT02036502|566528782|FG000|Part 3:Dose Expansion|Not Treated|0|||
156937160|NCT02036502|566528783|FG001|Part 3:Dose Expansion|Not Treated|0|||
156937161|NCT02036502|566528784|FG002|Part 3:Dose Expansion|Not Treated|0|||
156937162|NCT02036502|566528785|FG003|Part 3:Dose Expansion|Not Treated|0|||
156937163|NCT02036502|566528786|FG004|Part 3:Dose Expansion|Not Treated|0|||
156937164|NCT02036502|566528787|FG005|Part 3:Dose Expansion|Not Treated|2|||
156937165|NCT02036502|566528788|FG006|Part 3:Dose Expansion|Not Treated|0|||
156937166|NCT02036502|566528789|FG007|Part 3:Dose Expansion|Not Treated|0|||
156937167|NCT00811577|566528795|FG000|Overall Study|Lost to Follow-up|7|||
156937168|NCT00811577|566528796|FG001|Overall Study|Lost to Follow-up|1|||
156937169|NCT00811577|566528795|FG000|Overall Study|Withdrawal by Subject|3|||
156937170|NCT00811577|566528796|FG001|Overall Study|Withdrawal by Subject|0|||
156937171|NCT01068509|566528797|FG000|Overall Study|Death|0|||
156937172|NCT01068509|566528798|FG001|Overall Study|Death|0|||
156937173|NCT01068509|566528799|FG002|Overall Study|Death|1|||
156937174|NCT01068509|566528797|FG000|Overall Study|Disease Progression|5|||
156937175|NCT01068509|566528798|FG001|Overall Study|Disease Progression|20|||
156937176|NCT01068509|566528799|FG002|Overall Study|Disease Progression|18|||
156937177|NCT01068509|566528797|FG000|Overall Study|Lost to Follow-up|1|||
156937178|NCT01068509|566528798|FG001|Overall Study|Lost to Follow-up|0|||
156937179|NCT01068509|566528799|FG002|Overall Study|Lost to Follow-up|0|||
156937180|NCT01068509|566528797|FG000|Overall Study|Withdrew Consent|0|||
156937181|NCT01068509|566528798|FG001|Overall Study|Withdrew Consent|1|||
156937182|NCT01068509|566528799|FG002|Overall Study|Withdrew Consent|2|||
156937183|NCT01068509|566528797|FG000|Overall Study|Reason Not Specified|0|||
156937184|NCT01068509|566528798|FG001|Overall Study|Reason Not Specified|1|||
156937185|NCT01068509|566528799|FG002|Overall Study|Reason Not Specified|0|||
156937186|NCT00329407|566528804|FG000|Overall Study|Withdrawal by Subject|1|||
156937187|NCT02357940|566528805|FG000|Overall Study|Adverse Event|0|||
156937188|NCT02357940|566528806|FG001|Overall Study|Adverse Event|1|||
156937189|NCT02357940|566528805|FG000|Overall Study|Investigator's judgement|0|||
156937190|NCT02357940|566528806|FG001|Overall Study|Investigator's judgement|1|||
156937191|NCT02442778|566528807|FG000|Overall Study|Adverse Event|2|||
156937192|NCT02442778|566528808|FG001|Overall Study|Adverse Event|6|||
156937193|NCT02442778|566528809|FG002|Overall Study|Adverse Event|6|||
156937194|NCT02442778|566528807|FG000|Overall Study|Death|0|||
156937195|NCT02442778|566528808|FG001|Overall Study|Death|2|||
156937196|NCT02442778|566528809|FG002|Overall Study|Death|0|||
156937197|NCT02442778|566528807|FG000|Overall Study|Lack of Efficacy|1|||
156937198|NCT02442778|566528808|FG001|Overall Study|Lack of Efficacy|0|||
156937199|NCT02442778|566528809|FG002|Overall Study|Lack of Efficacy|0|||
156937200|NCT02442778|566528807|FG000|Overall Study|Lost to Follow-up|1|||
156937201|NCT02442778|566528808|FG001|Overall Study|Lost to Follow-up|1|||
156937202|NCT02442778|566528809|FG002|Overall Study|Lost to Follow-up|1|||
156937203|NCT02442778|566528807|FG000|Overall Study|Non-compliance with study drug|2|||
156937204|NCT02442778|566528808|FG001|Overall Study|Non-compliance with study drug|0|||
156937205|NCT02442778|566528809|FG002|Overall Study|Non-compliance with study drug|1|||
156937206|NCT02442778|566528807|FG000|Overall Study|Physician Decision|1|||
156937207|NCT02442778|566528808|FG001|Overall Study|Physician Decision|1|||
156937208|NCT02442778|566528809|FG002|Overall Study|Physician Decision|1|||
156937209|NCT02442778|566528807|FG000|Overall Study|Protocol Deviation|3|||
156937210|NCT02442778|566528808|FG001|Overall Study|Protocol Deviation|0|||
156937211|NCT02442778|566528809|FG002|Overall Study|Protocol Deviation|1|||
156937212|NCT02442778|566528807|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
156937213|NCT02442778|566528808|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
156937214|NCT02442778|566528809|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
156937215|NCT02442778|566528807|FG000|Overall Study|Withdrawal by Subject|4|||
156937216|NCT02442778|566528808|FG001|Overall Study|Withdrawal by Subject|4|||
156937217|NCT02442778|566528809|FG002|Overall Study|Withdrawal by Subject|3|||
156937218|NCT02442778|566528807|FG000|Overall Study|Reason not specified|1|||
156937219|NCT02442778|566528808|FG001|Overall Study|Reason not specified|4|||
156937220|NCT02442778|566528809|FG002|Overall Study|Reason not specified|0|||
156937221|NCT00978068|566528810|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
156937222|NCT00978068|566528811|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
156937223|NCT00978068|566528810|FG000|Overall Study|Death|1|||
156937224|NCT00978068|566528811|FG001|Overall Study|Death|2|||
156937225|NCT00978068|566528810|FG000|Overall Study|Lost to Follow-up|1|||
156937226|NCT00978068|566528811|FG001|Overall Study|Lost to Follow-up|2|||
156937227|NCT00978068|566528810|FG000|Overall Study|Physician Decision|0|||
156937228|NCT00978068|566528811|FG001|Overall Study|Physician Decision|1|||
156937229|NCT00978068|566528810|FG000|Overall Study|Unable to Comply with Study|0|||
156937230|NCT00978068|566528811|FG001|Overall Study|Unable to Comply with Study|2|||
156937231|NCT01644175|566528816|FG000|Overall Study|Randomized But Not Treated|0|||
156937232|NCT01644175|566528817|FG001|Overall Study|Randomized But Not Treated|2|||
156937233|NCT01644175|566528816|FG000|Overall Study|Adverse Event|8|||
156937234|NCT01644175|566528817|FG001|Overall Study|Adverse Event|13|||
156937235|NCT01644175|566528816|FG000|Overall Study|Death|1|||
156937236|NCT01644175|566528817|FG001|Overall Study|Death|2|||
156937237|NCT01644175|566528816|FG000|Overall Study|Poor compliance to protocol|9|||
156937238|NCT01644175|566528817|FG001|Overall Study|Poor compliance to protocol|10|||
156937239|NCT01644175|566528816|FG000|Overall Study|Physician Decision|1|||
156937240|NCT01644175|566528817|FG001|Overall Study|Physician Decision|2|||
156937241|NCT01644175|566528816|FG000|Overall Study|Participant Moved|1|||
156937242|NCT01644175|566528817|FG001|Overall Study|Participant Moved|2|||
156937243|NCT01644175|566528816|FG000|Overall Study|Consent withdrawn by participant|3|||
156937244|NCT01644175|566528817|FG001|Overall Study|Consent withdrawn by participant|4|||
156937245|NCT01644175|566528816|FG000|Overall Study|Related to Autoinjector Administration|2|||
156937246|NCT01644175|566528817|FG001|Overall Study|Related to Autoinjector Administration|1|||
156937247|NCT01644175|566528816|FG000|Overall Study|Last visit outside protocol visit window|4|||
156937248|NCT01644175|566528817|FG001|Overall Study|Last visit outside protocol visit window|11|||
156937249|NCT01644175|566528816|FG000|Overall Study|Selection criteria finally not met|0|||
156937250|NCT01644175|566528817|FG001|Overall Study|Selection criteria finally not met|1|||
156937251|NCT01644175|566528816|FG000|Overall Study|Site closure|2|||
156937252|NCT01644175|566528817|FG001|Overall Study|Site closure|2|||
156937253|NCT01644175|566528816|FG000|Overall Study|Lost to Follow-up|1|||
156937254|NCT01644175|566528817|FG001|Overall Study|Lost to Follow-up|0|||
156937255|NCT01644175|566528816|FG000|Overall Study|Other than specified above|0|||
156937256|NCT01644175|566528817|FG001|Overall Study|Other than specified above|3|||
156937257|NCT00451035|566528824|FG000|Overall Study|Disease progression|11|||
156937258|NCT00451035|566528824|FG000|Overall Study|Death|3|||
156937259|NCT00451035|566528824|FG000|Overall Study|New anti-neoplastic therapy|3|||
156937260|NCT01712256|566528830|FG000|Overall Study|Lost to Follow-up|1|||
156937261|NCT00344773|566528831|FG000|Overall Study|Adverse Event|2|||
156937262|NCT00344773|566528831|FG000|Overall Study|Objective Disease Progression|16|||
156937263|NCT00344773|566528831|FG000|Overall Study|Withdrawal by Subject|1|||
156937264|NCT00344773|566528831|FG000|Overall Study|Not Eligible for the study|2|||
156937265|NCT02849548|566528832|FG000|Overall Study|Lost to Follow-up|1|||
156937266|NCT02849548|566528833|FG001|Overall Study|Lost to Follow-up|2|||
156937267|NCT02849548|566528832|FG000|Overall Study|Protocol Violation|1|||
156937268|NCT02849548|566528833|FG001|Overall Study|Protocol Violation|0|||
156937269|NCT00714259|566528834|FG000|Overall Study|Death|2|||
156937270|NCT04804813|566528836|FG000|Overall Study|Protocol Violation|2|||
156937271|NCT04804813|566528837|FG001|Overall Study|Protocol Violation|0|||
156937272|NCT04804813|566528836|FG000|Overall Study|Withdrawal by Subject|1|||
156937273|NCT04804813|566528837|FG001|Overall Study|Withdrawal by Subject|0|||
156937274|NCT02357147|566528838|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
156937275|NCT02357147|566528839|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
156937276|NCT02357147|566528838|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
156937277|NCT02357147|566528839|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
156937278|NCT02357147|566528838|FG000|Combination Treatment Phase|Investigator Discretion|1|||
156937279|NCT02357147|566528839|FG001|Combination Treatment Phase|Investigator Discretion|1|||
156937280|NCT02357147|566528838|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
156937281|NCT02357147|566528839|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
156937282|NCT02357147|566528838|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
156937283|NCT02357147|566528839|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
156937284|NCT02357147|566528838|FG000|Combination Treatment Phase|Adverse Event|12|||
156937285|NCT02357147|566528839|FG001|Combination Treatment Phase|Adverse Event|4|||
156937286|NCT02357147|566528838|FG000|Combination Treatment Phase|Death|1|||
156937287|NCT02357147|566528839|FG001|Combination Treatment Phase|Death|1|||
156937288|NCT02357147|566528838|FG000|Combination Treatment Phase|Sponsor Decision|0|||
156937289|NCT02357147|566528839|FG001|Combination Treatment Phase|Sponsor Decision|12|||
156937290|NCT02357147|566528838|FG000|Combination Treatment Phase|Other|1|||
156937291|NCT02357147|566528839|FG001|Combination Treatment Phase|Other|0|||
156937292|NCT02357147|566528838|FG000|Combination Treatment Phase|Not treated|0|||
156937293|NCT02357147|566528839|FG001|Combination Treatment Phase|Not treated|2|||
156937294|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
156937295|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
156937296|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
156937297|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
156937298|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
156937299|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
156937300|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Adverse Event|0|||
157031273|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Other|0|||
157031274|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Other|0|||
157031275|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Other|0|||
157031276|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Other|0|||
157031277|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Other|0|||
157031278|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Other|0|||
157031279|NCT04585815|566870113|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
157031280|NCT04585815|566870114|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
157031281|NCT04585815|566870115|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
157031282|NCT04585815|566870116|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
157031283|NCT04585815|566870117|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
157031284|NCT04585815|566870118|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
157031285|NCT04585815|566870119|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
157031286|NCT04585815|566870113|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031287|NCT04585815|566870114|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
157031288|NCT04585815|566870115|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031289|NCT04585815|566870116|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031290|NCT04585815|566870117|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031291|NCT04585815|566870118|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031292|NCT04585815|566870119|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
157031293|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
157031294|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
157031295|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
157031296|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
157031297|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
157031298|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
157031299|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
157031300|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Death|0|||
157031301|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Death|0|||
157031302|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Death|0|||
157031303|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Death|1|||
157031304|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Death|0|||
157031305|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Death|0|||
157031306|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Death|0|||
157031307|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
157031308|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
157031309|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
157031310|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
157031311|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
157031312|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
157031313|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
157031314|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031315|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031316|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031317|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
157031318|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031319|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031320|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
157031321|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031322|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031323|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031324|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031325|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031326|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
157031327|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
157031328|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
157031329|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
157031330|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
157031331|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
157031332|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
157031333|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
157031334|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
157167156|NCT04321252|567352685|FG002|Overall Study|Withdrawal by Subject|0|||
157167157|NCT04321252|567352686|FG003|Overall Study|Withdrawal by Subject|0|||
157167158|NCT04321252|567352687|FG004|Overall Study|Withdrawal by Subject|0|||
157167159|NCT04321252|567352688|FG005|Overall Study|Withdrawal by Subject|1|||
157031335|NCT04585815|566870113|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
157031336|NCT04585815|566870114|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
157031337|NCT04585815|566870115|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
157167160|NCT04321252|567352689|FG006|Overall Study|Withdrawal by Subject|0|||
157167161|NCT04321252|567352690|FG007|Overall Study|Withdrawal by Subject|0|||
156937301|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Adverse Event|3|||
156937302|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
156937303|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
156937304|NCT02357147|566528838|FG000|Maintenance Treatment Phase|Not Treated|1|||
156937305|NCT02357147|566528839|FG001|Maintenance Treatment Phase|Not Treated|0|||
156937306|NCT00653224|566530339|FG000|Overall Study|Adverse Event|2|||
156937307|NCT00653224|566530340|FG001|Overall Study|Adverse Event|1|||
156937308|NCT00653224|566530339|FG000|Overall Study|Lack of Efficacy|1|||
156937309|NCT00653224|566530340|FG001|Overall Study|Lack of Efficacy|2|||
156937310|NCT00653224|566530339|FG000|Overall Study|Loss of efficacy|1|||
156937311|NCT00653224|566530340|FG001|Overall Study|Loss of efficacy|0|||
156937312|NCT00653224|566530339|FG000|Overall Study|Lost to Follow-up|1|||
156937313|NCT00653224|566530340|FG001|Overall Study|Lost to Follow-up|0|||
156937314|NCT00653224|566530339|FG000|Overall Study|Other|2|||
156937315|NCT00653224|566530340|FG001|Overall Study|Other|4|||
156937316|NCT03756558|566530341|FG000|Overall Study|Death|1|||
156937317|NCT03756558|566530341|FG000|Overall Study|Lost to Follow-up|2|||
156937318|NCT03756558|566530341|FG000|Overall Study|Withdrawal by Subject|2|||
156937319|NCT02586012|566530342|FG000|Overall Study|Withdrawal by Subject|1|||
156937320|NCT02586012|566530343|FG001|Overall Study|Withdrawal by Subject|1|||
156937321|NCT02586012|566530344|FG002|Overall Study|Withdrawal by Subject|0|||
156937322|NCT02586012|566530345|FG003|Overall Study|Withdrawal by Subject|1|||
156937323|NCT02586012|566530346|FG004|Overall Study|Withdrawal by Subject|0|||
156937324|NCT02586012|566530347|FG005|Overall Study|Withdrawal by Subject|2|||
156937325|NCT02586012|566530342|FG000|Overall Study|Protocol Violation|0|||
156937326|NCT02586012|566530343|FG001|Overall Study|Protocol Violation|0|||
156937327|NCT02586012|566530344|FG002|Overall Study|Protocol Violation|0|||
156937328|NCT02586012|566530345|FG003|Overall Study|Protocol Violation|0|||
156937329|NCT02586012|566530346|FG004|Overall Study|Protocol Violation|0|||
156937330|NCT02586012|566530347|FG005|Overall Study|Protocol Violation|1|||
156937331|NCT02586012|566530342|FG000|Overall Study|study terminated|0|||
156937332|NCT02586012|566530343|FG001|Overall Study|study terminated|2|||
156937333|NCT02586012|566530344|FG002|Overall Study|study terminated|1|||
156937334|NCT02586012|566530345|FG003|Overall Study|study terminated|1|||
156937335|NCT02586012|566530346|FG004|Overall Study|study terminated|1|||
156937336|NCT02586012|566530347|FG005|Overall Study|study terminated|0|||
156937337|NCT02984020|566530348|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
156937338|NCT02984020|566530348|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
156937339|NCT02984020|566530348|FG000|Overall Study|Other significant protocol violation|2|||
156937340|NCT01700179|566530349|FG000|Overall Study|Physician Decision|2|||
156937341|NCT01896895|566530350|FG000|Double-blind MP|Physician Decision|0|||
156937342|NCT01896895|566530351|FG001|Double-blind MP|Physician Decision|0|||
156937343|NCT01896895|566530352|FG002|Double-blind MP|Physician Decision|1|||
156937344|NCT01896895|566530353|FG003|Double-blind MP|Physician Decision|0|||
156937345|NCT01896895|566530350|FG000|Double-blind MP|Withdrawal by Subject|0|||
156937346|NCT01896895|566530351|FG001|Double-blind MP|Withdrawal by Subject|2|||
156937347|NCT01896895|566530352|FG002|Double-blind MP|Withdrawal by Subject|1|||
156937348|NCT01896895|566530353|FG003|Double-blind MP|Withdrawal by Subject|0|||
156937349|NCT01896895|566530350|FG000|Double-blind MP|Lost to Follow-up|1|||
156937350|NCT01896895|566530351|FG001|Double-blind MP|Lost to Follow-up|0|||
156937351|NCT01896895|566530352|FG002|Double-blind MP|Lost to Follow-up|1|||
156937352|NCT01896895|566530353|FG003|Double-blind MP|Lost to Follow-up|0|||
156937353|NCT03277846|566530354|FG000|Overall Study|Inpatient stay too brief|12|||
156937354|NCT03277846|566530355|FG001|Overall Study|Inpatient stay too brief|11|||
156937355|NCT01589822|566530356|FG000|Overall Study|Withdrawal by Subject|1|||
156937356|NCT01589822|566530357|FG001|Overall Study|Withdrawal by Subject|2|||
156937357|NCT01589822|566530358|FG002|Overall Study|Withdrawal by Subject|0|||
156937358|NCT01589822|566530356|FG000|Overall Study|Death|1|||
156937359|NCT01589822|566530357|FG001|Overall Study|Death|0|||
156937360|NCT01589822|566530358|FG002|Overall Study|Death|0|||
156937361|NCT01589822|566530356|FG000|Overall Study|Missed 90 day visit|2|||
157031338|NCT04585815|566870116|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
157031339|NCT04585815|566870117|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
156937362|NCT01589822|566530357|FG001|Overall Study|Missed 90 day visit|1|||
156937363|NCT01589822|566530358|FG002|Overall Study|Missed 90 day visit|1|||
156937364|NCT05168475|566530359|FG000|Period 1|Protocol Violation|1|||
157031340|NCT04585815|566870118|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
157227130|NCT01047345|567577742|FG000|Base Study|Protocol Violation|3|||
156937365|NCT05168475|566530359|FG000|Period 1|IMP shortage|2|||
156937366|NCT05168475|566530359|FG000|Period 1|Not randomised|2|||
156937367|NCT05168475|566530359|FG000|Period 2|IMP shortage|1|||
156937368|NCT01302964|566530363|FG000|Overall Study|Adverse Event|1|||
156937369|NCT01302964|566530364|FG001|Overall Study|Adverse Event|0|||
156937370|NCT01945489|566530367|FG000|Cycle 1|Adverse Event|2|||
156937371|NCT01945489|566530368|FG001|Cycle 1|Adverse Event|0|||
156937372|NCT01945489|566530367|FG000|Cycle 1|Lost to Follow-up|4|||
156937373|NCT01945489|566530368|FG001|Cycle 1|Lost to Follow-up|0|||
156937374|NCT01945489|566530367|FG000|Cycle 1|Personal Reasons|4|||
156937375|NCT01945489|566530368|FG001|Cycle 1|Personal Reasons|2|||
156937376|NCT01945489|566530367|FG000|Cycle 1|Protocol Violation|0|||
156937377|NCT01945489|566530368|FG001|Cycle 1|Protocol Violation|1|||
156937378|NCT01945489|566530367|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
156937379|NCT01945489|566530368|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
156937380|NCT01945489|566530367|FG000|Cycle 2|Adverse Event|1|||
156937381|NCT01945489|566530368|FG001|Cycle 2|Adverse Event|0|||
156937382|NCT01945489|566530367|FG000|Cycle 2|Lost to Follow-up|0|||
156937383|NCT01945489|566530368|FG001|Cycle 2|Lost to Follow-up|1|||
156937384|NCT02223767|566530373|FG000|Overall Study|Withdrawal by Subject|4|||
156937385|NCT02223767|566530374|FG001|Overall Study|Withdrawal by Subject|4|||
156937386|NCT02789176|566530375|FG000|Overall Study|Death|0|||
156937387|NCT02789176|566530376|FG001|Overall Study|Death|0|||
156937388|NCT02789176|566530377|FG002|Overall Study|Death|3|||
156937389|NCT02789176|566530378|FG003|Overall Study|Death|0|||
156937390|NCT02789176|566530375|FG000|Overall Study|Withdrawal by Subject|0|||
156937391|NCT02789176|566530376|FG001|Overall Study|Withdrawal by Subject|0|||
156937392|NCT02789176|566530377|FG002|Overall Study|Withdrawal by Subject|1|||
156937393|NCT02789176|566530378|FG003|Overall Study|Withdrawal by Subject|0|||
156937394|NCT02789176|566530375|FG000|Overall Study|Lost to Follow-up|8|||
156937395|NCT02789176|566530376|FG001|Overall Study|Lost to Follow-up|2|||
156937396|NCT02789176|566530377|FG002|Overall Study|Lost to Follow-up|6|||
156937397|NCT02789176|566530378|FG003|Overall Study|Lost to Follow-up|1|||
156937398|NCT02347527|566530381|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
156937399|NCT02347527|566530382|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
156937400|NCT02347527|566530383|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
156937401|NCT02347527|566530384|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
156937402|NCT02347527|566530381|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
156937403|NCT02347527|566530382|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
156937404|NCT02347527|566530383|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
156937405|NCT02347527|566530384|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
156937406|NCT02347527|566530381|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
156937407|NCT02347527|566530382|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
156937408|NCT02347527|566530383|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
156937409|NCT02347527|566530384|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
156937410|NCT02347527|566530381|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
156937411|NCT02347527|566530382|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
156937412|NCT02347527|566530383|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
156937413|NCT02347527|566530384|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
156937414|NCT02347527|566530381|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156937415|NCT02347527|566530382|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
156937416|NCT02347527|566530383|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156937417|NCT02347527|566530384|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
156937418|NCT00596011|566530385|FG000|Overall Study|Withdrawal by Subject|2|||
156937419|NCT00596011|566530386|FG001|Overall Study|Withdrawal by Subject|3|||
156937420|NCT00596011|566530385|FG000|Overall Study|Adverse Event|11|||
156937421|NCT00596011|566530386|FG001|Overall Study|Adverse Event|7|||
156937422|NCT00192075|566530387|FG000|Overall Study|Disease Progression|23|||
156937423|NCT00192075|566530388|FG001|Overall Study|Disease Progression|6|||
156937424|NCT00192075|566530387|FG000|Overall Study|Adverse Event|1|||
156937425|NCT00192075|566530388|FG001|Overall Study|Adverse Event|3|||
156937426|NCT00192075|566530387|FG000|Overall Study|Death|0|||
156937427|NCT00192075|566530388|FG001|Overall Study|Death|1|||
156937428|NCT00192075|566530387|FG000|Overall Study|Lack of Efficacy|0|||
156937429|NCT00192075|566530388|FG001|Overall Study|Lack of Efficacy|0|||
156937430|NCT00192075|566530387|FG000|Overall Study|Physician Decision|3|||
156937431|NCT00192075|566530388|FG001|Overall Study|Physician Decision|0|||
156937432|NCT00192075|566530387|FG000|Overall Study|Withdrawal by Subject|5|||
156937433|NCT00192075|566530388|FG001|Overall Study|Withdrawal by Subject|5|||
156937434|NCT00192075|566530387|FG000|Overall Study|Patient Non-Compliance|0|||
156937435|NCT00192075|566530388|FG001|Overall Study|Patient Non-Compliance|1|||
156937436|NCT00192075|566530387|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
156937437|NCT00192075|566530388|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
156937438|NCT00192075|566530387|FG000|Overall Study|Other|5|||
156937439|NCT00192075|566530388|FG001|Overall Study|Other|2|||
156937440|NCT00779675|566530389|FG000|Treatment Period|Adverse Event|87|||
156937441|NCT00779675|566530389|FG000|Treatment Period|Treatment Failure|80|||
156937442|NCT00779675|566530389|FG000|Treatment Period|Transferred to Another Study|38|||
156937443|NCT00779675|566530389|FG000|Treatment Period|Lost to Follow-up|23|||
156937444|NCT00779675|566530389|FG000|Treatment Period|Withdrawal by Subject|46|||
156937445|NCT00779675|566530389|FG000|Treatment Period|Protocol Violation|54|||
156937446|NCT00779675|566530389|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
156937447|NCT00779675|566530389|FG000|Treatment Period|Administrative|3|||
156937448|NCT00779675|566530389|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
157167162|NCT04321252|567352691|FG008|Overall Study|Withdrawal by Subject|0|||
157167163|NCT06245044|567352692|FG000|No MI help|Technical issues|18|||
156937449|NCT00779675|566530389|FG000|Extended Treatment Period|Protocol Violation|13|||
156937450|NCT00779675|566530389|FG000|Extended Treatment Period|Adverse Event|6|||
156937451|NCT00779675|566530389|FG000|Extended Treatment Period|Treatment Failure|11|||
156937452|NCT00779675|566530389|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
156937453|NCT00779675|566530389|FG000|Extended Treatment Period|Lost to Follow-up|6|||
156937454|NCT01633944|566530398|FG000|Open-label Titration Phase|Adverse Event|109|||
156937455|NCT01633944|566530399|FG001|Open-label Titration Phase|Adverse Event|0|||
156937456|NCT01633944|566530400|FG002|Open-label Titration Phase|Adverse Event|0|||
156937457|NCT01633944|566530398|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
156937458|NCT01633944|566530399|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
156937459|NCT01633944|566530400|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
156937460|NCT01633944|566530398|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
156937461|NCT01633944|566530399|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
156937462|NCT01633944|566530400|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
156937463|NCT01633944|566530398|FG000|Open-label Titration Phase|Protocol Violation|24|||
156937464|NCT01633944|566530399|FG001|Open-label Titration Phase|Protocol Violation|0|||
156937465|NCT01633944|566530400|FG002|Open-label Titration Phase|Protocol Violation|0|||
156937466|NCT01633944|566530398|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
156937467|NCT01633944|566530399|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
156937468|NCT01633944|566530400|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
156937469|NCT01633944|566530398|FG000|Open-label Titration Phase|Other|68|||
156937470|NCT01633944|566530399|FG001|Open-label Titration Phase|Other|0|||
156937471|NCT01633944|566530400|FG002|Open-label Titration Phase|Other|0|||
156937472|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Adverse Event|0|||
156937473|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Adverse Event|13|||
156937474|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Adverse Event|7|||
156937475|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
156937476|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
156937477|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
156937478|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
156937479|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
156937480|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
156937481|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
156937482|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
156937483|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
156937484|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
156937485|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
156937486|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
156937487|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
156937488|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
156937489|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
156937490|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
156937491|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
156937492|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
156937493|NCT01633944|566530398|FG000|Double-blind Treatment Phase|Other|0|||
156937494|NCT01633944|566530399|FG001|Double-blind Treatment Phase|Other|7|||
156937495|NCT01633944|566530400|FG002|Double-blind Treatment Phase|Other|0|||
156937496|NCT00463060|566530404|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
156937497|NCT00463060|566530404|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
156937498|NCT01400841|566530405|FG000|Initial Study Phase (6 Months)|Death|1|||
156937499|NCT01400841|566530405|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
156937500|NCT00701129|566530406|FG000|Overall Study|Death|2|||
156937501|NCT00910715|566530407|FG000|Overall Study|Lost to Follow-up|22|||
156937502|NCT00910715|566530408|FG001|Overall Study|Lost to Follow-up|26|||
156937503|NCT00910715|566530409|FG002|Overall Study|Lost to Follow-up|0|||
156937504|NCT00770120|566530412|FG000|Overall Study|Progression|31|||
156937505|NCT00770120|566530412|FG000|Overall Study|Adverse Event|11|||
156937506|NCT00770120|566530412|FG000|Overall Study|Not Protocol Specified|11|||
156937507|NCT00770120|566530412|FG000|Overall Study|Death|3|||
156937508|NCT00770120|566530412|FG000|Overall Study|Withdrawal by Subject|2|||
156937509|NCT00770120|566530412|FG000|Overall Study|Ineligible|1|||
156937510|NCT00770120|566530412|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
156937511|NCT00770120|566530412|FG000|Overall Study|Reason under Review|1|||
156937512|NCT02412631|566530413|FG000|Overall Study|Adverse Event|1|||
157031341|NCT04585815|566870119|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
157167164|NCT01658579|567352696|FG000|Treatment Period A|Other|0|||
157167165|NCT01658579|567352697|FG001|Treatment Period A|Other|0|||
156937513|NCT02412631|566530414|FG001|Overall Study|Adverse Event|2|||
157031342|NCT04585815|566870113|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
157031343|NCT04585815|566870114|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
157031344|NCT04585815|566870115|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
157031345|NCT04585815|566870116|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
157031346|NCT04585815|566870117|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
157031347|NCT04585815|566870118|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
157031348|NCT04585815|566870119|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
157031349|NCT04585815|566870113|FG000|Sub-study B- Follow-up Phase|Death|0|||
157031350|NCT04585815|566870114|FG001|Sub-study B- Follow-up Phase|Death|0|||
157031351|NCT04585815|566870115|FG002|Sub-study B- Follow-up Phase|Death|1|||
157031352|NCT04585815|566870116|FG003|Sub-study B- Follow-up Phase|Death|3|||
157031353|NCT04585815|566870117|FG004|Sub-study B- Follow-up Phase|Death|0|||
157031354|NCT04585815|566870118|FG005|Sub-study B- Follow-up Phase|Death|0|||
157031355|NCT04585815|566870119|FG006|Sub-study B- Follow-up Phase|Death|1|||
157031356|NCT02497950|566870122|FG000|Overall Study|Death|209|||
157031357|NCT02497950|566870122|FG000|Overall Study|Transplanted|85|||
157031358|NCT02497950|566870122|FG000|Overall Study|Explanted|8|||
157031359|NCT02497950|566870122|FG000|Overall Study|Device Permanently Deactivated|4|||
157031360|NCT02497950|566870122|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
157031361|NCT02497950|566870122|FG000|Overall Study|Lost to Follow-up|6|||
157031362|NCT02497950|566870122|FG000|Overall Study|Withdrawal by Subject|2|||
157031363|NCT02497950|566870122|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
157031364|NCT02497950|566870122|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
157031365|NCT04660539|566870123|FG000|Overall Study|Adverse Event|10|||
157167166|NCT01658579|567352698|FG002|Treatment Period A|Other|1|||
157167167|NCT01658579|567352699|FG003|Treatment Period A|Other|1|||
156937514|NCT02412631|566530413|FG000|Overall Study|Lost to Follow-up|5|||
156937515|NCT02412631|566530414|FG001|Overall Study|Lost to Follow-up|9|||
156937516|NCT02412631|566530413|FG000|Overall Study|Withdrawal by Subject|9|||
156937517|NCT02412631|566530414|FG001|Overall Study|Withdrawal by Subject|3|||
156937518|NCT02412631|566530413|FG000|Overall Study|Early stop by FDA|5|||
156937519|NCT02412631|566530414|FG001|Overall Study|Early stop by FDA|2|||
156937520|NCT02412631|566530413|FG000|Overall Study|Unspecified reason|6|||
156937521|NCT02412631|566530414|FG001|Overall Study|Unspecified reason|8|||
156937522|NCT02884089|566530415|FG000|Period 1|Dosing error|2|||
156937523|NCT02884089|566530416|FG001|Period 1|Dosing error|2|||
156937524|NCT02884089|566530417|FG002|Period 1|Dosing error|0|||
156937525|NCT02884089|566530418|FG003|Period 1|Dosing error|0|||
156937526|NCT02884089|566530415|FG000|Washout Period 1|Lost to Follow-up|0|||
156937527|NCT02884089|566530416|FG001|Washout Period 1|Lost to Follow-up|1|||
156937528|NCT02884089|566530417|FG002|Washout Period 1|Lost to Follow-up|0|||
156937529|NCT02884089|566530418|FG003|Washout Period 1|Lost to Follow-up|1|||
156937530|NCT02884089|566530415|FG000|Washout Period 1|Withdrawal by Subject|0|||
156937531|NCT02884089|566530416|FG001|Washout Period 1|Withdrawal by Subject|1|||
156937532|NCT02884089|566530417|FG002|Washout Period 1|Withdrawal by Subject|0|||
156937533|NCT02884089|566530418|FG003|Washout Period 1|Withdrawal by Subject|0|||
156937534|NCT02884089|566530415|FG000|Period 2|Adverse Event|1|||
156937535|NCT02884089|566530416|FG001|Period 2|Adverse Event|0|||
156937536|NCT02884089|566530417|FG002|Period 2|Adverse Event|0|||
156937537|NCT02884089|566530418|FG003|Period 2|Adverse Event|0|||
156937538|NCT02884089|566530415|FG000|Period 3|Withdrawal by Subject|0|||
156937539|NCT02884089|566530416|FG001|Period 3|Withdrawal by Subject|0|||
156937540|NCT02884089|566530417|FG002|Period 3|Withdrawal by Subject|1|||
156937541|NCT02884089|566530418|FG003|Period 3|Withdrawal by Subject|0|||
156937542|NCT02884089|566530415|FG000|Washout Period 3|Withdrawal by Subject|0|||
156937543|NCT02884089|566530416|FG001|Washout Period 3|Withdrawal by Subject|0|||
156937544|NCT02884089|566530417|FG002|Washout Period 3|Withdrawal by Subject|1|||
156937545|NCT02884089|566530418|FG003|Washout Period 3|Withdrawal by Subject|0|||
156937546|NCT02884089|566530415|FG000|Washout Period 3|Lost to Follow-up|0|||
156937547|NCT02884089|566530416|FG001|Washout Period 3|Lost to Follow-up|0|||
156937548|NCT02884089|566530417|FG002|Washout Period 3|Lost to Follow-up|0|||
156937549|NCT02884089|566530418|FG003|Washout Period 3|Lost to Follow-up|1|||
156937550|NCT02884089|566530415|FG000|Period 4|Withdrawal by Subject|0|||
156937551|NCT02884089|566530416|FG001|Period 4|Withdrawal by Subject|1|||
156937552|NCT02884089|566530417|FG002|Period 4|Withdrawal by Subject|0|||
156937553|NCT02884089|566530418|FG003|Period 4|Withdrawal by Subject|0|||
156937554|NCT02884089|566530415|FG000|Period 4|Lost to Follow-up|1|||
156937555|NCT02884089|566530416|FG001|Period 4|Lost to Follow-up|0|||
156937556|NCT02884089|566530417|FG002|Period 4|Lost to Follow-up|0|||
156937557|NCT02884089|566530418|FG003|Period 4|Lost to Follow-up|0|||
156937558|NCT02884089|566530415|FG000|Follow-up Visit|Withdrawal by Subject|1|||
156937559|NCT02884089|566530416|FG001|Follow-up Visit|Withdrawal by Subject|0|||
156937560|NCT02884089|566530417|FG002|Follow-up Visit|Withdrawal by Subject|0|||
157031366|NCT04660539|566870123|FG000|Overall Study|Lack of Efficacy|4|||
157031367|NCT04660539|566870123|FG000|Overall Study|Lost to Follow-up|5|||
156937561|NCT02884089|566530418|FG003|Follow-up Visit|Withdrawal by Subject|1|||
156937562|NCT04304001|566530424|FG000|Overall Study|Lost to Follow-up|13|||
156937563|NCT04304001|566530425|FG001|Overall Study|Lost to Follow-up|9|||
157031368|NCT04660539|566870123|FG000|Overall Study|Non-Compliance With Study Drug|3|||
156937564|NCT03400332|566530428|FG000|Pre-Treatment|Other reasons|0|||
156937565|NCT03400332|566530429|FG001|Pre-Treatment|Other reasons|0|||
156937566|NCT03400332|566530430|FG002|Pre-Treatment|Other reasons|0|||
156937567|NCT03400332|566530431|FG003|Pre-Treatment|Other reasons|0|||
156937568|NCT03400332|566530432|FG004|Pre-Treatment|Other reasons|0|||
156937569|NCT03400332|566530433|FG005|Pre-Treatment|Other reasons|0|||
156937570|NCT03400332|566530434|FG006|Pre-Treatment|Other reasons|0|||
156937571|NCT03400332|566530435|FG007|Pre-Treatment|Other reasons|0|||
156937572|NCT03400332|566530436|FG008|Pre-Treatment|Other reasons|1|||
156937573|NCT03400332|566530428|FG000|Pre-Treatment|No longer met study criteria|0|||
156937574|NCT03400332|566530429|FG001|Pre-Treatment|No longer met study criteria|0|||
156937575|NCT03400332|566530430|FG002|Pre-Treatment|No longer met study criteria|0|||
156937576|NCT03400332|566530431|FG003|Pre-Treatment|No longer met study criteria|0|||
156937577|NCT03400332|566530432|FG004|Pre-Treatment|No longer met study criteria|0|||
156937578|NCT03400332|566530433|FG005|Pre-Treatment|No longer met study criteria|0|||
156937579|NCT03400332|566530434|FG006|Pre-Treatment|No longer met study criteria|0|||
156937580|NCT03400332|566530435|FG007|Pre-Treatment|No longer met study criteria|0|||
156937581|NCT03400332|566530436|FG008|Pre-Treatment|No longer met study criteria|1|||
156937582|NCT03400332|566530428|FG000|Pre-Treatment|Withdrawal by Subject|0|||
156937583|NCT03400332|566530429|FG001|Pre-Treatment|Withdrawal by Subject|0|||
156937584|NCT03400332|566530430|FG002|Pre-Treatment|Withdrawal by Subject|0|||
156937585|NCT03400332|566530431|FG003|Pre-Treatment|Withdrawal by Subject|0|||
156937586|NCT03400332|566530432|FG004|Pre-Treatment|Withdrawal by Subject|0|||
156937587|NCT03400332|566530433|FG005|Pre-Treatment|Withdrawal by Subject|0|||
156937588|NCT03400332|566530434|FG006|Pre-Treatment|Withdrawal by Subject|0|||
156937589|NCT03400332|566530435|FG007|Pre-Treatment|Withdrawal by Subject|0|||
156937590|NCT03400332|566530436|FG008|Pre-Treatment|Withdrawal by Subject|1|||
156937591|NCT03400332|566530428|FG000|Treatment|Participant withdrew consent|2|||
156937592|NCT03400332|566530429|FG001|Treatment|Participant withdrew consent|2|||
156937593|NCT03400332|566530430|FG002|Treatment|Participant withdrew consent|0|||
156937594|NCT03400332|566530431|FG003|Treatment|Participant withdrew consent|0|||
156937595|NCT03400332|566530432|FG004|Treatment|Participant withdrew consent|3|||
156937596|NCT03400332|566530433|FG005|Treatment|Participant withdrew consent|3|||
156937597|NCT03400332|566530434|FG006|Treatment|Participant withdrew consent|1|||
156937598|NCT03400332|566530435|FG007|Treatment|Participant withdrew consent|1|||
156937599|NCT03400332|566530436|FG008|Treatment|Participant withdrew consent|1|||
156937600|NCT03400332|566530428|FG000|Treatment|Other reasons|0|||
156937601|NCT03400332|566530429|FG001|Treatment|Other reasons|1|||
156937602|NCT03400332|566530430|FG002|Treatment|Other reasons|1|||
156937603|NCT03400332|566530431|FG003|Treatment|Other reasons|0|||
156937604|NCT03400332|566530432|FG004|Treatment|Other reasons|3|||
156937605|NCT03400332|566530433|FG005|Treatment|Other reasons|1|||
156937606|NCT03400332|566530434|FG006|Treatment|Other reasons|2|||
156937607|NCT03400332|566530435|FG007|Treatment|Other reasons|0|||
156937608|NCT03400332|566530436|FG008|Treatment|Other reasons|1|||
156937609|NCT03400332|566530428|FG000|Treatment|Lost to Follow-up|0|||
156937610|NCT03400332|566530429|FG001|Treatment|Lost to Follow-up|1|||
156937611|NCT03400332|566530430|FG002|Treatment|Lost to Follow-up|0|||
156937612|NCT03400332|566530431|FG003|Treatment|Lost to Follow-up|0|||
156937613|NCT03400332|566530432|FG004|Treatment|Lost to Follow-up|0|||
156937614|NCT03400332|566530433|FG005|Treatment|Lost to Follow-up|0|||
156937615|NCT03400332|566530434|FG006|Treatment|Lost to Follow-up|0|||
156937616|NCT03400332|566530435|FG007|Treatment|Lost to Follow-up|0|||
156937617|NCT03400332|566530436|FG008|Treatment|Lost to Follow-up|0|||
156937618|NCT03400332|566530428|FG000|Treatment|Death|3|||
156937619|NCT03400332|566530429|FG001|Treatment|Death|1|||
156937620|NCT03400332|566530430|FG002|Treatment|Death|2|||
156937621|NCT03400332|566530431|FG003|Treatment|Death|3|||
156937622|NCT03400332|566530432|FG004|Treatment|Death|6|||
156937623|NCT03400332|566530433|FG005|Treatment|Death|2|||
156937624|NCT03400332|566530434|FG006|Treatment|Death|1|||
156937625|NCT03400332|566530435|FG007|Treatment|Death|3|||
156937626|NCT03400332|566530436|FG008|Treatment|Death|6|||
156937627|NCT03795610|566530440|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
156937628|NCT03795610|566530440|FG000|Overall Study|Withdrawal by Subject|1|||
156937629|NCT03795610|566530440|FG000|Overall Study|Screen Failure (Unknown)|1|||
156937630|NCT02775344|566530441|FG000|Overall Study|No ovarian cyst identified|3|||
156937631|NCT02775344|566530442|FG001|Overall Study|No ovarian cyst identified|2|||
156937632|NCT01800916|566530443|FG000|Test Period 1 (1 Week)|Convex product user|0|||
156937633|NCT01800916|566530444|FG001|Test Period 1 (1 Week)|Convex product user|0|||
156937634|NCT01800916|566530445|FG002|Test Period 1 (1 Week)|Convex product user|0|||
156937635|NCT01800916|566530446|FG003|Test Period 1 (1 Week)|Convex product user|1|||
156937636|NCT01800916|566530447|FG004|Test Period 1 (1 Week)|Convex product user|0|||
157167168|NCT01658579|567352696|FG000|Treatment Period A|Adverse Event|1|||
156937637|NCT01800916|566530448|FG005|Test Period 1 (1 Week)|Convex product user|0|||
156937638|NCT01800916|566530449|FG006|Test Period 1 (1 Week)|Convex product user|0|||
156937639|NCT01800916|566530450|FG007|Test Period 1 (1 Week)|Convex product user|0|||
156937640|NCT01800916|566530451|FG008|Test Period 1 (1 Week)|Convex product user|0|||
157031369|NCT04660539|566870123|FG000|Overall Study|Reason not Specified|12|||
157031370|NCT04660539|566870123|FG000|Overall Study|Pregnancy|2|||
157031371|NCT04660539|566870123|FG000|Overall Study|Protocol Violation|2|||
156937641|NCT01800916|566530443|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
156937642|NCT01800916|566530444|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
157031372|NCT04660539|566870123|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
157031373|NCT04660539|566870123|FG000|Overall Study|Withdrawal by Subject|21|||
157031374|NCT00429364|566870128|FG000|Overall Study|Withdrawal by Subject|11|||
157031375|NCT00429364|566870129|FG001|Overall Study|Withdrawal by Subject|5|||
157031376|NCT00429364|566870128|FG000|Overall Study|Physician Decision|4|||
157031377|NCT00429364|566870129|FG001|Overall Study|Physician Decision|2|||
157031378|NCT00429364|566870128|FG000|Overall Study|Lost to Follow-up|7|||
157031379|NCT00429364|566870129|FG001|Overall Study|Lost to Follow-up|6|||
157031380|NCT00429364|566870128|FG000|Overall Study|Death|0|||
157031381|NCT00429364|566870129|FG001|Overall Study|Death|1|||
157031382|NCT00429364|566870128|FG000|Overall Study|Underwent aortic root surgery|10|||
157031383|NCT00429364|566870129|FG001|Overall Study|Underwent aortic root surgery|18|||
157031384|NCT00429364|566870128|FG000|Overall Study|Pregnancy|0|||
157031385|NCT00429364|566870129|FG001|Overall Study|Pregnancy|1|||
157031386|NCT03556293|566870130|FG000|Overall Study|Ineligible for analysis|1904|||
157031387|NCT03556293|566870131|FG001|Overall Study|Ineligible for analysis|1471|||
157031388|NCT03556293|566870132|FG002|Overall Study|Ineligible for analysis|1091|||
157031389|NCT03556293|566870133|FG003|Overall Study|Ineligible for analysis|1269|||
157031390|NCT04862234|566870136|FG000|Overall Study|Surgery cancellation|1|||
157031391|NCT04862234|566870137|FG001|Overall Study|Surgery cancellation|2|||
157031392|NCT04862234|566870136|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
157031393|NCT04862234|566870137|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
157031394|NCT04862234|566870136|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
157031395|NCT04862234|566870137|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
157031396|NCT03292484|566870138|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
157031397|NCT03292484|566870138|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
157031398|NCT03292484|566870138|FG000|Overall Study|Protocol Violation|2|||
157031399|NCT03292484|566870138|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
157031400|NCT03292484|566870138|FG000|Overall Study|Sponsor decision|349|||
157031401|NCT03292484|566870138|FG000|Overall Study|Lost to Follow-up|7|||
157031402|NCT03292484|566870138|FG000|Overall Study|Coronavirus Disease 2019|1|||
157031403|NCT03292484|566870138|FG000|Overall Study|Other|20|||
157031404|NCT05290493|566870141|FG000|Overall Study|Withdrawal by Subject|2|||
156937643|NCT01800916|566530445|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
156937644|NCT01800916|566530446|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
156937645|NCT01800916|566530447|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
156937646|NCT01800916|566530448|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
156937647|NCT01800916|566530449|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
156937648|NCT01800916|566530450|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
156937649|NCT01800916|566530451|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
156937650|NCT04049760|566530452|FG000|Overall Study|Withdrawal by Subject|1|||
156937651|NCT00974571|566530453|FG000|Overall Study|Adverse Event|31|||
156937652|NCT00974571|566530454|FG001|Overall Study|Adverse Event|4|||
156937653|NCT00974571|566530455|FG002|Overall Study|Adverse Event|27|||
156937654|NCT00974571|566530453|FG000|Overall Study|Lack of Efficacy|3|||
156937655|NCT00974571|566530454|FG001|Overall Study|Lack of Efficacy|2|||
156937656|NCT00974571|566530455|FG002|Overall Study|Lack of Efficacy|9|||
156937657|NCT00974571|566530453|FG000|Overall Study|Lost to Follow-up|2|||
156937658|NCT00974571|566530454|FG001|Overall Study|Lost to Follow-up|1|||
157227131|NCT01047345|567577743|FG001|Base Study|Protocol Violation|1|||
157227132|NCT01047345|567577744|FG002|Base Study|Protocol Violation|0|||
157227133|NCT01047345|567577742|FG000|Base Study|Withdrawal by Subject|12|||
157227134|NCT01047345|567577743|FG001|Base Study|Withdrawal by Subject|4|||
157227135|NCT01047345|567577744|FG002|Base Study|Withdrawal by Subject|0|||
157227136|NCT01047345|567577742|FG000|Extension|Withdrawal by Subject|0|||
157227137|NCT01047345|567577743|FG001|Extension|Withdrawal by Subject|0|||
157227138|NCT01047345|567577744|FG002|Extension|Withdrawal by Subject|1|||
157227139|NCT01047345|567577742|FG000|Extension|Lost to Follow-up|0|||
156937659|NCT00974571|566530455|FG002|Overall Study|Lost to Follow-up|2|||
157227140|NCT01047345|567577743|FG001|Extension|Lost to Follow-up|0|||
157227141|NCT01047345|567577744|FG002|Extension|Lost to Follow-up|5|||
157227142|NCT00454636|567577745|FG000|Overall Study|Adverse Event|10|||
157227143|NCT00454636|567577746|FG001|Overall Study|Adverse Event|6|||
156937660|NCT00974571|566530453|FG000|Overall Study|Protocol Violation|13|||
156937661|NCT00974571|566530454|FG001|Overall Study|Protocol Violation|4|||
156937662|NCT00974571|566530455|FG002|Overall Study|Protocol Violation|18|||
156937663|NCT00974571|566530453|FG000|Overall Study|Withdrawal by Subject|14|||
156937664|NCT00974571|566530454|FG001|Overall Study|Withdrawal by Subject|5|||
157227144|NCT00454636|567577747|FG002|Overall Study|Adverse Event|9|||
157227145|NCT00454636|567577748|FG003|Overall Study|Adverse Event|15|||
157227146|NCT00454636|567577745|FG000|Overall Study|Disease Progression|11|||
157227147|NCT00454636|567577746|FG001|Overall Study|Disease Progression|12|||
157227148|NCT00454636|567577747|FG002|Overall Study|Disease Progression|4|||
157227149|NCT00454636|567577748|FG003|Overall Study|Disease Progression|11|||
157227150|NCT00454636|567577745|FG000|Overall Study|Protocol Violation|3|||
157227151|NCT00454636|567577746|FG001|Overall Study|Protocol Violation|2|||
157227152|NCT00454636|567577747|FG002|Overall Study|Protocol Violation|3|||
157227153|NCT00454636|567577748|FG003|Overall Study|Protocol Violation|3|||
157227154|NCT00454636|567577745|FG000|Overall Study|Death|6|||
157227155|NCT00454636|567577746|FG001|Overall Study|Death|1|||
157227156|NCT00454636|567577747|FG002|Overall Study|Death|1|||
157227157|NCT00454636|567577748|FG003|Overall Study|Death|1|||
157227158|NCT00454636|567577745|FG000|Overall Study|Patient refusal|1|||
157227159|NCT00454636|567577746|FG001|Overall Study|Patient refusal|1|||
157227160|NCT00454636|567577747|FG002|Overall Study|Patient refusal|3|||
157031405|NCT05290493|566870142|FG001|Overall Study|Withdrawal by Subject|2|||
157031406|NCT05290493|566870141|FG000|Overall Study|Adverse Event|1|||
157031407|NCT05290493|566870142|FG001|Overall Study|Adverse Event|0|||
157031408|NCT05237284|566870148|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
157031409|NCT05237284|566870149|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
157031410|NCT05237284|566870150|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
157031411|NCT05237284|566870151|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
157031412|NCT05237284|566870148|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
157031413|NCT05237284|566870149|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
157031414|NCT05237284|566870150|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
157031415|NCT05237284|566870151|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
157031416|NCT05237284|566870148|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
157031417|NCT05237284|566870149|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
157031418|NCT05237284|566870150|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
157031419|NCT05237284|566870151|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
157031420|NCT05237284|566870148|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
157031421|NCT05237284|566870149|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
157031422|NCT05237284|566870150|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
157031423|NCT05237284|566870151|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
157031424|NCT05237284|566870148|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
157031425|NCT05237284|566870149|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
157031426|NCT05237284|566870150|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
157031427|NCT05237284|566870151|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
157031428|NCT05237284|566870148|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
157031429|NCT05237284|566870149|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
157031430|NCT05237284|566870150|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
157031431|NCT05237284|566870151|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
157031432|NCT05237284|566870148|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
157031433|NCT05237284|566870149|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
157031434|NCT05237284|566870150|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
157031435|NCT05237284|566870151|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
157031436|NCT05237284|566870148|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
157031437|NCT05237284|566870149|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
157031438|NCT05237284|566870150|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
157031439|NCT05237284|566870151|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
157031440|NCT05237284|566870148|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
157031441|NCT05237284|566870149|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
157031442|NCT05237284|566870150|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
157031443|NCT05237284|566870151|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
157031444|NCT04999111|566870152|FG000|Overall Study|Lost to Follow-up|21|||
157031445|NCT04999111|566870153|FG001|Overall Study|Lost to Follow-up|16|||
157031446|NCT04999111|566870154|FG002|Overall Study|Lost to Follow-up|2|||
157031447|NCT04999111|566870155|FG003|Overall Study|Lost to Follow-up|26|||
157031448|NCT04999111|566870156|FG004|Overall Study|Lost to Follow-up|30|||
157031449|NCT04999111|566870157|FG005|Overall Study|Lost to Follow-up|6|||
157031450|NCT04999111|566870152|FG000|Overall Study|Physician Decision|1|||
157031451|NCT04999111|566870153|FG001|Overall Study|Physician Decision|3|||
157031452|NCT04999111|566870154|FG002|Overall Study|Physician Decision|0|||
157031453|NCT04999111|566870155|FG003|Overall Study|Physician Decision|1|||
157031454|NCT04999111|566870156|FG004|Overall Study|Physician Decision|2|||
157031455|NCT04999111|566870157|FG005|Overall Study|Physician Decision|0|||
157031456|NCT04999111|566870152|FG000|Overall Study|Withdrawal by Subject|23|||
157031457|NCT04999111|566870153|FG001|Overall Study|Withdrawal by Subject|29|||
157227161|NCT00454636|567577748|FG003|Overall Study|Patient refusal|2|||
157227162|NCT00454636|567577745|FG000|Overall Study|Lost to Follow-up|0|||
157227163|NCT00454636|567577746|FG001|Overall Study|Lost to Follow-up|1|||
157227164|NCT00454636|567577747|FG002|Overall Study|Lost to Follow-up|0|||
157227165|NCT00454636|567577748|FG003|Overall Study|Lost to Follow-up|0|||
156937665|NCT00974571|566530455|FG002|Overall Study|Withdrawal by Subject|16|||
156937666|NCT00974571|566530453|FG000|Overall Study|Patient Moved|1|||
156937667|NCT00974571|566530454|FG001|Overall Study|Patient Moved|0|||
156937668|NCT00974571|566530455|FG002|Overall Study|Patient Moved|1|||
156937669|NCT00974571|566530453|FG000|Overall Study|Other|4|||
156937670|NCT00974571|566530454|FG001|Overall Study|Other|0|||
156937671|NCT00974571|566530455|FG002|Overall Study|Other|10|||
156937672|NCT03778931|566530459|FG000|Overall Study|Withdrawal by Subject|12|||
156937673|NCT03778931|566530460|FG001|Overall Study|Withdrawal by Subject|25|||
156937674|NCT03778931|566530459|FG000|Overall Study|Physician Decision|1|||
156937675|NCT03778931|566530460|FG001|Overall Study|Physician Decision|3|||
156937676|NCT03778931|566530459|FG000|Overall Study|Participant Noncompliance|1|||
156937677|NCT03778931|566530460|FG001|Overall Study|Participant Noncompliance|1|||
156937678|NCT03778931|566530459|FG000|Overall Study|Lost to Follow-up|4|||
156937679|NCT03778931|566530460|FG001|Overall Study|Lost to Follow-up|1|||
156937680|NCT03778931|566530459|FG000|Overall Study|Death|69|||
156937681|NCT03778931|566530460|FG001|Overall Study|Death|79|||
156937682|NCT02130765|566530461|FG000|Overall Study|Did not receive treatment|4|||
156937683|NCT02130765|566530462|FG001|Overall Study|Did not receive treatment|0|||
156937684|NCT02130765|566530463|FG002|Overall Study|Did not receive treatment|0|||
156937685|NCT02130765|566530464|FG003|Overall Study|Did not receive treatment|0|||
156937686|NCT00717769|566530484|FG000|Overall Study|Adverse Event|9|||
156937687|NCT00717769|566530485|FG001|Overall Study|Adverse Event|6|||
156937688|NCT00717769|566530486|FG002|Overall Study|Adverse Event|1|||
156937689|NCT00717769|566530484|FG000|Overall Study|Lack of compliance|0|||
156937690|NCT00717769|566530485|FG001|Overall Study|Lack of compliance|2|||
156937691|NCT00717769|566530486|FG002|Overall Study|Lack of compliance|0|||
156937692|NCT00717769|566530484|FG000|Overall Study|Lost to Follow-up|3|||
156937693|NCT00717769|566530485|FG001|Overall Study|Lost to Follow-up|4|||
156937694|NCT00717769|566530486|FG002|Overall Study|Lost to Follow-up|0|||
156937695|NCT00717769|566530484|FG000|Overall Study|Lack of Efficacy|1|||
156937696|NCT00717769|566530485|FG001|Overall Study|Lack of Efficacy|2|||
156937697|NCT00717769|566530486|FG002|Overall Study|Lack of Efficacy|0|||
156937698|NCT00717769|566530484|FG000|Overall Study|Protocol Violation|0|||
156937699|NCT00717769|566530485|FG001|Overall Study|Protocol Violation|2|||
156937700|NCT00717769|566530486|FG002|Overall Study|Protocol Violation|0|||
156937701|NCT00717769|566530484|FG000|Overall Study|Sponsor decision|1|||
156937702|NCT00717769|566530485|FG001|Overall Study|Sponsor decision|0|||
156937703|NCT00717769|566530486|FG002|Overall Study|Sponsor decision|10|||
156937704|NCT00717769|566530484|FG000|Overall Study|Withdrew consent|2|||
156937705|NCT00717769|566530485|FG001|Overall Study|Withdrew consent|2|||
156937706|NCT00717769|566530486|FG002|Overall Study|Withdrew consent|0|||
156937707|NCT00692770|566530487|FG000|Overall Study|Protocol Violation|2|||
156937708|NCT00692770|566530488|FG001|Overall Study|Protocol Violation|7|||
156937709|NCT00692770|566530487|FG000|Overall Study|Withdrawal by Subject|97|||
156937710|NCT00692770|566530488|FG001|Overall Study|Withdrawal by Subject|36|||
156937711|NCT00692770|566530487|FG000|Overall Study|Adverse Event|136|||
156937712|NCT00692770|566530488|FG001|Overall Study|Adverse Event|41|||
156937713|NCT00692770|566530487|FG000|Overall Study|Death|10|||
156937714|NCT00692770|566530488|FG001|Overall Study|Death|5|||
156937715|NCT00692770|566530487|FG000|Overall Study|Lost to Follow-up|7|||
156937716|NCT00692770|566530488|FG001|Overall Study|Lost to Follow-up|3|||
156937717|NCT00692770|566530487|FG000|Overall Study|Non-compliant with study medication|11|||
156937718|NCT00692770|566530488|FG001|Overall Study|Non-compliant with study medication|5|||
156937719|NCT00692770|566530487|FG000|Overall Study|Progression by clinical judgment|2|||
156937720|NCT00692770|566530488|FG001|Overall Study|Progression by clinical judgment|3|||
156937721|NCT00692770|566530487|FG000|Overall Study|Physician decision not protocol driven|10|||
156937722|NCT00692770|566530488|FG001|Overall Study|Physician decision not protocol driven|14|||
156937723|NCT00692770|566530487|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
156937724|NCT00692770|566530488|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
156937725|NCT00692770|566530487|FG000|Overall Study|Protocol driven decision point|3|||
156937726|NCT00692770|566530488|FG001|Overall Study|Protocol driven decision point|7|||
156937727|NCT00692770|566530487|FG000|Overall Study|Completed all planned assessments|79|||
156937728|NCT00692770|566530488|FG001|Overall Study|Completed all planned assessments|101|||
156937729|NCT00692770|566530487|FG000|Overall Study|Radiological and clinical progression|8|||
156937730|NCT00692770|566530488|FG001|Overall Study|Radiological and clinical progression|8|||
156937731|NCT00692770|566530487|FG000|Overall Study|Clinical endpoint reached|16|||
156937732|NCT00692770|566530488|FG001|Overall Study|Clinical endpoint reached|43|||
156937733|NCT00692770|566530487|FG000|Overall Study|Study terminated by sponsor|2|||
156937734|NCT00692770|566530488|FG001|Overall Study|Study terminated by sponsor|2|||
156937735|NCT00692770|566530487|FG000|Overall Study|Randomized but not treated|3|||
156937736|NCT00692770|566530488|FG001|Overall Study|Randomized but not treated|4|||
156937737|NCT04327986|566530490|FG000|Overall Study|Physician Decision|2|||
156937738|NCT04327986|566530491|FG001|Overall Study|Physician Decision|0|||
156937739|NCT04327986|566530492|FG002|Overall Study|Physician Decision|0|||
156937740|NCT04327986|566530490|FG000|Overall Study|Death|1|||
156937741|NCT04327986|566530491|FG001|Overall Study|Death|0|||
156937742|NCT04327986|566530492|FG002|Overall Study|Death|0|||
157031458|NCT04999111|566870154|FG002|Overall Study|Withdrawal by Subject|15|||
157031459|NCT04999111|566870155|FG003|Overall Study|Withdrawal by Subject|30|||
157031460|NCT04999111|566870156|FG004|Overall Study|Withdrawal by Subject|35|||
157031461|NCT04999111|566870157|FG005|Overall Study|Withdrawal by Subject|10|||
157031462|NCT04999111|566870152|FG000|Overall Study|Other|6|||
157031463|NCT04999111|566870153|FG001|Overall Study|Other|6|||
157031464|NCT04999111|566870154|FG002|Overall Study|Other|3|||
157031465|NCT04999111|566870155|FG003|Overall Study|Other|8|||
157031466|NCT04999111|566870156|FG004|Overall Study|Other|8|||
157031467|NCT04999111|566870157|FG005|Overall Study|Other|5|||
157031468|NCT04999111|566870152|FG000|Overall Study|Non-compliance with study schedule|1|||
157031469|NCT04999111|566870153|FG001|Overall Study|Non-compliance with study schedule|0|||
157031470|NCT04999111|566870154|FG002|Overall Study|Non-compliance with study schedule|0|||
157031471|NCT04999111|566870155|FG003|Overall Study|Non-compliance with study schedule|1|||
157031472|NCT04999111|566870156|FG004|Overall Study|Non-compliance with study schedule|1|||
157031473|NCT04999111|566870157|FG005|Overall Study|Non-compliance with study schedule|1|||
156937743|NCT03962543|566530502|FG000|Treatment Phase|Death|0|||
156937744|NCT03962543|566530503|FG001|Treatment Phase|Death|1|||
156937745|NCT03962543|566530502|FG000|Treatment Phase|Withdrawal by Subject|3|||
156937746|NCT03962543|566530503|FG001|Treatment Phase|Withdrawal by Subject|0|||
156937747|NCT03962543|566530502|FG000|Treatment Phase|Adverse Event|3|||
156937748|NCT03962543|566530503|FG001|Treatment Phase|Adverse Event|12|||
156937749|NCT03962543|566530502|FG000|Treatment Phase|Lost to Follow-up|1|||
156937750|NCT03962543|566530503|FG001|Treatment Phase|Lost to Follow-up|2|||
156937751|NCT03962543|566530502|FG000|Treatment Phase|Radiographic PD|9|||
156937752|NCT03962543|566530503|FG001|Treatment Phase|Radiographic PD|3|||
156937753|NCT03962543|566530502|FG000|Treatment Phase|Participant Decision|3|||
156937754|NCT03962543|566530503|FG001|Treatment Phase|Participant Decision|8|||
156937755|NCT03962543|566530502|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
156937756|NCT03962543|566530503|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
156937757|NCT03962543|566530502|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
156937758|NCT03962543|566530503|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
156937759|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
156937760|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
156937761|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
156937762|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
156937763|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
156937764|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
156937765|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
156937766|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
156937767|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
156937768|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
156937769|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
156937770|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
156937771|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
156937772|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
156937773|NCT03962543|566530502|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
156937774|NCT03962543|566530503|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
156937775|NCT01101841|566532414|FG000|Overall Study|Adverse Event|15|||
156937776|NCT01101841|566532415|FG001|Overall Study|Adverse Event|15|||
156937777|NCT01101841|566532414|FG000|Overall Study|Lost to Follow-up|9|||
156937778|NCT01101841|566532415|FG001|Overall Study|Lost to Follow-up|3|||
156937779|NCT01101841|566532414|FG000|Overall Study|Withdrawal by Subject|21|||
156937780|NCT01101841|566532415|FG001|Overall Study|Withdrawal by Subject|40|||
156937781|NCT01101841|566532414|FG000|Overall Study|Protocol Violation|1|||
156937782|NCT01101841|566532415|FG001|Overall Study|Protocol Violation|1|||
156937783|NCT01101841|566532414|FG000|Overall Study|Physician Decision|0|||
156937784|NCT01101841|566532415|FG001|Overall Study|Physician Decision|2|||
156937785|NCT01101841|566532414|FG000|Overall Study|Lack of Efficacy|0|||
156937786|NCT01101841|566532415|FG001|Overall Study|Lack of Efficacy|2|||
157031474|NCT04999111|566870152|FG000|Overall Study|Randomized but not vaccinated|1|||
157227166|NCT01400113|567577749|FG000|Overall Study|Withdrawal by Subject|1|||
157227167|NCT01400113|567577750|FG001|Overall Study|Withdrawal by Subject|1|||
156937787|NCT01101841|566532414|FG000|Overall Study|Other|0|||
156937788|NCT01101841|566532415|FG001|Overall Study|Other|1|||
156937789|NCT01101841|566532414|FG000|Overall Study|Suicidality Tracking Scale|3|||
156937790|NCT01101841|566532415|FG001|Overall Study|Suicidality Tracking Scale|1|||
156937791|NCT01101841|566532414|FG000|Overall Study|Eligibility Criteria|1|||
156937792|NCT01101841|566532415|FG001|Overall Study|Eligibility Criteria|2|||
156937793|NCT02896400|566532417|FG000|1 Month Follow-up|Lost to Follow-up|7|||
156937794|NCT02896400|566532418|FG001|1 Month Follow-up|Lost to Follow-up|7|||
157031475|NCT04999111|566870153|FG001|Overall Study|Randomized but not vaccinated|2|||
157031476|NCT04999111|566870154|FG002|Overall Study|Randomized but not vaccinated|0|||
156937795|NCT02896400|566532419|FG002|1 Month Follow-up|Lost to Follow-up|5|||
156937796|NCT02896400|566532420|FG003|1 Month Follow-up|Lost to Follow-up|8|||
157227168|NCT00806156|567577751|FG000|Overall Study|Death|35|||
157167169|NCT01658579|567352697|FG001|Treatment Period A|Adverse Event|0|||
156937797|NCT02896400|566532421|FG004|1 Month Follow-up|Lost to Follow-up|9|||
156937798|NCT02896400|566532422|FG005|1 Month Follow-up|Lost to Follow-up|6|||
156937799|NCT02896400|566532423|FG006|1 Month Follow-up|Lost to Follow-up|5|||
156937800|NCT02896400|566532424|FG007|1 Month Follow-up|Lost to Follow-up|6|||
156937801|NCT02896400|566532425|FG008|1 Month Follow-up|Lost to Follow-up|4|||
156937802|NCT02896400|566532426|FG009|1 Month Follow-up|Lost to Follow-up|7|||
156937803|NCT02896400|566532427|FG010|1 Month Follow-up|Lost to Follow-up|5|||
156937804|NCT02896400|566532428|FG011|1 Month Follow-up|Lost to Follow-up|5|||
156937805|NCT02896400|566532429|FG012|1 Month Follow-up|Lost to Follow-up|3|||
156937806|NCT02896400|566532430|FG013|1 Month Follow-up|Lost to Follow-up|4|||
156937807|NCT02896400|566532431|FG014|1 Month Follow-up|Lost to Follow-up|1|||
156937808|NCT02896400|566532432|FG015|1 Month Follow-up|Lost to Follow-up|2|||
156937809|NCT02896400|566532417|FG000|1 Month Follow-up|Death|0|||
156937810|NCT02896400|566532418|FG001|1 Month Follow-up|Death|0|||
156937811|NCT02896400|566532419|FG002|1 Month Follow-up|Death|0|||
156937812|NCT02896400|566532420|FG003|1 Month Follow-up|Death|0|||
156937813|NCT02896400|566532421|FG004|1 Month Follow-up|Death|0|||
156937814|NCT02896400|566532422|FG005|1 Month Follow-up|Death|0|||
156937815|NCT02896400|566532423|FG006|1 Month Follow-up|Death|0|||
156937816|NCT02896400|566532424|FG007|1 Month Follow-up|Death|0|||
156937817|NCT02896400|566532425|FG008|1 Month Follow-up|Death|0|||
156937818|NCT02896400|566532426|FG009|1 Month Follow-up|Death|0|||
156937819|NCT02896400|566532427|FG010|1 Month Follow-up|Death|0|||
156937820|NCT02896400|566532428|FG011|1 Month Follow-up|Death|0|||
156937821|NCT02896400|566532429|FG012|1 Month Follow-up|Death|0|||
156937822|NCT02896400|566532430|FG013|1 Month Follow-up|Death|0|||
156937823|NCT02896400|566532431|FG014|1 Month Follow-up|Death|0|||
156937824|NCT02896400|566532432|FG015|1 Month Follow-up|Death|1|||
156937825|NCT02896400|566532417|FG000|3 Month Follow-up|Lost to Follow-up|6|||
156937826|NCT02896400|566532418|FG001|3 Month Follow-up|Lost to Follow-up|3|||
156937827|NCT02896400|566532419|FG002|3 Month Follow-up|Lost to Follow-up|6|||
156937828|NCT02896400|566532420|FG003|3 Month Follow-up|Lost to Follow-up|11|||
156937829|NCT02896400|566532421|FG004|3 Month Follow-up|Lost to Follow-up|12|||
156937830|NCT02896400|566532422|FG005|3 Month Follow-up|Lost to Follow-up|6|||
156937831|NCT02896400|566532423|FG006|3 Month Follow-up|Lost to Follow-up|4|||
156937832|NCT02896400|566532424|FG007|3 Month Follow-up|Lost to Follow-up|3|||
156937833|NCT02896400|566532425|FG008|3 Month Follow-up|Lost to Follow-up|6|||
156937834|NCT02896400|566532426|FG009|3 Month Follow-up|Lost to Follow-up|5|||
156937835|NCT02896400|566532427|FG010|3 Month Follow-up|Lost to Follow-up|6|||
156937836|NCT02896400|566532428|FG011|3 Month Follow-up|Lost to Follow-up|6|||
156937837|NCT02896400|566532429|FG012|3 Month Follow-up|Lost to Follow-up|3|||
156937838|NCT02896400|566532430|FG013|3 Month Follow-up|Lost to Follow-up|5|||
156937839|NCT02896400|566532431|FG014|3 Month Follow-up|Lost to Follow-up|3|||
156937840|NCT02896400|566532432|FG015|3 Month Follow-up|Lost to Follow-up|2|||
156937841|NCT02896400|566532417|FG000|3 Month Follow-up|Death|0|||
156937842|NCT02896400|566532418|FG001|3 Month Follow-up|Death|0|||
156937843|NCT02896400|566532419|FG002|3 Month Follow-up|Death|0|||
156937844|NCT02896400|566532420|FG003|3 Month Follow-up|Death|0|||
156937845|NCT02896400|566532421|FG004|3 Month Follow-up|Death|0|||
156937846|NCT02896400|566532422|FG005|3 Month Follow-up|Death|0|||
156937847|NCT02896400|566532423|FG006|3 Month Follow-up|Death|0|||
156937848|NCT02896400|566532424|FG007|3 Month Follow-up|Death|0|||
156937849|NCT02896400|566532425|FG008|3 Month Follow-up|Death|0|||
156937850|NCT02896400|566532426|FG009|3 Month Follow-up|Death|0|||
156937851|NCT02896400|566532427|FG010|3 Month Follow-up|Death|0|||
156937852|NCT02896400|566532428|FG011|3 Month Follow-up|Death|0|||
156937853|NCT02896400|566532429|FG012|3 Month Follow-up|Death|0|||
156937854|NCT02896400|566532430|FG013|3 Month Follow-up|Death|1|||
156937855|NCT02896400|566532431|FG014|3 Month Follow-up|Death|1|||
156937856|NCT02896400|566532432|FG015|3 Month Follow-up|Death|0|||
156937857|NCT02896400|566532417|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937858|NCT02896400|566532418|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156937859|NCT02896400|566532419|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937860|NCT02896400|566532420|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937861|NCT02896400|566532421|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156937862|NCT02896400|566532422|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937863|NCT02896400|566532423|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
156937864|NCT02896400|566532424|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
156937865|NCT02896400|566532425|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937866|NCT02896400|566532426|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937867|NCT02896400|566532427|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156937868|NCT02896400|566532428|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156937869|NCT02896400|566532429|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
156937870|NCT02896400|566532430|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
156937871|NCT02896400|566532431|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
156937872|NCT02896400|566532432|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
157167170|NCT01658579|567352698|FG002|Treatment Period A|Adverse Event|0|||
156937873|NCT02896400|566532417|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
156937874|NCT02896400|566532418|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156937875|NCT02896400|566532419|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
156937876|NCT02896400|566532420|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
156937877|NCT02896400|566532421|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
156937878|NCT02896400|566532422|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156937879|NCT02896400|566532423|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156937880|NCT02896400|566532424|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
156937881|NCT02896400|566532425|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
156937882|NCT02896400|566532426|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156937883|NCT02896400|566532427|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
156937884|NCT02896400|566532428|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
156937885|NCT02896400|566532429|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156937886|NCT02896400|566532430|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
156937887|NCT02896400|566532431|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
156937888|NCT02896400|566532432|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
156937889|NCT01207778|566532433|FG000|Overall Study|Lost to Follow-up|0|||
156937890|NCT01207778|566532434|FG001|Overall Study|Lost to Follow-up|3|||
156937891|NCT01207778|566532435|FG002|Overall Study|Lost to Follow-up|3|||
156937892|NCT00773175|566532438|FG000|Overall Study|Adverse Event|2|||
156937893|NCT00773175|566532439|FG001|Overall Study|Adverse Event|0|||
156937894|NCT00773175|566532438|FG000|Overall Study|Consent Withdrawn|0|||
156937895|NCT00773175|566532439|FG001|Overall Study|Consent Withdrawn|2|||
156937896|NCT00503841|566532440|FG000|Overall Study|All screen failures|44|||
156937897|NCT01982253|566532442|FG000|Overall Study|Withdrawal by Subject|1|||
156937898|NCT01982253|566532443|FG001|Overall Study|Withdrawal by Subject|0|||
156937899|NCT01982253|566532444|FG002|Overall Study|Withdrawal by Subject|0|||
156937900|NCT01982253|566532442|FG000|Overall Study|Study terminated by sponsor|1|||
156937901|NCT01982253|566532443|FG001|Overall Study|Study terminated by sponsor|4|||
156937902|NCT01982253|566532444|FG002|Overall Study|Study terminated by sponsor|4|||
156937903|NCT03752619|566532454|FG000|Overall Study|Lost to Follow-up|2|||
156937904|NCT03752619|566532455|FG001|Overall Study|Lost to Follow-up|1|||
156937905|NCT03752619|566532454|FG000|Overall Study|Withdrawal by Subject|1|||
156937906|NCT03752619|566532455|FG001|Overall Study|Withdrawal by Subject|1|||
156937907|NCT03752619|566532454|FG000|Overall Study|Adverse Event|0|||
156937908|NCT03752619|566532455|FG001|Overall Study|Adverse Event|1|||
156937909|NCT03907683|566532456|FG000|Overall Study|Pregnancy|1|||
156937910|NCT03907683|566532456|FG000|Overall Study|Withdrawal by Subject|1|||
156937911|NCT00235872|566532457|FG000|Overall Study|Adverse Event|34|||
156937912|NCT00235872|566532457|FG000|Overall Study|Death|1|||
156937913|NCT00235872|566532457|FG000|Overall Study|Lost to Follow-up|1|||
156937914|NCT00235872|566532457|FG000|Overall Study|Withdrawal by Subject|50|||
156937915|NCT00235872|566532457|FG000|Overall Study|Administrative reason|61|||
156937916|NCT02027844|566532458|FG000|Overall Study|Withdrawal by Subject|3|||
156937917|NCT02027844|566532459|FG001|Overall Study|Withdrawal by Subject|2|||
156937918|NCT02027844|566532460|FG002|Overall Study|Withdrawal by Subject|1|||
156937919|NCT02027844|566532458|FG000|Overall Study|Lost to Follow-up|0|||
156937920|NCT02027844|566532459|FG001|Overall Study|Lost to Follow-up|2|||
156937921|NCT02027844|566532460|FG002|Overall Study|Lost to Follow-up|1|||
156937922|NCT02027844|566532458|FG000|Overall Study|Protocol Violation|0|||
156937923|NCT02027844|566532459|FG001|Overall Study|Protocol Violation|2|||
156937924|NCT02027844|566532460|FG002|Overall Study|Protocol Violation|0|||
156937925|NCT02027844|566532458|FG000|Overall Study|Incomlete data|2|||
156937926|NCT02027844|566532459|FG001|Overall Study|Incomlete data|0|||
156937927|NCT02027844|566532460|FG002|Overall Study|Incomlete data|0|||
156937928|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
156937929|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
156937930|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Graft loss|1|||
156937931|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Graft loss|2|||
156937932|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Death|5|||
157167171|NCT01658579|567352699|FG003|Treatment Period A|Adverse Event|0|||
156937933|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Death|3|||
156937934|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
156937935|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
157031477|NCT04999111|566870155|FG003|Overall Study|Randomized but not vaccinated|3|||
157031478|NCT04999111|566870156|FG004|Overall Study|Randomized but not vaccinated|3|||
156937936|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
156937937|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
157031479|NCT04999111|566870157|FG005|Overall Study|Randomized but not vaccinated|0|||
157167172|NCT01658579|567352696|FG000|Treatment Period B|Other|0|||
157167173|NCT01658579|567352697|FG001|Treatment Period B|Other|0|||
157167174|NCT01658579|567352698|FG002|Treatment Period B|Other|0|||
157167175|NCT01658579|567352699|FG003|Treatment Period B|Other|1|||
157167176|NCT05590767|567352700|FG000|Overall Study|Protocol Violation|1|||
157167177|NCT05590767|567352700|FG000|Overall Study|surgery canceled|1|||
156937938|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
156937939|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
156937940|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
156937941|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
156937942|NCT00378014|566532461|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
156937943|NCT00378014|566532462|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
156937944|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
156937945|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
156937946|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Death|1|||
156937947|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Death|2|||
156937948|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
156937949|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
156937950|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
156937951|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
156937952|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
156937953|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
156937954|NCT00378014|566532461|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
156937955|NCT00378014|566532462|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
156937956|NCT00414661|566532463|FG000|Overall Study|Death|2|||
156937957|NCT00414661|566532464|FG001|Overall Study|Death|5|||
156937958|NCT00414661|566532465|FG002|Overall Study|Death|0|||
156937959|NCT00414661|566532466|FG003|Overall Study|Death|0|||
156937960|NCT00414661|566532463|FG000|Overall Study|Lost to Follow-up|1|||
156937961|NCT00414661|566532464|FG001|Overall Study|Lost to Follow-up|4|||
156937962|NCT00414661|566532465|FG002|Overall Study|Lost to Follow-up|0|||
156937963|NCT00414661|566532466|FG003|Overall Study|Lost to Follow-up|1|||
156937964|NCT00414661|566532463|FG000|Overall Study|Withdrawal by Subject|5|||
156937965|NCT00414661|566532464|FG001|Overall Study|Withdrawal by Subject|2|||
156937966|NCT00414661|566532465|FG002|Overall Study|Withdrawal by Subject|2|||
156937967|NCT00414661|566532466|FG003|Overall Study|Withdrawal by Subject|2|||
156937968|NCT00414661|566532463|FG000|Overall Study|Other|6|||
156937969|NCT00414661|566532464|FG001|Overall Study|Other|3|||
156937970|NCT00414661|566532465|FG002|Overall Study|Other|0|||
156937971|NCT00414661|566532466|FG003|Overall Study|Other|0|||
156937972|NCT02852265|566532470|FG000|3-month Follow-up|Lost to Follow-up|1|||
156937973|NCT02852265|566532471|FG001|3-month Follow-up|Lost to Follow-up|1|||
156937974|NCT04370691|566532482|FG000|Overall Study|Pending visit|48|||
156937975|NCT04370691|566532482|FG000|Overall Study|Have Not Reached Lower Window|15|||
156937976|NCT04370691|566532482|FG000|Overall Study|Termination|14|||
156937977|NCT04370691|566532482|FG000|Overall Study|Missed or Overdue|10|||
156937978|NCT00486265|566532483|FG000|Overall Study|Adverse Event|1|||
156937979|NCT00486265|566532483|FG000|Overall Study|Lack of Efficacy|8|||
156937980|NCT01452412|566532484|FG000|Overall Study|Withdrawal by Subject|15|||
156937981|NCT01452412|566532485|FG001|Overall Study|Withdrawal by Subject|11|||
156937982|NCT01452412|566532484|FG000|Overall Study|Adverse Event|4|||
156937983|NCT01452412|566532485|FG001|Overall Study|Adverse Event|3|||
156937984|NCT01452412|566532484|FG000|Overall Study|Lost to Follow-up|5|||
156937985|NCT01452412|566532485|FG001|Overall Study|Lost to Follow-up|3|||
156937986|NCT01452412|566532484|FG000|Overall Study|Death|1|||
156937987|NCT01452412|566532485|FG001|Overall Study|Death|0|||
156937988|NCT01452412|566532484|FG000|Overall Study|Initiated dialysis|1|||
156937989|NCT01452412|566532485|FG001|Overall Study|Initiated dialysis|0|||
156937990|NCT01452412|566532484|FG000|Overall Study|Other|2|||
156937991|NCT01452412|566532485|FG001|Overall Study|Other|0|||
156937992|NCT03013543|566532486|FG000|Overall Study|Withdrawal by Subject|0|||
156937993|NCT03013543|566532487|FG001|Overall Study|Withdrawal by Subject|2|||
156937994|NCT03013543|566532488|FG002|Overall Study|Withdrawal by Subject|0|||
156937995|NCT03013543|566532489|FG003|Overall Study|Withdrawal by Subject|5|||
156937996|NCT03013543|566532490|FG004|Overall Study|Withdrawal by Subject|6|||
156937997|NCT03013543|566532491|FG005|Overall Study|Withdrawal by Subject|2|||
156937998|NCT03013543|566532492|FG006|Overall Study|Withdrawal by Subject|3|||
156937999|NCT03013543|566532493|FG007|Overall Study|Withdrawal by Subject|1|||
156938000|NCT03013543|566532494|FG008|Overall Study|Withdrawal by Subject|0|||
156938001|NCT03013543|566532495|FG009|Overall Study|Withdrawal by Subject|4|||
156938002|NCT03013543|566532486|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156938003|NCT03013543|566532487|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
156938004|NCT03013543|566532488|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
156938005|NCT03013543|566532489|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
156938006|NCT03013543|566532490|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
156938007|NCT03013543|566532491|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
156938008|NCT03013543|566532492|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
157031480|NCT04999111|566870152|FG000|Overall Study|Adverse Event|1|||
156938009|NCT03013543|566532493|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
156938010|NCT03013543|566532494|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
156938011|NCT03013543|566532495|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
156938012|NCT03013543|566532486|FG000|Overall Study|Other|0|||
156938013|NCT03013543|566532487|FG001|Overall Study|Other|0|||
156938014|NCT03013543|566532488|FG002|Overall Study|Other|2|||
156938015|NCT03013543|566532489|FG003|Overall Study|Other|0|||
156938016|NCT03013543|566532490|FG004|Overall Study|Other|2|||
156938017|NCT03013543|566532491|FG005|Overall Study|Other|0|||
156938018|NCT03013543|566532492|FG006|Overall Study|Other|0|||
156938019|NCT03013543|566532493|FG007|Overall Study|Other|0|||
156938020|NCT03013543|566532494|FG008|Overall Study|Other|1|||
156938021|NCT03013543|566532495|FG009|Overall Study|Other|0|||
156938022|NCT03013543|566532486|FG000|Overall Study|Adverse Event|0|||
156938023|NCT03013543|566532487|FG001|Overall Study|Adverse Event|0|||
156938024|NCT03013543|566532488|FG002|Overall Study|Adverse Event|0|||
156938025|NCT03013543|566532489|FG003|Overall Study|Adverse Event|3|||
156938026|NCT03013543|566532490|FG004|Overall Study|Adverse Event|2|||
156938027|NCT03013543|566532491|FG005|Overall Study|Adverse Event|1|||
156938028|NCT03013543|566532492|FG006|Overall Study|Adverse Event|3|||
156938029|NCT03013543|566532493|FG007|Overall Study|Adverse Event|8|||
156938030|NCT03013543|566532494|FG008|Overall Study|Adverse Event|0|||
156938031|NCT03013543|566532495|FG009|Overall Study|Adverse Event|2|||
156938032|NCT03013543|566532486|FG000|Overall Study|Death|0|||
156938033|NCT03013543|566532487|FG001|Overall Study|Death|0|||
156938034|NCT03013543|566532488|FG002|Overall Study|Death|0|||
156938035|NCT03013543|566532489|FG003|Overall Study|Death|1|||
156938036|NCT03013543|566532490|FG004|Overall Study|Death|0|||
156938037|NCT03013543|566532491|FG005|Overall Study|Death|0|||
156938038|NCT03013543|566532492|FG006|Overall Study|Death|0|||
156938039|NCT03013543|566532493|FG007|Overall Study|Death|0|||
156938040|NCT03013543|566532494|FG008|Overall Study|Death|0|||
156938041|NCT03013543|566532495|FG009|Overall Study|Death|0|||
156938042|NCT03013543|566532486|FG000|Overall Study|Lack of Efficacy|0|||
156938043|NCT03013543|566532487|FG001|Overall Study|Lack of Efficacy|0|||
156938044|NCT03013543|566532488|FG002|Overall Study|Lack of Efficacy|0|||
156938045|NCT03013543|566532489|FG003|Overall Study|Lack of Efficacy|1|||
156938046|NCT03013543|566532490|FG004|Overall Study|Lack of Efficacy|0|||
156938047|NCT03013543|566532491|FG005|Overall Study|Lack of Efficacy|0|||
156938048|NCT03013543|566532492|FG006|Overall Study|Lack of Efficacy|0|||
156938049|NCT03013543|566532493|FG007|Overall Study|Lack of Efficacy|0|||
156938050|NCT03013543|566532494|FG008|Overall Study|Lack of Efficacy|0|||
156938051|NCT03013543|566532495|FG009|Overall Study|Lack of Efficacy|0|||
156938052|NCT03013543|566532486|FG000|Overall Study|Lost to Follow-up|0|||
156938053|NCT03013543|566532487|FG001|Overall Study|Lost to Follow-up|0|||
156938054|NCT03013543|566532488|FG002|Overall Study|Lost to Follow-up|0|||
156938055|NCT03013543|566532489|FG003|Overall Study|Lost to Follow-up|1|||
156938056|NCT03013543|566532490|FG004|Overall Study|Lost to Follow-up|0|||
156938057|NCT03013543|566532491|FG005|Overall Study|Lost to Follow-up|0|||
156938058|NCT03013543|566532492|FG006|Overall Study|Lost to Follow-up|1|||
156938059|NCT03013543|566532493|FG007|Overall Study|Lost to Follow-up|0|||
156938060|NCT03013543|566532494|FG008|Overall Study|Lost to Follow-up|0|||
156938061|NCT03013543|566532495|FG009|Overall Study|Lost to Follow-up|2|||
156938062|NCT03013543|566532486|FG000|Overall Study|Non-Compliance With Study Drug|0|||
156938063|NCT03013543|566532487|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157031481|NCT04999111|566870153|FG001|Overall Study|Adverse Event|1|||
157031482|NCT04999111|566870154|FG002|Overall Study|Adverse Event|0|||
157031483|NCT04999111|566870155|FG003|Overall Study|Adverse Event|0|||
157031484|NCT04999111|566870156|FG004|Overall Study|Adverse Event|0|||
157031485|NCT04999111|566870157|FG005|Overall Study|Adverse Event|0|||
157031486|NCT04999111|566870152|FG000|Overall Study|Initiated prohibited medication|0|||
157031487|NCT04999111|566870153|FG001|Overall Study|Initiated prohibited medication|0|||
156938064|NCT03013543|566532488|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156938065|NCT03013543|566532489|FG003|Overall Study|Non-Compliance With Study Drug|0|||
156938066|NCT03013543|566532490|FG004|Overall Study|Non-Compliance With Study Drug|0|||
156938067|NCT03013543|566532491|FG005|Overall Study|Non-Compliance With Study Drug|0|||
156938068|NCT03013543|566532492|FG006|Overall Study|Non-Compliance With Study Drug|0|||
156938069|NCT03013543|566532493|FG007|Overall Study|Non-Compliance With Study Drug|0|||
156938070|NCT03013543|566532494|FG008|Overall Study|Non-Compliance With Study Drug|1|||
156938071|NCT03013543|566532495|FG009|Overall Study|Non-Compliance With Study Drug|0|||
156938072|NCT03013543|566532486|FG000|Overall Study|Physician Decision|0|||
156938073|NCT03013543|566532487|FG001|Overall Study|Physician Decision|0|||
156938074|NCT03013543|566532488|FG002|Overall Study|Physician Decision|0|||
156938075|NCT03013543|566532489|FG003|Overall Study|Physician Decision|0|||
156938076|NCT03013543|566532490|FG004|Overall Study|Physician Decision|1|||
156938077|NCT03013543|566532491|FG005|Overall Study|Physician Decision|0|||
156938078|NCT03013543|566532492|FG006|Overall Study|Physician Decision|0|||
156938079|NCT03013543|566532493|FG007|Overall Study|Physician Decision|0|||
156938080|NCT03013543|566532494|FG008|Overall Study|Physician Decision|0|||
157227169|NCT00806156|567577752|FG001|Overall Study|Death|95|||
156938081|NCT03013543|566532495|FG009|Overall Study|Physician Decision|0|||
156938082|NCT03013543|566532486|FG000|Overall Study|Protocol Violation|0|||
156938083|NCT03013543|566532487|FG001|Overall Study|Protocol Violation|0|||
156938084|NCT03013543|566532488|FG002|Overall Study|Protocol Violation|0|||
156938085|NCT03013543|566532489|FG003|Overall Study|Protocol Violation|0|||
156938086|NCT03013543|566532490|FG004|Overall Study|Protocol Violation|0|||
156938087|NCT03013543|566532491|FG005|Overall Study|Protocol Violation|0|||
156938088|NCT03013543|566532492|FG006|Overall Study|Protocol Violation|0|||
156938089|NCT03013543|566532493|FG007|Overall Study|Protocol Violation|0|||
156938090|NCT03013543|566532494|FG008|Overall Study|Protocol Violation|0|||
156938091|NCT03013543|566532495|FG009|Overall Study|Protocol Violation|1|||
156938092|NCT00323414|566532496|FG000|Overall Study|Withdrawal by Subject|0|||
156938093|NCT00323414|566532497|FG001|Overall Study|Withdrawal by Subject|1|||
156938094|NCT02552316|566532499|FG000|Overall Study|Withdrawal by Subject|1|||
156938095|NCT02552316|566532499|FG000|Overall Study|Withdrawal due to non-compliance|1|||
156938096|NCT04382911|566532500|FG000|Overall Study|unable to be imaged prior to surgery|2|||
156938097|NCT04116710|566532504|FG000|Overall Study|Death|4|||
156938098|NCT04116710|566532505|FG001|Overall Study|Death|6|||
156938099|NCT04116710|566532506|FG002|Overall Study|Death|3|||
156938100|NCT04116710|566532507|FG003|Overall Study|Death|1|||
156938101|NCT04116710|566532504|FG000|Overall Study|Withdrawal by Subject|0|||
156938102|NCT04116710|566532505|FG001|Overall Study|Withdrawal by Subject|0|||
156938103|NCT04116710|566532506|FG002|Overall Study|Withdrawal by Subject|0|||
156938104|NCT04116710|566532507|FG003|Overall Study|Withdrawal by Subject|1|||
156938105|NCT01120210|566532508|FG000|MAIN INFUSION|Adverse Event|1|||
156938106|NCT01120210|566532509|FG001|MAIN INFUSION|Adverse Event|0|||
156938107|NCT01120210|566532508|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
156938108|NCT01120210|566532509|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
156938109|NCT02703636|566532526|FG000|Overall Study|Adverse Event|14|||
156938110|NCT02703636|566532526|FG000|Overall Study|Study stopped by sponsor|1|||
156938111|NCT02703636|566532526|FG000|Overall Study|Withdrawal by Subject|1|||
156938112|NCT01110915|566532533|FG000|Overall Study|Death|2|||
156938113|NCT01110915|566532534|FG001|Overall Study|Death|1|||
156938114|NCT01110915|566532533|FG000|Overall Study|Lost to Follow-up|1|||
156938115|NCT01110915|566532534|FG001|Overall Study|Lost to Follow-up|0|||
156938116|NCT01110915|566532533|FG000|Overall Study|Withdrawal by Subject|7|||
156938117|NCT01110915|566532534|FG001|Overall Study|Withdrawal by Subject|1|||
156938118|NCT01205165|566532536|FG000|Overall Study|Lost to Follow-up|2|||
156938119|NCT00477672|566532539|FG000|Overall Study|Adverse Event|3|||
156938120|NCT00477672|566532540|FG001|Overall Study|Adverse Event|5|||
156938121|NCT00477672|566532541|FG002|Overall Study|Adverse Event|6|||
156938122|NCT00477672|566532539|FG000|Overall Study|Death|0|||
156938123|NCT00477672|566532540|FG001|Overall Study|Death|1|||
156938124|NCT00477672|566532541|FG002|Overall Study|Death|0|||
156938125|NCT00477672|566532539|FG000|Overall Study|Disease progression|0|||
156938126|NCT00477672|566532540|FG001|Overall Study|Disease progression|1|||
156938127|NCT00477672|566532541|FG002|Overall Study|Disease progression|0|||
157227170|NCT00806156|567577751|FG000|Overall Study|Did not meet eligibility criteria|1|||
157227171|NCT00806156|567577752|FG001|Overall Study|Did not meet eligibility criteria|0|||
157227172|NCT00806156|567577751|FG000|Overall Study|Study terminated by Sponsor|2|||
157227173|NCT00806156|567577752|FG001|Overall Study|Study terminated by Sponsor|40|||
157227174|NCT00806156|567577751|FG000|Overall Study|Consent withdrawn by subject|1|||
157227175|NCT00806156|567577752|FG001|Overall Study|Consent withdrawn by subject|3|||
157227176|NCT00806156|567577751|FG000|Overall Study|Lost to Follow-up|0|||
157227177|NCT00806156|567577752|FG001|Overall Study|Lost to Follow-up|1|||
157227178|NCT01025037|567577760|FG000|Overall Study|Adverse Event|3|||
157227179|NCT01025037|567577760|FG000|Overall Study|Lost to Follow-up|7|||
157227180|NCT01025037|567577760|FG000|Overall Study|Withdrawal by Subject|1|||
157227181|NCT01890915|567577761|FG000|Overall Study|Adverse Event|1|||
157227182|NCT01890915|567577762|FG001|Overall Study|Adverse Event|0|||
157227183|NCT01890915|567577761|FG000|Overall Study|Protocol Violation|2|||
157227184|NCT01890915|567577762|FG001|Overall Study|Protocol Violation|0|||
157227185|NCT01890915|567577761|FG000|Overall Study|Equipment Malfunction|0|||
156938128|NCT00477672|566532539|FG000|Overall Study|Physician Decision|1|||
156938129|NCT00477672|566532540|FG001|Overall Study|Physician Decision|0|||
156938130|NCT00477672|566532541|FG002|Overall Study|Physician Decision|0|||
157227186|NCT01890915|567577762|FG001|Overall Study|Equipment Malfunction|1|||
156938131|NCT00477672|566532539|FG000|Overall Study|Protocol noncompliance|0|||
156938132|NCT00477672|566532540|FG001|Overall Study|Protocol noncompliance|2|||
157227187|NCT02796664|567577768|FG000|Overall Study|Withdrawal by Subject|0|||
156938133|NCT00477672|566532541|FG002|Overall Study|Protocol noncompliance|0|||
156938134|NCT00477672|566532539|FG000|Overall Study|Consent withdrawn|2|||
156938135|NCT00477672|566532540|FG001|Overall Study|Consent withdrawn|5|||
156938136|NCT00477672|566532541|FG002|Overall Study|Consent withdrawn|10|||
157227188|NCT02796664|567577769|FG001|Overall Study|Withdrawal by Subject|3|||
157227189|NCT02796664|567577768|FG000|Overall Study|Noncompliance|1|||
157227190|NCT02796664|567577769|FG001|Overall Study|Noncompliance|1|||
156938137|NCT00477672|566532539|FG000|Overall Study|Discretion of Sponsor|1|||
156938138|NCT00477672|566532540|FG001|Overall Study|Discretion of Sponsor|2|||
156938139|NCT00477672|566532541|FG002|Overall Study|Discretion of Sponsor|0|||
156938140|NCT01736696|566532542|FG000|Overall Study|Withdrawal by Subject|0|||
156938141|NCT01736696|566532543|FG001|Overall Study|Withdrawal by Subject|0|||
156938142|NCT01736696|566532544|FG002|Overall Study|Withdrawal by Subject|1|||
156938143|NCT01736696|566532545|FG003|Overall Study|Withdrawal by Subject|0|||
156938144|NCT01736696|566532546|FG004|Overall Study|Withdrawal by Subject|0|||
156938145|NCT01736696|566532547|FG005|Overall Study|Withdrawal by Subject|0|||
156938146|NCT01736696|566532548|FG006|Overall Study|Withdrawal by Subject|0|||
156938147|NCT04011410|566532549|FG000|Overall Study|Withdrawal by Subject|1|||
156938148|NCT02275481|566532550|FG000|Overall Study|Death|2|||
156938149|NCT02275481|566532551|FG001|Overall Study|Death|1|||
156938150|NCT02275481|566532550|FG000|Overall Study|Lost to Follow-up|2|||
156938151|NCT02275481|566532551|FG001|Overall Study|Lost to Follow-up|0|||
156938152|NCT02275481|566532550|FG000|Overall Study|Withdrawal by Subject|3|||
156938153|NCT02275481|566532551|FG001|Overall Study|Withdrawal by Subject|0|||
156938154|NCT02275481|566532550|FG000|Overall Study|all other reasons combined|2|||
156938155|NCT02275481|566532551|FG001|Overall Study|all other reasons combined|1|||
156938156|NCT02275481|566532550|FG000|Overall Study|Physician Decision|0|||
156938157|NCT02275481|566532551|FG001|Overall Study|Physician Decision|1|||
156938158|NCT01455012|566532552|FG000|Overall Study|Adverse Event|0|||
156938159|NCT01455012|566532553|FG001|Overall Study|Adverse Event|2|||
156938160|NCT01455012|566532552|FG000|Overall Study|Lack of Efficacy|6|||
156938161|NCT01455012|566532553|FG001|Overall Study|Lack of Efficacy|1|||
156938162|NCT01455012|566532552|FG000|Overall Study|Withdrawal by Subject|3|||
156938163|NCT01455012|566532553|FG001|Overall Study|Withdrawal by Subject|1|||
156938164|NCT01455012|566532552|FG000|Overall Study|Unknown reason|2|||
156938165|NCT01455012|566532553|FG001|Overall Study|Unknown reason|0|||
156938166|NCT01215227|566532554|FG000|Overall Study|Adverse Event|11|||
156938167|NCT01215227|566532555|FG001|Overall Study|Adverse Event|11|||
156938168|NCT01215227|566532556|FG002|Overall Study|Adverse Event|4|||
156938169|NCT01215227|566532557|FG003|Overall Study|Adverse Event|8|||
156938170|NCT01215227|566532558|FG004|Overall Study|Adverse Event|7|||
156938171|NCT01215227|566532559|FG005|Overall Study|Adverse Event|6|||
156938172|NCT01215227|566532554|FG000|Overall Study|Treatment Failure|8|||
156938173|NCT01215227|566532555|FG001|Overall Study|Treatment Failure|4|||
156938174|NCT01215227|566532556|FG002|Overall Study|Treatment Failure|1|||
156938175|NCT01215227|566532557|FG003|Overall Study|Treatment Failure|5|||
156938176|NCT01215227|566532558|FG004|Overall Study|Treatment Failure|1|||
156938177|NCT01215227|566532559|FG005|Overall Study|Treatment Failure|1|||
156938178|NCT01215227|566532554|FG000|Overall Study|Lost to Follow-up|1|||
156938179|NCT01215227|566532555|FG001|Overall Study|Lost to Follow-up|4|||
156938180|NCT01215227|566532556|FG002|Overall Study|Lost to Follow-up|1|||
156938181|NCT01215227|566532557|FG003|Overall Study|Lost to Follow-up|1|||
156938182|NCT01215227|566532558|FG004|Overall Study|Lost to Follow-up|1|||
156938183|NCT01215227|566532559|FG005|Overall Study|Lost to Follow-up|2|||
156938184|NCT01215227|566532554|FG000|Overall Study|Subject Withdrew Consent|16|||
156938185|NCT01215227|566532555|FG001|Overall Study|Subject Withdrew Consent|20|||
156938186|NCT01215227|566532556|FG002|Overall Study|Subject Withdrew Consent|7|||
156938187|NCT01215227|566532557|FG003|Overall Study|Subject Withdrew Consent|10|||
156938188|NCT01215227|566532558|FG004|Overall Study|Subject Withdrew Consent|11|||
156938189|NCT01215227|566532559|FG005|Overall Study|Subject Withdrew Consent|8|||
156938190|NCT01215227|566532554|FG000|Overall Study|Non-Compliance With Protocol|2|||
156938191|NCT01215227|566532555|FG001|Overall Study|Non-Compliance With Protocol|6|||
156938192|NCT01215227|566532556|FG002|Overall Study|Non-Compliance With Protocol|1|||
156938193|NCT01215227|566532557|FG003|Overall Study|Non-Compliance With Protocol|0|||
156938194|NCT01215227|566532558|FG004|Overall Study|Non-Compliance With Protocol|0|||
156938195|NCT01215227|566532559|FG005|Overall Study|Non-Compliance With Protocol|0|||
156938196|NCT01215227|566532554|FG000|Overall Study|Administrative|83|||
156938197|NCT01215227|566532555|FG001|Overall Study|Administrative|73|||
156938198|NCT01215227|566532556|FG002|Overall Study|Administrative|42|||
157031488|NCT04999111|566870154|FG002|Overall Study|Initiated prohibited medication|0|||
157031489|NCT04999111|566870155|FG003|Overall Study|Initiated prohibited medication|0|||
156938199|NCT01215227|566532557|FG003|Overall Study|Administrative|24|||
156938200|NCT01215227|566532558|FG004|Overall Study|Administrative|28|||
156938201|NCT01215227|566532559|FG005|Overall Study|Administrative|40|||
156938202|NCT01215227|566532554|FG000|Overall Study|Missing Status|0|||
157031490|NCT04999111|566870156|FG004|Overall Study|Initiated prohibited medication|1|||
156938203|NCT01215227|566532555|FG001|Overall Study|Missing Status|1|||
156938204|NCT01215227|566532556|FG002|Overall Study|Missing Status|0|||
156938205|NCT01215227|566532557|FG003|Overall Study|Missing Status|0|||
156938206|NCT01215227|566532558|FG004|Overall Study|Missing Status|0|||
156938207|NCT01215227|566532559|FG005|Overall Study|Missing Status|0|||
156938208|NCT01215227|566532554|FG000|Overall Study|Randomized but not treated|0|||
156938209|NCT01215227|566532555|FG001|Overall Study|Randomized but not treated|0|||
156938210|NCT01215227|566532556|FG002|Overall Study|Randomized but not treated|1|||
156938211|NCT01215227|566532557|FG003|Overall Study|Randomized but not treated|1|||
156938212|NCT01215227|566532558|FG004|Overall Study|Randomized but not treated|0|||
156938213|NCT01215227|566532559|FG005|Overall Study|Randomized but not treated|1|||
156938214|NCT01393405|566532564|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
156938215|NCT01393405|566532565|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
156938216|NCT01393405|566532566|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
156938217|NCT01393405|566532564|FG000|Induction Period (week1-16)|Adverse Event|16|||
156938218|NCT01393405|566532565|FG001|Induction Period (week1-16)|Adverse Event|0|||
156938219|NCT01393405|566532566|FG002|Induction Period (week1-16)|Adverse Event|0|||
156938220|NCT01393405|566532564|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
156938221|NCT01393405|566532565|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
156938222|NCT01393405|566532566|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
156938223|NCT01393405|566532564|FG000|Maintenance Period Week|Lack of Efficacy|0|||
156938224|NCT01393405|566532565|FG001|Maintenance Period Week|Lack of Efficacy|22|||
156938225|NCT01393405|566532566|FG002|Maintenance Period Week|Lack of Efficacy|22|||
156938226|NCT01393405|566532564|FG000|Maintenance Period Week|Adverse Event|0|||
156938227|NCT01393405|566532565|FG001|Maintenance Period Week|Adverse Event|5|||
156938228|NCT01393405|566532566|FG002|Maintenance Period Week|Adverse Event|2|||
156938229|NCT01393405|566532564|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
156938230|NCT01393405|566532565|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
156938231|NCT01393405|566532566|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
156938232|NCT01393405|566532564|FG000|Maintenance Period Week|Lost to Follow-up|0|||
156938233|NCT01393405|566532565|FG001|Maintenance Period Week|Lost to Follow-up|1|||
156938234|NCT01393405|566532566|FG002|Maintenance Period Week|Lost to Follow-up|0|||
156938235|NCT01434290|566532567|FG000|Overall Study|Protocol Violation|6|||
156938236|NCT01434290|566532568|FG001|Overall Study|Protocol Violation|3|||
156938237|NCT01434290|566532567|FG000|Overall Study|No protocol treatment|2|||
156938238|NCT01434290|566532568|FG001|Overall Study|No protocol treatment|4|||
156938239|NCT02281552|566532569|FG000|Overall Study|Medication error|1|||
156938240|NCT02281552|566532570|FG001|Overall Study|Medication error|0|||
156938241|NCT02281552|566532569|FG000|Overall Study|Insufficient clinical response|0|||
156938242|NCT02281552|566532570|FG001|Overall Study|Insufficient clinical response|1|||
156938243|NCT02281552|566532569|FG000|Overall Study|Adverse Event|3|||
156938244|NCT02281552|566532570|FG001|Overall Study|Adverse Event|9|||
156938245|NCT01224639|566532571|FG000|Overall Study|Withdrawal by Subject|0|||
156938246|NCT01224639|566532572|FG001|Overall Study|Withdrawal by Subject|0|||
156938247|NCT01224639|566532573|FG002|Overall Study|Withdrawal by Subject|0|||
156938248|NCT01224639|566532574|FG003|Overall Study|Withdrawal by Subject|0|||
156938249|NCT01224639|566532575|FG004|Overall Study|Withdrawal by Subject|2|||
156938250|NCT01224639|566532576|FG005|Overall Study|Withdrawal by Subject|0|||
156938251|NCT01224639|566532577|FG006|Overall Study|Withdrawal by Subject|1|||
156938252|NCT01224639|566532578|FG007|Overall Study|Withdrawal by Subject|1|||
156938253|NCT01224639|566532571|FG000|Overall Study|Adverse Event|0|||
156938254|NCT01224639|566532572|FG001|Overall Study|Adverse Event|0|||
156938255|NCT01224639|566532573|FG002|Overall Study|Adverse Event|0|||
156938256|NCT01224639|566532574|FG003|Overall Study|Adverse Event|0|||
156938257|NCT01224639|566532575|FG004|Overall Study|Adverse Event|0|||
156938258|NCT01224639|566532576|FG005|Overall Study|Adverse Event|0|||
156938259|NCT01224639|566532577|FG006|Overall Study|Adverse Event|0|||
156938260|NCT01224639|566532578|FG007|Overall Study|Adverse Event|1|||
156938261|NCT04656132|566532579|FG000|Overall Study|Lost to Follow-up|4|||
156938262|NCT04656132|566532579|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
156938263|NCT03925727|566532581|FG000|Overall Study|Adverse Event|4|||
156938264|NCT03925727|566532582|FG001|Overall Study|Adverse Event|0|||
156938265|NCT03925727|566532583|FG002|Overall Study|Adverse Event|3|||
156938266|NCT03925727|566532581|FG000|Overall Study|Protocol Violation|1|||
156938267|NCT03925727|566532582|FG001|Overall Study|Protocol Violation|2|||
156938268|NCT03925727|566532583|FG002|Overall Study|Protocol Violation|2|||
156938269|NCT03925727|566532581|FG000|Overall Study|Withdrawal by Subject|3|||
156938270|NCT03925727|566532582|FG001|Overall Study|Withdrawal by Subject|2|||
156938271|NCT03925727|566532583|FG002|Overall Study|Withdrawal by Subject|4|||
156938272|NCT03925727|566532581|FG000|Overall Study|Administrative Reasons|3|||
156938273|NCT03925727|566532582|FG001|Overall Study|Administrative Reasons|1|||
156938274|NCT03925727|566532583|FG002|Overall Study|Administrative Reasons|2|||
156938275|NCT03925727|566532581|FG000|Overall Study|Randomized in error or Disqualified|8|||
156938276|NCT03925727|566532582|FG001|Overall Study|Randomized in error or Disqualified|1|||
156938277|NCT03925727|566532583|FG002|Overall Study|Randomized in error or Disqualified|7|||
156938278|NCT00834912|566532596|FG000|Treatment Period 1|Adverse Event|0|||
156938279|NCT00834912|566532597|FG001|Treatment Period 1|Adverse Event|1|||
156938280|NCT00834912|566532598|FG002|Treatment Period 1|Adverse Event|0|||
156938281|NCT00834912|566532599|FG003|Treatment Period 1|Adverse Event|1|||
156938282|NCT00834912|566532600|FG004|Treatment Period 1|Adverse Event|0|||
156938283|NCT00834912|566532601|FG005|Treatment Period 1|Adverse Event|0|||
156938284|NCT00834912|566532596|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156938285|NCT00834912|566532597|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156938286|NCT00834912|566532598|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156938287|NCT00834912|566532599|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156938288|NCT00834912|566532600|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157031491|NCT04999111|566870157|FG005|Overall Study|Initiated prohibited medication|0|||
157031492|NCT04056611|566870164|FG000|Overall Study|Physician Decision|1|||
157031493|NCT03213873|566870165|FG000|Overall Study|Withdrawal by Subject|8|||
157031494|NCT03213873|566870166|FG001|Overall Study|Withdrawal by Subject|9|||
157031495|NCT03213873|566870165|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
157031496|NCT03213873|566870166|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
157031497|NCT03213873|566870165|FG000|Overall Study|Lost to Follow-up|0|||
157031498|NCT03213873|566870166|FG001|Overall Study|Lost to Follow-up|2|||
157031499|NCT04709419|566870167|FG000|Overall Study|Physician Decision|1|||
157031500|NCT04709419|566870168|FG001|Overall Study|Physician Decision|0|||
157031501|NCT05683340|566870169|FG000|Overall Study|Adverse Event|1|||
157031502|NCT05683340|566870170|FG001|Overall Study|Adverse Event|1|||
157031503|NCT05683340|566870169|FG000|Overall Study|Protocol Violation|1|||
157031504|NCT05683340|566870170|FG001|Overall Study|Protocol Violation|0|||
157031505|NCT05683340|566870169|FG000|Overall Study|Withdrawal by Subject|0|||
157031506|NCT05683340|566870170|FG001|Overall Study|Withdrawal by Subject|2|||
157031507|NCT02437136|566870171|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
157031508|NCT02437136|566870172|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031509|NCT02437136|566870173|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031510|NCT02437136|566870174|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031511|NCT02437136|566870175|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031512|NCT02437136|566870176|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031513|NCT02437136|566870177|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
157031514|NCT02437136|566870171|FG000|Expansion (Phase 2)|Death|0|||
157031515|NCT02437136|566870172|FG001|Expansion (Phase 2)|Death|0|||
157031516|NCT02437136|566870173|FG002|Expansion (Phase 2)|Death|0|||
157031517|NCT02437136|566870174|FG003|Expansion (Phase 2)|Death|6|||
157031518|NCT02437136|566870175|FG004|Expansion (Phase 2)|Death|37|||
157031519|NCT02437136|566870176|FG005|Expansion (Phase 2)|Death|29|||
157031520|NCT02437136|566870177|FG006|Expansion (Phase 2)|Death|24|||
157031521|NCT02437136|566870171|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
157031522|NCT02437136|566870172|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
157031523|NCT02437136|566870173|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
157031524|NCT02437136|566870174|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
157031525|NCT02437136|566870175|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
157031526|NCT02437136|566870176|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
157031527|NCT02437136|566870177|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
157031528|NCT02437136|566870171|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
157031529|NCT02437136|566870172|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
157031530|NCT02437136|566870173|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
157031531|NCT02437136|566870174|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
157031532|NCT02437136|566870175|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
157031533|NCT02437136|566870176|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
157031534|NCT02437136|566870177|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
157031535|NCT02056834|566870180|FG000|Overall Study|Lost to Follow-up|7|||
157031536|NCT03824366|566870199|FG000|Overall Study|Death|1|||
157031537|NCT03824366|566870199|FG000|Overall Study|Previously unidentified metal artifact|1|||
157031538|NCT03824366|566870199|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
157031539|NCT03824366|566870199|FG000|Overall Study|Withdrawal by Subject|1|||
157031540|NCT05069896|566870202|FG000|Overall Study|Adverse Event|0|||
157031541|NCT05069896|566870203|FG001|Overall Study|Adverse Event|1|||
156938289|NCT00834912|566532601|FG005|Treatment Period 2|Withdrawal by Subject|0|||
156938290|NCT00646204|566534560|FG000|Overall Study|Adverse Event|3|||
156938291|NCT00646204|566534561|FG001|Overall Study|Adverse Event|0|||
156938292|NCT00646204|566534560|FG000|Overall Study|Withdrawal by Subject|1|||
156938293|NCT00646204|566534561|FG001|Overall Study|Withdrawal by Subject|0|||
156938294|NCT05723770|566534562|FG000|Overall Study|Lost to Follow-up|4|||
156938295|NCT05723770|566534562|FG000|Overall Study|Withdrawal by Subject|2|||
156938296|NCT00145509|566534563|FG000|Overall Study|Adverse Event|10|||
156938297|NCT00145509|566534564|FG001|Overall Study|Adverse Event|3|||
156938298|NCT00145509|566534563|FG000|Overall Study|Lack of Efficacy|3|||
156938299|NCT00145509|566534564|FG001|Overall Study|Lack of Efficacy|1|||
156938300|NCT00145509|566534563|FG000|Overall Study|Lost to Follow-up|5|||
156938301|NCT00145509|566534564|FG001|Overall Study|Lost to Follow-up|9|||
156938302|NCT00145509|566534563|FG000|Overall Study|Withdrew Consent|2|||
156938303|NCT00145509|566534564|FG001|Overall Study|Withdrew Consent|7|||
157031542|NCT05069896|566870204|FG002|Overall Study|Adverse Event|1|||
157031543|NCT05069896|566870205|FG003|Overall Study|Adverse Event|0|||
156938304|NCT00145509|566534563|FG000|Overall Study|Reason not provided|2|||
156938305|NCT00145509|566534564|FG001|Overall Study|Reason not provided|1|||
157031544|NCT05069896|566870206|FG004|Overall Study|Adverse Event|0|||
157031545|NCT05069896|566870207|FG005|Overall Study|Adverse Event|0|||
157031546|NCT05069896|566870202|FG000|Overall Study|Lost to Follow-up|0|||
157031547|NCT05069896|566870203|FG001|Overall Study|Lost to Follow-up|0|||
157031548|NCT05069896|566870204|FG002|Overall Study|Lost to Follow-up|1|||
157031549|NCT05069896|566870205|FG003|Overall Study|Lost to Follow-up|0|||
157031550|NCT05069896|566870206|FG004|Overall Study|Lost to Follow-up|1|||
157031551|NCT05069896|566870207|FG005|Overall Study|Lost to Follow-up|2|||
156938306|NCT00326612|566534567|FG000|Overall Study|They did not have a seizure requiring tx|129|||
156938307|NCT00326612|566534568|FG001|Overall Study|They did not have a seizure requiring tx|137|||
156938308|NCT00749775|566534573|FG000|Overall Study|Protocol Violation|24|||
156938309|NCT00749775|566534573|FG000|Overall Study|Lost to Follow-up|36|||
156938310|NCT00749775|566534573|FG000|Overall Study|No visit after first day of treatment|44|||
156938311|NCT00749775|566534573|FG000|Overall Study|No drug administration|3|||
156938312|NCT03364049|566534574|FG000|Overall Study|Death|6|||
156938313|NCT03364049|566534575|FG001|Overall Study|Death|4|||
156938314|NCT03364049|566534576|FG002|Overall Study|Death|5|||
156938315|NCT03364049|566534577|FG003|Overall Study|Death|14|||
156938316|NCT03364049|566534574|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156938317|NCT03364049|566534575|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
156938318|NCT03364049|566534576|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156938319|NCT03364049|566534577|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
156938320|NCT03364049|566534574|FG000|Overall Study|Withdrawal by Subject|0|||
156938321|NCT03364049|566534575|FG001|Overall Study|Withdrawal by Subject|1|||
156938322|NCT03364049|566534576|FG002|Overall Study|Withdrawal by Subject|1|||
156938323|NCT03364049|566534577|FG003|Overall Study|Withdrawal by Subject|1|||
156938324|NCT01340976|566534578|FG000|Overall Study|Physician Decision|2|||
156938325|NCT01340976|566534579|FG001|Overall Study|Physician Decision|0|||
156938326|NCT01340976|566534580|FG002|Overall Study|Physician Decision|1|||
156938327|NCT01340976|566534581|FG003|Overall Study|Physician Decision|1|||
156938328|NCT01340976|566534582|FG004|Overall Study|Physician Decision|1|||
156938329|NCT01340976|566534583|FG005|Overall Study|Physician Decision|0|||
156938330|NCT01340976|566534578|FG000|Overall Study|Death|0|||
156938331|NCT01340976|566534579|FG001|Overall Study|Death|1|||
156938332|NCT01340976|566534580|FG002|Overall Study|Death|0|||
156938333|NCT01340976|566534581|FG003|Overall Study|Death|0|||
156938334|NCT01340976|566534582|FG004|Overall Study|Death|0|||
156938335|NCT01340976|566534583|FG005|Overall Study|Death|0|||
156938336|NCT01340976|566534578|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
156938337|NCT01340976|566534579|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156938338|NCT01340976|566534580|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156938339|NCT01340976|566534581|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156938340|NCT01340976|566534582|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156938341|NCT01340976|566534583|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
156938342|NCT01340976|566534578|FG000|Overall Study|Withdrawal by Subject|0|||
156938343|NCT01340976|566534579|FG001|Overall Study|Withdrawal by Subject|0|||
156938344|NCT01340976|566534580|FG002|Overall Study|Withdrawal by Subject|0|||
156938345|NCT01340976|566534581|FG003|Overall Study|Withdrawal by Subject|1|||
156938346|NCT01340976|566534582|FG004|Overall Study|Withdrawal by Subject|1|||
156938347|NCT01340976|566534583|FG005|Overall Study|Withdrawal by Subject|0|||
156938348|NCT01340976|566534578|FG000|Overall Study|Other anemia treatment|1|||
156938349|NCT01340976|566534579|FG001|Overall Study|Other anemia treatment|0|||
156938350|NCT01340976|566534580|FG002|Overall Study|Other anemia treatment|2|||
156938351|NCT01340976|566534581|FG003|Overall Study|Other anemia treatment|1|||
156938352|NCT01340976|566534582|FG004|Overall Study|Other anemia treatment|0|||
156938353|NCT01340976|566534583|FG005|Overall Study|Other anemia treatment|1|||
156938354|NCT01340976|566534578|FG000|Overall Study|Adverse Event|0|||
156938355|NCT01340976|566534579|FG001|Overall Study|Adverse Event|1|||
156938356|NCT01340976|566534580|FG002|Overall Study|Adverse Event|0|||
157031552|NCT04068831|566870208|FG000|Overall Study|Disease Progression|10|||
157031553|NCT04068831|566870209|FG001|Overall Study|Disease Progression|8|||
157031554|NCT05035654|566870213|FG000|Overall Study|Physician Decision|0|||
157031555|NCT05035654|566870214|FG001|Overall Study|Physician Decision|1|||
157031556|NCT05035654|566870215|FG002|Overall Study|Physician Decision|0|||
157031557|NCT05035654|566870213|FG000|Overall Study|Adverse Event|0|||
157227191|NCT02796664|567577768|FG000|Overall Study|Death|0|||
156938357|NCT01340976|566534581|FG003|Overall Study|Adverse Event|0|||
156938358|NCT01340976|566534582|FG004|Overall Study|Adverse Event|0|||
156938359|NCT01340976|566534583|FG005|Overall Study|Adverse Event|0|||
156938360|NCT02953821|566534584|FG000|Overall Study|Adverse Event|0|||
156938361|NCT02953821|566534585|FG001|Overall Study|Adverse Event|4|||
156938362|NCT02953821|566534584|FG000|Overall Study|Death|1|||
156938363|NCT02953821|566534585|FG001|Overall Study|Death|0|||
156938364|NCT02953821|566534584|FG000|Overall Study|Progressive Disease|5|||
156938365|NCT02953821|566534585|FG001|Overall Study|Progressive Disease|1|||
156938366|NCT02953821|566534584|FG000|Overall Study|Lost to Follow-up|2|||
156938367|NCT02953821|566534585|FG001|Overall Study|Lost to Follow-up|0|||
156938368|NCT02953821|566534584|FG000|Overall Study|Physician Decision|1|||
156938369|NCT02953821|566534585|FG001|Overall Study|Physician Decision|1|||
156938370|NCT02953821|566534584|FG000|Overall Study|Withdrawal by Subject|3|||
156938371|NCT02953821|566534585|FG001|Overall Study|Withdrawal by Subject|3|||
157031558|NCT05035654|566870214|FG001|Overall Study|Adverse Event|1|||
157227192|NCT02796664|567577769|FG001|Overall Study|Death|1|||
156938372|NCT02953821|566534584|FG000|Overall Study|Change of address|0|||
156938373|NCT02953821|566534585|FG001|Overall Study|Change of address|1|||
156938374|NCT02953821|566534584|FG000|Overall Study|Lack of Efficacy|1|||
156938375|NCT02953821|566534585|FG001|Overall Study|Lack of Efficacy|0|||
156938376|NCT02953821|566534584|FG000|Overall Study|Out of state for indeterminate time|0|||
156938377|NCT02953821|566534585|FG001|Overall Study|Out of state for indeterminate time|1|||
156938378|NCT02953821|566534584|FG000|Overall Study|No improvement|0|||
156938379|NCT02953821|566534585|FG001|Overall Study|No improvement|1|||
156938380|NCT02953821|566534584|FG000|Overall Study|Refused follow-up visit|2|||
156938381|NCT02953821|566534585|FG001|Overall Study|Refused follow-up visit|1|||
156938382|NCT01067352|566534586|FG000|Overall Study|Withdrawal by Subject|1|||
156938383|NCT01067352|566534587|FG001|Overall Study|Withdrawal by Subject|2|||
156938384|NCT01067352|566534588|FG002|Overall Study|Withdrawal by Subject|1|||
156938385|NCT01067352|566534586|FG000|Overall Study|Physician Decision|0|||
156938386|NCT01067352|566534587|FG001|Overall Study|Physician Decision|1|||
156938387|NCT01067352|566534588|FG002|Overall Study|Physician Decision|0|||
156938388|NCT02566759|566534589|FG000|All Parts|Withdrawal by Subject|0|||
156938389|NCT02566759|566534590|FG001|All Parts|Withdrawal by Subject|1|||
156938390|NCT02566759|566534591|FG002|All Parts|Withdrawal by Subject|0|||
156938391|NCT02566759|566534592|FG003|All Parts|Withdrawal by Subject|0|||
156938392|NCT02566759|566534593|FG004|All Parts|Withdrawal by Subject|0|||
156938393|NCT02566759|566534594|FG005|All Parts|Withdrawal by Subject|0|||
156938394|NCT02566759|566534595|FG006|All Parts|Withdrawal by Subject|0|||
156938395|NCT02566759|566534596|FG007|All Parts|Withdrawal by Subject|0|||
156938396|NCT02566759|566534597|FG008|All Parts|Withdrawal by Subject|0|||
156938397|NCT02566759|566534598|FG009|All Parts|Withdrawal by Subject|0|||
156938398|NCT02566759|566534599|FG010|All Parts|Withdrawal by Subject|0|||
157167178|NCT05590767|567352700|FG000|Overall Study|interscalene brachial block not performed|1|||
157167179|NCT01464788|567352701|FG000|Overall Study|Lost to Follow-up|0|||
157167180|NCT01464788|567352702|FG001|Overall Study|Lost to Follow-up|1|||
157167181|NCT01464788|567352703|FG002|Overall Study|Lost to Follow-up|0|||
157167182|NCT01464788|567352701|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
156938399|NCT02566759|566534600|FG011|All Parts|Withdrawal by Subject|0|||
156938400|NCT02566759|566534601|FG012|All Parts|Withdrawal by Subject|0|||
156938401|NCT02566759|566534602|FG013|All Parts|Withdrawal by Subject|0|||
156938402|NCT02566759|566534603|FG014|All Parts|Withdrawal by Subject|0|||
156938403|NCT02566759|566534604|FG015|All Parts|Withdrawal by Subject|0|||
156938404|NCT02566759|566534605|FG016|All Parts|Withdrawal by Subject|0|||
156938405|NCT02566759|566534589|FG000|All Parts|Adverse Event|0|||
156938406|NCT02566759|566534590|FG001|All Parts|Adverse Event|0|||
156938407|NCT02566759|566534591|FG002|All Parts|Adverse Event|0|||
156938408|NCT02566759|566534592|FG003|All Parts|Adverse Event|0|||
156938409|NCT02566759|566534593|FG004|All Parts|Adverse Event|0|||
156938410|NCT02566759|566534594|FG005|All Parts|Adverse Event|0|||
156938411|NCT02566759|566534595|FG006|All Parts|Adverse Event|0|||
156938412|NCT02566759|566534596|FG007|All Parts|Adverse Event|0|||
156938413|NCT02566759|566534597|FG008|All Parts|Adverse Event|0|||
157167183|NCT01464788|567352702|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
157167184|NCT01464788|567352703|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
157167185|NCT01577160|567352712|FG000|Overall Study|Adverse Event|9|||
157167186|NCT01577160|567352712|FG000|Overall Study|Lack of Efficacy|15|||
157167187|NCT01577160|567352712|FG000|Overall Study|Lost to Follow-up|40|||
157167188|NCT01577160|567352712|FG000|Overall Study|Withdrawal by Subject|18|||
157167189|NCT01577160|567352712|FG000|Overall Study|Subject Uncooperative|7|||
157167190|NCT01577160|567352712|FG000|Overall Study|Other|9|||
157167191|NCT01551758|567352713|FG000|Overall Study|Adverse Event|29|||
157167192|NCT01551758|567352714|FG001|Overall Study|Adverse Event|43|||
157167193|NCT01551758|567352713|FG000|Overall Study|Lack of Efficacy|0|||
157167194|NCT01551758|567352714|FG001|Overall Study|Lack of Efficacy|1|||
157167195|NCT01551758|567352713|FG000|Overall Study|Protocol Violation|5|||
157167196|NCT01551758|567352714|FG001|Overall Study|Protocol Violation|6|||
157167197|NCT01551758|567352713|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
157167198|NCT01551758|567352714|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
157167199|NCT01551758|567352713|FG000|Overall Study|Lost to Follow-up|29|||
156938414|NCT02566759|566534598|FG009|All Parts|Adverse Event|0|||
156938415|NCT02566759|566534599|FG010|All Parts|Adverse Event|0|||
156938416|NCT02566759|566534600|FG011|All Parts|Adverse Event|0|||
156938417|NCT02566759|566534601|FG012|All Parts|Adverse Event|1|||
156938418|NCT02566759|566534602|FG013|All Parts|Adverse Event|3|||
156938419|NCT02566759|566534603|FG014|All Parts|Adverse Event|0|||
156938420|NCT02566759|566534604|FG015|All Parts|Adverse Event|0|||
156938421|NCT02566759|566534605|FG016|All Parts|Adverse Event|0|||
156938422|NCT02566759|566534589|FG000|All Parts|Other|0|||
156938423|NCT02566759|566534590|FG001|All Parts|Other|0|||
156938424|NCT02566759|566534591|FG002|All Parts|Other|0|||
157167200|NCT01551758|567352714|FG001|Overall Study|Lost to Follow-up|25|||
157167201|NCT01551758|567352713|FG000|Overall Study|Physician Decision|9|||
156938425|NCT02566759|566534592|FG003|All Parts|Other|0|||
156938426|NCT02566759|566534593|FG004|All Parts|Other|0|||
156938427|NCT02566759|566534594|FG005|All Parts|Other|0|||
156938428|NCT02566759|566534595|FG006|All Parts|Other|0|||
156938429|NCT02566759|566534596|FG007|All Parts|Other|0|||
157031559|NCT05035654|566870215|FG002|Overall Study|Adverse Event|0|||
157031560|NCT05035654|566870213|FG000|Overall Study|Withdrawal by Subject|0|||
157031561|NCT05035654|566870214|FG001|Overall Study|Withdrawal by Subject|0|||
157031562|NCT05035654|566870215|FG002|Overall Study|Withdrawal by Subject|4|||
157031563|NCT05035654|566870213|FG000|Overall Study|Bilateral Dislodgement|1|||
157031564|NCT05035654|566870214|FG001|Overall Study|Bilateral Dislodgement|0|||
157031565|NCT05035654|566870215|FG002|Overall Study|Bilateral Dislodgement|0|||
157031566|NCT01199133|566870226|FG000|Year 1|Adverse Event|16|||
157031567|NCT01199133|566870227|FG001|Year 1|Adverse Event|4|||
157031568|NCT01199133|566870226|FG000|Year 1|Withdrawal by Subject|8|||
157031569|NCT01199133|566870227|FG001|Year 1|Withdrawal by Subject|4|||
157031570|NCT01199133|566870226|FG000|Year 1|Any other reason not above-mentioned|6|||
157031571|NCT01199133|566870227|FG001|Year 1|Any other reason not above-mentioned|7|||
157031572|NCT01199133|566870226|FG000|Year 2|Adverse Event|1|||
157031573|NCT01199133|566870227|FG001|Year 2|Adverse Event|0|||
157031574|NCT01199133|566870226|FG000|Year 2|Withdrawal by Subject|1|||
157031575|NCT01199133|566870227|FG001|Year 2|Withdrawal by Subject|1|||
157031576|NCT01199133|566870226|FG000|Year 2|Any other reason not above-mentioned|1|||
157031577|NCT01199133|566870227|FG001|Year 2|Any other reason not above-mentioned|2|||
157031578|NCT02575950|566870228|FG000|Overall Study|Withdrawal by Subject|0|||
157031579|NCT02575950|566870229|FG001|Overall Study|Withdrawal by Subject|0|||
157031580|NCT02575950|566870230|FG002|Overall Study|Withdrawal by Subject|0|||
157031581|NCT02575950|566870231|FG003|Overall Study|Withdrawal by Subject|2|||
157031582|NCT02575950|566870228|FG000|Overall Study|Lost to Follow-up|0|||
157031583|NCT02575950|566870229|FG001|Overall Study|Lost to Follow-up|1|||
157031584|NCT02575950|566870230|FG002|Overall Study|Lost to Follow-up|0|||
157031585|NCT02575950|566870231|FG003|Overall Study|Lost to Follow-up|3|||
157031586|NCT03106740|566871726|FG000|Overall Study|Lost to Follow-up|2|||
157031587|NCT03106740|566871727|FG001|Overall Study|Lost to Follow-up|2|||
157031588|NCT03106740|566871726|FG000|Overall Study|Withdrawal by Subject|2|||
157031589|NCT03106740|566871727|FG001|Overall Study|Withdrawal by Subject|4|||
157031590|NCT03106740|566871726|FG000|Overall Study|Physician Decision|0|||
157031591|NCT03106740|566871727|FG001|Overall Study|Physician Decision|1|||
157031592|NCT03106740|566871726|FG000|Overall Study|Partial data|1|||
157031593|NCT03106740|566871727|FG001|Overall Study|Partial data|0|||
157031594|NCT06262477|566871732|FG000|Overall Study|Withdrawal by Subject|1|||
157031595|NCT06262477|566871733|FG001|Overall Study|Withdrawal by Subject|0|||
157031596|NCT06262477|566871732|FG000|Overall Study|Adverse Event|0|||
157031597|NCT06262477|566871733|FG001|Overall Study|Adverse Event|1|||
157031598|NCT06262477|566871732|FG000|Overall Study|Lost to Follow-up|0|||
157031599|NCT06262477|566871733|FG001|Overall Study|Lost to Follow-up|1|||
157031600|NCT04565990|566871734|FG000|Overall Study|Death|5|||
157031601|NCT04565990|566871734|FG000|Overall Study|Lost to Follow-up|1|||
157031602|NCT04565990|566871734|FG000|Overall Study|Withdrawal by Subject|1|||
157031603|NCT04797858|566871735|FG000|Overall Study|Withdrawal by Subject|0|||
157031604|NCT04797858|566871736|FG001|Overall Study|Withdrawal by Subject|1|||
157031605|NCT04797858|566871735|FG000|Overall Study|Excluded due to administrative error|7|||
157031606|NCT04797858|566871736|FG001|Overall Study|Excluded due to administrative error|8|||
157031607|NCT04766892|566871743|FG000|Overall Study|Withdrawal by Subject|1|||
157031608|NCT04766892|566871743|FG000|Overall Study|Lost to Follow-up|1|||
157031609|NCT04766892|566871743|FG000|Overall Study|Adverse Event|3|||
157031610|NCT04766892|566871743|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
157031611|NCT04359654|566871746|FG000|Overall Study|Withdrawal by Subject|1|||
157031612|NCT04359654|566871747|FG001|Overall Study|Withdrawal by Subject|0|||
157031613|NCT04359654|566871746|FG000|Overall Study|Adverse Event|0|||
157031614|NCT04359654|566871747|FG001|Overall Study|Adverse Event|1|||
157031615|NCT04024020|566871748|FG000|Overall Study|Withdrawal by Subject|2|||
157031616|NCT04024020|566871749|FG001|Overall Study|Withdrawal by Subject|2|||
157031617|NCT05618587|566871764|FG000|Overall Study|Lost to Follow-up|2|||
157167202|NCT01551758|567352714|FG001|Overall Study|Physician Decision|3|||
157031618|NCT05618587|566871765|FG001|Overall Study|Lost to Follow-up|0|||
157031619|NCT02446236|566871768|FG000|Overall Study|Screen Failure|1|||
157031620|NCT02446236|566871769|FG001|Overall Study|Screen Failure|0|||
157167203|NCT01551758|567352713|FG000|Overall Study|Withdrawal by Subject|14|||
157167204|NCT01551758|567352714|FG001|Overall Study|Withdrawal by Subject|17|||
157031621|NCT02446236|566871770|FG002|Overall Study|Screen Failure|1|||
157031622|NCT02446236|566871768|FG000|Overall Study|Actively Receiving Therapy|0|||
157031623|NCT02446236|566871769|FG001|Overall Study|Actively Receiving Therapy|0|||
157031624|NCT02446236|566871770|FG002|Overall Study|Actively Receiving Therapy|1|||
157031625|NCT04136912|566871775|FG000|Overall Study|Operational reasons|0|||
157031626|NCT04136912|566871776|FG001|Overall Study|Operational reasons|0|||
157031627|NCT04136912|566871777|FG002|Overall Study|Operational reasons|2|||
157031628|NCT05524402|566871784|FG000|Overall Study|Withdrawal by Subject|3|||
157031629|NCT05524402|566871785|FG001|Overall Study|Withdrawal by Subject|1|||
157031630|NCT05524402|566871784|FG000|Overall Study|Lost to Follow-up|2|||
157031631|NCT05524402|566871785|FG001|Overall Study|Lost to Follow-up|1|||
157031632|NCT05976334|566871786|FG000|Part B|Death|0|||
157031633|NCT05976334|566871787|FG001|Part B|Death|1|||
156938430|NCT02566759|566534597|FG008|All Parts|Other|0|||
156938431|NCT02566759|566534598|FG009|All Parts|Other|0|||
156938432|NCT02566759|566534599|FG010|All Parts|Other|0|||
156938433|NCT02566759|566534600|FG011|All Parts|Other|0|||
156938434|NCT02566759|566534601|FG012|All Parts|Other|0|||
156938435|NCT02566759|566534602|FG013|All Parts|Other|2|||
156938436|NCT02566759|566534603|FG014|All Parts|Other|0|||
156938437|NCT02566759|566534604|FG015|All Parts|Other|0|||
156938438|NCT02566759|566534605|FG016|All Parts|Other|0|||
156938439|NCT02566759|566534589|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938440|NCT02566759|566534590|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938441|NCT02566759|566534591|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938442|NCT02566759|566534592|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938443|NCT02566759|566534593|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938444|NCT02566759|566534594|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938445|NCT02566759|566534595|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938446|NCT02566759|566534596|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938447|NCT02566759|566534597|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938448|NCT02566759|566534598|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938449|NCT02566759|566534599|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938450|NCT02566759|566534600|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938451|NCT02566759|566534601|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938452|NCT02566759|566534602|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938453|NCT02566759|566534603|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938454|NCT02566759|566534604|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
156938455|NCT02566759|566534605|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
156938456|NCT01096784|566534606|FG000|Overall Study|Withdrawal by Subject|2|||
156938457|NCT01096784|566534607|FG001|Overall Study|Withdrawal by Subject|1|||
156938458|NCT01096784|566534606|FG000|Overall Study|Adverse Event|11|||
156938459|NCT01096784|566534607|FG001|Overall Study|Adverse Event|9|||
156938460|NCT01096784|566534606|FG000|Overall Study|Protocol Deviation|2|||
156938461|NCT01096784|566534607|FG001|Overall Study|Protocol Deviation|2|||
156938462|NCT01096784|566534606|FG000|Overall Study|Administrative Decision|0|||
156938463|NCT01096784|566534607|FG001|Overall Study|Administrative Decision|1|||
156938464|NCT01096784|566534606|FG000|Overall Study|Other Unspecified|0|||
156938465|NCT01096784|566534607|FG001|Overall Study|Other Unspecified|1|||
156938466|NCT00976898|566534608|FG000|Overall Study|Protocol Violation|1|||
156938467|NCT00976898|566534608|FG000|Overall Study|Adverse Event|1|||
156938468|NCT00976898|566534608|FG000|Overall Study|Physician Decision|1|||
156938469|NCT00976898|566534608|FG000|Overall Study|Liver Transplant|1|||
156938470|NCT00976898|566534608|FG000|Overall Study|Progressive Disease|1|||
156938471|NCT05107128|566534609|FG000|Overall Study|Adverse Event|2|||
156938472|NCT05107128|566534610|FG001|Overall Study|Adverse Event|0|||
156938473|NCT05107128|566534609|FG000|Overall Study|Withdrawal by Subject|3|||
156938474|NCT05107128|566534610|FG001|Overall Study|Withdrawal by Subject|3|||
156938475|NCT05107128|566534609|FG000|Overall Study|Withdrawal of Consent|0|||
156938476|NCT05107128|566534610|FG001|Overall Study|Withdrawal of Consent|1|||
156938477|NCT05107128|566534609|FG000|Overall Study|Reason Not Specified|2|||
156938478|NCT05107128|566534610|FG001|Overall Study|Reason Not Specified|0|||
156938479|NCT03761628|566534611|FG000|Overall Study|Withdrawal by Subject|3|||
156938480|NCT03761628|566534611|FG000|Overall Study|Physician Decision|1|||
156938481|NCT03761628|566534611|FG000|Overall Study|Pregnancy|1|||
156938482|NCT03761628|566534611|FG000|Overall Study|Lost to Follow-up|1|||
156938483|NCT05459129|566534614|FG000|Overall Study|Death|1|||
156938484|NCT05459129|566534615|FG001|Overall Study|Death|0|||
156938485|NCT05459129|566534614|FG000|Overall Study|Study Terminated By Sponsor|5|||
156938486|NCT05459129|566534615|FG001|Overall Study|Study Terminated By Sponsor|6|||
156938487|NCT03064126|566534616|FG000|Overall Study|Death|40|||
157167205|NCT01586156|567352716|FG000|Overall Study|Pregnancy|0|||
156938488|NCT03064126|566534617|FG001|Overall Study|Death|16|||
156938489|NCT03064126|566534618|FG002|Overall Study|Death|4|||
156938490|NCT03064126|566534619|FG003|Overall Study|Death|2|||
156938491|NCT03064126|566534616|FG000|Overall Study|Withdrawal by Subject|17|||
156938492|NCT03064126|566534617|FG001|Overall Study|Withdrawal by Subject|9|||
156938493|NCT03064126|566534618|FG002|Overall Study|Withdrawal by Subject|0|||
156938494|NCT03064126|566534619|FG003|Overall Study|Withdrawal by Subject|2|||
156938495|NCT03064126|566534616|FG000|Overall Study|Lost to Follow-up|7|||
156938496|NCT03064126|566534617|FG001|Overall Study|Lost to Follow-up|3|||
156938497|NCT03064126|566534618|FG002|Overall Study|Lost to Follow-up|0|||
156938498|NCT03064126|566534619|FG003|Overall Study|Lost to Follow-up|0|||
157167206|NCT01586156|567352717|FG001|Overall Study|Pregnancy|1|||
156938499|NCT03064126|566534616|FG000|Overall Study|Adverse Event|2|||
156938500|NCT03064126|566534617|FG001|Overall Study|Adverse Event|0|||
156938501|NCT03064126|566534618|FG002|Overall Study|Adverse Event|0|||
156938502|NCT03064126|566534619|FG003|Overall Study|Adverse Event|0|||
156938503|NCT03064126|566534616|FG000|Overall Study|Physician Decision|3|||
156938504|NCT03064126|566534617|FG001|Overall Study|Physician Decision|0|||
157167207|NCT01586156|567352718|FG002|Overall Study|Pregnancy|0|||
156938505|NCT03064126|566534618|FG002|Overall Study|Physician Decision|0|||
156938506|NCT03064126|566534619|FG003|Overall Study|Physician Decision|0|||
156938507|NCT03064126|566534616|FG000|Overall Study|Other reason for early termination|3|||
156938508|NCT03064126|566534617|FG001|Overall Study|Other reason for early termination|2|||
156938509|NCT03064126|566534618|FG002|Overall Study|Other reason for early termination|0|||
156938510|NCT03064126|566534619|FG003|Overall Study|Other reason for early termination|0|||
156938511|NCT03064126|566534616|FG000|Overall Study|Missed Visit|3|||
156938512|NCT03064126|566534617|FG001|Overall Study|Missed Visit|1|||
156938513|NCT03064126|566534618|FG002|Overall Study|Missed Visit|0|||
156938514|NCT03064126|566534619|FG003|Overall Study|Missed Visit|0|||
156938515|NCT04649151|566534625|FG000|Overall Study|Pregnancy|0|||
156938516|NCT04649151|566534626|FG001|Overall Study|Pregnancy|0|||
156938517|NCT04649151|566534627|FG002|Overall Study|Pregnancy|0|||
156938518|NCT04649151|566534628|FG003|Overall Study|Pregnancy|0|||
156938519|NCT04649151|566534629|FG004|Overall Study|Pregnancy|3|||
156938520|NCT04649151|566534625|FG000|Overall Study|Physician Decision|10|||
156938521|NCT04649151|566534626|FG001|Overall Study|Physician Decision|0|||
156938522|NCT04649151|566534627|FG002|Overall Study|Physician Decision|0|||
156938523|NCT04649151|566534628|FG003|Overall Study|Physician Decision|1|||
156938524|NCT04649151|566534629|FG004|Overall Study|Physician Decision|1|||
156938525|NCT04649151|566534625|FG000|Overall Study|Protocol Deviation|25|||
156938526|NCT04649151|566534626|FG001|Overall Study|Protocol Deviation|3|||
156938527|NCT04649151|566534627|FG002|Overall Study|Protocol Deviation|0|||
156938528|NCT04649151|566534628|FG003|Overall Study|Protocol Deviation|0|||
156938529|NCT04649151|566534629|FG004|Overall Study|Protocol Deviation|0|||
156938530|NCT04649151|566534625|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
156938531|NCT04649151|566534626|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
156938532|NCT04649151|566534627|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156938533|NCT04649151|566534628|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156938534|NCT04649151|566534629|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
156938535|NCT04649151|566534625|FG000|Overall Study|Withdrawal by Subject|370|||
156938536|NCT04649151|566534626|FG001|Overall Study|Withdrawal by Subject|113|||
156938537|NCT04649151|566534627|FG002|Overall Study|Withdrawal by Subject|2|||
156938538|NCT04649151|566534628|FG003|Overall Study|Withdrawal by Subject|7|||
156938539|NCT04649151|566534629|FG004|Overall Study|Withdrawal by Subject|15|||
156938540|NCT04649151|566534625|FG000|Overall Study|Adverse Event|1|||
156938541|NCT04649151|566534626|FG001|Overall Study|Adverse Event|0|||
156938542|NCT04649151|566534627|FG002|Overall Study|Adverse Event|0|||
156938543|NCT04649151|566534628|FG003|Overall Study|Adverse Event|0|||
156938544|NCT04649151|566534629|FG004|Overall Study|Adverse Event|0|||
156938545|NCT04649151|566534625|FG000|Overall Study|Lost to Follow-up|256|||
156938546|NCT04649151|566534626|FG001|Overall Study|Lost to Follow-up|29|||
156938547|NCT04649151|566534627|FG002|Overall Study|Lost to Follow-up|10|||
156938548|NCT04649151|566534628|FG003|Overall Study|Lost to Follow-up|3|||
156938549|NCT04649151|566534629|FG004|Overall Study|Lost to Follow-up|6|||
156938550|NCT04649151|566534625|FG000|Overall Study|Other than specified|59|||
156938551|NCT04649151|566534626|FG001|Overall Study|Other than specified|294|||
156938552|NCT04649151|566534627|FG002|Overall Study|Other than specified|0|||
156938553|NCT04649151|566534628|FG003|Overall Study|Other than specified|0|||
156938554|NCT04649151|566534629|FG004|Overall Study|Other than specified|4|||
156938555|NCT04649151|566534625|FG000|Overall Study|Death|0|||
156938556|NCT04649151|566534626|FG001|Overall Study|Death|0|||
156938557|NCT04649151|566534627|FG002|Overall Study|Death|0|||
156938558|NCT04649151|566534628|FG003|Overall Study|Death|0|||
156938559|NCT04649151|566534629|FG004|Overall Study|Death|1|||
156938560|NCT04476017|566534630|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
156938561|NCT04476017|566534631|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
156938562|NCT03909165|566534639|FG000|Overall Study|Physician Decision|0|||
156938563|NCT03909165|566534640|FG001|Overall Study|Physician Decision|1|||
156938564|NCT03909165|566534641|FG002|Overall Study|Physician Decision|0|||
156938565|NCT03909165|566534642|FG003|Overall Study|Physician Decision|0|||
157167208|NCT00363246|567352719|FG000|Overall Study|Death|40|||
157167209|NCT00363246|567352719|FG000|Overall Study|Withdrawal by Subject|19|||
157167210|NCT00363246|567352719|FG000|Overall Study|Lost to Follow-up|14|||
157167211|NCT00363246|567352719|FG000|Overall Study|Bad health|6|||
156938566|NCT03909165|566534643|FG004|Overall Study|Physician Decision|0|||
156938567|NCT03909165|566534639|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156938568|NCT03909165|566534640|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156938569|NCT03909165|566534641|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156938570|NCT03909165|566534642|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
156938571|NCT03909165|566534643|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
156938572|NCT03909165|566534639|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
156938573|NCT03909165|566534640|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
156938574|NCT03909165|566534641|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
156938575|NCT03909165|566534642|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
157167212|NCT00363246|567352719|FG000|Overall Study|Stopped using wheelchair|11|||
157167213|NCT00363246|567352719|FG000|Overall Study|Subject expressed security concerns|2|||
156938576|NCT03909165|566534643|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
156938577|NCT03909165|566534639|FG000|Overall Study|Previous Drug Exposure|0|||
156938578|NCT03909165|566534640|FG001|Overall Study|Previous Drug Exposure|0|||
156938579|NCT03909165|566534641|FG002|Overall Study|Previous Drug Exposure|1|||
156938580|NCT03909165|566534642|FG003|Overall Study|Previous Drug Exposure|0|||
156938581|NCT03909165|566534643|FG004|Overall Study|Previous Drug Exposure|0|||
156938582|NCT03909165|566534639|FG000|Overall Study|Early Discharge|1|||
156938583|NCT03909165|566534640|FG001|Overall Study|Early Discharge|0|||
156938584|NCT03909165|566534641|FG002|Overall Study|Early Discharge|0|||
156938585|NCT03909165|566534642|FG003|Overall Study|Early Discharge|0|||
156938586|NCT03909165|566534643|FG004|Overall Study|Early Discharge|0|||
156938587|NCT06034496|566534644|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
156938588|NCT06034496|566534645|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
156938589|NCT06034496|566534644|FG000|Overall Study|Withdrawal by Subject|5|||
156938590|NCT06034496|566534645|FG001|Overall Study|Withdrawal by Subject|4|||
156938591|NCT02018458|566534646|FG000|Overall Study|Death|4|||
156938592|NCT04033159|566534647|FG000|Washout Period|Physician Decision|0|||
156938593|NCT04033159|566534648|FG001|Washout Period|Physician Decision|1|||
156938594|NCT04033159|566534649|FG002|Washout Period|Physician Decision|0|||
156938595|NCT04033159|566534647|FG000|Washout Period|Study terminated by Sponsor|0|||
156938596|NCT04033159|566534648|FG001|Washout Period|Study terminated by Sponsor|7|||
156938597|NCT04033159|566534649|FG002|Washout Period|Study terminated by Sponsor|0|||
156938598|NCT04033159|566534647|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
156938599|NCT04033159|566534648|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
156938600|NCT04033159|566534649|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
156938601|NCT01428193|566534652|FG000|Overall Study|Physician Decision|1|||
156938602|NCT01428193|566534652|FG000|Overall Study|Elevated screening liver enzymes|1|||
156938603|NCT03277261|566534659|FG000|Overall Study|Adverse Event|17|||
156938604|NCT03277261|566534660|FG001|Overall Study|Adverse Event|1|||
156938605|NCT03277261|566534659|FG000|Overall Study|Participant Withdrawal of Consent|6|||
156938606|NCT03277261|566534660|FG001|Overall Study|Participant Withdrawal of Consent|15|||
156938607|NCT03277261|566534659|FG000|Overall Study|Investigator / Sponsor Decision|4|||
156938608|NCT03277261|566534660|FG001|Overall Study|Investigator / Sponsor Decision|2|||
156938609|NCT03277261|566534659|FG000|Overall Study|Pregnancy|2|||
156938610|NCT03277261|566534660|FG001|Overall Study|Pregnancy|0|||
156938611|NCT03277261|566534659|FG000|Overall Study|Lost to Follow-up|2|||
156938612|NCT03277261|566534660|FG001|Overall Study|Lost to Follow-up|2|||
156938613|NCT03277261|566534659|FG000|Overall Study|Lack of Efficacy|2|||
156938614|NCT03277261|566534660|FG001|Overall Study|Lack of Efficacy|2|||
156938615|NCT03277261|566534659|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
156938616|NCT03277261|566534660|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
156938617|NCT03762083|566534661|FG000|Overall Study|Withdrawal by Subject|2|||
156938618|NCT03762083|566534661|FG000|Overall Study|Physician Decision|1|||
156938619|NCT00116558|566534662|FG000|Overall Study|Death|11|||
156938620|NCT00116558|566534663|FG001|Overall Study|Death|5|||
156938621|NCT00116558|566534664|FG002|Overall Study|Death|3|||
156938622|NCT00116558|566534662|FG000|Overall Study|Withdrawal by Subject|17|||
156938623|NCT00116558|566534663|FG001|Overall Study|Withdrawal by Subject|3|||
156938624|NCT00116558|566534664|FG002|Overall Study|Withdrawal by Subject|12|||
156938625|NCT00116558|566534662|FG000|Overall Study|disease progression|3|||
156938626|NCT00116558|566534663|FG001|Overall Study|disease progression|7|||
156938627|NCT00116558|566534664|FG002|Overall Study|disease progression|18|||
156938628|NCT00357370|566534665|FG000|Cohort 2|Lack of Efficacy|0|||
156938629|NCT00357370|566534666|FG001|Cohort 2|Lack of Efficacy|2|||
156938630|NCT00357370|566534667|FG002|Cohort 2|Lack of Efficacy|1|||
156938631|NCT00357370|566534665|FG000|Cohort 2|Adverse Event|1|||
156938632|NCT00357370|566534666|FG001|Cohort 2|Adverse Event|1|||
156938633|NCT00357370|566534667|FG002|Cohort 2|Adverse Event|1|||
156938634|NCT00357370|566534665|FG000|Cohort 2|Lost to Follow-up|0|||
156938635|NCT00357370|566534666|FG001|Cohort 2|Lost to Follow-up|1|||
156938636|NCT00357370|566534667|FG002|Cohort 2|Lost to Follow-up|0|||
156938637|NCT00357370|566534665|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
156938638|NCT00357370|566534666|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
156938639|NCT00357370|566534667|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
156938640|NCT00357370|566534665|FG000|Cohort 2|Withdrawal by Subject|0|||
156938641|NCT00357370|566534666|FG001|Cohort 2|Withdrawal by Subject|2|||
156938642|NCT00357370|566534667|FG002|Cohort 2|Withdrawal by Subject|0|||
156938643|NCT01143090|566534668|FG000|Overall Study|Lack of Efficacy|2|||
156938644|NCT01143090|566534668|FG000|Overall Study|Adverse Event|17|||
156938645|NCT01143090|566534668|FG000|Overall Study|Lost to Follow-up|9|||
156938646|NCT01143090|566534668|FG000|Overall Study|Protocol Violation|2|||
156938647|NCT01143090|566534668|FG000|Overall Study|Withdrawal by Subject|18|||
156938648|NCT01143090|566534668|FG000|Overall Study|Non-compliance with study drug|1|||
156938649|NCT01143090|566534668|FG000|Overall Study|Failure to meet eligibility criteria|1|||
156938650|NCT01143090|566534668|FG000|Overall Study|Administrative|1|||
156938651|NCT00499603|566534673|FG000|Overall Study|Adverse Event|0|||
156938652|NCT00499603|566534674|FG001|Overall Study|Adverse Event|1|||
156938653|NCT00727714|566534677|FG000|Overall Study|Lost to Follow-up|2|||
156938654|NCT01639040|566534678|FG000|Overall Study|Adverse Event|1|||
156938655|NCT01639040|566534679|FG001|Overall Study|Adverse Event|0|||
156938656|NCT05132127|566534681|FG000|Overall Study|Adverse Event|1|||
156938657|NCT05220397|566534682|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156938658|NCT05220397|566534683|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156938659|NCT05220397|566534684|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
156938660|NCT05220397|566534685|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156938661|NCT05220397|566534686|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
156938662|NCT02659020|566534687|FG000|Overall Study|Adverse Event|0|||
156938663|NCT02659020|566534688|FG001|Overall Study|Adverse Event|0|||
156938664|NCT02659020|566534689|FG002|Overall Study|Adverse Event|0|||
156938665|NCT02659020|566534690|FG003|Overall Study|Adverse Event|2|||
156938666|NCT02659020|566534691|FG004|Overall Study|Adverse Event|0|||
156938667|NCT02659020|566534692|FG005|Overall Study|Adverse Event|0|||
156938668|NCT02659020|566534693|FG006|Overall Study|Adverse Event|2|||
156938669|NCT02659020|566534687|FG000|Overall Study|Lost to Follow-up|1|||
156938670|NCT02659020|566534688|FG001|Overall Study|Lost to Follow-up|2|||
156938671|NCT02659020|566534689|FG002|Overall Study|Lost to Follow-up|1|||
156938672|NCT02659020|566534690|FG003|Overall Study|Lost to Follow-up|6|||
156938673|NCT02659020|566534691|FG004|Overall Study|Lost to Follow-up|1|||
156938674|NCT02659020|566534692|FG005|Overall Study|Lost to Follow-up|5|||
156938675|NCT02659020|566534693|FG006|Overall Study|Lost to Follow-up|0|||
156938676|NCT02659020|566534687|FG000|Overall Study|Physician Decision|0|||
156938677|NCT02659020|566534688|FG001|Overall Study|Physician Decision|0|||
156938678|NCT02659020|566534689|FG002|Overall Study|Physician Decision|0|||
156938679|NCT02659020|566534690|FG003|Overall Study|Physician Decision|1|||
156938680|NCT02659020|566534691|FG004|Overall Study|Physician Decision|1|||
156938681|NCT02659020|566534692|FG005|Overall Study|Physician Decision|0|||
156938682|NCT02659020|566534693|FG006|Overall Study|Physician Decision|1|||
156938683|NCT02659020|566534687|FG000|Overall Study|Withdrawal by Subject|2|||
156938684|NCT02659020|566534688|FG001|Overall Study|Withdrawal by Subject|1|||
156938685|NCT02659020|566534689|FG002|Overall Study|Withdrawal by Subject|0|||
156938686|NCT02659020|566534690|FG003|Overall Study|Withdrawal by Subject|3|||
156938687|NCT02659020|566534691|FG004|Overall Study|Withdrawal by Subject|3|||
156938688|NCT02659020|566534692|FG005|Overall Study|Withdrawal by Subject|6|||
156938689|NCT02659020|566534693|FG006|Overall Study|Withdrawal by Subject|3|||
156938690|NCT02659020|566534687|FG000|Overall Study|Progressive Disease|0|||
156938691|NCT02659020|566534688|FG001|Overall Study|Progressive Disease|0|||
156938692|NCT02659020|566534689|FG002|Overall Study|Progressive Disease|0|||
156938693|NCT02659020|566534690|FG003|Overall Study|Progressive Disease|4|||
156938694|NCT02659020|566534691|FG004|Overall Study|Progressive Disease|1|||
156938695|NCT02659020|566534692|FG005|Overall Study|Progressive Disease|0|||
156938696|NCT02659020|566534693|FG006|Overall Study|Progressive Disease|2|||
156938697|NCT02052739|566534694|FG000|Overall Study|Withdrew due to Adverse Event|3|||
156938698|NCT02052739|566534695|FG001|Overall Study|Withdrew due to Adverse Event|0|||
156938699|NCT02052739|566534694|FG000|Overall Study|Participant Died|2|||
156938700|NCT02052739|566534695|FG001|Overall Study|Participant Died|1|||
156938701|NCT02043015|566534696|FG000|Overall Study|Lost to Follow-up|4|||
156938702|NCT02043015|566534696|FG000|Overall Study|Withdrawal by Subject|4|||
156938703|NCT02043015|566534696|FG000|Overall Study|Removed once target enrollment reached|15|||
156938704|NCT02043015|566534696|FG000|Overall Study|Participant moved away from study city|4|||
156938705|NCT02043015|566534696|FG000|Overall Study|Incarceration|1|||
156938706|NCT02457598|566534697|FG000|Overall Study|Progressive Disease|2|||
156938707|NCT02457598|566534698|FG001|Overall Study|Progressive Disease|2|||
156938708|NCT02457598|566534699|FG002|Overall Study|Progressive Disease|1|||
156938709|NCT02457598|566534700|FG003|Overall Study|Progressive Disease|11|||
156938710|NCT02457598|566534701|FG004|Overall Study|Progressive Disease|7|||
156938711|NCT02457598|566534702|FG005|Overall Study|Progressive Disease|3|||
156938712|NCT02457598|566534703|FG006|Overall Study|Progressive Disease|2|||
157227193|NCT00927810|567577772|FG000|Overall Study|Withdrawal by Subject|0|||
157227194|NCT00927810|567577773|FG001|Overall Study|Withdrawal by Subject|3|||
156938713|NCT02457598|566534704|FG007|Overall Study|Progressive Disease|1|||
156938714|NCT02457598|566534705|FG008|Overall Study|Progressive Disease|1|||
156938715|NCT02457598|566534706|FG009|Overall Study|Progressive Disease|2|||
156938716|NCT02457598|566534707|FG010|Overall Study|Progressive Disease|45|||
156938717|NCT02457598|566534708|FG011|Overall Study|Progressive Disease|6|||
156938718|NCT02457598|566534709|FG012|Overall Study|Progressive Disease|2|||
156938719|NCT02457598|566534710|FG013|Overall Study|Progressive Disease|2|||
156938720|NCT02457598|566534711|FG014|Overall Study|Progressive Disease|10|||
156938721|NCT02457598|566534712|FG015|Overall Study|Progressive Disease|1|||
156938722|NCT02457598|566534713|FG016|Overall Study|Progressive Disease|1|||
156938723|NCT02457598|566534697|FG000|Overall Study|Investigator's Discretion|0|||
156938724|NCT02457598|566534698|FG001|Overall Study|Investigator's Discretion|2|||
156938725|NCT02457598|566534699|FG002|Overall Study|Investigator's Discretion|2|||
156938726|NCT02457598|566534700|FG003|Overall Study|Investigator's Discretion|2|||
156938727|NCT02457598|566534701|FG004|Overall Study|Investigator's Discretion|0|||
157167214|NCT00363246|567352719|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
157167215|NCT00264849|567352720|FG000|Overall Study|Adverse Event|7|||
157167216|NCT00264849|567352721|FG001|Overall Study|Adverse Event|2|||
157167217|NCT00264849|567352720|FG000|Overall Study|Withdrawal by Subject|7|||
157167218|NCT00264849|567352721|FG001|Overall Study|Withdrawal by Subject|11|||
156938728|NCT02457598|566534702|FG005|Overall Study|Investigator's Discretion|0|||
156938729|NCT02457598|566534703|FG006|Overall Study|Investigator's Discretion|0|||
156938730|NCT02457598|566534704|FG007|Overall Study|Investigator's Discretion|1|||
156938731|NCT02457598|566534705|FG008|Overall Study|Investigator's Discretion|2|||
156938732|NCT02457598|566534706|FG009|Overall Study|Investigator's Discretion|0|||
156938733|NCT02457598|566534707|FG010|Overall Study|Investigator's Discretion|10|||
156938734|NCT02457598|566534708|FG011|Overall Study|Investigator's Discretion|2|||
156938735|NCT02457598|566534709|FG012|Overall Study|Investigator's Discretion|2|||
156938736|NCT02457598|566534710|FG013|Overall Study|Investigator's Discretion|1|||
156938737|NCT02457598|566534711|FG014|Overall Study|Investigator's Discretion|5|||
156938738|NCT02457598|566534712|FG015|Overall Study|Investigator's Discretion|0|||
156938739|NCT02457598|566534713|FG016|Overall Study|Investigator's Discretion|0|||
156938740|NCT02457598|566534697|FG000|Overall Study|Study Terminated by Sponsor|0|||
156938741|NCT02457598|566534698|FG001|Overall Study|Study Terminated by Sponsor|1|||
156938742|NCT02457598|566534699|FG002|Overall Study|Study Terminated by Sponsor|0|||
156938743|NCT02457598|566534700|FG003|Overall Study|Study Terminated by Sponsor|4|||
156938744|NCT02457598|566534701|FG004|Overall Study|Study Terminated by Sponsor|1|||
156938745|NCT02457598|566534702|FG005|Overall Study|Study Terminated by Sponsor|0|||
156938746|NCT02457598|566534703|FG006|Overall Study|Study Terminated by Sponsor|1|||
156938747|NCT02457598|566534704|FG007|Overall Study|Study Terminated by Sponsor|0|||
156938748|NCT02457598|566534705|FG008|Overall Study|Study Terminated by Sponsor|0|||
156938749|NCT02457598|566534706|FG009|Overall Study|Study Terminated by Sponsor|0|||
156938750|NCT02457598|566534707|FG010|Overall Study|Study Terminated by Sponsor|4|||
156938751|NCT02457598|566534708|FG011|Overall Study|Study Terminated by Sponsor|0|||
156938752|NCT02457598|566534709|FG012|Overall Study|Study Terminated by Sponsor|1|||
156938753|NCT02457598|566534710|FG013|Overall Study|Study Terminated by Sponsor|0|||
156938754|NCT02457598|566534711|FG014|Overall Study|Study Terminated by Sponsor|8|||
156938755|NCT02457598|566534712|FG015|Overall Study|Study Terminated by Sponsor|1|||
156938756|NCT02457598|566534713|FG016|Overall Study|Study Terminated by Sponsor|0|||
156938757|NCT02457598|566534697|FG000|Overall Study|Adverse Event|0|||
156938758|NCT02457598|566534698|FG001|Overall Study|Adverse Event|1|||
156938759|NCT02457598|566534699|FG002|Overall Study|Adverse Event|1|||
156938760|NCT02457598|566534700|FG003|Overall Study|Adverse Event|4|||
156938761|NCT02457598|566534701|FG004|Overall Study|Adverse Event|1|||
156938762|NCT02457598|566534702|FG005|Overall Study|Adverse Event|0|||
156938763|NCT02457598|566534703|FG006|Overall Study|Adverse Event|0|||
156938764|NCT02457598|566534704|FG007|Overall Study|Adverse Event|1|||
156938765|NCT02457598|566534705|FG008|Overall Study|Adverse Event|0|||
156938766|NCT02457598|566534706|FG009|Overall Study|Adverse Event|1|||
156938767|NCT02457598|566534707|FG010|Overall Study|Adverse Event|6|||
156938768|NCT02457598|566534708|FG011|Overall Study|Adverse Event|0|||
156938769|NCT02457598|566534709|FG012|Overall Study|Adverse Event|0|||
156938770|NCT02457598|566534710|FG013|Overall Study|Adverse Event|1|||
156938771|NCT02457598|566534711|FG014|Overall Study|Adverse Event|2|||
156938772|NCT02457598|566534712|FG015|Overall Study|Adverse Event|0|||
156938773|NCT02457598|566534713|FG016|Overall Study|Adverse Event|0|||
156938774|NCT02457598|566534697|FG000|Overall Study|Death|0|||
156938775|NCT02457598|566534698|FG001|Overall Study|Death|0|||
156938776|NCT02457598|566534699|FG002|Overall Study|Death|0|||
156938777|NCT02457598|566534700|FG003|Overall Study|Death|3|||
156938778|NCT02457598|566534701|FG004|Overall Study|Death|0|||
156938779|NCT02457598|566534702|FG005|Overall Study|Death|1|||
156938780|NCT02457598|566534703|FG006|Overall Study|Death|0|||
156938781|NCT02457598|566534704|FG007|Overall Study|Death|0|||
156938782|NCT02457598|566534705|FG008|Overall Study|Death|0|||
156938783|NCT02457598|566534706|FG009|Overall Study|Death|0|||
156938784|NCT02457598|566534707|FG010|Overall Study|Death|3|||
156938785|NCT02457598|566534708|FG011|Overall Study|Death|0|||
157167219|NCT00264849|567352720|FG000|Overall Study|Protocol Violation|5|||
156938786|NCT02457598|566534709|FG012|Overall Study|Death|0|||
156938787|NCT02457598|566534710|FG013|Overall Study|Death|1|||
156938788|NCT02457598|566534711|FG014|Overall Study|Death|2|||
156938789|NCT02457598|566534712|FG015|Overall Study|Death|0|||
156938790|NCT02457598|566534713|FG016|Overall Study|Death|1|||
156938791|NCT02457598|566534697|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938792|NCT02457598|566534698|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
156938793|NCT02457598|566534699|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938794|NCT02457598|566534700|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
156938795|NCT02457598|566534701|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938796|NCT02457598|566534702|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
157167220|NCT00264849|567352721|FG001|Overall Study|Protocol Violation|3|||
157167221|NCT00264849|567352720|FG000|Overall Study|Lack of Efficacy|1|||
157167222|NCT00264849|567352721|FG001|Overall Study|Lack of Efficacy|6|||
157227195|NCT00927810|567577774|FG002|Overall Study|Withdrawal by Subject|0|||
157227196|NCT00927810|567577775|FG003|Overall Study|Withdrawal by Subject|1|||
157227197|NCT00927810|567577772|FG000|Overall Study|Lost to Follow-up|0|||
156938797|NCT02457598|566534703|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938798|NCT02457598|566534704|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
156938799|NCT02457598|566534705|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938800|NCT02457598|566534706|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938801|NCT02457598|566534707|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
156938802|NCT02457598|566534708|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938803|NCT02457598|566534709|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938804|NCT02457598|566534710|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
156938805|NCT02457598|566534711|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
156938806|NCT02457598|566534712|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
156938807|NCT02457598|566534713|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
156938808|NCT02457598|566534697|FG000|Overall Study|Withdrew Consent|0|||
156938809|NCT02457598|566534698|FG001|Overall Study|Withdrew Consent|0|||
156938810|NCT02457598|566534699|FG002|Overall Study|Withdrew Consent|0|||
156938811|NCT02457598|566534700|FG003|Overall Study|Withdrew Consent|0|||
156938812|NCT02457598|566534701|FG004|Overall Study|Withdrew Consent|0|||
156938813|NCT02457598|566534702|FG005|Overall Study|Withdrew Consent|0|||
156938814|NCT02457598|566534703|FG006|Overall Study|Withdrew Consent|0|||
156938815|NCT02457598|566534704|FG007|Overall Study|Withdrew Consent|2|||
156938816|NCT02457598|566534705|FG008|Overall Study|Withdrew Consent|0|||
156938817|NCT02457598|566534706|FG009|Overall Study|Withdrew Consent|0|||
156938818|NCT02457598|566534707|FG010|Overall Study|Withdrew Consent|3|||
156938819|NCT02457598|566534708|FG011|Overall Study|Withdrew Consent|0|||
156938820|NCT02457598|566534709|FG012|Overall Study|Withdrew Consent|0|||
156938821|NCT02457598|566534710|FG013|Overall Study|Withdrew Consent|1|||
156938822|NCT02457598|566534711|FG014|Overall Study|Withdrew Consent|0|||
156938823|NCT02457598|566534712|FG015|Overall Study|Withdrew Consent|0|||
156938824|NCT02457598|566534713|FG016|Overall Study|Withdrew Consent|0|||
156938825|NCT02457598|566534697|FG000|Overall Study|Unacceptable Toxicity|0|||
156938826|NCT02457598|566534698|FG001|Overall Study|Unacceptable Toxicity|0|||
156938827|NCT02457598|566534699|FG002|Overall Study|Unacceptable Toxicity|0|||
156938828|NCT02457598|566534700|FG003|Overall Study|Unacceptable Toxicity|0|||
156938829|NCT02457598|566534701|FG004|Overall Study|Unacceptable Toxicity|0|||
156938830|NCT02457598|566534702|FG005|Overall Study|Unacceptable Toxicity|0|||
156938831|NCT02457598|566534703|FG006|Overall Study|Unacceptable Toxicity|0|||
156938832|NCT02457598|566534704|FG007|Overall Study|Unacceptable Toxicity|0|||
156938833|NCT02457598|566534705|FG008|Overall Study|Unacceptable Toxicity|0|||
156938834|NCT02457598|566534706|FG009|Overall Study|Unacceptable Toxicity|0|||
156938835|NCT02457598|566534707|FG010|Overall Study|Unacceptable Toxicity|1|||
156938836|NCT02457598|566534708|FG011|Overall Study|Unacceptable Toxicity|0|||
156938837|NCT02457598|566534709|FG012|Overall Study|Unacceptable Toxicity|1|||
156938838|NCT02457598|566534710|FG013|Overall Study|Unacceptable Toxicity|1|||
156938839|NCT02457598|566534711|FG014|Overall Study|Unacceptable Toxicity|1|||
156938840|NCT02457598|566534712|FG015|Overall Study|Unacceptable Toxicity|0|||
156938841|NCT02457598|566534713|FG016|Overall Study|Unacceptable Toxicity|0|||
156938842|NCT02457598|566534697|FG000|Overall Study|Intercurrent Illness|0|||
156938843|NCT02457598|566534698|FG001|Overall Study|Intercurrent Illness|0|||
156938844|NCT02457598|566534699|FG002|Overall Study|Intercurrent Illness|0|||
156938845|NCT02457598|566534700|FG003|Overall Study|Intercurrent Illness|0|||
156938846|NCT02457598|566534701|FG004|Overall Study|Intercurrent Illness|0|||
156938847|NCT02457598|566534702|FG005|Overall Study|Intercurrent Illness|0|||
156938848|NCT02457598|566534703|FG006|Overall Study|Intercurrent Illness|0|||
156938849|NCT02457598|566534704|FG007|Overall Study|Intercurrent Illness|0|||
156938850|NCT02457598|566534705|FG008|Overall Study|Intercurrent Illness|0|||
157227198|NCT00927810|567577773|FG001|Overall Study|Lost to Follow-up|2|||
157227199|NCT00927810|567577774|FG002|Overall Study|Lost to Follow-up|1|||
156938851|NCT02457598|566534706|FG009|Overall Study|Intercurrent Illness|0|||
156938852|NCT02457598|566534707|FG010|Overall Study|Intercurrent Illness|1|||
156938853|NCT02457598|566534708|FG011|Overall Study|Intercurrent Illness|0|||
156938854|NCT02457598|566534709|FG012|Overall Study|Intercurrent Illness|0|||
156938855|NCT02457598|566534710|FG013|Overall Study|Intercurrent Illness|0|||
156938856|NCT02457598|566534711|FG014|Overall Study|Intercurrent Illness|0|||
156938857|NCT02457598|566534712|FG015|Overall Study|Intercurrent Illness|0|||
156938858|NCT02457598|566534713|FG016|Overall Study|Intercurrent Illness|0|||
156938859|NCT02457598|566534697|FG000|Overall Study|Protocol Violation|0|||
156938860|NCT02457598|566534698|FG001|Overall Study|Protocol Violation|0|||
156938861|NCT02457598|566534699|FG002|Overall Study|Protocol Violation|0|||
156938862|NCT02457598|566534700|FG003|Overall Study|Protocol Violation|0|||
156938863|NCT02457598|566534701|FG004|Overall Study|Protocol Violation|0|||
156938864|NCT02457598|566534702|FG005|Overall Study|Protocol Violation|0|||
156938865|NCT02457598|566534703|FG006|Overall Study|Protocol Violation|0|||
156938866|NCT02457598|566534704|FG007|Overall Study|Protocol Violation|0|||
156938867|NCT02457598|566534705|FG008|Overall Study|Protocol Violation|0|||
156938868|NCT02457598|566534706|FG009|Overall Study|Protocol Violation|0|||
156938869|NCT02457598|566534707|FG010|Overall Study|Protocol Violation|1|||
156938870|NCT02457598|566534708|FG011|Overall Study|Protocol Violation|0|||
156938871|NCT02457598|566534709|FG012|Overall Study|Protocol Violation|0|||
156938872|NCT02457598|566534710|FG013|Overall Study|Protocol Violation|0|||
156938873|NCT02457598|566534711|FG014|Overall Study|Protocol Violation|0|||
156938874|NCT02457598|566534712|FG015|Overall Study|Protocol Violation|0|||
156938875|NCT02457598|566534713|FG016|Overall Study|Protocol Violation|0|||
156938876|NCT01526889|566534714|FG000|Treatment Period|Adverse Event|2|||
156938877|NCT01526889|566534715|FG001|Treatment Period|Adverse Event|0|||
156938878|NCT01526889|566534714|FG000|Treatment Extension Period|Administrative problems|1|||
156938879|NCT01526889|566534715|FG001|Treatment Extension Period|Administrative problems|0|||
156938880|NCT01494610|566534716|FG000|Period 1|Withdrawal by Subject|1|||
156938881|NCT01494610|566534717|FG001|Period 1|Withdrawal by Subject|1|||
156938882|NCT01494610|566534716|FG000|Period 3|Adverse Event|1|||
156938883|NCT01494610|566534717|FG001|Period 3|Adverse Event|0|||
156938884|NCT01494610|566534716|FG000|Period 3|Withdrawal by Subject|1|||
156938885|NCT01494610|566534717|FG001|Period 3|Withdrawal by Subject|0|||
156938886|NCT01494610|566534716|FG000|Period 4|Protocol Violation|1|||
156938887|NCT01494610|566534717|FG001|Period 4|Protocol Violation|0|||
156938888|NCT02385799|566534718|FG000|Overall Study|Lost to Follow-up|1|||
156938889|NCT02385799|566534719|FG001|Overall Study|Lost to Follow-up|2|||
156938890|NCT02385799|566534718|FG000|Overall Study|Adverse Event|4|||
156938891|NCT02385799|566534719|FG001|Overall Study|Adverse Event|2|||
156938892|NCT02385799|566534718|FG000|Overall Study|Withdrawal by Subject|0|||
156938893|NCT02385799|566534719|FG001|Overall Study|Withdrawal by Subject|4|||
156938894|NCT00006184|566534720|FG000|Overall Study|Death|1|||
156938895|NCT00006184|566534721|FG001|Overall Study|Death|0|||
156938896|NCT02948842|566534722|FG000|Overall Study|Withdrawal by Subject|4|||
156938897|NCT01537783|566534723|FG000|Overall Study|Lost to Follow-up|11|||
156938898|NCT01537783|566534724|FG001|Overall Study|Lost to Follow-up|2|||
156938899|NCT02350309|566534726|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
156938900|NCT02350309|566534727|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
156938901|NCT02350309|566534728|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
156938902|NCT02350309|566534729|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
156938903|NCT02350309|566534730|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
156938904|NCT02350309|566534731|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
156938905|NCT02350309|566534726|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
156938906|NCT02350309|566534727|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
156938907|NCT02350309|566534728|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
156938908|NCT02350309|566534729|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
156938909|NCT02350309|566534730|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
156938910|NCT02350309|566534731|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
156938911|NCT01554618|566534732|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
156938912|NCT01554618|566534733|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
156938913|NCT01554618|566534732|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
156938914|NCT01554618|566534733|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
156938915|NCT01554618|566534732|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
156938916|NCT01554618|566534733|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
156938917|NCT01554618|566534732|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
156938918|NCT01554618|566534733|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
156938919|NCT01554618|566534732|FG000|Open-Label Extension Period|Physician Decision|0|||
156938920|NCT01554618|566534733|FG001|Open-Label Extension Period|Physician Decision|1|||
156938921|NCT01554618|566534732|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
156938922|NCT01554618|566534733|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
156938923|NCT04365699|566534740|FG000|Overall Study|Death|2|||
156938924|NCT04365699|566534741|FG001|Overall Study|Death|5|||
156938925|NCT04365699|566534742|FG002|Overall Study|Death|15|||
156938926|NCT02321462|566534743|FG000|Overall Study|Withdrawal by Subject|5|||
156938927|NCT02321462|566534744|FG001|Overall Study|Withdrawal by Subject|2|||
156938928|NCT02321462|566534743|FG000|Overall Study|Subject withdrawn before any treatment|1|||
156938929|NCT02321462|566534744|FG001|Overall Study|Subject withdrawn before any treatment|1|||
156938930|NCT03044197|566534745|FG000|Overall Study|Withdrawal by Subject|3|||
156938931|NCT03044197|566534746|FG001|Overall Study|Withdrawal by Subject|1|||
156938932|NCT01574352|566534749|FG000|Overall Study|Withdrawal by Subject|6|||
156938933|NCT01574352|566534750|FG001|Overall Study|Withdrawal by Subject|13|||
156938934|NCT01574352|566534749|FG000|Overall Study|Injury in non-camp related sport|1|||
156938935|NCT01574352|566534750|FG001|Overall Study|Injury in non-camp related sport|0|||
156938936|NCT03945981|566534751|FG000|Overall Study|Lost to Follow-up|12|||
156938937|NCT03945981|566534751|FG000|Overall Study|Physician Decision|4|||
156938938|NCT03945981|566534751|FG000|Overall Study|Withdrawal by Subject|6|||
156938939|NCT03945981|566534751|FG000|Overall Study|Protocol Violation|1|||
156938940|NCT00256698|566534754|FG000|Overall Study|Withdrawal by Subject|7|||
156938941|NCT00256698|566534755|FG001|Overall Study|Withdrawal by Subject|7|||
156938942|NCT00256698|566534754|FG000|Overall Study|Adverse Event|13|||
157031634|NCT05976334|566871786|FG000|Part B|Study Terminated by Sponsor|0|||
157031635|NCT05976334|566871787|FG001|Part B|Study Terminated by Sponsor|1|||
157031636|NCT05976334|566871786|FG000|Part B|Reason Not Specified|0|||
157031637|NCT05976334|566871787|FG001|Part B|Reason Not Specified|1|||
157031638|NCT03381586|566871788|FG000|Overall Study|Adverse Event|1|||
157031639|NCT03381586|566871789|FG001|Overall Study|Adverse Event|1|||
157031640|NCT03381586|566871788|FG000|Overall Study|Protocol Violation|1|||
157031641|NCT03381586|566871789|FG001|Overall Study|Protocol Violation|0|||
157031642|NCT03381586|566871788|FG000|Overall Study|Withdrawal by Subject|1|||
157031643|NCT03381586|566871789|FG001|Overall Study|Withdrawal by Subject|2|||
157031644|NCT05280574|566871791|FG000|Overall Study|Withdrawal by Subject|0|||
157031645|NCT05280574|566871792|FG001|Overall Study|Withdrawal by Subject|2|||
157031646|NCT05280574|566871793|FG002|Overall Study|Withdrawal by Subject|0|||
157031647|NCT05363163|566871794|FG000|Overall Study|Withdrawal by Subject|13|||
157031648|NCT05838027|566871798|FG000|Overall Study|Lost to Follow-up|5|||
157031649|NCT05838027|566871799|FG001|Overall Study|Lost to Follow-up|1|||
157031650|NCT05838027|566871798|FG000|Overall Study|Withdrawal by Subject|1|||
157031651|NCT05838027|566871799|FG001|Overall Study|Withdrawal by Subject|0|||
157031652|NCT03276676|566871802|FG000|Overall Study|Withdrawal by Subject|2|||
157031653|NCT03276676|566871803|FG001|Overall Study|Withdrawal by Subject|1|||
157031654|NCT03583333|566871811|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
157031655|NCT03583333|566871812|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
157031656|NCT03583333|566871811|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
157031657|NCT03583333|566871812|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
157031658|NCT03583333|566871811|FG000|Overall Study|Withdrawal by Subject|9|||
157031659|NCT03583333|566871812|FG001|Overall Study|Withdrawal by Subject|5|||
157031660|NCT03583333|566871811|FG000|Overall Study|Physician Decision|3|||
157031661|NCT03583333|566871812|FG001|Overall Study|Physician Decision|2|||
156938943|NCT00256698|566534755|FG001|Overall Study|Adverse Event|6|||
156938944|NCT00256698|566534754|FG000|Overall Study|Protocol Violation|6|||
156938945|NCT00256698|566534755|FG001|Overall Study|Protocol Violation|5|||
156938946|NCT00256698|566534754|FG000|Overall Study|Lost to Follow-up|1|||
156938947|NCT00256698|566534755|FG001|Overall Study|Lost to Follow-up|3|||
156938948|NCT00256698|566534754|FG000|Overall Study|disease progression|97|||
156938949|NCT00256698|566534755|FG001|Overall Study|disease progression|105|||
156938950|NCT00256698|566534754|FG000|Overall Study|still ongoing at data cut-off|41|||
156938951|NCT00256698|566534755|FG001|Overall Study|still ongoing at data cut-off|46|||
156938952|NCT00256698|566534754|FG000|Overall Study|withdrawn due to osteoporosis|1|||
156938953|NCT00256698|566534755|FG001|Overall Study|withdrawn due to osteoporosis|0|||
156938954|NCT00256698|566534754|FG000|Overall Study|Prematurely Discontinued|1|||
156938955|NCT00256698|566534755|FG001|Overall Study|Prematurely Discontinued|0|||
156938956|NCT02917031|566534758|FG000|Overall Study|Reason not specified|7|||
156938957|NCT02917031|566534759|FG001|Overall Study|Reason not specified|5|||
156938958|NCT02917031|566534760|FG002|Overall Study|Reason not specified|6|||
156938959|NCT02917031|566534758|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
156938960|NCT02917031|566534759|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
156938961|NCT02917031|566534760|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
156938962|NCT02917031|566534758|FG000|Overall Study|Withdrawal by Subject|3|||
156938963|NCT02917031|566534759|FG001|Overall Study|Withdrawal by Subject|3|||
156938964|NCT02917031|566534760|FG002|Overall Study|Withdrawal by Subject|0|||
157031662|NCT03583333|566871811|FG000|Overall Study|Death|12|||
157031663|NCT03583333|566871812|FG001|Overall Study|Death|7|||
157031664|NCT03926130|566871813|FG000|Overall Study|Adverse Event|9|||
157031665|NCT03926130|566871814|FG001|Overall Study|Adverse Event|11|||
157031666|NCT03926130|566871815|FG002|Overall Study|Adverse Event|2|||
157031667|NCT03926130|566871816|FG003|Overall Study|Adverse Event|0|||
157031668|NCT03926130|566871813|FG000|Overall Study|Death|2|||
157167223|NCT00264849|567352720|FG000|Overall Study|Lost to Follow-up|0|||
157167224|NCT00264849|567352721|FG001|Overall Study|Lost to Follow-up|2|||
157167225|NCT00264849|567352720|FG000|Overall Study|Death|0|||
157167226|NCT00264849|567352721|FG001|Overall Study|Death|1|||
157167227|NCT00264849|567352720|FG000|Overall Study|Administrative Problems|2|||
157167228|NCT00264849|567352721|FG001|Overall Study|Administrative Problems|0|||
157167229|NCT04465396|567352724|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
157167230|NCT04465396|567352725|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
157167231|NCT04465396|567352726|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
156938965|NCT02917031|566534758|FG000|Overall Study|Physician Decision|1|||
156938966|NCT02917031|566534759|FG001|Overall Study|Physician Decision|0|||
157031669|NCT03926130|566871814|FG001|Overall Study|Death|0|||
157031670|NCT03926130|566871815|FG002|Overall Study|Death|1|||
157031671|NCT03926130|566871816|FG003|Overall Study|Death|0|||
157031672|NCT03926130|566871813|FG000|Overall Study|Lack of Efficacy|14|||
157167232|NCT04465396|567352727|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
157167233|NCT01766817|567352728|FG000|Overall Study|Drug-related adverse event|1|||
157031673|NCT03926130|566871814|FG001|Overall Study|Lack of Efficacy|11|||
157031674|NCT03926130|566871815|FG002|Overall Study|Lack of Efficacy|7|||
156938967|NCT02917031|566534760|FG002|Overall Study|Physician Decision|0|||
156938968|NCT02917031|566534758|FG000|Overall Study|Adverse Event|4|||
156938969|NCT02917031|566534759|FG001|Overall Study|Adverse Event|1|||
156938970|NCT02917031|566534760|FG002|Overall Study|Adverse Event|5|||
156938971|NCT02917031|566534758|FG000|Overall Study|Death|2|||
156938972|NCT02917031|566534759|FG001|Overall Study|Death|3|||
156938973|NCT02917031|566534760|FG002|Overall Study|Death|4|||
156938974|NCT00293384|566536619|FG000|Overall Study|Non-compliance|2|||
156938975|NCT00293384|566536619|FG000|Overall Study|Missed dosage/study drug|1|||
156938976|NCT00293384|566536619|FG000|Overall Study|Ineligible|2|||
156938977|NCT01359592|566536620|FG000|Initial Registration|Adverse Event|1|||
156938978|NCT01359592|566536621|FG001|Initial Registration|Adverse Event|0|||
156938979|NCT01359592|566536622|FG002|Initial Registration|Adverse Event|0|||
156938980|NCT01359592|566536623|FG003|Initial Registration|Adverse Event|0|||
156938981|NCT01359592|566536620|FG000|Initial Registration|Death|1|||
156938982|NCT01359592|566536621|FG001|Initial Registration|Death|0|||
156938983|NCT01359592|566536622|FG002|Initial Registration|Death|0|||
156938984|NCT01359592|566536623|FG003|Initial Registration|Death|0|||
156938985|NCT01359592|566536620|FG000|Initial Registration|Other reason not protocol specified|1|||
156938986|NCT01359592|566536621|FG001|Initial Registration|Other reason not protocol specified|0|||
156938987|NCT01359592|566536622|FG002|Initial Registration|Other reason not protocol specified|0|||
156938988|NCT01359592|566536623|FG003|Initial Registration|Other reason not protocol specified|0|||
156938989|NCT01359592|566536620|FG000|Initial Registration|Ineligible|26|||
156938990|NCT01359592|566536621|FG001|Initial Registration|Ineligible|0|||
156938991|NCT01359592|566536622|FG002|Initial Registration|Ineligible|0|||
156938992|NCT01359592|566536623|FG003|Initial Registration|Ineligible|0|||
156938993|NCT01359592|566536620|FG000|PET-Directed Therapy|Adverse Event|0|||
156938994|NCT01359592|566536621|FG001|PET-Directed Therapy|Adverse Event|0|||
156938995|NCT01359592|566536622|FG002|PET-Directed Therapy|Adverse Event|1|||
156938996|NCT01359592|566536623|FG003|PET-Directed Therapy|Adverse Event|0|||
156938997|NCT01359592|566536620|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156938998|NCT01359592|566536621|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156938999|NCT01359592|566536622|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
156939000|NCT01359592|566536623|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
156939001|NCT01359592|566536620|FG000|PET-Directed Therapy|Ineligible|0|||
156939002|NCT01359592|566536621|FG001|PET-Directed Therapy|Ineligible|0|||
156939003|NCT01359592|566536622|FG002|PET-Directed Therapy|Ineligible|24|||
156939004|NCT01359592|566536623|FG003|PET-Directed Therapy|Ineligible|0|||
156939005|NCT00419562|566536626|FG000|Overall Study|Lost to Follow-up|12|||
156939006|NCT00419562|566536627|FG001|Overall Study|Lost to Follow-up|13|||
156939007|NCT00419562|566536626|FG000|Overall Study|Withdrawal by Subject|20|||
156939008|NCT00419562|566536627|FG001|Overall Study|Withdrawal by Subject|18|||
156939009|NCT00419562|566536626|FG000|Overall Study|Participant Institutionalized|1|||
156939010|NCT00419562|566536627|FG001|Overall Study|Participant Institutionalized|0|||
156939011|NCT02365636|566536628|FG000|Overall Study|Adverse Event|3|||
156939012|NCT02365636|566536629|FG001|Overall Study|Adverse Event|3|||
156939013|NCT02365636|566536630|FG002|Overall Study|Adverse Event|2|||
156939014|NCT02365636|566536628|FG000|Overall Study|Protocol Violation|1|||
156939015|NCT02365636|566536629|FG001|Overall Study|Protocol Violation|4|||
156939016|NCT02365636|566536630|FG002|Overall Study|Protocol Violation|0|||
156939017|NCT02365636|566536628|FG000|Overall Study|Lost to Follow-up|0|||
156939018|NCT02365636|566536629|FG001|Overall Study|Lost to Follow-up|0|||
156939019|NCT02365636|566536630|FG002|Overall Study|Lost to Follow-up|1|||
156939020|NCT02365636|566536628|FG000|Overall Study|Other|2|||
156939021|NCT02365636|566536629|FG001|Overall Study|Other|0|||
156939022|NCT02365636|566536630|FG002|Overall Study|Other|0|||
156939023|NCT00355238|566536631|FG000|Overall Study|Adverse event unrelated to study drug|2|||
156939024|NCT00355238|566536632|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156939025|NCT00355238|566536633|FG002|Overall Study|Adverse event unrelated to study drug|0|||
156939026|NCT00355238|566536634|FG003|Overall Study|Adverse event unrelated to study drug|1|||
156939027|NCT00355238|566536631|FG000|Overall Study|Death|1|||
156939028|NCT00355238|566536632|FG001|Overall Study|Death|0|||
156939029|NCT00355238|566536633|FG002|Overall Study|Death|0|||
156939030|NCT00355238|566536634|FG003|Overall Study|Death|0|||
156939031|NCT00355238|566536631|FG000|Overall Study|Disease progression|37|||
156939032|NCT00355238|566536632|FG001|Overall Study|Disease progression|36|||
156939033|NCT00355238|566536633|FG002|Overall Study|Disease progression|16|||
156939034|NCT00355238|566536634|FG003|Overall Study|Disease progression|11|||
156939035|NCT00355238|566536631|FG000|Overall Study|Study drug toxicity|11|||
157031675|NCT03926130|566871816|FG003|Overall Study|Lack of Efficacy|1|||
157031676|NCT03926130|566871813|FG000|Overall Study|Lost to Follow-up|0|||
156939036|NCT00355238|566536632|FG001|Overall Study|Study drug toxicity|7|||
156939037|NCT00355238|566536633|FG002|Overall Study|Study drug toxicity|5|||
156939038|NCT00355238|566536634|FG003|Overall Study|Study drug toxicity|2|||
156939039|NCT00355238|566536631|FG000|Overall Study|Participant withdrew consent|3|||
156939040|NCT00355238|566536632|FG001|Overall Study|Participant withdrew consent|1|||
156939041|NCT00355238|566536633|FG002|Overall Study|Participant withdrew consent|0|||
157031677|NCT03926130|566871814|FG001|Overall Study|Lost to Follow-up|7|||
156939042|NCT00355238|566536634|FG003|Overall Study|Participant withdrew consent|0|||
156939043|NCT00355238|566536631|FG000|Overall Study|Participant request to discontinue study treatment|1|||
156939044|NCT00355238|566536632|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156939045|NCT00355238|566536633|FG002|Overall Study|Participant request to discontinue study treatment|1|||
156939046|NCT00355238|566536634|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156939047|NCT01454934|566536635|FG000|Overall Study|Clinical progression|28|||
156939048|NCT01454934|566536636|FG001|Overall Study|Clinical progression|25|||
156939049|NCT01454934|566536635|FG000|Overall Study|Other|6|||
156939050|NCT01454934|566536636|FG001|Overall Study|Other|17|||
156939051|NCT01454934|566536635|FG000|Overall Study|Adverse Event|28|||
156939052|NCT01454934|566536636|FG001|Overall Study|Adverse Event|24|||
156939053|NCT01454934|566536635|FG000|Overall Study|Withdrawn consent|2|||
156939054|NCT01454934|566536636|FG001|Overall Study|Withdrawn consent|5|||
156939055|NCT01454934|566536635|FG000|Overall Study|Withdrawal by Subject|11|||
156939056|NCT01454934|566536636|FG001|Overall Study|Withdrawal by Subject|15|||
156939057|NCT01454934|566536635|FG000|Overall Study|Disease progression|194|||
156939058|NCT01454934|566536636|FG001|Overall Study|Disease progression|181|||
156939059|NCT01454934|566536635|FG000|Overall Study|Lost to Follow-up|0|||
156939060|NCT01454934|566536636|FG001|Overall Study|Lost to Follow-up|1|||
156939061|NCT01454934|566536635|FG000|Overall Study|Not treated|1|||
156939062|NCT01454934|566536636|FG001|Overall Study|Not treated|2|||
156939063|NCT05044234|566536637|FG000|Overall Study|Lost to Follow-up|2|||
156939064|NCT05044234|566536638|FG001|Overall Study|Lost to Follow-up|1|||
156939065|NCT05044234|566536639|FG002|Overall Study|Lost to Follow-up|1|||
156939066|NCT05044234|566536640|FG003|Overall Study|Lost to Follow-up|2|||
156939067|NCT05044234|566536637|FG000|Overall Study|Withdrawal by Subject|6|||
156939068|NCT05044234|566536638|FG001|Overall Study|Withdrawal by Subject|4|||
156939069|NCT05044234|566536639|FG002|Overall Study|Withdrawal by Subject|5|||
156939070|NCT05044234|566536640|FG003|Overall Study|Withdrawal by Subject|8|||
156939071|NCT05044234|566536637|FG000|Overall Study|Study terminated by Sponsor|21|||
156939072|NCT05044234|566536638|FG001|Overall Study|Study terminated by Sponsor|21|||
156939073|NCT05044234|566536639|FG002|Overall Study|Study terminated by Sponsor|20|||
156939074|NCT05044234|566536640|FG003|Overall Study|Study terminated by Sponsor|14|||
156939075|NCT05044234|566536637|FG000|Overall Study|Other, not specified|0|||
156939076|NCT05044234|566536638|FG001|Overall Study|Other, not specified|0|||
156939077|NCT05044234|566536639|FG002|Overall Study|Other, not specified|1|||
156939078|NCT05044234|566536640|FG003|Overall Study|Other, not specified|2|||
156939079|NCT05044234|566536637|FG000|Overall Study|Delayed data entry|0|||
156939080|NCT05044234|566536638|FG001|Overall Study|Delayed data entry|0|||
156939081|NCT05044234|566536639|FG002|Overall Study|Delayed data entry|0|||
156939082|NCT05044234|566536640|FG003|Overall Study|Delayed data entry|1|||
156939083|NCT00480636|566536641|FG000|Overall Study|Death|12|||
156939084|NCT00480636|566536641|FG000|Overall Study|Lost to Follow-up|4|||
156939085|NCT00480636|566536641|FG000|Overall Study|Other|2|||
156939086|NCT00480636|566536641|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
156939087|NCT03912233|566536642|FG000|Overall Study|Adverse Event|1|||
156939088|NCT03912233|566536643|FG001|Overall Study|Adverse Event|0|||
156939089|NCT03912233|566536644|FG002|Overall Study|Adverse Event|0|||
156939090|NCT03912233|566536645|FG003|Overall Study|Adverse Event|0|||
156939091|NCT03912233|566536646|FG004|Overall Study|Adverse Event|0|||
156939092|NCT03912233|566536647|FG005|Overall Study|Adverse Event|0|||
156939093|NCT03912233|566536642|FG000|Overall Study|Physician Decision|1|||
156939094|NCT03912233|566536643|FG001|Overall Study|Physician Decision|0|||
156939095|NCT03912233|566536644|FG002|Overall Study|Physician Decision|0|||
156939096|NCT03912233|566536645|FG003|Overall Study|Physician Decision|0|||
156939097|NCT03912233|566536646|FG004|Overall Study|Physician Decision|0|||
156939098|NCT03912233|566536647|FG005|Overall Study|Physician Decision|0|||
156939099|NCT03912233|566536642|FG000|Overall Study|Other|0|||
156939100|NCT03912233|566536643|FG001|Overall Study|Other|0|||
156939101|NCT03912233|566536644|FG002|Overall Study|Other|0|||
156939102|NCT03912233|566536645|FG003|Overall Study|Other|0|||
156939103|NCT03912233|566536646|FG004|Overall Study|Other|7|||
156939104|NCT03912233|566536647|FG005|Overall Study|Other|12|||
156939105|NCT02583256|566536648|FG000|Overall Study|Withdrawal by Subject|0|||
156939106|NCT02583256|566536649|FG001|Overall Study|Withdrawal by Subject|1|||
156939107|NCT02583256|566536650|FG002|Overall Study|Withdrawal by Subject|1|||
156939108|NCT02583256|566536651|FG003|Overall Study|Withdrawal by Subject|0|||
156939109|NCT02583256|566536648|FG000|Overall Study|Lost to Follow-up|1|||
156939110|NCT02583256|566536649|FG001|Overall Study|Lost to Follow-up|1|||
156939111|NCT02583256|566536650|FG002|Overall Study|Lost to Follow-up|0|||
156939112|NCT02583256|566536651|FG003|Overall Study|Lost to Follow-up|1|||
156939113|NCT02583256|566536648|FG000|Overall Study|Administrative/Other|2|||
157031678|NCT03926130|566871815|FG002|Overall Study|Lost to Follow-up|1|||
156939114|NCT02583256|566536649|FG001|Overall Study|Administrative/Other|0|||
156939115|NCT02583256|566536650|FG002|Overall Study|Administrative/Other|1|||
156939116|NCT02583256|566536651|FG003|Overall Study|Administrative/Other|2|||
156939117|NCT02177266|566536659|FG000|Overall Study|Adverse Event|0|||
156939118|NCT02177266|566536660|FG001|Overall Study|Adverse Event|1|||
157031679|NCT03926130|566871816|FG003|Overall Study|Lost to Follow-up|0|||
156939119|NCT02177266|566536659|FG000|Overall Study|Withdrawal by Subject|1|||
156939120|NCT02177266|566536660|FG001|Overall Study|Withdrawal by Subject|0|||
156939121|NCT01023659|566536661|FG000|Overall Study|Lost to Follow-up|73|||
156939122|NCT01023659|566536662|FG001|Overall Study|Lost to Follow-up|228|||
156939123|NCT01023659|566536663|FG002|Overall Study|Lost to Follow-up|99|||
156939124|NCT04537806|566536666|FG000|Overall Study|Randomized but not treated|1|||
156939125|NCT04537806|566536667|FG001|Overall Study|Randomized but not treated|0|||
156939126|NCT04537806|566536666|FG000|Overall Study|Adverse Event|1|||
156939127|NCT04537806|566536667|FG001|Overall Study|Adverse Event|1|||
156939128|NCT03019627|566536668|FG000|Overall Study|Adverse Event|8|||
156939129|NCT03019627|566536669|FG001|Overall Study|Adverse Event|0|||
156939130|NCT03019627|566536668|FG000|Overall Study|Unrelated to adverse event|1|||
156939131|NCT03019627|566536669|FG001|Overall Study|Unrelated to adverse event|3|||
156939132|NCT03019627|566536668|FG000|Overall Study|Lost to Follow-up|2|||
156939133|NCT03019627|566536669|FG001|Overall Study|Lost to Follow-up|1|||
156939134|NCT03019627|566536668|FG000|Overall Study|not compliance|2|||
156939135|NCT03019627|566536669|FG001|Overall Study|not compliance|2|||
156939136|NCT03019627|566536668|FG000|Overall Study|Other|2|||
156939137|NCT03019627|566536669|FG001|Overall Study|Other|2|||
156939138|NCT01802775|566536670|FG000|Overall Study|Death|0|||
156939139|NCT01802775|566536671|FG001|Overall Study|Death|3|||
156939140|NCT01802775|566536670|FG000|Overall Study|Reason not provided|0|||
156939141|NCT01802775|566536671|FG001|Overall Study|Reason not provided|1|||
156939142|NCT01802775|566536670|FG000|Overall Study|Physician Decision|1|||
156939143|NCT01802775|566536671|FG001|Overall Study|Physician Decision|0|||
156939144|NCT01802775|566536670|FG000|Overall Study|Adverse Event|1|||
156939145|NCT01802775|566536671|FG001|Overall Study|Adverse Event|1|||
156939146|NCT01802775|566536670|FG000|Overall Study|Withdrawal by Subject|3|||
156939147|NCT01802775|566536671|FG001|Overall Study|Withdrawal by Subject|5|||
156939148|NCT01802775|566536670|FG000|Overall Study|Lost to Follow-up|1|||
156939149|NCT01802775|566536671|FG001|Overall Study|Lost to Follow-up|2|||
156939150|NCT00519649|566536674|FG000|Overall Study|Withdrawal by Subject|1|||
156939151|NCT01465802|566536675|FG000|Overall Study|Study terminated by sponsor|1|||
156939152|NCT01465802|566536676|FG001|Overall Study|Study terminated by sponsor|0|||
156939153|NCT01465802|566536677|FG002|Overall Study|Study terminated by sponsor|0|||
156939154|NCT01465802|566536678|FG003|Overall Study|Study terminated by sponsor|1|||
156939155|NCT01465802|566536679|FG004|Overall Study|Study terminated by sponsor|7|||
156939156|NCT01465802|566536675|FG000|Overall Study|Withdrawal by Subject|7|||
156939157|NCT01465802|566536676|FG001|Overall Study|Withdrawal by Subject|7|||
156939158|NCT01465802|566536677|FG002|Overall Study|Withdrawal by Subject|0|||
156939159|NCT01465802|566536678|FG003|Overall Study|Withdrawal by Subject|8|||
156939160|NCT01465802|566536679|FG004|Overall Study|Withdrawal by Subject|1|||
156939161|NCT01465802|566536675|FG000|Overall Study|Lost to Follow-up|1|||
156939162|NCT01465802|566536676|FG001|Overall Study|Lost to Follow-up|1|||
156939163|NCT01465802|566536677|FG002|Overall Study|Lost to Follow-up|0|||
156939164|NCT01465802|566536678|FG003|Overall Study|Lost to Follow-up|0|||
156939165|NCT01465802|566536679|FG004|Overall Study|Lost to Follow-up|0|||
156939166|NCT01465802|566536675|FG000|Overall Study|Reason not specified|9|||
156939167|NCT01465802|566536676|FG001|Overall Study|Reason not specified|4|||
156939168|NCT01465802|566536677|FG002|Overall Study|Reason not specified|0|||
156939169|NCT01465802|566536678|FG003|Overall Study|Reason not specified|10|||
156939170|NCT01465802|566536679|FG004|Overall Study|Reason not specified|2|||
156939171|NCT01465802|566536675|FG000|Overall Study|Death|15|||
156939172|NCT01465802|566536676|FG001|Overall Study|Death|12|||
156939173|NCT01465802|566536677|FG002|Overall Study|Death|0|||
156939174|NCT01465802|566536678|FG003|Overall Study|Death|10|||
156939175|NCT01465802|566536679|FG004|Overall Study|Death|2|||
156939176|NCT03852316|566536680|FG000|Overall Study|Protocol Violation|1|||
156939177|NCT03852316|566536680|FG000|Overall Study|Withdrawal by Subject|2|||
156939178|NCT03852316|566536680|FG000|Overall Study|Enrolled but Device not Utilized|1|||
156939179|NCT02103478|566536681|FG000|Overall Study|Adverse Event|0|||
156939180|NCT02103478|566536682|FG001|Overall Study|Adverse Event|0|||
157031680|NCT03926130|566871813|FG000|Overall Study|As Reported by Investigator|2|||
157031681|NCT03926130|566871814|FG001|Overall Study|As Reported by Investigator|6|||
157167234|NCT01766817|567352729|FG001|Overall Study|Drug-related adverse event|2|||
157167235|NCT01766817|567352730|FG002|Overall Study|Drug-related adverse event|1|||
157167236|NCT01766817|567352728|FG000|Overall Study|Drug-unrelated adverse event|3|||
157167237|NCT01766817|567352729|FG001|Overall Study|Drug-unrelated adverse event|3|||
156939181|NCT02103478|566536683|FG002|Overall Study|Adverse Event|1|||
156939182|NCT02103478|566536684|FG003|Overall Study|Adverse Event|1|||
156939183|NCT02103478|566536685|FG004|Overall Study|Adverse Event|2|||
156939184|NCT02103478|566536686|FG005|Overall Study|Adverse Event|1|||
156939185|NCT02103478|566536687|FG006|Overall Study|Adverse Event|0|||
156939186|NCT02103478|566536688|FG007|Overall Study|Adverse Event|0|||
156939187|NCT02103478|566536689|FG008|Overall Study|Adverse Event|0|||
156939188|NCT02103478|566536681|FG000|Overall Study|Death|2|||
157167238|NCT01766817|567352730|FG002|Overall Study|Drug-unrelated adverse event|3|||
156939189|NCT02103478|566536682|FG001|Overall Study|Death|2|||
156939190|NCT02103478|566536683|FG002|Overall Study|Death|1|||
157031682|NCT03926130|566871815|FG002|Overall Study|As Reported by Investigator|6|||
157031683|NCT03926130|566871816|FG003|Overall Study|As Reported by Investigator|0|||
157031684|NCT03926130|566871813|FG000|Overall Study|Physician Decision|3|||
157031685|NCT03926130|566871814|FG001|Overall Study|Physician Decision|2|||
157031686|NCT03926130|566871815|FG002|Overall Study|Physician Decision|1|||
156939191|NCT02103478|566536684|FG003|Overall Study|Death|1|||
156939192|NCT02103478|566536685|FG004|Overall Study|Death|5|||
156939193|NCT02103478|566536686|FG005|Overall Study|Death|15|||
157031687|NCT03926130|566871816|FG003|Overall Study|Physician Decision|0|||
157031688|NCT03926130|566871813|FG000|Overall Study|Pregnancy|2|||
157031689|NCT03926130|566871814|FG001|Overall Study|Pregnancy|2|||
157031690|NCT03926130|566871815|FG002|Overall Study|Pregnancy|1|||
157031691|NCT03926130|566871816|FG003|Overall Study|Pregnancy|0|||
157031692|NCT03926130|566871813|FG000|Overall Study|Withdrawal by Subject|20|||
157031693|NCT03926130|566871814|FG001|Overall Study|Withdrawal by Subject|28|||
157031694|NCT03926130|566871815|FG002|Overall Study|Withdrawal by Subject|18|||
157031695|NCT03926130|566871816|FG003|Overall Study|Withdrawal by Subject|1|||
157031696|NCT03926130|566871813|FG000|Overall Study|Non-Compliance|1|||
157031697|NCT03926130|566871814|FG001|Overall Study|Non-Compliance|1|||
157031698|NCT03926130|566871815|FG002|Overall Study|Non-Compliance|0|||
157031699|NCT03926130|566871816|FG003|Overall Study|Non-Compliance|0|||
157031700|NCT03926130|566871813|FG000|Overall Study|Disposition Not Captured|0|||
157031701|NCT03926130|566871814|FG001|Overall Study|Disposition Not Captured|2|||
157031702|NCT03926130|566871815|FG002|Overall Study|Disposition Not Captured|1|||
157031703|NCT03926130|566871816|FG003|Overall Study|Disposition Not Captured|0|||
157031704|NCT05533190|566871826|FG000|Overall Study|Lost to Follow-up|19|||
157031705|NCT05533190|566871827|FG001|Overall Study|Lost to Follow-up|7|||
157031706|NCT05533190|566871826|FG000|Overall Study|Failed to download app|1|||
157031707|NCT05533190|566871827|FG001|Overall Study|Failed to download app|0|||
157031708|NCT05533190|566871826|FG000|Overall Study|Thought app was a scam|1|||
157031709|NCT05533190|566871827|FG001|Overall Study|Thought app was a scam|0|||
157031710|NCT05533190|566871826|FG000|Overall Study|Withdrawal by Subject|2|||
157031711|NCT05533190|566871827|FG001|Overall Study|Withdrawal by Subject|0|||
157031712|NCT05856435|566871828|FG000|Overall Study|Lost to Follow-up|6|||
157031713|NCT05660434|566871829|FG000|Overall Study|Never obtained study materials|2|||
157031714|NCT05660434|566871830|FG001|Overall Study|Never obtained study materials|1|||
157031715|NCT03213678|566871831|FG000|Overall Study|Death|1|||
157031716|NCT03213678|566871831|FG000|Overall Study|Physician Decision|1|||
157031717|NCT03213678|566871831|FG000|Overall Study|Progressive disease|16|||
157031718|NCT02413489|566871832|FG000|Overall Study|Death|11|||
157031719|NCT02413489|566871833|FG001|Overall Study|Death|3|||
156939194|NCT02103478|566536687|FG006|Overall Study|Death|14|||
156939195|NCT02103478|566536688|FG007|Overall Study|Death|10|||
156939196|NCT02103478|566536689|FG008|Overall Study|Death|11|||
156939197|NCT02103478|566536681|FG000|Overall Study|Progressive Disease|2|||
156939198|NCT02103478|566536682|FG001|Overall Study|Progressive Disease|1|||
156939199|NCT02103478|566536683|FG002|Overall Study|Progressive Disease|2|||
156939200|NCT02103478|566536684|FG003|Overall Study|Progressive Disease|0|||
156939201|NCT02103478|566536685|FG004|Overall Study|Progressive Disease|9|||
157031720|NCT02413489|566871834|FG002|Overall Study|Death|4|||
157031721|NCT02413489|566871832|FG000|Overall Study|Withdrawal by Subject|2|||
157031722|NCT02413489|566871833|FG001|Overall Study|Withdrawal by Subject|0|||
157031723|NCT02413489|566871834|FG002|Overall Study|Withdrawal by Subject|0|||
157031724|NCT02413489|566871832|FG000|Overall Study|Study Terminated By Sponsor|2|||
157031725|NCT02413489|566871833|FG001|Overall Study|Study Terminated By Sponsor|13|||
157031726|NCT02413489|566871834|FG002|Overall Study|Study Terminated By Sponsor|1|||
157031727|NCT04456296|566871835|FG000|Overall Study|Withdrawal by Subject|14|||
157031728|NCT04456296|566871836|FG001|Overall Study|Withdrawal by Subject|21|||
157031729|NCT04456296|566871837|FG002|Overall Study|Withdrawal by Subject|21|||
157031730|NCT04456296|566871835|FG000|Overall Study|Adverse Event|2|||
157031731|NCT04456296|566871836|FG001|Overall Study|Adverse Event|2|||
157031732|NCT04456296|566871837|FG002|Overall Study|Adverse Event|2|||
157031733|NCT04456296|566871835|FG000|Overall Study|Death|1|||
157031734|NCT04456296|566871836|FG001|Overall Study|Death|0|||
157031735|NCT04456296|566871837|FG002|Overall Study|Death|0|||
157031736|NCT04456296|566871835|FG000|Overall Study|Lost to Follow-up|3|||
157167239|NCT01766817|567352728|FG000|Overall Study|Death|1|||
156939202|NCT02103478|566536686|FG005|Overall Study|Progressive Disease|1|||
156939203|NCT02103478|566536687|FG006|Overall Study|Progressive Disease|2|||
157031737|NCT04456296|566871836|FG001|Overall Study|Lost to Follow-up|5|||
157031738|NCT04456296|566871837|FG002|Overall Study|Lost to Follow-up|6|||
157031739|NCT04456296|566871835|FG000|Overall Study|Other than specified|0|||
157031740|NCT04456296|566871836|FG001|Overall Study|Other than specified|1|||
157031741|NCT04456296|566871837|FG002|Overall Study|Other than specified|4|||
157031742|NCT04456296|566871835|FG000|Overall Study|Randomized, not treated|2|||
157031743|NCT04456296|566871836|FG001|Overall Study|Randomized, not treated|1|||
157031744|NCT04456296|566871837|FG002|Overall Study|Randomized, not treated|0|||
157031745|NCT05736458|566871838|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
157167240|NCT01766817|567352729|FG001|Overall Study|Death|1|||
156939204|NCT02103478|566536688|FG007|Overall Study|Progressive Disease|0|||
156939205|NCT02103478|566536689|FG008|Overall Study|Progressive Disease|1|||
156939206|NCT02103478|566536681|FG000|Overall Study|Withdrawal by Subject|2|||
156939207|NCT02103478|566536682|FG001|Overall Study|Withdrawal by Subject|0|||
156939208|NCT02103478|566536683|FG002|Overall Study|Withdrawal by Subject|0|||
156939209|NCT02103478|566536684|FG003|Overall Study|Withdrawal by Subject|4|||
156939210|NCT02103478|566536685|FG004|Overall Study|Withdrawal by Subject|0|||
156939211|NCT02103478|566536686|FG005|Overall Study|Withdrawal by Subject|0|||
156939212|NCT02103478|566536687|FG006|Overall Study|Withdrawal by Subject|1|||
156939213|NCT02103478|566536688|FG007|Overall Study|Withdrawal by Subject|1|||
156939214|NCT02103478|566536689|FG008|Overall Study|Withdrawal by Subject|0|||
156939215|NCT02103478|566536681|FG000|Overall Study|Lost to Follow-up|0|||
156939216|NCT02103478|566536682|FG001|Overall Study|Lost to Follow-up|0|||
156939217|NCT02103478|566536683|FG002|Overall Study|Lost to Follow-up|0|||
156939218|NCT02103478|566536684|FG003|Overall Study|Lost to Follow-up|0|||
156939219|NCT02103478|566536685|FG004|Overall Study|Lost to Follow-up|0|||
156939220|NCT02103478|566536686|FG005|Overall Study|Lost to Follow-up|0|||
156939221|NCT02103478|566536687|FG006|Overall Study|Lost to Follow-up|0|||
156939222|NCT02103478|566536688|FG007|Overall Study|Lost to Follow-up|1|||
156939223|NCT02103478|566536689|FG008|Overall Study|Lost to Follow-up|0|||
156939224|NCT02103478|566536681|FG000|Overall Study|Other|1|||
156939225|NCT02103478|566536682|FG001|Overall Study|Other|3|||
156939226|NCT02103478|566536683|FG002|Overall Study|Other|2|||
156939227|NCT02103478|566536684|FG003|Overall Study|Other|0|||
156939228|NCT02103478|566536685|FG004|Overall Study|Other|3|||
156939229|NCT02103478|566536686|FG005|Overall Study|Other|8|||
156939230|NCT02103478|566536687|FG006|Overall Study|Other|8|||
156939231|NCT02103478|566536688|FG007|Overall Study|Other|4|||
156939232|NCT02103478|566536689|FG008|Overall Study|Other|2|||
156939233|NCT03219333|566536690|FG000|Overall Study|Withdrawal by Subject|9|||
156939234|NCT03219333|566536691|FG001|Overall Study|Withdrawal by Subject|4|||
156939235|NCT03219333|566536690|FG000|Overall Study|Lost to Follow-up|1|||
156939236|NCT03219333|566536691|FG001|Overall Study|Lost to Follow-up|1|||
156939237|NCT03219333|566536690|FG000|Overall Study|Death|104|||
156939238|NCT03219333|566536691|FG001|Overall Study|Death|72|||
156939239|NCT03219333|566536690|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
156939240|NCT03219333|566536691|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
156939241|NCT03219333|566536690|FG000|Overall Study|Other|2|||
156939242|NCT03219333|566536691|FG001|Overall Study|Other|2|||
156939243|NCT00723606|566536692|FG000|Overall Study|Adverse Event|2|||
156939244|NCT00723606|566536693|FG001|Overall Study|Adverse Event|5|||
156939245|NCT00723606|566536692|FG000|Overall Study|Other|2|||
156939246|NCT00723606|566536693|FG001|Overall Study|Other|0|||
156939247|NCT00723606|566536692|FG000|Overall Study|Withdrawal by Subject|0|||
156939248|NCT00723606|566536693|FG001|Overall Study|Withdrawal by Subject|2|||
156939249|NCT01470469|566536694|FG000|Overall Study|Withdrawal by Subject|4|||
156939250|NCT01470469|566536695|FG001|Overall Study|Withdrawal by Subject|6|||
156939251|NCT01470469|566536694|FG000|Overall Study|Lack of Efficacy|1|||
156939252|NCT01470469|566536695|FG001|Overall Study|Lack of Efficacy|7|||
156939253|NCT01470469|566536694|FG000|Overall Study|Adverse Event|0|||
156939254|NCT01470469|566536695|FG001|Overall Study|Adverse Event|7|||
156939255|NCT01470469|566536694|FG000|Overall Study|Lost to Follow-up|2|||
156939256|NCT01470469|566536695|FG001|Overall Study|Lost to Follow-up|2|||
156939257|NCT01470469|566536694|FG000|Overall Study|Protocol Violation|1|||
156939258|NCT01470469|566536695|FG001|Overall Study|Protocol Violation|1|||
156939259|NCT01470469|566536694|FG000|Overall Study|Other|2|||
156939260|NCT01470469|566536695|FG001|Overall Study|Other|1|||
156939261|NCT03362502|566536696|FG000|Overall Study|Death|0|||
157227200|NCT00927810|567577775|FG003|Overall Study|Lost to Follow-up|1|||
156939262|NCT03362502|566536697|FG001|Overall Study|Death|0|||
156939263|NCT03362502|566536698|FG002|Overall Study|Death|1|||
156939264|NCT02075840|566536699|FG000|Overall Study|Withdrawal by Subject|13|||
156939265|NCT02075840|566536700|FG001|Overall Study|Withdrawal by Subject|22|||
156939266|NCT02075840|566536699|FG000|Overall Study|Reason not specified|1|||
156939267|NCT02075840|566536700|FG001|Overall Study|Reason not specified|0|||
156939268|NCT02075840|566536699|FG000|Overall Study|Adverse Event|0|||
156939269|NCT02075840|566536700|FG001|Overall Study|Adverse Event|2|||
156939270|NCT02075840|566536699|FG000|Overall Study|Death|35|||
156939271|NCT02075840|566536700|FG001|Overall Study|Death|40|||
156939272|NCT02075840|566536699|FG000|Overall Study|Lost to Follow-up|3|||
156939273|NCT02075840|566536700|FG001|Overall Study|Lost to Follow-up|2|||
156939274|NCT02075840|566536699|FG000|Overall Study|Physician Decision|1|||
156939275|NCT02075840|566536700|FG001|Overall Study|Physician Decision|3|||
156939276|NCT02075840|566536699|FG000|Overall Study|Ongoing at CCOD|99|||
157227201|NCT00927810|567577772|FG000|Overall Study|Death|0|||
156939277|NCT02075840|566536700|FG001|Overall Study|Ongoing at CCOD|82|||
156939278|NCT03491150|566536730|FG000|Overall Study|Adverse Event|1|||
156939279|NCT03491150|566536731|FG001|Overall Study|Adverse Event|0|||
156939280|NCT03491150|566536730|FG000|Overall Study|Study Terminated by Sponsor|74|||
156939281|NCT03491150|566536731|FG001|Overall Study|Study Terminated by Sponsor|70|||
156939282|NCT03491150|566536730|FG000|Overall Study|Other|0|||
156939283|NCT03491150|566536731|FG001|Overall Study|Other|1|||
156939284|NCT03491150|566536730|FG000|Overall Study|Withdrawal by Subject|1|||
156939285|NCT03491150|566536731|FG001|Overall Study|Withdrawal by Subject|2|||
156939286|NCT00937547|566536734|FG000|Overall Study|misdiagnosis|1|||
156939287|NCT00937547|566536735|FG001|Overall Study|misdiagnosis|6|||
156939288|NCT00937547|566536736|FG002|Overall Study|misdiagnosis|7|||
156939289|NCT00325234|566536737|FG000|Overall Study|Adverse Event|10|||
156939290|NCT00325234|566536738|FG001|Overall Study|Adverse Event|7|||
156939291|NCT00325234|566536737|FG000|Overall Study|Death due to Study Disease|1|||
156939292|NCT00325234|566536738|FG001|Overall Study|Death due to Study Disease|0|||
156939293|NCT00325234|566536737|FG000|Overall Study|Entry Criteria Not Met|1|||
156939294|NCT00325234|566536738|FG001|Overall Study|Entry Criteria Not Met|2|||
156939295|NCT00325234|566536737|FG000|Overall Study|Subject Decision|6|||
156939296|NCT00325234|566536738|FG001|Overall Study|Subject Decision|8|||
156939297|NCT00325234|566536737|FG000|Overall Study|Physician Decision|17|||
156939298|NCT00325234|566536738|FG001|Overall Study|Physician Decision|12|||
156939299|NCT00325234|566536737|FG000|Overall Study|Progressive Disease|34|||
156939300|NCT00325234|566536738|FG001|Overall Study|Progressive Disease|37|||
156939301|NCT01234467|566536739|FG000|Overall Study|Adverse Event|3|||
156939302|NCT01234467|566536739|FG000|Overall Study|Death|2|||
156939303|NCT01234467|566536739|FG000|Overall Study|Withdrawal by Subject|2|||
156939304|NCT01234467|566536739|FG000|Overall Study|Disease Progression|2|||
156939305|NCT01234467|566536739|FG000|Overall Study|Clinical deterioration|1|||
156939306|NCT01234467|566536739|FG000|Overall Study|Physician Decision|1|||
156939307|NCT01234467|566536739|FG000|Overall Study|Other complicating disease (stroke)|1|||
156939308|NCT02644967|566536745|FG000|Overall Study|Death|26|||
156939309|NCT02644967|566536745|FG000|Overall Study|Physician Decision|1|||
156939310|NCT02644967|566536745|FG000|Overall Study|Withdrawal by Subject|2|||
156939311|NCT02644967|566536745|FG000|Overall Study|Protocol Violation|1|||
156939312|NCT02644967|566536745|FG000|Overall Study|Progressive Disease|1|||
156939313|NCT02644967|566536745|FG000|Overall Study|Study Terminated by Sponsor|4|||
156939314|NCT02287896|566536746|FG000|Second Injection Visit|Withdrawal by Subject|0|||
156939315|NCT02287896|566536747|FG001|Second Injection Visit|Withdrawal by Subject|1|||
156939316|NCT05179421|566536748|FG000|First Infusion Day|Adverse Event|1|||
156939317|NCT05179421|566536749|FG001|First Infusion Day|Adverse Event|0|||
156939318|NCT03746522|566536751|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
156939319|NCT03746522|566536752|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
156939320|NCT03746522|566536753|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
156939321|NCT03746522|566536751|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
156939322|NCT03746522|566536752|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
156939323|NCT03746522|566536753|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
156939324|NCT03746522|566536751|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
156939325|NCT03746522|566536752|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
156939326|NCT03746522|566536753|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
156939327|NCT03746522|566536751|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
156939328|NCT03746522|566536752|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
156939329|NCT03746522|566536753|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
156939330|NCT03746522|566536751|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
156939331|NCT03746522|566536752|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
156939332|NCT03746522|566536753|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
156939333|NCT01077960|566536756|FG000|Overall Study|Adverse Event|6|||
156939334|NCT01077960|566536756|FG000|Overall Study|Protocol Violation|3|||
156939335|NCT01077960|566536756|FG000|Overall Study|Lost to Follow-up|5|||
156939336|NCT01077960|566536756|FG000|Overall Study|Subject decision|1|||
156939337|NCT01077960|566536756|FG000|Overall Study|Reason unspecified|1|||
156939338|NCT03837899|566536757|FG000|Overall Study|Death|6|||
156939339|NCT03837899|566536758|FG001|Overall Study|Death|8|||
156939340|NCT03837899|566536759|FG002|Overall Study|Death|3|||
156939341|NCT03837899|566536760|FG003|Overall Study|Death|7|||
156939342|NCT03837899|566536761|FG004|Overall Study|Death|8|||
156939343|NCT03837899|566536762|FG005|Overall Study|Death|7|||
156939344|NCT03837899|566536757|FG000|Overall Study|Moved to post-trial access program|0|||
156939345|NCT03837899|566536758|FG001|Overall Study|Moved to post-trial access program|1|||
156939346|NCT03837899|566536759|FG002|Overall Study|Moved to post-trial access program|0|||
156939347|NCT03837899|566536760|FG003|Overall Study|Moved to post-trial access program|0|||
156939348|NCT03837899|566536761|FG004|Overall Study|Moved to post-trial access program|0|||
156939349|NCT03837899|566536762|FG005|Overall Study|Moved to post-trial access program|0|||
156939350|NCT03837899|566536757|FG000|Overall Study|Other|0|||
156939351|NCT03837899|566536758|FG001|Overall Study|Other|0|||
156939352|NCT03837899|566536759|FG002|Overall Study|Other|0|||
156939353|NCT03837899|566536760|FG003|Overall Study|Other|0|||
156939354|NCT03837899|566536761|FG004|Overall Study|Other|0|||
156939355|NCT03837899|566536762|FG005|Overall Study|Other|2|||
156939356|NCT03837899|566536757|FG000|Overall Study|Lost to Follow-up|0|||
156939357|NCT03837899|566536758|FG001|Overall Study|Lost to Follow-up|1|||
157031746|NCT05736458|566871839|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
156939358|NCT03837899|566536759|FG002|Overall Study|Lost to Follow-up|0|||
156939359|NCT03837899|566536760|FG003|Overall Study|Lost to Follow-up|0|||
156939360|NCT03837899|566536761|FG004|Overall Study|Lost to Follow-up|0|||
156939361|NCT03837899|566536762|FG005|Overall Study|Lost to Follow-up|0|||
156939362|NCT03837899|566536757|FG000|Overall Study|Withdrawal by Subject|0|||
156939363|NCT03837899|566536758|FG001|Overall Study|Withdrawal by Subject|0|||
156939364|NCT03837899|566536759|FG002|Overall Study|Withdrawal by Subject|0|||
156939365|NCT03837899|566536760|FG003|Overall Study|Withdrawal by Subject|1|||
156939366|NCT03837899|566536761|FG004|Overall Study|Withdrawal by Subject|0|||
156939367|NCT03837899|566536762|FG005|Overall Study|Withdrawal by Subject|0|||
156939368|NCT03837899|566536757|FG000|Overall Study|Study specific discontinuation criteria|0|||
156939369|NCT03837899|566536758|FG001|Overall Study|Study specific discontinuation criteria|1|||
156939370|NCT03837899|566536759|FG002|Overall Study|Study specific discontinuation criteria|0|||
156939371|NCT03837899|566536760|FG003|Overall Study|Study specific discontinuation criteria|0|||
156939372|NCT03837899|566536761|FG004|Overall Study|Study specific discontinuation criteria|3|||
156939373|NCT03837899|566536762|FG005|Overall Study|Study specific discontinuation criteria|1|||
156939374|NCT01403974|566536763|FG000|Overall Study|Progressive disease according to RECIST|3|||
156939375|NCT01403974|566536764|FG001|Overall Study|Progressive disease according to RECIST|3|||
156939376|NCT01403974|566536765|FG002|Overall Study|Progressive disease according to RECIST|2|||
156939377|NCT01403974|566536766|FG003|Overall Study|Progressive disease according to RECIST|3|||
156939378|NCT01403974|566536767|FG004|Overall Study|Progressive disease according to RECIST|3|||
156939379|NCT01403974|566536768|FG005|Overall Study|Progressive disease according to RECIST|2|||
156939380|NCT01403974|566536769|FG006|Overall Study|Progressive disease according to RECIST|3|||
156939381|NCT01403974|566536770|FG007|Overall Study|Progressive disease according to RECIST|2|||
156939382|NCT01403974|566536771|FG008|Overall Study|Progressive disease according to RECIST|6|||
156939383|NCT01403974|566536772|FG009|Overall Study|Progressive disease according to RECIST|2|||
156939384|NCT01403974|566536773|FG010|Overall Study|Progressive disease according to RECIST|3|||
156939385|NCT01403974|566536774|FG011|Overall Study|Progressive disease according to RECIST|2|||
156939386|NCT01403974|566536775|FG012|Overall Study|Progressive disease according to RECIST|2|||
156939387|NCT01403974|566536776|FG013|Overall Study|Progressive disease according to RECIST|3|||
156939388|NCT01403974|566536777|FG014|Overall Study|Progressive disease according to RECIST|1|||
156939389|NCT01403974|566536778|FG015|Overall Study|Progressive disease according to RECIST|8|||
156939390|NCT01403974|566536763|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
156939391|NCT01403974|566536764|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
156939392|NCT01403974|566536765|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
156939393|NCT01403974|566536766|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
156939394|NCT01403974|566536767|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
156939395|NCT01403974|566536768|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
156939396|NCT01403974|566536769|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
156939397|NCT01403974|566536770|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
156939398|NCT01403974|566536771|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
156939399|NCT01403974|566536772|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
156939400|NCT01403974|566536773|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
156939401|NCT01403974|566536774|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
156939402|NCT01403974|566536775|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
156939403|NCT01403974|566536776|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
156939404|NCT01403974|566536777|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
156939405|NCT01403974|566536778|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
156939406|NCT01403974|566536763|FG000|Overall Study|Refused to continue study medication|0|||
156939407|NCT01403974|566536764|FG001|Overall Study|Refused to continue study medication|0|||
156939408|NCT01403974|566536765|FG002|Overall Study|Refused to continue study medication|0|||
156939409|NCT01403974|566536766|FG003|Overall Study|Refused to continue study medication|0|||
156939410|NCT01403974|566536767|FG004|Overall Study|Refused to continue study medication|0|||
156939411|NCT01403974|566536768|FG005|Overall Study|Refused to continue study medication|1|||
156939412|NCT01403974|566536769|FG006|Overall Study|Refused to continue study medication|0|||
156939413|NCT01403974|566536770|FG007|Overall Study|Refused to continue study medication|0|||
156939414|NCT01403974|566536771|FG008|Overall Study|Refused to continue study medication|1|||
156939415|NCT01403974|566536772|FG009|Overall Study|Refused to continue study medication|0|||
156939416|NCT01403974|566536773|FG010|Overall Study|Refused to continue study medication|1|||
156939417|NCT01403974|566536774|FG011|Overall Study|Refused to continue study medication|0|||
156939418|NCT01403974|566536775|FG012|Overall Study|Refused to continue study medication|0|||
156939419|NCT01403974|566536776|FG013|Overall Study|Refused to continue study medication|0|||
156939420|NCT01403974|566536777|FG014|Overall Study|Refused to continue study medication|0|||
156939421|NCT01403974|566536778|FG015|Overall Study|Refused to continue study medication|4|||
156939422|NCT01403974|566536763|FG000|Overall Study|Adverse Event|0|||
156939423|NCT01403974|566536764|FG001|Overall Study|Adverse Event|0|||
156939424|NCT01403974|566536765|FG002|Overall Study|Adverse Event|1|||
156939425|NCT01403974|566536766|FG003|Overall Study|Adverse Event|0|||
157227202|NCT00927810|567577773|FG001|Overall Study|Death|2|||
156939426|NCT01403974|566536767|FG004|Overall Study|Adverse Event|0|||
156939427|NCT01403974|566536768|FG005|Overall Study|Adverse Event|0|||
156939428|NCT01403974|566536769|FG006|Overall Study|Adverse Event|0|||
156939429|NCT01403974|566536770|FG007|Overall Study|Adverse Event|1|||
156939430|NCT01403974|566536771|FG008|Overall Study|Adverse Event|0|||
156939431|NCT01403974|566536772|FG009|Overall Study|Adverse Event|0|||
156939432|NCT01403974|566536773|FG010|Overall Study|Adverse Event|0|||
156939433|NCT01403974|566536774|FG011|Overall Study|Adverse Event|0|||
156939434|NCT01403974|566536775|FG012|Overall Study|Adverse Event|1|||
156939435|NCT01403974|566536776|FG013|Overall Study|Adverse Event|0|||
156939436|NCT01403974|566536777|FG014|Overall Study|Adverse Event|0|||
156939437|NCT01403974|566536778|FG015|Overall Study|Adverse Event|0|||
156939438|NCT01403974|566536763|FG000|Overall Study|Other than specified|0|||
156939439|NCT01403974|566536764|FG001|Overall Study|Other than specified|0|||
156939440|NCT01403974|566536765|FG002|Overall Study|Other than specified|0|||
156939441|NCT01403974|566536766|FG003|Overall Study|Other than specified|0|||
156939442|NCT01403974|566536767|FG004|Overall Study|Other than specified|0|||
156939443|NCT01403974|566536768|FG005|Overall Study|Other than specified|0|||
156939444|NCT01403974|566536769|FG006|Overall Study|Other than specified|0|||
156939445|NCT01403974|566536770|FG007|Overall Study|Other than specified|0|||
156939446|NCT01403974|566536771|FG008|Overall Study|Other than specified|0|||
156939447|NCT01403974|566536772|FG009|Overall Study|Other than specified|1|||
156939448|NCT01403974|566536773|FG010|Overall Study|Other than specified|0|||
156939449|NCT01403974|566536774|FG011|Overall Study|Other than specified|1|||
156939450|NCT01403974|566536775|FG012|Overall Study|Other than specified|0|||
156939451|NCT01403974|566536776|FG013|Overall Study|Other than specified|0|||
156939452|NCT01403974|566536777|FG014|Overall Study|Other than specified|0|||
156939453|NCT01403974|566536778|FG015|Overall Study|Other than specified|0|||
156939454|NCT00393939|566536784|FG000|Overall Study|Protocol Violation|1|||
156939455|NCT00393939|566536785|FG001|Overall Study|Protocol Violation|1|||
156939456|NCT00393939|566536784|FG000|Overall Study|Lost to Follow-up|2|||
156939457|NCT00393939|566536785|FG001|Overall Study|Lost to Follow-up|4|||
156939458|NCT00393939|566536784|FG000|Overall Study|Death|10|||
156939459|NCT00393939|566536785|FG001|Overall Study|Death|4|||
156939460|NCT00393939|566536784|FG000|Overall Study|Sponsor|5|||
156939461|NCT00393939|566536785|FG001|Overall Study|Sponsor|13|||
156939462|NCT00393939|566536784|FG000|Overall Study|Objective progression or relapse|239|||
156939463|NCT00393939|566536785|FG001|Overall Study|Objective progression or relapse|223|||
156939464|NCT00393939|566536784|FG000|Overall Study|Withdrawal by Subject|2|||
156939465|NCT00393939|566536785|FG001|Overall Study|Withdrawal by Subject|7|||
156939466|NCT00393939|566536784|FG000|Overall Study|Other|37|||
156939467|NCT00393939|566536785|FG001|Overall Study|Other|45|||
156939468|NCT03995953|566536786|FG000|Overall Study|Death|3|||
156939469|NCT03995953|566536787|FG001|Overall Study|Death|0|||
156939470|NCT03995953|566536788|FG002|Overall Study|Death|3|||
156939471|NCT03995953|566536789|FG003|Overall Study|Death|0|||
156939472|NCT03995953|566536790|FG004|Overall Study|Death|3|||
157167241|NCT01766817|567352730|FG002|Overall Study|Death|0|||
157167242|NCT01766817|567352728|FG000|Overall Study|Unable to take study drug|0|||
157167243|NCT01766817|567352729|FG001|Overall Study|Unable to take study drug|1|||
157167244|NCT01766817|567352730|FG002|Overall Study|Unable to take study drug|0|||
157167245|NCT01766817|567352728|FG000|Overall Study|Withdrawal by Subject|2|||
157167246|NCT01766817|567352729|FG001|Overall Study|Withdrawal by Subject|0|||
157167247|NCT01766817|567352730|FG002|Overall Study|Withdrawal by Subject|3|||
157167248|NCT01766817|567352728|FG000|Overall Study|Subject non-compliance|0|||
157167249|NCT01766817|567352729|FG001|Overall Study|Subject non-compliance|1|||
157167250|NCT01766817|567352730|FG002|Overall Study|Subject non-compliance|2|||
157167251|NCT01766817|567352728|FG000|Overall Study|Physician Decision|3|||
157167252|NCT01766817|567352729|FG001|Overall Study|Physician Decision|3|||
157167253|NCT01766817|567352730|FG002|Overall Study|Physician Decision|4|||
157167254|NCT01766817|567352728|FG000|Overall Study|Other|1|||
157167255|NCT01766817|567352729|FG001|Overall Study|Other|0|||
157167256|NCT01766817|567352730|FG002|Overall Study|Other|0|||
156939473|NCT03995953|566536791|FG005|Overall Study|Death|0|||
157167257|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
156939474|NCT03995953|566536792|FG006|Overall Study|Death|0|||
156939475|NCT03995953|566536793|FG007|Overall Study|Death|0|||
156939476|NCT03995953|566536794|FG008|Overall Study|Death|1|||
156939477|NCT03995953|566536795|FG009|Overall Study|Death|0|||
156939478|NCT03995953|566536796|FG010|Overall Study|Death|0|||
156939479|NCT03995953|566536797|FG011|Overall Study|Death|0|||
156939480|NCT03995953|566536786|FG000|Overall Study|Lost to Follow-up|6|||
156939481|NCT03995953|566536787|FG001|Overall Study|Lost to Follow-up|54|||
156939482|NCT03995953|566536788|FG002|Overall Study|Lost to Follow-up|3|||
156939483|NCT03995953|566536789|FG003|Overall Study|Lost to Follow-up|32|||
157167258|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
157167259|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
156939484|NCT03995953|566536790|FG004|Overall Study|Lost to Follow-up|5|||
157227203|NCT00927810|567577774|FG002|Overall Study|Death|0|||
156939485|NCT03995953|566536791|FG005|Overall Study|Lost to Follow-up|44|||
156939486|NCT03995953|566536792|FG006|Overall Study|Lost to Follow-up|0|||
156939487|NCT03995953|566536793|FG007|Overall Study|Lost to Follow-up|31|||
156939488|NCT03995953|566536794|FG008|Overall Study|Lost to Follow-up|8|||
156939489|NCT03995953|566536795|FG009|Overall Study|Lost to Follow-up|36|||
156939490|NCT03995953|566536796|FG010|Overall Study|Lost to Follow-up|5|||
156939491|NCT03995953|566536797|FG011|Overall Study|Lost to Follow-up|41|||
156939492|NCT03995953|566536786|FG000|Overall Study|Withdrawal by Subject|4|||
156939493|NCT03995953|566536787|FG001|Overall Study|Withdrawal by Subject|0|||
156939494|NCT03995953|566536788|FG002|Overall Study|Withdrawal by Subject|1|||
156939495|NCT03995953|566536789|FG003|Overall Study|Withdrawal by Subject|0|||
156939496|NCT03995953|566536790|FG004|Overall Study|Withdrawal by Subject|1|||
156939497|NCT03995953|566536791|FG005|Overall Study|Withdrawal by Subject|0|||
156939498|NCT03995953|566536792|FG006|Overall Study|Withdrawal by Subject|1|||
156939499|NCT03995953|566536793|FG007|Overall Study|Withdrawal by Subject|0|||
156939500|NCT03995953|566536794|FG008|Overall Study|Withdrawal by Subject|3|||
156939501|NCT03995953|566536795|FG009|Overall Study|Withdrawal by Subject|0|||
156939502|NCT03995953|566536796|FG010|Overall Study|Withdrawal by Subject|3|||
156939503|NCT03995953|566536797|FG011|Overall Study|Withdrawal by Subject|0|||
156939504|NCT03995953|566536786|FG000|Overall Study|Health Issues|0|||
156939505|NCT03995953|566536787|FG001|Overall Study|Health Issues|0|||
156939506|NCT03995953|566536788|FG002|Overall Study|Health Issues|0|||
156939507|NCT03995953|566536789|FG003|Overall Study|Health Issues|0|||
156939508|NCT03995953|566536790|FG004|Overall Study|Health Issues|1|||
156939509|NCT03995953|566536791|FG005|Overall Study|Health Issues|0|||
156939510|NCT03995953|566536792|FG006|Overall Study|Health Issues|0|||
156939511|NCT03995953|566536793|FG007|Overall Study|Health Issues|0|||
156939512|NCT03995953|566536794|FG008|Overall Study|Health Issues|4|||
156939513|NCT03995953|566536795|FG009|Overall Study|Health Issues|0|||
156939514|NCT03995953|566536796|FG010|Overall Study|Health Issues|0|||
156939515|NCT03995953|566536797|FG011|Overall Study|Health Issues|0|||
156939516|NCT03995953|566536786|FG000|Overall Study|Relocated|11|||
156939517|NCT03995953|566536787|FG001|Overall Study|Relocated|0|||
156939518|NCT03995953|566536788|FG002|Overall Study|Relocated|16|||
156939519|NCT03995953|566536789|FG003|Overall Study|Relocated|0|||
156939520|NCT03995953|566536790|FG004|Overall Study|Relocated|14|||
156939521|NCT03995953|566536791|FG005|Overall Study|Relocated|0|||
156939522|NCT03995953|566536792|FG006|Overall Study|Relocated|16|||
156939523|NCT03995953|566536793|FG007|Overall Study|Relocated|0|||
156939524|NCT03995953|566536794|FG008|Overall Study|Relocated|14|||
156939525|NCT03995953|566536795|FG009|Overall Study|Relocated|0|||
156939526|NCT03995953|566536796|FG010|Overall Study|Relocated|15|||
156939527|NCT03995953|566536797|FG011|Overall Study|Relocated|0|||
156939528|NCT02388997|566536798|FG000|Overall Study|Adverse Event|1|||
156939529|NCT02388997|566536799|FG001|Overall Study|Adverse Event|2|||
156939530|NCT02388997|566536798|FG000|Overall Study|Withdrawal by Subject|2|||
156939531|NCT02388997|566536799|FG001|Overall Study|Withdrawal by Subject|1|||
156939532|NCT02388997|566536798|FG000|Overall Study|Lung function exclusion criteria|0|||
156939533|NCT02388997|566536799|FG001|Overall Study|Lung function exclusion criteria|2|||
156939534|NCT02388997|566536798|FG000|Overall Study|Tested positive for virus during run-in|0|||
156939535|NCT02388997|566536799|FG001|Overall Study|Tested positive for virus during run-in|1|||
156939536|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
156939537|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
156939538|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
156939539|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
156939540|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
157031747|NCT05736458|566871840|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
157031748|NCT05736458|566871838|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
157031749|NCT05736458|566871839|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
156939541|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
156939542|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
156939543|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
157031750|NCT05736458|566871840|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
157031751|NCT05736458|566871838|FG000|TMS/fMRI #1|Physician Decision|0|||
157031752|NCT05736458|566871839|FG001|TMS/fMRI #1|Physician Decision|0|||
157031753|NCT05736458|566871840|FG002|TMS/fMRI #1|Physician Decision|2|||
157167260|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
157167261|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
157167262|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
157167263|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156939544|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
156939545|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
156939546|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
156939547|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
156939548|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
156939549|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
156939550|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
156939551|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
156939552|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
156939553|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
156939554|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
156939555|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
156939556|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
156939557|NCT02161718|566536802|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
156939558|NCT02161718|566536803|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
156939559|NCT02161718|566536804|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
156939560|NCT02161718|566536802|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
156939561|NCT02161718|566536803|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
156939562|NCT02161718|566536804|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
156939563|NCT02161718|566536802|FG000|Post- Randomization Period|Lost to Follow-up|0|||
156939564|NCT02161718|566536803|FG001|Post- Randomization Period|Lost to Follow-up|9|||
156939565|NCT02161718|566536804|FG002|Post- Randomization Period|Lost to Follow-up|15|||
156939566|NCT02161718|566536802|FG000|Post- Randomization Period|Adverse Event|0|||
156939567|NCT02161718|566536803|FG001|Post- Randomization Period|Adverse Event|9|||
156939568|NCT02161718|566536804|FG002|Post- Randomization Period|Adverse Event|10|||
156939569|NCT02161718|566536802|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
156939570|NCT02161718|566536803|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
156939571|NCT02161718|566536804|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
156939572|NCT02161718|566536802|FG000|Post- Randomization Period|Physician Decision|0|||
156939573|NCT02161718|566536803|FG001|Post- Randomization Period|Physician Decision|2|||
156939574|NCT02161718|566536804|FG002|Post- Randomization Period|Physician Decision|4|||
156939575|NCT02161718|566536802|FG000|Post- Randomization Period|Protocol Violation|0|||
156939576|NCT02161718|566536803|FG001|Post- Randomization Period|Protocol Violation|2|||
156939577|NCT02161718|566536804|FG002|Post- Randomization Period|Protocol Violation|3|||
156939578|NCT02161718|566536802|FG000|Post- Randomization Period|Lack of Efficacy|0|||
156939579|NCT02161718|566536803|FG001|Post- Randomization Period|Lack of Efficacy|0|||
156939580|NCT02161718|566536804|FG002|Post- Randomization Period|Lack of Efficacy|1|||
156939581|NCT02161718|566536802|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
156939582|NCT02161718|566536803|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
156939583|NCT02161718|566536804|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
156939584|NCT02161718|566536802|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
156939585|NCT02161718|566536803|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
156939586|NCT02161718|566536804|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
156939587|NCT02161718|566536802|FG000|Post- Randomization Period|Relocation|0|||
156939588|NCT02161718|566536803|FG001|Post- Randomization Period|Relocation|3|||
156939589|NCT02161718|566536804|FG002|Post- Randomization Period|Relocation|0|||
156939590|NCT00207142|566536806|FG000|Induction Phase|Adverse Event|9|||
156939591|NCT00207142|566536807|FG001|Induction Phase|Adverse Event|0|||
156939592|NCT00207142|566536808|FG002|Induction Phase|Adverse Event|0|||
156939593|NCT00207142|566536809|FG003|Induction Phase|Adverse Event|0|||
156939594|NCT00207142|566536806|FG000|Induction Phase|Death|1|||
156939595|NCT00207142|566536807|FG001|Induction Phase|Death|0|||
156939596|NCT00207142|566536808|FG002|Induction Phase|Death|0|||
156939597|NCT00207142|566536809|FG003|Induction Phase|Death|0|||
156939598|NCT00207142|566536806|FG000|Induction Phase|Lack of Efficacy|1|||
156939599|NCT00207142|566536807|FG001|Induction Phase|Lack of Efficacy|0|||
156939600|NCT00207142|566536808|FG002|Induction Phase|Lack of Efficacy|0|||
156939601|NCT00207142|566536809|FG003|Induction Phase|Lack of Efficacy|0|||
156939602|NCT00207142|566536806|FG000|Induction Phase|Lost to Follow-up|5|||
156939603|NCT00207142|566536807|FG001|Induction Phase|Lost to Follow-up|0|||
156939604|NCT00207142|566536808|FG002|Induction Phase|Lost to Follow-up|0|||
156939605|NCT00207142|566536809|FG003|Induction Phase|Lost to Follow-up|0|||
156939606|NCT00207142|566536806|FG000|Induction Phase|Physician Decision|2|||
156939607|NCT00207142|566536807|FG001|Induction Phase|Physician Decision|0|||
156939608|NCT00207142|566536808|FG002|Induction Phase|Physician Decision|0|||
156939609|NCT00207142|566536809|FG003|Induction Phase|Physician Decision|0|||
156939610|NCT00207142|566536806|FG000|Induction Phase|Poor/noncompliance|2|||
157031754|NCT05736458|566871838|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
157031755|NCT05736458|566871839|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
157031756|NCT05736458|566871840|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
156939611|NCT00207142|566536807|FG001|Induction Phase|Poor/noncompliance|0|||
156939612|NCT00207142|566536808|FG002|Induction Phase|Poor/noncompliance|0|||
156939613|NCT00207142|566536809|FG003|Induction Phase|Poor/noncompliance|0|||
156939614|NCT00207142|566536806|FG000|Induction Phase|Pregnancy|1|||
156939615|NCT00207142|566536807|FG001|Induction Phase|Pregnancy|0|||
156939616|NCT00207142|566536808|FG002|Induction Phase|Pregnancy|0|||
156939617|NCT00207142|566536809|FG003|Induction Phase|Pregnancy|0|||
156939618|NCT00207142|566536806|FG000|Induction Phase|Subject no longer meets study criteria|3|||
157227204|NCT00927810|567577775|FG003|Overall Study|Death|0|||
157031757|NCT04129554|566871846|FG000|Overall Study|Withdrawal by Subject|4|||
157031758|NCT04129554|566871847|FG001|Overall Study|Withdrawal by Subject|3|||
156939619|NCT00207142|566536807|FG001|Induction Phase|Subject no longer meets study criteria|0|||
156939620|NCT00207142|566536808|FG002|Induction Phase|Subject no longer meets study criteria|0|||
156939621|NCT00207142|566536809|FG003|Induction Phase|Subject no longer meets study criteria|0|||
156939622|NCT00207142|566536806|FG000|Induction Phase|Withdrawal by Subject|4|||
156939623|NCT00207142|566536807|FG001|Induction Phase|Withdrawal by Subject|0|||
156939624|NCT00207142|566536808|FG002|Induction Phase|Withdrawal by Subject|0|||
156939625|NCT00207142|566536809|FG003|Induction Phase|Withdrawal by Subject|0|||
156939626|NCT00207142|566536806|FG000|Induction Phase|Incarceration|1|||
156939627|NCT00207142|566536807|FG001|Induction Phase|Incarceration|0|||
156939628|NCT00207142|566536808|FG002|Induction Phase|Incarceration|0|||
156939629|NCT00207142|566536809|FG003|Induction Phase|Incarceration|0|||
156939630|NCT00207142|566536806|FG000|Induction Phase|Missing lab data|1|||
156939631|NCT00207142|566536807|FG001|Induction Phase|Missing lab data|0|||
156939632|NCT00207142|566536808|FG002|Induction Phase|Missing lab data|0|||
156939633|NCT00207142|566536809|FG003|Induction Phase|Missing lab data|0|||
156939634|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
156939635|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
156939636|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
156939637|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
156939638|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
156939639|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
156939640|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
156939641|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
156939642|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156939643|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156939644|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
156939645|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
156939646|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
156939647|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
156939648|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
156939649|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
156939650|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
156939651|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
156939652|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
156939653|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
156939654|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156939655|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156939656|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
156939657|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
156939658|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
156939659|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
156939660|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
156939661|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
156939662|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Death|0|||
156939663|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Death|0|||
156939664|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Death|0|||
156939665|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Death|1|||
156939666|NCT00207142|566536806|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156939667|NCT00207142|566536807|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156939668|NCT00207142|566536808|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
156939669|NCT00207142|566536809|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
156939670|NCT01857063|566536810|FG000|Period 1 (7 Days)|Adverse Event|0|||
156939671|NCT01857063|566536811|FG001|Period 1 (7 Days)|Adverse Event|1|||
156939672|NCT01857063|566536810|FG000|Period 1 (7 Days)|Physician Decision|1|||
156939673|NCT01857063|566536811|FG001|Period 1 (7 Days)|Physician Decision|0|||
156939674|NCT01857063|566536810|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
157227205|NCT00927810|567577772|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157227206|NCT00927810|567577773|FG001|Overall Study|Abnormal laboratory value(s)|1|||
156939675|NCT01857063|566536811|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
156939676|NCT01857063|566536810|FG000|Period 2 (7 Days)|Adverse Event|2|||
156939677|NCT01857063|566536811|FG001|Period 2 (7 Days)|Adverse Event|1|||
156939678|NCT01857063|566536810|FG000|Period 2 (7 Days)|Physician Decision|1|||
156939679|NCT01857063|566536811|FG001|Period 2 (7 Days)|Physician Decision|1|||
156939680|NCT01857063|566536810|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
156939681|NCT01857063|566536811|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
156939682|NCT01256710|566536812|FG000|Overall Study|Death|449|||
156939683|NCT01256710|566536812|FG000|Overall Study|System Explant|67|||
156939684|NCT01256710|566536812|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
156939685|NCT01256710|566536812|FG000|Overall Study|Lost to Follow-up|67|||
156939686|NCT01256710|566536812|FG000|Overall Study|Withdrawal by Subject|29|||
156939687|NCT01256710|566536812|FG000|Overall Study|Physician Decision|9|||
157227207|NCT00927810|567577774|FG002|Overall Study|Abnormal laboratory value(s)|0|||
156939688|NCT01256710|566536812|FG000|Overall Study|Subject Noncompliance|2|||
156939689|NCT01256710|566536812|FG000|Overall Study|Study Terminated by Sponsor|273|||
156939690|NCT00058825|566536813|FG000|Overall Study|Relapse|9|||
156939691|NCT00058825|566536813|FG000|Overall Study|Progressive Disease|5|||
156939692|NCT00058825|566536813|FG000|Overall Study|Graft Failure|5|||
156939693|NCT00058825|566536813|FG000|Overall Study|Death|3|||
156939694|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939695|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
156939696|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
157167264|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
157167265|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
156939697|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
156939698|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939699|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939700|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939701|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939702|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939703|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939704|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939705|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939706|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939707|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939708|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939709|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939710|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939711|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939712|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939713|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939714|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939715|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939716|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939717|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
156939718|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939719|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
156939720|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939721|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939722|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939723|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939724|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939725|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939726|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939727|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939728|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939729|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939730|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939731|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939732|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939733|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939734|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939735|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939736|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939737|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939738|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
157167266|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
157167267|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
157167268|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
157167269|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156939739|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939740|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
157167270|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
157167271|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
157167272|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
156939741|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
156939742|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939743|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
156939744|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
157031759|NCT04129554|566871846|FG000|Overall Study|Other|0|||
156939745|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939746|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939747|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939748|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939749|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939750|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939751|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939752|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939753|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939754|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939755|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939756|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939757|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939758|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939759|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939760|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939761|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939762|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939763|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939764|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939765|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
156939766|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
156939767|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
156939768|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
156939769|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
156939770|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939771|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939772|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939773|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939774|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939775|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939776|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939777|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939778|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939779|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939780|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939781|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939782|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939783|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939784|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939785|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939786|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939787|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939788|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939789|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
156939790|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
156939791|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
156939792|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
156939793|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
156939794|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939795|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939796|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939797|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939798|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939799|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939800|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939801|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939802|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939803|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939804|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939805|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939806|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939807|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939808|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
157031760|NCT04129554|566871847|FG001|Overall Study|Other|2|||
157031761|NCT01570361|566871848|FG000|Overall Study|Subject discontinued|1|||
157031762|NCT01570361|566871849|FG001|Overall Study|Subject discontinued|2|||
157031763|NCT01570361|566871848|FG000|Overall Study|Sponsor closing the study|51|||
157031764|NCT01570361|566871849|FG001|Overall Study|Sponsor closing the study|50|||
157031765|NCT01570361|566871848|FG000|Overall Study|Subject excluded|5|||
157031766|NCT01570361|566871849|FG001|Overall Study|Subject excluded|3|||
157031767|NCT01570361|566871848|FG000|Overall Study|Subject withdrew consent|14|||
157031768|NCT01570361|566871849|FG001|Overall Study|Subject withdrew consent|9|||
157031769|NCT01570361|566871848|FG000|Overall Study|Adverse Event|2|||
157031770|NCT01570361|566871849|FG001|Overall Study|Adverse Event|1|||
157031771|NCT01570361|566871848|FG000|Overall Study|Lost to Follow-up|4|||
157031772|NCT01570361|566871849|FG001|Overall Study|Lost to Follow-up|4|||
157031773|NCT01570361|566871848|FG000|Overall Study|Death|5|||
157031774|NCT01570361|566871849|FG001|Overall Study|Death|4|||
157031775|NCT01570361|566871848|FG000|Overall Study|Other|0|||
157031776|NCT01570361|566871849|FG001|Overall Study|Other|2|||
157031777|NCT05158504|566871852|FG000|Overall Study|Lost to Follow-up|2|||
157031778|NCT05158504|566871853|FG001|Overall Study|Lost to Follow-up|3|||
157031779|NCT03606512|566871854|FG000|Overall Study|Lost to Follow-up|0|||
157031780|NCT03606512|566871855|FG001|Overall Study|Lost to Follow-up|1|||
157031781|NCT03606512|566871854|FG000|Overall Study|'moved from study area|0|||
157031782|NCT03606512|566871855|FG001|Overall Study|'moved from study area|1|||
157031783|NCT05513937|566871856|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
157031784|NCT05513937|566871857|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
157031785|NCT05513937|566871858|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
157031786|NCT05513937|566871859|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
157031787|NCT05513937|566871856|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
157031788|NCT05513937|566871857|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
157031789|NCT05513937|566871858|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
157031790|NCT05513937|566871859|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
157031791|NCT05513937|566871856|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
157031792|NCT05513937|566871857|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
157031793|NCT05513937|566871858|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
157031794|NCT05513937|566871859|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
157031795|NCT05513937|566871856|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
157031796|NCT05513937|566871857|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
157031797|NCT05513937|566871858|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
157031798|NCT05513937|566871859|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
157031799|NCT05513937|566871856|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
157031800|NCT05513937|566871857|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
157031801|NCT05513937|566871858|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
157031802|NCT05513937|566871859|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
157031803|NCT05513937|566871856|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
157031804|NCT05513937|566871857|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
157031805|NCT05513937|566871858|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
157031806|NCT05513937|566871859|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
157031807|NCT02846545|566871860|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
157031808|NCT02846545|566871861|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
157031809|NCT02846545|566871860|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
157031810|NCT02846545|566871861|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
157031811|NCT02846545|566871860|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
157031812|NCT02846545|566871861|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
157031813|NCT02846545|566871860|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
157031814|NCT02846545|566871861|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
157031815|NCT02846545|566871860|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
157031816|NCT02846545|566871861|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
157031817|NCT05654662|566871864|FG000|Overall Study|Withdrawal by Subject|1|||
157031818|NCT05654662|566871865|FG001|Overall Study|Withdrawal by Subject|0|||
157031819|NCT05654662|566871864|FG000|Overall Study|A death in the family|1|||
157031820|NCT05654662|566871865|FG001|Overall Study|A death in the family|0|||
157031821|NCT04230681|566871866|FG000|Overall Study|Physician Decision|2|||
157031822|NCT04230681|566871867|FG001|Overall Study|Physician Decision|3|||
157031823|NCT04230681|566871866|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
157031824|NCT04230681|566871867|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
157031825|NCT04230681|566871866|FG000|Overall Study|IV inadvertently removed|0|||
157031826|NCT04230681|566871867|FG001|Overall Study|IV inadvertently removed|1|||
157227208|NCT00927810|567577775|FG003|Overall Study|Abnormal laboratory value(s)|0|||
157227209|NCT01626079|567577776|FG000|Overall Study|Death|167|||
157031827|NCT01064440|566873146|FG000|Overall Study|Lost to Follow-up|1|||
157031828|NCT01064440|566873147|FG001|Overall Study|Lost to Follow-up|1|||
157031829|NCT01064440|566873148|FG002|Overall Study|Lost to Follow-up|1|||
157031830|NCT01064440|566873146|FG000|Overall Study|Non-compliance|0|||
157031831|NCT01064440|566873147|FG001|Overall Study|Non-compliance|1|||
157031832|NCT01064440|566873148|FG002|Overall Study|Non-compliance|0|||
157031833|NCT01064440|566873146|FG000|Overall Study|Death|1|||
157031834|NCT01064440|566873147|FG001|Overall Study|Death|0|||
157031835|NCT01064440|566873148|FG002|Overall Study|Death|1|||
157031836|NCT01064440|566873146|FG000|Overall Study|Withdrawal by Subject|0|||
157031837|NCT01064440|566873147|FG001|Overall Study|Withdrawal by Subject|1|||
157031838|NCT01064440|566873148|FG002|Overall Study|Withdrawal by Subject|1|||
157031839|NCT01064440|566873146|FG000|Overall Study|Other: amputation|1|||
157031840|NCT01064440|566873147|FG001|Overall Study|Other: amputation|0|||
157031841|NCT01064440|566873148|FG002|Overall Study|Other: amputation|0|||
157031842|NCT01880515|566873149|FG000|Overall Study|Lost to Follow-up|3|||
157031843|NCT01880515|566873150|FG001|Overall Study|Lost to Follow-up|2|||
157031844|NCT01880515|566873149|FG000|Overall Study|Disease Progression|5|||
157031845|NCT01880515|566873150|FG001|Overall Study|Disease Progression|7|||
157031846|NCT05247034|566873151|FG000|Overall Study|Lost to Follow-up|3|||
157031847|NCT05247034|566873152|FG001|Overall Study|Lost to Follow-up|2|||
157031848|NCT05247034|566873151|FG000|Overall Study|Organizational problems when attending appointments|1|||
157031849|NCT05247034|566873152|FG001|Overall Study|Organizational problems when attending appointments|0|||
157031850|NCT03505710|566873153|FG000|Overall Study|Progressive Disease|24|||
157031851|NCT03505710|566873154|FG001|Overall Study|Progressive Disease|17|||
157031852|NCT03505710|566873155|FG002|Overall Study|Progressive Disease|43|||
157031853|NCT03505710|566873153|FG000|Overall Study|Clinical Progression|6|||
157031854|NCT03505710|566873154|FG001|Overall Study|Clinical Progression|8|||
157031855|NCT03505710|566873155|FG002|Overall Study|Clinical Progression|3|||
157031856|NCT03505710|566873153|FG000|Overall Study|Adverse Event|12|||
157031857|NCT03505710|566873154|FG001|Overall Study|Adverse Event|6|||
157031858|NCT03505710|566873155|FG002|Overall Study|Adverse Event|28|||
157031859|NCT03505710|566873153|FG000|Overall Study|Withdrawal by Subject|1|||
157031860|NCT03505710|566873154|FG001|Overall Study|Withdrawal by Subject|3|||
157031861|NCT03505710|566873155|FG002|Overall Study|Withdrawal by Subject|7|||
157031862|NCT03505710|566873153|FG000|Overall Study|Physician Decision|1|||
157031863|NCT03505710|566873154|FG001|Overall Study|Physician Decision|1|||
157031864|NCT03505710|566873155|FG002|Overall Study|Physician Decision|2|||
157031865|NCT03505710|566873153|FG000|Overall Study|Death|4|||
157031866|NCT03505710|566873154|FG001|Overall Study|Death|5|||
157031867|NCT03505710|566873155|FG002|Overall Study|Death|6|||
157031868|NCT03505710|566873153|FG000|Overall Study|Other Reasons|1|||
157031869|NCT03505710|566873154|FG001|Overall Study|Other Reasons|1|||
157031870|NCT03505710|566873155|FG002|Overall Study|Other Reasons|1|||
157031871|NCT03505710|566873153|FG000|Overall Study|Study Terminated by Sponsor|0|||
157031872|NCT03505710|566873154|FG001|Overall Study|Study Terminated by Sponsor|0|||
157031873|NCT03505710|566873155|FG002|Overall Study|Study Terminated by Sponsor|1|||
157031874|NCT01960452|566873156|FG000|Overall Study|Withdrawal by Subject|2|||
157031875|NCT01960452|566873157|FG001|Overall Study|Withdrawal by Subject|1|||
157031876|NCT01960452|566873156|FG000|Overall Study|Sleep apnea in Night 1|1|||
157031877|NCT01960452|566873157|FG001|Overall Study|Sleep apnea in Night 1|0|||
157031878|NCT01960452|566873156|FG000|Overall Study|Poor Sleep in Night 1|0|||
157031879|NCT01960452|566873157|FG001|Overall Study|Poor Sleep in Night 1|2|||
157031880|NCT01960452|566873156|FG000|Overall Study|No Sex/Age Match Night 1|1|||
157031881|NCT01960452|566873157|FG001|Overall Study|No Sex/Age Match Night 1|0|||
157031882|NCT01960452|566873156|FG000|Overall Study|No Sex/Age Match Night 2|0|||
157031883|NCT01960452|566873157|FG001|Overall Study|No Sex/Age Match Night 2|2|||
157031884|NCT01960452|566873156|FG000|Overall Study|Technical Difficulties Night 2|2|||
157031885|NCT01960452|566873157|FG001|Overall Study|Technical Difficulties Night 2|0|||
157031886|NCT04414722|566873158|FG000|Overall Study|Lost to Follow-up|3|||
157031887|NCT04414722|566873159|FG001|Overall Study|Lost to Follow-up|4|||
157167273|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
157031888|NCT04414722|566873160|FG002|Overall Study|Lost to Follow-up|3|||
157031889|NCT04414722|566873161|FG003|Overall Study|Lost to Follow-up|2|||
157031890|NCT04414722|566873162|FG004|Overall Study|Lost to Follow-up|3|||
157031891|NCT04414722|566873158|FG000|Overall Study|Withdrawal by Subject|6|||
157031892|NCT04414722|566873159|FG001|Overall Study|Withdrawal by Subject|3|||
157031893|NCT04414722|566873160|FG002|Overall Study|Withdrawal by Subject|1|||
157031894|NCT04414722|566873161|FG003|Overall Study|Withdrawal by Subject|5|||
157031895|NCT04414722|566873162|FG004|Overall Study|Withdrawal by Subject|1|||
157031896|NCT04414722|566873158|FG000|Overall Study|Physician Decision|0|||
157031897|NCT04414722|566873159|FG001|Overall Study|Physician Decision|1|||
157031898|NCT04414722|566873160|FG002|Overall Study|Physician Decision|2|||
157031899|NCT04414722|566873161|FG003|Overall Study|Physician Decision|0|||
157031900|NCT04414722|566873162|FG004|Overall Study|Physician Decision|0|||
157031901|NCT04414722|566873158|FG000|Overall Study|Non-participatory|0|||
157031902|NCT04414722|566873159|FG001|Overall Study|Non-participatory|1|||
157031903|NCT04414722|566873160|FG002|Overall Study|Non-participatory|1|||
156939809|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939810|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939811|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939812|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939813|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
156939814|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939815|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
156939816|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939817|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
156939818|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939819|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939820|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939821|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939822|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939823|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939824|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939825|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939826|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939827|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939828|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939829|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939830|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939831|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939832|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939833|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939834|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939835|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939836|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939837|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
156939838|NCT02346240|566536815|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939839|NCT02346240|566536816|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939840|NCT02346240|566536817|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
156939841|NCT02346240|566536818|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939842|NCT02346240|566536819|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939843|NCT02346240|566536820|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939844|NCT02346240|566536821|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939845|NCT02346240|566536822|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939846|NCT02346240|566536823|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939847|NCT02346240|566536824|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939848|NCT02346240|566536825|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939849|NCT02346240|566536826|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939850|NCT02346240|566536827|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939851|NCT02346240|566536828|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939852|NCT02346240|566536829|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939853|NCT02346240|566536830|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939854|NCT02346240|566536831|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939855|NCT02346240|566536832|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939856|NCT02346240|566536833|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939857|NCT02346240|566536834|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939858|NCT02346240|566536835|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939859|NCT02346240|566536836|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939860|NCT02346240|566536837|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939861|NCT02346240|566536838|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
156939862|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939863|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939864|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
157031904|NCT04414722|566873161|FG003|Overall Study|Non-participatory|0|||
157031905|NCT04414722|566873162|FG004|Overall Study|Non-participatory|0|||
157031906|NCT02668692|566873163|FG000|Overall Study|Adverse Event|1|||
157167274|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
157167275|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
157167276|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
157167277|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
157205210|NCT03669640|567496076|FG003|Overall Study|Study Terminated by Sponsor|0|||
156939865|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939866|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939867|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939868|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939869|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156939870|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156939871|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939872|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939873|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939874|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939875|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156939876|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
156939877|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
156939878|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
156939879|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939880|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939881|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939882|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939883|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939884|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939885|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
156939886|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939887|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939888|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939889|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939890|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939891|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939892|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939893|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939894|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939895|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939896|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939897|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939898|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939899|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
156939900|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939901|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
156939902|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939903|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939904|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939905|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939906|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939907|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939908|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939909|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
156939910|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939911|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939912|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939913|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939914|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939915|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
157031907|NCT02668692|566873164|FG001|Overall Study|Adverse Event|0|||
157031908|NCT03981926|566873165|FG000|Overall Study|Lost to Follow-up|5|||
156939916|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939917|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939918|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939919|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939920|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939921|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939922|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939923|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939924|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
156939925|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939926|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
157031909|NCT03981926|566873166|FG001|Overall Study|Lost to Follow-up|9|||
157031910|NCT03711474|566873168|FG000|Overall Study|Physician Decision|2|||
157227210|NCT01626079|567577777|FG001|Overall Study|Death|192|||
157227211|NCT01626079|567577778|FG002|Overall Study|Death|39|||
156939927|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939928|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939929|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939930|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939931|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939932|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939933|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
156939934|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939935|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939936|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939937|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939938|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939939|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939940|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939941|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939942|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939943|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939944|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939945|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156939946|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939947|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156939948|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
156939949|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
156939950|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
156939951|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939952|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939953|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939954|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939955|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939956|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939957|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
156939958|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939959|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939960|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939961|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939962|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939963|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939964|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939965|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939966|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939967|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939968|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939969|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939970|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939971|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
156939972|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
156939973|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
156939974|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
156939975|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939976|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939977|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939978|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939979|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939980|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939981|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
156939982|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939983|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939984|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939985|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939986|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
157227212|NCT01626079|567577776|FG000|Overall Study|Withdrawal by Subject|23|||
156939987|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939988|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
156939989|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939990|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939991|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939992|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939993|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939994|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939995|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939996|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939997|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939998|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156939999|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940000|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940001|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940002|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940003|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940004|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940005|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
156940006|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940007|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940008|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940009|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940010|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940011|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940012|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940013|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940014|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156940015|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940016|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940017|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156940018|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940019|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156940020|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
156940021|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940022|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940023|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940024|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940025|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940026|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940027|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940028|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940029|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
156940030|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940031|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940032|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940033|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940034|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940035|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940036|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940037|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940038|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940039|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
156940040|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940041|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940042|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940043|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
157031911|NCT03711474|566873169|FG001|Overall Study|Physician Decision|0|||
157031912|NCT04615273|566873172|FG000|Overall Study|Withdrawal by Subject|3|||
157031913|NCT04615273|566873173|FG001|Overall Study|Withdrawal by Subject|1|||
157031914|NCT04615273|566873174|FG002|Overall Study|Withdrawal by Subject|2|||
157031915|NCT04615273|566873172|FG000|Overall Study|Adverse Event|1|||
157031916|NCT04615273|566873173|FG001|Overall Study|Adverse Event|0|||
157031917|NCT04615273|566873174|FG002|Overall Study|Adverse Event|1|||
157031918|NCT04615273|566873172|FG000|Overall Study|Lost to Follow-up|0|||
157031919|NCT04615273|566873173|FG001|Overall Study|Lost to Follow-up|1|||
157031920|NCT04615273|566873174|FG002|Overall Study|Lost to Follow-up|0|||
157031921|NCT04615273|566873172|FG000|Overall Study|Physician Decision|0|||
157031922|NCT04615273|566873173|FG001|Overall Study|Physician Decision|0|||
157031923|NCT04615273|566873174|FG002|Overall Study|Physician Decision|1|||
157031924|NCT04615273|566873172|FG000|Overall Study|Other|0|||
157031925|NCT04615273|566873173|FG001|Overall Study|Other|1|||
157031926|NCT04615273|566873174|FG002|Overall Study|Other|0|||
157031927|NCT04615273|566873172|FG000|Overall Study|Randomized but not treated|1|||
157031928|NCT04615273|566873173|FG001|Overall Study|Randomized but not treated|3|||
157031929|NCT04615273|566873174|FG002|Overall Study|Randomized but not treated|1|||
157031930|NCT03677141|566873175|FG000|Overall Study|Death|2|||
157031931|NCT03677141|566873176|FG001|Overall Study|Death|1|||
157031932|NCT03677141|566873177|FG002|Overall Study|Death|6|||
157031933|NCT03677141|566873178|FG003|Overall Study|Death|9|||
157031934|NCT03677141|566873179|FG004|Overall Study|Death|5|||
157031935|NCT03677141|566873180|FG005|Overall Study|Death|3|||
157031936|NCT03677141|566873175|FG000|Overall Study|Lost to Follow-up|0|||
157031937|NCT03677141|566873176|FG001|Overall Study|Lost to Follow-up|0|||
157031938|NCT03677141|566873177|FG002|Overall Study|Lost to Follow-up|0|||
157031939|NCT03677141|566873178|FG003|Overall Study|Lost to Follow-up|2|||
157031940|NCT03677141|566873179|FG004|Overall Study|Lost to Follow-up|0|||
157031941|NCT03677141|566873180|FG005|Overall Study|Lost to Follow-up|0|||
157031942|NCT03677141|566873175|FG000|Overall Study|Screen failure or enrolled in error|0|||
157031943|NCT03677141|566873176|FG001|Overall Study|Screen failure or enrolled in error|0|||
157031944|NCT03677141|566873177|FG002|Overall Study|Screen failure or enrolled in error|0|||
156940044|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940045|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940046|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940047|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940048|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940049|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940050|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940051|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940052|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940053|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
156940054|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940055|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940056|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940057|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940058|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940059|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940060|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940061|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940062|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940063|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940064|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
156940065|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940066|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
157031945|NCT03677141|566873178|FG003|Overall Study|Screen failure or enrolled in error|0|||
157031946|NCT03677141|566873179|FG004|Overall Study|Screen failure or enrolled in error|2|||
157031947|NCT03677141|566873180|FG005|Overall Study|Screen failure or enrolled in error|0|||
157031948|NCT03677141|566873175|FG000|Overall Study|Physician Decision|0|||
157031949|NCT03677141|566873176|FG001|Overall Study|Physician Decision|0|||
157031950|NCT03677141|566873177|FG002|Overall Study|Physician Decision|0|||
157031951|NCT03677141|566873178|FG003|Overall Study|Physician Decision|0|||
157031952|NCT03677141|566873179|FG004|Overall Study|Physician Decision|1|||
157031953|NCT03677141|566873180|FG005|Overall Study|Physician Decision|0|||
157031954|NCT03677141|566873175|FG000|Overall Study|Withdrawal by Subject|0|||
157031955|NCT03677141|566873176|FG001|Overall Study|Withdrawal by Subject|0|||
157031956|NCT03677141|566873177|FG002|Overall Study|Withdrawal by Subject|1|||
157167278|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
157205211|NCT03669640|567496077|FG004|Overall Study|Study Terminated by Sponsor|1|||
156940067|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940068|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940069|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940070|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940071|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940072|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940073|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940074|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940075|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940076|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940077|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
156940078|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940079|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940080|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940081|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940082|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940083|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940084|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940085|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940086|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940087|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940088|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940089|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940090|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940091|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940092|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
156940093|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940094|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940095|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940096|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940097|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940098|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940099|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940100|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940101|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
156940102|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940103|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940104|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940105|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940106|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940107|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940108|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940109|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940110|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940111|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940112|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940113|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940114|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940115|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940116|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
156940117|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940118|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940119|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940120|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940121|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940122|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940123|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940124|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940125|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
156940126|NCT02346240|566536815|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940127|NCT02346240|566536816|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940128|NCT02346240|566536817|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940129|NCT02346240|566536818|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940130|NCT02346240|566536819|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940131|NCT02346240|566536820|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940132|NCT02346240|566536821|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940133|NCT02346240|566536822|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940134|NCT02346240|566536823|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940135|NCT02346240|566536824|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940136|NCT02346240|566536825|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940137|NCT02346240|566536826|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940138|NCT02346240|566536827|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940139|NCT02346240|566536828|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940140|NCT02346240|566536829|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
156940141|NCT02346240|566536830|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940142|NCT02346240|566536831|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940143|NCT02346240|566536832|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940144|NCT02346240|566536833|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940145|NCT02346240|566536834|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940146|NCT02346240|566536835|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940147|NCT02346240|566536836|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940148|NCT02346240|566536837|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940149|NCT02346240|566536838|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
156940150|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940151|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940152|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940153|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940154|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940155|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940156|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940157|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940158|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940159|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940160|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940161|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940162|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940163|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940164|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940165|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940166|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
156940167|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
156940168|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
156940169|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
156940170|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156940171|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
156940172|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156940173|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
156940174|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940175|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940176|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940177|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940178|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940179|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940180|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940181|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940182|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
157167279|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
157167280|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
157167281|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
156940183|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940184|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940185|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940186|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940187|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940188|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940189|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940190|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940191|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940192|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
156940193|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
156940194|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940195|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
156940196|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940197|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
156940198|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940199|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940200|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940201|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940202|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940203|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940204|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940205|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940206|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940207|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940208|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940209|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940210|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940211|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940212|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940213|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940214|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940215|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940216|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156940217|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940218|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940219|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
156940220|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940221|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
156940222|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940223|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940224|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940225|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940226|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940227|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940228|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940229|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940230|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940231|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940232|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940233|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940234|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940235|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940236|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940237|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940238|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940239|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940240|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940241|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
157167282|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
157167283|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
157167284|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
157167285|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
156940242|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
157031957|NCT03677141|566873178|FG003|Overall Study|Withdrawal by Subject|1|||
157031958|NCT03677141|566873179|FG004|Overall Study|Withdrawal by Subject|1|||
156940243|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
156940244|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940245|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
156940246|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940247|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940248|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
157031959|NCT03677141|566873180|FG005|Overall Study|Withdrawal by Subject|0|||
157031960|NCT04003246|566873184|FG000|Overall Study|Death|9|||
157031961|NCT01314105|566873187|FG000|Overall Study|Progressive Disease|6|||
157031962|NCT01314105|566873188|FG001|Overall Study|Progressive Disease|10|||
157031963|NCT01314105|566873187|FG000|Overall Study|Refused to continue taking medication|0|||
157031964|NCT01314105|566873188|FG001|Overall Study|Refused to continue taking medication|1|||
157031965|NCT01314105|566873187|FG000|Overall Study|Other Adverse Event|1|||
157031966|NCT01314105|566873188|FG001|Overall Study|Other Adverse Event|1|||
157031967|NCT04526886|566873189|FG000|Overall Study|Physician Decision|4|||
157031968|NCT03640286|566873197|FG000|Overall Study|Adverse Event|6|||
157031969|NCT03640286|566873198|FG001|Overall Study|Adverse Event|6|||
157031970|NCT03640286|566873197|FG000|Overall Study|Lost to Follow-up|3|||
157031971|NCT03640286|566873198|FG001|Overall Study|Lost to Follow-up|6|||
157031972|NCT03640286|566873197|FG000|Overall Study|Pregnancy|1|||
157031973|NCT03640286|566873198|FG001|Overall Study|Pregnancy|0|||
157031974|NCT03640286|566873197|FG000|Overall Study|Withdrawal by Subject|10|||
157031975|NCT03640286|566873198|FG001|Overall Study|Withdrawal by Subject|10|||
157031976|NCT03640286|566873197|FG000|Overall Study|Non-compliance|4|||
157031977|NCT03640286|566873198|FG001|Overall Study|Non-compliance|10|||
157031978|NCT03640286|566873197|FG000|Overall Study|Medication change|1|||
157031979|NCT03640286|566873198|FG001|Overall Study|Medication change|0|||
157031980|NCT03640286|566873197|FG000|Overall Study|Other|1|||
157031981|NCT03640286|566873198|FG001|Overall Study|Other|2|||
157031982|NCT03640286|566873197|FG000|Overall Study|Joined another lifestyle program|0|||
157031983|NCT03640286|566873198|FG001|Overall Study|Joined another lifestyle program|1|||
157031984|NCT03580356|566873201|FG000|Treatment Period|Withdrawal by Subject|13|||
157031985|NCT03580356|566873202|FG001|Treatment Period|Withdrawal by Subject|0|||
157031986|NCT03580356|566873203|FG002|Treatment Period|Withdrawal by Subject|13|||
157031987|NCT03580356|566873204|FG003|Treatment Period|Withdrawal by Subject|1|||
157031988|NCT03580356|566873205|FG004|Treatment Period|Withdrawal by Subject|17|||
157031989|NCT03580356|566873206|FG005|Treatment Period|Withdrawal by Subject|0|||
157031990|NCT03580356|566873207|FG006|Treatment Period|Withdrawal by Subject|5|||
157031991|NCT03580356|566873208|FG007|Treatment Period|Withdrawal by Subject|0|||
157031992|NCT03580356|566873201|FG000|Treatment Period|Adverse Event|10|||
157031993|NCT03580356|566873202|FG001|Treatment Period|Adverse Event|0|||
157031994|NCT03580356|566873203|FG002|Treatment Period|Adverse Event|13|||
157031995|NCT03580356|566873204|FG003|Treatment Period|Adverse Event|0|||
157031996|NCT03580356|566873205|FG004|Treatment Period|Adverse Event|5|||
157031997|NCT03580356|566873206|FG005|Treatment Period|Adverse Event|0|||
157031998|NCT03580356|566873207|FG006|Treatment Period|Adverse Event|8|||
157031999|NCT03580356|566873208|FG007|Treatment Period|Adverse Event|0|||
157032000|NCT03580356|566873201|FG000|Treatment Period|Protocol Violation|5|||
157032001|NCT03580356|566873202|FG001|Treatment Period|Protocol Violation|0|||
157032002|NCT03580356|566873203|FG002|Treatment Period|Protocol Violation|6|||
157167286|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
157167287|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156940249|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940250|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
157167288|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
157167289|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
157167290|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
156940251|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
157032003|NCT03580356|566873204|FG003|Treatment Period|Protocol Violation|1|||
157032004|NCT03580356|566873205|FG004|Treatment Period|Protocol Violation|9|||
157032005|NCT03580356|566873206|FG005|Treatment Period|Protocol Violation|1|||
157032006|NCT03580356|566873207|FG006|Treatment Period|Protocol Violation|1|||
157032007|NCT03580356|566873208|FG007|Treatment Period|Protocol Violation|0|||
157032008|NCT03580356|566873201|FG000|Treatment Period|Lack of Efficacy|6|||
157032009|NCT03580356|566873202|FG001|Treatment Period|Lack of Efficacy|0|||
157032010|NCT03580356|566873203|FG002|Treatment Period|Lack of Efficacy|2|||
157032011|NCT03580356|566873204|FG003|Treatment Period|Lack of Efficacy|0|||
157032012|NCT03580356|566873205|FG004|Treatment Period|Lack of Efficacy|3|||
157032013|NCT03580356|566873206|FG005|Treatment Period|Lack of Efficacy|0|||
157032014|NCT03580356|566873207|FG006|Treatment Period|Lack of Efficacy|3|||
157032015|NCT03580356|566873208|FG007|Treatment Period|Lack of Efficacy|0|||
157032016|NCT03580356|566873201|FG000|Treatment Period|Pregnancy|1|||
157032017|NCT03580356|566873202|FG001|Treatment Period|Pregnancy|0|||
157032018|NCT03580356|566873203|FG002|Treatment Period|Pregnancy|7|||
157032019|NCT03580356|566873204|FG003|Treatment Period|Pregnancy|0|||
157032020|NCT03580356|566873205|FG004|Treatment Period|Pregnancy|2|||
157032021|NCT03580356|566873206|FG005|Treatment Period|Pregnancy|0|||
157032022|NCT03580356|566873207|FG006|Treatment Period|Pregnancy|1|||
157032023|NCT03580356|566873208|FG007|Treatment Period|Pregnancy|0|||
157032024|NCT03580356|566873201|FG000|Treatment Period|Physician Decision|2|||
157032025|NCT03580356|566873202|FG001|Treatment Period|Physician Decision|0|||
157032026|NCT03580356|566873203|FG002|Treatment Period|Physician Decision|1|||
157032027|NCT03580356|566873204|FG003|Treatment Period|Physician Decision|0|||
157032028|NCT03580356|566873205|FG004|Treatment Period|Physician Decision|4|||
157032029|NCT03580356|566873206|FG005|Treatment Period|Physician Decision|0|||
157032030|NCT03580356|566873207|FG006|Treatment Period|Physician Decision|2|||
157032031|NCT03580356|566873208|FG007|Treatment Period|Physician Decision|0|||
157032032|NCT03580356|566873201|FG000|Treatment Period|Lost to Follow-up|1|||
157032033|NCT03580356|566873202|FG001|Treatment Period|Lost to Follow-up|1|||
157032034|NCT03580356|566873203|FG002|Treatment Period|Lost to Follow-up|1|||
157032035|NCT03580356|566873204|FG003|Treatment Period|Lost to Follow-up|0|||
157032036|NCT03580356|566873205|FG004|Treatment Period|Lost to Follow-up|3|||
157032037|NCT03580356|566873206|FG005|Treatment Period|Lost to Follow-up|0|||
157032038|NCT03580356|566873207|FG006|Treatment Period|Lost to Follow-up|1|||
157032039|NCT03580356|566873208|FG007|Treatment Period|Lost to Follow-up|0|||
157032040|NCT03580356|566873201|FG000|Treatment Period|Death|0|||
157032041|NCT03580356|566873202|FG001|Treatment Period|Death|0|||
157032042|NCT03580356|566873203|FG002|Treatment Period|Death|1|||
157032043|NCT03580356|566873204|FG003|Treatment Period|Death|0|||
157032044|NCT03580356|566873205|FG004|Treatment Period|Death|0|||
157032045|NCT03580356|566873206|FG005|Treatment Period|Death|0|||
157032046|NCT03580356|566873207|FG006|Treatment Period|Death|0|||
157032047|NCT03580356|566873208|FG007|Treatment Period|Death|0|||
157032048|NCT03580356|566873201|FG000|Treatment Period|Technical problems|0|||
157032049|NCT03580356|566873202|FG001|Treatment Period|Technical problems|0|||
157032050|NCT03580356|566873203|FG002|Treatment Period|Technical problems|0|||
157032051|NCT03580356|566873204|FG003|Treatment Period|Technical problems|0|||
157032052|NCT03580356|566873205|FG004|Treatment Period|Technical problems|1|||
157032053|NCT03580356|566873206|FG005|Treatment Period|Technical problems|0|||
157032054|NCT03580356|566873207|FG006|Treatment Period|Technical problems|0|||
157032055|NCT03580356|566873208|FG007|Treatment Period|Technical problems|0|||
157032056|NCT03580356|566873201|FG000|Treatment Period|Misrandomized, no treatment|0|||
157032057|NCT03580356|566873202|FG001|Treatment Period|Misrandomized, no treatment|0|||
157032058|NCT03580356|566873203|FG002|Treatment Period|Misrandomized, no treatment|1|||
157032059|NCT03580356|566873204|FG003|Treatment Period|Misrandomized, no treatment|0|||
157032060|NCT03580356|566873205|FG004|Treatment Period|Misrandomized, no treatment|2|||
157032061|NCT03580356|566873206|FG005|Treatment Period|Misrandomized, no treatment|0|||
157032062|NCT03580356|566873207|FG006|Treatment Period|Misrandomized, no treatment|0|||
157032063|NCT03580356|566873208|FG007|Treatment Period|Misrandomized, no treatment|0|||
157032064|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
157032065|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
157032066|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
157032067|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
156940252|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940253|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940254|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940255|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940256|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940257|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940258|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940259|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940260|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940261|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940262|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940263|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
156940264|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
156940265|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
156940266|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
156940267|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
157032068|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
157032069|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
157032070|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
157032071|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
157032072|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
156940268|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156940269|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
156940270|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940271|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940272|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940273|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940274|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940275|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940276|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940277|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940278|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940279|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940280|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940281|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940282|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940283|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940284|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940285|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940286|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940287|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940288|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
156940289|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156940290|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
156940291|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
156940292|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156940293|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
156940294|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940295|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940296|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940297|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940298|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940299|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940300|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940301|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940302|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940303|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940304|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940305|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940306|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940307|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940308|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940309|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940310|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940311|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940312|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
156940313|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940314|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
156940315|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
156940316|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
156940317|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
156940318|NCT02346240|566536815|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940319|NCT02346240|566536816|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940320|NCT02346240|566536817|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940321|NCT02346240|566536818|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940322|NCT02346240|566536819|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940323|NCT02346240|566536820|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940324|NCT02346240|566536821|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940325|NCT02346240|566536822|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940326|NCT02346240|566536823|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940327|NCT02346240|566536824|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940328|NCT02346240|566536825|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
157167291|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
157167292|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
157167293|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
157167294|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
157167295|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
157167296|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
157167297|NCT00383721|567352731|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
157167298|NCT00383721|567352732|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
157167299|NCT00383721|567352733|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
157227213|NCT01626079|567577777|FG001|Overall Study|Withdrawal by Subject|37|||
156940329|NCT02346240|566536826|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940330|NCT02346240|566536827|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940331|NCT02346240|566536828|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940332|NCT02346240|566536829|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940333|NCT02346240|566536830|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940334|NCT02346240|566536831|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940335|NCT02346240|566536832|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940336|NCT02346240|566536833|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
156940337|NCT02346240|566536834|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940338|NCT02346240|566536835|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940339|NCT02346240|566536836|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940340|NCT02346240|566536837|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940341|NCT02346240|566536838|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
156940342|NCT02942017|566536839|FG000|Overall Study|Adverse Event|0|||
156940343|NCT02942017|566536840|FG001|Overall Study|Adverse Event|1|||
156940344|NCT02942017|566536839|FG000|Overall Study|Withdrawal by Subject|0|||
156940345|NCT02942017|566536840|FG001|Overall Study|Withdrawal by Subject|1|||
156940346|NCT02942017|566536839|FG000|Overall Study|Lost to Follow-up|1|||
156940347|NCT02942017|566536840|FG001|Overall Study|Lost to Follow-up|1|||
156940348|NCT02942017|566536839|FG000|Overall Study|Randomized but not dosed|1|||
156940349|NCT02942017|566536840|FG001|Overall Study|Randomized but not dosed|3|||
156940350|NCT03417141|566536841|FG000|Overall Study|Withdrawal by Subject|1|||
156940351|NCT03417141|566536841|FG000|Overall Study|Protocol Violation|3|||
156940352|NCT00458484|566536842|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
156940353|NCT00458484|566536843|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
156940354|NCT00458484|566536844|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
156940355|NCT00458484|566536845|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
156940356|NCT00458484|566536846|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
156940357|NCT00458484|566536847|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
156940358|NCT00458484|566536848|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
156940359|NCT01838642|566536849|FG000|Overall Study|Died on study|1|||
156940360|NCT01557400|566536850|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
156940361|NCT01557400|566536850|FG000|Overall Study|Adverse Event|3|||
156940362|NCT01557400|566536850|FG000|Overall Study|Lost to Follow-up|5|||
156940363|NCT01557400|566536850|FG000|Overall Study|Withdrawal by Subject|9|||
156940364|NCT06425458|566536851|FG000|Overall Study|Removed by study team|2|||
156940365|NCT06425458|566536851|FG000|Overall Study|Lost to Follow-up|5|||
156940366|NCT02777125|566536854|FG000|Overall Study|Consent form violation|14|||
156940367|NCT02777125|566536855|FG001|Overall Study|Consent form violation|12|||
156940368|NCT02777125|566536854|FG000|Overall Study|Assent form violation|21|||
156940369|NCT02777125|566536855|FG001|Overall Study|Assent form violation|23|||
156940370|NCT02777125|566536854|FG000|Overall Study|Protocol Violation|8|||
156940371|NCT02777125|566536855|FG001|Overall Study|Protocol Violation|12|||
156940372|NCT03548584|566538278|FG000|Overall Study|Lost to Follow-up|0|||
156940373|NCT03548584|566538279|FG001|Overall Study|Lost to Follow-up|0|||
156940374|NCT03548584|566538280|FG002|Overall Study|Lost to Follow-up|1|||
156940375|NCT03548584|566538278|FG000|Overall Study|Adverse Event|1|||
157167300|NCT00383721|567352734|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
157167301|NCT00383721|567352735|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
157167302|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
157167303|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
157227214|NCT01626079|567577778|FG002|Overall Study|Withdrawal by Subject|5|||
157227215|NCT01626079|567577776|FG000|Overall Study|Lost to Follow-up|7|||
156940376|NCT03548584|566538279|FG001|Overall Study|Adverse Event|11|||
156940377|NCT03548584|566538280|FG002|Overall Study|Adverse Event|5|||
156940378|NCT03548584|566538278|FG000|Overall Study|Site Terminated by Sponsor|1|||
156940379|NCT03548584|566538279|FG001|Overall Study|Site Terminated by Sponsor|3|||
156940380|NCT03548584|566538280|FG002|Overall Study|Site Terminated by Sponsor|2|||
156940381|NCT03548584|566538278|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
156940382|NCT03548584|566538279|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
156940383|NCT03548584|566538280|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
156940384|NCT03548584|566538278|FG000|Overall Study|Lack of Efficacy|0|||
156940385|NCT03548584|566538279|FG001|Overall Study|Lack of Efficacy|1|||
156940386|NCT03548584|566538280|FG002|Overall Study|Lack of Efficacy|0|||
156940387|NCT03548584|566538278|FG000|Overall Study|Non-compliance with Study Drug|0|||
156940388|NCT03548584|566538279|FG001|Overall Study|Non-compliance with Study Drug|1|||
156940389|NCT03548584|566538280|FG002|Overall Study|Non-compliance with Study Drug|0|||
156940390|NCT03548584|566538278|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
156940391|NCT03548584|566538279|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
156940392|NCT03548584|566538280|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
156940393|NCT00634647|566538285|FG000|Overall Study|death on study|3|||
156940394|NCT00634647|566538285|FG000|Overall Study|refused further treatment|3|||
156940395|NCT00634647|566538285|FG000|Overall Study|declined to participate before treatment|1|||
156940396|NCT00667342|566538286|FG000|Overall Study|Protocol Violation|1|||
156940397|NCT00667342|566538287|FG001|Overall Study|Protocol Violation|0|||
156940398|NCT00667342|566538288|FG002|Overall Study|Protocol Violation|0|||
156940399|NCT00667342|566538286|FG000|Overall Study|Withdrawal by Subject|1|||
156940400|NCT00667342|566538287|FG001|Overall Study|Withdrawal by Subject|0|||
156940401|NCT00667342|566538288|FG002|Overall Study|Withdrawal by Subject|0|||
156940402|NCT00667342|566538286|FG000|Overall Study|Physician Decision|3|||
156940403|NCT00667342|566538287|FG001|Overall Study|Physician Decision|0|||
156940404|NCT00667342|566538288|FG002|Overall Study|Physician Decision|0|||
156940405|NCT00667342|566538286|FG000|Overall Study|Relapse or tumor progression|9|||
156940406|NCT00667342|566538287|FG001|Overall Study|Relapse or tumor progression|0|||
156940407|NCT00667342|566538288|FG002|Overall Study|Relapse or tumor progression|7|||
156940408|NCT00667342|566538286|FG000|Overall Study|Adverse Event|0|||
156940409|NCT00667342|566538287|FG001|Overall Study|Adverse Event|0|||
156940410|NCT00667342|566538288|FG002|Overall Study|Adverse Event|1|||
156940411|NCT00667342|566538286|FG000|Overall Study|Ineligible|0|||
156940412|NCT00667342|566538287|FG001|Overall Study|Ineligible|0|||
156940413|NCT00667342|566538288|FG002|Overall Study|Ineligible|1|||
156940414|NCT01433263|566538289|FG000|Overall Study|Adverse Event|3|||
156940415|NCT01433263|566538290|FG001|Overall Study|Adverse Event|1|||
156940416|NCT01433263|566538289|FG000|Overall Study|Death|5|||
156940417|NCT01433263|566538290|FG001|Overall Study|Death|3|||
156940418|NCT01433263|566538289|FG000|Overall Study|Lost to Follow-up|0|||
156940419|NCT01433263|566538290|FG001|Overall Study|Lost to Follow-up|1|||
156940420|NCT01433263|566538289|FG000|Overall Study|Protocol Deviation|1|||
156940421|NCT01433263|566538290|FG001|Overall Study|Protocol Deviation|0|||
156940422|NCT01433263|566538289|FG000|Overall Study|Withdrawal by Subject|10|||
156940423|NCT01433263|566538290|FG001|Overall Study|Withdrawal by Subject|7|||
156940424|NCT04709237|566538292|FG000|Overall Study|Lost to Follow-up|1|||
156940425|NCT04709237|566538293|FG001|Overall Study|Lost to Follow-up|0|||
156940426|NCT04709237|566538294|FG002|Overall Study|Lost to Follow-up|0|||
156940427|NCT02610192|566538295|FG000|Overall Study|Received other treatment|8|||
156940428|NCT02610192|566538295|FG000|Overall Study|Physician Decision|1|||
156940429|NCT00640510|566538301|FG000|Overall Study|Lack of Efficacy|0|||
156940430|NCT00640510|566538302|FG001|Overall Study|Lack of Efficacy|1|||
156940431|NCT00640510|566538301|FG000|Overall Study|Protocol Violation|1|||
156940432|NCT00640510|566538302|FG001|Overall Study|Protocol Violation|0|||
156940433|NCT00640510|566538301|FG000|Overall Study|Physician Decision|0|||
156940434|NCT00640510|566538302|FG001|Overall Study|Physician Decision|1|||
156940435|NCT01440322|566538303|FG000|Overall Study|Discomfort|2|||
156940436|NCT01440322|566538304|FG001|Overall Study|Discomfort|0|||
156940437|NCT01440322|566538303|FG000|Overall Study|Biomicroscopy|1|||
156940438|NCT01440322|566538304|FG001|Overall Study|Biomicroscopy|0|||
156940439|NCT01440322|566538303|FG000|Overall Study|Symptoms and Problems|1|||
156940440|NCT01440322|566538304|FG001|Overall Study|Symptoms and Problems|0|||
156940441|NCT01440322|566538303|FG000|Overall Study|Unacceptable Subjective Vision|1|||
156940442|NCT01440322|566538304|FG001|Overall Study|Unacceptable Subjective Vision|0|||
156940443|NCT01440322|566538303|FG000|Overall Study|Other Product Related|1|||
156940444|NCT01440322|566538304|FG001|Overall Study|Other Product Related|0|||
156940445|NCT01440322|566538303|FG000|Overall Study|Unrelated Medical Problem|0|||
156940446|NCT01440322|566538304|FG001|Overall Study|Unrelated Medical Problem|1|||
156940447|NCT01440322|566538303|FG000|Overall Study|Other Non-Product Related|1|||
156940448|NCT01440322|566538304|FG001|Overall Study|Other Non-Product Related|0|||
157167304|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
157167305|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
157167306|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
157167307|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
157167308|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
157167309|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
157167310|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156940449|NCT00546715|566538313|FG000|Overall Study|Withdrawal by Subject|0|||
156940450|NCT00546715|566538314|FG001|Overall Study|Withdrawal by Subject|1|||
157032073|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
157032074|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
157227216|NCT01626079|567577777|FG001|Overall Study|Lost to Follow-up|4|||
157227217|NCT01626079|567577778|FG002|Overall Study|Lost to Follow-up|2|||
157227218|NCT01626079|567577776|FG000|Overall Study|Missed Visits|1|||
157227219|NCT01626079|567577777|FG001|Overall Study|Missed Visits|4|||
157227220|NCT01626079|567577778|FG002|Overall Study|Missed Visits|6|||
157227221|NCT00950807|567577781|FG000|Treatment Period 1|Lack of Efficacy|1|||
157227222|NCT00950807|567577782|FG001|Treatment Period 1|Lack of Efficacy|0|||
157227223|NCT00950807|567577783|FG002|Treatment Period 1|Lack of Efficacy|0|||
157227224|NCT00950807|567577784|FG003|Treatment Period 1|Lack of Efficacy|0|||
157227225|NCT00950807|567577785|FG004|Treatment Period 1|Lack of Efficacy|0|||
157227226|NCT00950807|567577786|FG005|Treatment Period 1|Lack of Efficacy|1|||
157227227|NCT00950807|567577787|FG006|Treatment Period 1|Lack of Efficacy|0|||
157227228|NCT00950807|567577788|FG007|Treatment Period 1|Lack of Efficacy|0|||
157227229|NCT00950807|567577789|FG008|Treatment Period 1|Lack of Efficacy|0|||
157227230|NCT00950807|567577790|FG009|Treatment Period 1|Lack of Efficacy|0|||
157227231|NCT00950807|567577781|FG000|Treatment Period 1|Protocol Violation|1|||
157227232|NCT00950807|567577782|FG001|Treatment Period 1|Protocol Violation|0|||
157227233|NCT00950807|567577783|FG002|Treatment Period 1|Protocol Violation|0|||
156940451|NCT00546715|566538315|FG002|Overall Study|Withdrawal by Subject|0|||
157227234|NCT00950807|567577784|FG003|Treatment Period 1|Protocol Violation|0|||
157227235|NCT00950807|567577785|FG004|Treatment Period 1|Protocol Violation|0|||
157227236|NCT00950807|567577786|FG005|Treatment Period 1|Protocol Violation|0|||
157227237|NCT00950807|567577787|FG006|Treatment Period 1|Protocol Violation|0|||
157227238|NCT00950807|567577788|FG007|Treatment Period 1|Protocol Violation|0|||
157227239|NCT00950807|567577789|FG008|Treatment Period 1|Protocol Violation|0|||
157227240|NCT00950807|567577790|FG009|Treatment Period 1|Protocol Violation|0|||
157227241|NCT00950807|567577781|FG000|Treatment Period 1|Lost to Follow-up|0|||
157227242|NCT00950807|567577782|FG001|Treatment Period 1|Lost to Follow-up|0|||
157227243|NCT00950807|567577783|FG002|Treatment Period 1|Lost to Follow-up|1|||
157227244|NCT00950807|567577784|FG003|Treatment Period 1|Lost to Follow-up|0|||
156940452|NCT00546715|566538316|FG003|Overall Study|Withdrawal by Subject|0|||
156940453|NCT00418691|566538317|FG000|Overall Study|Lost to Follow-up|1|||
156940454|NCT00418691|566538318|FG001|Overall Study|Lost to Follow-up|2|||
156940455|NCT00418691|566538319|FG002|Overall Study|Lost to Follow-up|3|||
156940456|NCT00418691|566538317|FG000|Overall Study|Started new medication voiding entry|0|||
156940457|NCT00418691|566538318|FG001|Overall Study|Started new medication voiding entry|0|||
156940458|NCT00418691|566538319|FG002|Overall Study|Started new medication voiding entry|1|||
156940459|NCT00418691|566538317|FG000|Overall Study|Progressive Disease|1|||
156940460|NCT00418691|566538318|FG001|Overall Study|Progressive Disease|0|||
156940461|NCT00418691|566538319|FG002|Overall Study|Progressive Disease|1|||
156940462|NCT02477020|566538322|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
156940463|NCT02477020|566538323|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
156940464|NCT02477020|566538322|FG000|Overall Study|Voluntary Withdrawal|7|||
156940465|NCT02477020|566538323|FG001|Overall Study|Voluntary Withdrawal|16|||
156940466|NCT02477020|566538322|FG000|Overall Study|Reason not Specified|3|||
156940467|NCT02477020|566538323|FG001|Overall Study|Reason not Specified|1|||
156940468|NCT02477020|566538322|FG000|Overall Study|Lack of Efficacy|14|||
156940469|NCT02477020|566538323|FG001|Overall Study|Lack of Efficacy|5|||
156940470|NCT02975934|566538324|FG000|Treatment Phase|Never initiated study drug|0|||
156940471|NCT02975934|566538325|FG001|Treatment Phase|Never initiated study drug|5|||
156940472|NCT02975934|566538326|FG002|Treatment Phase|Never initiated study drug|0|||
156940473|NCT00433654|566538329|FG000|Overall Study|Death|4|||
156940474|NCT00433654|566538330|FG001|Overall Study|Death|0|||
156940475|NCT00433654|566538329|FG000|Overall Study|Missed visit|6|||
156940476|NCT00433654|566538330|FG001|Overall Study|Missed visit|3|||
156940477|NCT00433654|566538329|FG000|Overall Study|Subject not yet due for visit|4|||
156940478|NCT00433654|566538330|FG001|Overall Study|Subject not yet due for visit|0|||
156940479|NCT00433654|566538329|FG000|Overall Study|Withdrawal by Subject|1|||
156940480|NCT00433654|566538330|FG001|Overall Study|Withdrawal by Subject|2|||
156940481|NCT04399161|566538332|FG000|Overall Study|Withdrawal by Subject|1|||
157032075|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
157227245|NCT00950807|567577785|FG004|Treatment Period 1|Lost to Follow-up|0|||
157227246|NCT00950807|567577786|FG005|Treatment Period 1|Lost to Follow-up|0|||
157227247|NCT00950807|567577787|FG006|Treatment Period 1|Lost to Follow-up|0|||
156940482|NCT04399161|566538333|FG001|Overall Study|Withdrawal by Subject|0|||
156940483|NCT04399161|566538334|FG002|Overall Study|Withdrawal by Subject|2|||
156940484|NCT04399161|566538332|FG000|Overall Study|Protocol Violation|1|||
157227248|NCT00950807|567577788|FG007|Treatment Period 1|Lost to Follow-up|0|||
157227249|NCT00950807|567577789|FG008|Treatment Period 1|Lost to Follow-up|0|||
157227250|NCT00950807|567577790|FG009|Treatment Period 1|Lost to Follow-up|0|||
157227251|NCT00950807|567577781|FG000|Treatment Period 1|Withdrawal by Subject|1|||
156940485|NCT04399161|566538333|FG001|Overall Study|Protocol Violation|2|||
156940486|NCT04399161|566538334|FG002|Overall Study|Protocol Violation|0|||
156940487|NCT00838565|566538335|FG000|Overall Study|Withdrawal by Subject|0|||
156940488|NCT00838565|566538336|FG001|Overall Study|Withdrawal by Subject|0|||
156940489|NCT00838565|566538337|FG002|Overall Study|Withdrawal by Subject|1|||
156940490|NCT00838565|566538338|FG003|Overall Study|Withdrawal by Subject|0|||
156940491|NCT00838565|566538339|FG004|Overall Study|Withdrawal by Subject|0|||
156940492|NCT00838565|566538340|FG005|Overall Study|Withdrawal by Subject|2|||
156940493|NCT00838565|566538335|FG000|Overall Study|Other|0|||
156940494|NCT00838565|566538336|FG001|Overall Study|Other|2|||
156940495|NCT00838565|566538337|FG002|Overall Study|Other|0|||
156940496|NCT00838565|566538338|FG003|Overall Study|Other|0|||
156940497|NCT00838565|566538339|FG004|Overall Study|Other|0|||
156940498|NCT00838565|566538340|FG005|Overall Study|Other|0|||
156940499|NCT00838565|566538335|FG000|Overall Study|Randomized but not Treated|0|||
156940500|NCT00838565|566538336|FG001|Overall Study|Randomized but not Treated|1|||
156940501|NCT00838565|566538337|FG002|Overall Study|Randomized but not Treated|0|||
156940502|NCT00838565|566538338|FG003|Overall Study|Randomized but not Treated|0|||
156940503|NCT00838565|566538339|FG004|Overall Study|Randomized but not Treated|0|||
156940504|NCT00838565|566538340|FG005|Overall Study|Randomized but not Treated|0|||
156940505|NCT03571516|566538341|FG000|Overall Study|Severe diarrhea|1|||
156940506|NCT03571516|566538342|FG001|Overall Study|Severe diarrhea|0|||
156940507|NCT03571516|566538341|FG000|Overall Study|Withdrawal by Subject|0|||
156940508|NCT03571516|566538342|FG001|Overall Study|Withdrawal by Subject|1|||
156940509|NCT04907032|566538343|FG000|Overall Study|Withdrawal by Subject|7|||
156940510|NCT04907032|566538344|FG001|Overall Study|Withdrawal by Subject|1|||
156940511|NCT02253810|566538345|FG000|Overall Study|Withdrawal by Subject|2|||
156940512|NCT02253810|566538346|FG001|Overall Study|Withdrawal by Subject|1|||
156940513|NCT02253810|566538345|FG000|Overall Study|Unknown concomitant procedure|3|||
156940514|NCT02253810|566538346|FG001|Overall Study|Unknown concomitant procedure|2|||
156940515|NCT00291668|566538348|FG000|Overall Study|Lack of Efficacy|1|||
156940516|NCT00291668|566538349|FG001|Overall Study|Lack of Efficacy|0|||
156940517|NCT00291668|566538350|FG002|Overall Study|Lack of Efficacy|0|||
156940518|NCT00291668|566538348|FG000|Overall Study|SAE, non-fatal|1|||
156940519|NCT00291668|566538349|FG001|Overall Study|SAE, non-fatal|1|||
156940520|NCT00291668|566538350|FG002|Overall Study|SAE, non-fatal|1|||
156940521|NCT00291668|566538348|FG000|Overall Study|AE, non-serious non-fatal|1|||
156940522|NCT00291668|566538349|FG001|Overall Study|AE, non-serious non-fatal|0|||
156940523|NCT00291668|566538350|FG002|Overall Study|AE, non-serious non-fatal|0|||
156940524|NCT00291668|566538348|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
156940525|NCT00291668|566538349|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156940526|NCT00291668|566538350|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
156940527|NCT03465878|566538351|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156940528|NCT03465878|566538352|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
156940529|NCT03465878|566538353|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156940530|NCT03465878|566538354|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
156940531|NCT03465878|566538351|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156940532|NCT03465878|566538352|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156940533|NCT03465878|566538353|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
156940534|NCT03465878|566538354|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
156940535|NCT03465878|566538351|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156940536|NCT03465878|566538352|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156940537|NCT03465878|566538353|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
156940538|NCT03465878|566538354|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
156940539|NCT04019041|566538355|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
156940540|NCT04019041|566538356|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
156940541|NCT04019041|566538357|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
156940542|NCT04019041|566538358|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156940543|NCT04019041|566538359|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156940544|NCT04019041|566538360|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156940545|NCT04019041|566538355|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156940546|NCT04019041|566538356|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156940547|NCT04019041|566538357|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
157032076|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
156940548|NCT04019041|566538358|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156940549|NCT04019041|566538359|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
157032077|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
156940550|NCT04019041|566538360|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
156940551|NCT04019041|566538355|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
156940552|NCT04019041|566538356|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
156940553|NCT04019041|566538357|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
156940554|NCT04019041|566538358|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156940555|NCT04019041|566538359|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156940556|NCT04019041|566538360|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156940557|NCT04019041|566538355|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156940558|NCT04019041|566538356|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156940559|NCT04019041|566538357|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
156940560|NCT04019041|566538358|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156940561|NCT04019041|566538359|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156940562|NCT04019041|566538360|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
156940563|NCT04019041|566538355|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156940564|NCT04019041|566538356|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156940565|NCT04019041|566538357|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156940566|NCT04019041|566538358|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
156940567|NCT04019041|566538359|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
156940568|NCT04019041|566538360|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
156940569|NCT04019041|566538355|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156940570|NCT04019041|566538356|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156940571|NCT04019041|566538357|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156940572|NCT04019041|566538358|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
156940573|NCT04019041|566538359|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156940574|NCT04019041|566538360|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
156940575|NCT04019041|566538355|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156940576|NCT04019041|566538356|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156940577|NCT04019041|566538357|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156940578|NCT04019041|566538358|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156940579|NCT04019041|566538359|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
156940580|NCT04019041|566538360|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
156940581|NCT04019041|566538355|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156940582|NCT04019041|566538356|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156940583|NCT04019041|566538357|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156940584|NCT04019041|566538358|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
156940585|NCT04019041|566538359|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
156940586|NCT04019041|566538360|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156940587|NCT04019041|566538355|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156940588|NCT04019041|566538356|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156940589|NCT04019041|566538357|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156940590|NCT04019041|566538358|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156940591|NCT04019041|566538359|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
156940592|NCT04019041|566538360|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
156940593|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
156940594|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
156940595|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
156940596|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
156940597|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
156940598|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
156940599|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
156940600|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
156940601|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
156940602|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
156940603|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
156940604|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
156940605|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
156940606|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
156940607|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
156940608|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
156940609|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
157167311|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
156940610|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
156940611|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
156940612|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
156940613|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Other|3|||
156940614|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Other|0|||
156940615|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Other|2|||
156940616|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Other|2|||
156940617|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Other|7|||
156940618|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940619|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940620|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940621|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
156940622|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940623|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
157227252|NCT00950807|567577782|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157227253|NCT00950807|567577783|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157227254|NCT00950807|567577784|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157227255|NCT00950807|567577785|FG004|Treatment Period 1|Withdrawal by Subject|1|||
157227256|NCT00950807|567577786|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157227257|NCT00950807|567577787|FG006|Treatment Period 1|Withdrawal by Subject|0|||
157227258|NCT00950807|567577788|FG007|Treatment Period 1|Withdrawal by Subject|0|||
157227259|NCT00950807|567577789|FG008|Treatment Period 1|Withdrawal by Subject|1|||
157227260|NCT00950807|567577790|FG009|Treatment Period 1|Withdrawal by Subject|0|||
157227261|NCT00950807|567577781|FG000|Treatment Period 1|Adverse Event|0|||
157227262|NCT00950807|567577782|FG001|Treatment Period 1|Adverse Event|0|||
157227263|NCT00950807|567577783|FG002|Treatment Period 1|Adverse Event|0|||
157227264|NCT00950807|567577784|FG003|Treatment Period 1|Adverse Event|0|||
157227265|NCT00950807|567577785|FG004|Treatment Period 1|Adverse Event|0|||
157227266|NCT00950807|567577786|FG005|Treatment Period 1|Adverse Event|1|||
157227267|NCT00950807|567577787|FG006|Treatment Period 1|Adverse Event|0|||
157227268|NCT00950807|567577788|FG007|Treatment Period 1|Adverse Event|0|||
157227269|NCT00950807|567577789|FG008|Treatment Period 1|Adverse Event|0|||
157227270|NCT00950807|567577790|FG009|Treatment Period 1|Adverse Event|0|||
157227271|NCT00950807|567577781|FG000|Washout Period 1|Lack of Efficacy|0|||
157227272|NCT00950807|567577782|FG001|Washout Period 1|Lack of Efficacy|0|||
157227273|NCT00950807|567577783|FG002|Washout Period 1|Lack of Efficacy|0|||
157227274|NCT00950807|567577784|FG003|Washout Period 1|Lack of Efficacy|0|||
157227275|NCT00950807|567577785|FG004|Washout Period 1|Lack of Efficacy|0|||
157227276|NCT00950807|567577786|FG005|Washout Period 1|Lack of Efficacy|0|||
157227277|NCT00950807|567577787|FG006|Washout Period 1|Lack of Efficacy|1|||
156940624|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940625|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940626|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940627|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
156940628|NCT00213148|566538361|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
156940629|NCT00213148|566538362|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
156940630|NCT00213148|566538363|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
156940631|NCT00213148|566538364|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
156940632|NCT00213148|566538365|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
156940633|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
156940634|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
156940635|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
156940636|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
156940637|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
156940638|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
156940639|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
156940640|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
156940641|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
156940642|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
156940643|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Other|2|||
156940644|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Other|1|||
156940645|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Other|2|||
156940646|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Other|8|||
156940647|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Other|7|||
156940648|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
157227278|NCT00950807|567577788|FG007|Washout Period 1|Lack of Efficacy|0|||
157227279|NCT00950807|567577789|FG008|Washout Period 1|Lack of Efficacy|0|||
157227280|NCT00950807|567577790|FG009|Washout Period 1|Lack of Efficacy|0|||
157227281|NCT00950807|567577781|FG000|Washout Period 1|Withdrawal by Subject|0|||
157227282|NCT00950807|567577782|FG001|Washout Period 1|Withdrawal by Subject|0|||
157227283|NCT00950807|567577783|FG002|Washout Period 1|Withdrawal by Subject|0|||
157227284|NCT00950807|567577784|FG003|Washout Period 1|Withdrawal by Subject|0|||
157227285|NCT00950807|567577785|FG004|Washout Period 1|Withdrawal by Subject|0|||
157227286|NCT00950807|567577786|FG005|Washout Period 1|Withdrawal by Subject|0|||
157227287|NCT00950807|567577787|FG006|Washout Period 1|Withdrawal by Subject|0|||
157227288|NCT00950807|567577788|FG007|Washout Period 1|Withdrawal by Subject|0|||
157227289|NCT00950807|567577789|FG008|Washout Period 1|Withdrawal by Subject|1|||
157227290|NCT00950807|567577790|FG009|Washout Period 1|Withdrawal by Subject|0|||
157227291|NCT00950807|567577781|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
157227292|NCT00950807|567577782|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156940649|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
156940650|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940651|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940652|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
156940653|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
156940654|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940655|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
157227293|NCT00950807|567577783|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
157227294|NCT00950807|567577784|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
156940656|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940657|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
156940658|NCT00213148|566538361|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
156940659|NCT00213148|566538362|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
156940660|NCT00213148|566538363|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
156940661|NCT00213148|566538364|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
156940662|NCT00213148|566538365|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
156940663|NCT00213148|566538361|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156940664|NCT00213148|566538362|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
156940665|NCT00213148|566538363|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156940666|NCT00213148|566538364|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
156940667|NCT00213148|566538365|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
156940668|NCT00213148|566538361|FG000|Cycle 3 (1 Month)|Other|0|||
156940669|NCT00213148|566538362|FG001|Cycle 3 (1 Month)|Other|0|||
156940670|NCT00213148|566538363|FG002|Cycle 3 (1 Month)|Other|1|||
156940671|NCT00213148|566538364|FG003|Cycle 3 (1 Month)|Other|1|||
156940672|NCT00213148|566538365|FG004|Cycle 3 (1 Month)|Other|0|||
156940673|NCT01723228|566538367|FG000|Overall Study|Adverse Event|2|||
156940674|NCT01723228|566538368|FG001|Overall Study|Adverse Event|6|||
156940675|NCT01723228|566538367|FG000|Overall Study|Withdrawal by Subject|2|||
156940676|NCT01723228|566538368|FG001|Overall Study|Withdrawal by Subject|1|||
156940677|NCT01723228|566538367|FG000|Overall Study|Protocol Violation|0|||
156940678|NCT01723228|566538368|FG001|Overall Study|Protocol Violation|2|||
156940679|NCT01723228|566538367|FG000|Overall Study|Lost to Follow-up|2|||
156940680|NCT01723228|566538368|FG001|Overall Study|Lost to Follow-up|1|||
156940681|NCT01723228|566538367|FG000|Overall Study|Other|2|||
156940682|NCT01723228|566538368|FG001|Overall Study|Other|1|||
156940683|NCT02448875|566538369|FG000|Overall Study|Adverse Event|2|||
156940684|NCT02448875|566538370|FG001|Overall Study|Adverse Event|1|||
156940685|NCT02448875|566538371|FG002|Overall Study|Adverse Event|0|||
156940686|NCT02448875|566538369|FG000|Overall Study|Lost to Follow-up|1|||
156940687|NCT02448875|566538370|FG001|Overall Study|Lost to Follow-up|0|||
156940688|NCT02448875|566538371|FG002|Overall Study|Lost to Follow-up|0|||
156940689|NCT02448875|566538369|FG000|Overall Study|Investigator Decision|3|||
156940690|NCT02448875|566538370|FG001|Overall Study|Investigator Decision|0|||
156940691|NCT02448875|566538371|FG002|Overall Study|Investigator Decision|1|||
156940692|NCT02448875|566538369|FG000|Overall Study|Withdrawal by Subject|1|||
156940693|NCT02448875|566538370|FG001|Overall Study|Withdrawal by Subject|0|||
156940694|NCT02448875|566538371|FG002|Overall Study|Withdrawal by Subject|0|||
156940695|NCT01806896|566538372|FG000|Overall Study|Adverse Event|2|||
156940696|NCT01806896|566538373|FG001|Overall Study|Adverse Event|0|||
156940697|NCT01806896|566538372|FG000|Overall Study|Other|1|||
156940698|NCT01806896|566538373|FG001|Overall Study|Other|0|||
156940699|NCT01282216|566538374|FG000|Overall Study|Graft failure|0|||
156940700|NCT01282216|566538375|FG001|Overall Study|Graft failure|0|||
156940701|NCT01282216|566538376|FG002|Overall Study|Graft failure|3|||
156940702|NCT01282216|566538377|FG003|Overall Study|Graft failure|2|||
156940703|NCT01282216|566538374|FG000|Overall Study|Physician Decision|0|||
156940704|NCT01282216|566538375|FG001|Overall Study|Physician Decision|0|||
156940705|NCT01282216|566538376|FG002|Overall Study|Physician Decision|11|||
156940706|NCT01282216|566538377|FG003|Overall Study|Physician Decision|0|||
156940707|NCT01282216|566538374|FG000|Overall Study|Relapse|0|||
156940708|NCT01282216|566538375|FG001|Overall Study|Relapse|0|||
156940709|NCT01282216|566538376|FG002|Overall Study|Relapse|17|||
157032078|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
157032079|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
157167312|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
157167313|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156940710|NCT01282216|566538377|FG003|Overall Study|Relapse|6|||
156940711|NCT01282216|566538374|FG000|Overall Study|Death|0|||
156940712|NCT01282216|566538375|FG001|Overall Study|Death|0|||
156940713|NCT01282216|566538376|FG002|Overall Study|Death|2|||
156940714|NCT01282216|566538377|FG003|Overall Study|Death|0|||
156940715|NCT01864291|566538378|FG000|Overall Study|need for revision surgery|2|||
156940716|NCT02434770|566538380|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
156940717|NCT02434770|566538381|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
156940718|NCT02434770|566538382|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
156940719|NCT02434770|566538380|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
156940720|NCT02434770|566538381|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
156940721|NCT02434770|566538382|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
156940722|NCT02434770|566538380|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
156940723|NCT02434770|566538381|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
156940724|NCT02434770|566538382|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
156940725|NCT02434770|566538380|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
156940726|NCT02434770|566538381|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
156940727|NCT02434770|566538382|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
156940728|NCT02434770|566538380|FG000|Week 1 to Week 18|Death|1|||
156940729|NCT02434770|566538381|FG001|Week 1 to Week 18|Death|0|||
156940730|NCT02434770|566538382|FG002|Week 1 to Week 18|Death|0|||
156940731|NCT02434770|566538380|FG000|Week 18 to Week|Lost to Follow-up|2|||
156940732|NCT02434770|566538381|FG001|Week 18 to Week|Lost to Follow-up|2|||
156940733|NCT02434770|566538382|FG002|Week 18 to Week|Lost to Follow-up|1|||
156940734|NCT02434770|566538380|FG000|Week 18 to Week|Withdrawal by Subject|0|||
156940735|NCT02434770|566538381|FG001|Week 18 to Week|Withdrawal by Subject|0|||
156940736|NCT02434770|566538382|FG002|Week 18 to Week|Withdrawal by Subject|2|||
156940737|NCT02434770|566538380|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
156940738|NCT02434770|566538381|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
156940739|NCT02434770|566538382|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
156940740|NCT00245765|566538383|FG000|Overall Study|Adverse Event|1|||
156940741|NCT00245765|566538384|FG001|Overall Study|Adverse Event|1|||
156940742|NCT00245765|566538385|FG002|Overall Study|Adverse Event|0|||
156940743|NCT00245765|566538383|FG000|Overall Study|Lack of Efficacy|14|||
156940744|NCT00245765|566538384|FG001|Overall Study|Lack of Efficacy|7|||
156940745|NCT00245765|566538385|FG002|Overall Study|Lack of Efficacy|0|||
156940746|NCT00245765|566538383|FG000|Overall Study|Lost to Follow-up|1|||
156940747|NCT00245765|566538384|FG001|Overall Study|Lost to Follow-up|2|||
156940748|NCT00245765|566538385|FG002|Overall Study|Lost to Follow-up|0|||
156940749|NCT00245765|566538383|FG000|Overall Study|Withdrawal by Subject|1|||
156940750|NCT00245765|566538384|FG001|Overall Study|Withdrawal by Subject|0|||
156940751|NCT00245765|566538385|FG002|Overall Study|Withdrawal by Subject|3|||
156940752|NCT00245765|566538383|FG000|Overall Study|Other reason|2|||
156940753|NCT00245765|566538384|FG001|Overall Study|Other reason|0|||
156940754|NCT00245765|566538385|FG002|Overall Study|Other reason|1|||
156940755|NCT00245765|566538383|FG000|Overall Study|Other|13|||
156940756|NCT00245765|566538384|FG001|Overall Study|Other|4|||
156940757|NCT00245765|566538385|FG002|Overall Study|Other|4|||
156940758|NCT00660348|566538386|FG000|Overall Study|Withdrawal by Subject|1|||
156940759|NCT00660348|566538387|FG001|Overall Study|Withdrawal by Subject|0|||
156940760|NCT01282424|566538393|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
156940761|NCT01282424|566538393|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
156940762|NCT01282424|566538393|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
156940763|NCT01282424|566538393|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
156940764|NCT01282424|566538393|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
156940765|NCT01282424|566538393|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
156940766|NCT01282424|566538393|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
156940767|NCT01282424|566538393|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
156940768|NCT02741115|566538394|FG000|Overall Study|Adverse Event|1|||
156940769|NCT02741115|566538395|FG001|Overall Study|Adverse Event|0|||
156940770|NCT02741115|566538394|FG000|Overall Study|Lost to Follow-up|7|||
156940771|NCT02741115|566538395|FG001|Overall Study|Lost to Follow-up|4|||
156940772|NCT02741115|566538394|FG000|Overall Study|Withdrawal by Subject|4|||
156940773|NCT02741115|566538395|FG001|Overall Study|Withdrawal by Subject|2|||
156940774|NCT04602624|566538398|FG000|Overall Study|Protocol Deviation|1|||
156940775|NCT04602624|566538398|FG000|Overall Study|Withdrawal by Participant|1|||
156940776|NCT00445328|566538399|FG000|Overall Study|Death|0|||
156940777|NCT00445328|566538400|FG001|Overall Study|Death|1|||
156940778|NCT00445328|566538399|FG000|Overall Study|Adverse Event|0|||
156940779|NCT00445328|566538400|FG001|Overall Study|Adverse Event|3|||
156940780|NCT00445328|566538399|FG000|Overall Study|Other|0|||
156940781|NCT00445328|566538400|FG001|Overall Study|Other|2|||
156940782|NCT00445328|566538399|FG000|Overall Study|Withdrawal by Subject|2|||
156940783|NCT00445328|566538400|FG001|Overall Study|Withdrawal by Subject|0|||
156940784|NCT00445328|566538399|FG000|Overall Study|Protocol Violation|1|||
156940785|NCT00445328|566538400|FG001|Overall Study|Protocol Violation|0|||
156940786|NCT00316199|566538401|FG000|Overall Study|Adverse Event|2|||
156940787|NCT00316199|566538401|FG000|Overall Study|Death|8|||
156940788|NCT00316199|566538401|FG000|Overall Study|Lost to Follow-up|2|||
156940789|NCT00590954|566538402|FG000|Overall Study|Inevaluable|2|||
156940790|NCT04477304|566538403|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
156940791|NCT04477304|566538404|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
156940792|NCT03316872|566538405|FG000|Overall Study|Death|1|||
156940793|NCT04346615|566539779|FG000|Overall Study|Lost to Follow-up|0|||
156940794|NCT04346615|566539780|FG001|Overall Study|Lost to Follow-up|2|||
156940795|NCT04346615|566539779|FG000|Overall Study|Withdrawal by Subject|1|||
156940796|NCT04346615|566539780|FG001|Overall Study|Withdrawal by Subject|0|||
156940797|NCT04346615|566539779|FG000|Overall Study|Death|5|||
156940798|NCT04346615|566539780|FG001|Overall Study|Death|1|||
156940799|NCT04346615|566539779|FG000|Overall Study|Other|0|||
156940800|NCT04346615|566539780|FG001|Overall Study|Other|2|||
156940801|NCT04346615|566539779|FG000|Overall Study|Randomized not treated|1|||
156940802|NCT04346615|566539780|FG001|Overall Study|Randomized not treated|0|||
156940803|NCT00533949|566539783|FG000|Overall Study|Protocol Violation|12|||
156940804|NCT00533949|566539784|FG001|Overall Study|Protocol Violation|12|||
156940805|NCT00533949|566539785|FG002|Overall Study|Protocol Violation|9|||
156940806|NCT00533949|566539786|FG003|Overall Study|Protocol Violation|9|||
156940807|NCT00533949|566539783|FG000|Overall Study|Withdrawal by Subject|3|||
156940808|NCT00533949|566539784|FG001|Overall Study|Withdrawal by Subject|2|||
156940809|NCT00533949|566539785|FG002|Overall Study|Withdrawal by Subject|1|||
156940810|NCT00533949|566539786|FG003|Overall Study|Withdrawal by Subject|1|||
156940811|NCT00727194|566539787|FG000|Screening Period|Low QMG scores|0|||
156940812|NCT00727194|566539788|FG001|Screening Period|Low QMG scores|0|||
156940813|NCT00727194|566539789|FG002|Screening Period|Low QMG scores|6|||
156940814|NCT00727194|566539787|FG000|Screening Period|Lacked AChR antibodies|0|||
156940815|NCT00727194|566539788|FG001|Screening Period|Lacked AChR antibodies|0|||
156940816|NCT00727194|566539789|FG002|Screening Period|Lacked AChR antibodies|5|||
156940817|NCT00727194|566539787|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
156940818|NCT00727194|566539788|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
156940819|NCT00727194|566539789|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
156940820|NCT00727194|566539787|FG000|Screening Period|Severe infections|0|||
156940821|NCT00727194|566539788|FG001|Screening Period|Severe infections|0|||
156940822|NCT00727194|566539789|FG002|Screening Period|Severe infections|2|||
156940823|NCT00727194|566539787|FG000|Screening Period|History of thymoma|0|||
156940824|NCT00727194|566539788|FG001|Screening Period|History of thymoma|0|||
156940825|NCT00727194|566539789|FG002|Screening Period|History of thymoma|1|||
156940826|NCT00727194|566539787|FG000|Treatment Period 2|Lack of Efficacy|0|||
156940827|NCT00727194|566539788|FG001|Treatment Period 2|Lack of Efficacy|1|||
156940828|NCT00727194|566539789|FG002|Treatment Period 2|Lack of Efficacy|0|||
156940829|NCT01677195|566539792|FG000|Overall Study|Lost to Follow-up|14|||
156940830|NCT01677195|566539793|FG001|Overall Study|Lost to Follow-up|22|||
156940831|NCT01677195|566539794|FG002|Overall Study|Lost to Follow-up|22|||
156940832|NCT01677195|566539792|FG000|Overall Study|Withdrawal by Subject|1|||
156940833|NCT01677195|566539793|FG001|Overall Study|Withdrawal by Subject|0|||
156940834|NCT01677195|566539794|FG002|Overall Study|Withdrawal by Subject|1|||
156940835|NCT01677195|566539792|FG000|Overall Study|Adverse Event|6|||
156940836|NCT01677195|566539793|FG001|Overall Study|Adverse Event|4|||
156940837|NCT01677195|566539794|FG002|Overall Study|Adverse Event|1|||
156940838|NCT01677195|566539792|FG000|Overall Study|Physician Decision|1|||
156940839|NCT01677195|566539793|FG001|Overall Study|Physician Decision|2|||
156940840|NCT01677195|566539794|FG002|Overall Study|Physician Decision|2|||
156940841|NCT01677195|566539792|FG000|Overall Study|Pregnancy|0|||
156940842|NCT01677195|566539793|FG001|Overall Study|Pregnancy|1|||
156940843|NCT01677195|566539794|FG002|Overall Study|Pregnancy|0|||
156940844|NCT01677195|566539792|FG000|Overall Study|Protocol Violation|7|||
156940845|NCT01677195|566539793|FG001|Overall Study|Protocol Violation|3|||
156940846|NCT01677195|566539794|FG002|Overall Study|Protocol Violation|4|||
157032080|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
157032081|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
157032082|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
157032083|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
157032084|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
157032085|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
157032086|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
157032087|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
157032088|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032089|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032090|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
157032091|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032092|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
157032093|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032094|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032095|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
157032096|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
157032097|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
157032098|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
156940847|NCT04368429|566539795|FG000|Overall Study|Adverse Event|1|||
156940848|NCT04368429|566539796|FG001|Overall Study|Adverse Event|0|||
156940849|NCT03633396|566539799|FG000|Overall Study|Withdrawal by Subject|4|||
156940850|NCT03633396|566539800|FG001|Overall Study|Withdrawal by Subject|4|||
156940851|NCT03633396|566539799|FG000|Overall Study|Adverse Event|1|||
157032099|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
156940852|NCT03633396|566539800|FG001|Overall Study|Adverse Event|1|||
156940853|NCT03633396|566539799|FG000|Overall Study|Lack of Efficacy|1|||
156940854|NCT03633396|566539800|FG001|Overall Study|Lack of Efficacy|0|||
156940855|NCT03633396|566539799|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
156940856|NCT03633396|566539800|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
156940857|NCT01012817|566539801|FG000|Overall Study|Withdrawal by Subject|0|||
156940858|NCT01012817|566539802|FG001|Overall Study|Withdrawal by Subject|0|||
156940859|NCT01012817|566539803|FG002|Overall Study|Withdrawal by Subject|0|||
156940860|NCT01012817|566539804|FG003|Overall Study|Withdrawal by Subject|1|||
156940861|NCT01012817|566539805|FG004|Overall Study|Withdrawal by Subject|0|||
156940862|NCT01012817|566539806|FG005|Overall Study|Withdrawal by Subject|0|||
156940863|NCT01012817|566539807|FG006|Overall Study|Withdrawal by Subject|0|||
156940864|NCT01012817|566539808|FG007|Overall Study|Withdrawal by Subject|1|||
156940865|NCT01012817|566539809|FG008|Overall Study|Withdrawal by Subject|0|||
156940866|NCT01012817|566539810|FG009|Overall Study|Withdrawal by Subject|0|||
156940867|NCT01012817|566539811|FG010|Overall Study|Withdrawal by Subject|1|||
156940868|NCT01012817|566539812|FG011|Overall Study|Withdrawal by Subject|1|||
156940869|NCT01012817|566539813|FG012|Overall Study|Withdrawal by Subject|0|||
156940870|NCT01012817|566539814|FG013|Overall Study|Withdrawal by Subject|1|||
156940871|NCT01012817|566539801|FG000|Overall Study|Adverse Event|0|||
156940872|NCT01012817|566539802|FG001|Overall Study|Adverse Event|0|||
156940873|NCT01012817|566539803|FG002|Overall Study|Adverse Event|0|||
156940874|NCT01012817|566539804|FG003|Overall Study|Adverse Event|0|||
156940875|NCT01012817|566539805|FG004|Overall Study|Adverse Event|0|||
156940876|NCT01012817|566539806|FG005|Overall Study|Adverse Event|1|||
156940877|NCT01012817|566539807|FG006|Overall Study|Adverse Event|0|||
156940878|NCT01012817|566539808|FG007|Overall Study|Adverse Event|0|||
156940879|NCT01012817|566539809|FG008|Overall Study|Adverse Event|0|||
156940880|NCT01012817|566539810|FG009|Overall Study|Adverse Event|0|||
156940881|NCT01012817|566539811|FG010|Overall Study|Adverse Event|1|||
156940882|NCT01012817|566539812|FG011|Overall Study|Adverse Event|0|||
156940883|NCT01012817|566539813|FG012|Overall Study|Adverse Event|0|||
156940884|NCT01012817|566539814|FG013|Overall Study|Adverse Event|1|||
156940885|NCT00023673|566539815|FG000|Overall Study|Ineligible / no protocol treatment|0|||
156940886|NCT00023673|566539816|FG001|Overall Study|Ineligible / no protocol treatment|0|||
156940887|NCT00023673|566539817|FG002|Overall Study|Ineligible / no protocol treatment|0|||
156940888|NCT00023673|566539818|FG003|Overall Study|Ineligible / no protocol treatment|1|||
156940889|NCT00023673|566539815|FG000|Overall Study|Patient withdrew consent|0|||
156940890|NCT00023673|566539816|FG001|Overall Study|Patient withdrew consent|0|||
156940891|NCT00023673|566539817|FG002|Overall Study|Patient withdrew consent|0|||
156940892|NCT00023673|566539818|FG003|Overall Study|Patient withdrew consent|1|||
156940893|NCT00110266|566539819|FG000|Overall Study|Adverse Event|27|||
156940894|NCT00110266|566539819|FG000|Overall Study|Abnormal laboratory value|15|||
156940895|NCT00110266|566539819|FG000|Overall Study|Withdrawal by Subject|16|||
156940896|NCT00110266|566539819|FG000|Overall Study|Death|17|||
156940897|NCT00110266|566539819|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156940898|NCT00110266|566539819|FG000|Overall Study|Participant condition no longer requires study drug|1|||
156940899|NCT04300296|566539824|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
156940900|NCT04300296|566539825|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156940901|NCT04300296|566539826|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156940902|NCT04300296|566539827|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156940903|NCT04300296|566539828|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156940904|NCT04300296|566539829|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
156940905|NCT04300296|566539824|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156940906|NCT04300296|566539825|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156940907|NCT04300296|566539826|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156940908|NCT04300296|566539827|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156940909|NCT04300296|566539828|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
156940910|NCT04300296|566539829|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
156940911|NCT04300296|566539824|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
156940912|NCT04300296|566539825|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
156940913|NCT04300296|566539826|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156940914|NCT04300296|566539827|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156940915|NCT04300296|566539828|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
156940916|NCT04300296|566539829|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
156940917|NCT04300296|566539824|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
156940918|NCT04300296|566539825|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
156940919|NCT04300296|566539826|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
156940920|NCT04300296|566539827|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
157032100|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
157167314|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
157167315|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156940921|NCT04300296|566539828|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
156940922|NCT04300296|566539829|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
156940923|NCT04300296|566539824|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
156940924|NCT04300296|566539825|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156940925|NCT04300296|566539826|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
156940926|NCT04300296|566539827|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156940927|NCT04300296|566539828|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
156940928|NCT04300296|566539829|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
156940929|NCT04300296|566539824|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156940930|NCT04300296|566539825|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
156940931|NCT04300296|566539826|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156940932|NCT04300296|566539827|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156940933|NCT04300296|566539828|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156940934|NCT04300296|566539829|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
156940935|NCT04300296|566539824|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
156940936|NCT04300296|566539825|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
156940937|NCT04300296|566539826|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
156940938|NCT04300296|566539827|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
156940939|NCT04300296|566539828|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
156940940|NCT04300296|566539829|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
156940941|NCT00279708|566539830|FG000|Overall Study|Withdrawal by Subject|2|||
156940942|NCT00279708|566539831|FG001|Overall Study|Withdrawal by Subject|3|||
156940943|NCT00279708|566539830|FG000|Overall Study|Adverse Event|1|||
156940944|NCT00279708|566539831|FG001|Overall Study|Adverse Event|1|||
156940945|NCT02624284|566539832|FG000|Overall Study|Withdrawal by Subject|3|||
156940946|NCT02624284|566539833|FG001|Overall Study|Withdrawal by Subject|6|||
156940947|NCT02624284|566539834|FG002|Overall Study|Withdrawal by Subject|3|||
156940948|NCT02624284|566539832|FG000|Overall Study|Protocol Violation|9|||
156940949|NCT02624284|566539833|FG001|Overall Study|Protocol Violation|10|||
156940950|NCT02624284|566539834|FG002|Overall Study|Protocol Violation|7|||
156940951|NCT02624284|566539832|FG000|Overall Study|Revealed exclusionary condition|2|||
156940952|NCT02624284|566539833|FG001|Overall Study|Revealed exclusionary condition|2|||
156940953|NCT02624284|566539834|FG002|Overall Study|Revealed exclusionary condition|0|||
157167316|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
157167317|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
157167318|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
157167319|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
157167320|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
157167321|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
157167322|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
157167323|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
157167324|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
157167325|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
157167326|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
157167327|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
157167328|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
157167329|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
157167330|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
157167331|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
157167332|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
157167333|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
157167334|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
157167335|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
157167336|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
157167337|NCT00383721|567352731|FG000|26-Week Treatment Safety Extension|Administrative|1|||
157167338|NCT00383721|567352732|FG001|26-Week Treatment Safety Extension|Administrative|2|||
157167339|NCT00383721|567352733|FG002|26-Week Treatment Safety Extension|Administrative|3|||
157167340|NCT00383721|567352734|FG003|26-Week Treatment Safety Extension|Administrative|1|||
157167341|NCT00383721|567352735|FG004|26-Week Treatment Safety Extension|Administrative|0|||
157167342|NCT03519516|567352739|FG000|Overall Study|Adverse Event|0|||
157167343|NCT03519516|567352740|FG001|Overall Study|Adverse Event|1|||
157167344|NCT01244191|567352741|FG000|Overall Study|Progressive disease|295|||
157167345|NCT01244191|567352742|FG001|Overall Study|Progressive disease|350|||
157167346|NCT01244191|567352741|FG000|Overall Study|Clinical disease progression|54|||
156940954|NCT02624284|566539832|FG000|Overall Study|Adverse Event|0|||
156940955|NCT02624284|566539833|FG001|Overall Study|Adverse Event|0|||
156940956|NCT02624284|566539834|FG002|Overall Study|Adverse Event|1|||
156940957|NCT01782313|566539835|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
156940958|NCT01782313|566539835|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
156940959|NCT01782313|566539835|FG000|Treated Cycle 3|Progressive Disease|21|||
156940960|NCT01782313|566539835|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
156940961|NCT01782313|566539835|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
156940962|NCT01782313|566539835|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
157167347|NCT01244191|567352742|FG001|Overall Study|Clinical disease progression|36|||
156940963|NCT01782313|566539835|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
156940964|NCT01782313|566539835|FG000|Survival Follow up|Lost to Follow-up|1|||
156940965|NCT02940691|566539836|FG000|Overall Study|Lost to Follow-up|5|||
156940966|NCT02940691|566539836|FG000|Overall Study|Incarceration|1|||
156940967|NCT00958776|566539837|FG000|Overall Study|Adverse Event|0|||
156940968|NCT00958776|566539838|FG001|Overall Study|Adverse Event|1|||
156940969|NCT00958776|566539837|FG000|Overall Study|Physician Decision|1|||
156940970|NCT00958776|566539838|FG001|Overall Study|Physician Decision|0|||
156940971|NCT00958776|566539837|FG000|Overall Study|Lost to Follow-up|2|||
156940972|NCT00958776|566539838|FG001|Overall Study|Lost to Follow-up|6|||
156940973|NCT00958776|566539837|FG000|Overall Study|Withdrawal by Subject|7|||
156940974|NCT00958776|566539838|FG001|Overall Study|Withdrawal by Subject|16|||
156940975|NCT00958776|566539837|FG000|Overall Study|Protocol Violation|1|||
156940976|NCT00958776|566539838|FG001|Overall Study|Protocol Violation|1|||
156940977|NCT00958776|566539837|FG000|Overall Study|Death|2|||
156940978|NCT00958776|566539838|FG001|Overall Study|Death|1|||
156940979|NCT00958776|566539837|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
156940980|NCT00958776|566539838|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
156940981|NCT00958776|566539837|FG000|Overall Study|Missing|1|||
156940982|NCT00958776|566539838|FG001|Overall Study|Missing|1|||
156940983|NCT00326911|566539839|FG000|Overall Study|Hospitalization prior to treatment|0|||
156940984|NCT00326911|566539840|FG001|Overall Study|Hospitalization prior to treatment|1|||
156940985|NCT00326911|566539839|FG000|Overall Study|Physician decision prior to treatment|1|||
156940986|NCT00326911|566539840|FG001|Overall Study|Physician decision prior to treatment|0|||
156940987|NCT00326911|566539839|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
156940988|NCT00326911|566539840|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
156940989|NCT02506816|566539847|FG000|Overall Study|Adverse Event|3|||
156940990|NCT01049919|566539854|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
156940991|NCT01049919|566539855|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
156940992|NCT01049919|566539854|FG000|Overall Study|Withdrawal by Subject|5|||
156940993|NCT01049919|566539855|FG001|Overall Study|Withdrawal by Subject|0|||
156940994|NCT01049919|566539854|FG000|Overall Study|Lost to Follow-up|6|||
156940995|NCT01049919|566539855|FG001|Overall Study|Lost to Follow-up|1|||
156940996|NCT01049919|566539854|FG000|Overall Study|Physician Decision|2|||
156940997|NCT01049919|566539855|FG001|Overall Study|Physician Decision|0|||
156940998|NCT01049919|566539854|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
156940999|NCT01049919|566539855|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
156941000|NCT01049919|566539854|FG000|Overall Study|Early study termination by sponsor.|2|||
156941001|NCT01049919|566539855|FG001|Overall Study|Early study termination by sponsor.|0|||
156941002|NCT02984995|566539856|FG000|Overall Study|Required stem cell transplant|13|||
156941003|NCT02984995|566539857|FG001|Overall Study|Required stem cell transplant|2|||
156941004|NCT02984995|566539856|FG000|Overall Study|Progressive disease|11|||
156941005|NCT02984995|566539857|FG001|Overall Study|Progressive disease|1|||
156941006|NCT02984995|566539856|FG000|Overall Study|Adverse Event|1|||
156941007|NCT02984995|566539857|FG001|Overall Study|Adverse Event|0|||
156941008|NCT04354831|566539858|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
156941009|NCT04354831|566539859|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
156941010|NCT01018264|566539860|FG000|Overall Study|Withdrawal by Subject|1|||
156941011|NCT01018264|566539861|FG001|Overall Study|Withdrawal by Subject|0|||
156941012|NCT01018264|566539860|FG000|Overall Study|Lost to Follow-up|0|||
156941013|NCT01018264|566539861|FG001|Overall Study|Lost to Follow-up|1|||
156941014|NCT00812929|566539862|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
157167348|NCT01244191|567352741|FG000|Overall Study|Adverse Event|65|||
157167349|NCT01244191|567352742|FG001|Overall Study|Adverse Event|48|||
156941015|NCT00812929|566539863|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
156941016|NCT00812929|566539864|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
156941017|NCT00812929|566539865|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
156941018|NCT00812929|566539866|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
156941019|NCT00812929|566539867|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
156941020|NCT00812929|566539868|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
156941021|NCT00812929|566539869|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
156941022|NCT00812929|566539870|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
156941023|NCT00812929|566539871|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
156941024|NCT00812929|566539862|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
156941025|NCT00812929|566539863|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
156941026|NCT00812929|566539864|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
156941027|NCT00812929|566539865|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
156941028|NCT00812929|566539866|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
156941029|NCT00812929|566539867|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
156941030|NCT00812929|566539868|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
156941031|NCT00812929|566539869|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
156941032|NCT00812929|566539870|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
157227295|NCT00950807|567577785|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
157227296|NCT00950807|567577786|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
157227297|NCT00950807|567577787|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
157227298|NCT00950807|567577788|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
157227299|NCT00950807|567577789|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
157227300|NCT00950807|567577790|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
157227301|NCT00950807|567577781|FG000|Washout Period 1|Adverse Event|2|||
157227302|NCT00950807|567577782|FG001|Washout Period 1|Adverse Event|0|||
157227303|NCT00950807|567577783|FG002|Washout Period 1|Adverse Event|0|||
157227304|NCT00950807|567577784|FG003|Washout Period 1|Adverse Event|1|||
157227305|NCT00950807|567577785|FG004|Washout Period 1|Adverse Event|1|||
157227306|NCT00950807|567577786|FG005|Washout Period 1|Adverse Event|0|||
156941033|NCT00812929|566539871|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
156941034|NCT00812929|566539862|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
156941035|NCT00812929|566539863|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
156941036|NCT00812929|566539864|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
156941037|NCT00812929|566539865|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
156941038|NCT00812929|566539866|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
156941039|NCT00812929|566539867|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
156941040|NCT00812929|566539868|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
156941041|NCT00812929|566539869|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
156941042|NCT00812929|566539870|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
156941043|NCT00812929|566539871|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
156941044|NCT02504372|566539873|FG000|Overall Study|Death|136|||
156941045|NCT02504372|566539874|FG001|Overall Study|Death|154|||
156941046|NCT02504372|566539873|FG000|Overall Study|Lost to Follow-up|0|||
156941047|NCT02504372|566539874|FG001|Overall Study|Lost to Follow-up|2|||
156941048|NCT02504372|566539873|FG000|Overall Study|Withdrawal of consent|25|||
156941049|NCT02504372|566539874|FG001|Overall Study|Withdrawal of consent|16|||
156941050|NCT02504372|566539873|FG000|Overall Study|Participants ongoing|429|||
156941051|NCT02504372|566539874|FG001|Overall Study|Participants ongoing|415|||
156941052|NCT03323099|566539876|FG000|Overall Study|Withdrawal by Subject|6|||
156941053|NCT03323099|566539877|FG001|Overall Study|Withdrawal by Subject|12|||
156941054|NCT03323099|566539876|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
156941055|NCT03323099|566539877|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
156941056|NCT00079274|566539878|FG000|Overall Study|Withdrawal by Subject|111|||
156941057|NCT00079274|566539879|FG001|Overall Study|Withdrawal by Subject|10|||
156941058|NCT00079274|566539880|FG002|Overall Study|Withdrawal by Subject|12|||
156941059|NCT00079274|566539881|FG003|Overall Study|Withdrawal by Subject|163|||
156941060|NCT00079274|566539882|FG004|Overall Study|Withdrawal by Subject|7|||
156941061|NCT00079274|566539883|FG005|Overall Study|Withdrawal by Subject|8|||
156941062|NCT00079274|566539884|FG006|Overall Study|Withdrawal by Subject|0|||
156941063|NCT00079274|566539878|FG000|Overall Study|Adverse Event|130|||
156941064|NCT00079274|566539879|FG001|Overall Study|Adverse Event|8|||
156941065|NCT00079274|566539880|FG002|Overall Study|Adverse Event|8|||
156941066|NCT00079274|566539881|FG003|Overall Study|Adverse Event|184|||
156941067|NCT00079274|566539882|FG004|Overall Study|Adverse Event|7|||
156941068|NCT00079274|566539883|FG005|Overall Study|Adverse Event|8|||
156941069|NCT00079274|566539884|FG006|Overall Study|Adverse Event|0|||
156941070|NCT00079274|566539878|FG000|Overall Study|Recurrence|21|||
156941071|NCT00079274|566539879|FG001|Overall Study|Recurrence|0|||
156941072|NCT00079274|566539880|FG002|Overall Study|Recurrence|1|||
156941073|NCT00079274|566539881|FG003|Overall Study|Recurrence|15|||
156941074|NCT00079274|566539882|FG004|Overall Study|Recurrence|0|||
156941075|NCT00079274|566539883|FG005|Overall Study|Recurrence|2|||
156941076|NCT00079274|566539884|FG006|Overall Study|Recurrence|0|||
156941077|NCT00079274|566539878|FG000|Overall Study|Alternate Treatment|6|||
157227307|NCT00950807|567577787|FG006|Washout Period 1|Adverse Event|0|||
157227308|NCT00950807|567577788|FG007|Washout Period 1|Adverse Event|0|||
157227309|NCT00950807|567577789|FG008|Washout Period 1|Adverse Event|0|||
156941078|NCT00079274|566539879|FG001|Overall Study|Alternate Treatment|1|||
156941079|NCT00079274|566539880|FG002|Overall Study|Alternate Treatment|0|||
156941080|NCT00079274|566539881|FG003|Overall Study|Alternate Treatment|3|||
156941081|NCT00079274|566539882|FG004|Overall Study|Alternate Treatment|0|||
157032101|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
157032102|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
157227310|NCT00950807|567577790|FG009|Washout Period 1|Adverse Event|0|||
156941082|NCT00079274|566539883|FG005|Overall Study|Alternate Treatment|0|||
156941083|NCT00079274|566539884|FG006|Overall Study|Alternate Treatment|0|||
156941084|NCT00079274|566539878|FG000|Overall Study|Other Medical Problems|6|||
156941085|NCT00079274|566539879|FG001|Overall Study|Other Medical Problems|1|||
156941086|NCT00079274|566539880|FG002|Overall Study|Other Medical Problems|0|||
156941087|NCT00079274|566539881|FG003|Overall Study|Other Medical Problems|7|||
156941088|NCT00079274|566539882|FG004|Overall Study|Other Medical Problems|0|||
157032103|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
157227311|NCT00950807|567577781|FG000|Treatment Period 2|Lack of Efficacy|1|||
157032104|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
157032105|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
157032106|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
157032107|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
157032108|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
157032109|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
157032110|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
157032111|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
157032112|NCT03580356|566873201|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
157032113|NCT03580356|566873202|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
157032114|NCT03580356|566873203|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
157032115|NCT03580356|566873204|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
157032116|NCT03580356|566873205|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
157032117|NCT03580356|566873206|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
157032118|NCT03580356|566873207|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
157032119|NCT03580356|566873208|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
157032120|NCT05715528|566873209|FG000|Overall Study|Randomized but never treated|11|||
157032121|NCT05715528|566873210|FG001|Overall Study|Randomized but never treated|13|||
157032122|NCT05715528|566873209|FG000|Overall Study|Withdrew consent|7|||
157032123|NCT05715528|566873210|FG001|Overall Study|Withdrew consent|15|||
157032124|NCT05715528|566873209|FG000|Overall Study|Lost to Follow-up|5|||
157032125|NCT05715528|566873210|FG001|Overall Study|Lost to Follow-up|13|||
157032126|NCT05715528|566873209|FG000|Overall Study|Investigator's discretion|3|||
157032127|NCT05715528|566873210|FG001|Overall Study|Investigator's discretion|1|||
157032128|NCT05715528|566873209|FG000|Overall Study|Protocol Violation|2|||
157032129|NCT05715528|566873210|FG001|Overall Study|Protocol Violation|0|||
157032130|NCT05715528|566873209|FG000|Overall Study|Non-compliance with study drug|0|||
157032131|NCT05715528|566873210|FG001|Overall Study|Non-compliance with study drug|1|||
157032132|NCT03118518|566873211|FG000|Overall Study|Early Exit after treatment|2|||
157032133|NCT03118518|566873212|FG001|Overall Study|Early Exit after treatment|8|||
157032134|NCT03118518|566873211|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
157032135|NCT03118518|566873212|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
157032136|NCT02834390|566873213|FG000|Induction Phase|Progressive disease|0|||
157032137|NCT02834390|566873214|FG001|Induction Phase|Progressive disease|1|||
157032138|NCT02834390|566873213|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
157032139|NCT02834390|566873214|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
157032140|NCT02834390|566873213|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
157032141|NCT02834390|566873214|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
157032142|NCT02834390|566873213|FG000|Consolidation Phase|Physician Decision|1|||
157032143|NCT02834390|566873214|FG001|Consolidation Phase|Physician Decision|1|||
157032144|NCT03485729|566873217|FG000|Overall Study|Withdrawal by Subject|0|||
157032145|NCT03485729|566873218|FG001|Overall Study|Withdrawal by Subject|0|||
157032146|NCT03485729|566873219|FG002|Overall Study|Withdrawal by Subject|1|||
157032147|NCT03485729|566873217|FG000|Overall Study|Disease progression|8|||
157032148|NCT03485729|566873218|FG001|Overall Study|Disease progression|13|||
157167350|NCT01244191|567352741|FG000|Overall Study|Death|22|||
157167351|NCT01244191|567352742|FG001|Overall Study|Death|29|||
157167352|NCT01244191|567352741|FG000|Overall Study|Lost to Follow-up|0|||
157167353|NCT01244191|567352742|FG001|Overall Study|Lost to Follow-up|2|||
157167354|NCT01244191|567352741|FG000|Overall Study|Protocol Violation|1|||
157167355|NCT01244191|567352742|FG001|Overall Study|Protocol Violation|2|||
157167356|NCT01244191|567352741|FG000|Overall Study|Withdrawal by Subject|31|||
157167357|NCT01244191|567352742|FG001|Overall Study|Withdrawal by Subject|23|||
157167358|NCT01244191|567352741|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
157167359|NCT01244191|567352742|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
157167360|NCT01752842|567352743|FG000|Overall Study|Adverse Event|3|||
157167361|NCT01752842|567352744|FG001|Overall Study|Adverse Event|0|||
157167362|NCT01752842|567352743|FG000|Overall Study|Withdrawal by Subject|0|||
157227312|NCT00950807|567577782|FG001|Treatment Period 2|Lack of Efficacy|0|||
157032149|NCT03485729|566873219|FG002|Overall Study|Disease progression|1|||
157032150|NCT03485729|566873217|FG000|Overall Study|Hospice care|1|||
157032151|NCT03485729|566873218|FG001|Overall Study|Hospice care|0|||
157032152|NCT03485729|566873219|FG002|Overall Study|Hospice care|0|||
157032153|NCT03485729|566873217|FG000|Overall Study|Poor performance status|1|||
157032154|NCT03485729|566873218|FG001|Overall Study|Poor performance status|0|||
157032155|NCT03485729|566873219|FG002|Overall Study|Poor performance status|0|||
157227313|NCT00950807|567577783|FG002|Treatment Period 2|Lack of Efficacy|0|||
157032156|NCT03485729|566873217|FG000|Overall Study|Illness|0|||
157032157|NCT03485729|566873218|FG001|Overall Study|Illness|1|||
157032158|NCT03485729|566873219|FG002|Overall Study|Illness|0|||
157167363|NCT01752842|567352744|FG001|Overall Study|Withdrawal by Subject|2|||
157167364|NCT05584202|567352746|FG000|Overall Study|Withdrawal of Consent|3|||
157167365|NCT05584202|567352747|FG001|Overall Study|Withdrawal of Consent|2|||
157167366|NCT05584202|567352746|FG000|Overall Study|Lost to Follow-up|2|||
157032159|NCT05552508|566873220|FG000|Overall Study|Adverse Event|3|||
157032160|NCT04311632|566873222|FG000|Overall Study|Withdrawal by Subject|0|||
157032161|NCT04311632|566873223|FG001|Overall Study|Withdrawal by Subject|0|||
157032162|NCT04311632|566873224|FG002|Overall Study|Withdrawal by Subject|1|||
157032163|NCT04632225|566873225|FG000|Overall Study|Withdrawal by Subject|2|||
157032164|NCT04632225|566873226|FG001|Overall Study|Withdrawal by Subject|2|||
157032165|NCT02323880|566873227|FG000|Overall Study|Adverse Event|2|||
157032166|NCT02323880|566873228|FG001|Overall Study|Adverse Event|0|||
157032167|NCT02323880|566873229|FG002|Overall Study|Adverse Event|1|||
157032168|NCT02323880|566873230|FG003|Overall Study|Adverse Event|1|||
157032169|NCT02323880|566873231|FG004|Overall Study|Adverse Event|1|||
157032170|NCT02323880|566873232|FG005|Overall Study|Adverse Event|0|||
157032171|NCT02323880|566873233|FG006|Overall Study|Adverse Event|1|||
157032172|NCT02323880|566873234|FG007|Overall Study|Adverse Event|0|||
157032173|NCT02323880|566873227|FG000|Overall Study|Death|0|||
157032174|NCT02323880|566873228|FG001|Overall Study|Death|0|||
157032175|NCT02323880|566873229|FG002|Overall Study|Death|0|||
157032176|NCT02323880|566873230|FG003|Overall Study|Death|0|||
157032177|NCT02323880|566873231|FG004|Overall Study|Death|0|||
157032178|NCT02323880|566873232|FG005|Overall Study|Death|1|||
156941089|NCT00079274|566539883|FG005|Overall Study|Other Medical Problems|0|||
156941090|NCT00079274|566539884|FG006|Overall Study|Other Medical Problems|0|||
156941091|NCT00079274|566539878|FG000|Overall Study|Death|4|||
156941092|NCT00079274|566539879|FG001|Overall Study|Death|0|||
157032179|NCT02323880|566873233|FG006|Overall Study|Death|0|||
157032180|NCT02323880|566873234|FG007|Overall Study|Death|0|||
157032181|NCT02323880|566873227|FG000|Overall Study|Lack of Efficacy|4|||
156941093|NCT00079274|566539880|FG002|Overall Study|Death|1|||
156941094|NCT00079274|566539881|FG003|Overall Study|Death|15|||
156941095|NCT00079274|566539882|FG004|Overall Study|Death|0|||
156941096|NCT00079274|566539883|FG005|Overall Study|Death|0|||
156941097|NCT00079274|566539884|FG006|Overall Study|Death|0|||
156941098|NCT00079274|566539878|FG000|Overall Study|Cytogenetic resistance|0|||
156941099|NCT00079274|566539879|FG001|Overall Study|Cytogenetic resistance|0|||
156941100|NCT00079274|566539880|FG002|Overall Study|Cytogenetic resistance|0|||
156941101|NCT00079274|566539881|FG003|Overall Study|Cytogenetic resistance|2|||
156941102|NCT00079274|566539882|FG004|Overall Study|Cytogenetic resistance|0|||
156941103|NCT00079274|566539883|FG005|Overall Study|Cytogenetic resistance|0|||
156941104|NCT00079274|566539884|FG006|Overall Study|Cytogenetic resistance|0|||
156941105|NCT00079274|566539878|FG000|Overall Study|Other|43|||
156941106|NCT00079274|566539879|FG001|Overall Study|Other|7|||
156941107|NCT00079274|566539880|FG002|Overall Study|Other|5|||
156941108|NCT00079274|566539881|FG003|Overall Study|Other|55|||
156941109|NCT00079274|566539882|FG004|Overall Study|Other|1|||
156941110|NCT00079274|566539883|FG005|Overall Study|Other|2|||
156941111|NCT00079274|566539884|FG006|Overall Study|Other|0|||
156941112|NCT00767676|566539887|FG000|Overall Study|Investigator error|54|||
156941113|NCT01502644|566539888|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
156941114|NCT01502644|566539889|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156941115|NCT01502644|566539890|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156941116|NCT01502644|566539891|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
156941117|NCT01502644|566539888|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
156941118|NCT01502644|566539889|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156941119|NCT01502644|566539890|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156941120|NCT01502644|566539891|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
156941121|NCT01502644|566539888|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
156941122|NCT01502644|566539889|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
156941123|NCT01502644|566539890|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
157032182|NCT02323880|566873228|FG001|Overall Study|Lack of Efficacy|11|||
157032183|NCT02323880|566873229|FG002|Overall Study|Lack of Efficacy|5|||
157032184|NCT02323880|566873230|FG003|Overall Study|Lack of Efficacy|5|||
157032185|NCT02323880|566873231|FG004|Overall Study|Lack of Efficacy|4|||
157032186|NCT02323880|566873232|FG005|Overall Study|Lack of Efficacy|8|||
157032187|NCT02323880|566873233|FG006|Overall Study|Lack of Efficacy|4|||
157167367|NCT05584202|567352747|FG001|Overall Study|Lost to Follow-up|1|||
157032188|NCT02323880|566873234|FG007|Overall Study|Lack of Efficacy|6|||
157032189|NCT02323880|566873227|FG000|Overall Study|Physician Decision|0|||
157032190|NCT02323880|566873228|FG001|Overall Study|Physician Decision|0|||
157032191|NCT02323880|566873229|FG002|Overall Study|Physician Decision|0|||
157167368|NCT05584202|567352746|FG000|Overall Study|Death|0|||
157167369|NCT05584202|567352747|FG001|Overall Study|Death|1|||
157167370|NCT05757427|567352751|FG000|Overall Study|Adverse Event|1|||
157167371|NCT05757427|567352751|FG000|Overall Study|Device deficiency|1|||
157167372|NCT05757427|567352751|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
157167373|NCT05757427|567352751|FG000|Overall Study|MWBI scan of only 1 breast|3|||
157032192|NCT02323880|566873230|FG003|Overall Study|Physician Decision|0|||
157205212|NCT03669640|567496078|FG005|Overall Study|Study Terminated by Sponsor|0|||
156941124|NCT01502644|566539891|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
156941125|NCT01502644|566539888|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
156941126|NCT01502644|566539889|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
156941127|NCT01502644|566539890|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
156941128|NCT01502644|566539891|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
156941129|NCT01502644|566539888|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
156941130|NCT01502644|566539889|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
156941131|NCT01502644|566539890|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
156941132|NCT01502644|566539891|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
156941133|NCT04958109|566539896|FG000|Overall Study|Withdrawal by Subject|0|||
156941134|NCT04958109|566539897|FG001|Overall Study|Withdrawal by Subject|1|||
156941135|NCT04958109|566539896|FG000|Overall Study|Lost to Follow-up|0|||
156941136|NCT04958109|566539897|FG001|Overall Study|Lost to Follow-up|1|||
156941137|NCT00715793|566539898|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
156941138|NCT00715793|566539899|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
156941139|NCT00715793|566539898|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
156941140|NCT00715793|566539899|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
156941141|NCT01573624|566539900|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156941142|NCT01573624|566539901|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156941143|NCT01573624|566539902|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
156941144|NCT01573624|566539903|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156941145|NCT01573624|566539904|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156941146|NCT01573624|566539905|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
156941147|NCT01573624|566539906|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
156941148|NCT01573624|566539900|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
156941149|NCT01573624|566539901|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
156941150|NCT01573624|566539902|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
156941151|NCT01573624|566539903|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156941152|NCT01573624|566539904|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
156941153|NCT01573624|566539905|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
156941154|NCT01573624|566539906|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
156941155|NCT01573624|566539900|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
156941156|NCT01573624|566539901|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941157|NCT01573624|566539902|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941158|NCT01573624|566539903|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941159|NCT01573624|566539904|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941160|NCT01573624|566539905|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941161|NCT01573624|566539906|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
156941162|NCT01573624|566539900|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156941163|NCT01573624|566539901|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156941164|NCT01573624|566539902|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
156941165|NCT01573624|566539903|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156941166|NCT01573624|566539904|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156941167|NCT01573624|566539905|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
156941168|NCT01573624|566539906|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
156941169|NCT01573624|566539900|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156941170|NCT01573624|566539901|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156941171|NCT01573624|566539902|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156941172|NCT01573624|566539903|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156941173|NCT01573624|566539904|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
156941174|NCT01573624|566539905|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156941175|NCT01573624|566539906|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
156941176|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941177|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941178|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941179|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941180|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941181|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
156941182|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
156941183|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156941184|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
157227314|NCT00950807|567577784|FG003|Treatment Period 2|Lack of Efficacy|0|||
157227315|NCT00950807|567577785|FG004|Treatment Period 2|Lack of Efficacy|0|||
157227316|NCT00950807|567577786|FG005|Treatment Period 2|Lack of Efficacy|0|||
157032193|NCT02323880|566873231|FG004|Overall Study|Physician Decision|1|||
157032194|NCT02323880|566873232|FG005|Overall Study|Physician Decision|1|||
157032195|NCT02323880|566873233|FG006|Overall Study|Physician Decision|1|||
157032196|NCT02323880|566873234|FG007|Overall Study|Physician Decision|0|||
157032197|NCT02323880|566873227|FG000|Overall Study|Withdrawal by Subject|0|||
157032198|NCT02323880|566873228|FG001|Overall Study|Withdrawal by Subject|2|||
157032199|NCT02323880|566873229|FG002|Overall Study|Withdrawal by Subject|0|||
157032200|NCT02323880|566873230|FG003|Overall Study|Withdrawal by Subject|0|||
157032201|NCT02323880|566873231|FG004|Overall Study|Withdrawal by Subject|0|||
157032202|NCT02323880|566873232|FG005|Overall Study|Withdrawal by Subject|0|||
157032203|NCT02323880|566873233|FG006|Overall Study|Withdrawal by Subject|0|||
157032204|NCT02323880|566873234|FG007|Overall Study|Withdrawal by Subject|0|||
157032205|NCT03717935|566873237|FG000|Overall Study|Withdrawal by Subject|0|||
157032206|NCT03717935|566873238|FG001|Overall Study|Withdrawal by Subject|2|||
157032207|NCT05100628|566873241|FG000|Overall Study|Progressive Disease|1|||
157032208|NCT05100628|566873242|FG001|Overall Study|Progressive Disease|0|||
157032209|NCT05100628|566873243|FG002|Overall Study|Progressive Disease|0|||
157032210|NCT05100628|566873244|FG003|Overall Study|Progressive Disease|0|||
157032211|NCT05100628|566873241|FG000|Overall Study|Study Terminated by Sponsor|0|||
157032212|NCT05100628|566873242|FG001|Overall Study|Study Terminated by Sponsor|0|||
157167374|NCT05757427|567352751|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
156941185|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156941186|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
156941187|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156941188|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
156941189|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
156941190|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156941191|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156941192|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
156941193|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
156941194|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156941195|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156941196|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
156941197|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941198|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941199|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941200|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941201|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941202|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
156941203|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
156941204|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156941205|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156941206|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156941207|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
156941208|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156941209|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
156941210|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
156941211|NCT01573624|566539900|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941212|NCT01573624|566539901|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941213|NCT01573624|566539902|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941214|NCT01573624|566539903|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941215|NCT01573624|566539904|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941216|NCT01573624|566539905|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941217|NCT01573624|566539906|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941218|NCT01573624|566539900|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
156941219|NCT01573624|566539901|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
157032213|NCT05100628|566873243|FG002|Overall Study|Study Terminated by Sponsor|3|||
157032214|NCT05100628|566873244|FG003|Overall Study|Study Terminated by Sponsor|0|||
157032215|NCT05100628|566873241|FG000|Overall Study|unkown|0|||
157032216|NCT05100628|566873242|FG001|Overall Study|unkown|1|||
157032217|NCT05100628|566873243|FG002|Overall Study|unkown|0|||
157032218|NCT05100628|566873244|FG003|Overall Study|unkown|0|||
157032219|NCT05900154|566873247|FG000|Follow-Up Period|Lost to Follow-up|1|||
157032220|NCT05900154|566873248|FG001|Follow-Up Period|Lost to Follow-up|2|||
157032221|NCT05900154|566873249|FG002|Follow-Up Period|Lost to Follow-up|1|||
157032222|NCT05900154|566873250|FG003|Follow-Up Period|Lost to Follow-up|0|||
157032223|NCT05900154|566873251|FG004|Follow-Up Period|Lost to Follow-up|1|||
156941220|NCT01573624|566539902|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
156941221|NCT01573624|566539903|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
156941222|NCT01573624|566539904|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
156941223|NCT01573624|566539905|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
156941224|NCT01573624|566539906|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
156941225|NCT01573624|566539900|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156941226|NCT01573624|566539901|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
156941227|NCT01573624|566539902|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156941228|NCT01573624|566539903|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156941229|NCT01573624|566539904|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156941230|NCT01573624|566539905|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
156941231|NCT01573624|566539906|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
156941232|NCT01573624|566539900|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
156941233|NCT01573624|566539901|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941234|NCT01573624|566539902|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941235|NCT01573624|566539903|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941236|NCT01573624|566539904|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941237|NCT01573624|566539905|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941238|NCT01573624|566539906|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
156941239|NCT01573624|566539900|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156941240|NCT01573624|566539901|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156941241|NCT01573624|566539902|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156941242|NCT01573624|566539903|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156941243|NCT01573624|566539904|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156941244|NCT01573624|566539905|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
156941245|NCT01573624|566539906|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
156941246|NCT01573624|566539900|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
156941247|NCT01573624|566539901|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941248|NCT01573624|566539902|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941249|NCT01573624|566539903|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941250|NCT01573624|566539904|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941251|NCT01573624|566539905|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941252|NCT01573624|566539906|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
156941253|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
156941254|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156941255|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156941256|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156941257|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156941258|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
156941259|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
156941260|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
156941261|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156941262|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156941263|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156941264|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156941265|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
156941266|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
156941267|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941268|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
156941269|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941270|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941271|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941272|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941273|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
156941274|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941275|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
156941276|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941277|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941278|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941279|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941280|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
156941281|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156941282|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156941283|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156941284|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156941285|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
156941286|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156941287|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
156941288|NCT01573624|566539900|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941289|NCT01573624|566539901|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941290|NCT01573624|566539902|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941291|NCT01573624|566539903|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941292|NCT01573624|566539904|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941293|NCT01573624|566539905|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
156941294|NCT01573624|566539906|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
156941295|NCT01573624|566539900|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
156941296|NCT01573624|566539901|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156941297|NCT01573624|566539902|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156941298|NCT01573624|566539903|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
156941299|NCT01573624|566539904|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156941300|NCT01573624|566539905|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
156941301|NCT01573624|566539906|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
156941302|NCT01573624|566539900|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156941303|NCT01573624|566539901|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
156941304|NCT01573624|566539902|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156941305|NCT01573624|566539903|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156941306|NCT01573624|566539904|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156941307|NCT01573624|566539905|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
156941308|NCT01573624|566539906|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
156941309|NCT01573624|566539900|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
156941310|NCT01573624|566539901|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941311|NCT01573624|566539902|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941312|NCT01573624|566539903|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941313|NCT01573624|566539904|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941314|NCT01573624|566539905|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941315|NCT01573624|566539906|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
156941316|NCT01573624|566539900|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156941317|NCT01573624|566539901|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156941318|NCT01573624|566539902|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156941319|NCT01573624|566539903|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156941320|NCT01573624|566539904|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
156941321|NCT01573624|566539905|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
156941322|NCT01573624|566539906|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
156941323|NCT01573624|566539900|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
156941324|NCT01573624|566539901|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941325|NCT01573624|566539902|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941326|NCT01573624|566539903|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941327|NCT01573624|566539904|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941328|NCT01573624|566539905|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941329|NCT01573624|566539906|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
156941330|NCT02681302|566539907|FG000|Overall Study|Withdrawal by Subject|1|||
156941331|NCT02681302|566539908|FG001|Overall Study|Withdrawal by Subject|1|||
156941332|NCT02681302|566539909|FG002|Overall Study|Withdrawal by Subject|0|||
156941333|NCT02681302|566539910|FG003|Overall Study|Withdrawal by Subject|0|||
156941334|NCT02681302|566539911|FG004|Overall Study|Withdrawal by Subject|1|||
156941335|NCT02681302|566539912|FG005|Overall Study|Withdrawal by Subject|0|||
156941336|NCT02681302|566539907|FG000|Overall Study|Screen Failure|2|||
156941337|NCT02681302|566539908|FG001|Overall Study|Screen Failure|4|||
156941338|NCT02681302|566539909|FG002|Overall Study|Screen Failure|2|||
156941339|NCT02681302|566539910|FG003|Overall Study|Screen Failure|0|||
156941340|NCT02681302|566539911|FG004|Overall Study|Screen Failure|1|||
156941341|NCT02681302|566539912|FG005|Overall Study|Screen Failure|1|||
156941342|NCT02681302|566539907|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156941343|NCT02681302|566539908|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156941344|NCT02681302|566539909|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156941345|NCT02681302|566539910|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
156941346|NCT02681302|566539911|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
157167375|NCT01827319|567354521|FG000|Overall Study|Lost to Follow-up|3|||
156941347|NCT02681302|566539912|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
156941348|NCT04552587|566539921|FG000|Overall Study|Lost to Follow-up|4|||
156941349|NCT01822132|566539922|FG000|Overall Study|Lost to Follow-up|4|||
156941350|NCT01822132|566539923|FG001|Overall Study|Lost to Follow-up|2|||
156941351|NCT00313612|566539924|FG000|Overall Study|Patient never received treatment|0|||
156941352|NCT00313612|566539925|FG001|Overall Study|Patient never received treatment|1|||
156941353|NCT02540954|566539928|FG000|Overall Study|Physician Decision|3|||
156941354|NCT02540954|566539929|FG001|Overall Study|Physician Decision|1|||
156941355|NCT02540954|566539928|FG000|Overall Study|Withdrawal by Subject|6|||
156941356|NCT02540954|566539929|FG001|Overall Study|Withdrawal by Subject|5|||
156941357|NCT02540954|566539928|FG000|Overall Study|Lost to Follow-up|1|||
156941358|NCT02540954|566539929|FG001|Overall Study|Lost to Follow-up|1|||
156941359|NCT02540954|566539928|FG000|Overall Study|Adverse Event|4|||
156941360|NCT02540954|566539929|FG001|Overall Study|Adverse Event|2|||
156941361|NCT02540954|566539928|FG000|Overall Study|Death|0|||
156941362|NCT02540954|566539929|FG001|Overall Study|Death|3|||
156941363|NCT02540954|566539928|FG000|Overall Study|Treatment failure|1|||
156941364|NCT02540954|566539929|FG001|Overall Study|Treatment failure|0|||
156941365|NCT02540954|566539928|FG000|Overall Study|Other reason|4|||
156941366|NCT02540954|566539929|FG001|Overall Study|Other reason|2|||
156941367|NCT01393743|566539930|FG000|Core Study|Adverse Event|5|||
156941368|NCT01393743|566539931|FG001|Core Study|Adverse Event|9|||
156941369|NCT01393743|566539932|FG002|Core Study|Adverse Event|0|||
156941370|NCT01393743|566539930|FG000|Core Study|Lost to Follow-up|1|||
156941371|NCT01393743|566539931|FG001|Core Study|Lost to Follow-up|1|||
156941372|NCT01393743|566539932|FG002|Core Study|Lost to Follow-up|0|||
156941373|NCT01393743|566539930|FG000|Core Study|Participant's Choice|2|||
156941374|NCT01393743|566539931|FG001|Core Study|Participant's Choice|3|||
156941375|NCT01393743|566539932|FG002|Core Study|Participant's Choice|0|||
156941376|NCT01393743|566539930|FG000|Core Study|Inadequate therapeutic effect|2|||
156941377|NCT01393743|566539931|FG001|Core Study|Inadequate therapeutic effect|0|||
156941378|NCT01393743|566539932|FG002|Core Study|Inadequate therapeutic effect|0|||
156941379|NCT01393743|566539930|FG000|Extension Phase|Adverse Event|0|||
156941380|NCT01393743|566539931|FG001|Extension Phase|Adverse Event|0|||
156941381|NCT01393743|566539932|FG002|Extension Phase|Adverse Event|12|||
156941382|NCT01393743|566539930|FG000|Extension Phase|Lost to Follow-up|0|||
156941383|NCT01393743|566539931|FG001|Extension Phase|Lost to Follow-up|0|||
156941384|NCT01393743|566539932|FG002|Extension Phase|Lost to Follow-up|2|||
156941385|NCT01393743|566539930|FG000|Extension Phase|Participant choice|0|||
156941386|NCT01393743|566539931|FG001|Extension Phase|Participant choice|0|||
156941387|NCT01393743|566539932|FG002|Extension Phase|Participant choice|16|||
156941388|NCT01393743|566539930|FG000|Extension Phase|Inadequate therapeutic effect|0|||
156941389|NCT01393743|566539931|FG001|Extension Phase|Inadequate therapeutic effect|0|||
156941390|NCT01393743|566539932|FG002|Extension Phase|Inadequate therapeutic effect|7|||
156941391|NCT01393743|566539930|FG000|Extension Phase|Withdrawal by Subject|0|||
156941392|NCT01393743|566539931|FG001|Extension Phase|Withdrawal by Subject|0|||
156941393|NCT01393743|566539932|FG002|Extension Phase|Withdrawal by Subject|8|||
156941394|NCT01393743|566539930|FG000|Extension Phase|Pregnancy|0|||
156941395|NCT01393743|566539931|FG001|Extension Phase|Pregnancy|0|||
156941396|NCT01393743|566539932|FG002|Extension Phase|Pregnancy|1|||
156941397|NCT01393743|566539930|FG000|Extension Phase|Other|0|||
156941398|NCT01393743|566539931|FG001|Extension Phase|Other|0|||
156941399|NCT01393743|566539932|FG002|Extension Phase|Other|14|||
156941400|NCT01524770|566539939|FG000|First Intervention|Withdrawal by Subject|1|||
156941401|NCT01524770|566539940|FG001|First Intervention|Withdrawal by Subject|0|||
156941402|NCT01524770|566539939|FG000|First Intervention|Adverse Event|1|||
156941403|NCT01524770|566539940|FG001|First Intervention|Adverse Event|1|||
156941404|NCT01524770|566539939|FG000|First Intervention|Protocol Violation|1|||
156941405|NCT01524770|566539940|FG001|First Intervention|Protocol Violation|0|||
157167376|NCT03097614|567354525|FG000|Overall Study|Adverse Event|3|||
156941406|NCT03080961|566539942|FG000|Overall Study|Withdrawal by Subject|3|||
156941407|NCT03508219|566539945|FG000|Overall Study|Death|2|||
156941408|NCT03508219|566539945|FG000|Overall Study|Withdrawal by Subject|1|||
156941409|NCT03508219|566539945|FG000|Overall Study|Lost to Follow-up|4|||
156941410|NCT03508219|566539945|FG000|Overall Study|Missed visit|2|||
156941411|NCT04074317|566539947|FG000|Third Period|Withdrawal by Subject|0|||
156941412|NCT04074317|566539948|FG001|Third Period|Withdrawal by Subject|0|||
156941413|NCT04074317|566539949|FG002|Third Period|Withdrawal by Subject|0|||
156941414|NCT04074317|566539950|FG003|Third Period|Withdrawal by Subject|1|||
157167377|NCT00781963|567354526|FG000|Overall Study|Death|3|||
156941415|NCT04074317|566539951|FG004|Third Period|Withdrawal by Subject|0|||
156941416|NCT04074317|566539952|FG005|Third Period|Withdrawal by Subject|0|||
156941417|NCT01038778|566539953|FG000|Overall Study|Withdrawal by Subject|0|||
156941418|NCT01038778|566539954|FG001|Overall Study|Withdrawal by Subject|2|||
156941419|NCT01038778|566539955|FG002|Overall Study|Withdrawal by Subject|3|||
156941420|NCT04269161|566541134|FG000|Overall Study|Change of modality and no longer eligible|3|||
156941421|NCT04269161|566541135|FG001|Overall Study|Change of modality and no longer eligible|3|||
157167378|NCT00781963|567354527|FG001|Overall Study|Death|0|||
156941422|NCT04269161|566541134|FG000|Overall Study|Required procedure outside of NICU|1|||
156941423|NCT04269161|566541135|FG001|Overall Study|Required procedure outside of NICU|0|||
156941424|NCT04269161|566541134|FG000|Overall Study|Equipment issue|1|||
156941425|NCT04269161|566541135|FG001|Overall Study|Equipment issue|1|||
156941426|NCT01344057|566541140|FG000|Overall Study|Premature Withdrawal|1|||
156941427|NCT00548808|566541147|FG000|Overall Study|Lost to Follow-up|9|||
156941428|NCT00548808|566541148|FG001|Overall Study|Lost to Follow-up|3|||
156941429|NCT00548808|566541147|FG000|Overall Study|Protocol Violation|8|||
156941430|NCT00548808|566541148|FG001|Overall Study|Protocol Violation|8|||
156941431|NCT00548808|566541147|FG000|Overall Study|Withdrawal by Subject|8|||
156941432|NCT00548808|566541148|FG001|Overall Study|Withdrawal by Subject|4|||
156941433|NCT00548808|566541147|FG000|Overall Study|Physician Decision|6|||
156941434|NCT00548808|566541148|FG001|Overall Study|Physician Decision|3|||
156941435|NCT00548808|566541147|FG000|Overall Study|Adverse Event|4|||
156941436|NCT00548808|566541148|FG001|Overall Study|Adverse Event|5|||
156941437|NCT00548808|566541147|FG000|Overall Study|Death|2|||
156941438|NCT00548808|566541148|FG001|Overall Study|Death|0|||
156941439|NCT00548808|566541147|FG000|Overall Study|Entry Criteria Not Met|2|||
156941440|NCT00548808|566541148|FG001|Overall Study|Entry Criteria Not Met|2|||
156941441|NCT00548808|566541147|FG000|Overall Study|Lack of Efficacy|2|||
156941442|NCT00548808|566541148|FG001|Overall Study|Lack of Efficacy|0|||
156941443|NCT00548808|566541147|FG000|Overall Study|Sponsor Decision|1|||
156941444|NCT00548808|566541148|FG001|Overall Study|Sponsor Decision|1|||
156941445|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Adverse Event|9|||
156941446|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Adverse Event|2|||
156941447|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
156941448|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
156941449|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
156941450|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
156941451|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Physician Decision|1|||
156941452|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Physician Decision|1|||
156941453|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Pregnancy|2|||
156941454|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Pregnancy|0|||
156941455|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
156941456|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
156941457|NCT02896127|566541151|FG000|COMPLETED WEEK 52|Technical problems|1|||
156941458|NCT02896127|566541152|FG001|COMPLETED WEEK 52|Technical problems|0|||
156941459|NCT02896127|566541151|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
156941460|NCT02896127|566541152|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
156941461|NCT02896127|566541151|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
156941462|NCT02896127|566541152|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
156941463|NCT02896127|566541151|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
156941464|NCT02896127|566541152|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
156941465|NCT02896127|566541151|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
156941466|NCT02896127|566541152|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
156941467|NCT02896127|566541151|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
156941468|NCT02896127|566541152|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
156941469|NCT00501540|566541153|FG000|Overall Study|Death|5|||
156941470|NCT02331446|566541154|FG000|Overall Study|Lost to Follow-up|2|||
156941471|NCT02331446|566541155|FG001|Overall Study|Lost to Follow-up|1|||
156941472|NCT02331446|566541156|FG002|Overall Study|Lost to Follow-up|0|||
156941473|NCT02331446|566541157|FG003|Overall Study|Lost to Follow-up|1|||
156941474|NCT02331446|566541154|FG000|Overall Study|Personal Problem|2|||
156941475|NCT02331446|566541155|FG001|Overall Study|Personal Problem|0|||
156941476|NCT02331446|566541156|FG002|Overall Study|Personal Problem|0|||
156941477|NCT02331446|566541157|FG003|Overall Study|Personal Problem|0|||
156941478|NCT02331446|566541154|FG000|Overall Study|Disease|0|||
156941479|NCT02331446|566541155|FG001|Overall Study|Disease|2|||
156941480|NCT02331446|566541156|FG002|Overall Study|Disease|2|||
157032224|NCT05900154|566873252|FG005|Follow-Up Period|Lost to Follow-up|1|||
157032225|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
157167379|NCT00781963|567354526|FG000|Overall Study|Lost to Follow-up|2|||
156941481|NCT02331446|566541157|FG003|Overall Study|Disease|1|||
156941482|NCT02331446|566541154|FG000|Overall Study|Physician Decision|0|||
156941483|NCT02331446|566541155|FG001|Overall Study|Physician Decision|1|||
156941484|NCT02331446|566541156|FG002|Overall Study|Physician Decision|0|||
156941485|NCT02331446|566541157|FG003|Overall Study|Physician Decision|1|||
156941486|NCT02331446|566541154|FG000|Overall Study|Lost before baseline analysis|0|||
156941487|NCT02331446|566541155|FG001|Overall Study|Lost before baseline analysis|1|||
156941488|NCT02331446|566541156|FG002|Overall Study|Lost before baseline analysis|1|||
156941489|NCT02331446|566541157|FG003|Overall Study|Lost before baseline analysis|0|||
156941490|NCT04879745|566541158|FG000|Overall Study|Lost to Follow-up|4|||
156941491|NCT04879745|566541159|FG001|Overall Study|Lost to Follow-up|1|||
156941492|NCT04439240|566541160|FG000|Overall Study|Ineligible|2|||
156941493|NCT04439240|566541160|FG000|Overall Study|Never started treatment|2|||
156941494|NCT04439240|566541160|FG000|Overall Study|Adverse Event|12|||
156941495|NCT04439240|566541160|FG000|Overall Study|Death|2|||
156941496|NCT04439240|566541160|FG000|Overall Study|Disease progression|25|||
156941497|NCT04439240|566541160|FG000|Overall Study|Other diseases|2|||
156941498|NCT04439240|566541160|FG000|Overall Study|Withdrawal by Subject|3|||
156941499|NCT04439240|566541160|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
156941500|NCT04439240|566541160|FG000|Overall Study|Symptomatic decline|1|||
156941501|NCT04439240|566541160|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
156941502|NCT04439240|566541160|FG000|Overall Study|Clinical progression|1|||
156941503|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
156941504|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
156941505|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
156941506|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
156941507|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
156941508|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
156941509|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
156941510|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
156941511|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
156941512|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
156941513|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
156941514|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
156941515|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
156941516|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
156941517|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
156941518|NCT00280566|566541161|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
156941519|NCT00280566|566541162|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
156941520|NCT00280566|566541163|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
156941521|NCT00280566|566541161|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
156941522|NCT00280566|566541162|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
156941523|NCT00280566|566541163|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
156941524|NCT00280566|566541161|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
156941525|NCT00280566|566541162|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
156941526|NCT00280566|566541163|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
156941527|NCT00280566|566541161|FG000|Period 2 Double Blind|Adverse Event|0|||
156941528|NCT00280566|566541162|FG001|Period 2 Double Blind|Adverse Event|11|||
156941529|NCT00280566|566541163|FG002|Period 2 Double Blind|Adverse Event|15|||
156941530|NCT00280566|566541161|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
156941531|NCT00280566|566541162|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
156941532|NCT00280566|566541163|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
156941533|NCT00280566|566541161|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
156941534|NCT00280566|566541162|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
156941535|NCT00280566|566541163|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
156941536|NCT00280566|566541161|FG000|Period 2 Double Blind|miscellaneous|0|||
156941537|NCT00280566|566541162|FG001|Period 2 Double Blind|miscellaneous|10|||
156941538|NCT00280566|566541163|FG002|Period 2 Double Blind|miscellaneous|5|||
156941539|NCT00637195|566541164|FG000|Overall Study|Lost to Follow-up|1|||
156941540|NCT00637195|566541165|FG001|Overall Study|Lost to Follow-up|0|||
156941541|NCT00637195|566541164|FG000|Overall Study|Other|2|||
156941542|NCT00637195|566541165|FG001|Overall Study|Other|0|||
156941543|NCT00637195|566541164|FG000|Overall Study|Withdrawal by Subject|0|||
156941544|NCT00637195|566541165|FG001|Overall Study|Withdrawal by Subject|1|||
156941545|NCT00547703|566541166|FG000|Overall Study|Lost to Follow-up|1|||
156941546|NCT00547703|566541167|FG001|Overall Study|Lost to Follow-up|0|||
156941547|NCT01696032|566541168|FG000|Overall Study|Withdrawal by Subject|0|||
156941548|NCT01696032|566541169|FG001|Overall Study|Withdrawal by Subject|0|||
156941549|NCT01696032|566541170|FG002|Overall Study|Withdrawal by Subject|1|||
156941550|NCT01696032|566541171|FG003|Overall Study|Withdrawal by Subject|2|||
156941551|NCT01696032|566541168|FG000|Overall Study|Death|14|||
156941552|NCT01696032|566541169|FG001|Overall Study|Death|4|||
156941553|NCT01696032|566541170|FG002|Overall Study|Death|43|||
156941554|NCT01696032|566541171|FG003|Overall Study|Death|18|||
156941555|NCT01696032|566541168|FG000|Overall Study|Lost to Follow-up|0|||
156941556|NCT01696032|566541169|FG001|Overall Study|Lost to Follow-up|1|||
156941557|NCT01696032|566541170|FG002|Overall Study|Lost to Follow-up|0|||
156941558|NCT01696032|566541171|FG003|Overall Study|Lost to Follow-up|0|||
156941559|NCT01696032|566541168|FG000|Overall Study|Database lock|0|||
156941560|NCT01696032|566541169|FG001|Overall Study|Database lock|1|||
156941561|NCT01696032|566541170|FG002|Overall Study|Database lock|7|||
156941562|NCT01696032|566541171|FG003|Overall Study|Database lock|2|||
156941563|NCT00376168|566541174|FG000|Overall Study|Adverse Event|1|||
156941564|NCT00376168|566541175|FG001|Overall Study|Adverse Event|1|||
156941565|NCT00376168|566541174|FG000|Overall Study|Pregnancy|1|||
156941566|NCT00376168|566541175|FG001|Overall Study|Pregnancy|0|||
156941567|NCT02214121|566541178|FG000|Part A|Patient decision|2|||
156941568|NCT02214121|566541179|FG001|Part A|Patient decision|0|||
156941569|NCT02214121|566541180|FG002|Part A|Patient decision|0|||
156941570|NCT02214121|566541178|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
157032226|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
157032227|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
157032228|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
157032229|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
157032230|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
157032231|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
157032232|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
157032233|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
157032234|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
157032235|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
157032236|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
157032237|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
157032238|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
157032239|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
157032240|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
157032241|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
157032242|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
157032243|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
157032244|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
157032245|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
157032246|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
157032247|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
157032248|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
157032249|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
157032250|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
157032251|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
157032252|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
157032253|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
157032254|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
157032255|NCT04614948|566873255|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
157032256|NCT04614948|566873256|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
157032257|NCT04614948|566873257|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
157032258|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
157032259|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
157032260|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
157032261|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
157032262|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
157032263|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
157032264|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
157032265|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
157032266|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
157032267|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
157032268|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
157032269|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
157032270|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
157032271|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
157032272|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
157032273|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
157167380|NCT00781963|567354527|FG001|Overall Study|Lost to Follow-up|1|||
157167381|NCT00781963|567354526|FG000|Overall Study|Withdrawal by Subject|3|||
157167382|NCT00781963|567354527|FG001|Overall Study|Withdrawal by Subject|1|||
157167383|NCT00781963|567354526|FG000|Overall Study|Refused follow-up|9|||
157167384|NCT00781963|567354527|FG001|Overall Study|Refused follow-up|0|||
157167385|NCT03297216|567354528|FG000|Overall Study|Death|0|||
157167386|NCT03297216|567354529|FG001|Overall Study|Death|1|||
157167387|NCT03297216|567354528|FG000|Overall Study|Miscarriage|0|||
157167388|NCT03297216|567354529|FG001|Overall Study|Miscarriage|2|||
157167389|NCT03297216|567354528|FG000|Overall Study|Lost to Follow-up|3|||
157167390|NCT03297216|567354529|FG001|Overall Study|Lost to Follow-up|2|||
157032274|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
157167391|NCT00436982|567354533|FG000|Overall Study|Withdrawal by Subject|3|||
157167392|NCT00436982|567354534|FG001|Overall Study|Withdrawal by Subject|1|||
157032275|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
157032276|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
157032277|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
157032278|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
157032279|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
157167393|NCT00436982|567354533|FG000|Overall Study|Did not receive allocated intervention|0|||
156941571|NCT02214121|566541179|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
156941572|NCT02214121|566541180|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
156941573|NCT02214121|566541178|FG000|Part A|Other|1|||
156941574|NCT02214121|566541179|FG001|Part A|Other|0|||
156941575|NCT02214121|566541180|FG002|Part A|Other|0|||
156941576|NCT02214121|566541178|FG000|Part B|Patient decision|0|||
156941577|NCT02214121|566541179|FG001|Part B|Patient decision|1|||
156941578|NCT02214121|566541180|FG002|Part B|Patient decision|0|||
156941579|NCT02214121|566541178|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
156941580|NCT02214121|566541179|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
156941581|NCT02214121|566541180|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
156941582|NCT02214121|566541178|FG000|Part B|Lost to Follow-up|0|||
156941583|NCT02214121|566541179|FG001|Part B|Lost to Follow-up|0|||
156941584|NCT02214121|566541180|FG002|Part B|Lost to Follow-up|1|||
156941585|NCT04115358|566541181|FG000|Overall Study|exfoliation|0|||
156941586|NCT04115358|566541182|FG001|Overall Study|exfoliation|0|||
156941587|NCT04115358|566541183|FG002|Overall Study|exfoliation|1|||
156941588|NCT02722928|566541190|FG000|Overall Study|Standard CT was not as required per prot|5|||
156941589|NCT02722928|566541191|FG001|Overall Study|Standard CT was not as required per prot|13|||
156941590|NCT02722928|566541190|FG000|Overall Study|Required Intraoperative MRI|5|||
156941591|NCT02722928|566541191|FG001|Overall Study|Required Intraoperative MRI|7|||
156941592|NCT03120013|566541194|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
156941593|NCT03120013|566541195|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
156941594|NCT05059600|566541196|FG000|Overall Study|Enrolled but not Treated|10|||
156941595|NCT02098109|566541197|FG000|Overall Study|Protocol Violation|3|||
156941596|NCT02098109|566541198|FG001|Overall Study|Protocol Violation|0|||
156941597|NCT01565291|566541200|FG000|Overall Study|Withdrawal by Subject|1|||
156941598|NCT01565291|566541201|FG001|Overall Study|Withdrawal by Subject|0|||
156941599|NCT00613509|566541202|FG000|Cycle 1|Adverse Event|2|||
156941600|NCT00613509|566541203|FG001|Cycle 1|Adverse Event|1|||
156941601|NCT00613509|566541202|FG000|Cycle 1|Disease Progression|2|||
156941602|NCT00613509|566541203|FG001|Cycle 1|Disease Progression|6|||
156941603|NCT00613509|566541202|FG000|Cycle 1|Unacceptable Toxicity|1|||
156941604|NCT00613509|566541203|FG001|Cycle 1|Unacceptable Toxicity|0|||
156941605|NCT00613509|566541202|FG000|Cycle 1|Other administrative reason|0|||
156941606|NCT00613509|566541203|FG001|Cycle 1|Other administrative reason|1|||
156941607|NCT04847674|566541204|FG000|Overall Study|Withdrawal by Subject|0|||
156941608|NCT04847674|566541205|FG001|Overall Study|Withdrawal by Subject|1|||
156941609|NCT04847674|566541206|FG002|Overall Study|Withdrawal by Subject|0|||
156941610|NCT04847674|566541204|FG000|Overall Study|Lost to Follow-up|0|||
156941611|NCT04847674|566541205|FG001|Overall Study|Lost to Follow-up|0|||
156941612|NCT04847674|566541206|FG002|Overall Study|Lost to Follow-up|2|||
156941613|NCT04847674|566541204|FG000|Overall Study|Other than specified|21|||
156941614|NCT04847674|566541205|FG001|Overall Study|Other than specified|20|||
156941615|NCT04847674|566541206|FG002|Overall Study|Other than specified|20|||
156941616|NCT00677807|566541207|FG000|Overall Study|Adverse Event|4|||
156941617|NCT00677807|566541208|FG001|Overall Study|Adverse Event|1|||
156941618|NCT00677807|566541209|FG002|Overall Study|Adverse Event|6|||
156941619|NCT00677807|566541207|FG000|Overall Study|Lack of Efficacy|0|||
156941620|NCT00677807|566541208|FG001|Overall Study|Lack of Efficacy|0|||
156941621|NCT00677807|566541209|FG002|Overall Study|Lack of Efficacy|2|||
156941622|NCT00677807|566541207|FG000|Overall Study|Participant no longer needs study drug|0|||
156941623|NCT00677807|566541208|FG001|Overall Study|Participant no longer needs study drug|0|||
156941624|NCT00677807|566541209|FG002|Overall Study|Participant no longer needs study drug|1|||
156941625|NCT00677807|566541207|FG000|Overall Study|Withdrawal by Subject|10|||
156941626|NCT00677807|566541208|FG001|Overall Study|Withdrawal by Subject|3|||
156941627|NCT00677807|566541209|FG002|Overall Study|Withdrawal by Subject|6|||
156941628|NCT00677807|566541207|FG000|Overall Study|Lost to Follow-up|2|||
156941629|NCT00677807|566541208|FG001|Overall Study|Lost to Follow-up|2|||
156941630|NCT00677807|566541209|FG002|Overall Study|Lost to Follow-up|2|||
156941631|NCT00677807|566541207|FG000|Overall Study|Administrative problems|1|||
156941632|NCT00677807|566541208|FG001|Overall Study|Administrative problems|1|||
156941633|NCT00677807|566541209|FG002|Overall Study|Administrative problems|2|||
156941634|NCT00677807|566541207|FG000|Overall Study|Death|0|||
156941635|NCT00677807|566541208|FG001|Overall Study|Death|1|||
156941636|NCT00677807|566541209|FG002|Overall Study|Death|1|||
156941637|NCT00677807|566541207|FG000|Overall Study|Protocol Deviation|1|||
156941638|NCT00677807|566541208|FG001|Overall Study|Protocol Deviation|3|||
156941639|NCT00677807|566541209|FG002|Overall Study|Protocol Deviation|0|||
156941640|NCT00689481|566541210|FG000|Overall Study|Adverse Event|7|||
156941641|NCT00689481|566541211|FG001|Overall Study|Adverse Event|1|||
156941642|NCT00689481|566541210|FG000|Overall Study|Lost to Follow-up|4|||
156941643|NCT00689481|566541211|FG001|Overall Study|Lost to Follow-up|3|||
156941644|NCT00689481|566541210|FG000|Overall Study|Lack of Efficacy|4|||
156941645|NCT00689481|566541211|FG001|Overall Study|Lack of Efficacy|3|||
156941646|NCT00689481|566541210|FG000|Overall Study|Non-compliance with study treatment|1|||
156941647|NCT00689481|566541211|FG001|Overall Study|Non-compliance with study treatment|1|||
156941648|NCT00689481|566541210|FG000|Overall Study|Withdrawal by Subject|8|||
157227317|NCT00950807|567577787|FG006|Treatment Period 2|Lack of Efficacy|0|||
156941649|NCT00689481|566541211|FG001|Overall Study|Withdrawal by Subject|4|||
156941650|NCT00689481|566541210|FG000|Overall Study|Excluded medication started during study|0|||
156941651|NCT00689481|566541211|FG001|Overall Study|Excluded medication started during study|1|||
156941652|NCT00689481|566541210|FG000|Overall Study|Subject early term, left on vacation|0|||
156941653|NCT00689481|566541211|FG001|Overall Study|Subject early term, left on vacation|1|||
156941654|NCT04466891|566541212|FG000|Overall Study|Death|60|||
156941655|NCT04466891|566541213|FG001|Overall Study|Death|6|||
156941656|NCT04466891|566541212|FG000|Overall Study|Withdrawal by Subject|8|||
156941657|NCT04466891|566541213|FG001|Overall Study|Withdrawal by Subject|1|||
156941658|NCT04466891|566541212|FG000|Overall Study|Study terminated by sponsor|5|||
156941659|NCT04466891|566541213|FG001|Overall Study|Study terminated by sponsor|0|||
156941660|NCT04466891|566541212|FG000|Overall Study|Lost to Follow-up|2|||
156941661|NCT04466891|566541213|FG001|Overall Study|Lost to Follow-up|0|||
156941662|NCT04466891|566541212|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
156941663|NCT04466891|566541213|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
156941664|NCT03238911|566541218|FG000|Overall Study|Withdrawal by Subject|1|||
156941665|NCT03238911|566541219|FG001|Overall Study|Withdrawal by Subject|2|||
156941666|NCT03238911|566541218|FG000|Overall Study|Lost to Follow-up|2|||
156941667|NCT03238911|566541219|FG001|Overall Study|Lost to Follow-up|1|||
156941668|NCT02239536|566541220|FG000|Overall Study|Non-neoplastic polyp|23|||
156941669|NCT02239536|566541221|FG001|Overall Study|Non-neoplastic polyp|17|||
156941670|NCT03091192|566541222|FG000|Overall Study|Study terminated by sponsor|21|||
156941671|NCT03091192|566541223|FG001|Overall Study|Study terminated by sponsor|14|||
156941672|NCT03091192|566541222|FG000|Overall Study|Death|9|||
156941673|NCT03091192|566541223|FG001|Overall Study|Death|13|||
156941674|NCT03091192|566541222|FG000|Overall Study|Withdrawal by Subject|2|||
156941675|NCT03091192|566541223|FG001|Overall Study|Withdrawal by Subject|0|||
156941676|NCT03091192|566541222|FG000|Overall Study|Lost to Follow-up|1|||
156941677|NCT03091192|566541223|FG001|Overall Study|Lost to Follow-up|0|||
156941678|NCT06023394|566541224|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
156941679|NCT06023394|566541225|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
156941680|NCT06023394|566541224|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
156941681|NCT06023394|566541225|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
156941682|NCT06023394|566541224|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
156941683|NCT06023394|566541225|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
156941684|NCT06023394|566541224|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
156941685|NCT06023394|566541225|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
156941686|NCT05645432|566541226|FG000|Overall Study|Withdrawal by Subject|1|||
156941687|NCT02283788|566541227|FG000|Overall Study|Adverse Event|1|||
156941688|NCT02283788|566541228|FG001|Overall Study|Adverse Event|3|||
156941689|NCT02283788|566541229|FG002|Overall Study|Adverse Event|5|||
156941690|NCT02283788|566541230|FG003|Overall Study|Adverse Event|1|||
156941691|NCT02283788|566541227|FG000|Overall Study|Withdrawal by Subject|0|||
156941692|NCT02283788|566541228|FG001|Overall Study|Withdrawal by Subject|1|||
156941693|NCT02283788|566541229|FG002|Overall Study|Withdrawal by Subject|0|||
156941694|NCT02283788|566541230|FG003|Overall Study|Withdrawal by Subject|1|||
156941695|NCT02742103|566542641|FG000|Overall Study|Protocol Violation|1|||
156941696|NCT02742103|566542642|FG001|Overall Study|Protocol Violation|0|||
156941697|NCT02742103|566542641|FG000|Overall Study|Death|2|||
156941698|NCT02742103|566542642|FG001|Overall Study|Death|2|||
156941699|NCT02742103|566542641|FG000|Overall Study|Adverse Event|1|||
156941700|NCT02742103|566542642|FG001|Overall Study|Adverse Event|0|||
156941701|NCT02742103|566542641|FG000|Overall Study|Moved to another town|0|||
156941702|NCT02742103|566542642|FG001|Overall Study|Moved to another town|1|||
156941703|NCT02742103|566542641|FG000|Overall Study|Withdrawal by Subject|5|||
156941704|NCT02742103|566542642|FG001|Overall Study|Withdrawal by Subject|2|||
156941705|NCT02096835|566542648|FG000|Overall Study|Withdrawal by Subject|1|||
156941706|NCT02096835|566542649|FG001|Overall Study|Withdrawal by Subject|0|||
156941707|NCT02096835|566542650|FG002|Overall Study|Withdrawal by Subject|0|||
156941708|NCT02096835|566542648|FG000|Overall Study|converted to open procedures|1|||
156941709|NCT02096835|566542649|FG001|Overall Study|converted to open procedures|0|||
156941710|NCT02096835|566542650|FG002|Overall Study|converted to open procedures|0|||
156941711|NCT02096835|566542648|FG000|Overall Study|Lost to Follow-up|1|||
156941712|NCT02096835|566542649|FG001|Overall Study|Lost to Follow-up|0|||
156941713|NCT02096835|566542650|FG002|Overall Study|Lost to Follow-up|1|||
156941714|NCT02472756|566542651|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
156941715|NCT02472756|566542651|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
156941716|NCT02472756|566542651|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
156941717|NCT02472756|566542651|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
156941718|NCT02472756|566542651|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
156941719|NCT02143414|566542652|FG000|Induction|Adverse Event|1|||
156941720|NCT02143414|566542653|FG001|Induction|Adverse Event|2|||
156941721|NCT02143414|566542652|FG000|Induction|Death|1|||
156941722|NCT02143414|566542653|FG001|Induction|Death|2|||
156941723|NCT02143414|566542652|FG000|Induction|Patient refusal|1|||
156941724|NCT02143414|566542653|FG001|Induction|Patient refusal|1|||
156941725|NCT02143414|566542652|FG000|Induction|Refractory|1|||
156941726|NCT02143414|566542653|FG001|Induction|Refractory|0|||
156941727|NCT02143414|566542652|FG000|Induction|Began alternative treatment|1|||
156941728|NCT02143414|566542653|FG001|Induction|Began alternative treatment|0|||
156941729|NCT02143414|566542652|FG000|Induction|Ineligible for postremission|5|||
156941730|NCT02143414|566542653|FG001|Induction|Ineligible for postremission|1|||
156941731|NCT02143414|566542652|FG000|Post-remission|Adverse Event|0|||
156941732|NCT02143414|566542653|FG001|Post-remission|Adverse Event|2|||
156941733|NCT02143414|566542652|FG000|Post-remission|Disease progression/relapse|5|||
156941734|NCT02143414|566542653|FG001|Post-remission|Disease progression/relapse|0|||
156941735|NCT02143414|566542652|FG000|Maintenance|Adverse Event|4|||
156941736|NCT02143414|566542653|FG001|Maintenance|Adverse Event|6|||
156941737|NCT02143414|566542652|FG000|Maintenance|Disease progression/relapse|3|||
156941738|NCT02143414|566542653|FG001|Maintenance|Disease progression/relapse|2|||
156941739|NCT02143414|566542652|FG000|Maintenance|Patient refusal|2|||
156941740|NCT02143414|566542653|FG001|Maintenance|Patient refusal|1|||
156941741|NCT02143414|566542652|FG000|Maintenance|Physician Decision|1|||
156941742|NCT02143414|566542653|FG001|Maintenance|Physician Decision|0|||
156941743|NCT02143414|566542652|FG000|Maintenance|Death|0|||
156941744|NCT02143414|566542653|FG001|Maintenance|Death|1|||
156941745|NCT02143414|566542652|FG000|Maintenance|On protocol treatment|0|||
156941746|NCT02143414|566542653|FG001|Maintenance|On protocol treatment|6|||
156941747|NCT00978731|566542657|FG000|Overall Study|Death|4|||
156941748|NCT00978731|566542658|FG001|Overall Study|Death|1|||
156941749|NCT00978731|566542659|FG002|Overall Study|Death|1|||
156941750|NCT00978731|566542660|FG003|Overall Study|Death|0|||
156941751|NCT00978731|566542657|FG000|Overall Study|Lost to Follow-up|0|||
156941752|NCT00978731|566542658|FG001|Overall Study|Lost to Follow-up|0|||
156941753|NCT00978731|566542659|FG002|Overall Study|Lost to Follow-up|0|||
156941754|NCT00978731|566542660|FG003|Overall Study|Lost to Follow-up|1|||
156941755|NCT00978731|566542657|FG000|Overall Study|Adverse Event|5|||
156941756|NCT00978731|566542658|FG001|Overall Study|Adverse Event|2|||
156941757|NCT00978731|566542659|FG002|Overall Study|Adverse Event|0|||
156941758|NCT00978731|566542660|FG003|Overall Study|Adverse Event|0|||
156941759|NCT00978731|566542657|FG000|Overall Study|Participant's request|1|||
156941760|NCT00978731|566542658|FG001|Overall Study|Participant's request|0|||
156941761|NCT00978731|566542659|FG002|Overall Study|Participant's request|0|||
156941762|NCT00978731|566542660|FG003|Overall Study|Participant's request|0|||
156941763|NCT00978731|566542657|FG000|Overall Study|Administrative reason|3|||
156941764|NCT00978731|566542658|FG001|Overall Study|Administrative reason|3|||
156941765|NCT00978731|566542659|FG002|Overall Study|Administrative reason|1|||
156941766|NCT00978731|566542660|FG003|Overall Study|Administrative reason|0|||
156941767|NCT00978731|566542657|FG000|Overall Study|Deterioration without progression|0|||
156941768|NCT00978731|566542658|FG001|Overall Study|Deterioration without progression|1|||
156941769|NCT00978731|566542659|FG002|Overall Study|Deterioration without progression|0|||
156941770|NCT00978731|566542660|FG003|Overall Study|Deterioration without progression|0|||
156941771|NCT00978731|566542657|FG000|Overall Study|Disease progression/relapse|5|||
156941772|NCT00978731|566542658|FG001|Overall Study|Disease progression/relapse|4|||
156941773|NCT00978731|566542659|FG002|Overall Study|Disease progression/relapse|2|||
156941774|NCT00978731|566542660|FG003|Overall Study|Disease progression/relapse|2|||
156941775|NCT00978731|566542657|FG000|Overall Study|Study closure|3|||
156941776|NCT00978731|566542658|FG001|Overall Study|Study closure|4|||
156941777|NCT00978731|566542659|FG002|Overall Study|Study closure|1|||
156941778|NCT00978731|566542660|FG003|Overall Study|Study closure|1|||
156941779|NCT00978731|566542657|FG000|Overall Study|No response|1|||
156941780|NCT00978731|566542658|FG001|Overall Study|No response|0|||
156941781|NCT00978731|566542659|FG002|Overall Study|No response|0|||
157167394|NCT00436982|567354534|FG001|Overall Study|Did not receive allocated intervention|1|||
157167395|NCT00436982|567354533|FG000|Overall Study|no RSA data|1|||
157167396|NCT00436982|567354534|FG001|Overall Study|no RSA data|2|||
156941782|NCT00978731|566542660|FG003|Overall Study|No response|0|||
156941783|NCT02649972|566542666|FG000|Overall Study|Not treated|1|||
156941784|NCT03107988|566542670|FG000|Overall Study|Adverse Event|0|||
156941785|NCT03107988|566542671|FG001|Overall Study|Adverse Event|0|||
156941786|NCT03107988|566542672|FG002|Overall Study|Adverse Event|0|||
156941787|NCT03107988|566542673|FG003|Overall Study|Adverse Event|1|||
156941788|NCT03107988|566542674|FG004|Overall Study|Adverse Event|0|||
156941789|NCT03107988|566542675|FG005|Overall Study|Adverse Event|1|||
156941790|NCT03107988|566542676|FG006|Overall Study|Adverse Event|0|||
156941791|NCT03107988|566542677|FG007|Overall Study|Adverse Event|1|||
156941792|NCT03107988|566542678|FG008|Overall Study|Adverse Event|0|||
156941793|NCT03107988|566542679|FG009|Overall Study|Adverse Event|0|||
156941794|NCT03107988|566542680|FG010|Overall Study|Adverse Event|0|||
156941795|NCT03107988|566542681|FG011|Overall Study|Adverse Event|0|||
156941796|NCT03107988|566542682|FG012|Overall Study|Adverse Event|0|||
157167397|NCT00953225|567354538|FG000|Overall Study|Withdrawal by Subject|2|||
156941797|NCT03107988|566542670|FG000|Overall Study|Disease Progression or Relapse|1|||
156941798|NCT03107988|566542671|FG001|Overall Study|Disease Progression or Relapse|2|||
156941799|NCT03107988|566542672|FG002|Overall Study|Disease Progression or Relapse|2|||
156941800|NCT03107988|566542673|FG003|Overall Study|Disease Progression or Relapse|5|||
156941801|NCT03107988|566542674|FG004|Overall Study|Disease Progression or Relapse|1|||
156941802|NCT03107988|566542675|FG005|Overall Study|Disease Progression or Relapse|1|||
156941803|NCT03107988|566542676|FG006|Overall Study|Disease Progression or Relapse|0|||
156941804|NCT03107988|566542677|FG007|Overall Study|Disease Progression or Relapse|0|||
156941805|NCT03107988|566542678|FG008|Overall Study|Disease Progression or Relapse|0|||
156941806|NCT03107988|566542679|FG009|Overall Study|Disease Progression or Relapse|1|||
156941807|NCT03107988|566542680|FG010|Overall Study|Disease Progression or Relapse|4|||
156941808|NCT03107988|566542681|FG011|Overall Study|Disease Progression or Relapse|0|||
156941809|NCT03107988|566542682|FG012|Overall Study|Disease Progression or Relapse|0|||
156941810|NCT03107988|566542670|FG000|Overall Study|Ineligible|0|||
156941811|NCT03107988|566542671|FG001|Overall Study|Ineligible|0|||
156941812|NCT03107988|566542672|FG002|Overall Study|Ineligible|0|||
156941813|NCT03107988|566542673|FG003|Overall Study|Ineligible|0|||
156941814|NCT03107988|566542674|FG004|Overall Study|Ineligible|0|||
156941815|NCT03107988|566542675|FG005|Overall Study|Ineligible|0|||
156941816|NCT03107988|566542676|FG006|Overall Study|Ineligible|0|||
156941817|NCT03107988|566542677|FG007|Overall Study|Ineligible|0|||
156941818|NCT03107988|566542678|FG008|Overall Study|Ineligible|1|||
156941819|NCT03107988|566542679|FG009|Overall Study|Ineligible|0|||
156941820|NCT03107988|566542680|FG010|Overall Study|Ineligible|0|||
156941821|NCT03107988|566542681|FG011|Overall Study|Ineligible|0|||
156941822|NCT03107988|566542682|FG012|Overall Study|Ineligible|0|||
156941823|NCT00120042|566542683|FG000|Overall Study|all completed protocl|0|||
156941824|NCT00120042|566542684|FG001|Overall Study|all completed protocl|0|||
156941825|NCT00120042|566542685|FG002|Overall Study|all completed protocl|0|||
156941826|NCT04532112|566542688|FG000|Overall Study|Adverse Event|3|||
156941827|NCT04532112|566542689|FG001|Overall Study|Adverse Event|0|||
156941828|NCT00529386|566542690|FG000|Overall Study|Lost to Follow-up|1|||
156941829|NCT03592641|566542691|FG000|Overall Study|Withdrawal by Subject|1|||
156941830|NCT01126541|566542693|FG000|Overall Study|Adverse Event|0|||
156941831|NCT01126541|566542694|FG001|Overall Study|Adverse Event|2|||
156941832|NCT01126541|566542695|FG002|Overall Study|Adverse Event|4|||
156941833|NCT01126541|566542693|FG000|Overall Study|Death|0|||
156941834|NCT01126541|566542694|FG001|Overall Study|Death|1|||
156941835|NCT01126541|566542695|FG002|Overall Study|Death|0|||
156941836|NCT01126541|566542693|FG000|Overall Study|Lack of Efficacy|6|||
156941837|NCT01126541|566542694|FG001|Overall Study|Lack of Efficacy|1|||
156941838|NCT01126541|566542695|FG002|Overall Study|Lack of Efficacy|11|||
156941839|NCT01126541|566542693|FG000|Overall Study|Lost to Follow-up|1|||
156941840|NCT01126541|566542694|FG001|Overall Study|Lost to Follow-up|2|||
156941841|NCT01126541|566542695|FG002|Overall Study|Lost to Follow-up|2|||
156941842|NCT01126541|566542693|FG000|Overall Study|Withdrawal by Subject|2|||
156941843|NCT01126541|566542694|FG001|Overall Study|Withdrawal by Subject|5|||
156941844|NCT01126541|566542695|FG002|Overall Study|Withdrawal by Subject|6|||
156941845|NCT01126541|566542693|FG000|Overall Study|Protocol Violation|0|||
156941846|NCT01126541|566542694|FG001|Overall Study|Protocol Violation|0|||
156941847|NCT01126541|566542695|FG002|Overall Study|Protocol Violation|1|||
156941848|NCT01126541|566542693|FG000|Overall Study|Administrative reason or other|1|||
157032280|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
156941849|NCT01126541|566542694|FG001|Overall Study|Administrative reason or other|1|||
156941850|NCT01126541|566542695|FG002|Overall Study|Administrative reason or other|2|||
156941851|NCT04027686|566542696|FG000|Overall Study|Lost to Follow-up|2|||
156941852|NCT04027686|566542697|FG001|Overall Study|Lost to Follow-up|0|||
156941853|NCT04027686|566542696|FG000|Overall Study|Withdrawal by Subject|0|||
156941854|NCT04027686|566542697|FG001|Overall Study|Withdrawal by Subject|1|||
156941855|NCT02939404|566542698|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
156941856|NCT02939404|566542699|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
156941857|NCT02939404|566542698|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
156941858|NCT02939404|566542699|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
156941859|NCT04182100|566542700|FG000|Overall Study|Adverse Event|1|||
156941860|NCT04182100|566542700|FG000|Overall Study|Withdrawal by Subject|1|||
156941861|NCT00813124|566542708|FG000|Overall Study|Death|2|||
156941862|NCT00813124|566542708|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
156941863|NCT00813124|566542708|FG000|Overall Study|Withdrawal by Subject|1|||
156941864|NCT01147653|566542715|FG000|Year 2|Withdrawal by Subject|2|||
156941865|NCT01147653|566542716|FG001|Year 2|Withdrawal by Subject|3|||
156941866|NCT01302392|566542717|FG000|Overall Study|Lost to Follow-up|1|||
156941867|NCT01302392|566542718|FG001|Overall Study|Lost to Follow-up|0|||
156941868|NCT01302392|566542717|FG000|Overall Study|Withdrawal by Subject|6|||
156941869|NCT01302392|566542718|FG001|Overall Study|Withdrawal by Subject|1|||
156941870|NCT00670228|566542719|FG000|Overall Study|Adverse Event|1|||
156941871|NCT00670228|566542720|FG001|Overall Study|Adverse Event|0|||
157032281|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
157167398|NCT00953225|567354539|FG001|Overall Study|Withdrawal by Subject|0|||
157167399|NCT04058158|567354540|FG000|Period 1|Death|1|||
156941872|NCT00670228|566542719|FG000|Overall Study|Death or MACE|0|||
156941873|NCT00670228|566542720|FG001|Overall Study|Death or MACE|1|||
156941874|NCT00670228|566542719|FG000|Overall Study|Not treated|2|||
156941875|NCT00670228|566542720|FG001|Overall Study|Not treated|2|||
156941876|NCT00670228|566542719|FG000|Overall Study|Not meeting the selection criteria|2|||
156941877|NCT00670228|566542720|FG001|Overall Study|Not meeting the selection criteria|0|||
156941878|NCT03604692|566542724|FG000|Overall Study|Investigator's Decision|0|||
156941879|NCT03604692|566542725|FG001|Overall Study|Investigator's Decision|0|||
156941880|NCT03604692|566542726|FG002|Overall Study|Investigator's Decision|0|||
156941881|NCT03604692|566542727|FG003|Overall Study|Investigator's Decision|1|||
156941882|NCT03604692|566542728|FG004|Overall Study|Investigator's Decision|0|||
156941883|NCT03604692|566542729|FG005|Overall Study|Investigator's Decision|7|||
156941884|NCT03604692|566542724|FG000|Overall Study|Withdrawal by Subject|0|||
156941885|NCT03604692|566542725|FG001|Overall Study|Withdrawal by Subject|0|||
156941886|NCT03604692|566542726|FG002|Overall Study|Withdrawal by Subject|0|||
156941887|NCT03604692|566542727|FG003|Overall Study|Withdrawal by Subject|0|||
156941888|NCT03604692|566542728|FG004|Overall Study|Withdrawal by Subject|0|||
156941889|NCT03604692|566542729|FG005|Overall Study|Withdrawal by Subject|2|||
156941890|NCT03604692|566542724|FG000|Overall Study|Progressive Disease|1|||
156941891|NCT03604692|566542725|FG001|Overall Study|Progressive Disease|0|||
156941892|NCT03604692|566542726|FG002|Overall Study|Progressive Disease|1|||
156941893|NCT03604692|566542727|FG003|Overall Study|Progressive Disease|0|||
156941894|NCT03604692|566542728|FG004|Overall Study|Progressive Disease|3|||
156941895|NCT03604692|566542729|FG005|Overall Study|Progressive Disease|4|||
156941896|NCT03604692|566542724|FG000|Overall Study|Difficulty Coming into Site|0|||
156941897|NCT03604692|566542725|FG001|Overall Study|Difficulty Coming into Site|0|||
156941898|NCT03604692|566542726|FG002|Overall Study|Difficulty Coming into Site|0|||
156941899|NCT03604692|566542727|FG003|Overall Study|Difficulty Coming into Site|0|||
156941900|NCT03604692|566542728|FG004|Overall Study|Difficulty Coming into Site|0|||
156941901|NCT03604692|566542729|FG005|Overall Study|Difficulty Coming into Site|1|||
156941902|NCT03604692|566542724|FG000|Overall Study|Death|0|||
156941903|NCT03604692|566542725|FG001|Overall Study|Death|0|||
156941904|NCT03604692|566542726|FG002|Overall Study|Death|1|||
156941905|NCT03604692|566542727|FG003|Overall Study|Death|0|||
156941906|NCT03604692|566542728|FG004|Overall Study|Death|0|||
156941907|NCT03604692|566542729|FG005|Overall Study|Death|0|||
156941908|NCT03604692|566542724|FG000|Overall Study|Drug Intolerance|0|||
156941909|NCT03604692|566542725|FG001|Overall Study|Drug Intolerance|0|||
156941910|NCT03604692|566542726|FG002|Overall Study|Drug Intolerance|0|||
156941911|NCT03604692|566542727|FG003|Overall Study|Drug Intolerance|1|||
156941912|NCT03604692|566542728|FG004|Overall Study|Drug Intolerance|0|||
156941913|NCT03604692|566542729|FG005|Overall Study|Drug Intolerance|0|||
156941914|NCT03604692|566542724|FG000|Overall Study|Noncompliance with follow-up visit|0|||
156941915|NCT03604692|566542725|FG001|Overall Study|Noncompliance with follow-up visit|0|||
156941916|NCT03604692|566542726|FG002|Overall Study|Noncompliance with follow-up visit|0|||
156941917|NCT03604692|566542727|FG003|Overall Study|Noncompliance with follow-up visit|1|||
156941918|NCT03604692|566542728|FG004|Overall Study|Noncompliance with follow-up visit|0|||
156941919|NCT03604692|566542729|FG005|Overall Study|Noncompliance with follow-up visit|0|||
156941920|NCT03604692|566542724|FG000|Overall Study|Not Treated|0|||
156941921|NCT03604692|566542725|FG001|Overall Study|Not Treated|0|||
156941922|NCT03604692|566542726|FG002|Overall Study|Not Treated|0|||
156941923|NCT03604692|566542727|FG003|Overall Study|Not Treated|0|||
156941924|NCT03604692|566542728|FG004|Overall Study|Not Treated|1|||
157167400|NCT04058158|567354541|FG001|Period 1|Death|0|||
157167401|NCT04058158|567354540|FG000|Period 1|Adverse Event|1|||
157167402|NCT04058158|567354541|FG001|Period 1|Adverse Event|1|||
157167403|NCT04058158|567354540|FG000|Period 1|Pregnancy|0|||
157167404|NCT04058158|567354541|FG001|Period 1|Pregnancy|1|||
157167405|NCT01634113|567354542|FG000|Overall Study|Not treated|0|||
156941925|NCT03604692|566542729|FG005|Overall Study|Not Treated|0|||
156941926|NCT01193556|566542734|FG000|Overall Study|Study termination|26|||
156941927|NCT01193556|566542735|FG001|Overall Study|Study termination|25|||
156941928|NCT01020019|566542736|FG000|Overall Study|Lost to Follow-up|21|||
156941929|NCT01020019|566542737|FG001|Overall Study|Lost to Follow-up|18|||
156941930|NCT01020019|566542736|FG000|Overall Study|Adverse Event|1|||
156941931|NCT01020019|566542737|FG001|Overall Study|Adverse Event|5|||
156941932|NCT01020019|566542736|FG000|Overall Study|not interested in treatment|4|||
156941933|NCT01020019|566542737|FG001|Overall Study|not interested in treatment|4|||
156941934|NCT01020019|566542736|FG000|Overall Study|moving|0|||
156941935|NCT01020019|566542737|FG001|Overall Study|moving|2|||
156941936|NCT05091528|566542738|FG000|Overall Study|Study Termination by Sponsor|0|||
156941937|NCT05091528|566542739|FG001|Overall Study|Study Termination by Sponsor|1|||
156941938|NCT05091528|566542740|FG002|Overall Study|Study Termination by Sponsor|0|||
156941939|NCT05091528|566542741|FG003|Overall Study|Study Termination by Sponsor|1|||
157167406|NCT01634113|567354543|FG001|Overall Study|Not treated|0|||
156941940|NCT02375672|566542742|FG000|Overall Study|remain on follow up|20|||
157167407|NCT01634113|567354544|FG002|Overall Study|Not treated|1|||
157167408|NCT00520299|567354547|FG000|Overall Study|Withdrawal by Subject|0|||
156941941|NCT02203591|566542743|FG000|Overall Study|Did not meet treatment day baseline|147|||
156941942|NCT02203591|566542744|FG001|Overall Study|Did not meet treatment day baseline|141|||
156941943|NCT02203591|566542745|FG002|Overall Study|Did not meet treatment day baseline|150|||
156941944|NCT02203591|566542746|FG003|Overall Study|Did not meet treatment day baseline|45|||
156941945|NCT02203591|566542747|FG004|Overall Study|Did not meet treatment day baseline|33|||
156941946|NCT02203591|566542748|FG005|Overall Study|Did not meet treatment day baseline|35|||
156941947|NCT02203591|566542749|FG006|Overall Study|Did not meet treatment day baseline|29|||
156941948|NCT02203591|566542750|FG007|Overall Study|Did not meet treatment day baseline|12|||
156941949|NCT02203591|566542743|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
156941950|NCT02203591|566542744|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
156941951|NCT02203591|566542745|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
156941952|NCT02203591|566542746|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
156941953|NCT02203591|566542747|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
156941954|NCT02203591|566542748|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
156941955|NCT02203591|566542749|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
156941956|NCT02203591|566542750|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
156941957|NCT03306264|566542751|FG000|Overall Study|Death|33|||
156941958|NCT03306264|566542752|FG001|Overall Study|Death|25|||
156941959|NCT03306264|566542753|FG002|Overall Study|Death|34|||
156941960|NCT03306264|566542754|FG003|Overall Study|Death|34|||
156941961|NCT03306264|566542751|FG000|Overall Study|Complete Consent Withdrawal|4|||
156941962|NCT03306264|566542752|FG001|Overall Study|Complete Consent Withdrawal|4|||
156941963|NCT03306264|566542753|FG002|Overall Study|Complete Consent Withdrawal|1|||
156941964|NCT03306264|566542754|FG003|Overall Study|Complete Consent Withdrawal|8|||
156941965|NCT03306264|566542751|FG000|Overall Study|Lost to Follow-up|1|||
156941966|NCT03306264|566542752|FG001|Overall Study|Lost to Follow-up|0|||
156941967|NCT03306264|566542753|FG002|Overall Study|Lost to Follow-up|1|||
156941968|NCT03306264|566542754|FG003|Overall Study|Lost to Follow-up|0|||
156941969|NCT03306264|566542751|FG000|Overall Study|Rollover to ASTX727-06|10|||
156941970|NCT03306264|566542752|FG001|Overall Study|Rollover to ASTX727-06|18|||
156941971|NCT03306264|566542753|FG002|Overall Study|Rollover to ASTX727-06|4|||
156941972|NCT03306264|566542754|FG003|Overall Study|Rollover to ASTX727-06|2|||
156941973|NCT03306264|566542751|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
156941974|NCT03306264|566542752|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
156941975|NCT03306264|566542753|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
156941976|NCT03306264|566542754|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
156941977|NCT02114879|566542758|FG000|Overall Study|Withdrawal by Subject|9|||
156941978|NCT02114879|566542759|FG001|Overall Study|Withdrawal by Subject|5|||
156941979|NCT02114879|566542758|FG000|Overall Study|Death|6|||
157032282|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
157032283|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
157032284|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
157032285|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
157032286|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
157032287|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
157032288|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
157032289|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
157032290|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
157032291|NCT04614948|566873255|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
157032292|NCT04614948|566873256|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
157032293|NCT04614948|566873257|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
157032294|NCT04271046|566873258|FG000|Overall Study|Death|0|||
157032295|NCT04271046|566873259|FG001|Overall Study|Death|2|||
157032296|NCT04271046|566873260|FG002|Overall Study|Death|0|||
157032297|NCT04271046|566873261|FG003|Overall Study|Death|2|||
157032298|NCT04271046|566873258|FG000|Overall Study|Lost to Follow-up|12|||
157032299|NCT04271046|566873259|FG001|Overall Study|Lost to Follow-up|12|||
157032300|NCT04271046|566873260|FG002|Overall Study|Lost to Follow-up|11|||
156941980|NCT02114879|566542759|FG001|Overall Study|Death|11|||
156941981|NCT02114879|566542758|FG000|Overall Study|Lost to Follow-up|4|||
156941982|NCT02114879|566542759|FG001|Overall Study|Lost to Follow-up|6|||
156941983|NCT02114879|566542758|FG000|Overall Study|Physician Decision|0|||
156941984|NCT02114879|566542759|FG001|Overall Study|Physician Decision|2|||
157032301|NCT04271046|566873261|FG003|Overall Study|Lost to Follow-up|11|||
157032302|NCT04271046|566873258|FG000|Overall Study|Patient with Dementia Died|2|||
157032303|NCT04271046|566873259|FG001|Overall Study|Patient with Dementia Died|0|||
157032304|NCT04271046|566873260|FG002|Overall Study|Patient with Dementia Died|2|||
157032305|NCT04271046|566873261|FG003|Overall Study|Patient with Dementia Died|0|||
157032306|NCT04271046|566873258|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
157032307|NCT04271046|566873259|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
156941985|NCT02152995|566542761|FG000|Overall Study|Withdrawal by Subject|1|||
157032308|NCT04271046|566873260|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
156941986|NCT02152995|566542762|FG001|Overall Study|Withdrawal by Subject|0|||
156941987|NCT01541826|566542763|FG000|Overall Study|Lost to Follow-up|2|||
156941988|NCT01541826|566542764|FG001|Overall Study|Lost to Follow-up|3|||
156941989|NCT01541826|566542765|FG002|Overall Study|Lost to Follow-up|0|||
156941990|NCT01541826|566542763|FG000|Overall Study|Withdrawal by Subject|2|||
156941991|NCT01541826|566542764|FG001|Overall Study|Withdrawal by Subject|0|||
156941992|NCT01541826|566542765|FG002|Overall Study|Withdrawal by Subject|0|||
156941993|NCT01365273|566542768|FG000|Overall Study|Lost to Follow-up|1|||
156941994|NCT01365273|566542769|FG001|Overall Study|Lost to Follow-up|0|||
156941995|NCT01365273|566542768|FG000|Overall Study|Protocol Violation|0|||
156941996|NCT01365273|566542769|FG001|Overall Study|Protocol Violation|1|||
156941997|NCT01365273|566542768|FG000|Overall Study|Physician Decision|1|||
156941998|NCT01365273|566542769|FG001|Overall Study|Physician Decision|0|||
156941999|NCT02519712|566542774|FG000|Overall Study|Disease Relapse|1|||
156942000|NCT02519712|566542774|FG000|Overall Study|Disease Progression|1|||
156942001|NCT02519712|566542774|FG000|Overall Study|Accruals are donors|2|||
156942002|NCT02705820|566542775|FG000|Overall Study|Death|2|||
156942003|NCT02705820|566542775|FG000|Overall Study|Disease Progression|34|||
156942004|NCT02705820|566542775|FG000|Overall Study|Clinical Deterioration|3|||
156942005|NCT02702401|566542776|FG000|Overall Study|Death|242|||
156942006|NCT02702401|566542777|FG001|Overall Study|Death|125|||
156942007|NCT02702401|566542776|FG000|Overall Study|Withdrawal by Subject|15|||
156942008|NCT02702401|566542777|FG001|Overall Study|Withdrawal by Subject|5|||
156942009|NCT02702401|566542776|FG000|Overall Study|Sponsor Decision|19|||
156942010|NCT02702401|566542777|FG001|Overall Study|Sponsor Decision|3|||
156942011|NCT02702401|566542776|FG000|Overall Study|Physician Decision|1|||
156942012|NCT02702401|566542777|FG001|Overall Study|Physician Decision|2|||
156942013|NCT02702401|566542776|FG000|Overall Study|Lost to Follow-up|1|||
156942014|NCT02702401|566542777|FG001|Overall Study|Lost to Follow-up|0|||
156942015|NCT03400033|566542778|FG000|Overall Study|Withdrawal by Subject|1|||
156942016|NCT03400033|566542779|FG001|Overall Study|Withdrawal by Subject|2|||
156942017|NCT02782949|566542780|FG000|Overall Study|Protocol Violation|1|||
156942018|NCT02782949|566542781|FG001|Overall Study|Protocol Violation|0|||
156942019|NCT02782949|566542780|FG000|Overall Study|Withdrawal by Subject|0|||
156942020|NCT02782949|566542781|FG001|Overall Study|Withdrawal by Subject|1|||
156942021|NCT03195478|566542782|FG000|Overall Study|Disease Progression|5|||
156942022|NCT03195478|566542783|FG001|Overall Study|Disease Progression|4|||
156942023|NCT03195478|566542784|FG002|Overall Study|Disease Progression|6|||
156942024|NCT03195478|566542785|FG003|Overall Study|Disease Progression|1|||
156942025|NCT03195478|566542782|FG000|Overall Study|Study Drug Toxicity|2|||
156942026|NCT03195478|566542783|FG001|Overall Study|Study Drug Toxicity|0|||
156942027|NCT03195478|566542784|FG002|Overall Study|Study Drug Toxicity|0|||
156942028|NCT03195478|566542785|FG003|Overall Study|Study Drug Toxicity|1|||
156942029|NCT03195478|566542782|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
156942030|NCT03195478|566542783|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
156942031|NCT03195478|566542784|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
156942032|NCT03195478|566542785|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
156942033|NCT03195478|566542782|FG000|Overall Study|Participant Withdrew Consent|1|||
156942034|NCT03195478|566542783|FG001|Overall Study|Participant Withdrew Consent|0|||
156942035|NCT03195478|566542784|FG002|Overall Study|Participant Withdrew Consent|0|||
156942036|NCT03195478|566542785|FG003|Overall Study|Participant Withdrew Consent|0|||
156942037|NCT03195478|566542782|FG000|Overall Study|Maximum Clinical benefit|0|||
156942038|NCT03195478|566542783|FG001|Overall Study|Maximum Clinical benefit|0|||
156942039|NCT03195478|566542784|FG002|Overall Study|Maximum Clinical benefit|1|||
156942040|NCT03195478|566542785|FG003|Overall Study|Maximum Clinical benefit|0|||
156942041|NCT03195478|566542782|FG000|Overall Study|Other Reasons|0|||
156942042|NCT03195478|566542783|FG001|Overall Study|Other Reasons|0|||
156942043|NCT03195478|566542784|FG002|Overall Study|Other Reasons|1|||
156942044|NCT03195478|566542785|FG003|Overall Study|Other Reasons|0|||
156942045|NCT02097134|566544396|FG000|Overall Study|Physician Decision|4|||
156942046|NCT02097134|566544396|FG000|Overall Study|Non-Protocol Therapy|1|||
156942047|NCT02097134|566544396|FG000|Overall Study|Progressive Disease|3|||
156942048|NCT02097134|566544396|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
156942049|NCT02660359|566544398|FG000|Overall Study|Protocol Deviation|0|||
156942050|NCT02660359|566544399|FG001|Overall Study|Protocol Deviation|0|||
156942051|NCT02660359|566544400|FG002|Overall Study|Protocol Deviation|1|||
156942052|NCT02660359|566544398|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
156942053|NCT02660359|566544399|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
156942054|NCT02660359|566544400|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
156942055|NCT02660359|566544398|FG000|Overall Study|Lack of Efficacy|1|||
156942056|NCT02660359|566544399|FG001|Overall Study|Lack of Efficacy|1|||
156942057|NCT02660359|566544400|FG002|Overall Study|Lack of Efficacy|1|||
156942058|NCT02660359|566544398|FG000|Overall Study|Adverse Event|0|||
156942059|NCT02660359|566544399|FG001|Overall Study|Adverse Event|1|||
156942060|NCT02660359|566544400|FG002|Overall Study|Adverse Event|0|||
156942061|NCT02660359|566544398|FG000|Overall Study|Other|2|||
156942062|NCT02660359|566544399|FG001|Overall Study|Other|1|||
156942063|NCT02660359|566544400|FG002|Overall Study|Other|3|||
157032309|NCT04271046|566873261|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
157032310|NCT03663205|566873262|FG000|Overall Study|Death|144|||
157032311|NCT03663205|566873263|FG001|Overall Study|Death|69|||
157032312|NCT03663205|566873262|FG000|Overall Study|Sponsor decision|53|||
157032313|NCT03663205|566873263|FG001|Overall Study|Sponsor decision|19|||
157032314|NCT03663205|566873262|FG000|Overall Study|Withdrawal by Subject|8|||
157032315|NCT03663205|566873263|FG001|Overall Study|Withdrawal by Subject|11|||
157032316|NCT03663205|566873262|FG000|Overall Study|Lost to Follow-up|7|||
157032317|NCT03663205|566873263|FG001|Overall Study|Lost to Follow-up|9|||
157032318|NCT03663205|566873262|FG000|Overall Study|Transferred to long term extension study|11|||
157032319|NCT03663205|566873263|FG001|Overall Study|Transferred to long term extension study|3|||
157032320|NCT05962814|566873264|FG000|Overall Study|failed eligibility|1|||
157032321|NCT03057054|566873267|FG000|Overall Study|Death|4|||
157032322|NCT03057054|566873268|FG001|Overall Study|Death|4|||
157032323|NCT03057054|566873267|FG000|Overall Study|Withdrawal by Subject|6|||
157032324|NCT03057054|566873268|FG001|Overall Study|Withdrawal by Subject|3|||
157032325|NCT03057054|566873267|FG000|Overall Study|Ineligible|1|||
157032326|NCT03057054|566873268|FG001|Overall Study|Ineligible|1|||
157032327|NCT05507333|566874556|FG000|Overall Study|Protocol Violation|1|||
157032328|NCT03972150|566874559|FG000|Overall Study|Adverse Event|0|||
157032329|NCT03972150|566874560|FG001|Overall Study|Adverse Event|1|||
157032330|NCT03972150|566874561|FG002|Overall Study|Adverse Event|1|||
157032331|NCT03972150|566874562|FG003|Overall Study|Adverse Event|0|||
157032332|NCT03972150|566874563|FG004|Overall Study|Adverse Event|0|||
157032333|NCT03972150|566874559|FG000|Overall Study|Progressive disease|3|||
157032334|NCT03972150|566874560|FG001|Overall Study|Progressive disease|5|||
157032335|NCT03972150|566874561|FG002|Overall Study|Progressive disease|2|||
157032336|NCT03972150|566874562|FG003|Overall Study|Progressive disease|2|||
157032337|NCT03972150|566874563|FG004|Overall Study|Progressive disease|3|||
157032338|NCT05464069|566874566|FG000|Overall Study|Protocol Violation|3|||
157032339|NCT05464069|566874567|FG001|Overall Study|Protocol Violation|2|||
157032340|NCT03442309|566874568|FG000|Overall Study|Lost to Follow-up|1676|||
157032341|NCT03442309|566874569|FG001|Overall Study|Lost to Follow-up|1642|||
157032342|NCT02839265|566874590|FG000|Overall Study|Screen Failure|2|||
157032343|NCT02839265|566874590|FG000|Overall Study|Death|1|||
157032344|NCT02839265|566874590|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
157032345|NCT04451772|566874602|FG000|Overall Study|Adverse Event|1|||
157032346|NCT04451772|566874603|FG001|Overall Study|Adverse Event|0|||
157032347|NCT04451772|566874604|FG002|Overall Study|Adverse Event|1|||
157032348|NCT04451772|566874605|FG003|Overall Study|Adverse Event|1|||
157032349|NCT04451772|566874606|FG004|Overall Study|Adverse Event|0|||
157032350|NCT04451772|566874607|FG005|Overall Study|Adverse Event|3|||
157032351|NCT04451772|566874602|FG000|Overall Study|Withdrawal by Subject|2|||
157032352|NCT04451772|566874603|FG001|Overall Study|Withdrawal by Subject|7|||
157032353|NCT04451772|566874604|FG002|Overall Study|Withdrawal by Subject|2|||
157032354|NCT04451772|566874605|FG003|Overall Study|Withdrawal by Subject|1|||
157032355|NCT04451772|566874606|FG004|Overall Study|Withdrawal by Subject|1|||
157032356|NCT04451772|566874607|FG005|Overall Study|Withdrawal by Subject|0|||
157032357|NCT04451772|566874602|FG000|Overall Study|Other, not specified|1|||
157032358|NCT04451772|566874603|FG001|Overall Study|Other, not specified|2|||
157032359|NCT04451772|566874604|FG002|Overall Study|Other, not specified|1|||
157032360|NCT04451772|566874605|FG003|Overall Study|Other, not specified|0|||
157032361|NCT04451772|566874606|FG004|Overall Study|Other, not specified|0|||
157032362|NCT04451772|566874607|FG005|Overall Study|Other, not specified|1|||
157032363|NCT04451772|566874602|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
157032364|NCT04451772|566874603|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
157032365|NCT04451772|566874604|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
157032366|NCT04451772|566874605|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
157032367|NCT04451772|566874606|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
157032368|NCT04451772|566874607|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
157032369|NCT04605159|566874608|FG000|Overall Study|Adverse Event|6|||
157032370|NCT04605159|566874609|FG001|Overall Study|Adverse Event|3|||
157032371|NCT04605159|566874610|FG002|Overall Study|Adverse Event|21|||
157032372|NCT04605159|566874611|FG003|Overall Study|Adverse Event|4|||
157032373|NCT04605159|566874608|FG000|Overall Study|Lost to Follow-up|74|||
157227318|NCT00950807|567577788|FG007|Treatment Period 2|Lack of Efficacy|0|||
157032374|NCT04605159|566874609|FG001|Overall Study|Lost to Follow-up|45|||
157032375|NCT04605159|566874610|FG002|Overall Study|Lost to Follow-up|119|||
157032376|NCT04605159|566874611|FG003|Overall Study|Lost to Follow-up|80|||
157032377|NCT04605159|566874608|FG000|Overall Study|Protocol Violation|4|||
157032378|NCT04605159|566874609|FG001|Overall Study|Protocol Violation|5|||
157032379|NCT04605159|566874610|FG002|Overall Study|Protocol Violation|2|||
157032380|NCT04605159|566874611|FG003|Overall Study|Protocol Violation|0|||
157032381|NCT04605159|566874608|FG000|Overall Study|Withdrawal by Subject|66|||
157032382|NCT04605159|566874609|FG001|Overall Study|Withdrawal by Subject|37|||
157032383|NCT04605159|566874610|FG002|Overall Study|Withdrawal by Subject|68|||
156942064|NCT02660359|566544398|FG000|Overall Study|Withdrawal by Subject|7|||
156942065|NCT02660359|566544399|FG001|Overall Study|Withdrawal by Subject|5|||
156942066|NCT02660359|566544400|FG002|Overall Study|Withdrawal by Subject|8|||
156942067|NCT02660359|566544398|FG000|Overall Study|Lost to Follow-up|3|||
156942068|NCT02660359|566544399|FG001|Overall Study|Lost to Follow-up|3|||
156942069|NCT02660359|566544400|FG002|Overall Study|Lost to Follow-up|0|||
156942070|NCT04456699|566544408|FG000|Overall Study|Death|48|||
156942071|NCT04456699|566544409|FG001|Overall Study|Death|50|||
156942072|NCT04456699|566544410|FG002|Overall Study|Death|52|||
156942073|NCT04456699|566544408|FG000|Overall Study|Physician Decision|0|||
156942074|NCT04456699|566544409|FG001|Overall Study|Physician Decision|0|||
156942075|NCT04456699|566544410|FG002|Overall Study|Physician Decision|2|||
156942076|NCT04456699|566544408|FG000|Overall Study|Sponsor Decision|55|||
156942077|NCT04456699|566544409|FG001|Overall Study|Sponsor Decision|61|||
156942078|NCT04456699|566544410|FG002|Overall Study|Sponsor Decision|50|||
156942079|NCT04456699|566544408|FG000|Overall Study|Withdrawal by Subject|8|||
156942080|NCT04456699|566544409|FG001|Overall Study|Withdrawal by Subject|4|||
156942081|NCT04456699|566544410|FG002|Overall Study|Withdrawal by Subject|5|||
156942082|NCT02075437|566544418|FG000|Overall Study|Withdrawal by Subject|5|||
156942083|NCT02075437|566544418|FG000|Overall Study|Lost to Follow-up|1|||
156942084|NCT01632800|566544419|FG000|Overall Study|Subject did not fit in apparatus|1|||
156942085|NCT00094653|566544420|FG000|Overall Study|Death|306|||
156942086|NCT00094653|566544421|FG001|Overall Study|Death|100|||
156942087|NCT00094653|566544422|FG002|Overall Study|Death|119|||
156942088|NCT00094653|566544420|FG000|Overall Study|Subject Withdrew Consent|10|||
156942089|NCT00094653|566544421|FG001|Overall Study|Subject Withdrew Consent|2|||
156942090|NCT00094653|566544422|FG002|Overall Study|Subject Withdrew Consent|3|||
156942091|NCT00094653|566544420|FG000|Overall Study|Other|2|||
156942092|NCT00094653|566544421|FG001|Overall Study|Other|2|||
156942093|NCT00094653|566544422|FG002|Overall Study|Other|2|||
156942094|NCT00094653|566544420|FG000|Overall Study|Lost to Follow-up|3|||
156942095|NCT00094653|566544421|FG001|Overall Study|Lost to Follow-up|2|||
156942096|NCT00094653|566544422|FG002|Overall Study|Lost to Follow-up|1|||
156942097|NCT00094653|566544420|FG000|Overall Study|Protocol Violation|0|||
156942098|NCT00094653|566544421|FG001|Overall Study|Protocol Violation|0|||
156942099|NCT00094653|566544422|FG002|Overall Study|Protocol Violation|1|||
156942100|NCT03921411|566544423|FG000|Overall Study|Withdrawal by Subject|1|||
156942101|NCT03921411|566544423|FG000|Overall Study|Protocol Deviation|2|||
156942102|NCT03921411|566544423|FG000|Overall Study|Enrolled, but never treated|2|||
156942103|NCT00854581|566544434|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
156942104|NCT00854581|566544434|FG000|Induction (Up to Day 21)|Death|1|||
156942105|NCT00854581|566544434|FG000|Induction (Up to Day 21)|Physician Decision|1|||
156942106|NCT00854581|566544434|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
156942107|NCT03181542|566544437|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
156942108|NCT03181542|566544438|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
156942109|NCT04292730|566544440|FG000|Overall Study|Lost to Follow-up|8|||
156942110|NCT04292730|566544441|FG001|Overall Study|Lost to Follow-up|12|||
156942111|NCT04292730|566544442|FG002|Overall Study|Lost to Follow-up|12|||
156942112|NCT04292730|566544443|FG003|Overall Study|Lost to Follow-up|48|||
156942113|NCT04292730|566544440|FG000|Overall Study|Death|2|||
156942114|NCT04292730|566544441|FG001|Overall Study|Death|2|||
156942115|NCT04292730|566544442|FG002|Overall Study|Death|4|||
156942116|NCT04292730|566544443|FG003|Overall Study|Death|12|||
156942117|NCT04292730|566544440|FG000|Overall Study|Withdrew Consent|2|||
156942118|NCT04292730|566544441|FG001|Overall Study|Withdrew Consent|2|||
156942119|NCT04292730|566544442|FG002|Overall Study|Withdrew Consent|5|||
156942120|NCT04292730|566544443|FG003|Overall Study|Withdrew Consent|6|||
156942121|NCT04292730|566544440|FG000|Overall Study|Non-Compliance with Study Drug|0|||
156942122|NCT04292730|566544441|FG001|Overall Study|Non-Compliance with Study Drug|1|||
156942123|NCT04292730|566544442|FG002|Overall Study|Non-Compliance with Study Drug|0|||
156942124|NCT04292730|566544443|FG003|Overall Study|Non-Compliance with Study Drug|0|||
156942125|NCT04292730|566544440|FG000|Overall Study|Protocol Violation|0|||
157167409|NCT00520299|567354548|FG001|Overall Study|Withdrawal by Subject|0|||
157167410|NCT00520299|567354549|FG002|Overall Study|Withdrawal by Subject|2|||
156942126|NCT04292730|566544441|FG001|Overall Study|Protocol Violation|0|||
156942127|NCT04292730|566544442|FG002|Overall Study|Protocol Violation|1|||
156942128|NCT04292730|566544443|FG003|Overall Study|Protocol Violation|0|||
156942129|NCT04292730|566544440|FG000|Overall Study|Randomized but not Treated|8|||
157167411|NCT00520299|567354547|FG000|Overall Study|Progressive disease|0|||
157167412|NCT00520299|567354548|FG001|Overall Study|Progressive disease|3|||
156942130|NCT04292730|566544441|FG001|Overall Study|Randomized but not Treated|4|||
156942131|NCT04292730|566544442|FG002|Overall Study|Randomized but not Treated|0|||
156942132|NCT04292730|566544443|FG003|Overall Study|Randomized but not Treated|14|||
156942133|NCT01527292|566544444|FG000|Overall Study|Physician Decision|0|||
156942134|NCT01527292|566544445|FG001|Overall Study|Physician Decision|3|||
156942135|NCT00314366|566544446|FG000|Overall Study|not treated due to patient medical condi|1|||
156942136|NCT00314366|566544447|FG001|Overall Study|not treated due to patient medical condi|0|||
156942137|NCT00006916|566544450|FG000|Overall Study|Device not inserted|4|||
156942138|NCT00006916|566544450|FG000|Overall Study|Complication of device insertion|1|||
156942139|NCT00558103|566544451|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
156942140|NCT00558103|566544452|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
156942141|NCT00558103|566544453|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
156942142|NCT00558103|566544454|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
156942143|NCT00558103|566544455|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
156942144|NCT00558103|566544456|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
156942145|NCT00558103|566544451|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
156942146|NCT00558103|566544452|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
156942147|NCT00558103|566544453|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
156942148|NCT00558103|566544454|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
156942149|NCT00558103|566544455|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
156942150|NCT00558103|566544456|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
156942151|NCT00558103|566544451|FG000|Randomized Treatment Phase|Disease Progression|1|||
156942152|NCT00558103|566544452|FG001|Randomized Treatment Phase|Disease Progression|0|||
156942153|NCT00558103|566544453|FG002|Randomized Treatment Phase|Disease Progression|1|||
156942154|NCT00558103|566544454|FG003|Randomized Treatment Phase|Disease Progression|0|||
156942155|NCT00558103|566544455|FG004|Randomized Treatment Phase|Disease Progression|0|||
156942156|NCT00558103|566544456|FG005|Randomized Treatment Phase|Disease Progression|0|||
156942157|NCT00558103|566544451|FG000|Randomized Treatment Phase|Adverse Event|0|||
156942158|NCT00558103|566544452|FG001|Randomized Treatment Phase|Adverse Event|0|||
156942159|NCT00558103|566544453|FG002|Randomized Treatment Phase|Adverse Event|0|||
156942160|NCT00558103|566544454|FG003|Randomized Treatment Phase|Adverse Event|1|||
156942161|NCT00558103|566544455|FG004|Randomized Treatment Phase|Adverse Event|1|||
156942162|NCT00558103|566544456|FG005|Randomized Treatment Phase|Adverse Event|0|||
156942163|NCT00558103|566544451|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
156942164|NCT00558103|566544452|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
156942165|NCT00558103|566544453|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
156942166|NCT00558103|566544454|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
156942167|NCT00558103|566544455|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
156942168|NCT00558103|566544456|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
156942169|NCT00558103|566544451|FG000|Monotherapy Extension Phase|Disease Progression|0|||
156942170|NCT00558103|566544452|FG001|Monotherapy Extension Phase|Disease Progression|0|||
156942171|NCT00558103|566544453|FG002|Monotherapy Extension Phase|Disease Progression|0|||
156942172|NCT00558103|566544454|FG003|Monotherapy Extension Phase|Disease Progression|0|||
156942173|NCT00558103|566544455|FG004|Monotherapy Extension Phase|Disease Progression|0|||
156942174|NCT00558103|566544456|FG005|Monotherapy Extension Phase|Disease Progression|8|||
156942175|NCT02457325|566544457|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
156942176|NCT02457325|566544458|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
156942177|NCT01574703|566544459|FG000|Overall Study|Adverse Event|0|||
156942178|NCT01574703|566544460|FG001|Overall Study|Adverse Event|2|||
156942179|NCT01574703|566544461|FG002|Overall Study|Adverse Event|1|||
156942180|NCT01574703|566544462|FG003|Overall Study|Adverse Event|1|||
156942181|NCT01574703|566544459|FG000|Overall Study|Protocol Violation|0|||
156942182|NCT01574703|566544460|FG001|Overall Study|Protocol Violation|0|||
156942183|NCT01574703|566544461|FG002|Overall Study|Protocol Violation|0|||
156942184|NCT01574703|566544462|FG003|Overall Study|Protocol Violation|1|||
156942185|NCT01574703|566544459|FG000|Overall Study|Unspecified Reason|27|||
157032384|NCT04605159|566874611|FG003|Overall Study|Withdrawal by Subject|50|||
157032385|NCT04605159|566874608|FG000|Overall Study|Migrated / moved from the study area|32|||
157032386|NCT04605159|566874609|FG001|Overall Study|Migrated / moved from the study area|22|||
156942186|NCT01574703|566544460|FG001|Overall Study|Unspecified Reason|15|||
156942187|NCT01574703|566544461|FG002|Overall Study|Unspecified Reason|20|||
156942188|NCT01574703|566544462|FG003|Overall Study|Unspecified Reason|16|||
156942189|NCT01574703|566544459|FG000|Overall Study|Withdrawal by Subject|53|||
156942190|NCT01574703|566544460|FG001|Overall Study|Withdrawal by Subject|52|||
156942191|NCT01574703|566544461|FG002|Overall Study|Withdrawal by Subject|36|||
156942192|NCT01574703|566544462|FG003|Overall Study|Withdrawal by Subject|61|||
156942193|NCT01574703|566544459|FG000|Overall Study|Met Withdrawal Criteria|0|||
156942194|NCT01574703|566544460|FG001|Overall Study|Met Withdrawal Criteria|1|||
156942195|NCT01574703|566544461|FG002|Overall Study|Met Withdrawal Criteria|1|||
156942196|NCT01574703|566544462|FG003|Overall Study|Met Withdrawal Criteria|0|||
156942197|NCT01574703|566544459|FG000|Overall Study|Lost to Follow-up|43|||
156942198|NCT01574703|566544460|FG001|Overall Study|Lost to Follow-up|41|||
156942199|NCT01574703|566544461|FG002|Overall Study|Lost to Follow-up|46|||
156942200|NCT01574703|566544462|FG003|Overall Study|Lost to Follow-up|35|||
156942201|NCT01574703|566544459|FG000|Overall Study|Death|2|||
156942202|NCT01574703|566544460|FG001|Overall Study|Death|1|||
156942203|NCT01574703|566544461|FG002|Overall Study|Death|1|||
156942204|NCT01574703|566544462|FG003|Overall Study|Death|0|||
156942205|NCT01420081|566544466|FG000|Overall Study|Death|1|||
156942206|NCT01420081|566544467|FG001|Overall Study|Death|0|||
156942207|NCT01420081|566544468|FG002|Overall Study|Death|8|||
156942208|NCT01420081|566544469|FG003|Overall Study|Death|0|||
156942209|NCT01420081|566544470|FG004|Overall Study|Death|7|||
156942210|NCT01420081|566544471|FG005|Overall Study|Death|12|||
156942211|NCT01420081|566544472|FG006|Overall Study|Death|0|||
156942212|NCT01420081|566544473|FG007|Overall Study|Death|1|||
156942213|NCT01420081|566544474|FG008|Overall Study|Death|1|||
156942214|NCT01420081|566544466|FG000|Overall Study|Lost to Follow-up|0|||
156942215|NCT01420081|566544467|FG001|Overall Study|Lost to Follow-up|0|||
156942216|NCT01420081|566544468|FG002|Overall Study|Lost to Follow-up|0|||
156942217|NCT01420081|566544469|FG003|Overall Study|Lost to Follow-up|0|||
156942218|NCT01420081|566544470|FG004|Overall Study|Lost to Follow-up|1|||
156942219|NCT01420081|566544471|FG005|Overall Study|Lost to Follow-up|1|||
156942220|NCT01420081|566544472|FG006|Overall Study|Lost to Follow-up|0|||
156942221|NCT01420081|566544473|FG007|Overall Study|Lost to Follow-up|0|||
156942222|NCT01420081|566544474|FG008|Overall Study|Lost to Follow-up|0|||
156942223|NCT01420081|566544466|FG000|Overall Study|Study Terminated by Sponsor|2|||
156942224|NCT01420081|566544467|FG001|Overall Study|Study Terminated by Sponsor|1|||
156942225|NCT01420081|566544468|FG002|Overall Study|Study Terminated by Sponsor|1|||
156942226|NCT01420081|566544469|FG003|Overall Study|Study Terminated by Sponsor|3|||
156942227|NCT01420081|566544470|FG004|Overall Study|Study Terminated by Sponsor|11|||
156942228|NCT01420081|566544471|FG005|Overall Study|Study Terminated by Sponsor|7|||
156942229|NCT01420081|566544472|FG006|Overall Study|Study Terminated by Sponsor|3|||
156942230|NCT01420081|566544473|FG007|Overall Study|Study Terminated by Sponsor|2|||
156942231|NCT01420081|566544474|FG008|Overall Study|Study Terminated by Sponsor|2|||
156942232|NCT01420081|566544466|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
156942233|NCT01420081|566544467|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
156942234|NCT01420081|566544468|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
156942235|NCT01420081|566544469|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
156942236|NCT01420081|566544470|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
156942237|NCT01420081|566544471|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
156942238|NCT01420081|566544472|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
156942239|NCT01420081|566544473|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
156942240|NCT01420081|566544474|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
156942241|NCT01420081|566544466|FG000|Overall Study|Other Reasons|0|||
156942242|NCT01420081|566544467|FG001|Overall Study|Other Reasons|0|||
156942243|NCT01420081|566544468|FG002|Overall Study|Other Reasons|1|||
156942244|NCT01420081|566544469|FG003|Overall Study|Other Reasons|0|||
156942245|NCT01420081|566544470|FG004|Overall Study|Other Reasons|0|||
156942246|NCT01420081|566544471|FG005|Overall Study|Other Reasons|0|||
156942247|NCT01420081|566544472|FG006|Overall Study|Other Reasons|0|||
156942248|NCT01420081|566544473|FG007|Overall Study|Other Reasons|0|||
156942249|NCT01420081|566544474|FG008|Overall Study|Other Reasons|0|||
156942250|NCT02469610|566544475|FG000|Overall Study|Death|1|||
156942251|NCT02469610|566544476|FG001|Overall Study|Death|0|||
156942252|NCT02469610|566544475|FG000|Overall Study|Lost to Follow-up|1|||
156942253|NCT02469610|566544476|FG001|Overall Study|Lost to Follow-up|0|||
156942254|NCT02469610|566544475|FG000|Overall Study|exclusion criteria|2|||
156942255|NCT02469610|566544476|FG001|Overall Study|exclusion criteria|1|||
156942256|NCT00414388|566544479|FG000|Overall Study|Adverse Event|1|||
156942257|NCT03467425|566544480|FG000|Overall Study|Adverse Event|9|||
156942258|NCT03467425|566544481|FG001|Overall Study|Adverse Event|9|||
156942259|NCT03467425|566544480|FG000|Overall Study|Lack of Efficacy|3|||
156942260|NCT03467425|566544481|FG001|Overall Study|Lack of Efficacy|1|||
156942261|NCT03467425|566544480|FG000|Overall Study|Protocol Violation|0|||
156942262|NCT03467425|566544481|FG001|Overall Study|Protocol Violation|1|||
157032387|NCT04605159|566874610|FG002|Overall Study|Migrated / moved from the study area|41|||
157167413|NCT00520299|567354549|FG002|Overall Study|Progressive disease|4|||
157167414|NCT01352845|567354550|FG000|Overall Study|Lost to Follow-up|313|||
157167415|NCT01352845|567354551|FG001|Overall Study|Lost to Follow-up|92|||
156942263|NCT03467425|566544480|FG000|Overall Study|Lost to Follow-up|18|||
156942264|NCT03467425|566544481|FG001|Overall Study|Lost to Follow-up|25|||
156942265|NCT03467425|566544480|FG000|Overall Study|Physician Decision|2|||
156942266|NCT03467425|566544481|FG001|Overall Study|Physician Decision|1|||
156942267|NCT03467425|566544480|FG000|Overall Study|Withdrawal by Subject|15|||
156942268|NCT03467425|566544481|FG001|Overall Study|Withdrawal by Subject|17|||
156942269|NCT00025883|566544483|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
156942270|NCT00025883|566544483|FG000|Overall Study|no baseline data|1|||
156942271|NCT00025883|566544483|FG000|Overall Study|Death|1|||
156942272|NCT00025883|566544483|FG000|Overall Study|Adverse Event|1|||
156942273|NCT00025883|566544483|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
156942274|NCT00218543|566544484|FG000|Overall Study|Lost to Follow-up|8|||
156942275|NCT00218543|566544484|FG000|Overall Study|relocated|1|||
156942276|NCT00218543|566544484|FG000|Overall Study|Withdrawal by Subject|1|||
156942277|NCT00218543|566544484|FG000|Overall Study|Physician Decision|3|||
156942278|NCT00218543|566544484|FG000|Overall Study|Adverse Event|2|||
156942279|NCT00678561|566544485|FG000|Overall Study|Adverse Event|0|||
156942280|NCT00678561|566544486|FG001|Overall Study|Adverse Event|1|||
156942281|NCT00678561|566544487|FG002|Overall Study|Adverse Event|1|||
156942282|NCT00678561|566544488|FG003|Overall Study|Adverse Event|0|||
156942283|NCT00678561|566544489|FG004|Overall Study|Adverse Event|1|||
156942284|NCT00678561|566544490|FG005|Overall Study|Adverse Event|0|||
157032388|NCT04605159|566874611|FG003|Overall Study|Migrated / moved from the study area|21|||
157032389|NCT04605159|566874608|FG000|Overall Study|Other|1|||
157032390|NCT04605159|566874609|FG001|Overall Study|Other|2|||
157032391|NCT04605159|566874610|FG002|Overall Study|Other|7|||
157032392|NCT04605159|566874611|FG003|Overall Study|Other|3|||
157032393|NCT04934072|566874613|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
157032394|NCT04934072|566874614|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
157032395|NCT04934072|566874615|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
157032396|NCT04934072|566874616|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
157032397|NCT04934072|566874617|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
157032398|NCT04934072|566874613|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
157032399|NCT04934072|566874614|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
157032400|NCT04934072|566874615|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
156942285|NCT00678561|566544491|FG006|Overall Study|Adverse Event|0|||
156942286|NCT00678561|566544492|FG007|Overall Study|Adverse Event|0|||
156942287|NCT00678561|566544485|FG000|Overall Study|Protocol Violation|0|||
156942288|NCT00678561|566544486|FG001|Overall Study|Protocol Violation|0|||
156942289|NCT00678561|566544487|FG002|Overall Study|Protocol Violation|0|||
156942290|NCT00678561|566544488|FG003|Overall Study|Protocol Violation|0|||
156942291|NCT00678561|566544489|FG004|Overall Study|Protocol Violation|1|||
156942292|NCT00678561|566544490|FG005|Overall Study|Protocol Violation|1|||
156942293|NCT00678561|566544491|FG006|Overall Study|Protocol Violation|0|||
156942294|NCT00678561|566544492|FG007|Overall Study|Protocol Violation|0|||
156942295|NCT00678561|566544485|FG000|Overall Study|Withdrawal by Subject|0|||
156942296|NCT00678561|566544486|FG001|Overall Study|Withdrawal by Subject|0|||
156942297|NCT00678561|566544487|FG002|Overall Study|Withdrawal by Subject|0|||
156942298|NCT00678561|566544488|FG003|Overall Study|Withdrawal by Subject|0|||
156942299|NCT00678561|566544489|FG004|Overall Study|Withdrawal by Subject|0|||
156942300|NCT00678561|566544490|FG005|Overall Study|Withdrawal by Subject|0|||
156942301|NCT00678561|566544491|FG006|Overall Study|Withdrawal by Subject|0|||
156942302|NCT00678561|566544492|FG007|Overall Study|Withdrawal by Subject|1|||
156942303|NCT01451424|566544493|FG000|Overall Study|Withdrawal by Subject|1|||
156942304|NCT01451424|566544494|FG001|Overall Study|Withdrawal by Subject|1|||
156942305|NCT01451424|566544495|FG002|Overall Study|Withdrawal by Subject|0|||
156942306|NCT01451424|566544496|FG003|Overall Study|Withdrawal by Subject|2|||
156942307|NCT01451424|566544493|FG000|Overall Study|Lost to Follow-up|0|||
156942308|NCT01451424|566544494|FG001|Overall Study|Lost to Follow-up|1|||
156942309|NCT01451424|566544495|FG002|Overall Study|Lost to Follow-up|0|||
156942310|NCT01451424|566544496|FG003|Overall Study|Lost to Follow-up|1|||
156942311|NCT01451424|566544493|FG000|Overall Study|Physician Decision|0|||
156942312|NCT01451424|566544494|FG001|Overall Study|Physician Decision|0|||
156942313|NCT01451424|566544495|FG002|Overall Study|Physician Decision|1|||
156942314|NCT01451424|566544496|FG003|Overall Study|Physician Decision|1|||
156942315|NCT01451424|566544493|FG000|Overall Study|Adverse Event|0|||
156942316|NCT01451424|566544494|FG001|Overall Study|Adverse Event|0|||
156942317|NCT01451424|566544495|FG002|Overall Study|Adverse Event|0|||
156942318|NCT01451424|566544496|FG003|Overall Study|Adverse Event|1|||
156942319|NCT02920983|566544497|FG000|Dispense 1|Unacceptable Lens Fit|0|||
156942320|NCT02920983|566544498|FG001|Dispense 1|Unacceptable Lens Fit|0|||
156942321|NCT02920983|566544499|FG002|Dispense 1|Unacceptable Lens Fit|0|||
156942322|NCT02920983|566544500|FG003|Dispense 1|Unacceptable Lens Fit|0|||
156942323|NCT02920983|566544501|FG004|Dispense 1|Unacceptable Lens Fit|1|||
156942324|NCT02920983|566544502|FG005|Dispense 1|Unacceptable Lens Fit|0|||
156942325|NCT02920983|566544497|FG000|Dispense 2|Unscceptable lens fit|1|||
156942326|NCT02920983|566544498|FG001|Dispense 2|Unscceptable lens fit|0|||
157032401|NCT04934072|566874616|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
157167416|NCT01352845|567354550|FG000|Overall Study|No Longer Willing to Participate|205|||
156942327|NCT02920983|566544499|FG002|Dispense 2|Unscceptable lens fit|0|||
156942328|NCT02920983|566544500|FG003|Dispense 2|Unscceptable lens fit|0|||
156942329|NCT02920983|566544501|FG004|Dispense 2|Unscceptable lens fit|1|||
157032402|NCT04934072|566874617|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
157032403|NCT04934072|566874613|FG000|Day 0 to Week 52|Other|3|||
157032404|NCT04934072|566874614|FG001|Day 0 to Week 52|Other|1|||
157032405|NCT04934072|566874615|FG002|Day 0 to Week 52|Other|0|||
157167417|NCT01352845|567354551|FG001|Overall Study|No Longer Willing to Participate|58|||
156942330|NCT02920983|566544502|FG005|Dispense 2|Unscceptable lens fit|0|||
156942331|NCT02920983|566544497|FG000|Dispense 3|Unacceptable Lens Fit|1|||
157032406|NCT04934072|566874616|FG003|Day 0 to Week 52|Other|0|||
157032407|NCT04934072|566874617|FG004|Day 0 to Week 52|Other|0|||
157032408|NCT04934072|566874613|FG000|Day 0 to Week 52|Adverse Event|1|||
157167418|NCT01352845|567354550|FG000|Overall Study|Withdrawal by Subject|48|||
157032409|NCT04934072|566874614|FG001|Day 0 to Week 52|Adverse Event|3|||
157167419|NCT01352845|567354551|FG001|Overall Study|Withdrawal by Subject|16|||
156942332|NCT02920983|566544498|FG001|Dispense 3|Unacceptable Lens Fit|1|||
156942333|NCT02920983|566544499|FG002|Dispense 3|Unacceptable Lens Fit|0|||
156942334|NCT02920983|566544500|FG003|Dispense 3|Unacceptable Lens Fit|0|||
156942335|NCT02920983|566544501|FG004|Dispense 3|Unacceptable Lens Fit|1|||
156942336|NCT02920983|566544502|FG005|Dispense 3|Unacceptable Lens Fit|0|||
156942337|NCT01387607|566544508|FG000|Overall Study|Adverse Event|23|||
157032410|NCT04934072|566874615|FG002|Day 0 to Week 52|Adverse Event|0|||
157032411|NCT04934072|566874616|FG003|Day 0 to Week 52|Adverse Event|0|||
157032412|NCT04934072|566874617|FG004|Day 0 to Week 52|Adverse Event|0|||
157032413|NCT04934072|566874613|FG000|Week 52 to Week 78|Adverse Event|0|||
157032414|NCT04934072|566874614|FG001|Week 52 to Week 78|Adverse Event|0|||
157032415|NCT04934072|566874615|FG002|Week 52 to Week 78|Adverse Event|0|||
157032416|NCT04934072|566874616|FG003|Week 52 to Week 78|Adverse Event|1|||
157032417|NCT04934072|566874617|FG004|Week 52 to Week 78|Adverse Event|1|||
157032418|NCT04934072|566874613|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
157032419|NCT04934072|566874614|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
157032420|NCT04934072|566874615|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
157032421|NCT04934072|566874616|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
157032422|NCT04934072|566874617|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
157032423|NCT04934072|566874613|FG000|Week 52 to Week 78|Other|0|||
157032424|NCT04934072|566874614|FG001|Week 52 to Week 78|Other|0|||
157032425|NCT04934072|566874615|FG002|Week 52 to Week 78|Other|1|||
157032426|NCT04934072|566874616|FG003|Week 52 to Week 78|Other|0|||
157032427|NCT04934072|566874617|FG004|Week 52 to Week 78|Other|0|||
157032428|NCT04218851|566874623|FG000|Overall Study|Death|1|||
157032429|NCT04218851|566874624|FG001|Overall Study|Death|3|||
157032430|NCT00844415|566874625|FG000|Overall Study|Withdrawal by Subject|1|||
157032431|NCT03174275|566874628|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
157032432|NCT03174275|566874628|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
157032433|NCT03174275|566874628|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
157032434|NCT03174275|566874628|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
157032435|NCT03174275|566874628|FG000|Adjuvant Chemotherapy|Progression|1|||
157032436|NCT03174275|566874628|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
157032437|NCT03174275|566874628|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
157032438|NCT03174275|566874628|FG000|Adjuvant Durvalumab|Progression|1|||
157032439|NCT03174275|566874628|FG000|Adjuvant Durvalumab|Adverse Event|3|||
157032440|NCT03174275|566874628|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
157032441|NCT03174275|566874628|FG000|Adjuvant Radiotherapy|Progression|1|||
157032442|NCT03174275|566874628|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
157032443|NCT01820611|566874633|FG000|Overall Study|Death|8|||
157032444|NCT01820611|566874633|FG000|Overall Study|Adverse Event|1|||
157032445|NCT01820611|566874633|FG000|Overall Study|Withdrawal by Subject|9|||
157032446|NCT03484819|566874634|FG000|Overall Study|Death|2|||
157032447|NCT03484819|566874634|FG000|Overall Study|Adverse Event|2|||
157032448|NCT03484819|566874634|FG000|Overall Study|Physician Decision|1|||
157032449|NCT03484819|566874634|FG000|Overall Study|Withdrawal by Subject|2|||
157032450|NCT03484819|566874634|FG000|Overall Study|Disease Progression|4|||
157032451|NCT03484819|566874634|FG000|Overall Study|Complicating Condition|1|||
157032452|NCT03015532|566874635|FG000|Overall Study|Adverse Event|0|||
156942338|NCT01387607|566544509|FG001|Overall Study|Adverse Event|11|||
156942339|NCT01387607|566544508|FG000|Overall Study|Lack of Efficacy|8|||
156942340|NCT01387607|566544509|FG001|Overall Study|Lack of Efficacy|6|||
156942341|NCT01387607|566544508|FG000|Overall Study|Lost to Follow-up|2|||
156942342|NCT01387607|566544509|FG001|Overall Study|Lost to Follow-up|1|||
156942343|NCT01387607|566544508|FG000|Overall Study|No longer meets eligibility criteria|0|||
156942344|NCT01387607|566544509|FG001|Overall Study|No longer meets eligibility criteria|1|||
156942345|NCT01387607|566544508|FG000|Overall Study|Protocol Violation|1|||
156942346|NCT01387607|566544509|FG001|Overall Study|Protocol Violation|5|||
156942347|NCT01387607|566544508|FG000|Overall Study|Withdrawal by Subject|13|||
156942348|NCT01387607|566544509|FG001|Overall Study|Withdrawal by Subject|14|||
156942349|NCT01387607|566544508|FG000|Overall Study|Other|1|||
156942350|NCT01387607|566544509|FG001|Overall Study|Other|1|||
157032453|NCT03015532|566874636|FG001|Overall Study|Adverse Event|0|||
157032454|NCT03015532|566874637|FG002|Overall Study|Adverse Event|0|||
157032455|NCT03015532|566874638|FG003|Overall Study|Adverse Event|0|||
157032456|NCT03015532|566874639|FG004|Overall Study|Adverse Event|0|||
156942351|NCT01387607|566544508|FG000|Overall Study|Randomized, not treated|3|||
156942352|NCT01387607|566544509|FG001|Overall Study|Randomized, not treated|6|||
157032457|NCT03015532|566874640|FG005|Overall Study|Adverse Event|2|||
157032458|NCT03015532|566874641|FG006|Overall Study|Adverse Event|1|||
157032459|NCT03015532|566874642|FG007|Overall Study|Adverse Event|0|||
157032460|NCT03015532|566874635|FG000|Overall Study|Withdrawal by Subject|0|||
157032461|NCT03015532|566874636|FG001|Overall Study|Withdrawal by Subject|0|||
157032462|NCT03015532|566874637|FG002|Overall Study|Withdrawal by Subject|0|||
157032463|NCT03015532|566874638|FG003|Overall Study|Withdrawal by Subject|0|||
157032464|NCT03015532|566874639|FG004|Overall Study|Withdrawal by Subject|0|||
157032465|NCT03015532|566874640|FG005|Overall Study|Withdrawal by Subject|0|||
157032466|NCT03015532|566874641|FG006|Overall Study|Withdrawal by Subject|1|||
157032467|NCT03015532|566874642|FG007|Overall Study|Withdrawal by Subject|0|||
157032468|NCT05970861|566874643|FG000|Overall Study|Physician Decision|4|||
157032469|NCT05970861|566874644|FG001|Overall Study|Physician Decision|4|||
157032470|NCT05970861|566874643|FG000|Overall Study|Lost to Follow-up|4|||
156942353|NCT02908529|566544511|FG000|Overall Study|Lost to Follow-up|0|||
156942354|NCT02908529|566544512|FG001|Overall Study|Lost to Follow-up|2|||
156942355|NCT04497987|566544513|FG000|Overall Study|Adverse Event|1|||
156942356|NCT04497987|566544514|FG001|Overall Study|Adverse Event|0|||
156942357|NCT04497987|566544513|FG000|Overall Study|Death|21|||
156942358|NCT04497987|566544514|FG001|Overall Study|Death|13|||
156942359|NCT04497987|566544513|FG000|Overall Study|Lost to Follow-up|19|||
156942360|NCT04497987|566544514|FG001|Overall Study|Lost to Follow-up|17|||
156942361|NCT04497987|566544513|FG000|Overall Study|Other - as reported by the investigator|22|||
156942362|NCT04497987|566544514|FG001|Overall Study|Other - as reported by the investigator|16|||
156942363|NCT04497987|566544513|FG000|Overall Study|Physician Decision|1|||
156942364|NCT04497987|566544514|FG001|Overall Study|Physician Decision|0|||
156942365|NCT04497987|566544513|FG000|Overall Study|Withdrawal by Subject|35|||
156942366|NCT04497987|566544514|FG001|Overall Study|Withdrawal by Subject|21|||
156942367|NCT02553421|566544521|FG000|Overall Study|Lost to Follow-up|21|||
156942368|NCT02553421|566544522|FG001|Overall Study|Lost to Follow-up|1|||
156942369|NCT02553421|566544521|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
156942370|NCT02553421|566544522|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
156942371|NCT02553421|566544521|FG000|Overall Study|Improper Device Placement|3|||
156942372|NCT02553421|566544522|FG001|Overall Study|Improper Device Placement|0|||
156942373|NCT03337724|566544525|FG000|Overall Study|Reason not Specified|12|||
156942374|NCT03337724|566544526|FG001|Overall Study|Reason not Specified|21|||
156942375|NCT03337724|566544527|FG002|Overall Study|Reason not Specified|9|||
156942376|NCT03337724|566544528|FG003|Overall Study|Reason not Specified|9|||
156942377|NCT03337724|566544529|FG004|Overall Study|Reason not Specified|29|||
156942378|NCT03337724|566544525|FG000|Overall Study|Withdrawal by Subject|13|||
156942379|NCT03337724|566544526|FG001|Overall Study|Withdrawal by Subject|15|||
156942380|NCT03337724|566544527|FG002|Overall Study|Withdrawal by Subject|4|||
156942381|NCT03337724|566544528|FG003|Overall Study|Withdrawal by Subject|15|||
156942382|NCT03337724|566544529|FG004|Overall Study|Withdrawal by Subject|6|||
156942383|NCT03337724|566544525|FG000|Overall Study|Protocol Deviation|0|||
156942384|NCT03337724|566544526|FG001|Overall Study|Protocol Deviation|1|||
156942385|NCT03337724|566544527|FG002|Overall Study|Protocol Deviation|1|||
156942386|NCT03337724|566544528|FG003|Overall Study|Protocol Deviation|1|||
156942387|NCT03337724|566544529|FG004|Overall Study|Protocol Deviation|0|||
156942388|NCT03337724|566544525|FG000|Overall Study|Adverse Event|1|||
156942389|NCT03337724|566544526|FG001|Overall Study|Adverse Event|1|||
156942390|NCT03337724|566544527|FG002|Overall Study|Adverse Event|0|||
156942391|NCT03337724|566544528|FG003|Overall Study|Adverse Event|1|||
156942392|NCT03337724|566544529|FG004|Overall Study|Adverse Event|0|||
156942393|NCT03337724|566544525|FG000|Overall Study|Death|40|||
156942394|NCT03337724|566544526|FG001|Overall Study|Death|89|||
156942395|NCT03337724|566544527|FG002|Overall Study|Death|43|||
156942396|NCT03337724|566544528|FG003|Overall Study|Death|76|||
156942397|NCT03337724|566544529|FG004|Overall Study|Death|50|||
156942398|NCT03337724|566544525|FG000|Overall Study|Lost to Follow-up|5|||
156942399|NCT03337724|566544526|FG001|Overall Study|Lost to Follow-up|5|||
156942400|NCT03337724|566544527|FG002|Overall Study|Lost to Follow-up|4|||
156942401|NCT03337724|566544528|FG003|Overall Study|Lost to Follow-up|7|||
156942402|NCT03337724|566544529|FG004|Overall Study|Lost to Follow-up|4|||
156942403|NCT03337724|566544525|FG000|Overall Study|Physician Decision|16|||
156942404|NCT03337724|566544526|FG001|Overall Study|Physician Decision|34|||
156942405|NCT03337724|566544527|FG002|Overall Study|Physician Decision|14|||
156942406|NCT03337724|566544528|FG003|Overall Study|Physician Decision|34|||
156942407|NCT03337724|566544529|FG004|Overall Study|Physician Decision|13|||
156942408|NCT03337724|566544525|FG000|Overall Study|Progressive Disease|0|||
156942409|NCT03337724|566544526|FG001|Overall Study|Progressive Disease|2|||
156942410|NCT03337724|566544527|FG002|Overall Study|Progressive Disease|1|||
156942411|NCT03337724|566544528|FG003|Overall Study|Progressive Disease|2|||
156942412|NCT03337724|566544529|FG004|Overall Study|Progressive Disease|0|||
156942413|NCT03337724|566544525|FG000|Overall Study|Symptomatic Deterioration|0|||
156942414|NCT03337724|566544526|FG001|Overall Study|Symptomatic Deterioration|0|||
156942415|NCT03337724|566544527|FG002|Overall Study|Symptomatic Deterioration|0|||
156942416|NCT03337724|566544528|FG003|Overall Study|Symptomatic Deterioration|1|||
156942417|NCT03337724|566544529|FG004|Overall Study|Symptomatic Deterioration|0|||
156942418|NCT00528528|566544530|FG000|Overall Study|Lost to Follow-up|0|||
156942419|NCT00528528|566544531|FG001|Overall Study|Lost to Follow-up|0|||
156942420|NCT00528528|566544532|FG002|Overall Study|Lost to Follow-up|1|||
156942421|NCT00528528|566544533|FG003|Overall Study|Lost to Follow-up|1|||
156942422|NCT00528528|566544530|FG000|Overall Study|Ineligible to continue the trial|0|||
156942423|NCT00528528|566544531|FG001|Overall Study|Ineligible to continue the trial|0|||
156942424|NCT00528528|566544532|FG002|Overall Study|Ineligible to continue the trial|0|||
156942425|NCT00528528|566544533|FG003|Overall Study|Ineligible to continue the trial|1|||
156942426|NCT00528528|566544530|FG000|Overall Study|Other|0|||
156942427|NCT00528528|566544531|FG001|Overall Study|Other|1|||
156942428|NCT00528528|566544532|FG002|Overall Study|Other|0|||
156942429|NCT00528528|566544533|FG003|Overall Study|Other|0|||
156942430|NCT00528528|566544530|FG000|Overall Study|Withdrawal by Subject|3|||
156942431|NCT00528528|566544531|FG001|Overall Study|Withdrawal by Subject|2|||
156942432|NCT00528528|566544532|FG002|Overall Study|Withdrawal by Subject|1|||
156942433|NCT00528528|566544533|FG003|Overall Study|Withdrawal by Subject|1|||
156942434|NCT00528528|566544530|FG000|Overall Study|Ongoing participant|0|||
156942435|NCT00528528|566544531|FG001|Overall Study|Ongoing participant|0|||
156942436|NCT00528528|566544532|FG002|Overall Study|Ongoing participant|1|||
156942437|NCT00528528|566544533|FG003|Overall Study|Ongoing participant|0|||
156942438|NCT00773097|566544534|FG000|Overall Study|Withdrawal by Subject|1|||
156942439|NCT00773097|566544534|FG000|Overall Study|Physician Decision|6|||
156942440|NCT04084769|566544541|FG000|Overall Study|Protocol Violation|1|||
156942441|NCT04084769|566544542|FG001|Overall Study|Protocol Violation|3|||
156942442|NCT04084769|566544543|FG002|Overall Study|Protocol Violation|0|||
156942443|NCT04084769|566544544|FG003|Overall Study|Protocol Violation|1|||
156942444|NCT04084769|566544541|FG000|Overall Study|Withdrawal by Subject|0|||
156942445|NCT04084769|566544542|FG001|Overall Study|Withdrawal by Subject|1|||
156942446|NCT04084769|566544543|FG002|Overall Study|Withdrawal by Subject|0|||
156942447|NCT04084769|566544544|FG003|Overall Study|Withdrawal by Subject|0|||
156942448|NCT04084769|566544541|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156942449|NCT04084769|566544542|FG001|Overall Study|Withdrawal by parent/guardian|0|||
156942450|NCT04084769|566544543|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156942451|NCT04084769|566544544|FG003|Overall Study|Withdrawal by parent/guardian|1|||
156942452|NCT04084769|566544541|FG000|Overall Study|Lost to Follow-up|2|||
156942453|NCT04084769|566544542|FG001|Overall Study|Lost to Follow-up|0|||
156942454|NCT04084769|566544543|FG002|Overall Study|Lost to Follow-up|0|||
156942455|NCT04084769|566544544|FG003|Overall Study|Lost to Follow-up|0|||
156942456|NCT04579679|566544545|FG000|Overall Study|New Antitumor Therapy|6|||
156942457|NCT04579679|566544546|FG001|Overall Study|New Antitumor Therapy|4|||
156942458|NCT04579679|566544547|FG002|Overall Study|New Antitumor Therapy|7|||
156942459|NCT04579679|566544548|FG003|Overall Study|New Antitumor Therapy|0|||
156942460|NCT04579679|566544545|FG000|Overall Study|Withdrawal of Consent|1|||
156942461|NCT04579679|566544546|FG001|Overall Study|Withdrawal of Consent|1|||
156942462|NCT04579679|566544547|FG002|Overall Study|Withdrawal of Consent|2|||
156942463|NCT04579679|566544548|FG003|Overall Study|Withdrawal of Consent|4|||
156942464|NCT04579679|566544545|FG000|Overall Study|Death|2|||
156942465|NCT04579679|566544546|FG001|Overall Study|Death|2|||
156942466|NCT04579679|566544547|FG002|Overall Study|Death|2|||
156942467|NCT04579679|566544548|FG003|Overall Study|Death|0|||
156942468|NCT04579679|566544545|FG000|Overall Study|Adverse Event|0|||
156942469|NCT04579679|566544546|FG001|Overall Study|Adverse Event|4|||
156942470|NCT04579679|566544547|FG002|Overall Study|Adverse Event|0|||
156942471|NCT04579679|566544548|FG003|Overall Study|Adverse Event|0|||
156942472|NCT04579679|566544545|FG000|Overall Study|Disease Progression|9|||
156942473|NCT04579679|566544546|FG001|Overall Study|Disease Progression|13|||
156942474|NCT04579679|566544547|FG002|Overall Study|Disease Progression|7|||
156942475|NCT04579679|566544548|FG003|Overall Study|Disease Progression|0|||
156942476|NCT04579679|566544545|FG000|Overall Study|Physician Decision|0|||
156942477|NCT04579679|566544546|FG001|Overall Study|Physician Decision|0|||
156942478|NCT04579679|566544547|FG002|Overall Study|Physician Decision|1|||
156942479|NCT04579679|566544548|FG003|Overall Study|Physician Decision|0|||
156942480|NCT04579679|566544545|FG000|Overall Study|Study Terminated by Sponsor|2|||
156942481|NCT04579679|566544546|FG001|Overall Study|Study Terminated by Sponsor|7|||
156942482|NCT04579679|566544547|FG002|Overall Study|Study Terminated by Sponsor|1|||
156942483|NCT04579679|566544548|FG003|Overall Study|Study Terminated by Sponsor|0|||
156942484|NCT02573324|566546645|FG000|Overall Study|Withdrawal by Subject|26|||
156942485|NCT02573324|566546646|FG001|Overall Study|Withdrawal by Subject|23|||
156942486|NCT02573324|566546647|FG002|Overall Study|Withdrawal by Subject|3|||
156942487|NCT02573324|566546645|FG000|Overall Study|Lost to Follow-up|4|||
156942488|NCT02573324|566546646|FG001|Overall Study|Lost to Follow-up|5|||
156942489|NCT02573324|566546647|FG002|Overall Study|Lost to Follow-up|0|||
157032471|NCT05970861|566874644|FG001|Overall Study|Lost to Follow-up|3|||
156942490|NCT02573324|566546645|FG000|Overall Study|Study Terminated by Sponsor|107|||
156942491|NCT02573324|566546646|FG001|Overall Study|Study Terminated by Sponsor|89|||
156942492|NCT02573324|566546647|FG002|Overall Study|Study Terminated by Sponsor|2|||
156942493|NCT02573324|566546645|FG000|Overall Study|Death|182|||
156942494|NCT02573324|566546646|FG001|Overall Study|Death|200|||
156942495|NCT02573324|566546647|FG002|Overall Study|Death|1|||
156942496|NCT02573324|566546645|FG000|Overall Study|Other, Not Specified|20|||
156942497|NCT02573324|566546646|FG001|Overall Study|Other, Not Specified|27|||
156942498|NCT02573324|566546647|FG002|Overall Study|Other, Not Specified|0|||
156942499|NCT02573324|566546645|FG000|Overall Study|Unknown Reason|2|||
156942500|NCT02573324|566546646|FG001|Overall Study|Unknown Reason|0|||
156942501|NCT02573324|566546647|FG002|Overall Study|Unknown Reason|0|||
156942502|NCT02349711|566546648|FG000|Overall Study|Withdrawal by Subject|2|||
156942503|NCT02349711|566546649|FG001|Overall Study|Withdrawal by Subject|1|||
156942504|NCT02349711|566546648|FG000|Overall Study|Lost to Follow-up|1|||
156942505|NCT02349711|566546649|FG001|Overall Study|Lost to Follow-up|1|||
156942506|NCT00941733|566546650|FG000|Overall Study|Death|24|||
156942507|NCT00941733|566546651|FG001|Overall Study|Death|10|||
156942508|NCT00941733|566546650|FG000|Overall Study|Withdrawal by Subject|14|||
156942509|NCT00941733|566546651|FG001|Overall Study|Withdrawal by Subject|6|||
156942510|NCT00941733|566546650|FG000|Overall Study|Adverse Event|20|||
156942511|NCT00941733|566546651|FG001|Overall Study|Adverse Event|4|||
157032472|NCT02990338|566874645|FG000|Overall Study|Randomized and not treated|4|||
157032473|NCT02990338|566874646|FG001|Overall Study|Randomized and not treated|2|||
157032474|NCT02990338|566874645|FG000|Overall Study|Adverse Event|23|||
157032475|NCT02990338|566874646|FG001|Overall Study|Adverse Event|22|||
157032476|NCT02990338|566874645|FG000|Overall Study|Progressive disease|118|||
157032477|NCT02990338|566874646|FG001|Overall Study|Progressive disease|107|||
157032478|NCT02990338|566874645|FG000|Overall Study|Poor compliance to protocol|0|||
157032479|NCT02990338|566874646|FG001|Overall Study|Poor compliance to protocol|1|||
157032480|NCT02990338|566874645|FG000|Overall Study|Withdrawal by Subject|6|||
157032481|NCT02990338|566874646|FG001|Overall Study|Withdrawal by Subject|8|||
157032482|NCT02990338|566874645|FG000|Overall Study|Physician's decision|2|||
157032483|NCT02990338|566874646|FG001|Overall Study|Physician's decision|6|||
157032484|NCT02990338|566874645|FG000|Overall Study|Treatment extension study|0|||
157032485|NCT02990338|566874646|FG001|Overall Study|Treatment extension study|6|||
157032486|NCT02990338|566874645|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
157032487|NCT02990338|566874646|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
157032488|NCT02990338|566874645|FG000|Overall Study|Continue with therapy available commercially|0|||
157032489|NCT02990338|566874646|FG001|Overall Study|Continue with therapy available commercially|1|||
157032490|NCT04186819|566874648|FG000|Overall Study|Adverse Event|1|||
157032491|NCT04186819|566874648|FG000|Overall Study|Lost to Follow-up|1|||
157032492|NCT04186819|566874648|FG000|Overall Study|Opted for EBRT|1|||
157032493|NCT04186819|566874648|FG000|Overall Study|Opted SBRT|1|||
157032494|NCT04186819|566874648|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
157032495|NCT04186819|566874648|FG000|Overall Study|Physician Decision|1|||
157032496|NCT04186819|566874648|FG000|Overall Study|RP Delayed|1|||
157032497|NCT04186819|566874648|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
157032498|NCT04186819|566874648|FG000|Overall Study|Subject declined for financial reasons|1|||
157032499|NCT04186819|566874648|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
157032500|NCT04186819|566874648|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
157032501|NCT04186819|566874648|FG000|Overall Study|The subject opted for other treatment option|2|||
157032502|NCT04186819|566874648|FG000|Overall Study|The subject opted for other treatment options|1|||
157032503|NCT04186819|566874648|FG000|Overall Study|Withdrawal by Subject|3|||
157032504|NCT04186819|566874648|FG000|Overall Study|Reason not specified|1|||
157032505|NCT05013385|566874652|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
157032506|NCT01447719|566874653|FG000|Overall Study|Image acquisition failure|2|||
157032507|NCT01447719|566874653|FG000|Overall Study|Invalid image or not imaged|3|||
157032508|NCT01447719|566874653|FG000|Overall Study|Subject still living at end of study|79|||
157032509|NCT01447719|566874653|FG000|Overall Study|Withdrawal by Subject|2|||
157032510|NCT01447719|566874653|FG000|Overall Study|Family withdrew autopsy consent|7|||
157032511|NCT03914469|566874654|FG000|Overall Study|Lost to Follow-up|1|||
157032512|NCT03914469|566874655|FG001|Overall Study|Lost to Follow-up|4|||
157032513|NCT03252288|566874656|FG000|Overall Study|Death|1|||
157032514|NCT03252288|566874657|FG001|Overall Study|Death|0|||
157032515|NCT03252288|566874658|FG002|Overall Study|Death|0|||
157032516|NCT03252288|566874656|FG000|Overall Study|Death|11|||
157032517|NCT03252288|566874657|FG001|Overall Study|Death|0|||
157032518|NCT03252288|566874658|FG002|Overall Study|Death|0|||
157032519|NCT03252288|566874656|FG000|Overall Study|Withdrawal by Subject|2|||
157032520|NCT03252288|566874657|FG001|Overall Study|Withdrawal by Subject|0|||
157032521|NCT03252288|566874658|FG002|Overall Study|Withdrawal by Subject|0|||
157032522|NCT03252288|566874656|FG000|Overall Study|Lost to Follow-up|79|||
157032523|NCT03252288|566874657|FG001|Overall Study|Lost to Follow-up|0|||
157032524|NCT03252288|566874658|FG002|Overall Study|Lost to Follow-up|0|||
157032525|NCT03252288|566874656|FG000|Overall Study|Loss of baseline data on tablets|6|||
157032526|NCT03252288|566874657|FG001|Overall Study|Loss of baseline data on tablets|0|||
157032527|NCT03252288|566874658|FG002|Overall Study|Loss of baseline data on tablets|0|||
157032528|NCT00677365|566874659|FG000|Overall Study|Adverse Event|2|||
157032529|NCT00677365|566874660|FG001|Overall Study|Adverse Event|1|||
157032530|NCT00677365|566874661|FG002|Overall Study|Adverse Event|1|||
157032531|NCT00677365|566874662|FG003|Overall Study|Adverse Event|2|||
157032532|NCT00677365|566874659|FG000|Overall Study|Withdrawal by Subject|0|||
157032533|NCT00677365|566874660|FG001|Overall Study|Withdrawal by Subject|0|||
157032534|NCT00677365|566874661|FG002|Overall Study|Withdrawal by Subject|1|||
157032535|NCT00677365|566874662|FG003|Overall Study|Withdrawal by Subject|0|||
157032536|NCT00677365|566874659|FG000|Overall Study|Other reason|0|||
157032537|NCT00677365|566874660|FG001|Overall Study|Other reason|0|||
157032538|NCT00677365|566874661|FG002|Overall Study|Other reason|0|||
157032539|NCT00677365|566874662|FG003|Overall Study|Other reason|1|||
157032540|NCT04102111|566874664|FG000|Overall Study|Withdrawal by Subject|2|||
157032541|NCT04102111|566874665|FG001|Overall Study|Withdrawal by Subject|3|||
157032542|NCT04102111|566874664|FG000|Overall Study|Adverse Event|1|||
157032543|NCT04102111|566874665|FG001|Overall Study|Adverse Event|1|||
157032544|NCT04102111|566874664|FG000|Overall Study|Study terminated by sponsor|1|||
157032545|NCT04102111|566874665|FG001|Overall Study|Study terminated by sponsor|3|||
157032546|NCT02542631|566874666|FG000|Overall Study|Adverse Event|1|||
157167420|NCT01352845|567354550|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
156942512|NCT00941733|566546650|FG000|Overall Study|Lost to Follow-up|1|||
156942513|NCT00941733|566546651|FG001|Overall Study|Lost to Follow-up|2|||
156942514|NCT00941733|566546650|FG000|Overall Study|Protocol Violation|15|||
156942515|NCT00941733|566546651|FG001|Overall Study|Protocol Violation|6|||
156942516|NCT00194012|566546652|FG000|Randomized Phase|Lack of Efficacy|8|||
156942517|NCT00194012|566546653|FG001|Randomized Phase|Lack of Efficacy|18|||
156942518|NCT00194012|566546652|FG000|Randomized Phase|Study nonadherence|2|||
156942519|NCT00194012|566546653|FG001|Randomized Phase|Study nonadherence|1|||
156942520|NCT00194012|566546652|FG000|Randomized Phase|Withdrawal by Subject|3|||
156942521|NCT00194012|566546653|FG001|Randomized Phase|Withdrawal by Subject|3|||
156942522|NCT00194012|566546652|FG000|Randomized Phase|Adverse Event|2|||
156942523|NCT00194012|566546653|FG001|Randomized Phase|Adverse Event|1|||
156942524|NCT00194012|566546652|FG000|Randomized Phase|Participant reported having a rash|1|||
156942525|NCT00194012|566546653|FG001|Randomized Phase|Participant reported having a rash|0|||
156942526|NCT00194012|566546652|FG000|Randomized Phase|Emesis and enuresis|0|||
156942527|NCT00194012|566546653|FG001|Randomized Phase|Emesis and enuresis|1|||
156942528|NCT00194012|566546652|FG000|Randomized Phase|Oral/nasal twitching|0|||
156942529|NCT00194012|566546653|FG001|Randomized Phase|Oral/nasal twitching|1|||
156942530|NCT00194012|566546652|FG000|Open Label Extension (OLE)|Weight Gain|1|||
156942531|NCT00194012|566546653|FG001|Open Label Extension (OLE)|Weight Gain|0|||
156942532|NCT00194012|566546652|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
156942533|NCT00194012|566546653|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
156942534|NCT00194012|566546652|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
156942535|NCT00194012|566546653|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
156942536|NCT00194012|566546652|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
156942537|NCT00194012|566546653|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
156942538|NCT01105533|566546656|FG000|Overall Study|Death|0|||
156942539|NCT01105533|566546657|FG001|Overall Study|Death|0|||
156942540|NCT01105533|566546658|FG002|Overall Study|Death|0|||
156942541|NCT01105533|566546659|FG003|Overall Study|Death|0|||
156942542|NCT01105533|566546660|FG004|Overall Study|Death|1|||
156942543|NCT01105533|566546661|FG005|Overall Study|Death|0|||
156942544|NCT01105533|566546662|FG006|Overall Study|Death|0|||
156942545|NCT01105533|566546663|FG007|Overall Study|Death|0|||
156942546|NCT01105533|566546664|FG008|Overall Study|Death|0|||
156942547|NCT01105533|566546656|FG000|Overall Study|Lack of Efficacy|1|||
156942548|NCT01105533|566546657|FG001|Overall Study|Lack of Efficacy|1|||
156942549|NCT01105533|566546658|FG002|Overall Study|Lack of Efficacy|3|||
156942550|NCT01105533|566546659|FG003|Overall Study|Lack of Efficacy|3|||
156942551|NCT01105533|566546660|FG004|Overall Study|Lack of Efficacy|4|||
156942552|NCT01105533|566546661|FG005|Overall Study|Lack of Efficacy|5|||
156942553|NCT01105533|566546662|FG006|Overall Study|Lack of Efficacy|3|||
156942554|NCT01105533|566546663|FG007|Overall Study|Lack of Efficacy|2|||
156942555|NCT01105533|566546664|FG008|Overall Study|Lack of Efficacy|9|||
156942556|NCT01105533|566546656|FG000|Overall Study|Adverse Event|0|||
156942557|NCT01105533|566546657|FG001|Overall Study|Adverse Event|0|||
156942558|NCT01105533|566546658|FG002|Overall Study|Adverse Event|0|||
156942559|NCT01105533|566546659|FG003|Overall Study|Adverse Event|0|||
156942560|NCT01105533|566546660|FG004|Overall Study|Adverse Event|1|||
156942561|NCT01105533|566546661|FG005|Overall Study|Adverse Event|2|||
156942562|NCT01105533|566546662|FG006|Overall Study|Adverse Event|2|||
156942563|NCT01105533|566546663|FG007|Overall Study|Adverse Event|0|||
156942564|NCT01105533|566546664|FG008|Overall Study|Adverse Event|1|||
156942565|NCT01105533|566546656|FG000|Overall Study|Other|0|||
156942566|NCT01105533|566546657|FG001|Overall Study|Other|0|||
156942567|NCT01105533|566546658|FG002|Overall Study|Other|0|||
156942568|NCT01105533|566546659|FG003|Overall Study|Other|0|||
156942569|NCT01105533|566546660|FG004|Overall Study|Other|1|||
156942570|NCT01105533|566546661|FG005|Overall Study|Other|0|||
156942571|NCT01105533|566546662|FG006|Overall Study|Other|3|||
156942572|NCT01105533|566546663|FG007|Overall Study|Other|1|||
156942573|NCT01105533|566546664|FG008|Overall Study|Other|2|||
156942574|NCT01105533|566546656|FG000|Overall Study|Physician Decision|0|||
156942575|NCT01105533|566546657|FG001|Overall Study|Physician Decision|0|||
156942576|NCT01105533|566546658|FG002|Overall Study|Physician Decision|0|||
156942577|NCT01105533|566546659|FG003|Overall Study|Physician Decision|0|||
156942578|NCT01105533|566546660|FG004|Overall Study|Physician Decision|0|||
156942579|NCT01105533|566546661|FG005|Overall Study|Physician Decision|0|||
156942580|NCT01105533|566546662|FG006|Overall Study|Physician Decision|0|||
156942581|NCT01105533|566546663|FG007|Overall Study|Physician Decision|1|||
156942582|NCT01105533|566546664|FG008|Overall Study|Physician Decision|0|||
156942583|NCT03892889|566546666|FG000|Overall Study|Adverse Event|17|||
156942584|NCT03892889|566546666|FG000|Overall Study|Lack of Efficacy|1|||
156942585|NCT03892889|566546666|FG000|Overall Study|Lost to Follow-up|46|||
156942586|NCT03892889|566546666|FG000|Overall Study|Non-compliance with study drug|22|||
156942587|NCT03892889|566546666|FG000|Overall Study|Pregnancy|1|||
156942588|NCT03892889|566546666|FG000|Overall Study|Protocol Deviation|3|||
156942589|NCT03892889|566546666|FG000|Overall Study|Withdrawal by Subject|50|||
156942590|NCT03892889|566546666|FG000|Overall Study|Withdrawal by Caregiver|1|||
157227319|NCT00950807|567577789|FG008|Treatment Period 2|Lack of Efficacy|0|||
157227320|NCT00950807|567577790|FG009|Treatment Period 2|Lack of Efficacy|0|||
157227321|NCT00950807|567577781|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157227322|NCT00950807|567577782|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156942591|NCT03892889|566546666|FG000|Overall Study|Study Terminated by Sponsor|50|||
156942592|NCT03892889|566546666|FG000|Overall Study|Physician Decision|8|||
156942593|NCT03892889|566546666|FG000|Overall Study|Reason not Specified|5|||
156942594|NCT01610700|566546671|FG000|Overall Study|Adverse Event|3|||
156942595|NCT01610700|566546672|FG001|Overall Study|Adverse Event|1|||
156942596|NCT01610700|566546671|FG000|Overall Study|Withdrawal by Subject|0|||
156942597|NCT01610700|566546672|FG001|Overall Study|Withdrawal by Subject|1|||
156942598|NCT01610700|566546671|FG000|Overall Study|subject took one dose of street cannabis|0|||
156942599|NCT01610700|566546672|FG001|Overall Study|subject took one dose of street cannabis|1|||
156942600|NCT01639001|566546678|FG000|Overall Study|Refused further follow-up|9|||
156942601|NCT01639001|566546679|FG001|Overall Study|Refused further follow-up|12|||
156942602|NCT01639001|566546678|FG000|Overall Study|Lost to Follow-up|3|||
156942603|NCT01639001|566546679|FG001|Overall Study|Lost to Follow-up|0|||
156942604|NCT01639001|566546678|FG000|Overall Study|Death|62|||
156942605|NCT01639001|566546679|FG001|Overall Study|Death|61|||
156942606|NCT01639001|566546678|FG000|Overall Study|Randomized but not treated|0|||
156942607|NCT01639001|566546679|FG001|Overall Study|Randomized but not treated|2|||
156942608|NCT01639001|566546678|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
156942609|NCT01639001|566546679|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
156942610|NCT02453594|566546680|FG000|Overall Study|Protocol Violation|0|||
156942611|NCT02453594|566546681|FG001|Overall Study|Protocol Violation|0|||
156942612|NCT02453594|566546682|FG002|Overall Study|Protocol Violation|1|||
156942613|NCT02453594|566546680|FG000|Overall Study|Cohort Was Closed|17|||
156942614|NCT02453594|566546681|FG001|Overall Study|Cohort Was Closed|21|||
156942615|NCT02453594|566546682|FG002|Overall Study|Cohort Was Closed|14|||
156942616|NCT02453594|566546680|FG000|Overall Study|Death|20|||
156942617|NCT02453594|566546681|FG001|Overall Study|Death|24|||
156942618|NCT02453594|566546682|FG002|Overall Study|Death|16|||
156942619|NCT02453594|566546680|FG000|Overall Study|Lost to Follow-up|6|||
156942620|NCT02453594|566546681|FG001|Overall Study|Lost to Follow-up|14|||
156942621|NCT02453594|566546682|FG002|Overall Study|Lost to Follow-up|2|||
156942622|NCT02453594|566546680|FG000|Overall Study|Physician Decision|2|||
156942623|NCT02453594|566546681|FG001|Overall Study|Physician Decision|4|||
156942624|NCT02453594|566546682|FG002|Overall Study|Physician Decision|0|||
156942625|NCT02453594|566546680|FG000|Overall Study|Site Terminated by Sponsor|1|||
156942626|NCT02453594|566546681|FG001|Overall Study|Site Terminated by Sponsor|0|||
156942627|NCT02453594|566546682|FG002|Overall Study|Site Terminated by Sponsor|1|||
156942628|NCT02453594|566546680|FG000|Overall Study|Transitioned to Extension Study|16|||
156942629|NCT02453594|566546681|FG001|Overall Study|Transitioned to Extension Study|9|||
156942630|NCT02453594|566546682|FG002|Overall Study|Transitioned to Extension Study|16|||
156942631|NCT02453594|566546680|FG000|Overall Study|Withdrawal by Subject|7|||
156942632|NCT02453594|566546681|FG001|Overall Study|Withdrawal by Subject|9|||
156942633|NCT02453594|566546682|FG002|Overall Study|Withdrawal by Subject|11|||
156942634|NCT00679341|566546683|FG000|Overall Study|Disease progression|42|||
156942635|NCT00679341|566546684|FG001|Overall Study|Disease progression|36|||
156942636|NCT00679341|566546683|FG000|Overall Study|Adverse Event|5|||
156942637|NCT00679341|566546684|FG001|Overall Study|Adverse Event|6|||
156942638|NCT00679341|566546683|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
156942639|NCT00679341|566546684|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
157032547|NCT02542631|566874667|FG001|Overall Study|Adverse Event|1|||
157032548|NCT02542631|566874666|FG000|Overall Study|Sponsor Termination|1|||
157032549|NCT02542631|566874667|FG001|Overall Study|Sponsor Termination|0|||
157032550|NCT02542631|566874666|FG000|Overall Study|Withdrawal by Subject|11|||
157032551|NCT02542631|566874667|FG001|Overall Study|Withdrawal by Subject|16|||
157032552|NCT02542631|566874666|FG000|Overall Study|Protocol Violation|1|||
157032553|NCT02542631|566874667|FG001|Overall Study|Protocol Violation|1|||
157032554|NCT02542631|566874666|FG000|Overall Study|Physician Decision|6|||
157032555|NCT02542631|566874667|FG001|Overall Study|Physician Decision|4|||
157032556|NCT02542631|566874666|FG000|Overall Study|Lost to Follow-up|6|||
157032557|NCT02542631|566874667|FG001|Overall Study|Lost to Follow-up|5|||
157032558|NCT02542631|566874666|FG000|Overall Study|Death|1|||
157032559|NCT02542631|566874667|FG001|Overall Study|Death|2|||
157032560|NCT02542631|566874666|FG000|Overall Study|Other|2|||
157032561|NCT02542631|566874667|FG001|Overall Study|Other|1|||
156942640|NCT00679341|566546683|FG000|Overall Study|Death|1|||
156942641|NCT00679341|566546684|FG001|Overall Study|Death|1|||
156942642|NCT00679341|566546683|FG000|Overall Study|Other|1|||
156942643|NCT00679341|566546684|FG001|Overall Study|Other|0|||
156942644|NCT00679341|566546683|FG000|Overall Study|Physician Decision|1|||
156942645|NCT00679341|566546684|FG001|Overall Study|Physician Decision|0|||
156942646|NCT00679341|566546683|FG000|Overall Study|Not treated|0|||
156942647|NCT00679341|566546684|FG001|Overall Study|Not treated|2|||
157032562|NCT02542631|566874666|FG000|Overall Study|Used Prohibited Medication|2|||
157227323|NCT00950807|567577783|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157032563|NCT02542631|566874667|FG001|Overall Study|Used Prohibited Medication|1|||
157032564|NCT03334695|566874668|FG000|Overall Study|Lost to Follow-up|3|||
157032565|NCT03334695|566874669|FG001|Overall Study|Lost to Follow-up|3|||
157032566|NCT03334695|566874668|FG000|Overall Study|Physician Decision|1|||
157032567|NCT03334695|566874669|FG001|Overall Study|Physician Decision|2|||
157032568|NCT03334695|566874668|FG000|Overall Study|Protocol Violation|0|||
157032569|NCT03334695|566874669|FG001|Overall Study|Protocol Violation|1|||
157032570|NCT02641730|566874670|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
157032571|NCT02641730|566874671|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
157032572|NCT02641730|566874672|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
157032573|NCT02641730|566874673|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
157032574|NCT02641730|566874674|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
157032575|NCT02641730|566874670|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
157032576|NCT02641730|566874671|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
157032577|NCT02641730|566874672|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
157032578|NCT02641730|566874673|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
157032579|NCT02641730|566874674|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
157032580|NCT02641730|566874670|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
157032581|NCT02641730|566874671|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
157032582|NCT02641730|566874672|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
157032583|NCT02641730|566874673|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
157032584|NCT02641730|566874674|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
157032585|NCT02641730|566874670|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157032586|NCT02641730|566874671|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157032587|NCT02641730|566874672|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
157032588|NCT02641730|566874673|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
157032589|NCT02641730|566874674|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
157032590|NCT02641730|566874670|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
157032591|NCT02641730|566874671|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
157032592|NCT02641730|566874672|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
157032593|NCT02641730|566874673|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
157032594|NCT02641730|566874674|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
157032595|NCT02641730|566874670|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
157032596|NCT02641730|566874671|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
157032597|NCT02641730|566874672|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
157032598|NCT02641730|566874673|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
157032599|NCT02641730|566874674|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
157032600|NCT05460871|566874675|FG000|Overall Study|Withdrawal by Subject|1|||
157032601|NCT05460871|566874676|FG001|Overall Study|Withdrawal by Subject|2|||
157032602|NCT02938923|566874677|FG000|Overall Study|Death|1|||
157032603|NCT02938923|566874678|FG001|Overall Study|Death|0|||
157032604|NCT02938923|566874679|FG002|Overall Study|Death|0|||
157032605|NCT02938923|566874677|FG000|Overall Study|Physician Decision|0|||
157032606|NCT02938923|566874678|FG001|Overall Study|Physician Decision|2|||
157032607|NCT02938923|566874679|FG002|Overall Study|Physician Decision|0|||
157032608|NCT02938923|566874677|FG000|Overall Study|Withdrawal by Subject|0|||
157032609|NCT02938923|566874678|FG001|Overall Study|Withdrawal by Subject|1|||
157032610|NCT02938923|566874679|FG002|Overall Study|Withdrawal by Subject|1|||
157032611|NCT00721149|566874680|FG000|Overall Study|Physician Decision|1|||
157032612|NCT06010836|566874688|FG000|Overall Study|Lost to Follow-up|2|||
157032613|NCT06010836|566874689|FG001|Overall Study|Lost to Follow-up|2|||
157032614|NCT06010836|566874688|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
157032615|NCT06010836|566874689|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
157032616|NCT06010836|566874688|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
157032617|NCT06010836|566874689|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
157032618|NCT06010836|566874688|FG000|Overall Study|Did not receive intervention discussion|0|||
157032619|NCT06010836|566874689|FG001|Overall Study|Did not receive intervention discussion|4|||
157032620|NCT04505410|566874691|FG000|Overall Study|Adverse Event|2|||
157032621|NCT04505410|566874692|FG001|Overall Study|Adverse Event|0|||
157032622|NCT04505410|566874691|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
157032623|NCT04505410|566874692|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
157032624|NCT04505410|566874691|FG000|Overall Study|did not want to follow diet|1|||
157032625|NCT04505410|566874692|FG001|Overall Study|did not want to follow diet|0|||
157032626|NCT04505410|566874691|FG000|Overall Study|flare up of ulcerative colitis|0|||
157032627|NCT04505410|566874692|FG001|Overall Study|flare up of ulcerative colitis|1|||
157032628|NCT04505410|566874691|FG000|Overall Study|Lost to Follow-up|0|||
157032629|NCT04505410|566874692|FG001|Overall Study|Lost to Follow-up|2|||
157032630|NCT04505410|566874691|FG000|Overall Study|Lost to Follow-up|1|||
157032631|NCT04505410|566874692|FG001|Overall Study|Lost to Follow-up|0|||
157032632|NCT04505410|566874691|FG000|Overall Study|initiated another diet on their own|0|||
157032633|NCT04505410|566874692|FG001|Overall Study|initiated another diet on their own|2|||
156942648|NCT00679341|566546683|FG000|Overall Study|Physician/patient decision to withdraw|0|||
156942649|NCT00679341|566546684|FG001|Overall Study|Physician/patient decision to withdraw|6|||
156942650|NCT02664038|566546697|FG000|13 Week|Lost to Follow-up|7|||
156942651|NCT02664038|566546698|FG001|13 Week|Lost to Follow-up|14|||
156942652|NCT02664038|566546697|FG000|13 Week|Withdrawal by Subject|1|||
156942653|NCT02664038|566546698|FG001|13 Week|Withdrawal by Subject|0|||
156942654|NCT02664038|566546697|FG000|26 Week|Lost to Follow-up|5|||
156942655|NCT02664038|566546698|FG001|26 Week|Lost to Follow-up|4|||
156942656|NCT02606136|566546708|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
156942657|NCT02606136|566546708|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
156942658|NCT02606136|566546708|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
156942659|NCT02606136|566546708|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
156942660|NCT06640829|566546709|FG000|Overall Study|Withdrawal by Subject|1|||
156942661|NCT06640829|566546709|FG000|Overall Study|Lost to Follow-up|1|||
156942662|NCT01252290|566546710|FG000|Overall Study|Withdrawal by Subject|1|||
156942663|NCT02247349|566546711|FG000|Overall Study|Disease Progression|7|||
156942664|NCT02247349|566546712|FG001|Overall Study|Disease Progression|4|||
156942665|NCT02247349|566546713|FG002|Overall Study|Disease Progression|26|||
156942666|NCT02247349|566546714|FG003|Overall Study|Disease Progression|31|||
156942667|NCT02247349|566546715|FG004|Overall Study|Disease Progression|16|||
156942668|NCT02247349|566546716|FG005|Overall Study|Disease Progression|6|||
156942669|NCT02247349|566546711|FG000|Overall Study|Study drug toxicity|0|||
156942670|NCT02247349|566546712|FG001|Overall Study|Study drug toxicity|1|||
156942671|NCT02247349|566546713|FG002|Overall Study|Study drug toxicity|1|||
156942672|NCT02247349|566546714|FG003|Overall Study|Study drug toxicity|1|||
156942673|NCT02247349|566546715|FG004|Overall Study|Study drug toxicity|2|||
156942674|NCT02247349|566546716|FG005|Overall Study|Study drug toxicity|2|||
156942675|NCT02247349|566546711|FG000|Overall Study|Death|0|||
156942676|NCT02247349|566546712|FG001|Overall Study|Death|0|||
156942677|NCT02247349|566546713|FG002|Overall Study|Death|0|||
156942678|NCT02247349|566546714|FG003|Overall Study|Death|1|||
156942679|NCT02247349|566546715|FG004|Overall Study|Death|0|||
156942680|NCT02247349|566546716|FG005|Overall Study|Death|0|||
156942681|NCT02247349|566546711|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156942682|NCT02247349|566546712|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156942683|NCT02247349|566546713|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156942684|NCT02247349|566546714|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
156942685|NCT02247349|566546715|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
156942686|NCT02247349|566546716|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
156942687|NCT02247349|566546711|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156942688|NCT02247349|566546712|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156942689|NCT02247349|566546713|FG002|Overall Study|Participant request to discontinue study treatment|1|||
156942690|NCT02247349|566546714|FG003|Overall Study|Participant request to discontinue study treatment|2|||
156942691|NCT02247349|566546715|FG004|Overall Study|Participant request to discontinue study treatment|1|||
156942692|NCT02247349|566546716|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156942693|NCT02247349|566546711|FG000|Overall Study|Withdrawal by Subject|0|||
156942694|NCT02247349|566546712|FG001|Overall Study|Withdrawal by Subject|1|||
156942695|NCT02247349|566546713|FG002|Overall Study|Withdrawal by Subject|0|||
156942696|NCT02247349|566546714|FG003|Overall Study|Withdrawal by Subject|0|||
156942697|NCT02247349|566546715|FG004|Overall Study|Withdrawal by Subject|0|||
156942698|NCT02247349|566546716|FG005|Overall Study|Withdrawal by Subject|0|||
156942699|NCT02247349|566546711|FG000|Overall Study|Administrative reason by sponsor|0|||
156942700|NCT02247349|566546712|FG001|Overall Study|Administrative reason by sponsor|0|||
156942701|NCT02247349|566546713|FG002|Overall Study|Administrative reason by sponsor|0|||
156942702|NCT02247349|566546714|FG003|Overall Study|Administrative reason by sponsor|0|||
156942703|NCT02247349|566546715|FG004|Overall Study|Administrative reason by sponsor|1|||
156942704|NCT02247349|566546716|FG005|Overall Study|Administrative reason by sponsor|0|||
156942705|NCT02247349|566546711|FG000|Overall Study|Other reasons|0|||
156942706|NCT02247349|566546712|FG001|Overall Study|Other reasons|0|||
156942707|NCT02247349|566546713|FG002|Overall Study|Other reasons|1|||
156942708|NCT02247349|566546714|FG003|Overall Study|Other reasons|0|||
156942709|NCT02247349|566546715|FG004|Overall Study|Other reasons|0|||
156942710|NCT02247349|566546716|FG005|Overall Study|Other reasons|0|||
156942711|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Adverse Event|41|||
156942712|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Adverse Event|24|||
156942713|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
157167421|NCT01352845|567354551|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
157167422|NCT01352845|567354550|FG000|Overall Study|Pregnancy|27|||
157167423|NCT01352845|567354551|FG001|Overall Study|Pregnancy|7|||
156942714|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
156942715|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
156942716|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
156942717|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Physician Decision|0|||
156942718|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Physician Decision|6|||
157167424|NCT01352845|567354550|FG000|Overall Study|Adverse Event|22|||
156942719|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
156942720|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
156942721|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
156942722|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
156942723|NCT00673452|566546718|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
156942724|NCT00673452|566546719|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
156942725|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
156942726|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
156942727|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
156942728|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
156942729|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
156942730|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
156942731|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
156942732|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
156942733|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
156942734|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
156942735|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
156942736|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
156942737|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
156942738|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
156942739|NCT00673452|566546718|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
156942740|NCT00673452|566546719|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
156942741|NCT00617240|566546720|FG000|Overall Study|Lack of Efficacy|1|||
156942742|NCT00617240|566546721|FG001|Overall Study|Lack of Efficacy|0|||
156942743|NCT01611259|566546722|FG000|Overall Study|Physician Decision|1|||
156942744|NCT01611259|566546722|FG000|Overall Study|Lack of Efficacy|2|||
156942745|NCT01611259|566546722|FG000|Overall Study|Adverse Event|4|||
156942746|NCT01611259|566546722|FG000|Overall Study|Withdrawal by Subject|7|||
156942747|NCT04936685|566546723|FG000|Overall Study|Protocol Violation|1|||
156942748|NCT04936685|566546724|FG001|Overall Study|Protocol Violation|0|||
156942749|NCT02410811|566546728|FG000|Overall Study|Withdrawal by Subject|0|||
156942750|NCT02410811|566546729|FG001|Overall Study|Withdrawal by Subject|0|||
156942751|NCT02410811|566546730|FG002|Overall Study|Withdrawal by Subject|1|||
156942752|NCT02410811|566546731|FG003|Overall Study|Withdrawal by Subject|0|||
156942753|NCT00353366|566546732|FG000|Overall Study|Adverse Event|8|||
156942754|NCT00353366|566546732|FG000|Overall Study|Protocol Violation|12|||
156942755|NCT00353366|566546732|FG000|Overall Study|Withdrawal by Subject|12|||
156942756|NCT00353366|566546732|FG000|Overall Study|Lost to Follow-up|92|||
156942757|NCT00353366|566546732|FG000|Overall Study|Other|19|||
156942758|NCT00259857|566546733|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
156942759|NCT00259857|566546734|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
156942760|NCT00259857|566546733|FG000|24 Months Treatment|Lost to Follow-up|0|||
156942761|NCT00259857|566546734|FG001|24 Months Treatment|Lost to Follow-up|3|||
156942762|NCT05267054|566546735|FG000|Overall Study|Death|13|||
156942763|NCT05267054|566546736|FG001|Overall Study|Death|14|||
156942764|NCT05267054|566546735|FG000|Overall Study|Study Ended by Sponsor|9|||
156942765|NCT05267054|566546736|FG001|Overall Study|Study Ended by Sponsor|13|||
156942766|NCT05267054|566546735|FG000|Overall Study|Lost to Follow-up|1|||
156942767|NCT05267054|566546736|FG001|Overall Study|Lost to Follow-up|1|||
156942768|NCT05267054|566546735|FG000|Overall Study|Withdrawal by Subject|1|||
156942769|NCT05267054|566546736|FG001|Overall Study|Withdrawal by Subject|1|||
156942770|NCT01552226|566546739|FG000|Overall Study|Withdrawal by Subject|4|||
156942771|NCT01552226|566546740|FG001|Overall Study|Withdrawal by Subject|4|||
156942772|NCT03511560|566546743|FG000|Overall Study|Death|0|||
156942773|NCT03511560|566546744|FG001|Overall Study|Death|1|||
156942774|NCT03511560|566546743|FG000|Overall Study|Adverse Event|0|||
156942775|NCT03511560|566546744|FG001|Overall Study|Adverse Event|2|||
156942776|NCT03511560|566546743|FG000|Overall Study|Transplant cancelled|0|||
156942777|NCT03511560|566546744|FG001|Overall Study|Transplant cancelled|1|||
156942778|NCT03511560|566546743|FG000|Overall Study|Patient switched to another drug|1|||
156942779|NCT03511560|566546744|FG001|Overall Study|Patient switched to another drug|0|||
156942780|NCT01813019|566546750|FG000|Overall Study|Adverse Event|0|||
156942781|NCT01813019|566546751|FG001|Overall Study|Adverse Event|3|||
156942782|NCT01813019|566546750|FG000|Overall Study|Withdrawal by Subject|3|||
156942783|NCT01813019|566546751|FG001|Overall Study|Withdrawal by Subject|2|||
156942784|NCT01813019|566546750|FG000|Overall Study|administrative problems|2|||
156942785|NCT01813019|566546751|FG001|Overall Study|administrative problems|0|||
156942786|NCT01813019|566546750|FG000|Overall Study|Protocol Deviation|2|||
157032634|NCT03533257|566874701|FG000|Overall Study|Adverse Event|4|||
156942787|NCT01813019|566546751|FG001|Overall Study|Protocol Deviation|1|||
156942788|NCT00578565|566546753|FG000|Overall Study|Adverse Event|3|||
157032635|NCT03533257|566874702|FG001|Overall Study|Adverse Event|2|||
156942789|NCT03025828|566546754|FG000|Overall Study|Lost to Follow-up|1|||
156942790|NCT02143843|566546757|FG000|Overall Study|Adverse Event|8|||
156942791|NCT02143843|566546757|FG000|Overall Study|Lack of Efficacy|2|||
156942792|NCT02143843|566546757|FG000|Overall Study|Withdrawal by Subject|2|||
156942793|NCT00480779|566546758|FG000|Overall Study|Other|2|||
156942794|NCT00480779|566546759|FG001|Overall Study|Other|0|||
156942795|NCT00480779|566546758|FG000|Overall Study|Job and Health-related|0|||
156942796|NCT00480779|566546759|FG001|Overall Study|Job and Health-related|3|||
156942797|NCT01339390|566546762|FG000|Overall Study|Death|32|||
156942798|NCT01339390|566546763|FG001|Overall Study|Death|29|||
156942799|NCT01339390|566546762|FG000|Overall Study|Lost to Follow-up|125|||
156942800|NCT01339390|566546763|FG001|Overall Study|Lost to Follow-up|127|||
156942801|NCT01462357|566546772|FG000|Overall Study|Death|0|||
156942802|NCT01462357|566546773|FG001|Overall Study|Death|0|||
156942803|NCT01462357|566546774|FG002|Overall Study|Death|1|||
156942804|NCT01462357|566546772|FG000|Overall Study|Withdrawal by Subject|3|||
156942805|NCT01462357|566546773|FG001|Overall Study|Withdrawal by Subject|11|||
156942806|NCT01462357|566546774|FG002|Overall Study|Withdrawal by Subject|3|||
156942807|NCT01462357|566546772|FG000|Overall Study|Migrated/moved from study area|2|||
156942808|NCT01462357|566546773|FG001|Overall Study|Migrated/moved from study area|3|||
156942809|NCT01462357|566546774|FG002|Overall Study|Migrated/moved from study area|1|||
156942810|NCT01462357|566546772|FG000|Overall Study|Lost to Follow-up|3|||
156942811|NCT01462357|566546773|FG001|Overall Study|Lost to Follow-up|5|||
156942812|NCT01462357|566546774|FG002|Overall Study|Lost to Follow-up|7|||
156942813|NCT00806546|566546793|FG000|Overall Study|Enrolled, not treated|35|||
156942814|NCT00806546|566546793|FG000|Overall Study|Lost to Follow-up|32|||
156942815|NCT00806546|566546793|FG000|Overall Study|Adverse Event|74|||
156942816|NCT00806546|566546793|FG000|Overall Study|Withdrawal by Subject|75|||
156942817|NCT00806546|566546793|FG000|Overall Study|Protocol Violation|49|||
156942818|NCT00806546|566546793|FG000|Overall Study|Various|42|||
156942819|NCT01247090|566546794|FG000|Overall Study|Physician Decision|1|||
156942820|NCT01247090|566546795|FG001|Overall Study|Physician Decision|0|||
156942821|NCT01247090|566546796|FG002|Overall Study|Physician Decision|0|||
156942822|NCT01247090|566546794|FG000|Overall Study|Withdrawal by Subject|0|||
156942823|NCT01247090|566546795|FG001|Overall Study|Withdrawal by Subject|1|||
156942824|NCT01247090|566546796|FG002|Overall Study|Withdrawal by Subject|0|||
156942825|NCT02751983|566546801|FG000|Treatment|Stopped ACT, but Remained in study|2|||
156942826|NCT02751983|566546802|FG001|Treatment|Stopped ACT, but Remained in study|0|||
156942827|NCT02751983|566546801|FG000|Treatment|Discharged prior to beginning ACT|2|||
156942828|NCT02751983|566546802|FG001|Treatment|Discharged prior to beginning ACT|0|||
156942829|NCT02751983|566546801|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
156942830|NCT02751983|566546802|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
156942831|NCT02751983|566546801|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
156942832|NCT02751983|566546802|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
156942833|NCT02751983|566546801|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
156942834|NCT02751983|566546802|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
156942835|NCT00989833|566546803|FG000|Overall Study|Lost to Follow-up|0|||
156942836|NCT00989833|566546804|FG001|Overall Study|Lost to Follow-up|1|||
156942837|NCT00989833|566546805|FG002|Overall Study|Lost to Follow-up|0|||
156942838|NCT00989833|566546803|FG000|Overall Study|Protocol Violation|1|||
156942839|NCT00989833|566546804|FG001|Overall Study|Protocol Violation|2|||
156942840|NCT00989833|566546805|FG002|Overall Study|Protocol Violation|1|||
156942841|NCT00989833|566546803|FG000|Overall Study|Withdrawal by Subject|0|||
156942842|NCT00989833|566546804|FG001|Overall Study|Withdrawal by Subject|0|||
156942843|NCT00989833|566546805|FG002|Overall Study|Withdrawal by Subject|1|||
156942844|NCT00989833|566546803|FG000|Overall Study|Incorrectly randomized|1|||
156942845|NCT00989833|566546804|FG001|Overall Study|Incorrectly randomized|0|||
156942846|NCT00989833|566546805|FG002|Overall Study|Incorrectly randomized|0|||
156942847|NCT00308711|566546806|FG000|Overall Study|Withdrawal by Subject|1|||
156942848|NCT00308711|566546807|FG001|Overall Study|Withdrawal by Subject|0|||
156942849|NCT00308711|566546808|FG002|Overall Study|Withdrawal by Subject|1|||
156942850|NCT00308711|566546806|FG000|Overall Study|Protocol Violation|0|||
156942851|NCT00308711|566546807|FG001|Overall Study|Protocol Violation|1|||
156942852|NCT00308711|566546808|FG002|Overall Study|Protocol Violation|1|||
156942853|NCT00308711|566546806|FG000|Overall Study|Lost to Follow-up|0|||
156942854|NCT00308711|566546807|FG001|Overall Study|Lost to Follow-up|1|||
156942855|NCT00308711|566546808|FG002|Overall Study|Lost to Follow-up|0|||
156942856|NCT00308711|566546806|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
156942857|NCT00308711|566546807|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
156942858|NCT00308711|566546808|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
156942859|NCT00308711|566546806|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
156942860|NCT00308711|566546807|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
156942861|NCT00308711|566546808|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
156942862|NCT02318693|566546809|FG000|Overall Study|Protocol Violation|0|||
156942863|NCT02318693|566546810|FG001|Overall Study|Protocol Violation|1|||
156942864|NCT03890367|566546816|FG000|Overall Study|Withdrawal by parent/guardian|1|||
156942865|NCT03890367|566546817|FG001|Overall Study|Withdrawal by parent/guardian|3|||
156942866|NCT03890367|566546818|FG002|Overall Study|Withdrawal by parent/guardian|0|||
156942867|NCT03890367|566546816|FG000|Overall Study|Protocol deviation|2|||
156942868|NCT03890367|566546817|FG001|Overall Study|Protocol deviation|2|||
156942869|NCT03890367|566546818|FG002|Overall Study|Protocol deviation|1|||
156942870|NCT03890367|566546816|FG000|Overall Study|Lost to Follow-up|1|||
156942871|NCT03890367|566546817|FG001|Overall Study|Lost to Follow-up|1|||
156942872|NCT03890367|566546818|FG002|Overall Study|Lost to Follow-up|0|||
156942873|NCT00991302|566548844|FG000|Overall Study|Death|0|||
156942874|NCT00991302|566548845|FG001|Overall Study|Death|1|||
156942875|NCT00991302|566548844|FG000|Overall Study|Lost to Follow-up|14|||
156942876|NCT00991302|566548845|FG001|Overall Study|Lost to Follow-up|12|||
156942877|NCT03370341|566548846|FG000|Overall Study|Lost to Follow-up|0|||
156942878|NCT03370341|566548847|FG001|Overall Study|Lost to Follow-up|1|||
156942879|NCT02383758|566548848|FG000|Overall Study|Withdrawal by Subject|0|||
156942880|NCT02383758|566548849|FG001|Overall Study|Withdrawal by Subject|2|||
156942881|NCT01707004|566548852|FG000|Overall Study|Physician Decision|3|||
156942882|NCT03085927|566548856|FG000|Overall Study|Withdrawal by Subject|1|||
156942883|NCT03085927|566548857|FG001|Overall Study|Withdrawal by Subject|4|||
156942884|NCT03085927|566548856|FG000|Overall Study|Lost to Follow-up|3|||
156942885|NCT03085927|566548857|FG001|Overall Study|Lost to Follow-up|1|||
156942886|NCT03085927|566548856|FG000|Overall Study|Death|1|||
156942887|NCT03085927|566548857|FG001|Overall Study|Death|0|||
156942888|NCT03085927|566548856|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
156942889|NCT03085927|566548857|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
156942890|NCT03085927|566548856|FG000|Overall Study|Dyad Became Ineligible|0|||
156942891|NCT03085927|566548857|FG001|Overall Study|Dyad Became Ineligible|1|||
156942892|NCT01607905|566548858|FG000|Overall Study|Withdrawal by participant|7|||
156942893|NCT01607905|566548859|FG001|Overall Study|Withdrawal by participant|2|||
156942894|NCT01607905|566548860|FG002|Overall Study|Withdrawal by participant|4|||
156942895|NCT01607905|566548861|FG003|Overall Study|Withdrawal by participant|6|||
156942896|NCT01607905|566548862|FG004|Overall Study|Withdrawal by participant|0|||
156942897|NCT01607905|566548863|FG005|Overall Study|Withdrawal by participant|4|||
156942898|NCT01607905|566548864|FG006|Overall Study|Withdrawal by participant|12|||
156942899|NCT01607905|566548858|FG000|Overall Study|Incidence or severity of AEs|5|||
156942900|NCT01607905|566548859|FG001|Overall Study|Incidence or severity of AEs|1|||
156942901|NCT01607905|566548860|FG002|Overall Study|Incidence or severity of AEs|1|||
156942902|NCT01607905|566548861|FG003|Overall Study|Incidence or severity of AEs|3|||
156942903|NCT01607905|566548862|FG004|Overall Study|Incidence or severity of AEs|0|||
156942904|NCT01607905|566548863|FG005|Overall Study|Incidence or severity of AEs|2|||
156942905|NCT01607905|566548864|FG006|Overall Study|Incidence or severity of AEs|8|||
156942906|NCT01607905|566548858|FG000|Overall Study|Disease progression|44|||
156942907|NCT01607905|566548859|FG001|Overall Study|Disease progression|16|||
156942908|NCT01607905|566548860|FG002|Overall Study|Disease progression|15|||
156942909|NCT01607905|566548861|FG003|Overall Study|Disease progression|11|||
156942910|NCT01607905|566548862|FG004|Overall Study|Disease progression|6|||
156942911|NCT01607905|566548863|FG005|Overall Study|Disease progression|7|||
156942912|NCT01607905|566548864|FG006|Overall Study|Disease progression|21|||
156942913|NCT01607905|566548858|FG000|Overall Study|Non-compliance with study procedures|0|||
156942914|NCT01607905|566548859|FG001|Overall Study|Non-compliance with study procedures|0|||
156942915|NCT01607905|566548860|FG002|Overall Study|Non-compliance with study procedures|0|||
156942916|NCT01607905|566548861|FG003|Overall Study|Non-compliance with study procedures|0|||
156942917|NCT01607905|566548862|FG004|Overall Study|Non-compliance with study procedures|0|||
156942918|NCT01607905|566548863|FG005|Overall Study|Non-compliance with study procedures|0|||
156942919|NCT01607905|566548864|FG006|Overall Study|Non-compliance with study procedures|1|||
156942920|NCT01607905|566548858|FG000|Overall Study|Death|1|||
156942921|NCT01607905|566548859|FG001|Overall Study|Death|1|||
156942922|NCT01607905|566548860|FG002|Overall Study|Death|1|||
156942923|NCT01607905|566548861|FG003|Overall Study|Death|1|||
156942924|NCT01607905|566548862|FG004|Overall Study|Death|0|||
156942925|NCT01607905|566548863|FG005|Overall Study|Death|0|||
156942926|NCT01607905|566548864|FG006|Overall Study|Death|3|||
156942927|NCT01607905|566548858|FG000|Overall Study|Other treatments become available|1|||
156942928|NCT01607905|566548859|FG001|Overall Study|Other treatments become available|0|||
156942929|NCT01607905|566548860|FG002|Overall Study|Other treatments become available|0|||
156942930|NCT01607905|566548861|FG003|Overall Study|Other treatments become available|0|||
156942931|NCT01607905|566548862|FG004|Overall Study|Other treatments become available|0|||
156942932|NCT01607905|566548863|FG005|Overall Study|Other treatments become available|0|||
156942933|NCT01607905|566548864|FG006|Overall Study|Other treatments become available|1|||
156942934|NCT01607905|566548858|FG000|Overall Study|Investigator discretion|0|||
156942935|NCT01607905|566548859|FG001|Overall Study|Investigator discretion|0|||
156942936|NCT01607905|566548860|FG002|Overall Study|Investigator discretion|0|||
156942937|NCT01607905|566548861|FG003|Overall Study|Investigator discretion|0|||
156942938|NCT01607905|566548862|FG004|Overall Study|Investigator discretion|0|||
156942939|NCT01607905|566548863|FG005|Overall Study|Investigator discretion|1|||
156942940|NCT01607905|566548864|FG006|Overall Study|Investigator discretion|0|||
156942941|NCT01607905|566548858|FG000|Overall Study|Other|1|||
156942942|NCT01607905|566548859|FG001|Overall Study|Other|0|||
156942943|NCT01607905|566548860|FG002|Overall Study|Other|0|||
156942944|NCT01607905|566548861|FG003|Overall Study|Other|0|||
156942945|NCT01607905|566548862|FG004|Overall Study|Other|0|||
156942946|NCT01607905|566548863|FG005|Overall Study|Other|0|||
156942947|NCT01607905|566548864|FG006|Overall Study|Other|1|||
156942948|NCT01607905|566548858|FG000|Overall Study|Randomized but not treated|1|||
156942949|NCT01607905|566548859|FG001|Overall Study|Randomized but not treated|0|||
156942950|NCT01607905|566548860|FG002|Overall Study|Randomized but not treated|0|||
156942951|NCT01607905|566548861|FG003|Overall Study|Randomized but not treated|0|||
156942952|NCT01607905|566548862|FG004|Overall Study|Randomized but not treated|1|||
156942953|NCT01607905|566548863|FG005|Overall Study|Randomized but not treated|1|||
156942954|NCT01607905|566548864|FG006|Overall Study|Randomized but not treated|0|||
156942955|NCT01519518|566548865|FG000|Overall Study|Consent not available|7|||
156942956|NCT01519518|566548866|FG001|Overall Study|Consent not available|10|||
156942957|NCT00298896|566548868|FG000|Overall Study|Death|3|||
156942958|NCT00298896|566548868|FG000|Overall Study|Physician Decision|2|||
156942959|NCT00298896|566548868|FG000|Overall Study|Intercurrent Illness|1|||
156942960|NCT00298896|566548868|FG000|Overall Study|Disease Progression|41|||
156942961|NCT00298896|566548868|FG000|Overall Study|Withdrawal by Subject|2|||
156942962|NCT00298896|566548868|FG000|Overall Study|Assigned to treatment in error|1|||
156942963|NCT02880371|566548869|FG000|Phase 1b|Lost to Follow-up|1|||
156942964|NCT02880371|566548870|FG001|Phase 1b|Lost to Follow-up|0|||
156942965|NCT02880371|566548871|FG002|Phase 1b|Lost to Follow-up|0|||
156942966|NCT02880371|566548872|FG003|Phase 1b|Lost to Follow-up|0|||
156942967|NCT02880371|566548873|FG004|Phase 1b|Lost to Follow-up|0|||
156942968|NCT02880371|566548874|FG005|Phase 1b|Lost to Follow-up|0|||
156942969|NCT02880371|566548875|FG006|Phase 1b|Lost to Follow-up|0|||
156942970|NCT02880371|566548876|FG007|Phase 1b|Lost to Follow-up|0|||
156942971|NCT02880371|566548869|FG000|Phase 1b|Participants terminated by Sponsor|1|||
156942972|NCT02880371|566548870|FG001|Phase 1b|Participants terminated by Sponsor|0|||
156942973|NCT02880371|566548871|FG002|Phase 1b|Participants terminated by Sponsor|0|||
156942974|NCT02880371|566548872|FG003|Phase 1b|Participants terminated by Sponsor|0|||
156942975|NCT02880371|566548873|FG004|Phase 1b|Participants terminated by Sponsor|0|||
156942976|NCT02880371|566548874|FG005|Phase 1b|Participants terminated by Sponsor|0|||
156942977|NCT02880371|566548875|FG006|Phase 1b|Participants terminated by Sponsor|0|||
156942978|NCT02880371|566548876|FG007|Phase 1b|Participants terminated by Sponsor|0|||
156942979|NCT02880371|566548869|FG000|Phase 1b|Withdrawal by Subject|0|||
156942980|NCT02880371|566548870|FG001|Phase 1b|Withdrawal by Subject|0|||
156942981|NCT02880371|566548871|FG002|Phase 1b|Withdrawal by Subject|1|||
156942982|NCT02880371|566548872|FG003|Phase 1b|Withdrawal by Subject|0|||
156942983|NCT02880371|566548873|FG004|Phase 1b|Withdrawal by Subject|0|||
156942984|NCT02880371|566548874|FG005|Phase 1b|Withdrawal by Subject|0|||
156942985|NCT02880371|566548875|FG006|Phase 1b|Withdrawal by Subject|0|||
156942986|NCT02880371|566548876|FG007|Phase 1b|Withdrawal by Subject|0|||
156942987|NCT02880371|566548869|FG000|Phase 1b|Death|4|||
156942988|NCT02880371|566548870|FG001|Phase 1b|Death|6|||
156942989|NCT02880371|566548871|FG002|Phase 1b|Death|5|||
156942990|NCT02880371|566548872|FG003|Phase 1b|Death|1|||
156942991|NCT02880371|566548873|FG004|Phase 1b|Death|0|||
156942992|NCT02880371|566548874|FG005|Phase 1b|Death|0|||
156942993|NCT02880371|566548875|FG006|Phase 1b|Death|0|||
156942994|NCT02880371|566548876|FG007|Phase 1b|Death|0|||
156942995|NCT02880371|566548869|FG000|Phase 1b|Enrolled but not Treated|0|||
156942996|NCT02880371|566548870|FG001|Phase 1b|Enrolled but not Treated|1|||
156942997|NCT02880371|566548871|FG002|Phase 1b|Enrolled but not Treated|0|||
156942998|NCT02880371|566548872|FG003|Phase 1b|Enrolled but not Treated|0|||
156942999|NCT02880371|566548873|FG004|Phase 1b|Enrolled but not Treated|0|||
156943000|NCT02880371|566548874|FG005|Phase 1b|Enrolled but not Treated|0|||
156943001|NCT02880371|566548875|FG006|Phase 1b|Enrolled but not Treated|0|||
156943002|NCT02880371|566548876|FG007|Phase 1b|Enrolled but not Treated|0|||
156943003|NCT02880371|566548869|FG000|Phase 2|Enrolled but not Treated|0|||
156943004|NCT02880371|566548870|FG001|Phase 2|Enrolled but not Treated|0|||
156943005|NCT02880371|566548871|FG002|Phase 2|Enrolled but not Treated|0|||
156943006|NCT02880371|566548872|FG003|Phase 2|Enrolled but not Treated|0|||
156943007|NCT02880371|566548873|FG004|Phase 2|Enrolled but not Treated|0|||
157227324|NCT00950807|567577784|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156943008|NCT02880371|566548874|FG005|Phase 2|Enrolled but not Treated|1|||
156943009|NCT02880371|566548875|FG006|Phase 2|Enrolled but not Treated|1|||
156943010|NCT02880371|566548876|FG007|Phase 2|Enrolled but not Treated|0|||
156943011|NCT02880371|566548869|FG000|Phase 2|Other|0|||
156943012|NCT02880371|566548870|FG001|Phase 2|Other|0|||
156943013|NCT02880371|566548871|FG002|Phase 2|Other|0|||
156943014|NCT02880371|566548872|FG003|Phase 2|Other|0|||
157227325|NCT00950807|567577785|FG004|Treatment Period 2|Withdrawal by Subject|0|||
156943015|NCT02880371|566548873|FG004|Phase 2|Other|0|||
156943016|NCT02880371|566548874|FG005|Phase 2|Other|1|||
156943017|NCT02880371|566548875|FG006|Phase 2|Other|2|||
156943018|NCT02880371|566548876|FG007|Phase 2|Other|1|||
156943019|NCT02880371|566548869|FG000|Phase 2|Participants terminated by Sponsor|0|||
156943020|NCT02880371|566548870|FG001|Phase 2|Participants terminated by Sponsor|0|||
156943021|NCT02880371|566548871|FG002|Phase 2|Participants terminated by Sponsor|0|||
156943022|NCT02880371|566548872|FG003|Phase 2|Participants terminated by Sponsor|0|||
156943023|NCT02880371|566548873|FG004|Phase 2|Participants terminated by Sponsor|1|||
156943024|NCT02880371|566548874|FG005|Phase 2|Participants terminated by Sponsor|6|||
157167425|NCT01352845|567354551|FG001|Overall Study|Adverse Event|6|||
157167426|NCT01352845|567354550|FG000|Overall Study|Other|17|||
157167427|NCT01352845|567354551|FG001|Overall Study|Other|7|||
157167428|NCT01352845|567354550|FG000|Overall Study|Protocol Violation|12|||
156943025|NCT02880371|566548875|FG006|Phase 2|Participants terminated by Sponsor|1|||
156943026|NCT02880371|566548876|FG007|Phase 2|Participants terminated by Sponsor|5|||
156943027|NCT02880371|566548869|FG000|Phase 2|Death|0|||
156943028|NCT02880371|566548870|FG001|Phase 2|Death|0|||
156943029|NCT02880371|566548871|FG002|Phase 2|Death|0|||
156943030|NCT02880371|566548872|FG003|Phase 2|Death|0|||
156943031|NCT02880371|566548873|FG004|Phase 2|Death|1|||
156943032|NCT02880371|566548874|FG005|Phase 2|Death|10|||
156943033|NCT02880371|566548875|FG006|Phase 2|Death|20|||
156943034|NCT02880371|566548876|FG007|Phase 2|Death|5|||
156943035|NCT02880371|566548869|FG000|Phase 2|Lost to Follow-up|0|||
156943036|NCT02880371|566548870|FG001|Phase 2|Lost to Follow-up|0|||
156943037|NCT02880371|566548871|FG002|Phase 2|Lost to Follow-up|0|||
156943038|NCT02880371|566548872|FG003|Phase 2|Lost to Follow-up|0|||
156943039|NCT02880371|566548873|FG004|Phase 2|Lost to Follow-up|0|||
156943040|NCT02880371|566548874|FG005|Phase 2|Lost to Follow-up|0|||
156943041|NCT02880371|566548875|FG006|Phase 2|Lost to Follow-up|3|||
156943042|NCT02880371|566548876|FG007|Phase 2|Lost to Follow-up|0|||
156943043|NCT02880371|566548869|FG000|Phase 2|Withdrawal by Subject|0|||
156943044|NCT02880371|566548870|FG001|Phase 2|Withdrawal by Subject|0|||
156943045|NCT02880371|566548871|FG002|Phase 2|Withdrawal by Subject|0|||
156943046|NCT02880371|566548872|FG003|Phase 2|Withdrawal by Subject|0|||
156943047|NCT02880371|566548873|FG004|Phase 2|Withdrawal by Subject|0|||
156943048|NCT02880371|566548874|FG005|Phase 2|Withdrawal by Subject|1|||
156943049|NCT02880371|566548875|FG006|Phase 2|Withdrawal by Subject|1|||
156943050|NCT02880371|566548876|FG007|Phase 2|Withdrawal by Subject|0|||
156943051|NCT02880371|566548869|FG000|Phase 2|End of Study page not completed by error|0|||
156943052|NCT02880371|566548870|FG001|Phase 2|End of Study page not completed by error|0|||
156943053|NCT02880371|566548871|FG002|Phase 2|End of Study page not completed by error|0|||
156943054|NCT02880371|566548872|FG003|Phase 2|End of Study page not completed by error|0|||
156943055|NCT02880371|566548873|FG004|Phase 2|End of Study page not completed by error|0|||
156943056|NCT02880371|566548874|FG005|Phase 2|End of Study page not completed by error|1|||
156943057|NCT02880371|566548875|FG006|Phase 2|End of Study page not completed by error|0|||
156943058|NCT02880371|566548876|FG007|Phase 2|End of Study page not completed by error|0|||
156943059|NCT01777997|566548879|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
156943060|NCT01777997|566548879|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
156943061|NCT01777997|566548879|FG000|Weeks 48 to 72/96 on ART|Death|1|||
156943062|NCT01777997|566548879|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
156943063|NCT03285646|566548880|FG000|Overall Study|Adverse Event|1|||
156943064|NCT03285646|566548881|FG001|Overall Study|Adverse Event|0|||
156943065|NCT03285646|566548880|FG000|Overall Study|Withdrawal by Subject|10|||
156943066|NCT03285646|566548881|FG001|Overall Study|Withdrawal by Subject|2|||
156943067|NCT03285646|566548880|FG000|Overall Study|Lost to Follow-up|2|||
156943068|NCT03285646|566548881|FG001|Overall Study|Lost to Follow-up|1|||
156943069|NCT03285646|566548880|FG000|Overall Study|Investigator/Sponsor Decision|0|||
156943070|NCT03285646|566548881|FG001|Overall Study|Investigator/Sponsor Decision|1|||
156943071|NCT00306592|566548885|FG000|Overall Study|Adverse Event|8|||
156943072|NCT00306592|566548886|FG001|Overall Study|Adverse Event|15|||
156943073|NCT00306592|566548885|FG000|Overall Study|Lost to Follow-up|1|||
156943074|NCT00306592|566548886|FG001|Overall Study|Lost to Follow-up|0|||
156943075|NCT00306592|566548885|FG000|Overall Study|Noncompliance|0|||
156943076|NCT00306592|566548886|FG001|Overall Study|Noncompliance|2|||
156943077|NCT00306592|566548885|FG000|Overall Study|Persistent Antibodies|6|||
157167429|NCT01352845|567354551|FG001|Overall Study|Protocol Violation|6|||
157167430|NCT01352845|567354550|FG000|Overall Study|Death|3|||
157167431|NCT01352845|567354551|FG001|Overall Study|Death|0|||
156943078|NCT00306592|566548886|FG001|Overall Study|Persistent Antibodies|3|||
157167432|NCT02062463|567354552|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
156943079|NCT00306592|566548885|FG000|Overall Study|Voluntary|10|||
156943080|NCT00306592|566548886|FG001|Overall Study|Voluntary|6|||
156943081|NCT00306592|566548885|FG000|Overall Study|Other|5|||
156943082|NCT00306592|566548886|FG001|Overall Study|Other|10|||
156943083|NCT00306592|566548885|FG000|Overall Study|Other|1|||
156943084|NCT00306592|566548886|FG001|Overall Study|Other|2|||
157167433|NCT02062463|567354553|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
156943085|NCT00306592|566548885|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
156943086|NCT00306592|566548886|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
156943087|NCT04101526|566548887|FG000|Overall Study|Did not complete all sleep diary entries|0|||
156943088|NCT04101526|566548888|FG001|Overall Study|Did not complete all sleep diary entries|1|||
156943089|NCT00424372|566548890|FG000|Overall Study|Death|1|||
156943090|NCT00424372|566548890|FG000|Overall Study|Adverse Event|18|||
156943091|NCT00424372|566548890|FG000|Overall Study|Lack of Efficacy|6|||
156943092|NCT00424372|566548890|FG000|Overall Study|Withdrawal by Subject|4|||
156943093|NCT00424372|566548890|FG000|Overall Study|Protocol Violation|1|||
156943094|NCT00424372|566548890|FG000|Overall Study|Health deterioration|1|||
156943095|NCT02488629|566548891|FG000|Overall Study|Lack of Efficacy|3|||
156943096|NCT02488629|566548892|FG001|Overall Study|Lack of Efficacy|1|||
156943097|NCT02488629|566548893|FG002|Overall Study|Lack of Efficacy|0|||
156943098|NCT02488629|566548894|FG003|Overall Study|Lack of Efficacy|0|||
156943099|NCT02488629|566548891|FG000|Overall Study|Withdrawal by Subject|0|||
156943100|NCT02488629|566548892|FG001|Overall Study|Withdrawal by Subject|1|||
156943101|NCT02488629|566548893|FG002|Overall Study|Withdrawal by Subject|0|||
156943102|NCT02488629|566548894|FG003|Overall Study|Withdrawal by Subject|0|||
156943103|NCT02652624|566548895|FG000|Randomized Phase|Pregnancy|3|||
156943104|NCT02652624|566548896|FG001|Randomized Phase|Pregnancy|1|||
156943105|NCT02652624|566548895|FG000|Randomized Phase|Investigator's Discretion|0|||
156943106|NCT02652624|566548896|FG001|Randomized Phase|Investigator's Discretion|2|||
156943107|NCT02652624|566548895|FG000|Randomized Phase|Death|0|||
156943108|NCT02652624|566548896|FG001|Randomized Phase|Death|1|||
156943109|NCT02652624|566548895|FG000|Randomized Phase|Lost to Follow-up|0|||
156943110|NCT02652624|566548896|FG001|Randomized Phase|Lost to Follow-up|1|||
156943111|NCT02652624|566548895|FG000|Extension Phase|Lost to Follow-up|3|||
156943112|NCT02652624|566548896|FG001|Extension Phase|Lost to Follow-up|1|||
156943113|NCT02652624|566548895|FG000|Extension Phase|Pregnancy|1|||
156943114|NCT02652624|566548896|FG001|Extension Phase|Pregnancy|1|||
156943115|NCT02652624|566548895|FG000|Extension Phase|Adverse Event|0|||
156943116|NCT02652624|566548896|FG001|Extension Phase|Adverse Event|1|||
156943117|NCT02652624|566548895|FG000|Extension Phase|Withdrew Consent|0|||
156943118|NCT02652624|566548896|FG001|Extension Phase|Withdrew Consent|1|||
156943119|NCT00654628|566548897|FG000|6-week Active Treatment Period|Adverse Event|9|||
156943120|NCT00654628|566548897|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
156943121|NCT00654628|566548897|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
156943122|NCT00654628|566548897|FG000|6-week Active Treatment Period|Out of window period|1|||
156943123|NCT00654628|566548897|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
156943124|NCT00654628|566548897|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
156943125|NCT00912405|566548900|FG000|Overall Study|Lost to Follow-up|5|||
156943126|NCT00953329|566548901|FG000|Overall Study|Lack of Efficacy|1|||
156943127|NCT01434823|566548904|FG000|Overall Study|Incomplete data in medical record|4|||
156943128|NCT01434823|566548905|FG001|Overall Study|Incomplete data in medical record|7|||
156943129|NCT01797536|566548908|FG000|Overall Study|Adverse Event|0|||
156943130|NCT01797536|566548909|FG001|Overall Study|Adverse Event|1|||
156943131|NCT01797536|566548910|FG002|Overall Study|Adverse Event|0|||
156943132|NCT01797536|566548911|FG003|Overall Study|Adverse Event|0|||
156943133|NCT00796861|566548912|FG000|Overall Study|Withdrawal by Subject|2|||
156943134|NCT00796861|566548912|FG000|Overall Study|Death|2|||
156943135|NCT00844545|566548917|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
156943136|NCT00844545|566548917|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
156943137|NCT00844545|566548917|FG000|Extension Treatment Period|Adverse Event|2|||
156943138|NCT00844545|566548917|FG000|Post Treatment Period|Withdrawal by Subject|1|||
156943139|NCT01401530|566548923|FG000|Overall Study|Disease Progression|1|||
156943140|NCT01401530|566548924|FG001|Overall Study|Disease Progression|2|||
156943141|NCT01401530|566548925|FG002|Overall Study|Disease Progression|1|||
156943142|NCT01401530|566548923|FG000|Overall Study|Adverse Event|1|||
156943143|NCT01401530|566548924|FG001|Overall Study|Adverse Event|1|||
156943144|NCT01401530|566548925|FG002|Overall Study|Adverse Event|1|||
156943145|NCT01401530|566548923|FG000|Overall Study|Participant Choice|1|||
156943146|NCT01401530|566548924|FG001|Overall Study|Participant Choice|2|||
156943147|NCT01401530|566548925|FG002|Overall Study|Participant Choice|1|||
156943148|NCT01401530|566548923|FG000|Overall Study|Physician Decision|0|||
156943149|NCT01401530|566548924|FG001|Overall Study|Physician Decision|1|||
156943150|NCT01401530|566548925|FG002|Overall Study|Physician Decision|0|||
156943151|NCT03670810|566548926|FG000|Main Study|Adverse Event|37|||
156943152|NCT03670810|566548927|FG001|Main Study|Adverse Event|38|||
156943153|NCT03670810|566548928|FG002|Main Study|Adverse Event|3|||
156943154|NCT03670810|566548929|FG003|Main Study|Adverse Event|4|||
156943155|NCT03670810|566548930|FG004|Main Study|Adverse Event|4|||
156943156|NCT03670810|566548931|FG005|Main Study|Adverse Event|5|||
156943157|NCT03670810|566548932|FG006|Main Study|Adverse Event|0|||
156943158|NCT03670810|566548933|FG007|Main Study|Adverse Event|0|||
156943159|NCT03670810|566548934|FG008|Main Study|Adverse Event|0|||
156943160|NCT03670810|566548926|FG000|Main Study|Lack of Efficacy|8|||
156943161|NCT03670810|566548927|FG001|Main Study|Lack of Efficacy|9|||
156943162|NCT03670810|566548928|FG002|Main Study|Lack of Efficacy|3|||
156943163|NCT03670810|566548929|FG003|Main Study|Lack of Efficacy|4|||
156943164|NCT03670810|566548930|FG004|Main Study|Lack of Efficacy|0|||
156943165|NCT03670810|566548931|FG005|Main Study|Lack of Efficacy|0|||
156943166|NCT03670810|566548932|FG006|Main Study|Lack of Efficacy|0|||
156943167|NCT03670810|566548933|FG007|Main Study|Lack of Efficacy|0|||
156943168|NCT03670810|566548934|FG008|Main Study|Lack of Efficacy|0|||
156943169|NCT03670810|566548926|FG000|Main Study|Lost to Follow-up|9|||
156943170|NCT03670810|566548927|FG001|Main Study|Lost to Follow-up|7|||
156943171|NCT03670810|566548928|FG002|Main Study|Lost to Follow-up|4|||
156943172|NCT03670810|566548929|FG003|Main Study|Lost to Follow-up|6|||
156943173|NCT03670810|566548930|FG004|Main Study|Lost to Follow-up|1|||
156943174|NCT03670810|566548931|FG005|Main Study|Lost to Follow-up|0|||
156943175|NCT03670810|566548932|FG006|Main Study|Lost to Follow-up|0|||
156943176|NCT03670810|566548933|FG007|Main Study|Lost to Follow-up|0|||
156943177|NCT03670810|566548934|FG008|Main Study|Lost to Follow-up|0|||
156943178|NCT03670810|566548926|FG000|Main Study|Non-compliance with Study Drug|0|||
156943179|NCT03670810|566548927|FG001|Main Study|Non-compliance with Study Drug|2|||
156943180|NCT03670810|566548928|FG002|Main Study|Non-compliance with Study Drug|3|||
156943181|NCT03670810|566548929|FG003|Main Study|Non-compliance with Study Drug|0|||
156943182|NCT03670810|566548930|FG004|Main Study|Non-compliance with Study Drug|0|||
156943183|NCT03670810|566548931|FG005|Main Study|Non-compliance with Study Drug|0|||
156943184|NCT03670810|566548932|FG006|Main Study|Non-compliance with Study Drug|0|||
156943185|NCT03670810|566548933|FG007|Main Study|Non-compliance with Study Drug|1|||
156943186|NCT03670810|566548934|FG008|Main Study|Non-compliance with Study Drug|0|||
156943187|NCT03670810|566548926|FG000|Main Study|Physician Decision|3|||
156943188|NCT03670810|566548927|FG001|Main Study|Physician Decision|0|||
156943189|NCT03670810|566548928|FG002|Main Study|Physician Decision|1|||
156943190|NCT03670810|566548929|FG003|Main Study|Physician Decision|0|||
156943191|NCT03670810|566548930|FG004|Main Study|Physician Decision|0|||
156943192|NCT03670810|566548931|FG005|Main Study|Physician Decision|0|||
156943193|NCT03670810|566548932|FG006|Main Study|Physician Decision|1|||
156943194|NCT03670810|566548933|FG007|Main Study|Physician Decision|1|||
156943195|NCT03670810|566548934|FG008|Main Study|Physician Decision|0|||
156943196|NCT03670810|566548926|FG000|Main Study|Pregnancy|1|||
156943197|NCT03670810|566548927|FG001|Main Study|Pregnancy|2|||
156943198|NCT03670810|566548928|FG002|Main Study|Pregnancy|0|||
156943199|NCT03670810|566548929|FG003|Main Study|Pregnancy|0|||
156943200|NCT03670810|566548930|FG004|Main Study|Pregnancy|0|||
156943201|NCT03670810|566548931|FG005|Main Study|Pregnancy|0|||
156943202|NCT03670810|566548932|FG006|Main Study|Pregnancy|0|||
156943203|NCT03670810|566548933|FG007|Main Study|Pregnancy|0|||
156943204|NCT03670810|566548934|FG008|Main Study|Pregnancy|0|||
156943205|NCT03670810|566548926|FG000|Main Study|Protocol Deviation|2|||
156943206|NCT03670810|566548927|FG001|Main Study|Protocol Deviation|12|||
156943207|NCT03670810|566548928|FG002|Main Study|Protocol Deviation|8|||
156943208|NCT03670810|566548929|FG003|Main Study|Protocol Deviation|4|||
156943209|NCT03670810|566548930|FG004|Main Study|Protocol Deviation|0|||
156943210|NCT03670810|566548931|FG005|Main Study|Protocol Deviation|0|||
156943211|NCT03670810|566548932|FG006|Main Study|Protocol Deviation|0|||
156943212|NCT03670810|566548933|FG007|Main Study|Protocol Deviation|0|||
156943213|NCT03670810|566548934|FG008|Main Study|Protocol Deviation|0|||
156943214|NCT03670810|566548926|FG000|Main Study|Withdrawal by Subject|21|||
156943215|NCT03670810|566548927|FG001|Main Study|Withdrawal by Subject|21|||
156943216|NCT03670810|566548928|FG002|Main Study|Withdrawal by Subject|8|||
156943217|NCT03670810|566548929|FG003|Main Study|Withdrawal by Subject|9|||
156943218|NCT03670810|566548930|FG004|Main Study|Withdrawal by Subject|5|||
156943219|NCT03670810|566548931|FG005|Main Study|Withdrawal by Subject|2|||
156943220|NCT03670810|566548932|FG006|Main Study|Withdrawal by Subject|1|||
156943221|NCT03670810|566548933|FG007|Main Study|Withdrawal by Subject|1|||
156943222|NCT03670810|566548934|FG008|Main Study|Withdrawal by Subject|0|||
156943223|NCT03670810|566548926|FG000|Main Study|Participant did not want to take the three other treatments|1|||
156943224|NCT03670810|566548927|FG001|Main Study|Participant did not want to take the three other treatments|0|||
156943225|NCT03670810|566548928|FG002|Main Study|Participant did not want to take the three other treatments|0|||
156943226|NCT03670810|566548929|FG003|Main Study|Participant did not want to take the three other treatments|0|||
156943227|NCT03670810|566548930|FG004|Main Study|Participant did not want to take the three other treatments|0|||
156943228|NCT03670810|566548931|FG005|Main Study|Participant did not want to take the three other treatments|0|||
156943229|NCT03670810|566548932|FG006|Main Study|Participant did not want to take the three other treatments|0|||
156943230|NCT03670810|566548933|FG007|Main Study|Participant did not want to take the three other treatments|0|||
156943231|NCT03670810|566548934|FG008|Main Study|Participant did not want to take the three other treatments|0|||
156943232|NCT03670810|566548926|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943233|NCT03670810|566548927|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
156943234|NCT03670810|566548928|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943235|NCT03670810|566548929|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943236|NCT03670810|566548930|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943237|NCT03670810|566548931|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943238|NCT03670810|566548932|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943239|NCT03670810|566548933|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943240|NCT03670810|566548934|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
156943241|NCT03670810|566548926|FG000|Main Study|Travel and Coronavirus issues|0|||
156943242|NCT03670810|566548927|FG001|Main Study|Travel and Coronavirus issues|0|||
156943243|NCT03670810|566548928|FG002|Main Study|Travel and Coronavirus issues|0|||
157205213|NCT03669640|567496073|FG000|Overall Study|Lost to Follow-up|0|||
156943244|NCT03670810|566548929|FG003|Main Study|Travel and Coronavirus issues|1|||
156943245|NCT03670810|566548930|FG004|Main Study|Travel and Coronavirus issues|0|||
156943246|NCT03670810|566548931|FG005|Main Study|Travel and Coronavirus issues|0|||
156943247|NCT03670810|566548932|FG006|Main Study|Travel and Coronavirus issues|0|||
156943248|NCT03670810|566548933|FG007|Main Study|Travel and Coronavirus issues|0|||
156943249|NCT03670810|566548934|FG008|Main Study|Travel and Coronavirus issues|0|||
156943250|NCT03670810|566548926|FG000|Open Label Extension|Protocol Deviation|0|||
156943251|NCT03670810|566548927|FG001|Open Label Extension|Protocol Deviation|0|||
156943252|NCT03670810|566548928|FG002|Open Label Extension|Protocol Deviation|0|||
156943253|NCT03670810|566548929|FG003|Open Label Extension|Protocol Deviation|0|||
156943254|NCT03670810|566548930|FG004|Open Label Extension|Protocol Deviation|0|||
156943255|NCT03670810|566548931|FG005|Open Label Extension|Protocol Deviation|0|||
156943256|NCT03670810|566548932|FG006|Open Label Extension|Protocol Deviation|0|||
156943257|NCT03670810|566548933|FG007|Open Label Extension|Protocol Deviation|0|||
156943258|NCT03670810|566548934|FG008|Open Label Extension|Protocol Deviation|5|||
156943259|NCT03670810|566548926|FG000|Open Label Extension|Death|0|||
156943260|NCT03670810|566548927|FG001|Open Label Extension|Death|0|||
156943261|NCT03670810|566548928|FG002|Open Label Extension|Death|0|||
156943262|NCT03670810|566548929|FG003|Open Label Extension|Death|0|||
156943263|NCT03670810|566548930|FG004|Open Label Extension|Death|0|||
156943264|NCT03670810|566548931|FG005|Open Label Extension|Death|0|||
156943265|NCT03670810|566548932|FG006|Open Label Extension|Death|0|||
156943266|NCT03670810|566548933|FG007|Open Label Extension|Death|0|||
156943267|NCT03670810|566548934|FG008|Open Label Extension|Death|1|||
156943268|NCT03670810|566548926|FG000|Open Label Extension|COVID-19|0|||
156943269|NCT03670810|566548927|FG001|Open Label Extension|COVID-19|0|||
156943270|NCT03670810|566548928|FG002|Open Label Extension|COVID-19|0|||
156943271|NCT03670810|566548929|FG003|Open Label Extension|COVID-19|0|||
156943272|NCT03670810|566548930|FG004|Open Label Extension|COVID-19|0|||
156943273|NCT03670810|566548931|FG005|Open Label Extension|COVID-19|0|||
156943274|NCT03670810|566548932|FG006|Open Label Extension|COVID-19|0|||
156943275|NCT03670810|566548933|FG007|Open Label Extension|COVID-19|0|||
156943276|NCT03670810|566548934|FG008|Open Label Extension|COVID-19|1|||
156943277|NCT03670810|566548926|FG000|Open Label Extension|Lack of Efficacy|0|||
156943278|NCT03670810|566548927|FG001|Open Label Extension|Lack of Efficacy|0|||
156943279|NCT03670810|566548928|FG002|Open Label Extension|Lack of Efficacy|0|||
156943280|NCT03670810|566548929|FG003|Open Label Extension|Lack of Efficacy|0|||
156943281|NCT03670810|566548930|FG004|Open Label Extension|Lack of Efficacy|0|||
156943282|NCT03670810|566548931|FG005|Open Label Extension|Lack of Efficacy|0|||
156943283|NCT03670810|566548932|FG006|Open Label Extension|Lack of Efficacy|0|||
156943284|NCT03670810|566548933|FG007|Open Label Extension|Lack of Efficacy|0|||
156943285|NCT03670810|566548934|FG008|Open Label Extension|Lack of Efficacy|39|||
156943286|NCT03670810|566548926|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
156943287|NCT03670810|566548927|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
156943288|NCT03670810|566548928|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
156943289|NCT03670810|566548929|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
156943290|NCT03670810|566548930|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
156943291|NCT03670810|566548931|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
156943292|NCT03670810|566548932|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
156943293|NCT03670810|566548933|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
156943294|NCT03670810|566548934|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
156943295|NCT03670810|566548926|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943296|NCT03670810|566548927|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943297|NCT03670810|566548928|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943298|NCT03670810|566548929|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943299|NCT03670810|566548930|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943300|NCT03670810|566548931|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943301|NCT03670810|566548932|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943302|NCT03670810|566548933|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
156943303|NCT03670810|566548934|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
156943304|NCT03670810|566548926|FG000|Open Label Extension|Withdrawal by Subject|0|||
156943305|NCT03670810|566548927|FG001|Open Label Extension|Withdrawal by Subject|0|||
156943306|NCT03670810|566548928|FG002|Open Label Extension|Withdrawal by Subject|0|||
156943307|NCT03670810|566548929|FG003|Open Label Extension|Withdrawal by Subject|0|||
156943308|NCT03670810|566548930|FG004|Open Label Extension|Withdrawal by Subject|0|||
157032636|NCT03533257|566874701|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
156943309|NCT03670810|566548931|FG005|Open Label Extension|Withdrawal by Subject|0|||
156943310|NCT03670810|566548932|FG006|Open Label Extension|Withdrawal by Subject|0|||
156943311|NCT03670810|566548933|FG007|Open Label Extension|Withdrawal by Subject|0|||
156943312|NCT03670810|566548934|FG008|Open Label Extension|Withdrawal by Subject|46|||
157032637|NCT03533257|566874702|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
156943313|NCT03670810|566548926|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943314|NCT03670810|566548927|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943315|NCT03670810|566548928|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943316|NCT03670810|566548929|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943317|NCT03670810|566548930|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943318|NCT03670810|566548931|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943319|NCT03670810|566548932|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943320|NCT03670810|566548933|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
156943321|NCT03670810|566548934|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
156943322|NCT03670810|566548926|FG000|Open Label Extension|Physician Decision|0|||
156943323|NCT03670810|566548927|FG001|Open Label Extension|Physician Decision|0|||
156943324|NCT03670810|566548928|FG002|Open Label Extension|Physician Decision|0|||
156943325|NCT03670810|566548929|FG003|Open Label Extension|Physician Decision|0|||
156943326|NCT03670810|566548930|FG004|Open Label Extension|Physician Decision|0|||
156943327|NCT03670810|566548931|FG005|Open Label Extension|Physician Decision|0|||
156943328|NCT03670810|566548932|FG006|Open Label Extension|Physician Decision|0|||
156943329|NCT03670810|566548933|FG007|Open Label Extension|Physician Decision|0|||
156943330|NCT03670810|566548934|FG008|Open Label Extension|Physician Decision|2|||
156943331|NCT03670810|566548926|FG000|Open Label Extension|Non-compliance with study drug|0|||
156943332|NCT03670810|566548927|FG001|Open Label Extension|Non-compliance with study drug|0|||
156943333|NCT03670810|566548928|FG002|Open Label Extension|Non-compliance with study drug|0|||
156943334|NCT03670810|566548929|FG003|Open Label Extension|Non-compliance with study drug|0|||
156943335|NCT03670810|566548930|FG004|Open Label Extension|Non-compliance with study drug|0|||
156943336|NCT03670810|566548931|FG005|Open Label Extension|Non-compliance with study drug|0|||
156943337|NCT03670810|566548932|FG006|Open Label Extension|Non-compliance with study drug|0|||
156943338|NCT03670810|566548933|FG007|Open Label Extension|Non-compliance with study drug|0|||
156943339|NCT03670810|566548934|FG008|Open Label Extension|Non-compliance with study drug|5|||
156943340|NCT03670810|566548926|FG000|Open Label Extension|Pregnancy|0|||
156943341|NCT03670810|566548927|FG001|Open Label Extension|Pregnancy|0|||
156943342|NCT03670810|566548928|FG002|Open Label Extension|Pregnancy|0|||
156943343|NCT03670810|566548929|FG003|Open Label Extension|Pregnancy|0|||
156943344|NCT03670810|566548930|FG004|Open Label Extension|Pregnancy|0|||
156943345|NCT03670810|566548931|FG005|Open Label Extension|Pregnancy|0|||
156943346|NCT03670810|566548932|FG006|Open Label Extension|Pregnancy|0|||
156943347|NCT03670810|566548933|FG007|Open Label Extension|Pregnancy|0|||
156943348|NCT03670810|566548934|FG008|Open Label Extension|Pregnancy|3|||
156943349|NCT03670810|566548926|FG000|Open Label Extension|Adverse Event|0|||
156943350|NCT03670810|566548927|FG001|Open Label Extension|Adverse Event|0|||
156943351|NCT03670810|566548928|FG002|Open Label Extension|Adverse Event|0|||
156943352|NCT03670810|566548929|FG003|Open Label Extension|Adverse Event|0|||
156943353|NCT03670810|566548930|FG004|Open Label Extension|Adverse Event|0|||
156943354|NCT03670810|566548931|FG005|Open Label Extension|Adverse Event|0|||
156943355|NCT03670810|566548932|FG006|Open Label Extension|Adverse Event|0|||
156943356|NCT03670810|566548933|FG007|Open Label Extension|Adverse Event|0|||
156943357|NCT03670810|566548934|FG008|Open Label Extension|Adverse Event|24|||
156943358|NCT03670810|566548926|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
156943359|NCT03670810|566548927|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
156943360|NCT03670810|566548928|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
156943361|NCT03670810|566548929|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
156943362|NCT03670810|566548930|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
156943363|NCT03670810|566548931|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
156943364|NCT03670810|566548932|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
156943365|NCT03670810|566548933|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
156943366|NCT03670810|566548934|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
156943367|NCT03670810|566548926|FG000|Open Label Extension|Lost to Follow-up|0|||
156943368|NCT03670810|566548927|FG001|Open Label Extension|Lost to Follow-up|0|||
156943369|NCT03670810|566548928|FG002|Open Label Extension|Lost to Follow-up|0|||
156943370|NCT03670810|566548929|FG003|Open Label Extension|Lost to Follow-up|0|||
156943371|NCT03670810|566548930|FG004|Open Label Extension|Lost to Follow-up|0|||
156943372|NCT03670810|566548931|FG005|Open Label Extension|Lost to Follow-up|0|||
156943373|NCT03670810|566548932|FG006|Open Label Extension|Lost to Follow-up|0|||
156943374|NCT03670810|566548933|FG007|Open Label Extension|Lost to Follow-up|0|||
156943375|NCT03670810|566548934|FG008|Open Label Extension|Lost to Follow-up|23|||
156943376|NCT00678691|566548935|FG000|Overall Study|Adverse Event|6|||
156943377|NCT00678691|566548936|FG001|Overall Study|Adverse Event|4|||
156943378|NCT01469065|566548946|FG000|Overall Study|Lack of Efficacy|0|||
156943379|NCT01469065|566548947|FG001|Overall Study|Lack of Efficacy|0|||
156943380|NCT01469065|566548948|FG002|Overall Study|Lack of Efficacy|0|||
156943381|NCT01469065|566548949|FG003|Overall Study|Lack of Efficacy|0|||
156943382|NCT01469065|566548950|FG004|Overall Study|Lack of Efficacy|1|||
156943383|NCT01469065|566548946|FG000|Overall Study|Other|0|||
156943384|NCT01469065|566548947|FG001|Overall Study|Other|1|||
156943385|NCT01469065|566548948|FG002|Overall Study|Other|0|||
156943386|NCT01469065|566548949|FG003|Overall Study|Other|0|||
156943387|NCT01469065|566548950|FG004|Overall Study|Other|0|||
156943388|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
156943389|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
156943390|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
156943391|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
156943392|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
156943393|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
156943394|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
156943395|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
156943396|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
156943397|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
156943398|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
156943399|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
156943400|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
156943401|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
156943402|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
156943403|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
156943404|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
156943405|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
156943406|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
156943407|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
156943408|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
156943409|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
156943410|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
156943411|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
156943412|NCT04542070|566548951|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
156943413|NCT04542070|566548952|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
156943414|NCT04542070|566548953|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
156943415|NCT04542070|566548954|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
156943416|NCT04542070|566548951|FG000|Maintenance + Extension Period|Adverse Event|10|||
156943417|NCT04542070|566548952|FG001|Maintenance + Extension Period|Adverse Event|2|||
156943418|NCT04542070|566548953|FG002|Maintenance + Extension Period|Adverse Event|0|||
156943419|NCT04542070|566548954|FG003|Maintenance + Extension Period|Adverse Event|0|||
156943420|NCT04542070|566548951|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
156943421|NCT04542070|566548952|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
156943422|NCT04542070|566548953|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
156943423|NCT04542070|566548954|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
156943424|NCT04542070|566548951|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
156943425|NCT04542070|566548952|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
156943426|NCT04542070|566548953|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
156943427|NCT04542070|566548954|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
156943428|NCT04542070|566548951|FG000|Maintenance + Extension Period|Physician Decision|1|||
156943429|NCT04542070|566548952|FG001|Maintenance + Extension Period|Physician Decision|1|||
156943430|NCT04542070|566548953|FG002|Maintenance + Extension Period|Physician Decision|0|||
156943431|NCT04542070|566548954|FG003|Maintenance + Extension Period|Physician Decision|0|||
156943432|NCT04542070|566548951|FG000|Maintenance + Extension Period|Protocol Violation|2|||
156943433|NCT04542070|566548952|FG001|Maintenance + Extension Period|Protocol Violation|5|||
156943434|NCT04542070|566548953|FG002|Maintenance + Extension Period|Protocol Violation|0|||
156943435|NCT04542070|566548954|FG003|Maintenance + Extension Period|Protocol Violation|0|||
156943436|NCT04542070|566548951|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
156943437|NCT04542070|566548952|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
156943438|NCT04542070|566548953|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
156943439|NCT04542070|566548954|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
156943440|NCT04542070|566548951|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
156943441|NCT04542070|566548952|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
157032638|NCT05311176|566875909|FG000|Overall Study|Death|6|||
157032639|NCT05311176|566875909|FG000|Overall Study|Sponsor discontinued the study|1|||
156943442|NCT04542070|566548953|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
156943443|NCT04542070|566548954|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
157032640|NCT06106022|566875914|FG000|Overall Study|Lost to Follow-up|1|||
157032641|NCT06106022|566875915|FG001|Overall Study|Lost to Follow-up|0|||
157032642|NCT06106022|566875914|FG000|Overall Study|Voluntary Withdrawal|0|||
157032643|NCT06106022|566875915|FG001|Overall Study|Voluntary Withdrawal|2|||
156943444|NCT04542070|566548951|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156943445|NCT04542070|566548952|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156943446|NCT04542070|566548953|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
156943447|NCT04542070|566548954|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
156943448|NCT04542070|566548951|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156943449|NCT04542070|566548952|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156943450|NCT04542070|566548953|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
156943451|NCT04542070|566548954|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
156943452|NCT04542070|566548951|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156943453|NCT04542070|566548952|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156943454|NCT04542070|566548953|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
156943455|NCT04542070|566548954|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
156943456|NCT04542070|566548951|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156943457|NCT04542070|566548952|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156943458|NCT04542070|566548953|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
156943459|NCT04542070|566548954|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
156943460|NCT04542070|566548951|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156943461|NCT04542070|566548952|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156943462|NCT04542070|566548953|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
156943463|NCT04542070|566548954|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
156943464|NCT02985736|566548955|FG000|Overall Study|Lost to Follow-up|3|||
156943465|NCT03049813|566548956|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156943466|NCT03049813|566548957|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
156943467|NCT03049813|566548958|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156943468|NCT03049813|566548959|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
156943469|NCT03049813|566548956|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
156943470|NCT03049813|566548957|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
156943471|NCT03049813|566548958|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
156943472|NCT03049813|566548959|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
156943473|NCT03049813|566548956|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156943474|NCT03049813|566548957|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
156943475|NCT03049813|566548958|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156943476|NCT03049813|566548959|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
156943477|NCT03049813|566548956|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
156943478|NCT03049813|566548957|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
156943479|NCT03049813|566548958|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
156943480|NCT03049813|566548959|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
156943481|NCT00382733|566548960|FG000|Overall Study|Withdrawal by Subject|0|||
156943482|NCT00382733|566548961|FG001|Overall Study|Withdrawal by Subject|1|||
156943483|NCT00382733|566548962|FG002|Overall Study|Withdrawal by Subject|0|||
156943484|NCT00382733|566548963|FG003|Overall Study|Withdrawal by Subject|0|||
156943485|NCT00382733|566548964|FG004|Overall Study|Withdrawal by Subject|0|||
156943486|NCT00179413|566548965|FG000|Overall Study|Adverse Event|38|||
156943487|NCT00179413|566548966|FG001|Overall Study|Adverse Event|20|||
156943488|NCT00179413|566548965|FG000|Overall Study|Withdrawal by Subject|87|||
156943489|NCT00179413|566548966|FG001|Overall Study|Withdrawal by Subject|95|||
156943490|NCT00550836|566548967|FG000|Overall Study|Withdrawal by Subject|3|||
156943491|NCT00550836|566548968|FG001|Overall Study|Withdrawal by Subject|9|||
156943492|NCT03075644|566548971|FG000|Overall Study|Withdrawal by Subject|1|||
156943493|NCT03075644|566548972|FG001|Overall Study|Withdrawal by Subject|1|||
156943494|NCT00439140|566548975|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156943495|NCT00439140|566548976|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
156943496|NCT00439140|566548977|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
156943497|NCT00439140|566548975|FG000|Treatment Cycle 1|Personal reasons|0|||
156943498|NCT00439140|566548976|FG001|Treatment Cycle 1|Personal reasons|2|||
156943499|NCT00439140|566548977|FG002|Treatment Cycle 1|Personal reasons|0|||
156943500|NCT00439140|566548975|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
156943501|NCT00439140|566548976|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
156943502|NCT00439140|566548977|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
156943503|NCT00439140|566548975|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
156943504|NCT00439140|566548976|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
157032644|NCT04820322|566875916|FG000|Overall Study|Adverse Event|1|||
157032645|NCT04820322|566875917|FG001|Overall Study|Adverse Event|0|||
157227326|NCT00950807|567577786|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157227327|NCT00950807|567577787|FG006|Treatment Period 2|Withdrawal by Subject|1|||
157227328|NCT00950807|567577788|FG007|Treatment Period 2|Withdrawal by Subject|2|||
156943505|NCT00439140|566548977|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
156943506|NCT00439140|566548975|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
157032646|NCT03156465|566875918|FG000|Overall Study|Withdrawal by Subject|2|||
156943507|NCT00439140|566548976|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
156943508|NCT00439140|566548977|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
156943509|NCT01458171|566548981|FG000|Overall Study|Adverse Event|1|||
156943510|NCT01192152|566548985|FG000|Period 1|left prematurely (while on treatment B)|0|||
156943511|NCT01192152|566548986|FG001|Period 1|left prematurely (while on treatment B)|1|||
156943512|NCT01192152|566548985|FG000|Period 3|family emergency|1|||
156943513|NCT01192152|566548986|FG001|Period 3|family emergency|0|||
156943514|NCT00378703|566548988|FG000|Overall Study|Disease progression|59|||
156943515|NCT00378703|566548989|FG001|Overall Study|Disease progression|43|||
156943516|NCT00378703|566548990|FG002|Overall Study|Disease progression|48|||
156943517|NCT00378703|566548991|FG003|Overall Study|Disease progression|49|||
156943518|NCT00378703|566548988|FG000|Overall Study|Adverse Event|11|||
156943519|NCT00378703|566548989|FG001|Overall Study|Adverse Event|17|||
156943520|NCT00378703|566548990|FG002|Overall Study|Adverse Event|20|||
156943521|NCT00378703|566548991|FG003|Overall Study|Adverse Event|18|||
156943522|NCT00378703|566548988|FG000|Overall Study|Death|2|||
156943523|NCT00378703|566548989|FG001|Overall Study|Death|2|||
156943524|NCT00378703|566548990|FG002|Overall Study|Death|4|||
156943525|NCT00378703|566548991|FG003|Overall Study|Death|3|||
156943526|NCT00378703|566548988|FG000|Overall Study|Withdrawal by Subject|4|||
156943527|NCT00378703|566548989|FG001|Overall Study|Withdrawal by Subject|8|||
156943528|NCT00378703|566548990|FG002|Overall Study|Withdrawal by Subject|5|||
156943529|NCT00378703|566548991|FG003|Overall Study|Withdrawal by Subject|7|||
156943530|NCT00378703|566548988|FG000|Overall Study|Physician Decision|1|||
156943531|NCT00378703|566548989|FG001|Overall Study|Physician Decision|4|||
156943532|NCT00378703|566548990|FG002|Overall Study|Physician Decision|1|||
156943533|NCT00378703|566548991|FG003|Overall Study|Physician Decision|0|||
156943534|NCT00378703|566548988|FG000|Overall Study|Alternative therapy|4|||
156943535|NCT00378703|566548989|FG001|Overall Study|Alternative therapy|2|||
156943536|NCT00378703|566548990|FG002|Overall Study|Alternative therapy|0|||
156943537|NCT00378703|566548991|FG003|Overall Study|Alternative therapy|0|||
156943538|NCT00378703|566548988|FG000|Overall Study|Other complicated disease|0|||
156943539|NCT00378703|566548989|FG001|Overall Study|Other complicated disease|2|||
156943540|NCT00378703|566548990|FG002|Overall Study|Other complicated disease|2|||
156943541|NCT00378703|566548991|FG003|Overall Study|Other complicated disease|0|||
156943542|NCT00378703|566548988|FG000|Overall Study|Symptomatic deterioration|0|||
156943543|NCT00378703|566548989|FG001|Overall Study|Symptomatic deterioration|1|||
156943544|NCT00378703|566548990|FG002|Overall Study|Symptomatic deterioration|0|||
156943545|NCT00378703|566548991|FG003|Overall Study|Symptomatic deterioration|2|||
156943546|NCT00378703|566548988|FG000|Overall Study|Surgery|1|||
156943547|NCT00378703|566548989|FG001|Overall Study|Surgery|0|||
156943548|NCT00378703|566548990|FG002|Overall Study|Surgery|0|||
156943549|NCT00378703|566548991|FG003|Overall Study|Surgery|1|||
156943550|NCT00378703|566548988|FG000|Overall Study|Joint decision of physician and patient|1|||
156943551|NCT00378703|566548989|FG001|Overall Study|Joint decision of physician and patient|0|||
156943552|NCT00378703|566548990|FG002|Overall Study|Joint decision of physician and patient|0|||
156943553|NCT00378703|566548991|FG003|Overall Study|Joint decision of physician and patient|0|||
156943554|NCT00378703|566548988|FG000|Overall Study|Adverse events and progressive disease|0|||
156943555|NCT00378703|566548989|FG001|Overall Study|Adverse events and progressive disease|0|||
156943556|NCT00378703|566548990|FG002|Overall Study|Adverse events and progressive disease|0|||
156943557|NCT00378703|566548991|FG003|Overall Study|Adverse events and progressive disease|1|||
156943558|NCT00378703|566548988|FG000|Overall Study|Relocation|0|||
156943559|NCT00378703|566548989|FG001|Overall Study|Relocation|0|||
156943560|NCT00378703|566548990|FG002|Overall Study|Relocation|1|||
156943561|NCT00378703|566548991|FG003|Overall Study|Relocation|0|||
156943562|NCT00378703|566548988|FG000|Overall Study|Ineligible|4|||
156943563|NCT00378703|566548989|FG001|Overall Study|Ineligible|7|||
156943564|NCT00378703|566548990|FG002|Overall Study|Ineligible|7|||
156943565|NCT00378703|566548991|FG003|Overall Study|Ineligible|7|||
157032647|NCT03181516|566875919|FG000|Overall Study|Withdrawal by Subject|14|||
157032648|NCT03181516|566875920|FG001|Overall Study|Withdrawal by Subject|7|||
157032649|NCT03181516|566875919|FG000|Overall Study|Lost to Follow-up|2|||
157032650|NCT03181516|566875920|FG001|Overall Study|Lost to Follow-up|2|||
157032651|NCT04544007|566875921|FG000|Overall Study|Withdrawal by Subject|1|||
157032652|NCT04544007|566875921|FG000|Overall Study|Confirmed Progressive Disease|1|||
157032653|NCT05405985|566875922|FG000|Overall Study|Withdrawal by Subject|1|||
156943566|NCT00378703|566548988|FG000|Overall Study|Never started treatment|1|||
156943567|NCT00378703|566548989|FG001|Overall Study|Never started treatment|4|||
156943568|NCT00378703|566548990|FG002|Overall Study|Never started treatment|0|||
156943569|NCT00378703|566548991|FG003|Overall Study|Never started treatment|0|||
156943570|NCT00378703|566548988|FG000|Overall Study|Other|1|||
157032654|NCT05405985|566875923|FG001|Overall Study|Withdrawal by Subject|0|||
156943571|NCT00378703|566548989|FG001|Overall Study|Other|1|||
156943572|NCT00378703|566548990|FG002|Overall Study|Other|2|||
156943573|NCT00378703|566548991|FG003|Overall Study|Other|3|||
156943574|NCT01482767|566548997|FG000|Overall Study|Death|1|||
156943575|NCT01482767|566548998|FG001|Overall Study|Death|1|||
156943576|NCT01482767|566548997|FG000|Overall Study|Withdrawal by Subject|7|||
156943577|NCT01482767|566548998|FG001|Overall Study|Withdrawal by Subject|5|||
156943578|NCT01482767|566548997|FG000|Overall Study|Lost to Follow-up|12|||
156943579|NCT01482767|566548998|FG001|Overall Study|Lost to Follow-up|6|||
156943580|NCT01482767|566548997|FG000|Overall Study|Adverse Event|0|||
156943581|NCT01482767|566548998|FG001|Overall Study|Adverse Event|3|||
156943582|NCT01482767|566548997|FG000|Overall Study|Site closure|22|||
156943583|NCT01482767|566548998|FG001|Overall Study|Site closure|14|||
156943584|NCT01482767|566548997|FG000|Overall Study|Non-adherence to study requirements|4|||
156943585|NCT01482767|566548998|FG001|Overall Study|Non-adherence to study requirements|7|||
156943586|NCT01482767|566548997|FG000|Overall Study|Alternate HCV treatment|7|||
156943587|NCT01482767|566548998|FG001|Overall Study|Alternate HCV treatment|8|||
156943588|NCT01482767|566548997|FG000|Overall Study|Ineligible|0|||
156943589|NCT01482767|566548998|FG001|Overall Study|Ineligible|5|||
156943590|NCT01482767|566548997|FG000|Overall Study|Nurse error|1|||
156943591|NCT01482767|566548998|FG001|Overall Study|Nurse error|0|||
156943592|NCT01541930|566549010|FG000|Overall Study|Withdrawal by Subject|1|||
156943593|NCT03385239|566549011|FG000|Overall Study|Voluntary Withdrawal|2|||
156943594|NCT03385239|566549012|FG001|Overall Study|Voluntary Withdrawal|3|||
156943595|NCT03385239|566549013|FG002|Overall Study|Voluntary Withdrawal|2|||
156943596|NCT03385239|566549014|FG003|Overall Study|Voluntary Withdrawal|3|||
156943597|NCT03385239|566549015|FG004|Overall Study|Voluntary Withdrawal|0|||
156943598|NCT03385239|566549011|FG000|Overall Study|Adverse Event|0|||
156943599|NCT03385239|566549012|FG001|Overall Study|Adverse Event|0|||
156943600|NCT03385239|566549013|FG002|Overall Study|Adverse Event|1|||
156943601|NCT03385239|566549014|FG003|Overall Study|Adverse Event|0|||
156943602|NCT03385239|566549015|FG004|Overall Study|Adverse Event|0|||
156943603|NCT03385239|566549011|FG000|Overall Study|Other|0|||
156943604|NCT03385239|566549012|FG001|Overall Study|Other|0|||
156943605|NCT03385239|566549013|FG002|Overall Study|Other|0|||
156943606|NCT03385239|566549014|FG003|Overall Study|Other|1|||
156943607|NCT03385239|566549015|FG004|Overall Study|Other|0|||
156943608|NCT02167256|566549018|FG000|Overall Study|Adverse Event|13|||
156943609|NCT02167256|566549019|FG001|Overall Study|Adverse Event|6|||
156943610|NCT02167256|566549018|FG000|Overall Study|Withdrawal by Subject|4|||
156943611|NCT02167256|566549019|FG001|Overall Study|Withdrawal by Subject|4|||
156943612|NCT02167256|566549018|FG000|Overall Study|non-compliance|3|||
156943613|NCT02167256|566549019|FG001|Overall Study|non-compliance|0|||
156943614|NCT02167256|566549018|FG000|Overall Study|Study partner unable to participate|1|||
156943615|NCT02167256|566549019|FG001|Overall Study|Study partner unable to participate|0|||
156943616|NCT03139916|566549020|FG000|Overall Study|Withdrawal by Subject|2|||
156943617|NCT03139916|566549020|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
156943618|NCT01957475|566549021|FG000|Test Period 1|Withdrawal by Subject|1|||
156943619|NCT01957475|566549022|FG001|Test Period 1|Withdrawal by Subject|0|||
156943620|NCT01957475|566549021|FG000|Test Period 1|Other|1|||
156943621|NCT01957475|566549022|FG001|Test Period 1|Other|0|||
156943622|NCT01957475|566549021|FG000|Test Period 1|Lack of Efficacy|0|||
156943623|NCT01957475|566549022|FG001|Test Period 1|Lack of Efficacy|1|||
156943624|NCT01957475|566549021|FG000|Test Period 2|Adverse Event|1|||
156943625|NCT01957475|566549022|FG001|Test Period 2|Adverse Event|0|||
156943626|NCT01466192|566549023|FG000|Overall Study|Physician Decision|1|||
156943627|NCT01466192|566549023|FG000|Overall Study|Withdrawal by Subject|3|||
156943628|NCT03591575|566549026|FG000|Overall Study|Adverse Event|2|||
156943629|NCT03591575|566549027|FG001|Overall Study|Adverse Event|0|||
156943630|NCT03591575|566549026|FG000|Overall Study|Withdrawal by Subject|4|||
156943631|NCT03591575|566549027|FG001|Overall Study|Withdrawal by Subject|1|||
156943632|NCT00813358|566549028|FG000|Overall Study|Death|32|||
156943633|NCT00813358|566549028|FG000|Overall Study|Lost to Follow-up|12|||
156943634|NCT00813358|566549028|FG000|Overall Study|other endpoints|5|||
156943635|NCT00813358|566549028|FG000|Overall Study|Withdrawal by Subject|20|||
156943636|NCT00700011|566549030|FG000|Overall Study|Death|0|||
156943637|NCT00700011|566549031|FG001|Overall Study|Death|1|||
156943638|NCT00004031|566549032|FG000|Overall Study|Adverse Event|5|||
156943639|NCT00004031|566549033|FG001|Overall Study|Adverse Event|0|||
156943640|NCT00004031|566549032|FG000|Overall Study|Refusal unrelated to adverse events|2|||
156943641|NCT00004031|566549033|FG001|Overall Study|Refusal unrelated to adverse events|11|||
156943642|NCT00004031|566549032|FG000|Overall Study|Progression/relapse|9|||
156943643|NCT00004031|566549033|FG001|Overall Study|Progression/relapse|4|||
156943644|NCT00004031|566549032|FG000|Overall Study|Death|3|||
156943645|NCT00004031|566549033|FG001|Overall Study|Death|1|||
156943646|NCT00004031|566549032|FG000|Overall Study|Other- not protocol specified|3|||
156943647|NCT00004031|566549033|FG001|Overall Study|Other- not protocol specified|3|||
156943648|NCT00004031|566549032|FG000|Overall Study|Reason under review|3|||
156943649|NCT00004031|566549033|FG001|Overall Study|Reason under review|2|||
156943650|NCT03665038|566549034|FG000|Overall Study|Lost to Follow-up|0|||
156943651|NCT03665038|566549035|FG001|Overall Study|Lost to Follow-up|0|||
156943652|NCT03665038|566549036|FG002|Overall Study|Lost to Follow-up|1|||
156943653|NCT03013491|566549037|FG000|Main Study|Death|2|||
156943654|NCT03013491|566549038|FG001|Main Study|Death|2|||
156943655|NCT03013491|566549039|FG002|Main Study|Death|5|||
156943656|NCT03013491|566549040|FG003|Main Study|Death|3|||
156943657|NCT03013491|566549041|FG004|Main Study|Death|9|||
156943658|NCT03013491|566549042|FG005|Main Study|Death|12|||
156943659|NCT03013491|566549043|FG006|Main Study|Death|3|||
156943660|NCT03013491|566549044|FG007|Main Study|Death|5|||
156943661|NCT03013491|566549045|FG008|Main Study|Death|1|||
156943662|NCT03013491|566549046|FG009|Main Study|Death|2|||
156943663|NCT03013491|566549047|FG010|Main Study|Death|4|||
156943664|NCT03013491|566549048|FG011|Main Study|Death|1|||
156943665|NCT03013491|566549049|FG012|Main Study|Death|1|||
156943666|NCT03013491|566549050|FG013|Main Study|Death|4|||
156943667|NCT03013491|566549051|FG014|Main Study|Death|0|||
156943668|NCT03013491|566549052|FG015|Main Study|Death|3|||
156943669|NCT03013491|566549053|FG016|Main Study|Death|5|||
156943670|NCT03013491|566549054|FG017|Main Study|Death|1|||
156943671|NCT03013491|566549055|FG018|Main Study|Death|47|||
156943672|NCT03013491|566549037|FG000|Main Study|Lost to Follow-up|0|||
156943673|NCT03013491|566549038|FG001|Main Study|Lost to Follow-up|0|||
156943674|NCT03013491|566549039|FG002|Main Study|Lost to Follow-up|1|||
156943675|NCT03013491|566549040|FG003|Main Study|Lost to Follow-up|0|||
156943676|NCT03013491|566549041|FG004|Main Study|Lost to Follow-up|1|||
156943677|NCT03013491|566549042|FG005|Main Study|Lost to Follow-up|0|||
156943678|NCT03013491|566549043|FG006|Main Study|Lost to Follow-up|0|||
156943679|NCT03013491|566549044|FG007|Main Study|Lost to Follow-up|0|||
156943680|NCT03013491|566549045|FG008|Main Study|Lost to Follow-up|0|||
156943681|NCT03013491|566549046|FG009|Main Study|Lost to Follow-up|0|||
156943682|NCT03013491|566549047|FG010|Main Study|Lost to Follow-up|0|||
156943683|NCT03013491|566549048|FG011|Main Study|Lost to Follow-up|0|||
156943684|NCT03013491|566549049|FG012|Main Study|Lost to Follow-up|0|||
156943685|NCT03013491|566549050|FG013|Main Study|Lost to Follow-up|0|||
156943686|NCT03013491|566549051|FG014|Main Study|Lost to Follow-up|0|||
156943687|NCT03013491|566549052|FG015|Main Study|Lost to Follow-up|0|||
156943688|NCT03013491|566549053|FG016|Main Study|Lost to Follow-up|0|||
156943689|NCT03013491|566549054|FG017|Main Study|Lost to Follow-up|0|||
156943690|NCT03013491|566549055|FG018|Main Study|Lost to Follow-up|3|||
156943691|NCT03013491|566549037|FG000|Main Study|Termination of the study by Sponsor|0|||
156943692|NCT03013491|566549038|FG001|Main Study|Termination of the study by Sponsor|0|||
156943693|NCT03013491|566549039|FG002|Main Study|Termination of the study by Sponsor|2|||
156943694|NCT03013491|566549040|FG003|Main Study|Termination of the study by Sponsor|0|||
156943695|NCT03013491|566549041|FG004|Main Study|Termination of the study by Sponsor|1|||
156943696|NCT03013491|566549042|FG005|Main Study|Termination of the study by Sponsor|2|||
156943697|NCT03013491|566549043|FG006|Main Study|Termination of the study by Sponsor|0|||
156943698|NCT03013491|566549044|FG007|Main Study|Termination of the study by Sponsor|0|||
156943699|NCT03013491|566549045|FG008|Main Study|Termination of the study by Sponsor|1|||
156943700|NCT03013491|566549046|FG009|Main Study|Termination of the study by Sponsor|1|||
156943701|NCT03013491|566549047|FG010|Main Study|Termination of the study by Sponsor|1|||
156943702|NCT03013491|566549048|FG011|Main Study|Termination of the study by Sponsor|2|||
156943703|NCT03013491|566549049|FG012|Main Study|Termination of the study by Sponsor|0|||
156943704|NCT03013491|566549050|FG013|Main Study|Termination of the study by Sponsor|0|||
156943705|NCT03013491|566549051|FG014|Main Study|Termination of the study by Sponsor|0|||
156943706|NCT03013491|566549052|FG015|Main Study|Termination of the study by Sponsor|0|||
156943707|NCT03013491|566549053|FG016|Main Study|Termination of the study by Sponsor|0|||
156943708|NCT03013491|566549054|FG017|Main Study|Termination of the study by Sponsor|1|||
156943709|NCT03013491|566549055|FG018|Main Study|Termination of the study by Sponsor|13|||
156943710|NCT03013491|566549037|FG000|Main Study|Withdrawal by Subject|0|||
156943711|NCT03013491|566549038|FG001|Main Study|Withdrawal by Subject|0|||
156943712|NCT03013491|566549039|FG002|Main Study|Withdrawal by Subject|0|||
156943713|NCT03013491|566549040|FG003|Main Study|Withdrawal by Subject|4|||
156943714|NCT03013491|566549041|FG004|Main Study|Withdrawal by Subject|2|||
156943715|NCT03013491|566549042|FG005|Main Study|Withdrawal by Subject|1|||
156943716|NCT03013491|566549043|FG006|Main Study|Withdrawal by Subject|0|||
156943717|NCT03013491|566549044|FG007|Main Study|Withdrawal by Subject|0|||
156943718|NCT03013491|566549045|FG008|Main Study|Withdrawal by Subject|0|||
156943719|NCT03013491|566549046|FG009|Main Study|Withdrawal by Subject|0|||
156943720|NCT03013491|566549047|FG010|Main Study|Withdrawal by Subject|1|||
156943721|NCT03013491|566549048|FG011|Main Study|Withdrawal by Subject|2|||
156943722|NCT03013491|566549049|FG012|Main Study|Withdrawal by Subject|0|||
156943723|NCT03013491|566549050|FG013|Main Study|Withdrawal by Subject|2|||
156943724|NCT03013491|566549051|FG014|Main Study|Withdrawal by Subject|0|||
156943725|NCT03013491|566549052|FG015|Main Study|Withdrawal by Subject|0|||
156943726|NCT03013491|566549053|FG016|Main Study|Withdrawal by Subject|0|||
156943727|NCT03013491|566549054|FG017|Main Study|Withdrawal by Subject|0|||
156943728|NCT03013491|566549055|FG018|Main Study|Withdrawal by Subject|18|||
157032655|NCT04880733|566875924|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
156943729|NCT03013491|566549037|FG000|Main Study|Disease progression|0|||
156943730|NCT03013491|566549038|FG001|Main Study|Disease progression|0|||
156943731|NCT03013491|566549039|FG002|Main Study|Disease progression|0|||
156943732|NCT03013491|566549040|FG003|Main Study|Disease progression|1|||
156943733|NCT03013491|566549041|FG004|Main Study|Disease progression|0|||
156943734|NCT03013491|566549042|FG005|Main Study|Disease progression|0|||
156943735|NCT03013491|566549043|FG006|Main Study|Disease progression|0|||
156943736|NCT03013491|566549044|FG007|Main Study|Disease progression|0|||
157167434|NCT02062463|567354554|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
157167435|NCT02062463|567354555|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
157167436|NCT02062463|567354552|FG000|Stage 2|Adverse Event|0|||
157167437|NCT02062463|567354553|FG001|Stage 2|Adverse Event|0|||
157167438|NCT02062463|567354554|FG002|Stage 2|Adverse Event|12|||
157167439|NCT02062463|567354555|FG003|Stage 2|Adverse Event|20|||
156943737|NCT03013491|566549045|FG008|Main Study|Disease progression|1|||
156943738|NCT03013491|566549046|FG009|Main Study|Disease progression|0|||
156943739|NCT03013491|566549047|FG010|Main Study|Disease progression|1|||
156943740|NCT03013491|566549048|FG011|Main Study|Disease progression|0|||
156943741|NCT03013491|566549049|FG012|Main Study|Disease progression|0|||
156943742|NCT03013491|566549050|FG013|Main Study|Disease progression|0|||
156943743|NCT03013491|566549051|FG014|Main Study|Disease progression|0|||
156943744|NCT03013491|566549052|FG015|Main Study|Disease progression|0|||
156943745|NCT03013491|566549053|FG016|Main Study|Disease progression|0|||
156943746|NCT03013491|566549054|FG017|Main Study|Disease progression|0|||
156943747|NCT03013491|566549055|FG018|Main Study|Disease progression|4|||
156943748|NCT03013491|566549037|FG000|Main Study|Symptomatic deterioration|0|||
156943749|NCT03013491|566549038|FG001|Main Study|Symptomatic deterioration|0|||
156943750|NCT03013491|566549039|FG002|Main Study|Symptomatic deterioration|0|||
156943751|NCT03013491|566549040|FG003|Main Study|Symptomatic deterioration|0|||
156943752|NCT03013491|566549041|FG004|Main Study|Symptomatic deterioration|0|||
156943753|NCT03013491|566549042|FG005|Main Study|Symptomatic deterioration|1|||
156943754|NCT03013491|566549043|FG006|Main Study|Symptomatic deterioration|0|||
156943755|NCT03013491|566549044|FG007|Main Study|Symptomatic deterioration|0|||
156943756|NCT03013491|566549045|FG008|Main Study|Symptomatic deterioration|0|||
156943757|NCT03013491|566549046|FG009|Main Study|Symptomatic deterioration|0|||
156943758|NCT03013491|566549047|FG010|Main Study|Symptomatic deterioration|0|||
156943759|NCT03013491|566549048|FG011|Main Study|Symptomatic deterioration|0|||
156943760|NCT03013491|566549049|FG012|Main Study|Symptomatic deterioration|0|||
156943761|NCT03013491|566549050|FG013|Main Study|Symptomatic deterioration|0|||
156943762|NCT03013491|566549051|FG014|Main Study|Symptomatic deterioration|0|||
156943763|NCT03013491|566549052|FG015|Main Study|Symptomatic deterioration|0|||
156943764|NCT03013491|566549053|FG016|Main Study|Symptomatic deterioration|0|||
156943765|NCT03013491|566549054|FG017|Main Study|Symptomatic deterioration|0|||
156943766|NCT03013491|566549055|FG018|Main Study|Symptomatic deterioration|0|||
156943767|NCT03013491|566549037|FG000|Main Study|Protocol version 8.0 approval|0|||
156943768|NCT03013491|566549038|FG001|Main Study|Protocol version 8.0 approval|0|||
156943769|NCT03013491|566549039|FG002|Main Study|Protocol version 8.0 approval|0|||
156943770|NCT03013491|566549040|FG003|Main Study|Protocol version 8.0 approval|0|||
156943771|NCT03013491|566549041|FG004|Main Study|Protocol version 8.0 approval|0|||
156943772|NCT03013491|566549042|FG005|Main Study|Protocol version 8.0 approval|0|||
156943773|NCT03013491|566549043|FG006|Main Study|Protocol version 8.0 approval|0|||
156943774|NCT03013491|566549044|FG007|Main Study|Protocol version 8.0 approval|0|||
156943775|NCT03013491|566549045|FG008|Main Study|Protocol version 8.0 approval|0|||
156943776|NCT03013491|566549046|FG009|Main Study|Protocol version 8.0 approval|0|||
156943777|NCT03013491|566549047|FG010|Main Study|Protocol version 8.0 approval|1|||
156943778|NCT03013491|566549048|FG011|Main Study|Protocol version 8.0 approval|0|||
156943779|NCT03013491|566549049|FG012|Main Study|Protocol version 8.0 approval|0|||
156943780|NCT03013491|566549050|FG013|Main Study|Protocol version 8.0 approval|0|||
156943781|NCT03013491|566549051|FG014|Main Study|Protocol version 8.0 approval|0|||
156943782|NCT03013491|566549052|FG015|Main Study|Protocol version 8.0 approval|0|||
156943783|NCT03013491|566549053|FG016|Main Study|Protocol version 8.0 approval|0|||
156943784|NCT03013491|566549054|FG017|Main Study|Protocol version 8.0 approval|0|||
156943785|NCT03013491|566549055|FG018|Main Study|Protocol version 8.0 approval|0|||
156943786|NCT03013491|566549037|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
156943787|NCT03013491|566549038|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
156943788|NCT03013491|566549039|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
156943789|NCT03013491|566549040|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
157167440|NCT02062463|567354552|FG000|Stage 2|Lack of Efficacy|0|||
157167441|NCT02062463|567354553|FG001|Stage 2|Lack of Efficacy|0|||
157167442|NCT02062463|567354554|FG002|Stage 2|Lack of Efficacy|3|||
157167443|NCT02062463|567354555|FG003|Stage 2|Lack of Efficacy|4|||
156943790|NCT03013491|566549041|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
156943791|NCT03013491|566549042|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
156943792|NCT03013491|566549043|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
156943793|NCT03013491|566549044|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
156943794|NCT03013491|566549045|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
156943795|NCT03013491|566549046|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
156943796|NCT03013491|566549047|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
156943797|NCT03013491|566549048|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
156943798|NCT03013491|566549049|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
157167444|NCT02062463|567354552|FG000|Stage 2|Lost to Follow-up|0|||
157167445|NCT02062463|567354553|FG001|Stage 2|Lost to Follow-up|0|||
156943799|NCT03013491|566549050|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
156943800|NCT03013491|566549051|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
156943801|NCT03013491|566549052|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
156943802|NCT03013491|566549053|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
156943803|NCT03013491|566549054|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
156943804|NCT03013491|566549055|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
156943805|NCT03013491|566549037|FG000|Main Study|Start of new anticancer therapy|0|||
156943806|NCT03013491|566549038|FG001|Main Study|Start of new anticancer therapy|0|||
156943807|NCT03013491|566549039|FG002|Main Study|Start of new anticancer therapy|0|||
156943808|NCT03013491|566549040|FG003|Main Study|Start of new anticancer therapy|0|||
156943809|NCT03013491|566549041|FG004|Main Study|Start of new anticancer therapy|0|||
156943810|NCT03013491|566549042|FG005|Main Study|Start of new anticancer therapy|0|||
156943811|NCT03013491|566549043|FG006|Main Study|Start of new anticancer therapy|0|||
156943812|NCT03013491|566549044|FG007|Main Study|Start of new anticancer therapy|0|||
156943813|NCT03013491|566549045|FG008|Main Study|Start of new anticancer therapy|0|||
156943814|NCT03013491|566549046|FG009|Main Study|Start of new anticancer therapy|0|||
156943815|NCT03013491|566549047|FG010|Main Study|Start of new anticancer therapy|0|||
156943816|NCT03013491|566549048|FG011|Main Study|Start of new anticancer therapy|0|||
156943817|NCT03013491|566549049|FG012|Main Study|Start of new anticancer therapy|0|||
156943818|NCT03013491|566549050|FG013|Main Study|Start of new anticancer therapy|0|||
156943819|NCT03013491|566549051|FG014|Main Study|Start of new anticancer therapy|0|||
156943820|NCT03013491|566549052|FG015|Main Study|Start of new anticancer therapy|0|||
156943821|NCT03013491|566549053|FG016|Main Study|Start of new anticancer therapy|0|||
156943822|NCT03013491|566549054|FG017|Main Study|Start of new anticancer therapy|0|||
156943823|NCT03013491|566549055|FG018|Main Study|Start of new anticancer therapy|2|||
156943824|NCT03013491|566549037|FG000|Long-term Extension|Disease progression|0|||
156943825|NCT03013491|566549038|FG001|Long-term Extension|Disease progression|0|||
156943826|NCT03013491|566549039|FG002|Long-term Extension|Disease progression|0|||
156943827|NCT03013491|566549040|FG003|Long-term Extension|Disease progression|1|||
156943828|NCT03013491|566549041|FG004|Long-term Extension|Disease progression|0|||
156943829|NCT03013491|566549042|FG005|Long-term Extension|Disease progression|0|||
156943830|NCT03013491|566549043|FG006|Long-term Extension|Disease progression|0|||
156943831|NCT03013491|566549044|FG007|Long-term Extension|Disease progression|0|||
156943832|NCT03013491|566549045|FG008|Long-term Extension|Disease progression|0|||
156943833|NCT03013491|566549046|FG009|Long-term Extension|Disease progression|0|||
156943834|NCT03013491|566549047|FG010|Long-term Extension|Disease progression|0|||
156943835|NCT03013491|566549048|FG011|Long-term Extension|Disease progression|0|||
156943836|NCT03013491|566549049|FG012|Long-term Extension|Disease progression|0|||
156943837|NCT03013491|566549050|FG013|Long-term Extension|Disease progression|0|||
156943838|NCT03013491|566549051|FG014|Long-term Extension|Disease progression|0|||
156943839|NCT03013491|566549052|FG015|Long-term Extension|Disease progression|0|||
156943840|NCT03013491|566549053|FG016|Long-term Extension|Disease progression|0|||
156943841|NCT03013491|566549054|FG017|Long-term Extension|Disease progression|0|||
156943842|NCT03013491|566549055|FG018|Long-term Extension|Disease progression|1|||
156943843|NCT03013491|566549037|FG000|Long-term Extension|Withdrawal by Subject|0|||
156943844|NCT03013491|566549038|FG001|Long-term Extension|Withdrawal by Subject|0|||
156943845|NCT03013491|566549039|FG002|Long-term Extension|Withdrawal by Subject|0|||
156943846|NCT03013491|566549040|FG003|Long-term Extension|Withdrawal by Subject|0|||
156943847|NCT03013491|566549041|FG004|Long-term Extension|Withdrawal by Subject|0|||
156943848|NCT03013491|566549042|FG005|Long-term Extension|Withdrawal by Subject|0|||
156943849|NCT03013491|566549043|FG006|Long-term Extension|Withdrawal by Subject|0|||
156943850|NCT03013491|566549044|FG007|Long-term Extension|Withdrawal by Subject|1|||
156943851|NCT03013491|566549045|FG008|Long-term Extension|Withdrawal by Subject|0|||
156943852|NCT03013491|566549046|FG009|Long-term Extension|Withdrawal by Subject|0|||
156943853|NCT03013491|566549047|FG010|Long-term Extension|Withdrawal by Subject|0|||
156943854|NCT03013491|566549048|FG011|Long-term Extension|Withdrawal by Subject|0|||
156943855|NCT03013491|566549049|FG012|Long-term Extension|Withdrawal by Subject|0|||
156943856|NCT03013491|566549050|FG013|Long-term Extension|Withdrawal by Subject|0|||
156943857|NCT03013491|566549051|FG014|Long-term Extension|Withdrawal by Subject|0|||
156943858|NCT03013491|566549052|FG015|Long-term Extension|Withdrawal by Subject|0|||
156943859|NCT03013491|566549053|FG016|Long-term Extension|Withdrawal by Subject|0|||
156943860|NCT03013491|566549054|FG017|Long-term Extension|Withdrawal by Subject|0|||
156943861|NCT03013491|566549055|FG018|Long-term Extension|Withdrawal by Subject|0|||
156943862|NCT03013491|566549037|FG000|Long-term Extension|Adverse Event|0|||
156943863|NCT03013491|566549038|FG001|Long-term Extension|Adverse Event|0|||
156943864|NCT03013491|566549039|FG002|Long-term Extension|Adverse Event|0|||
156943865|NCT03013491|566549040|FG003|Long-term Extension|Adverse Event|0|||
156943866|NCT03013491|566549041|FG004|Long-term Extension|Adverse Event|0|||
156943867|NCT03013491|566549042|FG005|Long-term Extension|Adverse Event|0|||
156943868|NCT03013491|566549043|FG006|Long-term Extension|Adverse Event|0|||
156943869|NCT03013491|566549044|FG007|Long-term Extension|Adverse Event|0|||
156943870|NCT03013491|566549045|FG008|Long-term Extension|Adverse Event|0|||
156943871|NCT03013491|566549046|FG009|Long-term Extension|Adverse Event|0|||
156943872|NCT03013491|566549047|FG010|Long-term Extension|Adverse Event|0|||
156943873|NCT03013491|566549048|FG011|Long-term Extension|Adverse Event|0|||
156943874|NCT03013491|566549049|FG012|Long-term Extension|Adverse Event|0|||
156943875|NCT03013491|566549050|FG013|Long-term Extension|Adverse Event|0|||
156943876|NCT03013491|566549051|FG014|Long-term Extension|Adverse Event|0|||
156943877|NCT03013491|566549052|FG015|Long-term Extension|Adverse Event|0|||
156943878|NCT03013491|566549053|FG016|Long-term Extension|Adverse Event|0|||
156943879|NCT03013491|566549054|FG017|Long-term Extension|Adverse Event|0|||
156943880|NCT03013491|566549055|FG018|Long-term Extension|Adverse Event|1|||
156943881|NCT03013491|566549037|FG000|Long-term Extension|Death|0|||
156943882|NCT03013491|566549038|FG001|Long-term Extension|Death|0|||
156943883|NCT03013491|566549039|FG002|Long-term Extension|Death|0|||
156943884|NCT03013491|566549040|FG003|Long-term Extension|Death|0|||
156943885|NCT03013491|566549041|FG004|Long-term Extension|Death|0|||
156943886|NCT03013491|566549042|FG005|Long-term Extension|Death|0|||
156943887|NCT03013491|566549043|FG006|Long-term Extension|Death|0|||
156943888|NCT03013491|566549044|FG007|Long-term Extension|Death|0|||
156943889|NCT03013491|566549045|FG008|Long-term Extension|Death|0|||
156943890|NCT03013491|566549046|FG009|Long-term Extension|Death|0|||
156943891|NCT03013491|566549047|FG010|Long-term Extension|Death|0|||
156943892|NCT03013491|566549048|FG011|Long-term Extension|Death|0|||
156943893|NCT03013491|566549049|FG012|Long-term Extension|Death|0|||
156943894|NCT03013491|566549050|FG013|Long-term Extension|Death|0|||
156943895|NCT03013491|566549051|FG014|Long-term Extension|Death|0|||
156943896|NCT03013491|566549052|FG015|Long-term Extension|Death|0|||
156943897|NCT03013491|566549053|FG016|Long-term Extension|Death|0|||
156943898|NCT03013491|566549054|FG017|Long-term Extension|Death|0|||
156943899|NCT03013491|566549055|FG018|Long-term Extension|Death|1|||
156943900|NCT02556710|566551227|FG000|Overall Study|Surgical treatment|3|||
156943901|NCT02556710|566551228|FG001|Overall Study|Surgical treatment|0|||
156943902|NCT02556710|566551227|FG000|Overall Study|Required proscribed pain medication|2|||
156943903|NCT02556710|566551228|FG001|Overall Study|Required proscribed pain medication|1|||
156943904|NCT02556710|566551227|FG000|Overall Study|Lack of Efficacy|1|||
156943905|NCT02556710|566551228|FG001|Overall Study|Lack of Efficacy|0|||
156943906|NCT02556710|566551227|FG000|Overall Study|Worsening osteoarthritis|1|||
156943907|NCT02556710|566551228|FG001|Overall Study|Worsening osteoarthritis|0|||
156943908|NCT02556710|566551227|FG000|Overall Study|Moved out of state|1|||
156943909|NCT02556710|566551228|FG001|Overall Study|Moved out of state|0|||
156943910|NCT02556710|566551227|FG000|Overall Study|Missing reason|3|||
156943911|NCT02556710|566551228|FG001|Overall Study|Missing reason|1|||
156943912|NCT02556710|566551227|FG000|Overall Study|Pain as lack of efficacy|0|||
156943913|NCT02556710|566551228|FG001|Overall Study|Pain as lack of efficacy|4|||
156943914|NCT04524403|566551231|FG000|Overall Study|Withdrawal by Subject|10|||
156943915|NCT04524403|566551232|FG001|Overall Study|Withdrawal by Subject|3|||
156943916|NCT04524403|566551233|FG002|Overall Study|Withdrawal by Subject|8|||
156943917|NCT04524403|566551231|FG000|Overall Study|Lost to Follow-up|3|||
156943918|NCT04524403|566551232|FG001|Overall Study|Lost to Follow-up|4|||
156943919|NCT04524403|566551233|FG002|Overall Study|Lost to Follow-up|3|||
156943920|NCT04524403|566551231|FG000|Overall Study|Adverse Event|3|||
156943921|NCT04524403|566551232|FG001|Overall Study|Adverse Event|1|||
156943922|NCT04524403|566551233|FG002|Overall Study|Adverse Event|4|||
156943923|NCT04524403|566551231|FG000|Overall Study|Non-compliant with study drug|1|||
156943924|NCT04524403|566551232|FG001|Overall Study|Non-compliant with study drug|2|||
156943925|NCT04524403|566551233|FG002|Overall Study|Non-compliant with study drug|3|||
156943926|NCT04524403|566551231|FG000|Overall Study|Moved|0|||
156943927|NCT04524403|566551232|FG001|Overall Study|Moved|1|||
156943928|NCT04524403|566551233|FG002|Overall Study|Moved|0|||
156943929|NCT01709318|566551234|FG000|Overall Study|Adverse Event|3|||
156943930|NCT01709318|566551235|FG001|Overall Study|Adverse Event|4|||
156943931|NCT01709318|566551236|FG002|Overall Study|Adverse Event|2|||
156943932|NCT01709318|566551237|FG003|Overall Study|Adverse Event|2|||
156943933|NCT01709318|566551238|FG004|Overall Study|Adverse Event|0|||
156943934|NCT01709318|566551239|FG005|Overall Study|Adverse Event|1|||
156943935|NCT01709318|566551240|FG006|Overall Study|Adverse Event|2|||
156943936|NCT01709318|566551234|FG000|Overall Study|Lost to Follow-up|2|||
156943937|NCT01709318|566551235|FG001|Overall Study|Lost to Follow-up|0|||
156943938|NCT01709318|566551236|FG002|Overall Study|Lost to Follow-up|0|||
156943939|NCT01709318|566551237|FG003|Overall Study|Lost to Follow-up|0|||
156943940|NCT01709318|566551238|FG004|Overall Study|Lost to Follow-up|1|||
156943941|NCT01709318|566551239|FG005|Overall Study|Lost to Follow-up|1|||
156943942|NCT01709318|566551240|FG006|Overall Study|Lost to Follow-up|1|||
156943943|NCT01709318|566551234|FG000|Overall Study|Non-compliance with Study Drug|0|||
156943944|NCT01709318|566551235|FG001|Overall Study|Non-compliance with Study Drug|2|||
156943945|NCT01709318|566551236|FG002|Overall Study|Non-compliance with Study Drug|1|||
156943946|NCT01709318|566551237|FG003|Overall Study|Non-compliance with Study Drug|1|||
156943947|NCT01709318|566551238|FG004|Overall Study|Non-compliance with Study Drug|0|||
156943948|NCT01709318|566551239|FG005|Overall Study|Non-compliance with Study Drug|0|||
156943949|NCT01709318|566551240|FG006|Overall Study|Non-compliance with Study Drug|2|||
156943950|NCT01709318|566551234|FG000|Overall Study|Physician Decision|0|||
156943951|NCT01709318|566551235|FG001|Overall Study|Physician Decision|0|||
156943952|NCT01709318|566551236|FG002|Overall Study|Physician Decision|0|||
156943953|NCT01709318|566551237|FG003|Overall Study|Physician Decision|0|||
156943954|NCT01709318|566551238|FG004|Overall Study|Physician Decision|0|||
156943955|NCT01709318|566551239|FG005|Overall Study|Physician Decision|0|||
156943956|NCT01709318|566551240|FG006|Overall Study|Physician Decision|1|||
156943957|NCT01709318|566551234|FG000|Overall Study|Pregnancy|0|||
156943958|NCT01709318|566551235|FG001|Overall Study|Pregnancy|0|||
156943959|NCT01709318|566551236|FG002|Overall Study|Pregnancy|0|||
156943960|NCT01709318|566551237|FG003|Overall Study|Pregnancy|0|||
156943961|NCT01709318|566551238|FG004|Overall Study|Pregnancy|1|||
156943962|NCT01709318|566551239|FG005|Overall Study|Pregnancy|0|||
156943963|NCT01709318|566551240|FG006|Overall Study|Pregnancy|0|||
156943964|NCT01709318|566551234|FG000|Overall Study|Protocol Violation|0|||
156943965|NCT01709318|566551235|FG001|Overall Study|Protocol Violation|0|||
156943966|NCT01709318|566551236|FG002|Overall Study|Protocol Violation|0|||
156943967|NCT01709318|566551237|FG003|Overall Study|Protocol Violation|0|||
156943968|NCT01709318|566551238|FG004|Overall Study|Protocol Violation|2|||
156943969|NCT01709318|566551239|FG005|Overall Study|Protocol Violation|0|||
156943970|NCT01709318|566551240|FG006|Overall Study|Protocol Violation|1|||
156943971|NCT01709318|566551234|FG000|Overall Study|Technical Problems|1|||
156943972|NCT01709318|566551235|FG001|Overall Study|Technical Problems|0|||
156943973|NCT01709318|566551236|FG002|Overall Study|Technical Problems|0|||
156943974|NCT01709318|566551237|FG003|Overall Study|Technical Problems|0|||
156943975|NCT01709318|566551238|FG004|Overall Study|Technical Problems|0|||
156943976|NCT01709318|566551239|FG005|Overall Study|Technical Problems|0|||
156943977|NCT01709318|566551240|FG006|Overall Study|Technical Problems|0|||
156943978|NCT01709318|566551234|FG000|Overall Study|Withdrawal by Subject|3|||
156943979|NCT01709318|566551235|FG001|Overall Study|Withdrawal by Subject|0|||
156943980|NCT01709318|566551236|FG002|Overall Study|Withdrawal by Subject|3|||
156943981|NCT01709318|566551237|FG003|Overall Study|Withdrawal by Subject|3|||
156943982|NCT01709318|566551238|FG004|Overall Study|Withdrawal by Subject|0|||
156943983|NCT01709318|566551239|FG005|Overall Study|Withdrawal by Subject|2|||
156943984|NCT01709318|566551240|FG006|Overall Study|Withdrawal by Subject|4|||
156943985|NCT01709318|566551234|FG000|Overall Study|Other Protocol Specified Criteria|0|||
156943986|NCT01709318|566551235|FG001|Overall Study|Other Protocol Specified Criteria|1|||
156943987|NCT01709318|566551236|FG002|Overall Study|Other Protocol Specified Criteria|0|||
156943988|NCT01709318|566551237|FG003|Overall Study|Other Protocol Specified Criteria|0|||
156943989|NCT01709318|566551238|FG004|Overall Study|Other Protocol Specified Criteria|0|||
156943990|NCT01709318|566551239|FG005|Overall Study|Other Protocol Specified Criteria|0|||
156943991|NCT01709318|566551240|FG006|Overall Study|Other Protocol Specified Criteria|0|||
156943992|NCT00646958|566551245|FG000|Overall Study|Lack of Efficacy|1|||
156943993|NCT00646958|566551246|FG001|Overall Study|Lack of Efficacy|0|||
156943994|NCT00646958|566551247|FG002|Overall Study|Lack of Efficacy|0|||
156943995|NCT00646958|566551245|FG000|Overall Study|Adverse Event|4|||
156943996|NCT00646958|566551246|FG001|Overall Study|Adverse Event|0|||
156943997|NCT00646958|566551247|FG002|Overall Study|Adverse Event|0|||
156943998|NCT00646958|566551245|FG000|Overall Study|Lost to Follow-up|1|||
156943999|NCT00646958|566551246|FG001|Overall Study|Lost to Follow-up|5|||
156944000|NCT00646958|566551247|FG002|Overall Study|Lost to Follow-up|7|||
156944001|NCT00646958|566551245|FG000|Overall Study|Protocol Violation|1|||
156944002|NCT00646958|566551246|FG001|Overall Study|Protocol Violation|1|||
156944003|NCT00646958|566551247|FG002|Overall Study|Protocol Violation|0|||
156944004|NCT00646958|566551245|FG000|Overall Study|Abnormal screening lab tests|1|||
156944005|NCT00646958|566551246|FG001|Overall Study|Abnormal screening lab tests|1|||
156944006|NCT00646958|566551247|FG002|Overall Study|Abnormal screening lab tests|0|||
156944007|NCT00646958|566551245|FG000|Overall Study|Withdrawal by Subject|1|||
156944008|NCT00646958|566551246|FG001|Overall Study|Withdrawal by Subject|2|||
156944009|NCT00646958|566551247|FG002|Overall Study|Withdrawal by Subject|0|||
156944010|NCT00646958|566551245|FG000|Overall Study|Did not receive study drug|2|||
156944011|NCT00646958|566551246|FG001|Overall Study|Did not receive study drug|0|||
156944012|NCT00646958|566551247|FG002|Overall Study|Did not receive study drug|2|||
156944013|NCT00827372|566551248|FG000|Overall Study|Adverse Event|5|||
156944014|NCT00827372|566551248|FG000|Overall Study|Lack of Efficacy|3|||
156944015|NCT01310413|566551249|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
156944016|NCT01310413|566551250|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
156944017|NCT01310413|566551251|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
156944018|NCT01310413|566551252|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
156944019|NCT01310413|566551253|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
156944020|NCT01310413|566551254|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
156944021|NCT01310413|566551255|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
156944022|NCT01310413|566551249|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
156944023|NCT01310413|566551250|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
156944024|NCT01310413|566551251|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
156944025|NCT01310413|566551252|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
156944026|NCT01310413|566551253|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
156944027|NCT01310413|566551254|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
156944028|NCT01310413|566551255|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
156944029|NCT01310413|566551249|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
156944030|NCT01310413|566551250|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
156944031|NCT01310413|566551251|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
156944032|NCT01310413|566551252|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
156944033|NCT01310413|566551253|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
156944034|NCT01310413|566551254|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
156944035|NCT01310413|566551255|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
156944036|NCT01310413|566551249|FG000|Day 0 to Day 385|Other|1|||
156944037|NCT01310413|566551250|FG001|Day 0 to Day 385|Other|0|||
156944038|NCT01310413|566551251|FG002|Day 0 to Day 385|Other|3|||
156944039|NCT01310413|566551252|FG003|Day 0 to Day 385|Other|0|||
156944040|NCT01310413|566551253|FG004|Day 0 to Day 385|Other|0|||
156944041|NCT01310413|566551254|FG005|Day 0 to Day 385|Other|0|||
156944042|NCT01310413|566551255|FG006|Day 0 to Day 385|Other|0|||
156944043|NCT01310413|566551249|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944044|NCT01310413|566551250|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944045|NCT01310413|566551251|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944046|NCT01310413|566551252|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944047|NCT01310413|566551253|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944048|NCT01310413|566551254|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
156944049|NCT01310413|566551255|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
156944050|NCT01310413|566551249|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
156944051|NCT01310413|566551250|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
156944052|NCT01310413|566551251|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
156944053|NCT01310413|566551252|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
156944054|NCT01310413|566551253|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
156944055|NCT01310413|566551254|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
156944056|NCT01310413|566551255|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
156944057|NCT02564471|566551256|FG000|Overall Study|Adverse Event|1|||
156944058|NCT02564471|566551257|FG001|Overall Study|Adverse Event|0|||
156944059|NCT02564471|566551258|FG002|Overall Study|Adverse Event|0|||
156944060|NCT02564471|566551259|FG003|Overall Study|Adverse Event|0|||
156944061|NCT02564471|566551256|FG000|Overall Study|Withdrawal by Subject|2|||
156944062|NCT02564471|566551257|FG001|Overall Study|Withdrawal by Subject|1|||
156944063|NCT02564471|566551258|FG002|Overall Study|Withdrawal by Subject|3|||
156944064|NCT02564471|566551259|FG003|Overall Study|Withdrawal by Subject|0|||
156944065|NCT02564471|566551256|FG000|Overall Study|Lost to Follow-up|0|||
156944066|NCT02564471|566551257|FG001|Overall Study|Lost to Follow-up|2|||
156944067|NCT02564471|566551258|FG002|Overall Study|Lost to Follow-up|0|||
156944068|NCT02564471|566551259|FG003|Overall Study|Lost to Follow-up|0|||
156944069|NCT02066298|566551260|FG000|Overall Study|Lost to Follow-up|3|||
156944070|NCT02066298|566551261|FG001|Overall Study|Lost to Follow-up|2|||
156944071|NCT02066298|566551262|FG002|Overall Study|Lost to Follow-up|3|||
156944072|NCT02066298|566551263|FG003|Overall Study|Lost to Follow-up|2|||
156944073|NCT02066298|566551264|FG004|Overall Study|Lost to Follow-up|3|||
156944074|NCT02066298|566551265|FG005|Overall Study|Lost to Follow-up|4|||
156944075|NCT02066298|566551260|FG000|Overall Study|Withdrawal by Subject|6|||
156944076|NCT02066298|566551261|FG001|Overall Study|Withdrawal by Subject|6|||
156944077|NCT02066298|566551262|FG002|Overall Study|Withdrawal by Subject|6|||
156944078|NCT02066298|566551263|FG003|Overall Study|Withdrawal by Subject|4|||
156944079|NCT02066298|566551264|FG004|Overall Study|Withdrawal by Subject|5|||
156944080|NCT02066298|566551265|FG005|Overall Study|Withdrawal by Subject|8|||
156944081|NCT02066298|566551260|FG000|Overall Study|Physician Decision|0|||
156944082|NCT02066298|566551261|FG001|Overall Study|Physician Decision|0|||
156944083|NCT02066298|566551262|FG002|Overall Study|Physician Decision|1|||
156944084|NCT02066298|566551263|FG003|Overall Study|Physician Decision|0|||
156944085|NCT02066298|566551264|FG004|Overall Study|Physician Decision|1|||
156944086|NCT02066298|566551265|FG005|Overall Study|Physician Decision|0|||
156944087|NCT04260191|566551266|FG000|Overall Study|Decision by Sponsor|0|||
156944088|NCT04260191|566551267|FG001|Overall Study|Decision by Sponsor|1|||
156944089|NCT04260191|566551268|FG002|Overall Study|Decision by Sponsor|0|||
157032656|NCT04880733|566875925|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
157167446|NCT02062463|567354554|FG002|Stage 2|Lost to Follow-up|20|||
157167447|NCT02062463|567354555|FG003|Stage 2|Lost to Follow-up|20|||
156944090|NCT04260191|566551266|FG000|Overall Study|Withdrawal by Subject|1|||
156944091|NCT04260191|566551267|FG001|Overall Study|Withdrawal by Subject|0|||
156944092|NCT04260191|566551268|FG002|Overall Study|Withdrawal by Subject|3|||
156944093|NCT04260191|566551266|FG000|Overall Study|Death|4|||
156944094|NCT04260191|566551267|FG001|Overall Study|Death|3|||
156944095|NCT04260191|566551268|FG002|Overall Study|Death|2|||
157032657|NCT04880733|566875926|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
156944096|NCT00630877|566551271|FG000|Overall Study|Adverse Event|11|||
156944097|NCT00630877|566551272|FG001|Overall Study|Adverse Event|8|||
156944098|NCT00630877|566551273|FG002|Overall Study|Adverse Event|7|||
156944099|NCT00630877|566551271|FG000|Overall Study|Withdrawal by Subject|3|||
156944100|NCT00630877|566551272|FG001|Overall Study|Withdrawal by Subject|4|||
156944101|NCT00630877|566551273|FG002|Overall Study|Withdrawal by Subject|0|||
156944102|NCT00630877|566551271|FG000|Overall Study|Lost to Follow-up|2|||
156944103|NCT00630877|566551272|FG001|Overall Study|Lost to Follow-up|0|||
156944104|NCT00630877|566551273|FG002|Overall Study|Lost to Follow-up|0|||
156944105|NCT00630877|566551271|FG000|Overall Study|Noncompliance|2|||
156944106|NCT00630877|566551272|FG001|Overall Study|Noncompliance|3|||
156944107|NCT00630877|566551273|FG002|Overall Study|Noncompliance|1|||
156944108|NCT00630877|566551271|FG000|Overall Study|Protocol violation|1|||
156944109|NCT00630877|566551272|FG001|Overall Study|Protocol violation|0|||
156944110|NCT00630877|566551273|FG002|Overall Study|Protocol violation|1|||
156944111|NCT00630877|566551271|FG000|Overall Study|Personal reasons|0|||
156944112|NCT00630877|566551272|FG001|Overall Study|Personal reasons|0|||
156944113|NCT00630877|566551273|FG002|Overall Study|Personal reasons|1|||
156944114|NCT01643473|566551274|FG000|Overall Study|Lost to Follow-up|1|||
156944115|NCT01643473|566551275|FG001|Overall Study|Lost to Follow-up|0|||
156944116|NCT02033889|566551276|FG000|Overall Study|Adverse Event|3|||
156944117|NCT02033889|566551277|FG001|Overall Study|Adverse Event|1|||
156944118|NCT02033889|566551278|FG002|Overall Study|Adverse Event|3|||
156944119|NCT02033889|566551276|FG000|Overall Study|Death|3|||
156944120|NCT02033889|566551277|FG001|Overall Study|Death|1|||
156944121|NCT02033889|566551278|FG002|Overall Study|Death|2|||
156944122|NCT02033889|566551276|FG000|Overall Study|Excluded Medication|1|||
156944123|NCT02033889|566551277|FG001|Overall Study|Excluded Medication|1|||
156944124|NCT02033889|566551278|FG002|Overall Study|Excluded Medication|0|||
156944125|NCT02033889|566551276|FG000|Overall Study|Lost to Follow-up|8|||
156944126|NCT02033889|566551277|FG001|Overall Study|Lost to Follow-up|5|||
156944127|NCT02033889|566551278|FG002|Overall Study|Lost to Follow-up|6|||
156944128|NCT02033889|566551276|FG000|Overall Study|Non-Compliance With Study Drug|1|||
156944129|NCT02033889|566551277|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156944130|NCT02033889|566551278|FG002|Overall Study|Non-Compliance With Study Drug|0|||
156944131|NCT02033889|566551276|FG000|Overall Study|Physician Decision|0|||
156944132|NCT02033889|566551277|FG001|Overall Study|Physician Decision|1|||
156944133|NCT02033889|566551278|FG002|Overall Study|Physician Decision|1|||
156944134|NCT02033889|566551276|FG000|Overall Study|Participant moved|0|||
156944135|NCT02033889|566551277|FG001|Overall Study|Participant moved|1|||
156944136|NCT02033889|566551278|FG002|Overall Study|Participant moved|0|||
156944137|NCT02033889|566551276|FG000|Overall Study|Withdrawal by Subject|18|||
156944138|NCT02033889|566551277|FG001|Overall Study|Withdrawal by Subject|10|||
156944139|NCT02033889|566551278|FG002|Overall Study|Withdrawal by Subject|13|||
156944140|NCT02343458|566551279|FG000|Overall Study|Adverse Event|15|||
156944141|NCT02343458|566551280|FG001|Overall Study|Adverse Event|14|||
156944142|NCT02343458|566551281|FG002|Overall Study|Adverse Event|15|||
156944143|NCT02343458|566551282|FG003|Overall Study|Adverse Event|3|||
156944144|NCT02343458|566551279|FG000|Overall Study|Lack of Efficacy|3|||
156944145|NCT02343458|566551280|FG001|Overall Study|Lack of Efficacy|8|||
156944146|NCT02343458|566551281|FG002|Overall Study|Lack of Efficacy|4|||
156944147|NCT02343458|566551282|FG003|Overall Study|Lack of Efficacy|8|||
156944148|NCT02343458|566551279|FG000|Overall Study|Withdrawal by Subject|18|||
156944149|NCT02343458|566551280|FG001|Overall Study|Withdrawal by Subject|17|||
156944150|NCT02343458|566551281|FG002|Overall Study|Withdrawal by Subject|23|||
156944151|NCT02343458|566551282|FG003|Overall Study|Withdrawal by Subject|14|||
156944152|NCT02343458|566551279|FG000|Overall Study|Physician Decision|1|||
156944153|NCT02343458|566551280|FG001|Overall Study|Physician Decision|4|||
156944154|NCT02343458|566551281|FG002|Overall Study|Physician Decision|2|||
156944155|NCT02343458|566551282|FG003|Overall Study|Physician Decision|2|||
156944156|NCT02343458|566551279|FG000|Overall Study|Lost to Follow-up|5|||
156944157|NCT02343458|566551280|FG001|Overall Study|Lost to Follow-up|5|||
156944158|NCT02343458|566551281|FG002|Overall Study|Lost to Follow-up|3|||
156944159|NCT02343458|566551282|FG003|Overall Study|Lost to Follow-up|1|||
156944160|NCT02343458|566551279|FG000|Overall Study|Protocol Violation|2|||
156944161|NCT02343458|566551280|FG001|Overall Study|Protocol Violation|5|||
156944162|NCT02343458|566551281|FG002|Overall Study|Protocol Violation|2|||
157167448|NCT02062463|567354552|FG000|Stage 2|Non-Compliance|0|||
157167449|NCT02062463|567354553|FG001|Stage 2|Non-Compliance|0|||
157167450|NCT02062463|567354554|FG002|Stage 2|Non-Compliance|0|||
157167451|NCT02062463|567354555|FG003|Stage 2|Non-Compliance|1|||
156944163|NCT02343458|566551282|FG003|Overall Study|Protocol Violation|2|||
156944164|NCT02343458|566551279|FG000|Overall Study|Protocol Specified Criteria|17|||
157167452|NCT02062463|567354552|FG000|Stage 2|Other than specified|0|||
157167453|NCT02062463|567354553|FG001|Stage 2|Other than specified|0|||
156944165|NCT02343458|566551280|FG001|Overall Study|Protocol Specified Criteria|13|||
156944166|NCT02343458|566551281|FG002|Overall Study|Protocol Specified Criteria|14|||
156944167|NCT02343458|566551282|FG003|Overall Study|Protocol Specified Criteria|8|||
156944168|NCT01312909|566551283|FG000|Overall Study|Randomized but not treated|1|||
157032658|NCT04880733|566875924|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
156944169|NCT01312909|566551284|FG001|Overall Study|Randomized but not treated|3|||
156944170|NCT01312909|566551285|FG002|Overall Study|Randomized but not treated|1|||
156944171|NCT01312909|566551283|FG000|Overall Study|Adverse Event|1|||
156944172|NCT01312909|566551284|FG001|Overall Study|Adverse Event|0|||
156944173|NCT01312909|566551285|FG002|Overall Study|Adverse Event|3|||
156944174|NCT01312909|566551283|FG000|Overall Study|Protocol Violation|2|||
156944175|NCT01312909|566551284|FG001|Overall Study|Protocol Violation|0|||
156944176|NCT01312909|566551285|FG002|Overall Study|Protocol Violation|2|||
156944177|NCT01312909|566551283|FG000|Overall Study|Other|9|||
156944178|NCT01312909|566551284|FG001|Overall Study|Other|6|||
156944179|NCT01312909|566551285|FG002|Overall Study|Other|11|||
156944180|NCT01312909|566551283|FG000|Overall Study|Withdrawal by Subject|8|||
156944181|NCT01312909|566551284|FG001|Overall Study|Withdrawal by Subject|10|||
156944182|NCT01312909|566551285|FG002|Overall Study|Withdrawal by Subject|7|||
156944183|NCT01312909|566551283|FG000|Overall Study|Lost to Follow-up|21|||
156944184|NCT01312909|566551284|FG001|Overall Study|Lost to Follow-up|17|||
156944185|NCT01312909|566551285|FG002|Overall Study|Lost to Follow-up|20|||
156944186|NCT01312909|566551283|FG000|Overall Study|Insufficient clinical response|0|||
156944187|NCT01312909|566551284|FG001|Overall Study|Insufficient clinical response|0|||
156944188|NCT01312909|566551285|FG002|Overall Study|Insufficient clinical response|1|||
156944189|NCT01312909|566551283|FG000|Overall Study|Entrance criteria not met|0|||
156944190|NCT01312909|566551284|FG001|Overall Study|Entrance criteria not met|0|||
156944191|NCT01312909|566551285|FG002|Overall Study|Entrance criteria not met|2|||
156944192|NCT01913041|566551291|FG000|Overall Study|Protocol Violation|35|||
156944193|NCT01913041|566551291|FG000|Overall Study|Withdrawal by Subject|3|||
156944194|NCT01913041|566551291|FG000|Overall Study|Physician Decision|1|||
156944195|NCT01513317|566551292|FG000|Overall Study|Withdrawal by Subject|15|||
156944196|NCT01513317|566551293|FG001|Overall Study|Withdrawal by Subject|4|||
156944197|NCT01513317|566551292|FG000|Overall Study|Death|1|||
156944198|NCT01513317|566551293|FG001|Overall Study|Death|1|||
156944199|NCT01513317|566551292|FG000|Overall Study|Study terminated by sponsor|18|||
156944200|NCT01513317|566551293|FG001|Overall Study|Study terminated by sponsor|18|||
156944201|NCT01513317|566551292|FG000|Overall Study|Other|0|||
156944202|NCT01513317|566551293|FG001|Overall Study|Other|1|||
156944203|NCT00182689|566551294|FG000|Overall Study|Adverse Event|8|||
156944204|NCT00182689|566551295|FG001|Overall Study|Adverse Event|11|||
156944205|NCT00182689|566551294|FG000|Overall Study|Withdrawal by Subject|2|||
156944206|NCT00182689|566551295|FG001|Overall Study|Withdrawal by Subject|2|||
156944207|NCT00182689|566551294|FG000|Overall Study|Progression|27|||
156944208|NCT00182689|566551295|FG001|Overall Study|Progression|29|||
156944209|NCT00182689|566551294|FG000|Overall Study|Death|1|||
156944210|NCT00182689|566551295|FG001|Overall Study|Death|0|||
156944211|NCT00182689|566551294|FG000|Overall Study|not protocol specified|0|||
156944212|NCT00182689|566551295|FG001|Overall Study|not protocol specified|3|||
156944213|NCT00182689|566551294|FG000|Overall Study|Ineligible|1|||
156944214|NCT00182689|566551295|FG001|Overall Study|Ineligible|4|||
156944215|NCT00182689|566551294|FG000|Overall Study|Never received treatment|1|||
156944216|NCT00182689|566551295|FG001|Overall Study|Never received treatment|0|||
156944217|NCT02564198|566551296|FG000|Overall Study|Withdrawal by Subject|2|||
156944218|NCT02564198|566551297|FG001|Overall Study|Withdrawal by Subject|4|||
156944219|NCT02564198|566551298|FG002|Overall Study|Withdrawal by Subject|0|||
156944220|NCT02564198|566551296|FG000|Overall Study|Adverse Event|0|||
156944221|NCT02564198|566551297|FG001|Overall Study|Adverse Event|1|||
156944222|NCT02564198|566551298|FG002|Overall Study|Adverse Event|0|||
156944223|NCT00659646|566551299|FG000|Overall Study|Protocol Violation|12|||
156944224|NCT00659646|566551300|FG001|Overall Study|Protocol Violation|8|||
156944225|NCT00659646|566551299|FG000|Overall Study|Adverse Event|1|||
156944226|NCT00659646|566551300|FG001|Overall Study|Adverse Event|0|||
156944227|NCT00659646|566551299|FG000|Overall Study|Lost to Follow-up|1|||
156944228|NCT00659646|566551300|FG001|Overall Study|Lost to Follow-up|0|||
156944229|NCT00659646|566551299|FG000|Overall Study|protocol noncompliance after randomized|1|||
156944230|NCT00659646|566551300|FG001|Overall Study|protocol noncompliance after randomized|0|||
156944231|NCT01640301|566551301|FG000|Overall Study|Death|0|||
156944232|NCT01640301|566551302|FG001|Overall Study|Death|8|||
156944233|NCT02200042|566551306|FG000|Overall Study|Withdrawal by Subject|0|||
156944234|NCT02200042|566551307|FG001|Overall Study|Withdrawal by Subject|1|||
156944235|NCT01969838|566551308|FG000|Double-blind Phase|Adverse Event|10|||
156944236|NCT01969838|566551309|FG001|Double-blind Phase|Adverse Event|4|||
156944237|NCT01969838|566551310|FG002|Double-blind Phase|Adverse Event|0|||
157227329|NCT00950807|567577789|FG008|Treatment Period 2|Withdrawal by Subject|0|||
156944238|NCT01969838|566551311|FG003|Double-blind Phase|Adverse Event|0|||
156944239|NCT01969838|566551308|FG000|Double-blind Phase|Death|5|||
156944240|NCT01969838|566551309|FG001|Double-blind Phase|Death|2|||
156944241|NCT01969838|566551310|FG002|Double-blind Phase|Death|0|||
156944242|NCT01969838|566551311|FG003|Double-blind Phase|Death|0|||
156944243|NCT01969838|566551308|FG000|Double-blind Phase|Physician Decision|5|||
156944244|NCT01969838|566551309|FG001|Double-blind Phase|Physician Decision|1|||
156944245|NCT01969838|566551310|FG002|Double-blind Phase|Physician Decision|0|||
156944246|NCT01969838|566551311|FG003|Double-blind Phase|Physician Decision|0|||
156944247|NCT01969838|566551308|FG000|Double-blind Phase|Subject Decision|4|||
156944248|NCT01969838|566551309|FG001|Double-blind Phase|Subject Decision|2|||
156944249|NCT01969838|566551310|FG002|Double-blind Phase|Subject Decision|0|||
156944250|NCT01969838|566551311|FG003|Double-blind Phase|Subject Decision|0|||
156944251|NCT01969838|566551308|FG000|Double-blind Phase|Disease Progression|2|||
156944252|NCT01969838|566551309|FG001|Double-blind Phase|Disease Progression|0|||
156944253|NCT01969838|566551310|FG002|Double-blind Phase|Disease Progression|0|||
156944254|NCT01969838|566551311|FG003|Double-blind Phase|Disease Progression|0|||
156944255|NCT01969838|566551308|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
156944256|NCT01969838|566551309|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
156944257|NCT01969838|566551310|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
156944258|NCT01969838|566551311|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
156944259|NCT01969838|566551308|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
156944260|NCT01969838|566551309|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
156944261|NCT01969838|566551310|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
156944262|NCT01969838|566551311|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
156944263|NCT01969838|566551308|FG000|Open-label Phase|Adverse Event|0|||
156944264|NCT01969838|566551309|FG001|Open-label Phase|Adverse Event|0|||
156944265|NCT01969838|566551310|FG002|Open-label Phase|Adverse Event|37|||
156944266|NCT01969838|566551311|FG003|Open-label Phase|Adverse Event|49|||
156944267|NCT01969838|566551308|FG000|Open-label Phase|Disease Progression|0|||
156944268|NCT01969838|566551309|FG001|Open-label Phase|Disease Progression|0|||
156944269|NCT01969838|566551310|FG002|Open-label Phase|Disease Progression|26|||
156944270|NCT01969838|566551311|FG003|Open-label Phase|Disease Progression|27|||
156944271|NCT01969838|566551308|FG000|Open-label Phase|Lack of Efficacy|0|||
156944272|NCT01969838|566551309|FG001|Open-label Phase|Lack of Efficacy|0|||
156944273|NCT01969838|566551310|FG002|Open-label Phase|Lack of Efficacy|17|||
156944274|NCT01969838|566551311|FG003|Open-label Phase|Lack of Efficacy|19|||
156944275|NCT01969838|566551308|FG000|Open-label Phase|Subject Decision|0|||
156944276|NCT01969838|566551309|FG001|Open-label Phase|Subject Decision|0|||
156944277|NCT01969838|566551310|FG002|Open-label Phase|Subject Decision|14|||
156944278|NCT01969838|566551311|FG003|Open-label Phase|Subject Decision|15|||
156944279|NCT01969838|566551308|FG000|Open-label Phase|Death|0|||
156944280|NCT01969838|566551309|FG001|Open-label Phase|Death|0|||
156944281|NCT01969838|566551310|FG002|Open-label Phase|Death|13|||
156944282|NCT01969838|566551311|FG003|Open-label Phase|Death|11|||
156944283|NCT01969838|566551308|FG000|Open-label Phase|Physician Decision|0|||
156944284|NCT01969838|566551309|FG001|Open-label Phase|Physician Decision|0|||
156944285|NCT01969838|566551310|FG002|Open-label Phase|Physician Decision|9|||
156944286|NCT01969838|566551311|FG003|Open-label Phase|Physician Decision|14|||
156944287|NCT01969838|566551308|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
156944288|NCT01969838|566551309|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
156944289|NCT01969838|566551310|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
156944290|NCT01969838|566551311|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
156944291|NCT00408993|566551312|FG000|Overall Study|Adverse Event|15|||
156944292|NCT00408993|566551313|FG001|Overall Study|Adverse Event|4|||
156944293|NCT00408993|566551312|FG000|Overall Study|Protocol Violation|1|||
156944294|NCT00408993|566551313|FG001|Overall Study|Protocol Violation|6|||
156944295|NCT00408993|566551312|FG000|Overall Study|Lack of Efficacy|1|||
156944296|NCT00408993|566551313|FG001|Overall Study|Lack of Efficacy|4|||
156944297|NCT00408993|566551312|FG000|Overall Study|Withdrawal by Subject|2|||
156944298|NCT00408993|566551313|FG001|Overall Study|Withdrawal by Subject|3|||
156944299|NCT01694706|566551314|FG000|Overall Study|Adverse Event|0|||
156944300|NCT01694706|566551315|FG001|Overall Study|Adverse Event|1|||
156944301|NCT01694706|566551316|FG002|Overall Study|Adverse Event|0|||
156944302|NCT01694706|566551314|FG000|Overall Study|other reason not defined above|1|||
156944303|NCT01694706|566551315|FG001|Overall Study|other reason not defined above|0|||
156944304|NCT01694706|566551316|FG002|Overall Study|other reason not defined above|0|||
156944305|NCT01923181|566551317|FG000|Overall Study|Protocol Violation|2|||
156944306|NCT01923181|566551318|FG001|Overall Study|Protocol Violation|2|||
156944307|NCT01923181|566551319|FG002|Overall Study|Protocol Violation|0|||
156944308|NCT01923181|566551320|FG003|Overall Study|Protocol Violation|2|||
156944309|NCT01923181|566551321|FG004|Overall Study|Protocol Violation|2|||
156944310|NCT01923181|566551322|FG005|Overall Study|Protocol Violation|1|||
156944311|NCT01923181|566551323|FG006|Overall Study|Protocol Violation|1|||
156944312|NCT01923181|566551324|FG007|Overall Study|Protocol Violation|2|||
156944313|NCT01923181|566551325|FG008|Overall Study|Protocol Violation|1|||
156944314|NCT01923181|566551317|FG000|Overall Study|Withdrawal by Subject|0|||
156944315|NCT01923181|566551318|FG001|Overall Study|Withdrawal by Subject|1|||
156944316|NCT01923181|566551319|FG002|Overall Study|Withdrawal by Subject|0|||
156944317|NCT01923181|566551320|FG003|Overall Study|Withdrawal by Subject|1|||
156944318|NCT01923181|566551321|FG004|Overall Study|Withdrawal by Subject|4|||
156944319|NCT01923181|566551322|FG005|Overall Study|Withdrawal by Subject|2|||
156944320|NCT01923181|566551323|FG006|Overall Study|Withdrawal by Subject|4|||
157167454|NCT02062463|567354554|FG002|Stage 2|Other than specified|3|||
156944321|NCT01923181|566551324|FG007|Overall Study|Withdrawal by Subject|3|||
156944322|NCT01923181|566551325|FG008|Overall Study|Withdrawal by Subject|1|||
156944323|NCT01923181|566551317|FG000|Overall Study|Other|1|||
156944324|NCT01923181|566551318|FG001|Overall Study|Other|0|||
156944325|NCT01923181|566551319|FG002|Overall Study|Other|0|||
156944326|NCT01923181|566551320|FG003|Overall Study|Other|1|||
156944327|NCT01923181|566551321|FG004|Overall Study|Other|0|||
156944328|NCT01923181|566551322|FG005|Overall Study|Other|0|||
156944329|NCT01923181|566551323|FG006|Overall Study|Other|0|||
156944330|NCT01923181|566551324|FG007|Overall Study|Other|0|||
156944331|NCT01923181|566551325|FG008|Overall Study|Other|0|||
156944332|NCT01923181|566551317|FG000|Overall Study|Lost to Follow-up|0|||
156944333|NCT01923181|566551318|FG001|Overall Study|Lost to Follow-up|3|||
156944334|NCT01923181|566551319|FG002|Overall Study|Lost to Follow-up|2|||
156944335|NCT01923181|566551320|FG003|Overall Study|Lost to Follow-up|1|||
156944336|NCT01923181|566551321|FG004|Overall Study|Lost to Follow-up|2|||
156944337|NCT01923181|566551322|FG005|Overall Study|Lost to Follow-up|1|||
156944338|NCT01923181|566551323|FG006|Overall Study|Lost to Follow-up|3|||
156944339|NCT01923181|566551324|FG007|Overall Study|Lost to Follow-up|3|||
156944340|NCT01923181|566551325|FG008|Overall Study|Lost to Follow-up|1|||
156944341|NCT02944578|566551326|FG000|Overall Study|Physician Decision|1|||
156944342|NCT02944578|566551327|FG001|Overall Study|Physician Decision|0|||
156944343|NCT00451282|566551330|FG000|Overall Study|Lost to Follow-up|6|||
156944344|NCT00451282|566551331|FG001|Overall Study|Lost to Follow-up|5|||
156944345|NCT00098839|566551332|FG000|Overall Study|Adverse Event|5|||
156944346|NCT00098839|566551333|FG001|Overall Study|Adverse Event|2|||
156944347|NCT00098839|566551332|FG000|Overall Study|Death|1|||
156944348|NCT00098839|566551333|FG001|Overall Study|Death|2|||
156944349|NCT00098839|566551332|FG000|Overall Study|Physician Decision|4|||
156944350|NCT00098839|566551333|FG001|Overall Study|Physician Decision|14|||
156944351|NCT00098839|566551332|FG000|Overall Study|Withdrawal by Subject|1|||
156944352|NCT00098839|566551333|FG001|Overall Study|Withdrawal by Subject|0|||
156944353|NCT00098839|566551332|FG000|Overall Study|Refusal of further protocol therapy|3|||
156944354|NCT00098839|566551333|FG001|Overall Study|Refusal of further protocol therapy|1|||
156944355|NCT00098839|566551332|FG000|Overall Study|Relapse|6|||
156944356|NCT00098839|566551333|FG001|Overall Study|Relapse|3|||
156944357|NCT00098839|566551332|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
156944358|NCT00098839|566551333|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
156944359|NCT00098839|566551332|FG000|Overall Study|Ineligible|2|||
156944360|NCT00098839|566551333|FG001|Overall Study|Ineligible|0|||
156944361|NCT00577122|566551334|FG000|Overall Study|Adverse Event|0|||
156944362|NCT00577122|566551335|FG001|Overall Study|Adverse Event|2|||
156944363|NCT00577122|566551334|FG000|Overall Study|Progression, relapse during active trt|6|||
156944364|NCT00577122|566551335|FG001|Overall Study|Progression, relapse during active trt|8|||
156944365|NCT00577122|566551334|FG000|Overall Study|Prog, refract disease during active trt|8|||
156944366|NCT00577122|566551335|FG001|Overall Study|Prog, refract disease during active trt|5|||
156944367|NCT00577122|566551334|FG000|Overall Study|Alternative Therapy|0|||
156944368|NCT00577122|566551335|FG001|Overall Study|Alternative Therapy|1|||
156944369|NCT00456092|566551337|FG000|Extension Phase|Grade 2 or Greater AE|2|||
156944370|NCT00456092|566551338|FG001|Extension Phase|Grade 2 or Greater AE|2|||
156944371|NCT00456092|566551339|FG002|Extension Phase|Grade 2 or Greater AE|0|||
156944372|NCT00456092|566551340|FG003|Extension Phase|Grade 2 or Greater AE|0|||
156944373|NCT00456092|566551341|FG004|Extension Phase|Grade 2 or Greater AE|2|||
156944374|NCT00456092|566551337|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
156944375|NCT00456092|566551338|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
156944376|NCT00456092|566551339|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
156944377|NCT00456092|566551340|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
156944378|NCT00456092|566551341|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
156944379|NCT00456092|566551337|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
156944380|NCT00456092|566551338|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
156944381|NCT00456092|566551339|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
156944382|NCT00456092|566551340|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
156944383|NCT00456092|566551341|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
156944384|NCT00456092|566551337|FG000|Extension Phase|Withdrew Consent|2|||
156944385|NCT00456092|566551338|FG001|Extension Phase|Withdrew Consent|0|||
156944386|NCT00456092|566551339|FG002|Extension Phase|Withdrew Consent|0|||
156944387|NCT00456092|566551340|FG003|Extension Phase|Withdrew Consent|0|||
156944388|NCT00456092|566551341|FG004|Extension Phase|Withdrew Consent|0|||
156944389|NCT00456092|566551337|FG000|Extension Phase|Lost to Follow-up|1|||
156944390|NCT00456092|566551338|FG001|Extension Phase|Lost to Follow-up|1|||
156944391|NCT00456092|566551339|FG002|Extension Phase|Lost to Follow-up|0|||
156944392|NCT00456092|566551340|FG003|Extension Phase|Lost to Follow-up|0|||
156944393|NCT00456092|566551341|FG004|Extension Phase|Lost to Follow-up|1|||
156944394|NCT00456092|566551337|FG000|Extension Phase|Other|2|||
156944395|NCT00456092|566551338|FG001|Extension Phase|Other|0|||
156944396|NCT00456092|566551339|FG002|Extension Phase|Other|0|||
156944397|NCT00456092|566551340|FG003|Extension Phase|Other|1|||
156944398|NCT00456092|566551341|FG004|Extension Phase|Other|1|||
156944399|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
156944400|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
156944401|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
156944402|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
156944403|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
156944404|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
156944405|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
156944406|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156944407|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156944408|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
156944409|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
156944410|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156944411|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156944412|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156944413|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
156944414|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156944415|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
156944416|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
156944417|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156944418|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
156944419|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156944420|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
156944421|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
156944422|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156944423|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
156944424|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156944425|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
156944426|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
156944427|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156944428|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
156944429|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156944430|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
156944431|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
156944432|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156944433|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
156944434|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156944435|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156944436|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
156944437|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156944438|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
156944439|NCT00456092|566551337|FG000|Treatment Phase (12 Weeks)|Other|1|||
156944440|NCT00456092|566551338|FG001|Treatment Phase (12 Weeks)|Other|0|||
156944441|NCT00456092|566551339|FG002|Treatment Phase (12 Weeks)|Other|1|||
156944442|NCT00456092|566551340|FG003|Treatment Phase (12 Weeks)|Other|0|||
156944443|NCT00456092|566551341|FG004|Treatment Phase (12 Weeks)|Other|0|||
156944444|NCT03228680|566551342|FG000|Overall Study|Adverse Event|13|||
156944445|NCT03228680|566551343|FG001|Overall Study|Adverse Event|18|||
156944446|NCT03228680|566551342|FG000|Overall Study|Randomization failure|0|||
156944447|NCT03228680|566551343|FG001|Overall Study|Randomization failure|1|||
156944448|NCT03228680|566551342|FG000|Overall Study|Withdrawal by Subject|1|||
156944449|NCT03228680|566551343|FG001|Overall Study|Withdrawal by Subject|0|||
156944450|NCT03228680|566551342|FG000|Overall Study|Other|9|||
156944451|NCT03228680|566551343|FG001|Overall Study|Other|16|||
156944452|NCT00403455|566551355|FG000|Overall Study|Withdrawal by Subject|1|||
156944453|NCT01358981|566551356|FG000|Period 1|Withdrawal by Subject|0|||
156944454|NCT01358981|566551357|FG001|Period 1|Withdrawal by Subject|0|||
156944455|NCT01358981|566551358|FG002|Period 1|Withdrawal by Subject|0|||
156944456|NCT01358981|566551359|FG003|Period 1|Withdrawal by Subject|1|||
156944457|NCT01358981|566551360|FG004|Period 1|Withdrawal by Subject|0|||
156944458|NCT01358981|566551361|FG005|Period 1|Withdrawal by Subject|0|||
156944459|NCT01358981|566551362|FG006|Period 1|Withdrawal by Subject|0|||
156944460|NCT02992899|566551363|FG000|Overall Study|Withdrawal by Subject|1|||
156944461|NCT02992899|566551364|FG001|Overall Study|Withdrawal by Subject|0|||
156944462|NCT02992899|566551363|FG000|Overall Study|Lost to Follow-up|1|||
156944463|NCT02992899|566551364|FG001|Overall Study|Lost to Follow-up|3|||
156944464|NCT02738775|566551365|FG000|Overall Study|Withdrawal by Subject|0|||
156944465|NCT02738775|566551366|FG001|Overall Study|Withdrawal by Subject|1|||
156944466|NCT02738775|566551367|FG002|Overall Study|Withdrawal by Subject|0|||
156944467|NCT02738775|566551368|FG003|Overall Study|Withdrawal by Subject|0|||
157032659|NCT04880733|566875925|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
157032660|NCT04880733|566875926|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
157032661|NCT04880733|566875924|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
156944468|NCT02738775|566551369|FG004|Overall Study|Withdrawal by Subject|0|||
156944469|NCT02738775|566551370|FG005|Overall Study|Withdrawal by Subject|0|||
157032662|NCT04880733|566875925|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
156944470|NCT02738775|566551365|FG000|Overall Study|Adverse Event|0|||
156944471|NCT02738775|566551366|FG001|Overall Study|Adverse Event|0|||
156944472|NCT02738775|566551367|FG002|Overall Study|Adverse Event|0|||
157032663|NCT04880733|566875926|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
156944473|NCT02738775|566551368|FG003|Overall Study|Adverse Event|1|||
156944474|NCT02738775|566551369|FG004|Overall Study|Adverse Event|0|||
156944475|NCT02738775|566551370|FG005|Overall Study|Adverse Event|0|||
156944476|NCT02738775|566551365|FG000|Overall Study|Pregnancy|0|||
156944477|NCT02738775|566551366|FG001|Overall Study|Pregnancy|1|||
156944478|NCT02738775|566551367|FG002|Overall Study|Pregnancy|0|||
156944479|NCT02738775|566551368|FG003|Overall Study|Pregnancy|0|||
156944480|NCT02738775|566551369|FG004|Overall Study|Pregnancy|0|||
156944481|NCT02738775|566551370|FG005|Overall Study|Pregnancy|0|||
156944482|NCT02738775|566551365|FG000|Overall Study|Missing|0|||
156944483|NCT02738775|566551366|FG001|Overall Study|Missing|0|||
156944484|NCT02738775|566551367|FG002|Overall Study|Missing|0|||
156944485|NCT02738775|566551368|FG003|Overall Study|Missing|0|||
156944486|NCT02738775|566551369|FG004|Overall Study|Missing|0|||
156944487|NCT02738775|566551370|FG005|Overall Study|Missing|1|||
156944488|NCT01060384|566551371|FG000|Overall Study|Withdrawal by Subject|0|||
156944489|NCT01060384|566551372|FG001|Overall Study|Withdrawal by Subject|1|||
156944490|NCT01060384|566551373|FG002|Overall Study|Withdrawal by Subject|0|||
156944491|NCT01060384|566551374|FG003|Overall Study|Withdrawal by Subject|0|||
156944492|NCT01060384|566551375|FG004|Overall Study|Withdrawal by Subject|0|||
156944493|NCT01060384|566551371|FG000|Overall Study|Death|0|||
156944494|NCT01060384|566551372|FG001|Overall Study|Death|0|||
156944495|NCT01060384|566551373|FG002|Overall Study|Death|0|||
156944496|NCT01060384|566551374|FG003|Overall Study|Death|0|||
156944497|NCT01060384|566551375|FG004|Overall Study|Death|1|||
156944498|NCT01060384|566551371|FG000|Overall Study|Intercurrent illness|0|||
156944499|NCT01060384|566551372|FG001|Overall Study|Intercurrent illness|0|||
156944500|NCT01060384|566551373|FG002|Overall Study|Intercurrent illness|0|||
156944501|NCT01060384|566551374|FG003|Overall Study|Intercurrent illness|0|||
156944502|NCT01060384|566551375|FG004|Overall Study|Intercurrent illness|1|||
156944503|NCT01332305|566551378|FG000|Overall Study|Adverse Event|1|||
156944504|NCT01332305|566551379|FG001|Overall Study|Adverse Event|4|||
156944505|NCT01332305|566551380|FG002|Overall Study|Adverse Event|6|||
156944506|NCT01332305|566551381|FG003|Overall Study|Adverse Event|3|||
156944507|NCT01332305|566551382|FG004|Overall Study|Adverse Event|5|||
156944508|NCT01332305|566551378|FG000|Overall Study|Withdrawal by Subject|6|||
156944509|NCT01332305|566551379|FG001|Overall Study|Withdrawal by Subject|5|||
156944510|NCT01332305|566551380|FG002|Overall Study|Withdrawal by Subject|4|||
156944511|NCT01332305|566551381|FG003|Overall Study|Withdrawal by Subject|1|||
156944512|NCT01332305|566551382|FG004|Overall Study|Withdrawal by Subject|0|||
156944513|NCT01332305|566551378|FG000|Overall Study|Lost to Follow-up|0|||
156944514|NCT01332305|566551379|FG001|Overall Study|Lost to Follow-up|2|||
156944515|NCT01332305|566551380|FG002|Overall Study|Lost to Follow-up|3|||
156944516|NCT01332305|566551381|FG003|Overall Study|Lost to Follow-up|2|||
156944517|NCT01332305|566551382|FG004|Overall Study|Lost to Follow-up|3|||
156944518|NCT01332305|566551378|FG000|Overall Study|Protocol Violation|1|||
156944519|NCT01332305|566551379|FG001|Overall Study|Protocol Violation|2|||
156944520|NCT01332305|566551380|FG002|Overall Study|Protocol Violation|1|||
156944521|NCT01332305|566551381|FG003|Overall Study|Protocol Violation|0|||
156944522|NCT01332305|566551382|FG004|Overall Study|Protocol Violation|3|||
156944523|NCT01332305|566551378|FG000|Overall Study|Withdrawal by Sponsor|1|||
156944524|NCT01332305|566551379|FG001|Overall Study|Withdrawal by Sponsor|0|||
156944525|NCT01332305|566551380|FG002|Overall Study|Withdrawal by Sponsor|0|||
156944526|NCT01332305|566551381|FG003|Overall Study|Withdrawal by Sponsor|1|||
156944527|NCT01332305|566551382|FG004|Overall Study|Withdrawal by Sponsor|1|||
156944528|NCT01332305|566551378|FG000|Overall Study|Treatment Failure|1|||
156944529|NCT01332305|566551379|FG001|Overall Study|Treatment Failure|1|||
156944530|NCT01332305|566551380|FG002|Overall Study|Treatment Failure|0|||
156944531|NCT01332305|566551381|FG003|Overall Study|Treatment Failure|0|||
156944532|NCT01332305|566551382|FG004|Overall Study|Treatment Failure|0|||
156944533|NCT01332305|566551378|FG000|Overall Study|Physician Decision|0|||
156944534|NCT01332305|566551379|FG001|Overall Study|Physician Decision|0|||
156944535|NCT01332305|566551380|FG002|Overall Study|Physician Decision|0|||
156944536|NCT01332305|566551381|FG003|Overall Study|Physician Decision|1|||
156944537|NCT01332305|566551382|FG004|Overall Study|Physician Decision|0|||
156944538|NCT03217136|566551387|FG000|Overall Study|Lost to Follow-up|2|||
156944539|NCT03217136|566551388|FG001|Overall Study|Lost to Follow-up|1|||
156944540|NCT03217136|566551387|FG000|Overall Study|Site Randomized Participant in Error|0|||
156944541|NCT03217136|566551388|FG001|Overall Study|Site Randomized Participant in Error|1|||
156944542|NCT03217136|566551387|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
156944543|NCT03217136|566551388|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
156944544|NCT03217136|566551387|FG000|Overall Study|Dispensing Error|1|||
156944545|NCT03217136|566551388|FG001|Overall Study|Dispensing Error|0|||
156944546|NCT03217136|566551387|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
156944547|NCT03217136|566551388|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
156944548|NCT01350128|566551389|FG000|Overall Study|Withdrawal by Subject|3|||
156944549|NCT01350128|566551389|FG000|Overall Study|Protocol discontinuation criteria|8|||
156944550|NCT01350128|566551389|FG000|Overall Study|Physician Decision|1|||
156944551|NCT01350128|566551389|FG000|Overall Study|Lost to Follow-up|2|||
156944552|NCT03969212|566551393|FG000|Overall Study|Adverse Event|1|||
156944553|NCT03969212|566551394|FG001|Overall Study|Adverse Event|0|||
156944554|NCT03969212|566551395|FG002|Overall Study|Adverse Event|0|||
156944555|NCT03969212|566551396|FG003|Overall Study|Adverse Event|0|||
156944556|NCT03969212|566551393|FG000|Overall Study|Lost to Follow-up|2|||
156944557|NCT03969212|566551394|FG001|Overall Study|Lost to Follow-up|2|||
156944558|NCT03969212|566551395|FG002|Overall Study|Lost to Follow-up|2|||
156944559|NCT03969212|566551396|FG003|Overall Study|Lost to Follow-up|2|||
156944560|NCT03969212|566551393|FG000|Overall Study|Protocol Violation|0|||
156944561|NCT03969212|566551394|FG001|Overall Study|Protocol Violation|0|||
156944562|NCT03969212|566551395|FG002|Overall Study|Protocol Violation|0|||
156944563|NCT03969212|566551396|FG003|Overall Study|Protocol Violation|1|||
156944564|NCT03969212|566551393|FG000|Overall Study|Withdrawal by Subject|7|||
156944565|NCT03969212|566551394|FG001|Overall Study|Withdrawal by Subject|13|||
156944566|NCT03969212|566551395|FG002|Overall Study|Withdrawal by Subject|5|||
156944567|NCT03969212|566551396|FG003|Overall Study|Withdrawal by Subject|11|||
156944568|NCT03969212|566551393|FG000|Overall Study|Physician Decision|0|||
156944569|NCT03969212|566551394|FG001|Overall Study|Physician Decision|0|||
156944570|NCT03969212|566551395|FG002|Overall Study|Physician Decision|1|||
156944571|NCT03969212|566551396|FG003|Overall Study|Physician Decision|0|||
156944572|NCT03969212|566551393|FG000|Overall Study|Reason not Specified|22|||
156944573|NCT03969212|566551394|FG001|Overall Study|Reason not Specified|23|||
156944574|NCT03969212|566551395|FG002|Overall Study|Reason not Specified|28|||
156944575|NCT03969212|566551396|FG003|Overall Study|Reason not Specified|26|||
156944576|NCT03773757|566551397|FG000|Overall Study|Withdrawal by Subject|2|||
156944577|NCT03773757|566551398|FG001|Overall Study|Withdrawal by Subject|4|||
156944578|NCT04740034|566551399|FG000|Overall Study|Death|0|||
156944579|NCT04740034|566551400|FG001|Overall Study|Death|1|||
156944580|NCT04740034|566551401|FG002|Overall Study|Death|2|||
156944581|NCT04740034|566551402|FG003|Overall Study|Death|3|||
156944582|NCT04740034|566551403|FG004|Overall Study|Death|4|||
156944583|NCT04740034|566551404|FG005|Overall Study|Death|4|||
156944584|NCT04740034|566551405|FG006|Overall Study|Death|2|||
156944585|NCT04740034|566551406|FG007|Overall Study|Death|2|||
156944586|NCT04740034|566551407|FG008|Overall Study|Death|2|||
156944587|NCT04740034|566551408|FG009|Overall Study|Death|4|||
156944588|NCT04740034|566551409|FG010|Overall Study|Death|0|||
156944589|NCT04740034|566551399|FG000|Overall Study|Lost to Follow-up|0|||
156944590|NCT04740034|566551400|FG001|Overall Study|Lost to Follow-up|0|||
156944591|NCT04740034|566551401|FG002|Overall Study|Lost to Follow-up|0|||
156944592|NCT04740034|566551402|FG003|Overall Study|Lost to Follow-up|1|||
156944593|NCT04740034|566551403|FG004|Overall Study|Lost to Follow-up|2|||
156944594|NCT04740034|566551404|FG005|Overall Study|Lost to Follow-up|2|||
156944595|NCT04740034|566551405|FG006|Overall Study|Lost to Follow-up|0|||
156944596|NCT04740034|566551406|FG007|Overall Study|Lost to Follow-up|0|||
156944597|NCT04740034|566551407|FG008|Overall Study|Lost to Follow-up|0|||
156944598|NCT04740034|566551408|FG009|Overall Study|Lost to Follow-up|1|||
156944599|NCT04740034|566551409|FG010|Overall Study|Lost to Follow-up|0|||
156944600|NCT04740034|566551399|FG000|Overall Study|Withdrawal by Subject|1|||
156944601|NCT04740034|566551400|FG001|Overall Study|Withdrawal by Subject|0|||
156944602|NCT04740034|566551401|FG002|Overall Study|Withdrawal by Subject|0|||
156944603|NCT04740034|566551402|FG003|Overall Study|Withdrawal by Subject|0|||
157167455|NCT02062463|567354555|FG003|Stage 2|Other than specified|1|||
157167456|NCT02062463|567354552|FG000|Stage 2|Withdrawal by Subject|0|||
157167457|NCT02062463|567354553|FG001|Stage 2|Withdrawal by Subject|0|||
157167458|NCT02062463|567354554|FG002|Stage 2|Withdrawal by Subject|15|||
156944604|NCT04740034|566551403|FG004|Overall Study|Withdrawal by Subject|0|||
156944605|NCT04740034|566551404|FG005|Overall Study|Withdrawal by Subject|0|||
157167459|NCT02062463|567354555|FG003|Stage 2|Withdrawal by Subject|10|||
156944606|NCT04740034|566551405|FG006|Overall Study|Withdrawal by Subject|0|||
156944607|NCT04740034|566551406|FG007|Overall Study|Withdrawal by Subject|1|||
156944608|NCT04740034|566551407|FG008|Overall Study|Withdrawal by Subject|0|||
157167460|NCT01956240|567354564|FG000|Overall Study|Lost to Follow-up|6|||
156944609|NCT04740034|566551408|FG009|Overall Study|Withdrawal by Subject|1|||
156944610|NCT04740034|566551409|FG010|Overall Study|Withdrawal by Subject|0|||
157167461|NCT01956240|567354565|FG001|Overall Study|Lost to Follow-up|20|||
157167462|NCT01956240|567354564|FG000|Overall Study|Adverse Event|17|||
157167463|NCT01956240|567354565|FG001|Overall Study|Adverse Event|4|||
156944611|NCT04740034|566551399|FG000|Overall Study|Decision by sponsor|0|||
157167464|NCT00600028|567354568|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
156944612|NCT04740034|566551400|FG001|Overall Study|Decision by sponsor|0|||
156944613|NCT04740034|566551401|FG002|Overall Study|Decision by sponsor|1|||
156944614|NCT04740034|566551402|FG003|Overall Study|Decision by sponsor|0|||
156944615|NCT04740034|566551403|FG004|Overall Study|Decision by sponsor|0|||
157167465|NCT00600028|567354569|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
156944616|NCT04740034|566551404|FG005|Overall Study|Decision by sponsor|0|||
156944617|NCT04740034|566551405|FG006|Overall Study|Decision by sponsor|1|||
156944618|NCT04740034|566551406|FG007|Overall Study|Decision by sponsor|2|||
156944619|NCT04740034|566551407|FG008|Overall Study|Decision by sponsor|1|||
156944620|NCT04740034|566551408|FG009|Overall Study|Decision by sponsor|1|||
156944621|NCT04740034|566551409|FG010|Overall Study|Decision by sponsor|2|||
156944622|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
156944623|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156944624|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156944625|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156944626|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156944627|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
156944628|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
156944629|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156944630|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156944631|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156944632|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156944633|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
156944634|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
156944635|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156944636|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156944637|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156944638|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156944639|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
156944640|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
156944641|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156944642|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156944643|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156944644|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156944645|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
156944646|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
156944647|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156944648|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156944649|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156944650|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156944651|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
156944652|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
156944653|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
156944654|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
156944655|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
156944656|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
156944657|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
156944658|NCT02139644|566553096|FG000|Run-In Period (Pre-assignment)|Other|6|||
156944659|NCT02139644|566553097|FG001|Run-In Period (Pre-assignment)|Other|0|||
156944660|NCT02139644|566553098|FG002|Run-In Period (Pre-assignment)|Other|0|||
156944661|NCT02139644|566553099|FG003|Run-In Period (Pre-assignment)|Other|0|||
156944662|NCT02139644|566553100|FG004|Run-In Period (Pre-assignment)|Other|0|||
156944663|NCT02139644|566553101|FG005|Run-In Period (Pre-assignment)|Other|0|||
156944664|NCT02139644|566553096|FG000|Treatment Period|Adverse Event|0|||
156944665|NCT02139644|566553097|FG001|Treatment Period|Adverse Event|0|||
156944666|NCT02139644|566553098|FG002|Treatment Period|Adverse Event|3|||
156944667|NCT02139644|566553099|FG003|Treatment Period|Adverse Event|2|||
156944668|NCT02139644|566553100|FG004|Treatment Period|Adverse Event|1|||
156944669|NCT02139644|566553101|FG005|Treatment Period|Adverse Event|6|||
156944670|NCT02139644|566553096|FG000|Treatment Period|Withdrawal by Subject|0|||
156944671|NCT02139644|566553097|FG001|Treatment Period|Withdrawal by Subject|0|||
156944672|NCT02139644|566553098|FG002|Treatment Period|Withdrawal by Subject|2|||
156944673|NCT02139644|566553099|FG003|Treatment Period|Withdrawal by Subject|2|||
156944674|NCT02139644|566553100|FG004|Treatment Period|Withdrawal by Subject|3|||
156944675|NCT02139644|566553101|FG005|Treatment Period|Withdrawal by Subject|2|||
156944676|NCT02139644|566553096|FG000|Treatment Period|Non-compliance|0|||
156944677|NCT02139644|566553097|FG001|Treatment Period|Non-compliance|0|||
156944678|NCT02139644|566553098|FG002|Treatment Period|Non-compliance|0|||
156944679|NCT02139644|566553099|FG003|Treatment Period|Non-compliance|1|||
156944680|NCT02139644|566553100|FG004|Treatment Period|Non-compliance|0|||
156944681|NCT02139644|566553101|FG005|Treatment Period|Non-compliance|0|||
156944682|NCT02139644|566553096|FG000|Treatment Period|Protocol Violation|0|||
156944683|NCT02139644|566553097|FG001|Treatment Period|Protocol Violation|0|||
157032664|NCT04880733|566875924|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
156944684|NCT02139644|566553098|FG002|Treatment Period|Protocol Violation|0|||
156944685|NCT02139644|566553099|FG003|Treatment Period|Protocol Violation|1|||
156944686|NCT02139644|566553100|FG004|Treatment Period|Protocol Violation|1|||
156944687|NCT02139644|566553101|FG005|Treatment Period|Protocol Violation|1|||
156944688|NCT02139644|566553096|FG000|Treatment Period|Disease progression|0|||
156944689|NCT02139644|566553097|FG001|Treatment Period|Disease progression|0|||
156944690|NCT02139644|566553098|FG002|Treatment Period|Disease progression|0|||
156944691|NCT02139644|566553099|FG003|Treatment Period|Disease progression|1|||
156944692|NCT02139644|566553100|FG004|Treatment Period|Disease progression|1|||
156944693|NCT02139644|566553101|FG005|Treatment Period|Disease progression|2|||
156944694|NCT02139644|566553096|FG000|Treatment Period|Lost to Follow-up|0|||
156944695|NCT02139644|566553097|FG001|Treatment Period|Lost to Follow-up|0|||
156944696|NCT02139644|566553098|FG002|Treatment Period|Lost to Follow-up|1|||
156944697|NCT02139644|566553099|FG003|Treatment Period|Lost to Follow-up|1|||
156944698|NCT02139644|566553100|FG004|Treatment Period|Lost to Follow-up|1|||
156944699|NCT02139644|566553101|FG005|Treatment Period|Lost to Follow-up|1|||
156944700|NCT02139644|566553096|FG000|Treatment Period|Lack of Efficacy|0|||
156944701|NCT02139644|566553097|FG001|Treatment Period|Lack of Efficacy|0|||
156944702|NCT02139644|566553098|FG002|Treatment Period|Lack of Efficacy|1|||
156944703|NCT02139644|566553099|FG003|Treatment Period|Lack of Efficacy|0|||
156944704|NCT02139644|566553100|FG004|Treatment Period|Lack of Efficacy|1|||
156944705|NCT02139644|566553101|FG005|Treatment Period|Lack of Efficacy|4|||
156944706|NCT02139644|566553096|FG000|Treatment Period|Other|0|||
156944707|NCT02139644|566553097|FG001|Treatment Period|Other|3|||
156944708|NCT02139644|566553098|FG002|Treatment Period|Other|1|||
156944709|NCT02139644|566553099|FG003|Treatment Period|Other|1|||
156944710|NCT02139644|566553100|FG004|Treatment Period|Other|0|||
156944711|NCT02139644|566553101|FG005|Treatment Period|Other|1|||
156944712|NCT00201006|566553102|FG000|Overall Study|Withdrawal by Subject|7|||
156944713|NCT00201006|566553103|FG001|Overall Study|Withdrawal by Subject|2|||
156944714|NCT00201006|566553104|FG002|Overall Study|Withdrawal by Subject|3|||
156944715|NCT00201006|566553102|FG000|Overall Study|Adverse Event|1|||
156944716|NCT00201006|566553103|FG001|Overall Study|Adverse Event|0|||
156944717|NCT00201006|566553104|FG002|Overall Study|Adverse Event|1|||
156944718|NCT02086591|566553107|FG000|Overall Study|Adverse Event|1|||
156944719|NCT02086591|566553107|FG000|Overall Study|Withdrawal by Subject|1|||
156944720|NCT02086591|566553107|FG000|Overall Study|protocol terminated|3|||
156944721|NCT01529645|566553108|FG000|Overall Study|Lost to Follow-up|0|||
156944722|NCT01529645|566553109|FG001|Overall Study|Lost to Follow-up|1|||
156944723|NCT01529645|566553110|FG002|Overall Study|Lost to Follow-up|1|||
156944724|NCT01529645|566553111|FG003|Overall Study|Lost to Follow-up|1|||
156944725|NCT01529645|566553112|FG004|Overall Study|Lost to Follow-up|1|||
156944726|NCT01529645|566553113|FG005|Overall Study|Lost to Follow-up|0|||
156944727|NCT01529645|566553114|FG006|Overall Study|Lost to Follow-up|2|||
156944728|NCT01529645|566553115|FG007|Overall Study|Lost to Follow-up|0|||
156944729|NCT01529645|566553116|FG008|Overall Study|Lost to Follow-up|1|||
156944730|NCT01529645|566553117|FG009|Overall Study|Lost to Follow-up|0|||
156944731|NCT01529645|566553108|FG000|Overall Study|SAE - Premature contractions|0|||
156944732|NCT01529645|566553109|FG001|Overall Study|SAE - Premature contractions|0|||
156944733|NCT01529645|566553110|FG002|Overall Study|SAE - Premature contractions|1|||
156944734|NCT01529645|566553111|FG003|Overall Study|SAE - Premature contractions|0|||
156944735|NCT01529645|566553112|FG004|Overall Study|SAE - Premature contractions|0|||
156944736|NCT01529645|566553113|FG005|Overall Study|SAE - Premature contractions|0|||
156944737|NCT01529645|566553114|FG006|Overall Study|SAE - Premature contractions|0|||
156944738|NCT01529645|566553115|FG007|Overall Study|SAE - Premature contractions|0|||
156944739|NCT01529645|566553116|FG008|Overall Study|SAE - Premature contractions|0|||
156944740|NCT01529645|566553117|FG009|Overall Study|SAE - Premature contractions|0|||
156944741|NCT01529645|566553108|FG000|Overall Study|Withdrawal by Subject|2|||
156944742|NCT01529645|566553109|FG001|Overall Study|Withdrawal by Subject|0|||
156944743|NCT01529645|566553110|FG002|Overall Study|Withdrawal by Subject|0|||
156944744|NCT01529645|566553111|FG003|Overall Study|Withdrawal by Subject|1|||
156944745|NCT01529645|566553112|FG004|Overall Study|Withdrawal by Subject|1|||
156944746|NCT01529645|566553113|FG005|Overall Study|Withdrawal by Subject|1|||
156944747|NCT01529645|566553114|FG006|Overall Study|Withdrawal by Subject|0|||
156944748|NCT01529645|566553115|FG007|Overall Study|Withdrawal by Subject|0|||
156944749|NCT01529645|566553116|FG008|Overall Study|Withdrawal by Subject|0|||
156944750|NCT01529645|566553117|FG009|Overall Study|Withdrawal by Subject|0|||
156944751|NCT00274716|566553122|FG000|Phase A|Other non-reported reason|4|||
156944752|NCT00274716|566553123|FG001|Phase A|Other non-reported reason|2|||
156944753|NCT00274716|566553124|FG002|Phase A|Other non-reported reason|1|||
156944754|NCT00274716|566553125|FG003|Phase A|Other non-reported reason|2|||
156944755|NCT00274716|566553126|FG004|Phase A|Other non-reported reason|0|||
156944756|NCT00274716|566553127|FG005|Phase A|Other non-reported reason|1|||
156944757|NCT00274716|566553122|FG000|Phase A|Participant moved|0|||
156944758|NCT00274716|566553123|FG001|Phase A|Participant moved|0|||
156944759|NCT00274716|566553124|FG002|Phase A|Participant moved|1|||
156944760|NCT00274716|566553125|FG003|Phase A|Participant moved|0|||
156944761|NCT00274716|566553126|FG004|Phase A|Participant moved|0|||
156944762|NCT00274716|566553127|FG005|Phase A|Participant moved|1|||
156944763|NCT00274716|566553122|FG000|Phase A|Site Terminated|0|||
156944764|NCT00274716|566553123|FG001|Phase A|Site Terminated|0|||
156944765|NCT00274716|566553124|FG002|Phase A|Site Terminated|0|||
156944766|NCT00274716|566553125|FG003|Phase A|Site Terminated|1|||
156944767|NCT00274716|566553126|FG004|Phase A|Site Terminated|0|||
156944768|NCT00274716|566553127|FG005|Phase A|Site Terminated|0|||
156944769|NCT00274716|566553122|FG000|Phase A|Protocol Violation|1|||
156944770|NCT00274716|566553123|FG001|Phase A|Protocol Violation|0|||
156944771|NCT00274716|566553124|FG002|Phase A|Protocol Violation|0|||
156944772|NCT00274716|566553125|FG003|Phase A|Protocol Violation|1|||
156944773|NCT00274716|566553126|FG004|Phase A|Protocol Violation|0|||
156944774|NCT00274716|566553127|FG005|Phase A|Protocol Violation|0|||
156944775|NCT00274716|566553122|FG000|Phase A|Met criteria for discontinuation|1|||
156944776|NCT00274716|566553123|FG001|Phase A|Met criteria for discontinuation|1|||
156944777|NCT00274716|566553124|FG002|Phase A|Met criteria for discontinuation|0|||
156944778|NCT00274716|566553125|FG003|Phase A|Met criteria for discontinuation|0|||
156944779|NCT00274716|566553126|FG004|Phase A|Met criteria for discontinuation|0|||
156944780|NCT00274716|566553127|FG005|Phase A|Met criteria for discontinuation|0|||
156944781|NCT00274716|566553122|FG000|Phase A|Withdrawal by Subject|2|||
156944782|NCT00274716|566553123|FG001|Phase A|Withdrawal by Subject|2|||
156944783|NCT00274716|566553124|FG002|Phase A|Withdrawal by Subject|1|||
156944784|NCT00274716|566553125|FG003|Phase A|Withdrawal by Subject|3|||
156944785|NCT00274716|566553126|FG004|Phase A|Withdrawal by Subject|0|||
156944786|NCT00274716|566553127|FG005|Phase A|Withdrawal by Subject|1|||
156944787|NCT00274716|566553122|FG000|Phase A|Adverse Event|2|||
156944788|NCT00274716|566553123|FG001|Phase A|Adverse Event|3|||
156944789|NCT00274716|566553124|FG002|Phase A|Adverse Event|3|||
156944790|NCT00274716|566553125|FG003|Phase A|Adverse Event|0|||
156944791|NCT00274716|566553126|FG004|Phase A|Adverse Event|2|||
156944792|NCT00274716|566553127|FG005|Phase A|Adverse Event|0|||
156944793|NCT00274716|566553122|FG000|Phase A|Completed but did not enter Phase B|1|||
156944794|NCT00274716|566553123|FG001|Phase A|Completed but did not enter Phase B|2|||
156944795|NCT00274716|566553124|FG002|Phase A|Completed but did not enter Phase B|2|||
156944796|NCT00274716|566553125|FG003|Phase A|Completed but did not enter Phase B|2|||
156944797|NCT00274716|566553126|FG004|Phase A|Completed but did not enter Phase B|1|||
156944798|NCT00274716|566553127|FG005|Phase A|Completed but did not enter Phase B|1|||
156944799|NCT00274716|566553122|FG000|Phase B|Adverse Event|0|||
156944800|NCT00274716|566553123|FG001|Phase B|Adverse Event|0|||
156944801|NCT00274716|566553124|FG002|Phase B|Adverse Event|2|||
156944802|NCT00274716|566553125|FG003|Phase B|Adverse Event|0|||
156944803|NCT00274716|566553126|FG004|Phase B|Adverse Event|0|||
156944804|NCT00274716|566553127|FG005|Phase B|Adverse Event|1|||
156944805|NCT00274716|566553122|FG000|Phase B|Protocol Violation|0|||
156944806|NCT00274716|566553123|FG001|Phase B|Protocol Violation|2|||
156944807|NCT00274716|566553124|FG002|Phase B|Protocol Violation|0|||
156944808|NCT00274716|566553125|FG003|Phase B|Protocol Violation|0|||
156944809|NCT00274716|566553126|FG004|Phase B|Protocol Violation|0|||
156944810|NCT00274716|566553127|FG005|Phase B|Protocol Violation|0|||
156944811|NCT00274716|566553122|FG000|Phase B|Withdrawal by Subject|0|||
156944812|NCT00274716|566553123|FG001|Phase B|Withdrawal by Subject|1|||
156944813|NCT00274716|566553124|FG002|Phase B|Withdrawal by Subject|0|||
156944814|NCT00274716|566553125|FG003|Phase B|Withdrawal by Subject|0|||
156944815|NCT00274716|566553126|FG004|Phase B|Withdrawal by Subject|0|||
156944816|NCT00274716|566553127|FG005|Phase B|Withdrawal by Subject|0|||
156944817|NCT00274716|566553122|FG000|Phase B|Participant moved|1|||
156944818|NCT00274716|566553123|FG001|Phase B|Participant moved|0|||
156944819|NCT00274716|566553124|FG002|Phase B|Participant moved|0|||
156944820|NCT00274716|566553125|FG003|Phase B|Participant moved|0|||
156944821|NCT00274716|566553126|FG004|Phase B|Participant moved|0|||
156944822|NCT00274716|566553127|FG005|Phase B|Participant moved|0|||
157032665|NCT04880733|566875925|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
157032666|NCT04880733|566875926|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
157032667|NCT04880733|566875924|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
157032668|NCT04880733|566875925|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
157032669|NCT04880733|566875926|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
157032670|NCT05424380|566875932|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
157032671|NCT05424380|566875933|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
157032672|NCT05424380|566875934|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
157032673|NCT05424380|566875935|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
157167466|NCT00600028|567354568|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
156944823|NCT00274716|566553122|FG000|Phase B|Other non-reported reason|0|||
156944824|NCT00274716|566553123|FG001|Phase B|Other non-reported reason|0|||
156944825|NCT00274716|566553124|FG002|Phase B|Other non-reported reason|1|||
157032674|NCT05424380|566875936|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
157167467|NCT00600028|567354569|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
157167468|NCT00600028|567354568|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
157167469|NCT00600028|567354569|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
156944826|NCT00274716|566553125|FG003|Phase B|Other non-reported reason|1|||
156944827|NCT00274716|566553126|FG004|Phase B|Other non-reported reason|0|||
156944828|NCT00274716|566553127|FG005|Phase B|Other non-reported reason|0|||
156944829|NCT00274716|566553122|FG000|Phase B|Lost to Follow-up|0|||
156944830|NCT00274716|566553123|FG001|Phase B|Lost to Follow-up|1|||
156944831|NCT00274716|566553124|FG002|Phase B|Lost to Follow-up|0|||
156944832|NCT00274716|566553125|FG003|Phase B|Lost to Follow-up|0|||
156944833|NCT00274716|566553126|FG004|Phase B|Lost to Follow-up|0|||
156944834|NCT00274716|566553127|FG005|Phase B|Lost to Follow-up|0|||
156944835|NCT04193202|566553128|FG000|Overall Study|Adverse Event|2|||
156944836|NCT04193202|566553129|FG001|Overall Study|Adverse Event|1|||
156944837|NCT04193202|566553128|FG000|Overall Study|Death|0|||
156944838|NCT04193202|566553129|FG001|Overall Study|Death|1|||
156944839|NCT04193202|566553128|FG000|Overall Study|Physician Decision|1|||
156944840|NCT04193202|566553129|FG001|Overall Study|Physician Decision|1|||
156944841|NCT04193202|566553128|FG000|Overall Study|Protocol Violation|2|||
156944842|NCT04193202|566553129|FG001|Overall Study|Protocol Violation|2|||
156944843|NCT04193202|566553128|FG000|Overall Study|Withdrawal by Subject|11|||
156944844|NCT04193202|566553129|FG001|Overall Study|Withdrawal by Subject|5|||
156944845|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
156944846|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
156944847|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
156944848|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
156944849|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
156944850|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
156944851|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156944852|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
156944853|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
156944854|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156944855|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
156944856|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
156944857|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
156944858|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
156944859|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
156944860|NCT01257204|566553130|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
156944861|NCT01257204|566553131|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
156944862|NCT01257204|566553132|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
156944863|NCT01257204|566553130|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
156944864|NCT01257204|566553131|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
156944865|NCT01257204|566553132|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
156944866|NCT01257204|566553130|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
156944867|NCT01257204|566553131|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
156944868|NCT01257204|566553132|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
156944869|NCT01257204|566553130|FG000|Follow-up Period (up to Week 48)|Other|0|||
156944870|NCT01257204|566553131|FG001|Follow-up Period (up to Week 48)|Other|0|||
156944871|NCT01257204|566553132|FG002|Follow-up Period (up to Week 48)|Other|5|||
156944872|NCT03394391|566553134|FG000|Overall Study|Lost to Follow-up|1|||
156944873|NCT03394391|566553135|FG001|Overall Study|Lost to Follow-up|2|||
156944874|NCT02932891|566553136|FG000|Overall Study|Lost to Follow-up|2|||
156944875|NCT02932891|566553136|FG000|Overall Study|HPA Suppress|2|||
156944876|NCT04622254|566553137|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156944877|NCT04622254|566553138|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
156944878|NCT04622254|566553139|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156944879|NCT04622254|566553140|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156944880|NCT04622254|566553141|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156944881|NCT04622254|566553142|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
156944882|NCT04622254|566553137|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
156944883|NCT04622254|566553138|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
156944884|NCT04622254|566553139|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
156944885|NCT04622254|566553140|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156944886|NCT04622254|566553141|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
156944887|NCT04622254|566553142|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
157167470|NCT03172481|567354573|FG000|Double-blind|Withdrawal by Subject|1|||
157167471|NCT03172481|567354574|FG001|Double-blind|Withdrawal by Subject|0|||
156944888|NCT04622254|566553137|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
156944889|NCT04622254|566553138|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156944890|NCT04622254|566553139|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156944891|NCT04622254|566553140|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
157167472|NCT01830816|567354575|FG000|Overall Study|Progressive Disease|12|||
157167473|NCT01830816|567354576|FG001|Overall Study|Progressive Disease|7|||
157167474|NCT01830816|567354577|FG002|Overall Study|Progressive Disease|7|||
157167475|NCT01830816|567354575|FG000|Overall Study|Adverse Event|3|||
156944892|NCT04622254|566553141|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156944893|NCT04622254|566553142|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
156944894|NCT04622254|566553137|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156944895|NCT04622254|566553138|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
156944896|NCT04622254|566553139|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
156944897|NCT04622254|566553140|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
157167476|NCT01830816|567354576|FG001|Overall Study|Adverse Event|4|||
157167477|NCT01830816|567354577|FG002|Overall Study|Adverse Event|0|||
156944898|NCT04622254|566553141|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156944899|NCT04622254|566553142|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
156944900|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156944901|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156944902|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156944903|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
156944904|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156944905|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
156944906|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156944907|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156944908|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156944909|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
156944910|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
156944911|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
156944912|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156944913|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156944914|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156944915|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
156944916|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156944917|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
156944918|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156944919|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156944920|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156944921|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
156944922|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156944923|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
156944924|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156944925|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156944926|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
156944927|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
156944928|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
156944929|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
156944930|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156944931|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156944932|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
156944933|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
156944934|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
156944935|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
156944936|NCT04622254|566553137|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
156944937|NCT04622254|566553138|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
156944938|NCT04622254|566553139|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
156944939|NCT04622254|566553140|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
156944940|NCT04622254|566553141|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
156944941|NCT04622254|566553142|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
156944942|NCT00723801|566553144|FG000|Overall Study|Lost to Follow-up|1|||
156944943|NCT00723801|566553145|FG001|Overall Study|Lost to Follow-up|2|||
156944944|NCT00723801|566553144|FG000|Overall Study|Protocol Violation|2|||
156944945|NCT00723801|566553145|FG001|Overall Study|Protocol Violation|1|||
156944946|NCT02167035|566553146|FG000|Overall Study|Adverse Event|2|||
156944947|NCT02167035|566553147|FG001|Overall Study|Adverse Event|2|||
156944948|NCT02167035|566553146|FG000|Overall Study|Lost to Follow-up|3|||
156944949|NCT02167035|566553147|FG001|Overall Study|Lost to Follow-up|3|||
156944950|NCT02167035|566553146|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
156944951|NCT02167035|566553147|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
156944952|NCT02148003|566553148|FG000|Overall Study|Failed inclusion criteria|1|||
156944953|NCT02148003|566553149|FG001|Overall Study|Failed inclusion criteria|0|||
156944954|NCT02148003|566553148|FG000|Overall Study|Met exclusion criteria|0|||
156944955|NCT02148003|566553149|FG001|Overall Study|Met exclusion criteria|1|||
157167478|NCT01830816|567354575|FG000|Overall Study|Study Terminated by Sponsor|1|||
157167479|NCT01830816|567354576|FG001|Overall Study|Study Terminated by Sponsor|1|||
157167480|NCT01830816|567354577|FG002|Overall Study|Study Terminated by Sponsor|0|||
157167481|NCT01830816|567354575|FG000|Overall Study|Withdrawal by Subject|1|||
157167482|NCT01830816|567354576|FG001|Overall Study|Withdrawal by Subject|1|||
156944956|NCT02148003|566553148|FG000|Overall Study|Withdrawal by Subject|0|||
157167483|NCT01830816|567354577|FG002|Overall Study|Withdrawal by Subject|0|||
157167484|NCT01830816|567354575|FG000|Overall Study|Lost to Follow-up|0|||
157167485|NCT01830816|567354576|FG001|Overall Study|Lost to Follow-up|1|||
157167486|NCT01830816|567354577|FG002|Overall Study|Lost to Follow-up|0|||
157167487|NCT01830816|567354575|FG000|Overall Study|Symptomatic Deterioration|1|||
157167488|NCT01830816|567354576|FG001|Overall Study|Symptomatic Deterioration|0|||
157167489|NCT01830816|567354577|FG002|Overall Study|Symptomatic Deterioration|0|||
156944957|NCT02148003|566553149|FG001|Overall Study|Withdrawal by Subject|1|||
156944958|NCT02489981|566553150|FG000|Overall Study|Adverse Event|21|||
156944959|NCT02489981|566553150|FG000|Overall Study|Insufficient effectiveness|16|||
156944960|NCT02489981|566553150|FG000|Overall Study|Improved|31|||
156944961|NCT02489981|566553150|FG000|Overall Study|Lost to Follow-up|31|||
156944962|NCT02489981|566553150|FG000|Overall Study|Other than listed|28|||
156944963|NCT01565993|566553158|FG000|Overall Study|Physician Decision|0|||
156944964|NCT01565993|566553159|FG001|Overall Study|Physician Decision|3|||
156944965|NCT02039427|566553160|FG000|Overall Study|Duration of surgery > 3h|1|||
156944966|NCT02039427|566553161|FG001|Overall Study|Duration of surgery > 3h|1|||
156944967|NCT02039427|566553162|FG002|Overall Study|Duration of surgery > 3h|0|||
156944968|NCT02039427|566553163|FG003|Overall Study|Duration of surgery > 3h|0|||
156944969|NCT02039427|566553160|FG000|Overall Study|Withdrawal on concent|0|||
156944970|NCT02039427|566553161|FG001|Overall Study|Withdrawal on concent|0|||
156944971|NCT02039427|566553162|FG002|Overall Study|Withdrawal on concent|0|||
156944972|NCT02039427|566553163|FG003|Overall Study|Withdrawal on concent|1|||
156944973|NCT02039427|566553160|FG000|Overall Study|Cancellation of surgery|0|||
156944974|NCT02039427|566553161|FG001|Overall Study|Cancellation of surgery|0|||
156944975|NCT02039427|566553162|FG002|Overall Study|Cancellation of surgery|1|||
156944976|NCT02039427|566553163|FG003|Overall Study|Cancellation of surgery|0|||
156944977|NCT02039427|566553160|FG000|Overall Study|Loss of follow - up|1|||
156944978|NCT02039427|566553161|FG001|Overall Study|Loss of follow - up|0|||
156944979|NCT02039427|566553162|FG002|Overall Study|Loss of follow - up|2|||
156944980|NCT02039427|566553163|FG003|Overall Study|Loss of follow - up|4|||
156944981|NCT02039427|566553160|FG000|Overall Study|Steroid Use|1|||
156944982|NCT02039427|566553161|FG001|Overall Study|Steroid Use|0|||
156944983|NCT02039427|566553162|FG002|Overall Study|Steroid Use|0|||
156944984|NCT02039427|566553163|FG003|Overall Study|Steroid Use|0|||
156944985|NCT01532687|566553164|FG000|Overall Study|Death|2|||
156944986|NCT01532687|566553165|FG001|Overall Study|Death|0|||
156944987|NCT01532687|566553164|FG000|Overall Study|Adverse Event|6|||
156944988|NCT01532687|566553165|FG001|Overall Study|Adverse Event|1|||
156944989|NCT01532687|566553164|FG000|Overall Study|Withdrawal by Subject|1|||
156944990|NCT01532687|566553165|FG001|Overall Study|Withdrawal by Subject|0|||
156944991|NCT01532687|566553164|FG000|Overall Study|Physician Decision|2|||
156944992|NCT01532687|566553165|FG001|Overall Study|Physician Decision|1|||
156944993|NCT01532687|566553164|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
156944994|NCT01532687|566553165|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
156944995|NCT03160703|566553166|FG000|Overall Study|Withdrawal by Subject|0|||
156944996|NCT03160703|566553167|FG001|Overall Study|Withdrawal by Subject|0|||
156944997|NCT03160703|566553168|FG002|Overall Study|Withdrawal by Subject|0|||
156944998|NCT03160703|566553169|FG003|Overall Study|Withdrawal by Subject|1|||
156944999|NCT00087568|566553176|FG000|Overall Study|Adverse Event|4|||
156945000|NCT00087568|566553177|FG001|Overall Study|Adverse Event|0|||
156945001|NCT00087568|566553176|FG000|Overall Study|Withdrawal by Subject|1|||
156945002|NCT00087568|566553177|FG001|Overall Study|Withdrawal by Subject|1|||
156945003|NCT00087568|566553176|FG000|Overall Study|Lost to Follow-up|1|||
156945004|NCT00087568|566553177|FG001|Overall Study|Lost to Follow-up|0|||
156945005|NCT00087568|566553176|FG000|Overall Study|Lack of Efficacy|24|||
156945006|NCT00087568|566553177|FG001|Overall Study|Lack of Efficacy|1|||
156945007|NCT00226941|566553178|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
156945008|NCT00226941|566553179|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
156945009|NCT00226941|566553180|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
156945010|NCT00226941|566553181|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
156945011|NCT00226941|566553178|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156945012|NCT00226941|566553179|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156945013|NCT00226941|566553180|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
156945014|NCT00226941|566553181|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
156945015|NCT01513291|566553182|FG000|Treatment Period|Adverse Event|8|||
156945016|NCT01513291|566553183|FG001|Treatment Period|Adverse Event|4|||
156945017|NCT01513291|566553184|FG002|Treatment Period|Adverse Event|0|||
156945018|NCT01513291|566553185|FG003|Treatment Period|Adverse Event|0|||
156945019|NCT01513291|566553186|FG004|Treatment Period|Adverse Event|0|||
156945020|NCT01513291|566553182|FG000|Treatment Period|Lack of Efficacy|3|||
156945021|NCT01513291|566553183|FG001|Treatment Period|Lack of Efficacy|0|||
156945022|NCT01513291|566553184|FG002|Treatment Period|Lack of Efficacy|0|||
156945023|NCT01513291|566553185|FG003|Treatment Period|Lack of Efficacy|0|||
157167490|NCT01830816|567354575|FG000|Overall Study|Reason not Specified|2|||
157167491|NCT01830816|567354576|FG001|Overall Study|Reason not Specified|0|||
157167492|NCT01830816|567354577|FG002|Overall Study|Reason not Specified|0|||
157167493|NCT02716194|567354578|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
156945024|NCT01513291|566553186|FG004|Treatment Period|Lack of Efficacy|0|||
156945025|NCT01513291|566553182|FG000|Treatment Period|Lost to Follow-up|2|||
156945026|NCT01513291|566553183|FG001|Treatment Period|Lost to Follow-up|3|||
156945027|NCT01513291|566553184|FG002|Treatment Period|Lost to Follow-up|0|||
156945028|NCT01513291|566553185|FG003|Treatment Period|Lost to Follow-up|0|||
156945029|NCT01513291|566553186|FG004|Treatment Period|Lost to Follow-up|0|||
156945030|NCT01513291|566553182|FG000|Treatment Period|Physician Decision|1|||
156945031|NCT01513291|566553183|FG001|Treatment Period|Physician Decision|0|||
156945032|NCT01513291|566553184|FG002|Treatment Period|Physician Decision|0|||
156945033|NCT01513291|566553185|FG003|Treatment Period|Physician Decision|0|||
156945034|NCT01513291|566553186|FG004|Treatment Period|Physician Decision|0|||
156945035|NCT01513291|566553182|FG000|Treatment Period|Protocol Violation|1|||
156945036|NCT01513291|566553183|FG001|Treatment Period|Protocol Violation|2|||
156945037|NCT01513291|566553184|FG002|Treatment Period|Protocol Violation|0|||
156945038|NCT01513291|566553185|FG003|Treatment Period|Protocol Violation|0|||
156945039|NCT01513291|566553186|FG004|Treatment Period|Protocol Violation|0|||
156945040|NCT01513291|566553182|FG000|Treatment Period|Withdrawal by Subject|8|||
156945041|NCT01513291|566553183|FG001|Treatment Period|Withdrawal by Subject|5|||
156945042|NCT01513291|566553184|FG002|Treatment Period|Withdrawal by Subject|0|||
156945043|NCT01513291|566553185|FG003|Treatment Period|Withdrawal by Subject|0|||
156945044|NCT01513291|566553186|FG004|Treatment Period|Withdrawal by Subject|0|||
156945045|NCT01513291|566553182|FG000|Treatment Period|Randomized not treated|0|||
156945046|NCT01513291|566553183|FG001|Treatment Period|Randomized not treated|2|||
156945047|NCT01513291|566553184|FG002|Treatment Period|Randomized not treated|0|||
156945048|NCT01513291|566553185|FG003|Treatment Period|Randomized not treated|0|||
156945049|NCT01513291|566553186|FG004|Treatment Period|Randomized not treated|0|||
156945050|NCT01513291|566553182|FG000|Run-out Period|Lost to Follow-up|0|||
156945051|NCT01513291|566553183|FG001|Run-out Period|Lost to Follow-up|0|||
156945052|NCT01513291|566553184|FG002|Run-out Period|Lost to Follow-up|0|||
156945053|NCT01513291|566553185|FG003|Run-out Period|Lost to Follow-up|1|||
156945054|NCT01513291|566553186|FG004|Run-out Period|Lost to Follow-up|0|||
156945055|NCT01513291|566553182|FG000|Run-out Period|Withdrawal by Subject|0|||
156945056|NCT01513291|566553183|FG001|Run-out Period|Withdrawal by Subject|0|||
156945057|NCT01513291|566553184|FG002|Run-out Period|Withdrawal by Subject|0|||
156945058|NCT01513291|566553185|FG003|Run-out Period|Withdrawal by Subject|1|||
156945059|NCT01513291|566553186|FG004|Run-out Period|Withdrawal by Subject|0|||
156945060|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
156945061|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
156945062|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
156945063|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
156945064|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
156945065|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
156945066|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
156945067|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
156945068|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
156945069|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
156945070|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
156945071|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
156945072|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
156945073|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
156945074|NCT03732638|566553187|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
156945075|NCT03732638|566553188|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
156945076|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
156945077|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
157032675|NCT05424380|566875937|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
156945078|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
156945079|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
156945080|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
156945081|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
156945082|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
157032676|NCT05424380|566875932|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
157032677|NCT05424380|566875933|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
157032678|NCT05424380|566875934|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
157167494|NCT02716194|567354579|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
157167495|NCT02716194|567354580|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
157167496|NCT00363051|567354584|FG000|Overall Study|Adminstrative problems|1|||
157167497|NCT00363051|567354585|FG001|Overall Study|Adminstrative problems|1|||
157167498|NCT00363051|567354584|FG000|Overall Study|Adverse Event|21|||
156945083|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
156945084|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
156945085|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
156945086|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
156945087|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
156945088|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
157032679|NCT05424380|566875935|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
157032680|NCT05424380|566875936|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
157167499|NCT00363051|567354585|FG001|Overall Study|Adverse Event|12|||
157167500|NCT00363051|567354584|FG000|Overall Study|New Cancer Therapy|2|||
157167501|NCT00363051|567354585|FG001|Overall Study|New Cancer Therapy|1|||
157032681|NCT05424380|566875937|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
157032682|NCT05424380|566875932|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
157032683|NCT05424380|566875933|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
157032684|NCT05424380|566875934|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
157032685|NCT05424380|566875935|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
157032686|NCT05424380|566875936|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
157032687|NCT05424380|566875937|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
157032688|NCT05424380|566875932|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
157032689|NCT05424380|566875933|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
157032690|NCT05424380|566875934|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
157032691|NCT05424380|566875935|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
157032692|NCT05424380|566875936|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
157032693|NCT05424380|566875937|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
157032694|NCT05424380|566875932|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
157032695|NCT05424380|566875933|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
157032696|NCT05424380|566875934|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
157032697|NCT05424380|566875935|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
157032698|NCT05424380|566875936|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
157032699|NCT05424380|566875937|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
157032700|NCT05424380|566875932|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
157032701|NCT05424380|566875933|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
156945089|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
156945090|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
156945091|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
156945092|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
156945093|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
156945094|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
156945095|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
156945096|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
156945097|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
156945098|NCT03732638|566553187|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
156945099|NCT03732638|566553188|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
156945100|NCT03732638|566553187|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
156945101|NCT03732638|566553188|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
156945102|NCT03732638|566553187|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
156945103|NCT03732638|566553188|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
156945104|NCT03732638|566553187|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
156945105|NCT03732638|566553188|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
156945106|NCT03732638|566553187|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
156945107|NCT03732638|566553188|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
156945108|NCT03728582|566553193|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
156945109|NCT03728582|566553194|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
156945110|NCT03728582|566553193|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
156945111|NCT03728582|566553194|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
156945112|NCT02732847|566553195|FG000|Overall Study|some filled early|42|||
156945113|NCT02732847|566553196|FG001|Overall Study|some filled early|42|||
156945114|NCT02370888|566553197|FG000|Overall Study|disease progression|2|||
156945115|NCT02370888|566553197|FG000|Overall Study|did not meet chimerism criteria|6|||
156945116|NCT01034397|566553198|FG000|Overall Study|Lack of compliance|0|||
156945117|NCT01034397|566553199|FG001|Overall Study|Lack of compliance|1|||
156945118|NCT01034397|566553198|FG000|Overall Study|Lack of Efficacy|3|||
156945119|NCT01034397|566553199|FG001|Overall Study|Lack of Efficacy|0|||
156945120|NCT01034397|566553198|FG000|Overall Study|Adverse Event|4|||
156945121|NCT01034397|566553199|FG001|Overall Study|Adverse Event|0|||
156945122|NCT01034397|566553198|FG000|Overall Study|Other|0|||
156945123|NCT01034397|566553199|FG001|Overall Study|Other|1|||
156945124|NCT04574362|566553200|FG000|Overall Study|Other|0|||
156945125|NCT04574362|566553201|FG001|Overall Study|Other|5|||
156945126|NCT04574362|566553200|FG000|Overall Study|COVID-19|0|||
156945127|NCT04574362|566553201|FG001|Overall Study|COVID-19|1|||
156945128|NCT04574362|566553200|FG000|Overall Study|Adverse Event|1|||
156945129|NCT04574362|566553201|FG001|Overall Study|Adverse Event|1|||
156945130|NCT04574362|566553200|FG000|Overall Study|Withdrawal by Subject|2|||
156945131|NCT04574362|566553201|FG001|Overall Study|Withdrawal by Subject|4|||
156945132|NCT04574362|566553200|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
157167502|NCT00363051|567354584|FG000|Overall Study|Withdrawal by Subject|11|||
157167503|NCT00363051|567354585|FG001|Overall Study|Withdrawal by Subject|3|||
157167504|NCT00363051|567354584|FG000|Overall Study|Lost to Follow-up|0|||
156945133|NCT04574362|566553201|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
157032702|NCT05424380|566875934|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
157167505|NCT00363051|567354585|FG001|Overall Study|Lost to Follow-up|1|||
157167506|NCT00363051|567354584|FG000|Overall Study|Protocol Violation|0|||
156945134|NCT04574362|566553200|FG000|Overall Study|Participant refused to come to the hospital|1|||
156945135|NCT04574362|566553201|FG001|Overall Study|Participant refused to come to the hospital|0|||
156945136|NCT04574362|566553200|FG000|Overall Study|Participant refused the visit|1|||
156945137|NCT04574362|566553201|FG001|Overall Study|Participant refused the visit|0|||
156945138|NCT04574362|566553200|FG000|Overall Study|Participant quit early because of business trip|1|||
156945139|NCT04574362|566553201|FG001|Overall Study|Participant quit early because of business trip|0|||
156945140|NCT01600040|566553202|FG000|Overall Study|Withdrawal by Subject|1|||
156945141|NCT01263873|566553203|FG000|Overall Study|One provider unable to complete numbers|1|||
156945142|NCT01263873|566553204|FG001|Overall Study|One provider unable to complete numbers|1|||
156945143|NCT00642304|566553209|FG000|Overall Study|Adverse Event|1|||
156945144|NCT00642304|566553209|FG000|Overall Study|Death|1|||
156945145|NCT00642304|566553209|FG000|Overall Study|Blood transfusion|2|||
156945146|NCT00642304|566553209|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
156945147|NCT00642304|566553209|FG000|Overall Study|Transplantation|1|||
156945148|NCT02104557|566553210|FG000|Overall Study|Adverse Event|24|||
156945149|NCT02104557|566553210|FG000|Overall Study|Lost to Follow-up|34|||
156945150|NCT02104557|566553210|FG000|Overall Study|Violated the usage and dosage|14|||
156945151|NCT02104557|566553210|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
156945152|NCT02104557|566553210|FG000|Overall Study|Administered Sayana prior to the contract|1|||
156945153|NCT02104557|566553210|FG000|Overall Study|Other|17|||
156945154|NCT02104557|566553210|FG000|Overall Study|Change to other contraception methods|5|||
156945155|NCT02104557|566553210|FG000|Overall Study|Discontinuation due to no pain|1|||
156945156|NCT02104557|566553210|FG000|Overall Study|Withdrawal consent|2|||
156945157|NCT02104557|566553210|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
156945158|NCT02104557|566553210|FG000|Overall Study|Discontinuation of contraception|9|||
156945159|NCT03192150|566553211|FG000|Overall Study|Adverse Event|14|||
156945160|NCT03192150|566553212|FG001|Overall Study|Adverse Event|12|||
156945161|NCT03192150|566553211|FG000|Overall Study|Lack of Efficacy|23|||
156945162|NCT03192150|566553212|FG001|Overall Study|Lack of Efficacy|30|||
156945163|NCT03192150|566553211|FG000|Overall Study|Lost to Follow-up|1|||
156945164|NCT03192150|566553212|FG001|Overall Study|Lost to Follow-up|1|||
156945165|NCT03192150|566553211|FG000|Overall Study|Withdrawal by Subject|4|||
156945166|NCT03192150|566553212|FG001|Overall Study|Withdrawal by Subject|2|||
156945167|NCT03192150|566553211|FG000|Overall Study|Protocol Violation|5|||
156945168|NCT03192150|566553212|FG001|Overall Study|Protocol Violation|2|||
156945169|NCT03192150|566553211|FG000|Overall Study|Surgery Canceled|6|||
156945170|NCT03192150|566553212|FG001|Overall Study|Surgery Canceled|2|||
156945171|NCT03192150|566553211|FG000|Overall Study|Other-Various Administrative Reasons|2|||
156945172|NCT03192150|566553212|FG001|Overall Study|Other-Various Administrative Reasons|5|||
156945173|NCT00779766|566553213|FG000|Month 24|Serious Adverse Event|2|||
156945174|NCT00779766|566553214|FG001|Month 24|Serious Adverse Event|3|||
156945175|NCT00779766|566553213|FG000|Month 24|Adverse Event|3|||
156945176|NCT00779766|566553214|FG001|Month 24|Adverse Event|3|||
156945177|NCT00779766|566553213|FG000|Month 24|Protocol Violation|3|||
156945178|NCT00779766|566553214|FG001|Month 24|Protocol Violation|1|||
156945179|NCT00779766|566553213|FG000|Month 24|Withdrawal by Subject|159|||
156945180|NCT00779766|566553214|FG001|Month 24|Withdrawal by Subject|127|||
156945181|NCT00779766|566553213|FG000|Month 24|Migrated/moved from study area|138|||
156945182|NCT00779766|566553214|FG001|Month 24|Migrated/moved from study area|162|||
156945183|NCT00779766|566553213|FG000|Month 24|Lost to Follow-up|9|||
156945184|NCT00779766|566553214|FG001|Month 24|Lost to Follow-up|9|||
156945185|NCT00779766|566553213|FG000|Month 24|Other|18|||
156945186|NCT00779766|566553214|FG001|Month 24|Other|27|||
156945187|NCT00779766|566553213|FG000|Month 48|Withdrawal by Subject|68|||
156945188|NCT00779766|566553214|FG001|Month 48|Withdrawal by Subject|63|||
156945189|NCT00779766|566553213|FG000|Month 48|Migrated/moved from study area|76|||
156945190|NCT00779766|566553214|FG001|Month 48|Migrated/moved from study area|75|||
156945191|NCT00779766|566553213|FG000|Month 48|Lost to Follow-up|29|||
156945192|NCT00779766|566553214|FG001|Month 48|Lost to Follow-up|30|||
156945193|NCT00779766|566553213|FG000|Month 48|Other|1|||
156945194|NCT00779766|566553214|FG001|Month 48|Other|0|||
156945195|NCT00779766|566553213|FG000|Month 72|Withdrawal by Subject|55|||
156945196|NCT00779766|566553214|FG001|Month 72|Withdrawal by Subject|71|||
156945197|NCT00779766|566553213|FG000|Month 72|Migrated/moved from study area|124|||
156945198|NCT00779766|566553214|FG001|Month 72|Migrated/moved from study area|109|||
156945199|NCT00779766|566553213|FG000|Month 72|Lost to Follow-up|6|||
156945200|NCT00779766|566553214|FG001|Month 72|Lost to Follow-up|8|||
156945201|NCT00779766|566553213|FG000|Month 72|Other|0|||
156945202|NCT00779766|566553214|FG001|Month 72|Other|1|||
156945203|NCT01412424|566553215|FG000|Core Treatment Period|Treatment Failure|24|||
156945204|NCT01412424|566553215|FG000|Core Treatment Period|Adverse Event|21|||
156945205|NCT01412424|566553215|FG000|Core Treatment Period|Patient Request|5|||
156945206|NCT01412424|566553215|FG000|Core Treatment Period|Lost to Follow-up|2|||
156945207|NCT01412424|566553215|FG000|Core Treatment Period|Sponsor Request|1|||
156945208|NCT01412424|566553215|FG000|Extension Treatment Period|Adverse Event|2|||
156945209|NCT01412424|566553215|FG000|Extension Treatment Period|Treatment Failure|2|||
156945210|NCT01412424|566553215|FG000|Extension Treatment Period|Patient Request|2|||
157032703|NCT05424380|566875935|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
157032704|NCT05424380|566875936|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
157032705|NCT05424380|566875937|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
157032706|NCT05424380|566875932|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
157032707|NCT05424380|566875933|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
157032708|NCT05424380|566875934|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
157032709|NCT05424380|566875935|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
157032710|NCT05424380|566875936|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
157032711|NCT05424380|566875937|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
157032712|NCT05424380|566875932|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
157032713|NCT05424380|566875933|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
157032714|NCT05424380|566875934|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
157032715|NCT05424380|566875935|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
157032716|NCT05424380|566875936|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
157032717|NCT05424380|566875937|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
157032718|NCT05424380|566875932|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032719|NCT05424380|566875933|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032720|NCT05424380|566875934|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032721|NCT05424380|566875935|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
157032722|NCT05424380|566875936|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032723|NCT05424380|566875937|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032724|NCT05424380|566875932|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
157032725|NCT05424380|566875933|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
157032726|NCT05424380|566875934|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
157032727|NCT05424380|566875935|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
157032728|NCT05424380|566875936|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
157032729|NCT05424380|566875937|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
157032730|NCT05424380|566875932|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
157032731|NCT05424380|566875933|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
157032732|NCT05424380|566875934|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
157032733|NCT05424380|566875935|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
157032734|NCT05424380|566875936|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
157032735|NCT05424380|566875937|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
157032736|NCT05424380|566875932|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
157032737|NCT05424380|566875933|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
157032738|NCT05424380|566875934|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
157032739|NCT05424380|566875935|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
157032740|NCT05424380|566875936|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
157032741|NCT05424380|566875937|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
157032742|NCT05424380|566875932|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032743|NCT05424380|566875933|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032744|NCT05424380|566875934|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032745|NCT05424380|566875935|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032746|NCT05424380|566875936|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
157032747|NCT05424380|566875937|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
157032748|NCT05424380|566875932|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
157032749|NCT05424380|566875933|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
157032750|NCT05424380|566875934|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
157032751|NCT05424380|566875935|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
157032752|NCT05424380|566875936|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
157167507|NCT00363051|567354585|FG001|Overall Study|Protocol Violation|2|||
157167508|NCT00363051|567354584|FG000|Overall Study|Death|3|||
157167509|NCT00363051|567354585|FG001|Overall Study|Death|2|||
157167510|NCT02759562|567354586|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
157167511|NCT02759562|567354587|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
157167512|NCT02759562|567354586|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
157167513|NCT02759562|567354587|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
157167514|NCT02293993|567354588|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
157167515|NCT02293993|567354589|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
157167516|NCT02293993|567354590|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
157167517|NCT02293993|567354591|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
157167518|NCT02293993|567354588|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
157032753|NCT05424380|566875937|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
157032754|NCT03988621|566875942|FG000|Overall Study|Lost to Follow-up|16|||
157032755|NCT03988621|566875943|FG001|Overall Study|Lost to Follow-up|17|||
157032756|NCT03988621|566875942|FG000|Overall Study|Withdrawal by Subject|14|||
156945211|NCT01824303|566553218|FG000|Randomized Study|Withdrawal by Subject|1|||
156945212|NCT01824303|566553219|FG001|Randomized Study|Withdrawal by Subject|1|||
156945213|NCT01824303|566553218|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
156945214|NCT01824303|566553219|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
156945215|NCT03296696|566553220|FG000|Overall Study|Started Other Antitumor Therapy|1|||
156945216|NCT03296696|566553221|FG001|Overall Study|Started Other Antitumor Therapy|2|||
156945217|NCT03296696|566553222|FG002|Overall Study|Started Other Antitumor Therapy|1|||
156945218|NCT03296696|566553223|FG003|Overall Study|Started Other Antitumor Therapy|2|||
156945219|NCT03296696|566553224|FG004|Overall Study|Started Other Antitumor Therapy|1|||
156945220|NCT03296696|566553225|FG005|Overall Study|Started Other Antitumor Therapy|1|||
156945221|NCT03296696|566553226|FG006|Overall Study|Started Other Antitumor Therapy|2|||
156945222|NCT03296696|566553227|FG007|Overall Study|Started Other Antitumor Therapy|3|||
156945223|NCT03296696|566553228|FG008|Overall Study|Started Other Antitumor Therapy|1|||
156945224|NCT03296696|566553229|FG009|Overall Study|Started Other Antitumor Therapy|0|||
156945225|NCT03296696|566553220|FG000|Overall Study|Death|0|||
156945226|NCT03296696|566553221|FG001|Overall Study|Death|1|||
156945227|NCT03296696|566553222|FG002|Overall Study|Death|1|||
156945228|NCT03296696|566553223|FG003|Overall Study|Death|2|||
156945229|NCT03296696|566553224|FG004|Overall Study|Death|2|||
156945230|NCT03296696|566553225|FG005|Overall Study|Death|3|||
156945231|NCT03296696|566553226|FG006|Overall Study|Death|1|||
156945232|NCT03296696|566553227|FG007|Overall Study|Death|2|||
156945233|NCT03296696|566553228|FG008|Overall Study|Death|0|||
156945234|NCT03296696|566553229|FG009|Overall Study|Death|0|||
156945235|NCT03296696|566553220|FG000|Overall Study|Withdrawal by Subject|0|||
156945236|NCT03296696|566553221|FG001|Overall Study|Withdrawal by Subject|0|||
156945237|NCT03296696|566553222|FG002|Overall Study|Withdrawal by Subject|1|||
156945238|NCT03296696|566553223|FG003|Overall Study|Withdrawal by Subject|0|||
156945239|NCT03296696|566553224|FG004|Overall Study|Withdrawal by Subject|1|||
156945240|NCT03296696|566553225|FG005|Overall Study|Withdrawal by Subject|0|||
156945241|NCT03296696|566553226|FG006|Overall Study|Withdrawal by Subject|0|||
156945242|NCT03296696|566553227|FG007|Overall Study|Withdrawal by Subject|0|||
156945243|NCT03296696|566553228|FG008|Overall Study|Withdrawal by Subject|0|||
156945244|NCT03296696|566553229|FG009|Overall Study|Withdrawal by Subject|1|||
156945245|NCT04694131|566553232|FG000|Overall Study|Withdrawal by Subject|7|||
156945246|NCT04694131|566553232|FG000|Overall Study|Screen Failure|1|||
156945247|NCT04694131|566553232|FG000|Overall Study|High stimulation threshold|3|||
156945248|NCT01859715|566553236|FG000|Overall Study|No 2nd VAS|16|||
156945249|NCT01859715|566553237|FG001|Overall Study|No 2nd VAS|8|||
156945250|NCT01859715|566553238|FG002|Overall Study|No 2nd VAS|23|||
156945251|NCT00086580|566553239|FG000|Treatment Period|Disease progression|9|||
156945252|NCT00086580|566553240|FG001|Treatment Period|Disease progression|8|||
156945253|NCT00086580|566553239|FG000|Treatment Period|Unable to comply with protocol|3|||
156945254|NCT00086580|566553240|FG001|Treatment Period|Unable to comply with protocol|1|||
156945255|NCT00086580|566553239|FG000|Treatment Period|Withdrawal by Subject|7|||
156945256|NCT00086580|566553240|FG001|Treatment Period|Withdrawal by Subject|8|||
156945257|NCT00086580|566553239|FG000|Treatment Period|Physician Decision|13|||
156945258|NCT00086580|566553240|FG001|Treatment Period|Physician Decision|7|||
156945259|NCT00086580|566553239|FG000|Treatment Period|AE - not treatment related|7|||
156945260|NCT00086580|566553240|FG001|Treatment Period|AE - not treatment related|7|||
156945261|NCT00086580|566553239|FG000|Treatment Period|Toxicity - treatment related|15|||
156945262|NCT00086580|566553240|FG001|Treatment Period|Toxicity - treatment related|15|||
156945263|NCT00086580|566553239|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
156945264|NCT00086580|566553240|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
156945265|NCT00086580|566553239|FG000|Treatment Period|Death|5|||
156945266|NCT00086580|566553240|FG001|Treatment Period|Death|7|||
156945267|NCT00086580|566553239|FG000|Treatment Period|Other|5|||
156945268|NCT00086580|566553240|FG001|Treatment Period|Other|3|||
156945269|NCT00086580|566553239|FG000|Follow-up Period|Disease progression|72|||
156945270|NCT00086580|566553240|FG001|Follow-up Period|Disease progression|99|||
156945271|NCT00086580|566553239|FG000|Follow-up Period|Unable to comply with protocol|5|||
156945272|NCT00086580|566553240|FG001|Follow-up Period|Unable to comply with protocol|0|||
156945273|NCT00086580|566553239|FG000|Follow-up Period|Withdrawal by Subject|6|||
156945274|NCT00086580|566553240|FG001|Follow-up Period|Withdrawal by Subject|6|||
156945275|NCT00086580|566553239|FG000|Follow-up Period|Physician Decision|0|||
156945276|NCT00086580|566553240|FG001|Follow-up Period|Physician Decision|1|||
156945277|NCT00086580|566553239|FG000|Follow-up Period|AE - not related|1|||
156945278|NCT00086580|566553240|FG001|Follow-up Period|AE - not related|0|||
156945279|NCT00086580|566553239|FG000|Follow-up Period|Death|13|||
156945280|NCT00086580|566553240|FG001|Follow-up Period|Death|7|||
156945281|NCT00086580|566553239|FG000|Follow-up Period|Other|7|||
156945282|NCT00086580|566553240|FG001|Follow-up Period|Other|6|||
156945283|NCT00086580|566553239|FG000|Observation Period|Unable to comply with protocol|1|||
156945284|NCT00086580|566553240|FG001|Observation Period|Unable to comply with protocol|1|||
156945285|NCT00086580|566553239|FG000|Observation Period|Withdrawal by Subject|4|||
156945286|NCT00086580|566553240|FG001|Observation Period|Withdrawal by Subject|2|||
156945287|NCT00086580|566553239|FG000|Observation Period|Death|33|||
156945288|NCT00086580|566553240|FG001|Observation Period|Death|55|||
156945289|NCT00086580|566553239|FG000|Observation Period|Other|8|||
156945290|NCT00086580|566553240|FG001|Observation Period|Other|7|||
156945291|NCT00261716|566553242|FG000|Overall Study|Withdrawal by Subject|6|||
156945292|NCT00261716|566553243|FG001|Overall Study|Withdrawal by Subject|8|||
156945293|NCT00261716|566553242|FG000|Overall Study|Lost to Follow-up|0|||
156945294|NCT00261716|566553243|FG001|Overall Study|Lost to Follow-up|2|||
156945295|NCT00705575|566553246|FG000|Overall Study|Abnormal laboratory value(s)|0|||
156945296|NCT00705575|566553247|FG001|Overall Study|Abnormal laboratory value(s)|3|||
156945297|NCT00705575|566553246|FG000|Overall Study|Abnormal test procedure result(s)|2|||
156945298|NCT00705575|566553247|FG001|Overall Study|Abnormal test procedure result(s)|12|||
156945299|NCT00705575|566553246|FG000|Overall Study|Adverse Event|11|||
156945300|NCT00705575|566553247|FG001|Overall Study|Adverse Event|15|||
156945301|NCT00705575|566553246|FG000|Overall Study|Lost to Follow-up|3|||
156945302|NCT00705575|566553247|FG001|Overall Study|Lost to Follow-up|4|||
156945303|NCT00705575|566553246|FG000|Overall Study|Protocol Violation|2|||
156945304|NCT00705575|566553247|FG001|Overall Study|Protocol Violation|2|||
156945305|NCT00705575|566553246|FG000|Overall Study|Withdrawal by Subject|5|||
156945306|NCT00705575|566553247|FG001|Overall Study|Withdrawal by Subject|10|||
156945307|NCT01000051|566553251|FG000|Overall Study|Withdrawal by Subject|1|||
156945308|NCT01000051|566553252|FG001|Overall Study|Withdrawal by Subject|1|||
156945309|NCT01000051|566553251|FG000|Overall Study|Disease Progression|1|||
156945310|NCT01000051|566553252|FG001|Overall Study|Disease Progression|0|||
156945311|NCT01000051|566553251|FG000|Overall Study|Serious noncompliance|1|||
156945312|NCT01000051|566553252|FG001|Overall Study|Serious noncompliance|0|||
156945313|NCT02170727|566553253|FG000|Overall Study|Lost to Follow-up|1|||
156945314|NCT02170727|566553254|FG001|Overall Study|Lost to Follow-up|0|||
156945315|NCT02170727|566553253|FG000|Overall Study|Withdrawal by Subject|2|||
156945316|NCT02170727|566553254|FG001|Overall Study|Withdrawal by Subject|0|||
156945317|NCT01959581|566553259|FG000|Overall Study|Lost to Follow-up|5|||
156945318|NCT02802345|566553261|FG000|Overall Study|Not Treated|0|||
156945319|NCT02802345|566553262|FG001|Overall Study|Not Treated|1|||
156945320|NCT02802345|566553261|FG000|Overall Study|Adverse Event|28|||
156945321|NCT02802345|566553262|FG001|Overall Study|Adverse Event|20|||
156945322|NCT02802345|566553261|FG000|Overall Study|Withdrawal by Subject|3|||
156945323|NCT02802345|566553262|FG001|Overall Study|Withdrawal by Subject|3|||
156945324|NCT02802345|566553261|FG000|Overall Study|Protocol Violation|0|||
156945325|NCT02802345|566553262|FG001|Overall Study|Protocol Violation|1|||
156945326|NCT02802345|566553261|FG000|Overall Study|Other than listed|1|||
156945327|NCT02802345|566553262|FG001|Overall Study|Other than listed|5|||
156945328|NCT02075320|566553263|FG000|Overall Study|Withdrawal by Subject|2|||
156945329|NCT00057746|566553265|FG000|Overall Study|Withdrawal by Subject|0|||
156945330|NCT00057746|566553266|FG001|Overall Study|Withdrawal by Subject|0|||
156945331|NCT00057746|566553267|FG002|Overall Study|Withdrawal by Subject|1|||
156945332|NCT01660412|566553275|FG000|Overall Study|Protocol Violation|0|||
156945333|NCT01660412|566553276|FG001|Overall Study|Protocol Violation|3|||
156945334|NCT00600821|566554731|FG000|Overall Study|Death|45|||
156945335|NCT00600821|566554732|FG001|Overall Study|Death|46|||
156945336|NCT00600821|566554731|FG000|Overall Study|Lost to Follow-up|2|||
156945337|NCT00600821|566554732|FG001|Overall Study|Lost to Follow-up|2|||
156945338|NCT00600821|566554731|FG000|Overall Study|Withdrawal by Subject|1|||
156945339|NCT00600821|566554732|FG001|Overall Study|Withdrawal by Subject|1|||
156945340|NCT00600821|566554731|FG000|Overall Study|Terminated by sponsor|8|||
156945341|NCT00600821|566554732|FG001|Overall Study|Terminated by sponsor|6|||
156945342|NCT00600821|566554731|FG000|Overall Study|Objective progression or relapse|0|||
156945343|NCT00600821|566554732|FG001|Overall Study|Objective progression or relapse|1|||
156945344|NCT00600821|566554731|FG000|Overall Study|Randomized but not treated|0|||
156945345|NCT00600821|566554732|FG001|Overall Study|Randomized but not treated|1|||
156945346|NCT00600821|566554731|FG000|Overall Study|Other|2|||
156945347|NCT00600821|566554732|FG001|Overall Study|Other|3|||
156945348|NCT02602288|566554735|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
156945349|NCT02602288|566554736|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
156945350|NCT02602288|566554735|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
157167519|NCT02293993|567354589|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
157167520|NCT02293993|567354590|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
156945351|NCT02602288|566554736|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
156945352|NCT02602288|566554735|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
156945353|NCT02602288|566554736|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
156945354|NCT02602288|566554735|FG000|12 Month Follow-up|Lost to Follow-up|0|||
156945355|NCT02602288|566554736|FG001|12 Month Follow-up|Lost to Follow-up|4|||
156945356|NCT02602288|566554735|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
156945357|NCT02602288|566554736|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
156945358|NCT01076400|566554738|FG000|Overall Study|Adverse Event|2|||
156945359|NCT01076400|566554739|FG001|Overall Study|Adverse Event|0|||
156945360|NCT01076400|566554740|FG002|Overall Study|Adverse Event|0|||
157205214|NCT03669640|567496074|FG001|Overall Study|Lost to Follow-up|0|||
157032757|NCT03988621|566875943|FG001|Overall Study|Withdrawal by Subject|7|||
157032758|NCT03988621|566875942|FG000|Overall Study|Patient Lost to Follow Up|15|||
157032759|NCT03988621|566875943|FG001|Overall Study|Patient Lost to Follow Up|15|||
157032760|NCT03988621|566875942|FG000|Overall Study|Patient death|1|||
157032761|NCT03988621|566875943|FG001|Overall Study|Patient death|5|||
157032762|NCT02944968|566875945|FG000|Overall Study|Subject excluded before study procedure|1|||
156945361|NCT01076400|566554738|FG000|Overall Study|Progressive Disease|5|||
156945362|NCT01076400|566554739|FG001|Overall Study|Progressive Disease|0|||
156945363|NCT01076400|566554740|FG002|Overall Study|Progressive Disease|0|||
156945364|NCT02766608|566554743|FG000|Overall Study|Adverse Event|27|||
156945365|NCT02766608|566554744|FG001|Overall Study|Adverse Event|22|||
156945366|NCT02766608|566554745|FG002|Overall Study|Adverse Event|17|||
156945367|NCT02766608|566554746|FG003|Overall Study|Adverse Event|13|||
156945368|NCT02766608|566554747|FG004|Overall Study|Adverse Event|12|||
156945369|NCT02766608|566554743|FG000|Overall Study|Withdrawal by Subject|21|||
156945370|NCT02766608|566554744|FG001|Overall Study|Withdrawal by Subject|20|||
156945371|NCT02766608|566554745|FG002|Overall Study|Withdrawal by Subject|24|||
156945372|NCT02766608|566554746|FG003|Overall Study|Withdrawal by Subject|13|||
156945373|NCT02766608|566554747|FG004|Overall Study|Withdrawal by Subject|10|||
156945374|NCT02766608|566554743|FG000|Overall Study|Lack of Efficacy|16|||
156945375|NCT02766608|566554744|FG001|Overall Study|Lack of Efficacy|15|||
156945376|NCT02766608|566554745|FG002|Overall Study|Lack of Efficacy|32|||
156945377|NCT02766608|566554746|FG003|Overall Study|Lack of Efficacy|8|||
156945378|NCT02766608|566554747|FG004|Overall Study|Lack of Efficacy|2|||
156945379|NCT02766608|566554743|FG000|Overall Study|Lost to Follow-up|6|||
156945380|NCT02766608|566554744|FG001|Overall Study|Lost to Follow-up|3|||
156945381|NCT02766608|566554745|FG002|Overall Study|Lost to Follow-up|5|||
156945382|NCT02766608|566554746|FG003|Overall Study|Lost to Follow-up|2|||
156945383|NCT02766608|566554747|FG004|Overall Study|Lost to Follow-up|2|||
156945384|NCT02766608|566554743|FG000|Overall Study|Physician Decision|3|||
156945385|NCT02766608|566554744|FG001|Overall Study|Physician Decision|2|||
156945386|NCT02766608|566554745|FG002|Overall Study|Physician Decision|3|||
156945387|NCT02766608|566554746|FG003|Overall Study|Physician Decision|1|||
156945388|NCT02766608|566554747|FG004|Overall Study|Physician Decision|2|||
156945389|NCT02766608|566554743|FG000|Overall Study|Protocol disc criteria|3|||
156945390|NCT02766608|566554744|FG001|Overall Study|Protocol disc criteria|3|||
156945391|NCT02766608|566554745|FG002|Overall Study|Protocol disc criteria|4|||
156945392|NCT02766608|566554746|FG003|Overall Study|Protocol disc criteria|0|||
156945393|NCT02766608|566554747|FG004|Overall Study|Protocol disc criteria|0|||
156945394|NCT02766608|566554743|FG000|Overall Study|Protocol Violation|0|||
156945395|NCT02766608|566554744|FG001|Overall Study|Protocol Violation|4|||
156945396|NCT02766608|566554745|FG002|Overall Study|Protocol Violation|4|||
156945397|NCT02766608|566554746|FG003|Overall Study|Protocol Violation|0|||
156945398|NCT02766608|566554747|FG004|Overall Study|Protocol Violation|1|||
156945399|NCT02766608|566554743|FG000|Overall Study|Administrative Reasons|3|||
156945400|NCT02766608|566554744|FG001|Overall Study|Administrative Reasons|1|||
156945401|NCT02766608|566554745|FG002|Overall Study|Administrative Reasons|1|||
156945402|NCT02766608|566554746|FG003|Overall Study|Administrative Reasons|0|||
156945403|NCT02766608|566554747|FG004|Overall Study|Administrative Reasons|0|||
156945404|NCT02080091|566554749|FG000|Overall Study|Study Terminated|22|||
156945405|NCT02080091|566554749|FG000|Overall Study|Death|1|||
156945406|NCT02080091|566554749|FG000|Overall Study|Withdrawal by Subject|1|||
156945407|NCT02080091|566554749|FG000|Overall Study|Other|1|||
156945408|NCT03019536|566554750|FG000|Overall Study|Withdrawal by Subject|1|||
156945409|NCT03019536|566554751|FG001|Overall Study|Withdrawal by Subject|1|||
156945410|NCT03019536|566554752|FG002|Overall Study|Withdrawal by Subject|0|||
156945411|NCT03019536|566554750|FG000|Overall Study|Adverse Event|0|||
156945412|NCT03019536|566554751|FG001|Overall Study|Adverse Event|0|||
156945413|NCT03019536|566554752|FG002|Overall Study|Adverse Event|2|||
157032763|NCT02944968|566875945|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
157032764|NCT02905331|566875946|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
157032765|NCT02905331|566875947|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
157032766|NCT02905331|566875948|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
157032767|NCT02905331|566875946|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
157032768|NCT02905331|566875947|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
157032769|NCT02905331|566875948|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
156945414|NCT01265953|566554753|FG000|Overall Study|Non compliance|5|||
156945415|NCT01265953|566554754|FG001|Overall Study|Non compliance|3|||
156945416|NCT02391948|566554755|FG000|6-month Assessment|Death|0|||
156945417|NCT02391948|566554756|FG001|6-month Assessment|Death|0|||
156945418|NCT02391948|566554757|FG002|6-month Assessment|Death|0|||
156945419|NCT02391948|566554758|FG003|6-month Assessment|Death|0|||
156945420|NCT02391948|566554759|FG004|6-month Assessment|Death|1|||
156945421|NCT02391948|566554755|FG000|6-month Assessment|Withdrawal by Subject|0|||
156945422|NCT02391948|566554756|FG001|6-month Assessment|Withdrawal by Subject|0|||
156945423|NCT02391948|566554757|FG002|6-month Assessment|Withdrawal by Subject|1|||
156945424|NCT02391948|566554758|FG003|6-month Assessment|Withdrawal by Subject|2|||
156945425|NCT02391948|566554759|FG004|6-month Assessment|Withdrawal by Subject|0|||
156945426|NCT02391948|566554755|FG000|6-month Assessment|Lost to Follow-up|4|||
156945427|NCT02391948|566554756|FG001|6-month Assessment|Lost to Follow-up|5|||
156945428|NCT02391948|566554757|FG002|6-month Assessment|Lost to Follow-up|2|||
156945429|NCT02391948|566554758|FG003|6-month Assessment|Lost to Follow-up|3|||
157167521|NCT02293993|567354591|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
157167522|NCT02293993|567354588|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
157167523|NCT02293993|567354589|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
157167524|NCT02293993|567354590|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
156945430|NCT02391948|566554759|FG004|6-month Assessment|Lost to Follow-up|1|||
156945431|NCT02391948|566554755|FG000|6-month Assessment|Medical issue/illness|1|||
156945432|NCT02391948|566554756|FG001|6-month Assessment|Medical issue/illness|1|||
156945433|NCT02391948|566554757|FG002|6-month Assessment|Medical issue/illness|0|||
156945434|NCT02391948|566554758|FG003|6-month Assessment|Medical issue/illness|0|||
156945435|NCT02391948|566554759|FG004|6-month Assessment|Medical issue/illness|0|||
156945436|NCT02391948|566554755|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
156945437|NCT02391948|566554756|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
156945438|NCT02391948|566554757|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
156945439|NCT02391948|566554758|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
156945440|NCT02391948|566554759|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
156945441|NCT02391948|566554755|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
156945442|NCT02391948|566554756|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
156945443|NCT02391948|566554757|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
156945444|NCT02391948|566554758|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
156945445|NCT02391948|566554759|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
156945446|NCT02391948|566554755|FG000|12-month Assessment|Death|0|||
156945447|NCT02391948|566554756|FG001|12-month Assessment|Death|0|||
156945448|NCT02391948|566554757|FG002|12-month Assessment|Death|0|||
156945449|NCT02391948|566554758|FG003|12-month Assessment|Death|1|||
156945450|NCT02391948|566554759|FG004|12-month Assessment|Death|0|||
156945451|NCT02391948|566554755|FG000|12-month Assessment|Withdrawal by Subject|1|||
156945452|NCT02391948|566554756|FG001|12-month Assessment|Withdrawal by Subject|0|||
156945453|NCT02391948|566554757|FG002|12-month Assessment|Withdrawal by Subject|0|||
156945454|NCT02391948|566554758|FG003|12-month Assessment|Withdrawal by Subject|1|||
156945455|NCT02391948|566554759|FG004|12-month Assessment|Withdrawal by Subject|0|||
156945456|NCT02391948|566554755|FG000|12-month Assessment|Lost to Follow-up|5|||
156945457|NCT02391948|566554756|FG001|12-month Assessment|Lost to Follow-up|4|||
157032770|NCT02905331|566875946|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
157032771|NCT02905331|566875947|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
157032772|NCT02905331|566875948|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
157032773|NCT02905331|566875946|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
157032774|NCT02905331|566875947|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
157032775|NCT02905331|566875948|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
157032776|NCT02905331|566875946|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
157032777|NCT02905331|566875947|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
157032778|NCT02905331|566875948|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
157032779|NCT04424316|566875956|FG000|Overall Study|Adverse Event|0|||
157032780|NCT04424316|566875957|FG001|Overall Study|Adverse Event|1|||
157032781|NCT04424316|566875958|FG002|Overall Study|Adverse Event|0|||
157032782|NCT04424316|566875959|FG003|Overall Study|Adverse Event|0|||
157032783|NCT04424316|566875956|FG000|Overall Study|Death|1|||
157032784|NCT04424316|566875957|FG001|Overall Study|Death|0|||
157032785|NCT04424316|566875958|FG002|Overall Study|Death|8|||
157032786|NCT04424316|566875959|FG003|Overall Study|Death|14|||
157032787|NCT04424316|566875956|FG000|Overall Study|Lost to Follow-up|93|||
157032788|NCT04424316|566875957|FG001|Overall Study|Lost to Follow-up|88|||
157167525|NCT02293993|567354591|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
157167526|NCT02293993|567354588|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
157167527|NCT02293993|567354589|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
157167528|NCT02293993|567354590|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
157205215|NCT03669640|567496075|FG002|Overall Study|Lost to Follow-up|2|||
157032789|NCT04424316|566875958|FG002|Overall Study|Lost to Follow-up|224|||
157032790|NCT04424316|566875959|FG003|Overall Study|Lost to Follow-up|211|||
157032791|NCT04424316|566875956|FG000|Overall Study|No longer met eligibility criteria|1|||
157032792|NCT04424316|566875957|FG001|Overall Study|No longer met eligibility criteria|0|||
157032793|NCT04424316|566875958|FG002|Overall Study|No longer met eligibility criteria|0|||
157032794|NCT04424316|566875959|FG003|Overall Study|No longer met eligibility criteria|0|||
157032795|NCT04424316|566875956|FG000|Overall Study|Other|15|||
156945458|NCT02391948|566554757|FG002|12-month Assessment|Lost to Follow-up|4|||
156945459|NCT02391948|566554758|FG003|12-month Assessment|Lost to Follow-up|4|||
156945460|NCT02391948|566554759|FG004|12-month Assessment|Lost to Follow-up|5|||
156945461|NCT02391948|566554755|FG000|12-month Assessment|Medical issue/illness|0|||
157167529|NCT02293993|567354591|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
157167530|NCT02293993|567354588|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
157167531|NCT02293993|567354589|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
157167532|NCT02293993|567354590|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
156945462|NCT02391948|566554756|FG001|12-month Assessment|Medical issue/illness|1|||
156945463|NCT02391948|566554757|FG002|12-month Assessment|Medical issue/illness|0|||
156945464|NCT02391948|566554758|FG003|12-month Assessment|Medical issue/illness|1|||
156945465|NCT02391948|566554759|FG004|12-month Assessment|Medical issue/illness|0|||
156945466|NCT02391948|566554755|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
156945467|NCT02391948|566554756|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
156945468|NCT02391948|566554757|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
156945469|NCT02391948|566554758|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
156945470|NCT02391948|566554759|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
156945471|NCT02391948|566554755|FG000|18-month Assessment|Death|0|||
156945472|NCT02391948|566554756|FG001|18-month Assessment|Death|0|||
156945473|NCT02391948|566554757|FG002|18-month Assessment|Death|0|||
156945474|NCT02391948|566554758|FG003|18-month Assessment|Death|1|||
156945475|NCT02391948|566554759|FG004|18-month Assessment|Death|1|||
156945476|NCT02391948|566554755|FG000|18-month Assessment|Withdrawal by Subject|1|||
156945477|NCT02391948|566554756|FG001|18-month Assessment|Withdrawal by Subject|0|||
156945478|NCT02391948|566554757|FG002|18-month Assessment|Withdrawal by Subject|0|||
156945479|NCT02391948|566554758|FG003|18-month Assessment|Withdrawal by Subject|1|||
156945480|NCT02391948|566554759|FG004|18-month Assessment|Withdrawal by Subject|0|||
156945481|NCT02391948|566554755|FG000|18-month Assessment|Lost to Follow-up|2|||
156945482|NCT02391948|566554756|FG001|18-month Assessment|Lost to Follow-up|6|||
156945483|NCT02391948|566554757|FG002|18-month Assessment|Lost to Follow-up|2|||
156945484|NCT02391948|566554758|FG003|18-month Assessment|Lost to Follow-up|2|||
156945485|NCT02391948|566554759|FG004|18-month Assessment|Lost to Follow-up|3|||
156945486|NCT02391948|566554755|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
156945487|NCT02391948|566554756|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
156945488|NCT02391948|566554757|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
156945489|NCT02391948|566554758|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
156945490|NCT02391948|566554759|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
156945491|NCT02391948|566554755|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
156945492|NCT02391948|566554756|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
156945493|NCT02391948|566554757|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
156945494|NCT02391948|566554758|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
156945495|NCT02391948|566554759|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
156945496|NCT02391948|566554755|FG000|24-month Assessment|Death|0|||
156945497|NCT02391948|566554756|FG001|24-month Assessment|Death|0|||
156945498|NCT02391948|566554757|FG002|24-month Assessment|Death|0|||
156945499|NCT02391948|566554758|FG003|24-month Assessment|Death|0|||
156945500|NCT02391948|566554759|FG004|24-month Assessment|Death|1|||
156945501|NCT02391948|566554755|FG000|24-month Assessment|Withdrawal by Subject|1|||
156945502|NCT02391948|566554756|FG001|24-month Assessment|Withdrawal by Subject|1|||
156945503|NCT02391948|566554757|FG002|24-month Assessment|Withdrawal by Subject|0|||
156945504|NCT02391948|566554758|FG003|24-month Assessment|Withdrawal by Subject|0|||
156945505|NCT02391948|566554759|FG004|24-month Assessment|Withdrawal by Subject|1|||
156945506|NCT02391948|566554755|FG000|24-month Assessment|Lost to Follow-up|5|||
156945507|NCT02391948|566554756|FG001|24-month Assessment|Lost to Follow-up|4|||
156945508|NCT02391948|566554757|FG002|24-month Assessment|Lost to Follow-up|0|||
156945509|NCT02391948|566554758|FG003|24-month Assessment|Lost to Follow-up|0|||
156945510|NCT02391948|566554759|FG004|24-month Assessment|Lost to Follow-up|0|||
156945511|NCT02391948|566554755|FG000|24-month Assessment|Medical issue/illness|0|||
156945512|NCT02391948|566554756|FG001|24-month Assessment|Medical issue/illness|0|||
156945513|NCT02391948|566554757|FG002|24-month Assessment|Medical issue/illness|1|||
156945514|NCT02391948|566554758|FG003|24-month Assessment|Medical issue/illness|0|||
156945515|NCT02391948|566554759|FG004|24-month Assessment|Medical issue/illness|0|||
156945516|NCT02391948|566554755|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
156945517|NCT02391948|566554756|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
156945518|NCT02391948|566554757|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
156945519|NCT02391948|566554758|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
156945520|NCT02391948|566554759|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
156945521|NCT02348489|566554762|FG000|Overall Study|Death|336|||
156945522|NCT02348489|566554763|FG001|Overall Study|Death|335|||
156945523|NCT02348489|566554762|FG000|Overall Study|Withdrawal by Subject|14|||
156945524|NCT02348489|566554763|FG001|Overall Study|Withdrawal by Subject|27|||
156945525|NCT02348489|566554762|FG000|Overall Study|Lost to Follow-up|3|||
156945526|NCT02348489|566554763|FG001|Overall Study|Lost to Follow-up|5|||
156945527|NCT02866682|566554764|FG000|Overall Study|Death|0|||
156945528|NCT02866682|566554765|FG001|Overall Study|Death|1|||
156945529|NCT02866682|566554764|FG000|Overall Study|Lost to Follow-up|0|||
156945530|NCT02866682|566554765|FG001|Overall Study|Lost to Follow-up|4|||
156945531|NCT02866682|566554764|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
156945532|NCT02866682|566554765|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
156945533|NCT02866682|566554764|FG000|Overall Study|Other|0|||
156945534|NCT02866682|566554765|FG001|Overall Study|Other|1|||
156945535|NCT01750268|566554767|FG000|Overall Study|Lost to Follow-up|0|||
156945536|NCT01750268|566554768|FG001|Overall Study|Lost to Follow-up|2|||
156945537|NCT01750268|566554767|FG000|Overall Study|Physician Decision|0|||
156945538|NCT01750268|566554768|FG001|Overall Study|Physician Decision|3|||
156945539|NCT01750268|566554767|FG000|Overall Study|Withdrawal by Subject|2|||
156945540|NCT01750268|566554768|FG001|Overall Study|Withdrawal by Subject|0|||
156945541|NCT02212730|566554771|FG000|Overall Study|Tumor not of the required cell histology|1|||
156945542|NCT02212730|566554772|FG001|Overall Study|Tumor not of the required cell histology|0|||
156945543|NCT02212730|566554771|FG000|Overall Study|Withdrawal by Subject|1|||
156945544|NCT02212730|566554772|FG001|Overall Study|Withdrawal by Subject|0|||
156945545|NCT02212730|566554771|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
156945546|NCT02212730|566554772|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
156945547|NCT00436280|566554781|FG000|Period 1: Induction|Adverse Event|8|||
156945548|NCT00436280|566554781|FG000|Period 1: Induction|Progressive Disease|12|||
156945549|NCT00436280|566554781|FG000|Period 1: Induction|Stable Disease|6|||
156945550|NCT00436280|566554781|FG000|Period 1: Induction|Withdrawal by Subject|1|||
156945551|NCT00436280|566554781|FG000|Period 1: Induction|Death|1|||
156945552|NCT00436280|566554781|FG000|Period 2: Consolidation|Adverse Event|1|||
156945553|NCT00436280|566554781|FG000|Period 2: Consolidation|Progressive Disease|10|||
156945554|NCT00436280|566554781|FG000|Period 2: Consolidation|Stable Disease|1|||
156945555|NCT00436280|566554781|FG000|Period 2: Consolidation|Physician Decision|2|||
156945556|NCT00436280|566554781|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
156945557|NCT00436280|566554781|FG000|Period 2: Consolidation|Death|1|||
156945558|NCT00436280|566554781|FG000|Period 3: Maintenance|Adverse Event|6|||
156945559|NCT00436280|566554781|FG000|Period 3: Maintenance|Progressive Disease|12|||
156945560|NCT03603964|566554782|FG000|Overall Study|Death|9|||
156945561|NCT03603964|566554782|FG000|Overall Study|Withdrawal by participant|7|||
156945562|NCT03603964|566554782|FG000|Overall Study|Study terminated by Sponsor|19|||
156945563|NCT00563797|566554783|FG000|Overall Study|Lost to Follow-up|7|||
156945564|NCT00563797|566554784|FG001|Overall Study|Lost to Follow-up|2|||
156945565|NCT03586869|566554785|FG000|Overall Study|Progressive Disease|3|||
156945566|NCT04116229|566554786|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
156945567|NCT04116229|566554787|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
156945568|NCT04116229|566554786|FG000|Overall Study|Scheduling not possible.|0|||
156945569|NCT04116229|566554787|FG001|Overall Study|Scheduling not possible.|1|||
156945570|NCT02809976|566554790|FG000|Overall Study|Lost to Follow-up|1|||
156945571|NCT02809976|566554790|FG000|Overall Study|Withdrawal by Subject|1|||
156945572|NCT01785524|566554791|FG000|Overall Study|Withdrawal by Subject|2|||
156945573|NCT01785524|566554792|FG001|Overall Study|Withdrawal by Subject|2|||
156945574|NCT00211081|566554794|FG000|Overall Study|Withdrawal by Subject|2|||
156945575|NCT00113516|566554795|FG000|Part 1|Adverse Event|6|||
156945576|NCT00113516|566554796|FG001|Part 1|Adverse Event|0|||
156945577|NCT00113516|566554795|FG000|Part 1|Death|3|||
156945578|NCT00113516|566554796|FG001|Part 1|Death|0|||
156945579|NCT00113516|566554795|FG000|Part 1|Other|3|||
156945580|NCT00113516|566554796|FG001|Part 1|Other|0|||
156945581|NCT00113516|566554795|FG000|Part 1|Withdrawal by Subject|2|||
156945582|NCT00113516|566554796|FG001|Part 1|Withdrawal by Subject|0|||
156945583|NCT00113516|566554795|FG000|Part 1|Lack of Efficacy|2|||
156945584|NCT00113516|566554796|FG001|Part 1|Lack of Efficacy|0|||
156945585|NCT00113516|566554795|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
156945586|NCT00113516|566554796|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
156945587|NCT00113516|566554795|FG000|Part 1|Laboratory Abnormality|1|||
156945588|NCT00113516|566554796|FG001|Part 1|Laboratory Abnormality|0|||
156945589|NCT00113516|566554795|FG000|Part 1|Ongoing|1|||
156945590|NCT00113516|566554796|FG001|Part 1|Ongoing|0|||
156945591|NCT00113516|566554795|FG000|Part 1|Missing|65|||
156945592|NCT00113516|566554796|FG001|Part 1|Missing|0|||
156945593|NCT00113516|566554795|FG000|Part 2|Adverse Event|0|||
156945594|NCT00113516|566554796|FG001|Part 2|Adverse Event|16|||
156945595|NCT00113516|566554795|FG000|Part 2|Death|0|||
156945596|NCT00113516|566554796|FG001|Part 2|Death|5|||
156945597|NCT00113516|566554795|FG000|Part 2|Lack of Efficacy|0|||
156945598|NCT00113516|566554796|FG001|Part 2|Lack of Efficacy|37|||
156945599|NCT00113516|566554795|FG000|Part 2|Withdrawal by Subject|0|||
156945600|NCT00113516|566554796|FG001|Part 2|Withdrawal by Subject|3|||
156945601|NCT00113516|566554795|FG000|Part 2|Other|0|||
156945602|NCT00113516|566554796|FG001|Part 2|Other|3|||
156945603|NCT00113516|566554795|FG000|Part 2|Laboratory Abnormality|0|||
156945604|NCT00113516|566554796|FG001|Part 2|Laboratory Abnormality|1|||
156945605|NCT00113516|566554795|FG000|Part 2|Ongoing|0|||
156945606|NCT00113516|566554796|FG001|Part 2|Ongoing|1|||
156945607|NCT00047463|566554797|FG000|Overall Study|Withdrawal by Subject|0|||
157032796|NCT04424316|566875957|FG001|Overall Study|Other|11|||
157032797|NCT04424316|566875958|FG002|Overall Study|Other|34|||
157032798|NCT04424316|566875959|FG003|Overall Study|Other|45|||
157032799|NCT04424316|566875956|FG000|Overall Study|Physician Decision|1|||
157032800|NCT04424316|566875957|FG001|Overall Study|Physician Decision|0|||
157032801|NCT04424316|566875958|FG002|Overall Study|Physician Decision|1|||
157032802|NCT04424316|566875959|FG003|Overall Study|Physician Decision|1|||
157032803|NCT04424316|566875956|FG000|Overall Study|Protocol Violation|0|||
157032804|NCT04424316|566875957|FG001|Overall Study|Protocol Violation|1|||
157032805|NCT04424316|566875958|FG002|Overall Study|Protocol Violation|0|||
157032806|NCT04424316|566875959|FG003|Overall Study|Protocol Violation|0|||
157032807|NCT04424316|566875956|FG000|Overall Study|Withdrawal by Subject|71|||
157032808|NCT04424316|566875957|FG001|Overall Study|Withdrawal by Subject|77|||
157032809|NCT04424316|566875958|FG002|Overall Study|Withdrawal by Subject|0|||
157032810|NCT04424316|566875959|FG003|Overall Study|Withdrawal by Subject|0|||
157032811|NCT04424316|566875956|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157032812|NCT04424316|566875957|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157032813|NCT04424316|566875958|FG002|Overall Study|Withdrawal by parent/guardian|74|||
157032814|NCT04424316|566875959|FG003|Overall Study|Withdrawal by parent/guardian|81|||
157032815|NCT04424316|566875956|FG000|Overall Study|Randomized but not vaccinated|13|||
157032816|NCT04424316|566875957|FG001|Overall Study|Randomized but not vaccinated|21|||
157032817|NCT04424316|566875958|FG002|Overall Study|Randomized but not vaccinated|0|||
157032818|NCT04424316|566875959|FG003|Overall Study|Randomized but not vaccinated|0|||
157032819|NCT04424316|566875956|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
157032820|NCT04424316|566875957|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
157032821|NCT04424316|566875958|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
157032822|NCT04424316|566875959|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
157032823|NCT04633538|566875960|FG000|Overall Study|Death|1|||
157032824|NCT04633538|566875960|FG000|Overall Study|Lost to Follow-up|3|||
157032825|NCT04633538|566875960|FG000|Overall Study|Withdrawal by Subject|1|||
157032826|NCT03245840|566875961|FG000|Overall Study|Adverse Event|6|||
157032827|NCT03245840|566875962|FG001|Overall Study|Adverse Event|0|||
157032828|NCT03245840|566875961|FG000|Overall Study|Death|2|||
157032829|NCT03245840|566875962|FG001|Overall Study|Death|0|||
157032830|NCT03245840|566875961|FG000|Overall Study|Withdrawal by Subject|31|||
156945608|NCT00047463|566554798|FG001|Overall Study|Withdrawal by Subject|3|||
156945609|NCT03755765|566554803|FG000|Overall Study|Withdrawal by Subject|2|||
156945610|NCT03755765|566554804|FG001|Overall Study|Withdrawal by Subject|4|||
156945611|NCT03755765|566554805|FG002|Overall Study|Withdrawal by Subject|4|||
156945612|NCT01158222|566554808|FG000|Overall Study|Not eligible for intermediate phase|17|||
156945613|NCT02579616|566554811|FG000|Overall Study|Participants did not receive treatment|3|||
156945614|NCT02178475|566554812|FG000|Overall Study|Withdrawal by Subject|7|||
156945615|NCT02178475|566554812|FG000|Overall Study|Lost to Follow-up|10|||
156945616|NCT02178475|566554812|FG000|Overall Study|Death|13|||
156945617|NCT02178475|566554812|FG000|Overall Study|Protocol-specified Criteria|99|||
156945618|NCT01430585|566554813|FG000|Overall Study|Death|1|||
156945619|NCT01430585|566554813|FG000|Overall Study|Objective Progression or Relapse|3|||
156945620|NCT01430585|566554813|FG000|Overall Study|Study Terminated by Sponsor|3|||
156945621|NCT01430585|566554813|FG000|Overall Study|Other|7|||
156945622|NCT00482391|566554814|FG000|Overall Study|Withdrawal by Subject|1|||
156945623|NCT00482391|566554814|FG000|Overall Study|Adverse Event|1|||
156945624|NCT00482391|566554814|FG000|Overall Study|Death|1|||
157032831|NCT03245840|566875962|FG001|Overall Study|Withdrawal by Subject|1|||
157032832|NCT03245840|566875961|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
157032833|NCT03245840|566875962|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157032834|NCT03245840|566875961|FG000|Overall Study|Physician Decision|4|||
157032835|NCT03245840|566875962|FG001|Overall Study|Physician Decision|1|||
157032836|NCT03245840|566875961|FG000|Overall Study|Study Terminated by Sponsor|56|||
157032837|NCT03245840|566875962|FG001|Overall Study|Study Terminated by Sponsor|6|||
157032838|NCT03245840|566875961|FG000|Overall Study|Site Terminated by Sponsor|4|||
157227330|NCT00950807|567577790|FG009|Treatment Period 2|Withdrawal by Subject|0|||
156945625|NCT01448850|566554815|FG000|Overall Study|Death|3|||
156945626|NCT01448850|566554816|FG001|Overall Study|Death|6|||
156945627|NCT01448850|566554815|FG000|Overall Study|Withdrawal by Subject|13|||
157032839|NCT03245840|566875962|FG001|Overall Study|Site Terminated by Sponsor|0|||
157032840|NCT03245840|566875961|FG000|Overall Study|Lost to Follow-up|12|||
157032841|NCT03245840|566875962|FG001|Overall Study|Lost to Follow-up|2|||
157032842|NCT03245840|566875961|FG000|Overall Study|Pregnancy|2|||
157032843|NCT03245840|566875962|FG001|Overall Study|Pregnancy|0|||
157032844|NCT03245840|566875961|FG000|Overall Study|Non-Compliance with Study Drug|2|||
157032845|NCT03245840|566875962|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157032846|NCT03245840|566875961|FG000|Overall Study|Not treated|1|||
157032847|NCT03245840|566875962|FG001|Overall Study|Not treated|1|||
157032848|NCT03582033|566875965|FG000|Part A|Other|0|||
156945628|NCT01448850|566554816|FG001|Overall Study|Withdrawal by Subject|21|||
156945629|NCT01448850|566554815|FG000|Overall Study|Lost to Follow-up|3|||
156945630|NCT01448850|566554816|FG001|Overall Study|Lost to Follow-up|1|||
156945631|NCT01448850|566554815|FG000|Overall Study|Other|15|||
156945632|NCT01448850|566554816|FG001|Overall Study|Other|12|||
156945633|NCT01274637|566554823|FG000|Overall Study|Withdrawal by Subject|0|||
156945634|NCT01274637|566554824|FG001|Overall Study|Withdrawal by Subject|1|||
156945635|NCT01274637|566554823|FG000|Overall Study|Lost to Follow-up|0|||
156945636|NCT01274637|566554824|FG001|Overall Study|Lost to Follow-up|1|||
156945637|NCT03235024|566554832|FG000|Overall Study|Adverse Event|2|||
156945638|NCT03235024|566554833|FG001|Overall Study|Adverse Event|2|||
156945639|NCT03235024|566554832|FG000|Overall Study|Death|1|||
156945640|NCT03235024|566554833|FG001|Overall Study|Death|0|||
156945641|NCT03235024|566554832|FG000|Overall Study|Lost to Follow-up|2|||
156945642|NCT03235024|566554833|FG001|Overall Study|Lost to Follow-up|5|||
156945643|NCT03235024|566554832|FG000|Overall Study|Protocol Violation|1|||
156945644|NCT03235024|566554833|FG001|Overall Study|Protocol Violation|0|||
156945645|NCT03235024|566554832|FG000|Overall Study|Withdrawal by Subject|0|||
156945646|NCT03235024|566554833|FG001|Overall Study|Withdrawal by Subject|3|||
156945647|NCT02357576|566554834|FG000|Treatment Period|Withdrawal by Subject|0|||
156945648|NCT02357576|566554835|FG001|Treatment Period|Withdrawal by Subject|1|||
156945649|NCT02357576|566554834|FG000|Treatment Period|Physician Decision|0|||
156945650|NCT02357576|566554835|FG001|Treatment Period|Physician Decision|1|||
156945651|NCT02357576|566554834|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
156945652|NCT02357576|566554835|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
156945653|NCT02357576|566554834|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
156945654|NCT02357576|566554835|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
156945655|NCT02357576|566554834|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
156945656|NCT02357576|566554835|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
156945657|NCT02357576|566554834|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
156945658|NCT02357576|566554835|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
156945659|NCT02047110|566554836|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
156945660|NCT02047110|566554837|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
156945661|NCT02047110|566554838|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
156945662|NCT02047110|566554839|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
156945663|NCT02047110|566554836|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
156945664|NCT02047110|566554837|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156945665|NCT02047110|566554838|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156945666|NCT02047110|566554839|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
156945667|NCT02047110|566554836|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
156945668|NCT02047110|566554837|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
156945669|NCT02047110|566554838|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
156945670|NCT02047110|566554839|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
156945671|NCT02047110|566554836|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
156945672|NCT02047110|566554837|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
156945673|NCT02047110|566554838|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
156945674|NCT02047110|566554839|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
156945675|NCT02047110|566554836|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
156945676|NCT02047110|566554837|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
156945677|NCT02047110|566554838|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
156945678|NCT02047110|566554839|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
156945679|NCT02047110|566554836|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156945680|NCT02047110|566554837|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
156945681|NCT02047110|566554838|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156945682|NCT02047110|566554839|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
156945683|NCT02047110|566554836|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
156945684|NCT02047110|566554837|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
156945685|NCT02047110|566554838|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
156945686|NCT02047110|566554839|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
156945687|NCT02047110|566554836|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
156945688|NCT02047110|566554837|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
156945689|NCT02047110|566554838|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
156945690|NCT02047110|566554839|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
156945691|NCT02047110|566554836|FG000|Escape Treatment Period|Adverse Event|1|||
156945692|NCT02047110|566554837|FG001|Escape Treatment Period|Adverse Event|2|||
156945693|NCT02047110|566554838|FG002|Escape Treatment Period|Adverse Event|2|||
156945694|NCT02047110|566554839|FG003|Escape Treatment Period|Adverse Event|0|||
157032849|NCT03582033|566875966|FG001|Part A|Other|0|||
157032850|NCT03582033|566875967|FG002|Part A|Other|0|||
156945695|NCT02047110|566554836|FG000|Escape Treatment Period|Other than specified|1|||
156945696|NCT02047110|566554837|FG001|Escape Treatment Period|Other than specified|2|||
156945697|NCT02047110|566554838|FG002|Escape Treatment Period|Other than specified|0|||
156945698|NCT02047110|566554839|FG003|Escape Treatment Period|Other than specified|1|||
156945699|NCT02047110|566554836|FG000|OLE Treatment Period|Other than specified|0|||
157032851|NCT03582033|566875968|FG003|Part A|Other|0|||
156945700|NCT02047110|566554837|FG001|OLE Treatment Period|Other than specified|0|||
156945701|NCT02047110|566554838|FG002|OLE Treatment Period|Other than specified|1|||
156945702|NCT02047110|566554839|FG003|OLE Treatment Period|Other than specified|0|||
156945703|NCT00414050|566554840|FG000|Overall Study|Adverse Event|1|||
156945704|NCT00414050|566554841|FG001|Overall Study|Adverse Event|1|||
156945705|NCT00414050|566554842|FG002|Overall Study|Adverse Event|1|||
156945706|NCT00414050|566554843|FG003|Overall Study|Adverse Event|1|||
156945707|NCT00414050|566554840|FG000|Overall Study|Lost to Follow-up|2|||
156945708|NCT00414050|566554841|FG001|Overall Study|Lost to Follow-up|2|||
156945709|NCT00414050|566554842|FG002|Overall Study|Lost to Follow-up|1|||
156945710|NCT00414050|566554843|FG003|Overall Study|Lost to Follow-up|1|||
156945711|NCT00414050|566554840|FG000|Overall Study|Withdrawal by Subject|5|||
156945712|NCT00414050|566554841|FG001|Overall Study|Withdrawal by Subject|3|||
156945713|NCT00414050|566554842|FG002|Overall Study|Withdrawal by Subject|2|||
156945714|NCT00414050|566554843|FG003|Overall Study|Withdrawal by Subject|4|||
156945715|NCT00414050|566554840|FG000|Overall Study|Subject discontinued for other reason|1|||
156945716|NCT00414050|566554841|FG001|Overall Study|Subject discontinued for other reason|2|||
156945717|NCT00414050|566554842|FG002|Overall Study|Subject discontinued for other reason|2|||
156945718|NCT00414050|566554843|FG003|Overall Study|Subject discontinued for other reason|1|||
156945719|NCT00414050|566554840|FG000|Overall Study|Subject Moved|0|||
156945720|NCT00414050|566554841|FG001|Overall Study|Subject Moved|0|||
156945721|NCT00414050|566554842|FG002|Overall Study|Subject Moved|0|||
156945722|NCT00414050|566554843|FG003|Overall Study|Subject Moved|1|||
156945723|NCT03304379|566554855|FG000|Overall Study|Protocol Violation|8|||
156945724|NCT03304379|566554856|FG001|Overall Study|Protocol Violation|10|||
156945725|NCT03304379|566554857|FG002|Overall Study|Protocol Violation|5|||
156945726|NCT03304379|566554858|FG003|Overall Study|Protocol Violation|0|||
156945727|NCT03304379|566554859|FG004|Overall Study|Protocol Violation|2|||
156945728|NCT03304379|566554855|FG000|Overall Study|Adverse Event|4|||
156945729|NCT03304379|566554856|FG001|Overall Study|Adverse Event|20|||
156945730|NCT03304379|566554857|FG002|Overall Study|Adverse Event|17|||
156945731|NCT03304379|566554858|FG003|Overall Study|Adverse Event|1|||
156945732|NCT03304379|566554859|FG004|Overall Study|Adverse Event|0|||
156945733|NCT03304379|566554855|FG000|Overall Study|Lack of Efficacy|17|||
156945734|NCT03304379|566554856|FG001|Overall Study|Lack of Efficacy|16|||
156945735|NCT03304379|566554857|FG002|Overall Study|Lack of Efficacy|20|||
156945736|NCT03304379|566554858|FG003|Overall Study|Lack of Efficacy|0|||
156945737|NCT03304379|566554859|FG004|Overall Study|Lack of Efficacy|0|||
156945738|NCT03304379|566554855|FG000|Overall Study|Physician Decision|6|||
156945739|NCT03304379|566554856|FG001|Overall Study|Physician Decision|10|||
156945740|NCT03304379|566554857|FG002|Overall Study|Physician Decision|6|||
156945741|NCT03304379|566554858|FG003|Overall Study|Physician Decision|9|||
156945742|NCT03304379|566554859|FG004|Overall Study|Physician Decision|10|||
156945743|NCT03304379|566554855|FG000|Overall Study|Withdrawal by Subject|26|||
156945744|NCT03304379|566554856|FG001|Overall Study|Withdrawal by Subject|58|||
156945745|NCT03304379|566554857|FG002|Overall Study|Withdrawal by Subject|66|||
156945746|NCT03304379|566554858|FG003|Overall Study|Withdrawal by Subject|3|||
156945747|NCT03304379|566554859|FG004|Overall Study|Withdrawal by Subject|5|||
156945748|NCT03304379|566554855|FG000|Overall Study|Lost to Follow-up|8|||
156945749|NCT03304379|566554856|FG001|Overall Study|Lost to Follow-up|24|||
156945750|NCT03304379|566554857|FG002|Overall Study|Lost to Follow-up|35|||
156945751|NCT03304379|566554858|FG003|Overall Study|Lost to Follow-up|4|||
156945752|NCT03304379|566554859|FG004|Overall Study|Lost to Follow-up|0|||
156945753|NCT03304379|566554855|FG000|Overall Study|Death|1|||
156945754|NCT03304379|566554856|FG001|Overall Study|Death|2|||
156945755|NCT03304379|566554857|FG002|Overall Study|Death|0|||
156945756|NCT03304379|566554858|FG003|Overall Study|Death|0|||
156945757|NCT03304379|566554859|FG004|Overall Study|Death|0|||
156945758|NCT03304379|566554855|FG000|Overall Study|Other|0|||
156945759|NCT03304379|566554856|FG001|Overall Study|Other|1|||
156945760|NCT03304379|566554857|FG002|Overall Study|Other|0|||
156945761|NCT03304379|566554858|FG003|Overall Study|Other|0|||
156945762|NCT03304379|566554859|FG004|Overall Study|Other|0|||
156945763|NCT00512096|566554880|FG000|Overall Study|Adverse Event|2|||
156945764|NCT00512096|566554880|FG000|Overall Study|Withdrawal by Subject|2|||
156945765|NCT00512096|566554880|FG000|Overall Study|Lack of Efficacy|3|||
156945766|NCT02293005|566556383|FG000|Overall Study|Adverse Event|2|||
156945767|NCT02293005|566556383|FG000|Overall Study|Death|4|||
156945768|NCT02293005|566556383|FG000|Overall Study|Lost to Follow-up|1|||
156945769|NCT02293005|566556383|FG000|Overall Study|Withdrawal by Subject|2|||
156945770|NCT02293005|566556383|FG000|Overall Study|Progression|17|||
156945771|NCT03143829|566556391|FG000|Overall Study|Withdrawal by Subject|2|||
156945772|NCT03143829|566556392|FG001|Overall Study|Withdrawal by Subject|5|||
156945773|NCT03143829|566556391|FG000|Overall Study|Lost to Follow-up|0|||
156945774|NCT03143829|566556392|FG001|Overall Study|Lost to Follow-up|2|||
156945775|NCT03143829|566556391|FG000|Overall Study|Death|1|||
156945776|NCT03143829|566556392|FG001|Overall Study|Death|1|||
156945777|NCT03143829|566556391|FG000|Overall Study|changed treatment, no longer eligible|2|||
156945778|NCT03143829|566556392|FG001|Overall Study|changed treatment, no longer eligible|2|||
156945779|NCT02691455|566556400|FG000|Overall Study|Withdrawal by Subject|1|||
157032852|NCT03582033|566875969|FG004|Part A|Other|2|||
157032853|NCT03582033|566875970|FG005|Part A|Other|0|||
157032854|NCT03582033|566875971|FG006|Part A|Other|0|||
157032855|NCT03582033|566875972|FG007|Part A|Other|0|||
157032856|NCT03582033|566875973|FG008|Part A|Other|0|||
157032857|NCT03582033|566875974|FG009|Part A|Other|0|||
157032858|NCT03582033|566875965|FG000|Part A|Death|1|||
157032859|NCT03582033|566875966|FG001|Part A|Death|1|||
157032860|NCT03582033|566875967|FG002|Part A|Death|2|||
157032861|NCT03582033|566875968|FG003|Part A|Death|4|||
157032862|NCT03582033|566875969|FG004|Part A|Death|11|||
157032863|NCT03582033|566875970|FG005|Part A|Death|0|||
157032864|NCT03582033|566875971|FG006|Part A|Death|0|||
157032865|NCT03582033|566875972|FG007|Part A|Death|0|||
157032866|NCT03582033|566875973|FG008|Part A|Death|0|||
157032867|NCT03582033|566875974|FG009|Part A|Death|0|||
157032868|NCT03582033|566875965|FG000|Part A|Lost to Follow-up|0|||
157032869|NCT03582033|566875966|FG001|Part A|Lost to Follow-up|0|||
157032870|NCT03582033|566875967|FG002|Part A|Lost to Follow-up|0|||
157032871|NCT03582033|566875968|FG003|Part A|Lost to Follow-up|0|||
157167533|NCT02293993|567354591|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
157167534|NCT03587584|567354592|FG000|Overall Study|SOC deviations|4|||
157167535|NCT03587584|567354593|FG001|Overall Study|SOC deviations|6|||
157167536|NCT03587584|567354592|FG000|Overall Study|Incomplete data|0|||
157167537|NCT03587584|567354593|FG001|Overall Study|Incomplete data|3|||
157167538|NCT00830115|567354594|FG000|Overall Study|Adverse Event|2|||
157227331|NCT00950807|567577781|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
156945780|NCT02691455|566556401|FG001|Overall Study|Withdrawal by Subject|2|||
156945781|NCT02691455|566556400|FG000|Overall Study|Lost to Follow-up|15|||
156945782|NCT02691455|566556401|FG001|Overall Study|Lost to Follow-up|15|||
156945783|NCT02057757|566556402|FG000|Overall Study|Withdrawal by Subject|3|||
156945784|NCT02057757|566556403|FG001|Overall Study|Withdrawal by Subject|5|||
156945785|NCT02057757|566556402|FG000|Overall Study|Death|2|||
156945786|NCT02057757|566556403|FG001|Overall Study|Death|0|||
156945787|NCT02057757|566556402|FG000|Overall Study|Lost to Follow-up|8|||
156945788|NCT02057757|566556403|FG001|Overall Study|Lost to Follow-up|3|||
156945789|NCT02057757|566556402|FG000|Overall Study|Non-compliance|1|||
156945790|NCT02057757|566556403|FG001|Overall Study|Non-compliance|0|||
156945791|NCT00440271|566556404|FG000|Overall Study|Protocol Violation|1|||
156945792|NCT00440271|566556405|FG001|Overall Study|Protocol Violation|1|||
156945793|NCT00440271|566556404|FG000|Overall Study|Adverse Event|0|||
156945794|NCT00440271|566556405|FG001|Overall Study|Adverse Event|1|||
156945795|NCT00440271|566556404|FG000|Overall Study|Lost to Follow-up|1|||
156945796|NCT00440271|566556405|FG001|Overall Study|Lost to Follow-up|0|||
156945797|NCT00440271|566556404|FG000|Overall Study|Withdrawal by Subject|0|||
156945798|NCT00440271|566556405|FG001|Overall Study|Withdrawal by Subject|2|||
156945799|NCT00440271|566556404|FG000|Overall Study|Lack of Efficacy|0|||
156945800|NCT00440271|566556405|FG001|Overall Study|Lack of Efficacy|1|||
156945801|NCT00440271|566556404|FG000|Overall Study|Due to closure of trial|8|||
156945802|NCT00440271|566556405|FG001|Overall Study|Due to closure of trial|10|||
156945803|NCT00440271|566556404|FG000|Overall Study|Other|2|||
156945804|NCT00440271|566556405|FG001|Overall Study|Other|0|||
156945805|NCT04086472|566556415|FG000|Overall Study|Lost to Follow-up|1|||
156945806|NCT04086472|566556416|FG001|Overall Study|Lost to Follow-up|0|||
156945807|NCT04086472|566556417|FG002|Overall Study|Lost to Follow-up|0|||
156945808|NCT04086472|566556418|FG003|Overall Study|Lost to Follow-up|0|||
156945809|NCT04086472|566556419|FG004|Overall Study|Lost to Follow-up|1|||
156945810|NCT04086472|566556415|FG000|Overall Study|Physician Decision|0|||
156945811|NCT04086472|566556416|FG001|Overall Study|Physician Decision|1|||
156945812|NCT04086472|566556417|FG002|Overall Study|Physician Decision|1|||
156945813|NCT04086472|566556418|FG003|Overall Study|Physician Decision|0|||
156945814|NCT04086472|566556419|FG004|Overall Study|Physician Decision|0|||
156945815|NCT04086472|566556415|FG000|Overall Study|Withdrawal by Subject|1|||
156945816|NCT04086472|566556416|FG001|Overall Study|Withdrawal by Subject|1|||
156945817|NCT04086472|566556417|FG002|Overall Study|Withdrawal by Subject|1|||
156945818|NCT04086472|566556418|FG003|Overall Study|Withdrawal by Subject|0|||
156945819|NCT04086472|566556419|FG004|Overall Study|Withdrawal by Subject|0|||
157032872|NCT03582033|566875969|FG004|Part A|Lost to Follow-up|1|||
157032873|NCT03582033|566875970|FG005|Part A|Lost to Follow-up|0|||
157167539|NCT00830115|567354594|FG000|Overall Study|Improvement/recovery|1|||
157167540|NCT01107405|567354606|FG000|Overall Study|Adverse Event|1|||
157227332|NCT00950807|567577782|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
156945820|NCT04086472|566556415|FG000|Overall Study|Various reasons|2|||
157032874|NCT03582033|566875971|FG006|Part A|Lost to Follow-up|0|||
157032875|NCT03582033|566875972|FG007|Part A|Lost to Follow-up|0|||
157032876|NCT03582033|566875973|FG008|Part A|Lost to Follow-up|0|||
157032877|NCT03582033|566875974|FG009|Part A|Lost to Follow-up|0|||
157032878|NCT03582033|566875965|FG000|Part A|Study terminated by sponsor|0|||
157032879|NCT03582033|566875966|FG001|Part A|Study terminated by sponsor|0|||
157032880|NCT03582033|566875967|FG002|Part A|Study terminated by sponsor|0|||
157032881|NCT03582033|566875968|FG003|Part A|Study terminated by sponsor|2|||
157032882|NCT03582033|566875969|FG004|Part A|Study terminated by sponsor|1|||
157032883|NCT03582033|566875970|FG005|Part A|Study terminated by sponsor|0|||
157032884|NCT03582033|566875971|FG006|Part A|Study terminated by sponsor|0|||
157032885|NCT03582033|566875972|FG007|Part A|Study terminated by sponsor|0|||
157032886|NCT03582033|566875973|FG008|Part A|Study terminated by sponsor|0|||
157032887|NCT03582033|566875974|FG009|Part A|Study terminated by sponsor|0|||
157032888|NCT03582033|566875965|FG000|Part A|Withdrawal by Subject|1|||
157032889|NCT03582033|566875966|FG001|Part A|Withdrawal by Subject|1|||
157032890|NCT03582033|566875967|FG002|Part A|Withdrawal by Subject|0|||
157032891|NCT03582033|566875968|FG003|Part A|Withdrawal by Subject|1|||
157032892|NCT03582033|566875969|FG004|Part A|Withdrawal by Subject|7|||
157032893|NCT03582033|566875970|FG005|Part A|Withdrawal by Subject|0|||
157032894|NCT03582033|566875971|FG006|Part A|Withdrawal by Subject|0|||
157032895|NCT03582033|566875972|FG007|Part A|Withdrawal by Subject|0|||
157032896|NCT03582033|566875973|FG008|Part A|Withdrawal by Subject|0|||
157032897|NCT03582033|566875974|FG009|Part A|Withdrawal by Subject|0|||
157032898|NCT03582033|566875965|FG000|Part B|Death|0|||
157032899|NCT03582033|566875966|FG001|Part B|Death|0|||
157032900|NCT03582033|566875967|FG002|Part B|Death|0|||
157032901|NCT03582033|566875968|FG003|Part B|Death|0|||
157032902|NCT03582033|566875969|FG004|Part B|Death|0|||
157032903|NCT03582033|566875970|FG005|Part B|Death|2|||
157032904|NCT03582033|566875971|FG006|Part B|Death|0|||
157032905|NCT03582033|566875972|FG007|Part B|Death|0|||
157032906|NCT03582033|566875973|FG008|Part B|Death|0|||
157032907|NCT03582033|566875974|FG009|Part B|Death|0|||
157032908|NCT03582033|566875965|FG000|Part B|Study terminated by sponsor|0|||
157032909|NCT03582033|566875966|FG001|Part B|Study terminated by sponsor|0|||
157032910|NCT03582033|566875967|FG002|Part B|Study terminated by sponsor|0|||
157032911|NCT03582033|566875968|FG003|Part B|Study terminated by sponsor|0|||
157032912|NCT03582033|566875969|FG004|Part B|Study terminated by sponsor|0|||
157032913|NCT03582033|566875970|FG005|Part B|Study terminated by sponsor|12|||
157032914|NCT03582033|566875971|FG006|Part B|Study terminated by sponsor|0|||
157032915|NCT03582033|566875972|FG007|Part B|Study terminated by sponsor|0|||
157032916|NCT03582033|566875973|FG008|Part B|Study terminated by sponsor|0|||
157032917|NCT03582033|566875974|FG009|Part B|Study terminated by sponsor|0|||
157032918|NCT03582033|566875965|FG000|Part B|Withdrawal by Subject|0|||
157032919|NCT03582033|566875966|FG001|Part B|Withdrawal by Subject|0|||
157032920|NCT03582033|566875967|FG002|Part B|Withdrawal by Subject|0|||
157032921|NCT03582033|566875968|FG003|Part B|Withdrawal by Subject|0|||
157032922|NCT03582033|566875969|FG004|Part B|Withdrawal by Subject|0|||
157032923|NCT03582033|566875970|FG005|Part B|Withdrawal by Subject|6|||
157032924|NCT03582033|566875971|FG006|Part B|Withdrawal by Subject|0|||
157032925|NCT03582033|566875972|FG007|Part B|Withdrawal by Subject|0|||
157032926|NCT03582033|566875973|FG008|Part B|Withdrawal by Subject|0|||
157032927|NCT03582033|566875974|FG009|Part B|Withdrawal by Subject|0|||
157032928|NCT03582033|566875965|FG000|Part C|Other|0|||
157032929|NCT03582033|566875966|FG001|Part C|Other|0|||
157032930|NCT03582033|566875967|FG002|Part C|Other|0|||
157032931|NCT03582033|566875968|FG003|Part C|Other|0|||
157032932|NCT03582033|566875969|FG004|Part C|Other|0|||
157032933|NCT03582033|566875970|FG005|Part C|Other|0|||
157032934|NCT03582033|566875971|FG006|Part C|Other|2|||
157032935|NCT03582033|566875972|FG007|Part C|Other|0|||
157032936|NCT03582033|566875973|FG008|Part C|Other|0|||
157167541|NCT01107405|567354607|FG001|Overall Study|Adverse Event|1|||
157167542|NCT01107405|567354608|FG002|Overall Study|Adverse Event|0|||
157167543|NCT01107405|567354609|FG003|Overall Study|Adverse Event|0|||
157167544|NCT01107405|567354610|FG004|Overall Study|Adverse Event|2|||
157032937|NCT03582033|566875974|FG009|Part C|Other|0|||
157032938|NCT03582033|566875965|FG000|Part C|Death|0|||
157032939|NCT03582033|566875966|FG001|Part C|Death|0|||
157032940|NCT03582033|566875967|FG002|Part C|Death|0|||
157032941|NCT03582033|566875968|FG003|Part C|Death|0|||
157032942|NCT03582033|566875969|FG004|Part C|Death|0|||
157032943|NCT03582033|566875970|FG005|Part C|Death|0|||
157032944|NCT03582033|566875971|FG006|Part C|Death|6|||
157032945|NCT03582033|566875972|FG007|Part C|Death|1|||
157032946|NCT03582033|566875973|FG008|Part C|Death|2|||
157032947|NCT03582033|566875974|FG009|Part C|Death|0|||
157032948|NCT03582033|566875965|FG000|Part C|Study terminated by sponsor|0|||
157032949|NCT03582033|566875966|FG001|Part C|Study terminated by sponsor|0|||
157032950|NCT03582033|566875967|FG002|Part C|Study terminated by sponsor|0|||
157167545|NCT01107405|567354606|FG000|Overall Study|Withdrawal by Subject|1|||
157167546|NCT01107405|567354607|FG001|Overall Study|Withdrawal by Subject|0|||
157032951|NCT03582033|566875968|FG003|Part C|Study terminated by sponsor|0|||
157032952|NCT03582033|566875969|FG004|Part C|Study terminated by sponsor|0|||
157032953|NCT03582033|566875970|FG005|Part C|Study terminated by sponsor|0|||
157032954|NCT03582033|566875971|FG006|Part C|Study terminated by sponsor|3|||
157032955|NCT03582033|566875972|FG007|Part C|Study terminated by sponsor|3|||
157032956|NCT03582033|566875973|FG008|Part C|Study terminated by sponsor|2|||
157032957|NCT03582033|566875974|FG009|Part C|Study terminated by sponsor|0|||
157032958|NCT03582033|566875965|FG000|Part C|Withdrawal by Subject|0|||
157032959|NCT03582033|566875966|FG001|Part C|Withdrawal by Subject|0|||
157032960|NCT03582033|566875967|FG002|Part C|Withdrawal by Subject|0|||
156945821|NCT04086472|566556416|FG001|Overall Study|Various reasons|0|||
156945822|NCT04086472|566556417|FG002|Overall Study|Various reasons|0|||
156945823|NCT04086472|566556418|FG003|Overall Study|Various reasons|3|||
156945824|NCT04086472|566556419|FG004|Overall Study|Various reasons|1|||
156945825|NCT03348904|566556420|FG000|Overall Study|Administrative reason by the sponsor|0|||
156945826|NCT03348904|566556421|FG001|Overall Study|Administrative reason by the sponsor|1|||
156945827|NCT03348904|566556422|FG002|Overall Study|Administrative reason by the sponsor|0|||
156945828|NCT02252081|566556423|FG000|Overall Study|Withdrawal by Subject|2|||
156945829|NCT02252081|566556424|FG001|Overall Study|Withdrawal by Subject|1|||
156945830|NCT02252081|566556423|FG000|Overall Study|Adverse Event|4|||
156945831|NCT02252081|566556424|FG001|Overall Study|Adverse Event|1|||
156945832|NCT02252081|566556423|FG000|Overall Study|non compliance & others|0|||
156945833|NCT02252081|566556424|FG001|Overall Study|non compliance & others|2|||
156945834|NCT00048724|566556425|FG000|Overall Study|Adverse Event|53|||
156945835|NCT00048724|566556426|FG001|Overall Study|Adverse Event|12|||
156945836|NCT00048724|566556425|FG000|Overall Study|Withdrawal by Subject|34|||
156945837|NCT00048724|566556426|FG001|Overall Study|Withdrawal by Subject|54|||
156945838|NCT00048724|566556425|FG000|Overall Study|Lost to Follow-up|5|||
156945839|NCT00048724|566556426|FG001|Overall Study|Lost to Follow-up|5|||
156945840|NCT00048724|566556425|FG000|Overall Study|Protocol-defined Clinical Event|17|||
156945841|NCT00048724|566556426|FG001|Overall Study|Protocol-defined Clinical Event|32|||
156945842|NCT00048724|566556425|FG000|Overall Study|Noncompliance With Protocol|4|||
156945843|NCT00048724|566556426|FG001|Overall Study|Noncompliance With Protocol|12|||
156945844|NCT00048724|566556425|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
156945845|NCT00048724|566556426|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
156945846|NCT00048724|566556425|FG000|Overall Study|Administrative|1|||
156945847|NCT00048724|566556426|FG001|Overall Study|Administrative|1|||
156945848|NCT01743092|566556427|FG000|Overall Study|Lost to Follow-up|14|||
156945849|NCT01743092|566556428|FG001|Overall Study|Lost to Follow-up|15|||
156945850|NCT00111228|566556430|FG000|Overall Study|Withdrawal by Subject|5|||
156945851|NCT00111228|566556431|FG001|Overall Study|Withdrawal by Subject|1|||
156945852|NCT00111228|566556432|FG002|Overall Study|Withdrawal by Subject|0|||
156945853|NCT01490060|566556435|FG000|Cycle 1|Change of Treatment|0|||
156945854|NCT01490060|566556436|FG001|Cycle 1|Change of Treatment|1|||
156945855|NCT01490060|566556437|FG002|Cycle 1|Change of Treatment|1|||
156945856|NCT01490060|566556438|FG003|Cycle 1|Change of Treatment|1|||
156945857|NCT01490060|566556435|FG000|Cycle 1|Insurance Denied|0|||
156945858|NCT01490060|566556436|FG001|Cycle 1|Insurance Denied|0|||
156945859|NCT01490060|566556437|FG002|Cycle 1|Insurance Denied|2|||
156945860|NCT01490060|566556438|FG003|Cycle 1|Insurance Denied|0|||
156945861|NCT01490060|566556435|FG000|Cycle 1|Withdrawal by Subject|0|||
156945862|NCT01490060|566556436|FG001|Cycle 1|Withdrawal by Subject|0|||
156945863|NCT01490060|566556437|FG002|Cycle 1|Withdrawal by Subject|0|||
156945864|NCT01490060|566556438|FG003|Cycle 1|Withdrawal by Subject|1|||
156945865|NCT01490060|566556435|FG000|Cycle 1|Treatment at Another Facility|0|||
156945866|NCT01490060|566556436|FG001|Cycle 1|Treatment at Another Facility|0|||
156945867|NCT01490060|566556437|FG002|Cycle 1|Treatment at Another Facility|0|||
156945868|NCT01490060|566556438|FG003|Cycle 1|Treatment at Another Facility|1|||
156945869|NCT01490060|566556435|FG000|Cycle 2|Change of Treatment|1|||
156945870|NCT01490060|566556436|FG001|Cycle 2|Change of Treatment|1|||
156945871|NCT01490060|566556437|FG002|Cycle 2|Change of Treatment|0|||
156945872|NCT01490060|566556438|FG003|Cycle 2|Change of Treatment|0|||
156945873|NCT01490060|566556435|FG000|Cycle 2|Non-Compliance|0|||
156945874|NCT01490060|566556436|FG001|Cycle 2|Non-Compliance|0|||
156945875|NCT01490060|566556437|FG002|Cycle 2|Non-Compliance|1|||
156945876|NCT01490060|566556438|FG003|Cycle 2|Non-Compliance|0|||
156945877|NCT01490060|566556435|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
156945878|NCT01490060|566556436|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156945879|NCT01490060|566556437|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156945880|NCT01490060|566556438|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
156945881|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
156945882|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
156945883|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
156945884|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
156945885|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
156945886|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
156945887|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
156945888|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
156945889|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
156945890|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
156945891|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
156945892|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
156945893|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
156945894|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
156945895|NCT02464969|566556439|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
157032961|NCT03582033|566875968|FG003|Part C|Withdrawal by Subject|0|||
156945896|NCT02464969|566556440|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
156945897|NCT02464969|566556439|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
156945898|NCT02464969|566556440|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
156945899|NCT02464969|566556439|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
156945900|NCT02464969|566556440|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
156945901|NCT02464969|566556439|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
156945902|NCT02464969|566556440|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
156945903|NCT03698773|566556444|FG000|Overall Study|Lost to Follow-up|2|||
156945904|NCT03698773|566556445|FG001|Overall Study|Lost to Follow-up|1|||
156945905|NCT02399085|566556446|FG000|Overall Study|Adverse Event|16|||
156945906|NCT02399085|566556446|FG000|Overall Study|Death|2|||
156945907|NCT02399085|566556446|FG000|Overall Study|Withdrawal by Subject|8|||
156945908|NCT02399085|566556446|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
156945909|NCT02399085|566556446|FG000|Overall Study|Physician Decision|5|||
156945910|NCT00699699|566556447|FG000|Overall Study|Adverse Event|36|||
156945911|NCT00699699|566556447|FG000|Overall Study|Individual different reasons|21|||
156945912|NCT00720876|566556448|FG000|Overall Study|found to be ineligible after starting tx|2|||
156945913|NCT03495908|566556449|FG000|Overall Study|Withdrawal by Subject|3|||
156945914|NCT03495908|566556450|FG001|Overall Study|Withdrawal by Subject|1|||
156945915|NCT03495908|566556449|FG000|Overall Study|Lost to Follow-up|1|||
156945916|NCT03495908|566556450|FG001|Overall Study|Lost to Follow-up|4|||
156945917|NCT03495908|566556449|FG000|Overall Study|Adverse Event|0|||
156945918|NCT03495908|566556450|FG001|Overall Study|Adverse Event|2|||
156945919|NCT03495908|566556449|FG000|Overall Study|Death|1|||
156945920|NCT03495908|566556450|FG001|Overall Study|Death|0|||
156945921|NCT03495908|566556449|FG000|Overall Study|Physician Decision|5|||
156945922|NCT03495908|566556450|FG001|Overall Study|Physician Decision|4|||
156945923|NCT03495908|566556449|FG000|Overall Study|No documented reason|0|||
156945924|NCT03495908|566556450|FG001|Overall Study|No documented reason|2|||
156945925|NCT01109316|566556451|FG000|Study Period 1|Adverse Event|0|||
156945926|NCT01109316|566556452|FG001|Study Period 1|Adverse Event|0|||
156945927|NCT01109316|566556453|FG002|Study Period 1|Adverse Event|1|||
156945928|NCT01109316|566556454|FG003|Study Period 1|Adverse Event|0|||
156945929|NCT01109316|566556455|FG004|Study Period 1|Adverse Event|0|||
156945930|NCT01109316|566556456|FG005|Study Period 1|Adverse Event|0|||
156945931|NCT01109316|566556451|FG000|Study Period 1|Lost to Follow-up|0|||
156945932|NCT01109316|566556452|FG001|Study Period 1|Lost to Follow-up|0|||
156945933|NCT01109316|566556453|FG002|Study Period 1|Lost to Follow-up|1|||
156945934|NCT01109316|566556454|FG003|Study Period 1|Lost to Follow-up|1|||
156945935|NCT01109316|566556455|FG004|Study Period 1|Lost to Follow-up|0|||
156945936|NCT01109316|566556456|FG005|Study Period 1|Lost to Follow-up|0|||
156945937|NCT01109316|566556451|FG000|Study Period 1|Withdrawal by Subject|0|||
156945938|NCT01109316|566556452|FG001|Study Period 1|Withdrawal by Subject|0|||
156945939|NCT01109316|566556453|FG002|Study Period 1|Withdrawal by Subject|1|||
156945940|NCT01109316|566556454|FG003|Study Period 1|Withdrawal by Subject|0|||
156945941|NCT01109316|566556455|FG004|Study Period 1|Withdrawal by Subject|2|||
156945942|NCT01109316|566556456|FG005|Study Period 1|Withdrawal by Subject|0|||
156945943|NCT01109316|566556451|FG000|Study Period 1|Sponsor Decision|0|||
156945944|NCT01109316|566556452|FG001|Study Period 1|Sponsor Decision|0|||
156945945|NCT01109316|566556453|FG002|Study Period 1|Sponsor Decision|0|||
156945946|NCT01109316|566556454|FG003|Study Period 1|Sponsor Decision|0|||
156945947|NCT01109316|566556455|FG004|Study Period 1|Sponsor Decision|0|||
156945948|NCT01109316|566556456|FG005|Study Period 1|Sponsor Decision|2|||
156945949|NCT01109316|566556451|FG000|Study Period 2|Entry Criteria Not Met|0|||
156945950|NCT01109316|566556452|FG001|Study Period 2|Entry Criteria Not Met|1|||
156945951|NCT01109316|566556453|FG002|Study Period 2|Entry Criteria Not Met|0|||
156945952|NCT01109316|566556454|FG003|Study Period 2|Entry Criteria Not Met|0|||
156945953|NCT01109316|566556455|FG004|Study Period 2|Entry Criteria Not Met|0|||
157032962|NCT03582033|566875969|FG004|Part C|Withdrawal by Subject|0|||
157032963|NCT03582033|566875970|FG005|Part C|Withdrawal by Subject|0|||
157032964|NCT03582033|566875971|FG006|Part C|Withdrawal by Subject|1|||
156945954|NCT01109316|566556456|FG005|Study Period 2|Entry Criteria Not Met|0|||
156945955|NCT01109316|566556451|FG000|Study Period 2|Physician Decision|0|||
157032965|NCT03582033|566875972|FG007|Part C|Withdrawal by Subject|2|||
157032966|NCT03582033|566875973|FG008|Part C|Withdrawal by Subject|1|||
157167547|NCT01107405|567354608|FG002|Overall Study|Withdrawal by Subject|1|||
157167548|NCT01107405|567354609|FG003|Overall Study|Withdrawal by Subject|2|||
156945956|NCT01109316|566556452|FG001|Study Period 2|Physician Decision|0|||
156945957|NCT01109316|566556453|FG002|Study Period 2|Physician Decision|0|||
156945958|NCT01109316|566556454|FG003|Study Period 2|Physician Decision|1|||
156945959|NCT01109316|566556455|FG004|Study Period 2|Physician Decision|0|||
156945960|NCT01109316|566556456|FG005|Study Period 2|Physician Decision|0|||
156945961|NCT01109316|566556451|FG000|Study Period 2|Protocol Violation|1|||
156945962|NCT01109316|566556452|FG001|Study Period 2|Protocol Violation|0|||
156945963|NCT01109316|566556453|FG002|Study Period 2|Protocol Violation|0|||
156945964|NCT01109316|566556454|FG003|Study Period 2|Protocol Violation|0|||
156945965|NCT01109316|566556455|FG004|Study Period 2|Protocol Violation|0|||
157032967|NCT03582033|566875974|FG009|Part C|Withdrawal by Subject|0|||
157032968|NCT03582033|566875965|FG000|Part D|Death|0|||
157032969|NCT03582033|566875966|FG001|Part D|Death|0|||
157032970|NCT03582033|566875967|FG002|Part D|Death|0|||
157032971|NCT03582033|566875968|FG003|Part D|Death|0|||
157032972|NCT03582033|566875969|FG004|Part D|Death|0|||
157032973|NCT03582033|566875970|FG005|Part D|Death|0|||
157032974|NCT03582033|566875971|FG006|Part D|Death|0|||
157032975|NCT03582033|566875972|FG007|Part D|Death|0|||
157032976|NCT03582033|566875973|FG008|Part D|Death|0|||
157032977|NCT03582033|566875974|FG009|Part D|Death|1|||
157032978|NCT03582033|566875965|FG000|Part D|Study terminated by sponsor|0|||
157032979|NCT03582033|566875966|FG001|Part D|Study terminated by sponsor|0|||
157032980|NCT03582033|566875967|FG002|Part D|Study terminated by sponsor|0|||
157032981|NCT03582033|566875968|FG003|Part D|Study terminated by sponsor|0|||
157032982|NCT03582033|566875969|FG004|Part D|Study terminated by sponsor|0|||
157032983|NCT03582033|566875970|FG005|Part D|Study terminated by sponsor|0|||
157032984|NCT03582033|566875971|FG006|Part D|Study terminated by sponsor|0|||
157032985|NCT03582033|566875972|FG007|Part D|Study terminated by sponsor|0|||
157032986|NCT03582033|566875973|FG008|Part D|Study terminated by sponsor|0|||
157032987|NCT03582033|566875974|FG009|Part D|Study terminated by sponsor|4|||
157032988|NCT05741294|566875978|FG000|Overall Study|Lost to Follow-up|3|||
157032989|NCT05741294|566875978|FG000|Overall Study|Protocol deviation|3|||
157032990|NCT05741294|566875978|FG000|Overall Study|Withdrawal by Subject|1|||
157032991|NCT04707768|566875989|FG000|Overall Study|Adverse Event|9|||
157032992|NCT04707768|566875990|FG001|Overall Study|Adverse Event|18|||
157032993|NCT04707768|566875991|FG002|Overall Study|Adverse Event|3|||
157032994|NCT04707768|566875989|FG000|Overall Study|Investigator's Discretion|8|||
157032995|NCT04707768|566875990|FG001|Overall Study|Investigator's Discretion|4|||
157032996|NCT04707768|566875991|FG002|Overall Study|Investigator's Discretion|3|||
157032997|NCT04707768|566875989|FG000|Overall Study|Withdrawal by Subject|6|||
157032998|NCT04707768|566875990|FG001|Overall Study|Withdrawal by Subject|8|||
157032999|NCT04707768|566875991|FG002|Overall Study|Withdrawal by Subject|2|||
157033000|NCT04707768|566875989|FG000|Overall Study|Lack of Efficacy|1|||
157033001|NCT04707768|566875990|FG001|Overall Study|Lack of Efficacy|3|||
157033002|NCT04707768|566875991|FG002|Overall Study|Lack of Efficacy|0|||
157033003|NCT04707768|566875989|FG000|Overall Study|Lost to Follow-up|0|||
157033004|NCT04707768|566875990|FG001|Overall Study|Lost to Follow-up|0|||
157033005|NCT04707768|566875991|FG002|Overall Study|Lost to Follow-up|3|||
157033006|NCT04707768|566875989|FG000|Overall Study|Death|13|||
157033007|NCT04707768|566875990|FG001|Overall Study|Death|11|||
157033008|NCT04707768|566875991|FG002|Overall Study|Death|13|||
157033009|NCT04707768|566875989|FG000|Overall Study|Protocol Violation|2|||
157033010|NCT04707768|566875990|FG001|Overall Study|Protocol Violation|1|||
157033011|NCT04707768|566875991|FG002|Overall Study|Protocol Violation|0|||
157033012|NCT04707768|566875989|FG000|Overall Study|Non Compliance with Study Drug|1|||
157033013|NCT04707768|566875990|FG001|Overall Study|Non Compliance with Study Drug|0|||
157033014|NCT04707768|566875991|FG002|Overall Study|Non Compliance with Study Drug|0|||
157033015|NCT04707768|566875989|FG000|Overall Study|Transplant|4|||
157033016|NCT04707768|566875990|FG001|Overall Study|Transplant|4|||
157033017|NCT04707768|566875991|FG002|Overall Study|Transplant|8|||
157033018|NCT04707768|566875989|FG000|Overall Study|Other|9|||
157033019|NCT04707768|566875990|FG001|Overall Study|Other|5|||
157033020|NCT04707768|566875991|FG002|Overall Study|Other|2|||
157033021|NCT02518048|566875992|FG000|Overall Study|Withdrawal by Subject|1|||
157033022|NCT05890105|566875993|FG000|Overall Study|Adverse Event|1|||
157033023|NCT05890105|566875994|FG001|Overall Study|Adverse Event|0|||
157033024|NCT05890105|566875995|FG002|Overall Study|Adverse Event|0|||
157033025|NCT05890105|566875993|FG000|Overall Study|Other|1|||
157033026|NCT05890105|566875994|FG001|Overall Study|Other|2|||
157033027|NCT05890105|566875995|FG002|Overall Study|Other|0|||
157033028|NCT04206787|566875996|FG000|Overall Study|Other than listed|2|||
157033029|NCT04206787|566875996|FG000|Overall Study|Investigator decision|1|||
157033030|NCT04206787|566875996|FG000|Overall Study|Death|25|||
157033031|NCT04206787|566875996|FG000|Overall Study|Lost to Follow-up|9|||
157033032|NCT04206787|566875996|FG000|Overall Study|Withdrawal of consent|9|||
157033033|NCT05123027|566876001|FG000|Overall Study|Lost to Follow-up|17|||
157033034|NCT05123027|566876002|FG001|Overall Study|Lost to Follow-up|22|||
157033035|NCT05123027|566876001|FG000|Overall Study|Incarceration|3|||
157033036|NCT05123027|566876002|FG001|Overall Study|Incarceration|4|||
157033037|NCT05123027|566876001|FG000|Overall Study|Death|2|||
157033038|NCT05123027|566876002|FG001|Overall Study|Death|2|||
157033039|NCT05123027|566876001|FG000|Overall Study|Other|2|||
157033040|NCT05123027|566876002|FG001|Overall Study|Other|0|||
157033041|NCT03735979|566876003|FG000|Overall Study|Lost to Follow-up|1|||
157033042|NCT03735979|566876004|FG001|Overall Study|Lost to Follow-up|12|||
157033043|NCT03735979|566876005|FG002|Overall Study|Lost to Follow-up|14|||
157033044|NCT03735979|566876003|FG000|Overall Study|Withdrawal by Subject|1|||
157033045|NCT03735979|566876004|FG001|Overall Study|Withdrawal by Subject|5|||
157033046|NCT03735979|566876005|FG002|Overall Study|Withdrawal by Subject|2|||
157033047|NCT03735979|566876003|FG000|Overall Study|Not due to the above reasons|1|||
157033048|NCT03735979|566876004|FG001|Overall Study|Not due to the above reasons|0|||
156945966|NCT01109316|566556456|FG005|Study Period 2|Protocol Violation|0|||
156945967|NCT01109316|566556451|FG000|Study Period 2|Withdrawal by Subject|0|||
156945968|NCT01109316|566556452|FG001|Study Period 2|Withdrawal by Subject|0|||
156945969|NCT01109316|566556453|FG002|Study Period 2|Withdrawal by Subject|1|||
156945970|NCT01109316|566556454|FG003|Study Period 2|Withdrawal by Subject|0|||
156945971|NCT01109316|566556455|FG004|Study Period 2|Withdrawal by Subject|0|||
156945972|NCT01109316|566556456|FG005|Study Period 2|Withdrawal by Subject|1|||
156945973|NCT01109316|566556451|FG000|Study Period 3|Lost to Follow-up|0|||
156945974|NCT01109316|566556452|FG001|Study Period 3|Lost to Follow-up|0|||
156945975|NCT01109316|566556453|FG002|Study Period 3|Lost to Follow-up|0|||
156945976|NCT01109316|566556454|FG003|Study Period 3|Lost to Follow-up|0|||
156945977|NCT01109316|566556455|FG004|Study Period 3|Lost to Follow-up|1|||
156945978|NCT01109316|566556456|FG005|Study Period 3|Lost to Follow-up|0|||
156945979|NCT01109316|566556451|FG000|Study Period 3|Withdrawal by Subject|1|||
156945980|NCT01109316|566556452|FG001|Study Period 3|Withdrawal by Subject|0|||
156945981|NCT01109316|566556453|FG002|Study Period 3|Withdrawal by Subject|0|||
156945982|NCT01109316|566556454|FG003|Study Period 3|Withdrawal by Subject|0|||
156945983|NCT01109316|566556455|FG004|Study Period 3|Withdrawal by Subject|1|||
156945984|NCT01109316|566556456|FG005|Study Period 3|Withdrawal by Subject|0|||
156945985|NCT01559311|566556463|FG000|Overall Study|Protocol Violation|0|||
156945986|NCT01559311|566556464|FG001|Overall Study|Protocol Violation|0|||
156945987|NCT01559311|566556465|FG002|Overall Study|Protocol Violation|2|||
156945988|NCT01559311|566556463|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
156945989|NCT01559311|566556464|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
156945990|NCT01559311|566556465|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
156945991|NCT01559311|566556463|FG000|Overall Study|Withdrawal by Subject|2|||
156945992|NCT01559311|566556464|FG001|Overall Study|Withdrawal by Subject|1|||
156945993|NCT01559311|566556465|FG002|Overall Study|Withdrawal by Subject|0|||
156945994|NCT01559311|566556463|FG000|Overall Study|Death|0|||
156945995|NCT01559311|566556464|FG001|Overall Study|Death|2|||
156945996|NCT01559311|566556465|FG002|Overall Study|Death|3|||
156945997|NCT01559311|566556463|FG000|Overall Study|Lost to Follow-up|0|||
156945998|NCT01559311|566556464|FG001|Overall Study|Lost to Follow-up|3|||
156945999|NCT01559311|566556465|FG002|Overall Study|Lost to Follow-up|2|||
156946000|NCT01559311|566556463|FG000|Overall Study|Adverse Event|0|||
156946001|NCT01559311|566556464|FG001|Overall Study|Adverse Event|0|||
156946002|NCT01559311|566556465|FG002|Overall Study|Adverse Event|1|||
156946003|NCT01649856|566556466|FG000|Overall Study|Withdrawal by Subject|14|||
156946004|NCT01649856|566556467|FG001|Overall Study|Withdrawal by Subject|14|||
156946005|NCT01649856|566556466|FG000|Overall Study|Protocol Violation|4|||
156946006|NCT01649856|566556467|FG001|Overall Study|Protocol Violation|4|||
156946007|NCT01649856|566556466|FG000|Overall Study|Treatment Failure|1|||
156946008|NCT01649856|566556467|FG001|Overall Study|Treatment Failure|1|||
156946009|NCT01649856|566556466|FG000|Overall Study|Death|69|||
156946010|NCT01649856|566556467|FG001|Overall Study|Death|34|||
156946011|NCT01649856|566556466|FG000|Overall Study|Stable or Progressed Disease|5|||
156946012|NCT01649856|566556467|FG001|Overall Study|Stable or Progressed Disease|3|||
156946013|NCT01649856|566556466|FG000|Overall Study|Lost to Follow-up|20|||
156946014|NCT01649856|566556467|FG001|Overall Study|Lost to Follow-up|16|||
156946015|NCT01649856|566556466|FG000|Overall Study|Lack of Compliance|6|||
156946016|NCT01649856|566556467|FG001|Overall Study|Lack of Compliance|1|||
156946017|NCT01649856|566556466|FG000|Overall Study|Other|20|||
156946018|NCT01649856|566556467|FG001|Overall Study|Other|5|||
156946019|NCT00179647|566556468|FG000|Overall Study|Adverse Event|294|||
156946020|NCT00179647|566556468|FG000|Overall Study|Lack of Efficacy|478|||
156946021|NCT00179647|566556468|FG000|Overall Study|Withdrawal by Subject|83|||
156946022|NCT00179647|566556468|FG000|Overall Study|Lost to Follow-up|4|||
156946023|NCT00179647|566556468|FG000|Overall Study|Death|94|||
156946024|NCT00179647|566556468|FG000|Overall Study|Other|960|||
156946025|NCT05013905|566556469|FG000|Overall Study|Adverse Event|1|||
156946026|NCT05013905|566556469|FG000|Overall Study|Lack of Efficacy|1|||
156946027|NCT01849588|566556471|FG000|Overall Study|Lack of Efficacy|3|||
156946028|NCT02550652|566556479|FG000|Overall Study|Death|1|||
156946029|NCT02550652|566556480|FG001|Overall Study|Death|4|||
156946030|NCT02550652|566556479|FG000|Overall Study|Lack of Efficacy|1|||
156946031|NCT02550652|566556480|FG001|Overall Study|Lack of Efficacy|0|||
156946032|NCT02550652|566556479|FG000|Overall Study|Withdrawal by Subject|4|||
156946033|NCT02550652|566556480|FG001|Overall Study|Withdrawal by Subject|7|||
156946034|NCT02550652|566556479|FG000|Overall Study|Post Trial Access|1|||
156946035|NCT02550652|566556480|FG001|Overall Study|Post Trial Access|0|||
156946036|NCT02550652|566556479|FG000|Overall Study|Lost to Follow-up|1|||
156946037|NCT02550652|566556480|FG001|Overall Study|Lost to Follow-up|3|||
156946038|NCT02550652|566556479|FG000|Overall Study|Physician Decision|0|||
156946039|NCT02550652|566556480|FG001|Overall Study|Physician Decision|2|||
156946040|NCT02550652|566556479|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
156946041|NCT02550652|566556480|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
156946042|NCT03027466|566556481|FG000|Overall Study|Opting out of the app|1869|||
156946043|NCT03027466|566556482|FG001|Overall Study|Opting out of the app|1819|||
156946044|NCT03027466|566556483|FG002|Overall Study|Opting out of the app|1743|||
156946045|NCT03027466|566556484|FG003|Overall Study|Opting out of the app|1821|||
156946046|NCT01706250|566556485|FG000|Overall Study|Lost to Follow-up|2|||
156946047|NCT03286140|566556486|FG000|Overall Study|Withdrawal by Subject|10|||
156946048|NCT03286140|566556487|FG001|Overall Study|Withdrawal by Subject|5|||
156946049|NCT03286140|566556486|FG000|Overall Study|Lost to Follow-up|5|||
156946050|NCT03286140|566556487|FG001|Overall Study|Lost to Follow-up|10|||
156946051|NCT03286140|566556486|FG000|Overall Study|Failure to comply|0|||
156946052|NCT03286140|566556487|FG001|Overall Study|Failure to comply|1|||
156946053|NCT01826825|566556488|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
156946054|NCT01826825|566556489|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
156946055|NCT02158039|566556490|FG000|Overall Study|Withdrawal by Subject|1|||
156946056|NCT02158039|566556490|FG000|Overall Study|Screen Failure|9|||
156946057|NCT00515827|566556491|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
156946058|NCT00515827|566556492|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
156946059|NCT00515827|566556491|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
156946060|NCT00515827|566556492|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
156946061|NCT03254134|566556495|FG000|Overall Study|Not eligible patients|599|||
156946062|NCT03254134|566556496|FG001|Overall Study|Not eligible patients|3630|||
156946063|NCT02563028|566556497|FG000|Overall Study|Lack of equipment|1|||
156946064|NCT02563028|566556497|FG000|Overall Study|Unable to elicit VEP post induction|1|||
156946065|NCT01712984|566556502|FG000|Overall Study|Adverse Event|0|||
156946066|NCT01712984|566556503|FG001|Overall Study|Adverse Event|0|||
156946067|NCT01712984|566556504|FG002|Overall Study|Adverse Event|1|||
156946068|NCT01712984|566556502|FG000|Overall Study|Protocol Violation|2|||
156946069|NCT01712984|566556503|FG001|Overall Study|Protocol Violation|0|||
156946070|NCT01712984|566556504|FG002|Overall Study|Protocol Violation|1|||
156946071|NCT01712984|566556502|FG000|Overall Study|Lost to Follow-up|8|||
156946072|NCT01712984|566556503|FG001|Overall Study|Lost to Follow-up|10|||
156946073|NCT01712984|566556504|FG002|Overall Study|Lost to Follow-up|1|||
156946074|NCT01712984|566556502|FG000|Overall Study|Withdrawal by Subject|6|||
156946075|NCT01712984|566556503|FG001|Overall Study|Withdrawal by Subject|6|||
156946076|NCT01712984|566556504|FG002|Overall Study|Withdrawal by Subject|7|||
156946077|NCT01552772|566556505|FG000|Overall Study|Lost to Follow-up|2|||
156946078|NCT01552772|566556505|FG000|Overall Study|Adverse Event|1|||
156946079|NCT01552772|566556505|FG000|Overall Study|Protocol Deviation|1|||
156946080|NCT01848990|566556506|FG000|Overall Study|Adverse Event|6|||
156946081|NCT01848990|566556507|FG001|Overall Study|Adverse Event|2|||
156946082|NCT01848990|566556508|FG002|Overall Study|Adverse Event|0|||
156946083|NCT01848990|566556506|FG000|Overall Study|Lost to Follow-up|6|||
156946084|NCT01848990|566556507|FG001|Overall Study|Lost to Follow-up|2|||
156946085|NCT01848990|566556508|FG002|Overall Study|Lost to Follow-up|2|||
156946086|NCT01848990|566556506|FG000|Overall Study|Protocol Violation|1|||
156946087|NCT01848990|566556507|FG001|Overall Study|Protocol Violation|1|||
156946088|NCT01848990|566556508|FG002|Overall Study|Protocol Violation|0|||
156946089|NCT01848990|566556506|FG000|Overall Study|Withdrawal by Subject|29|||
156946090|NCT01848990|566556507|FG001|Overall Study|Withdrawal by Subject|10|||
156946091|NCT01848990|566556508|FG002|Overall Study|Withdrawal by Subject|11|||
156946092|NCT01848990|566556506|FG000|Overall Study|Physician Decision|1|||
156946093|NCT01848990|566556507|FG001|Overall Study|Physician Decision|1|||
156946094|NCT01848990|566556508|FG002|Overall Study|Physician Decision|0|||
156946095|NCT01848990|566556506|FG000|Overall Study|Non Compliance|1|||
156946096|NCT01848990|566556507|FG001|Overall Study|Non Compliance|0|||
156946097|NCT01848990|566556508|FG002|Overall Study|Non Compliance|0|||
156946098|NCT01848990|566556506|FG000|Overall Study|Death|1|||
156946099|NCT01848990|566556507|FG001|Overall Study|Death|0|||
156946100|NCT01848990|566556508|FG002|Overall Study|Death|1|||
156946101|NCT01848990|566556506|FG000|Overall Study|Other|1|||
156946102|NCT01848990|566556507|FG001|Overall Study|Other|4|||
156946103|NCT01848990|566556508|FG002|Overall Study|Other|2|||
156946104|NCT00298038|566556509|FG000|Overall Study|Lost to Follow-up|0|||
156946105|NCT00298038|566556510|FG001|Overall Study|Lost to Follow-up|1|||
156946106|NCT00298038|566556509|FG000|Overall Study|Liver Transplant|0|||
156946107|NCT00298038|566556510|FG001|Overall Study|Liver Transplant|1|||
156946108|NCT00298038|566556509|FG000|Overall Study|Protocol Violation|1|||
156946109|NCT00298038|566556510|FG001|Overall Study|Protocol Violation|3|||
156946110|NCT00298038|566556509|FG000|Overall Study|Death|6|||
156946111|NCT00298038|566556510|FG001|Overall Study|Death|3|||
156946112|NCT00298038|566556509|FG000|Overall Study|Withdrawal by Subject|6|||
156946113|NCT00298038|566556510|FG001|Overall Study|Withdrawal by Subject|9|||
156946114|NCT00298038|566556509|FG000|Overall Study|Adverse Event|8|||
156946115|NCT00298038|566556510|FG001|Overall Study|Adverse Event|7|||
156946116|NCT00298038|566556509|FG000|Overall Study|Breakthrough overt HE episode|28|||
156946117|NCT00298038|566556510|FG001|Overall Study|Breakthrough overt HE episode|69|||
156946118|NCT00298038|566556509|FG000|Overall Study|Noncompliance|1|||
156946119|NCT00298038|566556510|FG001|Overall Study|Noncompliance|0|||
156946120|NCT00298038|566556509|FG000|Overall Study|Cocaine Abuse|1|||
157205216|NCT03669640|567496076|FG003|Overall Study|Lost to Follow-up|0|||
156946121|NCT00298038|566556510|FG001|Overall Study|Cocaine Abuse|0|||
156946122|NCT00298038|566556509|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
156946123|NCT00298038|566556510|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
156946124|NCT02696096|566556511|FG000|Overall Study|ruled out at screening|1|||
156946125|NCT02696096|566556511|FG000|Overall Study|did not attend second fMRI|1|||
156946126|NCT01940705|566556515|FG000|Overall Study|Lost to Follow-up|1|||
156946127|NCT01940705|566556516|FG001|Overall Study|Lost to Follow-up|3|||
156946128|NCT01940705|566556517|FG002|Overall Study|Lost to Follow-up|2|||
156946129|NCT01940705|566556518|FG003|Overall Study|Lost to Follow-up|2|||
156946130|NCT01940705|566556515|FG000|Overall Study|Withdrawal by Subject|2|||
156946131|NCT01940705|566556516|FG001|Overall Study|Withdrawal by Subject|2|||
156946132|NCT01940705|566556517|FG002|Overall Study|Withdrawal by Subject|3|||
156946133|NCT01940705|566556518|FG003|Overall Study|Withdrawal by Subject|2|||
156946134|NCT01940705|566556515|FG000|Overall Study|Intervention not given|0|||
156946135|NCT01940705|566556516|FG001|Overall Study|Intervention not given|3|||
156946136|NCT01940705|566556517|FG002|Overall Study|Intervention not given|3|||
156946137|NCT01940705|566556518|FG003|Overall Study|Intervention not given|0|||
156946138|NCT01940705|566556515|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
156946139|NCT01940705|566556516|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
156946140|NCT01940705|566556517|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
156946141|NCT01940705|566556518|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
156946142|NCT02447991|566556519|FG000|Overall Study|Withdrawn by subject - no data|0|||
156946143|NCT02447991|566556520|FG001|Overall Study|Withdrawn by subject - no data|2|||
156946144|NCT02447991|566556519|FG000|Overall Study|Withdrawn by Subject - with data|4|||
156946145|NCT02447991|566556520|FG001|Overall Study|Withdrawn by Subject - with data|4|||
156946146|NCT02447991|566556519|FG000|Overall Study|Lost to Follow-up - no data|3|||
156946147|NCT02447991|566556520|FG001|Overall Study|Lost to Follow-up - no data|6|||
156946148|NCT02447991|566556519|FG000|Overall Study|Lost to follow-up - with data|0|||
156946149|NCT02447991|566556520|FG001|Overall Study|Lost to follow-up - with data|3|||
156946150|NCT02447991|566556519|FG000|Overall Study|End of study - no treatment results|3|||
156946151|NCT02447991|566556520|FG001|Overall Study|End of study - no treatment results|6|||
156946152|NCT02447991|566556519|FG000|Overall Study|End of study - partial treatment results|0|||
156946153|NCT02447991|566556520|FG001|Overall Study|End of study - partial treatment results|9|||
156946154|NCT00829621|566556521|FG000|Overall Study|Death|1|||
156946155|NCT00829621|566556522|FG001|Overall Study|Death|0|||
156946156|NCT00829621|566556521|FG000|Overall Study|Lost to Follow-up|3|||
156946157|NCT00829621|566556522|FG001|Overall Study|Lost to Follow-up|4|||
156946158|NCT02770391|566556525|FG000|Overall Study|Lost to Follow-up|2|||
156946159|NCT02770391|566556525|FG000|Overall Study|Withdrawal by Subject|1|||
156946160|NCT02770391|566556525|FG000|Overall Study|Surgery delayed unevaluable|2|||
156946161|NCT02770391|566556525|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
156946162|NCT01976845|566556528|FG000|Overall Study|Physician Decision|8|||
156946163|NCT01976845|566556529|FG001|Overall Study|Physician Decision|8|||
156946164|NCT01976845|566556530|FG002|Overall Study|Physician Decision|3|||
156946165|NCT03551210|566556533|FG000|Overall Study|Adverse Event|5|||
156946166|NCT03551210|566556534|FG001|Overall Study|Adverse Event|6|||
156946167|NCT03551210|566556533|FG000|Overall Study|Withdrawal by Subject|1|||
156946168|NCT03551210|566556534|FG001|Overall Study|Withdrawal by Subject|7|||
156946169|NCT03551210|566556533|FG000|Overall Study|Needed in other antibiotic treatment|2|||
156946170|NCT03551210|566556534|FG001|Overall Study|Needed in other antibiotic treatment|5|||
156946171|NCT03551210|566556533|FG000|Overall Study|Lost to Follow-up|1|||
156946172|NCT03551210|566556534|FG001|Overall Study|Lost to Follow-up|1|||
157167549|NCT01107405|567354610|FG004|Overall Study|Withdrawal by Subject|1|||
157167550|NCT01107405|567354606|FG000|Overall Study|Protocol Violation|0|||
157167551|NCT01107405|567354607|FG001|Overall Study|Protocol Violation|0|||
157167552|NCT01107405|567354608|FG002|Overall Study|Protocol Violation|1|||
157167553|NCT01107405|567354609|FG003|Overall Study|Protocol Violation|1|||
157167554|NCT01107405|567354610|FG004|Overall Study|Protocol Violation|0|||
157167555|NCT01895452|567354614|FG000|Overall Study|Adverse Event|1|||
157167556|NCT01895452|567354615|FG001|Overall Study|Adverse Event|4|||
157167557|NCT01895452|567354614|FG000|Overall Study|Lost to Follow-up|1|||
157167558|NCT01895452|567354615|FG001|Overall Study|Lost to Follow-up|5|||
157167559|NCT01895452|567354614|FG000|Overall Study|Pregnancy|0|||
157167560|NCT01895452|567354615|FG001|Overall Study|Pregnancy|1|||
156946173|NCT03551210|566556533|FG000|Overall Study|Absence of visit 4 and 5|1|||
156946174|NCT03551210|566556534|FG001|Overall Study|Absence of visit 4 and 5|0|||
156946175|NCT03551210|566556533|FG000|Overall Study|No drug for dispensing|0|||
156946176|NCT03551210|566556534|FG001|Overall Study|No drug for dispensing|1|||
156946177|NCT03265119|566556535|FG000|Overall Study|Adverse Event|2|||
156946178|NCT03265119|566556536|FG001|Overall Study|Adverse Event|1|||
156946179|NCT03265119|566556535|FG000|Overall Study|Lack of Efficacy|3|||
156946180|NCT03265119|566556536|FG001|Overall Study|Lack of Efficacy|0|||
156946181|NCT03265119|566556535|FG000|Overall Study|Protocol Violation|1|||
156946182|NCT03265119|566556536|FG001|Overall Study|Protocol Violation|2|||
156946183|NCT03265119|566556535|FG000|Overall Study|Withdrawal by Subject|2|||
157167561|NCT01895452|567354614|FG000|Overall Study|Withdrawal by Subject|2|||
157227333|NCT00950807|567577783|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227334|NCT00950807|567577784|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227335|NCT00950807|567577785|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227336|NCT00950807|567577786|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227337|NCT00950807|567577787|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227338|NCT00950807|567577788|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227339|NCT00950807|567577789|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227340|NCT00950807|567577790|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
157227341|NCT00950807|567577781|FG000|Treatment Period 2|Adverse Event|0|||
157227342|NCT00950807|567577782|FG001|Treatment Period 2|Adverse Event|1|||
157227343|NCT00950807|567577783|FG002|Treatment Period 2|Adverse Event|0|||
157227344|NCT00950807|567577784|FG003|Treatment Period 2|Adverse Event|1|||
157227345|NCT00950807|567577785|FG004|Treatment Period 2|Adverse Event|0|||
157227346|NCT00950807|567577786|FG005|Treatment Period 2|Adverse Event|1|||
157227347|NCT00950807|567577787|FG006|Treatment Period 2|Adverse Event|0|||
157227348|NCT00950807|567577788|FG007|Treatment Period 2|Adverse Event|1|||
156946184|NCT03265119|566556536|FG001|Overall Study|Withdrawal by Subject|4|||
156946185|NCT03265119|566556535|FG000|Overall Study|Lost to Follow-up|1|||
156946186|NCT03265119|566556536|FG001|Overall Study|Lost to Follow-up|0|||
156946187|NCT03265119|566556535|FG000|Overall Study|Lack of Compliance|1|||
156946188|NCT03265119|566556536|FG001|Overall Study|Lack of Compliance|0|||
156946189|NCT03042312|566558547|FG000|Overall Study|Administrative Reason|1|||
156946190|NCT03042312|566558548|FG001|Overall Study|Administrative Reason|1|||
156946191|NCT03042312|566558547|FG000|Overall Study|Adverse Event|0|||
156946192|NCT03042312|566558548|FG001|Overall Study|Adverse Event|1|||
156946193|NCT03042312|566558547|FG000|Overall Study|Lost to Follow-up|1|||
156946194|NCT03042312|566558548|FG001|Overall Study|Lost to Follow-up|3|||
156946195|NCT03042312|566558547|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
156946196|NCT03042312|566558548|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
156946197|NCT03042312|566558547|FG000|Overall Study|Withdrawal by Subject|4|||
156946198|NCT03042312|566558548|FG001|Overall Study|Withdrawal by Subject|5|||
156946199|NCT04258839|566558551|FG000|Overall Study|Adverse Event|2|||
156946200|NCT04258839|566558552|FG001|Overall Study|Adverse Event|4|||
156946201|NCT04258839|566558551|FG000|Overall Study|Lack of Efficacy|0|||
156946202|NCT04258839|566558552|FG001|Overall Study|Lack of Efficacy|2|||
156946203|NCT04258839|566558551|FG000|Overall Study|Lost to Follow-up|2|||
156946204|NCT04258839|566558552|FG001|Overall Study|Lost to Follow-up|0|||
156946205|NCT04258839|566558551|FG000|Overall Study|Withdrawal by Subject|1|||
156946206|NCT04258839|566558552|FG001|Overall Study|Withdrawal by Subject|2|||
156946207|NCT04258839|566558551|FG000|Overall Study|Withdrawal by Caregiver|5|||
156946208|NCT04258839|566558552|FG001|Overall Study|Withdrawal by Caregiver|6|||
156946209|NCT04258839|566558551|FG000|Overall Study|Reason not Specified|0|||
156946210|NCT04258839|566558552|FG001|Overall Study|Reason not Specified|1|||
156946211|NCT03328897|566558553|FG000|Randomized-treatment Epoch|Adverse Event|4|||
156946212|NCT03328897|566558554|FG001|Randomized-treatment Epoch|Adverse Event|1|||
156946213|NCT03328897|566558555|FG002|Randomized-treatment Epoch|Adverse Event|1|||
156946214|NCT03328897|566558553|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
156946215|NCT03328897|566558554|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
156946216|NCT03328897|566558555|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
156946217|NCT03328897|566558553|FG000|Randomized-treatment Epoch|Pregnancy|3|||
156946218|NCT03328897|566558554|FG001|Randomized-treatment Epoch|Pregnancy|0|||
156946219|NCT03328897|566558555|FG002|Randomized-treatment Epoch|Pregnancy|0|||
156946220|NCT03328897|566558553|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
156946221|NCT03328897|566558554|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
156946222|NCT03328897|566558555|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
156946223|NCT03328897|566558553|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
156946224|NCT03328897|566558554|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
156946225|NCT03328897|566558555|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
156946226|NCT03328897|566558553|FG000|Follow-up Epoch|Adverse Event|4|||
156946227|NCT03328897|566558554|FG001|Follow-up Epoch|Adverse Event|0|||
156946228|NCT03328897|566558555|FG002|Follow-up Epoch|Adverse Event|1|||
156946229|NCT03328897|566558553|FG000|Follow-up Epoch|Lack of Efficacy|1|||
156946230|NCT03328897|566558554|FG001|Follow-up Epoch|Lack of Efficacy|1|||
156946231|NCT03328897|566558555|FG002|Follow-up Epoch|Lack of Efficacy|1|||
156946232|NCT03328897|566558553|FG000|Follow-up Epoch|Lost to Follow-up|0|||
156946233|NCT03328897|566558554|FG001|Follow-up Epoch|Lost to Follow-up|1|||
156946234|NCT03328897|566558555|FG002|Follow-up Epoch|Lost to Follow-up|0|||
156946235|NCT03328897|566558553|FG000|Follow-up Epoch|Pregnancy|1|||
156946236|NCT03328897|566558554|FG001|Follow-up Epoch|Pregnancy|0|||
156946237|NCT03328897|566558555|FG002|Follow-up Epoch|Pregnancy|0|||
156946238|NCT03328897|566558553|FG000|Follow-up Epoch|Patient/guardian decision|2|||
157227349|NCT00950807|567577789|FG008|Treatment Period 2|Adverse Event|0|||
156946239|NCT03328897|566558554|FG001|Follow-up Epoch|Patient/guardian decision|1|||
156946240|NCT03328897|566558555|FG002|Follow-up Epoch|Patient/guardian decision|0|||
156946241|NCT02648698|566558559|FG000|Overall Study|Protocol Violation|1|||
156946242|NCT02648698|566558560|FG001|Overall Study|Protocol Violation|5|||
156946243|NCT00317772|566558563|FG000|Overall Study|Adverse Event|0|||
156946244|NCT00317772|566558564|FG001|Overall Study|Adverse Event|0|||
156946245|NCT00317772|566558565|FG002|Overall Study|Adverse Event|0|||
156946246|NCT00317772|566558566|FG003|Overall Study|Adverse Event|2|||
156946247|NCT00317772|566558563|FG000|Overall Study|Disease Progression|2|||
156946248|NCT00317772|566558564|FG001|Overall Study|Disease Progression|2|||
156946249|NCT00317772|566558565|FG002|Overall Study|Disease Progression|1|||
156946250|NCT00317772|566558566|FG003|Overall Study|Disease Progression|7|||
156946251|NCT00966940|566558567|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
156946252|NCT00966940|566558568|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
156946253|NCT00966940|566558567|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
156946254|NCT00966940|566558568|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
156946255|NCT01040871|566558571|FG000|Overall Study|Adverse Event|6|||
156946256|NCT01040871|566558572|FG001|Overall Study|Adverse Event|2|||
156946257|NCT01040871|566558571|FG000|Overall Study|Withdrawal by Subject|2|||
156946258|NCT01040871|566558572|FG001|Overall Study|Withdrawal by Subject|0|||
156946259|NCT01040871|566558571|FG000|Overall Study|Death|1|||
156946260|NCT01040871|566558572|FG001|Overall Study|Death|3|||
156946261|NCT01040871|566558571|FG000|Overall Study|Lack of Efficacy|1|||
156946262|NCT01040871|566558572|FG001|Overall Study|Lack of Efficacy|1|||
156946263|NCT01040871|566558571|FG000|Overall Study|drug supply issue|1|||
156946264|NCT01040871|566558572|FG001|Overall Study|drug supply issue|0|||
156946265|NCT01040871|566558571|FG000|Overall Study|Randomized and Not Treated|2|||
156946266|NCT01040871|566558572|FG001|Overall Study|Randomized and Not Treated|1|||
156946267|NCT02886572|566558573|FG000|Overall Study|Death|8|||
156946268|NCT00938431|566558575|FG000|Overall Study|Adverse Event|5|||
156946269|NCT00938431|566558576|FG001|Overall Study|Adverse Event|8|||
156946270|NCT00938431|566558577|FG002|Overall Study|Adverse Event|6|||
156946271|NCT00938431|566558575|FG000|Overall Study|Lack of Efficacy|0|||
156946272|NCT00938431|566558576|FG001|Overall Study|Lack of Efficacy|1|||
156946273|NCT00938431|566558577|FG002|Overall Study|Lack of Efficacy|0|||
156946274|NCT00938431|566558575|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
156946275|NCT00938431|566558576|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
156946276|NCT00938431|566558577|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
156946277|NCT00938431|566558575|FG000|Overall Study|Dosing compliance issue|0|||
156946278|NCT00938431|566558576|FG001|Overall Study|Dosing compliance issue|0|||
156946279|NCT00938431|566558577|FG002|Overall Study|Dosing compliance issue|1|||
156946280|NCT00938431|566558575|FG000|Overall Study|Reached maximum dose early|0|||
156946281|NCT00938431|566558576|FG001|Overall Study|Reached maximum dose early|0|||
156946282|NCT00938431|566558577|FG002|Overall Study|Reached maximum dose early|1|||
156946283|NCT03738865|566558582|FG000|Overall Study|Withdrawal by Subject|3|||
156946284|NCT03738865|566558583|FG001|Overall Study|Withdrawal by Subject|3|||
156946285|NCT03738865|566558582|FG000|Overall Study|Adverse Event|2|||
156946286|NCT03738865|566558583|FG001|Overall Study|Adverse Event|0|||
156946287|NCT03738865|566558582|FG000|Overall Study|Physician Decision|0|||
156946288|NCT03738865|566558583|FG001|Overall Study|Physician Decision|1|||
156946289|NCT01774903|566558584|FG000|Overall Study|Adverse Event|7|||
156946290|NCT01774903|566558584|FG000|Overall Study|Withdrawal by Subject|2|||
156946291|NCT01774903|566558584|FG000|Overall Study|Lack of Efficacy|1|||
156946292|NCT01774903|566558584|FG000|Overall Study|Ineligible to continue the trial|1|||
156946293|NCT01602315|566558585|FG000|Overall Study|Protocol Violation|0|||
156946294|NCT01602315|566558586|FG001|Overall Study|Protocol Violation|0|||
156946295|NCT01602315|566558587|FG002|Overall Study|Protocol Violation|0|||
156946296|NCT01602315|566558588|FG003|Overall Study|Protocol Violation|0|||
156946297|NCT01602315|566558589|FG004|Overall Study|Protocol Violation|0|||
156946298|NCT01602315|566558590|FG005|Overall Study|Protocol Violation|1|||
156946299|NCT01602315|566558591|FG006|Overall Study|Protocol Violation|0|||
156946300|NCT01602315|566558585|FG000|Overall Study|Physician Decision|2|||
156946301|NCT01602315|566558586|FG001|Overall Study|Physician Decision|0|||
156946302|NCT01602315|566558587|FG002|Overall Study|Physician Decision|0|||
156946303|NCT01602315|566558588|FG003|Overall Study|Physician Decision|0|||
157033049|NCT03735979|566876005|FG002|Overall Study|Not due to the above reasons|0|||
157033050|NCT04761198|566876006|FG000|Overall Study|Progressive Disease|1|||
156946304|NCT01602315|566558589|FG004|Overall Study|Physician Decision|2|||
156946305|NCT01602315|566558590|FG005|Overall Study|Physician Decision|1|||
156946306|NCT01602315|566558591|FG006|Overall Study|Physician Decision|1|||
156946307|NCT01602315|566558585|FG000|Overall Study|Disease progression|6|||
156946308|NCT01602315|566558586|FG001|Overall Study|Disease progression|3|||
156946309|NCT01602315|566558587|FG002|Overall Study|Disease progression|10|||
156946310|NCT01602315|566558588|FG003|Overall Study|Disease progression|1|||
156946311|NCT01602315|566558589|FG004|Overall Study|Disease progression|41|||
156946312|NCT01602315|566558590|FG005|Overall Study|Disease progression|12|||
156946313|NCT01602315|566558591|FG006|Overall Study|Disease progression|15|||
156946314|NCT01602315|566558585|FG000|Overall Study|Death|1|||
156946315|NCT01602315|566558586|FG001|Overall Study|Death|1|||
156946316|NCT01602315|566558587|FG002|Overall Study|Death|1|||
156946317|NCT01602315|566558588|FG003|Overall Study|Death|1|||
156946318|NCT01602315|566558589|FG004|Overall Study|Death|7|||
157033051|NCT04761198|566876007|FG001|Overall Study|Progressive Disease|0|||
157033052|NCT04761198|566876008|FG002|Overall Study|Progressive Disease|0|||
157033053|NCT04761198|566876009|FG003|Overall Study|Progressive Disease|1|||
157033054|NCT04761198|566876010|FG004|Overall Study|Progressive Disease|4|||
157033055|NCT04761198|566876011|FG005|Overall Study|Progressive Disease|1|||
157033056|NCT04761198|566876012|FG006|Overall Study|Progressive Disease|2|||
157033057|NCT04761198|566876006|FG000|Overall Study|Protocol Violation|0|||
157033058|NCT04761198|566876007|FG001|Overall Study|Protocol Violation|0|||
157033059|NCT04761198|566876008|FG002|Overall Study|Protocol Violation|0|||
157033060|NCT04761198|566876009|FG003|Overall Study|Protocol Violation|0|||
157033061|NCT04761198|566876010|FG004|Overall Study|Protocol Violation|1|||
157033062|NCT04761198|566876011|FG005|Overall Study|Protocol Violation|0|||
157033063|NCT04761198|566876012|FG006|Overall Study|Protocol Violation|0|||
157033064|NCT04761198|566876006|FG000|Overall Study|Death|2|||
157033065|NCT04761198|566876007|FG001|Overall Study|Death|1|||
157033066|NCT04761198|566876008|FG002|Overall Study|Death|2|||
157033067|NCT04761198|566876009|FG003|Overall Study|Death|5|||
157033068|NCT04761198|566876010|FG004|Overall Study|Death|14|||
157033069|NCT04761198|566876011|FG005|Overall Study|Death|2|||
157033070|NCT04761198|566876012|FG006|Overall Study|Death|5|||
157033071|NCT04761198|566876006|FG000|Overall Study|Lost to Follow-up|0|||
157033072|NCT04761198|566876007|FG001|Overall Study|Lost to Follow-up|0|||
157033073|NCT04761198|566876008|FG002|Overall Study|Lost to Follow-up|0|||
157033074|NCT04761198|566876009|FG003|Overall Study|Lost to Follow-up|0|||
157033075|NCT04761198|566876010|FG004|Overall Study|Lost to Follow-up|1|||
157033076|NCT04761198|566876011|FG005|Overall Study|Lost to Follow-up|0|||
157033077|NCT04761198|566876012|FG006|Overall Study|Lost to Follow-up|0|||
157033078|NCT04761198|566876006|FG000|Overall Study|Withdrawal by Subject|2|||
157033079|NCT04761198|566876007|FG001|Overall Study|Withdrawal by Subject|0|||
157033080|NCT04761198|566876008|FG002|Overall Study|Withdrawal by Subject|1|||
157033081|NCT04761198|566876009|FG003|Overall Study|Withdrawal by Subject|0|||
157033082|NCT04761198|566876010|FG004|Overall Study|Withdrawal by Subject|2|||
157033083|NCT04761198|566876011|FG005|Overall Study|Withdrawal by Subject|0|||
157033084|NCT04761198|566876012|FG006|Overall Study|Withdrawal by Subject|1|||
157033085|NCT04761198|566876006|FG000|Overall Study|Study Terminated by Sponsor|6|||
157033086|NCT04761198|566876007|FG001|Overall Study|Study Terminated by Sponsor|0|||
157033087|NCT04761198|566876008|FG002|Overall Study|Study Terminated by Sponsor|5|||
157033088|NCT04761198|566876009|FG003|Overall Study|Study Terminated by Sponsor|3|||
157033089|NCT04761198|566876010|FG004|Overall Study|Study Terminated by Sponsor|10|||
157033090|NCT04761198|566876011|FG005|Overall Study|Study Terminated by Sponsor|1|||
157033091|NCT04761198|566876012|FG006|Overall Study|Study Terminated by Sponsor|2|||
157033092|NCT05525104|566876013|FG000|Overall Study|Failed caudal analgesia|1|||
157033093|NCT05525104|566876014|FG001|Overall Study|Failed caudal analgesia|3|||
157033094|NCT05525104|566876013|FG000|Overall Study|Premedication needed|0|||
157033095|NCT05525104|566876014|FG001|Overall Study|Premedication needed|1|||
157033096|NCT05525104|566876013|FG000|Overall Study|Protocol Violation|10|||
157033097|NCT05525104|566876014|FG001|Overall Study|Protocol Violation|0|||
157033098|NCT05525104|566876013|FG000|Overall Study|Cancelled operation|1|||
157033099|NCT05525104|566876014|FG001|Overall Study|Cancelled operation|0|||
157033100|NCT02039401|566876015|FG000|Overall Study|Adverse Event|0|||
157033101|NCT02039401|566876016|FG001|Overall Study|Adverse Event|1|||
157033102|NCT04108130|566877404|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
157033103|NCT04108130|566877405|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
157033104|NCT04108130|566877404|FG000|Overall Study|Consent Withdrawn|9|||
157033105|NCT04108130|566877405|FG001|Overall Study|Consent Withdrawn|6|||
157033106|NCT04108130|566877404|FG000|Overall Study|Surgery Cancelled|4|||
157033107|NCT04108130|566877405|FG001|Overall Study|Surgery Cancelled|4|||
157033108|NCT04108130|566877404|FG000|Overall Study|Found Ineligible for Study|4|||
156946319|NCT01602315|566558590|FG005|Overall Study|Death|2|||
156946320|NCT01602315|566558591|FG006|Overall Study|Death|2|||
156946321|NCT01602315|566558585|FG000|Overall Study|Withdrawal by Subject|2|||
156946322|NCT01602315|566558586|FG001|Overall Study|Withdrawal by Subject|0|||
156946323|NCT01602315|566558587|FG002|Overall Study|Withdrawal by Subject|2|||
156946324|NCT01602315|566558588|FG003|Overall Study|Withdrawal by Subject|0|||
156946325|NCT01602315|566558589|FG004|Overall Study|Withdrawal by Subject|6|||
156946326|NCT01602315|566558590|FG005|Overall Study|Withdrawal by Subject|0|||
156946327|NCT01602315|566558591|FG006|Overall Study|Withdrawal by Subject|1|||
157033109|NCT04108130|566877405|FG001|Overall Study|Found Ineligible for Study|3|||
157033110|NCT04108130|566877404|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
157033111|NCT04108130|566877405|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
157033112|NCT04108130|566877404|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
157033113|NCT04108130|566877405|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
157033114|NCT04427007|566877408|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
157033115|NCT04427007|566877409|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
157167562|NCT01895452|567354615|FG001|Overall Study|Withdrawal by Subject|14|||
157033116|NCT01130883|566877410|FG000|Overall Study|Patient Noncompliance|6|||
156946328|NCT01602315|566558585|FG000|Overall Study|Adverse Event|5|||
156946329|NCT01602315|566558586|FG001|Overall Study|Adverse Event|1|||
156946330|NCT01602315|566558587|FG002|Overall Study|Adverse Event|5|||
156946331|NCT01602315|566558588|FG003|Overall Study|Adverse Event|4|||
156946332|NCT01602315|566558589|FG004|Overall Study|Adverse Event|15|||
156946333|NCT01602315|566558590|FG005|Overall Study|Adverse Event|3|||
156946334|NCT01602315|566558591|FG006|Overall Study|Adverse Event|9|||
156946335|NCT01602315|566558585|FG000|Overall Study|Subject/guardian decision|0|||
156946336|NCT01602315|566558586|FG001|Overall Study|Subject/guardian decision|0|||
156946337|NCT01602315|566558587|FG002|Overall Study|Subject/guardian decision|0|||
156946338|NCT01602315|566558588|FG003|Overall Study|Subject/guardian decision|0|||
156946339|NCT01602315|566558589|FG004|Overall Study|Subject/guardian decision|0|||
156946340|NCT01602315|566558590|FG005|Overall Study|Subject/guardian decision|0|||
156946341|NCT01602315|566558591|FG006|Overall Study|Subject/guardian decision|1|||
156946342|NCT01602315|566558585|FG000|Overall Study|Cross-over patients to combo treatment|0|||
156946343|NCT01602315|566558586|FG001|Overall Study|Cross-over patients to combo treatment|0|||
156946344|NCT01602315|566558587|FG002|Overall Study|Cross-over patients to combo treatment|0|||
156946345|NCT01602315|566558588|FG003|Overall Study|Cross-over patients to combo treatment|0|||
156946346|NCT01602315|566558589|FG004|Overall Study|Cross-over patients to combo treatment|0|||
156946347|NCT01602315|566558590|FG005|Overall Study|Cross-over patients to combo treatment|16|||
156946348|NCT01602315|566558591|FG006|Overall Study|Cross-over patients to combo treatment|0|||
156946349|NCT00961259|566558594|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
156946350|NCT00961259|566558595|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
156946351|NCT00961259|566558596|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
156946352|NCT01252251|566558597|FG000|Overall Study|Withdrawal by Subject|1|||
156946353|NCT01858194|566558603|FG000|Overall Study|Total Artificial Heart Implant|0|||
156946354|NCT01858194|566558604|FG001|Overall Study|Total Artificial Heart Implant|1|||
156946355|NCT01858194|566558603|FG000|Overall Study|Lost to Follow-up|0|||
156946356|NCT01858194|566558604|FG001|Overall Study|Lost to Follow-up|1|||
156946357|NCT00205712|566558616|FG000|Overall Study|Lost to Follow-up|0|||
156946358|NCT00205712|566558617|FG001|Overall Study|Lost to Follow-up|1|||
156946359|NCT01009099|566558618|FG000|Overall Study|Lost to Follow-up|1|||
156946360|NCT01009099|566558619|FG001|Overall Study|Lost to Follow-up|0|||
156946361|NCT01009099|566558618|FG000|Overall Study|Physician Decision|3|||
156946362|NCT01009099|566558619|FG001|Overall Study|Physician Decision|2|||
156946363|NCT01009099|566558618|FG000|Overall Study|Withdrawal by Subject|1|||
156946364|NCT01009099|566558619|FG001|Overall Study|Withdrawal by Subject|1|||
156946365|NCT01009099|566558618|FG000|Overall Study|Death|0|||
156946366|NCT01009099|566558619|FG001|Overall Study|Death|1|||
156946367|NCT01856543|566558620|FG000|Overall Study|Treatment discontinued|6|||
156946368|NCT01856543|566558621|FG001|Overall Study|Treatment discontinued|3|||
156946369|NCT01856543|566558620|FG000|Overall Study|Withdrawn before start|7|||
156946370|NCT01856543|566558621|FG001|Overall Study|Withdrawn before start|3|||
156946371|NCT02188485|566558622|FG000|Overall Study|Withdrawal by Subject|2|||
156946372|NCT02188485|566558623|FG001|Overall Study|Withdrawal by Subject|1|||
156946373|NCT02188485|566558622|FG000|Overall Study|PI withdrew, lack of capacity|0|||
156946374|NCT02188485|566558623|FG001|Overall Study|PI withdrew, lack of capacity|2|||
156946375|NCT00799617|566558624|FG000|Main Testosterone Trial|Randomized in error|1|||
156946376|NCT00799617|566558625|FG001|Main Testosterone Trial|Randomized in error|1|||
156946377|NCT00799617|566558624|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
156946378|NCT00799617|566558625|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
156946379|NCT00799617|566558624|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
156946380|NCT00799617|566558625|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
156946381|NCT00799617|566558624|FG000|Sexual Funtion Trial|No Baseline Data|4|||
156946382|NCT00799617|566558625|FG001|Sexual Funtion Trial|No Baseline Data|7|||
156946383|NCT00799617|566558624|FG000|Physical Function Trial|Lost to Follow-up|6|||
156946384|NCT00799617|566558625|FG001|Physical Function Trial|Lost to Follow-up|11|||
156946385|NCT00799617|566558624|FG000|Vitality Trial|Lost to Follow-up|7|||
156946386|NCT00799617|566558625|FG001|Vitality Trial|Lost to Follow-up|22|||
156946387|NCT00799617|566558624|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
156946388|NCT00799617|566558625|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
156946389|NCT00799617|566558624|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
156946390|NCT00799617|566558625|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
156946391|NCT00799617|566558624|FG000|Bone Trial|Month 12 scan not available|6|||
156946392|NCT00799617|566558625|FG001|Bone Trial|Month 12 scan not available|16|||
156946393|NCT00799617|566558624|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
156946394|NCT00799617|566558625|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
156946395|NCT00799617|566558624|FG000|Anemia Trial|Withdrawal by Subject|3|||
156946396|NCT00799617|566558625|FG001|Anemia Trial|Withdrawal by Subject|3|||
156946397|NCT04545515|566558626|FG000|Overall Study|Adverse Event|1|||
156946398|NCT04545515|566558626|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
156946399|NCT04545515|566558626|FG000|Overall Study|Commercial drug is available for participant|7|||
156946400|NCT00096044|566558629|FG000|Overall Study|Withdrawal by Subject|9|||
156946401|NCT00096044|566558629|FG000|Overall Study|Adverse Event|21|||
156946402|NCT00096044|566558629|FG000|Overall Study|Disease Progression|4|||
156946403|NCT03149237|566558630|FG000|Overall Study|Withdrawal by Subject|4|||
156946404|NCT03149237|566558631|FG001|Overall Study|Withdrawal by Subject|5|||
156946405|NCT02442830|566558632|FG000|Overall Study|Technical Failure|0|||
156946406|NCT02442830|566558633|FG001|Overall Study|Technical Failure|1|||
156946407|NCT04587193|566558634|FG000|Overall Study|Screen failure after consent|3|||
156946408|NCT04587193|566558635|FG001|Overall Study|Screen failure after consent|0|||
156946409|NCT04587193|566558634|FG000|Overall Study|Device broke during study|3|||
156946410|NCT04587193|566558635|FG001|Overall Study|Device broke during study|2|||
156946411|NCT02052466|566558636|FG000|Overall Study|Withdrawal by Subject|1|||
156946412|NCT02052466|566558636|FG000|Overall Study|Acromial fracture|1|||
156946413|NCT00508742|566558637|FG000|Period 1: Infant Series|Adverse Event|5|||
156946414|NCT00508742|566558638|FG001|Period 1: Infant Series|Adverse Event|4|||
156946415|NCT00508742|566558637|FG000|Period 1: Infant Series|Protocol Violation|1|||
156946416|NCT00508742|566558638|FG001|Period 1: Infant Series|Protocol Violation|0|||
156946417|NCT00508742|566558637|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
156946418|NCT00508742|566558638|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
156946419|NCT00508742|566558637|FG000|Period 1: Infant Series|Physician Decision|1|||
156946420|NCT00508742|566558638|FG001|Period 1: Infant Series|Physician Decision|0|||
156946421|NCT00508742|566558637|FG000|Period 1: Infant Series|Other|4|||
156946422|NCT00508742|566558638|FG001|Period 1: Infant Series|Other|1|||
156946423|NCT00508742|566558637|FG000|Period 2: After Infant Series|Adverse Event|2|||
156946424|NCT00508742|566558638|FG001|Period 2: After Infant Series|Adverse Event|6|||
156946425|NCT00508742|566558637|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
156946426|NCT00508742|566558638|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
156946427|NCT00508742|566558637|FG000|Period 2: After Infant Series|Protocol Violation|1|||
156946428|NCT00508742|566558638|FG001|Period 2: After Infant Series|Protocol Violation|0|||
156946429|NCT00508742|566558637|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
156946430|NCT00508742|566558638|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
156946431|NCT00508742|566558637|FG000|Period 2: After Infant Series|Failed to Return|1|||
156946432|NCT00508742|566558638|FG001|Period 2: After Infant Series|Failed to Return|0|||
156946433|NCT00508742|566558637|FG000|Period 2: After Infant Series|Other|2|||
156946434|NCT00508742|566558638|FG001|Period 2: After Infant Series|Other|1|||
156946435|NCT00508742|566558637|FG000|Period 3: Toddler Dose|Adverse Event|1|||
156946436|NCT00508742|566558638|FG001|Period 3: Toddler Dose|Adverse Event|0|||
156946437|NCT00508742|566558637|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
156946438|NCT00508742|566558638|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
156946439|NCT00508742|566558637|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
156946440|NCT00508742|566558638|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
156946441|NCT00508742|566558637|FG000|Period 3: Toddler Dose|Other|5|||
156946442|NCT00508742|566558638|FG001|Period 3: Toddler Dose|Other|4|||
156946443|NCT02501096|566558639|FG000|Overall Study|Lost to Follow-up|0|||
156946444|NCT02501096|566558640|FG001|Overall Study|Lost to Follow-up|0|||
156946445|NCT02501096|566558641|FG002|Overall Study|Lost to Follow-up|0|||
156946446|NCT02501096|566558642|FG003|Overall Study|Lost to Follow-up|0|||
156946447|NCT02501096|566558643|FG004|Overall Study|Lost to Follow-up|1|||
156946448|NCT02501096|566558644|FG005|Overall Study|Lost to Follow-up|1|||
156946449|NCT02501096|566558645|FG006|Overall Study|Lost to Follow-up|3|||
156946450|NCT02501096|566558646|FG007|Overall Study|Lost to Follow-up|0|||
156946451|NCT02501096|566558647|FG008|Overall Study|Lost to Follow-up|0|||
156946452|NCT02501096|566558639|FG000|Overall Study|Withdrawal by Subject|1|||
156946453|NCT02501096|566558640|FG001|Overall Study|Withdrawal by Subject|0|||
156946454|NCT02501096|566558641|FG002|Overall Study|Withdrawal by Subject|7|||
156946455|NCT02501096|566558642|FG003|Overall Study|Withdrawal by Subject|13|||
156946456|NCT02501096|566558643|FG004|Overall Study|Withdrawal by Subject|2|||
156946457|NCT02501096|566558644|FG005|Overall Study|Withdrawal by Subject|2|||
156946458|NCT02501096|566558645|FG006|Overall Study|Withdrawal by Subject|2|||
156946459|NCT02501096|566558646|FG007|Overall Study|Withdrawal by Subject|3|||
156946460|NCT02501096|566558647|FG008|Overall Study|Withdrawal by Subject|0|||
156946461|NCT02501096|566558639|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
156946462|NCT02501096|566558640|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
156946463|NCT02501096|566558641|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
156946464|NCT02501096|566558642|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
156946465|NCT02501096|566558643|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
156946466|NCT02501096|566558644|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
156946467|NCT02501096|566558645|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
156946468|NCT02501096|566558646|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
156946469|NCT02501096|566558647|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
156946470|NCT02501096|566558639|FG000|Overall Study|Death|1|||
156946471|NCT02501096|566558640|FG001|Overall Study|Death|1|||
157227350|NCT00950807|567577790|FG009|Treatment Period 2|Adverse Event|0|||
156946472|NCT02501096|566558641|FG002|Overall Study|Death|88|||
156946473|NCT02501096|566558642|FG003|Overall Study|Death|74|||
156946474|NCT02501096|566558643|FG004|Overall Study|Death|15|||
156946475|NCT02501096|566558644|FG005|Overall Study|Death|16|||
156946476|NCT02501096|566558645|FG006|Overall Study|Death|15|||
156946477|NCT02501096|566558646|FG007|Overall Study|Death|16|||
156946478|NCT02501096|566558647|FG008|Overall Study|Death|1|||
156946479|NCT00437034|566558648|FG000|Overall Study|Adverse Event|1|||
156946480|NCT00437034|566558648|FG000|Overall Study|Disease progression during treatment|5|||
156946481|NCT00595582|566558651|FG000|Overall Study|Pilot study that PI terminated|2|||
156946482|NCT00595582|566558651|FG000|Overall Study|Lost to Follow-up|1|||
156946483|NCT00595582|566558651|FG000|Overall Study|Adverse Event|2|||
156946484|NCT00595582|566558651|FG000|Overall Study|Physician Decision|5|||
156946485|NCT03878134|566558652|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
156946486|NCT03851016|566558653|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
156946487|NCT03851016|566558654|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
156946488|NCT02460224|566558655|FG000|Overall Study|Adverse Event|0|||
156946489|NCT02460224|566558656|FG001|Overall Study|Adverse Event|0|||
156946490|NCT02460224|566558657|FG002|Overall Study|Adverse Event|0|||
156946491|NCT02460224|566558658|FG003|Overall Study|Adverse Event|0|||
156946492|NCT02460224|566558659|FG004|Overall Study|Adverse Event|0|||
156946493|NCT02460224|566558660|FG005|Overall Study|Adverse Event|0|||
156946494|NCT02460224|566558661|FG006|Overall Study|Adverse Event|1|||
156946495|NCT02460224|566558662|FG007|Overall Study|Adverse Event|0|||
156946496|NCT02460224|566558663|FG008|Overall Study|Adverse Event|0|||
156946497|NCT02460224|566558664|FG009|Overall Study|Adverse Event|0|||
156946498|NCT02460224|566558665|FG010|Overall Study|Adverse Event|0|||
156946499|NCT02460224|566558666|FG011|Overall Study|Adverse Event|0|||
156946500|NCT02460224|566558667|FG012|Overall Study|Adverse Event|1|||
156946501|NCT02460224|566558668|FG013|Overall Study|Adverse Event|0|||
156946502|NCT02460224|566558669|FG014|Overall Study|Adverse Event|0|||
156946503|NCT02460224|566558670|FG015|Overall Study|Adverse Event|0|||
156946504|NCT02460224|566558671|FG016|Overall Study|Adverse Event|1|||
156946505|NCT02460224|566558672|FG017|Overall Study|Adverse Event|0|||
156946506|NCT02460224|566558673|FG018|Overall Study|Adverse Event|1|||
156946507|NCT02460224|566558674|FG019|Overall Study|Adverse Event|0|||
156946508|NCT02460224|566558675|FG020|Overall Study|Adverse Event|1|||
156946509|NCT02460224|566558676|FG021|Overall Study|Adverse Event|1|||
156946510|NCT02460224|566558677|FG022|Overall Study|Adverse Event|1|||
156946511|NCT02460224|566558678|FG023|Overall Study|Adverse Event|0|||
156946512|NCT02460224|566558679|FG024|Overall Study|Adverse Event|0|||
156946513|NCT02460224|566558680|FG025|Overall Study|Adverse Event|0|||
156946514|NCT02460224|566558681|FG026|Overall Study|Adverse Event|11|||
156946515|NCT02460224|566558682|FG027|Overall Study|Adverse Event|1|||
156946516|NCT02460224|566558683|FG028|Overall Study|Adverse Event|6|||
156946517|NCT02460224|566558655|FG000|Overall Study|Death|0|||
156946518|NCT02460224|566558656|FG001|Overall Study|Death|0|||
156946519|NCT02460224|566558657|FG002|Overall Study|Death|0|||
156946520|NCT02460224|566558658|FG003|Overall Study|Death|0|||
156946521|NCT02460224|566558659|FG004|Overall Study|Death|0|||
156946522|NCT02460224|566558660|FG005|Overall Study|Death|2|||
156946523|NCT02460224|566558661|FG006|Overall Study|Death|1|||
156946524|NCT02460224|566558662|FG007|Overall Study|Death|0|||
156946525|NCT02460224|566558663|FG008|Overall Study|Death|0|||
156946526|NCT02460224|566558664|FG009|Overall Study|Death|1|||
156946527|NCT02460224|566558665|FG010|Overall Study|Death|0|||
156946528|NCT02460224|566558666|FG011|Overall Study|Death|0|||
156946529|NCT02460224|566558667|FG012|Overall Study|Death|0|||
156946530|NCT02460224|566558668|FG013|Overall Study|Death|1|||
156946531|NCT02460224|566558669|FG014|Overall Study|Death|0|||
156946532|NCT02460224|566558670|FG015|Overall Study|Death|0|||
156946533|NCT02460224|566558671|FG016|Overall Study|Death|2|||
156946534|NCT02460224|566558672|FG017|Overall Study|Death|1|||
156946535|NCT02460224|566558673|FG018|Overall Study|Death|0|||
156946536|NCT02460224|566558674|FG019|Overall Study|Death|2|||
156946537|NCT02460224|566558675|FG020|Overall Study|Death|0|||
156946538|NCT02460224|566558676|FG021|Overall Study|Death|0|||
156946539|NCT02460224|566558677|FG022|Overall Study|Death|0|||
156946540|NCT02460224|566558678|FG023|Overall Study|Death|0|||
156946541|NCT02460224|566558679|FG024|Overall Study|Death|1|||
156946542|NCT02460224|566558680|FG025|Overall Study|Death|1|||
157167563|NCT01895452|567354614|FG000|Overall Study|Underlying disease|0|||
156946543|NCT02460224|566558681|FG026|Overall Study|Death|5|||
156946544|NCT02460224|566558682|FG027|Overall Study|Death|0|||
156946545|NCT02460224|566558683|FG028|Overall Study|Death|1|||
157167564|NCT01895452|567354615|FG001|Overall Study|Underlying disease|3|||
156946546|NCT02460224|566558655|FG000|Overall Study|Lost to Follow-up|0|||
156946547|NCT02460224|566558656|FG001|Overall Study|Lost to Follow-up|0|||
156946548|NCT02460224|566558657|FG002|Overall Study|Lost to Follow-up|0|||
156946549|NCT02460224|566558658|FG003|Overall Study|Lost to Follow-up|0|||
156946550|NCT02460224|566558659|FG004|Overall Study|Lost to Follow-up|0|||
156946551|NCT02460224|566558660|FG005|Overall Study|Lost to Follow-up|0|||
156946552|NCT02460224|566558661|FG006|Overall Study|Lost to Follow-up|0|||
156946553|NCT02460224|566558662|FG007|Overall Study|Lost to Follow-up|0|||
156946554|NCT02460224|566558663|FG008|Overall Study|Lost to Follow-up|0|||
156946555|NCT02460224|566558664|FG009|Overall Study|Lost to Follow-up|0|||
156946556|NCT02460224|566558665|FG010|Overall Study|Lost to Follow-up|0|||
156946557|NCT02460224|566558666|FG011|Overall Study|Lost to Follow-up|0|||
156946558|NCT02460224|566558667|FG012|Overall Study|Lost to Follow-up|0|||
156946559|NCT02460224|566558668|FG013|Overall Study|Lost to Follow-up|0|||
156946560|NCT02460224|566558669|FG014|Overall Study|Lost to Follow-up|0|||
156946561|NCT02460224|566558670|FG015|Overall Study|Lost to Follow-up|0|||
156946562|NCT02460224|566558671|FG016|Overall Study|Lost to Follow-up|0|||
156946563|NCT02460224|566558672|FG017|Overall Study|Lost to Follow-up|0|||
156946564|NCT02460224|566558673|FG018|Overall Study|Lost to Follow-up|0|||
156946565|NCT02460224|566558674|FG019|Overall Study|Lost to Follow-up|0|||
156946566|NCT02460224|566558675|FG020|Overall Study|Lost to Follow-up|0|||
156946567|NCT02460224|566558676|FG021|Overall Study|Lost to Follow-up|0|||
156946568|NCT02460224|566558677|FG022|Overall Study|Lost to Follow-up|1|||
156946569|NCT02460224|566558678|FG023|Overall Study|Lost to Follow-up|0|||
156946570|NCT02460224|566558679|FG024|Overall Study|Lost to Follow-up|0|||
156946571|NCT02460224|566558680|FG025|Overall Study|Lost to Follow-up|0|||
156946572|NCT02460224|566558681|FG026|Overall Study|Lost to Follow-up|0|||
156946573|NCT02460224|566558682|FG027|Overall Study|Lost to Follow-up|0|||
156946574|NCT02460224|566558683|FG028|Overall Study|Lost to Follow-up|0|||
156946575|NCT02460224|566558655|FG000|Overall Study|Physician Decision|0|||
156946576|NCT02460224|566558656|FG001|Overall Study|Physician Decision|1|||
156946577|NCT02460224|566558657|FG002|Overall Study|Physician Decision|0|||
156946578|NCT02460224|566558658|FG003|Overall Study|Physician Decision|0|||
156946579|NCT02460224|566558659|FG004|Overall Study|Physician Decision|1|||
156946580|NCT02460224|566558660|FG005|Overall Study|Physician Decision|0|||
156946581|NCT02460224|566558661|FG006|Overall Study|Physician Decision|0|||
156946582|NCT02460224|566558662|FG007|Overall Study|Physician Decision|1|||
156946583|NCT02460224|566558663|FG008|Overall Study|Physician Decision|0|||
156946584|NCT02460224|566558664|FG009|Overall Study|Physician Decision|0|||
156946585|NCT02460224|566558665|FG010|Overall Study|Physician Decision|0|||
156946586|NCT02460224|566558666|FG011|Overall Study|Physician Decision|1|||
156946587|NCT02460224|566558667|FG012|Overall Study|Physician Decision|0|||
156946588|NCT02460224|566558668|FG013|Overall Study|Physician Decision|1|||
156946589|NCT02460224|566558669|FG014|Overall Study|Physician Decision|0|||
156946590|NCT02460224|566558670|FG015|Overall Study|Physician Decision|0|||
156946591|NCT02460224|566558671|FG016|Overall Study|Physician Decision|2|||
156946592|NCT02460224|566558672|FG017|Overall Study|Physician Decision|1|||
156946593|NCT02460224|566558673|FG018|Overall Study|Physician Decision|1|||
156946594|NCT02460224|566558674|FG019|Overall Study|Physician Decision|2|||
156946595|NCT02460224|566558675|FG020|Overall Study|Physician Decision|1|||
156946596|NCT02460224|566558676|FG021|Overall Study|Physician Decision|1|||
156946597|NCT02460224|566558677|FG022|Overall Study|Physician Decision|0|||
156946598|NCT02460224|566558678|FG023|Overall Study|Physician Decision|0|||
156946599|NCT02460224|566558679|FG024|Overall Study|Physician Decision|1|||
156946600|NCT02460224|566558680|FG025|Overall Study|Physician Decision|0|||
156946601|NCT02460224|566558681|FG026|Overall Study|Physician Decision|14|||
156946602|NCT02460224|566558682|FG027|Overall Study|Physician Decision|1|||
156946603|NCT02460224|566558683|FG028|Overall Study|Physician Decision|6|||
156946604|NCT02460224|566558655|FG000|Overall Study|Progressive disease|15|||
156946605|NCT02460224|566558656|FG001|Overall Study|Progressive disease|11|||
156946606|NCT02460224|566558657|FG002|Overall Study|Progressive disease|5|||
156946607|NCT02460224|566558658|FG003|Overall Study|Progressive disease|6|||
156946608|NCT02460224|566558659|FG004|Overall Study|Progressive disease|3|||
156946609|NCT02460224|566558660|FG005|Overall Study|Progressive disease|26|||
156946610|NCT02460224|566558661|FG006|Overall Study|Progressive disease|28|||
156946611|NCT02460224|566558662|FG007|Overall Study|Progressive disease|4|||
156946612|NCT02460224|566558663|FG008|Overall Study|Progressive disease|5|||
156946613|NCT02460224|566558664|FG009|Overall Study|Progressive disease|9|||
156946614|NCT02460224|566558665|FG010|Overall Study|Progressive disease|5|||
156946615|NCT02460224|566558666|FG011|Overall Study|Progressive disease|4|||
157167565|NCT01895452|567354614|FG000|Overall Study|Noncompliance with study drug|0|||
156946616|NCT02460224|566558667|FG012|Overall Study|Progressive disease|5|||
156946617|NCT02460224|566558668|FG013|Overall Study|Progressive disease|4|||
156946618|NCT02460224|566558669|FG014|Overall Study|Progressive disease|5|||
156946619|NCT02460224|566558670|FG015|Overall Study|Progressive disease|5|||
156946620|NCT02460224|566558671|FG016|Overall Study|Progressive disease|15|||
156946621|NCT02460224|566558672|FG017|Overall Study|Progressive disease|3|||
156946622|NCT02460224|566558673|FG018|Overall Study|Progressive disease|8|||
156946623|NCT02460224|566558674|FG019|Overall Study|Progressive disease|3|||
156946624|NCT02460224|566558675|FG020|Overall Study|Progressive disease|4|||
156946625|NCT02460224|566558676|FG021|Overall Study|Progressive disease|9|||
156946626|NCT02460224|566558677|FG022|Overall Study|Progressive disease|4|||
156946627|NCT02460224|566558678|FG023|Overall Study|Progressive disease|11|||
156946628|NCT02460224|566558679|FG024|Overall Study|Progressive disease|4|||
156946629|NCT02460224|566558680|FG025|Overall Study|Progressive disease|5|||
156946630|NCT02460224|566558681|FG026|Overall Study|Progressive disease|85|||
156946631|NCT02460224|566558682|FG027|Overall Study|Progressive disease|17|||
156946632|NCT02460224|566558683|FG028|Overall Study|Progressive disease|77|||
156946633|NCT02460224|566558655|FG000|Overall Study|Subject/guardian decision|2|||
156946634|NCT02460224|566558656|FG001|Overall Study|Subject/guardian decision|0|||
156946635|NCT02460224|566558657|FG002|Overall Study|Subject/guardian decision|1|||
156946636|NCT02460224|566558658|FG003|Overall Study|Subject/guardian decision|0|||
156946637|NCT02460224|566558659|FG004|Overall Study|Subject/guardian decision|2|||
156946638|NCT02460224|566558660|FG005|Overall Study|Subject/guardian decision|2|||
156946639|NCT02460224|566558661|FG006|Overall Study|Subject/guardian decision|0|||
156946640|NCT02460224|566558662|FG007|Overall Study|Subject/guardian decision|0|||
156946641|NCT02460224|566558663|FG008|Overall Study|Subject/guardian decision|1|||
156946642|NCT02460224|566558664|FG009|Overall Study|Subject/guardian decision|1|||
156946643|NCT02460224|566558665|FG010|Overall Study|Subject/guardian decision|0|||
156946644|NCT02460224|566558666|FG011|Overall Study|Subject/guardian decision|1|||
156946645|NCT02460224|566558667|FG012|Overall Study|Subject/guardian decision|0|||
156946646|NCT02460224|566558668|FG013|Overall Study|Subject/guardian decision|0|||
156946647|NCT02460224|566558669|FG014|Overall Study|Subject/guardian decision|0|||
156946648|NCT02460224|566558670|FG015|Overall Study|Subject/guardian decision|1|||
156946649|NCT02460224|566558671|FG016|Overall Study|Subject/guardian decision|0|||
156946650|NCT02460224|566558672|FG017|Overall Study|Subject/guardian decision|1|||
156946651|NCT02460224|566558673|FG018|Overall Study|Subject/guardian decision|2|||
156946652|NCT02460224|566558674|FG019|Overall Study|Subject/guardian decision|0|||
156946653|NCT02460224|566558675|FG020|Overall Study|Subject/guardian decision|0|||
156946654|NCT02460224|566558676|FG021|Overall Study|Subject/guardian decision|1|||
156946655|NCT02460224|566558677|FG022|Overall Study|Subject/guardian decision|0|||
156946656|NCT02460224|566558678|FG023|Overall Study|Subject/guardian decision|0|||
156946657|NCT02460224|566558679|FG024|Overall Study|Subject/guardian decision|0|||
156946658|NCT02460224|566558680|FG025|Overall Study|Subject/guardian decision|0|||
156946659|NCT02460224|566558681|FG026|Overall Study|Subject/guardian decision|6|||
156946660|NCT02460224|566558682|FG027|Overall Study|Subject/guardian decision|2|||
156946661|NCT02460224|566558683|FG028|Overall Study|Subject/guardian decision|3|||
156946662|NCT00853658|566558684|FG000|Overall Study|Death|713|||
156946663|NCT00853658|566558685|FG001|Overall Study|Death|768|||
156946664|NCT00853658|566558686|FG002|Overall Study|Death|753|||
156946665|NCT00853658|566558684|FG000|Overall Study|Lost to Follow-up|11|||
156946666|NCT00853658|566558685|FG001|Overall Study|Lost to Follow-up|6|||
156946667|NCT00853658|566558686|FG002|Overall Study|Lost to Follow-up|11|||
156946668|NCT00853658|566558684|FG000|Overall Study|H.A. Request|26|||
156946669|NCT00853658|566558685|FG001|Overall Study|H.A. Request|23|||
156946670|NCT00853658|566558686|FG002|Overall Study|H.A. Request|19|||
156946671|NCT00853658|566558684|FG000|Overall Study|IRB request|0|||
156946672|NCT00853658|566558685|FG001|Overall Study|IRB request|0|||
156946673|NCT00853658|566558686|FG002|Overall Study|IRB request|2|||
156946674|NCT00853658|566558684|FG000|Overall Study|Vital Status known (alive) at study end|2|||
156946675|NCT00853658|566558685|FG001|Overall Study|Vital Status known (alive) at study end|3|||
156946676|NCT00853658|566558686|FG002|Overall Study|Vital Status known (alive) at study end|3|||
156946677|NCT00853658|566558684|FG000|Overall Study|Vital Status unknown at study end|1|||
156946678|NCT00853658|566558685|FG001|Overall Study|Vital Status unknown at study end|1|||
156946679|NCT00853658|566558686|FG002|Overall Study|Vital Status unknown at study end|0|||
156946680|NCT00853658|566558684|FG000|Overall Study|Vital Status at study end N/A|8|||
156946681|NCT00853658|566558685|FG001|Overall Study|Vital Status at study end N/A|10|||
156946682|NCT00853658|566558686|FG002|Overall Study|Vital Status at study end N/A|10|||
156946683|NCT00853658|566558684|FG000|Overall Study|Patient's request|21|||
156946684|NCT00853658|566558685|FG001|Overall Study|Patient's request|17|||
156946685|NCT00853658|566558686|FG002|Overall Study|Patient's request|11|||
156946686|NCT00853658|566558684|FG000|Overall Study|Missing study completion information|5|||
156946687|NCT00853658|566558685|FG001|Overall Study|Missing study completion information|4|||
156946688|NCT00853658|566558686|FG002|Overall Study|Missing study completion information|6|||
156946689|NCT00586469|566558687|FG000|Overall Study|Adverse Event|0|||
156946690|NCT00586469|566558688|FG001|Overall Study|Adverse Event|1|||
156946691|NCT02797262|566558689|FG000|Overall Study|Withdrawal by Subject|5|||
156946692|NCT02797262|566558690|FG001|Overall Study|Withdrawal by Subject|1|||
156946693|NCT02797262|566558689|FG000|Overall Study|Lost to Follow-up|10|||
156946694|NCT02797262|566558690|FG001|Overall Study|Lost to Follow-up|7|||
156946695|NCT02797262|566558689|FG000|Overall Study|Death|1|||
156946696|NCT02797262|566558690|FG001|Overall Study|Death|2|||
156946697|NCT02797262|566558689|FG000|Overall Study|Adverse Event|1|||
156946698|NCT02797262|566558690|FG001|Overall Study|Adverse Event|0|||
156946699|NCT02797262|566558689|FG000|Overall Study|COVID-19|2|||
156946700|NCT02797262|566558690|FG001|Overall Study|COVID-19|1|||
156946701|NCT02797262|566558689|FG000|Overall Study|Out-of-country|1|||
157227351|NCT00950807|567577781|FG000|Washout Period 2|Lack of Efficacy|1|||
156946702|NCT02797262|566558690|FG001|Overall Study|Out-of-country|0|||
156946703|NCT01600586|566558691|FG000|Overall Study|Physician Decision|3|||
156946704|NCT01600586|566558692|FG001|Overall Study|Physician Decision|3|||
156946705|NCT01227512|566558694|FG000|Overall Study|Physician Decision|6|||
156946706|NCT01227512|566558695|FG001|Overall Study|Physician Decision|6|||
156946707|NCT01227512|566558694|FG000|Overall Study|Adverse Event|4|||
156946708|NCT01227512|566558695|FG001|Overall Study|Adverse Event|3|||
156946709|NCT01227512|566558694|FG000|Overall Study|Withdrawal by Subject|3|||
156946710|NCT01227512|566558695|FG001|Overall Study|Withdrawal by Subject|0|||
156946711|NCT01227512|566558694|FG000|Overall Study|Participant met withdrawal criteria|0|||
156946712|NCT01227512|566558695|FG001|Overall Study|Participant met withdrawal criteria|1|||
157167566|NCT01895452|567354615|FG001|Overall Study|Noncompliance with study drug|1|||
156946713|NCT01978184|566558696|FG000|Overall Study|Progressive disease|5|||
156946714|NCT01978184|566558697|FG001|Overall Study|Progressive disease|5|||
156946715|NCT01978184|566558696|FG000|Overall Study|Other than PDA|2|||
156946716|NCT01978184|566558697|FG001|Overall Study|Other than PDA|2|||
156946717|NCT01978184|566558696|FG000|Overall Study|Physician Decision|0|||
156946718|NCT01978184|566558697|FG001|Overall Study|Physician Decision|3|||
156946719|NCT01978184|566558696|FG000|Overall Study|Noncompliance|1|||
156946720|NCT01978184|566558697|FG001|Overall Study|Noncompliance|2|||
156946721|NCT01978184|566558696|FG000|Overall Study|Death|1|||
156946722|NCT01978184|566558697|FG001|Overall Study|Death|0|||
156946723|NCT01978184|566558696|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
156946724|NCT01978184|566558697|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
156946725|NCT04055116|566558705|FG000|First Intervention|Physician Decision|2|||
156946726|NCT04055116|566558706|FG001|First Intervention|Physician Decision|7|||
156946727|NCT02774681|566558707|FG000|Treatment on Study|Progressive Disease|7|||
156946728|NCT02774681|566558707|FG000|Follow-Up for 3 Years|Death|11|||
156946729|NCT02774681|566558707|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
156946730|NCT01069289|566558708|FG000|Overall Study|Withdrawal by Subject|15|||
156946731|NCT01069289|566558709|FG001|Overall Study|Withdrawal by Subject|26|||
156946732|NCT01069289|566558708|FG000|Overall Study|Adverse Event|21|||
156946733|NCT01069289|566558709|FG001|Overall Study|Adverse Event|28|||
156946734|NCT01069289|566558708|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156946735|NCT01069289|566558709|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156946736|NCT01069289|566558708|FG000|Overall Study|Severe non-compliance to protocol|3|||
156946737|NCT01069289|566558709|FG001|Overall Study|Severe non-compliance to protocol|2|||
156946738|NCT01069289|566558708|FG000|Overall Study|Due to deteriorating health condition|1|||
156946739|NCT01069289|566558709|FG001|Overall Study|Due to deteriorating health condition|0|||
156946740|NCT00608829|566560180|FG000|Overall Study|Death|6|||
156946741|NCT00608829|566560180|FG000|Overall Study|Withdrawal by Subject|4|||
156946742|NCT00608829|566560180|FG000|Overall Study|Subject refuses to follow up or return.|5|||
156946743|NCT00672477|566560181|FG000|Overall Study|Adverse Event|10|||
156946744|NCT00672477|566560182|FG001|Overall Study|Adverse Event|7|||
156946745|NCT00672477|566560181|FG000|Overall Study|Death|7|||
156946746|NCT00672477|566560182|FG001|Overall Study|Death|11|||
156946747|NCT00672477|566560181|FG000|Overall Study|Physician Decision|2|||
156946748|NCT00672477|566560182|FG001|Overall Study|Physician Decision|0|||
156946749|NCT00672477|566560181|FG000|Overall Study|Protocol Violation|1|||
156946750|NCT00672477|566560182|FG001|Overall Study|Protocol Violation|1|||
156946751|NCT00672477|566560181|FG000|Overall Study|Withdrawal by Subject|5|||
156946752|NCT00672477|566560182|FG001|Overall Study|Withdrawal by Subject|3|||
156946753|NCT00672477|566560181|FG000|Overall Study|Lack of Efficacy|1|||
156946754|NCT00672477|566560182|FG001|Overall Study|Lack of Efficacy|1|||
156946755|NCT00672477|566560181|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
156946756|NCT00672477|566560182|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
156946757|NCT02621606|566560184|FG000|Overall Study|Withdrawal by Subject|0|||
156946758|NCT02621606|566560185|FG001|Overall Study|Withdrawal by Subject|1|||
156946759|NCT02621606|566560186|FG002|Overall Study|Withdrawal by Subject|0|||
156946760|NCT01175824|566560187|FG000|Overall Study|Adverse Event|2|||
156946761|NCT01175824|566560188|FG001|Overall Study|Adverse Event|1|||
156946762|NCT01175824|566560187|FG000|Overall Study|Lack of Efficacy|2|||
156946763|NCT01175824|566560188|FG001|Overall Study|Lack of Efficacy|0|||
156946764|NCT01175824|566560187|FG000|Overall Study|Lost to Follow-up|0|||
156946765|NCT01175824|566560188|FG001|Overall Study|Lost to Follow-up|1|||
156946766|NCT01175824|566560187|FG000|Overall Study|Physician Decision|0|||
156946767|NCT01175824|566560188|FG001|Overall Study|Physician Decision|4|||
156946768|NCT01175824|566560187|FG000|Overall Study|Protocol Violation|2|||
156946769|NCT01175824|566560188|FG001|Overall Study|Protocol Violation|5|||
156946770|NCT01175824|566560187|FG000|Overall Study|Withdrawal by Subject|3|||
156946771|NCT01175824|566560188|FG001|Overall Study|Withdrawal by Subject|7|||
156946772|NCT01175824|566560187|FG000|Overall Study|Sponsor Decision|1|||
156946773|NCT01175824|566560188|FG001|Overall Study|Sponsor Decision|0|||
156946774|NCT01175824|566560187|FG000|Overall Study|Entry Criteria Not Met|6|||
156946775|NCT01175824|566560188|FG001|Overall Study|Entry Criteria Not Met|4|||
156946776|NCT03455855|566560189|FG000|Overall Study|Lost to Follow-up|4|||
156946777|NCT03455855|566560190|FG001|Overall Study|Lost to Follow-up|2|||
156946778|NCT00924950|566560191|FG000|Overall Study|Lost to Follow-up|2|||
156946779|NCT00982319|566560192|FG000|Overall Study|Surgery date change|1|||
156946780|NCT00982319|566560193|FG001|Overall Study|Surgery date change|0|||
156946781|NCT00982319|566560192|FG000|Overall Study|Preop values out of acceptable range|1|||
156946782|NCT00982319|566560193|FG001|Overall Study|Preop values out of acceptable range|1|||
156946783|NCT00982319|566560192|FG000|Overall Study|Pregnancy|0|||
156946784|NCT00982319|566560193|FG001|Overall Study|Pregnancy|1|||
156946785|NCT01324024|566560194|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
156946786|NCT01324024|566560195|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156946787|NCT00009737|566560196|FG000|Overall Study|Adverse Event|112|||
156946788|NCT00009737|566560197|FG001|Overall Study|Adverse Event|75|||
157033117|NCT01130883|566877410|FG000|Overall Study|Reason Unknown|1|||
157033118|NCT01130883|566877410|FG000|Overall Study|Adverse Event|3|||
156946789|NCT00009737|566560196|FG000|Overall Study|Death|4|||
156946790|NCT00009737|566560197|FG001|Overall Study|Death|6|||
156946791|NCT00009737|566560196|FG000|Overall Study|Lack of Efficacy|17|||
156946792|NCT00009737|566560197|FG001|Overall Study|Lack of Efficacy|15|||
156946793|NCT00009737|566560196|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
156946794|NCT00009737|566560197|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
156946795|NCT00009737|566560196|FG000|Overall Study|Other Protocol Violation|1|||
156946796|NCT00009737|566560197|FG001|Overall Study|Other Protocol Violation|0|||
156946797|NCT00009737|566560196|FG000|Overall Study|Refused Treatment|15|||
156946798|NCT00009737|566560197|FG001|Overall Study|Refused Treatment|16|||
156946799|NCT00009737|566560196|FG000|Overall Study|Lost to Follow-up|1|||
156946800|NCT00009737|566560197|FG001|Overall Study|Lost to Follow-up|1|||
156946801|NCT00009737|566560196|FG000|Overall Study|Administrative/Other Reasons|7|||
156946802|NCT00009737|566560197|FG001|Overall Study|Administrative/Other Reasons|1|||
156946803|NCT01163682|566560198|FG000|Overall Study|Lost to Follow-up|6|||
156946804|NCT01163682|566560199|FG001|Overall Study|Lost to Follow-up|9|||
156946805|NCT00530023|566560200|FG000|Overall Study|Withdrawal by Subject|0|||
156946806|NCT00530023|566560201|FG001|Overall Study|Withdrawal by Subject|1|||
156946807|NCT01931839|566560202|FG000|Overall Study|Death|0|||
156946808|NCT01931839|566560203|FG001|Overall Study|Death|1|||
156946809|NCT01931839|566560204|FG002|Overall Study|Death|2|||
156946810|NCT01931839|566560205|FG003|Overall Study|Death|0|||
156946811|NCT01931839|566560206|FG004|Overall Study|Death|0|||
156946812|NCT01931839|566560207|FG005|Overall Study|Death|0|||
156946813|NCT01931839|566560208|FG006|Overall Study|Death|0|||
156946814|NCT01931839|566560202|FG000|Overall Study|Physician Decision|1|||
156946815|NCT01931839|566560203|FG001|Overall Study|Physician Decision|0|||
156946816|NCT01931839|566560204|FG002|Overall Study|Physician Decision|1|||
156946817|NCT01931839|566560205|FG003|Overall Study|Physician Decision|0|||
156946818|NCT01931839|566560206|FG004|Overall Study|Physician Decision|0|||
156946819|NCT01931839|566560207|FG005|Overall Study|Physician Decision|0|||
156946820|NCT01931839|566560208|FG006|Overall Study|Physician Decision|1|||
156946821|NCT01931839|566560202|FG000|Overall Study|Withdrawal of consent|0|||
156946822|NCT01931839|566560203|FG001|Overall Study|Withdrawal of consent|0|||
156946823|NCT01931839|566560204|FG002|Overall Study|Withdrawal of consent|0|||
156946824|NCT01931839|566560205|FG003|Overall Study|Withdrawal of consent|0|||
156946825|NCT01931839|566560206|FG004|Overall Study|Withdrawal of consent|1|||
156946826|NCT01931839|566560207|FG005|Overall Study|Withdrawal of consent|0|||
156946827|NCT01931839|566560208|FG006|Overall Study|Withdrawal of consent|0|||
156946828|NCT01931839|566560202|FG000|Overall Study|Adverse Event|9|||
156946829|NCT01931839|566560203|FG001|Overall Study|Adverse Event|4|||
156946830|NCT01931839|566560204|FG002|Overall Study|Adverse Event|1|||
156946831|NCT01931839|566560205|FG003|Overall Study|Adverse Event|3|||
156946832|NCT01931839|566560206|FG004|Overall Study|Adverse Event|0|||
156946833|NCT01931839|566560207|FG005|Overall Study|Adverse Event|0|||
156946834|NCT01931839|566560208|FG006|Overall Study|Adverse Event|1|||
156946835|NCT01931839|566560202|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
156946836|NCT01931839|566560203|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
156946837|NCT01931839|566560204|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
156946838|NCT01931839|566560205|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
156946839|NCT01931839|566560206|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
156946840|NCT01931839|566560207|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
156946841|NCT01931839|566560208|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
156946842|NCT01931839|566560202|FG000|Overall Study|Other non-compliance|15|||
156946843|NCT01931839|566560203|FG001|Overall Study|Other non-compliance|9|||
156946844|NCT01931839|566560204|FG002|Overall Study|Other non-compliance|12|||
156946845|NCT01931839|566560205|FG003|Overall Study|Other non-compliance|3|||
156946846|NCT01931839|566560206|FG004|Overall Study|Other non-compliance|0|||
156946847|NCT01931839|566560207|FG005|Overall Study|Other non-compliance|3|||
156946848|NCT01931839|566560208|FG006|Overall Study|Other non-compliance|0|||
157033119|NCT02585323|566877411|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
157167567|NCT01653158|567354616|FG000|Overall Study|Death|0|||
157167568|NCT01653158|567354617|FG001|Overall Study|Death|0|||
156946849|NCT01931839|566560202|FG000|Overall Study|Lost to Follow-up|1|||
156946850|NCT01931839|566560203|FG001|Overall Study|Lost to Follow-up|2|||
156946851|NCT01931839|566560204|FG002|Overall Study|Lost to Follow-up|4|||
156946852|NCT01931839|566560205|FG003|Overall Study|Lost to Follow-up|5|||
156946853|NCT01931839|566560206|FG004|Overall Study|Lost to Follow-up|0|||
156946854|NCT01931839|566560207|FG005|Overall Study|Lost to Follow-up|0|||
157033120|NCT02585323|566877412|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
156946855|NCT01931839|566560208|FG006|Overall Study|Lost to Follow-up|0|||
156946856|NCT01931839|566560202|FG000|Overall Study|Other|4|||
156946857|NCT01931839|566560203|FG001|Overall Study|Other|2|||
156946858|NCT01931839|566560204|FG002|Overall Study|Other|6|||
156946859|NCT01931839|566560205|FG003|Overall Study|Other|0|||
156946860|NCT01931839|566560206|FG004|Overall Study|Other|0|||
156946861|NCT01931839|566560207|FG005|Overall Study|Other|0|||
156946862|NCT01931839|566560208|FG006|Overall Study|Other|0|||
156946863|NCT03224468|566560209|FG000|Overall Study|Did not obtain MM card|53|||
156946864|NCT03224468|566560210|FG001|Overall Study|Did not obtain MM card|0|||
156946865|NCT03224468|566560209|FG000|Overall Study|Lost to Follow-up|4|||
156946866|NCT03224468|566560210|FG001|Overall Study|Lost to Follow-up|11|||
156946867|NCT03224468|566560209|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
156946868|NCT03224468|566560210|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
156946869|NCT02571452|566560211|FG000|Overall Study Treatment|Protocol Violation|0|||
156946870|NCT02571452|566560212|FG001|Overall Study Treatment|Protocol Violation|1|||
156946871|NCT02571452|566560211|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
156946872|NCT02571452|566560212|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
156946873|NCT02571452|566560211|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
156946874|NCT02571452|566560212|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
156946875|NCT02863354|566560215|FG000|Year 1|Lost to Follow-up|1|||
156946876|NCT02863354|566560216|FG001|Year 1|Lost to Follow-up|1|||
156946877|NCT02863354|566560215|FG000|Year 1|Withdrawal by Subject|3|||
156946878|NCT02863354|566560216|FG001|Year 1|Withdrawal by Subject|0|||
156946879|NCT02863354|566560215|FG000|Year 1|Death|0|||
156946880|NCT02863354|566560216|FG001|Year 1|Death|1|||
156946881|NCT02863354|566560215|FG000|Year 2|Lost to Follow-up|2|||
156946882|NCT02863354|566560216|FG001|Year 2|Lost to Follow-up|2|||
156946883|NCT00724451|566560222|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
156946884|NCT00724451|566560222|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
156946885|NCT00724451|566560222|FG000|Overall Study|Not Eligible for Treatment|431|||
156946886|NCT00724451|566560222|FG000|Overall Study|Participant Refused Treatment|89|||
156946887|NCT00724451|566560222|FG000|Overall Study|Never Started Treatment|89|||
156946888|NCT00724451|566560222|FG000|Overall Study|Unknown; No Data Sources Available|9|||
156946889|NCT00724451|566560222|FG000|Overall Study|Physician Decision|116|||
156946890|NCT00724451|566560222|FG000|Overall Study|Withdrawal by Subject|45|||
156946891|NCT00724451|566560222|FG000|Overall Study|Investigator + Participant Decision|13|||
156946892|NCT01731171|566560228|FG000|Overall Study|Withdrawal by Subject|4|||
156946893|NCT01731171|566560229|FG001|Overall Study|Withdrawal by Subject|1|||
156946894|NCT01731171|566560228|FG000|Overall Study|Lost to Follow-up|3|||
156946895|NCT01731171|566560229|FG001|Overall Study|Lost to Follow-up|2|||
156946896|NCT01731171|566560228|FG000|Overall Study|Moved out of Area|0|||
156946897|NCT01731171|566560229|FG001|Overall Study|Moved out of Area|2|||
156946898|NCT01731171|566560228|FG000|Overall Study|Terminated for Lack of Adherence|0|||
156946899|NCT01731171|566560229|FG001|Overall Study|Terminated for Lack of Adherence|1|||
156946900|NCT01731171|566560228|FG000|Overall Study|Terminated for Safety Reasons|0|||
156946901|NCT01731171|566560229|FG001|Overall Study|Terminated for Safety Reasons|1|||
156946902|NCT02604589|566560235|FG000|Overall Study|catheter dislodgement|0|||
156946903|NCT02604589|566560236|FG001|Overall Study|catheter dislodgement|0|||
156946904|NCT02604589|566560237|FG002|Overall Study|catheter dislodgement|1|||
156946905|NCT04632940|566560241|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
156946906|NCT04632940|566560242|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
156946907|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
156946908|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
156946909|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
156946910|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
156946911|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
156946912|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
156946913|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
156946914|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
156946915|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
156946916|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
156946917|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Other than specified|0|||
156946918|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Other than specified|1|||
156946919|NCT04632940|566560241|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
156946920|NCT04632940|566560242|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
156946921|NCT02520531|566560247|FG000|Overall Study|Revision of study device components|2|||
156946922|NCT02520531|566560248|FG001|Overall Study|Revision of study device components|2|||
156946923|NCT02520531|566560247|FG000|Overall Study|Death|1|||
156946924|NCT02520531|566560248|FG001|Overall Study|Death|2|||
156946925|NCT02520531|566560247|FG000|Overall Study|Lost to Follow-up|1|||
156946926|NCT02520531|566560248|FG001|Overall Study|Lost to Follow-up|1|||
157167569|NCT01653158|567354618|FG002|Overall Study|Death|0|||
157167570|NCT01653158|567354619|FG003|Overall Study|Death|1|||
157167571|NCT01653158|567354620|FG004|Overall Study|Death|0|||
157167572|NCT01653158|567354621|FG005|Overall Study|Death|0|||
157167573|NCT01653158|567354622|FG006|Overall Study|Death|0|||
156946927|NCT02520531|566560247|FG000|Overall Study|Meet exclusion criterion|0|||
156946928|NCT02520531|566560248|FG001|Overall Study|Meet exclusion criterion|1|||
157167574|NCT01653158|567354623|FG007|Overall Study|Death|2|||
157167575|NCT01653158|567354616|FG000|Overall Study|Adverse Event|0|||
157167576|NCT01653158|567354617|FG001|Overall Study|Adverse Event|0|||
157033121|NCT02585323|566877411|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
157033122|NCT02585323|566877412|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
157033123|NCT02585323|566877411|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
157033124|NCT02585323|566877412|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
157033125|NCT02585323|566877411|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
157033126|NCT02585323|566877412|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
157033127|NCT05524116|566877421|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
157033128|NCT05524116|566877422|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
157033129|NCT05524116|566877421|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
157033130|NCT05524116|566877422|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
157033131|NCT05524116|566877421|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
157033132|NCT05524116|566877422|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
157033133|NCT05524116|566877421|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
157033134|NCT05524116|566877422|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
157033135|NCT05524116|566877421|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
157033136|NCT05524116|566877422|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
157033137|NCT04389957|566877430|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
157033138|NCT04389957|566877431|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
157033139|NCT04389957|566877432|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
157033140|NCT04389957|566877433|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
157033141|NCT04389957|566877434|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
157033142|NCT02473445|566877436|FG000|Overall Study|Withdrawal by Subject|2|||
157033143|NCT02473445|566877436|FG000|Overall Study|Sponsor Decision|20|||
157033144|NCT04247802|566877437|FG000|Overall Study|Withdrawal by Subject|1|||
157033145|NCT04247802|566877438|FG001|Overall Study|Withdrawal by Subject|3|||
157033146|NCT04247802|566877437|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
157033147|NCT04247802|566877438|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
157033148|NCT04778410|566877447|FG000|Safety Run-in Period|Death|5|||
157033149|NCT04778410|566877448|FG001|Safety Run-in Period|Death|6|||
157033150|NCT04778410|566877449|FG002|Safety Run-in Period|Death|0|||
157033151|NCT04778410|566877450|FG003|Safety Run-in Period|Death|0|||
157033152|NCT04778410|566877451|FG004|Safety Run-in Period|Death|0|||
157033153|NCT04778410|566877452|FG005|Safety Run-in Period|Death|0|||
157033154|NCT04778410|566877447|FG000|Phase 2 Period|Death|0|||
157033155|NCT04778410|566877448|FG001|Phase 2 Period|Death|0|||
157033156|NCT04778410|566877449|FG002|Phase 2 Period|Death|0|||
157033157|NCT04778410|566877450|FG003|Phase 2 Period|Death|5|||
157033158|NCT04778410|566877451|FG004|Phase 2 Period|Death|18|||
157033159|NCT04778410|566877452|FG005|Phase 2 Period|Death|0|||
157033160|NCT04778410|566877447|FG000|Phase 2 Period|Lost to Follow-up|0|||
157033161|NCT04778410|566877448|FG001|Phase 2 Period|Lost to Follow-up|0|||
157033162|NCT04778410|566877449|FG002|Phase 2 Period|Lost to Follow-up|0|||
157033163|NCT04778410|566877450|FG003|Phase 2 Period|Lost to Follow-up|1|||
157033164|NCT04778410|566877451|FG004|Phase 2 Period|Lost to Follow-up|1|||
157033165|NCT04778410|566877452|FG005|Phase 2 Period|Lost to Follow-up|0|||
157033166|NCT04778410|566877447|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
157033167|NCT04778410|566877448|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
156946929|NCT02520531|566560247|FG000|Overall Study|Withdrawal by Subject|1|||
156946930|NCT02520531|566560248|FG001|Overall Study|Withdrawal by Subject|0|||
156946931|NCT02520531|566560247|FG000|Overall Study|Not study device|1|||
156946932|NCT02520531|566560248|FG001|Overall Study|Not study device|0|||
156946933|NCT00622635|566560253|FG000|Treatment Period 1|Adverse Event|0|||
156946934|NCT00622635|566560254|FG001|Treatment Period 1|Adverse Event|0|||
156946935|NCT00622635|566560255|FG002|Treatment Period 1|Adverse Event|1|||
156946936|NCT00622635|566560256|FG003|Treatment Period 1|Adverse Event|0|||
156946937|NCT00622635|566560257|FG004|Treatment Period 1|Adverse Event|0|||
156946938|NCT00622635|566560258|FG005|Treatment Period 1|Adverse Event|0|||
156946939|NCT00622635|566560253|FG000|Treatment Period 1|Withdrawal by Subject|0|||
156946940|NCT00622635|566560254|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157033168|NCT04778410|566877449|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
157033169|NCT04778410|566877450|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
157033170|NCT04778410|566877451|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
157033171|NCT04778410|566877452|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
157033172|NCT04778410|566877447|FG000|Phase 2 Period|Withdrew Consent|0|||
157033173|NCT04778410|566877448|FG001|Phase 2 Period|Withdrew Consent|0|||
157033174|NCT04778410|566877449|FG002|Phase 2 Period|Withdrew Consent|0|||
157033175|NCT04778410|566877450|FG003|Phase 2 Period|Withdrew Consent|0|||
157033176|NCT04778410|566877451|FG004|Phase 2 Period|Withdrew Consent|2|||
157033177|NCT04778410|566877452|FG005|Phase 2 Period|Withdrew Consent|0|||
157033178|NCT05422885|566877458|FG000|Overall Study|Lost to Follow-up|1|||
156946941|NCT00622635|566560255|FG002|Treatment Period 1|Withdrawal by Subject|0|||
156946942|NCT00622635|566560256|FG003|Treatment Period 1|Withdrawal by Subject|0|||
156946943|NCT00622635|566560257|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157033179|NCT05422885|566877458|FG000|Overall Study|Withdrawal by Subject|2|||
156946944|NCT00622635|566560258|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157033180|NCT01385202|566877461|FG000|Overall Study|Lost to Follow-up|6|||
157033181|NCT01385202|566877461|FG000|Overall Study|Not Eligible|11|||
157033182|NCT01385202|566877461|FG000|Overall Study|Withdrawn|1|||
157033183|NCT02095691|566877462|FG000|Overall Study|Physician Decision|1|||
157033184|NCT03681262|566877463|FG000|Overall Study|Continuing on study|3|||
157033185|NCT03681262|566877464|FG001|Overall Study|Continuing on study|3|||
157033186|NCT03681262|566877463|FG000|Overall Study|Lost to Follow-up|1|||
157033187|NCT03681262|566877464|FG001|Overall Study|Lost to Follow-up|0|||
157033188|NCT04583280|566877465|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
157033189|NCT04583280|566877466|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
157033190|NCT03691298|566877473|FG000|Overall Study|Lost to Follow-up|8|||
157033191|NCT03691298|566877473|FG000|Overall Study|Sponsor terminated study|2|||
157033192|NCT02326974|566877477|FG000|Overall Study|Withdrawal by Subject|2|||
157033193|NCT02326974|566877477|FG000|Overall Study|failed heterogenity evaluation|5|||
157033194|NCT02577354|566877478|FG000|Overall Study|Lack of Efficacy|4|||
157033195|NCT02577354|566877479|FG001|Overall Study|Lack of Efficacy|4|||
157033196|NCT02577354|566877478|FG000|Overall Study|Lost to Follow-up|3|||
157033197|NCT02577354|566877479|FG001|Overall Study|Lost to Follow-up|1|||
157033198|NCT02577354|566877478|FG000|Overall Study|Missed Visit|4|||
157033199|NCT02577354|566877479|FG001|Overall Study|Missed Visit|3|||
157033200|NCT02577354|566877478|FG000|Overall Study|Adverse Event|4|||
156946945|NCT00622635|566560253|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
156946946|NCT00622635|566560254|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
156946947|NCT00622635|566560255|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
156946948|NCT00622635|566560256|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
156946949|NCT00622635|566560257|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
156946950|NCT00622635|566560258|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
156946951|NCT00622635|566560253|FG000|Treatment Period 2|Adverse Event|1|||
156946952|NCT00622635|566560254|FG001|Treatment Period 2|Adverse Event|0|||
156946953|NCT00622635|566560255|FG002|Treatment Period 2|Adverse Event|0|||
156946954|NCT00622635|566560256|FG003|Treatment Period 2|Adverse Event|0|||
156946955|NCT00622635|566560257|FG004|Treatment Period 2|Adverse Event|0|||
156946956|NCT00622635|566560258|FG005|Treatment Period 2|Adverse Event|0|||
156946957|NCT00622635|566560253|FG000|Treatment Period 3|Adverse Event|0|||
156946958|NCT00622635|566560254|FG001|Treatment Period 3|Adverse Event|0|||
156946959|NCT00622635|566560255|FG002|Treatment Period 3|Adverse Event|0|||
156946960|NCT00622635|566560256|FG003|Treatment Period 3|Adverse Event|2|||
156946961|NCT00622635|566560257|FG004|Treatment Period 3|Adverse Event|0|||
156946962|NCT00622635|566560258|FG005|Treatment Period 3|Adverse Event|0|||
156946963|NCT00622635|566560253|FG000|Treatment Period 3|Withdrawal by Subject|0|||
156946964|NCT00622635|566560254|FG001|Treatment Period 3|Withdrawal by Subject|0|||
156946965|NCT00622635|566560255|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156946966|NCT00622635|566560256|FG003|Treatment Period 3|Withdrawal by Subject|1|||
156946967|NCT00622635|566560257|FG004|Treatment Period 3|Withdrawal by Subject|0|||
156946968|NCT00622635|566560258|FG005|Treatment Period 3|Withdrawal by Subject|0|||
156946969|NCT00281840|566560259|FG000|Overall Study|Adverse Event|12|||
156946970|NCT00281840|566560259|FG000|Overall Study|Physician Decision|6|||
156946971|NCT00281840|566560259|FG000|Overall Study|Withdrawal by Subject|3|||
156946972|NCT00281840|566560259|FG000|Overall Study|Disease Progression|2|||
156946973|NCT00281840|566560259|FG000|Overall Study|exceed maximum delay in treatment|1|||
156946974|NCT00281840|566560259|FG000|Overall Study|Complicating Disease|1|||
156946975|NCT00835406|566560260|FG000|Period: First Intervention|Adverse Event|0|||
156946976|NCT00835406|566560261|FG001|Period: First Intervention|Adverse Event|1|||
156946977|NCT00835406|566560260|FG000|Period: First Intervention|Withdrawal by Subject|2|||
156946978|NCT00835406|566560261|FG001|Period: First Intervention|Withdrawal by Subject|0|||
156946979|NCT00835406|566560260|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
156946980|NCT00835406|566560261|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
156946981|NCT02138214|566560264|FG000|Overall Study|Withdrawal by Subject|0|||
156946982|NCT02138214|566560265|FG001|Overall Study|Withdrawal by Subject|1|||
156946983|NCT02138214|566560266|FG002|Overall Study|Withdrawal by Subject|0|||
156946984|NCT02138214|566560264|FG000|Overall Study|Lost to Follow-up|0|||
156946985|NCT02138214|566560265|FG001|Overall Study|Lost to Follow-up|2|||
156946986|NCT02138214|566560266|FG002|Overall Study|Lost to Follow-up|4|||
156946987|NCT02138214|566560264|FG000|Overall Study|Screen Failure|0|||
156946988|NCT02138214|566560265|FG001|Overall Study|Screen Failure|1|||
156946989|NCT02138214|566560266|FG002|Overall Study|Screen Failure|0|||
156946990|NCT02185768|566560267|FG000|Overall Study|Patients were not treated|2|||
156946991|NCT02486406|566560269|FG000|Overall Study|Withdrew consent|1|||
156946992|NCT02486406|566560270|FG001|Overall Study|Withdrew consent|0|||
156946993|NCT02486406|566560271|FG002|Overall Study|Withdrew consent|0|||
156946994|NCT02486406|566560272|FG003|Overall Study|Withdrew consent|1|||
156946995|NCT02486406|566560269|FG000|Overall Study|Lost to Follow-up|1|||
156946996|NCT02486406|566560270|FG001|Overall Study|Lost to Follow-up|3|||
157033201|NCT02577354|566877479|FG001|Overall Study|Adverse Event|5|||
157033202|NCT04214834|566877485|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
157033203|NCT04214834|566877486|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
156946997|NCT02486406|566560271|FG002|Overall Study|Lost to Follow-up|1|||
156946998|NCT02486406|566560272|FG003|Overall Study|Lost to Follow-up|3|||
156946999|NCT02486406|566560269|FG000|Overall Study|Other, not specified|0|||
156947000|NCT02486406|566560270|FG001|Overall Study|Other, not specified|0|||
156947001|NCT02486406|566560271|FG002|Overall Study|Other, not specified|1|||
156947002|NCT02486406|566560272|FG003|Overall Study|Other, not specified|0|||
156947003|NCT01079234|566560275|FG000|Main: Week 0 to 26|Adverse Event|5|||
156947004|NCT01079234|566560276|FG001|Main: Week 0 to 26|Adverse Event|4|||
156947005|NCT01079234|566560277|FG002|Main: Week 0 to 26|Adverse Event|1|||
156947006|NCT01079234|566560278|FG003|Main: Week 0 to 26|Adverse Event|0|||
156947007|NCT01079234|566560275|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
156947008|NCT01079234|566560276|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
156947009|NCT01079234|566560277|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
156947010|NCT01079234|566560278|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
156947011|NCT01079234|566560275|FG000|Main: Week 0 to 26|Protocol Violation|6|||
156947012|NCT01079234|566560276|FG001|Main: Week 0 to 26|Protocol Violation|2|||
156947013|NCT01079234|566560277|FG002|Main: Week 0 to 26|Protocol Violation|4|||
156947014|NCT01079234|566560278|FG003|Main: Week 0 to 26|Protocol Violation|0|||
156947015|NCT01079234|566560275|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
156947016|NCT01079234|566560276|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
156947017|NCT01079234|566560277|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
156947018|NCT01079234|566560278|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
156947019|NCT01079234|566560275|FG000|Main: Week 0 to 26|Unclassified|7|||
156947020|NCT01079234|566560276|FG001|Main: Week 0 to 26|Unclassified|13|||
156947021|NCT01079234|566560277|FG002|Main: Week 0 to 26|Unclassified|4|||
156947022|NCT01079234|566560278|FG003|Main: Week 0 to 26|Unclassified|0|||
156947023|NCT01079234|566560275|FG000|Extension: Week 27 to 52|Adverse Event|0|||
156947024|NCT01079234|566560276|FG001|Extension: Week 27 to 52|Adverse Event|0|||
156947025|NCT01079234|566560277|FG002|Extension: Week 27 to 52|Adverse Event|1|||
156947026|NCT01079234|566560278|FG003|Extension: Week 27 to 52|Adverse Event|0|||
156947027|NCT01079234|566560275|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
156947028|NCT01079234|566560276|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
156947029|NCT01079234|566560277|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
156947030|NCT01079234|566560278|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
156947031|NCT01079234|566560275|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
156947032|NCT01079234|566560276|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
156947033|NCT01079234|566560277|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
156947034|NCT01079234|566560278|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
156947035|NCT01079234|566560275|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
156947036|NCT01079234|566560276|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
156947037|NCT01079234|566560277|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
156947038|NCT01079234|566560278|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
156947039|NCT01079234|566560275|FG000|Extension: Week 27 to 52|Unclassified|0|||
156947040|NCT01079234|566560276|FG001|Extension: Week 27 to 52|Unclassified|0|||
156947041|NCT01079234|566560277|FG002|Extension: Week 27 to 52|Unclassified|4|||
156947042|NCT01079234|566560278|FG003|Extension: Week 27 to 52|Unclassified|7|||
156947043|NCT01071512|566560279|FG000|Overall Study|Adverse Event|1|||
156947044|NCT01071512|566560279|FG000|Overall Study|Development of antibodies to drug|2|||
156947045|NCT01071512|566560279|FG000|Overall Study|positive anti-JC virus antibody test|2|||
156947046|NCT03146650|566560284|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
156947047|NCT03146650|566560284|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
156947048|NCT03146650|566560284|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
156947049|NCT03146650|566560284|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
156947050|NCT03146650|566560284|FG000|2 Year Follow-up|Death|11|||
156947051|NCT03146650|566560284|FG000|2 Year Follow-up|Still in follow-up|7|||
156947052|NCT03146650|566560284|FG000|2 Year Follow-up|Lost to Follow-up|1|||
156947053|NCT02460198|566560287|FG000|Overall Study|Adverse Event|1|||
156947054|NCT02460198|566560288|FG001|Overall Study|Adverse Event|3|||
156947055|NCT02460198|566560287|FG000|Overall Study|Death|36|||
156947056|NCT02460198|566560288|FG001|Overall Study|Death|28|||
156947057|NCT02460198|566560287|FG000|Overall Study|Lost to Follow-up|1|||
156947058|NCT02460198|566560288|FG001|Overall Study|Lost to Follow-up|1|||
156947059|NCT02460198|566560287|FG000|Overall Study|Transferred to Extension Study|15|||
156947060|NCT02460198|566560288|FG001|Overall Study|Transferred to Extension Study|15|||
156947061|NCT02460198|566560287|FG000|Overall Study|Withdrawal by Subject|2|||
156947062|NCT02460198|566560288|FG001|Overall Study|Withdrawal by Subject|4|||
156947063|NCT02460198|566560287|FG000|Overall Study|Site Terminated By Sponsor|0|||
156947064|NCT02460198|566560288|FG001|Overall Study|Site Terminated By Sponsor|1|||
156947065|NCT02460198|566560287|FG000|Overall Study|Did Not Continue on Extension Study|6|||
156947066|NCT02460198|566560288|FG001|Overall Study|Did Not Continue on Extension Study|11|||
156947067|NCT00931307|566560289|FG000|Overall Study|Lack of Efficacy|12|||
156947068|NCT00931307|566560289|FG000|Overall Study|Biomicroscopy|1|||
156947069|NCT00965848|566560292|FG000|Overall Study|Protocol Violation|3|||
156947070|NCT00965848|566560293|FG001|Overall Study|Protocol Violation|0|||
156947071|NCT00965848|566560294|FG002|Overall Study|Protocol Violation|1|||
157033204|NCT04924400|566877487|FG000|Overall Study|Lost to Follow-up|3|||
157033205|NCT04924400|566877488|FG001|Overall Study|Lost to Follow-up|0|||
157033206|NCT05070741|566877491|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
157033207|NCT03812614|566877492|FG000|Intervention|Withdrawal by Subject|7|||
157033208|NCT03812614|566877493|FG001|Intervention|Withdrawal by Subject|2|||
157033209|NCT03812614|566877494|FG002|Intervention|Withdrawal by Subject|7|||
157033210|NCT03812614|566877495|FG003|Intervention|Withdrawal by Subject|2|||
157033211|NCT03812614|566877492|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
157033212|NCT03812614|566877493|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
157033213|NCT03812614|566877494|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
157033214|NCT03812614|566877495|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
157033215|NCT03812614|566877492|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
157033216|NCT03812614|566877493|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
157033217|NCT03812614|566877494|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
157033218|NCT03812614|566877495|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
157033219|NCT03812614|566877492|FG000|6-month Follow-up|Lost to Follow-up|0|||
157033220|NCT03812614|566877493|FG001|6-month Follow-up|Lost to Follow-up|0|||
157033221|NCT03812614|566877494|FG002|6-month Follow-up|Lost to Follow-up|12|||
157033222|NCT03812614|566877495|FG003|6-month Follow-up|Lost to Follow-up|8|||
157033223|NCT03812614|566877492|FG000|12-month Follow-up|Lost to Follow-up|18|||
157033224|NCT03812614|566877493|FG001|12-month Follow-up|Lost to Follow-up|17|||
157033225|NCT03812614|566877494|FG002|12-month Follow-up|Lost to Follow-up|5|||
157033226|NCT03812614|566877495|FG003|12-month Follow-up|Lost to Follow-up|2|||
157033227|NCT05652010|566877496|FG000|First Intervention|Withdrawal by Subject|0|||
157033228|NCT05652010|566877497|FG001|First Intervention|Withdrawal by Subject|1|||
157033229|NCT05652010|566877496|FG000|Second Intervention|Withdrawal by Subject|1|||
157033230|NCT05652010|566877497|FG001|Second Intervention|Withdrawal by Subject|0|||
157033231|NCT05451693|566877498|FG000|Overall Study|Withdrawal by Subject|1|||
157033232|NCT05451693|566877499|FG001|Overall Study|Withdrawal by Subject|1|||
157033233|NCT04490109|566877506|FG000|Overall Study|Lost to Follow-up|3|||
157033234|NCT04490109|566877507|FG001|Overall Study|Lost to Follow-up|10|||
157033235|NCT04490109|566877508|FG002|Overall Study|Lost to Follow-up|4|||
157033236|NCT04490109|566877506|FG000|Overall Study|Withdrawal by Subject|8|||
157033237|NCT04490109|566877507|FG001|Overall Study|Withdrawal by Subject|6|||
157033238|NCT04490109|566877508|FG002|Overall Study|Withdrawal by Subject|9|||
157033239|NCT04490109|566877506|FG000|Overall Study|Physician Decision|0|||
157033240|NCT04490109|566877507|FG001|Overall Study|Physician Decision|2|||
157033241|NCT04490109|566877508|FG002|Overall Study|Physician Decision|3|||
157033242|NCT04490109|566877506|FG000|Overall Study|Adverse Event|2|||
157033243|NCT04490109|566877507|FG001|Overall Study|Adverse Event|1|||
157033244|NCT04490109|566877508|FG002|Overall Study|Adverse Event|0|||
157167577|NCT01653158|567354618|FG002|Overall Study|Adverse Event|0|||
157167578|NCT01653158|567354619|FG003|Overall Study|Adverse Event|1|||
157167579|NCT01653158|567354620|FG004|Overall Study|Adverse Event|0|||
156947072|NCT00965848|566560292|FG000|Overall Study|Death|11|||
156947073|NCT00965848|566560293|FG001|Overall Study|Death|1|||
156947074|NCT00965848|566560294|FG002|Overall Study|Death|5|||
156947075|NCT00965848|566560292|FG000|Overall Study|Lost to Follow-up|0|||
156947076|NCT00965848|566560293|FG001|Overall Study|Lost to Follow-up|0|||
156947077|NCT00965848|566560294|FG002|Overall Study|Lost to Follow-up|1|||
156947078|NCT00965848|566560292|FG000|Overall Study|Withdrawal by Subject|1|||
156947079|NCT00965848|566560293|FG001|Overall Study|Withdrawal by Subject|0|||
156947080|NCT00965848|566560294|FG002|Overall Study|Withdrawal by Subject|0|||
156947081|NCT00965848|566560292|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
156947082|NCT00965848|566560293|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
156947083|NCT00965848|566560294|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
156947084|NCT00965848|566560292|FG000|Overall Study|Not Clinically Evaluable|7|||
156947085|NCT00965848|566560293|FG001|Overall Study|Not Clinically Evaluable|1|||
156947086|NCT00965848|566560294|FG002|Overall Study|Not Clinically Evaluable|1|||
156947087|NCT00965848|566560292|FG000|Overall Study|Other|5|||
156947088|NCT00965848|566560293|FG001|Overall Study|Other|0|||
157033245|NCT04490109|566877506|FG000|Overall Study|Significant Non-Compliance|2|||
157033246|NCT04490109|566877507|FG001|Overall Study|Significant Non-Compliance|4|||
157033247|NCT04490109|566877508|FG002|Overall Study|Significant Non-Compliance|4|||
157033248|NCT04490109|566877506|FG000|Overall Study|Significant Clinical Event|0|||
157033249|NCT04490109|566877507|FG001|Overall Study|Significant Clinical Event|1|||
157033250|NCT04490109|566877508|FG002|Overall Study|Significant Clinical Event|0|||
157033251|NCT04490109|566877506|FG000|Overall Study|Other Reason|4|||
157033252|NCT04490109|566877507|FG001|Overall Study|Other Reason|1|||
157033253|NCT04490109|566877508|FG002|Overall Study|Other Reason|1|||
157033254|NCT03372057|566877509|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
157167580|NCT01653158|567354621|FG005|Overall Study|Adverse Event|0|||
157033255|NCT03372057|566877510|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
157033256|NCT03372057|566877511|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
157033257|NCT03372057|566877509|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
157033258|NCT03372057|566877510|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
157033259|NCT03372057|566877511|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
157033260|NCT03372057|566877509|FG000|Dose Optimization Phase|Death|16|||
157033261|NCT03372057|566877510|FG001|Dose Optimization Phase|Death|11|||
157033262|NCT03372057|566877511|FG002|Dose Optimization Phase|Death|0|||
157033263|NCT03372057|566877509|FG000|Expansion Phase|Withdrawal by Subject|0|||
157033264|NCT03372057|566877510|FG001|Expansion Phase|Withdrawal by Subject|0|||
157033265|NCT03372057|566877511|FG002|Expansion Phase|Withdrawal by Subject|4|||
157033266|NCT03372057|566877509|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
157033267|NCT03372057|566877510|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
157033268|NCT03372057|566877511|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
157033269|NCT03372057|566877509|FG000|Expansion Phase|Death|0|||
157033270|NCT03372057|566877510|FG001|Expansion Phase|Death|0|||
157033271|NCT03372057|566877511|FG002|Expansion Phase|Death|78|||
157033272|NCT03372057|566877509|FG000|Expansion Phase|Progressive Disease|0|||
157033273|NCT03372057|566877510|FG001|Expansion Phase|Progressive Disease|0|||
157033274|NCT03372057|566877511|FG002|Expansion Phase|Progressive Disease|1|||
157033275|NCT03372057|566877509|FG000|Expansion Phase|Adverse Event|0|||
157033276|NCT03372057|566877510|FG001|Expansion Phase|Adverse Event|0|||
157033277|NCT03372057|566877511|FG002|Expansion Phase|Adverse Event|1|||
157033278|NCT04330040|566877514|FG000|Overall Study|Other: Adverse event|5|||
157033279|NCT04330040|566877515|FG001|Overall Study|Other: Adverse event|0|||
157033280|NCT04330040|566877516|FG002|Overall Study|Other: Adverse event|0|||
157033281|NCT04330040|566877514|FG000|Overall Study|Disease progression|38|||
157033282|NCT04330040|566877515|FG001|Overall Study|Disease progression|10|||
157033283|NCT04330040|566877516|FG002|Overall Study|Disease progression|0|||
157033284|NCT04330040|566877514|FG000|Overall Study|Physician Decision|5|||
157033285|NCT04330040|566877515|FG001|Overall Study|Physician Decision|3|||
157033286|NCT04330040|566877516|FG002|Overall Study|Physician Decision|0|||
157033287|NCT04330040|566877514|FG000|Overall Study|Lost to Follow-up|1|||
157033288|NCT04330040|566877515|FG001|Overall Study|Lost to Follow-up|1|||
157033289|NCT04330040|566877516|FG002|Overall Study|Lost to Follow-up|0|||
157033290|NCT04330040|566877514|FG000|Overall Study|Death|2|||
157033291|NCT04330040|566877515|FG001|Overall Study|Death|1|||
157033292|NCT04330040|566877516|FG002|Overall Study|Death|0|||
157033293|NCT04330040|566877514|FG000|Overall Study|Withdrawal by Subject|3|||
157033294|NCT04330040|566877515|FG001|Overall Study|Withdrawal by Subject|3|||
157033295|NCT04330040|566877516|FG002|Overall Study|Withdrawal by Subject|0|||
157033296|NCT04330040|566877514|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
157033297|NCT04330040|566877515|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
157033298|NCT04330040|566877516|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
157033299|NCT04330040|566877514|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
156947089|NCT00965848|566560294|FG002|Overall Study|Other|1|||
156947090|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
156947091|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156947092|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156947093|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
156947094|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
156947095|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
156947096|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
156947097|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
156947098|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156947099|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156947100|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
156947101|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
156947102|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156947103|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156947104|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
156947105|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
156947106|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
157033300|NCT04330040|566877515|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
157033301|NCT04330040|566877516|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
157033302|NCT04330040|566877514|FG000|Overall Study|Other: Disease progression|1|||
157033303|NCT04330040|566877515|FG001|Overall Study|Other: Disease progression|0|||
157033304|NCT04330040|566877516|FG002|Overall Study|Other: Disease progression|0|||
157091645|NCT01775124|567089188|FG001|Core Period|Administrative problems|0|||
156947107|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
156947108|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
156947109|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
156947110|NCT00813761|566560295|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156947111|NCT00813761|566560296|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
156947112|NCT00813761|566560297|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156947113|NCT00813761|566560298|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
156947114|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
156947115|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
156947116|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
156947117|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
156947118|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
156947119|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
156947120|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
156947121|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
156947122|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
156947123|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
156947124|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
156947125|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
156947126|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156947127|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156947128|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
156947129|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
156947130|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
156947131|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
156947132|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
156947133|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
156947134|NCT00813761|566560295|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
156947135|NCT00813761|566560296|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
156947136|NCT00813761|566560297|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
156947137|NCT00813761|566560298|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
156947138|NCT00691210|566560299|FG000|Overall Study|Progression of Disease|0|||
156947139|NCT00691210|566560300|FG001|Overall Study|Progression of Disease|0|||
156947140|NCT00691210|566560301|FG002|Overall Study|Progression of Disease|0|||
156947141|NCT00691210|566560302|FG003|Overall Study|Progression of Disease|2|||
156947142|NCT00691210|566560303|FG004|Overall Study|Progression of Disease|0|||
156947143|NCT00691210|566560304|FG005|Overall Study|Progression of Disease|0|||
156947144|NCT00691210|566560305|FG006|Overall Study|Progression of Disease|0|||
156947145|NCT00691210|566560306|FG007|Overall Study|Progression of Disease|0|||
156947146|NCT00691210|566560299|FG000|Overall Study|Lack of Efficacy|0|||
156947147|NCT00691210|566560300|FG001|Overall Study|Lack of Efficacy|0|||
156947148|NCT00691210|566560301|FG002|Overall Study|Lack of Efficacy|0|||
156947149|NCT00691210|566560302|FG003|Overall Study|Lack of Efficacy|1|||
156947150|NCT00691210|566560303|FG004|Overall Study|Lack of Efficacy|0|||
156947151|NCT00691210|566560304|FG005|Overall Study|Lack of Efficacy|1|||
156947152|NCT00691210|566560305|FG006|Overall Study|Lack of Efficacy|0|||
156947153|NCT00691210|566560306|FG007|Overall Study|Lack of Efficacy|0|||
156947154|NCT02047604|566560307|FG000|Overall Study|Withdrawal by Subject|0|||
156947155|NCT02047604|566560308|FG001|Overall Study|Withdrawal by Subject|0|||
156947156|NCT02047604|566560309|FG002|Overall Study|Withdrawal by Subject|0|||
156947157|NCT02047604|566560310|FG003|Overall Study|Withdrawal by Subject|0|||
156947158|NCT02047604|566560311|FG004|Overall Study|Withdrawal by Subject|1|||
156947159|NCT02047604|566560312|FG005|Overall Study|Withdrawal by Subject|1|||
156947160|NCT00983814|566560313|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
156947161|NCT00983814|566560314|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
156947162|NCT00983814|566560315|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
156947163|NCT00983814|566560313|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
156947164|NCT00983814|566560314|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
156947165|NCT00983814|566560315|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
156947166|NCT00983814|566560313|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
156947167|NCT00983814|566560314|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
156947168|NCT00983814|566560315|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
156947169|NCT00983814|566560313|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
156947170|NCT00983814|566560314|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
156947171|NCT00983814|566560315|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
156947172|NCT00983814|566560313|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
156947173|NCT00983814|566560314|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
156947174|NCT00983814|566560315|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
156947175|NCT01181895|566560316|FG000|Overall Study|Adverse Event|3|||
156947176|NCT01181895|566560317|FG001|Overall Study|Adverse Event|1|||
156947177|NCT01181895|566560318|FG002|Overall Study|Adverse Event|1|||
156947178|NCT01181895|566560316|FG000|Overall Study|Lack of Efficacy|8|||
156947179|NCT01181895|566560317|FG001|Overall Study|Lack of Efficacy|9|||
156947180|NCT01181895|566560318|FG002|Overall Study|Lack of Efficacy|9|||
156947181|NCT01181895|566560316|FG000|Overall Study|Protocol Violation|2|||
156947182|NCT01181895|566560317|FG001|Overall Study|Protocol Violation|1|||
156947183|NCT01181895|566560318|FG002|Overall Study|Protocol Violation|0|||
157227352|NCT00950807|567577782|FG001|Washout Period 2|Lack of Efficacy|0|||
156947184|NCT01181895|566560316|FG000|Overall Study|Lost to Follow-up|0|||
156947185|NCT01181895|566560317|FG001|Overall Study|Lost to Follow-up|1|||
156947186|NCT01181895|566560318|FG002|Overall Study|Lost to Follow-up|2|||
156947187|NCT01181895|566560316|FG000|Overall Study|Investigator Discretion|1|||
156947188|NCT01181895|566560317|FG001|Overall Study|Investigator Discretion|2|||
156947189|NCT01181895|566560318|FG002|Overall Study|Investigator Discretion|1|||
156947190|NCT01181895|566560316|FG000|Overall Study|Withdrawal by Subject|3|||
156947191|NCT01181895|566560317|FG001|Overall Study|Withdrawal by Subject|0|||
156947192|NCT01181895|566560318|FG002|Overall Study|Withdrawal by Subject|5|||
156947193|NCT00555438|566560319|FG000|10 Days Post-operative|Death|4|||
156947194|NCT00555438|566560319|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
156947195|NCT02707640|566560320|FG000|Overall Study|Adverse Event|4|||
156947196|NCT02707640|566560321|FG001|Overall Study|Adverse Event|2|||
156947197|NCT02707640|566560320|FG000|Overall Study|Death|1|||
156947198|NCT02707640|566560321|FG001|Overall Study|Death|2|||
156947199|NCT02707640|566560320|FG000|Overall Study|Physician Decision|2|||
156947200|NCT02707640|566560321|FG001|Overall Study|Physician Decision|0|||
156947201|NCT02707640|566560320|FG000|Overall Study|Withdrawal by Subject|0|||
156947202|NCT02707640|566560321|FG001|Overall Study|Withdrawal by Subject|1|||
156947203|NCT02707640|566560320|FG000|Overall Study|Participant's Personal Decision|1|||
156947204|NCT02707640|566560321|FG001|Overall Study|Participant's Personal Decision|2|||
156947205|NCT02707640|566560320|FG000|Overall Study|Sponsor Discretion|1|||
156947206|NCT02707640|566560321|FG001|Overall Study|Sponsor Discretion|0|||
156947207|NCT02517905|566560322|FG000|Overall Study|Lost to Follow-up|4|||
156947208|NCT02517905|566560323|FG001|Overall Study|Lost to Follow-up|0|||
156947209|NCT02517905|566560322|FG000|Overall Study|Withdrawal by Subject|4|||
156947210|NCT02517905|566560323|FG001|Overall Study|Withdrawal by Subject|0|||
156947211|NCT02517905|566560322|FG000|Overall Study|Screen failure|2|||
156947212|NCT02517905|566560323|FG001|Overall Study|Screen failure|2|||
156947213|NCT02758236|566560324|FG000|Overall Study|Investigator discretion|43|||
156947214|NCT00023452|566560325|FG000|Overall Study|Ineligible for Study|163|||
156947215|NCT00023452|566560326|FG001|Overall Study|Ineligible for Study|159|||
156947216|NCT00023452|566560325|FG000|Overall Study|Out of Window|129|||
156947217|NCT00023452|566560326|FG001|Overall Study|Out of Window|69|||
156947218|NCT00023452|566560325|FG000|Overall Study|Death|2|||
156947219|NCT00023452|566560326|FG001|Overall Study|Death|0|||
156947220|NCT00023452|566560325|FG000|Overall Study|Withdrawal by Subject|66|||
156947221|NCT00023452|566560326|FG001|Overall Study|Withdrawal by Subject|54|||
156947222|NCT00023452|566560325|FG000|Overall Study|Adverse Event|139|||
156947223|NCT00023452|566560326|FG001|Overall Study|Adverse Event|196|||
156947224|NCT00023452|566560325|FG000|Overall Study|Lost to Follow-up|293|||
156947225|NCT00023452|566560326|FG001|Overall Study|Lost to Follow-up|60|||
156947226|NCT00023452|566560325|FG000|Overall Study|Physician Decision|49|||
156947227|NCT00023452|566560326|FG001|Overall Study|Physician Decision|21|||
156947228|NCT00023452|566560325|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
156947229|NCT00023452|566560326|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
156947230|NCT00023452|566560325|FG000|Overall Study|Pregnant|53|||
156947231|NCT00023452|566560326|FG001|Overall Study|Pregnant|20|||
156947232|NCT00023452|566560325|FG000|Overall Study|Other|204|||
156947233|NCT00023452|566560326|FG001|Overall Study|Other|69|||
156947234|NCT01994395|566560327|FG000|Overall Study|Withdrawal by Subject|1|||
156947235|NCT01994395|566560328|FG001|Overall Study|Withdrawal by Subject|2|||
156947236|NCT00459134|566560334|FG000|Overall Study|Physician Decision|1|||
156947237|NCT00459134|566560335|FG001|Overall Study|Physician Decision|1|||
156947238|NCT00459134|566560334|FG000|Overall Study|Withdrawal by Subject|8|||
156947239|NCT00459134|566560335|FG001|Overall Study|Withdrawal by Subject|7|||
157033305|NCT04330040|566877514|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
157033306|NCT04330040|566877515|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
157033307|NCT04330040|566877516|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
157033308|NCT04330040|566877514|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
157033309|NCT04330040|566877515|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
157033310|NCT04330040|566877516|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
157033311|NCT04330040|566877514|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
157033312|NCT04330040|566877515|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
157033313|NCT04330040|566877516|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
156947240|NCT00459134|566560334|FG000|Overall Study|Lost to Follow-up|6|||
156947241|NCT00459134|566560335|FG001|Overall Study|Lost to Follow-up|7|||
156947242|NCT00459134|566560334|FG000|Overall Study|Surgery|1|||
156947243|NCT00459134|566560335|FG001|Overall Study|Surgery|2|||
156947244|NCT00459134|566560334|FG000|Overall Study|Toxicity|4|||
156947245|NCT00459134|566560335|FG001|Overall Study|Toxicity|5|||
156947246|NCT00459134|566560334|FG000|Overall Study|Progression|1|||
156947247|NCT00459134|566560335|FG001|Overall Study|Progression|0|||
156947248|NCT00459134|566560334|FG000|Overall Study|Multiple Reasons|2|||
156947249|NCT00459134|566560335|FG001|Overall Study|Multiple Reasons|3|||
156947250|NCT03246529|566560342|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
156947251|NCT03246529|566560343|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
156947252|NCT03246529|566560344|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
156947253|NCT03246529|566560342|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
156947254|NCT03246529|566560343|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
156947255|NCT03246529|566560344|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
156947256|NCT03246529|566560342|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
156947257|NCT03246529|566560343|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
156947258|NCT03246529|566560344|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
156947259|NCT03246529|566560342|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
156947260|NCT03246529|566560343|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
156947261|NCT03246529|566560344|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
156947262|NCT03246529|566560342|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
156947263|NCT03246529|566560343|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
156947264|NCT03246529|566560344|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
156947265|NCT03246529|566560342|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
156947266|NCT03246529|566560343|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
156947267|NCT03246529|566560344|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
156947268|NCT03246529|566560342|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
156947269|NCT03246529|566560343|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
156947270|NCT03246529|566560344|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
156947271|NCT03246529|566560342|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
156947272|NCT03246529|566560343|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
156947273|NCT03246529|566560344|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
156947274|NCT03246529|566560342|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
156947275|NCT03246529|566560343|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
156947276|NCT03246529|566560344|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
156947277|NCT00441337|566560345|FG000|Overall Study|Disease Progression|6|||
156947278|NCT00441337|566560346|FG001|Overall Study|Disease Progression|6|||
156947279|NCT00441337|566560347|FG002|Overall Study|Disease Progression|4|||
156947280|NCT00441337|566560348|FG003|Overall Study|Disease Progression|18|||
156947281|NCT00441337|566560345|FG000|Overall Study|Lost to Follow-up|0|||
156947282|NCT00441337|566560346|FG001|Overall Study|Lost to Follow-up|0|||
156947283|NCT00441337|566560347|FG002|Overall Study|Lost to Follow-up|0|||
156947284|NCT00441337|566560348|FG003|Overall Study|Lost to Follow-up|1|||
156947285|NCT00441337|566560345|FG000|Overall Study|Sponsor Decision|0|||
156947286|NCT00441337|566560346|FG001|Overall Study|Sponsor Decision|0|||
156947287|NCT00441337|566560347|FG002|Overall Study|Sponsor Decision|1|||
156947288|NCT00441337|566560348|FG003|Overall Study|Sponsor Decision|2|||
156947289|NCT00441337|566560345|FG000|Overall Study|Did not meet inclusion criteria|0|||
156947290|NCT00441337|566560346|FG001|Overall Study|Did not meet inclusion criteria|0|||
156947291|NCT00441337|566560347|FG002|Overall Study|Did not meet inclusion criteria|1|||
156947292|NCT00441337|566560348|FG003|Overall Study|Did not meet inclusion criteria|0|||
156947293|NCT01818336|566561522|FG000|Overall Study|Declined retest visit|0|||
156947294|NCT01818336|566561523|FG001|Overall Study|Declined retest visit|11|||
156947295|NCT01818336|566561522|FG000|Overall Study|Lost to Follow-up|0|||
156947296|NCT01818336|566561523|FG001|Overall Study|Lost to Follow-up|1|||
156947297|NCT00975975|566561526|FG000|Overall Study|Death|6|||
156947298|NCT02114892|566561537|FG000|Overall Study|Lost to Follow-up|1|||
156947299|NCT02114892|566561538|FG001|Overall Study|Lost to Follow-up|2|||
156947300|NCT02013765|566561539|FG000|Overall Study|Trial was terminated by sponsor|1|||
156947301|NCT00718042|566561545|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156947302|NCT00718042|566561546|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156947303|NCT00718042|566561547|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156947304|NCT00718042|566561548|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156947305|NCT00718042|566561549|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
156947306|NCT00718042|566561550|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
156947307|NCT00718042|566561545|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
156947308|NCT00718042|566561546|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156947309|NCT00718042|566561547|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156947310|NCT00718042|566561548|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156947311|NCT00718042|566561549|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
156947312|NCT00718042|566561550|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
156947313|NCT00718042|566561545|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156947314|NCT00718042|566561546|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
156947315|NCT00718042|566561547|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
156947316|NCT00718042|566561548|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156947317|NCT00718042|566561549|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156947318|NCT00718042|566561550|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
156947319|NCT00718042|566561545|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
157033314|NCT02994927|566877519|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157033315|NCT02994927|566877520|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157033316|NCT02994927|566877519|FG000|Overall Study|Did not meet eligibility criteria|0|||
157033317|NCT02994927|566877520|FG001|Overall Study|Did not meet eligibility criteria|1|||
157033318|NCT02994927|566877519|FG000|Overall Study|Physician Decision|4|||
157033319|NCT02994927|566877520|FG001|Overall Study|Physician Decision|3|||
157033320|NCT02994927|566877519|FG000|Overall Study|Death|4|||
157033321|NCT02994927|566877520|FG001|Overall Study|Death|2|||
157033322|NCT02994927|566877519|FG000|Overall Study|Adverse Event|2|||
157033323|NCT02994927|566877520|FG001|Overall Study|Adverse Event|1|||
157033324|NCT02994927|566877519|FG000|Overall Study|Withdrawal by Subject|3|||
157033325|NCT02994927|566877520|FG001|Overall Study|Withdrawal by Subject|6|||
157033326|NCT02994927|566877519|FG000|Overall Study|Lost to Follow-up|2|||
157033327|NCT02994927|566877520|FG001|Overall Study|Lost to Follow-up|1|||
157033328|NCT04089865|566879293|FG000|Overall Study|Withdrawal by Subject|2|||
157033329|NCT04089865|566879294|FG001|Overall Study|Withdrawal by Subject|2|||
157033330|NCT04089865|566879295|FG002|Overall Study|Withdrawal by Subject|7|||
157033331|NCT04089865|566879296|FG003|Overall Study|Withdrawal by Subject|2|||
157033332|NCT04282980|566879301|FG000|Overall Study|Remained on treatment|6|||
157033333|NCT04282980|566879301|FG000|Overall Study|Survival follow-up|11|||
157033334|NCT04282980|566879301|FG000|Overall Study|Withdrawal of informed consent|1|||
157033335|NCT04282980|566879301|FG000|Overall Study|Lost to Follow-up|1|||
156947320|NCT00718042|566561546|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
157033336|NCT01917084|566879303|FG000|Overall Study|Withdrawal by Subject|1|||
157033337|NCT03571386|566879304|FG000|Overall Study|scheduling conflict|4|||
156947321|NCT00718042|566561547|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156947322|NCT00718042|566561548|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156947323|NCT00718042|566561549|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156947324|NCT00718042|566561550|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
156947325|NCT00718042|566561545|FG000|Donor Follow-up|Lost to Follow-up|13|||
156947326|NCT00718042|566561546|FG001|Donor Follow-up|Lost to Follow-up|0|||
156947327|NCT00718042|566561547|FG002|Donor Follow-up|Lost to Follow-up|0|||
156947328|NCT00718042|566561548|FG003|Donor Follow-up|Lost to Follow-up|0|||
156947329|NCT00718042|566561549|FG004|Donor Follow-up|Lost to Follow-up|19|||
156947330|NCT00718042|566561550|FG005|Donor Follow-up|Lost to Follow-up|0|||
156947331|NCT04327934|566561551|FG000|Overall Study|Did not qualify|7|||
156947332|NCT04327934|566561552|FG001|Overall Study|Did not qualify|4|||
156947333|NCT04327934|566561551|FG000|Overall Study|Physician Decision|0|||
156947334|NCT04327934|566561552|FG001|Overall Study|Physician Decision|1|||
156947335|NCT02443298|566561553|FG000|Overall Study|Adverse Event|3|||
156947336|NCT02443298|566561554|FG001|Overall Study|Adverse Event|3|||
156947337|NCT02443298|566561553|FG000|Overall Study|Withdrawal by Subject|1|||
156947338|NCT02443298|566561554|FG001|Overall Study|Withdrawal by Subject|2|||
156947339|NCT01260922|566561555|FG000|First Intervention|Withdrawal by Subject|0|||
156947340|NCT01260922|566561556|FG001|First Intervention|Withdrawal by Subject|1|||
156947341|NCT01260922|566561555|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
156947342|NCT01260922|566561556|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
156947343|NCT01260922|566561555|FG000|Second Intervention|Emesis|0|||
156947344|NCT01260922|566561556|FG001|Second Intervention|Emesis|2|||
156947345|NCT01599650|566561557|FG000|Overall Study|Administrative issue|1|||
156947346|NCT01599650|566561558|FG001|Overall Study|Administrative issue|0|||
156947347|NCT01599650|566561559|FG002|Overall Study|Administrative issue|1|||
156947348|NCT01599650|566561557|FG000|Overall Study|Physician Decision|2|||
156947349|NCT01599650|566561558|FG001|Overall Study|Physician Decision|0|||
156947350|NCT01599650|566561559|FG002|Overall Study|Physician Decision|7|||
156947351|NCT01599650|566561557|FG000|Overall Study|Protocol Violation|0|||
156947352|NCT01599650|566561558|FG001|Overall Study|Protocol Violation|3|||
156947353|NCT01599650|566561559|FG002|Overall Study|Protocol Violation|0|||
156947354|NCT01599650|566561557|FG000|Overall Study|Death|2|||
156947355|NCT01599650|566561558|FG001|Overall Study|Death|1|||
156947356|NCT01599650|566561559|FG002|Overall Study|Death|2|||
157033338|NCT03571386|566879305|FG001|Overall Study|scheduling conflict|0|||
157033339|NCT03571386|566879304|FG000|Overall Study|Withdrawal by Subject|15|||
157033340|NCT03571386|566879305|FG001|Overall Study|Withdrawal by Subject|5|||
157033341|NCT02909686|566879313|FG000|Overall Study|Physician Decision|3|||
157033342|NCT02909686|566879313|FG000|Overall Study|Withdrawal by Subject|2|||
156947357|NCT01599650|566561557|FG000|Overall Study|Lost to Follow-up|3|||
157227353|NCT00950807|567577783|FG002|Washout Period 2|Lack of Efficacy|0|||
156947358|NCT01599650|566561558|FG001|Overall Study|Lost to Follow-up|3|||
156947359|NCT01599650|566561559|FG002|Overall Study|Lost to Follow-up|3|||
156947360|NCT01599650|566561557|FG000|Overall Study|Withdrawal by Subject|11|||
156947361|NCT01599650|566561558|FG001|Overall Study|Withdrawal by Subject|11|||
156947362|NCT01599650|566561559|FG002|Overall Study|Withdrawal by Subject|10|||
156947363|NCT01599650|566561557|FG000|Overall Study|Adverse Event|3|||
157033343|NCT04084574|566879315|FG000|Overall Study|Lost to Follow-up|1|||
157033344|NCT04084574|566879316|FG001|Overall Study|Lost to Follow-up|0|||
157033345|NCT04084574|566879315|FG000|Overall Study|Physician Decision|1|||
157033346|NCT04084574|566879316|FG001|Overall Study|Physician Decision|0|||
156947364|NCT01599650|566561558|FG001|Overall Study|Adverse Event|8|||
156947365|NCT01599650|566561559|FG002|Overall Study|Adverse Event|4|||
156947366|NCT01410110|566561560|FG000|Overall Study|Withdrawal by Subject|4|||
156947367|NCT01410110|566561561|FG001|Overall Study|Withdrawal by Subject|2|||
156947368|NCT01416805|566561562|FG000|Overall Study|Lost to Follow-up|4|||
156947369|NCT01416805|566561563|FG001|Overall Study|Lost to Follow-up|4|||
156947370|NCT01700946|566561570|FG000|Overall Study|Lost to Follow-up|1|||
156947371|NCT01700946|566561571|FG001|Overall Study|Lost to Follow-up|0|||
156947372|NCT01700946|566561570|FG000|Overall Study|Physician Decision|7|||
156947373|NCT01700946|566561571|FG001|Overall Study|Physician Decision|12|||
156947374|NCT01700946|566561570|FG000|Overall Study|Withdrawal by Subject|0|||
156947375|NCT01700946|566561571|FG001|Overall Study|Withdrawal by Subject|2|||
156947376|NCT01700946|566561570|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
156947377|NCT01700946|566561571|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
156947378|NCT01700946|566561570|FG000|Overall Study|Relapse|2|||
156947379|NCT01700946|566561571|FG001|Overall Study|Relapse|1|||
156947380|NCT01700946|566561570|FG000|Overall Study|Unacceptable toxicity|1|||
156947381|NCT01700946|566561571|FG001|Overall Study|Unacceptable toxicity|0|||
156947382|NCT00684424|566561576|FG000|Overall Study|Adverse Event|1|||
156947383|NCT00684424|566561576|FG000|Overall Study|Lost to Follow-up|2|||
156947384|NCT00684424|566561576|FG000|Overall Study|Other|2|||
156947385|NCT03062891|566561579|FG000|Overall Study|Withdrawal by Subject|2|||
156947386|NCT03062891|566561580|FG001|Overall Study|Withdrawal by Subject|0|||
156947387|NCT03062891|566561579|FG000|Overall Study|Lost to Follow-up|50|||
156947388|NCT03062891|566561580|FG001|Overall Study|Lost to Follow-up|38|||
156947389|NCT03509948|566561593|FG000|Overall Study|Protocol Violation|0|||
156947390|NCT03509948|566561594|FG001|Overall Study|Protocol Violation|1|||
156947391|NCT03221257|566561595|FG000|Overall Study|Lost to Follow-up|0|||
156947392|NCT03221257|566561596|FG001|Overall Study|Lost to Follow-up|1|||
156947393|NCT03221257|566561595|FG000|Overall Study|Withdrawal by Subject|1|||
156947394|NCT03221257|566561596|FG001|Overall Study|Withdrawal by Subject|1|||
156947395|NCT05402995|566561597|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
156947396|NCT05402995|566561598|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156947397|NCT05402995|566561599|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156947398|NCT05402995|566561600|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
156947399|NCT01334866|566561609|FG000|Overall Study|Withdrawal by Subject|10|||
156947400|NCT01334866|566561609|FG000|Overall Study|Lost to Follow-up|3|||
156947401|NCT01334866|566561609|FG000|Overall Study|Physician Decision|3|||
156947402|NCT01334866|566561609|FG000|Overall Study|medically necessary prior to procedure|2|||
156947403|NCT01334866|566561609|FG000|Overall Study|medically necessary post-procedure|1|||
156947404|NCT02316717|566561618|FG000|Overall Study|Adverse Event|2|||
156947405|NCT02316717|566561619|FG001|Overall Study|Adverse Event|2|||
156947406|NCT02316717|566561620|FG002|Overall Study|Adverse Event|0|||
156947407|NCT02316717|566561618|FG000|Overall Study|Lost to Follow-up|1|||
156947408|NCT02316717|566561619|FG001|Overall Study|Lost to Follow-up|2|||
156947409|NCT02316717|566561620|FG002|Overall Study|Lost to Follow-up|1|||
156947410|NCT02316717|566561618|FG000|Overall Study|Non compliance|3|||
156947411|NCT02316717|566561619|FG001|Overall Study|Non compliance|1|||
156947412|NCT02316717|566561620|FG002|Overall Study|Non compliance|0|||
156947413|NCT02316717|566561618|FG000|Overall Study|Protocol Violation|2|||
156947414|NCT02316717|566561619|FG001|Overall Study|Protocol Violation|0|||
156947415|NCT02316717|566561620|FG002|Overall Study|Protocol Violation|0|||
156947416|NCT02316717|566561618|FG000|Overall Study|Withdrawal by Subject|2|||
156947417|NCT02316717|566561619|FG001|Overall Study|Withdrawal by Subject|1|||
156947418|NCT02316717|566561620|FG002|Overall Study|Withdrawal by Subject|1|||
156947419|NCT02316717|566561618|FG000|Overall Study|Death|0|||
156947420|NCT02316717|566561619|FG001|Overall Study|Death|0|||
156947421|NCT02316717|566561620|FG002|Overall Study|Death|1|||
156947422|NCT02316717|566561618|FG000|Overall Study|Physician Decision|0|||
156947423|NCT02316717|566561619|FG001|Overall Study|Physician Decision|1|||
157227354|NCT00950807|567577784|FG003|Washout Period 2|Lack of Efficacy|0|||
156947424|NCT02316717|566561620|FG002|Overall Study|Physician Decision|0|||
156947425|NCT02316717|566561618|FG000|Overall Study|TBC|1|||
156947426|NCT02316717|566561619|FG001|Overall Study|TBC|0|||
156947427|NCT02316717|566561620|FG002|Overall Study|TBC|0|||
156947428|NCT00183872|566561621|FG000|Overall Study|Death|3|||
156947429|NCT00183872|566561621|FG000|Overall Study|Adverse Event|9|||
156947430|NCT00183872|566561621|FG000|Overall Study|Withdrawal by Subject|2|||
156947431|NCT00183872|566561621|FG000|Overall Study|Drug delayed more than 28 days|2|||
156947432|NCT01208233|566561626|FG000|Overall Study|Adverse Event|0|||
156947433|NCT01208233|566561627|FG001|Overall Study|Adverse Event|1|||
156947434|NCT01208233|566561628|FG002|Overall Study|Adverse Event|2|||
156947435|NCT01208233|566561629|FG003|Overall Study|Adverse Event|0|||
156947436|NCT01208233|566561630|FG004|Overall Study|Adverse Event|3|||
156947437|NCT01208233|566561631|FG005|Overall Study|Adverse Event|5|||
156947438|NCT01208233|566561626|FG000|Overall Study|Death|0|||
156947439|NCT01208233|566561627|FG001|Overall Study|Death|0|||
156947440|NCT01208233|566561628|FG002|Overall Study|Death|0|||
156947441|NCT01208233|566561629|FG003|Overall Study|Death|0|||
156947442|NCT01208233|566561630|FG004|Overall Study|Death|3|||
156947443|NCT01208233|566561631|FG005|Overall Study|Death|5|||
156947444|NCT01208233|566561626|FG000|Overall Study|Did not meet entrance criteria|2|||
156947445|NCT01208233|566561627|FG001|Overall Study|Did not meet entrance criteria|1|||
156947446|NCT01208233|566561628|FG002|Overall Study|Did not meet entrance criteria|1|||
156947447|NCT01208233|566561629|FG003|Overall Study|Did not meet entrance criteria|0|||
156947448|NCT01208233|566561630|FG004|Overall Study|Did not meet entrance criteria|1|||
156947449|NCT01208233|566561631|FG005|Overall Study|Did not meet entrance criteria|0|||
156947450|NCT01208233|566561626|FG000|Overall Study|Medication error without adverse event|0|||
156947451|NCT01208233|566561627|FG001|Overall Study|Medication error without adverse event|0|||
156947452|NCT01208233|566561628|FG002|Overall Study|Medication error without adverse event|0|||
156947453|NCT01208233|566561629|FG003|Overall Study|Medication error without adverse event|0|||
156947454|NCT01208233|566561630|FG004|Overall Study|Medication error without adverse event|0|||
156947455|NCT01208233|566561631|FG005|Overall Study|Medication error without adverse event|1|||
156947456|NCT01208233|566561626|FG000|Overall Study|Study terminated by sponsor|0|||
156947457|NCT01208233|566561627|FG001|Overall Study|Study terminated by sponsor|0|||
156947458|NCT01208233|566561628|FG002|Overall Study|Study terminated by sponsor|0|||
156947459|NCT01208233|566561629|FG003|Overall Study|Study terminated by sponsor|0|||
156947460|NCT01208233|566561630|FG004|Overall Study|Study terminated by sponsor|10|||
156947461|NCT01208233|566561631|FG005|Overall Study|Study terminated by sponsor|7|||
156947462|NCT01208233|566561626|FG000|Overall Study|Protocol Violation|0|||
156947463|NCT01208233|566561627|FG001|Overall Study|Protocol Violation|0|||
156947464|NCT01208233|566561628|FG002|Overall Study|Protocol Violation|0|||
156947465|NCT01208233|566561629|FG003|Overall Study|Protocol Violation|0|||
156947466|NCT01208233|566561630|FG004|Overall Study|Protocol Violation|3|||
156947467|NCT01208233|566561631|FG005|Overall Study|Protocol Violation|0|||
156947468|NCT01208233|566561626|FG000|Overall Study|Other|2|||
156947469|NCT01208233|566561627|FG001|Overall Study|Other|1|||
156947470|NCT01208233|566561628|FG002|Overall Study|Other|0|||
156947471|NCT01208233|566561629|FG003|Overall Study|Other|0|||
156947472|NCT01208233|566561630|FG004|Overall Study|Other|0|||
156947473|NCT01208233|566561631|FG005|Overall Study|Other|1|||
156947474|NCT01208233|566561626|FG000|Overall Study|Withdrawal by Subject|1|||
156947475|NCT01208233|566561627|FG001|Overall Study|Withdrawal by Subject|0|||
156947476|NCT01208233|566561628|FG002|Overall Study|Withdrawal by Subject|1|||
156947477|NCT01208233|566561629|FG003|Overall Study|Withdrawal by Subject|1|||
156947478|NCT01208233|566561630|FG004|Overall Study|Withdrawal by Subject|4|||
156947479|NCT01208233|566561631|FG005|Overall Study|Withdrawal by Subject|2|||
156947480|NCT05789875|566561639|FG000|Overall Study|Lost to Follow-up|6|||
156947481|NCT03333486|566561644|FG000|Overall Study|Withdrawal by Subject|1|||
156947482|NCT03333486|566561644|FG000|Overall Study|Lost to Follow-up|1|||
156947483|NCT01755416|566561648|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
156947484|NCT01755416|566561649|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
156947485|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
156947486|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
156947487|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
156947488|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Death|1|||
156947489|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Death|0|||
156947490|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Death|0|||
156947491|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
156947492|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
156947493|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
156947494|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
156947495|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
156947496|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
156947497|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
156947498|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
156947499|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
156947500|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
156947501|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
156947502|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
156947503|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
156947504|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
156947505|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
156947506|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
156947507|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
156947508|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
157033347|NCT04084574|566879315|FG000|Overall Study|Relocated out of state|1|||
157033348|NCT04084574|566879316|FG001|Overall Study|Relocated out of state|0|||
157033349|NCT01121588|566879317|FG000|Overall Study|Death|5|||
157033350|NCT01121588|566879318|FG001|Overall Study|Death|3|||
157033351|NCT01121588|566879319|FG002|Overall Study|Death|13|||
157033352|NCT01121588|566879317|FG000|Overall Study|Study Terminated by Sponsor|1|||
157033353|NCT01121588|566879318|FG001|Overall Study|Study Terminated by Sponsor|1|||
157033354|NCT01121588|566879319|FG002|Overall Study|Study Terminated by Sponsor|0|||
157033355|NCT01121588|566879317|FG000|Overall Study|Participant Refused Further Followup|2|||
157033356|NCT01121588|566879318|FG001|Overall Study|Participant Refused Further Followup|0|||
157033357|NCT01121588|566879319|FG002|Overall Study|Participant Refused Further Followup|2|||
157033358|NCT01121588|566879317|FG000|Overall Study|Lost to Follow-up|0|||
157033359|NCT01121588|566879318|FG001|Overall Study|Lost to Follow-up|1|||
157033360|NCT01121588|566879319|FG002|Overall Study|Lost to Follow-up|1|||
157033361|NCT01121588|566879317|FG000|Overall Study|Non-Specified Reasons|9|||
157033362|NCT01121588|566879318|FG001|Overall Study|Non-Specified Reasons|4|||
157033363|NCT01121588|566879319|FG002|Overall Study|Non-Specified Reasons|2|||
157033364|NCT00942877|566879320|FG000|Overall Study|Refused further treatment|1|||
157033365|NCT00942877|566879321|FG001|Overall Study|Refused further treatment|1|||
157033366|NCT00942877|566879320|FG000|Overall Study|Patient was not treated|1|||
157033367|NCT00942877|566879321|FG001|Overall Study|Patient was not treated|0|||
157033368|NCT00942877|566879320|FG000|Overall Study|Adverse Event|1|||
157033369|NCT00942877|566879321|FG001|Overall Study|Adverse Event|0|||
157033370|NCT00942877|566879320|FG000|Overall Study|Progressive disease|42|||
157033371|NCT00942877|566879321|FG001|Overall Study|Progressive disease|3|||
157033372|NCT05007080|566879322|FG000|Overall Study|Lost to Follow-up|0|||
157033373|NCT05007080|566879323|FG001|Overall Study|Lost to Follow-up|1|||
157033374|NCT05007080|566879324|FG002|Overall Study|Lost to Follow-up|0|||
157033375|NCT05007080|566879325|FG003|Overall Study|Lost to Follow-up|1|||
157033376|NCT05007080|566879326|FG004|Overall Study|Lost to Follow-up|1|||
157033377|NCT05007080|566879327|FG005|Overall Study|Lost to Follow-up|1|||
157033378|NCT05007080|566879322|FG000|Overall Study|Death|0|||
157033379|NCT05007080|566879323|FG001|Overall Study|Death|1|||
157033380|NCT05007080|566879324|FG002|Overall Study|Death|0|||
157033381|NCT05007080|566879325|FG003|Overall Study|Death|0|||
157033382|NCT05007080|566879326|FG004|Overall Study|Death|0|||
157033383|NCT05007080|566879327|FG005|Overall Study|Death|0|||
157033384|NCT05007080|566879322|FG000|Overall Study|Withdrawal by Subject|1|||
157033385|NCT05007080|566879323|FG001|Overall Study|Withdrawal by Subject|2|||
157033386|NCT05007080|566879324|FG002|Overall Study|Withdrawal by Subject|0|||
157033387|NCT05007080|566879325|FG003|Overall Study|Withdrawal by Subject|2|||
157033388|NCT05007080|566879326|FG004|Overall Study|Withdrawal by Subject|1|||
157033389|NCT05007080|566879327|FG005|Overall Study|Withdrawal by Subject|1|||
157033390|NCT05007080|566879322|FG000|Overall Study|Other|1|||
157033391|NCT05007080|566879323|FG001|Overall Study|Other|0|||
157033392|NCT05007080|566879324|FG002|Overall Study|Other|1|||
157033393|NCT05007080|566879325|FG003|Overall Study|Other|1|||
157033394|NCT05007080|566879326|FG004|Overall Study|Other|0|||
157033395|NCT05007080|566879327|FG005|Overall Study|Other|2|||
157033396|NCT05007080|566879322|FG000|Overall Study|Randomized not vaccinated|0|||
157033397|NCT05007080|566879323|FG001|Overall Study|Randomized not vaccinated|0|||
157033398|NCT05007080|566879324|FG002|Overall Study|Randomized not vaccinated|0|||
157033399|NCT05007080|566879325|FG003|Overall Study|Randomized not vaccinated|0|||
157167581|NCT01653158|567354622|FG006|Overall Study|Adverse Event|0|||
157167582|NCT01653158|567354623|FG007|Overall Study|Adverse Event|3|||
157167583|NCT01653158|567354616|FG000|Overall Study|Other|0|||
157167584|NCT01653158|567354617|FG001|Overall Study|Other|0|||
157167585|NCT01653158|567354618|FG002|Overall Study|Other|0|||
156947509|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
156947510|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
156947511|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
156947512|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
156947513|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
156947514|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
156947515|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
156947516|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
157033400|NCT05007080|566879326|FG004|Overall Study|Randomized not vaccinated|0|||
157033401|NCT05007080|566879327|FG005|Overall Study|Randomized not vaccinated|1|||
157033402|NCT00964392|566879328|FG000|Overall Study|Withdrawal by Subject|4|||
157033403|NCT00964392|566879329|FG001|Overall Study|Withdrawal by Subject|6|||
157033404|NCT00964392|566879328|FG000|Overall Study|Lost to Follow-up|4|||
157033405|NCT00964392|566879329|FG001|Overall Study|Lost to Follow-up|10|||
157167586|NCT01653158|567354619|FG003|Overall Study|Other|0|||
157167587|NCT01653158|567354620|FG004|Overall Study|Other|0|||
157033406|NCT00964392|566879328|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
157033407|NCT00964392|566879329|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
157033408|NCT00964392|566879328|FG000|Overall Study|Not completed|44|||
157033409|NCT00964392|566879329|FG001|Overall Study|Not completed|168|||
157167588|NCT01653158|567354621|FG005|Overall Study|Other|0|||
157033410|NCT00631475|566879330|FG000|Overall Study|Death|18|||
157033411|NCT00631475|566879330|FG000|Overall Study|Adverse Event|14|||
157167589|NCT01653158|567354622|FG006|Overall Study|Other|0|||
157167590|NCT01653158|567354623|FG007|Overall Study|Other|1|||
157167591|NCT01653158|567354616|FG000|Overall Study|Progressive disease|0|||
157167592|NCT01653158|567354617|FG001|Overall Study|Progressive disease|0|||
157167593|NCT01653158|567354618|FG002|Overall Study|Progressive disease|0|||
157167594|NCT01653158|567354619|FG003|Overall Study|Progressive disease|0|||
157167595|NCT01653158|567354620|FG004|Overall Study|Progressive disease|1|||
157167596|NCT01653158|567354621|FG005|Overall Study|Progressive disease|1|||
157167597|NCT01653158|567354622|FG006|Overall Study|Progressive disease|2|||
157167598|NCT01653158|567354623|FG007|Overall Study|Progressive disease|9|||
156947517|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
156947518|NCT03655236|566561652|FG000|Subject Disposition in Part 1 Period|Other|0|||
156947519|NCT03655236|566561653|FG001|Subject Disposition in Part 1 Period|Other|2|||
156947520|NCT03655236|566561654|FG002|Subject Disposition in Part 1 Period|Other|2|||
156947521|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
156947522|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
156947523|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
156947524|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
156947525|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
156947526|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
156947527|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
156947528|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
156947529|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
156947530|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
156947531|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
156947532|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
156947533|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
156947534|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
156947535|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
156947536|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
156947537|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
156947538|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
156947539|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
156947540|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
156947541|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
156947542|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
156947543|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
156947544|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
156947545|NCT03655236|566561652|FG000|Subject Disposition in Part 2 Period|Other|1|||
156947546|NCT03655236|566561653|FG001|Subject Disposition in Part 2 Period|Other|0|||
156947547|NCT03655236|566561654|FG002|Subject Disposition in Part 2 Period|Other|0|||
156947548|NCT06748040|566561655|FG000|Overall Study|Death|3|||
156947549|NCT06748040|566561656|FG001|Overall Study|Death|4|||
156947550|NCT06748040|566561655|FG000|Overall Study|Lost to Follow-up|134|||
156947551|NCT06748040|566561656|FG001|Overall Study|Lost to Follow-up|132|||
156947552|NCT06748040|566561655|FG000|Overall Study|Withdrawal by Subject|3|||
156947553|NCT06748040|566561656|FG001|Overall Study|Withdrawal by Subject|5|||
156947554|NCT03136068|566563540|FG000|Overall Study|Lost to Follow-up|1|||
156947555|NCT03136068|566563541|FG001|Overall Study|Lost to Follow-up|1|||
156947556|NCT03136068|566563540|FG000|Overall Study|Protocol Violation|1|||
156947557|NCT03136068|566563541|FG001|Overall Study|Protocol Violation|0|||
156947558|NCT00432380|566563545|FG000|Overall Study|Migrated/moved from study area|3|||
156947559|NCT00432380|566563546|FG001|Overall Study|Migrated/moved from study area|4|||
156947560|NCT00432380|566563547|FG002|Overall Study|Migrated/moved from study area|1|||
156947561|NCT00432380|566563545|FG000|Overall Study|Adverse Event|1|||
156947562|NCT00432380|566563546|FG001|Overall Study|Adverse Event|0|||
156947563|NCT00432380|566563547|FG002|Overall Study|Adverse Event|0|||
156947564|NCT01071395|566563555|FG000|Overall Study|Withdrawal by Subject|2|||
156947565|NCT01071395|566563556|FG001|Overall Study|Withdrawal by Subject|1|||
156947566|NCT01071395|566563555|FG000|Overall Study|Adverse Event|3|||
156947567|NCT01071395|566563556|FG001|Overall Study|Adverse Event|1|||
156947568|NCT02805257|566563557|FG000|Overall Study|Lost to Follow-up|7|||
156947569|NCT02805257|566563558|FG001|Overall Study|Lost to Follow-up|6|||
156947570|NCT02805257|566563557|FG000|Overall Study|Death|0|||
156947571|NCT02805257|566563558|FG001|Overall Study|Death|1|||
156947572|NCT00612066|566563559|FG000|Overall Study|Adverse Event|1|||
156947573|NCT01043874|566563563|FG000|Overall Study|Adverse Event|3|||
156947574|NCT01043874|566563563|FG000|Overall Study|Withdrawal by Subject|1|||
156947575|NCT01043874|566563563|FG000|Overall Study|Lack of Efficacy|1|||
156947576|NCT01043874|566563563|FG000|Overall Study|Administrative Problems|1|||
156947577|NCT03422003|566563564|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
157167599|NCT01653158|567354616|FG000|Overall Study|Withdrawal by Subject|1|||
157167600|NCT01653158|567354617|FG001|Overall Study|Withdrawal by Subject|0|||
157167601|NCT01653158|567354618|FG002|Overall Study|Withdrawal by Subject|0|||
157167602|NCT01653158|567354619|FG003|Overall Study|Withdrawal by Subject|0|||
157167603|NCT01653158|567354620|FG004|Overall Study|Withdrawal by Subject|0|||
157167604|NCT01653158|567354621|FG005|Overall Study|Withdrawal by Subject|0|||
156947578|NCT03422003|566563565|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
156947579|NCT03422003|566563564|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
156947580|NCT03422003|566563565|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
156947581|NCT01337089|566563566|FG000|Overall Study|Adverse Event|237|||
156947582|NCT01337089|566563566|FG000|Overall Study|Withdrawal by Subject|129|||
156947583|NCT01337089|566563566|FG000|Overall Study|Withdrawal by Investigator|33|||
156947584|NCT01337089|566563566|FG000|Overall Study|Met Withdrawal Criteria|3|||
156947585|NCT01337089|566563566|FG000|Overall Study|Lost to Follow-up|2|||
156947586|NCT01404312|566563567|FG000|Overall Study|Death|21|||
156947587|NCT01404312|566563568|FG001|Overall Study|Death|27|||
156947588|NCT01404312|566563567|FG000|Overall Study|Withdrawal by Subject|15|||
156947589|NCT01404312|566563568|FG001|Overall Study|Withdrawal by Subject|18|||
156947590|NCT01404312|566563567|FG000|Overall Study|Participant Unable to get to clinic|93|||
156947591|NCT01404312|566563568|FG001|Overall Study|Participant Unable to get to clinic|103|||
156947592|NCT01404312|566563567|FG000|Overall Study|Lost to Follow-up|115|||
156947593|NCT01404312|566563568|FG001|Overall Study|Lost to Follow-up|111|||
156947594|NCT01404312|566563567|FG000|Overall Study|Site closed|22|||
156947595|NCT01404312|566563568|FG001|Overall Study|Site closed|21|||
156947596|NCT01404312|566563567|FG000|Overall Study|Participant not willing to adhere to req|31|||
156947597|NCT01404312|566563568|FG001|Overall Study|Participant not willing to adhere to req|29|||
156947598|NCT01404312|566563567|FG000|Overall Study|Severe debilitation, unable to continue|1|||
156947599|NCT01404312|566563568|FG001|Overall Study|Severe debilitation, unable to continue|2|||
156947600|NCT04419493|566563569|FG000|Wash-out After Period 1|Adverse Event|1|||
156947601|NCT04419493|566563570|FG001|Wash-out After Period 1|Adverse Event|2|||
156947602|NCT04419493|566563571|FG002|Wash-out After Period 1|Adverse Event|1|||
156947603|NCT04419493|566563572|FG003|Wash-out After Period 1|Adverse Event|0|||
156947604|NCT00524134|566563573|FG000|Overall Study|Withdrawal by Subject|1|||
156947605|NCT00524134|566563573|FG000|Overall Study|Physician Decision|1|||
156947606|NCT03266588|566563574|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
156947607|NCT03266588|566563575|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
156947608|NCT03266588|566563576|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
156947609|NCT03266588|566563574|FG000|Observational Period|Withdrawal by Subject|44|||
156947610|NCT03266588|566563575|FG001|Observational Period|Withdrawal by Subject|22|||
156947611|NCT03266588|566563576|FG002|Observational Period|Withdrawal by Subject|13|||
156947612|NCT03266588|566563574|FG000|Observational Period|Non-compliance|18|||
156947613|NCT03266588|566563575|FG001|Observational Period|Non-compliance|12|||
156947614|NCT03266588|566563576|FG002|Observational Period|Non-compliance|10|||
156947615|NCT03266588|566563574|FG000|Observational Period|Lost to Follow-up|8|||
156947616|NCT03266588|566563575|FG001|Observational Period|Lost to Follow-up|12|||
156947617|NCT03266588|566563576|FG002|Observational Period|Lost to Follow-up|4|||
156947618|NCT03266588|566563574|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
156947619|NCT03266588|566563575|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
156947620|NCT03266588|566563576|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
156947621|NCT03266588|566563574|FG000|Observational Period|Protocol Deviation|1|||
156947622|NCT03266588|566563575|FG001|Observational Period|Protocol Deviation|0|||
156947623|NCT03266588|566563576|FG002|Observational Period|Protocol Deviation|0|||
156947624|NCT03266588|566563574|FG000|Observational Period|Other Reasons|3|||
156947625|NCT03266588|566563575|FG001|Observational Period|Other Reasons|0|||
156947626|NCT03266588|566563576|FG002|Observational Period|Other Reasons|1|||
156947627|NCT03266588|566563574|FG000|Long-term Treatment Period|Adverse Event|33|||
156947628|NCT03266588|566563575|FG001|Long-term Treatment Period|Adverse Event|17|||
156947629|NCT03266588|566563576|FG002|Long-term Treatment Period|Adverse Event|8|||
156947630|NCT03266588|566563574|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
156947631|NCT03266588|566563575|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
156947632|NCT03266588|566563576|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
156947633|NCT03266588|566563574|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
156947634|NCT03266588|566563575|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
156947635|NCT03266588|566563576|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
156947636|NCT03266588|566563574|FG000|Long-term Treatment Period|Non-Compliance|126|||
156947637|NCT03266588|566563575|FG001|Long-term Treatment Period|Non-Compliance|57|||
156947638|NCT03266588|566563576|FG002|Long-term Treatment Period|Non-Compliance|7|||
157167605|NCT01653158|567354622|FG006|Overall Study|Withdrawal by Subject|0|||
157167606|NCT01653158|567354623|FG007|Overall Study|Withdrawal by Subject|0|||
157167607|NCT02310906|567354634|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
157167608|NCT02310906|567354635|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
157205217|NCT03669640|567496077|FG004|Overall Study|Lost to Follow-up|0|||
157033412|NCT00631475|566879330|FG000|Overall Study|Withdrew consent|5|||
157033413|NCT00631475|566879330|FG000|Overall Study|Preparation for lung transplant|8|||
157033414|NCT02492711|566879333|FG000|Overall Study|Adverse Event|9|||
157033415|NCT02492711|566879334|FG001|Overall Study|Adverse Event|9|||
157033416|NCT02492711|566879335|FG002|Overall Study|Adverse Event|2|||
157033417|NCT02492711|566879333|FG000|Overall Study|Death|3|||
157033418|NCT02492711|566879334|FG001|Overall Study|Death|3|||
157033419|NCT02492711|566879335|FG002|Overall Study|Death|0|||
157033420|NCT02492711|566879333|FG000|Overall Study|Withdrawal by Subject|10|||
157033421|NCT02492711|566879334|FG001|Overall Study|Withdrawal by Subject|16|||
157033422|NCT02492711|566879335|FG002|Overall Study|Withdrawal by Subject|5|||
157033423|NCT02492711|566879333|FG000|Overall Study|Physician Decision|10|||
157033424|NCT02492711|566879334|FG001|Overall Study|Physician Decision|6|||
157033425|NCT02492711|566879335|FG002|Overall Study|Physician Decision|4|||
157033426|NCT02492711|566879333|FG000|Overall Study|Lost to Follow-up|0|||
157033427|NCT02492711|566879334|FG001|Overall Study|Lost to Follow-up|0|||
157033428|NCT02492711|566879335|FG002|Overall Study|Lost to Follow-up|1|||
157033429|NCT02492711|566879333|FG000|Overall Study|study treatment delay|2|||
157033430|NCT02492711|566879334|FG001|Overall Study|study treatment delay|1|||
157033431|NCT02492711|566879335|FG002|Overall Study|study treatment delay|0|||
157033432|NCT02492711|566879333|FG000|Overall Study|change in chemotherapy|0|||
157033433|NCT02492711|566879334|FG001|Overall Study|change in chemotherapy|1|||
157033434|NCT02492711|566879335|FG002|Overall Study|change in chemotherapy|0|||
157033435|NCT02492711|566879333|FG000|Overall Study|never treated|2|||
157033436|NCT02492711|566879334|FG001|Overall Study|never treated|4|||
157033437|NCT02492711|566879335|FG002|Overall Study|never treated|0|||
157033438|NCT02492711|566879333|FG000|Overall Study|Other|0|||
157033439|NCT02492711|566879334|FG001|Overall Study|Other|0|||
157033440|NCT02492711|566879335|FG002|Overall Study|Other|1|||
157033441|NCT05830799|566879340|FG000|Overall Study|Withdrawal by Subject|1|||
157033442|NCT03652272|566879341|FG000|3 Month|Withdrawal by Subject|1|||
157033443|NCT03652272|566879342|FG001|3 Month|Withdrawal by Subject|1|||
157033444|NCT03652272|566879341|FG000|3 Month|Lost to Follow-up|16|||
157033445|NCT03652272|566879342|FG001|3 Month|Lost to Follow-up|14|||
157033446|NCT04369911|566879354|FG000|Overall Study|Lost to Follow-up|3|||
157033447|NCT04369911|566879355|FG001|Overall Study|Lost to Follow-up|3|||
157033448|NCT04369911|566879354|FG000|Overall Study|Withdrawal by Subject|1|||
157033449|NCT04369911|566879355|FG001|Overall Study|Withdrawal by Subject|2|||
157033450|NCT04163991|566879356|FG000|Overall Study|Adverse Event|0|||
157033451|NCT04163991|566879357|FG001|Overall Study|Adverse Event|0|||
157033452|NCT04163991|566879358|FG002|Overall Study|Adverse Event|0|||
157033453|NCT04163991|566879359|FG003|Overall Study|Adverse Event|1|||
157033454|NCT04163991|566879360|FG004|Overall Study|Adverse Event|0|||
157033455|NCT04163991|566879356|FG000|Overall Study|Death|0|||
157033456|NCT04163991|566879357|FG001|Overall Study|Death|0|||
157033457|NCT04163991|566879358|FG002|Overall Study|Death|1|||
157167609|NCT02310906|567354636|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
157167610|NCT02310906|567354637|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
157167611|NCT02310906|567354634|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
157167612|NCT02310906|567354635|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
157033458|NCT04163991|566879359|FG003|Overall Study|Death|0|||
157033459|NCT04163991|566879360|FG004|Overall Study|Death|0|||
157033460|NCT04163991|566879356|FG000|Overall Study|Lost to Follow-up|0|||
157033461|NCT04163991|566879357|FG001|Overall Study|Lost to Follow-up|1|||
157033462|NCT04163991|566879358|FG002|Overall Study|Lost to Follow-up|0|||
157033463|NCT04163991|566879359|FG003|Overall Study|Lost to Follow-up|0|||
157033464|NCT04163991|566879360|FG004|Overall Study|Lost to Follow-up|0|||
157033465|NCT04163991|566879356|FG000|Overall Study|Withdrawal by Subject|1|||
157033466|NCT04163991|566879357|FG001|Overall Study|Withdrawal by Subject|1|||
157033467|NCT04163991|566879358|FG002|Overall Study|Withdrawal by Subject|3|||
157167613|NCT02310906|567354636|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
157167614|NCT02310906|567354637|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
157167615|NCT02310906|567354634|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
157167616|NCT02310906|567354635|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
157033468|NCT04163991|566879359|FG003|Overall Study|Withdrawal by Subject|1|||
157167617|NCT02310906|567354636|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
157033469|NCT04163991|566879360|FG004|Overall Study|Withdrawal by Subject|1|||
157033470|NCT04163991|566879356|FG000|Overall Study|Other, Not Specified|0|||
157033471|NCT04163991|566879357|FG001|Overall Study|Other, Not Specified|1|||
157033472|NCT04163991|566879358|FG002|Overall Study|Other, Not Specified|1|||
157033473|NCT04163991|566879359|FG003|Overall Study|Other, Not Specified|1|||
157033474|NCT04163991|566879360|FG004|Overall Study|Other, Not Specified|0|||
157033475|NCT05953740|566879361|FG000|Period 1|Physician Decision|0|||
157033476|NCT05953740|566879362|FG001|Period 1|Physician Decision|1|||
157033477|NCT05953740|566879363|FG002|Period 1|Physician Decision|0|||
157033478|NCT05953740|566879364|FG003|Period 1|Physician Decision|0|||
157033479|NCT05953740|566879365|FG004|Period 1|Physician Decision|0|||
157167618|NCT02310906|567354637|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
156947639|NCT03266588|566563574|FG000|Long-term Treatment Period|Pregnancy|11|||
156947640|NCT03266588|566563575|FG001|Long-term Treatment Period|Pregnancy|5|||
156947641|NCT03266588|566563576|FG002|Long-term Treatment Period|Pregnancy|0|||
156947642|NCT03266588|566563574|FG000|Long-term Treatment Period|Protocol Deviation|17|||
156947643|NCT03266588|566563575|FG001|Long-term Treatment Period|Protocol Deviation|10|||
156947644|NCT03266588|566563576|FG002|Long-term Treatment Period|Protocol Deviation|4|||
156947645|NCT03266588|566563574|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
156947646|NCT03266588|566563575|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
156947647|NCT03266588|566563576|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
156947648|NCT03266588|566563574|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
156947649|NCT03266588|566563575|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
156947650|NCT03266588|566563576|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
156947651|NCT03266588|566563574|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
156947652|NCT03266588|566563575|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
156947653|NCT03266588|566563576|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
156947654|NCT03266588|566563574|FG000|Long-term Treatment Period|Other Reasons|5|||
156947655|NCT03266588|566563575|FG001|Long-term Treatment Period|Other Reasons|0|||
156947656|NCT03266588|566563576|FG002|Long-term Treatment Period|Other Reasons|0|||
156947657|NCT03266588|566563574|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
156947658|NCT03266588|566563575|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
156947659|NCT03266588|566563576|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
156947660|NCT02627677|566563578|FG000|Overall Study|Adverse event (not progressive disease)|1|||
156947661|NCT02627677|566563579|FG001|Overall Study|Adverse event (not progressive disease)|4|||
156947662|NCT02627677|566563580|FG002|Overall Study|Adverse event (not progressive disease)|1|||
156947663|NCT02627677|566563578|FG000|Overall Study|Progressive disease|1|||
156947664|NCT02627677|566563579|FG001|Overall Study|Progressive disease|3|||
156947665|NCT02627677|566563580|FG002|Overall Study|Progressive disease|0|||
156947666|NCT02627677|566563578|FG000|Overall Study|Lack of Efficacy|1|||
156947667|NCT02627677|566563579|FG001|Overall Study|Lack of Efficacy|2|||
156947668|NCT02627677|566563580|FG002|Overall Study|Lack of Efficacy|0|||
156947669|NCT02627677|566563578|FG000|Overall Study|Lost to Follow-up|0|||
156947670|NCT02627677|566563579|FG001|Overall Study|Lost to Follow-up|0|||
156947671|NCT02627677|566563580|FG002|Overall Study|Lost to Follow-up|1|||
156947672|NCT02627677|566563578|FG000|Overall Study|Pregnancy|0|||
156947673|NCT02627677|566563579|FG001|Overall Study|Pregnancy|1|||
156947674|NCT02627677|566563580|FG002|Overall Study|Pregnancy|0|||
156947675|NCT02627677|566563578|FG000|Overall Study|Study Terminated by Sponsor|5|||
156947676|NCT02627677|566563579|FG001|Overall Study|Study Terminated by Sponsor|10|||
156947677|NCT02627677|566563580|FG002|Overall Study|Study Terminated by Sponsor|6|||
156947678|NCT02627677|566563578|FG000|Overall Study|Physician Decision|0|||
156947679|NCT02627677|566563579|FG001|Overall Study|Physician Decision|0|||
156947680|NCT02627677|566563580|FG002|Overall Study|Physician Decision|2|||
156947681|NCT02627677|566563578|FG000|Overall Study|Withdrawal by Subject|2|||
156947682|NCT02627677|566563579|FG001|Overall Study|Withdrawal by Subject|1|||
156947683|NCT02627677|566563580|FG002|Overall Study|Withdrawal by Subject|1|||
156947684|NCT02627677|566563578|FG000|Overall Study|Reason not Specified|0|||
156947685|NCT02627677|566563579|FG001|Overall Study|Reason not Specified|0|||
156947686|NCT02627677|566563580|FG002|Overall Study|Reason not Specified|1|||
156947687|NCT02627677|566563578|FG000|Overall Study|Randomized but not Treated|1|||
156947688|NCT02627677|566563579|FG001|Overall Study|Randomized but not Treated|0|||
156947689|NCT02627677|566563580|FG002|Overall Study|Randomized but not Treated|0|||
156947690|NCT03087591|566563583|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
156947691|NCT03087591|566563583|FG000|Overall Study|Withdrawal by Subject|1|||
156947692|NCT01073618|566563586|FG000|Overall Study|Death|208|||
156947693|NCT01073618|566563586|FG000|Overall Study|Adverse Event|19|||
156947694|NCT01073618|566563586|FG000|Overall Study|Other|80|||
156947695|NCT02696850|566563587|FG000|Overall Study|Withdrawal by Subject|3|||
156947696|NCT02696850|566563588|FG001|Overall Study|Withdrawal by Subject|3|||
156947697|NCT02696850|566563587|FG000|Overall Study|Lost to Follow-up|8|||
156947698|NCT02696850|566563588|FG001|Overall Study|Lost to Follow-up|5|||
156947699|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
156947700|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
156947701|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
156947702|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
156947703|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Death|235|||
156947704|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Death|167|||
156947705|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Death|1|||
156947706|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Death|0|||
156947707|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
156947708|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
156947709|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
157167619|NCT02310906|567354634|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
156947710|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
156947711|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
156947712|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
156947713|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
156947714|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
156947715|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Other|1|||
156947716|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Other|2|||
156947717|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Other|0|||
156947718|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Other|0|||
156947719|NCT00673049|566563591|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
156947720|NCT00673049|566563592|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
156947721|NCT00673049|566563593|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
156947722|NCT00673049|566563594|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
156947723|NCT00673049|566563591|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
156947724|NCT00673049|566563592|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
156947725|NCT00673049|566563593|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
156947726|NCT00673049|566563594|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
156947727|NCT00673049|566563591|FG000|After Progression on Erlotinib|Death|0|||
156947728|NCT00673049|566563592|FG001|After Progression on Erlotinib|Death|0|||
156947729|NCT00673049|566563593|FG002|After Progression on Erlotinib|Death|0|||
156947730|NCT00673049|566563594|FG003|After Progression on Erlotinib|Death|71|||
156947731|NCT00673049|566563591|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
156947732|NCT00673049|566563592|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
156947733|NCT00673049|566563593|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
156947734|NCT00673049|566563594|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
156947735|NCT00673049|566563591|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
156947736|NCT00673049|566563592|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
156947737|NCT00673049|566563593|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
156947738|NCT00673049|566563594|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
156947739|NCT00673049|566563591|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
156947740|NCT00673049|566563592|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
156947741|NCT00673049|566563593|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
156947742|NCT00673049|566563594|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
156947743|NCT01933334|566563601|FG000|Overall Study|Adverse Event|5|||
156947744|NCT01933334|566563602|FG001|Overall Study|Adverse Event|1|||
156947745|NCT01933334|566563601|FG000|Overall Study|Withdrawal by Subject|0|||
156947746|NCT01933334|566563602|FG001|Overall Study|Withdrawal by Subject|1|||
156947747|NCT00767000|566563603|FG000|54-week Study|Adverse Event|4|||
156947748|NCT00767000|566563604|FG001|54-week Study|Adverse Event|6|||
156947749|NCT00767000|566563605|FG002|54-week Study|Adverse Event|6|||
156947750|NCT00767000|566563606|FG003|54-week Study|Adverse Event|8|||
156947751|NCT00767000|566563607|FG004|54-week Study|Adverse Event|4|||
156947752|NCT00767000|566563603|FG000|54-week Study|Creaninine/creatinine clearance|2|||
156947753|NCT00767000|566563604|FG001|54-week Study|Creaninine/creatinine clearance|1|||
156947754|NCT00767000|566563605|FG002|54-week Study|Creaninine/creatinine clearance|2|||
156947755|NCT00767000|566563606|FG003|54-week Study|Creaninine/creatinine clearance|2|||
156947756|NCT00767000|566563607|FG004|54-week Study|Creaninine/creatinine clearance|4|||
156947757|NCT00767000|566563603|FG000|54-week Study|Hyperglycemia|0|||
156947758|NCT00767000|566563604|FG001|54-week Study|Hyperglycemia|0|||
156947759|NCT00767000|566563605|FG002|54-week Study|Hyperglycemia|1|||
156947760|NCT00767000|566563606|FG003|54-week Study|Hyperglycemia|0|||
156947761|NCT00767000|566563607|FG004|54-week Study|Hyperglycemia|1|||
156947762|NCT00767000|566563603|FG000|54-week Study|Hypoglycemia|0|||
156947763|NCT00767000|566563604|FG001|54-week Study|Hypoglycemia|1|||
156947764|NCT00767000|566563605|FG002|54-week Study|Hypoglycemia|0|||
156947765|NCT00767000|566563606|FG003|54-week Study|Hypoglycemia|0|||
156947766|NCT00767000|566563607|FG004|54-week Study|Hypoglycemia|0|||
156947767|NCT00767000|566563603|FG000|54-week Study|Interruption of study medication|0|||
156947768|NCT00767000|566563604|FG001|54-week Study|Interruption of study medication|0|||
156947769|NCT00767000|566563605|FG002|54-week Study|Interruption of study medication|1|||
156947770|NCT00767000|566563606|FG003|54-week Study|Interruption of study medication|0|||
156947771|NCT00767000|566563607|FG004|54-week Study|Interruption of study medication|0|||
156947772|NCT00767000|566563603|FG000|54-week Study|Lack of Efficacy|2|||
156947773|NCT00767000|566563604|FG001|54-week Study|Lack of Efficacy|0|||
156947774|NCT00767000|566563605|FG002|54-week Study|Lack of Efficacy|1|||
156947775|NCT00767000|566563606|FG003|54-week Study|Lack of Efficacy|0|||
156947776|NCT00767000|566563607|FG004|54-week Study|Lack of Efficacy|5|||
156947777|NCT00767000|566563603|FG000|54-week Study|Lost to Follow-up|4|||
156947778|NCT00767000|566563604|FG001|54-week Study|Lost to Follow-up|0|||
156947779|NCT00767000|566563605|FG002|54-week Study|Lost to Follow-up|1|||
156947780|NCT00767000|566563606|FG003|54-week Study|Lost to Follow-up|4|||
156947781|NCT00767000|566563607|FG004|54-week Study|Lost to Follow-up|2|||
156947782|NCT00767000|566563603|FG000|54-week Study|Physician Decision|4|||
157167620|NCT02310906|567354635|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
157167621|NCT02310906|567354636|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
157167622|NCT02310906|567354637|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
157167623|NCT00433446|567354638|FG000|Overall Study|Adverse Event|4|||
156947783|NCT00767000|566563604|FG001|54-week Study|Physician Decision|0|||
156947784|NCT00767000|566563605|FG002|54-week Study|Physician Decision|1|||
156947785|NCT00767000|566563606|FG003|54-week Study|Physician Decision|1|||
156947786|NCT00767000|566563607|FG004|54-week Study|Physician Decision|1|||
156947787|NCT00767000|566563603|FG000|54-week Study|Progressive disease|0|||
156947788|NCT00767000|566563604|FG001|54-week Study|Progressive disease|0|||
156947789|NCT00767000|566563605|FG002|54-week Study|Progressive disease|1|||
156947790|NCT00767000|566563606|FG003|54-week Study|Progressive disease|0|||
156947791|NCT00767000|566563607|FG004|54-week Study|Progressive disease|0|||
156947792|NCT00767000|566563603|FG000|54-week Study|Protocol Violation|0|||
156947793|NCT00767000|566563604|FG001|54-week Study|Protocol Violation|0|||
156947794|NCT00767000|566563605|FG002|54-week Study|Protocol Violation|1|||
156947795|NCT00767000|566563606|FG003|54-week Study|Protocol Violation|2|||
156947796|NCT00767000|566563607|FG004|54-week Study|Protocol Violation|0|||
156947797|NCT00767000|566563603|FG000|54-week Study|Withdrawal by Subject|2|||
156947798|NCT00767000|566563604|FG001|54-week Study|Withdrawal by Subject|3|||
156947799|NCT00767000|566563605|FG002|54-week Study|Withdrawal by Subject|5|||
156947800|NCT00767000|566563606|FG003|54-week Study|Withdrawal by Subject|11|||
156947801|NCT00767000|566563607|FG004|54-week Study|Withdrawal by Subject|13|||
156947802|NCT00767000|566563603|FG000|54-week Study|Study terminated by sponsor|90|||
156947803|NCT00767000|566563604|FG001|54-week Study|Study terminated by sponsor|102|||
156947804|NCT00767000|566563605|FG002|54-week Study|Study terminated by sponsor|89|||
156947805|NCT00767000|566563606|FG003|54-week Study|Study terminated by sponsor|196|||
156947806|NCT00767000|566563607|FG004|54-week Study|Study terminated by sponsor|194|||
156947807|NCT00767000|566563603|FG000|54-week Study|Reason not reported|0|||
156947808|NCT00767000|566563604|FG001|54-week Study|Reason not reported|0|||
156947809|NCT00767000|566563605|FG002|54-week Study|Reason not reported|0|||
156947810|NCT00767000|566563606|FG003|54-week Study|Reason not reported|1|||
156947811|NCT00767000|566563607|FG004|54-week Study|Reason not reported|0|||
156947812|NCT00767000|566563603|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
156947813|NCT00767000|566563604|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
156947814|NCT00767000|566563605|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
156947815|NCT00767000|566563606|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
156947816|NCT00767000|566563607|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
156947817|NCT00097591|566563611|FG000|Overall Study|Withdrawal of consent|342|||
156947818|NCT00097591|566563612|FG001|Overall Study|Withdrawal of consent|323|||
156947819|NCT00097591|566563611|FG000|Overall Study|Less than 6 months on study drug|9|||
156947820|NCT00097591|566563612|FG001|Overall Study|Less than 6 months on study drug|7|||
156947821|NCT00097591|566563611|FG000|Overall Study|Unable to attend termination visit|53|||
156947822|NCT00097591|566563612|FG001|Overall Study|Unable to attend termination visit|51|||
156947823|NCT00097591|566563611|FG000|Overall Study|Lost to follow up|6|||
156947824|NCT00097591|566563612|FG001|Overall Study|Lost to follow up|10|||
156947825|NCT00097591|566563611|FG000|Overall Study|Other|0|||
156947826|NCT00097591|566563612|FG001|Overall Study|Other|3|||
156947827|NCT00807092|566563619|FG000|Overall Study|Adverse Event|0|||
156947828|NCT00807092|566563620|FG001|Overall Study|Adverse Event|1|||
156947829|NCT00807092|566563619|FG000|Overall Study|Protocol Violation|0|||
156947830|NCT00807092|566563620|FG001|Overall Study|Protocol Violation|2|||
156947831|NCT00807092|566563619|FG000|Overall Study|Withdrawal by Subject|1|||
156947832|NCT00807092|566563620|FG001|Overall Study|Withdrawal by Subject|0|||
156947833|NCT00807092|566563619|FG000|Overall Study|CGMS data collection failed|0|||
156947834|NCT00807092|566563620|FG001|Overall Study|CGMS data collection failed|1|||
156947835|NCT02956629|566563623|FG000|Overall Study|Adverse Event|0|||
156947836|NCT02956629|566563624|FG001|Overall Study|Adverse Event|0|||
156947837|NCT02956629|566563625|FG002|Overall Study|Adverse Event|1|||
156947838|NCT02956629|566563626|FG003|Overall Study|Adverse Event|0|||
156947839|NCT02956629|566563627|FG004|Overall Study|Adverse Event|0|||
156947840|NCT02956629|566563628|FG005|Overall Study|Adverse Event|0|||
157167624|NCT00433446|567354638|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
157167625|NCT00433446|567354638|FG000|Overall Study|Progression|44|||
157167626|NCT00433446|567354638|FG000|Overall Study|Other - Not Protocol specified|3|||
157167627|NCT00433446|567354638|FG000|Overall Study|Ineligible|9|||
156947841|NCT02956629|566563623|FG000|Overall Study|Lost to Follow-up|2|||
156947842|NCT02956629|566563624|FG001|Overall Study|Lost to Follow-up|5|||
156947843|NCT02956629|566563625|FG002|Overall Study|Lost to Follow-up|3|||
156947844|NCT02956629|566563626|FG003|Overall Study|Lost to Follow-up|1|||
156947845|NCT02956629|566563627|FG004|Overall Study|Lost to Follow-up|0|||
156947846|NCT02956629|566563628|FG005|Overall Study|Lost to Follow-up|1|||
156947847|NCT02956629|566563623|FG000|Overall Study|Withdrawal by Subject|3|||
156947848|NCT02956629|566563624|FG001|Overall Study|Withdrawal by Subject|1|||
156947849|NCT02956629|566563625|FG002|Overall Study|Withdrawal by Subject|0|||
156947850|NCT02956629|566563626|FG003|Overall Study|Withdrawal by Subject|0|||
156947851|NCT02956629|566563627|FG004|Overall Study|Withdrawal by Subject|0|||
156947852|NCT02956629|566563628|FG005|Overall Study|Withdrawal by Subject|0|||
156947853|NCT00003498|566563629|FG000|Overall Study|Not evaluable.|4|||
156947854|NCT04713748|566563640|FG000|Overall Study|Not enough kits allocated|35|||
156947855|NCT00406029|566563641|FG000|Overall Study|Adverse Event|12|||
156947856|NCT00406029|566563642|FG001|Overall Study|Adverse Event|2|||
156947857|NCT00406029|566563643|FG002|Overall Study|Adverse Event|5|||
156947858|NCT00406029|566563644|FG003|Overall Study|Adverse Event|10|||
156947859|NCT00406029|566563645|FG004|Overall Study|Adverse Event|7|||
156947860|NCT00406029|566563641|FG000|Overall Study|Withdrawal by Subject|3|||
156947861|NCT00406029|566563642|FG001|Overall Study|Withdrawal by Subject|4|||
156947862|NCT00406029|566563643|FG002|Overall Study|Withdrawal by Subject|2|||
156947863|NCT00406029|566563644|FG003|Overall Study|Withdrawal by Subject|2|||
156947864|NCT00406029|566563645|FG004|Overall Study|Withdrawal by Subject|0|||
156947865|NCT00406029|566563641|FG000|Overall Study|Protocol Violation|1|||
156947866|NCT00406029|566563642|FG001|Overall Study|Protocol Violation|2|||
156947867|NCT00406029|566563643|FG002|Overall Study|Protocol Violation|0|||
156947868|NCT00406029|566563644|FG003|Overall Study|Protocol Violation|2|||
156947869|NCT00406029|566563645|FG004|Overall Study|Protocol Violation|0|||
156947870|NCT00406029|566563641|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156947871|NCT00406029|566563642|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
156947872|NCT00406029|566563643|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
156947873|NCT00406029|566563644|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
156947874|NCT00406029|566563645|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
156947875|NCT00406029|566563641|FG000|Overall Study|Randomized in Error|0|||
156947876|NCT00406029|566563642|FG001|Overall Study|Randomized in Error|0|||
156947877|NCT00406029|566563643|FG002|Overall Study|Randomized in Error|2|||
156947878|NCT00406029|566563644|FG003|Overall Study|Randomized in Error|3|||
156947879|NCT00406029|566563645|FG004|Overall Study|Randomized in Error|1|||
156947880|NCT01557946|566563646|FG000|Overall Study|Adverse Event|3|||
156947881|NCT01557946|566563647|FG001|Overall Study|Adverse Event|0|||
156947882|NCT04067141|566563648|FG000|First Intervention|Withdrawal by Subject|0|||
156947883|NCT04067141|566563649|FG001|First Intervention|Withdrawal by Subject|1|||
156947884|NCT04067141|566563648|FG000|Second Intervention|Adverse Event|0|||
156947885|NCT04067141|566563649|FG001|Second Intervention|Adverse Event|2|||
156947886|NCT00812812|566563652|FG000|Overall Study|Adverse Event|2|||
156947887|NCT00812812|566563653|FG001|Overall Study|Adverse Event|1|||
156947888|NCT00812812|566563652|FG000|Overall Study|Lack of Efficacy|1|||
156947889|NCT00812812|566563653|FG001|Overall Study|Lack of Efficacy|0|||
157033480|NCT05953740|566879366|FG005|Period 1|Physician Decision|0|||
157033481|NCT05953740|566879367|FG006|Period 1|Physician Decision|0|||
157033482|NCT05953740|566879368|FG007|Period 1|Physician Decision|0|||
157033483|NCT05953740|566879361|FG000|Period 2|Withdrawal by Subject|0|||
157033484|NCT05953740|566879362|FG001|Period 2|Withdrawal by Subject|1|||
157033485|NCT05953740|566879363|FG002|Period 2|Withdrawal by Subject|1|||
157033486|NCT05953740|566879364|FG003|Period 2|Withdrawal by Subject|0|||
157033487|NCT05953740|566879365|FG004|Period 2|Withdrawal by Subject|0|||
157033488|NCT05953740|566879366|FG005|Period 2|Withdrawal by Subject|0|||
157033489|NCT05953740|566879367|FG006|Period 2|Withdrawal by Subject|0|||
157033490|NCT05953740|566879368|FG007|Period 2|Withdrawal by Subject|0|||
157033491|NCT03880955|566879369|FG000|Overall Study|Adverse Event|1|||
157033492|NCT03880955|566879369|FG000|Overall Study|Death|1|||
157033493|NCT03880955|566879369|FG000|Overall Study|Lost to Follow-up|12|||
157033494|NCT03880955|566879369|FG000|Overall Study|Withdrawal by Subject|4|||
157033495|NCT03880955|566879369|FG000|Overall Study|Missing- Study Site Closed|27|||
157033496|NCT02510235|566879371|FG000|Overall Study|Withdrawal by Subject|1|||
157033497|NCT02510235|566879372|FG001|Overall Study|Withdrawal by Subject|0|||
157033498|NCT00450216|566879373|FG000|Overall Study|Adverse Event|38|||
157033499|NCT00450216|566879374|FG001|Overall Study|Adverse Event|23|||
157033500|NCT00450216|566879373|FG000|Overall Study|Withdrawal by Subject|48|||
157033501|NCT00450216|566879374|FG001|Overall Study|Withdrawal by Subject|26|||
157033502|NCT00450216|566879373|FG000|Overall Study|Lost to Follow-up|16|||
157033503|NCT00450216|566879374|FG001|Overall Study|Lost to Follow-up|9|||
157033504|NCT00450216|566879373|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
157033505|NCT00450216|566879374|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
157033506|NCT00450216|566879373|FG000|Overall Study|misc|21|||
157033507|NCT00450216|566879374|FG001|Overall Study|misc|20|||
157033508|NCT03011034|566879382|FG000|Overall Study|Adverse Event|1|||
157033509|NCT03011034|566879383|FG001|Overall Study|Adverse Event|0|||
157033510|NCT05112900|566879388|FG000|Overall Study|Withdrawal by Subject|960|||
157033511|NCT05112900|566879389|FG001|Overall Study|Withdrawal by Subject|921|||
156947890|NCT00812812|566563652|FG000|Overall Study|Lost to Follow-up|0|||
156947891|NCT00812812|566563653|FG001|Overall Study|Lost to Follow-up|1|||
156947892|NCT00812812|566563652|FG000|Overall Study|Withdrawal by Subject|0|||
156947893|NCT00812812|566563653|FG001|Overall Study|Withdrawal by Subject|2|||
156947894|NCT03095417|566563654|FG000|Overall Study|missed|1|||
157033512|NCT05112900|566879390|FG002|Overall Study|Withdrawal by Subject|968|||
157033513|NCT00319111|566879391|FG000|Overall Study|Adverse Event|20|||
157033514|NCT00319111|566879391|FG000|Overall Study|Withdrawal of consent|11|||
157033515|NCT00319111|566879391|FG000|Overall Study|Death|9|||
157167628|NCT01188538|567354639|FG000|Overall Study|Lost to Follow-up|0|||
157167629|NCT01188538|567354640|FG001|Overall Study|Lost to Follow-up|1|||
157167630|NCT02899377|567354644|FG000|Overall Study|Adverse Event|1|||
157167631|NCT02899377|567354645|FG001|Overall Study|Adverse Event|0|||
157167632|NCT01170702|567354646|FG000|Overall Study|Exclusion criteria met after consent|1|||
157167633|NCT01170702|567354647|FG001|Overall Study|Exclusion criteria met after consent|2|||
157167634|NCT01170702|567354648|FG002|Overall Study|Exclusion criteria met after consent|0|||
156947895|NCT03095417|566563655|FG001|Overall Study|missed|2|||
156947896|NCT03095417|566563656|FG002|Overall Study|missed|0|||
157033516|NCT00319111|566879391|FG000|Overall Study|Lack of clinical improvement|4|||
157033517|NCT00319111|566879391|FG000|Overall Study|Administrative|2|||
157033518|NCT00319111|566879391|FG000|Overall Study|Treatment failure|1|||
157033519|NCT01475786|566879392|FG000|Overall Study|Adverse Event|0|||
157033520|NCT01475786|566879393|FG001|Overall Study|Adverse Event|1|||
157033521|NCT01475786|566879394|FG002|Overall Study|Adverse Event|0|||
157033522|NCT01475786|566879392|FG000|Overall Study|Lost to Follow-up|1|||
157033523|NCT01475786|566879393|FG001|Overall Study|Lost to Follow-up|2|||
157033524|NCT01475786|566879394|FG002|Overall Study|Lost to Follow-up|1|||
157033525|NCT01475786|566879392|FG000|Overall Study|Withdrawal by Subject|0|||
157033526|NCT01475786|566879393|FG001|Overall Study|Withdrawal by Subject|1|||
157033527|NCT01475786|566879394|FG002|Overall Study|Withdrawal by Subject|1|||
157033528|NCT01475786|566879392|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
157033529|NCT01475786|566879393|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
157033530|NCT01475786|566879394|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
157033531|NCT03165955|566879396|FG000|Treatment|Withdrawal by Subject|3|||
156947897|NCT03095417|566563657|FG003|Overall Study|missed|1|||
156947898|NCT03095417|566563654|FG000|Overall Study|Lost to Follow-up|2|||
156947899|NCT03095417|566563655|FG001|Overall Study|Lost to Follow-up|2|||
156947900|NCT03095417|566563656|FG002|Overall Study|Lost to Follow-up|1|||
156947901|NCT03095417|566563657|FG003|Overall Study|Lost to Follow-up|0|||
156947902|NCT03095417|566563654|FG000|Overall Study|refusal|0|||
156947903|NCT03095417|566563655|FG001|Overall Study|refusal|1|||
156947904|NCT03095417|566563656|FG002|Overall Study|refusal|0|||
156947905|NCT03095417|566563657|FG003|Overall Study|refusal|1|||
156947906|NCT03095417|566563654|FG000|Overall Study|Withdrawal by Subject|8|||
156947907|NCT03095417|566563655|FG001|Overall Study|Withdrawal by Subject|2|||
156947908|NCT03095417|566563656|FG002|Overall Study|Withdrawal by Subject|5|||
156947909|NCT03095417|566563657|FG003|Overall Study|Withdrawal by Subject|4|||
156947910|NCT03095417|566563654|FG000|Overall Study|Physician Decision|1|||
156947911|NCT03095417|566563655|FG001|Overall Study|Physician Decision|2|||
156947912|NCT03095417|566563656|FG002|Overall Study|Physician Decision|2|||
156947913|NCT03095417|566563657|FG003|Overall Study|Physician Decision|2|||
156947914|NCT03095417|566563654|FG000|Overall Study|Death|1|||
156947915|NCT03095417|566563655|FG001|Overall Study|Death|2|||
156947916|NCT03095417|566563656|FG002|Overall Study|Death|1|||
156947917|NCT03095417|566563657|FG003|Overall Study|Death|3|||
156947918|NCT01877421|566563658|FG000|Phase 2|Lost to Follow-up|0|||
156947919|NCT01877421|566563659|FG001|Phase 2|Lost to Follow-up|0|||
156947920|NCT01877421|566563660|FG002|Phase 2|Lost to Follow-up|0|||
156947921|NCT01877421|566563661|FG003|Phase 2|Lost to Follow-up|0|||
156947922|NCT01877421|566563662|FG004|Phase 2|Lost to Follow-up|0|||
156947923|NCT01877421|566563663|FG005|Phase 2|Lost to Follow-up|0|||
156947924|NCT01877421|566563664|FG006|Phase 2|Lost to Follow-up|1|||
156947925|NCT01877421|566563665|FG007|Phase 2|Lost to Follow-up|0|||
156947926|NCT01877421|566563666|FG008|Phase 2|Lost to Follow-up|0|||
156947927|NCT01877421|566563667|FG009|Phase 2|Lost to Follow-up|0|||
156947928|NCT01877421|566563668|FG010|Phase 2|Lost to Follow-up|0|||
156947929|NCT01877421|566563669|FG011|Phase 2|Lost to Follow-up|0|||
157033532|NCT03165955|566879396|FG000|Treatment|Death|1|||
157033533|NCT03165955|566879396|FG000|Treatment|Adverse Event|1|||
157033534|NCT03165955|566879396|FG000|Treatment|Progressive disease|3|||
157033535|NCT02865538|566879398|FG000|Overall Study|Withdrawal by Subject|0|||
157033536|NCT02865538|566879399|FG001|Overall Study|Withdrawal by Subject|0|||
157167635|NCT01170702|567354649|FG003|Overall Study|Exclusion criteria met after consent|2|||
156947930|NCT01877421|566563670|FG012|Phase 2|Lost to Follow-up|0|||
156947931|NCT01877421|566563671|FG013|Phase 2|Lost to Follow-up|0|||
157167636|NCT01677507|567354650|FG000|Initial Assignment|Adverse Event|0|||
156947932|NCT01877421|566563672|FG014|Phase 2|Lost to Follow-up|0|||
156947933|NCT01877421|566563673|FG015|Phase 2|Lost to Follow-up|0|||
156947934|NCT01877421|566563674|FG016|Phase 2|Lost to Follow-up|0|||
156947935|NCT01877421|566563675|FG017|Phase 2|Lost to Follow-up|0|||
156947936|NCT01877421|566563658|FG000|Phase 2|Withdrawal by Subject|0|||
156947937|NCT01877421|566563659|FG001|Phase 2|Withdrawal by Subject|0|||
156947938|NCT01877421|566563660|FG002|Phase 2|Withdrawal by Subject|0|||
157167637|NCT01677507|567354651|FG001|Initial Assignment|Adverse Event|1|||
156947939|NCT01877421|566563661|FG003|Phase 2|Withdrawal by Subject|0|||
156947940|NCT01877421|566563662|FG004|Phase 2|Withdrawal by Subject|0|||
156947941|NCT01877421|566563663|FG005|Phase 2|Withdrawal by Subject|0|||
156947942|NCT01877421|566563664|FG006|Phase 2|Withdrawal by Subject|0|||
156947943|NCT01877421|566563665|FG007|Phase 2|Withdrawal by Subject|0|||
157033537|NCT02865538|566879400|FG002|Overall Study|Withdrawal by Subject|1|||
157033538|NCT02865538|566879401|FG003|Overall Study|Withdrawal by Subject|0|||
157033539|NCT02865538|566879402|FG004|Overall Study|Withdrawal by Subject|0|||
157033540|NCT02865538|566879398|FG000|Overall Study|Lost to Follow-up|1|||
157033541|NCT02865538|566879399|FG001|Overall Study|Lost to Follow-up|0|||
157033542|NCT02865538|566879400|FG002|Overall Study|Lost to Follow-up|0|||
157033543|NCT02865538|566879401|FG003|Overall Study|Lost to Follow-up|0|||
157033544|NCT02865538|566879402|FG004|Overall Study|Lost to Follow-up|0|||
157033545|NCT04244175|566880577|FG000|Overall Study|Adverse Event|3|||
157033546|NCT04244175|566880578|FG001|Overall Study|Adverse Event|2|||
157033547|NCT04244175|566880579|FG002|Overall Study|Adverse Event|5|||
157033548|NCT04244175|566880577|FG000|Overall Study|Lack of Efficacy|1|||
157033549|NCT04244175|566880578|FG001|Overall Study|Lack of Efficacy|0|||
157033550|NCT04244175|566880579|FG002|Overall Study|Lack of Efficacy|1|||
157033551|NCT04244175|566880577|FG000|Overall Study|Lost to Follow-up|1|||
157033552|NCT04244175|566880578|FG001|Overall Study|Lost to Follow-up|0|||
157033553|NCT04244175|566880579|FG002|Overall Study|Lost to Follow-up|0|||
157033554|NCT04244175|566880577|FG000|Overall Study|Non-compliance with study drug|1|||
157033555|NCT04244175|566880578|FG001|Overall Study|Non-compliance with study drug|0|||
157033556|NCT04244175|566880579|FG002|Overall Study|Non-compliance with study drug|1|||
157033557|NCT04244175|566880577|FG000|Overall Study|Protocol deviation|0|||
157033558|NCT04244175|566880578|FG001|Overall Study|Protocol deviation|1|||
157033559|NCT04244175|566880579|FG002|Overall Study|Protocol deviation|0|||
157033560|NCT04244175|566880577|FG000|Overall Study|Withdrawal by Subject|1|||
157033561|NCT04244175|566880578|FG001|Overall Study|Withdrawal by Subject|3|||
157033562|NCT04244175|566880579|FG002|Overall Study|Withdrawal by Subject|1|||
157033563|NCT04244175|566880577|FG000|Overall Study|Other, not specified|0|||
157033564|NCT04244175|566880578|FG001|Overall Study|Other, not specified|1|||
157033565|NCT04244175|566880579|FG002|Overall Study|Other, not specified|2|||
157033566|NCT03417284|566880580|FG000|Overall Study|Inadequate supply on study drug|1|||
157033567|NCT03417284|566880581|FG001|Overall Study|Inadequate supply on study drug|0|||
157033568|NCT03417284|566880582|FG002|Overall Study|Inadequate supply on study drug|0|||
157033569|NCT03417284|566880583|FG003|Overall Study|Inadequate supply on study drug|0|||
157033570|NCT03417284|566880580|FG000|Overall Study|Disease Progression|0|||
157033571|NCT03417284|566880581|FG001|Overall Study|Disease Progression|0|||
157033572|NCT03417284|566880582|FG002|Overall Study|Disease Progression|1|||
157033573|NCT03417284|566880583|FG003|Overall Study|Disease Progression|0|||
157033574|NCT03636490|566880584|FG000|Overall Study|Dropped out or incomplete data|141|||
157033575|NCT04165213|566880594|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
157033576|NCT04165213|566880595|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
157033577|NCT04165213|566880594|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
157033578|NCT04165213|566880595|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
157033579|NCT04165213|566880594|FG000|Clinician Enrollment|Termination from site|0|||
157033580|NCT04165213|566880595|FG001|Clinician Enrollment|Termination from site|1|||
157033581|NCT04165213|566880594|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
157033582|NCT04165213|566880595|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
157033583|NCT04165213|566880594|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
157033584|NCT04165213|566880595|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
157033585|NCT04165213|566880594|FG000|Caregiver Enrollment|Physician Decision|1|||
156947944|NCT01877421|566563666|FG008|Phase 2|Withdrawal by Subject|1|||
156947945|NCT01877421|566563667|FG009|Phase 2|Withdrawal by Subject|0|||
156947946|NCT01877421|566563668|FG010|Phase 2|Withdrawal by Subject|1|||
156947947|NCT01877421|566563669|FG011|Phase 2|Withdrawal by Subject|0|||
156947948|NCT01877421|566563670|FG012|Phase 2|Withdrawal by Subject|1|||
156947949|NCT01877421|566563671|FG013|Phase 2|Withdrawal by Subject|0|||
156947950|NCT01877421|566563672|FG014|Phase 2|Withdrawal by Subject|0|||
156947951|NCT01877421|566563673|FG015|Phase 2|Withdrawal by Subject|1|||
156947952|NCT01877421|566563674|FG016|Phase 2|Withdrawal by Subject|0|||
156947953|NCT01877421|566563675|FG017|Phase 2|Withdrawal by Subject|0|||
156947954|NCT01877421|566563658|FG000|Phase 2|Protocol Violation|0|||
157033586|NCT04165213|566880595|FG001|Caregiver Enrollment|Physician Decision|0|||
156947955|NCT01877421|566563659|FG001|Phase 2|Protocol Violation|0|||
156947956|NCT01877421|566563660|FG002|Phase 2|Protocol Violation|0|||
157033587|NCT04165213|566880594|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
157033588|NCT04165213|566880595|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
157033589|NCT04165213|566880594|FG000|Caregiver Enrollment|PLWD death|2|||
157033590|NCT04165213|566880595|FG001|Caregiver Enrollment|PLWD death|0|||
157033591|NCT04165213|566880594|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
157033592|NCT04165213|566880595|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
157033593|NCT04165213|566880594|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
157033594|NCT04165213|566880595|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
157167638|NCT01677507|567354650|FG000|Initial Assignment|Protocol Violation|0|||
157167639|NCT01677507|567354651|FG001|Initial Assignment|Protocol Violation|1|||
157033595|NCT04165213|566880594|FG000|PLWD Enrollment|Lost to Follow-up|1|||
156947957|NCT01877421|566563661|FG003|Phase 2|Protocol Violation|0|||
156947958|NCT01877421|566563662|FG004|Phase 2|Protocol Violation|0|||
156947959|NCT01877421|566563663|FG005|Phase 2|Protocol Violation|0|||
157033596|NCT04165213|566880595|FG001|PLWD Enrollment|Lost to Follow-up|1|||
157033597|NCT04165213|566880594|FG000|PLWD Enrollment|Physician Decision|1|||
157033598|NCT04165213|566880595|FG001|PLWD Enrollment|Physician Decision|0|||
157033599|NCT04165213|566880594|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
157033600|NCT04165213|566880595|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
157033601|NCT04165213|566880594|FG000|PLWD Enrollment|Death|2|||
157033602|NCT04165213|566880595|FG001|PLWD Enrollment|Death|0|||
157033603|NCT04165213|566880594|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
157033604|NCT04165213|566880595|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
157033605|NCT04464564|566880596|FG000|Period A (Placebo lead-in)|Other|5|||
157033606|NCT04464564|566880597|FG001|Period A (Placebo lead-in)|Other|0|||
157033607|NCT04464564|566880598|FG002|Period A (Placebo lead-in)|Other|0|||
157033608|NCT04464564|566880599|FG003|Period A (Placebo lead-in)|Other|0|||
157033609|NCT04464564|566880596|FG000|Period B (Randomization Period)|Adverse Event|0|||
157033610|NCT04464564|566880597|FG001|Period B (Randomization Period)|Adverse Event|1|||
157033611|NCT04464564|566880598|FG002|Period B (Randomization Period)|Adverse Event|2|||
157033612|NCT04464564|566880599|FG003|Period B (Randomization Period)|Adverse Event|8|||
157033613|NCT04464564|566880596|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
157033614|NCT04464564|566880597|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
157033615|NCT04464564|566880598|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
157033616|NCT04464564|566880599|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
157033617|NCT04464564|566880596|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
157033618|NCT04464564|566880597|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
157033619|NCT04464564|566880598|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
157033620|NCT04464564|566880599|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
157033621|NCT04464564|566880596|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
157033622|NCT04464564|566880597|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
157033623|NCT04464564|566880598|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
157033624|NCT04464564|566880599|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
157033625|NCT04464564|566880596|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
157033626|NCT04464564|566880597|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
157033627|NCT04464564|566880598|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
157033628|NCT04464564|566880599|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
157033629|NCT04464564|566880596|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
157033630|NCT04464564|566880597|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
157033631|NCT04464564|566880598|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
157033632|NCT04464564|566880599|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
157033633|NCT04464564|566880596|FG000|Period B (Randomization Period)|Reason not Specified|0|||
157033634|NCT04464564|566880597|FG001|Period B (Randomization Period)|Reason not Specified|3|||
157033635|NCT04464564|566880598|FG002|Period B (Randomization Period)|Reason not Specified|3|||
157033636|NCT04464564|566880599|FG003|Period B (Randomization Period)|Reason not Specified|3|||
157033637|NCT02278211|566880600|FG000|Overall Study|Unable to analyse PET scan|2|||
157033638|NCT03858517|566880601|FG000|Overall Study|Adverse Event|1|||
157033639|NCT03858517|566880601|FG000|Overall Study|Lost to Follow-up|1|||
157033640|NCT03858517|566880601|FG000|Overall Study|removed for being incarcerated|1|||
157033641|NCT03858517|566880601|FG000|Overall Study|Sponsor Closure|48|||
157033642|NCT06037668|566880604|FG000|Overall Study|Lost to Follow-up|1|||
157033643|NCT06037668|566880605|FG001|Overall Study|Lost to Follow-up|1|||
157033644|NCT06037668|566880604|FG000|Overall Study|Protocol Violation|1|||
157033645|NCT06037668|566880605|FG001|Overall Study|Protocol Violation|0|||
157033646|NCT06037668|566880604|FG000|Overall Study|Withdrawal by Subject|1|||
157033647|NCT06037668|566880605|FG001|Overall Study|Withdrawal by Subject|0|||
157033648|NCT06037668|566880604|FG000|Overall Study|Other Study Discontinuation Reason|1|||
157033649|NCT06037668|566880605|FG001|Overall Study|Other Study Discontinuation Reason|0|||
157033650|NCT04804540|566880606|FG000|Overall Study|Adverse Event|26|||
157033651|NCT04804540|566880607|FG001|Overall Study|Adverse Event|13|||
157033652|NCT05172232|566880608|FG000|Overall Study|Lost to Follow-up|3|||
157033653|NCT04881461|566880609|FG000|Overall Study|Adverse Event|2|||
157033654|NCT04881461|566880610|FG001|Overall Study|Adverse Event|4|||
157033655|NCT04881461|566880609|FG000|Overall Study|Withdrawal by Subject|19|||
157033656|NCT04881461|566880610|FG001|Overall Study|Withdrawal by Subject|19|||
157033657|NCT04881461|566880609|FG000|Overall Study|Lost to Follow-up|4|||
157033658|NCT04881461|566880610|FG001|Overall Study|Lost to Follow-up|4|||
157033659|NCT04881461|566880609|FG000|Overall Study|Lack of Efficacy|1|||
157033660|NCT04881461|566880610|FG001|Overall Study|Lack of Efficacy|0|||
157033661|NCT04881461|566880609|FG000|Overall Study|"Reason stated as other in CRF"|1|||
157033662|NCT04881461|566880610|FG001|Overall Study|"Reason stated as other in CRF"|2|||
157033663|NCT02997202|566880611|FG000|Overall Study|Miscellaneous|2|||
157033664|NCT02997202|566880612|FG001|Overall Study|Miscellaneous|2|||
157033665|NCT02997202|566880611|FG000|Overall Study|Withdrawal by Subject|8|||
157033666|NCT02997202|566880612|FG001|Overall Study|Withdrawal by Subject|12|||
157033667|NCT02997202|566880611|FG000|Overall Study|Lost to Follow-up|5|||
157033668|NCT02997202|566880612|FG001|Overall Study|Lost to Follow-up|3|||
157033669|NCT02997202|566880611|FG000|Overall Study|Death|41|||
157033670|NCT02997202|566880612|FG001|Overall Study|Death|45|||
157033671|NCT04629339|566880616|FG000|Overall Study|Death|1|||
157033672|NCT04629339|566880617|FG001|Overall Study|Death|0|||
157033673|NCT04629339|566880618|FG002|Overall Study|Death|2|||
157033674|NCT04629339|566880619|FG003|Overall Study|Death|2|||
157033675|NCT04629339|566880620|FG004|Overall Study|Death|0|||
157033676|NCT04629339|566880616|FG000|Overall Study|Disease Progression|0|||
157033677|NCT04629339|566880617|FG001|Overall Study|Disease Progression|0|||
157033678|NCT04629339|566880618|FG002|Overall Study|Disease Progression|1|||
157033679|NCT04629339|566880619|FG003|Overall Study|Disease Progression|1|||
157033680|NCT04629339|566880620|FG004|Overall Study|Disease Progression|0|||
157033681|NCT04629339|566880616|FG000|Overall Study|Lost to Follow-up|0|||
157033682|NCT04629339|566880617|FG001|Overall Study|Lost to Follow-up|0|||
157033683|NCT04629339|566880618|FG002|Overall Study|Lost to Follow-up|0|||
157033684|NCT04629339|566880619|FG003|Overall Study|Lost to Follow-up|1|||
157033685|NCT04629339|566880620|FG004|Overall Study|Lost to Follow-up|0|||
157033686|NCT04629339|566880616|FG000|Overall Study|Physician Decision|0|||
157033687|NCT04629339|566880617|FG001|Overall Study|Physician Decision|1|||
157033688|NCT04629339|566880618|FG002|Overall Study|Physician Decision|0|||
157033689|NCT04629339|566880619|FG003|Overall Study|Physician Decision|0|||
157033690|NCT04629339|566880620|FG004|Overall Study|Physician Decision|0|||
157033691|NCT04629339|566880616|FG000|Overall Study|Study Terminated by Sponsor|0|||
157033692|NCT04629339|566880617|FG001|Overall Study|Study Terminated by Sponsor|0|||
157033693|NCT04629339|566880618|FG002|Overall Study|Study Terminated by Sponsor|0|||
157033694|NCT04629339|566880619|FG003|Overall Study|Study Terminated by Sponsor|1|||
157033695|NCT04629339|566880620|FG004|Overall Study|Study Terminated by Sponsor|0|||
157033696|NCT04629339|566880616|FG000|Overall Study|Withdrawal by Subject|0|||
157033697|NCT04629339|566880617|FG001|Overall Study|Withdrawal by Subject|0|||
157033698|NCT04629339|566880618|FG002|Overall Study|Withdrawal by Subject|2|||
157033699|NCT04629339|566880619|FG003|Overall Study|Withdrawal by Subject|2|||
157033700|NCT04629339|566880620|FG004|Overall Study|Withdrawal by Subject|0|||
157033701|NCT04158739|566880621|FG000|Overall Study|Adverse Event|1|||
157033702|NCT04158739|566880622|FG001|Overall Study|Adverse Event|0|||
157033703|NCT04158739|566880621|FG000|Overall Study|Death|0|||
157033704|NCT04158739|566880622|FG001|Overall Study|Death|1|||
157033705|NCT04158739|566880621|FG000|Overall Study|Lack of Efficacy|3|||
157033706|NCT04158739|566880622|FG001|Overall Study|Lack of Efficacy|7|||
157033707|NCT04158739|566880621|FG000|Overall Study|Physician Decision|0|||
157033708|NCT04158739|566880622|FG001|Overall Study|Physician Decision|1|||
157033709|NCT04158739|566880621|FG000|Overall Study|Withdrawal by Subject|3|||
157033710|NCT04158739|566880622|FG001|Overall Study|Withdrawal by Subject|0|||
157033711|NCT00887198|566880628|FG000|Randomized Period|Ongoing|42|||
157033712|NCT00887198|566880629|FG001|Randomized Period|Ongoing|0|||
157033713|NCT00887198|566880630|FG002|Randomized Period|Ongoing|0|||
157033714|NCT00887198|566880628|FG000|Randomized Period|Adverse Event|50|||
156947960|NCT01877421|566563664|FG006|Phase 2|Protocol Violation|0|||
156947961|NCT01877421|566563665|FG007|Phase 2|Protocol Violation|0|||
156947962|NCT01877421|566563666|FG008|Phase 2|Protocol Violation|0|||
156947963|NCT01877421|566563667|FG009|Phase 2|Protocol Violation|0|||
156947964|NCT01877421|566563668|FG010|Phase 2|Protocol Violation|1|||
156947965|NCT01877421|566563669|FG011|Phase 2|Protocol Violation|0|||
156947966|NCT01877421|566563670|FG012|Phase 2|Protocol Violation|0|||
156947967|NCT01877421|566563671|FG013|Phase 2|Protocol Violation|0|||
156947968|NCT01877421|566563672|FG014|Phase 2|Protocol Violation|0|||
157033715|NCT00887198|566880629|FG001|Randomized Period|Adverse Event|33|||
157033716|NCT00887198|566880630|FG002|Randomized Period|Adverse Event|0|||
157033717|NCT00887198|566880628|FG000|Randomized Period|Lost to Follow-up|1|||
157033718|NCT00887198|566880629|FG001|Randomized Period|Lost to Follow-up|0|||
157033719|NCT00887198|566880630|FG002|Randomized Period|Lost to Follow-up|0|||
157033720|NCT00887198|566880628|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
157033721|NCT00887198|566880629|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
157033722|NCT00887198|566880630|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
157033723|NCT00887198|566880628|FG000|Randomized Period|Withdrawal by Subject|41|||
157033724|NCT00887198|566880629|FG001|Randomized Period|Withdrawal by Subject|56|||
157033725|NCT00887198|566880630|FG002|Randomized Period|Withdrawal by Subject|0|||
157205218|NCT03669640|567496078|FG005|Overall Study|Lost to Follow-up|0|||
156947969|NCT01877421|566563673|FG015|Phase 2|Protocol Violation|0|||
157033726|NCT00887198|566880628|FG000|Randomized Period|Progressive disease|366|||
157033727|NCT00887198|566880629|FG001|Randomized Period|Progressive disease|370|||
157033728|NCT00887198|566880630|FG002|Randomized Period|Progressive disease|0|||
157033729|NCT00887198|566880628|FG000|Randomized Period|Other|42|||
157033730|NCT00887198|566880629|FG001|Randomized Period|Other|30|||
157033731|NCT00887198|566880630|FG002|Randomized Period|Other|0|||
157033732|NCT00887198|566880628|FG000|Randomized Period|Randomized, Not treated|4|||
157033733|NCT00887198|566880629|FG001|Randomized Period|Randomized, Not treated|2|||
156947970|NCT01877421|566563674|FG016|Phase 2|Protocol Violation|0|||
156947971|NCT01877421|566563675|FG017|Phase 2|Protocol Violation|0|||
157033734|NCT00887198|566880630|FG002|Randomized Period|Randomized, Not treated|0|||
156947972|NCT01158924|566563688|FG000|Overall Study|Withdrawal by Subject|1|||
156947973|NCT01158924|566563689|FG001|Overall Study|Withdrawal by Subject|2|||
156947974|NCT01158924|566563688|FG000|Overall Study|Lost to Follow-up|0|||
156947975|NCT01158924|566563689|FG001|Overall Study|Lost to Follow-up|1|||
156947976|NCT02822794|566563690|FG000|Overall Study|Withdrew Consent|1|||
156947977|NCT02822794|566563691|FG001|Overall Study|Withdrew Consent|0|||
156947978|NCT04788147|566563692|FG000|Overall Study|Screen Failure|3|||
156947979|NCT04788147|566563693|FG001|Overall Study|Screen Failure|10|||
156947980|NCT04788147|566563692|FG000|Overall Study|Incomplete RMRS image session|2|||
156947981|NCT04788147|566563693|FG001|Overall Study|Incomplete RMRS image session|0|||
156947982|NCT05101252|566563694|FG000|Overall Study|Unsatisfactory Test Article|1|||
156947983|NCT05101252|566563695|FG001|Overall Study|Unsatisfactory Test Article|0|||
156947984|NCT05101252|566563694|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156947985|NCT05101252|566563695|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156947986|NCT05101252|566563694|FG000|Overall Study|Withdrew Consent during study|0|||
156947987|NCT05101252|566563695|FG001|Overall Study|Withdrew Consent during study|1|||
156947988|NCT05101252|566563694|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
156947989|NCT05101252|566563695|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
156947990|NCT03732248|566563696|FG000|Overall Study|Withdrawal by Subject|1|||
156947991|NCT03732248|566563697|FG001|Overall Study|Withdrawal by Subject|0|||
156947992|NCT02266381|566563698|FG000|Overall Study|Physician Decision|3|||
156947993|NCT02266381|566563699|FG001|Overall Study|Physician Decision|5|||
156947994|NCT02266381|566563700|FG002|Overall Study|Physician Decision|4|||
156947995|NCT03653429|566563703|FG000|Overall Study|Physician Decision|4|||
156947996|NCT03653429|566563704|FG001|Overall Study|Physician Decision|10|||
156947997|NCT00403546|566563705|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
156947998|NCT00403546|566563706|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
156947999|NCT00403546|566563707|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
156948000|NCT00403546|566563705|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
156948001|NCT00403546|566563706|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
156948002|NCT00403546|566563707|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
156948003|NCT00403546|566563705|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
156948004|NCT00403546|566563706|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
156948005|NCT00403546|566563707|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
156948006|NCT00403546|566563705|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
156948007|NCT00403546|566563706|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
156948008|NCT00403546|566563707|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
156948009|NCT00403546|566563705|FG000|Screening Phase|Screening Failure|22|||
156948010|NCT00403546|566563706|FG001|Screening Phase|Screening Failure|0|||
156948011|NCT00403546|566563707|FG002|Screening Phase|Screening Failure|0|||
156948012|NCT00403546|566563705|FG000|Screening Phase|Adverse Event|1|||
156948013|NCT00403546|566563706|FG001|Screening Phase|Adverse Event|0|||
156948014|NCT00403546|566563707|FG002|Screening Phase|Adverse Event|0|||
156948015|NCT00403546|566563705|FG000|Screening Phase|Terminated Prior to Randomization|5|||
156948016|NCT00403546|566563706|FG001|Screening Phase|Terminated Prior to Randomization|0|||
156948017|NCT00403546|566563707|FG002|Screening Phase|Terminated Prior to Randomization|0|||
156948018|NCT00403546|566563705|FG000|Randomized Trial|Early Terminations|0|||
156948019|NCT00403546|566563706|FG001|Randomized Trial|Early Terminations|17|||
156948020|NCT00403546|566563707|FG002|Randomized Trial|Early Terminations|16|||
156948021|NCT00793910|566563708|FG000|Overall Study|discarded study pills|0|||
156948022|NCT00793910|566563709|FG001|Overall Study|discarded study pills|1|||
156948023|NCT00793910|566563708|FG000|Overall Study|did not pick up medications|1|||
156948024|NCT00793910|566563709|FG001|Overall Study|did not pick up medications|1|||
156948025|NCT00793910|566563708|FG000|Overall Study|ineligible based on entry criteria|2|||
156948026|NCT00793910|566563709|FG001|Overall Study|ineligible based on entry criteria|3|||
156948027|NCT00793910|566563708|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
156948028|NCT00793910|566563709|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
156948029|NCT00793910|566563708|FG000|Overall Study|Withdrawal by Subject|0|||
156948030|NCT00793910|566563709|FG001|Overall Study|Withdrawal by Subject|1|||
156948031|NCT03634579|566563710|FG000|Overall Study|study termination|9|||
156948032|NCT02480621|566563711|FG000|Randomization|Withdrawal by Subject|1|||
156948033|NCT02480621|566563712|FG001|Randomization|Withdrawal by Subject|0|||
156948034|NCT02480621|566563711|FG000|Randomization|Surgeon did not give intervention|0|||
156948035|NCT02480621|566563712|FG001|Randomization|Surgeon did not give intervention|1|||
156948036|NCT02480621|566563711|FG000|Follow Up|Lost to Follow-up|4|||
156948037|NCT02480621|566563712|FG001|Follow Up|Lost to Follow-up|2|||
156948038|NCT01723904|566563715|FG000|Overall Study|Noncompliant|3|||
156948039|NCT01723904|566563715|FG000|Overall Study|Adverse Event|5|||
156948040|NCT01723904|566563715|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
156948041|NCT02610140|566563726|FG000|Randomization and Treatment Period|Radiological progression|23|||
156948042|NCT02610140|566563727|FG001|Randomization and Treatment Period|Radiological progression|15|||
156948043|NCT02610140|566563726|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
157033735|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
157033736|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
157033737|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
157033738|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
157033739|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
157033740|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
157033741|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
157033742|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
157033743|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
157091646|NCT01775124|567089187|FG000|Core Period|Withdrawal by Subject|4|||
157091647|NCT01775124|567089188|FG001|Core Period|Withdrawal by Subject|2|||
157091648|NCT01775124|567089187|FG000|Core Period|Adverse Event|5|||
157091649|NCT01775124|567089188|FG001|Core Period|Adverse Event|5|||
157091650|NCT01775124|567089187|FG000|Extension Period|Adverse Event|3|||
157091651|NCT01775124|567089188|FG001|Extension Period|Adverse Event|2|||
157091652|NCT01775124|567089187|FG000|Extension Period|Physician Decision|0|||
157091653|NCT01775124|567089188|FG001|Extension Period|Physician Decision|2|||
157091654|NCT01775124|567089187|FG000|Extension Period|Administrative problems|0|||
157091655|NCT01775124|567089188|FG001|Extension Period|Administrative problems|1|||
157091656|NCT01775124|567089187|FG000|Extension Period|Lost to Follow-up|0|||
157091657|NCT01775124|567089188|FG001|Extension Period|Lost to Follow-up|1|||
157091658|NCT01775124|567089187|FG000|Extension Period|Withdrawal by Subject|9|||
157091659|NCT01775124|567089188|FG001|Extension Period|Withdrawal by Subject|12|||
157091660|NCT00727311|567089189|FG000|Overall Study|Did not receive drug|316|||
156948044|NCT02610140|566563727|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
156948045|NCT02610140|566563726|FG000|Randomization and Treatment Period|Protocol Violation|1|||
156948046|NCT02610140|566563727|FG001|Randomization and Treatment Period|Protocol Violation|0|||
156948047|NCT02610140|566563726|FG000|Randomization and Treatment Period|Physician Decision|0|||
156948048|NCT02610140|566563727|FG001|Randomization and Treatment Period|Physician Decision|1|||
156948049|NCT02610140|566563726|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
156948050|NCT02610140|566563727|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
156948051|NCT02610140|566563726|FG000|Randomization and Treatment Period|Death|7|||
156948052|NCT02610140|566563727|FG001|Randomization and Treatment Period|Death|1|||
156948053|NCT02610140|566563726|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
156948054|NCT02610140|566563727|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
156948055|NCT02610140|566563726|FG000|Randomization and Treatment Period|Adverse Event|44|||
156948056|NCT02610140|566563727|FG001|Randomization and Treatment Period|Adverse Event|13|||
156948057|NCT02610140|566563726|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
156948058|NCT02610140|566563727|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
156948059|NCT02610140|566563726|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
156948060|NCT02610140|566563727|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
156948061|NCT02610140|566563726|FG000|Randomization and Treatment Period|Not treated|3|||
156948062|NCT02610140|566563727|FG001|Randomization and Treatment Period|Not treated|10|||
156948063|NCT02610140|566563726|FG000|Safety Follow-up|Other|0|||
156948064|NCT02610140|566563727|FG001|Safety Follow-up|Other|2|||
156948065|NCT02610140|566563726|FG000|Safety Follow-up|Lost to Follow-up|1|||
156948066|NCT02610140|566563727|FG001|Safety Follow-up|Lost to Follow-up|0|||
156948067|NCT02610140|566563726|FG000|Safety Follow-up|No follow-up|5|||
156948068|NCT02610140|566563727|FG001|Safety Follow-up|No follow-up|3|||
156948069|NCT02610140|566563726|FG000|Safety Follow-up|Death|12|||
156948070|NCT02610140|566563727|FG001|Safety Follow-up|Death|2|||
156948071|NCT02610140|566563726|FG000|Safety Follow-up|Deterioration of general conditions|15|||
156948072|NCT02610140|566563727|FG001|Safety Follow-up|Deterioration of general conditions|5|||
156948073|NCT02610140|566563726|FG000|Safety Follow-up|Withdrawal by Subject|12|||
156948074|NCT02610140|566563727|FG001|Safety Follow-up|Withdrawal by Subject|12|||
156948075|NCT02610140|566563726|FG000|Active Follow-up|Progressive disease - radiological|30|||
156948076|NCT02610140|566563727|FG001|Active Follow-up|Progressive disease - radiological|22|||
156948077|NCT02610140|566563726|FG000|Active Follow-up|Death|8|||
156948078|NCT02610140|566563727|FG001|Active Follow-up|Death|1|||
156948079|NCT02610140|566563726|FG000|Active Follow-up|Withdrawal by Subject|4|||
156948080|NCT02610140|566563727|FG001|Active Follow-up|Withdrawal by Subject|0|||
156948081|NCT02610140|566563726|FG000|Active Follow-up|Progressive disease - clinical|1|||
156948082|NCT02610140|566563727|FG001|Active Follow-up|Progressive disease - clinical|2|||
156948083|NCT02610140|566563726|FG000|Active Follow-up|Deterioration of general conditions|1|||
156948084|NCT02610140|566563727|FG001|Active Follow-up|Deterioration of general conditions|0|||
156948085|NCT02610140|566563726|FG000|Active Follow-up|Ongoing but not completed|4|||
156948086|NCT02610140|566563727|FG001|Active Follow-up|Ongoing but not completed|1|||
156948087|NCT02610140|566563726|FG000|Long-term Follow-up|Death|86|||
156948088|NCT02610140|566563727|FG001|Long-term Follow-up|Death|44|||
156948089|NCT02610140|566563726|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
156948090|NCT02610140|566563727|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
157033744|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
157033745|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
157033746|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
157033747|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
157033748|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
157033749|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
157033750|NCT00887198|566880628|FG000|Cross Over (Placebo to AA)|Other|0|||
157033751|NCT00887198|566880629|FG001|Cross Over (Placebo to AA)|Other|0|||
157033752|NCT00887198|566880630|FG002|Cross Over (Placebo to AA)|Other|19|||
157033753|NCT02782676|566880631|FG000|Overall Study|Lost to Follow-up|0|||
157033754|NCT02782676|566880632|FG001|Overall Study|Lost to Follow-up|1|||
157033755|NCT02874742|566880636|FG000|Overall Study|Death|0|||
157033756|NCT02874742|566880637|FG001|Overall Study|Death|1|||
157033757|NCT02874742|566880638|FG002|Overall Study|Death|0|||
157033758|NCT02874742|566880636|FG000|Overall Study|Lost to Follow-up|5|||
157033759|NCT02874742|566880637|FG001|Overall Study|Lost to Follow-up|4|||
157033760|NCT02874742|566880638|FG002|Overall Study|Lost to Follow-up|1|||
157033761|NCT02874742|566880636|FG000|Overall Study|Withdrawal by Subject|17|||
157033762|NCT02874742|566880637|FG001|Overall Study|Withdrawal by Subject|8|||
157033763|NCT02874742|566880638|FG002|Overall Study|Withdrawal by Subject|0|||
157033764|NCT02874742|566880636|FG000|Overall Study|Other|4|||
157033765|NCT02874742|566880637|FG001|Overall Study|Other|1|||
157033766|NCT02874742|566880638|FG002|Overall Study|Other|0|||
157033767|NCT02874742|566880636|FG000|Overall Study|Progressive Disease|1|||
157033768|NCT02874742|566880637|FG001|Overall Study|Progressive Disease|0|||
157033769|NCT02874742|566880638|FG002|Overall Study|Progressive Disease|0|||
157033770|NCT02874742|566880636|FG000|Overall Study|Screen Failure|0|||
157033771|NCT02874742|566880637|FG001|Overall Study|Screen Failure|2|||
157033772|NCT02874742|566880638|FG002|Overall Study|Screen Failure|0|||
157033773|NCT00303459|566880644|FG000|Overall Study|Death|33|||
157033774|NCT00303459|566880645|FG001|Overall Study|Death|44|||
157033775|NCT00303459|566880644|FG000|Overall Study|Withdrawal of consent|32|||
157033776|NCT00303459|566880645|FG001|Overall Study|Withdrawal of consent|26|||
157033777|NCT00303459|566880644|FG000|Overall Study|Lost to Follow-up|5|||
157033778|NCT00303459|566880645|FG001|Overall Study|Lost to Follow-up|4|||
157033779|NCT00303459|566880644|FG000|Overall Study|Administrative reason|7|||
157033780|NCT00303459|566880645|FG001|Overall Study|Administrative reason|7|||
157033781|NCT00303459|566880644|FG000|Overall Study|Decision by the investigator|5|||
157033782|NCT00303459|566880645|FG001|Overall Study|Decision by the investigator|7|||
157033783|NCT00303459|566880644|FG000|Overall Study|Lung transplantation|1|||
157033784|NCT00303459|566880645|FG001|Overall Study|Lung transplantation|1|||
157033785|NCT04055012|566880646|FG000|Overall Study|Withdrawal by Subject|1|||
157033786|NCT04055012|566880647|FG001|Overall Study|Withdrawal by Subject|3|||
157033787|NCT04055012|566880648|FG002|Overall Study|Withdrawal by Subject|1|||
157033788|NCT04055012|566880649|FG003|Overall Study|Withdrawal by Subject|0|||
157033789|NCT04055012|566880646|FG000|Overall Study|Metformin Recall|1|||
157033790|NCT04055012|566880647|FG001|Overall Study|Metformin Recall|1|||
157033791|NCT04055012|566880648|FG002|Overall Study|Metformin Recall|1|||
157033792|NCT04055012|566880649|FG003|Overall Study|Metformin Recall|0|||
157033793|NCT04173247|566880650|FG000|Overall Study|Withdrawal by Subject|0|||
157033794|NCT04173247|566880651|FG001|Overall Study|Withdrawal by Subject|2|||
157227355|NCT00950807|567577785|FG004|Washout Period 2|Lack of Efficacy|0|||
157227356|NCT00950807|567577786|FG005|Washout Period 2|Lack of Efficacy|0|||
157033795|NCT04173247|566880650|FG000|Overall Study|Death|1|||
157033796|NCT04173247|566880651|FG001|Overall Study|Death|0|||
157033797|NCT04173247|566880650|FG000|Overall Study|Physician Decision|1|||
157033798|NCT04173247|566880651|FG001|Overall Study|Physician Decision|0|||
157033799|NCT04109066|566880656|FG000|Pre-treatment|Participant withdrew consent|2|||
157033800|NCT04109066|566880657|FG001|Pre-treatment|Participant withdrew consent|0|||
157033801|NCT04109066|566880656|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
157033802|NCT04109066|566880657|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
157033803|NCT04109066|566880656|FG000|Treatment|Lack of Efficacy|2|||
157033804|NCT04109066|566880657|FG001|Treatment|Lack of Efficacy|4|||
157033805|NCT04109066|566880656|FG000|Treatment|Adverse Event|23|||
157033806|NCT04109066|566880657|FG001|Treatment|Adverse Event|7|||
157033807|NCT04109066|566880656|FG000|Treatment|Participant request to discontinue Study treatment|15|||
157033808|NCT04109066|566880657|FG001|Treatment|Participant request to discontinue Study treatment|14|||
157033809|NCT04109066|566880656|FG000|Treatment|Withdrawal by Subject|8|||
157033810|NCT04109066|566880657|FG001|Treatment|Withdrawal by Subject|8|||
157033811|NCT04109066|566880656|FG000|Treatment|Death|3|||
157033812|NCT04109066|566880657|FG001|Treatment|Death|0|||
157033813|NCT04109066|566880656|FG000|Treatment|Participant no longer meets study criteria|2|||
157033814|NCT04109066|566880657|FG001|Treatment|Participant no longer meets study criteria|2|||
157033815|NCT04109066|566880656|FG000|Treatment|Administrative reasons by sponsor|2|||
157033816|NCT04109066|566880657|FG001|Treatment|Administrative reasons by sponsor|3|||
157033817|NCT04109066|566880656|FG000|Treatment|Other reasons|17|||
157033818|NCT04109066|566880657|FG001|Treatment|Other reasons|23|||
157033819|NCT04109066|566880656|FG000|Treatment|Disease Progression|4|||
157033820|NCT04109066|566880657|FG001|Treatment|Disease Progression|7|||
157033821|NCT04109066|566880656|FG000|Treatment|Study drug toxicity|12|||
157033822|NCT04109066|566880657|FG001|Treatment|Study drug toxicity|5|||
157033823|NCT04109066|566880656|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
157033824|NCT04109066|566880657|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
157033825|NCT04109066|566880656|FG000|Treatment|Disease Recurrence|0|||
157033826|NCT04109066|566880657|FG001|Treatment|Disease Recurrence|2|||
157033827|NCT04109066|566880656|FG000|Treatment|Not reported|4|||
157033828|NCT04109066|566880657|FG001|Treatment|Not reported|8|||
157033829|NCT05205161|566880658|FG000|Overall Study|Study terminated by sponsor|3|||
157033830|NCT05205161|566880659|FG001|Overall Study|Study terminated by sponsor|3|||
157033831|NCT05205161|566880660|FG002|Overall Study|Study terminated by sponsor|1|||
157033832|NCT03744676|566880664|FG000|Pre-Treatment Phase|Disease related complications|2|||
157033833|NCT03744676|566880664|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
157033834|NCT03744676|566880664|FG000|Pre-Treatment Phase|Death|7|||
157033835|NCT03744676|566880664|FG000|Pre-Treatment Phase|Other Reasons|7|||
157033836|NCT03744676|566880664|FG000|Treatment Phase|Participant withdrew consent|8|||
157033837|NCT03744676|566880664|FG000|Treatment Phase|Death|33|||
157033838|NCT03744676|566880664|FG000|Treatment Phase|other reasons|6|||
157033839|NCT05008055|566880667|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
157033840|NCT05008055|566880668|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
157033841|NCT05008055|566880669|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
157033842|NCT03418740|566880671|FG000|Overall Study|Lost to Follow-up|13|||
157033843|NCT03418740|566880671|FG000|Overall Study|Scheduling Issues|7|||
157033844|NCT03418740|566880671|FG000|Overall Study|Withdrawal by Subject|2|||
157033845|NCT03418740|566880671|FG000|Overall Study|Unable to Continue Consent|1|||
157033846|NCT02461134|566880676|FG000|Overall Study|Adverse Event|1|||
157033847|NCT00626795|566880677|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
157033848|NCT00626795|566880678|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
157033849|NCT00626795|566880679|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
157033850|NCT00626795|566880677|FG000|Blinded Treatment|Lack of Efficacy|2|||
157033851|NCT00626795|566880678|FG001|Blinded Treatment|Lack of Efficacy|0|||
157033852|NCT00626795|566880679|FG002|Blinded Treatment|Lack of Efficacy|0|||
157033853|NCT00626795|566880677|FG000|Blinded Treatment|Unacceptable adverse event|0|||
157033854|NCT00626795|566880678|FG001|Blinded Treatment|Unacceptable adverse event|0|||
157033855|NCT00626795|566880679|FG002|Blinded Treatment|Unacceptable adverse event|1|||
157033856|NCT00626795|566880677|FG000|Blinded Treatment|Protocol Violation|0|||
157033857|NCT00626795|566880678|FG001|Blinded Treatment|Protocol Violation|1|||
157033858|NCT00626795|566880679|FG002|Blinded Treatment|Protocol Violation|1|||
157033859|NCT00626795|566880677|FG000|Blinded Treatment|Withdrawal by Subject|1|||
157033860|NCT00626795|566880678|FG001|Blinded Treatment|Withdrawal by Subject|1|||
157033861|NCT00626795|566880679|FG002|Blinded Treatment|Withdrawal by Subject|0|||
157033862|NCT00626795|566880677|FG000|Blinded Treatment|Other reasons|2|||
157033863|NCT00626795|566880678|FG001|Blinded Treatment|Other reasons|0|||
157033864|NCT00626795|566880679|FG002|Blinded Treatment|Other reasons|2|||
157033865|NCT00626795|566880677|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
157033866|NCT00626795|566880678|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
157033867|NCT00626795|566880679|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
157033868|NCT03493542|566880682|FG000|Base Study|Withdrawal by Subject|0|||
157033869|NCT03493542|566880683|FG001|Base Study|Withdrawal by Subject|4|||
157033870|NCT03493542|566880684|FG002|Base Study|Withdrawal by Subject|0|||
157033871|NCT03493542|566880682|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
157033872|NCT03493542|566880683|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
157033873|NCT03493542|566880684|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
157033874|NCT03493542|566880682|FG000|Extension Study|Withdrawal by Subject|0|||
157033875|NCT03493542|566880683|FG001|Extension Study|Withdrawal by Subject|0|||
157033876|NCT03493542|566880684|FG002|Extension Study|Withdrawal by Subject|25|||
157033877|NCT04499521|566880687|FG000|Overall Study|Disease Progression|1|||
157033878|NCT04499521|566880688|FG001|Overall Study|Disease Progression|0|||
157033879|NCT01828021|566881159|FG000|Overall Study|Adverse Event|5|||
157033880|NCT01828021|566881159|FG000|Overall Study|Lack of Efficacy|17|||
157033881|NCT01828021|566881159|FG000|Overall Study|Withdrawal by Subject|2|||
157033882|NCT01828021|566881159|FG000|Overall Study|Ileal obstruction, unrelated|1|||
157033883|NCT02163694|566881169|FG000|Overall Study|Adverse event- related to progression|4|||
157033884|NCT02163694|566881170|FG001|Overall Study|Adverse event- related to progression|10|||
157033885|NCT02163694|566881169|FG000|Overall Study|Adverse event- not related to progression|7|||
157033886|NCT02163694|566881170|FG001|Overall Study|Adverse event- not related to progression|22|||
157033887|NCT02163694|566881169|FG000|Overall Study|Withdrew consent|13|||
157033888|NCT02163694|566881170|FG001|Overall Study|Withdrew consent|28|||
157033889|NCT02163694|566881169|FG000|Overall Study|Lost to Follow-up|2|||
157033890|NCT02163694|566881170|FG001|Overall Study|Lost to Follow-up|2|||
157033891|NCT02163694|566881169|FG000|Overall Study|Sponsor discontinued study|3|||
157033892|NCT02163694|566881170|FG001|Overall Study|Sponsor discontinued study|29|||
157033893|NCT02163694|566881169|FG000|Overall Study|Progressive disease per protocol|125|||
156948091|NCT02610140|566563726|FG000|Long-term Follow-up|Lost to Follow-up|1|||
156948092|NCT02610140|566563727|FG001|Long-term Follow-up|Lost to Follow-up|2|||
156948093|NCT02610140|566563726|FG000|Long-term Follow-up|Ongoing but not completed|30|||
156948094|NCT02610140|566563727|FG001|Long-term Follow-up|Ongoing but not completed|17|||
156948095|NCT00887341|566563728|FG000|Overall Study|Refused treatment|1|||
156948096|NCT00887341|566563729|FG001|Overall Study|Refused treatment|0|||
156948097|NCT00887341|566563728|FG000|Overall Study|Withdrawal by Subject|1|||
156948098|NCT00887341|566563729|FG001|Overall Study|Withdrawal by Subject|1|||
156948099|NCT00887341|566563728|FG000|Overall Study|Adverse Event|0|||
156948100|NCT00887341|566563729|FG001|Overall Study|Adverse Event|1|||
156948101|NCT00887341|566563728|FG000|Overall Study|Lost to Follow-up|0|||
156948102|NCT00887341|566563729|FG001|Overall Study|Lost to Follow-up|1|||
156948103|NCT02617589|566563730|FG000|Randomization|Request to Discontinue Study Treatment|1|||
156948104|NCT02617589|566563731|FG001|Randomization|Request to Discontinue Study Treatment|3|||
156948105|NCT02617589|566563730|FG000|Randomization|Participant Withdrew Consent|1|||
156948106|NCT02617589|566563731|FG001|Randomization|Participant Withdrew Consent|2|||
156948107|NCT02617589|566563730|FG000|Treatment|Other Reasons|3|||
156948108|NCT02617589|566563731|FG001|Treatment|Other Reasons|3|||
156948109|NCT02617589|566563730|FG000|Treatment|Poor/Non Compliance|1|||
156948110|NCT02617589|566563731|FG001|Treatment|Poor/Non Compliance|1|||
156948111|NCT02617589|566563730|FG000|Treatment|Maximum Clinical Benefit|0|||
156948112|NCT02617589|566563731|FG001|Treatment|Maximum Clinical Benefit|2|||
156948113|NCT02617589|566563730|FG000|Treatment|Participant Withdrew Consent|2|||
156948114|NCT02617589|566563731|FG001|Treatment|Participant Withdrew Consent|6|||
156948115|NCT02617589|566563730|FG000|Treatment|Participant Request to Discontinue|12|||
156948116|NCT02617589|566563731|FG001|Treatment|Participant Request to Discontinue|21|||
156948117|NCT02617589|566563730|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
156948118|NCT02617589|566563731|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
156948119|NCT02617589|566563730|FG000|Treatment|Death|1|||
156948120|NCT02617589|566563731|FG001|Treatment|Death|1|||
156948121|NCT02617589|566563730|FG000|Treatment|Study Drug Toxicity|27|||
156948122|NCT02617589|566563731|FG001|Treatment|Study Drug Toxicity|20|||
156948123|NCT02617589|566563730|FG000|Treatment|Disease Progression|216|||
156948124|NCT02617589|566563731|FG001|Treatment|Disease Progression|136|||
156948125|NCT01752933|566563734|FG000|Treatment|Disease Progression|3|||
156948126|NCT01752933|566563735|FG001|Treatment|Disease Progression|29|||
156948127|NCT01752933|566563734|FG000|Treatment|Withdrawal by Subject|0|||
156948128|NCT01752933|566563735|FG001|Treatment|Withdrawal by Subject|5|||
156948129|NCT01752933|566563734|FG000|Treatment|Adverse Event|1|||
156948130|NCT01752933|566563735|FG001|Treatment|Adverse Event|4|||
156948131|NCT01752933|566563734|FG000|Treatment|Physician Decision|0|||
156948132|NCT01752933|566563735|FG001|Treatment|Physician Decision|3|||
156948133|NCT01752933|566563734|FG000|Treatment|Death|0|||
156948134|NCT01752933|566563735|FG001|Treatment|Death|2|||
156948135|NCT01752933|566563734|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
156948136|NCT01752933|566563735|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
156948137|NCT01752933|566563734|FG000|Treatment|Patient noncompliant|0|||
156948138|NCT01752933|566563735|FG001|Treatment|Patient noncompliant|1|||
156948139|NCT01752933|566563734|FG000|Treatment|Patient unable to travel to appointments|0|||
156948140|NCT01752933|566563735|FG001|Treatment|Patient unable to travel to appointments|1|||
156948141|NCT01752933|566563734|FG000|Overall Study and Follow-up|Death|4|||
156948142|NCT01752933|566563735|FG001|Overall Study and Follow-up|Death|34|||
156948143|NCT01752933|566563734|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
156948144|NCT01752933|566563735|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
156948145|NCT01752933|566563734|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
156948146|NCT01752933|566563735|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
156948147|NCT01752933|566563734|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
156948148|NCT01752933|566563735|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
157167640|NCT01677507|567354650|FG000|Second Assigment|Withdrawal by Subject|2|||
157167641|NCT01677507|567354651|FG001|Second Assigment|Withdrawal by Subject|2|||
157167642|NCT01677507|567354650|FG000|Second Assigment|Adverse Event|1|||
157167643|NCT01677507|567354651|FG001|Second Assigment|Adverse Event|3|||
156948149|NCT01591681|566563736|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
156948150|NCT01591681|566563736|FG000|Overall Study|Failed to use system during run-in|1|||
156948151|NCT00958880|566563742|FG000|Overall Study|Lost to Follow-up|2|||
156948152|NCT00958880|566563743|FG001|Overall Study|Lost to Follow-up|2|||
156948153|NCT01971346|566563744|FG000|Overall Study|Protocol Violation|3|||
156948154|NCT01971346|566563744|FG000|Overall Study|Lost to Follow-up|2|||
156948155|NCT01971346|566563744|FG000|Overall Study|Withdrawal by Subject|2|||
156948156|NCT01971346|566563744|FG000|Overall Study|Physician Decision|1|||
156948157|NCT04187196|566563747|FG000|Overall Study|Screen Failure|2|||
156948158|NCT04187196|566563748|FG001|Overall Study|Screen Failure|0|||
156948159|NCT01687166|566563749|FG000|Overall Study|Attempt subject|2|||
156948160|NCT01687166|566563750|FG001|Overall Study|Attempt subject|3|||
156948161|NCT01687166|566563751|FG002|Overall Study|Attempt subject|2|||
156948162|NCT01687166|566563752|FG003|Overall Study|Attempt subject|0|||
156948163|NCT01687166|566563749|FG000|Overall Study|Did not meet eligibility criteria|4|||
157033894|NCT02163694|566881170|FG001|Overall Study|Progressive disease per protocol|224|||
157033895|NCT02163694|566881169|FG000|Overall Study|Other, not specified|17|||
156948164|NCT01687166|566563750|FG001|Overall Study|Did not meet eligibility criteria|6|||
156948165|NCT01687166|566563751|FG002|Overall Study|Did not meet eligibility criteria|1|||
156948166|NCT01687166|566563752|FG003|Overall Study|Did not meet eligibility criteria|1|||
156948167|NCT01687166|566563749|FG000|Overall Study|Adverse Event|2|||
156948168|NCT01687166|566563750|FG001|Overall Study|Adverse Event|1|||
156948169|NCT01687166|566563751|FG002|Overall Study|Adverse Event|0|||
156948170|NCT01687166|566563752|FG003|Overall Study|Adverse Event|0|||
156948171|NCT01687166|566563749|FG000|Overall Study|Physician Decision|3|||
156948172|NCT01687166|566563750|FG001|Overall Study|Physician Decision|2|||
156948173|NCT01687166|566563751|FG002|Overall Study|Physician Decision|1|||
156948174|NCT01687166|566563752|FG003|Overall Study|Physician Decision|0|||
156948175|NCT01687166|566563749|FG000|Overall Study|Withdrawal by Subject|11|||
156948176|NCT01687166|566563750|FG001|Overall Study|Withdrawal by Subject|4|||
156948177|NCT01687166|566563751|FG002|Overall Study|Withdrawal by Subject|3|||
156948178|NCT01687166|566563752|FG003|Overall Study|Withdrawal by Subject|0|||
156948179|NCT01687166|566563749|FG000|Overall Study|Lost to Follow-up|2|||
156948180|NCT01687166|566563750|FG001|Overall Study|Lost to Follow-up|5|||
156948181|NCT01687166|566563751|FG002|Overall Study|Lost to Follow-up|1|||
156948182|NCT01687166|566563752|FG003|Overall Study|Lost to Follow-up|0|||
156948183|NCT01687166|566563749|FG000|Overall Study|Equipment/Device Availability|0|||
156948184|NCT01687166|566563750|FG001|Overall Study|Equipment/Device Availability|1|||
156948185|NCT01687166|566563751|FG002|Overall Study|Equipment/Device Availability|0|||
156948186|NCT01687166|566563752|FG003|Overall Study|Equipment/Device Availability|0|||
156948187|NCT01687166|566563749|FG000|Overall Study|Death|1|||
156948188|NCT01687166|566563750|FG001|Overall Study|Death|1|||
156948189|NCT01687166|566563751|FG002|Overall Study|Death|0|||
156948190|NCT01687166|566563752|FG003|Overall Study|Death|0|||
156948191|NCT01687166|566563749|FG000|Overall Study|Protocol Violation|1|||
156948192|NCT01687166|566563750|FG001|Overall Study|Protocol Violation|1|||
156948193|NCT01687166|566563751|FG002|Overall Study|Protocol Violation|1|||
156948194|NCT01687166|566563752|FG003|Overall Study|Protocol Violation|0|||
156948195|NCT01687166|566563749|FG000|Overall Study|Subject moved out of state|0|||
156948196|NCT01687166|566563750|FG001|Overall Study|Subject moved out of state|1|||
156948197|NCT01687166|566563751|FG002|Overall Study|Subject moved out of state|0|||
156948198|NCT01687166|566563752|FG003|Overall Study|Subject moved out of state|0|||
156948199|NCT01687166|566563749|FG000|Overall Study|Patient unable to be compliant|1|||
156948200|NCT01687166|566563750|FG001|Overall Study|Patient unable to be compliant|0|||
156948201|NCT01687166|566563751|FG002|Overall Study|Patient unable to be compliant|0|||
156948202|NCT01687166|566563752|FG003|Overall Study|Patient unable to be compliant|0|||
156948203|NCT01687166|566563749|FG000|Overall Study|Physician choice to use different device|1|||
156948204|NCT01687166|566563750|FG001|Overall Study|Physician choice to use different device|2|||
156948205|NCT01687166|566563751|FG002|Overall Study|Physician choice to use different device|4|||
156948206|NCT01687166|566563752|FG003|Overall Study|Physician choice to use different device|0|||
156948207|NCT01687166|566563749|FG000|Overall Study|Insurance|0|||
156948208|NCT01687166|566563750|FG001|Overall Study|Insurance|0|||
156948209|NCT01687166|566563751|FG002|Overall Study|Insurance|1|||
156948210|NCT01687166|566563752|FG003|Overall Study|Insurance|1|||
156948211|NCT02755831|566563753|FG000|Overall Study|Lost to Follow-up|3|||
156948212|NCT02755831|566563754|FG001|Overall Study|Lost to Follow-up|3|||
156948213|NCT02296112|566563755|FG000|Overall Study|Disease progression|7|||
156948214|NCT02296112|566563755|FG000|Overall Study|Toxicity|1|||
156948215|NCT02296112|566563755|FG000|Overall Study|Began an alternate therapy|1|||
156948216|NCT00298831|566563756|FG000|Overall Study|Adverse Event|1|||
156948217|NCT00298831|566563756|FG000|Overall Study|Lost to Follow-up|3|||
156948218|NCT00298831|566563756|FG000|Overall Study|Withdrawal by Subject|1|||
156948219|NCT00298831|566563756|FG000|Overall Study|Participants did not receive treatment|27|||
156948220|NCT01516879|566563757|FG000|Overall Study|Withdrawal by Subject|9|||
156948221|NCT01516879|566563758|FG001|Overall Study|Withdrawal by Subject|11|||
156948222|NCT01516879|566563757|FG000|Overall Study|Death|0|||
156948223|NCT01516879|566563758|FG001|Overall Study|Death|2|||
156948224|NCT01516879|566563757|FG000|Overall Study|Lost to Follow-up|2|||
156948225|NCT01516879|566563758|FG001|Overall Study|Lost to Follow-up|11|||
156948226|NCT01516879|566563757|FG000|Overall Study|Other|5|||
156948227|NCT01516879|566563758|FG001|Overall Study|Other|10|||
156948228|NCT01720069|566563759|FG000|Overall Study|Could not use e-diary correctly|0|||
156948229|NCT01720069|566563760|FG001|Overall Study|Could not use e-diary correctly|1|||
157033896|NCT02163694|566881170|FG001|Overall Study|Other, not specified|22|||
157033897|NCT02163694|566881169|FG000|Overall Study|Randomized but Not Treated|1|||
157033898|NCT02163694|566881170|FG001|Overall Study|Randomized but Not Treated|0|||
157033899|NCT02163694|566881169|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
157033900|NCT02163694|566881170|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
156948230|NCT01720069|566563761|FG002|Overall Study|Could not use e-diary correctly|1|||
156948231|NCT01720069|566563759|FG000|Overall Study|Randomised without baseline values|0|||
156948232|NCT01720069|566563760|FG001|Overall Study|Randomised without baseline values|0|||
157033901|NCT04967599|566881177|FG000|Overall Study|Lost to Follow-up|35|||
157033902|NCT04967599|566881178|FG001|Overall Study|Lost to Follow-up|19|||
157033903|NCT04967599|566881179|FG002|Overall Study|Lost to Follow-up|23|||
157167644|NCT03779334|567354652|FG000|Overall Study|Withdrawal by Subject|3|||
157167645|NCT03779334|567354653|FG001|Overall Study|Withdrawal by Subject|0|||
157167646|NCT03779334|567354654|FG002|Overall Study|Withdrawal by Subject|0|||
156948233|NCT01720069|566563761|FG002|Overall Study|Randomised without baseline values|1|||
156948234|NCT01720069|566563759|FG000|Overall Study|Adverse Event|0|||
156948235|NCT01720069|566563760|FG001|Overall Study|Adverse Event|0|||
156948236|NCT01720069|566563761|FG002|Overall Study|Adverse Event|1|||
156948237|NCT01720069|566563759|FG000|Overall Study|Lack of Efficacy|0|||
156948238|NCT01720069|566563760|FG001|Overall Study|Lack of Efficacy|4|||
156948239|NCT01720069|566563761|FG002|Overall Study|Lack of Efficacy|0|||
156948240|NCT01720069|566563759|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
156948241|NCT01720069|566563760|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
156948242|NCT01720069|566563761|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
156948243|NCT01720069|566563759|FG000|Overall Study|Withdrawal by Subject|0|||
156948244|NCT01720069|566563760|FG001|Overall Study|Withdrawal by Subject|2|||
156948245|NCT01720069|566563761|FG002|Overall Study|Withdrawal by Subject|1|||
156948246|NCT01720069|566563759|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
156948247|NCT01720069|566563760|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
156948248|NCT01720069|566563761|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
156948249|NCT01720069|566563759|FG000|Overall Study|Non-compliance on using e-diary|0|||
156948250|NCT01720069|566563760|FG001|Overall Study|Non-compliance on using e-diary|0|||
156948251|NCT01720069|566563761|FG002|Overall Study|Non-compliance on using e-diary|1|||
156948252|NCT01720069|566563759|FG000|Overall Study|Lost to Follow-up|0|||
156948253|NCT01720069|566563760|FG001|Overall Study|Lost to Follow-up|0|||
156948254|NCT01720069|566563761|FG002|Overall Study|Lost to Follow-up|1|||
156948255|NCT04568122|566563762|FG000|Overall Study|Lost to Follow-up|48|||
156948256|NCT04568122|566563763|FG001|Overall Study|Lost to Follow-up|44|||
156948257|NCT04568122|566563764|FG002|Overall Study|Lost to Follow-up|4|||
156948258|NCT04568122|566563765|FG003|Overall Study|Lost to Follow-up|0|||
156948259|NCT04568122|566563766|FG004|Overall Study|Lost to Follow-up|0|||
156948260|NCT01782131|566566038|FG000|Overall Study|Death|93|||
156948261|NCT01782131|566566039|FG001|Overall Study|Death|96|||
156948262|NCT01782131|566566038|FG000|Overall Study|Lost to Follow-up|1|||
156948263|NCT01782131|566566039|FG001|Overall Study|Lost to Follow-up|3|||
156948264|NCT01782131|566566038|FG000|Overall Study|Withdrawal by Subject|10|||
156948265|NCT01782131|566566039|FG001|Overall Study|Withdrawal by Subject|10|||
156948266|NCT01782131|566566038|FG000|Overall Study|Randomized but not treated|5|||
156948267|NCT01782131|566566039|FG001|Overall Study|Randomized but not treated|5|||
156948268|NCT01782131|566566038|FG000|Overall Study|Reason not provided|0|||
156948269|NCT01782131|566566039|FG001|Overall Study|Reason not provided|1|||
156948270|NCT01627249|566566040|FG000|Overall Study|Death|3|||
156948271|NCT01627249|566566041|FG001|Overall Study|Death|5|||
156948272|NCT01627249|566566042|FG002|Overall Study|Death|3|||
156948273|NCT01627249|566566040|FG000|Overall Study|Withdrawal by Subject|12|||
156948274|NCT01627249|566566041|FG001|Overall Study|Withdrawal by Subject|6|||
156948275|NCT01627249|566566042|FG002|Overall Study|Withdrawal by Subject|9|||
156948276|NCT01627249|566566040|FG000|Overall Study|Missed Visit|1|||
156948277|NCT01627249|566566041|FG001|Overall Study|Missed Visit|1|||
156948278|NCT01627249|566566042|FG002|Overall Study|Missed Visit|0|||
156948279|NCT00796718|566566043|FG000|Overall Study|Adverse Event|2|||
156948280|NCT00796718|566566043|FG000|Overall Study|Exclusion Criteria|1|||
156948281|NCT00796718|566566043|FG000|Overall Study|Lost to Follow-up|5|||
156948282|NCT00796718|566566043|FG000|Overall Study|Withdrawal by Informed Consent|1|||
156948283|NCT02039505|566566044|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
156948284|NCT02039505|566566045|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
156948285|NCT02039505|566566046|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
157167647|NCT03779334|567354652|FG000|Overall Study|Ongoing in Study|5|||
156948286|NCT02039505|566566047|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156948287|NCT02039505|566566048|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156948288|NCT02039505|566566049|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156948289|NCT02039505|566566050|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
156948290|NCT02039505|566566044|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
156948291|NCT02039505|566566045|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
156948292|NCT02039505|566566046|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
156948293|NCT02039505|566566047|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156948294|NCT02039505|566566048|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156948295|NCT02039505|566566049|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
157167648|NCT03779334|567354653|FG001|Overall Study|Ongoing in Study|13|||
157167649|NCT03779334|567354654|FG002|Overall Study|Ongoing in Study|5|||
157167650|NCT00085917|567354655|FG000|Overall Study|Adverse Event|4|||
157167651|NCT00085917|567354656|FG001|Overall Study|Adverse Event|3|||
157167652|NCT03670641|567354661|FG000|Overall Study|Lost to Follow-up|3|||
157167653|NCT00125190|567354667|FG000|Overall Study|Subject/Parent Decision|7|||
157167654|NCT00125190|567354667|FG000|Overall Study|Non-compliance|2|||
157167655|NCT00125190|567354667|FG000|Overall Study|Adverse Event|1|||
157167656|NCT00125190|567354667|FG000|Overall Study|Other|1|||
157167657|NCT00125190|567354667|FG000|Overall Study|Lost to Follow-up|4|||
157167658|NCT00916370|567354668|FG000|Overall Study|Death|3|||
157167659|NCT00916370|567354669|FG001|Overall Study|Death|1|||
157167660|NCT00916370|567354668|FG000|Overall Study|Withdrawal by Subject|2|||
157167661|NCT00916370|567354669|FG001|Overall Study|Withdrawal by Subject|0|||
157167662|NCT00916370|567354668|FG000|Overall Study|Physician Decision|0|||
157167663|NCT00916370|567354669|FG001|Overall Study|Physician Decision|1|||
156948296|NCT02039505|566566050|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
156948297|NCT02039505|566566044|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
156948298|NCT02039505|566566045|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948299|NCT02039505|566566046|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948300|NCT02039505|566566047|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948301|NCT02039505|566566048|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948302|NCT02039505|566566049|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948303|NCT02039505|566566050|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
156948304|NCT02039505|566566044|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156948305|NCT02039505|566566045|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156948306|NCT02039505|566566046|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156948307|NCT02039505|566566047|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
156948308|NCT02039505|566566048|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
156948309|NCT02039505|566566049|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
156948310|NCT02039505|566566050|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
156948311|NCT02039505|566566044|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156948312|NCT02039505|566566045|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156948313|NCT02039505|566566046|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156948314|NCT02039505|566566047|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
156948315|NCT02039505|566566048|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
156948316|NCT02039505|566566049|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
156948317|NCT02039505|566566050|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
156948318|NCT02039505|566566044|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156948319|NCT02039505|566566045|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156948320|NCT02039505|566566046|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156948321|NCT02039505|566566047|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
156948322|NCT02039505|566566048|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
156948323|NCT02039505|566566049|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
156948324|NCT02039505|566566050|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
156948325|NCT02039505|566566044|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948326|NCT02039505|566566045|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948327|NCT02039505|566566046|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948328|NCT02039505|566566047|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
156948329|NCT02039505|566566048|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948330|NCT02039505|566566049|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948331|NCT02039505|566566050|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
156948332|NCT02039505|566566044|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948333|NCT02039505|566566045|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948334|NCT02039505|566566046|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948335|NCT02039505|566566047|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948336|NCT02039505|566566048|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948337|NCT02039505|566566049|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
156948338|NCT02039505|566566050|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
156948339|NCT02039505|566566044|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
157033904|NCT03817983|566881180|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
157167664|NCT00414960|567354670|FG000|Overall Study|Adverse Event|4|||
157167665|NCT00414960|567354671|FG001|Overall Study|Adverse Event|0|||
157167666|NCT00414960|567354670|FG000|Overall Study|Withdrawal by Subject|3|||
157167667|NCT00414960|567354671|FG001|Overall Study|Withdrawal by Subject|0|||
157167668|NCT00414960|567354670|FG000|Overall Study|Physician Decision|0|||
157167669|NCT00414960|567354671|FG001|Overall Study|Physician Decision|1|||
157167670|NCT03722784|567354674|FG000|Overall Study|Withdrawal by Subject|1|||
157167671|NCT03722784|567354675|FG001|Overall Study|Withdrawal by Subject|0|||
157167672|NCT03722784|567354674|FG000|Overall Study|Physician Decision|1|||
157167673|NCT03722784|567354675|FG001|Overall Study|Physician Decision|1|||
157167674|NCT03722784|567354674|FG000|Overall Study|Protocol Violation|0|||
157033905|NCT03817983|566881181|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
157033906|NCT03817983|566881182|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
157033907|NCT05541484|566881185|FG000|Overall Study|Withdrawal by Subject|1|||
157033908|NCT05541484|566881186|FG001|Overall Study|Withdrawal by Subject|0|||
157033909|NCT01438853|566881189|FG000|Overall Study|Death|0|||
157033910|NCT01438853|566881190|FG001|Overall Study|Death|0|||
157033911|NCT01438853|566881191|FG002|Overall Study|Death|0|||
157033912|NCT01438853|566881192|FG003|Overall Study|Death|1|||
157033913|NCT01438853|566881189|FG000|Overall Study|Withdrawal by Subject|0|||
157033914|NCT01438853|566881190|FG001|Overall Study|Withdrawal by Subject|0|||
157033915|NCT01438853|566881191|FG002|Overall Study|Withdrawal by Subject|1|||
157033916|NCT01438853|566881192|FG003|Overall Study|Withdrawal by Subject|0|||
157033917|NCT02919917|566881193|FG000|Overall Study|Withdrawal by Subject|4|||
157033918|NCT02919917|566881194|FG001|Overall Study|Withdrawal by Subject|8|||
157033919|NCT04743973|566881198|FG000|Overall Study|Withdrawal by Subject|5|||
157033920|NCT04159519|566881199|FG000|Overall Study|Adverse Event|1|||
157033921|NCT04159519|566881200|FG001|Overall Study|Adverse Event|1|||
157033922|NCT04159519|566881199|FG000|Overall Study|Lack of Efficacy|1|||
157033923|NCT04159519|566881200|FG001|Overall Study|Lack of Efficacy|0|||
157033924|NCT04159519|566881199|FG000|Overall Study|Discontinued from study|1|||
157033925|NCT04159519|566881200|FG001|Overall Study|Discontinued from study|0|||
157033926|NCT04159519|566881199|FG000|Overall Study|Protocol Violation|1|||
157033927|NCT04159519|566881200|FG001|Overall Study|Protocol Violation|1|||
157033928|NCT04159519|566881199|FG000|Overall Study|Withdrawal by Subject|4|||
157033929|NCT04159519|566881200|FG001|Overall Study|Withdrawal by Subject|4|||
157033930|NCT04678856|566881204|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
157033931|NCT04678856|566881205|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
157033932|NCT04678856|566881204|FG000|Overall Study|Withdrawal by Subject|5|||
157033933|NCT04678856|566881205|FG001|Overall Study|Withdrawal by Subject|1|||
157033934|NCT04595331|566881749|FG000|Overall Study|Withdrawal by Subject|0|||
157033935|NCT04595331|566881750|FG001|Overall Study|Withdrawal by Subject|1|||
157167675|NCT03722784|567354675|FG001|Overall Study|Protocol Violation|1|||
157167676|NCT00738374|567354676|FG000|Induction Treatment Phase|Adverse Event|14|||
157033936|NCT04595331|566881749|FG000|Overall Study|Lost to Follow-up|0|||
157033937|NCT04595331|566881750|FG001|Overall Study|Lost to Follow-up|5|||
157033938|NCT04595331|566881749|FG000|Overall Study|Medical reason|0|||
157033939|NCT04595331|566881750|FG001|Overall Study|Medical reason|1|||
157033940|NCT02246127|566881751|FG000|First Course Treatment|Adverse Event|9|||
157033941|NCT02246127|566881752|FG001|First Course Treatment|Adverse Event|7|||
157033942|NCT02246127|566881751|FG000|First Course Treatment|Withdrawal by Subject|6|||
157033943|NCT02246127|566881752|FG001|First Course Treatment|Withdrawal by Subject|7|||
157033944|NCT02246127|566881751|FG000|First Course Treatment|Physician Decision|9|||
157033945|NCT02246127|566881752|FG001|First Course Treatment|Physician Decision|9|||
157033946|NCT02246127|566881751|FG000|First Course Treatment|Death|3|||
157033947|NCT02246127|566881752|FG001|First Course Treatment|Death|3|||
157033948|NCT02246127|566881751|FG000|First Course Treatment|Not reported reasons|6|||
157033949|NCT02246127|566881752|FG001|First Course Treatment|Not reported reasons|7|||
157033950|NCT02246127|566881751|FG000|First Course Treatment|Not treated|3|||
157033951|NCT02246127|566881752|FG001|First Course Treatment|Not treated|3|||
157033952|NCT03635567|566881753|FG000|Overall Study|Lost to Follow-up|4|||
157033953|NCT03635567|566881754|FG001|Overall Study|Lost to Follow-up|1|||
157167677|NCT00738374|567354677|FG001|Induction Treatment Phase|Adverse Event|0|||
157167678|NCT00738374|567354678|FG002|Induction Treatment Phase|Adverse Event|0|||
157167679|NCT00738374|567354679|FG003|Induction Treatment Phase|Adverse Event|0|||
157167680|NCT00738374|567354676|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
157167681|NCT00738374|567354677|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
157167682|NCT00738374|567354678|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
157167683|NCT00738374|567354679|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
157033954|NCT03635567|566881753|FG000|Overall Study|Withdrawal by Subject|11|||
157033955|NCT03635567|566881754|FG001|Overall Study|Withdrawal by Subject|16|||
157033956|NCT03635567|566881753|FG000|Overall Study|Sponsor Decision|99|||
157033957|NCT03635567|566881754|FG001|Overall Study|Sponsor Decision|57|||
157033958|NCT03635567|566881753|FG000|Overall Study|Death|194|||
157033959|NCT03635567|566881754|FG001|Overall Study|Death|235|||
157033960|NCT00739908|566881755|FG000|Overall Study|Adverse Event|5|||
157033961|NCT00739908|566881756|FG001|Overall Study|Adverse Event|6|||
157033962|NCT00739908|566881755|FG000|Overall Study|Withdrawal by Subject|4|||
157033963|NCT00739908|566881756|FG001|Overall Study|Withdrawal by Subject|2|||
157033964|NCT00739908|566881755|FG000|Overall Study|Lost to Follow-up|14|||
157033965|NCT00739908|566881756|FG001|Overall Study|Lost to Follow-up|9|||
157033966|NCT00739908|566881755|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
157033967|NCT00739908|566881756|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
157033968|NCT00739908|566881755|FG000|Overall Study|Non-Compliance With Study Medication|0|||
157033969|NCT00739908|566881756|FG001|Overall Study|Non-Compliance With Study Medication|3|||
157033970|NCT00739908|566881755|FG000|Overall Study|Lack of Efficacy|0|||
157227357|NCT00950807|567577787|FG006|Washout Period 2|Lack of Efficacy|0|||
157227358|NCT00950807|567577788|FG007|Washout Period 2|Lack of Efficacy|0|||
157227359|NCT00950807|567577789|FG008|Washout Period 2|Lack of Efficacy|0|||
157227360|NCT00950807|567577790|FG009|Washout Period 2|Lack of Efficacy|0|||
156948340|NCT02039505|566566045|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156948341|NCT02039505|566566046|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156948342|NCT02039505|566566047|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156948343|NCT02039505|566566048|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156948344|NCT02039505|566566049|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
156948345|NCT02039505|566566050|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
156948346|NCT02039505|566566044|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948347|NCT02039505|566566045|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948348|NCT02039505|566566046|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948349|NCT02039505|566566047|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948350|NCT02039505|566566048|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948351|NCT02039505|566566049|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
156948352|NCT02039505|566566050|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
156948353|NCT02039505|566566044|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948354|NCT02039505|566566045|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948355|NCT02039505|566566046|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948356|NCT02039505|566566047|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948357|NCT02039505|566566048|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948358|NCT02039505|566566049|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
156948359|NCT02039505|566566050|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
156948360|NCT01722331|566566051|FG000|Part 1|Adverse Event|5|||
156948361|NCT01722331|566566052|FG001|Part 1|Adverse Event|0|||
156948362|NCT01722331|566566053|FG002|Part 1|Adverse Event|0|||
156948363|NCT01722331|566566054|FG003|Part 1|Adverse Event|0|||
156948364|NCT01722331|566566055|FG004|Part 1|Adverse Event|0|||
156948365|NCT01722331|566566056|FG005|Part 1|Adverse Event|0|||
156948366|NCT01722331|566566057|FG006|Part 1|Adverse Event|0|||
156948367|NCT01722331|566566051|FG000|Part 1|Lack of Efficacy|0|||
156948368|NCT01722331|566566052|FG001|Part 1|Lack of Efficacy|0|||
156948369|NCT01722331|566566053|FG002|Part 1|Lack of Efficacy|1|||
156948370|NCT01722331|566566054|FG003|Part 1|Lack of Efficacy|0|||
156948371|NCT01722331|566566055|FG004|Part 1|Lack of Efficacy|2|||
156948372|NCT01722331|566566056|FG005|Part 1|Lack of Efficacy|0|||
156948373|NCT01722331|566566057|FG006|Part 1|Lack of Efficacy|0|||
156948374|NCT01722331|566566051|FG000|Part 1|Lost to Follow-up|1|||
156948375|NCT01722331|566566052|FG001|Part 1|Lost to Follow-up|0|||
156948376|NCT01722331|566566053|FG002|Part 1|Lost to Follow-up|2|||
156948377|NCT01722331|566566054|FG003|Part 1|Lost to Follow-up|0|||
156948378|NCT01722331|566566055|FG004|Part 1|Lost to Follow-up|1|||
156948379|NCT01722331|566566056|FG005|Part 1|Lost to Follow-up|0|||
156948380|NCT01722331|566566057|FG006|Part 1|Lost to Follow-up|0|||
156948381|NCT01722331|566566051|FG000|Part 1|Physician Decision|0|||
156948382|NCT01722331|566566052|FG001|Part 1|Physician Decision|0|||
156948383|NCT01722331|566566053|FG002|Part 1|Physician Decision|3|||
156948384|NCT01722331|566566054|FG003|Part 1|Physician Decision|0|||
156948385|NCT01722331|566566055|FG004|Part 1|Physician Decision|1|||
156948386|NCT01722331|566566056|FG005|Part 1|Physician Decision|0|||
156948387|NCT01722331|566566057|FG006|Part 1|Physician Decision|0|||
156948388|NCT01722331|566566051|FG000|Part 1|Pregnancy|1|||
156948389|NCT01722331|566566052|FG001|Part 1|Pregnancy|0|||
156948390|NCT01722331|566566053|FG002|Part 1|Pregnancy|0|||
156948391|NCT01722331|566566054|FG003|Part 1|Pregnancy|0|||
156948392|NCT01722331|566566055|FG004|Part 1|Pregnancy|0|||
156948393|NCT01722331|566566056|FG005|Part 1|Pregnancy|0|||
156948394|NCT01722331|566566057|FG006|Part 1|Pregnancy|0|||
156948395|NCT01722331|566566051|FG000|Part 1|Progressive Disease|0|||
156948396|NCT01722331|566566052|FG001|Part 1|Progressive Disease|0|||
156948397|NCT01722331|566566053|FG002|Part 1|Progressive Disease|0|||
156948398|NCT01722331|566566054|FG003|Part 1|Progressive Disease|0|||
156948399|NCT01722331|566566055|FG004|Part 1|Progressive Disease|1|||
156948400|NCT01722331|566566056|FG005|Part 1|Progressive Disease|0|||
156948401|NCT01722331|566566057|FG006|Part 1|Progressive Disease|0|||
156948402|NCT01722331|566566051|FG000|Part 1|Protocol Violation|1|||
156948403|NCT01722331|566566052|FG001|Part 1|Protocol Violation|0|||
156948404|NCT01722331|566566053|FG002|Part 1|Protocol Violation|0|||
156948405|NCT01722331|566566054|FG003|Part 1|Protocol Violation|0|||
156948406|NCT01722331|566566055|FG004|Part 1|Protocol Violation|1|||
156948407|NCT01722331|566566056|FG005|Part 1|Protocol Violation|0|||
156948408|NCT01722331|566566057|FG006|Part 1|Protocol Violation|0|||
156948409|NCT01722331|566566051|FG000|Part 1|Withdrawal by Subject|2|||
156948410|NCT01722331|566566052|FG001|Part 1|Withdrawal by Subject|0|||
156948411|NCT01722331|566566053|FG002|Part 1|Withdrawal by Subject|3|||
156948412|NCT01722331|566566054|FG003|Part 1|Withdrawal by Subject|0|||
156948413|NCT01722331|566566055|FG004|Part 1|Withdrawal by Subject|3|||
157227361|NCT00950807|567577781|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
157033971|NCT00739908|566881756|FG001|Overall Study|Lack of Efficacy|1|||
157033972|NCT00739908|566881755|FG000|Overall Study|Relocation|0|||
157033973|NCT00739908|566881756|FG001|Overall Study|Relocation|1|||
157033974|NCT05157841|566881757|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
157033975|NCT05157841|566881758|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
157033976|NCT05157841|566881759|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
157033977|NCT05157841|566881757|FG000|Part A (14 Days)|Adverse Event|1|||
157033978|NCT05157841|566881758|FG001|Part A (14 Days)|Adverse Event|0|||
157033979|NCT05157841|566881759|FG002|Part A (14 Days)|Adverse Event|0|||
157033980|NCT05157841|566881757|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
157033981|NCT05157841|566881758|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
157033982|NCT05157841|566881759|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
157033983|NCT03884101|566881760|FG000|Overall Study|Participant Ongoing in Study|202|||
157033984|NCT03884101|566881761|FG001|Overall Study|Participant Ongoing in Study|186|||
157033985|NCT03884101|566881760|FG000|Overall Study|Death|212|||
157033986|NCT03884101|566881761|FG001|Overall Study|Death|224|||
157033987|NCT03884101|566881760|FG000|Overall Study|Lost to Follow-up|0|||
157033988|NCT03884101|566881761|FG001|Overall Study|Lost to Follow-up|1|||
157033989|NCT03884101|566881760|FG000|Overall Study|Withdrawal by Subject|6|||
157033990|NCT03884101|566881761|FG001|Overall Study|Withdrawal by Subject|11|||
157033991|NCT04560179|566881762|FG000|Overall Study|Physician Decision|1|||
157167684|NCT00738374|567354676|FG000|Induction Treatment Phase|Physician Decision|2|||
157167685|NCT00738374|567354677|FG001|Induction Treatment Phase|Physician Decision|0|||
157167686|NCT00738374|567354678|FG002|Induction Treatment Phase|Physician Decision|0|||
157167687|NCT00738374|567354679|FG003|Induction Treatment Phase|Physician Decision|0|||
157167688|NCT00738374|567354676|FG000|Induction Treatment Phase|Protocol Violation|2|||
157167689|NCT00738374|567354677|FG001|Induction Treatment Phase|Protocol Violation|0|||
157167690|NCT00738374|567354678|FG002|Induction Treatment Phase|Protocol Violation|0|||
157167691|NCT00738374|567354679|FG003|Induction Treatment Phase|Protocol Violation|0|||
156948414|NCT01722331|566566056|FG005|Part 1|Withdrawal by Subject|0|||
156948415|NCT01722331|566566057|FG006|Part 1|Withdrawal by Subject|0|||
156948416|NCT01722331|566566051|FG000|Part 2|Adverse Event|3|||
156948417|NCT01722331|566566052|FG001|Part 2|Adverse Event|0|||
156948418|NCT01722331|566566053|FG002|Part 2|Adverse Event|0|||
156948419|NCT01722331|566566054|FG003|Part 2|Adverse Event|0|||
156948420|NCT01722331|566566055|FG004|Part 2|Adverse Event|0|||
156948421|NCT01722331|566566056|FG005|Part 2|Adverse Event|1|||
156948422|NCT01722331|566566057|FG006|Part 2|Adverse Event|0|||
156948423|NCT01722331|566566051|FG000|Part 2|Lack of Efficacy|3|||
156948424|NCT01722331|566566052|FG001|Part 2|Lack of Efficacy|0|||
156948425|NCT01722331|566566053|FG002|Part 2|Lack of Efficacy|11|||
156948426|NCT01722331|566566054|FG003|Part 2|Lack of Efficacy|0|||
156948427|NCT01722331|566566055|FG004|Part 2|Lack of Efficacy|0|||
156948428|NCT01722331|566566056|FG005|Part 2|Lack of Efficacy|3|||
156948429|NCT01722331|566566057|FG006|Part 2|Lack of Efficacy|3|||
156948430|NCT01722331|566566051|FG000|Part 2|Lost to Follow-up|0|||
156948431|NCT01722331|566566052|FG001|Part 2|Lost to Follow-up|0|||
156948432|NCT01722331|566566053|FG002|Part 2|Lost to Follow-up|3|||
156948433|NCT01722331|566566054|FG003|Part 2|Lost to Follow-up|0|||
156948434|NCT01722331|566566055|FG004|Part 2|Lost to Follow-up|0|||
156948435|NCT01722331|566566056|FG005|Part 2|Lost to Follow-up|1|||
156948436|NCT01722331|566566057|FG006|Part 2|Lost to Follow-up|1|||
156948437|NCT01722331|566566051|FG000|Part 2|Non-Compliance with Study Drug|1|||
156948438|NCT01722331|566566052|FG001|Part 2|Non-Compliance with Study Drug|0|||
156948439|NCT01722331|566566053|FG002|Part 2|Non-Compliance with Study Drug|1|||
156948440|NCT01722331|566566054|FG003|Part 2|Non-Compliance with Study Drug|0|||
156948441|NCT01722331|566566055|FG004|Part 2|Non-Compliance with Study Drug|0|||
156948442|NCT01722331|566566056|FG005|Part 2|Non-Compliance with Study Drug|0|||
156948443|NCT01722331|566566057|FG006|Part 2|Non-Compliance with Study Drug|0|||
156948444|NCT01722331|566566051|FG000|Part 2|Physician Decision|0|||
156948445|NCT01722331|566566052|FG001|Part 2|Physician Decision|0|||
156948446|NCT01722331|566566053|FG002|Part 2|Physician Decision|2|||
156948447|NCT01722331|566566054|FG003|Part 2|Physician Decision|0|||
156948448|NCT01722331|566566055|FG004|Part 2|Physician Decision|0|||
156948449|NCT01722331|566566056|FG005|Part 2|Physician Decision|0|||
156948450|NCT01722331|566566057|FG006|Part 2|Physician Decision|0|||
156948451|NCT01722331|566566051|FG000|Part 2|Pregnancy|0|||
156948452|NCT01722331|566566052|FG001|Part 2|Pregnancy|0|||
156948453|NCT01722331|566566053|FG002|Part 2|Pregnancy|0|||
156948454|NCT01722331|566566054|FG003|Part 2|Pregnancy|0|||
156948455|NCT01722331|566566055|FG004|Part 2|Pregnancy|0|||
156948456|NCT01722331|566566056|FG005|Part 2|Pregnancy|1|||
156948457|NCT01722331|566566057|FG006|Part 2|Pregnancy|0|||
156948458|NCT01722331|566566051|FG000|Part 2|Progressive Disease|0|||
156948459|NCT01722331|566566052|FG001|Part 2|Progressive Disease|0|||
156948460|NCT01722331|566566053|FG002|Part 2|Progressive Disease|1|||
156948461|NCT01722331|566566054|FG003|Part 2|Progressive Disease|0|||
156948462|NCT01722331|566566055|FG004|Part 2|Progressive Disease|0|||
156948463|NCT01722331|566566056|FG005|Part 2|Progressive Disease|0|||
156948464|NCT01722331|566566057|FG006|Part 2|Progressive Disease|0|||
157033992|NCT04560179|566881763|FG001|Overall Study|Physician Decision|0|||
157033993|NCT04560179|566881764|FG002|Overall Study|Physician Decision|0|||
157033994|NCT04560179|566881765|FG003|Overall Study|Physician Decision|0|||
157033995|NCT04560179|566881766|FG004|Overall Study|Physician Decision|0|||
157033996|NCT04560179|566881762|FG000|Overall Study|Adverse Event|0|||
157033997|NCT04560179|566881763|FG001|Overall Study|Adverse Event|0|||
157033998|NCT04560179|566881764|FG002|Overall Study|Adverse Event|0|||
157033999|NCT04560179|566881765|FG003|Overall Study|Adverse Event|1|||
157034000|NCT04560179|566881766|FG004|Overall Study|Adverse Event|0|||
157034001|NCT04631016|566881767|FG000|Overall Study|Adverse Event|3|||
157034002|NCT04631016|566881768|FG001|Overall Study|Adverse Event|0|||
157034003|NCT04631016|566881767|FG000|Overall Study|Withdrawal by Subject|5|||
157034004|NCT04631016|566881768|FG001|Overall Study|Withdrawal by Subject|4|||
157034005|NCT04631016|566881767|FG000|Overall Study|Reason unspecified|1|||
157034006|NCT04631016|566881768|FG001|Overall Study|Reason unspecified|0|||
157034007|NCT04631016|566881767|FG000|Overall Study|Failure to meet randomization criteria|2|||
157034008|NCT04631016|566881768|FG001|Overall Study|Failure to meet randomization criteria|1|||
157034009|NCT05454514|566881774|FG000|Overall Study|Withdrawal by Subject|4|||
157034010|NCT02624050|566881780|FG000|Overall Study|Physician Decision|4|||
157034011|NCT02624050|566881781|FG001|Overall Study|Physician Decision|0|||
157034012|NCT02624050|566881780|FG000|Overall Study|Protocol Violation|2|||
157034013|NCT02624050|566881781|FG001|Overall Study|Protocol Violation|0|||
157034014|NCT04795245|566881782|FG000|Overall Study|Unkown reason|7|||
157034015|NCT04795245|566881782|FG000|Overall Study|Death|17|||
157034016|NCT04795245|566881782|FG000|Overall Study|Other than listed|19|||
157034017|NCT04795245|566881782|FG000|Overall Study|Adverse Event|143|||
157034018|NCT04795245|566881782|FG000|Overall Study|Progressive disease|512|||
157034019|NCT04795245|566881782|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
157034020|NCT03904576|566881783|FG000|Washout Period|Protocol Violation|1|||
157034021|NCT03904576|566881784|FG001|Washout Period|Protocol Violation|1|||
157034022|NCT03279978|566881785|FG000|Overall Study|Withdrawal by Subject|0|||
157034023|NCT03279978|566881786|FG001|Overall Study|Withdrawal by Subject|1|||
157034024|NCT03279978|566881787|FG002|Overall Study|Withdrawal by Subject|0|||
157034025|NCT03279978|566881788|FG003|Overall Study|Withdrawal by Subject|0|||
157034026|NCT03279978|566881789|FG004|Overall Study|Withdrawal by Subject|0|||
157034027|NCT03279978|566881790|FG005|Overall Study|Withdrawal by Subject|0|||
157034028|NCT03279978|566881791|FG006|Overall Study|Withdrawal by Subject|0|||
157034029|NCT03279978|566881792|FG007|Overall Study|Withdrawal by Subject|0|||
157034030|NCT03279978|566881793|FG008|Overall Study|Withdrawal by Subject|0|||
157034031|NCT03279978|566881794|FG009|Overall Study|Withdrawal by Subject|1|||
157034032|NCT03279978|566881785|FG000|Overall Study|Lost to Follow-up|1|||
157034033|NCT03279978|566881786|FG001|Overall Study|Lost to Follow-up|0|||
157034034|NCT03279978|566881787|FG002|Overall Study|Lost to Follow-up|1|||
157034035|NCT03279978|566881788|FG003|Overall Study|Lost to Follow-up|0|||
157034036|NCT03279978|566881789|FG004|Overall Study|Lost to Follow-up|0|||
157034037|NCT03279978|566881790|FG005|Overall Study|Lost to Follow-up|0|||
157034038|NCT03279978|566881791|FG006|Overall Study|Lost to Follow-up|0|||
157034039|NCT03279978|566881792|FG007|Overall Study|Lost to Follow-up|0|||
157034040|NCT03279978|566881793|FG008|Overall Study|Lost to Follow-up|0|||
157034041|NCT03279978|566881794|FG009|Overall Study|Lost to Follow-up|0|||
157034042|NCT03279978|566881785|FG000|Overall Study|Other than stated above|0|||
157034043|NCT03279978|566881786|FG001|Overall Study|Other than stated above|0|||
157034044|NCT03279978|566881787|FG002|Overall Study|Other than stated above|0|||
157034045|NCT03279978|566881788|FG003|Overall Study|Other than stated above|0|||
157034046|NCT03279978|566881789|FG004|Overall Study|Other than stated above|0|||
157034047|NCT03279978|566881790|FG005|Overall Study|Other than stated above|0|||
157034048|NCT03279978|566881791|FG006|Overall Study|Other than stated above|1|||
157034049|NCT03279978|566881792|FG007|Overall Study|Other than stated above|0|||
157034050|NCT03279978|566881793|FG008|Overall Study|Other than stated above|0|||
157167692|NCT00738374|567354676|FG000|Induction Treatment Phase|Non-compliance|1|||
157167693|NCT00738374|567354677|FG001|Induction Treatment Phase|Non-compliance|0|||
157167694|NCT00738374|567354678|FG002|Induction Treatment Phase|Non-compliance|0|||
157034051|NCT03279978|566881794|FG009|Overall Study|Other than stated above|0|||
157034052|NCT01756300|566881795|FG000|Overall Study|Death|1|||
157034053|NCT01756300|566881795|FG000|Overall Study|Withdrawal by Subject|1|||
157034054|NCT04780581|566881796|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
157034055|NCT04780581|566881797|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
157034056|NCT04780581|566881796|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
157034057|NCT04780581|566881797|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
157034058|NCT02765412|566881798|FG000|Overall Study|Death|482|||
157034059|NCT02765412|566881799|FG001|Overall Study|Death|855|||
157034060|NCT03734029|566881800|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
157034061|NCT03734029|566881801|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
157034062|NCT03734029|566881800|FG000|Overall Study|Adverse Event|60|||
157034063|NCT03734029|566881801|FG001|Overall Study|Adverse Event|14|||
157034064|NCT03734029|566881800|FG000|Overall Study|Withdrawal by Subject|12|||
157034065|NCT03734029|566881801|FG001|Overall Study|Withdrawal by Subject|11|||
157167695|NCT00738374|567354679|FG003|Induction Treatment Phase|Non-compliance|0|||
157167696|NCT00738374|567354676|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
157167697|NCT00738374|567354677|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
157167698|NCT00738374|567354678|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
157167699|NCT00738374|567354679|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
157167700|NCT00738374|567354676|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
157167701|NCT00738374|567354677|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
157167702|NCT00738374|567354678|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
157227362|NCT00950807|567577782|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156948465|NCT01722331|566566051|FG000|Part 2|Protocol Violation|1|||
156948466|NCT01722331|566566052|FG001|Part 2|Protocol Violation|0|||
156948467|NCT01722331|566566053|FG002|Part 2|Protocol Violation|0|||
156948468|NCT01722331|566566054|FG003|Part 2|Protocol Violation|0|||
156948469|NCT01722331|566566055|FG004|Part 2|Protocol Violation|0|||
156948470|NCT01722331|566566056|FG005|Part 2|Protocol Violation|0|||
156948471|NCT01722331|566566057|FG006|Part 2|Protocol Violation|0|||
156948472|NCT01722331|566566051|FG000|Part 2|Withdrawal by Subject|5|||
156948473|NCT01722331|566566052|FG001|Part 2|Withdrawal by Subject|0|||
156948474|NCT01722331|566566053|FG002|Part 2|Withdrawal by Subject|3|||
156948475|NCT01722331|566566054|FG003|Part 2|Withdrawal by Subject|0|||
156948476|NCT01722331|566566055|FG004|Part 2|Withdrawal by Subject|0|||
156948477|NCT01722331|566566056|FG005|Part 2|Withdrawal by Subject|2|||
156948478|NCT01722331|566566057|FG006|Part 2|Withdrawal by Subject|2|||
156948479|NCT01722331|566566051|FG000|Part 2|Other Protocol Specified Criteria|6|||
156948480|NCT01722331|566566052|FG001|Part 2|Other Protocol Specified Criteria|0|||
156948481|NCT01722331|566566053|FG002|Part 2|Other Protocol Specified Criteria|10|||
156948482|NCT01722331|566566054|FG003|Part 2|Other Protocol Specified Criteria|0|||
156948483|NCT01722331|566566055|FG004|Part 2|Other Protocol Specified Criteria|0|||
156948484|NCT01722331|566566056|FG005|Part 2|Other Protocol Specified Criteria|2|||
156948485|NCT01722331|566566057|FG006|Part 2|Other Protocol Specified Criteria|1|||
156948486|NCT01722331|566566051|FG000|Part 3|Adverse Event|2|||
156948487|NCT01722331|566566052|FG001|Part 3|Adverse Event|2|||
156948488|NCT01722331|566566053|FG002|Part 3|Adverse Event|0|||
156948489|NCT01722331|566566054|FG003|Part 3|Adverse Event|1|||
156948490|NCT01722331|566566055|FG004|Part 3|Adverse Event|0|||
156948491|NCT01722331|566566056|FG005|Part 3|Adverse Event|0|||
156948492|NCT01722331|566566057|FG006|Part 3|Adverse Event|0|||
156948493|NCT01722331|566566051|FG000|Part 3|Death|1|||
156948494|NCT01722331|566566052|FG001|Part 3|Death|0|||
156948495|NCT01722331|566566053|FG002|Part 3|Death|0|||
156948496|NCT01722331|566566054|FG003|Part 3|Death|0|||
156948497|NCT01722331|566566055|FG004|Part 3|Death|0|||
156948498|NCT01722331|566566056|FG005|Part 3|Death|0|||
156948499|NCT01722331|566566057|FG006|Part 3|Death|0|||
156948500|NCT01722331|566566051|FG000|Part 3|Lack of Efficacy|1|||
156948501|NCT01722331|566566052|FG001|Part 3|Lack of Efficacy|0|||
156948502|NCT01722331|566566053|FG002|Part 3|Lack of Efficacy|0|||
156948503|NCT01722331|566566054|FG003|Part 3|Lack of Efficacy|0|||
156948504|NCT01722331|566566055|FG004|Part 3|Lack of Efficacy|0|||
156948505|NCT01722331|566566056|FG005|Part 3|Lack of Efficacy|0|||
156948506|NCT01722331|566566057|FG006|Part 3|Lack of Efficacy|0|||
156948507|NCT01722331|566566051|FG000|Part 3|Lost to Follow-up|3|||
156948508|NCT01722331|566566052|FG001|Part 3|Lost to Follow-up|4|||
156948509|NCT01722331|566566053|FG002|Part 3|Lost to Follow-up|0|||
156948510|NCT01722331|566566054|FG003|Part 3|Lost to Follow-up|0|||
156948511|NCT01722331|566566055|FG004|Part 3|Lost to Follow-up|0|||
156948512|NCT01722331|566566056|FG005|Part 3|Lost to Follow-up|1|||
156948513|NCT01722331|566566057|FG006|Part 3|Lost to Follow-up|0|||
156948514|NCT01722331|566566051|FG000|Part 3|Non-Compliance with Study Drug|0|||
156948515|NCT01722331|566566052|FG001|Part 3|Non-Compliance with Study Drug|1|||
156948516|NCT01722331|566566053|FG002|Part 3|Non-Compliance with Study Drug|0|||
156948517|NCT01722331|566566054|FG003|Part 3|Non-Compliance with Study Drug|0|||
156948518|NCT01722331|566566055|FG004|Part 3|Non-Compliance with Study Drug|0|||
156948519|NCT01722331|566566056|FG005|Part 3|Non-Compliance with Study Drug|0|||
156948520|NCT01722331|566566057|FG006|Part 3|Non-Compliance with Study Drug|0|||
156948521|NCT01722331|566566051|FG000|Part 3|Physician Decision|1|||
156948522|NCT01722331|566566052|FG001|Part 3|Physician Decision|1|||
156948523|NCT01722331|566566053|FG002|Part 3|Physician Decision|0|||
156948524|NCT01722331|566566054|FG003|Part 3|Physician Decision|0|||
156948525|NCT01722331|566566055|FG004|Part 3|Physician Decision|0|||
156948526|NCT01722331|566566056|FG005|Part 3|Physician Decision|0|||
156948527|NCT01722331|566566057|FG006|Part 3|Physician Decision|1|||
156948528|NCT01722331|566566051|FG000|Part 3|Protocol Violation|2|||
156948529|NCT01722331|566566052|FG001|Part 3|Protocol Violation|1|||
156948530|NCT01722331|566566053|FG002|Part 3|Protocol Violation|0|||
156948531|NCT01722331|566566054|FG003|Part 3|Protocol Violation|0|||
156948532|NCT01722331|566566055|FG004|Part 3|Protocol Violation|0|||
156948533|NCT01722331|566566056|FG005|Part 3|Protocol Violation|0|||
156948534|NCT01722331|566566057|FG006|Part 3|Protocol Violation|0|||
156948535|NCT01722331|566566051|FG000|Part 3|Withdrawal by Subject|4|||
156948536|NCT01722331|566566052|FG001|Part 3|Withdrawal by Subject|7|||
156948537|NCT01722331|566566053|FG002|Part 3|Withdrawal by Subject|0|||
156948538|NCT01722331|566566054|FG003|Part 3|Withdrawal by Subject|0|||
157167703|NCT00738374|567354679|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
157167704|NCT00738374|567354676|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
157167705|NCT00738374|567354677|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
157167706|NCT00738374|567354678|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
157167707|NCT00738374|567354679|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
157167708|NCT00738374|567354676|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
157034066|NCT03734029|566881800|FG000|Overall Study|Clinical progression by investigator|10|||
157034067|NCT03734029|566881801|FG001|Overall Study|Clinical progression by investigator|8|||
157034068|NCT03734029|566881800|FG000|Overall Study|Death|5|||
157034069|NCT03734029|566881801|FG001|Overall Study|Death|2|||
157034070|NCT03734029|566881800|FG000|Overall Study|Physician Decision|4|||
157034071|NCT03734029|566881801|FG001|Overall Study|Physician Decision|3|||
157034072|NCT03734029|566881800|FG000|Overall Study|Other|2|||
157034073|NCT03734029|566881801|FG001|Overall Study|Other|0|||
157034074|NCT03734029|566881800|FG000|Overall Study|Lost to Follow-up|0|||
157034075|NCT03734029|566881801|FG001|Overall Study|Lost to Follow-up|1|||
157034076|NCT03734029|566881800|FG000|Overall Study|Randomized, but not treated|2|||
157034077|NCT03734029|566881801|FG001|Overall Study|Randomized, but not treated|12|||
157034078|NCT05412004|566882484|FG000|Overall Study|Adverse Event|0|||
157034079|NCT05412004|566882485|FG001|Overall Study|Adverse Event|2|||
157034080|NCT05412004|566882486|FG002|Overall Study|Adverse Event|1|||
157034081|NCT05412004|566882487|FG003|Overall Study|Adverse Event|5|||
157034082|NCT05412004|566882484|FG000|Overall Study|Assigned Treatment by Mistake|5|||
157034083|NCT05412004|566882485|FG001|Overall Study|Assigned Treatment by Mistake|10|||
157034084|NCT05412004|566882486|FG002|Overall Study|Assigned Treatment by Mistake|2|||
157167709|NCT00738374|567354677|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
157167710|NCT00738374|567354678|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
157167711|NCT00738374|567354679|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
157167712|NCT00738374|567354676|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
156948539|NCT01722331|566566055|FG004|Part 3|Withdrawal by Subject|0|||
156948540|NCT01722331|566566056|FG005|Part 3|Withdrawal by Subject|2|||
156948541|NCT01722331|566566057|FG006|Part 3|Withdrawal by Subject|1|||
156948542|NCT01722331|566566051|FG000|Part 3|Other Protocol Specified Criteria|1|||
156948543|NCT01722331|566566052|FG001|Part 3|Other Protocol Specified Criteria|1|||
156948544|NCT01722331|566566053|FG002|Part 3|Other Protocol Specified Criteria|0|||
156948545|NCT01722331|566566054|FG003|Part 3|Other Protocol Specified Criteria|0|||
156948546|NCT01722331|566566055|FG004|Part 3|Other Protocol Specified Criteria|0|||
156948547|NCT01722331|566566056|FG005|Part 3|Other Protocol Specified Criteria|0|||
156948548|NCT01722331|566566057|FG006|Part 3|Other Protocol Specified Criteria|0|||
156948549|NCT04265755|566566067|FG000|Overall Study|Withdrawal by Subject|39|||
156948550|NCT04265755|566566067|FG000|Overall Study|Decision by sponsor|2|||
156948551|NCT04265755|566566067|FG000|Overall Study|Lost to Follow-up|11|||
156948552|NCT04265755|566566067|FG000|Overall Study|Death|1|||
156948553|NCT01863446|566566070|FG000|Overall Study|Withdrawal by Subject|1|||
156948554|NCT01863446|566566071|FG001|Overall Study|Withdrawal by Subject|0|||
156948555|NCT01863446|566566072|FG002|Overall Study|Withdrawal by Subject|1|||
156948556|NCT01863446|566566073|FG003|Overall Study|Withdrawal by Subject|2|||
156948557|NCT01863446|566566070|FG000|Overall Study|Physician Decision|0|||
156948558|NCT01863446|566566071|FG001|Overall Study|Physician Decision|0|||
156948559|NCT01863446|566566072|FG002|Overall Study|Physician Decision|1|||
156948560|NCT01863446|566566073|FG003|Overall Study|Physician Decision|0|||
156948561|NCT02554773|566566074|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
156948562|NCT02554773|566566075|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
156948563|NCT02554773|566566074|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
156948564|NCT02554773|566566075|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
156948565|NCT02554773|566566074|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
156948566|NCT02554773|566566075|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
156948567|NCT02554773|566566074|FG000|Original Dose Regimen (SAS 1)|Death|1|||
156948568|NCT02554773|566566075|FG001|Original Dose Regimen (SAS 1)|Death|0|||
156948569|NCT02554773|566566074|FG000|Original Dose Regimen (SAS 1)|Other|4|||
156948570|NCT02554773|566566075|FG001|Original Dose Regimen (SAS 1)|Other|0|||
156948571|NCT02554773|566566074|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
157034085|NCT05412004|566882487|FG003|Overall Study|Assigned Treatment by Mistake|5|||
157034086|NCT05412004|566882484|FG000|Overall Study|Lost to Follow-up|3|||
157034087|NCT05412004|566882485|FG001|Overall Study|Lost to Follow-up|0|||
156948572|NCT02554773|566566075|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
156948573|NCT02554773|566566074|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
156948574|NCT02554773|566566075|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
156948575|NCT02554773|566566074|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
156948576|NCT02554773|566566075|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
156948577|NCT02554773|566566074|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
157034088|NCT05412004|566882486|FG002|Overall Study|Lost to Follow-up|0|||
157034089|NCT05412004|566882487|FG003|Overall Study|Lost to Follow-up|0|||
157167713|NCT00738374|567354677|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
157167714|NCT00738374|567354678|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
157167715|NCT00738374|567354679|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
157167716|NCT00738374|567354676|FG000|Maintenance Treatment/Observation Phase|Other|0|||
157167717|NCT00738374|567354677|FG001|Maintenance Treatment/Observation Phase|Other|1|||
157167718|NCT00738374|567354678|FG002|Maintenance Treatment/Observation Phase|Other|0|||
157167719|NCT00738374|567354679|FG003|Maintenance Treatment/Observation Phase|Other|0|||
157167720|NCT00603733|567355820|FG000|Active Phase ITT|Adverse Event|8|||
157167721|NCT00603733|567355821|FG001|Active Phase ITT|Adverse Event|7|||
157167722|NCT00603733|567355820|FG000|Active Phase ITT|Withdrawal by Subject|0|||
157167723|NCT00603733|567355821|FG001|Active Phase ITT|Withdrawal by Subject|3|||
157167724|NCT00603733|567355820|FG000|Active Phase ITT|Lost to Follow-up|0|||
157167725|NCT00603733|567355821|FG001|Active Phase ITT|Lost to Follow-up|1|||
157167726|NCT00603733|567355820|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
157167727|NCT00603733|567355821|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
157167728|NCT00603733|567355820|FG000|Active Phase ITT|Lack of Efficacy|1|||
157167729|NCT00603733|567355821|FG001|Active Phase ITT|Lack of Efficacy|2|||
157167730|NCT00603733|567355820|FG000|Active Phase ITT|Subject moved, site closed|1|||
157167731|NCT00603733|567355821|FG001|Active Phase ITT|Subject moved, site closed|1|||
157167732|NCT00603733|567355820|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
157167733|NCT00603733|567355821|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
157167734|NCT00603733|567355820|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
157167735|NCT00603733|567355821|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
157167736|NCT00603733|567355820|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
157167737|NCT00603733|567355821|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
157167738|NCT00603733|567355820|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
157167739|NCT00603733|567355821|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
157167740|NCT00603733|567355820|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
157167741|NCT00603733|567355821|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
157167742|NCT00603733|567355820|FG000|Maintenance Phase ITT|Adverse Event|3|||
157167743|NCT00603733|567355821|FG001|Maintenance Phase ITT|Adverse Event|6|||
157167744|NCT00603733|567355820|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
157167745|NCT00603733|567355821|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
157167746|NCT00603733|567355820|FG000|Maintenance Phase ITT|Protocol Violation|1|||
157167747|NCT00603733|567355821|FG001|Maintenance Phase ITT|Protocol Violation|1|||
157167748|NCT00603733|567355820|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
157167749|NCT00603733|567355821|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
157167750|NCT00603733|567355820|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
157167751|NCT00603733|567355821|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
157167752|NCT00603733|567355820|FG000|Maintenance Phase ITT|Physician Decision|0|||
157167753|NCT00603733|567355821|FG001|Maintenance Phase ITT|Physician Decision|1|||
157167754|NCT00603733|567355820|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
157167755|NCT00603733|567355821|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
157167756|NCT02215616|567355827|FG000|Overall Study|Sponsor requested to stop study drug|0|||
157167757|NCT02215616|567355828|FG001|Overall Study|Sponsor requested to stop study drug|0|||
157167758|NCT02215616|567355829|FG002|Overall Study|Sponsor requested to stop study drug|1|||
157167759|NCT02215616|567355830|FG003|Overall Study|Sponsor requested to stop study drug|4|||
157167760|NCT02215616|567355827|FG000|Overall Study|Death|1|||
157167761|NCT02215616|567355828|FG001|Overall Study|Death|0|||
156948578|NCT02554773|566566075|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
156948579|NCT02496884|566566076|FG000|Overall Study|Counted twice as enrolled|2|||
156948580|NCT02496884|566566077|FG001|Overall Study|Counted twice as enrolled|0|||
156948581|NCT02496884|566566078|FG002|Overall Study|Counted twice as enrolled|0|||
156948582|NCT02496884|566566079|FG003|Overall Study|Counted twice as enrolled|0|||
156948583|NCT02496884|566566076|FG000|Overall Study|Withdrawal by Subject|0|||
156948584|NCT02496884|566566077|FG001|Overall Study|Withdrawal by Subject|3|||
156948585|NCT02496884|566566078|FG002|Overall Study|Withdrawal by Subject|0|||
156948586|NCT02496884|566566079|FG003|Overall Study|Withdrawal by Subject|0|||
156948587|NCT01794949|566566080|FG000|Overall Study|Lost to Follow-up|1|||
156948588|NCT01794949|566566081|FG001|Overall Study|Lost to Follow-up|0|||
156948589|NCT03766646|566566082|FG000|Overall Study|Withdrawal by Subject|1|||
156948590|NCT03766646|566566083|FG001|Overall Study|Withdrawal by Subject|0|||
156948591|NCT03766646|566566082|FG000|Overall Study|Protocol Violation|0|||
156948592|NCT03766646|566566083|FG001|Overall Study|Protocol Violation|3|||
157167762|NCT02215616|567355829|FG002|Overall Study|Death|0|||
157167763|NCT02215616|567355830|FG003|Overall Study|Death|0|||
157167764|NCT02215616|567355827|FG000|Overall Study|Adverse Event|7|||
157167765|NCT02215616|567355828|FG001|Overall Study|Adverse Event|4|||
157167766|NCT02215616|567355829|FG002|Overall Study|Adverse Event|9|||
157167767|NCT02215616|567355830|FG003|Overall Study|Adverse Event|2|||
157167768|NCT02215616|567355827|FG000|Overall Study|Withdrawal by Subject|1|||
157167769|NCT02215616|567355828|FG001|Overall Study|Withdrawal by Subject|8|||
157167770|NCT02215616|567355829|FG002|Overall Study|Withdrawal by Subject|2|||
157034090|NCT05412004|566882484|FG000|Overall Study|Patient could not travel to site|0|||
157034091|NCT05412004|566882485|FG001|Overall Study|Patient could not travel to site|1|||
157034092|NCT05412004|566882486|FG002|Overall Study|Patient could not travel to site|0|||
157034093|NCT05412004|566882487|FG003|Overall Study|Patient could not travel to site|0|||
157034094|NCT05412004|566882484|FG000|Overall Study|Physician Decision|0|||
157034095|NCT05412004|566882485|FG001|Overall Study|Physician Decision|1|||
157034096|NCT05412004|566882486|FG002|Overall Study|Physician Decision|0|||
157034097|NCT05412004|566882487|FG003|Overall Study|Physician Decision|0|||
157034098|NCT05412004|566882484|FG000|Overall Study|Pregnancy|0|||
157034099|NCT05412004|566882485|FG001|Overall Study|Pregnancy|1|||
157034100|NCT05412004|566882486|FG002|Overall Study|Pregnancy|0|||
157034101|NCT05412004|566882487|FG003|Overall Study|Pregnancy|0|||
157034102|NCT05412004|566882484|FG000|Overall Study|Protocol Violation|1|||
157034103|NCT05412004|566882485|FG001|Overall Study|Protocol Violation|0|||
157034104|NCT05412004|566882486|FG002|Overall Study|Protocol Violation|0|||
157034105|NCT05412004|566882487|FG003|Overall Study|Protocol Violation|0|||
157034106|NCT05412004|566882484|FG000|Overall Study|Withdrawal by Subject|4|||
157034107|NCT05412004|566882485|FG001|Overall Study|Withdrawal by Subject|19|||
157034108|NCT05412004|566882486|FG002|Overall Study|Withdrawal by Subject|4|||
157034109|NCT05412004|566882487|FG003|Overall Study|Withdrawal by Subject|14|||
157034110|NCT05412004|566882484|FG000|Overall Study|Screen Failure|0|||
157034111|NCT05412004|566882485|FG001|Overall Study|Screen Failure|0|||
157034112|NCT05412004|566882486|FG002|Overall Study|Screen Failure|0|||
157034113|NCT05412004|566882487|FG003|Overall Study|Screen Failure|1|||
157034114|NCT05412004|566882484|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
157034115|NCT05412004|566882485|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
157034116|NCT05412004|566882486|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
157034117|NCT05412004|566882487|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
157034118|NCT03781089|566882488|FG000|Overall Study|Constipation|1|||
157034119|NCT03781089|566882489|FG001|Overall Study|Constipation|0|||
157034120|NCT03781089|566882488|FG000|Overall Study|Positive pregnancy test|0|||
157034121|NCT03781089|566882489|FG001|Overall Study|Positive pregnancy test|1|||
157034122|NCT04644029|566882490|FG000|Overall Study|Death|1|||
157034123|NCT04644029|566882491|FG001|Overall Study|Death|0|||
157034124|NCT04644029|566882490|FG000|Overall Study|Physician Decision|1|||
157034125|NCT04644029|566882491|FG001|Overall Study|Physician Decision|2|||
157034126|NCT04644029|566882490|FG000|Overall Study|Withdrawal by Subject|21|||
157034127|NCT04644029|566882491|FG001|Overall Study|Withdrawal by Subject|19|||
157034128|NCT04644029|566882490|FG000|Overall Study|Lost to Follow-up|31|||
157034129|NCT04644029|566882491|FG001|Overall Study|Lost to Follow-up|34|||
157034130|NCT04644029|566882490|FG000|Overall Study|Study Terminated by Sponsor|308|||
157034131|NCT04644029|566882491|FG001|Overall Study|Study Terminated by Sponsor|309|||
157034132|NCT04644029|566882490|FG000|Overall Study|Randomized in Error|2|||
157034133|NCT04644029|566882491|FG001|Overall Study|Randomized in Error|1|||
157034134|NCT04644029|566882490|FG000|Overall Study|Other|0|||
157034135|NCT04644029|566882491|FG001|Overall Study|Other|1|||
157034136|NCT05132400|566882492|FG000|Overall Study|Withdrawal by Subject|14|||
157034137|NCT05132400|566882493|FG001|Overall Study|Withdrawal by Subject|8|||
157034138|NCT05132400|566882492|FG000|Overall Study|Lost to Follow-up|132|||
157034139|NCT05132400|566882493|FG001|Overall Study|Lost to Follow-up|121|||
157034140|NCT03934931|566882494|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
157034141|NCT03934931|566882495|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
157034142|NCT03934931|566882496|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
157034143|NCT02076009|566882499|FG000|Overall Study|Death|172|||
157167771|NCT02215616|567355830|FG003|Overall Study|Withdrawal by Subject|5|||
157167772|NCT02215616|567355827|FG000|Overall Study|Non-compliance|0|||
157167773|NCT02215616|567355828|FG001|Overall Study|Non-compliance|2|||
157167774|NCT02215616|567355829|FG002|Overall Study|Non-compliance|1|||
157167775|NCT02215616|567355830|FG003|Overall Study|Non-compliance|0|||
157034144|NCT02076009|566882500|FG001|Overall Study|Death|153|||
157034145|NCT02076009|566882499|FG000|Overall Study|Withdrawal by Subject|16|||
157034146|NCT02076009|566882500|FG001|Overall Study|Withdrawal by Subject|12|||
157167776|NCT02215616|567355827|FG000|Overall Study|Protocol Violation|0|||
157167777|NCT02215616|567355828|FG001|Overall Study|Protocol Violation|2|||
157167778|NCT02215616|567355829|FG002|Overall Study|Protocol Violation|0|||
157034147|NCT02076009|566882499|FG000|Overall Study|Lost to Follow-up|4|||
157034148|NCT02076009|566882500|FG001|Overall Study|Lost to Follow-up|2|||
157034149|NCT02076009|566882499|FG000|Overall Study|Progressive Disease|1|||
157034150|NCT02076009|566882500|FG001|Overall Study|Progressive Disease|0|||
157034151|NCT02076009|566882499|FG000|Overall Study|Physician Decision|0|||
157034152|NCT02076009|566882500|FG001|Overall Study|Physician Decision|1|||
157034153|NCT02076009|566882499|FG000|Overall Study|End of data collection|90|||
157034154|NCT02076009|566882500|FG001|Overall Study|End of data collection|118|||
157167779|NCT02215616|567355830|FG003|Overall Study|Protocol Violation|0|||
157167780|NCT02215616|567355827|FG000|Overall Study|Lost to Follow-up|1|||
157034155|NCT03786926|566882503|FG000|Overall Study|Adverse Event|0|||
156948593|NCT02530619|566566093|FG000|Registered for Study|Withdrawal by Subject|2|||
156948594|NCT02530619|566566093|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
156948595|NCT02530619|566566093|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
156948596|NCT02530619|566566093|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
156948597|NCT02530619|566566093|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
156948598|NCT02530619|566566093|FG000|Follow-up Period (6 Months)|Death|4|||
156948599|NCT02530619|566566093|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
156948600|NCT02530619|566566093|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
156948601|NCT01854554|566566101|FG000|Overall Study|Denial of Insurance Coverage|12|||
156948602|NCT01854554|566566102|FG001|Overall Study|Denial of Insurance Coverage|0|||
156948603|NCT01854554|566566101|FG000|Overall Study|Decided to get treatment locally|1|||
156948604|NCT01854554|566566102|FG001|Overall Study|Decided to get treatment locally|5|||
156948605|NCT01854554|566566101|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
156948606|NCT01854554|566566102|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
156948607|NCT01854554|566566101|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156948608|NCT01854554|566566102|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
156948609|NCT01854554|566566101|FG000|Overall Study|Progression|0|||
156948610|NCT01854554|566566102|FG001|Overall Study|Progression|1|||
156948611|NCT01854554|566566101|FG000|Overall Study|Lost to Follow-up|0|||
156948612|NCT01854554|566566102|FG001|Overall Study|Lost to Follow-up|1|||
156948613|NCT02819726|566566103|FG000|Part A (All Participants)|Lost to Follow-up|0|||
156948614|NCT02819726|566566104|FG001|Part A (All Participants)|Lost to Follow-up|1|||
156948615|NCT02819726|566566105|FG002|Part A (All Participants)|Lost to Follow-up|0|||
156948616|NCT02819726|566566106|FG003|Part A (All Participants)|Lost to Follow-up|0|||
156948617|NCT02819726|566566103|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
156948618|NCT02819726|566566104|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
156948619|NCT02819726|566566105|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
156948620|NCT02819726|566566106|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
156948621|NCT02819726|566566103|FG000|Part A (All Participants)|Protocol non-compliance|3|||
156948622|NCT02819726|566566104|FG001|Part A (All Participants)|Protocol non-compliance|4|||
156948623|NCT02819726|566566105|FG002|Part A (All Participants)|Protocol non-compliance|5|||
156948624|NCT02819726|566566106|FG003|Part A (All Participants)|Protocol non-compliance|0|||
156948625|NCT02819726|566566103|FG000|Part B (All Participants)|Lost to Follow-up|1|||
156948626|NCT02819726|566566104|FG001|Part B (All Participants)|Lost to Follow-up|1|||
156948627|NCT02819726|566566105|FG002|Part B (All Participants)|Lost to Follow-up|2|||
156948628|NCT02819726|566566106|FG003|Part B (All Participants)|Lost to Follow-up|2|||
156948629|NCT02819726|566566103|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
156948630|NCT02819726|566566104|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
156948631|NCT02819726|566566105|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
156948632|NCT02819726|566566106|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
156948633|NCT02819726|566566103|FG000|Part B (All Participants)|Protocol non-compliance|0|||
156948634|NCT02819726|566566104|FG001|Part B (All Participants)|Protocol non-compliance|0|||
156948635|NCT02819726|566566105|FG002|Part B (All Participants)|Protocol non-compliance|1|||
156948636|NCT02819726|566566106|FG003|Part B (All Participants)|Protocol non-compliance|0|||
156948637|NCT00359762|566566107|FG000|Period II|Adverse Event|17|||
156948638|NCT00359762|566566108|FG001|Period II|Adverse Event|0|||
156948639|NCT00359762|566566109|FG002|Period II|Adverse Event|0|||
156948640|NCT00359762|566566110|FG003|Period II|Adverse Event|0|||
156948641|NCT00359762|566566111|FG004|Period II|Adverse Event|49|||
156948642|NCT00359762|566566107|FG000|Period II|Protocol Violation|18|||
156948643|NCT00359762|566566108|FG001|Period II|Protocol Violation|0|||
156948644|NCT00359762|566566109|FG002|Period II|Protocol Violation|0|||
156948645|NCT00359762|566566110|FG003|Period II|Protocol Violation|0|||
156948646|NCT00359762|566566111|FG004|Period II|Protocol Violation|11|||
156948647|NCT00359762|566566107|FG000|Period II|Physician Decision|17|||
156948648|NCT00359762|566566108|FG001|Period II|Physician Decision|0|||
156948649|NCT00359762|566566109|FG002|Period II|Physician Decision|0|||
156948650|NCT00359762|566566110|FG003|Period II|Physician Decision|0|||
156948651|NCT00359762|566566111|FG004|Period II|Physician Decision|23|||
156948652|NCT00359762|566566107|FG000|Period II|Death|2|||
156948653|NCT00359762|566566108|FG001|Period II|Death|0|||
157167781|NCT02215616|567355828|FG001|Overall Study|Lost to Follow-up|1|||
156948654|NCT00359762|566566109|FG002|Period II|Death|0|||
156948655|NCT00359762|566566110|FG003|Period II|Death|0|||
156948656|NCT00359762|566566111|FG004|Period II|Death|4|||
156948657|NCT00359762|566566107|FG000|Period II|Lack of Efficacy|11|||
156948658|NCT00359762|566566108|FG001|Period II|Lack of Efficacy|0|||
156948659|NCT00359762|566566109|FG002|Period II|Lack of Efficacy|0|||
156948660|NCT00359762|566566110|FG003|Period II|Lack of Efficacy|0|||
156948661|NCT00359762|566566111|FG004|Period II|Lack of Efficacy|8|||
156948662|NCT00359762|566566107|FG000|Period II|Lost to follow up|5|||
156948663|NCT00359762|566566108|FG001|Period II|Lost to follow up|0|||
156948664|NCT00359762|566566109|FG002|Period II|Lost to follow up|0|||
156948665|NCT00359762|566566110|FG003|Period II|Lost to follow up|0|||
157167782|NCT02215616|567355829|FG002|Overall Study|Lost to Follow-up|0|||
157167783|NCT02215616|567355830|FG003|Overall Study|Lost to Follow-up|1|||
156948666|NCT00359762|566566111|FG004|Period II|Lost to follow up|5|||
156948667|NCT00359762|566566107|FG000|Period II|Entry Criteria Not Met|8|||
156948668|NCT00359762|566566108|FG001|Period II|Entry Criteria Not Met|0|||
156948669|NCT00359762|566566109|FG002|Period II|Entry Criteria Not Met|0|||
156948670|NCT00359762|566566110|FG003|Period II|Entry Criteria Not Met|0|||
156948671|NCT00359762|566566111|FG004|Period II|Entry Criteria Not Met|4|||
156948672|NCT00359762|566566107|FG000|Period II|Subject Decision|50|||
156948673|NCT00359762|566566108|FG001|Period II|Subject Decision|0|||
156948674|NCT00359762|566566109|FG002|Period II|Subject Decision|0|||
156948675|NCT00359762|566566110|FG003|Period II|Subject Decision|0|||
156948676|NCT00359762|566566111|FG004|Period II|Subject Decision|70|||
156948677|NCT00359762|566566107|FG000|Period III|Protocol Violation|0|||
156948678|NCT00359762|566566108|FG001|Period III|Protocol Violation|5|||
156948679|NCT00359762|566566109|FG002|Period III|Protocol Violation|3|||
156948680|NCT00359762|566566110|FG003|Period III|Protocol Violation|8|||
156948681|NCT00359762|566566111|FG004|Period III|Protocol Violation|0|||
156948682|NCT00359762|566566107|FG000|Period III|Adverse Event|0|||
156948683|NCT00359762|566566108|FG001|Period III|Adverse Event|3|||
156948684|NCT00359762|566566109|FG002|Period III|Adverse Event|4|||
156948685|NCT00359762|566566110|FG003|Period III|Adverse Event|10|||
156948686|NCT00359762|566566111|FG004|Period III|Adverse Event|0|||
156948687|NCT00359762|566566107|FG000|Period III|Physician Decision|0|||
156948688|NCT00359762|566566108|FG001|Period III|Physician Decision|5|||
156948689|NCT00359762|566566109|FG002|Period III|Physician Decision|9|||
156948690|NCT00359762|566566110|FG003|Period III|Physician Decision|15|||
156948691|NCT00359762|566566111|FG004|Period III|Physician Decision|0|||
156948692|NCT00359762|566566107|FG000|Period III|Lack of Efficacy|0|||
156948693|NCT00359762|566566108|FG001|Period III|Lack of Efficacy|7|||
156948694|NCT00359762|566566109|FG002|Period III|Lack of Efficacy|5|||
156948695|NCT00359762|566566110|FG003|Period III|Lack of Efficacy|9|||
156948696|NCT00359762|566566111|FG004|Period III|Lack of Efficacy|0|||
156948697|NCT00359762|566566107|FG000|Period III|Lost to follow up|0|||
156948698|NCT00359762|566566108|FG001|Period III|Lost to follow up|1|||
156948699|NCT00359762|566566109|FG002|Period III|Lost to follow up|1|||
156948700|NCT00359762|566566110|FG003|Period III|Lost to follow up|2|||
156948701|NCT00359762|566566111|FG004|Period III|Lost to follow up|0|||
156948702|NCT00359762|566566107|FG000|Period III|Entry Criteria Not Met|0|||
156948703|NCT00359762|566566108|FG001|Period III|Entry Criteria Not Met|1|||
156948704|NCT00359762|566566109|FG002|Period III|Entry Criteria Not Met|0|||
156948705|NCT00359762|566566110|FG003|Period III|Entry Criteria Not Met|1|||
156948706|NCT00359762|566566111|FG004|Period III|Entry Criteria Not Met|0|||
156948707|NCT00359762|566566107|FG000|Period III|Subject Decision|0|||
156948708|NCT00359762|566566108|FG001|Period III|Subject Decision|7|||
156948709|NCT00359762|566566109|FG002|Period III|Subject Decision|8|||
156948710|NCT00359762|566566110|FG003|Period III|Subject Decision|20|||
156948711|NCT00359762|566566111|FG004|Period III|Subject Decision|0|||
156948712|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
156948713|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
156948714|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
156948715|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948716|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948717|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948718|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948719|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948720|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
156948721|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
156948722|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
156948723|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
156948724|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948725|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948726|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948727|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948728|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948729|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
156948730|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948731|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
156948732|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
156948733|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948734|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948735|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948736|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948737|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
156948738|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
157034156|NCT03786926|566882504|FG001|Overall Study|Adverse Event|0|||
157034157|NCT03786926|566882505|FG002|Overall Study|Adverse Event|0|||
157034158|NCT03786926|566882506|FG003|Overall Study|Adverse Event|0|||
157034159|NCT03786926|566882507|FG004|Overall Study|Adverse Event|0|||
157034160|NCT03786926|566882508|FG005|Overall Study|Adverse Event|0|||
157034161|NCT03786926|566882509|FG006|Overall Study|Adverse Event|0|||
157034162|NCT03786926|566882510|FG007|Overall Study|Adverse Event|1|||
157034163|NCT03786926|566882511|FG008|Overall Study|Adverse Event|1|||
157034164|NCT03786926|566882512|FG009|Overall Study|Adverse Event|0|||
157034165|NCT03786926|566882513|FG010|Overall Study|Adverse Event|1|||
157034166|NCT03786926|566882503|FG000|Overall Study|Progressive disease|3|||
157034167|NCT03786926|566882504|FG001|Overall Study|Progressive disease|0|||
157034168|NCT03786926|566882505|FG002|Overall Study|Progressive disease|3|||
157034169|NCT03786926|566882506|FG003|Overall Study|Progressive disease|1|||
157034170|NCT03786926|566882507|FG004|Overall Study|Progressive disease|2|||
157034171|NCT03786926|566882508|FG005|Overall Study|Progressive disease|2|||
157034172|NCT03786926|566882509|FG006|Overall Study|Progressive disease|1|||
157034173|NCT03786926|566882510|FG007|Overall Study|Progressive disease|6|||
157034174|NCT03786926|566882511|FG008|Overall Study|Progressive disease|1|||
157034175|NCT03786926|566882512|FG009|Overall Study|Progressive disease|1|||
157034176|NCT03786926|566882513|FG010|Overall Study|Progressive disease|1|||
157034177|NCT03786926|566882503|FG000|Overall Study|Death|0|||
157034178|NCT03786926|566882504|FG001|Overall Study|Death|1|||
157034179|NCT03786926|566882505|FG002|Overall Study|Death|1|||
157034180|NCT03786926|566882506|FG003|Overall Study|Death|0|||
157034181|NCT03786926|566882507|FG004|Overall Study|Death|0|||
157034182|NCT03786926|566882508|FG005|Overall Study|Death|0|||
157034183|NCT03786926|566882509|FG006|Overall Study|Death|0|||
157034184|NCT03786926|566882510|FG007|Overall Study|Death|0|||
157034185|NCT03786926|566882511|FG008|Overall Study|Death|0|||
157034186|NCT03786926|566882512|FG009|Overall Study|Death|1|||
157034187|NCT03786926|566882513|FG010|Overall Study|Death|2|||
156948739|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
156948740|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
156948741|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
156948742|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948743|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948744|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948745|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948746|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948747|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
156948748|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948749|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
156948750|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948751|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948752|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948753|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948754|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948755|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948756|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
156948757|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
156948758|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948759|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948760|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948761|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
157034188|NCT03786926|566882503|FG000|Overall Study|Physician Decision|0|||
157034189|NCT03786926|566882504|FG001|Overall Study|Physician Decision|1|||
157034190|NCT03786926|566882505|FG002|Overall Study|Physician Decision|0|||
157034191|NCT03786926|566882506|FG003|Overall Study|Physician Decision|1|||
157034192|NCT03786926|566882507|FG004|Overall Study|Physician Decision|2|||
157034193|NCT03786926|566882508|FG005|Overall Study|Physician Decision|0|||
157034194|NCT03786926|566882509|FG006|Overall Study|Physician Decision|0|||
157034195|NCT03786926|566882510|FG007|Overall Study|Physician Decision|2|||
157034196|NCT03786926|566882511|FG008|Overall Study|Physician Decision|1|||
157034197|NCT03786926|566882512|FG009|Overall Study|Physician Decision|1|||
157034198|NCT03786926|566882513|FG010|Overall Study|Physician Decision|0|||
157034199|NCT03786926|566882503|FG000|Overall Study|Withdrawal by Subject|0|||
157034200|NCT03786926|566882504|FG001|Overall Study|Withdrawal by Subject|1|||
157034201|NCT03786926|566882505|FG002|Overall Study|Withdrawal by Subject|1|||
157034202|NCT03786926|566882506|FG003|Overall Study|Withdrawal by Subject|0|||
157034203|NCT03786926|566882507|FG004|Overall Study|Withdrawal by Subject|0|||
157034204|NCT03786926|566882508|FG005|Overall Study|Withdrawal by Subject|0|||
157034205|NCT03786926|566882509|FG006|Overall Study|Withdrawal by Subject|1|||
157034206|NCT03786926|566882510|FG007|Overall Study|Withdrawal by Subject|0|||
157034207|NCT03786926|566882511|FG008|Overall Study|Withdrawal by Subject|1|||
157034208|NCT03786926|566882512|FG009|Overall Study|Withdrawal by Subject|0|||
157034209|NCT03786926|566882513|FG010|Overall Study|Withdrawal by Subject|1|||
157034210|NCT03786926|566882503|FG000|Overall Study|Study terminated by Sponsor|0|||
157034211|NCT03786926|566882504|FG001|Overall Study|Study terminated by Sponsor|0|||
157034212|NCT03786926|566882505|FG002|Overall Study|Study terminated by Sponsor|0|||
157034213|NCT03786926|566882506|FG003|Overall Study|Study terminated by Sponsor|0|||
157034214|NCT03786926|566882507|FG004|Overall Study|Study terminated by Sponsor|1|||
157034215|NCT03786926|566882508|FG005|Overall Study|Study terminated by Sponsor|0|||
157034216|NCT03786926|566882509|FG006|Overall Study|Study terminated by Sponsor|0|||
157034217|NCT03786926|566882510|FG007|Overall Study|Study terminated by Sponsor|4|||
157034218|NCT03786926|566882511|FG008|Overall Study|Study terminated by Sponsor|0|||
157034219|NCT03786926|566882512|FG009|Overall Study|Study terminated by Sponsor|0|||
157034220|NCT03786926|566882513|FG010|Overall Study|Study terminated by Sponsor|0|||
157034221|NCT03786926|566882503|FG000|Overall Study|Anti-neoplasm treatment|0|||
157034222|NCT03786926|566882504|FG001|Overall Study|Anti-neoplasm treatment|0|||
157034223|NCT03786926|566882505|FG002|Overall Study|Anti-neoplasm treatment|0|||
157034224|NCT03786926|566882506|FG003|Overall Study|Anti-neoplasm treatment|0|||
157034225|NCT03786926|566882507|FG004|Overall Study|Anti-neoplasm treatment|1|||
157034226|NCT03786926|566882508|FG005|Overall Study|Anti-neoplasm treatment|0|||
157034227|NCT03786926|566882509|FG006|Overall Study|Anti-neoplasm treatment|1|||
157034228|NCT03786926|566882510|FG007|Overall Study|Anti-neoplasm treatment|0|||
157034229|NCT03786926|566882511|FG008|Overall Study|Anti-neoplasm treatment|0|||
157034230|NCT03786926|566882512|FG009|Overall Study|Anti-neoplasm treatment|0|||
157034231|NCT03786926|566882513|FG010|Overall Study|Anti-neoplasm treatment|0|||
157034232|NCT03786926|566882503|FG000|Overall Study|Other|0|||
157034233|NCT03786926|566882504|FG001|Overall Study|Other|0|||
157034234|NCT03786926|566882505|FG002|Overall Study|Other|0|||
157034235|NCT03786926|566882506|FG003|Overall Study|Other|1|||
157034236|NCT03786926|566882507|FG004|Overall Study|Other|0|||
157034237|NCT03786926|566882508|FG005|Overall Study|Other|1|||
157034238|NCT03786926|566882509|FG006|Overall Study|Other|0|||
157034239|NCT03786926|566882510|FG007|Overall Study|Other|0|||
157034240|NCT03786926|566882511|FG008|Overall Study|Other|2|||
157034241|NCT03786926|566882512|FG009|Overall Study|Other|0|||
157034242|NCT03786926|566882513|FG010|Overall Study|Other|0|||
157034243|NCT05988398|566882519|FG000|Overall Study|Lack of time|21|||
157034244|NCT05988398|566882520|FG001|Overall Study|Lack of time|0|||
157034245|NCT05988398|566882519|FG000|Overall Study|Absent from school|0|||
157034246|NCT05988398|566882520|FG001|Overall Study|Absent from school|38|||
157034247|NCT05988398|566882519|FG000|Overall Study|Chose not to participate|0|||
157034248|NCT05988398|566882520|FG001|Overall Study|Chose not to participate|42|||
157034249|NCT05988398|566882519|FG000|Overall Study|Other commitments (e.g., sports)|0|||
157034250|NCT05988398|566882520|FG001|Overall Study|Other commitments (e.g., sports)|25|||
157034251|NCT00942734|566882522|FG000|Overall Study|Adverse Event|2|||
157034252|NCT00942734|566882522|FG000|Overall Study|Protocol Violation|3|||
157034253|NCT00942734|566882522|FG000|Overall Study|Disease Progression|2|||
157034254|NCT00942734|566882522|FG000|Overall Study|Physician Decision|1|||
156948762|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948763|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948764|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948765|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
156948766|NCT01172938|566566115|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948767|NCT01172938|566566116|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
156948768|NCT01172938|566566117|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
156948769|NCT01172938|566566118|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948770|NCT01172938|566566119|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948771|NCT01172938|566566120|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948772|NCT01172938|566566121|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948773|NCT01172938|566566122|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948774|NCT01172938|566566123|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
156948775|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156948776|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
157034255|NCT00319046|566882523|FG000|Overall Study|withdrawal of subject's consent|7|||
156948777|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
156948778|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
156948779|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
156948780|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
156948781|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
157034256|NCT00319046|566882523|FG000|Overall Study|administrative reason|1|||
157034257|NCT05147584|566882524|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
157034258|NCT03370913|566882530|FG000|Overall Study|Death|1|||
157034259|NCT03370913|566882530|FG000|Overall Study|Lost to Follow-up|1|||
157034260|NCT04496752|566882535|FG000|Second Assessment|Lost to Follow-up|3|||
157034261|NCT04496752|566882536|FG001|Second Assessment|Lost to Follow-up|3|||
157034262|NCT04496752|566882535|FG000|Second Assessment|Adverse Event|2|||
157034263|NCT04496752|566882536|FG001|Second Assessment|Adverse Event|0|||
157034264|NCT04078152|566882537|FG000|Overall Study|Other|83|||
156948782|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156948783|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
156948784|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156948785|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
156948786|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
156948787|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
156948788|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
156948789|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
156948790|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156948791|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156948792|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
156948793|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948794|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948795|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
156948796|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948797|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948798|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948799|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948800|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948801|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
156948802|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156948803|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
156948804|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
156948805|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
156948806|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
156948807|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
156948808|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
156948809|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156948810|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
156948811|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948812|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156948813|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156948814|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
156948815|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948816|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948817|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948818|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948819|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
156948820|NCT01172938|566566115|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948821|NCT01172938|566566116|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948822|NCT01172938|566566117|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948823|NCT01172938|566566118|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948824|NCT01172938|566566119|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948825|NCT01172938|566566120|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
156948826|NCT01172938|566566121|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
156948827|NCT01172938|566566122|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948828|NCT01172938|566566123|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
156948829|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156948830|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
156948831|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
156948832|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156948833|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156948834|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156948835|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
156948836|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
156948837|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
156948838|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948839|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
157167784|NCT02215616|567355827|FG000|Overall Study|Other than specified|1|||
157167785|NCT02215616|567355828|FG001|Overall Study|Other than specified|0|||
157167786|NCT02215616|567355829|FG002|Overall Study|Other than specified|1|||
157167787|NCT02215616|567355830|FG003|Overall Study|Other than specified|1|||
157167788|NCT01957709|567355831|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
157167789|NCT01061736|567355833|FG000|Overall Study|Dose regimen not selected|0|||
157167790|NCT01061736|567355834|FG001|Overall Study|Dose regimen not selected|0|||
156948840|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
156948841|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948842|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948843|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948844|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948845|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
156948846|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
156948847|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948848|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948849|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
156948850|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948851|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948852|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948853|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948854|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948855|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
156948856|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156948857|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
156948858|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
156948859|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156948860|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
157034265|NCT04078152|566882538|FG001|Overall Study|Other|22|||
157034266|NCT04078152|566882539|FG002|Overall Study|Other|25|||
157034267|NCT04078152|566882537|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
157034268|NCT04078152|566882538|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
157034269|NCT04078152|566882539|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
157034270|NCT04078152|566882537|FG000|Overall Study|Withdrawal by Subject|5|||
157034271|NCT04078152|566882538|FG001|Overall Study|Withdrawal by Subject|0|||
157034272|NCT04078152|566882539|FG002|Overall Study|Withdrawal by Subject|1|||
157034273|NCT04078152|566882537|FG000|Overall Study|Death|10|||
157034274|NCT04078152|566882538|FG001|Overall Study|Death|2|||
157034275|NCT04078152|566882539|FG002|Overall Study|Death|12|||
157034276|NCT04078152|566882537|FG000|Overall Study|Adverse Event|1|||
157034277|NCT04078152|566882538|FG001|Overall Study|Adverse Event|0|||
157034278|NCT04078152|566882539|FG002|Overall Study|Adverse Event|0|||
157034279|NCT04679389|566882540|FG000|Overall Study|Adverse Event|1|||
157034280|NCT04679389|566882541|FG001|Overall Study|Adverse Event|0|||
157034281|NCT04679389|566882540|FG000|Overall Study|Protocol Violation|2|||
157034282|NCT04679389|566882541|FG001|Overall Study|Protocol Violation|0|||
157034283|NCT04679389|566882540|FG000|Overall Study|Physician Decision|3|||
157034284|NCT04679389|566882541|FG001|Overall Study|Physician Decision|5|||
157034285|NCT04679389|566882540|FG000|Overall Study|Withdrawal by Subject|5|||
157034286|NCT04679389|566882541|FG001|Overall Study|Withdrawal by Subject|7|||
157034287|NCT01651000|566882549|FG000|Overall Study|Adverse Event|2|||
157034288|NCT01651000|566882550|FG001|Overall Study|Adverse Event|8|||
157034289|NCT01651000|566882549|FG000|Overall Study|Lost to Follow-up|3|||
157034290|NCT01651000|566882550|FG001|Overall Study|Lost to Follow-up|2|||
157034291|NCT01651000|566882549|FG000|Overall Study|Protocol Violation|0|||
157034292|NCT01651000|566882550|FG001|Overall Study|Protocol Violation|3|||
157034293|NCT01651000|566882549|FG000|Overall Study|Withdrawal by Subject|2|||
157034294|NCT01651000|566882550|FG001|Overall Study|Withdrawal by Subject|10|||
157034295|NCT01651000|566882549|FG000|Overall Study|Subject noncompliance|0|||
157034296|NCT01651000|566882550|FG001|Overall Study|Subject noncompliance|3|||
157034297|NCT01651000|566882549|FG000|Overall Study|Lack of Efficacy|1|||
157034298|NCT01651000|566882550|FG001|Overall Study|Lack of Efficacy|1|||
157034299|NCT01651000|566882549|FG000|Overall Study|Physician Decision|1|||
157034300|NCT01651000|566882550|FG001|Overall Study|Physician Decision|0|||
157034301|NCT01651000|566882549|FG000|Overall Study|Administrative reason|1|||
157034302|NCT01651000|566882550|FG001|Overall Study|Administrative reason|0|||
157034303|NCT01651000|566882549|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
157034304|NCT01651000|566882550|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
157034305|NCT03990883|566882551|FG000|Blinded Treatment Phase|Adverse Event|1|||
157034306|NCT03990883|566882552|FG001|Blinded Treatment Phase|Adverse Event|1|||
157034307|NCT03990883|566882553|FG002|Blinded Treatment Phase|Adverse Event|0|||
157034308|NCT03990883|566882551|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
157034309|NCT03990883|566882552|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
157034310|NCT03990883|566882553|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
157034311|NCT03990883|566882551|FG000|Blinded Treatment Phase|Physician Decision|1|||
157167791|NCT01061736|567355835|FG002|Overall Study|Dose regimen not selected|0|||
157167792|NCT01061736|567355836|FG003|Overall Study|Dose regimen not selected|0|||
157167793|NCT01061736|567355837|FG004|Overall Study|Dose regimen not selected|0|||
157205219|NCT03669640|567496073|FG000|Overall Study|Death|0|||
157167794|NCT01061736|567355838|FG005|Overall Study|Dose regimen not selected|0|||
157167795|NCT01061736|567355839|FG006|Overall Study|Dose regimen not selected|79|||
157167796|NCT01061736|567355840|FG007|Overall Study|Dose regimen not selected|0|||
157167797|NCT01061736|567355841|FG008|Overall Study|Dose regimen not selected|0|||
157167798|NCT01061736|567355842|FG009|Overall Study|Dose regimen not selected|0|||
157167799|NCT01061736|567355833|FG000|Overall Study|Adverse Event|13|||
157167800|NCT01061736|567355834|FG001|Overall Study|Adverse Event|1|||
157167801|NCT01061736|567355835|FG002|Overall Study|Adverse Event|3|||
157167802|NCT01061736|567355836|FG003|Overall Study|Adverse Event|2|||
157167803|NCT01061736|567355837|FG004|Overall Study|Adverse Event|4|||
157167804|NCT01061736|567355838|FG005|Overall Study|Adverse Event|1|||
157167805|NCT01061736|567355839|FG006|Overall Study|Adverse Event|4|||
157167806|NCT01061736|567355840|FG007|Overall Study|Adverse Event|63|||
157167807|NCT01061736|567355841|FG008|Overall Study|Adverse Event|67|||
157167808|NCT01061736|567355842|FG009|Overall Study|Adverse Event|34|||
157167809|NCT01061736|567355833|FG000|Overall Study|Lack of Efficacy|0|||
157167810|NCT01061736|567355834|FG001|Overall Study|Lack of Efficacy|2|||
157167811|NCT01061736|567355835|FG002|Overall Study|Lack of Efficacy|1|||
157167812|NCT01061736|567355836|FG003|Overall Study|Lack of Efficacy|1|||
157167813|NCT01061736|567355837|FG004|Overall Study|Lack of Efficacy|1|||
157167814|NCT01061736|567355838|FG005|Overall Study|Lack of Efficacy|2|||
157167815|NCT01061736|567355839|FG006|Overall Study|Lack of Efficacy|1|||
157167816|NCT01061736|567355840|FG007|Overall Study|Lack of Efficacy|9|||
157167817|NCT01061736|567355841|FG008|Overall Study|Lack of Efficacy|9|||
157167818|NCT01061736|567355842|FG009|Overall Study|Lack of Efficacy|10|||
157167819|NCT01061736|567355833|FG000|Overall Study|Poor compliance to protocol|0|||
157167820|NCT01061736|567355834|FG001|Overall Study|Poor compliance to protocol|0|||
157167821|NCT01061736|567355835|FG002|Overall Study|Poor compliance to protocol|0|||
157167822|NCT01061736|567355836|FG003|Overall Study|Poor compliance to protocol|0|||
157167823|NCT01061736|567355837|FG004|Overall Study|Poor compliance to protocol|0|||
157167824|NCT01061736|567355838|FG005|Overall Study|Poor compliance to protocol|0|||
157167825|NCT01061736|567355839|FG006|Overall Study|Poor compliance to protocol|0|||
157167826|NCT01061736|567355840|FG007|Overall Study|Poor compliance to protocol|2|||
157167827|NCT01061736|567355841|FG008|Overall Study|Poor compliance to protocol|5|||
157167828|NCT01061736|567355842|FG009|Overall Study|Poor compliance to protocol|9|||
157167829|NCT01061736|567355833|FG000|Overall Study|Not treated|0|||
157167830|NCT01061736|567355834|FG001|Overall Study|Not treated|0|||
157167831|NCT01061736|567355835|FG002|Overall Study|Not treated|0|||
157167832|NCT01061736|567355836|FG003|Overall Study|Not treated|0|||
157167833|NCT01061736|567355837|FG004|Overall Study|Not treated|1|||
157167834|NCT01061736|567355838|FG005|Overall Study|Not treated|0|||
157167835|NCT01061736|567355839|FG006|Overall Study|Not treated|0|||
157167836|NCT01061736|567355840|FG007|Overall Study|Not treated|2|||
156948861|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156948862|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
156948863|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
156948864|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
156948865|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948866|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
157167837|NCT01061736|567355841|FG008|Overall Study|Not treated|1|||
157167838|NCT01061736|567355842|FG009|Overall Study|Not treated|0|||
157167839|NCT01061736|567355833|FG000|Overall Study|Other than specified above|0|||
157167840|NCT01061736|567355834|FG001|Overall Study|Other than specified above|1|||
157167841|NCT01061736|567355835|FG002|Overall Study|Other than specified above|2|||
157167842|NCT01061736|567355836|FG003|Overall Study|Other than specified above|0|||
157167843|NCT01061736|567355837|FG004|Overall Study|Other than specified above|1|||
157167844|NCT01061736|567355838|FG005|Overall Study|Other than specified above|0|||
157167845|NCT01061736|567355839|FG006|Overall Study|Other than specified above|0|||
157167846|NCT01061736|567355840|FG007|Overall Study|Other than specified above|18|||
157167847|NCT01061736|567355841|FG008|Overall Study|Other than specified above|15|||
157167848|NCT01061736|567355842|FG009|Overall Study|Other than specified above|21|||
157167849|NCT01925612|567355843|FG000|Overall Study|Progressive Disease|1|||
157167850|NCT01925612|567355844|FG001|Overall Study|Progressive Disease|1|||
157167851|NCT01925612|567355845|FG002|Overall Study|Progressive Disease|1|||
157167852|NCT01925612|567355846|FG003|Overall Study|Progressive Disease|0|||
157167853|NCT01925612|567355847|FG004|Overall Study|Progressive Disease|0|||
157167854|NCT01925612|567355843|FG000|Overall Study|Adverse Event|3|||
157167855|NCT01925612|567355844|FG001|Overall Study|Adverse Event|3|||
157167856|NCT01925612|567355845|FG002|Overall Study|Adverse Event|0|||
157167857|NCT01925612|567355846|FG003|Overall Study|Adverse Event|1|||
157167858|NCT01925612|567355847|FG004|Overall Study|Adverse Event|2|||
157167859|NCT01093755|567355849|FG000|Overall Study|Withdrawal by Subject|3|||
157167860|NCT01093755|567355850|FG001|Overall Study|Withdrawal by Subject|4|||
157167861|NCT03115112|567355851|FG000|Overall Study|Adverse Event|5|||
157167862|NCT03115112|567355852|FG001|Overall Study|Adverse Event|1|||
157167863|NCT03115112|567355851|FG000|Overall Study|Withdrawal by Subject|4|||
157167864|NCT03115112|567355852|FG001|Overall Study|Withdrawal by Subject|2|||
157167865|NCT03115112|567355851|FG000|Overall Study|Lost to Follow-up|0|||
156948867|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
156948868|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948869|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948870|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948871|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948872|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948873|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
156948874|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948875|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
156948876|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
156948877|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948878|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948879|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948880|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948881|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
156948882|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
156948883|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948884|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
156948885|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948886|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948887|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948888|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948889|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948890|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
156948891|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
156948892|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948893|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
156948894|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948895|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948896|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948897|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948898|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948899|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948900|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
156948901|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948902|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948903|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948904|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948905|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948906|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948907|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948908|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
156948909|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
156948910|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156948911|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
156948912|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156948913|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156948914|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156948915|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156948916|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
156948917|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156948918|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
156948919|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156948920|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
156948921|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
156948922|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156948923|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156948924|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156948925|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
156948926|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
156948927|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
156948928|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948929|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948930|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948931|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
157227363|NCT00950807|567577783|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156948932|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948933|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948934|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948935|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
156948936|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
156948937|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948938|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
156948939|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948940|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948941|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948942|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948943|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948944|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948945|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
156948946|NCT01172938|566566115|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948947|NCT01172938|566566116|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948948|NCT01172938|566566117|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
156948949|NCT01172938|566566118|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948950|NCT01172938|566566119|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948951|NCT01172938|566566120|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948952|NCT01172938|566566121|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948953|NCT01172938|566566122|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948954|NCT01172938|566566123|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
156948955|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948956|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
156948957|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
156948958|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948959|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948960|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948961|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948962|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
156948963|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
156948964|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156948965|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
156948966|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
156948967|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156948968|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156948969|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156948970|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
156948971|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
156948972|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
156948973|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156948974|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
156948975|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
156948976|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156948977|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156948978|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156948979|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
156948980|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
156948981|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
156948982|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948983|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948984|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
156948985|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948986|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948987|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948988|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948989|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
156948990|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
157167866|NCT03115112|567355852|FG001|Overall Study|Lost to Follow-up|1|||
157167867|NCT03115112|567355851|FG000|Overall Study|Death|1|||
157167868|NCT03115112|567355852|FG001|Overall Study|Death|0|||
157167869|NCT03115112|567355851|FG000|Overall Study|Pregnancy|1|||
156948991|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
157167870|NCT03115112|567355852|FG001|Overall Study|Pregnancy|0|||
157167871|NCT03115112|567355851|FG000|Overall Study|Site closure|1|||
157167872|NCT03115112|567355852|FG001|Overall Study|Site closure|1|||
156948992|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948993|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948994|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948995|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948996|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948997|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156948998|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
156948999|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
156949000|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949001|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949002|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156949003|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949004|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949005|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949006|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
156949007|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156949008|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
156949009|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949010|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949011|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
156949012|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949013|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949014|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949015|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949016|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949017|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
156949018|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949019|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
156949020|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949021|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949022|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949023|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949024|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949025|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
156949026|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
156949027|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949028|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
156949029|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
156949030|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949031|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949032|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949033|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949034|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
156949035|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
156949036|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949037|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949038|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
156949039|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949040|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949041|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949042|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949043|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949044|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
156949045|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949046|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949047|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
156949048|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949049|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949050|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949051|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949052|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949053|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
156949054|NCT01172938|566566115|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949055|NCT01172938|566566116|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949056|NCT01172938|566566117|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949057|NCT01172938|566566118|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949058|NCT01172938|566566119|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949059|NCT01172938|566566120|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949060|NCT01172938|566566121|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949061|NCT01172938|566566122|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
156949062|NCT01172938|566566123|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
156949063|NCT01033747|566566124|FG000|Overall Study|Adverse Event|9|||
156949064|NCT01033747|566566125|FG001|Overall Study|Adverse Event|4|||
156949065|NCT01033747|566566124|FG000|Overall Study|Abnormal Laboratory Value|1|||
156949066|NCT01033747|566566125|FG001|Overall Study|Abnormal Laboratory Value|0|||
156949067|NCT01033747|566566124|FG000|Overall Study|Abnormal test procedure|0|||
156949068|NCT01033747|566566125|FG001|Overall Study|Abnormal test procedure|1|||
156949069|NCT01033747|566566124|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
156949070|NCT01033747|566566125|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
156949071|NCT01033747|566566124|FG000|Overall Study|Protocol Violation|1|||
156949072|NCT01033747|566566125|FG001|Overall Study|Protocol Violation|0|||
156949073|NCT01033747|566566124|FG000|Overall Study|Withdrawal by Subject|9|||
156949074|NCT01033747|566566125|FG001|Overall Study|Withdrawal by Subject|6|||
156949075|NCT01033747|566566124|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
156949076|NCT01033747|566566125|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
156949077|NCT01033747|566566124|FG000|Overall Study|Stopped at end of Extension 1|2|||
156949078|NCT01033747|566566125|FG001|Overall Study|Stopped at end of Extension 1|0|||
156949079|NCT02613481|566566126|FG000|Overall Study|Lost to Follow-up|7|||
156949080|NCT02613481|566566126|FG000|Overall Study|Withdrawal by Subject|2|||
156949081|NCT04382326|566566127|FG000|Overall Study|Adverse Event, not serious|1|||
156949082|NCT04382326|566566128|FG001|Overall Study|Adverse Event, not serious|2|||
156949083|NCT04382326|566566127|FG000|Overall Study|Other|1|||
156949084|NCT04382326|566566128|FG001|Overall Study|Other|0|||
156949085|NCT04382326|566566127|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
156949086|NCT04382326|566566128|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
156949087|NCT04382326|566566127|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
156949088|NCT04382326|566566128|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
156949089|NCT04382326|566566127|FG000|Overall Study|Protocol Violation|29|||
156949090|NCT04382326|566566128|FG001|Overall Study|Protocol Violation|23|||
156949091|NCT04382326|566566127|FG000|Overall Study|Physician Decision|0|||
156949092|NCT04382326|566566128|FG001|Overall Study|Physician Decision|1|||
156949093|NCT04382326|566566127|FG000|Overall Study|Lost to Follow-up|48|||
156949094|NCT04382326|566566128|FG001|Overall Study|Lost to Follow-up|63|||
156949095|NCT04382326|566566127|FG000|Overall Study|Adverse Event, non-fatal|1|||
156949096|NCT04382326|566566128|FG001|Overall Study|Adverse Event, non-fatal|1|||
156949097|NCT01038921|566566140|FG000|Overall Study|Withdrawal by Subject|1|||
156949098|NCT01038921|566566141|FG001|Overall Study|Withdrawal by Subject|0|||
156949099|NCT01038921|566566140|FG000|Overall Study|Physician Decision|1|||
156949100|NCT01038921|566566141|FG001|Overall Study|Physician Decision|0|||
156949101|NCT01978119|566566142|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
156949102|NCT01978119|566566143|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
156949103|NCT01978119|566566142|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
156949104|NCT01978119|566566143|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
156949105|NCT01978119|566566142|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
156949106|NCT01978119|566566143|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
156949107|NCT02519504|566566145|FG000|Overall Study|Protocol Violation|6|||
156949108|NCT02519504|566566146|FG001|Overall Study|Protocol Violation|5|||
156949109|NCT02519504|566566145|FG000|Overall Study|Ineligible for direct testing|12|||
156949110|NCT02519504|566566146|FG001|Overall Study|Ineligible for direct testing|12|||
156949111|NCT02519504|566566145|FG000|Overall Study|Did not participate in direct testing|95|||
156949112|NCT02519504|566566146|FG001|Overall Study|Did not participate in direct testing|86|||
156949113|NCT00889421|566566147|FG000|Overall Study|Lack of Efficacy|3|||
156949114|NCT01958918|566566148|FG000|Overall Study|Death|1|||
156949115|NCT01958918|566566149|FG001|Overall Study|Death|3|||
156949116|NCT01958918|566566148|FG000|Overall Study|Lost to Follow-up|4|||
157034312|NCT03990883|566882552|FG001|Blinded Treatment Phase|Physician Decision|0|||
157167873|NCT01610076|567355853|FG000|Overall Study|Technical issue with video|0|||
157167874|NCT01610076|567355854|FG001|Overall Study|Technical issue with video|1|||
156949117|NCT01958918|566566149|FG001|Overall Study|Lost to Follow-up|7|||
156949118|NCT01958918|566566148|FG000|Overall Study|Withdrawal by Subject|13|||
156949119|NCT01958918|566566149|FG001|Overall Study|Withdrawal by Subject|8|||
156949120|NCT01958918|566566148|FG000|Overall Study|Lack of Efficacy|13|||
156949121|NCT01958918|566566149|FG001|Overall Study|Lack of Efficacy|10|||
157167875|NCT01610076|567355853|FG000|Overall Study|Lost to Follow-up|3|||
156949122|NCT01958918|566566148|FG000|Overall Study|Adverse Event|12|||
156949123|NCT01958918|566566149|FG001|Overall Study|Adverse Event|12|||
156949124|NCT01958918|566566148|FG000|Overall Study|administrative problems|0|||
156949125|NCT01958918|566566149|FG001|Overall Study|administrative problems|2|||
157034313|NCT03990883|566882553|FG002|Blinded Treatment Phase|Physician Decision|0|||
157034314|NCT03990883|566882551|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
156949126|NCT04479618|566566156|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
156949127|NCT04479618|566566157|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
156949128|NCT04479618|566566158|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
156949129|NCT04479618|566566156|FG000|Overall Study|Lack of Efficacy|1|||
156949130|NCT04479618|566566157|FG001|Overall Study|Lack of Efficacy|0|||
156949131|NCT04479618|566566158|FG002|Overall Study|Lack of Efficacy|0|||
156949132|NCT04479618|566566156|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
156949133|NCT04479618|566566157|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
156949134|NCT04479618|566566158|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
156949135|NCT04479618|566566156|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
156949136|NCT04479618|566566157|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
156949137|NCT04479618|566566158|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
156949138|NCT04479618|566566156|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
156949139|NCT04479618|566566157|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
156949140|NCT04479618|566566158|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
156949141|NCT04479618|566566156|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
156949142|NCT04479618|566566157|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
156949143|NCT04479618|566566158|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
156949144|NCT00659269|566566161|FG000|Overall Study|Physician Decision|1|||
156949145|NCT00659269|566566162|FG001|Overall Study|Physician Decision|1|||
156949146|NCT01047683|566566163|FG000|Overall Study|Adverse Event|3|||
156949147|NCT01047683|566566164|FG001|Overall Study|Adverse Event|1|||
156949148|NCT01047683|566566165|FG002|Overall Study|Adverse Event|0|||
156949149|NCT01047683|566566163|FG000|Overall Study|Withdrew Consent|1|||
156949150|NCT01047683|566566164|FG001|Overall Study|Withdrew Consent|4|||
156949151|NCT01047683|566566165|FG002|Overall Study|Withdrew Consent|2|||
156949152|NCT01047683|566566163|FG000|Overall Study|Lost to Follow-up|0|||
156949153|NCT01047683|566566164|FG001|Overall Study|Lost to Follow-up|1|||
156949154|NCT01047683|566566165|FG002|Overall Study|Lost to Follow-up|0|||
156949155|NCT01047683|566566163|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
156949156|NCT01047683|566566164|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
156949157|NCT01047683|566566165|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
156949158|NCT00908960|566566167|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
156949159|NCT00908960|566566168|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
156949160|NCT00908960|566566169|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
156949161|NCT03795922|566566170|FG000|Overall Study|Adverse Event|2|||
156949162|NCT03795922|566566171|FG001|Overall Study|Adverse Event|1|||
156949163|NCT03795922|566566170|FG000|Overall Study|Withdrawal by Subject|5|||
156949164|NCT03795922|566566171|FG001|Overall Study|Withdrawal by Subject|13|||
156949165|NCT03795922|566566170|FG000|Overall Study|Lost to Follow-up|2|||
156949166|NCT03795922|566566171|FG001|Overall Study|Lost to Follow-up|3|||
156949167|NCT03795922|566566170|FG000|Overall Study|Pregnancy|0|||
156949168|NCT03795922|566566171|FG001|Overall Study|Pregnancy|1|||
156949169|NCT03795922|566566170|FG000|Overall Study|Physician Decision|1|||
156949170|NCT03795922|566566171|FG001|Overall Study|Physician Decision|2|||
156949171|NCT03795922|566566170|FG000|Overall Study|Protocol Violation|0|||
156949172|NCT03795922|566566171|FG001|Overall Study|Protocol Violation|1|||
156949173|NCT03795922|566566170|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
157034315|NCT03990883|566882552|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
157034316|NCT03990883|566882553|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
157034317|NCT03990883|566882551|FG000|Blinded Treatment Phase|COVID-19|3|||
157034318|NCT03990883|566882552|FG001|Blinded Treatment Phase|COVID-19|2|||
157034319|NCT03990883|566882553|FG002|Blinded Treatment Phase|COVID-19|0|||
157034320|NCT03990883|566882551|FG000|Blinded Treatment Phase|Personal Reasons|6|||
157034321|NCT03990883|566882552|FG001|Blinded Treatment Phase|Personal Reasons|3|||
157034322|NCT03990883|566882553|FG002|Blinded Treatment Phase|Personal Reasons|0|||
157034323|NCT03990883|566882551|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
156949174|NCT03795922|566566171|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
156949175|NCT00781326|566566174|FG000|Phase I|Adverse Event|1|||
157034324|NCT03990883|566882552|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
157167876|NCT01610076|567355854|FG001|Overall Study|Lost to Follow-up|4|||
157167877|NCT00980343|567355859|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
157167878|NCT00980343|567355860|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
157167879|NCT01231607|567355861|FG000|Overall Study|Adverse Event|0|||
157167880|NCT01231607|567355862|FG001|Overall Study|Adverse Event|8|||
157167881|NCT01231607|567355863|FG002|Overall Study|Adverse Event|4|||
156949176|NCT00781326|566566174|FG000|Phase I|Withdrawal by Subject|1|||
156949177|NCT00781326|566566174|FG000|Phase I|Physician Decision|2|||
156949178|NCT01916304|566566182|FG000|Overall Study|Screening failure|17|||
156949179|NCT01898793|566566183|FG000|Overall Study|Death|2|||
156949180|NCT01898793|566566184|FG001|Overall Study|Death|1|||
156949181|NCT01898793|566566185|FG002|Overall Study|Death|4|||
156949182|NCT01898793|566566186|FG003|Overall Study|Death|0|||
156949183|NCT01898793|566566187|FG004|Overall Study|Death|0|||
156949184|NCT01898793|566566188|FG005|Overall Study|Death|0|||
156949185|NCT01898793|566566189|FG006|Overall Study|Death|0|||
156949186|NCT04666441|566566192|FG000|Overall Study|Lost to Follow-up|1|||
156949187|NCT04666441|566566193|FG001|Overall Study|Lost to Follow-up|4|||
156949188|NCT04666441|566566194|FG002|Overall Study|Lost to Follow-up|1|||
156949189|NCT04666441|566566195|FG003|Overall Study|Lost to Follow-up|3|||
156949190|NCT04666441|566566196|FG004|Overall Study|Lost to Follow-up|0|||
156949191|NCT04666441|566566197|FG005|Overall Study|Lost to Follow-up|2|||
156949192|NCT04666441|566566198|FG006|Overall Study|Lost to Follow-up|2|||
156949193|NCT04666441|566566199|FG007|Overall Study|Lost to Follow-up|2|||
156949194|NCT04666441|566566192|FG000|Overall Study|Subject Decision|1|||
156949195|NCT04666441|566566193|FG001|Overall Study|Subject Decision|1|||
156949196|NCT04666441|566566194|FG002|Overall Study|Subject Decision|3|||
156949197|NCT04666441|566566195|FG003|Overall Study|Subject Decision|1|||
156949198|NCT04666441|566566196|FG004|Overall Study|Subject Decision|0|||
156949199|NCT04666441|566566197|FG005|Overall Study|Subject Decision|1|||
156949200|NCT04666441|566566198|FG006|Overall Study|Subject Decision|3|||
156949201|NCT04666441|566566199|FG007|Overall Study|Subject Decision|2|||
156949202|NCT01306617|566566203|FG000|Overall Study|Adverse Event|1|||
156949203|NCT01306617|566566204|FG001|Overall Study|Adverse Event|0|||
156949204|NCT01306617|566566205|FG002|Overall Study|Adverse Event|0|||
156949205|NCT01306617|566566203|FG000|Overall Study|Virologic Failure|0|||
156949206|NCT01306617|566566204|FG001|Overall Study|Virologic Failure|0|||
156949207|NCT01306617|566566205|FG002|Overall Study|Virologic Failure|5|||
156949208|NCT01306617|566566203|FG000|Overall Study|Non-compliance|0|||
156949209|NCT01306617|566566204|FG001|Overall Study|Non-compliance|1|||
156949210|NCT01306617|566566205|FG002|Overall Study|Non-compliance|0|||
156949211|NCT04028388|566566213|FG000|Overall Study|Evaluations missing|3|||
156949212|NCT04028388|566566214|FG001|Overall Study|Evaluations missing|6|||
156949213|NCT04028388|566566213|FG000|Overall Study|Not started|2|||
156949214|NCT04028388|566566214|FG001|Overall Study|Not started|0|||
156949215|NCT00766415|566566217|FG000|Overall Study|Withdrawal by Subject|0|||
156949216|NCT00766415|566566218|FG001|Overall Study|Withdrawal by Subject|1|||
156949217|NCT01114516|566566223|FG000|Overall Study|Lost to Follow-up|2|||
156949218|NCT01114516|566566224|FG001|Overall Study|Lost to Follow-up|1|||
156949219|NCT01431508|566566225|FG000|Overall Study|Lack of Efficacy|1|||
156949220|NCT01431508|566566225|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
156949221|NCT00132769|566566226|FG000|Overall Study|Withdrawal by Subject|1|||
156949222|NCT00132769|566566227|FG001|Overall Study|Withdrawal by Subject|3|||
156949223|NCT00132769|566566226|FG000|Overall Study|Lack of Efficacy|7|||
156949224|NCT00132769|566566227|FG001|Overall Study|Lack of Efficacy|6|||
156949225|NCT00132769|566566226|FG000|Overall Study|Adverse Event|2|||
156949226|NCT00132769|566566227|FG001|Overall Study|Adverse Event|1|||
156949227|NCT00132769|566566226|FG000|Overall Study|Protocol Violation|1|||
156949228|NCT00132769|566566227|FG001|Overall Study|Protocol Violation|1|||
156949229|NCT00129259|566566229|FG000|Overall Study|Lost to Follow-up|1|||
156949230|NCT00129259|566566230|FG001|Overall Study|Lost to Follow-up|1|||
156949231|NCT00129259|566566229|FG000|Overall Study|Withdrawal by Subject|2|||
156949232|NCT00129259|566566230|FG001|Overall Study|Withdrawal by Subject|1|||
156949233|NCT00129259|566566229|FG000|Overall Study|Only available minimal phone assessments|0|||
156949234|NCT00129259|566566230|FG001|Overall Study|Only available minimal phone assessments|1|||
156949235|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
157167882|NCT01231607|567355864|FG003|Overall Study|Adverse Event|4|||
156949236|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
157167883|NCT01231607|567355865|FG004|Overall Study|Adverse Event|5|||
156949237|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949238|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949239|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156949240|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949241|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949242|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156949243|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156949244|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949245|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156949246|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
156949247|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949248|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949249|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949250|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
156949251|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156949252|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156949253|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156949254|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
156949255|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
156949256|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
156949257|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
156949258|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
156949259|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156949260|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156949261|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
156949262|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
156949263|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156949264|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156949265|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156949266|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
156949267|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949268|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949269|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949270|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949271|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949272|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156949273|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156949274|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949275|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949276|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
156949277|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
156949278|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
156949279|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949280|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949281|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949282|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
156949283|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949284|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949285|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949286|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949287|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949288|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
156949289|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949290|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949291|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949292|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949293|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949294|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
156949295|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949296|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949297|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949298|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
156949299|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949300|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949301|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949302|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949303|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949304|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
156949305|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949306|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949307|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949308|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949309|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949310|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949311|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949312|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949313|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
157167884|NCT01231607|567355861|FG000|Overall Study|Lost to Follow-up|13|||
157034325|NCT03990883|566882553|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
157034326|NCT03990883|566882551|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
157034327|NCT03990883|566882552|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
157034328|NCT03990883|566882553|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
157034329|NCT03990883|566882551|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
157034330|NCT03990883|566882552|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
157034331|NCT03990883|566882553|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
157034332|NCT05020353|566883377|FG000|Overall Study|Protocol Violation|7|||
157034333|NCT05020353|566883377|FG000|Overall Study|Withdrawal by Subject|33|||
157034334|NCT04633278|566883381|FG000|Overall Study|Adverse Event|1|||
157034335|NCT04633278|566883382|FG001|Overall Study|Adverse Event|0|||
157034336|NCT04633278|566883381|FG000|Overall Study|Withdrawal by Subject|1|||
157034337|NCT04633278|566883382|FG001|Overall Study|Withdrawal by Subject|0|||
157034338|NCT04633278|566883381|FG000|Overall Study|Death|11|||
157034339|NCT04633278|566883382|FG001|Overall Study|Death|7|||
157034340|NCT04633278|566883381|FG000|Overall Study|Sponsor Decision|3|||
157034341|NCT04633278|566883382|FG001|Overall Study|Sponsor Decision|0|||
157034342|NCT04633278|566883381|FG000|Overall Study|Not Listed|1|||
157034343|NCT04633278|566883382|FG001|Overall Study|Not Listed|0|||
157034344|NCT02611687|566883383|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
157034345|NCT02611687|566883384|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
157034346|NCT02075554|566883388|FG000|Overall Study|Lost to Follow-up|7|||
157034347|NCT02075554|566883388|FG000|Overall Study|Withdrawal by Subject|5|||
157034348|NCT02075554|566883388|FG000|Overall Study|Physician Decision|3|||
157034349|NCT04933474|566883394|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
157034350|NCT04933474|566883395|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
157034351|NCT04933474|566883394|FG000|Overall Study|Lost to Follow-up|19|||
157034352|NCT04933474|566883395|FG001|Overall Study|Lost to Follow-up|9|||
157034353|NCT04933474|566883394|FG000|Overall Study|Life Burden - unable to participate|6|||
157034354|NCT04933474|566883395|FG001|Overall Study|Life Burden - unable to participate|2|||
157034355|NCT04933474|566883394|FG000|Overall Study|Disease Burden - unable to participate|4|||
157034356|NCT04933474|566883395|FG001|Overall Study|Disease Burden - unable to participate|1|||
157034357|NCT04933474|566883394|FG000|Overall Study|Surgery/Hospitalization|1|||
157034358|NCT04933474|566883395|FG001|Overall Study|Surgery/Hospitalization|2|||
157034359|NCT04933474|566883394|FG000|Overall Study|Dissatisfied with Intervention|1|||
157034360|NCT04933474|566883395|FG001|Overall Study|Dissatisfied with Intervention|1|||
157034361|NCT04933474|566883394|FG000|Overall Study|Withdrew interest in participation|1|||
157034362|NCT04933474|566883395|FG001|Overall Study|Withdrew interest in participation|0|||
157034363|NCT04933474|566883394|FG000|Overall Study|Had previously enrolled in the study|0|||
157034364|NCT04933474|566883395|FG001|Overall Study|Had previously enrolled in the study|1|||
157034365|NCT04757753|566883400|FG000|Overall Study|Lost to Follow-up|7|||
157034366|NCT04757753|566883401|FG001|Overall Study|Lost to Follow-up|7|||
157034367|NCT04757753|566883400|FG000|Overall Study|Withdrawal by Subject|0|||
157034368|NCT04757753|566883401|FG001|Overall Study|Withdrawal by Subject|3|||
157034369|NCT04757753|566883400|FG000|Overall Study|Endodontic treatment failure|1|||
157034370|NCT04757753|566883401|FG001|Overall Study|Endodontic treatment failure|2|||
157034371|NCT04757753|566883400|FG000|Overall Study|Tooth fracture/extraction|3|||
157034372|NCT04757753|566883401|FG001|Overall Study|Tooth fracture/extraction|0|||
157034373|NCT03816397|566883406|FG000|Overall Study|Censored at interim analysis date.|13|||
157034374|NCT03816397|566883407|FG001|Overall Study|Censored at interim analysis date.|6|||
157034375|NCT03816397|566883406|FG000|Overall Study|Withdrawal by Subject|1|||
157034376|NCT03816397|566883407|FG001|Overall Study|Withdrawal by Subject|1|||
157034377|NCT03547271|566883408|FG000|Overall Study|Adverse Event|1|||
157034378|NCT03547271|566883409|FG001|Overall Study|Adverse Event|1|||
157034379|NCT03547271|566883410|FG002|Overall Study|Adverse Event|0|||
157034380|NCT03547271|566883411|FG003|Overall Study|Adverse Event|0|||
157034381|NCT03547271|566883408|FG000|Overall Study|Protocol deviation|5|||
157034382|NCT03547271|566883409|FG001|Overall Study|Protocol deviation|7|||
157034383|NCT03547271|566883410|FG002|Overall Study|Protocol deviation|3|||
157034384|NCT03547271|566883411|FG003|Overall Study|Protocol deviation|0|||
157034385|NCT03547271|566883408|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
157034386|NCT03547271|566883409|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
157034387|NCT03547271|566883410|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
157034388|NCT03547271|566883411|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
157034389|NCT03547271|566883408|FG000|Overall Study|Lost to Follow-up|3|||
157034390|NCT03547271|566883409|FG001|Overall Study|Lost to Follow-up|3|||
157034391|NCT03547271|566883410|FG002|Overall Study|Lost to Follow-up|1|||
157034392|NCT03547271|566883411|FG003|Overall Study|Lost to Follow-up|0|||
157034393|NCT06065735|566883416|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
157034394|NCT06065735|566883417|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
157034395|NCT06065735|566883418|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
157034396|NCT06065735|566883416|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
157034397|NCT06065735|566883417|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
157034398|NCT06065735|566883418|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
156949314|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
156949315|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949316|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
157167885|NCT01231607|567355862|FG001|Overall Study|Lost to Follow-up|11|||
157167886|NCT01231607|567355863|FG002|Overall Study|Lost to Follow-up|10|||
157167887|NCT01231607|567355864|FG003|Overall Study|Lost to Follow-up|10|||
157167888|NCT01231607|567355865|FG004|Overall Study|Lost to Follow-up|4|||
157167889|NCT01231607|567355861|FG000|Overall Study|Physician Decision|4|||
157167890|NCT01231607|567355862|FG001|Overall Study|Physician Decision|4|||
157167891|NCT01231607|567355863|FG002|Overall Study|Physician Decision|3|||
157167892|NCT01231607|567355864|FG003|Overall Study|Physician Decision|5|||
157167893|NCT01231607|567355865|FG004|Overall Study|Physician Decision|4|||
157167894|NCT01231607|567355861|FG000|Overall Study|Protocol Violation|3|||
157167895|NCT01231607|567355862|FG001|Overall Study|Protocol Violation|2|||
157167896|NCT01231607|567355863|FG002|Overall Study|Protocol Violation|0|||
157167897|NCT01231607|567355864|FG003|Overall Study|Protocol Violation|2|||
157167898|NCT01231607|567355865|FG004|Overall Study|Protocol Violation|2|||
157167899|NCT01231607|567355861|FG000|Overall Study|Withdrawal by Subject|9|||
157167900|NCT01231607|567355862|FG001|Overall Study|Withdrawal by Subject|9|||
157167901|NCT01231607|567355863|FG002|Overall Study|Withdrawal by Subject|14|||
157167902|NCT01231607|567355864|FG003|Overall Study|Withdrawal by Subject|17|||
157167903|NCT01231607|567355865|FG004|Overall Study|Withdrawal by Subject|9|||
157167904|NCT00469209|567355869|FG000|Overall Study|Adverse Event|1|||
157167905|NCT00469209|567355870|FG001|Overall Study|Adverse Event|0|||
157167906|NCT00469209|567355871|FG002|Overall Study|Adverse Event|1|||
157167907|NCT01082367|567355880|FG000|Double-blind Period|Administrative problems|0|||
157167908|NCT01082367|567355881|FG001|Double-blind Period|Administrative problems|1|||
157167909|NCT01082367|567355880|FG000|Double-blind Period|Lack of Efficacy|5|||
157167910|NCT01082367|567355881|FG001|Double-blind Period|Lack of Efficacy|11|||
157167911|NCT01082367|567355880|FG000|Double-blind Period|Adverse Event|0|||
157167912|NCT01082367|567355881|FG001|Double-blind Period|Adverse Event|1|||
157167913|NCT01082367|567355880|FG000|Follow-up (F-U) Period|Administrative problems|1|||
157167914|NCT01082367|567355881|FG001|Follow-up (F-U) Period|Administrative problems|0|||
157167915|NCT01082367|567355880|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
157167916|NCT01082367|567355881|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
157167917|NCT01082367|567355880|FG000|Follow-up (F-U) Period|Adverse Event|0|||
157167918|NCT01082367|567355881|FG001|Follow-up (F-U) Period|Adverse Event|1|||
157167919|NCT00098020|567355884|FG000|Overall Study|Adverse Event|2|||
157167920|NCT00098020|567355884|FG000|Overall Study|Lost to Follow-up|1|||
157167921|NCT00098020|567355884|FG000|Overall Study|elevated liver enzymes|1|||
157167922|NCT00098020|567355884|FG000|Overall Study|Low urine PCR|1|||
157167923|NCT00098020|567355884|FG000|Overall Study|Low epidermal growth factor receptor|1|||
157167924|NCT02022033|567355890|FG000|Overall Study|Physician Decision|1|||
157167925|NCT01429077|567355891|FG000|Overall Study|Lost to Follow-up|0|||
157167926|NCT01429077|567355892|FG001|Overall Study|Lost to Follow-up|3|||
157167927|NCT01360762|567355895|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
157167928|NCT01360762|567355895|FG000|Main Study Period (12-month Treatment)|Death|5|||
157167929|NCT01360762|567355895|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
157167930|NCT01360762|567355895|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
157167931|NCT01360762|567355895|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
157167932|NCT01360762|567355895|FG000|Whole Study Period|Lost to Follow-up|10|||
157167933|NCT01360762|567355895|FG000|Whole Study Period|Death|7|||
157167934|NCT01360762|567355895|FG000|Whole Study Period|Patient relapsed|18|||
157167935|NCT01360762|567355895|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
157167936|NCT01103778|567355896|FG000|Overall Study|Lost to Follow-up|1|||
157167937|NCT01103778|567355896|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
157167938|NCT01103778|567355896|FG000|Overall Study|Screen failure|1|||
157167939|NCT03084718|567355897|FG000|Overall Study|Withdrawal by Subject|4|||
157167940|NCT03084718|567355898|FG001|Overall Study|Withdrawal by Subject|3|||
156949317|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
157167941|NCT03084718|567355899|FG002|Overall Study|Withdrawal by Subject|4|||
157167942|NCT03084718|567355900|FG003|Overall Study|Withdrawal by Subject|0|||
157167943|NCT03084718|567355901|FG004|Overall Study|Withdrawal by Subject|0|||
157167944|NCT03084718|567355897|FG000|Overall Study|Physician Decision|1|||
157227364|NCT00950807|567577784|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
157227365|NCT00950807|567577785|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
156949318|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949319|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949320|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
157167945|NCT03084718|567355898|FG001|Overall Study|Physician Decision|0|||
157167946|NCT03084718|567355899|FG002|Overall Study|Physician Decision|0|||
157167947|NCT03084718|567355900|FG003|Overall Study|Physician Decision|0|||
157167948|NCT03084718|567355901|FG004|Overall Study|Physician Decision|0|||
157227366|NCT00950807|567577786|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
157034399|NCT06065735|566883416|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
157034400|NCT06065735|566883417|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
157034401|NCT06065735|566883418|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
157034402|NCT06065735|566883416|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
157034403|NCT06065735|566883417|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
157034404|NCT06065735|566883418|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
157034405|NCT06065735|566883416|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
157034406|NCT06065735|566883417|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
157034407|NCT06065735|566883418|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
157034408|NCT03522298|566883419|FG000|Overall Study|Adverse Event|1|||
157034409|NCT03522298|566883420|FG001|Overall Study|Adverse Event|0|||
157034410|NCT03522298|566883421|FG002|Overall Study|Adverse Event|0|||
157034411|NCT03522298|566883422|FG003|Overall Study|Adverse Event|1|||
157034412|NCT03522298|566883419|FG000|Overall Study|Death|2|||
157034413|NCT03522298|566883420|FG001|Overall Study|Death|4|||
157034414|NCT03522298|566883421|FG002|Overall Study|Death|8|||
157034415|NCT03522298|566883422|FG003|Overall Study|Death|8|||
157034416|NCT03522298|566883419|FG000|Overall Study|Patient decision|0|||
157034417|NCT03522298|566883420|FG001|Overall Study|Patient decision|2|||
157034418|NCT03522298|566883421|FG002|Overall Study|Patient decision|2|||
157034419|NCT03522298|566883422|FG003|Overall Study|Patient decision|2|||
157034420|NCT05718687|566883425|FG000|Overall Study|Withdrawal by Subject|3|||
157034421|NCT01897441|566883428|FG000|Overall Study|Lost to Follow-up|0|||
157034422|NCT01897441|566883429|FG001|Overall Study|Lost to Follow-up|0|||
157034423|NCT01897441|566883430|FG002|Overall Study|Lost to Follow-up|1|||
157034424|NCT01897441|566883431|FG003|Overall Study|Lost to Follow-up|0|||
157034425|NCT01897441|566883432|FG004|Overall Study|Lost to Follow-up|0|||
157034426|NCT01897441|566883433|FG005|Overall Study|Lost to Follow-up|0|||
157034427|NCT01897441|566883428|FG000|Overall Study|Withdrawal by Subject|0|||
157034428|NCT01897441|566883429|FG001|Overall Study|Withdrawal by Subject|0|||
157034429|NCT01897441|566883430|FG002|Overall Study|Withdrawal by Subject|0|||
157034430|NCT01897441|566883431|FG003|Overall Study|Withdrawal by Subject|0|||
157034431|NCT01897441|566883432|FG004|Overall Study|Withdrawal by Subject|1|||
157034432|NCT01897441|566883433|FG005|Overall Study|Withdrawal by Subject|0|||
157034433|NCT01897441|566883428|FG000|Overall Study|Withdrawn by Provider|0|||
157034434|NCT01897441|566883429|FG001|Overall Study|Withdrawn by Provider|2|||
157034435|NCT01897441|566883430|FG002|Overall Study|Withdrawn by Provider|0|||
157034436|NCT01897441|566883431|FG003|Overall Study|Withdrawn by Provider|0|||
157034437|NCT01897441|566883432|FG004|Overall Study|Withdrawn by Provider|0|||
157034438|NCT01897441|566883433|FG005|Overall Study|Withdrawn by Provider|0|||
157034439|NCT03250676|566883438|FG000|Overall Study|Adverse Event|0|||
157034440|NCT03250676|566883439|FG001|Overall Study|Adverse Event|0|||
157034441|NCT03250676|566883440|FG002|Overall Study|Adverse Event|0|||
157034442|NCT03250676|566883441|FG003|Overall Study|Adverse Event|1|||
157034443|NCT03250676|566883442|FG004|Overall Study|Adverse Event|2|||
157034444|NCT03250676|566883443|FG005|Overall Study|Adverse Event|9|||
157034445|NCT03250676|566883438|FG000|Overall Study|Withdrawal by Subject|1|||
157034446|NCT03250676|566883439|FG001|Overall Study|Withdrawal by Subject|0|||
157034447|NCT03250676|566883440|FG002|Overall Study|Withdrawal by Subject|0|||
157034448|NCT03250676|566883441|FG003|Overall Study|Withdrawal by Subject|1|||
157034449|NCT03250676|566883442|FG004|Overall Study|Withdrawal by Subject|1|||
157034450|NCT03250676|566883443|FG005|Overall Study|Withdrawal by Subject|2|||
157034451|NCT03250676|566883438|FG000|Overall Study|Physician Decision|0|||
157034452|NCT03250676|566883439|FG001|Overall Study|Physician Decision|0|||
157034453|NCT03250676|566883440|FG002|Overall Study|Physician Decision|0|||
157034454|NCT03250676|566883441|FG003|Overall Study|Physician Decision|2|||
157034455|NCT03250676|566883442|FG004|Overall Study|Physician Decision|0|||
157034456|NCT03250676|566883443|FG005|Overall Study|Physician Decision|3|||
157034457|NCT03250676|566883438|FG000|Overall Study|Withdrawal of consent|0|||
157034458|NCT03250676|566883439|FG001|Overall Study|Withdrawal of consent|0|||
157034459|NCT03250676|566883440|FG002|Overall Study|Withdrawal of consent|2|||
157034460|NCT03250676|566883441|FG003|Overall Study|Withdrawal of consent|0|||
157034461|NCT03250676|566883442|FG004|Overall Study|Withdrawal of consent|0|||
157034462|NCT03250676|566883443|FG005|Overall Study|Withdrawal of consent|2|||
157034463|NCT03250676|566883438|FG000|Overall Study|Other|1|||
157034464|NCT03250676|566883439|FG001|Overall Study|Other|0|||
157034465|NCT03250676|566883440|FG002|Overall Study|Other|0|||
157034466|NCT03250676|566883441|FG003|Overall Study|Other|0|||
157167949|NCT03084718|567355897|FG000|Overall Study|Adverse Event|3|||
157034467|NCT03250676|566883442|FG004|Overall Study|Other|0|||
157034468|NCT03250676|566883443|FG005|Overall Study|Other|0|||
157034469|NCT03250676|566883438|FG000|Overall Study|Disease progression|4|||
157034470|NCT03250676|566883439|FG001|Overall Study|Disease progression|12|||
157034471|NCT03250676|566883440|FG002|Overall Study|Disease progression|9|||
157034472|NCT03250676|566883441|FG003|Overall Study|Disease progression|7|||
157034473|NCT03250676|566883442|FG004|Overall Study|Disease progression|4|||
157034474|NCT03250676|566883443|FG005|Overall Study|Disease progression|88|||
157034475|NCT01499368|566883444|FG000|Overall Study|Did not meet I/E criteria|8|||
157167950|NCT03084718|567355898|FG001|Overall Study|Adverse Event|5|||
157167951|NCT03084718|567355899|FG002|Overall Study|Adverse Event|5|||
157167952|NCT03084718|567355900|FG003|Overall Study|Adverse Event|8|||
157167953|NCT03084718|567355901|FG004|Overall Study|Adverse Event|2|||
156949321|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949322|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949323|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
156949324|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949325|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949326|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949327|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949328|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949329|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949330|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
156949331|NCT01609556|566566231|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
156949332|NCT01609556|566566232|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949333|NCT01609556|566566233|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949334|NCT01609556|566566234|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949335|NCT01609556|566566235|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949336|NCT01609556|566566236|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
156949337|NCT01609556|566566237|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949338|NCT01609556|566566238|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949339|NCT01609556|566566239|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949340|NCT01609556|566566240|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949341|NCT01609556|566566241|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
156949342|NCT01609556|566566242|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949343|NCT01609556|566566243|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949344|NCT01609556|566566244|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949345|NCT01609556|566566245|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949346|NCT01609556|566566246|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
156949347|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949348|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949349|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949350|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949351|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949352|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949353|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949354|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949355|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949356|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949357|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949358|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
156949359|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
156949360|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156949361|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156949362|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
156949363|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949364|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949365|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949366|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949367|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949368|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949369|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949370|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949371|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
157034476|NCT01499368|566883445|FG001|Overall Study|Did not meet I/E criteria|4|||
157034477|NCT01499368|566883446|FG002|Overall Study|Did not meet I/E criteria|4|||
157034478|NCT01499368|566883444|FG000|Overall Study|Prohibited Concomitant medication|1|||
157034479|NCT01499368|566883445|FG001|Overall Study|Prohibited Concomitant medication|1|||
157034480|NCT01499368|566883446|FG002|Overall Study|Prohibited Concomitant medication|0|||
157034481|NCT01499368|566883444|FG000|Overall Study|Withdrawal by Subject|11|||
157034482|NCT01499368|566883445|FG001|Overall Study|Withdrawal by Subject|10|||
157034483|NCT01499368|566883446|FG002|Overall Study|Withdrawal by Subject|8|||
157034484|NCT01499368|566883444|FG000|Overall Study|Lost to Follow-up|3|||
157034485|NCT01499368|566883445|FG001|Overall Study|Lost to Follow-up|2|||
157034486|NCT01499368|566883446|FG002|Overall Study|Lost to Follow-up|5|||
157034487|NCT01499368|566883444|FG000|Overall Study|Adverse Event|4|||
157034488|NCT01499368|566883445|FG001|Overall Study|Adverse Event|0|||
157167954|NCT03084718|567355897|FG000|Overall Study|Lack of Efficacy|2|||
157167955|NCT03084718|567355898|FG001|Overall Study|Lack of Efficacy|0|||
157167956|NCT03084718|567355899|FG002|Overall Study|Lack of Efficacy|1|||
157167957|NCT03084718|567355900|FG003|Overall Study|Lack of Efficacy|4|||
157167958|NCT03084718|567355901|FG004|Overall Study|Lack of Efficacy|0|||
157167959|NCT03084718|567355897|FG000|Overall Study|Lost to Follow-up|0|||
157167960|NCT03084718|567355898|FG001|Overall Study|Lost to Follow-up|1|||
157167961|NCT03084718|567355899|FG002|Overall Study|Lost to Follow-up|0|||
156949372|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949373|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949374|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
156949375|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
156949376|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
156949377|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
156949378|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
156949379|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949380|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949381|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949382|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949383|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949384|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949385|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949386|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949387|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949388|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949389|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949390|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
156949391|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156949392|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156949393|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
156949394|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
156949395|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949396|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949397|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949398|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949399|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949400|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949401|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949402|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949403|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949404|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949405|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949406|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949407|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
156949408|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949409|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949410|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
156949411|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949412|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949413|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949414|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949415|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949416|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949417|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949418|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949419|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949420|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949421|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949422|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
156949423|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
156949424|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
156949425|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
156949426|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
156949427|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949428|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949429|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
157167962|NCT03084718|567355900|FG003|Overall Study|Lost to Follow-up|0|||
157167963|NCT03084718|567355901|FG004|Overall Study|Lost to Follow-up|2|||
157167964|NCT03084718|567355897|FG000|Overall Study|Protocol Violation|0|||
157167965|NCT03084718|567355898|FG001|Overall Study|Protocol Violation|0|||
157167966|NCT03084718|567355899|FG002|Overall Study|Protocol Violation|1|||
157167967|NCT03084718|567355900|FG003|Overall Study|Protocol Violation|0|||
157167968|NCT03084718|567355901|FG004|Overall Study|Protocol Violation|0|||
157167969|NCT03084718|567355897|FG000|Overall Study|Death|0|||
157167970|NCT03084718|567355898|FG001|Overall Study|Death|1|||
157167971|NCT03084718|567355899|FG002|Overall Study|Death|0|||
157167972|NCT03084718|567355900|FG003|Overall Study|Death|0|||
157167973|NCT03084718|567355901|FG004|Overall Study|Death|0|||
157167974|NCT03084718|567355897|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
157167975|NCT03084718|567355898|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
157167976|NCT03084718|567355899|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
157167977|NCT03084718|567355900|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
157167978|NCT03084718|567355901|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
157167979|NCT02806947|567355902|FG000|Overall Study|Withdrawal by Subject|5|||
157167980|NCT02806947|567355903|FG001|Overall Study|Withdrawal by Subject|1|||
157167981|NCT04929613|567355904|FG000|Overall Study|Withdrawal by Subject|12|||
157167982|NCT00865189|567355905|FG000|Overall Study|Other|1|||
157167983|NCT00865189|567355906|FG001|Overall Study|Other|2|||
157167984|NCT00865189|567355905|FG000|Overall Study|Death|4|||
157167985|NCT00865189|567355906|FG001|Overall Study|Death|11|||
157167986|NCT00865189|567355905|FG000|Overall Study|Lost to Follow-up|6|||
157167987|NCT00865189|567355906|FG001|Overall Study|Lost to Follow-up|6|||
157167988|NCT00865189|567355905|FG000|Overall Study|Withdrawal by Subject|1|||
157167989|NCT00865189|567355906|FG001|Overall Study|Withdrawal by Subject|0|||
157167990|NCT00634114|567355909|FG000|Overall Study|Adverse Event|6|||
157167991|NCT00634114|567355910|FG001|Overall Study|Adverse Event|8|||
157167992|NCT00634114|567355911|FG002|Overall Study|Adverse Event|3|||
157167993|NCT00634114|567355909|FG000|Overall Study|Withdrawal by Subject|9|||
157167994|NCT00634114|567355910|FG001|Overall Study|Withdrawal by Subject|6|||
157167995|NCT00634114|567355911|FG002|Overall Study|Withdrawal by Subject|11|||
157167996|NCT00634114|567355909|FG000|Overall Study|Lost to Follow-up|0|||
157167997|NCT00634114|567355910|FG001|Overall Study|Lost to Follow-up|0|||
157167998|NCT00634114|567355911|FG002|Overall Study|Lost to Follow-up|1|||
157167999|NCT00634114|567355909|FG000|Overall Study|Protocol Violation|3|||
157168000|NCT00634114|567355910|FG001|Overall Study|Protocol Violation|3|||
157168001|NCT00634114|567355911|FG002|Overall Study|Protocol Violation|1|||
157168002|NCT00634114|567355909|FG000|Overall Study|Pregnancy|1|||
157168003|NCT00634114|567355910|FG001|Overall Study|Pregnancy|0|||
157168004|NCT00634114|567355911|FG002|Overall Study|Pregnancy|0|||
157168005|NCT00634114|567355909|FG000|Overall Study|Incorrect enrolment|0|||
157168006|NCT00634114|567355910|FG001|Overall Study|Incorrect enrolment|1|||
157168007|NCT00634114|567355911|FG002|Overall Study|Incorrect enrolment|0|||
157168008|NCT00634114|567355909|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
157168009|NCT00634114|567355910|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
157168010|NCT00634114|567355911|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
157168011|NCT00634114|567355909|FG000|Overall Study|Difficult to continue|3|||
157168012|NCT00634114|567355910|FG001|Overall Study|Difficult to continue|1|||
157168013|NCT00634114|567355911|FG002|Overall Study|Difficult to continue|1|||
157168014|NCT00634114|567355909|FG000|Overall Study|Other reason|1|||
157168015|NCT00634114|567355910|FG001|Overall Study|Other reason|1|||
156949430|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
157168016|NCT00634114|567355911|FG002|Overall Study|Other reason|1|||
157168017|NCT01599754|567355912|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
157168018|NCT01599754|567355913|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
157168019|NCT01599754|567355912|FG000|Overall Study|Participant noncompliance|4|||
157168020|NCT01599754|567355913|FG001|Overall Study|Participant noncompliance|4|||
157168021|NCT01599754|567355912|FG000|Overall Study|Lost to Follow-up|13|||
157168022|NCT01599754|567355913|FG001|Overall Study|Lost to Follow-up|6|||
157168023|NCT01599754|567355912|FG000|Overall Study|Death|31|||
157168024|NCT01599754|567355913|FG001|Overall Study|Death|33|||
157168025|NCT01599754|567355912|FG000|Overall Study|Adverse Event|3|||
157168026|NCT01599754|567355913|FG001|Overall Study|Adverse Event|2|||
157168027|NCT01599754|567355912|FG000|Overall Study|Investigator decision|1|||
157168028|NCT01599754|567355913|FG001|Overall Study|Investigator decision|3|||
157168029|NCT01599754|567355912|FG000|Overall Study|Withdrawal by Subject|24|||
157168030|NCT01599754|567355913|FG001|Overall Study|Withdrawal by Subject|25|||
157168031|NCT01599754|567355912|FG000|Overall Study|Study terminated by sponsor|282|||
157168032|NCT01599754|567355913|FG001|Overall Study|Study terminated by sponsor|285|||
157168033|NCT03550131|567355915|FG000|Overall Study|Lost to Follow-up|16|||
157168034|NCT03550131|567355916|FG001|Overall Study|Lost to Follow-up|24|||
157168035|NCT03550131|567355915|FG000|Overall Study|Withdrawal by Subject|36|||
157168036|NCT03550131|567355916|FG001|Overall Study|Withdrawal by Subject|28|||
157168037|NCT03550131|567355915|FG000|Overall Study|Illness of dyad member|10|||
157168038|NCT03550131|567355916|FG001|Overall Study|Illness of dyad member|2|||
157034489|NCT01499368|566883446|FG002|Overall Study|Adverse Event|2|||
157034490|NCT01499368|566883444|FG000|Overall Study|Physician Decision|0|||
157034491|NCT01499368|566883445|FG001|Overall Study|Physician Decision|1|||
157034492|NCT01499368|566883446|FG002|Overall Study|Physician Decision|0|||
157034493|NCT01499368|566883444|FG000|Overall Study|Deviation from visit window|0|||
157034494|NCT01499368|566883445|FG001|Overall Study|Deviation from visit window|0|||
157034495|NCT01499368|566883446|FG002|Overall Study|Deviation from visit window|1|||
157034496|NCT01499368|566883444|FG000|Overall Study|Error of Prescriptions|0|||
157034497|NCT01499368|566883445|FG001|Overall Study|Error of Prescriptions|0|||
157034498|NCT01499368|566883446|FG002|Overall Study|Error of Prescriptions|1|||
157034499|NCT03092674|566883447|FG000|Overall Study|Adverse Event or Side Effects|1|||
157034500|NCT03092674|566883448|FG001|Overall Study|Adverse Event or Side Effects|4|||
157034501|NCT03092674|566883449|FG002|Overall Study|Adverse Event or Side Effects|4|||
157034502|NCT03092674|566883447|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
157034503|NCT03092674|566883448|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
157034504|NCT03092674|566883449|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
157034505|NCT03092674|566883447|FG000|Overall Study|Progression/Relapse|5|||
157034506|NCT03092674|566883448|FG001|Overall Study|Progression/Relapse|4|||
157034507|NCT03092674|566883449|FG002|Overall Study|Progression/Relapse|8|||
157034508|NCT03092674|566883447|FG000|Overall Study|Death|4|||
157034509|NCT03092674|566883448|FG001|Overall Study|Death|8|||
157034510|NCT03092674|566883449|FG002|Overall Study|Death|2|||
157034511|NCT03092674|566883447|FG000|Overall Study|Other - Not Protocol Specified|11|||
157034512|NCT03092674|566883448|FG001|Overall Study|Other - Not Protocol Specified|8|||
157034513|NCT03092674|566883449|FG002|Overall Study|Other - Not Protocol Specified|8|||
157034514|NCT02325154|566883450|FG000|Overall Study|Physician Decision|1|||
157034515|NCT03512301|566884468|FG000|Overall Study|Protocol Violation|2|||
157034516|NCT03512301|566884468|FG000|Overall Study|Did Not Qualify|3|||
157034517|NCT03512301|566884468|FG000|Overall Study|Age-ineligible|1|||
157034518|NCT03512301|566884468|FG000|Overall Study|Inadequate fluency with the English language|3|||
157034519|NCT01773993|566884474|FG000|Overall Study|No Visit After Treatment|35|||
157034520|NCT04408755|566884486|FG000|Period A (Placebo lead-in)|Other|11|||
157034521|NCT04408755|566884487|FG001|Period A (Placebo lead-in)|Other|0|||
157034522|NCT04408755|566884488|FG002|Period A (Placebo lead-in)|Other|0|||
157034523|NCT04408755|566884489|FG003|Period A (Placebo lead-in)|Other|0|||
157034524|NCT04408755|566884486|FG000|Period B (Randomization Period)|Adverse Event|0|||
157034525|NCT04408755|566884487|FG001|Period B (Randomization Period)|Adverse Event|3|||
157034526|NCT04408755|566884488|FG002|Period B (Randomization Period)|Adverse Event|0|||
157034527|NCT04408755|566884489|FG003|Period B (Randomization Period)|Adverse Event|1|||
157034528|NCT04408755|566884486|FG000|Period B (Randomization Period)|Death|0|||
157034529|NCT04408755|566884487|FG001|Period B (Randomization Period)|Death|0|||
157034530|NCT04408755|566884488|FG002|Period B (Randomization Period)|Death|1|||
157034531|NCT04408755|566884489|FG003|Period B (Randomization Period)|Death|0|||
157034532|NCT04408755|566884486|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
157034533|NCT04408755|566884487|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
157034534|NCT04408755|566884488|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
157034535|NCT04408755|566884489|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
157034536|NCT04408755|566884486|FG000|Period B (Randomization Period)|Physician Decision|0|||
157034537|NCT04408755|566884487|FG001|Period B (Randomization Period)|Physician Decision|0|||
157034538|NCT04408755|566884488|FG002|Period B (Randomization Period)|Physician Decision|1|||
157034539|NCT04408755|566884489|FG003|Period B (Randomization Period)|Physician Decision|0|||
157034540|NCT04408755|566884486|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
157034541|NCT04408755|566884487|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
157034542|NCT04408755|566884488|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
157034543|NCT04408755|566884489|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
157034544|NCT04408755|566884486|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
157034545|NCT04408755|566884487|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
157034546|NCT04408755|566884488|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
157034547|NCT04408755|566884489|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
157034548|NCT04408755|566884486|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
157034549|NCT04408755|566884487|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
157034550|NCT04408755|566884488|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
157034551|NCT04408755|566884489|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
157034552|NCT04408755|566884486|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
157034553|NCT04408755|566884487|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
157034554|NCT04408755|566884488|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
157034555|NCT04408755|566884489|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
157034556|NCT04408755|566884486|FG000|Period B (Randomization Period)|Reason not Specified|0|||
157034557|NCT04408755|566884487|FG001|Period B (Randomization Period)|Reason not Specified|1|||
157034558|NCT04408755|566884488|FG002|Period B (Randomization Period)|Reason not Specified|0|||
157205220|NCT03669640|567496074|FG001|Overall Study|Death|0|||
157034559|NCT04408755|566884489|FG003|Period B (Randomization Period)|Reason not Specified|2|||
157034560|NCT03733626|566884490|FG000|Overall Study|Physician Decision|4|||
157034561|NCT03733626|566884491|FG001|Overall Study|Physician Decision|4|||
157034562|NCT06655818|566884492|FG000|Overall Study|Withdrawal by Subject|1|||
157034563|NCT00412607|566884499|FG000|Overall Study|Withdrawal by Subject|9|||
157034564|NCT00412607|566884499|FG000|Overall Study|Lost to Follow-up|19|||
157034565|NCT00412607|566884499|FG000|Overall Study|Death|61|||
157034566|NCT00412607|566884499|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
157034567|NCT03662022|566884500|FG000|Year 1 2019|prevalent case|83|||
157034568|NCT03662022|566884501|FG001|Year 1 2019|prevalent case|116|||
157034569|NCT03662022|566884502|FG002|Year 1 2019|prevalent case|158|||
157034570|NCT03662022|566884503|FG003|Year 1 2019|prevalent case|99|||
157034571|NCT03662022|566884500|FG000|Year 2 2020|incident case|18|||
157034572|NCT03662022|566884501|FG001|Year 2 2020|incident case|18|||
157034573|NCT03662022|566884502|FG002|Year 2 2020|incident case|16|||
157034574|NCT03662022|566884503|FG003|Year 2 2020|incident case|26|||
157034575|NCT03662022|566884500|FG000|Year 2 2020|other case|18|||
157034576|NCT03662022|566884501|FG001|Year 2 2020|other case|16|||
157034577|NCT03662022|566884502|FG002|Year 2 2020|other case|16|||
157034578|NCT03662022|566884503|FG003|Year 2 2020|other case|24|||
157034579|NCT03662022|566884500|FG000|Year 2 2020|Lost to Follow-up|1633|||
157034580|NCT03662022|566884501|FG001|Year 2 2020|Lost to Follow-up|1183|||
157034581|NCT03662022|566884502|FG002|Year 2 2020|Lost to Follow-up|1381|||
157034582|NCT03662022|566884503|FG003|Year 2 2020|Lost to Follow-up|2858|||
157034583|NCT03662022|566884500|FG000|Year 3 2021|incident case|24|||
157034584|NCT03662022|566884501|FG001|Year 3 2021|incident case|27|||
157034585|NCT03662022|566884502|FG002|Year 3 2021|incident case|24|||
157034586|NCT03662022|566884503|FG003|Year 3 2021|incident case|11|||
157034587|NCT03662022|566884500|FG000|Year 3 2021|other case|4|||
157034588|NCT03662022|566884501|FG001|Year 3 2021|other case|15|||
157034589|NCT03662022|566884502|FG002|Year 3 2021|other case|10|||
157034590|NCT03662022|566884503|FG003|Year 3 2021|other case|14|||
157034591|NCT03662022|566884500|FG000|Year 3 2021|Lost to Follow-up|179|||
157034592|NCT03662022|566884501|FG001|Year 3 2021|Lost to Follow-up|244|||
157034593|NCT03662022|566884502|FG002|Year 3 2021|Lost to Follow-up|480|||
157034594|NCT03662022|566884503|FG003|Year 3 2021|Lost to Follow-up|477|||
157034595|NCT03662022|566884500|FG000|Year 4 2022|incident case|25|||
157034596|NCT03662022|566884501|FG001|Year 4 2022|incident case|41|||
157034597|NCT03662022|566884502|FG002|Year 4 2022|incident case|28|||
157034598|NCT03662022|566884503|FG003|Year 4 2022|incident case|7|||
157034599|NCT03662022|566884500|FG000|Year 4 2022|other case|8|||
157034600|NCT03662022|566884501|FG001|Year 4 2022|other case|19|||
157034601|NCT03662022|566884502|FG002|Year 4 2022|other case|13|||
157034602|NCT03662022|566884503|FG003|Year 4 2022|other case|7|||
157034603|NCT03662022|566884500|FG000|Year 4 2022|Lost to Follow-up|986|||
157034604|NCT03662022|566884501|FG001|Year 4 2022|Lost to Follow-up|1079|||
157034605|NCT03662022|566884502|FG002|Year 4 2022|Lost to Follow-up|1236|||
157034606|NCT03662022|566884503|FG003|Year 4 2022|Lost to Follow-up|1826|||
157034607|NCT04214418|566884506|FG000|Overall Study|Withdrawal by Subject|1|||
157034608|NCT04214418|566884507|FG001|Overall Study|Withdrawal by Subject|0|||
157034609|NCT04214418|566884508|FG002|Overall Study|Withdrawal by Subject|0|||
157034610|NCT04214418|566884509|FG003|Overall Study|Withdrawal by Subject|0|||
157034611|NCT04214418|566884510|FG004|Overall Study|Withdrawal by Subject|0|||
157034612|NCT04214418|566884511|FG005|Overall Study|Withdrawal by Subject|0|||
157034613|NCT04214418|566884506|FG000|Overall Study|Adverse Event|0|||
157034614|NCT04214418|566884507|FG001|Overall Study|Adverse Event|2|||
157034615|NCT04214418|566884508|FG002|Overall Study|Adverse Event|0|||
157034616|NCT04214418|566884509|FG003|Overall Study|Adverse Event|0|||
157034617|NCT04214418|566884510|FG004|Overall Study|Adverse Event|0|||
157034618|NCT04214418|566884511|FG005|Overall Study|Adverse Event|0|||
157034619|NCT04214418|566884506|FG000|Overall Study|Death|1|||
157034620|NCT04214418|566884507|FG001|Overall Study|Death|0|||
157034621|NCT04214418|566884508|FG002|Overall Study|Death|0|||
157034622|NCT04214418|566884509|FG003|Overall Study|Death|0|||
157034623|NCT04214418|566884510|FG004|Overall Study|Death|0|||
157034624|NCT04214418|566884511|FG005|Overall Study|Death|0|||
157034625|NCT04908930|566884519|FG000|Overall Study|Lost to Follow-up|1|||
157034626|NCT04908930|566884520|FG001|Overall Study|Lost to Follow-up|1|||
157034627|NCT04908930|566884521|FG002|Overall Study|Lost to Follow-up|0|||
157034628|NCT04908930|566884522|FG003|Overall Study|Lost to Follow-up|0|||
157034629|NCT04908930|566884523|FG004|Overall Study|Lost to Follow-up|0|||
157034630|NCT04908930|566884519|FG000|Overall Study|hardware in mouth|1|||
157034631|NCT04908930|566884520|FG001|Overall Study|hardware in mouth|1|||
157034632|NCT04908930|566884521|FG002|Overall Study|hardware in mouth|0|||
157034633|NCT04908930|566884522|FG003|Overall Study|hardware in mouth|0|||
157034634|NCT04908930|566884523|FG004|Overall Study|hardware in mouth|0|||
157034635|NCT04908930|566884519|FG000|Overall Study|wrong team|1|||
157034636|NCT04908930|566884520|FG001|Overall Study|wrong team|0|||
157034637|NCT04908930|566884521|FG002|Overall Study|wrong team|0|||
157034638|NCT04908930|566884522|FG003|Overall Study|wrong team|0|||
157034639|NCT04908930|566884523|FG004|Overall Study|wrong team|0|||
157034640|NCT04908930|566884519|FG000|Overall Study|quit team|2|||
157034641|NCT04908930|566884520|FG001|Overall Study|quit team|4|||
156949431|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949432|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949433|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949434|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949435|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949436|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949437|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949438|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949439|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949440|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949441|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
156949442|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
156949443|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949444|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949445|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949446|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949447|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949448|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949449|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949450|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949451|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949452|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949453|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949454|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949455|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
156949456|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
156949457|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
156949458|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
156949459|NCT01609556|566566231|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949460|NCT01609556|566566232|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949461|NCT01609556|566566233|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949462|NCT01609556|566566234|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949463|NCT01609556|566566235|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949464|NCT01609556|566566236|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949465|NCT01609556|566566237|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949466|NCT01609556|566566238|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949467|NCT01609556|566566239|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949468|NCT01609556|566566240|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949469|NCT01609556|566566241|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949470|NCT01609556|566566242|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949471|NCT01609556|566566243|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
156949472|NCT01609556|566566244|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949473|NCT01609556|566566245|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949474|NCT01609556|566566246|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
156949475|NCT01632579|566566249|FG000|Washout Period|Adverse Event|1|||
156949476|NCT01632579|566566250|FG001|Washout Period|Adverse Event|0|||
156949477|NCT01632579|566566251|FG002|Washout Period|Adverse Event|0|||
156949478|NCT01632579|566566252|FG003|Washout Period|Adverse Event|0|||
156949479|NCT01632579|566566253|FG004|Washout Period|Adverse Event|0|||
156949480|NCT01632579|566566254|FG005|Washout Period|Adverse Event|0|||
156949481|NCT01632579|566566255|FG006|Washout Period|Adverse Event|0|||
156949482|NCT01632579|566566256|FG007|Washout Period|Adverse Event|0|||
156949483|NCT01632579|566566257|FG008|Washout Period|Adverse Event|0|||
156949484|NCT01632579|566566249|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
156949485|NCT01632579|566566250|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
156949486|NCT01632579|566566251|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
156949487|NCT01632579|566566252|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
156949488|NCT01632579|566566253|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
156949489|NCT01632579|566566254|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
156949490|NCT01632579|566566255|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
156949491|NCT01632579|566566256|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
157168039|NCT03550131|567355915|FG000|Overall Study|Death of person with dementia|4|||
156949492|NCT01632579|566566257|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
156949493|NCT03794089|566567709|FG000|Overall Study|Lost to Follow-up|4|||
156949494|NCT03794089|566567710|FG001|Overall Study|Lost to Follow-up|1|||
156949495|NCT03794089|566567709|FG000|Overall Study|Withdrawal by Subject|2|||
156949496|NCT03794089|566567710|FG001|Overall Study|Withdrawal by Subject|0|||
156949497|NCT03985423|566567711|FG000|Overall Study|Adverse Event|1|||
156949498|NCT03985423|566567711|FG000|Overall Study|Death|2|||
156949499|NCT03985423|566567711|FG000|Overall Study|Physician Decision|1|||
156949500|NCT03985423|566567711|FG000|Overall Study|Withdrawal by Subject|2|||
156949501|NCT03985423|566567711|FG000|Overall Study|Lack of insurance and citizenship|1|||
156949502|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Adverse Event|5|||
156949503|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Adverse Event|8|||
156949504|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Adverse Event|4|||
156949505|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Adverse Event|8|||
156949506|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
156949507|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
156949508|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
156949509|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
156949510|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156949511|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
156949512|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156949513|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
156949514|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Physician Decision|1|||
156949515|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Physician Decision|0|||
156949516|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Physician Decision|0|||
156949517|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Physician Decision|0|||
156949518|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
156949519|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
156949520|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
156949521|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
156949522|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Pregnancy|0|||
156949523|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Pregnancy|1|||
156949524|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Pregnancy|0|||
156949525|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Pregnancy|0|||
156949526|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
156949527|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
156949528|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
156949529|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
156949530|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Death|0|||
156949531|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Death|1|||
156949532|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Death|0|||
156949533|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Death|0|||
156949534|NCT00071487|566567721|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
156949535|NCT00071487|566567722|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
156949536|NCT00071487|566567723|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
156949537|NCT00071487|566567724|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
156949538|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
156949539|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
156949540|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
156949541|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
156949542|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156949543|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156949544|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
156949545|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
156949546|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156949547|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156949548|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
156949549|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
156949550|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
156949551|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
156949552|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
156949553|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
156949554|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156949555|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156949556|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
156949557|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
156949558|NCT00071487|566567721|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156949559|NCT00071487|566567722|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156949560|NCT00071487|566567723|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
156949561|NCT00071487|566567724|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
156949562|NCT02044510|566567727|FG000|Overall Study|Adverse Event|1|||
156949563|NCT02044510|566567728|FG001|Overall Study|Adverse Event|2|||
156949564|NCT00353704|566567729|FG000|Overall Study|Protocol Violation|3|||
156949565|NCT00353704|566567730|FG001|Overall Study|Protocol Violation|1|||
156949566|NCT01154166|566567731|FG000|Overall Study|Adverse Event|14|||
156949567|NCT01154166|566567732|FG001|Overall Study|Adverse Event|9|||
156949568|NCT01154166|566567731|FG000|Overall Study|Lost to Follow-up|1|||
156949569|NCT01154166|566567732|FG001|Overall Study|Lost to Follow-up|1|||
156949570|NCT01154166|566567731|FG000|Overall Study|Protocol Violation|4|||
156949571|NCT01154166|566567732|FG001|Overall Study|Protocol Violation|1|||
157168040|NCT03550131|567355916|FG001|Overall Study|Death of person with dementia|8|||
157168041|NCT01318512|567355917|FG000|Maintenance Period (6 Months)|Death|2|||
157168042|NCT01318512|567355917|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
157168043|NCT02756650|567355920|FG000|Overall Study|Physician Decision|1|||
157168044|NCT02756650|567355920|FG000|Overall Study|Adverse Event|1|||
157168045|NCT04348591|567355925|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
157168046|NCT04348591|567355926|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
157168047|NCT04348591|567355925|FG000|Imaging Session (120 Min)|Physician Decision|0|||
157168048|NCT04348591|567355926|FG001|Imaging Session (120 Min)|Physician Decision|1|||
157168049|NCT04348591|567355925|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
157168050|NCT04348591|567355926|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
157168051|NCT00910429|567355930|FG000|Overall Study|Death|18|||
157168052|NCT00910429|567355931|FG001|Overall Study|Death|12|||
157168053|NCT00910429|567355930|FG000|Overall Study|Withdrawal by Subject|3|||
157168054|NCT00910429|567355931|FG001|Overall Study|Withdrawal by Subject|2|||
157168055|NCT00910429|567355930|FG000|Overall Study|Protocol Violation|1|||
157168056|NCT00910429|567355931|FG001|Overall Study|Protocol Violation|0|||
157168057|NCT00910429|567355930|FG000|Overall Study|Lost to Follow-up|2|||
157168058|NCT00910429|567355931|FG001|Overall Study|Lost to Follow-up|1|||
156949572|NCT01154166|566567731|FG000|Overall Study|Withdrawal by Subject|10|||
156949573|NCT01154166|566567732|FG001|Overall Study|Withdrawal by Subject|1|||
156949574|NCT01154166|566567731|FG000|Overall Study|Lack of Efficacy|3|||
156949575|NCT01154166|566567732|FG001|Overall Study|Lack of Efficacy|0|||
156949576|NCT01154166|566567731|FG000|Overall Study|Disease Progression|1|||
156949577|NCT01154166|566567732|FG001|Overall Study|Disease Progression|0|||
157168059|NCT00910429|567355930|FG000|Overall Study|Adverse Event|10|||
156949578|NCT01154166|566567731|FG000|Overall Study|Poor Compliance|1|||
156949579|NCT01154166|566567732|FG001|Overall Study|Poor Compliance|0|||
156949580|NCT01375049|566567733|FG000|Overall Study|Adverse Event|2|||
156949581|NCT01375049|566567733|FG000|Overall Study|Lost to Follow-up|1|||
156949582|NCT01375049|566567733|FG000|Overall Study|Withdrawal by Subject|2|||
156949583|NCT01375049|566567733|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
156949584|NCT03614793|566567734|FG000|Overall Study|Lost to Follow-up|1|||
156949585|NCT03614793|566567735|FG001|Overall Study|Lost to Follow-up|2|||
156949586|NCT03614793|566567734|FG000|Overall Study|Lack of Efficacy|0|||
156949587|NCT03614793|566567735|FG001|Overall Study|Lack of Efficacy|5|||
156949588|NCT03614793|566567734|FG000|Overall Study|Withdrawal by Subject|0|||
156949589|NCT03614793|566567735|FG001|Overall Study|Withdrawal by Subject|1|||
156949590|NCT03614793|566567734|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
156949591|NCT03614793|566567735|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
156949592|NCT02082522|566567736|FG000|Overall Study|Sponsor termination|5|||
156949593|NCT02082522|566567737|FG001|Overall Study|Sponsor termination|3|||
156949594|NCT02082522|566567736|FG000|Overall Study|Withdrawal by Subject|2|||
156949595|NCT02082522|566567737|FG001|Overall Study|Withdrawal by Subject|4|||
156949596|NCT02082522|566567736|FG000|Overall Study|Death|1|||
156949597|NCT02082522|566567737|FG001|Overall Study|Death|0|||
156949598|NCT02082522|566567736|FG000|Overall Study|Lost to Follow-up|1|||
156949599|NCT02082522|566567737|FG001|Overall Study|Lost to Follow-up|0|||
156949600|NCT02082522|566567736|FG000|Overall Study|Physician Decision|3|||
156949601|NCT02082522|566567737|FG001|Overall Study|Physician Decision|1|||
156949602|NCT02082522|566567736|FG000|Overall Study|Disease progression|2|||
156949603|NCT02082522|566567737|FG001|Overall Study|Disease progression|2|||
156949604|NCT02082522|566567736|FG000|Overall Study|Chemotherapy change|1|||
156949605|NCT02082522|566567737|FG001|Overall Study|Chemotherapy change|3|||
156949606|NCT01575561|566567738|FG000|Overall Study|Adverse Event|9|||
156949607|NCT01575561|566567738|FG000|Overall Study|Lack of Efficacy|8|||
156949608|NCT01575561|566567738|FG000|Overall Study|Lost to Follow-up|6|||
156949609|NCT01575561|566567738|FG000|Overall Study|Protocol Violation|4|||
156949610|NCT01575561|566567738|FG000|Overall Study|Withdrawal by Subject|11|||
156949611|NCT01575561|566567738|FG000|Overall Study|administration|1|||
156949612|NCT00633984|566567739|FG000|Overall Study|Lost to Follow-up|0|||
156949613|NCT00633984|566567740|FG001|Overall Study|Lost to Follow-up|6|||
156949614|NCT00633984|566567739|FG000|Overall Study|Withdrawal by Subject|8|||
156949615|NCT00633984|566567740|FG001|Overall Study|Withdrawal by Subject|7|||
156949616|NCT00633984|566567739|FG000|Overall Study|Hospitalized|1|||
156949617|NCT00633984|566567740|FG001|Overall Study|Hospitalized|0|||
156949618|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
156949619|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
157168060|NCT00910429|567355931|FG001|Overall Study|Adverse Event|5|||
157168061|NCT00910429|567355930|FG000|Overall Study|Drug non-compliance|1|||
157168062|NCT00910429|567355931|FG001|Overall Study|Drug non-compliance|0|||
157168063|NCT00910429|567355930|FG000|Overall Study|Lack of Efficacy|4|||
157168064|NCT00910429|567355931|FG001|Overall Study|Lack of Efficacy|1|||
156949620|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
156949621|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Death|1|||
156949622|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
156949623|NCT02840877|566567741|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
156949624|NCT02840877|566567741|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
156949625|NCT02840877|566567741|FG000|12 Weeks to 6 Months|Treatment failure|1|||
156949626|NCT02840877|566567741|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
156949627|NCT02840877|566567741|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
156949628|NCT02840877|566567741|FG000|12 Weeks to 6 Months|Death|1|||
156949629|NCT02840877|566567741|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
156949630|NCT02840877|566567741|FG000|6 Months to 18 Months|Treatment failure|7|||
156949631|NCT02840877|566567741|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
156949632|NCT02840877|566567741|FG000|6 Months to 18 Months|Moved/transferred out|6|||
156949633|NCT02840877|566567741|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
156949634|NCT02840877|566567741|FG000|6 Months to 18 Months|Death|4|||
156949635|NCT02840877|566567741|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
156949636|NCT02840877|566567741|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
156949637|NCT02840877|566567741|FG000|6 Months to 18 Months|Still in study.|14|||
156949638|NCT01168999|566567742|FG000|Overall Study|Lost to Follow-up|2|||
156949639|NCT01168999|566567743|FG001|Overall Study|Lost to Follow-up|1|||
156949640|NCT01168999|566567744|FG002|Overall Study|Lost to Follow-up|0|||
156949641|NCT01168999|566567745|FG003|Overall Study|Lost to Follow-up|0|||
156949642|NCT04317586|566567746|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
156949643|NCT04317586|566567746|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
156949644|NCT01276327|566567747|FG000|Overall Study|Adverse Event|1|||
156949645|NCT01276327|566567748|FG001|Overall Study|Adverse Event|3|||
156949646|NCT01276327|566567747|FG000|Overall Study|Withdrawal by Subject|1|||
156949647|NCT01276327|566567748|FG001|Overall Study|Withdrawal by Subject|0|||
156949648|NCT03003676|566567749|FG000|Overall Study|Lack of Efficacy|5|||
156949649|NCT03003676|566567750|FG001|Overall Study|Lack of Efficacy|7|||
156949650|NCT03003676|566567749|FG000|Overall Study|Withdrawal by Subject|0|||
156949651|NCT03003676|566567750|FG001|Overall Study|Withdrawal by Subject|1|||
156949652|NCT03003676|566567749|FG000|Overall Study|Hepatitis B infection|1|||
156949653|NCT03003676|566567750|FG001|Overall Study|Hepatitis B infection|0|||
156949654|NCT02647658|566567759|FG000|Overall Study|Consent refusal|15|||
156949655|NCT02647658|566567760|FG001|Overall Study|Consent refusal|24|||
156949656|NCT00803023|566567761|FG000|Overall Study|Adverse Event|5|||
156949657|NCT00803023|566567762|FG001|Overall Study|Adverse Event|4|||
156949658|NCT00803023|566567763|FG002|Overall Study|Adverse Event|8|||
156949659|NCT00803023|566567764|FG003|Overall Study|Adverse Event|6|||
156949660|NCT00803023|566567761|FG000|Overall Study|Withdrawal by Subject|0|||
156949661|NCT00803023|566567762|FG001|Overall Study|Withdrawal by Subject|2|||
156949662|NCT00803023|566567763|FG002|Overall Study|Withdrawal by Subject|0|||
156949663|NCT00803023|566567764|FG003|Overall Study|Withdrawal by Subject|0|||
156949664|NCT00803023|566567761|FG000|Overall Study|Lost to Follow-up|0|||
156949665|NCT00803023|566567762|FG001|Overall Study|Lost to Follow-up|1|||
156949666|NCT00803023|566567763|FG002|Overall Study|Lost to Follow-up|2|||
156949667|NCT00803023|566567764|FG003|Overall Study|Lost to Follow-up|1|||
156949668|NCT00803023|566567761|FG000|Overall Study|Lack of Efficacy|0|||
156949669|NCT00803023|566567762|FG001|Overall Study|Lack of Efficacy|1|||
156949670|NCT00803023|566567763|FG002|Overall Study|Lack of Efficacy|1|||
156949671|NCT00803023|566567764|FG003|Overall Study|Lack of Efficacy|1|||
156949672|NCT01542528|566567769|FG000|Overall Study|Lost to Follow-up|2|||
156949673|NCT01542528|566567770|FG001|Overall Study|Lost to Follow-up|1|||
156949674|NCT01542528|566567769|FG000|Overall Study|Physician Decision|1|||
156949675|NCT01542528|566567770|FG001|Overall Study|Physician Decision|0|||
156949676|NCT01542528|566567769|FG000|Overall Study|Withdrawal by Subject|9|||
156949677|NCT01542528|566567770|FG001|Overall Study|Withdrawal by Subject|6|||
156949678|NCT05282004|566567771|FG000|Overall Study|Adverse Event|2|||
156949679|NCT04808609|566567772|FG000|Overall Study|Lost to Follow-up|0|||
156949680|NCT04808609|566567773|FG001|Overall Study|Lost to Follow-up|2|||
156949681|NCT04808609|566567772|FG000|Overall Study|Administrative Withdrawal|0|||
156949682|NCT04808609|566567773|FG001|Overall Study|Administrative Withdrawal|1|||
157034642|NCT04908930|566884521|FG002|Overall Study|quit team|0|||
157034643|NCT04908930|566884522|FG003|Overall Study|quit team|0|||
157034644|NCT04908930|566884523|FG004|Overall Study|quit team|0|||
157168065|NCT01317615|567355932|FG000|Overall Study|Disease progression|25|||
156949683|NCT00562159|566567775|FG000|Overall Study|Adverse Event|11|||
156949684|NCT00562159|566567776|FG001|Overall Study|Adverse Event|8|||
156949685|NCT00562159|566567775|FG000|Overall Study|Lost to Follow-up|5|||
156949686|NCT00562159|566567776|FG001|Overall Study|Lost to Follow-up|4|||
156949687|NCT00562159|566567775|FG000|Overall Study|Withdrawal by Subject|9|||
156949688|NCT00562159|566567776|FG001|Overall Study|Withdrawal by Subject|8|||
156949689|NCT00562159|566567775|FG000|Overall Study|Protocol Violation|12|||
156949690|NCT00562159|566567776|FG001|Overall Study|Protocol Violation|12|||
156949691|NCT00562159|566567775|FG000|Overall Study|Did not meet protocol eligibility|1|||
156949692|NCT00562159|566567776|FG001|Overall Study|Did not meet protocol eligibility|1|||
156949693|NCT01181921|566567779|FG000|Overall Study|Lost to Follow-up|1|||
156949694|NCT02461589|566567780|FG000|Overall Study|Withdrawal by Subject|5|||
157034645|NCT04908930|566884519|FG000|Overall Study|Withdrawal by Subject|1|||
157034646|NCT04908930|566884520|FG001|Overall Study|Withdrawal by Subject|2|||
157168066|NCT01317615|567355932|FG000|Overall Study|New cancer therapy|5|||
157168067|NCT01317615|567355932|FG000|Overall Study|Death|6|||
157168068|NCT01317615|567355932|FG000|Overall Study|Withdrawal by Subject|5|||
157168069|NCT01317615|567355932|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157168070|NCT01317615|567355932|FG000|Overall Study|Adverse Event|7|||
157168071|NCT02648724|567355935|FG000|Overall Study|Withdrawal by Subject|0|||
157168072|NCT02648724|567355936|FG001|Overall Study|Withdrawal by Subject|1|||
157168073|NCT02648724|567355937|FG002|Overall Study|Withdrawal by Subject|1|||
157168074|NCT02648724|567355938|FG003|Overall Study|Withdrawal by Subject|0|||
157168075|NCT02648724|567355939|FG004|Overall Study|Withdrawal by Subject|1|||
157168076|NCT02648724|567355940|FG005|Overall Study|Withdrawal by Subject|0|||
157168077|NCT02648724|567355941|FG006|Overall Study|Withdrawal by Subject|0|||
157168078|NCT02648724|567355935|FG000|Overall Study|Progressive disease|2|||
157168079|NCT02648724|567355936|FG001|Overall Study|Progressive disease|2|||
157168080|NCT02648724|567355937|FG002|Overall Study|Progressive disease|2|||
157168081|NCT02648724|567355938|FG003|Overall Study|Progressive disease|3|||
157168082|NCT02648724|567355939|FG004|Overall Study|Progressive disease|22|||
157168083|NCT02648724|567355940|FG005|Overall Study|Progressive disease|7|||
157168084|NCT02648724|567355941|FG006|Overall Study|Progressive disease|8|||
157168085|NCT02648724|567355935|FG000|Overall Study|Other reason (unknown)|1|||
157168086|NCT02648724|567355936|FG001|Overall Study|Other reason (unknown)|0|||
156949695|NCT02461589|566567781|FG001|Overall Study|Withdrawal by Subject|1|||
156949696|NCT02461589|566567782|FG002|Overall Study|Withdrawal by Subject|3|||
156949697|NCT02461589|566567783|FG003|Overall Study|Withdrawal by Subject|2|||
156949698|NCT02461589|566567784|FG004|Overall Study|Withdrawal by Subject|1|||
156949699|NCT02461589|566567785|FG005|Overall Study|Withdrawal by Subject|2|||
156949700|NCT02461589|566567786|FG006|Overall Study|Withdrawal by Subject|1|||
156949701|NCT02461589|566567787|FG007|Overall Study|Withdrawal by Subject|3|||
156949702|NCT02461589|566567788|FG008|Overall Study|Withdrawal by Subject|3|||
156949703|NCT02461589|566567789|FG009|Overall Study|Withdrawal by Subject|1|||
156949704|NCT02461589|566567780|FG000|Overall Study|Lost to Follow-up|0|||
156949705|NCT02461589|566567781|FG001|Overall Study|Lost to Follow-up|0|||
156949706|NCT02461589|566567782|FG002|Overall Study|Lost to Follow-up|2|||
156949707|NCT02461589|566567783|FG003|Overall Study|Lost to Follow-up|3|||
156949708|NCT02461589|566567784|FG004|Overall Study|Lost to Follow-up|1|||
156949709|NCT02461589|566567785|FG005|Overall Study|Lost to Follow-up|1|||
156949710|NCT02461589|566567786|FG006|Overall Study|Lost to Follow-up|3|||
156949711|NCT02461589|566567787|FG007|Overall Study|Lost to Follow-up|1|||
156949712|NCT02461589|566567788|FG008|Overall Study|Lost to Follow-up|3|||
156949713|NCT02461589|566567789|FG009|Overall Study|Lost to Follow-up|1|||
156949714|NCT02461589|566567780|FG000|Overall Study|Death|0|||
156949715|NCT02461589|566567781|FG001|Overall Study|Death|0|||
156949716|NCT02461589|566567782|FG002|Overall Study|Death|0|||
156949717|NCT02461589|566567783|FG003|Overall Study|Death|0|||
156949718|NCT02461589|566567784|FG004|Overall Study|Death|0|||
156949719|NCT02461589|566567785|FG005|Overall Study|Death|0|||
156949720|NCT02461589|566567786|FG006|Overall Study|Death|0|||
156949721|NCT02461589|566567787|FG007|Overall Study|Death|1|||
156949722|NCT02461589|566567788|FG008|Overall Study|Death|0|||
156949723|NCT02461589|566567789|FG009|Overall Study|Death|0|||
156949724|NCT02461589|566567780|FG000|Overall Study|Unclassified|0|||
156949725|NCT02461589|566567781|FG001|Overall Study|Unclassified|0|||
156949726|NCT02461589|566567782|FG002|Overall Study|Unclassified|0|||
156949727|NCT02461589|566567783|FG003|Overall Study|Unclassified|0|||
156949728|NCT02461589|566567784|FG004|Overall Study|Unclassified|0|||
156949729|NCT02461589|566567785|FG005|Overall Study|Unclassified|0|||
156949730|NCT02461589|566567786|FG006|Overall Study|Unclassified|1|||
156949731|NCT02461589|566567787|FG007|Overall Study|Unclassified|0|||
156949732|NCT02461589|566567788|FG008|Overall Study|Unclassified|0|||
156949733|NCT02461589|566567789|FG009|Overall Study|Unclassified|2|||
156949734|NCT02461589|566567780|FG000|Overall Study|Missing follow-up information|1|||
156949735|NCT02461589|566567781|FG001|Overall Study|Missing follow-up information|1|||
156949736|NCT02461589|566567782|FG002|Overall Study|Missing follow-up information|0|||
156949737|NCT02461589|566567783|FG003|Overall Study|Missing follow-up information|0|||
156949738|NCT02461589|566567784|FG004|Overall Study|Missing follow-up information|0|||
156949739|NCT02461589|566567785|FG005|Overall Study|Missing follow-up information|0|||
157168087|NCT02648724|567355937|FG002|Overall Study|Other reason (unknown)|0|||
157168088|NCT02648724|567355938|FG003|Overall Study|Other reason (unknown)|0|||
156949740|NCT02461589|566567786|FG006|Overall Study|Missing follow-up information|1|||
156949741|NCT02461589|566567787|FG007|Overall Study|Missing follow-up information|0|||
156949742|NCT02461589|566567788|FG008|Overall Study|Missing follow-up information|0|||
156949743|NCT02461589|566567789|FG009|Overall Study|Missing follow-up information|0|||
156949744|NCT02461589|566567780|FG000|Overall Study|Withdrawal from trial before exposure|0|||
156949745|NCT02461589|566567781|FG001|Overall Study|Withdrawal from trial before exposure|0|||
156949746|NCT02461589|566567782|FG002|Overall Study|Withdrawal from trial before exposure|0|||
157168089|NCT02648724|567355939|FG004|Overall Study|Other reason (unknown)|0|||
156949747|NCT02461589|566567783|FG003|Overall Study|Withdrawal from trial before exposure|0|||
157168090|NCT02648724|567355940|FG005|Overall Study|Other reason (unknown)|0|||
157168091|NCT02648724|567355941|FG006|Overall Study|Other reason (unknown)|0|||
157168092|NCT02648724|567355935|FG000|Overall Study|Protocol Violation|0|||
157168093|NCT02648724|567355936|FG001|Overall Study|Protocol Violation|0|||
157168094|NCT02648724|567355937|FG002|Overall Study|Protocol Violation|0|||
157168095|NCT02648724|567355938|FG003|Overall Study|Protocol Violation|0|||
157168096|NCT02648724|567355939|FG004|Overall Study|Protocol Violation|1|||
157168097|NCT02648724|567355940|FG005|Overall Study|Protocol Violation|0|||
157168098|NCT02648724|567355941|FG006|Overall Study|Protocol Violation|0|||
157168099|NCT02648724|567355935|FG000|Overall Study|Death|0|||
157168100|NCT02648724|567355936|FG001|Overall Study|Death|0|||
157168101|NCT02648724|567355937|FG002|Overall Study|Death|0|||
157168102|NCT02648724|567355938|FG003|Overall Study|Death|0|||
157168103|NCT02648724|567355939|FG004|Overall Study|Death|0|||
157168104|NCT02648724|567355940|FG005|Overall Study|Death|0|||
157168105|NCT02648724|567355941|FG006|Overall Study|Death|3|||
157168106|NCT02648724|567355935|FG000|Overall Study|Physician Decision|0|||
157168107|NCT02648724|567355936|FG001|Overall Study|Physician Decision|0|||
157168108|NCT02648724|567355937|FG002|Overall Study|Physician Decision|0|||
157168109|NCT02648724|567355938|FG003|Overall Study|Physician Decision|0|||
157168110|NCT02648724|567355939|FG004|Overall Study|Physician Decision|1|||
157168111|NCT02648724|567355940|FG005|Overall Study|Physician Decision|0|||
157168112|NCT02648724|567355941|FG006|Overall Study|Physician Decision|1|||
157168113|NCT02648724|567355935|FG000|Overall Study|Transferred to named patient program|0|||
157168114|NCT02648724|567355936|FG001|Overall Study|Transferred to named patient program|0|||
157168115|NCT02648724|567355937|FG002|Overall Study|Transferred to named patient program|0|||
157168116|NCT02648724|567355938|FG003|Overall Study|Transferred to named patient program|0|||
157168117|NCT02648724|567355939|FG004|Overall Study|Transferred to named patient program|0|||
157168118|NCT02648724|567355940|FG005|Overall Study|Transferred to named patient program|1|||
157168119|NCT02648724|567355941|FG006|Overall Study|Transferred to named patient program|0|||
157168120|NCT00302718|567355943|FG000|Overall Study|Participant left the hospital|1|||
157168121|NCT00302718|567355944|FG001|Overall Study|Participant left the hospital|0|||
157168122|NCT00302718|567355945|FG002|Overall Study|Participant left the hospital|0|||
157168123|NCT00302718|567355946|FG003|Overall Study|Participant left the hospital|1|||
157168124|NCT00302718|567355943|FG000|Overall Study|Withdrawal by Subject|0|||
157168125|NCT00302718|567355944|FG001|Overall Study|Withdrawal by Subject|1|||
157168126|NCT00302718|567355945|FG002|Overall Study|Withdrawal by Subject|0|||
157168127|NCT00302718|567355946|FG003|Overall Study|Withdrawal by Subject|0|||
157168128|NCT00302718|567355943|FG000|Overall Study|Participant left primary care setting|0|||
157168129|NCT00302718|567355944|FG001|Overall Study|Participant left primary care setting|0|||
157168130|NCT00302718|567355945|FG002|Overall Study|Participant left primary care setting|2|||
157168131|NCT00302718|567355946|FG003|Overall Study|Participant left primary care setting|1|||
157168132|NCT00632541|567355947|FG000|Overall Study|Adverse Event|7|||
157168133|NCT03250377|567357777|FG000|Overall Study|Adverse Event|2|||
157168134|NCT03250377|567357778|FG001|Overall Study|Adverse Event|4|||
157168135|NCT03250377|567357779|FG002|Overall Study|Adverse Event|0|||
157168136|NCT03250377|567357780|FG003|Overall Study|Adverse Event|4|||
157168137|NCT03250377|567357777|FG000|Overall Study|Lack of Efficacy|5|||
157168138|NCT03250377|567357778|FG001|Overall Study|Lack of Efficacy|14|||
156949748|NCT02461589|566567784|FG004|Overall Study|Withdrawal from trial before exposure|0|||
156949749|NCT02461589|566567785|FG005|Overall Study|Withdrawal from trial before exposure|0|||
156949750|NCT02461589|566567786|FG006|Overall Study|Withdrawal from trial before exposure|0|||
156949751|NCT02461589|566567787|FG007|Overall Study|Withdrawal from trial before exposure|0|||
156949752|NCT02461589|566567788|FG008|Overall Study|Withdrawal from trial before exposure|0|||
156949753|NCT02461589|566567789|FG009|Overall Study|Withdrawal from trial before exposure|1|||
156949754|NCT03295201|566567791|FG000|Overall Study|Lost to Follow-up|1|||
156949755|NCT03295201|566567792|FG001|Overall Study|Lost to Follow-up|1|||
156949756|NCT03295201|566567791|FG000|Overall Study|Hospital admission|0|||
156949757|NCT03295201|566567792|FG001|Overall Study|Hospital admission|1|||
156949758|NCT01831089|566567793|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
157168139|NCT03250377|567357779|FG002|Overall Study|Lack of Efficacy|1|||
157168140|NCT03250377|567357780|FG003|Overall Study|Lack of Efficacy|3|||
157168141|NCT03250377|567357777|FG000|Overall Study|Protocol Violation|0|||
157168142|NCT03250377|567357778|FG001|Overall Study|Protocol Violation|2|||
157168143|NCT03250377|567357779|FG002|Overall Study|Protocol Violation|0|||
157168144|NCT03250377|567357780|FG003|Overall Study|Protocol Violation|1|||
157168145|NCT03250377|567357777|FG000|Overall Study|Lost to Follow-up|0|||
157168146|NCT03250377|567357778|FG001|Overall Study|Lost to Follow-up|1|||
157168147|NCT03250377|567357779|FG002|Overall Study|Lost to Follow-up|0|||
157168148|NCT03250377|567357780|FG003|Overall Study|Lost to Follow-up|0|||
157168149|NCT03250377|567357777|FG000|Overall Study|Withdrawal by Subject|7|||
157168150|NCT03250377|567357778|FG001|Overall Study|Withdrawal by Subject|7|||
157168151|NCT03250377|567357779|FG002|Overall Study|Withdrawal by Subject|0|||
156949759|NCT01831089|566567794|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
156949760|NCT01831089|566567795|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
157168152|NCT03250377|567357780|FG003|Overall Study|Withdrawal by Subject|4|||
156949761|NCT01831089|566567796|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
157168153|NCT03250377|567357777|FG000|Overall Study|Investigator's Judgment|1|||
157168154|NCT03250377|567357778|FG001|Overall Study|Investigator's Judgment|0|||
157168155|NCT03250377|567357779|FG002|Overall Study|Investigator's Judgment|0|||
157168156|NCT03250377|567357780|FG003|Overall Study|Investigator's Judgment|0|||
157168157|NCT03250377|567357777|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
157168158|NCT03250377|567357778|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
157168159|NCT03250377|567357779|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
156949762|NCT01831089|566567797|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
156949763|NCT01831089|566567798|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
156949764|NCT01831089|566567793|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
156949765|NCT01831089|566567794|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
156949766|NCT01831089|566567795|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
156949767|NCT01831089|566567796|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
156949768|NCT01831089|566567797|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
156949769|NCT01831089|566567798|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
156949770|NCT01831089|566567793|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156949771|NCT01831089|566567794|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
156949772|NCT01831089|566567795|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156949773|NCT01831089|566567796|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156949774|NCT01831089|566567797|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156949775|NCT01831089|566567798|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
156949776|NCT01831089|566567793|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
156949777|NCT01831089|566567794|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
156949778|NCT01831089|566567795|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
156949779|NCT01831089|566567796|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
156949780|NCT01831089|566567797|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
156949781|NCT01831089|566567798|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
156949782|NCT01831089|566567793|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156949783|NCT01831089|566567794|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156949784|NCT01831089|566567795|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
156949785|NCT01831089|566567796|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156949786|NCT01831089|566567797|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156949787|NCT01831089|566567798|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
156949788|NCT01831089|566567793|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
156949789|NCT01831089|566567794|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
156949790|NCT01831089|566567795|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
156949791|NCT01831089|566567796|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
156949792|NCT01831089|566567797|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
156949793|NCT01831089|566567798|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
156949794|NCT01831089|566567793|FG000|Cohort III: Dose Level 3|Global end of study|0|||
156949795|NCT01831089|566567794|FG001|Cohort III: Dose Level 3|Global end of study|0|||
156949796|NCT01831089|566567795|FG002|Cohort III: Dose Level 3|Global end of study|1|||
156949797|NCT01831089|566567796|FG003|Cohort III: Dose Level 3|Global end of study|0|||
156949798|NCT01831089|566567797|FG004|Cohort III: Dose Level 3|Global end of study|0|||
156949799|NCT01831089|566567798|FG005|Cohort III: Dose Level 3|Global end of study|0|||
156949800|NCT01831089|566567793|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
156949801|NCT01831089|566567794|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
156949802|NCT01831089|566567795|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
156949803|NCT01831089|566567796|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
156949804|NCT01831089|566567797|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
156949805|NCT01831089|566567798|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
156949806|NCT01831089|566567793|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
156949807|NCT01831089|566567794|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
156949808|NCT01831089|566567795|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
156949809|NCT01831089|566567796|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
156949810|NCT01831089|566567797|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
156949811|NCT01831089|566567798|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
156949812|NCT01831089|566567793|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156949813|NCT01831089|566567794|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156949814|NCT01831089|566567795|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156949815|NCT01831089|566567796|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156949816|NCT01831089|566567797|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
156949817|NCT01831089|566567798|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
156949818|NCT01831089|566567793|FG000|Cohort V: Dose Level 5|Death|0|||
156949819|NCT01831089|566567794|FG001|Cohort V: Dose Level 5|Death|0|||
156949820|NCT01831089|566567795|FG002|Cohort V: Dose Level 5|Death|0|||
156949821|NCT01831089|566567796|FG003|Cohort V: Dose Level 5|Death|0|||
156949822|NCT01831089|566567797|FG004|Cohort V: Dose Level 5|Death|1|||
156949823|NCT01831089|566567798|FG005|Cohort V: Dose Level 5|Death|0|||
157168160|NCT03250377|567357780|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
157205221|NCT03669640|567496075|FG002|Overall Study|Death|1|||
156949824|NCT01831089|566567793|FG000|Cohort V: Dose Level 5|Global end of study|0|||
157034647|NCT04908930|566884521|FG002|Overall Study|Withdrawal by Subject|0|||
157034648|NCT04908930|566884522|FG003|Overall Study|Withdrawal by Subject|0|||
157034649|NCT04908930|566884523|FG004|Overall Study|Withdrawal by Subject|0|||
157034650|NCT04908930|566884519|FG000|Overall Study|parent not liking program|0|||
157034651|NCT04908930|566884520|FG001|Overall Study|parent not liking program|1|||
157034652|NCT04908930|566884521|FG002|Overall Study|parent not liking program|0|||
157034653|NCT04908930|566884522|FG003|Overall Study|parent not liking program|0|||
157034654|NCT04908930|566884523|FG004|Overall Study|parent not liking program|0|||
157034655|NCT03248479|566884524|FG000|Overall Study|Death|12|||
157034656|NCT03248479|566884525|FG001|Overall Study|Death|44|||
157034657|NCT03248479|566884526|FG002|Overall Study|Death|1|||
156949825|NCT01831089|566567794|FG001|Cohort V: Dose Level 5|Global end of study|0|||
156949826|NCT01831089|566567795|FG002|Cohort V: Dose Level 5|Global end of study|0|||
156949827|NCT01831089|566567796|FG003|Cohort V: Dose Level 5|Global end of study|0|||
156949828|NCT01831089|566567797|FG004|Cohort V: Dose Level 5|Global end of study|2|||
156949829|NCT01831089|566567798|FG005|Cohort V: Dose Level 5|Global end of study|0|||
156949830|NCT01831089|566567793|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156949831|NCT01831089|566567794|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156949832|NCT01831089|566567795|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156949833|NCT01831089|566567796|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156949834|NCT01831089|566567797|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
156949835|NCT01831089|566567798|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
156949836|NCT01831089|566567793|FG000|Cohort B: Arm B|Progressive disease|0|||
156949837|NCT01831089|566567794|FG001|Cohort B: Arm B|Progressive disease|0|||
156949838|NCT01831089|566567795|FG002|Cohort B: Arm B|Progressive disease|0|||
156949839|NCT01831089|566567796|FG003|Cohort B: Arm B|Progressive disease|0|||
156949840|NCT01831089|566567797|FG004|Cohort B: Arm B|Progressive disease|0|||
156949841|NCT01831089|566567798|FG005|Cohort B: Arm B|Progressive disease|8|||
156949842|NCT01831089|566567793|FG000|Cohort B: Arm B|Physician Decision|0|||
156949843|NCT01831089|566567794|FG001|Cohort B: Arm B|Physician Decision|0|||
156949844|NCT01831089|566567795|FG002|Cohort B: Arm B|Physician Decision|0|||
156949845|NCT01831089|566567796|FG003|Cohort B: Arm B|Physician Decision|0|||
156949846|NCT01831089|566567797|FG004|Cohort B: Arm B|Physician Decision|0|||
156949847|NCT01831089|566567798|FG005|Cohort B: Arm B|Physician Decision|2|||
156949848|NCT01831089|566567793|FG000|Cohort B: Arm B|Never treated|0|||
156949849|NCT01831089|566567794|FG001|Cohort B: Arm B|Never treated|0|||
156949850|NCT01831089|566567795|FG002|Cohort B: Arm B|Never treated|0|||
156949851|NCT01831089|566567796|FG003|Cohort B: Arm B|Never treated|0|||
156949852|NCT01831089|566567797|FG004|Cohort B: Arm B|Never treated|0|||
156949853|NCT01831089|566567798|FG005|Cohort B: Arm B|Never treated|2|||
156949854|NCT01831089|566567793|FG000|Cohort B: Arm B|Adverse Event|0|||
156949855|NCT01831089|566567794|FG001|Cohort B: Arm B|Adverse Event|0|||
156949856|NCT01831089|566567795|FG002|Cohort B: Arm B|Adverse Event|0|||
156949857|NCT01831089|566567796|FG003|Cohort B: Arm B|Adverse Event|0|||
156949858|NCT01831089|566567797|FG004|Cohort B: Arm B|Adverse Event|0|||
156949859|NCT01831089|566567798|FG005|Cohort B: Arm B|Adverse Event|1|||
156949860|NCT01831089|566567793|FG000|Cohort B: Arm B|Global end of study|0|||
156949861|NCT01831089|566567794|FG001|Cohort B: Arm B|Global end of study|0|||
156949862|NCT01831089|566567795|FG002|Cohort B: Arm B|Global end of study|0|||
156949863|NCT01831089|566567796|FG003|Cohort B: Arm B|Global end of study|0|||
156949864|NCT01831089|566567797|FG004|Cohort B: Arm B|Global end of study|0|||
156949865|NCT01831089|566567798|FG005|Cohort B: Arm B|Global end of study|1|||
156949866|NCT02548962|566567799|FG000|Overall Study|Withdrawal by Subject|1|||
156949867|NCT02548962|566567800|FG001|Overall Study|Withdrawal by Subject|0|||
156949868|NCT00096941|566567803|FG000|Overall Study|disease progression|3|||
156949869|NCT05061446|566567807|FG000|Overall Study|Adverse Event|2|||
156949870|NCT05061446|566567808|FG001|Overall Study|Adverse Event|0|||
156949871|NCT05061446|566567809|FG002|Overall Study|Adverse Event|0|||
156949872|NCT05061446|566567807|FG000|Overall Study|Participant no longer available due to personal reason|0|||
156949873|NCT05061446|566567808|FG001|Overall Study|Participant no longer available due to personal reason|1|||
156949874|NCT05061446|566567809|FG002|Overall Study|Participant no longer available due to personal reason|0|||
156949875|NCT04111497|566567810|FG000|Overall Study|relapse of primary disease|1|||
156949876|NCT04111497|566567810|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
156949877|NCT01993719|566567813|FG000|First Drug Administration|Not treated|1|||
156949878|NCT01993719|566567814|FG001|First Drug Administration|Not treated|0|||
156949879|NCT01993719|566567815|FG002|First Drug Administration|Not treated|0|||
156949880|NCT01993719|566567816|FG003|First Drug Administration|Not treated|0|||
156949881|NCT01993719|566567817|FG004|First Drug Administration|Not treated|0|||
156949882|NCT05857527|566567820|FG000|Overall Study|Withdrawal by Subject|0|||
156949883|NCT05857527|566567821|FG001|Overall Study|Withdrawal by Subject|1|||
157034658|NCT03248479|566884527|FG003|Overall Study|Death|72|||
157034659|NCT03248479|566884528|FG004|Overall Study|Death|17|||
157034660|NCT03248479|566884529|FG005|Overall Study|Death|6|||
157034661|NCT03248479|566884530|FG006|Overall Study|Death|1|||
157034662|NCT03248479|566884531|FG007|Overall Study|Death|14|||
157034663|NCT03248479|566884532|FG008|Overall Study|Death|3|||
157034664|NCT03248479|566884533|FG009|Overall Study|Death|7|||
157034665|NCT03248479|566884534|FG010|Overall Study|Death|3|||
157034666|NCT03248479|566884535|FG011|Overall Study|Death|1|||
157034667|NCT03248479|566884536|FG012|Overall Study|Death|1|||
157034668|NCT03248479|566884524|FG000|Overall Study|Study terminated by sponsor|12|||
157034669|NCT03248479|566884525|FG001|Overall Study|Study terminated by sponsor|15|||
157034670|NCT03248479|566884526|FG002|Overall Study|Study terminated by sponsor|0|||
157034671|NCT03248479|566884527|FG003|Overall Study|Study terminated by sponsor|5|||
157034672|NCT03248479|566884528|FG004|Overall Study|Study terminated by sponsor|0|||
157034673|NCT03248479|566884529|FG005|Overall Study|Study terminated by sponsor|0|||
157034674|NCT03248479|566884530|FG006|Overall Study|Study terminated by sponsor|0|||
157034675|NCT03248479|566884531|FG007|Overall Study|Study terminated by sponsor|1|||
157034676|NCT03248479|566884532|FG008|Overall Study|Study terminated by sponsor|1|||
157034677|NCT03248479|566884533|FG009|Overall Study|Study terminated by sponsor|0|||
157034678|NCT03248479|566884534|FG010|Overall Study|Study terminated by sponsor|5|||
157034679|NCT03248479|566884535|FG011|Overall Study|Study terminated by sponsor|4|||
157034680|NCT03248479|566884536|FG012|Overall Study|Study terminated by sponsor|0|||
157034681|NCT03248479|566884524|FG000|Overall Study|Consent withdrawn|6|||
157034682|NCT03248479|566884525|FG001|Overall Study|Consent withdrawn|3|||
157034683|NCT03248479|566884526|FG002|Overall Study|Consent withdrawn|0|||
157034684|NCT03248479|566884527|FG003|Overall Study|Consent withdrawn|9|||
157034685|NCT03248479|566884528|FG004|Overall Study|Consent withdrawn|1|||
157034686|NCT03248479|566884529|FG005|Overall Study|Consent withdrawn|0|||
157034687|NCT03248479|566884530|FG006|Overall Study|Consent withdrawn|0|||
157034688|NCT03248479|566884531|FG007|Overall Study|Consent withdrawn|1|||
157034689|NCT03248479|566884532|FG008|Overall Study|Consent withdrawn|0|||
157034690|NCT03248479|566884533|FG009|Overall Study|Consent withdrawn|3|||
157034691|NCT03248479|566884534|FG010|Overall Study|Consent withdrawn|1|||
157034692|NCT03248479|566884535|FG011|Overall Study|Consent withdrawn|0|||
157034693|NCT03248479|566884536|FG012|Overall Study|Consent withdrawn|1|||
157034694|NCT03248479|566884524|FG000|Overall Study|Lost to Follow-up|2|||
157034695|NCT03248479|566884525|FG001|Overall Study|Lost to Follow-up|1|||
157034696|NCT03248479|566884526|FG002|Overall Study|Lost to Follow-up|0|||
157034697|NCT03248479|566884527|FG003|Overall Study|Lost to Follow-up|0|||
157034698|NCT03248479|566884528|FG004|Overall Study|Lost to Follow-up|0|||
157034699|NCT03248479|566884529|FG005|Overall Study|Lost to Follow-up|0|||
157034700|NCT03248479|566884530|FG006|Overall Study|Lost to Follow-up|0|||
157034701|NCT03248479|566884531|FG007|Overall Study|Lost to Follow-up|0|||
157034702|NCT03248479|566884532|FG008|Overall Study|Lost to Follow-up|0|||
157034703|NCT03248479|566884533|FG009|Overall Study|Lost to Follow-up|0|||
157034704|NCT03248479|566884534|FG010|Overall Study|Lost to Follow-up|0|||
157034705|NCT03248479|566884535|FG011|Overall Study|Lost to Follow-up|0|||
157034706|NCT03248479|566884536|FG012|Overall Study|Lost to Follow-up|1|||
157034707|NCT03248479|566884524|FG000|Overall Study|Not reported|0|||
157034708|NCT03248479|566884525|FG001|Overall Study|Not reported|0|||
157034709|NCT03248479|566884526|FG002|Overall Study|Not reported|0|||
157034710|NCT03248479|566884527|FG003|Overall Study|Not reported|1|||
157034711|NCT03248479|566884528|FG004|Overall Study|Not reported|1|||
157034712|NCT03248479|566884529|FG005|Overall Study|Not reported|0|||
157034713|NCT03248479|566884530|FG006|Overall Study|Not reported|0|||
157034714|NCT03248479|566884531|FG007|Overall Study|Not reported|1|||
157034715|NCT03248479|566884532|FG008|Overall Study|Not reported|1|||
157034716|NCT03248479|566884533|FG009|Overall Study|Not reported|0|||
157034717|NCT03248479|566884534|FG010|Overall Study|Not reported|0|||
157034718|NCT03248479|566884535|FG011|Overall Study|Not reported|0|||
157034719|NCT03248479|566884536|FG012|Overall Study|Not reported|0|||
157034720|NCT02777593|566884539|FG000|Overall Study|Still in study|1|||
157034721|NCT02777593|566884540|FG001|Overall Study|Still in study|32|||
157034722|NCT02777593|566884541|FG002|Overall Study|Still in study|3|||
157034723|NCT02777593|566884542|FG003|Overall Study|Still in study|6|||
157034724|NCT02777593|566884543|FG004|Overall Study|Still in study|5|||
157034725|NCT02777593|566884539|FG000|Overall Study|Death|21|||
157034726|NCT02777593|566884540|FG001|Overall Study|Death|28|||
157034727|NCT02777593|566884541|FG002|Overall Study|Death|0|||
157034728|NCT02777593|566884542|FG003|Overall Study|Death|5|||
157034729|NCT02777593|566884543|FG004|Overall Study|Death|0|||
157034730|NCT02777593|566884539|FG000|Overall Study|Withdrawal by Subject|8|||
157168161|NCT03250377|567357777|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
157168162|NCT03250377|567357778|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
157168163|NCT03250377|567357779|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
157168164|NCT03250377|567357780|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
157168165|NCT03250377|567357777|FG000|Overall Study|Epilepsy Surgery|0|||
157034731|NCT02777593|566884540|FG001|Overall Study|Withdrawal by Subject|4|||
157034732|NCT02777593|566884541|FG002|Overall Study|Withdrawal by Subject|1|||
157034733|NCT02777593|566884542|FG003|Overall Study|Withdrawal by Subject|1|||
157034734|NCT02777593|566884543|FG004|Overall Study|Withdrawal by Subject|0|||
157034735|NCT02777593|566884539|FG000|Overall Study|Lost to Follow-up|8|||
157034736|NCT02777593|566884540|FG001|Overall Study|Lost to Follow-up|16|||
157034737|NCT02777593|566884541|FG002|Overall Study|Lost to Follow-up|5|||
156949884|NCT02799082|566567823|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
156949885|NCT02799082|566567824|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
156949886|NCT02799082|566567823|FG000|Overall Study|Protocol Violation|0|||
156949887|NCT02799082|566567824|FG001|Overall Study|Protocol Violation|1|||
156949888|NCT01592708|566567825|FG000|Overall Study|Protocol Violation|3|||
156949889|NCT01592708|566567826|FG001|Overall Study|Protocol Violation|0|||
156949890|NCT01748994|566567828|FG000|Overall Study|Lost to Follow-up|8|||
156949891|NCT01748994|566567829|FG001|Overall Study|Lost to Follow-up|6|||
156949892|NCT03105362|566567830|FG000|Overall Study|Withdrawal by Subject|1|||
156949893|NCT03105362|566567830|FG000|Overall Study|Lost to Follow-up|1|||
156949894|NCT00861341|566567833|FG000|Overall Study|Withdrawal by Subject|2|||
156949895|NCT01440946|566567834|FG000|Overall Study|Lost to Follow-up|1|||
156949896|NCT01440946|566567835|FG001|Overall Study|Lost to Follow-up|1|||
156949897|NCT01440946|566567834|FG000|Overall Study|Physician Decision|1|||
156949898|NCT01440946|566567835|FG001|Overall Study|Physician Decision|0|||
156949899|NCT01975389|566567836|FG000|Overall Study|Adverse Event|10|||
156949900|NCT01975389|566567837|FG001|Overall Study|Adverse Event|6|||
156949901|NCT01975389|566567836|FG000|Overall Study|Death|61|||
156949902|NCT01975389|566567837|FG001|Overall Study|Death|54|||
156949903|NCT01975389|566567836|FG000|Overall Study|Lost to Follow-up|81|||
156949904|NCT01975389|566567837|FG001|Overall Study|Lost to Follow-up|86|||
156949905|NCT01975389|566567836|FG000|Overall Study|Withdrawal by Subject|90|||
156949906|NCT01975389|566567837|FG001|Overall Study|Withdrawal by Subject|76|||
156949907|NCT01975389|566567836|FG000|Overall Study|Other|6|||
156949908|NCT01975389|566567837|FG001|Overall Study|Other|9|||
156949909|NCT01975389|566567836|FG000|Overall Study|Randomized, not treated|4|||
156949910|NCT01975389|566567837|FG001|Overall Study|Randomized, not treated|5|||
156949911|NCT01312961|566567838|FG000|Overall Study|Adverse Event|3|||
156949912|NCT01312961|566567839|FG001|Overall Study|Adverse Event|3|||
156949913|NCT01312961|566567838|FG000|Overall Study|Lack of Efficacy|11|||
156949914|NCT01312961|566567839|FG001|Overall Study|Lack of Efficacy|1|||
156949915|NCT01312961|566567838|FG000|Overall Study|Poor compliance to protocol|1|||
156949916|NCT01312961|566567839|FG001|Overall Study|Poor compliance to protocol|0|||
156949917|NCT01312961|566567838|FG000|Overall Study|Other than specified above|2|||
156949918|NCT01312961|566567839|FG001|Overall Study|Other than specified above|3|||
156949919|NCT00235989|566567841|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
156949920|NCT00235989|566567842|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
156949921|NCT00235989|566567843|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
156949922|NCT00235989|566567844|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
156949923|NCT00235989|566567845|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
156949924|NCT00235989|566567846|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
156949925|NCT00235989|566567841|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
156949926|NCT00235989|566567842|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
156949927|NCT00235989|566567843|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
156949928|NCT00235989|566567844|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
156949929|NCT00235989|566567845|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
156949930|NCT00235989|566567846|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
156949931|NCT00235989|566567841|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
156949932|NCT00235989|566567842|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156949933|NCT00235989|566567843|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
156949934|NCT00235989|566567844|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156949935|NCT00235989|566567845|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156949936|NCT00235989|566567846|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
156949937|NCT00235989|566567841|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156949938|NCT00235989|566567842|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156949939|NCT00235989|566567843|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
156949940|NCT00235989|566567844|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
156949941|NCT00235989|566567845|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
156949942|NCT00235989|566567846|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
156949943|NCT00235989|566567841|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
156949944|NCT00235989|566567842|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
156949945|NCT00235989|566567843|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
156949946|NCT00235989|566567844|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
156949947|NCT00235989|566567845|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
156949948|NCT00235989|566567846|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
156949949|NCT01337297|566567852|FG000|Overall Study|They entered to single anodal tDCS|4|||
156949950|NCT01337297|566567853|FG001|Overall Study|They entered to single anodal tDCS|3|||
156949951|NCT01337297|566567852|FG000|Overall Study|Lost to Follow-up|1|||
156949952|NCT01337297|566567853|FG001|Overall Study|Lost to Follow-up|3|||
156949953|NCT00360334|566567854|FG000|Overall Study|Adverse Event|7|||
156949954|NCT00360334|566567855|FG001|Overall Study|Adverse Event|4|||
156949955|NCT00360334|566567854|FG000|Overall Study|Protocol Violation|1|||
156949956|NCT00360334|566567855|FG001|Overall Study|Protocol Violation|1|||
156949957|NCT00360334|566567854|FG000|Overall Study|Physician Decision|2|||
157034738|NCT02777593|566884542|FG003|Overall Study|Lost to Follow-up|0|||
157034739|NCT02777593|566884543|FG004|Overall Study|Lost to Follow-up|1|||
157034740|NCT02777593|566884539|FG000|Overall Study|Physician Decision|2|||
157034741|NCT02777593|566884540|FG001|Overall Study|Physician Decision|2|||
157034742|NCT02777593|566884541|FG002|Overall Study|Physician Decision|0|||
157034743|NCT02777593|566884542|FG003|Overall Study|Physician Decision|0|||
157034744|NCT02777593|566884543|FG004|Overall Study|Physician Decision|0|||
157034745|NCT02777593|566884539|FG000|Overall Study|Discontinued due to Other|1|||
157034746|NCT02777593|566884540|FG001|Overall Study|Discontinued due to Other|0|||
157034747|NCT02777593|566884541|FG002|Overall Study|Discontinued due to Other|0|||
157034748|NCT02777593|566884542|FG003|Overall Study|Discontinued due to Other|0|||
157034749|NCT02777593|566884543|FG004|Overall Study|Discontinued due to Other|0|||
157034750|NCT05785130|566884547|FG000|Overall Study|Withdrawal by Subject|1|||
157168166|NCT03250377|567357778|FG001|Overall Study|Epilepsy Surgery|1|||
157168167|NCT03250377|567357779|FG002|Overall Study|Epilepsy Surgery|2|||
156949958|NCT00360334|566567855|FG001|Overall Study|Physician Decision|3|||
156949959|NCT00360334|566567854|FG000|Overall Study|Lack of Efficacy|0|||
156949960|NCT00360334|566567855|FG001|Overall Study|Lack of Efficacy|1|||
156949961|NCT00360334|566567854|FG000|Overall Study|Entry criterion not met|1|||
156949962|NCT00360334|566567855|FG001|Overall Study|Entry criterion not met|2|||
156949963|NCT00360334|566567854|FG000|Overall Study|Subject decision|8|||
156949964|NCT00360334|566567855|FG001|Overall Study|Subject decision|2|||
156949965|NCT00836875|566567860|FG000|Overall Study|Death|3|||
156949966|NCT00836875|566567861|FG001|Overall Study|Death|2|||
156949967|NCT00836875|566567860|FG000|Overall Study|Withdrawal by Subject|0|||
156949968|NCT00836875|566567861|FG001|Overall Study|Withdrawal by Subject|1|||
156977499|NCT02223754|566670721|FG000|Period 1|Test Article No Longer Available|1|||
156977500|NCT02223754|566670722|FG001|Period 1|Test Article No Longer Available|5|||
156977501|NCT02223754|566670721|FG000|Period 1|Unsatisfactory Visual Response|0|||
156977502|NCT02223754|566670722|FG001|Period 1|Unsatisfactory Visual Response|1|||
156977503|NCT02223754|566670721|FG000|Period 2|Adverse Event|0|||
156977504|NCT02223754|566670722|FG001|Period 2|Adverse Event|1|||
156977505|NCT02223754|566670721|FG000|Period 2|Protocol Violation|1|||
156977506|NCT02223754|566670722|FG001|Period 2|Protocol Violation|0|||
156977507|NCT02223754|566670721|FG000|Period 2|Lens Discomfort|1|||
156977508|NCT02223754|566670722|FG001|Period 2|Lens Discomfort|1|||
156977509|NCT02223754|566670721|FG000|Period 2|Lost to Follow-up|1|||
156977510|NCT02223754|566670722|FG001|Period 2|Lost to Follow-up|0|||
156977511|NCT02223754|566670721|FG000|Period 2|Test Article No Longer Available|0|||
156977512|NCT02223754|566670722|FG001|Period 2|Test Article No Longer Available|1|||
156977513|NCT02668016|566670724|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
156977514|NCT02668016|566670724|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
156977515|NCT02668016|566670724|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
156977516|NCT02668016|566670724|FG000|Month 4|Withdrawal due to severe symptoms|1|||
156977517|NCT02668016|566670724|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
156977518|NCT02668016|566670724|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
156977519|NCT02668016|566670724|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
156977520|NCT02668016|566670724|FG000|Month 6|Withdrawal due to severe symptoms|2|||
156977521|NCT02668016|566670724|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
156977522|NCT02668016|566670724|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
156977523|NCT02668016|566670724|FG000|Month 8|Withdrawal due to severe symptoms|1|||
156977524|NCT02668016|566670724|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
156977525|NCT02668016|566670724|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
156977526|NCT02668016|566670724|FG000|Month 10|Withdrawal due to severe symptoms|1|||
156977527|NCT02668016|566670724|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
156977528|NCT01555164|566670736|FG000|Overall Study|Adverse Event|5|||
156977529|NCT01555164|566670737|FG001|Overall Study|Adverse Event|7|||
156977530|NCT01555164|566670736|FG000|Overall Study|Hyperglycemia|0|||
156977531|NCT01555164|566670737|FG001|Overall Study|Hyperglycemia|1|||
156977532|NCT01555164|566670736|FG000|Overall Study|Investigator's Discretion|2|||
156977533|NCT01555164|566670737|FG001|Overall Study|Investigator's Discretion|2|||
156977534|NCT01555164|566670736|FG000|Overall Study|Lost to Follow-up|4|||
157034751|NCT05785130|566884548|FG001|Overall Study|Withdrawal by Subject|0|||
157034752|NCT05785130|566884547|FG000|Overall Study|Lack of Efficacy|0|||
156977535|NCT01555164|566670737|FG001|Overall Study|Lost to Follow-up|3|||
157034753|NCT05785130|566884548|FG001|Overall Study|Lack of Efficacy|1|||
157034754|NCT05215054|566884552|FG000|Overall Study|Lost to Follow-up|1|||
157034755|NCT05215054|566884553|FG001|Overall Study|Lost to Follow-up|1|||
157034756|NCT05215054|566884552|FG000|Overall Study|Protocol Violation|1|||
157034757|NCT05215054|566884553|FG001|Overall Study|Protocol Violation|1|||
157034758|NCT05215054|566884552|FG000|Overall Study|Withdrawal by Subject|4|||
157168168|NCT03250377|567357780|FG003|Overall Study|Epilepsy Surgery|0|||
157168169|NCT03250377|567357777|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
156977536|NCT01555164|566670736|FG000|Overall Study|Protocol Violation|9|||
156949969|NCT01539291|566569711|FG000|Study GS-US-312-0116|Adverse Event|9|||
156949970|NCT01539291|566569712|FG001|Study GS-US-312-0116|Adverse Event|0|||
156949971|NCT01539291|566569713|FG002|Study GS-US-312-0116|Adverse Event|0|||
156949972|NCT01539291|566569714|FG003|Study GS-US-312-0116|Adverse Event|0|||
156949973|NCT01539291|566569711|FG000|Study GS-US-312-0116|Physician Decision|1|||
156949974|NCT01539291|566569712|FG001|Study GS-US-312-0116|Physician Decision|0|||
156949975|NCT01539291|566569713|FG002|Study GS-US-312-0116|Physician Decision|0|||
156949976|NCT01539291|566569714|FG003|Study GS-US-312-0116|Physician Decision|0|||
156949977|NCT01539291|566569711|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
156949978|NCT01539291|566569712|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
156949979|NCT01539291|566569713|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
156949980|NCT01539291|566569714|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
156949981|NCT01539291|566569711|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
156949982|NCT01539291|566569712|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156949983|NCT01539291|566569713|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156949984|NCT01539291|566569714|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
156949985|NCT01539291|566569711|FG000|Study GS-US-312-0116|Other|1|||
156949986|NCT01539291|566569712|FG001|Study GS-US-312-0116|Other|0|||
156949987|NCT01539291|566569713|FG002|Study GS-US-312-0116|Other|0|||
156949988|NCT01539291|566569714|FG003|Study GS-US-312-0116|Other|0|||
156949989|NCT01539291|566569711|FG000|Study GS-US-312-0117|Adverse Event|22|||
156949990|NCT01539291|566569712|FG001|Study GS-US-312-0117|Adverse Event|1|||
156949991|NCT01539291|566569713|FG002|Study GS-US-312-0117|Adverse Event|9|||
156949992|NCT01539291|566569714|FG003|Study GS-US-312-0117|Adverse Event|12|||
156949993|NCT01539291|566569711|FG000|Study GS-US-312-0117|Physician Decision|9|||
156949994|NCT01539291|566569712|FG001|Study GS-US-312-0117|Physician Decision|0|||
156949995|NCT01539291|566569713|FG002|Study GS-US-312-0117|Physician Decision|6|||
156949996|NCT01539291|566569714|FG003|Study GS-US-312-0117|Physician Decision|4|||
156949997|NCT01539291|566569711|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
156949998|NCT01539291|566569712|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
156949999|NCT01539291|566569713|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
156950000|NCT01539291|566569714|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
156950001|NCT01539291|566569711|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
156950002|NCT01539291|566569712|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
156950003|NCT01539291|566569713|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
156950004|NCT01539291|566569714|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
156950005|NCT01539291|566569711|FG000|Study GS-US-312-0117|Other|2|||
156950006|NCT01539291|566569712|FG001|Study GS-US-312-0117|Other|1|||
156950007|NCT01539291|566569713|FG002|Study GS-US-312-0117|Other|1|||
156950008|NCT01539291|566569714|FG003|Study GS-US-312-0117|Other|1|||
156950009|NCT01045447|566569725|FG000|Overall Study|Adverse Event|0|||
156950010|NCT01045447|566569726|FG001|Overall Study|Adverse Event|1|||
156950011|NCT01045447|566569725|FG000|Overall Study|Lack of Efficacy|3|||
156950012|NCT01045447|566569726|FG001|Overall Study|Lack of Efficacy|1|||
156950013|NCT01045447|566569725|FG000|Overall Study|Protocol Violation|6|||
156950014|NCT01045447|566569726|FG001|Overall Study|Protocol Violation|3|||
156950015|NCT01045447|566569725|FG000|Overall Study|Withdrawal Criteria|10|||
156950016|NCT01045447|566569726|FG001|Overall Study|Withdrawal Criteria|10|||
156950017|NCT01045447|566569725|FG000|Overall Study|Unclassified|17|||
156950018|NCT01045447|566569726|FG001|Overall Study|Unclassified|13|||
156950019|NCT00129987|566569727|FG000|1st Educational Session|Withdrawal by Subject|141|||
156950020|NCT00129987|566569728|FG001|1st Educational Session|Withdrawal by Subject|109|||
156950021|NCT00129987|566569727|FG000|1 Year|Withdrawal by Subject|32|||
156950022|NCT00129987|566569728|FG001|1 Year|Withdrawal by Subject|21|||
156950023|NCT00116805|566569729|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
156950024|NCT00116805|566569730|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
156950025|NCT00116805|566569729|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
157168170|NCT03250377|567357778|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
157168171|NCT03250377|567357779|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
156950026|NCT00116805|566569730|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
156950027|NCT00116805|566569729|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
157168172|NCT03250377|567357780|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
157168173|NCT03250377|567357777|FG000|Overall Study|Request From The Sponsor|0|||
157168174|NCT03250377|567357778|FG001|Overall Study|Request From The Sponsor|1|||
156950028|NCT00116805|566569730|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
156950029|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
156950030|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
156950031|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
156950032|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
156950033|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
157168175|NCT03250377|567357779|FG002|Overall Study|Request From The Sponsor|0|||
156950034|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
156950035|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
156950036|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
156950037|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
156950038|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
156950039|NCT00116805|566569729|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
156950040|NCT00116805|566569730|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
156950041|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
156950042|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
156950043|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
156950044|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
156950045|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
156950046|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
156950047|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
156950048|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
156950049|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
156950050|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
156950051|NCT00116805|566569729|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
156950052|NCT00116805|566569730|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
156950053|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
156950054|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
156950055|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
156950056|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
156950057|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
156950058|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
156950059|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
156950060|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
156950061|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
156950062|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
156950063|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
156950064|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
156950065|NCT00116805|566569729|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
156950066|NCT00116805|566569730|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
156950067|NCT00116805|566569729|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
156950068|NCT00116805|566569730|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
156950069|NCT00116805|566569729|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
156950070|NCT00116805|566569730|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
156950071|NCT00116805|566569729|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
156950072|NCT00116805|566569730|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
156950073|NCT00116805|566569729|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156950074|NCT00116805|566569730|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156950075|NCT00116805|566569729|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
156950076|NCT00116805|566569730|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
156950077|NCT00116805|566569729|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
156950078|NCT00116805|566569730|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
156950079|NCT00116805|566569729|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
156950080|NCT00116805|566569730|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
156950081|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
156950082|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
156950083|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
156950084|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
156950085|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
156950086|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
156950087|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
156950088|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
156950089|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
156950090|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
156950091|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
156950092|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
156950093|NCT00116805|566569729|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
156950094|NCT00116805|566569730|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
156950095|NCT00116805|566569729|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
157034759|NCT05215054|566884553|FG001|Overall Study|Withdrawal by Subject|4|||
157034760|NCT02933489|566884554|FG000|Overall Study|Ineligible|3|||
157034761|NCT02933489|566884555|FG001|Overall Study|Ineligible|3|||
157034762|NCT02933489|566884554|FG000|Overall Study|Withdrawal by Subject|27|||
156950096|NCT00116805|566569730|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
157168176|NCT03250377|567357780|FG003|Overall Study|Request From The Sponsor|0|||
157168177|NCT03250377|567357777|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
157168178|NCT03250377|567357778|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
157168179|NCT03250377|567357779|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
157168180|NCT03250377|567357780|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
157168181|NCT03250377|567357777|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
156950097|NCT00116805|566569729|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
156950098|NCT00116805|566569730|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
156950099|NCT00116805|566569729|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
156950100|NCT00116805|566569730|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
156950101|NCT00116805|566569729|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
156950102|NCT00116805|566569730|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
156950103|NCT00116805|566569729|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
156950104|NCT00116805|566569730|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
156950105|NCT00116805|566569729|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
156950106|NCT00116805|566569730|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
156950107|NCT00116805|566569729|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
156950108|NCT00116805|566569730|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
156950109|NCT00116805|566569729|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
156950110|NCT00116805|566569730|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
156950111|NCT00116805|566569729|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
156950112|NCT00116805|566569730|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
156950113|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
156950114|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
156950115|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
156950116|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
156950117|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Adverse Event|5|||
156950118|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Adverse Event|3|||
156950119|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Adverse Event|4|||
156950120|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Adverse Event|10|||
156950121|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
156950122|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
156950123|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
156950124|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
156950125|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156950126|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156950127|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
156950128|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
156950129|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Pregnancy|5|||
156950130|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Pregnancy|0|||
156950131|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Pregnancy|3|||
156950132|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Pregnancy|2|||
156950133|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Non-compliance|1|||
156950134|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Non-compliance|4|||
156950135|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Non-compliance|0|||
156950136|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Non-compliance|3|||
156950137|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Other|0|||
156950138|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Other|3|||
156950139|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Other|3|||
156950140|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Other|1|||
156950141|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
156950142|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
156950143|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
156950144|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
156950145|NCT01760954|566569731|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
156950146|NCT01760954|566569732|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
156950147|NCT01760954|566569733|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
156950148|NCT01760954|566569734|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
156950149|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
156950150|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
156950151|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
156950152|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
156950153|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
156950154|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
157168182|NCT03250377|567357778|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
157168183|NCT03250377|567357779|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
156950155|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
156950156|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
156950157|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
156950158|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
156950159|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
156950160|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
156950161|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
156950162|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
156950163|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
156950164|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
156950165|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156950166|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156950167|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
156950168|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
156950169|NCT01760954|566569731|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
156950170|NCT01760954|566569732|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
156950171|NCT01760954|566569733|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
156950172|NCT01760954|566569734|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
156950173|NCT01159938|566569735|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156950174|NCT01159938|566569736|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156950175|NCT01159938|566569737|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
156950176|NCT01159938|566569738|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156950177|NCT01159938|566569739|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
156950178|NCT02318329|566569740|FG000|Overall Study|Progressive Disease|2|||
156950179|NCT02318329|566569741|FG001|Overall Study|Progressive Disease|3|||
156950180|NCT02318329|566569742|FG002|Overall Study|Progressive Disease|2|||
156950181|NCT02318329|566569743|FG003|Overall Study|Progressive Disease|3|||
156950182|NCT02318329|566569744|FG004|Overall Study|Progressive Disease|3|||
156950183|NCT02318329|566569745|FG005|Overall Study|Progressive Disease|3|||
156950184|NCT02318329|566569746|FG006|Overall Study|Progressive Disease|1|||
156950185|NCT02318329|566569747|FG007|Overall Study|Progressive Disease|1|||
156950186|NCT02318329|566569748|FG008|Overall Study|Progressive Disease|5|||
156950187|NCT02318329|566569749|FG009|Overall Study|Progressive Disease|39|||
156950188|NCT02318329|566569740|FG000|Overall Study|Death|0|||
156950189|NCT02318329|566569741|FG001|Overall Study|Death|0|||
156950190|NCT02318329|566569742|FG002|Overall Study|Death|0|||
156950191|NCT02318329|566569743|FG003|Overall Study|Death|0|||
156950192|NCT02318329|566569744|FG004|Overall Study|Death|0|||
156950193|NCT02318329|566569745|FG005|Overall Study|Death|0|||
156950194|NCT02318329|566569746|FG006|Overall Study|Death|0|||
156950195|NCT02318329|566569747|FG007|Overall Study|Death|0|||
156950196|NCT02318329|566569748|FG008|Overall Study|Death|0|||
156950197|NCT02318329|566569749|FG009|Overall Study|Death|5|||
156950198|NCT02318329|566569740|FG000|Overall Study|Lost to Follow-up|0|||
156950199|NCT02318329|566569741|FG001|Overall Study|Lost to Follow-up|0|||
156950200|NCT02318329|566569742|FG002|Overall Study|Lost to Follow-up|0|||
156950201|NCT02318329|566569743|FG003|Overall Study|Lost to Follow-up|0|||
156950202|NCT02318329|566569744|FG004|Overall Study|Lost to Follow-up|0|||
156950203|NCT02318329|566569745|FG005|Overall Study|Lost to Follow-up|0|||
156950204|NCT02318329|566569746|FG006|Overall Study|Lost to Follow-up|0|||
156950205|NCT02318329|566569747|FG007|Overall Study|Lost to Follow-up|0|||
156950206|NCT02318329|566569748|FG008|Overall Study|Lost to Follow-up|0|||
156950207|NCT02318329|566569749|FG009|Overall Study|Lost to Follow-up|1|||
156950208|NCT02318329|566569740|FG000|Overall Study|Withdrawal by Subject|0|||
156950209|NCT02318329|566569741|FG001|Overall Study|Withdrawal by Subject|0|||
156950210|NCT02318329|566569742|FG002|Overall Study|Withdrawal by Subject|0|||
156950211|NCT02318329|566569743|FG003|Overall Study|Withdrawal by Subject|0|||
156950212|NCT02318329|566569744|FG004|Overall Study|Withdrawal by Subject|0|||
156950213|NCT02318329|566569745|FG005|Overall Study|Withdrawal by Subject|0|||
156950214|NCT02318329|566569746|FG006|Overall Study|Withdrawal by Subject|0|||
156950215|NCT02318329|566569747|FG007|Overall Study|Withdrawal by Subject|0|||
156950216|NCT02318329|566569748|FG008|Overall Study|Withdrawal by Subject|0|||
156950217|NCT02318329|566569749|FG009|Overall Study|Withdrawal by Subject|6|||
156950218|NCT02318329|566569740|FG000|Overall Study|Other|1|||
156950219|NCT02318329|566569741|FG001|Overall Study|Other|1|||
156950220|NCT02318329|566569742|FG002|Overall Study|Other|1|||
156950221|NCT02318329|566569743|FG003|Overall Study|Other|0|||
156950222|NCT02318329|566569744|FG004|Overall Study|Other|0|||
156950223|NCT02318329|566569745|FG005|Overall Study|Other|0|||
156950224|NCT02318329|566569746|FG006|Overall Study|Other|0|||
156950225|NCT02318329|566569747|FG007|Overall Study|Other|0|||
156950226|NCT02318329|566569748|FG008|Overall Study|Other|1|||
156950227|NCT02318329|566569749|FG009|Overall Study|Other|1|||
156950228|NCT04837482|566569750|FG000|Period 2|Withdrawal by Subject|0|||
156950229|NCT04837482|566569751|FG001|Period 2|Withdrawal by Subject|1|||
156950230|NCT00581945|566569754|FG000|Overall Study|Adverse Event|4|||
156950231|NCT00581945|566569755|FG001|Overall Study|Adverse Event|4|||
156950232|NCT00581945|566569754|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156950233|NCT00581945|566569755|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156950234|NCT00581945|566569754|FG000|Overall Study|Withdrawal by Subject|2|||
156950235|NCT00581945|566569755|FG001|Overall Study|Withdrawal by Subject|6|||
156950236|NCT00581945|566569754|FG000|Overall Study|Death|1|||
156950237|NCT00581945|566569755|FG001|Overall Study|Death|0|||
156950238|NCT02979535|566569756|FG000|Overall Study|Non compliance with the protocol|78|||
156950239|NCT02979535|566569757|FG001|Overall Study|Non compliance with the protocol|82|||
156950240|NCT02979535|566569756|FG000|Overall Study|Consent withdrawn by participant|11|||
156950241|NCT02979535|566569757|FG001|Overall Study|Consent withdrawn by participant|18|||
156950242|NCT02979535|566569756|FG000|Overall Study|Lost to Follow-up|6|||
156950243|NCT02979535|566569757|FG001|Overall Study|Lost to Follow-up|1|||
156950244|NCT04820673|566569761|FG000|Overall Study|Adverse Event|6|||
156950245|NCT04820673|566569761|FG000|Overall Study|Due to Lack of Effectiveness|1|||
156950246|NCT04820673|566569761|FG000|Overall Study|Pregnancy|1|||
156950247|NCT04820673|566569761|FG000|Overall Study|Voluntary Withdrawal|20|||
156950248|NCT04820673|566569761|FG000|Overall Study|Lost to Follow-up|10|||
156950249|NCT00587587|566569764|FG000|Overall Study|Lost to Follow-up|6|||
156950250|NCT00587587|566569765|FG001|Overall Study|Lost to Follow-up|1|||
156950251|NCT02032901|566569768|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
156950252|NCT02032901|566569769|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
156950253|NCT02032901|566569768|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
156950254|NCT02032901|566569769|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
156950255|NCT00982020|566569770|FG000|Overall Study|Adverse Event|19|||
156950256|NCT00982020|566569771|FG001|Overall Study|Adverse Event|15|||
156950257|NCT00982020|566569770|FG000|Overall Study|Withdrawal by Subject|11|||
156950258|NCT00982020|566569771|FG001|Overall Study|Withdrawal by Subject|14|||
156950259|NCT00982020|566569770|FG000|Overall Study|Lost to Follow-up|5|||
156950260|NCT00982020|566569771|FG001|Overall Study|Lost to Follow-up|11|||
156950261|NCT00982020|566569770|FG000|Overall Study|Lack of Efficacy|10|||
156950262|NCT00982020|566569771|FG001|Overall Study|Lack of Efficacy|4|||
156950263|NCT00982020|566569770|FG000|Overall Study|Parent/Caregiver Decision|5|||
156950264|NCT00982020|566569771|FG001|Overall Study|Parent/Caregiver Decision|5|||
156950265|NCT00982020|566569770|FG000|Overall Study|Treatment Non-compliance|3|||
156950266|NCT00982020|566569771|FG001|Overall Study|Treatment Non-compliance|6|||
156950267|NCT00982020|566569770|FG000|Overall Study|Physician Decision|2|||
156950268|NCT00982020|566569771|FG001|Overall Study|Physician Decision|5|||
156950269|NCT00982020|566569770|FG000|Overall Study|Entry Criteria Not Met|2|||
156950270|NCT00982020|566569771|FG001|Overall Study|Entry Criteria Not Met|1|||
156950271|NCT00982020|566569770|FG000|Overall Study|Protocol Violation|0|||
156950272|NCT00982020|566569771|FG001|Overall Study|Protocol Violation|2|||
156950273|NCT00982020|566569770|FG000|Overall Study|Clinical Relapse|0|||
156950274|NCT00982020|566569771|FG001|Overall Study|Clinical Relapse|1|||
156950275|NCT02525133|566569775|FG000|Overall Study|Adverse Event|0|||
156950276|NCT02525133|566569776|FG001|Overall Study|Adverse Event|1|||
156950277|NCT02525133|566569775|FG000|Overall Study|Death|0|||
156950278|NCT02525133|566569776|FG001|Overall Study|Death|1|||
156950279|NCT02525133|566569775|FG000|Overall Study|did not meet randomization criteria|1|||
156950280|NCT02525133|566569776|FG001|Overall Study|did not meet randomization criteria|0|||
156950281|NCT02525133|566569775|FG000|Overall Study|Lost to Follow-up|5|||
156950282|NCT02525133|566569776|FG001|Overall Study|Lost to Follow-up|1|||
156950283|NCT02525133|566569775|FG000|Overall Study|randomized not enrolled|3|||
156950284|NCT02525133|566569776|FG001|Overall Study|randomized not enrolled|0|||
156950285|NCT02525133|566569775|FG000|Overall Study|Withdrawal by Subject|1|||
156950286|NCT02525133|566569776|FG001|Overall Study|Withdrawal by Subject|0|||
156950287|NCT01343082|566569777|FG000|The run-in Period|Not meeting criteria|3|||
156950288|NCT01343082|566569778|FG001|The run-in Period|Not meeting criteria|4|||
156950289|NCT01343082|566569779|FG002|The run-in Period|Not meeting criteria|5|||
156950290|NCT01343082|566569777|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
156950291|NCT01343082|566569778|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
156950292|NCT01343082|566569779|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
156950293|NCT01343082|566569777|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
156950294|NCT01343082|566569778|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
156950295|NCT01343082|566569779|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
156950296|NCT01343082|566569777|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
156950297|NCT01343082|566569778|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
157034763|NCT02933489|566884555|FG001|Overall Study|Withdrawal by Subject|18|||
157034764|NCT02933489|566884554|FG000|Overall Study|Unable to complete exams (other)|14|||
157034765|NCT02933489|566884555|FG001|Overall Study|Unable to complete exams (other)|7|||
156950298|NCT01343082|566569779|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
156950299|NCT01343082|566569777|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
156950300|NCT01343082|566569778|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
156950301|NCT01343082|566569779|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
156950302|NCT01465334|566569782|FG000|Overall Study|Disease Progression|1|||
156950303|NCT01465334|566569783|FG001|Overall Study|Disease Progression|0|||
156950304|NCT01465334|566569782|FG000|Overall Study|Adverse Event|1|||
156950305|NCT01465334|566569783|FG001|Overall Study|Adverse Event|0|||
156950306|NCT01465334|566569782|FG000|Overall Study|Richter's transformation|0|||
156950307|NCT01465334|566569783|FG001|Overall Study|Richter's transformation|3|||
156950308|NCT01465334|566569782|FG000|Overall Study|Refractory Disease|0|||
156950309|NCT01465334|566569783|FG001|Overall Study|Refractory Disease|3|||
156950310|NCT00572572|566569784|FG000|Overall Study|Withdrawal by Subject|3|||
156950311|NCT00572572|566569785|FG001|Overall Study|Withdrawal by Subject|6|||
156950312|NCT01925183|566569791|FG000|Overall Study|Adverse Event|1|||
156950313|NCT01925183|566569792|FG001|Overall Study|Adverse Event|0|||
156950314|NCT01485861|566569799|FG000|Phase Ib|Death|1|||
156950315|NCT01485861|566569800|FG001|Phase Ib|Death|0|||
156950316|NCT01485861|566569801|FG002|Phase Ib|Death|0|||
156950317|NCT01485861|566569802|FG003|Phase Ib|Death|0|||
156950318|NCT01485861|566569803|FG004|Phase Ib|Death|0|||
156950319|NCT01485861|566569804|FG005|Phase Ib|Death|0|||
156950320|NCT01485861|566569799|FG000|Phase Ib|Physician Decision|1|||
156950321|NCT01485861|566569800|FG001|Phase Ib|Physician Decision|1|||
156950322|NCT01485861|566569801|FG002|Phase Ib|Physician Decision|0|||
156950323|NCT01485861|566569802|FG003|Phase Ib|Physician Decision|0|||
156950324|NCT01485861|566569803|FG004|Phase Ib|Physician Decision|0|||
156950325|NCT01485861|566569804|FG005|Phase Ib|Physician Decision|0|||
156950326|NCT01485861|566569799|FG000|Phase Ib|Adverse Event|0|||
156950327|NCT01485861|566569800|FG001|Phase Ib|Adverse Event|4|||
156950328|NCT01485861|566569801|FG002|Phase Ib|Adverse Event|0|||
156950329|NCT01485861|566569802|FG003|Phase Ib|Adverse Event|0|||
156950330|NCT01485861|566569803|FG004|Phase Ib|Adverse Event|0|||
156950331|NCT01485861|566569804|FG005|Phase Ib|Adverse Event|0|||
156950332|NCT01485861|566569799|FG000|Phase Ib|Progression of disease|5|||
156950333|NCT01485861|566569800|FG001|Phase Ib|Progression of disease|0|||
156950334|NCT01485861|566569801|FG002|Phase Ib|Progression of disease|0|||
156950335|NCT01485861|566569802|FG003|Phase Ib|Progression of disease|0|||
156950336|NCT01485861|566569803|FG004|Phase Ib|Progression of disease|0|||
156950337|NCT01485861|566569804|FG005|Phase Ib|Progression of disease|0|||
156950338|NCT01485861|566569799|FG000|Phase Ib|Other|3|||
156950339|NCT01485861|566569800|FG001|Phase Ib|Other|0|||
156950340|NCT01485861|566569801|FG002|Phase Ib|Other|0|||
156950341|NCT01485861|566569802|FG003|Phase Ib|Other|0|||
156950342|NCT01485861|566569803|FG004|Phase Ib|Other|0|||
156950343|NCT01485861|566569804|FG005|Phase Ib|Other|0|||
156950344|NCT01485861|566569799|FG000|Phase Ib|Withdrawal by Subject|4|||
156950345|NCT01485861|566569800|FG001|Phase Ib|Withdrawal by Subject|1|||
156950346|NCT01485861|566569801|FG002|Phase Ib|Withdrawal by Subject|0|||
156950347|NCT01485861|566569802|FG003|Phase Ib|Withdrawal by Subject|0|||
156950348|NCT01485861|566569803|FG004|Phase Ib|Withdrawal by Subject|0|||
156950349|NCT01485861|566569804|FG005|Phase Ib|Withdrawal by Subject|0|||
156950350|NCT01485861|566569799|FG000|Phase II|Death|0|||
156950351|NCT01485861|566569800|FG001|Phase II|Death|0|||
156950352|NCT01485861|566569801|FG002|Phase II|Death|67|||
156950353|NCT01485861|566569802|FG003|Phase II|Death|71|||
156950354|NCT01485861|566569803|FG004|Phase II|Death|68|||
156950355|NCT01485861|566569804|FG005|Phase II|Death|0|||
156950356|NCT01485861|566569799|FG000|Phase II|Progression of Disease|0|||
156950357|NCT01485861|566569800|FG001|Phase II|Progression of Disease|0|||
156950358|NCT01485861|566569801|FG002|Phase II|Progression of Disease|1|||
156950359|NCT01485861|566569802|FG003|Phase II|Progression of Disease|0|||
156950360|NCT01485861|566569803|FG004|Phase II|Progression of Disease|0|||
156950361|NCT01485861|566569804|FG005|Phase II|Progression of Disease|0|||
156950362|NCT01485861|566569799|FG000|Phase II|Other|0|||
156950363|NCT01485861|566569800|FG001|Phase II|Other|0|||
156950364|NCT01485861|566569801|FG002|Phase II|Other|0|||
156950365|NCT01485861|566569802|FG003|Phase II|Other|1|||
156950366|NCT01485861|566569803|FG004|Phase II|Other|0|||
156950367|NCT01485861|566569804|FG005|Phase II|Other|0|||
156950368|NCT01485861|566569799|FG000|Phase II|Withdrawal by Subject|0|||
156950369|NCT01485861|566569800|FG001|Phase II|Withdrawal by Subject|0|||
156950370|NCT01485861|566569801|FG002|Phase II|Withdrawal by Subject|6|||
156950371|NCT01485861|566569802|FG003|Phase II|Withdrawal by Subject|3|||
156950372|NCT01485861|566569803|FG004|Phase II|Withdrawal by Subject|4|||
157205222|NCT03669640|567496076|FG003|Overall Study|Death|0|||
156950373|NCT01485861|566569804|FG005|Phase II|Withdrawal by Subject|0|||
156950374|NCT01485861|566569799|FG000|Phase II|Lost to Follow-up|0|||
156950375|NCT01485861|566569800|FG001|Phase II|Lost to Follow-up|0|||
156950376|NCT01485861|566569801|FG002|Phase II|Lost to Follow-up|2|||
156950377|NCT01485861|566569802|FG003|Phase II|Lost to Follow-up|3|||
156950378|NCT01485861|566569803|FG004|Phase II|Lost to Follow-up|5|||
156950379|NCT01485861|566569804|FG005|Phase II|Lost to Follow-up|0|||
156950380|NCT01485861|566569799|FG000|Phase II|Study Ended|0|||
156950381|NCT01485861|566569800|FG001|Phase II|Study Ended|0|||
156950382|NCT01485861|566569801|FG002|Phase II|Study Ended|7|||
156950383|NCT01485861|566569802|FG003|Phase II|Study Ended|8|||
156950384|NCT01485861|566569803|FG004|Phase II|Study Ended|6|||
156950385|NCT01485861|566569804|FG005|Phase II|Study Ended|0|||
156950386|NCT01485861|566569799|FG000|Safety Phase|Death|0|||
157034766|NCT05485935|566884556|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
157034767|NCT05485935|566884557|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
157034768|NCT05485935|566884556|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
157034769|NCT05485935|566884557|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
157034770|NCT05485935|566884556|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
157034771|NCT05485935|566884557|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
157034772|NCT05485935|566884556|FG000|Period 2 (T2 and V3)|loss of contact|0|||
157034773|NCT05485935|566884557|FG001|Period 2 (T2 and V3)|loss of contact|1|||
157034774|NCT04626427|566884558|FG000|Overall Study|Death|1|||
157034775|NCT04626427|566884558|FG000|Overall Study|Withdrawal by Subject|1|||
157034776|NCT04626427|566884558|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
157034777|NCT04626427|566884558|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
157034778|NCT03982186|566884559|FG000|Overall Study|Lost to Follow-up|0|||
157034779|NCT03982186|566884560|FG001|Overall Study|Lost to Follow-up|1|||
157034780|NCT03982186|566884561|FG002|Overall Study|Lost to Follow-up|2|||
157034781|NCT03982186|566884562|FG003|Overall Study|Lost to Follow-up|1|||
157034782|NCT03982186|566884563|FG004|Overall Study|Lost to Follow-up|1|||
157034783|NCT03982186|566884564|FG005|Overall Study|Lost to Follow-up|0|||
157034784|NCT03982186|566884559|FG000|Overall Study|Physician Decision|0|||
157034785|NCT03982186|566884560|FG001|Overall Study|Physician Decision|1|||
157034786|NCT03982186|566884561|FG002|Overall Study|Physician Decision|0|||
157034787|NCT03982186|566884562|FG003|Overall Study|Physician Decision|0|||
157034788|NCT03982186|566884563|FG004|Overall Study|Physician Decision|0|||
157034789|NCT03982186|566884564|FG005|Overall Study|Physician Decision|0|||
157034790|NCT03982186|566884559|FG000|Overall Study|Withdrawal by Subject|3|||
157034791|NCT03982186|566884560|FG001|Overall Study|Withdrawal by Subject|4|||
157034792|NCT03982186|566884561|FG002|Overall Study|Withdrawal by Subject|1|||
157034793|NCT03982186|566884562|FG003|Overall Study|Withdrawal by Subject|7|||
157034794|NCT03982186|566884563|FG004|Overall Study|Withdrawal by Subject|2|||
157034795|NCT03982186|566884564|FG005|Overall Study|Withdrawal by Subject|0|||
157034796|NCT03982186|566884559|FG000|Overall Study|Randomized and not treated|0|||
157034797|NCT03982186|566884560|FG001|Overall Study|Randomized and not treated|0|||
157034798|NCT03982186|566884561|FG002|Overall Study|Randomized and not treated|0|||
157034799|NCT03982186|566884562|FG003|Overall Study|Randomized and not treated|1|||
157034800|NCT03982186|566884563|FG004|Overall Study|Randomized and not treated|0|||
157034801|NCT03982186|566884564|FG005|Overall Study|Randomized and not treated|0|||
157034802|NCT01265537|566884565|FG000|Overall Study|Adverse Event|2|||
157034803|NCT01265537|566884566|FG001|Overall Study|Adverse Event|1|||
157034804|NCT01265537|566884565|FG000|Overall Study|Physician Decision|0|||
157034805|NCT01265537|566884566|FG001|Overall Study|Physician Decision|1|||
157034806|NCT02720068|566885482|FG000|Overall Study|Adverse Event|0|||
157034807|NCT02720068|566885483|FG001|Overall Study|Adverse Event|0|||
157034808|NCT02720068|566885484|FG002|Overall Study|Adverse Event|0|||
157034809|NCT02720068|566885485|FG003|Overall Study|Adverse Event|0|||
157034810|NCT02720068|566885486|FG004|Overall Study|Adverse Event|0|||
157034811|NCT02720068|566885487|FG005|Overall Study|Adverse Event|0|||
157034812|NCT02720068|566885488|FG006|Overall Study|Adverse Event|0|||
157034813|NCT02720068|566885489|FG007|Overall Study|Adverse Event|0|||
157034814|NCT02720068|566885490|FG008|Overall Study|Adverse Event|0|||
157034815|NCT02720068|566885491|FG009|Overall Study|Adverse Event|0|||
157034816|NCT02720068|566885492|FG010|Overall Study|Adverse Event|0|||
157034817|NCT02720068|566885493|FG011|Overall Study|Adverse Event|1|||
157034818|NCT02720068|566885494|FG012|Overall Study|Adverse Event|0|||
157034819|NCT02720068|566885495|FG013|Overall Study|Adverse Event|0|||
157034820|NCT02720068|566885496|FG014|Overall Study|Adverse Event|0|||
157034821|NCT02720068|566885497|FG015|Overall Study|Adverse Event|0|||
157034822|NCT02720068|566885498|FG016|Overall Study|Adverse Event|0|||
157034823|NCT02720068|566885499|FG017|Overall Study|Adverse Event|0|||
157034824|NCT02720068|566885482|FG000|Overall Study|Death|1|||
157034825|NCT02720068|566885483|FG001|Overall Study|Death|3|||
157034826|NCT02720068|566885484|FG002|Overall Study|Death|2|||
157034827|NCT02720068|566885485|FG003|Overall Study|Death|1|||
157168184|NCT03250377|567357780|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
157168185|NCT03250377|567357777|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
157168186|NCT03250377|567357778|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
157168187|NCT03250377|567357779|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
157034828|NCT02720068|566885486|FG004|Overall Study|Death|2|||
157034829|NCT02720068|566885487|FG005|Overall Study|Death|1|||
157034830|NCT02720068|566885488|FG006|Overall Study|Death|2|||
157034831|NCT02720068|566885489|FG007|Overall Study|Death|2|||
157034832|NCT02720068|566885490|FG008|Overall Study|Death|3|||
157034833|NCT02720068|566885491|FG009|Overall Study|Death|1|||
157034834|NCT02720068|566885492|FG010|Overall Study|Death|20|||
157034835|NCT02720068|566885493|FG011|Overall Study|Death|166|||
157034836|NCT02720068|566885494|FG012|Overall Study|Death|34|||
157034837|NCT02720068|566885495|FG013|Overall Study|Death|30|||
157034838|NCT02720068|566885496|FG014|Overall Study|Death|45|||
157034839|NCT02720068|566885497|FG015|Overall Study|Death|16|||
157034840|NCT02720068|566885498|FG016|Overall Study|Death|20|||
157034841|NCT02720068|566885499|FG017|Overall Study|Death|28|||
157034842|NCT02720068|566885482|FG000|Overall Study|Lost to Follow-up|0|||
157034843|NCT02720068|566885483|FG001|Overall Study|Lost to Follow-up|0|||
157034844|NCT02720068|566885484|FG002|Overall Study|Lost to Follow-up|0|||
157034845|NCT02720068|566885485|FG003|Overall Study|Lost to Follow-up|0|||
157034846|NCT02720068|566885486|FG004|Overall Study|Lost to Follow-up|0|||
157034847|NCT02720068|566885487|FG005|Overall Study|Lost to Follow-up|0|||
157034848|NCT02720068|566885488|FG006|Overall Study|Lost to Follow-up|0|||
157034849|NCT02720068|566885489|FG007|Overall Study|Lost to Follow-up|0|||
157034850|NCT02720068|566885490|FG008|Overall Study|Lost to Follow-up|0|||
157227367|NCT00950807|567577787|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
157227368|NCT00950807|567577788|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
157227369|NCT00950807|567577789|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
157227370|NCT00950807|567577790|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
156950387|NCT01485861|566569800|FG001|Safety Phase|Death|0|||
156950388|NCT01485861|566569801|FG002|Safety Phase|Death|0|||
156950389|NCT01485861|566569802|FG003|Safety Phase|Death|0|||
157034851|NCT02720068|566885491|FG009|Overall Study|Lost to Follow-up|0|||
157034852|NCT02720068|566885492|FG010|Overall Study|Lost to Follow-up|0|||
157034853|NCT02720068|566885493|FG011|Overall Study|Lost to Follow-up|1|||
157034854|NCT02720068|566885494|FG012|Overall Study|Lost to Follow-up|0|||
157034855|NCT02720068|566885495|FG013|Overall Study|Lost to Follow-up|1|||
157034856|NCT02720068|566885496|FG014|Overall Study|Lost to Follow-up|2|||
157034857|NCT02720068|566885497|FG015|Overall Study|Lost to Follow-up|0|||
157034858|NCT02720068|566885498|FG016|Overall Study|Lost to Follow-up|0|||
157034859|NCT02720068|566885499|FG017|Overall Study|Lost to Follow-up|1|||
156950390|NCT01485861|566569803|FG004|Safety Phase|Death|0|||
156950391|NCT01485861|566569804|FG005|Safety Phase|Death|2|||
156950392|NCT01485861|566569799|FG000|Safety Phase|Adverse Event|0|||
156950393|NCT01485861|566569800|FG001|Safety Phase|Adverse Event|0|||
156950394|NCT01485861|566569801|FG002|Safety Phase|Adverse Event|0|||
156950395|NCT01485861|566569802|FG003|Safety Phase|Adverse Event|0|||
156950396|NCT01485861|566569803|FG004|Safety Phase|Adverse Event|0|||
156950397|NCT01485861|566569804|FG005|Safety Phase|Adverse Event|1|||
156950398|NCT01485861|566569799|FG000|Safety Phase|Other|0|||
156950399|NCT01485861|566569800|FG001|Safety Phase|Other|0|||
156950400|NCT01485861|566569801|FG002|Safety Phase|Other|0|||
156950401|NCT01485861|566569802|FG003|Safety Phase|Other|0|||
156950402|NCT01485861|566569803|FG004|Safety Phase|Other|0|||
156950403|NCT01485861|566569804|FG005|Safety Phase|Other|5|||
156950404|NCT01485861|566569799|FG000|Safety Phase|Progression of Disease|0|||
156950405|NCT01485861|566569800|FG001|Safety Phase|Progression of Disease|0|||
156950406|NCT01485861|566569801|FG002|Safety Phase|Progression of Disease|0|||
156950407|NCT01485861|566569802|FG003|Safety Phase|Progression of Disease|0|||
156950408|NCT01485861|566569803|FG004|Safety Phase|Progression of Disease|0|||
156950409|NCT01485861|566569804|FG005|Safety Phase|Progression of Disease|9|||
156950410|NCT01485861|566569799|FG000|Safety Phase|Withdrawal by Subject|0|||
156950411|NCT01485861|566569800|FG001|Safety Phase|Withdrawal by Subject|0|||
156950412|NCT01485861|566569801|FG002|Safety Phase|Withdrawal by Subject|0|||
156950413|NCT01485861|566569802|FG003|Safety Phase|Withdrawal by Subject|0|||
156950414|NCT01485861|566569803|FG004|Safety Phase|Withdrawal by Subject|0|||
156950415|NCT01485861|566569804|FG005|Safety Phase|Withdrawal by Subject|6|||
156950416|NCT01485861|566569799|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
156950417|NCT01485861|566569800|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
156950418|NCT01485861|566569801|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
156950419|NCT01485861|566569802|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
156950420|NCT01485861|566569803|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
156950421|NCT01485861|566569804|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
157034860|NCT02720068|566885482|FG000|Overall Study|Physician Decision|0|||
157034861|NCT02720068|566885483|FG001|Overall Study|Physician Decision|0|||
157034862|NCT02720068|566885484|FG002|Overall Study|Physician Decision|0|||
157034863|NCT02720068|566885485|FG003|Overall Study|Physician Decision|1|||
157034864|NCT02720068|566885486|FG004|Overall Study|Physician Decision|0|||
156950422|NCT02401672|566569805|FG000|Overall Study|Withdrawal by Subject|1|||
156950423|NCT02401672|566569806|FG001|Overall Study|Withdrawal by Subject|3|||
156950424|NCT03056690|566569812|FG000|Overall Study|Adverse Event|3|||
156950425|NCT03056690|566569813|FG001|Overall Study|Adverse Event|2|||
156950426|NCT03056690|566569812|FG000|Overall Study|Lack of Efficacy|1|||
156950427|NCT03056690|566569813|FG001|Overall Study|Lack of Efficacy|2|||
156950428|NCT03056690|566569812|FG000|Overall Study|Lost to Follow-up|3|||
157034865|NCT02720068|566885487|FG005|Overall Study|Physician Decision|0|||
157034866|NCT02720068|566885488|FG006|Overall Study|Physician Decision|0|||
157034867|NCT02720068|566885489|FG007|Overall Study|Physician Decision|0|||
157034868|NCT02720068|566885490|FG008|Overall Study|Physician Decision|0|||
157034869|NCT02720068|566885491|FG009|Overall Study|Physician Decision|0|||
157034870|NCT02720068|566885492|FG010|Overall Study|Physician Decision|0|||
157034871|NCT02720068|566885493|FG011|Overall Study|Physician Decision|1|||
157034872|NCT02720068|566885494|FG012|Overall Study|Physician Decision|0|||
157227371|NCT00950807|567577781|FG000|Washout Period 2|Adverse Event|3|||
157034873|NCT02720068|566885495|FG013|Overall Study|Physician Decision|0|||
157034874|NCT02720068|566885496|FG014|Overall Study|Physician Decision|0|||
157034875|NCT02720068|566885497|FG015|Overall Study|Physician Decision|0|||
156950429|NCT03056690|566569813|FG001|Overall Study|Lost to Follow-up|2|||
157034876|NCT02720068|566885498|FG016|Overall Study|Physician Decision|0|||
157034877|NCT02720068|566885499|FG017|Overall Study|Physician Decision|1|||
157034878|NCT02720068|566885482|FG000|Overall Study|Progressive Disease|2|||
157034879|NCT02720068|566885483|FG001|Overall Study|Progressive Disease|3|||
157034880|NCT02720068|566885484|FG002|Overall Study|Progressive Disease|1|||
157034881|NCT02720068|566885485|FG003|Overall Study|Progressive Disease|1|||
157034882|NCT02720068|566885486|FG004|Overall Study|Progressive Disease|1|||
157034883|NCT02720068|566885487|FG005|Overall Study|Progressive Disease|2|||
157034884|NCT02720068|566885488|FG006|Overall Study|Progressive Disease|1|||
157034885|NCT02720068|566885489|FG007|Overall Study|Progressive Disease|1|||
157034886|NCT02720068|566885490|FG008|Overall Study|Progressive Disease|0|||
157034887|NCT02720068|566885491|FG009|Overall Study|Progressive Disease|1|||
157034888|NCT02720068|566885492|FG010|Overall Study|Progressive Disease|0|||
157034889|NCT02720068|566885493|FG011|Overall Study|Progressive Disease|4|||
157034890|NCT02720068|566885494|FG012|Overall Study|Progressive Disease|1|||
157034891|NCT02720068|566885495|FG013|Overall Study|Progressive Disease|0|||
156950430|NCT03056690|566569812|FG000|Overall Study|Protocol Violation|2|||
156950431|NCT03056690|566569813|FG001|Overall Study|Protocol Violation|2|||
156950432|NCT03056690|566569812|FG000|Overall Study|Withdrawal by Subject|3|||
156950433|NCT03056690|566569813|FG001|Overall Study|Withdrawal by Subject|6|||
156950434|NCT03056690|566569812|FG000|Overall Study|Non-compliance with Study Drug|1|||
156950435|NCT03056690|566569813|FG001|Overall Study|Non-compliance with Study Drug|0|||
156950436|NCT03056690|566569812|FG000|Overall Study|Miscellaneous|1|||
156950437|NCT03056690|566569813|FG001|Overall Study|Miscellaneous|2|||
156950438|NCT02328326|566569818|FG000|Overall Study|Withdrawal by Subject|10|||
156950439|NCT02328326|566569819|FG001|Overall Study|Withdrawal by Subject|3|||
156950440|NCT02328326|566569818|FG000|Overall Study|Death|2|||
156950441|NCT02328326|566569819|FG001|Overall Study|Death|1|||
156950442|NCT02328326|566569818|FG000|Overall Study|Lost to Follow-up|10|||
156950443|NCT02328326|566569819|FG001|Overall Study|Lost to Follow-up|4|||
156950444|NCT02056301|566569820|FG000|Overall Study|Protocol Violation|1|||
156950445|NCT02056301|566569821|FG001|Overall Study|Protocol Violation|2|||
156950446|NCT02056301|566569820|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
156950447|NCT02056301|566569821|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
156950448|NCT02056301|566569820|FG000|Overall Study|Withdrawal by Subject|0|||
156950449|NCT02056301|566569821|FG001|Overall Study|Withdrawal by Subject|1|||
156950450|NCT02056301|566569820|FG000|Overall Study|Issues with epidural|0|||
156950451|NCT02056301|566569821|FG001|Overall Study|Issues with epidural|3|||
156950452|NCT02543346|566569822|FG000|Second Priming Visit|Withdrawal by Subject|0|||
156950453|NCT02543346|566569823|FG001|Second Priming Visit|Withdrawal by Subject|2|||
156950454|NCT02543346|566569824|FG002|Second Priming Visit|Withdrawal by Subject|2|||
156950455|NCT02543346|566569825|FG003|Second Priming Visit|Withdrawal by Subject|2|||
156950456|NCT02543346|566569822|FG000|Second Priming Visit|Adverse Event|1|||
156950457|NCT02543346|566569823|FG001|Second Priming Visit|Adverse Event|0|||
156950458|NCT02543346|566569824|FG002|Second Priming Visit|Adverse Event|0|||
156950459|NCT02543346|566569825|FG003|Second Priming Visit|Adverse Event|0|||
156950460|NCT03433456|566569826|FG000|Overall Study|Death|1|||
156950461|NCT03433456|566569827|FG001|Overall Study|Death|1|||
156950462|NCT03433456|566569826|FG000|Overall Study|Lost to Follow-up|14|||
156950463|NCT03433456|566569827|FG001|Overall Study|Lost to Follow-up|11|||
156950464|NCT03433456|566569826|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
156950465|NCT03433456|566569827|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
157034892|NCT02720068|566885496|FG014|Overall Study|Progressive Disease|0|||
157034893|NCT02720068|566885497|FG015|Overall Study|Progressive Disease|0|||
157034894|NCT02720068|566885498|FG016|Overall Study|Progressive Disease|0|||
157034895|NCT02720068|566885499|FG017|Overall Study|Progressive Disease|0|||
157034896|NCT02720068|566885482|FG000|Overall Study|Sponsor Decision|0|||
157034897|NCT02720068|566885483|FG001|Overall Study|Sponsor Decision|0|||
157034898|NCT02720068|566885484|FG002|Overall Study|Sponsor Decision|0|||
157034899|NCT02720068|566885485|FG003|Overall Study|Sponsor Decision|0|||
156950466|NCT01198600|566569828|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
156950467|NCT01198600|566569829|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
157034900|NCT02720068|566885486|FG004|Overall Study|Sponsor Decision|0|||
157034901|NCT02720068|566885487|FG005|Overall Study|Sponsor Decision|0|||
157034902|NCT02720068|566885488|FG006|Overall Study|Sponsor Decision|0|||
156950468|NCT01198600|566569830|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
156950469|NCT01198600|566569831|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
157034903|NCT02720068|566885489|FG007|Overall Study|Sponsor Decision|0|||
157034904|NCT02720068|566885490|FG008|Overall Study|Sponsor Decision|0|||
157034905|NCT02720068|566885491|FG009|Overall Study|Sponsor Decision|0|||
157034906|NCT02720068|566885492|FG010|Overall Study|Sponsor Decision|0|||
157034907|NCT02720068|566885493|FG011|Overall Study|Sponsor Decision|6|||
157034908|NCT02720068|566885494|FG012|Overall Study|Sponsor Decision|3|||
156950470|NCT01198600|566569828|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
156950471|NCT01198600|566569829|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156950472|NCT01198600|566569830|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156950473|NCT01198600|566569831|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
156950474|NCT01198600|566569828|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156950475|NCT01198600|566569829|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
156950476|NCT01198600|566569830|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156950477|NCT01198600|566569831|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
156950478|NCT01198600|566569828|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
157168188|NCT03250377|567357780|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
157168189|NCT03250377|567357777|FG000|Overall Study|Pregnancy Event|0|||
156950479|NCT01198600|566569829|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
156950480|NCT01198600|566569830|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
156950481|NCT01198600|566569831|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
156950482|NCT01198600|566569828|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
156950483|NCT01198600|566569829|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
156950484|NCT01198600|566569830|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
156950485|NCT01198600|566569831|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
156950486|NCT01198600|566569828|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
156950487|NCT01198600|566569829|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
156950488|NCT01198600|566569830|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
156950489|NCT01198600|566569831|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
156950490|NCT01198600|566569828|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156950491|NCT01198600|566569829|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156950492|NCT01198600|566569830|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
156950493|NCT01198600|566569831|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
156950494|NCT02141516|566569832|FG000|Overall Study|Adverse Event|0|||
156950495|NCT02141516|566569833|FG001|Overall Study|Adverse Event|1|||
156950496|NCT02141516|566569834|FG002|Overall Study|Adverse Event|0|||
156950497|NCT02141516|566569832|FG000|Overall Study|Lost to Follow-up|0|||
156950498|NCT02141516|566569833|FG001|Overall Study|Lost to Follow-up|1|||
156950499|NCT02141516|566569834|FG002|Overall Study|Lost to Follow-up|0|||
156950500|NCT02141516|566569832|FG000|Overall Study|Other|0|||
156950501|NCT02141516|566569833|FG001|Overall Study|Other|3|||
156950502|NCT02141516|566569834|FG002|Overall Study|Other|0|||
156950503|NCT00153101|566569835|FG000|Overall Study|Lost to Follow-up|14|||
156950504|NCT00153101|566569836|FG001|Overall Study|Lost to Follow-up|14|||
156950505|NCT00153101|566569837|FG002|Overall Study|Lost to Follow-up|12|||
156950506|NCT00153101|566569838|FG003|Overall Study|Lost to Follow-up|5|||
156950507|NCT00153101|566569839|FG004|Overall Study|Lost to Follow-up|5|||
156950508|NCT00153101|566569835|FG000|Overall Study|Withdrawal by Subject|3|||
156950509|NCT00153101|566569836|FG001|Overall Study|Withdrawal by Subject|4|||
156950510|NCT00153101|566569837|FG002|Overall Study|Withdrawal by Subject|3|||
156950511|NCT00153101|566569838|FG003|Overall Study|Withdrawal by Subject|3|||
156950512|NCT00153101|566569839|FG004|Overall Study|Withdrawal by Subject|5|||
156950513|NCT03169153|566569840|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156950514|NCT03169153|566569841|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
156950515|NCT03169153|566569840|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
156950516|NCT03169153|566569841|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
156950517|NCT03169153|566569840|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
156950518|NCT03169153|566569841|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
156950519|NCT03169153|566569840|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
156950520|NCT03169153|566569841|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
156950521|NCT02127307|566569844|FG000|Overall Study|Protocol Violation|36|||
156950522|NCT02127307|566569844|FG000|Overall Study|Lost to Follow-up|2|||
156950523|NCT02127307|566569844|FG000|Overall Study|Death|101|||
156950524|NCT02127307|566569844|FG000|Overall Study|Other than specified above|169|||
156950525|NCT03299192|566569845|FG000|Overall Study|Fell before classes started|1|||
156950526|NCT03299192|566569846|FG001|Overall Study|Fell before classes started|0|||
156950527|NCT03299192|566569847|FG002|Overall Study|Fell before classes started|0|||
156950528|NCT03299192|566569845|FG000|Overall Study|Other|0|||
156950529|NCT03299192|566569846|FG001|Overall Study|Other|2|||
156950530|NCT03299192|566569847|FG002|Overall Study|Other|1|||
156950531|NCT00983580|566569853|FG000|Overall Study|Cancel Prior to treatment|1|||
156950532|NCT00983580|566569854|FG001|Overall Study|Cancel Prior to treatment|3|||
156950533|NCT00983580|566569853|FG000|Overall Study|Protocol Violation|1|||
156950534|NCT00983580|566569854|FG001|Overall Study|Protocol Violation|1|||
156950535|NCT00983580|566569853|FG000|Overall Study|Ineligible|3|||
156950536|NCT00983580|566569854|FG001|Overall Study|Ineligible|0|||
156950537|NCT01800903|566569859|FG000|Second Test Period|unable to catheterise|1|||
157168190|NCT03250377|567357778|FG001|Overall Study|Pregnancy Event|1|||
157168191|NCT03250377|567357779|FG002|Overall Study|Pregnancy Event|0|||
156950538|NCT01800903|566569860|FG001|Second Test Period|unable to catheterise|0|||
157168192|NCT03250377|567357780|FG003|Overall Study|Pregnancy Event|0|||
157168193|NCT03250377|567357777|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
157168194|NCT03250377|567357778|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
157168195|NCT03250377|567357779|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
157168196|NCT03250377|567357780|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
156950539|NCT01800903|566569861|FG002|Second Test Period|unable to catheterise|0|||
156950540|NCT01800903|566569862|FG003|Second Test Period|unable to catheterise|0|||
157168197|NCT03250377|567357777|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
157168198|NCT03250377|567357778|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
156950541|NCT01800903|566569863|FG004|Second Test Period|unable to catheterise|0|||
156950542|NCT01800903|566569864|FG005|Second Test Period|unable to catheterise|0|||
156950543|NCT02778204|566569865|FG000|Overall Study|Adverse Event|1|||
156950544|NCT02778204|566569866|FG001|Overall Study|Adverse Event|0|||
156950545|NCT02778204|566569867|FG002|Overall Study|Adverse Event|0|||
156950546|NCT02778204|566569868|FG003|Overall Study|Adverse Event|0|||
156950547|NCT02778204|566569865|FG000|Overall Study|Withdrawal by Subject|0|||
156950548|NCT02778204|566569866|FG001|Overall Study|Withdrawal by Subject|0|||
156950549|NCT02778204|566569867|FG002|Overall Study|Withdrawal by Subject|1|||
156950550|NCT02778204|566569868|FG003|Overall Study|Withdrawal by Subject|2|||
156950551|NCT02778204|566569865|FG000|Overall Study|Lost to Follow-up|1|||
156950552|NCT02778204|566569866|FG001|Overall Study|Lost to Follow-up|0|||
156950553|NCT02778204|566569867|FG002|Overall Study|Lost to Follow-up|2|||
156950554|NCT02778204|566569868|FG003|Overall Study|Lost to Follow-up|1|||
156950555|NCT02778204|566569865|FG000|Overall Study|Protocol Violation|0|||
156950556|NCT02778204|566569866|FG001|Overall Study|Protocol Violation|0|||
156950557|NCT02778204|566569867|FG002|Overall Study|Protocol Violation|1|||
156950558|NCT02778204|566569868|FG003|Overall Study|Protocol Violation|0|||
156950559|NCT02778204|566569865|FG000|Overall Study|Eligibility Violation|0|||
156950560|NCT02778204|566569866|FG001|Overall Study|Eligibility Violation|0|||
156950561|NCT02778204|566569867|FG002|Overall Study|Eligibility Violation|0|||
156950562|NCT02778204|566569868|FG003|Overall Study|Eligibility Violation|1|||
156950563|NCT04122443|566569869|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
156950564|NCT04122443|566569870|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
156950565|NCT04122443|566569871|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
156950566|NCT04122443|566569869|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
156950567|NCT04122443|566569870|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
156950568|NCT04122443|566569871|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
156950569|NCT01072201|566569872|FG000|Overall Study|Lost to Follow-up|0|||
156950570|NCT01072201|566569873|FG001|Overall Study|Lost to Follow-up|1|||
156950571|NCT04382612|566569874|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
156950572|NCT01328002|566569876|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
156950573|NCT01328002|566569877|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
156950574|NCT01328002|566569876|FG000|Open-Label Period|Adverse Event|8|||
156950575|NCT01328002|566569877|FG001|Open-Label Period|Adverse Event|0|||
156950576|NCT01328002|566569876|FG000|Open-Label Period|Lack of Efficacy|3|||
156950577|NCT01328002|566569877|FG001|Open-Label Period|Lack of Efficacy|0|||
156950578|NCT01328002|566569876|FG000|Open-Label Period|Protocol Violation|2|||
156950579|NCT01328002|566569877|FG001|Open-Label Period|Protocol Violation|0|||
156950580|NCT01328002|566569876|FG000|Open-Label Period|Withdrawal by Subject|9|||
156950581|NCT01328002|566569877|FG001|Open-Label Period|Withdrawal by Subject|0|||
156950582|NCT01328002|566569876|FG000|Open-Label Period|Lost to Follow-up|6|||
156950583|NCT01328002|566569877|FG001|Open-Label Period|Lost to Follow-up|0|||
156950584|NCT01328002|566569876|FG000|Open-Label Period|Other Reason|2|||
156950585|NCT01328002|566569877|FG001|Open-Label Period|Other Reason|0|||
156950586|NCT01328002|566569876|FG000|Double-Blind Period|Adverse Event|1|||
156950587|NCT01328002|566569877|FG001|Double-Blind Period|Adverse Event|0|||
156950588|NCT01328002|566569876|FG000|Double-Blind Period|Lack of Efficacy|1|||
156950589|NCT01328002|566569877|FG001|Double-Blind Period|Lack of Efficacy|0|||
156950590|NCT01578551|566569878|FG000|Overall Study|Adverse Event|1|||
156950591|NCT01578551|566569879|FG001|Overall Study|Adverse Event|0|||
156950592|NCT05204134|566569880|FG000|Overall Study|Withdrawal by Subject|3|||
156950593|NCT05204134|566569880|FG000|Overall Study|Physician Decision|1|||
157168199|NCT03250377|567357779|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
157168200|NCT03250377|567357780|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
157168201|NCT03250377|567357777|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
156950594|NCT00061048|566569882|FG000|Overall Study|Adverse Event|2|||
156950595|NCT00061048|566569882|FG000|Overall Study|disease progression|20|||
156950596|NCT01312467|566569883|FG000|Overall Study|Adverse Event|4|||
157168202|NCT03250377|567357778|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
157168203|NCT03250377|567357779|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
156950597|NCT01312467|566569883|FG000|Overall Study|Lost to Follow-up|1|||
156950598|NCT01312467|566569883|FG000|Overall Study|Withdrawal by Subject|2|||
156950599|NCT01312467|566569883|FG000|Overall Study|Deported to country of origin|1|||
157227372|NCT00950807|567577782|FG001|Washout Period 2|Adverse Event|0|||
157227373|NCT00950807|567577783|FG002|Washout Period 2|Adverse Event|0|||
156950600|NCT01312467|566569883|FG000|Overall Study|Another medical condition|1|||
156950601|NCT01312467|566569883|FG000|Overall Study|Ineligible|4|||
156950602|NCT03779841|566569887|FG000|Randomized Population|Did Not Receive Treatment|3|||
156950603|NCT03779841|566569888|FG001|Randomized Population|Did Not Receive Treatment|1|||
156950604|NCT03779841|566569889|FG002|Randomized Population|Did Not Receive Treatment|0|||
156950605|NCT03779841|566569887|FG000|Treated (Safety) Population|Adverse Event|1|||
156950606|NCT03779841|566569888|FG001|Treated (Safety) Population|Adverse Event|1|||
156950607|NCT03779841|566569889|FG002|Treated (Safety) Population|Adverse Event|0|||
156950608|NCT03779841|566569887|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
156950609|NCT03779841|566569888|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
156950610|NCT03779841|566569889|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
156950611|NCT03779841|566569887|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
156950612|NCT03779841|566569888|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
156950613|NCT03779841|566569889|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
156950614|NCT03779841|566569887|FG000|Treated (Safety) Population|Death|1|||
156950615|NCT03779841|566569888|FG001|Treated (Safety) Population|Death|0|||
156950616|NCT03779841|566569889|FG002|Treated (Safety) Population|Death|2|||
156950617|NCT00162136|566569890|FG000|Overall Study|Adverse Event|1|||
156950618|NCT00162136|566569890|FG000|Overall Study|Death|1|||
156950619|NCT00162136|566569890|FG000|Overall Study|Disease Progression/Relapse|23|||
156950620|NCT00162136|566569890|FG000|Overall Study|Investigator Request|5|||
156950621|NCT00162136|566569890|FG000|Overall Study|Study Drug Toxicity|4|||
156950622|NCT00162136|566569890|FG000|Overall Study|Withdrawal by Subject|1|||
156950623|NCT04450264|566572318|FG000|Overall Study|Incomplete survey|13|||
156950624|NCT04450264|566572319|FG001|Overall Study|Incomplete survey|19|||
156950625|NCT00466193|566572322|FG000|Overall Study|Adverse Event|0|||
156950626|NCT00466193|566572323|FG001|Overall Study|Adverse Event|1|||
156950627|NCT00466193|566572322|FG000|Overall Study|Lost to Follow-up|2|||
156950628|NCT00466193|566572323|FG001|Overall Study|Lost to Follow-up|4|||
156950629|NCT00466193|566572322|FG000|Overall Study|Physician Decision|1|||
156950630|NCT00466193|566572323|FG001|Overall Study|Physician Decision|0|||
157034909|NCT02720068|566885495|FG013|Overall Study|Sponsor Decision|2|||
157034910|NCT02720068|566885496|FG014|Overall Study|Sponsor Decision|4|||
157034911|NCT02720068|566885497|FG015|Overall Study|Sponsor Decision|4|||
157034912|NCT02720068|566885498|FG016|Overall Study|Sponsor Decision|0|||
157034913|NCT02720068|566885499|FG017|Overall Study|Sponsor Decision|8|||
157034914|NCT02720068|566885482|FG000|Overall Study|Withdrawal by Subject|0|||
157034915|NCT02720068|566885483|FG001|Overall Study|Withdrawal by Subject|0|||
157034916|NCT02720068|566885484|FG002|Overall Study|Withdrawal by Subject|0|||
157034917|NCT02720068|566885485|FG003|Overall Study|Withdrawal by Subject|0|||
157034918|NCT02720068|566885486|FG004|Overall Study|Withdrawal by Subject|0|||
157034919|NCT02720068|566885487|FG005|Overall Study|Withdrawal by Subject|0|||
157034920|NCT02720068|566885488|FG006|Overall Study|Withdrawal by Subject|0|||
157034921|NCT02720068|566885489|FG007|Overall Study|Withdrawal by Subject|0|||
157034922|NCT02720068|566885490|FG008|Overall Study|Withdrawal by Subject|0|||
157034923|NCT02720068|566885491|FG009|Overall Study|Withdrawal by Subject|1|||
157034924|NCT02720068|566885492|FG010|Overall Study|Withdrawal by Subject|0|||
157034925|NCT02720068|566885493|FG011|Overall Study|Withdrawal by Subject|27|||
157034926|NCT02720068|566885494|FG012|Overall Study|Withdrawal by Subject|2|||
157034927|NCT02720068|566885495|FG013|Overall Study|Withdrawal by Subject|8|||
157034928|NCT02720068|566885496|FG014|Overall Study|Withdrawal by Subject|7|||
157034929|NCT02720068|566885497|FG015|Overall Study|Withdrawal by Subject|0|||
157034930|NCT02720068|566885498|FG016|Overall Study|Withdrawal by Subject|0|||
157034931|NCT02720068|566885499|FG017|Overall Study|Withdrawal by Subject|2|||
157034932|NCT02720068|566885482|FG000|Overall Study|Protocol Violation|0|||
157034933|NCT02720068|566885483|FG001|Overall Study|Protocol Violation|0|||
157034934|NCT02720068|566885484|FG002|Overall Study|Protocol Violation|0|||
157034935|NCT02720068|566885485|FG003|Overall Study|Protocol Violation|0|||
157034936|NCT02720068|566885486|FG004|Overall Study|Protocol Violation|0|||
157034937|NCT02720068|566885487|FG005|Overall Study|Protocol Violation|0|||
157034938|NCT02720068|566885488|FG006|Overall Study|Protocol Violation|0|||
157034939|NCT02720068|566885489|FG007|Overall Study|Protocol Violation|0|||
157034940|NCT02720068|566885490|FG008|Overall Study|Protocol Violation|0|||
157034941|NCT02720068|566885491|FG009|Overall Study|Protocol Violation|0|||
157034942|NCT02720068|566885492|FG010|Overall Study|Protocol Violation|1|||
157034943|NCT02720068|566885493|FG011|Overall Study|Protocol Violation|0|||
156950631|NCT00466193|566572322|FG000|Overall Study|Protocol Violation|1|||
156950632|NCT00466193|566572323|FG001|Overall Study|Protocol Violation|1|||
156950633|NCT00466193|566572322|FG000|Overall Study|Withdrawal by Subject|7|||
157034944|NCT02720068|566885494|FG012|Overall Study|Protocol Violation|0|||
157034945|NCT02720068|566885495|FG013|Overall Study|Protocol Violation|0|||
157034946|NCT02720068|566885496|FG014|Overall Study|Protocol Violation|1|||
157034947|NCT02720068|566885497|FG015|Overall Study|Protocol Violation|0|||
157034948|NCT02720068|566885498|FG016|Overall Study|Protocol Violation|1|||
157034949|NCT02720068|566885499|FG017|Overall Study|Protocol Violation|0|||
157227374|NCT00950807|567577784|FG003|Washout Period 2|Adverse Event|1|||
157168204|NCT03250377|567357780|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
157168205|NCT03250377|567357777|FG000|Overall Study|Patient requested to change hospital|0|||
157168206|NCT03250377|567357778|FG001|Overall Study|Patient requested to change hospital|0|||
157168207|NCT03250377|567357779|FG002|Overall Study|Patient requested to change hospital|0|||
157168208|NCT03250377|567357780|FG003|Overall Study|Patient requested to change hospital|1|||
157168209|NCT03250377|567357777|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
157168210|NCT03250377|567357778|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
157168211|NCT03250377|567357779|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
157168212|NCT03250377|567357780|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
157168213|NCT02168803|567357781|FG000|Overall Study|Lost to Follow-up|1|||
157168214|NCT02168803|567357782|FG001|Overall Study|Lost to Follow-up|0|||
157168215|NCT02168803|567357783|FG002|Overall Study|Lost to Follow-up|1|||
157168216|NCT02168803|567357781|FG000|Overall Study|Withdrawal by Subject|1|||
157168217|NCT02168803|567357782|FG001|Overall Study|Withdrawal by Subject|1|||
157168218|NCT02168803|567357783|FG002|Overall Study|Withdrawal by Subject|2|||
157168219|NCT02168803|567357781|FG000|Overall Study|Physician Decision|0|||
157168220|NCT02168803|567357782|FG001|Overall Study|Physician Decision|1|||
157168221|NCT02168803|567357783|FG002|Overall Study|Physician Decision|0|||
157168222|NCT02168803|567357781|FG000|Overall Study|Adverse Event|0|||
157168223|NCT02168803|567357782|FG001|Overall Study|Adverse Event|1|||
157168224|NCT02168803|567357783|FG002|Overall Study|Adverse Event|1|||
157168225|NCT02168803|567357781|FG000|Overall Study|Death|0|||
157168226|NCT02168803|567357782|FG001|Overall Study|Death|0|||
157168227|NCT02168803|567357783|FG002|Overall Study|Death|1|||
157168228|NCT02168803|567357781|FG000|Overall Study|Sponsor Decision|0|||
157168229|NCT02168803|567357782|FG001|Overall Study|Sponsor Decision|0|||
157168230|NCT02168803|567357783|FG002|Overall Study|Sponsor Decision|1|||
157168231|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
157168232|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
157168233|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
157168234|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
157168235|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
157168236|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
157168237|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
157168238|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
157168239|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
157168240|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
157168241|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
157168242|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
157168243|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
157168244|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
157168245|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
156950634|NCT00466193|566572323|FG001|Overall Study|Withdrawal by Subject|2|||
156950635|NCT00466193|566572322|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
156950636|NCT00466193|566572323|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
156950637|NCT00086346|566572324|FG000|Randomization|Did not receive test article|4|||
156950638|NCT00086346|566572325|FG001|Randomization|Did not receive test article|4|||
156950639|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Adverse Event|94|||
156950640|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Adverse Event|11|||
156950641|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
156950642|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
156950643|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
156950644|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
157034950|NCT04993677|566885501|FG000|Overall Study|Lost to Follow-up|1|||
157168246|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
157168247|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
157168248|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
157168249|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
157168250|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
156950645|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
156950646|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
157034951|NCT04993677|566885502|FG001|Overall Study|Lost to Follow-up|0|||
157168251|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
157168252|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
157168253|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
157168254|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
157168255|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
157168256|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
157168257|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
157205223|NCT03669640|567496077|FG004|Overall Study|Death|0|||
157034952|NCT04993677|566885503|FG002|Overall Study|Lost to Follow-up|0|||
157034953|NCT04993677|566885504|FG003|Overall Study|Lost to Follow-up|0|||
157034954|NCT04993677|566885501|FG000|Overall Study|Death|11|||
157034955|NCT04993677|566885502|FG001|Overall Study|Death|8|||
157034956|NCT04993677|566885503|FG002|Overall Study|Death|3|||
157034957|NCT04993677|566885504|FG003|Overall Study|Death|1|||
157034958|NCT04993677|566885501|FG000|Overall Study|Subject withdrawal of consent|4|||
157034959|NCT04993677|566885502|FG001|Overall Study|Subject withdrawal of consent|3|||
157034960|NCT04993677|566885503|FG002|Overall Study|Subject withdrawal of consent|0|||
157034961|NCT04993677|566885504|FG003|Overall Study|Subject withdrawal of consent|2|||
157034962|NCT04993677|566885501|FG000|Overall Study|Study termination by sponsor|3|||
157034963|NCT04993677|566885502|FG001|Overall Study|Study termination by sponsor|25|||
157034964|NCT04993677|566885503|FG002|Overall Study|Study termination by sponsor|3|||
157034965|NCT04993677|566885504|FG003|Overall Study|Study termination by sponsor|3|||
157034966|NCT04993677|566885501|FG000|Overall Study|Other|2|||
157034967|NCT04993677|566885502|FG001|Overall Study|Other|3|||
157034968|NCT04993677|566885503|FG002|Overall Study|Other|3|||
157034969|NCT04993677|566885504|FG003|Overall Study|Other|2|||
157034970|NCT04664881|566885505|FG000|Overall Study|Withdrawal by Subject|1|||
157034971|NCT04664881|566885506|FG001|Overall Study|Withdrawal by Subject|8|||
157034972|NCT04664881|566885505|FG000|Overall Study|Physician Decision|0|||
157034973|NCT04664881|566885506|FG001|Overall Study|Physician Decision|5|||
157034974|NCT04664881|566885505|FG000|Overall Study|Lost to Follow-up|1|||
157034975|NCT04664881|566885506|FG001|Overall Study|Lost to Follow-up|0|||
157034976|NCT04772534|566885517|FG000|Overall Study|Physician Decision|1|||
157034977|NCT04772534|566885518|FG001|Overall Study|Physician Decision|0|||
157034978|NCT04772534|566885519|FG002|Overall Study|Physician Decision|0|||
157034979|NCT04772534|566885517|FG000|Overall Study|Withdrawal by Subject|3|||
157034980|NCT04772534|566885518|FG001|Overall Study|Withdrawal by Subject|0|||
157034981|NCT04772534|566885519|FG002|Overall Study|Withdrawal by Subject|1|||
157034982|NCT04194450|566885520|FG000|Overall Study|not eligible|1|||
157034983|NCT04194450|566885521|FG001|Overall Study|not eligible|0|||
157034984|NCT05875701|566885530|FG000|Overall Study|Lost to Follow-up|2|||
157034985|NCT05875701|566885531|FG001|Overall Study|Lost to Follow-up|0|||
157034986|NCT05875701|566885530|FG000|Overall Study|Withdrawal by Subject|1|||
157034987|NCT05875701|566885531|FG001|Overall Study|Withdrawal by Subject|1|||
157034988|NCT00308997|566885539|FG000|Overall Study|Subject feigned clinical data|0|||
157168258|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
157168259|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
157168260|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
157168261|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
157168262|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
157168263|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
157168264|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
157168265|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
157168266|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
157168267|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
157168268|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
157168269|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
157227375|NCT00950807|567577785|FG004|Washout Period 2|Adverse Event|0|||
157227376|NCT00950807|567577786|FG005|Washout Period 2|Adverse Event|0|||
157227377|NCT00950807|567577787|FG006|Washout Period 2|Adverse Event|0|||
157227378|NCT00950807|567577788|FG007|Washout Period 2|Adverse Event|0|||
157227379|NCT00950807|567577789|FG008|Washout Period 2|Adverse Event|0|||
157034989|NCT00308997|566885540|FG001|Overall Study|Subject feigned clinical data|1|||
157034990|NCT00308997|566885539|FG000|Overall Study|Unable to tolerate intervention|1|||
157034991|NCT00308997|566885540|FG001|Overall Study|Unable to tolerate intervention|0|||
157227380|NCT00950807|567577790|FG009|Washout Period 2|Adverse Event|0|||
157034992|NCT04490356|566885542|FG000|Overall Study|Lost to Follow-up|1|||
157034993|NCT05836012|566885550|FG000|Overall Study|Lost to Follow-up|1|||
157034994|NCT05836012|566885551|FG001|Overall Study|Lost to Follow-up|0|||
157034995|NCT05836012|566885550|FG000|Overall Study|Withdrawal by Subject|1|||
157034996|NCT05836012|566885551|FG001|Overall Study|Withdrawal by Subject|3|||
157034997|NCT05836012|566885550|FG000|Overall Study|Reason not included in pre-specified categories|2|||
157034998|NCT05836012|566885551|FG001|Overall Study|Reason not included in pre-specified categories|1|||
157034999|NCT03884439|566885552|FG000|Overall Study|No informed consent for publication of study results|38|||
157035000|NCT03884439|566885552|FG000|Overall Study|Contract violation/deficiency|7|||
157035001|NCT04093869|566885553|FG000|Overall Study|Death|0|||
157035002|NCT04093869|566885554|FG001|Overall Study|Death|1|||
157035003|NCT04093869|566885553|FG000|Overall Study|Withdrawal by Subject|1|||
157168270|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
157227381|NCT00950807|567577781|FG000|Treatment Period 3|Withdrawal by Subject|0|||
157227382|NCT00950807|567577782|FG001|Treatment Period 3|Withdrawal by Subject|0|||
157035004|NCT04093869|566885554|FG001|Overall Study|Withdrawal by Subject|0|||
157035005|NCT02806726|566885555|FG000|Overall Study|Lost to Follow-up|1|||
157035006|NCT05129501|566885556|FG000|Overall Study|Lost to Follow-up|54|||
157035007|NCT05129501|566885557|FG001|Overall Study|Lost to Follow-up|41|||
157035008|NCT03142009|566885560|FG000|Overall Study|Lost to Follow-up|45|||
157035009|NCT03142009|566885561|FG001|Overall Study|Lost to Follow-up|30|||
157035010|NCT01527188|566885562|FG000|Overall Study|Adverse Event|5|||
157035011|NCT01527188|566885563|FG001|Overall Study|Adverse Event|5|||
157035012|NCT01527188|566885564|FG002|Overall Study|Adverse Event|11|||
157035013|NCT01527188|566885565|FG003|Overall Study|Adverse Event|0|||
157035014|NCT01527188|566885562|FG000|Overall Study|Withdrawal by Subject|3|||
157035015|NCT01527188|566885563|FG001|Overall Study|Withdrawal by Subject|6|||
157035016|NCT01527188|566885564|FG002|Overall Study|Withdrawal by Subject|4|||
157035017|NCT01527188|566885565|FG003|Overall Study|Withdrawal by Subject|4|||
157035018|NCT01527188|566885562|FG000|Overall Study|Any other reason not above-mentioned|6|||
157035019|NCT01527188|566885563|FG001|Overall Study|Any other reason not above-mentioned|7|||
157035020|NCT01527188|566885564|FG002|Overall Study|Any other reason not above-mentioned|8|||
157035021|NCT01527188|566885565|FG003|Overall Study|Any other reason not above-mentioned|8|||
157035022|NCT04518943|566886154|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
157035023|NCT04518943|566886155|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
157035024|NCT04518943|566886156|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
157035025|NCT04518943|566886157|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
157035026|NCT04518943|566886158|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
157035027|NCT04518943|566886159|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
157035028|NCT04518943|566886160|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
157035029|NCT04518943|566886161|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
157035030|NCT04518943|566886162|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
157035031|NCT04518943|566886163|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
157035032|NCT04518943|566886164|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
157035033|NCT04518943|566886165|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
157035034|NCT04518943|566886166|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
157035035|NCT04518943|566886167|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
157035036|NCT04518943|566886168|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
157035037|NCT04518943|566886169|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
157035038|NCT03705793|566886173|FG000|Overall Study|Lost to Follow-up|3|||
157035039|NCT03705793|566886174|FG001|Overall Study|Lost to Follow-up|4|||
157035040|NCT03705793|566886173|FG000|Overall Study|Withdrawal by Subject|2|||
157035041|NCT03705793|566886174|FG001|Overall Study|Withdrawal by Subject|1|||
157035042|NCT00447980|566886175|FG000|Overall Study|Withdrawal by Subject|1|||
157035043|NCT00447980|566886176|FG001|Overall Study|Withdrawal by Subject|1|||
157035044|NCT00447980|566886177|FG002|Overall Study|Withdrawal by Subject|4|||
157035045|NCT00447980|566886178|FG003|Overall Study|Withdrawal by Subject|4|||
157035046|NCT00447980|566886175|FG000|Overall Study|Lost to Follow-up|1|||
157035047|NCT00447980|566886176|FG001|Overall Study|Lost to Follow-up|1|||
157035048|NCT00447980|566886177|FG002|Overall Study|Lost to Follow-up|0|||
157035049|NCT00447980|566886178|FG003|Overall Study|Lost to Follow-up|0|||
157035050|NCT00447980|566886175|FG000|Overall Study|Did not proceed with surgery|3|||
157035051|NCT00447980|566886176|FG001|Overall Study|Did not proceed with surgery|3|||
157035052|NCT00447980|566886177|FG002|Overall Study|Did not proceed with surgery|2|||
157035053|NCT00447980|566886178|FG003|Overall Study|Did not proceed with surgery|2|||
157035054|NCT06408870|566886179|FG000|Washout period|Withdrawal by Subject|1|||
157035055|NCT06408870|566886180|FG001|Washout period|Withdrawal by Subject|0|||
157035056|NCT06408870|566886179|FG000|Washout period|Adverse Event|2|||
157035057|NCT06408870|566886180|FG001|Washout period|Adverse Event|0|||
157035058|NCT04174170|566886187|FG000|Placebo Run-in Period|Not Randomized|38|||
157035059|NCT04174170|566886188|FG001|Placebo Run-in Period|Not Randomized|0|||
157035060|NCT04174170|566886189|FG002|Placebo Run-in Period|Not Randomized|0|||
157035061|NCT04174170|566886190|FG003|Placebo Run-in Period|Not Randomized|0|||
157035062|NCT04174170|566886187|FG000|Double Blind Treatment Period|Adverse Event|0|||
157035063|NCT04174170|566886188|FG001|Double Blind Treatment Period|Adverse Event|9|||
157035064|NCT04174170|566886189|FG002|Double Blind Treatment Period|Adverse Event|9|||
157035065|NCT04174170|566886190|FG003|Double Blind Treatment Period|Adverse Event|8|||
157035066|NCT04174170|566886187|FG000|Double Blind Treatment Period|Death|0|||
157035067|NCT04174170|566886188|FG001|Double Blind Treatment Period|Death|1|||
157035068|NCT04174170|566886189|FG002|Double Blind Treatment Period|Death|0|||
157035069|NCT04174170|566886190|FG003|Double Blind Treatment Period|Death|0|||
157035070|NCT04174170|566886187|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
157035071|NCT04174170|566886188|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
157035072|NCT04174170|566886189|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
157035073|NCT04174170|566886190|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
157035074|NCT04174170|566886187|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
157035075|NCT04174170|566886188|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
157035076|NCT04174170|566886189|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
157035077|NCT04174170|566886190|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
157035078|NCT04174170|566886187|FG000|Double Blind Treatment Period|Physician Decision|0|||
157035079|NCT04174170|566886188|FG001|Double Blind Treatment Period|Physician Decision|1|||
157035080|NCT04174170|566886189|FG002|Double Blind Treatment Period|Physician Decision|0|||
157035081|NCT04174170|566886190|FG003|Double Blind Treatment Period|Physician Decision|1|||
157035082|NCT04174170|566886187|FG000|Double Blind Treatment Period|Pregnancy|0|||
157035083|NCT04174170|566886188|FG001|Double Blind Treatment Period|Pregnancy|1|||
157035084|NCT04174170|566886189|FG002|Double Blind Treatment Period|Pregnancy|0|||
157035085|NCT04174170|566886190|FG003|Double Blind Treatment Period|Pregnancy|1|||
157035086|NCT04174170|566886187|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
157035087|NCT04174170|566886188|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
157035088|NCT04174170|566886189|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
157035089|NCT04174170|566886190|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
157035090|NCT04174170|566886187|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
157035091|NCT04174170|566886188|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
157035092|NCT04174170|566886189|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
157035093|NCT04174170|566886190|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
157035094|NCT04174170|566886187|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
157035095|NCT04174170|566886188|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
157035096|NCT04174170|566886189|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
157035097|NCT04174170|566886190|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
157035098|NCT02656706|566886192|FG000|Overall Study|Insurance Denial|1|||
157035099|NCT04675034|566886199|FG000|Overall Study|Lost to Follow-up|1|||
157035100|NCT04675034|566886200|FG001|Overall Study|Lost to Follow-up|1|||
157035101|NCT04675034|566886201|FG002|Overall Study|Lost to Follow-up|0|||
157035102|NCT04675034|566886202|FG003|Overall Study|Lost to Follow-up|2|||
157035103|NCT04675034|566886203|FG004|Overall Study|Lost to Follow-up|0|||
157035104|NCT04675034|566886199|FG000|Overall Study|Protocol Violation|1|||
157035105|NCT04675034|566886200|FG001|Overall Study|Protocol Violation|0|||
157035106|NCT04675034|566886201|FG002|Overall Study|Protocol Violation|0|||
157035107|NCT04675034|566886202|FG003|Overall Study|Protocol Violation|1|||
157035108|NCT04675034|566886203|FG004|Overall Study|Protocol Violation|3|||
157035109|NCT04675034|566886199|FG000|Overall Study|Withdrawal by Subject|9|||
157035110|NCT04675034|566886200|FG001|Overall Study|Withdrawal by Subject|3|||
157035111|NCT04675034|566886201|FG002|Overall Study|Withdrawal by Subject|4|||
157035112|NCT04675034|566886202|FG003|Overall Study|Withdrawal by Subject|8|||
157035113|NCT04675034|566886203|FG004|Overall Study|Withdrawal by Subject|6|||
157035114|NCT03201939|566886208|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
157035115|NCT03201939|566886209|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
157035116|NCT04281498|566886216|FG000|Overall Study|Progression of disease|1|||
157035117|NCT04281498|566886216|FG000|Overall Study|Planned SCT|1|||
157035118|NCT04281498|566886216|FG000|Overall Study|Alternative Treatment|1|||
157035119|NCT03587805|566886217|FG000|Overall Study|Adverse Event|72|||
157035120|NCT03587805|566886217|FG000|Overall Study|Death|1|||
157035121|NCT03587805|566886217|FG000|Overall Study|Lost to Follow-up|78|||
157035122|NCT03587805|566886217|FG000|Overall Study|Withdrawal by Subject|105|||
157035123|NCT03587805|566886217|FG000|Overall Study|Lack of Efficacy|119|||
157035124|NCT03587805|566886217|FG000|Overall Study|Reason unknown|26|||
157035125|NCT03587805|566886217|FG000|Overall Study|COVID_19 pandemic|4|||
157035126|NCT03587805|566886217|FG000|Overall Study|Various reasons|121|||
157035127|NCT03587805|566886217|FG000|Overall Study|Withdrawal by parent/guardian|3|||
157035128|NCT03008382|566886218|FG000|Overall Study|Withdrawal by Subject|2|||
157035129|NCT03008382|566886219|FG001|Overall Study|Withdrawal by Subject|5|||
157035130|NCT03008382|566886220|FG002|Overall Study|Withdrawal by Subject|2|||
157035131|NCT03008382|566886221|FG003|Overall Study|Withdrawal by Subject|0|||
157035132|NCT03008382|566886218|FG000|Overall Study|Protocol Violation|1|||
157035133|NCT03008382|566886219|FG001|Overall Study|Protocol Violation|0|||
157035134|NCT03008382|566886220|FG002|Overall Study|Protocol Violation|0|||
157035135|NCT03008382|566886221|FG003|Overall Study|Protocol Violation|0|||
157035136|NCT03008382|566886218|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
157035137|NCT03008382|566886219|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
157035138|NCT03008382|566886220|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
157035139|NCT03008382|566886221|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
157035140|NCT03008382|566886218|FG000|Overall Study|Lost to Follow-up|0|||
157035141|NCT03008382|566886219|FG001|Overall Study|Lost to Follow-up|0|||
157035142|NCT03008382|566886220|FG002|Overall Study|Lost to Follow-up|1|||
157035143|NCT03008382|566886221|FG003|Overall Study|Lost to Follow-up|0|||
157035144|NCT03008382|566886218|FG000|Overall Study|Screenfail|0|||
157035145|NCT03008382|566886219|FG001|Overall Study|Screenfail|0|||
157035146|NCT03008382|566886220|FG002|Overall Study|Screenfail|2|||
157035147|NCT03008382|566886221|FG003|Overall Study|Screenfail|0|||
157035148|NCT05267639|566887039|FG000|Overall Study|Withdrawal by Subject|1|||
157035149|NCT05267639|566887040|FG001|Overall Study|Withdrawal by Subject|0|||
157035150|NCT04732871|566887041|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
156950647|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
156950648|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
156950649|NCT00086346|566572324|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
156950650|NCT00086346|566572325|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
156950651|NCT04495374|566572326|FG000|Overall Study|Protocol Violation|2|||
156950652|NCT04495374|566572327|FG001|Overall Study|Protocol Violation|1|||
156950653|NCT02807948|566572328|FG000|Overall Study|Physician Decision|1|||
156950654|NCT02807948|566572329|FG001|Overall Study|Physician Decision|0|||
156950655|NCT03727750|566572330|FG000|Overall Study|Death|45|||
156950656|NCT03727750|566572330|FG000|Overall Study|Withdrawal by Subject|2|||
156950657|NCT03727750|566572330|FG000|Overall Study|Lost to Follow-up|1|||
156950658|NCT03727750|566572330|FG000|Overall Study|Other|1|||
156950659|NCT02473614|566572331|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
156950660|NCT02473614|566572332|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
156950661|NCT01762761|566572336|FG000|Overall Study|Adverse Event|15|||
156950662|NCT01762761|566572337|FG001|Overall Study|Adverse Event|17|||
156950663|NCT01762761|566572336|FG000|Overall Study|Lack of Efficacy|9|||
156950664|NCT01762761|566572337|FG001|Overall Study|Lack of Efficacy|25|||
156950665|NCT01762761|566572336|FG000|Overall Study|Protocol Violation|1|||
156950666|NCT01762761|566572337|FG001|Overall Study|Protocol Violation|1|||
156950667|NCT01762761|566572336|FG000|Overall Study|Study closed/terminated|0|||
156950668|NCT01762761|566572337|FG001|Overall Study|Study closed/terminated|2|||
156950669|NCT01762761|566572336|FG000|Overall Study|Lost to Follow-up|3|||
156950670|NCT01762761|566572337|FG001|Overall Study|Lost to Follow-up|6|||
156950671|NCT01762761|566572336|FG000|Overall Study|Physician Decision|4|||
156950672|NCT01762761|566572337|FG001|Overall Study|Physician Decision|6|||
156950673|NCT01762761|566572336|FG000|Overall Study|Withdrawal by Subject|7|||
156950674|NCT01762761|566572337|FG001|Overall Study|Withdrawal by Subject|8|||
156950675|NCT01992536|566572338|FG000|Overall Study|Administrative Reason|0|||
156950676|NCT01992536|566572339|FG001|Overall Study|Administrative Reason|0|||
156950677|NCT01992536|566572340|FG002|Overall Study|Administrative Reason|0|||
156950678|NCT01992536|566572341|FG003|Overall Study|Administrative Reason|0|||
156950679|NCT01992536|566572342|FG004|Overall Study|Administrative Reason|0|||
156950680|NCT01992536|566572343|FG005|Overall Study|Administrative Reason|0|||
156950681|NCT01992536|566572344|FG006|Overall Study|Administrative Reason|7|||
156950682|NCT01992536|566572345|FG007|Overall Study|Administrative Reason|0|||
156950683|NCT01992536|566572346|FG008|Overall Study|Administrative Reason|0|||
156950684|NCT01992536|566572347|FG009|Overall Study|Administrative Reason|0|||
156950685|NCT01992536|566572338|FG000|Overall Study|Lost to Follow-up|4|||
156950686|NCT01992536|566572339|FG001|Overall Study|Lost to Follow-up|2|||
156950687|NCT01992536|566572340|FG002|Overall Study|Lost to Follow-up|1|||
156950688|NCT01992536|566572341|FG003|Overall Study|Lost to Follow-up|0|||
156950689|NCT01992536|566572342|FG004|Overall Study|Lost to Follow-up|0|||
156950690|NCT01992536|566572343|FG005|Overall Study|Lost to Follow-up|1|||
156950691|NCT01992536|566572344|FG006|Overall Study|Lost to Follow-up|0|||
156950692|NCT01992536|566572345|FG007|Overall Study|Lost to Follow-up|0|||
156950693|NCT01992536|566572346|FG008|Overall Study|Lost to Follow-up|1|||
156950694|NCT01992536|566572347|FG009|Overall Study|Lost to Follow-up|1|||
156950695|NCT01992536|566572338|FG000|Overall Study|Withdrawal by Subject|0|||
156950696|NCT01992536|566572339|FG001|Overall Study|Withdrawal by Subject|1|||
156950697|NCT01992536|566572340|FG002|Overall Study|Withdrawal by Subject|0|||
156950698|NCT01992536|566572341|FG003|Overall Study|Withdrawal by Subject|2|||
156950699|NCT01992536|566572342|FG004|Overall Study|Withdrawal by Subject|0|||
156950700|NCT01992536|566572343|FG005|Overall Study|Withdrawal by Subject|0|||
156950701|NCT01992536|566572344|FG006|Overall Study|Withdrawal by Subject|0|||
156950702|NCT01992536|566572345|FG007|Overall Study|Withdrawal by Subject|0|||
156950703|NCT01992536|566572346|FG008|Overall Study|Withdrawal by Subject|0|||
156950704|NCT01992536|566572347|FG009|Overall Study|Withdrawal by Subject|0|||
156950705|NCT01709227|566572350|FG000|Overall Study|Physician Decision|1|||
156950706|NCT01709227|566572351|FG001|Overall Study|Physician Decision|0|||
156950707|NCT01709227|566572350|FG000|Overall Study|Pleural Peritoneal communication|0|||
156950708|NCT01709227|566572351|FG001|Overall Study|Pleural Peritoneal communication|9|||
156950709|NCT03669081|566572352|FG000|Overall Study|Data could not be validated|1|||
156950710|NCT03669081|566572353|FG001|Overall Study|Data could not be validated|1|||
156950711|NCT02352493|566572354|FG000|Overall Study|Pregnancy|0|||
156950712|NCT02352493|566572355|FG001|Overall Study|Pregnancy|0|||
156950713|NCT02352493|566572356|FG002|Overall Study|Pregnancy|0|||
156950714|NCT02352493|566572357|FG003|Overall Study|Pregnancy|0|||
156950715|NCT02352493|566572358|FG004|Overall Study|Pregnancy|0|||
156950716|NCT02352493|566572359|FG005|Overall Study|Pregnancy|0|||
156950717|NCT02352493|566572360|FG006|Overall Study|Pregnancy|1|||
156950718|NCT02352493|566572361|FG007|Overall Study|Pregnancy|0|||
156950719|NCT02352493|566572362|FG008|Overall Study|Pregnancy|1|||
156950720|NCT02352493|566572363|FG009|Overall Study|Pregnancy|0|||
156950721|NCT02352493|566572364|FG010|Overall Study|Pregnancy|0|||
156950722|NCT02352493|566572365|FG011|Overall Study|Pregnancy|0|||
156950723|NCT02352493|566572366|FG012|Overall Study|Pregnancy|0|||
156950724|NCT02352493|566572367|FG013|Overall Study|Pregnancy|0|||
156950725|NCT02352493|566572368|FG014|Overall Study|Pregnancy|0|||
157168271|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
157168272|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
157168273|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
157168274|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
157168275|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
157168276|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
157168277|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
157168278|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
157168279|NCT03444870|567357784|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
157168280|NCT03444870|567357785|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
157168281|NCT03444870|567357786|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156950726|NCT02352493|566572369|FG015|Overall Study|Pregnancy|0|||
156950727|NCT02352493|566572370|FG016|Overall Study|Pregnancy|0|||
156950728|NCT02352493|566572371|FG017|Overall Study|Pregnancy|0|||
156950729|NCT02352493|566572354|FG000|Overall Study|Withdrawal by Subject|0|||
156950730|NCT02352493|566572355|FG001|Overall Study|Withdrawal by Subject|0|||
156950731|NCT02352493|566572356|FG002|Overall Study|Withdrawal by Subject|0|||
156950732|NCT02352493|566572357|FG003|Overall Study|Withdrawal by Subject|0|||
156950733|NCT02352493|566572358|FG004|Overall Study|Withdrawal by Subject|0|||
156950734|NCT02352493|566572359|FG005|Overall Study|Withdrawal by Subject|0|||
157168282|NCT03444870|567357787|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
157168283|NCT03444870|567357788|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
156950735|NCT02352493|566572360|FG006|Overall Study|Withdrawal by Subject|0|||
156950736|NCT02352493|566572361|FG007|Overall Study|Withdrawal by Subject|0|||
156950737|NCT02352493|566572362|FG008|Overall Study|Withdrawal by Subject|1|||
156950738|NCT02352493|566572363|FG009|Overall Study|Withdrawal by Subject|0|||
156950739|NCT02352493|566572364|FG010|Overall Study|Withdrawal by Subject|0|||
156950740|NCT02352493|566572365|FG011|Overall Study|Withdrawal by Subject|0|||
156950741|NCT02352493|566572366|FG012|Overall Study|Withdrawal by Subject|0|||
156950742|NCT02352493|566572367|FG013|Overall Study|Withdrawal by Subject|0|||
156950743|NCT02352493|566572368|FG014|Overall Study|Withdrawal by Subject|1|||
156950744|NCT02352493|566572369|FG015|Overall Study|Withdrawal by Subject|0|||
156950745|NCT02352493|566572370|FG016|Overall Study|Withdrawal by Subject|0|||
156950746|NCT02352493|566572371|FG017|Overall Study|Withdrawal by Subject|0|||
156950747|NCT02352493|566572354|FG000|Overall Study|Lost to Follow-up|0|||
156950748|NCT02352493|566572355|FG001|Overall Study|Lost to Follow-up|0|||
156950749|NCT02352493|566572356|FG002|Overall Study|Lost to Follow-up|0|||
156950750|NCT02352493|566572357|FG003|Overall Study|Lost to Follow-up|0|||
156950751|NCT02352493|566572358|FG004|Overall Study|Lost to Follow-up|0|||
156950752|NCT02352493|566572359|FG005|Overall Study|Lost to Follow-up|0|||
156950753|NCT02352493|566572360|FG006|Overall Study|Lost to Follow-up|0|||
156950754|NCT02352493|566572361|FG007|Overall Study|Lost to Follow-up|0|||
156950755|NCT02352493|566572362|FG008|Overall Study|Lost to Follow-up|0|||
156950756|NCT02352493|566572363|FG009|Overall Study|Lost to Follow-up|1|||
156950757|NCT02352493|566572364|FG010|Overall Study|Lost to Follow-up|0|||
156950758|NCT02352493|566572365|FG011|Overall Study|Lost to Follow-up|0|||
156950759|NCT02352493|566572366|FG012|Overall Study|Lost to Follow-up|1|||
156950760|NCT02352493|566572367|FG013|Overall Study|Lost to Follow-up|2|||
156950761|NCT02352493|566572368|FG014|Overall Study|Lost to Follow-up|0|||
156950762|NCT02352493|566572369|FG015|Overall Study|Lost to Follow-up|0|||
156950763|NCT02352493|566572370|FG016|Overall Study|Lost to Follow-up|0|||
156950764|NCT02352493|566572371|FG017|Overall Study|Lost to Follow-up|0|||
156950765|NCT02162810|566572372|FG000|Overall Study|Protocol Violation|1|||
156950766|NCT02162810|566572373|FG001|Overall Study|Protocol Violation|0|||
156950767|NCT02162810|566572372|FG000|Overall Study|patients did not report compliance|4|||
157168284|NCT03444870|567357789|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
157168285|NCT03444870|567357784|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157227383|NCT00950807|567577783|FG002|Treatment Period 3|Withdrawal by Subject|0|||
156950768|NCT02162810|566572373|FG001|Overall Study|patients did not report compliance|1|||
156950769|NCT00389324|566572374|FG000|Run-In Phase|Adverse Event|1|||
156950770|NCT00389324|566572374|FG000|Run-In Phase|Lost to Follow-up|1|||
156950771|NCT00389324|566572374|FG000|Run-In Phase|Withdrawal by Subject|1|||
156950772|NCT00389324|566572374|FG000|Subcutaneous Phase|Adverse Event|2|||
156950773|NCT00389324|566572374|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
156950774|NCT00389324|566572374|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
156950775|NCT00389324|566572374|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
156950776|NCT02317575|566572379|FG000|Period 1|Difficulty with venous cannulation|0|||
156950777|NCT02317575|566572380|FG001|Period 1|Difficulty with venous cannulation|1|||
156950778|NCT02317575|566572381|FG002|Period 1|Difficulty with venous cannulation|0|||
157227384|NCT00950807|567577784|FG003|Treatment Period 3|Withdrawal by Subject|0|||
156950779|NCT02317575|566572382|FG003|Period 1|Difficulty with venous cannulation|0|||
156950780|NCT02317575|566572383|FG004|Period 1|Difficulty with venous cannulation|0|||
156950781|NCT02317575|566572379|FG000|Period 1|Withdrawal by Subject|1|||
156950782|NCT02317575|566572380|FG001|Period 1|Withdrawal by Subject|0|||
156950783|NCT02317575|566572381|FG002|Period 1|Withdrawal by Subject|0|||
157035151|NCT04732871|566887042|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
157035152|NCT04732871|566887043|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
157035153|NCT04732871|566887041|FG000|Overall Study|Lost to Follow-up|7|||
157035154|NCT04732871|566887042|FG001|Overall Study|Lost to Follow-up|4|||
157035155|NCT04732871|566887043|FG002|Overall Study|Lost to Follow-up|3|||
157035156|NCT04732871|566887041|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
157035157|NCT04732871|566887042|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
157035158|NCT04732871|566887043|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
157035159|NCT04732871|566887041|FG000|Overall Study|Migrated / moved from the study area|5|||
157227385|NCT00950807|567577785|FG004|Treatment Period 3|Withdrawal by Subject|0|||
157227386|NCT00950807|567577786|FG005|Treatment Period 3|Withdrawal by Subject|0|||
157227387|NCT00950807|567577787|FG006|Treatment Period 3|Withdrawal by Subject|0|||
157227388|NCT00950807|567577788|FG007|Treatment Period 3|Withdrawal by Subject|0|||
157227389|NCT00950807|567577789|FG008|Treatment Period 3|Withdrawal by Subject|0|||
157227390|NCT00950807|567577790|FG009|Treatment Period 3|Withdrawal by Subject|1|||
157227391|NCT00950807|567577781|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
157227392|NCT00950807|567577782|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227393|NCT00950807|567577783|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227394|NCT00950807|567577784|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227395|NCT00950807|567577785|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227396|NCT00950807|567577786|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227397|NCT00950807|567577787|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227398|NCT00950807|567577788|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
157227399|NCT00950807|567577789|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227400|NCT00950807|567577790|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
157227401|NCT00950807|567577781|FG000|Treatment Period 3|Adverse Event|0|||
157227402|NCT00950807|567577782|FG001|Treatment Period 3|Adverse Event|0|||
157227403|NCT00950807|567577783|FG002|Treatment Period 3|Adverse Event|0|||
157227404|NCT00950807|567577784|FG003|Treatment Period 3|Adverse Event|0|||
157227405|NCT00950807|567577785|FG004|Treatment Period 3|Adverse Event|0|||
157227406|NCT00950807|567577786|FG005|Treatment Period 3|Adverse Event|0|||
157227407|NCT00950807|567577787|FG006|Treatment Period 3|Adverse Event|1|||
157227408|NCT00950807|567577788|FG007|Treatment Period 3|Adverse Event|0|||
157227409|NCT00950807|567577789|FG008|Treatment Period 3|Adverse Event|0|||
157227410|NCT00950807|567577790|FG009|Treatment Period 3|Adverse Event|0|||
156950784|NCT02317575|566572382|FG003|Period 1|Withdrawal by Subject|0|||
156950785|NCT02317575|566572383|FG004|Period 1|Withdrawal by Subject|0|||
156950786|NCT04831736|566572386|FG000|Overall Study|Withdrawal by Subject|0|||
156950787|NCT04831736|566572387|FG001|Overall Study|Withdrawal by Subject|1|||
156950788|NCT00795600|566572388|FG000|Overall Study|Adverse Event|1|||
156950789|NCT00795600|566572389|FG001|Overall Study|Adverse Event|1|||
156950790|NCT00795600|566572388|FG000|Overall Study|Protocol Violation|1|||
156950791|NCT00795600|566572389|FG001|Overall Study|Protocol Violation|2|||
156950792|NCT00795600|566572388|FG000|Overall Study|Withdrawal by Subject|1|||
156950793|NCT00795600|566572389|FG001|Overall Study|Withdrawal by Subject|0|||
156950794|NCT00795600|566572388|FG000|Overall Study|Unclassified|1|||
156950795|NCT00795600|566572389|FG001|Overall Study|Unclassified|1|||
156950796|NCT01659021|566572393|FG000|Main Study|Adverse Event|2|||
156950797|NCT01659021|566572394|FG001|Main Study|Adverse Event|3|||
156950798|NCT01659021|566572393|FG000|Main Study|Lost to Follow-up|1|||
156950799|NCT01659021|566572394|FG001|Main Study|Lost to Follow-up|0|||
156950800|NCT01659021|566572393|FG000|Main Study|Unknown Reasons|2|||
156950801|NCT01659021|566572394|FG001|Main Study|Unknown Reasons|1|||
156950802|NCT01659021|566572393|FG000|Main Study|Physician Decision|34|||
156950803|NCT01659021|566572394|FG001|Main Study|Physician Decision|16|||
156950804|NCT01659021|566572393|FG000|Main Study|Withdrawal by Subject|19|||
156950805|NCT01659021|566572394|FG001|Main Study|Withdrawal by Subject|16|||
156950806|NCT01659021|566572393|FG000|Main Study|Study Terminated by Sponsor|16|||
156950807|NCT01659021|566572394|FG001|Main Study|Study Terminated by Sponsor|1|||
156950808|NCT01659021|566572393|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
156950809|NCT01659021|566572394|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
156950810|NCT01659021|566572393|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
157035160|NCT04732871|566887042|FG001|Overall Study|Migrated / moved from the study area|0|||
156950811|NCT01659021|566572394|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
156950812|NCT03936244|566572395|FG000|Overall Study|Lost to Follow-up|5|||
156950813|NCT03936244|566572396|FG001|Overall Study|Lost to Follow-up|1|||
157035161|NCT04732871|566887043|FG002|Overall Study|Migrated / moved from the study area|0|||
157227411|NCT00337077|567577791|FG000|Overall Study|Progressive disease|25|||
157227412|NCT00337077|567577792|FG001|Overall Study|Progressive disease|37|||
157227413|NCT00337077|567577793|FG002|Overall Study|Progressive disease|19|||
156950814|NCT03936244|566572395|FG000|Overall Study|Physician Decision|7|||
157227414|NCT00337077|567577791|FG000|Overall Study|Adverse Event|7|||
157227415|NCT00337077|567577792|FG001|Overall Study|Adverse Event|7|||
157227416|NCT00337077|567577793|FG002|Overall Study|Adverse Event|1|||
157227417|NCT00337077|567577791|FG000|Overall Study|Death|0|||
157168286|NCT03444870|567357785|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157168287|NCT03444870|567357786|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157168288|NCT03444870|567357787|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157168289|NCT03444870|567357788|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
157168290|NCT03444870|567357789|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
157168291|NCT03444870|567357784|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
157168292|NCT03444870|567357785|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
157168293|NCT03444870|567357786|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
157168294|NCT03444870|567357787|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
157168295|NCT03444870|567357788|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
157168296|NCT03444870|567357789|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
157168297|NCT03444870|567357784|FG000|Open-Label Extension (OLE) Period|Death|0|||
157168298|NCT03444870|567357785|FG001|Open-Label Extension (OLE) Period|Death|0|||
157168299|NCT03444870|567357786|FG002|Open-Label Extension (OLE) Period|Death|0|||
157168300|NCT03444870|567357787|FG003|Open-Label Extension (OLE) Period|Death|0|||
157168301|NCT03444870|567357788|FG004|Open-Label Extension (OLE) Period|Death|1|||
157168302|NCT03444870|567357789|FG005|Open-Label Extension (OLE) Period|Death|0|||
157168303|NCT02034552|567357790|FG000|Overall Study|Never treated|3|||
156950815|NCT03936244|566572396|FG001|Overall Study|Physician Decision|3|||
156950816|NCT03551938|566572397|FG000|3-Month Follow Up|Lost to Follow-up|39|||
156950817|NCT03551938|566572398|FG001|3-Month Follow Up|Lost to Follow-up|38|||
156950818|NCT03551938|566572397|FG000|6-Month Follow Up|Lost to Follow-up|46|||
156950819|NCT03551938|566572398|FG001|6-Month Follow Up|Lost to Follow-up|42|||
156950820|NCT03551938|566572397|FG000|9-Month Follow Up|Lost to Follow-up|44|||
156950821|NCT03551938|566572398|FG001|9-Month Follow Up|Lost to Follow-up|43|||
156950822|NCT01046110|566572399|FG000|Overall Study|Adverse Event|9|||
156950823|NCT01046110|566572400|FG001|Overall Study|Adverse Event|2|||
156950824|NCT01046110|566572399|FG000|Overall Study|Lack of Efficacy|0|||
156950825|NCT01046110|566572400|FG001|Overall Study|Lack of Efficacy|1|||
156950826|NCT01046110|566572399|FG000|Overall Study|Protocol Violation|7|||
156950827|NCT01046110|566572400|FG001|Overall Study|Protocol Violation|12|||
156950828|NCT01046110|566572399|FG000|Overall Study|Withdrawal Criteria|3|||
156950829|NCT01046110|566572400|FG001|Overall Study|Withdrawal Criteria|5|||
156950830|NCT01046110|566572399|FG000|Overall Study|Unclassified|36|||
156950831|NCT01046110|566572400|FG001|Overall Study|Unclassified|35|||
156950832|NCT01114646|566572401|FG000|Overall Study|Withdrawal by Subject|3|||
156950833|NCT01114646|566572402|FG001|Overall Study|Withdrawal by Subject|2|||
156950834|NCT02159482|566572405|FG000|Overall Study|Withdrawal by Subject|2|||
156950835|NCT02159482|566572405|FG000|Overall Study|Physician Decision|3|||
156950836|NCT01233817|566572406|FG000|Overall Study|Lost to Follow-up|1|||
156950837|NCT01233817|566572406|FG000|Overall Study|Withdrawal by Subject|2|||
156950838|NCT01248884|566572409|FG000|Overall Study|Withdrawal by Subject|1|||
156950839|NCT01248884|566572410|FG001|Overall Study|Withdrawal by Subject|3|||
156950840|NCT01248884|566572411|FG002|Overall Study|Withdrawal by Subject|1|||
156950841|NCT01248884|566572409|FG000|Overall Study|Adverse Event|1|||
156950842|NCT01248884|566572410|FG001|Overall Study|Adverse Event|0|||
156950843|NCT01248884|566572411|FG002|Overall Study|Adverse Event|0|||
156950844|NCT01202773|566572412|FG000|Overall Study|Adverse Event|4|||
156950845|NCT01202773|566572413|FG001|Overall Study|Adverse Event|5|||
156950846|NCT01202773|566572414|FG002|Overall Study|Adverse Event|5|||
156950847|NCT01202773|566572412|FG000|Overall Study|Lack of Efficacy|5|||
156950848|NCT01202773|566572413|FG001|Overall Study|Lack of Efficacy|4|||
156950849|NCT01202773|566572414|FG002|Overall Study|Lack of Efficacy|9|||
156950850|NCT01202773|566572412|FG000|Overall Study|Entry Criteria Not Met|2|||
156950851|NCT01202773|566572413|FG001|Overall Study|Entry Criteria Not Met|0|||
156950852|NCT01202773|566572414|FG002|Overall Study|Entry Criteria Not Met|1|||
156950853|NCT01202773|566572412|FG000|Overall Study|Lost to Follow-up|1|||
156950854|NCT01202773|566572413|FG001|Overall Study|Lost to Follow-up|2|||
156950855|NCT01202773|566572414|FG002|Overall Study|Lost to Follow-up|2|||
157168304|NCT02034552|567357791|FG001|Overall Study|Never treated|2|||
157168305|NCT02034552|567357792|FG002|Overall Study|Never treated|0|||
156950856|NCT01202773|566572412|FG000|Overall Study|Withdrawal by Subject|13|||
156950857|NCT01202773|566572413|FG001|Overall Study|Withdrawal by Subject|6|||
156950858|NCT01202773|566572414|FG002|Overall Study|Withdrawal by Subject|5|||
156950859|NCT01202773|566572412|FG000|Overall Study|Physician Decision|2|||
156950860|NCT01202773|566572413|FG001|Overall Study|Physician Decision|0|||
156950861|NCT01202773|566572414|FG002|Overall Study|Physician Decision|0|||
156950862|NCT01202773|566572412|FG000|Overall Study|Protocol Violation|11|||
157168306|NCT02034552|567357790|FG000|Overall Study|Radiological progression|3|||
156950863|NCT01202773|566572413|FG001|Overall Study|Protocol Violation|6|||
156950864|NCT01202773|566572414|FG002|Overall Study|Protocol Violation|10|||
156950865|NCT01202773|566572412|FG000|Overall Study|Sponsor Decision|19|||
156950866|NCT01202773|566572413|FG001|Overall Study|Sponsor Decision|20|||
156950867|NCT01202773|566572414|FG002|Overall Study|Sponsor Decision|23|||
156950868|NCT03465540|566572419|FG000|Overall Study|Withdrawal by Subject|0|||
156950869|NCT03465540|566572420|FG001|Overall Study|Withdrawal by Subject|0|||
156950870|NCT03465540|566572421|FG002|Overall Study|Withdrawal by Subject|1|||
156950871|NCT03465540|566572422|FG003|Overall Study|Withdrawal by Subject|1|||
156950872|NCT03465540|566572423|FG004|Overall Study|Withdrawal by Subject|1|||
156950873|NCT03465540|566572424|FG005|Overall Study|Withdrawal by Subject|0|||
156950874|NCT03465540|566572419|FG000|Overall Study|Lost to Follow-up|0|||
156950875|NCT03465540|566572420|FG001|Overall Study|Lost to Follow-up|1|||
156950876|NCT03465540|566572421|FG002|Overall Study|Lost to Follow-up|0|||
156950877|NCT03465540|566572422|FG003|Overall Study|Lost to Follow-up|0|||
156950878|NCT03465540|566572423|FG004|Overall Study|Lost to Follow-up|1|||
156950879|NCT03465540|566572424|FG005|Overall Study|Lost to Follow-up|0|||
156950880|NCT03465540|566572419|FG000|Overall Study|Death|1|||
156950881|NCT03465540|566572420|FG001|Overall Study|Death|1|||
156950882|NCT03465540|566572421|FG002|Overall Study|Death|0|||
156950883|NCT03465540|566572422|FG003|Overall Study|Death|2|||
156950884|NCT03465540|566572423|FG004|Overall Study|Death|0|||
156950885|NCT03465540|566572424|FG005|Overall Study|Death|2|||
156950886|NCT03465540|566572419|FG000|Overall Study|Protocol specified criteria|0|||
156950887|NCT03465540|566572420|FG001|Overall Study|Protocol specified criteria|2|||
156950888|NCT03465540|566572421|FG002|Overall Study|Protocol specified criteria|2|||
156950889|NCT03465540|566572422|FG003|Overall Study|Protocol specified criteria|0|||
156950890|NCT03465540|566572423|FG004|Overall Study|Protocol specified criteria|2|||
156950891|NCT03465540|566572424|FG005|Overall Study|Protocol specified criteria|0|||
156950892|NCT02667912|566572425|FG000|Overall Study|Death|3|||
156950893|NCT02667912|566572426|FG001|Overall Study|Death|1|||
156950894|NCT02667912|566572425|FG000|Overall Study|Withdrawal by Subject|1|||
156950895|NCT02667912|566572426|FG001|Overall Study|Withdrawal by Subject|2|||
156950896|NCT02667912|566572425|FG000|Overall Study|Withdrawal by Subject|1|||
156950897|NCT02667912|566572426|FG001|Overall Study|Withdrawal by Subject|0|||
156950898|NCT04443218|566572427|FG000|Overall Study|Exited study for other reasons|9|||
156950899|NCT04443218|566572427|FG000|Overall Study|Withdrawal by Subject|1|||
156950900|NCT04443218|566572427|FG000|Overall Study|Lost to Follow-up|4|||
156950901|NCT04443218|566572427|FG000|Overall Study|Death|19|||
156950902|NCT04096560|566572428|FG000|Overall Study|Reason not Specified|1|||
156950903|NCT04096560|566572429|FG001|Overall Study|Reason not Specified|0|||
156950904|NCT04096560|566572430|FG002|Overall Study|Reason not Specified|0|||
156950905|NCT04096560|566572431|FG003|Overall Study|Reason not Specified|0|||
156950906|NCT04096560|566572432|FG004|Overall Study|Reason not Specified|1|||
156950907|NCT04096560|566572433|FG005|Overall Study|Reason not Specified|1|||
156950908|NCT04096560|566572434|FG006|Overall Study|Reason not Specified|1|||
156950909|NCT04096560|566572435|FG007|Overall Study|Reason not Specified|0|||
156950910|NCT04096560|566572428|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156950911|NCT04096560|566572429|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156950912|NCT04096560|566572430|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156950913|NCT04096560|566572431|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156950914|NCT04096560|566572432|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
156950915|NCT04096560|566572433|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
156950916|NCT04096560|566572434|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
156950917|NCT04096560|566572435|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
157205224|NCT03669640|567496078|FG005|Overall Study|Death|0|||
156950918|NCT04096560|566572428|FG000|Overall Study|Study Terminated by Sponsor|0|||
156950919|NCT04096560|566572429|FG001|Overall Study|Study Terminated by Sponsor|0|||
156950920|NCT04096560|566572430|FG002|Overall Study|Study Terminated by Sponsor|0|||
156950921|NCT04096560|566572431|FG003|Overall Study|Study Terminated by Sponsor|5|||
156950922|NCT04096560|566572432|FG004|Overall Study|Study Terminated by Sponsor|6|||
156950923|NCT04096560|566572433|FG005|Overall Study|Study Terminated by Sponsor|4|||
156950924|NCT04096560|566572434|FG006|Overall Study|Study Terminated by Sponsor|6|||
156950925|NCT04096560|566572435|FG007|Overall Study|Study Terminated by Sponsor|1|||
156950926|NCT04096560|566572428|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950927|NCT04096560|566572429|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950928|NCT04096560|566572430|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950929|NCT04096560|566572431|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950930|NCT04096560|566572432|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950931|NCT04096560|566572433|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950932|NCT04096560|566572434|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
156950933|NCT04096560|566572435|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
156950934|NCT00534352|566572436|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
156950935|NCT00534352|566572436|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
156950936|NCT00534352|566572436|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
156950937|NCT00534352|566572436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
156950938|NCT00534352|566572436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
156950939|NCT00534352|566572436|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
156950940|NCT00833924|566572437|FG000|Overall Study|Death|21|||
156950941|NCT00833924|566572437|FG000|Overall Study|Conversion|2|||
156950942|NCT00833924|566572437|FG000|Overall Study|Lost to Follow-up|2|||
156950943|NCT00833924|566572437|FG000|Overall Study|Withdrawal by Subject|13|||
156950944|NCT00833924|566572437|FG000|Overall Study|In study follow-up|71|||
156950945|NCT04796610|566572442|FG000|Overall Study|Withdrawal by Subject|1|||
156950946|NCT04796610|566572443|FG001|Overall Study|Withdrawal by Subject|0|||
156950947|NCT04796610|566572444|FG002|Overall Study|Withdrawal by Subject|0|||
156950948|NCT04796610|566572445|FG003|Overall Study|Withdrawal by Subject|0|||
156950949|NCT04796610|566572442|FG000|Overall Study|Lost to Follow-up|2|||
156950950|NCT04796610|566572443|FG001|Overall Study|Lost to Follow-up|0|||
156950951|NCT04796610|566572444|FG002|Overall Study|Lost to Follow-up|1|||
156950952|NCT04796610|566572445|FG003|Overall Study|Lost to Follow-up|1|||
156950953|NCT01459796|566572446|FG000|Overall Study|Non compliance with protocol|2|||
156950954|NCT01459796|566572447|FG001|Overall Study|Non compliance with protocol|4|||
156950955|NCT01459796|566572446|FG000|Overall Study|Adverse Event|5|||
156950956|NCT01459796|566572447|FG001|Overall Study|Adverse Event|5|||
156950957|NCT01459796|566572446|FG000|Overall Study|Withdrawal by Subject|6|||
156950958|NCT01459796|566572447|FG001|Overall Study|Withdrawal by Subject|3|||
156950959|NCT01459796|566572446|FG000|Overall Study|Lost to Follow-up|5|||
156950960|NCT01459796|566572447|FG001|Overall Study|Lost to Follow-up|4|||
156950961|NCT01459796|566572446|FG000|Overall Study|Reason unspecified|1|||
156950962|NCT01459796|566572447|FG001|Overall Study|Reason unspecified|2|||
156950963|NCT01459796|566572446|FG000|Overall Study|Decision by the sponsor|75|||
156950964|NCT01459796|566572447|FG001|Overall Study|Decision by the sponsor|108|||
156950965|NCT00701051|566572448|FG000|Screening|Failed Screening|40|||
156950966|NCT00701051|566572449|FG001|Screening|Failed Screening|0|||
156950967|NCT00701051|566572450|FG002|Screening|Failed Screening|0|||
156950968|NCT00701051|566572448|FG000|Screening|Time conflicts|19|||
156950969|NCT00701051|566572449|FG001|Screening|Time conflicts|0|||
156950970|NCT00701051|566572450|FG002|Screening|Time conflicts|0|||
156950971|NCT00701051|566572448|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
156950972|NCT00701051|566572449|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
156950973|NCT00701051|566572450|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
156950974|NCT03321019|566572458|FG000|Overall Study|Withdrawal by Subject|0|||
156950975|NCT03321019|566572459|FG001|Overall Study|Withdrawal by Subject|6|||
156950976|NCT03321019|566572458|FG000|Overall Study|Lost to Follow-up|0|||
156950977|NCT03321019|566572459|FG001|Overall Study|Lost to Follow-up|22|||
156950978|NCT03880578|566572460|FG000|Overall Study|Withdrawal by Subject|0|||
156950979|NCT03880578|566572461|FG001|Overall Study|Withdrawal by Subject|3|||
156950980|NCT03880578|566572462|FG002|Overall Study|Withdrawal by Subject|1|||
156950981|NCT03880578|566572460|FG000|Overall Study|Death|0|||
156950982|NCT03880578|566572461|FG001|Overall Study|Death|1|||
156950983|NCT03880578|566572462|FG002|Overall Study|Death|0|||
156950984|NCT04934670|566572463|FG000|Overall Study|Death|4|||
156950985|NCT04934670|566572464|FG001|Overall Study|Death|0|||
156950986|NCT04934670|566572463|FG000|Overall Study|Lost to Follow-up|1|||
156950987|NCT04934670|566572464|FG001|Overall Study|Lost to Follow-up|4|||
156950988|NCT01985126|566572467|FG000|Overall Study|Death|15|||
156950989|NCT01985126|566572468|FG001|Overall Study|Death|69|||
156950990|NCT01985126|566572467|FG000|Overall Study|Lost to Follow-up|0|||
156950991|NCT01985126|566572468|FG001|Overall Study|Lost to Follow-up|8|||
156950992|NCT01985126|566572467|FG000|Overall Study|Study Terminated By Sponsor|1|||
156950993|NCT01985126|566572468|FG001|Overall Study|Study Terminated By Sponsor|22|||
156950994|NCT01985126|566572467|FG000|Overall Study|Withdrawal by Subject|2|||
156950995|NCT01985126|566572468|FG001|Overall Study|Withdrawal by Subject|7|||
156950996|NCT01785602|566572475|FG000|Overall Study|Withdrawal by Subject|2|||
156950997|NCT01785602|566572476|FG001|Overall Study|Withdrawal by Subject|0|||
156950998|NCT01785602|566572475|FG000|Overall Study|Lost to Follow-up|1|||
156950999|NCT01785602|566572476|FG001|Overall Study|Lost to Follow-up|1|||
156951000|NCT01785602|566572475|FG000|Overall Study|Adverse Event|3|||
156951001|NCT01785602|566572476|FG001|Overall Study|Adverse Event|5|||
157227418|NCT00337077|567577792|FG001|Overall Study|Death|1|||
156951002|NCT01785602|566572475|FG000|Overall Study|Administrative problems|7|||
156951003|NCT01785602|566572476|FG001|Overall Study|Administrative problems|3|||
156951004|NCT02041429|566572479|FG000|Overall Study|Progressive Disease|2|||
156951005|NCT02041429|566572480|FG001|Overall Study|Progressive Disease|2|||
156951006|NCT02041429|566572481|FG002|Overall Study|Progressive Disease|3|||
156951007|NCT02041429|566572482|FG003|Overall Study|Progressive Disease|2|||
156951008|NCT02041429|566572479|FG000|Overall Study|Toxicity|0|||
156951009|NCT02041429|566572480|FG001|Overall Study|Toxicity|1|||
156951010|NCT02041429|566572481|FG002|Overall Study|Toxicity|4|||
156951011|NCT02041429|566572482|FG003|Overall Study|Toxicity|2|||
156951012|NCT02041429|566572479|FG000|Overall Study|Withdrawal by Subject|0|||
156951013|NCT02041429|566572480|FG001|Overall Study|Withdrawal by Subject|1|||
156951014|NCT02041429|566572481|FG002|Overall Study|Withdrawal by Subject|0|||
156951015|NCT02041429|566572482|FG003|Overall Study|Withdrawal by Subject|0|||
156951016|NCT02041429|566572479|FG000|Overall Study|On Maintenance Therapy|1|||
156951017|NCT02041429|566572480|FG001|Overall Study|On Maintenance Therapy|0|||
156951018|NCT02041429|566572481|FG002|Overall Study|On Maintenance Therapy|0|||
156951019|NCT02041429|566572482|FG003|Overall Study|On Maintenance Therapy|2|||
156951020|NCT03251924|566572483|FG000|Overall Study|Disease Progression|6|||
156951021|NCT03251924|566572484|FG001|Overall Study|Disease Progression|6|||
156951022|NCT03251924|566572485|FG002|Overall Study|Disease Progression|7|||
156951023|NCT03251924|566572486|FG003|Overall Study|Disease Progression|8|||
156951024|NCT03251924|566572487|FG004|Overall Study|Disease Progression|8|||
156951025|NCT03251924|566572488|FG005|Overall Study|Disease Progression|7|||
156951026|NCT03251924|566572489|FG006|Overall Study|Disease Progression|6|||
156951027|NCT03251924|566572490|FG007|Overall Study|Disease Progression|10|||
156951028|NCT03251924|566572491|FG008|Overall Study|Disease Progression|6|||
156951029|NCT03251924|566572483|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
156951030|NCT03251924|566572484|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
156951031|NCT03251924|566572485|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
156951032|NCT03251924|566572486|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
156951033|NCT03251924|566572487|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
156951034|NCT03251924|566572488|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
156951035|NCT03251924|566572489|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
156951036|NCT03251924|566572490|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
156951037|NCT03251924|566572491|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
156951038|NCT03251924|566572483|FG000|Overall Study|Death|0|||
156951039|NCT03251924|566572484|FG001|Overall Study|Death|1|||
157035162|NCT04732871|566887041|FG000|Overall Study|Other|1|||
157035163|NCT04732871|566887042|FG001|Overall Study|Other|0|||
157035164|NCT04732871|566887043|FG002|Overall Study|Other|1|||
157035165|NCT04732871|566887041|FG000|Overall Study|Ongoing|6|||
157035166|NCT04732871|566887042|FG001|Overall Study|Ongoing|0|||
157035167|NCT04732871|566887043|FG002|Overall Study|Ongoing|1|||
157035168|NCT04732871|566887041|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
157035169|NCT04732871|566887042|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
157035170|NCT04732871|566887043|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
157227419|NCT00337077|567577793|FG002|Overall Study|Death|0|||
157035171|NCT05180539|566887053|FG000|Overall Study|Lost to Follow-up|27|||
157035172|NCT05180539|566887054|FG001|Overall Study|Lost to Follow-up|30|||
157035173|NCT00968149|566887058|FG000|Overall Study|Adverse Event|5|||
157035174|NCT00968149|566887059|FG001|Overall Study|Adverse Event|1|||
157035175|NCT00968149|566887058|FG000|Overall Study|Lack of Efficacy|0|||
157035176|NCT00968149|566887059|FG001|Overall Study|Lack of Efficacy|4|||
157035177|NCT00968149|566887058|FG000|Overall Study|Lost to Follow-up|0|||
157035178|NCT00968149|566887059|FG001|Overall Study|Lost to Follow-up|1|||
157035179|NCT00968149|566887058|FG000|Overall Study|Protocol Violation|4|||
157035180|NCT00968149|566887059|FG001|Overall Study|Protocol Violation|0|||
157035181|NCT00968149|566887058|FG000|Overall Study|Withdrawal by Subject|2|||
157035182|NCT00968149|566887059|FG001|Overall Study|Withdrawal by Subject|0|||
157035183|NCT02467270|566887060|FG000|Overall Study|Participants Never Treated|0|||
157035184|NCT02467270|566887061|FG001|Overall Study|Participants Never Treated|1|||
157035185|NCT02467270|566887062|FG002|Overall Study|Participants Never Treated|0|||
157035186|NCT02467270|566887060|FG000|Overall Study|Ongoing|50|||
157035187|NCT02467270|566887061|FG001|Overall Study|Ongoing|41|||
157035188|NCT02467270|566887062|FG002|Overall Study|Ongoing|43|||
157035189|NCT02467270|566887060|FG000|Overall Study|Adverse Event|16|||
157035190|NCT02467270|566887061|FG001|Overall Study|Adverse Event|15|||
157035191|NCT02467270|566887062|FG002|Overall Study|Adverse Event|14|||
157035192|NCT02467270|566887060|FG000|Overall Study|Progressive Disease|7|||
157035193|NCT02467270|566887061|FG001|Overall Study|Progressive Disease|7|||
157035194|NCT02467270|566887062|FG002|Overall Study|Progressive Disease|4|||
157035195|NCT02467270|566887060|FG000|Overall Study|Death|2|||
157035196|NCT02467270|566887061|FG001|Overall Study|Death|0|||
157035197|NCT02467270|566887062|FG002|Overall Study|Death|2|||
157035198|NCT02467270|566887060|FG000|Overall Study|Lack of Efficacy|12|||
157035199|NCT02467270|566887061|FG001|Overall Study|Lack of Efficacy|18|||
157035200|NCT02467270|566887062|FG002|Overall Study|Lack of Efficacy|23|||
157035201|NCT02467270|566887060|FG000|Overall Study|Non-compliance With Study Drug|0|||
157035202|NCT02467270|566887061|FG001|Overall Study|Non-compliance With Study Drug|2|||
157035203|NCT02467270|566887062|FG002|Overall Study|Non-compliance With Study Drug|1|||
157035204|NCT02467270|566887060|FG000|Overall Study|Lost to Follow-up|2|||
157035205|NCT02467270|566887061|FG001|Overall Study|Lost to Follow-up|1|||
156951040|NCT03251924|566572485|FG002|Overall Study|Death|0|||
156951041|NCT03251924|566572486|FG003|Overall Study|Death|1|||
156951042|NCT03251924|566572487|FG004|Overall Study|Death|1|||
156951043|NCT03251924|566572488|FG005|Overall Study|Death|1|||
156951044|NCT03251924|566572489|FG006|Overall Study|Death|0|||
156951045|NCT03251924|566572490|FG007|Overall Study|Death|0|||
156951046|NCT03251924|566572491|FG008|Overall Study|Death|0|||
156951047|NCT03251924|566572483|FG000|Overall Study|Study Drug Toxicity|0|||
156951048|NCT03251924|566572484|FG001|Overall Study|Study Drug Toxicity|0|||
156951049|NCT03251924|566572485|FG002|Overall Study|Study Drug Toxicity|0|||
157035206|NCT02467270|566887062|FG002|Overall Study|Lost to Follow-up|0|||
157035207|NCT02467270|566887060|FG000|Overall Study|Pregnancy|0|||
157035208|NCT02467270|566887061|FG001|Overall Study|Pregnancy|1|||
157035209|NCT02467270|566887062|FG002|Overall Study|Pregnancy|0|||
157168307|NCT02034552|567357791|FG001|Overall Study|Radiological progression|5|||
157168308|NCT02034552|567357792|FG002|Overall Study|Radiological progression|4|||
157168309|NCT02034552|567357790|FG000|Overall Study|AE not assoc. with disease progression|1|||
157168310|NCT02034552|567357791|FG001|Overall Study|AE not assoc. with disease progression|4|||
157168311|NCT02034552|567357792|FG002|Overall Study|AE not assoc. with disease progression|2|||
157168312|NCT02034552|567357790|FG000|Overall Study|AE associated with disease progression|0|||
157168313|NCT02034552|567357791|FG001|Overall Study|AE associated with disease progression|1|||
157227420|NCT00337077|567577791|FG000|Overall Study|Withdrawal by Subject|7|||
157227421|NCT00337077|567577792|FG001|Overall Study|Withdrawal by Subject|2|||
156951050|NCT03251924|566572486|FG003|Overall Study|Study Drug Toxicity|1|||
156951051|NCT03251924|566572487|FG004|Overall Study|Study Drug Toxicity|0|||
156951052|NCT03251924|566572488|FG005|Overall Study|Study Drug Toxicity|0|||
156951053|NCT03251924|566572489|FG006|Overall Study|Study Drug Toxicity|0|||
156951054|NCT03251924|566572490|FG007|Overall Study|Study Drug Toxicity|0|||
156951055|NCT03251924|566572491|FG008|Overall Study|Study Drug Toxicity|1|||
156951056|NCT03251924|566572483|FG000|Overall Study|Other Reasons|0|||
156951057|NCT03251924|566572484|FG001|Overall Study|Other Reasons|0|||
156951058|NCT03251924|566572485|FG002|Overall Study|Other Reasons|0|||
156951059|NCT03251924|566572486|FG003|Overall Study|Other Reasons|0|||
156951060|NCT03251924|566572487|FG004|Overall Study|Other Reasons|0|||
156951061|NCT03251924|566572488|FG005|Overall Study|Other Reasons|0|||
156951062|NCT03251924|566572489|FG006|Overall Study|Other Reasons|0|||
156951063|NCT03251924|566572490|FG007|Overall Study|Other Reasons|0|||
156951064|NCT03251924|566572491|FG008|Overall Study|Other Reasons|1|||
156951065|NCT03251924|566572483|FG000|Overall Study|Participant request to discontinue study treatment|0|||
156951066|NCT03251924|566572484|FG001|Overall Study|Participant request to discontinue study treatment|0|||
156951067|NCT03251924|566572485|FG002|Overall Study|Participant request to discontinue study treatment|0|||
156951068|NCT03251924|566572486|FG003|Overall Study|Participant request to discontinue study treatment|0|||
156951069|NCT03251924|566572487|FG004|Overall Study|Participant request to discontinue study treatment|0|||
156951070|NCT03251924|566572488|FG005|Overall Study|Participant request to discontinue study treatment|0|||
156951071|NCT03251924|566572489|FG006|Overall Study|Participant request to discontinue study treatment|0|||
156951072|NCT03251924|566572490|FG007|Overall Study|Participant request to discontinue study treatment|1|||
156951073|NCT03251924|566572491|FG008|Overall Study|Participant request to discontinue study treatment|0|||
156951074|NCT00439777|566572492|FG000|Treatment Period|Death|29|||
156951075|NCT00439777|566572493|FG001|Treatment Period|Death|21|||
156951076|NCT00439777|566572492|FG000|Treatment Period|Study terminated by sponsor|125|||
156951077|NCT00439777|566572493|FG001|Treatment Period|Study terminated by sponsor|132|||
156951078|NCT00439777|566572492|FG000|Treatment Period|Site closed by investigator|0|||
156951079|NCT00439777|566572493|FG001|Treatment Period|Site closed by investigator|1|||
156951080|NCT00439777|566572492|FG000|Treatment Period|Did not take study treatment|7|||
156951081|NCT00439777|566572493|FG001|Treatment Period|Did not take study treatment|8|||
156951082|NCT00439777|566572492|FG000|Treatment Period|Adverse Event|111|||
156951083|NCT00439777|566572493|FG001|Treatment Period|Adverse Event|92|||
156951084|NCT00439777|566572492|FG000|Treatment Period|Protocol Violation|23|||
156951085|NCT00439777|566572493|FG001|Treatment Period|Protocol Violation|30|||
156951086|NCT00439777|566572492|FG000|Treatment Period|Withdrawal by Subject|66|||
156951087|NCT00439777|566572493|FG001|Treatment Period|Withdrawal by Subject|118|||
156951088|NCT00439777|566572492|FG000|Treatment Period|Lack of Efficacy|1|||
156951089|NCT00439777|566572493|FG001|Treatment Period|Lack of Efficacy|4|||
156951090|NCT00439777|566572492|FG000|Treatment Period|Lost to Follow-up|8|||
156951091|NCT00439777|566572493|FG001|Treatment Period|Lost to Follow-up|10|||
156951092|NCT00439777|566572492|FG000|Treatment Period|Protocol driven decision point|1|||
156951093|NCT00439777|566572493|FG001|Treatment Period|Protocol driven decision point|3|||
156951094|NCT00439777|566572492|FG000|Treatment Period|Physician Decision|7|||
157168314|NCT02034552|567357792|FG002|Overall Study|AE associated with disease progression|0|||
157168315|NCT02034552|567357790|FG000|Overall Study|Withdrawal by Subject|2|||
157227422|NCT00337077|567577793|FG002|Overall Study|Withdrawal by Subject|2|||
157227423|NCT00337077|567577791|FG000|Overall Study|Alternative therapy|1|||
157227424|NCT00337077|567577792|FG001|Overall Study|Alternative therapy|0|||
157227425|NCT00337077|567577793|FG002|Overall Study|Alternative therapy|0|||
157227426|NCT00337077|567577791|FG000|Overall Study|Physician Decision|1|||
156951095|NCT00439777|566572493|FG001|Treatment Period|Physician Decision|18|||
156951096|NCT00439777|566572492|FG000|Treatment Period|Clinical endpoint reached|26|||
156951097|NCT00439777|566572493|FG001|Treatment Period|Clinical endpoint reached|13|||
156951098|NCT00439777|566572492|FG000|Treatment Period|Technical problems|3|||
156951099|NCT00439777|566572493|FG001|Treatment Period|Technical problems|1|||
156951100|NCT00439777|566572492|FG000|Treatment Period|Participant convenience|12|||
156951101|NCT00439777|566572493|FG001|Treatment Period|Participant convenience|8|||
156951102|NCT00439777|566572492|FG000|Observational Period|Protocol Violation|0|||
156951103|NCT00439777|566572493|FG001|Observational Period|Protocol Violation|2|||
156951104|NCT00439777|566572492|FG000|Observational Period|Withdrawal by Subject|9|||
156951105|NCT00439777|566572493|FG001|Observational Period|Withdrawal by Subject|5|||
156951106|NCT00439777|566572492|FG000|Observational Period|Lost to Follow-up|1|||
157035210|NCT02467270|566887060|FG000|Overall Study|Physician Decision|0|||
157035211|NCT02467270|566887061|FG001|Overall Study|Physician Decision|4|||
157035212|NCT02467270|566887062|FG002|Overall Study|Physician Decision|1|||
157035213|NCT02467270|566887060|FG000|Overall Study|Withdrawal by Subject|4|||
157035214|NCT02467270|566887061|FG001|Overall Study|Withdrawal by Subject|3|||
157035215|NCT02467270|566887062|FG002|Overall Study|Withdrawal by Subject|5|||
157035216|NCT02467270|566887060|FG000|Overall Study|Reason not Specified|1|||
157035217|NCT02467270|566887061|FG001|Overall Study|Reason not Specified|2|||
157035218|NCT02467270|566887062|FG002|Overall Study|Reason not Specified|1|||
157035219|NCT00495677|566887064|FG000|Stage 1 (25 Days)|Adverse Event|0|||
157035220|NCT00495677|566887065|FG001|Stage 1 (25 Days)|Adverse Event|0|||
157035221|NCT00495677|566887066|FG002|Stage 1 (25 Days)|Adverse Event|1|||
157035222|NCT00495677|566887067|FG003|Stage 1 (25 Days)|Adverse Event|0|||
157035223|NCT00495677|566887068|FG004|Stage 1 (25 Days)|Adverse Event|0|||
157035224|NCT00495677|566887069|FG005|Stage 1 (25 Days)|Adverse Event|0|||
157035225|NCT00495677|566887070|FG006|Stage 1 (25 Days)|Adverse Event|0|||
157035226|NCT05162586|566887071|FG000|Overall Study|Other|0|||
157035227|NCT05162586|566887072|FG001|Overall Study|Other|0|||
157035228|NCT05162586|566887073|FG002|Overall Study|Other|0|||
157035229|NCT05162586|566887074|FG003|Overall Study|Other|0|||
157035230|NCT05162586|566887075|FG004|Overall Study|Other|1|||
157035231|NCT05162586|566887076|FG005|Overall Study|Other|0|||
157035232|NCT05162586|566887077|FG006|Overall Study|Other|2|||
157035233|NCT05162586|566887078|FG007|Overall Study|Other|2|||
157035234|NCT05162586|566887071|FG000|Overall Study|Lack of Efficacy|0|||
157035235|NCT05162586|566887072|FG001|Overall Study|Lack of Efficacy|0|||
157035236|NCT05162586|566887073|FG002|Overall Study|Lack of Efficacy|0|||
157035237|NCT05162586|566887074|FG003|Overall Study|Lack of Efficacy|0|||
157035238|NCT05162586|566887075|FG004|Overall Study|Lack of Efficacy|1|||
157035239|NCT05162586|566887076|FG005|Overall Study|Lack of Efficacy|0|||
157035240|NCT05162586|566887077|FG006|Overall Study|Lack of Efficacy|0|||
157035241|NCT05162586|566887078|FG007|Overall Study|Lack of Efficacy|1|||
157035242|NCT05162586|566887071|FG000|Overall Study|Lost to Follow-up|0|||
157035243|NCT05162586|566887072|FG001|Overall Study|Lost to Follow-up|0|||
157035244|NCT05162586|566887073|FG002|Overall Study|Lost to Follow-up|0|||
157035245|NCT05162586|566887074|FG003|Overall Study|Lost to Follow-up|0|||
157035246|NCT05162586|566887075|FG004|Overall Study|Lost to Follow-up|2|||
157035247|NCT05162586|566887076|FG005|Overall Study|Lost to Follow-up|0|||
157035248|NCT05162586|566887077|FG006|Overall Study|Lost to Follow-up|0|||
157035249|NCT05162586|566887078|FG007|Overall Study|Lost to Follow-up|2|||
157035250|NCT05162586|566887071|FG000|Overall Study|Non-Compliance|0|||
157035251|NCT05162586|566887072|FG001|Overall Study|Non-Compliance|1|||
157035252|NCT05162586|566887073|FG002|Overall Study|Non-Compliance|0|||
157035253|NCT05162586|566887074|FG003|Overall Study|Non-Compliance|0|||
157035254|NCT05162586|566887075|FG004|Overall Study|Non-Compliance|1|||
157035255|NCT05162586|566887076|FG005|Overall Study|Non-Compliance|0|||
157035256|NCT05162586|566887077|FG006|Overall Study|Non-Compliance|0|||
157035257|NCT05162586|566887078|FG007|Overall Study|Non-Compliance|1|||
157035258|NCT05162586|566887071|FG000|Overall Study|Withdrawal by Subject|2|||
157035259|NCT05162586|566887072|FG001|Overall Study|Withdrawal by Subject|0|||
157035260|NCT05162586|566887073|FG002|Overall Study|Withdrawal by Subject|0|||
157035261|NCT05162586|566887074|FG003|Overall Study|Withdrawal by Subject|0|||
157035262|NCT05162586|566887075|FG004|Overall Study|Withdrawal by Subject|7|||
157035263|NCT05162586|566887076|FG005|Overall Study|Withdrawal by Subject|6|||
157035264|NCT05162586|566887077|FG006|Overall Study|Withdrawal by Subject|2|||
157035265|NCT05162586|566887078|FG007|Overall Study|Withdrawal by Subject|2|||
157035266|NCT05162586|566887071|FG000|Overall Study|Adverse Event|2|||
157035267|NCT05162586|566887072|FG001|Overall Study|Adverse Event|0|||
157035268|NCT05162586|566887073|FG002|Overall Study|Adverse Event|1|||
157035269|NCT05162586|566887074|FG003|Overall Study|Adverse Event|2|||
157035270|NCT05162586|566887075|FG004|Overall Study|Adverse Event|4|||
157035271|NCT05162586|566887076|FG005|Overall Study|Adverse Event|1|||
157035272|NCT05162586|566887077|FG006|Overall Study|Adverse Event|5|||
157035273|NCT05162586|566887078|FG007|Overall Study|Adverse Event|2|||
157035274|NCT02567435|566887081|FG000|Overall Study|Death|1|||
157035275|NCT02567435|566887082|FG001|Overall Study|Death|1|||
157035276|NCT02567435|566887083|FG002|Overall Study|Death|0|||
157035277|NCT02567435|566887084|FG003|Overall Study|Death|0|||
157035278|NCT02567435|566887081|FG000|Overall Study|Ineligible|1|||
157035279|NCT02567435|566887082|FG001|Overall Study|Ineligible|3|||
157035280|NCT02567435|566887083|FG002|Overall Study|Ineligible|0|||
157227427|NCT00337077|567577792|FG001|Overall Study|Physician Decision|4|||
156977537|NCT01555164|566670737|FG001|Overall Study|Protocol Violation|5|||
156977538|NCT01555164|566670736|FG000|Overall Study|Subject Non-compliance|14|||
156977539|NCT01555164|566670737|FG001|Overall Study|Subject Non-compliance|6|||
156977540|NCT01555164|566670736|FG000|Overall Study|Subject Withdrew Consent|6|||
156977541|NCT01555164|566670737|FG001|Overall Study|Subject Withdrew Consent|11|||
156977542|NCT05879198|566670738|FG000|Overall Study|Lost to Follow-up|1|||
156977543|NCT01598298|566670739|FG000|Overall Study|Not eligible|5|||
156977544|NCT01598298|566670740|FG001|Overall Study|Not eligible|5|||
156977545|NCT01598298|566670739|FG000|Overall Study|Adverse Event|21|||
156951107|NCT00439777|566572493|FG001|Observational Period|Lost to Follow-up|11|||
156951108|NCT00439777|566572492|FG000|Observational Period|Death|27|||
156951109|NCT00439777|566572493|FG001|Observational Period|Death|20|||
156951110|NCT00439777|566572492|FG000|Observational Period|Study terminated by sponsor|3|||
156951111|NCT00439777|566572493|FG001|Observational Period|Study terminated by sponsor|1|||
156951112|NCT00439777|566572492|FG000|Observational Period|Protocol driven decision point|0|||
156951113|NCT00439777|566572493|FG001|Observational Period|Protocol driven decision point|1|||
156951114|NCT00439777|566572492|FG000|Observational Period|Lack of Efficacy|1|||
156951115|NCT00439777|566572493|FG001|Observational Period|Lack of Efficacy|0|||
156951116|NCT00439777|566572492|FG000|Observational Period|Technical problems|0|||
156951117|NCT00439777|566572493|FG001|Observational Period|Technical problems|1|||
156951118|NCT00784043|566572494|FG000|Overall Study|Withdrawal by Subject|8|||
156951119|NCT00784043|566572495|FG001|Overall Study|Withdrawal by Subject|5|||
156951120|NCT00784043|566572494|FG000|Overall Study|Protocol Terminated|23|||
156951121|NCT00784043|566572495|FG001|Overall Study|Protocol Terminated|1|||
156951122|NCT03791398|566572502|FG000|Overall Study|Progression of Disease Under Study|2|||
156951123|NCT03791398|566572503|FG001|Overall Study|Progression of Disease Under Study|0|||
156951124|NCT03791398|566572504|FG002|Overall Study|Progression of Disease Under Study|0|||
156951125|NCT02207829|566572505|FG000|Overall Study|Adverse Event|10|||
156951126|NCT02207829|566572506|FG001|Overall Study|Adverse Event|9|||
156951127|NCT02207829|566572505|FG000|Overall Study|Lack of Efficacy|7|||
156951128|NCT02207829|566572506|FG001|Overall Study|Lack of Efficacy|5|||
156951129|NCT02207829|566572505|FG000|Overall Study|Lost to Follow-up|2|||
156951130|NCT02207829|566572506|FG001|Overall Study|Lost to Follow-up|2|||
156951131|NCT02207829|566572505|FG000|Overall Study|Protocol deviation|5|||
156951132|NCT02207829|566572506|FG001|Overall Study|Protocol deviation|4|||
156951133|NCT02207829|566572505|FG000|Overall Study|Withdrew consent|18|||
156951134|NCT02207829|566572506|FG001|Overall Study|Withdrew consent|14|||
156951135|NCT01418209|566572507|FG000|Overall Study|Withdrawal by Subject|1|||
156951136|NCT01418209|566572508|FG001|Overall Study|Withdrawal by Subject|0|||
156951137|NCT01418209|566572509|FG002|Overall Study|Withdrawal by Subject|1|||
156951138|NCT01418209|566572507|FG000|Overall Study|Did not provide hot flash diary data|1|||
156951139|NCT01418209|566572508|FG001|Overall Study|Did not provide hot flash diary data|3|||
156951140|NCT01418209|566572509|FG002|Overall Study|Did not provide hot flash diary data|3|||
156951141|NCT00101101|566572510|FG000|Overall Study|never received vaccine|20|||
156951142|NCT01603875|566572511|FG000|Overall Study|Preexisting rabies antibody|3|||
156951143|NCT01603875|566572512|FG001|Overall Study|Preexisting rabies antibody|4|||
156951144|NCT01603875|566572513|FG002|Overall Study|Preexisting rabies antibody|3|||
156951145|NCT01603875|566572511|FG000|Overall Study|Lost to Follow-up|4|||
156951146|NCT01603875|566572512|FG001|Overall Study|Lost to Follow-up|3|||
156951147|NCT01603875|566572513|FG002|Overall Study|Lost to Follow-up|6|||
156951148|NCT01603875|566572511|FG000|Overall Study|Protocol Violation|0|||
156951149|NCT01603875|566572512|FG001|Overall Study|Protocol Violation|1|||
156951150|NCT01603875|566572513|FG002|Overall Study|Protocol Violation|0|||
156951151|NCT01652716|566572514|FG000|Overall Study|Loss of glucose control|1|||
156951152|NCT01652716|566572515|FG001|Overall Study|Loss of glucose control|0|||
156951153|NCT01652716|566572514|FG000|Overall Study|Administrative|0|||
156951154|NCT01652716|566572515|FG001|Overall Study|Administrative|2|||
156951155|NCT01652716|566572514|FG000|Overall Study|Investigator decision|1|||
156951156|NCT01652716|566572515|FG001|Overall Study|Investigator decision|4|||
156951157|NCT01652716|566572514|FG000|Overall Study|Lost to Follow-up|12|||
156951158|NCT01652716|566572515|FG001|Overall Study|Lost to Follow-up|11|||
156951159|NCT01652716|566572514|FG000|Overall Study|Protocol Violation|2|||
156951160|NCT01652716|566572515|FG001|Overall Study|Protocol Violation|1|||
156951161|NCT01652716|566572514|FG000|Overall Study|Adverse Event|7|||
156951162|NCT01652716|566572515|FG001|Overall Study|Adverse Event|10|||
156951163|NCT01652716|566572514|FG000|Overall Study|Withdrawal by Subject|33|||
156951164|NCT01652716|566572515|FG001|Overall Study|Withdrawal by Subject|18|||
156951165|NCT02752048|566572519|FG000|Overall Study|Withdrawal by Subject|0|||
156951166|NCT02752048|566572520|FG001|Overall Study|Withdrawal by Subject|0|||
156951167|NCT02752048|566572521|FG002|Overall Study|Withdrawal by Subject|3|||
156951168|NCT02788175|566572522|FG000|Overall Study|Protocol Violation|3|||
156951169|NCT02788175|566572522|FG000|Overall Study|Withdrawal by Subject|4|||
156951170|NCT02788175|566572522|FG000|Overall Study|Ineligible prior to study agent|6|||
156951171|NCT00818441|566572523|FG000|Overall Study|Death|69|||
156951172|NCT00818441|566572524|FG001|Overall Study|Death|26|||
156951173|NCT00818441|566572523|FG000|Overall Study|Other|5|||
156951174|NCT00818441|566572524|FG001|Overall Study|Other|0|||
156951175|NCT00818441|566572523|FG000|Overall Study|Lost to Follow-up|2|||
156951176|NCT00818441|566572524|FG001|Overall Study|Lost to Follow-up|1|||
156951177|NCT00818441|566572523|FG000|Overall Study|Withdrawal by Subject|2|||
156951178|NCT00818441|566572524|FG001|Overall Study|Withdrawal by Subject|0|||
156951179|NCT00818441|566572523|FG000|Overall Study|Adverse Event|0|||
156951180|NCT00818441|566572524|FG001|Overall Study|Adverse Event|1|||
156951181|NCT00818441|566572523|FG000|Overall Study|Study terminated by sponsor|11|||
156951182|NCT00818441|566572524|FG001|Overall Study|Study terminated by sponsor|2|||
156951183|NCT00898677|566572525|FG000|Overall Study|Adverse Event|0|||
156951184|NCT00898677|566572526|FG001|Overall Study|Adverse Event|0|||
156951185|NCT00898677|566572527|FG002|Overall Study|Adverse Event|1|||
156951186|NCT00898677|566572528|FG003|Overall Study|Adverse Event|0|||
156951187|NCT00898677|566572525|FG000|Overall Study|Lost to Follow-up|0|||
156951188|NCT00898677|566572526|FG001|Overall Study|Lost to Follow-up|0|||
156951189|NCT00898677|566572527|FG002|Overall Study|Lost to Follow-up|2|||
156951190|NCT00898677|566572528|FG003|Overall Study|Lost to Follow-up|0|||
156951191|NCT00898677|566572525|FG000|Overall Study|Protocol Violation|1|||
156951192|NCT00898677|566572526|FG001|Overall Study|Protocol Violation|1|||
156951193|NCT00898677|566572527|FG002|Overall Study|Protocol Violation|2|||
156951194|NCT00898677|566572528|FG003|Overall Study|Protocol Violation|0|||
156951195|NCT00898677|566572525|FG000|Overall Study|Withdrawal by Subject|0|||
156951196|NCT00898677|566572526|FG001|Overall Study|Withdrawal by Subject|0|||
156951197|NCT00898677|566572527|FG002|Overall Study|Withdrawal by Subject|0|||
156951198|NCT00898677|566572528|FG003|Overall Study|Withdrawal by Subject|1|||
156951199|NCT00898677|566572525|FG000|Overall Study|Not Treated: Adverse Event|0|||
156951200|NCT00898677|566572526|FG001|Overall Study|Not Treated: Adverse Event|2|||
156951201|NCT00898677|566572527|FG002|Overall Study|Not Treated: Adverse Event|1|||
156951202|NCT00898677|566572528|FG003|Overall Study|Not Treated: Adverse Event|0|||
156951203|NCT00898677|566572525|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
156951204|NCT00898677|566572526|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
156951205|NCT00898677|566572527|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
156951206|NCT00898677|566572528|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
156951207|NCT00898677|566572525|FG000|Overall Study|Not Treated: Pregnancy|0|||
156951208|NCT00898677|566572526|FG001|Overall Study|Not Treated: Pregnancy|0|||
156951209|NCT00898677|566572527|FG002|Overall Study|Not Treated: Pregnancy|1|||
156951210|NCT00898677|566572528|FG003|Overall Study|Not Treated: Pregnancy|0|||
156951211|NCT00898677|566572525|FG000|Overall Study|Not Treated: Protocol Violation|2|||
156951212|NCT00898677|566572526|FG001|Overall Study|Not Treated: Protocol Violation|0|||
156951213|NCT00898677|566572527|FG002|Overall Study|Not Treated: Protocol Violation|2|||
156951214|NCT00898677|566572528|FG003|Overall Study|Not Treated: Protocol Violation|0|||
156951215|NCT00898677|566572525|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
156951216|NCT00898677|566572526|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
156951217|NCT00898677|566572527|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
156951218|NCT00898677|566572528|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
156951219|NCT00898677|566572525|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
156951220|NCT00898677|566572526|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
156951221|NCT00898677|566572527|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
156951222|NCT00898677|566572528|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
156951223|NCT00898677|566572525|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156951224|NCT00898677|566572526|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156951225|NCT00898677|566572527|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
156951226|NCT00898677|566572528|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
156951227|NCT00898677|566572525|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
156951228|NCT00898677|566572526|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156951229|NCT00898677|566572527|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156951230|NCT00898677|566572528|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
156951231|NCT00898677|566572525|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
156951232|NCT00898677|566572526|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
156951233|NCT00898677|566572527|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
156951234|NCT00898677|566572528|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
156951235|NCT00898677|566572525|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
156951236|NCT00898677|566572526|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
156951237|NCT00898677|566572527|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
156951238|NCT00898677|566572528|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
156951239|NCT00898677|566572525|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
156951240|NCT00898677|566572526|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
156951241|NCT00898677|566572527|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
156951242|NCT00898677|566572528|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
156951243|NCT00774995|566572530|FG000|Overall Study|Protocol Violation|0|||
156951244|NCT00774995|566572531|FG001|Overall Study|Protocol Violation|0|||
156951245|NCT00774995|566572532|FG002|Overall Study|Protocol Violation|1|||
156951246|NCT00774995|566572533|FG003|Overall Study|Protocol Violation|0|||
156951247|NCT03964454|566572538|FG000|Overall Study|Lost to Follow-up|13|||
157168316|NCT02034552|567357791|FG001|Overall Study|Withdrawal by Subject|1|||
156951248|NCT03964454|566572539|FG001|Overall Study|Lost to Follow-up|7|||
156951249|NCT03964454|566572538|FG000|Overall Study|Withdrawal by Subject|4|||
156951250|NCT03964454|566572539|FG001|Overall Study|Withdrawal by Subject|11|||
156951251|NCT00074282|566574243|FG000|Step 1|Adverse Event|32|||
156951252|NCT00074282|566574244|FG001|Step 1|Adverse Event|0|||
156951253|NCT00074282|566574245|FG002|Step 1|Adverse Event|0|||
156951254|NCT00074282|566574243|FG000|Step 1|Death|6|||
156951255|NCT00074282|566574244|FG001|Step 1|Death|0|||
156951256|NCT00074282|566574245|FG002|Step 1|Death|0|||
156951257|NCT00074282|566574243|FG000|Step 1|Withdrawal by Subject|7|||
156951258|NCT00074282|566574244|FG001|Step 1|Withdrawal by Subject|0|||
156951259|NCT00074282|566574245|FG002|Step 1|Withdrawal by Subject|0|||
156951260|NCT00074282|566574243|FG000|Step 1|Disease progression|2|||
156951261|NCT00074282|566574244|FG001|Step 1|Disease progression|0|||
156951262|NCT00074282|566574245|FG002|Step 1|Disease progression|0|||
156951263|NCT00074282|566574243|FG000|Step 1|Alternative therapy|2|||
156951264|NCT00074282|566574244|FG001|Step 1|Alternative therapy|0|||
156951265|NCT00074282|566574245|FG002|Step 1|Alternative therapy|0|||
156951266|NCT00074282|566574243|FG000|Step 1|Other complicating disease|2|||
156951267|NCT00074282|566574244|FG001|Step 1|Other complicating disease|0|||
156951268|NCT00074282|566574245|FG002|Step 1|Other complicating disease|0|||
156951269|NCT00074282|566574243|FG000|Step 1|Physician Decision|1|||
156951270|NCT00074282|566574244|FG001|Step 1|Physician Decision|0|||
156951271|NCT00074282|566574245|FG002|Step 1|Physician Decision|0|||
156951272|NCT00074282|566574243|FG000|Step 1|Ineligible|4|||
156951273|NCT00074282|566574244|FG001|Step 1|Ineligible|0|||
156951274|NCT00074282|566574245|FG002|Step 1|Ineligible|0|||
156951275|NCT00074282|566574243|FG000|Step 1|Never started treatment|2|||
156951276|NCT00074282|566574244|FG001|Step 1|Never started treatment|0|||
156951277|NCT00074282|566574245|FG002|Step 1|Never started treatment|0|||
156951278|NCT00074282|566574243|FG000|Step 2|Adverse Event|0|||
156951279|NCT00074282|566574244|FG001|Step 2|Adverse Event|2|||
156951280|NCT00074282|566574245|FG002|Step 2|Adverse Event|12|||
156951281|NCT00074282|566574243|FG000|Step 2|Disease progression|0|||
156951282|NCT00074282|566574244|FG001|Step 2|Disease progression|0|||
156951283|NCT00074282|566574245|FG002|Step 2|Disease progression|5|||
156951284|NCT00074282|566574243|FG000|Step 2|Death|0|||
156951285|NCT00074282|566574244|FG001|Step 2|Death|0|||
156951286|NCT00074282|566574245|FG002|Step 2|Death|3|||
156951287|NCT00074282|566574243|FG000|Step 2|Withdrawal by Subject|0|||
156951288|NCT00074282|566574244|FG001|Step 2|Withdrawal by Subject|0|||
156951289|NCT00074282|566574245|FG002|Step 2|Withdrawal by Subject|2|||
156951290|NCT00074282|566574243|FG000|Step 2|Physician Decision|0|||
156951291|NCT00074282|566574244|FG001|Step 2|Physician Decision|0|||
156951292|NCT00074282|566574245|FG002|Step 2|Physician Decision|1|||
156951293|NCT00074282|566574243|FG000|Step 2|Ineligible|0|||
156951294|NCT00074282|566574244|FG001|Step 2|Ineligible|0|||
156951295|NCT00074282|566574245|FG002|Step 2|Ineligible|1|||
156951296|NCT00464542|566574246|FG000|Pre-treatment|Withdrawal by Subject|2|||
156951297|NCT02055352|566574248|FG000|Overall Study|Adverse Event|0|||
156951298|NCT02055352|566574249|FG001|Overall Study|Adverse Event|1|||
156951299|NCT02055352|566574248|FG000|Overall Study|Non-eligible|0|||
156951300|NCT02055352|566574249|FG001|Overall Study|Non-eligible|1|||
156951301|NCT02055352|566574248|FG000|Overall Study|Poor compliance|1|||
156951302|NCT02055352|566574249|FG001|Overall Study|Poor compliance|1|||
156951303|NCT02055352|566574248|FG000|Overall Study|Death|1|||
156951304|NCT02055352|566574249|FG001|Overall Study|Death|2|||
156951305|NCT02055352|566574248|FG000|Overall Study|Patient decision|1|||
156951306|NCT02055352|566574249|FG001|Overall Study|Patient decision|1|||
156951307|NCT02055352|566574248|FG000|Overall Study|Use of prohibited treatment|0|||
156951308|NCT02055352|566574249|FG001|Overall Study|Use of prohibited treatment|3|||
156951309|NCT02055352|566574248|FG000|Overall Study|AE, study drug would be detrimental|1|||
156951310|NCT02055352|566574249|FG001|Overall Study|AE, study drug would be detrimental|3|||
156951311|NCT02055352|566574248|FG000|Overall Study|Withdrawal of informed consent|1|||
156951312|NCT02055352|566574249|FG001|Overall Study|Withdrawal of informed consent|0|||
156951313|NCT02055352|566574248|FG000|Overall Study|Reason unknown|1|||
156951314|NCT02055352|566574249|FG001|Overall Study|Reason unknown|5|||
156951315|NCT00970502|566574251|FG000|Overall Study|Withdrawal by Subject|1|||
156951316|NCT02707055|566574252|FG000|Phase 1|Withdrawal by Subject|1|||
156951317|NCT02707055|566574253|FG001|Phase 1|Withdrawal by Subject|2|||
156951318|NCT02707055|566574252|FG000|Phase 1|Physician Decision|0|||
157168317|NCT02034552|567357792|FG002|Overall Study|Withdrawal by Subject|1|||
157168318|NCT02034552|567357790|FG000|Overall Study|Non-compliance with study drug|0|||
156951319|NCT02707055|566574253|FG001|Phase 1|Physician Decision|1|||
156951320|NCT02707055|566574252|FG000|Phase 2|Adverse Event|1|||
156951321|NCT02707055|566574253|FG001|Phase 2|Adverse Event|2|||
156951322|NCT01880424|566574254|FG000|Overall Study|Adverse Event|7|||
156951323|NCT01880424|566574255|FG001|Overall Study|Adverse Event|6|||
156951324|NCT01880424|566574254|FG000|Overall Study|Lack of Efficacy|1|||
156951325|NCT01880424|566574255|FG001|Overall Study|Lack of Efficacy|4|||
156951326|NCT01880424|566574254|FG000|Overall Study|Lost to Follow-up|3|||
156951327|NCT01880424|566574255|FG001|Overall Study|Lost to Follow-up|2|||
156951328|NCT01880424|566574254|FG000|Overall Study|Protocol Violation|11|||
156951329|NCT01880424|566574255|FG001|Overall Study|Protocol Violation|13|||
156951330|NCT01880424|566574254|FG000|Overall Study|Withdrawal by Subject|10|||
156951331|NCT01880424|566574255|FG001|Overall Study|Withdrawal by Subject|30|||
156951332|NCT01880424|566574254|FG000|Overall Study|Other|1|||
156951333|NCT01880424|566574255|FG001|Overall Study|Other|0|||
156951334|NCT02280044|566574258|FG000|Overall Study|Planned alternate|0|||
156951335|NCT02280044|566574259|FG001|Overall Study|Planned alternate|2|||
156951336|NCT02105116|566574262|FG000|Overall Study|not eligible for step 2 of trial|5|||
157035281|NCT02567435|566887084|FG003|Overall Study|Ineligible|0|||
157035282|NCT02567435|566887081|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
157035283|NCT02567435|566887082|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
157035284|NCT02567435|566887083|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
157035285|NCT02567435|566887084|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
157035286|NCT02532621|566887087|FG000|Overall Study|Death|3|||
157035287|NCT02532621|566887087|FG000|Overall Study|Lost to Follow-up|3|||
157035288|NCT02532621|566887087|FG000|Overall Study|Withdrawal by Subject|6|||
157035289|NCT02532621|566887087|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
157035290|NCT02532621|566887087|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
157035291|NCT05771467|566887088|FG000|Overall Study|Lost to Follow-up|6|||
157035292|NCT05771467|566887089|FG001|Overall Study|Lost to Follow-up|3|||
157035293|NCT01220531|566887092|FG000|Overall Study|Death|7|||
157035294|NCT01220531|566887092|FG000|Overall Study|Lost to Follow-up|1|||
157035295|NCT01553149|566887095|FG000|Overall Study|Adverse Event|0|||
157035296|NCT01553149|566887096|FG001|Overall Study|Adverse Event|9|||
157035297|NCT01553149|566887095|FG000|Overall Study|Physician Decision|5|||
157035298|NCT01553149|566887096|FG001|Overall Study|Physician Decision|10|||
157035299|NCT01553149|566887095|FG000|Overall Study|Ineligible|0|||
157035300|NCT01553149|566887096|FG001|Overall Study|Ineligible|1|||
157035301|NCT05866926|566887098|FG000|Overall Study|Death|16|||
157035302|NCT05866926|566887099|FG001|Overall Study|Death|9|||
157035303|NCT05866926|566887098|FG000|Overall Study|Lost to Follow-up|0|||
157035304|NCT05866926|566887099|FG001|Overall Study|Lost to Follow-up|1|||
157035305|NCT05866926|566887098|FG000|Overall Study|Adverse Event|1|||
157035306|NCT05866926|566887099|FG001|Overall Study|Adverse Event|0|||
157227428|NCT00337077|567577793|FG002|Overall Study|Physician Decision|2|||
157227429|NCT00337077|567577791|FG000|Overall Study|Never started treatment|1|||
156951337|NCT02105116|566574262|FG000|Overall Study|Death|1|||
156951338|NCT01075321|566574263|FG000|Overall Study|Withdrawal by Subject|0|||
156951339|NCT01075321|566574264|FG001|Overall Study|Withdrawal by Subject|0|||
156951340|NCT01075321|566574265|FG002|Overall Study|Withdrawal by Subject|1|||
156951341|NCT01075321|566574266|FG003|Overall Study|Withdrawal by Subject|1|||
156951342|NCT01075321|566574263|FG000|Overall Study|Protocol Violation|0|||
156951343|NCT01075321|566574264|FG001|Overall Study|Protocol Violation|0|||
156951344|NCT01075321|566574265|FG002|Overall Study|Protocol Violation|1|||
156951345|NCT01075321|566574266|FG003|Overall Study|Protocol Violation|0|||
156951346|NCT01075321|566574263|FG000|Overall Study|Treatment Incomplete due to progression|1|||
156951347|NCT01075321|566574264|FG001|Overall Study|Treatment Incomplete due to progression|0|||
156951348|NCT01075321|566574265|FG002|Overall Study|Treatment Incomplete due to progression|0|||
156951349|NCT01075321|566574266|FG003|Overall Study|Treatment Incomplete due to progression|0|||
156951350|NCT01075321|566574263|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
156951351|NCT01075321|566574264|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
156951352|NCT01075321|566574265|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
156951353|NCT01075321|566574266|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
156951354|NCT02246998|566574267|FG000|Overall Study|Adverse Event|0|||
156951355|NCT02246998|566574268|FG001|Overall Study|Adverse Event|1|||
156951356|NCT02246998|566574269|FG002|Overall Study|Adverse Event|1|||
156951357|NCT02246998|566574270|FG003|Overall Study|Adverse Event|0|||
156951358|NCT02246998|566574267|FG000|Overall Study|Lost to Follow-up|1|||
156951359|NCT02246998|566574268|FG001|Overall Study|Lost to Follow-up|0|||
156951360|NCT02246998|566574269|FG002|Overall Study|Lost to Follow-up|0|||
156951361|NCT02246998|566574270|FG003|Overall Study|Lost to Follow-up|1|||
156951362|NCT02246998|566574267|FG000|Overall Study|Randomized but Never Dosed|1|||
156951363|NCT02246998|566574268|FG001|Overall Study|Randomized but Never Dosed|2|||
156951364|NCT02246998|566574269|FG002|Overall Study|Randomized but Never Dosed|2|||
156951365|NCT02246998|566574270|FG003|Overall Study|Randomized but Never Dosed|1|||
156951366|NCT01075074|566574273|FG000|Overall Study|Surgeon changed to open incisional case|1|||
156951367|NCT01075074|566574274|FG001|Overall Study|Surgeon changed to open incisional case|2|||
156951368|NCT01075074|566574275|FG002|Overall Study|Surgeon changed to open incisional case|2|||
156951369|NCT01054729|566574277|FG000|Overall Study|Randomized but Not Treated|0|||
156951370|NCT01054729|566574278|FG001|Overall Study|Randomized but Not Treated|1|||
156951371|NCT01054729|566574279|FG002|Overall Study|Randomized but Not Treated|0|||
156951372|NCT01054729|566574280|FG003|Overall Study|Randomized but Not Treated|0|||
157035307|NCT05866926|566887098|FG000|Overall Study|Withdrawal by Subject|5|||
157035308|NCT05866926|566887099|FG001|Overall Study|Withdrawal by Subject|1|||
157035309|NCT05866926|566887098|FG000|Overall Study|Disease progression|1|||
157035310|NCT05866926|566887099|FG001|Overall Study|Disease progression|0|||
156951373|NCT01054729|566574277|FG000|Overall Study|Adverse Event|1|||
156951374|NCT01054729|566574278|FG001|Overall Study|Adverse Event|1|||
156951375|NCT01054729|566574279|FG002|Overall Study|Adverse Event|2|||
156951376|NCT01054729|566574280|FG003|Overall Study|Adverse Event|1|||
156951377|NCT01054729|566574277|FG000|Overall Study|Withdrawal by Subject|1|||
157035311|NCT05866926|566887098|FG000|Overall Study|other causes|2|||
157035312|NCT05866926|566887099|FG001|Overall Study|other causes|1|||
157035313|NCT01105091|566887100|FG000|Overall Study|Death|2|||
156951378|NCT01054729|566574278|FG001|Overall Study|Withdrawal by Subject|0|||
156951379|NCT01054729|566574279|FG002|Overall Study|Withdrawal by Subject|1|||
156951380|NCT01054729|566574280|FG003|Overall Study|Withdrawal by Subject|0|||
156951381|NCT01054729|566574277|FG000|Overall Study|Lost to Follow-up|0|||
156951382|NCT01054729|566574278|FG001|Overall Study|Lost to Follow-up|1|||
156951383|NCT01054729|566574279|FG002|Overall Study|Lost to Follow-up|0|||
156951384|NCT01054729|566574280|FG003|Overall Study|Lost to Follow-up|0|||
156951385|NCT01054729|566574277|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156951386|NCT01054729|566574278|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
156951387|NCT01054729|566574279|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156951388|NCT01054729|566574280|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
156951389|NCT01054729|566574277|FG000|Overall Study|Non-responder|1|||
156951390|NCT01054729|566574278|FG001|Overall Study|Non-responder|0|||
156951391|NCT01054729|566574279|FG002|Overall Study|Non-responder|1|||
156951392|NCT01054729|566574280|FG003|Overall Study|Non-responder|1|||
156951393|NCT01054729|566574277|FG000|Overall Study|PEG/RBV Non-responder|1|||
156951394|NCT01054729|566574278|FG001|Overall Study|PEG/RBV Non-responder|0|||
156951395|NCT01054729|566574279|FG002|Overall Study|PEG/RBV Non-responder|1|||
156951396|NCT01054729|566574280|FG003|Overall Study|PEG/RBV Non-responder|0|||
156951397|NCT01054729|566574277|FG000|Overall Study|Personal/Obligations|0|||
156951398|NCT01054729|566574278|FG001|Overall Study|Personal/Obligations|1|||
156951399|NCT01054729|566574279|FG002|Overall Study|Personal/Obligations|0|||
156951400|NCT01054729|566574280|FG003|Overall Study|Personal/Obligations|0|||
156951401|NCT01054729|566574277|FG000|Overall Study|Subject moved|0|||
156951402|NCT01054729|566574278|FG001|Overall Study|Subject moved|0|||
156951403|NCT01054729|566574279|FG002|Overall Study|Subject moved|1|||
156951404|NCT01054729|566574280|FG003|Overall Study|Subject moved|0|||
156951405|NCT01054729|566574277|FG000|Overall Study|Lack of Efficacy|0|||
156951406|NCT01054729|566574278|FG001|Overall Study|Lack of Efficacy|0|||
156951407|NCT01054729|566574279|FG002|Overall Study|Lack of Efficacy|0|||
156951408|NCT01054729|566574280|FG003|Overall Study|Lack of Efficacy|1|||
156951409|NCT00844194|566574283|FG000|Overall Study|Adverse Event|17|||
156951410|NCT00844194|566574284|FG001|Overall Study|Adverse Event|5|||
156951411|NCT00844194|566574283|FG000|Overall Study|Protocol Violation|1|||
156951412|NCT00844194|566574284|FG001|Overall Study|Protocol Violation|1|||
156951413|NCT00844194|566574283|FG000|Overall Study|Lost to Follow-up|1|||
156951414|NCT00844194|566574284|FG001|Overall Study|Lost to Follow-up|1|||
156951415|NCT00844194|566574283|FG000|Overall Study|Withdrawal by Subject|2|||
156951416|NCT00844194|566574284|FG001|Overall Study|Withdrawal by Subject|1|||
156951417|NCT00844194|566574283|FG000|Overall Study|Lack of Efficacy|3|||
156951418|NCT00844194|566574284|FG001|Overall Study|Lack of Efficacy|0|||
156951419|NCT00844194|566574283|FG000|Overall Study|Other reason (not specified)|1|||
156951420|NCT00844194|566574284|FG001|Overall Study|Other reason (not specified)|0|||
156951421|NCT00575588|566574290|FG000|Overall Study|Adverse Event|11|||
156951422|NCT00575588|566574291|FG001|Overall Study|Adverse Event|13|||
156951423|NCT00575588|566574290|FG000|Overall Study|Withdrawal by Subject|27|||
156951424|NCT00575588|566574291|FG001|Overall Study|Withdrawal by Subject|31|||
156951425|NCT00575588|566574290|FG000|Overall Study|Lost to Follow-up|1|||
156951426|NCT00575588|566574291|FG001|Overall Study|Lost to Follow-up|3|||
156951427|NCT00575588|566574290|FG000|Overall Study|Death|4|||
156951428|NCT00575588|566574291|FG001|Overall Study|Death|2|||
156951429|NCT00575588|566574290|FG000|Overall Study|Incorrect enrollment|8|||
156951430|NCT00575588|566574291|FG001|Overall Study|Incorrect enrollment|4|||
156951431|NCT00575588|566574290|FG000|Overall Study|Study specific discontinuation criteria|203|||
156951432|NCT00575588|566574291|FG001|Overall Study|Study specific discontinuation criteria|218|||
156951433|NCT00575588|566574290|FG000|Overall Study|Severe non-compliance to protocol|5|||
156951434|NCT00575588|566574291|FG001|Overall Study|Severe non-compliance to protocol|7|||
156951435|NCT00575588|566574290|FG000|Overall Study|Safety reasons|2|||
156951436|NCT00575588|566574291|FG001|Overall Study|Safety reasons|1|||
157168319|NCT02034552|567357791|FG001|Overall Study|Non-compliance with study drug|0|||
156951437|NCT00575588|566574290|FG000|Overall Study|Elevated triglyceride|1|||
156951438|NCT00575588|566574291|FG001|Overall Study|Elevated triglyceride|0|||
156951439|NCT00575588|566574290|FG000|Overall Study|Patient moved|1|||
156951440|NCT00575588|566574291|FG001|Overall Study|Patient moved|3|||
156951441|NCT00575588|566574290|FG000|Overall Study|Impossible to determine HbA1c|0|||
156951442|NCT00575588|566574291|FG001|Overall Study|Impossible to determine HbA1c|1|||
156951443|NCT01430130|566574292|FG000|Overall Study|Lost to Follow-up|1|||
156951444|NCT01430130|566574292|FG000|Overall Study|Infection on Control Side of Incision|1|||
156951445|NCT02828111|566574294|FG000|Overall Study|Withdrawal by Subject|0|||
156951446|NCT02828111|566574295|FG001|Overall Study|Withdrawal by Subject|0|||
156951447|NCT02828111|566574296|FG002|Overall Study|Withdrawal by Subject|2|||
156951448|NCT02828111|566574297|FG003|Overall Study|Withdrawal by Subject|0|||
156951449|NCT02828111|566574298|FG004|Overall Study|Withdrawal by Subject|0|||
156951450|NCT02828111|566574294|FG000|Overall Study|Lost to Follow-up|0|||
156951451|NCT02828111|566574295|FG001|Overall Study|Lost to Follow-up|0|||
156951452|NCT02828111|566574296|FG002|Overall Study|Lost to Follow-up|0|||
156951453|NCT02828111|566574297|FG003|Overall Study|Lost to Follow-up|1|||
156951454|NCT02828111|566574298|FG004|Overall Study|Lost to Follow-up|1|||
156951455|NCT00840970|566574299|FG000|Overall Study|Adverse Event|0|||
156951456|NCT00840970|566574300|FG001|Overall Study|Adverse Event|0|||
156951457|NCT00840970|566574301|FG002|Overall Study|Adverse Event|1|||
156951458|NCT01854827|566574302|FG000|Overall Study|Death|1|||
156951459|NCT02843568|566574303|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
156951460|NCT02843568|566574304|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
156951461|NCT02843568|566574303|FG000|Overall Study|Death|3|||
156951462|NCT02843568|566574304|FG001|Overall Study|Death|3|||
156951463|NCT02843568|566574303|FG000|Overall Study|Withdrawal by Subject|1|||
156951464|NCT02843568|566574304|FG001|Overall Study|Withdrawal by Subject|1|||
157168320|NCT02034552|567357792|FG002|Overall Study|Non-compliance with study drug|1|||
156951465|NCT02843568|566574303|FG000|Overall Study|Lost to Follow-up|2|||
156951466|NCT02843568|566574304|FG001|Overall Study|Lost to Follow-up|0|||
156951467|NCT03586999|566574305|FG000|Overall Study|Lack of Efficacy|2|||
156951468|NCT03447769|566574306|FG000|Overall Study|Progressive disease|138|||
156951469|NCT03447769|566574307|FG001|Overall Study|Progressive disease|148|||
156951470|NCT03447769|566574306|FG000|Overall Study|Study terminated by Sponsor|60|||
156951471|NCT03447769|566574307|FG001|Overall Study|Study terminated by Sponsor|44|||
156951472|NCT03447769|566574306|FG000|Overall Study|Adverse Event|34|||
156951473|NCT03447769|566574307|FG001|Overall Study|Adverse Event|31|||
156951474|NCT03447769|566574306|FG000|Overall Study|Patient decision|27|||
156951475|NCT03447769|566574307|FG001|Overall Study|Patient decision|27|||
156951476|NCT03447769|566574306|FG000|Overall Study|Protocol deviation|4|||
156951477|NCT03447769|566574307|FG001|Overall Study|Protocol deviation|6|||
156951478|NCT03447769|566574306|FG000|Overall Study|Death|2|||
156951479|NCT03447769|566574307|FG001|Overall Study|Death|7|||
156951480|NCT03447769|566574306|FG000|Overall Study|Technical problems|1|||
156951481|NCT03447769|566574307|FG001|Overall Study|Technical problems|0|||
156951482|NCT03447769|566574306|FG000|Overall Study|Lost to Follow-up|0|||
156951483|NCT03447769|566574307|FG001|Overall Study|Lost to Follow-up|1|||
156951484|NCT03447769|566574306|FG000|Overall Study|Physician Decision|13|||
156951485|NCT03447769|566574307|FG001|Overall Study|Physician Decision|5|||
156951486|NCT03264989|566574312|FG000|Overall Study|Lost to Follow-up|1|||
156951487|NCT03264989|566574313|FG001|Overall Study|Lost to Follow-up|0|||
156951488|NCT03264989|566574312|FG000|Overall Study|New Therapy for study Indication|1|||
156951489|NCT03264989|566574313|FG001|Overall Study|New Therapy for study Indication|0|||
156951490|NCT03264989|566574312|FG000|Overall Study|Protocol Violation|0|||
156951491|NCT03264989|566574313|FG001|Overall Study|Protocol Violation|1|||
156951492|NCT03264989|566574312|FG000|Overall Study|Patient decision|13|||
156951493|NCT03264989|566574313|FG001|Overall Study|Patient decision|0|||
156951494|NCT03264989|566574312|FG000|Overall Study|Physician Decision|6|||
156951495|NCT03264989|566574313|FG001|Overall Study|Physician Decision|4|||
156951496|NCT03264989|566574312|FG000|Overall Study|Adverse Event|2|||
156951497|NCT03264989|566574313|FG001|Overall Study|Adverse Event|1|||
156951498|NCT03264989|566574312|FG000|Overall Study|Death|1|||
156951499|NCT03264989|566574313|FG001|Overall Study|Death|1|||
156951500|NCT03264989|566574312|FG000|Overall Study|Pregnancy|2|||
156951501|NCT03264989|566574313|FG001|Overall Study|Pregnancy|0|||
156951502|NCT03264989|566574312|FG000|Overall Study|End of Study|19|||
156951503|NCT03264989|566574313|FG001|Overall Study|End of Study|5|||
156951504|NCT00797667|566574319|FG000|Overall Study|Lack of Efficacy|0|||
156951505|NCT00797667|566574320|FG001|Overall Study|Lack of Efficacy|1|||
156951506|NCT00797667|566574321|FG002|Overall Study|Lack of Efficacy|0|||
156951507|NCT00797667|566574319|FG000|Overall Study|Lost to Follow-up|8|||
156951508|NCT00797667|566574320|FG001|Overall Study|Lost to Follow-up|12|||
156951509|NCT00797667|566574321|FG002|Overall Study|Lost to Follow-up|2|||
156951510|NCT00797667|566574319|FG000|Overall Study|Physician Decision|3|||
156951511|NCT00797667|566574320|FG001|Overall Study|Physician Decision|1|||
156951512|NCT00797667|566574321|FG002|Overall Study|Physician Decision|0|||
156951513|NCT00797667|566574319|FG000|Overall Study|Pregnancy|2|||
156951514|NCT00797667|566574320|FG001|Overall Study|Pregnancy|0|||
156951515|NCT00797667|566574321|FG002|Overall Study|Pregnancy|0|||
156951516|NCT00797667|566574319|FG000|Overall Study|Protocol Violation|2|||
156951517|NCT00797667|566574320|FG001|Overall Study|Protocol Violation|7|||
157035314|NCT01105091|566887101|FG001|Overall Study|Death|0|||
156951518|NCT00797667|566574321|FG002|Overall Study|Protocol Violation|0|||
156951519|NCT00797667|566574319|FG000|Overall Study|Study Terminated by Sponsor|217|||
156951520|NCT00797667|566574320|FG001|Overall Study|Study Terminated by Sponsor|216|||
156951521|NCT00797667|566574321|FG002|Overall Study|Study Terminated by Sponsor|115|||
156951522|NCT00797667|566574319|FG000|Overall Study|Withdrawal by Subject|9|||
156951523|NCT00797667|566574320|FG001|Overall Study|Withdrawal by Subject|14|||
156951524|NCT00797667|566574321|FG002|Overall Study|Withdrawal by Subject|2|||
157168321|NCT02034552|567357790|FG000|Overall Study|Clinical progression|5|||
156951525|NCT00797667|566574319|FG000|Overall Study|Adverse Event|19|||
156951526|NCT00797667|566574320|FG001|Overall Study|Adverse Event|8|||
156951527|NCT00797667|566574321|FG002|Overall Study|Adverse Event|8|||
156951528|NCT01986829|566574326|FG000|Overall Study|Death|1|||
156951529|NCT00733824|566574327|FG000|Phase I|Withdrawal by Subject|1|||
156951530|NCT00733824|566574328|FG001|Phase I|Withdrawal by Subject|0|||
156951531|NCT00733824|566574329|FG002|Phase I|Withdrawal by Subject|0|||
156951532|NCT00733824|566574330|FG003|Phase I|Withdrawal by Subject|0|||
156951533|NCT00733824|566574331|FG004|Phase I|Withdrawal by Subject|0|||
156951534|NCT01243944|566574333|FG000|Overall Study|Adverse Event|15|||
156951535|NCT01243944|566574334|FG001|Overall Study|Adverse Event|13|||
156951536|NCT01243944|566574333|FG000|Overall Study|Lost to Follow-up|2|||
156951537|NCT01243944|566574334|FG001|Overall Study|Lost to Follow-up|1|||
156951538|NCT01243944|566574333|FG000|Overall Study|Physician Decision|2|||
156951539|NCT01243944|566574334|FG001|Overall Study|Physician Decision|7|||
156951540|NCT01243944|566574333|FG000|Overall Study|Disease progression|12|||
156951541|NCT01243944|566574334|FG001|Overall Study|Disease progression|11|||
156951542|NCT01243944|566574333|FG000|Overall Study|Protocol deviation|1|||
156951543|NCT01243944|566574334|FG001|Overall Study|Protocol deviation|1|||
156951544|NCT01243944|566574333|FG000|Overall Study|Participant decision|10|||
156951545|NCT01243944|566574334|FG001|Overall Study|Participant decision|15|||
156951546|NCT01243944|566574333|FG000|Overall Study|Death|2|||
156951547|NCT01243944|566574334|FG001|Overall Study|Death|3|||
156951548|NCT01243944|566574333|FG000|Overall Study|Non-compliance with study treatment|1|||
156951549|NCT01243944|566574334|FG001|Overall Study|Non-compliance with study treatment|0|||
156951550|NCT02673697|566574340|FG000|Overall Study|Adverse Event|2|||
156951551|NCT02673697|566574341|FG001|Overall Study|Adverse Event|0|||
156951552|NCT02673697|566574340|FG000|Overall Study|Death|32|||
156951553|NCT02673697|566574341|FG001|Overall Study|Death|24|||
156951554|NCT02673697|566574340|FG000|Overall Study|Lost to Follow-up|5|||
156951555|NCT02673697|566574341|FG001|Overall Study|Lost to Follow-up|2|||
156951556|NCT02673697|566574340|FG000|Overall Study|Physician Decision|2|||
156951557|NCT02673697|566574341|FG001|Overall Study|Physician Decision|1|||
156951558|NCT02673697|566574340|FG000|Overall Study|Withdrawal by Subject|10|||
156951559|NCT02673697|566574341|FG001|Overall Study|Withdrawal by Subject|7|||
156951560|NCT02673697|566574340|FG000|Overall Study|Change subj medical status|1|||
156951561|NCT02673697|566574341|FG001|Overall Study|Change subj medical status|2|||
156951562|NCT02673697|566574340|FG000|Overall Study|Explant|10|||
156951563|NCT02673697|566574341|FG001|Overall Study|Explant|5|||
156951564|NCT02673697|566574340|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
156951565|NCT02673697|566574341|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
156951566|NCT00437489|566574342|FG000|Overall Study|Study terminated by sponsor|23|||
156951567|NCT00437489|566574343|FG001|Overall Study|Study terminated by sponsor|21|||
156951568|NCT00437489|566574342|FG000|Overall Study|Lost to Follow-up|0|||
156951569|NCT00437489|566574343|FG001|Overall Study|Lost to Follow-up|1|||
156951570|NCT01525082|566574351|FG000|Overall Study|Death|1|||
156951571|NCT03321981|566574359|FG000|Overall Study|Progressive Disease (PD)|15|||
156951572|NCT03321981|566574360|FG001|Overall Study|Progressive Disease (PD)|30|||
156951573|NCT03321981|566574361|FG002|Overall Study|Progressive Disease (PD)|47|||
156951574|NCT03321981|566574359|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
156951575|NCT03321981|566574360|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
156951576|NCT03321981|566574361|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
156951577|NCT03321981|566574359|FG000|Overall Study|Adverse Event|0|||
156951578|NCT03321981|566574360|FG001|Overall Study|Adverse Event|0|||
156951579|NCT03321981|566574361|FG002|Overall Study|Adverse Event|2|||
156951580|NCT03321981|566574359|FG000|Overall Study|symptomatic deterioration|0|||
156951581|NCT03321981|566574360|FG001|Overall Study|symptomatic deterioration|1|||
156951582|NCT03321981|566574361|FG002|Overall Study|symptomatic deterioration|1|||
156951583|NCT03321981|566574359|FG000|Overall Study|Lack of compliance|0|||
156951584|NCT03321981|566574360|FG001|Overall Study|Lack of compliance|1|||
156951585|NCT03321981|566574361|FG002|Overall Study|Lack of compliance|0|||
156951586|NCT03321981|566574359|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
156951587|NCT03321981|566574360|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
156951588|NCT03321981|566574361|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
156951589|NCT03321981|566574359|FG000|Overall Study|Death|0|||
156951590|NCT03321981|566574360|FG001|Overall Study|Death|1|||
157168322|NCT02034552|567357791|FG001|Overall Study|Clinical progression|7|||
157168323|NCT02034552|567357792|FG002|Overall Study|Clinical progression|9|||
157168324|NCT04116073|567357797|FG000|Overall Study|Withdrawal by Subject|2|||
157168325|NCT04116073|567357797|FG000|Overall Study|failed to maintained eligibility|1|||
157168326|NCT01453998|567357800|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
157168327|NCT01453998|567357801|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
157168328|NCT01453998|567357802|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
157168329|NCT01840228|567357812|FG000|Overall Study|Lost to Follow-up|1|||
157168330|NCT01840228|567357813|FG001|Overall Study|Lost to Follow-up|1|||
157168331|NCT03495453|567357816|FG000|Overall Study|Withdrawal by Subject|0|||
157168332|NCT03495453|567357817|FG001|Overall Study|Withdrawal by Subject|1|||
157168333|NCT00712933|567357818|FG000|Overall Study|Adverse Event|69|||
156951591|NCT03321981|566574361|FG002|Overall Study|Death|0|||
156951592|NCT03321981|566574359|FG000|Overall Study|Subject withdrawal of investigational product|0|||
156951593|NCT03321981|566574360|FG001|Overall Study|Subject withdrawal of investigational product|1|||
156951594|NCT03321981|566574361|FG002|Overall Study|Subject withdrawal of investigational product|0|||
156951595|NCT03321981|566574359|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
156951596|NCT03321981|566574360|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
156951597|NCT03321981|566574361|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
156951598|NCT03321981|566574359|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
156951599|NCT03321981|566574360|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
156951600|NCT03321981|566574361|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
156951601|NCT00022516|566574362|FG000|Overall Study|Adverse Event|0|||
156951602|NCT00022516|566574363|FG001|Overall Study|Adverse Event|59|||
156951603|NCT00022516|566574362|FG000|Overall Study|Lack of Efficacy|0|||
156951604|NCT00022516|566574363|FG001|Overall Study|Lack of Efficacy|27|||
156951605|NCT00022516|566574362|FG000|Overall Study|Physician Decision|0|||
156951606|NCT00022516|566574363|FG001|Overall Study|Physician Decision|1|||
156951607|NCT00022516|566574362|FG000|Overall Study|Protocol Violation|1|||
156951608|NCT00022516|566574363|FG001|Overall Study|Protocol Violation|3|||
156951609|NCT00022516|566574362|FG000|Overall Study|Withdrawal by Subject|2|||
156951610|NCT00022516|566574363|FG001|Overall Study|Withdrawal by Subject|113|||
156951611|NCT00022516|566574362|FG000|Overall Study|Incomplete documentation|0|||
156951612|NCT00022516|566574363|FG001|Overall Study|Incomplete documentation|27|||
156951613|NCT01568047|566574366|FG000|Overall Study|Ineligibility|1|||
156951614|NCT01568047|566574367|FG001|Overall Study|Ineligibility|0|||
156951615|NCT01568047|566574368|FG002|Overall Study|Ineligibility|0|||
156951616|NCT01568047|566574369|FG003|Overall Study|Ineligibility|0|||
156951617|NCT01568047|566574366|FG000|Overall Study|Withdrawal by Subject|0|||
156951618|NCT01568047|566574367|FG001|Overall Study|Withdrawal by Subject|1|||
156951619|NCT01568047|566574368|FG002|Overall Study|Withdrawal by Subject|0|||
156951620|NCT01568047|566574369|FG003|Overall Study|Withdrawal by Subject|0|||
156951621|NCT01568047|566574366|FG000|Overall Study|Adverse Event|0|||
156951622|NCT01568047|566574367|FG001|Overall Study|Adverse Event|0|||
156951623|NCT01568047|566574368|FG002|Overall Study|Adverse Event|1|||
156951624|NCT01568047|566574369|FG003|Overall Study|Adverse Event|1|||
156951625|NCT03783923|566574370|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
156951626|NCT03783923|566574371|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
156951627|NCT03783923|566574370|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
156951628|NCT03783923|566574371|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
156951629|NCT03783923|566574370|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
156951630|NCT03783923|566574371|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
156951631|NCT03783923|566574370|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
156951632|NCT03783923|566574371|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
156951633|NCT03783923|566574370|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
156951634|NCT03783923|566574371|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
156951635|NCT03067441|566574372|FG000|Overall Study|Withdrawal by Subject|16|||
156951636|NCT03067441|566574373|FG001|Overall Study|Withdrawal by Subject|34|||
156951637|NCT03067441|566574372|FG000|Overall Study|Lost to Follow-up|7|||
156951638|NCT03067441|566574373|FG001|Overall Study|Lost to Follow-up|5|||
156951639|NCT03067441|566574372|FG000|Overall Study|Adverse Event|7|||
156951640|NCT03067441|566574373|FG001|Overall Study|Adverse Event|14|||
156951641|NCT03067441|566574372|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
156951642|NCT03067441|566574373|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
156951643|NCT03067441|566574372|FG000|Overall Study|Physician Decision|1|||
156951644|NCT03067441|566574373|FG001|Overall Study|Physician Decision|3|||
156951645|NCT03067441|566574372|FG000|Overall Study|Other|1|||
156951646|NCT03067441|566574373|FG001|Overall Study|Other|1|||
156951647|NCT02209324|566574386|FG000|Overall Study|Adverse Event|2|||
156951648|NCT02209324|566574386|FG000|Overall Study|Lack of Efficacy|1|||
156951649|NCT02209324|566574386|FG000|Overall Study|Lost to Follow-up|1|||
156951650|NCT02209324|566574386|FG000|Overall Study|Physician Decision|3|||
156951651|NCT02209324|566574386|FG000|Overall Study|Protocol Violation|14|||
156951652|NCT02209324|566574386|FG000|Overall Study|Withdrawal by Subject|8|||
157227430|NCT00337077|567577792|FG001|Overall Study|Never started treatment|1|||
156951653|NCT02209324|566574386|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
156951654|NCT02209324|566574386|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
156951655|NCT02209324|566574386|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
156951656|NCT04177108|566574390|FG000|Overall Study|Withdrawal by Subject|4|||
156951657|NCT04177108|566574391|FG001|Overall Study|Withdrawal by Subject|8|||
156951658|NCT04177108|566574392|FG002|Overall Study|Withdrawal by Subject|9|||
156951659|NCT04177108|566574393|FG003|Overall Study|Withdrawal by Subject|11|||
156951660|NCT04177108|566574394|FG004|Overall Study|Withdrawal by Subject|13|||
156951661|NCT04177108|566574390|FG000|Overall Study|Physician Decision|23|||
156951662|NCT04177108|566574391|FG001|Overall Study|Physician Decision|15|||
156951663|NCT04177108|566574392|FG002|Overall Study|Physician Decision|18|||
156951664|NCT04177108|566574393|FG003|Overall Study|Physician Decision|29|||
156951665|NCT04177108|566574394|FG004|Overall Study|Physician Decision|23|||
156951666|NCT04177108|566574390|FG000|Overall Study|Reason Not Specified|0|||
156951667|NCT04177108|566574391|FG001|Overall Study|Reason Not Specified|1|||
156951668|NCT04177108|566574392|FG002|Overall Study|Reason Not Specified|0|||
156951669|NCT04177108|566574393|FG003|Overall Study|Reason Not Specified|0|||
156951670|NCT04177108|566574394|FG004|Overall Study|Reason Not Specified|2|||
156951671|NCT04177108|566574390|FG000|Overall Study|Lost to Follow-up|0|||
156951672|NCT04177108|566574391|FG001|Overall Study|Lost to Follow-up|0|||
156951673|NCT04177108|566574392|FG002|Overall Study|Lost to Follow-up|1|||
156951674|NCT04177108|566574393|FG003|Overall Study|Lost to Follow-up|1|||
156951675|NCT04177108|566574394|FG004|Overall Study|Lost to Follow-up|1|||
156951676|NCT04177108|566574390|FG000|Overall Study|Death|16|||
156951677|NCT04177108|566574391|FG001|Overall Study|Death|19|||
157035315|NCT04039113|566887104|FG000|Overall Study|Withdrawal by Subject|8|||
157035316|NCT04039113|566887105|FG001|Overall Study|Withdrawal by Subject|11|||
157035317|NCT04039113|566887104|FG000|Overall Study|Lost to Follow-up|1|||
157035318|NCT04039113|566887105|FG001|Overall Study|Lost to Follow-up|1|||
157035319|NCT04039113|566887104|FG000|Overall Study|Adverse Event|2|||
157035320|NCT04039113|566887105|FG001|Overall Study|Adverse Event|2|||
157035321|NCT04039113|566887104|FG000|Overall Study|Death|2|||
157035322|NCT04039113|566887105|FG001|Overall Study|Death|4|||
157035323|NCT04039113|566887104|FG000|Overall Study|Site Closure|6|||
157035324|NCT04039113|566887105|FG001|Overall Study|Site Closure|0|||
156951678|NCT04177108|566574392|FG002|Overall Study|Death|13|||
156951679|NCT04177108|566574393|FG003|Overall Study|Death|17|||
156951680|NCT04177108|566574394|FG004|Overall Study|Death|18|||
156951681|NCT04496258|566574395|FG000|Overall Study|Withdrawal by Subject|2|||
156951682|NCT04496258|566574396|FG001|Overall Study|Withdrawal by Subject|1|||
156951683|NCT01427712|566574397|FG000|Overall Study|Transfer to a different hospital|2|||
156951684|NCT01427712|566574397|FG000|Overall Study|Lost to Follow-up|1|||
156951685|NCT01427712|566574397|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
156951686|NCT01427712|566574397|FG000|Overall Study|Failure to visit|1|||
156951687|NCT00852397|566574398|FG000|Overall Study|Adverse Event|4|||
156951688|NCT00852397|566574399|FG001|Overall Study|Adverse Event|6|||
156951689|NCT00852397|566574400|FG002|Overall Study|Adverse Event|4|||
156951690|NCT00852397|566574398|FG000|Overall Study|Death|0|||
156951691|NCT00852397|566574399|FG001|Overall Study|Death|0|||
156951692|NCT00852397|566574400|FG002|Overall Study|Death|1|||
156951693|NCT00852397|566574398|FG000|Overall Study|Withdrawal by Subject|4|||
156951694|NCT00852397|566574399|FG001|Overall Study|Withdrawal by Subject|1|||
156951695|NCT00852397|566574400|FG002|Overall Study|Withdrawal by Subject|2|||
156951696|NCT00852397|566574398|FG000|Overall Study|Study terminated by sponsor|2|||
156951697|NCT00852397|566574399|FG001|Overall Study|Study terminated by sponsor|1|||
156951698|NCT00852397|566574400|FG002|Overall Study|Study terminated by sponsor|6|||
156951699|NCT00852397|566574398|FG000|Overall Study|Difficulty in study site visit|1|||
156951700|NCT00852397|566574399|FG001|Overall Study|Difficulty in study site visit|0|||
156951701|NCT00852397|566574400|FG002|Overall Study|Difficulty in study site visit|0|||
156951702|NCT00852397|566574398|FG000|Overall Study|Protocol Violation|0|||
156951703|NCT00852397|566574399|FG001|Overall Study|Protocol Violation|0|||
156951704|NCT00852397|566574400|FG002|Overall Study|Protocol Violation|1|||
156951705|NCT02239510|566576156|FG000|Overall Study|Lost to Follow-up|2|||
156951706|NCT02239510|566576157|FG001|Overall Study|Lost to Follow-up|1|||
156951707|NCT01773226|566576158|FG000|Overall Study|Withdrawal by Subject|1|||
156951708|NCT05349617|566576159|FG000|Overall Study|Death|1|||
156951709|NCT05349617|566576160|FG001|Overall Study|Death|1|||
156951710|NCT05349617|566576159|FG000|Overall Study|Lost to Follow-up|3|||
157035325|NCT04039113|566887104|FG000|Overall Study|Failure to meet randomisation criteria|4|||
157035326|NCT04039113|566887105|FG001|Overall Study|Failure to meet randomisation criteria|0|||
157091661|NCT00727311|567089189|FG000|Overall Study|Missing end of therapy data|205|||
157091662|NCT00727311|567089189|FG000|Overall Study|Adverse Event|58|||
157091663|NCT00727311|567089189|FG000|Overall Study|Lack of Efficacy|242|||
157091664|NCT00727311|567089189|FG000|Overall Study|Lost to Follow-up|73|||
156951711|NCT05349617|566576160|FG001|Overall Study|Lost to Follow-up|8|||
156951712|NCT05349617|566576159|FG000|Overall Study|Withdrawal by Subject|2|||
156951713|NCT05349617|566576160|FG001|Overall Study|Withdrawal by Subject|10|||
156951714|NCT05706506|566576161|FG000|Overall Study|Adverse Event|1|||
156951715|NCT05706506|566576161|FG000|Overall Study|Withdrawal by Subject|4|||
157091665|NCT00727311|567089189|FG000|Overall Study|Withdrawal by Subject|77|||
157091666|NCT00727311|567089189|FG000|Overall Study|Other|97|||
157168334|NCT00712933|567357818|FG000|Overall Study|Lack of Efficacy|6|||
156951716|NCT05706506|566576161|FG000|Overall Study|Lost to Follow-up|2|||
156951717|NCT05706506|566576161|FG000|Overall Study|Inadvertent Enrolment|12|||
156951718|NCT05706506|566576161|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
156951719|NCT05706506|566576161|FG000|Overall Study|Participant Moved Out of State|1|||
157091667|NCT00727311|567089189|FG000|Overall Study|Multiple reasons|39|||
157168335|NCT00712933|567357818|FG000|Overall Study|Lost to Follow-up|22|||
157168336|NCT00712933|567357818|FG000|Overall Study|Non-compliance with study drug|13|||
156951720|NCT01303627|566576165|FG000|Overall Study|the failure while performing URS|0|||
156951721|NCT01303627|566576166|FG001|Overall Study|the failure while performing URS|1|||
156951722|NCT00321919|566576167|FG000|Overall Study|Adverse Event|17|||
156951723|NCT00321919|566576168|FG001|Overall Study|Adverse Event|10|||
156951724|NCT00321919|566576167|FG000|Overall Study|Death|21|||
156951725|NCT00321919|566576168|FG001|Overall Study|Death|17|||
156951726|NCT00321919|566576167|FG000|Overall Study|Insufficient Therapeutic Response|1|||
156951727|NCT00321919|566576168|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156951728|NCT00321919|566576167|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
156951729|NCT00321919|566576168|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
156951730|NCT00321919|566576167|FG000|Overall Study|Refused Treatment|23|||
156951731|NCT00321919|566576168|FG001|Overall Study|Refused Treatment|14|||
156951732|NCT00321919|566576167|FG000|Overall Study|Other Protocol Violation|2|||
156951733|NCT00321919|566576168|FG001|Overall Study|Other Protocol Violation|3|||
156951734|NCT00321919|566576167|FG000|Overall Study|Failure to Return|3|||
156951735|NCT00321919|566576168|FG001|Overall Study|Failure to Return|1|||
156951736|NCT00321919|566576167|FG000|Overall Study|Other withdrawal reason|7|||
156951737|NCT00321919|566576168|FG001|Overall Study|Other withdrawal reason|6|||
156951738|NCT02590354|566576169|FG000|Phase 1|Active hepatitis B or C infection|1|||
156951739|NCT02590354|566576169|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
156951740|NCT02590354|566576169|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
156951741|NCT02590354|566576169|FG000|Phase 1|Subject does not want to participate|20|||
156951742|NCT02590354|566576169|FG000|Phase 1|Lost to Follow-up|1|||
156951743|NCT02590354|566576169|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
156951744|NCT00996996|566576170|FG000|Overall Study|Progressive Disease|10|||
156951745|NCT00996996|566576170|FG000|Overall Study|Non-compliance|8|||
156951746|NCT00996996|566576170|FG000|Overall Study|Lost to Follow-up|9|||
156951747|NCT00996996|566576170|FG000|Overall Study|Death|5|||
156951748|NCT00996996|566576170|FG000|Overall Study|Did Not Receive Study Medications|1|||
156951749|NCT02019719|566576171|FG000|Overall Study|Adverse Event|1|||
156951750|NCT02019719|566576172|FG001|Overall Study|Adverse Event|0|||
156951751|NCT02019719|566576173|FG002|Overall Study|Adverse Event|0|||
156951752|NCT02019719|566576174|FG003|Overall Study|Adverse Event|1|||
156951753|NCT02019719|566576175|FG004|Overall Study|Adverse Event|1|||
156951754|NCT02019719|566576171|FG000|Overall Study|Protocol Violation|1|||
156951755|NCT02019719|566576172|FG001|Overall Study|Protocol Violation|1|||
156951756|NCT02019719|566576173|FG002|Overall Study|Protocol Violation|0|||
156951757|NCT02019719|566576174|FG003|Overall Study|Protocol Violation|0|||
156951758|NCT02019719|566576175|FG004|Overall Study|Protocol Violation|0|||
156951759|NCT02019719|566576171|FG000|Overall Study|Protocol defined stopping criteria|2|||
156951760|NCT02019719|566576172|FG001|Overall Study|Protocol defined stopping criteria|0|||
156951761|NCT02019719|566576173|FG002|Overall Study|Protocol defined stopping criteria|0|||
156951762|NCT02019719|566576174|FG003|Overall Study|Protocol defined stopping criteria|1|||
156951763|NCT02019719|566576175|FG004|Overall Study|Protocol defined stopping criteria|1|||
156951764|NCT02019719|566576171|FG000|Overall Study|Physician Decision|2|||
156951765|NCT02019719|566576172|FG001|Overall Study|Physician Decision|0|||
156951766|NCT02019719|566576173|FG002|Overall Study|Physician Decision|0|||
156951767|NCT02019719|566576174|FG003|Overall Study|Physician Decision|0|||
156951768|NCT02019719|566576175|FG004|Overall Study|Physician Decision|0|||
156951769|NCT01055639|566576177|FG000|Overall Study|Adverse Event|0|||
156951770|NCT01055639|566576178|FG001|Overall Study|Adverse Event|1|||
156951771|NCT01055639|566576177|FG000|Overall Study|Lack of Efficacy|0|||
156951772|NCT01055639|566576178|FG001|Overall Study|Lack of Efficacy|1|||
156951773|NCT01055639|566576177|FG000|Overall Study|Lost to Follow-up|8|||
156951774|NCT01055639|566576178|FG001|Overall Study|Lost to Follow-up|11|||
156951775|NCT01055639|566576177|FG000|Overall Study|Protocol Violation|5|||
156951776|NCT01055639|566576178|FG001|Overall Study|Protocol Violation|5|||
156951777|NCT01055639|566576177|FG000|Overall Study|Withdrawal by Subject|8|||
156951778|NCT01055639|566576178|FG001|Overall Study|Withdrawal by Subject|11|||
156951779|NCT02546544|566576182|FG000|Overall Study|Disease Progression|14|||
156951780|NCT02546544|566576182|FG000|Overall Study|Adverse Event|1|||
156951781|NCT02546544|566576182|FG000|Overall Study|Withdrawal by Subject|1|||
156951782|NCT01921348|566576183|FG000|Overall Study|Withdrawal by Subject|1|||
156951783|NCT01921348|566576184|FG001|Overall Study|Withdrawal by Subject|0|||
156951784|NCT01921348|566576183|FG000|Overall Study|Lost to Follow-up|0|||
156951785|NCT01921348|566576184|FG001|Overall Study|Lost to Follow-up|2|||
156951786|NCT02223390|566576185|FG000|Overall Study|Lost to Follow-up|9|||
156951787|NCT02223390|566576186|FG001|Overall Study|Lost to Follow-up|4|||
156951788|NCT02896855|566576188|FG000|Overall Study|Death|50|||
156951789|NCT02896855|566576189|FG001|Overall Study|Death|40|||
156951790|NCT02896855|566576188|FG000|Overall Study|Lost to Follow-up|15|||
156951791|NCT02896855|566576189|FG001|Overall Study|Lost to Follow-up|9|||
156951792|NCT02896855|566576188|FG000|Overall Study|Withdrawal by Subject|7|||
156951793|NCT02896855|566576189|FG001|Overall Study|Withdrawal by Subject|4|||
156951794|NCT02169674|566576190|FG000|Overall Study|Withdrawal by Subject|2|||
156951795|NCT02169674|566576191|FG001|Overall Study|Withdrawal by Subject|1|||
156951796|NCT02169674|566576190|FG000|Overall Study|Seroprotected|30|||
156951797|NCT02169674|566576191|FG001|Overall Study|Seroprotected|76|||
156951798|NCT02169674|566576190|FG000|Overall Study|Lost to Follow-up|0|||
156951799|NCT02169674|566576191|FG001|Overall Study|Lost to Follow-up|1|||
156951800|NCT02511431|566576192|FG000|Treatment|Lost to Follow-up|0|||
156951801|NCT02511431|566576193|FG001|Treatment|Lost to Follow-up|0|||
156951802|NCT02511431|566576194|FG002|Treatment|Lost to Follow-up|1|||
156951803|NCT02511431|566576195|FG003|Treatment|Lost to Follow-up|0|||
156951804|NCT02511431|566576196|FG004|Treatment|Lost to Follow-up|0|||
156951805|NCT02511431|566576197|FG005|Treatment|Lost to Follow-up|1|||
156951806|NCT03525834|566576200|FG000|Overall Study|Progressive disease|1|||
156951807|NCT00614939|566576203|FG000|Overall Study|Withdrawal by Subject|10|||
156951808|NCT00614939|566576204|FG001|Overall Study|Withdrawal by Subject|17|||
156951809|NCT00614939|566576203|FG000|Overall Study|Study specific discontinuation criteris|13|||
156951810|NCT00614939|566576204|FG001|Overall Study|Study specific discontinuation criteris|16|||
156951811|NCT00614939|566576203|FG000|Overall Study|Adverse Event|2|||
156951812|NCT00614939|566576204|FG001|Overall Study|Adverse Event|5|||
156951813|NCT00614939|566576203|FG000|Overall Study|Incorrect enrollment|1|||
156951814|NCT00614939|566576204|FG001|Overall Study|Incorrect enrollment|2|||
156951815|NCT00614939|566576203|FG000|Overall Study|Death|4|||
156951816|NCT00614939|566576204|FG001|Overall Study|Death|3|||
156951817|NCT00614939|566576203|FG000|Overall Study|Poor/non-compliance|4|||
156951818|NCT00614939|566576204|FG001|Overall Study|Poor/non-compliance|0|||
156951819|NCT00614939|566576203|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
156951820|NCT00614939|566576204|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
156951821|NCT00504829|566576205|FG000|Overall Study|Protocol Violation|6|||
156951822|NCT00504829|566576206|FG001|Overall Study|Protocol Violation|4|||
156951823|NCT00504829|566576207|FG002|Overall Study|Protocol Violation|10|||
156951824|NCT00736996|566576208|FG000|Overall Study|Lost to Follow-up|1|||
156951825|NCT00736996|566576209|FG001|Overall Study|Lost to Follow-up|9|||
156951826|NCT00736996|566576210|FG002|Overall Study|Lost to Follow-up|2|||
156951827|NCT00462384|566576211|FG000|Overall Study|Adverse Event|2|||
156951828|NCT00462384|566576211|FG000|Overall Study|Death|2|||
156951829|NCT00462384|566576211|FG000|Overall Study|Withdrawal by Subject|1|||
156951830|NCT00462384|566576211|FG000|Overall Study|Other|4|||
156951831|NCT04000165|566576212|FG000|Overall Study|Physician Decision|1|||
156951832|NCT04000165|566576212|FG000|Overall Study|Withdrawal by Subject|1|||
156951833|NCT01753193|566576213|FG000|Overall Study|Withdrawal by Subject|23|||
156951834|NCT01753193|566576213|FG000|Overall Study|Lost to Follow-up|6|||
156951835|NCT01753193|566576213|FG000|Overall Study|Death|1|||
156951836|NCT01753193|566576213|FG000|Overall Study|Other|16|||
156951837|NCT02682264|566576214|FG000|Overall Study|Withdrawal by Subject|56|||
156951838|NCT02682264|566576215|FG001|Overall Study|Withdrawal by Subject|45|||
156951839|NCT02682264|566576214|FG000|Overall Study|Lost to Follow-up|49|||
156951840|NCT02682264|566576215|FG001|Overall Study|Lost to Follow-up|41|||
156951841|NCT02682264|566576214|FG000|Overall Study|Lack of Efficacy|14|||
156951842|NCT02682264|566576215|FG001|Overall Study|Lack of Efficacy|16|||
156951843|NCT02682264|566576214|FG000|Overall Study|Withdrawal by Parent|6|||
156951844|NCT02682264|566576215|FG001|Overall Study|Withdrawal by Parent|7|||
156951845|NCT02682264|566576214|FG000|Overall Study|Adverse Event|9|||
156951846|NCT02682264|566576215|FG001|Overall Study|Adverse Event|0|||
156951847|NCT02682264|566576214|FG000|Overall Study|Noncompliance with study drug|1|||
156951848|NCT02682264|566576215|FG001|Overall Study|Noncompliance with study drug|4|||
156951849|NCT02682264|566576214|FG000|Overall Study|Pregnancy|1|||
156951850|NCT02682264|566576215|FG001|Overall Study|Pregnancy|2|||
156951851|NCT02682264|566576214|FG000|Overall Study|Recovery|1|||
156951852|NCT02682264|566576215|FG001|Overall Study|Recovery|2|||
156951853|NCT02682264|566576214|FG000|Overall Study|Progressive Disease|1|||
156951854|NCT02682264|566576215|FG001|Overall Study|Progressive Disease|0|||
156951855|NCT02682264|566576214|FG000|Overall Study|Technical Problems|0|||
156951856|NCT02682264|566576215|FG001|Overall Study|Technical Problems|1|||
156951857|NCT02682264|566576214|FG000|Overall Study|Moved abroad and unable to continue|0|||
156951858|NCT02682264|566576215|FG001|Overall Study|Moved abroad and unable to continue|3|||
156951859|NCT02682264|566576214|FG000|Overall Study|Stopped test article application|0|||
156951860|NCT02682264|566576215|FG001|Overall Study|Stopped test article application|1|||
156951861|NCT01131312|566576216|FG000|Overall Study|Lost to Follow-up|425|||
156951862|NCT01131312|566576217|FG001|Overall Study|Lost to Follow-up|229|||
156951863|NCT01131312|566576218|FG002|Overall Study|Lost to Follow-up|351|||
156951864|NCT01751568|566576231|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
156951865|NCT01751568|566576232|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
156951866|NCT01751568|566576233|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
156951867|NCT02660944|566576234|FG000|Overall Study|Adverse Event|3|||
156951868|NCT02660944|566576235|FG001|Overall Study|Adverse Event|4|||
156951869|NCT02660944|566576234|FG000|Overall Study|Physician Decision|3|||
156951870|NCT02660944|566576235|FG001|Overall Study|Physician Decision|1|||
156951871|NCT02660944|566576234|FG000|Overall Study|Withdrawal by Subject|5|||
156951872|NCT02660944|566576235|FG001|Overall Study|Withdrawal by Subject|3|||
156951873|NCT02660944|566576234|FG000|Overall Study|Lost to Follow-up|4|||
156951874|NCT02660944|566576235|FG001|Overall Study|Lost to Follow-up|1|||
157168337|NCT00712933|567357818|FG000|Overall Study|Other Pregnancy|37|||
157168338|NCT00712933|567357818|FG000|Overall Study|Sponsor decision|14|||
157168339|NCT00712933|567357818|FG000|Overall Study|Withdrew consent|4|||
156951875|NCT02660944|566576234|FG000|Overall Study|Subject schedule|0|||
156951876|NCT02660944|566576235|FG001|Overall Study|Subject schedule|1|||
156951877|NCT02660944|566576234|FG000|Overall Study|Exclusion criteria met|2|||
156951878|NCT02660944|566576235|FG001|Overall Study|Exclusion criteria met|0|||
156951879|NCT03879798|566576237|FG000|Overall Study|Adverse Event|0|||
156951880|NCT03879798|566576238|FG001|Overall Study|Adverse Event|0|||
156951881|NCT03879798|566576239|FG002|Overall Study|Adverse Event|0|||
156951882|NCT03879798|566576240|FG003|Overall Study|Adverse Event|0|||
156951883|NCT03879798|566576241|FG004|Overall Study|Adverse Event|0|||
156951884|NCT03879798|566576242|FG005|Overall Study|Adverse Event|1|||
156951885|NCT03879798|566576237|FG000|Overall Study|Lack of Efficacy|0|||
156951886|NCT03879798|566576238|FG001|Overall Study|Lack of Efficacy|0|||
156951887|NCT03879798|566576239|FG002|Overall Study|Lack of Efficacy|0|||
156951888|NCT03879798|566576240|FG003|Overall Study|Lack of Efficacy|0|||
156951889|NCT03879798|566576241|FG004|Overall Study|Lack of Efficacy|0|||
156951890|NCT03879798|566576242|FG005|Overall Study|Lack of Efficacy|1|||
156951891|NCT03879798|566576237|FG000|Overall Study|Withdrawal by Subject|0|||
156951892|NCT03879798|566576238|FG001|Overall Study|Withdrawal by Subject|0|||
156951893|NCT03879798|566576239|FG002|Overall Study|Withdrawal by Subject|0|||
156951894|NCT03879798|566576240|FG003|Overall Study|Withdrawal by Subject|0|||
156951895|NCT03879798|566576241|FG004|Overall Study|Withdrawal by Subject|0|||
156951896|NCT03879798|566576242|FG005|Overall Study|Withdrawal by Subject|1|||
156951897|NCT01343407|566576243|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
156951898|NCT01343407|566576244|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
156951899|NCT01343407|566576245|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
156951900|NCT01343407|566576246|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
156951901|NCT01343407|566576247|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
156951902|NCT01343407|566576248|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
156951903|NCT01343407|566576243|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
156951904|NCT01343407|566576244|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
156951905|NCT01343407|566576245|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
156951906|NCT01343407|566576246|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
156951907|NCT01343407|566576247|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
156951908|NCT01343407|566576248|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
156951909|NCT04079933|566576251|FG000|Overall Study|Withdrawal by Subject|3|||
156951910|NCT04079933|566576252|FG001|Overall Study|Withdrawal by Subject|4|||
156951911|NCT04079933|566576251|FG000|Overall Study|Lost to Follow-up|0|||
156951912|NCT04079933|566576252|FG001|Overall Study|Lost to Follow-up|1|||
156951913|NCT02504866|566576253|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
156951914|NCT02504866|566576254|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
156951915|NCT02504866|566576255|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
156951916|NCT01229436|566576256|FG000|Overall Study|Withdrawal by Subject|2|||
156951917|NCT01229436|566576256|FG000|Overall Study|Lost to Follow-up|3|||
156951918|NCT01775137|566576257|FG000|Overall Study|Death|1|||
156951919|NCT01775137|566576257|FG000|Overall Study|Protocol deviation|2|||
156951920|NCT01775137|566576257|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156951921|NCT01775137|566576257|FG000|Overall Study|Adverse Event|1|||
156951922|NCT01775137|566576257|FG000|Overall Study|Withdrawal by participants|5|||
156951923|NCT01343056|566576258|FG000|Overall Study|Lost to Follow-up|7|||
156951924|NCT01343056|566576259|FG001|Overall Study|Lost to Follow-up|5|||
156951925|NCT01343056|566576260|FG002|Overall Study|Lost to Follow-up|3|||
156951926|NCT01343056|566576261|FG003|Overall Study|Lost to Follow-up|9|||
156951927|NCT02059148|566576262|FG000|Treatment 1|Protocol Violation|0|||
156951928|NCT02059148|566576263|FG001|Treatment 1|Protocol Violation|0|||
156951929|NCT02059148|566576264|FG002|Treatment 1|Protocol Violation|0|||
156951930|NCT02059148|566576265|FG003|Treatment 1|Protocol Violation|0|||
156951931|NCT02059148|566576266|FG004|Treatment 1|Protocol Violation|0|||
156951932|NCT02059148|566576267|FG005|Treatment 1|Protocol Violation|1|||
156951933|NCT03893448|566576268|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
156951934|NCT03893448|566576269|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
156951935|NCT03893448|566576268|FG000|Overall Study|Physician Decision|8|||
156951936|NCT03893448|566576269|FG001|Overall Study|Physician Decision|14|||
156951937|NCT03893448|566576268|FG000|Overall Study|Lost to Follow-up|34|||
156951938|NCT03893448|566576269|FG001|Overall Study|Lost to Follow-up|27|||
156951939|NCT03893448|566576268|FG000|Overall Study|Death|1|||
156951940|NCT03893448|566576269|FG001|Overall Study|Death|0|||
157168340|NCT00712933|567357818|FG000|Overall Study|Hip replacement surgery|1|||
157168341|NCT00712933|567357818|FG000|Overall Study|Involved in Clinical research|3|||
157168342|NCT00712933|567357818|FG000|Overall Study|Participant hospitalized|1|||
157168343|NCT00712933|567357818|FG000|Overall Study|Participant travelled overseas|2|||
156951941|NCT01944046|566576270|FG000|Randomized to DB|Adverse Event|5|||
156951942|NCT01944046|566576271|FG001|Randomized to DB|Adverse Event|2|||
156951943|NCT01944046|566576270|FG000|Randomized to DB|Clinical Worsening|3|||
156951944|NCT01944046|566576271|FG001|Randomized to DB|Clinical Worsening|2|||
157168344|NCT00712933|567357818|FG000|Overall Study|Death of patient|1|||
156951945|NCT01944046|566576270|FG000|Randomized to DB|Lost to Follow-up|3|||
156951946|NCT01944046|566576271|FG001|Randomized to DB|Lost to Follow-up|3|||
156951947|NCT01944046|566576270|FG000|Randomized to DB|Withdrawal by Subject|2|||
156951948|NCT01944046|566576271|FG001|Randomized to DB|Withdrawal by Subject|4|||
156951949|NCT01944046|566576270|FG000|Randomized to DB|Physician Decision|1|||
156951950|NCT01944046|566576271|FG001|Randomized to DB|Physician Decision|2|||
156951951|NCT01944046|566576270|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
156951952|NCT01944046|566576271|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
156951953|NCT01944046|566576270|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
156951954|NCT01944046|566576271|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
156951955|NCT01944046|566576270|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
156951956|NCT01944046|566576271|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
156951957|NCT01944046|566576270|FG000|Open Label Eligible and Consented|Adverse Event|6|||
156951958|NCT01944046|566576271|FG001|Open Label Eligible and Consented|Adverse Event|1|||
156951959|NCT01944046|566576270|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
156951960|NCT01944046|566576271|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
156951961|NCT01944046|566576270|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
156951962|NCT01944046|566576271|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
156951963|NCT02007577|566576274|FG000|Overall Study|Adverse Event|1|||
156951964|NCT02007577|566576275|FG001|Overall Study|Adverse Event|0|||
156951965|NCT02007577|566576274|FG000|Overall Study|Withdrawal by Subject|0|||
156951966|NCT02007577|566576275|FG001|Overall Study|Withdrawal by Subject|1|||
156951967|NCT00661492|566576281|FG000|Overall Study|Adverse Event|16|||
156951968|NCT00661492|566576282|FG001|Overall Study|Adverse Event|13|||
156951969|NCT00661492|566576281|FG000|Overall Study|Disease Progression|44|||
156951970|NCT00661492|566576282|FG001|Overall Study|Disease Progression|14|||
156951971|NCT00661492|566576281|FG000|Overall Study|Patient Request|6|||
156951972|NCT00661492|566576282|FG001|Overall Study|Patient Request|1|||
156951973|NCT00661492|566576281|FG000|Overall Study|Investigator Request|1|||
156951974|NCT00661492|566576282|FG001|Overall Study|Investigator Request|0|||
156951975|NCT00661492|566576281|FG000|Overall Study|Lost to Follow-up|0|||
156951976|NCT00661492|566576282|FG001|Overall Study|Lost to Follow-up|1|||
156951977|NCT00661492|566576281|FG000|Overall Study|Other|1|||
156951978|NCT00661492|566576282|FG001|Overall Study|Other|0|||
156951979|NCT01143259|566576283|FG000|Overall Study|Withdrawal by Subject|3|||
156951980|NCT01143259|566576284|FG001|Overall Study|Withdrawal by Subject|2|||
156951981|NCT01143259|566576283|FG000|Overall Study|Protocol Violation|13|||
156951982|NCT01143259|566576284|FG001|Overall Study|Protocol Violation|9|||
156951983|NCT01143259|566576283|FG000|Overall Study|Screen Failure|7|||
156951984|NCT01143259|566576284|FG001|Overall Study|Screen Failure|9|||
156951985|NCT00099983|566576285|FG000|Overall Study|Lost to Follow-up|2|||
156951986|NCT00099983|566576286|FG001|Overall Study|Lost to Follow-up|3|||
156951987|NCT00099983|566576285|FG000|Overall Study|Missing Source Documents|14|||
156951988|NCT00099983|566576286|FG001|Overall Study|Missing Source Documents|15|||
156951989|NCT00099983|566576285|FG000|Overall Study|Withdrawal by Subject|3|||
156951990|NCT00099983|566576286|FG001|Overall Study|Withdrawal by Subject|2|||
156951991|NCT00099983|566576285|FG000|Overall Study|Adverse Event|1|||
156951992|NCT00099983|566576286|FG001|Overall Study|Adverse Event|1|||
156951993|NCT00099983|566576285|FG000|Overall Study|Lack of Efficacy|0|||
156951994|NCT00099983|566576286|FG001|Overall Study|Lack of Efficacy|1|||
156951995|NCT00099983|566576285|FG000|Overall Study|Unable to return for appointments|1|||
156951996|NCT00099983|566576286|FG001|Overall Study|Unable to return for appointments|1|||
156951997|NCT00099983|566576285|FG000|Overall Study|Moved|1|||
156951998|NCT00099983|566576286|FG001|Overall Study|Moved|0|||
156951999|NCT00099983|566576285|FG000|Overall Study|Other psychiatric problem|1|||
156952000|NCT00099983|566576286|FG001|Overall Study|Other psychiatric problem|0|||
156952001|NCT00099983|566576285|FG000|Overall Study|Incarcerated|0|||
156952002|NCT00099983|566576286|FG001|Overall Study|Incarcerated|1|||
156952003|NCT00099983|566576285|FG000|Overall Study|Intolerant of burden of visits|0|||
156952004|NCT00099983|566576286|FG001|Overall Study|Intolerant of burden of visits|1|||
157168345|NCT00712933|567357818|FG000|Overall Study|Other Physician decision|1|||
157168346|NCT00712933|567357818|FG000|Overall Study|Not committed to contraception|1|||
157168347|NCT00712933|567357818|FG000|Overall Study|Participant received medication|1|||
157168348|NCT00712933|567357818|FG000|Overall Study|Physician Decision|36|||
157168349|NCT00712933|567357818|FG000|Overall Study|Protocol Violation|4|||
156952005|NCT00099983|566576285|FG000|Overall Study|Other issue|1|||
156952006|NCT00099983|566576286|FG001|Overall Study|Other issue|0|||
156952007|NCT02641080|566576287|FG000|Overall Study|Physician Decision|2|||
157168350|NCT00712933|567357818|FG000|Overall Study|Withdrawal by Subject|151|||
156952008|NCT02641080|566576288|FG001|Overall Study|Physician Decision|0|||
156952009|NCT02641080|566576287|FG000|Overall Study|Withdrawal by Subject|0|||
156952010|NCT02641080|566576288|FG001|Overall Study|Withdrawal by Subject|1|||
156952011|NCT02641080|566576287|FG000|Overall Study|Rehab Center denied use of pumps|0|||
156952012|NCT02641080|566576288|FG001|Overall Study|Rehab Center denied use of pumps|3|||
157168351|NCT01413542|567357820|FG000|Overall Study|Physician Decision|1|||
157168352|NCT01413542|567357821|FG001|Overall Study|Physician Decision|0|||
157168353|NCT01413542|567357822|FG002|Overall Study|Physician Decision|3|||
156952013|NCT02641080|566576287|FG000|Overall Study|Lost to Follow-up|0|||
156952014|NCT02641080|566576288|FG001|Overall Study|Lost to Follow-up|3|||
156952015|NCT00803634|566576289|FG000|Overall Study|Withdrew Consent|1|||
156952016|NCT00803634|566576290|FG001|Overall Study|Withdrew Consent|0|||
156952017|NCT00803634|566576289|FG000|Overall Study|Lost to Follow-up|2|||
156952018|NCT00803634|566576290|FG001|Overall Study|Lost to Follow-up|3|||
156952019|NCT00803634|566576289|FG000|Overall Study|Death|3|||
156952020|NCT00803634|566576290|FG001|Overall Study|Death|2|||
156952021|NCT04307186|566576291|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
156952022|NCT04307186|566576291|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
156952023|NCT04307186|566576291|FG000|Washout 3-14 Days|Progressive disease|1|||
156952024|NCT04307186|566576291|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
156952025|NCT04307186|566576291|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
156952026|NCT01618838|566576294|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
156952027|NCT03835533|566576295|FG000|Overall Study|Death|5|||
156952028|NCT03835533|566576296|FG001|Overall Study|Death|10|||
156952029|NCT03835533|566576297|FG002|Overall Study|Death|9|||
156952030|NCT03835533|566576295|FG000|Overall Study|Withdrawal by Subject|2|||
156952031|NCT03835533|566576296|FG001|Overall Study|Withdrawal by Subject|2|||
156952032|NCT03835533|566576297|FG002|Overall Study|Withdrawal by Subject|2|||
156952033|NCT03835533|566576295|FG000|Overall Study|Lost to Follow-up|1|||
156952034|NCT03835533|566576296|FG001|Overall Study|Lost to Follow-up|0|||
156952035|NCT03835533|566576297|FG002|Overall Study|Lost to Follow-up|0|||
156952036|NCT01866709|566576304|FG000|Overall Study|Adverse Event|1|||
156952037|NCT01866709|566576305|FG001|Overall Study|Adverse Event|0|||
156952038|NCT00499889|566576306|FG000|Overall Study|Infection prior to treatment|1|||
156952039|NCT00766376|566576310|FG000|Overall Study|Withdrawal by Subject|27|||
156952040|NCT03149328|566576313|FG000|Overall Study|Withdrawal by Subject|30|||
156952041|NCT03149328|566576314|FG001|Overall Study|Withdrawal by Subject|26|||
156952042|NCT03149328|566576313|FG000|Overall Study|Changed Dialysis Modality|18|||
156952043|NCT03149328|566576314|FG001|Overall Study|Changed Dialysis Modality|1|||
156952044|NCT03149328|566576313|FG000|Overall Study|Transplant|9|||
156952045|NCT03149328|566576314|FG001|Overall Study|Transplant|1|||
156952046|NCT03149328|566576313|FG000|Overall Study|Lost to Follow-up|25|||
156952047|NCT03149328|566576314|FG001|Overall Study|Lost to Follow-up|16|||
156952048|NCT03149328|566576313|FG000|Overall Study|Left Study Site|1|||
156952049|NCT03149328|566576314|FG001|Overall Study|Left Study Site|2|||
156952050|NCT03149328|566576313|FG000|Overall Study|Language Barrier|1|||
156952051|NCT03149328|566576314|FG001|Overall Study|Language Barrier|0|||
156952052|NCT01968434|566576330|FG000|Overall Study|Lost to Follow-up|3|||
156952053|NCT01968434|566576331|FG001|Overall Study|Lost to Follow-up|6|||
156952054|NCT02199691|566576332|FG000|Overall Study|Protocol Violation|3|||
156952055|NCT02199691|566576333|FG001|Overall Study|Protocol Violation|3|||
156952056|NCT02199691|566576334|FG002|Overall Study|Protocol Violation|6|||
156952057|NCT02199691|566576335|FG003|Overall Study|Protocol Violation|7|||
156952058|NCT02199691|566576332|FG000|Overall Study|Withdrawal by Subject|5|||
156952059|NCT02199691|566576333|FG001|Overall Study|Withdrawal by Subject|3|||
156952060|NCT02199691|566576334|FG002|Overall Study|Withdrawal by Subject|12|||
156952061|NCT02199691|566576335|FG003|Overall Study|Withdrawal by Subject|13|||
156952062|NCT02199691|566576332|FG000|Overall Study|Lost to Follow-up|2|||
156952063|NCT02199691|566576333|FG001|Overall Study|Lost to Follow-up|1|||
157035327|NCT02502266|566887792|FG000|Overall Study|Adverse Event|0|||
157168354|NCT01413542|567357823|FG003|Overall Study|Physician Decision|0|||
157168355|NCT01413542|567357820|FG000|Overall Study|Adverse Event|0|||
157168356|NCT01413542|567357821|FG001|Overall Study|Adverse Event|0|||
156952064|NCT02199691|566576334|FG002|Overall Study|Lost to Follow-up|9|||
156952065|NCT02199691|566576335|FG003|Overall Study|Lost to Follow-up|10|||
156952066|NCT00136955|566578167|FG000|Overall Study|Adverse Event|8|||
156952067|NCT00136955|566578167|FG000|Overall Study|Lost to Follow-up|1|||
156952068|NCT00136955|566578167|FG000|Overall Study|Withdrawal by Subject|2|||
156952069|NCT00136955|566578167|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
156952070|NCT04745169|566578171|FG000|Overall Study|Kidney transplantation|1|||
156952071|NCT04745169|566578171|FG000|Overall Study|Participant health problems|3|||
156952072|NCT04745169|566578171|FG000|Overall Study|Physician Decision|2|||
156952073|NCT00993447|566578172|FG000|Overall Study|Withdrawal by Subject|23|||
156952074|NCT00993447|566578173|FG001|Overall Study|Withdrawal by Subject|8|||
157035328|NCT02502266|566887793|FG001|Overall Study|Adverse Event|0|||
157168357|NCT01413542|567357822|FG002|Overall Study|Adverse Event|0|||
156952075|NCT00993447|566578172|FG000|Overall Study|Protocol Violation|12|||
156952076|NCT00993447|566578173|FG001|Overall Study|Protocol Violation|8|||
156952077|NCT00993447|566578172|FG000|Overall Study|Lost to Follow-up|1|||
156952078|NCT00993447|566578173|FG001|Overall Study|Lost to Follow-up|3|||
156952079|NCT00993447|566578172|FG000|Overall Study|Adverse Event|1|||
156952080|NCT00993447|566578173|FG001|Overall Study|Adverse Event|0|||
156952081|NCT01438411|566578175|FG000|Overall Study|Adverse Event|8|||
157168358|NCT01413542|567357823|FG003|Overall Study|Adverse Event|1|||
157168359|NCT01879319|567357826|FG000|Overall Study|Withdrawal by Subject|1|||
156952082|NCT01438411|566578175|FG000|Overall Study|Lost to Follow-up|1|||
156952083|NCT01438411|566578175|FG000|Overall Study|Lack of Efficacy|1|||
156952084|NCT01438411|566578175|FG000|Overall Study|Withdrawal by Subject|3|||
156952085|NCT01863680|566578176|FG000|Overall Study|Adverse Event|17|||
157168360|NCT01879319|567357827|FG001|Overall Study|Withdrawal by Subject|0|||
157168361|NCT01879319|567357826|FG000|Overall Study|Lost to Follow-up|1|||
157168362|NCT01879319|567357827|FG001|Overall Study|Lost to Follow-up|5|||
157168363|NCT00084929|567357831|FG000|Overall Study|ineligible - medical contraindication|1|||
157168364|NCT00084929|567357831|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
157168365|NCT00084929|567357831|FG000|Overall Study|Ineligible - Medical history|6|||
157168366|NCT00084929|567357831|FG000|Overall Study|Withdrawal by Subject|10|||
157168367|NCT00084929|567357831|FG000|Overall Study|Missing/incomplete CTC exam|9|||
157168368|NCT00084929|567357831|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
157168369|NCT00664209|567357832|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
157168370|NCT00664209|567357832|FG000|Study Treatment Period|Physician Decision|4|||
157168371|NCT00664209|567357832|FG000|Study Treatment Period|Withdrawal by Subject|2|||
157168372|NCT02767856|567357843|FG000|Overall Study|Lost to Follow-up|9|||
157168373|NCT02767856|567357844|FG001|Overall Study|Lost to Follow-up|1|||
157168374|NCT02767856|567357843|FG000|Overall Study|Withdrawal by Subject|2|||
157168375|NCT02767856|567357844|FG001|Overall Study|Withdrawal by Subject|1|||
157168376|NCT00091026|567357847|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
157168377|NCT00091026|567357848|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
157168378|NCT00091026|567357847|FG000|Overall Study|Patient withdrew and never received trea|0|||
157168379|NCT00091026|567357848|FG001|Overall Study|Patient withdrew and never received trea|2|||
157168380|NCT00091026|567357847|FG000|Overall Study|Unknown-never received treatment|0|||
157168381|NCT00091026|567357848|FG001|Overall Study|Unknown-never received treatment|1|||
157168382|NCT00843843|567357851|FG000|Overall Study|Physician Decision|1|||
157168383|NCT00843843|567357852|FG001|Overall Study|Physician Decision|1|||
157168384|NCT00843843|567357851|FG000|Overall Study|Protocol Violation|1|||
157168385|NCT00843843|567357852|FG001|Overall Study|Protocol Violation|1|||
157168386|NCT00418379|567357853|FG000|Year 1|Adverse Event|9|||
157168387|NCT00418379|567357854|FG001|Year 1|Adverse Event|15|||
157168388|NCT00418379|567357855|FG002|Year 1|Adverse Event|3|||
157168389|NCT00418379|567357853|FG000|Year 1|Withdrawal by Subject|7|||
157168390|NCT00418379|567357854|FG001|Year 1|Withdrawal by Subject|8|||
157168391|NCT00418379|567357855|FG002|Year 1|Withdrawal by Subject|5|||
157168392|NCT00418379|567357853|FG000|Year 1|Any other reason not above-mentioned|2|||
157168393|NCT00418379|567357854|FG001|Year 1|Any other reason not above-mentioned|5|||
157168394|NCT00418379|567357855|FG002|Year 1|Any other reason not above-mentioned|7|||
157168395|NCT00418379|567357853|FG000|Year 2|Adverse Event|5|||
157168396|NCT00418379|567357854|FG001|Year 2|Adverse Event|2|||
157168397|NCT00418379|567357855|FG002|Year 2|Adverse Event|1|||
157168398|NCT00418379|567357853|FG000|Year 2|Withdrawal by Subject|1|||
157168399|NCT00418379|567357854|FG001|Year 2|Withdrawal by Subject|1|||
157168400|NCT00418379|567357855|FG002|Year 2|Withdrawal by Subject|3|||
157168401|NCT00418379|567357853|FG000|Year 2|Any other reason not above-mentioned|2|||
157168402|NCT00418379|567357854|FG001|Year 2|Any other reason not above-mentioned|1|||
157168403|NCT00418379|567357855|FG002|Year 2|Any other reason not above-mentioned|6|||
157168404|NCT00418379|567357853|FG000|Year 3|Withdrawal by Subject|1|||
157168405|NCT00418379|567357854|FG001|Year 3|Withdrawal by Subject|1|||
157168406|NCT00418379|567357855|FG002|Year 3|Withdrawal by Subject|2|||
157168407|NCT00418379|567357853|FG000|Year 3|Any other reason not above-mentioned|2|||
157168408|NCT00418379|567357854|FG001|Year 3|Any other reason not above-mentioned|1|||
157168409|NCT00418379|567357855|FG002|Year 3|Any other reason not above-mentioned|1|||
157168410|NCT00418379|567357853|FG000|Year 4|Adverse Event|0|||
157168411|NCT00418379|567357854|FG001|Year 4|Adverse Event|1|||
157168412|NCT00418379|567357855|FG002|Year 4|Adverse Event|0|||
157168413|NCT00418379|567357853|FG000|Year 4|Withdrawal by Subject|2|||
157168414|NCT00418379|567357854|FG001|Year 4|Withdrawal by Subject|3|||
157168415|NCT00418379|567357855|FG002|Year 4|Withdrawal by Subject|2|||
157168416|NCT00418379|567357853|FG000|Year 4|Any other reason not above-mentioned|1|||
157168417|NCT00418379|567357854|FG001|Year 4|Any other reason not above-mentioned|1|||
157168418|NCT00418379|567357855|FG002|Year 4|Any other reason not above-mentioned|0|||
157168419|NCT00418379|567357853|FG000|Year 5|Adverse Event|0|||
157168420|NCT00418379|567357854|FG001|Year 5|Adverse Event|1|||
157168421|NCT00418379|567357855|FG002|Year 5|Adverse Event|0|||
157168422|NCT00418379|567357853|FG000|Year 5|Any other reason not above-mentioned|2|||
157168423|NCT00418379|567357854|FG001|Year 5|Any other reason not above-mentioned|4|||
157168424|NCT00418379|567357855|FG002|Year 5|Any other reason not above-mentioned|3|||
157168425|NCT01797965|567357856|FG000|Overall Study|Adverse Event|104|||
157227431|NCT00337077|567577793|FG002|Overall Study|Never started treatment|0|||
157168426|NCT01797965|567357857|FG001|Overall Study|Adverse Event|129|||
157227432|NCT00337077|567577791|FG000|Overall Study|Ineligible|1|||
156952086|NCT01863680|566578176|FG000|Overall Study|Risk of OHSS|17|||
157168427|NCT01797965|567357858|FG002|Overall Study|Adverse Event|4|||
157168428|NCT01797965|567357859|FG003|Overall Study|Adverse Event|21|||
157227433|NCT00337077|567577792|FG001|Overall Study|Ineligible|1|||
157168429|NCT01797965|567357856|FG000|Overall Study|Lost to Follow-up|9|||
157227434|NCT00337077|567577793|FG002|Overall Study|Ineligible|1|||
157227435|NCT01492400|567577798|FG000|Overall Study|Miscellaneous Reasons|2|||
157227436|NCT01492400|567577799|FG001|Overall Study|Miscellaneous Reasons|3|||
157227437|NCT01492400|567577798|FG000|Overall Study|Personal Reasons|0|||
157227438|NCT01492400|567577799|FG001|Overall Study|Personal Reasons|5|||
157227439|NCT01492400|567577798|FG000|Overall Study|Lost to Follow-up|3|||
157227440|NCT01492400|567577799|FG001|Overall Study|Lost to Follow-up|1|||
157227441|NCT01492400|567577798|FG000|Overall Study|Pregnancy|0|||
157227442|NCT01492400|567577799|FG001|Overall Study|Pregnancy|1|||
157227443|NCT01492400|567577798|FG000|Overall Study|Lack of Efficacy|1|||
157227444|NCT01492400|567577799|FG001|Overall Study|Lack of Efficacy|1|||
157227445|NCT01492400|567577798|FG000|Overall Study|Adverse Event|10|||
157227446|NCT01492400|567577799|FG001|Overall Study|Adverse Event|5|||
157227447|NCT00659607|567577800|FG000|Overall Study|No blood pressure recorded|147|||
157227448|NCT00659607|567577800|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
157227449|NCT00659607|567577800|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
157227450|NCT00659607|567577800|FG000|Overall Study|No recorded efficacy data|15|||
157227451|NCT00659607|567577800|FG000|Overall Study|Inconsistent BP measuring date|2|||
157227452|NCT01457053|567577801|FG000|Overall Study|Unable to undergo selected treatment|1|||
157227453|NCT01457053|567577802|FG001|Overall Study|Unable to undergo selected treatment|1|||
157227454|NCT02073643|567577804|FG000|Overall Study|Lost to Follow-up|24|||
157227455|NCT02430870|567577805|FG000|Part 2|Voluntary Withdrawal|0|||
157227456|NCT02430870|567577806|FG001|Part 2|Voluntary Withdrawal|0|||
157227457|NCT02430870|567577807|FG002|Part 2|Voluntary Withdrawal|0|||
157227458|NCT02430870|567577808|FG003|Part 2|Voluntary Withdrawal|0|||
157227459|NCT02430870|567577809|FG004|Part 2|Voluntary Withdrawal|0|||
157227460|NCT02430870|567577810|FG005|Part 2|Voluntary Withdrawal|0|||
157227461|NCT02430870|567577811|FG006|Part 2|Voluntary Withdrawal|1|||
157227462|NCT02430870|567577812|FG007|Part 2|Voluntary Withdrawal|0|||
157227463|NCT02430870|567577805|FG000|Part 2|Other Reason Not Specified|0|||
157227464|NCT02430870|567577806|FG001|Part 2|Other Reason Not Specified|0|||
157227465|NCT02430870|567577807|FG002|Part 2|Other Reason Not Specified|0|||
157227466|NCT02430870|567577808|FG003|Part 2|Other Reason Not Specified|0|||
157227467|NCT02430870|567577809|FG004|Part 2|Other Reason Not Specified|0|||
157227468|NCT02430870|567577810|FG005|Part 2|Other Reason Not Specified|0|||
157227469|NCT02430870|567577811|FG006|Part 2|Other Reason Not Specified|0|||
157227470|NCT02430870|567577812|FG007|Part 2|Other Reason Not Specified|1|||
157227471|NCT02364557|567577816|FG000|Overall Study|Protocol Violation|3|||
157227472|NCT02364557|567577817|FG001|Overall Study|Protocol Violation|1|||
157227473|NCT04347239|567577818|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
157227474|NCT04347239|567577819|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
157227475|NCT04347239|567577820|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
157227476|NCT04347239|567577818|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
157227477|NCT04347239|567577819|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
157227478|NCT04347239|567577820|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
157227479|NCT02153736|567577825|FG000|Overall Study|Lost to Follow-up|1|||
157227480|NCT02153736|567577826|FG001|Overall Study|Lost to Follow-up|0|||
157227481|NCT02153736|567577825|FG000|Overall Study|Medical status change made ineligible|1|||
157227482|NCT02153736|567577826|FG001|Overall Study|Medical status change made ineligible|0|||
157227483|NCT02153736|567577825|FG000|Overall Study|Death|0|||
157227484|NCT02153736|567577826|FG001|Overall Study|Death|1|||
156952087|NCT01863680|566578176|FG000|Overall Study|Spontaneous pregnancy|2|||
156952088|NCT01863680|566578176|FG000|Overall Study|Withdrawal by Subject|1|||
156952089|NCT01863680|566578176|FG000|Overall Study|Did not undergo IVF/ET|14|||
157168430|NCT01797965|567357857|FG001|Overall Study|Lost to Follow-up|8|||
157168431|NCT01797965|567357858|FG002|Overall Study|Lost to Follow-up|1|||
157168432|NCT01797965|567357859|FG003|Overall Study|Lost to Follow-up|2|||
157168433|NCT01797965|567357856|FG000|Overall Study|Consent withdrawn|130|||
157168434|NCT01797965|567357857|FG001|Overall Study|Consent withdrawn|117|||
157168435|NCT01797965|567357858|FG002|Overall Study|Consent withdrawn|3|||
157168436|NCT01797965|567357859|FG003|Overall Study|Consent withdrawn|35|||
157168437|NCT01797965|567357856|FG000|Overall Study|Investigator decision|21|||
157168438|NCT01797965|567357857|FG001|Overall Study|Investigator decision|15|||
157227485|NCT02153736|567577825|FG000|Overall Study|Withdrawal by Subject|0|||
157227486|NCT02153736|567577826|FG001|Overall Study|Withdrawal by Subject|1|||
157227487|NCT02568384|567577831|FG000|Overall Study|Mobile devices incompatible with App|2|||
157227488|NCT00796510|567577836|FG000|Overall Study|Death|1|||
157227489|NCT00796510|567577837|FG001|Overall Study|Death|0|||
157227490|NCT00796510|567577836|FG000|Overall Study|Study Terminated|2|||
157227491|NCT00796510|567577837|FG001|Overall Study|Study Terminated|0|||
157227492|NCT00720122|567577846|FG000|Overall Study|Lost to Follow-up|1|||
157227493|NCT00720122|567577846|FG000|Overall Study|Physician Decision|1|||
157168439|NCT01797965|567357858|FG002|Overall Study|Investigator decision|0|||
157227494|NCT00720122|567577846|FG000|Overall Study|Withdrawal by Subject|7|||
157227495|NCT04025229|567579088|FG000|Overall Study|Adverse Event|1|||
157168440|NCT01797965|567357859|FG003|Overall Study|Investigator decision|0|||
157168441|NCT01797965|567357856|FG000|Overall Study|Death|2|||
157168442|NCT01797965|567357857|FG001|Overall Study|Death|4|||
157168443|NCT01797965|567357858|FG002|Overall Study|Death|0|||
157168444|NCT01797965|567357859|FG003|Overall Study|Death|0|||
157168445|NCT01797965|567357856|FG000|Overall Study|Disease progression, defined by protocol|3|||
157168446|NCT01797965|567357857|FG001|Overall Study|Disease progression, defined by protocol|1|||
157168447|NCT01797965|567357858|FG002|Overall Study|Disease progression, defined by protocol|0|||
157168448|NCT01797965|567357859|FG003|Overall Study|Disease progression, defined by protocol|0|||
157168449|NCT01797965|567357856|FG000|Overall Study|Reason Not Specified|280|||
157168450|NCT01797965|567357857|FG001|Overall Study|Reason Not Specified|295|||
157168451|NCT01797965|567357858|FG002|Overall Study|Reason Not Specified|0|||
157168452|NCT01797965|567357859|FG003|Overall Study|Reason Not Specified|15|||
157168453|NCT01764256|567357860|FG000|Received All Vaccinations|Adverse Event|1|||
157168454|NCT01764256|567357861|FG001|Received All Vaccinations|Adverse Event|1|||
157168455|NCT01764256|567357862|FG002|Received All Vaccinations|Adverse Event|0|||
157168456|NCT01764256|567357863|FG003|Received All Vaccinations|Adverse Event|0|||
157168457|NCT01764256|567357860|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
157168458|NCT01764256|567357861|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
157168459|NCT01764256|567357862|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
157168460|NCT01764256|567357863|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
157168461|NCT01764256|567357860|FG000|Received All Vaccinations|Lost to Follow-up|1|||
157168462|NCT01764256|567357861|FG001|Received All Vaccinations|Lost to Follow-up|0|||
157168463|NCT01764256|567357862|FG002|Received All Vaccinations|Lost to Follow-up|0|||
157168464|NCT01764256|567357863|FG003|Received All Vaccinations|Lost to Follow-up|0|||
157168465|NCT01764256|567357860|FG000|Completed Study|Lost to Follow-up|0|||
157168466|NCT01764256|567357861|FG001|Completed Study|Lost to Follow-up|0|||
157168467|NCT01764256|567357862|FG002|Completed Study|Lost to Follow-up|0|||
157168468|NCT01764256|567357863|FG003|Completed Study|Lost to Follow-up|1|||
157168469|NCT00565058|567357864|FG000|Overall Study|Adverse Event|1|||
157168470|NCT00565058|567357865|FG001|Overall Study|Adverse Event|0|||
157168471|NCT00304915|567357866|FG000|Overall Study|Lost to Follow-up|11|||
157168472|NCT00304915|567357867|FG001|Overall Study|Lost to Follow-up|11|||
157168473|NCT00304915|567357866|FG000|Overall Study|Death|4|||
157168474|NCT00304915|567357867|FG001|Overall Study|Death|5|||
157168475|NCT00304915|567357866|FG000|Overall Study|Withdrawal by Subject|3|||
157168476|NCT00304915|567357867|FG001|Overall Study|Withdrawal by Subject|0|||
157168477|NCT02029638|567357868|FG000|Overall Study|Death|0|||
157168478|NCT02029638|567357869|FG001|Overall Study|Death|0|||
157168479|NCT02029638|567357870|FG002|Overall Study|Death|1|||
157168480|NCT02029638|567357868|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
157168481|NCT02029638|567357869|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
157168482|NCT02029638|567357870|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
157168483|NCT05489081|567357872|FG000|Overall Study|student left classroom|0|||
157168484|NCT05489081|567357873|FG001|Overall Study|student left classroom|1|||
157168485|NCT05489081|567357872|FG000|Overall Study|teacher left school|0|||
157168486|NCT05489081|567357873|FG001|Overall Study|teacher left school|2|||
157168487|NCT00973921|567357876|FG000|Overall Study|IVUS results were not available|9|||
157168488|NCT02670330|567357887|FG000|Overall Study|Protocol Deviation|1|||
157168489|NCT02670330|567357888|FG001|Overall Study|Protocol Deviation|0|||
157168490|NCT02670330|567357887|FG000|Overall Study|Study Terminated By Sponsor|36|||
157168491|NCT02670330|567357888|FG001|Overall Study|Study Terminated By Sponsor|43|||
157168492|NCT02670330|567357887|FG000|Overall Study|Adverse Event|1|||
157168493|NCT02670330|567357888|FG001|Overall Study|Adverse Event|3|||
157168494|NCT02670330|567357887|FG000|Overall Study|Withdrawal by Subject|34|||
157168495|NCT02670330|567357888|FG001|Overall Study|Withdrawal by Subject|29|||
157168496|NCT02670330|567357887|FG000|Overall Study|Lost to Follow-up|3|||
157168497|NCT02670330|567357888|FG001|Overall Study|Lost to Follow-up|2|||
157168498|NCT04404010|567357889|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
157168499|NCT04404010|567357890|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
157168500|NCT02120157|567357891|FG000|Overall Study|Death|8|||
157168501|NCT03176277|567357895|FG000|Part A Dose Escalation Study|Adverse Event|1|||
157168502|NCT03176277|567357896|FG001|Part A Dose Escalation Study|Adverse Event|0|||
157168503|NCT03176277|567357897|FG002|Part A Dose Escalation Study|Adverse Event|1|||
157168504|NCT03176277|567357898|FG003|Part A Dose Escalation Study|Adverse Event|0|||
157168505|NCT03176277|567357895|FG000|Part A Dose Escalation Study|Physician Decision|1|||
157168506|NCT03176277|567357896|FG001|Part A Dose Escalation Study|Physician Decision|1|||
157168507|NCT03176277|567357897|FG002|Part A Dose Escalation Study|Physician Decision|2|||
157168508|NCT03176277|567357898|FG003|Part A Dose Escalation Study|Physician Decision|0|||
157168509|NCT03176277|567357895|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
157168510|NCT03176277|567357896|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
157168511|NCT03176277|567357897|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
157168512|NCT03176277|567357898|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
157227496|NCT04025229|567579089|FG001|Overall Study|Adverse Event|0|||
157168513|NCT03176277|567357895|FG000|Part A Dose Escalation Study|Progressive disease|3|||
157168514|NCT03176277|567357896|FG001|Part A Dose Escalation Study|Progressive disease|1|||
157168515|NCT03176277|567357897|FG002|Part A Dose Escalation Study|Progressive disease|3|||
157168516|NCT03176277|567357898|FG003|Part A Dose Escalation Study|Progressive disease|0|||
157168517|NCT02802878|567357899|FG000|Overall Study|Withdrawal by Subject|3|||
157168518|NCT02802878|567357900|FG001|Overall Study|Withdrawal by Subject|3|||
157168519|NCT02802878|567357899|FG000|Overall Study|Protocol Violation|1|||
157168520|NCT02802878|567357900|FG001|Overall Study|Protocol Violation|0|||
157168521|NCT00702052|567357901|FG000|Overall Study|Adverse Event|23|||
157168522|NCT00702052|567357901|FG000|Overall Study|Disease Progression|30|||
157168523|NCT00702052|567357901|FG000|Overall Study|Withdrawal by Subject|5|||
157168524|NCT00101192|567357902|FG000|Overall Study|Ineligible|6|||
157168525|NCT00101192|567357902|FG000|Overall Study|Inevaluable|1|||
157168526|NCT03691610|567357903|FG000|Overall Study|Adverse Event|0|||
157168527|NCT03691610|567357904|FG001|Overall Study|Adverse Event|1|||
157168528|NCT03691610|567357905|FG002|Overall Study|Adverse Event|0|||
157168529|NCT03691610|567357906|FG003|Overall Study|Adverse Event|0|||
157168530|NCT03691610|567357903|FG000|Overall Study|Protocol Deviation|15|||
157168531|NCT03691610|567357904|FG001|Overall Study|Protocol Deviation|8|||
157168532|NCT03691610|567357905|FG002|Overall Study|Protocol Deviation|1|||
157168533|NCT03691610|567357906|FG003|Overall Study|Protocol Deviation|2|||
157168534|NCT03691610|567357903|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
157168535|NCT03691610|567357904|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
157168536|NCT03691610|567357905|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
157168537|NCT03691610|567357906|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
157168538|NCT03691610|567357903|FG000|Overall Study|Lost to Follow-up|20|||
157168539|NCT03691610|567357904|FG001|Overall Study|Lost to Follow-up|11|||
157168540|NCT03691610|567357905|FG002|Overall Study|Lost to Follow-up|5|||
157168541|NCT03691610|567357906|FG003|Overall Study|Lost to Follow-up|2|||
157168542|NCT00242580|567357907|FG000|Overall Study|Adverse Event|3|||
157168543|NCT00242580|567357908|FG001|Overall Study|Adverse Event|0|||
157168544|NCT00242580|567357909|FG002|Overall Study|Adverse Event|2|||
157168545|NCT00242580|567357907|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157168546|NCT00242580|567357908|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
157168547|NCT00242580|567357909|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
157168548|NCT00242580|567357907|FG000|Overall Study|Protocol Violation|0|||
157168549|NCT00242580|567357908|FG001|Overall Study|Protocol Violation|0|||
157168550|NCT00242580|567357909|FG002|Overall Study|Protocol Violation|1|||
157168551|NCT00242580|567357907|FG000|Overall Study|Subject withdrew consent|2|||
157168552|NCT00242580|567357908|FG001|Overall Study|Subject withdrew consent|2|||
157168553|NCT00242580|567357909|FG002|Overall Study|Subject withdrew consent|5|||
157168554|NCT00242580|567357907|FG000|Overall Study|Lost to Follow-up|0|||
157168555|NCT00242580|567357908|FG001|Overall Study|Lost to Follow-up|3|||
157168556|NCT00242580|567357909|FG002|Overall Study|Lost to Follow-up|0|||
157168557|NCT00242580|567357907|FG000|Overall Study|Death|1|||
157168558|NCT00242580|567357908|FG001|Overall Study|Death|2|||
157168559|NCT00242580|567357909|FG002|Overall Study|Death|1|||
157168560|NCT01232894|567357910|FG000|Overall Study|Lost to Follow-up|0|||
157168561|NCT01232894|567357911|FG001|Overall Study|Lost to Follow-up|1|||
157168562|NCT01232894|567357910|FG000|Overall Study|Death|1|||
157168563|NCT01232894|567357911|FG001|Overall Study|Death|0|||
157168564|NCT01232894|567357910|FG000|Overall Study|Protocol Violation|1|||
157168565|NCT01232894|567357911|FG001|Overall Study|Protocol Violation|1|||
157168566|NCT01232894|567357910|FG000|Overall Study|Withdrawal by Subject|8|||
157168567|NCT01232894|567357911|FG001|Overall Study|Withdrawal by Subject|5|||
157168568|NCT01232894|567357910|FG000|Overall Study|Physician Decision|2|||
157168569|NCT01232894|567357911|FG001|Overall Study|Physician Decision|1|||
157168570|NCT03970395|567357912|FG000|Overall Study|Withdrawal by Subject|3|||
157168571|NCT03970395|567357913|FG001|Overall Study|Withdrawal by Subject|4|||
157168572|NCT03970395|567357912|FG000|Overall Study|Lost to Follow-up|4|||
157168573|NCT03970395|567357913|FG001|Overall Study|Lost to Follow-up|8|||
157168574|NCT00929734|567357914|FG000|Overall Study|Lost to Follow-up|2|||
157168575|NCT00929734|567357915|FG001|Overall Study|Lost to Follow-up|1|||
157168576|NCT00929734|567357914|FG000|Overall Study|Withdrawal by Subject|0|||
157168577|NCT00929734|567357915|FG001|Overall Study|Withdrawal by Subject|2|||
157168578|NCT02921919|567357916|FG000|Overall Study|Other|5|||
157168579|NCT02921919|567357917|FG001|Overall Study|Other|6|||
157168580|NCT02921919|567357916|FG000|Overall Study|Lost to Follow-up|0|||
157168581|NCT02921919|567357917|FG001|Overall Study|Lost to Follow-up|1|||
157168582|NCT02921919|567357916|FG000|Overall Study|Withdrawal by Subject|5|||
157168583|NCT02921919|567357917|FG001|Overall Study|Withdrawal by Subject|1|||
157168584|NCT02921919|567357916|FG000|Overall Study|Disease Progression|47|||
157168585|NCT02921919|567357917|FG001|Overall Study|Disease Progression|38|||
157168586|NCT02921919|567357916|FG000|Overall Study|Physician Decision|3|||
157168587|NCT02921919|567357917|FG001|Overall Study|Physician Decision|2|||
157168588|NCT02921919|567357916|FG000|Overall Study|Adverse Event|6|||
157168589|NCT02921919|567357917|FG001|Overall Study|Adverse Event|4|||
157168590|NCT00980980|567357918|FG000|Overall Study|Withdrawal by Hospital|0|||
157168591|NCT00980980|567357919|FG001|Overall Study|Withdrawal by Hospital|1|||
157168592|NCT00980980|567357920|FG002|Overall Study|Withdrawal by Hospital|0|||
157168593|NCT03666858|567357921|FG000|Cohort 1|Adverse Event|1|||
157168594|NCT03666858|567357922|FG001|Cohort 1|Adverse Event|0|||
157168595|NCT03666858|567357921|FG000|Cohort 2|Adverse Event|0|||
157168596|NCT03666858|567357922|FG001|Cohort 2|Adverse Event|1|||
157168597|NCT00121992|567357923|FG000|Overall Study|Treatment not received|2|||
157168598|NCT00121992|567357924|FG001|Overall Study|Treatment not received|11|||
157168599|NCT00622869|567357925|FG000|Overall Study|Subject Withdrew Consent|13|||
157168600|NCT00622869|567357926|FG001|Overall Study|Subject Withdrew Consent|17|||
157168601|NCT00622869|567357927|FG002|Overall Study|Subject Withdrew Consent|11|||
157168602|NCT00622869|567357925|FG000|Overall Study|Administrative Problems|11|||
157168603|NCT00622869|567357926|FG001|Overall Study|Administrative Problems|17|||
157168604|NCT00622869|567357927|FG002|Overall Study|Administrative Problems|13|||
157168605|NCT00622869|567357925|FG000|Overall Study|Death|12|||
157168606|NCT00622869|567357926|FG001|Overall Study|Death|15|||
157168607|NCT00622869|567357927|FG002|Overall Study|Death|10|||
157168608|NCT00622869|567357925|FG000|Overall Study|Lost to Follow-up|2|||
157168609|NCT00622869|567357926|FG001|Overall Study|Lost to Follow-up|4|||
157168610|NCT00622869|567357927|FG002|Overall Study|Lost to Follow-up|2|||
157168611|NCT00622869|567357925|FG000|Overall Study|Graft Loss|5|||
157168612|NCT00622869|567357926|FG001|Overall Study|Graft Loss|3|||
157168613|NCT00622869|567357927|FG002|Overall Study|Graft Loss|2|||
157168614|NCT00622869|567357925|FG000|Overall Study|Missing|0|||
157168615|NCT00622869|567357926|FG001|Overall Study|Missing|1|||
157168616|NCT00622869|567357927|FG002|Overall Study|Missing|1|||
157168617|NCT02927873|567357928|FG000|Overall Study|Lost to Follow-up|0|||
157168618|NCT02927873|567357929|FG001|Overall Study|Lost to Follow-up|1|||
157168619|NCT02927873|567357930|FG002|Overall Study|Lost to Follow-up|0|||
157168620|NCT02927873|567357931|FG003|Overall Study|Lost to Follow-up|0|||
157168621|NCT02927873|567357932|FG004|Overall Study|Lost to Follow-up|0|||
157168622|NCT02927873|567357933|FG005|Overall Study|Lost to Follow-up|0|||
157168623|NCT02927873|567357928|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
157168624|NCT02927873|567357929|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
157168625|NCT02927873|567357930|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
157168626|NCT02927873|567357931|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
157168627|NCT02927873|567357932|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
157168628|NCT02927873|567357933|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
157168629|NCT02927873|567357928|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157168630|NCT02927873|567357929|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157168631|NCT02927873|567357930|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157168632|NCT02927873|567357931|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157168633|NCT02927873|567357932|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
157168634|NCT02927873|567357933|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
157168635|NCT02927873|567357928|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
157168636|NCT02927873|567357929|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
157168637|NCT02927873|567357930|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
157168638|NCT02927873|567357931|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
157168639|NCT02927873|567357932|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
157168640|NCT02927873|567357933|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
157168641|NCT02927873|567357928|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
157168642|NCT02927873|567357929|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
157168643|NCT02927873|567357930|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
157168644|NCT02927873|567357931|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
157168645|NCT02927873|567357932|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
157168646|NCT02927873|567357933|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
157168647|NCT02927873|567357928|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
157168648|NCT02927873|567357929|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156952090|NCT01863680|566578176|FG000|Overall Study|Other|6|||
157168649|NCT02927873|567357930|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
157168650|NCT02927873|567357931|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
157168651|NCT02927873|567357932|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
156952091|NCT00566228|566578181|FG000|Overall Study|Withdrawal by Subject|1|||
156952092|NCT00566228|566578182|FG001|Overall Study|Withdrawal by Subject|0|||
156952093|NCT00566228|566578181|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
156952094|NCT00566228|566578182|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
156952095|NCT00566228|566578181|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
156952096|NCT00566228|566578182|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
156952097|NCT00566228|566578181|FG000|Overall Study|progressed before infusion could occur|0|||
156952098|NCT00566228|566578182|FG001|Overall Study|progressed before infusion could occur|1|||
156952099|NCT03320070|566578185|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
157035329|NCT02502266|566887794|FG002|Overall Study|Adverse Event|0|||
157035330|NCT02502266|566887795|FG003|Overall Study|Adverse Event|0|||
157035331|NCT02502266|566887796|FG004|Overall Study|Adverse Event|1|||
157035332|NCT02502266|566887797|FG005|Overall Study|Adverse Event|1|||
157035333|NCT02502266|566887798|FG006|Overall Study|Adverse Event|1|||
157035334|NCT02502266|566887792|FG000|Overall Study|Withdrawal by Subject|30|||
157035335|NCT02502266|566887793|FG001|Overall Study|Withdrawal by Subject|15|||
157035336|NCT02502266|566887794|FG002|Overall Study|Withdrawal by Subject|16|||
157035337|NCT02502266|566887795|FG003|Overall Study|Withdrawal by Subject|0|||
157035338|NCT02502266|566887796|FG004|Overall Study|Withdrawal by Subject|0|||
157035339|NCT02502266|566887797|FG005|Overall Study|Withdrawal by Subject|0|||
157035340|NCT02502266|566887798|FG006|Overall Study|Withdrawal by Subject|0|||
157035341|NCT02502266|566887792|FG000|Overall Study|Still on Treatment|0|||
157035342|NCT02502266|566887793|FG001|Overall Study|Still on Treatment|0|||
157035343|NCT02502266|566887794|FG002|Overall Study|Still on Treatment|1|||
157035344|NCT02502266|566887795|FG003|Overall Study|Still on Treatment|0|||
157035345|NCT02502266|566887796|FG004|Overall Study|Still on Treatment|0|||
157035346|NCT02502266|566887797|FG005|Overall Study|Still on Treatment|0|||
157035347|NCT02502266|566887798|FG006|Overall Study|Still on Treatment|0|||
157035348|NCT02502266|566887792|FG000|Overall Study|Other Reasons|19|||
157035349|NCT02502266|566887793|FG001|Overall Study|Other Reasons|6|||
157035350|NCT02502266|566887794|FG002|Overall Study|Other Reasons|14|||
157035351|NCT02502266|566887795|FG003|Overall Study|Other Reasons|0|||
157035352|NCT02502266|566887796|FG004|Overall Study|Other Reasons|1|||
157035353|NCT02502266|566887797|FG005|Overall Study|Other Reasons|1|||
157035354|NCT02502266|566887798|FG006|Overall Study|Other Reasons|0|||
157035355|NCT02502266|566887792|FG000|Overall Study|Arm 4 Discontinued|0|||
157035356|NCT02502266|566887793|FG001|Overall Study|Arm 4 Discontinued|0|||
157035357|NCT02502266|566887794|FG002|Overall Study|Arm 4 Discontinued|0|||
157035358|NCT02502266|566887795|FG003|Overall Study|Arm 4 Discontinued|52|||
157035359|NCT02502266|566887796|FG004|Overall Study|Arm 4 Discontinued|0|||
157035360|NCT02502266|566887797|FG005|Overall Study|Arm 4 Discontinued|0|||
157035361|NCT02502266|566887798|FG006|Overall Study|Arm 4 Discontinued|0|||
157035362|NCT02502266|566887792|FG000|Overall Study|Never treated|0|||
157035363|NCT02502266|566887793|FG001|Overall Study|Never treated|0|||
157035364|NCT02502266|566887794|FG002|Overall Study|Never treated|0|||
157035365|NCT02502266|566887795|FG003|Overall Study|Never treated|0|||
157035366|NCT02502266|566887796|FG004|Overall Study|Never treated|0|||
157035367|NCT02502266|566887797|FG005|Overall Study|Never treated|1|||
157035368|NCT02502266|566887798|FG006|Overall Study|Never treated|0|||
157035369|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Other|0|||
157035370|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Other|2|||
157035371|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Other|1|||
157035372|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Other|2|||
157168652|NCT02927873|567357933|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
157168653|NCT01518244|567357934|FG000|Overall Study|Adverse Event|3|||
157168654|NCT00870818|567357935|FG000|Overall Study|Lost to Follow-up|3|||
157168655|NCT00870818|567357936|FG001|Overall Study|Lost to Follow-up|2|||
157168656|NCT00870818|567357937|FG002|Overall Study|Lost to Follow-up|1|||
157168657|NCT00870818|567357938|FG003|Overall Study|Lost to Follow-up|0|||
157168658|NCT00870818|567357939|FG004|Overall Study|Lost to Follow-up|0|||
157168659|NCT00870818|567357935|FG000|Overall Study|Withdrawal by Subject|0|||
157168660|NCT00870818|567357936|FG001|Overall Study|Withdrawal by Subject|0|||
157168661|NCT00870818|567357937|FG002|Overall Study|Withdrawal by Subject|1|||
157168662|NCT00870818|567357938|FG003|Overall Study|Withdrawal by Subject|2|||
157168663|NCT00870818|567357939|FG004|Overall Study|Withdrawal by Subject|0|||
157168664|NCT00870818|567357935|FG000|Overall Study|Terminated by sponsor|29|||
157168665|NCT00870818|567357936|FG001|Overall Study|Terminated by sponsor|70|||
157035373|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Other|2|||
157035374|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Other|0|||
157035375|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Other|0|||
157035376|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Other|0|||
157035377|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Other|0|||
157168666|NCT00870818|567357937|FG002|Overall Study|Terminated by sponsor|36|||
157168667|NCT00870818|567357938|FG003|Overall Study|Terminated by sponsor|36|||
157168668|NCT00870818|567357939|FG004|Overall Study|Terminated by sponsor|38|||
157168669|NCT00870818|567357935|FG000|Overall Study|Other|0|||
157168670|NCT00870818|567357936|FG001|Overall Study|Other|1|||
157168671|NCT00870818|567357937|FG002|Overall Study|Other|0|||
157168672|NCT00870818|567357938|FG003|Overall Study|Other|0|||
157168673|NCT00870818|567357939|FG004|Overall Study|Other|0|||
157168674|NCT04900038|567357940|FG000|Overall Study|Adverse Event|1|||
157168675|NCT04900038|567357941|FG001|Overall Study|Adverse Event|0|||
157035378|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Other|0|||
157035379|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Other|0|||
157035380|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Other|0|||
157035381|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Other|0|||
157035382|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Other|0|||
157035383|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Other|0|||
157035384|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Other|0|||
157227497|NCT04025229|567579088|FG000|Overall Study|Withdrawal by Subject|0|||
157227498|NCT04025229|567579089|FG001|Overall Study|Withdrawal by Subject|2|||
157227499|NCT04025229|567579088|FG000|Overall Study|Death|0|||
157227500|NCT04025229|567579089|FG001|Overall Study|Death|1|||
157227501|NCT04025229|567579088|FG000|Overall Study|Physician Decision|0|||
157227502|NCT04025229|567579089|FG001|Overall Study|Physician Decision|1|||
157227503|NCT03815942|567579090|FG000|Overall Study|Withdrawal by Subject|0|||
157227504|NCT03815942|567579091|FG001|Overall Study|Withdrawal by Subject|17|||
157227505|NCT03717064|567579092|FG000|Period 2|Adverse Event|1|||
157227506|NCT01298570|567579093|FG000|Overall Study|Disease progression, relapse during acti|64|||
157227507|NCT01298570|567579094|FG001|Overall Study|Disease progression, relapse during acti|40|||
157227508|NCT01298570|567579093|FG000|Overall Study|Adverse Event|20|||
157227509|NCT01298570|567579094|FG001|Overall Study|Adverse Event|2|||
157227510|NCT01298570|567579093|FG000|Overall Study|Withdrawal by Subject|21|||
157227511|NCT01298570|567579094|FG001|Overall Study|Withdrawal by Subject|6|||
157227512|NCT01298570|567579093|FG000|Overall Study|Treatment delay > 4 weeks|4|||
157227513|NCT01298570|567579094|FG001|Overall Study|Treatment delay > 4 weeks|5|||
157227514|NCT01298570|567579093|FG000|Overall Study|Physician Decision|4|||
157227515|NCT01298570|567579094|FG001|Overall Study|Physician Decision|2|||
157227516|NCT01298570|567579093|FG000|Overall Study|Other complicating disease|2|||
157227517|NCT01298570|567579094|FG001|Overall Study|Other complicating disease|1|||
157227518|NCT01298570|567579093|FG000|Overall Study|Surgery|2|||
157227519|NCT01298570|567579094|FG001|Overall Study|Surgery|1|||
156952100|NCT03320070|566578186|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
156952101|NCT03320070|566578185|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
156952102|NCT03320070|566578186|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
156952103|NCT03320070|566578185|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
156952104|NCT03320070|566578186|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
156952105|NCT03320070|566578185|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
156952106|NCT03320070|566578186|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
156952107|NCT03320070|566578185|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
156952108|NCT03320070|566578186|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
156952109|NCT03320070|566578185|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
156952110|NCT03320070|566578186|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
156952111|NCT03564496|566578187|FG000|Overall Study|Withdrawal by Subject|1|||
156952112|NCT03564496|566578188|FG001|Overall Study|Withdrawal by Subject|1|||
156952113|NCT03564496|566578189|FG002|Overall Study|Withdrawal by Subject|0|||
156952114|NCT03564496|566578187|FG000|Overall Study|Screen failure|0|||
156952115|NCT03564496|566578188|FG001|Overall Study|Screen failure|3|||
156952116|NCT03564496|566578189|FG002|Overall Study|Screen failure|0|||
156952117|NCT02053350|566578194|FG000|Overall Study|Withdrawal by Subject|1|||
156952118|NCT02053350|566578194|FG000|Overall Study|Adverse Event|4|||
156952119|NCT03521635|566578195|FG000|Overall Study|Adverse Event|1|||
156952120|NCT03521635|566578196|FG001|Overall Study|Adverse Event|1|||
156952121|NCT03521635|566578195|FG000|Overall Study|Refused to complete study visit|1|||
156952122|NCT03521635|566578196|FG001|Overall Study|Refused to complete study visit|0|||
156952123|NCT03521635|566578195|FG000|Overall Study|Refused to continue trial medication|2|||
156952124|NCT03521635|566578196|FG001|Overall Study|Refused to continue trial medication|2|||
156952125|NCT03521635|566578195|FG000|Overall Study|Lost to Follow-up|0|||
156952126|NCT03521635|566578196|FG001|Overall Study|Lost to Follow-up|1|||
156952127|NCT03521635|566578195|FG000|Overall Study|Meet exclusion criteria|0|||
156952128|NCT03521635|566578196|FG001|Overall Study|Meet exclusion criteria|1|||
156952129|NCT03521635|566578195|FG000|Overall Study|Patient not taken study medicine|0|||
156952130|NCT03521635|566578196|FG001|Overall Study|Patient not taken study medicine|1|||
156952131|NCT02244944|566578197|FG000|Overall Study|Withdrawal by Subject|1|||
156952132|NCT02244944|566578197|FG000|Overall Study|Study Terminated|1|||
156952133|NCT01747772|566578198|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
156952134|NCT00896168|566578199|FG000|Overall Study|Adverse Event|4|||
156952135|NCT00896168|566578200|FG001|Overall Study|Adverse Event|7|||
156952136|NCT00896168|566578199|FG000|Overall Study|Treatment failure|8|||
156952137|NCT00896168|566578200|FG001|Overall Study|Treatment failure|10|||
156952138|NCT00896168|566578199|FG000|Overall Study|Lost to Follow-up|1|||
156952139|NCT00896168|566578200|FG001|Overall Study|Lost to Follow-up|1|||
156952140|NCT00896168|566578199|FG000|Overall Study|Other|1|||
156952141|NCT00896168|566578200|FG001|Overall Study|Other|1|||
156952142|NCT02492100|566578201|FG000|Overall Study|Death|1|||
156952143|NCT03832010|566578202|FG000|Overall Study|Withdrawal by Subject|2|||
156952144|NCT03832010|566578203|FG001|Overall Study|Withdrawal by Subject|1|||
157227520|NCT01298570|567579093|FG000|Overall Study|Symptomatic progression/deterioration|3|||
157227521|NCT01298570|567579094|FG001|Overall Study|Symptomatic progression/deterioration|2|||
157227522|NCT01298570|567579093|FG000|Overall Study|Death|0|||
157227523|NCT01298570|567579094|FG001|Overall Study|Death|1|||
157227524|NCT01298570|567579093|FG000|Overall Study|Ineligibility|0|||
156952145|NCT03832010|566578204|FG002|Overall Study|Withdrawal by Subject|0|||
156952146|NCT03832010|566578202|FG000|Overall Study|Lost to Follow-up|2|||
156952147|NCT03832010|566578203|FG001|Overall Study|Lost to Follow-up|1|||
157035385|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Other|0|||
157035386|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
157035387|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
157035388|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
157035389|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
157035390|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
157035391|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
157035392|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035393|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035394|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035395|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035396|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035397|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035398|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035399|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035400|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157168676|NCT04900038|567357942|FG002|Overall Study|Adverse Event|1|||
157168677|NCT04900038|567357943|FG003|Overall Study|Adverse Event|1|||
156952148|NCT03832010|566578204|FG002|Overall Study|Lost to Follow-up|1|||
156952149|NCT00987467|566578209|FG000|Overall Study|Lost to Follow-up|2|||
156952150|NCT00262834|566578210|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
156952151|NCT00262834|566578211|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
156952152|NCT02646423|566578212|FG000|Overall Study|Adverse Event|5|||
156952153|NCT02646423|566578213|FG001|Overall Study|Adverse Event|7|||
156952154|NCT02646423|566578212|FG000|Overall Study|Ineligible|2|||
156952155|NCT02646423|566578213|FG001|Overall Study|Ineligible|1|||
156952156|NCT00003457|566578214|FG000|Overall Study|Not evaluable|9|||
156952157|NCT02416791|566578219|FG000|6 Months|Lost to Follow-up|0|||
156952158|NCT02416791|566578220|FG001|6 Months|Lost to Follow-up|0|||
156952159|NCT02416791|566578221|FG002|6 Months|Lost to Follow-up|1|||
156952160|NCT01054820|566578222|FG000|Overall Study|Withdrawal by Subject|2|||
156952161|NCT02624804|566578223|FG000|Overall Study|Screen Failure|5|||
156952162|NCT00760929|566578224|FG000|Overall Study|Adverse Event|2|||
156952163|NCT00760929|566578225|FG001|Overall Study|Adverse Event|0|||
156952164|NCT00760929|566578226|FG002|Overall Study|Adverse Event|6|||
156952165|NCT00760929|566578227|FG003|Overall Study|Adverse Event|10|||
156952166|NCT00760929|566578224|FG000|Overall Study|Lack of Efficacy|0|||
156952167|NCT00760929|566578225|FG001|Overall Study|Lack of Efficacy|2|||
156952168|NCT00760929|566578226|FG002|Overall Study|Lack of Efficacy|1|||
156952169|NCT00760929|566578227|FG003|Overall Study|Lack of Efficacy|0|||
156952170|NCT00760929|566578224|FG000|Overall Study|Withdrawal by Subject|1|||
156952171|NCT00760929|566578225|FG001|Overall Study|Withdrawal by Subject|0|||
156952172|NCT00760929|566578226|FG002|Overall Study|Withdrawal by Subject|9|||
156952173|NCT00760929|566578227|FG003|Overall Study|Withdrawal by Subject|1|||
156952174|NCT00760929|566578224|FG000|Overall Study|Lost to Follow-up|0|||
156952175|NCT00760929|566578225|FG001|Overall Study|Lost to Follow-up|0|||
156952176|NCT00760929|566578226|FG002|Overall Study|Lost to Follow-up|1|||
156952177|NCT00760929|566578227|FG003|Overall Study|Lost to Follow-up|0|||
156952178|NCT00760929|566578224|FG000|Overall Study|Progression of Disease|21|||
156952179|NCT00760929|566578225|FG001|Overall Study|Progression of Disease|26|||
156952180|NCT00760929|566578226|FG002|Overall Study|Progression of Disease|38|||
156952181|NCT00760929|566578227|FG003|Overall Study|Progression of Disease|42|||
156952182|NCT00760929|566578224|FG000|Overall Study|Other|2|||
156952183|NCT00760929|566578225|FG001|Overall Study|Other|0|||
157035401|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035402|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
157035403|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035404|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
157035405|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
157035406|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035407|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
157035408|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
157168678|NCT04900038|567357940|FG000|Overall Study|Withdrawal by Subject|0|||
157168679|NCT04900038|567357941|FG001|Overall Study|Withdrawal by Subject|1|||
157168680|NCT04900038|567357942|FG002|Overall Study|Withdrawal by Subject|0|||
157168681|NCT04900038|567357943|FG003|Overall Study|Withdrawal by Subject|0|||
157168682|NCT04900038|567357940|FG000|Overall Study|Study terminated by sponsor|18|||
156952184|NCT00760929|566578226|FG002|Overall Study|Other|2|||
156952185|NCT00760929|566578227|FG003|Overall Study|Other|1|||
156952186|NCT00760929|566578224|FG000|Overall Study|Death|0|||
156952187|NCT00760929|566578225|FG001|Overall Study|Death|0|||
156952188|NCT00760929|566578226|FG002|Overall Study|Death|1|||
156952189|NCT00760929|566578227|FG003|Overall Study|Death|0|||
156952190|NCT00760929|566578224|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
157035409|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035410|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035411|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156952191|NCT00760929|566578225|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
156952192|NCT00760929|566578226|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
156952193|NCT00760929|566578227|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
156952194|NCT01227889|566578228|FG000|Randomized Phase (RP)|Adverse Event|13|||
156952195|NCT01227889|566578229|FG001|Randomized Phase (RP)|Adverse Event|0|||
156952196|NCT01227889|566578228|FG000|Randomized Phase (RP)|Physician Decision|13|||
156952197|NCT01227889|566578229|FG001|Randomized Phase (RP)|Physician Decision|5|||
156952198|NCT01227889|566578228|FG000|Randomized Phase (RP)|Progressive Disease|135|||
156952199|NCT01227889|566578229|FG001|Randomized Phase (RP)|Progressive Disease|52|||
156952200|NCT01227889|566578228|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
156952201|NCT01227889|566578229|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
156952202|NCT01227889|566578228|FG000|Randomized Phase (RP)|Missing|1|||
156952203|NCT01227889|566578229|FG001|Randomized Phase (RP)|Missing|3|||
156952204|NCT01227889|566578228|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
156952205|NCT01227889|566578229|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
156952206|NCT01227889|566578228|FG000|Crossover Phase|Adverse Event|0|||
156952207|NCT01227889|566578229|FG001|Crossover Phase|Adverse Event|1|||
156952208|NCT01227889|566578228|FG000|Crossover Phase|Physician Decision|0|||
156952209|NCT01227889|566578229|FG001|Crossover Phase|Physician Decision|3|||
156952210|NCT01227889|566578228|FG000|Crossover Phase|Progressive Disease|0|||
156952211|NCT01227889|566578229|FG001|Crossover Phase|Progressive Disease|31|||
156952212|NCT01227889|566578228|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
156952213|NCT01227889|566578229|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
156952214|NCT01227889|566578228|FG000|Crossover Phase|Withdrawal by Subject|0|||
156952215|NCT01227889|566578229|FG001|Crossover Phase|Withdrawal by Subject|1|||
156952216|NCT04121962|566578230|FG000|Overall Study|Lost to Follow-up|42|||
156952217|NCT04121962|566578231|FG001|Overall Study|Lost to Follow-up|39|||
156952218|NCT02348216|566578236|FG000|Overall Study|Death|5|||
156952219|NCT02348216|566578237|FG001|Overall Study|Death|53|||
156952220|NCT02348216|566578238|FG002|Overall Study|Death|11|||
156952221|NCT02348216|566578239|FG003|Overall Study|Death|20|||
156952222|NCT02348216|566578240|FG004|Overall Study|Death|16|||
156952223|NCT02348216|566578241|FG005|Overall Study|Death|32|||
156952224|NCT02348216|566578242|FG006|Overall Study|Death|17|||
156952225|NCT02348216|566578236|FG000|Overall Study|Full consent withdrawal|0|||
156952226|NCT02348216|566578237|FG001|Overall Study|Full consent withdrawal|0|||
156952227|NCT02348216|566578238|FG002|Overall Study|Full consent withdrawal|0|||
156952228|NCT02348216|566578239|FG003|Overall Study|Full consent withdrawal|1|||
156952229|NCT02348216|566578240|FG004|Overall Study|Full consent withdrawal|3|||
157168683|NCT04900038|567357941|FG001|Overall Study|Study terminated by sponsor|15|||
157168684|NCT04900038|567357942|FG002|Overall Study|Study terminated by sponsor|17|||
157168685|NCT04900038|567357943|FG003|Overall Study|Study terminated by sponsor|14|||
157168686|NCT04900038|567357940|FG000|Overall Study|Protocol Deviation|1|||
157168687|NCT04900038|567357941|FG001|Overall Study|Protocol Deviation|1|||
157168688|NCT04900038|567357942|FG002|Overall Study|Protocol Deviation|0|||
156952230|NCT02348216|566578241|FG005|Overall Study|Full consent withdrawal|0|||
156952231|NCT02348216|566578242|FG006|Overall Study|Full consent withdrawal|3|||
156952232|NCT02348216|566578236|FG000|Overall Study|Lost to Follow-up|0|||
156952233|NCT02348216|566578237|FG001|Overall Study|Lost to Follow-up|5|||
156952234|NCT02348216|566578238|FG002|Overall Study|Lost to Follow-up|2|||
156952235|NCT02348216|566578239|FG003|Overall Study|Lost to Follow-up|0|||
156952236|NCT02348216|566578240|FG004|Overall Study|Lost to Follow-up|1|||
156952237|NCT02348216|566578241|FG005|Overall Study|Lost to Follow-up|1|||
156952238|NCT02348216|566578242|FG006|Overall Study|Lost to Follow-up|1|||
156952239|NCT02348216|566578236|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
156952240|NCT02348216|566578237|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
156952241|NCT02348216|566578238|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
156952242|NCT02348216|566578239|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
156952243|NCT02348216|566578240|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
156952244|NCT02348216|566578241|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
156952245|NCT02348216|566578242|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
156952246|NCT02348216|566578236|FG000|Overall Study|Reason not specified|2|||
156952247|NCT02348216|566578237|FG001|Overall Study|Reason not specified|19|||
156952248|NCT02348216|566578238|FG002|Overall Study|Reason not specified|11|||
156952249|NCT02348216|566578239|FG003|Overall Study|Reason not specified|17|||
156952250|NCT02348216|566578240|FG004|Overall Study|Reason not specified|21|||
156952251|NCT02348216|566578241|FG005|Overall Study|Reason not specified|17|||
156952252|NCT02348216|566578242|FG006|Overall Study|Reason not specified|19|||
157168689|NCT04900038|567357943|FG003|Overall Study|Protocol Deviation|0|||
157168690|NCT04900038|567357940|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
157168691|NCT04900038|567357941|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
156952253|NCT00765245|566578243|FG000|Overall Study|disease progression|3|||
156952254|NCT00765245|566578244|FG001|Overall Study|disease progression|2|||
157168692|NCT04900038|567357942|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
157035412|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035413|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035414|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035415|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035416|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035417|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
156952255|NCT00765245|566578243|FG000|Overall Study|Withdrawal by Subject|3|||
156952256|NCT00765245|566578244|FG001|Overall Study|Withdrawal by Subject|0|||
156952257|NCT00765245|566578243|FG000|Overall Study|Adverse Event|5|||
156952258|NCT00765245|566578244|FG001|Overall Study|Adverse Event|0|||
156952259|NCT00765245|566578243|FG000|Overall Study|Physician Decision|1|||
156952260|NCT00765245|566578244|FG001|Overall Study|Physician Decision|0|||
156952261|NCT00765245|566578243|FG000|Overall Study|Death|1|||
156952262|NCT00765245|566578244|FG001|Overall Study|Death|0|||
156952263|NCT02417246|566578245|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
156952264|NCT02417246|566578246|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
156952265|NCT02417246|566578245|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
156952266|NCT02417246|566578246|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
156952267|NCT02417246|566578245|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
156952268|NCT02417246|566578246|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
156952269|NCT02417246|566578245|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
156952270|NCT02417246|566578246|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
156952271|NCT06027216|566578250|FG000|Overall Study|Did not qualify|8|||
156952272|NCT03231371|566578251|FG000|Overall Study|Withdrawal by Subject|1|||
156952273|NCT03231371|566578251|FG000|Overall Study|chose or were ineligible to have MRI|12|||
156952274|NCT00345579|566578255|FG000|Overall Study|Adverse Event|9|||
156952275|NCT00345579|566578256|FG001|Overall Study|Adverse Event|6|||
156952276|NCT00345579|566578255|FG000|Overall Study|Protocol Violation|14|||
156952277|NCT00345579|566578256|FG001|Overall Study|Protocol Violation|5|||
156952278|NCT00345579|566578255|FG000|Overall Study|Withdrawal by Subject|50|||
156952279|NCT00345579|566578256|FG001|Overall Study|Withdrawal by Subject|17|||
156952280|NCT00345579|566578255|FG000|Overall Study|Lost to Follow-up|82|||
156952281|NCT00345579|566578256|FG001|Overall Study|Lost to Follow-up|36|||
156952282|NCT00345579|566578255|FG000|Overall Study|Other|9|||
156952283|NCT00345579|566578256|FG001|Overall Study|Other|1|||
156952284|NCT03029208|566578257|FG000|Overall Study|Withdrawal by Subject|2|||
156952285|NCT03029208|566578258|FG001|Overall Study|Withdrawal by Subject|3|||
156952286|NCT03029208|566578257|FG000|Overall Study|Lost to Follow-up|0|||
156952287|NCT03029208|566578258|FG001|Overall Study|Lost to Follow-up|1|||
156952288|NCT03207750|566578261|FG000|Overall Study|Adverse Event|3|||
156952289|NCT03207750|566578262|FG001|Overall Study|Adverse Event|2|||
156952290|NCT03207750|566578261|FG000|Overall Study|Lost to Follow-up|21|||
156952291|NCT03207750|566578262|FG001|Overall Study|Lost to Follow-up|29|||
156952292|NCT03207750|566578261|FG000|Overall Study|Protocol Violation|0|||
156952293|NCT03207750|566578262|FG001|Overall Study|Protocol Violation|1|||
156952294|NCT03207750|566578261|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
156952295|NCT03207750|566578262|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
156952296|NCT03207750|566578261|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
156952297|NCT03207750|566578262|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
156952298|NCT03207750|566578261|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
156952299|NCT03207750|566578262|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
156952300|NCT03207750|566578261|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
156952301|NCT03207750|566578262|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
156952302|NCT03207750|566578261|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
156952303|NCT03207750|566578262|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
156952304|NCT02493361|566578263|FG000|Overall Study|Withdrawal by Subject|3|||
157035418|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157035419|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
157227525|NCT01298570|567579094|FG001|Overall Study|Ineligibility|1|||
156952305|NCT00856583|566578266|FG000|Overall Study|Lack of Efficacy|389|||
156952306|NCT00856583|566578267|FG001|Overall Study|Lack of Efficacy|377|||
156952307|NCT00856583|566578266|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
156952308|NCT00856583|566578267|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
156952309|NCT00856583|566578266|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
156952310|NCT00856583|566578267|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
156952311|NCT00856583|566578266|FG000|Overall Study|Non-compliance|305|||
156952312|NCT00856583|566578267|FG001|Overall Study|Non-compliance|262|||
156952313|NCT00856583|566578266|FG000|Overall Study|Withdrawal by Subject|1092|||
156952314|NCT00856583|566578267|FG001|Overall Study|Withdrawal by Subject|919|||
156952315|NCT00856583|566578266|FG000|Overall Study|Physician Decision|59|||
156952316|NCT00856583|566578267|FG001|Overall Study|Physician Decision|82|||
156952317|NCT00856583|566578266|FG000|Overall Study|Pregnancy|14|||
156952318|NCT00856583|566578267|FG001|Overall Study|Pregnancy|5|||
156952319|NCT00856583|566578266|FG000|Overall Study|Other|92|||
157035420|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Death|2|||
157035421|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Death|1|||
156952320|NCT00856583|566578267|FG001|Overall Study|Other|104|||
156952321|NCT00856583|566578266|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
156952322|NCT00856583|566578267|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
156952323|NCT02937545|566578268|FG000|Overall Study|Withdrawal by Subject|1|||
156952324|NCT02937545|566578269|FG001|Overall Study|Withdrawal by Subject|2|||
156952325|NCT02937545|566578270|FG002|Overall Study|Withdrawal by Subject|6|||
156952326|NCT02937545|566578271|FG003|Overall Study|Withdrawal by Subject|7|||
156952327|NCT02937545|566578268|FG000|Overall Study|Lost to Follow-up|1|||
156952328|NCT02937545|566578269|FG001|Overall Study|Lost to Follow-up|0|||
156952329|NCT02937545|566578270|FG002|Overall Study|Lost to Follow-up|0|||
156952330|NCT02937545|566578271|FG003|Overall Study|Lost to Follow-up|0|||
156952331|NCT02504294|566578274|FG000|Overall Study|Adverse Event|15|||
156952332|NCT02504294|566578275|FG001|Overall Study|Adverse Event|12|||
156952333|NCT02504294|566578274|FG000|Overall Study|Withdrawal by Subject|7|||
156952334|NCT02504294|566578275|FG001|Overall Study|Withdrawal by Subject|1|||
156952335|NCT02504294|566578274|FG000|Overall Study|Protocol Violation|27|||
156952336|NCT02504294|566578275|FG001|Overall Study|Protocol Violation|26|||
156952337|NCT02504294|566578274|FG000|Overall Study|Physician Decision|1|||
156952338|NCT02504294|566578275|FG001|Overall Study|Physician Decision|2|||
156952339|NCT02504294|566578274|FG000|Overall Study|Lost to Follow-up|6|||
156952340|NCT02504294|566578275|FG001|Overall Study|Lost to Follow-up|7|||
156952341|NCT02252211|566578276|FG000|Overall Study|Adverse Event|0|||
156952342|NCT02252211|566578277|FG001|Overall Study|Adverse Event|1|||
156952343|NCT02252211|566578278|FG002|Overall Study|Adverse Event|0|||
156952344|NCT02252211|566578276|FG000|Overall Study|Progressive disease|3|||
156952345|NCT02252211|566578277|FG001|Overall Study|Progressive disease|2|||
156952346|NCT02252211|566578278|FG002|Overall Study|Progressive disease|0|||
156952347|NCT02252211|566578276|FG000|Overall Study|Withdrawal by Subject|1|||
156952348|NCT02252211|566578277|FG001|Overall Study|Withdrawal by Subject|0|||
156952349|NCT02252211|566578278|FG002|Overall Study|Withdrawal by Subject|0|||
156952350|NCT02252211|566578276|FG000|Overall Study|Serious Adverse Event During Screening|1|||
156952351|NCT02252211|566578277|FG001|Overall Study|Serious Adverse Event During Screening|0|||
156952352|NCT02252211|566578278|FG002|Overall Study|Serious Adverse Event During Screening|1|||
156952353|NCT05799495|566578285|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
156952354|NCT05799495|566578286|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
156952355|NCT05799495|566578287|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
156952356|NCT05799495|566578288|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
156952357|NCT05799495|566578285|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156952358|NCT05799495|566578286|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156952359|NCT05799495|566578287|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
156952360|NCT05799495|566578288|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
156952361|NCT05799495|566578285|FG000|Treatment (Up to 5 Days)|Other|0|||
156952362|NCT05799495|566578286|FG001|Treatment (Up to 5 Days)|Other|1|||
156952363|NCT05799495|566578287|FG002|Treatment (Up to 5 Days)|Other|0|||
156952364|NCT05799495|566578288|FG003|Treatment (Up to 5 Days)|Other|0|||
156952365|NCT05799495|566578285|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156952366|NCT05799495|566578286|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156952367|NCT05799495|566578287|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
156952368|NCT05799495|566578288|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
156952369|NCT05799495|566578285|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
156952370|NCT05799495|566578286|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
156952371|NCT05799495|566578287|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
156952372|NCT05799495|566578288|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
156952373|NCT05799495|566578285|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156952374|NCT05799495|566578286|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156952375|NCT05799495|566578287|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
156952376|NCT05799495|566578288|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
156952377|NCT03694548|566578289|FG000|Part A Survey|Protocol Violation|3|||
156952378|NCT03694548|566578290|FG001|Part A Survey|Protocol Violation|3|||
156952379|NCT03694548|566578291|FG002|Part A Survey|Protocol Violation|0|||
156952380|NCT03694548|566578289|FG000|Part B Yoga Program|Protocol Violation|0|||
156952381|NCT03694548|566578290|FG001|Part B Yoga Program|Protocol Violation|0|||
156952382|NCT03694548|566578291|FG002|Part B Yoga Program|Protocol Violation|3|||
157035422|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Death|1|||
157035423|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Death|0|||
156952383|NCT03694548|566578289|FG000|Part B Yoga Program|Did not attend intervention|0|||
156952384|NCT03694548|566578290|FG001|Part B Yoga Program|Did not attend intervention|0|||
156952385|NCT03694548|566578291|FG002|Part B Yoga Program|Did not attend intervention|8|||
156952386|NCT06281548|566578293|FG000|Overall Study|Lost to Follow-up|3|||
156952387|NCT01587651|566578294|FG000|Overall Study|Adverse Event|0|||
156952388|NCT01587651|566578295|FG001|Overall Study|Adverse Event|1|||
156952389|NCT01587651|566578296|FG002|Overall Study|Adverse Event|0|||
156952390|NCT01587651|566578294|FG000|Overall Study|Protocol Violation|0|||
156952391|NCT01587651|566578295|FG001|Overall Study|Protocol Violation|1|||
156952392|NCT01587651|566578296|FG002|Overall Study|Protocol Violation|1|||
157035424|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Death|0|||
156952393|NCT01587651|566578294|FG000|Overall Study|Withdrawal by Subject|0|||
156952394|NCT01587651|566578295|FG001|Overall Study|Withdrawal by Subject|1|||
156952395|NCT01587651|566578296|FG002|Overall Study|Withdrawal by Subject|0|||
156952396|NCT03285477|566578297|FG000|Treatment and Response Assessment Period|Death|1|||
156952397|NCT03285477|566578298|FG001|Treatment and Response Assessment Period|Death|0|||
156952398|NCT03285477|566578297|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
156952399|NCT03285477|566578298|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
157035425|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Death|0|||
157035426|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Death|0|||
157035427|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Death|0|||
157035428|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Death|0|||
156952400|NCT03285477|566578297|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
156952401|NCT03285477|566578298|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
156952402|NCT03285477|566578297|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
156952403|NCT03285477|566578298|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
156952404|NCT03285477|566578297|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
156952405|NCT03285477|566578298|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
156952406|NCT00560833|566578299|FG000|Overall Study|Adverse Event|16|||
156952407|NCT00560833|566578300|FG001|Overall Study|Adverse Event|10|||
156952408|NCT00560833|566578301|FG002|Overall Study|Adverse Event|25|||
156952409|NCT00560833|566578302|FG003|Overall Study|Adverse Event|23|||
156952410|NCT00560833|566578303|FG004|Overall Study|Adverse Event|35|||
156952411|NCT00560833|566578299|FG000|Overall Study|Lost to Follow-up|0|||
156952412|NCT00560833|566578300|FG001|Overall Study|Lost to Follow-up|0|||
156952413|NCT00560833|566578301|FG002|Overall Study|Lost to Follow-up|1|||
156952414|NCT00560833|566578302|FG003|Overall Study|Lost to Follow-up|0|||
156952415|NCT00560833|566578303|FG004|Overall Study|Lost to Follow-up|0|||
156952416|NCT00560833|566578299|FG000|Overall Study|Lack of Efficacy|22|||
156952417|NCT00560833|566578300|FG001|Overall Study|Lack of Efficacy|9|||
156952418|NCT00560833|566578301|FG002|Overall Study|Lack of Efficacy|6|||
156952419|NCT00560833|566578302|FG003|Overall Study|Lack of Efficacy|4|||
156952420|NCT00560833|566578303|FG004|Overall Study|Lack of Efficacy|4|||
156952421|NCT00560833|566578299|FG000|Overall Study|Participant uncooperative|5|||
156952422|NCT00560833|566578300|FG001|Overall Study|Participant uncooperative|5|||
156952423|NCT00560833|566578301|FG002|Overall Study|Participant uncooperative|4|||
156952424|NCT00560833|566578302|FG003|Overall Study|Participant uncooperative|4|||
156952425|NCT00560833|566578303|FG004|Overall Study|Participant uncooperative|2|||
156952426|NCT00560833|566578299|FG000|Overall Study|Other|1|||
156952427|NCT00560833|566578300|FG001|Overall Study|Other|1|||
156952428|NCT00560833|566578301|FG002|Overall Study|Other|3|||
156952429|NCT00560833|566578302|FG003|Overall Study|Other|0|||
156952430|NCT00560833|566578303|FG004|Overall Study|Other|0|||
156952431|NCT00560833|566578299|FG000|Overall Study|Never received drug|0|||
156952432|NCT00560833|566578300|FG001|Overall Study|Never received drug|1|||
156952433|NCT00560833|566578301|FG002|Overall Study|Never received drug|0|||
156952434|NCT00560833|566578302|FG003|Overall Study|Never received drug|0|||
156952435|NCT00560833|566578303|FG004|Overall Study|Never received drug|1|||
156952436|NCT03283670|566578304|FG000|Placebo Gas|Withdrawal by Subject|2|||
156952437|NCT03283670|566578304|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
156952438|NCT03283670|566578304|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
156952439|NCT01059617|566578307|FG000|Overall Study|Other|7|||
156952440|NCT01059617|566578308|FG001|Overall Study|Other|1|||
156952441|NCT01059617|566578309|FG002|Overall Study|Other|8|||
157035429|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Death|0|||
157035430|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Death|0|||
157035431|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Death|0|||
157035432|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Death|0|||
157035433|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Death|0|||
157035434|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Death|0|||
156952442|NCT01059617|566578310|FG003|Overall Study|Other|6|||
157035435|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Death|0|||
157035436|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Death|0|||
157227526|NCT02841709|567579095|FG000|5th Intervention|Adverse Event|2|||
157227527|NCT02841709|567579096|FG001|5th Intervention|Adverse Event|0|||
156952443|NCT01307501|566578311|FG000|Overall Study|Treatment Failure|1|||
156952444|NCT01307501|566578311|FG000|Overall Study|Death|20|||
156952445|NCT01307501|566578311|FG000|Overall Study|Lost to Follow-up|1|||
156952446|NCT01307501|566578311|FG000|Overall Study|Starting Hospice|1|||
156952447|NCT00612313|566578318|FG000|Overall Study|Withdrawal by Subject|6|||
156952448|NCT00612313|566578319|FG001|Overall Study|Withdrawal by Subject|9|||
156952449|NCT00612313|566578318|FG000|Overall Study|Lost to Follow-up|11|||
156952450|NCT00612313|566578319|FG001|Overall Study|Lost to Follow-up|4|||
156952451|NCT01209624|566578325|FG000|Overall Study|Death|2|||
156952452|NCT01209624|566578325|FG000|Overall Study|Adverse Event|13|||
157035437|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035438|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
157035439|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
157168693|NCT04900038|567357943|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
157168694|NCT04900038|567357940|FG000|Overall Study|Lost to Follow-up|0|||
157168695|NCT04900038|567357941|FG001|Overall Study|Lost to Follow-up|0|||
156952453|NCT01209624|566578325|FG000|Overall Study|Lack of Efficacy|17|||
157168696|NCT04900038|567357942|FG002|Overall Study|Lost to Follow-up|0|||
157168697|NCT04900038|567357943|FG003|Overall Study|Lost to Follow-up|1|||
157168698|NCT03245723|567357950|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
157168699|NCT03245723|567357951|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
157168700|NCT03245723|567357950|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
157168701|NCT03245723|567357951|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
157168702|NCT03245723|567357950|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
157168703|NCT03245723|567357951|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
157168704|NCT03245723|567357950|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
157168705|NCT03245723|567357951|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
157168706|NCT06025396|567359777|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
157168707|NCT06025396|567359778|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
157168708|NCT06025396|567359779|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
157168709|NCT06025396|567359780|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
157168710|NCT06025396|567359781|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
157168711|NCT06025396|567359777|FG000|Overall Study|Withdrawal by Subject|0|||
157168712|NCT06025396|567359778|FG001|Overall Study|Withdrawal by Subject|1|||
157168713|NCT06025396|567359779|FG002|Overall Study|Withdrawal by Subject|1|||
157168714|NCT06025396|567359780|FG003|Overall Study|Withdrawal by Subject|0|||
157168715|NCT06025396|567359781|FG004|Overall Study|Withdrawal by Subject|0|||
157168716|NCT01512108|567359782|FG000|Overall Study|Adverse Event|9|||
157168717|NCT01512108|567359783|FG001|Overall Study|Adverse Event|4|||
157168718|NCT01512108|567359782|FG000|Overall Study|Protocol Violation|1|||
157168719|NCT01512108|567359783|FG001|Overall Study|Protocol Violation|2|||
157168720|NCT01512108|567359782|FG000|Overall Study|Withdrawal Criteria|1|||
157168721|NCT01512108|567359783|FG001|Overall Study|Withdrawal Criteria|0|||
157168722|NCT01512108|567359782|FG000|Overall Study|Unclassified|11|||
157168723|NCT01512108|567359783|FG001|Overall Study|Unclassified|3|||
157168724|NCT06422377|567359784|FG000|Overall Study|Study Terminated by Sponsor|1|||
157168725|NCT02017899|567359785|FG000|Overall Study|Withdrawal by Subject|0|||
157168726|NCT02017899|567359786|FG001|Overall Study|Withdrawal by Subject|0|||
157168727|NCT02017899|567359787|FG002|Overall Study|Withdrawal by Subject|0|||
157168728|NCT02017899|567359788|FG003|Overall Study|Withdrawal by Subject|1|||
157168729|NCT02017899|567359789|FG004|Overall Study|Withdrawal by Subject|1|||
157168730|NCT02017899|567359790|FG005|Overall Study|Withdrawal by Subject|0|||
156952454|NCT01209624|566578325|FG000|Overall Study|Lost to Follow-up|290|||
156952455|NCT01209624|566578325|FG000|Overall Study|Other|4|||
156952456|NCT03403634|566578326|FG000|Overall Study|Disease progression|3|||
156952457|NCT03403634|566578326|FG000|Overall Study|Did not meet eligibility criteria|4|||
156952458|NCT00428610|566578327|FG000|Overall Study|Death Due to Adverse Event|3|||
156952459|NCT00428610|566578328|FG001|Overall Study|Death Due to Adverse Event|0|||
156952460|NCT00428610|566578329|FG002|Overall Study|Death Due to Adverse Event|5|||
156952461|NCT00428610|566578327|FG000|Overall Study|Death Due to Progressive Disease|0|||
156952462|NCT00428610|566578328|FG001|Overall Study|Death Due to Progressive Disease|0|||
156952463|NCT00428610|566578329|FG002|Overall Study|Death Due to Progressive Disease|2|||
156952464|NCT00428610|566578327|FG000|Overall Study|Adverse Event|2|||
156952465|NCT00428610|566578328|FG001|Overall Study|Adverse Event|3|||
156952466|NCT00428610|566578329|FG002|Overall Study|Adverse Event|2|||
156952467|NCT00428610|566578327|FG000|Overall Study|Investigator Decision|2|||
156952468|NCT00428610|566578328|FG001|Overall Study|Investigator Decision|1|||
157168731|NCT02420795|567359792|FG000|Overall Study|Withdrawal by Subject|1|||
157168732|NCT02420795|567359793|FG001|Overall Study|Withdrawal by Subject|0|||
157168733|NCT02420795|567359794|FG002|Overall Study|Withdrawal by Subject|0|||
157168734|NCT02420795|567359792|FG000|Overall Study|Adverse Event|1|||
157168735|NCT02420795|567359793|FG001|Overall Study|Adverse Event|0|||
157168736|NCT02420795|567359794|FG002|Overall Study|Adverse Event|0|||
157168737|NCT02420795|567359792|FG000|Overall Study|Progressive disease|2|||
157168738|NCT02420795|567359793|FG001|Overall Study|Progressive disease|2|||
157168739|NCT02420795|567359794|FG002|Overall Study|Progressive disease|4|||
157168740|NCT02420795|567359792|FG000|Overall Study|Death|0|||
157168741|NCT02420795|567359793|FG001|Overall Study|Death|0|||
157168742|NCT02420795|567359794|FG002|Overall Study|Death|1|||
157168743|NCT00971425|567359795|FG000|Overall Study|Adverse Event|1|||
157168744|NCT00971425|567359796|FG001|Overall Study|Adverse Event|1|||
157168745|NCT00971425|567359795|FG000|Overall Study|Withdrawal by Subject|0|||
157168746|NCT00971425|567359796|FG001|Overall Study|Withdrawal by Subject|1|||
157168747|NCT02528253|567359799|FG000|Overall Study|Adverse Event|3|||
157168748|NCT02528253|567359800|FG001|Overall Study|Adverse Event|4|||
156952469|NCT00428610|566578329|FG002|Overall Study|Investigator Decision|1|||
156952470|NCT00428610|566578327|FG000|Overall Study|Progressive Disease|42|||
156952471|NCT00428610|566578328|FG001|Overall Study|Progressive Disease|14|||
157227528|NCT02841709|567579097|FG002|5th Intervention|Adverse Event|0|||
157035440|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035441|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
157035442|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
157035443|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
156952472|NCT00428610|566578329|FG002|Overall Study|Progressive Disease|22|||
156952473|NCT00428610|566578327|FG000|Overall Study|Withdrawal by Subject|4|||
157035444|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035445|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035446|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035447|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035448|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035449|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035450|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035451|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035452|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035453|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
157035454|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035455|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035456|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035457|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035458|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
157035459|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
157035460|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035461|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035462|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035463|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035464|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
156952474|NCT00428610|566578328|FG001|Overall Study|Withdrawal by Subject|0|||
156952475|NCT00428610|566578329|FG002|Overall Study|Withdrawal by Subject|0|||
156952476|NCT03859323|566580595|FG000|Overall Study|Lost to Follow-up|0|||
156952477|NCT03859323|566580596|FG001|Overall Study|Lost to Follow-up|0|||
156952478|NCT03859323|566580597|FG002|Overall Study|Lost to Follow-up|0|||
156952479|NCT03859323|566580598|FG003|Overall Study|Lost to Follow-up|0|||
156952480|NCT03859323|566580599|FG004|Overall Study|Lost to Follow-up|0|||
156952481|NCT03859323|566580600|FG005|Overall Study|Lost to Follow-up|0|||
156952482|NCT03859323|566580601|FG006|Overall Study|Lost to Follow-up|1|||
156952483|NCT03859323|566580602|FG007|Overall Study|Lost to Follow-up|0|||
156952484|NCT03859323|566580603|FG008|Overall Study|Lost to Follow-up|0|||
156952485|NCT03859323|566580604|FG009|Overall Study|Lost to Follow-up|0|||
156952486|NCT03859323|566580605|FG010|Overall Study|Lost to Follow-up|0|||
156952487|NCT03859323|566580606|FG011|Overall Study|Lost to Follow-up|0|||
156952488|NCT03859323|566580607|FG012|Overall Study|Lost to Follow-up|0|||
156952489|NCT03859323|566580595|FG000|Overall Study|Withdrawal by Subject|0|||
156952490|NCT03859323|566580596|FG001|Overall Study|Withdrawal by Subject|0|||
156952491|NCT03859323|566580597|FG002|Overall Study|Withdrawal by Subject|1|||
156952492|NCT03859323|566580598|FG003|Overall Study|Withdrawal by Subject|0|||
156952493|NCT03859323|566580599|FG004|Overall Study|Withdrawal by Subject|0|||
156952494|NCT03859323|566580600|FG005|Overall Study|Withdrawal by Subject|1|||
156952495|NCT03859323|566580601|FG006|Overall Study|Withdrawal by Subject|0|||
156952496|NCT03859323|566580602|FG007|Overall Study|Withdrawal by Subject|0|||
156952497|NCT03859323|566580603|FG008|Overall Study|Withdrawal by Subject|0|||
156952498|NCT03859323|566580604|FG009|Overall Study|Withdrawal by Subject|1|||
156952499|NCT03859323|566580605|FG010|Overall Study|Withdrawal by Subject|1|||
156952500|NCT03859323|566580606|FG011|Overall Study|Withdrawal by Subject|2|||
156952501|NCT03859323|566580607|FG012|Overall Study|Withdrawal by Subject|1|||
156952502|NCT03859323|566580595|FG000|Overall Study|Pregnancy|0|||
156952503|NCT03859323|566580596|FG001|Overall Study|Pregnancy|0|||
156952504|NCT03859323|566580597|FG002|Overall Study|Pregnancy|0|||
156952505|NCT03859323|566580598|FG003|Overall Study|Pregnancy|0|||
156952506|NCT03859323|566580599|FG004|Overall Study|Pregnancy|0|||
156952507|NCT03859323|566580600|FG005|Overall Study|Pregnancy|0|||
156952508|NCT03859323|566580601|FG006|Overall Study|Pregnancy|0|||
157035465|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035466|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035467|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035468|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
157035469|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
156952509|NCT03859323|566580602|FG007|Overall Study|Pregnancy|0|||
156952510|NCT03859323|566580603|FG008|Overall Study|Pregnancy|0|||
156952511|NCT03859323|566580604|FG009|Overall Study|Pregnancy|1|||
156952512|NCT03859323|566580605|FG010|Overall Study|Pregnancy|0|||
156952513|NCT03859323|566580606|FG011|Overall Study|Pregnancy|0|||
156952514|NCT03859323|566580607|FG012|Overall Study|Pregnancy|0|||
156952515|NCT01682460|566580609|FG000|Overall Study|Withdrawal by Subject|2|||
156952516|NCT01682460|566580609|FG000|Overall Study|Did not meet inclusion criteria|2|||
156952517|NCT00724282|566580618|FG000|Overall Study|Withdrawal by Subject|3|||
156952518|NCT00724282|566580618|FG000|Overall Study|Physician Decision|1|||
156952519|NCT03811912|566580619|FG000|Overall Study|Withdrew Consent|4|||
156952520|NCT03811912|566580620|FG001|Overall Study|Withdrew Consent|2|||
156952521|NCT04401579|566580621|FG000|Overall Study|Death|23|||
156952522|NCT04401579|566580622|FG001|Overall Study|Death|36|||
156952523|NCT04401579|566580621|FG000|Overall Study|Lost to Follow-up|40|||
156952524|NCT04401579|566580622|FG001|Overall Study|Lost to Follow-up|41|||
156952525|NCT04401579|566580621|FG000|Overall Study|Withdrawal by Subject|8|||
156952526|NCT04401579|566580622|FG001|Overall Study|Withdrawal by Subject|16|||
156952527|NCT04401579|566580621|FG000|Overall Study|Physician Decision|1|||
156952528|NCT04401579|566580622|FG001|Overall Study|Physician Decision|2|||
156952529|NCT04401579|566580621|FG000|Overall Study|Became ineligible after enrollment|1|||
156952530|NCT04401579|566580622|FG001|Overall Study|Became ineligible after enrollment|1|||
156952531|NCT04401579|566580621|FG000|Overall Study|Enrolled but treatment not administered|7|||
156952532|NCT04401579|566580622|FG001|Overall Study|Enrolled but treatment not administered|9|||
156952533|NCT04401579|566580621|FG000|Overall Study|Adverse Event|2|||
156952534|NCT04401579|566580622|FG001|Overall Study|Adverse Event|1|||
156952535|NCT04401579|566580621|FG000|Overall Study|Scheduling error|1|||
156952536|NCT04401579|566580622|FG001|Overall Study|Scheduling error|2|||
156952537|NCT04401579|566580621|FG000|Overall Study|Transferred to another hospital|1|||
156952538|NCT04401579|566580622|FG001|Overall Study|Transferred to another hospital|2|||
156952539|NCT00489970|566580623|FG000|Persistence Year 9|Lost to Follow-up|2|||
156952540|NCT00489970|566580624|FG001|Persistence Year 9|Lost to Follow-up|2|||
156952541|NCT00489970|566580625|FG002|Persistence Year 9|Lost to Follow-up|3|||
156952542|NCT00489970|566580623|FG000|Persistence Year 9|Other|1|||
156952543|NCT00489970|566580624|FG001|Persistence Year 9|Other|0|||
156952544|NCT00489970|566580625|FG002|Persistence Year 9|Other|2|||
156952545|NCT00618514|566580626|FG000|Overall Study|Lost to Follow-up|11|||
156952546|NCT00618514|566580627|FG001|Overall Study|Lost to Follow-up|12|||
156952547|NCT00618514|566580628|FG002|Overall Study|Lost to Follow-up|4|||
156952548|NCT03586648|566580631|FG000|Period 1|Withdrawal by Subject|0|||
156952549|NCT03586648|566580632|FG001|Period 1|Withdrawal by Subject|1|||
156952550|NCT03586648|566580631|FG000|Period 1|Lost to Follow-up|1|||
156952551|NCT03586648|566580632|FG001|Period 1|Lost to Follow-up|1|||
156952552|NCT03586648|566580631|FG000|Period 1|Adverse Event|1|||
156952553|NCT03586648|566580632|FG001|Period 1|Adverse Event|0|||
156952554|NCT03586648|566580631|FG000|Period 1|Study related symptoms or complaints|2|||
156952555|NCT03586648|566580632|FG001|Period 1|Study related symptoms or complaints|1|||
156952556|NCT03586648|566580631|FG000|Period 1|Physician Decision|0|||
156952557|NCT03586648|566580632|FG001|Period 1|Physician Decision|1|||
156952558|NCT03586648|566580631|FG000|Period 2|Adverse Event|1|||
156952559|NCT03586648|566580632|FG001|Period 2|Adverse Event|0|||
156952560|NCT02041195|566580633|FG000|Overall Study|Adverse Event|1|||
156952561|NCT02041195|566580634|FG001|Overall Study|Adverse Event|2|||
156952562|NCT02041195|566580635|FG002|Overall Study|Adverse Event|0|||
156952563|NCT02041195|566580636|FG003|Overall Study|Adverse Event|0|||
156952564|NCT02041195|566580637|FG004|Overall Study|Adverse Event|0|||
157168749|NCT02528253|567359801|FG002|Overall Study|Adverse Event|4|||
157168750|NCT02528253|567359802|FG003|Overall Study|Adverse Event|8|||
157168751|NCT02528253|567359803|FG004|Overall Study|Adverse Event|18|||
157168752|NCT02528253|567359799|FG000|Overall Study|Death|2|||
157168753|NCT02528253|567359800|FG001|Overall Study|Death|2|||
157168754|NCT02528253|567359801|FG002|Overall Study|Death|1|||
157168755|NCT02528253|567359802|FG003|Overall Study|Death|0|||
157168756|NCT02528253|567359803|FG004|Overall Study|Death|1|||
157168757|NCT02528253|567359799|FG000|Overall Study|Insufficient clinical response|7|||
157168758|NCT02528253|567359800|FG001|Overall Study|Insufficient clinical response|10|||
157168759|NCT02528253|567359801|FG002|Overall Study|Insufficient clinical response|13|||
157168760|NCT02528253|567359802|FG003|Overall Study|Insufficient clinical response|12|||
157168761|NCT02528253|567359803|FG004|Overall Study|Insufficient clinical response|16|||
157168762|NCT02528253|567359799|FG000|Overall Study|Lost to Follow-up|16|||
157168763|NCT02528253|567359800|FG001|Overall Study|Lost to Follow-up|9|||
156952565|NCT02041195|566580638|FG005|Overall Study|Adverse Event|0|||
157168764|NCT02528253|567359801|FG002|Overall Study|Lost to Follow-up|31|||
157168765|NCT02528253|567359802|FG003|Overall Study|Lost to Follow-up|16|||
157168766|NCT02528253|567359803|FG004|Overall Study|Lost to Follow-up|34|||
157168767|NCT02528253|567359799|FG000|Overall Study|Other|21|||
156952566|NCT02041195|566580639|FG006|Overall Study|Adverse Event|3|||
156952567|NCT02041195|566580640|FG007|Overall Study|Adverse Event|0|||
156952568|NCT02041195|566580633|FG000|Overall Study|Withdrawal by Subject|1|||
156952569|NCT02041195|566580634|FG001|Overall Study|Withdrawal by Subject|0|||
156952570|NCT02041195|566580635|FG002|Overall Study|Withdrawal by Subject|0|||
156952571|NCT02041195|566580636|FG003|Overall Study|Withdrawal by Subject|0|||
156952572|NCT02041195|566580637|FG004|Overall Study|Withdrawal by Subject|0|||
156952573|NCT02041195|566580638|FG005|Overall Study|Withdrawal by Subject|0|||
156952574|NCT02041195|566580639|FG006|Overall Study|Withdrawal by Subject|4|||
156952575|NCT02041195|566580640|FG007|Overall Study|Withdrawal by Subject|3|||
156952576|NCT02041195|566580633|FG000|Overall Study|Unable to comply with study visits|0|||
156952577|NCT02041195|566580634|FG001|Overall Study|Unable to comply with study visits|1|||
157168768|NCT02528253|567359800|FG001|Overall Study|Other|22|||
156952578|NCT02041195|566580635|FG002|Overall Study|Unable to comply with study visits|0|||
156952579|NCT02041195|566580636|FG003|Overall Study|Unable to comply with study visits|0|||
156952580|NCT02041195|566580637|FG004|Overall Study|Unable to comply with study visits|1|||
156952581|NCT02041195|566580638|FG005|Overall Study|Unable to comply with study visits|0|||
156952582|NCT02041195|566580639|FG006|Overall Study|Unable to comply with study visits|0|||
156952583|NCT02041195|566580640|FG007|Overall Study|Unable to comply with study visits|0|||
156952584|NCT00674986|566580641|FG000|Overall Study|Adverse Event|2|||
156952585|NCT00674986|566580642|FG001|Overall Study|Adverse Event|1|||
156952586|NCT00674986|566580641|FG000|Overall Study|Subject withdrew consent|12|||
156952587|NCT00674986|566580642|FG001|Overall Study|Subject withdrew consent|19|||
156952588|NCT00674986|566580641|FG000|Overall Study|Lost to Follow-up|25|||
156952589|NCT00674986|566580642|FG001|Overall Study|Lost to Follow-up|53|||
156952590|NCT00674986|566580641|FG000|Overall Study|Other reasons|4|||
156952591|NCT00674986|566580642|FG001|Overall Study|Other reasons|8|||
156952592|NCT00377234|566580643|FG000|Overall Study|Adverse Event|14|||
156952593|NCT00377234|566580644|FG001|Overall Study|Adverse Event|17|||
156952594|NCT00377234|566580643|FG000|Overall Study|Withdrawal by Subject|11|||
156952595|NCT00377234|566580644|FG001|Overall Study|Withdrawal by Subject|9|||
156952596|NCT00377234|566580643|FG000|Overall Study|Lost to Follow-up|4|||
156952597|NCT00377234|566580644|FG001|Overall Study|Lost to Follow-up|2|||
156952598|NCT00377234|566580643|FG000|Overall Study|Administrative|2|||
156952599|NCT00377234|566580644|FG001|Overall Study|Administrative|1|||
156952600|NCT00377234|566580643|FG000|Overall Study|Not assigned|3|||
156952601|NCT00377234|566580644|FG001|Overall Study|Not assigned|2|||
156952602|NCT00626522|566580649|FG000|Overall Study|Protocol Violation|0|||
156952603|NCT00626522|566580650|FG001|Overall Study|Protocol Violation|0|||
156952604|NCT00626522|566580651|FG002|Overall Study|Protocol Violation|0|||
156952605|NCT00626522|566580652|FG003|Overall Study|Protocol Violation|0|||
156952606|NCT00626522|566580653|FG004|Overall Study|Protocol Violation|1|||
156952607|NCT00626522|566580654|FG005|Overall Study|Protocol Violation|0|||
156952608|NCT00626522|566580649|FG000|Overall Study|Adverse Event|2|||
156952609|NCT00626522|566580650|FG001|Overall Study|Adverse Event|1|||
156952610|NCT00626522|566580651|FG002|Overall Study|Adverse Event|2|||
156952611|NCT00626522|566580652|FG003|Overall Study|Adverse Event|0|||
156952612|NCT00626522|566580653|FG004|Overall Study|Adverse Event|1|||
156952613|NCT00626522|566580654|FG005|Overall Study|Adverse Event|1|||
156952614|NCT00626522|566580649|FG000|Overall Study|Withdrawal by Subject|2|||
156952615|NCT00626522|566580650|FG001|Overall Study|Withdrawal by Subject|5|||
156952616|NCT00626522|566580651|FG002|Overall Study|Withdrawal by Subject|5|||
156952617|NCT00626522|566580652|FG003|Overall Study|Withdrawal by Subject|0|||
156952618|NCT00626522|566580653|FG004|Overall Study|Withdrawal by Subject|4|||
156952619|NCT00626522|566580654|FG005|Overall Study|Withdrawal by Subject|1|||
156952620|NCT00626522|566580649|FG000|Overall Study|COPD exacerbation|0|||
156952621|NCT00626522|566580650|FG001|Overall Study|COPD exacerbation|0|||
156952622|NCT00626522|566580651|FG002|Overall Study|COPD exacerbation|0|||
156952623|NCT00626522|566580652|FG003|Overall Study|COPD exacerbation|1|||
156952624|NCT00626522|566580653|FG004|Overall Study|COPD exacerbation|1|||
156952625|NCT00626522|566580654|FG005|Overall Study|COPD exacerbation|0|||
156952626|NCT00626522|566580649|FG000|Overall Study|Lost to Follow-up|0|||
156952627|NCT00626522|566580650|FG001|Overall Study|Lost to Follow-up|1|||
156952628|NCT00626522|566580651|FG002|Overall Study|Lost to Follow-up|0|||
156952629|NCT00626522|566580652|FG003|Overall Study|Lost to Follow-up|0|||
156952630|NCT00626522|566580653|FG004|Overall Study|Lost to Follow-up|0|||
156952631|NCT00626522|566580654|FG005|Overall Study|Lost to Follow-up|0|||
156952632|NCT00626522|566580649|FG000|Overall Study|Inconsistent reason reported|1|||
156952633|NCT00626522|566580650|FG001|Overall Study|Inconsistent reason reported|0|||
156952634|NCT00626522|566580651|FG002|Overall Study|Inconsistent reason reported|0|||
156952635|NCT00626522|566580652|FG003|Overall Study|Inconsistent reason reported|0|||
156952636|NCT00626522|566580653|FG004|Overall Study|Inconsistent reason reported|0|||
156952637|NCT00626522|566580654|FG005|Overall Study|Inconsistent reason reported|0|||
156952638|NCT00626522|566580649|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156952639|NCT00626522|566580650|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
156952640|NCT00626522|566580651|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156952641|NCT00626522|566580652|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
156952642|NCT00626522|566580653|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
157168769|NCT02528253|567359801|FG002|Overall Study|Other|58|||
157168770|NCT02528253|567359802|FG003|Overall Study|Other|52|||
156952643|NCT00626522|566580654|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
156952644|NCT01928719|566580655|FG000|Overall Study|Lost to Follow-up|26|||
156952645|NCT01928719|566580656|FG001|Overall Study|Lost to Follow-up|11|||
156952646|NCT01928719|566580655|FG000|Overall Study|Withdrawal by Subject|22|||
156952647|NCT01928719|566580656|FG001|Overall Study|Withdrawal by Subject|7|||
156952648|NCT01928719|566580655|FG000|Overall Study|Protocol Violation|3|||
156952649|NCT01928719|566580656|FG001|Overall Study|Protocol Violation|1|||
156952650|NCT01928719|566580655|FG000|Overall Study|Adverse Event|1|||
156952651|NCT01928719|566580656|FG001|Overall Study|Adverse Event|0|||
156952652|NCT02367911|566580659|FG000|Overall Study|Withdrawal by Subject|3|||
157168771|NCT02528253|567359803|FG004|Overall Study|Other|76|||
157168772|NCT02528253|567359799|FG000|Overall Study|Withdrawal by Subject|25|||
157168773|NCT02528253|567359800|FG001|Overall Study|Withdrawal by Subject|20|||
157168774|NCT02528253|567359801|FG002|Overall Study|Withdrawal by Subject|29|||
156952653|NCT02367911|566580660|FG001|Overall Study|Withdrawal by Subject|2|||
156952654|NCT02367911|566580659|FG000|Overall Study|Lost to Follow-up|2|||
156952655|NCT02367911|566580660|FG001|Overall Study|Lost to Follow-up|2|||
156952656|NCT00263666|566580661|FG000|Overall Study|Adverse Event|6|||
156952657|NCT00263666|566580662|FG001|Overall Study|Adverse Event|8|||
156952658|NCT00263666|566580661|FG000|Overall Study|Lost to Follow-up|1|||
156952659|NCT00263666|566580662|FG001|Overall Study|Lost to Follow-up|2|||
156952660|NCT00263666|566580661|FG000|Overall Study|Withdrawal by Subject|0|||
156952661|NCT00263666|566580662|FG001|Overall Study|Withdrawal by Subject|1|||
156952662|NCT00902304|566580663|FG000|Overall Study|Adverse Event|4|||
156952663|NCT00902304|566580664|FG001|Overall Study|Adverse Event|10|||
156952664|NCT00902304|566580665|FG002|Overall Study|Adverse Event|25|||
156952665|NCT00902304|566580663|FG000|Overall Study|Investigator discretion|3|||
156952666|NCT00902304|566580664|FG001|Overall Study|Investigator discretion|5|||
156952667|NCT00902304|566580665|FG002|Overall Study|Investigator discretion|13|||
156952668|NCT00902304|566580663|FG000|Overall Study|Lost to Follow-up|7|||
156952669|NCT00902304|566580664|FG001|Overall Study|Lost to Follow-up|7|||
156952670|NCT00902304|566580665|FG002|Overall Study|Lost to Follow-up|7|||
156952671|NCT00902304|566580663|FG000|Overall Study|Protocol Violation|9|||
156952672|NCT00902304|566580664|FG001|Overall Study|Protocol Violation|18|||
156952673|NCT00902304|566580665|FG002|Overall Study|Protocol Violation|20|||
156952674|NCT00902304|566580663|FG000|Overall Study|Withdrawal by Subject|32|||
156952675|NCT00902304|566580664|FG001|Overall Study|Withdrawal by Subject|22|||
156952676|NCT00902304|566580665|FG002|Overall Study|Withdrawal by Subject|43|||
156952677|NCT00902304|566580663|FG000|Overall Study|includes pregnancy|3|||
156952678|NCT00902304|566580664|FG001|Overall Study|includes pregnancy|9|||
156952679|NCT00902304|566580665|FG002|Overall Study|includes pregnancy|2|||
156952680|NCT03422250|566580666|FG000|Intervention|Adverse Event|0|||
156952681|NCT03422250|566580667|FG001|Intervention|Adverse Event|1|||
156952682|NCT03422250|566580668|FG002|Intervention|Adverse Event|0|||
156952683|NCT03422250|566580669|FG003|Intervention|Adverse Event|1|||
156952684|NCT03422250|566580666|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
156952685|NCT03422250|566580667|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
156952686|NCT03422250|566580668|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
156952687|NCT03422250|566580669|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
156952688|NCT03422250|566580666|FG000|Follow-up|Withdrawal by Subject|0|||
156952689|NCT03422250|566580667|FG001|Follow-up|Withdrawal by Subject|0|||
156952690|NCT03422250|566580668|FG002|Follow-up|Withdrawal by Subject|0|||
156952691|NCT03422250|566580669|FG003|Follow-up|Withdrawal by Subject|1|||
156952692|NCT03422250|566580666|FG000|Follow-up|Adverse Event|0|||
156952693|NCT03422250|566580667|FG001|Follow-up|Adverse Event|0|||
156952694|NCT03422250|566580668|FG002|Follow-up|Adverse Event|0|||
156952695|NCT03422250|566580669|FG003|Follow-up|Adverse Event|1|||
156952696|NCT00377819|566580672|FG000|Overall Study|Adverse Event|2|||
156952697|NCT00377819|566580673|FG001|Overall Study|Adverse Event|3|||
156952698|NCT00377819|566580672|FG000|Overall Study|Withdrawal by Subject|10|||
157035470|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
157168775|NCT02528253|567359802|FG003|Overall Study|Withdrawal by Subject|48|||
157168776|NCT02528253|567359803|FG004|Overall Study|Withdrawal by Subject|73|||
157168777|NCT02528253|567359799|FG000|Overall Study|Protocol Violation|1|||
157168778|NCT02528253|567359800|FG001|Overall Study|Protocol Violation|2|||
157168779|NCT02528253|567359801|FG002|Overall Study|Protocol Violation|4|||
157168780|NCT02528253|567359802|FG003|Overall Study|Protocol Violation|0|||
157168781|NCT02528253|567359803|FG004|Overall Study|Protocol Violation|4|||
157168782|NCT02528253|567359799|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
157168783|NCT02528253|567359800|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
157168784|NCT02528253|567359801|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
157168785|NCT02528253|567359802|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
157168786|NCT02528253|567359803|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
157168787|NCT00505752|567359804|FG000|Overall Study|Adverse Event|1|||
157168788|NCT00505752|567359805|FG001|Overall Study|Adverse Event|0|||
156952699|NCT00377819|566580673|FG001|Overall Study|Withdrawal by Subject|4|||
157168789|NCT00505752|567359806|FG002|Overall Study|Adverse Event|1|||
157168790|NCT00505752|567359807|FG003|Overall Study|Adverse Event|0|||
156952700|NCT00377819|566580672|FG000|Overall Study|Death|0|||
156952701|NCT00377819|566580673|FG001|Overall Study|Death|1|||
156952702|NCT00377819|566580672|FG000|Overall Study|Lost to Follow-up|0|||
156952703|NCT00377819|566580673|FG001|Overall Study|Lost to Follow-up|1|||
156952704|NCT00377819|566580672|FG000|Overall Study|Protocol Violation|1|||
156952705|NCT00377819|566580673|FG001|Overall Study|Protocol Violation|1|||
156952706|NCT01917526|566580674|FG000|Overall Study|Protocol Violation|1|||
156952707|NCT01917526|566580675|FG001|Overall Study|Protocol Violation|1|||
157035471|NCT02719574|566887799|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157168791|NCT00505752|567359804|FG000|Overall Study|Lost to Follow-up|1|||
157168792|NCT00505752|567359805|FG001|Overall Study|Lost to Follow-up|0|||
157168793|NCT00505752|567359806|FG002|Overall Study|Lost to Follow-up|0|||
157168794|NCT00505752|567359807|FG003|Overall Study|Lost to Follow-up|0|||
157168795|NCT00505752|567359804|FG000|Overall Study|Lack of ovarian response|1|||
157168796|NCT00505752|567359805|FG001|Overall Study|Lack of ovarian response|3|||
157168797|NCT00505752|567359806|FG002|Overall Study|Lack of ovarian response|0|||
157168798|NCT00505752|567359807|FG003|Overall Study|Lack of ovarian response|0|||
157168799|NCT00505752|567359804|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
156952708|NCT02099838|566580676|FG000|Overall Study|Death|1|||
156952709|NCT02099838|566580677|FG001|Overall Study|Death|0|||
156952710|NCT02099838|566580676|FG000|Overall Study|Lost to Follow-up|3|||
156952711|NCT02099838|566580677|FG001|Overall Study|Lost to Follow-up|1|||
156952712|NCT02099838|566580676|FG000|Overall Study|Withdrawal by Subject|0|||
156952713|NCT02099838|566580677|FG001|Overall Study|Withdrawal by Subject|1|||
156952714|NCT00774787|566580678|FG000|Overall Study|Lost to Follow-up|1|||
156952715|NCT04535037|566580679|FG000|Overall Study|Protocol Violation|1|||
156952716|NCT04535037|566580680|FG001|Overall Study|Protocol Violation|0|||
156952717|NCT04535037|566580679|FG000|Overall Study|Withdrawal by Subject|8|||
156952718|NCT04535037|566580680|FG001|Overall Study|Withdrawal by Subject|9|||
156952719|NCT04535037|566580679|FG000|Overall Study|Migrated / moved from the study area|1|||
156952720|NCT04535037|566580680|FG001|Overall Study|Migrated / moved from the study area|4|||
156952721|NCT04535037|566580679|FG000|Overall Study|Other|2|||
156952722|NCT04535037|566580680|FG001|Overall Study|Other|5|||
156952723|NCT02031276|566580681|FG000|Period 1 Double-blind IV|Adverse Event|6|||
156952724|NCT02031276|566580682|FG001|Period 1 Double-blind IV|Adverse Event|5|||
156952725|NCT02031276|566580683|FG002|Period 1 Double-blind IV|Adverse Event|1|||
156952726|NCT02031276|566580681|FG000|Period 1 Double-blind IV|Other|0|||
156952727|NCT02031276|566580682|FG001|Period 1 Double-blind IV|Other|1|||
156952728|NCT02031276|566580683|FG002|Period 1 Double-blind IV|Other|0|||
156952729|NCT02031276|566580681|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
156952730|NCT02031276|566580682|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
156952731|NCT02031276|566580683|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
156952732|NCT02031276|566580681|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
156952733|NCT02031276|566580682|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
156952734|NCT02031276|566580683|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
156952735|NCT02031276|566580681|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
156952736|NCT02031276|566580682|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
156952737|NCT02031276|566580683|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
156952738|NCT02031276|566580681|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
156952739|NCT02031276|566580682|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
156952740|NCT02031276|566580683|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
156952741|NCT02031276|566580681|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
156952742|NCT02031276|566580682|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
156952743|NCT02031276|566580683|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
156952744|NCT02031276|566580681|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156952745|NCT02031276|566580682|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156952746|NCT02031276|566580683|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
156952747|NCT02031276|566580681|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
156952748|NCT02031276|566580682|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
156952749|NCT02031276|566580683|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
156952750|NCT01148810|566580684|FG000|Overall Study|Adverse Event|0|||
157168800|NCT00505752|567359805|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
157168801|NCT00505752|567359806|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
157168802|NCT00505752|567359807|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
157168803|NCT00505752|567359804|FG000|Overall Study|No oocytes retrieved|0|||
157168804|NCT00505752|567359805|FG001|Overall Study|No oocytes retrieved|2|||
157168805|NCT00505752|567359806|FG002|Overall Study|No oocytes retrieved|0|||
157168806|NCT00505752|567359807|FG003|Overall Study|No oocytes retrieved|1|||
156952751|NCT01148810|566580685|FG001|Overall Study|Adverse Event|2|||
156952752|NCT01148810|566580684|FG000|Overall Study|Lack of Efficacy|0|||
156952753|NCT01148810|566580685|FG001|Overall Study|Lack of Efficacy|1|||
156952754|NCT01148810|566580684|FG000|Overall Study|Withdrawal by Subject|0|||
156952755|NCT01148810|566580685|FG001|Overall Study|Withdrawal by Subject|2|||
156952756|NCT01148810|566580684|FG000|Overall Study|Protocol Violation|1|||
156952757|NCT01148810|566580685|FG001|Overall Study|Protocol Violation|0|||
156952758|NCT02731131|566580689|FG000|Overall Study|Psychiatric Disorder|0|||
156952759|NCT02731131|566580690|FG001|Overall Study|Psychiatric Disorder|1|||
156952760|NCT02731131|566580689|FG000|Overall Study|Refused Therapy|0|||
156952761|NCT02731131|566580690|FG001|Overall Study|Refused Therapy|1|||
156952762|NCT04408469|566580698|FG000|Overall Study|Lost to Follow-up|6|||
156952763|NCT04408469|566580699|FG001|Overall Study|Lost to Follow-up|9|||
156952764|NCT04408469|566580698|FG000|Overall Study|Withdrawal by Subject|6|||
156952765|NCT04408469|566580699|FG001|Overall Study|Withdrawal by Subject|1|||
156952766|NCT04408469|566580698|FG000|Overall Study|Dismissal due to ineligibility|0|||
157168807|NCT00505752|567359804|FG000|Overall Study|No Fertilization|1|||
157035472|NCT02719574|566887800|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
156952767|NCT04408469|566580699|FG001|Overall Study|Dismissal due to ineligibility|1|||
156952768|NCT04321460|566580700|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
156952769|NCT04321460|566580701|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
156952770|NCT01308749|566580702|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
156952771|NCT01308749|566580703|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
156952772|NCT01308749|566580702|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
156952773|NCT01308749|566580703|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
156952774|NCT01308749|566580702|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
156952775|NCT01308749|566580703|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
156952776|NCT01197950|566580706|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
156952777|NCT01197950|566580707|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
156952778|NCT01197950|566580708|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
156952779|NCT02553330|566580709|FG000|Overall Study|Study Terminated by Sponsor|2|||
156952780|NCT02553330|566580710|FG001|Overall Study|Study Terminated by Sponsor|13|||
156952781|NCT02553330|566580711|FG002|Overall Study|Study Terminated by Sponsor|12|||
156952782|NCT02553330|566580709|FG000|Overall Study|Withdrawal by Subject|3|||
156952783|NCT02553330|566580710|FG001|Overall Study|Withdrawal by Subject|19|||
156952784|NCT02553330|566580711|FG002|Overall Study|Withdrawal by Subject|21|||
156952785|NCT02553330|566580709|FG000|Overall Study|Other|0|||
156952786|NCT02553330|566580710|FG001|Overall Study|Other|1|||
156952787|NCT02553330|566580711|FG002|Overall Study|Other|0|||
156952788|NCT02553330|566580709|FG000|Overall Study|Non compliance to study treatment|0|||
156952789|NCT02553330|566580710|FG001|Overall Study|Non compliance to study treatment|1|||
156952790|NCT02553330|566580711|FG002|Overall Study|Non compliance to study treatment|0|||
156952791|NCT02553330|566580709|FG000|Overall Study|Adverse Event|0|||
156952792|NCT02553330|566580710|FG001|Overall Study|Adverse Event|1|||
156952793|NCT02553330|566580711|FG002|Overall Study|Adverse Event|0|||
156952794|NCT02553330|566580709|FG000|Overall Study|Lost to Follow-up|0|||
156952795|NCT02553330|566580710|FG001|Overall Study|Lost to Follow-up|4|||
156952796|NCT02553330|566580711|FG002|Overall Study|Lost to Follow-up|4|||
156952797|NCT01205685|566580712|FG000|Overall Study|Disease Progression|10|||
156952798|NCT01205685|566580712|FG000|Overall Study|Withdrawal by Subject|1|||
156952799|NCT01666002|566580713|FG000|Overall Study|Lost to Follow-up|5|||
156952800|NCT01666002|566580714|FG001|Overall Study|Lost to Follow-up|0|||
156952801|NCT03058679|566580727|FG000|Baseline to Week 6|Lost to Follow-up|3|||
156952802|NCT03058679|566580728|FG001|Baseline to Week 6|Lost to Follow-up|2|||
156952803|NCT03058679|566580727|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
156952804|NCT03058679|566580728|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
156952805|NCT03058679|566580727|FG000|Baseline to Week 6|Adverse Event|6|||
156952806|NCT03058679|566580728|FG001|Baseline to Week 6|Adverse Event|6|||
156952807|NCT03058679|566580727|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
156952808|NCT03058679|566580728|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
156952809|NCT03058679|566580727|FG000|Baseline to Week 6|Difficulty following the diet|0|||
156952810|NCT03058679|566580728|FG001|Baseline to Week 6|Difficulty following the diet|2|||
156952811|NCT03058679|566580727|FG000|Baseline to Week 6|Physician Decision|1|||
156952812|NCT03058679|566580728|FG001|Baseline to Week 6|Physician Decision|0|||
156952813|NCT03058679|566580727|FG000|Week 6 to Week 12|Change in medication|5|||
156952814|NCT03058679|566580728|FG001|Week 6 to Week 12|Change in medication|7|||
156952815|NCT03058679|566580727|FG000|Week 6 to Week 12|Adverse Event|4|||
156952816|NCT03058679|566580728|FG001|Week 6 to Week 12|Adverse Event|3|||
156952817|NCT03058679|566580727|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
156952818|NCT03058679|566580728|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
156952819|NCT03058679|566580727|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
157035473|NCT02719574|566887801|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
157168808|NCT00505752|567359805|FG001|Overall Study|No Fertilization|1|||
157168809|NCT00505752|567359806|FG002|Overall Study|No Fertilization|2|||
157168810|NCT00505752|567359807|FG003|Overall Study|No Fertilization|1|||
157168811|NCT00505752|567359804|FG000|Overall Study|All embryos/blastocysts discarded|0|||
157168812|NCT00505752|567359805|FG001|Overall Study|All embryos/blastocysts discarded|0|||
157168813|NCT00505752|567359806|FG002|Overall Study|All embryos/blastocysts discarded|1|||
156952820|NCT03058679|566580728|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
156952821|NCT04137380|566580737|FG000|Overall Study|Physician Decision|0|||
156952822|NCT04137380|566580738|FG001|Overall Study|Physician Decision|0|||
156952823|NCT04137380|566580739|FG002|Overall Study|Physician Decision|0|||
156952824|NCT04137380|566580740|FG003|Overall Study|Physician Decision|1|||
156952825|NCT04137380|566580741|FG004|Overall Study|Physician Decision|0|||
156952826|NCT04137380|566580742|FG005|Overall Study|Physician Decision|0|||
156952827|NCT04137380|566580743|FG006|Overall Study|Physician Decision|0|||
156952828|NCT02265705|566580747|FG000|Treatment Period Week 0-24|Adverse Event|3|||
156952829|NCT02265705|566580748|FG001|Treatment Period Week 0-24|Adverse Event|2|||
157035474|NCT02719574|566887802|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157168814|NCT00505752|567359807|FG003|Overall Study|All embryos/blastocysts discarded|1|||
156952830|NCT02265705|566580749|FG002|Treatment Period Week 0-24|Adverse Event|0|||
156952831|NCT02265705|566580750|FG003|Treatment Period Week 0-24|Adverse Event|0|||
156952832|NCT02265705|566580751|FG004|Treatment Period Week 0-24|Adverse Event|0|||
156952833|NCT02265705|566580752|FG005|Treatment Period Week 0-24|Adverse Event|0|||
156952834|NCT02265705|566580753|FG006|Treatment Period Week 0-24|Adverse Event|0|||
156952835|NCT02265705|566580747|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
156952836|NCT02265705|566580748|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
156952837|NCT02265705|566580749|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156952838|NCT02265705|566580750|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156952839|NCT02265705|566580751|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156952840|NCT02265705|566580752|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156952841|NCT02265705|566580753|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
156952842|NCT02265705|566580747|FG000|Treatment Period Week 0-24|Physician Decision|1|||
156952843|NCT02265705|566580748|FG001|Treatment Period Week 0-24|Physician Decision|0|||
156952844|NCT02265705|566580749|FG002|Treatment Period Week 0-24|Physician Decision|0|||
156952845|NCT02265705|566580750|FG003|Treatment Period Week 0-24|Physician Decision|0|||
156952846|NCT02265705|566580751|FG004|Treatment Period Week 0-24|Physician Decision|0|||
156952847|NCT02265705|566580752|FG005|Treatment Period Week 0-24|Physician Decision|0|||
156952848|NCT02265705|566580753|FG006|Treatment Period Week 0-24|Physician Decision|0|||
156952849|NCT02265705|566580747|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
156952850|NCT02265705|566580748|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
156952851|NCT02265705|566580749|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156952852|NCT02265705|566580750|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156952853|NCT02265705|566580751|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156952854|NCT02265705|566580752|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156952855|NCT02265705|566580753|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
156952856|NCT02265705|566580747|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952857|NCT02265705|566580748|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
156952858|NCT02265705|566580749|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952859|NCT02265705|566580750|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952860|NCT02265705|566580751|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952861|NCT02265705|566580752|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952862|NCT02265705|566580753|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
156952863|NCT02265705|566580747|FG000|Rescue Period|Withdrawal by Subject|0|||
156952864|NCT02265705|566580748|FG001|Rescue Period|Withdrawal by Subject|0|||
156952865|NCT02265705|566580749|FG002|Rescue Period|Withdrawal by Subject|1|||
156952866|NCT02265705|566580750|FG003|Rescue Period|Withdrawal by Subject|0|||
156952867|NCT02265705|566580751|FG004|Rescue Period|Withdrawal by Subject|0|||
156952868|NCT02265705|566580752|FG005|Rescue Period|Withdrawal by Subject|0|||
156952869|NCT02265705|566580753|FG006|Rescue Period|Withdrawal by Subject|0|||
156952870|NCT02265705|566580747|FG000|Rescue Period|Death|0|||
156952871|NCT02265705|566580748|FG001|Rescue Period|Death|0|||
156952872|NCT02265705|566580749|FG002|Rescue Period|Death|1|||
156952873|NCT02265705|566580750|FG003|Rescue Period|Death|0|||
156952874|NCT02265705|566580751|FG004|Rescue Period|Death|0|||
156952875|NCT02265705|566580752|FG005|Rescue Period|Death|0|||
156952876|NCT02265705|566580753|FG006|Rescue Period|Death|0|||
156952877|NCT02265705|566580747|FG000|Rescue Period|Lack of Efficacy|0|||
156952878|NCT02265705|566580748|FG001|Rescue Period|Lack of Efficacy|0|||
156952879|NCT02265705|566580749|FG002|Rescue Period|Lack of Efficacy|1|||
156952880|NCT02265705|566580750|FG003|Rescue Period|Lack of Efficacy|0|||
156952881|NCT02265705|566580751|FG004|Rescue Period|Lack of Efficacy|0|||
156952882|NCT02265705|566580752|FG005|Rescue Period|Lack of Efficacy|0|||
156952883|NCT02265705|566580753|FG006|Rescue Period|Lack of Efficacy|0|||
156952884|NCT02265705|566580747|FG000|Open Label Period|Adverse Event|0|||
156952885|NCT02265705|566580748|FG001|Open Label Period|Adverse Event|0|||
156952886|NCT02265705|566580749|FG002|Open Label Period|Adverse Event|0|||
156952887|NCT02265705|566580750|FG003|Open Label Period|Adverse Event|2|||
156952888|NCT02265705|566580751|FG004|Open Label Period|Adverse Event|2|||
156952889|NCT02265705|566580752|FG005|Open Label Period|Adverse Event|0|||
156952890|NCT02265705|566580753|FG006|Open Label Period|Adverse Event|0|||
156952891|NCT02265705|566580747|FG000|Open Label Period|Physician Decision|0|||
156952892|NCT02265705|566580748|FG001|Open Label Period|Physician Decision|0|||
156952893|NCT02265705|566580749|FG002|Open Label Period|Physician Decision|0|||
156952894|NCT02265705|566580750|FG003|Open Label Period|Physician Decision|0|||
156952895|NCT02265705|566580751|FG004|Open Label Period|Physician Decision|1|||
156952896|NCT02265705|566580752|FG005|Open Label Period|Physician Decision|0|||
156952897|NCT02265705|566580753|FG006|Open Label Period|Physician Decision|0|||
156952898|NCT02265705|566580747|FG000|Open Label Period|Withdrawal by Subject|0|||
156952899|NCT02265705|566580748|FG001|Open Label Period|Withdrawal by Subject|0|||
156952900|NCT02265705|566580749|FG002|Open Label Period|Withdrawal by Subject|0|||
156952901|NCT02265705|566580750|FG003|Open Label Period|Withdrawal by Subject|0|||
156952902|NCT02265705|566580751|FG004|Open Label Period|Withdrawal by Subject|2|||
156952903|NCT02265705|566580752|FG005|Open Label Period|Withdrawal by Subject|0|||
156952904|NCT02265705|566580753|FG006|Open Label Period|Withdrawal by Subject|0|||
157035475|NCT02719574|566887803|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035476|NCT02719574|566887804|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035477|NCT02719574|566887805|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035478|NCT02719574|566887806|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035479|NCT02719574|566887807|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035480|NCT02719574|566887808|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035481|NCT02719574|566887809|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035482|NCT02719574|566887810|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035483|NCT02719574|566887811|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035484|NCT02719574|566887812|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035485|NCT02719574|566887813|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035486|NCT02719574|566887814|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035487|NCT02719574|566887815|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157035488|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035489|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035490|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035491|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035492|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035493|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035494|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
157035495|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
157035496|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
157035497|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035498|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035499|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035500|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035501|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035502|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035503|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035504|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
157035505|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035506|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035507|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035508|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035509|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035510|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035511|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
157035512|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
157035513|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035514|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035515|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035516|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035517|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035518|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035519|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035520|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035521|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
157035522|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|Death|0|||
157035523|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|Death|0|||
157035524|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|Death|0|||
157035525|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|Death|0|||
157035526|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|Death|0|||
156952905|NCT02265705|566580747|FG000|Follow-up Period|Sponsor Decision|0|||
156952906|NCT02265705|566580748|FG001|Follow-up Period|Sponsor Decision|0|||
156952907|NCT02265705|566580749|FG002|Follow-up Period|Sponsor Decision|0|||
156952908|NCT02265705|566580750|FG003|Follow-up Period|Sponsor Decision|0|||
156952909|NCT02265705|566580751|FG004|Follow-up Period|Sponsor Decision|0|||
156952910|NCT02265705|566580752|FG005|Follow-up Period|Sponsor Decision|1|||
156952911|NCT02265705|566580753|FG006|Follow-up Period|Sponsor Decision|6|||
156952912|NCT02265705|566580747|FG000|Follow-up Period|Adverse Event|0|||
156952913|NCT02265705|566580748|FG001|Follow-up Period|Adverse Event|0|||
156952914|NCT02265705|566580749|FG002|Follow-up Period|Adverse Event|0|||
156952915|NCT02265705|566580750|FG003|Follow-up Period|Adverse Event|0|||
157035527|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|Death|0|||
157035528|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|Death|1|||
157035529|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|Death|6|||
157035530|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|Death|0|||
157035531|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|Death|0|||
157035532|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|Death|0|||
157035533|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|Death|0|||
157035534|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|Death|0|||
156952916|NCT02265705|566580751|FG004|Follow-up Period|Adverse Event|0|||
156952917|NCT02265705|566580752|FG005|Follow-up Period|Adverse Event|0|||
156952918|NCT02265705|566580753|FG006|Follow-up Period|Adverse Event|3|||
156952919|NCT02265705|566580747|FG000|Follow-up Period|Physician Decision|0|||
157168815|NCT00505752|567359804|FG000|Overall Study|Other|1|||
157168816|NCT00505752|567359805|FG001|Overall Study|Other|2|||
157168817|NCT00505752|567359806|FG002|Overall Study|Other|1|||
157168818|NCT00505752|567359807|FG003|Overall Study|Other|2|||
157168819|NCT01624506|567359808|FG000|Overall Study|Lost to Follow-up|29|||
157168820|NCT01624506|567359809|FG001|Overall Study|Lost to Follow-up|15|||
156952920|NCT02265705|566580748|FG001|Follow-up Period|Physician Decision|0|||
156952921|NCT02265705|566580749|FG002|Follow-up Period|Physician Decision|0|||
156952922|NCT02265705|566580750|FG003|Follow-up Period|Physician Decision|0|||
156952923|NCT02265705|566580751|FG004|Follow-up Period|Physician Decision|0|||
156952924|NCT02265705|566580752|FG005|Follow-up Period|Physician Decision|0|||
156952925|NCT02265705|566580753|FG006|Follow-up Period|Physician Decision|1|||
156952926|NCT02265705|566580747|FG000|Follow-up Period|Withdrawal by Subject|0|||
156952927|NCT02265705|566580748|FG001|Follow-up Period|Withdrawal by Subject|0|||
156952928|NCT02265705|566580749|FG002|Follow-up Period|Withdrawal by Subject|0|||
156952929|NCT02265705|566580750|FG003|Follow-up Period|Withdrawal by Subject|0|||
156952930|NCT02265705|566580751|FG004|Follow-up Period|Withdrawal by Subject|0|||
156952931|NCT02265705|566580752|FG005|Follow-up Period|Withdrawal by Subject|0|||
156952932|NCT02265705|566580753|FG006|Follow-up Period|Withdrawal by Subject|1|||
156952933|NCT00346034|566580757|FG000|Overall Study|Adverse Event|34|||
156952934|NCT00346034|566580757|FG000|Overall Study|Lack of Efficacy|8|||
156952935|NCT00346034|566580757|FG000|Overall Study|Withdrawal by Subject|13|||
156952936|NCT00346034|566580757|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
156952937|NCT00346034|566580757|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
156952938|NCT02079805|566580761|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
156952939|NCT02079805|566580762|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
156952940|NCT02079805|566580761|FG000|Overall Study|Voluntary Withdrawal|0|||
156952941|NCT02079805|566580762|FG001|Overall Study|Voluntary Withdrawal|1|||
156952942|NCT01255358|566580763|FG000|Overall Study|Adverse Event|2|||
156952943|NCT01255358|566580763|FG000|Overall Study|Protocol Violation|2|||
156952944|NCT01767116|566580764|FG000|Overall Study|Lost to Follow-up|2|||
156952945|NCT01767116|566580765|FG001|Overall Study|Lost to Follow-up|2|||
156952946|NCT00968669|566580766|FG000|Overall Study|Lost to Follow-up|5|||
156952947|NCT00968669|566580767|FG001|Overall Study|Lost to Follow-up|2|||
156952948|NCT00968669|566580768|FG002|Overall Study|Lost to Follow-up|1|||
156952949|NCT00968669|566580769|FG003|Overall Study|Lost to Follow-up|4|||
156952950|NCT00968669|566580766|FG000|Overall Study|Withdrawal by Subject|9|||
156952951|NCT00968669|566580767|FG001|Overall Study|Withdrawal by Subject|7|||
156952952|NCT00968669|566580768|FG002|Overall Study|Withdrawal by Subject|5|||
156952953|NCT00968669|566580769|FG003|Overall Study|Withdrawal by Subject|3|||
156952954|NCT00968669|566580766|FG000|Overall Study|Pregnancy|0|||
156952955|NCT00968669|566580767|FG001|Overall Study|Pregnancy|0|||
156952956|NCT00968669|566580768|FG002|Overall Study|Pregnancy|2|||
156952957|NCT00968669|566580769|FG003|Overall Study|Pregnancy|0|||
156952958|NCT00968669|566580766|FG000|Overall Study|AE|1|||
156952959|NCT00968669|566580767|FG001|Overall Study|AE|0|||
156952960|NCT00968669|566580768|FG002|Overall Study|AE|0|||
156952961|NCT00968669|566580769|FG003|Overall Study|AE|0|||
156952962|NCT00968669|566580766|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156952963|NCT00968669|566580767|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156952964|NCT00968669|566580768|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
156952965|NCT00968669|566580769|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
156952966|NCT00968669|566580766|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
156952967|NCT00968669|566580767|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156952968|NCT00968669|566580768|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156952969|NCT00968669|566580769|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
156952970|NCT00968669|566580766|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
156952971|NCT00968669|566580767|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156952972|NCT00968669|566580768|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156952973|NCT00968669|566580769|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
156952974|NCT00968669|566580766|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156952975|NCT00968669|566580767|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156952976|NCT00968669|566580768|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
156952977|NCT00968669|566580769|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
156952978|NCT00968669|566580766|FG000|Overall Study|EARLY WITHDRAWAL|0|||
156952979|NCT00968669|566580767|FG001|Overall Study|EARLY WITHDRAWAL|1|||
156952980|NCT00968669|566580768|FG002|Overall Study|EARLY WITHDRAWAL|0|||
156952981|NCT00968669|566580769|FG003|Overall Study|EARLY WITHDRAWAL|0|||
156952982|NCT00968669|566580766|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156952983|NCT00968669|566580767|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156977546|NCT01598298|566670740|FG001|Overall Study|Adverse Event|19|||
156977547|NCT01598298|566670739|FG000|Overall Study|Progression/relapse|0|||
156977548|NCT01598298|566670740|FG001|Overall Study|Progression/relapse|2|||
156977549|NCT01598298|566670739|FG000|Overall Study|Withdrawal by Subject|10|||
156977550|NCT01598298|566670740|FG001|Overall Study|Withdrawal by Subject|15|||
156977551|NCT01598298|566670739|FG000|Overall Study|Other reason (not protocol specified)|4|||
156952984|NCT00968669|566580768|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
156952985|NCT00968669|566580769|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
156952986|NCT00968669|566580766|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
156952987|NCT00968669|566580767|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156952988|NCT00968669|566580768|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156952989|NCT00968669|566580769|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
156952990|NCT00968669|566580766|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156952991|NCT00968669|566580767|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
156952992|NCT00968669|566580768|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156952993|NCT00968669|566580769|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
156952994|NCT00968669|566580766|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156952995|NCT00968669|566580767|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
156952996|NCT00968669|566580768|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156952997|NCT00968669|566580769|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
156952998|NCT00968669|566580766|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156952999|NCT00968669|566580767|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
156953000|NCT00968669|566580768|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156953001|NCT00968669|566580769|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
156953002|NCT00968669|566580766|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156953003|NCT00968669|566580767|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
156953004|NCT00968669|566580768|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156953005|NCT00968669|566580769|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
156953006|NCT00968669|566580766|FG000|Overall Study|SPONSOR DECISION|0|||
156953007|NCT00968669|566580767|FG001|Overall Study|SPONSOR DECISION|1|||
156953008|NCT00968669|566580768|FG002|Overall Study|SPONSOR DECISION|0|||
156953009|NCT00968669|566580769|FG003|Overall Study|SPONSOR DECISION|0|||
156953010|NCT00968669|566580766|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156953011|NCT00968669|566580767|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156953012|NCT00968669|566580768|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
156953013|NCT00968669|566580769|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
156953014|NCT00968669|566580766|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156953015|NCT00968669|566580767|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
156953016|NCT00968669|566580768|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156953017|NCT00968669|566580769|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
156953018|NCT00968669|566580766|FG000|Overall Study|SUBJECT INCARCERATED|0|||
156953019|NCT00968669|566580767|FG001|Overall Study|SUBJECT INCARCERATED|1|||
156953020|NCT00968669|566580768|FG002|Overall Study|SUBJECT INCARCERATED|0|||
156953021|NCT00968669|566580769|FG003|Overall Study|SUBJECT INCARCERATED|0|||
156953022|NCT00968669|566580766|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156953023|NCT00968669|566580767|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
156953024|NCT00968669|566580768|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156953025|NCT00968669|566580769|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
156953026|NCT00968669|566580766|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156953027|NCT00968669|566580767|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156953028|NCT00968669|566580768|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
156953029|NCT00968669|566580769|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
156953030|NCT04102501|566580772|FG000|Overall Study|Withdrawal by Subject|7|||
156953031|NCT04102501|566580773|FG001|Overall Study|Withdrawal by Subject|9|||
156953032|NCT04102501|566580772|FG000|Overall Study|Adverse Event|1|||
156953033|NCT04102501|566580773|FG001|Overall Study|Adverse Event|3|||
156953034|NCT02338362|566580774|FG000|Overall Study|Withdrawal by Subject|1|||
156953035|NCT02338362|566580775|FG001|Overall Study|Withdrawal by Subject|1|||
156953036|NCT01669343|566580777|FG000|Part A: All Patients|Withdrawal by Subject|7|||
156953037|NCT01669343|566580777|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
156953038|NCT01669343|566580777|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
156953039|NCT01669343|566580777|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
156953040|NCT01669343|566580777|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
156953041|NCT04798586|566580778|FG000|Overall Study|Death|2|||
156953042|NCT00968617|566580779|FG000|Overall Study|Study terminated by sponsor|6|||
156953043|NCT02371369|566580784|FG000|Part 1|Physician Decision|0|||
156953044|NCT02371369|566580785|FG001|Part 1|Physician Decision|3|||
156953045|NCT02371369|566580784|FG000|Part 1|Adverse Event|8|||
156953046|NCT02371369|566580785|FG001|Part 1|Adverse Event|0|||
156953047|NCT02371369|566580784|FG000|Part 1|Withdrawal by Subject|1|||
156953048|NCT02371369|566580785|FG001|Part 1|Withdrawal by Subject|6|||
156953049|NCT02371369|566580784|FG000|Part 1|Disease progression|0|||
156953050|NCT02371369|566580785|FG001|Part 1|Disease progression|1|||
156953051|NCT02371369|566580784|FG000|Part 1|Protocol Violation|0|||
156953052|NCT02371369|566580785|FG001|Part 1|Protocol Violation|1|||
156953053|NCT02371369|566580784|FG000|Part 2|Adverse Event|6|||
157168821|NCT01624506|567359808|FG000|Overall Study|Withdrawal by Subject|9|||
156953054|NCT02371369|566580785|FG001|Part 2|Adverse Event|5|||
156953055|NCT02371369|566580784|FG000|Part 2|Withdrawal by Subject|16|||
156953056|NCT02371369|566580785|FG001|Part 2|Withdrawal by Subject|6|||
156953057|NCT02371369|566580784|FG000|Part 2|Investigator decision|1|||
156953058|NCT02371369|566580785|FG001|Part 2|Investigator decision|2|||
156953059|NCT02371369|566580784|FG000|Part 2|Death|0|||
156953060|NCT02371369|566580785|FG001|Part 2|Death|1|||
156953061|NCT02371369|566580784|FG000|Part 2|Disease progression|1|||
156953062|NCT02371369|566580785|FG001|Part 2|Disease progression|0|||
156953063|NCT02371369|566580784|FG000|Part 2|Subject Noncompliance|1|||
156953064|NCT02371369|566580785|FG001|Part 2|Subject Noncompliance|0|||
156953065|NCT02371369|566580784|FG000|Part 2|Lost to Follow-up|1|||
156953066|NCT02371369|566580785|FG001|Part 2|Lost to Follow-up|1|||
156953067|NCT02371369|566580784|FG000|Part 2|Subject transitioned to commercial supply|6|||
156953068|NCT02371369|566580785|FG001|Part 2|Subject transitioned to commercial supply|4|||
156953069|NCT02371369|566580784|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
156953070|NCT02371369|566580785|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
156953071|NCT02371369|566580784|FG000|Part 2|Surgical resection of tumor|1|||
156953072|NCT02371369|566580785|FG001|Part 2|Surgical resection of tumor|1|||
156953073|NCT02371369|566580784|FG000|Part 2|Other|0|||
156953074|NCT02371369|566580785|FG001|Part 2|Other|1|||
156953075|NCT00586105|566580787|FG000|Overall Study|Adverse Event|4|||
156953076|NCT00586105|566580787|FG000|Overall Study|Death|2|||
156953077|NCT00586105|566580787|FG000|Overall Study|Protocol Violation|1|||
156953078|NCT00586105|566580787|FG000|Overall Study|Withdrawal by Subject|3|||
156953079|NCT00586105|566580787|FG000|Overall Study|Disease progression|19|||
156953080|NCT00586105|566580787|FG000|Overall Study|Switched to commercial drug|9|||
156953081|NCT00586105|566580787|FG000|Overall Study|Reason not reported|1|||
156953082|NCT03191903|566580791|FG000|Overall Study|Withdrawal by Subject|6|||
156953083|NCT03191903|566580792|FG001|Overall Study|Withdrawal by Subject|5|||
156953084|NCT03191903|566580793|FG002|Overall Study|Withdrawal by Subject|4|||
156953085|NCT03191903|566580791|FG000|Overall Study|Adverse Event|1|||
156953086|NCT03191903|566580792|FG001|Overall Study|Adverse Event|0|||
156953087|NCT03191903|566580793|FG002|Overall Study|Adverse Event|0|||
156953088|NCT00503685|566580797|FG000|Overall Study|Adverse Event|0|||
156953089|NCT00503685|566580798|FG001|Overall Study|Adverse Event|0|||
156953090|NCT00503685|566580799|FG002|Overall Study|Adverse Event|2|||
156953091|NCT00503685|566580797|FG000|Overall Study|Withdrawal by Subject|0|||
156953092|NCT00503685|566580798|FG001|Overall Study|Withdrawal by Subject|1|||
156953093|NCT00503685|566580799|FG002|Overall Study|Withdrawal by Subject|0|||
156953094|NCT00503685|566580797|FG000|Overall Study|Protocol Violation|0|||
156953095|NCT00503685|566580798|FG001|Overall Study|Protocol Violation|1|||
156953096|NCT00503685|566580799|FG002|Overall Study|Protocol Violation|0|||
156953097|NCT00503685|566580797|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156953098|NCT00503685|566580798|FG001|Overall Study|Eligibility Criteria Not Met|1|||
156953099|NCT00503685|566580799|FG002|Overall Study|Eligibility Criteria Not Met|0|||
156953100|NCT00927927|566580800|FG000|Overall Study|Withdrawal by Subject|0|||
156953101|NCT00927927|566580801|FG001|Overall Study|Withdrawal by Subject|0|||
156953102|NCT00927927|566580802|FG002|Overall Study|Withdrawal by Subject|0|||
156953103|NCT00927927|566580803|FG003|Overall Study|Withdrawal by Subject|0|||
156953104|NCT00927927|566580804|FG004|Overall Study|Withdrawal by Subject|0|||
156953105|NCT00927927|566580805|FG005|Overall Study|Withdrawal by Subject|0|||
156953106|NCT00927927|566580806|FG006|Overall Study|Withdrawal by Subject|0|||
156953107|NCT00927927|566580807|FG007|Overall Study|Withdrawal by Subject|2|||
156953108|NCT00927927|566580808|FG008|Overall Study|Withdrawal by Subject|0|||
156953109|NCT00927927|566580809|FG009|Overall Study|Withdrawal by Subject|0|||
156953110|NCT00927927|566580810|FG010|Overall Study|Withdrawal by Subject|0|||
156953111|NCT00927927|566580811|FG011|Overall Study|Withdrawal by Subject|2|||
156953112|NCT00927927|566580812|FG012|Overall Study|Withdrawal by Subject|0|||
156953113|NCT00927927|566580813|FG013|Overall Study|Withdrawal by Subject|0|||
156953114|NCT00927927|566580814|FG014|Overall Study|Withdrawal by Subject|0|||
156953115|NCT01110239|566580821|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
156953116|NCT01110239|566580822|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
156953117|NCT01110239|566580823|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
156953118|NCT01110239|566580824|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
156953119|NCT01110239|566580821|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
156953120|NCT01110239|566580822|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
156953121|NCT01110239|566580823|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
156953122|NCT01110239|566580824|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
156953123|NCT00080223|566580827|FG000|Overall Study|Adverse Event|23|||
156953124|NCT00080223|566580827|FG000|Overall Study|Death|21|||
156953125|NCT00080223|566580827|FG000|Overall Study|Withdrawal by Subject|13|||
156953126|NCT00080223|566580827|FG000|Overall Study|Lung Transplantation|9|||
156953127|NCT00080223|566580827|FG000|Overall Study|Non-compliance With Study Treatment|7|||
156953128|NCT00080223|566580827|FG000|Overall Study|Participant unwilling to continue|2|||
156953129|NCT00080223|566580827|FG000|Overall Study|Physician Decision|1|||
156953130|NCT04827576|566582762|FG000|Overall Study|Death|5|||
156953131|NCT04827576|566582763|FG001|Overall Study|Death|17|||
156953132|NCT04827576|566582764|FG002|Overall Study|Death|17|||
156953133|NCT04827576|566582765|FG003|Overall Study|Death|32|||
156953134|NCT04827576|566582762|FG000|Overall Study|Study Terminated by Sponsor|2|||
156953135|NCT04827576|566582763|FG001|Overall Study|Study Terminated by Sponsor|9|||
156953136|NCT04827576|566582764|FG002|Overall Study|Study Terminated by Sponsor|7|||
156953137|NCT04827576|566582765|FG003|Overall Study|Study Terminated by Sponsor|5|||
156953138|NCT04827576|566582762|FG000|Overall Study|Investigator's Discretion|1|||
156953139|NCT04827576|566582763|FG001|Overall Study|Investigator's Discretion|0|||
156953140|NCT04827576|566582764|FG002|Overall Study|Investigator's Discretion|2|||
156953141|NCT04827576|566582765|FG003|Overall Study|Investigator's Discretion|5|||
156953142|NCT04827576|566582762|FG000|Overall Study|Withdrew Consent|0|||
156953143|NCT04827576|566582763|FG001|Overall Study|Withdrew Consent|3|||
156953144|NCT04827576|566582764|FG002|Overall Study|Withdrew Consent|0|||
156953145|NCT04827576|566582765|FG003|Overall Study|Withdrew Consent|0|||
156953146|NCT04827576|566582762|FG000|Overall Study|Lost to Follow-up|1|||
156953147|NCT04827576|566582763|FG001|Overall Study|Lost to Follow-up|0|||
156953148|NCT04827576|566582764|FG002|Overall Study|Lost to Follow-up|0|||
156953149|NCT04827576|566582765|FG003|Overall Study|Lost to Follow-up|0|||
156953150|NCT04295564|566582766|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
156953151|NCT04295564|566582767|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
156953152|NCT04537923|566582768|FG000|Overall Study|Adverse Event|2|||
156953153|NCT04537923|566582769|FG001|Overall Study|Adverse Event|1|||
156953154|NCT04537923|566582770|FG002|Overall Study|Adverse Event|2|||
156953155|NCT04537923|566582771|FG003|Overall Study|Adverse Event|4|||
156953156|NCT04537923|566582768|FG000|Overall Study|Death|3|||
156953157|NCT04537923|566582769|FG001|Overall Study|Death|3|||
156953158|NCT04537923|566582770|FG002|Overall Study|Death|1|||
156953159|NCT04537923|566582771|FG003|Overall Study|Death|11|||
156953160|NCT04537923|566582768|FG000|Overall Study|Lost to Follow-up|1|||
156953161|NCT04537923|566582769|FG001|Overall Study|Lost to Follow-up|2|||
156953162|NCT04537923|566582770|FG002|Overall Study|Lost to Follow-up|1|||
156953163|NCT04537923|566582771|FG003|Overall Study|Lost to Follow-up|6|||
156953164|NCT04537923|566582768|FG000|Overall Study|Physician Decision|1|||
156953165|NCT04537923|566582769|FG001|Overall Study|Physician Decision|0|||
156953166|NCT04537923|566582770|FG002|Overall Study|Physician Decision|2|||
156953167|NCT04537923|566582771|FG003|Overall Study|Physician Decision|5|||
156953168|NCT04537923|566582768|FG000|Overall Study|Pregnancy|1|||
156953169|NCT04537923|566582769|FG001|Overall Study|Pregnancy|0|||
156953170|NCT04537923|566582770|FG002|Overall Study|Pregnancy|0|||
156953171|NCT04537923|566582771|FG003|Overall Study|Pregnancy|0|||
156953172|NCT04537923|566582768|FG000|Overall Study|Withdrawal by Subject|4|||
156953173|NCT04537923|566582769|FG001|Overall Study|Withdrawal by Subject|4|||
156953174|NCT04537923|566582770|FG002|Overall Study|Withdrawal by Subject|4|||
156953175|NCT04537923|566582771|FG003|Overall Study|Withdrawal by Subject|58|||
156953176|NCT04537923|566582768|FG000|Overall Study|Missed study visits|2|||
156953177|NCT04537923|566582769|FG001|Overall Study|Missed study visits|0|||
156953178|NCT04537923|566582770|FG002|Overall Study|Missed study visits|0|||
156953179|NCT04537923|566582771|FG003|Overall Study|Missed study visits|3|||
156953180|NCT04537923|566582768|FG000|Overall Study|Sponsor's decision|0|||
156953181|NCT04537923|566582769|FG001|Overall Study|Sponsor's decision|0|||
156953182|NCT04537923|566582770|FG002|Overall Study|Sponsor's decision|1|||
156953183|NCT04537923|566582771|FG003|Overall Study|Sponsor's decision|1|||
156953184|NCT04537923|566582768|FG000|Overall Study|Safety reasons|1|||
156953185|NCT04537923|566582769|FG001|Overall Study|Safety reasons|0|||
156953186|NCT04537923|566582770|FG002|Overall Study|Safety reasons|0|||
156953187|NCT04537923|566582771|FG003|Overall Study|Safety reasons|0|||
156953188|NCT02527798|566582772|FG000|Overall Study|Physician Decision|1|||
156953189|NCT02527798|566582773|FG001|Overall Study|Physician Decision|0|||
156953190|NCT02527798|566582774|FG002|Overall Study|Physician Decision|1|||
156953191|NCT02527798|566582775|FG003|Overall Study|Physician Decision|1|||
156953192|NCT02527798|566582776|FG004|Overall Study|Physician Decision|0|||
156953193|NCT02527798|566582777|FG005|Overall Study|Physician Decision|0|||
156953194|NCT02527798|566582772|FG000|Overall Study|Death|0|||
156953195|NCT02527798|566582773|FG001|Overall Study|Death|0|||
156953196|NCT02527798|566582774|FG002|Overall Study|Death|1|||
157227529|NCT02841709|567579098|FG003|5th Intervention|Adverse Event|0|||
157227530|NCT02841709|567579099|FG004|5th Intervention|Adverse Event|2|||
156953197|NCT02527798|566582775|FG003|Overall Study|Death|0|||
156953198|NCT02527798|566582776|FG004|Overall Study|Death|0|||
156953199|NCT02527798|566582777|FG005|Overall Study|Death|0|||
156953200|NCT02527798|566582772|FG000|Overall Study|Withdrawal by Subject|0|||
156953201|NCT02527798|566582773|FG001|Overall Study|Withdrawal by Subject|1|||
156953202|NCT02527798|566582774|FG002|Overall Study|Withdrawal by Subject|2|||
156953203|NCT02527798|566582775|FG003|Overall Study|Withdrawal by Subject|0|||
156953204|NCT02527798|566582776|FG004|Overall Study|Withdrawal by Subject|0|||
156953205|NCT02527798|566582777|FG005|Overall Study|Withdrawal by Subject|0|||
156953206|NCT02527798|566582772|FG000|Overall Study|Reason undisclosed|1|||
156953207|NCT02527798|566582773|FG001|Overall Study|Reason undisclosed|0|||
156953208|NCT02527798|566582774|FG002|Overall Study|Reason undisclosed|1|||
156953209|NCT02527798|566582775|FG003|Overall Study|Reason undisclosed|0|||
156953210|NCT02527798|566582776|FG004|Overall Study|Reason undisclosed|0|||
156953211|NCT02527798|566582777|FG005|Overall Study|Reason undisclosed|0|||
156953212|NCT02527798|566582772|FG000|Overall Study|Did not receive intervention|1|||
156953213|NCT02527798|566582773|FG001|Overall Study|Did not receive intervention|1|||
156953214|NCT02527798|566582774|FG002|Overall Study|Did not receive intervention|0|||
156953215|NCT02527798|566582775|FG003|Overall Study|Did not receive intervention|0|||
156953216|NCT02527798|566582776|FG004|Overall Study|Did not receive intervention|0|||
156953217|NCT02527798|566582777|FG005|Overall Study|Did not receive intervention|0|||
156953218|NCT01275625|566582778|FG000|Overall Study|Death|1|||
156953219|NCT01275625|566582778|FG000|Overall Study|Lack of Efficacy|2|||
156953220|NCT01275625|566582778|FG000|Overall Study|Lost to Follow-up|1|||
156953221|NCT01275625|566582778|FG000|Overall Study|Withdrawal by Subject|3|||
156953222|NCT01275625|566582778|FG000|Overall Study|Protocol Violation|1|||
156953223|NCT01275625|566582778|FG000|Overall Study|Adverse Event|4|||
156953224|NCT01275625|566582778|FG000|Overall Study|Other|1|||
156953225|NCT05732454|566582779|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
156953226|NCT05732454|566582780|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
156953227|NCT05732454|566582779|FG000|Part 1: DB Period|Adverse Event|1|||
156953228|NCT05732454|566582780|FG001|Part 1: DB Period|Adverse Event|0|||
156953229|NCT05732454|566582779|FG000|Part 1: DB Period|Lost to Follow-up|1|||
156953230|NCT05732454|566582780|FG001|Part 1: DB Period|Lost to Follow-up|0|||
156953231|NCT05732454|566582779|FG000|Part 1: DB Period|Protocol Violation|0|||
156953232|NCT05732454|566582780|FG001|Part 1: DB Period|Protocol Violation|1|||
156953233|NCT05732454|566582779|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
156953234|NCT05732454|566582780|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
156953235|NCT05732454|566582779|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
156953236|NCT05732454|566582780|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
156953237|NCT05732454|566582779|FG000|Part 1: OLE Period|Adverse Event|0|||
156953238|NCT05732454|566582780|FG001|Part 1: OLE Period|Adverse Event|1|||
156953239|NCT05732454|566582779|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
156953240|NCT05732454|566582780|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
156953241|NCT03725982|566582783|FG000|First Intervention|Withdrawal by Subject|0|||
156953242|NCT03725982|566582784|FG001|First Intervention|Withdrawal by Subject|1|||
156953243|NCT03725982|566582783|FG000|First Intervention|Physician Decision|1|||
156953244|NCT03725982|566582784|FG001|First Intervention|Physician Decision|1|||
156953245|NCT00838110|566582785|FG000|Overall Study|Death|0|||
156953246|NCT00838110|566582786|FG001|Overall Study|Death|0|||
156953247|NCT00838110|566582787|FG002|Overall Study|Death|1|||
156953248|NCT00838110|566582788|FG003|Overall Study|Death|2|||
156953249|NCT00838110|566582785|FG000|Overall Study|Adverse Event|11|||
156953250|NCT00838110|566582786|FG001|Overall Study|Adverse Event|10|||
156953251|NCT00838110|566582787|FG002|Overall Study|Adverse Event|8|||
156953252|NCT00838110|566582788|FG003|Overall Study|Adverse Event|7|||
156953253|NCT00838110|566582785|FG000|Overall Study|Withdrawal by Subject|5|||
156953254|NCT00838110|566582786|FG001|Overall Study|Withdrawal by Subject|6|||
156953255|NCT00838110|566582787|FG002|Overall Study|Withdrawal by Subject|3|||
156953256|NCT00838110|566582788|FG003|Overall Study|Withdrawal by Subject|4|||
156953257|NCT00838110|566582785|FG000|Overall Study|Other|3|||
156953258|NCT00838110|566582786|FG001|Overall Study|Other|3|||
156953259|NCT00838110|566582787|FG002|Overall Study|Other|3|||
156953260|NCT00838110|566582788|FG003|Overall Study|Other|2|||
156953261|NCT00838110|566582785|FG000|Overall Study|Protocol Violation|0|||
156953262|NCT00838110|566582786|FG001|Overall Study|Protocol Violation|2|||
156953263|NCT00838110|566582787|FG002|Overall Study|Protocol Violation|1|||
156953264|NCT00838110|566582788|FG003|Overall Study|Protocol Violation|1|||
156953265|NCT00838110|566582785|FG000|Overall Study|Lost to Follow-up|3|||
156953266|NCT00838110|566582786|FG001|Overall Study|Lost to Follow-up|0|||
156953267|NCT00838110|566582787|FG002|Overall Study|Lost to Follow-up|0|||
157168822|NCT01624506|567359809|FG001|Overall Study|Withdrawal by Subject|2|||
157168823|NCT01624506|567359808|FG000|Overall Study|Death|1|||
157168824|NCT01624506|567359809|FG001|Overall Study|Death|0|||
156953268|NCT00838110|566582788|FG003|Overall Study|Lost to Follow-up|0|||
156953269|NCT00838110|566582785|FG000|Overall Study|Did not meet eligibility criteria|0|||
156953270|NCT00838110|566582786|FG001|Overall Study|Did not meet eligibility criteria|0|||
156953271|NCT00838110|566582787|FG002|Overall Study|Did not meet eligibility criteria|1|||
156953272|NCT00838110|566582788|FG003|Overall Study|Did not meet eligibility criteria|2|||
156953273|NCT00838110|566582785|FG000|Overall Study|Randomized but not treated|0|||
156953274|NCT00838110|566582786|FG001|Overall Study|Randomized but not treated|1|||
156953275|NCT00838110|566582787|FG002|Overall Study|Randomized but not treated|0|||
157035535|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|Death|0|||
156953276|NCT00838110|566582788|FG003|Overall Study|Randomized but not treated|0|||
156953277|NCT01003899|566582789|FG000|Overall Study|Other Adverse Event|8|||
156953278|NCT01003899|566582789|FG000|Overall Study|Not entered|4|||
156953279|NCT01003899|566582789|FG000|Overall Study|Not treated|1|||
156953280|NCT01003899|566582789|FG000|Overall Study|Progressive disease|34|||
156953281|NCT00352365|566582790|FG000|Induction Therapy|Adverse Event|7|||
156953282|NCT00352365|566582790|FG000|Induction Therapy|Progression/Relapse|8|||
156953283|NCT00352365|566582790|FG000|Induction Therapy|Death|7|||
156953284|NCT00352365|566582790|FG000|Induction Therapy|Not protocol specified|1|||
156953285|NCT00352365|566582790|FG000|Induction Therapy|Not eligible|3|||
156953286|NCT00352365|566582790|FG000|Induction Therapy|Death before starting protocol therapy|1|||
156953287|NCT00352365|566582790|FG000|Maintenance Therapy|Progression/Relapse|3|||
156953288|NCT00352365|566582790|FG000|Maintenance Therapy|Death|2|||
156953289|NCT00352365|566582790|FG000|Maintenance Therapy|Not protocol specified|3|||
156953290|NCT00352365|566582790|FG000|Maintenance Therapy|Not eligible|4|||
156953291|NCT01262651|566582791|FG000|Overall Study|Adverse Event|40|||
156953292|NCT01262651|566582792|FG001|Overall Study|Adverse Event|35|||
156953293|NCT01262651|566582791|FG000|Overall Study|Withdrawal by Subject|15|||
156953294|NCT01262651|566582792|FG001|Overall Study|Withdrawal by Subject|11|||
156953295|NCT01262651|566582791|FG000|Overall Study|Withdrawal by Investigator|2|||
156953296|NCT01262651|566582792|FG001|Overall Study|Withdrawal by Investigator|2|||
156953297|NCT01262651|566582791|FG000|Overall Study|Met Withdrawal Criteria|1|||
156953298|NCT01262651|566582792|FG001|Overall Study|Met Withdrawal Criteria|0|||
156953299|NCT02811861|566582793|FG000|Overall Study|Radiological Disease Progression|123|||
156953300|NCT02811861|566582794|FG001|Overall Study|Radiological Disease Progression|97|||
156953301|NCT02811861|566582795|FG002|Overall Study|Radiological Disease Progression|174|||
156953302|NCT02811861|566582793|FG000|Overall Study|Clinical Disease Progression|20|||
156953303|NCT02811861|566582794|FG001|Overall Study|Clinical Disease Progression|19|||
156953304|NCT02811861|566582795|FG002|Overall Study|Clinical Disease Progression|22|||
156953305|NCT02811861|566582793|FG000|Overall Study|Adverse Event|63|||
156953306|NCT02811861|566582794|FG001|Overall Study|Adverse Event|60|||
156953307|NCT02811861|566582795|FG002|Overall Study|Adverse Event|41|||
156953308|NCT02811861|566582793|FG000|Overall Study|Lost to Follow-up|0|||
156953309|NCT02811861|566582794|FG001|Overall Study|Lost to Follow-up|0|||
156953310|NCT02811861|566582795|FG002|Overall Study|Lost to Follow-up|1|||
156953311|NCT02811861|566582793|FG000|Overall Study|Subject Choice|29|||
156953312|NCT02811861|566582794|FG001|Overall Study|Subject Choice|17|||
156953313|NCT02811861|566582795|FG002|Overall Study|Subject Choice|23|||
156953314|NCT02811861|566582793|FG000|Overall Study|Withdrawal by Subject|4|||
156953315|NCT02811861|566582794|FG001|Overall Study|Withdrawal by Subject|4|||
156953316|NCT02811861|566582795|FG002|Overall Study|Withdrawal by Subject|9|||
156953317|NCT02811861|566582793|FG000|Overall Study|Other|4|||
156953318|NCT02811861|566582794|FG001|Overall Study|Other|13|||
156953319|NCT02811861|566582795|FG002|Overall Study|Other|3|||
156953320|NCT02811861|566582793|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
156953321|NCT02811861|566582794|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
156953322|NCT02811861|566582795|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
156953323|NCT02811861|566582793|FG000|Overall Study|Randomized but not treated|2|||
156953324|NCT02811861|566582794|FG001|Overall Study|Randomized but not treated|3|||
156953325|NCT02811861|566582795|FG002|Overall Study|Randomized but not treated|17|||
156953326|NCT04743908|566582796|FG000|Overall Study|Death|1|||
156953327|NCT04743908|566582797|FG001|Overall Study|Death|0|||
156953328|NCT04743908|566582796|FG000|Overall Study|Lost to Follow-up|181|||
156953329|NCT04743908|566582797|FG001|Overall Study|Lost to Follow-up|180|||
156953330|NCT04743908|566582796|FG000|Overall Study|Withdrawal by Subject|1|||
156953331|NCT04743908|566582797|FG001|Overall Study|Withdrawal by Subject|2|||
156953332|NCT03822533|566582798|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
156953333|NCT03822533|566582799|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
156953334|NCT03822533|566582798|FG000|3 Month Follow-up|Lost to Follow-up|2|||
156953335|NCT03822533|566582799|FG001|3 Month Follow-up|Lost to Follow-up|2|||
156953336|NCT03822533|566582798|FG000|6 Month Follow-up|Lost to Follow-up|3|||
156953337|NCT03822533|566582799|FG001|6 Month Follow-up|Lost to Follow-up|0|||
156953338|NCT03822533|566582798|FG000|12 Month Follow-up|Lost to Follow-up|2|||
156953339|NCT03822533|566582799|FG001|12 Month Follow-up|Lost to Follow-up|3|||
156953340|NCT03822533|566582798|FG000|12 Month Follow-up|Pregnancy|0|||
156953341|NCT03822533|566582799|FG001|12 Month Follow-up|Pregnancy|1|||
156953342|NCT03822533|566582798|FG000|12 Month Follow-up|Surgery|2|||
156953343|NCT03822533|566582799|FG001|12 Month Follow-up|Surgery|0|||
156953344|NCT03822533|566582798|FG000|12 Month Follow-up|Wrong address|1|||
156953345|NCT03822533|566582799|FG001|12 Month Follow-up|Wrong address|0|||
156953346|NCT03822533|566582798|FG000|12 Month Follow-up|No symptoms|1|||
156953347|NCT03822533|566582799|FG001|12 Month Follow-up|No symptoms|0|||
156953348|NCT03822533|566582798|FG000|12 Month Follow-up|Changed primary care center|0|||
156953349|NCT03822533|566582799|FG001|12 Month Follow-up|Changed primary care center|1|||
156953350|NCT04969783|566582802|FG000|Overall Study|Lost to Follow-up|2|||
156953351|NCT04969783|566582803|FG001|Overall Study|Lost to Follow-up|0|||
156953352|NCT04969783|566582802|FG000|Overall Study|Withdrawal by Subject|4|||
156953353|NCT04969783|566582803|FG001|Overall Study|Withdrawal by Subject|0|||
156953354|NCT04969783|566582802|FG000|Overall Study|Physician Decision|6|||
156953355|NCT04969783|566582803|FG001|Overall Study|Physician Decision|0|||
156953356|NCT02489500|566582804|FG000|Overall Study|Death|1|||
156953357|NCT02489500|566582805|FG001|Overall Study|Death|1|||
156953358|NCT00512135|566582806|FG000|Overall Study|Not Treated|5|||
156953359|NCT00512135|566582806|FG000|Overall Study|Lack of Efficacy|2|||
156953360|NCT00512135|566582806|FG000|Overall Study|Adverse Event|6|||
156953361|NCT00512135|566582806|FG000|Overall Study|Withdrawal by Subject|22|||
156953362|NCT00512135|566582806|FG000|Overall Study|Lost to Follow-up|27|||
156953363|NCT00512135|566582806|FG000|Overall Study|Other|22|||
156953364|NCT01175382|566582812|FG000|Overall Study|Lost to Follow-up|4|||
156953365|NCT01175382|566582813|FG001|Overall Study|Lost to Follow-up|3|||
156953366|NCT01175382|566582814|FG002|Overall Study|Lost to Follow-up|1|||
156953367|NCT01175382|566582812|FG000|Overall Study|Physician Decision|0|||
156953368|NCT01175382|566582813|FG001|Overall Study|Physician Decision|1|||
156953369|NCT01175382|566582814|FG002|Overall Study|Physician Decision|0|||
156953370|NCT01175382|566582812|FG000|Overall Study|Withdrawal by Subject|0|||
156953371|NCT01175382|566582813|FG001|Overall Study|Withdrawal by Subject|0|||
156953372|NCT01175382|566582814|FG002|Overall Study|Withdrawal by Subject|1|||
156953373|NCT01175382|566582812|FG000|Overall Study|No longer having problem|1|||
156953374|NCT01175382|566582813|FG001|Overall Study|No longer having problem|0|||
156953375|NCT01175382|566582814|FG002|Overall Study|No longer having problem|1|||
156953376|NCT01175382|566582812|FG000|Overall Study|Unable/unwilling to attend visits|3|||
156953377|NCT01175382|566582813|FG001|Overall Study|Unable/unwilling to attend visits|1|||
156953378|NCT01175382|566582814|FG002|Overall Study|Unable/unwilling to attend visits|2|||
156953379|NCT01175382|566582812|FG000|Overall Study|Unwilling to follow protocol|0|||
156953380|NCT01175382|566582813|FG001|Overall Study|Unwilling to follow protocol|1|||
156953381|NCT01175382|566582814|FG002|Overall Study|Unwilling to follow protocol|0|||
156953382|NCT01175382|566582812|FG000|Overall Study|Unable to tolerate study meds|0|||
156953383|NCT01175382|566582813|FG001|Overall Study|Unable to tolerate study meds|1|||
156953384|NCT01175382|566582814|FG002|Overall Study|Unable to tolerate study meds|1|||
156953385|NCT00941603|566582815|FG000|Overall Study|Adverse Event|10|||
156953386|NCT00941603|566582816|FG001|Overall Study|Adverse Event|15|||
156953387|NCT00941603|566582817|FG002|Overall Study|Adverse Event|5|||
156953388|NCT00941603|566582818|FG003|Overall Study|Adverse Event|1|||
156953389|NCT00941603|566582819|FG004|Overall Study|Adverse Event|4|||
156953390|NCT00941603|566582820|FG005|Overall Study|Adverse Event|0|||
156953391|NCT00941603|566582815|FG000|Overall Study|Lost to Follow-up|0|||
156953392|NCT00941603|566582816|FG001|Overall Study|Lost to Follow-up|0|||
156953393|NCT00941603|566582817|FG002|Overall Study|Lost to Follow-up|0|||
156953394|NCT00941603|566582818|FG003|Overall Study|Lost to Follow-up|1|||
156953395|NCT00941603|566582819|FG004|Overall Study|Lost to Follow-up|0|||
156953396|NCT00941603|566582820|FG005|Overall Study|Lost to Follow-up|2|||
156953397|NCT00941603|566582815|FG000|Overall Study|Withdrawal by Subject|0|||
156953398|NCT00941603|566582816|FG001|Overall Study|Withdrawal by Subject|0|||
156953399|NCT00941603|566582817|FG002|Overall Study|Withdrawal by Subject|0|||
156953400|NCT00941603|566582818|FG003|Overall Study|Withdrawal by Subject|2|||
156953401|NCT00941603|566582819|FG004|Overall Study|Withdrawal by Subject|0|||
156953402|NCT00941603|566582820|FG005|Overall Study|Withdrawal by Subject|1|||
156953403|NCT00941603|566582815|FG000|Overall Study|Protocol Violation|0|||
156953404|NCT00941603|566582816|FG001|Overall Study|Protocol Violation|1|||
156953405|NCT00941603|566582817|FG002|Overall Study|Protocol Violation|0|||
156953406|NCT00941603|566582818|FG003|Overall Study|Protocol Violation|0|||
156953407|NCT00941603|566582819|FG004|Overall Study|Protocol Violation|0|||
156953408|NCT00941603|566582820|FG005|Overall Study|Protocol Violation|0|||
156953409|NCT00941603|566582815|FG000|Overall Study|Did not meet protocol eligibility|1|||
156953410|NCT00941603|566582816|FG001|Overall Study|Did not meet protocol eligibility|0|||
156953411|NCT00941603|566582817|FG002|Overall Study|Did not meet protocol eligibility|0|||
156953412|NCT00941603|566582818|FG003|Overall Study|Did not meet protocol eligibility|0|||
156953413|NCT00941603|566582819|FG004|Overall Study|Did not meet protocol eligibility|0|||
156953414|NCT00941603|566582820|FG005|Overall Study|Did not meet protocol eligibility|0|||
156953415|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
156953416|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
156953417|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
156953418|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
156953419|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
156953420|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156953421|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
157035536|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|Death|0|||
157035537|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|Death|0|||
157035538|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|Death|0|||
157035539|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035540|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035541|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
156953422|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
156953423|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
156953424|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
156953425|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
156953426|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
156953427|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
156953428|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156953429|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
156953430|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
157035542|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
156953431|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
156953432|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
156953433|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
156953434|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
156953435|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
156953436|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
156953437|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
156953438|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
156953439|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
156953440|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
156953441|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
156953442|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
156953443|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
156953444|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
156953445|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
156953446|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
156953447|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
156953448|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
156953449|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
156953450|NCT00383435|566582821|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
156953451|NCT00383435|566582822|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
156953452|NCT00383435|566582823|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
156953453|NCT00383435|566582824|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
156953454|NCT00383435|566582825|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
156953455|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
156953456|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
156953457|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
156953458|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
156953459|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
156953460|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156953461|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156953462|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156953463|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
156953464|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
156953465|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156953466|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
156953467|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156953468|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
156953469|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
156953470|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
156953471|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
156953472|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
156953473|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
156953474|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
156953475|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156953476|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
156953477|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
156953478|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
156953479|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
156953480|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
156953481|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156953482|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156953483|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
156953484|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
156953485|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156953486|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156953487|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156953488|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
156953489|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
156953490|NCT00383435|566582821|FG000|26-Week Treatment Safety Extension|Administrative|1|||
156953491|NCT00383435|566582822|FG001|26-Week Treatment Safety Extension|Administrative|1|||
157168825|NCT01624506|567359808|FG000|Overall Study|LINX explants|23|||
156953492|NCT00383435|566582823|FG002|26-Week Treatment Safety Extension|Administrative|0|||
156953493|NCT00383435|566582824|FG003|26-Week Treatment Safety Extension|Administrative|1|||
156953494|NCT00383435|566582825|FG004|26-Week Treatment Safety Extension|Administrative|0|||
156953495|NCT00583557|566582826|FG000|Overall Study|Withdrawal by Subject|18|||
156953496|NCT00583557|566582826|FG000|Overall Study|Adverse Event|9|||
156953497|NCT00583557|566582826|FG000|Overall Study|Lack of Efficacy|31|||
156953498|NCT00583557|566582826|FG000|Overall Study|Lack of Compliance|5|||
156953499|NCT00583557|566582826|FG000|Overall Study|Other|5|||
156953500|NCT00583557|566582826|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
156953501|NCT02347761|566582827|FG000|All Collected|Death|1|||
156953502|NCT02347761|566582828|FG001|All Collected|Death|0|||
156953503|NCT02347761|566582829|FG002|All Collected|Death|0|||
156953504|NCT02347761|566582827|FG000|All Collected|Lost to Follow-up|3|||
156953505|NCT02347761|566582828|FG001|All Collected|Lost to Follow-up|2|||
156953506|NCT02347761|566582829|FG002|All Collected|Lost to Follow-up|3|||
156953507|NCT02347761|566582827|FG000|All Collected|Withdrawal by Subject|11|||
156953508|NCT02347761|566582828|FG001|All Collected|Withdrawal by Subject|11|||
156953509|NCT02347761|566582829|FG002|All Collected|Withdrawal by Subject|22|||
156953510|NCT02347761|566582827|FG000|All Collected|invetigator disretion|2|||
156953511|NCT02347761|566582828|FG001|All Collected|invetigator disretion|0|||
156953512|NCT02347761|566582829|FG002|All Collected|invetigator disretion|0|||
156953513|NCT02347761|566582827|FG000|All Collected|instillation site pain|0|||
156953514|NCT02347761|566582828|FG001|All Collected|instillation site pain|0|||
156953515|NCT02347761|566582829|FG002|All Collected|instillation site pain|1|||
156953516|NCT02347761|566582827|FG000|All Collected|exacerbation of COPD|0|||
156953517|NCT02347761|566582828|FG001|All Collected|exacerbation of COPD|0|||
156953518|NCT02347761|566582829|FG002|All Collected|exacerbation of COPD|1|||
156953519|NCT02347761|566582827|FG000|All Collected|moved/travel|0|||
156953520|NCT02347761|566582828|FG001|All Collected|moved/travel|1|||
156953521|NCT02347761|566582829|FG002|All Collected|moved/travel|0|||
156953522|NCT02347761|566582827|FG000|On Study Treatment|Lack of Efficacy|2|||
156953523|NCT02347761|566582828|FG001|On Study Treatment|Lack of Efficacy|3|||
156953524|NCT02347761|566582829|FG002|On Study Treatment|Lack of Efficacy|4|||
156953525|NCT02347761|566582827|FG000|On Study Treatment|non-compliance with study medication|0|||
156953526|NCT02347761|566582828|FG001|On Study Treatment|non-compliance with study medication|0|||
156953527|NCT02347761|566582829|FG002|On Study Treatment|non-compliance with study medication|2|||
156953528|NCT02347761|566582827|FG000|On Study Treatment|Withdrawal by Subject|7|||
156953529|NCT02347761|566582828|FG001|On Study Treatment|Withdrawal by Subject|3|||
156953530|NCT02347761|566582829|FG002|On Study Treatment|Withdrawal by Subject|5|||
156953531|NCT02347761|566582827|FG000|On Study Treatment|move/travel|2|||
156953532|NCT02347761|566582828|FG001|On Study Treatment|move/travel|6|||
156953533|NCT02347761|566582829|FG002|On Study Treatment|move/travel|5|||
156953534|NCT02347761|566582827|FG000|On Study Treatment|dissastisfaction with device|2|||
156953535|NCT02347761|566582828|FG001|On Study Treatment|dissastisfaction with device|1|||
156953536|NCT02347761|566582829|FG002|On Study Treatment|dissastisfaction with device|4|||
156953537|NCT02347761|566582827|FG000|On Study Treatment|Lost to Follow-up|2|||
156953538|NCT02347761|566582828|FG001|On Study Treatment|Lost to Follow-up|1|||
156953539|NCT02347761|566582829|FG002|On Study Treatment|Lost to Follow-up|1|||
156953540|NCT02347761|566582827|FG000|On Study Treatment|investigator discretion|2|||
156953541|NCT02347761|566582828|FG001|On Study Treatment|investigator discretion|0|||
156953542|NCT02347761|566582829|FG002|On Study Treatment|investigator discretion|0|||
156953543|NCT02347761|566582827|FG000|On Study Treatment|durg not working|0|||
156953544|NCT02347761|566582828|FG001|On Study Treatment|durg not working|1|||
156953545|NCT02347761|566582829|FG002|On Study Treatment|durg not working|1|||
156953546|NCT02347761|566582827|FG000|On Study Treatment|Adverse Event|10|||
156953547|NCT02347761|566582828|FG001|On Study Treatment|Adverse Event|8|||
156953548|NCT02347761|566582829|FG002|On Study Treatment|Adverse Event|20|||
156953549|NCT03950739|566582830|FG000|Treatment Phase|Adverse Event|2|||
156953550|NCT03950739|566582830|FG000|Optional Extension Phase|Death|1|||
156953551|NCT03950739|566582830|FG000|Optional Extension Phase|Progressive Disease|5|||
156953552|NCT03950739|566582830|FG000|Optional Extension Phase|Adverse Event|7|||
156953553|NCT03950739|566582830|FG000|Optional Extension Phase|Lost to Follow-up|2|||
156953554|NCT03950739|566582830|FG000|Optional Extension Phase|Site Closure|2|||
156953555|NCT03950739|566582830|FG000|Optional Extension Phase|Pregnancy|1|||
157168826|NCT01624506|567359809|FG001|Overall Study|LINX explants|0|||
157168827|NCT01624506|567359808|FG000|Overall Study|Adverse Event|3|||
156953556|NCT03625570|566582831|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
156953557|NCT03625570|566582832|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
156953558|NCT03625570|566582831|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
156953559|NCT03625570|566582832|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
156953560|NCT03625570|566582831|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
156953561|NCT03625570|566582832|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
156953562|NCT03646513|566582833|FG000|Overall Study|Premature study termination|4|||
156953563|NCT01732835|566582834|FG000|6-month Primary Endpoint|Did not receive device|19|||
156953564|NCT01732835|566582834|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
156953565|NCT01732835|566582834|FG000|6-month Primary Endpoint|Adverse Event|3|||
156953566|NCT01732835|566582834|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
156953567|NCT01732835|566582834|FG000|2-year Extended Follow-up|Adverse Event|3|||
156953568|NCT01732835|566582834|FG000|2-year Extended Follow-up|Death|1|||
156953569|NCT02334748|566582835|FG000|Overall Study|Adverse Event|1|||
156953570|NCT02334748|566582835|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
156953571|NCT02334748|566582835|FG000|Overall Study|Patient no longer required study drug|2|||
156953572|NCT02334748|566582835|FG000|Overall Study|Lack of Efficacy|4|||
156953573|NCT01046643|566582836|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156953574|NCT01046643|566582837|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
156953575|NCT01046643|566582838|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156953576|NCT01046643|566582839|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
156953577|NCT00093145|566582844|FG000|Overall Study|Unacceptable Toxicity Only|2|||
156953578|NCT00093145|566582844|FG000|Overall Study|Physician Decision|5|||
156953579|NCT00093145|566582844|FG000|Overall Study|Withdrawal by Subject|9|||
156953580|NCT00093145|566582844|FG000|Overall Study|Other|1|||
156953581|NCT01175668|566582845|FG000|Overall Study|Withdrawal by Subject|2|||
156953582|NCT01175668|566582846|FG001|Overall Study|Withdrawal by Subject|0|||
156953583|NCT02043782|566582847|FG000|Period 1|Adverse Event|0|||
156953584|NCT02043782|566582848|FG001|Period 1|Adverse Event|0|||
156953585|NCT02043782|566582849|FG002|Period 1|Adverse Event|1|||
156953586|NCT02043782|566582850|FG003|Period 1|Adverse Event|0|||
156953587|NCT02043782|566582851|FG004|Period 1|Adverse Event|0|||
156953588|NCT02043782|566582852|FG005|Period 1|Adverse Event|0|||
156953589|NCT00874029|566582853|FG000|Overall Study|Withdrawal by Subject|10|||
156953590|NCT00874029|566582853|FG000|Overall Study|Pregnancy|4|||
156953591|NCT00874029|566582853|FG000|Overall Study|Physician Decision|1|||
156953592|NCT00874029|566582853|FG000|Overall Study|Adverse Event|1|||
156953593|NCT00874029|566582853|FG000|Overall Study|Lost to Follow-up|5|||
156953594|NCT01024387|566582857|FG000|Overall Study|Radiographic Progression|29|||
156953595|NCT01024387|566582857|FG000|Overall Study|Symptomatic Progression|10|||
156953596|NCT01024387|566582857|FG000|Overall Study|Physician Decision|5|||
156953597|NCT01024387|566582857|FG000|Overall Study|Withdrawal by Subject|5|||
156953598|NCT01024387|566582857|FG000|Overall Study|Death|2|||
156953599|NCT01024387|566582857|FG000|Overall Study|Prolonged Treatment Delay|1|||
156953600|NCT01024387|566582857|FG000|Overall Study|Adverse Event|3|||
156953601|NCT01024387|566582857|FG000|Overall Study|Other|5|||
156953602|NCT03855189|566582858|FG000|Overall Study|Adverse Event|5|||
156953603|NCT03855189|566582859|FG001|Overall Study|Adverse Event|2|||
156953604|NCT03855189|566582860|FG002|Overall Study|Adverse Event|4|||
156953605|NCT03855189|566582858|FG000|Overall Study|Treatment Failure|1|||
156953606|NCT03855189|566582859|FG001|Overall Study|Treatment Failure|1|||
156953607|NCT03855189|566582860|FG002|Overall Study|Treatment Failure|2|||
156953608|NCT03855189|566582858|FG000|Overall Study|Noncompliance with Protocol|0|||
156953609|NCT03855189|566582859|FG001|Overall Study|Noncompliance with Protocol|1|||
156953610|NCT03855189|566582860|FG002|Overall Study|Noncompliance with Protocol|0|||
156953611|NCT03855189|566582858|FG000|Overall Study|Did Not Return|4|||
156953612|NCT03855189|566582859|FG001|Overall Study|Did Not Return|3|||
156953613|NCT03855189|566582860|FG002|Overall Study|Did Not Return|0|||
156953614|NCT00288587|566582862|FG000|Overall Study|Death|4|||
156953615|NCT00288587|566582863|FG001|Overall Study|Death|4|||
156953616|NCT00288587|566582862|FG000|Overall Study|Transplant|0|||
156953617|NCT00288587|566582863|FG001|Overall Study|Transplant|3|||
156953618|NCT00288587|566582862|FG000|Overall Study|Adverse Event|0|||
156953619|NCT00288587|566582863|FG001|Overall Study|Adverse Event|1|||
156953620|NCT00288587|566582862|FG000|Overall Study|Physician Decision|0|||
156953621|NCT00288587|566582863|FG001|Overall Study|Physician Decision|2|||
156953622|NCT00288587|566582862|FG000|Overall Study|Severe Aortic Stenosis|1|||
156953623|NCT00288587|566582863|FG001|Overall Study|Severe Aortic Stenosis|0|||
157035543|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035544|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035545|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
156953624|NCT01764945|566582868|FG000|Overall Study|Adverse Event|0|||
156953625|NCT01764945|566582869|FG001|Overall Study|Adverse Event|1|||
156953626|NCT01764945|566582870|FG002|Overall Study|Adverse Event|0|||
156953627|NCT01764945|566582871|FG003|Overall Study|Adverse Event|0|||
156953628|NCT01764945|566582872|FG004|Overall Study|Adverse Event|0|||
156953629|NCT01764945|566582873|FG005|Overall Study|Adverse Event|0|||
156953630|NCT01764945|566582874|FG006|Overall Study|Adverse Event|1|||
156953631|NCT01764945|566582875|FG007|Overall Study|Adverse Event|0|||
156953632|NCT02911948|566582879|FG000|Overall Study|Protocol Violation|0|||
156953633|NCT02911948|566582880|FG001|Overall Study|Protocol Violation|1|||
156953634|NCT02911948|566582879|FG000|Overall Study|Withdrawal by Subject|0|||
156953635|NCT02911948|566582880|FG001|Overall Study|Withdrawal by Subject|2|||
156953636|NCT02911948|566582879|FG000|Overall Study|Lack of Efficacy|0|||
156953637|NCT02911948|566582880|FG001|Overall Study|Lack of Efficacy|1|||
156953638|NCT02911948|566582879|FG000|Overall Study|Unclassified|0|||
156953639|NCT02911948|566582880|FG001|Overall Study|Unclassified|3|||
156953640|NCT03238001|566582884|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
156953641|NCT03238001|566582884|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
156953642|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
156953643|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
156953644|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
156953645|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
156953646|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
156953647|NCT03238001|566582884|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
156953648|NCT02265237|566582885|FG000|As Treated (Overall Study)|Adverse Event|1|||
156953649|NCT02265237|566582886|FG001|As Treated (Overall Study)|Adverse Event|1|||
156953650|NCT02265237|566582887|FG002|As Treated (Overall Study)|Adverse Event|0|||
156953651|NCT02265237|566582888|FG003|As Treated (Overall Study)|Adverse Event|0|||
156953652|NCT02265237|566582885|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
156953653|NCT02265237|566582886|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
156953654|NCT02265237|566582887|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
156953655|NCT02265237|566582888|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
156953656|NCT02265237|566582885|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
156953657|NCT02265237|566582886|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
156953658|NCT02265237|566582887|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
156953659|NCT02265237|566582888|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
156953660|NCT02265237|566582885|FG000|As Treated (Overall Study)|Other|2|||
156953661|NCT02265237|566582886|FG001|As Treated (Overall Study)|Other|0|||
156953662|NCT02265237|566582887|FG002|As Treated (Overall Study)|Other|3|||
156953663|NCT02265237|566582888|FG003|As Treated (Overall Study)|Other|1|||
156953664|NCT01178853|566582890|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
156953665|NCT01178853|566582891|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
156953666|NCT01178853|566582890|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
156953667|NCT01178853|566582891|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
156953668|NCT01178853|566582890|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
156953669|NCT01178853|566582891|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
156953670|NCT01178853|566582890|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
156953671|NCT01178853|566582891|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
156953672|NCT01178853|566582890|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
156953673|NCT01178853|566582891|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
156953674|NCT03550313|566582892|FG000|Overall Study|Adverse Event|0|||
156953675|NCT03550313|566582893|FG001|Overall Study|Adverse Event|1|||
156953676|NCT03550313|566582894|FG002|Overall Study|Adverse Event|0|||
156953677|NCT03550313|566582892|FG000|Overall Study|Lost to Follow-up|5|||
156953678|NCT03550313|566582893|FG001|Overall Study|Lost to Follow-up|7|||
156953679|NCT03550313|566582894|FG002|Overall Study|Lost to Follow-up|12|||
156953680|NCT03550313|566582892|FG000|Overall Study|Study terminated by sponsor|44|||
156953681|NCT03550313|566582893|FG001|Overall Study|Study terminated by sponsor|37|||
156953682|NCT03550313|566582894|FG002|Overall Study|Study terminated by sponsor|48|||
156953683|NCT03550313|566582892|FG000|Overall Study|No longer met eligibility criteria|3|||
156953684|NCT03550313|566582893|FG001|Overall Study|No longer met eligibility criteria|5|||
156953685|NCT03550313|566582894|FG002|Overall Study|No longer met eligibility criteria|6|||
156953686|NCT03550313|566582892|FG000|Overall Study|Withdrawal by parent/guardian|20|||
156953687|NCT03550313|566582893|FG001|Overall Study|Withdrawal by parent/guardian|18|||
156953688|NCT03550313|566582894|FG002|Overall Study|Withdrawal by parent/guardian|26|||
156953689|NCT03550313|566582892|FG000|Overall Study|Other|4|||
156953690|NCT03550313|566582893|FG001|Overall Study|Other|2|||
156953691|NCT03550313|566582894|FG002|Overall Study|Other|2|||
156953692|NCT03550313|566582892|FG000|Overall Study|Randomized but not vaccinated|3|||
156953693|NCT03550313|566582893|FG001|Overall Study|Randomized but not vaccinated|23|||
156953694|NCT03550313|566582894|FG002|Overall Study|Randomized but not vaccinated|2|||
156953695|NCT03550313|566582892|FG000|Overall Study|Sites terminated due to quality issues|18|||
156953696|NCT03550313|566582893|FG001|Overall Study|Sites terminated due to quality issues|17|||
156953697|NCT03550313|566582894|FG002|Overall Study|Sites terminated due to quality issues|18|||
156953698|NCT00839072|566582895|FG000|First Intervention Period|Withdrawal by Subject|1|||
156953699|NCT00839072|566582896|FG001|First Intervention Period|Withdrawal by Subject|0|||
156953700|NCT00839072|566582895|FG000|First Intervention Period|Adverse Event|1|||
156953701|NCT00839072|566582896|FG001|First Intervention Period|Adverse Event|1|||
157168828|NCT01624506|567359809|FG001|Overall Study|Adverse Event|0|||
157168829|NCT01149343|567359810|FG000|Overall Study|Withdrawal by Subject|1|||
157168830|NCT01149343|567359811|FG001|Overall Study|Withdrawal by Subject|1|||
156953702|NCT00839072|566582895|FG000|Second Intervention Period|Withdrawal by Subject|1|||
156953703|NCT00839072|566582896|FG001|Second Intervention Period|Withdrawal by Subject|0|||
156953704|NCT00380068|566582897|FG000|Overall Study|Adverse Event|40|||
156953705|NCT00380068|566582897|FG000|Overall Study|Withdrawal by Subject|10|||
156953706|NCT00380068|566582897|FG000|Overall Study|Not compliant|6|||
156953707|NCT00380068|566582897|FG000|Overall Study|Lost to Follow-up|1|||
156953708|NCT00380068|566582897|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
157035546|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
157035547|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035548|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035549|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035550|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035551|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035552|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035553|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035554|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035555|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
157035556|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035557|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035558|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035559|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035560|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035561|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035562|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
157035563|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
157035564|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
157168831|NCT01149343|567359812|FG002|Overall Study|Withdrawal by Subject|1|||
157168832|NCT01149343|567359813|FG003|Overall Study|Withdrawal by Subject|5|||
157168833|NCT01149343|567359810|FG000|Overall Study|Death|10|||
157168834|NCT01149343|567359811|FG001|Overall Study|Death|13|||
157168835|NCT01149343|567359812|FG002|Overall Study|Death|18|||
157168836|NCT01149343|567359813|FG003|Overall Study|Death|18|||
157168837|NCT01149343|567359810|FG000|Overall Study|Lost to Follow-up|1|||
157168838|NCT01149343|567359811|FG001|Overall Study|Lost to Follow-up|0|||
157168839|NCT01149343|567359812|FG002|Overall Study|Lost to Follow-up|0|||
157168840|NCT01149343|567359813|FG003|Overall Study|Lost to Follow-up|1|||
157168841|NCT01149343|567359810|FG000|Overall Study|Other|8|||
157168842|NCT01149343|567359811|FG001|Overall Study|Other|10|||
157168843|NCT01149343|567359812|FG002|Overall Study|Other|2|||
157168844|NCT01149343|567359813|FG003|Overall Study|Other|14|||
157168845|NCT01149343|567359810|FG000|Overall Study|Sponsor study termination|0|||
157168846|NCT01149343|567359811|FG001|Overall Study|Sponsor study termination|0|||
157168847|NCT01149343|567359812|FG002|Overall Study|Sponsor study termination|0|||
157168848|NCT01149343|567359813|FG003|Overall Study|Sponsor study termination|2|||
157168849|NCT01149343|567359810|FG000|Overall Study|Recurrence / Progressive disease|0|||
157168850|NCT01149343|567359811|FG001|Overall Study|Recurrence / Progressive disease|0|||
157168851|NCT01149343|567359812|FG002|Overall Study|Recurrence / Progressive disease|1|||
157168852|NCT01149343|567359813|FG003|Overall Study|Recurrence / Progressive disease|0|||
157168853|NCT00132314|567359822|FG000|Overall Study|Lost to Follow-up|70|||
157168854|NCT00132314|567359823|FG001|Overall Study|Lost to Follow-up|62|||
157168855|NCT00132314|567359822|FG000|Overall Study|Lacked SSN|1|||
157168856|NCT00132314|567359823|FG001|Overall Study|Lacked SSN|3|||
157168857|NCT00132314|567359822|FG000|Overall Study|Refused intervention at baseline|2|||
157168858|NCT00132314|567359823|FG001|Overall Study|Refused intervention at baseline|7|||
157168859|NCT04019795|567359838|FG000|Overall Study|Withdrawal by Subject|1|||
157168860|NCT04019795|567359839|FG001|Overall Study|Withdrawal by Subject|2|||
157168861|NCT04019795|567359840|FG002|Overall Study|Withdrawal by Subject|2|||
157168862|NCT04019795|567359841|FG003|Overall Study|Withdrawal by Subject|1|||
157168863|NCT04019795|567359838|FG000|Overall Study|Lost to Follow-up|0|||
157168864|NCT04019795|567359839|FG001|Overall Study|Lost to Follow-up|1|||
157168865|NCT04019795|567359840|FG002|Overall Study|Lost to Follow-up|1|||
157168866|NCT04019795|567359841|FG003|Overall Study|Lost to Follow-up|2|||
157035565|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035566|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035567|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035568|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035569|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
157168867|NCT04019795|567359838|FG000|Overall Study|Treatment non-compliance|3|||
157168868|NCT04019795|567359839|FG001|Overall Study|Treatment non-compliance|1|||
157035570|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035571|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
157168869|NCT04019795|567359840|FG002|Overall Study|Treatment non-compliance|2|||
157168870|NCT04019795|567359841|FG003|Overall Study|Treatment non-compliance|0|||
157168871|NCT04019795|567359838|FG000|Overall Study|Physician Decision|0|||
157168872|NCT04019795|567359839|FG001|Overall Study|Physician Decision|0|||
157168873|NCT04019795|567359840|FG002|Overall Study|Physician Decision|1|||
157168874|NCT04019795|567359841|FG003|Overall Study|Physician Decision|0|||
157168875|NCT04019795|567359838|FG000|Overall Study|Adverse Event|1|||
157168876|NCT04019795|567359839|FG001|Overall Study|Adverse Event|0|||
157168877|NCT04019795|567359840|FG002|Overall Study|Adverse Event|0|||
157168878|NCT04019795|567359841|FG003|Overall Study|Adverse Event|0|||
157168879|NCT03625141|567359842|FG000|Overall Study|Adverse Event|0|||
157168880|NCT03625141|567359843|FG001|Overall Study|Adverse Event|2|||
156953709|NCT00380068|566582897|FG000|Overall Study|Lung transplant|3|||
156953710|NCT00380068|566582897|FG000|Overall Study|Physician Decision|2|||
156953711|NCT00380068|566582897|FG000|Overall Study|Partipant moved away|1|||
156953712|NCT00380068|566582897|FG000|Overall Study|Lack of Efficacy|5|||
156953713|NCT01297062|566582898|FG000|Overall Study|Adverse Event|2|||
156953714|NCT01297062|566582899|FG001|Overall Study|Adverse Event|0|||
156953715|NCT01297062|566582900|FG002|Overall Study|Adverse Event|1|||
156953716|NCT01297062|566582901|FG003|Overall Study|Adverse Event|0|||
156953717|NCT01297062|566582902|FG004|Overall Study|Adverse Event|0|||
156953718|NCT01297062|566582903|FG005|Overall Study|Adverse Event|0|||
156953719|NCT01297062|566582904|FG006|Overall Study|Adverse Event|0|||
156953720|NCT01297062|566582898|FG000|Overall Study|Physician Decision|1|||
156953721|NCT01297062|566582899|FG001|Overall Study|Physician Decision|0|||
156953722|NCT01297062|566582900|FG002|Overall Study|Physician Decision|1|||
156953723|NCT01297062|566582901|FG003|Overall Study|Physician Decision|0|||
156953724|NCT01297062|566582902|FG004|Overall Study|Physician Decision|0|||
156953725|NCT01297062|566582903|FG005|Overall Study|Physician Decision|0|||
156953726|NCT01297062|566582904|FG006|Overall Study|Physician Decision|6|||
156953727|NCT01297062|566582898|FG000|Overall Study|Protocol Violation|0|||
156953728|NCT01297062|566582899|FG001|Overall Study|Protocol Violation|0|||
156953729|NCT01297062|566582900|FG002|Overall Study|Protocol Violation|0|||
156953730|NCT01297062|566582901|FG003|Overall Study|Protocol Violation|0|||
156953731|NCT01297062|566582902|FG004|Overall Study|Protocol Violation|1|||
156953732|NCT01297062|566582903|FG005|Overall Study|Protocol Violation|0|||
156953733|NCT01297062|566582904|FG006|Overall Study|Protocol Violation|0|||
156953734|NCT01297062|566582898|FG000|Overall Study|Subject Decision|1|||
156953735|NCT01297062|566582899|FG001|Overall Study|Subject Decision|1|||
156953736|NCT01297062|566582900|FG002|Overall Study|Subject Decision|0|||
156953737|NCT01297062|566582901|FG003|Overall Study|Subject Decision|1|||
156953738|NCT01297062|566582902|FG004|Overall Study|Subject Decision|1|||
156953739|NCT01297062|566582903|FG005|Overall Study|Subject Decision|1|||
156953740|NCT01297062|566582904|FG006|Overall Study|Subject Decision|2|||
156953741|NCT04964089|566582907|FG000|Overall Study|Adverse Event|8|||
156953742|NCT04964089|566582908|FG001|Overall Study|Adverse Event|6|||
156953743|NCT04964089|566582907|FG000|Overall Study|Non-compliance with study schedule|1|||
156953744|NCT04964089|566582908|FG001|Overall Study|Non-compliance with study schedule|0|||
156953745|NCT04964089|566582907|FG000|Overall Study|Withdrawal by Subject|6|||
156953746|NCT04964089|566582908|FG001|Overall Study|Withdrawal by Subject|5|||
156953747|NCT04964089|566582907|FG000|Overall Study|Lost to Follow-up|1|||
156953748|NCT04964089|566582908|FG001|Overall Study|Lost to Follow-up|1|||
156953749|NCT04964089|566582907|FG000|Overall Study|Progressive disease|4|||
156953750|NCT04964089|566582908|FG001|Overall Study|Progressive disease|0|||
156953751|NCT04964089|566582907|FG000|Overall Study|Physician Decision|1|||
156953752|NCT04964089|566582908|FG001|Overall Study|Physician Decision|0|||
156953753|NCT04964089|566582907|FG000|Overall Study|Participant did not want to continue study treatment|1|||
156953754|NCT04964089|566582908|FG001|Overall Study|Participant did not want to continue study treatment|0|||
156953755|NCT04964089|566582907|FG000|Overall Study|Participant moved to different state|1|||
156953756|NCT04964089|566582908|FG001|Overall Study|Participant moved to different state|0|||
156953757|NCT04964089|566582907|FG000|Overall Study|Participant decided to discontinue|0|||
156953758|NCT04964089|566582908|FG001|Overall Study|Participant decided to discontinue|1|||
156953759|NCT01682837|566582909|FG000|Baseline|Withdrawal by Subject|5|||
156953760|NCT03021187|566582912|FG000|Overall Study|Death|0|||
156953761|NCT03021187|566582913|FG001|Overall Study|Death|0|||
156953762|NCT03021187|566582914|FG002|Overall Study|Death|3|||
157168881|NCT03625141|567359842|FG000|Overall Study|Study Terminated By Sponsor|1|||
156953763|NCT03021187|566582915|FG003|Overall Study|Death|0|||
156953764|NCT03021187|566582912|FG000|Overall Study|Withdrawal by Subject|0|||
156953765|NCT03021187|566582913|FG001|Overall Study|Withdrawal by Subject|6|||
156953766|NCT03021187|566582914|FG002|Overall Study|Withdrawal by Subject|2|||
156953767|NCT03021187|566582915|FG003|Overall Study|Withdrawal by Subject|5|||
156953768|NCT03021187|566582912|FG000|Overall Study|Lost to Follow-up|10|||
156953769|NCT03021187|566582913|FG001|Overall Study|Lost to Follow-up|3|||
156953770|NCT03021187|566582914|FG002|Overall Study|Lost to Follow-up|1|||
157168882|NCT03625141|567359843|FG001|Overall Study|Study Terminated By Sponsor|13|||
157168883|NCT03625141|567359842|FG000|Overall Study|Withdrawal by Subject|3|||
156953771|NCT03021187|566582915|FG003|Overall Study|Lost to Follow-up|4|||
156953772|NCT01664078|566582916|FG000|Overall Study|Death|9|||
156953773|NCT01664078|566582916|FG000|Overall Study|Withdrawal by Subject|4|||
156953774|NCT01664078|566582916|FG000|Overall Study|Lost to Follow-up|2|||
156953775|NCT01664078|566582916|FG000|Overall Study|missed 5 year visit|1|||
156953776|NCT01664078|566582916|FG000|Overall Study|Other|53|||
156953777|NCT03099382|566582917|FG000|Overall Study|Protocol Violation|2|||
156953778|NCT03099382|566582918|FG001|Overall Study|Protocol Violation|3|||
156953779|NCT00499369|566582919|FG000|Overall Study|Adverse Event|2|||
156953780|NCT00499369|566582920|FG001|Overall Study|Adverse Event|2|||
156953781|NCT00499369|566582921|FG002|Overall Study|Adverse Event|3|||
156953782|NCT00499369|566582922|FG003|Overall Study|Adverse Event|1|||
156953783|NCT00499369|566582923|FG004|Overall Study|Adverse Event|2|||
157168884|NCT03625141|567359843|FG001|Overall Study|Withdrawal by Subject|0|||
157035572|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
157035573|NCT02719574|566887799|FG000|Phase 1 (Dose Expansion)|Other|0|||
157035574|NCT02719574|566887800|FG001|Phase 1 (Dose Expansion)|Other|0|||
157035575|NCT02719574|566887801|FG002|Phase 1 (Dose Expansion)|Other|0|||
157035576|NCT02719574|566887802|FG003|Phase 1 (Dose Expansion)|Other|0|||
157035577|NCT02719574|566887803|FG004|Phase 1 (Dose Expansion)|Other|0|||
157035578|NCT02719574|566887804|FG005|Phase 1 (Dose Expansion)|Other|0|||
157035579|NCT02719574|566887805|FG006|Phase 1 (Dose Expansion)|Other|1|||
157035580|NCT02719574|566887806|FG007|Phase 1 (Dose Expansion)|Other|7|||
157035581|NCT02719574|566887807|FG008|Phase 1 (Dose Expansion)|Other|0|||
157035582|NCT02719574|566887808|FG009|Phase 1 (Dose Expansion)|Other|0|||
157035583|NCT02719574|566887809|FG010|Phase 1 (Dose Expansion)|Other|0|||
157035584|NCT02719574|566887810|FG011|Phase 1 (Dose Expansion)|Other|0|||
157035585|NCT02719574|566887811|FG012|Phase 1 (Dose Expansion)|Other|0|||
157035586|NCT02719574|566887812|FG013|Phase 1 (Dose Expansion)|Other|0|||
157035587|NCT02719574|566887813|FG014|Phase 1 (Dose Expansion)|Other|0|||
157035588|NCT02719574|566887814|FG015|Phase 1 (Dose Expansion)|Other|0|||
157035589|NCT02719574|566887815|FG016|Phase 1 (Dose Expansion)|Other|0|||
157035590|NCT02719574|566887799|FG000|Phase 2|Protocol Defined Disease Progression|0|||
157035591|NCT02719574|566887800|FG001|Phase 2|Protocol Defined Disease Progression|0|||
157035592|NCT02719574|566887801|FG002|Phase 2|Protocol Defined Disease Progression|0|||
157035593|NCT02719574|566887802|FG003|Phase 2|Protocol Defined Disease Progression|0|||
157035594|NCT02719574|566887803|FG004|Phase 2|Protocol Defined Disease Progression|0|||
157035595|NCT02719574|566887804|FG005|Phase 2|Protocol Defined Disease Progression|0|||
157035596|NCT02719574|566887805|FG006|Phase 2|Protocol Defined Disease Progression|0|||
157035597|NCT02719574|566887806|FG007|Phase 2|Protocol Defined Disease Progression|0|||
157035598|NCT02719574|566887807|FG008|Phase 2|Protocol Defined Disease Progression|0|||
157035599|NCT02719574|566887808|FG009|Phase 2|Protocol Defined Disease Progression|65|||
157035600|NCT02719574|566887809|FG010|Phase 2|Protocol Defined Disease Progression|8|||
157035601|NCT02719574|566887810|FG011|Phase 2|Protocol Defined Disease Progression|2|||
157035602|NCT02719574|566887811|FG012|Phase 2|Protocol Defined Disease Progression|4|||
157035603|NCT02719574|566887812|FG013|Phase 2|Protocol Defined Disease Progression|9|||
157035604|NCT02719574|566887813|FG014|Phase 2|Protocol Defined Disease Progression|11|||
157035605|NCT02719574|566887814|FG015|Phase 2|Protocol Defined Disease Progression|3|||
157035606|NCT02719574|566887815|FG016|Phase 2|Protocol Defined Disease Progression|4|||
157035607|NCT02719574|566887799|FG000|Phase 2|Adverse Event|0|||
157035608|NCT02719574|566887800|FG001|Phase 2|Adverse Event|0|||
157035609|NCT02719574|566887801|FG002|Phase 2|Adverse Event|0|||
157035610|NCT02719574|566887802|FG003|Phase 2|Adverse Event|0|||
157035611|NCT02719574|566887803|FG004|Phase 2|Adverse Event|0|||
157035612|NCT02719574|566887804|FG005|Phase 2|Adverse Event|0|||
157035613|NCT02719574|566887805|FG006|Phase 2|Adverse Event|0|||
157035614|NCT02719574|566887806|FG007|Phase 2|Adverse Event|0|||
157035615|NCT02719574|566887807|FG008|Phase 2|Adverse Event|0|||
157035616|NCT02719574|566887808|FG009|Phase 2|Adverse Event|27|||
157035617|NCT02719574|566887809|FG010|Phase 2|Adverse Event|0|||
157035618|NCT02719574|566887810|FG011|Phase 2|Adverse Event|1|||
157035619|NCT02719574|566887811|FG012|Phase 2|Adverse Event|1|||
157035620|NCT02719574|566887812|FG013|Phase 2|Adverse Event|1|||
157035621|NCT02719574|566887813|FG014|Phase 2|Adverse Event|2|||
157035622|NCT02719574|566887814|FG015|Phase 2|Adverse Event|2|||
157035623|NCT02719574|566887815|FG016|Phase 2|Adverse Event|3|||
157035624|NCT02719574|566887799|FG000|Phase 2|Other|0|||
157035625|NCT02719574|566887800|FG001|Phase 2|Other|0|||
157035626|NCT02719574|566887801|FG002|Phase 2|Other|0|||
157035627|NCT02719574|566887802|FG003|Phase 2|Other|0|||
157035628|NCT02719574|566887803|FG004|Phase 2|Other|0|||
157035629|NCT02719574|566887804|FG005|Phase 2|Other|0|||
157035630|NCT02719574|566887805|FG006|Phase 2|Other|0|||
157035631|NCT02719574|566887806|FG007|Phase 2|Other|0|||
157035632|NCT02719574|566887807|FG008|Phase 2|Other|0|||
157035633|NCT02719574|566887808|FG009|Phase 2|Other|20|||
157035634|NCT02719574|566887809|FG010|Phase 2|Other|7|||
157035635|NCT02719574|566887810|FG011|Phase 2|Other|0|||
157035636|NCT02719574|566887811|FG012|Phase 2|Other|5|||
157035637|NCT02719574|566887812|FG013|Phase 2|Other|7|||
157035638|NCT02719574|566887813|FG014|Phase 2|Other|0|||
157035639|NCT02719574|566887814|FG015|Phase 2|Other|1|||
157035640|NCT02719574|566887815|FG016|Phase 2|Other|4|||
157035641|NCT02719574|566887799|FG000|Phase 2|Transplant|0|||
157035642|NCT02719574|566887800|FG001|Phase 2|Transplant|0|||
157035643|NCT02719574|566887801|FG002|Phase 2|Transplant|0|||
157035644|NCT02719574|566887802|FG003|Phase 2|Transplant|0|||
157035645|NCT02719574|566887803|FG004|Phase 2|Transplant|0|||
157035646|NCT02719574|566887804|FG005|Phase 2|Transplant|0|||
157035647|NCT02719574|566887805|FG006|Phase 2|Transplant|0|||
157035648|NCT02719574|566887806|FG007|Phase 2|Transplant|0|||
157035649|NCT02719574|566887807|FG008|Phase 2|Transplant|0|||
157035650|NCT02719574|566887808|FG009|Phase 2|Transplant|15|||
157035651|NCT02719574|566887809|FG010|Phase 2|Transplant|2|||
157035652|NCT02719574|566887810|FG011|Phase 2|Transplant|0|||
157035653|NCT02719574|566887811|FG012|Phase 2|Transplant|6|||
157035654|NCT02719574|566887812|FG013|Phase 2|Transplant|1|||
157035655|NCT02719574|566887813|FG014|Phase 2|Transplant|1|||
156953784|NCT00499369|566582919|FG000|Overall Study|Withdrawal by Subject|0|||
156953785|NCT00499369|566582920|FG001|Overall Study|Withdrawal by Subject|1|||
156953786|NCT00499369|566582921|FG002|Overall Study|Withdrawal by Subject|1|||
156953787|NCT00499369|566582922|FG003|Overall Study|Withdrawal by Subject|0|||
156953788|NCT00499369|566582923|FG004|Overall Study|Withdrawal by Subject|0|||
156953789|NCT00499369|566582919|FG000|Overall Study|Progression|10|||
156953790|NCT00499369|566582920|FG001|Overall Study|Progression|12|||
156953791|NCT00499369|566582921|FG002|Overall Study|Progression|9|||
156953792|NCT00499369|566582922|FG003|Overall Study|Progression|6|||
156953793|NCT00499369|566582923|FG004|Overall Study|Progression|10|||
156953794|NCT00499369|566582919|FG000|Overall Study|Death|0|||
156953795|NCT00499369|566582920|FG001|Overall Study|Death|1|||
156953796|NCT00499369|566582921|FG002|Overall Study|Death|0|||
156953797|NCT00499369|566582922|FG003|Overall Study|Death|0|||
156953798|NCT00499369|566582923|FG004|Overall Study|Death|0|||
156953799|NCT00499369|566582919|FG000|Overall Study|Not protocol specified|2|||
156953800|NCT00499369|566582920|FG001|Overall Study|Not protocol specified|0|||
156953801|NCT00499369|566582921|FG002|Overall Study|Not protocol specified|3|||
156953802|NCT00499369|566582922|FG003|Overall Study|Not protocol specified|1|||
156953803|NCT00499369|566582923|FG004|Overall Study|Not protocol specified|0|||
156953804|NCT00499369|566582919|FG000|Overall Study|Ineligible|2|||
156953805|NCT00499369|566582920|FG001|Overall Study|Ineligible|2|||
156953806|NCT00499369|566582921|FG002|Overall Study|Ineligible|1|||
156953807|NCT00499369|566582922|FG003|Overall Study|Ineligible|1|||
156953808|NCT00499369|566582923|FG004|Overall Study|Ineligible|0|||
156953809|NCT01898195|566582925|FG000|Smoking Abstinence|Did not have good measurements|35|||
156953810|NCT01898195|566582926|FG001|Smoking Abstinence|Did not have good measurements|38|||
156953811|NCT01898195|566582927|FG002|Smoking Abstinence|Did not have good measurements|36|||
156953812|NCT01802411|566582928|FG000|Overall Study|Death|2|||
156953813|NCT01802411|566582929|FG001|Overall Study|Death|1|||
156953814|NCT01802411|566582928|FG000|Overall Study|Adverse Event|2|||
156953815|NCT01802411|566582929|FG001|Overall Study|Adverse Event|7|||
156953816|NCT01802411|566582928|FG000|Overall Study|Lack of Efficacy|8|||
156953817|NCT01802411|566582929|FG001|Overall Study|Lack of Efficacy|10|||
156953818|NCT01802411|566582928|FG000|Overall Study|Withdrawal by Subject|0|||
156953819|NCT01802411|566582929|FG001|Overall Study|Withdrawal by Subject|2|||
156953820|NCT01802411|566582928|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
156953821|NCT01802411|566582929|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
156953822|NCT01802411|566582928|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
156953823|NCT01802411|566582929|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
156953824|NCT01802411|566582928|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
156953825|NCT01802411|566582929|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
156953826|NCT01337245|566582930|FG000|Overall Study|Lost to Follow-up|1|||
156953827|NCT03930745|566582931|FG000|Overall Study|Lost to Follow-up|10|||
156953828|NCT03930745|566582932|FG001|Overall Study|Lost to Follow-up|5|||
156953829|NCT03930745|566582931|FG000|Overall Study|Withdrawal by Subject|1|||
156953830|NCT03930745|566582932|FG001|Overall Study|Withdrawal by Subject|2|||
156953831|NCT03930745|566582931|FG000|Overall Study|Protocol Violation|2|||
156953832|NCT03930745|566582932|FG001|Overall Study|Protocol Violation|2|||
156953833|NCT03930745|566582931|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
156953834|NCT03930745|566582932|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
156953835|NCT03930745|566582931|FG000|Overall Study|Adverse Event|0|||
156953836|NCT03930745|566582932|FG001|Overall Study|Adverse Event|1|||
156953837|NCT03930745|566582931|FG000|Overall Study|Pregnancy|0|||
156953838|NCT03930745|566582932|FG001|Overall Study|Pregnancy|1|||
156953839|NCT04095858|566582935|FG000|Overall Study|Death|1|||
156953840|NCT04095858|566582936|FG001|Overall Study|Death|0|||
156953841|NCT04095858|566582935|FG000|Overall Study|Study terminated by Sponsor|2|||
156953842|NCT04095858|566582936|FG001|Overall Study|Study terminated by Sponsor|4|||
156953843|NCT01344460|566582937|FG000|Overall Study|Withdrawal by Subject|1|||
156953844|NCT01344460|566582937|FG000|Overall Study|Lost to Follow-up|2|||
156953845|NCT01165281|566582938|FG000|Overall Study|Adverse Event|12|||
157035656|NCT02719574|566887814|FG015|Phase 2|Transplant|0|||
156953846|NCT01165281|566582939|FG001|Overall Study|Adverse Event|14|||
156953847|NCT01165281|566582938|FG000|Overall Study|Death|3|||
157035657|NCT02719574|566887815|FG016|Phase 2|Transplant|0|||
157035658|NCT02719574|566887799|FG000|Phase 2|Death|0|||
157035659|NCT02719574|566887800|FG001|Phase 2|Death|0|||
157035660|NCT02719574|566887801|FG002|Phase 2|Death|0|||
157035661|NCT02719574|566887802|FG003|Phase 2|Death|0|||
157035662|NCT02719574|566887803|FG004|Phase 2|Death|0|||
156953848|NCT01165281|566582939|FG001|Overall Study|Death|4|||
156953849|NCT01165281|566582938|FG000|Overall Study|Lack of Efficacy|4|||
156953850|NCT01165281|566582939|FG001|Overall Study|Lack of Efficacy|1|||
156953851|NCT01165281|566582938|FG000|Overall Study|Lost to Follow-up|0|||
156953852|NCT01165281|566582939|FG001|Overall Study|Lost to Follow-up|1|||
156953853|NCT01165281|566582938|FG000|Overall Study|Physician Decision|8|||
156953854|NCT01165281|566582939|FG001|Overall Study|Physician Decision|1|||
156953855|NCT01165281|566582938|FG000|Overall Study|Protocol Violation|6|||
156953856|NCT01165281|566582939|FG001|Overall Study|Protocol Violation|5|||
157035663|NCT02719574|566887804|FG005|Phase 2|Death|0|||
156953857|NCT01165281|566582938|FG000|Overall Study|Withdrawal by Subject|8|||
156953858|NCT01165281|566582939|FG001|Overall Study|Withdrawal by Subject|7|||
156953859|NCT01165281|566582938|FG000|Overall Study|Noncompliance with Study Drug|1|||
156953860|NCT01165281|566582939|FG001|Overall Study|Noncompliance with Study Drug|4|||
156953861|NCT01165281|566582938|FG000|Overall Study|Progressive Disease|10|||
156953862|NCT01165281|566582939|FG001|Overall Study|Progressive Disease|14|||
156953863|NCT01165281|566582938|FG000|Overall Study|Other|6|||
156953864|NCT01165281|566582939|FG001|Overall Study|Other|0|||
156953865|NCT02863991|566582940|FG000|Overall Study|Death|0|||
156953866|NCT02863991|566582941|FG001|Overall Study|Death|3|||
156953867|NCT02863991|566582940|FG000|Overall Study|Lack of Efficacy|0|||
156953868|NCT02863991|566582941|FG001|Overall Study|Lack of Efficacy|1|||
156953869|NCT02863991|566582940|FG000|Overall Study|Study Terminated|2|||
156953870|NCT02863991|566582941|FG001|Overall Study|Study Terminated|8|||
156953871|NCT00558285|566582942|FG000|Overall Study|Adverse Event|1|||
156953872|NCT00558285|566582943|FG001|Overall Study|Adverse Event|1|||
156953873|NCT00558285|566582944|FG002|Overall Study|Adverse Event|4|||
156953874|NCT00558285|566582945|FG003|Overall Study|Adverse Event|1|||
156953875|NCT00558285|566582946|FG004|Overall Study|Adverse Event|2|||
156953876|NCT00558285|566582942|FG000|Overall Study|Abnormal test procedure result(s)|1|||
156953877|NCT00558285|566582943|FG001|Overall Study|Abnormal test procedure result(s)|0|||
156953878|NCT00558285|566582944|FG002|Overall Study|Abnormal test procedure result(s)|0|||
156953879|NCT00558285|566582945|FG003|Overall Study|Abnormal test procedure result(s)|0|||
156953880|NCT00558285|566582946|FG004|Overall Study|Abnormal test procedure result(s)|0|||
156953881|NCT00558285|566582942|FG000|Overall Study|Subject withdrew consent|2|||
156953882|NCT00558285|566582943|FG001|Overall Study|Subject withdrew consent|0|||
156953883|NCT00558285|566582944|FG002|Overall Study|Subject withdrew consent|1|||
156953884|NCT00558285|566582945|FG003|Overall Study|Subject withdrew consent|1|||
156953885|NCT00558285|566582946|FG004|Overall Study|Subject withdrew consent|1|||
156953886|NCT00558285|566582942|FG000|Overall Study|Lost to Follow-up|1|||
156953887|NCT00558285|566582943|FG001|Overall Study|Lost to Follow-up|1|||
156953888|NCT00558285|566582944|FG002|Overall Study|Lost to Follow-up|0|||
156953889|NCT00558285|566582945|FG003|Overall Study|Lost to Follow-up|0|||
156953890|NCT00558285|566582946|FG004|Overall Study|Lost to Follow-up|0|||
156953891|NCT00558285|566582942|FG000|Overall Study|Administrative problems|0|||
156953892|NCT00558285|566582943|FG001|Overall Study|Administrative problems|0|||
156953893|NCT00558285|566582944|FG002|Overall Study|Administrative problems|0|||
156953894|NCT00558285|566582945|FG003|Overall Study|Administrative problems|1|||
156953895|NCT00558285|566582946|FG004|Overall Study|Administrative problems|1|||
156953896|NCT00558285|566582942|FG000|Overall Study|Protocol deviation|1|||
156953897|NCT00558285|566582943|FG001|Overall Study|Protocol deviation|1|||
156953898|NCT00558285|566582944|FG002|Overall Study|Protocol deviation|0|||
156953899|NCT00558285|566582945|FG003|Overall Study|Protocol deviation|1|||
156953900|NCT00558285|566582946|FG004|Overall Study|Protocol deviation|0|||
156953901|NCT00467870|566585008|FG000|Overall Study|Adverse Event|13|||
156953902|NCT00467870|566585009|FG001|Overall Study|Adverse Event|9|||
156953903|NCT00467870|566585010|FG002|Overall Study|Adverse Event|1|||
156953904|NCT00467870|566585011|FG003|Overall Study|Adverse Event|15|||
156953905|NCT00467870|566585012|FG004|Overall Study|Adverse Event|15|||
156953906|NCT00467870|566585013|FG005|Overall Study|Adverse Event|1|||
156953907|NCT00467870|566585008|FG000|Overall Study|Protocol Violation|2|||
156953908|NCT00467870|566585009|FG001|Overall Study|Protocol Violation|1|||
156953909|NCT00467870|566585010|FG002|Overall Study|Protocol Violation|1|||
156953910|NCT00467870|566585011|FG003|Overall Study|Protocol Violation|2|||
156953911|NCT00467870|566585012|FG004|Overall Study|Protocol Violation|0|||
156953912|NCT00467870|566585013|FG005|Overall Study|Protocol Violation|0|||
156953913|NCT00467870|566585008|FG000|Overall Study|Withdrawal by Subject|14|||
156953914|NCT00467870|566585009|FG001|Overall Study|Withdrawal by Subject|21|||
156953915|NCT00467870|566585010|FG002|Overall Study|Withdrawal by Subject|0|||
156953916|NCT00467870|566585011|FG003|Overall Study|Withdrawal by Subject|9|||
156953917|NCT00467870|566585012|FG004|Overall Study|Withdrawal by Subject|10|||
156953918|NCT00467870|566585013|FG005|Overall Study|Withdrawal by Subject|1|||
156953919|NCT00467870|566585008|FG000|Overall Study|Lost to Follow-up|5|||
156953920|NCT00467870|566585009|FG001|Overall Study|Lost to Follow-up|3|||
156953921|NCT00467870|566585010|FG002|Overall Study|Lost to Follow-up|1|||
156953922|NCT00467870|566585011|FG003|Overall Study|Lost to Follow-up|1|||
156953923|NCT00467870|566585012|FG004|Overall Study|Lost to Follow-up|3|||
156953924|NCT00467870|566585013|FG005|Overall Study|Lost to Follow-up|0|||
156953925|NCT00467870|566585008|FG000|Overall Study|Subject Non-compliance|3|||
156953926|NCT00467870|566585009|FG001|Overall Study|Subject Non-compliance|4|||
156953927|NCT00467870|566585010|FG002|Overall Study|Subject Non-compliance|0|||
156953928|NCT00467870|566585011|FG003|Overall Study|Subject Non-compliance|1|||
156953929|NCT00467870|566585012|FG004|Overall Study|Subject Non-compliance|5|||
156953930|NCT00467870|566585013|FG005|Overall Study|Subject Non-compliance|0|||
156953931|NCT00467870|566585008|FG000|Overall Study|Other/Unknown|8|||
156953932|NCT00467870|566585009|FG001|Overall Study|Other/Unknown|5|||
156953933|NCT00467870|566585010|FG002|Overall Study|Other/Unknown|1|||
156953934|NCT00467870|566585011|FG003|Overall Study|Other/Unknown|5|||
156953935|NCT00467870|566585012|FG004|Overall Study|Other/Unknown|4|||
156953936|NCT00467870|566585013|FG005|Overall Study|Other/Unknown|0|||
156953937|NCT03489304|566585014|FG000|Overall Study|Lost to Follow-up|4|||
156953938|NCT02239679|566585015|FG000|Overall Study|Lost to Follow-up|1|||
156953939|NCT02239679|566585016|FG001|Overall Study|Lost to Follow-up|0|||
156953940|NCT02239679|566585017|FG002|Overall Study|Lost to Follow-up|0|||
156953941|NCT02239679|566585015|FG000|Overall Study|Withdrawal by Subject|2|||
156953942|NCT02239679|566585016|FG001|Overall Study|Withdrawal by Subject|3|||
156953943|NCT02239679|566585017|FG002|Overall Study|Withdrawal by Subject|1|||
156953944|NCT02261363|566585018|FG000|Overall Study|Lost to Follow-up|21|||
156953945|NCT01517802|566585019|FG000|Overall Study|Death|1|||
156953946|NCT02605954|566585020|FG000|Overall Study|Adverse Event|5|||
156953947|NCT02605954|566585021|FG001|Overall Study|Adverse Event|1|||
156953948|NCT02605954|566585020|FG000|Overall Study|Investigator's Discretion|1|||
156953949|NCT02605954|566585021|FG001|Overall Study|Investigator's Discretion|0|||
156953950|NCT02605954|566585020|FG000|Overall Study|Non-Compliance with Study Drug|1|||
156953951|NCT02605954|566585021|FG001|Overall Study|Non-Compliance with Study Drug|0|||
156953952|NCT02605954|566585020|FG000|Overall Study|Withdrew Consent|2|||
156953953|NCT02605954|566585021|FG001|Overall Study|Withdrew Consent|2|||
156953954|NCT02605954|566585020|FG000|Overall Study|Lost to Follow-up|3|||
156953955|NCT02605954|566585021|FG001|Overall Study|Lost to Follow-up|0|||
156953956|NCT02605954|566585020|FG000|Overall Study|Randomized but not treated|0|||
156953957|NCT02605954|566585021|FG001|Overall Study|Randomized but not treated|1|||
156953958|NCT01310036|566585022|FG000|Overall Study|Administrative/other|10|||
156953959|NCT01310036|566585022|FG000|Overall Study|Withdrew Consent|11|||
156953960|NCT01310036|566585022|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
156953961|NCT01310036|566585022|FG000|Overall Study|Progression of Disease|164|||
156953962|NCT01310036|566585022|FG000|Overall Study|Death|1|||
156953963|NCT01310036|566585022|FG000|Overall Study|Adverse event or intercurrent illness|12|||
156953964|NCT00817089|566585023|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
156953965|NCT00817089|566585024|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
156953966|NCT00817089|566585025|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
156953967|NCT00817089|566585026|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
156953968|NCT00817089|566585023|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
156953969|NCT00817089|566585024|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
156953970|NCT00817089|566585025|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
156953971|NCT00817089|566585026|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
156953972|NCT00709722|566585027|FG000|Overall Study|Adverse Event|1|||
156953973|NCT04667117|566585028|FG000|Investigational Period|Lost to Follow-up|0|||
156953974|NCT04667117|566585029|FG001|Investigational Period|Lost to Follow-up|0|||
156953975|NCT04667117|566585030|FG002|Investigational Period|Lost to Follow-up|1|||
156953976|NCT04667117|566585028|FG000|Investigational Period|Protocol Deviation|0|||
156953977|NCT04667117|566585029|FG001|Investigational Period|Protocol Deviation|1|||
156953978|NCT04667117|566585030|FG002|Investigational Period|Protocol Deviation|0|||
156953979|NCT04667117|566585028|FG000|Extension Period|Lost to Follow-up|1|||
156953980|NCT04667117|566585029|FG001|Extension Period|Lost to Follow-up|0|||
156953981|NCT04667117|566585030|FG002|Extension Period|Lost to Follow-up|0|||
156953982|NCT03359096|566585031|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
156953983|NCT03359096|566585032|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
156953984|NCT03359096|566585031|FG000|First Intervention (4 Weeks)|Death|1|||
156953985|NCT03359096|566585032|FG001|First Intervention (4 Weeks)|Death|0|||
156953986|NCT03359096|566585031|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
156953987|NCT03359096|566585032|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
156953988|NCT01953926|566585040|FG000|Overall Study|Withdrawal by Subject|23|||
156953989|NCT01953926|566585041|FG001|Overall Study|Withdrawal by Subject|3|||
156953990|NCT01953926|566585042|FG002|Overall Study|Withdrawal by Subject|3|||
156953991|NCT01953926|566585043|FG003|Overall Study|Withdrawal by Subject|5|||
156953992|NCT01953926|566585044|FG004|Overall Study|Withdrawal by Subject|6|||
156953993|NCT01953926|566585045|FG005|Overall Study|Withdrawal by Subject|0|||
156953994|NCT01953926|566585046|FG006|Overall Study|Withdrawal by Subject|1|||
156953995|NCT01953926|566585040|FG000|Overall Study|Physician Decision|1|||
156953996|NCT01953926|566585041|FG001|Overall Study|Physician Decision|0|||
156953997|NCT01953926|566585042|FG002|Overall Study|Physician Decision|0|||
156953998|NCT01953926|566585043|FG003|Overall Study|Physician Decision|0|||
156953999|NCT01953926|566585044|FG004|Overall Study|Physician Decision|2|||
156954000|NCT01953926|566585045|FG005|Overall Study|Physician Decision|0|||
156954001|NCT01953926|566585046|FG006|Overall Study|Physician Decision|0|||
156954002|NCT01953926|566585040|FG000|Overall Study|Lost to Follow-up|18|||
156954003|NCT01953926|566585041|FG001|Overall Study|Lost to Follow-up|3|||
156954004|NCT01953926|566585042|FG002|Overall Study|Lost to Follow-up|0|||
156954005|NCT01953926|566585043|FG003|Overall Study|Lost to Follow-up|5|||
156954006|NCT01953926|566585044|FG004|Overall Study|Lost to Follow-up|3|||
156954007|NCT01953926|566585045|FG005|Overall Study|Lost to Follow-up|0|||
156954008|NCT01953926|566585046|FG006|Overall Study|Lost to Follow-up|0|||
156954009|NCT01953926|566585040|FG000|Overall Study|Protocol Violation|1|||
156954010|NCT01953926|566585041|FG001|Overall Study|Protocol Violation|0|||
156954011|NCT01953926|566585042|FG002|Overall Study|Protocol Violation|0|||
156954012|NCT01953926|566585043|FG003|Overall Study|Protocol Violation|0|||
156954013|NCT01953926|566585044|FG004|Overall Study|Protocol Violation|0|||
156954014|NCT01953926|566585045|FG005|Overall Study|Protocol Violation|0|||
156954015|NCT01953926|566585046|FG006|Overall Study|Protocol Violation|0|||
156954016|NCT01953926|566585040|FG000|Overall Study|Other, Disease progression|2|||
156954017|NCT01953926|566585041|FG001|Overall Study|Other, Disease progression|1|||
156954018|NCT01953926|566585042|FG002|Overall Study|Other, Disease progression|0|||
156954019|NCT01953926|566585043|FG003|Overall Study|Other, Disease progression|0|||
156954020|NCT01953926|566585044|FG004|Overall Study|Other, Disease progression|1|||
156954021|NCT01953926|566585045|FG005|Overall Study|Other, Disease progression|0|||
156954022|NCT01953926|566585046|FG006|Overall Study|Other, Disease progression|0|||
156954023|NCT01953926|566585040|FG000|Overall Study|Discontinuation of study by sponsor|41|||
156954024|NCT01953926|566585041|FG001|Overall Study|Discontinuation of study by sponsor|7|||
156954025|NCT01953926|566585042|FG002|Overall Study|Discontinuation of study by sponsor|5|||
156954026|NCT01953926|566585043|FG003|Overall Study|Discontinuation of study by sponsor|12|||
156954027|NCT01953926|566585044|FG004|Overall Study|Discontinuation of study by sponsor|46|||
156954028|NCT01953926|566585045|FG005|Overall Study|Discontinuation of study by sponsor|5|||
156954029|NCT01953926|566585046|FG006|Overall Study|Discontinuation of study by sponsor|6|||
156954030|NCT01953926|566585040|FG000|Overall Study|Not Treated|1|||
156954031|NCT01953926|566585041|FG001|Overall Study|Not Treated|0|||
156954032|NCT01953926|566585042|FG002|Overall Study|Not Treated|1|||
156954033|NCT01953926|566585043|FG003|Overall Study|Not Treated|0|||
156954034|NCT01953926|566585044|FG004|Overall Study|Not Treated|0|||
156954035|NCT01953926|566585045|FG005|Overall Study|Not Treated|0|||
156954036|NCT01953926|566585046|FG006|Overall Study|Not Treated|0|||
156954037|NCT01949480|566585048|FG000|Overall Study|Physician Decision|5|||
156954038|NCT01949480|566585049|FG001|Overall Study|Physician Decision|8|||
156954039|NCT00144339|566585050|FG000|Overall Study|Adverse Event|746|||
156954040|NCT00144339|566585051|FG001|Overall Study|Adverse Event|627|||
156954041|NCT00144339|566585050|FG000|Overall Study|Protocol Violation|75|||
156954042|NCT00144339|566585051|FG001|Overall Study|Protocol Violation|48|||
156954043|NCT00144339|566585050|FG000|Overall Study|Withdrawal by Subject|403|||
156954044|NCT00144339|566585051|FG001|Overall Study|Withdrawal by Subject|300|||
156954045|NCT00144339|566585050|FG000|Overall Study|Lost to Follow-up|76|||
156954046|NCT00144339|566585051|FG001|Overall Study|Lost to Follow-up|64|||
156954047|NCT00144339|566585050|FG000|Overall Study|Other|58|||
156954048|NCT00144339|566585051|FG001|Overall Study|Other|60|||
156954049|NCT00305058|566585052|FG000|Overall Study|Participant too young|1|||
156954050|NCT00305058|566585053|FG001|Overall Study|Participant too young|0|||
156954051|NCT00305058|566585052|FG000|Overall Study|Missing data collection instrument|3|||
156954052|NCT00305058|566585053|FG001|Overall Study|Missing data collection instrument|2|||
156954053|NCT00305058|566585052|FG000|Overall Study|Missing outcome data|3|||
156954054|NCT00305058|566585053|FG001|Overall Study|Missing outcome data|2|||
156954055|NCT04433767|566585055|FG000|Overall Study|Adverse Event|1|||
156954056|NCT03538626|566585062|FG000|Overall Study|Withdrawal by Subject|0|||
156954057|NCT03538626|566585063|FG001|Overall Study|Withdrawal by Subject|1|||
156954058|NCT03538626|566585064|FG002|Overall Study|Withdrawal by Subject|0|||
156954059|NCT03538626|566585065|FG003|Overall Study|Withdrawal by Subject|0|||
156954060|NCT03538626|566585066|FG004|Overall Study|Withdrawal by Subject|0|||
156954061|NCT03538626|566585067|FG005|Overall Study|Withdrawal by Subject|0|||
156954062|NCT03538626|566585068|FG006|Overall Study|Withdrawal by Subject|0|||
156954063|NCT03538626|566585069|FG007|Overall Study|Withdrawal by Subject|0|||
156954064|NCT03538626|566585062|FG000|Overall Study|Lost to Follow-up|0|||
156954065|NCT03538626|566585063|FG001|Overall Study|Lost to Follow-up|0|||
156954066|NCT03538626|566585064|FG002|Overall Study|Lost to Follow-up|0|||
156954067|NCT03538626|566585065|FG003|Overall Study|Lost to Follow-up|0|||
156954068|NCT03538626|566585066|FG004|Overall Study|Lost to Follow-up|0|||
156954069|NCT03538626|566585067|FG005|Overall Study|Lost to Follow-up|0|||
156954070|NCT03538626|566585068|FG006|Overall Study|Lost to Follow-up|1|||
156954071|NCT03538626|566585069|FG007|Overall Study|Lost to Follow-up|0|||
156954072|NCT01434602|566585074|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156954073|NCT01434602|566585075|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
156954074|NCT01434602|566585076|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156954075|NCT01434602|566585077|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156954076|NCT01434602|566585078|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
156954077|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156954078|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156954079|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
156954080|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
156954081|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
157035664|NCT02719574|566887805|FG006|Phase 2|Death|0|||
157035665|NCT02719574|566887806|FG007|Phase 2|Death|0|||
157035666|NCT02719574|566887807|FG008|Phase 2|Death|0|||
156954082|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156954083|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156954084|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156954085|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
156954086|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
156954087|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156954088|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156954089|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156954090|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
156954091|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
156954092|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156954093|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156954094|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156954095|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
156954096|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
156954097|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156954098|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156954099|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156954100|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
156954101|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
156954102|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156954103|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156954104|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156954105|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
156954106|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
156954107|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156954108|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156954109|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
156954110|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
156954111|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
156954112|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156954113|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156954114|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156954115|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
156954116|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
156954117|NCT01434602|566585074|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156954118|NCT01434602|566585075|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156954119|NCT01434602|566585076|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156954120|NCT01434602|566585077|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
156954121|NCT01434602|566585078|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
156954122|NCT02232893|566585080|FG000|Overall Study|Withdrawal by Subject|4|||
156954123|NCT02232893|566585081|FG001|Overall Study|Withdrawal by Subject|1|||
156954124|NCT02232893|566585080|FG000|Overall Study|Adverse Event|0|||
156954125|NCT02232893|566585081|FG001|Overall Study|Adverse Event|1|||
156954126|NCT02232893|566585080|FG000|Overall Study|Sponsor request early termination|0|||
156954127|NCT02232893|566585081|FG001|Overall Study|Sponsor request early termination|1|||
156954128|NCT02232893|566585080|FG000|Overall Study|Developed exclusion criteria|0|||
156954129|NCT02232893|566585081|FG001|Overall Study|Developed exclusion criteria|1|||
156954130|NCT02232893|566585080|FG000|Overall Study|Other|0|||
156954131|NCT02232893|566585081|FG001|Overall Study|Other|3|||
156954132|NCT05077267|566585083|FG000|Treatment Period|Lost to Follow-up|0|||
156954133|NCT05077267|566585084|FG001|Treatment Period|Lost to Follow-up|1|||
156954134|NCT05077267|566585085|FG002|Treatment Period|Lost to Follow-up|0|||
157168885|NCT03625141|567359842|FG000|Overall Study|Withdrawal Of Consent|0|||
156954135|NCT05077267|566585083|FG000|Treatment Period|Withdrawal by Subject|0|||
156954136|NCT05077267|566585084|FG001|Treatment Period|Withdrawal by Subject|1|||
156954137|NCT05077267|566585085|FG002|Treatment Period|Withdrawal by Subject|0|||
156954138|NCT05077267|566585083|FG000|Follow-up Period|Lost to Follow-up|0|||
156954139|NCT05077267|566585084|FG001|Follow-up Period|Lost to Follow-up|5|||
156954140|NCT05077267|566585085|FG002|Follow-up Period|Lost to Follow-up|7|||
156954141|NCT05077267|566585083|FG000|Follow-up Period|Withdrawal by Subject|0|||
156954142|NCT05077267|566585084|FG001|Follow-up Period|Withdrawal by Subject|2|||
156954143|NCT05077267|566585085|FG002|Follow-up Period|Withdrawal by Subject|5|||
156954144|NCT05077267|566585083|FG000|Follow-up Period|Study terminated by sponsor|0|||
156954145|NCT05077267|566585084|FG001|Follow-up Period|Study terminated by sponsor|27|||
156954146|NCT05077267|566585085|FG002|Follow-up Period|Study terminated by sponsor|23|||
156954147|NCT05077267|566585083|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
156954148|NCT05077267|566585084|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
156954149|NCT05077267|566585085|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
156954150|NCT05077267|566585083|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
156954151|NCT05077267|566585084|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
156954152|NCT05077267|566585085|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
156954153|NCT01136291|566585090|FG000|Overall Study|Lost to Follow-up|1|||
156954154|NCT01136291|566585091|FG001|Overall Study|Lost to Follow-up|1|||
156954155|NCT03965052|566585092|FG000|Overall Study|Protocol Violation|1|||
156954156|NCT03965052|566585093|FG001|Overall Study|Protocol Violation|0|||
156954157|NCT03864900|566585107|FG000|Overall Study|Withdrawal by Subject|1|||
156954158|NCT03864900|566585108|FG001|Overall Study|Withdrawal by Subject|1|||
156954159|NCT03864900|566585107|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
156954160|NCT03864900|566585108|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
156954161|NCT02308033|566585109|FG000|Overall Study|Normal Gram stain at Baseline|13|||
156954162|NCT02308033|566585110|FG001|Overall Study|Normal Gram stain at Baseline|10|||
156954163|NCT02308033|566585109|FG000|Overall Study|Positive for STD at Baseline|7|||
156954164|NCT02308033|566585110|FG001|Overall Study|Positive for STD at Baseline|4|||
156954165|NCT02308033|566585109|FG000|Overall Study|Lost to Follow-up|6|||
156954166|NCT02308033|566585110|FG001|Overall Study|Lost to Follow-up|5|||
156954167|NCT03165045|566585111|FG000|Visit 1|No registration after visit 1|9|||
157168886|NCT03625141|567359843|FG001|Overall Study|Withdrawal Of Consent|1|||
157168887|NCT03625141|567359842|FG000|Overall Study|Death|11|||
157168888|NCT03625141|567359843|FG001|Overall Study|Death|47|||
157168889|NCT03625141|567359842|FG000|Overall Study|Progressive Disease|0|||
157168890|NCT03625141|567359843|FG001|Overall Study|Progressive Disease|2|||
157168891|NCT01114373|567359844|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
157168892|NCT01114373|567359845|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
157168893|NCT01114373|567359844|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
157168894|NCT01114373|567359845|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
157168895|NCT01114373|567359844|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
157168896|NCT01114373|567359845|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
157168897|NCT01114373|567359844|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
157168898|NCT01114373|567359845|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
157168899|NCT03819218|567359846|FG000|Overall Study|Protocol Violation|1|||
157168900|NCT02501902|567359847|FG000|Overall Study|Subject Refused Further Follow-up|0|||
157168901|NCT02501902|567359848|FG001|Overall Study|Subject Refused Further Follow-up|0|||
157168902|NCT02501902|567359849|FG002|Overall Study|Subject Refused Further Follow-up|0|||
157168903|NCT02501902|567359850|FG003|Overall Study|Subject Refused Further Follow-up|0|||
157168904|NCT02501902|567359851|FG004|Overall Study|Subject Refused Further Follow-up|0|||
157227531|NCT01929109|567579100|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
157227532|NCT01929109|567579101|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
156954168|NCT03165045|566585111|FG000|Visit 1|No treatment documented|10|||
156954169|NCT03165045|566585111|FG000|Visit 1|No visit 1|10|||
156954170|NCT03165045|566585111|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
156954171|NCT03165045|566585111|FG000|Visit 2|No available total CCQ score at all|29|||
156954172|NCT03165045|566585111|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
156954173|NCT00759109|566585112|FG000|Overall Study|Adverse Event|17|||
156954174|NCT00759109|566585113|FG001|Overall Study|Adverse Event|12|||
156954175|NCT00759109|566585112|FG000|Overall Study|Inability to comply|1|||
156954176|NCT00759109|566585113|FG001|Overall Study|Inability to comply|1|||
157168905|NCT02501902|567359852|FG005|Overall Study|Subject Refused Further Follow-up|0|||
157227533|NCT01929109|567579102|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
157227534|NCT01929109|567579103|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
157227535|NCT01929109|567579104|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
157227536|NCT00076102|567579105|FG000|Overall Study|Clinical progression|1|||
156954177|NCT00759109|566585112|FG000|Overall Study|Withdrawal by Subject|9|||
156954178|NCT00759109|566585113|FG001|Overall Study|Withdrawal by Subject|5|||
156954179|NCT00759109|566585112|FG000|Overall Study|Death|4|||
156954180|NCT00759109|566585113|FG001|Overall Study|Death|3|||
156954181|NCT00759109|566585112|FG000|Overall Study|Lost to Follow-up|4|||
156954182|NCT00759109|566585113|FG001|Overall Study|Lost to Follow-up|6|||
157168906|NCT02501902|567359853|FG006|Overall Study|Subject Refused Further Follow-up|0|||
157168907|NCT02501902|567359854|FG007|Overall Study|Subject Refused Further Follow-up|1|||
157168908|NCT02501902|567359847|FG000|Overall Study|Study Terminated by Sponsor|0|||
157168909|NCT02501902|567359848|FG001|Overall Study|Study Terminated by Sponsor|3|||
157168910|NCT02501902|567359849|FG002|Overall Study|Study Terminated by Sponsor|0|||
157168911|NCT02501902|567359850|FG003|Overall Study|Study Terminated by Sponsor|1|||
157168912|NCT02501902|567359851|FG004|Overall Study|Study Terminated by Sponsor|1|||
157168913|NCT02501902|567359852|FG005|Overall Study|Study Terminated by Sponsor|0|||
157227537|NCT00076102|567579105|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
157227538|NCT00076102|567579105|FG000|Overall Study|plexiform neurofibroma surgery|1|||
157227539|NCT00076102|567579105|FG000|Overall Study|refusal of further therapy|2|||
157227540|NCT02180711|567579107|FG000|Overall Study|Death|0|||
157227541|NCT02180711|567579108|FG001|Overall Study|Death|1|||
157227542|NCT02180711|567579109|FG002|Overall Study|Death|0|||
157227543|NCT02180711|567579110|FG003|Overall Study|Death|0|||
157227544|NCT02180711|567579111|FG004|Overall Study|Death|7|||
157227545|NCT02180711|567579112|FG005|Overall Study|Death|0|||
157227546|NCT02180711|567579113|FG006|Overall Study|Death|1|||
157227547|NCT02180711|567579114|FG007|Overall Study|Death|3|||
157227548|NCT02180711|567579107|FG000|Overall Study|Lost to Follow-up|0|||
157227549|NCT02180711|567579108|FG001|Overall Study|Lost to Follow-up|1|||
157227550|NCT02180711|567579109|FG002|Overall Study|Lost to Follow-up|0|||
157227551|NCT02180711|567579110|FG003|Overall Study|Lost to Follow-up|0|||
157227552|NCT02180711|567579111|FG004|Overall Study|Lost to Follow-up|1|||
157227553|NCT02180711|567579112|FG005|Overall Study|Lost to Follow-up|1|||
157227554|NCT02180711|567579113|FG006|Overall Study|Lost to Follow-up|0|||
157227555|NCT02180711|567579114|FG007|Overall Study|Lost to Follow-up|3|||
157227556|NCT02180711|567579107|FG000|Overall Study|Withdrawal by Subject|2|||
157227557|NCT02180711|567579108|FG001|Overall Study|Withdrawal by Subject|1|||
157227558|NCT02180711|567579109|FG002|Overall Study|Withdrawal by Subject|0|||
157227559|NCT02180711|567579110|FG003|Overall Study|Withdrawal by Subject|4|||
157227560|NCT02180711|567579111|FG004|Overall Study|Withdrawal by Subject|3|||
157227561|NCT02180711|567579112|FG005|Overall Study|Withdrawal by Subject|0|||
157227562|NCT02180711|567579113|FG006|Overall Study|Withdrawal by Subject|3|||
157227563|NCT02180711|567579114|FG007|Overall Study|Withdrawal by Subject|2|||
157227564|NCT02180711|567579107|FG000|Overall Study|- Disease Progression|0|||
157227565|NCT02180711|567579108|FG001|Overall Study|- Disease Progression|1|||
157227566|NCT02180711|567579109|FG002|Overall Study|- Disease Progression|0|||
157227567|NCT02180711|567579110|FG003|Overall Study|- Disease Progression|0|||
157227568|NCT02180711|567579111|FG004|Overall Study|- Disease Progression|0|||
156954183|NCT00759109|566585112|FG000|Overall Study|Started new therapy|2|||
156954184|NCT00759109|566585113|FG001|Overall Study|Started new therapy|6|||
156954185|NCT00759109|566585112|FG000|Overall Study|HCV RNA negative|1|||
156954186|NCT00759109|566585113|FG001|Overall Study|HCV RNA negative|0|||
156954187|NCT00759109|566585112|FG000|Overall Study|Participant moved to a different city|0|||
156954188|NCT00759109|566585113|FG001|Overall Study|Participant moved to a different city|1|||
156954189|NCT00759109|566585112|FG000|Overall Study|Participant had a liver transplant|0|||
156954190|NCT00759109|566585113|FG001|Overall Study|Participant had a liver transplant|1|||
156954191|NCT00759109|566585112|FG000|Overall Study|Lost during study|1|||
156954192|NCT00759109|566585113|FG001|Overall Study|Lost during study|0|||
156954193|NCT01827904|566585114|FG000|Main Study|Withdrawal by Subject|1|||
156954194|NCT01827904|566585115|FG001|Main Study|Withdrawal by Subject|0|||
156954195|NCT01827904|566585116|FG002|Main Study|Withdrawal by Subject|0|||
156954196|NCT01827904|566585114|FG000|Main Study|Adverse Event|1|||
156954197|NCT01827904|566585115|FG001|Main Study|Adverse Event|0|||
156954198|NCT01827904|566585116|FG002|Main Study|Adverse Event|0|||
156954199|NCT01827904|566585114|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
156954200|NCT01827904|566585115|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
156954201|NCT01827904|566585116|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
156954202|NCT01827904|566585114|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
156954203|NCT01827904|566585115|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
156954204|NCT01827904|566585116|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
156954205|NCT01827904|566585114|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
156954206|NCT01827904|566585115|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
156954207|NCT01827904|566585116|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
156954208|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
157035667|NCT02719574|566887808|FG009|Phase 2|Death|14|||
157035668|NCT02719574|566887809|FG010|Phase 2|Death|0|||
157035669|NCT02719574|566887810|FG011|Phase 2|Death|0|||
157035670|NCT02719574|566887811|FG012|Phase 2|Death|1|||
157035671|NCT02719574|566887812|FG013|Phase 2|Death|1|||
157035672|NCT02719574|566887813|FG014|Phase 2|Death|2|||
157035673|NCT02719574|566887814|FG015|Phase 2|Death|0|||
157035674|NCT02719574|566887815|FG016|Phase 2|Death|0|||
157035675|NCT02719574|566887799|FG000|Phase 2|Investigator Decision|0|||
157227569|NCT02180711|567579112|FG005|Overall Study|- Disease Progression|0|||
156954209|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
156954210|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
157035676|NCT02719574|566887800|FG001|Phase 2|Investigator Decision|0|||
157227570|NCT02180711|567579113|FG006|Overall Study|- Disease Progression|0|||
157227571|NCT02180711|567579114|FG007|Overall Study|- Disease Progression|0|||
157227572|NCT02180711|567579107|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
157227573|NCT02180711|567579108|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
157227574|NCT02180711|567579109|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
156954211|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
156954212|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
156954213|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
156954214|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
156954215|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
156954216|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
156954217|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
156954218|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
156954219|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
156954220|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Physician Decision|1|||
156954221|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Physician Decision|0|||
156954222|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Physician Decision|0|||
156954223|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
156954224|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
156954225|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
156954226|NCT01827904|566585114|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
156954227|NCT01827904|566585115|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
156954228|NCT01827904|566585116|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
156954229|NCT04323436|566585127|FG000|Overall Study|Adverse Event|7|||
156954230|NCT04323436|566585128|FG001|Overall Study|Adverse Event|0|||
156954231|NCT04323436|566585129|FG002|Overall Study|Adverse Event|0|||
156954232|NCT04323436|566585127|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
156954233|NCT04323436|566585128|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
156954234|NCT04323436|566585129|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
156954235|NCT04323436|566585127|FG000|Overall Study|Death|1|||
156954236|NCT04323436|566585128|FG001|Overall Study|Death|0|||
156954237|NCT04323436|566585129|FG002|Overall Study|Death|0|||
156954238|NCT04323436|566585127|FG000|Overall Study|Physician Decision|2|||
156954239|NCT04323436|566585128|FG001|Overall Study|Physician Decision|0|||
156954240|NCT04323436|566585129|FG002|Overall Study|Physician Decision|0|||
156954241|NCT04323436|566585127|FG000|Overall Study|Progressive disease|10|||
156954242|NCT04323436|566585128|FG001|Overall Study|Progressive disease|0|||
156954243|NCT04323436|566585129|FG002|Overall Study|Progressive disease|0|||
156954244|NCT04323436|566585127|FG000|Overall Study|Subject decision|3|||
156954245|NCT04323436|566585128|FG001|Overall Study|Subject decision|0|||
156954246|NCT04323436|566585129|FG002|Overall Study|Subject decision|0|||
156954247|NCT00142909|566585130|FG000|Randomization|Various Reasons|7|||
156954248|NCT00142909|566585131|FG001|Randomization|Various Reasons|10|||
156954249|NCT00142909|566585130|FG000|Medications Begin|Protocol Violation|2|||
156954250|NCT00142909|566585131|FG001|Medications Begin|Protocol Violation|0|||
156954251|NCT00142909|566585130|FG000|Medications Begin|Withdrawal by Subject|5|||
156954252|NCT00142909|566585131|FG001|Medications Begin|Withdrawal by Subject|3|||
156954253|NCT00142909|566585130|FG000|Medications Begin|Withdrawal by Subject|2|||
156954254|NCT00142909|566585131|FG001|Medications Begin|Withdrawal by Subject|0|||
156954255|NCT03325712|566585132|FG000|Overall Study|Protocol Violation|0|||
156954256|NCT03325712|566585133|FG001|Overall Study|Protocol Violation|0|||
156954257|NCT03325712|566585134|FG002|Overall Study|Protocol Violation|0|||
156954258|NCT03325712|566585135|FG003|Overall Study|Protocol Violation|0|||
156954259|NCT03325712|566585136|FG004|Overall Study|Protocol Violation|1|||
156954260|NCT03325712|566585137|FG005|Overall Study|Protocol Violation|0|||
156954261|NCT03325712|566585138|FG006|Overall Study|Protocol Violation|0|||
156954262|NCT03325712|566585139|FG007|Overall Study|Protocol Violation|0|||
156954263|NCT03325712|566585132|FG000|Overall Study|Adverse Event|0|||
156954264|NCT03325712|566585133|FG001|Overall Study|Adverse Event|0|||
156954265|NCT03325712|566585134|FG002|Overall Study|Adverse Event|0|||
156954266|NCT03325712|566585135|FG003|Overall Study|Adverse Event|0|||
156954267|NCT03325712|566585136|FG004|Overall Study|Adverse Event|1|||
156954268|NCT03325712|566585137|FG005|Overall Study|Adverse Event|0|||
156954269|NCT03325712|566585138|FG006|Overall Study|Adverse Event|0|||
156954270|NCT03325712|566585139|FG007|Overall Study|Adverse Event|0|||
156954271|NCT04782323|566585141|FG000|Overall Study|Death|1|||
156954272|NCT04782323|566585142|FG001|Overall Study|Death|0|||
156954273|NCT04782323|566585143|FG002|Overall Study|Death|0|||
156954274|NCT04782323|566585144|FG003|Overall Study|Death|0|||
157035677|NCT02719574|566887801|FG002|Phase 2|Investigator Decision|0|||
157035678|NCT02719574|566887802|FG003|Phase 2|Investigator Decision|0|||
156954275|NCT04782323|566585145|FG004|Overall Study|Death|1|||
156954276|NCT04782323|566585146|FG005|Overall Study|Death|1|||
156954277|NCT04782323|566585147|FG006|Overall Study|Death|1|||
156954278|NCT04782323|566585148|FG007|Overall Study|Death|0|||
156954279|NCT04782323|566585141|FG000|Overall Study|Withdrawal by Subject|0|||
156954280|NCT04782323|566585142|FG001|Overall Study|Withdrawal by Subject|0|||
156954281|NCT04782323|566585143|FG002|Overall Study|Withdrawal by Subject|1|||
156954282|NCT04782323|566585144|FG003|Overall Study|Withdrawal by Subject|0|||
156954283|NCT04782323|566585145|FG004|Overall Study|Withdrawal by Subject|0|||
157035679|NCT02719574|566887803|FG004|Phase 2|Investigator Decision|0|||
157168914|NCT02501902|567359853|FG006|Overall Study|Study Terminated by Sponsor|2|||
157168915|NCT02501902|567359854|FG007|Overall Study|Study Terminated by Sponsor|4|||
157168916|NCT02501902|567359847|FG000|Overall Study|Death|3|||
157168917|NCT02501902|567359848|FG001|Overall Study|Death|4|||
157168918|NCT02501902|567359849|FG002|Overall Study|Death|4|||
156954284|NCT04782323|566585146|FG005|Overall Study|Withdrawal by Subject|1|||
156954285|NCT04782323|566585147|FG006|Overall Study|Withdrawal by Subject|0|||
156954286|NCT04782323|566585148|FG007|Overall Study|Withdrawal by Subject|1|||
156954287|NCT04782323|566585141|FG000|Overall Study|Lost to Follow-up|0|||
156954288|NCT04782323|566585142|FG001|Overall Study|Lost to Follow-up|1|||
156954289|NCT04782323|566585143|FG002|Overall Study|Lost to Follow-up|1|||
156954290|NCT04782323|566585144|FG003|Overall Study|Lost to Follow-up|0|||
156954291|NCT04782323|566585145|FG004|Overall Study|Lost to Follow-up|0|||
156954292|NCT04782323|566585146|FG005|Overall Study|Lost to Follow-up|1|||
156954293|NCT04782323|566585147|FG006|Overall Study|Lost to Follow-up|1|||
156954294|NCT04782323|566585148|FG007|Overall Study|Lost to Follow-up|2|||
156954295|NCT04782323|566585141|FG000|Overall Study|randomization in error|1|||
156954296|NCT04782323|566585142|FG001|Overall Study|randomization in error|0|||
156954297|NCT04782323|566585143|FG002|Overall Study|randomization in error|0|||
156954298|NCT04782323|566585144|FG003|Overall Study|randomization in error|0|||
156954299|NCT04782323|566585145|FG004|Overall Study|randomization in error|0|||
156954300|NCT04782323|566585146|FG005|Overall Study|randomization in error|0|||
156954301|NCT04782323|566585147|FG006|Overall Study|randomization in error|0|||
156954302|NCT04782323|566585148|FG007|Overall Study|randomization in error|0|||
156954303|NCT03351049|566585149|FG000|Overall Study|Withdrawal|26|||
156954304|NCT03351049|566585150|FG001|Overall Study|Withdrawal|22|||
156954305|NCT04369469|566585153|FG000|Overall Study|Lost to Follow-up|2|||
156954306|NCT04369469|566585154|FG001|Overall Study|Lost to Follow-up|4|||
156954307|NCT04369469|566585153|FG000|Overall Study|Physician Decision|2|||
156954308|NCT04369469|566585154|FG001|Overall Study|Physician Decision|1|||
156954309|NCT04369469|566585153|FG000|Overall Study|Withdrawal by Subject|2|||
156954310|NCT04369469|566585154|FG001|Overall Study|Withdrawal by Subject|3|||
156954311|NCT04369469|566585153|FG000|Overall Study|Adverse Event|1|||
156954312|NCT04369469|566585154|FG001|Overall Study|Adverse Event|0|||
156954313|NCT04369469|566585153|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
156954314|NCT04369469|566585154|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
156954315|NCT04369469|566585153|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
156954316|NCT04369469|566585154|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
156954317|NCT04369469|566585153|FG000|Overall Study|Unable to Provide Consent|0|||
156954318|NCT04369469|566585154|FG001|Overall Study|Unable to Provide Consent|1|||
156954319|NCT03135522|566585155|FG000|Overall Study|Adverse Event|1|||
156954320|NCT03135522|566585156|FG001|Overall Study|Adverse Event|0|||
156954321|NCT03832192|566585159|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
156954322|NCT03832192|566585160|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
156954323|NCT03483623|566585164|FG000|Overall Study|43 complete sets achieved|1|||
156954324|NCT01261611|566587089|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
156954325|NCT01261611|566587090|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
156954326|NCT01261611|566587091|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
156954327|NCT01261611|566587089|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
156954328|NCT01261611|566587090|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
156954329|NCT01261611|566587091|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
156954330|NCT01261611|566587089|FG000|Treatment Cycle 1|Adverse Event|0|||
156954331|NCT01261611|566587090|FG001|Treatment Cycle 1|Adverse Event|1|||
156954332|NCT01261611|566587091|FG002|Treatment Cycle 1|Adverse Event|0|||
156954333|NCT01261611|566587089|FG000|Treatment Cycle 1|Protocol Violation|0|||
156954334|NCT01261611|566587090|FG001|Treatment Cycle 1|Protocol Violation|0|||
156954335|NCT01261611|566587091|FG002|Treatment Cycle 1|Protocol Violation|2|||
156954336|NCT01261611|566587089|FG000|Treatment Cycle 2|Completed study|4|||
156954337|NCT01261611|566587090|FG001|Treatment Cycle 2|Completed study|0|||
156954338|NCT01261611|566587091|FG002|Treatment Cycle 2|Completed study|0|||
156954339|NCT01261611|566587089|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
156954340|NCT01261611|566587090|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
156954341|NCT01261611|566587091|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
156954342|NCT01261611|566587089|FG000|Treatment Cycle 2|Adverse Event|1|||
156954343|NCT01261611|566587090|FG001|Treatment Cycle 2|Adverse Event|0|||
157168919|NCT02501902|567359850|FG003|Overall Study|Death|10|||
156954344|NCT01261611|566587091|FG002|Treatment Cycle 2|Adverse Event|0|||
156954345|NCT01261611|566587089|FG000|Treatment Cycle 2|Protocol Violation|2|||
156954346|NCT01261611|566587090|FG001|Treatment Cycle 2|Protocol Violation|0|||
156954347|NCT01261611|566587091|FG002|Treatment Cycle 2|Protocol Violation|0|||
156954348|NCT01261611|566587089|FG000|Treatment Cycle 2|Not otherwise specified|2|||
156954349|NCT01261611|566587090|FG001|Treatment Cycle 2|Not otherwise specified|0|||
156954350|NCT01261611|566587091|FG002|Treatment Cycle 2|Not otherwise specified|0|||
156954351|NCT01261611|566587089|FG000|Treatment Cycle 3|Completed study|24|||
156954352|NCT01261611|566587090|FG001|Treatment Cycle 3|Completed study|0|||
156954353|NCT01261611|566587091|FG002|Treatment Cycle 3|Completed study|0|||
157168920|NCT02501902|567359851|FG004|Overall Study|Death|10|||
156954354|NCT01261611|566587089|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
156954355|NCT01261611|566587090|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
156954356|NCT01261611|566587091|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
156954357|NCT01261611|566587089|FG000|Treatment Cycle 3|Adverse Event|1|||
156954358|NCT01261611|566587090|FG001|Treatment Cycle 3|Adverse Event|0|||
156954359|NCT01261611|566587091|FG002|Treatment Cycle 3|Adverse Event|0|||
156954360|NCT01261611|566587089|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
156954361|NCT01261611|566587090|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
156954362|NCT01261611|566587091|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
156954363|NCT01261611|566587089|FG000|Treatment Cycle 4|Completed study|87|||
156954364|NCT01261611|566587090|FG001|Treatment Cycle 4|Completed study|0|||
156954365|NCT01261611|566587091|FG002|Treatment Cycle 4|Completed study|0|||
156954366|NCT01261611|566587089|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
156954367|NCT01261611|566587090|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
156954368|NCT01261611|566587091|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
156954369|NCT01261611|566587089|FG000|Treatment Cycle 4|Adverse Event|1|||
156954370|NCT01261611|566587090|FG001|Treatment Cycle 4|Adverse Event|0|||
156954371|NCT01261611|566587091|FG002|Treatment Cycle 4|Adverse Event|0|||
156954372|NCT01261611|566587089|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
156954373|NCT01261611|566587090|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
156954374|NCT01261611|566587091|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
156954375|NCT01261611|566587089|FG000|Treatment Cycle 4|Not otherwise specified|3|||
156954376|NCT01261611|566587090|FG001|Treatment Cycle 4|Not otherwise specified|0|||
156954377|NCT01261611|566587091|FG002|Treatment Cycle 4|Not otherwise specified|0|||
156954378|NCT01261611|566587089|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
156954379|NCT01261611|566587090|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
156954380|NCT01261611|566587091|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
156954381|NCT01261611|566587089|FG000|Treatment Cycle 5|Adverse Event|1|||
156954382|NCT01261611|566587090|FG001|Treatment Cycle 5|Adverse Event|0|||
156954383|NCT01261611|566587091|FG002|Treatment Cycle 5|Adverse Event|0|||
156954384|NCT01261611|566587089|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
156954385|NCT01261611|566587090|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
156954386|NCT01261611|566587091|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
156954387|NCT01625897|566587094|FG000|Overall Study|Adverse Event|27|||
156954388|NCT01625897|566587095|FG001|Overall Study|Adverse Event|10|||
156954389|NCT01625897|566587094|FG000|Overall Study|Physician Decision|0|||
156954390|NCT01625897|566587095|FG001|Overall Study|Physician Decision|1|||
156954391|NCT01625897|566587094|FG000|Overall Study|Withdrawal by Subject|25|||
156954392|NCT01625897|566587095|FG001|Overall Study|Withdrawal by Subject|3|||
156954393|NCT00156065|566587097|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
156954394|NCT00156065|566587098|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
156954395|NCT00156065|566587099|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
156954396|NCT00156065|566587097|FG000|Overall Study|Adverse Event|8|||
156954397|NCT00156065|566587098|FG001|Overall Study|Adverse Event|11|||
156954398|NCT00156065|566587099|FG002|Overall Study|Adverse Event|4|||
156954399|NCT00156065|566587097|FG000|Overall Study|Lack of Efficacy|2|||
156954400|NCT00156065|566587098|FG001|Overall Study|Lack of Efficacy|9|||
156954401|NCT00156065|566587099|FG002|Overall Study|Lack of Efficacy|3|||
156954402|NCT00156065|566587097|FG000|Overall Study|Withdrawal by Subject|13|||
156954403|NCT00156065|566587098|FG001|Overall Study|Withdrawal by Subject|26|||
156954404|NCT00156065|566587099|FG002|Overall Study|Withdrawal by Subject|16|||
156954405|NCT00156065|566587097|FG000|Overall Study|Lost to Follow-up|5|||
156954406|NCT00156065|566587098|FG001|Overall Study|Lost to Follow-up|7|||
156954407|NCT00156065|566587099|FG002|Overall Study|Lost to Follow-up|1|||
156954408|NCT00156065|566587097|FG000|Overall Study|Other|2|||
156954409|NCT00156065|566587098|FG001|Overall Study|Other|9|||
156954410|NCT00156065|566587099|FG002|Overall Study|Other|3|||
156954411|NCT01432366|566587100|FG000|Overall Study|Non-Responder|7|||
156954412|NCT01432366|566587100|FG000|Overall Study|Adverse Event|8|||
156954413|NCT01432366|566587100|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
156954414|NCT01432366|566587100|FG000|Overall Study|Pregnancy|1|||
156954415|NCT01432366|566587100|FG000|Overall Study|Lost to Follow-up|13|||
156954416|NCT01432366|566587100|FG000|Overall Study|Lack of Efficacy|1|||
156954417|NCT01432366|566587100|FG000|Overall Study|Site Closed|20|||
157168921|NCT02501902|567359852|FG005|Overall Study|Death|11|||
157168922|NCT02501902|567359853|FG006|Overall Study|Death|7|||
156954418|NCT01432366|566587100|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
156954419|NCT01432366|566587100|FG000|Overall Study|Other|14|||
156954420|NCT01808690|566587101|FG000|Overall Study|Withdrawal by Subject|1|||
156954421|NCT01808690|566587102|FG001|Overall Study|Withdrawal by Subject|2|||
156954422|NCT02891187|566587103|FG000|Overall Study|Lost to Follow-up|1|||
156954423|NCT02891187|566587104|FG001|Overall Study|Lost to Follow-up|2|||
156954424|NCT02395120|566587105|FG000|Overall Study|Missed follow-up dental exam|57|||
156954425|NCT02395120|566587106|FG001|Overall Study|Missed follow-up dental exam|62|||
157168923|NCT02501902|567359854|FG007|Overall Study|Death|15|||
156954426|NCT02395120|566587107|FG002|Overall Study|Missed follow-up dental exam|6|||
156954427|NCT02395120|566587108|FG003|Overall Study|Missed follow-up dental exam|6|||
156954428|NCT02395120|566587109|FG004|Overall Study|Missed follow-up dental exam|51|||
156954429|NCT04546581|566587111|FG000|Overall Study|Adverse Event|9|||
156954430|NCT04546581|566587112|FG001|Overall Study|Adverse Event|3|||
156954431|NCT04546581|566587111|FG000|Overall Study|Physician Decision|0|||
156954432|NCT04546581|566587112|FG001|Overall Study|Physician Decision|1|||
156954433|NCT04546581|566587111|FG000|Overall Study|Protocol Violation|1|||
156954434|NCT04546581|566587112|FG001|Overall Study|Protocol Violation|2|||
156954435|NCT04546581|566587111|FG000|Overall Study|Withdrawal by Subject|3|||
156954436|NCT04546581|566587112|FG001|Overall Study|Withdrawal by Subject|7|||
156954437|NCT02526693|566587113|FG000|Overall Study|Physician Decision|3|||
156954438|NCT02526693|566587114|FG001|Overall Study|Physician Decision|1|||
156954439|NCT01585103|566587116|FG000|Overall Study|Unable to swallow Cytosponge|6|||
156954440|NCT01349569|566587117|FG000|Overall Study|Lack of Efficacy|4|||
156954441|NCT03581305|566587118|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
156954442|NCT03581305|566587119|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
156954443|NCT03581305|566587118|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
156954444|NCT03581305|566587119|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
156954445|NCT03581305|566587118|FG000|Serotonergic Study|Withdrawal by Subject|5|||
156954446|NCT03581305|566587119|FG001|Serotonergic Study|Withdrawal by Subject|1|||
156954447|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
156954448|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
156954449|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
156954450|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
156954451|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
156954452|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
156954453|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
156954454|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
156954455|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
156954456|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
156954457|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
156954458|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
156954459|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
156954460|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
156954461|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
156954462|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
156954463|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
156954464|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
156954465|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
156954466|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
156954467|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
156954468|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
156954469|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
156954470|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
156954471|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954472|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954473|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954474|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954475|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954476|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954477|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954478|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954479|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954480|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954481|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954482|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954483|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954484|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954485|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954486|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
156954487|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954488|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954489|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
156954490|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
156954491|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
156954492|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954493|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954494|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954495|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954496|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954497|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954498|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954499|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
157168924|NCT02267278|567359855|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
157168925|NCT02267278|567359855|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
157168926|NCT02267278|567359855|FG000|Overall Study|Developed new cancer diagnoses|2|||
157168927|NCT02267278|567359855|FG000|Overall Study|prescribed prohibited medication|1|||
157168928|NCT02513771|567359856|FG000|Overall Study|Lost to Follow-up|1|||
157168929|NCT02513771|567359857|FG001|Overall Study|Lost to Follow-up|1|||
157168930|NCT02513771|567359856|FG000|Overall Study|Not being able to get to clinic|1|||
157168931|NCT02513771|567359857|FG001|Overall Study|Not being able to get to clinic|0|||
157168932|NCT00650091|567359861|FG000|Amended Study Design|Withdrawal by Subject|12|||
157168933|NCT00650091|567359862|FG001|Amended Study Design|Withdrawal by Subject|11|||
157168934|NCT00650091|567359863|FG002|Amended Study Design|Withdrawal by Subject|0|||
157168935|NCT00650091|567359861|FG000|Amended Study Design|Physician Decision|5|||
157168936|NCT00650091|567359862|FG001|Amended Study Design|Physician Decision|0|||
157168937|NCT00650091|567359863|FG002|Amended Study Design|Physician Decision|0|||
157168938|NCT00650091|567359861|FG000|Amended Study Design|Adverse Event|1|||
157168939|NCT00650091|567359862|FG001|Amended Study Design|Adverse Event|4|||
157168940|NCT00650091|567359863|FG002|Amended Study Design|Adverse Event|0|||
157168941|NCT00650091|567359861|FG000|Amended Study Design|Lung transplantation|4|||
157168942|NCT00650091|567359862|FG001|Amended Study Design|Lung transplantation|2|||
157168943|NCT00650091|567359863|FG002|Amended Study Design|Lung transplantation|0|||
157168944|NCT00650091|567359861|FG000|Amended Study Design|Other|1|||
157168945|NCT00650091|567359862|FG001|Amended Study Design|Other|3|||
157168946|NCT00650091|567359863|FG002|Amended Study Design|Other|0|||
157168947|NCT04295356|567359870|FG000|Overall Study|Physician Decision|1|||
156954500|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954501|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954502|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954503|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954504|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954505|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954506|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
156954507|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
156954508|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
156954509|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
156954510|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
156954511|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
156954512|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
156954513|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
156954514|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
156954515|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
156954516|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
156954517|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
156954518|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
156954519|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
156954520|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
156954521|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
156954522|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
156954523|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
156954524|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
156954525|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
156954526|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
156954527|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
156954528|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954529|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954530|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954531|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954532|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954533|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954534|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954535|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
157168948|NCT04295356|567359871|FG001|Overall Study|Physician Decision|0|||
157168949|NCT04295356|567359870|FG000|Overall Study|Lost to Follow-up|0|||
157168950|NCT04295356|567359871|FG001|Overall Study|Lost to Follow-up|3|||
157168951|NCT04295356|567359870|FG000|Overall Study|Protocol Violation|0|||
157168952|NCT04295356|567359871|FG001|Overall Study|Protocol Violation|1|||
157168953|NCT01280266|567359872|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
157168954|NCT01280266|567359873|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
157168955|NCT01280266|567359872|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
157168956|NCT01280266|567359873|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
156954536|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
157035680|NCT02719574|566887804|FG005|Phase 2|Investigator Decision|0|||
157035681|NCT02719574|566887805|FG006|Phase 2|Investigator Decision|0|||
157035682|NCT02719574|566887806|FG007|Phase 2|Investigator Decision|0|||
157035683|NCT02719574|566887807|FG008|Phase 2|Investigator Decision|0|||
157035684|NCT02719574|566887808|FG009|Phase 2|Investigator Decision|6|||
157035685|NCT02719574|566887809|FG010|Phase 2|Investigator Decision|1|||
157035686|NCT02719574|566887810|FG011|Phase 2|Investigator Decision|2|||
157035687|NCT02719574|566887811|FG012|Phase 2|Investigator Decision|3|||
157035688|NCT02719574|566887812|FG013|Phase 2|Investigator Decision|1|||
157035689|NCT02719574|566887813|FG014|Phase 2|Investigator Decision|3|||
157035690|NCT02719574|566887814|FG015|Phase 2|Investigator Decision|2|||
157035691|NCT02719574|566887815|FG016|Phase 2|Investigator Decision|0|||
157035692|NCT02719574|566887799|FG000|Phase 2|Withdrawal by Subject|0|||
157035693|NCT02719574|566887800|FG001|Phase 2|Withdrawal by Subject|0|||
157035694|NCT02719574|566887801|FG002|Phase 2|Withdrawal by Subject|0|||
157035695|NCT02719574|566887802|FG003|Phase 2|Withdrawal by Subject|0|||
157035696|NCT02719574|566887803|FG004|Phase 2|Withdrawal by Subject|0|||
157035697|NCT02719574|566887804|FG005|Phase 2|Withdrawal by Subject|0|||
157035698|NCT02719574|566887805|FG006|Phase 2|Withdrawal by Subject|0|||
157035699|NCT02719574|566887806|FG007|Phase 2|Withdrawal by Subject|0|||
157035700|NCT02719574|566887807|FG008|Phase 2|Withdrawal by Subject|0|||
157035701|NCT02719574|566887808|FG009|Phase 2|Withdrawal by Subject|5|||
157035702|NCT02719574|566887809|FG010|Phase 2|Withdrawal by Subject|0|||
157035703|NCT02719574|566887810|FG011|Phase 2|Withdrawal by Subject|0|||
157035704|NCT02719574|566887811|FG012|Phase 2|Withdrawal by Subject|0|||
157035705|NCT02719574|566887812|FG013|Phase 2|Withdrawal by Subject|1|||
157035706|NCT02719574|566887813|FG014|Phase 2|Withdrawal by Subject|1|||
157035707|NCT02719574|566887814|FG015|Phase 2|Withdrawal by Subject|2|||
157035708|NCT02719574|566887815|FG016|Phase 2|Withdrawal by Subject|0|||
157035709|NCT02719574|566887799|FG000|Phase 2|Protocol Violation|0|||
157035710|NCT02719574|566887800|FG001|Phase 2|Protocol Violation|0|||
157035711|NCT02719574|566887801|FG002|Phase 2|Protocol Violation|0|||
157035712|NCT02719574|566887802|FG003|Phase 2|Protocol Violation|0|||
157035713|NCT02719574|566887803|FG004|Phase 2|Protocol Violation|0|||
157035714|NCT02719574|566887804|FG005|Phase 2|Protocol Violation|0|||
157035715|NCT02719574|566887805|FG006|Phase 2|Protocol Violation|0|||
157035716|NCT02719574|566887806|FG007|Phase 2|Protocol Violation|0|||
157035717|NCT02719574|566887807|FG008|Phase 2|Protocol Violation|0|||
157035718|NCT02719574|566887808|FG009|Phase 2|Protocol Violation|1|||
157035719|NCT02719574|566887809|FG010|Phase 2|Protocol Violation|0|||
157035720|NCT02719574|566887810|FG011|Phase 2|Protocol Violation|0|||
157035721|NCT02719574|566887811|FG012|Phase 2|Protocol Violation|0|||
157035722|NCT02719574|566887812|FG013|Phase 2|Protocol Violation|0|||
157035723|NCT02719574|566887813|FG014|Phase 2|Protocol Violation|0|||
157035724|NCT02719574|566887814|FG015|Phase 2|Protocol Violation|0|||
157035725|NCT02719574|566887815|FG016|Phase 2|Protocol Violation|0|||
157035726|NCT00113360|566887817|FG000|Overall Study|Adverse Event|3|||
157035727|NCT00113360|566887817|FG000|Overall Study|Subject required surgery|1|||
157035728|NCT00113360|566887817|FG000|Overall Study|Did not meet eligibility criteria|3|||
157035729|NCT01976936|566887830|FG000|Overall Study|Did not receive at least 9 doses|9|||
157035730|NCT01976936|566887831|FG001|Overall Study|Did not receive at least 9 doses|4|||
157035731|NCT02231749|566887835|FG000|Overall Study|Disease progression|229|||
157035732|NCT02231749|566887836|FG001|Overall Study|Disease progression|297|||
157168957|NCT03067129|567359884|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
157168958|NCT03067129|567359885|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
157168959|NCT03067129|567359886|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
157035733|NCT02231749|566887835|FG000|Overall Study|Study Drug Toxicity|134|||
157035734|NCT02231749|566887836|FG001|Overall Study|Study Drug Toxicity|63|||
157035735|NCT02231749|566887835|FG000|Overall Study|Death|1|||
157035736|NCT02231749|566887836|FG001|Overall Study|Death|1|||
157035737|NCT02231749|566887835|FG000|Overall Study|AE unrelated to Study drug|32|||
157035738|NCT02231749|566887836|FG001|Overall Study|AE unrelated to Study drug|31|||
157035739|NCT02231749|566887835|FG000|Overall Study|Participant's request to discontinue|10|||
157035740|NCT02231749|566887836|FG001|Overall Study|Participant's request to discontinue|21|||
157035741|NCT02231749|566887835|FG000|Overall Study|Participant withdrew Consent|8|||
157035742|NCT02231749|566887836|FG001|Overall Study|Participant withdrew Consent|15|||
157168960|NCT03067129|567359887|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
157035743|NCT02231749|566887835|FG000|Overall Study|Lost to Follow-up|1|||
157035744|NCT02231749|566887836|FG001|Overall Study|Lost to Follow-up|2|||
157035745|NCT02231749|566887835|FG000|Overall Study|Maximum Clinical Benefit|5|||
157035746|NCT02231749|566887836|FG001|Overall Study|Maximum Clinical Benefit|8|||
157035747|NCT02231749|566887835|FG000|Overall Study|Poor/Non-Compliance|0|||
157035748|NCT02231749|566887836|FG001|Overall Study|Poor/Non-Compliance|3|||
157035749|NCT02231749|566887835|FG000|Overall Study|Pregnancy|1|||
157035750|NCT02231749|566887836|FG001|Overall Study|Pregnancy|0|||
157035751|NCT02231749|566887835|FG000|Overall Study|other|0|||
157035752|NCT02231749|566887836|FG001|Overall Study|other|8|||
157035753|NCT02231749|566887835|FG000|Overall Study|No longer meets Study Criteria|1|||
157168961|NCT03067129|567359884|FG000|Overall Study|Withdrawal by Subject|0|||
156954537|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954538|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954539|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954540|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954541|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954542|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954543|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954544|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954545|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954546|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
156954547|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156954548|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156954549|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954550|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
156954551|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
156954552|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954553|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954554|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954555|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954556|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954557|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954558|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954559|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954560|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954561|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954562|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954563|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954564|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954565|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954566|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
156954567|NCT01490632|566587120|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954568|NCT01490632|566587121|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954569|NCT01490632|566587122|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954570|NCT01490632|566587123|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954571|NCT01490632|566587124|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
156954572|NCT01490632|566587125|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954573|NCT01490632|566587126|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954574|NCT01490632|566587127|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954575|NCT01490632|566587128|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954576|NCT01490632|566587129|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954577|NCT01490632|566587130|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954578|NCT01490632|566587131|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954579|NCT01490632|566587132|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954580|NCT01490632|566587133|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954581|NCT01490632|566587134|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954582|NCT01490632|566587135|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954583|NCT01490632|566587136|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954584|NCT01490632|566587137|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954585|NCT01490632|566587138|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954586|NCT01490632|566587139|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
156954587|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954588|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954589|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954590|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954591|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954592|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
156954593|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
156954594|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954595|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954596|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
156954597|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
157168962|NCT03067129|567359885|FG001|Overall Study|Withdrawal by Subject|0|||
157168963|NCT03067129|567359886|FG002|Overall Study|Withdrawal by Subject|1|||
157168964|NCT03067129|567359887|FG003|Overall Study|Withdrawal by Subject|2|||
156954598|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
156954599|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954600|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954601|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954602|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954603|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954604|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954605|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954606|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
156954607|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954608|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954609|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954610|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954611|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954612|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954613|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156954614|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954615|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156954616|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
156954617|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
156954618|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954619|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954620|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954621|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954622|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954623|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954624|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954625|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954626|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
156954627|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954628|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954629|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954630|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954631|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954632|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954633|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
156954634|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954635|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954636|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
156954637|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954638|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954639|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954640|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954641|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954642|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954643|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954644|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954645|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
156954646|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
157168965|NCT03067129|567359884|FG000|Overall Study|Lost to Follow-up|5|||
156954647|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954648|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
157035754|NCT02231749|566887836|FG001|Overall Study|No longer meets Study Criteria|0|||
157035755|NCT02989662|566887843|FG000|Overall Study|Lost to Follow-up|0|||
157035756|NCT02989662|566887844|FG001|Overall Study|Lost to Follow-up|0|||
157035757|NCT02989662|566887845|FG002|Overall Study|Lost to Follow-up|0|||
157035758|NCT02989662|566887846|FG003|Overall Study|Lost to Follow-up|2|||
157035759|NCT02989662|566887843|FG000|Overall Study|Physician Decision|3|||
157035760|NCT02989662|566887844|FG001|Overall Study|Physician Decision|0|||
157035761|NCT02989662|566887845|FG002|Overall Study|Physician Decision|0|||
157035762|NCT02989662|566887846|FG003|Overall Study|Physician Decision|0|||
157035763|NCT02989662|566887843|FG000|Overall Study|Withdrawal by Subject|1|||
157035764|NCT02989662|566887844|FG001|Overall Study|Withdrawal by Subject|0|||
157035765|NCT02989662|566887845|FG002|Overall Study|Withdrawal by Subject|0|||
157035766|NCT02989662|566887846|FG003|Overall Study|Withdrawal by Subject|0|||
157035767|NCT00328783|566887847|FG000|Overall Study|Could not tolerate ABC|21|||
157035768|NCT00328783|566887847|FG000|Overall Study|No heart in RT field|4|||
157035769|NCT00328783|566887847|FG000|Overall Study|Withdrawal by Subject|1|||
157035770|NCT00357682|566887848|FG000|Overall Study|Did not receive allocated Treatment|10|||
157168966|NCT03067129|567359885|FG001|Overall Study|Lost to Follow-up|5|||
157168967|NCT03067129|567359886|FG002|Overall Study|Lost to Follow-up|4|||
157168968|NCT03067129|567359887|FG003|Overall Study|Lost to Follow-up|3|||
157168969|NCT03372603|567359888|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
157168970|NCT03372603|567359889|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
157168971|NCT03372603|567359888|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
157168972|NCT03372603|567359889|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
157168973|NCT00065442|567359895|FG000|Overall Study|Lost to Follow-up|1|||
157168974|NCT00065442|567359896|FG001|Overall Study|Lost to Follow-up|1|||
157168975|NCT00065442|567359895|FG000|Overall Study|Death|121|||
157168976|NCT00065442|567359896|FG001|Overall Study|Death|210|||
157168977|NCT00065442|567359895|FG000|Overall Study|Withdrawal by Subject|3|||
157168978|NCT00065442|567359896|FG001|Overall Study|Withdrawal by Subject|9|||
157168979|NCT01594333|567359897|FG000|Overall Study|Death|96|||
157168980|NCT01594333|567359898|FG001|Overall Study|Death|83|||
157168981|NCT01594333|567359897|FG000|Overall Study|Lost to Follow-up|5|||
157168982|NCT01594333|567359898|FG001|Overall Study|Lost to Follow-up|5|||
157168983|NCT01594333|567359897|FG000|Overall Study|Withdrawal by Subject|60|||
157168984|NCT01594333|567359898|FG001|Overall Study|Withdrawal by Subject|63|||
157168985|NCT00712322|567359902|FG000|Overall Study|Protocol deviation|0|||
157168986|NCT00712322|567359903|FG001|Overall Study|Protocol deviation|1|||
157168987|NCT00712322|567359904|FG002|Overall Study|Protocol deviation|0|||
157168988|NCT00400712|567359907|FG000|Overall Study|Death|1|||
157168989|NCT00400712|567359908|FG001|Overall Study|Death|0|||
157168990|NCT00400712|567359907|FG000|Overall Study|Withdrawal by Subject|11|||
157168991|NCT00400712|567359908|FG001|Overall Study|Withdrawal by Subject|12|||
157168992|NCT00400712|567359907|FG000|Overall Study|Physician Decision|5|||
157168993|NCT00400712|567359908|FG001|Overall Study|Physician Decision|4|||
157168994|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
157168995|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
157168996|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
157168997|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
157168998|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
157168999|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
157169000|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Death|1|||
157169001|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Death|3|||
157169002|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
157169003|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
157169004|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
157169005|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
157169006|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
157169007|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
157169008|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
157169009|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
157169010|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
156954649|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954650|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954651|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954652|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954653|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
156954654|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954655|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954656|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954657|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954658|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954659|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954660|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954661|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954662|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954663|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
157035771|NCT00357682|566887849|FG001|Overall Study|Did not receive allocated Treatment|9|||
157169011|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
157169012|NCT02553317|567359912|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
157169013|NCT02553317|567359913|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
157169014|NCT01354431|567359915|FG000|Pre-Treatment Period|Not reported|1|||
157035772|NCT00357682|566887850|FG002|Overall Study|Did not receive allocated Treatment|9|||
157169015|NCT01354431|567359916|FG001|Pre-Treatment Period|Not reported|0|||
156954664|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
157035773|NCT00357682|566887851|FG003|Overall Study|Did not receive allocated Treatment|10|||
157169016|NCT01354431|567359917|FG002|Pre-Treatment Period|Not reported|0|||
156954665|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
157169017|NCT01354431|567359915|FG000|Treatment Period|Disease Progression|50|||
157169018|NCT01354431|567359916|FG001|Treatment Period|Disease Progression|40|||
157169019|NCT01354431|567359917|FG002|Treatment Period|Disease Progression|44|||
157169020|NCT01354431|567359915|FG000|Treatment Period|Study Drug Toxicity|5|||
156954666|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
156954667|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954668|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954669|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954670|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954671|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954672|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
156954673|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954674|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954675|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954676|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954677|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954678|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954679|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954680|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954681|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954682|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954683|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954684|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954685|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954686|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
156954687|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954688|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954689|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954690|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954691|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954692|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954693|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156954694|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954695|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156954696|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954697|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
156954698|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
156954699|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954700|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954701|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954702|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954703|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954704|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954705|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954706|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
156954707|NCT01490632|566587120|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954708|NCT01490632|566587121|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954709|NCT01490632|566587122|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954710|NCT01490632|566587123|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954711|NCT01490632|566587124|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954712|NCT01490632|566587125|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
156954713|NCT01490632|566587126|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
156954714|NCT01490632|566587127|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
156954715|NCT01490632|566587128|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
156954716|NCT01490632|566587129|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
156954717|NCT01490632|566587130|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
156954718|NCT01490632|566587131|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
156954719|NCT01490632|566587132|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954720|NCT01490632|566587133|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954721|NCT01490632|566587134|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
157169021|NCT01354431|567359916|FG001|Treatment Period|Study Drug Toxicity|8|||
157169022|NCT01354431|567359917|FG002|Treatment Period|Study Drug Toxicity|4|||
157169023|NCT01354431|567359915|FG000|Treatment Period|Death|0|||
156954722|NCT01490632|566587135|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954723|NCT01490632|566587136|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954724|NCT01490632|566587137|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954725|NCT01490632|566587138|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954726|NCT01490632|566587139|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
156954727|NCT01490632|566587120|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954728|NCT01490632|566587121|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954729|NCT01490632|566587122|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954730|NCT01490632|566587123|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954731|NCT01490632|566587124|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954732|NCT01490632|566587125|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954733|NCT01490632|566587126|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954734|NCT01490632|566587127|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954735|NCT01490632|566587128|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954736|NCT01490632|566587129|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954737|NCT01490632|566587130|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954738|NCT01490632|566587131|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954739|NCT01490632|566587132|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954740|NCT01490632|566587133|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954741|NCT01490632|566587134|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
156954742|NCT01490632|566587135|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
156954743|NCT01490632|566587136|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954744|NCT01490632|566587137|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954745|NCT01490632|566587138|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954746|NCT01490632|566587139|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
156954747|NCT01490632|566587120|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954748|NCT01490632|566587121|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954749|NCT01490632|566587122|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954750|NCT01490632|566587123|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954751|NCT01490632|566587124|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954752|NCT01490632|566587125|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954753|NCT01490632|566587126|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954754|NCT01490632|566587127|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954755|NCT01490632|566587128|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954756|NCT01490632|566587129|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954757|NCT01490632|566587130|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954758|NCT01490632|566587131|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954759|NCT01490632|566587132|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954760|NCT01490632|566587133|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
156954761|NCT01490632|566587134|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954762|NCT01490632|566587135|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954763|NCT01490632|566587136|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954764|NCT01490632|566587137|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954765|NCT01490632|566587138|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954766|NCT01490632|566587139|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
156954767|NCT01490632|566587120|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954768|NCT01490632|566587121|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954769|NCT01490632|566587122|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954770|NCT01490632|566587123|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954771|NCT01490632|566587124|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954772|NCT01490632|566587125|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954773|NCT01490632|566587126|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954774|NCT01490632|566587127|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954775|NCT01490632|566587128|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954776|NCT01490632|566587129|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954777|NCT01490632|566587130|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954778|NCT01490632|566587131|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954779|NCT01490632|566587132|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954780|NCT01490632|566587133|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954781|NCT01490632|566587134|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
156954782|NCT01490632|566587135|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
156954783|NCT01490632|566587136|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954784|NCT01490632|566587137|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954785|NCT01490632|566587138|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954786|NCT01490632|566587139|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
156954787|NCT01490632|566587120|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
157169024|NCT01354431|567359916|FG001|Treatment Period|Death|1|||
156954788|NCT01490632|566587121|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954789|NCT01490632|566587122|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954790|NCT01490632|566587123|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954791|NCT01490632|566587124|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954792|NCT01490632|566587125|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954793|NCT01490632|566587126|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954794|NCT01490632|566587127|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954795|NCT01490632|566587128|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954796|NCT01490632|566587129|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954797|NCT01490632|566587130|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954798|NCT01490632|566587131|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954799|NCT01490632|566587132|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
156954800|NCT01490632|566587133|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
156954801|NCT01490632|566587134|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
156954802|NCT01490632|566587135|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
156954803|NCT01490632|566587136|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954804|NCT01490632|566587137|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954805|NCT01490632|566587138|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954806|NCT01490632|566587139|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
156954807|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
156954808|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
156954809|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
156954810|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
156954811|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
156954812|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
156954813|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
156954814|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
156954815|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
156954816|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
156954817|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
156954818|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
156954819|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
156954820|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
156954821|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
156954822|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
156954823|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
156954824|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
156954825|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
156954826|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
156954827|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Death|0|||
156954828|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Death|0|||
156954829|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Death|0|||
156954830|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Death|0|||
156954831|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Death|0|||
156954832|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Death|0|||
156954833|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Death|0|||
156954834|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Death|0|||
156954835|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Death|0|||
156954836|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Death|0|||
156954837|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Death|0|||
156954838|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Death|0|||
156954839|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Death|0|||
156954840|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Death|0|||
156954841|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Death|0|||
156954842|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Death|0|||
156954843|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Death|0|||
156954844|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Death|0|||
156954845|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Death|1|||
156954846|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Death|0|||
156954847|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
157169025|NCT01354431|567359917|FG002|Treatment Period|Death|0|||
157169026|NCT01354431|567359915|FG000|Treatment Period|AE unrelated to study drug|1|||
156954848|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954849|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954850|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954851|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
157169027|NCT01354431|567359916|FG001|Treatment Period|AE unrelated to study drug|2|||
157169028|NCT01354431|567359917|FG002|Treatment Period|AE unrelated to study drug|5|||
157035774|NCT00357682|566887848|FG000|Overall Study|Withdrew consent|6|||
157035775|NCT00357682|566887849|FG001|Overall Study|Withdrew consent|6|||
157035776|NCT00357682|566887850|FG002|Overall Study|Withdrew consent|5|||
157035777|NCT00357682|566887851|FG003|Overall Study|Withdrew consent|5|||
157035778|NCT00357682|566887848|FG000|Overall Study|Lost to Follow-up|39|||
157035779|NCT00357682|566887849|FG001|Overall Study|Lost to Follow-up|33|||
157035780|NCT00357682|566887850|FG002|Overall Study|Lost to Follow-up|26|||
157035781|NCT00357682|566887851|FG003|Overall Study|Lost to Follow-up|35|||
157035782|NCT00357682|566887848|FG000|Overall Study|Adverse Event|24|||
157035783|NCT00357682|566887849|FG001|Overall Study|Adverse Event|32|||
157035784|NCT00357682|566887850|FG002|Overall Study|Adverse Event|22|||
157035785|NCT00357682|566887851|FG003|Overall Study|Adverse Event|27|||
157035786|NCT00357682|566887848|FG000|Overall Study|Physician Decision|32|||
157035787|NCT00357682|566887849|FG001|Overall Study|Physician Decision|20|||
157035788|NCT00357682|566887850|FG002|Overall Study|Physician Decision|24|||
157035789|NCT00357682|566887851|FG003|Overall Study|Physician Decision|30|||
157035790|NCT00357682|566887848|FG000|Overall Study|Patient decision|73|||
157035791|NCT00357682|566887849|FG001|Overall Study|Patient decision|80|||
157035792|NCT00357682|566887850|FG002|Overall Study|Patient decision|51|||
157035793|NCT00357682|566887851|FG003|Overall Study|Patient decision|59|||
157035794|NCT00357682|566887848|FG000|Overall Study|Other reason|157|||
157035795|NCT00357682|566887849|FG001|Overall Study|Other reason|130|||
157035796|NCT00357682|566887850|FG002|Overall Study|Other reason|114|||
157035797|NCT00357682|566887851|FG003|Overall Study|Other reason|99|||
157035798|NCT05424718|566887858|FG000|Overall Study|Lost to Follow-up|5|||
157035799|NCT05424718|566887859|FG001|Overall Study|Lost to Follow-up|4|||
157035800|NCT04046549|566887860|FG000|Overall Study|Adverse Event|1|||
157035801|NCT04046549|566887860|FG000|Overall Study|Physician Decision|1|||
157035802|NCT04046549|566887860|FG000|Overall Study|Withdrawal by Subject|3|||
157035803|NCT04046549|566887860|FG000|Overall Study|Other, Not Specified|5|||
157035804|NCT06059443|566887861|FG000|Overall Study|Withdrawal by Subject|2|||
157035805|NCT06059443|566887862|FG001|Overall Study|Withdrawal by Subject|0|||
157035806|NCT06059443|566887861|FG000|Overall Study|Lost to Follow-up|2|||
157035807|NCT06059443|566887862|FG001|Overall Study|Lost to Follow-up|2|||
156954852|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954853|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954854|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954855|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954856|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954857|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954858|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954859|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954860|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
157169029|NCT01354431|567359915|FG000|Treatment Period|Participant request to discontinue|2|||
157169030|NCT01354431|567359916|FG001|Treatment Period|Participant request to discontinue|2|||
156954861|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954862|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954863|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
156954864|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
156954865|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
156954866|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
156954867|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954868|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954869|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954870|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
157035808|NCT00709956|566887867|FG000|Overall Study|Withdrawal by Subject|1|||
157035809|NCT00709956|566887868|FG001|Overall Study|Withdrawal by Subject|1|||
156954871|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954872|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954873|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954874|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954875|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
157035810|NCT00709956|566887867|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
156954876|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954877|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
157035811|NCT00709956|566887868|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
157035812|NCT04479787|566887869|FG000|Through 6 Months|Withdrawal by Subject|16|||
157035813|NCT04479787|566887870|FG001|Through 6 Months|Withdrawal by Subject|14|||
157035814|NCT04479787|566887869|FG000|Through 6 Months|Unsuccessful Trial|17|||
157035815|NCT04479787|566887870|FG001|Through 6 Months|Unsuccessful Trial|0|||
156954878|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
157035816|NCT04479787|566887869|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
157035817|NCT04479787|566887870|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
157035818|NCT04479787|566887869|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
156954879|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954880|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954881|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954882|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954883|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954884|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954885|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
156954886|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
156954887|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
156954888|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
156954889|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
156954890|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
156954891|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
156954892|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
156954893|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
156954894|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
156954895|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
156954896|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
156954897|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
156954898|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
156954899|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
156954900|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
156954901|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
156954902|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
156954903|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
156954904|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
156954905|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
156954906|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
156954907|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
156954908|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
156954909|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
156954910|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
156954911|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
156954912|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
156954913|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
156954914|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
156954915|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
156954916|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
156954917|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
156954918|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
156954919|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
156954920|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
156954921|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
156954922|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
156954923|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
156954924|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
156954925|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
156954926|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
156954927|NCT01490632|566587120|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954928|NCT01490632|566587121|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954929|NCT01490632|566587122|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954930|NCT01490632|566587123|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954931|NCT01490632|566587124|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954932|NCT01490632|566587125|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954933|NCT01490632|566587126|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954934|NCT01490632|566587127|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954935|NCT01490632|566587128|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954936|NCT01490632|566587129|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954937|NCT01490632|566587130|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954938|NCT01490632|566587131|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954939|NCT01490632|566587132|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954940|NCT01490632|566587133|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954941|NCT01490632|566587134|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954942|NCT01490632|566587135|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954943|NCT01490632|566587136|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
156954944|NCT01490632|566587137|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156954945|NCT01490632|566587138|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156954946|NCT01490632|566587139|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
156954947|NCT02332720|566587141|FG000|Part A and Part B|Lost to Follow-up|1|||
156954948|NCT02332720|566587142|FG001|Part A and Part B|Lost to Follow-up|0|||
157169031|NCT01354431|567359917|FG002|Treatment Period|Participant request to discontinue|1|||
157169032|NCT01354431|567359915|FG000|Treatment Period|Participant withdrew consent|0|||
157169033|NCT01354431|567359916|FG001|Treatment Period|Participant withdrew consent|1|||
157169034|NCT01354431|567359917|FG002|Treatment Period|Participant withdrew consent|0|||
157169035|NCT01354431|567359915|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
157169036|NCT01354431|567359916|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
157169037|NCT01354431|567359917|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
157169038|NCT00536978|567359918|FG000|Overall Study|Not eligible for Adback Infusion|22|||
156954949|NCT02332720|566587143|FG002|Part A and Part B|Lost to Follow-up|0|||
156954950|NCT02332720|566587144|FG003|Part A and Part B|Lost to Follow-up|0|||
156954951|NCT02332720|566587145|FG004|Part A and Part B|Lost to Follow-up|0|||
156954952|NCT02332720|566587146|FG005|Part A and Part B|Lost to Follow-up|2|||
156954953|NCT02332720|566587147|FG006|Part A and Part B|Lost to Follow-up|1|||
156954954|NCT02332720|566587148|FG007|Part A and Part B|Lost to Follow-up|1|||
156954955|NCT02332720|566587149|FG008|Part A and Part B|Lost to Follow-up|0|||
156954956|NCT02332720|566587150|FG009|Part A and Part B|Lost to Follow-up|0|||
156954957|NCT02332720|566587151|FG010|Part A and Part B|Lost to Follow-up|0|||
156954958|NCT02332720|566587152|FG011|Part A and Part B|Lost to Follow-up|0|||
156954959|NCT02332720|566587153|FG012|Part A and Part B|Lost to Follow-up|0|||
156954960|NCT02332720|566587154|FG013|Part A and Part B|Lost to Follow-up|0|||
156954961|NCT02332720|566587155|FG014|Part A and Part B|Lost to Follow-up|0|||
156954962|NCT02332720|566587156|FG015|Part A and Part B|Lost to Follow-up|1|||
156954963|NCT02332720|566587157|FG016|Part A and Part B|Lost to Follow-up|0|||
156954964|NCT02332720|566587158|FG017|Part A and Part B|Lost to Follow-up|0|||
156954965|NCT02332720|566587159|FG018|Part A and Part B|Lost to Follow-up|0|||
156954966|NCT02332720|566587160|FG019|Part A and Part B|Lost to Follow-up|0|||
156954967|NCT02332720|566587161|FG020|Part A and Part B|Lost to Follow-up|0|||
156954968|NCT02332720|566587162|FG021|Part A and Part B|Lost to Follow-up|0|||
156954969|NCT02332720|566587163|FG022|Part A and Part B|Lost to Follow-up|0|||
156954970|NCT02332720|566587141|FG000|Part A and Part B|Adverse Event|0|||
156954971|NCT02332720|566587142|FG001|Part A and Part B|Adverse Event|0|||
156954972|NCT02332720|566587143|FG002|Part A and Part B|Adverse Event|0|||
156954973|NCT02332720|566587144|FG003|Part A and Part B|Adverse Event|0|||
156954974|NCT02332720|566587145|FG004|Part A and Part B|Adverse Event|0|||
156954975|NCT02332720|566587146|FG005|Part A and Part B|Adverse Event|0|||
156954976|NCT02332720|566587147|FG006|Part A and Part B|Adverse Event|0|||
156954977|NCT02332720|566587148|FG007|Part A and Part B|Adverse Event|0|||
156954978|NCT02332720|566587149|FG008|Part A and Part B|Adverse Event|0|||
156954979|NCT02332720|566587150|FG009|Part A and Part B|Adverse Event|0|||
156954980|NCT02332720|566587151|FG010|Part A and Part B|Adverse Event|0|||
156954981|NCT02332720|566587152|FG011|Part A and Part B|Adverse Event|0|||
156954982|NCT02332720|566587153|FG012|Part A and Part B|Adverse Event|0|||
156954983|NCT02332720|566587154|FG013|Part A and Part B|Adverse Event|0|||
156954984|NCT02332720|566587155|FG014|Part A and Part B|Adverse Event|0|||
156954985|NCT02332720|566587156|FG015|Part A and Part B|Adverse Event|0|||
156954986|NCT02332720|566587157|FG016|Part A and Part B|Adverse Event|0|||
156954987|NCT02332720|566587158|FG017|Part A and Part B|Adverse Event|1|||
156954988|NCT02332720|566587159|FG018|Part A and Part B|Adverse Event|0|||
156954989|NCT02332720|566587160|FG019|Part A and Part B|Adverse Event|0|||
156954990|NCT02332720|566587161|FG020|Part A and Part B|Adverse Event|0|||
156954991|NCT02332720|566587162|FG021|Part A and Part B|Adverse Event|0|||
156954992|NCT02332720|566587163|FG022|Part A and Part B|Adverse Event|0|||
156954993|NCT02332720|566587141|FG000|Part A and Part B|Physician Decision|0|||
156954994|NCT02332720|566587142|FG001|Part A and Part B|Physician Decision|0|||
156954995|NCT02332720|566587143|FG002|Part A and Part B|Physician Decision|0|||
156954996|NCT02332720|566587144|FG003|Part A and Part B|Physician Decision|0|||
156954997|NCT02332720|566587145|FG004|Part A and Part B|Physician Decision|0|||
156954998|NCT02332720|566587146|FG005|Part A and Part B|Physician Decision|0|||
156954999|NCT02332720|566587147|FG006|Part A and Part B|Physician Decision|0|||
156955000|NCT02332720|566587148|FG007|Part A and Part B|Physician Decision|0|||
156955001|NCT02332720|566587149|FG008|Part A and Part B|Physician Decision|0|||
156955002|NCT02332720|566587150|FG009|Part A and Part B|Physician Decision|0|||
156955003|NCT02332720|566587151|FG010|Part A and Part B|Physician Decision|0|||
156955004|NCT02332720|566587152|FG011|Part A and Part B|Physician Decision|0|||
156955005|NCT02332720|566587153|FG012|Part A and Part B|Physician Decision|0|||
156955006|NCT02332720|566587154|FG013|Part A and Part B|Physician Decision|0|||
156955007|NCT02332720|566587155|FG014|Part A and Part B|Physician Decision|0|||
156955008|NCT02332720|566587156|FG015|Part A and Part B|Physician Decision|0|||
156955009|NCT02332720|566587157|FG016|Part A and Part B|Physician Decision|0|||
156955010|NCT02332720|566587158|FG017|Part A and Part B|Physician Decision|0|||
156955011|NCT02332720|566587159|FG018|Part A and Part B|Physician Decision|1|||
156955012|NCT02332720|566587160|FG019|Part A and Part B|Physician Decision|0|||
156955013|NCT02332720|566587161|FG020|Part A and Part B|Physician Decision|0|||
156955014|NCT02332720|566587162|FG021|Part A and Part B|Physician Decision|0|||
156955015|NCT02332720|566587163|FG022|Part A and Part B|Physician Decision|0|||
156955016|NCT02332720|566587141|FG000|Part A and Part B|Withdrawal by Subject|0|||
156955017|NCT02332720|566587142|FG001|Part A and Part B|Withdrawal by Subject|0|||
156955018|NCT02332720|566587143|FG002|Part A and Part B|Withdrawal by Subject|0|||
156955019|NCT02332720|566587144|FG003|Part A and Part B|Withdrawal by Subject|0|||
156955020|NCT02332720|566587145|FG004|Part A and Part B|Withdrawal by Subject|0|||
156955021|NCT02332720|566587146|FG005|Part A and Part B|Withdrawal by Subject|1|||
156955022|NCT02332720|566587147|FG006|Part A and Part B|Withdrawal by Subject|0|||
156955023|NCT02332720|566587148|FG007|Part A and Part B|Withdrawal by Subject|0|||
156955024|NCT02332720|566587149|FG008|Part A and Part B|Withdrawal by Subject|0|||
156955025|NCT02332720|566587150|FG009|Part A and Part B|Withdrawal by Subject|0|||
156955026|NCT02332720|566587151|FG010|Part A and Part B|Withdrawal by Subject|0|||
156955027|NCT02332720|566587152|FG011|Part A and Part B|Withdrawal by Subject|0|||
156955028|NCT02332720|566587153|FG012|Part A and Part B|Withdrawal by Subject|0|||
156955029|NCT02332720|566587154|FG013|Part A and Part B|Withdrawal by Subject|0|||
156955030|NCT02332720|566587155|FG014|Part A and Part B|Withdrawal by Subject|0|||
156955031|NCT02332720|566587156|FG015|Part A and Part B|Withdrawal by Subject|0|||
156955032|NCT02332720|566587157|FG016|Part A and Part B|Withdrawal by Subject|0|||
156955033|NCT02332720|566587158|FG017|Part A and Part B|Withdrawal by Subject|0|||
156955034|NCT02332720|566587159|FG018|Part A and Part B|Withdrawal by Subject|0|||
156955035|NCT02332720|566587160|FG019|Part A and Part B|Withdrawal by Subject|1|||
156955036|NCT02332720|566587161|FG020|Part A and Part B|Withdrawal by Subject|0|||
156955037|NCT02332720|566587162|FG021|Part A and Part B|Withdrawal by Subject|0|||
156955038|NCT02332720|566587163|FG022|Part A and Part B|Withdrawal by Subject|0|||
156955039|NCT01153633|566587164|FG000|Overall Study|Protocol Violation|1|||
156955040|NCT01153633|566587165|FG001|Overall Study|Protocol Violation|1|||
156955041|NCT01153633|566587164|FG000|Overall Study|Therapeutic failure|3|||
156955042|NCT01153633|566587165|FG001|Overall Study|Therapeutic failure|3|||
156955043|NCT00384085|566587166|FG000|Overall Study|Adverse Event|5|||
156955044|NCT00384085|566587167|FG001|Overall Study|Adverse Event|5|||
156955045|NCT00384085|566587168|FG002|Overall Study|Adverse Event|4|||
156955046|NCT00384085|566587166|FG000|Overall Study|Lack of Efficacy|0|||
156955047|NCT00384085|566587167|FG001|Overall Study|Lack of Efficacy|3|||
156955048|NCT00384085|566587168|FG002|Overall Study|Lack of Efficacy|2|||
156955049|NCT00384085|566587166|FG000|Overall Study|No longer Requires Study Treatment|1|||
156955050|NCT00384085|566587167|FG001|Overall Study|No longer Requires Study Treatment|0|||
156955051|NCT00384085|566587168|FG002|Overall Study|No longer Requires Study Treatment|1|||
156955052|NCT00384085|566587166|FG000|Overall Study|Protocol Violation|2|||
156955053|NCT00384085|566587167|FG001|Overall Study|Protocol Violation|2|||
156955054|NCT00384085|566587168|FG002|Overall Study|Protocol Violation|2|||
156955055|NCT00384085|566587166|FG000|Overall Study|Lost to Follow-up|9|||
156955056|NCT00384085|566587167|FG001|Overall Study|Lost to Follow-up|9|||
156955057|NCT00384085|566587168|FG002|Overall Study|Lost to Follow-up|10|||
156955058|NCT00384085|566587166|FG000|Overall Study|Progressive Disease|0|||
156955059|NCT00384085|566587167|FG001|Overall Study|Progressive Disease|1|||
156955060|NCT00384085|566587168|FG002|Overall Study|Progressive Disease|0|||
156955061|NCT00384085|566587166|FG000|Overall Study|Withdrawal by Subject|14|||
156955062|NCT00384085|566587167|FG001|Overall Study|Withdrawal by Subject|19|||
156955063|NCT00384085|566587168|FG002|Overall Study|Withdrawal by Subject|29|||
156955064|NCT00384085|566587166|FG000|Overall Study|Patient non-compliant|4|||
156955065|NCT00384085|566587167|FG001|Overall Study|Patient non-compliant|4|||
156955066|NCT00384085|566587168|FG002|Overall Study|Patient non-compliant|5|||
156955067|NCT00384085|566587166|FG000|Overall Study|Physician Decision|1|||
156955068|NCT00384085|566587167|FG001|Overall Study|Physician Decision|0|||
156955069|NCT00384085|566587168|FG002|Overall Study|Physician Decision|0|||
156955070|NCT00384085|566587166|FG000|Overall Study|Loss of site personnel|1|||
156955071|NCT00384085|566587167|FG001|Overall Study|Loss of site personnel|0|||
156955072|NCT00384085|566587168|FG002|Overall Study|Loss of site personnel|1|||
156955073|NCT00384085|566587166|FG000|Overall Study|Sponsor decision|1|||
156955074|NCT00384085|566587167|FG001|Overall Study|Sponsor decision|2|||
156955075|NCT00384085|566587168|FG002|Overall Study|Sponsor decision|1|||
156955076|NCT00384085|566587166|FG000|Overall Study|Patient moved|1|||
156955077|NCT00384085|566587167|FG001|Overall Study|Patient moved|0|||
156955078|NCT00384085|566587168|FG002|Overall Study|Patient moved|1|||
156955079|NCT00384085|566587166|FG000|Overall Study|Patient required surgery|0|||
156955080|NCT00384085|566587167|FG001|Overall Study|Patient required surgery|1|||
156955081|NCT00384085|566587168|FG002|Overall Study|Patient required surgery|0|||
156955082|NCT00455195|566587174|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
156955083|NCT00455195|566587175|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
156955084|NCT00455195|566587174|FG000|Double-blind Study AGLU02704|Death|1|||
157035819|NCT04479787|566887870|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
157035820|NCT04479787|566887869|FG000|Through 6 Months|Lost to Follow-up|3|||
157035821|NCT04479787|566887870|FG001|Through 6 Months|Lost to Follow-up|2|||
157169039|NCT03282357|567359921|FG000|Overall Study|Lost to Follow-up|3|||
156955085|NCT00455195|566587175|FG001|Double-blind Study AGLU02704|Death|0|||
156955086|NCT00455195|566587174|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
156955087|NCT00455195|566587175|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
156955088|NCT00455195|566587174|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
157169040|NCT03282357|567359921|FG000|Overall Study|Withdrawal by Subject|4|||
157169041|NCT03282357|567359921|FG000|Overall Study|Adverse Event|1|||
157169042|NCT03282357|567359921|FG000|Overall Study|Other|9|||
157169043|NCT03076190|567359922|FG000|Overall Study|Lost to Follow-up|9|||
157169044|NCT03076190|567359923|FG001|Overall Study|Lost to Follow-up|34|||
157169045|NCT03076190|567359922|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
157169046|NCT03076190|567359923|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
157169047|NCT00077376|567359932|FG000|Overall Study|Adverse Event|8|||
157169048|NCT00077376|567359932|FG000|Overall Study|Withdrawal by Subject|2|||
157169049|NCT00077376|567359932|FG000|Overall Study|Death|1|||
157169050|NCT00077376|567359932|FG000|Overall Study|Physician Decision|1|||
157169051|NCT00077376|567359932|FG000|Overall Study|Alternative therapy|5|||
157169052|NCT00077376|567359932|FG000|Overall Study|Complicating disease|1|||
157169053|NCT00077376|567359932|FG000|Overall Study|Still on treatment|1|||
157169054|NCT00077376|567359932|FG000|Overall Study|Symptomatic deterioration|1|||
157169055|NCT00077376|567359932|FG000|Overall Study|Surgery|1|||
157169056|NCT00077376|567359932|FG000|Overall Study|Insurance ran out|1|||
157169057|NCT03784027|567359933|FG000|Period 1|Withdrawal by Subject|0|||
157169058|NCT03784027|567359934|FG001|Period 1|Withdrawal by Subject|1|||
157169059|NCT05691829|567361270|FG000|Overall Study|Physician Decision|2|||
157169060|NCT05691829|567361270|FG000|Overall Study|Eligibility criteria not met|3|||
157169061|NCT02843178|567361273|FG000|Overall Study|Lost to Follow-up|8|||
157169062|NCT02843178|567361274|FG001|Overall Study|Lost to Follow-up|8|||
157169063|NCT02843178|567361275|FG002|Overall Study|Lost to Follow-up|6|||
157169064|NCT02843178|567361276|FG003|Overall Study|Lost to Follow-up|3|||
157169065|NCT02843178|567361273|FG000|Overall Study|Withdrawal by Subject|0|||
157169066|NCT02843178|567361274|FG001|Overall Study|Withdrawal by Subject|0|||
157169067|NCT02843178|567361275|FG002|Overall Study|Withdrawal by Subject|1|||
157169068|NCT02843178|567361276|FG003|Overall Study|Withdrawal by Subject|1|||
157169069|NCT00646113|567361277|FG000|Overall Study|Lost to Follow-up|5|||
157169070|NCT00646113|567361277|FG000|Overall Study|Adverse Event|3|||
157169071|NCT03927911|567361286|FG000|Overall Study|problems with eDiary|0|||
157169072|NCT03927911|567361287|FG001|Overall Study|problems with eDiary|1|||
157169073|NCT03927911|567361288|FG002|Overall Study|problems with eDiary|0|||
157169074|NCT03927911|567361289|FG003|Overall Study|problems with eDiary|1|||
157169075|NCT03927911|567361290|FG004|Overall Study|problems with eDiary|0|||
156955089|NCT00455195|566587175|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
156955090|NCT02117570|566587176|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
156955091|NCT02117570|566587177|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
156955092|NCT02117570|566587178|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
156955093|NCT02117570|566587176|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
156955094|NCT02117570|566587177|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
156955095|NCT02117570|566587178|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
156955096|NCT02117570|566587176|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
156955097|NCT02117570|566587177|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
156955098|NCT02117570|566587178|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
156955099|NCT02117570|566587176|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
156955100|NCT02117570|566587177|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
156955101|NCT02117570|566587178|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
156955102|NCT02117570|566587176|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
156955103|NCT02117570|566587177|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
156955104|NCT02117570|566587178|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
156955105|NCT02117570|566587176|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
156955106|NCT02117570|566587177|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
156955107|NCT02117570|566587178|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
156955108|NCT02117570|566587176|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
156955109|NCT02117570|566587177|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
156955110|NCT02117570|566587178|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
156955111|NCT02148250|566587179|FG000|Screening|Withdrawal by Subject|5|||
156955112|NCT02148250|566587180|FG001|Screening|Withdrawal by Subject|0|||
156955113|NCT01286779|566587184|FG000|Overall Study|Withdrawal by Subject|9|||
156955114|NCT01286779|566587184|FG000|Overall Study|Protocol Violation|5|||
156955115|NCT01286779|566587184|FG000|Overall Study|Physician Decision|2|||
156955116|NCT01286779|566587184|FG000|Overall Study|Participant had scheduled surgery|1|||
156955117|NCT01286779|566587184|FG000|Overall Study|Participant moved to another country|1|||
156955118|NCT01286779|566587184|FG000|Overall Study|Discontinued by sponsor|1|||
156955119|NCT04827212|566587185|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
156955120|NCT04827212|566587186|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
156955121|NCT04827212|566587185|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
156955122|NCT04827212|566587186|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
157169076|NCT03927911|567361291|FG005|Overall Study|problems with eDiary|4|||
157169077|NCT03927911|567361286|FG000|Overall Study|Adverse Event|0|||
156955123|NCT00574080|566587187|FG000|Overall Study|Death|10|||
156955124|NCT00574080|566587188|FG001|Overall Study|Death|10|||
156955125|NCT00599326|566587189|FG000|Overall Study|Lost to Follow-up|1|||
156955126|NCT00599326|566587189|FG000|Overall Study|Noncompliant|1|||
156955127|NCT00784810|566587190|FG000|Overall Study|Adverse Event|32|||
156955128|NCT00784810|566587191|FG001|Overall Study|Adverse Event|20|||
156955129|NCT00784810|566587190|FG000|Overall Study|Lack of Efficacy|14|||
156955130|NCT00784810|566587191|FG001|Overall Study|Lack of Efficacy|11|||
156955131|NCT00784810|566587190|FG000|Overall Study|Withdrawal by Subject|11|||
156955132|NCT00784810|566587191|FG001|Overall Study|Withdrawal by Subject|9|||
156955133|NCT00784810|566587190|FG000|Overall Study|Administrative|5|||
156955134|NCT00784810|566587191|FG001|Overall Study|Administrative|8|||
156955135|NCT00784810|566587190|FG000|Overall Study|Lost to Follow-up|1|||
156955136|NCT00784810|566587191|FG001|Overall Study|Lost to Follow-up|1|||
156955137|NCT04969250|566587194|FG000|Overall Study|Protocol Violation|0|||
156955138|NCT04969250|566587195|FG001|Overall Study|Protocol Violation|2|||
156955139|NCT04969250|566587196|FG002|Overall Study|Protocol Violation|3|||
156955140|NCT04969250|566587197|FG003|Overall Study|Protocol Violation|8|||
156955141|NCT04969250|566587194|FG000|Overall Study|Withdrawal by Subject|0|||
156955142|NCT04969250|566587195|FG001|Overall Study|Withdrawal by Subject|1|||
156955143|NCT04969250|566587196|FG002|Overall Study|Withdrawal by Subject|0|||
156955144|NCT04969250|566587197|FG003|Overall Study|Withdrawal by Subject|0|||
156955145|NCT00563784|566587198|FG000|Overall Study|Withdrawal by Subject|2|||
156955146|NCT00563784|566587198|FG000|Overall Study|Screen Failures|20|||
156955147|NCT02119416|566587199|FG000|Overall Study|Protocol Violation|1|||
156955148|NCT02119416|566587200|FG001|Overall Study|Protocol Violation|1|||
156955149|NCT02119416|566587201|FG002|Overall Study|Protocol Violation|1|||
156955150|NCT02119416|566587199|FG000|Overall Study|wrong pubertal stage|1|||
156955151|NCT02119416|566587200|FG001|Overall Study|wrong pubertal stage|0|||
156955152|NCT02119416|566587201|FG002|Overall Study|wrong pubertal stage|1|||
156955153|NCT04004611|566587202|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955154|NCT04004611|566587203|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955155|NCT04004611|566587204|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955156|NCT04004611|566587205|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955157|NCT04004611|566587206|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955158|NCT04004611|566587207|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955159|NCT04004611|566587208|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
156955160|NCT04004611|566587209|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
157035822|NCT04479787|566887869|FG000|Through 6 Months|Death|3|||
157035823|NCT04479787|566887870|FG001|Through 6 Months|Death|0|||
157035824|NCT04479787|566887869|FG000|Through 6 Months|Inclusion/Exclusion|2|||
157035825|NCT04479787|566887870|FG001|Through 6 Months|Inclusion/Exclusion|1|||
157035826|NCT04479787|566887869|FG000|Through 6 Months|Subject Became Pregnant|1|||
157035827|NCT04479787|566887870|FG001|Through 6 Months|Subject Became Pregnant|1|||
157035828|NCT04479787|566887869|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
157035829|NCT04479787|566887870|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
157035830|NCT04479787|566887869|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
157035831|NCT04479787|566887870|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
157035832|NCT04479787|566887869|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
157035833|NCT04479787|566887870|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
157035834|NCT04479787|566887869|FG000|After 6 Months|Withdrawal by Subject|3|||
157035835|NCT04479787|566887870|FG001|After 6 Months|Withdrawal by Subject|13|||
157035836|NCT04479787|566887869|FG000|After 6 Months|Unsuccessful Trial|0|||
157035837|NCT04479787|566887870|FG001|After 6 Months|Unsuccessful Trial|7|||
157035838|NCT04479787|566887869|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
157035839|NCT04479787|566887870|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
157035840|NCT04479787|566887869|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
157035841|NCT04479787|566887870|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
157035842|NCT04479787|566887869|FG000|After 6 Months|Death|2|||
157035843|NCT04479787|566887870|FG001|After 6 Months|Death|0|||
157035844|NCT04479787|566887869|FG000|After 6 Months|Lost to Follow-up|1|||
157035845|NCT04479787|566887870|FG001|After 6 Months|Lost to Follow-up|1|||
157035846|NCT04479787|566887869|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
157035847|NCT04479787|566887870|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
157035848|NCT04479787|566887869|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
157035849|NCT04479787|566887870|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
157035850|NCT04479787|566887869|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
157035851|NCT04479787|566887870|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
156955161|NCT04004611|566587210|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
156955162|NCT04004611|566587202|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156955163|NCT04004611|566587203|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
157169078|NCT03927911|567361287|FG001|Overall Study|Adverse Event|0|||
156955164|NCT04004611|566587204|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
157169079|NCT03927911|567361288|FG002|Overall Study|Adverse Event|0|||
156955165|NCT04004611|566587205|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
157169080|NCT03927911|567361289|FG003|Overall Study|Adverse Event|0|||
157169081|NCT03927911|567361290|FG004|Overall Study|Adverse Event|0|||
157169082|NCT03927911|567361291|FG005|Overall Study|Adverse Event|1|||
157169083|NCT03927911|567361286|FG000|Overall Study|not treated -study terminated by sponsor|0|||
157169084|NCT03927911|567361287|FG001|Overall Study|not treated -study terminated by sponsor|1|||
157169085|NCT03927911|567361288|FG002|Overall Study|not treated -study terminated by sponsor|0|||
157169086|NCT03927911|567361289|FG003|Overall Study|not treated -study terminated by sponsor|0|||
157169087|NCT03927911|567361290|FG004|Overall Study|not treated -study terminated by sponsor|0|||
157169088|NCT03927911|567361291|FG005|Overall Study|not treated -study terminated by sponsor|0|||
157169089|NCT03927911|567361286|FG000|Overall Study|Surgery cancelled|0|||
157169090|NCT03927911|567361287|FG001|Overall Study|Surgery cancelled|0|||
157169091|NCT03927911|567361288|FG002|Overall Study|Surgery cancelled|0|||
157169092|NCT03927911|567361289|FG003|Overall Study|Surgery cancelled|1|||
157169093|NCT03927911|567361290|FG004|Overall Study|Surgery cancelled|0|||
156955166|NCT04004611|566587206|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156955167|NCT04004611|566587207|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
156955168|NCT04004611|566587208|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
156955169|NCT04004611|566587209|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
156955170|NCT04004611|566587210|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
156955171|NCT04004611|566587202|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955172|NCT04004611|566587203|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955173|NCT04004611|566587204|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955174|NCT04004611|566587205|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955175|NCT04004611|566587206|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
156955176|NCT04004611|566587207|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955177|NCT04004611|566587208|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955178|NCT04004611|566587209|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955179|NCT04004611|566587210|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
156955180|NCT04004611|566587202|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
156955181|NCT04004611|566587203|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
156955182|NCT04004611|566587204|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
156955183|NCT04004611|566587205|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
156955184|NCT04004611|566587206|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
156955185|NCT04004611|566587207|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
156955186|NCT04004611|566587208|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
156955187|NCT04004611|566587209|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
156955188|NCT04004611|566587210|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
156955189|NCT04004611|566587202|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
156955190|NCT04004611|566587203|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955191|NCT04004611|566587204|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
156955192|NCT04004611|566587205|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955193|NCT04004611|566587206|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955194|NCT04004611|566587207|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955195|NCT04004611|566587208|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955196|NCT04004611|566587209|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955197|NCT04004611|566587210|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
156955198|NCT04004611|566587202|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955199|NCT04004611|566587203|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
156955200|NCT04004611|566587204|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955201|NCT04004611|566587205|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955202|NCT04004611|566587206|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955203|NCT04004611|566587207|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955204|NCT04004611|566587208|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955205|NCT04004611|566587209|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955206|NCT04004611|566587210|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
156955207|NCT03434119|566587211|FG000|Overall Study|Randomized but not treated|1|||
156955208|NCT03434119|566587212|FG001|Overall Study|Randomized but not treated|0|||
156955209|NCT03434119|566587211|FG000|Overall Study|Adverse Event|1|||
156955210|NCT03434119|566587212|FG001|Overall Study|Adverse Event|0|||
156955211|NCT03434119|566587211|FG000|Overall Study|Poor Compliance to Protocol|0|||
156955212|NCT03434119|566587212|FG001|Overall Study|Poor Compliance to Protocol|1|||
156955213|NCT03434119|566587211|FG000|Overall Study|Study Terminated by Sponsor|91|||
157169094|NCT03927911|567361291|FG005|Overall Study|Surgery cancelled|1|||
157169095|NCT03927911|567361286|FG000|Overall Study|Protocol Violation|0|||
157169096|NCT03927911|567361287|FG001|Overall Study|Protocol Violation|0|||
157169097|NCT03927911|567361288|FG002|Overall Study|Protocol Violation|0|||
157169098|NCT03927911|567361289|FG003|Overall Study|Protocol Violation|0|||
157035852|NCT04479787|566887869|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
157035853|NCT04479787|566887870|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
157035854|NCT02206828|566887871|FG000|Overall Study|Lost to Follow-up|7|||
157035855|NCT00353496|566887876|FG000|Overall Study|Adverse Event|1|||
157035856|NCT00353496|566887877|FG001|Overall Study|Adverse Event|0|||
157035857|NCT00353496|566887876|FG000|Overall Study|Protocol Violation|2|||
157035858|NCT00353496|566887877|FG001|Overall Study|Protocol Violation|2|||
157035859|NCT00353496|566887876|FG000|Overall Study|Withdrawal by Subject|3|||
157035860|NCT00353496|566887877|FG001|Overall Study|Withdrawal by Subject|4|||
157035861|NCT00353496|566887876|FG000|Overall Study|Physician Decision|6|||
157035862|NCT00353496|566887877|FG001|Overall Study|Physician Decision|9|||
157035863|NCT00353496|566887876|FG000|Overall Study|Not otherwise specified|4|||
157035864|NCT00353496|566887877|FG001|Overall Study|Not otherwise specified|2|||
157035865|NCT00945724|566887878|FG000|Overall Study|Withdrawal by Subject|2|||
157035866|NCT00945724|566887878|FG000|Overall Study|Physician Decision|1|||
157035867|NCT00945724|566887878|FG000|Overall Study|Adverse Event|5|||
157035868|NCT00945724|566887878|FG000|Overall Study|Second malignancy|1|||
157035869|NCT03983382|566888515|FG000|Overall Study|Death|1|||
157035870|NCT03983382|566888515|FG000|Overall Study|Lost to Follow-up|3|||
157035871|NCT03983382|566888515|FG000|Overall Study|Physician Decision|2|||
157035872|NCT03983382|566888515|FG000|Overall Study|Withdrawal by Subject|10|||
157035873|NCT03983382|566888515|FG000|Overall Study|Change in cancer treatment|2|||
157035874|NCT02166463|566888522|FG000|Overall Study|Lost to Follow-up|0|||
157169099|NCT03927911|567361290|FG004|Overall Study|Protocol Violation|0|||
157169100|NCT03927911|567361291|FG005|Overall Study|Protocol Violation|1|||
157169101|NCT02658968|567361292|FG000|Received Rituximab|Adverse Event|0|||
157169102|NCT02658968|567361293|FG001|Received Rituximab|Adverse Event|0|||
157169103|NCT02658968|567361294|FG002|Received Rituximab|Adverse Event|0|||
157169104|NCT02658968|567361295|FG003|Received Rituximab|Adverse Event|0|||
157169105|NCT02658968|567361296|FG004|Received Rituximab|Adverse Event|1|||
157169106|NCT02658968|567361292|FG000|Received Rituximab|Progressive disease|0|||
157169107|NCT02658968|567361293|FG001|Received Rituximab|Progressive disease|0|||
157169108|NCT02658968|567361294|FG002|Received Rituximab|Progressive disease|0|||
157169109|NCT02658968|567361295|FG003|Received Rituximab|Progressive disease|0|||
157169110|NCT02658968|567361296|FG004|Received Rituximab|Progressive disease|1|||
157169111|NCT02658968|567361292|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
157169112|NCT02658968|567361293|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
157169113|NCT02658968|567361294|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
157169114|NCT02658968|567361295|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
157169115|NCT02658968|567361296|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
157169116|NCT02658968|567361292|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
157169117|NCT02658968|567361293|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
157169118|NCT02658968|567361294|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
157169119|NCT02658968|567361295|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
157169120|NCT02658968|567361296|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
157169121|NCT02658968|567361292|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
157169122|NCT02658968|567361293|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
157169123|NCT02658968|567361294|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
157169124|NCT02658968|567361295|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
157169125|NCT02658968|567361296|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
157169126|NCT02658968|567361292|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
157169127|NCT02658968|567361293|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
157169128|NCT02658968|567361294|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
157169129|NCT02658968|567361295|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
157169130|NCT02658968|567361296|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
157169131|NCT02658968|567361292|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
157169132|NCT02658968|567361293|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
157169133|NCT02658968|567361294|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
157169134|NCT02658968|567361295|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
157169135|NCT02658968|567361296|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
157169136|NCT00949910|567361299|FG000|Overall Study|Progressive Disease|3750|||
157169137|NCT00949910|567361299|FG000|Overall Study|Symptomatic Deterioration|1088|||
157169138|NCT00949910|567361299|FG000|Overall Study|Lost to Follow-up|100|||
157169139|NCT00949910|567361299|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
157169140|NCT00949910|567361299|FG000|Overall Study|Participant Refusal|390|||
157169141|NCT00949910|567361299|FG000|Overall Study|Death Due to Malignant Disease|456|||
157169142|NCT00949910|567361299|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
157169143|NCT00949910|567361299|FG000|Overall Study|Death Due to Adverse Event|115|||
157169144|NCT00949910|567361299|FG000|Overall Study|Death Due to Toxicity|3|||
157035875|NCT02166463|566888523|FG001|Overall Study|Lost to Follow-up|1|||
156955214|NCT03434119|566587212|FG001|Overall Study|Study Terminated by Sponsor|102|||
156955215|NCT03434119|566587211|FG000|Overall Study|Withdrawal by Subject|7|||
156955216|NCT03434119|566587212|FG001|Overall Study|Withdrawal by Subject|5|||
156955217|NCT03434119|566587211|FG000|Overall Study|Other than specified|7|||
156955218|NCT03434119|566587212|FG001|Overall Study|Other than specified|5|||
156955219|NCT04360824|566587213|FG000|Overall Study|Withdrawal by Subject|2|||
156955220|NCT04360824|566587214|FG001|Overall Study|Withdrawal by Subject|1|||
156955221|NCT04360824|566587213|FG000|Overall Study|Did not receive assigned treatment|1|||
156955222|NCT04360824|566587214|FG001|Overall Study|Did not receive assigned treatment|3|||
156955223|NCT00304070|566587215|FG000|Overall Study|Death|0|||
156955224|NCT00304070|566587216|FG001|Overall Study|Death|0|||
156955225|NCT00304070|566587217|FG002|Overall Study|Death|3|||
156955226|NCT00304070|566587215|FG000|Overall Study|Lost to Follow-up|0|||
156955227|NCT00304070|566587216|FG001|Overall Study|Lost to Follow-up|0|||
157169145|NCT00949910|567361299|FG000|Overall Study|Death from Unknown Cause|5|||
157169146|NCT00949910|567361299|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
157169147|NCT00949910|567361299|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
157169148|NCT00949910|567361299|FG000|Overall Study|Switched to Commercial Treatment|4|||
157169149|NCT00949910|567361299|FG000|Overall Study|Violation of Eligibility|23|||
157169150|NCT00949910|567361299|FG000|Overall Study|Logistical Reasons|13|||
157169151|NCT00949910|567361299|FG000|Overall Study|Non-Compliance|10|||
157169152|NCT00949910|567361299|FG000|Overall Study|Prolonged Dosing Interruption|4|||
157169153|NCT00949910|567361299|FG000|Overall Study|Adverse Event|83|||
157169154|NCT00949910|567361299|FG000|Overall Study|Serious Adverse Event|6|||
157169155|NCT00949910|567361299|FG000|Overall Study|Physician/Participant Decision|7|||
157169156|NCT00949910|567361299|FG000|Overall Study|Other|4|||
157169157|NCT00949910|567361299|FG000|Overall Study|No Data|9|||
157169158|NCT03287869|567361300|FG000|Overall Study|Adverse Event|14|||
157169159|NCT03287869|567361301|FG001|Overall Study|Adverse Event|12|||
157169160|NCT03287869|567361300|FG000|Overall Study|Lack of Efficacy|1|||
157169161|NCT03287869|567361301|FG001|Overall Study|Lack of Efficacy|0|||
157169162|NCT03287869|567361300|FG000|Overall Study|Lost to Follow-up|13|||
157169163|NCT03287869|567361301|FG001|Overall Study|Lost to Follow-up|19|||
157169164|NCT03287869|567361300|FG000|Overall Study|Non-Compliance With Study Drug|5|||
157169165|NCT03287869|567361301|FG001|Overall Study|Non-Compliance With Study Drug|9|||
157169166|NCT03287869|567361300|FG000|Overall Study|Progressive Disease|1|||
157169167|NCT03287869|567361301|FG001|Overall Study|Progressive Disease|0|||
157169168|NCT03287869|567361300|FG000|Overall Study|Protocol Deviation|2|||
157169169|NCT03287869|567361301|FG001|Overall Study|Protocol Deviation|1|||
157169170|NCT03287869|567361300|FG000|Overall Study|Withdrawal by Subject|36|||
157169171|NCT03287869|567361301|FG001|Overall Study|Withdrawal by Subject|43|||
157169172|NCT03287869|567361300|FG000|Overall Study|Early Closure of the Site|0|||
157169173|NCT03287869|567361301|FG001|Overall Study|Early Closure of the Site|1|||
157169174|NCT03287869|567361300|FG000|Overall Study|Physician Decision|5|||
157169175|NCT03287869|567361301|FG001|Overall Study|Physician Decision|5|||
157169176|NCT03287869|567361300|FG000|Overall Study|Reason not Specified|6|||
157169177|NCT03287869|567361301|FG001|Overall Study|Reason not Specified|3|||
157169178|NCT02591238|567361303|FG000|Overall Study|Pregnancy|1|||
157169179|NCT02591238|567361304|FG001|Overall Study|Pregnancy|0|||
156955228|NCT00304070|566587217|FG002|Overall Study|Lost to Follow-up|1|||
156955229|NCT00304070|566587215|FG000|Overall Study|Physician Decision|0|||
156955230|NCT00304070|566587216|FG001|Overall Study|Physician Decision|0|||
156955231|NCT00304070|566587217|FG002|Overall Study|Physician Decision|3|||
156955232|NCT00304070|566587215|FG000|Overall Study|Withdrawal by Subject|0|||
156955233|NCT00304070|566587216|FG001|Overall Study|Withdrawal by Subject|0|||
156955234|NCT00304070|566587217|FG002|Overall Study|Withdrawal by Subject|1|||
156955235|NCT00304070|566587215|FG000|Overall Study|Progressive Disease|3|||
156955236|NCT00304070|566587216|FG001|Overall Study|Progressive Disease|7|||
156955237|NCT00304070|566587217|FG002|Overall Study|Progressive Disease|4|||
156955238|NCT00320216|566587218|FG000|Overall Study|Adverse Event|0|||
156955239|NCT00320216|566587219|FG001|Overall Study|Adverse Event|6|||
156955240|NCT00320216|566587220|FG002|Overall Study|Adverse Event|0|||
157169180|NCT02591238|567361305|FG002|Overall Study|Pregnancy|0|||
157169181|NCT02591238|567361306|FG003|Overall Study|Pregnancy|0|||
157169182|NCT02591238|567361303|FG000|Overall Study|Withdrawal by Subject|0|||
156955241|NCT00320216|566587221|FG003|Overall Study|Adverse Event|2|||
156955242|NCT00320216|566587222|FG004|Overall Study|Adverse Event|2|||
156955243|NCT00320216|566587218|FG000|Overall Study|Lack of Efficacy|6|||
157035876|NCT02166463|566888522|FG000|Overall Study|Physician Decision|10|||
156955244|NCT00320216|566587219|FG001|Overall Study|Lack of Efficacy|2|||
156955245|NCT00320216|566587220|FG002|Overall Study|Lack of Efficacy|1|||
156955246|NCT00320216|566587221|FG003|Overall Study|Lack of Efficacy|0|||
157169183|NCT02591238|567361304|FG001|Overall Study|Withdrawal by Subject|0|||
157169184|NCT02591238|567361305|FG002|Overall Study|Withdrawal by Subject|0|||
157169185|NCT02591238|567361306|FG003|Overall Study|Withdrawal by Subject|1|||
157169186|NCT02591238|567361303|FG000|Overall Study|influenza|0|||
157169187|NCT02591238|567361304|FG001|Overall Study|influenza|0|||
157169188|NCT02591238|567361305|FG002|Overall Study|influenza|0|||
157169189|NCT02591238|567361306|FG003|Overall Study|influenza|1|||
157169190|NCT02591238|567361303|FG000|Overall Study|personal circumstances|0|||
156955247|NCT00320216|566587222|FG004|Overall Study|Lack of Efficacy|1|||
156955248|NCT00320216|566587218|FG000|Overall Study|Lost to Follow-up|3|||
156955249|NCT00320216|566587219|FG001|Overall Study|Lost to Follow-up|0|||
156955250|NCT00320216|566587220|FG002|Overall Study|Lost to Follow-up|0|||
156955251|NCT00320216|566587221|FG003|Overall Study|Lost to Follow-up|0|||
156955252|NCT00320216|566587222|FG004|Overall Study|Lost to Follow-up|0|||
156955253|NCT00320216|566587218|FG000|Overall Study|Other|7|||
156955254|NCT00320216|566587219|FG001|Overall Study|Other|2|||
156955255|NCT00320216|566587220|FG002|Overall Study|Other|5|||
156955256|NCT00320216|566587221|FG003|Overall Study|Other|1|||
156955257|NCT00320216|566587222|FG004|Overall Study|Other|3|||
156955258|NCT00779246|566587231|FG000|Overall Study|Missing sufficient data for analysis|33|||
156955259|NCT00779246|566587232|FG001|Overall Study|Missing sufficient data for analysis|53|||
156955260|NCT03579459|566587233|FG000|Overall Study|Adverse Event|7|||
156955261|NCT03579459|566587234|FG001|Overall Study|Adverse Event|6|||
156955262|NCT03579459|566587235|FG002|Overall Study|Adverse Event|2|||
156955263|NCT03579459|566587236|FG003|Overall Study|Adverse Event|6|||
156955264|NCT03579459|566587233|FG000|Overall Study|Death|1|||
156955265|NCT03579459|566587234|FG001|Overall Study|Death|0|||
156955266|NCT03579459|566587235|FG002|Overall Study|Death|1|||
156955267|NCT03579459|566587236|FG003|Overall Study|Death|2|||
156955268|NCT03579459|566587233|FG000|Overall Study|Lost to Follow-up|6|||
156955269|NCT03579459|566587234|FG001|Overall Study|Lost to Follow-up|2|||
156955270|NCT03579459|566587235|FG002|Overall Study|Lost to Follow-up|4|||
156955271|NCT03579459|566587236|FG003|Overall Study|Lost to Follow-up|1|||
157169191|NCT02591238|567361304|FG001|Overall Study|personal circumstances|0|||
156955272|NCT03579459|566587233|FG000|Overall Study|Physician Decision|0|||
156955273|NCT03579459|566587234|FG001|Overall Study|Physician Decision|1|||
156955274|NCT03579459|566587235|FG002|Overall Study|Physician Decision|0|||
156955275|NCT03579459|566587236|FG003|Overall Study|Physician Decision|1|||
156955276|NCT03579459|566587233|FG000|Overall Study|Protocol Violation|1|||
156955277|NCT03579459|566587234|FG001|Overall Study|Protocol Violation|2|||
156955278|NCT03579459|566587235|FG002|Overall Study|Protocol Violation|3|||
156955279|NCT03579459|566587236|FG003|Overall Study|Protocol Violation|5|||
156955280|NCT03579459|566587233|FG000|Overall Study|Withdrawal by Subject|12|||
156955281|NCT03579459|566587234|FG001|Overall Study|Withdrawal by Subject|8|||
156955282|NCT03579459|566587235|FG002|Overall Study|Withdrawal by Subject|11|||
156955283|NCT03579459|566587236|FG003|Overall Study|Withdrawal by Subject|8|||
156955284|NCT03579459|566587233|FG000|Overall Study|Medication error without associated adverse event|2|||
156955285|NCT03579459|566587234|FG001|Overall Study|Medication error without associated adverse event|1|||
156955286|NCT03579459|566587235|FG002|Overall Study|Medication error without associated adverse event|1|||
156955287|NCT03579459|566587236|FG003|Overall Study|Medication error without associated adverse event|0|||
156955288|NCT03579459|566587233|FG000|Overall Study|Other|0|||
156955289|NCT03579459|566587234|FG001|Overall Study|Other|1|||
156955290|NCT03579459|566587235|FG002|Overall Study|Other|1|||
156955291|NCT03579459|566587236|FG003|Overall Study|Other|0|||
156955292|NCT03579459|566587233|FG000|Overall Study|Randomized not vaccinated|0|||
156955293|NCT03579459|566587234|FG001|Overall Study|Randomized not vaccinated|2|||
156955294|NCT03579459|566587235|FG002|Overall Study|Randomized not vaccinated|0|||
156955295|NCT03579459|566587236|FG003|Overall Study|Randomized not vaccinated|1|||
156955296|NCT00148343|566587239|FG000|Overall Study|Withdrawal by Subject|12|||
156955297|NCT00148343|566587240|FG001|Overall Study|Withdrawal by Subject|7|||
156955298|NCT00148343|566587239|FG000|Overall Study|Physician Decision|3|||
156955299|NCT00148343|566587240|FG001|Overall Study|Physician Decision|4|||
156955300|NCT02844946|566587244|FG000|Overall Study|Lost to Follow-up|7|||
156955301|NCT02844946|566587245|FG001|Overall Study|Lost to Follow-up|0|||
156955302|NCT02806986|566587246|FG000|Treatment Stage 1|Adverse Event|1|||
156955303|NCT02806986|566587246|FG000|Treatment Stage 2|Adverse Event|3|||
156955304|NCT02806986|566587246|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
156955305|NCT02528214|566587252|FG000|Overall Study|Protocol Violation|0|||
157169192|NCT02591238|567361305|FG002|Overall Study|personal circumstances|0|||
157169193|NCT02591238|567361306|FG003|Overall Study|personal circumstances|1|||
156955306|NCT02528214|566587253|FG001|Overall Study|Protocol Violation|1|||
156955307|NCT02528214|566587252|FG000|Overall Study|Adverse Event|0|||
157035877|NCT02166463|566888523|FG001|Overall Study|Physician Decision|10|||
156955308|NCT02528214|566587253|FG001|Overall Study|Adverse Event|1|||
156955309|NCT02528214|566587252|FG000|Overall Study|Other than specified above|0|||
156955310|NCT02528214|566587253|FG001|Overall Study|Other than specified above|1|||
156955311|NCT01605617|566587254|FG000|First Intervention|Adverse Event|0|||
156955312|NCT01605617|566587255|FG001|First Intervention|Adverse Event|1|||
156955313|NCT01605617|566587254|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
156955314|NCT01605617|566587255|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
156955315|NCT01660763|566587259|FG000|Overall Study|Lack of Efficacy|45|||
156955316|NCT01660763|566587260|FG001|Overall Study|Lack of Efficacy|50|||
156955317|NCT01660763|566587259|FG000|Overall Study|Adverse Event|22|||
156955318|NCT01660763|566587260|FG001|Overall Study|Adverse Event|7|||
156955319|NCT01660763|566587259|FG000|Overall Study|Protocol Violation|1|||
157035878|NCT02166463|566888522|FG000|Overall Study|Ineligible|11|||
157169194|NCT02591238|567361303|FG000|Overall Study|personal circumstances|0|||
157169195|NCT02591238|567361304|FG001|Overall Study|personal circumstances|1|||
156955320|NCT01660763|566587260|FG001|Overall Study|Protocol Violation|0|||
156955321|NCT01660763|566587259|FG000|Overall Study|Withdrawal by Subject|4|||
156955322|NCT01660763|566587260|FG001|Overall Study|Withdrawal by Subject|0|||
156955323|NCT01660763|566587259|FG000|Overall Study|Patient ready for early discharge|28|||
156955324|NCT01660763|566587260|FG001|Overall Study|Patient ready for early discharge|4|||
156955325|NCT01870843|566587261|FG000|Overall Study|Adverse Event|10|||
156955326|NCT01870843|566587261|FG000|Overall Study|Lost to Follow-up|24|||
156955327|NCT01870843|566587261|FG000|Overall Study|Death|1|||
156955328|NCT01870843|566587261|FG000|Overall Study|Withdrawal by Subject|18|||
156955329|NCT00345397|566587262|FG000|Overall Study|Death|1|||
156955330|NCT02715765|566587265|FG000|Overall Study|Study Termination|3|||
156955331|NCT02715765|566587266|FG001|Overall Study|Study Termination|0|||
156955332|NCT02715765|566587267|FG002|Overall Study|Study Termination|0|||
156955333|NCT02838017|566587269|FG000|Overall Study|Lost to Follow-up|14|||
156955334|NCT02838017|566587270|FG001|Overall Study|Lost to Follow-up|11|||
156955335|NCT01692197|566587271|FG000|Overall Study|Failed Screening|3|||
156955336|NCT02120924|566587272|FG000|Overall Study|Lack of Efficacy|1|||
156955337|NCT02120924|566587273|FG001|Overall Study|Lack of Efficacy|2|||
156955338|NCT02120924|566587274|FG002|Overall Study|Lack of Efficacy|3|||
156955339|NCT02120924|566587272|FG000|Overall Study|Adverse Event|0|||
156955340|NCT02120924|566587273|FG001|Overall Study|Adverse Event|1|||
156955341|NCT02120924|566587274|FG002|Overall Study|Adverse Event|3|||
156955342|NCT02120924|566587272|FG000|Overall Study|Withdrawal by Subject|16|||
156955343|NCT02120924|566587273|FG001|Overall Study|Withdrawal by Subject|20|||
156955344|NCT02120924|566587274|FG002|Overall Study|Withdrawal by Subject|8|||
156955345|NCT02120924|566587272|FG000|Overall Study|Lost to Follow-up|14|||
156955346|NCT02120924|566587273|FG001|Overall Study|Lost to Follow-up|14|||
156955347|NCT02120924|566587274|FG002|Overall Study|Lost to Follow-up|11|||
156955348|NCT02120924|566587272|FG000|Overall Study|Pregnancy|2|||
156955349|NCT02120924|566587273|FG001|Overall Study|Pregnancy|0|||
156955350|NCT02120924|566587274|FG002|Overall Study|Pregnancy|0|||
156955351|NCT02120924|566587272|FG000|Overall Study|Protocol Violation|3|||
156955352|NCT02120924|566587273|FG001|Overall Study|Protocol Violation|7|||
156955353|NCT02120924|566587274|FG002|Overall Study|Protocol Violation|2|||
156955354|NCT02120924|566587272|FG000|Overall Study|Physician Decision|0|||
156955355|NCT02120924|566587273|FG001|Overall Study|Physician Decision|1|||
156955356|NCT02120924|566587274|FG002|Overall Study|Physician Decision|1|||
156955357|NCT02120924|566587272|FG000|Overall Study|Death|1|||
156955358|NCT02120924|566587273|FG001|Overall Study|Death|0|||
156955359|NCT02120924|566587274|FG002|Overall Study|Death|0|||
156955360|NCT02120924|566587272|FG000|Overall Study|Compliance with IP|5|||
156955361|NCT02120924|566587273|FG001|Overall Study|Compliance with IP|1|||
156955362|NCT02120924|566587274|FG002|Overall Study|Compliance with IP|1|||
156955363|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
156955364|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
156955365|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
156955366|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
156955367|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
156955368|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
156955369|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
156955370|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
156955371|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
156955372|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
156955373|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
156955374|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
156955375|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
156955376|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
156955377|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
156955378|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
157035879|NCT02166463|566888523|FG001|Overall Study|Ineligible|2|||
157169196|NCT02591238|567361305|FG002|Overall Study|personal circumstances|0|||
157169197|NCT02591238|567361306|FG003|Overall Study|personal circumstances|0|||
156955379|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
156955380|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
156955381|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
156955382|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
156955383|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
156955384|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
156955385|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
157035880|NCT02166463|566888522|FG000|Overall Study|Progressive Disease|9|||
156955386|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
156955387|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
156955388|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
157169198|NCT00640146|567361307|FG000|Overall Study|Adverse Event|2|||
157169199|NCT00640146|567361308|FG001|Overall Study|Adverse Event|0|||
157169200|NCT00640146|567361307|FG000|Overall Study|Lost to Follow-up|0|||
157169201|NCT00640146|567361308|FG001|Overall Study|Lost to Follow-up|1|||
157169202|NCT00640146|567361307|FG000|Overall Study|Lack of Efficacy|0|||
156955389|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
156955390|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
156955391|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
156955392|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
156955393|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
156955394|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
156955395|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
156955396|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
156955397|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
156955398|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
156955399|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
156955400|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
156955401|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
156955402|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
156955403|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
156955404|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
156955405|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
156955406|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
156955407|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
156955408|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
156955409|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
156955410|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
156955411|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
156955412|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
156955413|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
156955414|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
156955415|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
156955416|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
156955417|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
156955418|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
156955419|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
156955420|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
156955421|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
156955422|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
156955423|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
156955424|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
156955425|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
156955426|NCT01884350|566587275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
156955427|NCT01884350|566587276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
156955428|NCT01884350|566587277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
156955429|NCT03588572|566587284|FG000|Visitation 1|Lack of Efficacy|1|||
156955430|NCT03588572|566587285|FG001|Visitation 1|Lack of Efficacy|1|||
156955431|NCT03588572|566587284|FG000|Visitation 2|Lost to Follow-up|1|||
156955432|NCT03588572|566587285|FG001|Visitation 2|Lost to Follow-up|1|||
156955433|NCT03588572|566587284|FG000|Visitation 2|Lack of Efficacy|0|||
156955434|NCT03588572|566587285|FG001|Visitation 2|Lack of Efficacy|1|||
156955435|NCT03588572|566587284|FG000|Visitation 2|Withdrawal by Subject|1|||
156955436|NCT03588572|566587285|FG001|Visitation 2|Withdrawal by Subject|0|||
156955437|NCT03588572|566587284|FG000|Visitation 3|Lost to Follow-up|1|||
156955438|NCT03588572|566587285|FG001|Visitation 3|Lost to Follow-up|1|||
156955439|NCT03588572|566587284|FG000|Visitation 3|Physician Decision|1|||
157169203|NCT00640146|567361308|FG001|Overall Study|Lack of Efficacy|1|||
157169204|NCT00640146|567361307|FG000|Overall Study|Withdrawal by Subject|1|||
157169205|NCT00640146|567361308|FG001|Overall Study|Withdrawal by Subject|1|||
156955440|NCT03588572|566587285|FG001|Visitation 3|Physician Decision|1|||
156955441|NCT03588572|566587284|FG000|Visitation 3|Withdrawal by Subject|1|||
157169206|NCT00640146|567361307|FG000|Overall Study|Randomized but not treated|1|||
157169207|NCT00640146|567361308|FG001|Overall Study|Randomized but not treated|3|||
157169208|NCT02455388|567361309|FG000|Overall Study|Protocol Violation|1|||
157227575|NCT02180711|567579110|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
157227576|NCT02180711|567579111|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156955442|NCT03588572|566587285|FG001|Visitation 3|Withdrawal by Subject|0|||
156955443|NCT00364858|566587295|FG000|Overall Study|Adverse Event|1|||
156955444|NCT00364858|566587296|FG001|Overall Study|Adverse Event|5|||
156955445|NCT00364858|566587295|FG000|Overall Study|Withdrawal by Subject|1|||
156955446|NCT00364858|566587296|FG001|Overall Study|Withdrawal by Subject|1|||
156955447|NCT00364858|566587295|FG000|Overall Study|Pregnancy|1|||
156955448|NCT00364858|566587296|FG001|Overall Study|Pregnancy|1|||
156955449|NCT00364858|566587295|FG000|Overall Study|Clinical failure|2|||
156955450|NCT00364858|566587296|FG001|Overall Study|Clinical failure|13|||
156955451|NCT00364858|566587295|FG000|Overall Study|Discontinuation at baseline|1|||
156955452|NCT00364858|566587296|FG001|Overall Study|Discontinuation at baseline|0|||
156955453|NCT00364858|566587295|FG000|Overall Study|Non-compliant|1|||
156955454|NCT00364858|566587296|FG001|Overall Study|Non-compliant|0|||
156955455|NCT00364858|566587295|FG000|Overall Study|Return to Q2 regimen|0|||
156955456|NCT00364858|566587296|FG001|Overall Study|Return to Q2 regimen|1|||
156955457|NCT00364858|566587295|FG000|Overall Study|Clinical baseline issue|0|||
156955458|NCT00364858|566587296|FG001|Overall Study|Clinical baseline issue|1|||
156955459|NCT00363766|566587297|FG000|Overall Study|Progressive Disease|15|||
156955460|NCT00363766|566587298|FG001|Overall Study|Progressive Disease|9|||
156955461|NCT00363766|566587297|FG000|Overall Study|Adverse Event|10|||
156955462|NCT00363766|566587298|FG001|Overall Study|Adverse Event|2|||
156955463|NCT00363766|566587297|FG000|Overall Study|Disease Related Death|1|||
156955464|NCT00363766|566587298|FG001|Overall Study|Disease Related Death|3|||
156955465|NCT00363766|566587297|FG000|Overall Study|Not Disease Related Death|3|||
156955466|NCT00363766|566587298|FG001|Overall Study|Not Disease Related Death|4|||
156955467|NCT00363766|566587297|FG000|Overall Study|Withdrawal by Subject|2|||
156955468|NCT00363766|566587298|FG001|Overall Study|Withdrawal by Subject|0|||
156955469|NCT00363766|566587297|FG000|Overall Study|Physician Decision|1|||
156955470|NCT00363766|566587298|FG001|Overall Study|Physician Decision|2|||
156955471|NCT02730819|566587305|FG000|Overall Study|Lost to Follow-up|9|||
156955472|NCT02345512|566587306|FG000|Overall Study|Adverse Event|1|||
156955473|NCT02345512|566587306|FG000|Overall Study|Withdrawal by Subject|1|||
156955474|NCT02121847|566587307|FG000|Overall Study|Administrative Reasons|1|||
156955475|NCT02121847|566587307|FG000|Overall Study|Adverse Event|2|||
156955476|NCT01660906|566587308|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
156955477|NCT03478891|566587314|FG000|Overall Study|Enrolled, but product never administered|0|||
156955478|NCT03478891|566587315|FG001|Overall Study|Enrolled, but product never administered|0|||
156955479|NCT03478891|566587316|FG002|Overall Study|Enrolled, but product never administered|1|||
156955480|NCT03478891|566587314|FG000|Overall Study|Moved from area|0|||
156955481|NCT03478891|566587315|FG001|Overall Study|Moved from area|0|||
156955482|NCT03478891|566587316|FG002|Overall Study|Moved from area|1|||
156955483|NCT03478891|566587314|FG000|Overall Study|Lost to Follow-up|1|||
156955484|NCT03478891|566587315|FG001|Overall Study|Lost to Follow-up|0|||
156955485|NCT03478891|566587316|FG002|Overall Study|Lost to Follow-up|1|||
156955486|NCT01308580|566587318|FG000|Overall Study|Lost to Follow-up|12|||
156955487|NCT01308580|566587319|FG001|Overall Study|Lost to Follow-up|7|||
156955488|NCT03823651|566587320|FG000|Overall Study|Death|5|||
156955489|NCT03823651|566587321|FG001|Overall Study|Death|0|||
156955490|NCT03823651|566587320|FG000|Overall Study|Physician Decision|1|||
156955491|NCT03823651|566587321|FG001|Overall Study|Physician Decision|0|||
156955492|NCT03823651|566587320|FG000|Overall Study|Caregiver to patient who died|0|||
156955493|NCT03823651|566587321|FG001|Overall Study|Caregiver to patient who died|5|||
156955494|NCT03823651|566587320|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
156955495|NCT03823651|566587321|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
156955496|NCT03864614|566587325|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
156955497|NCT03864614|566587326|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
156955498|NCT03864614|566587327|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
156955499|NCT03864614|566587328|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
156955500|NCT03864614|566587325|FG000|Overall Study|Withdrawal by Subject|72|||
156955501|NCT03864614|566587326|FG001|Overall Study|Withdrawal by Subject|100|||
156955502|NCT03864614|566587327|FG002|Overall Study|Withdrawal by Subject|1|||
156955503|NCT03864614|566587328|FG003|Overall Study|Withdrawal by Subject|21|||
156955504|NCT03864614|566587325|FG000|Overall Study|Lost to Follow-up|45|||
156955505|NCT03864614|566587326|FG001|Overall Study|Lost to Follow-up|54|||
156955506|NCT03864614|566587327|FG002|Overall Study|Lost to Follow-up|0|||
156955507|NCT03864614|566587328|FG003|Overall Study|Lost to Follow-up|9|||
156955508|NCT03864614|566587325|FG000|Overall Study|Adverse Event|42|||
156955509|NCT03864614|566587326|FG001|Overall Study|Adverse Event|30|||
156955510|NCT03864614|566587327|FG002|Overall Study|Adverse Event|1|||
156955511|NCT03864614|566587328|FG003|Overall Study|Adverse Event|9|||
156955512|NCT03864614|566587325|FG000|Overall Study|Protocol Deviation|6|||
156955513|NCT03864614|566587326|FG001|Overall Study|Protocol Deviation|26|||
156955514|NCT03864614|566587327|FG002|Overall Study|Protocol Deviation|0|||
157035881|NCT02166463|566888523|FG001|Overall Study|Progressive Disease|6|||
157035882|NCT02166463|566888522|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
157035883|NCT02166463|566888523|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
157035884|NCT02166463|566888522|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
157035885|NCT02166463|566888523|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
157035886|NCT02166463|566888522|FG000|Overall Study|Refusal of further protocol therapy|5|||
157035887|NCT02166463|566888523|FG001|Overall Study|Refusal of further protocol therapy|6|||
157035888|NCT00982644|566888524|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
157035889|NCT00982644|566888525|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
157035890|NCT00982644|566888524|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
157035891|NCT00982644|566888525|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
157035892|NCT00982644|566888524|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
157035893|NCT00982644|566888525|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
157035894|NCT00982644|566888524|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
157035895|NCT00982644|566888525|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
157035896|NCT00982644|566888524|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
157035897|NCT00982644|566888525|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
157035898|NCT00982644|566888524|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
157035899|NCT00982644|566888525|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
157035900|NCT00982644|566888524|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
157035901|NCT00982644|566888525|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
157035902|NCT00982644|566888524|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
157035903|NCT00982644|566888525|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
157035904|NCT00982644|566888524|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
157035905|NCT00982644|566888525|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
157035906|NCT00982644|566888524|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
157035907|NCT00982644|566888525|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
157035908|NCT03767335|566888526|FG000|Overall Study|Physician Decision|1|||
157035909|NCT03767335|566888527|FG001|Overall Study|Physician Decision|1|||
157035910|NCT03767335|566888528|FG002|Overall Study|Physician Decision|0|||
157035911|NCT03767335|566888526|FG000|Overall Study|Withdrawal by Subject|0|||
157035912|NCT03767335|566888527|FG001|Overall Study|Withdrawal by Subject|0|||
157035913|NCT03767335|566888528|FG002|Overall Study|Withdrawal by Subject|6|||
157035914|NCT03767335|566888526|FG000|Overall Study|Participant excluded from efficacy population|0|||
157035915|NCT03767335|566888527|FG001|Overall Study|Participant excluded from efficacy population|0|||
157035916|NCT03767335|566888528|FG002|Overall Study|Participant excluded from efficacy population|1|||
157035917|NCT03767335|566888526|FG000|Overall Study|Death|0|||
157035918|NCT03767335|566888527|FG001|Overall Study|Death|0|||
157035919|NCT03767335|566888528|FG002|Overall Study|Death|2|||
157035920|NCT03767335|566888526|FG000|Overall Study|Progressive Disease|2|||
157035921|NCT03767335|566888527|FG001|Overall Study|Progressive Disease|2|||
157035922|NCT03767335|566888528|FG002|Overall Study|Progressive Disease|2|||
157035923|NCT03767335|566888526|FG000|Overall Study|Disease progression needing additional medication|0|||
157035924|NCT03767335|566888527|FG001|Overall Study|Disease progression needing additional medication|0|||
157035925|NCT03767335|566888528|FG002|Overall Study|Disease progression needing additional medication|17|||
157035926|NCT03767335|566888526|FG000|Overall Study|Sponsor decision|0|||
157035927|NCT03767335|566888527|FG001|Overall Study|Sponsor decision|0|||
157035928|NCT03767335|566888528|FG002|Overall Study|Sponsor decision|2|||
157035929|NCT03767335|566888526|FG000|Overall Study|Other Medical Reasons|0|||
157035930|NCT03767335|566888527|FG001|Overall Study|Other Medical Reasons|0|||
157035931|NCT03767335|566888528|FG002|Overall Study|Other Medical Reasons|3|||
157035932|NCT03705390|566888529|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
157035933|NCT03705390|566888529|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
157169209|NCT02455388|567361310|FG001|Overall Study|Protocol Violation|0|||
157169210|NCT02455388|567361311|FG002|Overall Study|Protocol Violation|4|||
157169211|NCT02455388|567361309|FG000|Overall Study|Withdrawal by Subject|0|||
157169212|NCT02455388|567361310|FG001|Overall Study|Withdrawal by Subject|0|||
157169213|NCT02455388|567361311|FG002|Overall Study|Withdrawal by Subject|7|||
157169214|NCT00324740|567361312|FG000|Overall Study|Withdrawal by Subject|1|||
157169215|NCT00324740|567361313|FG001|Overall Study|Withdrawal by Subject|0|||
157169216|NCT00324740|567361314|FG002|Overall Study|Withdrawal by Subject|1|||
157169217|NCT03472040|567361317|FG000|Overall Study|Physician Decision|0|||
157035934|NCT03660930|566888530|FG000|Overall Study|Adverse Event|0|||
157035935|NCT03660930|566888531|FG001|Overall Study|Adverse Event|0|||
157035936|NCT03660930|566888532|FG002|Overall Study|Adverse Event|0|||
157035937|NCT03660930|566888533|FG003|Overall Study|Adverse Event|2|||
157035938|NCT03660930|566888534|FG004|Overall Study|Adverse Event|0|||
157169218|NCT03472040|567361318|FG001|Overall Study|Physician Decision|3|||
157169219|NCT03472040|567361317|FG000|Overall Study|Withdrawal by Subject|10|||
157169220|NCT03472040|567361318|FG001|Overall Study|Withdrawal by Subject|23|||
157169221|NCT03472040|567361317|FG000|Overall Study|Perceived Lack of Efficacy|29|||
157169222|NCT03472040|567361318|FG001|Overall Study|Perceived Lack of Efficacy|30|||
157169223|NCT03472040|567361317|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
157169224|NCT03472040|567361318|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
157169225|NCT03472040|567361317|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
157169226|NCT03472040|567361318|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
157169227|NCT03472040|567361317|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
157169228|NCT03472040|567361318|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
157169229|NCT03472040|567361317|FG000|Overall Study|Subject Non-compliance|2|||
157169230|NCT03472040|567361318|FG001|Overall Study|Subject Non-compliance|5|||
157169231|NCT03472040|567361317|FG000|Overall Study|Discontinuation due to Rash|0|||
156955515|NCT03864614|566587328|FG003|Overall Study|Protocol Deviation|1|||
156955516|NCT03864614|566587325|FG000|Overall Study|Physician Decision|7|||
156955517|NCT03864614|566587326|FG001|Overall Study|Physician Decision|10|||
156955518|NCT03864614|566587327|FG002|Overall Study|Physician Decision|1|||
156955519|NCT03864614|566587328|FG003|Overall Study|Physician Decision|5|||
156955520|NCT03864614|566587325|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
156955521|NCT03864614|566587326|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
156955522|NCT03864614|566587327|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
156955523|NCT03864614|566587328|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
156955524|NCT03864614|566587325|FG000|Overall Study|Sponsor Decision|1|||
156955525|NCT03864614|566587326|FG001|Overall Study|Sponsor Decision|2|||
156955526|NCT03864614|566587327|FG002|Overall Study|Sponsor Decision|0|||
156955527|NCT03864614|566587328|FG003|Overall Study|Sponsor Decision|0|||
156955528|NCT03864614|566587325|FG000|Overall Study|Pregnancy|0|||
156955529|NCT03864614|566587326|FG001|Overall Study|Pregnancy|1|||
156955530|NCT03864614|566587327|FG002|Overall Study|Pregnancy|0|||
156955531|NCT03864614|566587328|FG003|Overall Study|Pregnancy|0|||
156955532|NCT03864614|566587325|FG000|Overall Study|Other|7|||
156955533|NCT03864614|566587326|FG001|Overall Study|Other|9|||
156955534|NCT03864614|566587327|FG002|Overall Study|Other|1|||
156955535|NCT03864614|566587328|FG003|Overall Study|Other|4|||
156955536|NCT03864614|566587325|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
156955537|NCT03864614|566587326|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
156955538|NCT03864614|566587327|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
156955539|NCT03864614|566587328|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
156955540|NCT01850004|566587329|FG000|Overall Study|Poor/Non-compliance|1|||
156955541|NCT01850004|566587329|FG000|Overall Study|Participant Withdrew Consent|9|||
156955542|NCT01850004|566587329|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
156955543|NCT01850004|566587329|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
156955544|NCT01850004|566587329|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
156955545|NCT01850004|566587329|FG000|Overall Study|Other Reasons|2|||
156955546|NCT01850004|566587329|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
156955547|NCT01850004|566587329|FG000|Overall Study|Maximum Clinical Benefit|4|||
156955548|NCT00791765|566588922|FG000|Weeks 1 to 12|Adverse Event|0|||
156955549|NCT00791765|566588923|FG001|Weeks 1 to 12|Adverse Event|1|||
156955550|NCT00791765|566588922|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
156955551|NCT00791765|566588923|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
156955552|NCT00791765|566588922|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
156955553|NCT00791765|566588923|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
156955554|NCT00791765|566588922|FG000|Weeks 1 to 12|Physician Decision|1|||
156955555|NCT00791765|566588923|FG001|Weeks 1 to 12|Physician Decision|0|||
156955556|NCT00791765|566588922|FG000|Weeks 1 to 12|Disease progression|3|||
156955557|NCT00791765|566588923|FG001|Weeks 1 to 12|Disease progression|0|||
156955558|NCT00791765|566588922|FG000|Weeks 1 to 12|Ineligibility determined|0|||
156955559|NCT00791765|566588923|FG001|Weeks 1 to 12|Ineligibility determined|3|||
156955560|NCT00791765|566588922|FG000|Weeks 13 to 24|Protocol deviation|2|||
156955561|NCT00791765|566588923|FG001|Weeks 13 to 24|Protocol deviation|0|||
156955562|NCT00791765|566588922|FG000|Weeks 13 to 24|Adverse Event|0|||
156955563|NCT00791765|566588923|FG001|Weeks 13 to 24|Adverse Event|3|||
156955564|NCT00791765|566588922|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
156955565|NCT00791765|566588923|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
156955566|NCT00791765|566588922|FG000|Weeks 13 to 24|Disease progression|0|||
157169232|NCT03472040|567361318|FG001|Overall Study|Discontinuation due to Rash|1|||
157169233|NCT03472040|567361317|FG000|Overall Study|Subsequent Ineligibility|0|||
157169234|NCT03472040|567361318|FG001|Overall Study|Subsequent Ineligibility|2|||
156955567|NCT00791765|566588923|FG001|Weeks 13 to 24|Disease progression|1|||
156955568|NCT00791765|566588922|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
156955569|NCT00791765|566588923|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
156955570|NCT00791765|566588922|FG000|Weeks 13 to 24|Other|0|||
156955571|NCT00791765|566588923|FG001|Weeks 13 to 24|Other|1|||
156955572|NCT00924287|566588925|FG000|Overall Study|Death|1|||
156955573|NCT01798927|566588930|FG000|Overall Study|Withdrawal by Subject|1|||
156955574|NCT01159691|566588931|FG000|Overall Study|Lost to Follow-up|2|||
156955575|NCT01159691|566588931|FG000|Overall Study|Unknown reasons|1|||
156955576|NCT01159691|566588931|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
156955577|NCT01159691|566588931|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
156955578|NCT01159691|566588931|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
156955579|NCT01159691|566588931|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
156955580|NCT01159691|566588931|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
156955581|NCT01159691|566588931|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
156955582|NCT04579757|566588943|FG000|Overall Study|Adverse Event|0|||
156955583|NCT04579757|566588944|FG001|Overall Study|Adverse Event|0|||
156955584|NCT04579757|566588945|FG002|Overall Study|Adverse Event|0|||
156955585|NCT04579757|566588946|FG003|Overall Study|Adverse Event|2|||
156955586|NCT04579757|566588947|FG004|Overall Study|Adverse Event|1|||
156955587|NCT04579757|566588948|FG005|Overall Study|Adverse Event|1|||
156955588|NCT04579757|566588949|FG006|Overall Study|Adverse Event|0|||
156955589|NCT04579757|566588950|FG007|Overall Study|Adverse Event|0|||
156955590|NCT04579757|566588951|FG008|Overall Study|Adverse Event|0|||
156955591|NCT04579757|566588943|FG000|Overall Study|Death|4|||
156955592|NCT04579757|566588944|FG001|Overall Study|Death|1|||
156955593|NCT04579757|566588945|FG002|Overall Study|Death|14|||
156955594|NCT04579757|566588946|FG003|Overall Study|Death|3|||
156955595|NCT04579757|566588947|FG004|Overall Study|Death|2|||
156955596|NCT04579757|566588948|FG005|Overall Study|Death|7|||
156955597|NCT04579757|566588949|FG006|Overall Study|Death|0|||
156955598|NCT04579757|566588950|FG007|Overall Study|Death|1|||
156955599|NCT04579757|566588951|FG008|Overall Study|Death|3|||
156955600|NCT04579757|566588943|FG000|Overall Study|Physician Decision|0|||
156955601|NCT04579757|566588944|FG001|Overall Study|Physician Decision|0|||
156955602|NCT04579757|566588945|FG002|Overall Study|Physician Decision|0|||
156955603|NCT04579757|566588946|FG003|Overall Study|Physician Decision|2|||
156955604|NCT04579757|566588947|FG004|Overall Study|Physician Decision|1|||
156955605|NCT04579757|566588948|FG005|Overall Study|Physician Decision|1|||
156955606|NCT04579757|566588949|FG006|Overall Study|Physician Decision|1|||
156955607|NCT04579757|566588950|FG007|Overall Study|Physician Decision|0|||
156955608|NCT04579757|566588951|FG008|Overall Study|Physician Decision|0|||
156955609|NCT04579757|566588943|FG000|Overall Study|Study Terminated By Sponsor|0|||
156955610|NCT04579757|566588944|FG001|Overall Study|Study Terminated By Sponsor|0|||
156955611|NCT04579757|566588945|FG002|Overall Study|Study Terminated By Sponsor|0|||
156955612|NCT04579757|566588946|FG003|Overall Study|Study Terminated By Sponsor|0|||
156955613|NCT04579757|566588947|FG004|Overall Study|Study Terminated By Sponsor|2|||
156955614|NCT04579757|566588948|FG005|Overall Study|Study Terminated By Sponsor|0|||
156955615|NCT04579757|566588949|FG006|Overall Study|Study Terminated By Sponsor|0|||
156955616|NCT04579757|566588950|FG007|Overall Study|Study Terminated By Sponsor|2|||
156955617|NCT04579757|566588951|FG008|Overall Study|Study Terminated By Sponsor|0|||
156955618|NCT04579757|566588943|FG000|Overall Study|Withdrawal by Subject|1|||
156955619|NCT04579757|566588944|FG001|Overall Study|Withdrawal by Subject|1|||
156955620|NCT04579757|566588945|FG002|Overall Study|Withdrawal by Subject|0|||
156955621|NCT04579757|566588946|FG003|Overall Study|Withdrawal by Subject|0|||
156955622|NCT04579757|566588947|FG004|Overall Study|Withdrawal by Subject|2|||
156955623|NCT04579757|566588948|FG005|Overall Study|Withdrawal by Subject|1|||
156955624|NCT04579757|566588949|FG006|Overall Study|Withdrawal by Subject|0|||
156955625|NCT04579757|566588950|FG007|Overall Study|Withdrawal by Subject|3|||
156955626|NCT04579757|566588951|FG008|Overall Study|Withdrawal by Subject|0|||
156955627|NCT04579757|566588943|FG000|Overall Study|Radiological or Clinical PD|1|||
156955628|NCT04579757|566588944|FG001|Overall Study|Radiological or Clinical PD|4|||
156955629|NCT04579757|566588945|FG002|Overall Study|Radiological or Clinical PD|1|||
156955630|NCT04579757|566588946|FG003|Overall Study|Radiological or Clinical PD|3|||
156955631|NCT04579757|566588947|FG004|Overall Study|Radiological or Clinical PD|9|||
156955632|NCT04579757|566588948|FG005|Overall Study|Radiological or Clinical PD|4|||
156955633|NCT04579757|566588949|FG006|Overall Study|Radiological or Clinical PD|2|||
156955634|NCT04579757|566588950|FG007|Overall Study|Radiological or Clinical PD|2|||
156955635|NCT04579757|566588951|FG008|Overall Study|Radiological or Clinical PD|0|||
156955636|NCT04579757|566588943|FG000|Overall Study|Start of New Therapy|0|||
156955637|NCT04579757|566588944|FG001|Overall Study|Start of New Therapy|0|||
156955638|NCT04579757|566588945|FG002|Overall Study|Start of New Therapy|0|||
156955639|NCT04579757|566588946|FG003|Overall Study|Start of New Therapy|0|||
156955640|NCT04579757|566588947|FG004|Overall Study|Start of New Therapy|2|||
157035939|NCT03660930|566888535|FG005|Overall Study|Adverse Event|1|||
157205225|NCT03669640|567496073|FG000|Overall Study|Withdrawal by Subject|1|||
156955641|NCT04579757|566588948|FG005|Overall Study|Start of New Therapy|1|||
156955642|NCT04579757|566588949|FG006|Overall Study|Start of New Therapy|0|||
156955643|NCT04579757|566588950|FG007|Overall Study|Start of New Therapy|0|||
156955644|NCT04579757|566588951|FG008|Overall Study|Start of New Therapy|0|||
156955645|NCT01944631|566588952|FG000|Overall Study|Adverse Event|1|||
156955646|NCT01944631|566588953|FG001|Overall Study|Adverse Event|0|||
156955647|NCT01944631|566588952|FG000|Overall Study|Lost to Follow-up|3|||
156955648|NCT01944631|566588953|FG001|Overall Study|Lost to Follow-up|1|||
156955649|NCT01944631|566588952|FG000|Overall Study|Withdrawal by Subject|0|||
156955650|NCT01944631|566588953|FG001|Overall Study|Withdrawal by Subject|1|||
156955651|NCT01843192|566588954|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
157035940|NCT03660930|566888536|FG006|Overall Study|Adverse Event|0|||
157035941|NCT03660930|566888537|FG007|Overall Study|Adverse Event|0|||
157035942|NCT03660930|566888530|FG000|Overall Study|Withdrawal by Subject|0|||
157035943|NCT03660930|566888531|FG001|Overall Study|Withdrawal by Subject|0|||
157035944|NCT03660930|566888532|FG002|Overall Study|Withdrawal by Subject|0|||
157035945|NCT03660930|566888533|FG003|Overall Study|Withdrawal by Subject|0|||
157035946|NCT03660930|566888534|FG004|Overall Study|Withdrawal by Subject|0|||
157035947|NCT03660930|566888535|FG005|Overall Study|Withdrawal by Subject|1|||
157035948|NCT03660930|566888536|FG006|Overall Study|Withdrawal by Subject|0|||
157035949|NCT03660930|566888537|FG007|Overall Study|Withdrawal by Subject|0|||
157035950|NCT02726386|566888542|FG000|Overall Study|Adverse Event|17|||
157035951|NCT02726386|566888543|FG001|Overall Study|Adverse Event|20|||
157035952|NCT02726386|566888542|FG000|Overall Study|Withdrawal by Subject|14|||
157035953|NCT02726386|566888543|FG001|Overall Study|Withdrawal by Subject|28|||
157035954|NCT02726386|566888542|FG000|Overall Study|Other reasons|7|||
157035955|NCT02726386|566888543|FG001|Overall Study|Other reasons|8|||
157035956|NCT02112916|566888548|FG000|Overall Study|Adverse Event|6|||
157035957|NCT02112916|566888549|FG001|Overall Study|Adverse Event|9|||
157035958|NCT02112916|566888550|FG002|Overall Study|Adverse Event|3|||
157035959|NCT02112916|566888551|FG003|Overall Study|Adverse Event|2|||
157035960|NCT02112916|566888548|FG000|Overall Study|Death|9|||
157035961|NCT02112916|566888549|FG001|Overall Study|Death|9|||
157035962|NCT02112916|566888550|FG002|Overall Study|Death|3|||
157035963|NCT02112916|566888551|FG003|Overall Study|Death|4|||
157035964|NCT02112916|566888548|FG000|Overall Study|Lost to Follow-up|1|||
157035965|NCT02112916|566888549|FG001|Overall Study|Lost to Follow-up|0|||
157035966|NCT02112916|566888550|FG002|Overall Study|Lost to Follow-up|0|||
157035967|NCT02112916|566888551|FG003|Overall Study|Lost to Follow-up|0|||
157035968|NCT02112916|566888548|FG000|Overall Study|Physician Decision|94|||
157035969|NCT02112916|566888549|FG001|Overall Study|Physician Decision|72|||
157035970|NCT02112916|566888550|FG002|Overall Study|Physician Decision|24|||
157035971|NCT02112916|566888551|FG003|Overall Study|Physician Decision|15|||
157035972|NCT02112916|566888548|FG000|Overall Study|Withdrawal by Subject|5|||
157035973|NCT02112916|566888549|FG001|Overall Study|Withdrawal by Subject|3|||
157035974|NCT02112916|566888550|FG002|Overall Study|Withdrawal by Subject|1|||
157035975|NCT02112916|566888551|FG003|Overall Study|Withdrawal by Subject|1|||
157035976|NCT02112916|566888548|FG000|Overall Study|Ineligible|4|||
157035977|NCT02112916|566888549|FG001|Overall Study|Ineligible|8|||
157035978|NCT02112916|566888550|FG002|Overall Study|Ineligible|3|||
157035979|NCT02112916|566888551|FG003|Overall Study|Ineligible|8|||
157035980|NCT02112916|566888548|FG000|Overall Study|Inevaluable|6|||
157035981|NCT02112916|566888549|FG001|Overall Study|Inevaluable|4|||
157035982|NCT02112916|566888550|FG002|Overall Study|Inevaluable|5|||
157035983|NCT02112916|566888551|FG003|Overall Study|Inevaluable|5|||
157035984|NCT02112916|566888548|FG000|Overall Study|Refusal of further protocol therapy|19|||
157035985|NCT02112916|566888549|FG001|Overall Study|Refusal of further protocol therapy|16|||
157035986|NCT02112916|566888550|FG002|Overall Study|Refusal of further protocol therapy|1|||
157035987|NCT02112916|566888551|FG003|Overall Study|Refusal of further protocol therapy|7|||
157035988|NCT02112916|566888548|FG000|Overall Study|Development of SMN|1|||
157035989|NCT02112916|566888549|FG001|Overall Study|Development of SMN|0|||
157035990|NCT02112916|566888550|FG002|Overall Study|Development of SMN|0|||
157035991|NCT02112916|566888551|FG003|Overall Study|Development of SMN|1|||
157035992|NCT02112916|566888548|FG000|Overall Study|Relapse/Progression|10|||
157035993|NCT02112916|566888549|FG001|Overall Study|Relapse/Progression|18|||
157035994|NCT02112916|566888550|FG002|Overall Study|Relapse/Progression|15|||
157035995|NCT02112916|566888551|FG003|Overall Study|Relapse/Progression|2|||
157035996|NCT02112916|566888548|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
157035997|NCT02112916|566888549|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
157035998|NCT02112916|566888550|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
157035999|NCT02112916|566888551|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
157169235|NCT03472040|567361317|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
157169236|NCT03472040|567361318|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
157169237|NCT02769832|567361319|FG000|Overall Study|Death|30|||
157036000|NCT02112916|566888548|FG000|Overall Study|Still on Therapy|44|||
157036001|NCT02112916|566888549|FG001|Overall Study|Still on Therapy|47|||
157036002|NCT02112916|566888550|FG002|Overall Study|Still on Therapy|3|||
157036003|NCT02112916|566888551|FG003|Overall Study|Still on Therapy|2|||
157036004|NCT02112916|566888548|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
157036005|NCT02112916|566888549|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
157036006|NCT02112916|566888550|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
157036007|NCT02112916|566888551|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
157036008|NCT02112916|566888548|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
157036009|NCT02112916|566888549|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
157036010|NCT02112916|566888550|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
157036011|NCT02112916|566888551|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
156955652|NCT01843192|566588955|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
156955653|NCT01843192|566588956|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
156955654|NCT00328510|566588959|FG000|Overall Study|Gag disorder, could not use frame|4|||
156955655|NCT00328510|566588960|FG001|Overall Study|Gag disorder, could not use frame|0|||
156955656|NCT00328510|566588959|FG000|Overall Study|Dentition problems, could not use frame|1|||
156955657|NCT00328510|566588960|FG001|Overall Study|Dentition problems, could not use frame|0|||
156955658|NCT00328510|566588959|FG000|Overall Study|Withdrawal by Subject|4|||
156955659|NCT00328510|566588960|FG001|Overall Study|Withdrawal by Subject|2|||
156955660|NCT00328510|566588959|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
156955661|NCT00328510|566588960|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
156955662|NCT00328510|566588959|FG000|Overall Study|Treatment changed to a single fraction|1|||
156955663|NCT00328510|566588960|FG001|Overall Study|Treatment changed to a single fraction|1|||
156955664|NCT01412944|566588961|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156955665|NCT01412944|566588962|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156955666|NCT01412944|566588963|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
156955667|NCT01412944|566588964|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156955668|NCT01412944|566588965|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156955669|NCT01412944|566588966|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
156955670|NCT01412944|566588961|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156955671|NCT01412944|566588962|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156955672|NCT01412944|566588963|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156955673|NCT01412944|566588964|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156955674|NCT01412944|566588965|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
156955675|NCT01412944|566588966|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
156955676|NCT01412944|566588961|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156955677|NCT01412944|566588962|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156955678|NCT01412944|566588963|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156955679|NCT01412944|566588964|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156955680|NCT01412944|566588965|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
156955681|NCT01412944|566588966|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
156955682|NCT01412944|566588961|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
156955683|NCT01412944|566588962|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156955684|NCT01412944|566588963|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156955685|NCT01412944|566588964|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156955686|NCT01412944|566588965|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156955687|NCT01412944|566588966|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
156955688|NCT01412944|566588961|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
156955689|NCT01412944|566588962|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
156955690|NCT01412944|566588963|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
156955691|NCT01412944|566588964|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
156955692|NCT01412944|566588965|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
156955693|NCT01412944|566588966|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
156955694|NCT01412944|566588961|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156955695|NCT01412944|566588962|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
156955696|NCT01412944|566588963|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156955697|NCT01412944|566588964|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156955698|NCT01412944|566588965|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156955699|NCT01412944|566588966|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
156955700|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955701|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955702|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156955703|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156955704|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156955705|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955706|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Adverse Event|0|||
156955707|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Adverse Event|0|||
156955708|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Adverse Event|0|||
156955709|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Adverse Event|0|||
156955710|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Adverse Event|1|||
156955711|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Adverse Event|0|||
156955712|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
156955713|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
156955714|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
156955715|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
156955716|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
156955717|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
156955718|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955719|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
157169238|NCT00225147|567361320|FG000|Open-label Phase|Lost to Follow-up|0|||
156955720|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955721|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955722|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955723|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
156955724|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955725|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955726|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955727|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955728|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
156955729|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955730|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
156955731|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
156955732|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955733|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955734|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955735|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
156955736|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
156955737|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
156955738|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
156955739|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
156955740|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
156955741|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
156955742|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955743|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
156955744|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955745|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955746|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955747|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
156955748|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955749|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
156955750|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955751|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955752|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955753|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
156955754|NCT01412944|566588961|FG000|Entire: IV + Maintenance|Adverse Event|0|||
156955755|NCT01412944|566588962|FG001|Entire: IV + Maintenance|Adverse Event|1|||
156955756|NCT01412944|566588963|FG002|Entire: IV + Maintenance|Adverse Event|0|||
156955757|NCT01412944|566588964|FG003|Entire: IV + Maintenance|Adverse Event|0|||
156955758|NCT01412944|566588965|FG004|Entire: IV + Maintenance|Adverse Event|0|||
156955759|NCT01412944|566588966|FG005|Entire: IV + Maintenance|Adverse Event|0|||
156955760|NCT01990950|566588967|FG000|Overall Study|Death|3|||
156955761|NCT01990950|566588967|FG000|Overall Study|Lost to Follow-up|2|||
156955762|NCT01990950|566588967|FG000|Overall Study|Withdrawal by Subject|6|||
156955763|NCT02863926|566588968|FG000|Overall Study|Physician Decision|1|||
156955764|NCT02863926|566588969|FG001|Overall Study|Physician Decision|0|||
156955765|NCT02863926|566588968|FG000|Overall Study|Lost to Follow-up|1|||
156955766|NCT02863926|566588969|FG001|Overall Study|Lost to Follow-up|1|||
156955767|NCT02301143|566588972|FG000|Induction Period|Enrolled But Not Treated|1|||
156955768|NCT02301143|566588973|FG001|Induction Period|Enrolled But Not Treated|0|||
156955769|NCT02301143|566588972|FG000|Induction Period|Death|1|||
156955770|NCT02301143|566588973|FG001|Induction Period|Death|0|||
156955771|NCT02301143|566588972|FG000|Induction Period|Adverse Event|22|||
156955772|NCT02301143|566588973|FG001|Induction Period|Adverse Event|0|||
156955773|NCT02301143|566588972|FG000|Induction Period|Progressive Disease|8|||
156955774|NCT02301143|566588973|FG001|Induction Period|Progressive Disease|0|||
156955775|NCT02301143|566588972|FG000|Induction Period|Withdrawal by Subject|3|||
156955776|NCT02301143|566588973|FG001|Induction Period|Withdrawal by Subject|0|||
156955777|NCT02301143|566588972|FG000|Induction Period|Noncompliance with Study Drug|1|||
156955778|NCT02301143|566588973|FG001|Induction Period|Noncompliance with Study Drug|0|||
156955779|NCT02301143|566588972|FG000|Induction Period|Physician Decision|4|||
156955780|NCT02301143|566588973|FG001|Induction Period|Physician Decision|0|||
156955781|NCT02301143|566588972|FG000|Induction Period|Symptomatic Deterioration|2|||
156955782|NCT02301143|566588973|FG001|Induction Period|Symptomatic Deterioration|0|||
156955783|NCT02301143|566588972|FG000|Induction Period|Protocol Violation|2|||
156955784|NCT02301143|566588973|FG001|Induction Period|Protocol Violation|0|||
156955785|NCT02301143|566588972|FG000|Induction Period|Other|1|||
156955786|NCT02301143|566588973|FG001|Induction Period|Other|0|||
156955787|NCT02301143|566588972|FG000|Investigator's Choice|Adverse Event|0|||
156955788|NCT02301143|566588973|FG001|Investigator's Choice|Adverse Event|3|||
156955789|NCT02301143|566588972|FG000|Investigator's Choice|Progressive Disease|0|||
156955790|NCT02301143|566588973|FG001|Investigator's Choice|Progressive Disease|3|||
156955791|NCT02301143|566588972|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
156955792|NCT02301143|566588973|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
157036012|NCT03333915|566888553|FG000|Overall Study|Lost to Follow-up|0|||
157036013|NCT03333915|566888554|FG001|Overall Study|Lost to Follow-up|0|||
157036014|NCT03333915|566888555|FG002|Overall Study|Lost to Follow-up|1|||
157036015|NCT03333915|566888556|FG003|Overall Study|Lost to Follow-up|0|||
157036016|NCT03333915|566888557|FG004|Overall Study|Lost to Follow-up|0|||
157036017|NCT03333915|566888553|FG000|Overall Study|Disease Progression|0|||
157036018|NCT03333915|566888554|FG001|Overall Study|Disease Progression|1|||
157036019|NCT03333915|566888555|FG002|Overall Study|Disease Progression|0|||
157036020|NCT03333915|566888556|FG003|Overall Study|Disease Progression|0|||
157036021|NCT03333915|566888557|FG004|Overall Study|Disease Progression|0|||
157036022|NCT03333915|566888553|FG000|Overall Study|Death|0|||
157036023|NCT03333915|566888554|FG001|Overall Study|Death|0|||
157036024|NCT03333915|566888555|FG002|Overall Study|Death|0|||
157036025|NCT03333915|566888556|FG003|Overall Study|Death|37|||
157036026|NCT03333915|566888557|FG004|Overall Study|Death|18|||
157036027|NCT03333915|566888553|FG000|Overall Study|Sponsor's Decision|0|||
157036028|NCT03333915|566888554|FG001|Overall Study|Sponsor's Decision|0|||
157036029|NCT03333915|566888555|FG002|Overall Study|Sponsor's Decision|0|||
157036030|NCT03333915|566888556|FG003|Overall Study|Sponsor's Decision|48|||
157036031|NCT03333915|566888557|FG004|Overall Study|Sponsor's Decision|4|||
157036032|NCT03333915|566888553|FG000|Overall Study|Withdrawal by Subject|0|||
157036033|NCT03333915|566888554|FG001|Overall Study|Withdrawal by Subject|0|||
157036034|NCT03333915|566888555|FG002|Overall Study|Withdrawal by Subject|0|||
157036035|NCT03333915|566888556|FG003|Overall Study|Withdrawal by Subject|5|||
157036036|NCT03333915|566888557|FG004|Overall Study|Withdrawal by Subject|1|||
157036037|NCT04174560|566888575|FG000|Overall Study|Lost to Follow-up|1|||
157036038|NCT04174560|566888576|FG001|Overall Study|Lost to Follow-up|0|||
157036039|NCT04174560|566888577|FG002|Overall Study|Lost to Follow-up|0|||
157036040|NCT04174560|566888578|FG003|Overall Study|Lost to Follow-up|0|||
157036041|NCT04174560|566888575|FG000|Overall Study|Withdrawal by Subject|0|||
157036042|NCT04174560|566888576|FG001|Overall Study|Withdrawal by Subject|0|||
157036043|NCT04174560|566888577|FG002|Overall Study|Withdrawal by Subject|2|||
157036044|NCT04174560|566888578|FG003|Overall Study|Withdrawal by Subject|0|||
157036045|NCT04940624|566888581|FG000|Overall Study|Adverse Event|4|||
157036046|NCT04940624|566888582|FG001|Overall Study|Adverse Event|11|||
157036047|NCT04940624|566888581|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157036048|NCT04940624|566888582|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
157036049|NCT04940624|566888581|FG000|Overall Study|Physician Decision|1|||
157036050|NCT04940624|566888582|FG001|Overall Study|Physician Decision|0|||
157036051|NCT04940624|566888581|FG000|Overall Study|Lost to Follow-up|1|||
157036052|NCT04940624|566888582|FG001|Overall Study|Lost to Follow-up|0|||
157036053|NCT04940624|566888581|FG000|Overall Study|Reason Not Specified|1|||
157036054|NCT04940624|566888582|FG001|Overall Study|Reason Not Specified|0|||
157036055|NCT00557492|566888957|FG000|Overall Study|Change in health insurance|1|||
157036056|NCT03653364|566888958|FG000|Overall Study|Withdrawal by Subject|1|||
157036057|NCT03653364|566888958|FG000|Overall Study|Enrolled in Error|1|||
157036058|NCT03653364|566888958|FG000|Overall Study|Death|1|||
157036059|NCT02306161|566888961|FG000|Overall Study|Death|1|||
157036060|NCT02306161|566888962|FG001|Overall Study|Death|3|||
157036061|NCT02306161|566888961|FG000|Overall Study|Lack of Efficacy|20|||
157036062|NCT02306161|566888962|FG001|Overall Study|Lack of Efficacy|43|||
157036063|NCT02306161|566888961|FG000|Overall Study|Physician Decision|30|||
157036064|NCT02306161|566888962|FG001|Overall Study|Physician Decision|18|||
157036065|NCT02306161|566888961|FG000|Overall Study|Withdrawal by Subject|4|||
157036066|NCT02306161|566888962|FG001|Overall Study|Withdrawal by Subject|0|||
157036067|NCT02306161|566888961|FG000|Overall Study|Ineligible|9|||
157036068|NCT02306161|566888962|FG001|Overall Study|Ineligible|5|||
157036069|NCT03047213|566888967|FG000|Overall Study|Withdrawal by Subject|2|||
157036070|NCT03047213|566888968|FG001|Overall Study|Withdrawal by Subject|0|||
157036071|NCT03047213|566888967|FG000|Overall Study|Adverse Event|2|||
157036072|NCT03047213|566888968|FG001|Overall Study|Adverse Event|0|||
157036073|NCT02446600|566888970|FG000|Overall Study|Never treated|20|||
157036074|NCT02446600|566888971|FG001|Overall Study|Never treated|2|||
157036075|NCT02446600|566888972|FG002|Overall Study|Never treated|6|||
157036076|NCT02446600|566888973|FG003|Overall Study|Never treated|0|||
157036077|NCT02446600|566888970|FG000|Overall Study|Withdrawal by Subject|19|||
157036078|NCT02446600|566888971|FG001|Overall Study|Withdrawal by Subject|5|||
157036079|NCT02446600|566888972|FG002|Overall Study|Withdrawal by Subject|17|||
157036080|NCT02446600|566888973|FG003|Overall Study|Withdrawal by Subject|0|||
157036081|NCT02446600|566888970|FG000|Overall Study|Ineligible|1|||
157036082|NCT02446600|566888971|FG001|Overall Study|Ineligible|4|||
157036083|NCT02446600|566888972|FG002|Overall Study|Ineligible|4|||
157036084|NCT02446600|566888973|FG003|Overall Study|Ineligible|1|||
157036085|NCT02446600|566888970|FG000|Overall Study|Duplicate Enrollment|0|||
157036086|NCT02446600|566888971|FG001|Overall Study|Duplicate Enrollment|1|||
157036087|NCT02446600|566888972|FG002|Overall Study|Duplicate Enrollment|0|||
157036088|NCT02446600|566888973|FG003|Overall Study|Duplicate Enrollment|0|||
157036089|NCT03725332|566888974|FG000|Overall Study|Adverse Event|5|||
157036090|NCT03725332|566888975|FG001|Overall Study|Adverse Event|10|||
157036091|NCT03725332|566888974|FG000|Overall Study|Death|1|||
157169239|NCT00225147|567361321|FG001|Open-label Phase|Lost to Follow-up|0|||
157169240|NCT00225147|567361322|FG002|Open-label Phase|Lost to Follow-up|0|||
157169241|NCT00225147|567361323|FG003|Open-label Phase|Lost to Follow-up|4|||
157169242|NCT00225147|567361320|FG000|Open-label Phase|Withdrawal by Subject|0|||
157169243|NCT00225147|567361321|FG001|Open-label Phase|Withdrawal by Subject|0|||
156955793|NCT02301143|566588972|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
156955794|NCT02301143|566588973|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
156955795|NCT02301143|566588972|FG000|Investigator's Choice|Other|0|||
156955796|NCT02301143|566588973|FG001|Investigator's Choice|Other|1|||
156955797|NCT02301143|566588972|FG000|Investigator's Choice|Unresectable Surgery|0|||
156955798|NCT02301143|566588973|FG001|Investigator's Choice|Unresectable Surgery|1|||
156955799|NCT03214367|566588976|FG000|Lead-in Period|Withdrawal by Subject|50|||
156955800|NCT03214367|566588977|FG001|Lead-in Period|Withdrawal by Subject|0|||
156955801|NCT03214367|566588978|FG002|Lead-in Period|Withdrawal by Subject|0|||
156955802|NCT03214367|566588979|FG003|Lead-in Period|Withdrawal by Subject|0|||
156955803|NCT03214367|566588980|FG004|Lead-in Period|Withdrawal by Subject|2|||
156955804|NCT03214367|566588981|FG005|Lead-in Period|Withdrawal by Subject|0|||
156955805|NCT03214367|566588982|FG006|Lead-in Period|Withdrawal by Subject|0|||
156955806|NCT03214367|566588983|FG007|Lead-in Period|Withdrawal by Subject|0|||
156955807|NCT03214367|566588976|FG000|Lead-in Period|Adverse Event|3|||
156955808|NCT03214367|566588977|FG001|Lead-in Period|Adverse Event|0|||
156955809|NCT03214367|566588978|FG002|Lead-in Period|Adverse Event|0|||
156955810|NCT03214367|566588979|FG003|Lead-in Period|Adverse Event|0|||
156955811|NCT03214367|566588980|FG004|Lead-in Period|Adverse Event|0|||
156955812|NCT03214367|566588981|FG005|Lead-in Period|Adverse Event|0|||
156955813|NCT03214367|566588982|FG006|Lead-in Period|Adverse Event|0|||
156955814|NCT03214367|566588983|FG007|Lead-in Period|Adverse Event|0|||
156955815|NCT03214367|566588976|FG000|Lead-in Period|Lost to Follow-up|12|||
156955816|NCT03214367|566588977|FG001|Lead-in Period|Lost to Follow-up|0|||
156955817|NCT03214367|566588978|FG002|Lead-in Period|Lost to Follow-up|0|||
156955818|NCT03214367|566588979|FG003|Lead-in Period|Lost to Follow-up|0|||
156955819|NCT03214367|566588980|FG004|Lead-in Period|Lost to Follow-up|0|||
156955820|NCT03214367|566588981|FG005|Lead-in Period|Lost to Follow-up|0|||
156955821|NCT03214367|566588982|FG006|Lead-in Period|Lost to Follow-up|0|||
156955822|NCT03214367|566588983|FG007|Lead-in Period|Lost to Follow-up|0|||
156955823|NCT03214367|566588976|FG000|Lead-in Period|Sponsor Decision|11|||
156955824|NCT03214367|566588977|FG001|Lead-in Period|Sponsor Decision|0|||
156955825|NCT03214367|566588978|FG002|Lead-in Period|Sponsor Decision|0|||
156955826|NCT03214367|566588979|FG003|Lead-in Period|Sponsor Decision|0|||
156955827|NCT03214367|566588980|FG004|Lead-in Period|Sponsor Decision|0|||
156955828|NCT03214367|566588981|FG005|Lead-in Period|Sponsor Decision|0|||
156955829|NCT03214367|566588982|FG006|Lead-in Period|Sponsor Decision|0|||
156955830|NCT03214367|566588983|FG007|Lead-in Period|Sponsor Decision|0|||
156955831|NCT03214367|566588976|FG000|Lead-in Period|Physician Decision|12|||
156955832|NCT03214367|566588977|FG001|Lead-in Period|Physician Decision|0|||
156955833|NCT03214367|566588978|FG002|Lead-in Period|Physician Decision|0|||
156955834|NCT03214367|566588979|FG003|Lead-in Period|Physician Decision|0|||
156955835|NCT03214367|566588980|FG004|Lead-in Period|Physician Decision|0|||
156955836|NCT03214367|566588981|FG005|Lead-in Period|Physician Decision|0|||
156955837|NCT03214367|566588982|FG006|Lead-in Period|Physician Decision|0|||
156955838|NCT03214367|566588983|FG007|Lead-in Period|Physician Decision|0|||
156955839|NCT03214367|566588976|FG000|Lead-in Period|Protocol Violation|5|||
156955840|NCT03214367|566588977|FG001|Lead-in Period|Protocol Violation|0|||
156955841|NCT03214367|566588978|FG002|Lead-in Period|Protocol Violation|0|||
156955842|NCT03214367|566588979|FG003|Lead-in Period|Protocol Violation|0|||
156955843|NCT03214367|566588980|FG004|Lead-in Period|Protocol Violation|0|||
156955844|NCT03214367|566588981|FG005|Lead-in Period|Protocol Violation|0|||
156955845|NCT03214367|566588982|FG006|Lead-in Period|Protocol Violation|0|||
156955846|NCT03214367|566588983|FG007|Lead-in Period|Protocol Violation|0|||
156955847|NCT03214367|566588976|FG000|Lead-in Period|Treatment Interruption|1|||
156955848|NCT03214367|566588977|FG001|Lead-in Period|Treatment Interruption|0|||
156955849|NCT03214367|566588978|FG002|Lead-in Period|Treatment Interruption|0|||
157169244|NCT00225147|567361322|FG002|Open-label Phase|Withdrawal by Subject|0|||
156955850|NCT03214367|566588979|FG003|Lead-in Period|Treatment Interruption|0|||
156955851|NCT03214367|566588980|FG004|Lead-in Period|Treatment Interruption|0|||
156955852|NCT03214367|566588981|FG005|Lead-in Period|Treatment Interruption|0|||
156955853|NCT03214367|566588982|FG006|Lead-in Period|Treatment Interruption|0|||
156955854|NCT03214367|566588983|FG007|Lead-in Period|Treatment Interruption|0|||
156955855|NCT03214367|566588976|FG000|Treatment Period|Adverse Event|0|||
156955856|NCT03214367|566588977|FG001|Treatment Period|Adverse Event|1|||
156955857|NCT03214367|566588978|FG002|Treatment Period|Adverse Event|4|||
156955858|NCT03214367|566588979|FG003|Treatment Period|Adverse Event|2|||
156955859|NCT03214367|566588980|FG004|Treatment Period|Adverse Event|0|||
156955860|NCT03214367|566588981|FG005|Treatment Period|Adverse Event|0|||
156955861|NCT03214367|566588982|FG006|Treatment Period|Adverse Event|0|||
156955862|NCT03214367|566588983|FG007|Treatment Period|Adverse Event|0|||
156955863|NCT03214367|566588976|FG000|Treatment Period|Death|0|||
156955864|NCT03214367|566588977|FG001|Treatment Period|Death|1|||
156955865|NCT03214367|566588978|FG002|Treatment Period|Death|1|||
157169245|NCT00225147|567361323|FG003|Open-label Phase|Withdrawal by Subject|6|||
157169246|NCT02197897|567361324|FG000|Overall Study|not eligible|1|||
157169247|NCT01204697|567361325|FG000|Overall Study|Death|26|||
157169248|NCT01204697|567361326|FG001|Overall Study|Death|27|||
157169249|NCT01204697|567361325|FG000|Overall Study|Lost to Follow-up|3|||
157169250|NCT01204697|567361326|FG001|Overall Study|Lost to Follow-up|4|||
157169251|NCT01204697|567361325|FG000|Overall Study|Withdrawal by Subject|2|||
157227577|NCT02180711|567579112|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
157227578|NCT02180711|567579113|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
156955866|NCT03214367|566588979|FG003|Treatment Period|Death|1|||
156955867|NCT03214367|566588980|FG004|Treatment Period|Death|0|||
156955868|NCT03214367|566588981|FG005|Treatment Period|Death|0|||
156955869|NCT03214367|566588982|FG006|Treatment Period|Death|0|||
156955870|NCT03214367|566588983|FG007|Treatment Period|Death|0|||
156955871|NCT03214367|566588976|FG000|Treatment Period|Lost to Follow-up|0|||
156955872|NCT03214367|566588977|FG001|Treatment Period|Lost to Follow-up|5|||
156955873|NCT03214367|566588978|FG002|Treatment Period|Lost to Follow-up|3|||
156955874|NCT03214367|566588979|FG003|Treatment Period|Lost to Follow-up|2|||
156955875|NCT03214367|566588980|FG004|Treatment Period|Lost to Follow-up|0|||
156955876|NCT03214367|566588981|FG005|Treatment Period|Lost to Follow-up|2|||
156955877|NCT03214367|566588982|FG006|Treatment Period|Lost to Follow-up|1|||
156955878|NCT03214367|566588983|FG007|Treatment Period|Lost to Follow-up|0|||
156955879|NCT03214367|566588976|FG000|Treatment Period|Sponsor Decision|0|||
156955880|NCT03214367|566588977|FG001|Treatment Period|Sponsor Decision|3|||
156955881|NCT03214367|566588978|FG002|Treatment Period|Sponsor Decision|0|||
156955882|NCT03214367|566588979|FG003|Treatment Period|Sponsor Decision|0|||
156955883|NCT03214367|566588980|FG004|Treatment Period|Sponsor Decision|0|||
156955884|NCT03214367|566588981|FG005|Treatment Period|Sponsor Decision|0|||
156955885|NCT03214367|566588982|FG006|Treatment Period|Sponsor Decision|0|||
156955886|NCT03214367|566588983|FG007|Treatment Period|Sponsor Decision|0|||
156955887|NCT03214367|566588976|FG000|Treatment Period|Physician Decision|0|||
156955888|NCT03214367|566588977|FG001|Treatment Period|Physician Decision|1|||
156955889|NCT03214367|566588978|FG002|Treatment Period|Physician Decision|2|||
156955890|NCT03214367|566588979|FG003|Treatment Period|Physician Decision|0|||
156955891|NCT03214367|566588980|FG004|Treatment Period|Physician Decision|0|||
156955892|NCT03214367|566588981|FG005|Treatment Period|Physician Decision|0|||
156955893|NCT03214367|566588982|FG006|Treatment Period|Physician Decision|0|||
156955894|NCT03214367|566588983|FG007|Treatment Period|Physician Decision|0|||
156955895|NCT03214367|566588976|FG000|Treatment Period|Protocol Violation|0|||
156955896|NCT03214367|566588977|FG001|Treatment Period|Protocol Violation|3|||
156955897|NCT03214367|566588978|FG002|Treatment Period|Protocol Violation|0|||
156955898|NCT03214367|566588979|FG003|Treatment Period|Protocol Violation|0|||
156955899|NCT03214367|566588980|FG004|Treatment Period|Protocol Violation|0|||
156955900|NCT03214367|566588981|FG005|Treatment Period|Protocol Violation|0|||
156955901|NCT03214367|566588982|FG006|Treatment Period|Protocol Violation|0|||
156955902|NCT03214367|566588983|FG007|Treatment Period|Protocol Violation|0|||
156955903|NCT03214367|566588976|FG000|Treatment Period|Withdrawal by Subject|0|||
156955904|NCT03214367|566588977|FG001|Treatment Period|Withdrawal by Subject|20|||
156955905|NCT03214367|566588978|FG002|Treatment Period|Withdrawal by Subject|23|||
156955906|NCT03214367|566588979|FG003|Treatment Period|Withdrawal by Subject|14|||
156955907|NCT03214367|566588980|FG004|Treatment Period|Withdrawal by Subject|0|||
156955908|NCT03214367|566588981|FG005|Treatment Period|Withdrawal by Subject|1|||
156955909|NCT03214367|566588982|FG006|Treatment Period|Withdrawal by Subject|1|||
156955910|NCT03214367|566588983|FG007|Treatment Period|Withdrawal by Subject|1|||
156955911|NCT03268811|566588986|FG000|Overall Study|Adverse Event|0|||
156955912|NCT03268811|566588987|FG001|Overall Study|Adverse Event|1|||
156955913|NCT04726709|566588992|FG000|Overall Study|Withdrawal by Subject|2|||
156955914|NCT04726709|566588993|FG001|Overall Study|Withdrawal by Subject|2|||
156955915|NCT02473952|566588994|FG000|Overall Study|Adverse Event|2|||
156955916|NCT02473952|566588995|FG001|Overall Study|Adverse Event|2|||
156955917|NCT02473952|566588994|FG000|Overall Study|Withdrawal by Subject|0|||
156955918|NCT02473952|566588995|FG001|Overall Study|Withdrawal by Subject|6|||
156955919|NCT00823719|566588998|FG000|Overall Study|Adverse Event|1|||
156955920|NCT00823719|566588999|FG001|Overall Study|Adverse Event|2|||
156955921|NCT00823719|566588998|FG000|Overall Study|Physician Decision|1|||
156955922|NCT00823719|566588999|FG001|Overall Study|Physician Decision|4|||
156955923|NCT00823719|566588998|FG000|Overall Study|Withdrawal by Subject|0|||
156955924|NCT00823719|566588999|FG001|Overall Study|Withdrawal by Subject|1|||
156955925|NCT00823719|566588998|FG000|Overall Study|Disease Progression|4|||
156955926|NCT00823719|566588999|FG001|Overall Study|Disease Progression|4|||
157169252|NCT01204697|567361326|FG001|Overall Study|Withdrawal by Subject|4|||
156955927|NCT00407537|566589000|FG000|Overall Study|Death|5|||
156955928|NCT00407537|566589001|FG001|Overall Study|Death|2|||
156955929|NCT00407537|566589000|FG000|Overall Study|Adverse Event|36|||
156955930|NCT00407537|566589001|FG001|Overall Study|Adverse Event|0|||
157169253|NCT01204697|567361325|FG000|Overall Study|Randomized, but not treated|0|||
157169254|NCT01204697|567361326|FG001|Overall Study|Randomized, but not treated|1|||
156955931|NCT00407537|566589000|FG000|Overall Study|Lost to Follow-up|12|||
157036092|NCT03725332|566888975|FG001|Overall Study|Death|3|||
157036093|NCT03725332|566888974|FG000|Overall Study|Lost to Follow-up|43|||
157036094|NCT03725332|566888975|FG001|Overall Study|Lost to Follow-up|122|||
157036095|NCT03725332|566888974|FG000|Overall Study|Withdrawal by Subject|0|||
157036096|NCT03725332|566888975|FG001|Overall Study|Withdrawal by Subject|1|||
157036097|NCT03725332|566888974|FG000|Overall Study|Duplicate enrollment|0|||
157036098|NCT03725332|566888975|FG001|Overall Study|Duplicate enrollment|1|||
157036099|NCT03725332|566888974|FG000|Overall Study|Did not consent|0|||
157036100|NCT03725332|566888975|FG001|Overall Study|Did not consent|1|||
157036101|NCT03242915|566888978|FG000|Overall Study|Adverse Event|5|||
157036102|NCT03242915|566888979|FG001|Overall Study|Adverse Event|1|||
157036103|NCT03242915|566888978|FG000|Overall Study|Withdrawal by Subject|0|||
157036104|NCT03242915|566888979|FG001|Overall Study|Withdrawal by Subject|2|||
157169255|NCT03939637|567361331|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
157169256|NCT03939637|567361332|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
157169257|NCT03939637|567361331|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
157169258|NCT03939637|567361332|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
157169259|NCT04268004|567361333|FG000|Overall Study|Excluded from analyses|0|||
157169260|NCT04268004|567361334|FG001|Overall Study|Excluded from analyses|1|||
157036105|NCT03242915|566888978|FG000|Overall Study|Physician Decision|4|||
157036106|NCT03242915|566888979|FG001|Overall Study|Physician Decision|1|||
157036107|NCT02754596|566888980|FG000|Overall Study|Withdrawal by Subject|3|||
157036108|NCT02754596|566888981|FG001|Overall Study|Withdrawal by Subject|4|||
157036109|NCT02754596|566888982|FG002|Overall Study|Withdrawal by Subject|0|||
157036110|NCT02754596|566888980|FG000|Overall Study|Physician Decision|1|||
157036111|NCT02754596|566888981|FG001|Overall Study|Physician Decision|1|||
157036112|NCT02754596|566888982|FG002|Overall Study|Physician Decision|1|||
157036113|NCT02754596|566888980|FG000|Overall Study|Lost to Follow-up|1|||
157036114|NCT02754596|566888981|FG001|Overall Study|Lost to Follow-up|1|||
157036115|NCT02754596|566888982|FG002|Overall Study|Lost to Follow-up|2|||
157036116|NCT02754596|566888980|FG000|Overall Study|Death|0|||
157036117|NCT02754596|566888981|FG001|Overall Study|Death|2|||
157036118|NCT02754596|566888982|FG002|Overall Study|Death|0|||
157036119|NCT02754596|566888980|FG000|Overall Study|Adverse Event|1|||
157036120|NCT02754596|566888981|FG001|Overall Study|Adverse Event|0|||
157036121|NCT02754596|566888982|FG002|Overall Study|Adverse Event|1|||
157036122|NCT02754596|566888980|FG000|Overall Study|Other|1|||
157036123|NCT02754596|566888981|FG001|Overall Study|Other|0|||
157036124|NCT02754596|566888982|FG002|Overall Study|Other|0|||
157036125|NCT03872466|566888983|FG000|Overall Study|Withdrawal by Subject|1|||
157036126|NCT03872466|566888984|FG001|Overall Study|Withdrawal by Subject|0|||
157036127|NCT03872466|566888983|FG000|Overall Study|Physician Decision|2|||
157036128|NCT03872466|566888984|FG001|Overall Study|Physician Decision|0|||
157036129|NCT01778686|566888985|FG000|Overall Study|Adverse Event|0|||
157036130|NCT01778686|566888986|FG001|Overall Study|Adverse Event|0|||
157036131|NCT01778686|566888987|FG002|Overall Study|Adverse Event|1|||
157036132|NCT05714059|566888990|FG000|Overall Study|Withdrawal by Subject|2|||
157036133|NCT05714059|566888991|FG001|Overall Study|Withdrawal by Subject|2|||
157036134|NCT05714059|566888990|FG000|Overall Study|Adverse Event|0|||
157036135|NCT05714059|566888991|FG001|Overall Study|Adverse Event|1|||
157036136|NCT05714059|566888990|FG000|Overall Study|Lost to Follow-up|0|||
157036137|NCT05714059|566888991|FG001|Overall Study|Lost to Follow-up|1|||
157036138|NCT05714059|566888990|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
157036139|NCT05714059|566888991|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
157036140|NCT05714059|566888990|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
157036141|NCT05714059|566888991|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
157036142|NCT04899674|566888992|FG000|Test|Adverse Event|1|||
157036143|NCT02890355|566888993|FG000|Overall Study|Adverse Event|5|||
157036144|NCT02890355|566888994|FG001|Overall Study|Adverse Event|5|||
157036145|NCT02890355|566888993|FG000|Overall Study|Refusal unrelated to adverse event|5|||
157036146|NCT02890355|566888994|FG001|Overall Study|Refusal unrelated to adverse event|10|||
157036147|NCT02890355|566888993|FG000|Overall Study|Progression/relapse|46|||
157036148|NCT02890355|566888994|FG001|Overall Study|Progression/relapse|39|||
157169261|NCT04724733|567361337|FG000|Overall Study|Lost to Follow-up|1|||
157169262|NCT04724733|567361338|FG001|Overall Study|Lost to Follow-up|1|||
157169263|NCT04724733|567361339|FG002|Overall Study|Lost to Follow-up|1|||
157036149|NCT02890355|566888993|FG000|Overall Study|Not protocol specified|3|||
157036150|NCT02890355|566888994|FG001|Overall Study|Not protocol specified|4|||
157036151|NCT02180867|566888996|FG000|Overall Study|Adverse Event|3|||
157036152|NCT02180867|566888997|FG001|Overall Study|Adverse Event|4|||
157036153|NCT02180867|566888998|FG002|Overall Study|Adverse Event|1|||
157036154|NCT02180867|566888999|FG003|Overall Study|Adverse Event|5|||
157036155|NCT02180867|566889000|FG004|Overall Study|Adverse Event|0|||
157036156|NCT02180867|566889001|FG005|Overall Study|Adverse Event|0|||
157036157|NCT02180867|566889002|FG006|Overall Study|Adverse Event|0|||
157036158|NCT02180867|566888996|FG000|Overall Study|Death|0|||
157036159|NCT02180867|566888997|FG001|Overall Study|Death|0|||
157036160|NCT02180867|566888998|FG002|Overall Study|Death|0|||
157036161|NCT02180867|566888999|FG003|Overall Study|Death|0|||
157036162|NCT02180867|566889000|FG004|Overall Study|Death|1|||
157036163|NCT02180867|566889001|FG005|Overall Study|Death|0|||
157036164|NCT02180867|566889002|FG006|Overall Study|Death|0|||
157036165|NCT02180867|566888996|FG000|Overall Study|Lack of Efficacy|0|||
157036166|NCT02180867|566888997|FG001|Overall Study|Lack of Efficacy|2|||
157036167|NCT02180867|566888998|FG002|Overall Study|Lack of Efficacy|0|||
157036168|NCT02180867|566888999|FG003|Overall Study|Lack of Efficacy|1|||
157036169|NCT02180867|566889000|FG004|Overall Study|Lack of Efficacy|6|||
157036170|NCT02180867|566889001|FG005|Overall Study|Lack of Efficacy|0|||
157036171|NCT02180867|566889002|FG006|Overall Study|Lack of Efficacy|1|||
157036172|NCT02180867|566888996|FG000|Overall Study|Physician Decision|1|||
157036173|NCT02180867|566888997|FG001|Overall Study|Physician Decision|3|||
157036174|NCT02180867|566888998|FG002|Overall Study|Physician Decision|1|||
157169264|NCT03341923|567361340|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
157169265|NCT03341923|567361341|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
157169266|NCT03986190|567361342|FG000|Overall Study|Withdrawal by Subject|12|||
157169267|NCT03986190|567361343|FG001|Overall Study|Withdrawal by Subject|0|||
157169268|NCT04511819|567361344|FG000|Overall Study|Non-compliance with study drug|5|||
157169269|NCT04511819|567361345|FG001|Overall Study|Non-compliance with study drug|1|||
157169270|NCT04511819|567361344|FG000|Overall Study|Withdrawal by Subject|0|||
157036175|NCT02180867|566888999|FG003|Overall Study|Physician Decision|10|||
157036176|NCT02180867|566889000|FG004|Overall Study|Physician Decision|9|||
157036177|NCT02180867|566889001|FG005|Overall Study|Physician Decision|3|||
157036178|NCT02180867|566889002|FG006|Overall Study|Physician Decision|4|||
157036179|NCT02180867|566888996|FG000|Overall Study|Withdrawal by Subject|0|||
157036180|NCT02180867|566888997|FG001|Overall Study|Withdrawal by Subject|0|||
157036181|NCT02180867|566888998|FG002|Overall Study|Withdrawal by Subject|0|||
157036182|NCT02180867|566888999|FG003|Overall Study|Withdrawal by Subject|1|||
157036183|NCT02180867|566889000|FG004|Overall Study|Withdrawal by Subject|1|||
157036184|NCT02180867|566889001|FG005|Overall Study|Withdrawal by Subject|0|||
157036185|NCT02180867|566889002|FG006|Overall Study|Withdrawal by Subject|0|||
157036186|NCT02180867|566888996|FG000|Overall Study|Ineligible|1|||
157036187|NCT02180867|566888997|FG001|Overall Study|Ineligible|2|||
157036188|NCT02180867|566888998|FG002|Overall Study|Ineligible|0|||
157036189|NCT02180867|566888999|FG003|Overall Study|Ineligible|3|||
157036190|NCT02180867|566889000|FG004|Overall Study|Ineligible|5|||
157036191|NCT02180867|566889001|FG005|Overall Study|Ineligible|0|||
157036192|NCT02180867|566889002|FG006|Overall Study|Ineligible|0|||
157036193|NCT02180867|566888996|FG000|Overall Study|Repeat Eligibility Studies|0|||
157036194|NCT02180867|566888997|FG001|Overall Study|Repeat Eligibility Studies|0|||
157036195|NCT02180867|566888998|FG002|Overall Study|Repeat Eligibility Studies|0|||
157036196|NCT02180867|566888999|FG003|Overall Study|Repeat Eligibility Studies|0|||
157036197|NCT02180867|566889000|FG004|Overall Study|Repeat Eligibility Studies|1|||
157036198|NCT02180867|566889001|FG005|Overall Study|Repeat Eligibility Studies|0|||
157036199|NCT02180867|566889002|FG006|Overall Study|Repeat Eligibility Studies|0|||
157036200|NCT02180867|566888996|FG000|Overall Study|Refusal of further protocol therapy|1|||
157036201|NCT02180867|566888997|FG001|Overall Study|Refusal of further protocol therapy|0|||
157036202|NCT02180867|566888998|FG002|Overall Study|Refusal of further protocol therapy|2|||
157036203|NCT02180867|566888999|FG003|Overall Study|Refusal of further protocol therapy|6|||
157036204|NCT02180867|566889000|FG004|Overall Study|Refusal of further protocol therapy|4|||
157036205|NCT02180867|566889001|FG005|Overall Study|Refusal of further protocol therapy|0|||
157036206|NCT02180867|566889002|FG006|Overall Study|Refusal of further protocol therapy|0|||
157036207|NCT04129450|566889003|FG000|Overall Study|Lost to Follow-up|20|||
157036208|NCT04129450|566889004|FG001|Overall Study|Lost to Follow-up|10|||
157036209|NCT04129450|566889003|FG000|Overall Study|Withdrawal by Subject|9|||
157036210|NCT04129450|566889004|FG001|Overall Study|Withdrawal by Subject|5|||
157036211|NCT04129450|566889003|FG000|Overall Study|Work Family Obligations|2|||
157036212|NCT04129450|566889004|FG001|Overall Study|Work Family Obligations|0|||
157036213|NCT04129450|566889003|FG000|Overall Study|Other|3|||
157036214|NCT04129450|566889004|FG001|Overall Study|Other|0|||
157036215|NCT05039021|566889497|FG000|Overall Study|Death|1|||
157036216|NCT05039021|566889497|FG000|Overall Study|Lost to Follow-up|3|||
157169271|NCT04511819|567361345|FG001|Overall Study|Withdrawal by Subject|3|||
157169272|NCT04511819|567361344|FG000|Overall Study|Adverse Event|0|||
157169273|NCT04511819|567361345|FG001|Overall Study|Adverse Event|1|||
157227579|NCT02180711|567579114|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
157036217|NCT00994643|566889498|FG000|Overall Study|Withdrawal by Subject|1|||
157036218|NCT03391466|566889500|FG000|Overall Study|Death|84|||
157036219|NCT03391466|566889501|FG001|Overall Study|Death|91|||
157036220|NCT03391466|566889500|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
157036221|NCT03391466|566889501|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
157036222|NCT03391466|566889500|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
157036223|NCT03391466|566889501|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
157036224|NCT03391466|566889500|FG000|Overall Study|Lost to Follow-up|9|||
157169274|NCT04511819|567361344|FG000|Overall Study|Protocol deviation|1|||
157169275|NCT04511819|567361345|FG001|Overall Study|Protocol deviation|0|||
156955932|NCT00407537|566589001|FG001|Overall Study|Lost to Follow-up|19|||
156955933|NCT00407537|566589000|FG000|Overall Study|Other|6|||
156955934|NCT00407537|566589001|FG001|Overall Study|Other|7|||
156955935|NCT00407537|566589000|FG000|Overall Study|Withdrawal by Subject|34|||
156955936|NCT00407537|566589001|FG001|Overall Study|Withdrawal by Subject|16|||
156955937|NCT02384759|566589002|FG000|Overall Study|Patients not treated|3|||
156955938|NCT02384759|566589003|FG001|Overall Study|Patients not treated|2|||
156955939|NCT00121238|566589005|FG000|Overall Study|disease progression before intervention|1|||
156955940|NCT00121238|566589005|FG000|Overall Study|Protocol Violation|2|||
156955941|NCT01380327|566589006|FG000|Overall Study|Lost to Follow-up|0|||
156955942|NCT01380327|566589007|FG001|Overall Study|Lost to Follow-up|1|||
156955943|NCT01380327|566589008|FG002|Overall Study|Lost to Follow-up|1|||
156955944|NCT01380327|566589006|FG000|Overall Study|Protocol Violation|3|||
156955945|NCT01380327|566589007|FG001|Overall Study|Protocol Violation|2|||
156955946|NCT01380327|566589008|FG002|Overall Study|Protocol Violation|3|||
156955947|NCT01380327|566589006|FG000|Overall Study|Withdrawal by Subject|0|||
156955948|NCT01380327|566589007|FG001|Overall Study|Withdrawal by Subject|0|||
156955949|NCT01380327|566589008|FG002|Overall Study|Withdrawal by Subject|1|||
156955950|NCT01380327|566589006|FG000|Overall Study|Housing situation precluded ability to k|0|||
156955951|NCT01380327|566589007|FG001|Overall Study|Housing situation precluded ability to k|0|||
156955952|NCT01380327|566589008|FG002|Overall Study|Housing situation precluded ability to k|1|||
156955953|NCT01380327|566589006|FG000|Overall Study|Questionable onset of epilepsy|0|||
156955954|NCT01380327|566589007|FG001|Overall Study|Questionable onset of epilepsy|0|||
156955955|NCT01380327|566589008|FG002|Overall Study|Questionable onset of epilepsy|1|||
156955956|NCT03043664|566589009|FG000|Overall Study|Lost to Follow-up|1|||
156955957|NCT01540851|566589010|FG000|Overall Study|Lost to Follow-up|14|||
156955958|NCT01540851|566589011|FG001|Overall Study|Lost to Follow-up|15|||
156955959|NCT01540851|566589010|FG000|Overall Study|Withdrawal by Subject|7|||
156955960|NCT01540851|566589011|FG001|Overall Study|Withdrawal by Subject|3|||
156955961|NCT00325468|566589012|FG000|Overall Study|Adverse Event|1|||
156955962|NCT00325468|566589013|FG001|Overall Study|Adverse Event|1|||
156955963|NCT00325468|566589014|FG002|Overall Study|Adverse Event|0|||
156955964|NCT00325468|566589015|FG003|Overall Study|Adverse Event|5|||
156955965|NCT00325468|566589016|FG004|Overall Study|Adverse Event|1|||
156955966|NCT00325468|566589012|FG000|Overall Study|Death|2|||
156955967|NCT00325468|566589013|FG001|Overall Study|Death|0|||
156955968|NCT00325468|566589014|FG002|Overall Study|Death|2|||
156955969|NCT00325468|566589015|FG003|Overall Study|Death|4|||
156955970|NCT00325468|566589016|FG004|Overall Study|Death|0|||
156955971|NCT00325468|566589012|FG000|Overall Study|Lost to Follow-up|0|||
156955972|NCT00325468|566589013|FG001|Overall Study|Lost to Follow-up|0|||
156955973|NCT00325468|566589014|FG002|Overall Study|Lost to Follow-up|1|||
156955974|NCT00325468|566589015|FG003|Overall Study|Lost to Follow-up|2|||
156955975|NCT00325468|566589016|FG004|Overall Study|Lost to Follow-up|2|||
156955976|NCT00325468|566589012|FG000|Overall Study|Physician Decision|1|||
156955977|NCT00325468|566589013|FG001|Overall Study|Physician Decision|1|||
156955978|NCT00325468|566589014|FG002|Overall Study|Physician Decision|0|||
156955979|NCT00325468|566589015|FG003|Overall Study|Physician Decision|1|||
156955980|NCT00325468|566589016|FG004|Overall Study|Physician Decision|0|||
156955981|NCT00325468|566589012|FG000|Overall Study|Withdrawal by Subject|3|||
156955982|NCT00325468|566589013|FG001|Overall Study|Withdrawal by Subject|1|||
156955983|NCT00325468|566589014|FG002|Overall Study|Withdrawal by Subject|0|||
156955984|NCT00325468|566589015|FG003|Overall Study|Withdrawal by Subject|14|||
156955985|NCT00325468|566589016|FG004|Overall Study|Withdrawal by Subject|4|||
156955986|NCT00325468|566589012|FG000|Overall Study|site closure etc|4|||
156955987|NCT00325468|566589013|FG001|Overall Study|site closure etc|2|||
156955988|NCT00325468|566589014|FG002|Overall Study|site closure etc|1|||
156955989|NCT00325468|566589015|FG003|Overall Study|site closure etc|8|||
156955990|NCT00325468|566589016|FG004|Overall Study|site closure etc|1|||
156955991|NCT03593655|566589017|FG000|First Product Use Period|Withdrawal by Subject|1|||
156955992|NCT03593655|566589018|FG001|First Product Use Period|Withdrawal by Subject|1|||
156955993|NCT03593655|566589017|FG000|First Product Use Period|Lost to Follow-up|1|||
156955994|NCT03593655|566589018|FG001|First Product Use Period|Lost to Follow-up|3|||
156955995|NCT03593655|566589017|FG000|Second Product Use Period|Withdrawal by Subject|1|||
156955996|NCT03593655|566589018|FG001|Second Product Use Period|Withdrawal by Subject|1|||
156955997|NCT03593655|566589017|FG000|Second Product Use Period|Lost to Follow-up|1|||
156955998|NCT03593655|566589018|FG001|Second Product Use Period|Lost to Follow-up|0|||
156955999|NCT03593655|566589017|FG000|Third Product Use Period|Lost to Follow-up|1|||
156956000|NCT03593655|566589018|FG001|Third Product Use Period|Lost to Follow-up|2|||
156956001|NCT03593655|566589017|FG000|Third Product Use Period|Physician Decision|0|||
156956002|NCT03593655|566589018|FG001|Third Product Use Period|Physician Decision|1|||
156956003|NCT03593655|566589017|FG000|Third Product Use Period|Withdrawal by Subject|0|||
156956004|NCT03593655|566589018|FG001|Third Product Use Period|Withdrawal by Subject|1|||
156956005|NCT03732209|566589019|FG000|Overall Study|Lost to Follow-up|4|||
156956006|NCT03732209|566589020|FG001|Overall Study|Lost to Follow-up|4|||
156956007|NCT03732209|566589019|FG000|Overall Study|Withdrawal by Subject|8|||
156956008|NCT03732209|566589020|FG001|Overall Study|Withdrawal by Subject|9|||
157036225|NCT03391466|566889501|FG001|Overall Study|Lost to Follow-up|5|||
157036226|NCT03391466|566889500|FG000|Overall Study|Reason Not Specified|2|||
157036227|NCT03391466|566889501|FG001|Overall Study|Reason Not Specified|2|||
157036228|NCT03391466|566889500|FG000|Overall Study|Investigator Decision|0|||
157036229|NCT03391466|566889501|FG001|Overall Study|Investigator Decision|1|||
157036230|NCT03140670|566889502|FG000|Overall Study|Withdrawal by Subject|2|||
157036231|NCT03140670|566889502|FG000|Overall Study|Lost to Follow-up|1|||
157036232|NCT03140670|566889502|FG000|Overall Study|Physician Decision|1|||
157036233|NCT03699163|566889503|FG000|Overall Study|Physician Decision|12|||
157036234|NCT03699163|566889504|FG001|Overall Study|Physician Decision|0|||
157036235|NCT03699163|566889503|FG000|Overall Study|failed QC measures|205|||
157036236|NCT03699163|566889504|FG001|Overall Study|failed QC measures|206|||
157036237|NCT01260896|566889509|FG000|First Intervention|Withdrawn Due to Emesis|2|||
157036238|NCT01260896|566889510|FG001|First Intervention|Withdrawn Due to Emesis|0|||
157036239|NCT05030584|566889516|FG000|Overall Study|Adverse Event|17|||
157036240|NCT05030584|566889517|FG001|Overall Study|Adverse Event|2|||
157036241|NCT05030584|566889516|FG000|Overall Study|Lack of Efficacy|0|||
157036242|NCT05030584|566889517|FG001|Overall Study|Lack of Efficacy|6|||
157036243|NCT05030584|566889516|FG000|Overall Study|Lost to Follow-up|5|||
157036244|NCT05030584|566889517|FG001|Overall Study|Lost to Follow-up|2|||
157036245|NCT05030584|566889516|FG000|Overall Study|Non-Compliance with Study Drug|2|||
157036246|NCT05030584|566889517|FG001|Overall Study|Non-Compliance with Study Drug|3|||
157036247|NCT05030584|566889516|FG000|Overall Study|Other reason|4|||
157036248|NCT05030584|566889517|FG001|Overall Study|Other reason|3|||
157036249|NCT05030584|566889516|FG000|Overall Study|Physician Decision|1|||
157036250|NCT05030584|566889517|FG001|Overall Study|Physician Decision|4|||
157036251|NCT05030584|566889516|FG000|Overall Study|Protocol Violation|0|||
157036252|NCT05030584|566889517|FG001|Overall Study|Protocol Violation|2|||
157036253|NCT05030584|566889516|FG000|Overall Study|Randomized by Mistake|0|||
157036254|NCT05030584|566889517|FG001|Overall Study|Randomized by Mistake|2|||
157036255|NCT05030584|566889516|FG000|Overall Study|Withdrawal by Subject|21|||
157036256|NCT05030584|566889517|FG001|Overall Study|Withdrawal by Subject|28|||
157036257|NCT05030584|566889516|FG000|Overall Study|Technical Problems|0|||
157036258|NCT05030584|566889517|FG001|Overall Study|Technical Problems|1|||
157036259|NCT05030584|566889516|FG000|Overall Study|Completed post-treatment/FU visits|41|||
157036260|NCT05030584|566889517|FG001|Overall Study|Completed post-treatment/FU visits|31|||
157036261|NCT06393127|566889518|FG000|Washout period|Withdrawal by Subject|1|||
157036262|NCT06393127|566889519|FG001|Washout period|Withdrawal by Subject|0|||
157036263|NCT06393127|566889518|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
157036264|NCT06393127|566889519|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
157036265|NCT02466971|566889522|FG000|Overall Study|eligible and never treated|14|||
157036266|NCT02466971|566889523|FG001|Overall Study|eligible and never treated|20|||
157036267|NCT02466971|566889522|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
157036268|NCT02466971|566889523|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
157036269|NCT02466971|566889522|FG000|Overall Study|ineligible and treated|1|||
157036270|NCT02466971|566889523|FG001|Overall Study|ineligible and treated|0|||
157036271|NCT02466971|566889522|FG000|Overall Study|ineligible and never treated|0|||
157036272|NCT02466971|566889523|FG001|Overall Study|ineligible and never treated|1|||
157036273|NCT02101853|566889524|FG000|Block 1 Induction|Adverse Event|11|||
157036274|NCT02101853|566889525|FG001|Block 1 Induction|Adverse Event|0|||
157036275|NCT02101853|566889526|FG002|Block 1 Induction|Adverse Event|0|||
157036276|NCT02101853|566889527|FG003|Block 1 Induction|Adverse Event|0|||
157036277|NCT02101853|566889528|FG004|Block 1 Induction|Adverse Event|0|||
157036278|NCT02101853|566889529|FG005|Block 1 Induction|Adverse Event|0|||
157036279|NCT02101853|566889524|FG000|Block 1 Induction|Death|20|||
157036280|NCT02101853|566889525|FG001|Block 1 Induction|Death|0|||
157036281|NCT02101853|566889526|FG002|Block 1 Induction|Death|0|||
157036282|NCT02101853|566889527|FG003|Block 1 Induction|Death|0|||
157036283|NCT02101853|566889528|FG004|Block 1 Induction|Death|0|||
157036284|NCT02101853|566889529|FG005|Block 1 Induction|Death|0|||
157036285|NCT02101853|566889524|FG000|Block 1 Induction|Lack of Efficacy|6|||
157036286|NCT02101853|566889525|FG001|Block 1 Induction|Lack of Efficacy|0|||
157227580|NCT02180711|567579107|FG000|Overall Study|- Study Terminated by Sponsor|2|||
157036287|NCT02101853|566889526|FG002|Block 1 Induction|Lack of Efficacy|0|||
157036288|NCT02101853|566889527|FG003|Block 1 Induction|Lack of Efficacy|0|||
157036289|NCT02101853|566889528|FG004|Block 1 Induction|Lack of Efficacy|0|||
157036290|NCT02101853|566889529|FG005|Block 1 Induction|Lack of Efficacy|0|||
157036291|NCT02101853|566889524|FG000|Block 1 Induction|Physician Decision|61|||
157036292|NCT02101853|566889525|FG001|Block 1 Induction|Physician Decision|0|||
157036293|NCT02101853|566889526|FG002|Block 1 Induction|Physician Decision|0|||
157036294|NCT02101853|566889527|FG003|Block 1 Induction|Physician Decision|0|||
157036295|NCT02101853|566889528|FG004|Block 1 Induction|Physician Decision|0|||
157036296|NCT02101853|566889529|FG005|Block 1 Induction|Physician Decision|0|||
157036297|NCT02101853|566889524|FG000|Block 1 Induction|Protocol Violation|2|||
157036298|NCT02101853|566889525|FG001|Block 1 Induction|Protocol Violation|0|||
157227581|NCT02180711|567579108|FG001|Overall Study|- Study Terminated by Sponsor|3|||
157036299|NCT02101853|566889526|FG002|Block 1 Induction|Protocol Violation|0|||
157036300|NCT02101853|566889527|FG003|Block 1 Induction|Protocol Violation|0|||
157036301|NCT02101853|566889528|FG004|Block 1 Induction|Protocol Violation|0|||
157036302|NCT02101853|566889529|FG005|Block 1 Induction|Protocol Violation|0|||
157036303|NCT02101853|566889524|FG000|Block 1 Induction|Withdrawal by Subject|65|||
157036304|NCT02101853|566889525|FG001|Block 1 Induction|Withdrawal by Subject|0|||
157036305|NCT02101853|566889526|FG002|Block 1 Induction|Withdrawal by Subject|0|||
157036306|NCT02101853|566889527|FG003|Block 1 Induction|Withdrawal by Subject|0|||
157036307|NCT02101853|566889528|FG004|Block 1 Induction|Withdrawal by Subject|0|||
157036308|NCT02101853|566889529|FG005|Block 1 Induction|Withdrawal by Subject|0|||
157036309|NCT02101853|566889524|FG000|Block 1 Induction|Ineligible|8|||
157036310|NCT02101853|566889525|FG001|Block 1 Induction|Ineligible|0|||
157036311|NCT02101853|566889526|FG002|Block 1 Induction|Ineligible|0|||
157036312|NCT02101853|566889527|FG003|Block 1 Induction|Ineligible|0|||
157036313|NCT02101853|566889528|FG004|Block 1 Induction|Ineligible|0|||
157036314|NCT02101853|566889529|FG005|Block 1 Induction|Ineligible|0|||
157036315|NCT02101853|566889524|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
157036316|NCT02101853|566889525|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
157036317|NCT02101853|566889526|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
157036318|NCT02101853|566889527|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
157036319|NCT02101853|566889528|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
157036320|NCT02101853|566889529|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
157036321|NCT02101853|566889524|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
157036322|NCT02101853|566889525|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036323|NCT02101853|566889526|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036324|NCT02101853|566889527|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036325|NCT02101853|566889528|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036326|NCT02101853|566889529|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036327|NCT02101853|566889524|FG000|Post Induction Randomization|Adverse Event|0|||
157036328|NCT02101853|566889525|FG001|Post Induction Randomization|Adverse Event|3|||
157036329|NCT02101853|566889526|FG002|Post Induction Randomization|Adverse Event|8|||
157036330|NCT02101853|566889527|FG003|Post Induction Randomization|Adverse Event|4|||
157036331|NCT02101853|566889528|FG004|Post Induction Randomization|Adverse Event|4|||
157036332|NCT02101853|566889529|FG005|Post Induction Randomization|Adverse Event|0|||
157036333|NCT02101853|566889524|FG000|Post Induction Randomization|Death|0|||
157036334|NCT02101853|566889525|FG001|Post Induction Randomization|Death|9|||
157036335|NCT02101853|566889526|FG002|Post Induction Randomization|Death|2|||
157036336|NCT02101853|566889527|FG003|Post Induction Randomization|Death|2|||
157036337|NCT02101853|566889528|FG004|Post Induction Randomization|Death|0|||
157036338|NCT02101853|566889529|FG005|Post Induction Randomization|Death|0|||
157036339|NCT02101853|566889524|FG000|Post Induction Randomization|Lack of Efficacy|0|||
157036340|NCT02101853|566889525|FG001|Post Induction Randomization|Lack of Efficacy|14|||
157036341|NCT02101853|566889526|FG002|Post Induction Randomization|Lack of Efficacy|23|||
157036342|NCT02101853|566889527|FG003|Post Induction Randomization|Lack of Efficacy|18|||
157036343|NCT02101853|566889528|FG004|Post Induction Randomization|Lack of Efficacy|21|||
157036344|NCT02101853|566889529|FG005|Post Induction Randomization|Lack of Efficacy|0|||
157036345|NCT02101853|566889524|FG000|Post Induction Randomization|Physician Decision|0|||
157036346|NCT02101853|566889525|FG001|Post Induction Randomization|Physician Decision|43|||
157036347|NCT02101853|566889526|FG002|Post Induction Randomization|Physician Decision|23|||
157036348|NCT02101853|566889527|FG003|Post Induction Randomization|Physician Decision|14|||
157036349|NCT02101853|566889528|FG004|Post Induction Randomization|Physician Decision|14|||
157036350|NCT02101853|566889529|FG005|Post Induction Randomization|Physician Decision|0|||
157036351|NCT02101853|566889524|FG000|Post Induction Randomization|Protocol Violation|0|||
157036352|NCT02101853|566889525|FG001|Post Induction Randomization|Protocol Violation|3|||
157036353|NCT02101853|566889526|FG002|Post Induction Randomization|Protocol Violation|0|||
157036354|NCT02101853|566889527|FG003|Post Induction Randomization|Protocol Violation|0|||
157036355|NCT02101853|566889528|FG004|Post Induction Randomization|Protocol Violation|0|||
157036356|NCT02101853|566889529|FG005|Post Induction Randomization|Protocol Violation|0|||
157036357|NCT02101853|566889524|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
157036358|NCT02101853|566889525|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
157036359|NCT02101853|566889526|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
157036360|NCT02101853|566889527|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
157036361|NCT02101853|566889528|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
157036362|NCT02101853|566889529|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
157036363|NCT02101853|566889524|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157169276|NCT00844649|567361346|FG000|Overall Study|Progressive Disease|196|||
157036364|NCT02101853|566889525|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036365|NCT02101853|566889526|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036366|NCT02101853|566889527|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
157036367|NCT02101853|566889528|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036368|NCT02101853|566889529|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
157036369|NCT02101853|566889524|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
157036370|NCT02101853|566889525|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
157036371|NCT02101853|566889526|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
157036372|NCT02101853|566889527|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
157036373|NCT02101853|566889528|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
157036374|NCT02101853|566889529|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
157036375|NCT02101853|566889524|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
157036376|NCT02101853|566889525|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
157036377|NCT02101853|566889526|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
157036378|NCT02101853|566889527|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
157036379|NCT02101853|566889528|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
157036380|NCT02101853|566889529|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
157036381|NCT02101853|566889524|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
157036382|NCT02101853|566889525|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
157036383|NCT02101853|566889526|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
157036384|NCT02101853|566889527|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
157036385|NCT02101853|566889528|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
157036386|NCT02101853|566889529|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
157036387|NCT02101853|566889524|FG000|Blinatumomab Salvage Therapy|Death|0|||
157036388|NCT02101853|566889525|FG001|Blinatumomab Salvage Therapy|Death|0|||
157036389|NCT02101853|566889526|FG002|Blinatumomab Salvage Therapy|Death|0|||
157036390|NCT02101853|566889527|FG003|Blinatumomab Salvage Therapy|Death|0|||
157036391|NCT02101853|566889528|FG004|Blinatumomab Salvage Therapy|Death|0|||
157036392|NCT02101853|566889529|FG005|Blinatumomab Salvage Therapy|Death|2|||
157036393|NCT02101853|566889524|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
157036394|NCT02101853|566889525|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
157036395|NCT02101853|566889526|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
157036396|NCT02101853|566889527|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
157036397|NCT02101853|566889528|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
157036398|NCT02101853|566889529|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
157036399|NCT02101853|566889524|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
157036400|NCT02101853|566889525|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
157036401|NCT02101853|566889526|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
157036402|NCT02101853|566889527|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
157036403|NCT02101853|566889528|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
157036404|NCT02101853|566889529|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
157036405|NCT02101853|566889524|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
157036406|NCT02101853|566889525|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
157036407|NCT02101853|566889526|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
157036408|NCT02101853|566889527|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
157036409|NCT02101853|566889528|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
157036410|NCT02101853|566889529|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
157036411|NCT05707351|566889533|FG000|Overall Study|Withdrawal by Subject|2|||
157036412|NCT05707351|566889533|FG000|Overall Study|Reason Not Specified|1|||
157036413|NCT04012567|566889537|FG000|Overall Study|Lost to Follow-up|0|||
157036414|NCT04012567|566889538|FG001|Overall Study|Lost to Follow-up|1|||
157036415|NCT04012567|566889537|FG000|Overall Study|Withdrawal by Subject|1|||
157036416|NCT04012567|566889538|FG001|Overall Study|Withdrawal by Subject|0|||
157036417|NCT03782116|566889544|FG000|Completed Intervetion|Lost to Follow-up|11|||
157036418|NCT03782116|566889545|FG001|Completed Intervetion|Lost to Follow-up|7|||
157036419|NCT03782116|566889544|FG000|Completed Intervetion|Withdrawal by Subject|6|||
157036420|NCT03782116|566889545|FG001|Completed Intervetion|Withdrawal by Subject|5|||
157036421|NCT03782116|566889544|FG000|Included in Analysis|Protocol Violation|5|||
157036422|NCT03782116|566889545|FG001|Included in Analysis|Protocol Violation|5|||
157036423|NCT04908514|566889546|FG000|Overall Study|Lost to Follow-up|2|||
157169277|NCT00844649|567361347|FG001|Overall Study|Progressive Disease|245|||
157169278|NCT00844649|567361346|FG000|Overall Study|Adverse Event|128|||
157169279|NCT00844649|567361347|FG001|Overall Study|Adverse Event|73|||
157169280|NCT00844649|567361346|FG000|Overall Study|Physician Decision|25|||
157169281|NCT00844649|567361347|FG001|Overall Study|Physician Decision|18|||
157169282|NCT00844649|567361346|FG000|Overall Study|Protocol Violation|10|||
157036424|NCT04908514|566889546|FG000|Overall Study|Withdrawal by Subject|1|||
157036425|NCT05934292|566889548|FG000|Overall Study|Lost to Follow-up|0|||
157036426|NCT05934292|566889549|FG001|Overall Study|Lost to Follow-up|0|||
157036427|NCT05934292|566889550|FG002|Overall Study|Lost to Follow-up|1|||
157036428|NCT05934292|566889551|FG003|Overall Study|Lost to Follow-up|0|||
157036429|NCT02566889|566890658|FG000|Overall Study|Withdrawal by Subject|3|||
157036430|NCT02566889|566890659|FG001|Overall Study|Withdrawal by Subject|1|||
157036431|NCT02566889|566890658|FG000|Overall Study|Adverse Event|4|||
157036432|NCT02566889|566890659|FG001|Overall Study|Adverse Event|2|||
157036433|NCT02566889|566890658|FG000|Overall Study|Other|6|||
157036434|NCT02566889|566890659|FG001|Overall Study|Other|2|||
157036435|NCT04974047|566890660|FG000|Overall Study|Sponsor Ended Study|20|||
157036436|NCT04974047|566890661|FG001|Overall Study|Sponsor Ended Study|22|||
157036437|NCT04974047|566890660|FG000|Overall Study|Death|8|||
157036438|NCT04974047|566890661|FG001|Overall Study|Death|17|||
157036439|NCT04974047|566890660|FG000|Overall Study|Lost to Follow-up|2|||
157036440|NCT04974047|566890661|FG001|Overall Study|Lost to Follow-up|0|||
157036441|NCT04974047|566890660|FG000|Overall Study|Withdrawal by Subject|0|||
157036442|NCT04974047|566890661|FG001|Overall Study|Withdrawal by Subject|1|||
157036443|NCT00655499|566890662|FG000|Overall Study|not eligible|4|||
157036444|NCT00220805|566890663|FG000|Overall Study|Adverse Event|1|||
157036445|NCT00220805|566890664|FG001|Overall Study|Adverse Event|3|||
157036446|NCT00220805|566890663|FG000|Overall Study|Withdrawal by Subject|3|||
157036447|NCT00220805|566890664|FG001|Overall Study|Withdrawal by Subject|0|||
157036448|NCT00220805|566890663|FG000|Overall Study|Lack of Efficacy|1|||
157036449|NCT00220805|566890664|FG001|Overall Study|Lack of Efficacy|0|||
157036450|NCT00220805|566890663|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
157036451|NCT00220805|566890664|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
157036452|NCT02325466|566890665|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
157036453|NCT02325466|566890666|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
157036454|NCT02325466|566890667|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
157036455|NCT02325466|566890665|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
157036456|NCT02325466|566890666|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
157036457|NCT02325466|566890667|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
157036458|NCT02325466|566890665|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
157036459|NCT02325466|566890666|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
157036460|NCT02325466|566890667|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
157036461|NCT02325466|566890665|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
157036462|NCT02325466|566890666|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
157036463|NCT02325466|566890667|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
157036464|NCT02325466|566890665|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
157036465|NCT02325466|566890666|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
157036466|NCT02325466|566890667|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
157036467|NCT02325466|566890665|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
157036468|NCT02325466|566890666|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
157036469|NCT02325466|566890667|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
157036470|NCT02325466|566890665|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
157036471|NCT02325466|566890666|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
157036472|NCT02325466|566890667|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
157036473|NCT02325466|566890665|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
157036474|NCT02325466|566890666|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
157036475|NCT02325466|566890667|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
157036476|NCT02325466|566890665|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
157036477|NCT02325466|566890666|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
157036478|NCT02325466|566890667|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
157036479|NCT01596972|566890670|FG000|Overall Study|Physician Decision|1|||
157036480|NCT01596972|566890671|FG001|Overall Study|Physician Decision|9|||
157036481|NCT01596972|566890670|FG000|Overall Study|Lost to Follow-up|0|||
157036482|NCT01596972|566890671|FG001|Overall Study|Lost to Follow-up|4|||
157036483|NCT01596972|566890670|FG000|Overall Study|Withdrawal by Subject|0|||
157036484|NCT01596972|566890671|FG001|Overall Study|Withdrawal by Subject|1|||
157036485|NCT01639131|566890672|FG000|Overall Study|Disease Progression|6|||
157036486|NCT01964300|566890673|FG000|Overall Study|Ineligible after enrollment|0|||
157036487|NCT01964300|566890674|FG001|Overall Study|Ineligible after enrollment|1|||
157036488|NCT01964300|566890673|FG000|Overall Study|Adverse Event|1|||
157036489|NCT01964300|566890674|FG001|Overall Study|Adverse Event|1|||
157036490|NCT01964300|566890673|FG000|Overall Study|Lack of Efficacy|3|||
157036491|NCT01964300|566890674|FG001|Overall Study|Lack of Efficacy|5|||
157036492|NCT01964300|566890673|FG000|Overall Study|Withdrawal by Subject|0|||
157036493|NCT01964300|566890674|FG001|Overall Study|Withdrawal by Subject|1|||
157036494|NCT01964300|566890673|FG000|Overall Study|To receive alternative therapy|1|||
157036495|NCT01964300|566890674|FG001|Overall Study|To receive alternative therapy|2|||
157036496|NCT01964300|566890673|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
157036497|NCT01964300|566890674|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
157036498|NCT01964300|566890673|FG000|Overall Study|Weight criteria not met|0|||
157036499|NCT01964300|566890674|FG001|Overall Study|Weight criteria not met|1|||
157036500|NCT01637402|566890675|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
157036501|NCT01637402|566890676|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
157036502|NCT01637402|566890675|FG000|Standard Dose Regimen|Adverse Event|1|||
157036503|NCT01637402|566890676|FG001|Standard Dose Regimen|Adverse Event|0|||
157036504|NCT01637402|566890675|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
157036505|NCT01637402|566890676|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
157036506|NCT01637402|566890675|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
157036507|NCT01637402|566890676|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
157036508|NCT01637402|566890675|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
157036509|NCT01637402|566890676|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
157036510|NCT01637402|566890675|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
157036511|NCT01637402|566890676|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
157036512|NCT02285270|566890677|FG000|Overall Study|Lost to Follow-up|1|||
157036513|NCT02285270|566890677|FG000|Overall Study|Physician Decision|3|||
157036514|NCT02285270|566890677|FG000|Overall Study|Determined to be ineligible|1|||
157036515|NCT02111096|566890678|FG000|Overall Study|Adverse Event|4|||
157036516|NCT02111096|566890679|FG001|Overall Study|Adverse Event|1|||
157036517|NCT02111096|566890680|FG002|Overall Study|Adverse Event|2|||
157036518|NCT02111096|566890678|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157036519|NCT02111096|566890679|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157036520|NCT02111096|566890680|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157036521|NCT02111096|566890678|FG000|Overall Study|Lost to Follow Up|1|||
157036522|NCT02111096|566890679|FG001|Overall Study|Lost to Follow Up|1|||
157036523|NCT02111096|566890680|FG002|Overall Study|Lost to Follow Up|1|||
157036524|NCT02111096|566890678|FG000|Overall Study|Physician Decision|0|||
157036525|NCT02111096|566890679|FG001|Overall Study|Physician Decision|1|||
157036526|NCT02111096|566890680|FG002|Overall Study|Physician Decision|0|||
157036527|NCT02111096|566890678|FG000|Overall Study|Protocol Violation|1|||
157036528|NCT02111096|566890679|FG001|Overall Study|Protocol Violation|0|||
157036529|NCT02111096|566890680|FG002|Overall Study|Protocol Violation|1|||
157036530|NCT02111096|566890678|FG000|Overall Study|Terminated by Sponsor|53|||
157169283|NCT00844649|567361347|FG001|Overall Study|Protocol Violation|6|||
157036531|NCT02111096|566890679|FG001|Overall Study|Terminated by Sponsor|35|||
157036532|NCT02111096|566890680|FG002|Overall Study|Terminated by Sponsor|54|||
157036533|NCT02111096|566890678|FG000|Overall Study|Withdrawal by Subject|4|||
157036534|NCT02111096|566890679|FG001|Overall Study|Withdrawal by Subject|2|||
157036535|NCT02111096|566890680|FG002|Overall Study|Withdrawal by Subject|8|||
157036536|NCT00439270|566890683|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
157036537|NCT00439270|566890684|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
157036538|NCT00439270|566890685|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
157036539|NCT00439270|566890686|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
157036540|NCT00439270|566890687|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
157036541|NCT00439270|566890683|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
157036542|NCT00439270|566890684|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
157036543|NCT00439270|566890685|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
157036544|NCT00439270|566890686|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
157036545|NCT00439270|566890687|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
157036546|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
157036547|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
157036548|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
157036549|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
157036550|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
157036551|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
157036552|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
157036553|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
157036554|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
157036555|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
157036556|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
157169284|NCT00844649|567361346|FG000|Overall Study|Withdrawal by Subject|28|||
157169285|NCT00844649|567361347|FG001|Overall Study|Withdrawal by Subject|39|||
157036557|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
157036558|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
157036559|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
157169286|NCT00844649|567361346|FG000|Overall Study|Other|7|||
157036560|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
157036561|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
157036562|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
157036563|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
157169287|NCT00844649|567361347|FG001|Overall Study|Other|10|||
157036564|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
157036565|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
157036566|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
157036567|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
157036568|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
157036569|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
157036570|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
157036571|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
157036572|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
157036573|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
157036574|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
157036575|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
157036576|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
157036577|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
157036578|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
157036579|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
157036580|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
157036581|NCT00439270|566890683|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
157036582|NCT00439270|566890684|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
157036583|NCT00439270|566890685|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
157036584|NCT00439270|566890686|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
157036585|NCT00439270|566890687|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
157036586|NCT01268306|566890688|FG000|Overall Study|Lost to Follow-up|1|||
157036587|NCT04334317|566890689|FG000|Overall Study|Adverse Event|1|||
157036588|NCT04334317|566890690|FG001|Overall Study|Adverse Event|2|||
157036589|NCT04334317|566890691|FG002|Overall Study|Adverse Event|0|||
157036590|NCT04334317|566890692|FG003|Overall Study|Adverse Event|0|||
157036591|NCT04334317|566890689|FG000|Overall Study|Protocol Deviation|0|||
157036592|NCT04334317|566890690|FG001|Overall Study|Protocol Deviation|1|||
157036593|NCT04334317|566890691|FG002|Overall Study|Protocol Deviation|0|||
157036594|NCT04334317|566890692|FG003|Overall Study|Protocol Deviation|0|||
157036595|NCT04334317|566890689|FG000|Overall Study|Withdrawal by Subject|2|||
157036596|NCT04334317|566890690|FG001|Overall Study|Withdrawal by Subject|2|||
157036597|NCT04334317|566890691|FG002|Overall Study|Withdrawal by Subject|0|||
157036598|NCT04334317|566890692|FG003|Overall Study|Withdrawal by Subject|0|||
157036599|NCT04121546|566890697|FG000|Overall Study|Lost to Follow-up|1|||
157036600|NCT04121546|566890698|FG001|Overall Study|Lost to Follow-up|3|||
157036601|NCT04129164|566890699|FG000|Overall Study|Non-compliance with procedures|0|||
157036602|NCT04129164|566890700|FG001|Overall Study|Non-compliance with procedures|0|||
157036603|NCT04129164|566890701|FG002|Overall Study|Non-compliance with procedures|2|||
157036604|NCT04129164|566890702|FG003|Overall Study|Non-compliance with procedures|0|||
157036605|NCT04129164|566890699|FG000|Overall Study|Adverse Event|0|||
157036606|NCT04129164|566890700|FG001|Overall Study|Adverse Event|0|||
157036607|NCT04129164|566890701|FG002|Overall Study|Adverse Event|2|||
157036608|NCT04129164|566890702|FG003|Overall Study|Adverse Event|0|||
157036609|NCT04129164|566890699|FG000|Overall Study|Pregnancy|0|||
157036610|NCT04129164|566890700|FG001|Overall Study|Pregnancy|0|||
157036611|NCT04129164|566890701|FG002|Overall Study|Pregnancy|0|||
157036612|NCT04129164|566890702|FG003|Overall Study|Pregnancy|1|||
157036613|NCT04129164|566890699|FG000|Overall Study|Withdrawal by Subject|3|||
157036614|NCT04129164|566890700|FG001|Overall Study|Withdrawal by Subject|2|||
157036615|NCT04129164|566890701|FG002|Overall Study|Withdrawal by Subject|4|||
157036616|NCT04129164|566890702|FG003|Overall Study|Withdrawal by Subject|6|||
157036617|NCT04129164|566890699|FG000|Overall Study|Death|0|||
157036618|NCT04129164|566890700|FG001|Overall Study|Death|1|||
157036619|NCT04129164|566890701|FG002|Overall Study|Death|0|||
157036620|NCT04129164|566890702|FG003|Overall Study|Death|0|||
157036621|NCT04129164|566890699|FG000|Overall Study|Lost to Follow-up|0|||
157036622|NCT04129164|566890700|FG001|Overall Study|Lost to Follow-up|1|||
157036623|NCT04129164|566890701|FG002|Overall Study|Lost to Follow-up|0|||
157036624|NCT04129164|566890702|FG003|Overall Study|Lost to Follow-up|0|||
157036625|NCT03286114|566890707|FG000|Overall Study|Adverse Event|6|||
157036626|NCT03286114|566890707|FG000|Overall Study|Death|3|||
157036627|NCT00943917|566890721|FG000|Stage I|Adverse Event|1|||
157227582|NCT02180711|567579109|FG002|Overall Study|- Study Terminated by Sponsor|0|||
157227583|NCT02180711|567579110|FG003|Overall Study|- Study Terminated by Sponsor|5|||
157036628|NCT00943917|566890722|FG001|Stage I|Adverse Event|2|||
157036629|NCT00943917|566890723|FG002|Stage I|Adverse Event|2|||
157036630|NCT00943917|566890724|FG003|Stage I|Adverse Event|0|||
157036631|NCT00943917|566890725|FG004|Stage I|Adverse Event|0|||
157036632|NCT00943917|566890726|FG005|Stage I|Adverse Event|0|||
157036633|NCT00943917|566890727|FG006|Stage I|Adverse Event|0|||
157036634|NCT00943917|566890728|FG007|Stage I|Adverse Event|0|||
157036635|NCT00943917|566890729|FG008|Stage I|Adverse Event|0|||
157036636|NCT00943917|566890730|FG009|Stage I|Adverse Event|0|||
157036637|NCT00943917|566890731|FG010|Stage I|Adverse Event|0|||
157036638|NCT00943917|566890732|FG011|Stage I|Adverse Event|0|||
157036639|NCT00943917|566890733|FG012|Stage I|Adverse Event|0|||
157036640|NCT00943917|566890734|FG013|Stage I|Adverse Event|0|||
157036641|NCT00943917|566890735|FG014|Stage I|Adverse Event|0|||
157036642|NCT00943917|566890721|FG000|Stage I|Lost to Follow-up|0|||
157036643|NCT00943917|566890722|FG001|Stage I|Lost to Follow-up|0|||
157036644|NCT00943917|566890723|FG002|Stage I|Lost to Follow-up|1|||
157036645|NCT00943917|566890724|FG003|Stage I|Lost to Follow-up|0|||
157036646|NCT00943917|566890725|FG004|Stage I|Lost to Follow-up|0|||
157036647|NCT00943917|566890726|FG005|Stage I|Lost to Follow-up|0|||
157036648|NCT00943917|566890727|FG006|Stage I|Lost to Follow-up|0|||
157036649|NCT00943917|566890728|FG007|Stage I|Lost to Follow-up|0|||
157036650|NCT00943917|566890729|FG008|Stage I|Lost to Follow-up|0|||
157036651|NCT00943917|566890730|FG009|Stage I|Lost to Follow-up|0|||
157036652|NCT00943917|566890731|FG010|Stage I|Lost to Follow-up|0|||
157036653|NCT00943917|566890732|FG011|Stage I|Lost to Follow-up|0|||
157036654|NCT00943917|566890733|FG012|Stage I|Lost to Follow-up|0|||
157036655|NCT00943917|566890734|FG013|Stage I|Lost to Follow-up|0|||
157036656|NCT00943917|566890735|FG014|Stage I|Lost to Follow-up|0|||
157036657|NCT00943917|566890721|FG000|Stage I|hyperglycemia|0|||
157036658|NCT00943917|566890722|FG001|Stage I|hyperglycemia|0|||
157036659|NCT00943917|566890723|FG002|Stage I|hyperglycemia|1|||
157036660|NCT00943917|566890724|FG003|Stage I|hyperglycemia|0|||
157036661|NCT00943917|566890725|FG004|Stage I|hyperglycemia|0|||
157036662|NCT00943917|566890726|FG005|Stage I|hyperglycemia|0|||
157036663|NCT00943917|566890727|FG006|Stage I|hyperglycemia|0|||
157036664|NCT00943917|566890728|FG007|Stage I|hyperglycemia|0|||
157036665|NCT00943917|566890729|FG008|Stage I|hyperglycemia|0|||
157036666|NCT00943917|566890730|FG009|Stage I|hyperglycemia|0|||
157036667|NCT00943917|566890731|FG010|Stage I|hyperglycemia|0|||
157036668|NCT00943917|566890732|FG011|Stage I|hyperglycemia|0|||
157036669|NCT00943917|566890733|FG012|Stage I|hyperglycemia|0|||
157169288|NCT00844649|567361346|FG000|Overall Study|Withdrew prior to starting treatment|11|||
157169289|NCT00844649|567361347|FG001|Overall Study|Withdrew prior to starting treatment|27|||
157169290|NCT00168064|567361348|FG000|Overall Study|Adverse Event|26|||
157169291|NCT00168064|567361349|FG001|Overall Study|Adverse Event|22|||
157169292|NCT00168064|567361348|FG000|Overall Study|Withdrawal by Subject|3|||
157169293|NCT00168064|567361349|FG001|Overall Study|Withdrawal by Subject|4|||
157169294|NCT00168064|567361348|FG000|Overall Study|Lack of Efficacy|4|||
157169295|NCT00168064|567361349|FG001|Overall Study|Lack of Efficacy|4|||
157169296|NCT00168064|567361348|FG000|Overall Study|Lost to Follow-up|4|||
157169297|NCT00168064|567361349|FG001|Overall Study|Lost to Follow-up|3|||
157169298|NCT00168064|567361348|FG000|Overall Study|Non-compliance|2|||
157169299|NCT00168064|567361349|FG001|Overall Study|Non-compliance|3|||
157169300|NCT00168064|567361348|FG000|Overall Study|Concurrent Illness|4|||
157169301|NCT00168064|567361349|FG001|Overall Study|Concurrent Illness|3|||
157169302|NCT00168064|567361348|FG000|Overall Study|Subject's Best interest|2|||
157169303|NCT00168064|567361349|FG001|Overall Study|Subject's Best interest|2|||
157169304|NCT00168064|567361348|FG000|Overall Study|Various|4|||
157169305|NCT00168064|567361349|FG001|Overall Study|Various|3|||
157169306|NCT00589979|567361351|FG000|Run-In Period|Adverse Event|5|||
157169307|NCT00589979|567361352|FG001|Run-In Period|Adverse Event|0|||
157169308|NCT00589979|567361353|FG002|Run-In Period|Adverse Event|0|||
157169309|NCT00589979|567361351|FG000|Run-In Period|Protocol Violation|3|||
157169310|NCT00589979|567361352|FG001|Run-In Period|Protocol Violation|0|||
157169311|NCT00589979|567361353|FG002|Run-In Period|Protocol Violation|0|||
157169312|NCT00589979|567361351|FG000|Run-In Period|Did not qualify for randomization|54|||
157169313|NCT00589979|567361352|FG001|Run-In Period|Did not qualify for randomization|0|||
157169314|NCT00589979|567361353|FG002|Run-In Period|Did not qualify for randomization|0|||
157169315|NCT00589979|567361351|FG000|Run-In Period|Withdrawal by Subject|10|||
157169316|NCT00589979|567361352|FG001|Run-In Period|Withdrawal by Subject|0|||
157169317|NCT00589979|567361353|FG002|Run-In Period|Withdrawal by Subject|0|||
157169318|NCT00589979|567361351|FG000|Run-In Period|Informed Consent Withdrawn|4|||
157169319|NCT00589979|567361352|FG001|Run-In Period|Informed Consent Withdrawn|0|||
157169320|NCT00589979|567361353|FG002|Run-In Period|Informed Consent Withdrawn|0|||
157169321|NCT00589979|567361351|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
157169322|NCT00589979|567361352|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
157169323|NCT00589979|567361353|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
157169324|NCT00589979|567361351|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
157169325|NCT00589979|567361352|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
157169326|NCT00589979|567361353|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
157036670|NCT00943917|566890734|FG013|Stage I|hyperglycemia|0|||
157036671|NCT00943917|566890735|FG014|Stage I|hyperglycemia|0|||
157036672|NCT00943917|566890721|FG000|Stage I|A1C elevation|1|||
157036673|NCT00943917|566890722|FG001|Stage I|A1C elevation|0|||
157036674|NCT00943917|566890723|FG002|Stage I|A1C elevation|0|||
157036675|NCT00943917|566890724|FG003|Stage I|A1C elevation|0|||
157036676|NCT00943917|566890725|FG004|Stage I|A1C elevation|0|||
157036677|NCT00943917|566890726|FG005|Stage I|A1C elevation|0|||
157036678|NCT00943917|566890727|FG006|Stage I|A1C elevation|0|||
157036679|NCT00943917|566890728|FG007|Stage I|A1C elevation|0|||
157036680|NCT00943917|566890729|FG008|Stage I|A1C elevation|0|||
157036681|NCT00943917|566890730|FG009|Stage I|A1C elevation|0|||
157036682|NCT00943917|566890731|FG010|Stage I|A1C elevation|0|||
157036683|NCT00943917|566890732|FG011|Stage I|A1C elevation|0|||
157036684|NCT00943917|566890733|FG012|Stage I|A1C elevation|0|||
157036685|NCT00943917|566890734|FG013|Stage I|A1C elevation|0|||
157036686|NCT00943917|566890735|FG014|Stage I|A1C elevation|0|||
157036687|NCT00943917|566890721|FG000|Stage I|Withdrawal by Subject|2|||
157036688|NCT00943917|566890722|FG001|Stage I|Withdrawal by Subject|1|||
157036689|NCT00943917|566890723|FG002|Stage I|Withdrawal by Subject|2|||
157036690|NCT00943917|566890724|FG003|Stage I|Withdrawal by Subject|0|||
157036691|NCT00943917|566890725|FG004|Stage I|Withdrawal by Subject|0|||
157036692|NCT00943917|566890726|FG005|Stage I|Withdrawal by Subject|0|||
157036693|NCT00943917|566890727|FG006|Stage I|Withdrawal by Subject|0|||
157036694|NCT00943917|566890728|FG007|Stage I|Withdrawal by Subject|0|||
157036695|NCT00943917|566890729|FG008|Stage I|Withdrawal by Subject|0|||
157036696|NCT00943917|566890730|FG009|Stage I|Withdrawal by Subject|0|||
157036697|NCT00943917|566890731|FG010|Stage I|Withdrawal by Subject|0|||
157036698|NCT00943917|566890732|FG011|Stage I|Withdrawal by Subject|0|||
157036699|NCT00943917|566890733|FG012|Stage I|Withdrawal by Subject|0|||
157036700|NCT00943917|566890734|FG013|Stage I|Withdrawal by Subject|0|||
157036701|NCT00943917|566890735|FG014|Stage I|Withdrawal by Subject|0|||
157036702|NCT00943917|566890721|FG000|Stage II|Adverse Event|0|||
157036703|NCT00943917|566890722|FG001|Stage II|Adverse Event|0|||
157036704|NCT00943917|566890723|FG002|Stage II|Adverse Event|0|||
157036705|NCT00943917|566890724|FG003|Stage II|Adverse Event|0|||
157036706|NCT00943917|566890725|FG004|Stage II|Adverse Event|0|||
157036707|NCT00943917|566890726|FG005|Stage II|Adverse Event|1|||
157036708|NCT00943917|566890727|FG006|Stage II|Adverse Event|3|||
157036709|NCT00943917|566890728|FG007|Stage II|Adverse Event|0|||
157036710|NCT00943917|566890729|FG008|Stage II|Adverse Event|1|||
157036711|NCT00943917|566890730|FG009|Stage II|Adverse Event|0|||
157036712|NCT00943917|566890731|FG010|Stage II|Adverse Event|0|||
157036713|NCT00943917|566890732|FG011|Stage II|Adverse Event|0|||
157036714|NCT00943917|566890733|FG012|Stage II|Adverse Event|0|||
157036715|NCT00943917|566890734|FG013|Stage II|Adverse Event|0|||
157036716|NCT00943917|566890735|FG014|Stage II|Adverse Event|0|||
157036717|NCT00943917|566890721|FG000|Stage II|Withdrawal by Subject|0|||
157036718|NCT00943917|566890722|FG001|Stage II|Withdrawal by Subject|0|||
157036719|NCT00943917|566890723|FG002|Stage II|Withdrawal by Subject|0|||
157036720|NCT00943917|566890724|FG003|Stage II|Withdrawal by Subject|0|||
157036721|NCT00943917|566890725|FG004|Stage II|Withdrawal by Subject|0|||
157036722|NCT00943917|566890726|FG005|Stage II|Withdrawal by Subject|1|||
157036723|NCT00943917|566890727|FG006|Stage II|Withdrawal by Subject|0|||
157036724|NCT00943917|566890728|FG007|Stage II|Withdrawal by Subject|0|||
157036725|NCT00943917|566890729|FG008|Stage II|Withdrawal by Subject|0|||
157036726|NCT00943917|566890730|FG009|Stage II|Withdrawal by Subject|0|||
157036727|NCT00943917|566890731|FG010|Stage II|Withdrawal by Subject|0|||
157036728|NCT00943917|566890732|FG011|Stage II|Withdrawal by Subject|0|||
157036729|NCT00943917|566890733|FG012|Stage II|Withdrawal by Subject|0|||
157036730|NCT00943917|566890734|FG013|Stage II|Withdrawal by Subject|0|||
157036731|NCT00943917|566890735|FG014|Stage II|Withdrawal by Subject|0|||
157036732|NCT00943917|566890721|FG000|Stage II|Pregnancy|0|||
157036733|NCT00943917|566890722|FG001|Stage II|Pregnancy|0|||
157036734|NCT00943917|566890723|FG002|Stage II|Pregnancy|0|||
157036735|NCT00943917|566890724|FG003|Stage II|Pregnancy|0|||
157036736|NCT00943917|566890725|FG004|Stage II|Pregnancy|0|||
157169327|NCT00589979|567361351|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
157169328|NCT00589979|567361352|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
157036737|NCT00943917|566890726|FG005|Stage II|Pregnancy|1|||
157036738|NCT00943917|566890727|FG006|Stage II|Pregnancy|0|||
157036739|NCT00943917|566890728|FG007|Stage II|Pregnancy|0|||
157036740|NCT00943917|566890729|FG008|Stage II|Pregnancy|0|||
157169329|NCT00589979|567361353|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
157169330|NCT00589979|567361351|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
157036741|NCT00943917|566890730|FG009|Stage II|Pregnancy|0|||
157036742|NCT00943917|566890731|FG010|Stage II|Pregnancy|0|||
157036743|NCT00943917|566890732|FG011|Stage II|Pregnancy|0|||
157036744|NCT00943917|566890733|FG012|Stage II|Pregnancy|0|||
157036745|NCT00943917|566890734|FG013|Stage II|Pregnancy|0|||
157036746|NCT00943917|566890735|FG014|Stage II|Pregnancy|0|||
157169331|NCT00589979|567361352|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
157036747|NCT00943917|566890721|FG000|Stage II Continuation|Adverse Event|0|||
157036748|NCT00943917|566890722|FG001|Stage II Continuation|Adverse Event|0|||
157036749|NCT00943917|566890723|FG002|Stage II Continuation|Adverse Event|0|||
157036750|NCT00943917|566890724|FG003|Stage II Continuation|Adverse Event|0|||
157036751|NCT00943917|566890725|FG004|Stage II Continuation|Adverse Event|0|||
157036752|NCT00943917|566890726|FG005|Stage II Continuation|Adverse Event|0|||
157036753|NCT00943917|566890727|FG006|Stage II Continuation|Adverse Event|0|||
157036754|NCT00943917|566890728|FG007|Stage II Continuation|Adverse Event|0|||
157036755|NCT00943917|566890729|FG008|Stage II Continuation|Adverse Event|0|||
157036756|NCT00943917|566890730|FG009|Stage II Continuation|Adverse Event|0|||
157036757|NCT00943917|566890731|FG010|Stage II Continuation|Adverse Event|0|||
157036758|NCT00943917|566890732|FG011|Stage II Continuation|Adverse Event|1|||
157036759|NCT00943917|566890733|FG012|Stage II Continuation|Adverse Event|2|||
157036760|NCT00943917|566890734|FG013|Stage II Continuation|Adverse Event|1|||
157036761|NCT00943917|566890735|FG014|Stage II Continuation|Adverse Event|1|||
157036762|NCT00943917|566890721|FG000|Stage II Continuation|Withdrawal by Subject|0|||
157036763|NCT00943917|566890722|FG001|Stage II Continuation|Withdrawal by Subject|0|||
157036764|NCT00943917|566890723|FG002|Stage II Continuation|Withdrawal by Subject|0|||
157036765|NCT00943917|566890724|FG003|Stage II Continuation|Withdrawal by Subject|0|||
157036766|NCT00943917|566890725|FG004|Stage II Continuation|Withdrawal by Subject|0|||
157036767|NCT00943917|566890726|FG005|Stage II Continuation|Withdrawal by Subject|0|||
157036768|NCT00943917|566890727|FG006|Stage II Continuation|Withdrawal by Subject|0|||
157036769|NCT00943917|566890728|FG007|Stage II Continuation|Withdrawal by Subject|0|||
157036770|NCT00943917|566890729|FG008|Stage II Continuation|Withdrawal by Subject|0|||
157036771|NCT00943917|566890730|FG009|Stage II Continuation|Withdrawal by Subject|0|||
157036772|NCT00943917|566890731|FG010|Stage II Continuation|Withdrawal by Subject|0|||
157036773|NCT00943917|566890732|FG011|Stage II Continuation|Withdrawal by Subject|0|||
157036774|NCT00943917|566890733|FG012|Stage II Continuation|Withdrawal by Subject|0|||
157036775|NCT00943917|566890734|FG013|Stage II Continuation|Withdrawal by Subject|1|||
157036776|NCT00943917|566890735|FG014|Stage II Continuation|Withdrawal by Subject|3|||
157036777|NCT00943917|566890721|FG000|Stage II Continuation|Protocol Violation|0|||
157036778|NCT00943917|566890722|FG001|Stage II Continuation|Protocol Violation|0|||
157036779|NCT00943917|566890723|FG002|Stage II Continuation|Protocol Violation|0|||
157036780|NCT00943917|566890724|FG003|Stage II Continuation|Protocol Violation|0|||
157036781|NCT00943917|566890725|FG004|Stage II Continuation|Protocol Violation|0|||
157036782|NCT00943917|566890726|FG005|Stage II Continuation|Protocol Violation|0|||
157036783|NCT00943917|566890727|FG006|Stage II Continuation|Protocol Violation|0|||
157036784|NCT00943917|566890728|FG007|Stage II Continuation|Protocol Violation|0|||
157036785|NCT00943917|566890729|FG008|Stage II Continuation|Protocol Violation|0|||
157036786|NCT00943917|566890730|FG009|Stage II Continuation|Protocol Violation|1|||
157036787|NCT00943917|566890731|FG010|Stage II Continuation|Protocol Violation|0|||
157036788|NCT00943917|566890732|FG011|Stage II Continuation|Protocol Violation|1|||
157036789|NCT00943917|566890733|FG012|Stage II Continuation|Protocol Violation|0|||
157036790|NCT00943917|566890734|FG013|Stage II Continuation|Protocol Violation|0|||
157036791|NCT00943917|566890735|FG014|Stage II Continuation|Protocol Violation|0|||
157036792|NCT00943917|566890721|FG000|Stage II Continuation|hypoglycemia|0|||
157036793|NCT00943917|566890722|FG001|Stage II Continuation|hypoglycemia|0|||
157036794|NCT00943917|566890723|FG002|Stage II Continuation|hypoglycemia|0|||
157036795|NCT00943917|566890724|FG003|Stage II Continuation|hypoglycemia|0|||
157036796|NCT00943917|566890725|FG004|Stage II Continuation|hypoglycemia|0|||
157036797|NCT00943917|566890726|FG005|Stage II Continuation|hypoglycemia|0|||
157036798|NCT00943917|566890727|FG006|Stage II Continuation|hypoglycemia|0|||
157036799|NCT00943917|566890728|FG007|Stage II Continuation|hypoglycemia|0|||
157036800|NCT00943917|566890729|FG008|Stage II Continuation|hypoglycemia|0|||
157036801|NCT00943917|566890730|FG009|Stage II Continuation|hypoglycemia|0|||
157036802|NCT00943917|566890731|FG010|Stage II Continuation|hypoglycemia|0|||
157036803|NCT00943917|566890732|FG011|Stage II Continuation|hypoglycemia|0|||
157036804|NCT00943917|566890733|FG012|Stage II Continuation|hypoglycemia|1|||
157036805|NCT00943917|566890734|FG013|Stage II Continuation|hypoglycemia|0|||
157036806|NCT00943917|566890735|FG014|Stage II Continuation|hypoglycemia|0|||
157036807|NCT00943917|566890721|FG000|Stage II Continuation|A1C elevation|0|||
157036808|NCT00943917|566890722|FG001|Stage II Continuation|A1C elevation|0|||
157036809|NCT00943917|566890723|FG002|Stage II Continuation|A1C elevation|0|||
157036810|NCT00943917|566890724|FG003|Stage II Continuation|A1C elevation|0|||
157036811|NCT00943917|566890725|FG004|Stage II Continuation|A1C elevation|0|||
157036812|NCT00943917|566890726|FG005|Stage II Continuation|A1C elevation|0|||
157036813|NCT00943917|566890727|FG006|Stage II Continuation|A1C elevation|0|||
157036814|NCT00943917|566890728|FG007|Stage II Continuation|A1C elevation|0|||
157036815|NCT00943917|566890729|FG008|Stage II Continuation|A1C elevation|0|||
157036816|NCT00943917|566890730|FG009|Stage II Continuation|A1C elevation|0|||
157036817|NCT00943917|566890731|FG010|Stage II Continuation|A1C elevation|0|||
157036818|NCT00943917|566890732|FG011|Stage II Continuation|A1C elevation|0|||
157036819|NCT00943917|566890733|FG012|Stage II Continuation|A1C elevation|0|||
157036820|NCT00943917|566890734|FG013|Stage II Continuation|A1C elevation|1|||
157036821|NCT00943917|566890735|FG014|Stage II Continuation|A1C elevation|0|||
157036822|NCT00003222|566890738|FG000|Overall Study|Physician Decision|0|||
157036823|NCT00003222|566890739|FG001|Overall Study|Physician Decision|1|||
157036824|NCT03248492|566890745|FG000|Overall Study|Progressive Disease|24|||
157036825|NCT03248492|566890746|FG001|Overall Study|Progressive Disease|23|||
157036826|NCT03248492|566890747|FG002|Overall Study|Progressive Disease|11|||
157036827|NCT03248492|566890748|FG003|Overall Study|Progressive Disease|66|||
157036828|NCT03248492|566890749|FG004|Overall Study|Progressive Disease|1|||
157036829|NCT03248492|566890745|FG000|Overall Study|Adverse Event|14|||
157036830|NCT03248492|566890746|FG001|Overall Study|Adverse Event|13|||
157036831|NCT03248492|566890747|FG002|Overall Study|Adverse Event|9|||
157036832|NCT03248492|566890748|FG003|Overall Study|Adverse Event|22|||
157036833|NCT03248492|566890749|FG004|Overall Study|Adverse Event|2|||
157036834|NCT03248492|566890745|FG000|Overall Study|Withdrawal by Subject|5|||
157036835|NCT03248492|566890746|FG001|Overall Study|Withdrawal by Subject|4|||
157036836|NCT03248492|566890747|FG002|Overall Study|Withdrawal by Subject|0|||
157036837|NCT03248492|566890748|FG003|Overall Study|Withdrawal by Subject|8|||
157036838|NCT03248492|566890749|FG004|Overall Study|Withdrawal by Subject|1|||
157036839|NCT03248492|566890745|FG000|Overall Study|Physician Decision|1|||
157036840|NCT03248492|566890746|FG001|Overall Study|Physician Decision|1|||
157036841|NCT03248492|566890747|FG002|Overall Study|Physician Decision|1|||
157036842|NCT03248492|566890748|FG003|Overall Study|Physician Decision|7|||
157036843|NCT03248492|566890749|FG004|Overall Study|Physician Decision|0|||
157036844|NCT03248492|566890745|FG000|Overall Study|Death|1|||
157036845|NCT03248492|566890746|FG001|Overall Study|Death|1|||
157036846|NCT03248492|566890747|FG002|Overall Study|Death|0|||
157036847|NCT03248492|566890748|FG003|Overall Study|Death|6|||
157036848|NCT03248492|566890749|FG004|Overall Study|Death|0|||
157036849|NCT03248492|566890745|FG000|Overall Study|Study Terminated by Sponsor|3|||
157036850|NCT03248492|566890746|FG001|Overall Study|Study Terminated by Sponsor|1|||
157036851|NCT03248492|566890747|FG002|Overall Study|Study Terminated by Sponsor|0|||
157036852|NCT03248492|566890748|FG003|Overall Study|Study Terminated by Sponsor|7|||
157036853|NCT03248492|566890749|FG004|Overall Study|Study Terminated by Sponsor|0|||
157036854|NCT03248492|566890745|FG000|Overall Study|Other|2|||
157036855|NCT03248492|566890746|FG001|Overall Study|Other|5|||
157036856|NCT03248492|566890747|FG002|Overall Study|Other|0|||
157036857|NCT03248492|566890748|FG003|Overall Study|Other|14|||
157036858|NCT03248492|566890749|FG004|Overall Study|Other|0|||
157036859|NCT01313559|566890753|FG000|Overall Study|Withdrawal by Subject|1|||
157036860|NCT01313559|566890754|FG001|Overall Study|Withdrawal by Subject|2|||
157036861|NCT01313559|566890753|FG000|Overall Study|Disease progression|1|||
157036862|NCT01313559|566890754|FG001|Overall Study|Disease progression|0|||
157036863|NCT01313559|566890753|FG000|Overall Study|Rising PSA|2|||
157036864|NCT01313559|566890754|FG001|Overall Study|Rising PSA|0|||
157036865|NCT04018495|566890755|FG000|Overall Study|Physician Decision|1|||
157036866|NCT03774472|566890764|FG000|Overall Study|Physician Decision|1|||
157036867|NCT03774472|566890765|FG001|Overall Study|Physician Decision|0|||
157036868|NCT03774472|566890766|FG002|Overall Study|Physician Decision|0|||
157036869|NCT03774472|566890764|FG000|Overall Study|Progression prior to 4 weeks|0|||
157036870|NCT03774472|566890765|FG001|Overall Study|Progression prior to 4 weeks|1|||
157036871|NCT03774472|566890766|FG002|Overall Study|Progression prior to 4 weeks|0|||
157036872|NCT03774472|566890764|FG000|Overall Study|Withdrawal by Subject|0|||
157036873|NCT03774472|566890765|FG001|Overall Study|Withdrawal by Subject|1|||
157036874|NCT03774472|566890766|FG002|Overall Study|Withdrawal by Subject|0|||
157036875|NCT05155306|566890767|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
157036876|NCT05155306|566890768|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
157036877|NCT05155306|566890769|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
157036878|NCT05155306|566890770|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
157036879|NCT05155306|566890767|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
157036880|NCT05155306|566890768|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
157036881|NCT05155306|566890769|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
157036882|NCT05155306|566890770|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
157036883|NCT03150862|566890771|FG000|Overall Study|Death|2|||
157036884|NCT03150862|566890772|FG001|Overall Study|Death|7|||
157036885|NCT03150862|566890773|FG002|Overall Study|Death|8|||
157036886|NCT03150862|566890774|FG003|Overall Study|Death|27|||
157036887|NCT03150862|566890775|FG004|Overall Study|Death|4|||
157036888|NCT03150862|566890776|FG005|Overall Study|Death|8|||
157036889|NCT03150862|566890777|FG006|Overall Study|Death|6|||
157036890|NCT03150862|566890778|FG007|Overall Study|Death|21|||
157036891|NCT03150862|566890771|FG000|Overall Study|Withdrawal by Subject|1|||
157036892|NCT03150862|566890772|FG001|Overall Study|Withdrawal by Subject|1|||
157036893|NCT03150862|566890773|FG002|Overall Study|Withdrawal by Subject|0|||
157169332|NCT00589979|567361353|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
157036894|NCT03150862|566890774|FG003|Overall Study|Withdrawal by Subject|3|||
157036895|NCT03150862|566890775|FG004|Overall Study|Withdrawal by Subject|1|||
157036896|NCT03150862|566890776|FG005|Overall Study|Withdrawal by Subject|1|||
157036897|NCT03150862|566890777|FG006|Overall Study|Withdrawal by Subject|1|||
157036898|NCT03150862|566890778|FG007|Overall Study|Withdrawal by Subject|3|||
157036899|NCT03150862|566890771|FG000|Overall Study|Lost to Follow-up|0|||
157169333|NCT00589979|567361351|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
157036900|NCT03150862|566890772|FG001|Overall Study|Lost to Follow-up|0|||
157036901|NCT03150862|566890773|FG002|Overall Study|Lost to Follow-up|1|||
157169334|NCT00589979|567361352|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
157169335|NCT00589979|567361353|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
157036902|NCT03150862|566890774|FG003|Overall Study|Lost to Follow-up|0|||
157036903|NCT03150862|566890775|FG004|Overall Study|Lost to Follow-up|0|||
157036904|NCT03150862|566890776|FG005|Overall Study|Lost to Follow-up|0|||
157036905|NCT03150862|566890777|FG006|Overall Study|Lost to Follow-up|0|||
157036906|NCT03150862|566890778|FG007|Overall Study|Lost to Follow-up|2|||
157169336|NCT00589979|567361351|FG000|Double-Blind Treatment Period 2|Other|0|||
157169337|NCT00589979|567361352|FG001|Double-Blind Treatment Period 2|Other|0|||
157169338|NCT00589979|567361353|FG002|Double-Blind Treatment Period 2|Other|1|||
157169339|NCT00589979|567361351|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
157169340|NCT00589979|567361352|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
157169341|NCT00589979|567361353|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
157169342|NCT00589979|567361351|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
157169343|NCT00589979|567361352|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
157169344|NCT00589979|567361353|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
157169345|NCT01153841|567361354|FG000|Overall Study|Adverse Event|1|||
157169346|NCT01153841|567361355|FG001|Overall Study|Adverse Event|0|||
157169347|NCT01153841|567361354|FG000|Overall Study|Withdrawal by Subject|1|||
156956009|NCT05046795|566589021|FG000|Overall Study|Adverse Event|13|||
156956010|NCT05046795|566589022|FG001|Overall Study|Adverse Event|15|||
157036907|NCT03150862|566890771|FG000|Overall Study|Sponsor's decision|0|||
157036908|NCT03150862|566890772|FG001|Overall Study|Sponsor's decision|0|||
157036909|NCT03150862|566890773|FG002|Overall Study|Sponsor's decision|0|||
157036910|NCT03150862|566890774|FG003|Overall Study|Sponsor's decision|10|||
157036911|NCT03150862|566890775|FG004|Overall Study|Sponsor's decision|3|||
157036912|NCT03150862|566890776|FG005|Overall Study|Sponsor's decision|0|||
157036913|NCT03150862|566890777|FG006|Overall Study|Sponsor's decision|1|||
157036914|NCT03150862|566890778|FG007|Overall Study|Sponsor's decision|1|||
157036915|NCT03150862|566890771|FG000|Overall Study|Change in Methylation status|0|||
157036916|NCT03150862|566890772|FG001|Overall Study|Change in Methylation status|0|||
157036917|NCT03150862|566890773|FG002|Overall Study|Change in Methylation status|0|||
157036918|NCT03150862|566890774|FG003|Overall Study|Change in Methylation status|0|||
157036919|NCT03150862|566890775|FG004|Overall Study|Change in Methylation status|1|||
157036920|NCT03150862|566890776|FG005|Overall Study|Change in Methylation status|0|||
157169348|NCT01153841|567361355|FG001|Overall Study|Withdrawal by Subject|0|||
157227584|NCT02180711|567579111|FG004|Overall Study|- Study Terminated by Sponsor|32|||
156956011|NCT05046795|566589021|FG000|Overall Study|Withdrawal by Subject|4|||
156956012|NCT05046795|566589022|FG001|Overall Study|Withdrawal by Subject|7|||
156956013|NCT05046795|566589021|FG000|Overall Study|Physician Decision|1|||
156956014|NCT05046795|566589022|FG001|Overall Study|Physician Decision|2|||
156956015|NCT05046795|566589021|FG000|Overall Study|Protocol Violation|1|||
156956016|NCT05046795|566589022|FG001|Overall Study|Protocol Violation|2|||
156956017|NCT05046795|566589021|FG000|Overall Study|Death|1|||
156956018|NCT05046795|566589022|FG001|Overall Study|Death|0|||
156956019|NCT05046795|566589021|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
156956020|NCT05046795|566589022|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
156956021|NCT01127178|566589023|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
156956022|NCT01127178|566589024|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
156956023|NCT01127178|566589023|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
156956024|NCT01127178|566589024|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
156956025|NCT01127178|566589023|FG000|Dose Escalation: Treatment Phase|Other|2|||
156956026|NCT01127178|566589024|FG001|Dose Escalation: Treatment Phase|Other|0|||
156956027|NCT01127178|566589023|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
156956028|NCT01127178|566589024|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
156956029|NCT01127178|566589023|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
156956030|NCT01127178|566589024|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
156956031|NCT01127178|566589023|FG000|Dose Escalation: Extension Phase|Other|1|||
156956032|NCT01127178|566589024|FG001|Dose Escalation: Extension Phase|Other|0|||
156956033|NCT04139317|566589025|FG000|Overall Study|Adverse Event|10|||
156956034|NCT04139317|566589026|FG001|Overall Study|Adverse Event|2|||
156956035|NCT04139317|566589025|FG000|Overall Study|Death|6|||
156956036|NCT04139317|566589026|FG001|Overall Study|Death|4|||
156956037|NCT04139317|566589025|FG000|Overall Study|Lost to Follow-up|1|||
156956038|NCT04139317|566589026|FG001|Overall Study|Lost to Follow-up|0|||
156956039|NCT04139317|566589025|FG000|Overall Study|Physician Decision|3|||
156956040|NCT04139317|566589026|FG001|Overall Study|Physician Decision|1|||
156956041|NCT04139317|566589025|FG000|Overall Study|Progressive Disease|19|||
156956042|NCT04139317|566589026|FG001|Overall Study|Progressive Disease|9|||
156956043|NCT04139317|566589025|FG000|Overall Study|Subject Decision|2|||
156956044|NCT04139317|566589026|FG001|Overall Study|Subject Decision|2|||
156956045|NCT02365467|566589029|FG000|Overall Study|Death|3|||
156956046|NCT01306162|566589030|FG000|Period 1|Adverse Event|0|||
156956047|NCT01306162|566589031|FG001|Period 1|Adverse Event|0|||
156956048|NCT01306162|566589032|FG002|Period 1|Adverse Event|0|||
156956049|NCT01306162|566589033|FG003|Period 1|Adverse Event|1|||
156956050|NCT01306162|566589030|FG000|Washout 1|Non-compliance to protocol|0|||
157036921|NCT03150862|566890777|FG006|Overall Study|Change in Methylation status|0|||
157036922|NCT03150862|566890778|FG007|Overall Study|Change in Methylation status|0|||
157036923|NCT03150862|566890771|FG000|Overall Study|Roll over in to Long Term Extension|0|||
157036924|NCT03150862|566890772|FG001|Overall Study|Roll over in to Long Term Extension|0|||
157169349|NCT01153841|567361354|FG000|Overall Study|Protocol Violation|2|||
157036925|NCT03150862|566890773|FG002|Overall Study|Roll over in to Long Term Extension|0|||
157036926|NCT03150862|566890774|FG003|Overall Study|Roll over in to Long Term Extension|0|||
157036927|NCT03150862|566890775|FG004|Overall Study|Roll over in to Long Term Extension|0|||
157036928|NCT03150862|566890776|FG005|Overall Study|Roll over in to Long Term Extension|0|||
157036929|NCT03150862|566890777|FG006|Overall Study|Roll over in to Long Term Extension|0|||
157036930|NCT03150862|566890778|FG007|Overall Study|Roll over in to Long Term Extension|1|||
157036931|NCT03150862|566890771|FG000|Overall Study|Progressive Disease|0|||
157036932|NCT03150862|566890772|FG001|Overall Study|Progressive Disease|0|||
157036933|NCT03150862|566890773|FG002|Overall Study|Progressive Disease|0|||
157036934|NCT03150862|566890774|FG003|Overall Study|Progressive Disease|0|||
157036935|NCT03150862|566890775|FG004|Overall Study|Progressive Disease|0|||
157036936|NCT03150862|566890776|FG005|Overall Study|Progressive Disease|0|||
157036937|NCT03150862|566890777|FG006|Overall Study|Progressive Disease|0|||
157036938|NCT03150862|566890778|FG007|Overall Study|Progressive Disease|2|||
157169350|NCT01153841|567361355|FG001|Overall Study|Protocol Violation|0|||
157169351|NCT01153841|567361354|FG000|Overall Study|Lost to Follow-up|2|||
157169352|NCT01153841|567361355|FG001|Overall Study|Lost to Follow-up|0|||
157169353|NCT00830804|567361359|FG000|Overall Study|Lost to Follow-up|4|||
157169354|NCT00830804|567361359|FG000|Overall Study|Death|1|||
157169355|NCT00830804|567361359|FG000|Overall Study|Unable to get to clinic|7|||
157169356|NCT00830804|567361359|FG000|Overall Study|Consent withdrawn|2|||
157169357|NCT00830804|567361359|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
157169358|NCT03428997|567361365|FG000|Overall Study|Sponsor decision.|1|||
157169359|NCT03428997|567361365|FG000|Overall Study|Withdrawal by Subject|3|||
157169360|NCT03428997|567361365|FG000|Overall Study|Lost to Follow-up|4|||
157169361|NCT00510068|567361369|FG000|Double-blind Period|Disease progression|98|||
157169362|NCT00510068|567361370|FG001|Double-blind Period|Disease progression|169|||
157169363|NCT00510068|567361369|FG000|Double-blind Period|Final primary analysis|52|||
157169364|NCT00510068|567361370|FG001|Double-blind Period|Final primary analysis|18|||
157169365|NCT00510068|567361369|FG000|Double-blind Period|Adverse Event|37|||
157169366|NCT00510068|567361370|FG001|Double-blind Period|Adverse Event|7|||
157169367|NCT00510068|567361369|FG000|Double-blind Period|Withdrawal by Subject|8|||
157169368|NCT00510068|567361370|FG001|Double-blind Period|Withdrawal by Subject|6|||
157169369|NCT00510068|567361369|FG000|Double-blind Period|Death|4|||
157169370|NCT00510068|567361370|FG001|Double-blind Period|Death|3|||
157169371|NCT00510068|567361369|FG000|Double-blind Period|Abnormal test result (s)|1|||
157169372|NCT00510068|567361370|FG001|Double-blind Period|Abnormal test result (s)|0|||
157169373|NCT00510068|567361369|FG000|Double-blind Period|Lost to Follow-up|1|||
157169374|NCT00510068|567361370|FG001|Double-blind Period|Lost to Follow-up|0|||
157169375|NCT00510068|567361369|FG000|Double-blind Period|Protocol Violation|6|||
157169376|NCT00510068|567361370|FG001|Double-blind Period|Protocol Violation|0|||
157169377|NCT00510068|567361369|FG000|Open-label Period|Disease Progression|124|||
157036939|NCT04158141|566890779|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
157036940|NCT04158141|566890780|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
157169378|NCT00510068|567361370|FG001|Open-label Period|Disease Progression|0|||
157169379|NCT00510068|567361369|FG000|Open-label Period|Adverse Event|46|||
157169380|NCT00510068|567361370|FG001|Open-label Period|Adverse Event|0|||
156956051|NCT01306162|566589031|FG001|Washout 1|Non-compliance to protocol|1|||
156956052|NCT01306162|566589032|FG002|Washout 1|Non-compliance to protocol|0|||
156956053|NCT01306162|566589033|FG003|Washout 1|Non-compliance to protocol|0|||
156956054|NCT01109992|566589034|FG000|Overall Study|Withdrawal by Subject|0|||
156956055|NCT01109992|566589035|FG001|Overall Study|Withdrawal by Subject|1|||
156956056|NCT01109992|566589034|FG000|Overall Study|Movement during rest scan.|0|||
156956057|NCT01109992|566589035|FG001|Overall Study|Movement during rest scan.|1|||
156956058|NCT00690755|566589036|FG000|Overall Study|Physician Decision|2|||
156956059|NCT00690755|566589037|FG001|Overall Study|Physician Decision|0|||
156956060|NCT00690755|566589038|FG002|Overall Study|Physician Decision|46|||
156956061|NCT00690755|566589039|FG003|Overall Study|Physician Decision|5|||
156956062|NCT00690755|566589040|FG004|Overall Study|Physician Decision|0|||
156956063|NCT00690755|566589041|FG005|Overall Study|Physician Decision|4|||
156956064|NCT00690755|566589042|FG006|Overall Study|Physician Decision|0|||
156956065|NCT04287920|566589043|FG000|Overall Study|Lost to Follow-up|1|||
156956066|NCT04287920|566589044|FG001|Overall Study|Lost to Follow-up|1|||
156956067|NCT04287920|566589043|FG000|Overall Study|Withdrawal by Subject|0|||
156956068|NCT04287920|566589044|FG001|Overall Study|Withdrawal by Subject|3|||
156956069|NCT01435577|566589047|FG000|Overall Study|Adverse Event|10|||
157036941|NCT04158141|566890781|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
157036942|NCT04158141|566890779|FG000|Step 1: Registration|Adverse Event|1|||
156956070|NCT01435577|566589048|FG001|Overall Study|Adverse Event|0|||
156956071|NCT01435577|566589047|FG000|Overall Study|Lack of Efficacy|7|||
157036943|NCT04158141|566890780|FG001|Step 1: Registration|Adverse Event|0|||
157169381|NCT00510068|567361369|FG000|Open-label Period|Withdrawal by Subject|21|||
157169382|NCT00510068|567361370|FG001|Open-label Period|Withdrawal by Subject|0|||
157169383|NCT00510068|567361369|FG000|Open-label Period|Administrative problems|17|||
157169384|NCT00510068|567361370|FG001|Open-label Period|Administrative problems|0|||
157169385|NCT00510068|567361369|FG000|Open-label Period|Death|7|||
157169386|NCT00510068|567361370|FG001|Open-label Period|Death|0|||
157169387|NCT00510068|567361369|FG000|Open-label Period|New cancer therapy|7|||
157169388|NCT00510068|567361370|FG001|Open-label Period|New cancer therapy|0|||
157169389|NCT00510068|567361369|FG000|Open-label Period|Protocol Violation|2|||
157169390|NCT00510068|567361370|FG001|Open-label Period|Protocol Violation|0|||
157169391|NCT00510068|567361369|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
157169392|NCT00510068|567361370|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
157169393|NCT01397448|567361371|FG000|Overall Study|Adverse Event|4|||
157169394|NCT01397448|567361372|FG001|Overall Study|Adverse Event|4|||
157169395|NCT01397448|567361373|FG002|Overall Study|Adverse Event|6|||
157169396|NCT01397448|567361371|FG000|Overall Study|Withdrawal by Subject|4|||
157169397|NCT01397448|567361372|FG001|Overall Study|Withdrawal by Subject|4|||
157169398|NCT01397448|567361373|FG002|Overall Study|Withdrawal by Subject|3|||
157169399|NCT01397448|567361371|FG000|Overall Study|Lack of Efficacy|2|||
157169400|NCT01397448|567361372|FG001|Overall Study|Lack of Efficacy|0|||
157169401|NCT01397448|567361373|FG002|Overall Study|Lack of Efficacy|5|||
156956072|NCT01435577|566589048|FG001|Overall Study|Lack of Efficacy|51|||
156956073|NCT01435577|566589047|FG000|Overall Study|Alternative treatment started|0|||
156956074|NCT01435577|566589048|FG001|Overall Study|Alternative treatment started|1|||
156956075|NCT01910519|566589050|FG000|Overall Study|Withdrawal by Subject|2|||
156956076|NCT01910519|566589051|FG001|Overall Study|Withdrawal by Subject|0|||
156956077|NCT01910519|566589050|FG000|Overall Study|Adverse Event|2|||
157169402|NCT01397448|567361371|FG000|Overall Study|Other|8|||
157169403|NCT01397448|567361372|FG001|Overall Study|Other|7|||
157227585|NCT02180711|567579112|FG005|Overall Study|- Study Terminated by Sponsor|0|||
156956078|NCT01910519|566589051|FG001|Overall Study|Adverse Event|0|||
156956079|NCT04266028|566589052|FG000|Overall Study|Adverse Event|0|||
156956080|NCT04266028|566589053|FG001|Overall Study|Adverse Event|0|||
156956081|NCT04266028|566589054|FG002|Overall Study|Adverse Event|1|||
156956082|NCT04266028|566589055|FG003|Overall Study|Adverse Event|0|||
156956083|NCT04266028|566589056|FG004|Overall Study|Adverse Event|1|||
156956084|NCT04266028|566589057|FG005|Overall Study|Adverse Event|0|||
156956085|NCT04266028|566589058|FG006|Overall Study|Adverse Event|2|||
156956086|NCT04266028|566589059|FG007|Overall Study|Adverse Event|0|||
156956087|NCT04266028|566589052|FG000|Overall Study|temporary halt of the study|0|||
156956088|NCT04266028|566589053|FG001|Overall Study|temporary halt of the study|0|||
156956089|NCT04266028|566589054|FG002|Overall Study|temporary halt of the study|0|||
156956090|NCT04266028|566589055|FG003|Overall Study|temporary halt of the study|0|||
156956091|NCT04266028|566589056|FG004|Overall Study|temporary halt of the study|0|||
156956092|NCT04266028|566589057|FG005|Overall Study|temporary halt of the study|0|||
156956093|NCT04266028|566589058|FG006|Overall Study|temporary halt of the study|2|||
156956094|NCT04266028|566589059|FG007|Overall Study|temporary halt of the study|1|||
156956095|NCT04266028|566589052|FG000|Overall Study|Onset of birch pollen season|0|||
156956096|NCT04266028|566589053|FG001|Overall Study|Onset of birch pollen season|0|||
156956097|NCT04266028|566589054|FG002|Overall Study|Onset of birch pollen season|0|||
156956098|NCT04266028|566589055|FG003|Overall Study|Onset of birch pollen season|0|||
156956099|NCT04266028|566589056|FG004|Overall Study|Onset of birch pollen season|1|||
156956100|NCT04266028|566589057|FG005|Overall Study|Onset of birch pollen season|0|||
156956101|NCT04266028|566589058|FG006|Overall Study|Onset of birch pollen season|0|||
156956102|NCT04266028|566589059|FG007|Overall Study|Onset of birch pollen season|0|||
156956103|NCT01365494|566589060|FG000|Overall Study|Adverse Event|1|||
156956104|NCT01365494|566589061|FG001|Overall Study|Adverse Event|0|||
156956105|NCT01365494|566589060|FG000|Overall Study|Withdrawal by Subject|0|||
156956106|NCT01365494|566589061|FG001|Overall Study|Withdrawal by Subject|1|||
156956107|NCT01365494|566589060|FG000|Overall Study|Lost to Follow-up|1|||
156956108|NCT01365494|566589061|FG001|Overall Study|Lost to Follow-up|2|||
156956109|NCT02663128|566589062|FG000|Period 2|Physician Decision|0|||
156956110|NCT02663128|566589063|FG001|Period 2|Physician Decision|0|||
156956111|NCT02663128|566589064|FG002|Period 2|Physician Decision|0|||
157227586|NCT02180711|567579113|FG006|Overall Study|- Study Terminated by Sponsor|4|||
157227587|NCT02180711|567579114|FG007|Overall Study|- Study Terminated by Sponsor|13|||
157227588|NCT02180711|567579107|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
157169404|NCT01397448|567361373|FG002|Overall Study|Other|4|||
157169405|NCT02180217|567361377|FG000|Overall Study|Adverse Event|3|||
157169406|NCT02180217|567361378|FG001|Overall Study|Adverse Event|2|||
157169407|NCT02180217|567361379|FG002|Overall Study|Adverse Event|22|||
157169408|NCT02180217|567361377|FG000|Overall Study|Death|1|||
157169409|NCT02180217|567361378|FG001|Overall Study|Death|1|||
157169410|NCT02180217|567361379|FG002|Overall Study|Death|0|||
157169411|NCT02180217|567361377|FG000|Overall Study|Withdrawal by Subject|1|||
157169412|NCT02180217|567361378|FG001|Overall Study|Withdrawal by Subject|1|||
156956112|NCT02663128|566589065|FG003|Period 2|Physician Decision|0|||
157169413|NCT02180217|567361379|FG002|Overall Study|Withdrawal by Subject|4|||
156956113|NCT02663128|566589066|FG004|Period 2|Physician Decision|1|||
156956114|NCT02663128|566589067|FG005|Period 2|Physician Decision|0|||
156956115|NCT02720484|566589068|FG000|Treatment on Study|Adverse Event|1|||
157227589|NCT02180711|567579108|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
156956116|NCT02720484|566589068|FG000|Treatment on Study|Withdrawal by Subject|1|||
157169414|NCT02180217|567361377|FG000|Overall Study|Subject/Guardian decision|5|||
157169415|NCT02180217|567361378|FG001|Overall Study|Subject/Guardian decision|3|||
157169416|NCT02180217|567361379|FG002|Overall Study|Subject/Guardian decision|6|||
157169417|NCT02180217|567361377|FG000|Overall Study|Physician Decision|1|||
157169418|NCT02180217|567361378|FG001|Overall Study|Physician Decision|1|||
157169419|NCT02180217|567361379|FG002|Overall Study|Physician Decision|6|||
157169420|NCT02180217|567361377|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157169421|NCT02180217|567361378|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157169422|NCT02180217|567361379|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
157169423|NCT00776555|567361382|FG000|Overall Study|Study terminated|3|||
157169424|NCT00776555|567361383|FG001|Overall Study|Study terminated|0|||
157169425|NCT03483116|567361385|FG000|Overall Study|Adverse Event|0|||
157169426|NCT03483116|567361386|FG001|Overall Study|Adverse Event|1|||
157169427|NCT03483116|567361387|FG002|Overall Study|Adverse Event|0|||
157169428|NCT03483116|567361388|FG003|Overall Study|Adverse Event|1|||
157169429|NCT03483116|567361385|FG000|Overall Study|Protocol Violation|1|||
157169430|NCT03483116|567361386|FG001|Overall Study|Protocol Violation|0|||
157169431|NCT03483116|567361387|FG002|Overall Study|Protocol Violation|0|||
157169432|NCT03483116|567361388|FG003|Overall Study|Protocol Violation|7|||
157169433|NCT03483116|567361385|FG000|Overall Study|Lost to Follow-up|9|||
157169434|NCT03483116|567361386|FG001|Overall Study|Lost to Follow-up|4|||
157169435|NCT03483116|567361387|FG002|Overall Study|Lost to Follow-up|9|||
157169436|NCT03483116|567361388|FG003|Overall Study|Lost to Follow-up|5|||
157169437|NCT03483116|567361385|FG000|Overall Study|Death|1|||
157169438|NCT03483116|567361386|FG001|Overall Study|Death|0|||
157169439|NCT03483116|567361387|FG002|Overall Study|Death|2|||
157169440|NCT03483116|567361388|FG003|Overall Study|Death|1|||
157169441|NCT03483116|567361385|FG000|Overall Study|Withdrawal by Subject|14|||
157169442|NCT03483116|567361386|FG001|Overall Study|Withdrawal by Subject|16|||
157169443|NCT03483116|567361387|FG002|Overall Study|Withdrawal by Subject|14|||
157169444|NCT03483116|567361388|FG003|Overall Study|Withdrawal by Subject|16|||
157169445|NCT03483116|567361385|FG000|Overall Study|Unknown other reason|3|||
157169446|NCT03483116|567361386|FG001|Overall Study|Unknown other reason|2|||
157169447|NCT03483116|567361387|FG002|Overall Study|Unknown other reason|1|||
157169448|NCT03483116|567361388|FG003|Overall Study|Unknown other reason|1|||
157169449|NCT01181102|567361389|FG000|Overall Study|Adverse Event|28|||
157169450|NCT01181102|567361390|FG001|Overall Study|Adverse Event|26|||
157169451|NCT01181102|567361389|FG000|Overall Study|Lack of Efficacy|3|||
157169452|NCT01181102|567361390|FG001|Overall Study|Lack of Efficacy|1|||
157169453|NCT01181102|567361389|FG000|Overall Study|Lost to Follow-up|2|||
157169454|NCT01181102|567361390|FG001|Overall Study|Lost to Follow-up|0|||
157169455|NCT01181102|567361389|FG000|Overall Study|Physician Decision|3|||
157169456|NCT01181102|567361390|FG001|Overall Study|Physician Decision|1|||
157169457|NCT01181102|567361389|FG000|Overall Study|Protocol Violation|5|||
157169458|NCT01181102|567361390|FG001|Overall Study|Protocol Violation|6|||
157169459|NCT01181102|567361389|FG000|Overall Study|Withdrawal by Subject|10|||
157169460|NCT01181102|567361390|FG001|Overall Study|Withdrawal by Subject|12|||
157169461|NCT00239837|567361393|FG000|Overall Study|Lost to Follow-up|3|||
157169462|NCT00239837|567361394|FG001|Overall Study|Lost to Follow-up|7|||
157169463|NCT01838590|567361395|FG000|Overall Study|Lack of Efficacy|12|||
157169464|NCT01838590|567361396|FG001|Overall Study|Lack of Efficacy|4|||
157169465|NCT01838590|567361395|FG000|Overall Study|Lost to Follow-up|0|||
157169466|NCT01838590|567361396|FG001|Overall Study|Lost to Follow-up|1|||
157169467|NCT04685499|567361397|FG000|Overall Study|Study Terminated Early|1|||
157169468|NCT00393913|567361399|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
157169469|NCT00393913|567361399|FG000|Initial Assessment|Withdrawal by Subject|16|||
157169470|NCT00393913|567361399|FG000|CPAP|Withdrawal by Subject|3|||
157169471|NCT00393913|567361399|FG000|CPAP|Physician Decision|1|||
157169472|NCT00393913|567361399|FG000|CPAP|TEchnical problem with CPAP|3|||
157169473|NCT00178464|567361400|FG000|Overall Study|Withdrawal by Subject|1|||
157169474|NCT00178464|567361400|FG000|Overall Study|Physician Decision|1|||
157169475|NCT04093258|567361401|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
157169476|NCT04093258|567361402|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
157169477|NCT00594204|567361403|FG000|Overall Study|Adverse Event|15|||
157169478|NCT00594204|567361404|FG001|Overall Study|Adverse Event|3|||
157169479|NCT00594204|567361403|FG000|Overall Study|Lost to Follow-up|9|||
156956117|NCT02720484|566589068|FG000|Treatment on Study|Progressive Disease|4|||
156956118|NCT02720484|566589068|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
156956119|NCT02720484|566589068|FG000|Follow Up for 2 Years|Death|3|||
156956120|NCT02720484|566589068|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
156956121|NCT01617629|566589071|FG000|Overall Study|Death|2|||
156956122|NCT01617629|566589071|FG000|Overall Study|Investigator's Clinical Judgement|1|||
156956123|NCT01617629|566589071|FG000|Overall Study|Reason Not Specified|1|||
156956124|NCT01617629|566589071|FG000|Overall Study|Participant Withdrew Consent|2|||
156956125|NCT01663636|566589072|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
156956126|NCT01663636|566589073|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
156956127|NCT03277313|566589074|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
156956128|NCT03277313|566589075|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
157036944|NCT04158141|566890781|FG002|Step 1: Registration|Adverse Event|0|||
157036945|NCT04158141|566890779|FG000|Step 1: Registration|Withdrawal by Subject|1|||
157036946|NCT04158141|566890780|FG001|Step 1: Registration|Withdrawal by Subject|0|||
157036947|NCT04158141|566890781|FG002|Step 1: Registration|Withdrawal by Subject|0|||
157036948|NCT04158141|566890779|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
157036949|NCT04158141|566890780|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
157036950|NCT04158141|566890781|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
157036951|NCT04121741|566890782|FG000|Overall Study|Protocol Violation|1|||
157036952|NCT04121741|566890783|FG001|Overall Study|Protocol Violation|0|||
157036953|NCT04121741|566890784|FG002|Overall Study|Protocol Violation|0|||
157036954|NCT04121741|566890785|FG003|Overall Study|Protocol Violation|0|||
157036955|NCT04121741|566890786|FG004|Overall Study|Protocol Violation|0|||
157036956|NCT04121741|566890787|FG005|Overall Study|Protocol Violation|0|||
157036957|NCT03473223|566890789|FG000|Overall Study|Lost to Follow-up|1|||
157036958|NCT03473223|566890790|FG001|Overall Study|Lost to Follow-up|1|||
157036959|NCT03473223|566890789|FG000|Overall Study|Withdrawal by Subject|47|||
157036960|NCT03473223|566890790|FG001|Overall Study|Withdrawal by Subject|42|||
157036961|NCT03473223|566890789|FG000|Overall Study|Indirect contact|32|||
157036962|NCT03473223|566890790|FG001|Overall Study|Indirect contact|29|||
157036963|NCT03473223|566890789|FG000|Overall Study|Other (Not specified)|32|||
157036964|NCT03473223|566890790|FG001|Overall Study|Other (Not specified)|20|||
157036965|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
157036966|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
157036967|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
157036968|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
157036969|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
157036970|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
157036971|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
157036972|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
157036973|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
157036974|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
157036975|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
157036976|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
157036977|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
157036978|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
157036979|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
157036980|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
157036981|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
157036982|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
157036983|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
157036984|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
157036985|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
157036986|NCT04505722|566890791|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
157036987|NCT04505722|566890792|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
157036988|NCT04505722|566890793|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
157036989|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
157036990|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
157036991|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
157036992|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
157036993|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
157036994|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
157036995|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
157036996|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
157036997|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
157036998|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
157036999|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
157037000|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
157037001|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
157169480|NCT00594204|567361404|FG001|Overall Study|Lost to Follow-up|5|||
157169481|NCT00594204|567361403|FG000|Overall Study|Withdrawal by Subject|23|||
157169482|NCT00594204|567361404|FG001|Overall Study|Withdrawal by Subject|29|||
157169483|NCT00594204|567361403|FG000|Overall Study|Other|4|||
157169484|NCT00594204|567361404|FG001|Overall Study|Other|3|||
157169485|NCT00594204|567361403|FG000|Overall Study|Lack of Efficacy|3|||
157169486|NCT00594204|567361404|FG001|Overall Study|Lack of Efficacy|4|||
157037002|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
157037003|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
157037004|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
157037005|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
157169487|NCT00594204|567361403|FG000|Overall Study|Randomized but not treated|4|||
157169488|NCT00594204|567361404|FG001|Overall Study|Randomized but not treated|1|||
157169489|NCT00567541|567361405|FG000|Overall Study|Adverse Event|0|||
157169490|NCT00567541|567361406|FG001|Overall Study|Adverse Event|1|||
157169491|NCT01529385|567361407|FG000|Overall Study|Lost to Follow-up|2|||
157169492|NCT01529385|567361408|FG001|Overall Study|Lost to Follow-up|1|||
157169493|NCT00805545|567361409|FG000|Overall Study|Protocol Violation|3|||
157169494|NCT00805545|567361410|FG001|Overall Study|Protocol Violation|2|||
157169495|NCT00805545|567361409|FG000|Overall Study|Protocol Violation|3|||
157169496|NCT00805545|567361410|FG001|Overall Study|Protocol Violation|1|||
156956129|NCT03277313|566589074|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
156956130|NCT03277313|566589075|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
156956131|NCT03277313|566589074|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
156956132|NCT03277313|566589075|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
156956133|NCT03277313|566589074|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
156956134|NCT03277313|566589075|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
156956135|NCT03277313|566589074|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
156956136|NCT03277313|566589075|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
156956137|NCT00932893|566589081|FG000|Overall Study|Death|115|||
156956138|NCT00932893|566589082|FG001|Overall Study|Death|24|||
156956139|NCT00932893|566589081|FG000|Overall Study|Lost to Follow-up|8|||
156956140|NCT00932893|566589082|FG001|Overall Study|Lost to Follow-up|0|||
156956141|NCT00932893|566589081|FG000|Overall Study|Withdrawal by Subject|5|||
156956142|NCT00932893|566589082|FG001|Overall Study|Withdrawal by Subject|2|||
156956143|NCT00932893|566589081|FG000|Overall Study|Other|5|||
156956144|NCT00932893|566589082|FG001|Overall Study|Other|144|||
156956145|NCT05350449|566589087|FG000|Overall Study|Withdrawal by Subject|4|||
156956146|NCT05350449|566589088|FG001|Overall Study|Withdrawal by Subject|8|||
156956147|NCT05912400|566591271|FG000|Overall Study|Lost to Follow-up|1|||
156956148|NCT05912400|566591272|FG001|Overall Study|Lost to Follow-up|0|||
156956149|NCT05912400|566591271|FG000|Overall Study|Physician Decision|6|||
156956150|NCT05912400|566591272|FG001|Overall Study|Physician Decision|0|||
156956151|NCT05912400|566591271|FG000|Overall Study|Withdrawal by Subject|1|||
156956152|NCT05912400|566591272|FG001|Overall Study|Withdrawal by Subject|0|||
156956153|NCT01914926|566591273|FG000|Overall Study|Adverse Event|1|||
156956154|NCT01914926|566591274|FG001|Overall Study|Adverse Event|0|||
156956155|NCT01914926|566591273|FG000|Overall Study|uncooperative, agitated and removed|0|||
156956156|NCT01914926|566591274|FG001|Overall Study|uncooperative, agitated and removed|1|||
156956157|NCT00856856|566591276|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
156956158|NCT00856856|566591276|FG000|4-year Clinical Follow-up|Missed visit|1|||
156956159|NCT00434057|566591279|FG000|Overall Study|Withdrawal by Subject|1|||
156956160|NCT03073603|566591281|FG000|Overall Study|Noncompliance|3|||
156956161|NCT03073603|566591282|FG001|Overall Study|Noncompliance|1|||
156956162|NCT03073603|566591281|FG000|Overall Study|Adverse Event|5|||
156956163|NCT03073603|566591282|FG001|Overall Study|Adverse Event|3|||
156956164|NCT03073603|566591281|FG000|Overall Study|Physician Decision|1|||
156956165|NCT03073603|566591282|FG001|Overall Study|Physician Decision|2|||
156956166|NCT03073603|566591281|FG000|Overall Study|Required treatment not allowed by protocol|1|||
156956167|NCT03073603|566591282|FG001|Overall Study|Required treatment not allowed by protocol|0|||
156956168|NCT03073603|566591281|FG000|Overall Study|Financial or insurance-related|8|||
156956169|NCT03073603|566591282|FG001|Overall Study|Financial or insurance-related|0|||
156956170|NCT03073603|566591281|FG000|Overall Study|Withdrawal by Subject|0|||
156956171|NCT03073603|566591282|FG001|Overall Study|Withdrawal by Subject|1|||
156956172|NCT03073603|566591281|FG000|Overall Study|Discontinued DMT|4|||
156956173|NCT03073603|566591282|FG001|Overall Study|Discontinued DMT|0|||
156956174|NCT03073603|566591281|FG000|Overall Study|Restarted DMT|0|||
156956175|NCT03073603|566591282|FG001|Overall Study|Restarted DMT|1|||
156956176|NCT00922428|566591285|FG000|Overall Study|retrospective/extremely implausible data|2|||
156956177|NCT00922428|566591285|FG000|Overall Study|no medication use or questionable use|13|||
156956178|NCT03701555|566591297|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
156956179|NCT03701555|566591298|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
156956180|NCT03701555|566591299|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
156956181|NCT03701555|566591300|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
156956182|NCT03701555|566591301|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
156956183|NCT03701555|566591302|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
156956184|NCT03701555|566591303|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
156956185|NCT03701555|566591304|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
156956186|NCT03701555|566591305|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
156956187|NCT03701555|566591306|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
156956188|NCT03701555|566591307|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
156956189|NCT03701555|566591308|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
156956190|NCT03701555|566591309|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
157169497|NCT01401465|567361411|FG000|Treatment Period 1|Adverse Event|4|||
157169498|NCT01401465|567361412|FG001|Treatment Period 1|Adverse Event|1|||
157169499|NCT01401465|567361411|FG000|Treatment Period 1|Pregnancy|0|||
156956191|NCT03701555|566591310|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
156956192|NCT03701555|566591311|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
156956193|NCT03701555|566591312|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
156956194|NCT03701555|566591313|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
157169500|NCT01401465|567361412|FG001|Treatment Period 1|Pregnancy|1|||
157169501|NCT01401465|567361411|FG000|Treatment Period 1|Protocol Violation|5|||
157169502|NCT01401465|567361412|FG001|Treatment Period 1|Protocol Violation|0|||
157169503|NCT01401465|567361411|FG000|Treatment Period 1|Withdrawal by Subject|1|||
157169504|NCT01401465|567361412|FG001|Treatment Period 1|Withdrawal by Subject|4|||
157169505|NCT01401465|567361411|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
157169506|NCT01401465|567361412|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
157169507|NCT01401465|567361411|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
157169508|NCT01401465|567361412|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
157169509|NCT01401465|567361411|FG000|Treatment Period 1|Scheduling Difficulties|1|||
157169510|NCT01401465|567361412|FG001|Treatment Period 1|Scheduling Difficulties|1|||
157227590|NCT02180711|567579109|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
157227591|NCT02180711|567579110|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
156956195|NCT03701555|566591314|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
156956196|NCT03701555|566591315|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
156956197|NCT03701555|566591316|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
156956198|NCT03701555|566591317|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
156956199|NCT03701555|566591318|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
156956200|NCT03701555|566591319|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
156956201|NCT03701555|566591320|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
156956202|NCT03701555|566591321|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
156956203|NCT03701555|566591322|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
156956204|NCT03701555|566591323|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
156956205|NCT03701555|566591324|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
156956206|NCT03701555|566591325|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
156956207|NCT03701555|566591326|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
156956208|NCT03701555|566591327|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
156956209|NCT03701555|566591328|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
156956210|NCT03701555|566591329|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
156956211|NCT03701555|566591330|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
156956212|NCT03701555|566591331|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
156956213|NCT03701555|566591332|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
156956214|NCT03701555|566591297|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
156956215|NCT03701555|566591298|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
156956216|NCT03701555|566591299|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
156956217|NCT03701555|566591300|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
156956218|NCT03701555|566591301|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
156956219|NCT03701555|566591302|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
156956220|NCT03701555|566591303|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
156956221|NCT03701555|566591304|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
156956222|NCT03701555|566591305|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
156956223|NCT03701555|566591306|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
156956224|NCT03701555|566591307|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
156956225|NCT03701555|566591308|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
156956226|NCT03701555|566591309|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
156956227|NCT03701555|566591310|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
156956228|NCT03701555|566591311|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
156956229|NCT03701555|566591312|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
156956230|NCT03701555|566591313|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
156956231|NCT03701555|566591314|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
156956232|NCT03701555|566591315|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
156956233|NCT03701555|566591316|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
156956234|NCT03701555|566591317|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
156956235|NCT03701555|566591318|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
156956236|NCT03701555|566591319|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
156956237|NCT03701555|566591320|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
156956238|NCT03701555|566591321|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
156956239|NCT03701555|566591322|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
156956240|NCT03701555|566591323|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
156956241|NCT03701555|566591324|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
156956242|NCT03701555|566591325|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
156956243|NCT03701555|566591326|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
156956244|NCT03701555|566591327|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
156956245|NCT03701555|566591328|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
156956246|NCT03701555|566591329|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
156956247|NCT03701555|566591330|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
156956248|NCT03701555|566591331|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
156956249|NCT03701555|566591332|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
156956250|NCT03701555|566591297|FG000|Part 2 (Day 1)|Other|0|||
156956251|NCT03701555|566591298|FG001|Part 2 (Day 1)|Other|0|||
156956252|NCT03701555|566591299|FG002|Part 2 (Day 1)|Other|0|||
156956253|NCT03701555|566591300|FG003|Part 2 (Day 1)|Other|0|||
156956254|NCT03701555|566591301|FG004|Part 2 (Day 1)|Other|0|||
156956255|NCT03701555|566591302|FG005|Part 2 (Day 1)|Other|0|||
156956256|NCT03701555|566591303|FG006|Part 2 (Day 1)|Other|0|||
156956257|NCT03701555|566591304|FG007|Part 2 (Day 1)|Other|0|||
156956258|NCT03701555|566591305|FG008|Part 2 (Day 1)|Other|0|||
157169511|NCT01401465|567361411|FG000|Treatment Period 2|Lost to Follow-up|0|||
157169512|NCT01401465|567361412|FG001|Treatment Period 2|Lost to Follow-up|1|||
157169513|NCT01401465|567361411|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157169514|NCT01401465|567361412|FG001|Treatment Period 2|Withdrawal by Subject|1|||
157037006|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
157037007|NCT04505722|566890791|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
157037008|NCT04505722|566890792|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
157037009|NCT04505722|566890793|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
157037010|NCT04755595|566890794|FG000|Overall Study|Lost to Follow-up|1|||
157037011|NCT00319696|566890795|FG000|Overall Study|Adverse Event|36|||
157037012|NCT00319696|566890795|FG000|Overall Study|withdrawal of consent|14|||
157037013|NCT00319696|566890795|FG000|Overall Study|administrative|7|||
157037014|NCT00319696|566890795|FG000|Overall Study|Lost to Follow-up|3|||
157037015|NCT01171976|566891323|FG000|Overall Study|Protocol Violation|0|||
157037016|NCT01171976|566891324|FG001|Overall Study|Protocol Violation|0|||
157037017|NCT01171976|566891325|FG002|Overall Study|Protocol Violation|1|||
157037018|NCT01171976|566891323|FG000|Overall Study|Death|2|||
157037019|NCT01171976|566891324|FG001|Overall Study|Death|4|||
157037020|NCT01171976|566891325|FG002|Overall Study|Death|1|||
157037021|NCT01171976|566891323|FG000|Overall Study|Lost to Follow-up|4|||
157037022|NCT01171976|566891324|FG001|Overall Study|Lost to Follow-up|0|||
157037023|NCT01171976|566891325|FG002|Overall Study|Lost to Follow-up|2|||
157037024|NCT01171976|566891323|FG000|Overall Study|Withdrawal by Subject|1|||
157037025|NCT01171976|566891324|FG001|Overall Study|Withdrawal by Subject|5|||
157037026|NCT01171976|566891325|FG002|Overall Study|Withdrawal by Subject|6|||
157037027|NCT01171976|566891323|FG000|Overall Study|Abnormal test result|1|||
157037028|NCT01171976|566891324|FG001|Overall Study|Abnormal test result|0|||
157037029|NCT01171976|566891325|FG002|Overall Study|Abnormal test result|0|||
157037030|NCT01171976|566891323|FG000|Overall Study|Adverse Event|6|||
157037031|NCT01171976|566891324|FG001|Overall Study|Adverse Event|2|||
157169515|NCT01115738|567361413|FG000|Overall Study|Death|1|||
157169516|NCT01115738|567361414|FG001|Overall Study|Death|0|||
157169517|NCT01115738|567361415|FG002|Overall Study|Death|0|||
157169518|NCT01115738|567361413|FG000|Overall Study|Lost to Follow-up|0|||
157169519|NCT01115738|567361414|FG001|Overall Study|Lost to Follow-up|0|||
156956259|NCT03701555|566591306|FG009|Part 2 (Day 1)|Other|0|||
156956260|NCT03701555|566591307|FG010|Part 2 (Day 1)|Other|3|||
156956261|NCT03701555|566591308|FG011|Part 2 (Day 1)|Other|1|||
156956262|NCT03701555|566591309|FG012|Part 2 (Day 1)|Other|0|||
156956263|NCT03701555|566591310|FG013|Part 2 (Day 1)|Other|1|||
156956264|NCT03701555|566591311|FG014|Part 2 (Day 1)|Other|0|||
156956265|NCT03701555|566591312|FG015|Part 2 (Day 1)|Other|2|||
156956266|NCT03701555|566591313|FG016|Part 2 (Day 1)|Other|2|||
156956267|NCT03701555|566591314|FG017|Part 2 (Day 1)|Other|0|||
156956268|NCT03701555|566591315|FG018|Part 2 (Day 1)|Other|0|||
156956269|NCT03701555|566591316|FG019|Part 2 (Day 1)|Other|0|||
156956270|NCT03701555|566591317|FG020|Part 2 (Day 1)|Other|0|||
156956271|NCT03701555|566591318|FG021|Part 2 (Day 1)|Other|0|||
156956272|NCT03701555|566591319|FG022|Part 2 (Day 1)|Other|0|||
156956273|NCT03701555|566591320|FG023|Part 2 (Day 1)|Other|0|||
156956274|NCT03701555|566591321|FG024|Part 2 (Day 1)|Other|0|||
156956275|NCT03701555|566591322|FG025|Part 2 (Day 1)|Other|0|||
156956276|NCT03701555|566591323|FG026|Part 2 (Day 1)|Other|0|||
156956277|NCT03701555|566591324|FG027|Part 2 (Day 1)|Other|0|||
156956278|NCT03701555|566591325|FG028|Part 2 (Day 1)|Other|0|||
156956279|NCT03701555|566591326|FG029|Part 2 (Day 1)|Other|0|||
156956280|NCT03701555|566591327|FG030|Part 2 (Day 1)|Other|0|||
156956281|NCT03701555|566591328|FG031|Part 2 (Day 1)|Other|0|||
156956282|NCT03701555|566591329|FG032|Part 2 (Day 1)|Other|0|||
156956283|NCT03701555|566591330|FG033|Part 2 (Day 1)|Other|0|||
156956284|NCT03701555|566591331|FG034|Part 2 (Day 1)|Other|0|||
156956285|NCT03701555|566591332|FG035|Part 2 (Day 1)|Other|0|||
156956286|NCT03701555|566591297|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
156956287|NCT03701555|566591298|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
156956288|NCT03701555|566591299|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
156956289|NCT03701555|566591300|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
156956290|NCT03701555|566591301|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
156956291|NCT03701555|566591302|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
156956292|NCT03701555|566591303|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
156956293|NCT03701555|566591304|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
156956294|NCT03701555|566591305|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
157037032|NCT01171976|566891325|FG002|Overall Study|Adverse Event|5|||
156956295|NCT03701555|566591306|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
157037033|NCT04495621|566891326|FG000|Overall Study|Withdrawal by Subject|0|||
157037034|NCT04495621|566891327|FG001|Overall Study|Withdrawal by Subject|3|||
157037035|NCT04495621|566891326|FG000|Overall Study|Death|7|||
156956296|NCT03701555|566591307|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
156956297|NCT03701555|566591308|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
156956298|NCT03701555|566591309|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
157037036|NCT04495621|566891327|FG001|Overall Study|Death|11|||
157037037|NCT04495621|566891326|FG000|Overall Study|Investigator Decision|0|||
157169520|NCT01115738|567361415|FG002|Overall Study|Lost to Follow-up|1|||
157169521|NCT01115738|567361413|FG000|Overall Study|Physician Decision|18|||
157169522|NCT01115738|567361414|FG001|Overall Study|Physician Decision|15|||
157169523|NCT01115738|567361415|FG002|Overall Study|Physician Decision|17|||
157169524|NCT01115738|567361413|FG000|Overall Study|Withdrawal by Subject|6|||
157169525|NCT01115738|567361414|FG001|Overall Study|Withdrawal by Subject|6|||
157169526|NCT01115738|567361415|FG002|Overall Study|Withdrawal by Subject|9|||
157169527|NCT02379390|567361418|FG000|Overall Study|Adverse Event|1|||
157169528|NCT02379390|567361419|FG001|Overall Study|Adverse Event|1|||
157169529|NCT02379390|567361418|FG000|Overall Study|Investigator's decision|1|||
157169530|NCT02379390|567361419|FG001|Overall Study|Investigator's decision|0|||
157169531|NCT02379390|567361418|FG000|Overall Study|Study Termination|0|||
157169532|NCT02379390|567361419|FG001|Overall Study|Study Termination|1|||
157169533|NCT00772382|567361420|FG000|Overall Study|Adverse Event|19|||
157169534|NCT00772382|567361420|FG000|Overall Study|Death|6|||
157169535|NCT00772382|567361420|FG000|Overall Study|Lack of Efficacy|4|||
157169536|NCT00772382|567361420|FG000|Overall Study|Physician Decision|5|||
157169537|NCT00772382|567361420|FG000|Overall Study|Protocol Violation|1|||
157169538|NCT00772382|567361420|FG000|Overall Study|Withdrawal by Subject|10|||
157169539|NCT00772382|567361420|FG000|Overall Study|Other Reasons|10|||
157169540|NCT02721251|567361422|FG000|Overall Study|Withdrawal by Subject|8|||
157169541|NCT02721251|567361423|FG001|Overall Study|Withdrawal by Subject|7|||
157169542|NCT02721251|567361424|FG002|Overall Study|Withdrawal by Subject|9|||
157169543|NCT02721251|567361422|FG000|Overall Study|poor adherence|2|||
157169544|NCT02721251|567361423|FG001|Overall Study|poor adherence|2|||
157169545|NCT02721251|567361424|FG002|Overall Study|poor adherence|2|||
157169546|NCT02921763|567361427|FG000|Overall Study|Adverse Event|4|||
157169547|NCT02921763|567361427|FG000|Overall Study|Lost to Follow-up|4|||
157169548|NCT02921763|567361427|FG000|Overall Study|Lack of Efficacy|3|||
157169549|NCT02921763|567361427|FG000|Overall Study|Protocol Violation|2|||
157169550|NCT02921763|567361427|FG000|Overall Study|Withdrawal by Subject|2|||
157169551|NCT02921763|567361427|FG000|Overall Study|Physician Decision|1|||
157169552|NCT02921763|567361427|FG000|Overall Study|No data obtained|2|||
157169553|NCT01740388|567361428|FG000|Overall Study|Withdrawal by Subject|1|||
157037038|NCT04495621|566891327|FG001|Overall Study|Investigator Decision|7|||
157037039|NCT04495621|566891326|FG000|Overall Study|Lost to Follow-up|0|||
157037040|NCT04495621|566891327|FG001|Overall Study|Lost to Follow-up|1|||
157037041|NCT04059406|566891334|FG000|Overall Study|Early Treatment Termination|5|||
157037042|NCT04059406|566891335|FG001|Overall Study|Early Treatment Termination|5|||
157037043|NCT04059406|566891336|FG002|Overall Study|Early Treatment Termination|15|||
157037044|NCT01084863|566891342|FG000|Main Study Treatment Period|Disease progression|11|||
157037045|NCT01084863|566891343|FG001|Main Study Treatment Period|Disease progression|7|||
157037046|NCT01084863|566891342|FG000|Main Study Treatment Period|Adverse Event|5|||
157037047|NCT01084863|566891343|FG001|Main Study Treatment Period|Adverse Event|3|||
157037048|NCT01084863|566891342|FG000|Main Study Treatment Period|Other Reason|0|||
157037049|NCT01084863|566891343|FG001|Main Study Treatment Period|Other Reason|1|||
157037050|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
157037051|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
157037052|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
157037053|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
157037054|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
157037055|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
157037056|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
157037057|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
157037058|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Other|0|||
157037059|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Other|1|||
157037060|NCT01084863|566891342|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
157037061|NCT01084863|566891343|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
157037062|NCT04305327|566891347|FG000|Overall Study|Study early termination|2|||
157037063|NCT04305327|566891348|FG001|Overall Study|Study early termination|5|||
157037064|NCT04305327|566891349|FG002|Overall Study|Study early termination|2|||
157037065|NCT04305327|566891350|FG003|Overall Study|Study early termination|2|||
157037066|NCT04305327|566891347|FG000|Overall Study|Withdrawal by Subject|0|||
157037067|NCT04305327|566891348|FG001|Overall Study|Withdrawal by Subject|1|||
157037068|NCT04305327|566891349|FG002|Overall Study|Withdrawal by Subject|0|||
157037069|NCT04305327|566891350|FG003|Overall Study|Withdrawal by Subject|0|||
157037070|NCT04530487|566892451|FG000|Overall Study|Death|1|||
157037071|NCT00146172|566892462|FG000|Overall Study|Adverse Event|0|||
157037072|NCT00146172|566892463|FG001|Overall Study|Adverse Event|0|||
157037073|NCT00146172|566892464|FG002|Overall Study|Adverse Event|1|||
157169554|NCT01740388|567361429|FG001|Overall Study|Withdrawal by Subject|2|||
157037074|NCT00146172|566892465|FG003|Overall Study|Adverse Event|1|||
157037075|NCT00146172|566892466|FG004|Overall Study|Adverse Event|0|||
157169555|NCT01740388|567361428|FG000|Overall Study|Lost to Follow-up|2|||
157169556|NCT01740388|567361429|FG001|Overall Study|Lost to Follow-up|0|||
157169557|NCT01740388|567361428|FG000|Overall Study|Physician Decision|2|||
157169558|NCT01740388|567361429|FG001|Overall Study|Physician Decision|6|||
157037076|NCT00146172|566892467|FG005|Overall Study|Adverse Event|2|||
157037077|NCT00146172|566892468|FG006|Overall Study|Adverse Event|3|||
157037078|NCT00146172|566892469|FG007|Overall Study|Adverse Event|10|||
157037079|NCT00146172|566892462|FG000|Overall Study|Lost to Follow-up|0|||
157037080|NCT00146172|566892463|FG001|Overall Study|Lost to Follow-up|0|||
157037081|NCT00146172|566892464|FG002|Overall Study|Lost to Follow-up|0|||
157037082|NCT00146172|566892465|FG003|Overall Study|Lost to Follow-up|0|||
157037083|NCT00146172|566892466|FG004|Overall Study|Lost to Follow-up|0|||
157037084|NCT00146172|566892467|FG005|Overall Study|Lost to Follow-up|0|||
157037085|NCT00146172|566892468|FG006|Overall Study|Lost to Follow-up|0|||
157037086|NCT00146172|566892469|FG007|Overall Study|Lost to Follow-up|1|||
157037087|NCT00146172|566892462|FG000|Overall Study|Disease Progression|2|||
157037088|NCT00146172|566892463|FG001|Overall Study|Disease Progression|4|||
157037089|NCT00146172|566892464|FG002|Overall Study|Disease Progression|2|||
157037090|NCT00146172|566892465|FG003|Overall Study|Disease Progression|5|||
157037091|NCT00146172|566892466|FG004|Overall Study|Disease Progression|2|||
157037092|NCT00146172|566892467|FG005|Overall Study|Disease Progression|2|||
157037093|NCT00146172|566892468|FG006|Overall Study|Disease Progression|1|||
157037094|NCT00146172|566892469|FG007|Overall Study|Disease Progression|22|||
157037095|NCT00146172|566892462|FG000|Overall Study|Death|0|||
157037096|NCT00146172|566892463|FG001|Overall Study|Death|0|||
157037097|NCT00146172|566892464|FG002|Overall Study|Death|0|||
157037098|NCT00146172|566892465|FG003|Overall Study|Death|0|||
157037099|NCT00146172|566892466|FG004|Overall Study|Death|0|||
157037100|NCT00146172|566892467|FG005|Overall Study|Death|0|||
157037101|NCT00146172|566892468|FG006|Overall Study|Death|1|||
157037102|NCT00146172|566892469|FG007|Overall Study|Death|0|||
157037103|NCT00146172|566892462|FG000|Overall Study|Physician Decision|0|||
157037104|NCT00146172|566892463|FG001|Overall Study|Physician Decision|0|||
157037105|NCT00146172|566892464|FG002|Overall Study|Physician Decision|0|||
157037106|NCT00146172|566892465|FG003|Overall Study|Physician Decision|0|||
157037107|NCT00146172|566892466|FG004|Overall Study|Physician Decision|0|||
157037108|NCT00146172|566892467|FG005|Overall Study|Physician Decision|0|||
157037109|NCT00146172|566892468|FG006|Overall Study|Physician Decision|0|||
157037110|NCT00146172|566892469|FG007|Overall Study|Physician Decision|1|||
157037111|NCT00146172|566892462|FG000|Overall Study|Withdrawal by Subject|0|||
157037112|NCT00146172|566892463|FG001|Overall Study|Withdrawal by Subject|0|||
157037113|NCT00146172|566892464|FG002|Overall Study|Withdrawal by Subject|0|||
157037114|NCT00146172|566892465|FG003|Overall Study|Withdrawal by Subject|0|||
157037115|NCT00146172|566892466|FG004|Overall Study|Withdrawal by Subject|0|||
157037116|NCT00146172|566892467|FG005|Overall Study|Withdrawal by Subject|1|||
157037117|NCT00146172|566892468|FG006|Overall Study|Withdrawal by Subject|1|||
157037118|NCT00146172|566892469|FG007|Overall Study|Withdrawal by Subject|4|||
157037119|NCT00146172|566892462|FG000|Overall Study|Symptomatic Deterioration|1|||
157037120|NCT00146172|566892463|FG001|Overall Study|Symptomatic Deterioration|0|||
157037121|NCT00146172|566892464|FG002|Overall Study|Symptomatic Deterioration|1|||
157037122|NCT00146172|566892465|FG003|Overall Study|Symptomatic Deterioration|0|||
157037123|NCT00146172|566892466|FG004|Overall Study|Symptomatic Deterioration|1|||
157037124|NCT00146172|566892467|FG005|Overall Study|Symptomatic Deterioration|2|||
157037125|NCT00146172|566892468|FG006|Overall Study|Symptomatic Deterioration|0|||
157037126|NCT00146172|566892469|FG007|Overall Study|Symptomatic Deterioration|2|||
157037127|NCT00210106|566892470|FG000|Overall Study|Death|1|||
157037128|NCT00210106|566892470|FG000|Overall Study|Protocol Violation|13|||
157037129|NCT00786864|566892471|FG000|Overall Study|Lost to Follow-up|0|||
157037130|NCT00786864|566892472|FG001|Overall Study|Lost to Follow-up|1|||
157037131|NCT00786864|566892471|FG000|Overall Study|Sustained serious back injury|1|||
157037132|NCT00786864|566892472|FG001|Overall Study|Sustained serious back injury|0|||
157037133|NCT02422615|566892473|FG000|Treatment Period|Progressive disease|314|||
157037134|NCT02422615|566892474|FG001|Treatment Period|Progressive disease|200|||
157037135|NCT02422615|566892473|FG000|Treatment Period|Adverse Event|51|||
157037136|NCT02422615|566892474|FG001|Treatment Period|Adverse Event|9|||
157037137|NCT02422615|566892473|FG000|Treatment Period|Physician Decision|32|||
157037138|NCT02422615|566892474|FG001|Treatment Period|Physician Decision|8|||
157037139|NCT02422615|566892473|FG000|Treatment Period|Subject/guardian decision|38|||
157037140|NCT02422615|566892474|FG001|Treatment Period|Subject/guardian decision|8|||
157169559|NCT01740388|567361428|FG000|Overall Study|Subjects missing data, completed|41|||
157169560|NCT01740388|567361429|FG001|Overall Study|Subjects missing data, completed|36|||
157037141|NCT02422615|566892473|FG000|Treatment Period|Death|2|||
157037142|NCT02422615|566892474|FG001|Treatment Period|Death|1|||
157037143|NCT02422615|566892473|FG000|Treatment Period|Technical problems|0|||
157037144|NCT02422615|566892474|FG001|Treatment Period|Technical problems|1|||
157037145|NCT02422615|566892473|FG000|Treatment Period|Protocol deviation|1|||
157037146|NCT02422615|566892474|FG001|Treatment Period|Protocol deviation|1|||
157037147|NCT02422615|566892473|FG000|Treatment Period|Study terminated as per protocol|46|||
157037148|NCT02422615|566892474|FG001|Treatment Period|Study terminated as per protocol|14|||
157037149|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
157037150|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
157037151|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Death|2|||
157169561|NCT00453180|567363463|FG000|Overall Study|Lost to Follow-up|2|||
156956299|NCT03701555|566591310|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
156956300|NCT03701555|566591311|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
156956301|NCT03701555|566591312|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
156956302|NCT03701555|566591313|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
156956303|NCT03701555|566591314|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
156956304|NCT03701555|566591315|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
156956305|NCT03701555|566591316|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
156956306|NCT03701555|566591317|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
156956307|NCT03701555|566591318|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
156956308|NCT03701555|566591319|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
156956309|NCT03701555|566591320|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
156956310|NCT03701555|566591321|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
156956311|NCT03701555|566591322|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
156956312|NCT03701555|566591323|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
156956313|NCT03701555|566591324|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
156956314|NCT03701555|566591325|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
156956315|NCT03701555|566591326|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
156956316|NCT03701555|566591327|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
156956317|NCT03701555|566591328|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
156956318|NCT03701555|566591329|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
156956319|NCT03701555|566591330|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
156956320|NCT03701555|566591331|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
156956321|NCT03701555|566591332|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
156956322|NCT03701555|566591297|FG000|Part 3 (Day 1)|Subject Decision|0|||
156956323|NCT03701555|566591298|FG001|Part 3 (Day 1)|Subject Decision|0|||
156956324|NCT03701555|566591299|FG002|Part 3 (Day 1)|Subject Decision|0|||
156956325|NCT03701555|566591300|FG003|Part 3 (Day 1)|Subject Decision|0|||
156956326|NCT03701555|566591301|FG004|Part 3 (Day 1)|Subject Decision|0|||
156956327|NCT03701555|566591302|FG005|Part 3 (Day 1)|Subject Decision|0|||
156956328|NCT03701555|566591303|FG006|Part 3 (Day 1)|Subject Decision|0|||
156956329|NCT03701555|566591304|FG007|Part 3 (Day 1)|Subject Decision|0|||
156956330|NCT03701555|566591305|FG008|Part 3 (Day 1)|Subject Decision|0|||
156956331|NCT03701555|566591306|FG009|Part 3 (Day 1)|Subject Decision|0|||
156956332|NCT03701555|566591307|FG010|Part 3 (Day 1)|Subject Decision|0|||
156956333|NCT03701555|566591308|FG011|Part 3 (Day 1)|Subject Decision|0|||
156956334|NCT03701555|566591309|FG012|Part 3 (Day 1)|Subject Decision|0|||
156956335|NCT03701555|566591310|FG013|Part 3 (Day 1)|Subject Decision|0|||
156956336|NCT03701555|566591311|FG014|Part 3 (Day 1)|Subject Decision|0|||
156956337|NCT03701555|566591312|FG015|Part 3 (Day 1)|Subject Decision|0|||
156956338|NCT03701555|566591313|FG016|Part 3 (Day 1)|Subject Decision|0|||
156956339|NCT03701555|566591314|FG017|Part 3 (Day 1)|Subject Decision|0|||
156956340|NCT03701555|566591315|FG018|Part 3 (Day 1)|Subject Decision|0|||
156956341|NCT03701555|566591316|FG019|Part 3 (Day 1)|Subject Decision|0|||
156956342|NCT03701555|566591317|FG020|Part 3 (Day 1)|Subject Decision|0|||
156956343|NCT03701555|566591318|FG021|Part 3 (Day 1)|Subject Decision|0|||
156956344|NCT03701555|566591319|FG022|Part 3 (Day 1)|Subject Decision|0|||
156956345|NCT03701555|566591320|FG023|Part 3 (Day 1)|Subject Decision|0|||
156956346|NCT03701555|566591321|FG024|Part 3 (Day 1)|Subject Decision|0|||
156956347|NCT03701555|566591322|FG025|Part 3 (Day 1)|Subject Decision|0|||
156956348|NCT03701555|566591323|FG026|Part 3 (Day 1)|Subject Decision|1|||
156956349|NCT03701555|566591324|FG027|Part 3 (Day 1)|Subject Decision|0|||
156956350|NCT03701555|566591325|FG028|Part 3 (Day 1)|Subject Decision|0|||
156956351|NCT03701555|566591326|FG029|Part 3 (Day 1)|Subject Decision|0|||
156956352|NCT03701555|566591327|FG030|Part 3 (Day 1)|Subject Decision|0|||
156956353|NCT03701555|566591328|FG031|Part 3 (Day 1)|Subject Decision|2|||
156956354|NCT03701555|566591329|FG032|Part 3 (Day 1)|Subject Decision|1|||
156956355|NCT03701555|566591330|FG033|Part 3 (Day 1)|Subject Decision|1|||
156956356|NCT03701555|566591331|FG034|Part 3 (Day 1)|Subject Decision|0|||
156956357|NCT03701555|566591332|FG035|Part 3 (Day 1)|Subject Decision|0|||
156956358|NCT03701555|566591297|FG000|Part 3 (Day 1)|Other|0|||
156956359|NCT03701555|566591298|FG001|Part 3 (Day 1)|Other|0|||
156956360|NCT03701555|566591299|FG002|Part 3 (Day 1)|Other|0|||
156956361|NCT03701555|566591300|FG003|Part 3 (Day 1)|Other|0|||
156956362|NCT03701555|566591301|FG004|Part 3 (Day 1)|Other|0|||
156956363|NCT03701555|566591302|FG005|Part 3 (Day 1)|Other|0|||
156956364|NCT03701555|566591303|FG006|Part 3 (Day 1)|Other|0|||
156956365|NCT03701555|566591304|FG007|Part 3 (Day 1)|Other|0|||
156956366|NCT03701555|566591305|FG008|Part 3 (Day 1)|Other|0|||
156956367|NCT03701555|566591306|FG009|Part 3 (Day 1)|Other|0|||
156956368|NCT03701555|566591307|FG010|Part 3 (Day 1)|Other|0|||
156956369|NCT03701555|566591308|FG011|Part 3 (Day 1)|Other|0|||
157169562|NCT00453180|567363464|FG001|Overall Study|Lost to Follow-up|1|||
157169563|NCT00453180|567363463|FG000|Overall Study|Adverse Event|1|||
156956370|NCT03701555|566591309|FG012|Part 3 (Day 1)|Other|0|||
156956371|NCT03701555|566591310|FG013|Part 3 (Day 1)|Other|0|||
156956372|NCT03701555|566591311|FG014|Part 3 (Day 1)|Other|0|||
156956373|NCT03701555|566591312|FG015|Part 3 (Day 1)|Other|0|||
156956374|NCT03701555|566591313|FG016|Part 3 (Day 1)|Other|0|||
156956375|NCT03701555|566591314|FG017|Part 3 (Day 1)|Other|0|||
156956376|NCT03701555|566591315|FG018|Part 3 (Day 1)|Other|0|||
157037152|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Death|1|||
157037153|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
157037154|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
157037155|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
157037156|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
157037157|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
157037158|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
157037159|NCT02422615|566892473|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
157037160|NCT02422615|566892474|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
157037161|NCT01288443|566892475|FG000|Overall Study|Adverse Event|0|||
157037162|NCT01288443|566892476|FG001|Overall Study|Adverse Event|0|||
157037163|NCT01288443|566892477|FG002|Overall Study|Adverse Event|1|||
157037164|NCT01288443|566892478|FG003|Overall Study|Adverse Event|1|||
157037165|NCT01288443|566892479|FG004|Overall Study|Adverse Event|3|||
157037166|NCT01288443|566892480|FG005|Overall Study|Adverse Event|1|||
157037167|NCT01288443|566892475|FG000|Overall Study|Poor compliance to protocol|0|||
157037168|NCT01288443|566892476|FG001|Overall Study|Poor compliance to protocol|0|||
157037169|NCT01288443|566892477|FG002|Overall Study|Poor compliance to protocol|0|||
157037170|NCT01288443|566892478|FG003|Overall Study|Poor compliance to protocol|0|||
157037171|NCT01288443|566892479|FG004|Overall Study|Poor compliance to protocol|0|||
157037172|NCT01288443|566892480|FG005|Overall Study|Poor compliance to protocol|1|||
157037173|NCT01288443|566892475|FG000|Overall Study|Participant Moved|0|||
157037174|NCT01288443|566892476|FG001|Overall Study|Participant Moved|0|||
157037175|NCT01288443|566892477|FG002|Overall Study|Participant Moved|0|||
157037176|NCT01288443|566892478|FG003|Overall Study|Participant Moved|1|||
157037177|NCT01288443|566892479|FG004|Overall Study|Participant Moved|2|||
157037178|NCT01288443|566892480|FG005|Overall Study|Participant Moved|1|||
157037179|NCT01288443|566892475|FG000|Overall Study|Consent withdrawn by Participant|0|||
157037180|NCT01288443|566892476|FG001|Overall Study|Consent withdrawn by Participant|0|||
157037181|NCT01288443|566892477|FG002|Overall Study|Consent withdrawn by Participant|0|||
157037182|NCT01288443|566892478|FG003|Overall Study|Consent withdrawn by Participant|0|||
157037183|NCT01288443|566892479|FG004|Overall Study|Consent withdrawn by Participant|0|||
157037184|NCT01288443|566892480|FG005|Overall Study|Consent withdrawn by Participant|1|||
157037185|NCT01288443|566892475|FG000|Overall Study|Lost to Follow-up|0|||
157037186|NCT01288443|566892476|FG001|Overall Study|Lost to Follow-up|1|||
157037187|NCT01288443|566892477|FG002|Overall Study|Lost to Follow-up|0|||
157037188|NCT01288443|566892478|FG003|Overall Study|Lost to Follow-up|0|||
157037189|NCT01288443|566892479|FG004|Overall Study|Lost to Follow-up|0|||
157037190|NCT01288443|566892480|FG005|Overall Study|Lost to Follow-up|0|||
157037191|NCT01288443|566892475|FG000|Overall Study|Study drug auto-injector administration|0|||
157037192|NCT01288443|566892476|FG001|Overall Study|Study drug auto-injector administration|0|||
157037193|NCT01288443|566892477|FG002|Overall Study|Study drug auto-injector administration|0|||
157037194|NCT01288443|566892478|FG003|Overall Study|Study drug auto-injector administration|0|||
157037195|NCT01288443|566892479|FG004|Overall Study|Study drug auto-injector administration|1|||
157037196|NCT01288443|566892480|FG005|Overall Study|Study drug auto-injector administration|1|||
157037197|NCT01288443|566892475|FG000|Overall Study|Other than above|0|||
157037198|NCT01288443|566892476|FG001|Overall Study|Other than above|0|||
157037199|NCT01288443|566892477|FG002|Overall Study|Other than above|0|||
157037200|NCT01288443|566892478|FG003|Overall Study|Other than above|2|||
157037201|NCT01288443|566892479|FG004|Overall Study|Other than above|1|||
157037202|NCT01288443|566892480|FG005|Overall Study|Other than above|0|||
157037203|NCT02438137|566892485|FG000|Overall Study|Lost to Follow-up|3|||
157037204|NCT02438137|566892486|FG001|Overall Study|Lost to Follow-up|2|||
157037205|NCT02438137|566892485|FG000|Overall Study|Adverse Event|1|||
157037206|NCT02438137|566892486|FG001|Overall Study|Adverse Event|0|||
157037207|NCT02438137|566892485|FG000|Overall Study|Withdrawal by Subject|4|||
157037208|NCT02438137|566892486|FG001|Overall Study|Withdrawal by Subject|3|||
157037209|NCT02438137|566892485|FG000|Overall Study|Physician Decision|0|||
157037210|NCT02438137|566892486|FG001|Overall Study|Physician Decision|1|||
157037211|NCT00692913|566892487|FG000|Overall Study|Adverse Event|8|||
157037212|NCT00692913|566892488|FG001|Overall Study|Adverse Event|4|||
157037213|NCT00692913|566892487|FG000|Overall Study|Lost to Follow-up|3|||
157037214|NCT00692913|566892488|FG001|Overall Study|Lost to Follow-up|5|||
157037215|NCT00692913|566892487|FG000|Overall Study|Physician Decision|2|||
157037216|NCT00692913|566892488|FG001|Overall Study|Physician Decision|0|||
157169564|NCT00453180|567363464|FG001|Overall Study|Adverse Event|2|||
157169565|NCT00804843|567363465|FG000|Overall Study|Protocol Violation|1|||
157169566|NCT00804843|567363466|FG001|Overall Study|Protocol Violation|0|||
157037217|NCT00692913|566892487|FG000|Overall Study|Protocol Violation|1|||
157169567|NCT00804843|567363465|FG000|Overall Study|Adverse Event|8|||
157037218|NCT00692913|566892488|FG001|Overall Study|Protocol Violation|1|||
157037219|NCT00692913|566892487|FG000|Overall Study|Withdrawal by Subject|15|||
157169568|NCT00804843|567363466|FG001|Overall Study|Adverse Event|5|||
157037220|NCT00692913|566892488|FG001|Overall Study|Withdrawal by Subject|20|||
157037221|NCT02291913|566892489|FG000|Overall Study|Progressive Disease|32|||
157037222|NCT02291913|566892489|FG000|Overall Study|Adverse Event|11|||
157037223|NCT02291913|566892489|FG000|Overall Study|Death|2|||
157037224|NCT02291913|566892489|FG000|Overall Study|Physician Decision|1|||
157037225|NCT02291913|566892489|FG000|Overall Study|Withdrawal by Subject|1|||
157037226|NCT02291913|566892489|FG000|Overall Study|Protocol Violation|1|||
157037227|NCT04876417|566892490|FG000|Overall Study|Lost to Follow-up|5|||
157037228|NCT04876417|566892491|FG001|Overall Study|Lost to Follow-up|8|||
157037229|NCT04876417|566892492|FG002|Overall Study|Lost to Follow-up|0|||
157037230|NCT04876417|566892493|FG003|Overall Study|Lost to Follow-up|0|||
157037231|NCT03621735|566892494|FG000|Overall Study|Withdrawal by Subject|13|||
157037232|NCT03621735|566892495|FG001|Overall Study|Withdrawal by Subject|13|||
157037233|NCT03875313|566892500|FG000|Overall Study|Withdrawal by Subject|1|||
157037234|NCT03875313|566892501|FG001|Overall Study|Withdrawal by Subject|3|||
157037235|NCT03875313|566892502|FG002|Overall Study|Withdrawal by Subject|0|||
157037236|NCT03875313|566892503|FG003|Overall Study|Withdrawal by Subject|0|||
157037237|NCT03875313|566892504|FG004|Overall Study|Withdrawal by Subject|0|||
157037238|NCT03875313|566892500|FG000|Overall Study|Death|0|||
157037239|NCT03875313|566892501|FG001|Overall Study|Death|0|||
157037240|NCT03875313|566892502|FG002|Overall Study|Death|0|||
157037241|NCT03875313|566892503|FG003|Overall Study|Death|0|||
157037242|NCT03875313|566892504|FG004|Overall Study|Death|1|||
157037243|NCT03875313|566892500|FG000|Overall Study|Lost to Follow-up|0|||
157037244|NCT03875313|566892501|FG001|Overall Study|Lost to Follow-up|0|||
157037245|NCT03875313|566892502|FG002|Overall Study|Lost to Follow-up|0|||
157037246|NCT03875313|566892503|FG003|Overall Study|Lost to Follow-up|0|||
157037247|NCT03875313|566892504|FG004|Overall Study|Lost to Follow-up|1|||
157037248|NCT03875313|566892500|FG000|Overall Study|Study Termination by Sponsor|0|||
157037249|NCT03875313|566892501|FG001|Overall Study|Study Termination by Sponsor|1|||
157037250|NCT03875313|566892502|FG002|Overall Study|Study Termination by Sponsor|1|||
157037251|NCT03875313|566892503|FG003|Overall Study|Study Termination by Sponsor|0|||
157037252|NCT03875313|566892504|FG004|Overall Study|Study Termination by Sponsor|1|||
157037253|NCT03875313|566892500|FG000|Overall Study|New Anticancer Treatment|0|||
157037254|NCT03875313|566892501|FG001|Overall Study|New Anticancer Treatment|1|||
157037255|NCT03875313|566892502|FG002|Overall Study|New Anticancer Treatment|2|||
157037256|NCT03875313|566892503|FG003|Overall Study|New Anticancer Treatment|1|||
157037257|NCT03875313|566892504|FG004|Overall Study|New Anticancer Treatment|0|||
157037258|NCT03875313|566892500|FG000|Overall Study|Other, Not Specified|2|||
157037259|NCT03875313|566892501|FG001|Overall Study|Other, Not Specified|11|||
157037260|NCT03875313|566892502|FG002|Overall Study|Other, Not Specified|3|||
157037261|NCT03875313|566892503|FG003|Overall Study|Other, Not Specified|3|||
157037262|NCT03875313|566892504|FG004|Overall Study|Other, Not Specified|1|||
157037263|NCT01092416|566892505|FG000|Enrollment|Atherectomy device not inserted|3|||
157037264|NCT01092416|566892505|FG000|30-Day Follow-up|Death|2|||
157037265|NCT01092416|566892505|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
157037266|NCT01092416|566892505|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
157037267|NCT01092416|566892505|FG000|12-Month Follow-up|Death|16|||
157037268|NCT01092416|566892505|FG000|12-Month Follow-up|Lost to Follow-up|4|||
157037269|NCT01092416|566892505|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
157037270|NCT01092416|566892505|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
157037271|NCT01092416|566892505|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
157037272|NCT03709706|566892506|FG000|Overall Study|Adverse Event|0|||
157037273|NCT03709706|566892507|FG001|Overall Study|Adverse Event|1|||
157037274|NCT03709706|566892506|FG000|Overall Study|Physician Decision|14|||
157037275|NCT03709706|566892507|FG001|Overall Study|Physician Decision|8|||
157037276|NCT03709706|566892506|FG000|Overall Study|Withdrawal by Subject|2|||
157037277|NCT03709706|566892507|FG001|Overall Study|Withdrawal by Subject|1|||
157037278|NCT03709706|566892506|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
157037279|NCT03709706|566892507|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
157037280|NCT01105975|566892508|FG000|Overall Study|Adverse Event|2|||
157037281|NCT01105975|566892509|FG001|Overall Study|Adverse Event|1|||
156956377|NCT03701555|566591316|FG019|Part 3 (Day 1)|Other|0|||
156956378|NCT03701555|566591317|FG020|Part 3 (Day 1)|Other|0|||
156956379|NCT03701555|566591318|FG021|Part 3 (Day 1)|Other|0|||
156956380|NCT03701555|566591319|FG022|Part 3 (Day 1)|Other|0|||
156956381|NCT03701555|566591320|FG023|Part 3 (Day 1)|Other|0|||
156956382|NCT03701555|566591321|FG024|Part 3 (Day 1)|Other|1|||
156956383|NCT03701555|566591322|FG025|Part 3 (Day 1)|Other|1|||
156956384|NCT03701555|566591323|FG026|Part 3 (Day 1)|Other|0|||
156956385|NCT03701555|566591324|FG027|Part 3 (Day 1)|Other|0|||
157037282|NCT01105975|566892510|FG002|Overall Study|Adverse Event|5|||
157037283|NCT01105975|566892511|FG003|Overall Study|Adverse Event|1|||
157037284|NCT01105975|566892512|FG004|Overall Study|Adverse Event|0|||
157037285|NCT01105975|566892513|FG005|Overall Study|Adverse Event|1|||
157037286|NCT01105975|566892514|FG006|Overall Study|Adverse Event|2|||
156956386|NCT03701555|566591325|FG028|Part 3 (Day 1)|Other|0|||
156956387|NCT03701555|566591326|FG029|Part 3 (Day 1)|Other|1|||
156956388|NCT03701555|566591327|FG030|Part 3 (Day 1)|Other|1|||
156956389|NCT03701555|566591328|FG031|Part 3 (Day 1)|Other|0|||
156956390|NCT03701555|566591329|FG032|Part 3 (Day 1)|Other|1|||
157037287|NCT01105975|566892515|FG007|Overall Study|Adverse Event|4|||
157037288|NCT01105975|566892516|FG008|Overall Study|Adverse Event|1|||
157037289|NCT01105975|566892517|FG009|Overall Study|Adverse Event|4|||
157037290|NCT01105975|566892508|FG000|Overall Study|Withdrawal by Subject|2|||
157037291|NCT01105975|566892509|FG001|Overall Study|Withdrawal by Subject|2|||
157037292|NCT01105975|566892510|FG002|Overall Study|Withdrawal by Subject|2|||
157037293|NCT01105975|566892511|FG003|Overall Study|Withdrawal by Subject|0|||
157037294|NCT01105975|566892512|FG004|Overall Study|Withdrawal by Subject|4|||
157037295|NCT01105975|566892513|FG005|Overall Study|Withdrawal by Subject|1|||
157037296|NCT01105975|566892514|FG006|Overall Study|Withdrawal by Subject|2|||
157037297|NCT01105975|566892515|FG007|Overall Study|Withdrawal by Subject|1|||
157037298|NCT01105975|566892516|FG008|Overall Study|Withdrawal by Subject|0|||
157037299|NCT01105975|566892517|FG009|Overall Study|Withdrawal by Subject|3|||
157037300|NCT01105975|566892508|FG000|Overall Study|Lost to Follow-up|1|||
157037301|NCT01105975|566892509|FG001|Overall Study|Lost to Follow-up|0|||
157037302|NCT01105975|566892510|FG002|Overall Study|Lost to Follow-up|0|||
157037303|NCT01105975|566892511|FG003|Overall Study|Lost to Follow-up|1|||
157037304|NCT01105975|566892512|FG004|Overall Study|Lost to Follow-up|1|||
157037305|NCT01105975|566892513|FG005|Overall Study|Lost to Follow-up|0|||
157037306|NCT01105975|566892514|FG006|Overall Study|Lost to Follow-up|0|||
157037307|NCT01105975|566892515|FG007|Overall Study|Lost to Follow-up|0|||
157037308|NCT01105975|566892516|FG008|Overall Study|Lost to Follow-up|1|||
157037309|NCT01105975|566892517|FG009|Overall Study|Lost to Follow-up|0|||
157037310|NCT01105975|566892508|FG000|Overall Study|Physician Decision|0|||
157037311|NCT01105975|566892509|FG001|Overall Study|Physician Decision|0|||
157037312|NCT01105975|566892510|FG002|Overall Study|Physician Decision|0|||
157037313|NCT01105975|566892511|FG003|Overall Study|Physician Decision|0|||
157037314|NCT01105975|566892512|FG004|Overall Study|Physician Decision|0|||
157037315|NCT01105975|566892513|FG005|Overall Study|Physician Decision|0|||
157037316|NCT01105975|566892514|FG006|Overall Study|Physician Decision|2|||
157037317|NCT01105975|566892515|FG007|Overall Study|Physician Decision|0|||
157037318|NCT01105975|566892516|FG008|Overall Study|Physician Decision|0|||
157037319|NCT01105975|566892517|FG009|Overall Study|Physician Decision|0|||
157037320|NCT01105975|566892508|FG000|Overall Study|Protocol Violation|0|||
157037321|NCT01105975|566892509|FG001|Overall Study|Protocol Violation|2|||
157037322|NCT01105975|566892510|FG002|Overall Study|Protocol Violation|2|||
157037323|NCT01105975|566892511|FG003|Overall Study|Protocol Violation|0|||
157037324|NCT01105975|566892512|FG004|Overall Study|Protocol Violation|1|||
157037325|NCT01105975|566892513|FG005|Overall Study|Protocol Violation|1|||
157037326|NCT01105975|566892514|FG006|Overall Study|Protocol Violation|1|||
157037327|NCT01105975|566892515|FG007|Overall Study|Protocol Violation|1|||
157037328|NCT01105975|566892516|FG008|Overall Study|Protocol Violation|2|||
157037329|NCT01105975|566892517|FG009|Overall Study|Protocol Violation|2|||
157037330|NCT01105975|566892508|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157037331|NCT01105975|566892509|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157037332|NCT01105975|566892510|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157037333|NCT01105975|566892511|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157037334|NCT01105975|566892512|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157037335|NCT01105975|566892513|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
157037336|NCT01105975|566892514|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157037337|NCT01105975|566892515|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157037338|NCT01105975|566892516|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
157037339|NCT01105975|566892517|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157037340|NCT04868617|566892518|FG000|Overall Study|Death|1|||
157037341|NCT04868617|566892519|FG001|Overall Study|Death|0|||
157037342|NCT04868617|566892518|FG000|Overall Study|Adverse Event|1|||
157037343|NCT04868617|566892519|FG001|Overall Study|Adverse Event|0|||
157037344|NCT04868617|566892518|FG000|Overall Study|Withdrawal by Subject|1|||
157037345|NCT04868617|566892519|FG001|Overall Study|Withdrawal by Subject|0|||
157169569|NCT00804843|567363465|FG000|Overall Study|Withdrawal by Subject|1|||
157169570|NCT00804843|567363466|FG001|Overall Study|Withdrawal by Subject|2|||
157037346|NCT04868617|566892518|FG000|Overall Study|Device deficiency|1|||
157037347|NCT04868617|566892519|FG001|Overall Study|Device deficiency|0|||
157037348|NCT02502526|566892520|FG000|Overall Study|Lost to Follow-up|2|||
157037349|NCT02502526|566892521|FG001|Overall Study|Lost to Follow-up|2|||
157037350|NCT02502526|566892522|FG002|Overall Study|Lost to Follow-up|3|||
157037351|NCT02502526|566892520|FG000|Overall Study|Withdrawal by Subject|0|||
157037352|NCT02502526|566892521|FG001|Overall Study|Withdrawal by Subject|1|||
157169571|NCT03326869|567363468|FG000|Overall Study|Study data has been lost to natural disa|1|||
157037353|NCT02502526|566892522|FG002|Overall Study|Withdrawal by Subject|1|||
157037354|NCT02502526|566892520|FG000|Overall Study|Disqualified due to cataract grading|0|||
157037355|NCT02502526|566892521|FG001|Overall Study|Disqualified due to cataract grading|0|||
157037356|NCT02502526|566892522|FG002|Overall Study|Disqualified due to cataract grading|1|||
157037357|NCT02502526|566892520|FG000|Overall Study|Enrollment suspension|4|||
157037358|NCT02502526|566892521|FG001|Overall Study|Enrollment suspension|1|||
157037359|NCT02502526|566892522|FG002|Overall Study|Enrollment suspension|1|||
157169572|NCT03326869|567363469|FG001|Overall Study|Study data has been lost to natural disa|1|||
156956391|NCT03701555|566591330|FG033|Part 3 (Day 1)|Other|1|||
156956392|NCT03701555|566591331|FG034|Part 3 (Day 1)|Other|0|||
156956393|NCT03701555|566591332|FG035|Part 3 (Day 1)|Other|0|||
156956394|NCT04757649|566591333|FG000|Overall Study|Withdrawal by Subject|1|||
156956395|NCT04757649|566591333|FG000|Overall Study|Adverse Event|1|||
156956396|NCT02508311|566591341|FG000|Overall Study|Withdrawal by Subject|1|||
156956397|NCT02508311|566591342|FG001|Overall Study|Withdrawal by Subject|0|||
156956398|NCT04862143|566591343|FG000|Overall Study|Adverse Event|1|||
156956399|NCT04862143|566591343|FG000|Overall Study|Study terminated by sponsor|1|||
156956400|NCT02103439|566591344|FG000|Overall Study|Adverse Event|0|||
156956401|NCT02103439|566591345|FG001|Overall Study|Adverse Event|2|||
156956402|NCT02103439|566591344|FG000|Overall Study|Withdrawal by Subject|3|||
156956403|NCT02103439|566591345|FG001|Overall Study|Withdrawal by Subject|1|||
156956404|NCT02370602|566591346|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156956405|NCT02370602|566591347|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156956406|NCT02370602|566591348|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
156956407|NCT02370602|566591349|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
156956408|NCT02370602|566591350|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
156956409|NCT02370602|566591351|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
156956410|NCT04955639|566591353|FG000|Overall Study|Withdrawal by Subject|2|||
156956411|NCT04955639|566591354|FG001|Overall Study|Withdrawal by Subject|2|||
156956412|NCT04955639|566591353|FG000|Overall Study|Week 26 survey not completed|2|||
156956413|NCT04955639|566591354|FG001|Overall Study|Week 26 survey not completed|2|||
156956414|NCT04447404|566591355|FG000|Overall Study|Death|2|||
156956415|NCT04447404|566591356|FG001|Overall Study|Death|0|||
156956416|NCT00413153|566591357|FG000|Overall Study|Withdrawal by Subject|1|||
156956417|NCT00413153|566591358|FG001|Overall Study|Withdrawal by Subject|1|||
156956418|NCT00413153|566591357|FG000|Overall Study|Adverse Event|1|||
156956419|NCT00413153|566591358|FG001|Overall Study|Adverse Event|0|||
156956420|NCT01221597|566591361|FG000|Overall Study|Adverse Event|4|||
156956421|NCT01221597|566591362|FG001|Overall Study|Adverse Event|1|||
156956422|NCT01221597|566591361|FG000|Overall Study|Withdrawal by Subject|20|||
156956423|NCT01221597|566591362|FG001|Overall Study|Withdrawal by Subject|6|||
156956424|NCT01221597|566591361|FG000|Overall Study|Lost to Follow-up|6|||
156956425|NCT01221597|566591362|FG001|Overall Study|Lost to Follow-up|5|||
156956426|NCT01221597|566591361|FG000|Overall Study|Protocol Violation|1|||
156956427|NCT01221597|566591362|FG001|Overall Study|Protocol Violation|0|||
156956428|NCT01221597|566591361|FG000|Overall Study|Other|3|||
156956429|NCT01221597|566591362|FG001|Overall Study|Other|4|||
156956430|NCT01221597|566591361|FG000|Overall Study|Death|2|||
156956431|NCT01221597|566591362|FG001|Overall Study|Death|0|||
156956432|NCT04420689|566591364|FG000|Overall Study|COVID-19 related hospitalization|0|||
156956433|NCT04420689|566591365|FG001|Overall Study|COVID-19 related hospitalization|0|||
156956434|NCT04420689|566591366|FG002|Overall Study|COVID-19 related hospitalization|0|||
156956435|NCT04420689|566591367|FG003|Overall Study|COVID-19 related hospitalization|0|||
156956436|NCT04420689|566591368|FG004|Overall Study|COVID-19 related hospitalization|1|||
156956437|NCT04420689|566591369|FG005|Overall Study|COVID-19 related hospitalization|0|||
156956438|NCT04420689|566591370|FG006|Overall Study|COVID-19 related hospitalization|0|||
156956439|NCT04420689|566591364|FG000|Overall Study|Physician Decision|0|||
156956440|NCT04420689|566591365|FG001|Overall Study|Physician Decision|0|||
156956441|NCT04420689|566591366|FG002|Overall Study|Physician Decision|0|||
156956442|NCT04420689|566591367|FG003|Overall Study|Physician Decision|0|||
156956443|NCT04420689|566591368|FG004|Overall Study|Physician Decision|0|||
156956444|NCT04420689|566591369|FG005|Overall Study|Physician Decision|1|||
156956445|NCT04420689|566591370|FG006|Overall Study|Physician Decision|0|||
156956446|NCT02278328|566591376|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
156956447|NCT02278328|566591377|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
156956448|NCT02278328|566591378|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
156956449|NCT02278328|566591376|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
156956450|NCT02278328|566591377|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
157169573|NCT01002742|567363472|FG000|Overall Study|Determined to be ineligible|0|||
156956451|NCT02278328|566591378|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
156956452|NCT02278328|566591376|FG000|Neuropsych Screening|incomplete consent|0|||
156956453|NCT02278328|566591377|FG001|Neuropsych Screening|incomplete consent|0|||
156956454|NCT02278328|566591378|FG002|Neuropsych Screening|incomplete consent|2|||
156956455|NCT00377676|566591379|FG000|Overall Study|Adverse Event|498|||
156956456|NCT00377676|566591380|FG001|Overall Study|Adverse Event|107|||
156956457|NCT00377676|566591379|FG000|Overall Study|Protocol Violation|33|||
156956458|NCT00377676|566591380|FG001|Overall Study|Protocol Violation|27|||
156956459|NCT00377676|566591379|FG000|Overall Study|Death|5|||
156956460|NCT00377676|566591380|FG001|Overall Study|Death|2|||
156956461|NCT00377676|566591379|FG000|Overall Study|Withdrawal by Subject|187|||
156956462|NCT00377676|566591380|FG001|Overall Study|Withdrawal by Subject|72|||
156956463|NCT00377676|566591379|FG000|Overall Study|Lost to Follow-up|120|||
156956464|NCT00377676|566591380|FG001|Overall Study|Lost to Follow-up|56|||
156956465|NCT00377676|566591379|FG000|Overall Study|Other|118|||
157037360|NCT02964741|566892523|FG000|Overall Study|Protocol Violation|1|||
157037361|NCT02964741|566892524|FG001|Overall Study|Protocol Violation|0|||
157037362|NCT02964741|566892525|FG002|Overall Study|Protocol Violation|0|||
157037363|NCT02964741|566892523|FG000|Overall Study|Withdrawal by Subject|0|||
157037364|NCT02964741|566892524|FG001|Overall Study|Withdrawal by Subject|1|||
157037365|NCT02964741|566892525|FG002|Overall Study|Withdrawal by Subject|0|||
157037366|NCT02964741|566892523|FG000|Overall Study|claustrophobia|1|||
157037367|NCT02964741|566892524|FG001|Overall Study|claustrophobia|0|||
157037368|NCT02964741|566892525|FG002|Overall Study|claustrophobia|0|||
157037369|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
157037370|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
157037371|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
157037372|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
157037373|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
157037374|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
157037375|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
157037376|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
157037377|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
157037378|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
157037379|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
157037380|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
157037381|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
156956466|NCT00377676|566591380|FG001|Overall Study|Other|58|||
156956467|NCT03834779|566591381|FG000|Overall Study|Death|1|||
156956468|NCT03834779|566591382|FG001|Overall Study|Death|2|||
156956469|NCT03834779|566591381|FG000|Overall Study|Lost to Follow-up|6|||
156956470|NCT03834779|566591382|FG001|Overall Study|Lost to Follow-up|4|||
156956471|NCT01519206|566591388|FG000|Overall Study|Lost to Follow-up|3|||
156956472|NCT01519206|566591388|FG000|Overall Study|Missed Visit|2|||
156956473|NCT02014116|566591389|FG000|Overall Study|Progressive Disease|3|||
157037382|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
157037383|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
157037384|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
157037385|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
157037386|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
157037387|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
157037388|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
157037389|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
157037390|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
157037391|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
157037392|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
157037393|NCT01074294|566892529|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
157037394|NCT01074294|566892530|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
157037395|NCT01074294|566892531|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
157037396|NCT01074294|566892532|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
157037397|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
157037398|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
157037399|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
157037400|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
157037401|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
157037402|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
157037403|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
157037404|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
157037405|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
157037406|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
157037407|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
157037408|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
156956474|NCT02014116|566591390|FG001|Overall Study|Progressive Disease|4|||
156956475|NCT02014116|566591391|FG002|Overall Study|Progressive Disease|2|||
156956476|NCT02014116|566591392|FG003|Overall Study|Progressive Disease|6|||
157037409|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
157037410|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
157037411|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
157037412|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
157037413|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
156956477|NCT02014116|566591393|FG004|Overall Study|Progressive Disease|1|||
156956478|NCT02014116|566591394|FG005|Overall Study|Progressive Disease|13|||
156956479|NCT02014116|566591395|FG006|Overall Study|Progressive Disease|1|||
156956480|NCT02014116|566591396|FG007|Overall Study|Progressive Disease|3|||
157037414|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
157037415|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
157037416|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
157037417|NCT01074294|566892529|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
157037418|NCT01074294|566892530|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
157037419|NCT01074294|566892531|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
157037420|NCT01074294|566892532|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
157037421|NCT00640159|566892533|FG000|Overall Study|Lost to Follow-up|2|||
157037422|NCT00112359|566892534|FG000|Overall Study|Unrelated adverse event|16|||
157037423|NCT00112359|566892535|FG001|Overall Study|Unrelated adverse event|8|||
157037424|NCT00112359|566892534|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
157037425|NCT00112359|566892535|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
157037426|NCT00112359|566892534|FG000|Overall Study|Related adverse event|5|||
157037427|NCT00112359|566892535|FG001|Overall Study|Related adverse event|3|||
157037428|NCT00112359|566892534|FG000|Overall Study|Lost to Follow-up|0|||
157037429|NCT00112359|566892535|FG001|Overall Study|Lost to Follow-up|1|||
157037430|NCT00112359|566892534|FG000|Overall Study|Personal/administrative|1|||
157037431|NCT00112359|566892535|FG001|Overall Study|Personal/administrative|1|||
157037432|NCT00112359|566892534|FG000|Overall Study|Other|3|||
157037433|NCT00112359|566892535|FG001|Overall Study|Other|0|||
157037434|NCT00312208|566892536|FG000|Overall Study|Adverse Event|97|||
157037435|NCT00312208|566892537|FG001|Overall Study|Adverse Event|61|||
157037436|NCT00312208|566892536|FG000|Overall Study|Protocol Violation|5|||
157037437|NCT00312208|566892537|FG001|Overall Study|Protocol Violation|3|||
157037438|NCT00312208|566892536|FG000|Overall Study|Death|2|||
157037439|NCT00312208|566892537|FG001|Overall Study|Death|1|||
157227592|NCT02180711|567579111|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
157227593|NCT02180711|567579112|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
157227594|NCT02180711|567579113|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
157227595|NCT02180711|567579114|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
157227596|NCT02180711|567579107|FG000|Overall Study|- Other|1|||
157227597|NCT02180711|567579108|FG001|Overall Study|- Other|0|||
157227598|NCT02180711|567579109|FG002|Overall Study|- Other|0|||
157227599|NCT02180711|567579110|FG003|Overall Study|- Other|1|||
157227600|NCT02180711|567579111|FG004|Overall Study|- Other|0|||
157227601|NCT02180711|567579112|FG005|Overall Study|- Other|0|||
157227602|NCT02180711|567579113|FG006|Overall Study|- Other|0|||
157227603|NCT02180711|567579114|FG007|Overall Study|- Other|0|||
157227604|NCT00444145|567579118|FG000|Overall Study|Withdrawal by Subject|2|||
157227605|NCT00444145|567579118|FG000|Overall Study|Lost to Follow-up|1|||
157227606|NCT00444145|567579118|FG000|Overall Study|non-compliant|11|||
157227607|NCT00444145|567579118|FG000|Overall Study|Screen Failures|5|||
157227608|NCT01619800|567579119|FG000|Overall Study|study terminated|2|||
157227609|NCT01619800|567579120|FG001|Overall Study|study terminated|0|||
157227610|NCT00414466|567579122|FG000|Overall Study|Adverse Event|0|||
157227611|NCT00414466|567579123|FG001|Overall Study|Adverse Event|0|||
157227612|NCT00414466|567579124|FG002|Overall Study|Adverse Event|1|||
157227613|NCT00414466|567579125|FG003|Overall Study|Adverse Event|1|||
156956481|NCT02014116|566591397|FG008|Overall Study|Progressive Disease|7|||
156956482|NCT02014116|566591389|FG000|Overall Study|Adverse Event|0|||
156956483|NCT02014116|566591390|FG001|Overall Study|Adverse Event|0|||
156956484|NCT02014116|566591391|FG002|Overall Study|Adverse Event|0|||
156956485|NCT02014116|566591392|FG003|Overall Study|Adverse Event|0|||
156956486|NCT02014116|566591393|FG004|Overall Study|Adverse Event|1|||
156956487|NCT02014116|566591394|FG005|Overall Study|Adverse Event|0|||
156956488|NCT02014116|566591395|FG006|Overall Study|Adverse Event|0|||
156956489|NCT02014116|566591396|FG007|Overall Study|Adverse Event|1|||
156956490|NCT02014116|566591397|FG008|Overall Study|Adverse Event|0|||
156956491|NCT02014116|566591389|FG000|Overall Study|Lost to Follow-up|0|||
156956492|NCT02014116|566591390|FG001|Overall Study|Lost to Follow-up|0|||
156956493|NCT02014116|566591391|FG002|Overall Study|Lost to Follow-up|0|||
156956494|NCT02014116|566591392|FG003|Overall Study|Lost to Follow-up|0|||
156956495|NCT02014116|566591393|FG004|Overall Study|Lost to Follow-up|0|||
156956496|NCT02014116|566591394|FG005|Overall Study|Lost to Follow-up|1|||
156956497|NCT02014116|566591395|FG006|Overall Study|Lost to Follow-up|0|||
156956498|NCT02014116|566591396|FG007|Overall Study|Lost to Follow-up|0|||
156956499|NCT02014116|566591397|FG008|Overall Study|Lost to Follow-up|1|||
156956500|NCT02014116|566591389|FG000|Overall Study|Death|0|||
157037440|NCT00312208|566892536|FG000|Overall Study|Lack of Efficacy|7|||
157037441|NCT00312208|566892537|FG001|Overall Study|Lack of Efficacy|4|||
157037442|NCT00312208|566892536|FG000|Overall Study|Lost to Follow-up|3|||
157037443|NCT00312208|566892537|FG001|Overall Study|Lost to Follow-up|5|||
157227614|NCT00414466|567579122|FG000|Overall Study|Lack of Efficacy|1|||
157227615|NCT00414466|567579123|FG001|Overall Study|Lack of Efficacy|0|||
157227616|NCT00414466|567579124|FG002|Overall Study|Lack of Efficacy|0|||
157227617|NCT00414466|567579125|FG003|Overall Study|Lack of Efficacy|0|||
157227618|NCT00414466|567579122|FG000|Overall Study|Withdrawn by Sponsor|1|||
157227619|NCT00414466|567579123|FG001|Overall Study|Withdrawn by Sponsor|0|||
157037444|NCT00312208|566892536|FG000|Overall Study|Withdrawal by Subject|53|||
157037445|NCT00312208|566892537|FG001|Overall Study|Withdrawal by Subject|42|||
157037446|NCT00312208|566892536|FG000|Overall Study|Other|5|||
157037447|NCT00312208|566892537|FG001|Overall Study|Other|7|||
157037448|NCT01315132|566892538|FG000|Overall Study|not treated due to disease progression|1|||
157037449|NCT03213457|566892544|FG000|Screening Period|Withdrawal by Subject|0|||
157037450|NCT03213457|566892545|FG001|Screening Period|Withdrawal by Subject|1|||
157037451|NCT03213457|566892546|FG002|Screening Period|Withdrawal by Subject|0|||
157037452|NCT03213457|566892544|FG000|Screening Period|Other|1|||
157037453|NCT03213457|566892545|FG001|Screening Period|Other|0|||
157037454|NCT03213457|566892546|FG002|Screening Period|Other|0|||
157037455|NCT03213457|566892544|FG000|Double-Blind Period|Adverse Event|3|||
157037456|NCT03213457|566892545|FG001|Double-Blind Period|Adverse Event|2|||
157037457|NCT03213457|566892546|FG002|Double-Blind Period|Adverse Event|7|||
157037458|NCT03213457|566892544|FG000|Double-Blind Period|Withdrawal by Subject|14|||
157037459|NCT03213457|566892545|FG001|Double-Blind Period|Withdrawal by Subject|2|||
157037460|NCT03213457|566892546|FG002|Double-Blind Period|Withdrawal by Subject|14|||
157037461|NCT03213457|566892544|FG000|Double-Blind Period|Lost to Follow-up|2|||
157037462|NCT03213457|566892545|FG001|Double-Blind Period|Lost to Follow-up|3|||
157037463|NCT03213457|566892546|FG002|Double-Blind Period|Lost to Follow-up|9|||
157037464|NCT03213457|566892544|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
157037465|NCT03213457|566892545|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
157037466|NCT03213457|566892546|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
157037467|NCT03213457|566892544|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
157037468|NCT03213457|566892545|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
157037469|NCT03213457|566892546|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
157037470|NCT03213457|566892544|FG000|Double-Blind Period|Pregnancy|5|||
157037471|NCT03213457|566892545|FG001|Double-Blind Period|Pregnancy|0|||
157037472|NCT03213457|566892546|FG002|Double-Blind Period|Pregnancy|0|||
157037473|NCT03213457|566892544|FG000|Double-Blind Period|Other|10|||
157037474|NCT03213457|566892545|FG001|Double-Blind Period|Other|3|||
157037475|NCT03213457|566892546|FG002|Double-Blind Period|Other|17|||
157037476|NCT03213457|566892544|FG000|Open-Label Period|Adverse Event|1|||
157037477|NCT03213457|566892545|FG001|Open-Label Period|Adverse Event|2|||
157037478|NCT03213457|566892546|FG002|Open-Label Period|Adverse Event|2|||
157037479|NCT03213457|566892544|FG000|Open-Label Period|Withdrawal by Subject|12|||
157037480|NCT03213457|566892545|FG001|Open-Label Period|Withdrawal by Subject|5|||
157169574|NCT01002742|567363473|FG001|Overall Study|Determined to be ineligible|1|||
157169575|NCT00562640|567363474|FG000|Overall Study|Death|0|||
157169576|NCT00562640|567363475|FG001|Overall Study|Death|1|||
157169577|NCT00562640|567363476|FG002|Overall Study|Death|1|||
157169578|NCT00562640|567363477|FG003|Overall Study|Death|0|||
157169579|NCT01297309|567363478|FG000|Overall Study|Eligibility failure|2|||
157169580|NCT01297309|567363478|FG000|Overall Study|Screen failure|2|||
157169581|NCT01297309|567363478|FG000|Overall Study|Withdrawal by Subject|5|||
157169582|NCT01297309|567363478|FG000|Overall Study|Adverse Event|1|||
157169583|NCT01297309|567363478|FG000|Overall Study|Investigator Decision|2|||
157169584|NCT01297309|567363478|FG000|Overall Study|Death|1|||
157169585|NCT01297309|567363478|FG000|Overall Study|Participant not entering extensionperiod|1|||
157169586|NCT02670928|567363479|FG000|Overall Study|Adverse Event|3|||
157169587|NCT02670928|567363480|FG001|Overall Study|Adverse Event|1|||
157169588|NCT02670928|567363479|FG000|Overall Study|Withdrawal by Subject|4|||
157169589|NCT02670928|567363480|FG001|Overall Study|Withdrawal by Subject|0|||
157169590|NCT02670928|567363479|FG000|Overall Study|Lost to Follow-up|1|||
157169591|NCT02670928|567363480|FG001|Overall Study|Lost to Follow-up|0|||
157169592|NCT02670928|567363479|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
157169593|NCT02670928|567363480|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
157169594|NCT02678312|567363481|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
157169595|NCT02678312|567363482|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
157169596|NCT02678312|567363483|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
157169597|NCT02678312|567363484|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
157169598|NCT02678312|567363485|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
157169599|NCT02678312|567363481|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
157169600|NCT02678312|567363482|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
157169601|NCT02678312|567363483|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
157169602|NCT02678312|567363484|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
157037481|NCT03213457|566892546|FG002|Open-Label Period|Withdrawal by Subject|24|||
157037482|NCT03213457|566892544|FG000|Open-Label Period|Lost to Follow-up|1|||
157037483|NCT03213457|566892545|FG001|Open-Label Period|Lost to Follow-up|2|||
157037484|NCT03213457|566892546|FG002|Open-Label Period|Lost to Follow-up|8|||
157169603|NCT02678312|567363485|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
157169604|NCT02678312|567363481|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
157169605|NCT02678312|567363482|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
157169606|NCT02678312|567363483|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
157169607|NCT02678312|567363484|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
157169608|NCT02678312|567363485|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
157169609|NCT02678312|567363481|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
156956501|NCT02014116|566591390|FG001|Overall Study|Death|0|||
156956502|NCT02014116|566591391|FG002|Overall Study|Death|0|||
156956503|NCT02014116|566591392|FG003|Overall Study|Death|0|||
156956504|NCT02014116|566591393|FG004|Overall Study|Death|0|||
156956505|NCT02014116|566591394|FG005|Overall Study|Death|0|||
156956506|NCT02014116|566591395|FG006|Overall Study|Death|0|||
156956507|NCT02014116|566591396|FG007|Overall Study|Death|1|||
156956508|NCT02014116|566591397|FG008|Overall Study|Death|1|||
156956509|NCT02014116|566591389|FG000|Overall Study|Withdrawal by Subject|0|||
156956510|NCT02014116|566591390|FG001|Overall Study|Withdrawal by Subject|0|||
156956511|NCT02014116|566591391|FG002|Overall Study|Withdrawal by Subject|1|||
156956512|NCT02014116|566591392|FG003|Overall Study|Withdrawal by Subject|1|||
156956513|NCT02014116|566591393|FG004|Overall Study|Withdrawal by Subject|0|||
156956514|NCT02014116|566591394|FG005|Overall Study|Withdrawal by Subject|1|||
156956515|NCT02014116|566591395|FG006|Overall Study|Withdrawal by Subject|0|||
156956516|NCT02014116|566591396|FG007|Overall Study|Withdrawal by Subject|0|||
156956517|NCT02014116|566591397|FG008|Overall Study|Withdrawal by Subject|0|||
156956518|NCT02014116|566591389|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
156956519|NCT02014116|566591390|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
156956520|NCT02014116|566591391|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
156956521|NCT02014116|566591392|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
156956522|NCT02014116|566591393|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
156956523|NCT02014116|566591394|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
156956524|NCT02014116|566591395|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
156956525|NCT02014116|566591396|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
156956526|NCT02014116|566591397|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
156956527|NCT02014116|566591389|FG000|Overall Study|Physician Decision|0|||
156956528|NCT02014116|566591390|FG001|Overall Study|Physician Decision|0|||
156956529|NCT02014116|566591391|FG002|Overall Study|Physician Decision|0|||
156956530|NCT02014116|566591392|FG003|Overall Study|Physician Decision|0|||
156956531|NCT02014116|566591393|FG004|Overall Study|Physician Decision|0|||
156956532|NCT02014116|566591394|FG005|Overall Study|Physician Decision|0|||
156956533|NCT02014116|566591395|FG006|Overall Study|Physician Decision|0|||
156956534|NCT02014116|566591396|FG007|Overall Study|Physician Decision|0|||
156956535|NCT02014116|566591397|FG008|Overall Study|Physician Decision|1|||
156956536|NCT02864082|566591398|FG000|Overall Study|Adverse Event|1|||
156956537|NCT02864082|566591399|FG001|Overall Study|Adverse Event|1|||
156956538|NCT02864082|566591398|FG000|Overall Study|Lost to Follow-up|0|||
156956539|NCT02864082|566591399|FG001|Overall Study|Lost to Follow-up|1|||
156956540|NCT02864082|566591398|FG000|Overall Study|Withdrawal by Subject|2|||
156956541|NCT02864082|566591399|FG001|Overall Study|Withdrawal by Subject|2|||
156956542|NCT03621696|566591400|FG000|Overall Study|Not eligible|0|||
156956543|NCT03621696|566591401|FG001|Overall Study|Not eligible|0|||
156956544|NCT03621696|566591402|FG002|Overall Study|Not eligible|0|||
156956545|NCT03621696|566591403|FG003|Overall Study|Not eligible|5|||
156956546|NCT03621696|566591400|FG000|Overall Study|Withdrawal by Subject|1|||
156956547|NCT03621696|566591401|FG001|Overall Study|Withdrawal by Subject|1|||
156956548|NCT03621696|566591402|FG002|Overall Study|Withdrawal by Subject|1|||
156956549|NCT03621696|566591403|FG003|Overall Study|Withdrawal by Subject|0|||
156956550|NCT03621696|566591400|FG000|Overall Study|Physician Decision|0|||
156956551|NCT03621696|566591401|FG001|Overall Study|Physician Decision|0|||
156956552|NCT03621696|566591402|FG002|Overall Study|Physician Decision|1|||
156956553|NCT03621696|566591403|FG003|Overall Study|Physician Decision|0|||
156956554|NCT00413413|566591404|FG000|Single-Blind|Adverse Event|0|||
156956555|NCT00413413|566591405|FG001|Single-Blind|Adverse Event|9|||
156956556|NCT00413413|566591406|FG002|Single-Blind|Adverse Event|0|||
156956557|NCT00413413|566591404|FG000|Single-Blind|Lack of Efficacy|0|||
156956558|NCT00413413|566591405|FG001|Single-Blind|Lack of Efficacy|5|||
156956559|NCT00413413|566591406|FG002|Single-Blind|Lack of Efficacy|0|||
156956560|NCT00413413|566591404|FG000|Single-Blind|Subject no longer requires study drug|0|||
156956561|NCT00413413|566591405|FG001|Single-Blind|Subject no longer requires study drug|151|||
156956562|NCT00413413|566591406|FG002|Single-Blind|Subject no longer requires study drug|0|||
156956563|NCT00413413|566591404|FG000|Single-Blind|Protocol Violation|0|||
156956564|NCT00413413|566591405|FG001|Single-Blind|Protocol Violation|16|||
156956565|NCT00413413|566591406|FG002|Single-Blind|Protocol Violation|0|||
156956566|NCT00413413|566591404|FG000|Single-Blind|Withdrawal by Subject|0|||
156956567|NCT00413413|566591405|FG001|Single-Blind|Withdrawal by Subject|27|||
156956568|NCT00413413|566591406|FG002|Single-Blind|Withdrawal by Subject|0|||
156956569|NCT00413413|566591404|FG000|Single-Blind|Lost to Follow-up|0|||
156956570|NCT00413413|566591405|FG001|Single-Blind|Lost to Follow-up|8|||
156956571|NCT00413413|566591406|FG002|Single-Blind|Lost to Follow-up|0|||
156956572|NCT00413413|566591404|FG000|Double-Blind|Adverse Event|6|||
156956573|NCT00413413|566591405|FG001|Double-Blind|Adverse Event|0|||
156956574|NCT00413413|566591406|FG002|Double-Blind|Adverse Event|5|||
157169610|NCT02678312|567363482|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
157169611|NCT02678312|567363483|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
157169612|NCT02678312|567363484|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
157169613|NCT02678312|567363485|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
157169614|NCT02678312|567363481|FG000|Part 2 Double Blind Epoch|Death|0|||
157169615|NCT02678312|567363482|FG001|Part 2 Double Blind Epoch|Death|0|||
157169616|NCT02678312|567363483|FG002|Part 2 Double Blind Epoch|Death|0|||
157169617|NCT02678312|567363484|FG003|Part 2 Double Blind Epoch|Death|8|||
157169618|NCT02678312|567363485|FG004|Part 2 Double Blind Epoch|Death|12|||
157169619|NCT02678312|567363481|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
157169620|NCT02678312|567363482|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
157169621|NCT02678312|567363483|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
157169622|NCT02678312|567363484|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
157169623|NCT02678312|567363485|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
157169624|NCT02678312|567363481|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
157169625|NCT02678312|567363482|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
157169626|NCT02678312|567363483|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
157169627|NCT02678312|567363484|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
157169628|NCT02678312|567363485|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
157169629|NCT02678312|567363481|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
157169630|NCT02678312|567363482|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
157169631|NCT02678312|567363483|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
157169632|NCT02678312|567363484|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
157169633|NCT02678312|567363485|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
157169634|NCT00656084|567363486|FG000|Overall Study|Adverse Event|4|||
157169635|NCT00656084|567363486|FG000|Overall Study|Withdrawal by Subject|1|||
157169636|NCT00656084|567363486|FG000|Overall Study|Patient Request|1|||
157169637|NCT00656084|567363486|FG000|Overall Study|Investigator Request|1|||
157169638|NCT00525785|567363493|FG000|Overall Study|Withdrawal by Subject|1|||
157169639|NCT00525785|567363493|FG000|Overall Study|Lack of Efficacy|1|||
157169640|NCT00525785|567363493|FG000|Overall Study|Physician Decision|1|||
157169641|NCT04847141|567363494|FG000|Overall Study|Adverse Event|1|||
157169642|NCT04847141|567363495|FG001|Overall Study|Adverse Event|0|||
157169643|NCT04847141|567363496|FG002|Overall Study|Adverse Event|1|||
157169644|NCT04847141|567363494|FG000|Overall Study|Withdrawal by Subject|2|||
157169645|NCT04847141|567363495|FG001|Overall Study|Withdrawal by Subject|4|||
157169646|NCT04847141|567363496|FG002|Overall Study|Withdrawal by Subject|3|||
157169647|NCT04847141|567363494|FG000|Overall Study|Lost to Follow-up|7|||
157169648|NCT04847141|567363495|FG001|Overall Study|Lost to Follow-up|5|||
157169649|NCT04847141|567363496|FG002|Overall Study|Lost to Follow-up|7|||
157169650|NCT04847141|567363494|FG000|Overall Study|Reason not Specified|0|||
157169651|NCT04847141|567363495|FG001|Overall Study|Reason not Specified|1|||
157169652|NCT04847141|567363496|FG002|Overall Study|Reason not Specified|0|||
157169653|NCT01357980|567363500|FG000|Overall Study|Lack of Efficacy|0|||
157169654|NCT01357980|567363501|FG001|Overall Study|Lack of Efficacy|1|||
157169655|NCT01357980|567363502|FG002|Overall Study|Lack of Efficacy|0|||
157169656|NCT01357980|567363503|FG003|Overall Study|Lack of Efficacy|0|||
157169657|NCT01357980|567363500|FG000|Overall Study|Consent withdrawn|0|||
157169658|NCT01357980|567363501|FG001|Overall Study|Consent withdrawn|0|||
157169659|NCT01357980|567363502|FG002|Overall Study|Consent withdrawn|1|||
157169660|NCT01357980|567363503|FG003|Overall Study|Consent withdrawn|0|||
157169661|NCT00094835|567363507|FG000|Overall Study|Physician Decision|1|||
157169662|NCT00094835|567363508|FG001|Overall Study|Physician Decision|0|||
157169663|NCT00094835|567363509|FG002|Overall Study|Physician Decision|0|||
157169664|NCT00094835|567363510|FG003|Overall Study|Physician Decision|0|||
157169665|NCT00094835|567363511|FG004|Overall Study|Physician Decision|0|||
157169666|NCT00094835|567363512|FG005|Overall Study|Physician Decision|1|||
157169667|NCT00094835|567363513|FG006|Overall Study|Physician Decision|0|||
157169668|NCT00094835|567363507|FG000|Overall Study|Withdrawal by Subject|0|||
157169669|NCT00094835|567363508|FG001|Overall Study|Withdrawal by Subject|0|||
157169670|NCT00094835|567363509|FG002|Overall Study|Withdrawal by Subject|0|||
156956575|NCT00413413|566591404|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
156956576|NCT00413413|566591405|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
156956577|NCT00413413|566591406|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
156956578|NCT00413413|566591404|FG000|Double-Blind|Protocol deviation|1|||
156956579|NCT00413413|566591405|FG001|Double-Blind|Protocol deviation|2|||
156956580|NCT00413413|566591406|FG002|Double-Blind|Protocol deviation|1|||
157169671|NCT00094835|567363510|FG003|Overall Study|Withdrawal by Subject|0|||
157169672|NCT00094835|567363511|FG004|Overall Study|Withdrawal by Subject|0|||
157169673|NCT00094835|567363512|FG005|Overall Study|Withdrawal by Subject|0|||
157169674|NCT00094835|567363513|FG006|Overall Study|Withdrawal by Subject|1|||
157169675|NCT00094835|567363507|FG000|Overall Study|Lost to Follow-up|0|||
157169676|NCT00094835|567363508|FG001|Overall Study|Lost to Follow-up|0|||
157169677|NCT00094835|567363509|FG002|Overall Study|Lost to Follow-up|0|||
157169678|NCT00094835|567363510|FG003|Overall Study|Lost to Follow-up|0|||
157169679|NCT00094835|567363511|FG004|Overall Study|Lost to Follow-up|1|||
157169680|NCT00094835|567363512|FG005|Overall Study|Lost to Follow-up|0|||
157169681|NCT00094835|567363513|FG006|Overall Study|Lost to Follow-up|0|||
157169682|NCT00094835|567363507|FG000|Overall Study|Death|1|||
157169683|NCT00094835|567363508|FG001|Overall Study|Death|0|||
157169684|NCT00094835|567363509|FG002|Overall Study|Death|0|||
157169685|NCT00094835|567363510|FG003|Overall Study|Death|0|||
157169686|NCT00094835|567363511|FG004|Overall Study|Death|1|||
157169687|NCT00094835|567363512|FG005|Overall Study|Death|0|||
157169688|NCT00094835|567363513|FG006|Overall Study|Death|0|||
157169689|NCT00094835|567363507|FG000|Overall Study|Non-compliance|1|||
157169690|NCT00094835|567363508|FG001|Overall Study|Non-compliance|2|||
157169691|NCT00094835|567363509|FG002|Overall Study|Non-compliance|2|||
157169692|NCT00094835|567363510|FG003|Overall Study|Non-compliance|0|||
157169693|NCT00094835|567363511|FG004|Overall Study|Non-compliance|2|||
157169694|NCT00094835|567363512|FG005|Overall Study|Non-compliance|2|||
157169695|NCT00094835|567363513|FG006|Overall Study|Non-compliance|1|||
157169696|NCT00094835|567363507|FG000|Overall Study|Other|1|||
157169697|NCT00094835|567363508|FG001|Overall Study|Other|1|||
156956581|NCT00413413|566591404|FG000|Double-Blind|Subject withdrew consent|4|||
156956582|NCT00413413|566591405|FG001|Double-Blind|Subject withdrew consent|6|||
156956583|NCT00413413|566591406|FG002|Double-Blind|Subject withdrew consent|9|||
156956584|NCT00413413|566591404|FG000|Double-Blind|Lost to Follow-up|3|||
156956585|NCT00413413|566591405|FG001|Double-Blind|Lost to Follow-up|4|||
156956586|NCT00413413|566591406|FG002|Double-Blind|Lost to Follow-up|2|||
156956587|NCT05348681|566591407|FG000|Overall Study|Study terminated by Sponsor|8|||
156956588|NCT05348681|566591408|FG001|Overall Study|Study terminated by Sponsor|3|||
156956589|NCT05348681|566591407|FG000|Overall Study|Withdrawal by Subject|1|||
157169698|NCT00094835|567363509|FG002|Overall Study|Other|1|||
157169699|NCT00094835|567363510|FG003|Overall Study|Other|1|||
157169700|NCT00094835|567363511|FG004|Overall Study|Other|0|||
157169701|NCT00094835|567363512|FG005|Overall Study|Other|0|||
157169702|NCT00094835|567363513|FG006|Overall Study|Other|0|||
156956590|NCT05348681|566591408|FG001|Overall Study|Withdrawal by Subject|1|||
156956591|NCT05348681|566591407|FG000|Overall Study|Lost to Follow-up|1|||
156956592|NCT05348681|566591408|FG001|Overall Study|Lost to Follow-up|1|||
156956593|NCT05348681|566591407|FG000|Overall Study|Adverse Event|1|||
156956594|NCT05348681|566591408|FG001|Overall Study|Adverse Event|0|||
156956595|NCT05348681|566591407|FG000|Overall Study|Other|2|||
156956596|NCT05348681|566591408|FG001|Overall Study|Other|1|||
156956597|NCT00782340|566591409|FG000|Open Label Titration|Adverse Event|12|||
156956598|NCT00782340|566591410|FG001|Open Label Titration|Adverse Event|0|||
156956599|NCT00782340|566591411|FG002|Open Label Titration|Adverse Event|0|||
156956600|NCT00782340|566591409|FG000|Open Label Titration|Treatment failure|50|||
156956601|NCT00782340|566591410|FG001|Open Label Titration|Treatment failure|0|||
156956602|NCT00782340|566591411|FG002|Open Label Titration|Treatment failure|0|||
156956603|NCT00782340|566591409|FG000|Open Label Titration|Protocol Violation|5|||
156956604|NCT00782340|566591410|FG001|Open Label Titration|Protocol Violation|0|||
157169703|NCT00387348|567363514|FG000|Overall Study|Death|1|||
157169704|NCT00387348|567363515|FG001|Overall Study|Death|1|||
157169705|NCT00387348|567363516|FG002|Overall Study|Death|0|||
157169706|NCT00387348|567363514|FG000|Overall Study|Physician Decision|1|||
156956605|NCT00782340|566591411|FG002|Open Label Titration|Protocol Violation|0|||
156956606|NCT00782340|566591409|FG000|Open Label Titration|Withdrawal by Subject|5|||
156956607|NCT00782340|566591410|FG001|Open Label Titration|Withdrawal by Subject|0|||
156956608|NCT00782340|566591411|FG002|Open Label Titration|Withdrawal by Subject|0|||
156956609|NCT00782340|566591409|FG000|Open Label Titration|Enrollment capped|16|||
156956610|NCT00782340|566591410|FG001|Open Label Titration|Enrollment capped|0|||
157169707|NCT00387348|567363515|FG001|Overall Study|Physician Decision|0|||
157169708|NCT00387348|567363516|FG002|Overall Study|Physician Decision|1|||
156956611|NCT00782340|566591411|FG002|Open Label Titration|Enrollment capped|0|||
156956612|NCT00782340|566591409|FG000|Open Label Titration|Did not meet responder criteria|2|||
156956613|NCT00782340|566591410|FG001|Open Label Titration|Did not meet responder criteria|0|||
156956614|NCT00782340|566591411|FG002|Open Label Titration|Did not meet responder criteria|0|||
156956615|NCT00782340|566591409|FG000|Open Label Titration|Lost to Follow-up|5|||
156956616|NCT00782340|566591410|FG001|Open Label Titration|Lost to Follow-up|0|||
156956617|NCT00782340|566591411|FG002|Open Label Titration|Lost to Follow-up|0|||
156956618|NCT00782340|566591409|FG000|Open Label Titration|Randomized in error|6|||
156956619|NCT00782340|566591410|FG001|Open Label Titration|Randomized in error|0|||
156956620|NCT00782340|566591411|FG002|Open Label Titration|Randomized in error|0|||
156956621|NCT00553267|566591419|FG000|Overall Study|Adverse Event|8|||
157169709|NCT00387348|567363514|FG000|Overall Study|Withdrawal by Subject|0|||
157169710|NCT00387348|567363515|FG001|Overall Study|Withdrawal by Subject|2|||
157169711|NCT00387348|567363516|FG002|Overall Study|Withdrawal by Subject|2|||
156956622|NCT00553267|566591420|FG001|Overall Study|Adverse Event|10|||
157169712|NCT00387348|567363514|FG000|Overall Study|Adverse Event|1|||
157169713|NCT00387348|567363515|FG001|Overall Study|Adverse Event|0|||
157169714|NCT00387348|567363516|FG002|Overall Study|Adverse Event|1|||
157169715|NCT00868166|567363529|FG000|Overall Study|Death|58|||
157169716|NCT00868166|567363530|FG001|Overall Study|Death|65|||
157169717|NCT00868166|567363529|FG000|Overall Study|Withdrawal by Subject|33|||
156956623|NCT00553267|566591421|FG002|Overall Study|Adverse Event|5|||
156956624|NCT00553267|566591419|FG000|Overall Study|Non compliant with protocol|3|||
156956625|NCT00553267|566591420|FG001|Overall Study|Non compliant with protocol|3|||
156956626|NCT00553267|566591421|FG002|Overall Study|Non compliant with protocol|2|||
156956627|NCT00553267|566591419|FG000|Overall Study|Lost to Follow-up|0|||
156956628|NCT00553267|566591420|FG001|Overall Study|Lost to Follow-up|0|||
156956629|NCT00553267|566591421|FG002|Overall Study|Lost to Follow-up|1|||
156956630|NCT00553267|566591419|FG000|Overall Study|Consent withdrawn|2|||
156956631|NCT00553267|566591420|FG001|Overall Study|Consent withdrawn|3|||
156956632|NCT00553267|566591421|FG002|Overall Study|Consent withdrawn|1|||
156956633|NCT00553267|566591419|FG000|Overall Study|Specified category|1|||
156956634|NCT00553267|566591420|FG001|Overall Study|Specified category|2|||
156956635|NCT00553267|566591421|FG002|Overall Study|Specified category|1|||
156956636|NCT04389840|566591422|FG000|Overall Study|Adverse Event|0|||
156956637|NCT04389840|566591423|FG001|Overall Study|Adverse Event|0|||
156956638|NCT04389840|566591424|FG002|Overall Study|Adverse Event|0|||
156956639|NCT04389840|566591425|FG003|Overall Study|Adverse Event|1|||
156956640|NCT04389840|566591426|FG004|Overall Study|Adverse Event|0|||
156956641|NCT04389840|566591427|FG005|Overall Study|Adverse Event|0|||
156956642|NCT04389840|566591422|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
156956643|NCT04389840|566591423|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
156956644|NCT04389840|566591424|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
156956645|NCT04389840|566591425|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
156956646|NCT04389840|566591426|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
156956647|NCT04389840|566591427|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
156956648|NCT04389840|566591422|FG000|Overall Study|Death|0|||
156956649|NCT04389840|566591423|FG001|Overall Study|Death|1|||
156956650|NCT04389840|566591424|FG002|Overall Study|Death|0|||
156956651|NCT04389840|566591425|FG003|Overall Study|Death|0|||
156956652|NCT04389840|566591426|FG004|Overall Study|Death|0|||
156956653|NCT04389840|566591427|FG005|Overall Study|Death|0|||
156956654|NCT03273946|566591428|FG000|Overall Study|Withdrawal by Subject|5|||
156956655|NCT03273946|566591428|FG000|Overall Study|Unwillingness of the guardian|1|||
156956656|NCT03273946|566591428|FG000|Overall Study|Participant refused to use the drug|2|||
156956657|NCT03273946|566591428|FG000|Overall Study|Participant relative refused to use drug|1|||
156956658|NCT01220557|566591429|FG000|Overall Study|Lost to Follow-up|5|||
156956659|NCT01220557|566591430|FG001|Overall Study|Lost to Follow-up|3|||
156956660|NCT01220557|566591429|FG000|Overall Study|attended less than 6 lessons|1|||
156956661|NCT01220557|566591430|FG001|Overall Study|attended less than 6 lessons|2|||
156956662|NCT02199028|566591431|FG000|Week 1|Adverse Event|1|||
156956663|NCT02199028|566591432|FG001|Week 1|Adverse Event|0|||
156956664|NCT02199028|566591431|FG000|Week 3|Adverse Event|1|||
156956665|NCT02199028|566591432|FG001|Week 3|Adverse Event|0|||
156956666|NCT01881126|566591435|FG000|Overall Study|Non-compliance|1|||
156956667|NCT01881126|566591436|FG001|Overall Study|Non-compliance|1|||
156956668|NCT01881126|566591435|FG000|Overall Study|Adverse Event|0|||
156956669|NCT01881126|566591436|FG001|Overall Study|Adverse Event|1|||
156956670|NCT05045625|566591437|FG000|Overall Study|Lost to Follow-up|3|||
156956671|NCT01458574|566591438|FG000|Overall Study|Adverse Event|5|||
156956672|NCT01458574|566591439|FG001|Overall Study|Adverse Event|9|||
156956673|NCT01458574|566591440|FG002|Overall Study|Adverse Event|7|||
156956674|NCT01458574|566591438|FG000|Overall Study|Lack of Efficacy|70|||
156956675|NCT01458574|566591439|FG001|Overall Study|Lack of Efficacy|53|||
156956676|NCT01458574|566591440|FG002|Overall Study|Lack of Efficacy|132|||
156956677|NCT01458574|566591438|FG000|Overall Study|Lost to Follow-up|3|||
156956678|NCT01458574|566591439|FG001|Overall Study|Lost to Follow-up|2|||
156956679|NCT01458574|566591440|FG002|Overall Study|Lost to Follow-up|1|||
156956680|NCT01458574|566591438|FG000|Overall Study|Pregnancy|1|||
156956681|NCT01458574|566591439|FG001|Overall Study|Pregnancy|1|||
156956682|NCT01458574|566591440|FG002|Overall Study|Pregnancy|0|||
156956683|NCT01458574|566591438|FG000|Overall Study|Protocol Violation|0|||
156956684|NCT01458574|566591439|FG001|Overall Study|Protocol Violation|1|||
156956685|NCT01458574|566591440|FG002|Overall Study|Protocol Violation|0|||
156956686|NCT01458574|566591438|FG000|Overall Study|Withdrawal by Subject|6|||
156956687|NCT01458574|566591439|FG001|Overall Study|Withdrawal by Subject|3|||
156956688|NCT01458574|566591440|FG002|Overall Study|Withdrawal by Subject|5|||
156956689|NCT01458574|566591438|FG000|Overall Study|Other|2|||
156956690|NCT01458574|566591439|FG001|Overall Study|Other|1|||
156956691|NCT01458574|566591440|FG002|Overall Study|Other|0|||
156956692|NCT01458574|566591438|FG000|Overall Study|Randomized but not treated|0|||
157169718|NCT00868166|567363530|FG001|Overall Study|Withdrawal by Subject|25|||
156956693|NCT01458574|566591439|FG001|Overall Study|Randomized but not treated|1|||
156956694|NCT01458574|566591440|FG002|Overall Study|Randomized but not treated|0|||
156956695|NCT02125786|566591441|FG000|Overall Study|Still in Follow-up|3|||
156956696|NCT02125786|566591441|FG000|Overall Study|Screen Failure|2|||
156956697|NCT02125786|566591441|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
156956698|NCT02125786|566591441|FG000|Overall Study|Progressive Disease|44|||
156956699|NCT02125786|566591441|FG000|Overall Study|Death|8|||
156956700|NCT05070897|566591445|FG000|Overall Study|Protocol Violation|123|||
156956701|NCT05070897|566591446|FG001|Overall Study|Protocol Violation|68|||
156956702|NCT03832946|566591447|FG000|Overall Study|Adverse Event|3|||
156956703|NCT03832946|566591448|FG001|Overall Study|Adverse Event|1|||
156956704|NCT03832946|566591447|FG000|Overall Study|Lost to Follow-up|1|||
156956705|NCT03832946|566591448|FG001|Overall Study|Lost to Follow-up|0|||
156956706|NCT03832946|566591447|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
156956707|NCT03832946|566591448|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
156956708|NCT03832946|566591447|FG000|Overall Study|Lack of Efficacy|1|||
156956709|NCT03832946|566591448|FG001|Overall Study|Lack of Efficacy|0|||
156956710|NCT03832946|566591447|FG000|Overall Study|Withdrawal by Subject|12|||
156956711|NCT03832946|566591448|FG001|Overall Study|Withdrawal by Subject|9|||
156956712|NCT03394924|566591449|FG000|Overall Study|Adverse Event|0|||
156956713|NCT03394924|566591450|FG001|Overall Study|Adverse Event|5|||
156956714|NCT03394924|566591451|FG002|Overall Study|Adverse Event|0|||
156956715|NCT03394924|566591449|FG000|Overall Study|Withdrawal by Subject|2|||
156956716|NCT03394924|566591450|FG001|Overall Study|Withdrawal by Subject|0|||
156956717|NCT03394924|566591451|FG002|Overall Study|Withdrawal by Subject|0|||
156956718|NCT03394924|566591449|FG000|Overall Study|Lost to Follow-up|0|||
156956719|NCT03394924|566591450|FG001|Overall Study|Lost to Follow-up|1|||
156956720|NCT03394924|566591451|FG002|Overall Study|Lost to Follow-up|0|||
156956721|NCT03394924|566591449|FG000|Overall Study|Did not meet all inclusion criteria|1|||
156956722|NCT03394924|566591450|FG001|Overall Study|Did not meet all inclusion criteria|0|||
156956723|NCT03394924|566591451|FG002|Overall Study|Did not meet all inclusion criteria|0|||
156956724|NCT02005471|566591458|FG000|Main Study|Adverse Event|0|||
156956725|NCT02005471|566591459|FG001|Main Study|Adverse Event|1|||
156956726|NCT02005471|566591460|FG002|Main Study|Adverse Event|0|||
156956727|NCT02005471|566591461|FG003|Main Study|Adverse Event|0|||
156956728|NCT02005471|566591458|FG000|Main Study|Death|83|||
156956729|NCT02005471|566591459|FG001|Main Study|Death|52|||
156956730|NCT02005471|566591460|FG002|Main Study|Death|0|||
156956731|NCT02005471|566591461|FG003|Main Study|Death|0|||
156956732|NCT02005471|566591458|FG000|Main Study|Lost to Follow-up|4|||
156956733|NCT02005471|566591459|FG001|Main Study|Lost to Follow-up|5|||
156956734|NCT02005471|566591460|FG002|Main Study|Lost to Follow-up|0|||
156956735|NCT02005471|566591461|FG003|Main Study|Lost to Follow-up|0|||
156956736|NCT02005471|566591458|FG000|Main Study|Physician Decision|3|||
156956737|NCT02005471|566591459|FG001|Main Study|Physician Decision|1|||
156956738|NCT02005471|566591460|FG002|Main Study|Physician Decision|0|||
156956739|NCT02005471|566591461|FG003|Main Study|Physician Decision|0|||
156956740|NCT02005471|566591458|FG000|Main Study|Withdrawal by Subject|26|||
156956741|NCT02005471|566591459|FG001|Main Study|Withdrawal by Subject|11|||
156956742|NCT02005471|566591460|FG002|Main Study|Withdrawal by Subject|0|||
156956743|NCT02005471|566591461|FG003|Main Study|Withdrawal by Subject|0|||
156956744|NCT02005471|566591458|FG000|Main Study|Reason not Specified|0|||
156956745|NCT02005471|566591459|FG001|Main Study|Reason not Specified|6|||
156956746|NCT02005471|566591460|FG002|Main Study|Reason not Specified|0|||
156956747|NCT02005471|566591461|FG003|Main Study|Reason not Specified|0|||
156956748|NCT02005471|566591458|FG000|Main Study|Randomized but not Dosed|8|||
156956749|NCT02005471|566591459|FG001|Main Study|Randomized but not Dosed|0|||
156956750|NCT02005471|566591460|FG002|Main Study|Randomized but not Dosed|0|||
156956751|NCT02005471|566591461|FG003|Main Study|Randomized but not Dosed|0|||
156956752|NCT02005471|566591458|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156956753|NCT02005471|566591459|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156956754|NCT02005471|566591460|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
156956755|NCT02005471|566591461|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
156956756|NCT02005471|566591458|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
156956757|NCT02005471|566591459|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
156956758|NCT02005471|566591460|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
156956759|NCT02005471|566591461|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
156956760|NCT02005471|566591458|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
156956761|NCT02005471|566591459|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
156956762|NCT02005471|566591460|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
156956763|NCT02005471|566591461|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
156956764|NCT00627705|566591462|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
156956765|NCT00627705|566591463|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
156956766|NCT00627705|566591462|FG000|Overall Study|Adverse Event|1|||
156956767|NCT00627705|566591463|FG001|Overall Study|Adverse Event|0|||
156956768|NCT00627705|566591462|FG000|Overall Study|Withdrawal by Subject|0|||
156956769|NCT00627705|566591463|FG001|Overall Study|Withdrawal by Subject|2|||
156956770|NCT00627705|566591462|FG000|Overall Study|Lost to Follow-up|0|||
156956771|NCT00627705|566591463|FG001|Overall Study|Lost to Follow-up|1|||
156956772|NCT02663817|566591464|FG000|Overall Study|Screen failure|2|||
156956773|NCT01410448|566591467|FG000|Overall Study|No conversion to everolimus|0|||
156956774|NCT01410448|566591468|FG001|Overall Study|No conversion to everolimus|24|||
156956775|NCT01410448|566591467|FG000|Overall Study|Graft loss|4|||
156956776|NCT01410448|566591468|FG001|Overall Study|Graft loss|1|||
156956777|NCT01410448|566591467|FG000|Overall Study|Administrative issues|2|||
156956778|NCT01410448|566591468|FG001|Overall Study|Administrative issues|1|||
156956779|NCT01410448|566591467|FG000|Overall Study|Lost to Follow-up|1|||
156956780|NCT01410448|566591468|FG001|Overall Study|Lost to Follow-up|0|||
156956781|NCT01410448|566591467|FG000|Overall Study|Withdrawal by Subject|3|||
156956782|NCT01410448|566591468|FG001|Overall Study|Withdrawal by Subject|2|||
156956783|NCT01410448|566591467|FG000|Overall Study|Protocol Violation|0|||
156956784|NCT01410448|566591468|FG001|Overall Study|Protocol Violation|4|||
156956785|NCT01410448|566591467|FG000|Overall Study|Death|2|||
156956786|NCT01410448|566591468|FG001|Overall Study|Death|3|||
156956787|NCT02535065|566591469|FG000|Overall Study|Death|13|||
156956788|NCT02535065|566591469|FG000|Overall Study|Lost to Follow-up|1|||
156956789|NCT02535065|566591469|FG000|Overall Study|Withdrawal by Subject|6|||
156956790|NCT03712917|566591470|FG000|Overall Study|Pregnancy|0|||
156956791|NCT03712917|566591471|FG001|Overall Study|Pregnancy|0|||
156956792|NCT03712917|566591472|FG002|Overall Study|Pregnancy|1|||
156956793|NCT03712917|566591470|FG000|Overall Study|Adverse Event|0|||
156956794|NCT03712917|566591471|FG001|Overall Study|Adverse Event|4|||
156956795|NCT03712917|566591472|FG002|Overall Study|Adverse Event|3|||
156956796|NCT03712917|566591470|FG000|Overall Study|Lost to Follow-up|9|||
156956797|NCT03712917|566591471|FG001|Overall Study|Lost to Follow-up|4|||
156956798|NCT03712917|566591472|FG002|Overall Study|Lost to Follow-up|5|||
156956799|NCT00110617|566591473|FG000|Overall Study|Adverse Event|2|||
156956800|NCT00110617|566591474|FG001|Overall Study|Adverse Event|4|||
156956801|NCT00110617|566591473|FG000|Overall Study|Abnormal Laboratory Value|4|||
156956802|NCT00110617|566591474|FG001|Overall Study|Abnormal Laboratory Value|2|||
156956803|NCT00110617|566591473|FG000|Overall Study|Lack of Efficacy|1|||
156956804|NCT00110617|566591474|FG001|Overall Study|Lack of Efficacy|0|||
156956805|NCT00110617|566591473|FG000|Overall Study|Patient no longer requires study drug|1|||
156956806|NCT00110617|566591474|FG001|Overall Study|Patient no longer requires study drug|0|||
156956807|NCT00110617|566591473|FG000|Overall Study|Protocol Violation|5|||
156956808|NCT00110617|566591474|FG001|Overall Study|Protocol Violation|0|||
156956809|NCT00110617|566591473|FG000|Overall Study|Withdrawal by Subject|10|||
156956810|NCT00110617|566591474|FG001|Overall Study|Withdrawal by Subject|4|||
156956811|NCT00110617|566591473|FG000|Overall Study|Lost to Follow-up|9|||
156956812|NCT00110617|566591474|FG001|Overall Study|Lost to Follow-up|1|||
156956813|NCT00110617|566591473|FG000|Overall Study|Administrative problems|6|||
156956814|NCT00110617|566591474|FG001|Overall Study|Administrative problems|5|||
156956815|NCT00110617|566591473|FG000|Overall Study|Death|1|||
156956816|NCT00110617|566591474|FG001|Overall Study|Death|1|||
156956817|NCT00110617|566591473|FG000|Overall Study|Did not receive study drug|0|||
156956818|NCT00110617|566591474|FG001|Overall Study|Did not receive study drug|12|||
156956819|NCT04764396|566591475|FG000|Overall Study|Physician Decision|1|||
156956820|NCT04764396|566591476|FG001|Overall Study|Physician Decision|0|||
156956821|NCT03230916|566591477|FG000|Overall Study|Withdrawal by Subject|0|||
156956822|NCT03230916|566591478|FG001|Overall Study|Withdrawal by Subject|0|||
156956823|NCT03230916|566591479|FG002|Overall Study|Withdrawal by Subject|0|||
156956824|NCT03230916|566591480|FG003|Overall Study|Withdrawal by Subject|0|||
156956825|NCT03230916|566591481|FG004|Overall Study|Withdrawal by Subject|0|||
156956826|NCT03230916|566591482|FG005|Overall Study|Withdrawal by Subject|1|||
156956827|NCT03230916|566591483|FG006|Overall Study|Withdrawal by Subject|0|||
156956828|NCT03230916|566591484|FG007|Overall Study|Withdrawal by Subject|0|||
156956829|NCT03230916|566591485|FG008|Overall Study|Withdrawal by Subject|0|||
156956830|NCT03230916|566591486|FG009|Overall Study|Withdrawal by Subject|0|||
157169719|NCT00868166|567363529|FG000|Overall Study|Protocol Violation|1|||
157169720|NCT00868166|567363530|FG001|Overall Study|Protocol Violation|0|||
156956831|NCT03230916|566591487|FG010|Overall Study|Withdrawal by Subject|0|||
157169721|NCT00868166|567363529|FG000|Overall Study|Lost to Follow-up|1|||
157169722|NCT00868166|567363530|FG001|Overall Study|Lost to Follow-up|3|||
157169723|NCT00868166|567363529|FG000|Overall Study|Adverse Event|9|||
157169724|NCT00868166|567363530|FG001|Overall Study|Adverse Event|10|||
157169725|NCT00868166|567363529|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
157169726|NCT00868166|567363530|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
157169727|NCT00868166|567363529|FG000|Overall Study|Non-compliance with IMP|1|||
156956832|NCT01983293|566594545|FG000|Overall Study|Withdrawal by Subject|29|||
156956833|NCT01983293|566594546|FG001|Overall Study|Withdrawal by Subject|15|||
156956834|NCT01983293|566594545|FG000|Overall Study|Missing 12-month visit|3|||
156956835|NCT01983293|566594546|FG001|Overall Study|Missing 12-month visit|3|||
156956836|NCT01983293|566594545|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
156956837|NCT01983293|566594546|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
156956838|NCT03147248|566594547|FG000|Overall Study|Adverse Event|0|||
156956839|NCT03147248|566594548|FG001|Overall Study|Adverse Event|2|||
156956840|NCT03147248|566594549|FG002|Overall Study|Adverse Event|2|||
157169728|NCT00868166|567363530|FG001|Overall Study|Non-compliance with IMP|1|||
157169729|NCT00171314|567363538|FG000|Overall Study|Adverse Event|44|||
156956841|NCT03147248|566594550|FG003|Overall Study|Adverse Event|2|||
156956842|NCT03147248|566594551|FG004|Overall Study|Adverse Event|6|||
156956843|NCT03147248|566594552|FG005|Overall Study|Adverse Event|11|||
156956844|NCT03147248|566594547|FG000|Overall Study|Disease progression|1|||
156956845|NCT03147248|566594548|FG001|Overall Study|Disease progression|0|||
156956846|NCT03147248|566594549|FG002|Overall Study|Disease progression|0|||
156956847|NCT03147248|566594550|FG003|Overall Study|Disease progression|0|||
156956848|NCT03147248|566594551|FG004|Overall Study|Disease progression|0|||
156956849|NCT03147248|566594552|FG005|Overall Study|Disease progression|2|||
156956850|NCT03147248|566594547|FG000|Overall Study|Withdrawal by Subject|0|||
156956851|NCT03147248|566594548|FG001|Overall Study|Withdrawal by Subject|0|||
156956852|NCT03147248|566594549|FG002|Overall Study|Withdrawal by Subject|0|||
156956853|NCT03147248|566594550|FG003|Overall Study|Withdrawal by Subject|0|||
156956854|NCT03147248|566594551|FG004|Overall Study|Withdrawal by Subject|12|||
156956855|NCT03147248|566594552|FG005|Overall Study|Withdrawal by Subject|9|||
156956856|NCT03147248|566594547|FG000|Overall Study|Protocol Violation|0|||
156956857|NCT03147248|566594548|FG001|Overall Study|Protocol Violation|0|||
156956858|NCT03147248|566594549|FG002|Overall Study|Protocol Violation|0|||
156956859|NCT03147248|566594550|FG003|Overall Study|Protocol Violation|0|||
156956860|NCT03147248|566594551|FG004|Overall Study|Protocol Violation|2|||
156956861|NCT03147248|566594552|FG005|Overall Study|Protocol Violation|0|||
156956862|NCT03147248|566594547|FG000|Overall Study|Lost to Follow-up|0|||
156956863|NCT03147248|566594548|FG001|Overall Study|Lost to Follow-up|0|||
156956864|NCT03147248|566594549|FG002|Overall Study|Lost to Follow-up|0|||
156956865|NCT03147248|566594550|FG003|Overall Study|Lost to Follow-up|0|||
156956866|NCT03147248|566594551|FG004|Overall Study|Lost to Follow-up|2|||
156956867|NCT03147248|566594552|FG005|Overall Study|Lost to Follow-up|0|||
156956868|NCT03147248|566594547|FG000|Overall Study|Pregnancy|0|||
156956869|NCT03147248|566594548|FG001|Overall Study|Pregnancy|0|||
156956870|NCT03147248|566594549|FG002|Overall Study|Pregnancy|0|||
156956871|NCT03147248|566594550|FG003|Overall Study|Pregnancy|0|||
156956872|NCT03147248|566594551|FG004|Overall Study|Pregnancy|1|||
156956873|NCT03147248|566594552|FG005|Overall Study|Pregnancy|0|||
156956874|NCT03147248|566594547|FG000|Overall Study|Death|0|||
156956875|NCT03147248|566594548|FG001|Overall Study|Death|0|||
156956876|NCT03147248|566594549|FG002|Overall Study|Death|0|||
156956877|NCT03147248|566594550|FG003|Overall Study|Death|0|||
156956878|NCT03147248|566594551|FG004|Overall Study|Death|0|||
156956879|NCT03147248|566594552|FG005|Overall Study|Death|4|||
156956880|NCT03147248|566594547|FG000|Overall Study|Physician Decision|0|||
156956881|NCT03147248|566594548|FG001|Overall Study|Physician Decision|0|||
156956882|NCT03147248|566594549|FG002|Overall Study|Physician Decision|0|||
156956883|NCT03147248|566594550|FG003|Overall Study|Physician Decision|0|||
156956884|NCT03147248|566594551|FG004|Overall Study|Physician Decision|2|||
156956885|NCT03147248|566594552|FG005|Overall Study|Physician Decision|4|||
156956886|NCT03147248|566594547|FG000|Overall Study|Prolonged Dosing Interval|0|||
156956887|NCT03147248|566594548|FG001|Overall Study|Prolonged Dosing Interval|0|||
156956888|NCT03147248|566594549|FG002|Overall Study|Prolonged Dosing Interval|0|||
156956889|NCT03147248|566594550|FG003|Overall Study|Prolonged Dosing Interval|0|||
156956890|NCT03147248|566594551|FG004|Overall Study|Prolonged Dosing Interval|1|||
156956891|NCT03147248|566594552|FG005|Overall Study|Prolonged Dosing Interval|1|||
156956892|NCT03750552|566594553|FG000|Overall Study|Adverse Event|5|||
156956893|NCT03750552|566594554|FG001|Overall Study|Adverse Event|1|||
156956894|NCT03750552|566594553|FG000|Overall Study|Withdrawal by Subject|1|||
156956895|NCT03750552|566594554|FG001|Overall Study|Withdrawal by Subject|1|||
156956896|NCT03750552|566594553|FG000|Overall Study|Other|2|||
156956897|NCT03750552|566594554|FG001|Overall Study|Other|0|||
156956898|NCT02062632|566594555|FG000|Overall Study|No treatment data|1|||
156956899|NCT00773968|566594557|FG000|Overall Study|Adverse Event|2|||
156956900|NCT00773968|566594557|FG000|Overall Study|Death|1|||
156956901|NCT00773968|566594557|FG000|Overall Study|Failure to Return|2|||
156956902|NCT00773968|566594557|FG000|Overall Study|Lack of Efficacy|3|||
156956903|NCT00773968|566594557|FG000|Overall Study|Protocol Violation|1|||
156956904|NCT00773968|566594557|FG000|Overall Study|Withdrawal by Subject|11|||
156956905|NCT00773968|566594557|FG000|Overall Study|Screen Failure|17|||
156956906|NCT00773968|566594557|FG000|Overall Study|Other|8|||
156956907|NCT02008890|566594561|FG000|Period 1|Withdrawal by Subject|7|||
156956908|NCT02008890|566594562|FG001|Period 1|Withdrawal by Subject|7|||
156956909|NCT02008890|566594563|FG002|Period 1|Withdrawal by Subject|5|||
156956910|NCT02008890|566594564|FG003|Period 1|Withdrawal by Subject|0|||
156956911|NCT02008890|566594565|FG004|Period 1|Withdrawal by Subject|0|||
156956912|NCT02008890|566594561|FG000|Period 1|Pregnancy|1|||
156956913|NCT02008890|566594562|FG001|Period 1|Pregnancy|0|||
156956914|NCT02008890|566594563|FG002|Period 1|Pregnancy|0|||
156956915|NCT02008890|566594564|FG003|Period 1|Pregnancy|0|||
157169730|NCT00171314|567363539|FG001|Overall Study|Adverse Event|41|||
157169731|NCT00171314|567363538|FG000|Overall Study|Lack of Efficacy|19|||
156956916|NCT02008890|566594565|FG004|Period 1|Pregnancy|0|||
157169732|NCT00171314|567363539|FG001|Overall Study|Lack of Efficacy|14|||
156956917|NCT02008890|566594561|FG000|Period 1|Physician Decision|1|||
156956918|NCT02008890|566594562|FG001|Period 1|Physician Decision|0|||
156956919|NCT02008890|566594563|FG002|Period 1|Physician Decision|1|||
156956920|NCT02008890|566594564|FG003|Period 1|Physician Decision|0|||
156956921|NCT02008890|566594565|FG004|Period 1|Physician Decision|0|||
157169733|NCT00171314|567363538|FG000|Overall Study|Withdrawal by Subject|9|||
157169734|NCT00171314|567363539|FG001|Overall Study|Withdrawal by Subject|6|||
157169735|NCT00171314|567363538|FG000|Overall Study|Abnormal Test Procedure Results|9|||
157169736|NCT00171314|567363539|FG001|Overall Study|Abnormal Test Procedure Results|3|||
157169737|NCT00171314|567363538|FG000|Overall Study|Protocol Violation|3|||
157169738|NCT00171314|567363539|FG001|Overall Study|Protocol Violation|7|||
157169739|NCT00171314|567363538|FG000|Overall Study|Administrative Problems|4|||
157169740|NCT00171314|567363539|FG001|Overall Study|Administrative Problems|3|||
157169741|NCT00171314|567363538|FG000|Overall Study|Lost to Follow-up|1|||
157169742|NCT00171314|567363539|FG001|Overall Study|Lost to Follow-up|3|||
157169743|NCT00171314|567363538|FG000|Overall Study|Death|2|||
157169744|NCT00171314|567363539|FG001|Overall Study|Death|1|||
157169745|NCT01309841|567363544|FG000|Overall Study|Other|0|||
157169746|NCT01309841|567363545|FG001|Overall Study|Other|1|||
157169747|NCT01309841|567363546|FG002|Overall Study|Other|1|||
157169748|NCT01309841|567363544|FG000|Overall Study|Lost to Follow-up|7|||
157169749|NCT01309841|567363545|FG001|Overall Study|Lost to Follow-up|6|||
157169750|NCT01309841|567363546|FG002|Overall Study|Lost to Follow-up|4|||
157169751|NCT01309841|567363544|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
157169752|NCT01309841|567363545|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
157169753|NCT01309841|567363546|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
156956922|NCT02008890|566594561|FG000|Period 1|Adverse Event|6|||
156956923|NCT02008890|566594562|FG001|Period 1|Adverse Event|8|||
156956924|NCT02008890|566594563|FG002|Period 1|Adverse Event|6|||
156956925|NCT02008890|566594564|FG003|Period 1|Adverse Event|0|||
156956926|NCT02008890|566594565|FG004|Period 1|Adverse Event|0|||
156956927|NCT02008890|566594561|FG000|Period 2|Adverse Event|12|||
156956928|NCT02008890|566594562|FG001|Period 2|Adverse Event|7|||
156956929|NCT02008890|566594563|FG002|Period 2|Adverse Event|0|||
156956930|NCT02008890|566594564|FG003|Period 2|Adverse Event|5|||
156956931|NCT02008890|566594565|FG004|Period 2|Adverse Event|5|||
156956932|NCT02008890|566594561|FG000|Period 2|Withdrawal by Subject|11|||
156956933|NCT02008890|566594562|FG001|Period 2|Withdrawal by Subject|8|||
156956934|NCT02008890|566594563|FG002|Period 2|Withdrawal by Subject|0|||
156956935|NCT02008890|566594564|FG003|Period 2|Withdrawal by Subject|7|||
156956936|NCT02008890|566594565|FG004|Period 2|Withdrawal by Subject|2|||
156956937|NCT02008890|566594561|FG000|Period 2|Physician Decision|4|||
156956938|NCT02008890|566594562|FG001|Period 2|Physician Decision|0|||
156956939|NCT02008890|566594563|FG002|Period 2|Physician Decision|0|||
156956940|NCT02008890|566594564|FG003|Period 2|Physician Decision|2|||
156956941|NCT02008890|566594565|FG004|Period 2|Physician Decision|1|||
156956942|NCT02008890|566594561|FG000|Period 2|Lost to Follow-up|0|||
156956943|NCT02008890|566594562|FG001|Period 2|Lost to Follow-up|0|||
156956944|NCT02008890|566594563|FG002|Period 2|Lost to Follow-up|1|||
156956945|NCT02008890|566594564|FG003|Period 2|Lost to Follow-up|0|||
156956946|NCT02008890|566594565|FG004|Period 2|Lost to Follow-up|0|||
156956947|NCT02008890|566594561|FG000|Extension Period|Withdrawal by Subject|3|||
156956948|NCT02008890|566594562|FG001|Extension Period|Withdrawal by Subject|2|||
156956949|NCT02008890|566594563|FG002|Extension Period|Withdrawal by Subject|0|||
156956950|NCT02008890|566594564|FG003|Extension Period|Withdrawal by Subject|4|||
156956951|NCT02008890|566594565|FG004|Extension Period|Withdrawal by Subject|2|||
156956952|NCT02008890|566594561|FG000|Extension Period|Lost to Follow-up|1|||
156956953|NCT02008890|566594562|FG001|Extension Period|Lost to Follow-up|0|||
156956954|NCT02008890|566594563|FG002|Extension Period|Lost to Follow-up|0|||
156956955|NCT02008890|566594564|FG003|Extension Period|Lost to Follow-up|0|||
156956956|NCT02008890|566594565|FG004|Extension Period|Lost to Follow-up|0|||
156956957|NCT02008890|566594561|FG000|Extension Period|Adverse Event|1|||
156956958|NCT02008890|566594562|FG001|Extension Period|Adverse Event|3|||
157169754|NCT01309841|567363544|FG000|Overall Study|Lack of Efficacy|0|||
157169755|NCT01309841|567363545|FG001|Overall Study|Lack of Efficacy|0|||
156956959|NCT02008890|566594563|FG002|Extension Period|Adverse Event|0|||
156956960|NCT02008890|566594564|FG003|Extension Period|Adverse Event|0|||
156956961|NCT02008890|566594565|FG004|Extension Period|Adverse Event|2|||
156956962|NCT02207816|566594566|FG000|Overall Study|Serious Adverse Event|0|||
156956963|NCT02207816|566594567|FG001|Overall Study|Serious Adverse Event|5|||
156956964|NCT02207816|566594568|FG002|Overall Study|Serious Adverse Event|2|||
156956965|NCT02207816|566594566|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156956966|NCT02207816|566594567|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
156956967|NCT02207816|566594568|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
156956968|NCT02207816|566594566|FG000|Overall Study|Withdrawal by Subject|4|||
156956969|NCT02207816|566594567|FG001|Overall Study|Withdrawal by Subject|9|||
157169756|NCT01309841|567363546|FG002|Overall Study|Lack of Efficacy|2|||
157169757|NCT01309841|567363544|FG000|Overall Study|Adverse Event|9|||
157169758|NCT01309841|567363545|FG001|Overall Study|Adverse Event|22|||
157169759|NCT01309841|567363546|FG002|Overall Study|Adverse Event|11|||
157169760|NCT01309841|567363544|FG000|Overall Study|Death|1|||
157169761|NCT01309841|567363545|FG001|Overall Study|Death|0|||
157169762|NCT01309841|567363546|FG002|Overall Study|Death|0|||
156956970|NCT02207816|566594568|FG002|Overall Study|Withdrawal by Subject|7|||
156956971|NCT02207816|566594566|FG000|Overall Study|Migrated/Moved From Study Area|41|||
156956972|NCT02207816|566594567|FG001|Overall Study|Migrated/Moved From Study Area|60|||
156956973|NCT02207816|566594568|FG002|Overall Study|Migrated/Moved From Study Area|51|||
156956974|NCT02207816|566594566|FG000|Overall Study|Lost to Follow-up|3|||
156956975|NCT02207816|566594567|FG001|Overall Study|Lost to Follow-up|9|||
156956976|NCT02207816|566594568|FG002|Overall Study|Lost to Follow-up|1|||
156956977|NCT02207816|566594566|FG000|Overall Study|Other|1|||
156956978|NCT02207816|566594567|FG001|Overall Study|Other|2|||
156956979|NCT02207816|566594568|FG002|Overall Study|Other|4|||
156956980|NCT02522494|566594569|FG000|Overall Study|Lost to Follow-up|6|||
156956981|NCT02522494|566594570|FG001|Overall Study|Lost to Follow-up|2|||
156956982|NCT02522494|566594569|FG000|Overall Study|Withdrawal by Subject|1|||
156956983|NCT02522494|566594570|FG001|Overall Study|Withdrawal by Subject|0|||
156956984|NCT02522494|566594569|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
156956985|NCT02522494|566594570|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
156956986|NCT02522494|566594569|FG000|Overall Study|Participant did not watch the video|1|||
156956987|NCT02522494|566594570|FG001|Overall Study|Participant did not watch the video|0|||
156956988|NCT02522494|566594569|FG000|Overall Study|Death|0|||
156956989|NCT02522494|566594570|FG001|Overall Study|Death|1|||
156956990|NCT03240588|566594571|FG000|Overall Study|Death|3|||
156956991|NCT03240588|566594572|FG001|Overall Study|Death|0|||
156956992|NCT03240588|566594573|FG002|Overall Study|Death|0|||
156956993|NCT03240588|566594571|FG000|Overall Study|Adverse Event|5|||
156956994|NCT03240588|566594572|FG001|Overall Study|Adverse Event|4|||
156956995|NCT03240588|566594573|FG002|Overall Study|Adverse Event|0|||
156956996|NCT03240588|566594571|FG000|Overall Study|Lost to Follow-up|9|||
156956997|NCT03240588|566594572|FG001|Overall Study|Lost to Follow-up|4|||
156956998|NCT03240588|566594573|FG002|Overall Study|Lost to Follow-up|0|||
156956999|NCT03240588|566594571|FG000|Overall Study|Physician Decision|3|||
156957000|NCT03240588|566594572|FG001|Overall Study|Physician Decision|2|||
156957001|NCT03240588|566594573|FG002|Overall Study|Physician Decision|0|||
156957002|NCT03240588|566594571|FG000|Overall Study|Did not meet eligibility criteria|0|||
156957003|NCT03240588|566594572|FG001|Overall Study|Did not meet eligibility criteria|6|||
156957004|NCT03240588|566594573|FG002|Overall Study|Did not meet eligibility criteria|0|||
156957005|NCT03240588|566594571|FG000|Overall Study|No longer meets protocol criteria|12|||
156957006|NCT03240588|566594572|FG001|Overall Study|No longer meets protocol criteria|7|||
156957007|NCT03240588|566594573|FG002|Overall Study|No longer meets protocol criteria|0|||
156957008|NCT03240588|566594571|FG000|Overall Study|Withdrawal by Subject|60|||
156957009|NCT03240588|566594572|FG001|Overall Study|Withdrawal by Subject|52|||
156957010|NCT03240588|566594573|FG002|Overall Study|Withdrawal by Subject|7|||
156957011|NCT03240588|566594571|FG000|Overall Study|Other, additional details not available.|0|||
156957012|NCT03240588|566594572|FG001|Overall Study|Other, additional details not available.|12|||
156957013|NCT03240588|566594573|FG002|Overall Study|Other, additional details not available.|1|||
156957014|NCT03240588|566594571|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
156957015|NCT03240588|566594572|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
156957016|NCT03240588|566594573|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
156957017|NCT03240588|566594571|FG000|Overall Study|Closure of study|55|||
156957018|NCT03240588|566594572|FG001|Overall Study|Closure of study|3|||
156957019|NCT03240588|566594573|FG002|Overall Study|Closure of study|0|||
156957020|NCT03240588|566594571|FG000|Overall Study|Subject non-compliance|23|||
156957021|NCT03240588|566594572|FG001|Overall Study|Subject non-compliance|2|||
156957022|NCT03240588|566594573|FG002|Overall Study|Subject non-compliance|1|||
156957023|NCT03240588|566594571|FG000|Overall Study|Device Deficiency|1|||
156957024|NCT03240588|566594572|FG001|Overall Study|Device Deficiency|0|||
156957025|NCT03240588|566594573|FG002|Overall Study|Device Deficiency|0|||
156957026|NCT03240588|566594571|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
156957027|NCT03240588|566594572|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
156957028|NCT03240588|566594573|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
156957029|NCT03204279|566594578|FG000|Overall Study|Withdrawal by Subject|0|||
156957030|NCT03204279|566594579|FG001|Overall Study|Withdrawal by Subject|1|||
156957031|NCT01064739|566594580|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
156957032|NCT00454051|566594581|FG000|Overall Study|Adverse Event|1|||
156957033|NCT00454051|566594582|FG001|Overall Study|Adverse Event|2|||
156957034|NCT00454051|566594581|FG000|Overall Study|Withdrawal by Subject|1|||
156957035|NCT00454051|566594582|FG001|Overall Study|Withdrawal by Subject|0|||
156957036|NCT00454051|566594581|FG000|Overall Study|Protocol Violation|1|||
156957037|NCT00454051|566594582|FG001|Overall Study|Protocol Violation|1|||
156957038|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
156957039|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
156957040|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
156957041|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
156957042|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
156957043|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
156957044|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
156957045|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
156957046|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
156957047|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
156957048|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
156957049|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
156957050|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
156957051|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
156957052|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
156957053|NCT01571362|566594583|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
156957054|NCT01571362|566594584|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
156957055|NCT01571362|566594585|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
156957056|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
156957057|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
156957058|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
156957059|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
156957060|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
156957061|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
156957062|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Adverse Event|0|||
156957063|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Adverse Event|9|||
156957064|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Adverse Event|14|||
156957065|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
156957066|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
156957067|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
156957068|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
156957069|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
156957070|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
156957071|NCT01571362|566594583|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
156957072|NCT01571362|566594584|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
156957073|NCT01571362|566594585|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
156957074|NCT04258020|566594586|FG000|Overall Study|Withdrawal by Subject|1|||
156957075|NCT04258020|566594587|FG001|Overall Study|Withdrawal by Subject|0|||
156957076|NCT02097472|566594588|FG000|Received Vaccination 2|Adverse Event|0|||
156957077|NCT02097472|566594589|FG001|Received Vaccination 2|Adverse Event|0|||
156957078|NCT02097472|566594590|FG002|Received Vaccination 2|Adverse Event|0|||
156957079|NCT02097472|566594591|FG003|Received Vaccination 2|Adverse Event|0|||
156957080|NCT02097472|566594592|FG004|Received Vaccination 2|Adverse Event|0|||
156957081|NCT02097472|566594593|FG005|Received Vaccination 2|Adverse Event|0|||
156957082|NCT02097472|566594594|FG006|Received Vaccination 2|Adverse Event|1|||
156957083|NCT02097472|566594595|FG007|Received Vaccination 2|Adverse Event|0|||
156957084|NCT02862106|566594598|FG000|Overall Study|Adverse Event|4|||
156957085|NCT02862106|566594599|FG001|Overall Study|Adverse Event|0|||
156957086|NCT02862106|566594598|FG000|Overall Study|Protocol Violation|16|||
156957087|NCT02862106|566594599|FG001|Overall Study|Protocol Violation|1|||
156957088|NCT02862106|566594598|FG000|Overall Study|Lost to Follow-up|15|||
156957089|NCT02862106|566594599|FG001|Overall Study|Lost to Follow-up|5|||
156957090|NCT02862106|566594598|FG000|Overall Study|Withdrawal by Subject|2|||
156957091|NCT02862106|566594599|FG001|Overall Study|Withdrawal by Subject|0|||
156957092|NCT02862106|566594598|FG000|Overall Study|Subjects moved to other city|1|||
156957093|NCT02862106|566594599|FG001|Overall Study|Subjects moved to other city|0|||
156957094|NCT03966157|566594600|FG000|Overall Study|Physician Decision|1|||
156957095|NCT03966157|566594601|FG001|Overall Study|Physician Decision|0|||
156957096|NCT03305016|566594604|FG000|Overall Study|Withdrawal by Subject|2|||
156957097|NCT00130533|566594610|FG000|Overall Study|Withdrawal by Subject|33|||
156957098|NCT00130533|566594611|FG001|Overall Study|Withdrawal by Subject|6|||
156957099|NCT00130533|566594610|FG000|Overall Study|Adverse Event|34|||
156957100|NCT00130533|566594611|FG001|Overall Study|Adverse Event|1|||
156957101|NCT00130533|566594610|FG000|Overall Study|Disease relapse|9|||
156957102|NCT00130533|566594611|FG001|Overall Study|Disease relapse|13|||
157169763|NCT01309841|567363544|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
157169764|NCT01309841|567363545|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
157169765|NCT01309841|567363546|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
157169766|NCT01309841|567363544|FG000|Overall Study|Withdrawal by Subject|17|||
157169767|NCT01309841|567363545|FG001|Overall Study|Withdrawal by Subject|6|||
157169768|NCT01309841|567363546|FG002|Overall Study|Withdrawal by Subject|13|||
156957103|NCT00130533|566594610|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
157037485|NCT03213457|566892544|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
156957104|NCT00130533|566594611|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
156957105|NCT00130533|566594610|FG000|Overall Study|Death|4|||
156957106|NCT00130533|566594611|FG001|Overall Study|Death|2|||
157169769|NCT01309841|567363544|FG000|Overall Study|Did Not Receive Treatment|2|||
157169770|NCT01309841|567363545|FG001|Overall Study|Did Not Receive Treatment|0|||
157169771|NCT01309841|567363546|FG002|Overall Study|Did Not Receive Treatment|1|||
157169772|NCT01309841|567363544|FG000|Overall Study|Severe non-compliance with protocol|0|||
157169773|NCT01309841|567363545|FG001|Overall Study|Severe non-compliance with protocol|5|||
157169774|NCT01309841|567363546|FG002|Overall Study|Severe non-compliance with protocol|2|||
157169775|NCT01996904|567363549|FG000|Overall Study|Lost to Follow-up|38|||
157169776|NCT01996904|567363550|FG001|Overall Study|Lost to Follow-up|27|||
157169777|NCT04664855|567363551|FG000|Overall Study|Withdrawal by Subject|0|||
157169778|NCT04664855|567363552|FG001|Overall Study|Withdrawal by Subject|2|||
157169779|NCT01441115|567363553|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
157169780|NCT02475395|567363561|FG000|Overall Study|Protocol Violation|30|||
157169781|NCT02475395|567363562|FG001|Overall Study|Protocol Violation|3|||
157169782|NCT01086150|567363563|FG000|Overall Study|Withdrawal by Subject|0|||
157169783|NCT01086150|567363564|FG001|Overall Study|Withdrawal by Subject|4|||
157169784|NCT01086150|567363565|FG002|Overall Study|Withdrawal by Subject|1|||
157169785|NCT01086150|567363563|FG000|Overall Study|Lost to Follow-up|0|||
157169786|NCT01086150|567363564|FG001|Overall Study|Lost to Follow-up|1|||
157169787|NCT01086150|567363565|FG002|Overall Study|Lost to Follow-up|0|||
157169788|NCT01086150|567363563|FG000|Overall Study|Screen Failure|0|||
157169789|NCT01086150|567363564|FG001|Overall Study|Screen Failure|1|||
157169790|NCT01086150|567363565|FG002|Overall Study|Screen Failure|0|||
157169791|NCT01681576|567363566|FG000|Period 1|Adverse Event|1|||
157169792|NCT01681576|567363567|FG001|Period 1|Adverse Event|0|||
157169793|NCT01681576|567363566|FG000|Period 1|Protocol Deviation|1|||
157169794|NCT01681576|567363567|FG001|Period 1|Protocol Deviation|0|||
157169795|NCT01681576|567363566|FG000|Period 2|subject/guardian decision|3|||
157169796|NCT01681576|567363567|FG001|Period 2|subject/guardian decision|1|||
157169797|NCT01681576|567363566|FG000|Period 2|Non-compliance with study treatment|1|||
157169798|NCT01681576|567363567|FG001|Period 2|Non-compliance with study treatment|0|||
157169799|NCT03543358|567363569|FG000|Overall Study|Death|1|||
157169800|NCT03543358|567363570|FG001|Overall Study|Death|0|||
157169801|NCT03543358|567363569|FG000|Overall Study|Disease Progression|1|||
157169802|NCT03543358|567363570|FG001|Overall Study|Disease Progression|0|||
157169803|NCT03543358|567363569|FG000|Overall Study|Parent Study Closure|1|||
157169804|NCT03543358|567363570|FG001|Overall Study|Parent Study Closure|0|||
157169805|NCT02260648|567363571|FG000|Overall Study|Adverse Event|3|||
157169806|NCT02260648|567363572|FG001|Overall Study|Adverse Event|0|||
157169807|NCT02260648|567363573|FG002|Overall Study|Adverse Event|1|||
157169808|NCT02260648|567363571|FG000|Overall Study|Withdrawal by Subject|1|||
157169809|NCT02260648|567363572|FG001|Overall Study|Withdrawal by Subject|1|||
157169810|NCT02260648|567363573|FG002|Overall Study|Withdrawal by Subject|0|||
157169811|NCT02260648|567363571|FG000|Overall Study|Protocol Violation|1|||
157169812|NCT02260648|567363572|FG001|Overall Study|Protocol Violation|0|||
157169813|NCT02260648|567363573|FG002|Overall Study|Protocol Violation|0|||
157169814|NCT02260648|567363571|FG000|Overall Study|Discontinue Due to Study Termination|13|||
157169815|NCT02260648|567363572|FG001|Overall Study|Discontinue Due to Study Termination|12|||
157169816|NCT02260648|567363573|FG002|Overall Study|Discontinue Due to Study Termination|7|||
157169817|NCT01890512|567363574|FG000|Overall Study|Physician Decision|1|||
157169818|NCT01890512|567363574|FG000|Overall Study|Withdrawal by Subject|1|||
157169819|NCT01890512|567363574|FG000|Overall Study|Protocol Violation|1|||
157169820|NCT00986427|567363575|FG000|Overall Study|Lost to Follow-up|2|||
157169821|NCT00986427|567363576|FG001|Overall Study|Lost to Follow-up|0|||
157169822|NCT00986427|567363575|FG000|Overall Study|Lack of Efficacy|1|||
157169823|NCT00986427|567363576|FG001|Overall Study|Lack of Efficacy|0|||
157169824|NCT00986427|567363575|FG000|Overall Study|Withdrawal by Subject|1|||
156957107|NCT00130533|566594610|FG000|Overall Study|Protocol Violation|5|||
156957108|NCT00130533|566594611|FG001|Overall Study|Protocol Violation|1|||
156957109|NCT00130533|566594610|FG000|Overall Study|Lost to Follow-up|1|||
156957110|NCT00130533|566594611|FG001|Overall Study|Lost to Follow-up|1|||
157169825|NCT00986427|567363576|FG001|Overall Study|Withdrawal by Subject|0|||
157169826|NCT00575094|567363579|FG000|Overall Study|Adverse Event|2|||
157169827|NCT00575094|567363579|FG000|Overall Study|Withdrawal by Subject|1|||
157169828|NCT04142216|567363581|FG000|Overall Study|Hospitalization|0|||
157169829|NCT04142216|567363582|FG001|Overall Study|Hospitalization|2|||
157169830|NCT04142216|567363581|FG000|Overall Study|Death|3|||
156957111|NCT00130533|566594610|FG000|Overall Study|Sponsor´s decision|2|||
157169831|NCT04142216|567363582|FG001|Overall Study|Death|1|||
157169832|NCT04142216|567363581|FG000|Overall Study|Referral to another hemodialysis unit|3|||
157169833|NCT04142216|567363582|FG001|Overall Study|Referral to another hemodialysis unit|2|||
157169834|NCT04142216|567363581|FG000|Overall Study|Use of clove|0|||
157169835|NCT04142216|567363582|FG001|Overall Study|Use of clove|1|||
157169836|NCT00862121|567363585|FG000|Overall Study|Adverse Event|1|||
157169837|NCT00862121|567363586|FG001|Overall Study|Adverse Event|2|||
157169838|NCT00862121|567363585|FG000|Overall Study|Lack of Efficacy|0|||
157169839|NCT00862121|567363586|FG001|Overall Study|Lack of Efficacy|3|||
157169840|NCT00862121|567363585|FG000|Overall Study|Protocol Violation|0|||
157169841|NCT00862121|567363586|FG001|Overall Study|Protocol Violation|1|||
156957112|NCT00130533|566594611|FG001|Overall Study|Sponsor´s decision|0|||
156957113|NCT00130533|566594610|FG000|Overall Study|Second Primary Malignancy|0|||
156957114|NCT00130533|566594611|FG001|Overall Study|Second Primary Malignancy|1|||
156957115|NCT00130533|566594610|FG000|Overall Study|Other|12|||
156957116|NCT00130533|566594611|FG001|Overall Study|Other|5|||
156957117|NCT03927950|566594612|FG000|Overall Study|Adverse Event|9|||
156957118|NCT01491854|566594613|FG000|Overall Study|mainly due to premature termination|93|||
156957119|NCT01491854|566594613|FG000|Overall Study|Death|1|||
156957120|NCT01491854|566594613|FG000|Overall Study|Withdrawal by Subject|3|||
156957121|NCT01491854|566594613|FG000|Overall Study|Lost to Follow-up|33|||
156957122|NCT01026974|566594614|FG000|Overall Study|Withdrawal by Subject|0|||
156957123|NCT01026974|566594615|FG001|Overall Study|Withdrawal by Subject|1|||
156957124|NCT01026974|566594616|FG002|Overall Study|Withdrawal by Subject|7|||
156957125|NCT01026974|566594617|FG003|Overall Study|Withdrawal by Subject|2|||
156957126|NCT01026974|566594614|FG000|Overall Study|Lost to Follow-up|1|||
156957127|NCT01026974|566594615|FG001|Overall Study|Lost to Follow-up|1|||
156957128|NCT01026974|566594616|FG002|Overall Study|Lost to Follow-up|4|||
156957129|NCT01026974|566594617|FG003|Overall Study|Lost to Follow-up|0|||
156957130|NCT01026974|566594614|FG000|Overall Study|Adverse Event|0|||
156957131|NCT01026974|566594615|FG001|Overall Study|Adverse Event|0|||
156957132|NCT01026974|566594616|FG002|Overall Study|Adverse Event|0|||
156957133|NCT01026974|566594617|FG003|Overall Study|Adverse Event|1|||
156957134|NCT01026974|566594614|FG000|Overall Study|Inappropriate enrollment|0|||
156957135|NCT01026974|566594615|FG001|Overall Study|Inappropriate enrollment|0|||
156957136|NCT01026974|566594616|FG002|Overall Study|Inappropriate enrollment|1|||
156957137|NCT01026974|566594617|FG003|Overall Study|Inappropriate enrollment|0|||
156957138|NCT01040130|566594618|FG000|Overall Study|Adverse Event|1|||
156957139|NCT01040130|566594619|FG001|Overall Study|Adverse Event|1|||
156957140|NCT01040130|566594620|FG002|Overall Study|Adverse Event|0|||
156957141|NCT01040130|566594621|FG003|Overall Study|Adverse Event|5|||
156957142|NCT01040130|566594622|FG004|Overall Study|Adverse Event|0|||
156957143|NCT01040130|566594623|FG005|Overall Study|Adverse Event|3|||
156957144|NCT01040130|566594618|FG000|Overall Study|Protocol Violation|0|||
156957145|NCT01040130|566594619|FG001|Overall Study|Protocol Violation|0|||
156957146|NCT01040130|566594620|FG002|Overall Study|Protocol Violation|2|||
156957147|NCT01040130|566594621|FG003|Overall Study|Protocol Violation|0|||
156957148|NCT01040130|566594622|FG004|Overall Study|Protocol Violation|0|||
156957149|NCT01040130|566594623|FG005|Overall Study|Protocol Violation|0|||
156957150|NCT01040130|566594618|FG000|Overall Study|Withdrawal by Subject|0|||
156957151|NCT01040130|566594619|FG001|Overall Study|Withdrawal by Subject|2|||
156957152|NCT01040130|566594620|FG002|Overall Study|Withdrawal by Subject|0|||
156957153|NCT01040130|566594621|FG003|Overall Study|Withdrawal by Subject|0|||
156957154|NCT01040130|566594622|FG004|Overall Study|Withdrawal by Subject|0|||
156957155|NCT01040130|566594623|FG005|Overall Study|Withdrawal by Subject|1|||
156957156|NCT01040130|566594618|FG000|Overall Study|Other reasons not listed above|2|||
156957157|NCT01040130|566594619|FG001|Overall Study|Other reasons not listed above|0|||
156957158|NCT01040130|566594620|FG002|Overall Study|Other reasons not listed above|0|||
156957159|NCT01040130|566594621|FG003|Overall Study|Other reasons not listed above|0|||
156957160|NCT01040130|566594622|FG004|Overall Study|Other reasons not listed above|0|||
156957161|NCT01040130|566594623|FG005|Overall Study|Other reasons not listed above|0|||
156957162|NCT01618864|566594624|FG000|Overall Study|Withdrawal by Subject|2|||
156957163|NCT01618864|566594624|FG000|Overall Study|Lost to Follow-up|2|||
156957164|NCT00096135|566594630|FG000|Overall Study|Physician Decision|20|||
156957165|NCT00096135|566594631|FG001|Overall Study|Physician Decision|4|||
156957166|NCT00096135|566594630|FG000|Overall Study|Refusal of further protocol therapy|4|||
156957167|NCT00096135|566594631|FG001|Overall Study|Refusal of further protocol therapy|1|||
156957168|NCT00096135|566594630|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
156957169|NCT00096135|566594631|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
156957170|NCT00096135|566594630|FG000|Overall Study|Other, specify|15|||
156957171|NCT00096135|566594631|FG001|Overall Study|Other, specify|3|||
156957172|NCT00096135|566594630|FG000|Overall Study|Ineligible|2|||
156957173|NCT00096135|566594631|FG001|Overall Study|Ineligible|0|||
156957174|NCT00833989|566594639|FG000|Overall Study|Physician Decision|0|||
156957175|NCT00833989|566594640|FG001|Overall Study|Physician Decision|0|||
156957176|NCT00833989|566594641|FG002|Overall Study|Physician Decision|0|||
156957177|NCT00833989|566594642|FG003|Overall Study|Physician Decision|1|||
156957178|NCT00833989|566594639|FG000|Overall Study|Withdrawal by Subject|3|||
156957179|NCT00833989|566594640|FG001|Overall Study|Withdrawal by Subject|0|||
156957180|NCT00833989|566594641|FG002|Overall Study|Withdrawal by Subject|1|||
156957181|NCT00833989|566594642|FG003|Overall Study|Withdrawal by Subject|1|||
156957182|NCT02310750|566594645|FG000|HP Period 1|Lost to Follow-up|0|||
156957183|NCT02310750|566594646|FG001|HP Period 1|Lost to Follow-up|0|||
156957184|NCT02310750|566594647|FG002|HP Period 1|Lost to Follow-up|0|||
156957185|NCT02310750|566594648|FG003|HP Period 1|Lost to Follow-up|0|||
156957186|NCT02310750|566594649|FG004|HP Period 1|Lost to Follow-up|0|||
156957187|NCT02310750|566594650|FG005|HP Period 1|Lost to Follow-up|0|||
156957188|NCT02310750|566594651|FG006|HP Period 1|Lost to Follow-up|1|||
156957189|NCT02310750|566594652|FG007|HP Period 1|Lost to Follow-up|0|||
156957190|NCT02310750|566594653|FG008|HP Period 1|Lost to Follow-up|0|||
157169842|NCT00862121|567363585|FG000|Overall Study|Exclusion criterion violation|0|||
157169843|NCT00862121|567363586|FG001|Overall Study|Exclusion criterion violation|1|||
157169844|NCT00862121|567363585|FG000|Overall Study|Incorrect randomisation|0|||
157169845|NCT00862121|567363586|FG001|Overall Study|Incorrect randomisation|1|||
157169846|NCT01582971|567363587|FG000|Overall Study|Death|2|||
157169847|NCT01582971|567363588|FG001|Overall Study|Death|1|||
157169848|NCT01582971|567363587|FG000|Overall Study|Lost to Follow-up|18|||
156957191|NCT02310750|566594654|FG009|HP Period 1|Lost to Follow-up|0|||
156957192|NCT02310750|566594655|FG010|HP Period 1|Lost to Follow-up|0|||
156957193|NCT02310750|566594656|FG011|HP Period 1|Lost to Follow-up|0|||
156957194|NCT02310750|566594657|FG012|HP Period 1|Lost to Follow-up|0|||
156957195|NCT02310750|566594658|FG013|HP Period 1|Lost to Follow-up|0|||
156957196|NCT02310750|566594659|FG014|HP Period 1|Lost to Follow-up|0|||
156957197|NCT02310750|566594660|FG015|HP Period 1|Lost to Follow-up|0|||
156957198|NCT02310750|566594645|FG000|HP Period 1|Withdrawal by Subject|1|||
156957199|NCT02310750|566594646|FG001|HP Period 1|Withdrawal by Subject|0|||
156957200|NCT02310750|566594647|FG002|HP Period 1|Withdrawal by Subject|0|||
156957201|NCT02310750|566594648|FG003|HP Period 1|Withdrawal by Subject|1|||
157169849|NCT01582971|567363588|FG001|Overall Study|Lost to Follow-up|21|||
157169850|NCT01582971|567363587|FG000|Overall Study|Withdrawal by Subject|4|||
156957202|NCT02310750|566594649|FG004|HP Period 1|Withdrawal by Subject|0|||
156957203|NCT02310750|566594650|FG005|HP Period 1|Withdrawal by Subject|0|||
156957204|NCT02310750|566594651|FG006|HP Period 1|Withdrawal by Subject|0|||
156957205|NCT02310750|566594652|FG007|HP Period 1|Withdrawal by Subject|0|||
156957206|NCT02310750|566594653|FG008|HP Period 1|Withdrawal by Subject|0|||
156957207|NCT02310750|566594654|FG009|HP Period 1|Withdrawal by Subject|0|||
156957208|NCT02310750|566594655|FG010|HP Period 1|Withdrawal by Subject|0|||
156957209|NCT02310750|566594656|FG011|HP Period 1|Withdrawal by Subject|0|||
156957210|NCT02310750|566594657|FG012|HP Period 1|Withdrawal by Subject|0|||
156957211|NCT02310750|566594658|FG013|HP Period 1|Withdrawal by Subject|0|||
156957212|NCT02310750|566594659|FG014|HP Period 1|Withdrawal by Subject|0|||
156957213|NCT02310750|566594660|FG015|HP Period 1|Withdrawal by Subject|0|||
156957214|NCT02310750|566594645|FG000|HP Washout 1|Lost to Follow-up|0|||
156957215|NCT02310750|566594646|FG001|HP Washout 1|Lost to Follow-up|0|||
156957216|NCT02310750|566594647|FG002|HP Washout 1|Lost to Follow-up|1|||
156957217|NCT02310750|566594648|FG003|HP Washout 1|Lost to Follow-up|1|||
156957218|NCT02310750|566594649|FG004|HP Washout 1|Lost to Follow-up|2|||
156957219|NCT02310750|566594650|FG005|HP Washout 1|Lost to Follow-up|2|||
156957220|NCT02310750|566594651|FG006|HP Washout 1|Lost to Follow-up|3|||
156957221|NCT02310750|566594652|FG007|HP Washout 1|Lost to Follow-up|0|||
156957222|NCT02310750|566594653|FG008|HP Washout 1|Lost to Follow-up|0|||
156957223|NCT02310750|566594654|FG009|HP Washout 1|Lost to Follow-up|0|||
156957224|NCT02310750|566594655|FG010|HP Washout 1|Lost to Follow-up|0|||
156957225|NCT02310750|566594656|FG011|HP Washout 1|Lost to Follow-up|0|||
156957226|NCT02310750|566594657|FG012|HP Washout 1|Lost to Follow-up|0|||
156957227|NCT02310750|566594658|FG013|HP Washout 1|Lost to Follow-up|0|||
156957228|NCT02310750|566594659|FG014|HP Washout 1|Lost to Follow-up|0|||
156957229|NCT02310750|566594660|FG015|HP Washout 1|Lost to Follow-up|0|||
156957230|NCT02310750|566594645|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957231|NCT02310750|566594646|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957232|NCT02310750|566594647|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957233|NCT02310750|566594648|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
156957234|NCT02310750|566594649|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957235|NCT02310750|566594650|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
156957236|NCT02310750|566594651|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957237|NCT02310750|566594652|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957238|NCT02310750|566594653|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
156957239|NCT02310750|566594654|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
156957240|NCT02310750|566594655|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957241|NCT02310750|566594656|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957242|NCT02310750|566594657|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957243|NCT02310750|566594658|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
157169851|NCT01582971|567363588|FG001|Overall Study|Withdrawal by Subject|2|||
157169852|NCT01582971|567363587|FG000|Overall Study|Other|15|||
156957244|NCT02310750|566594659|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
157227620|NCT00414466|567579124|FG002|Overall Study|Withdrawn by Sponsor|0|||
156957245|NCT02310750|566594660|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
156957246|NCT02310750|566594645|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957247|NCT02310750|566594646|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957248|NCT02310750|566594647|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957249|NCT02310750|566594648|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957250|NCT02310750|566594649|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957251|NCT02310750|566594650|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957252|NCT02310750|566594651|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
157169853|NCT01582971|567363588|FG001|Overall Study|Other|13|||
157169854|NCT02007954|567363591|FG000|Overall Study|Received liver transplant|3|||
156957253|NCT02310750|566594652|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957254|NCT02310750|566594653|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957255|NCT02310750|566594654|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
156957256|NCT02310750|566594655|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957257|NCT02310750|566594656|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957258|NCT02310750|566594657|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957259|NCT02310750|566594658|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957260|NCT02310750|566594659|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957261|NCT02310750|566594660|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
156957262|NCT02310750|566594645|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957263|NCT02310750|566594646|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957264|NCT02310750|566594647|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957265|NCT02310750|566594648|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957266|NCT02310750|566594649|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957267|NCT02310750|566594650|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957268|NCT02310750|566594651|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957269|NCT02310750|566594652|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156957270|NCT02310750|566594653|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156957271|NCT02310750|566594654|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
156957272|NCT02310750|566594655|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957273|NCT02310750|566594656|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957274|NCT02310750|566594657|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957275|NCT02310750|566594658|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957276|NCT02310750|566594659|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957277|NCT02310750|566594660|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
156957278|NCT02310750|566594645|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957279|NCT02310750|566594646|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957280|NCT02310750|566594647|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957281|NCT02310750|566594648|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957282|NCT02310750|566594649|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957283|NCT02310750|566594650|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957284|NCT02310750|566594651|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957285|NCT02310750|566594652|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
156957286|NCT02310750|566594653|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
156957287|NCT02310750|566594654|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957288|NCT02310750|566594655|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957289|NCT02310750|566594656|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957290|NCT02310750|566594657|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957291|NCT02310750|566594658|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957292|NCT02310750|566594659|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957293|NCT02310750|566594660|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
156957294|NCT02310750|566594645|FG000|HP Washout 2|Lost to Follow-up|0|||
156957295|NCT02310750|566594646|FG001|HP Washout 2|Lost to Follow-up|0|||
156957296|NCT02310750|566594647|FG002|HP Washout 2|Lost to Follow-up|0|||
156957297|NCT02310750|566594648|FG003|HP Washout 2|Lost to Follow-up|0|||
156957298|NCT02310750|566594649|FG004|HP Washout 2|Lost to Follow-up|1|||
156957299|NCT02310750|566594650|FG005|HP Washout 2|Lost to Follow-up|0|||
156957300|NCT02310750|566594651|FG006|HP Washout 2|Lost to Follow-up|7|||
156957301|NCT02310750|566594652|FG007|HP Washout 2|Lost to Follow-up|0|||
156957302|NCT02310750|566594653|FG008|HP Washout 2|Lost to Follow-up|0|||
156957303|NCT02310750|566594654|FG009|HP Washout 2|Lost to Follow-up|0|||
156957304|NCT02310750|566594655|FG010|HP Washout 2|Lost to Follow-up|0|||
156957305|NCT02310750|566594656|FG011|HP Washout 2|Lost to Follow-up|0|||
156957306|NCT02310750|566594657|FG012|HP Washout 2|Lost to Follow-up|0|||
156957307|NCT02310750|566594658|FG013|HP Washout 2|Lost to Follow-up|0|||
156957308|NCT02310750|566594659|FG014|HP Washout 2|Lost to Follow-up|0|||
156957309|NCT02310750|566594660|FG015|HP Washout 2|Lost to Follow-up|0|||
156957310|NCT02952924|566594661|FG000|Overall Study|Protocol Violation|0|||
156957311|NCT02952924|566594662|FG001|Overall Study|Protocol Violation|0|||
156957312|NCT02952924|566594663|FG002|Overall Study|Protocol Violation|0|||
156957313|NCT02952924|566594664|FG003|Overall Study|Protocol Violation|0|||
156957314|NCT02952924|566594665|FG004|Overall Study|Protocol Violation|0|||
157169855|NCT02007954|567363591|FG000|Overall Study|Switch in treatment modality|2|||
156957315|NCT02952924|566594666|FG005|Overall Study|Protocol Violation|0|||
156957316|NCT02952924|566594667|FG006|Overall Study|Protocol Violation|0|||
156957317|NCT02952924|566594668|FG007|Overall Study|Protocol Violation|0|||
156957318|NCT02952924|566594669|FG008|Overall Study|Protocol Violation|0|||
156957319|NCT02952924|566594670|FG009|Overall Study|Protocol Violation|0|||
157169856|NCT02007954|567363591|FG000|Overall Study|Disease progression and unrelated AE|1|||
157169857|NCT02007954|567363591|FG000|Overall Study|Death|1|||
157169858|NCT01054976|567363592|FG000|Overall Study|Adverse Event|16|||
156957320|NCT02952924|566594671|FG010|Overall Study|Protocol Violation|0|||
156957321|NCT02952924|566594672|FG011|Overall Study|Protocol Violation|0|||
156957322|NCT02952924|566594673|FG012|Overall Study|Protocol Violation|0|||
156957323|NCT02952924|566594674|FG013|Overall Study|Protocol Violation|0|||
156957324|NCT02952924|566594675|FG014|Overall Study|Protocol Violation|0|||
156957325|NCT02952924|566594676|FG015|Overall Study|Protocol Violation|0|||
156957326|NCT02952924|566594677|FG016|Overall Study|Protocol Violation|0|||
156957327|NCT02952924|566594678|FG017|Overall Study|Protocol Violation|0|||
156957328|NCT02952924|566594679|FG018|Overall Study|Protocol Violation|0|||
156957329|NCT02952924|566594680|FG019|Overall Study|Protocol Violation|1|||
156957330|NCT02952924|566594681|FG020|Overall Study|Protocol Violation|0|||
156957331|NCT02952924|566594682|FG021|Overall Study|Protocol Violation|0|||
156957332|NCT02952924|566594661|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
156957333|NCT02952924|566594662|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
156957334|NCT02952924|566594663|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
156957335|NCT02952924|566594664|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
156957336|NCT02952924|566594665|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
156957337|NCT02952924|566594666|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
156957338|NCT02952924|566594667|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
156957339|NCT02952924|566594668|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
156957340|NCT02952924|566594669|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
156957341|NCT02952924|566594670|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
156957342|NCT02952924|566594671|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
156957343|NCT02952924|566594672|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
156957344|NCT02952924|566594673|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
156957345|NCT02952924|566594674|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
156957346|NCT02952924|566594675|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
156957347|NCT02952924|566594676|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
156957348|NCT02952924|566594677|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
156957349|NCT02952924|566594678|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
156957350|NCT02952924|566594679|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
156957351|NCT02952924|566594680|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
156957352|NCT02952924|566594681|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
156957353|NCT02952924|566594682|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
156957354|NCT02952924|566594661|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957355|NCT02952924|566594662|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957356|NCT02952924|566594663|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957357|NCT02952924|566594664|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957358|NCT02952924|566594665|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957359|NCT02952924|566594666|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957360|NCT02952924|566594667|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957361|NCT02952924|566594668|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957362|NCT02952924|566594669|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957363|NCT02952924|566594670|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957364|NCT02952924|566594671|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957365|NCT02952924|566594672|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957366|NCT02952924|566594673|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957367|NCT02952924|566594674|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957368|NCT02952924|566594675|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957369|NCT02952924|566594676|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957370|NCT02952924|566594677|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957371|NCT02952924|566594678|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957372|NCT02952924|566594679|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957373|NCT02952924|566594680|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957374|NCT02952924|566594681|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
156957375|NCT02952924|566594682|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
156957376|NCT02952924|566594661|FG000|Overall Study|Noncompliance with study drug|0|||
156957377|NCT02952924|566594662|FG001|Overall Study|Noncompliance with study drug|0|||
156957378|NCT02952924|566594663|FG002|Overall Study|Noncompliance with study drug|0|||
156957379|NCT02952924|566594664|FG003|Overall Study|Noncompliance with study drug|0|||
156957380|NCT02952924|566594665|FG004|Overall Study|Noncompliance with study drug|0|||
156957381|NCT02952924|566594666|FG005|Overall Study|Noncompliance with study drug|0|||
156957382|NCT02952924|566594667|FG006|Overall Study|Noncompliance with study drug|0|||
156957383|NCT02952924|566594668|FG007|Overall Study|Noncompliance with study drug|0|||
157169859|NCT01054976|567363592|FG000|Overall Study|Uncooperative participations to study|7|||
157169860|NCT01054976|567363592|FG000|Overall Study|Withdrawal by Subject|4|||
157169861|NCT01054976|567363592|FG000|Overall Study|Other|8|||
157169862|NCT01641991|567363593|FG000|Overall Study|Physician Decision|0|||
157169863|NCT01641991|567363594|FG001|Overall Study|Physician Decision|1|||
157169864|NCT01641991|567363595|FG002|Overall Study|Physician Decision|7|||
157169865|NCT01641991|567363596|FG003|Overall Study|Physician Decision|5|||
157169866|NCT01641991|567363593|FG000|Overall Study|Withdrawal by Subject|4|||
157169867|NCT01641991|567363594|FG001|Overall Study|Withdrawal by Subject|2|||
156957384|NCT02952924|566594669|FG008|Overall Study|Noncompliance with study drug|0|||
156957385|NCT02952924|566594670|FG009|Overall Study|Noncompliance with study drug|0|||
156957386|NCT02952924|566594671|FG010|Overall Study|Noncompliance with study drug|0|||
156957387|NCT02952924|566594672|FG011|Overall Study|Noncompliance with study drug|0|||
156957388|NCT02952924|566594673|FG012|Overall Study|Noncompliance with study drug|0|||
156957389|NCT02952924|566594674|FG013|Overall Study|Noncompliance with study drug|0|||
156957390|NCT02952924|566594675|FG014|Overall Study|Noncompliance with study drug|0|||
156957391|NCT02952924|566594676|FG015|Overall Study|Noncompliance with study drug|0|||
156957392|NCT02952924|566594677|FG016|Overall Study|Noncompliance with study drug|0|||
156957393|NCT02952924|566594678|FG017|Overall Study|Noncompliance with study drug|0|||
156957394|NCT02952924|566594679|FG018|Overall Study|Noncompliance with study drug|0|||
156957395|NCT02952924|566594680|FG019|Overall Study|Noncompliance with study drug|0|||
156957396|NCT02952924|566594681|FG020|Overall Study|Noncompliance with study drug|0|||
156957397|NCT02952924|566594682|FG021|Overall Study|Noncompliance with study drug|1|||
156957398|NCT03585244|566594685|FG000|Overall Study|Withdrawal by Subject|15|||
156957399|NCT01934218|566594687|FG000|Double-blind Phase|Adverse Event|8|||
156957400|NCT01934218|566594688|FG001|Double-blind Phase|Adverse Event|8|||
156957401|NCT01934218|566594687|FG000|Double-blind Phase|Lack of Efficacy|6|||
156957402|NCT01934218|566594688|FG001|Double-blind Phase|Lack of Efficacy|7|||
156957403|NCT01934218|566594687|FG000|Double-blind Phase|Lost to Follow-up|7|||
156957404|NCT01934218|566594688|FG001|Double-blind Phase|Lost to Follow-up|14|||
156957405|NCT01934218|566594687|FG000|Double-blind Phase|Physician Decision|1|||
156957406|NCT01934218|566594688|FG001|Double-blind Phase|Physician Decision|2|||
156957407|NCT01934218|566594687|FG000|Double-blind Phase|Protocol Violation|4|||
156957408|NCT01934218|566594688|FG001|Double-blind Phase|Protocol Violation|0|||
156957409|NCT01934218|566594687|FG000|Double-blind Phase|Withdrawal by Subject|16|||
156957410|NCT01934218|566594688|FG001|Double-blind Phase|Withdrawal by Subject|13|||
156957411|NCT01934218|566594687|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
156957412|NCT01934218|566594688|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
156957413|NCT01934218|566594687|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
156957414|NCT01934218|566594688|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
156957415|NCT01934218|566594687|FG000|Open-Label Phase|Adverse Event|2|||
156957416|NCT01934218|566594688|FG001|Open-Label Phase|Adverse Event|4|||
156957417|NCT01934218|566594687|FG000|Open-Label Phase|Lack of Efficacy|1|||
156957418|NCT01934218|566594688|FG001|Open-Label Phase|Lack of Efficacy|4|||
156957419|NCT01934218|566594687|FG000|Open-Label Phase|Lost to Follow-up|4|||
156957420|NCT01934218|566594688|FG001|Open-Label Phase|Lost to Follow-up|2|||
156957421|NCT01934218|566594687|FG000|Open-Label Phase|Physician Decision|1|||
156957422|NCT01934218|566594688|FG001|Open-Label Phase|Physician Decision|0|||
156957423|NCT01934218|566594687|FG000|Open-Label Phase|Protocol Violation|1|||
156957424|NCT01934218|566594688|FG001|Open-Label Phase|Protocol Violation|0|||
156957425|NCT01934218|566594687|FG000|Open-Label Phase|Withdrawal by Subject|13|||
156957426|NCT01934218|566594688|FG001|Open-Label Phase|Withdrawal by Subject|11|||
156957427|NCT01934218|566594687|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
156957428|NCT01934218|566594688|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
156957429|NCT01934218|566594687|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
156957430|NCT01934218|566594688|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
156957431|NCT01090453|566594696|FG000|Overall Study|Withdrawal by Subject|1|||
156957432|NCT01090453|566594697|FG001|Overall Study|Withdrawal by Subject|2|||
156957433|NCT01090453|566594696|FG000|Overall Study|Lost to Follow-up|7|||
156957434|NCT01090453|566594697|FG001|Overall Study|Lost to Follow-up|7|||
156957435|NCT01090453|566594696|FG000|Overall Study|Non serious AEs|1|||
157169868|NCT01641991|567363595|FG002|Overall Study|Withdrawal by Subject|1|||
156957436|NCT01090453|566594697|FG001|Overall Study|Non serious AEs|0|||
156957437|NCT01090453|566594696|FG000|Overall Study|Protocol Violation|2|||
156957438|NCT01090453|566594697|FG001|Overall Study|Protocol Violation|0|||
156957439|NCT01090453|566594696|FG000|Overall Study|Other|2|||
156957440|NCT01090453|566594697|FG001|Overall Study|Other|4|||
156957441|NCT01090453|566594696|FG000|Overall Study|Eligibility Criteria|0|||
156957442|NCT01090453|566594697|FG001|Overall Study|Eligibility Criteria|1|||
156957443|NCT03867734|566594698|FG000|Overall Study|Lost to Follow-up|2|||
156957444|NCT00718718|566594700|FG000|Prior to Week 12|Adverse Event|0|||
156957445|NCT00718718|566594701|FG001|Prior to Week 12|Adverse Event|0|||
157169869|NCT01641991|567363596|FG003|Overall Study|Withdrawal by Subject|5|||
157169870|NCT01641991|567363593|FG000|Overall Study|Adverse Event|2|||
157169871|NCT01641991|567363594|FG001|Overall Study|Adverse Event|1|||
157169872|NCT01641991|567363595|FG002|Overall Study|Adverse Event|2|||
156957446|NCT00718718|566594702|FG002|Prior to Week 12|Adverse Event|0|||
156957447|NCT00718718|566594703|FG003|Prior to Week 12|Adverse Event|0|||
156957448|NCT00718718|566594704|FG004|Prior to Week 12|Adverse Event|0|||
156957449|NCT00718718|566594705|FG005|Prior to Week 12|Adverse Event|0|||
156957450|NCT00718718|566594706|FG006|Prior to Week 12|Adverse Event|0|||
156957451|NCT00718718|566594707|FG007|Prior to Week 12|Adverse Event|1|||
156957452|NCT00718718|566594708|FG008|Prior to Week 12|Adverse Event|1|||
156957453|NCT00718718|566594709|FG009|Prior to Week 12|Adverse Event|0|||
156957454|NCT00718718|566594700|FG000|Prior to Week 12|Withdrawal by Subject|0|||
156957455|NCT00718718|566594701|FG001|Prior to Week 12|Withdrawal by Subject|0|||
156957456|NCT00718718|566594702|FG002|Prior to Week 12|Withdrawal by Subject|0|||
156957457|NCT00718718|566594703|FG003|Prior to Week 12|Withdrawal by Subject|0|||
156957458|NCT00718718|566594704|FG004|Prior to Week 12|Withdrawal by Subject|3|||
156957459|NCT00718718|566594705|FG005|Prior to Week 12|Withdrawal by Subject|0|||
156957460|NCT00718718|566594706|FG006|Prior to Week 12|Withdrawal by Subject|1|||
156957461|NCT00718718|566594707|FG007|Prior to Week 12|Withdrawal by Subject|1|||
156957462|NCT00718718|566594708|FG008|Prior to Week 12|Withdrawal by Subject|1|||
156957463|NCT00718718|566594709|FG009|Prior to Week 12|Withdrawal by Subject|0|||
156957464|NCT00718718|566594700|FG000|Prior to Week 12|Other|1|||
156957465|NCT00718718|566594701|FG001|Prior to Week 12|Other|0|||
156957466|NCT00718718|566594702|FG002|Prior to Week 12|Other|1|||
156957467|NCT00718718|566594703|FG003|Prior to Week 12|Other|0|||
156957468|NCT00718718|566594704|FG004|Prior to Week 12|Other|0|||
156957469|NCT00718718|566594705|FG005|Prior to Week 12|Other|0|||
156957470|NCT00718718|566594706|FG006|Prior to Week 12|Other|0|||
156957471|NCT00718718|566594707|FG007|Prior to Week 12|Other|0|||
156957472|NCT00718718|566594708|FG008|Prior to Week 12|Other|0|||
156957473|NCT00718718|566594709|FG009|Prior to Week 12|Other|0|||
156957474|NCT00718718|566594700|FG000|Week 12 to End of Study|Adverse Event|0|||
156957475|NCT00718718|566594701|FG001|Week 12 to End of Study|Adverse Event|0|||
156957476|NCT00718718|566594702|FG002|Week 12 to End of Study|Adverse Event|0|||
156957477|NCT00718718|566594703|FG003|Week 12 to End of Study|Adverse Event|0|||
156957478|NCT00718718|566594704|FG004|Week 12 to End of Study|Adverse Event|0|||
156957479|NCT00718718|566594705|FG005|Week 12 to End of Study|Adverse Event|0|||
156957480|NCT00718718|566594706|FG006|Week 12 to End of Study|Adverse Event|0|||
156957481|NCT00718718|566594707|FG007|Week 12 to End of Study|Adverse Event|1|||
156957482|NCT00718718|566594708|FG008|Week 12 to End of Study|Adverse Event|0|||
156957483|NCT00718718|566594709|FG009|Week 12 to End of Study|Adverse Event|0|||
156957484|NCT00718718|566594700|FG000|Week 12 to End of Study|Death|0|||
156957485|NCT00718718|566594701|FG001|Week 12 to End of Study|Death|0|||
156957486|NCT00718718|566594702|FG002|Week 12 to End of Study|Death|0|||
156957487|NCT00718718|566594703|FG003|Week 12 to End of Study|Death|0|||
156957488|NCT00718718|566594704|FG004|Week 12 to End of Study|Death|0|||
156957489|NCT00718718|566594705|FG005|Week 12 to End of Study|Death|1|||
156957490|NCT00718718|566594706|FG006|Week 12 to End of Study|Death|0|||
156957491|NCT00718718|566594707|FG007|Week 12 to End of Study|Death|0|||
156957492|NCT00718718|566594708|FG008|Week 12 to End of Study|Death|0|||
156957493|NCT00718718|566594709|FG009|Week 12 to End of Study|Death|0|||
156957494|NCT00718718|566594700|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
156957495|NCT00718718|566594701|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
156957496|NCT00718718|566594702|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
156957497|NCT00718718|566594703|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
156957498|NCT00718718|566594704|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
156957499|NCT00718718|566594705|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
157169873|NCT01641991|567363596|FG003|Overall Study|Adverse Event|1|||
157169874|NCT01641991|567363593|FG000|Overall Study|Lost to Follow-up|0|||
156957500|NCT00718718|566594706|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
156957501|NCT00718718|566594707|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
156957502|NCT00718718|566594708|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
156957503|NCT00718718|566594709|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
156957504|NCT00718718|566594700|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
156957505|NCT00718718|566594701|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
156957506|NCT00718718|566594702|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
156957507|NCT00718718|566594703|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
156957508|NCT00718718|566594704|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
156957509|NCT00718718|566594705|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
156957510|NCT00718718|566594706|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
157037486|NCT03213457|566892545|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
157037487|NCT03213457|566892546|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
156957511|NCT00718718|566594707|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
156957512|NCT00718718|566594708|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
156957513|NCT00718718|566594709|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
156957514|NCT00718718|566594700|FG000|Week 12 to End of Study|Other|0|||
156957515|NCT00718718|566594701|FG001|Week 12 to End of Study|Other|1|||
156957516|NCT00718718|566594702|FG002|Week 12 to End of Study|Other|0|||
156957517|NCT00718718|566594703|FG003|Week 12 to End of Study|Other|1|||
157169875|NCT01641991|567363594|FG001|Overall Study|Lost to Follow-up|2|||
157169876|NCT01641991|567363595|FG002|Overall Study|Lost to Follow-up|3|||
157169877|NCT01641991|567363596|FG003|Overall Study|Lost to Follow-up|1|||
157169878|NCT01641991|567363593|FG000|Overall Study|Protocol Violation|1|||
157169879|NCT01641991|567363594|FG001|Overall Study|Protocol Violation|1|||
157169880|NCT01641991|567363595|FG002|Overall Study|Protocol Violation|3|||
157169881|NCT01641991|567363596|FG003|Overall Study|Protocol Violation|0|||
157227621|NCT00414466|567579125|FG003|Overall Study|Withdrawn by Sponsor|0|||
157227622|NCT04526210|567579126|FG000|Overall Study|Sponsor decision|7|||
157227623|NCT04526210|567579127|FG001|Overall Study|Sponsor decision|5|||
157227624|NCT04526210|567579126|FG000|Overall Study|Withdrawal by Subject|3|||
157227625|NCT04526210|567579127|FG001|Overall Study|Withdrawal by Subject|2|||
157227626|NCT02637232|567579128|FG000|Overall Study|Lost to Follow-up|42|||
157227627|NCT02637232|567579128|FG000|Overall Study|Adverse Event|11|||
157227628|NCT02637232|567579128|FG000|Overall Study|patient 's decision|2|||
157227629|NCT01781637|567579129|FG000|Overall Study|Adverse Event|1|||
157227630|NCT01781637|567579130|FG001|Overall Study|Adverse Event|0|||
157227631|NCT01781637|567579129|FG000|Overall Study|Lack of Efficacy|2|||
157227632|NCT01781637|567579130|FG001|Overall Study|Lack of Efficacy|6|||
157227633|NCT01781637|567579129|FG000|Overall Study|Withdrawal by Subject|1|||
157227634|NCT01781637|567579130|FG001|Overall Study|Withdrawal by Subject|0|||
157227635|NCT00090857|567579132|FG000|Overall Study|Lost to Follow-up|0|||
157227636|NCT00090857|567579133|FG001|Overall Study|Lost to Follow-up|1|||
157227637|NCT00090857|567579132|FG000|Overall Study|Withdrawal by Subject|2|||
157227638|NCT00090857|567579133|FG001|Overall Study|Withdrawal by Subject|0|||
157227639|NCT00090857|567579132|FG000|Overall Study|Adverse Event|2|||
157227640|NCT00090857|567579133|FG001|Overall Study|Adverse Event|2|||
157227641|NCT05097326|567579134|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
157227642|NCT05097326|567579135|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
157227643|NCT03480425|567579137|FG000|Overall Study|Force transducer technical failure|1|||
157227644|NCT01244126|567579138|FG000|Overall Study|Protocol Violation|3|||
157227645|NCT01244126|567579139|FG001|Overall Study|Protocol Violation|3|||
157227646|NCT01244126|567579140|FG002|Overall Study|Protocol Violation|9|||
157227647|NCT00863746|567579144|FG000|Treatment|Not treated|4|||
157227648|NCT00863746|567579145|FG001|Treatment|Not treated|2|||
157227649|NCT00863746|567579144|FG000|Treatment|Adverse Event|41|||
157227650|NCT00863746|567579145|FG001|Treatment|Adverse Event|16|||
157227651|NCT00863746|567579144|FG000|Treatment|non-compliant with study medication|4|||
157227652|NCT00863746|567579145|FG001|Treatment|non-compliant with study medication|0|||
157227653|NCT00863746|567579144|FG000|Treatment|Consent withdrawn|15|||
157227654|NCT00863746|567579145|FG001|Treatment|Consent withdrawn|14|||
157227655|NCT00863746|567579144|FG000|Treatment|Lost to Follow-up|1|||
157227656|NCT00863746|567579145|FG001|Treatment|Lost to Follow-up|0|||
157227657|NCT00863746|567579144|FG000|Treatment|Protocol Violation|5|||
157227658|NCT00863746|567579145|FG001|Treatment|Protocol Violation|3|||
157227659|NCT00863746|567579144|FG000|Treatment|Other|1|||
157227660|NCT00863746|567579145|FG001|Treatment|Other|0|||
157227661|NCT00863746|567579144|FG000|Survival Follow up|Death|244|||
157227662|NCT00863746|567579145|FG001|Survival Follow up|Death|271|||
157227663|NCT00863746|567579144|FG000|Survival Follow up|Lost to Follow-up|2|||
157227664|NCT00863746|567579145|FG001|Survival Follow up|Lost to Follow-up|1|||
157227665|NCT00863746|567579144|FG000|Survival Follow up|Consent Withdrawn|7|||
157227666|NCT00863746|567579145|FG001|Survival Follow up|Consent Withdrawn|8|||
157227667|NCT02395822|567579146|FG000|Overall Study|Withdrawal by Subject|1|||
157227668|NCT02395822|567579146|FG000|Overall Study|Death|1|||
157227669|NCT03292653|567579147|FG000|Overall Study|Adverse Event|0|||
157227670|NCT03292653|567579148|FG001|Overall Study|Adverse Event|0|||
157227671|NCT03292653|567579149|FG002|Overall Study|Adverse Event|1|||
157227672|NCT03292653|567579147|FG000|Overall Study|Did not Receive Treatment|1|||
157227673|NCT03292653|567579148|FG001|Overall Study|Did not Receive Treatment|0|||
157227674|NCT03292653|567579149|FG002|Overall Study|Did not Receive Treatment|0|||
157227675|NCT04720664|567579150|FG000|Overall Study|Adverse Event|2|||
157227676|NCT04720664|567579150|FG000|Overall Study|Lack of Efficacy|9|||
157227677|NCT03311646|567579155|FG000|Overall Study|Physician Decision|1|||
156957518|NCT00718718|566594704|FG004|Week 12 to End of Study|Other|0|||
156957519|NCT00718718|566594705|FG005|Week 12 to End of Study|Other|0|||
156957520|NCT00718718|566594706|FG006|Week 12 to End of Study|Other|1|||
157169882|NCT01641991|567363593|FG000|Overall Study|Pregnancy|0|||
157169883|NCT01641991|567363594|FG001|Overall Study|Pregnancy|0|||
157169884|NCT01641991|567363595|FG002|Overall Study|Pregnancy|1|||
157169885|NCT01641991|567363596|FG003|Overall Study|Pregnancy|0|||
157227678|NCT03311646|567579155|FG000|Overall Study|Withdrawal by Subject|5|||
157227679|NCT03311646|567579155|FG000|Overall Study|Lost to Follow-up|5|||
157227680|NCT03311646|567579155|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
157169886|NCT01641991|567363593|FG000|Overall Study|no longer eligible|2|||
157227681|NCT03103100|567579156|FG000|Overall Study|Adverse Event|1|||
157227682|NCT03103100|567579157|FG001|Overall Study|Adverse Event|0|||
157227683|NCT03103100|567579158|FG002|Overall Study|Adverse Event|0|||
157227684|NCT03103100|567579156|FG000|Overall Study|Physician Decision|1|||
157227685|NCT03103100|567579157|FG001|Overall Study|Physician Decision|0|||
156957521|NCT00718718|566594707|FG007|Week 12 to End of Study|Other|0|||
156957522|NCT00718718|566594708|FG008|Week 12 to End of Study|Other|0|||
156957523|NCT00718718|566594709|FG009|Week 12 to End of Study|Other|0|||
156957524|NCT02276482|566594712|FG000|Overall Study|Adverse Event|1|||
156957525|NCT02276482|566594713|FG001|Overall Study|Adverse Event|0|||
156957526|NCT02276482|566594712|FG000|Overall Study|Withdrawal by Subject|1|||
156957527|NCT02276482|566594713|FG001|Overall Study|Withdrawal by Subject|0|||
156957528|NCT02276482|566594712|FG000|Overall Study|Gram-negative infection|1|||
156957529|NCT02276482|566594713|FG001|Overall Study|Gram-negative infection|0|||
156957530|NCT02276482|566594712|FG000|Overall Study|Reason not specified|0|||
156957531|NCT02276482|566594713|FG001|Overall Study|Reason not specified|1|||
156957532|NCT01218438|566594714|FG000|Epoch 1|Physician Decision|2|||
156957533|NCT01218438|566594714|FG000|Epoch 1|Adverse Event|1|||
156957534|NCT01218438|566594714|FG000|Epoch 3|Withdrawal by Subject|3|||
156957535|NCT01218438|566594714|FG000|Epoch 3|Adverse Event|1|||
156957536|NCT01218438|566594714|FG000|Epoch 4|Physician Decision|1|||
156957537|NCT01218438|566594714|FG000|Epoch 4|Withdrawal by Subject|2|||
156957538|NCT03096782|566594718|FG000|Overall Study|Death|1|||
156957539|NCT03096782|566594718|FG000|Overall Study|Participant Relapsed|1|||
156957540|NCT03156023|566594719|FG000|Overall Study|Withdrawal by Subject|1|||
156957541|NCT03156023|566594720|FG001|Overall Study|Withdrawal by Subject|0|||
156957542|NCT03156023|566594721|FG002|Overall Study|Withdrawal by Subject|2|||
156957543|NCT03156023|566594722|FG003|Overall Study|Withdrawal by Subject|1|||
156957544|NCT03156023|566594723|FG004|Overall Study|Withdrawal by Subject|1|||
156957545|NCT03156023|566594719|FG000|Overall Study|Lost to Follow-up|0|||
156957546|NCT03156023|566594720|FG001|Overall Study|Lost to Follow-up|0|||
156957547|NCT03156023|566594721|FG002|Overall Study|Lost to Follow-up|0|||
156957548|NCT03156023|566594722|FG003|Overall Study|Lost to Follow-up|0|||
156957549|NCT03156023|566594723|FG004|Overall Study|Lost to Follow-up|1|||
156957550|NCT02075593|566594724|FG000|Overall Study|Withdrawal by Subject|1|||
156957551|NCT05819749|566594729|FG000|Overall Study|Lost to Follow-up|1|||
156957552|NCT00844857|566597212|FG000|Overall Study|Adverse Event|24|||
156957553|NCT00844857|566597213|FG001|Overall Study|Adverse Event|5|||
156957554|NCT00844857|566597212|FG000|Overall Study|Sponsor Decision|1|||
156957555|NCT00844857|566597213|FG001|Overall Study|Sponsor Decision|1|||
156957556|NCT00844857|566597212|FG000|Overall Study|Physician Decision|2|||
156957557|NCT00844857|566597213|FG001|Overall Study|Physician Decision|0|||
156957558|NCT00844857|566597212|FG000|Overall Study|Parent/Caregiver Decision|6|||
156957559|NCT00844857|566597213|FG001|Overall Study|Parent/Caregiver Decision|2|||
156957560|NCT00844857|566597212|FG000|Overall Study|Withdrawal by Subject|8|||
156957561|NCT00844857|566597213|FG001|Overall Study|Withdrawal by Subject|7|||
156957562|NCT00844857|566597212|FG000|Overall Study|Protocol Violation|6|||
156957563|NCT00844857|566597213|FG001|Overall Study|Protocol Violation|0|||
156957564|NCT00844857|566597212|FG000|Overall Study|Lack of Efficacy|5|||
156957565|NCT00844857|566597213|FG001|Overall Study|Lack of Efficacy|5|||
156957566|NCT00844857|566597212|FG000|Overall Study|Clinical Relapse|0|||
156957567|NCT00844857|566597213|FG001|Overall Study|Clinical Relapse|1|||
156957568|NCT00844857|566597212|FG000|Overall Study|Entry Criteria Not Met|0|||
156957569|NCT00844857|566597213|FG001|Overall Study|Entry Criteria Not Met|1|||
156957570|NCT00844857|566597212|FG000|Overall Study|Lost to Follow-up|2|||
156957571|NCT00844857|566597213|FG001|Overall Study|Lost to Follow-up|3|||
156957572|NCT00844857|566597212|FG000|Overall Study|Did Not Take Study Drug|3|||
156957573|NCT00844857|566597213|FG001|Overall Study|Did Not Take Study Drug|1|||
156957574|NCT00844857|566597212|FG000|Overall Study|Good Clinical Practice Violations|21|||
156957575|NCT00844857|566597213|FG001|Overall Study|Good Clinical Practice Violations|11|||
156957576|NCT00570674|566597214|FG000|Overall Study|Withdrawal by Subject|0|||
156957577|NCT00570674|566597215|FG001|Overall Study|Withdrawal by Subject|0|||
156957578|NCT00570674|566597216|FG002|Overall Study|Withdrawal by Subject|1|||
156957579|NCT00570674|566597217|FG003|Overall Study|Withdrawal by Subject|0|||
156957580|NCT00570674|566597218|FG004|Overall Study|Withdrawal by Subject|0|||
156957581|NCT00570674|566597219|FG005|Overall Study|Withdrawal by Subject|0|||
156957582|NCT00570674|566597220|FG006|Overall Study|Withdrawal by Subject|0|||
156957583|NCT03069482|566597221|FG000|Overall Study|Lost to Follow-up|0|||
156957584|NCT03069482|566597222|FG001|Overall Study|Lost to Follow-up|1|||
156957585|NCT03069482|566597221|FG000|Overall Study|Physician Decision|1|||
156957586|NCT03069482|566597222|FG001|Overall Study|Physician Decision|0|||
156957587|NCT01912612|566597231|FG000|Overall Study|Adverse Event|4|||
156957588|NCT01912612|566597232|FG001|Overall Study|Adverse Event|0|||
156957589|NCT01912612|566597233|FG002|Overall Study|Adverse Event|0|||
156957590|NCT01912612|566597231|FG000|Overall Study|Withdrew consent|1|||
156957591|NCT01912612|566597232|FG001|Overall Study|Withdrew consent|0|||
156957592|NCT01912612|566597233|FG002|Overall Study|Withdrew consent|0|||
156957593|NCT01912612|566597231|FG000|Overall Study|Study design change|0|||
156957594|NCT01912612|566597232|FG001|Overall Study|Study design change|0|||
156957595|NCT01912612|566597233|FG002|Overall Study|Study design change|3|||
156957596|NCT02349295|566597238|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
156957597|NCT02349295|566597239|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
156957598|NCT02349295|566597240|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
157169887|NCT01641991|567363594|FG001|Overall Study|no longer eligible|1|||
157169888|NCT01641991|567363595|FG002|Overall Study|no longer eligible|0|||
157169889|NCT01641991|567363596|FG003|Overall Study|no longer eligible|4|||
157169890|NCT01763866|567363599|FG000|Overall Study|Withdrawal by Subject|2|||
157169891|NCT01763866|567363600|FG001|Overall Study|Withdrawal by Subject|1|||
157169892|NCT01763866|567363601|FG002|Overall Study|Withdrawal by Subject|4|||
157169893|NCT01763866|567363602|FG003|Overall Study|Withdrawal by Subject|0|||
157169894|NCT01763866|567363603|FG004|Overall Study|Withdrawal by Subject|0|||
157169895|NCT01763866|567363604|FG005|Overall Study|Withdrawal by Subject|3|||
157169896|NCT01763866|567363605|FG006|Overall Study|Withdrawal by Subject|4|||
157169897|NCT01763866|567363606|FG007|Overall Study|Withdrawal by Subject|0|||
157169898|NCT01763866|567363607|FG008|Overall Study|Withdrawal by Subject|1|||
157169899|NCT01763866|567363608|FG009|Overall Study|Withdrawal by Subject|1|||
157169900|NCT01763866|567363609|FG010|Overall Study|Withdrawal by Subject|2|||
157169901|NCT01763866|567363610|FG011|Overall Study|Withdrawal by Subject|2|||
157169902|NCT01763866|567363611|FG012|Overall Study|Withdrawal by Subject|2|||
157169903|NCT01763866|567363612|FG013|Overall Study|Withdrawal by Subject|0|||
157169904|NCT01763866|567363613|FG014|Overall Study|Withdrawal by Subject|6|||
157169905|NCT01763866|567363614|FG015|Overall Study|Withdrawal by Subject|3|||
157169906|NCT01763866|567363615|FG016|Overall Study|Withdrawal by Subject|0|||
157169907|NCT01763866|567363616|FG017|Overall Study|Withdrawal by Subject|1|||
157169908|NCT01763866|567363617|FG018|Overall Study|Withdrawal by Subject|1|||
157169909|NCT01763866|567363618|FG019|Overall Study|Withdrawal by Subject|1|||
157169910|NCT01763866|567363619|FG020|Overall Study|Withdrawal by Subject|2|||
157169911|NCT01763866|567363620|FG021|Overall Study|Withdrawal by Subject|1|||
157169912|NCT01763866|567363621|FG022|Overall Study|Withdrawal by Subject|2|||
157169913|NCT01763866|567363622|FG023|Overall Study|Withdrawal by Subject|1|||
157169914|NCT01763866|567363599|FG000|Overall Study|Decision by sponsor|0|||
157169915|NCT01763866|567363600|FG001|Overall Study|Decision by sponsor|0|||
157169916|NCT01763866|567363601|FG002|Overall Study|Decision by sponsor|1|||
157169917|NCT01763866|567363602|FG003|Overall Study|Decision by sponsor|0|||
157169918|NCT01763866|567363603|FG004|Overall Study|Decision by sponsor|2|||
157169919|NCT01763866|567363604|FG005|Overall Study|Decision by sponsor|0|||
157169920|NCT01763866|567363605|FG006|Overall Study|Decision by sponsor|2|||
157169921|NCT01763866|567363606|FG007|Overall Study|Decision by sponsor|0|||
157169922|NCT01763866|567363607|FG008|Overall Study|Decision by sponsor|2|||
157169923|NCT01763866|567363608|FG009|Overall Study|Decision by sponsor|0|||
157169924|NCT01763866|567363609|FG010|Overall Study|Decision by sponsor|6|||
157169925|NCT01763866|567363610|FG011|Overall Study|Decision by sponsor|0|||
157169926|NCT01763866|567363611|FG012|Overall Study|Decision by sponsor|1|||
157169927|NCT01763866|567363612|FG013|Overall Study|Decision by sponsor|0|||
157169928|NCT01763866|567363613|FG014|Overall Study|Decision by sponsor|5|||
157169929|NCT01763866|567363614|FG015|Overall Study|Decision by sponsor|0|||
157169930|NCT01763866|567363615|FG016|Overall Study|Decision by sponsor|0|||
157169931|NCT01763866|567363616|FG017|Overall Study|Decision by sponsor|0|||
157169932|NCT01763866|567363617|FG018|Overall Study|Decision by sponsor|4|||
157169933|NCT01763866|567363618|FG019|Overall Study|Decision by sponsor|0|||
157169934|NCT01763866|567363619|FG020|Overall Study|Decision by sponsor|2|||
157169935|NCT01763866|567363620|FG021|Overall Study|Decision by sponsor|0|||
157169936|NCT01763866|567363621|FG022|Overall Study|Decision by sponsor|1|||
157169937|NCT01763866|567363622|FG023|Overall Study|Decision by sponsor|0|||
157169938|NCT01763866|567363599|FG000|Overall Study|Lost to Follow-up|0|||
157169939|NCT01763866|567363600|FG001|Overall Study|Lost to Follow-up|0|||
157169940|NCT01763866|567363601|FG002|Overall Study|Lost to Follow-up|0|||
157169941|NCT01763866|567363602|FG003|Overall Study|Lost to Follow-up|0|||
157169942|NCT01763866|567363603|FG004|Overall Study|Lost to Follow-up|0|||
157169943|NCT01763866|567363604|FG005|Overall Study|Lost to Follow-up|0|||
156957599|NCT02349295|566597241|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957600|NCT02349295|566597242|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957601|NCT02349295|566597243|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957602|NCT02349295|566597244|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
157169944|NCT01763866|567363605|FG006|Overall Study|Lost to Follow-up|1|||
157169945|NCT01763866|567363606|FG007|Overall Study|Lost to Follow-up|0|||
157169946|NCT01763866|567363607|FG008|Overall Study|Lost to Follow-up|0|||
157169947|NCT01763866|567363608|FG009|Overall Study|Lost to Follow-up|0|||
157169948|NCT01763866|567363609|FG010|Overall Study|Lost to Follow-up|0|||
157169949|NCT01763866|567363610|FG011|Overall Study|Lost to Follow-up|0|||
157169950|NCT01763866|567363611|FG012|Overall Study|Lost to Follow-up|1|||
157169951|NCT01763866|567363612|FG013|Overall Study|Lost to Follow-up|0|||
157169952|NCT01763866|567363613|FG014|Overall Study|Lost to Follow-up|1|||
157169953|NCT01763866|567363614|FG015|Overall Study|Lost to Follow-up|0|||
157169954|NCT01763866|567363615|FG016|Overall Study|Lost to Follow-up|0|||
157169955|NCT01763866|567363616|FG017|Overall Study|Lost to Follow-up|0|||
157169956|NCT01763866|567363617|FG018|Overall Study|Lost to Follow-up|1|||
157169957|NCT01763866|567363618|FG019|Overall Study|Lost to Follow-up|1|||
157169958|NCT01763866|567363619|FG020|Overall Study|Lost to Follow-up|0|||
157169959|NCT01763866|567363620|FG021|Overall Study|Lost to Follow-up|0|||
157169960|NCT01763866|567363621|FG022|Overall Study|Lost to Follow-up|0|||
157169961|NCT01763866|567363622|FG023|Overall Study|Lost to Follow-up|1|||
157169962|NCT01763866|567363599|FG000|Overall Study|Death|0|||
157169963|NCT01763866|567363600|FG001|Overall Study|Death|0|||
157169964|NCT01763866|567363601|FG002|Overall Study|Death|0|||
157169965|NCT01763866|567363602|FG003|Overall Study|Death|0|||
157169966|NCT01763866|567363603|FG004|Overall Study|Death|0|||
157169967|NCT01763866|567363604|FG005|Overall Study|Death|0|||
157169968|NCT01763866|567363605|FG006|Overall Study|Death|0|||
157169969|NCT01763866|567363606|FG007|Overall Study|Death|0|||
157169970|NCT01763866|567363607|FG008|Overall Study|Death|0|||
157169971|NCT01763866|567363608|FG009|Overall Study|Death|0|||
157169972|NCT01763866|567363609|FG010|Overall Study|Death|0|||
157169973|NCT01763866|567363610|FG011|Overall Study|Death|0|||
157169974|NCT01763866|567363611|FG012|Overall Study|Death|0|||
157169975|NCT01763866|567363612|FG013|Overall Study|Death|0|||
157169976|NCT01763866|567363613|FG014|Overall Study|Death|0|||
157169977|NCT01763866|567363614|FG015|Overall Study|Death|0|||
156957603|NCT02349295|566597245|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957604|NCT02349295|566597246|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957605|NCT02349295|566597247|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957606|NCT02349295|566597248|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957607|NCT02349295|566597249|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957608|NCT02349295|566597250|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957609|NCT02349295|566597251|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
156957610|NCT02349295|566597238|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
156957611|NCT02349295|566597239|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
156957612|NCT02349295|566597240|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
156957613|NCT02349295|566597241|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957614|NCT02349295|566597242|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957615|NCT02349295|566597243|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957616|NCT02349295|566597244|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957617|NCT02349295|566597245|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957618|NCT02349295|566597246|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957619|NCT02349295|566597247|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957620|NCT02349295|566597248|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957621|NCT02349295|566597249|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957622|NCT02349295|566597250|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957623|NCT02349295|566597251|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
156957624|NCT02349295|566597238|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
156957625|NCT02349295|566597239|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
156957626|NCT02349295|566597240|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
156957627|NCT02349295|566597241|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957628|NCT02349295|566597242|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957629|NCT02349295|566597243|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957630|NCT02349295|566597244|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957631|NCT02349295|566597245|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957632|NCT02349295|566597246|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957633|NCT02349295|566597247|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957634|NCT02349295|566597248|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957635|NCT02349295|566597249|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957636|NCT02349295|566597250|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957637|NCT02349295|566597251|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
156957638|NCT02349295|566597238|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
156957639|NCT02349295|566597239|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
156957640|NCT02349295|566597240|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
156957641|NCT02349295|566597241|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957642|NCT02349295|566597242|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957643|NCT02349295|566597243|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957644|NCT02349295|566597244|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957645|NCT02349295|566597245|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957646|NCT02349295|566597246|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957647|NCT02349295|566597247|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957648|NCT02349295|566597248|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
157169978|NCT01763866|567363615|FG016|Overall Study|Death|1|||
157169979|NCT01763866|567363616|FG017|Overall Study|Death|0|||
157169980|NCT01763866|567363617|FG018|Overall Study|Death|0|||
157169981|NCT01763866|567363618|FG019|Overall Study|Death|0|||
157169982|NCT01763866|567363619|FG020|Overall Study|Death|0|||
157169983|NCT01763866|567363620|FG021|Overall Study|Death|0|||
157169984|NCT01763866|567363621|FG022|Overall Study|Death|0|||
157169985|NCT01763866|567363622|FG023|Overall Study|Death|0|||
157169986|NCT01164865|567363632|FG000|Overall Study|Lost to Follow-up|2|||
157169987|NCT01164865|567363633|FG001|Overall Study|Lost to Follow-up|1|||
157169988|NCT00475540|567363634|FG000|36 Months|Lost to Follow-up|4|||
157169989|NCT00475540|567363635|FG001|36 Months|Lost to Follow-up|4|||
157169990|NCT00475540|567363634|FG000|36 Months|Death|1|||
157169991|NCT00475540|567363635|FG001|36 Months|Death|2|||
157169992|NCT00475540|567363634|FG000|36 Months|Censored due to reoperation|3|||
157169993|NCT00475540|567363635|FG001|36 Months|Censored due to reoperation|0|||
157169994|NCT00377429|567363636|FG000|Overall Study|Withdrawal by Subject|5|||
157169995|NCT00377429|567363636|FG000|Overall Study|Adverse Event|8|||
157169996|NCT00377429|567363636|FG000|Overall Study|Physician Decision|1|||
157169997|NCT00377429|567363636|FG000|Overall Study|Patient non-compliance|1|||
157169998|NCT02394795|567363639|FG000|Overall Study|Adverse Event|92|||
157169999|NCT02394795|567363640|FG001|Overall Study|Adverse Event|70|||
157170000|NCT02394795|567363639|FG000|Overall Study|Lost to Follow-up|0|||
157170001|NCT02394795|567363640|FG001|Overall Study|Lost to Follow-up|1|||
156957649|NCT02349295|566597249|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957650|NCT02349295|566597250|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957651|NCT02349295|566597251|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
156957652|NCT02349295|566597238|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957653|NCT02349295|566597239|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
156957654|NCT02349295|566597240|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
156957655|NCT02349295|566597241|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957656|NCT02349295|566597242|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957657|NCT02349295|566597243|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957658|NCT02349295|566597244|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957659|NCT02349295|566597245|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957660|NCT02349295|566597246|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957661|NCT02349295|566597247|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957662|NCT02349295|566597248|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957663|NCT02349295|566597249|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957664|NCT02349295|566597250|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957665|NCT02349295|566597251|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
156957666|NCT02349295|566597238|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
156957667|NCT02349295|566597239|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
156957668|NCT02349295|566597240|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
156957669|NCT02349295|566597241|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
156957670|NCT02349295|566597242|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
156957671|NCT02349295|566597243|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
156957672|NCT02349295|566597244|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
156957673|NCT02349295|566597245|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
156957674|NCT02349295|566597246|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
156957675|NCT02349295|566597247|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
156957676|NCT02349295|566597248|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
156957677|NCT02349295|566597249|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
156957678|NCT02349295|566597250|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
156957679|NCT02349295|566597251|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
156957680|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957681|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957682|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957683|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957684|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957685|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957686|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957687|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
156957688|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
156957689|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
156957690|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
156957691|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957692|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957693|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
156957694|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957695|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957696|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957697|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957698|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957699|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957700|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
157170002|NCT02394795|567363639|FG000|Overall Study|Withdrawal by Subject|17|||
157170003|NCT02394795|567363640|FG001|Overall Study|Withdrawal by Subject|26|||
157170004|NCT02394795|567363639|FG000|Overall Study|Lack of Efficacy|181|||
157170005|NCT02394795|567363640|FG001|Overall Study|Lack of Efficacy|211|||
157170006|NCT02394795|567363639|FG000|Overall Study|Death|4|||
157170007|NCT02394795|567363640|FG001|Overall Study|Death|5|||
157170008|NCT02394795|567363639|FG000|Overall Study|Physician Decision|109|||
157170009|NCT02394795|567363640|FG001|Overall Study|Physician Decision|93|||
157170010|NCT02939599|567363642|FG000|Overall Study|Adverse Event|1|||
157170011|NCT02939599|567363643|FG001|Overall Study|Adverse Event|0|||
157170012|NCT02939599|567363642|FG000|Overall Study|Study Terminated By Sponsor|2|||
157170013|NCT02939599|567363643|FG001|Overall Study|Study Terminated By Sponsor|2|||
157170014|NCT01669811|567363644|FG000|Overall Study|Investigator decision|0|||
157170015|NCT01669811|567363645|FG001|Overall Study|Investigator decision|1|||
157170016|NCT01669811|567363644|FG000|Overall Study|Withdrawal by Subject|1|||
157170017|NCT01669811|567363645|FG001|Overall Study|Withdrawal by Subject|2|||
157170018|NCT01669811|567363644|FG000|Overall Study|Adverse Event|2|||
157170019|NCT01669811|567363645|FG001|Overall Study|Adverse Event|6|||
157170020|NCT01669811|567363644|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
157170021|NCT01669811|567363645|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
157170022|NCT04507776|567365118|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
157170023|NCT03628599|567365119|FG000|Overall Study|Adverse Event|0|||
157170024|NCT03628599|567365120|FG001|Overall Study|Adverse Event|1|||
157170025|NCT01136746|567365123|FG000|Overall Study|Lost to Follow-up|0|||
157170026|NCT01136746|567365124|FG001|Overall Study|Lost to Follow-up|2|||
157170027|NCT01136746|567365123|FG000|Overall Study|Protocol Violation|2|||
157170028|NCT01136746|567365124|FG001|Overall Study|Protocol Violation|1|||
157170029|NCT01136746|567365123|FG000|Overall Study|Death|1|||
157170030|NCT01136746|567365124|FG001|Overall Study|Death|0|||
157170031|NCT00092677|567365125|FG000|Overall Study|Lost to Follow-up|0|||
157170032|NCT00092677|567365126|FG001|Overall Study|Lost to Follow-up|2|||
157170033|NCT00092677|567365125|FG000|Overall Study|Adminstrative|5|||
157170034|NCT00092677|567365126|FG001|Overall Study|Adminstrative|9|||
157170035|NCT04624672|567365127|FG000|Overall Study|Early Study Closure|2|||
157170036|NCT04624672|567365128|FG001|Overall Study|Early Study Closure|1|||
157170037|NCT00010803|567365139|FG000|Overall Study|Withdrawal by Subject|97|||
157170038|NCT00010803|567365140|FG001|Overall Study|Withdrawal by Subject|98|||
157170039|NCT05905601|567365141|FG000|Overall Study|Lost to Follow-up|1|||
157170040|NCT05905601|567365142|FG001|Overall Study|Lost to Follow-up|3|||
157170041|NCT03024255|567365143|FG000|Overall Study|Adverse Event|1|||
157170042|NCT03024255|567365144|FG001|Overall Study|Adverse Event|4|||
157170043|NCT03024255|567365145|FG002|Overall Study|Adverse Event|8|||
157170044|NCT03024255|567365146|FG003|Overall Study|Adverse Event|0|||
157170045|NCT03024255|567365143|FG000|Overall Study|Withdrawal by Subject|3|||
157170046|NCT03024255|567365144|FG001|Overall Study|Withdrawal by Subject|1|||
157170047|NCT03024255|567365145|FG002|Overall Study|Withdrawal by Subject|0|||
157170048|NCT03024255|567365146|FG003|Overall Study|Withdrawal by Subject|3|||
157170049|NCT03024255|567365143|FG000|Overall Study|Protocol Violation|0|||
157170050|NCT03024255|567365144|FG001|Overall Study|Protocol Violation|0|||
157170051|NCT03024255|567365145|FG002|Overall Study|Protocol Violation|2|||
157170052|NCT03024255|567365146|FG003|Overall Study|Protocol Violation|0|||
157170053|NCT03024255|567365143|FG000|Overall Study|Lost to Follow-up|1|||
157170054|NCT03024255|567365144|FG001|Overall Study|Lost to Follow-up|2|||
157170055|NCT03024255|567365145|FG002|Overall Study|Lost to Follow-up|1|||
156957701|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
156957702|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
156957703|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
156957704|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
156957705|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957706|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957707|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
156957708|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957709|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
157170056|NCT03024255|567365146|FG003|Overall Study|Lost to Follow-up|1|||
157170057|NCT03024255|567365143|FG000|Overall Study|Lack of Efficacy|1|||
156957710|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
157170058|NCT03024255|567365144|FG001|Overall Study|Lack of Efficacy|0|||
157170059|NCT03024255|567365145|FG002|Overall Study|Lack of Efficacy|0|||
157170060|NCT03024255|567365146|FG003|Overall Study|Lack of Efficacy|0|||
157170061|NCT03024255|567365143|FG000|Overall Study|Protocol Noncompliance|1|||
157170062|NCT03024255|567365144|FG001|Overall Study|Protocol Noncompliance|1|||
157170063|NCT03024255|567365145|FG002|Overall Study|Protocol Noncompliance|0|||
157170064|NCT03024255|567365146|FG003|Overall Study|Protocol Noncompliance|1|||
157170065|NCT01415908|567365147|FG000|Overall Study|Withdrawal by Subject|1|||
157170066|NCT01415908|567365148|FG001|Overall Study|Withdrawal by Subject|0|||
157170067|NCT02685995|567365151|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
157170068|NCT02685995|567365152|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
157170069|NCT01188096|567365154|FG000|Overall Study|progression of disease|4|||
157170070|NCT01188096|567365154|FG000|Overall Study|Withdrawal by Subject|2|||
157170071|NCT02384395|567365155|FG000|Overall Study|Physician Decision|4|||
157170072|NCT02384395|567365155|FG000|Overall Study|Withdrawal by Subject|3|||
157170073|NCT02384395|567365155|FG000|Overall Study|Lost to Follow-up|3|||
157170074|NCT01779648|567365156|FG000|Overall Study|Protocol Violation|1|||
157170075|NCT01779648|567365157|FG001|Overall Study|Protocol Violation|0|||
157170076|NCT01797445|567365158|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
157170077|NCT01797445|567365159|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
157170078|NCT01797445|567365158|FG000|Double-Blind Phase|Adverse Event|3|||
157170079|NCT01797445|567365159|FG001|Double-Blind Phase|Adverse Event|0|||
157170080|NCT01797445|567365158|FG000|Double-Blind Phase|Death|5|||
157170081|NCT01797445|567365159|FG001|Double-Blind Phase|Death|4|||
157170082|NCT01797445|567365158|FG000|Double-Blind Phase|Pregnancy|0|||
157170083|NCT01797445|567365159|FG001|Double-Blind Phase|Pregnancy|1|||
157170084|NCT01797445|567365158|FG000|Double-Blind Phase|Lack of Efficacy|1|||
156957711|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957712|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957713|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957714|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957715|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
156957716|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957717|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
156957718|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957719|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957720|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957721|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
156957722|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
156957723|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
156957724|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
156957725|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
156957726|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
156957727|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
156957728|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
156957729|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
156957730|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
156957731|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
156957732|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
156957733|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
156957734|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
156957735|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
156957736|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957737|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957738|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957739|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957740|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957741|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957742|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957743|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
156957744|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
156957745|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
156957746|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
156957747|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957748|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957749|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
156957750|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957751|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957752|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957753|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957754|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957755|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957756|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957757|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
156957758|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
156957759|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957760|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957761|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957762|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
157170085|NCT01797445|567365159|FG001|Double-Blind Phase|Lack of Efficacy|2|||
157170086|NCT01797445|567365158|FG000|Double-Blind Phase|Investigator's Discretion|15|||
157170087|NCT01797445|567365159|FG001|Double-Blind Phase|Investigator's Discretion|17|||
157170088|NCT01797445|567365158|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
157170089|NCT01797445|567365159|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
157170090|NCT01797445|567365158|FG000|Double-Blind Phase|Protocol Violation|0|||
157170091|NCT01797445|567365159|FG001|Double-Blind Phase|Protocol Violation|1|||
157170092|NCT01797445|567365158|FG000|Double-Blind Phase|Withdrew Consent|20|||
157170093|NCT01797445|567365159|FG001|Double-Blind Phase|Withdrew Consent|35|||
157170094|NCT01797445|567365158|FG000|Double-Blind Phase|Lost to Follow-up|34|||
157170095|NCT01797445|567365159|FG001|Double-Blind Phase|Lost to Follow-up|26|||
157170096|NCT01797445|567365158|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
157170097|NCT01797445|567365159|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
157170098|NCT00688545|567365160|FG000|Overall Study|Lost to Follow-up|1|||
157170099|NCT00688545|567365161|FG001|Overall Study|Lost to Follow-up|4|||
157170100|NCT00688545|567365160|FG000|Overall Study|Insurance/cost of drug|0|||
157170101|NCT00688545|567365161|FG001|Overall Study|Insurance/cost of drug|1|||
157170102|NCT00688545|567365160|FG000|Overall Study|Withdrawal by Subject|2|||
157170103|NCT00688545|567365161|FG001|Overall Study|Withdrawal by Subject|3|||
157170104|NCT00688545|567365160|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
157170105|NCT00688545|567365161|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
156957763|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
156957764|NCT02349295|566597238|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957765|NCT02349295|566597239|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957766|NCT02349295|566597240|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957767|NCT02349295|566597241|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957768|NCT02349295|566597242|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957769|NCT02349295|566597243|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957770|NCT02349295|566597244|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957771|NCT02349295|566597245|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
156957772|NCT02349295|566597246|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
156957773|NCT02349295|566597247|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957774|NCT02349295|566597248|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957775|NCT02349295|566597249|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957776|NCT02349295|566597250|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957777|NCT02349295|566597251|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
156957778|NCT02349295|566597238|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957779|NCT02349295|566597239|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957780|NCT02349295|566597240|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957781|NCT02349295|566597241|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957782|NCT02349295|566597242|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957783|NCT02349295|566597243|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957784|NCT02349295|566597244|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957785|NCT02349295|566597245|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957786|NCT02349295|566597246|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957787|NCT02349295|566597247|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957788|NCT02349295|566597248|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
156957789|NCT02349295|566597249|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
156957790|NCT02349295|566597250|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
156957791|NCT02349295|566597251|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
156957792|NCT02349295|566597238|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957793|NCT02349295|566597239|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957794|NCT02349295|566597240|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957795|NCT02349295|566597241|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957796|NCT02349295|566597242|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957797|NCT02349295|566597243|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957798|NCT02349295|566597244|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957799|NCT02349295|566597245|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957800|NCT02349295|566597246|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957801|NCT02349295|566597247|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957802|NCT02349295|566597248|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957803|NCT02349295|566597249|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
156957804|NCT02349295|566597250|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
156957805|NCT02349295|566597251|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
156957806|NCT02349295|566597238|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
157170106|NCT01878097|567365164|FG000|Baseline|Surveys not fully completed|2497|||
157170107|NCT01878097|567365165|FG001|Baseline|Surveys not fully completed|1800|||
157227686|NCT03103100|567579158|FG002|Overall Study|Physician Decision|2|||
157170108|NCT01878097|567365164|FG000|Implementation Year 1|Surveys not fully completed|3202|||
157170109|NCT01878097|567365165|FG001|Implementation Year 1|Surveys not fully completed|2549|||
156957807|NCT02349295|566597239|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957808|NCT02349295|566597240|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957809|NCT02349295|566597241|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957810|NCT02349295|566597242|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957811|NCT02349295|566597243|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957812|NCT02349295|566597244|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957813|NCT02349295|566597245|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957814|NCT02349295|566597246|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957815|NCT02349295|566597247|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957816|NCT02349295|566597248|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957817|NCT02349295|566597249|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
156957818|NCT02349295|566597250|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
156957819|NCT02349295|566597251|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
156957820|NCT02349295|566597238|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957821|NCT02349295|566597239|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957822|NCT02349295|566597240|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957823|NCT02349295|566597241|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957824|NCT02349295|566597242|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957825|NCT02349295|566597243|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957826|NCT02349295|566597244|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957827|NCT02349295|566597245|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957828|NCT02349295|566597246|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957829|NCT02349295|566597247|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957830|NCT02349295|566597248|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957831|NCT02349295|566597249|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
156957832|NCT02349295|566597250|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957833|NCT02349295|566597251|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
156957834|NCT02349295|566597238|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957835|NCT02349295|566597239|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957836|NCT02349295|566597240|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957837|NCT02349295|566597241|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957838|NCT02349295|566597242|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957839|NCT02349295|566597243|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957840|NCT02349295|566597244|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957841|NCT02349295|566597245|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957842|NCT02349295|566597246|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957843|NCT02349295|566597247|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957844|NCT02349295|566597248|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957845|NCT02349295|566597249|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
156957846|NCT02349295|566597250|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957847|NCT02349295|566597251|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
156957848|NCT01259713|566597254|FG000|Overall Study|Adverse Event|54|||
156957849|NCT01259713|566597255|FG001|Overall Study|Adverse Event|23|||
156957850|NCT01259713|566597254|FG000|Overall Study|Death Not Related to IFI|8|||
156957851|NCT01259713|566597255|FG001|Overall Study|Death Not Related to IFI|1|||
156957852|NCT01259713|566597254|FG000|Overall Study|Investigators Discretion|14|||
156957853|NCT01259713|566597255|FG001|Overall Study|Investigators Discretion|6|||
156957854|NCT01259713|566597254|FG000|Overall Study|Lack of Efficacy|2|||
156957855|NCT01259713|566597255|FG001|Overall Study|Lack of Efficacy|0|||
156957856|NCT01259713|566597254|FG000|Overall Study|Protocol Violation|5|||
156957857|NCT01259713|566597255|FG001|Overall Study|Protocol Violation|4|||
156957858|NCT01259713|566597254|FG000|Overall Study|Subject Withdrew Consent|12|||
156957859|NCT01259713|566597255|FG001|Overall Study|Subject Withdrew Consent|7|||
156957860|NCT02091726|566597256|FG000|Overall Study|Lost to Follow-up|6|||
156957861|NCT06111742|566597263|FG000|Overall Study|Did not receive intervention|1|||
156957862|NCT06111742|566597264|FG001|Overall Study|Did not receive intervention|0|||
156957863|NCT06111742|566597265|FG002|Overall Study|Did not receive intervention|0|||
156957864|NCT06111742|566597263|FG000|Overall Study|Withdrawal by Subject|2|||
156957865|NCT06111742|566597264|FG001|Overall Study|Withdrawal by Subject|0|||
156957866|NCT06111742|566597265|FG002|Overall Study|Withdrawal by Subject|0|||
156957867|NCT03461003|566597266|FG000|Overall Study|Lost to Follow-up|2|||
156957868|NCT03461003|566597267|FG001|Overall Study|Lost to Follow-up|2|||
156957869|NCT03461003|566597266|FG000|Overall Study|Withdrawal by Subject|3|||
156957870|NCT03461003|566597267|FG001|Overall Study|Withdrawal by Subject|1|||
156957871|NCT00620750|566597273|FG000|Overall Study|Lost to Follow-up|25|||
156957872|NCT04477187|566597274|FG000|Overall Study|Lost to Follow-up|2|||
156957873|NCT02047045|566597275|FG000|Baseline|Withdrawal by Subject|3|||
156957874|NCT02047045|566597276|FG001|Baseline|Withdrawal by Subject|2|||
156957875|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
157227687|NCT00531206|567579159|FG000|Overall Study|Adverse Event related|5|||
157170110|NCT01878097|567365164|FG000|Implementation Year 2|Surveys not fully completed|3281|||
157170111|NCT01878097|567365165|FG001|Implementation Year 2|Surveys not fully completed|2841|||
157170112|NCT01878097|567365164|FG000|Implementation Year 3|Surveys not fully completed|3494|||
157170113|NCT01878097|567365165|FG001|Implementation Year 3|Surveys not fully completed|2980|||
157170114|NCT01878097|567365164|FG000|Implementation Year 4|Surveys not fully completed|3604|||
157170115|NCT01878097|567365165|FG001|Implementation Year 4|Surveys not fully completed|3007|||
156957876|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
156957877|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
156957878|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
156957879|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
156957880|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
156957881|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
156957882|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
157170116|NCT01595438|567365166|FG000|Overall Study|Lost to Follow-up|20|||
157170117|NCT01595438|567365167|FG001|Overall Study|Lost to Follow-up|20|||
157170118|NCT01595438|567365166|FG000|Overall Study|Withdrawal by Subject|12|||
157170119|NCT01595438|567365167|FG001|Overall Study|Withdrawal by Subject|12|||
157170120|NCT01595438|567365166|FG000|Overall Study|Other Eligibility criteria|11|||
157170121|NCT01595438|567365167|FG001|Overall Study|Other Eligibility criteria|9|||
157170122|NCT00985738|567365170|FG000|Overall Study|Study closed prematurely|8|||
157170123|NCT00985738|567365171|FG001|Overall Study|Study closed prematurely|8|||
157170124|NCT02119026|567365174|FG000|1st-line Treatment|Adverse Event|9|||
157227688|NCT00531206|567579159|FG000|Overall Study|Lack of Efficacy|2|||
156957883|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
156957884|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
156957885|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
156957886|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
156957887|NCT02047045|566597275|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
156957888|NCT02047045|566597276|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
156957889|NCT02047045|566597275|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
156957890|NCT02047045|566597276|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
156957891|NCT03508843|566597278|FG000|Overall Study|Withdrawal by Subject|1|||
156957892|NCT03508843|566597278|FG000|Overall Study|technical difficulties|2|||
156957893|NCT04717596|566597279|FG000|Overall Study|Withdrawal by Subject|4|||
156957894|NCT00765843|566597280|FG000|Overall Study|Lost to Follow-up|1|||
156957895|NCT00765843|566597281|FG001|Overall Study|Lost to Follow-up|3|||
156957896|NCT00765843|566597282|FG002|Overall Study|Lost to Follow-up|2|||
156957897|NCT00765843|566597280|FG000|Overall Study|did not return to receive intervention|0|||
156957898|NCT00765843|566597281|FG001|Overall Study|did not return to receive intervention|1|||
156957899|NCT00765843|566597282|FG002|Overall Study|did not return to receive intervention|0|||
156957900|NCT00765843|566597280|FG000|Overall Study|Adverse Event|0|||
156957901|NCT00765843|566597281|FG001|Overall Study|Adverse Event|0|||
156957902|NCT00765843|566597282|FG002|Overall Study|Adverse Event|1|||
156957903|NCT03555396|566597283|FG000|Overall Study|Death|3|||
156957904|NCT03555396|566597284|FG001|Overall Study|Death|1|||
156957905|NCT03555396|566597283|FG000|Overall Study|Lost to Follow-up|0|||
156957906|NCT03555396|566597284|FG001|Overall Study|Lost to Follow-up|2|||
156957907|NCT02536508|566597285|FG000|Overall Study|Withdrawal by Subject|18|||
156957908|NCT02536508|566597286|FG001|Overall Study|Withdrawal by Subject|13|||
156957909|NCT02536508|566597287|FG002|Overall Study|Withdrawal by Subject|7|||
156957910|NCT02536508|566597285|FG000|Overall Study|Adverse Event|14|||
156957911|NCT02536508|566597286|FG001|Overall Study|Adverse Event|13|||
156957912|NCT02536508|566597287|FG002|Overall Study|Adverse Event|6|||
156957913|NCT02536508|566597285|FG000|Overall Study|Lost to Follow-up|12|||
156957914|NCT02536508|566597286|FG001|Overall Study|Lost to Follow-up|4|||
156957915|NCT02536508|566597287|FG002|Overall Study|Lost to Follow-up|0|||
156957916|NCT02536508|566597285|FG000|Overall Study|Lack of Efficacy|3|||
156957917|NCT02536508|566597286|FG001|Overall Study|Lack of Efficacy|5|||
156957918|NCT02536508|566597287|FG002|Overall Study|Lack of Efficacy|4|||
156957919|NCT02536508|566597285|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
156957920|NCT02536508|566597286|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
156957921|NCT02536508|566597287|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
156957922|NCT02536508|566597285|FG000|Overall Study|Physician Decision|0|||
156957923|NCT02536508|566597286|FG001|Overall Study|Physician Decision|4|||
156957924|NCT02536508|566597287|FG002|Overall Study|Physician Decision|2|||
156957925|NCT02536508|566597285|FG000|Overall Study|Major Protocol Deviation|2|||
156957926|NCT02536508|566597286|FG001|Overall Study|Major Protocol Deviation|2|||
157170125|NCT02119026|567365175|FG001|1st-line Treatment|Adverse Event|14|||
157170126|NCT02119026|567365174|FG000|1st-line Treatment|Physician Decision|3|||
157227689|NCT00531206|567579159|FG000|Overall Study|Lost to Follow-up|5|||
157170127|NCT02119026|567365175|FG001|1st-line Treatment|Physician Decision|8|||
157170128|NCT02119026|567365174|FG000|1st-line Treatment|Withdrawal by Subject|4|||
157170129|NCT02119026|567365175|FG001|1st-line Treatment|Withdrawal by Subject|10|||
156957927|NCT02536508|566597287|FG002|Overall Study|Major Protocol Deviation|2|||
156957928|NCT02536508|566597285|FG000|Overall Study|Administrative Reasons|0|||
157170130|NCT02119026|567365174|FG000|1st-line Treatment|Patient condition or compliance|6|||
156957929|NCT02536508|566597286|FG001|Overall Study|Administrative Reasons|1|||
156957930|NCT02536508|566597287|FG002|Overall Study|Administrative Reasons|0|||
156957931|NCT04066114|566597288|FG000|Overall Study|Adverse Event|1|||
156957932|NCT04066114|566597289|FG001|Overall Study|Adverse Event|0|||
156957933|NCT04066114|566597290|FG002|Overall Study|Adverse Event|0|||
156957934|NCT04066114|566597288|FG000|Overall Study|Withdrawal by Subject|1|||
156957935|NCT04066114|566597289|FG001|Overall Study|Withdrawal by Subject|0|||
156957936|NCT04066114|566597290|FG002|Overall Study|Withdrawal by Subject|0|||
156957937|NCT04066114|566597288|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
156957938|NCT04066114|566597289|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
156957939|NCT04066114|566597290|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
156957940|NCT02460991|566597291|FG000|Overall Study|Withdrawal by Subject|0|||
156957941|NCT02460991|566597292|FG001|Overall Study|Withdrawal by Subject|2|||
156957942|NCT02564523|566597293|FG000|Overall Study|Withdrawal by Subject|3|||
156957943|NCT02564523|566597294|FG001|Overall Study|Withdrawal by Subject|0|||
156957944|NCT02564523|566597295|FG002|Overall Study|Withdrawal by Subject|1|||
156957945|NCT02564523|566597296|FG003|Overall Study|Withdrawal by Subject|0|||
156957946|NCT02564523|566597297|FG004|Overall Study|Withdrawal by Subject|1|||
156957947|NCT02564523|566597298|FG005|Overall Study|Withdrawal by Subject|0|||
156957948|NCT02564523|566597299|FG006|Overall Study|Withdrawal by Subject|1|||
156957949|NCT02564523|566597300|FG007|Overall Study|Withdrawal by Subject|0|||
156957950|NCT02564523|566597301|FG008|Overall Study|Withdrawal by Subject|0|||
156957951|NCT02564523|566597302|FG009|Overall Study|Withdrawal by Subject|0|||
156957952|NCT02564523|566597303|FG010|Overall Study|Withdrawal by Subject|1|||
156957953|NCT02564523|566597304|FG011|Overall Study|Withdrawal by Subject|0|||
156957954|NCT02564523|566597305|FG012|Overall Study|Withdrawal by Subject|1|||
156957955|NCT02564523|566597306|FG013|Overall Study|Withdrawal by Subject|0|||
156957956|NCT02564523|566597307|FG014|Overall Study|Withdrawal by Subject|0|||
156957957|NCT02564523|566597308|FG015|Overall Study|Withdrawal by Subject|0|||
156957958|NCT02564523|566597309|FG016|Overall Study|Withdrawal by Subject|0|||
156957959|NCT02564523|566597310|FG017|Overall Study|Withdrawal by Subject|0|||
156957960|NCT02564523|566597293|FG000|Overall Study|Adverse Event|0|||
156957961|NCT02564523|566597294|FG001|Overall Study|Adverse Event|0|||
156957962|NCT02564523|566597295|FG002|Overall Study|Adverse Event|0|||
156957963|NCT02564523|566597296|FG003|Overall Study|Adverse Event|0|||
156957964|NCT02564523|566597297|FG004|Overall Study|Adverse Event|0|||
156957965|NCT02564523|566597298|FG005|Overall Study|Adverse Event|0|||
156957966|NCT02564523|566597299|FG006|Overall Study|Adverse Event|0|||
156957967|NCT02564523|566597300|FG007|Overall Study|Adverse Event|0|||
156957968|NCT02564523|566597301|FG008|Overall Study|Adverse Event|0|||
156957969|NCT02564523|566597302|FG009|Overall Study|Adverse Event|0|||
156957970|NCT02564523|566597303|FG010|Overall Study|Adverse Event|0|||
156957971|NCT02564523|566597304|FG011|Overall Study|Adverse Event|0|||
156957972|NCT02564523|566597305|FG012|Overall Study|Adverse Event|0|||
156957973|NCT02564523|566597306|FG013|Overall Study|Adverse Event|0|||
156957974|NCT02564523|566597307|FG014|Overall Study|Adverse Event|0|||
156957975|NCT02564523|566597308|FG015|Overall Study|Adverse Event|0|||
156957976|NCT02564523|566597309|FG016|Overall Study|Adverse Event|0|||
156957977|NCT02564523|566597310|FG017|Overall Study|Adverse Event|1|||
156957978|NCT02564523|566597293|FG000|Overall Study|Death|0|||
156957979|NCT02564523|566597294|FG001|Overall Study|Death|0|||
156957980|NCT02564523|566597295|FG002|Overall Study|Death|0|||
156957981|NCT02564523|566597296|FG003|Overall Study|Death|0|||
156957982|NCT02564523|566597297|FG004|Overall Study|Death|0|||
156957983|NCT02564523|566597298|FG005|Overall Study|Death|0|||
156957984|NCT02564523|566597299|FG006|Overall Study|Death|1|||
156957985|NCT02564523|566597300|FG007|Overall Study|Death|0|||
156957986|NCT02564523|566597301|FG008|Overall Study|Death|0|||
156957987|NCT02564523|566597302|FG009|Overall Study|Death|0|||
156957988|NCT02564523|566597303|FG010|Overall Study|Death|1|||
157170131|NCT02119026|567365175|FG001|1st-line Treatment|Patient condition or compliance|4|||
157170132|NCT02119026|567365174|FG000|1st-line Treatment|Surgery of metastases|2|||
157170133|NCT02119026|567365175|FG001|1st-line Treatment|Surgery of metastases|1|||
157170134|NCT02119026|567365174|FG000|1st-line Treatment|Death|2|||
157170135|NCT02119026|567365175|FG001|1st-line Treatment|Death|1|||
156957989|NCT02564523|566597304|FG011|Overall Study|Death|0|||
156957990|NCT02564523|566597305|FG012|Overall Study|Death|0|||
156957991|NCT02564523|566597306|FG013|Overall Study|Death|0|||
156957992|NCT02564523|566597307|FG014|Overall Study|Death|0|||
156957993|NCT02564523|566597308|FG015|Overall Study|Death|0|||
156957994|NCT02564523|566597309|FG016|Overall Study|Death|0|||
156957995|NCT02564523|566597310|FG017|Overall Study|Death|0|||
156957996|NCT02564523|566597293|FG000|Overall Study|Lost to Follow-up|2|||
156957997|NCT02564523|566597294|FG001|Overall Study|Lost to Follow-up|1|||
156957998|NCT02564523|566597295|FG002|Overall Study|Lost to Follow-up|4|||
156957999|NCT02564523|566597296|FG003|Overall Study|Lost to Follow-up|0|||
157170136|NCT02119026|567365174|FG000|2nd-line Treatment|Lost to Follow-up|2|||
157170137|NCT02119026|567365175|FG001|2nd-line Treatment|Lost to Follow-up|0|||
156958000|NCT02564523|566597297|FG004|Overall Study|Lost to Follow-up|1|||
156958001|NCT02564523|566597298|FG005|Overall Study|Lost to Follow-up|0|||
157170138|NCT02119026|567365174|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
157170139|NCT02119026|567365175|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
157170140|NCT02119026|567365174|FG000|2nd-line Treatment|Adverse Event|4|||
157170141|NCT02119026|567365175|FG001|2nd-line Treatment|Adverse Event|1|||
157170142|NCT03783442|567365179|FG000|Overall Study|Death|252|||
157170143|NCT03783442|567365180|FG001|Overall Study|Death|268|||
157170144|NCT03783442|567365179|FG000|Overall Study|Withdrawal by Subject|19|||
157170145|NCT03783442|567365180|FG001|Overall Study|Withdrawal by Subject|21|||
157170146|NCT03783442|567365179|FG000|Overall Study|Lost to Follow-up|7|||
157170147|NCT03783442|567365180|FG001|Overall Study|Lost to Follow-up|6|||
157170148|NCT03783442|567365179|FG000|Overall Study|Sponsor Ended Study|48|||
157170149|NCT03783442|567365180|FG001|Overall Study|Sponsor Ended Study|28|||
157170150|NCT00493467|567365183|FG000|Overall Study|Death|1|||
157227690|NCT00531206|567579159|FG000|Overall Study|including non-related adverse events|8|||
157227691|NCT00436007|567579166|FG000|Overall Study|Withdrawal by Subject|5|||
157227692|NCT00436007|567579167|FG001|Overall Study|Withdrawal by Subject|3|||
157227693|NCT00436007|567579168|FG002|Overall Study|Withdrawal by Subject|4|||
157227694|NCT00436007|567579166|FG000|Overall Study|Lost to Follow-up|14|||
157227695|NCT00436007|567579167|FG001|Overall Study|Lost to Follow-up|10|||
157227696|NCT00436007|567579168|FG002|Overall Study|Lost to Follow-up|13|||
157227697|NCT00436007|567579166|FG000|Overall Study|Physician Decision|0|||
157227698|NCT00436007|567579167|FG001|Overall Study|Physician Decision|0|||
157227699|NCT00436007|567579168|FG002|Overall Study|Physician Decision|2|||
157227700|NCT00436007|567579166|FG000|Overall Study|Death|0|||
157227701|NCT00436007|567579167|FG001|Overall Study|Death|1|||
157227702|NCT00436007|567579168|FG002|Overall Study|Death|3|||
157227703|NCT00436007|567579166|FG000|Overall Study|Other|0|||
157227704|NCT00436007|567579167|FG001|Overall Study|Other|0|||
157227705|NCT00436007|567579168|FG002|Overall Study|Other|1|||
157227706|NCT00282256|567579170|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
157227707|NCT00282256|567579170|FG000|Extension Treatment Period|Adverse Event|2|||
157227708|NCT02899338|567579172|FG000|Overall Study|Adverse Event|1|||
157227709|NCT02899338|567579173|FG001|Overall Study|Adverse Event|2|||
156958002|NCT02564523|566597299|FG006|Overall Study|Lost to Follow-up|1|||
156958003|NCT02564523|566597300|FG007|Overall Study|Lost to Follow-up|0|||
156958004|NCT02564523|566597301|FG008|Overall Study|Lost to Follow-up|0|||
156958005|NCT02564523|566597302|FG009|Overall Study|Lost to Follow-up|0|||
156958006|NCT02564523|566597303|FG010|Overall Study|Lost to Follow-up|0|||
156958007|NCT02564523|566597304|FG011|Overall Study|Lost to Follow-up|1|||
156958008|NCT02564523|566597305|FG012|Overall Study|Lost to Follow-up|1|||
156958009|NCT02564523|566597306|FG013|Overall Study|Lost to Follow-up|0|||
156958010|NCT02564523|566597307|FG014|Overall Study|Lost to Follow-up|0|||
156958011|NCT02564523|566597308|FG015|Overall Study|Lost to Follow-up|0|||
156958012|NCT02564523|566597309|FG016|Overall Study|Lost to Follow-up|0|||
156958013|NCT02564523|566597310|FG017|Overall Study|Lost to Follow-up|0|||
156958014|NCT02564523|566597293|FG000|Overall Study|Physician Decision|0|||
156958015|NCT02564523|566597294|FG001|Overall Study|Physician Decision|0|||
156958016|NCT02564523|566597295|FG002|Overall Study|Physician Decision|0|||
156958017|NCT02564523|566597296|FG003|Overall Study|Physician Decision|0|||
156958018|NCT02564523|566597297|FG004|Overall Study|Physician Decision|1|||
156958019|NCT02564523|566597298|FG005|Overall Study|Physician Decision|0|||
156958020|NCT02564523|566597299|FG006|Overall Study|Physician Decision|0|||
156958021|NCT02564523|566597300|FG007|Overall Study|Physician Decision|0|||
156958022|NCT02564523|566597301|FG008|Overall Study|Physician Decision|0|||
156958023|NCT02564523|566597302|FG009|Overall Study|Physician Decision|0|||
156958024|NCT02564523|566597303|FG010|Overall Study|Physician Decision|1|||
156958025|NCT02564523|566597304|FG011|Overall Study|Physician Decision|0|||
157170151|NCT03074149|567365186|FG000|Overall Study|Reason unknown|22|||
157170152|NCT03074149|567365187|FG001|Overall Study|Reason unknown|35|||
157170153|NCT03074149|567365186|FG000|Overall Study|Death|10|||
157227710|NCT02899338|567579172|FG000|Overall Study|Withdrawal by Subject|2|||
157227711|NCT02899338|567579173|FG001|Overall Study|Withdrawal by Subject|0|||
157227712|NCT06179108|567579174|FG000|Overall Study|Withdrawal by Subject|16|||
156958026|NCT02564523|566597305|FG012|Overall Study|Physician Decision|0|||
156958027|NCT02564523|566597306|FG013|Overall Study|Physician Decision|0|||
156958028|NCT02564523|566597307|FG014|Overall Study|Physician Decision|0|||
156958029|NCT02564523|566597308|FG015|Overall Study|Physician Decision|0|||
156958030|NCT02564523|566597309|FG016|Overall Study|Physician Decision|0|||
156958031|NCT02564523|566597310|FG017|Overall Study|Physician Decision|0|||
156958032|NCT02564523|566597293|FG000|Overall Study|Protocol Violation|2|||
157170154|NCT03074149|567365187|FG001|Overall Study|Death|45|||
157170155|NCT00225212|567365190|FG000|Overall Study|Disease progression|2|||
157170156|NCT00225212|567365190|FG000|Overall Study|Death|1|||
157170157|NCT00225212|567365190|FG000|Overall Study|Adverse Event|2|||
157170158|NCT00225212|567365190|FG000|Overall Study|Intercurrent illness|1|||
157227713|NCT06179108|567579175|FG001|Overall Study|Withdrawal by Subject|19|||
157227714|NCT06179108|567579176|FG002|Overall Study|Withdrawal by Subject|10|||
157227715|NCT06179108|567579177|FG003|Overall Study|Withdrawal by Subject|11|||
156958033|NCT02564523|566597294|FG001|Overall Study|Protocol Violation|2|||
156958034|NCT02564523|566597295|FG002|Overall Study|Protocol Violation|5|||
156958035|NCT02564523|566597296|FG003|Overall Study|Protocol Violation|0|||
156958036|NCT02564523|566597297|FG004|Overall Study|Protocol Violation|1|||
156958037|NCT02564523|566597298|FG005|Overall Study|Protocol Violation|0|||
156958038|NCT02564523|566597299|FG006|Overall Study|Protocol Violation|0|||
156958039|NCT02564523|566597300|FG007|Overall Study|Protocol Violation|0|||
156958040|NCT02564523|566597301|FG008|Overall Study|Protocol Violation|0|||
156958041|NCT02564523|566597302|FG009|Overall Study|Protocol Violation|0|||
156958042|NCT02564523|566597303|FG010|Overall Study|Protocol Violation|0|||
156958043|NCT02564523|566597304|FG011|Overall Study|Protocol Violation|0|||
156958044|NCT02564523|566597305|FG012|Overall Study|Protocol Violation|0|||
156958045|NCT02564523|566597306|FG013|Overall Study|Protocol Violation|0|||
156958046|NCT02564523|566597307|FG014|Overall Study|Protocol Violation|0|||
156958047|NCT02564523|566597308|FG015|Overall Study|Protocol Violation|0|||
156958048|NCT02564523|566597309|FG016|Overall Study|Protocol Violation|0|||
156958049|NCT02564523|566597310|FG017|Overall Study|Protocol Violation|0|||
156958050|NCT02564523|566597293|FG000|Overall Study|Other|3|||
156958051|NCT02564523|566597294|FG001|Overall Study|Other|0|||
156958052|NCT02564523|566597295|FG002|Overall Study|Other|0|||
156958053|NCT02564523|566597296|FG003|Overall Study|Other|1|||
156958054|NCT02564523|566597297|FG004|Overall Study|Other|0|||
156958055|NCT02564523|566597298|FG005|Overall Study|Other|0|||
156958056|NCT02564523|566597299|FG006|Overall Study|Other|0|||
156958057|NCT02564523|566597300|FG007|Overall Study|Other|0|||
156958058|NCT02564523|566597301|FG008|Overall Study|Other|0|||
156958059|NCT02564523|566597302|FG009|Overall Study|Other|0|||
156958060|NCT02564523|566597303|FG010|Overall Study|Other|0|||
156958061|NCT02564523|566597304|FG011|Overall Study|Other|0|||
156958062|NCT02564523|566597305|FG012|Overall Study|Other|0|||
156958063|NCT02564523|566597306|FG013|Overall Study|Other|0|||
156958064|NCT02564523|566597307|FG014|Overall Study|Other|0|||
156958065|NCT02564523|566597308|FG015|Overall Study|Other|0|||
156958066|NCT02564523|566597309|FG016|Overall Study|Other|0|||
156958067|NCT02564523|566597310|FG017|Overall Study|Other|0|||
156958068|NCT00448539|566597315|FG000|Overall Study|Medication non-compliance|4|||
156958069|NCT00448539|566597316|FG001|Overall Study|Medication non-compliance|1|||
156958070|NCT00448539|566597315|FG000|Overall Study|Protocol Violation|1|||
156958071|NCT00448539|566597316|FG001|Overall Study|Protocol Violation|0|||
156958072|NCT00448539|566597315|FG000|Overall Study|Request of the investigator or sponsor|67|||
156958073|NCT00448539|566597316|FG001|Overall Study|Request of the investigator or sponsor|54|||
156958074|NCT00448539|566597315|FG000|Overall Study|Withdrawal by Subject|20|||
156958075|NCT00448539|566597316|FG001|Overall Study|Withdrawal by Subject|24|||
156958076|NCT00448539|566597315|FG000|Overall Study|Diary non-compliance|1|||
156958077|NCT00448539|566597316|FG001|Overall Study|Diary non-compliance|0|||
156958078|NCT00448539|566597315|FG000|Overall Study|Adverse Event|9|||
156958079|NCT00448539|566597316|FG001|Overall Study|Adverse Event|26|||
156958080|NCT00448539|566597315|FG000|Overall Study|Lack of Efficacy|27|||
156958081|NCT00448539|566597316|FG001|Overall Study|Lack of Efficacy|40|||
156958082|NCT00448539|566597315|FG000|Overall Study|Miscellaneous|2|||
156958083|NCT00448539|566597316|FG001|Overall Study|Miscellaneous|1|||
156958084|NCT00448539|566597315|FG000|Overall Study|Change of meds|2|||
156958085|NCT00448539|566597316|FG001|Overall Study|Change of meds|3|||
156958086|NCT00448539|566597315|FG000|Overall Study|Lost to Follow-up|1|||
156958087|NCT00448539|566597316|FG001|Overall Study|Lost to Follow-up|3|||
156958088|NCT03349710|566597317|FG000|Treatment Period|Death|0|||
156958089|NCT03349710|566597318|FG001|Treatment Period|Death|0|||
156958090|NCT03349710|566597319|FG002|Treatment Period|Death|1|||
156958091|NCT03349710|566597320|FG003|Treatment Period|Death|0|||
156958092|NCT03349710|566597317|FG000|Treatment Period|Disease Progression|0|||
156958093|NCT03349710|566597318|FG001|Treatment Period|Disease Progression|2|||
156958094|NCT03349710|566597319|FG002|Treatment Period|Disease Progression|0|||
156958095|NCT03349710|566597320|FG003|Treatment Period|Disease Progression|1|||
156958096|NCT03349710|566597317|FG000|Treatment Period|Study Drug Toxicity|1|||
156958097|NCT03349710|566597318|FG001|Treatment Period|Study Drug Toxicity|0|||
156958098|NCT03349710|566597319|FG002|Treatment Period|Study Drug Toxicity|1|||
157170159|NCT01335698|567365193|FG000|Treatment Stage 1|Lack of Efficacy|3|||
156958099|NCT03349710|566597320|FG003|Treatment Period|Study Drug Toxicity|1|||
156958100|NCT03349710|566597317|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
156958101|NCT03349710|566597318|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
156958102|NCT03349710|566597319|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
156958103|NCT03349710|566597320|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
156958104|NCT03349710|566597317|FG000|Treatment Period|admin reason by sponsor|0|||
156958105|NCT03349710|566597318|FG001|Treatment Period|admin reason by sponsor|7|||
156958106|NCT03349710|566597319|FG002|Treatment Period|admin reason by sponsor|0|||
156958107|NCT03349710|566597320|FG003|Treatment Period|admin reason by sponsor|19|||
156958108|NCT03349710|566597317|FG000|Treatment Period|Other Reason|2|||
156958109|NCT03349710|566597318|FG001|Treatment Period|Other Reason|0|||
156958110|NCT03349710|566597319|FG002|Treatment Period|Other Reason|2|||
157170160|NCT01335698|567365194|FG001|Treatment Stage 1|Lack of Efficacy|1|||
157170161|NCT01335698|567365195|FG002|Treatment Stage 1|Lack of Efficacy|3|||
157170162|NCT01335698|567365196|FG003|Treatment Stage 1|Lack of Efficacy|3|||
157170163|NCT01335698|567365197|FG004|Treatment Stage 1|Lack of Efficacy|1|||
157170164|NCT01335698|567365193|FG000|Treatment Stage 1|Adverse Event|1|||
157170165|NCT01335698|567365194|FG001|Treatment Stage 1|Adverse Event|2|||
157170166|NCT01335698|567365195|FG002|Treatment Stage 1|Adverse Event|2|||
157170167|NCT01335698|567365196|FG003|Treatment Stage 1|Adverse Event|1|||
157170168|NCT01335698|567365197|FG004|Treatment Stage 1|Adverse Event|1|||
157170169|NCT01335698|567365193|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
157170170|NCT01335698|567365194|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
157170171|NCT01335698|567365195|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
157170172|NCT01335698|567365196|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
157170173|NCT01335698|567365197|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
157170174|NCT01335698|567365193|FG000|Treatment Stage 1|Lost to Follow-up|1|||
157170175|NCT01335698|567365194|FG001|Treatment Stage 1|Lost to Follow-up|1|||
157170176|NCT01335698|567365195|FG002|Treatment Stage 1|Lost to Follow-up|0|||
157170177|NCT01335698|567365196|FG003|Treatment Stage 1|Lost to Follow-up|0|||
157170178|NCT01335698|567365197|FG004|Treatment Stage 1|Lost to Follow-up|0|||
157170179|NCT01335698|567365193|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
156958111|NCT03349710|566597320|FG003|Treatment Period|Other Reason|1|||
156958112|NCT03349710|566597317|FG000|Treatment Period|completed|6|||
156958113|NCT03349710|566597318|FG001|Treatment Period|completed|0|||
156958114|NCT03349710|566597319|FG002|Treatment Period|completed|18|||
156958115|NCT03349710|566597320|FG003|Treatment Period|completed|1|||
156958116|NCT03349710|566597317|FG000|Treatment Period|participant request to discontinue|0|||
156958117|NCT03349710|566597318|FG001|Treatment Period|participant request to discontinue|0|||
156958118|NCT03349710|566597319|FG002|Treatment Period|participant request to discontinue|4|||
156958119|NCT03349710|566597320|FG003|Treatment Period|participant request to discontinue|0|||
156958120|NCT03349710|566597317|FG000|Treatment Period|participant withdrew consent|1|||
156958121|NCT03349710|566597318|FG001|Treatment Period|participant withdrew consent|0|||
156958122|NCT03349710|566597319|FG002|Treatment Period|participant withdrew consent|0|||
156958123|NCT03349710|566597320|FG003|Treatment Period|participant withdrew consent|0|||
156958124|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
156958125|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
156958126|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
156958127|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
156958128|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
156958129|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
156958130|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
156958131|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
156958132|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
156958133|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
156958134|NCT00695903|566597321|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
156958135|NCT00695903|566597322|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
156958136|NCT00695903|566597321|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
156958137|NCT00695903|566597322|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
156958138|NCT00695903|566597321|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
156958139|NCT00695903|566597322|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
156958140|NCT00695903|566597321|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
156958141|NCT00695903|566597322|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
156958142|NCT02696317|566597323|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
156958143|NCT02696317|566597324|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
156958144|NCT02696317|566597323|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
156958145|NCT02696317|566597324|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
156958146|NCT01343368|566597325|FG000|Overall Study|Death|1|||
156958147|NCT01343368|566597326|FG001|Overall Study|Death|0|||
156958148|NCT01343368|566597325|FG000|Overall Study|Lost to Follow-up|1|||
156958149|NCT01343368|566597326|FG001|Overall Study|Lost to Follow-up|0|||
156958150|NCT01296568|566597332|FG000|Continued Access Phase|Lost to Follow-up|1|||
156958151|NCT01296568|566597332|FG000|Continued Access Phase|Withdrawal by Subject|1|||
156958152|NCT01296568|566597332|FG000|Continued Access Phase|Disease Progression|1|||
156958153|NCT00237744|566597333|FG000|Overall Study|Withdrawal by Subject|3|||
157170180|NCT01335698|567365194|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
157170181|NCT01335698|567365195|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
156958154|NCT00237744|566597334|FG001|Overall Study|Withdrawal by Subject|1|||
156958155|NCT00237744|566597335|FG002|Overall Study|Withdrawal by Subject|0|||
156958156|NCT00321854|566597338|FG000|Overall Study|Adverse Event|41|||
157170182|NCT01335698|567365196|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
157170183|NCT01335698|567365197|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
157170184|NCT01335698|567365193|FG000|Treatment Stage 1|No longer meets study criteria|1|||
157170185|NCT01335698|567365194|FG001|Treatment Stage 1|No longer meets study criteria|1|||
157170186|NCT01335698|567365195|FG002|Treatment Stage 1|No longer meets study criteria|0|||
156958157|NCT00321854|566597339|FG001|Overall Study|Adverse Event|43|||
156958158|NCT00321854|566597338|FG000|Overall Study|Lack of Efficacy|9|||
156958159|NCT00321854|566597339|FG001|Overall Study|Lack of Efficacy|14|||
156958160|NCT00321854|566597338|FG000|Overall Study|Protocol Violation|6|||
156958161|NCT00321854|566597339|FG001|Overall Study|Protocol Violation|5|||
156958162|NCT00321854|566597338|FG000|Overall Study|Lost to Follow-up|0|||
156958163|NCT00321854|566597339|FG001|Overall Study|Lost to Follow-up|2|||
156958164|NCT00321854|566597338|FG000|Overall Study|Withdrawal by Subject|6|||
156958165|NCT00321854|566597339|FG001|Overall Study|Withdrawal by Subject|17|||
156958166|NCT00321854|566597338|FG000|Overall Study|Other|1|||
156958167|NCT00321854|566597339|FG001|Overall Study|Other|1|||
156958168|NCT01369342|566597340|FG000|Overall Study|Withdrawal by Subject|7|||
156958169|NCT01369342|566597341|FG001|Overall Study|Withdrawal by Subject|7|||
156958170|NCT01369342|566597342|FG002|Overall Study|Withdrawal by Subject|2|||
156958171|NCT01369342|566597340|FG000|Overall Study|Lost to Follow-up|5|||
156958172|NCT01369342|566597341|FG001|Overall Study|Lost to Follow-up|2|||
156958173|NCT01369342|566597342|FG002|Overall Study|Lost to Follow-up|1|||
156958174|NCT01369342|566597340|FG000|Overall Study|Not Treated|1|||
156958175|NCT01369342|566597341|FG001|Overall Study|Not Treated|0|||
156958176|NCT01369342|566597342|FG002|Overall Study|Not Treated|0|||
156958177|NCT01816594|566597343|FG000|Overall Study|Local Progress|0|||
156958178|NCT01816594|566597344|FG001|Overall Study|Local Progress|2|||
156958179|NCT01816594|566597343|FG000|Overall Study|Adverse Event|9|||
156958180|NCT01816594|566597344|FG001|Overall Study|Adverse Event|0|||
156958181|NCT01816594|566597343|FG000|Overall Study|Withdrawal by Subject|1|||
156958182|NCT01816594|566597344|FG001|Overall Study|Withdrawal by Subject|0|||
156958183|NCT01816594|566597343|FG000|Overall Study|Physician Decision|1|||
156958184|NCT01816594|566597344|FG001|Overall Study|Physician Decision|0|||
156958185|NCT03905655|566597345|FG000|Overall Study|Adverse Event|1|||
156958186|NCT03905655|566597346|FG001|Overall Study|Adverse Event|0|||
156958187|NCT03905655|566597347|FG002|Overall Study|Adverse Event|1|||
156958188|NCT03905655|566597348|FG003|Overall Study|Adverse Event|1|||
156958189|NCT04723576|566597349|FG000|Overall Study|Withdrawal by Subject|2133|||
156958190|NCT04723576|566597350|FG001|Overall Study|Withdrawal by Subject|3234|||
156958191|NCT02277106|566597351|FG000|Stage 2|Adverse Event|0|||
156958192|NCT02277106|566597352|FG001|Stage 2|Adverse Event|0|||
156958193|NCT02277106|566597353|FG002|Stage 2|Adverse Event|1|||
156958194|NCT03117738|566597354|FG000|Overall Study|Withdrawal by Subject|3|||
156958195|NCT03117738|566597355|FG001|Overall Study|Withdrawal by Subject|1|||
156958196|NCT03117738|566597354|FG000|Overall Study|Lost to Follow-up|1|||
156958197|NCT03117738|566597355|FG001|Overall Study|Lost to Follow-up|4|||
156958198|NCT01669629|566597356|FG000|Period 1|protocol deviation|1|||
156958199|NCT01669629|566597357|FG001|Period 1|protocol deviation|2|||
156958200|NCT03638141|566597358|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
156958201|NCT03526250|566597361|FG000|Overall Study|Adverse Event|4|||
156958202|NCT03526250|566597361|FG000|Overall Study|Progressive Disease|16|||
156958203|NCT03526250|566597361|FG000|Overall Study|No Treatment|3|||
156958204|NCT04420221|566597362|FG000|Overall Study|Withdrawal by Subject|0|||
156958205|NCT04420221|566597363|FG001|Overall Study|Withdrawal by Subject|0|||
156958206|NCT04420221|566597364|FG002|Overall Study|Withdrawal by Subject|0|||
156958207|NCT04420221|566597365|FG003|Overall Study|Withdrawal by Subject|0|||
156958208|NCT04420221|566597366|FG004|Overall Study|Withdrawal by Subject|0|||
156958209|NCT04420221|566597367|FG005|Overall Study|Withdrawal by Subject|20|||
156958210|NCT04420221|566597368|FG006|Overall Study|Withdrawal by Subject|5|||
156958211|NCT04420221|566597362|FG000|Overall Study|Other|0|||
156958212|NCT04420221|566597363|FG001|Overall Study|Other|0|||
156958213|NCT04420221|566597364|FG002|Overall Study|Other|0|||
156958214|NCT04420221|566597365|FG003|Overall Study|Other|0|||
156958215|NCT04420221|566597366|FG004|Overall Study|Other|0|||
156958216|NCT04420221|566597367|FG005|Overall Study|Other|1|||
156958217|NCT04420221|566597368|FG006|Overall Study|Other|1|||
156958218|NCT04420221|566597362|FG000|Overall Study|Lost to Follow-up|0|||
157170187|NCT01335698|567365196|FG003|Treatment Stage 1|No longer meets study criteria|1|||
157170188|NCT01335698|567365197|FG004|Treatment Stage 1|No longer meets study criteria|0|||
157170189|NCT01335698|567365193|FG000|Treatment Stage 1|Other|1|||
157170190|NCT01335698|567365194|FG001|Treatment Stage 1|Other|0|||
156958219|NCT04420221|566597363|FG001|Overall Study|Lost to Follow-up|0|||
157170191|NCT01335698|567365195|FG002|Treatment Stage 1|Other|0|||
157170192|NCT01335698|567365196|FG003|Treatment Stage 1|Other|1|||
157170193|NCT01335698|567365197|FG004|Treatment Stage 1|Other|0|||
156958220|NCT04420221|566597364|FG002|Overall Study|Lost to Follow-up|0|||
156958221|NCT04420221|566597365|FG003|Overall Study|Lost to Follow-up|0|||
156958222|NCT04420221|566597366|FG004|Overall Study|Lost to Follow-up|0|||
156958223|NCT04420221|566597367|FG005|Overall Study|Lost to Follow-up|3|||
156958224|NCT04420221|566597368|FG006|Overall Study|Lost to Follow-up|2|||
156958225|NCT04420221|566597362|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
156958226|NCT04420221|566597363|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
156958227|NCT04420221|566597364|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
157170194|NCT01335698|567365193|FG000|Treatment Stage 2|Lack of Efficacy|2|||
157170195|NCT01335698|567365194|FG001|Treatment Stage 2|Lack of Efficacy|1|||
157170196|NCT01335698|567365195|FG002|Treatment Stage 2|Lack of Efficacy|3|||
157170197|NCT01335698|567365196|FG003|Treatment Stage 2|Lack of Efficacy|1|||
157170198|NCT01335698|567365197|FG004|Treatment Stage 2|Lack of Efficacy|0|||
157170199|NCT01335698|567365193|FG000|Treatment Stage 2|Adverse Event|2|||
157170200|NCT01335698|567365194|FG001|Treatment Stage 2|Adverse Event|0|||
157170201|NCT01335698|567365195|FG002|Treatment Stage 2|Adverse Event|0|||
156958228|NCT04420221|566597365|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
156958229|NCT04420221|566597366|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
156958230|NCT04420221|566597367|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
156958231|NCT04420221|566597368|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
156958232|NCT00990652|566597376|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
156958233|NCT00990652|566597376|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
156958234|NCT01581281|566597377|FG000|Overall Study|Early Study Closure|15|||
156958235|NCT01581281|566597378|FG001|Overall Study|Early Study Closure|6|||
156958236|NCT01581281|566597379|FG002|Overall Study|Early Study Closure|12|||
156958237|NCT00522275|566597383|FG000|Overall Study|Adverse Event|35|||
156958238|NCT00522275|566597383|FG000|Overall Study|Lack of Efficacy|80|||
156958239|NCT00522275|566597383|FG000|Overall Study|Subject withdrew consent|16|||
156958240|NCT00522275|566597383|FG000|Overall Study|Protocol deviation|1|||
156958241|NCT00522275|566597383|FG000|Overall Study|Unsatisfactory compliance|11|||
156958242|NCT00522275|566597383|FG000|Overall Study|Lost to Follow-up|8|||
156958243|NCT00522275|566597383|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
156958244|NCT00522275|566597383|FG000|Overall Study|Other: Subject is pregnant|2|||
156958245|NCT00522275|566597383|FG000|Overall Study|Other: Subject relocated|2|||
156958246|NCT00522275|566597383|FG000|Overall Study|Other: Subject arrested|1|||
156958247|NCT00522275|566597383|FG000|Overall Study|Other: Site / clinic closed|4|||
156958248|NCT00522275|566597383|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
156958249|NCT00522275|566597383|FG000|Overall Study|Other: Sponsor request|2|||
156958250|NCT00522275|566597383|FG000|Overall Study|Other: Subject ran out of medication|1|||
156958251|NCT00522275|566597383|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
156958252|NCT00360529|566597387|FG000|Overall Study|Adverse Event|10|||
156958253|NCT00360529|566597388|FG001|Overall Study|Adverse Event|23|||
156958254|NCT00360529|566597389|FG002|Overall Study|Adverse Event|33|||
156958255|NCT00360529|566597387|FG000|Overall Study|Protocol Violation|3|||
156958256|NCT00360529|566597388|FG001|Overall Study|Protocol Violation|3|||
156958257|NCT00360529|566597389|FG002|Overall Study|Protocol Violation|11|||
156958258|NCT00360529|566597387|FG000|Overall Study|Lost to Follow-up|14|||
156958259|NCT00360529|566597388|FG001|Overall Study|Lost to Follow-up|10|||
156958260|NCT00360529|566597389|FG002|Overall Study|Lost to Follow-up|13|||
156958261|NCT00360529|566597387|FG000|Overall Study|Withdrawal by Subject|22|||
156958262|NCT00360529|566597388|FG001|Overall Study|Withdrawal by Subject|14|||
156958263|NCT00360529|566597389|FG002|Overall Study|Withdrawal by Subject|18|||
156958264|NCT00360529|566597387|FG000|Overall Study|Lack of Efficacy|8|||
156958265|NCT00360529|566597388|FG001|Overall Study|Lack of Efficacy|6|||
156958266|NCT00360529|566597389|FG002|Overall Study|Lack of Efficacy|5|||
156958267|NCT00360529|566597387|FG000|Overall Study|Reason discontinued not explained above|4|||
156958268|NCT00360529|566597388|FG001|Overall Study|Reason discontinued not explained above|9|||
156958269|NCT00360529|566597389|FG002|Overall Study|Reason discontinued not explained above|11|||
156958270|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
156958271|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
156958272|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
156958273|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
156958274|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
156958275|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
156958276|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
156958277|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
156958278|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
156958279|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
156958280|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
156958281|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
156958282|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
156958283|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
156958284|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
156958285|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
156958286|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
156958287|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
156958288|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
157170202|NCT01335698|567365196|FG003|Treatment Stage 2|Adverse Event|3|||
156958289|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
156958290|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
157170203|NCT01335698|567365197|FG004|Treatment Stage 2|Adverse Event|0|||
157170204|NCT01335698|567365193|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
157170205|NCT01335698|567365194|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
156958291|NCT01781572|566597395|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
156958292|NCT01781572|566597396|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
156958293|NCT01781572|566597397|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
156958294|NCT01781572|566597395|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
156958295|NCT01781572|566597396|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
156958296|NCT01781572|566597397|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
156958297|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
156958298|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
156958299|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
156958300|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
156958301|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
156958302|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
156958303|NCT01781572|566597395|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
156958304|NCT01781572|566597396|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
157170206|NCT01335698|567365195|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
156958305|NCT01781572|566597397|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
156958306|NCT01781572|566597395|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
156958307|NCT01781572|566597396|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
156958308|NCT01781572|566597397|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
156958309|NCT01781572|566597395|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
156958310|NCT01781572|566597396|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
156958311|NCT01781572|566597397|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
156958312|NCT01781572|566597395|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
156958313|NCT01781572|566597396|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
156958314|NCT01781572|566597397|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
156958315|NCT01781572|566597395|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
156958316|NCT01781572|566597396|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
156958317|NCT01781572|566597397|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
156958318|NCT01781572|566597395|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
157170207|NCT01335698|567365196|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
157170208|NCT01335698|567365197|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
157170209|NCT01335698|567365193|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
157170210|NCT01335698|567365194|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
157170211|NCT01335698|567365195|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
157170212|NCT01335698|567365196|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
157170213|NCT01335698|567365197|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
157170214|NCT01335698|567365193|FG000|Treatment Stage 2|Lost to Follow-up|1|||
157170215|NCT01335698|567365194|FG001|Treatment Stage 2|Lost to Follow-up|0|||
157170216|NCT01335698|567365195|FG002|Treatment Stage 2|Lost to Follow-up|0|||
157170217|NCT01335698|567365196|FG003|Treatment Stage 2|Lost to Follow-up|0|||
157170218|NCT01335698|567365197|FG004|Treatment Stage 2|Lost to Follow-up|0|||
157170219|NCT01335698|567365193|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
157170220|NCT01335698|567365194|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
157170221|NCT01335698|567365195|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
157170222|NCT01335698|567365196|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
157170223|NCT01335698|567365197|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
157170224|NCT01335698|567365193|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
157170225|NCT01335698|567365194|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
157170226|NCT01335698|567365195|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
157170227|NCT01335698|567365196|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
157170228|NCT01335698|567365197|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
157170229|NCT01335698|567365193|FG000|Treatment Stage 2|Switched to another formulation|1|||
157170230|NCT01335698|567365194|FG001|Treatment Stage 2|Switched to another formulation|1|||
157170231|NCT01335698|567365195|FG002|Treatment Stage 2|Switched to another formulation|0|||
157170232|NCT01335698|567365196|FG003|Treatment Stage 2|Switched to another formulation|0|||
157170233|NCT01335698|567365197|FG004|Treatment Stage 2|Switched to another formulation|0|||
156958319|NCT01781572|566597396|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
156958320|NCT01781572|566597397|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
156958321|NCT01781572|566597395|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
157170234|NCT00764946|567365198|FG000|Overall Study|Lack of Efficacy|1|||
157170235|NCT00764946|567365199|FG001|Overall Study|Lack of Efficacy|0|||
156958322|NCT01781572|566597396|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
156958323|NCT01781572|566597397|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
156958324|NCT01438541|566597398|FG000|Overall Study|Physician Decision|1|||
157170236|NCT00764946|567365200|FG002|Overall Study|Lack of Efficacy|0|||
157170237|NCT00764946|567365198|FG000|Overall Study|Lost to Follow-up|3|||
157170238|NCT00764946|567365199|FG001|Overall Study|Lost to Follow-up|4|||
157170239|NCT00764946|567365200|FG002|Overall Study|Lost to Follow-up|0|||
156958325|NCT01438541|566597398|FG000|Overall Study|Withdrawal by Subject|1|||
156958326|NCT01438541|566597398|FG000|Overall Study|discharge from the hospital|5|||
156958327|NCT02091167|566597399|FG000|Overall Study|Lost to Follow-up|0|||
156958328|NCT02091167|566597400|FG001|Overall Study|Lost to Follow-up|2|||
156958329|NCT01218646|566597401|FG000|Overall Study|Adverse Event|0|||
156958330|NCT01218646|566597402|FG001|Overall Study|Adverse Event|0|||
156958331|NCT01218646|566597403|FG002|Overall Study|Adverse Event|1|||
156958332|NCT01218646|566597404|FG003|Overall Study|Adverse Event|0|||
156958333|NCT01218646|566597401|FG000|Overall Study|Lost to Follow-up|1|||
156958334|NCT01218646|566597402|FG001|Overall Study|Lost to Follow-up|0|||
156958335|NCT01218646|566597403|FG002|Overall Study|Lost to Follow-up|0|||
156958336|NCT01218646|566597404|FG003|Overall Study|Lost to Follow-up|0|||
156958337|NCT01218646|566597401|FG000|Overall Study|Protocol Violation|0|||
156958338|NCT01218646|566597402|FG001|Overall Study|Protocol Violation|0|||
156958339|NCT01218646|566597403|FG002|Overall Study|Protocol Violation|1|||
156958340|NCT01218646|566597404|FG003|Overall Study|Protocol Violation|1|||
156958341|NCT00722761|566597405|FG000|Overall Study|Lost to Follow-up|1|||
156958342|NCT00722761|566597406|FG001|Overall Study|Lost to Follow-up|4|||
156958343|NCT00722761|566597405|FG000|Overall Study|Withdrawal by Subject|5|||
156958344|NCT00722761|566597406|FG001|Overall Study|Withdrawal by Subject|2|||
156958345|NCT02693665|566597412|FG000|Overall Study|Death|3|||
156958346|NCT02693665|566597413|FG001|Overall Study|Death|2|||
156958347|NCT02693665|566597412|FG000|Overall Study|Lost to Follow-up|7|||
156958348|NCT02693665|566597413|FG001|Overall Study|Lost to Follow-up|3|||
156958349|NCT02693665|566597412|FG000|Overall Study|Protocol Violation|1|||
156958350|NCT02693665|566597413|FG001|Overall Study|Protocol Violation|0|||
156958351|NCT02693665|566597412|FG000|Overall Study|Withdrawal by Subject|2|||
156958352|NCT02693665|566597413|FG001|Overall Study|Withdrawal by Subject|0|||
156958353|NCT02693665|566597412|FG000|Overall Study|patient wanted to leave it behind|1|||
156958354|NCT02693665|566597413|FG001|Overall Study|patient wanted to leave it behind|0|||
156958355|NCT02693665|566597412|FG000|Overall Study|anxiety|1|||
156958356|NCT02693665|566597413|FG001|Overall Study|anxiety|0|||
156958357|NCT02693665|566597412|FG000|Overall Study|family issues|1|||
156958358|NCT02693665|566597413|FG001|Overall Study|family issues|0|||
156958359|NCT02693665|566597412|FG000|Overall Study|no reason given|1|||
156958360|NCT02693665|566597413|FG001|Overall Study|no reason given|0|||
156958361|NCT01588184|566598944|FG000|Overall Study|Death|1|||
156958362|NCT01588184|566598945|FG001|Overall Study|Death|0|||
156958363|NCT01588184|566598946|FG002|Overall Study|Death|0|||
156958364|NCT01588184|566598947|FG003|Overall Study|Death|1|||
156958365|NCT01588184|566598948|FG004|Overall Study|Death|1|||
156958366|NCT01588184|566598949|FG005|Overall Study|Death|1|||
156958367|NCT01588184|566598944|FG000|Overall Study|Withdrawal by Subject|2|||
156958368|NCT01588184|566598945|FG001|Overall Study|Withdrawal by Subject|4|||
156958369|NCT01588184|566598946|FG002|Overall Study|Withdrawal by Subject|0|||
156958370|NCT01588184|566598947|FG003|Overall Study|Withdrawal by Subject|1|||
156958371|NCT01588184|566598948|FG004|Overall Study|Withdrawal by Subject|0|||
156958372|NCT01588184|566598949|FG005|Overall Study|Withdrawal by Subject|0|||
156958373|NCT01588184|566598944|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
156958374|NCT01588184|566598945|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
156958375|NCT01588184|566598946|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
156958376|NCT01588184|566598947|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
156958377|NCT01588184|566598948|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
156958378|NCT01588184|566598949|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
156958379|NCT01588184|566598944|FG000|Overall Study|multiple reasons|0|||
156958380|NCT01588184|566598945|FG001|Overall Study|multiple reasons|3|||
156958381|NCT01588184|566598946|FG002|Overall Study|multiple reasons|0|||
156958382|NCT01588184|566598947|FG003|Overall Study|multiple reasons|1|||
156958383|NCT01588184|566598948|FG004|Overall Study|multiple reasons|0|||
156958384|NCT01588184|566598949|FG005|Overall Study|multiple reasons|0|||
156958385|NCT01292928|566598950|FG000|Overall Study|Death|8|||
156958386|NCT01292928|566598950|FG000|Overall Study|Withdrawal by Subject|8|||
156958387|NCT01292928|566598950|FG000|Overall Study|Lost to Follow-up|6|||
156958388|NCT01292928|566598950|FG000|Overall Study|Physician Decision|2|||
156958389|NCT01059565|566598951|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
156958390|NCT01059565|566598952|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
156958391|NCT01059565|566598951|FG000|24-Week Randomized Phase|Adverse Event|5|||
156958392|NCT01059565|566598952|FG001|24-Week Randomized Phase|Adverse Event|0|||
156958393|NCT01059565|566598951|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
156958394|NCT01059565|566598952|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
156958395|NCT01059565|566598951|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
156958396|NCT01059565|566598952|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
156958397|NCT01059565|566598951|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
156958398|NCT01059565|566598952|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
156958399|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Adverse Event|2|||
156958400|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Adverse Event|0|||
156958401|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
156958402|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
156958403|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
156958404|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
157170240|NCT00764946|567365198|FG000|Overall Study|Physician Decision|2|||
157170241|NCT00764946|567365199|FG001|Overall Study|Physician Decision|4|||
157170242|NCT00764946|567365200|FG002|Overall Study|Physician Decision|0|||
157170243|NCT00764946|567365198|FG000|Overall Study|Adverse Event|3|||
157170244|NCT00764946|567365199|FG001|Overall Study|Adverse Event|2|||
157170245|NCT00764946|567365200|FG002|Overall Study|Adverse Event|1|||
157170246|NCT00764946|567365198|FG000|Overall Study|Withdrawal by Subject|3|||
157170247|NCT00764946|567365199|FG001|Overall Study|Withdrawal by Subject|6|||
157170248|NCT00764946|567365200|FG002|Overall Study|Withdrawal by Subject|2|||
157170249|NCT00764946|567365198|FG000|Overall Study|Never Treated|1|||
157170250|NCT00764946|567365199|FG001|Overall Study|Never Treated|1|||
157170251|NCT00764946|567365200|FG002|Overall Study|Never Treated|1|||
157170252|NCT01162304|567365201|FG000|Overall Study|Beck scale to high|11|||
157170253|NCT00585923|567365203|FG000|Overall Study|Physician decided not to continue|31|||
157170254|NCT00585923|567365204|FG001|Overall Study|Physician decided not to continue|33|||
157170255|NCT00878215|567365205|FG000|Overall Study|Determined to be ineligible|0|||
157170256|NCT00878215|567365206|FG001|Overall Study|Determined to be ineligible|10|||
157170257|NCT00878215|567365207|FG002|Overall Study|Determined to be ineligible|0|||
157170258|NCT00878215|567365208|FG003|Overall Study|Determined to be ineligible|0|||
157170259|NCT02815293|567365209|FG000|Overall Study|Study termination by sponsor|10|||
157170260|NCT02815293|567365210|FG001|Overall Study|Study termination by sponsor|7|||
157170261|NCT02815293|567365211|FG002|Overall Study|Study termination by sponsor|0|||
157170262|NCT02815293|567365209|FG000|Overall Study|Participants not randomized|0|||
157170263|NCT02815293|567365210|FG001|Overall Study|Participants not randomized|0|||
157170264|NCT02815293|567365211|FG002|Overall Study|Participants not randomized|18|||
157170265|NCT02815293|567365209|FG000|Overall Study|Adverse Event|0|||
157170266|NCT02815293|567365210|FG001|Overall Study|Adverse Event|1|||
157170267|NCT02815293|567365211|FG002|Overall Study|Adverse Event|0|||
157170268|NCT01167582|567365214|FG000|Overall Study|Lost to Follow-up|0|||
157170269|NCT01167582|567365215|FG001|Overall Study|Lost to Follow-up|1|||
156958405|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
156958406|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
157170270|NCT03956225|567365218|FG000|Overall Study|Lack of Efficacy|1|||
157170271|NCT03956225|567365219|FG001|Overall Study|Lack of Efficacy|1|||
157170272|NCT03956225|567365218|FG000|Overall Study|Lost to Follow-up|0|||
157170273|NCT03956225|567365219|FG001|Overall Study|Lost to Follow-up|1|||
157170274|NCT03956225|567365218|FG000|Overall Study|Withdrawal by Subject|2|||
157170275|NCT03956225|567365219|FG001|Overall Study|Withdrawal by Subject|1|||
157170276|NCT03956225|567365218|FG000|Overall Study|Other Reasons|2|||
157170277|NCT03956225|567365219|FG001|Overall Study|Other Reasons|1|||
157170278|NCT02157506|567365224|FG000|Overall Study|Adverse Event|0|||
157170279|NCT02157506|567365225|FG001|Overall Study|Adverse Event|1|||
157170280|NCT02157506|567365226|FG002|Overall Study|Adverse Event|0|||
157170281|NCT02157506|567365227|FG003|Overall Study|Adverse Event|0|||
157170282|NCT02157506|567365228|FG004|Overall Study|Adverse Event|0|||
157170283|NCT02157506|567365224|FG000|Overall Study|Lost to Follow-up|0|||
157170284|NCT02157506|567365225|FG001|Overall Study|Lost to Follow-up|0|||
157170285|NCT02157506|567365226|FG002|Overall Study|Lost to Follow-up|1|||
157170286|NCT02157506|567365227|FG003|Overall Study|Lost to Follow-up|0|||
157170287|NCT02157506|567365228|FG004|Overall Study|Lost to Follow-up|0|||
157170288|NCT03448224|567365229|FG000|Overall Study|Provided same answer to every question|1|||
157170289|NCT03448224|567365230|FG001|Overall Study|Provided same answer to every question|0|||
157170290|NCT03103906|567365234|FG000|Overall Study|Adverse Event|2|||
156958407|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
156958408|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
156958409|NCT01059565|566598951|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
156958410|NCT01059565|566598952|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
156958411|NCT03263429|566598954|FG000|Overall Study|Withdrawal by Subject|0|||
156958412|NCT03263429|566598955|FG001|Overall Study|Withdrawal by Subject|1|||
156958413|NCT03263429|566598956|FG002|Overall Study|Withdrawal by Subject|0|||
156958414|NCT03263429|566598954|FG000|Overall Study|Follow-Up Period Completed|0|||
156958415|NCT03263429|566598955|FG001|Overall Study|Follow-Up Period Completed|2|||
156958416|NCT03263429|566598956|FG002|Overall Study|Follow-Up Period Completed|0|||
156958417|NCT03263429|566598954|FG000|Overall Study|Death|3|||
157170291|NCT03103906|567365235|FG001|Overall Study|Adverse Event|3|||
157170292|NCT03103906|567365234|FG000|Overall Study|Other|2|||
157170293|NCT03103906|567365235|FG001|Overall Study|Other|0|||
157170294|NCT00764478|567365236|FG000|Overall Study|Adverse Event|1|||
157170295|NCT00764478|567365237|FG001|Overall Study|Adverse Event|1|||
157170296|NCT00764478|567365238|FG002|Overall Study|Adverse Event|1|||
157170297|NCT00764478|567365236|FG000|Overall Study|Withdrawal by Subject|7|||
157170298|NCT00764478|567365237|FG001|Overall Study|Withdrawal by Subject|12|||
157170299|NCT00764478|567365238|FG002|Overall Study|Withdrawal by Subject|1|||
157170300|NCT00764478|567365236|FG000|Overall Study|Lost to Follow-up|7|||
157170301|NCT00764478|567365237|FG001|Overall Study|Lost to Follow-up|8|||
157170302|NCT00764478|567365238|FG002|Overall Study|Lost to Follow-up|5|||
157170303|NCT00764478|567365236|FG000|Overall Study|Protocol Violation|0|||
157170304|NCT00764478|567365237|FG001|Overall Study|Protocol Violation|1|||
157170305|NCT00764478|567365238|FG002|Overall Study|Protocol Violation|1|||
157170306|NCT00643604|567365239|FG000|Overall Study|Death|1|||
157170307|NCT02702011|567365242|FG000|Overall Study|Withdrawal by Subject|0|||
157170308|NCT02702011|567365243|FG001|Overall Study|Withdrawal by Subject|1|||
157170309|NCT02702011|567365244|FG002|Overall Study|Withdrawal by Subject|0|||
157170310|NCT02702011|567365245|FG003|Overall Study|Withdrawal by Subject|0|||
157170311|NCT03498287|567365249|FG000|Overall Study|Withdrawal by Subject|3|||
157170312|NCT03498287|567365250|FG001|Overall Study|Withdrawal by Subject|0|||
157170313|NCT03498287|567365249|FG000|Overall Study|Protocol Violation|0|||
157170314|NCT03498287|567365250|FG001|Overall Study|Protocol Violation|4|||
157170315|NCT03498287|567365249|FG000|Overall Study|Adverse Event|0|||
157170316|NCT03498287|567365250|FG001|Overall Study|Adverse Event|1|||
157170317|NCT01195363|567365253|FG000|Overall Study|Lost to Follow-up|7|||
157170318|NCT01195363|567365254|FG001|Overall Study|Lost to Follow-up|4|||
157170319|NCT01195363|567365253|FG000|Overall Study|Adverse Event|3|||
157170320|NCT01195363|567365254|FG001|Overall Study|Adverse Event|1|||
157170321|NCT01195363|567365253|FG000|Overall Study|Lack of Efficacy|0|||
157170322|NCT01195363|567365254|FG001|Overall Study|Lack of Efficacy|4|||
157170323|NCT01195363|567365253|FG000|Overall Study|incarceration|1|||
157170324|NCT01195363|567365254|FG001|Overall Study|incarceration|0|||
157170325|NCT03288493|567365255|FG000|Overall Study|Withdrawal by Subject|4|||
157170326|NCT03288493|567365256|FG001|Overall Study|Withdrawal by Subject|0|||
157170327|NCT03288493|567365257|FG002|Overall Study|Withdrawal by Subject|0|||
157170328|NCT03288493|567365258|FG003|Overall Study|Withdrawal by Subject|0|||
157170329|NCT03288493|567365259|FG004|Overall Study|Withdrawal by Subject|0|||
157170330|NCT03288493|567365260|FG005|Overall Study|Withdrawal by Subject|2|||
157170331|NCT03288493|567365261|FG006|Overall Study|Withdrawal by Subject|0|||
157170332|NCT03288493|567365255|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
157170333|NCT03288493|567365256|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
157170334|NCT03288493|567365257|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
157170335|NCT03288493|567365258|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
157170336|NCT03288493|567365259|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
157170337|NCT03288493|567365260|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
157170338|NCT03288493|567365261|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
157170339|NCT03288493|567365255|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
157170340|NCT03288493|567365256|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
157170341|NCT03288493|567365257|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
157170342|NCT03288493|567365258|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
157170343|NCT03288493|567365259|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
157170344|NCT03288493|567365260|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
157170345|NCT03288493|567365261|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
157170346|NCT03288493|567365255|FG000|Overall Study|Death|2|||
157170347|NCT03288493|567365256|FG001|Overall Study|Death|0|||
157170348|NCT03288493|567365257|FG002|Overall Study|Death|0|||
157170349|NCT03288493|567365258|FG003|Overall Study|Death|0|||
157170350|NCT03288493|567365259|FG004|Overall Study|Death|0|||
156958418|NCT03263429|566598955|FG001|Overall Study|Death|5|||
156958419|NCT03263429|566598956|FG002|Overall Study|Death|16|||
156958420|NCT03263429|566598954|FG000|Overall Study|Participant unable to return|0|||
156958421|NCT03263429|566598955|FG001|Overall Study|Participant unable to return|0|||
156958422|NCT03263429|566598956|FG002|Overall Study|Participant unable to return|1|||
156958423|NCT03263429|566598954|FG000|Overall Study|Study Closed|0|||
156958424|NCT03263429|566598955|FG001|Overall Study|Study Closed|0|||
156958425|NCT03263429|566598956|FG002|Overall Study|Study Closed|1|||
156958426|NCT04530448|566598957|FG000|Overall Study|Physician Decision|3|||
156958427|NCT04530448|566598958|FG001|Overall Study|Physician Decision|0|||
157170351|NCT03288493|567365260|FG005|Overall Study|Death|0|||
156958428|NCT03579563|566598972|FG000|Overall Study|Lost to Follow-up|0|||
156958429|NCT03579563|566598973|FG001|Overall Study|Lost to Follow-up|0|||
156958430|NCT03579563|566598974|FG002|Overall Study|Lost to Follow-up|0|||
157170352|NCT03288493|567365261|FG006|Overall Study|Death|0|||
157170353|NCT03288493|567365255|FG000|Overall Study|other reason not listed above|2|||
157170354|NCT03288493|567365256|FG001|Overall Study|other reason not listed above|0|||
157227716|NCT06179108|567579174|FG000|Overall Study|Lost to Follow-up|12|||
156958431|NCT03579563|566598975|FG003|Overall Study|Lost to Follow-up|0|||
156958432|NCT03579563|566598976|FG004|Overall Study|Lost to Follow-up|1|||
156958433|NCT03579563|566598977|FG005|Overall Study|Lost to Follow-up|0|||
156958434|NCT03579563|566598972|FG000|Overall Study|Lack of Efficacy|1|||
156958435|NCT03579563|566598973|FG001|Overall Study|Lack of Efficacy|1|||
156958436|NCT03579563|566598974|FG002|Overall Study|Lack of Efficacy|4|||
156958437|NCT03579563|566598975|FG003|Overall Study|Lack of Efficacy|1|||
156958438|NCT03579563|566598976|FG004|Overall Study|Lack of Efficacy|2|||
156958439|NCT03579563|566598977|FG005|Overall Study|Lack of Efficacy|3|||
156958440|NCT03579563|566598972|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156958441|NCT03579563|566598973|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156958442|NCT03579563|566598974|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
156958443|NCT03579563|566598975|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
156958444|NCT03579563|566598976|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156958445|NCT03579563|566598977|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
156958446|NCT03579563|566598972|FG000|Overall Study|Time/distance concern|0|||
156958447|NCT03579563|566598973|FG001|Overall Study|Time/distance concern|0|||
156958448|NCT03579563|566598974|FG002|Overall Study|Time/distance concern|1|||
156958449|NCT03579563|566598975|FG003|Overall Study|Time/distance concern|0|||
156958450|NCT03579563|566598976|FG004|Overall Study|Time/distance concern|0|||
156958451|NCT03579563|566598977|FG005|Overall Study|Time/distance concern|1|||
156958452|NCT03579563|566598972|FG000|Overall Study|COVID shutdown|2|||
156958453|NCT03579563|566598973|FG001|Overall Study|COVID shutdown|3|||
156958454|NCT03579563|566598974|FG002|Overall Study|COVID shutdown|4|||
156958455|NCT03579563|566598975|FG003|Overall Study|COVID shutdown|3|||
156958456|NCT03579563|566598976|FG004|Overall Study|COVID shutdown|1|||
156958457|NCT03579563|566598977|FG005|Overall Study|COVID shutdown|2|||
156958458|NCT03579563|566598972|FG000|Overall Study|Protocol administration error|1|||
156958459|NCT03579563|566598973|FG001|Overall Study|Protocol administration error|0|||
156958460|NCT03579563|566598974|FG002|Overall Study|Protocol administration error|1|||
156958461|NCT03579563|566598975|FG003|Overall Study|Protocol administration error|0|||
156958462|NCT03579563|566598976|FG004|Overall Study|Protocol administration error|1|||
156958463|NCT03579563|566598977|FG005|Overall Study|Protocol administration error|5|||
156958464|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
156958465|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
156958466|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
156958467|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
156958468|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
156958469|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156958470|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156958471|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
156958472|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
156958473|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156958474|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156958475|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
156958476|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
156958477|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156958478|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156958479|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
156958480|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
156958481|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156958482|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156958483|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
156958484|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
156958485|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156958486|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156958487|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
156958488|NCT01715805|566598978|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
156958489|NCT01715805|566598979|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156958490|NCT01715805|566598980|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156958491|NCT01715805|566598981|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
156958492|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
156958493|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
156958494|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
157170355|NCT03288493|567365257|FG002|Overall Study|other reason not listed above|0|||
157170356|NCT03288493|567365258|FG003|Overall Study|other reason not listed above|0|||
156958495|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
156958496|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
156958497|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
156958498|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
156958499|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
156958500|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
157170357|NCT03288493|567365259|FG004|Overall Study|other reason not listed above|0|||
157170358|NCT03288493|567365260|FG005|Overall Study|other reason not listed above|0|||
157170359|NCT03288493|567365261|FG006|Overall Study|other reason not listed above|0|||
157170360|NCT01871896|567365262|FG000|Overall Study|Lost to Follow-up|1|||
157170361|NCT05263921|567367100|FG000|Overall Study|Other: family emergency.|0|||
157170362|NCT05263921|567367101|FG001|Overall Study|Other: family emergency.|0|||
157170363|NCT05263921|567367102|FG002|Overall Study|Other: family emergency.|1|||
157170364|NCT05263921|567367103|FG003|Overall Study|Other: family emergency.|0|||
157170365|NCT00340834|567367108|FG000|Core Phase of Study|Adverse Event|26|||
157170366|NCT00340834|567367109|FG001|Core Phase of Study|Adverse Event|9|||
157170367|NCT00340834|567367110|FG002|Core Phase of Study|Adverse Event|9|||
157170368|NCT00340834|567367111|FG003|Core Phase of Study|Adverse Event|0|||
157170369|NCT00340834|567367112|FG004|Core Phase of Study|Adverse Event|0|||
157170370|NCT00340834|567367108|FG000|Core Phase of Study|Withdrawal by Subject|11|||
157170371|NCT00340834|567367109|FG001|Core Phase of Study|Withdrawal by Subject|9|||
157170372|NCT00340834|567367110|FG002|Core Phase of Study|Withdrawal by Subject|16|||
157170373|NCT00340834|567367111|FG003|Core Phase of Study|Withdrawal by Subject|0|||
157170374|NCT00340834|567367112|FG004|Core Phase of Study|Withdrawal by Subject|0|||
157170375|NCT00340834|567367108|FG000|Core Phase of Study|Administrative Problems|6|||
157170376|NCT00340834|567367109|FG001|Core Phase of Study|Administrative Problems|2|||
157170377|NCT00340834|567367110|FG002|Core Phase of Study|Administrative Problems|7|||
157170378|NCT00340834|567367111|FG003|Core Phase of Study|Administrative Problems|0|||
157170379|NCT00340834|567367112|FG004|Core Phase of Study|Administrative Problems|0|||
157170380|NCT00340834|567367108|FG000|Core Phase of Study|Lack of Efficacy|3|||
157170381|NCT00340834|567367109|FG001|Core Phase of Study|Lack of Efficacy|3|||
157170382|NCT00340834|567367110|FG002|Core Phase of Study|Lack of Efficacy|7|||
157170383|NCT00340834|567367111|FG003|Core Phase of Study|Lack of Efficacy|0|||
157170384|NCT00340834|567367112|FG004|Core Phase of Study|Lack of Efficacy|0|||
157170385|NCT00340834|567367108|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
157170386|NCT00340834|567367109|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
157170387|NCT00340834|567367110|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
157170388|NCT00340834|567367111|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
157170389|NCT00340834|567367112|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
157170390|NCT00340834|567367108|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
157170391|NCT00340834|567367109|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
157170392|NCT00340834|567367110|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
157170393|NCT00340834|567367111|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
157170394|NCT00340834|567367112|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
157170395|NCT00340834|567367108|FG000|Core Phase of Study|Lost to Follow-up|1|||
157170396|NCT00340834|567367109|FG001|Core Phase of Study|Lost to Follow-up|1|||
157170397|NCT00340834|567367110|FG002|Core Phase of Study|Lost to Follow-up|4|||
157170398|NCT00340834|567367111|FG003|Core Phase of Study|Lost to Follow-up|0|||
157170399|NCT00340834|567367112|FG004|Core Phase of Study|Lost to Follow-up|0|||
157170400|NCT00340834|567367108|FG000|Core Phase of Study|Death|2|||
157170401|NCT00340834|567367109|FG001|Core Phase of Study|Death|0|||
157170402|NCT00340834|567367110|FG002|Core Phase of Study|Death|0|||
157170403|NCT00340834|567367111|FG003|Core Phase of Study|Death|0|||
157170404|NCT00340834|567367112|FG004|Core Phase of Study|Death|0|||
157170405|NCT00340834|567367108|FG000|Core Phase of Study|Protocol Violation|0|||
157170406|NCT00340834|567367109|FG001|Core Phase of Study|Protocol Violation|0|||
157170407|NCT00340834|567367110|FG002|Core Phase of Study|Protocol Violation|2|||
157170408|NCT00340834|567367111|FG003|Core Phase of Study|Protocol Violation|0|||
157170409|NCT00340834|567367112|FG004|Core Phase of Study|Protocol Violation|0|||
157170410|NCT00340834|567367108|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
157170411|NCT00340834|567367109|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
157170412|NCT00340834|567367110|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
157170413|NCT00340834|567367111|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
157170414|NCT00340834|567367112|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
156958501|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
157170415|NCT00340834|567367108|FG000|Extension Phase of Study|Subject withdrew consent|26|||
157170416|NCT00340834|567367109|FG001|Extension Phase of Study|Subject withdrew consent|31|||
157170417|NCT00340834|567367110|FG002|Extension Phase of Study|Subject withdrew consent|0|||
157170418|NCT00340834|567367111|FG003|Extension Phase of Study|Subject withdrew consent|12|||
157170419|NCT00340834|567367112|FG004|Extension Phase of Study|Subject withdrew consent|15|||
157170420|NCT00340834|567367108|FG000|Extension Phase of Study|Adverse Event|21|||
157170421|NCT00340834|567367109|FG001|Extension Phase of Study|Adverse Event|22|||
157170422|NCT00340834|567367110|FG002|Extension Phase of Study|Adverse Event|0|||
157170423|NCT00340834|567367111|FG003|Extension Phase of Study|Adverse Event|19|||
157170424|NCT00340834|567367112|FG004|Extension Phase of Study|Adverse Event|7|||
157170425|NCT00340834|567367108|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
157170426|NCT00340834|567367109|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
157170427|NCT00340834|567367110|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
157227717|NCT06179108|567579175|FG001|Overall Study|Lost to Follow-up|4|||
157170428|NCT00340834|567367111|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
156958502|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
156958503|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
156958504|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
157170429|NCT00340834|567367112|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
157170430|NCT00340834|567367108|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
157170431|NCT00340834|567367109|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
157170432|NCT00340834|567367110|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
157170433|NCT00340834|567367111|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
157170434|NCT00340834|567367112|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
157170435|NCT00340834|567367108|FG000|Extension Phase of Study|Lost to Follow-up|1|||
157170436|NCT00340834|567367109|FG001|Extension Phase of Study|Lost to Follow-up|1|||
157170437|NCT00340834|567367110|FG002|Extension Phase of Study|Lost to Follow-up|0|||
157170438|NCT00340834|567367111|FG003|Extension Phase of Study|Lost to Follow-up|2|||
157170439|NCT00340834|567367112|FG004|Extension Phase of Study|Lost to Follow-up|3|||
157170440|NCT00340834|567367108|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
157170441|NCT00340834|567367109|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
157170442|NCT00340834|567367110|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
157170443|NCT00340834|567367111|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
157170444|NCT00340834|567367112|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
157170445|NCT00340834|567367108|FG000|Extension Phase of Study|Administrative problems|3|||
157170446|NCT00340834|567367109|FG001|Extension Phase of Study|Administrative problems|0|||
157170447|NCT00340834|567367110|FG002|Extension Phase of Study|Administrative problems|0|||
157170448|NCT00340834|567367111|FG003|Extension Phase of Study|Administrative problems|1|||
157170449|NCT00340834|567367112|FG004|Extension Phase of Study|Administrative problems|1|||
157170450|NCT00340834|567367108|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
157170451|NCT00340834|567367109|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
157170452|NCT00340834|567367110|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
157170453|NCT00340834|567367111|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
157170454|NCT00340834|567367112|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
157170455|NCT00340834|567367108|FG000|Extension Phase of Study|Protocol Violation|3|||
157170456|NCT00340834|567367109|FG001|Extension Phase of Study|Protocol Violation|0|||
157170457|NCT00340834|567367110|FG002|Extension Phase of Study|Protocol Violation|0|||
157170458|NCT00340834|567367111|FG003|Extension Phase of Study|Protocol Violation|0|||
157170459|NCT00340834|567367112|FG004|Extension Phase of Study|Protocol Violation|0|||
157170460|NCT00340834|567367108|FG000|Extension Phase of Study|Death|0|||
157170461|NCT00340834|567367109|FG001|Extension Phase of Study|Death|0|||
157170462|NCT00340834|567367110|FG002|Extension Phase of Study|Death|0|||
157170463|NCT00340834|567367111|FG003|Extension Phase of Study|Death|0|||
157170464|NCT00340834|567367112|FG004|Extension Phase of Study|Death|1|||
157170465|NCT00291499|567367113|FG000|Overall Study|Adverse Event|3|||
157170466|NCT00291499|567367114|FG001|Overall Study|Adverse Event|8|||
157170467|NCT00291499|567367113|FG000|Overall Study|Change to other therapy|2|||
157170468|NCT00291499|567367114|FG001|Overall Study|Change to other therapy|1|||
157170469|NCT00291499|567367113|FG000|Overall Study|Intercurrent illness|1|||
157170470|NCT00291499|567367114|FG001|Overall Study|Intercurrent illness|0|||
157170471|NCT00291499|567367113|FG000|Overall Study|Protocol Violation|2|||
157170472|NCT00291499|567367114|FG001|Overall Study|Protocol Violation|2|||
157170473|NCT00291499|567367113|FG000|Overall Study|Other reasons|1|||
157170474|NCT00291499|567367114|FG001|Overall Study|Other reasons|4|||
157170475|NCT02786836|567367115|FG000|Overall Study|Death|1|||
157170476|NCT02786836|567367115|FG000|Overall Study|Lack of Efficacy|2|||
157170477|NCT02786836|567367115|FG000|Overall Study|Protocol Violation|3|||
157170478|NCT02786836|567367115|FG000|Overall Study|Withdrawal by Subject|3|||
157170479|NCT02786836|567367115|FG000|Overall Study|Liver Transplantation|2|||
157170480|NCT02786836|567367115|FG000|Overall Study|Device or Pharmacy Issues|3|||
157170481|NCT01143714|567367116|FG000|Overall Study|Adverse Event|4|||
157170482|NCT01143714|567367117|FG001|Overall Study|Adverse Event|2|||
157170483|NCT01143714|567367116|FG000|Overall Study|Withdrawal by Subject|1|||
157170484|NCT01143714|567367117|FG001|Overall Study|Withdrawal by Subject|0|||
157227718|NCT06179108|567579176|FG002|Overall Study|Lost to Follow-up|1|||
156958505|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
157170485|NCT01143714|567367116|FG000|Overall Study|Subject non-compliance|0|||
157170486|NCT01143714|567367117|FG001|Overall Study|Subject non-compliance|1|||
157170487|NCT01143714|567367116|FG000|Overall Study|wound closed = deemed healed|1|||
157170488|NCT01143714|567367117|FG001|Overall Study|wound closed = deemed healed|0|||
157170489|NCT01143714|567367116|FG000|Overall Study|wound size increased|1|||
157170490|NCT01143714|567367117|FG001|Overall Study|wound size increased|0|||
157170491|NCT02016898|567367127|FG000|Overall Study|Death|1|||
157170492|NCT02016898|567367128|FG001|Overall Study|Death|1|||
157170493|NCT02016898|567367127|FG000|Overall Study|Lost to Follow-up|4|||
157170494|NCT02016898|567367128|FG001|Overall Study|Lost to Follow-up|4|||
157170495|NCT01381718|567367129|FG000|Overall Study|Withdrawal by Subject|2|||
157170496|NCT01381718|567367130|FG001|Overall Study|Withdrawal by Subject|5|||
157170497|NCT01381718|567367129|FG000|Overall Study|Lost to Follow-up|3|||
157170498|NCT01381718|567367130|FG001|Overall Study|Lost to Follow-up|5|||
157170499|NCT01381718|567367129|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
157170500|NCT01381718|567367130|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
157170501|NCT01306032|567367135|FG000|First Intervention|Adverse Event|1|||
157170502|NCT01306032|567367136|FG001|First Intervention|Adverse Event|0|||
157170503|NCT01306032|567367137|FG002|First Intervention|Adverse Event|1|||
157170504|NCT01306032|567367138|FG003|First Intervention|Adverse Event|0|||
157170505|NCT01306032|567367139|FG004|First Intervention|Adverse Event|0|||
157170506|NCT01306032|567367140|FG005|First Intervention|Adverse Event|1|||
157170507|NCT01306032|567367135|FG000|First Intervention|Withdrawal by Subject|0|||
157170508|NCT01306032|567367136|FG001|First Intervention|Withdrawal by Subject|2|||
157170509|NCT01306032|567367137|FG002|First Intervention|Withdrawal by Subject|0|||
157170510|NCT01306032|567367138|FG003|First Intervention|Withdrawal by Subject|1|||
157170511|NCT01306032|567367139|FG004|First Intervention|Withdrawal by Subject|0|||
157170512|NCT01306032|567367140|FG005|First Intervention|Withdrawal by Subject|0|||
156958506|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
156958507|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
156958508|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
157170513|NCT01306032|567367135|FG000|First Intervention|Death|0|||
156958509|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
156958510|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
156958511|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
156958512|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
156958513|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
156958514|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
156958515|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
156958516|NCT01715805|566598978|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156958517|NCT01715805|566598979|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
156958518|NCT01715805|566598980|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156958519|NCT01715805|566598981|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
156958520|NCT02219932|566598982|FG000|Overall Study|Other|5|||
156958521|NCT02219932|566598983|FG001|Overall Study|Other|11|||
156958522|NCT02219932|566598982|FG000|Overall Study|Death|1|||
156958523|NCT02219932|566598983|FG001|Overall Study|Death|1|||
156958524|NCT02219932|566598982|FG000|Overall Study|Investigator Decision|0|||
156958525|NCT02219932|566598983|FG001|Overall Study|Investigator Decision|1|||
156958526|NCT02219932|566598982|FG000|Overall Study|Consent Withdrawn|11|||
156958527|NCT02219932|566598983|FG001|Overall Study|Consent Withdrawn|7|||
156958528|NCT02219932|566598982|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
156958529|NCT02219932|566598983|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
156958530|NCT02219932|566598982|FG000|Overall Study|Protocol Violation|10|||
156958531|NCT02219932|566598983|FG001|Overall Study|Protocol Violation|6|||
156958532|NCT02219932|566598982|FG000|Overall Study|Pregnancy|1|||
156958533|NCT02219932|566598983|FG001|Overall Study|Pregnancy|0|||
156958534|NCT02219932|566598982|FG000|Overall Study|Lost to Follow-up|4|||
156958535|NCT02219932|566598983|FG001|Overall Study|Lost to Follow-up|2|||
156958536|NCT02219932|566598982|FG000|Overall Study|Adverse Event|23|||
156958537|NCT02219932|566598983|FG001|Overall Study|Adverse Event|21|||
156958538|NCT00511004|566598984|FG000|Overall Study|Lost to Follow-up|0|||
156958539|NCT00511004|566598985|FG001|Overall Study|Lost to Follow-up|0|||
156958540|NCT00511004|566598986|FG002|Overall Study|Lost to Follow-up|4|||
156958541|NCT05177770|566598987|FG000|Overall Study|Death|4|||
156958542|NCT05177770|566598987|FG000|Overall Study|Withdrawal by Subject|1|||
156958543|NCT05177770|566598987|FG000|Overall Study|Adverse Event prior to dosing|1|||
156958544|NCT01672801|566598992|FG000|Overall Study|Screen Failure|0|||
156958545|NCT01672801|566598993|FG001|Overall Study|Screen Failure|1|||
156958546|NCT02384954|566599001|FG000|Phase 1|Progressive Disease|2|||
156958547|NCT02384954|566599002|FG001|Phase 1|Progressive Disease|0|||
156958548|NCT02384954|566599003|FG002|Phase 1|Progressive Disease|1|||
157170514|NCT01306032|567367136|FG001|First Intervention|Death|0|||
156958549|NCT02384954|566599004|FG003|Phase 1|Progressive Disease|1|||
156958550|NCT02384954|566599005|FG004|Phase 1|Progressive Disease|0|||
156958551|NCT02384954|566599006|FG005|Phase 1|Progressive Disease|0|||
156958552|NCT02384954|566599007|FG006|Phase 1|Progressive Disease|0|||
156958553|NCT02384954|566599008|FG007|Phase 1|Progressive Disease|0|||
157170515|NCT01306032|567367137|FG002|First Intervention|Death|1|||
157170516|NCT01306032|567367138|FG003|First Intervention|Death|0|||
157170517|NCT01306032|567367139|FG004|First Intervention|Death|0|||
157170518|NCT01306032|567367140|FG005|First Intervention|Death|0|||
157170519|NCT01306032|567367135|FG000|First Intervention|Ineligible|0|||
157170520|NCT01306032|567367136|FG001|First Intervention|Ineligible|0|||
157170521|NCT01306032|567367137|FG002|First Intervention|Ineligible|0|||
156958554|NCT02384954|566599009|FG008|Phase 1|Progressive Disease|0|||
156958555|NCT02384954|566599001|FG000|Phase 1|Adverse Event|0|||
156958556|NCT02384954|566599002|FG001|Phase 1|Adverse Event|0|||
156958557|NCT02384954|566599003|FG002|Phase 1|Adverse Event|1|||
156958558|NCT02384954|566599004|FG003|Phase 1|Adverse Event|0|||
156958559|NCT02384954|566599005|FG004|Phase 1|Adverse Event|0|||
156958560|NCT02384954|566599006|FG005|Phase 1|Adverse Event|0|||
156958561|NCT02384954|566599007|FG006|Phase 1|Adverse Event|0|||
156958562|NCT02384954|566599008|FG007|Phase 1|Adverse Event|0|||
156958563|NCT02384954|566599009|FG008|Phase 1|Adverse Event|0|||
156958564|NCT02384954|566599001|FG000|Phase 2|Progressive Disease|0|||
156958565|NCT02384954|566599002|FG001|Phase 2|Progressive Disease|0|||
156958566|NCT02384954|566599003|FG002|Phase 2|Progressive Disease|0|||
156958567|NCT02384954|566599004|FG003|Phase 2|Progressive Disease|0|||
156958568|NCT02384954|566599005|FG004|Phase 2|Progressive Disease|0|||
156958569|NCT02384954|566599006|FG005|Phase 2|Progressive Disease|0|||
156958570|NCT02384954|566599007|FG006|Phase 2|Progressive Disease|0|||
156958571|NCT02384954|566599008|FG007|Phase 2|Progressive Disease|1|||
156958572|NCT02384954|566599009|FG008|Phase 2|Progressive Disease|2|||
156958573|NCT02384954|566599001|FG000|Phase 2|Adverse Event|0|||
156958574|NCT02384954|566599002|FG001|Phase 2|Adverse Event|0|||
156958575|NCT02384954|566599003|FG002|Phase 2|Adverse Event|0|||
156958576|NCT02384954|566599004|FG003|Phase 2|Adverse Event|0|||
156958577|NCT02384954|566599005|FG004|Phase 2|Adverse Event|0|||
156958578|NCT02384954|566599006|FG005|Phase 2|Adverse Event|0|||
156958579|NCT02384954|566599007|FG006|Phase 2|Adverse Event|0|||
156958580|NCT02384954|566599008|FG007|Phase 2|Adverse Event|1|||
156958581|NCT02384954|566599009|FG008|Phase 2|Adverse Event|1|||
156958582|NCT02384954|566599001|FG000|Phase 2|Failure to meet continuation criteria|0|||
156958583|NCT02384954|566599002|FG001|Phase 2|Failure to meet continuation criteria|0|||
156958584|NCT02384954|566599003|FG002|Phase 2|Failure to meet continuation criteria|0|||
156958585|NCT02384954|566599004|FG003|Phase 2|Failure to meet continuation criteria|0|||
156958586|NCT02384954|566599005|FG004|Phase 2|Failure to meet continuation criteria|0|||
156958587|NCT02384954|566599006|FG005|Phase 2|Failure to meet continuation criteria|0|||
156958588|NCT02384954|566599007|FG006|Phase 2|Failure to meet continuation criteria|0|||
156958589|NCT02384954|566599008|FG007|Phase 2|Failure to meet continuation criteria|1|||
156958590|NCT02384954|566599009|FG008|Phase 2|Failure to meet continuation criteria|0|||
156958591|NCT02372396|566599010|FG000|Overall Study|Lost to Follow-up|7|||
156958592|NCT02372396|566599011|FG001|Overall Study|Lost to Follow-up|9|||
156958593|NCT00214136|566599014|FG000|Overall Study|Death|5|||
156958594|NCT04313634|566599015|FG000|Overall Study|Adverse Event|2|||
156958595|NCT04313634|566599016|FG001|Overall Study|Adverse Event|2|||
156958596|NCT04313634|566599017|FG002|Overall Study|Adverse Event|0|||
156958597|NCT04313634|566599015|FG000|Overall Study|Withdrawal by Subject|1|||
156958598|NCT04313634|566599016|FG001|Overall Study|Withdrawal by Subject|0|||
156958599|NCT04313634|566599017|FG002|Overall Study|Withdrawal by Subject|1|||
156958600|NCT04313634|566599015|FG000|Overall Study|Protocol Violation|0|||
156958601|NCT04313634|566599016|FG001|Overall Study|Protocol Violation|0|||
156958602|NCT04313634|566599017|FG002|Overall Study|Protocol Violation|1|||
156958603|NCT01226745|566599020|FG000|Overall Study|Did not complete schedule of assessments|8|||
156958604|NCT01226745|566599021|FG001|Overall Study|Did not complete schedule of assessments|3|||
156958605|NCT01226745|566599022|FG002|Overall Study|Did not complete schedule of assessments|6|||
156958606|NCT01226745|566599023|FG003|Overall Study|Did not complete schedule of assessments|0|||
156958607|NCT01226745|566599024|FG004|Overall Study|Did not complete schedule of assessments|0|||
156958608|NCT01226745|566599025|FG005|Overall Study|Did not complete schedule of assessments|1|||
156958609|NCT01226745|566599020|FG000|Overall Study|Lost to Follow-up|2|||
156958610|NCT01226745|566599021|FG001|Overall Study|Lost to Follow-up|6|||
156958611|NCT01226745|566599022|FG002|Overall Study|Lost to Follow-up|6|||
156958612|NCT01226745|566599023|FG003|Overall Study|Lost to Follow-up|1|||
156958613|NCT01226745|566599024|FG004|Overall Study|Lost to Follow-up|1|||
156958614|NCT01226745|566599025|FG005|Overall Study|Lost to Follow-up|2|||
156958615|NCT01226745|566599020|FG000|Overall Study|Death|1|||
156958616|NCT01226745|566599021|FG001|Overall Study|Death|0|||
156958617|NCT01226745|566599022|FG002|Overall Study|Death|0|||
156958618|NCT01226745|566599023|FG003|Overall Study|Death|0|||
156958619|NCT01226745|566599024|FG004|Overall Study|Death|0|||
156958620|NCT01226745|566599025|FG005|Overall Study|Death|1|||
156958621|NCT01226745|566599020|FG000|Overall Study|Other|6|||
156958622|NCT01226745|566599021|FG001|Overall Study|Other|7|||
156958623|NCT01226745|566599022|FG002|Overall Study|Other|8|||
156958624|NCT01226745|566599023|FG003|Overall Study|Other|4|||
156958625|NCT01226745|566599024|FG004|Overall Study|Other|3|||
156958626|NCT01226745|566599025|FG005|Overall Study|Other|1|||
156958627|NCT02105948|566599026|FG000|Overall Study|Adverse Event|10|||
156958628|NCT02105948|566599027|FG001|Overall Study|Adverse Event|7|||
156958629|NCT02105948|566599028|FG002|Overall Study|Adverse Event|11|||
156958630|NCT02105948|566599029|FG003|Overall Study|Adverse Event|11|||
156958631|NCT02105948|566599026|FG000|Overall Study|Lack of Efficacy|0|||
156958632|NCT02105948|566599027|FG001|Overall Study|Lack of Efficacy|1|||
156958633|NCT02105948|566599028|FG002|Overall Study|Lack of Efficacy|3|||
156958634|NCT02105948|566599029|FG003|Overall Study|Lack of Efficacy|2|||
156958635|NCT02105948|566599026|FG000|Overall Study|Lost to Follow-up|0|||
156958636|NCT02105948|566599027|FG001|Overall Study|Lost to Follow-up|0|||
156958637|NCT02105948|566599028|FG002|Overall Study|Lost to Follow-up|2|||
156958638|NCT02105948|566599029|FG003|Overall Study|Lost to Follow-up|1|||
156958639|NCT02105948|566599026|FG000|Overall Study|Physician Decision|2|||
156958640|NCT02105948|566599027|FG001|Overall Study|Physician Decision|2|||
156958641|NCT02105948|566599028|FG002|Overall Study|Physician Decision|2|||
156958642|NCT02105948|566599029|FG003|Overall Study|Physician Decision|2|||
156958643|NCT02105948|566599026|FG000|Overall Study|Withdrawal by Subject|15|||
156958644|NCT02105948|566599027|FG001|Overall Study|Withdrawal by Subject|10|||
156958645|NCT02105948|566599028|FG002|Overall Study|Withdrawal by Subject|10|||
156958646|NCT02105948|566599029|FG003|Overall Study|Withdrawal by Subject|11|||
156958647|NCT02187991|566599031|FG000|Overall Study|Adverse Event|13|||
156958648|NCT02187991|566599032|FG001|Overall Study|Adverse Event|14|||
156958649|NCT02187991|566599033|FG002|Overall Study|Adverse Event|3|||
156958650|NCT02187991|566599034|FG003|Overall Study|Adverse Event|2|||
156958651|NCT02187991|566599031|FG000|Overall Study|Withdrawal by Subject|9|||
156958652|NCT02187991|566599032|FG001|Overall Study|Withdrawal by Subject|6|||
156958653|NCT02187991|566599033|FG002|Overall Study|Withdrawal by Subject|3|||
156958654|NCT02187991|566599034|FG003|Overall Study|Withdrawal by Subject|2|||
156958655|NCT02187991|566599031|FG000|Overall Study|Physician Decision|4|||
156958656|NCT02187991|566599032|FG001|Overall Study|Physician Decision|4|||
156958657|NCT02187991|566599033|FG002|Overall Study|Physician Decision|0|||
156958658|NCT02187991|566599034|FG003|Overall Study|Physician Decision|2|||
156958659|NCT02187991|566599031|FG000|Overall Study|Other, unrelated complication|7|||
156958660|NCT02187991|566599032|FG001|Overall Study|Other, unrelated complication|1|||
156958661|NCT02187991|566599033|FG002|Overall Study|Other, unrelated complication|1|||
156958662|NCT02187991|566599034|FG003|Overall Study|Other, unrelated complication|2|||
156958663|NCT02187991|566599031|FG000|Overall Study|Death|1|||
156958664|NCT02187991|566599032|FG001|Overall Study|Death|3|||
156958665|NCT02187991|566599033|FG002|Overall Study|Death|0|||
156958666|NCT02187991|566599034|FG003|Overall Study|Death|0|||
156958667|NCT04072159|566599038|FG000|Overall Study|Lost to Follow-up|6|||
156958668|NCT04072159|566599039|FG001|Overall Study|Lost to Follow-up|6|||
157170522|NCT01306032|567367138|FG003|First Intervention|Ineligible|0|||
157170523|NCT01306032|567367139|FG004|First Intervention|Ineligible|0|||
157170524|NCT01306032|567367140|FG005|First Intervention|Ineligible|1|||
157170525|NCT01306032|567367135|FG000|First Intervention|Progressive disease|0|||
157170526|NCT01306032|567367136|FG001|First Intervention|Progressive disease|0|||
157170527|NCT01306032|567367137|FG002|First Intervention|Progressive disease|0|||
157170528|NCT01306032|567367138|FG003|First Intervention|Progressive disease|0|||
157170529|NCT01306032|567367139|FG004|First Intervention|Progressive disease|2|||
157170530|NCT01306032|567367140|FG005|First Intervention|Progressive disease|0|||
156958669|NCT04072159|566599038|FG000|Overall Study|Withdrawal by Subject|2|||
156958670|NCT04072159|566599039|FG001|Overall Study|Withdrawal by Subject|0|||
156958671|NCT04656847|566599041|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
156958672|NCT03301051|566599042|FG000|Overall Study|Adverse Event|0|||
156958673|NCT03301051|566599043|FG001|Overall Study|Adverse Event|4|||
156958674|NCT03301051|566599042|FG000|Overall Study|Withdrawal by Subject|59|||
156958675|NCT03301051|566599043|FG001|Overall Study|Withdrawal by Subject|65|||
156958676|NCT03301051|566599042|FG000|Overall Study|Lost to Follow-up|263|||
156958677|NCT03301051|566599043|FG001|Overall Study|Lost to Follow-up|282|||
156958678|NCT03301051|566599042|FG000|Overall Study|Protocol Violation|1|||
156958679|NCT03301051|566599043|FG001|Overall Study|Protocol Violation|3|||
156958680|NCT03301051|566599042|FG000|Overall Study|Physician Decision|1|||
156958681|NCT03301051|566599043|FG001|Overall Study|Physician Decision|3|||
156958682|NCT03301051|566599042|FG000|Overall Study|Death|1|||
156958683|NCT03301051|566599043|FG001|Overall Study|Death|1|||
156958684|NCT03301051|566599042|FG000|Overall Study|Miscellaneous|8|||
156958685|NCT03301051|566599043|FG001|Overall Study|Miscellaneous|4|||
156958686|NCT03301051|566599042|FG000|Overall Study|Randomized, not vaccinated|13|||
156958687|NCT03301051|566599043|FG001|Overall Study|Randomized, not vaccinated|10|||
156958688|NCT00047879|566599044|FG000|Overall Study|Progressive disease|4|||
156958689|NCT00047879|566599045|FG001|Overall Study|Progressive disease|3|||
156958690|NCT01196975|566599046|FG000|Overall Study|Adverse Event|2|||
156958691|NCT01196975|566599047|FG001|Overall Study|Adverse Event|2|||
156958692|NCT01196975|566599048|FG002|Overall Study|Adverse Event|0|||
156958693|NCT01196975|566599049|FG003|Overall Study|Adverse Event|0|||
157170531|NCT01306032|567367135|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
156958694|NCT01196975|566599050|FG004|Overall Study|Adverse Event|2|||
156958695|NCT01196975|566599046|FG000|Overall Study|Withdrawal by Subject|2|||
156958696|NCT01196975|566599047|FG001|Overall Study|Withdrawal by Subject|1|||
156958697|NCT01196975|566599048|FG002|Overall Study|Withdrawal by Subject|0|||
156958698|NCT01196975|566599049|FG003|Overall Study|Withdrawal by Subject|1|||
157170532|NCT01306032|567367136|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
157170533|NCT01306032|567367137|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
156958699|NCT01196975|566599050|FG004|Overall Study|Withdrawal by Subject|0|||
156958700|NCT01196975|566599046|FG000|Overall Study|Lost to Follow-up|11|||
156958701|NCT01196975|566599047|FG001|Overall Study|Lost to Follow-up|6|||
156958702|NCT01196975|566599048|FG002|Overall Study|Lost to Follow-up|5|||
156958703|NCT01196975|566599049|FG003|Overall Study|Lost to Follow-up|5|||
156958704|NCT01196975|566599050|FG004|Overall Study|Lost to Follow-up|11|||
156958705|NCT04558346|566599068|FG000|Overall Study|Withdrawal by Subject|2|||
156958706|NCT04558346|566599069|FG001|Overall Study|Withdrawal by Subject|0|||
156958707|NCT04558346|566599068|FG000|Overall Study|Lost to Follow-up|0|||
156958708|NCT04558346|566599069|FG001|Overall Study|Lost to Follow-up|1|||
156958709|NCT04558346|566599068|FG000|Overall Study|Adverse Event|0|||
156958710|NCT04558346|566599069|FG001|Overall Study|Adverse Event|1|||
156958711|NCT00724971|566599072|FG000|Overall Study|Adverse Event|5|||
156958712|NCT00724971|566599072|FG000|Overall Study|Withdrawal by Subject|1|||
156958713|NCT01462344|566599073|FG000|Overall Study|Withdrawal by Subject|245|||
156958714|NCT01462344|566599074|FG001|Overall Study|Withdrawal by Subject|226|||
156958715|NCT01462344|566599073|FG000|Overall Study|Adverse Event|24|||
156958716|NCT01462344|566599074|FG001|Overall Study|Adverse Event|23|||
156958717|NCT01462344|566599073|FG000|Overall Study|Asthma Exacerbation|34|||
156958718|NCT01462344|566599074|FG001|Overall Study|Asthma Exacerbation|35|||
156958719|NCT01462344|566599073|FG000|Overall Study|Lack of Efficacy|5|||
156958720|NCT01462344|566599074|FG001|Overall Study|Lack of Efficacy|6|||
156958721|NCT01462344|566599073|FG000|Overall Study|Protocol Violation|68|||
156958722|NCT01462344|566599074|FG001|Overall Study|Protocol Violation|53|||
156958723|NCT01462344|566599073|FG000|Overall Study|Lost to Follow-up|7|||
156958724|NCT01462344|566599074|FG001|Overall Study|Lost to Follow-up|7|||
156958725|NCT01003249|566599077|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156958726|NCT01003249|566599078|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
156958727|NCT01003249|566599077|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
156958728|NCT01003249|566599078|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
156958729|NCT01003249|566599077|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
156958730|NCT01003249|566599078|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
156958731|NCT01003249|566599077|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
156958732|NCT01003249|566599078|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
156958733|NCT01962974|566599079|FG000|Overall Study|Study termination|7|||
156958734|NCT03086447|566599080|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
157170534|NCT01306032|567367138|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
157170535|NCT01306032|567367139|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
157170536|NCT01306032|567367140|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
157170537|NCT01306032|567367135|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
157170538|NCT01306032|567367136|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
157170539|NCT01306032|567367137|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
157170540|NCT01306032|567367138|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
157170541|NCT01306032|567367139|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
157170542|NCT01306032|567367140|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
157170543|NCT00992186|567367141|FG000|Overall Study|Withdrawal by Subject|2|||
157170544|NCT00992186|567367141|FG000|Overall Study|Protocol Violation|1|||
157170545|NCT00992186|567367141|FG000|Overall Study|Physician Decision|1|||
157170546|NCT00992186|567367141|FG000|Overall Study|Adverse Event|9|||
157170547|NCT00992186|567367141|FG000|Overall Study|Progressive Disease|30|||
157170548|NCT00992186|567367141|FG000|Overall Study|Refusal To Receive Study Agent|3|||
157170549|NCT00973622|567367145|FG000|Overall Study|did not attend MRI|14|||
157170550|NCT00973622|567367146|FG001|Overall Study|did not attend MRI|3|||
157170551|NCT00973622|567367145|FG000|Overall Study|did not pass MRI screen|6|||
157170552|NCT00973622|567367146|FG001|Overall Study|did not pass MRI screen|0|||
156958735|NCT03086447|566599081|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
156958736|NCT03086447|566599080|FG000|Overall Study|Lost Lens|2|||
156958737|NCT03086447|566599081|FG001|Overall Study|Lost Lens|5|||
156958738|NCT03086447|566599080|FG000|Overall Study|Product quality complaint|0|||
156958739|NCT03086447|566599081|FG001|Overall Study|Product quality complaint|1|||
156958740|NCT03086447|566599080|FG000|Overall Study|Lens Damage|1|||
156958741|NCT03086447|566599081|FG001|Overall Study|Lens Damage|6|||
157170553|NCT00973622|567367145|FG000|Overall Study|did not complete rTMS sessions|11|||
157227719|NCT06179108|567579177|FG003|Overall Study|Lost to Follow-up|9|||
156958742|NCT03086447|566599080|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156958743|NCT03086447|566599081|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156958744|NCT03086447|566599080|FG000|Overall Study|Test Article No Longer Available|1|||
156958745|NCT03086447|566599081|FG001|Overall Study|Test Article No Longer Available|0|||
156958746|NCT03086447|566599080|FG000|Overall Study|Protocol Violation|2|||
156958747|NCT03086447|566599081|FG001|Overall Study|Protocol Violation|4|||
156958748|NCT03086447|566599080|FG000|Overall Study|Lost to Follow-up|0|||
156958749|NCT03086447|566599081|FG001|Overall Study|Lost to Follow-up|1|||
157170554|NCT00973622|567367146|FG001|Overall Study|did not complete rTMS sessions|2|||
157170555|NCT00555568|567367147|FG000|Overall Study|Lost to Follow-up|26|||
157170556|NCT00555568|567367148|FG001|Overall Study|Lost to Follow-up|16|||
157170557|NCT00555568|567367149|FG002|Overall Study|Lost to Follow-up|16|||
157170558|NCT01588353|567367150|FG000|Step2|Withdrawal by Subject|0|||
156958750|NCT03086447|566599080|FG000|Overall Study|Adverse Event|3|||
156958751|NCT03086447|566599081|FG001|Overall Study|Adverse Event|0|||
156958752|NCT03086447|566599080|FG000|Overall Study|Lens Discomfort|2|||
156958753|NCT03086447|566599081|FG001|Overall Study|Lens Discomfort|1|||
156958754|NCT04598152|566599082|FG000|Overall Study|Lost to Follow-up|0|||
156958755|NCT04598152|566599083|FG001|Overall Study|Lost to Follow-up|1|||
156958756|NCT01965834|566599088|FG000|Overall Study|Lack of Efficacy|4|||
156958757|NCT00253864|566599095|FG000|Overall Study|Lost to Follow-up|5|||
156958758|NCT00253864|566599096|FG001|Overall Study|Lost to Follow-up|8|||
156958759|NCT00659334|566599097|FG000|Overall Study|Screen Failure|8|||
156958760|NCT00659334|566599098|FG001|Overall Study|Screen Failure|5|||
156958761|NCT00659334|566599099|FG002|Overall Study|Screen Failure|0|||
156958762|NCT00659334|566599100|FG003|Overall Study|Screen Failure|0|||
156958763|NCT00659334|566599101|FG004|Overall Study|Screen Failure|0|||
156958764|NCT00659334|566599102|FG005|Overall Study|Screen Failure|0|||
156958765|NCT00659334|566599103|FG006|Overall Study|Screen Failure|1|||
156958766|NCT03034577|566599104|FG000|Overall Study|Withdrawal by Subject|6|||
156958767|NCT03034577|566599105|FG001|Overall Study|Withdrawal by Subject|9|||
156958768|NCT03034577|566599104|FG000|Overall Study|Lost to Follow-up|25|||
156958769|NCT03034577|566599105|FG001|Overall Study|Lost to Follow-up|26|||
156958770|NCT01174342|566599106|FG000|Overall Study|Conversion to cesarean section|4|||
156958771|NCT02625623|566599107|FG000|Overall Study|Participants randomized but not treated|9|||
156958772|NCT02625623|566599108|FG001|Overall Study|Participants randomized but not treated|1|||
156958773|NCT01128413|566599110|FG000|Overall Study|Withdrawal by Subject|1|||
156958774|NCT01128413|566599111|FG001|Overall Study|Withdrawal by Subject|0|||
156958775|NCT01128413|566599110|FG000|Overall Study|NICOM Monitor Problems|2|||
156958776|NCT01128413|566599111|FG001|Overall Study|NICOM Monitor Problems|1|||
156958777|NCT01128413|566599110|FG000|Overall Study|Pt made DNR|1|||
156958778|NCT01128413|566599111|FG001|Overall Study|Pt made DNR|0|||
156958779|NCT00045110|566599112|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
156958780|NCT00045110|566599113|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
156958781|NCT00045110|566599114|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
156958782|NCT00045110|566599112|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
156958783|NCT00045110|566599113|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
156958784|NCT00045110|566599114|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
156958785|NCT00045110|566599112|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
156958786|NCT00045110|566599113|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
156958787|NCT00045110|566599114|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
156958788|NCT03662750|566599115|FG000|Overall Study|Withdrawal by Subject|1|||
156958789|NCT00726752|566599116|FG000|Overall Study|Lack of Efficacy|6|||
156958790|NCT00907153|566601363|FG000|Overall Study|Lost to Follow-up|1|||
156958791|NCT00907153|566601364|FG001|Overall Study|Lost to Follow-up|1|||
156958792|NCT00907153|566601363|FG000|Overall Study|Withdrawal by Subject|1|||
156958793|NCT00907153|566601364|FG001|Overall Study|Withdrawal by Subject|3|||
156958794|NCT02338154|566601372|FG000|Overall Study|Death|46|||
156958795|NCT02338154|566601372|FG000|Overall Study|Valve Implant Failure|17|||
156958796|NCT02338154|566601372|FG000|Overall Study|Valve Explant|11|||
156958797|NCT02338154|566601372|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
156958798|NCT02338154|566601372|FG000|Overall Study|Lost to Follow-up|8|||
156958799|NCT02338154|566601372|FG000|Overall Study|Other Reason|3|||
156958800|NCT02338154|566601372|FG000|Overall Study|Patients Without Exit Form|47|||
156958801|NCT02338154|566601372|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
156958802|NCT03393000|566601377|FG000|Overall Study|Death|11|||
156958803|NCT03393000|566601377|FG000|Overall Study|Withdrawal by Subject|2|||
156958804|NCT03393000|566601377|FG000|Overall Study|Physician Decision|1|||
156958805|NCT01773070|566601378|FG000|Overall Study|Withdrawal by Subject|24|||
156958806|NCT01773070|566601378|FG000|Overall Study|Lost to Follow-up|39|||
156958807|NCT01773070|566601378|FG000|Overall Study|Other|15|||
156958808|NCT01773070|566601378|FG000|Overall Study|Death (unrelated to study procedures)|3|||
156958809|NCT01559844|566601379|FG000|Overall Study|Consent Withdrawn|7|||
156958810|NCT01559844|566601379|FG000|Overall Study|Death|5|||
156958811|NCT01559844|566601379|FG000|Overall Study|Efficacy Failure|10|||
157170559|NCT01588353|567367151|FG001|Step2|Withdrawal by Subject|1|||
157170560|NCT01588353|567367152|FG002|Step2|Withdrawal by Subject|0|||
156958812|NCT01559844|566601379|FG000|Overall Study|No Longer A Transplant Candidate|3|||
156958813|NCT02181803|566601380|FG000|Overall Study|Withdrawal by Subject|0|||
156958814|NCT02181803|566601381|FG001|Overall Study|Withdrawal by Subject|2|||
157170561|NCT01588353|567367150|FG000|Step3|Adverse Event|0|||
157170562|NCT01588353|567367151|FG001|Step3|Adverse Event|0|||
156958815|NCT02181803|566601382|FG002|Overall Study|Withdrawal by Subject|0|||
156958816|NCT02181803|566601383|FG003|Overall Study|Withdrawal by Subject|0|||
156958817|NCT02181803|566601384|FG004|Overall Study|Withdrawal by Subject|0|||
156958818|NCT02181803|566601385|FG005|Overall Study|Withdrawal by Subject|0|||
156958819|NCT02181803|566601386|FG006|Overall Study|Withdrawal by Subject|0|||
157170563|NCT01588353|567367152|FG002|Step3|Adverse Event|2|||
157170564|NCT01409993|567367153|FG000|Overall Study|Adverse Event|4|||
156958820|NCT02181803|566601387|FG007|Overall Study|Withdrawal by Subject|0|||
156958821|NCT02181803|566601388|FG008|Overall Study|Withdrawal by Subject|0|||
156958822|NCT02181803|566601380|FG000|Overall Study|Physician Decision|0|||
156958823|NCT02181803|566601381|FG001|Overall Study|Physician Decision|0|||
156958824|NCT02181803|566601382|FG002|Overall Study|Physician Decision|0|||
156958825|NCT02181803|566601383|FG003|Overall Study|Physician Decision|1|||
156958826|NCT02181803|566601384|FG004|Overall Study|Physician Decision|0|||
156958827|NCT02181803|566601385|FG005|Overall Study|Physician Decision|0|||
156958828|NCT02181803|566601386|FG006|Overall Study|Physician Decision|0|||
156958829|NCT02181803|566601387|FG007|Overall Study|Physician Decision|1|||
156958830|NCT02181803|566601388|FG008|Overall Study|Physician Decision|0|||
156958831|NCT02181803|566601380|FG000|Overall Study|Adverse Event|0|||
157170565|NCT01409993|567367154|FG001|Overall Study|Adverse Event|4|||
156958832|NCT02181803|566601381|FG001|Overall Study|Adverse Event|2|||
156958833|NCT02181803|566601382|FG002|Overall Study|Adverse Event|0|||
156958834|NCT02181803|566601383|FG003|Overall Study|Adverse Event|1|||
156958835|NCT02181803|566601384|FG004|Overall Study|Adverse Event|0|||
156958836|NCT02181803|566601385|FG005|Overall Study|Adverse Event|0|||
156958837|NCT02181803|566601386|FG006|Overall Study|Adverse Event|1|||
156958838|NCT02181803|566601387|FG007|Overall Study|Adverse Event|0|||
156958839|NCT02181803|566601388|FG008|Overall Study|Adverse Event|0|||
156958840|NCT00951041|566601389|FG000|Overall Study|Withdrawal by Subject|1|||
156958841|NCT00951041|566601390|FG001|Overall Study|Withdrawal by Subject|1|||
156958842|NCT00951041|566601389|FG000|Overall Study|Lost to Follow-up|1|||
156958843|NCT00951041|566601390|FG001|Overall Study|Lost to Follow-up|0|||
156958844|NCT00951041|566601389|FG000|Overall Study|Other|3|||
156958845|NCT00951041|566601390|FG001|Overall Study|Other|0|||
156958846|NCT02388724|566601395|FG000|Overall Study|Reason not Specified|0|||
156958847|NCT02388724|566601396|FG001|Overall Study|Reason not Specified|1|||
156958848|NCT02388724|566601395|FG000|Overall Study|Major Protocol Deviation|3|||
156958849|NCT02388724|566601396|FG001|Overall Study|Major Protocol Deviation|3|||
156958850|NCT02388724|566601395|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
156958851|NCT02388724|566601396|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
156958852|NCT02388724|566601395|FG000|Overall Study|Voluntary Withdrawal|6|||
156958853|NCT02388724|566601396|FG001|Overall Study|Voluntary Withdrawal|5|||
156958854|NCT02388724|566601395|FG000|Overall Study|Randomized but not Treated|0|||
156958855|NCT02388724|566601396|FG001|Overall Study|Randomized but not Treated|2|||
156958856|NCT01217073|566601397|FG000|Base Period|Adverse Event|1|||
156958857|NCT01217073|566601398|FG001|Base Period|Adverse Event|0|||
156958858|NCT01217073|566601399|FG002|Base Period|Adverse Event|1|||
156958859|NCT01217073|566601400|FG003|Base Period|Adverse Event|0|||
156958860|NCT01217073|566601401|FG004|Base Period|Adverse Event|4|||
156958861|NCT01217073|566601402|FG005|Base Period|Adverse Event|1|||
156958862|NCT01217073|566601403|FG006|Base Period|Adverse Event|0|||
156958863|NCT01217073|566601404|FG007|Base Period|Adverse Event|0|||
156958864|NCT01217073|566601397|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
156958865|NCT01217073|566601398|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958866|NCT01217073|566601399|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958867|NCT01217073|566601400|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958868|NCT01217073|566601401|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958869|NCT01217073|566601402|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958870|NCT01217073|566601403|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958871|NCT01217073|566601404|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
156958872|NCT01217073|566601397|FG000|Base Period|Excluded medication|0|||
156958873|NCT01217073|566601398|FG001|Base Period|Excluded medication|0|||
156958874|NCT01217073|566601399|FG002|Base Period|Excluded medication|0|||
156958875|NCT01217073|566601400|FG003|Base Period|Excluded medication|0|||
156958876|NCT01217073|566601401|FG004|Base Period|Excluded medication|1|||
156958877|NCT01217073|566601402|FG005|Base Period|Excluded medication|0|||
156958878|NCT01217073|566601403|FG006|Base Period|Excluded medication|0|||
156958879|NCT01217073|566601404|FG007|Base Period|Excluded medication|0|||
156958880|NCT01217073|566601397|FG000|Base Period|Lack of Efficacy|0|||
156958881|NCT01217073|566601398|FG001|Base Period|Lack of Efficacy|0|||
156958882|NCT01217073|566601399|FG002|Base Period|Lack of Efficacy|0|||
157170566|NCT01409993|567367155|FG002|Overall Study|Adverse Event|3|||
156958883|NCT01217073|566601400|FG003|Base Period|Lack of Efficacy|0|||
156958884|NCT01217073|566601401|FG004|Base Period|Lack of Efficacy|0|||
156958885|NCT01217073|566601402|FG005|Base Period|Lack of Efficacy|1|||
156958886|NCT01217073|566601403|FG006|Base Period|Lack of Efficacy|0|||
156958887|NCT01217073|566601404|FG007|Base Period|Lack of Efficacy|0|||
156958888|NCT01217073|566601397|FG000|Base Period|Lost to Follow-up|0|||
156958889|NCT01217073|566601398|FG001|Base Period|Lost to Follow-up|0|||
156958890|NCT01217073|566601399|FG002|Base Period|Lost to Follow-up|1|||
156958891|NCT01217073|566601400|FG003|Base Period|Lost to Follow-up|1|||
156958892|NCT01217073|566601401|FG004|Base Period|Lost to Follow-up|3|||
156958893|NCT01217073|566601402|FG005|Base Period|Lost to Follow-up|0|||
156958894|NCT01217073|566601403|FG006|Base Period|Lost to Follow-up|0|||
156958895|NCT01217073|566601404|FG007|Base Period|Lost to Follow-up|0|||
156958896|NCT01217073|566601397|FG000|Base Period|Physician Decision|0|||
156958897|NCT01217073|566601398|FG001|Base Period|Physician Decision|0|||
156958898|NCT01217073|566601399|FG002|Base Period|Physician Decision|0|||
156958899|NCT01217073|566601400|FG003|Base Period|Physician Decision|0|||
156958900|NCT01217073|566601401|FG004|Base Period|Physician Decision|1|||
156958901|NCT01217073|566601402|FG005|Base Period|Physician Decision|0|||
156958902|NCT01217073|566601403|FG006|Base Period|Physician Decision|0|||
156958903|NCT01217073|566601404|FG007|Base Period|Physician Decision|0|||
156958904|NCT01217073|566601397|FG000|Base Period|Protocol Violation|1|||
156958905|NCT01217073|566601398|FG001|Base Period|Protocol Violation|0|||
156958906|NCT01217073|566601399|FG002|Base Period|Protocol Violation|0|||
156958907|NCT01217073|566601400|FG003|Base Period|Protocol Violation|0|||
156958908|NCT01217073|566601401|FG004|Base Period|Protocol Violation|1|||
156958909|NCT01217073|566601402|FG005|Base Period|Protocol Violation|2|||
156958910|NCT01217073|566601403|FG006|Base Period|Protocol Violation|0|||
156958911|NCT01217073|566601404|FG007|Base Period|Protocol Violation|0|||
156958912|NCT01217073|566601397|FG000|Base Period|Withdrawal by Subject|4|||
156958913|NCT01217073|566601398|FG001|Base Period|Withdrawal by Subject|5|||
156958914|NCT01217073|566601399|FG002|Base Period|Withdrawal by Subject|5|||
156958915|NCT01217073|566601400|FG003|Base Period|Withdrawal by Subject|1|||
156958916|NCT01217073|566601401|FG004|Base Period|Withdrawal by Subject|5|||
156958917|NCT01217073|566601402|FG005|Base Period|Withdrawal by Subject|5|||
156958918|NCT01217073|566601403|FG006|Base Period|Withdrawal by Subject|0|||
156958919|NCT01217073|566601404|FG007|Base Period|Withdrawal by Subject|0|||
156958920|NCT01217073|566601397|FG000|Extension Period|Adverse Event|0|||
156958921|NCT01217073|566601398|FG001|Extension Period|Adverse Event|0|||
156958922|NCT01217073|566601399|FG002|Extension Period|Adverse Event|0|||
156958923|NCT01217073|566601400|FG003|Extension Period|Adverse Event|0|||
156958924|NCT01217073|566601401|FG004|Extension Period|Adverse Event|0|||
156958925|NCT01217073|566601402|FG005|Extension Period|Adverse Event|0|||
156958926|NCT01217073|566601403|FG006|Extension Period|Adverse Event|19|||
156958927|NCT01217073|566601404|FG007|Extension Period|Adverse Event|5|||
156958928|NCT01217073|566601397|FG000|Extension Period|ALT/AST|0|||
156958929|NCT01217073|566601398|FG001|Extension Period|ALT/AST|0|||
156958930|NCT01217073|566601399|FG002|Extension Period|ALT/AST|0|||
156958931|NCT01217073|566601400|FG003|Extension Period|ALT/AST|0|||
156958932|NCT01217073|566601401|FG004|Extension Period|ALT/AST|0|||
156958933|NCT01217073|566601402|FG005|Extension Period|ALT/AST|0|||
156958934|NCT01217073|566601403|FG006|Extension Period|ALT/AST|2|||
156958935|NCT01217073|566601404|FG007|Extension Period|ALT/AST|0|||
156958936|NCT01217073|566601397|FG000|Extension Period|Contraindication to study medication|0|||
156958937|NCT01217073|566601398|FG001|Extension Period|Contraindication to study medication|0|||
156958938|NCT01217073|566601399|FG002|Extension Period|Contraindication to study medication|0|||
156958939|NCT01217073|566601400|FG003|Extension Period|Contraindication to study medication|0|||
156958940|NCT01217073|566601401|FG004|Extension Period|Contraindication to study medication|0|||
156958941|NCT01217073|566601402|FG005|Extension Period|Contraindication to study medication|0|||
156958942|NCT01217073|566601403|FG006|Extension Period|Contraindication to study medication|1|||
156958943|NCT01217073|566601404|FG007|Extension Period|Contraindication to study medication|0|||
156958944|NCT01217073|566601397|FG000|Extension Period|Creatinine/eGFR|0|||
156958945|NCT01217073|566601398|FG001|Extension Period|Creatinine/eGFR|0|||
156958946|NCT01217073|566601399|FG002|Extension Period|Creatinine/eGFR|0|||
156958947|NCT01217073|566601400|FG003|Extension Period|Creatinine/eGFR|0|||
156958948|NCT01217073|566601401|FG004|Extension Period|Creatinine/eGFR|0|||
156958949|NCT01217073|566601402|FG005|Extension Period|Creatinine/eGFR|0|||
156958950|NCT01217073|566601403|FG006|Extension Period|Creatinine/eGFR|11|||
156958951|NCT01217073|566601404|FG007|Extension Period|Creatinine/eGFR|1|||
156958952|NCT01217073|566601397|FG000|Extension Period|Death|0|||
156958953|NCT01217073|566601398|FG001|Extension Period|Death|0|||
156958954|NCT01217073|566601399|FG002|Extension Period|Death|0|||
157170567|NCT01409993|567367156|FG003|Overall Study|Adverse Event|1|||
157170568|NCT01409993|567367153|FG000|Overall Study|Withdrawal by Subject|0|||
157170569|NCT01409993|567367154|FG001|Overall Study|Withdrawal by Subject|0|||
157170570|NCT01409993|567367155|FG002|Overall Study|Withdrawal by Subject|0|||
156958955|NCT01217073|566601400|FG003|Extension Period|Death|0|||
156958956|NCT01217073|566601401|FG004|Extension Period|Death|0|||
156958957|NCT01217073|566601402|FG005|Extension Period|Death|0|||
156958958|NCT01217073|566601403|FG006|Extension Period|Death|1|||
156958959|NCT01217073|566601404|FG007|Extension Period|Death|0|||
156958960|NCT01217073|566601397|FG000|Extension Period|Excluded medication|0|||
156958961|NCT01217073|566601398|FG001|Extension Period|Excluded medication|0|||
157170571|NCT01409993|567367156|FG003|Overall Study|Withdrawal by Subject|4|||
156958962|NCT01217073|566601399|FG002|Extension Period|Excluded medication|0|||
156958963|NCT01217073|566601400|FG003|Extension Period|Excluded medication|0|||
156958964|NCT01217073|566601401|FG004|Extension Period|Excluded medication|0|||
156958965|NCT01217073|566601402|FG005|Extension Period|Excluded medication|0|||
156958966|NCT01217073|566601403|FG006|Extension Period|Excluded medication|2|||
156958967|NCT01217073|566601404|FG007|Extension Period|Excluded medication|0|||
156958968|NCT01217073|566601397|FG000|Extension Period|Lack of Efficacy|0|||
156958969|NCT01217073|566601398|FG001|Extension Period|Lack of Efficacy|0|||
156958970|NCT01217073|566601399|FG002|Extension Period|Lack of Efficacy|0|||
156958971|NCT01217073|566601400|FG003|Extension Period|Lack of Efficacy|0|||
156958972|NCT01217073|566601401|FG004|Extension Period|Lack of Efficacy|0|||
156958973|NCT01217073|566601402|FG005|Extension Period|Lack of Efficacy|0|||
156958974|NCT01217073|566601403|FG006|Extension Period|Lack of Efficacy|3|||
157170572|NCT01409993|567367153|FG000|Overall Study|Lost to Follow-up|0|||
157170573|NCT01409993|567367154|FG001|Overall Study|Lost to Follow-up|1|||
157170574|NCT01409993|567367155|FG002|Overall Study|Lost to Follow-up|0|||
157170575|NCT01409993|567367156|FG003|Overall Study|Lost to Follow-up|0|||
157170576|NCT02677220|567367157|FG000|Overall Study|Adverse Event|1|||
157170577|NCT00830960|567367158|FG000|Overall Study|Death|5|||
157170578|NCT00830960|567367159|FG001|Overall Study|Death|4|||
157170579|NCT00830960|567367160|FG002|Overall Study|Death|3|||
157170580|NCT00830960|567367161|FG003|Overall Study|Death|2|||
157170581|NCT00830960|567367162|FG004|Overall Study|Death|6|||
157170582|NCT00830960|567367163|FG005|Overall Study|Death|1|||
157170583|NCT00830960|567367158|FG000|Overall Study|Lost to Follow-up|1|||
157170584|NCT00830960|567367159|FG001|Overall Study|Lost to Follow-up|1|||
157170585|NCT00830960|567367160|FG002|Overall Study|Lost to Follow-up|1|||
157170586|NCT00830960|567367161|FG003|Overall Study|Lost to Follow-up|0|||
157170587|NCT00830960|567367162|FG004|Overall Study|Lost to Follow-up|0|||
157227720|NCT06179108|567579174|FG000|Overall Study|Adverse Event|2|||
157227721|NCT06179108|567579175|FG001|Overall Study|Adverse Event|3|||
156958975|NCT01217073|566601404|FG007|Extension Period|Lack of Efficacy|0|||
156958976|NCT01217073|566601397|FG000|Extension Period|Lost to Follow-up|0|||
156958977|NCT01217073|566601398|FG001|Extension Period|Lost to Follow-up|0|||
156958978|NCT01217073|566601399|FG002|Extension Period|Lost to Follow-up|0|||
156958979|NCT01217073|566601400|FG003|Extension Period|Lost to Follow-up|0|||
156958980|NCT01217073|566601401|FG004|Extension Period|Lost to Follow-up|0|||
156958981|NCT01217073|566601402|FG005|Extension Period|Lost to Follow-up|0|||
156958982|NCT01217073|566601403|FG006|Extension Period|Lost to Follow-up|9|||
156958983|NCT01217073|566601404|FG007|Extension Period|Lost to Follow-up|1|||
156958984|NCT01217073|566601397|FG000|Extension Period|Non-compliance with study drug|0|||
156958985|NCT01217073|566601398|FG001|Extension Period|Non-compliance with study drug|0|||
156958986|NCT01217073|566601399|FG002|Extension Period|Non-compliance with study drug|0|||
156958987|NCT01217073|566601400|FG003|Extension Period|Non-compliance with study drug|0|||
156958988|NCT01217073|566601401|FG004|Extension Period|Non-compliance with study drug|0|||
156958989|NCT01217073|566601402|FG005|Extension Period|Non-compliance with study drug|0|||
156958990|NCT01217073|566601403|FG006|Extension Period|Non-compliance with study drug|0|||
156958991|NCT01217073|566601404|FG007|Extension Period|Non-compliance with study drug|1|||
156958992|NCT01217073|566601397|FG000|Extension Period|Physician Decision|0|||
156958993|NCT01217073|566601398|FG001|Extension Period|Physician Decision|0|||
156958994|NCT01217073|566601399|FG002|Extension Period|Physician Decision|0|||
156958995|NCT01217073|566601400|FG003|Extension Period|Physician Decision|0|||
156958996|NCT01217073|566601401|FG004|Extension Period|Physician Decision|0|||
156958997|NCT01217073|566601402|FG005|Extension Period|Physician Decision|0|||
156958998|NCT01217073|566601403|FG006|Extension Period|Physician Decision|4|||
156958999|NCT01217073|566601404|FG007|Extension Period|Physician Decision|1|||
156959000|NCT01217073|566601397|FG000|Extension Period|Protocol Violation|0|||
156959001|NCT01217073|566601398|FG001|Extension Period|Protocol Violation|0|||
156959002|NCT01217073|566601399|FG002|Extension Period|Protocol Violation|0|||
156959003|NCT01217073|566601400|FG003|Extension Period|Protocol Violation|0|||
156959004|NCT01217073|566601401|FG004|Extension Period|Protocol Violation|0|||
156959005|NCT01217073|566601402|FG005|Extension Period|Protocol Violation|0|||
156959006|NCT01217073|566601403|FG006|Extension Period|Protocol Violation|2|||
156959007|NCT01217073|566601404|FG007|Extension Period|Protocol Violation|1|||
156959008|NCT01217073|566601397|FG000|Extension Period|Site discontinued study participation|0|||
156959009|NCT01217073|566601398|FG001|Extension Period|Site discontinued study participation|0|||
156959010|NCT01217073|566601399|FG002|Extension Period|Site discontinued study participation|0|||
156959011|NCT01217073|566601400|FG003|Extension Period|Site discontinued study participation|0|||
156959012|NCT01217073|566601401|FG004|Extension Period|Site discontinued study participation|0|||
156959013|NCT01217073|566601402|FG005|Extension Period|Site discontinued study participation|0|||
156959014|NCT01217073|566601403|FG006|Extension Period|Site discontinued study participation|7|||
156959015|NCT01217073|566601404|FG007|Extension Period|Site discontinued study participation|2|||
156959016|NCT01217073|566601397|FG000|Extension Period|Withdrawal by Subject|0|||
156959017|NCT01217073|566601398|FG001|Extension Period|Withdrawal by Subject|0|||
156959018|NCT01217073|566601399|FG002|Extension Period|Withdrawal by Subject|0|||
156959019|NCT01217073|566601400|FG003|Extension Period|Withdrawal by Subject|0|||
156959020|NCT01217073|566601401|FG004|Extension Period|Withdrawal by Subject|0|||
156959021|NCT01217073|566601402|FG005|Extension Period|Withdrawal by Subject|0|||
156959022|NCT01217073|566601403|FG006|Extension Period|Withdrawal by Subject|30|||
156959023|NCT01217073|566601404|FG007|Extension Period|Withdrawal by Subject|8|||
157170588|NCT00830960|567367163|FG005|Overall Study|Lost to Follow-up|1|||
157170589|NCT00830960|567367158|FG000|Overall Study|Withdrawal by Subject|19|||
157170590|NCT00830960|567367159|FG001|Overall Study|Withdrawal by Subject|19|||
157170591|NCT00830960|567367160|FG002|Overall Study|Withdrawal by Subject|18|||
157170592|NCT00830960|567367161|FG003|Overall Study|Withdrawal by Subject|23|||
157227722|NCT06179108|567579176|FG002|Overall Study|Adverse Event|3|||
156959024|NCT05545072|566601421|FG000|Overall Study|Lost to Follow-up|1|||
156959025|NCT05545072|566601422|FG001|Overall Study|Lost to Follow-up|0|||
156959026|NCT05545072|566601421|FG000|Overall Study|Study ended prematurely due to funding|2|||
156959027|NCT05545072|566601422|FG001|Overall Study|Study ended prematurely due to funding|2|||
156959028|NCT02395042|566601423|FG000|Treatment 1 Period|Adverse Event|1|||
156959029|NCT02395042|566601424|FG001|Treatment 1 Period|Adverse Event|3|||
156959030|NCT02395042|566601425|FG002|Treatment 1 Period|Adverse Event|1|||
156959031|NCT02395042|566601423|FG000|Treatment 1 Period|Lack of Efficacy|1|||
156959032|NCT02395042|566601424|FG001|Treatment 1 Period|Lack of Efficacy|1|||
156959033|NCT02395042|566601425|FG002|Treatment 1 Period|Lack of Efficacy|0|||
156959034|NCT02395042|566601423|FG000|Treatment 1 Period|Lost to Follow-up|1|||
156959035|NCT02395042|566601424|FG001|Treatment 1 Period|Lost to Follow-up|0|||
156959036|NCT02395042|566601425|FG002|Treatment 1 Period|Lost to Follow-up|0|||
156959037|NCT02395042|566601423|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
156959038|NCT02395042|566601424|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
156959039|NCT02395042|566601425|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
156959040|NCT02395042|566601423|FG000|Treatment 2 Period|Lack of Efficacy|1|||
156959041|NCT02395042|566601424|FG001|Treatment 2 Period|Lack of Efficacy|1|||
156959042|NCT02395042|566601425|FG002|Treatment 2 Period|Lack of Efficacy|0|||
156959043|NCT03996473|566601426|FG000|Treatment Assignment|Withdrawal by Subject|1|||
156959044|NCT03996473|566601426|FG000|Treatment Assignment|Progressive disease|6|||
156959045|NCT03996473|566601426|FG000|Treatment Assignment|Study drug never administered|1|||
156959046|NCT03996473|566601426|FG000|Active Follow-up|Death|1|||
156959047|NCT03996473|566601426|FG000|Long-term Follow-up|Death|5|||
156959048|NCT03759873|566601427|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
156959049|NCT03759873|566601428|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
156959050|NCT03759873|566601429|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
156959051|NCT03759873|566601430|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
156959052|NCT03759873|566601427|FG000|Overall Study|Moved outside eligible area|0|||
156959053|NCT03759873|566601428|FG001|Overall Study|Moved outside eligible area|2|||
156959054|NCT03759873|566601429|FG002|Overall Study|Moved outside eligible area|0|||
156959055|NCT03759873|566601430|FG003|Overall Study|Moved outside eligible area|0|||
156959056|NCT03759873|566601427|FG000|Overall Study|Withdrawal by Subject|0|||
156959057|NCT03759873|566601428|FG001|Overall Study|Withdrawal by Subject|0|||
156959058|NCT03759873|566601429|FG002|Overall Study|Withdrawal by Subject|1|||
156959059|NCT03759873|566601430|FG003|Overall Study|Withdrawal by Subject|0|||
156959060|NCT04349553|566601434|FG000|Overall Study|Withdrawal by Subject|1|||
156959061|NCT04349553|566601435|FG001|Overall Study|Withdrawal by Subject|0|||
156959062|NCT04349553|566601436|FG002|Overall Study|Withdrawal by Subject|1|||
156959063|NCT04349553|566601437|FG003|Overall Study|Withdrawal by Subject|0|||
156959064|NCT02647359|566601438|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
156959065|NCT02647359|566601439|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
156959066|NCT02647359|566601438|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
156959067|NCT02647359|566601439|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
156959068|NCT02647359|566601438|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
156959069|NCT02647359|566601439|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
156959070|NCT02647359|566601438|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
156959071|NCT02647359|566601439|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
156959072|NCT02647359|566601438|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
156959073|NCT02647359|566601439|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
156959074|NCT02647359|566601438|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
156959075|NCT02647359|566601439|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
156959076|NCT04642638|566601440|FG000|Overall Study|Withdrawal by Subject|23|||
156959077|NCT04642638|566601441|FG001|Overall Study|Withdrawal by Subject|29|||
156959078|NCT04642638|566601442|FG002|Overall Study|Withdrawal by Subject|9|||
156959079|NCT04642638|566601443|FG003|Overall Study|Withdrawal by Subject|7|||
156959080|NCT04642638|566601444|FG004|Overall Study|Withdrawal by Subject|61|||
156959081|NCT04642638|566601445|FG005|Overall Study|Withdrawal by Subject|27|||
156959082|NCT04642638|566601440|FG000|Overall Study|Lost to Follow-up|17|||
157170593|NCT00830960|567367162|FG004|Overall Study|Withdrawal by Subject|16|||
156959083|NCT04642638|566601441|FG001|Overall Study|Lost to Follow-up|18|||
156959084|NCT04642638|566601442|FG002|Overall Study|Lost to Follow-up|5|||
157170594|NCT00830960|567367163|FG005|Overall Study|Withdrawal by Subject|21|||
157170595|NCT00830960|567367158|FG000|Overall Study|Sponsor Decision|1|||
157170596|NCT00830960|567367159|FG001|Overall Study|Sponsor Decision|2|||
156959085|NCT04642638|566601443|FG003|Overall Study|Lost to Follow-up|5|||
156959086|NCT04642638|566601444|FG004|Overall Study|Lost to Follow-up|6|||
156959087|NCT04642638|566601445|FG005|Overall Study|Lost to Follow-up|3|||
156959088|NCT04642638|566601440|FG000|Overall Study|Adverse Event|0|||
156959089|NCT04642638|566601441|FG001|Overall Study|Adverse Event|0|||
156959090|NCT04642638|566601442|FG002|Overall Study|Adverse Event|1|||
156959091|NCT04642638|566601443|FG003|Overall Study|Adverse Event|0|||
157170597|NCT00830960|567367160|FG002|Overall Study|Sponsor Decision|3|||
157170598|NCT00830960|567367161|FG003|Overall Study|Sponsor Decision|4|||
156959092|NCT04642638|566601444|FG004|Overall Study|Adverse Event|10|||
156959093|NCT04642638|566601445|FG005|Overall Study|Adverse Event|3|||
156959094|NCT04642638|566601440|FG000|Overall Study|Reason Not Specified|1|||
156959095|NCT04642638|566601441|FG001|Overall Study|Reason Not Specified|4|||
156959096|NCT04642638|566601442|FG002|Overall Study|Reason Not Specified|0|||
156959097|NCT04642638|566601443|FG003|Overall Study|Reason Not Specified|0|||
156959098|NCT04642638|566601444|FG004|Overall Study|Reason Not Specified|38|||
156959099|NCT04642638|566601445|FG005|Overall Study|Reason Not Specified|16|||
156959100|NCT04642638|566601440|FG000|Overall Study|Physician Decision|0|||
156959101|NCT04642638|566601441|FG001|Overall Study|Physician Decision|0|||
156959102|NCT04642638|566601442|FG002|Overall Study|Physician Decision|0|||
156959103|NCT04642638|566601443|FG003|Overall Study|Physician Decision|0|||
156959104|NCT04642638|566601444|FG004|Overall Study|Physician Decision|2|||
156959105|NCT04642638|566601445|FG005|Overall Study|Physician Decision|1|||
156959106|NCT04642638|566601440|FG000|Overall Study|Protocol Deviation|0|||
156959107|NCT04642638|566601441|FG001|Overall Study|Protocol Deviation|0|||
156959108|NCT04642638|566601442|FG002|Overall Study|Protocol Deviation|0|||
156959109|NCT04642638|566601443|FG003|Overall Study|Protocol Deviation|0|||
156959110|NCT04642638|566601444|FG004|Overall Study|Protocol Deviation|1|||
156959111|NCT04642638|566601445|FG005|Overall Study|Protocol Deviation|3|||
156959112|NCT04642638|566601440|FG000|Overall Study|Study Terminated|0|||
156959113|NCT04642638|566601441|FG001|Overall Study|Study Terminated|0|||
156959114|NCT04642638|566601442|FG002|Overall Study|Study Terminated|0|||
156959115|NCT04642638|566601443|FG003|Overall Study|Study Terminated|0|||
156959116|NCT04642638|566601444|FG004|Overall Study|Study Terminated|484|||
156959117|NCT04642638|566601445|FG005|Overall Study|Study Terminated|250|||
156959118|NCT04642638|566601440|FG000|Overall Study|Pregnancy|0|||
156959119|NCT04642638|566601441|FG001|Overall Study|Pregnancy|0|||
156959120|NCT04642638|566601442|FG002|Overall Study|Pregnancy|0|||
156959121|NCT04642638|566601443|FG003|Overall Study|Pregnancy|0|||
156959122|NCT04642638|566601444|FG004|Overall Study|Pregnancy|1|||
156959123|NCT04642638|566601445|FG005|Overall Study|Pregnancy|0|||
156959124|NCT01869491|566601448|FG000|Overall Study|Adverse Event|3|||
156959125|NCT01869491|566601449|FG001|Overall Study|Adverse Event|5|||
156959126|NCT01869491|566601448|FG000|Overall Study|Lack of Efficacy|0|||
156959127|NCT01869491|566601449|FG001|Overall Study|Lack of Efficacy|3|||
156959128|NCT01869491|566601448|FG000|Overall Study|Withdrawal by Subject|6|||
156959129|NCT01869491|566601449|FG001|Overall Study|Withdrawal by Subject|7|||
156959130|NCT01869491|566601448|FG000|Overall Study|Lost to Follow-up|11|||
156959131|NCT01869491|566601449|FG001|Overall Study|Lost to Follow-up|9|||
156959132|NCT01869491|566601448|FG000|Overall Study|No further need of investigational product|1|||
156959133|NCT01869491|566601449|FG001|Overall Study|No further need of investigational product|0|||
156959134|NCT06476366|566601450|FG000|Overall Study|Lost to Follow-up|1|||
156959135|NCT06476366|566601451|FG001|Overall Study|Lost to Follow-up|3|||
156959136|NCT06476366|566601450|FG000|Overall Study|Adverse Event|1|||
156959137|NCT06476366|566601451|FG001|Overall Study|Adverse Event|0|||
156959138|NCT04313881|566601452|FG000|Overall Study|Death|138|||
156959139|NCT04313881|566601453|FG001|Overall Study|Death|126|||
156959140|NCT04313881|566601452|FG000|Overall Study|Study terminated by sponsor|108|||
156959141|NCT04313881|566601453|FG001|Overall Study|Study terminated by sponsor|129|||
156959142|NCT04313881|566601452|FG000|Overall Study|Consent withdrawn|19|||
156959143|NCT04313881|566601453|FG001|Overall Study|Consent withdrawn|15|||
156959144|NCT04313881|566601452|FG000|Overall Study|Reason not Specified|3|||
156959145|NCT04313881|566601453|FG001|Overall Study|Reason not Specified|1|||
156959146|NCT00727272|566601454|FG000|Washout Period A|Adverse Event|0|||
156959147|NCT00727272|566601455|FG001|Washout Period A|Adverse Event|0|||
156959148|NCT00727272|566601456|FG002|Washout Period A|Adverse Event|1|||
156959149|NCT00727272|566601454|FG000|Washout Period B|Withdrawal by Subject|0|||
156959150|NCT00727272|566601455|FG001|Washout Period B|Withdrawal by Subject|0|||
156959151|NCT00727272|566601456|FG002|Washout Period B|Withdrawal by Subject|1|||
156959152|NCT00651664|566601457|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
156959153|NCT00651664|566601458|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
156959154|NCT00651664|566601459|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
156959155|NCT00651664|566601460|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
156959156|NCT00651664|566601461|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
156959157|NCT00651664|566601462|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
156959158|NCT00651664|566601463|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
156959159|NCT00651664|566601464|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
156959160|NCT00651664|566601465|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
156959161|NCT00651664|566601466|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
156959162|NCT00651664|566601457|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
156959163|NCT00651664|566601458|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156959164|NCT00651664|566601459|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
157170599|NCT00830960|567367162|FG004|Overall Study|Sponsor Decision|5|||
157170600|NCT00830960|567367163|FG005|Overall Study|Sponsor Decision|7|||
156959165|NCT00651664|566601460|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
156959166|NCT00651664|566601461|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
156959167|NCT00651664|566601462|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
156959168|NCT00651664|566601463|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
156959169|NCT00651664|566601464|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
156959170|NCT00651664|566601465|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
156959171|NCT00651664|566601466|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
156959172|NCT00651664|566601457|FG000|Overall Study|Progressive Disease|3|||
156959173|NCT00651664|566601458|FG001|Overall Study|Progressive Disease|3|||
156959174|NCT00651664|566601459|FG002|Overall Study|Progressive Disease|3|||
156959175|NCT00651664|566601460|FG003|Overall Study|Progressive Disease|12|||
156959176|NCT00651664|566601461|FG004|Overall Study|Progressive Disease|4|||
156959177|NCT00651664|566601462|FG005|Overall Study|Progressive Disease|1|||
156959178|NCT00651664|566601463|FG006|Overall Study|Progressive Disease|3|||
156959179|NCT00651664|566601464|FG007|Overall Study|Progressive Disease|6|||
156959180|NCT00651664|566601465|FG008|Overall Study|Progressive Disease|5|||
156959181|NCT00651664|566601466|FG009|Overall Study|Progressive Disease|5|||
156959182|NCT00651664|566601457|FG000|Overall Study|Patient Declined Further Treatment|0|||
156959183|NCT00651664|566601458|FG001|Overall Study|Patient Declined Further Treatment|0|||
156959184|NCT00651664|566601459|FG002|Overall Study|Patient Declined Further Treatment|0|||
156959185|NCT00651664|566601460|FG003|Overall Study|Patient Declined Further Treatment|1|||
156959186|NCT00651664|566601461|FG004|Overall Study|Patient Declined Further Treatment|1|||
156959187|NCT00651664|566601462|FG005|Overall Study|Patient Declined Further Treatment|1|||
156959188|NCT00651664|566601463|FG006|Overall Study|Patient Declined Further Treatment|0|||
156959189|NCT00651664|566601464|FG007|Overall Study|Patient Declined Further Treatment|0|||
156959190|NCT00651664|566601465|FG008|Overall Study|Patient Declined Further Treatment|0|||
156959191|NCT00651664|566601466|FG009|Overall Study|Patient Declined Further Treatment|1|||
156959192|NCT00651664|566601457|FG000|Overall Study|Symptomatic Deterioration|0|||
156959193|NCT00651664|566601458|FG001|Overall Study|Symptomatic Deterioration|0|||
156959194|NCT00651664|566601459|FG002|Overall Study|Symptomatic Deterioration|0|||
156959195|NCT00651664|566601460|FG003|Overall Study|Symptomatic Deterioration|1|||
156959196|NCT00651664|566601461|FG004|Overall Study|Symptomatic Deterioration|0|||
156959197|NCT00651664|566601462|FG005|Overall Study|Symptomatic Deterioration|0|||
156959198|NCT00651664|566601463|FG006|Overall Study|Symptomatic Deterioration|1|||
156959199|NCT00651664|566601464|FG007|Overall Study|Symptomatic Deterioration|0|||
156959200|NCT00651664|566601465|FG008|Overall Study|Symptomatic Deterioration|1|||
156959201|NCT00651664|566601466|FG009|Overall Study|Symptomatic Deterioration|0|||
156959202|NCT00651664|566601457|FG000|Overall Study|Reason not Specified|0|||
156959203|NCT00651664|566601458|FG001|Overall Study|Reason not Specified|0|||
156959204|NCT00651664|566601459|FG002|Overall Study|Reason not Specified|0|||
156959205|NCT00651664|566601460|FG003|Overall Study|Reason not Specified|0|||
156959206|NCT00651664|566601461|FG004|Overall Study|Reason not Specified|0|||
156959207|NCT00651664|566601462|FG005|Overall Study|Reason not Specified|0|||
156959208|NCT00651664|566601463|FG006|Overall Study|Reason not Specified|1|||
156959209|NCT00651664|566601464|FG007|Overall Study|Reason not Specified|0|||
156959210|NCT00651664|566601465|FG008|Overall Study|Reason not Specified|0|||
156959211|NCT00651664|566601466|FG009|Overall Study|Reason not Specified|0|||
156959212|NCT04053764|566601467|FG000|Overall Study|Withdrawal by Subject|6|||
156959213|NCT04053764|566601468|FG001|Overall Study|Withdrawal by Subject|2|||
156959214|NCT04053764|566601467|FG000|Overall Study|Physician Decision|2|||
156959215|NCT04053764|566601468|FG001|Overall Study|Physician Decision|1|||
156959216|NCT04053764|566601467|FG000|Overall Study|Adverse Event|1|||
156959217|NCT04053764|566601468|FG001|Overall Study|Adverse Event|0|||
156959218|NCT04053764|566601467|FG000|Overall Study|Pregnancy|1|||
156959219|NCT04053764|566601468|FG001|Overall Study|Pregnancy|0|||
156959220|NCT04732286|566601472|FG000|Overall Study|Progressive Disease|2|||
156959221|NCT04732286|566601472|FG000|Overall Study|Physician Decision|1|||
156959222|NCT04732286|566601472|FG000|Overall Study|Study Terminated by Sponsor|31|||
156959223|NCT04732286|566601472|FG000|Overall Study|Withdrawal by Subject|10|||
156959224|NCT04732286|566601472|FG000|Overall Study|Non-compliance With Study Drug|1|||
156959225|NCT04732286|566601472|FG000|Overall Study|Lost to Follow-up|4|||
156959226|NCT04732286|566601472|FG000|Overall Study|Death|51|||
156959227|NCT01910129|566601484|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
156959228|NCT01910129|566601485|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
156959229|NCT01910129|566601486|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
156959230|NCT01910129|566601484|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
156959231|NCT01910129|566601485|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
156959232|NCT01910129|566601486|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
156959233|NCT01272934|566601489|FG000|Overall Study|Adverse Event|0|||
156959234|NCT01272934|566601490|FG001|Overall Study|Adverse Event|1|||
156959235|NCT01272934|566601489|FG000|Overall Study|Abnormal Laboratory Value|0|||
156959236|NCT01272934|566601490|FG001|Overall Study|Abnormal Laboratory Value|1|||
156959237|NCT00319098|566601491|FG000|Overall Study|Serious adverse event|3|||
156959238|NCT00319098|566601492|FG001|Overall Study|Serious adverse event|0|||
156959239|NCT00319098|566601491|FG000|Overall Study|Adverse Event|20|||
156959240|NCT00319098|566601492|FG001|Overall Study|Adverse Event|1|||
156959241|NCT00319098|566601491|FG000|Overall Study|Withdrawal by Subject|37|||
156959242|NCT00319098|566601492|FG001|Overall Study|Withdrawal by Subject|8|||
156959243|NCT00319098|566601491|FG000|Overall Study|Migrated/moved from study area|2|||
156959244|NCT00319098|566601492|FG001|Overall Study|Migrated/moved from study area|1|||
156959245|NCT00319098|566601491|FG000|Overall Study|Lost to Follow-up|37|||
156959246|NCT00319098|566601492|FG001|Overall Study|Lost to Follow-up|13|||
156959247|NCT00319098|566601491|FG000|Overall Study|Others|33|||
156959248|NCT00319098|566601492|FG001|Overall Study|Others|8|||
156959249|NCT00319098|566601491|FG000|Overall Study|Protocol Violation|3|||
156959250|NCT00319098|566601492|FG001|Overall Study|Protocol Violation|1|||
156959251|NCT03449030|566601493|FG000|Overall Study|Withdrawal by Subject|0|||
156959252|NCT03449030|566601494|FG001|Overall Study|Withdrawal by Subject|0|||
156959253|NCT03449030|566601495|FG002|Overall Study|Withdrawal by Subject|0|||
156959254|NCT03449030|566601496|FG003|Overall Study|Withdrawal by Subject|1|||
156959255|NCT03449030|566601497|FG004|Overall Study|Withdrawal by Subject|1|||
156959256|NCT03449030|566601498|FG005|Overall Study|Withdrawal by Subject|1|||
156959257|NCT03449030|566601499|FG006|Overall Study|Withdrawal by Subject|1|||
156959258|NCT03449030|566601500|FG007|Overall Study|Withdrawal by Subject|2|||
156959259|NCT03449030|566601501|FG008|Overall Study|Withdrawal by Subject|0|||
156959260|NCT03449030|566601502|FG009|Overall Study|Withdrawal by Subject|0|||
156959261|NCT03449030|566601493|FG000|Overall Study|Symptomatic Deterioration|0|||
156959262|NCT03449030|566601494|FG001|Overall Study|Symptomatic Deterioration|1|||
156959263|NCT03449030|566601495|FG002|Overall Study|Symptomatic Deterioration|0|||
156959264|NCT03449030|566601496|FG003|Overall Study|Symptomatic Deterioration|0|||
156959265|NCT03449030|566601497|FG004|Overall Study|Symptomatic Deterioration|0|||
156959266|NCT03449030|566601498|FG005|Overall Study|Symptomatic Deterioration|1|||
156959267|NCT03449030|566601499|FG006|Overall Study|Symptomatic Deterioration|1|||
156959268|NCT03449030|566601500|FG007|Overall Study|Symptomatic Deterioration|0|||
156959269|NCT03449030|566601501|FG008|Overall Study|Symptomatic Deterioration|2|||
156959270|NCT03449030|566601502|FG009|Overall Study|Symptomatic Deterioration|0|||
156959271|NCT03449030|566601493|FG000|Overall Study|Progressive Disease|1|||
156959272|NCT03449030|566601494|FG001|Overall Study|Progressive Disease|0|||
156959273|NCT03449030|566601495|FG002|Overall Study|Progressive Disease|1|||
156959274|NCT03449030|566601496|FG003|Overall Study|Progressive Disease|4|||
156959275|NCT03449030|566601497|FG004|Overall Study|Progressive Disease|5|||
156959276|NCT03449030|566601498|FG005|Overall Study|Progressive Disease|3|||
156959277|NCT03449030|566601499|FG006|Overall Study|Progressive Disease|0|||
156959278|NCT03449030|566601500|FG007|Overall Study|Progressive Disease|1|||
156959279|NCT03449030|566601501|FG008|Overall Study|Progressive Disease|1|||
156959280|NCT03449030|566601502|FG009|Overall Study|Progressive Disease|1|||
156959281|NCT03449030|566601493|FG000|Overall Study|Adverse Event|0|||
156959282|NCT03449030|566601494|FG001|Overall Study|Adverse Event|0|||
156959283|NCT03449030|566601495|FG002|Overall Study|Adverse Event|0|||
156959284|NCT03449030|566601496|FG003|Overall Study|Adverse Event|0|||
156959285|NCT03449030|566601497|FG004|Overall Study|Adverse Event|0|||
156959286|NCT03449030|566601498|FG005|Overall Study|Adverse Event|2|||
157170601|NCT00830960|567367158|FG000|Overall Study|No study drug received|7|||
157170602|NCT00830960|567367159|FG001|Overall Study|No study drug received|2|||
157170603|NCT00830960|567367160|FG002|Overall Study|No study drug received|4|||
156959287|NCT03449030|566601499|FG006|Overall Study|Adverse Event|0|||
156959288|NCT03449030|566601500|FG007|Overall Study|Adverse Event|0|||
156959289|NCT03449030|566601501|FG008|Overall Study|Adverse Event|0|||
156959290|NCT03449030|566601502|FG009|Overall Study|Adverse Event|0|||
156959291|NCT03449030|566601493|FG000|Overall Study|Death|0|||
156959292|NCT03449030|566601494|FG001|Overall Study|Death|0|||
156959293|NCT03449030|566601495|FG002|Overall Study|Death|0|||
156959294|NCT03449030|566601496|FG003|Overall Study|Death|0|||
156959295|NCT03449030|566601497|FG004|Overall Study|Death|1|||
156959296|NCT03449030|566601498|FG005|Overall Study|Death|0|||
156959297|NCT03449030|566601499|FG006|Overall Study|Death|0|||
156959298|NCT03449030|566601500|FG007|Overall Study|Death|0|||
156959299|NCT03449030|566601501|FG008|Overall Study|Death|0|||
156959300|NCT03449030|566601502|FG009|Overall Study|Death|0|||
156959301|NCT00965523|566601503|FG000|Study 221|Progressive Disease|4|||
157170604|NCT00830960|567367161|FG003|Overall Study|No study drug received|3|||
157170605|NCT00830960|567367162|FG004|Overall Study|No study drug received|5|||
156959302|NCT00965523|566601503|FG000|Study 221|Physician Decision|3|||
156959303|NCT00965523|566601503|FG000|Study 224|Progressive Disease|5|||
156959304|NCT00965523|566601503|FG000|Study 224|Physician Decision|1|||
156959305|NCT02415400|566601506|FG000|Overall Study|Adverse Event|0|||
156959306|NCT02415400|566601507|FG001|Overall Study|Adverse Event|1|||
156959307|NCT02415400|566601508|FG002|Overall Study|Adverse Event|1|||
156959308|NCT02415400|566601509|FG003|Overall Study|Adverse Event|2|||
156959309|NCT02415400|566601506|FG000|Overall Study|Participant request to stop therapy|4|||
156959310|NCT02415400|566601507|FG001|Overall Study|Participant request to stop therapy|3|||
156959311|NCT02415400|566601508|FG002|Overall Study|Participant request to stop therapy|8|||
156959312|NCT02415400|566601509|FG003|Overall Study|Participant request to stop therapy|6|||
156959313|NCT02415400|566601506|FG000|Overall Study|Participant withdrew consent|14|||
156959314|NCT02415400|566601507|FG001|Overall Study|Participant withdrew consent|12|||
156959315|NCT02415400|566601508|FG002|Overall Study|Participant withdrew consent|30|||
156959316|NCT02415400|566601509|FG003|Overall Study|Participant withdrew consent|21|||
157170606|NCT00830960|567367163|FG005|Overall Study|No study drug received|7|||
156959317|NCT02415400|566601506|FG000|Overall Study|Death|39|||
156959318|NCT02415400|566601507|FG001|Overall Study|Death|41|||
156959319|NCT02415400|566601508|FG002|Overall Study|Death|35|||
156959320|NCT02415400|566601509|FG003|Overall Study|Death|42|||
156959321|NCT02415400|566601506|FG000|Overall Study|Lost to Follow-up|3|||
156959322|NCT02415400|566601507|FG001|Overall Study|Lost to Follow-up|3|||
156959323|NCT02415400|566601508|FG002|Overall Study|Lost to Follow-up|2|||
156959324|NCT02415400|566601509|FG003|Overall Study|Lost to Follow-up|5|||
156959325|NCT02415400|566601506|FG000|Overall Study|Poor/Non-Compliance|0|||
156959326|NCT02415400|566601507|FG001|Overall Study|Poor/Non-Compliance|1|||
156959327|NCT02415400|566601508|FG002|Overall Study|Poor/Non-Compliance|3|||
156959328|NCT02415400|566601509|FG003|Overall Study|Poor/Non-Compliance|4|||
156959329|NCT02415400|566601506|FG000|Overall Study|Participant no longer meets criteria|2|||
156959330|NCT02415400|566601507|FG001|Overall Study|Participant no longer meets criteria|0|||
156959331|NCT02415400|566601508|FG002|Overall Study|Participant no longer meets criteria|0|||
156959332|NCT02415400|566601509|FG003|Overall Study|Participant no longer meets criteria|1|||
156959333|NCT02415400|566601506|FG000|Overall Study|Participant doesn't answer phone|1|||
157170607|NCT02855450|567367164|FG000|Overall Study|Adverse Event|1|||
157170608|NCT02855450|567367165|FG001|Overall Study|Adverse Event|0|||
157170609|NCT02855450|567367164|FG000|Overall Study|Lost to Follow-up|4|||
157170610|NCT02855450|567367165|FG001|Overall Study|Lost to Follow-up|0|||
157170611|NCT01803711|567367172|FG000|Overall Study|Adverse Event|1|||
157170612|NCT01803711|567367173|FG001|Overall Study|Adverse Event|1|||
157170613|NCT05159362|567367174|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
157170614|NCT05159362|567367175|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
157170615|NCT05159362|567367176|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
157170616|NCT01170221|567367177|FG000|Overall Study|Lost to Follow-up|22|||
157170617|NCT01170221|567367178|FG001|Overall Study|Lost to Follow-up|21|||
157170618|NCT01170221|567367177|FG000|Overall Study|Withdrawal by Subject|9|||
157170619|NCT01170221|567367178|FG001|Overall Study|Withdrawal by Subject|7|||
157170620|NCT01170221|567367177|FG000|Overall Study|Subject completed only screening and LFU|1|||
157170621|NCT01170221|567367178|FG001|Overall Study|Subject completed only screening and LFU|0|||
157170622|NCT01170221|567367177|FG000|Overall Study|Randomized but not treated|1|||
157170623|NCT01170221|567367178|FG001|Overall Study|Randomized but not treated|0|||
157170624|NCT00050960|567367179|FG000|Overall Study|Progressive Disease|137|||
157170625|NCT00050960|567367180|FG001|Overall Study|Progressive Disease|93|||
157170626|NCT00050960|567367179|FG000|Overall Study|Stable Disease|19|||
156959334|NCT02415400|566601507|FG001|Overall Study|Participant doesn't answer phone|0|||
157170627|NCT00050960|567367180|FG001|Overall Study|Stable Disease|48|||
157170628|NCT00050960|567367179|FG000|Overall Study|Partial Response|14|||
157170629|NCT00050960|567367180|FG001|Overall Study|Partial Response|19|||
157170630|NCT00050960|567367179|FG000|Overall Study|Complete Response|0|||
157170631|NCT00050960|567367180|FG001|Overall Study|Complete Response|2|||
157170632|NCT00050960|567367179|FG000|Overall Study|Adverse Event|62|||
157170633|NCT00050960|567367180|FG001|Overall Study|Adverse Event|61|||
157170634|NCT00050960|567367179|FG000|Overall Study|Lost to Follow-up|0|||
157170635|NCT00050960|567367180|FG001|Overall Study|Lost to Follow-up|1|||
157170636|NCT00050960|567367179|FG000|Overall Study|Withdrawal by Subject|23|||
157170637|NCT00050960|567367180|FG001|Overall Study|Withdrawal by Subject|18|||
157170638|NCT00050960|567367179|FG000|Overall Study|Administrative|31|||
157170639|NCT00050960|567367180|FG001|Overall Study|Administrative|46|||
157170640|NCT00050960|567367179|FG000|Overall Study|Non-compliance|3|||
157170641|NCT00050960|567367180|FG001|Overall Study|Non-compliance|1|||
157170642|NCT00050960|567367179|FG000|Overall Study|Death|13|||
157170643|NCT00050960|567367180|FG001|Overall Study|Death|15|||
157170644|NCT01315847|567367181|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
157170645|NCT01315847|567367182|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
157170646|NCT01315847|567367181|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
157170647|NCT01315847|567367182|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
157170648|NCT02940626|567367183|FG000|Overall Study|Death|40|||
157170649|NCT02940626|567367184|FG001|Overall Study|Death|32|||
157170650|NCT02940626|567367183|FG000|Overall Study|Lost to Follow-up|5|||
157170651|NCT02940626|567367184|FG001|Overall Study|Lost to Follow-up|2|||
157170652|NCT02940626|567367183|FG000|Overall Study|Withdrawal by Subject|1|||
157170653|NCT02940626|567367184|FG001|Overall Study|Withdrawal by Subject|0|||
157170654|NCT02940626|567367183|FG000|Overall Study|Transfer to Hospice Care|1|||
157170655|NCT02940626|567367184|FG001|Overall Study|Transfer to Hospice Care|0|||
157170656|NCT02940626|567367183|FG000|Overall Study|Prohibited Concomitant Medication|0|||
157170657|NCT02940626|567367184|FG001|Overall Study|Prohibited Concomitant Medication|1|||
157170658|NCT00618449|567367185|FG000|Overall Study|Lost to Follow-up|98|||
157170659|NCT00618449|567367186|FG001|Overall Study|Lost to Follow-up|110|||
157170660|NCT00138424|567367187|FG000|Overall Study|Physician Decision|0|||
157170661|NCT00138424|567367188|FG001|Overall Study|Physician Decision|1|||
157170662|NCT00138424|567367189|FG002|Overall Study|Physician Decision|0|||
157170663|NCT00138424|567367190|FG003|Overall Study|Physician Decision|0|||
156959335|NCT02415400|566601508|FG002|Overall Study|Participant doesn't answer phone|0|||
157170664|NCT00413062|567367197|FG000|Overall Study|Adverse event/serious adverse event|289|||
157170665|NCT00413062|567367198|FG001|Overall Study|Adverse event/serious adverse event|56|||
157170666|NCT00413062|567367197|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
157170667|NCT00413062|567367198|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
157170668|NCT00413062|567367197|FG000|Overall Study|Withdrawal of informed consent|111|||
157170669|NCT00413062|567367198|FG001|Overall Study|Withdrawal of informed consent|36|||
157170670|NCT00413062|567367197|FG000|Overall Study|Pregnancy|15|||
156959336|NCT02415400|566601509|FG003|Overall Study|Participant doesn't answer phone|0|||
156959337|NCT02415400|566601506|FG000|Overall Study|Participant wanted home visits|1|||
156959338|NCT02415400|566601507|FG001|Overall Study|Participant wanted home visits|0|||
156959339|NCT02415400|566601508|FG002|Overall Study|Participant wanted home visits|0|||
156959340|NCT02415400|566601509|FG003|Overall Study|Participant wanted home visits|0|||
156959341|NCT02415400|566601506|FG000|Overall Study|Randomized in error|2|||
156959342|NCT02415400|566601507|FG001|Overall Study|Randomized in error|0|||
156959343|NCT02415400|566601508|FG002|Overall Study|Randomized in error|0|||
156959344|NCT02415400|566601509|FG003|Overall Study|Randomized in error|0|||
156959345|NCT02415400|566601506|FG000|Overall Study|No study drug on site|0|||
156959346|NCT02415400|566601507|FG001|Overall Study|No study drug on site|1|||
156959347|NCT02415400|566601508|FG002|Overall Study|No study drug on site|0|||
156959348|NCT02415400|566601509|FG003|Overall Study|No study drug on site|0|||
156959349|NCT02415400|566601506|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
156959350|NCT02415400|566601507|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
156959351|NCT02415400|566601508|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
156959352|NCT02415400|566601509|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
156959353|NCT02415400|566601506|FG000|Overall Study|Coagulation values cannot be set|0|||
156959354|NCT02415400|566601507|FG001|Overall Study|Coagulation values cannot be set|0|||
156959355|NCT02415400|566601508|FG002|Overall Study|Coagulation values cannot be set|1|||
156959356|NCT02415400|566601509|FG003|Overall Study|Coagulation values cannot be set|0|||
156959357|NCT02415400|566601506|FG000|Overall Study|State regulations prevent participation|0|||
156959358|NCT02415400|566601507|FG001|Overall Study|State regulations prevent participation|0|||
156959359|NCT02415400|566601508|FG002|Overall Study|State regulations prevent participation|1|||
156959360|NCT02415400|566601509|FG003|Overall Study|State regulations prevent participation|0|||
156959361|NCT02415400|566601506|FG000|Overall Study|Poor treatment monitoring|0|||
156959362|NCT02415400|566601507|FG001|Overall Study|Poor treatment monitoring|0|||
156959363|NCT02415400|566601508|FG002|Overall Study|Poor treatment monitoring|1|||
156959364|NCT02415400|566601509|FG003|Overall Study|Poor treatment monitoring|0|||
156959365|NCT02415400|566601506|FG000|Overall Study|Participant in jail|0|||
156959366|NCT02415400|566601507|FG001|Overall Study|Participant in jail|0|||
156959367|NCT02415400|566601508|FG002|Overall Study|Participant in jail|1|||
156959368|NCT02415400|566601509|FG003|Overall Study|Participant in jail|0|||
156959369|NCT02415400|566601506|FG000|Overall Study|Investigator decision|0|||
156959370|NCT02415400|566601507|FG001|Overall Study|Investigator decision|0|||
156959371|NCT02415400|566601508|FG002|Overall Study|Investigator decision|1|||
156959372|NCT02415400|566601509|FG003|Overall Study|Investigator decision|1|||
156959373|NCT02415400|566601506|FG000|Overall Study|Site closure; participant won't transfer|0|||
156959374|NCT02415400|566601507|FG001|Overall Study|Site closure; participant won't transfer|0|||
156959375|NCT02415400|566601508|FG002|Overall Study|Site closure; participant won't transfer|0|||
156959376|NCT02415400|566601509|FG003|Overall Study|Site closure; participant won't transfer|1|||
156959377|NCT03595904|566601518|FG000|Overall Study|Protocol Violation|3|||
156959378|NCT03595904|566601519|FG001|Overall Study|Protocol Violation|1|||
156959379|NCT03595904|566601518|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
156959380|NCT03595904|566601519|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
156959381|NCT03595904|566601518|FG000|Overall Study|Insurance complications|1|||
156959382|NCT03595904|566601519|FG001|Overall Study|Insurance complications|0|||
156959383|NCT03595904|566601518|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
156959384|NCT03595904|566601519|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
156959385|NCT01650259|566601520|FG000|Overall Study|Improvement|105|||
156959386|NCT01650259|566601521|FG001|Overall Study|Improvement|0|||
156959387|NCT01650259|566601520|FG000|Overall Study|Adverse Event|127|||
156959388|NCT01650259|566601521|FG001|Overall Study|Adverse Event|0|||
156959389|NCT01650259|566601520|FG000|Overall Study|Lack of Efficacy|143|||
156959390|NCT01650259|566601521|FG001|Overall Study|Lack of Efficacy|0|||
156959391|NCT01650259|566601520|FG000|Overall Study|Lost to Follow-up|435|||
156959392|NCT01650259|566601521|FG001|Overall Study|Lost to Follow-up|0|||
156959393|NCT01650259|566601520|FG000|Overall Study|Patients had no visit after entry|70|||
156959394|NCT01650259|566601521|FG001|Overall Study|Patients had no visit after entry|0|||
156959395|NCT01650259|566601520|FG000|Overall Study|CRF not collected|98|||
156959396|NCT01650259|566601521|FG001|Overall Study|CRF not collected|82|||
156959397|NCT01650259|566601520|FG000|Overall Study|Not treated|1|||
157170671|NCT00413062|567367198|FG001|Overall Study|Pregnancy|5|||
157170672|NCT00413062|567367197|FG000|Overall Study|Pregnancy wish|17|||
157170673|NCT00413062|567367198|FG001|Overall Study|Pregnancy wish|6|||
157170674|NCT00413062|567367197|FG000|Overall Study|Lost to Follow-up|175|||
157170675|NCT00413062|567367198|FG001|Overall Study|Lost to Follow-up|73|||
157170676|NCT00413062|567367197|FG000|Overall Study|Other reason|70|||
157170677|NCT00413062|567367198|FG001|Overall Study|Other reason|34|||
157170678|NCT02176291|567367199|FG000|Overall Study|Death|1|||
157170679|NCT02176291|567367200|FG001|Overall Study|Death|0|||
157170680|NCT02176291|567367199|FG000|Overall Study|non compliance with protocol|2|||
157170681|NCT02176291|567367200|FG001|Overall Study|non compliance with protocol|0|||
157170682|NCT02176291|567367199|FG000|Overall Study|Withdrawal by Subject|2|||
157170683|NCT02176291|567367200|FG001|Overall Study|Withdrawal by Subject|0|||
157170684|NCT01969799|567367201|FG000|Overall Study|Adverse Event|0|||
157170685|NCT01969799|567367202|FG001|Overall Study|Adverse Event|1|||
157170686|NCT01969799|567367201|FG000|Overall Study|Death|16|||
157170687|NCT01969799|567367202|FG001|Overall Study|Death|11|||
157170688|NCT01969799|567367201|FG000|Overall Study|Lost to Follow-up|0|||
157170689|NCT01969799|567367202|FG001|Overall Study|Lost to Follow-up|2|||
157170690|NCT01969799|567367201|FG000|Overall Study|Physician Decision|1|||
157170691|NCT01969799|567367202|FG001|Overall Study|Physician Decision|0|||
157170692|NCT00006604|567367203|FG000|Overall Study|Met study objective - no further FU|1|||
157170693|NCT00006604|567367204|FG001|Overall Study|Met study objective - no further FU|0|||
157170694|NCT00006604|567367205|FG002|Overall Study|Met study objective - no further FU|0|||
156959398|NCT01650259|566601521|FG001|Overall Study|Not treated|7|||
156959399|NCT01650259|566601520|FG000|Overall Study|Other than listed|64|||
156959400|NCT01650259|566601521|FG001|Overall Study|Other than listed|146|||
156959401|NCT00936858|566601522|FG000|Overall Study|Death|3|||
156959402|NCT00936858|566601522|FG000|Overall Study|Progression|29|||
156959403|NCT00936858|566601522|FG000|Overall Study|Withdrawal by Subject|5|||
156959404|NCT00936858|566601522|FG000|Overall Study|Adverse Event|1|||
156959405|NCT00936858|566601522|FG000|Overall Study|Physician Decision|7|||
156959406|NCT00936858|566601522|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
156959407|NCT00936858|566601522|FG000|Overall Study|Lost to Follow-up|1|||
156959408|NCT00584727|566601531|FG000|First Intervention|Discontinuation|0|||
156959409|NCT00584727|566601532|FG001|First Intervention|Discontinuation|0|||
156959410|NCT00584727|566601533|FG002|First Intervention|Discontinuation|1|||
156959411|NCT00584727|566601534|FG003|First Intervention|Discontinuation|0|||
156959412|NCT00584727|566601535|FG004|First Intervention|Discontinuation|0|||
156959413|NCT00584727|566601536|FG005|First Intervention|Discontinuation|0|||
156959414|NCT00584727|566601531|FG000|Third Intervention|Protocol Violation|0|||
156959415|NCT00584727|566601532|FG001|Third Intervention|Protocol Violation|0|||
156959416|NCT00584727|566601533|FG002|Third Intervention|Protocol Violation|1|||
156959417|NCT00584727|566601534|FG003|Third Intervention|Protocol Violation|0|||
156959418|NCT00584727|566601535|FG004|Third Intervention|Protocol Violation|4|||
156959419|NCT00584727|566601536|FG005|Third Intervention|Protocol Violation|2|||
156959420|NCT00989287|566601540|FG000|Overall Study|Adverse Event|1|||
156959421|NCT00989287|566601541|FG001|Overall Study|Adverse Event|0|||
156959422|NCT00989287|566601540|FG000|Overall Study|Lost to Follow-up|0|||
156959423|NCT00989287|566601541|FG001|Overall Study|Lost to Follow-up|1|||
156959424|NCT01358526|566601543|FG000|Open-label Titration Period|Adverse Event|95|||
156959425|NCT01358526|566601544|FG001|Open-label Titration Period|Adverse Event|0|||
156959426|NCT01358526|566601545|FG002|Open-label Titration Period|Adverse Event|0|||
156959427|NCT01358526|566601543|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
156959428|NCT01358526|566601544|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
156959429|NCT01358526|566601545|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
156959430|NCT01358526|566601543|FG000|Open-label Titration Period|Lost to Follow-up|25|||
156959431|NCT01358526|566601544|FG001|Open-label Titration Period|Lost to Follow-up|0|||
156959432|NCT01358526|566601545|FG002|Open-label Titration Period|Lost to Follow-up|0|||
156959433|NCT01358526|566601543|FG000|Open-label Titration Period|Lack of Efficacy|107|||
156959434|NCT01358526|566601544|FG001|Open-label Titration Period|Lack of Efficacy|0|||
156959435|NCT01358526|566601545|FG002|Open-label Titration Period|Lack of Efficacy|0|||
156959436|NCT01358526|566601543|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
156959437|NCT01358526|566601544|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
156959438|NCT01358526|566601545|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
156959439|NCT01358526|566601543|FG000|Open-label Titration Period|Administrative|8|||
156959440|NCT01358526|566601544|FG001|Open-label Titration Period|Administrative|0|||
156959441|NCT01358526|566601545|FG002|Open-label Titration Period|Administrative|0|||
156959442|NCT01358526|566601543|FG000|Open-label Titration Period|Did not qualify|178|||
156959443|NCT01358526|566601544|FG001|Open-label Titration Period|Did not qualify|0|||
156959444|NCT01358526|566601545|FG002|Open-label Titration Period|Did not qualify|0|||
156959445|NCT01358526|566601543|FG000|Double-blind Phase|Adverse Event|0|||
156959446|NCT01358526|566601544|FG001|Double-blind Phase|Adverse Event|24|||
156959447|NCT01358526|566601545|FG002|Double-blind Phase|Adverse Event|23|||
156959448|NCT01358526|566601543|FG000|Double-blind Phase|Withdrawal by Subject|0|||
157170695|NCT00006604|567367206|FG003|Overall Study|Met study objective - no further FU|0|||
157170696|NCT00006604|567367207|FG004|Overall Study|Met study objective - no further FU|0|||
157227723|NCT06179108|567579177|FG003|Overall Study|Adverse Event|2|||
156959449|NCT01358526|566601544|FG001|Double-blind Phase|Withdrawal by Subject|10|||
156959450|NCT01358526|566601545|FG002|Double-blind Phase|Withdrawal by Subject|8|||
156959451|NCT01358526|566601543|FG000|Double-blind Phase|Lost to Follow-up|0|||
156959452|NCT01358526|566601544|FG001|Double-blind Phase|Lost to Follow-up|4|||
156959453|NCT01358526|566601545|FG002|Double-blind Phase|Lost to Follow-up|1|||
156959454|NCT01358526|566601543|FG000|Double-blind Phase|Lack of Efficacy|0|||
156959455|NCT01358526|566601544|FG001|Double-blind Phase|Lack of Efficacy|31|||
156959456|NCT01358526|566601545|FG002|Double-blind Phase|Lack of Efficacy|73|||
156959457|NCT01358526|566601543|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
156959458|NCT01358526|566601544|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
156959459|NCT01358526|566601545|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
156959460|NCT01358526|566601543|FG000|Double-blind Phase|Administrative|0|||
156959461|NCT01358526|566601544|FG001|Double-blind Phase|Administrative|6|||
156959462|NCT01358526|566601545|FG002|Double-blind Phase|Administrative|10|||
156959463|NCT03674177|566601547|FG000|Overall Study|Lost to Follow-up|2|||
156959464|NCT03674177|566601548|FG001|Overall Study|Lost to Follow-up|1|||
156959465|NCT03674177|566601549|FG002|Overall Study|Lost to Follow-up|0|||
156959466|NCT03674177|566601550|FG003|Overall Study|Lost to Follow-up|2|||
156959467|NCT03387852|566601551|FG000|Overall Study|Adverse event (AE)|3|||
156959468|NCT03387852|566601552|FG001|Overall Study|Adverse event (AE)|0|||
156959469|NCT03387852|566601553|FG002|Overall Study|Adverse event (AE)|2|||
156959470|NCT03387852|566601554|FG003|Overall Study|Adverse event (AE)|0|||
156959471|NCT03387852|566601551|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
156959472|NCT03387852|566601552|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
156959473|NCT03387852|566601553|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
156959474|NCT03387852|566601554|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
156959475|NCT03387852|566601551|FG000|Overall Study|Withdrawal by participant|1|||
156959476|NCT03387852|566601552|FG001|Overall Study|Withdrawal by participant|1|||
156959477|NCT03387852|566601553|FG002|Overall Study|Withdrawal by participant|3|||
156959478|NCT03387852|566601554|FG003|Overall Study|Withdrawal by participant|2|||
156959479|NCT03387852|566601551|FG000|Overall Study|Other- Unspecified|1|||
156959480|NCT03387852|566601552|FG001|Overall Study|Other- Unspecified|1|||
156959481|NCT03387852|566601553|FG002|Overall Study|Other- Unspecified|2|||
156959482|NCT03387852|566601554|FG003|Overall Study|Other- Unspecified|1|||
156959483|NCT03387852|566601551|FG000|Overall Study|Poor compliance to protocol|0|||
156959484|NCT03387852|566601552|FG001|Overall Study|Poor compliance to protocol|0|||
156959485|NCT03387852|566601553|FG002|Overall Study|Poor compliance to protocol|0|||
156959486|NCT03387852|566601554|FG003|Overall Study|Poor compliance to protocol|1|||
156959487|NCT03387852|566601551|FG000|Overall Study|Randomized and not treated|0|||
156959488|NCT03387852|566601552|FG001|Overall Study|Randomized and not treated|0|||
156959489|NCT03387852|566601553|FG002|Overall Study|Randomized and not treated|0|||
156959490|NCT03387852|566601554|FG003|Overall Study|Randomized and not treated|1|||
156959491|NCT02194621|566601555|FG000|Overall Study|6 withdrew prior to randomization|2|||
156959492|NCT02194621|566601556|FG001|Overall Study|6 withdrew prior to randomization|2|||
156959493|NCT02194621|566601557|FG002|Overall Study|6 withdrew prior to randomization|2|||
156959494|NCT02194621|566601555|FG000|Overall Study|Withdrawal by Subject|4|||
156959495|NCT02194621|566601556|FG001|Overall Study|Withdrawal by Subject|4|||
156959496|NCT02194621|566601557|FG002|Overall Study|Withdrawal by Subject|7|||
156959497|NCT02493127|566601565|FG000|Overall Study|Lost to Follow-up|1|||
156959498|NCT02493127|566601566|FG001|Overall Study|Lost to Follow-up|1|||
156959499|NCT00809757|566601567|FG000|Overall Study|Adverse Event|2|||
156959500|NCT00809757|566601568|FG001|Overall Study|Adverse Event|3|||
156959501|NCT00809757|566601569|FG002|Overall Study|Adverse Event|3|||
156959502|NCT00809757|566601567|FG000|Overall Study|Lost to Follow-up|0|||
156959503|NCT00809757|566601568|FG001|Overall Study|Lost to Follow-up|0|||
156959504|NCT00809757|566601569|FG002|Overall Study|Lost to Follow-up|1|||
156959505|NCT00809757|566601567|FG000|Overall Study|Protocol Violation|1|||
156959506|NCT00809757|566601568|FG001|Overall Study|Protocol Violation|1|||
156959507|NCT00809757|566601569|FG002|Overall Study|Protocol Violation|1|||
156959508|NCT00809757|566601567|FG000|Overall Study|Withdrawal by Subject|2|||
156959509|NCT00809757|566601568|FG001|Overall Study|Withdrawal by Subject|1|||
157170697|NCT00006604|567367208|FG005|Overall Study|Met study objective - no further FU|0|||
157170698|NCT00006604|567367209|FG006|Overall Study|Met study objective - no further FU|0|||
157170699|NCT00006604|567367210|FG007|Overall Study|Met study objective - no further FU|0|||
157170700|NCT00006604|567367211|FG008|Overall Study|Met study objective - no further FU|0|||
156959510|NCT00809757|566601569|FG002|Overall Study|Withdrawal by Subject|3|||
156959511|NCT00809757|566601567|FG000|Overall Study|Subject Uncooperative|1|||
156959512|NCT00809757|566601568|FG001|Overall Study|Subject Uncooperative|0|||
156959513|NCT00809757|566601569|FG002|Overall Study|Subject Uncooperative|2|||
156959514|NCT00809757|566601567|FG000|Overall Study|Noncompliance with Medication|0|||
156959515|NCT00809757|566601568|FG001|Overall Study|Noncompliance with Medication|0|||
156959516|NCT00809757|566601569|FG002|Overall Study|Noncompliance with Medication|1|||
156959517|NCT01949311|566603873|FG000|Overall Study|Lost to Follow-up|73|||
156959518|NCT01949311|566603873|FG000|Overall Study|Terminated by Sponsor|708|||
156959519|NCT01949311|566603873|FG000|Overall Study|Withdrawal by Subject|375|||
156959520|NCT01949311|566603873|FG000|Overall Study|Lack of Efficacy|50|||
156959521|NCT01949311|566603873|FG000|Overall Study|Protocol Deviation|34|||
156959522|NCT01949311|566603873|FG000|Overall Study|Pregnancy|20|||
157170701|NCT00006604|567367212|FG009|Overall Study|Met study objective - no further FU|0|||
157170702|NCT00006604|567367213|FG010|Overall Study|Met study objective - no further FU|0|||
157170703|NCT00006604|567367214|FG011|Overall Study|Met study objective - no further FU|0|||
156959523|NCT01949311|566603873|FG000|Overall Study|Physician Decision|9|||
156959524|NCT01949311|566603873|FG000|Overall Study|Other|4|||
156959525|NCT01949311|566603873|FG000|Overall Study|Adverse Event|107|||
156959526|NCT04786444|566603876|FG000|Overall Study|Withdrawal by Subject|4|||
156959527|NCT04786444|566603877|FG001|Overall Study|Withdrawal by Subject|7|||
156959528|NCT04786444|566603878|FG002|Overall Study|Withdrawal by Subject|2|||
156959529|NCT04786444|566603876|FG000|Overall Study|Lost to Follow-up|11|||
156959530|NCT04786444|566603877|FG001|Overall Study|Lost to Follow-up|9|||
156959531|NCT04786444|566603878|FG002|Overall Study|Lost to Follow-up|10|||
156959532|NCT04786444|566603876|FG000|Overall Study|Subject would like to become pregnant|0|||
156959533|NCT04786444|566603877|FG001|Overall Study|Subject would like to become pregnant|1|||
156959534|NCT04786444|566603878|FG002|Overall Study|Subject would like to become pregnant|0|||
156959535|NCT03166618|566603879|FG000|Overall Study|Study was Terminated|0|||
156959536|NCT03166618|566603880|FG001|Overall Study|Study was Terminated|1|||
156959537|NCT03137303|566603882|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
156959538|NCT03137303|566603883|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
156959539|NCT03137303|566603882|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
156959540|NCT03137303|566603883|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
156959541|NCT03137303|566603882|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
156959542|NCT03137303|566603883|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
156959543|NCT03137303|566603882|FG000|T3: 9-month Follow-up|Death|1|||
156959544|NCT03137303|566603883|FG001|T3: 9-month Follow-up|Death|0|||
156959545|NCT03137303|566603882|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
156959546|NCT03137303|566603883|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
156959547|NCT03137303|566603882|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
156959548|NCT03137303|566603883|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
156959549|NCT03137303|566603882|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
156959550|NCT03137303|566603883|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
156959551|NCT03561090|566603884|FG000|Overall Study|Adverse Event|11|||
156959552|NCT03561090|566603885|FG001|Overall Study|Adverse Event|7|||
156959553|NCT03561090|566603884|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156959554|NCT03561090|566603885|FG001|Overall Study|Non-Compliance With Study Drug|0|||
156959555|NCT03561090|566603884|FG000|Overall Study|Protocol Violation|2|||
156959556|NCT03561090|566603885|FG001|Overall Study|Protocol Violation|2|||
156959557|NCT03561090|566603884|FG000|Overall Study|Withdrawal by Subject|7|||
156959558|NCT03561090|566603885|FG001|Overall Study|Withdrawal by Subject|7|||
156959559|NCT03561090|566603884|FG000|Overall Study|Lost to Follow-up|7|||
156959560|NCT03561090|566603885|FG001|Overall Study|Lost to Follow-up|2|||
156959561|NCT03561090|566603884|FG000|Overall Study|Study Terminated by Sponsor|10|||
156959562|NCT03561090|566603885|FG001|Overall Study|Study Terminated by Sponsor|15|||
156959563|NCT03561090|566603884|FG000|Overall Study|Randomized by Mistake|1|||
156959564|NCT03561090|566603885|FG001|Overall Study|Randomized by Mistake|1|||
156959565|NCT03561090|566603884|FG000|Overall Study|Other Not Specified|0|||
156959566|NCT03561090|566603885|FG001|Overall Study|Other Not Specified|2|||
156959567|NCT00725452|566603894|FG000|Overall Study|Adverse Event|3|||
156959568|NCT00725452|566603894|FG000|Overall Study|Lack of Efficacy|2|||
156959569|NCT00725452|566603894|FG000|Overall Study|Reason not specified|1|||
156959570|NCT00725452|566603894|FG000|Overall Study|Physician Decision|1|||
156959571|NCT00725452|566603894|FG000|Overall Study|Withdrawal by Subject|3|||
156959572|NCT00725452|566603894|FG000|Overall Study|Lost to Follow-up|1|||
156959573|NCT00713648|566603896|FG000|Overall Study|Adverse Event|1|||
156959574|NCT00713648|566603896|FG000|Overall Study|Unclassified|2|||
156959575|NCT00713648|566603896|FG000|Overall Study|According to Protocol|2|||
156959576|NCT00713648|566603896|FG000|Overall Study|Development of antibodies|3|||
156959577|NCT01733732|566603897|FG000|Overall Study|Adverse Event|1|||
156959578|NCT01733732|566603898|FG001|Overall Study|Adverse Event|0|||
156959579|NCT01733732|566603897|FG000|Overall Study|Did not attend all study visits|1|||
156959580|NCT01733732|566603898|FG001|Overall Study|Did not attend all study visits|0|||
156959581|NCT00464815|566603899|FG000|Overall Study|Withdrawal by Subject|6|||
156959582|NCT00464815|566603900|FG001|Overall Study|Withdrawal by Subject|3|||
156959583|NCT02566031|566603903|FG000|Overall Study|Patient/guardian decision|14|||
156959584|NCT02566031|566603904|FG001|Overall Study|Patient/guardian decision|7|||
156959585|NCT02566031|566603903|FG000|Overall Study|Protocol deviation|2|||
157170704|NCT00006604|567367215|FG012|Overall Study|Met study objective - no further FU|0|||
156959586|NCT02566031|566603904|FG001|Overall Study|Protocol deviation|3|||
156959587|NCT02566031|566603903|FG000|Overall Study|Adverse Event|3|||
156959588|NCT02566031|566603904|FG001|Overall Study|Adverse Event|1|||
156959589|NCT02566031|566603903|FG000|Overall Study|Lost to Follow-up|1|||
156959590|NCT02566031|566603904|FG001|Overall Study|Lost to Follow-up|1|||
156959591|NCT03031938|566603905|FG000|Overall Study|Death|1|||
156959592|NCT03031938|566603906|FG001|Overall Study|Death|0|||
156959593|NCT02479412|566603911|FG000|Overall Study|Adverse Event|0|||
156959594|NCT02479412|566603912|FG001|Overall Study|Adverse Event|0|||
156959595|NCT02479412|566603913|FG002|Overall Study|Adverse Event|1|||
156959596|NCT02479412|566603914|FG003|Overall Study|Adverse Event|0|||
156959597|NCT02479412|566603915|FG004|Overall Study|Adverse Event|0|||
156959598|NCT02479412|566603916|FG005|Overall Study|Adverse Event|0|||
156959599|NCT02479412|566603917|FG006|Overall Study|Adverse Event|0|||
156959600|NCT02479412|566603918|FG007|Overall Study|Adverse Event|0|||
156959601|NCT02479412|566603919|FG008|Overall Study|Adverse Event|0|||
156959602|NCT02479412|566603911|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156959603|NCT02479412|566603912|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156959604|NCT02479412|566603913|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156959605|NCT02479412|566603914|FG003|Overall Study|Study-specific withdrawal criteria|1|||
156959606|NCT02479412|566603915|FG004|Overall Study|Study-specific withdrawal criteria|0|||
156959607|NCT02479412|566603916|FG005|Overall Study|Study-specific withdrawal criteria|0|||
156959608|NCT02479412|566603917|FG006|Overall Study|Study-specific withdrawal criteria|0|||
156959609|NCT02479412|566603918|FG007|Overall Study|Study-specific withdrawal criteria|1|||
156959610|NCT02479412|566603919|FG008|Overall Study|Study-specific withdrawal criteria|1|||
156959611|NCT02479412|566603911|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
156959612|NCT02479412|566603912|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
156959613|NCT02479412|566603913|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
156959614|NCT02479412|566603914|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
156959615|NCT02479412|566603915|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
156959616|NCT02479412|566603916|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
156959617|NCT02479412|566603917|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
156959618|NCT02479412|566603918|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
156959619|NCT02479412|566603919|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
156959620|NCT04402866|566603924|FG000|Overall Study|Discontinued Prior to Treatment|0|||
156959621|NCT04402866|566603925|FG001|Overall Study|Discontinued Prior to Treatment|0|||
156959622|NCT04402866|566603926|FG002|Overall Study|Discontinued Prior to Treatment|0|||
156959623|NCT04402866|566603927|FG003|Overall Study|Discontinued Prior to Treatment|0|||
156959624|NCT04402866|566603928|FG004|Overall Study|Discontinued Prior to Treatment|2|||
156959625|NCT04402866|566603929|FG005|Overall Study|Discontinued Prior to Treatment|3|||
156959626|NCT04402866|566603924|FG000|Overall Study|Adverse Event|2|||
156959627|NCT04402866|566603925|FG001|Overall Study|Adverse Event|1|||
156959628|NCT04402866|566603926|FG002|Overall Study|Adverse Event|0|||
156959629|NCT04402866|566603927|FG003|Overall Study|Adverse Event|0|||
156959630|NCT04402866|566603928|FG004|Overall Study|Adverse Event|13|||
156959631|NCT04402866|566603929|FG005|Overall Study|Adverse Event|8|||
156959632|NCT04402866|566603924|FG000|Overall Study|Miscellaneous|0|||
156959633|NCT04402866|566603925|FG001|Overall Study|Miscellaneous|0|||
156959634|NCT04402866|566603926|FG002|Overall Study|Miscellaneous|1|||
156959635|NCT04402866|566603927|FG003|Overall Study|Miscellaneous|0|||
156959636|NCT04402866|566603928|FG004|Overall Study|Miscellaneous|0|||
156959637|NCT04402866|566603929|FG005|Overall Study|Miscellaneous|0|||
156959638|NCT04402866|566603924|FG000|Overall Study|Lost to Follow-up|0|||
156959639|NCT04402866|566603925|FG001|Overall Study|Lost to Follow-up|0|||
156959640|NCT04402866|566603926|FG002|Overall Study|Lost to Follow-up|0|||
156959641|NCT04402866|566603927|FG003|Overall Study|Lost to Follow-up|0|||
156959642|NCT04402866|566603928|FG004|Overall Study|Lost to Follow-up|0|||
156959643|NCT04402866|566603929|FG005|Overall Study|Lost to Follow-up|1|||
156959644|NCT04402866|566603924|FG000|Overall Study|Withdrawal by Subject|0|||
156959645|NCT04402866|566603925|FG001|Overall Study|Withdrawal by Subject|0|||
156959646|NCT04402866|566603926|FG002|Overall Study|Withdrawal by Subject|0|||
156959647|NCT04402866|566603927|FG003|Overall Study|Withdrawal by Subject|0|||
156959648|NCT04402866|566603928|FG004|Overall Study|Withdrawal by Subject|0|||
156959649|NCT04402866|566603929|FG005|Overall Study|Withdrawal by Subject|2|||
156959650|NCT03667053|566603930|FG000|Overall Study|Withdrawal by Subject|1|||
156959651|NCT03667053|566603931|FG001|Overall Study|Withdrawal by Subject|0|||
156959652|NCT03667053|566603932|FG002|Overall Study|Withdrawal by Subject|0|||
156959653|NCT02732938|566603934|FG000|Overall Study|Death|0|||
156959654|NCT02732938|566603935|FG001|Overall Study|Death|11|||
156959655|NCT02732938|566603936|FG002|Overall Study|Death|0|||
156959656|NCT02732938|566603934|FG000|Overall Study|Randomized but did not receive treatment|0|||
156959657|NCT02732938|566603935|FG001|Overall Study|Randomized but did not receive treatment|1|||
156959658|NCT02732938|566603936|FG002|Overall Study|Randomized but did not receive treatment|0|||
156959659|NCT02732938|566603934|FG000|Overall Study|Refused further follow-up|1|||
156959660|NCT02732938|566603935|FG001|Overall Study|Refused further follow-up|0|||
156959661|NCT02732938|566603936|FG002|Overall Study|Refused further follow-up|0|||
156959662|NCT02732938|566603934|FG000|Overall Study|Study terminated by sponsor|3|||
156959663|NCT02732938|566603935|FG001|Overall Study|Study terminated by sponsor|6|||
156959664|NCT02732938|566603936|FG002|Overall Study|Study terminated by sponsor|0|||
156959665|NCT02015676|566603937|FG000|Overall Study|Adverse Event|2|||
156959666|NCT02015676|566603938|FG001|Overall Study|Adverse Event|18|||
156959667|NCT02015676|566603939|FG002|Overall Study|Adverse Event|0|||
156959668|NCT02015676|566603937|FG000|Overall Study|Lack of Efficacy|2|||
156959669|NCT02015676|566603938|FG001|Overall Study|Lack of Efficacy|4|||
156959670|NCT02015676|566603939|FG002|Overall Study|Lack of Efficacy|0|||
156959671|NCT02015676|566603937|FG000|Overall Study|Protocol Violation|1|||
156959672|NCT02015676|566603938|FG001|Overall Study|Protocol Violation|0|||
156959673|NCT02015676|566603939|FG002|Overall Study|Protocol Violation|0|||
156959674|NCT02015676|566603937|FG000|Overall Study|Withdrawal by Subject|1|||
156959675|NCT02015676|566603938|FG001|Overall Study|Withdrawal by Subject|7|||
157170705|NCT00006604|567367216|FG013|Overall Study|Met study objective - no further FU|0|||
157170706|NCT00006604|567367217|FG014|Overall Study|Met study objective - no further FU|1|||
157170707|NCT00006604|567367218|FG015|Overall Study|Met study objective - no further FU|1|||
157170708|NCT00006604|567367219|FG016|Overall Study|Met study objective - no further FU|0|||
157170709|NCT00006604|567367203|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
157170710|NCT00006604|567367204|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
157170711|NCT00006604|567367205|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
157170712|NCT00006604|567367206|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
157170713|NCT00006604|567367207|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
157170714|NCT00006604|567367208|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
157170715|NCT00006604|567367209|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
157170716|NCT00006604|567367210|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
157170717|NCT00006604|567367211|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
157170718|NCT00006604|567367212|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
157170719|NCT00006604|567367213|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
157170720|NCT00006604|567367214|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
157170721|NCT00006604|567367215|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
157170722|NCT00006604|567367216|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
157170723|NCT00006604|567367217|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
157170724|NCT00006604|567367218|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
157170725|NCT00006604|567367219|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
157170726|NCT00006604|567367203|FG000|Overall Study|Death|0|||
157170727|NCT00006604|567367204|FG001|Overall Study|Death|0|||
157170728|NCT00006604|567367205|FG002|Overall Study|Death|0|||
157170729|NCT00006604|567367206|FG003|Overall Study|Death|0|||
157170730|NCT00006604|567367207|FG004|Overall Study|Death|0|||
156959676|NCT02015676|566603939|FG002|Overall Study|Withdrawal by Subject|1|||
156959677|NCT02015676|566603937|FG000|Overall Study|Administrative reasons|0|||
156959678|NCT02015676|566603938|FG001|Overall Study|Administrative reasons|3|||
156959679|NCT02015676|566603939|FG002|Overall Study|Administrative reasons|1|||
156959680|NCT02015676|566603937|FG000|Overall Study|Death|0|||
156959681|NCT02015676|566603938|FG001|Overall Study|Death|1|||
156959682|NCT02015676|566603939|FG002|Overall Study|Death|0|||
156959683|NCT02015676|566603937|FG000|Overall Study|Disease progression|3|||
156959684|NCT02015676|566603938|FG001|Overall Study|Disease progression|1|||
156959685|NCT02015676|566603939|FG002|Overall Study|Disease progression|1|||
156959686|NCT00476476|566603941|FG000|Overall Study|Adverse Event|2|||
156959687|NCT00476476|566603942|FG001|Overall Study|Adverse Event|7|||
156959688|NCT00476476|566603941|FG000|Overall Study|Progressive Disease|0|||
156959689|NCT00476476|566603942|FG001|Overall Study|Progressive Disease|17|||
156959690|NCT00971048|566603946|FG000|Overall Study|Protocol Violation|1|||
156959691|NCT00971048|566603947|FG001|Overall Study|Protocol Violation|2|||
156959692|NCT00971048|566603948|FG002|Overall Study|Protocol Violation|0|||
156959693|NCT00971048|566603949|FG003|Overall Study|Protocol Violation|1|||
156959694|NCT00971048|566603946|FG000|Overall Study|Adverse Event|0|||
156959695|NCT00971048|566603947|FG001|Overall Study|Adverse Event|0|||
156959696|NCT00971048|566603948|FG002|Overall Study|Adverse Event|1|||
156959697|NCT00971048|566603949|FG003|Overall Study|Adverse Event|0|||
156959698|NCT00971048|566603946|FG000|Overall Study|Physician Decision|0|||
156959699|NCT00971048|566603947|FG001|Overall Study|Physician Decision|0|||
156959700|NCT00971048|566603948|FG002|Overall Study|Physician Decision|0|||
156959701|NCT00971048|566603949|FG003|Overall Study|Physician Decision|1|||
156959702|NCT03321396|566603950|FG000|Overall Study|Physician Decision|1|||
156959703|NCT03280121|566603951|FG000|Overall Study|Physician Decision|1|||
157170731|NCT00006604|567367208|FG005|Overall Study|Death|0|||
157170732|NCT00006604|567367209|FG006|Overall Study|Death|0|||
157170733|NCT00006604|567367210|FG007|Overall Study|Death|0|||
157170734|NCT00006604|567367211|FG008|Overall Study|Death|0|||
157170735|NCT00006604|567367212|FG009|Overall Study|Death|1|||
157227724|NCT06179108|567579174|FG000|Overall Study|Protocol Violation|0|||
156959704|NCT03280121|566603951|FG000|Overall Study|Lost to Follow-up|1|||
156959705|NCT03280121|566603951|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
156959706|NCT02633137|566603956|FG000|Overall Study|Adverse Event|1|||
156959707|NCT02633137|566603956|FG000|Overall Study|Lack of Efficacy|2|||
157170736|NCT00006604|567367213|FG010|Overall Study|Death|1|||
156959708|NCT02633137|566603956|FG000|Overall Study|Withdrawal by Subject|1|||
156959709|NCT04307004|566603957|FG000|Randomization 1|Withdrawal by Subject|25|||
156959710|NCT04307004|566603958|FG001|Randomization 1|Withdrawal by Subject|26|||
156959711|NCT04307004|566603959|FG002|Randomization 1|Withdrawal by Subject|0|||
156959712|NCT04307004|566603960|FG003|Randomization 1|Withdrawal by Subject|0|||
156959713|NCT04307004|566603957|FG000|Randomization 2|Withdrawal by Subject|0|||
157170737|NCT00006604|567367214|FG011|Overall Study|Death|1|||
157170738|NCT00006604|567367215|FG012|Overall Study|Death|0|||
157170739|NCT00006604|567367216|FG013|Overall Study|Death|0|||
157170740|NCT00006604|567367217|FG014|Overall Study|Death|0|||
157170741|NCT00006604|567367218|FG015|Overall Study|Death|0|||
157170742|NCT00006604|567367219|FG016|Overall Study|Death|0|||
157170743|NCT00006604|567367203|FG000|Overall Study|Severe debilitation, unable to continue|0|||
157170744|NCT00006604|567367204|FG001|Overall Study|Severe debilitation, unable to continue|0|||
157170745|NCT00006604|567367205|FG002|Overall Study|Severe debilitation, unable to continue|0|||
157170746|NCT00006604|567367206|FG003|Overall Study|Severe debilitation, unable to continue|0|||
157170747|NCT00006604|567367207|FG004|Overall Study|Severe debilitation, unable to continue|0|||
157170748|NCT00006604|567367208|FG005|Overall Study|Severe debilitation, unable to continue|0|||
157170749|NCT00006604|567367209|FG006|Overall Study|Severe debilitation, unable to continue|3|||
157170750|NCT00006604|567367210|FG007|Overall Study|Severe debilitation, unable to continue|0|||
157170751|NCT00006604|567367211|FG008|Overall Study|Severe debilitation, unable to continue|0|||
157170752|NCT00006604|567367212|FG009|Overall Study|Severe debilitation, unable to continue|5|||
157170753|NCT00006604|567367213|FG010|Overall Study|Severe debilitation, unable to continue|0|||
157170754|NCT00006604|567367214|FG011|Overall Study|Severe debilitation, unable to continue|2|||
157170755|NCT00006604|567367215|FG012|Overall Study|Severe debilitation, unable to continue|1|||
157170756|NCT00006604|567367216|FG013|Overall Study|Severe debilitation, unable to continue|0|||
157170757|NCT00006604|567367217|FG014|Overall Study|Severe debilitation, unable to continue|2|||
157170758|NCT00006604|567367218|FG015|Overall Study|Severe debilitation, unable to continue|0|||
157170759|NCT00006604|567367219|FG016|Overall Study|Severe debilitation, unable to continue|0|||
157170760|NCT00006604|567367203|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
157170761|NCT00006604|567367204|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
157170762|NCT00006604|567367205|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
157170763|NCT00006604|567367206|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
157170764|NCT00006604|567367207|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
157170765|NCT00006604|567367208|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
157170766|NCT00006604|567367209|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
157170767|NCT00006604|567367210|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
157170768|NCT00006604|567367211|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
157170769|NCT00006604|567367212|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
157170770|NCT00006604|567367213|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
157170771|NCT00006604|567367214|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
157170772|NCT00006604|567367215|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
157170773|NCT00006604|567367216|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
157170774|NCT00006604|567367217|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
157170775|NCT00006604|567367218|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
157170776|NCT00006604|567367219|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
157170777|NCT00006604|567367203|FG000|Overall Study|Site closing|0|||
157170778|NCT00006604|567367204|FG001|Overall Study|Site closing|0|||
157170779|NCT00006604|567367205|FG002|Overall Study|Site closing|1|||
157170780|NCT00006604|567367206|FG003|Overall Study|Site closing|1|||
157170781|NCT00006604|567367207|FG004|Overall Study|Site closing|0|||
157170782|NCT00006604|567367208|FG005|Overall Study|Site closing|0|||
157170783|NCT00006604|567367209|FG006|Overall Study|Site closing|0|||
157170784|NCT00006604|567367210|FG007|Overall Study|Site closing|1|||
157170785|NCT00006604|567367211|FG008|Overall Study|Site closing|0|||
156959714|NCT04307004|566603958|FG001|Randomization 2|Withdrawal by Subject|0|||
156959715|NCT04307004|566603959|FG002|Randomization 2|Withdrawal by Subject|28|||
156959716|NCT04307004|566603960|FG003|Randomization 2|Withdrawal by Subject|23|||
156959717|NCT01972841|566603961|FG000|Overall Study|Randomized but Never Received Treatment|2|||
156959718|NCT01972841|566603962|FG001|Overall Study|Randomized but Never Received Treatment|5|||
156959719|NCT01972841|566603963|FG002|Overall Study|Randomized but Never Received Treatment|4|||
156959720|NCT01972841|566603964|FG003|Overall Study|Randomized but Never Received Treatment|2|||
156959721|NCT01972841|566603965|FG004|Overall Study|Randomized but Never Received Treatment|6|||
156959722|NCT01972841|566603966|FG005|Overall Study|Randomized but Never Received Treatment|13|||
156959723|NCT01972841|566603961|FG000|Overall Study|Adverse Event|13|||
156959724|NCT01972841|566603962|FG001|Overall Study|Adverse Event|8|||
156959725|NCT01972841|566603963|FG002|Overall Study|Adverse Event|12|||
157170786|NCT00006604|567367212|FG009|Overall Study|Site closing|0|||
157170787|NCT00006604|567367213|FG010|Overall Study|Site closing|0|||
157170788|NCT00006604|567367214|FG011|Overall Study|Site closing|1|||
157170789|NCT00006604|567367215|FG012|Overall Study|Site closing|1|||
157170790|NCT00006604|567367216|FG013|Overall Study|Site closing|1|||
157170791|NCT00006604|567367217|FG014|Overall Study|Site closing|0|||
157170792|NCT00006604|567367218|FG015|Overall Study|Site closing|0|||
157170793|NCT00006604|567367219|FG016|Overall Study|Site closing|1|||
157170794|NCT00006604|567367203|FG000|Overall Study|Withdrawal by Subject|1|||
157170795|NCT00006604|567367204|FG001|Overall Study|Withdrawal by Subject|0|||
157170796|NCT00006604|567367205|FG002|Overall Study|Withdrawal by Subject|2|||
156959726|NCT01972841|566603964|FG003|Overall Study|Adverse Event|9|||
156959727|NCT01972841|566603965|FG004|Overall Study|Adverse Event|21|||
156959728|NCT01972841|566603966|FG005|Overall Study|Adverse Event|26|||
156959729|NCT01972841|566603961|FG000|Overall Study|Lack of Efficacy|1|||
156959730|NCT01972841|566603962|FG001|Overall Study|Lack of Efficacy|0|||
156959731|NCT01972841|566603963|FG002|Overall Study|Lack of Efficacy|0|||
156959732|NCT01972841|566603964|FG003|Overall Study|Lack of Efficacy|2|||
156959733|NCT01972841|566603965|FG004|Overall Study|Lack of Efficacy|4|||
156959734|NCT01972841|566603966|FG005|Overall Study|Lack of Efficacy|1|||
156959735|NCT01972841|566603961|FG000|Overall Study|Lost to Follow-up|4|||
156959736|NCT01972841|566603962|FG001|Overall Study|Lost to Follow-up|2|||
156959737|NCT01972841|566603963|FG002|Overall Study|Lost to Follow-up|4|||
156959738|NCT01972841|566603964|FG003|Overall Study|Lost to Follow-up|2|||
156959739|NCT01972841|566603965|FG004|Overall Study|Lost to Follow-up|9|||
156959740|NCT01972841|566603966|FG005|Overall Study|Lost to Follow-up|3|||
156959741|NCT01972841|566603961|FG000|Overall Study|Protocol Violation|2|||
156959742|NCT01972841|566603962|FG001|Overall Study|Protocol Violation|2|||
156959743|NCT01972841|566603963|FG002|Overall Study|Protocol Violation|3|||
156959744|NCT01972841|566603964|FG003|Overall Study|Protocol Violation|5|||
156959745|NCT01972841|566603965|FG004|Overall Study|Protocol Violation|9|||
156959746|NCT01972841|566603966|FG005|Overall Study|Protocol Violation|4|||
156959747|NCT01972841|566603961|FG000|Overall Study|Withdrawal by participants|21|||
156959748|NCT01972841|566603962|FG001|Overall Study|Withdrawal by participants|27|||
156959749|NCT01972841|566603963|FG002|Overall Study|Withdrawal by participants|23|||
156959750|NCT01972841|566603964|FG003|Overall Study|Withdrawal by participants|16|||
156959751|NCT01972841|566603965|FG004|Overall Study|Withdrawal by participants|33|||
156959752|NCT01972841|566603966|FG005|Overall Study|Withdrawal by participants|34|||
156959753|NCT01972841|566603961|FG000|Overall Study|Miscellaneous|0|||
156959754|NCT01972841|566603962|FG001|Overall Study|Miscellaneous|0|||
156959755|NCT01972841|566603963|FG002|Overall Study|Miscellaneous|4|||
156959756|NCT01972841|566603964|FG003|Overall Study|Miscellaneous|1|||
156959757|NCT01972841|566603965|FG004|Overall Study|Miscellaneous|0|||
156959758|NCT01972841|566603966|FG005|Overall Study|Miscellaneous|4|||
156959759|NCT01972841|566603961|FG000|Overall Study|Did not have end of treatment page|0|||
156959760|NCT01972841|566603962|FG001|Overall Study|Did not have end of treatment page|0|||
156959761|NCT01972841|566603963|FG002|Overall Study|Did not have end of treatment page|0|||
156959762|NCT01972841|566603964|FG003|Overall Study|Did not have end of treatment page|0|||
156959763|NCT01972841|566603965|FG004|Overall Study|Did not have end of treatment page|1|||
156959764|NCT01972841|566603966|FG005|Overall Study|Did not have end of treatment page|0|||
156959765|NCT02734212|566603967|FG000|Overall Study|Lost to Follow-up|5|||
156959766|NCT02734212|566603968|FG001|Overall Study|Lost to Follow-up|10|||
156959767|NCT00688636|566603969|FG000|Overall Study|Adverse Event|2|||
156959768|NCT00688636|566603970|FG001|Overall Study|Adverse Event|1|||
156959769|NCT01572727|566603971|FG000|Overall Study|Adverse Event|43|||
156959770|NCT01572727|566603972|FG001|Overall Study|Adverse Event|15|||
156959771|NCT01572727|566603971|FG000|Overall Study|Lost to Follow-up|1|||
156959772|NCT01572727|566603972|FG001|Overall Study|Lost to Follow-up|1|||
156959773|NCT01572727|566603971|FG000|Overall Study|Physician Decision|23|||
156959774|NCT01572727|566603972|FG001|Overall Study|Physician Decision|9|||
156959775|NCT01572727|566603971|FG000|Overall Study|Progressive disease|59|||
156959776|NCT01572727|566603972|FG001|Overall Study|Progressive disease|82|||
156959777|NCT01572727|566603971|FG000|Overall Study|Protocol Violation|0|||
156959778|NCT01572727|566603972|FG001|Overall Study|Protocol Violation|1|||
156959779|NCT01572727|566603971|FG000|Overall Study|Study terminated by sponsor|61|||
156959780|NCT01572727|566603972|FG001|Overall Study|Study terminated by sponsor|83|||
156959781|NCT01572727|566603971|FG000|Overall Study|Parent/guardian decision|14|||
156959782|NCT01572727|566603972|FG001|Overall Study|Parent/guardian decision|9|||
156959783|NCT01572727|566603971|FG000|Overall Study|Death|2|||
156959784|NCT01572727|566603972|FG001|Overall Study|Death|2|||
156959785|NCT01572727|566603971|FG000|Overall Study|Untreated|4|||
157170797|NCT00006604|567367206|FG003|Overall Study|Withdrawal by Subject|0|||
157170798|NCT00006604|567367207|FG004|Overall Study|Withdrawal by Subject|1|||
156959786|NCT01572727|566603972|FG001|Overall Study|Untreated|7|||
157170799|NCT00006604|567367208|FG005|Overall Study|Withdrawal by Subject|2|||
156959787|NCT01392560|566603975|FG000|Overall Study|Adverse Event|2|||
156959788|NCT01392560|566603975|FG000|Overall Study|not entered|8|||
156959789|NCT01392560|566603975|FG000|Overall Study|discontinued during placebo run-in|2|||
156959790|NCT02081846|566603978|FG000|Overall Study|Withdrawal by Subject|1|||
156959791|NCT02081846|566603979|FG001|Overall Study|Withdrawal by Subject|0|||
156959792|NCT02081846|566603978|FG000|Overall Study|invalid consent|1|||
156959793|NCT02081846|566603979|FG001|Overall Study|invalid consent|0|||
157170800|NCT00006604|567367209|FG006|Overall Study|Withdrawal by Subject|2|||
156959794|NCT01939028|566603980|FG000|Overall Study|Withdrawal by Subject|5|||
156959795|NCT01939028|566603980|FG000|Overall Study|Physician Decision|7|||
156959796|NCT00295750|566603984|FG000|Overall Study|Adverse Event|19|||
156959797|NCT00295750|566603985|FG001|Overall Study|Adverse Event|15|||
156959798|NCT00295750|566603986|FG002|Overall Study|Adverse Event|12|||
156959799|NCT00295750|566603984|FG000|Overall Study|Lack of Efficacy|1|||
157170801|NCT00006604|567367210|FG007|Overall Study|Withdrawal by Subject|0|||
156959800|NCT00295750|566603985|FG001|Overall Study|Lack of Efficacy|1|||
156959801|NCT00295750|566603986|FG002|Overall Study|Lack of Efficacy|0|||
156959802|NCT00295750|566603984|FG000|Overall Study|Lost to Follow-up|1|||
156959803|NCT00295750|566603985|FG001|Overall Study|Lost to Follow-up|4|||
156959804|NCT00295750|566603986|FG002|Overall Study|Lost to Follow-up|1|||
156959805|NCT00295750|566603984|FG000|Overall Study|Taking prohibited therapy|2|||
156959806|NCT00295750|566603985|FG001|Overall Study|Taking prohibited therapy|3|||
156959807|NCT00295750|566603986|FG002|Overall Study|Taking prohibited therapy|2|||
156959808|NCT00295750|566603984|FG000|Overall Study|Administrative errors|2|||
156959809|NCT00295750|566603985|FG001|Overall Study|Administrative errors|4|||
156959810|NCT00295750|566603986|FG002|Overall Study|Administrative errors|5|||
156959811|NCT00295750|566603984|FG000|Overall Study|Trial drug errors|1|||
156959812|NCT00295750|566603985|FG001|Overall Study|Trial drug errors|1|||
156959813|NCT00295750|566603986|FG002|Overall Study|Trial drug errors|0|||
156959814|NCT00295750|566603984|FG000|Overall Study|Disease progression|2|||
156959815|NCT00295750|566603985|FG001|Overall Study|Disease progression|1|||
156959816|NCT00295750|566603986|FG002|Overall Study|Disease progression|0|||
156959817|NCT00295750|566603984|FG000|Overall Study|Personal reasons|0|||
156959818|NCT00295750|566603985|FG001|Overall Study|Personal reasons|1|||
156959819|NCT00295750|566603986|FG002|Overall Study|Personal reasons|0|||
156959820|NCT00295750|566603984|FG000|Overall Study|Randomized but never received trial drug|4|||
156959821|NCT00295750|566603985|FG001|Overall Study|Randomized but never received trial drug|3|||
156959822|NCT00295750|566603986|FG002|Overall Study|Randomized but never received trial drug|3|||
157170802|NCT00006604|567367211|FG008|Overall Study|Withdrawal by Subject|1|||
157170803|NCT00006604|567367212|FG009|Overall Study|Withdrawal by Subject|3|||
157170804|NCT00006604|567367213|FG010|Overall Study|Withdrawal by Subject|2|||
156959823|NCT00295750|566603984|FG000|Overall Study|Withdrawal by Subject|9|||
156959824|NCT00295750|566603985|FG001|Overall Study|Withdrawal by Subject|4|||
156959825|NCT00295750|566603986|FG002|Overall Study|Withdrawal by Subject|7|||
156959826|NCT00295750|566603984|FG000|Overall Study|Protocol Violation|2|||
156959827|NCT00295750|566603985|FG001|Overall Study|Protocol Violation|4|||
156959828|NCT00295750|566603986|FG002|Overall Study|Protocol Violation|2|||
156959829|NCT00322348|566603987|FG000|Overall Study|Adverse Event|0|||
156959830|NCT00322348|566603988|FG001|Overall Study|Adverse Event|1|||
156959831|NCT00322348|566603987|FG000|Overall Study|Withdrawal by Subject|1|||
156959832|NCT00322348|566603988|FG001|Overall Study|Withdrawal by Subject|4|||
156959833|NCT00322348|566603987|FG000|Overall Study|Lost to Follow-up|1|||
156959834|NCT00322348|566603988|FG001|Overall Study|Lost to Follow-up|0|||
156959835|NCT00322348|566603987|FG000|Overall Study|Death|0|||
156959836|NCT00322348|566603988|FG001|Overall Study|Death|2|||
156959837|NCT00322348|566603987|FG000|Overall Study|Disease Progression|30|||
156959838|NCT00322348|566603988|FG001|Overall Study|Disease Progression|25|||
156959839|NCT00322348|566603987|FG000|Overall Study|Reasons not specified|5|||
156959840|NCT00322348|566603988|FG001|Overall Study|Reasons not specified|1|||
156959841|NCT00695669|566603989|FG000|Overall Study|Adverse Event|0|||
156959842|NCT00695669|566603990|FG001|Overall Study|Adverse Event|0|||
156959843|NCT00695669|566603991|FG002|Overall Study|Adverse Event|2|||
156959844|NCT00695669|566603992|FG003|Overall Study|Adverse Event|0|||
156959845|NCT00695669|566603989|FG000|Overall Study|Lost to Follow-up|4|||
156959846|NCT00695669|566603990|FG001|Overall Study|Lost to Follow-up|4|||
156959847|NCT00695669|566603991|FG002|Overall Study|Lost to Follow-up|1|||
156959848|NCT00695669|566603992|FG003|Overall Study|Lost to Follow-up|4|||
156959849|NCT00092131|566603993|FG000|Treatment Period I|Adverse Event|1|||
156959850|NCT00092131|566603994|FG001|Treatment Period I|Adverse Event|0|||
156959851|NCT00092131|566603993|FG000|Treatment Period II|Adverse Event|0|||
156959852|NCT00092131|566603994|FG001|Treatment Period II|Adverse Event|1|||
156959853|NCT02341417|566603995|FG000|Overall Study|Withdrawal by Subject|0|||
156959854|NCT02341417|566603996|FG001|Overall Study|Withdrawal by Subject|2|||
156959855|NCT02341417|566603997|FG002|Overall Study|Withdrawal by Subject|0|||
156959856|NCT02341417|566603995|FG000|Overall Study|Decision by sponsor|2|||
156959857|NCT02341417|566603996|FG001|Overall Study|Decision by sponsor|0|||
156959858|NCT02341417|566603997|FG002|Overall Study|Decision by sponsor|0|||
156959859|NCT02341417|566603995|FG000|Overall Study|Death|0|||
156959860|NCT02341417|566603996|FG001|Overall Study|Death|0|||
156959861|NCT02341417|566603997|FG002|Overall Study|Death|1|||
156959862|NCT03738150|566604019|FG000|Base Study|Withdrawal by Subject|1|||
156959863|NCT03738150|566604019|FG000|Extension Study|Withdrawal by Subject|1|||
156959864|NCT00714168|566604023|FG000|Overall Study|Pregnancy|5|||
156959865|NCT00714168|566604024|FG001|Overall Study|Pregnancy|4|||
156959866|NCT00714168|566604023|FG000|Overall Study|Lost to Follow-up|32|||
156959867|NCT00714168|566604024|FG001|Overall Study|Lost to Follow-up|50|||
156959868|NCT00714168|566604023|FG000|Overall Study|Relocation|4|||
156959869|NCT00714168|566604024|FG001|Overall Study|Relocation|3|||
156959870|NCT00714168|566604023|FG000|Overall Study|Non-study medical condition|3|||
156959871|NCT00714168|566604024|FG001|Overall Study|Non-study medical condition|2|||
156959872|NCT04988308|566604026|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
156959873|NCT04988308|566604027|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
156959874|NCT04988308|566604028|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
157170805|NCT00006604|567367214|FG011|Overall Study|Withdrawal by Subject|0|||
157170806|NCT00006604|567367215|FG012|Overall Study|Withdrawal by Subject|1|||
157170807|NCT00006604|567367216|FG013|Overall Study|Withdrawal by Subject|2|||
157170808|NCT00006604|567367217|FG014|Overall Study|Withdrawal by Subject|1|||
157170809|NCT00006604|567367218|FG015|Overall Study|Withdrawal by Subject|0|||
157170810|NCT00006604|567367219|FG016|Overall Study|Withdrawal by Subject|1|||
157170811|NCT00006604|567367203|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
157170812|NCT00006604|567367204|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
157170813|NCT00006604|567367205|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
157170814|NCT00006604|567367206|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
157170815|NCT00006604|567367207|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
157170816|NCT00006604|567367208|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
157170817|NCT00006604|567367209|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
157170818|NCT00006604|567367210|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
157170819|NCT00006604|567367211|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
157170820|NCT00006604|567367212|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
157170821|NCT00006604|567367213|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
157170822|NCT00006604|567367214|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
157170823|NCT00006604|567367215|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
156959875|NCT04988308|566604029|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156959876|NCT04988308|566604030|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156959877|NCT04988308|566604031|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
156959878|NCT04988308|566604026|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156959879|NCT04988308|566604027|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156959880|NCT04988308|566604028|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
156959881|NCT04988308|566604029|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156959882|NCT04988308|566604030|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156959883|NCT04988308|566604031|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
156959884|NCT04988308|566604026|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
156959885|NCT04988308|566604027|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
156959886|NCT04988308|566604028|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156959887|NCT04988308|566604029|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156959888|NCT04988308|566604030|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156959889|NCT04988308|566604031|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
156959890|NCT04988308|566604026|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
156959891|NCT04988308|566604027|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
156959892|NCT04988308|566604028|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
156959893|NCT04988308|566604029|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156959894|NCT04988308|566604030|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156959895|NCT04988308|566604031|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
156959896|NCT04988308|566604026|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
156959897|NCT04988308|566604027|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
156959898|NCT04988308|566604028|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
156959899|NCT04988308|566604029|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156959900|NCT04988308|566604030|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156959901|NCT04988308|566604031|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
156959902|NCT04988308|566604026|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156959903|NCT04988308|566604027|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156959904|NCT04988308|566604028|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
156959905|NCT04988308|566604029|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
156959906|NCT04988308|566604030|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
156959907|NCT04988308|566604031|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
156959908|NCT04988308|566604026|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156959909|NCT04988308|566604027|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156959910|NCT04988308|566604028|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
156959911|NCT04988308|566604029|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156959912|NCT04988308|566604030|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
156959913|NCT04988308|566604031|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
156959914|NCT04988308|566604026|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156959915|NCT04988308|566604027|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156959916|NCT04988308|566604028|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
156959917|NCT04988308|566604029|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
156959918|NCT04988308|566604030|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
157170824|NCT00006604|567367216|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
157170825|NCT00006604|567367217|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
157170826|NCT00006604|567367218|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
156959919|NCT04988308|566604031|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
156959920|NCT04988308|566604026|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156959921|NCT04988308|566604027|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156959922|NCT04988308|566604028|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
156959923|NCT04988308|566604029|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
156959924|NCT04988308|566604030|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
156959925|NCT04988308|566604031|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
156959926|NCT02298192|566604032|FG000|Overall Study|Unclassified|3|||
156959927|NCT02298192|566604033|FG001|Overall Study|Unclassified|2|||
156959928|NCT02298192|566604032|FG000|Overall Study|Withdrawal criteria|2|||
156959929|NCT02298192|566604033|FG001|Overall Study|Withdrawal criteria|0|||
156959930|NCT02298192|566604032|FG000|Overall Study|Withdrawal by Subject|6|||
156959931|NCT02298192|566604033|FG001|Overall Study|Withdrawal by Subject|1|||
156959932|NCT02298192|566604032|FG000|Overall Study|Lost to Follow-up|2|||
156959933|NCT02298192|566604033|FG001|Overall Study|Lost to Follow-up|1|||
156959934|NCT02298192|566604032|FG000|Overall Study|Adverse Event|6|||
156959935|NCT02298192|566604033|FG001|Overall Study|Adverse Event|2|||
156959936|NCT02352948|566604037|FG000|Overall Study|Death|47|||
156959937|NCT02352948|566604038|FG001|Overall Study|Death|48|||
156959938|NCT02352948|566604039|FG002|Overall Study|Death|114|||
156959939|NCT02352948|566604040|FG003|Overall Study|Death|74|||
156959940|NCT02352948|566604041|FG004|Overall Study|Death|77|||
156959941|NCT02352948|566604042|FG005|Overall Study|Death|44|||
156959942|NCT02352948|566604037|FG000|Overall Study|Lost to Follow-up|1|||
156959943|NCT02352948|566604038|FG001|Overall Study|Lost to Follow-up|0|||
156959944|NCT02352948|566604039|FG002|Overall Study|Lost to Follow-up|2|||
156959945|NCT02352948|566604040|FG003|Overall Study|Lost to Follow-up|1|||
156959946|NCT02352948|566604041|FG004|Overall Study|Lost to Follow-up|2|||
156959947|NCT02352948|566604042|FG005|Overall Study|Lost to Follow-up|1|||
156959948|NCT02352948|566604037|FG000|Overall Study|Withdrawal by Subject|1|||
156959949|NCT02352948|566604038|FG001|Overall Study|Withdrawal by Subject|10|||
156959950|NCT02352948|566604039|FG002|Overall Study|Withdrawal by Subject|11|||
156959951|NCT02352948|566604040|FG003|Overall Study|Withdrawal by Subject|23|||
156959952|NCT02352948|566604041|FG004|Overall Study|Withdrawal by Subject|9|||
156959953|NCT02352948|566604042|FG005|Overall Study|Withdrawal by Subject|4|||
156959954|NCT02352948|566604037|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
156959955|NCT02352948|566604038|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
156959956|NCT02352948|566604039|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
156959957|NCT02352948|566604040|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
156959958|NCT02352948|566604041|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
156959959|NCT02352948|566604042|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
156959960|NCT02352948|566604037|FG000|Overall Study|Other|0|||
156959961|NCT02352948|566604038|FG001|Overall Study|Other|0|||
156959962|NCT02352948|566604039|FG002|Overall Study|Other|2|||
156959963|NCT02352948|566604040|FG003|Overall Study|Other|0|||
156959964|NCT02352948|566604041|FG004|Overall Study|Other|0|||
156959965|NCT02352948|566604042|FG005|Overall Study|Other|0|||
156959966|NCT02763384|566604048|FG000|Overall Study|Physician Decision|1|||
156959967|NCT02763384|566604048|FG000|Overall Study|Rapid decline - went on hospice|1|||
156959968|NCT02096900|566604049|FG000|Overall Study|Did not receive medication|3|||
156959969|NCT02096900|566604050|FG001|Overall Study|Did not receive medication|1|||
156959970|NCT02096900|566604049|FG000|Overall Study|Surgery cancelled- medication received|1|||
156959971|NCT02096900|566604050|FG001|Overall Study|Surgery cancelled- medication received|1|||
156959972|NCT04657211|566604051|FG000|Overall Study|Withdrawal by Subject|21|||
156959973|NCT04657211|566604051|FG000|Overall Study|Lost to Follow-up|113|||
156959974|NCT04657211|566604051|FG000|Overall Study|Death|47|||
156959975|NCT04657211|566604051|FG000|Overall Study|Transfer to another institution|21|||
156959976|NCT04657211|566604051|FG000|Overall Study|Other|29|||
156959977|NCT06273774|566604054|FG000|Overall Study|Participant was out of state.|0|||
156959978|NCT06273774|566604055|FG001|Overall Study|Participant was out of state.|0|||
156959979|NCT06273774|566604056|FG002|Overall Study|Participant was out of state.|0|||
156959980|NCT06273774|566604057|FG003|Overall Study|Participant was out of state.|0|||
156959981|NCT06273774|566604058|FG004|Overall Study|Participant was out of state.|0|||
156959982|NCT06273774|566604059|FG005|Overall Study|Participant was out of state.|1|||
156959983|NCT06273774|566604054|FG000|Overall Study|Lost to Follow-up|0|||
156959984|NCT06273774|566604055|FG001|Overall Study|Lost to Follow-up|0|||
156959985|NCT06273774|566604056|FG002|Overall Study|Lost to Follow-up|0|||
156959986|NCT06273774|566604057|FG003|Overall Study|Lost to Follow-up|0|||
156959987|NCT06273774|566604058|FG004|Overall Study|Lost to Follow-up|1|||
156959988|NCT06273774|566604059|FG005|Overall Study|Lost to Follow-up|0|||
156959989|NCT02010060|566604060|FG000|Overall Study|Lost to Follow-up|1|||
156959990|NCT02010060|566604061|FG001|Overall Study|Lost to Follow-up|2|||
156959991|NCT02010060|566604062|FG002|Overall Study|Lost to Follow-up|2|||
156959992|NCT02010060|566604060|FG000|Overall Study|Injury|0|||
156959993|NCT02010060|566604061|FG001|Overall Study|Injury|1|||
156959994|NCT02010060|566604062|FG002|Overall Study|Injury|0|||
157170827|NCT00006604|567367219|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
157170828|NCT00006604|567367203|FG000|Overall Study|Lost to Follow-up|0|||
157170829|NCT00006604|567367204|FG001|Overall Study|Lost to Follow-up|0|||
157170830|NCT00006604|567367205|FG002|Overall Study|Lost to Follow-up|0|||
157170831|NCT00006604|567367206|FG003|Overall Study|Lost to Follow-up|0|||
157170832|NCT00006604|567367207|FG004|Overall Study|Lost to Follow-up|0|||
157170833|NCT00006604|567367208|FG005|Overall Study|Lost to Follow-up|0|||
157170834|NCT00006604|567367209|FG006|Overall Study|Lost to Follow-up|0|||
157170835|NCT00006604|567367210|FG007|Overall Study|Lost to Follow-up|1|||
157227725|NCT06179108|567579175|FG001|Overall Study|Protocol Violation|1|||
157227726|NCT06179108|567579176|FG002|Overall Study|Protocol Violation|0|||
157227727|NCT06179108|567579177|FG003|Overall Study|Protocol Violation|1|||
157227728|NCT06179108|567579174|FG000|Overall Study|Physician Decision|1|||
157227729|NCT06179108|567579175|FG001|Overall Study|Physician Decision|1|||
157227730|NCT06179108|567579176|FG002|Overall Study|Physician Decision|0|||
157227731|NCT06179108|567579177|FG003|Overall Study|Physician Decision|0|||
157227732|NCT06179108|567579174|FG000|Overall Study|Lack of Efficacy|0|||
157227733|NCT06179108|567579175|FG001|Overall Study|Lack of Efficacy|0|||
157227734|NCT06179108|567579176|FG002|Overall Study|Lack of Efficacy|0|||
157227735|NCT06179108|567579177|FG003|Overall Study|Lack of Efficacy|1|||
157227736|NCT06179108|567579174|FG000|Overall Study|Death|0|||
157227737|NCT06179108|567579175|FG001|Overall Study|Death|0|||
157227738|NCT06179108|567579176|FG002|Overall Study|Death|0|||
157227739|NCT06179108|567579177|FG003|Overall Study|Death|1|||
157227740|NCT00814463|567579178|FG000|Overall Study|Lost to Follow-up|1|||
157227741|NCT02353169|567579179|FG000|Overall Study|QTc > 450 msec|1|||
157227742|NCT02353169|567579180|FG001|Overall Study|QTc > 450 msec|1|||
157227743|NCT02353169|567579181|FG002|Overall Study|QTc > 450 msec|1|||
157227744|NCT02353169|567579182|FG003|Overall Study|QTc > 450 msec|1|||
157227745|NCT02353169|567579179|FG000|Overall Study|OR team declined|2|||
157227746|NCT02353169|567579180|FG001|Overall Study|OR team declined|0|||
157227747|NCT02353169|567579181|FG002|Overall Study|OR team declined|0|||
157227748|NCT02353169|567579182|FG003|Overall Study|OR team declined|0|||
157227749|NCT02353169|567579179|FG000|Overall Study|Inhalational induction|0|||
157227750|NCT02353169|567579180|FG001|Overall Study|Inhalational induction|2|||
157227751|NCT02353169|567579181|FG002|Overall Study|Inhalational induction|0|||
157227752|NCT02353169|567579182|FG003|Overall Study|Inhalational induction|0|||
157227753|NCT02353169|567579179|FG000|Overall Study|ECG data error|0|||
157227754|NCT02353169|567579180|FG001|Overall Study|ECG data error|3|||
157227755|NCT02353169|567579181|FG002|Overall Study|ECG data error|2|||
157227756|NCT02353169|567579182|FG003|Overall Study|ECG data error|2|||
157227757|NCT02353169|567579179|FG000|Overall Study|Pre-op medication|0|||
157227758|NCT02353169|567579180|FG001|Overall Study|Pre-op medication|0|||
157227759|NCT02353169|567579181|FG002|Overall Study|Pre-op medication|1|||
157227760|NCT02353169|567579182|FG003|Overall Study|Pre-op medication|0|||
157227761|NCT00414765|567579183|FG000|Overall Study|Adverse Event|5|||
157227762|NCT00414765|567579184|FG001|Overall Study|Adverse Event|9|||
157227763|NCT00414765|567579183|FG000|Overall Study|Withdrawal by Subject|1|||
157227764|NCT00414765|567579184|FG001|Overall Study|Withdrawal by Subject|1|||
157227765|NCT00414765|567579183|FG000|Overall Study|Disease Progression|0|||
157227766|NCT00414765|567579184|FG001|Overall Study|Disease Progression|1|||
157227767|NCT05694013|567579185|FG000|Overall Study|Death|6|||
157227768|NCT05694013|567579186|FG001|Overall Study|Death|2|||
157227769|NCT05694013|567579185|FG000|Overall Study|Participant Decision|0|||
157227770|NCT05694013|567579186|FG001|Overall Study|Participant Decision|1|||
157227771|NCT05694013|567579185|FG000|Overall Study|Physician Decision|1|||
157227772|NCT05694013|567579186|FG001|Overall Study|Physician Decision|0|||
157227773|NCT05694013|567579185|FG000|Overall Study|Progressive Disease|0|||
157227774|NCT05694013|567579186|FG001|Overall Study|Progressive Disease|1|||
156959995|NCT04414696|566604063|FG000|3-month Follow up|Withdrawal by Subject|1|||
156959996|NCT04414696|566604064|FG001|3-month Follow up|Withdrawal by Subject|0|||
156959997|NCT04414696|566604063|FG000|3-month Follow up|Lost to Follow-up|22|||
156959998|NCT04414696|566604064|FG001|3-month Follow up|Lost to Follow-up|23|||
156959999|NCT04414696|566604063|FG000|6-month Follow up|Withdrawal by Subject|1|||
156960000|NCT04414696|566604064|FG001|6-month Follow up|Withdrawal by Subject|2|||
156960001|NCT04414696|566604063|FG000|6-month Follow up|Lost to Follow-up|5|||
157170836|NCT00006604|567367211|FG008|Overall Study|Lost to Follow-up|0|||
157227775|NCT05694013|567579185|FG000|Overall Study|Study Terminated by Sponsor|12|||
157227776|NCT05694013|567579186|FG001|Overall Study|Study Terminated by Sponsor|17|||
157170837|NCT00006604|567367212|FG009|Overall Study|Lost to Follow-up|2|||
157170838|NCT00006604|567367213|FG010|Overall Study|Lost to Follow-up|0|||
157170839|NCT00006604|567367214|FG011|Overall Study|Lost to Follow-up|0|||
157227777|NCT05694013|567579185|FG000|Overall Study|Withdrawal by Subject|3|||
157227778|NCT05694013|567579186|FG001|Overall Study|Withdrawal by Subject|0|||
157227779|NCT04817891|567579187|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
157227780|NCT04817891|567579187|FG000|Overall Study|Adverse Event|1|||
157227781|NCT04817891|567579187|FG000|Overall Study|Withdrawal by Subject|1|||
157227782|NCT03982433|567579188|FG000|Overall Study|Lost to Follow-up|1|||
157227783|NCT04981912|567579189|FG000|Overall Study|Physician Decision|2|||
157170840|NCT00006604|567367215|FG012|Overall Study|Lost to Follow-up|0|||
157170841|NCT00006604|567367216|FG013|Overall Study|Lost to Follow-up|0|||
157170842|NCT00006604|567367217|FG014|Overall Study|Lost to Follow-up|0|||
157170843|NCT00006604|567367218|FG015|Overall Study|Lost to Follow-up|1|||
157170844|NCT00006604|567367219|FG016|Overall Study|Lost to Follow-up|3|||
157170845|NCT00006604|567367203|FG000|Overall Study|Other Reason|0|||
157170846|NCT00006604|567367204|FG001|Overall Study|Other Reason|0|||
157170847|NCT00006604|567367205|FG002|Overall Study|Other Reason|0|||
156960002|NCT04414696|566604064|FG001|6-month Follow up|Lost to Follow-up|2|||
156960003|NCT00660010|566604067|FG000|Overall Study|Withdrawal by Subject|2|||
156960004|NCT00660010|566604067|FG000|Overall Study|Lost to Follow-up|3|||
156960005|NCT00660010|566604067|FG000|Overall Study|Adverse Event|1|||
156960006|NCT00660010|566604067|FG000|Overall Study|Noncompliance with visit schedule|3|||
156960007|NCT06167031|566604070|FG000|Overall Study|Lost to Follow-up|5|||
156960008|NCT06167031|566604071|FG001|Overall Study|Lost to Follow-up|1|||
156960009|NCT00003508|566606491|FG000|Overall Study|Not evaluable|5|||
156960010|NCT02160314|566606492|FG000|Overall Study|Adverse Event|0|||
156960011|NCT02160314|566606493|FG001|Overall Study|Adverse Event|6|||
156960012|NCT02160314|566606492|FG000|Overall Study|Protocol Violation|0|||
156960013|NCT02160314|566606493|FG001|Overall Study|Protocol Violation|4|||
156960014|NCT02160314|566606492|FG000|Overall Study|Withdrawal by Subject|1|||
156960015|NCT02160314|566606493|FG001|Overall Study|Withdrawal by Subject|2|||
156960016|NCT02160314|566606492|FG000|Overall Study|Lost to Follow-up|0|||
156960017|NCT02160314|566606493|FG001|Overall Study|Lost to Follow-up|1|||
156960018|NCT00593567|566606494|FG000|Overall Study|Adverse Event|2|||
156960019|NCT00593567|566606495|FG001|Overall Study|Adverse Event|0|||
156960020|NCT00593567|566606494|FG000|Overall Study|Physician Decision|2|||
156960021|NCT00593567|566606495|FG001|Overall Study|Physician Decision|0|||
156960022|NCT00593567|566606494|FG000|Overall Study|Protocol Violation|13|||
156960023|NCT00593567|566606495|FG001|Overall Study|Protocol Violation|7|||
156960024|NCT00593567|566606494|FG000|Overall Study|Lack of Efficacy|2|||
156960025|NCT00593567|566606495|FG001|Overall Study|Lack of Efficacy|1|||
156960026|NCT00593567|566606494|FG000|Overall Study|Withdrawal by Subject|1|||
156960027|NCT00593567|566606495|FG001|Overall Study|Withdrawal by Subject|2|||
156960028|NCT03576768|566606501|FG000|Overall Study|Lost to Follow-up|3|||
156960029|NCT03576768|566606502|FG001|Overall Study|Lost to Follow-up|3|||
156960030|NCT03576768|566606503|FG002|Overall Study|Lost to Follow-up|0|||
156960031|NCT03576768|566606504|FG003|Overall Study|Lost to Follow-up|0|||
156960032|NCT00590902|566606505|FG000|Overall Study|Death|1|||
156960033|NCT00785291|566606506|FG000|Overall Study|Never began treatment|8|||
156960034|NCT00785291|566606507|FG001|Overall Study|Never began treatment|4|||
156960035|NCT00785291|566606508|FG002|Overall Study|Never began treatment|4|||
156960036|NCT00785291|566606506|FG000|Overall Study|Adverse Event|39|||
156960037|NCT00785291|566606507|FG001|Overall Study|Adverse Event|70|||
156960038|NCT00785291|566606508|FG002|Overall Study|Adverse Event|56|||
156960039|NCT00785291|566606506|FG000|Overall Study|Death|7|||
156960040|NCT00785291|566606507|FG001|Overall Study|Death|4|||
156960041|NCT00785291|566606508|FG002|Overall Study|Death|3|||
156960042|NCT00785291|566606506|FG000|Overall Study|Withdrawal by Subject|35|||
156960043|NCT00785291|566606507|FG001|Overall Study|Withdrawal by Subject|36|||
156960044|NCT00785291|566606508|FG002|Overall Study|Withdrawal by Subject|17|||
156960045|NCT00785291|566606506|FG000|Overall Study|Alternative Therapy|12|||
156960046|NCT00785291|566606507|FG001|Overall Study|Alternative Therapy|6|||
156960047|NCT00785291|566606508|FG002|Overall Study|Alternative Therapy|7|||
156960048|NCT00785291|566606506|FG000|Overall Study|Complicating illness|6|||
156960049|NCT00785291|566606507|FG001|Overall Study|Complicating illness|4|||
156960050|NCT00785291|566606508|FG002|Overall Study|Complicating illness|4|||
156960051|NCT00785291|566606506|FG000|Overall Study|Other Medical Reasons|29|||
156960052|NCT00785291|566606507|FG001|Overall Study|Other Medical Reasons|25|||
156960053|NCT00785291|566606508|FG002|Overall Study|Other Medical Reasons|15|||
156960054|NCT02119260|566606509|FG000|Overall Study|Adverse Event|1|||
156960055|NCT02119260|566606510|FG001|Overall Study|Adverse Event|0|||
156960056|NCT02119260|566606511|FG002|Overall Study|Adverse Event|0|||
156960057|NCT02119260|566606512|FG003|Overall Study|Adverse Event|0|||
156960058|NCT02119260|566606513|FG004|Overall Study|Adverse Event|0|||
156960059|NCT02119260|566606514|FG005|Overall Study|Adverse Event|0|||
156960060|NCT02119260|566606515|FG006|Overall Study|Adverse Event|0|||
156960061|NCT02119260|566606509|FG000|Overall Study|Withdrew consent|0|||
156960062|NCT02119260|566606510|FG001|Overall Study|Withdrew consent|1|||
156960063|NCT02119260|566606511|FG002|Overall Study|Withdrew consent|1|||
157037488|NCT03213457|566892544|FG000|Open-Label Period|Non-compliance with study procedures|1|||
157170848|NCT00006604|567367206|FG003|Overall Study|Other Reason|0|||
156960064|NCT02119260|566606512|FG003|Overall Study|Withdrew consent|0|||
156960065|NCT02119260|566606513|FG004|Overall Study|Withdrew consent|0|||
156960066|NCT02119260|566606514|FG005|Overall Study|Withdrew consent|0|||
156960067|NCT02119260|566606515|FG006|Overall Study|Withdrew consent|0|||
157227784|NCT01734772|567579200|FG000|Overall Study|Adverse Event|1|||
157037489|NCT03213457|566892545|FG001|Open-Label Period|Non-compliance with study procedures|1|||
157170849|NCT00006604|567367207|FG004|Overall Study|Other Reason|0|||
157170850|NCT00006604|567367208|FG005|Overall Study|Other Reason|1|||
157170851|NCT00006604|567367209|FG006|Overall Study|Other Reason|0|||
156960068|NCT02057874|566606517|FG000|Overall Study|participant did not return for scan|1|||
156960069|NCT02979639|566606518|FG000|Overall Study|Withdrawal based on medical judgement|1|||
156960070|NCT02979639|566606518|FG000|Overall Study|Lost to Follow-up|8|||
156960071|NCT02979639|566606518|FG000|Overall Study|Withdrawal by Subject|3|||
156960072|NCT02979639|566606518|FG000|Overall Study|Adverse Event|2|||
156960073|NCT01877408|566606522|FG000|Overall Study|Lost to Follow-up|0|||
156960074|NCT01877408|566606523|FG001|Overall Study|Lost to Follow-up|2|||
156960075|NCT02621931|566606524|FG000|Overall Study|Death|0|||
156960076|NCT02621931|566606525|FG001|Overall Study|Death|1|||
156960077|NCT02621931|566606526|FG002|Overall Study|Death|0|||
156960078|NCT02621931|566606524|FG000|Overall Study|Adverse Event|8|||
156960079|NCT02621931|566606525|FG001|Overall Study|Adverse Event|5|||
156960080|NCT02621931|566606526|FG002|Overall Study|Adverse Event|7|||
156960081|NCT02621931|566606524|FG000|Overall Study|Withdrawal by Subject|12|||
156960082|NCT02621931|566606525|FG001|Overall Study|Withdrawal by Subject|10|||
156960083|NCT02621931|566606526|FG002|Overall Study|Withdrawal by Subject|11|||
156960084|NCT02621931|566606524|FG000|Overall Study|Protocol Violation|2|||
156960085|NCT02621931|566606525|FG001|Overall Study|Protocol Violation|2|||
156960086|NCT02621931|566606526|FG002|Overall Study|Protocol Violation|2|||
156960087|NCT02621931|566606524|FG000|Overall Study|Pregnancy|2|||
156960088|NCT02621931|566606525|FG001|Overall Study|Pregnancy|0|||
156960089|NCT02621931|566606526|FG002|Overall Study|Pregnancy|0|||
156960090|NCT02621931|566606524|FG000|Overall Study|Noncompliance to study procedures|0|||
156960091|NCT02621931|566606525|FG001|Overall Study|Noncompliance to study procedures|1|||
156960092|NCT02621931|566606526|FG002|Overall Study|Noncompliance to study procedures|2|||
156960093|NCT02621931|566606524|FG000|Overall Study|Lost to Follow-up|8|||
156960094|NCT02621931|566606525|FG001|Overall Study|Lost to Follow-up|7|||
156960095|NCT02621931|566606526|FG002|Overall Study|Lost to Follow-up|10|||
156960096|NCT02621931|566606524|FG000|Overall Study|Lack of Efficacy|0|||
156960097|NCT02621931|566606525|FG001|Overall Study|Lack of Efficacy|0|||
156960098|NCT02621931|566606526|FG002|Overall Study|Lack of Efficacy|1|||
156960099|NCT02621931|566606524|FG000|Overall Study|Other|1|||
156960100|NCT02621931|566606525|FG001|Overall Study|Other|1|||
156960101|NCT02621931|566606526|FG002|Overall Study|Other|3|||
156960102|NCT01292603|566606527|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156960103|NCT01292603|566606528|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156960104|NCT01292603|566606529|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156960105|NCT01292603|566606530|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
156960106|NCT01292603|566606531|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156960107|NCT01292603|566606532|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
156960108|NCT01292603|566606527|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
156960109|NCT01292603|566606528|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
156960110|NCT01292603|566606529|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
156960111|NCT01292603|566606530|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
156960112|NCT01292603|566606531|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
156960113|NCT01292603|566606532|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
156960114|NCT01292603|566606527|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156960115|NCT01292603|566606528|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156960116|NCT01292603|566606529|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156960117|NCT01292603|566606530|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
156960118|NCT01292603|566606531|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156960119|NCT01292603|566606532|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
156960120|NCT01292603|566606527|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156960121|NCT01292603|566606528|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156960122|NCT01292603|566606529|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156960123|NCT01292603|566606530|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
156960124|NCT01292603|566606531|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
157037490|NCT03213457|566892546|FG002|Open-Label Period|Non-compliance with study procedures|2|||
157037491|NCT03213457|566892544|FG000|Open-Label Period|Exclusionary medications|0|||
157037492|NCT03213457|566892545|FG001|Open-Label Period|Exclusionary medications|0|||
157037493|NCT03213457|566892546|FG002|Open-Label Period|Exclusionary medications|1|||
157037494|NCT03213457|566892544|FG000|Open-Label Period|Other|1|||
157037495|NCT03213457|566892545|FG001|Open-Label Period|Other|1|||
157037496|NCT03213457|566892546|FG002|Open-Label Period|Other|6|||
157037497|NCT03213457|566892544|FG000|Follow-Up Period|Adverse Event|16|||
157037498|NCT03213457|566892545|FG001|Follow-Up Period|Adverse Event|8|||
156960125|NCT01292603|566606532|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
156960126|NCT01292603|566606527|FG000|Part 1: Regular Follow-Up Period|Death|3|||
156960127|NCT01292603|566606528|FG001|Part 1: Regular Follow-Up Period|Death|1|||
156960128|NCT01292603|566606529|FG002|Part 1: Regular Follow-Up Period|Death|3|||
156960129|NCT01292603|566606530|FG003|Part 1: Regular Follow-Up Period|Death|1|||
157037499|NCT03213457|566892546|FG002|Follow-Up Period|Adverse Event|37|||
157037500|NCT03213457|566892544|FG000|Follow-Up Period|Withdrawal by Subject|18|||
157170852|NCT00006604|567367210|FG007|Overall Study|Other Reason|0|||
156960130|NCT01292603|566606531|FG004|Part 1: Regular Follow-Up Period|Death|0|||
156960131|NCT01292603|566606532|FG005|Part 1: Regular Follow-Up Period|Death|0|||
156960132|NCT01292603|566606527|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
156960133|NCT01292603|566606528|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
156960134|NCT01292603|566606529|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
156960135|NCT01292603|566606530|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156960136|NCT01292603|566606531|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156960137|NCT01292603|566606532|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
156960138|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Death|0|||
156960139|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Death|0|||
156960140|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Death|0|||
156960141|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Death|0|||
156960142|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Death|1|||
156960143|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Death|0|||
156960144|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
156960145|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
156960146|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
156960147|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
156960148|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
156960149|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
156960150|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156960151|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156960152|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156960153|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
156960154|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
156960155|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
156960156|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
156960157|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
156960158|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
156960159|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
156960160|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
156960161|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
156960162|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156960163|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156960164|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156960165|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
156960166|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
156960167|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
156960168|NCT01292603|566606527|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156960169|NCT01292603|566606528|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156960170|NCT01292603|566606529|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156960171|NCT01292603|566606530|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156960172|NCT01292603|566606531|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
156960173|NCT01292603|566606532|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
156960174|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Death|0|||
156960175|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Death|0|||
156960176|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Death|0|||
156960177|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Death|0|||
156960178|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Death|6|||
156960179|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Death|3|||
156960180|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
156960181|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
156960182|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
156960183|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
156960184|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
156960185|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
156960186|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
156960187|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
156960188|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
156960189|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
156960190|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
156960191|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
156960192|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156960193|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156960194|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156960195|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156960196|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
156960197|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
156960198|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
156960199|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
156960200|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
156960201|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
156960202|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
156960203|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
156960204|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
156960205|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
156960206|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
156960207|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
156960208|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
156960209|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
156960210|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156960211|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156960212|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156960213|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
156960214|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
156960215|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
156960216|NCT01292603|566606527|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
156960217|NCT01292603|566606528|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
156960218|NCT01292603|566606529|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
156960219|NCT01292603|566606530|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
156960220|NCT01292603|566606531|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
156960221|NCT01292603|566606532|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
156960222|NCT01292603|566606527|FG000|Overall Survival Status|Death|3|||
156960223|NCT01292603|566606528|FG001|Overall Survival Status|Death|1|||
156960224|NCT01292603|566606529|FG002|Overall Survival Status|Death|3|||
156960225|NCT01292603|566606530|FG003|Overall Survival Status|Death|1|||
156960226|NCT01292603|566606531|FG004|Overall Survival Status|Death|16|||
156960227|NCT01292603|566606532|FG005|Overall Survival Status|Death|10|||
156960228|NCT03870763|566606535|FG000|Overall Study|Study terminated by sponsor|0|||
156960229|NCT03870763|566606536|FG001|Overall Study|Study terminated by sponsor|2|||
156960230|NCT03870763|566606537|FG002|Overall Study|Study terminated by sponsor|0|||
156960231|NCT03870763|566606535|FG000|Overall Study|Withdrawal by Subject|0|||
156960232|NCT03870763|566606536|FG001|Overall Study|Withdrawal by Subject|1|||
156960233|NCT03870763|566606537|FG002|Overall Study|Withdrawal by Subject|0|||
156960234|NCT03870763|566606535|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
156960235|NCT03870763|566606536|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
156960236|NCT03870763|566606537|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
156960237|NCT02985866|566606538|FG000|Overall Study|Poor CGM data|1|||
156960238|NCT02985866|566606539|FG001|Overall Study|Poor CGM data|1|||
156960239|NCT04279314|566606540|FG000|Overall Study|Adverse Event|55|||
156960240|NCT04279314|566606540|FG000|Overall Study|Withdrawal by Subject|5|||
156960241|NCT04279314|566606540|FG000|Overall Study|Lack of Efficacy|5|||
156960242|NCT04279314|566606540|FG000|Overall Study|Protocol Violation|3|||
156960243|NCT04279314|566606540|FG000|Overall Study|Other (not COVID-19 related)|2|||
156960244|NCT02120027|566606541|FG000|Overall Study|Adverse Event|4|||
156960245|NCT02120027|566606542|FG001|Overall Study|Adverse Event|5|||
156960246|NCT02120027|566606541|FG000|Overall Study|Lack of Efficacy|3|||
156960247|NCT02120027|566606542|FG001|Overall Study|Lack of Efficacy|5|||
156960248|NCT02120027|566606541|FG000|Overall Study|Lost to Follow-up|5|||
156960249|NCT02120027|566606542|FG001|Overall Study|Lost to Follow-up|13|||
156960250|NCT02120027|566606541|FG000|Overall Study|Other|4|||
156960251|NCT02120027|566606542|FG001|Overall Study|Other|0|||
156960252|NCT02120027|566606541|FG000|Overall Study|Physician Decision|4|||
156960253|NCT02120027|566606542|FG001|Overall Study|Physician Decision|3|||
156960254|NCT02120027|566606541|FG000|Overall Study|Protocol Violation|18|||
156960255|NCT02120027|566606542|FG001|Overall Study|Protocol Violation|21|||
156960256|NCT02120027|566606541|FG000|Overall Study|Study terminated by Sponsor|45|||
156960257|NCT02120027|566606542|FG001|Overall Study|Study terminated by Sponsor|47|||
156960258|NCT02120027|566606541|FG000|Overall Study|Withdrawal by Subject|33|||
156960259|NCT02120027|566606542|FG001|Overall Study|Withdrawal by Subject|25|||
156960260|NCT01471054|566606547|FG000|Overall Study|Study terminated prematurely|4|||
156960261|NCT01471054|566606548|FG001|Overall Study|Study terminated prematurely|0|||
156960262|NCT00360308|566606549|FG000|Overall Study|Adverse Event|15|||
156960263|NCT00360308|566606550|FG001|Overall Study|Adverse Event|14|||
156960264|NCT00360308|566606551|FG002|Overall Study|Adverse Event|25|||
156960265|NCT00360308|566606549|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
156960266|NCT00360308|566606550|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
156960267|NCT00360308|566606551|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
156960268|NCT00360308|566606549|FG000|Overall Study|Protocol Violation|2|||
156960269|NCT00360308|566606550|FG001|Overall Study|Protocol Violation|1|||
156960270|NCT00360308|566606551|FG002|Overall Study|Protocol Violation|2|||
156960271|NCT00360308|566606549|FG000|Overall Study|Withdrawal by Subject|11|||
156960272|NCT00360308|566606550|FG001|Overall Study|Withdrawal by Subject|7|||
156960273|NCT00360308|566606551|FG002|Overall Study|Withdrawal by Subject|14|||
157037501|NCT03213457|566892545|FG001|Follow-Up Period|Withdrawal by Subject|11|||
157037502|NCT03213457|566892546|FG002|Follow-Up Period|Withdrawal by Subject|55|||
157037503|NCT03213457|566892544|FG000|Follow-Up Period|Lost to Follow-up|28|||
157037504|NCT03213457|566892545|FG001|Follow-Up Period|Lost to Follow-up|15|||
157037505|NCT03213457|566892546|FG002|Follow-Up Period|Lost to Follow-up|50|||
157037506|NCT03213457|566892544|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
157037507|NCT03213457|566892545|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
157037508|NCT03213457|566892546|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
157037509|NCT03213457|566892544|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
157037510|NCT03213457|566892545|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
157037511|NCT03213457|566892546|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
157037512|NCT03213457|566892544|FG000|Follow-Up Period|Pregnancy|7|||
157037513|NCT03213457|566892545|FG001|Follow-Up Period|Pregnancy|0|||
157037514|NCT03213457|566892546|FG002|Follow-Up Period|Pregnancy|18|||
157037515|NCT03213457|566892544|FG000|Follow-Up Period|Exclusionary medications|1|||
157037516|NCT03213457|566892545|FG001|Follow-Up Period|Exclusionary medications|1|||
157037517|NCT03213457|566892546|FG002|Follow-Up Period|Exclusionary medications|5|||
157037518|NCT03213457|566892544|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
157037519|NCT03213457|566892545|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
157037520|NCT03213457|566892546|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
157037521|NCT03213457|566892544|FG000|Follow-Up Period|Other|14|||
157037522|NCT03213457|566892545|FG001|Follow-Up Period|Other|10|||
157037523|NCT03213457|566892546|FG002|Follow-Up Period|Other|31|||
157037524|NCT03275285|566892553|FG000|Overall Study|Ongoing|45|||
157037525|NCT03275285|566892554|FG001|Overall Study|Ongoing|69|||
157037526|NCT00115934|566892555|FG000|Overall Study|Lost to Follow-up|1|||
157037527|NCT00115934|566892556|FG001|Overall Study|Lost to Follow-up|0|||
157037528|NCT00115934|566892555|FG000|Overall Study|Did not receive intervention|3|||
157037529|NCT00115934|566892556|FG001|Overall Study|Did not receive intervention|2|||
157037530|NCT00747565|566892557|FG000|Overall Study|Withdrawal by Subject|10|||
157037531|NCT00747565|566892558|FG001|Overall Study|Withdrawal by Subject|6|||
157037532|NCT00747565|566892557|FG000|Overall Study|Lost to Follow-up|4|||
157037533|NCT00747565|566892558|FG001|Overall Study|Lost to Follow-up|1|||
157037534|NCT03777657|566892559|FG000|Overall Study|Death|397|||
157037535|NCT03777657|566892560|FG001|Overall Study|Death|431|||
157037536|NCT03777657|566892559|FG000|Overall Study|Study Closed by Sponsor|77|||
157037537|NCT03777657|566892560|FG001|Overall Study|Study Closed by Sponsor|38|||
157037538|NCT03777657|566892559|FG000|Overall Study|Withdrawal by Subject|20|||
157037539|NCT03777657|566892560|FG001|Overall Study|Withdrawal by Subject|17|||
157037540|NCT03777657|566892559|FG000|Overall Study|Lost to Follow-up|6|||
157037541|NCT03777657|566892560|FG001|Overall Study|Lost to Follow-up|10|||
157037542|NCT00319020|566892565|FG000|Overall Study|Death|2|||
157037543|NCT00319020|566892566|FG001|Overall Study|Death|2|||
157037544|NCT00319020|566892565|FG000|Overall Study|Withdrawal by Subject|4|||
157037545|NCT00319020|566892566|FG001|Overall Study|Withdrawal by Subject|1|||
157037546|NCT00319020|566892565|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
157037547|NCT00319020|566892566|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
157037548|NCT00319020|566892565|FG000|Overall Study|Administrative reason|0|||
157037549|NCT00319020|566892566|FG001|Overall Study|Administrative reason|5|||
157037550|NCT00319020|566892565|FG000|Overall Study|Disease progression|0|||
157037551|NCT00319020|566892566|FG001|Overall Study|Disease progression|2|||
157037552|NCT00319020|566892565|FG000|Overall Study|Transplant|0|||
157037553|NCT00319020|566892566|FG001|Overall Study|Transplant|1|||
157037554|NCT00319020|566892565|FG000|Overall Study|Treatment failure|0|||
157037555|NCT00319020|566892566|FG001|Overall Study|Treatment failure|1|||
157037556|NCT00319020|566892565|FG000|Overall Study|Adverse Event|0|||
157037557|NCT00319020|566892566|FG001|Overall Study|Adverse Event|1|||
157037558|NCT05864209|566893543|FG000|Overall Study|Lost to Follow-up|2|||
157037559|NCT05864209|566893544|FG001|Overall Study|Lost to Follow-up|3|||
157037560|NCT04977583|566893545|FG000|Overall Study|Lost to Follow-up|8|||
157037561|NCT04977583|566893546|FG001|Overall Study|Lost to Follow-up|4|||
157037562|NCT04977583|566893547|FG002|Overall Study|Lost to Follow-up|13|||
157037563|NCT04977583|566893545|FG000|Overall Study|Withdrawal by Subject|3|||
157037564|NCT04977583|566893546|FG001|Overall Study|Withdrawal by Subject|2|||
157037565|NCT04977583|566893547|FG002|Overall Study|Withdrawal by Subject|1|||
157037566|NCT02722434|566893553|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
157037567|NCT02722434|566893554|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
157037568|NCT02722434|566893553|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
157037569|NCT02722434|566893554|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
157037570|NCT04559698|566893555|FG000|Overall Study|Lost to Follow-up|14|||
157037571|NCT04559698|566893556|FG001|Overall Study|Lost to Follow-up|15|||
157037572|NCT04559698|566893555|FG000|Overall Study|Withdrawal by Subject|0|||
157037573|NCT04559698|566893556|FG001|Overall Study|Withdrawal by Subject|1|||
157037574|NCT03437733|566893557|FG000|Overall Study|Eligibility criteria not met|0|||
157037575|NCT03437733|566893558|FG001|Overall Study|Eligibility criteria not met|3|||
156960274|NCT00360308|566606549|FG000|Overall Study|Lack of Efficacy|3|||
156960275|NCT00360308|566606550|FG001|Overall Study|Lack of Efficacy|0|||
156960276|NCT00360308|566606551|FG002|Overall Study|Lack of Efficacy|2|||
156960277|NCT00360308|566606549|FG000|Overall Study|Other|2|||
156960278|NCT00360308|566606550|FG001|Overall Study|Other|1|||
156960279|NCT00360308|566606551|FG002|Overall Study|Other|1|||
156960280|NCT00360308|566606549|FG000|Overall Study|Study termination by sponsor|43|||
156960281|NCT00360308|566606550|FG001|Overall Study|Study termination by sponsor|55|||
156960282|NCT00360308|566606551|FG002|Overall Study|Study termination by sponsor|44|||
156960283|NCT02131272|566606552|FG000|Overall Study|Withdrawal by parent|0|||
156960284|NCT02131272|566606553|FG001|Overall Study|Withdrawal by parent|1|||
156960285|NCT02131272|566606552|FG000|Overall Study|Withdrawal by Subject|0|||
156960286|NCT02131272|566606553|FG001|Overall Study|Withdrawal by Subject|1|||
156960287|NCT02131272|566606552|FG000|Overall Study|Withdrawal Criteria|1|||
156960288|NCT02131272|566606553|FG001|Overall Study|Withdrawal Criteria|0|||
156960289|NCT01925950|566606554|FG000|Part 2|Withdrawal by Subject|1|||
156960290|NCT01925950|566606555|FG001|Part 2|Withdrawal by Subject|0|||
156960291|NCT00381940|566606556|FG000|Overall Study|Lack of Efficacy|3|||
156960292|NCT00381940|566606556|FG000|Overall Study|Protocol Violation|1|||
156960293|NCT00381940|566606556|FG000|Overall Study|Ineligible|1|||
156960294|NCT03162224|566606557|FG000|Overall Study|Death|4|||
156960295|NCT03162224|566606558|FG001|Overall Study|Death|5|||
156960296|NCT03162224|566606559|FG002|Overall Study|Death|8|||
156960297|NCT03162224|566606557|FG000|Overall Study|Withdrawal by Subject|1|||
156960298|NCT03162224|566606558|FG001|Overall Study|Withdrawal by Subject|0|||
156960299|NCT03162224|566606559|FG002|Overall Study|Withdrawal by Subject|1|||
156960300|NCT03162224|566606557|FG000|Overall Study|Lost to Follow-up|0|||
156960301|NCT03162224|566606558|FG001|Overall Study|Lost to Follow-up|1|||
156960302|NCT03162224|566606559|FG002|Overall Study|Lost to Follow-up|0|||
156960303|NCT03162224|566606557|FG000|Overall Study|Other|6|||
156960304|NCT03162224|566606558|FG001|Overall Study|Other|2|||
156960305|NCT03162224|566606559|FG002|Overall Study|Other|1|||
156960306|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
156960307|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
156960308|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
156960309|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
156960310|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
156960311|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
156960312|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
156960313|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
156960314|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
156960315|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
156960316|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
156960317|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
156960318|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
156960319|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
156960320|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
156960321|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
156960322|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
156960323|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
156960324|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
156960325|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
156960326|NCT04162769|566606560|FG000|Double-blind Treatment (12-Week)|Other|0|||
156960327|NCT04162769|566606561|FG001|Double-blind Treatment (12-Week)|Other|1|||
156960328|NCT04162769|566606562|FG002|Double-blind Treatment (12-Week)|Other|1|||
156960329|NCT04162769|566606563|FG003|Double-blind Treatment (12-Week)|Other|0|||
156960330|NCT04162769|566606560|FG000|OLE Period (52-Week)|Adverse Event|0|||
156960331|NCT04162769|566606561|FG001|OLE Period (52-Week)|Adverse Event|0|||
156960332|NCT04162769|566606562|FG002|OLE Period (52-Week)|Adverse Event|0|||
156960333|NCT04162769|566606563|FG003|OLE Period (52-Week)|Adverse Event|5|||
156960334|NCT04162769|566606560|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
156960335|NCT04162769|566606561|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
156960336|NCT04162769|566606562|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
156960337|NCT04162769|566606563|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
156960338|NCT04162769|566606560|FG000|OLE Period (52-Week)|Physician Decision|0|||
156960339|NCT04162769|566606561|FG001|OLE Period (52-Week)|Physician Decision|0|||
156960340|NCT04162769|566606562|FG002|OLE Period (52-Week)|Physician Decision|0|||
156960341|NCT04162769|566606563|FG003|OLE Period (52-Week)|Physician Decision|1|||
156960342|NCT04162769|566606560|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
156960343|NCT04162769|566606561|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
156960344|NCT04162769|566606562|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
156960345|NCT04162769|566606563|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
156960346|NCT04162769|566606560|FG000|OLE Period (52-Week)|Protocol deviation|0|||
156960347|NCT04162769|566606561|FG001|OLE Period (52-Week)|Protocol deviation|0|||
156960348|NCT04162769|566606562|FG002|OLE Period (52-Week)|Protocol deviation|0|||
156960349|NCT04162769|566606563|FG003|OLE Period (52-Week)|Protocol deviation|2|||
156960350|NCT00515502|566606566|FG000|Treatment Period 1|Adverse Event|0|||
156960351|NCT00515502|566606567|FG001|Treatment Period 1|Adverse Event|0|||
156960352|NCT00515502|566606568|FG002|Treatment Period 1|Adverse Event|0|||
156960353|NCT00515502|566606569|FG003|Treatment Period 1|Adverse Event|0|||
156960354|NCT00515502|566606570|FG004|Treatment Period 1|Adverse Event|0|||
156960355|NCT00515502|566606571|FG005|Treatment Period 1|Adverse Event|0|||
156960356|NCT00515502|566606572|FG006|Treatment Period 1|Adverse Event|1|||
156960357|NCT00515502|566606573|FG007|Treatment Period 1|Adverse Event|0|||
156960358|NCT00515502|566606574|FG008|Treatment Period 1|Adverse Event|1|||
156960359|NCT00515502|566606575|FG009|Treatment Period 1|Adverse Event|0|||
156960360|NCT00515502|566606576|FG010|Treatment Period 1|Adverse Event|0|||
156960361|NCT00515502|566606577|FG011|Treatment Period 1|Adverse Event|1|||
156960362|NCT00515502|566606566|FG000|Treatment Period 2|Adverse Event|0|||
156960363|NCT00515502|566606567|FG001|Treatment Period 2|Adverse Event|1|||
156960364|NCT00515502|566606568|FG002|Treatment Period 2|Adverse Event|0|||
156960365|NCT00515502|566606569|FG003|Treatment Period 2|Adverse Event|0|||
156960366|NCT00515502|566606570|FG004|Treatment Period 2|Adverse Event|0|||
156960367|NCT00515502|566606571|FG005|Treatment Period 2|Adverse Event|0|||
156960368|NCT00515502|566606572|FG006|Treatment Period 2|Adverse Event|0|||
156960369|NCT00515502|566606573|FG007|Treatment Period 2|Adverse Event|0|||
156960370|NCT00515502|566606574|FG008|Treatment Period 2|Adverse Event|0|||
156960371|NCT00515502|566606575|FG009|Treatment Period 2|Adverse Event|0|||
156960372|NCT00515502|566606576|FG010|Treatment Period 2|Adverse Event|0|||
156960373|NCT00515502|566606577|FG011|Treatment Period 2|Adverse Event|0|||
156960374|NCT03647501|566606578|FG000|Overall Study|Lost to Follow-up|1|||
156960375|NCT03647501|566606579|FG001|Overall Study|Lost to Follow-up|1|||
156960376|NCT03647501|566606578|FG000|Overall Study|Withdrawal by Subject|0|||
156960377|NCT03647501|566606579|FG001|Overall Study|Withdrawal by Subject|1|||
156960378|NCT01613248|566606580|FG000|Overall Study|Adverse Event|0|||
156960379|NCT01613248|566606581|FG001|Overall Study|Adverse Event|0|||
156960380|NCT01613248|566606582|FG002|Overall Study|Adverse Event|0|||
156960381|NCT01613248|566606583|FG003|Overall Study|Adverse Event|1|||
156960382|NCT01613248|566606584|FG004|Overall Study|Adverse Event|0|||
156960383|NCT01613248|566606585|FG005|Overall Study|Adverse Event|0|||
156960384|NCT01613248|566606580|FG000|Overall Study|Withdrawal by Subject|3|||
156960385|NCT01613248|566606581|FG001|Overall Study|Withdrawal by Subject|2|||
156960386|NCT01613248|566606582|FG002|Overall Study|Withdrawal by Subject|2|||
156960387|NCT01613248|566606583|FG003|Overall Study|Withdrawal by Subject|5|||
156960388|NCT01613248|566606584|FG004|Overall Study|Withdrawal by Subject|0|||
156960389|NCT01613248|566606585|FG005|Overall Study|Withdrawal by Subject|1|||
156960390|NCT01613248|566606580|FG000|Overall Study|Lost to Follow-up|5|||
156960391|NCT01613248|566606581|FG001|Overall Study|Lost to Follow-up|7|||
156960392|NCT01613248|566606582|FG002|Overall Study|Lost to Follow-up|4|||
156960393|NCT01613248|566606583|FG003|Overall Study|Lost to Follow-up|8|||
156960394|NCT01613248|566606584|FG004|Overall Study|Lost to Follow-up|4|||
156960395|NCT01613248|566606585|FG005|Overall Study|Lost to Follow-up|2|||
156960396|NCT01613248|566606580|FG000|Overall Study|Study Terminated by Sponsor|4|||
156960397|NCT01613248|566606581|FG001|Overall Study|Study Terminated by Sponsor|6|||
156960398|NCT01613248|566606582|FG002|Overall Study|Study Terminated by Sponsor|8|||
156960399|NCT01613248|566606583|FG003|Overall Study|Study Terminated by Sponsor|8|||
156960400|NCT01613248|566606584|FG004|Overall Study|Study Terminated by Sponsor|9|||
156960401|NCT01613248|566606585|FG005|Overall Study|Study Terminated by Sponsor|11|||
156960402|NCT01613248|566606580|FG000|Overall Study|Physician Decision|8|||
156960403|NCT01613248|566606581|FG001|Overall Study|Physician Decision|8|||
156960404|NCT01613248|566606582|FG002|Overall Study|Physician Decision|9|||
156960405|NCT01613248|566606583|FG003|Overall Study|Physician Decision|4|||
156960406|NCT01613248|566606584|FG004|Overall Study|Physician Decision|7|||
156960407|NCT01613248|566606585|FG005|Overall Study|Physician Decision|6|||
156960408|NCT01613248|566606580|FG000|Overall Study|Lack of Qualifying Event|9|||
156960409|NCT01613248|566606581|FG001|Overall Study|Lack of Qualifying Event|11|||
156960410|NCT01613248|566606582|FG002|Overall Study|Lack of Qualifying Event|10|||
156960411|NCT01613248|566606583|FG003|Overall Study|Lack of Qualifying Event|11|||
156960412|NCT01613248|566606584|FG004|Overall Study|Lack of Qualifying Event|15|||
157037576|NCT01982682|566893559|FG000|Overall Study|Physician Decision|1|||
156960413|NCT01613248|566606585|FG005|Overall Study|Lack of Qualifying Event|18|||
156960414|NCT01613248|566606580|FG000|Overall Study|Pregnancy|0|||
156960415|NCT01613248|566606581|FG001|Overall Study|Pregnancy|0|||
156960416|NCT01613248|566606582|FG002|Overall Study|Pregnancy|0|||
156960417|NCT01613248|566606583|FG003|Overall Study|Pregnancy|1|||
156960418|NCT01613248|566606584|FG004|Overall Study|Pregnancy|0|||
156960419|NCT01613248|566606585|FG005|Overall Study|Pregnancy|0|||
156960420|NCT01324271|566606594|FG000|Overall Study|Lost to Follow-up|3|||
156960421|NCT01324271|566606595|FG001|Overall Study|Lost to Follow-up|0|||
156960422|NCT01324271|566606594|FG000|Overall Study|Physician Decision|1|||
156960423|NCT01324271|566606595|FG001|Overall Study|Physician Decision|0|||
156960424|NCT02807558|566606596|FG000|Overall Study|Consent withdrawn by participant|4|||
156960425|NCT02807558|566606597|FG001|Overall Study|Consent withdrawn by participant|0|||
157037577|NCT02760654|566893560|FG000|Overall Study|Lost to Follow-up|3|||
157037578|NCT02760654|566893561|FG001|Overall Study|Lost to Follow-up|3|||
157037579|NCT02760654|566893560|FG000|Overall Study|Withdrawal by Subject|4|||
157037580|NCT02760654|566893561|FG001|Overall Study|Withdrawal by Subject|3|||
157037581|NCT03876457|566893563|FG000|Overall Study|Lost to Follow-up|1|||
157037582|NCT03876457|566893564|FG001|Overall Study|Lost to Follow-up|3|||
157037583|NCT01036724|566893565|FG000|Overall Study|Adverse Event|1|||
157037584|NCT01036724|566893566|FG001|Overall Study|Adverse Event|2|||
157037585|NCT01036724|566893565|FG000|Overall Study|Lack of Efficacy|1|||
157037586|NCT01036724|566893566|FG001|Overall Study|Lack of Efficacy|1|||
157037587|NCT01036724|566893565|FG000|Overall Study|Protocol Violation|4|||
157037588|NCT01036724|566893566|FG001|Overall Study|Protocol Violation|5|||
157037589|NCT01574716|566893568|FG000|Part 1|Death|3|||
157037590|NCT01574716|566893569|FG001|Part 1|Death|1|||
157037591|NCT01574716|566893570|FG002|Part 1|Death|8|||
157037592|NCT01574716|566893571|FG003|Part 1|Death|0|||
157037593|NCT01574716|566893572|FG004|Part 1|Death|0|||
157037594|NCT01574716|566893568|FG000|Part 1|Discontinuation of study by sponsor|0|||
157037595|NCT01574716|566893569|FG001|Part 1|Discontinuation of study by sponsor|0|||
157037596|NCT01574716|566893570|FG002|Part 1|Discontinuation of study by sponsor|1|||
157037597|NCT01574716|566893571|FG003|Part 1|Discontinuation of study by sponsor|0|||
156960426|NCT02807558|566606598|FG002|Overall Study|Consent withdrawn by participant|4|||
156960427|NCT02807558|566606599|FG003|Overall Study|Consent withdrawn by participant|2|||
156960428|NCT02807558|566606600|FG004|Overall Study|Consent withdrawn by participant|1|||
156960429|NCT02807558|566606601|FG005|Overall Study|Consent withdrawn by participant|0|||
156960430|NCT02807558|566606596|FG000|Overall Study|Non-compliance with Study Drug|0|||
156960431|NCT02807558|566606597|FG001|Overall Study|Non-compliance with Study Drug|0|||
156960432|NCT02807558|566606598|FG002|Overall Study|Non-compliance with Study Drug|1|||
156960433|NCT02807558|566606599|FG003|Overall Study|Non-compliance with Study Drug|0|||
156960434|NCT02807558|566606600|FG004|Overall Study|Non-compliance with Study Drug|0|||
156960435|NCT02807558|566606601|FG005|Overall Study|Non-compliance with Study Drug|0|||
156960436|NCT02807558|566606596|FG000|Overall Study|Adverse Event|0|||
156960437|NCT02807558|566606597|FG001|Overall Study|Adverse Event|0|||
156960438|NCT02807558|566606598|FG002|Overall Study|Adverse Event|9|||
156960439|NCT02807558|566606599|FG003|Overall Study|Adverse Event|0|||
156960440|NCT02807558|566606600|FG004|Overall Study|Adverse Event|0|||
156960441|NCT02807558|566606601|FG005|Overall Study|Adverse Event|0|||
156960442|NCT02807558|566606596|FG000|Overall Study|Death|23|||
156960443|NCT02807558|566606597|FG001|Overall Study|Death|2|||
156960444|NCT02807558|566606598|FG002|Overall Study|Death|3|||
156960445|NCT02807558|566606599|FG003|Overall Study|Death|43|||
156960446|NCT02807558|566606600|FG004|Overall Study|Death|24|||
156960447|NCT02807558|566606601|FG005|Overall Study|Death|15|||
156960448|NCT02807558|566606596|FG000|Overall Study|Progressive Disease|0|||
156960449|NCT02807558|566606597|FG001|Overall Study|Progressive Disease|0|||
156960450|NCT02807558|566606598|FG002|Overall Study|Progressive Disease|1|||
156960451|NCT02807558|566606599|FG003|Overall Study|Progressive Disease|0|||
156960452|NCT02807558|566606600|FG004|Overall Study|Progressive Disease|0|||
156960453|NCT02807558|566606601|FG005|Overall Study|Progressive Disease|0|||
156960454|NCT02807558|566606596|FG000|Overall Study|Other than specified|1|||
156960455|NCT02807558|566606597|FG001|Overall Study|Other than specified|0|||
156960456|NCT02807558|566606598|FG002|Overall Study|Other than specified|2|||
156960457|NCT02807558|566606599|FG003|Overall Study|Other than specified|0|||
156960458|NCT02807558|566606600|FG004|Overall Study|Other than specified|1|||
156960459|NCT02807558|566606601|FG005|Overall Study|Other than specified|1|||
156960460|NCT02807558|566606596|FG000|Overall Study|Lack of Efficacy|0|||
156960461|NCT02807558|566606597|FG001|Overall Study|Lack of Efficacy|0|||
156960462|NCT02807558|566606598|FG002|Overall Study|Lack of Efficacy|9|||
156960463|NCT02807558|566606599|FG003|Overall Study|Lack of Efficacy|0|||
156960464|NCT02807558|566606600|FG004|Overall Study|Lack of Efficacy|0|||
156960465|NCT02807558|566606601|FG005|Overall Study|Lack of Efficacy|0|||
156960466|NCT06116591|566606602|FG000|Overall Study|No longer met eligibility criteria|0|||
156960467|NCT06116591|566606603|FG001|Overall Study|No longer met eligibility criteria|1|||
156960468|NCT06116591|566606602|FG000|Overall Study|Other: Change in life situation|0|||
156960469|NCT06116591|566606603|FG001|Overall Study|Other: Change in life situation|1|||
156960470|NCT05585307|566606604|FG000|Overall Study|Lost to Follow-up|0|||
156960471|NCT05585307|566606605|FG001|Overall Study|Lost to Follow-up|0|||
156960472|NCT05585307|566606606|FG002|Overall Study|Lost to Follow-up|0|||
156960473|NCT05585307|566606607|FG003|Overall Study|Lost to Follow-up|0|||
157037598|NCT01574716|566893572|FG004|Part 1|Discontinuation of study by sponsor|0|||
156960474|NCT05585307|566606608|FG004|Overall Study|Lost to Follow-up|0|||
157037599|NCT01574716|566893568|FG000|Part 1|Withdrawal by Subject|0|||
157037600|NCT01574716|566893569|FG001|Part 1|Withdrawal by Subject|2|||
156960475|NCT05585307|566606609|FG005|Overall Study|Lost to Follow-up|0|||
156960476|NCT05585307|566606610|FG006|Overall Study|Lost to Follow-up|1|||
156960477|NCT05585307|566606611|FG007|Overall Study|Lost to Follow-up|0|||
156960478|NCT02195986|566606614|FG000|Overall Study|Adverse Event|3|||
156960479|NCT02195986|566606615|FG001|Overall Study|Adverse Event|0|||
157037601|NCT01574716|566893570|FG002|Part 1|Withdrawal by Subject|0|||
157037602|NCT01574716|566893571|FG003|Part 1|Withdrawal by Subject|0|||
157037603|NCT01574716|566893572|FG004|Part 1|Withdrawal by Subject|0|||
157037604|NCT01574716|566893568|FG000|Part 1|Lost to Follow-up|0|||
157037605|NCT01574716|566893569|FG001|Part 1|Lost to Follow-up|1|||
157037606|NCT01574716|566893570|FG002|Part 1|Lost to Follow-up|0|||
157037607|NCT01574716|566893571|FG003|Part 1|Lost to Follow-up|0|||
157037608|NCT01574716|566893572|FG004|Part 1|Lost to Follow-up|0|||
157037609|NCT01574716|566893568|FG000|Part 2|Progressive disease|0|||
157037610|NCT01574716|566893569|FG001|Part 2|Progressive disease|0|||
157037611|NCT01574716|566893570|FG002|Part 2|Progressive disease|0|||
157037612|NCT01574716|566893571|FG003|Part 2|Progressive disease|1|||
157037613|NCT01574716|566893572|FG004|Part 2|Progressive disease|0|||
157037614|NCT01574716|566893568|FG000|Part 2|Death|0|||
157037615|NCT01574716|566893569|FG001|Part 2|Death|0|||
157037616|NCT01574716|566893570|FG002|Part 2|Death|0|||
157037617|NCT01574716|566893571|FG003|Part 2|Death|76|||
157037618|NCT01574716|566893572|FG004|Part 2|Death|35|||
157037619|NCT01574716|566893568|FG000|Part 2|Discontinuation of study by sponsor|0|||
157037620|NCT01574716|566893569|FG001|Part 2|Discontinuation of study by sponsor|0|||
157037621|NCT01574716|566893570|FG002|Part 2|Discontinuation of study by sponsor|0|||
157037622|NCT01574716|566893571|FG003|Part 2|Discontinuation of study by sponsor|51|||
157037623|NCT01574716|566893572|FG004|Part 2|Discontinuation of study by sponsor|31|||
157037624|NCT01574716|566893568|FG000|Part 2|Withdrawal by Subject|0|||
157037625|NCT01574716|566893569|FG001|Part 2|Withdrawal by Subject|0|||
157037626|NCT01574716|566893570|FG002|Part 2|Withdrawal by Subject|0|||
157037627|NCT01574716|566893571|FG003|Part 2|Withdrawal by Subject|5|||
157037628|NCT01574716|566893572|FG004|Part 2|Withdrawal by Subject|4|||
157037629|NCT01574716|566893568|FG000|Part 2|Brain metastases|0|||
157037630|NCT01574716|566893569|FG001|Part 2|Brain metastases|0|||
157037631|NCT01574716|566893570|FG002|Part 2|Brain metastases|0|||
157037632|NCT01574716|566893571|FG003|Part 2|Brain metastases|1|||
157037633|NCT01574716|566893572|FG004|Part 2|Brain metastases|0|||
157037634|NCT01574716|566893568|FG000|Part 2|Lost to Follow-up|0|||
157037635|NCT01574716|566893569|FG001|Part 2|Lost to Follow-up|0|||
157037636|NCT01574716|566893570|FG002|Part 2|Lost to Follow-up|0|||
157037637|NCT01574716|566893571|FG003|Part 2|Lost to Follow-up|3|||
157037638|NCT01574716|566893572|FG004|Part 2|Lost to Follow-up|0|||
157037639|NCT00945321|566893573|FG000|Period 1|Adverse Event|0|||
157170853|NCT00006604|567367211|FG008|Overall Study|Other Reason|0|||
157170854|NCT00006604|567367212|FG009|Overall Study|Other Reason|1|||
157170855|NCT00006604|567367213|FG010|Overall Study|Other Reason|0|||
157170856|NCT00006604|567367214|FG011|Overall Study|Other Reason|0|||
157037640|NCT00945321|566893574|FG001|Period 1|Adverse Event|0|||
157037641|NCT00945321|566893575|FG002|Period 1|Adverse Event|0|||
157037642|NCT00945321|566893576|FG003|Period 1|Adverse Event|0|||
157037643|NCT00945321|566893577|FG004|Period 1|Adverse Event|1|||
157170857|NCT00006604|567367215|FG012|Overall Study|Other Reason|0|||
157170858|NCT00006604|567367216|FG013|Overall Study|Other Reason|0|||
157170859|NCT00006604|567367217|FG014|Overall Study|Other Reason|0|||
157170860|NCT00006604|567367218|FG015|Overall Study|Other Reason|0|||
157170861|NCT00006604|567367219|FG016|Overall Study|Other Reason|0|||
157170862|NCT02431468|567367220|FG000|Overall Study|Adverse Event|2|||
157170863|NCT02431468|567367221|FG001|Overall Study|Adverse Event|4|||
157170864|NCT02431468|567367222|FG002|Overall Study|Adverse Event|5|||
157170865|NCT02431468|567367220|FG000|Overall Study|Withdrawal by Subject|4|||
157170866|NCT02431468|567367221|FG001|Overall Study|Withdrawal by Subject|12|||
157170867|NCT02431468|567367222|FG002|Overall Study|Withdrawal by Subject|2|||
157170868|NCT02431468|567367220|FG000|Overall Study|noncompliance, investigator termination,|2|||
157170869|NCT02431468|567367221|FG001|Overall Study|noncompliance, investigator termination,|2|||
157170870|NCT02431468|567367222|FG002|Overall Study|noncompliance, investigator termination,|2|||
157170871|NCT01361919|567367223|FG000|Overall Study|technical issues|10|||
157170872|NCT01361919|567367224|FG001|Overall Study|technical issues|12|||
157170873|NCT01361919|567367225|FG002|Overall Study|technical issues|10|||
157170874|NCT01056341|567367226|FG000|Overall Study|Treatment Intolerance|0|||
157037644|NCT00945321|566893578|FG005|Period 1|Adverse Event|0|||
157037645|NCT00945321|566893573|FG000|Period 4|Lost to Follow-up|0|||
157037646|NCT00945321|566893574|FG001|Period 4|Lost to Follow-up|0|||
157037647|NCT00945321|566893575|FG002|Period 4|Lost to Follow-up|0|||
157037648|NCT00945321|566893576|FG003|Period 4|Lost to Follow-up|0|||
157037649|NCT00945321|566893577|FG004|Period 4|Lost to Follow-up|0|||
157037650|NCT00945321|566893578|FG005|Period 4|Lost to Follow-up|1|||
157037651|NCT00605306|566893580|FG000|Overall Study|Adverse Event|0|||
157037652|NCT00605306|566893581|FG001|Overall Study|Adverse Event|1|||
157037653|NCT01750684|566893582|FG000|Overall Study|Death|1|||
157170875|NCT01056341|567367227|FG001|Overall Study|Treatment Intolerance|2|||
157170876|NCT01056341|567367228|FG002|Overall Study|Treatment Intolerance|0|||
157170877|NCT01056341|567367229|FG003|Overall Study|Treatment Intolerance|2|||
157037654|NCT01750684|566893583|FG001|Overall Study|Death|0|||
157037655|NCT01750684|566893582|FG000|Overall Study|Non-compliance with Study Drug|0|||
157037656|NCT01750684|566893583|FG001|Overall Study|Non-compliance with Study Drug|1|||
157037657|NCT01750684|566893582|FG000|Overall Study|Withdrawn by Sponsor|0|||
157170878|NCT01056341|567367230|FG004|Overall Study|Treatment Intolerance|0|||
157170879|NCT01056341|567367226|FG000|Overall Study|Lack of Efficacy|32|||
157170880|NCT01056341|567367227|FG001|Overall Study|Lack of Efficacy|30|||
156960480|NCT02195986|566606616|FG002|Overall Study|Adverse Event|0|||
156960481|NCT02195986|566606614|FG000|Overall Study|Withdrawal by Subject|0|||
156960482|NCT02195986|566606615|FG001|Overall Study|Withdrawal by Subject|3|||
156960483|NCT02195986|566606616|FG002|Overall Study|Withdrawal by Subject|0|||
156960484|NCT02195986|566606614|FG000|Overall Study|Family Emergency|0|||
156960485|NCT02195986|566606615|FG001|Overall Study|Family Emergency|0|||
156960486|NCT02195986|566606616|FG002|Overall Study|Family Emergency|1|||
156960487|NCT02195986|566606614|FG000|Overall Study|Protocol Violation|0|||
156960488|NCT02195986|566606615|FG001|Overall Study|Protocol Violation|1|||
156960489|NCT02195986|566606616|FG002|Overall Study|Protocol Violation|1|||
156960490|NCT02195986|566606614|FG000|Overall Study|Non-compliance|0|||
156960491|NCT02195986|566606615|FG001|Overall Study|Non-compliance|1|||
156960492|NCT02195986|566606616|FG002|Overall Study|Non-compliance|0|||
156960493|NCT02834780|566606617|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
156960494|NCT02834780|566606618|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156960495|NCT02834780|566606619|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
156960496|NCT02834780|566606620|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
156960497|NCT02834780|566606621|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
156960498|NCT02834780|566606622|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
156960499|NCT02834780|566606623|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
156960500|NCT02834780|566606624|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
156960501|NCT02834780|566606625|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156960502|NCT02834780|566606626|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
156960503|NCT02834780|566606627|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
156960504|NCT02834780|566606628|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
156960505|NCT02834780|566606629|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
156960506|NCT02834780|566606617|FG000|Overall Study|Withdrawal by Subject|0|||
156960507|NCT02834780|566606618|FG001|Overall Study|Withdrawal by Subject|0|||
156960508|NCT02834780|566606619|FG002|Overall Study|Withdrawal by Subject|1|||
156960509|NCT02834780|566606620|FG003|Overall Study|Withdrawal by Subject|0|||
156960510|NCT02834780|566606621|FG004|Overall Study|Withdrawal by Subject|0|||
156960511|NCT02834780|566606622|FG005|Overall Study|Withdrawal by Subject|0|||
156960512|NCT02834780|566606623|FG006|Overall Study|Withdrawal by Subject|0|||
156960513|NCT02834780|566606624|FG007|Overall Study|Withdrawal by Subject|0|||
156960514|NCT02834780|566606625|FG008|Overall Study|Withdrawal by Subject|0|||
156960515|NCT02834780|566606626|FG009|Overall Study|Withdrawal by Subject|0|||
156960516|NCT02834780|566606627|FG010|Overall Study|Withdrawal by Subject|1|||
156960517|NCT02834780|566606628|FG011|Overall Study|Withdrawal by Subject|0|||
156960518|NCT02834780|566606629|FG012|Overall Study|Withdrawal by Subject|0|||
156960519|NCT02834780|566606617|FG000|Overall Study|Adverse Event|0|||
156960520|NCT02834780|566606618|FG001|Overall Study|Adverse Event|0|||
156960521|NCT02834780|566606619|FG002|Overall Study|Adverse Event|0|||
156960522|NCT02834780|566606620|FG003|Overall Study|Adverse Event|0|||
156960523|NCT02834780|566606621|FG004|Overall Study|Adverse Event|1|||
156960524|NCT02834780|566606622|FG005|Overall Study|Adverse Event|0|||
156960525|NCT02834780|566606623|FG006|Overall Study|Adverse Event|1|||
156960526|NCT02834780|566606624|FG007|Overall Study|Adverse Event|1|||
156960527|NCT02834780|566606625|FG008|Overall Study|Adverse Event|0|||
156960528|NCT02834780|566606626|FG009|Overall Study|Adverse Event|2|||
156960529|NCT02834780|566606627|FG010|Overall Study|Adverse Event|0|||
156960530|NCT02834780|566606628|FG011|Overall Study|Adverse Event|3|||
156960531|NCT02834780|566606629|FG012|Overall Study|Adverse Event|2|||
156960532|NCT02834780|566606617|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960533|NCT02834780|566606618|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
156960534|NCT02834780|566606619|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
156960535|NCT02834780|566606620|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960536|NCT02834780|566606621|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960537|NCT02834780|566606622|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960538|NCT02834780|566606623|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960539|NCT02834780|566606624|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
156960540|NCT02834780|566606625|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
156960541|NCT02834780|566606626|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
156960542|NCT02834780|566606627|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
156960543|NCT02834780|566606628|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
156960544|NCT02834780|566606629|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
156960545|NCT02834780|566606617|FG000|Overall Study|Other|1|||
156960546|NCT02834780|566606618|FG001|Overall Study|Other|0|||
156960547|NCT02834780|566606619|FG002|Overall Study|Other|1|||
156960548|NCT02834780|566606620|FG003|Overall Study|Other|2|||
156960549|NCT02834780|566606621|FG004|Overall Study|Other|0|||
157170881|NCT01056341|567367228|FG002|Overall Study|Lack of Efficacy|7|||
157037658|NCT01750684|566893583|FG001|Overall Study|Withdrawn by Sponsor|1|||
157037659|NCT01750684|566893582|FG000|Overall Study|Protocol Violation|1|||
157037660|NCT01750684|566893583|FG001|Overall Study|Protocol Violation|0|||
157037661|NCT02185794|566893585|FG000|Overall Study|Enrolled but Never Dosed|1|||
157037662|NCT02185794|566893586|FG001|Overall Study|Enrolled but Never Dosed|6|||
157037663|NCT02185794|566893587|FG002|Overall Study|Enrolled but Never Dosed|3|||
157037664|NCT02185794|566893588|FG003|Overall Study|Enrolled but Never Dosed|1|||
157037665|NCT02185794|566893589|FG004|Overall Study|Enrolled but Never Dosed|1|||
157037666|NCT02185794|566893590|FG005|Overall Study|Enrolled but Never Dosed|0|||
157037667|NCT02185794|566893585|FG000|Overall Study|Investigator's Discretion|1|||
157037668|NCT02185794|566893586|FG001|Overall Study|Investigator's Discretion|0|||
157037669|NCT02185794|566893587|FG002|Overall Study|Investigator's Discretion|1|||
157037670|NCT02185794|566893588|FG003|Overall Study|Investigator's Discretion|2|||
157037671|NCT02185794|566893589|FG004|Overall Study|Investigator's Discretion|2|||
157037672|NCT02185794|566893590|FG005|Overall Study|Investigator's Discretion|15|||
157037673|NCT02185794|566893585|FG000|Overall Study|Withdrew Consent|2|||
157037674|NCT02185794|566893586|FG001|Overall Study|Withdrew Consent|5|||
157037675|NCT02185794|566893587|FG002|Overall Study|Withdrew Consent|10|||
157037676|NCT02185794|566893588|FG003|Overall Study|Withdrew Consent|2|||
157037677|NCT02185794|566893589|FG004|Overall Study|Withdrew Consent|0|||
157037678|NCT02185794|566893590|FG005|Overall Study|Withdrew Consent|0|||
157037679|NCT02185794|566893585|FG000|Overall Study|Lost to Follow-up|1|||
157037680|NCT02185794|566893586|FG001|Overall Study|Lost to Follow-up|2|||
157037681|NCT02185794|566893587|FG002|Overall Study|Lost to Follow-up|2|||
157037682|NCT02185794|566893588|FG003|Overall Study|Lost to Follow-up|3|||
157037683|NCT02185794|566893589|FG004|Overall Study|Lost to Follow-up|0|||
157037684|NCT02185794|566893590|FG005|Overall Study|Lost to Follow-up|1|||
157037685|NCT00336505|566893591|FG000|Overall Study|Adverse Event|10|||
157037686|NCT00336505|566893592|FG001|Overall Study|Adverse Event|9|||
157037687|NCT00336505|566893591|FG000|Overall Study|Lack of Efficacy|8|||
157037688|NCT00336505|566893592|FG001|Overall Study|Lack of Efficacy|4|||
157037689|NCT00336505|566893591|FG000|Overall Study|Lost to Follow-up|7|||
157037690|NCT00336505|566893592|FG001|Overall Study|Lost to Follow-up|4|||
157037691|NCT00336505|566893591|FG000|Overall Study|Withdrawal by Subject|5|||
157037692|NCT00336505|566893592|FG001|Overall Study|Withdrawal by Subject|3|||
157037693|NCT00336505|566893591|FG000|Overall Study|Other|7|||
157037694|NCT00336505|566893592|FG001|Overall Study|Other|7|||
157037695|NCT00366249|566893593|FG000|Overall Study|Adverse Event|53|||
157037696|NCT00366249|566893594|FG001|Overall Study|Adverse Event|28|||
157037697|NCT00366249|566893593|FG000|Overall Study|Death|0|||
157037698|NCT00366249|566893594|FG001|Overall Study|Death|1|||
157037699|NCT00366249|566893593|FG000|Overall Study|Physician Decision|5|||
157037700|NCT00366249|566893594|FG001|Overall Study|Physician Decision|2|||
157037701|NCT00366249|566893593|FG000|Overall Study|Lost to Follow-up|2|||
157037702|NCT00366249|566893594|FG001|Overall Study|Lost to Follow-up|0|||
157037703|NCT00366249|566893593|FG000|Overall Study|Protocol Violation|1|||
157037704|NCT00366249|566893594|FG001|Overall Study|Protocol Violation|2|||
157037705|NCT00366249|566893593|FG000|Overall Study|Withdrawal by Subject|18|||
157037706|NCT00366249|566893594|FG001|Overall Study|Withdrawal by Subject|4|||
157037707|NCT00366249|566893593|FG000|Overall Study|Lack of Efficacy|21|||
157037708|NCT00366249|566893594|FG001|Overall Study|Lack of Efficacy|21|||
157037709|NCT00366249|566893593|FG000|Overall Study|Most due to osteomylitis status|31|||
157037710|NCT00366249|566893594|FG001|Overall Study|Most due to osteomylitis status|20|||
157037711|NCT00246805|566893595|FG000|Phase 1|Lost to Follow-up|1|||
157037712|NCT00246805|566893596|FG001|Phase 1|Lost to Follow-up|0|||
157037713|NCT03183050|566893597|FG000|Overall Study|Lost to Follow-up|23|||
157037714|NCT00686595|566893601|FG000|Overall Study|Adverse Event|3|||
157037715|NCT00686595|566893601|FG000|Overall Study|Protocol Violation|1|||
157037716|NCT00686595|566893601|FG000|Overall Study|Lost to Follow-up|1|||
157037717|NCT00686595|566893601|FG000|Overall Study|Lack of Efficacy|1|||
157037718|NCT00686595|566893601|FG000|Overall Study|Poor Compliance|1|||
157037719|NCT02797132|566893602|FG000|Part A (15 Days)|Adverse Event|1|||
157037720|NCT02797132|566893602|FG000|Part B (24 Weeks)|Adverse Event|3|||
157037721|NCT01342367|566893604|FG000|Overall Study|Death|1|||
157037722|NCT01342367|566893605|FG001|Overall Study|Death|0|||
157037723|NCT01342367|566893604|FG000|Overall Study|Withdrawal by Subject|1|||
157037724|NCT01342367|566893605|FG001|Overall Study|Withdrawal by Subject|2|||
157037725|NCT01961609|566893606|FG000|Initiation|Missing|3|||
157037726|NCT01961609|566893607|FG001|Initiation|Missing|2|||
157037727|NCT01961609|566893608|FG002|Initiation|Missing|0|||
157037728|NCT01961609|566893609|FG003|Initiation|Missing|0|||
157037729|NCT01961609|566893606|FG000|Initiation|Protocol deviation|1|||
157037730|NCT01961609|566893607|FG001|Initiation|Protocol deviation|0|||
157037731|NCT01961609|566893608|FG002|Initiation|Protocol deviation|0|||
157037732|NCT01961609|566893609|FG003|Initiation|Protocol deviation|0|||
157037733|NCT01961609|566893606|FG000|Initiation|Death|0|||
157037734|NCT01961609|566893607|FG001|Initiation|Death|1|||
157037735|NCT01961609|566893608|FG002|Initiation|Death|0|||
157037736|NCT01961609|566893609|FG003|Initiation|Death|0|||
157037737|NCT01961609|566893606|FG000|Initiation|Administrative problems|1|||
157037738|NCT01961609|566893607|FG001|Initiation|Administrative problems|0|||
157037739|NCT01961609|566893608|FG002|Initiation|Administrative problems|0|||
157037740|NCT01961609|566893609|FG003|Initiation|Administrative problems|0|||
157037741|NCT01961609|566893606|FG000|Initiation|Withdrawal by Subject|1|||
157227785|NCT01734772|567579201|FG001|Overall Study|Adverse Event|2|||
157227786|NCT01734772|567579200|FG000|Overall Study|Withdrawal by Subject|0|||
157227787|NCT01734772|567579201|FG001|Overall Study|Withdrawal by Subject|1|||
157037742|NCT01961609|566893607|FG001|Initiation|Withdrawal by Subject|2|||
157037743|NCT01961609|566893608|FG002|Initiation|Withdrawal by Subject|0|||
157037744|NCT01961609|566893609|FG003|Initiation|Withdrawal by Subject|0|||
157037745|NCT01961609|566893606|FG000|Initiation|Lack of Efficacy|2|||
157037746|NCT01961609|566893607|FG001|Initiation|Lack of Efficacy|1|||
157037747|NCT01961609|566893608|FG002|Initiation|Lack of Efficacy|0|||
157037748|NCT01961609|566893609|FG003|Initiation|Lack of Efficacy|0|||
157037749|NCT01961609|566893606|FG000|Initiation|Abnormal lab values|0|||
157037750|NCT01961609|566893607|FG001|Initiation|Abnormal lab values|1|||
157037751|NCT01961609|566893608|FG002|Initiation|Abnormal lab values|0|||
157037752|NCT01961609|566893609|FG003|Initiation|Abnormal lab values|0|||
157037753|NCT01961609|566893606|FG000|Initiation|Adverse Event|3|||
157037754|NCT01961609|566893607|FG001|Initiation|Adverse Event|5|||
157037755|NCT01961609|566893608|FG002|Initiation|Adverse Event|0|||
157037756|NCT01961609|566893609|FG003|Initiation|Adverse Event|0|||
157037757|NCT01961609|566893606|FG000|Initiation|Randomized but not treated|1|||
157037758|NCT01961609|566893607|FG001|Initiation|Randomized but not treated|1|||
157037759|NCT01961609|566893608|FG002|Initiation|Randomized but not treated|0|||
157037760|NCT01961609|566893609|FG003|Initiation|Randomized but not treated|0|||
157037761|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
157037762|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
157037763|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
157037764|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
157037765|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
157037766|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
157037767|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
157037768|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
157037769|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
157037770|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
157037771|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
157037772|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
157037773|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
157037774|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
157037775|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
157037776|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
157037777|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
157037778|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
157037779|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
157037780|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
157037781|NCT01961609|566893606|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
157037782|NCT01961609|566893607|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
157037783|NCT01961609|566893608|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
157037784|NCT01961609|566893609|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
157037785|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
157037786|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
157037787|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
157037788|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
157037789|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
157037790|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
157037791|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
157037792|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
157037793|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
157037794|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
157037795|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
157037796|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
157037797|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
157037798|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
157037799|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
157037800|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
157037801|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
157037802|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
157037803|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
157037804|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
157037805|NCT01961609|566893606|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
157227788|NCT01139164|567579202|FG000|Overall Study|Withdrawn prior to study start|0|||
157037806|NCT01961609|566893607|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
157037807|NCT01961609|566893608|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
157037808|NCT01961609|566893609|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
157037809|NCT02284113|566893610|FG000|Overall Study|Adverse Event|1|||
157037810|NCT02284113|566893611|FG001|Overall Study|Adverse Event|0|||
157037811|NCT02284113|566893610|FG000|Overall Study|non-compliance|0|||
157037812|NCT02284113|566893611|FG001|Overall Study|non-compliance|1|||
157037813|NCT02284113|566893610|FG000|Overall Study|Withdrawal by Subject|0|||
157037814|NCT02284113|566893611|FG001|Overall Study|Withdrawal by Subject|1|||
157037815|NCT02284113|566893610|FG000|Overall Study|not provided|0|||
157037816|NCT02284113|566893611|FG001|Overall Study|not provided|1|||
157037817|NCT02284113|566893610|FG000|Overall Study|surgery cancelled|2|||
157037818|NCT02284113|566893611|FG001|Overall Study|surgery cancelled|0|||
157037819|NCT04191824|566893612|FG000|Overall Study|Death|13|||
157037820|NCT04191824|566893613|FG001|Overall Study|Death|12|||
157037821|NCT04191824|566893612|FG000|Overall Study|Lost to Follow-up|456|||
157037822|NCT04191824|566893613|FG001|Overall Study|Lost to Follow-up|435|||
157037823|NCT04191824|566893612|FG000|Overall Study|Physician Decision|2|||
157037824|NCT04191824|566893613|FG001|Overall Study|Physician Decision|1|||
157037825|NCT04191824|566893612|FG000|Overall Study|Protocol Violation|0|||
157037826|NCT04191824|566893613|FG001|Overall Study|Protocol Violation|2|||
157037827|NCT04191824|566893612|FG000|Overall Study|Withdrawal by Subject|16|||
157037828|NCT04191824|566893613|FG001|Overall Study|Withdrawal by Subject|18|||
157037829|NCT04191824|566893612|FG000|Overall Study|Early site closure|24|||
157037830|NCT04191824|566893613|FG001|Overall Study|Early site closure|22|||
157037831|NCT01218009|566893616|FG000|Overall Study|Protocol Violation|2|||
157037832|NCT01218009|566893617|FG001|Overall Study|Protocol Violation|1|||
157037833|NCT01218009|566893616|FG000|Overall Study|Withdrawal by Subject|3|||
157037834|NCT01218009|566893617|FG001|Overall Study|Withdrawal by Subject|1|||
157037835|NCT01218009|566893616|FG000|Overall Study|Sponsor terminated study|161|||
157037836|NCT01218009|566893617|FG001|Overall Study|Sponsor terminated study|163|||
157037837|NCT01324310|566893618|FG000|Overall Study|Adverse Event|1|||
157037838|NCT01324310|566893618|FG000|Overall Study|Disease Progression|1|||
157037839|NCT03170882|566893619|FG000|Overall Study|Death|17|||
157037840|NCT03170882|566893620|FG001|Overall Study|Death|29|||
157037841|NCT03170882|566893619|FG000|Overall Study|Lost to Follow-up|0|||
157037842|NCT03170882|566893620|FG001|Overall Study|Lost to Follow-up|1|||
157037843|NCT03170882|566893619|FG000|Overall Study|Withdrawal by Subject|4|||
157037844|NCT03170882|566893620|FG001|Overall Study|Withdrawal by Subject|7|||
157037845|NCT03170882|566893619|FG000|Overall Study|Reason not Specified|28|||
157037846|NCT03170882|566893620|FG001|Overall Study|Reason not Specified|36|||
157037847|NCT03891758|566893625|FG000|Overall Study|Adverse Event|2|||
157037848|NCT03891758|566893626|FG001|Overall Study|Adverse Event|0|||
157037849|NCT03891758|566893625|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157037850|NCT03891758|566893626|FG001|Overall Study|Withdrawal by parent/guardian|2|||
157037851|NCT01983683|566893629|FG000|Overall Study|Withdrawal by Subject|14|||
157037852|NCT01983683|566893630|FG001|Overall Study|Withdrawal by Subject|18|||
157037853|NCT01983683|566893629|FG000|Overall Study|Death|11|||
157037854|NCT01983683|566893630|FG001|Overall Study|Death|15|||
157037855|NCT01983683|566893629|FG000|Overall Study|Physician Decision|8|||
157037856|NCT01983683|566893630|FG001|Overall Study|Physician Decision|9|||
157037857|NCT01983683|566893629|FG000|Overall Study|Lost to Follow-up|4|||
157037858|NCT01983683|566893630|FG001|Overall Study|Lost to Follow-up|8|||
157037859|NCT01983683|566893629|FG000|Overall Study|Sponsor Decision|1|||
157037860|NCT01983683|566893630|FG001|Overall Study|Sponsor Decision|1|||
157037861|NCT02549352|566893633|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
157037862|NCT02549352|566893634|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
157037863|NCT02549352|566893633|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
157037864|NCT02549352|566893634|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
157037865|NCT02549352|566893633|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
157037866|NCT02549352|566893634|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
157037867|NCT02549352|566893633|FG000|12-month Follow-up|Withdrawal by Subject|4|||
157037868|NCT02549352|566893634|FG001|12-month Follow-up|Withdrawal by Subject|5|||
157037869|NCT02549352|566893633|FG000|12-month Follow-up|Lost to Follow-up|3|||
157037870|NCT02549352|566893634|FG001|12-month Follow-up|Lost to Follow-up|2|||
157037871|NCT02549352|566893633|FG000|12-month Follow-up|Death|0|||
157037872|NCT02549352|566893634|FG001|12-month Follow-up|Death|1|||
157037873|NCT02549352|566893633|FG000|12-month Follow-up|Protocol Violation|0|||
157037874|NCT02549352|566893634|FG001|12-month Follow-up|Protocol Violation|1|||
157037875|NCT02549352|566893633|FG000|12-month Follow-up|Other|1|||
157037876|NCT02549352|566893634|FG001|12-month Follow-up|Other|3|||
157170882|NCT01056341|567367229|FG003|Overall Study|Lack of Efficacy|25|||
157037877|NCT04980300|566893635|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
157037878|NCT04980300|566893636|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
157037879|NCT04980300|566893635|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
157037880|NCT04980300|566893636|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
157037881|NCT04980300|566893635|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
157170883|NCT01056341|567367230|FG004|Overall Study|Lack of Efficacy|9|||
157037882|NCT04980300|566893636|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
157037883|NCT04980300|566893635|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
157037884|NCT04980300|566893636|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
157037885|NCT00536120|566894276|FG000|Overall Study|Lost to Follow-up|1|||
157037886|NCT00536120|566894277|FG001|Overall Study|Lost to Follow-up|0|||
157037887|NCT00536120|566894276|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
157037888|NCT00536120|566894277|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
157037889|NCT00536120|566894276|FG000|Overall Study|Non-compliance|1|||
157037890|NCT00536120|566894277|FG001|Overall Study|Non-compliance|0|||
157037891|NCT00536120|566894276|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
157037892|NCT00536120|566894277|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
157037893|NCT00536120|566894276|FG000|Overall Study|Steroid Use|0|||
157037894|NCT00536120|566894277|FG001|Overall Study|Steroid Use|2|||
157037895|NCT00536120|566894276|FG000|Overall Study|Missed Study Visit|0|||
157037896|NCT00536120|566894277|FG001|Overall Study|Missed Study Visit|1|||
157037897|NCT04989816|566894278|FG000|Overall Study|Death|77|||
157037898|NCT04989816|566894278|FG000|Overall Study|Lost to Follow-up|3|||
157037899|NCT01184326|566894282|FG000|Overall Study|Adverse Event|1|||
157037900|NCT01184326|566894283|FG001|Overall Study|Adverse Event|2|||
157037901|NCT01184326|566894284|FG002|Overall Study|Adverse Event|0|||
157037902|NCT01184326|566894282|FG000|Overall Study|Death|0|||
157037903|NCT01184326|566894283|FG001|Overall Study|Death|0|||
157037904|NCT01184326|566894284|FG002|Overall Study|Death|1|||
157037905|NCT01184326|566894282|FG000|Overall Study|Withdrawal by Subject|0|||
157037906|NCT01184326|566894283|FG001|Overall Study|Withdrawal by Subject|0|||
157037907|NCT01184326|566894284|FG002|Overall Study|Withdrawal by Subject|1|||
157037908|NCT01184326|566894282|FG000|Overall Study|Physician Decision|1|||
157037909|NCT01184326|566894283|FG001|Overall Study|Physician Decision|1|||
157037910|NCT01184326|566894284|FG002|Overall Study|Physician Decision|0|||
157037911|NCT01184326|566894282|FG000|Overall Study|Disease Progression|1|||
157037912|NCT01184326|566894283|FG001|Overall Study|Disease Progression|3|||
157037913|NCT01184326|566894284|FG002|Overall Study|Disease Progression|12|||
157037914|NCT01084694|566894285|FG000|Overall Study|Withdrawal by Subject|2|||
157037915|NCT01084694|566894286|FG001|Overall Study|Withdrawal by Subject|1|||
157037916|NCT01084694|566894285|FG000|Overall Study|Death|2|||
157037917|NCT01084694|566894286|FG001|Overall Study|Death|12|||
157037918|NCT01084694|566894285|FG000|Overall Study|eligibility not maintained|2|||
157037919|NCT01084694|566894286|FG001|Overall Study|eligibility not maintained|7|||
157037920|NCT04017611|566894292|FG000|Overall Study|Withdrawn prior to completion|1|||
157037921|NCT00777049|566894303|FG000|Overall Study|Withdrawal by Subject|1|||
157037922|NCT00777049|566894304|FG001|Overall Study|Withdrawal by Subject|0|||
157037923|NCT00777049|566894303|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
157037924|NCT00777049|566894304|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
157037925|NCT00609869|566894305|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
157037926|NCT00609869|566894305|FG000|Overall Study|Severe hematologic toxicity|1|||
157037927|NCT00609869|566894305|FG000|Overall Study|Withdrawal by Subject|1|||
157037928|NCT00609869|566894305|FG000|Overall Study|Seizures|1|||
157037929|NCT00609869|566894305|FG000|Overall Study|Severe tumor flare reaction|1|||
157037930|NCT00609869|566894305|FG000|Overall Study|Hepatitis B infection|1|||
157037931|NCT00609869|566894305|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
157037932|NCT00609869|566894305|FG000|Overall Study|Mantle cell: not evaluable|4|||
157037933|NCT03478969|566894306|FG000|Overall Study|Withdrawal by Subject|4|||
157037934|NCT03478969|566894307|FG001|Overall Study|Withdrawal by Subject|7|||
157037935|NCT03478969|566894308|FG002|Overall Study|Withdrawal by Subject|6|||
157037936|NCT03478969|566894306|FG000|Overall Study|Adverse Event|2|||
157037937|NCT03478969|566894307|FG001|Overall Study|Adverse Event|0|||
157037938|NCT03478969|566894308|FG002|Overall Study|Adverse Event|1|||
157037939|NCT03478969|566894306|FG000|Overall Study|Pregnancy|1|||
157037940|NCT03478969|566894307|FG001|Overall Study|Pregnancy|0|||
157037941|NCT03478969|566894308|FG002|Overall Study|Pregnancy|0|||
157037942|NCT03478969|566894306|FG000|Overall Study|Personal Reasons|1|||
157037943|NCT03478969|566894307|FG001|Overall Study|Personal Reasons|0|||
157037944|NCT03478969|566894308|FG002|Overall Study|Personal Reasons|1|||
157037945|NCT03478969|566894306|FG000|Overall Study|Covid-19|1|||
157037946|NCT03478969|566894307|FG001|Overall Study|Covid-19|4|||
157037947|NCT03478969|566894308|FG002|Overall Study|Covid-19|3|||
157037948|NCT03478969|566894306|FG000|Overall Study|Multiple Reasons|0|||
157037949|NCT03478969|566894307|FG001|Overall Study|Multiple Reasons|1|||
157037950|NCT03478969|566894308|FG002|Overall Study|Multiple Reasons|1|||
157037951|NCT03478969|566894306|FG000|Overall Study|Eligibility Criteria|0|||
157037952|NCT03478969|566894307|FG001|Overall Study|Eligibility Criteria|0|||
157037953|NCT03478969|566894308|FG002|Overall Study|Eligibility Criteria|5|||
157037954|NCT03478969|566894306|FG000|Overall Study|Lost to Follow-up|0|||
157037955|NCT03478969|566894307|FG001|Overall Study|Lost to Follow-up|0|||
157037956|NCT03478969|566894308|FG002|Overall Study|Lost to Follow-up|1|||
157037957|NCT01436175|566894309|FG000|Overall Study|Adverse Event|111|||
157037958|NCT01436175|566894309|FG000|Overall Study|Protocol Violation|49|||
157037959|NCT01436175|566894309|FG000|Overall Study|Withdrawal by Subject|108|||
157037960|NCT01436175|566894309|FG000|Overall Study|Lost to Follow-up|89|||
157170884|NCT01056341|567367226|FG000|Overall Study|Other reasons|4|||
157170885|NCT01056341|567367227|FG001|Overall Study|Other reasons|4|||
157170886|NCT01056341|567367228|FG002|Overall Study|Other reasons|8|||
157170887|NCT01056341|567367229|FG003|Overall Study|Other reasons|9|||
157170888|NCT01056341|567367230|FG004|Overall Study|Other reasons|5|||
157170889|NCT03454412|567367231|FG000|Baseline Assesment|Physician Decision|12|||
157037961|NCT01436175|566894309|FG000|Overall Study|Lack of Efficacy|24|||
157037962|NCT01436175|566894309|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
157037963|NCT01436175|566894309|FG000|Overall Study|Other|826|||
157037964|NCT03066609|566894312|FG000|INDUCTION|Pregnancy|0|||
157037965|NCT03066609|566894313|FG001|INDUCTION|Pregnancy|0|||
157037966|NCT03066609|566894314|FG002|INDUCTION|Pregnancy|1|||
157037967|NCT03066609|566894315|FG003|INDUCTION|Pregnancy|0|||
157037968|NCT03066609|566894312|FG000|INDUCTION|Lack of Efficacy|0|||
157037969|NCT03066609|566894313|FG001|INDUCTION|Lack of Efficacy|0|||
157037970|NCT03066609|566894314|FG002|INDUCTION|Lack of Efficacy|1|||
157037971|NCT03066609|566894315|FG003|INDUCTION|Lack of Efficacy|0|||
157037972|NCT03066609|566894312|FG000|INDUCTION|Adverse Event|2|||
157037973|NCT03066609|566894313|FG001|INDUCTION|Adverse Event|2|||
157037974|NCT03066609|566894314|FG002|INDUCTION|Adverse Event|0|||
157037975|NCT03066609|566894315|FG003|INDUCTION|Adverse Event|0|||
157037976|NCT03066609|566894312|FG000|MAINTENANCE|Adverse Event|0|||
157037977|NCT03066609|566894313|FG001|MAINTENANCE|Adverse Event|0|||
157037978|NCT03066609|566894314|FG002|MAINTENANCE|Adverse Event|0|||
157037979|NCT03066609|566894315|FG003|MAINTENANCE|Adverse Event|1|||
157037980|NCT03066609|566894312|FG000|MAINTENANCE|Withdrawal by Subject|4|||
157037981|NCT03066609|566894313|FG001|MAINTENANCE|Withdrawal by Subject|2|||
157037982|NCT03066609|566894314|FG002|MAINTENANCE|Withdrawal by Subject|1|||
157037983|NCT03066609|566894315|FG003|MAINTENANCE|Withdrawal by Subject|1|||
157037984|NCT03066609|566894312|FG000|MAINTENANCE|Lost to Follow-up|0|||
157037985|NCT03066609|566894313|FG001|MAINTENANCE|Lost to Follow-up|1|||
157037986|NCT03066609|566894314|FG002|MAINTENANCE|Lost to Follow-up|1|||
157037987|NCT03066609|566894315|FG003|MAINTENANCE|Lost to Follow-up|0|||
157037988|NCT03066609|566894312|FG000|MAINTENANCE|Pregnancy|1|||
157037989|NCT03066609|566894313|FG001|MAINTENANCE|Pregnancy|0|||
157037990|NCT03066609|566894314|FG002|MAINTENANCE|Pregnancy|0|||
157037991|NCT03066609|566894315|FG003|MAINTENANCE|Pregnancy|0|||
157037992|NCT03066609|566894312|FG000|MAINTENANCE|Lack of Efficacy|2|||
157037993|NCT03066609|566894313|FG001|MAINTENANCE|Lack of Efficacy|1|||
157037994|NCT03066609|566894314|FG002|MAINTENANCE|Lack of Efficacy|0|||
157037995|NCT03066609|566894315|FG003|MAINTENANCE|Lack of Efficacy|1|||
157037996|NCT03066609|566894312|FG000|OVERALL STUDY|Adverse Event|2|||
157037997|NCT03066609|566894313|FG001|OVERALL STUDY|Adverse Event|2|||
157037998|NCT03066609|566894314|FG002|OVERALL STUDY|Adverse Event|0|||
157037999|NCT03066609|566894315|FG003|OVERALL STUDY|Adverse Event|1|||
157038000|NCT03066609|566894312|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
157038001|NCT03066609|566894313|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
157038002|NCT03066609|566894314|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
157038003|NCT03066609|566894315|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
157038004|NCT03066609|566894312|FG000|OVERALL STUDY|Lost to Follow-up|1|||
157038005|NCT03066609|566894313|FG001|OVERALL STUDY|Lost to Follow-up|1|||
157038006|NCT03066609|566894314|FG002|OVERALL STUDY|Lost to Follow-up|1|||
157038007|NCT03066609|566894315|FG003|OVERALL STUDY|Lost to Follow-up|1|||
157038008|NCT03066609|566894312|FG000|OVERALL STUDY|Pregnancy|1|||
157038009|NCT03066609|566894313|FG001|OVERALL STUDY|Pregnancy|0|||
157038010|NCT03066609|566894314|FG002|OVERALL STUDY|Pregnancy|1|||
157038011|NCT03066609|566894315|FG003|OVERALL STUDY|Pregnancy|0|||
157170890|NCT02227108|567367232|FG000|Overall Study|Did not receive treatment|2|||
157170891|NCT02227108|567367232|FG000|Overall Study|Other|3|||
157170892|NCT02227108|567367232|FG000|Overall Study|Progressive disease|17|||
157170893|NCT02227108|567367232|FG000|Overall Study|Initiation of alternative therapy|2|||
157170894|NCT02227108|567367232|FG000|Overall Study|Investigator discretion|1|||
157170895|NCT02227108|567367232|FG000|Overall Study|Adverse Event|6|||
157170896|NCT02486952|567367233|FG000|Overall Study|Not Started Induction Therapy|3|||
157170897|NCT02486952|567367233|FG000|Overall Study|Adverse Event|1|||
157170898|NCT02486952|567367233|FG000|Overall Study|Death|15|||
157170899|NCT02486952|567367233|FG000|Overall Study|Lack of Efficacy|3|||
157038012|NCT03066609|566894312|FG000|OVERALL STUDY|Lack of Efficacy|2|||
157038013|NCT03066609|566894313|FG001|OVERALL STUDY|Lack of Efficacy|1|||
157038014|NCT03066609|566894314|FG002|OVERALL STUDY|Lack of Efficacy|1|||
157038015|NCT03066609|566894315|FG003|OVERALL STUDY|Lack of Efficacy|1|||
157038016|NCT03066609|566894312|FG000|OVERALL STUDY|discontinued follow up|0|||
157038017|NCT03066609|566894313|FG001|OVERALL STUDY|discontinued follow up|2|||
157170900|NCT02486952|567367233|FG000|Overall Study|Lost to Follow-up|26|||
157038018|NCT03066609|566894314|FG002|OVERALL STUDY|discontinued follow up|0|||
157038019|NCT03066609|566894315|FG003|OVERALL STUDY|discontinued follow up|0|||
157038020|NCT03885232|566894316|FG000|Overall Study|Lost to Follow-up|74|||
157038021|NCT03885232|566894317|FG001|Overall Study|Lost to Follow-up|32|||
157038022|NCT03885232|566894316|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
157038023|NCT03885232|566894317|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
157170901|NCT02486952|567367233|FG000|Overall Study|Other|2|||
156960550|NCT02834780|566606622|FG005|Overall Study|Other|0|||
156960551|NCT02834780|566606623|FG006|Overall Study|Other|0|||
156960552|NCT02834780|566606624|FG007|Overall Study|Other|0|||
156960553|NCT02834780|566606625|FG008|Overall Study|Other|0|||
156960554|NCT02834780|566606626|FG009|Overall Study|Other|0|||
156960555|NCT02834780|566606627|FG010|Overall Study|Other|0|||
156960556|NCT02834780|566606628|FG011|Overall Study|Other|0|||
156960557|NCT02834780|566606629|FG012|Overall Study|Other|1|||
156960558|NCT03150056|566606630|FG000|Overall Study|Withdrawal by Subject|0|||
156960559|NCT03150056|566606631|FG001|Overall Study|Withdrawal by Subject|0|||
156960560|NCT03150056|566606632|FG002|Overall Study|Withdrawal by Subject|0|||
156960561|NCT03150056|566606633|FG003|Overall Study|Withdrawal by Subject|0|||
156960562|NCT03150056|566606634|FG004|Overall Study|Withdrawal by Subject|0|||
156960563|NCT03150056|566606635|FG005|Overall Study|Withdrawal by Subject|2|||
156960564|NCT03150056|566606630|FG000|Overall Study|Study terminated by Sponsor|1|||
156960565|NCT03150056|566606631|FG001|Overall Study|Study terminated by Sponsor|3|||
156960566|NCT03150056|566606632|FG002|Overall Study|Study terminated by Sponsor|1|||
156960567|NCT03150056|566606633|FG003|Overall Study|Study terminated by Sponsor|1|||
156960568|NCT03150056|566606634|FG004|Overall Study|Study terminated by Sponsor|5|||
156960569|NCT03150056|566606635|FG005|Overall Study|Study terminated by Sponsor|6|||
156960570|NCT03150056|566606630|FG000|Overall Study|Death|9|||
156960571|NCT03150056|566606631|FG001|Overall Study|Death|2|||
156960572|NCT03150056|566606632|FG002|Overall Study|Death|2|||
156960573|NCT03150056|566606633|FG003|Overall Study|Death|7|||
156960574|NCT03150056|566606634|FG004|Overall Study|Death|8|||
156960575|NCT03150056|566606635|FG005|Overall Study|Death|10|||
156960576|NCT00700401|566606636|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
156960577|NCT00700401|566606636|FG000|Overall Study|Adverse Event|5|||
156960578|NCT00700401|566606636|FG000|Overall Study|Refused Treatment|2|||
156960579|NCT00700401|566606636|FG000|Overall Study|Lost to Follow-up|1|||
156960580|NCT00700401|566606636|FG000|Overall Study|Treatment never started|1|||
156960581|NCT00700401|566606636|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
156960582|NCT00700401|566606636|FG000|Overall Study|Withdrawal by Subject|2|||
156960583|NCT02491671|566606637|FG000|Overall Study|Adverse Event|6|||
156960584|NCT02491671|566606638|FG001|Overall Study|Adverse Event|8|||
156960585|NCT02491671|566606637|FG000|Overall Study|Death|0|||
156960586|NCT02491671|566606638|FG001|Overall Study|Death|2|||
156960587|NCT02491671|566606637|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
156960588|NCT02491671|566606638|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
156960589|NCT02251990|566606642|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
156960590|NCT02251990|566606643|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
156960591|NCT02251990|566606642|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
156960592|NCT02251990|566606643|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
156960593|NCT02251990|566606642|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
156960594|NCT02251990|566606643|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
156960595|NCT02251990|566606642|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
156960596|NCT02251990|566606643|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
156960597|NCT02251990|566606642|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
156960598|NCT02251990|566606643|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
156960599|NCT02251990|566606642|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
156960600|NCT02251990|566606643|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
156960601|NCT03265600|566606644|FG000|Overall Study|Lost to Follow-up|17|||
156960602|NCT03265600|566606645|FG001|Overall Study|Lost to Follow-up|5|||
156960603|NCT03265600|566606644|FG000|Overall Study|Withdrawal by Subject|4|||
156960604|NCT03265600|566606645|FG001|Overall Study|Withdrawal by Subject|2|||
156960605|NCT03265600|566606644|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
156960606|NCT03265600|566606645|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
156960607|NCT00535730|566606646|FG000|Overall Study|Adverse Event|1|||
156960608|NCT00535730|566606647|FG001|Overall Study|Adverse Event|1|||
156960609|NCT00535730|566606646|FG000|Overall Study|Lost to Follow-up|0|||
156960610|NCT00535730|566606647|FG001|Overall Study|Lost to Follow-up|1|||
156960611|NCT00535730|566606646|FG000|Overall Study|Physician Decision|0|||
156960612|NCT00535730|566606647|FG001|Overall Study|Physician Decision|1|||
156960613|NCT00535730|566606646|FG000|Overall Study|Protocol Violation|1|||
156960614|NCT00535730|566606647|FG001|Overall Study|Protocol Violation|0|||
156960615|NCT00535730|566606646|FG000|Overall Study|Withdrawal by Subject|0|||
156960616|NCT00535730|566606647|FG001|Overall Study|Withdrawal by Subject|4|||
156960617|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
156960618|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
156960619|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
156960620|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
156960621|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
156960622|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156960623|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
156960624|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
157038024|NCT02397096|566894318|FG000|Day 1 to Week 24|Adverse Event|7|||
157170902|NCT01928485|567367234|FG000|Overall Study|Physician Decision|0|||
157170903|NCT01928485|567367235|FG001|Overall Study|Physician Decision|1|||
157170904|NCT03589885|567367236|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
157170905|NCT03589885|567367237|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
157170906|NCT03589885|567367238|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
157170907|NCT03589885|567367239|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
157170908|NCT03589885|567367240|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
157170909|NCT03589885|567367236|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
157170910|NCT03589885|567367237|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
157170911|NCT03589885|567367238|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
157170912|NCT03589885|567367239|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
157170913|NCT03589885|567367240|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
157170914|NCT03589885|567367236|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
157170915|NCT03589885|567367237|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
157170916|NCT03589885|567367238|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
157170917|NCT03589885|567367239|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
157170918|NCT03589885|567367240|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
157170919|NCT03589885|567367236|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
157170920|NCT03589885|567367237|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
157170921|NCT03589885|567367238|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
157170922|NCT03589885|567367239|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
157170923|NCT03589885|567367240|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
157170924|NCT03589885|567367236|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
157170925|NCT03589885|567367237|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
157170926|NCT03589885|567367238|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
157170927|NCT03589885|567367239|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
157170928|NCT03589885|567367240|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
157170929|NCT03589885|567367236|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
157170930|NCT03589885|567367237|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
157170931|NCT03589885|567367238|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
157170932|NCT03589885|567367239|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
157170933|NCT03589885|567367240|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
157170934|NCT03589885|567367236|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
157170935|NCT03589885|567367237|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
157170936|NCT03589885|567367238|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
157170937|NCT03589885|567367239|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
157170938|NCT03589885|567367240|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
157170939|NCT03589885|567367236|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
157170940|NCT03589885|567367237|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
157170941|NCT03589885|567367238|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
157170942|NCT03589885|567367239|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
157170943|NCT03589885|567367240|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
157170944|NCT04111107|567367241|FG000|Overall Study|Withdrawal by Subject|6|||
157170945|NCT04111107|567367241|FG000|Overall Study|Declining Health|5|||
157170946|NCT01714817|567367242|FG000|Year 1 Period|Lack of Efficacy|11|||
157170947|NCT01714817|567367243|FG001|Year 1 Period|Lack of Efficacy|9|||
157170948|NCT01714817|567367242|FG000|Year 1 Period|Adverse Event|20|||
157170949|NCT01714817|567367243|FG001|Year 1 Period|Adverse Event|17|||
157170950|NCT01714817|567367242|FG000|Year 1 Period|Withdrawal by Subject|6|||
157170951|NCT01714817|567367243|FG001|Year 1 Period|Withdrawal by Subject|7|||
157170952|NCT01714817|567367242|FG000|Year 1 Period|Death|1|||
157170953|NCT01714817|567367243|FG001|Year 1 Period|Death|1|||
157170954|NCT01714817|567367242|FG000|Year 1 Period|Lost to Follow-up|0|||
157170955|NCT01714817|567367243|FG001|Year 1 Period|Lost to Follow-up|2|||
157170956|NCT01714817|567367242|FG000|Year 1 Period|Poor / non-compliance|0|||
157170957|NCT01714817|567367243|FG001|Year 1 Period|Poor / non-compliance|1|||
157170958|NCT01714817|567367242|FG000|Year 1 Period|Pregnancy|2|||
157170959|NCT01714817|567367243|FG001|Year 1 Period|Pregnancy|0|||
157170960|NCT01714817|567367242|FG000|Year 1 Period|Participant no longer meets criteria|6|||
157170961|NCT01714817|567367243|FG001|Year 1 Period|Participant no longer meets criteria|2|||
157170962|NCT01714817|567367242|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
157227789|NCT01139164|567579203|FG001|Overall Study|Withdrawn prior to study start|2|||
157227790|NCT01139164|567579204|FG002|Overall Study|Withdrawn prior to study start|0|||
156960625|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156960626|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
156960627|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
156960628|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
156960629|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
156960630|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
156960631|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
157038025|NCT02397096|566894319|FG001|Day 1 to Week 24|Adverse Event|1|||
157038026|NCT02397096|566894318|FG000|Day 1 to Week 24|Death|1|||
157038027|NCT02397096|566894319|FG001|Day 1 to Week 24|Death|0|||
157038028|NCT02397096|566894318|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
157038029|NCT02397096|566894319|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
157038030|NCT02397096|566894318|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
157038031|NCT02397096|566894319|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
157038032|NCT02397096|566894318|FG000|Day 1 to Week 24|Physician Decision|2|||
157038033|NCT02397096|566894319|FG001|Day 1 to Week 24|Physician Decision|3|||
157038034|NCT02397096|566894318|FG000|Day 1 to Week 24|Protocol Violation|1|||
157038035|NCT02397096|566894319|FG001|Day 1 to Week 24|Protocol Violation|4|||
157038036|NCT02397096|566894318|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
157038037|NCT02397096|566894319|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
157038038|NCT02397096|566894318|FG000|Day 1 to Week 24|Randomized, not treated|3|||
157038039|NCT02397096|566894319|FG001|Day 1 to Week 24|Randomized, not treated|0|||
157038040|NCT02397096|566894318|FG000|Week 24 to Week 48|Adverse Event|6|||
157170963|NCT01714817|567367243|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
157170964|NCT01714817|567367242|FG000|Year 1 Period|Change in Concomitant Medication|0|||
157170965|NCT01714817|567367243|FG001|Year 1 Period|Change in Concomitant Medication|1|||
157038041|NCT02397096|566894319|FG001|Week 24 to Week 48|Adverse Event|2|||
157038042|NCT02397096|566894318|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
157038043|NCT02397096|566894319|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
157038044|NCT02397096|566894318|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
157038045|NCT02397096|566894319|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
157038046|NCT02397096|566894318|FG000|Week 24 to Week 48|Physician Decision|2|||
157038047|NCT02397096|566894319|FG001|Week 24 to Week 48|Physician Decision|1|||
157038048|NCT02397096|566894318|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
157038049|NCT02397096|566894319|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
157038050|NCT02397096|566894318|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
157038051|NCT02397096|566894319|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
157038052|NCT02397096|566894318|FG000|Study Extension 1|Adverse Event|7|||
157038053|NCT02397096|566894319|FG001|Study Extension 1|Adverse Event|5|||
157038054|NCT02397096|566894318|FG000|Study Extension 1|Death|1|||
157038055|NCT02397096|566894319|FG001|Study Extension 1|Death|0|||
157038056|NCT02397096|566894318|FG000|Study Extension 1|Lack of Efficacy|2|||
157038057|NCT02397096|566894319|FG001|Study Extension 1|Lack of Efficacy|5|||
157038058|NCT02397096|566894318|FG000|Study Extension 1|Lost to Follow-up|2|||
157038059|NCT02397096|566894319|FG001|Study Extension 1|Lost to Follow-up|3|||
157038060|NCT02397096|566894318|FG000|Study Extension 1|Non-compliance with study drug|3|||
157038061|NCT02397096|566894319|FG001|Study Extension 1|Non-compliance with study drug|0|||
157038062|NCT02397096|566894318|FG000|Study Extension 1|Physician Decision|4|||
157038063|NCT02397096|566894319|FG001|Study Extension 1|Physician Decision|2|||
157038064|NCT02397096|566894318|FG000|Study Extension 1|Pregnancy|1|||
157038065|NCT02397096|566894319|FG001|Study Extension 1|Pregnancy|0|||
157038066|NCT02397096|566894318|FG000|Study Extension 1|Protocol Violation|0|||
157038067|NCT02397096|566894319|FG001|Study Extension 1|Protocol Violation|1|||
157038068|NCT02397096|566894318|FG000|Study Extension 1|Withdrawal by Subject|21|||
157038069|NCT02397096|566894319|FG001|Study Extension 1|Withdrawal by Subject|7|||
157038070|NCT02397096|566894318|FG000|Study Extension 2|Adverse Event|3|||
157038071|NCT02397096|566894319|FG001|Study Extension 2|Adverse Event|3|||
157038072|NCT02397096|566894318|FG000|Study Extension 2|Availability of study medication locally|152|||
157038073|NCT02397096|566894319|FG001|Study Extension 2|Availability of study medication locally|64|||
157038074|NCT02397096|566894318|FG000|Study Extension 2|Death|2|||
157038075|NCT02397096|566894319|FG001|Study Extension 2|Death|0|||
157038076|NCT02397096|566894318|FG000|Study Extension 2|Lack of Efficacy|1|||
157038077|NCT02397096|566894319|FG001|Study Extension 2|Lack of Efficacy|0|||
157038078|NCT02397096|566894318|FG000|Study Extension 2|Lost to Follow-up|2|||
157038079|NCT02397096|566894319|FG001|Study Extension 2|Lost to Follow-up|1|||
157170966|NCT01714817|567367242|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
157170967|NCT01714817|567367243|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
157170968|NCT01714817|567367242|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
157170969|NCT01714817|567367243|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
157038080|NCT02397096|566894318|FG000|Study Extension 2|Non-compliance with study drug|1|||
157038081|NCT02397096|566894319|FG001|Study Extension 2|Non-compliance with study drug|0|||
157038082|NCT02397096|566894318|FG000|Study Extension 2|Physician Decision|2|||
157038083|NCT02397096|566894319|FG001|Study Extension 2|Physician Decision|5|||
157038084|NCT02397096|566894318|FG000|Study Extension 2|Pregnancy|1|||
157038085|NCT02397096|566894319|FG001|Study Extension 2|Pregnancy|0|||
157038086|NCT02397096|566894318|FG000|Study Extension 2|Withdrawal by Subject|10|||
157038087|NCT02397096|566894319|FG001|Study Extension 2|Withdrawal by Subject|3|||
157038088|NCT02397096|566894318|FG000|Study Extension 3|Adverse Event|1|||
157038089|NCT02397096|566894319|FG001|Study Extension 3|Adverse Event|0|||
157170970|NCT01714817|567367242|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
157170971|NCT01714817|567367243|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
157038090|NCT02397096|566894318|FG000|Study Extension 3|Availability of study medication locally|11|||
157038091|NCT02397096|566894319|FG001|Study Extension 3|Availability of study medication locally|3|||
157038092|NCT02397096|566894318|FG000|Study Extension 3|Lost to Follow-up|1|||
157038093|NCT02397096|566894319|FG001|Study Extension 3|Lost to Follow-up|0|||
157038094|NCT02397096|566894318|FG000|Study Extension 3|Withdrawal by Subject|2|||
157038095|NCT02397096|566894319|FG001|Study Extension 3|Withdrawal by Subject|1|||
157038096|NCT01371994|566894320|FG000|Overall Study|Adverse Event|3|||
157038097|NCT01371994|566894321|FG001|Overall Study|Adverse Event|6|||
157038098|NCT01371994|566894320|FG000|Overall Study|Lack of Efficacy|3|||
157038099|NCT01371994|566894321|FG001|Overall Study|Lack of Efficacy|0|||
157038100|NCT01371994|566894320|FG000|Overall Study|Withdrawal by Subject|13|||
157038101|NCT01371994|566894321|FG001|Overall Study|Withdrawal by Subject|7|||
157038102|NCT01371994|566894320|FG000|Overall Study|Lost to Follow-up|1|||
157038103|NCT01371994|566894321|FG001|Overall Study|Lost to Follow-up|1|||
157038104|NCT01371994|566894320|FG000|Overall Study|Protocol Violation|24|||
157038105|NCT01371994|566894321|FG001|Overall Study|Protocol Violation|17|||
157038106|NCT01371994|566894320|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
157038107|NCT01371994|566894321|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
157038108|NCT01371994|566894320|FG000|Overall Study|Physician Decision|1|||
157038109|NCT01371994|566894321|FG001|Overall Study|Physician Decision|1|||
157038110|NCT01371994|566894320|FG000|Overall Study|Miscellaneous Reasons|6|||
157038111|NCT01371994|566894321|FG001|Overall Study|Miscellaneous Reasons|4|||
157038112|NCT00087685|566894322|FG000|Overall Study|Adverse Event|5|||
157038113|NCT00087685|566894322|FG000|Overall Study|Non-Compliance|1|||
157038114|NCT00087685|566894322|FG000|Overall Study|Progressive Disease|5|||
157038115|NCT00087685|566894322|FG000|Overall Study|Withdrawal by Subject|3|||
157038116|NCT05139992|566894323|FG000|Overall Study|Withdrawal by Subject|12|||
157170972|NCT01714817|567367242|FG000|Year 2 Period|Lack of Efficacy|4|||
157170973|NCT01714817|567367243|FG001|Year 2 Period|Lack of Efficacy|12|||
157170974|NCT01714817|567367242|FG000|Year 2 Period|Adverse Event|7|||
157170975|NCT01714817|567367243|FG001|Year 2 Period|Adverse Event|6|||
157170976|NCT01714817|567367242|FG000|Year 2 Period|Participant request to stop treatment|4|||
157170977|NCT01714817|567367243|FG001|Year 2 Period|Participant request to stop treatment|4|||
157170978|NCT01714817|567367242|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
157170979|NCT01714817|567367243|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
157170980|NCT01714817|567367242|FG000|Year 2 Period|Participant withdrew consent|1|||
157170981|NCT01714817|567367243|FG001|Year 2 Period|Participant withdrew consent|5|||
157170982|NCT01714817|567367242|FG000|Year 2 Period|Participant no longer meets criteria|1|||
157170983|NCT01714817|567367243|FG001|Year 2 Period|Participant no longer meets criteria|4|||
157170984|NCT01714817|567367242|FG000|Year 2 Period|Lost to Follow-up|2|||
157170985|NCT01714817|567367243|FG001|Year 2 Period|Lost to Follow-up|0|||
157170986|NCT01714817|567367242|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
157170987|NCT01714817|567367243|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
157170988|NCT01714817|567367242|FG000|Year 2 Period|Pregnancy|1|||
157170989|NCT01714817|567367243|FG001|Year 2 Period|Pregnancy|1|||
157170990|NCT01714817|567367242|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
157170991|NCT01714817|567367243|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
157170992|NCT01714817|567367242|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
157170993|NCT01714817|567367243|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
157170994|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
157170995|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
157170996|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
157170997|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
157170998|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
157170999|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
157171000|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
157171001|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
157171002|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
157171003|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
157171004|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
157171005|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
157171006|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157171007|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
157038117|NCT05139992|566894323|FG000|Overall Study|Lost to Follow-up|6|||
157038118|NCT05521516|566894324|FG000|Overall Study|Withdrawal by Subject|1|||
157171008|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
157171009|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
157171010|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
157038119|NCT05521516|566894325|FG001|Overall Study|Withdrawal by Subject|1|||
157038120|NCT04882917|566894328|FG000|Overall Study|Adverse Event|0|||
157038121|NCT04882917|566894329|FG001|Overall Study|Adverse Event|1|||
157038122|NCT04882917|566894330|FG002|Overall Study|Adverse Event|2|||
157171011|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
157171012|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
157171013|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
157171014|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
157171015|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
157171016|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
156960632|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156960633|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156960634|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
156960635|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156960636|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
156960637|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156960638|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156960639|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
156960640|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156960641|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
156960642|NCT03152552|566606649|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156960643|NCT03152552|566606650|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156960644|NCT03152552|566606651|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156960645|NCT03152552|566606652|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
156960646|NCT03152552|566606653|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
156960647|NCT03152552|566606649|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
156960648|NCT03152552|566606650|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
156960649|NCT03152552|566606651|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
156960650|NCT03152552|566606652|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
156960651|NCT03152552|566606653|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
156960652|NCT01857531|566606660|FG000|Overall Study|Withdrawal by Subject|4|||
156960653|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
156960654|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
156960655|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
156960656|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
156960657|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
156960658|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
156960659|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
156960660|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
156960661|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
156960662|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
156960663|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
156960664|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
156960665|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
156960666|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
156960667|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
156960668|NCT00355082|566606661|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
156960669|NCT00355082|566606662|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
156960670|NCT00355082|566606663|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
156960671|NCT00355082|566606661|FG000|Continuation Phase|Adverse Event|2|||
156960672|NCT00355082|566606662|FG001|Continuation Phase|Adverse Event|0|||
156960673|NCT00355082|566606663|FG002|Continuation Phase|Adverse Event|1|||
156960674|NCT00355082|566606661|FG000|Continuation Phase|Lost to Follow-up|2|||
156960675|NCT00355082|566606662|FG001|Continuation Phase|Lost to Follow-up|0|||
156960676|NCT00355082|566606663|FG002|Continuation Phase|Lost to Follow-up|1|||
156960677|NCT00355082|566606661|FG000|Continuation Phase|Protocol Violation|1|||
156960678|NCT00355082|566606662|FG001|Continuation Phase|Protocol Violation|0|||
156960679|NCT00355082|566606663|FG002|Continuation Phase|Protocol Violation|1|||
156960680|NCT00355082|566606661|FG000|Continuation Phase|Withdrawal by Subject|4|||
156960681|NCT00355082|566606662|FG001|Continuation Phase|Withdrawal by Subject|0|||
156960682|NCT00355082|566606663|FG002|Continuation Phase|Withdrawal by Subject|0|||
156960683|NCT00355082|566606661|FG000|Continuation Phase|Lack of Efficacy|5|||
156960684|NCT00355082|566606662|FG001|Continuation Phase|Lack of Efficacy|0|||
156960685|NCT00355082|566606663|FG002|Continuation Phase|Lack of Efficacy|0|||
156960686|NCT00355082|566606661|FG000|Continuation Phase|Site Closed by Sponsor|8|||
156960687|NCT00355082|566606662|FG001|Continuation Phase|Site Closed by Sponsor|0|||
156960688|NCT00355082|566606663|FG002|Continuation Phase|Site Closed by Sponsor|0|||
156960689|NCT00355082|566606661|FG000|Continuation Phase|Scheduling Error|1|||
157038123|NCT04882917|566894331|FG003|Overall Study|Adverse Event|2|||
156960690|NCT00355082|566606662|FG001|Continuation Phase|Scheduling Error|0|||
156960691|NCT00355082|566606663|FG002|Continuation Phase|Scheduling Error|0|||
156960692|NCT00355082|566606661|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
156960693|NCT00355082|566606662|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
157171017|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
157171018|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
157171019|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
157171020|NCT01714817|567367242|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
157171021|NCT01714817|567367243|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
157171022|NCT01374217|567367244|FG000|Overall Study|Lack of Efficacy|13|||
157171023|NCT04169061|567367245|FG000|Overall Study|Adverse Event|2|||
157171024|NCT04169061|567367245|FG000|Overall Study|Death|1|||
157171025|NCT04169061|567367245|FG000|Overall Study|Withdrawal by Subject|1|||
157171026|NCT04169061|567367245|FG000|Overall Study|Protocol Violation|1|||
157171027|NCT02555657|567367248|FG000|Overall Study|Death|274|||
157171028|NCT02555657|567367249|FG001|Overall Study|Death|262|||
157171029|NCT02555657|567367248|FG000|Overall Study|Physician Decision|0|||
157171030|NCT02555657|567367249|FG001|Overall Study|Physician Decision|1|||
157171031|NCT02555657|567367248|FG000|Overall Study|Sponsor Decision|27|||
157171032|NCT02555657|567367249|FG001|Overall Study|Sponsor Decision|15|||
157171033|NCT02555657|567367248|FG000|Overall Study|Withdrawal by Subject|11|||
157171034|NCT02555657|567367249|FG001|Overall Study|Withdrawal by Subject|32|||
157171035|NCT02807363|567367250|FG000|Dosing Period|Adverse Event|0|||
157171036|NCT02807363|567367251|FG001|Dosing Period|Adverse Event|1|||
157171037|NCT02807363|567367252|FG002|Dosing Period|Adverse Event|0|||
157171038|NCT02807363|567367253|FG003|Dosing Period|Adverse Event|0|||
157171039|NCT02188719|567367254|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
157171040|NCT02188719|567367255|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
157171041|NCT02188719|567367256|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
157171042|NCT02188719|567367257|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
157171043|NCT00192036|567367261|FG000|Overall Study|Protocol Violation|3|||
157171044|NCT00192036|567367261|FG000|Overall Study|Adverse Event|6|||
157171045|NCT00192036|567367261|FG000|Overall Study|Patient/Physician Perception|1|||
157171046|NCT00192036|567367261|FG000|Overall Study|Objective Tumor Progression|4|||
157171047|NCT00192036|567367261|FG000|Overall Study|Clinical Disease Progression|1|||
157171048|NCT00192036|567367261|FG000|Overall Study|Death|1|||
157171049|NCT00192036|567367261|FG000|Overall Study|Unknown or Not Specified|5|||
157171050|NCT03371732|567367262|FG000|Overall Study|Withdrawal by Subject|9|||
157171051|NCT03371732|567367263|FG001|Overall Study|Withdrawal by Subject|3|||
157171052|NCT03371732|567367262|FG000|Overall Study|Refusal to continue|3|||
157171053|NCT03371732|567367263|FG001|Overall Study|Refusal to continue|4|||
157171054|NCT02133742|567367265|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
157171055|NCT02133742|567367265|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
157171056|NCT02133742|567367265|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
157171057|NCT02133742|567367265|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
157171058|NCT02133742|567367265|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
157171059|NCT03479216|567367266|FG000|Overall Study|Withdrawal by Subject|3|||
157171060|NCT03479216|567367267|FG001|Overall Study|Withdrawal by Subject|2|||
157171061|NCT03479216|567367266|FG000|Overall Study|Physician Decision|2|||
157171062|NCT03479216|567367267|FG001|Overall Study|Physician Decision|3|||
157171063|NCT03337139|567367274|FG000|Phase I|Withdrawal by Subject|10|||
157171064|NCT03337139|567367275|FG001|Phase I|Withdrawal by Subject|0|||
157171065|NCT01561560|567367282|FG000|First Two Weeks of Wear|Time/job conflict|0|||
157171066|NCT01561560|567367283|FG001|First Two Weeks of Wear|Time/job conflict|1|||
157171067|NCT01561560|567367282|FG000|First Two Weeks of Wear|Adverse Event|0|||
157171068|NCT01561560|567367283|FG001|First Two Weeks of Wear|Adverse Event|1|||
157171069|NCT01561560|567367282|FG000|Second Two Weeks of Wear|Adverse Event|0|||
157171070|NCT01561560|567367283|FG001|Second Two Weeks of Wear|Adverse Event|1|||
157171071|NCT03862131|567367284|FG000|Overall Study|Lost to Follow-up|1|||
157171072|NCT03862131|567367285|FG001|Overall Study|Lost to Follow-up|0|||
157171073|NCT03862131|567367286|FG002|Overall Study|Lost to Follow-up|1|||
157171074|NCT03862131|567367284|FG000|Overall Study|Determined to be ineligible|0|||
157171075|NCT03862131|567367285|FG001|Overall Study|Determined to be ineligible|0|||
157171076|NCT03862131|567367286|FG002|Overall Study|Determined to be ineligible|5|||
156960694|NCT00355082|566606663|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
156960695|NCT02576067|566606664|FG000|Overall Study|Death|0|||
157171077|NCT03862131|567367284|FG000|Overall Study|Death|4|||
157171078|NCT03862131|567367285|FG001|Overall Study|Death|4|||
157171079|NCT03862131|567367286|FG002|Overall Study|Death|0|||
157171080|NCT03862131|567367284|FG000|Overall Study|Withdrawal by Subject|5|||
157171081|NCT03862131|567367285|FG001|Overall Study|Withdrawal by Subject|3|||
157171082|NCT03862131|567367286|FG002|Overall Study|Withdrawal by Subject|0|||
157171083|NCT03862131|567367284|FG000|Overall Study|Physician Decision|0|||
157171084|NCT03862131|567367285|FG001|Overall Study|Physician Decision|1|||
156960696|NCT02576067|566606665|FG001|Overall Study|Death|1|||
157171085|NCT03862131|567367286|FG002|Overall Study|Physician Decision|0|||
157171086|NCT00093470|567369011|FG000|Overall Study|Disease progression|39|||
156960697|NCT02576067|566606664|FG000|Overall Study|Lack of Efficacy|1|||
157171087|NCT00093470|567369012|FG001|Overall Study|Disease progression|0|||
156960698|NCT02576067|566606665|FG001|Overall Study|Lack of Efficacy|0|||
156960699|NCT02576067|566606664|FG000|Overall Study|Lost to Follow-up|11|||
156960700|NCT02576067|566606665|FG001|Overall Study|Lost to Follow-up|0|||
156960701|NCT02576067|566606664|FG000|Overall Study|Withdrawal by Subject|11|||
156960702|NCT02576067|566606665|FG001|Overall Study|Withdrawal by Subject|2|||
156960703|NCT02576067|566606664|FG000|Overall Study|study closure of main CIRT trial)|0|||
156960704|NCT02576067|566606665|FG001|Overall Study|study closure of main CIRT trial)|8|||
156960705|NCT02576067|566606664|FG000|Overall Study|not randomized, failed run-in|7|||
156960706|NCT02576067|566606665|FG001|Overall Study|not randomized, failed run-in|0|||
156960707|NCT02576067|566606664|FG000|Overall Study|screen failure/ re-enrolled|0|||
156960708|NCT02576067|566606665|FG001|Overall Study|screen failure/ re-enrolled|25|||
157038124|NCT04882917|566894328|FG000|Overall Study|Withdrawal by Subject|1|||
157038125|NCT04882917|566894329|FG001|Overall Study|Withdrawal by Subject|0|||
157038126|NCT04882917|566894330|FG002|Overall Study|Withdrawal by Subject|2|||
157038127|NCT04882917|566894331|FG003|Overall Study|Withdrawal by Subject|1|||
157171088|NCT00093470|567369011|FG000|Overall Study|Adverse Event|15|||
157171089|NCT00093470|567369012|FG001|Overall Study|Adverse Event|0|||
157171090|NCT00093470|567369011|FG000|Overall Study|Death|2|||
157171091|NCT00093470|567369012|FG001|Overall Study|Death|0|||
157171092|NCT00093470|567369011|FG000|Overall Study|Withdrawal by Subject|8|||
157171093|NCT00093470|567369012|FG001|Overall Study|Withdrawal by Subject|0|||
157171094|NCT00093470|567369011|FG000|Overall Study|Alternative therapy|2|||
157171095|NCT00093470|567369012|FG001|Overall Study|Alternative therapy|0|||
157171096|NCT00093470|567369011|FG000|Overall Study|Other complicating disease|3|||
157171097|NCT00093470|567369012|FG001|Overall Study|Other complicating disease|0|||
157171098|NCT00093470|567369011|FG000|Overall Study|Physician Decision|2|||
157171099|NCT00093470|567369012|FG001|Overall Study|Physician Decision|0|||
157171100|NCT00093470|567369011|FG000|Overall Study|Never started treatment|1|||
157171101|NCT00093470|567369012|FG001|Overall Study|Never started treatment|0|||
157171102|NCT00093470|567369011|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
157171103|NCT00093470|567369012|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
157171104|NCT02514772|567369018|FG000|Overall Study|Adverse Event|1|||
157171105|NCT02514772|567369019|FG001|Overall Study|Adverse Event|0|||
157171106|NCT02514772|567369018|FG000|Overall Study|Death|0|||
157171107|NCT02514772|567369019|FG001|Overall Study|Death|1|||
157171108|NCT02514772|567369018|FG000|Overall Study|Withdrawal by Subject|2|||
157171109|NCT02514772|567369019|FG001|Overall Study|Withdrawal by Subject|1|||
157171110|NCT00877006|567369020|FG000|Treatment Period|Death|2|||
157171111|NCT00877006|567369021|FG001|Treatment Period|Death|1|||
157171112|NCT00877006|567369020|FG000|Treatment Period|Adverse Event|10|||
157171113|NCT00877006|567369021|FG001|Treatment Period|Adverse Event|3|||
157171114|NCT00877006|567369020|FG000|Treatment Period|Withdrawal by Subject|2|||
157171115|NCT00877006|567369021|FG001|Treatment Period|Withdrawal by Subject|3|||
157171116|NCT00877006|567369020|FG000|Treatment Period|Protocol Violation|1|||
157171117|NCT00877006|567369021|FG001|Treatment Period|Protocol Violation|0|||
157171118|NCT00877006|567369020|FG000|Treatment Period|Lost to Follow-up|0|||
157171119|NCT00877006|567369021|FG001|Treatment Period|Lost to Follow-up|1|||
157171120|NCT00877006|567369020|FG000|Treatment Period|Disease Progression|1|||
157171121|NCT00877006|567369021|FG001|Treatment Period|Disease Progression|2|||
157171122|NCT00877006|567369020|FG000|Treatment Period|Started New Treatment Regimen|2|||
157171123|NCT00877006|567369021|FG001|Treatment Period|Started New Treatment Regimen|5|||
157171124|NCT00877006|567369020|FG000|Treatment Period|Other|4|||
157171125|NCT00877006|567369021|FG001|Treatment Period|Other|4|||
157171126|NCT00877006|567369020|FG000|Treatment Period|Randomized but Not Treated|3|||
157171127|NCT00877006|567369021|FG001|Treatment Period|Randomized but Not Treated|8|||
157171128|NCT00877006|567369020|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
157171129|NCT00877006|567369021|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
157171130|NCT00877006|567369020|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
157171131|NCT00877006|567369021|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
157171132|NCT00877006|567369020|FG000|Long-Term Follow-up Period|Death|26|||
157171133|NCT00877006|567369021|FG001|Long-Term Follow-up Period|Death|18|||
157171134|NCT00877006|567369020|FG000|Long-Term Follow-up Period|Other|7|||
157171135|NCT00877006|567369021|FG001|Long-Term Follow-up Period|Other|9|||
157171136|NCT04671342|567369022|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
157171137|NCT04671342|567369022|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
157171138|NCT04671342|567369022|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
157171139|NCT04671342|567369022|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
157171140|NCT04671342|567369022|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
156960709|NCT02576067|566606664|FG000|Overall Study|Physician Decision|4|||
157171141|NCT04671342|567369022|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
157171142|NCT03583606|567369023|FG000|Overall Study|Lost to Follow-up|0|||
157171143|NCT03583606|567369024|FG001|Overall Study|Lost to Follow-up|1|||
156960710|NCT02576067|566606665|FG001|Overall Study|Physician Decision|0|||
156960711|NCT03570619|566606668|FG000|Overall Study|Adverse Event|2|||
156960712|NCT03570619|566606669|FG001|Overall Study|Adverse Event|0|||
156960713|NCT03570619|566606670|FG002|Overall Study|Adverse Event|1|||
156960714|NCT03570619|566606668|FG000|Overall Study|new diagnosis of new malignancy|1|||
156960715|NCT03570619|566606669|FG001|Overall Study|new diagnosis of new malignancy|0|||
156960716|NCT03570619|566606670|FG002|Overall Study|new diagnosis of new malignancy|0|||
156960717|NCT03570619|566606668|FG000|Overall Study|Physician Decision|1|||
156960718|NCT03570619|566606669|FG001|Overall Study|Physician Decision|1|||
156960719|NCT03570619|566606670|FG002|Overall Study|Physician Decision|0|||
156960720|NCT03570619|566606668|FG000|Overall Study|Withdrawal by Subject|0|||
156960721|NCT03570619|566606669|FG001|Overall Study|Withdrawal by Subject|2|||
156960722|NCT03570619|566606670|FG002|Overall Study|Withdrawal by Subject|0|||
156960723|NCT04773587|566606671|FG000|Overall Study|Lost to Follow-up|11|||
156960724|NCT04773587|566606672|FG001|Overall Study|Lost to Follow-up|3|||
156960725|NCT04773587|566606671|FG000|Overall Study|Adverse Event|6|||
156960726|NCT04773587|566606672|FG001|Overall Study|Adverse Event|3|||
156960727|NCT04773587|566606671|FG000|Overall Study|Lack of Efficacy|5|||
156960728|NCT04773587|566606672|FG001|Overall Study|Lack of Efficacy|2|||
156960729|NCT04773587|566606671|FG000|Overall Study|Withdrawal by Subject|4|||
156960730|NCT04773587|566606672|FG001|Overall Study|Withdrawal by Subject|5|||
156960731|NCT04773587|566606671|FG000|Overall Study|Noncompliance|1|||
156960732|NCT04773587|566606672|FG001|Overall Study|Noncompliance|0|||
156960733|NCT04773587|566606671|FG000|Overall Study|Protocol Violation|1|||
156960734|NCT04773587|566606672|FG001|Overall Study|Protocol Violation|0|||
156960735|NCT04773587|566606671|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
156960736|NCT04773587|566606672|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
156960737|NCT02372409|566606673|FG000|Overall Study|Lost to Follow-up|1|||
156960738|NCT02372409|566606674|FG001|Overall Study|Lost to Follow-up|0|||
156960739|NCT02372409|566606673|FG000|Overall Study|Disease progression|1|||
156960740|NCT02372409|566606674|FG001|Overall Study|Disease progression|1|||
156960741|NCT01808313|566606677|FG000|Overall Study|Adverse Event|5|||
156960742|NCT01808313|566606677|FG000|Overall Study|Protocol Violation|2|||
156960743|NCT01808313|566606677|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
156960744|NCT01808313|566606677|FG000|Overall Study|Lost to Follow-up|1|||
156960745|NCT01808313|566606677|FG000|Overall Study|Physician Decision|1|||
156960746|NCT04084314|566606678|FG000|Overall Study|Subject/guardian decision|91|||
156960747|NCT04084314|566606678|FG000|Overall Study|Adverse Event|24|||
156960748|NCT04084314|566606678|FG000|Overall Study|Lost to Follow-up|19|||
156960749|NCT04084314|566606678|FG000|Overall Study|New therapy for study indication|9|||
156960750|NCT04084314|566606678|FG000|Overall Study|Pregnancy|9|||
156960751|NCT04084314|566606678|FG000|Overall Study|Withdrawal of informed consent|8|||
156960752|NCT04084314|566606678|FG000|Overall Study|Physician Decision|4|||
156960753|NCT04084314|566606678|FG000|Overall Study|Protocol Deviation|3|||
156960754|NCT00622167|566606679|FG000|Overall Study|Did not meet angiographic criteria|20|||
156960755|NCT01954017|566606682|FG000|Overall Study|Adverse Event|0|||
156960756|NCT01954017|566606683|FG001|Overall Study|Adverse Event|0|||
156960757|NCT01954017|566606684|FG002|Overall Study|Adverse Event|1|||
156960758|NCT01954017|566606682|FG000|Overall Study|Death|2|||
156960759|NCT01954017|566606683|FG001|Overall Study|Death|1|||
156960760|NCT01954017|566606684|FG002|Overall Study|Death|1|||
156960761|NCT01954017|566606682|FG000|Overall Study|Withdrawal by Subject|0|||
156960762|NCT01954017|566606683|FG001|Overall Study|Withdrawal by Subject|1|||
156960763|NCT01954017|566606684|FG002|Overall Study|Withdrawal by Subject|0|||
156960764|NCT01954017|566606682|FG000|Overall Study|Protocol Violation|0|||
156960765|NCT01954017|566606683|FG001|Overall Study|Protocol Violation|3|||
156960766|NCT01954017|566606684|FG002|Overall Study|Protocol Violation|2|||
156960767|NCT01954017|566606682|FG000|Overall Study|Necrotizing enterocolitis|1|||
156960768|NCT01954017|566606683|FG001|Overall Study|Necrotizing enterocolitis|0|||
156960769|NCT01954017|566606684|FG002|Overall Study|Necrotizing enterocolitis|1|||
156960770|NCT01954017|566606682|FG000|Overall Study|Enteral intake stopped >7 days|0|||
156960771|NCT01954017|566606683|FG001|Overall Study|Enteral intake stopped >7 days|1|||
156960772|NCT01954017|566606684|FG002|Overall Study|Enteral intake stopped >7 days|1|||
156960773|NCT01954017|566606682|FG000|Overall Study|All other reasons|2|||
156960774|NCT01954017|566606683|FG001|Overall Study|All other reasons|2|||
156960775|NCT01954017|566606684|FG002|Overall Study|All other reasons|7|||
156960776|NCT03346759|566606685|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
156960777|NCT03346759|566606686|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
156960778|NCT03346759|566606685|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
156960779|NCT03346759|566606686|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
156960780|NCT03346759|566606685|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
156960781|NCT03346759|566606686|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
156960782|NCT00435370|566606687|FG000|Overall Study|Adverse Event|8|||
156960783|NCT00435370|566606688|FG001|Overall Study|Adverse Event|8|||
156960784|NCT00435370|566606687|FG000|Overall Study|Withdrawal by Subject|10|||
156960785|NCT00435370|566606688|FG001|Overall Study|Withdrawal by Subject|10|||
156960786|NCT00435370|566606687|FG000|Overall Study|Antipsychotic medication changed|4|||
156960787|NCT00435370|566606688|FG001|Overall Study|Antipsychotic medication changed|2|||
156960788|NCT02132611|566606689|FG000|Overall Study|Death|2|||
156960789|NCT03943095|566606690|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
156960790|NCT03943095|566606691|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
156960791|NCT03943095|566606690|FG000|Overall Study|Withdrawal by Subject|1|||
156960792|NCT03943095|566606691|FG001|Overall Study|Withdrawal by Subject|0|||
156960793|NCT00744653|566606697|FG000|Overall Study|antineoplastic treatment|11|||
156960794|NCT00744653|566606697|FG000|Overall Study|Death|1|||
156960795|NCT00744653|566606697|FG000|Overall Study|Lost to Follow-up|1|||
156960796|NCT00744653|566606697|FG000|Overall Study|Physician Decision|3|||
156960797|NCT03826667|566606698|FG000|Overall Study|Protocol deviation|21|||
156960798|NCT00808808|566606699|FG000|Overall Study|Vaccinated; survey not completed|131|||
156960799|NCT00808808|566606700|FG001|Overall Study|Vaccinated; survey not completed|169|||
156960800|NCT00808808|566606701|FG002|Overall Study|Vaccinated; survey not completed|302|||
156960801|NCT00808808|566606699|FG000|Overall Study|Employee was not vaccinated.|2686|||
156960802|NCT00808808|566606700|FG001|Overall Study|Employee was not vaccinated.|2268|||
156960803|NCT00808808|566606701|FG002|Overall Study|Employee was not vaccinated.|2255|||
156960804|NCT01738984|566608224|FG000|Overall Study|Pregnancy|4|||
156960805|NCT01738984|566608225|FG001|Overall Study|Pregnancy|0|||
156960806|NCT01738984|566608224|FG000|Overall Study|Withdrawal by Subject|1|||
156960807|NCT01738984|566608225|FG001|Overall Study|Withdrawal by Subject|0|||
156960808|NCT01738984|566608224|FG000|Overall Study|Lost to Follow-up|59|||
156960809|NCT01738984|566608225|FG001|Overall Study|Lost to Follow-up|39|||
156960810|NCT00920426|566608226|FG000|ITZ111451|Adverse Event|1|||
156960811|NCT00920426|566608227|FG001|ITZ111451|Adverse Event|0|||
156960812|NCT00920426|566608228|FG002|ITZ111451|Adverse Event|0|||
156960813|NCT00920426|566608229|FG003|ITZ111451|Adverse Event|0|||
156960814|NCT02925455|566608233|FG000|Overall Study|Withdrawal by Subject|2|||
156960815|NCT02925455|566608234|FG001|Overall Study|Withdrawal by Subject|0|||
156960816|NCT00686166|566608240|FG000|Overall Study|Adverse Event|7|||
156960817|NCT00686166|566608240|FG000|Overall Study|Withdrawal by Subject|1|||
156960818|NCT00686166|566608240|FG000|Overall Study|Progression/Relapse|1|||
156960819|NCT00686166|566608240|FG000|Overall Study|Death|1|||
156960820|NCT00686166|566608240|FG000|Overall Study|Not Protocol Specified|1|||
156960821|NCT00686166|566608240|FG000|Overall Study|Ineligible|5|||
156960822|NCT00686166|566608240|FG000|Overall Study|Did not begin protocol therapy|4|||
156960823|NCT01514448|566608241|FG000|Overall Study|Death|7|||
156960824|NCT01514448|566608242|FG001|Overall Study|Death|8|||
156960825|NCT01514448|566608241|FG000|Overall Study|Withdrawal by Subject|2|||
156960826|NCT01514448|566608242|FG001|Overall Study|Withdrawal by Subject|0|||
156960827|NCT01514448|566608241|FG000|Overall Study|Lost to Follow-up|2|||
156960828|NCT01514448|566608242|FG001|Overall Study|Lost to Follow-up|0|||
156960829|NCT01514448|566608241|FG000|Overall Study|New Cancer Therapy|1|||
156960830|NCT01514448|566608242|FG001|Overall Study|New Cancer Therapy|0|||
156960831|NCT00985725|566608243|FG000|Overall Study|Adverse Event|4|||
156960832|NCT00985725|566608244|FG001|Overall Study|Adverse Event|1|||
156960833|NCT00985725|566608243|FG000|Overall Study|Protocol Violation|1|||
156960834|NCT00985725|566608244|FG001|Overall Study|Protocol Violation|3|||
156960835|NCT00985725|566608243|FG000|Overall Study|Withdrawal by Subject|4|||
156960836|NCT00985725|566608244|FG001|Overall Study|Withdrawal by Subject|4|||
156960837|NCT00985725|566608243|FG000|Overall Study|Lost to Follow-up|1|||
156960838|NCT00985725|566608244|FG001|Overall Study|Lost to Follow-up|1|||
156960839|NCT00985725|566608243|FG000|Overall Study|Lack of Efficacy|0|||
156960840|NCT00985725|566608244|FG001|Overall Study|Lack of Efficacy|1|||
156960841|NCT00985725|566608243|FG000|Overall Study|Non-compliance|1|||
156960842|NCT00985725|566608244|FG001|Overall Study|Non-compliance|2|||
156960843|NCT00985725|566608243|FG000|Overall Study|Out-of-window visits|0|||
156960844|NCT00985725|566608244|FG001|Overall Study|Out-of-window visits|1|||
156960845|NCT03151005|566608248|FG000|Overall Study|Lost to Follow-up|5|||
156960846|NCT03151005|566608249|FG001|Overall Study|Lost to Follow-up|5|||
156960847|NCT03912259|566608250|FG000|Overall Study|Adverse Event (AE)|2|||
156960848|NCT03912259|566608251|FG001|Overall Study|Adverse Event (AE)|4|||
156960849|NCT03912259|566608250|FG000|Overall Study|Lack of Efficacy|4|||
156960850|NCT03912259|566608251|FG001|Overall Study|Lack of Efficacy|1|||
156960851|NCT03912259|566608250|FG000|Overall Study|Withdrawal by Subject|11|||
156960852|NCT03912259|566608251|FG001|Overall Study|Withdrawal by Subject|1|||
156960853|NCT01549613|566608252|FG000|Overall Study|Lost to Follow-up|11|||
156960854|NCT01549613|566608253|FG001|Overall Study|Lost to Follow-up|11|||
156960855|NCT05159622|566608254|FG000|Overall Study|Lost to Follow-up|4|||
156960856|NCT05159622|566608255|FG001|Overall Study|Lost to Follow-up|5|||
156960857|NCT00082173|566608256|FG000|Overall Study|Withdrawal by Subject|3|||
156960858|NCT00082173|566608257|FG001|Overall Study|Withdrawal by Subject|5|||
156960859|NCT00082173|566608256|FG000|Overall Study|Lost to Follow-up|1|||
156960860|NCT00082173|566608257|FG001|Overall Study|Lost to Follow-up|0|||
156960861|NCT00082173|566608256|FG000|Overall Study|Adverse Event|1|||
156960862|NCT00082173|566608257|FG001|Overall Study|Adverse Event|0|||
156960863|NCT00082173|566608256|FG000|Overall Study|Culture negative or resistant at baselin|5|||
156960864|NCT00082173|566608257|FG001|Overall Study|Culture negative or resistant at baselin|6|||
157038128|NCT04882917|566894328|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
156960865|NCT04052204|566608265|FG000|Overall Study|Death|1|||
156960866|NCT04052204|566608266|FG001|Overall Study|Death|0|||
157171144|NCT03583606|567369025|FG002|Overall Study|Lost to Follow-up|0|||
156960867|NCT04052204|566608267|FG002|Overall Study|Death|0|||
156960868|NCT04052204|566608265|FG000|Overall Study|Progressive disease|1|||
156960869|NCT04052204|566608266|FG001|Overall Study|Progressive disease|0|||
156960870|NCT04052204|566608267|FG002|Overall Study|Progressive disease|0|||
156960871|NCT04052204|566608265|FG000|Overall Study|Other|1|||
156960872|NCT04052204|566608266|FG001|Overall Study|Other|0|||
156960873|NCT04052204|566608267|FG002|Overall Study|Other|0|||
156960874|NCT01433354|566608268|FG000|Overall Study|Adverse Event|6|||
156960875|NCT01433354|566608268|FG000|Overall Study|Lost to Follow-up|1|||
156960876|NCT01433354|566608268|FG000|Overall Study|Administrative problems|90|||
156960877|NCT01433354|566608268|FG000|Overall Study|Protocol Violation|2|||
156960878|NCT01433354|566608268|FG000|Overall Study|Lack of Efficacy|17|||
156960879|NCT01433354|566608268|FG000|Overall Study|Subject Withdrew Consent|3|||
156960880|NCT01362140|566608279|FG000|Overall Study|Noncompliance|1|||
156960881|NCT01362140|566608280|FG001|Overall Study|Noncompliance|0|||
156960882|NCT01362140|566608279|FG000|Overall Study|Adverse Event|2|||
156960883|NCT01362140|566608280|FG001|Overall Study|Adverse Event|2|||
156960884|NCT01362140|566608279|FG000|Overall Study|Withdrawal by Subject|3|||
156960885|NCT01362140|566608280|FG001|Overall Study|Withdrawal by Subject|3|||
156960886|NCT01362140|566608279|FG000|Overall Study|Administrative Decision|0|||
156960887|NCT01362140|566608280|FG001|Overall Study|Administrative Decision|1|||
156960888|NCT01362140|566608279|FG000|Overall Study|Death|2|||
156960889|NCT01362140|566608280|FG001|Overall Study|Death|1|||
156960890|NCT01362140|566608279|FG000|Overall Study|Other|1|||
156960891|NCT01362140|566608280|FG001|Overall Study|Other|1|||
156960892|NCT01362140|566608279|FG000|Overall Study|Protocol-specified Criteria|1|||
156960893|NCT01362140|566608280|FG001|Overall Study|Protocol-specified Criteria|2|||
156960894|NCT01362140|566608279|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
156960895|NCT01362140|566608280|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
156960896|NCT05553808|566608281|FG000|Overall Study|Death|25|||
156960897|NCT05553808|566608282|FG001|Overall Study|Death|62|||
156960898|NCT05553808|566608281|FG000|Overall Study|Site Closed|6|||
156960899|NCT05553808|566608282|FG001|Overall Study|Site Closed|6|||
156960900|NCT05553808|566608281|FG000|Overall Study|Lost to Follow-up|1|||
156960901|NCT05553808|566608282|FG001|Overall Study|Lost to Follow-up|0|||
156960902|NCT05553808|566608281|FG000|Overall Study|Withdrawal by Subject|3|||
156960903|NCT05553808|566608282|FG001|Overall Study|Withdrawal by Subject|2|||
156960904|NCT00492284|566608283|FG000|Overall Study|Adverse Event|0|||
156960905|NCT00492284|566608284|FG001|Overall Study|Adverse Event|1|||
156960906|NCT00492284|566608285|FG002|Overall Study|Adverse Event|1|||
156960907|NCT00492284|566608286|FG003|Overall Study|Adverse Event|2|||
156960908|NCT00492284|566608283|FG000|Overall Study|Lost to Follow-up|0|||
156960909|NCT00492284|566608284|FG001|Overall Study|Lost to Follow-up|0|||
156960910|NCT00492284|566608285|FG002|Overall Study|Lost to Follow-up|3|||
156960911|NCT00492284|566608286|FG003|Overall Study|Lost to Follow-up|1|||
156960912|NCT00492284|566608283|FG000|Overall Study|Death|0|||
156960913|NCT00492284|566608284|FG001|Overall Study|Death|3|||
156960914|NCT00492284|566608285|FG002|Overall Study|Death|2|||
156960915|NCT00492284|566608286|FG003|Overall Study|Death|5|||
156960916|NCT00492284|566608283|FG000|Overall Study|Withdrawal by Subject|1|||
156960917|NCT00492284|566608284|FG001|Overall Study|Withdrawal by Subject|0|||
156960918|NCT00492284|566608285|FG002|Overall Study|Withdrawal by Subject|0|||
156960919|NCT00492284|566608286|FG003|Overall Study|Withdrawal by Subject|2|||
156960920|NCT02270450|566608297|FG000|Overall Study|Refusal unrelated to adverse event|3|||
156960921|NCT02270450|566608298|FG001|Overall Study|Refusal unrelated to adverse event|1|||
156960922|NCT02270450|566608299|FG002|Overall Study|Refusal unrelated to adverse event|5|||
156960923|NCT02270450|566608300|FG003|Overall Study|Refusal unrelated to adverse event|14|||
156960924|NCT02270450|566608297|FG000|Overall Study|Progression/relapse|1|||
156960925|NCT02270450|566608298|FG001|Overall Study|Progression/relapse|2|||
156960926|NCT02270450|566608299|FG002|Overall Study|Progression/relapse|4|||
156960927|NCT02270450|566608300|FG003|Overall Study|Progression/relapse|9|||
156960928|NCT02270450|566608297|FG000|Overall Study|Death|19|||
156960929|NCT02270450|566608298|FG001|Overall Study|Death|19|||
156960930|NCT02270450|566608299|FG002|Overall Study|Death|31|||
157227791|NCT01790568|567579205|FG000|Overall Study|Progression prior to transplant|0|||
156960931|NCT02270450|566608300|FG003|Overall Study|Death|59|||
156960932|NCT02363738|566608301|FG000|Overall Study|Adverse Event|5|||
156960933|NCT02363738|566608302|FG001|Overall Study|Adverse Event|2|||
156960934|NCT02363738|566608301|FG000|Overall Study|Lack of Efficacy|1|||
156960935|NCT02363738|566608302|FG001|Overall Study|Lack of Efficacy|2|||
156960936|NCT02363738|566608301|FG000|Overall Study|Lost to Follow-up|2|||
156960937|NCT02363738|566608302|FG001|Overall Study|Lost to Follow-up|1|||
156960938|NCT03282227|566608303|FG000|Overall Study|Exposure Goals Achieved|60|||
156960939|NCT03282227|566608303|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
156960940|NCT03282227|566608303|FG000|Overall Study|Adverse Event|15|||
156960941|NCT03282227|566608303|FG000|Overall Study|Lost to Follow-up|21|||
156960942|NCT03282227|566608303|FG000|Overall Study|Withdrawal by Subject|20|||
156960943|NCT03282227|566608303|FG000|Overall Study|Lack of Efficacy|12|||
156960944|NCT03282227|566608303|FG000|Overall Study|Sponsor decision|3|||
156960945|NCT03282227|566608303|FG000|Overall Study|Physician Decision|2|||
157038129|NCT04882917|566894329|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
157038130|NCT04882917|566894330|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
157038131|NCT04882917|566894331|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
157038132|NCT03959423|566894335|FG000|Overall Study|Withdrawal by Subject|2|||
157038133|NCT03959423|566894336|FG001|Overall Study|Withdrawal by Subject|3|||
157038134|NCT03959423|566894335|FG000|Overall Study|Physician Decision|0|||
157038135|NCT03959423|566894336|FG001|Overall Study|Physician Decision|1|||
157038136|NCT03959423|566894335|FG000|Overall Study|Lost to Follow-up|1|||
157038137|NCT03959423|566894336|FG001|Overall Study|Lost to Follow-up|0|||
157038138|NCT03959423|566894335|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
157038139|NCT03959423|566894336|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157038140|NCT01128595|566895325|FG000|Treatment Period 3|Withdrawal by Subject|0|||
157038141|NCT01128595|566895326|FG001|Treatment Period 3|Withdrawal by Subject|1|||
157038142|NCT01128595|566895327|FG002|Treatment Period 3|Withdrawal by Subject|0|||
157038143|NCT01128595|566895328|FG003|Treatment Period 3|Withdrawal by Subject|0|||
157038144|NCT01561300|566895330|FG000|Run in on Placebo|Adverse Event|1|||
157038145|NCT01561300|566895331|FG001|Run in on Placebo|Adverse Event|0|||
157038146|NCT01185600|566895332|FG000|Overall Study|Adverse Event|1|||
157038147|NCT01185600|566895333|FG001|Overall Study|Adverse Event|1|||
157038148|NCT01185600|566895332|FG000|Overall Study|Death|0|||
157038149|NCT01185600|566895333|FG001|Overall Study|Death|1|||
157038150|NCT01185600|566895332|FG000|Overall Study|Lost to Follow-up|0|||
157038151|NCT01185600|566895333|FG001|Overall Study|Lost to Follow-up|5|||
157038152|NCT01185600|566895332|FG000|Overall Study|Physician Decision|29|||
157038153|NCT01185600|566895333|FG001|Overall Study|Physician Decision|35|||
157038154|NCT01185600|566895332|FG000|Overall Study|Withdrawal by Subject|1|||
157038155|NCT01185600|566895333|FG001|Overall Study|Withdrawal by Subject|1|||
157038156|NCT01185600|566895332|FG000|Overall Study|Hold by DSMB|1|||
157038157|NCT01185600|566895333|FG001|Overall Study|Hold by DSMB|2|||
157038158|NCT05405244|566895334|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
157038159|NCT05405244|566895335|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
157038160|NCT05405244|566895334|FG000|Washout (2 Weeks)|Adverse Event|2|||
157038161|NCT05405244|566895335|FG001|Washout (2 Weeks)|Adverse Event|0|||
157038162|NCT05405244|566895334|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
157038163|NCT05405244|566895335|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
157038164|NCT00739934|566895336|FG000|Voriconazole IV|Adverse Event|6|||
157038165|NCT00739934|566895336|FG000|Voriconazole Oral|Other|3|||
157038166|NCT04353492|566895342|FG000|Overall Study|Subject decision|24|||
157038167|NCT04353492|566895342|FG000|Overall Study|Physician Decision|5|||
157038168|NCT04353492|566895342|FG000|Overall Study|Adverse Event|3|||
157038169|NCT04353492|566895342|FG000|Overall Study|Pregnancy|3|||
157038170|NCT04353492|566895342|FG000|Overall Study|Lost to Follow-up|2|||
157038171|NCT04353492|566895342|FG000|Overall Study|Protocol deviation|1|||
157038172|NCT04353492|566895342|FG000|Overall Study|Technical problems|1|||
157038173|NCT04250194|566895343|FG000|Overall Study|Declined to schedule biopsy|6|||
157038174|NCT04250194|566895344|FG001|Overall Study|Declined to schedule biopsy|10|||
157038175|NCT04250194|566895343|FG000|Overall Study|Medically Unfit for Biopsy|2|||
157038176|NCT04250194|566895344|FG001|Overall Study|Medically Unfit for Biopsy|1|||
157038177|NCT04250194|566895343|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
157038178|NCT04250194|566895344|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
157038179|NCT04250194|566895343|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
157038180|NCT04250194|566895344|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
157038181|NCT04250194|566895343|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
157038182|NCT04250194|566895344|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
157038183|NCT01500200|566895345|FG000|Stage 1|Adverse Event|1|||
157038184|NCT01500200|566895346|FG001|Stage 1|Adverse Event|4|||
157038185|NCT01500200|566895347|FG002|Stage 1|Adverse Event|5|||
157038186|NCT01500200|566895348|FG003|Stage 1|Adverse Event|0|||
157171145|NCT03583606|567369023|FG000|Overall Study|Ineligible at baseline|1|||
157171146|NCT03583606|567369024|FG001|Overall Study|Ineligible at baseline|0|||
157171147|NCT03583606|567369025|FG002|Overall Study|Ineligible at baseline|0|||
157171148|NCT00817206|567369026|FG000|Overall Study|Adverse Event|10|||
157171149|NCT00817206|567369027|FG001|Overall Study|Adverse Event|3|||
157171150|NCT00817206|567369026|FG000|Overall Study|Protocol Violation|0|||
157171151|NCT00817206|567369027|FG001|Overall Study|Protocol Violation|2|||
157171152|NCT00817206|567369026|FG000|Overall Study|Lost to Follow-up|0|||
157171153|NCT00817206|567369027|FG001|Overall Study|Lost to Follow-up|1|||
157038187|NCT01500200|566895349|FG004|Stage 1|Adverse Event|0|||
157171154|NCT00817206|567369026|FG000|Overall Study|Death|2|||
157038188|NCT01500200|566895350|FG005|Stage 1|Adverse Event|0|||
157038189|NCT01500200|566895345|FG000|Stage 1|Lost to Follow-up|2|||
157171155|NCT00817206|567369027|FG001|Overall Study|Death|0|||
157171156|NCT00817206|567369026|FG000|Overall Study|Withdrawal by Subject|7|||
157171157|NCT00817206|567369027|FG001|Overall Study|Withdrawal by Subject|3|||
157038190|NCT01500200|566895346|FG001|Stage 1|Lost to Follow-up|2|||
157171158|NCT00817206|567369026|FG000|Overall Study|Physician Decision|2|||
157171159|NCT00817206|567369027|FG001|Overall Study|Physician Decision|0|||
157171160|NCT00126581|567369028|FG000|Overall Study|Adverse Event|3|||
157171161|NCT00126581|567369029|FG001|Overall Study|Adverse Event|7|||
157171162|NCT00126581|567369028|FG000|Overall Study|Death|3|||
156960946|NCT03282227|566608303|FG000|Overall Study|Pregnancy|2|||
156960947|NCT03282227|566608303|FG000|Overall Study|Other|1|||
156960948|NCT02293538|566608311|FG000|Overall Study|Adverse Event|0|||
156960949|NCT02293538|566608312|FG001|Overall Study|Adverse Event|1|||
156960950|NCT02293538|566608311|FG000|Overall Study|Lost to Follow-up|1|||
156960951|NCT02293538|566608312|FG001|Overall Study|Lost to Follow-up|0|||
156960952|NCT02293538|566608311|FG000|Overall Study|Withdrawal by Subject|0|||
156960953|NCT02293538|566608312|FG001|Overall Study|Withdrawal by Subject|1|||
156960954|NCT04177758|566608324|FG000|Overall Study|Lost to Follow-up|19|||
156960955|NCT04177758|566608325|FG001|Overall Study|Lost to Follow-up|11|||
156960956|NCT00679939|566608329|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
156960957|NCT00679939|566608330|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
156960958|NCT00679939|566608329|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
156960959|NCT00679939|566608330|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
156960960|NCT00679939|566608329|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
156960961|NCT00679939|566608330|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
156960962|NCT00679939|566608329|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
156960963|NCT00679939|566608330|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
156960964|NCT00679939|566608329|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
156960965|NCT00679939|566608330|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
156960966|NCT00679939|566608329|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
156960967|NCT00679939|566608330|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
156960968|NCT00679939|566608329|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
156960969|NCT00679939|566608330|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
156960970|NCT00679939|566608329|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
156960971|NCT00679939|566608330|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
156960972|NCT00679939|566608329|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
156960973|NCT00679939|566608330|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
156960974|NCT00679939|566608329|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
156960975|NCT00679939|566608330|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
156960976|NCT01453595|566608332|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156960977|NCT01453595|566608333|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156960978|NCT01453595|566608334|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156960979|NCT02653482|566608337|FG000|Overall Study|Death|1|||
156960980|NCT02653482|566608338|FG001|Overall Study|Death|1|||
156960981|NCT03762473|566608341|FG000|Overall Study|Death|1|||
156960982|NCT03762473|566608342|FG001|Overall Study|Death|0|||
156960983|NCT01864564|566608344|FG000|Overall Study|Lost to Follow-up|17|||
156960984|NCT01864564|566608345|FG001|Overall Study|Lost to Follow-up|23|||
156960985|NCT01864564|566608344|FG000|Overall Study|Withdrawal by Subject|20|||
156960986|NCT01864564|566608345|FG001|Overall Study|Withdrawal by Subject|11|||
156960987|NCT01864564|566608344|FG000|Overall Study|Protocol Violation|0|||
156960988|NCT01864564|566608345|FG001|Overall Study|Protocol Violation|27|||
156960989|NCT01864564|566608344|FG000|Overall Study|not reported|0|||
156960990|NCT01864564|566608345|FG001|Overall Study|not reported|34|||
156960991|NCT03077724|566608346|FG000|Overall Study|Lost to Follow-up|5|||
156960992|NCT03077724|566608347|FG001|Overall Study|Lost to Follow-up|1|||
156960993|NCT03077724|566608346|FG000|Overall Study|Withdrawal by Subject|3|||
156960994|NCT03077724|566608347|FG001|Overall Study|Withdrawal by Subject|1|||
156960995|NCT02269670|566608348|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
156960996|NCT00234065|566608349|FG000|Overall Study|Adverse Event|268|||
156960997|NCT00234065|566608350|FG001|Overall Study|Adverse Event|166|||
156960998|NCT00234065|566608349|FG000|Overall Study|Withdrawal by Subject|73|||
156960999|NCT00234065|566608350|FG001|Overall Study|Withdrawal by Subject|56|||
156961000|NCT00234065|566608349|FG000|Overall Study|Physician Decision|23|||
156961001|NCT00234065|566608350|FG001|Overall Study|Physician Decision|22|||
156961002|NCT00234065|566608349|FG000|Overall Study|Not Classified|111|||
156961003|NCT00234065|566608350|FG001|Overall Study|Not Classified|112|||
156961004|NCT00126438|566608351|FG000|Overall Study|Withdrawal due to adverse event|1|||
156961005|NCT00126438|566608352|FG001|Overall Study|Withdrawal due to adverse event|0|||
156961006|NCT00126438|566608351|FG000|Overall Study|Lost to Follow-up|22|||
156961007|NCT00126438|566608352|FG001|Overall Study|Lost to Follow-up|0|||
156961008|NCT00126438|566608351|FG000|Overall Study|Protocol Violation|8|||
156961009|NCT00126438|566608352|FG001|Overall Study|Protocol Violation|8|||
156961010|NCT00126438|566608351|FG000|Overall Study|Withdrawal by Subject|3|||
156961011|NCT00126438|566608352|FG001|Overall Study|Withdrawal by Subject|2|||
156961012|NCT02313428|566608353|FG000|Overall Study|Lost to Follow-up|1|||
156961013|NCT02313428|566608354|FG001|Overall Study|Lost to Follow-up|1|||
156961014|NCT05374421|566608355|FG000|Overall Study|Withdrawal by Subject|3|||
156961015|NCT05374421|566608356|FG001|Overall Study|Withdrawal by Subject|4|||
157171163|NCT00126581|567369029|FG001|Overall Study|Death|2|||
156961016|NCT05132699|566608357|FG000|Overall Study|Withdrawal by Subject|3|||
156961017|NCT05132699|566608358|FG001|Overall Study|Withdrawal by Subject|0|||
156961018|NCT04370054|566608359|FG000|Treatment Phase|Lost to Follow-up|1|||
156961019|NCT04370054|566608359|FG000|Treatment Phase|Withdrawal by Subject|1|||
156961020|NCT04370054|566608359|FG000|Follow-Up Phase|Ongoing|75|||
156961021|NCT00710424|566608362|FG000|Overall Study|Adverse Event|30|||
156961022|NCT00710424|566608363|FG001|Overall Study|Adverse Event|12|||
156961023|NCT00710424|566608362|FG000|Overall Study|Lack of Efficacy|4|||
156961024|NCT00710424|566608363|FG001|Overall Study|Lack of Efficacy|5|||
156961025|NCT00710424|566608362|FG000|Overall Study|Withdrawal by Subject|5|||
156961026|NCT00710424|566608363|FG001|Overall Study|Withdrawal by Subject|3|||
156961027|NCT00710424|566608362|FG000|Overall Study|Lost to Follow-up|0|||
156961028|NCT00710424|566608363|FG001|Overall Study|Lost to Follow-up|1|||
156961029|NCT00710424|566608362|FG000|Overall Study|Refused medication, no side effects|1|||
156961030|NCT00710424|566608363|FG001|Overall Study|Refused medication, no side effects|0|||
156961031|NCT00710424|566608362|FG000|Overall Study|Non-compliance with stable analgesia|1|||
156961032|NCT00710424|566608363|FG001|Overall Study|Non-compliance with stable analgesia|0|||
156961033|NCT00710424|566608362|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
156961034|NCT00710424|566608363|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
156961035|NCT00710424|566608362|FG000|Overall Study|Subject thought medication changed|1|||
156961036|NCT00710424|566608363|FG001|Overall Study|Subject thought medication changed|0|||
156961037|NCT00710424|566608362|FG000|Overall Study|Ceased treatment due to travel|1|||
156961038|NCT00710424|566608363|FG001|Overall Study|Ceased treatment due to travel|0|||
156961039|NCT00710424|566608362|FG000|Overall Study|Subject preferred paracetamol|0|||
156961040|NCT00710424|566608363|FG001|Overall Study|Subject preferred paracetamol|1|||
156961041|NCT00710424|566608362|FG000|Overall Study|Felt good so stopped treatment|0|||
156961042|NCT00710424|566608363|FG001|Overall Study|Felt good so stopped treatment|1|||
156961043|NCT00955357|566609666|FG000|Titration Phase|Adverse Event|9|||
156961044|NCT00955357|566609667|FG001|Titration Phase|Adverse Event|46|||
156961045|NCT00955357|566609666|FG000|Titration Phase|Lack of Efficacy|0|||
156961046|NCT00955357|566609667|FG001|Titration Phase|Lack of Efficacy|2|||
156961047|NCT00955357|566609666|FG000|Titration Phase|Protocol Violation|3|||
156961048|NCT00955357|566609667|FG001|Titration Phase|Protocol Violation|7|||
156961049|NCT00955357|566609666|FG000|Titration Phase|Lost to Follow-up|1|||
156961050|NCT00955357|566609667|FG001|Titration Phase|Lost to Follow-up|3|||
156961051|NCT00955357|566609666|FG000|Titration Phase|Withdrawal by Subject|3|||
156961052|NCT00955357|566609667|FG001|Titration Phase|Withdrawal by Subject|5|||
156961053|NCT00955357|566609666|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
156961054|NCT00955357|566609667|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
156961055|NCT00955357|566609666|FG000|Titration Phase|Study medication not tolerated|0|||
156961056|NCT00955357|566609667|FG001|Titration Phase|Study medication not tolerated|1|||
156961057|NCT00955357|566609666|FG000|Titration Phase|Non compliance to study procedures|0|||
156961058|NCT00955357|566609667|FG001|Titration Phase|Non compliance to study procedures|1|||
156961059|NCT00955357|566609666|FG000|Maintenance Phase|Adverse Event|3|||
156961060|NCT00955357|566609667|FG001|Maintenance Phase|Adverse Event|23|||
156961061|NCT00955357|566609666|FG000|Maintenance Phase|Lack of Efficacy|0|||
156961062|NCT00955357|566609667|FG001|Maintenance Phase|Lack of Efficacy|4|||
156961063|NCT00955357|566609666|FG000|Maintenance Phase|Protocol Violation|2|||
156961064|NCT00955357|566609667|FG001|Maintenance Phase|Protocol Violation|6|||
156961065|NCT00955357|566609666|FG000|Maintenance Phase|Lost to Follow-up|2|||
156961066|NCT00955357|566609667|FG001|Maintenance Phase|Lost to Follow-up|7|||
156961067|NCT00955357|566609666|FG000|Maintenance Phase|Withdrawal by Subject|4|||
156961068|NCT00955357|566609667|FG001|Maintenance Phase|Withdrawal by Subject|4|||
156961069|NCT00955357|566609666|FG000|Maintenance Phase|Patient moving out of area|0|||
156961070|NCT00955357|566609667|FG001|Maintenance Phase|Patient moving out of area|1|||
156961071|NCT00955357|566609666|FG000|Maintenance Phase|Non compliance to study procedures|1|||
156961072|NCT00955357|566609667|FG001|Maintenance Phase|Non compliance to study procedures|0|||
156961073|NCT02481310|566609668|FG000|Follow up|Still in follow up|0|||
156961074|NCT02481310|566609669|FG001|Follow up|Still in follow up|3|||
156961075|NCT02481310|566609670|FG002|Follow up|Still in follow up|0|||
156961076|NCT00643916|566609672|FG000|Overall Study|Protocol Violation|0|||
156961077|NCT00643916|566609673|FG001|Overall Study|Protocol Violation|1|||
156961078|NCT00643916|566609674|FG002|Overall Study|Protocol Violation|1|||
156961079|NCT00643916|566609675|FG003|Overall Study|Protocol Violation|1|||
156961080|NCT00643916|566609676|FG004|Overall Study|Protocol Violation|0|||
156961081|NCT00643916|566609677|FG005|Overall Study|Protocol Violation|0|||
156961082|NCT00643916|566609672|FG000|Overall Study|Lost to Follow-up|0|||
156961083|NCT00643916|566609673|FG001|Overall Study|Lost to Follow-up|1|||
157038191|NCT01500200|566895347|FG002|Stage 1|Lost to Follow-up|1|||
156961084|NCT00643916|566609674|FG002|Overall Study|Lost to Follow-up|0|||
156961085|NCT00643916|566609675|FG003|Overall Study|Lost to Follow-up|0|||
156961086|NCT00643916|566609676|FG004|Overall Study|Lost to Follow-up|0|||
156961087|NCT00643916|566609677|FG005|Overall Study|Lost to Follow-up|0|||
156961088|NCT00643916|566609672|FG000|Overall Study|Withdrawal by Subject|2|||
156961089|NCT00643916|566609673|FG001|Overall Study|Withdrawal by Subject|2|||
156961090|NCT00643916|566609674|FG002|Overall Study|Withdrawal by Subject|2|||
156961091|NCT00643916|566609675|FG003|Overall Study|Withdrawal by Subject|1|||
156961092|NCT00643916|566609676|FG004|Overall Study|Withdrawal by Subject|0|||
156961093|NCT00643916|566609677|FG005|Overall Study|Withdrawal by Subject|1|||
156961094|NCT00643916|566609672|FG000|Overall Study|Not Vaccinated|2|||
156961095|NCT00643916|566609673|FG001|Overall Study|Not Vaccinated|2|||
156961096|NCT00643916|566609674|FG002|Overall Study|Not Vaccinated|3|||
156961097|NCT00643916|566609675|FG003|Overall Study|Not Vaccinated|0|||
156961098|NCT00643916|566609676|FG004|Overall Study|Not Vaccinated|2|||
156961099|NCT00643916|566609677|FG005|Overall Study|Not Vaccinated|0|||
156961100|NCT03643952|566609679|FG000|Overall Study|Lack of Efficacy|1|||
156961101|NCT01358968|566609680|FG000|Period 2|Adverse Event|0|||
156961102|NCT01358968|566609681|FG001|Period 2|Adverse Event|1|||
156961103|NCT01358968|566609682|FG002|Period 2|Adverse Event|0|||
156961104|NCT01358968|566609683|FG003|Period 2|Adverse Event|0|||
156961105|NCT01358968|566609680|FG000|Continued Access Phase|Progression of Disease|0|||
156961106|NCT01358968|566609681|FG001|Continued Access Phase|Progression of Disease|0|||
156961107|NCT01358968|566609682|FG002|Continued Access Phase|Progression of Disease|8|||
156961108|NCT01358968|566609683|FG003|Continued Access Phase|Progression of Disease|4|||
156961109|NCT01358968|566609680|FG000|Continued Access Phase|Protocol Violation|0|||
156961110|NCT01358968|566609681|FG001|Continued Access Phase|Protocol Violation|0|||
156961111|NCT01358968|566609682|FG002|Continued Access Phase|Protocol Violation|0|||
156961112|NCT01358968|566609683|FG003|Continued Access Phase|Protocol Violation|2|||
156961113|NCT01358968|566609680|FG000|Continued Access Phase|Withdrawal by Subject|0|||
156961114|NCT01358968|566609681|FG001|Continued Access Phase|Withdrawal by Subject|0|||
156961115|NCT01358968|566609682|FG002|Continued Access Phase|Withdrawal by Subject|3|||
156961116|NCT01358968|566609683|FG003|Continued Access Phase|Withdrawal by Subject|0|||
156961117|NCT01358968|566609680|FG000|Continued Access Phase|Death|0|||
156961118|NCT01358968|566609681|FG001|Continued Access Phase|Death|0|||
156961119|NCT01358968|566609682|FG002|Continued Access Phase|Death|1|||
156961120|NCT01358968|566609683|FG003|Continued Access Phase|Death|1|||
156961121|NCT03252587|566609691|FG000|Overall Study|Adverse Event|3|||
156961122|NCT03252587|566609692|FG001|Overall Study|Adverse Event|8|||
156961123|NCT03252587|566609693|FG002|Overall Study|Adverse Event|6|||
156961124|NCT03252587|566609694|FG003|Overall Study|Adverse Event|12|||
156961125|NCT03252587|566609691|FG000|Overall Study|Lack of Efficacy|7|||
156961126|NCT03252587|566609692|FG001|Overall Study|Lack of Efficacy|2|||
156961127|NCT03252587|566609693|FG002|Overall Study|Lack of Efficacy|2|||
156961128|NCT03252587|566609694|FG003|Overall Study|Lack of Efficacy|4|||
156961129|NCT03252587|566609691|FG000|Overall Study|Lost to Follow-up|2|||
156961130|NCT03252587|566609692|FG001|Overall Study|Lost to Follow-up|0|||
156961131|NCT03252587|566609693|FG002|Overall Study|Lost to Follow-up|0|||
156961132|NCT03252587|566609694|FG003|Overall Study|Lost to Follow-up|2|||
156961133|NCT03252587|566609691|FG000|Overall Study|Pregnancy|2|||
156961134|NCT03252587|566609692|FG001|Overall Study|Pregnancy|1|||
156961135|NCT03252587|566609693|FG002|Overall Study|Pregnancy|0|||
156961136|NCT03252587|566609694|FG003|Overall Study|Pregnancy|1|||
156961137|NCT03252587|566609691|FG000|Overall Study|Withdrawal by Subject|8|||
156961138|NCT03252587|566609692|FG001|Overall Study|Withdrawal by Subject|4|||
156961139|NCT03252587|566609693|FG002|Overall Study|Withdrawal by Subject|4|||
156961140|NCT03252587|566609694|FG003|Overall Study|Withdrawal by Subject|4|||
156961141|NCT03252587|566609691|FG000|Overall Study|Other Reasons|2|||
156961142|NCT03252587|566609692|FG001|Overall Study|Other Reasons|5|||
156961143|NCT03252587|566609693|FG002|Overall Study|Other Reasons|5|||
156961144|NCT03252587|566609694|FG003|Overall Study|Other Reasons|4|||
156961145|NCT03945188|566609695|FG000|Overall Study|Protocol Violation|1|||
156961146|NCT03945188|566609696|FG001|Overall Study|Protocol Violation|0|||
156961147|NCT03945188|566609695|FG000|Overall Study|Disease worsening|79|||
156961148|NCT03945188|566609696|FG001|Overall Study|Disease worsening|73|||
156961149|NCT03945188|566609695|FG000|Overall Study|Physician Decision|2|||
156961150|NCT03945188|566609696|FG001|Overall Study|Physician Decision|2|||
156961151|NCT03945188|566609695|FG000|Overall Study|Lack of Efficacy|7|||
156961152|NCT03945188|566609696|FG001|Overall Study|Lack of Efficacy|4|||
156961153|NCT03945188|566609695|FG000|Overall Study|Pregnancy|2|||
156961154|NCT03945188|566609696|FG001|Overall Study|Pregnancy|0|||
156961155|NCT03945188|566609695|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
156961156|NCT03945188|566609696|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
156961157|NCT03945188|566609695|FG000|Overall Study|Adverse Event|10|||
156961158|NCT03945188|566609696|FG001|Overall Study|Adverse Event|5|||
156961159|NCT03945188|566609695|FG000|Overall Study|Other|2|||
156961160|NCT03945188|566609696|FG001|Overall Study|Other|2|||
156961161|NCT03945188|566609695|FG000|Overall Study|Lost to Follow-up|1|||
156961162|NCT03945188|566609696|FG001|Overall Study|Lost to Follow-up|2|||
156961163|NCT01618162|566609697|FG000|Overall Study|Protocol Violation|13|||
156961164|NCT01618162|566609698|FG001|Overall Study|Protocol Violation|10|||
156961165|NCT01618162|566609697|FG000|Overall Study|Adverse Event|9|||
156961166|NCT01618162|566609698|FG001|Overall Study|Adverse Event|2|||
156961167|NCT01618162|566609697|FG000|Overall Study|Withdrawal Criteria|2|||
156961168|NCT01618162|566609698|FG001|Overall Study|Withdrawal Criteria|10|||
156961169|NCT01618162|566609697|FG000|Overall Study|Unclassified|14|||
156961170|NCT01618162|566609698|FG001|Overall Study|Unclassified|13|||
156961171|NCT04391023|566609704|FG000|Overall Study|Withdrawal by Subject|2|||
156961172|NCT04391023|566609705|FG001|Overall Study|Withdrawal by Subject|2|||
156961173|NCT01270347|566609707|FG000|Core Phase|Adverse Event|1|||
156961174|NCT01270347|566609708|FG001|Core Phase|Adverse Event|6|||
156961175|NCT01270347|566609707|FG000|Core Phase|Withdrawal by Subject|1|||
156961176|NCT01270347|566609708|FG001|Core Phase|Withdrawal by Subject|2|||
156961177|NCT01270347|566609707|FG000|Core Phase|Lost to Follow-up|0|||
156961178|NCT01270347|566609708|FG001|Core Phase|Lost to Follow-up|1|||
156961179|NCT01270347|566609707|FG000|Core Phase|Miscellaneous|8|||
156961180|NCT01270347|566609708|FG001|Core Phase|Miscellaneous|14|||
156961181|NCT01270347|566609707|FG000|Extension Phase|Adverse Event|1|||
156961182|NCT01270347|566609708|FG001|Extension Phase|Adverse Event|3|||
156961183|NCT01270347|566609707|FG000|Extension Phase|Withdrawal by Subject|3|||
156961184|NCT01270347|566609708|FG001|Extension Phase|Withdrawal by Subject|4|||
156961185|NCT01270347|566609707|FG000|Extension Phase|Miscellaneous|2|||
156961186|NCT01270347|566609708|FG001|Extension Phase|Miscellaneous|2|||
156961187|NCT02085408|566609709|FG000|Step 1: Induction|Disease Progression|19|||
156961188|NCT02085408|566609710|FG001|Step 1: Induction|Disease Progression|19|||
156961189|NCT02085408|566609709|FG000|Step 1: Induction|Adverse Event|18|||
156961190|NCT02085408|566609710|FG001|Step 1: Induction|Adverse Event|17|||
156961191|NCT02085408|566609709|FG000|Step 1: Induction|Death|33|||
156961192|NCT02085408|566609710|FG001|Step 1: Induction|Death|30|||
156961193|NCT02085408|566609709|FG000|Step 1: Induction|Withdrawal by Subject|16|||
156961194|NCT02085408|566609710|FG001|Step 1: Induction|Withdrawal by Subject|8|||
156961195|NCT02085408|566609709|FG000|Step 1: Induction|Alternative Therapy|15|||
156961196|NCT02085408|566609710|FG001|Step 1: Induction|Alternative Therapy|19|||
156961197|NCT02085408|566609709|FG000|Step 1: Induction|Complicating Disease|2|||
156961198|NCT02085408|566609710|FG001|Step 1: Induction|Complicating Disease|3|||
156961199|NCT02085408|566609709|FG000|Step 1: Induction|Other|27|||
156961200|NCT02085408|566609710|FG001|Step 1: Induction|Other|39|||
156961201|NCT02085408|566609709|FG000|Step 1: Induction|Never started treatment|6|||
156961202|NCT02085408|566609710|FG001|Step 1: Induction|Never started treatment|4|||
156961203|NCT02085408|566609709|FG000|Step 2: Consolidation|Disease Progression|5|||
156961204|NCT02085408|566609710|FG001|Step 2: Consolidation|Disease Progression|20|||
156961205|NCT02085408|566609709|FG000|Step 2: Consolidation|Adverse Event|9|||
156961206|NCT02085408|566609710|FG001|Step 2: Consolidation|Adverse Event|8|||
156961207|NCT02085408|566609709|FG000|Step 2: Consolidation|Death|4|||
156961208|NCT02085408|566609710|FG001|Step 2: Consolidation|Death|3|||
156961209|NCT02085408|566609709|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
156961210|NCT02085408|566609710|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
156961211|NCT02085408|566609709|FG000|Step 2: Consolidation|Alternative Therapy|9|||
156961212|NCT02085408|566609710|FG001|Step 2: Consolidation|Alternative Therapy|3|||
156961213|NCT02085408|566609709|FG000|Step 2: Consolidation|Complicating Disease|0|||
156961214|NCT02085408|566609710|FG001|Step 2: Consolidation|Complicating Disease|2|||
156961215|NCT02085408|566609709|FG000|Step 2: Consolidation|Other|6|||
156961216|NCT02085408|566609710|FG001|Step 2: Consolidation|Other|6|||
156961217|NCT02085408|566609709|FG000|Step 2: Consolidation|Never started treatment|4|||
156961218|NCT02085408|566609710|FG001|Step 2: Consolidation|Never started treatment|3|||
156961219|NCT02085408|566609709|FG000|Step 3: Maintenance|Disease Progression|13|||
156961220|NCT02085408|566609710|FG001|Step 3: Maintenance|Disease Progression|11|||
156961221|NCT02085408|566609709|FG000|Step 3: Maintenance|Adverse Event|2|||
156961222|NCT02085408|566609710|FG001|Step 3: Maintenance|Adverse Event|4|||
156961223|NCT02085408|566609709|FG000|Step 3: Maintenance|Death|1|||
156961224|NCT02085408|566609710|FG001|Step 3: Maintenance|Death|2|||
156961225|NCT02085408|566609709|FG000|Step 3: Maintenance|Alternative Therapy|1|||
156961226|NCT02085408|566609710|FG001|Step 3: Maintenance|Alternative Therapy|1|||
156961227|NCT02085408|566609709|FG000|Step 3: Maintenance|Complicating Disease|0|||
156961228|NCT02085408|566609710|FG001|Step 3: Maintenance|Complicating Disease|1|||
156961229|NCT02085408|566609709|FG000|Step 3: Maintenance|Other|3|||
156961230|NCT02085408|566609710|FG001|Step 3: Maintenance|Other|2|||
156961231|NCT02085408|566609709|FG000|Step 3: Maintenance|Never started treatment|5|||
156961232|NCT02085408|566609710|FG001|Step 3: Maintenance|Never started treatment|1|||
156961233|NCT02189798|566609711|FG000|Extended Use Phase|Withdrawal by Subject|0|||
156961234|NCT02189798|566609712|FG001|Extended Use Phase|Withdrawal by Subject|4|||
156961235|NCT02189798|566609711|FG000|Extended Use Phase|Physician Decision|1|||
156961236|NCT02189798|566609712|FG001|Extended Use Phase|Physician Decision|0|||
156961237|NCT02189798|566609711|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
156961238|NCT02189798|566609712|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
156961239|NCT02189798|566609711|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
156961240|NCT02189798|566609712|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
156961241|NCT02189798|566609711|FG000|Extended Use Phase|Travel Issues|2|||
156961242|NCT02189798|566609712|FG001|Extended Use Phase|Travel Issues|1|||
156961243|NCT02189798|566609711|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
156961244|NCT02189798|566609712|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
157171164|NCT00126581|567369028|FG000|Overall Study|Withdrawal by Subject|1|||
157171165|NCT00126581|567369029|FG001|Overall Study|Withdrawal by Subject|4|||
157171166|NCT00126581|567369028|FG000|Overall Study|Alternative therapy|3|||
157171167|NCT00126581|567369029|FG001|Overall Study|Alternative therapy|3|||
157171168|NCT00126581|567369028|FG000|Overall Study|Other illness/MD discretion|3|||
157171169|NCT00126581|567369029|FG001|Overall Study|Other illness/MD discretion|4|||
157171170|NCT00793182|567369030|FG000|Overall Study|Adverse Event|0|||
157171171|NCT00793182|567369031|FG001|Overall Study|Adverse Event|1|||
156961245|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
156961246|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
156961247|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
156961248|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
156961249|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
156961250|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
156961251|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
156961252|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
156961253|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
156961254|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
156961255|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
156961256|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
156961257|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
156961258|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
156961259|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
156961260|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
156961261|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
156961262|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
156961263|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
156961264|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
156961265|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
156961266|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156961267|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156961268|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
156961269|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
156961270|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156961271|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156961272|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
156961273|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156961274|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156961275|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
156961276|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
156961277|NCT04818346|566609715|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156961278|NCT04818346|566609716|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156961279|NCT04818346|566609717|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
156961280|NCT04818346|566609718|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
156961281|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
156961282|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
156961283|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
156961284|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
156961285|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156961286|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
156961287|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156961288|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
156961289|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
156961290|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
156961291|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
156961292|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
156961293|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
156961294|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
157038192|NCT01500200|566895348|FG003|Stage 1|Lost to Follow-up|0|||
157171172|NCT03728140|567369032|FG000|Overall Study|Abnormal embryo transfer operation|10|||
157171173|NCT03728140|567369033|FG001|Overall Study|Abnormal embryo transfer operation|7|||
157171174|NCT00851253|567369034|FG000|Overall Study|Disease Progression|1|||
157171175|NCT00851253|567369035|FG001|Overall Study|Disease Progression|0|||
157171176|NCT03892707|567369043|FG000|Overall Study|Screen failure|6|||
157171177|NCT03892707|567369044|FG001|Overall Study|Screen failure|0|||
157171178|NCT03892707|567369043|FG000|Overall Study|Pain resolution|0|||
157171179|NCT03892707|567369044|FG001|Overall Study|Pain resolution|4|||
157171180|NCT03892707|567369043|FG000|Overall Study|Withdrawal by Subject|0|||
157171181|NCT03892707|567369044|FG001|Overall Study|Withdrawal by Subject|1|||
157171182|NCT03892707|567369043|FG000|Overall Study|Other (long business trip)|0|||
157171183|NCT03892707|567369044|FG001|Overall Study|Other (long business trip)|1|||
157171184|NCT04190186|567369045|FG000|Overall Study|ILR is no longer functioning|0|||
157171185|NCT04190186|567369046|FG001|Overall Study|ILR is no longer functioning|1|||
157171186|NCT04190186|567369045|FG000|Overall Study|Lost to Follow-up|0|||
157171187|NCT04190186|567369046|FG001|Overall Study|Lost to Follow-up|1|||
157171188|NCT04190186|567369045|FG000|Overall Study|Withdrawal by Subject|2|||
157171189|NCT04190186|567369046|FG001|Overall Study|Withdrawal by Subject|0|||
157171190|NCT04190186|567369045|FG000|Overall Study|Subject choice to explant|1|||
157171191|NCT04190186|567369046|FG001|Overall Study|Subject choice to explant|0|||
157171192|NCT04190186|567369045|FG000|Overall Study|Physician Decision|0|||
157171193|NCT04190186|567369046|FG001|Overall Study|Physician Decision|1|||
157171194|NCT04190186|567369045|FG000|Overall Study|Study was stopped|4|||
157171195|NCT04190186|567369046|FG001|Overall Study|Study was stopped|5|||
157171196|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
157171197|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
157171198|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
157171199|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
157171200|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
157171201|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
157171202|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
157171203|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
157171204|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
157171205|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
157171206|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
157171207|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
157171208|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
157171209|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
157171210|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
157171211|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
157171212|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
157171213|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
157171214|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
157171215|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
157171216|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
157171217|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
157171218|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
157171219|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
157171220|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
157171221|NCT01457924|567369047|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
157171222|NCT01457924|567369048|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
157171223|NCT01457924|567369049|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
157171224|NCT01457924|567369050|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
157171225|NCT01457924|567369051|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
157171226|NCT01457924|567369047|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
157171227|NCT01457924|567369048|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
157171228|NCT01457924|567369049|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
157171229|NCT01457924|567369050|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
157171230|NCT01457924|567369051|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
157171231|NCT01457924|567369047|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
157171232|NCT01457924|567369048|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
157171233|NCT01457924|567369049|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
157171234|NCT01457924|567369050|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
157171235|NCT01457924|567369051|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
157171236|NCT01457924|567369047|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
157171237|NCT01457924|567369048|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
157171238|NCT01457924|567369049|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
157171239|NCT01457924|567369050|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
157171240|NCT01457924|567369051|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
157171241|NCT01457924|567369047|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
157038193|NCT01500200|566895349|FG004|Stage 1|Lost to Follow-up|0|||
157171242|NCT01457924|567369048|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
157171243|NCT01457924|567369049|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
157171244|NCT01457924|567369050|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
157171245|NCT01457924|567369051|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
157171246|NCT01457924|567369047|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
157171247|NCT01457924|567369048|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
156961295|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
156961296|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
156961297|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156961298|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
156961299|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156961300|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
156961301|NCT04818346|566609715|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156961302|NCT04818346|566609716|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156961303|NCT04818346|566609717|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
156961304|NCT04818346|566609718|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
156961305|NCT02273141|566609721|FG000|Overall Study|Adverse Event|0|||
156961306|NCT02273141|566609722|FG001|Overall Study|Adverse Event|1|||
156961307|NCT02273141|566609721|FG000|Overall Study|Lost to Follow-up|1|||
156961308|NCT02273141|566609722|FG001|Overall Study|Lost to Follow-up|3|||
156961309|NCT02273141|566609721|FG000|Overall Study|Withdrawal by Subject|10|||
156961310|NCT02273141|566609722|FG001|Overall Study|Withdrawal by Subject|15|||
156961311|NCT02273141|566609721|FG000|Overall Study|Various|6|||
156961312|NCT02273141|566609722|FG001|Overall Study|Various|6|||
156961313|NCT00529399|566609723|FG000|Overall Study|Lost to Follow-up|1|||
156961314|NCT00529399|566609724|FG001|Overall Study|Lost to Follow-up|0|||
156961315|NCT00529399|566609725|FG002|Overall Study|Lost to Follow-up|1|||
156961316|NCT00529399|566609723|FG000|Overall Study|Withdrawal by Subject|1|||
156961317|NCT00529399|566609724|FG001|Overall Study|Withdrawal by Subject|0|||
156961318|NCT00529399|566609725|FG002|Overall Study|Withdrawal by Subject|1|||
156961319|NCT00529399|566609723|FG000|Overall Study|Non-compliant|0|||
156961320|NCT00529399|566609724|FG001|Overall Study|Non-compliant|1|||
156961321|NCT00529399|566609725|FG002|Overall Study|Non-compliant|0|||
156961322|NCT03695172|566609726|FG000|Overall Study|Withdrawal by Subject|1|||
156961323|NCT03695172|566609727|FG001|Overall Study|Withdrawal by Subject|1|||
156961324|NCT03695172|566609728|FG002|Overall Study|Withdrawal by Subject|0|||
156961325|NCT01474681|566609740|FG000|Overall Study|Death|0|||
156961326|NCT01474681|566609741|FG001|Overall Study|Death|3|||
156961327|NCT01474681|566609742|FG002|Overall Study|Death|2|||
156961328|NCT01474681|566609743|FG003|Overall Study|Death|6|||
156961329|NCT01483924|566609744|FG000|Overall Study|Withdrawal by Subject|2|||
156961330|NCT01483924|566609745|FG001|Overall Study|Withdrawal by Subject|0|||
156961331|NCT01483924|566609746|FG002|Overall Study|Withdrawal by Subject|0|||
156961332|NCT01483924|566609747|FG003|Overall Study|Withdrawal by Subject|1|||
156961333|NCT01483924|566609748|FG004|Overall Study|Withdrawal by Subject|1|||
156961334|NCT01483924|566609744|FG000|Overall Study|Adverse Event|0|||
156961335|NCT01483924|566609745|FG001|Overall Study|Adverse Event|0|||
156961336|NCT01483924|566609746|FG002|Overall Study|Adverse Event|1|||
156961337|NCT01483924|566609747|FG003|Overall Study|Adverse Event|1|||
156961338|NCT01483924|566609748|FG004|Overall Study|Adverse Event|0|||
156961339|NCT01483924|566609744|FG000|Overall Study|Non-compliance|0|||
156961340|NCT01483924|566609745|FG001|Overall Study|Non-compliance|0|||
156961341|NCT01483924|566609746|FG002|Overall Study|Non-compliance|0|||
156961342|NCT01483924|566609747|FG003|Overall Study|Non-compliance|1|||
156961343|NCT01483924|566609748|FG004|Overall Study|Non-compliance|1|||
156961344|NCT01483924|566609744|FG000|Overall Study|Sponsor concern over ECG result|0|||
156961345|NCT01483924|566609745|FG001|Overall Study|Sponsor concern over ECG result|0|||
156961346|NCT01483924|566609746|FG002|Overall Study|Sponsor concern over ECG result|0|||
156961347|NCT01483924|566609747|FG003|Overall Study|Sponsor concern over ECG result|1|||
156961348|NCT01483924|566609748|FG004|Overall Study|Sponsor concern over ECG result|0|||
156961349|NCT00003298|566609749|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
156961350|NCT00003298|566609749|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
156961351|NCT00003298|566609749|FG000|Surgery|Unresectable at surgery|3|||
156961352|NCT00003298|566609749|FG000|Surgery|Progression before surgery|2|||
156961353|NCT00003298|566609749|FG000|Surgery|Unevaluable and off study|2|||
156961354|NCT00003298|566609749|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
156961355|NCT00003298|566609749|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
156961356|NCT00003298|566609749|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
156961357|NCT00003298|566609749|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
157038194|NCT01500200|566895350|FG005|Stage 1|Lost to Follow-up|0|||
157038195|NCT01500200|566895345|FG000|Stage 1|Withdrawal by Subject|3|||
157171248|NCT01457924|567369049|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
157171249|NCT01457924|567369050|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
157171250|NCT01457924|567369051|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
157171251|NCT01457924|567369047|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
157171252|NCT01457924|567369048|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
157171253|NCT01457924|567369049|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
156961358|NCT00003298|566609749|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
156961359|NCT00003298|566609749|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
156961360|NCT00003298|566609749|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
156961361|NCT00003298|566609749|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
156961362|NCT00003298|566609749|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
156961363|NCT00003298|566609749|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
156961364|NCT00335322|566609751|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
156961365|NCT00335322|566609752|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
156961366|NCT00335322|566609753|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
156961367|NCT02576678|566609758|FG000|Overall Study|Adverse Event|0|||
156961368|NCT02576678|566609759|FG001|Overall Study|Adverse Event|0|||
156961369|NCT02576678|566609760|FG002|Overall Study|Adverse Event|2|||
156961370|NCT02576678|566609758|FG000|Overall Study|Withdrawal by Subject|3|||
156961371|NCT02576678|566609759|FG001|Overall Study|Withdrawal by Subject|1|||
156961372|NCT02576678|566609760|FG002|Overall Study|Withdrawal by Subject|2|||
156961373|NCT02576678|566609758|FG000|Overall Study|Lost to Follow-up|0|||
156961374|NCT02576678|566609759|FG001|Overall Study|Lost to Follow-up|0|||
156961375|NCT02576678|566609760|FG002|Overall Study|Lost to Follow-up|1|||
156961376|NCT02576678|566609758|FG000|Overall Study|Miscellaneous|2|||
156961377|NCT02576678|566609759|FG001|Overall Study|Miscellaneous|0|||
156961378|NCT02576678|566609760|FG002|Overall Study|Miscellaneous|0|||
156961379|NCT01988779|566609773|FG000|Overall Study|Withdrawal by Subject|2|||
156961380|NCT01988779|566609774|FG001|Overall Study|Withdrawal by Subject|2|||
156961381|NCT01988779|566609773|FG000|Overall Study|Protocol Violation|1|||
156961382|NCT01988779|566609774|FG001|Overall Study|Protocol Violation|0|||
156961383|NCT00729833|566609777|FG000|Overall Study|Death|5|||
156961384|NCT00729833|566609778|FG001|Overall Study|Death|1|||
156961385|NCT00729833|566609779|FG002|Overall Study|Death|3|||
156961386|NCT00729833|566609780|FG003|Overall Study|Death|5|||
156961387|NCT00729833|566609777|FG000|Overall Study|Study Terminated by Sponsor|0|||
156961388|NCT00729833|566609778|FG001|Overall Study|Study Terminated by Sponsor|0|||
156961389|NCT00729833|566609779|FG002|Overall Study|Study Terminated by Sponsor|1|||
156961390|NCT00729833|566609780|FG003|Overall Study|Study Terminated by Sponsor|0|||
156961391|NCT00729833|566609777|FG000|Overall Study|Lost to Follow-up|1|||
156961392|NCT00729833|566609778|FG001|Overall Study|Lost to Follow-up|0|||
156961393|NCT00729833|566609779|FG002|Overall Study|Lost to Follow-up|0|||
156961394|NCT00729833|566609780|FG003|Overall Study|Lost to Follow-up|0|||
156961395|NCT00729833|566609777|FG000|Overall Study|Withdrawal by Subject|3|||
156961396|NCT00729833|566609778|FG001|Overall Study|Withdrawal by Subject|1|||
156961397|NCT00729833|566609779|FG002|Overall Study|Withdrawal by Subject|3|||
156961398|NCT00729833|566609780|FG003|Overall Study|Withdrawal by Subject|0|||
156961399|NCT00729833|566609777|FG000|Overall Study|Unspecified Reasons|11|||
156961400|NCT00729833|566609778|FG001|Overall Study|Unspecified Reasons|5|||
156961401|NCT00729833|566609779|FG002|Overall Study|Unspecified Reasons|5|||
156961402|NCT00729833|566609780|FG003|Overall Study|Unspecified Reasons|1|||
156961403|NCT01041638|566609781|FG000|Overall Study|Adverse Event|4|||
156961404|NCT01041638|566609781|FG000|Overall Study|Death|1|||
156961405|NCT01041638|566609781|FG000|Overall Study|Lack of Efficacy|7|||
156961406|NCT01041638|566609781|FG000|Overall Study|Physician Decision|4|||
156961407|NCT01041638|566609781|FG000|Overall Study|Withdrawal by Subject|11|||
156961408|NCT01687257|566609782|FG000|Overall Study|Efficacy Failure|6|||
156961409|NCT01687257|566609783|FG001|Overall Study|Efficacy Failure|0|||
156961410|NCT01687257|566609784|FG002|Overall Study|Efficacy Failure|5|||
156961411|NCT01687257|566609782|FG000|Overall Study|Subject Withdrew Consent|1|||
156961412|NCT01687257|566609783|FG001|Overall Study|Subject Withdrew Consent|1|||
156961413|NCT01687257|566609784|FG002|Overall Study|Subject Withdrew Consent|1|||
156961414|NCT01687257|566609782|FG000|Overall Study|Adverse Event|1|||
156961415|NCT01687257|566609783|FG001|Overall Study|Adverse Event|0|||
156961416|NCT01687257|566609784|FG002|Overall Study|Adverse Event|0|||
156961417|NCT01687257|566609782|FG000|Overall Study|Investigator's Discretion|0|||
156961418|NCT01687257|566609783|FG001|Overall Study|Investigator's Discretion|3|||
156961419|NCT01687257|566609784|FG002|Overall Study|Investigator's Discretion|0|||
157227792|NCT01790568|567579206|FG001|Overall Study|Progression prior to transplant|1|||
157227793|NCT03184441|567579207|FG000|Overall Study|Withdrawal by Subject|1|||
157227794|NCT02994056|567579208|FG000|Overall Study|Death|8|||
157227795|NCT02994056|567579208|FG000|Overall Study|Withdrew Consent|1|||
156961420|NCT01922076|566609785|FG000|Overall Study|Adverse Event|0|||
156961421|NCT01922076|566609786|FG001|Overall Study|Adverse Event|0|||
156961422|NCT01922076|566609787|FG002|Overall Study|Adverse Event|0|||
156961423|NCT01922076|566609788|FG003|Overall Study|Adverse Event|0|||
156961424|NCT01922076|566609789|FG004|Overall Study|Adverse Event|1|||
156961425|NCT01922076|566609790|FG005|Overall Study|Adverse Event|0|||
156961426|NCT01922076|566609791|FG006|Overall Study|Adverse Event|0|||
156961427|NCT01922076|566609785|FG000|Overall Study|Physician Decision|0|||
157038196|NCT01500200|566895346|FG001|Stage 1|Withdrawal by Subject|0|||
157038197|NCT01500200|566895347|FG002|Stage 1|Withdrawal by Subject|0|||
156961428|NCT01922076|566609786|FG001|Overall Study|Physician Decision|0|||
156961429|NCT01922076|566609787|FG002|Overall Study|Physician Decision|1|||
157227796|NCT00979628|567579209|FG000|Overall Study|received regimen < 24 hours|7|||
156961430|NCT01922076|566609788|FG003|Overall Study|Physician Decision|0|||
157171254|NCT01457924|567369050|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
157171255|NCT01457924|567369051|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
157171256|NCT01457924|567369047|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
157171257|NCT01457924|567369048|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
157171258|NCT01457924|567369049|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
157171259|NCT01457924|567369050|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
157171260|NCT01457924|567369051|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
157171261|NCT03017846|567369052|FG000|Overall Study|Lost to Follow-up|3|||
157171262|NCT03017846|567369052|FG000|Overall Study|Adverse Event|2|||
157171263|NCT02505542|567369053|FG000|Part A: Open-Label Period|Adverse Event|31|||
157171264|NCT02505542|567369054|FG001|Part A: Open-Label Period|Adverse Event|0|||
157171265|NCT02505542|567369055|FG002|Part A: Open-Label Period|Adverse Event|0|||
157171266|NCT02505542|567369056|FG003|Part A: Open-Label Period|Adverse Event|0|||
157171267|NCT02505542|567369053|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
157171268|NCT02505542|567369054|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
157171269|NCT02505542|567369055|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
157171270|NCT02505542|567369056|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
157171271|NCT02505542|567369053|FG000|Part A: Open-Label Period|Protocol Violation|1|||
157171272|NCT02505542|567369054|FG001|Part A: Open-Label Period|Protocol Violation|0|||
157171273|NCT02505542|567369055|FG002|Part A: Open-Label Period|Protocol Violation|0|||
157171274|NCT02505542|567369056|FG003|Part A: Open-Label Period|Protocol Violation|0|||
157171275|NCT02505542|567369053|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
157171276|NCT02505542|567369054|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
157171277|NCT02505542|567369055|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
157171278|NCT02505542|567369056|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
157171279|NCT02505542|567369053|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
157171280|NCT02505542|567369054|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
157227797|NCT00979628|567579210|FG001|Overall Study|received regimen < 24 hours|6|||
157227798|NCT00979628|567579211|FG002|Overall Study|received regimen < 24 hours|5|||
157171281|NCT02505542|567369055|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
157171282|NCT02505542|567369056|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
157171283|NCT02505542|567369053|FG000|Part A: Open-Label Period|New medical history available|1|||
157171284|NCT02505542|567369054|FG001|Part A: Open-Label Period|New medical history available|0|||
157171285|NCT02505542|567369055|FG002|Part A: Open-Label Period|New medical history available|0|||
157171286|NCT02505542|567369056|FG003|Part A: Open-Label Period|New medical history available|0|||
157171287|NCT02505542|567369053|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
157171288|NCT02505542|567369054|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
157171289|NCT02505542|567369055|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
157171290|NCT02505542|567369056|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
157171291|NCT02505542|567369053|FG000|Part A: Open-Label Period|Pregnancy|2|||
157171292|NCT02505542|567369054|FG001|Part A: Open-Label Period|Pregnancy|0|||
157171293|NCT02505542|567369055|FG002|Part A: Open-Label Period|Pregnancy|0|||
157171294|NCT02505542|567369056|FG003|Part A: Open-Label Period|Pregnancy|0|||
157171295|NCT02505542|567369053|FG000|Part A: Open-Label Period|Sponsor directive|1|||
157171296|NCT02505542|567369054|FG001|Part A: Open-Label Period|Sponsor directive|0|||
157171297|NCT02505542|567369055|FG002|Part A: Open-Label Period|Sponsor directive|0|||
157171298|NCT02505542|567369056|FG003|Part A: Open-Label Period|Sponsor directive|0|||
157171299|NCT02505542|567369053|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
157171300|NCT02505542|567369054|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
157171301|NCT02505542|567369055|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
157171302|NCT02505542|567369056|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
157171303|NCT02505542|567369053|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
157171304|NCT02505542|567369054|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
157171305|NCT02505542|567369055|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
157171306|NCT02505542|567369056|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
157171307|NCT02505542|567369053|FG000|Part A: Open-Label Period|Non-compliance|1|||
157171308|NCT02505542|567369054|FG001|Part A: Open-Label Period|Non-compliance|0|||
157171309|NCT02505542|567369055|FG002|Part A: Open-Label Period|Non-compliance|0|||
157171310|NCT02505542|567369056|FG003|Part A: Open-Label Period|Non-compliance|0|||
157171311|NCT02505542|567369053|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
157227799|NCT00979628|567579209|FG000|Overall Study|received steroids|1|||
156961431|NCT01922076|566609789|FG004|Overall Study|Physician Decision|0|||
156961432|NCT01922076|566609790|FG005|Overall Study|Physician Decision|0|||
157171312|NCT02505542|567369054|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
157171313|NCT02505542|567369055|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
157171314|NCT02505542|567369056|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
157227800|NCT00979628|567579210|FG001|Overall Study|received steroids|1|||
157227801|NCT00979628|567579211|FG002|Overall Study|received steroids|0|||
156961433|NCT01922076|566609791|FG006|Overall Study|Physician Decision|0|||
156961434|NCT01922076|566609785|FG000|Overall Study|Withdrawal by Subject|0|||
156961435|NCT01922076|566609786|FG001|Overall Study|Withdrawal by Subject|0|||
156961436|NCT01922076|566609787|FG002|Overall Study|Withdrawal by Subject|0|||
156961437|NCT01922076|566609788|FG003|Overall Study|Withdrawal by Subject|1|||
156961438|NCT01922076|566609789|FG004|Overall Study|Withdrawal by Subject|0|||
156961439|NCT01922076|566609790|FG005|Overall Study|Withdrawal by Subject|1|||
156961440|NCT01922076|566609791|FG006|Overall Study|Withdrawal by Subject|1|||
156961441|NCT04899349|566609799|FG000|Overall Study|Study terminated by Sponsor|2|||
156961442|NCT04899349|566609800|FG001|Overall Study|Study terminated by Sponsor|0|||
156961443|NCT01018394|566609801|FG000|Overall Study|Withdrawal by Subject|5|||
156961444|NCT01018394|566609802|FG001|Overall Study|Withdrawal by Subject|5|||
156961445|NCT01018394|566609801|FG000|Overall Study|Lost to Follow-up|4|||
156961446|NCT01018394|566609802|FG001|Overall Study|Lost to Follow-up|3|||
156961447|NCT00683644|566609803|FG000|Overall Study|Withdrawal by Subject|4|||
156961448|NCT00683644|566609804|FG001|Overall Study|Withdrawal by Subject|2|||
156961449|NCT00683644|566609803|FG000|Overall Study|Lost to Follow-up|1|||
156961450|NCT00683644|566609804|FG001|Overall Study|Lost to Follow-up|4|||
156961451|NCT00683644|566609803|FG000|Overall Study|Adverse Event|1|||
156961452|NCT00683644|566609804|FG001|Overall Study|Adverse Event|2|||
156961453|NCT00683644|566609803|FG000|Overall Study|Low copper, other health problems,|7|||
156961454|NCT00683644|566609804|FG001|Overall Study|Low copper, other health problems,|6|||
156961455|NCT03240692|566609805|FG000|Overall Study|Physician Decision|1|||
156961456|NCT03240692|566609805|FG000|Overall Study|Withdrawal by Subject|1|||
156961457|NCT03336619|566609807|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
156961458|NCT03336619|566609808|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
156961459|NCT03336619|566609807|FG000|Overall Study|Withdrawal by Subject|17|||
156961460|NCT03336619|566609808|FG001|Overall Study|Withdrawal by Subject|16|||
156961461|NCT03336619|566609807|FG000|Overall Study|Adverse Event|2|||
157171315|NCT02505542|567369053|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
157171316|NCT02505542|567369054|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
157171317|NCT02505542|567369055|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
157171318|NCT02505542|567369056|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
157171319|NCT02505542|567369053|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
157171320|NCT02505542|567369054|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
157171321|NCT02505542|567369055|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
157171322|NCT02505542|567369056|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
157171323|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Adverse Event|0|||
157171324|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Adverse Event|0|||
157171325|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Adverse Event|1|||
157171326|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Adverse Event|3|||
157171327|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
157171328|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
157171329|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
156961462|NCT03336619|566609808|FG001|Overall Study|Adverse Event|5|||
156961463|NCT03336619|566609807|FG000|Overall Study|Physician Decision|3|||
156961464|NCT03336619|566609808|FG001|Overall Study|Physician Decision|0|||
156961465|NCT01300546|566609809|FG000|Overall Study|Withdrawal by Subject|1|||
156961466|NCT01300546|566609810|FG001|Overall Study|Withdrawal by Subject|0|||
156961467|NCT01300546|566609809|FG000|Overall Study|Lost to Follow-up|0|||
156961468|NCT01300546|566609810|FG001|Overall Study|Lost to Follow-up|2|||
156961469|NCT01300546|566609809|FG000|Overall Study|Lack of Efficacy|0|||
156961470|NCT01300546|566609810|FG001|Overall Study|Lack of Efficacy|3|||
156961471|NCT01300546|566609809|FG000|Overall Study|Adverse Event|0|||
156961472|NCT01300546|566609810|FG001|Overall Study|Adverse Event|1|||
156961473|NCT02820623|566609811|FG000|Overall Study|Withdrawal by Subject|1|||
156961474|NCT02820623|566609812|FG001|Overall Study|Withdrawal by Subject|3|||
156961475|NCT02820623|566609813|FG002|Overall Study|Withdrawal by Subject|3|||
156961476|NCT02820623|566609811|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
156961477|NCT02820623|566609812|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
156961478|NCT02820623|566609813|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
156961479|NCT02820623|566609811|FG000|Overall Study|Therapist unable to enroll clients|1|||
156961480|NCT02820623|566609812|FG001|Overall Study|Therapist unable to enroll clients|1|||
156961481|NCT02820623|566609813|FG002|Overall Study|Therapist unable to enroll clients|3|||
156961482|NCT02820623|566609811|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
156961483|NCT02820623|566609812|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
157038198|NCT01500200|566895348|FG003|Stage 1|Withdrawal by Subject|0|||
157038199|NCT01500200|566895349|FG004|Stage 1|Withdrawal by Subject|0|||
156961484|NCT02820623|566609813|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
156961485|NCT05207813|566609814|FG000|Overall Study|Lost to Follow-up|2|||
156961486|NCT00617344|566609816|FG000|Overall Study|Serious adverse event|1|||
157038200|NCT01500200|566895350|FG005|Stage 1|Withdrawal by Subject|0|||
156961487|NCT00617344|566609817|FG001|Overall Study|Serious adverse event|0|||
156961488|NCT00617344|566609818|FG002|Overall Study|Serious adverse event|0|||
156961489|NCT00617344|566609816|FG000|Overall Study|Other Adverse Event|1|||
156961490|NCT00617344|566609817|FG001|Overall Study|Other Adverse Event|1|||
156961491|NCT00617344|566609818|FG002|Overall Study|Other Adverse Event|0|||
156961492|NCT00617344|566609816|FG000|Overall Study|Protocol Violation|10|||
156961493|NCT00617344|566609817|FG001|Overall Study|Protocol Violation|8|||
156961494|NCT00617344|566609818|FG002|Overall Study|Protocol Violation|5|||
156961495|NCT00617344|566609816|FG000|Overall Study|Lost to Follow-up|5|||
156961496|NCT00617344|566609817|FG001|Overall Study|Lost to Follow-up|4|||
156961497|NCT00617344|566609818|FG002|Overall Study|Lost to Follow-up|1|||
156961498|NCT00617344|566609816|FG000|Overall Study|Withdrawal by Subject|8|||
156961499|NCT00617344|566609817|FG001|Overall Study|Withdrawal by Subject|9|||
156961500|NCT00617344|566609818|FG002|Overall Study|Withdrawal by Subject|2|||
156961501|NCT02943408|566611648|FG000|Overall Study|Lost to Follow-up|7|||
156961502|NCT02943408|566611649|FG001|Overall Study|Lost to Follow-up|1|||
156961503|NCT02943408|566611648|FG000|Overall Study|Withdrawal by Subject|0|||
156961504|NCT02943408|566611649|FG001|Overall Study|Withdrawal by Subject|1|||
156961505|NCT01621126|566611652|FG000|Overall Study|Physician Decision|6|||
156961506|NCT00886340|566611653|FG000|Overall Study|Withdrawal by Subject|0|||
156961507|NCT00886340|566611654|FG001|Overall Study|Withdrawal by Subject|7|||
156961508|NCT03751631|566611655|FG000|Overall Study|Withdrawal by Subject|0|||
156961509|NCT03751631|566611656|FG001|Overall Study|Withdrawal by Subject|0|||
156961510|NCT03751631|566611657|FG002|Overall Study|Withdrawal by Subject|1|||
156961511|NCT03751631|566611658|FG003|Overall Study|Withdrawal by Subject|1|||
156961512|NCT03751631|566611659|FG004|Overall Study|Withdrawal by Subject|0|||
156961513|NCT03751631|566611660|FG005|Overall Study|Withdrawal by Subject|0|||
157038201|NCT01500200|566895345|FG000|Stage 1|Noncompliance with Study Drug|1|||
157038202|NCT01500200|566895346|FG001|Stage 1|Noncompliance with Study Drug|0|||
157038203|NCT01500200|566895347|FG002|Stage 1|Noncompliance with Study Drug|0|||
157038204|NCT01500200|566895348|FG003|Stage 1|Noncompliance with Study Drug|0|||
157038205|NCT01500200|566895349|FG004|Stage 1|Noncompliance with Study Drug|0|||
157038206|NCT01500200|566895350|FG005|Stage 1|Noncompliance with Study Drug|0|||
157038207|NCT01500200|566895345|FG000|Stage 1|Physician Decision|1|||
157038208|NCT01500200|566895346|FG001|Stage 1|Physician Decision|0|||
157038209|NCT01500200|566895347|FG002|Stage 1|Physician Decision|0|||
157038210|NCT01500200|566895348|FG003|Stage 1|Physician Decision|0|||
157038211|NCT01500200|566895349|FG004|Stage 1|Physician Decision|0|||
157038212|NCT01500200|566895350|FG005|Stage 1|Physician Decision|0|||
157038213|NCT01500200|566895345|FG000|Stage 2|Adverse Event|0|||
157038214|NCT01500200|566895346|FG001|Stage 2|Adverse Event|0|||
157038215|NCT01500200|566895347|FG002|Stage 2|Adverse Event|0|||
157038216|NCT01500200|566895348|FG003|Stage 2|Adverse Event|0|||
157038217|NCT01500200|566895349|FG004|Stage 2|Adverse Event|5|||
157038218|NCT01500200|566895350|FG005|Stage 2|Adverse Event|4|||
157038219|NCT01952366|566895351|FG000|Overall Study|Death|22|||
157038220|NCT01952366|566895351|FG000|Overall Study|Withdrawal by Subject|9|||
157038221|NCT00623194|566895352|FG000|Overall Study|Lack of Efficacy|1|||
157038222|NCT00623194|566895352|FG000|Overall Study|Protocol Violation|3|||
157038223|NCT00623194|566895352|FG000|Overall Study|Unclassified|1|||
157038224|NCT00857766|566895353|FG000|Overall Study|Adverse Event|13|||
157038225|NCT00857766|566895354|FG001|Overall Study|Adverse Event|12|||
157038226|NCT00857766|566895353|FG000|Overall Study|Protocol Violation|11|||
157038227|NCT00857766|566895354|FG001|Overall Study|Protocol Violation|11|||
157038228|NCT00857766|566895353|FG000|Overall Study|Lost to Follow-up|1|||
157038229|NCT00857766|566895354|FG001|Overall Study|Lost to Follow-up|0|||
157038230|NCT00857766|566895353|FG000|Overall Study|Investigator Discretion|2|||
157038231|NCT00857766|566895354|FG001|Overall Study|Investigator Discretion|3|||
157038232|NCT00857766|566895353|FG000|Overall Study|Participant Withdrew Consent|4|||
157038233|NCT00857766|566895354|FG001|Overall Study|Participant Withdrew Consent|4|||
157038234|NCT01212744|566895357|FG000|Overall Study|Withdrawal by Subject|1|||
157038235|NCT02167451|566895359|FG000|Overall Study|Withdrawal by Subject|1|||
157171330|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
157171331|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
157038236|NCT00571649|566895360|FG000|Treatment Period|Adverse Event|438|||
157038237|NCT00571649|566895361|FG001|Treatment Period|Adverse Event|385|||
157038238|NCT00571649|566895360|FG000|Treatment Period|Clinical endpoint reached|50|||
157038239|NCT00571649|566895361|FG001|Treatment Period|Clinical endpoint reached|56|||
157038240|NCT00571649|566895360|FG000|Treatment Period|Withdrawal by Subject|285|||
157038241|NCT00571649|566895361|FG001|Treatment Period|Withdrawal by Subject|255|||
157038242|NCT00571649|566895360|FG000|Treatment Period|Death|76|||
157038243|NCT00571649|566895361|FG001|Treatment Period|Death|59|||
156961514|NCT03224182|566611661|FG000|Overall Study|Study Drug Not Instilled|6|||
156961515|NCT03224182|566611662|FG001|Overall Study|Study Drug Not Instilled|1|||
156961516|NCT03224182|566611661|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
156961517|NCT03224182|566611662|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
156961518|NCT03224182|566611661|FG000|Overall Study|Withdrew of Consent|4|||
156961519|NCT03224182|566611662|FG001|Overall Study|Withdrew of Consent|2|||
157171332|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
157171333|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
157171334|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
157171335|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
157171336|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
157171337|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
157171338|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
157171339|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
157171340|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
157171341|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
157171342|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
157171343|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
157171344|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
157171345|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
157171346|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
157171347|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
157171348|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
157171349|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
157171350|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
157171351|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Miscalculation|0|||
157171352|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Miscalculation|1|||
157171353|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Miscalculation|0|||
157171354|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Miscalculation|0|||
157171355|NCT02505542|567369053|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
157171356|NCT02505542|567369054|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
157171357|NCT02505542|567369055|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
157171358|NCT02505542|567369056|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
157171359|NCT02151682|567369057|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
157171360|NCT02151682|567369058|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
157171361|NCT02151682|567369059|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
157171362|NCT02151682|567369060|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
157171363|NCT02151682|567369061|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
157171364|NCT02151682|567369062|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
157171365|NCT02151682|567369057|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
157171366|NCT02151682|567369058|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
157171367|NCT02151682|567369059|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
157171368|NCT02151682|567369060|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
157171369|NCT02151682|567369061|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
157171370|NCT02151682|567369062|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
157171371|NCT02151682|567369057|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
157171372|NCT02151682|567369058|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
157171373|NCT02151682|567369059|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
157171374|NCT02151682|567369060|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
157171375|NCT02151682|567369061|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
157171376|NCT02151682|567369062|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
157171377|NCT02151682|567369057|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
157171378|NCT02151682|567369058|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
157171379|NCT02151682|567369059|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
157171380|NCT02151682|567369060|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
157171381|NCT02151682|567369061|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
157171382|NCT02151682|567369062|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
157171383|NCT02151682|567369057|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
157171384|NCT02151682|567369058|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
157171385|NCT02151682|567369059|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
157171386|NCT02151682|567369060|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
157171387|NCT02151682|567369061|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
157171388|NCT02151682|567369062|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
157171389|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
157171390|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
157171391|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
157171392|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
157171393|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
157171394|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
157171395|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
157171396|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
157171397|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
157171398|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
157171399|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
157171400|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
157171401|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
157171402|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
157171403|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
157171404|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
157171405|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
157171406|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
157171407|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
157171408|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
157171409|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
157171410|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
157227802|NCT00979628|567579209|FG000|Overall Study|transferred to ICU|1|||
157227803|NCT00979628|567579210|FG001|Overall Study|transferred to ICU|2|||
156961520|NCT03224182|566611661|FG000|Overall Study|Investigator Decision|3|||
156961521|NCT03224182|566611662|FG001|Overall Study|Investigator Decision|1|||
156961522|NCT03224182|566611661|FG000|Overall Study|Sponsor Decision|26|||
156961523|NCT03224182|566611662|FG001|Overall Study|Sponsor Decision|12|||
156961524|NCT03224182|566611661|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
156961525|NCT03224182|566611662|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
156961526|NCT03224182|566611661|FG000|Overall Study|Lost to Follow-up|1|||
156961527|NCT03224182|566611662|FG001|Overall Study|Lost to Follow-up|0|||
156961528|NCT03224182|566611661|FG000|Overall Study|Participant Had Recurrence|11|||
156961529|NCT03224182|566611662|FG001|Overall Study|Participant Had Recurrence|5|||
156961530|NCT03224182|566611661|FG000|Overall Study|Death|0|||
156961531|NCT03224182|566611662|FG001|Overall Study|Death|1|||
156961532|NCT03224182|566611661|FG000|Overall Study|Reason not Specified|3|||
156961533|NCT03224182|566611662|FG001|Overall Study|Reason not Specified|3|||
156961534|NCT03224182|566611661|FG000|Overall Study|Other|1|||
156961535|NCT03224182|566611662|FG001|Overall Study|Other|0|||
156961536|NCT00447057|566611665|FG000|Overall Study|Adverse Event|4|||
156961537|NCT00447057|566611666|FG001|Overall Study|Adverse Event|10|||
156961538|NCT00447057|566611667|FG002|Overall Study|Adverse Event|0|||
156961539|NCT00447057|566611668|FG003|Overall Study|Adverse Event|3|||
156961540|NCT00447057|566611665|FG000|Overall Study|Death due to study disease|6|||
156961541|NCT00447057|566611666|FG001|Overall Study|Death due to study disease|4|||
156961542|NCT00447057|566611667|FG002|Overall Study|Death due to study disease|1|||
156961543|NCT00447057|566611668|FG003|Overall Study|Death due to study disease|1|||
156961544|NCT00447057|566611665|FG000|Overall Study|Lost to Follow-up|0|||
156961545|NCT00447057|566611666|FG001|Overall Study|Lost to Follow-up|1|||
156961546|NCT00447057|566611667|FG002|Overall Study|Lost to Follow-up|0|||
156961547|NCT00447057|566611668|FG003|Overall Study|Lost to Follow-up|0|||
156961548|NCT00447057|566611665|FG000|Overall Study|Entry criteria not met|1|||
156961549|NCT00447057|566611666|FG001|Overall Study|Entry criteria not met|1|||
156961550|NCT00447057|566611667|FG002|Overall Study|Entry criteria not met|0|||
156961551|NCT00447057|566611668|FG003|Overall Study|Entry criteria not met|0|||
156961552|NCT00447057|566611665|FG000|Overall Study|Protocol Violation|0|||
156961553|NCT00447057|566611666|FG001|Overall Study|Protocol Violation|1|||
156961554|NCT00447057|566611667|FG002|Overall Study|Protocol Violation|0|||
156961555|NCT00447057|566611668|FG003|Overall Study|Protocol Violation|0|||
156961556|NCT00447057|566611665|FG000|Overall Study|Withdrawal by Subject|4|||
156961557|NCT00447057|566611666|FG001|Overall Study|Withdrawal by Subject|5|||
156961558|NCT00447057|566611667|FG002|Overall Study|Withdrawal by Subject|1|||
156961559|NCT00447057|566611668|FG003|Overall Study|Withdrawal by Subject|1|||
156961560|NCT00447057|566611665|FG000|Overall Study|Physician Decision|9|||
156961561|NCT00447057|566611666|FG001|Overall Study|Physician Decision|6|||
156961562|NCT00447057|566611667|FG002|Overall Study|Physician Decision|3|||
156961563|NCT00447057|566611668|FG003|Overall Study|Physician Decision|1|||
156961564|NCT00447057|566611665|FG000|Overall Study|Sponsor decision|1|||
156961565|NCT00447057|566611666|FG001|Overall Study|Sponsor decision|1|||
156961566|NCT00447057|566611667|FG002|Overall Study|Sponsor decision|0|||
156961567|NCT00447057|566611668|FG003|Overall Study|Sponsor decision|0|||
156961568|NCT00447057|566611665|FG000|Overall Study|Progressive disease|58|||
157171411|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
156961569|NCT00447057|566611666|FG001|Overall Study|Progressive disease|43|||
156961570|NCT00447057|566611667|FG002|Overall Study|Progressive disease|13|||
156961571|NCT00447057|566611668|FG003|Overall Study|Progressive disease|18|||
157227804|NCT00979628|567579211|FG002|Overall Study|transferred to ICU|1|||
156961572|NCT00447057|566611665|FG000|Overall Study|Death due to adverse event|0|||
156961573|NCT00447057|566611666|FG001|Overall Study|Death due to adverse event|0|||
156961574|NCT00447057|566611667|FG002|Overall Study|Death due to adverse event|1|||
156961575|NCT00447057|566611668|FG003|Overall Study|Death due to adverse event|2|||
156961576|NCT00447057|566611665|FG000|Overall Study|Death, study drug related|0|||
156961577|NCT00447057|566611666|FG001|Overall Study|Death, study drug related|1|||
157038244|NCT00571649|566895360|FG000|Treatment Period|Physician Decision|8|||
157038245|NCT00571649|566895361|FG001|Treatment Period|Physician Decision|9|||
157038246|NCT00571649|566895360|FG000|Treatment Period|Lost to Follow-up|43|||
157038247|NCT00571649|566895361|FG001|Treatment Period|Lost to Follow-up|41|||
157038248|NCT00571649|566895360|FG000|Treatment Period|Non-compliant with study medication|88|||
157038249|NCT00571649|566895361|FG001|Treatment Period|Non-compliant with study medication|89|||
157038250|NCT00571649|566895360|FG000|Treatment Period|Patient convenience|11|||
157038251|NCT00571649|566895361|FG001|Treatment Period|Patient convenience|13|||
157038252|NCT00571649|566895360|FG000|Treatment Period|Protocol Violation|90|||
157038253|NCT00571649|566895361|FG001|Treatment Period|Protocol Violation|92|||
157038254|NCT00571649|566895360|FG000|Treatment Period|Technical problems|3|||
157038255|NCT00571649|566895361|FG001|Treatment Period|Technical problems|5|||
157038256|NCT00571649|566895360|FG000|Follow-up Period|Adverse Event|46|||
157038257|NCT00571649|566895361|FG001|Follow-up Period|Adverse Event|40|||
157038258|NCT00571649|566895360|FG000|Follow-up Period|Clinical endpoint reached|5|||
157038259|NCT00571649|566895361|FG001|Follow-up Period|Clinical endpoint reached|2|||
157038260|NCT00571649|566895360|FG000|Follow-up Period|Withdrawal by Subject|119|||
157038261|NCT00571649|566895361|FG001|Follow-up Period|Withdrawal by Subject|115|||
157038262|NCT00571649|566895360|FG000|Follow-up Period|Death|132|||
157038263|NCT00571649|566895361|FG001|Follow-up Period|Death|133|||
157038264|NCT00571649|566895360|FG000|Follow-up Period|Physician Decision|7|||
157038265|NCT00571649|566895361|FG001|Follow-up Period|Physician Decision|13|||
157038266|NCT00571649|566895360|FG000|Follow-up Period|Lost to Follow-up|95|||
157038267|NCT00571649|566895361|FG001|Follow-up Period|Lost to Follow-up|92|||
157038268|NCT00571649|566895360|FG000|Follow-up Period|Patient convenience|136|||
157038269|NCT00571649|566895361|FG001|Follow-up Period|Patient convenience|121|||
157038270|NCT00571649|566895360|FG000|Follow-up Period|Protocol Violation|5|||
157038271|NCT00571649|566895361|FG001|Follow-up Period|Protocol Violation|12|||
157038272|NCT01218659|566895362|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
157038273|NCT01218659|566895363|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
157038274|NCT01218659|566895364|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
157038275|NCT01218659|566895362|FG000|18-Month Randomized Period|Did not receive study drug|0|||
157038276|NCT01218659|566895363|FG001|18-Month Randomized Period|Did not receive study drug|3|||
157038277|NCT01218659|566895364|FG002|18-Month Randomized Period|Did not receive study drug|0|||
157038278|NCT01218659|566895362|FG000|12-Month OLE|Withdrawal by Subject|0|||
157038279|NCT01218659|566895363|FG001|12-Month OLE|Withdrawal by Subject|0|||
157038280|NCT01218659|566895364|FG002|12-Month OLE|Withdrawal by Subject|2|||
157038281|NCT01218659|566895362|FG000|12-Month OLE|Physician Decision|0|||
157038282|NCT01218659|566895363|FG001|12-Month OLE|Physician Decision|0|||
157038283|NCT01218659|566895364|FG002|12-Month OLE|Physician Decision|1|||
157038284|NCT01218659|566895362|FG000|12-Month OLE|Lost to Follow-up|0|||
157038285|NCT01218659|566895363|FG001|12-Month OLE|Lost to Follow-up|0|||
157038286|NCT01218659|566895364|FG002|12-Month OLE|Lost to Follow-up|1|||
157038287|NCT01218659|566895362|FG000|12-Month OLE|Pregnancy|0|||
157038288|NCT01218659|566895363|FG001|12-Month OLE|Pregnancy|0|||
157038289|NCT01218659|566895364|FG002|12-Month OLE|Pregnancy|1|||
157038290|NCT01218659|566895362|FG000|12-Month OLE|Lack of Efficacy|0|||
157038291|NCT01218659|566895363|FG001|12-Month OLE|Lack of Efficacy|0|||
157038292|NCT01218659|566895364|FG002|12-Month OLE|Lack of Efficacy|1|||
157038293|NCT01218659|566895362|FG000|12-Month OLE|Declined to participate in the OLE|0|||
157038294|NCT01218659|566895363|FG001|12-Month OLE|Declined to participate in the OLE|0|||
157038295|NCT01218659|566895364|FG002|12-Month OLE|Declined to participate in the OLE|4|||
157038296|NCT03355573|566895371|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
157038297|NCT03355573|566895371|FG000|Overall Study|Sponsor's decision|1|||
157038298|NCT03355573|566895371|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
157038299|NCT03355573|566895371|FG000|Overall Study|PI's decision|2|||
157171412|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
157171413|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
157171414|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
157171415|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
157038300|NCT03355573|566895371|FG000|Overall Study|Withdrawal by Subject|23|||
157038301|NCT03355573|566895371|FG000|Overall Study|Lost to Follow-up|4|||
157038302|NCT03355573|566895371|FG000|Overall Study|Lack of Efficacy|2|||
157038303|NCT03355573|566895371|FG000|Overall Study|Adverse Event, non-fatal|17|||
157038304|NCT03355573|566895371|FG000|Overall Study|Adverse Event, serious fatal|2|||
157038305|NCT01566890|566895372|FG000|Overall Study|Adverse Event|1|||
157038306|NCT01566890|566895373|FG001|Overall Study|Adverse Event|0|||
157038307|NCT01566890|566895374|FG002|Overall Study|Adverse Event|0|||
157038308|NCT01566890|566895375|FG003|Overall Study|Adverse Event|0|||
157038309|NCT01566890|566895376|FG004|Overall Study|Adverse Event|0|||
157038310|NCT01566890|566895372|FG000|Overall Study|Withdrawal by Subject|3|||
157038311|NCT01566890|566895373|FG001|Overall Study|Withdrawal by Subject|1|||
157038312|NCT01566890|566895374|FG002|Overall Study|Withdrawal by Subject|1|||
157038313|NCT01566890|566895375|FG003|Overall Study|Withdrawal by Subject|1|||
157038314|NCT01566890|566895376|FG004|Overall Study|Withdrawal by Subject|0|||
156961578|NCT00447057|566611667|FG002|Overall Study|Death, study drug related|0|||
156961579|NCT00447057|566611668|FG003|Overall Study|Death, study drug related|0|||
156961580|NCT00677833|566611669|FG000|Overall Study|Withdrawal by Subject|4|||
156961581|NCT00677833|566611670|FG001|Overall Study|Withdrawal by Subject|0|||
156961582|NCT00677833|566611671|FG002|Overall Study|Withdrawal by Subject|1|||
156961583|NCT00677833|566611672|FG003|Overall Study|Withdrawal by Subject|3|||
156961584|NCT00677833|566611669|FG000|Overall Study|Lost to Follow-up|0|||
156961585|NCT00677833|566611670|FG001|Overall Study|Lost to Follow-up|0|||
156961586|NCT00677833|566611671|FG002|Overall Study|Lost to Follow-up|1|||
156961587|NCT00677833|566611672|FG003|Overall Study|Lost to Follow-up|0|||
156961588|NCT02606279|566611677|FG000|Overall Study|Lost to Follow-up|0|||
156961589|NCT02606279|566611678|FG001|Overall Study|Lost to Follow-up|1|||
156961590|NCT02184611|566611679|FG000|Overall Study|Lack of Efficacy|11|||
156961591|NCT02184611|566611680|FG001|Overall Study|Lack of Efficacy|15|||
156961592|NCT02184611|566611679|FG000|Overall Study|Withdrawal by Subject|5|||
156961593|NCT02184611|566611680|FG001|Overall Study|Withdrawal by Subject|6|||
156961594|NCT02184611|566611679|FG000|Overall Study|Adverse Event|4|||
156961595|NCT02184611|566611680|FG001|Overall Study|Adverse Event|5|||
156961596|NCT02184611|566611679|FG000|Overall Study|Protocol Violation|1|||
156961597|NCT02184611|566611680|FG001|Overall Study|Protocol Violation|1|||
156961598|NCT02184611|566611679|FG000|Overall Study|Protocol defined stopping criteria|0|||
156961599|NCT02184611|566611680|FG001|Overall Study|Protocol defined stopping criteria|1|||
156961600|NCT00160680|566611681|FG000|Overall Study|Adverse Event|0|||
156961601|NCT00160680|566611682|FG001|Overall Study|Adverse Event|1|||
156961602|NCT00160680|566611681|FG000|Overall Study|Lack of Efficacy|2|||
156961603|NCT00160680|566611682|FG001|Overall Study|Lack of Efficacy|1|||
156961604|NCT00160680|566611681|FG000|Overall Study|Lost to Follow-up|3|||
156961605|NCT00160680|566611682|FG001|Overall Study|Lost to Follow-up|2|||
156961606|NCT00160680|566611681|FG000|Overall Study|Withdrawal by Subject|4|||
156961607|NCT00160680|566611682|FG001|Overall Study|Withdrawal by Subject|9|||
156961608|NCT04493216|566611683|FG000|Overall Study|Study terminated by sponsor|30|||
156961609|NCT04493216|566611684|FG001|Overall Study|Study terminated by sponsor|33|||
156961610|NCT04493216|566611685|FG002|Overall Study|Study terminated by sponsor|28|||
156961611|NCT04493216|566611686|FG003|Overall Study|Study terminated by sponsor|27|||
156961612|NCT04493216|566611683|FG000|Overall Study|Withdrawal by Subject|2|||
156961613|NCT04493216|566611684|FG001|Overall Study|Withdrawal by Subject|1|||
156961614|NCT04493216|566611685|FG002|Overall Study|Withdrawal by Subject|1|||
156961615|NCT04493216|566611686|FG003|Overall Study|Withdrawal by Subject|2|||
156961616|NCT04493216|566611683|FG000|Overall Study|Protocol Violation|1|||
156961617|NCT04493216|566611684|FG001|Overall Study|Protocol Violation|2|||
156961618|NCT04493216|566611685|FG002|Overall Study|Protocol Violation|0|||
156961619|NCT04493216|566611686|FG003|Overall Study|Protocol Violation|2|||
156961620|NCT04493216|566611683|FG000|Overall Study|Physician Decision|0|||
156961621|NCT04493216|566611684|FG001|Overall Study|Physician Decision|0|||
156961622|NCT04493216|566611685|FG002|Overall Study|Physician Decision|1|||
156961623|NCT04493216|566611686|FG003|Overall Study|Physician Decision|0|||
156961624|NCT04493216|566611683|FG000|Overall Study|Lost to Follow-up|2|||
156961625|NCT04493216|566611684|FG001|Overall Study|Lost to Follow-up|1|||
156961626|NCT04493216|566611685|FG002|Overall Study|Lost to Follow-up|0|||
156961627|NCT04493216|566611686|FG003|Overall Study|Lost to Follow-up|1|||
156961628|NCT04493216|566611683|FG000|Overall Study|Adverse Event|1|||
156961629|NCT04493216|566611684|FG001|Overall Study|Adverse Event|4|||
156961630|NCT04493216|566611685|FG002|Overall Study|Adverse Event|5|||
156961631|NCT04493216|566611686|FG003|Overall Study|Adverse Event|2|||
156961632|NCT04493216|566611683|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
156961633|NCT04493216|566611684|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
156961634|NCT04493216|566611685|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
156961635|NCT04493216|566611686|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
156961636|NCT02314624|566611689|FG000|Overall Study|No participating patient|16|||
156961637|NCT02314624|566611690|FG001|Overall Study|No participating patient|13|||
156961638|NCT02314624|566611689|FG000|Overall Study|Participant withdrew|7|||
156961639|NCT02314624|566611690|FG001|Overall Study|Participant withdrew|2|||
156961640|NCT02314624|566611689|FG000|Overall Study|Lost to Follow-up|2|||
157227805|NCT00911859|567579212|FG000|Treatment Period|Adverse Event|3|||
156961641|NCT02314624|566611690|FG001|Overall Study|Lost to Follow-up|5|||
156961642|NCT02314624|566611689|FG000|Overall Study|Dropped/Excluded by PI|6|||
156961643|NCT02314624|566611690|FG001|Overall Study|Dropped/Excluded by PI|6|||
156961644|NCT02583425|566611691|FG000|Screening|Did not meet entry criteria|12|||
156961645|NCT02583425|566611691|FG000|Baseline|Did not meet continued criteria|5|||
156961646|NCT02583425|566611691|FG000|Treatment Period|Adverse Event|1|||
156961647|NCT02163733|566611694|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
156961648|NCT02163733|566611695|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
156961649|NCT02163733|566611696|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
156961650|NCT02163733|566611694|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
156961651|NCT02163733|566611695|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
156961652|NCT02163733|566611696|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
157171416|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
157171417|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
157171418|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
157171419|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
157171420|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
157171421|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
157171422|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156961653|NCT02723864|566611697|FG000|Overall Study|Refused further treatment|1|||
156961654|NCT02723864|566611698|FG001|Overall Study|Refused further treatment|0|||
156961655|NCT02723864|566611699|FG002|Overall Study|Refused further treatment|0|||
156961656|NCT02723864|566611700|FG003|Overall Study|Refused further treatment|0|||
156961657|NCT02723864|566611701|FG004|Overall Study|Refused further treatment|1|||
156961658|NCT02723864|566611702|FG005|Overall Study|Refused further treatment|2|||
156961659|NCT02723864|566611703|FG006|Overall Study|Refused further treatment|0|||
156961660|NCT02723864|566611697|FG000|Overall Study|Exceed treatment hold time|0|||
156961661|NCT02723864|566611698|FG001|Overall Study|Exceed treatment hold time|1|||
156961662|NCT02723864|566611699|FG002|Overall Study|Exceed treatment hold time|0|||
156961663|NCT02723864|566611700|FG003|Overall Study|Exceed treatment hold time|0|||
156961664|NCT02723864|566611701|FG004|Overall Study|Exceed treatment hold time|0|||
156961665|NCT02723864|566611702|FG005|Overall Study|Exceed treatment hold time|0|||
156961666|NCT02723864|566611703|FG006|Overall Study|Exceed treatment hold time|0|||
156961667|NCT02723864|566611697|FG000|Overall Study|Clinical progression|0|||
156961668|NCT02723864|566611698|FG001|Overall Study|Clinical progression|0|||
156961669|NCT02723864|566611699|FG002|Overall Study|Clinical progression|1|||
156961670|NCT02723864|566611700|FG003|Overall Study|Clinical progression|0|||
156961671|NCT02723864|566611701|FG004|Overall Study|Clinical progression|0|||
156961672|NCT02723864|566611702|FG005|Overall Study|Clinical progression|3|||
156961673|NCT02723864|566611703|FG006|Overall Study|Clinical progression|1|||
156961674|NCT02723864|566611697|FG000|Overall Study|Physician Decision|0|||
156961675|NCT02723864|566611698|FG001|Overall Study|Physician Decision|0|||
156961676|NCT02723864|566611699|FG002|Overall Study|Physician Decision|0|||
156961677|NCT02723864|566611700|FG003|Overall Study|Physician Decision|0|||
156961678|NCT02723864|566611701|FG004|Overall Study|Physician Decision|0|||
156961679|NCT02723864|566611702|FG005|Overall Study|Physician Decision|0|||
156961680|NCT02723864|566611703|FG006|Overall Study|Physician Decision|1|||
156961681|NCT02723864|566611697|FG000|Overall Study|Changes in patient condition|0|||
156961682|NCT02723864|566611698|FG001|Overall Study|Changes in patient condition|0|||
156961683|NCT02723864|566611699|FG002|Overall Study|Changes in patient condition|0|||
156961684|NCT02723864|566611700|FG003|Overall Study|Changes in patient condition|0|||
156961685|NCT02723864|566611701|FG004|Overall Study|Changes in patient condition|0|||
156961686|NCT02723864|566611702|FG005|Overall Study|Changes in patient condition|1|||
156961687|NCT02723864|566611703|FG006|Overall Study|Changes in patient condition|0|||
156961688|NCT02723864|566611697|FG000|Overall Study|Patient choice|0|||
156961689|NCT02723864|566611698|FG001|Overall Study|Patient choice|0|||
156961690|NCT02723864|566611699|FG002|Overall Study|Patient choice|0|||
156961691|NCT02723864|566611700|FG003|Overall Study|Patient choice|0|||
156961692|NCT02723864|566611701|FG004|Overall Study|Patient choice|0|||
156961693|NCT02723864|566611702|FG005|Overall Study|Patient choice|1|||
156961694|NCT02723864|566611703|FG006|Overall Study|Patient choice|0|||
156961695|NCT02723864|566611697|FG000|Overall Study|Adverse Event|0|||
156961696|NCT02723864|566611698|FG001|Overall Study|Adverse Event|0|||
156961697|NCT02723864|566611699|FG002|Overall Study|Adverse Event|0|||
156961698|NCT02723864|566611700|FG003|Overall Study|Adverse Event|0|||
156961699|NCT02723864|566611701|FG004|Overall Study|Adverse Event|0|||
156961700|NCT02723864|566611702|FG005|Overall Study|Adverse Event|1|||
156961701|NCT02723864|566611703|FG006|Overall Study|Adverse Event|0|||
156961702|NCT02723864|566611697|FG000|Overall Study|Started new treatment|0|||
156961703|NCT02723864|566611698|FG001|Overall Study|Started new treatment|0|||
156961704|NCT02723864|566611699|FG002|Overall Study|Started new treatment|0|||
156961705|NCT02723864|566611700|FG003|Overall Study|Started new treatment|0|||
156961706|NCT02723864|566611701|FG004|Overall Study|Started new treatment|0|||
157171423|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
156961707|NCT02723864|566611702|FG005|Overall Study|Started new treatment|1|||
156961708|NCT02723864|566611703|FG006|Overall Study|Started new treatment|0|||
156961709|NCT02723864|566611697|FG000|Overall Study|Switched to alternative treatment|0|||
156961710|NCT02723864|566611698|FG001|Overall Study|Switched to alternative treatment|0|||
156961711|NCT02723864|566611699|FG002|Overall Study|Switched to alternative treatment|0|||
156961712|NCT02723864|566611700|FG003|Overall Study|Switched to alternative treatment|0|||
156961713|NCT02723864|566611701|FG004|Overall Study|Switched to alternative treatment|0|||
156961714|NCT02723864|566611702|FG005|Overall Study|Switched to alternative treatment|1|||
156961715|NCT02723864|566611703|FG006|Overall Study|Switched to alternative treatment|0|||
156961716|NCT02723864|566611697|FG000|Overall Study|Late determination of ineligibility|0|||
156961717|NCT02723864|566611698|FG001|Overall Study|Late determination of ineligibility|0|||
156961718|NCT02723864|566611699|FG002|Overall Study|Late determination of ineligibility|0|||
156961719|NCT02723864|566611700|FG003|Overall Study|Late determination of ineligibility|0|||
156961720|NCT02723864|566611701|FG004|Overall Study|Late determination of ineligibility|0|||
156961721|NCT02723864|566611702|FG005|Overall Study|Late determination of ineligibility|1|||
156961722|NCT02723864|566611703|FG006|Overall Study|Late determination of ineligibility|0|||
156961723|NCT03232983|566611704|FG000|Period 1|Physician Decision|0|||
156961724|NCT03232983|566611705|FG001|Period 1|Physician Decision|0|||
156961725|NCT03232983|566611706|FG002|Period 1|Physician Decision|1|||
156961726|NCT03232983|566611707|FG003|Period 1|Physician Decision|0|||
156961727|NCT03232983|566611704|FG000|Washout Period 2|Physician Decision|0|||
156961728|NCT03232983|566611705|FG001|Washout Period 2|Physician Decision|0|||
156961729|NCT03232983|566611706|FG002|Washout Period 2|Physician Decision|1|||
156961730|NCT03232983|566611707|FG003|Washout Period 2|Physician Decision|0|||
156961731|NCT03232983|566611704|FG000|Washout Period 2|Withdrawal by Subject|0|||
156961732|NCT03232983|566611705|FG001|Washout Period 2|Withdrawal by Subject|0|||
156961733|NCT03232983|566611706|FG002|Washout Period 2|Withdrawal by Subject|0|||
156961734|NCT03232983|566611707|FG003|Washout Period 2|Withdrawal by Subject|1|||
156961735|NCT03232983|566611704|FG000|Period 4|Withdrawal by Subject|1|||
156961736|NCT03232983|566611705|FG001|Period 4|Withdrawal by Subject|0|||
156961737|NCT03232983|566611706|FG002|Period 4|Withdrawal by Subject|0|||
156961738|NCT03232983|566611707|FG003|Period 4|Withdrawal by Subject|0|||
156961739|NCT00746590|566611708|FG000|Overall Study|Death|1|||
156961740|NCT02633800|566611711|FG000|Overall Study|Death|3|||
156961741|NCT02633800|566611712|FG001|Overall Study|Death|3|||
156961742|NCT02633800|566611711|FG000|Overall Study|Reason not provided|1|||
156961743|NCT02633800|566611712|FG001|Overall Study|Reason not provided|0|||
156961744|NCT02633800|566611711|FG000|Overall Study|Radiologic(al) progression|23|||
156961745|NCT02633800|566611712|FG001|Overall Study|Radiologic(al) progression|23|||
156961746|NCT02633800|566611711|FG000|Overall Study|Clinical progression|3|||
156961747|NCT02633800|566611712|FG001|Overall Study|Clinical progression|6|||
156961748|NCT02633800|566611711|FG000|Overall Study|Study terminated by sponsor|6|||
156961749|NCT02633800|566611712|FG001|Overall Study|Study terminated by sponsor|5|||
156961750|NCT02633800|566611711|FG000|Overall Study|Adverse event, non-fatal|7|||
156961751|NCT02633800|566611712|FG001|Overall Study|Adverse event, non-fatal|2|||
156961752|NCT02633800|566611711|FG000|Overall Study|Withdrawal by Subject|0|||
156961753|NCT02633800|566611712|FG001|Overall Study|Withdrawal by Subject|3|||
156961754|NCT02633800|566611711|FG000|Overall Study|Patient Request|1|||
156961755|NCT02633800|566611712|FG001|Overall Study|Patient Request|1|||
156961756|NCT01597050|566611716|FG000|Overall Study|Withdrawal by Subject|1|||
156961757|NCT01597050|566611717|FG001|Overall Study|Withdrawal by Subject|0|||
156961758|NCT00483184|566611718|FG000|Overall Study|Withdrawal by Subject|2|||
156961759|NCT00483184|566611719|FG001|Overall Study|Withdrawal by Subject|2|||
156961760|NCT00483184|566611720|FG002|Overall Study|Withdrawal by Subject|0|||
156961761|NCT00483184|566611718|FG000|Overall Study|Lost to Follow-up|1|||
156961762|NCT00483184|566611719|FG001|Overall Study|Lost to Follow-up|0|||
156961763|NCT00483184|566611720|FG002|Overall Study|Lost to Follow-up|0|||
156961764|NCT00483184|566611718|FG000|Overall Study|Adverse Event|1|||
156961765|NCT00483184|566611719|FG001|Overall Study|Adverse Event|2|||
156961766|NCT00483184|566611720|FG002|Overall Study|Adverse Event|2|||
156961767|NCT00483184|566611718|FG000|Overall Study|Protocol Violation|1|||
156961768|NCT00483184|566611719|FG001|Overall Study|Protocol Violation|0|||
156961769|NCT00483184|566611720|FG002|Overall Study|Protocol Violation|1|||
156961770|NCT02065336|566611721|FG000|Extension Phase|Study Terminated by Sponsor|0|||
156961771|NCT02065336|566611722|FG001|Extension Phase|Study Terminated by Sponsor|0|||
156961772|NCT02065336|566611723|FG002|Extension Phase|Study Terminated by Sponsor|0|||
156961773|NCT02065336|566611724|FG003|Extension Phase|Study Terminated by Sponsor|0|||
156961774|NCT02065336|566611725|FG004|Extension Phase|Study Terminated by Sponsor|0|||
156961775|NCT02065336|566611726|FG005|Extension Phase|Study Terminated by Sponsor|0|||
156961776|NCT02065336|566611727|FG006|Extension Phase|Study Terminated by Sponsor|0|||
156961777|NCT02065336|566611728|FG007|Extension Phase|Study Terminated by Sponsor|0|||
156961778|NCT02065336|566611729|FG008|Extension Phase|Study Terminated by Sponsor|2|||
156961779|NCT02065336|566611730|FG009|Extension Phase|Study Terminated by Sponsor|8|||
156961780|NCT00530855|566611731|FG000|Overall Study|Lack of Efficacy|20|||
156961781|NCT00530855|566611731|FG000|Overall Study|Withdrawal by Subject|30|||
156961782|NCT00530855|566611731|FG000|Overall Study|Fatal Serious AE|3|||
156961783|NCT00530855|566611731|FG000|Overall Study|Non Fatal Serious AE|7|||
156961784|NCT00530855|566611731|FG000|Overall Study|Non Fatal Non Serious AE|12|||
156961785|NCT00530855|566611731|FG000|Overall Study|Protocol Violation|3|||
156961786|NCT00530855|566611731|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
156961787|NCT00530855|566611731|FG000|Overall Study|Lost to Follow-up|9|||
156961788|NCT00530855|566611731|FG000|Overall Study|Other reason for premature termination|17|||
156961789|NCT00815295|566611732|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
156961790|NCT00815295|566611733|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
156961791|NCT00815295|566611734|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
156961792|NCT02794285|566611735|FG000|Overall Study|Adverse Event|11|||
156961793|NCT02794285|566611736|FG001|Overall Study|Adverse Event|4|||
156961794|NCT02794285|566611737|FG002|Overall Study|Adverse Event|5|||
156961795|NCT02794285|566611738|FG003|Overall Study|Adverse Event|8|||
156961796|NCT02794285|566611735|FG000|Overall Study|Condition Under Investigation Improved|1|||
156961797|NCT02794285|566611736|FG001|Overall Study|Condition Under Investigation Improved|0|||
156961798|NCT02794285|566611737|FG002|Overall Study|Condition Under Investigation Improved|0|||
156961799|NCT02794285|566611738|FG003|Overall Study|Condition Under Investigation Improved|0|||
156961800|NCT02794285|566611735|FG000|Overall Study|Condition Under Investigation Worsened|0|||
156961801|NCT02794285|566611736|FG001|Overall Study|Condition Under Investigation Worsened|2|||
156961802|NCT02794285|566611737|FG002|Overall Study|Condition Under Investigation Worsened|1|||
156961803|NCT02794285|566611738|FG003|Overall Study|Condition Under Investigation Worsened|0|||
156961804|NCT02794285|566611735|FG000|Overall Study|Death|2|||
156961805|NCT02794285|566611736|FG001|Overall Study|Death|1|||
156961806|NCT02794285|566611737|FG002|Overall Study|Death|2|||
156961807|NCT02794285|566611738|FG003|Overall Study|Death|0|||
156961808|NCT02794285|566611735|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
156961809|NCT02794285|566611736|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
156961810|NCT02794285|566611737|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
156961811|NCT02794285|566611738|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
156961812|NCT02794285|566611735|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
156961813|NCT02794285|566611736|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
157038315|NCT01566890|566895372|FG000|Overall Study|Screen failure|6|||
157038316|NCT01566890|566895373|FG001|Overall Study|Screen failure|0|||
157038317|NCT01566890|566895374|FG002|Overall Study|Screen failure|1|||
157038318|NCT01566890|566895375|FG003|Overall Study|Screen failure|1|||
157038319|NCT01566890|566895376|FG004|Overall Study|Screen failure|0|||
157038320|NCT01566890|566895372|FG000|Overall Study|Incomplete CEU data|1|||
157171424|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
157171425|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
157171426|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
157171427|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
157171428|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
157171429|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
157171430|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
157171431|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
157171432|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
157171433|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
157171434|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
157171435|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
157171436|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
157171437|NCT02151682|567369057|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
157171438|NCT02151682|567369058|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
157171439|NCT02151682|567369059|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
157171440|NCT02151682|567369060|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
157171441|NCT02151682|567369061|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
157171442|NCT02151682|567369062|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
157171443|NCT02151682|567369057|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
157171444|NCT02151682|567369058|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
157171445|NCT02151682|567369059|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
157171446|NCT02151682|567369060|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
157171447|NCT02151682|567369061|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
157171448|NCT02151682|567369062|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
157171449|NCT02151682|567369057|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
157171450|NCT02151682|567369058|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
157171451|NCT02151682|567369059|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
157171452|NCT02151682|567369060|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
157171453|NCT02151682|567369061|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
157171454|NCT02151682|567369062|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
157171455|NCT02151682|567369057|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
157171456|NCT02151682|567369058|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
157171457|NCT02151682|567369059|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
157171458|NCT02151682|567369060|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
157171459|NCT02151682|567369061|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
157171460|NCT02151682|567369062|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
157171461|NCT02151682|567369057|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
157171462|NCT02151682|567369058|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
157171463|NCT02151682|567369059|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
157171464|NCT02151682|567369060|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
157227806|NCT00911859|567579213|FG001|Treatment Period|Adverse Event|3|||
157171465|NCT02151682|567369061|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
157171466|NCT02151682|567369062|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
157171467|NCT01213264|567369063|FG000|Overall Study|Adverse Event|1|||
157171468|NCT01213264|567369064|FG001|Overall Study|Adverse Event|0|||
157171469|NCT01213264|567369065|FG002|Overall Study|Adverse Event|0|||
157171470|NCT01213264|567369063|FG000|Overall Study|Lost to Follow-up|1|||
157171471|NCT01213264|567369064|FG001|Overall Study|Lost to Follow-up|2|||
157171472|NCT01213264|567369065|FG002|Overall Study|Lost to Follow-up|6|||
157171473|NCT01438307|567369066|FG000|Overall Study|Death|1|||
157171474|NCT01438307|567369067|FG001|Overall Study|Death|1|||
157171475|NCT06000501|567369068|FG000|Overall Study|Screen failure|3|||
157171476|NCT06000501|567369068|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
157171477|NCT06000501|567369068|FG000|Overall Study|Physician Decision|4|||
157171478|NCT06000501|567369068|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
157171479|NCT06000501|567369068|FG000|Overall Study|Scheduling issues|2|||
157171480|NCT02378883|567369069|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
157171481|NCT02378883|567369069|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
157171482|NCT02378883|567369069|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
157171483|NCT02378883|567369069|FG000|30 Day Follow-Up|Physician Decision|2|||
157171484|NCT02378883|567369069|FG000|30 Day Follow-Up|Missed Visit|2|||
157171485|NCT02378883|567369069|FG000|30 Day Follow-Up|Death|1|||
157171486|NCT02378883|567369069|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
157171487|NCT02378883|567369069|FG000|12 Months Follow-Up|Death|2|||
157171488|NCT00318565|567369070|FG000|Overall Study|Excluded per protocol|24|||
157171489|NCT01504971|567369075|FG000|Overall Study|Physician Decision|13|||
157171490|NCT00050622|567369076|FG000|Overall Study|Adverse Event|1|||
157171491|NCT00936117|567369079|FG000|Overall Study|Adverse Event|7|||
157171492|NCT00936117|567369079|FG000|Overall Study|Unable to continue oral medication|3|||
157171493|NCT04581863|567369080|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
157227807|NCT00911859|567579214|FG002|Treatment Period|Adverse Event|7|||
157171494|NCT04581863|567369081|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
157171495|NCT01376245|567369084|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
157171496|NCT01376245|567369085|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
157171497|NCT01376245|567369086|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
157227808|NCT00911859|567579212|FG000|Treatment Period|Death|1|||
156961814|NCT02794285|566611737|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
156961815|NCT02794285|566611738|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
156961816|NCT02794285|566611735|FG000|Overall Study|Lack of Efficacy|10|||
156961817|NCT02794285|566611736|FG001|Overall Study|Lack of Efficacy|6|||
156961818|NCT02794285|566611737|FG002|Overall Study|Lack of Efficacy|3|||
156961819|NCT02794285|566611738|FG003|Overall Study|Lack of Efficacy|3|||
156961820|NCT02794285|566611735|FG000|Overall Study|Lost to Follow-up|5|||
156961821|NCT02794285|566611736|FG001|Overall Study|Lost to Follow-up|6|||
156961822|NCT02794285|566611737|FG002|Overall Study|Lost to Follow-up|3|||
156961823|NCT02794285|566611738|FG003|Overall Study|Lost to Follow-up|1|||
156961824|NCT02794285|566611735|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
156961825|NCT02794285|566611736|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
156961826|NCT02794285|566611737|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
156961827|NCT02794285|566611738|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
156961828|NCT02794285|566611735|FG000|Overall Study|Withdrawal by Subject|38|||
156961829|NCT02794285|566611736|FG001|Overall Study|Withdrawal by Subject|29|||
156961830|NCT02794285|566611737|FG002|Overall Study|Withdrawal by Subject|20|||
156961831|NCT02794285|566611738|FG003|Overall Study|Withdrawal by Subject|12|||
156961832|NCT02794285|566611735|FG000|Overall Study|Missing|1|||
156961833|NCT02794285|566611736|FG001|Overall Study|Missing|0|||
156961834|NCT02794285|566611737|FG002|Overall Study|Missing|0|||
156961835|NCT02794285|566611738|FG003|Overall Study|Missing|0|||
156961836|NCT02794285|566611735|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
156961837|NCT02794285|566611736|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
156961838|NCT02794285|566611737|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
156961839|NCT02794285|566611738|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
156961840|NCT02794285|566611735|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
156961841|NCT02794285|566611736|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
156961842|NCT02794285|566611737|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
156961843|NCT02794285|566611738|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
156961844|NCT04794803|566611761|FG000|Overall Study|Death|1|||
156961845|NCT04794803|566611762|FG001|Overall Study|Death|3|||
156961846|NCT04794803|566611761|FG000|Overall Study|Lost to Follow-up|2|||
156961847|NCT04794803|566611762|FG001|Overall Study|Lost to Follow-up|2|||
156961848|NCT04794803|566611761|FG000|Overall Study|Withdrawal by Subject|1|||
156961849|NCT04794803|566611762|FG001|Overall Study|Withdrawal by Subject|0|||
156961850|NCT04794803|566611761|FG000|Overall Study|Physician Decision|1|||
156961851|NCT04794803|566611762|FG001|Overall Study|Physician Decision|1|||
156961852|NCT04794803|566611761|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
157171498|NCT01376245|567369087|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
157171499|NCT01376245|567369088|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
157171500|NCT01376245|567369084|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
157171501|NCT01376245|567369085|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
157171502|NCT01376245|567369086|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
157171503|NCT01376245|567369087|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
157171504|NCT01376245|567369088|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
157171505|NCT01376245|567369084|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
157171506|NCT01376245|567369085|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156961853|NCT04794803|566611762|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
156961854|NCT04794803|566611761|FG000|Overall Study|Refused to continue the treatment|1|||
156961855|NCT04794803|566611762|FG001|Overall Study|Refused to continue the treatment|0|||
156961856|NCT04794803|566611761|FG000|Overall Study|Patient admitted to ICU|0|||
156961857|NCT04794803|566611762|FG001|Overall Study|Patient admitted to ICU|1|||
156961858|NCT04124926|566611763|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
156961859|NCT04124926|566611764|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
156961860|NCT04124926|566611765|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156961861|NCT04124926|566611766|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156961862|NCT04124926|566611767|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
156961863|NCT04124926|566611763|FG000|Healing Phase|Protocol Violation|0|||
156961864|NCT04124926|566611764|FG001|Healing Phase|Protocol Violation|1|||
156961865|NCT04124926|566611765|FG002|Healing Phase|Protocol Violation|0|||
156961866|NCT04124926|566611766|FG003|Healing Phase|Protocol Violation|0|||
156961867|NCT04124926|566611767|FG004|Healing Phase|Protocol Violation|0|||
156961868|NCT04124926|566611763|FG000|Healing Phase|Lost to Follow-up|5|||
156961869|NCT04124926|566611764|FG001|Healing Phase|Lost to Follow-up|4|||
156961870|NCT04124926|566611765|FG002|Healing Phase|Lost to Follow-up|0|||
156961871|NCT04124926|566611766|FG003|Healing Phase|Lost to Follow-up|0|||
156961872|NCT04124926|566611767|FG004|Healing Phase|Lost to Follow-up|0|||
156961873|NCT04124926|566611763|FG000|Healing Phase|Voluntary Withdrawal|10|||
156961874|NCT04124926|566611764|FG001|Healing Phase|Voluntary Withdrawal|7|||
156961875|NCT04124926|566611765|FG002|Healing Phase|Voluntary Withdrawal|0|||
156961876|NCT04124926|566611766|FG003|Healing Phase|Voluntary Withdrawal|0|||
156961877|NCT04124926|566611767|FG004|Healing Phase|Voluntary Withdrawal|0|||
156961878|NCT04124926|566611763|FG000|Healing Phase|Withdrawal of Consent|5|||
156961879|NCT04124926|566611764|FG001|Healing Phase|Withdrawal of Consent|3|||
156961880|NCT04124926|566611765|FG002|Healing Phase|Withdrawal of Consent|0|||
156961881|NCT04124926|566611766|FG003|Healing Phase|Withdrawal of Consent|0|||
156961882|NCT04124926|566611767|FG004|Healing Phase|Withdrawal of Consent|0|||
156961883|NCT04124926|566611763|FG000|Healing Phase|Miscellaneous|8|||
156961884|NCT04124926|566611764|FG001|Healing Phase|Miscellaneous|7|||
156961885|NCT04124926|566611765|FG002|Healing Phase|Miscellaneous|0|||
156961886|NCT04124926|566611766|FG003|Healing Phase|Miscellaneous|0|||
156961887|NCT04124926|566611767|FG004|Healing Phase|Miscellaneous|0|||
156961888|NCT04124926|566611763|FG000|Healing Phase|Randomized but not Treated|0|||
156961889|NCT04124926|566611764|FG001|Healing Phase|Randomized but not Treated|3|||
156961890|NCT04124926|566611765|FG002|Healing Phase|Randomized but not Treated|0|||
156961891|NCT04124926|566611766|FG003|Healing Phase|Randomized but not Treated|0|||
156961892|NCT04124926|566611767|FG004|Healing Phase|Randomized but not Treated|0|||
156961893|NCT04124926|566611763|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
156961894|NCT04124926|566611764|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
156961895|NCT04124926|566611765|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
156961896|NCT04124926|566611766|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
156961897|NCT04124926|566611767|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
156961898|NCT04124926|566611763|FG000|Maintenance Phase|Protocol Violation|0|||
156961899|NCT04124926|566611764|FG001|Maintenance Phase|Protocol Violation|0|||
156961900|NCT04124926|566611765|FG002|Maintenance Phase|Protocol Violation|3|||
156961901|NCT04124926|566611766|FG003|Maintenance Phase|Protocol Violation|0|||
156961902|NCT04124926|566611767|FG004|Maintenance Phase|Protocol Violation|0|||
156961903|NCT04124926|566611763|FG000|Maintenance Phase|Lost to Follow-up|0|||
156961904|NCT04124926|566611764|FG001|Maintenance Phase|Lost to Follow-up|0|||
156961905|NCT04124926|566611765|FG002|Maintenance Phase|Lost to Follow-up|7|||
156961906|NCT04124926|566611766|FG003|Maintenance Phase|Lost to Follow-up|8|||
156961907|NCT04124926|566611767|FG004|Maintenance Phase|Lost to Follow-up|9|||
157171507|NCT01376245|567369086|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
156961908|NCT04124926|566611763|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
156961909|NCT04124926|566611764|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
156961910|NCT04124926|566611765|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
156961911|NCT04124926|566611766|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
156961912|NCT04124926|566611767|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
156961913|NCT04124926|566611763|FG000|Maintenance Phase|Pregnancy|0|||
156961914|NCT04124926|566611764|FG001|Maintenance Phase|Pregnancy|0|||
157038321|NCT01566890|566895373|FG001|Overall Study|Incomplete CEU data|3|||
157038322|NCT01566890|566895374|FG002|Overall Study|Incomplete CEU data|5|||
157038323|NCT01566890|566895375|FG003|Overall Study|Incomplete CEU data|8|||
157038324|NCT01566890|566895376|FG004|Overall Study|Incomplete CEU data|0|||
157038325|NCT01566890|566895372|FG000|Overall Study|Lost to Follow-up|0|||
157038326|NCT01566890|566895373|FG001|Overall Study|Lost to Follow-up|0|||
157038327|NCT01566890|566895374|FG002|Overall Study|Lost to Follow-up|4|||
157038328|NCT01566890|566895375|FG003|Overall Study|Lost to Follow-up|4|||
157038329|NCT01566890|566895376|FG004|Overall Study|Lost to Follow-up|0|||
157038330|NCT01566890|566895372|FG000|Overall Study|Other|0|||
157038331|NCT01566890|566895373|FG001|Overall Study|Other|0|||
157038332|NCT01566890|566895374|FG002|Overall Study|Other|0|||
157038333|NCT01566890|566895375|FG003|Overall Study|Other|0|||
157038334|NCT01566890|566895376|FG004|Overall Study|Other|7|||
157038335|NCT00523419|566895382|FG000|Overall Study|Adverse Event|1|||
157038336|NCT00523419|566895382|FG000|Overall Study|Withdrawal by Subject|1|||
157038337|NCT00523419|566895382|FG000|Overall Study|Physician Decision|2|||
157038338|NCT00523419|566895382|FG000|Overall Study|Progressive Disease|22|||
157038339|NCT00523419|566895382|FG000|Overall Study|Death due to Study Disease|4|||
157038340|NCT00523419|566895382|FG000|Overall Study|Death due to Adverse Event|2|||
157038341|NCT00822120|566895383|FG000|Initial Registration|Adverse Event|1|||
157038342|NCT00822120|566895384|FG001|Initial Registration|Adverse Event|0|||
157038343|NCT00822120|566895385|FG002|Initial Registration|Adverse Event|0|||
157038344|NCT00822120|566895386|FG003|Initial Registration|Adverse Event|0|||
157038345|NCT00822120|566895387|FG004|Initial Registration|Adverse Event|0|||
157038346|NCT00822120|566895388|FG005|Initial Registration|Adverse Event|0|||
157038347|NCT00822120|566895383|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
157038348|NCT00822120|566895384|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157038349|NCT00822120|566895385|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157038350|NCT00822120|566895386|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157038351|NCT00822120|566895387|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157038352|NCT00822120|566895388|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
157038353|NCT00822120|566895383|FG000|Initial Registration|Reasons not Protocol Specified|2|||
157038354|NCT00822120|566895384|FG001|Initial Registration|Reasons not Protocol Specified|0|||
157038355|NCT00822120|566895385|FG002|Initial Registration|Reasons not Protocol Specified|0|||
157038356|NCT00822120|566895386|FG003|Initial Registration|Reasons not Protocol Specified|0|||
157038357|NCT00822120|566895387|FG004|Initial Registration|Reasons not Protocol Specified|0|||
157038358|NCT00822120|566895388|FG005|Initial Registration|Reasons not Protocol Specified|0|||
157038359|NCT00822120|566895383|FG000|Initial Registration|Ineligible|22|||
157038360|NCT00822120|566895384|FG001|Initial Registration|Ineligible|1|||
157038361|NCT00822120|566895385|FG002|Initial Registration|Ineligible|0|||
157038362|NCT00822120|566895386|FG003|Initial Registration|Ineligible|0|||
157038363|NCT00822120|566895387|FG004|Initial Registration|Ineligible|0|||
157038364|NCT00822120|566895388|FG005|Initial Registration|Ineligible|0|||
157038365|NCT00822120|566895383|FG000|PET-directed Therapy|Adverse Event|0|||
157038366|NCT00822120|566895384|FG001|PET-directed Therapy|Adverse Event|0|||
157038367|NCT00822120|566895385|FG002|PET-directed Therapy|Adverse Event|0|||
157038368|NCT00822120|566895386|FG003|PET-directed Therapy|Adverse Event|1|||
157038369|NCT00822120|566895387|FG004|PET-directed Therapy|Adverse Event|0|||
157038370|NCT00822120|566895388|FG005|PET-directed Therapy|Adverse Event|0|||
157171508|NCT01376245|567369087|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
157038371|NCT00822120|566895383|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
157038372|NCT00822120|566895384|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
157038373|NCT00822120|566895385|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
157171509|NCT01376245|567369088|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
157171510|NCT01376245|567369084|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
157171511|NCT01376245|567369085|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
157171512|NCT01376245|567369086|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
157171513|NCT01376245|567369087|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
157171514|NCT01376245|567369088|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
157171515|NCT01376245|567369084|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
157171516|NCT01376245|567369085|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
157038374|NCT00822120|566895386|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
157171517|NCT01376245|567369086|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
157171518|NCT01376245|567369087|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
157038375|NCT00822120|566895387|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
157038376|NCT00822120|566895388|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
157038377|NCT00822120|566895383|FG000|PET-directed Therapy|Death|0|||
157038378|NCT00822120|566895384|FG001|PET-directed Therapy|Death|0|||
157038379|NCT00822120|566895385|FG002|PET-directed Therapy|Death|0|||
157038380|NCT00822120|566895386|FG003|PET-directed Therapy|Death|2|||
157038381|NCT00822120|566895387|FG004|PET-directed Therapy|Death|0|||
157038382|NCT00822120|566895388|FG005|PET-directed Therapy|Death|0|||
157038383|NCT00822120|566895383|FG000|PET-directed Therapy|Protocol Violation|0|||
157038384|NCT00822120|566895384|FG001|PET-directed Therapy|Protocol Violation|0|||
157038385|NCT00822120|566895385|FG002|PET-directed Therapy|Protocol Violation|0|||
157038386|NCT00822120|566895386|FG003|PET-directed Therapy|Protocol Violation|6|||
157038387|NCT00822120|566895387|FG004|PET-directed Therapy|Protocol Violation|0|||
157038388|NCT00822120|566895388|FG005|PET-directed Therapy|Protocol Violation|0|||
157038389|NCT01437319|566895390|FG000|Phase I|Lost to Follow-up|2|||
157038390|NCT01437319|566895391|FG001|Phase I|Lost to Follow-up|0|||
157038391|NCT01437319|566895392|FG002|Phase I|Lost to Follow-up|0|||
157038392|NCT01437319|566895390|FG000|Phase I|Protocol Violation|1|||
157038393|NCT01437319|566895391|FG001|Phase I|Protocol Violation|0|||
157038394|NCT01437319|566895392|FG002|Phase I|Protocol Violation|0|||
157038395|NCT01437319|566895390|FG000|Phase I|Study related symptoms/complaints|27|||
156961915|NCT04124926|566611765|FG002|Maintenance Phase|Pregnancy|0|||
156961916|NCT04124926|566611766|FG003|Maintenance Phase|Pregnancy|1|||
156961917|NCT04124926|566611767|FG004|Maintenance Phase|Pregnancy|0|||
156961918|NCT04124926|566611763|FG000|Maintenance Phase|Lack of Efficacy|0|||
156961919|NCT04124926|566611764|FG001|Maintenance Phase|Lack of Efficacy|0|||
156961920|NCT04124926|566611765|FG002|Maintenance Phase|Lack of Efficacy|0|||
156961921|NCT04124926|566611766|FG003|Maintenance Phase|Lack of Efficacy|0|||
156961922|NCT04124926|566611767|FG004|Maintenance Phase|Lack of Efficacy|1|||
156961923|NCT04124926|566611763|FG000|Maintenance Phase|Withdrawal of Consent|0|||
156961924|NCT04124926|566611764|FG001|Maintenance Phase|Withdrawal of Consent|0|||
156961925|NCT04124926|566611765|FG002|Maintenance Phase|Withdrawal of Consent|5|||
156961926|NCT04124926|566611766|FG003|Maintenance Phase|Withdrawal of Consent|5|||
156961927|NCT04124926|566611767|FG004|Maintenance Phase|Withdrawal of Consent|5|||
156961928|NCT04124926|566611763|FG000|Maintenance Phase|Miscellaneous|0|||
156961929|NCT04124926|566611764|FG001|Maintenance Phase|Miscellaneous|0|||
156961930|NCT04124926|566611765|FG002|Maintenance Phase|Miscellaneous|1|||
156961931|NCT04124926|566611766|FG003|Maintenance Phase|Miscellaneous|2|||
156961932|NCT04124926|566611767|FG004|Maintenance Phase|Miscellaneous|4|||
156961933|NCT04124926|566611763|FG000|Maintenance Phase|Randomized but not Treated|0|||
156961934|NCT04124926|566611764|FG001|Maintenance Phase|Randomized but not Treated|0|||
156961935|NCT04124926|566611765|FG002|Maintenance Phase|Randomized but not Treated|2|||
156961936|NCT04124926|566611766|FG003|Maintenance Phase|Randomized but not Treated|2|||
156961937|NCT04124926|566611767|FG004|Maintenance Phase|Randomized but not Treated|0|||
156961938|NCT01654549|566611772|FG000|Overall Study|H.pylori eradication not successful|0|||
156961939|NCT01654549|566611773|FG001|Overall Study|H.pylori eradication not successful|1|||
156961940|NCT00937924|566611776|FG000|Overall Study|Lost to Follow-up|44|||
156961941|NCT00937924|566611777|FG001|Overall Study|Lost to Follow-up|44|||
156961942|NCT00937924|566611778|FG002|Overall Study|Lost to Follow-up|41|||
156961943|NCT03152526|566611781|FG000|Overall Study|Withdrawal by Subject|0|||
156961944|NCT03152526|566611782|FG001|Overall Study|Withdrawal by Subject|1|||
156961945|NCT04009291|566611783|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156961946|NCT04009291|566611784|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156961947|NCT04009291|566611785|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156961948|NCT04009291|566611786|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
156961949|NCT04009291|566611787|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
156961950|NCT04009291|566611783|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156961951|NCT04009291|566611784|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156961952|NCT04009291|566611785|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156961953|NCT04009291|566611786|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
156961954|NCT04009291|566611787|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
156961955|NCT03998618|566611793|FG000|Overall Study|Death|7|||
156961956|NCT03998618|566611794|FG001|Overall Study|Death|11|||
156961957|NCT03998618|566611793|FG000|Overall Study|hospice enrollment|3|||
156961958|NCT03998618|566611794|FG001|Overall Study|hospice enrollment|3|||
156961959|NCT03998618|566611793|FG000|Overall Study|Not feeling well/health problems|3|||
156961960|NCT03998618|566611794|FG001|Overall Study|Not feeling well/health problems|5|||
156961961|NCT03998618|566611793|FG000|Overall Study|Lost to Follow-up|6|||
156961962|NCT03998618|566611794|FG001|Overall Study|Lost to Follow-up|6|||
156961963|NCT03998618|566611793|FG000|Overall Study|Withdrawal by Subject|0|||
156961964|NCT03998618|566611794|FG001|Overall Study|Withdrawal by Subject|4|||
156961965|NCT04330638|566611795|FG000|Overall Study|Adverse Event|9|||
156961966|NCT04330638|566611796|FG001|Overall Study|Adverse Event|10|||
156961967|NCT04330638|566611797|FG002|Overall Study|Adverse Event|15|||
156961968|NCT04330638|566611798|FG003|Overall Study|Adverse Event|6|||
156961969|NCT04330638|566611799|FG004|Overall Study|Adverse Event|10|||
156961970|NCT04330638|566611800|FG005|Overall Study|Adverse Event|5|||
157038396|NCT01437319|566895391|FG001|Phase I|Study related symptoms/complaints|0|||
156961971|NCT04330638|566611795|FG000|Overall Study|Other|2|||
156961972|NCT04330638|566611796|FG001|Overall Study|Other|2|||
156961973|NCT04330638|566611797|FG002|Overall Study|Other|5|||
156961974|NCT04330638|566611798|FG003|Overall Study|Other|1|||
156961975|NCT04330638|566611799|FG004|Overall Study|Other|3|||
156961976|NCT04330638|566611800|FG005|Overall Study|Other|2|||
157038397|NCT01437319|566895392|FG002|Phase I|Study related symptoms/complaints|0|||
157038398|NCT01437319|566895390|FG000|Phase I|Withdrawal by Subject|25|||
157038399|NCT01437319|566895391|FG001|Phase I|Withdrawal by Subject|0|||
157038400|NCT01437319|566895392|FG002|Phase I|Withdrawal by Subject|0|||
157038401|NCT01437319|566895390|FG000|Phase II|Withdrawal by Subject|0|||
157038402|NCT01437319|566895391|FG001|Phase II|Withdrawal by Subject|8|||
157038403|NCT01437319|566895392|FG002|Phase II|Withdrawal by Subject|16|||
157038404|NCT01437319|566895390|FG000|Phase II|Lost to Follow-up|0|||
157038405|NCT01437319|566895391|FG001|Phase II|Lost to Follow-up|7|||
157038406|NCT01437319|566895392|FG002|Phase II|Lost to Follow-up|2|||
157038407|NCT01437319|566895390|FG000|Phase II|Study related symptoms/complaints|0|||
157038408|NCT01437319|566895391|FG001|Phase II|Study related symptoms/complaints|28|||
157038409|NCT01437319|566895392|FG002|Phase II|Study related symptoms/complaints|19|||
157171519|NCT01376245|567369088|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
157038410|NCT01437319|566895390|FG000|Phase II|Protocol Violation|0|||
157038411|NCT01437319|566895391|FG001|Phase II|Protocol Violation|1|||
157038412|NCT01437319|566895392|FG002|Phase II|Protocol Violation|0|||
157038413|NCT00811941|566895393|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
157038414|NCT00811941|566895394|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
157038415|NCT00811941|566895393|FG000|All Treated Patients|Adverse Event|2|||
157038416|NCT00811941|566895394|FG001|All Treated Patients|Adverse Event|43|||
157038417|NCT00811941|566895393|FG000|All Treated Patients|Lack of Efficacy|2|||
157038418|NCT00811941|566895394|FG001|All Treated Patients|Lack of Efficacy|3|||
157038419|NCT00811941|566895393|FG000|All Treated Patients|Non-compliance|1|||
157038420|NCT00811941|566895394|FG001|All Treated Patients|Non-compliance|8|||
157038421|NCT00811941|566895393|FG000|All Treated Patients|Protocol Violation|5|||
157038422|NCT00811941|566895394|FG001|All Treated Patients|Protocol Violation|17|||
157038423|NCT00811941|566895393|FG000|All Treated Patients|Withdrawal by Subject|35|||
157038424|NCT00811941|566895394|FG001|All Treated Patients|Withdrawal by Subject|94|||
157038425|NCT00811941|566895393|FG000|All Treated Patients|Lost to Follow-up|3|||
157038426|NCT00811941|566895394|FG001|All Treated Patients|Lost to Follow-up|12|||
157038427|NCT00811941|566895393|FG000|All Treated Patients|Other Reason|4|||
157038428|NCT00811941|566895394|FG001|All Treated Patients|Other Reason|14|||
157038429|NCT00942266|566895397|FG000|Overall Study|Withdrawal by Subject|1|||
157038430|NCT00942266|566895398|FG001|Overall Study|Withdrawal by Subject|0|||
157038431|NCT00942266|566895397|FG000|Overall Study|Adverse Event|2|||
157038432|NCT00942266|566895398|FG001|Overall Study|Adverse Event|1|||
157038433|NCT00942266|566895397|FG000|Overall Study|Disease Progression|38|||
157038434|NCT00942266|566895398|FG001|Overall Study|Disease Progression|11|||
157038435|NCT00942266|566895397|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
157038436|NCT00942266|566895398|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
157038437|NCT00942266|566895397|FG000|Overall Study|Intercurrent illness|0|||
157038438|NCT00942266|566895398|FG001|Overall Study|Intercurrent illness|1|||
157038439|NCT00942266|566895397|FG000|Overall Study|Physician Decision|2|||
157038440|NCT00942266|566895398|FG001|Overall Study|Physician Decision|0|||
157038441|NCT00942266|566895397|FG000|Overall Study|medical deterioration (pneumonia)|0|||
157038442|NCT00942266|566895398|FG001|Overall Study|medical deterioration (pneumonia)|1|||
157038443|NCT05018143|566895417|FG000|Overall Study|Lost to Follow-up|5|||
157038444|NCT05018143|566895418|FG001|Overall Study|Lost to Follow-up|4|||
157038445|NCT05018143|566895417|FG000|Overall Study|Withdrawal by Subject|0|||
157038446|NCT05018143|566895418|FG001|Overall Study|Withdrawal by Subject|1|||
157038447|NCT01830595|566895419|FG000|First Period|Withdrawal by Subject|1|||
157038448|NCT01830595|566895420|FG001|First Period|Withdrawal by Subject|3|||
157038449|NCT01830595|566895419|FG000|Washout|Withdrawal by Subject|2|||
157038450|NCT01830595|566895420|FG001|Washout|Withdrawal by Subject|2|||
157038451|NCT06688357|566895421|FG000|Overall Study|Adverse Event|0|||
157038452|NCT06688357|566895422|FG001|Overall Study|Adverse Event|1|||
157038453|NCT05116774|566895423|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
157038454|NCT05116774|566895424|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
157171520|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
157171521|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
157171522|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
157171523|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
157038455|NCT05116774|566895423|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
157038456|NCT05116774|566895424|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
157038457|NCT05116774|566895423|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
157038458|NCT05116774|566895424|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
157038459|NCT05116774|566895423|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
157038460|NCT05116774|566895424|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
157038461|NCT03280030|566895425|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
157038462|NCT03280030|566895426|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
157038463|NCT03280030|566895427|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
157038464|NCT03280030|566895425|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
157038465|NCT03280030|566895426|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
157038466|NCT03280030|566895427|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
157038467|NCT03280030|566895425|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
157038468|NCT03280030|566895426|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
157038469|NCT03280030|566895427|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
157038470|NCT03280030|566895425|FG000|Part 2 - Efficacy|Adverse Event|0|||
157038471|NCT03280030|566895426|FG001|Part 2 - Efficacy|Adverse Event|4|||
157038472|NCT03280030|566895427|FG002|Part 2 - Efficacy|Adverse Event|6|||
157038473|NCT03280030|566895425|FG000|Part 2 - Efficacy|Death|0|||
157038474|NCT03280030|566895426|FG001|Part 2 - Efficacy|Death|3|||
157038475|NCT03280030|566895427|FG002|Part 2 - Efficacy|Death|0|||
157038476|NCT03280030|566895425|FG000|Part 2 - Efficacy|Physician Decision|0|||
157038477|NCT03280030|566895426|FG001|Part 2 - Efficacy|Physician Decision|10|||
157038478|NCT03280030|566895427|FG002|Part 2 - Efficacy|Physician Decision|16|||
157038479|NCT03280030|566895425|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
157038480|NCT03280030|566895426|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
157038481|NCT03280030|566895427|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
157038482|NCT03280030|566895425|FG000|Part 2 - Efficacy|Progressive disease|0|||
157038483|NCT03280030|566895426|FG001|Part 2 - Efficacy|Progressive disease|7|||
157038484|NCT03280030|566895427|FG002|Part 2 - Efficacy|Progressive disease|5|||
157038485|NCT05601882|566895428|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
157038486|NCT05601882|566895429|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
157038487|NCT05601882|566895430|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
157038488|NCT05601882|566895431|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
157038489|NCT05601882|566895428|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
157038490|NCT05601882|566895429|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
157038491|NCT05601882|566895430|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
157038492|NCT05601882|566895431|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
157038493|NCT05601882|566895428|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
157038494|NCT05601882|566895429|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
157038495|NCT05601882|566895430|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
157038496|NCT05601882|566895431|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
157038497|NCT05601882|566895428|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
157038498|NCT05601882|566895429|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
157038499|NCT05601882|566895430|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
157038500|NCT05601882|566895431|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
157038501|NCT05601882|566895428|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
157038502|NCT05601882|566895429|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
157038503|NCT05601882|566895430|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
157038504|NCT05601882|566895431|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
157038505|NCT05601882|566895428|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
157038506|NCT05601882|566895429|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
157038507|NCT05601882|566895430|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
157038508|NCT05601882|566895431|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
157038509|NCT02500576|566895435|FG000|Overall Study|Adverse Event|0|||
157038510|NCT02500576|566895436|FG001|Overall Study|Adverse Event|1|||
157038511|NCT02500576|566895435|FG000|Overall Study|Death|2|||
157038512|NCT02500576|566895436|FG001|Overall Study|Death|1|||
157038513|NCT02500576|566895435|FG000|Overall Study|Lack of Efficacy|5|||
157038514|NCT02500576|566895436|FG001|Overall Study|Lack of Efficacy|5|||
157038515|NCT02500576|566895435|FG000|Overall Study|Withdrawal by Subject|1|||
157038516|NCT02500576|566895436|FG001|Overall Study|Withdrawal by Subject|1|||
157038517|NCT00227266|566895443|FG000|Overall Study|Withdrawal by Subject|0|||
157038518|NCT00227266|566895444|FG001|Overall Study|Withdrawal by Subject|0|||
157038519|NCT00227266|566895445|FG002|Overall Study|Withdrawal by Subject|1|||
157038520|NCT00227266|566895443|FG000|Overall Study|Protocol Violation|1|||
157038521|NCT00227266|566895444|FG001|Overall Study|Protocol Violation|0|||
157038522|NCT00227266|566895445|FG002|Overall Study|Protocol Violation|1|||
157038523|NCT00227266|566895443|FG000|Overall Study|Excessive weight gain|0|||
157038524|NCT00227266|566895444|FG001|Overall Study|Excessive weight gain|0|||
157038525|NCT00227266|566895445|FG002|Overall Study|Excessive weight gain|2|||
157038526|NCT04926740|566895448|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
157038527|NCT04926740|566895449|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
157038528|NCT04926740|566895448|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
157038529|NCT04926740|566895449|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
157038530|NCT01470144|566895452|FG000|Overall Study|Adverse Event|2|||
157038531|NCT01470144|566895452|FG000|Overall Study|Death|1|||
157038532|NCT01470144|566895452|FG000|Overall Study|Lung transplant|6|||
157038533|NCT01470144|566895452|FG000|Overall Study|Patient's and investigator's decision|1|||
157038534|NCT00593840|566895453|FG000|Overall Study|Withdrawal by Subject|1|||
157038535|NCT04503681|566896653|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
157171524|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
157038536|NCT04503681|566896654|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
157038537|NCT03352713|566896657|FG000|Overall Study|Lost to Follow-up|8|||
157038538|NCT03352713|566896657|FG000|Overall Study|Withdrawn by investigator|5|||
156961977|NCT04330638|566611795|FG000|Overall Study|Withdrawal by Subject|4|||
156961978|NCT04330638|566611796|FG001|Overall Study|Withdrawal by Subject|0|||
156961979|NCT04330638|566611797|FG002|Overall Study|Withdrawal by Subject|0|||
156961980|NCT04330638|566611798|FG003|Overall Study|Withdrawal by Subject|0|||
156961981|NCT04330638|566611799|FG004|Overall Study|Withdrawal by Subject|0|||
156961982|NCT04330638|566611800|FG005|Overall Study|Withdrawal by Subject|0|||
156961983|NCT04330638|566611795|FG000|Overall Study|Lost to Follow-up|3|||
156961984|NCT04330638|566611796|FG001|Overall Study|Lost to Follow-up|2|||
156961985|NCT04330638|566611797|FG002|Overall Study|Lost to Follow-up|3|||
156961986|NCT04330638|566611798|FG003|Overall Study|Lost to Follow-up|2|||
156961987|NCT04330638|566611799|FG004|Overall Study|Lost to Follow-up|3|||
156961988|NCT04330638|566611800|FG005|Overall Study|Lost to Follow-up|0|||
156961989|NCT02275065|566611802|FG000|Overall Study|Randomized but not treated|1|||
156961990|NCT02275065|566611803|FG001|Overall Study|Randomized but not treated|0|||
156961991|NCT02275065|566611804|FG002|Overall Study|Randomized but not treated|1|||
156961992|NCT02275065|566611805|FG003|Overall Study|Randomized but not treated|1|||
156961993|NCT02275065|566611806|FG004|Overall Study|Randomized but not treated|0|||
156961994|NCT00417079|566611808|FG000|Overall Study|Disease progression|267|||
156961995|NCT00417079|566611809|FG001|Overall Study|Disease progression|180|||
156961996|NCT00417079|566611808|FG000|Overall Study|Adverse Event|32|||
156961997|NCT00417079|566611809|FG001|Overall Study|Adverse Event|67|||
156961998|NCT00417079|566611808|FG000|Overall Study|Non-compliance to protocol|0|||
156961999|NCT00417079|566611809|FG001|Overall Study|Non-compliance to protocol|1|||
156962000|NCT00417079|566611808|FG000|Overall Study|Lost to Follow-up|2|||
156962001|NCT00417079|566611809|FG001|Overall Study|Lost to Follow-up|0|||
156962002|NCT00417079|566611808|FG000|Overall Study|Withdrawal by Subject|17|||
156962003|NCT00417079|566611809|FG001|Overall Study|Withdrawal by Subject|8|||
156962004|NCT00417079|566611808|FG000|Overall Study|Not treated|6|||
156962005|NCT00417079|566611809|FG001|Overall Study|Not treated|7|||
156962006|NCT00417079|566611808|FG000|Overall Study|Screened failure|2|||
156962007|NCT00417079|566611809|FG001|Overall Study|Screened failure|1|||
156962008|NCT00417079|566611808|FG000|Overall Study|Investigator's decision|1|||
156962009|NCT00417079|566611809|FG001|Overall Study|Investigator's decision|4|||
156962010|NCT00417079|566611808|FG000|Overall Study|Non-confirmed Disease progression|1|||
156962011|NCT00417079|566611809|FG001|Overall Study|Non-confirmed Disease progression|1|||
156962012|NCT00417079|566611808|FG000|Overall Study|Clinical deterioration|1|||
156962013|NCT00417079|566611809|FG001|Overall Study|Clinical deterioration|0|||
156962014|NCT00417079|566611808|FG000|Overall Study|Screening error|2|||
156962015|NCT00417079|566611809|FG001|Overall Study|Screening error|1|||
156962016|NCT00417079|566611808|FG000|Overall Study|Withdrawal by subject's family|0|||
156962017|NCT00417079|566611809|FG001|Overall Study|Withdrawal by subject's family|1|||
156962018|NCT00417079|566611808|FG000|Overall Study|Patient unable to come to the clinic|0|||
156962019|NCT00417079|566611809|FG001|Overall Study|Patient unable to come to the clinic|1|||
156962020|NCT00417079|566611808|FG000|Overall Study|abnormal liver function tests|0|||
156962021|NCT00417079|566611809|FG001|Overall Study|abnormal liver function tests|1|||
156962022|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
156962023|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
156962024|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
156962025|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
156962026|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
156962027|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
156962028|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
156962029|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
156962030|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
156962031|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
156962032|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
156962033|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
156962034|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156962035|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156962036|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
156962037|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
156962038|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
156962039|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
156962040|NCT00833638|566611811|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
156962041|NCT00833638|566611812|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
156962042|NCT00833638|566611813|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
156962043|NCT00833638|566611811|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
156962044|NCT00833638|566611812|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
156962045|NCT00833638|566611813|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
156962046|NCT00833638|566611811|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
156962047|NCT00833638|566611812|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
157038539|NCT03352713|566896657|FG000|Overall Study|Completed 0 EMAs|8|||
157171525|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
156962048|NCT00833638|566611813|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
156962049|NCT00490646|566611814|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
156962050|NCT00490646|566611815|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
156962051|NCT00490646|566611814|FG000|Overall Study|Never Treated (had an adverse event)|1|||
156962052|NCT00490646|566611815|FG001|Overall Study|Never Treated (had an adverse event)|0|||
156962053|NCT00490646|566611814|FG000|Overall Study|Never Treated (withdrew consent)|0|||
156962054|NCT00490646|566611815|FG001|Overall Study|Never Treated (withdrew consent)|1|||
156962055|NCT01178086|566611816|FG000|Overall Study|Participant refusal|7|||
156962056|NCT01178086|566611816|FG000|Overall Study|Physician Decision|44|||
156962057|NCT01178086|566611816|FG000|Overall Study|Switch to other CLL therapy|113|||
156962058|NCT01178086|566611816|FG000|Overall Study|Death|59|||
156962059|NCT01178086|566611816|FG000|Overall Study|Other unspecified|89|||
156962060|NCT01178086|566611816|FG000|Overall Study|Excluded from EAS|20|||
156962061|NCT01400503|566611818|FG000|Overall Study|Withdrawal by Subject|1|||
156962062|NCT01400503|566611818|FG000|Overall Study|Study Terminated by Sponsor|58|||
156962063|NCT01400503|566611818|FG000|Overall Study|Other|1|||
156962064|NCT00983073|566611819|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
156962065|NCT00983073|566611819|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
156962066|NCT00983073|566611819|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
156962067|NCT00983073|566611819|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
156962068|NCT00983073|566611819|FG000|Titration and Optimal Dose Period|Other reason|4|||
156962069|NCT00983073|566611819|FG000|Maintenance Period|Adverse Event|5|||
156962070|NCT00983073|566611819|FG000|Maintenance Period|Withdrawal by Subject|2|||
156962071|NCT00983073|566611819|FG000|Maintenance Period|Lack of Efficacy|2|||
156962072|NCT00983073|566611819|FG000|Maintenance Period|Other Reason|7|||
156962073|NCT01669122|566611822|FG000|Period I|Lost to Follow-up|1|||
156962074|NCT01669122|566611822|FG000|Washout Period II|Protocol Violation|2|||
156962075|NCT02962908|566611825|FG000|Overall Study|Lost to Follow-up|0|||
156962076|NCT02962908|566611826|FG001|Overall Study|Lost to Follow-up|3|||
156962077|NCT02962908|566611827|FG002|Overall Study|Lost to Follow-up|0|||
156962078|NCT02962908|566611828|FG003|Overall Study|Lost to Follow-up|1|||
156962079|NCT02962908|566611825|FG000|Overall Study|Withdrawal by Subject|0|||
156962080|NCT02962908|566611826|FG001|Overall Study|Withdrawal by Subject|3|||
156962081|NCT02962908|566611827|FG002|Overall Study|Withdrawal by Subject|0|||
156962082|NCT02962908|566611828|FG003|Overall Study|Withdrawal by Subject|2|||
156962083|NCT02962908|566611825|FG000|Overall Study|Protocol Violation|0|||
156962084|NCT02962908|566611826|FG001|Overall Study|Protocol Violation|1|||
156962085|NCT02962908|566611827|FG002|Overall Study|Protocol Violation|0|||
156962086|NCT02962908|566611828|FG003|Overall Study|Protocol Violation|0|||
156962087|NCT02962908|566611825|FG000|Overall Study|Physician Decision|0|||
156962088|NCT02962908|566611826|FG001|Overall Study|Physician Decision|1|||
156962089|NCT02962908|566611827|FG002|Overall Study|Physician Decision|0|||
156962090|NCT02962908|566611828|FG003|Overall Study|Physician Decision|0|||
156962091|NCT03543254|566611829|FG000|Overall Study|Lost to Follow-up|1|||
156962092|NCT02077166|566611830|FG000|Overall Study|Death|6|||
156962093|NCT02077166|566611831|FG001|Overall Study|Death|7|||
156962094|NCT02077166|566611832|FG002|Overall Study|Death|5|||
156962095|NCT02077166|566611833|FG003|Overall Study|Death|6|||
156962096|NCT02077166|566611834|FG004|Overall Study|Death|4|||
156962097|NCT02077166|566611835|FG005|Overall Study|Death|32|||
156962098|NCT02077166|566611836|FG006|Overall Study|Death|22|||
156962099|NCT02077166|566611830|FG000|Overall Study|Study Closure by Sponsor|3|||
156962100|NCT02077166|566611831|FG001|Overall Study|Study Closure by Sponsor|0|||
156962101|NCT02077166|566611832|FG002|Overall Study|Study Closure by Sponsor|2|||
156962102|NCT02077166|566611833|FG003|Overall Study|Study Closure by Sponsor|2|||
156962103|NCT02077166|566611834|FG004|Overall Study|Study Closure by Sponsor|2|||
156962104|NCT02077166|566611835|FG005|Overall Study|Study Closure by Sponsor|12|||
156962105|NCT02077166|566611836|FG006|Overall Study|Study Closure by Sponsor|4|||
156962106|NCT02077166|566611830|FG000|Overall Study|Lost to Follow-up|0|||
156962107|NCT02077166|566611831|FG001|Overall Study|Lost to Follow-up|0|||
157038540|NCT03352713|566896657|FG000|Overall Study|Device incompatible/stolen|5|||
157038541|NCT01812759|566896658|FG000|Overall Study|Physician Decision|0|||
157038542|NCT01812759|566896659|FG001|Overall Study|Physician Decision|0|||
156962108|NCT02077166|566611832|FG002|Overall Study|Lost to Follow-up|0|||
156962109|NCT02077166|566611833|FG003|Overall Study|Lost to Follow-up|0|||
156962110|NCT02077166|566611834|FG004|Overall Study|Lost to Follow-up|0|||
156962111|NCT02077166|566611835|FG005|Overall Study|Lost to Follow-up|1|||
156962112|NCT02077166|566611836|FG006|Overall Study|Lost to Follow-up|0|||
156962113|NCT02077166|566611830|FG000|Overall Study|Withdrawal by Subject|3|||
156962114|NCT02077166|566611831|FG001|Overall Study|Withdrawal by Subject|0|||
156962115|NCT02077166|566611832|FG002|Overall Study|Withdrawal by Subject|1|||
156962116|NCT02077166|566611833|FG003|Overall Study|Withdrawal by Subject|1|||
156962117|NCT02077166|566611834|FG004|Overall Study|Withdrawal by Subject|1|||
156962118|NCT02077166|566611835|FG005|Overall Study|Withdrawal by Subject|3|||
156962119|NCT02077166|566611836|FG006|Overall Study|Withdrawal by Subject|0|||
157038543|NCT01812759|566896660|FG002|Overall Study|Physician Decision|1|||
157038544|NCT04213807|566896661|FG000|Overall Study|Physician Decision|0|||
157038545|NCT04213807|566896662|FG001|Overall Study|Physician Decision|0|||
157038546|NCT04213807|566896663|FG002|Overall Study|Physician Decision|1|||
157038547|NCT03442777|566896664|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
157038548|NCT03442777|566896665|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
157038549|NCT03442777|566896666|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
157038550|NCT02866942|566896667|FG000|Overall Study|Invalid consent|1|||
157038551|NCT03418922|566896669|FG000|Overall Study|Withdrawal by Subject|0|||
157038552|NCT03418922|566896670|FG001|Overall Study|Withdrawal by Subject|2|||
157038553|NCT03418922|566896669|FG000|Overall Study|Adverse Event|2|||
157038554|NCT03418922|566896670|FG001|Overall Study|Adverse Event|2|||
157038555|NCT03418922|566896669|FG000|Overall Study|Death|0|||
157038556|NCT03418922|566896670|FG001|Overall Study|Death|1|||
157038557|NCT03418922|566896669|FG000|Overall Study|Physician Decision|0|||
157038558|NCT03418922|566896670|FG001|Overall Study|Physician Decision|1|||
157038559|NCT03577106|566896671|FG000|Overall Study|Withdrawal by Subject|3|||
157038560|NCT00754065|566896674|FG000|Overall Study|Never received treatment|12|||
157038561|NCT00754065|566896675|FG001|Overall Study|Never received treatment|2|||
157038562|NCT00754065|566896674|FG000|Overall Study|Adverse Event|19|||
157038563|NCT00754065|566896675|FG001|Overall Study|Adverse Event|25|||
157038564|NCT00754065|566896674|FG000|Overall Study|Lost to Follow-up|7|||
157038565|NCT00754065|566896675|FG001|Overall Study|Lost to Follow-up|11|||
157038566|NCT00754065|566896674|FG000|Overall Study|Protocol Violation|12|||
157038567|NCT00754065|566896675|FG001|Overall Study|Protocol Violation|10|||
157038568|NCT00754065|566896674|FG000|Overall Study|Withdrawal by Subject|4|||
157038569|NCT00754065|566896675|FG001|Overall Study|Withdrawal by Subject|5|||
157038570|NCT00754065|566896674|FG000|Overall Study|Pregnancy|6|||
157038571|NCT00754065|566896675|FG001|Overall Study|Pregnancy|0|||
157038572|NCT00754065|566896674|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
157038573|NCT00754065|566896675|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
157038574|NCT04860505|566896678|FG000|Overall Study|Lost to Follow-up|2|||
157038575|NCT01988402|566896679|FG000|Overall Study|Adverse Event|1|||
157038576|NCT01988402|566896680|FG001|Overall Study|Adverse Event|2|||
157038577|NCT01988402|566896679|FG000|Overall Study|Withdrawal by Subject|1|||
157038578|NCT01988402|566896680|FG001|Overall Study|Withdrawal by Subject|0|||
157038579|NCT01759862|566896684|FG000|Overall Study|Physician Decision|3|||
157038580|NCT01759862|566896685|FG001|Overall Study|Physician Decision|1|||
157038581|NCT01759862|566896684|FG000|Overall Study|Adverse Event|0|||
157038582|NCT01759862|566896685|FG001|Overall Study|Adverse Event|1|||
157038583|NCT04060212|566896686|FG000|Overall Study|Withdrawal by Subject|7|||
157038584|NCT01499849|566896687|FG000|Overall Study|Adverse Event|28|||
157038585|NCT01499849|566896688|FG001|Overall Study|Adverse Event|32|||
157038586|NCT01499849|566896687|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
157038587|NCT01499849|566896688|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
157038588|NCT01499849|566896687|FG000|Overall Study|Withdrawal by Subject|43|||
157038589|NCT01499849|566896688|FG001|Overall Study|Withdrawal by Subject|43|||
157038590|NCT01499849|566896687|FG000|Overall Study|Death|5|||
157038591|NCT01499849|566896688|FG001|Overall Study|Death|7|||
157038592|NCT01499849|566896687|FG000|Overall Study|Disease Progression|11|||
157038593|NCT01499849|566896688|FG001|Overall Study|Disease Progression|10|||
157038594|NCT01499849|566896687|FG000|Overall Study|Protocol Violation|11|||
157038595|NCT01499849|566896688|FG001|Overall Study|Protocol Violation|11|||
157038596|NCT01499849|566896687|FG000|Overall Study|Physician Decision|20|||
157038597|NCT01499849|566896688|FG001|Overall Study|Physician Decision|19|||
157171526|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
157171527|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
157171528|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
157171529|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
157171530|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
157171531|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
157171532|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
157171533|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
157171534|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
157171535|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
157038598|NCT01499849|566896687|FG000|Overall Study|Lack of Efficacy|3|||
157038599|NCT01499849|566896688|FG001|Overall Study|Lack of Efficacy|4|||
157038600|NCT01499849|566896687|FG000|Overall Study|Lost to Follow-up|6|||
157038601|NCT01499849|566896688|FG001|Overall Study|Lost to Follow-up|3|||
157038602|NCT01499849|566896687|FG000|Overall Study|Other Reasons|27|||
157038603|NCT01499849|566896688|FG001|Overall Study|Other Reasons|30|||
157038604|NCT00622700|566896694|FG000|Core Treatment Period|Randomized but Not Treated|0|||
157038605|NCT00622700|566896695|FG001|Core Treatment Period|Randomized but Not Treated|2|||
157038606|NCT00622700|566896696|FG002|Core Treatment Period|Randomized but Not Treated|2|||
157038607|NCT00622700|566896697|FG003|Core Treatment Period|Randomized but Not Treated|0|||
157171536|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
157171537|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
157171538|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
157171539|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
157171540|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157171541|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
157171542|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
157171543|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
157171544|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
157171545|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
157171546|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
157171547|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
157171548|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
156962120|NCT02077166|566611830|FG000|Overall Study|Other, Not Specified|0|||
156962121|NCT02077166|566611831|FG001|Overall Study|Other, Not Specified|0|||
156962122|NCT02077166|566611832|FG002|Overall Study|Other, Not Specified|1|||
156962123|NCT02077166|566611833|FG003|Overall Study|Other, Not Specified|0|||
156962124|NCT02077166|566611834|FG004|Overall Study|Other, Not Specified|1|||
156962125|NCT02077166|566611835|FG005|Overall Study|Other, Not Specified|7|||
156962126|NCT02077166|566611836|FG006|Overall Study|Other, Not Specified|8|||
156962127|NCT01261338|566611837|FG000|Overall Study|Withdrawal by Subject|3|||
156962128|NCT01261338|566611838|FG001|Overall Study|Withdrawal by Subject|2|||
156962129|NCT05245864|566611841|FG000|Overall Study|Withdrawal by Subject|1|||
156962130|NCT05245864|566611842|FG001|Overall Study|Withdrawal by Subject|1|||
156962131|NCT01475136|566611845|FG000|Overall Study|Sponsor Decision|0|||
156962132|NCT01475136|566611846|FG001|Overall Study|Sponsor Decision|1|||
156962133|NCT01475136|566611847|FG002|Overall Study|Sponsor Decision|0|||
156962134|NCT01475136|566611848|FG003|Overall Study|Sponsor Decision|0|||
156962135|NCT01475136|566611845|FG000|Overall Study|Entry Criteria Not Met|0|||
156962136|NCT01475136|566611846|FG001|Overall Study|Entry Criteria Not Met|2|||
156962137|NCT01475136|566611847|FG002|Overall Study|Entry Criteria Not Met|3|||
156962138|NCT01475136|566611848|FG003|Overall Study|Entry Criteria Not Met|1|||
156962139|NCT01475136|566611845|FG000|Overall Study|Withdrawal by Subject|0|||
156962140|NCT01475136|566611846|FG001|Overall Study|Withdrawal by Subject|0|||
156962141|NCT01475136|566611847|FG002|Overall Study|Withdrawal by Subject|0|||
156962142|NCT01475136|566611848|FG003|Overall Study|Withdrawal by Subject|2|||
156962143|NCT01475136|566611845|FG000|Overall Study|Adverse Event|1|||
156962144|NCT01475136|566611846|FG001|Overall Study|Adverse Event|0|||
156962145|NCT01475136|566611847|FG002|Overall Study|Adverse Event|0|||
156962146|NCT01475136|566611848|FG003|Overall Study|Adverse Event|1|||
156962147|NCT01475136|566611845|FG000|Overall Study|Death|0|||
156962148|NCT01475136|566611846|FG001|Overall Study|Death|0|||
156962149|NCT01475136|566611847|FG002|Overall Study|Death|0|||
156962150|NCT01475136|566611848|FG003|Overall Study|Death|1|||
156962151|NCT04918784|566614153|FG000|Overall Study|Amputation - no longer eligible|1|||
156962152|NCT04918784|566614154|FG001|Overall Study|Amputation - no longer eligible|2|||
156962153|NCT04918784|566614153|FG000|Overall Study|Death|1|||
156962154|NCT04918784|566614154|FG001|Overall Study|Death|0|||
156962155|NCT04918784|566614153|FG000|Overall Study|patient non-compliance|3|||
156962156|NCT04918784|566614154|FG001|Overall Study|patient non-compliance|1|||
156962157|NCT04918784|566614153|FG000|Overall Study|Adverse Event|1|||
156962158|NCT04918784|566614154|FG001|Overall Study|Adverse Event|0|||
156962159|NCT01986881|566614159|FG000|Overall Study|Death|228|||
156962160|NCT01986881|566614160|FG001|Overall Study|Death|233|||
156962161|NCT01986881|566614161|FG002|Overall Study|Death|247|||
156962162|NCT01986881|566614159|FG000|Overall Study|Lost to Follow-up|51|||
156962163|NCT01986881|566614160|FG001|Overall Study|Lost to Follow-up|44|||
156962164|NCT01986881|566614161|FG002|Overall Study|Lost to Follow-up|55|||
156962165|NCT01986881|566614159|FG000|Overall Study|Physician Decision|7|||
156962166|NCT01986881|566614160|FG001|Overall Study|Physician Decision|4|||
156962167|NCT01986881|566614161|FG002|Overall Study|Physician Decision|6|||
156962168|NCT01986881|566614159|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
156962169|NCT01986881|566614160|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
156962170|NCT01986881|566614161|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
156962171|NCT01986881|566614159|FG000|Overall Study|Withdrawal by Subject|41|||
156962172|NCT01986881|566614160|FG001|Overall Study|Withdrawal by Subject|60|||
156962173|NCT01986881|566614161|FG002|Overall Study|Withdrawal by Subject|45|||
156962174|NCT01986881|566614159|FG000|Overall Study|Subject Moved|0|||
156962175|NCT01986881|566614160|FG001|Overall Study|Subject Moved|1|||
156962176|NCT01986881|566614161|FG002|Overall Study|Subject Moved|0|||
156962177|NCT01986881|566614159|FG000|Overall Study|Other|1|||
156962178|NCT01986881|566614160|FG001|Overall Study|Other|2|||
157227809|NCT00911859|567579213|FG001|Treatment Period|Death|3|||
156962179|NCT01986881|566614161|FG002|Overall Study|Other|2|||
156962180|NCT01258608|566614166|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
157038608|NCT00622700|566896698|FG004|Core Treatment Period|Randomized but Not Treated|0|||
157038609|NCT00622700|566896699|FG005|Core Treatment Period|Randomized but Not Treated|0|||
157038610|NCT00622700|566896700|FG006|Core Treatment Period|Randomized but Not Treated|0|||
157038611|NCT00622700|566896694|FG000|Core Treatment Period|Adverse Event|18|||
157038612|NCT00622700|566896695|FG001|Core Treatment Period|Adverse Event|25|||
157038613|NCT00622700|566896696|FG002|Core Treatment Period|Adverse Event|18|||
157038614|NCT00622700|566896697|FG003|Core Treatment Period|Adverse Event|0|||
157038615|NCT00622700|566896698|FG004|Core Treatment Period|Adverse Event|0|||
157038616|NCT00622700|566896699|FG005|Core Treatment Period|Adverse Event|0|||
157038617|NCT00622700|566896700|FG006|Core Treatment Period|Adverse Event|0|||
157038618|NCT00622700|566896694|FG000|Core Treatment Period|Lack of Efficacy|19|||
157038619|NCT00622700|566896695|FG001|Core Treatment Period|Lack of Efficacy|6|||
157038620|NCT00622700|566896696|FG002|Core Treatment Period|Lack of Efficacy|12|||
157038621|NCT00622700|566896697|FG003|Core Treatment Period|Lack of Efficacy|0|||
157038622|NCT00622700|566896698|FG004|Core Treatment Period|Lack of Efficacy|0|||
157038623|NCT00622700|566896699|FG005|Core Treatment Period|Lack of Efficacy|0|||
157038624|NCT00622700|566896700|FG006|Core Treatment Period|Lack of Efficacy|0|||
157038625|NCT00622700|566896694|FG000|Core Treatment Period|Lost to Follow-up|1|||
157038626|NCT00622700|566896695|FG001|Core Treatment Period|Lost to Follow-up|1|||
157038627|NCT00622700|566896696|FG002|Core Treatment Period|Lost to Follow-up|1|||
157038628|NCT00622700|566896697|FG003|Core Treatment Period|Lost to Follow-up|0|||
157038629|NCT00622700|566896698|FG004|Core Treatment Period|Lost to Follow-up|0|||
157038630|NCT00622700|566896699|FG005|Core Treatment Period|Lost to Follow-up|0|||
157038631|NCT00622700|566896700|FG006|Core Treatment Period|Lost to Follow-up|0|||
157038632|NCT00622700|566896694|FG000|Core Treatment Period|Death|1|||
157038633|NCT00622700|566896695|FG001|Core Treatment Period|Death|0|||
157038634|NCT00622700|566896696|FG002|Core Treatment Period|Death|0|||
157038635|NCT00622700|566896697|FG003|Core Treatment Period|Death|0|||
157038636|NCT00622700|566896698|FG004|Core Treatment Period|Death|0|||
157038637|NCT00622700|566896699|FG005|Core Treatment Period|Death|0|||
157038638|NCT00622700|566896700|FG006|Core Treatment Period|Death|0|||
157038639|NCT00622700|566896694|FG000|Core Treatment Period|Progressive Disease|3|||
157038640|NCT00622700|566896695|FG001|Core Treatment Period|Progressive Disease|1|||
157038641|NCT00622700|566896696|FG002|Core Treatment Period|Progressive Disease|0|||
157038642|NCT00622700|566896697|FG003|Core Treatment Period|Progressive Disease|0|||
157038643|NCT00622700|566896698|FG004|Core Treatment Period|Progressive Disease|0|||
157038644|NCT00622700|566896699|FG005|Core Treatment Period|Progressive Disease|0|||
157038645|NCT00622700|566896700|FG006|Core Treatment Period|Progressive Disease|0|||
157038646|NCT00622700|566896694|FG000|Core Treatment Period|Withdrawal by Subject|12|||
157038647|NCT00622700|566896695|FG001|Core Treatment Period|Withdrawal by Subject|18|||
157038648|NCT00622700|566896696|FG002|Core Treatment Period|Withdrawal by Subject|15|||
157038649|NCT00622700|566896697|FG003|Core Treatment Period|Withdrawal by Subject|0|||
157038650|NCT00622700|566896698|FG004|Core Treatment Period|Withdrawal by Subject|0|||
157038651|NCT00622700|566896699|FG005|Core Treatment Period|Withdrawal by Subject|0|||
157038652|NCT00622700|566896700|FG006|Core Treatment Period|Withdrawal by Subject|0|||
157038653|NCT00622700|566896694|FG000|Core Treatment Period|Other than specified above|2|||
157038654|NCT00622700|566896695|FG001|Core Treatment Period|Other than specified above|2|||
157038655|NCT00622700|566896696|FG002|Core Treatment Period|Other than specified above|5|||
157038656|NCT00622700|566896697|FG003|Core Treatment Period|Other than specified above|0|||
157038657|NCT00622700|566896698|FG004|Core Treatment Period|Other than specified above|0|||
157038658|NCT00622700|566896699|FG005|Core Treatment Period|Other than specified above|0|||
157038659|NCT00622700|566896700|FG006|Core Treatment Period|Other than specified above|0|||
157038660|NCT00622700|566896694|FG000|Extension Treatment Period|Adverse Event|0|||
157038661|NCT00622700|566896695|FG001|Extension Treatment Period|Adverse Event|0|||
157038662|NCT00622700|566896696|FG002|Extension Treatment Period|Adverse Event|0|||
157038663|NCT00622700|566896697|FG003|Extension Treatment Period|Adverse Event|5|||
157038664|NCT00622700|566896698|FG004|Extension Treatment Period|Adverse Event|9|||
157038665|NCT00622700|566896699|FG005|Extension Treatment Period|Adverse Event|6|||
157038666|NCT00622700|566896700|FG006|Extension Treatment Period|Adverse Event|8|||
156962181|NCT01258608|566614167|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
156962182|NCT01258608|566614166|FG000|Overall Study|Clinical progression|1|||
156962183|NCT01258608|566614167|FG001|Overall Study|Clinical progression|0|||
156962184|NCT01258608|566614166|FG000|Overall Study|Sponsor decision|0|||
156962185|NCT01258608|566614167|FG001|Overall Study|Sponsor decision|1|||
156962186|NCT01258608|566614166|FG000|Overall Study|Physician Decision|6|||
156962187|NCT01258608|566614167|FG001|Overall Study|Physician Decision|1|||
156962188|NCT01258608|566614166|FG000|Overall Study|Lost to Follow-up|0|||
156962189|NCT01258608|566614167|FG001|Overall Study|Lost to Follow-up|1|||
156962190|NCT01258608|566614166|FG000|Overall Study|Lack of compliance|1|||
157038667|NCT00622700|566896694|FG000|Extension Treatment Period|Lack of Efficacy|0|||
157038668|NCT00622700|566896695|FG001|Extension Treatment Period|Lack of Efficacy|0|||
157038669|NCT00622700|566896696|FG002|Extension Treatment Period|Lack of Efficacy|0|||
157038670|NCT00622700|566896697|FG003|Extension Treatment Period|Lack of Efficacy|2|||
156962191|NCT01258608|566614167|FG001|Overall Study|Lack of compliance|0|||
157038671|NCT00622700|566896698|FG004|Extension Treatment Period|Lack of Efficacy|8|||
157038672|NCT00622700|566896699|FG005|Extension Treatment Period|Lack of Efficacy|1|||
157038673|NCT00622700|566896700|FG006|Extension Treatment Period|Lack of Efficacy|9|||
157038674|NCT00622700|566896694|FG000|Extension Treatment Period|Protocol Violation|0|||
157038675|NCT00622700|566896695|FG001|Extension Treatment Period|Protocol Violation|0|||
157038676|NCT00622700|566896696|FG002|Extension Treatment Period|Protocol Violation|0|||
157038677|NCT00622700|566896697|FG003|Extension Treatment Period|Protocol Violation|0|||
157038678|NCT00622700|566896698|FG004|Extension Treatment Period|Protocol Violation|0|||
157038679|NCT00622700|566896699|FG005|Extension Treatment Period|Protocol Violation|2|||
157038680|NCT00622700|566896700|FG006|Extension Treatment Period|Protocol Violation|0|||
157038681|NCT00622700|566896694|FG000|Extension Treatment Period|Lost to Follow-up|0|||
157038682|NCT00622700|566896695|FG001|Extension Treatment Period|Lost to Follow-up|0|||
157038683|NCT00622700|566896696|FG002|Extension Treatment Period|Lost to Follow-up|0|||
157038684|NCT00622700|566896697|FG003|Extension Treatment Period|Lost to Follow-up|0|||
157038685|NCT00622700|566896698|FG004|Extension Treatment Period|Lost to Follow-up|1|||
157038686|NCT00622700|566896699|FG005|Extension Treatment Period|Lost to Follow-up|0|||
157038687|NCT00622700|566896700|FG006|Extension Treatment Period|Lost to Follow-up|0|||
157038688|NCT00622700|566896694|FG000|Extension Treatment Period|Progressive Disease|0|||
157038689|NCT00622700|566896695|FG001|Extension Treatment Period|Progressive Disease|0|||
157038690|NCT00622700|566896696|FG002|Extension Treatment Period|Progressive Disease|0|||
157038691|NCT00622700|566896697|FG003|Extension Treatment Period|Progressive Disease|1|||
157038692|NCT00622700|566896698|FG004|Extension Treatment Period|Progressive Disease|2|||
157038693|NCT00622700|566896699|FG005|Extension Treatment Period|Progressive Disease|0|||
157038694|NCT00622700|566896700|FG006|Extension Treatment Period|Progressive Disease|2|||
157038695|NCT00622700|566896694|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
157038696|NCT00622700|566896695|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
157038697|NCT00622700|566896696|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
157038698|NCT00622700|566896697|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
157038699|NCT00622700|566896698|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
157038700|NCT00622700|566896699|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
157038701|NCT00622700|566896700|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
157038702|NCT00622700|566896694|FG000|Extension Treatment Period|Missing|0|||
157038703|NCT00622700|566896695|FG001|Extension Treatment Period|Missing|0|||
157038704|NCT00622700|566896696|FG002|Extension Treatment Period|Missing|0|||
157038705|NCT00622700|566896697|FG003|Extension Treatment Period|Missing|2|||
157038706|NCT00622700|566896698|FG004|Extension Treatment Period|Missing|3|||
157038707|NCT00622700|566896699|FG005|Extension Treatment Period|Missing|1|||
157038708|NCT00622700|566896700|FG006|Extension Treatment Period|Missing|0|||
157038709|NCT00622700|566896694|FG000|Extension Treatment Period|Other than specified above|0|||
157038710|NCT00622700|566896695|FG001|Extension Treatment Period|Other than specified above|0|||
157038711|NCT00622700|566896696|FG002|Extension Treatment Period|Other than specified above|0|||
157038712|NCT00622700|566896697|FG003|Extension Treatment Period|Other than specified above|0|||
157038713|NCT00622700|566896698|FG004|Extension Treatment Period|Other than specified above|0|||
157038714|NCT00622700|566896699|FG005|Extension Treatment Period|Other than specified above|1|||
157038715|NCT00622700|566896700|FG006|Extension Treatment Period|Other than specified above|1|||
157038716|NCT02646618|566896703|FG000|Overall Study|Lost to Follow-up|10|||
157038717|NCT02646618|566896704|FG001|Overall Study|Lost to Follow-up|14|||
157038718|NCT04035447|566896705|FG000|Treatment Period|Lost to Follow-up|6|||
157038719|NCT04035447|566896706|FG001|Treatment Period|Lost to Follow-up|5|||
157038720|NCT04035447|566896705|FG000|Treatment Period|Physician Decision|0|||
157038721|NCT04035447|566896706|FG001|Treatment Period|Physician Decision|2|||
157038722|NCT00274261|566896707|FG000|Overall Study|Adverse Event|19|||
157038723|NCT00274261|566896708|FG001|Overall Study|Adverse Event|11|||
157038724|NCT00274261|566896707|FG000|Overall Study|Pregnancy|114|||
157038725|NCT00274261|566896708|FG001|Overall Study|Pregnancy|83|||
157038726|NCT00274261|566896707|FG000|Overall Study|Withdrawal by Subject|179|||
157038727|NCT00274261|566896708|FG001|Overall Study|Withdrawal by Subject|126|||
157038728|NCT00274261|566896707|FG000|Overall Study|Protocol Violation|71|||
157038729|NCT00274261|566896708|FG001|Overall Study|Protocol Violation|42|||
157038730|NCT00274261|566896707|FG000|Overall Study|Lost to Follow-up|106|||
157038731|NCT00274261|566896708|FG001|Overall Study|Lost to Follow-up|75|||
157038732|NCT03500549|566896709|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
157038733|NCT03500549|566896710|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
157038734|NCT03500549|566896709|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
157171549|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
157171550|NCT01376245|567369084|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
157171551|NCT01376245|567369085|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
157227810|NCT00911859|567579214|FG002|Treatment Period|Death|5|||
157038735|NCT03500549|566896710|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
157038736|NCT05509816|566896711|FG000|Overall Study|Lost to Follow-up|1|||
157038737|NCT00918203|566896715|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
157038738|NCT00918203|566896716|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
157171552|NCT01376245|567369086|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
157171553|NCT01376245|567369087|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
157171554|NCT01376245|567369088|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
157171555|NCT01357889|567369089|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
157171556|NCT01357889|567369090|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
157171557|NCT01357889|567369089|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
157171558|NCT01357889|567369090|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
157171559|NCT01357889|567369089|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
157227811|NCT00911859|567579212|FG000|Treatment Period|Lack of Efficacy|1|||
156962192|NCT01258608|566614166|FG000|Overall Study|Lack of Efficacy|0|||
156962193|NCT01258608|566614167|FG001|Overall Study|Lack of Efficacy|1|||
156962194|NCT01258608|566614166|FG000|Overall Study|Adverse Event|6|||
156962195|NCT01258608|566614167|FG001|Overall Study|Adverse Event|10|||
156962196|NCT01258608|566614166|FG000|Overall Study|Withdrawal by Subject|6|||
156962197|NCT01258608|566614167|FG001|Overall Study|Withdrawal by Subject|5|||
156962198|NCT04205630|566614168|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
156962199|NCT04205630|566614168|FG000|Overall Study|Disease clinical progression|7|||
156962200|NCT04205630|566614168|FG000|Overall Study|Withdrawal by Subject|2|||
156962201|NCT04205630|566614168|FG000|Overall Study|Adverse Event|17|||
156962202|NCT04205630|566614168|FG000|Overall Study|Other|1|||
156962203|NCT02822222|566614174|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
156962204|NCT02822222|566614175|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
156962205|NCT00440531|566614177|FG000|Overall Study|Adverse Event|1|||
156962206|NCT00440531|566614178|FG001|Overall Study|Adverse Event|0|||
156962207|NCT00440531|566614179|FG002|Overall Study|Adverse Event|2|||
156962208|NCT00440531|566614177|FG000|Overall Study|Withdrawal by Subject|2|||
156962209|NCT00440531|566614178|FG001|Overall Study|Withdrawal by Subject|0|||
156962210|NCT00440531|566614179|FG002|Overall Study|Withdrawal by Subject|0|||
156962211|NCT00440531|566614177|FG000|Overall Study|Protocol Violation|1|||
156962212|NCT00440531|566614178|FG001|Overall Study|Protocol Violation|2|||
156962213|NCT00440531|566614179|FG002|Overall Study|Protocol Violation|0|||
156962214|NCT00440531|566614177|FG000|Overall Study|Lost to Follow-up|4|||
156962215|NCT00440531|566614178|FG001|Overall Study|Lost to Follow-up|3|||
156962216|NCT00440531|566614179|FG002|Overall Study|Lost to Follow-up|5|||
156962217|NCT00440531|566614177|FG000|Overall Study|see pre-assignment details|2|||
156962218|NCT00440531|566614178|FG001|Overall Study|see pre-assignment details|0|||
156962219|NCT00440531|566614179|FG002|Overall Study|see pre-assignment details|0|||
156962220|NCT02216123|566614184|FG000|Overall Study|Lost to Follow-up|4|||
156962221|NCT02216123|566614185|FG001|Overall Study|Lost to Follow-up|2|||
156962222|NCT02216123|566614184|FG000|Overall Study|Withdrawal by Subject|2|||
156962223|NCT02216123|566614185|FG001|Overall Study|Withdrawal by Subject|0|||
156962224|NCT03318523|566614186|FG000|PC Period: Up to Year 1|Adverse Event|1|||
156962225|NCT03318523|566614187|FG001|PC Period: Up to Year 1|Adverse Event|0|||
156962226|NCT03318523|566614188|FG002|PC Period: Up to Year 1|Adverse Event|2|||
156962227|NCT03318523|566614189|FG003|PC Period: Up to Year 1|Adverse Event|0|||
156962228|NCT03318523|566614190|FG004|PC Period: Up to Year 1|Adverse Event|0|||
156962229|NCT03318523|566614191|FG005|PC Period: Up to Year 1|Adverse Event|0|||
156962230|NCT03318523|566614192|FG006|PC Period: Up to Year 1|Adverse Event|0|||
156962231|NCT03318523|566614193|FG007|PC Period: Up to Year 1|Adverse Event|0|||
156962232|NCT03318523|566614194|FG008|PC Period: Up to Year 1|Adverse Event|0|||
156962233|NCT03318523|566614195|FG009|PC Period: Up to Year 1|Adverse Event|0|||
156962234|NCT03318523|566614186|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
156962235|NCT03318523|566614187|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
156962236|NCT03318523|566614188|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962237|NCT03318523|566614189|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
156962238|NCT03318523|566614190|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962239|NCT03318523|566614191|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962240|NCT03318523|566614192|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962241|NCT03318523|566614193|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962242|NCT03318523|566614194|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962243|NCT03318523|566614195|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
156962244|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962245|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962246|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962247|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962248|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
156962249|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962250|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962251|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
156962252|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
156962253|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
156962254|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156962255|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
157171560|NCT01357889|567369090|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
157171561|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
157171562|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
157171563|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
157171564|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
157171565|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
157171566|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
157171567|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
157171568|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
157171569|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
157171570|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
157171571|NCT01357889|567369089|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
157171572|NCT01357889|567369090|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
157171573|NCT01357889|567369089|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
157171574|NCT01357889|567369090|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
157171575|NCT01357889|567369089|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
157171576|NCT01357889|567369090|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
157171577|NCT01357889|567369089|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
157171578|NCT01357889|567369090|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
157171579|NCT01357889|567369089|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
157171580|NCT01357889|567369090|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
157171581|NCT02693691|567369091|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
157171582|NCT02693691|567369091|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
157171583|NCT02693691|567369091|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
157171584|NCT02693691|567369091|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
157171585|NCT02693691|567369091|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
157171586|NCT02693691|567369091|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
157171587|NCT02693691|567369091|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
157171588|NCT01324622|567369097|FG000|Overall Study|Lost to Follow-up|7|||
157171589|NCT01324622|567369098|FG001|Overall Study|Lost to Follow-up|7|||
157171590|NCT01324622|567369097|FG000|Overall Study|Death|1|||
157171591|NCT01324622|567369098|FG001|Overall Study|Death|0|||
157171592|NCT01324622|567369097|FG000|Overall Study|Lack of Efficacy|1|||
157171593|NCT01324622|567369098|FG001|Overall Study|Lack of Efficacy|0|||
157171594|NCT02219087|567369099|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
157171595|NCT02219087|567369100|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
157171596|NCT05127421|567369101|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
157171597|NCT05127421|567369102|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
157171598|NCT05127421|567369103|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
157171599|NCT05127421|567369104|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
157171600|NCT05127421|567369101|FG000|4-Week Double-Blind Period|Physician Decision|1|||
157171601|NCT05127421|567369102|FG001|4-Week Double-Blind Period|Physician Decision|0|||
157171602|NCT05127421|567369103|FG002|4-Week Double-Blind Period|Physician Decision|0|||
157171603|NCT05127421|567369104|FG003|4-Week Double-Blind Period|Physician Decision|0|||
156962256|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156962257|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156962258|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
156962259|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156962260|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
156962261|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
156962262|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
156962263|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
156962264|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962265|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962266|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962267|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962268|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962269|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
156962270|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962271|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962272|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962273|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
156962274|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962275|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962276|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962277|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962278|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
157038739|NCT00918203|566896717|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
157038740|NCT00918203|566896715|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
157171604|NCT05127421|567369101|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
157171605|NCT05127421|567369102|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
157171606|NCT05127421|567369103|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
157171607|NCT05127421|567369104|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
157171608|NCT05127421|567369101|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
157171609|NCT05127421|567369102|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
157171610|NCT05127421|567369103|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
157171611|NCT05127421|567369104|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
157171612|NCT05127421|567369101|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
157171613|NCT05127421|567369102|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
157171614|NCT05127421|567369103|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
157171615|NCT05127421|567369104|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
157171616|NCT05127421|567369101|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
157171617|NCT05127421|567369102|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
157171618|NCT05127421|567369103|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
157171619|NCT05127421|567369104|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
157171620|NCT05127421|567369101|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
157171621|NCT05127421|567369102|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
157171622|NCT05127421|567369103|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
157171623|NCT05127421|567369104|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
157171624|NCT05127421|567369101|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
157171625|NCT05127421|567369102|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
157171626|NCT05127421|567369103|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
157171627|NCT05127421|567369104|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
157171628|NCT04311177|567369105|FG000|Overall Study|Adverse Event|3|||
157171629|NCT04311177|567369106|FG001|Overall Study|Adverse Event|1|||
157171630|NCT04311177|567369105|FG000|Overall Study|Physician Decision|4|||
157171631|NCT04311177|567369106|FG001|Overall Study|Physician Decision|3|||
157171632|NCT04311177|567369105|FG000|Overall Study|Withdrawal by Subject|1|||
157171633|NCT04311177|567369106|FG001|Overall Study|Withdrawal by Subject|0|||
157171634|NCT00574496|567369109|FG000|Overall Study|Withdrawal by Subject|1|||
157171635|NCT00039741|567369112|FG000|Overall Study|Death|0|||
157171636|NCT00039741|567369113|FG001|Overall Study|Death|1|||
157171637|NCT00039741|567369114|FG002|Overall Study|Death|0|||
157171638|NCT00039741|567369115|FG003|Overall Study|Death|0|||
157171639|NCT00039741|567369112|FG000|Overall Study|Lost to Follow-up|3|||
157171640|NCT00039741|567369113|FG001|Overall Study|Lost to Follow-up|1|||
157171641|NCT00039741|567369114|FG002|Overall Study|Lost to Follow-up|5|||
157171642|NCT00039741|567369115|FG003|Overall Study|Lost to Follow-up|2|||
157171643|NCT00039741|567369112|FG000|Overall Study|Confounding medical condition|1|||
157171644|NCT00039741|567369113|FG001|Overall Study|Confounding medical condition|0|||
157038741|NCT00918203|566896716|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
157038742|NCT00918203|566896717|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
157038743|NCT00918203|566896715|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
157038744|NCT00918203|566896716|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
157038745|NCT00918203|566896717|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
157038746|NCT00918203|566896715|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
157038747|NCT00918203|566896716|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
157038748|NCT00918203|566896717|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
157038749|NCT00589875|566896718|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
157038750|NCT00589875|566896718|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
157038751|NCT03357952|566896721|FG000|Overall Study|Withdrawal by Subject|0|||
157038752|NCT03357952|566896722|FG001|Overall Study|Withdrawal by Subject|1|||
157038753|NCT03357952|566896721|FG000|Overall Study|Sponsor Decision|9|||
157038754|NCT03357952|566896722|FG001|Overall Study|Sponsor Decision|0|||
157171645|NCT00039741|567369114|FG002|Overall Study|Confounding medical condition|0|||
157171646|NCT00039741|567369115|FG003|Overall Study|Confounding medical condition|0|||
157171647|NCT00039741|567369112|FG000|Overall Study|Not able to get to clinic|5|||
157038755|NCT02016872|566896723|FG000|Overall Study|Withdrawal by Subject|10|||
157038756|NCT02016872|566896723|FG000|Overall Study|Death Progression|2|||
157038757|NCT02016872|566896723|FG000|Overall Study|No FMISO scan|1|||
157171648|NCT00039741|567369113|FG001|Overall Study|Not able to get to clinic|2|||
157171649|NCT00039741|567369114|FG002|Overall Study|Not able to get to clinic|0|||
157171650|NCT00039741|567369115|FG003|Overall Study|Not able to get to clinic|3|||
157171651|NCT00039741|567369112|FG000|Overall Study|Moved|3|||
157171652|NCT00039741|567369113|FG001|Overall Study|Moved|2|||
157038758|NCT02016872|566896723|FG000|Overall Study|Ineligible|2|||
157038759|NCT03222609|566896724|FG000|Overall Study|Withdrew consent|2|||
157038760|NCT03222609|566896725|FG001|Overall Study|Withdrew consent|3|||
157038761|NCT03222609|566896726|FG002|Overall Study|Withdrew consent|4|||
156962279|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962280|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962281|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962282|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
156962283|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
156962284|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156962285|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156962286|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156962287|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
156962288|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
156962289|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
156962290|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
156962291|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
156962292|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
156962293|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
156962294|NCT03318523|566614186|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962295|NCT03318523|566614187|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962296|NCT03318523|566614188|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962297|NCT03318523|566614189|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962298|NCT03318523|566614190|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
156962299|NCT03318523|566614191|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962300|NCT03318523|566614192|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962301|NCT03318523|566614193|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
156962302|NCT03318523|566614194|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
156962303|NCT03318523|566614195|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
156962304|NCT00254982|566614198|FG000|Overall Study|Other|2|||
156962305|NCT00254982|566614199|FG001|Overall Study|Other|1|||
156962306|NCT00254982|566614198|FG000|Overall Study|Lack of Efficacy|5|||
156962307|NCT00254982|566614199|FG001|Overall Study|Lack of Efficacy|3|||
156962308|NCT00254982|566614198|FG000|Overall Study|Lost to Follow-up|5|||
156962309|NCT00254982|566614199|FG001|Overall Study|Lost to Follow-up|3|||
156962310|NCT00254982|566614198|FG000|Overall Study|Adverse Event|18|||
156962311|NCT00254982|566614199|FG001|Overall Study|Adverse Event|16|||
156962312|NCT00254982|566614198|FG000|Overall Study|Withdrawal by Subject|1|||
156962313|NCT00254982|566614199|FG001|Overall Study|Withdrawal by Subject|1|||
156962314|NCT00254982|566614198|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
156962315|NCT00254982|566614199|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
156962316|NCT00254982|566614198|FG000|Overall Study|Protocol deviation|1|||
156962317|NCT00254982|566614199|FG001|Overall Study|Protocol deviation|1|||
156962318|NCT00254982|566614198|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
156962319|NCT00254982|566614199|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
156962320|NCT00254982|566614198|FG000|Overall Study|Malignancy|0|||
156962321|NCT00254982|566614199|FG001|Overall Study|Malignancy|2|||
156962322|NCT00254982|566614198|FG000|Overall Study|Opportunistic infection|1|||
156962323|NCT00254982|566614199|FG001|Overall Study|Opportunistic infection|0|||
156962324|NCT00254982|566614198|FG000|Overall Study|Abnormal liver function tests|2|||
156962325|NCT00254982|566614199|FG001|Overall Study|Abnormal liver function tests|1|||
156962326|NCT02261493|566614200|FG000|Overall Study|Noncompliance|0|||
156962327|NCT02261493|566614201|FG001|Overall Study|Noncompliance|0|||
156962328|NCT02261493|566614202|FG002|Overall Study|Noncompliance|2|||
156962329|NCT02261493|566614200|FG000|Overall Study|Physician Decision|0|||
156962330|NCT02261493|566614201|FG001|Overall Study|Physician Decision|1|||
156962331|NCT02261493|566614202|FG002|Overall Study|Physician Decision|0|||
156962332|NCT02261493|566614200|FG000|Overall Study|Undisclosed alcohol abuse|0|||
156962333|NCT02261493|566614201|FG001|Overall Study|Undisclosed alcohol abuse|1|||
156962334|NCT02261493|566614202|FG002|Overall Study|Undisclosed alcohol abuse|0|||
156962335|NCT02261493|566614200|FG000|Overall Study|Protocol Violation|1|||
156962336|NCT02261493|566614201|FG001|Overall Study|Protocol Violation|0|||
156962337|NCT02261493|566614202|FG002|Overall Study|Protocol Violation|0|||
156962338|NCT02261493|566614200|FG000|Overall Study|Personal Reasons|14|||
156962339|NCT02261493|566614201|FG001|Overall Study|Personal Reasons|14|||
156962340|NCT02261493|566614202|FG002|Overall Study|Personal Reasons|16|||
156962341|NCT02261493|566614200|FG000|Overall Study|Lost to Follow-up|14|||
156962342|NCT02261493|566614201|FG001|Overall Study|Lost to Follow-up|27|||
156962343|NCT02261493|566614202|FG002|Overall Study|Lost to Follow-up|8|||
156962344|NCT02261493|566614200|FG000|Overall Study|Pregnancy|1|||
156962345|NCT02261493|566614201|FG001|Overall Study|Pregnancy|2|||
156962346|NCT02261493|566614202|FG002|Overall Study|Pregnancy|0|||
156962347|NCT02261493|566614200|FG000|Overall Study|Lack of Efficacy|0|||
156962348|NCT02261493|566614201|FG001|Overall Study|Lack of Efficacy|1|||
156962349|NCT02261493|566614202|FG002|Overall Study|Lack of Efficacy|0|||
157227812|NCT00911859|567579213|FG001|Treatment Period|Lack of Efficacy|7|||
157227813|NCT00911859|567579214|FG002|Treatment Period|Lack of Efficacy|5|||
157227814|NCT00911859|567579212|FG000|Treatment Period|Physician Decision|3|||
156962350|NCT02261493|566614200|FG000|Overall Study|Adverse Event|0|||
156962351|NCT02261493|566614201|FG001|Overall Study|Adverse Event|1|||
156962352|NCT02261493|566614202|FG002|Overall Study|Adverse Event|0|||
156962353|NCT02013622|566614210|FG000|Overall Study|Lost to Follow-up|10|||
156962354|NCT02013622|566614210|FG000|Overall Study|Adverse Event|3|||
156962355|NCT02013622|566614210|FG000|Overall Study|Met Withdrawal Criteria|3|||
156962356|NCT02013622|566614210|FG000|Overall Study|Withdrawal by Subject|6|||
157171653|NCT00039741|567369114|FG002|Overall Study|Moved|3|||
157171654|NCT00039741|567369115|FG003|Overall Study|Moved|6|||
157171655|NCT00039741|567369112|FG000|Overall Study|Non-compliance with protocol|1|||
157171656|NCT00039741|567369113|FG001|Overall Study|Non-compliance with protocol|0|||
157171657|NCT00039741|567369114|FG002|Overall Study|Non-compliance with protocol|1|||
157171658|NCT00039741|567369115|FG003|Overall Study|Non-compliance with protocol|0|||
157171659|NCT00039741|567369112|FG000|Overall Study|Withdrew consent|0|||
157171660|NCT00039741|567369113|FG001|Overall Study|Withdrew consent|5|||
157171661|NCT00039741|567369114|FG002|Overall Study|Withdrew consent|0|||
157171662|NCT00039741|567369115|FG003|Overall Study|Withdrew consent|1|||
157171663|NCT00039741|567369112|FG000|Overall Study|Missed final visit|2|||
157171664|NCT00039741|567369113|FG001|Overall Study|Missed final visit|1|||
157171665|NCT00039741|567369114|FG002|Overall Study|Missed final visit|2|||
157171666|NCT00039741|567369115|FG003|Overall Study|Missed final visit|2|||
157171667|NCT00946881|567369116|FG000|First Treatment|Withdrawal by Subject|1|||
157171668|NCT00946881|567369116|FG000|First Treatment|Patient relocated to another state|1|||
157171669|NCT00946881|567369116|FG000|Retreatment|Withdrawal by Subject|1|||
157171670|NCT00293423|567369117|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
157171671|NCT00293423|567369118|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
157171672|NCT00293423|567369117|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
157171673|NCT00293423|567369118|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
157171674|NCT00293423|567369117|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
157171675|NCT00293423|567369118|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
157171676|NCT00293423|567369117|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
157171677|NCT00293423|567369118|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
157171678|NCT00293423|567369117|FG000|Surgical Resection|processing error during surgical resection|1|||
157171679|NCT00293423|567369118|FG001|Surgical Resection|processing error during surgical resection|0|||
157171680|NCT00293423|567369117|FG000|Surgical Resection|Withdrawal by Subject|4|||
157171681|NCT00293423|567369118|FG001|Surgical Resection|Withdrawal by Subject|0|||
157171682|NCT00293423|567369117|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
157171683|NCT00293423|567369118|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
157171684|NCT01182337|567369121|FG000|Overall Study|Withdrawal by Subject|3|||
157171685|NCT01182337|567369122|FG001|Overall Study|Withdrawal by Subject|1|||
157171686|NCT01182337|567369121|FG000|Overall Study|Lost to Follow-up|0|||
157171687|NCT01182337|567369122|FG001|Overall Study|Lost to Follow-up|1|||
157171688|NCT01578785|567369128|FG000|Overall Study|Withdrawal by Subject|0|||
157171689|NCT01578785|567369129|FG001|Overall Study|Withdrawal by Subject|1|||
157171690|NCT01578785|567369128|FG000|Overall Study|Study terminated by sponsor|59|||
157171691|NCT01578785|567369129|FG001|Overall Study|Study terminated by sponsor|118|||
157171692|NCT00599027|567369130|FG000|Overall Study|Withdrawal by Subject|1|||
157171693|NCT00599027|567369131|FG001|Overall Study|Withdrawal by Subject|1|||
157171694|NCT00599027|567369130|FG000|Overall Study|Adverse Event|0|||
157171695|NCT00599027|567369131|FG001|Overall Study|Adverse Event|1|||
157171696|NCT00599027|567369130|FG000|Overall Study|Treatment Failure|0|||
157171697|NCT00599027|567369131|FG001|Overall Study|Treatment Failure|1|||
157171698|NCT02581982|567369132|FG000|Overall Study|Lack of Efficacy|12|||
157171699|NCT02581982|567369132|FG000|Overall Study|Adverse Event|3|||
157171700|NCT02581982|567369132|FG000|Overall Study|Physician Decision|1|||
157171701|NCT00405821|567369133|FG000|Overall Study|Death|5|||
157171702|NCT00405821|567369134|FG001|Overall Study|Death|7|||
157171703|NCT00405821|567369133|FG000|Overall Study|Lost to Follow-up|7|||
157171704|NCT00405821|567369134|FG001|Overall Study|Lost to Follow-up|7|||
157171705|NCT00405821|567369133|FG000|Overall Study|Protocol Violation|1|||
157171706|NCT00405821|567369134|FG001|Overall Study|Protocol Violation|0|||
157171707|NCT00405821|567369133|FG000|Overall Study|initiated ART|9|||
157171708|NCT00405821|567369134|FG001|Overall Study|initiated ART|8|||
157171709|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
157171710|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
157171711|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
157171712|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
157171713|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
157171714|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
157171715|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
156962357|NCT02013622|566614210|FG000|Overall Study|Protocol Deviation|1|||
156962358|NCT02013622|566614210|FG000|Overall Study|Lack of Efficacy|1|||
157038762|NCT03222609|566896727|FG003|Overall Study|Withdrew consent|2|||
157171716|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
157171717|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
157171718|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
157171719|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
157171720|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
157171721|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
157171722|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
157171723|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
157171724|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
157171725|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
157171726|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
157171727|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
157171728|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
157171729|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
157171730|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
157171731|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
157171732|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
157171733|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
157171734|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
157171735|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
157171736|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
157171737|NCT00476996|567369140|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
157171738|NCT00476996|567369141|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
157171739|NCT00476996|567369142|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
157171740|NCT00476996|567369143|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
157171741|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
157171742|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
157171743|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
157171744|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
157171745|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
157171746|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
157171747|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
157171748|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
157171749|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Death|0|||
157171750|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Death|0|||
157171751|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Death|0|||
157171752|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Death|7|||
157171753|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
157171754|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
157171755|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
157171756|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
157171757|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
157171758|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
157171759|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
157171760|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
157171761|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
157171762|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
157171763|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
157171764|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
157171765|NCT00476996|567369140|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
157171766|NCT00476996|567369141|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
157171767|NCT00476996|567369142|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
157171768|NCT00476996|567369143|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
157171769|NCT02031432|567369174|FG000|Overall Study|Protocol Violation|1|||
157171770|NCT02031432|567369174|FG000|Overall Study|Lack of Efficacy|5|||
157171771|NCT02031432|567369174|FG000|Overall Study|Cancer Progression|2|||
157171772|NCT02031432|567369174|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
157171773|NCT02031432|567369174|FG000|Overall Study|Adverse Event|8|||
157171774|NCT02031432|567369174|FG000|Overall Study|Withdrawal by Subject|5|||
157171775|NCT02031432|567369174|FG000|Overall Study|Lost to Follow-up|1|||
157171776|NCT02031432|567369174|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
157171777|NCT02031432|567369174|FG000|Overall Study|Death|10|||
157171778|NCT02148211|567369175|FG000|Overall Study|Lost to Follow-up|352|||
157171779|NCT01617187|567369176|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
157171780|NCT01617187|567369177|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
157227815|NCT00911859|567579213|FG001|Treatment Period|Physician Decision|3|||
157227816|NCT00911859|567579214|FG002|Treatment Period|Physician Decision|3|||
157227817|NCT00911859|567579212|FG000|Treatment Period|Withdrawal by Subject|0|||
157227818|NCT00911859|567579213|FG001|Treatment Period|Withdrawal by Subject|4|||
157171781|NCT01617187|567369178|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
157171782|NCT01617187|567369179|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
157171783|NCT01617187|567369176|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
157171784|NCT01617187|567369177|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
157171785|NCT01617187|567369178|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
157171786|NCT01617187|567369179|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
157171787|NCT01617187|567369176|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
157171788|NCT01617187|567369177|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
157171789|NCT01617187|567369178|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
157171790|NCT01617187|567369179|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
157171791|NCT01617187|567369176|FG000|Treatment Through Study Completion|Adverse Event|1|||
157171792|NCT01617187|567369177|FG001|Treatment Through Study Completion|Adverse Event|1|||
157171793|NCT01617187|567369178|FG002|Treatment Through Study Completion|Adverse Event|0|||
157171794|NCT01617187|567369179|FG003|Treatment Through Study Completion|Adverse Event|1|||
157171795|NCT01617187|567369176|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
157171796|NCT01617187|567369177|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
157171797|NCT01617187|567369178|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
157171798|NCT01617187|567369179|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
157171799|NCT01617187|567369176|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
157171800|NCT01617187|567369177|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
157171801|NCT01617187|567369178|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
157171802|NCT01617187|567369179|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
157171803|NCT01617187|567369176|FG000|Treatment Through Study Completion|Protocol Violation|1|||
157171804|NCT01617187|567369177|FG001|Treatment Through Study Completion|Protocol Violation|0|||
157171805|NCT01617187|567369178|FG002|Treatment Through Study Completion|Protocol Violation|0|||
157171806|NCT01617187|567369179|FG003|Treatment Through Study Completion|Protocol Violation|1|||
157171807|NCT05406440|567371046|FG000|Overall Study|Lost to Follow-up|0|||
157171808|NCT05406440|567371047|FG001|Overall Study|Lost to Follow-up|0|||
157171809|NCT05406440|567371048|FG002|Overall Study|Lost to Follow-up|0|||
157171810|NCT05406440|567371049|FG003|Overall Study|Lost to Follow-up|0|||
157171811|NCT05406440|567371050|FG004|Overall Study|Lost to Follow-up|2|||
157171812|NCT05406440|567371051|FG005|Overall Study|Lost to Follow-up|0|||
157171813|NCT05406440|567371052|FG006|Overall Study|Lost to Follow-up|0|||
157171814|NCT05406440|567371046|FG000|Overall Study|Physician Decision|0|||
157171815|NCT05406440|567371047|FG001|Overall Study|Physician Decision|0|||
157171816|NCT05406440|567371048|FG002|Overall Study|Physician Decision|0|||
157171817|NCT05406440|567371049|FG003|Overall Study|Physician Decision|0|||
157171818|NCT05406440|567371050|FG004|Overall Study|Physician Decision|1|||
157171819|NCT05406440|567371051|FG005|Overall Study|Physician Decision|0|||
157171820|NCT05406440|567371052|FG006|Overall Study|Physician Decision|0|||
157171821|NCT05406440|567371046|FG000|Overall Study|Withdrawal by Subject|0|||
157171822|NCT05406440|567371047|FG001|Overall Study|Withdrawal by Subject|0|||
157171823|NCT05406440|567371048|FG002|Overall Study|Withdrawal by Subject|0|||
157171824|NCT05406440|567371049|FG003|Overall Study|Withdrawal by Subject|0|||
157171825|NCT05406440|567371050|FG004|Overall Study|Withdrawal by Subject|0|||
157171826|NCT05406440|567371051|FG005|Overall Study|Withdrawal by Subject|2|||
157171827|NCT05406440|567371052|FG006|Overall Study|Withdrawal by Subject|0|||
157171828|NCT01412151|567371053|FG000|Week 0 - 306 - Treatment Period|Death|1|||
157171829|NCT01412151|567371053|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
157171830|NCT01412151|567371053|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
157171831|NCT01412151|567371053|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
157171832|NCT03127852|567371054|FG000|Overall Study|Withdrawal by Subject|4|||
157171833|NCT03127852|567371055|FG001|Overall Study|Withdrawal by Subject|1|||
157171834|NCT03127852|567371054|FG000|Overall Study|Death|1|||
157171835|NCT03127852|567371055|FG001|Overall Study|Death|1|||
157171836|NCT01824693|567371056|FG000|Overall Study|Death|0|||
157171837|NCT01824693|567371057|FG001|Overall Study|Death|1|||
157171838|NCT01824693|567371058|FG002|Overall Study|Death|0|||
157171839|NCT01824693|567371056|FG000|Overall Study|Physician Decision|1|||
157171840|NCT01824693|567371057|FG001|Overall Study|Physician Decision|1|||
157171841|NCT01824693|567371058|FG002|Overall Study|Physician Decision|1|||
157171842|NCT01824693|567371056|FG000|Overall Study|Withdrawal by Subject|0|||
157171843|NCT01824693|567371057|FG001|Overall Study|Withdrawal by Subject|0|||
157171844|NCT01824693|567371058|FG002|Overall Study|Withdrawal by Subject|1|||
157171845|NCT01824693|567371056|FG000|Overall Study|Progressive Disease|0|||
157171846|NCT01824693|567371057|FG001|Overall Study|Progressive Disease|5|||
157171847|NCT01824693|567371058|FG002|Overall Study|Progressive Disease|0|||
157171848|NCT01824693|567371056|FG000|Overall Study|Ineligible|0|||
157171849|NCT01824693|567371057|FG001|Overall Study|Ineligible|0|||
157171850|NCT01824693|567371058|FG002|Overall Study|Ineligible|3|||
157171851|NCT01824693|567371056|FG000|Overall Study|No Transplant Planned|0|||
157171852|NCT01824693|567371057|FG001|Overall Study|No Transplant Planned|0|||
157038763|NCT03222609|566896724|FG000|Overall Study|Lost to Follow-up|1|||
157038764|NCT03222609|566896725|FG001|Overall Study|Lost to Follow-up|0|||
157038765|NCT03222609|566896726|FG002|Overall Study|Lost to Follow-up|0|||
157038766|NCT03222609|566896727|FG003|Overall Study|Lost to Follow-up|0|||
157038767|NCT03222609|566896724|FG000|Overall Study|Death|16|||
157038768|NCT03222609|566896725|FG001|Overall Study|Death|13|||
157038769|NCT03222609|566896726|FG002|Overall Study|Death|9|||
157038770|NCT03222609|566896727|FG003|Overall Study|Death|6|||
157038771|NCT03222609|566896724|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
157038772|NCT03222609|566896725|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
157038773|NCT03222609|566896726|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
157038774|NCT03222609|566896727|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
157038775|NCT03834740|566896728|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
157038776|NCT03834740|566896729|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
157038777|NCT03834740|566896730|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
157038778|NCT01208974|566896731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
157038779|NCT01208974|566896732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
157038780|NCT01208974|566896733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
157038781|NCT01208974|566896734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
157038782|NCT01208974|566896731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
157038783|NCT01208974|566896732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
157038784|NCT01208974|566896733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
157038785|NCT01208974|566896734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
157038786|NCT01208974|566896731|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
157038787|NCT01208974|566896732|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
157038788|NCT01208974|566896733|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
157038789|NCT01208974|566896734|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
157038790|NCT03789110|566896735|FG000|Overall Study|Adverse Event|2|||
157038791|NCT03789110|566896735|FG000|Overall Study|Physician Decision|1|||
157038792|NCT03789110|566896735|FG000|Overall Study|Withdrawal by Subject|2|||
157038793|NCT03789110|566896735|FG000|Overall Study|Lack of Efficacy|22|||
157038794|NCT03789110|566896735|FG000|Overall Study|still on treatment|3|||
157038795|NCT00545545|566896736|FG000|Overall Study|Progressive Neoplastic Disease|1|||
157038796|NCT00545545|566896737|FG001|Overall Study|Progressive Neoplastic Disease|5|||
157038797|NCT00545545|566896738|FG002|Overall Study|Progressive Neoplastic Disease|0|||
157038798|NCT00545545|566896739|FG003|Overall Study|Progressive Neoplastic Disease|4|||
157038799|NCT00545545|566896740|FG004|Overall Study|Progressive Neoplastic Disease|8|||
157038800|NCT00545545|566896741|FG005|Overall Study|Progressive Neoplastic Disease|7|||
157038801|NCT00545545|566896736|FG000|Overall Study|Withdrawal by Subject|0|||
157038802|NCT00545545|566896737|FG001|Overall Study|Withdrawal by Subject|1|||
157038803|NCT00545545|566896738|FG002|Overall Study|Withdrawal by Subject|0|||
157038804|NCT00545545|566896739|FG003|Overall Study|Withdrawal by Subject|0|||
157038805|NCT00545545|566896740|FG004|Overall Study|Withdrawal by Subject|0|||
157038806|NCT00545545|566896741|FG005|Overall Study|Withdrawal by Subject|0|||
157038807|NCT00545545|566896736|FG000|Overall Study|Physician Decision|1|||
157038808|NCT00545545|566896737|FG001|Overall Study|Physician Decision|0|||
157038809|NCT00545545|566896738|FG002|Overall Study|Physician Decision|0|||
157038810|NCT00545545|566896739|FG003|Overall Study|Physician Decision|0|||
157038811|NCT00545545|566896740|FG004|Overall Study|Physician Decision|0|||
157038812|NCT00545545|566896741|FG005|Overall Study|Physician Decision|1|||
157038813|NCT00545545|566896736|FG000|Overall Study|Irinotecan intolerance|1|||
157038814|NCT00545545|566896737|FG001|Overall Study|Irinotecan intolerance|1|||
157038815|NCT00545545|566896738|FG002|Overall Study|Irinotecan intolerance|0|||
157038816|NCT00545545|566896739|FG003|Overall Study|Irinotecan intolerance|0|||
157038817|NCT00545545|566896740|FG004|Overall Study|Irinotecan intolerance|0|||
157038818|NCT00545545|566896741|FG005|Overall Study|Irinotecan intolerance|0|||
157038819|NCT00545545|566896736|FG000|Overall Study|No target lesions to track post surgery|0|||
157038820|NCT00545545|566896737|FG001|Overall Study|No target lesions to track post surgery|0|||
157038821|NCT00545545|566896738|FG002|Overall Study|No target lesions to track post surgery|0|||
157038822|NCT00545545|566896739|FG003|Overall Study|No target lesions to track post surgery|0|||
157038823|NCT00545545|566896740|FG004|Overall Study|No target lesions to track post surgery|1|||
157171853|NCT01824693|567371058|FG002|Overall Study|No Transplant Planned|10|||
157171854|NCT02150213|567371059|FG000|Overall Study|Lost to Follow-up|1|||
157171855|NCT02150213|567371059|FG000|Overall Study|Withdrawal by Subject|1|||
157171856|NCT01175590|567371060|FG000|Overall Study|Lost to Follow-up|1|||
157038824|NCT00545545|566896741|FG005|Overall Study|No target lesions to track post surgery|1|||
157038825|NCT03691493|566896742|FG000|Overall Study|Withdrawal by Subject|1|||
157038826|NCT05786612|566896743|FG000|Overall Study|Adverse Event|1|||
157171857|NCT01175590|567371061|FG001|Overall Study|Lost to Follow-up|0|||
157038827|NCT05786612|566896744|FG001|Overall Study|Adverse Event|2|||
157038828|NCT05786612|566896743|FG000|Overall Study|one screening failure|0|||
157038829|NCT05786612|566896744|FG001|Overall Study|one screening failure|2|||
157171858|NCT01175590|567371060|FG000|Overall Study|Withdrawal by Subject|0|||
157038830|NCT02798471|566896749|FG000|Overall Study|Adverse Event|7|||
157038831|NCT02798471|566896750|FG001|Overall Study|Adverse Event|2|||
157038832|NCT02798471|566896749|FG000|Overall Study|Physician Decision|3|||
157038833|NCT02798471|566896750|FG001|Overall Study|Physician Decision|7|||
157038834|NCT02798471|566896749|FG000|Overall Study|Death|2|||
157171859|NCT01175590|567371061|FG001|Overall Study|Withdrawal by Subject|2|||
157171860|NCT01175590|567371060|FG000|Overall Study|Adverse Event|4|||
157171861|NCT01175590|567371061|FG001|Overall Study|Adverse Event|0|||
157171862|NCT01175590|567371060|FG000|Overall Study|Physician Decision|1|||
157171863|NCT01175590|567371061|FG001|Overall Study|Physician Decision|4|||
157171864|NCT01175590|567371060|FG000|Overall Study|Lack of Efficacy|1|||
157171865|NCT01175590|567371061|FG001|Overall Study|Lack of Efficacy|1|||
157171866|NCT01175590|567371060|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
156962359|NCT00224874|566614211|FG000|Overall Study|Withdrawal by Subject|0|||
156962360|NCT00224874|566614212|FG001|Overall Study|Withdrawal by Subject|0|||
156962361|NCT00224874|566614213|FG002|Overall Study|Withdrawal by Subject|1|||
156962362|NCT00224874|566614214|FG003|Overall Study|Withdrawal by Subject|0|||
156962363|NCT02355002|566614215|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
156962364|NCT02355002|566614216|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
156962365|NCT02355002|566614215|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
156962366|NCT02355002|566614216|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
156962367|NCT02355002|566614215|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
156962368|NCT02355002|566614216|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
156962369|NCT02355002|566614215|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
156962370|NCT02355002|566614216|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
156962371|NCT02355002|566614215|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
156962372|NCT02355002|566614216|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
156962373|NCT02355002|566614215|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
156962374|NCT02355002|566614216|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
156962375|NCT02355002|566614215|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
156962376|NCT02355002|566614216|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
156962377|NCT05554237|566614217|FG000|Part 2 (7 Days)|Adverse Event|0|||
156962378|NCT05554237|566614218|FG001|Part 2 (7 Days)|Adverse Event|0|||
156962379|NCT05554237|566614219|FG002|Part 2 (7 Days)|Adverse Event|0|||
156962380|NCT05554237|566614220|FG003|Part 2 (7 Days)|Adverse Event|0|||
156962381|NCT05554237|566614221|FG004|Part 2 (7 Days)|Adverse Event|2|||
156962382|NCT05554237|566614222|FG005|Part 2 (7 Days)|Adverse Event|0|||
156962383|NCT05554237|566614223|FG006|Part 2 (7 Days)|Adverse Event|0|||
156962384|NCT05554237|566614224|FG007|Part 2 (7 Days)|Adverse Event|0|||
156962385|NCT05554237|566614225|FG008|Part 2 (7 Days)|Adverse Event|0|||
156962386|NCT05554237|566614226|FG009|Part 2 (7 Days)|Adverse Event|1|||
156962387|NCT05554237|566614227|FG010|Part 2 (7 Days)|Adverse Event|0|||
156962388|NCT05554237|566614228|FG011|Part 2 (7 Days)|Adverse Event|0|||
156962389|NCT05554237|566614229|FG012|Part 2 (7 Days)|Adverse Event|1|||
156962390|NCT05554237|566614230|FG013|Part 2 (7 Days)|Adverse Event|0|||
156962391|NCT05130970|566614233|FG000|Overall Study|Adverse Event|1|||
156962392|NCT05130970|566614234|FG001|Overall Study|Adverse Event|1|||
156962393|NCT05130970|566614233|FG000|Overall Study|Death|0|||
156962394|NCT05130970|566614234|FG001|Overall Study|Death|1|||
156962395|NCT05130970|566614233|FG000|Overall Study|Lost to Follow-up|0|||
156962396|NCT05130970|566614234|FG001|Overall Study|Lost to Follow-up|1|||
156962397|NCT05130970|566614233|FG000|Overall Study|Physician Decision|0|||
156962398|NCT05130970|566614234|FG001|Overall Study|Physician Decision|1|||
156962399|NCT05130970|566614233|FG000|Overall Study|Withdrawal by Subject|1|||
156962400|NCT05130970|566614234|FG001|Overall Study|Withdrawal by Subject|1|||
156962401|NCT03644186|566614235|FG000|Overall Study|Withdrawal by Subject|1|||
156962402|NCT03644186|566614236|FG001|Overall Study|Withdrawal by Subject|1|||
156962403|NCT04969198|566614239|FG000|Overall Study|Withdrawal by Subject|20|||
156962404|NCT04969198|566614239|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
156962405|NCT04969198|566614239|FG000|Overall Study|Lost to Follow-up|20|||
156962406|NCT02701985|566614240|FG000|Overall Study|Withdrawal by Subject|1|||
156962407|NCT02701985|566614241|FG001|Overall Study|Withdrawal by Subject|1|||
156962408|NCT02701985|566614240|FG000|Overall Study|Lost to Follow-up|1|||
156962409|NCT02701985|566614241|FG001|Overall Study|Lost to Follow-up|0|||
156962410|NCT02701985|566614240|FG000|Overall Study|Death|1|||
156962411|NCT02701985|566614241|FG001|Overall Study|Death|0|||
156962412|NCT02701985|566614240|FG000|Overall Study|Adverse Event|0|||
156962413|NCT02701985|566614241|FG001|Overall Study|Adverse Event|5|||
156962414|NCT01640808|566614243|FG000|Overall Study|Unable to continue dynamic CT|14|||
156962415|NCT01640808|566614244|FG001|Overall Study|Unable to continue dynamic CT|4|||
157038835|NCT02798471|566896750|FG001|Overall Study|Death|3|||
157038836|NCT02798471|566896749|FG000|Overall Study|Lost to Follow-up|0|||
157171867|NCT01175590|567371061|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
157171868|NCT01175590|567371060|FG000|Overall Study|Treated not as randomized|3|||
157038837|NCT02798471|566896750|FG001|Overall Study|Lost to Follow-up|1|||
157038838|NCT02798471|566896749|FG000|Overall Study|Other|5|||
157038839|NCT02798471|566896750|FG001|Overall Study|Other|3|||
157038840|NCT02798471|566896749|FG000|Overall Study|Subject withdrew consent|0|||
157038841|NCT02798471|566896750|FG001|Overall Study|Subject withdrew consent|6|||
157038842|NCT02798471|566896749|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
157038843|NCT02798471|566896750|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
157038844|NCT02798471|566896749|FG000|Overall Study|Randomized, but not treated|0|||
157038845|NCT02798471|566896750|FG001|Overall Study|Randomized, but not treated|2|||
157038846|NCT06056310|566898239|FG000|Overall Study|Other Reasons|2|||
157038847|NCT06056310|566898239|FG000|Overall Study|Sponsor Request|16|||
157038848|NCT03758638|566898244|FG000|Overall Study|Pregnancy|17|||
157038849|NCT03758638|566898245|FG001|Overall Study|Pregnancy|25|||
157038850|NCT03758638|566898244|FG000|Overall Study|Lost to Follow-up|60|||
157038851|NCT03758638|566898245|FG001|Overall Study|Lost to Follow-up|54|||
157038852|NCT03758638|566898244|FG000|Overall Study|Protocol Violation|2|||
157038853|NCT03758638|566898245|FG001|Overall Study|Protocol Violation|0|||
157038854|NCT03758638|566898244|FG000|Overall Study|Withdrawal by Subject|8|||
157038855|NCT03758638|566898245|FG001|Overall Study|Withdrawal by Subject|2|||
157038856|NCT03758638|566898244|FG000|Overall Study|Providers not included in the primary outcome.|183|||
157038857|NCT03758638|566898245|FG001|Overall Study|Providers not included in the primary outcome.|128|||
157038858|NCT00372775|566898247|FG000|Overall Study|Adverse Event|8|||
157038859|NCT00372775|566898247|FG000|Overall Study|Death|15|||
157038860|NCT00372775|566898247|FG000|Overall Study|Objective progression or relapse|30|||
157038861|NCT00372775|566898247|FG000|Overall Study|Global deterioration of health status|6|||
157038862|NCT00372775|566898247|FG000|Overall Study|Withdrawal by Subject|1|||
157038863|NCT00372775|566898247|FG000|Overall Study|Other|1|||
157038864|NCT00372775|566898247|FG000|Overall Study|Not Treated|2|||
157038865|NCT00790569|566898248|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
157038866|NCT00790569|566898249|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
157038867|NCT00790569|566898250|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
157038868|NCT00790569|566898248|FG000|End of Treatment (6 Month Interview)|Death|0|||
157038869|NCT00790569|566898249|FG001|End of Treatment (6 Month Interview)|Death|2|||
157038870|NCT00790569|566898250|FG002|End of Treatment (6 Month Interview)|Death|1|||
157038871|NCT00790569|566898248|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
157038872|NCT00790569|566898249|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
157038873|NCT00790569|566898250|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
157038874|NCT00790569|566898248|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
157038875|NCT00790569|566898249|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
157038876|NCT00790569|566898250|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
157038877|NCT00790569|566898248|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
157038878|NCT00790569|566898249|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
157038879|NCT00790569|566898250|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
157038880|NCT00790569|566898248|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
157038881|NCT00790569|566898249|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
157038882|NCT00790569|566898250|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
157038883|NCT01627561|566898251|FG000|Overall Study|Lost to Follow-up|1|||
157038884|NCT01627561|566898252|FG001|Overall Study|Lost to Follow-up|0|||
157038885|NCT01627561|566898251|FG000|Overall Study|Withdrawal by Subject|0|||
157038886|NCT01627561|566898252|FG001|Overall Study|Withdrawal by Subject|1|||
157038887|NCT01627561|566898251|FG000|Overall Study|Migrated/moved from study area|0|||
157038888|NCT01627561|566898252|FG001|Overall Study|Migrated/moved from study area|2|||
157038889|NCT00724126|566898253|FG000|Overall Study|Adverse Event|2|||
157038890|NCT00724126|566898254|FG001|Overall Study|Adverse Event|0|||
157038891|NCT00724126|566898253|FG000|Overall Study|Withdrawal by Subject|8|||
157038892|NCT00724126|566898254|FG001|Overall Study|Withdrawal by Subject|6|||
156962416|NCT01640808|566614243|FG000|Overall Study|Withdrawal by Subject|12|||
156962417|NCT01640808|566614244|FG001|Overall Study|Withdrawal by Subject|4|||
156962418|NCT01640808|566614243|FG000|Overall Study|Lost to Follow-up|4|||
156962419|NCT01640808|566614244|FG001|Overall Study|Lost to Follow-up|0|||
156962420|NCT01640808|566614243|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
156962421|NCT01640808|566614244|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
156962422|NCT01640808|566614243|FG000|Overall Study|Administration of anticancer drugs|2|||
156962423|NCT01640808|566614244|FG001|Overall Study|Administration of anticancer drugs|1|||
156962424|NCT01640808|566614243|FG000|Overall Study|Physician Decision|19|||
156962425|NCT01640808|566614244|FG001|Overall Study|Physician Decision|5|||
156962426|NCT01640808|566614243|FG000|Overall Study|Randomized but not treated|4|||
157038893|NCT00724126|566898253|FG000|Overall Study|Lost to Follow-up|6|||
156962427|NCT01640808|566614244|FG001|Overall Study|Randomized but not treated|2|||
156962428|NCT02477111|566614245|FG000|Overall Study|Death|28|||
156962429|NCT02477111|566614245|FG000|Overall Study|Withdrawal by Subject|19|||
156962430|NCT02477111|566614245|FG000|Overall Study|Lost to Follow-up|4|||
157038894|NCT00724126|566898254|FG001|Overall Study|Lost to Follow-up|6|||
157171869|NCT01175590|567371061|FG001|Overall Study|Treated not as randomized|2|||
157171870|NCT01175590|567371060|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
157171871|NCT01175590|567371061|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
157171872|NCT01175590|567371060|FG000|Overall Study|Protocol Violation|0|||
157171873|NCT01175590|567371061|FG001|Overall Study|Protocol Violation|1|||
157171874|NCT02966353|567371064|FG000|Overall Study|Withdrawal by Subject|7|||
157171875|NCT02966353|567371064|FG000|Overall Study|Adverse Event|4|||
157171876|NCT02966353|567371064|FG000|Overall Study|Death|4|||
157171877|NCT02966353|567371064|FG000|Overall Study|Physician Decision|3|||
157171878|NCT02966353|567371064|FG000|Overall Study|Progressive disease|2|||
157171879|NCT02966353|567371064|FG000|Overall Study|Protocol deviation|2|||
157171880|NCT01090102|567371065|FG000|First 12 Weeks|Withdrawal by Subject|1|||
157171881|NCT01090102|567371066|FG001|First 12 Weeks|Withdrawal by Subject|1|||
157171882|NCT01090102|567371065|FG000|First 12 Weeks|Adverse Event|2|||
157171883|NCT01090102|567371066|FG001|First 12 Weeks|Adverse Event|0|||
157171884|NCT01090102|567371065|FG000|First 12 Weeks|Death|1|||
157171885|NCT01090102|567371066|FG001|First 12 Weeks|Death|1|||
157171886|NCT01090102|567371065|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
157171887|NCT01090102|567371066|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
157171888|NCT03518034|567371067|FG000|Overall Study|Not Treated|5|||
157171889|NCT03518034|567371068|FG001|Overall Study|Not Treated|1|||
157171890|NCT03518034|567371067|FG000|Overall Study|Withdrawal by Subject|309|||
157171891|NCT03518034|567371068|FG001|Overall Study|Withdrawal by Subject|351|||
157171892|NCT03518034|567371067|FG000|Overall Study|Lost to Follow-up|446|||
157171893|NCT03518034|567371068|FG001|Overall Study|Lost to Follow-up|458|||
157171894|NCT03518034|567371067|FG000|Overall Study|Adverse Event|138|||
157171895|NCT03518034|567371068|FG001|Overall Study|Adverse Event|130|||
157171896|NCT03518034|567371067|FG000|Overall Study|Lack of Efficacy|11|||
157171897|NCT03518034|567371068|FG001|Overall Study|Lack of Efficacy|23|||
157171898|NCT03518034|567371067|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
157171899|NCT03518034|567371068|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
157171900|NCT03518034|567371067|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
157171901|NCT03518034|567371068|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
157171902|NCT03518034|567371067|FG000|Overall Study|Other, Not Specified|84|||
157171903|NCT03518034|567371068|FG001|Overall Study|Other, Not Specified|53|||
157171904|NCT03518034|567371067|FG000|Overall Study|Reason Missing|2|||
157171905|NCT03518034|567371068|FG001|Overall Study|Reason Missing|3|||
157171906|NCT01019252|567371069|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
157171907|NCT01019252|567371070|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
157171908|NCT01019252|567371069|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
157171909|NCT01019252|567371070|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
157171910|NCT01019252|567371069|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
157171911|NCT01019252|567371070|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
157171912|NCT01019252|567371069|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
157171913|NCT01019252|567371070|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
157171914|NCT02273037|567371072|FG000|Overall Study|Lost to Follow-up|1|||
157171915|NCT02273037|567371073|FG001|Overall Study|Lost to Follow-up|0|||
157171916|NCT02273037|567371072|FG000|Overall Study|Delivered before monitoring initiated|1|||
157171917|NCT02273037|567371073|FG001|Overall Study|Delivered before monitoring initiated|3|||
157171918|NCT02273037|567371072|FG000|Overall Study|Breech delivery|2|||
157171919|NCT02273037|567371073|FG001|Overall Study|Breech delivery|3|||
157171920|NCT02273037|567371072|FG000|Overall Study|Multiple delivery|2|||
157171921|NCT02273037|567371073|FG001|Overall Study|Multiple delivery|2|||
157171922|NCT02273037|567371072|FG000|Overall Study|Other complication|2|||
157171923|NCT02273037|567371073|FG001|Overall Study|Other complication|0|||
157171924|NCT02062398|567371074|FG000|Overall Study|Implant removal|1|||
157171925|NCT00415519|567371075|FG000|Overall Study|Adverse Event|1|||
157171926|NCT00415519|567371076|FG001|Overall Study|Adverse Event|0|||
157171927|NCT00415519|567371075|FG000|Overall Study|Withdrawal by Subject|2|||
157171928|NCT00415519|567371076|FG001|Overall Study|Withdrawal by Subject|0|||
156962431|NCT02192502|566614247|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
156962432|NCT02192502|566614248|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
156962433|NCT02192502|566614247|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
156962434|NCT02192502|566614248|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
156962435|NCT02192502|566614247|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
156962436|NCT02192502|566614248|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
157171929|NCT00415519|567371075|FG000|Overall Study|Patient's convenience|1|||
157171930|NCT00415519|567371076|FG001|Overall Study|Patient's convenience|0|||
157171931|NCT03351478|567371077|FG000|Overall Study|At the subject's own request|11|||
157171932|NCT03351478|567371078|FG001|Overall Study|At the subject's own request|12|||
157171933|NCT03351478|567371079|FG002|Overall Study|At the subject's own request|5|||
157171934|NCT03351478|567371077|FG000|Overall Study|Adverse Event|1|||
157171935|NCT03351478|567371078|FG001|Overall Study|Adverse Event|2|||
157171936|NCT03351478|567371079|FG002|Overall Study|Adverse Event|1|||
156962437|NCT01381692|566614249|FG000|Overall Study|Adverse Event|1|||
156962438|NCT01381692|566614250|FG001|Overall Study|Adverse Event|0|||
156962439|NCT01381692|566614251|FG002|Overall Study|Adverse Event|0|||
156962440|NCT01381692|566614252|FG003|Overall Study|Adverse Event|0|||
156962441|NCT01381692|566614253|FG004|Overall Study|Adverse Event|0|||
156962442|NCT01381692|566614254|FG005|Overall Study|Adverse Event|0|||
156962443|NCT03896035|566614259|FG000|Overall Study|Lost to Follow-up|2|||
156962444|NCT03896035|566614260|FG001|Overall Study|Lost to Follow-up|6|||
156962445|NCT03896035|566614259|FG000|Overall Study|Withdrawal by Subject|0|||
156962446|NCT03896035|566614260|FG001|Overall Study|Withdrawal by Subject|1|||
156962447|NCT03896035|566614259|FG000|Overall Study|Health/family health issues during COVID|0|||
156962448|NCT03896035|566614260|FG001|Overall Study|Health/family health issues during COVID|4|||
156962449|NCT01556438|566614261|FG000|Overall Study|Adverse Event|4|||
156962450|NCT01556438|566614262|FG001|Overall Study|Adverse Event|2|||
156962451|NCT01556438|566614261|FG000|Overall Study|Sponsor Decision|0|||
156962452|NCT01556438|566614262|FG001|Overall Study|Sponsor Decision|2|||
156962453|NCT01556438|566614261|FG000|Overall Study|Progressive Disease|0|||
156962454|NCT01556438|566614262|FG001|Overall Study|Progressive Disease|6|||
156962455|NCT01556438|566614261|FG000|Overall Study|Death|0|||
156962456|NCT01556438|566614262|FG001|Overall Study|Death|1|||
156962457|NCT01506193|566614265|FG000|Overall Study|Protocol Violation|1|||
156962458|NCT01506193|566614266|FG001|Overall Study|Protocol Violation|0|||
156962459|NCT01506193|566614267|FG002|Overall Study|Protocol Violation|1|||
156962460|NCT01506193|566614265|FG000|Overall Study|Migrated/moved from study area|0|||
156962461|NCT01506193|566614266|FG001|Overall Study|Migrated/moved from study area|0|||
156962462|NCT01506193|566614267|FG002|Overall Study|Migrated/moved from study area|1|||
156962463|NCT01506193|566614265|FG000|Overall Study|Adverse event, non-fatal|0|||
156962464|NCT01506193|566614266|FG001|Overall Study|Adverse event, non-fatal|0|||
156962465|NCT01506193|566614267|FG002|Overall Study|Adverse event, non-fatal|1|||
156962466|NCT01506193|566614265|FG000|Overall Study|Withdrawal by Subject|5|||
156962467|NCT01506193|566614266|FG001|Overall Study|Withdrawal by Subject|1|||
156962468|NCT01506193|566614267|FG002|Overall Study|Withdrawal by Subject|8|||
156962469|NCT01506193|566614265|FG000|Overall Study|Lost to Follow-up|8|||
156962470|NCT01506193|566614266|FG001|Overall Study|Lost to Follow-up|3|||
156962471|NCT01506193|566614267|FG002|Overall Study|Lost to Follow-up|3|||
156962472|NCT01388816|566614271|FG000|Overall Study|Adverse Event|0|||
156962473|NCT01388816|566614272|FG001|Overall Study|Adverse Event|2|||
156962474|NCT01388816|566614273|FG002|Overall Study|Adverse Event|0|||
156962475|NCT01388816|566614274|FG003|Overall Study|Adverse Event|0|||
156962476|NCT01388816|566614271|FG000|Overall Study|Lost to Follow-up|0|||
156962477|NCT01388816|566614272|FG001|Overall Study|Lost to Follow-up|1|||
156962478|NCT01388816|566614273|FG002|Overall Study|Lost to Follow-up|0|||
156962479|NCT01388816|566614274|FG003|Overall Study|Lost to Follow-up|0|||
156962480|NCT01388816|566614271|FG000|Overall Study|Withdrawal by Subject|2|||
156962481|NCT01388816|566614272|FG001|Overall Study|Withdrawal by Subject|1|||
156962482|NCT01388816|566614273|FG002|Overall Study|Withdrawal by Subject|1|||
156962483|NCT01388816|566614274|FG003|Overall Study|Withdrawal by Subject|0|||
156962484|NCT01388816|566614271|FG000|Overall Study|Protocol Violation|0|||
156962485|NCT01388816|566614272|FG001|Overall Study|Protocol Violation|0|||
156962486|NCT01388816|566614273|FG002|Overall Study|Protocol Violation|2|||
156962487|NCT01388816|566614274|FG003|Overall Study|Protocol Violation|0|||
156962488|NCT04575467|566614275|FG000|Overall Study|Adverse Event|0|||
156962489|NCT04575467|566614276|FG001|Overall Study|Adverse Event|1|||
156962490|NCT04575467|566614277|FG002|Overall Study|Adverse Event|0|||
156962491|NCT04575467|566614278|FG003|Overall Study|Adverse Event|0|||
156962492|NCT00743366|566614279|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
156962493|NCT00743366|566614280|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
156962494|NCT01328574|566614281|FG000|Overall Study|Refused further treatment|1|||
156962495|NCT03206203|566614282|FG000|Treatment|Death|38|||
156962496|NCT03206203|566614283|FG001|Treatment|Death|26|||
156962497|NCT03206203|566614284|FG002|Treatment|Death|0|||
156962498|NCT03206203|566614282|FG000|Treatment|Withdrawal by Subject|1|||
156962499|NCT03206203|566614283|FG001|Treatment|Withdrawal by Subject|0|||
157171937|NCT03351478|567371077|FG000|Overall Study|Poor compliance to protocol|1|||
157171938|NCT03351478|567371078|FG001|Overall Study|Poor compliance to protocol|0|||
157171939|NCT03351478|567371079|FG002|Overall Study|Poor compliance to protocol|0|||
157171940|NCT03351478|567371077|FG000|Overall Study|Reason not Specified|1|||
156962500|NCT03206203|566614284|FG002|Treatment|Withdrawal by Subject|0|||
156962501|NCT03206203|566614282|FG000|Treatment|Lost to Follow-up|4|||
156962502|NCT03206203|566614283|FG001|Treatment|Lost to Follow-up|0|||
156962503|NCT03206203|566614284|FG002|Treatment|Lost to Follow-up|0|||
157171941|NCT03351478|567371078|FG001|Overall Study|Reason not Specified|3|||
156962504|NCT03206203|566614282|FG000|Treatment|N/A in Follow-Up|8|||
156962505|NCT03206203|566614283|FG001|Treatment|N/A in Follow-Up|1|||
156962506|NCT03206203|566614284|FG002|Treatment|N/A in Follow-Up|0|||
156962507|NCT03206203|566614282|FG000|Treatment|Disease progression|0|||
156962508|NCT03206203|566614283|FG001|Treatment|Disease progression|1|||
156962509|NCT03206203|566614284|FG002|Treatment|Disease progression|0|||
156962510|NCT03206203|566614282|FG000|Treatment|Refused follow-up|0|||
157038895|NCT00724126|566898253|FG000|Overall Study|Noncompliance|2|||
157038896|NCT00724126|566898254|FG001|Overall Study|Noncompliance|1|||
157038897|NCT00724126|566898253|FG000|Overall Study|Subject randomized although ineligible|1|||
157038898|NCT00724126|566898254|FG001|Overall Study|Subject randomized although ineligible|1|||
157038899|NCT00724126|566898253|FG000|Overall Study|Subject had to leave vicinity of site|0|||
157038900|NCT00724126|566898254|FG001|Overall Study|Subject had to leave vicinity of site|1|||
157038901|NCT01579318|566898255|FG000|Overall Study|Disease Progression|1|||
157038902|NCT03601715|566898258|FG000|Second Intervention|Lost to Follow-up|1|||
157038903|NCT03601715|566898259|FG001|Second Intervention|Lost to Follow-up|1|||
157038904|NCT03601715|566898260|FG002|Second Intervention|Lost to Follow-up|0|||
157038905|NCT02347332|566898261|FG000|Overall Study|Not treated|5|||
157038906|NCT02347332|566898262|FG001|Overall Study|Not treated|2|||
157038907|NCT02347332|566898261|FG000|Overall Study|Progressive disease|141|||
157038908|NCT02347332|566898262|FG001|Overall Study|Progressive disease|159|||
157038909|NCT02347332|566898261|FG000|Overall Study|Adverse Event|50|||
157038910|NCT02347332|566898262|FG001|Overall Study|Adverse Event|41|||
157038911|NCT02347332|566898261|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
157038912|NCT02347332|566898262|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
157038913|NCT02347332|566898261|FG000|Overall Study|Protocol Violation|1|||
157038914|NCT02347332|566898262|FG001|Overall Study|Protocol Violation|1|||
157038915|NCT02347332|566898261|FG000|Overall Study|Lost to Follow-up|2|||
157038916|NCT02347332|566898262|FG001|Overall Study|Lost to Follow-up|1|||
157038917|NCT02347332|566898261|FG000|Overall Study|Physician Decision|4|||
157038918|NCT02347332|566898262|FG001|Overall Study|Physician Decision|3|||
157038919|NCT02347332|566898261|FG000|Overall Study|Withdrawal by Subject|20|||
157038920|NCT02347332|566898262|FG001|Overall Study|Withdrawal by Subject|14|||
157038921|NCT02347332|566898261|FG000|Overall Study|Protocol requirement|1|||
157038922|NCT02347332|566898262|FG001|Overall Study|Protocol requirement|1|||
157038923|NCT02347332|566898261|FG000|Overall Study|Switch Post-Trial program|0|||
157038924|NCT02347332|566898262|FG001|Overall Study|Switch Post-Trial program|1|||
157038925|NCT01478594|566898263|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
157038926|NCT01478594|566898264|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
157038927|NCT01478594|566898263|FG000|Overall Study|Death|45|||
157038928|NCT01478594|566898264|FG001|Overall Study|Death|18|||
157038929|NCT01478594|566898263|FG000|Overall Study|Lost to Follow-up|3|||
157038930|NCT01478594|566898264|FG001|Overall Study|Lost to Follow-up|1|||
157038931|NCT01478594|566898263|FG000|Overall Study|Withdrawal by Subject|9|||
157038932|NCT01478594|566898264|FG001|Overall Study|Withdrawal by Subject|3|||
157038933|NCT01478594|566898263|FG000|Overall Study|Study Closed by Sponsor|8|||
157038934|NCT01478594|566898264|FG001|Overall Study|Study Closed by Sponsor|5|||
157038935|NCT01313884|566898265|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
157038936|NCT01970007|566898266|FG000|Overall Study|Death|5|||
157038937|NCT01970007|566898266|FG000|Overall Study|Withdrawal by Subject|23|||
157038938|NCT01970007|566898266|FG000|Overall Study|Lost to Follow-up|24|||
157038939|NCT01970007|566898266|FG000|Overall Study|"Other endpoint"|3|||
157038940|NCT00776009|566898267|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
157038941|NCT00776009|566898268|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
157038942|NCT00776009|566898269|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
157038943|NCT00776009|566898270|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
157038944|NCT00776009|566898271|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
157038945|NCT00776009|566898272|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
157038946|NCT00776009|566898267|FG000|Period 1: First Intervention|Protocol Violation|0|||
157038947|NCT00776009|566898268|FG001|Period 1: First Intervention|Protocol Violation|1|||
157038948|NCT00776009|566898269|FG002|Period 1: First Intervention|Protocol Violation|0|||
157038949|NCT00776009|566898270|FG003|Period 1: First Intervention|Protocol Violation|0|||
157038950|NCT00776009|566898271|FG004|Period 1: First Intervention|Protocol Violation|1|||
157038951|NCT00776009|566898272|FG005|Period 1: First Intervention|Protocol Violation|0|||
157038952|NCT00776009|566898267|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
157038953|NCT00776009|566898268|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
157038954|NCT00776009|566898269|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
157038955|NCT00776009|566898270|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
157038956|NCT00776009|566898271|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
157038957|NCT00776009|566898272|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
157038958|NCT00776009|566898267|FG000|Period 2: Second Intervention|Protocol Violation|1|||
157038959|NCT00776009|566898268|FG001|Period 2: Second Intervention|Protocol Violation|0|||
157038960|NCT00776009|566898269|FG002|Period 2: Second Intervention|Protocol Violation|1|||
157038961|NCT00776009|566898270|FG003|Period 2: Second Intervention|Protocol Violation|0|||
157038962|NCT00776009|566898271|FG004|Period 2: Second Intervention|Protocol Violation|0|||
157038963|NCT00776009|566898272|FG005|Period 2: Second Intervention|Protocol Violation|0|||
157038964|NCT00776009|566898267|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
157038965|NCT00776009|566898268|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
157038966|NCT00776009|566898269|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
157038967|NCT00776009|566898270|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
157171942|NCT03351478|567371079|FG002|Overall Study|Reason not Specified|0|||
157171943|NCT03351478|567371077|FG000|Overall Study|Lost to Follow-up|0|||
157171944|NCT03351478|567371078|FG001|Overall Study|Lost to Follow-up|0|||
157171945|NCT03351478|567371079|FG002|Overall Study|Lost to Follow-up|1|||
157171946|NCT03485222|567371080|FG000|Overall Study|Death|0|||
157171947|NCT03485222|567371081|FG001|Overall Study|Death|1|||
157171948|NCT03485222|567371080|FG000|Overall Study|Lost to Follow-up|2|||
157171949|NCT03485222|567371081|FG001|Overall Study|Lost to Follow-up|1|||
157171950|NCT03657810|567371084|FG000|Overall Study|Adverse Event|0|||
157171951|NCT03657810|567371085|FG001|Overall Study|Adverse Event|1|||
157171952|NCT03657810|567371086|FG002|Overall Study|Adverse Event|0|||
157171953|NCT03657810|567371084|FG000|Overall Study|Lack of Efficacy|4|||
157171954|NCT03657810|567371085|FG001|Overall Study|Lack of Efficacy|1|||
157171955|NCT03657810|567371086|FG002|Overall Study|Lack of Efficacy|3|||
157171956|NCT03657810|567371084|FG000|Overall Study|Protocol Violation|1|||
157171957|NCT03657810|567371085|FG001|Overall Study|Protocol Violation|0|||
157171958|NCT03657810|567371086|FG002|Overall Study|Protocol Violation|0|||
157171959|NCT03657810|567371084|FG000|Overall Study|Lost to Follow-up|0|||
157171960|NCT03657810|567371085|FG001|Overall Study|Lost to Follow-up|1|||
157171961|NCT03657810|567371086|FG002|Overall Study|Lost to Follow-up|0|||
157171962|NCT03657810|567371084|FG000|Overall Study|Not provided|0|||
157171963|NCT03657810|567371085|FG001|Overall Study|Not provided|1|||
157171964|NCT03657810|567371086|FG002|Overall Study|Not provided|0|||
157171965|NCT03911869|567371087|FG000|Safety Lead-in Phase|Death|7|||
157171966|NCT03911869|567371088|FG001|Safety Lead-in Phase|Death|0|||
157171967|NCT03911869|567371089|FG002|Safety Lead-in Phase|Death|0|||
157171968|NCT03911869|567371087|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
157171969|NCT03911869|567371088|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
157171970|NCT03911869|567371089|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
157171971|NCT03911869|567371087|FG000|Safety Lead-in Phase|Other|1|||
157171972|NCT03911869|567371088|FG001|Safety Lead-in Phase|Other|0|||
157171973|NCT03911869|567371089|FG002|Safety Lead-in Phase|Other|0|||
157171974|NCT03911869|567371087|FG000|Phase 2|Death|0|||
157171975|NCT03911869|567371088|FG001|Phase 2|Death|3|||
157171976|NCT03911869|567371089|FG002|Phase 2|Death|0|||
157171977|NCT01527110|567371091|FG000|Overall Study|Adverse Event|1|||
157171978|NCT02007252|567371092|FG000|Overall Study|Administrative problems|3|||
157171979|NCT02007252|567371093|FG001|Overall Study|Administrative problems|7|||
157171980|NCT02007252|567371092|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157171981|NCT02007252|567371093|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157171982|NCT02007252|567371092|FG000|Overall Study|Adverse Event|7|||
157171983|NCT02007252|567371093|FG001|Overall Study|Adverse Event|4|||
157171984|NCT00608881|567371094|FG000|Overall Study|Death|22|||
157171985|NCT00608881|567371095|FG001|Overall Study|Death|13|||
157171986|NCT00608881|567371094|FG000|Overall Study|Adverse Event|5|||
157171987|NCT00608881|567371095|FG001|Overall Study|Adverse Event|3|||
157171988|NCT00608881|567371094|FG000|Overall Study|Lost to Follow-up|28|||
157171989|NCT00608881|567371095|FG001|Overall Study|Lost to Follow-up|14|||
157171990|NCT00608881|567371094|FG000|Overall Study|Withdrawal by Subject|18|||
157171991|NCT00608881|567371095|FG001|Overall Study|Withdrawal by Subject|29|||
157171992|NCT00608881|567371094|FG000|Overall Study|Physician Decision|5|||
157171993|NCT00608881|567371095|FG001|Overall Study|Physician Decision|5|||
157171994|NCT00608881|567371094|FG000|Overall Study|Institutionalized|1|||
157171995|NCT00608881|567371095|FG001|Overall Study|Institutionalized|2|||
157171996|NCT00367341|567371097|FG000|Overall Study|Physician Decision|1|||
157171997|NCT00367341|567371098|FG001|Overall Study|Physician Decision|0|||
157171998|NCT00367341|567371097|FG000|Overall Study|Protocol Violation|1|||
157171999|NCT00367341|567371098|FG001|Overall Study|Protocol Violation|0|||
157172000|NCT03325556|567371099|FG000|Open-label Period|Lack of Response in OL period|70|||
157172001|NCT03325556|567371100|FG001|Open-label Period|Lack of Response in OL period|0|||
157172002|NCT03325556|567371101|FG002|Open-label Period|Lack of Response in OL period|0|||
157172003|NCT03325556|567371099|FG000|Open-label Period|Adverse Event|27|||
157172004|NCT03325556|567371100|FG001|Open-label Period|Adverse Event|0|||
157227819|NCT00911859|567579214|FG002|Treatment Period|Withdrawal by Subject|5|||
157227820|NCT00911859|567579212|FG000|Treatment Period|Did not receive study treatment|0|||
157172005|NCT03325556|567371101|FG002|Open-label Period|Adverse Event|0|||
157172006|NCT03325556|567371099|FG000|Open-label Period|Death|1|||
157172007|NCT03325556|567371100|FG001|Open-label Period|Death|0|||
157227821|NCT00911859|567579213|FG001|Treatment Period|Did not receive study treatment|1|||
157227822|NCT00911859|567579214|FG002|Treatment Period|Did not receive study treatment|0|||
157172008|NCT03325556|567371101|FG002|Open-label Period|Death|0|||
157172009|NCT03325556|567371099|FG000|Open-label Period|Lost to Follow-up|1|||
157172010|NCT03325556|567371100|FG001|Open-label Period|Lost to Follow-up|0|||
157172011|NCT03325556|567371101|FG002|Open-label Period|Lost to Follow-up|0|||
157172012|NCT03325556|567371099|FG000|Open-label Period|Non-compliance with study drug|5|||
157172013|NCT03325556|567371100|FG001|Open-label Period|Non-compliance with study drug|0|||
157172014|NCT03325556|567371101|FG002|Open-label Period|Non-compliance with study drug|0|||
157172015|NCT03325556|567371099|FG000|Open-label Period|Use of prohibited medication|1|||
157172016|NCT03325556|567371100|FG001|Open-label Period|Use of prohibited medication|0|||
156962511|NCT03206203|566614283|FG001|Treatment|Refused follow-up|1|||
156962512|NCT03206203|566614284|FG002|Treatment|Refused follow-up|0|||
156962513|NCT03206203|566614282|FG000|Treatment|Cross over to Arm 1|0|||
156962514|NCT03206203|566614283|FG001|Treatment|Cross over to Arm 1|19|||
156962515|NCT03206203|566614284|FG002|Treatment|Cross over to Arm 1|0|||
156962516|NCT03206203|566614282|FG000|Optional Cross-Over|Death|0|||
156962517|NCT03206203|566614283|FG001|Optional Cross-Over|Death|0|||
156962518|NCT03206203|566614284|FG002|Optional Cross-Over|Death|14|||
156962519|NCT03206203|566614282|FG000|Optional Cross-Over|Refused follow-up|0|||
156962520|NCT03206203|566614283|FG001|Optional Cross-Over|Refused follow-up|0|||
156962521|NCT03206203|566614284|FG002|Optional Cross-Over|Refused follow-up|2|||
156962522|NCT01152580|566614291|FG000|Overall Study|Withdrawal by Subject|0|||
156962523|NCT01152580|566614292|FG001|Overall Study|Withdrawal by Subject|1|||
156962524|NCT01994954|566614293|FG000|Overall Study|Death|1|||
156962525|NCT01994954|566614294|FG001|Overall Study|Death|0|||
156962526|NCT01994954|566614293|FG000|Overall Study|Withdrawal by Subject|9|||
156962527|NCT01994954|566614294|FG001|Overall Study|Withdrawal by Subject|14|||
156962528|NCT01994954|566614293|FG000|Overall Study|Physician Decision|2|||
156962529|NCT01994954|566614294|FG001|Overall Study|Physician Decision|2|||
156962530|NCT01994954|566614293|FG000|Overall Study|Lost to Follow-up|8|||
156962531|NCT01994954|566614294|FG001|Overall Study|Lost to Follow-up|10|||
156962532|NCT01994954|566614293|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
156962533|NCT01994954|566614294|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
156962534|NCT00449176|566614295|FG000|Overall Study|Withdrawal by Subject|39|||
156962535|NCT00449176|566614296|FG001|Overall Study|Withdrawal by Subject|43|||
156962536|NCT00449176|566614297|FG002|Overall Study|Withdrawal by Subject|59|||
156962537|NCT00449176|566614295|FG000|Overall Study|Lost to Follow-up|13|||
156962538|NCT00449176|566614296|FG001|Overall Study|Lost to Follow-up|8|||
156962539|NCT00449176|566614297|FG002|Overall Study|Lost to Follow-up|12|||
156962540|NCT00449176|566614295|FG000|Overall Study|Adverse Event|51|||
156962541|NCT00449176|566614296|FG001|Overall Study|Adverse Event|107|||
156962542|NCT00449176|566614297|FG002|Overall Study|Adverse Event|15|||
156962543|NCT00449176|566614295|FG000|Overall Study|Lack of Efficacy|13|||
156962544|NCT00449176|566614296|FG001|Overall Study|Lack of Efficacy|7|||
156962545|NCT00449176|566614297|FG002|Overall Study|Lack of Efficacy|50|||
156962546|NCT00449176|566614295|FG000|Overall Study|Study drug non-compliant|14|||
156962547|NCT00449176|566614296|FG001|Overall Study|Study drug non-compliant|11|||
156962548|NCT00449176|566614297|FG002|Overall Study|Study drug non-compliant|11|||
156962549|NCT00449176|566614295|FG000|Overall Study|all other|22|||
156962550|NCT00449176|566614296|FG001|Overall Study|all other|19|||
156962551|NCT00449176|566614297|FG002|Overall Study|all other|20|||
156962552|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
156962553|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
156962554|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|disease progression|58|||
156962555|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|disease progression|47|||
156962556|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Death|3|||
156962557|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Death|6|||
156962558|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
156962559|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
156962560|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
156962561|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
156962562|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
156962563|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
156962564|NCT02472964|566614298|FG000|Part 1 (up to Week 24)|Other|2|||
156962565|NCT02472964|566614299|FG001|Part 1 (up to Week 24)|Other|1|||
156962566|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
156962567|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
156962568|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
156962569|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
156962570|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Death|0|||
156962571|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Death|1|||
156962572|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
156962573|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
156962574|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
156962575|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
156962576|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
156962577|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
156962578|NCT02472964|566614298|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
156962579|NCT02472964|566614299|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
156962580|NCT01454583|566614300|FG000|1st Year|Lost to Follow-up|1057|||
156962581|NCT01454583|566614301|FG001|1st Year|Lost to Follow-up|318|||
156962582|NCT01454583|566614302|FG002|1st Year|Lost to Follow-up|180|||
156962583|NCT01454583|566614300|FG000|2nd Year|Lost to Follow-up|3965|||
156962584|NCT01454583|566614301|FG001|2nd Year|Lost to Follow-up|1049|||
156962585|NCT01454583|566614302|FG002|2nd Year|Lost to Follow-up|737|||
156962586|NCT01454583|566614300|FG000|3rd Year|Lost to Follow-up|1959|||
156962587|NCT01454583|566614301|FG001|3rd Year|Lost to Follow-up|512|||
156962588|NCT01454583|566614302|FG002|3rd Year|Lost to Follow-up|297|||
157172017|NCT03325556|567371101|FG002|Open-label Period|Use of prohibited medication|0|||
157172018|NCT03325556|567371099|FG000|Open-label Period|Protocol Violation|4|||
157172019|NCT03325556|567371100|FG001|Open-label Period|Protocol Violation|0|||
157172020|NCT03325556|567371101|FG002|Open-label Period|Protocol Violation|0|||
157172021|NCT03325556|567371099|FG000|Open-label Period|Withdrawal by Subject|17|||
157172022|NCT03325556|567371100|FG001|Open-label Period|Withdrawal by Subject|0|||
157172023|NCT03325556|567371101|FG002|Open-label Period|Withdrawal by Subject|0|||
157172024|NCT03325556|567371099|FG000|Open-label Period|Not otherwise specified|8|||
157172025|NCT03325556|567371100|FG001|Open-label Period|Not otherwise specified|0|||
157172026|NCT03325556|567371101|FG002|Open-label Period|Not otherwise specified|0|||
157172027|NCT03325556|567371099|FG000|Open-label Period|Administrative discont. at study termination|41|||
157172028|NCT03325556|567371100|FG001|Open-label Period|Administrative discont. at study termination|0|||
157172029|NCT03325556|567371101|FG002|Open-label Period|Administrative discont. at study termination|0|||
157172030|NCT03325556|567371099|FG000|Double-blind Period|Relapse|0|||
157172031|NCT03325556|567371100|FG001|Double-blind Period|Relapse|15|||
157172032|NCT03325556|567371101|FG002|Double-blind Period|Relapse|34|||
157172033|NCT03325556|567371099|FG000|Double-blind Period|Adverse Event|0|||
157172034|NCT03325556|567371100|FG001|Double-blind Period|Adverse Event|3|||
157172035|NCT03325556|567371101|FG002|Double-blind Period|Adverse Event|1|||
157172036|NCT03325556|567371099|FG000|Double-blind Period|Noncompliance with study drug|0|||
157172037|NCT03325556|567371100|FG001|Double-blind Period|Noncompliance with study drug|0|||
157172038|NCT03325556|567371101|FG002|Double-blind Period|Noncompliance with study drug|1|||
157172039|NCT03325556|567371099|FG000|Double-blind Period|Use of prohibited medication|0|||
156962589|NCT01967732|566614303|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
157038968|NCT00776009|566898271|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
157038969|NCT00776009|566898272|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
156962590|NCT01967732|566614304|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
156962591|NCT01967732|566614305|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
156962592|NCT01967732|566614306|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
156962593|NCT01967732|566614303|FG000|First Intervention (Day 1)|Poor venous access|0|||
156962594|NCT01967732|566614304|FG001|First Intervention (Day 1)|Poor venous access|1|||
156962595|NCT01967732|566614305|FG002|First Intervention (Day 1)|Poor venous access|0|||
156962596|NCT01967732|566614306|FG003|First Intervention (Day 1)|Poor venous access|0|||
156962597|NCT00377403|566614308|FG000|Overall Study|Unable to contact for telephone intervie|4|||
156962598|NCT00377403|566614309|FG001|Overall Study|Unable to contact for telephone intervie|7|||
157038970|NCT01640951|566898273|FG000|Overall Study|Adverse Event|8|||
157038971|NCT01640951|566898274|FG001|Overall Study|Adverse Event|3|||
157038972|NCT01640951|566898275|FG002|Overall Study|Adverse Event|10|||
157038973|NCT01640951|566898276|FG003|Overall Study|Adverse Event|6|||
157038974|NCT01640951|566898277|FG004|Overall Study|Adverse Event|1|||
157038975|NCT01640951|566898278|FG005|Overall Study|Adverse Event|11|||
157038976|NCT01640951|566898279|FG006|Overall Study|Adverse Event|1|||
157038977|NCT01640951|566898280|FG007|Overall Study|Adverse Event|3|||
157038978|NCT01640951|566898273|FG000|Overall Study|Lack of Efficacy|20|||
157038979|NCT01640951|566898274|FG001|Overall Study|Lack of Efficacy|1|||
157038980|NCT01640951|566898275|FG002|Overall Study|Lack of Efficacy|7|||
157038981|NCT01640951|566898276|FG003|Overall Study|Lack of Efficacy|14|||
157038982|NCT01640951|566898277|FG004|Overall Study|Lack of Efficacy|0|||
157038983|NCT01640951|566898278|FG005|Overall Study|Lack of Efficacy|6|||
157038984|NCT01640951|566898279|FG006|Overall Study|Lack of Efficacy|5|||
157038985|NCT01640951|566898280|FG007|Overall Study|Lack of Efficacy|6|||
157038986|NCT01640951|566898273|FG000|Overall Study|Lost to Follow-up|1|||
157038987|NCT01640951|566898274|FG001|Overall Study|Lost to Follow-up|0|||
157038988|NCT01640951|566898275|FG002|Overall Study|Lost to Follow-up|6|||
157038989|NCT01640951|566898276|FG003|Overall Study|Lost to Follow-up|2|||
157038990|NCT01640951|566898277|FG004|Overall Study|Lost to Follow-up|2|||
157038991|NCT01640951|566898278|FG005|Overall Study|Lost to Follow-up|3|||
157038992|NCT01640951|566898279|FG006|Overall Study|Lost to Follow-up|1|||
157038993|NCT01640951|566898280|FG007|Overall Study|Lost to Follow-up|1|||
157038994|NCT01640951|566898273|FG000|Overall Study|Non-compliance with study treatment|0|||
157038995|NCT01640951|566898274|FG001|Overall Study|Non-compliance with study treatment|0|||
157038996|NCT01640951|566898275|FG002|Overall Study|Non-compliance with study treatment|1|||
157038997|NCT01640951|566898276|FG003|Overall Study|Non-compliance with study treatment|1|||
157038998|NCT01640951|566898277|FG004|Overall Study|Non-compliance with study treatment|1|||
157038999|NCT01640951|566898278|FG005|Overall Study|Non-compliance with study treatment|4|||
157039000|NCT01640951|566898279|FG006|Overall Study|Non-compliance with study treatment|1|||
157039001|NCT01640951|566898280|FG007|Overall Study|Non-compliance with study treatment|0|||
157039002|NCT01640951|566898273|FG000|Overall Study|Physician Decision|2|||
157039003|NCT01640951|566898274|FG001|Overall Study|Physician Decision|5|||
157039004|NCT01640951|566898275|FG002|Overall Study|Physician Decision|2|||
157039005|NCT01640951|566898276|FG003|Overall Study|Physician Decision|2|||
157172040|NCT03325556|567371100|FG001|Double-blind Period|Use of prohibited medication|1|||
157039006|NCT01640951|566898277|FG004|Overall Study|Physician Decision|2|||
157172041|NCT03325556|567371101|FG002|Double-blind Period|Use of prohibited medication|0|||
156962599|NCT01207102|566614313|FG000|Overall Study|Withdrawal by Subject|5|||
156962600|NCT01207102|566614313|FG000|Overall Study|Adverse Event|2|||
156962601|NCT01207102|566614313|FG000|Overall Study|progression|2|||
156962602|NCT01207102|566614313|FG000|Overall Study|Withdrawal by Treating Physician|1|||
156962603|NCT03792126|566614314|FG000|Overall Study|Adverse Event|1|||
156962604|NCT03792126|566614315|FG001|Overall Study|Adverse Event|2|||
156962605|NCT03792126|566614314|FG000|Overall Study|Death|0|||
156962606|NCT03792126|566614315|FG001|Overall Study|Death|1|||
156962607|NCT03792126|566614314|FG000|Overall Study|Lost to Follow-up|1|||
156962608|NCT03792126|566614315|FG001|Overall Study|Lost to Follow-up|0|||
156962609|NCT03792126|566614314|FG000|Overall Study|Withdrawal by Subject|0|||
156962610|NCT03792126|566614315|FG001|Overall Study|Withdrawal by Subject|1|||
156962611|NCT03792126|566614314|FG000|Overall Study|COVID-19 Restrictions|1|||
156962612|NCT03792126|566614315|FG001|Overall Study|COVID-19 Restrictions|3|||
156962613|NCT03792126|566614314|FG000|Overall Study|Symptoms resolved|0|||
156962614|NCT03792126|566614315|FG001|Overall Study|Symptoms resolved|3|||
156962615|NCT02899728|566614316|FG000|Overall Study|Withdrawal by Subject|1|||
156962616|NCT02899728|566614317|FG001|Overall Study|Withdrawal by Subject|1|||
156962617|NCT05557942|566614318|FG000|Overall Study|Death|0|||
156962618|NCT05557942|566614319|FG001|Overall Study|Death|0|||
156962619|NCT05557942|566614320|FG002|Overall Study|Death|0|||
156962620|NCT05557942|566614321|FG003|Overall Study|Death|2|||
156962621|NCT05557942|566614322|FG004|Overall Study|Death|1|||
156962622|NCT05557942|566614323|FG005|Overall Study|Death|1|||
156962623|NCT05557942|566614318|FG000|Overall Study|Physician Decision|1|||
156962624|NCT05557942|566614319|FG001|Overall Study|Physician Decision|1|||
156962625|NCT05557942|566614320|FG002|Overall Study|Physician Decision|2|||
156962626|NCT05557942|566614321|FG003|Overall Study|Physician Decision|3|||
156962627|NCT05557942|566614322|FG004|Overall Study|Physician Decision|0|||
156962628|NCT05557942|566614323|FG005|Overall Study|Physician Decision|2|||
156962629|NCT05557942|566614318|FG000|Overall Study|Study terminated by sponsor|17|||
156962630|NCT05557942|566614319|FG001|Overall Study|Study terminated by sponsor|17|||
156962631|NCT05557942|566614320|FG002|Overall Study|Study terminated by sponsor|14|||
156962632|NCT05557942|566614321|FG003|Overall Study|Study terminated by sponsor|40|||
156962633|NCT05557942|566614322|FG004|Overall Study|Study terminated by sponsor|45|||
156962634|NCT05557942|566614323|FG005|Overall Study|Study terminated by sponsor|37|||
156962635|NCT05557942|566614318|FG000|Overall Study|Protocol Violation|0|||
156962636|NCT05557942|566614319|FG001|Overall Study|Protocol Violation|0|||
156962637|NCT05557942|566614320|FG002|Overall Study|Protocol Violation|0|||
156962638|NCT05557942|566614321|FG003|Overall Study|Protocol Violation|0|||
156962639|NCT05557942|566614322|FG004|Overall Study|Protocol Violation|0|||
156962640|NCT05557942|566614323|FG005|Overall Study|Protocol Violation|1|||
156962641|NCT05557942|566614318|FG000|Overall Study|Withdrawal by Subject|0|||
156962642|NCT05557942|566614319|FG001|Overall Study|Withdrawal by Subject|0|||
156962643|NCT05557942|566614320|FG002|Overall Study|Withdrawal by Subject|0|||
156962644|NCT05557942|566614321|FG003|Overall Study|Withdrawal by Subject|0|||
156962645|NCT05557942|566614322|FG004|Overall Study|Withdrawal by Subject|2|||
156962646|NCT05557942|566614323|FG005|Overall Study|Withdrawal by Subject|0|||
156962647|NCT01962493|566614324|FG000|Overall Study|Adverse Event|1|||
156962648|NCT01962493|566614325|FG001|Overall Study|Adverse Event|2|||
156962649|NCT01962493|566614324|FG000|Overall Study|Protocol Violation|0|||
156962650|NCT01962493|566614325|FG001|Overall Study|Protocol Violation|1|||
156962651|NCT01962493|566614324|FG000|Overall Study|Withdrawal by Subject|4|||
156962652|NCT01962493|566614325|FG001|Overall Study|Withdrawal by Subject|2|||
156962653|NCT03776136|566614326|FG000|Overall Study|Death|85|||
156962654|NCT03776136|566614326|FG000|Overall Study|Withdrawal by Subject|3|||
156962655|NCT03776136|566614326|FG000|Overall Study|Sponsor Decision|15|||
156962656|NCT03754803|566614333|FG000|Overall Study|Withdrawal by Subject|2|||
156962657|NCT04348604|566614336|FG000|Week 8|Withdrawal by Subject|1|||
156962658|NCT04348604|566614337|FG001|Week 8|Withdrawal by Subject|1|||
156962659|NCT04348604|566614336|FG000|Week 8|Lost to Follow-up|1|||
156962660|NCT04348604|566614337|FG001|Week 8|Lost to Follow-up|2|||
156962661|NCT04348604|566614336|FG000|Week 8|Suspended|0|||
156962662|NCT04348604|566614337|FG001|Week 8|Suspended|1|||
157039007|NCT01640951|566898278|FG005|Overall Study|Physician Decision|3|||
157039008|NCT01640951|566898279|FG006|Overall Study|Physician Decision|3|||
156962663|NCT04348604|566614336|FG000|Week 12|Lost to Follow-up|1|||
156962664|NCT04348604|566614337|FG001|Week 12|Lost to Follow-up|2|||
156962665|NCT04348604|566614336|FG000|Week 12|Withdrawal by Subject|1|||
157172042|NCT03325556|567371099|FG000|Double-blind Period|Physician Decision|0|||
157172043|NCT03325556|567371100|FG001|Double-blind Period|Physician Decision|0|||
156962666|NCT04348604|566614337|FG001|Week 12|Withdrawal by Subject|0|||
156962667|NCT04348604|566614336|FG000|Week 24|Lost to Follow-up|2|||
156962668|NCT04348604|566614337|FG001|Week 24|Lost to Follow-up|1|||
156962669|NCT02097108|566614338|FG000|Overall Study|Adverse Event|1|||
156962670|NCT02097108|566614338|FG000|Overall Study|patient was abroad for 6 months|1|||
156962671|NCT00127608|566614341|FG000|Overall Study|VZV DNA negative|1|||
156962672|NCT01329029|566614342|FG000|Overall Study|Withdrawal by Subject|117|||
156962673|NCT01329029|566614343|FG001|Overall Study|Withdrawal by Subject|87|||
156962674|NCT01329029|566614342|FG000|Overall Study|Adverse Event|82|||
156962675|NCT01329029|566614343|FG001|Overall Study|Adverse Event|29|||
156962676|NCT01329029|566614342|FG000|Overall Study|Death|16|||
156962677|NCT01329029|566614343|FG001|Overall Study|Death|19|||
156962678|NCT01329029|566614342|FG000|Overall Study|Other|14|||
156962679|NCT01329029|566614343|FG001|Overall Study|Other|20|||
156962680|NCT01329029|566614342|FG000|Overall Study|COPD Exacerbation|11|||
156962681|NCT01329029|566614343|FG001|Overall Study|COPD Exacerbation|18|||
156962682|NCT01329029|566614342|FG000|Overall Study|Physician Decision|16|||
156962683|NCT01329029|566614343|FG001|Overall Study|Physician Decision|13|||
156962684|NCT01329029|566614342|FG000|Overall Study|Lost to Follow-up|8|||
156962685|NCT01329029|566614343|FG001|Overall Study|Lost to Follow-up|5|||
156962686|NCT01329029|566614342|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
156962687|NCT01329029|566614343|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
156962688|NCT01323530|566616020|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
156962689|NCT01323530|566616021|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156962690|NCT01323530|566616022|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156962691|NCT01323530|566616023|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156962692|NCT01323530|566616024|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156962693|NCT01323530|566616025|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
156962694|NCT01323530|566616026|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
156962695|NCT01323530|566616020|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156962696|NCT01323530|566616021|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156962697|NCT01323530|566616022|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
156962698|NCT01323530|566616023|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156962699|NCT01323530|566616024|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
156962700|NCT01323530|566616025|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156962701|NCT01323530|566616026|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
156962702|NCT01323530|566616020|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156962703|NCT01323530|566616021|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156962704|NCT01323530|566616022|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156962705|NCT01323530|566616023|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156962706|NCT01323530|566616024|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156962707|NCT01323530|566616025|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
156962708|NCT01323530|566616026|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
156962709|NCT01323530|566616020|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962710|NCT01323530|566616021|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962711|NCT01323530|566616022|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962712|NCT01323530|566616023|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962713|NCT01323530|566616024|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962714|NCT01323530|566616025|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
156962715|NCT01323530|566616026|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
156962716|NCT01323530|566616020|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962717|NCT01323530|566616021|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962718|NCT01323530|566616022|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962719|NCT01323530|566616023|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962720|NCT01323530|566616024|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962721|NCT01323530|566616025|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
156962722|NCT01323530|566616026|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
156962723|NCT01323530|566616020|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962724|NCT01323530|566616021|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962725|NCT01323530|566616022|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962726|NCT01323530|566616023|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962727|NCT01323530|566616024|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962728|NCT01323530|566616025|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
156962729|NCT01323530|566616026|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
156962730|NCT01323530|566616020|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962731|NCT01323530|566616021|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962732|NCT01323530|566616022|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962733|NCT01323530|566616023|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962734|NCT01323530|566616024|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962735|NCT01323530|566616025|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
156962736|NCT01323530|566616026|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
157172044|NCT03325556|567371101|FG002|Double-blind Period|Physician Decision|1|||
157172045|NCT03325556|567371099|FG000|Double-blind Period|Withdrawal by Subject|0|||
157172046|NCT03325556|567371100|FG001|Double-blind Period|Withdrawal by Subject|6|||
157172047|NCT03325556|567371101|FG002|Double-blind Period|Withdrawal by Subject|4|||
157172048|NCT03325556|567371099|FG000|Double-blind Period|Not otherwise specified|0|||
157172049|NCT03325556|567371100|FG001|Double-blind Period|Not otherwise specified|1|||
157172050|NCT03325556|567371101|FG002|Double-blind Period|Not otherwise specified|5|||
157039009|NCT01640951|566898280|FG007|Overall Study|Physician Decision|0|||
157039010|NCT01640951|566898273|FG000|Overall Study|Pregnancy|3|||
157039011|NCT01640951|566898274|FG001|Overall Study|Pregnancy|0|||
157039012|NCT01640951|566898275|FG002|Overall Study|Pregnancy|0|||
157039013|NCT01640951|566898276|FG003|Overall Study|Pregnancy|4|||
157039014|NCT01640951|566898277|FG004|Overall Study|Pregnancy|0|||
157039015|NCT01640951|566898278|FG005|Overall Study|Pregnancy|0|||
157039016|NCT01640951|566898279|FG006|Overall Study|Pregnancy|2|||
157039017|NCT01640951|566898280|FG007|Overall Study|Pregnancy|0|||
157039018|NCT01640951|566898273|FG000|Overall Study|Protocol Deviation|0|||
157039019|NCT01640951|566898274|FG001|Overall Study|Protocol Deviation|1|||
157039020|NCT01640951|566898275|FG002|Overall Study|Protocol Deviation|2|||
157039021|NCT01640951|566898276|FG003|Overall Study|Protocol Deviation|1|||
157039022|NCT01640951|566898277|FG004|Overall Study|Protocol Deviation|0|||
157039023|NCT01640951|566898278|FG005|Overall Study|Protocol Deviation|1|||
157039024|NCT01640951|566898279|FG006|Overall Study|Protocol Deviation|0|||
157039025|NCT01640951|566898280|FG007|Overall Study|Protocol Deviation|0|||
157039026|NCT01640951|566898273|FG000|Overall Study|Subject/Guardian decision|12|||
157039027|NCT01640951|566898274|FG001|Overall Study|Subject/Guardian decision|4|||
157039028|NCT01640951|566898275|FG002|Overall Study|Subject/Guardian decision|13|||
157039029|NCT01640951|566898276|FG003|Overall Study|Subject/Guardian decision|15|||
156962737|NCT01323530|566616020|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962738|NCT01323530|566616021|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962739|NCT01323530|566616022|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962740|NCT01323530|566616023|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962741|NCT01323530|566616024|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962742|NCT01323530|566616025|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
156962743|NCT01323530|566616026|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
156962744|NCT01194570|566616027|FG000|Overall Study|Adverse Event|22|||
156962745|NCT01194570|566616028|FG001|Overall Study|Adverse Event|40|||
156962746|NCT01194570|566616027|FG000|Overall Study|Death|6|||
156962747|NCT01194570|566616028|FG001|Overall Study|Death|20|||
156962748|NCT01194570|566616027|FG000|Overall Study|Lack of Efficacy|32|||
156962749|NCT01194570|566616028|FG001|Overall Study|Lack of Efficacy|33|||
156962750|NCT01194570|566616027|FG000|Overall Study|Lost to Follow-up|4|||
156962751|NCT01194570|566616028|FG001|Overall Study|Lost to Follow-up|15|||
156962752|NCT01194570|566616027|FG000|Overall Study|Non-Compliance|2|||
156962753|NCT01194570|566616028|FG001|Overall Study|Non-Compliance|2|||
156962754|NCT01194570|566616027|FG000|Overall Study|Non-Compliance With Study Drug|2|||
156962755|NCT01194570|566616028|FG001|Overall Study|Non-Compliance With Study Drug|2|||
156962756|NCT01194570|566616027|FG000|Overall Study|Other|18|||
156962757|NCT01194570|566616028|FG001|Overall Study|Other|47|||
156962758|NCT01194570|566616027|FG000|Overall Study|Physician Decision|10|||
156962759|NCT01194570|566616028|FG001|Overall Study|Physician Decision|25|||
156962760|NCT01194570|566616027|FG000|Overall Study|Protocol Violation|1|||
156962761|NCT01194570|566616028|FG001|Overall Study|Protocol Violation|2|||
156962762|NCT01194570|566616027|FG000|Overall Study|Study Terminated By Sponsor|0|||
156962763|NCT01194570|566616028|FG001|Overall Study|Study Terminated By Sponsor|1|||
156962764|NCT01194570|566616027|FG000|Overall Study|Withdrawal by Subject|57|||
156962765|NCT01194570|566616028|FG001|Overall Study|Withdrawal by Subject|82|||
156962766|NCT01194570|566616027|FG000|Overall Study|Pregnancy|1|||
156962767|NCT01194570|566616028|FG001|Overall Study|Pregnancy|1|||
156962768|NCT01712009|566616032|FG000|Overall Study|Withdrawal by Subject|24|||
156962769|NCT01712009|566616033|FG001|Overall Study|Withdrawal by Subject|15|||
156962770|NCT01712009|566616034|FG002|Overall Study|Withdrawal by Subject|8|||
156962771|NCT01712009|566616032|FG000|Overall Study|Lost to Follow-up|2|||
156962772|NCT01712009|566616033|FG001|Overall Study|Lost to Follow-up|0|||
156962773|NCT01712009|566616034|FG002|Overall Study|Lost to Follow-up|1|||
156962774|NCT01712009|566616032|FG000|Overall Study|Decision by Sponsor|12|||
156962775|NCT01712009|566616033|FG001|Overall Study|Decision by Sponsor|14|||
156962776|NCT01712009|566616034|FG002|Overall Study|Decision by Sponsor|12|||
156962777|NCT01111123|566616035|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
156962778|NCT01111123|566616036|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
156962779|NCT01111123|566616035|FG000|Maintenance Phase|Lost to Follow-up|0|||
156962780|NCT01111123|566616036|FG001|Maintenance Phase|Lost to Follow-up|2|||
156962781|NCT01203930|566616038|FG000|Overall Study|Disease Progression|0|||
156962782|NCT01203930|566616039|FG001|Overall Study|Disease Progression|4|||
156962783|NCT01203930|566616038|FG000|Overall Study|Death|3|||
156962784|NCT01203930|566616039|FG001|Overall Study|Death|1|||
156962785|NCT01203930|566616038|FG000|Overall Study|Withdrew Consent|1|||
156962786|NCT01203930|566616039|FG001|Overall Study|Withdrew Consent|10|||
156962787|NCT01203930|566616038|FG000|Overall Study|Investigator Request|0|||
157039030|NCT01640951|566898277|FG004|Overall Study|Subject/Guardian decision|7|||
157039031|NCT01640951|566898278|FG005|Overall Study|Subject/Guardian decision|19|||
157039032|NCT01640951|566898279|FG006|Overall Study|Subject/Guardian decision|5|||
157039033|NCT01640951|566898280|FG007|Overall Study|Subject/Guardian decision|4|||
157039034|NCT01640951|566898273|FG000|Overall Study|Death|0|||
157039035|NCT01640951|566898274|FG001|Overall Study|Death|1|||
157227823|NCT00911859|567579212|FG000|Maintainance Period|Lack of Efficacy|0|||
157227824|NCT00911859|567579213|FG001|Maintainance Period|Lack of Efficacy|0|||
157227825|NCT00911859|567579214|FG002|Maintainance Period|Lack of Efficacy|9|||
157227826|NCT00911859|567579212|FG000|Maintainance Period|Physician Decision|0|||
157227827|NCT00911859|567579213|FG001|Maintainance Period|Physician Decision|0|||
157227828|NCT00911859|567579214|FG002|Maintainance Period|Physician Decision|9|||
157227829|NCT00911859|567579212|FG000|Maintainance Period|Withdrawal by Subject|0|||
157227830|NCT00911859|567579213|FG001|Maintainance Period|Withdrawal by Subject|0|||
157227831|NCT00911859|567579214|FG002|Maintainance Period|Withdrawal by Subject|3|||
157227832|NCT00911859|567579212|FG000|Follow-up Period|Death|5|||
157227833|NCT00911859|567579213|FG001|Follow-up Period|Death|8|||
157227834|NCT00911859|567579214|FG002|Follow-up Period|Death|10|||
157227835|NCT00911859|567579212|FG000|Follow-up Period|Lost to Follow-up|1|||
157227836|NCT00911859|567579213|FG001|Follow-up Period|Lost to Follow-up|1|||
157227837|NCT00911859|567579214|FG002|Follow-up Period|Lost to Follow-up|0|||
157227838|NCT00911859|567579212|FG000|Follow-up Period|Withdrawal by Subject|0|||
157227839|NCT00911859|567579213|FG001|Follow-up Period|Withdrawal by Subject|4|||
157227840|NCT00911859|567579214|FG002|Follow-up Period|Withdrawal by Subject|4|||
157227841|NCT00911859|567579212|FG000|Follow-up Period|Study terminated by sponsor|5|||
157227842|NCT00911859|567579213|FG001|Follow-up Period|Study terminated by sponsor|33|||
157227843|NCT00911859|567579214|FG002|Follow-up Period|Study terminated by sponsor|27|||
157227844|NCT03008460|567579217|FG000|Overall Study|Protocol deviation|0|||
157227845|NCT03008460|567579218|FG001|Overall Study|Protocol deviation|2|||
156962788|NCT01203930|566616039|FG001|Overall Study|Investigator Request|8|||
156962789|NCT01203930|566616038|FG000|Overall Study|Study Terminated by Sponsor|0|||
156962790|NCT01203930|566616039|FG001|Overall Study|Study Terminated by Sponsor|12|||
156962791|NCT01203930|566616038|FG000|Overall Study|Poor tolerance of study drug|0|||
156962792|NCT01203930|566616039|FG001|Overall Study|Poor tolerance of study drug|1|||
156962793|NCT01203930|566616038|FG000|Overall Study|Adverse Event|17|||
156962794|NCT01203930|566616039|FG001|Overall Study|Adverse Event|5|||
156962795|NCT04050865|566616042|FG000|Overall Study|Adverse Event|1|||
156962796|NCT04050865|566616043|FG001|Overall Study|Adverse Event|0|||
156962797|NCT04050865|566616042|FG000|Overall Study|no insert|1|||
156962798|NCT04050865|566616043|FG001|Overall Study|no insert|0|||
156962799|NCT04050865|566616042|FG000|Overall Study|Only 1 insert|2|||
156962800|NCT04050865|566616043|FG001|Overall Study|Only 1 insert|3|||
156962801|NCT04050865|566616042|FG000|Overall Study|Physician Decision|0|||
156962802|NCT04050865|566616043|FG001|Overall Study|Physician Decision|1|||
156962803|NCT04050865|566616042|FG000|Overall Study|Withdrawal by Subject|0|||
156962804|NCT04050865|566616043|FG001|Overall Study|Withdrawal by Subject|1|||
156962805|NCT01266850|566616044|FG000|Overall Study|Lost to Follow-up|19|||
156962806|NCT01266850|566616045|FG001|Overall Study|Lost to Follow-up|19|||
156962807|NCT01266850|566616046|FG002|Overall Study|Lost to Follow-up|13|||
156962808|NCT01266850|566616047|FG003|Overall Study|Lost to Follow-up|13|||
156962809|NCT01266850|566616048|FG004|Overall Study|Lost to Follow-up|12|||
156962810|NCT01266850|566616044|FG000|Overall Study|Withdrawal by Subject|8|||
156962811|NCT01266850|566616045|FG001|Overall Study|Withdrawal by Subject|9|||
156962812|NCT01266850|566616046|FG002|Overall Study|Withdrawal by Subject|6|||
156962813|NCT01266850|566616047|FG003|Overall Study|Withdrawal by Subject|9|||
156962814|NCT01266850|566616048|FG004|Overall Study|Withdrawal by Subject|12|||
156962815|NCT01266850|566616044|FG000|Overall Study|Physician Decision|3|||
156962816|NCT01266850|566616045|FG001|Overall Study|Physician Decision|6|||
156962817|NCT01266850|566616046|FG002|Overall Study|Physician Decision|4|||
156962818|NCT01266850|566616047|FG003|Overall Study|Physician Decision|4|||
156962819|NCT01266850|566616048|FG004|Overall Study|Physician Decision|3|||
156962820|NCT01266850|566616044|FG000|Overall Study|Protocol Violation|0|||
156962821|NCT01266850|566616045|FG001|Overall Study|Protocol Violation|1|||
156962822|NCT01266850|566616046|FG002|Overall Study|Protocol Violation|0|||
156962823|NCT01266850|566616047|FG003|Overall Study|Protocol Violation|1|||
156962824|NCT01266850|566616048|FG004|Overall Study|Protocol Violation|2|||
156962825|NCT01266850|566616044|FG000|Overall Study|Adverse Event|0|||
156962826|NCT01266850|566616045|FG001|Overall Study|Adverse Event|0|||
156962827|NCT01266850|566616046|FG002|Overall Study|Adverse Event|0|||
156962828|NCT01266850|566616047|FG003|Overall Study|Adverse Event|0|||
156962829|NCT01266850|566616048|FG004|Overall Study|Adverse Event|1|||
156962830|NCT01266850|566616044|FG000|Overall Study|Site Closure|0|||
156962831|NCT01266850|566616045|FG001|Overall Study|Site Closure|1|||
156962832|NCT01266850|566616046|FG002|Overall Study|Site Closure|1|||
156962833|NCT01266850|566616047|FG003|Overall Study|Site Closure|1|||
156962834|NCT01266850|566616048|FG004|Overall Study|Site Closure|0|||
156962835|NCT00857207|566616049|FG000|Overall Study|Withdrawal by Subject|13|||
156962836|NCT00857207|566616050|FG001|Overall Study|Withdrawal by Subject|0|||
156962837|NCT00857207|566616049|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
156977552|NCT01598298|566670740|FG001|Overall Study|Other reason (not protocol specified)|0|||
157227846|NCT03008460|567579217|FG000|Overall Study|Study drug not dispensed|0|||
157227847|NCT03008460|567579218|FG001|Overall Study|Study drug not dispensed|1|||
157227848|NCT03008460|567579217|FG000|Overall Study|Adverse Event|0|||
157227849|NCT03008460|567579218|FG001|Overall Study|Adverse Event|1|||
157039036|NCT01640951|566898275|FG002|Overall Study|Death|1|||
157039037|NCT01640951|566898276|FG003|Overall Study|Death|0|||
157039038|NCT01640951|566898277|FG004|Overall Study|Death|0|||
157039039|NCT01640951|566898278|FG005|Overall Study|Death|0|||
157039040|NCT01640951|566898279|FG006|Overall Study|Death|0|||
157039041|NCT01640951|566898280|FG007|Overall Study|Death|2|||
157039042|NCT00582972|566898281|FG000|Overall Study|Protocol Violation|2|||
157039043|NCT00293397|566898285|FG000|Overall Study|Death|2|||
157039044|NCT03631407|566898288|FG000|Overall Study|Withdrawal by Subject|3|||
157039045|NCT03631407|566898289|FG001|Overall Study|Withdrawal by Subject|2|||
157039046|NCT03631407|566898288|FG000|Overall Study|Sponsor Decision|0|||
157039047|NCT03631407|566898289|FG001|Overall Study|Sponsor Decision|2|||
157039048|NCT03631407|566898288|FG000|Overall Study|Death|16|||
157039049|NCT03631407|566898289|FG001|Overall Study|Death|16|||
157039050|NCT03631407|566898288|FG000|Overall Study|Randomized by mistake without study treatment|1|||
157039051|NCT03631407|566898289|FG001|Overall Study|Randomized by mistake without study treatment|0|||
157039052|NCT03304587|566898297|FG000|Overall Study|Headache after intervention|0|||
157039053|NCT03304587|566898298|FG001|Overall Study|Headache after intervention|1|||
157172051|NCT03325556|567371099|FG000|Double-blind Period|Administrative discont. at study termination|0|||
157172052|NCT03325556|567371100|FG001|Double-blind Period|Administrative discont. at study termination|35|||
157172053|NCT03325556|567371101|FG002|Double-blind Period|Administrative discont. at study termination|31|||
157172054|NCT01705587|567371102|FG000|Overall Study|Withdrawal by Subject|0|||
157172055|NCT01705587|567371103|FG001|Overall Study|Withdrawal by Subject|1|||
157172056|NCT02227849|567371104|FG000|Overall Study|Adverse Event|4|||
157172057|NCT02227849|567371104|FG000|Overall Study|Physician Decision|1|||
157172058|NCT02227849|567371104|FG000|Overall Study|Withdrawal by Subject|3|||
157172059|NCT01373918|567371107|FG000|Overall Study|Physician Decision|0|||
157172060|NCT01373918|567371108|FG001|Overall Study|Physician Decision|1|||
157172061|NCT00510484|567371109|FG000|Wash-out Period|Adverse Event|0|||
157172062|NCT00510484|567371110|FG001|Wash-out Period|Adverse Event|1|||
157172063|NCT01590212|567371111|FG000|Overall Study|Withdrawal by Subject|2|||
157172064|NCT01590212|567371112|FG001|Overall Study|Withdrawal by Subject|2|||
157172065|NCT01590212|567371113|FG002|Overall Study|Withdrawal by Subject|2|||
157172066|NCT01590212|567371111|FG000|Overall Study|Lost to Follow-up|1|||
157172067|NCT01590212|567371112|FG001|Overall Study|Lost to Follow-up|2|||
157172068|NCT01590212|567371113|FG002|Overall Study|Lost to Follow-up|3|||
157172069|NCT00762268|567371114|FG000|Overall Study|Withdrawal by Subject|3|||
157172070|NCT00762268|567371115|FG001|Overall Study|Withdrawal by Subject|3|||
157172071|NCT03004976|567371116|FG000|Overall Study|Lost to Follow-up|7|||
157172072|NCT03004976|567371117|FG001|Overall Study|Lost to Follow-up|5|||
157172073|NCT03004976|567371116|FG000|Overall Study|Physician Decision|1|||
157172074|NCT03004976|567371117|FG001|Overall Study|Physician Decision|0|||
157172075|NCT03004976|567371116|FG000|Overall Study|Withdrawal by Subject|1|||
157172076|NCT03004976|567371117|FG001|Overall Study|Withdrawal by Subject|0|||
157172077|NCT03004976|567371116|FG000|Overall Study|Death|4|||
157172078|NCT03004976|567371117|FG001|Overall Study|Death|1|||
157172079|NCT02533401|567371118|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
157172080|NCT02533401|567371118|FG000|Overall Study|Death|5|||
157172081|NCT02533401|567371118|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
157172082|NCT02533401|567371118|FG000|Overall Study|Lost to Follow-up|1|||
157172083|NCT02533401|567371118|FG000|Overall Study|Violation of Selection Criteria|1|||
157172084|NCT01106391|567371121|FG000|Overall Study|Death|12|||
157172085|NCT01106391|567371121|FG000|Overall Study|Withdrawal by Subject|7|||
157172086|NCT01387074|567371122|FG000|Overall Study|Lost to Follow-up|7|||
157172087|NCT01387074|567371122|FG000|Overall Study|Lack of Efficacy|1|||
157172088|NCT00150345|567371123|FG000|Overall Study|Death|5|||
157172089|NCT00150345|567371124|FG001|Overall Study|Death|2|||
157172090|NCT00150345|567371123|FG000|Overall Study|Adverse Event|8|||
157172091|NCT00150345|567371124|FG001|Overall Study|Adverse Event|6|||
157172092|NCT00150345|567371123|FG000|Overall Study|Lack of Efficacy|5|||
157172093|NCT00150345|567371124|FG001|Overall Study|Lack of Efficacy|4|||
157172094|NCT00150345|567371123|FG000|Overall Study|Withdrawal by Subject|3|||
157172095|NCT00150345|567371124|FG001|Overall Study|Withdrawal by Subject|4|||
157172096|NCT00150345|567371123|FG000|Overall Study|Laboratory abnormality|1|||
157227850|NCT03008460|567579217|FG000|Overall Study|Withdrawal by Subject|5|||
157039054|NCT03304587|566898297|FG000|Overall Study|Withdrawal by Subject|1|||
157039055|NCT03304587|566898298|FG001|Overall Study|Withdrawal by Subject|0|||
157172097|NCT00150345|567371124|FG001|Overall Study|Laboratory abnormality|2|||
157172098|NCT00150345|567371123|FG000|Overall Study|Other|12|||
157172099|NCT00150345|567371124|FG001|Overall Study|Other|14|||
157172100|NCT01392742|567371125|FG000|Overall Study|Premature study termination|42|||
157172101|NCT01392742|567371125|FG000|Overall Study|Failure to return|35|||
157172102|NCT01392742|567371125|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
157172103|NCT01392742|567371125|FG000|Overall Study|Lost to Follow-up|34|||
157172104|NCT01392742|567371125|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
157039056|NCT01458366|566898300|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
157039057|NCT01458366|566898301|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
157172105|NCT01392742|567371125|FG000|Overall Study|ITR and Protocol deviation|1|||
157227851|NCT03008460|567579218|FG001|Overall Study|Withdrawal by Subject|6|||
157227852|NCT03008460|567579217|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
156962838|NCT00857207|566616050|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
156962839|NCT00857207|566616049|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
156962840|NCT00857207|566616050|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
156962841|NCT01332227|566616051|FG000|Overall Study|Adverse Event|4|||
156962842|NCT01332227|566616052|FG001|Overall Study|Adverse Event|1|||
156962843|NCT01332227|566616051|FG000|Overall Study|Withdrawal by Subject|5|||
156962844|NCT01332227|566616052|FG001|Overall Study|Withdrawal by Subject|1|||
156962845|NCT01332227|566616051|FG000|Overall Study|Lost to Follow-up|2|||
156962846|NCT01332227|566616052|FG001|Overall Study|Lost to Follow-up|0|||
156962847|NCT01332227|566616051|FG000|Overall Study|Lack of Efficacy|3|||
156962848|NCT01332227|566616052|FG001|Overall Study|Lack of Efficacy|1|||
156962849|NCT01332227|566616051|FG000|Overall Study|Poor compliance/noncompliance|1|||
156962850|NCT01332227|566616052|FG001|Overall Study|Poor compliance/noncompliance|1|||
156962851|NCT01332227|566616051|FG000|Overall Study|Patient moved from area|1|||
156962852|NCT01332227|566616052|FG001|Overall Study|Patient moved from area|0|||
156962853|NCT01332227|566616051|FG000|Overall Study|Patient began prohibited medication|0|||
156962854|NCT01332227|566616052|FG001|Overall Study|Patient began prohibited medication|1|||
156962855|NCT00428090|566616058|FG000|Overall Study|Adverse Event|10|||
156962856|NCT00428090|566616059|FG001|Overall Study|Adverse Event|8|||
156962857|NCT00428090|566616060|FG002|Overall Study|Adverse Event|10|||
156962858|NCT00428090|566616061|FG003|Overall Study|Adverse Event|11|||
156962859|NCT00428090|566616058|FG000|Overall Study|Lost to Follow-up|3|||
156962860|NCT00428090|566616059|FG001|Overall Study|Lost to Follow-up|6|||
156962861|NCT00428090|566616060|FG002|Overall Study|Lost to Follow-up|1|||
156962862|NCT00428090|566616061|FG003|Overall Study|Lost to Follow-up|4|||
156962863|NCT00428090|566616058|FG000|Overall Study|Protocol Violation|3|||
156962864|NCT00428090|566616059|FG001|Overall Study|Protocol Violation|1|||
156962865|NCT00428090|566616060|FG002|Overall Study|Protocol Violation|3|||
156962866|NCT00428090|566616061|FG003|Overall Study|Protocol Violation|3|||
156962867|NCT00428090|566616058|FG000|Overall Study|Withdrawal by Subject|10|||
156962868|NCT00428090|566616059|FG001|Overall Study|Withdrawal by Subject|12|||
156962869|NCT00428090|566616060|FG002|Overall Study|Withdrawal by Subject|15|||
156962870|NCT00428090|566616061|FG003|Overall Study|Withdrawal by Subject|5|||
156962871|NCT00428090|566616058|FG000|Overall Study|Sponsor terminated study|0|||
156962872|NCT00428090|566616059|FG001|Overall Study|Sponsor terminated study|1|||
156962873|NCT00428090|566616060|FG002|Overall Study|Sponsor terminated study|0|||
156962874|NCT00428090|566616061|FG003|Overall Study|Sponsor terminated study|0|||
156962875|NCT00428090|566616058|FG000|Overall Study|Non-compliance|4|||
156962876|NCT00428090|566616059|FG001|Overall Study|Non-compliance|0|||
156962877|NCT00428090|566616060|FG002|Overall Study|Non-compliance|1|||
156962878|NCT00428090|566616061|FG003|Overall Study|Non-compliance|3|||
156962879|NCT00428090|566616058|FG000|Overall Study|Par. did not returned to visit|1|||
156962880|NCT00428090|566616059|FG001|Overall Study|Par. did not returned to visit|0|||
156962881|NCT00428090|566616060|FG002|Overall Study|Par. did not returned to visit|0|||
156962882|NCT00428090|566616061|FG003|Overall Study|Par. did not returned to visit|1|||
156962883|NCT00428090|566616058|FG000|Overall Study|Follow-Up visit not possible|1|||
156962884|NCT00428090|566616059|FG001|Overall Study|Follow-Up visit not possible|0|||
156962885|NCT00428090|566616060|FG002|Overall Study|Follow-Up visit not possible|0|||
156962886|NCT00428090|566616061|FG003|Overall Study|Follow-Up visit not possible|0|||
156962887|NCT00428090|566616058|FG000|Overall Study|Prohibited medication used for SAE|1|||
156962888|NCT00428090|566616059|FG001|Overall Study|Prohibited medication used for SAE|0|||
156962889|NCT00428090|566616060|FG002|Overall Study|Prohibited medication used for SAE|0|||
156962890|NCT00428090|566616061|FG003|Overall Study|Prohibited medication used for SAE|0|||
156962891|NCT00428090|566616058|FG000|Overall Study|Death of par.|1|||
156962892|NCT00428090|566616059|FG001|Overall Study|Death of par.|0|||
156962893|NCT00428090|566616060|FG002|Overall Study|Death of par.|1|||
156962894|NCT00428090|566616061|FG003|Overall Study|Death of par.|0|||
156962895|NCT00428090|566616058|FG000|Overall Study|Visit 7 exceed the visit window|0|||
156962896|NCT00428090|566616059|FG001|Overall Study|Visit 7 exceed the visit window|1|||
156962897|NCT00428090|566616060|FG002|Overall Study|Visit 7 exceed the visit window|0|||
156962898|NCT00428090|566616061|FG003|Overall Study|Visit 7 exceed the visit window|0|||
156962899|NCT00428090|566616058|FG000|Overall Study|Medical monitor terminated par.|0|||
156962900|NCT00428090|566616059|FG001|Overall Study|Medical monitor terminated par.|1|||
156962901|NCT00428090|566616060|FG002|Overall Study|Medical monitor terminated par.|0|||
156962902|NCT00428090|566616061|FG003|Overall Study|Medical monitor terminated par.|0|||
156962903|NCT00428090|566616058|FG000|Overall Study|Mental status of par. was|0|||
156962904|NCT00428090|566616059|FG001|Overall Study|Mental status of par. was|1|||
156962905|NCT00428090|566616060|FG002|Overall Study|Mental status of par. was|0|||
156962906|NCT00428090|566616061|FG003|Overall Study|Mental status of par. was|0|||
156962907|NCT00428090|566616058|FG000|Overall Study|Worsening of AD|0|||
157039058|NCT01458366|566898302|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
157039059|NCT01458366|566898303|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
157039060|NCT01458366|566898304|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
157039061|NCT01458366|566898300|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
157039062|NCT01458366|566898301|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
157039063|NCT01458366|566898302|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
157039064|NCT01458366|566898303|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
157039065|NCT01458366|566898304|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
157039066|NCT04647487|566898305|FG000|Overall Study|Protocol Deviation|0|||
157039067|NCT04647487|566898306|FG001|Overall Study|Protocol Deviation|0|||
157039068|NCT04647487|566898307|FG002|Overall Study|Protocol Deviation|1|||
157039069|NCT04647487|566898305|FG000|Overall Study|Withdrawal by Subject|1|||
157039070|NCT04647487|566898306|FG001|Overall Study|Withdrawal by Subject|0|||
157039071|NCT04647487|566898307|FG002|Overall Study|Withdrawal by Subject|2|||
157039072|NCT00174252|566898308|FG000|Overall Study|Protocol Violation|2|||
157039073|NCT02107261|566898315|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
157039074|NCT02107261|566898316|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
157039075|NCT02107261|566898315|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
157039076|NCT02107261|566898316|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
157039077|NCT01738438|566898318|FG000|Overall Study|Disease Progression|32|||
157039078|NCT01738438|566898318|FG000|Overall Study|Adverse Event|3|||
157039079|NCT02130557|566898320|FG000|Overall Study|Withdrawal by Subject|12|||
157039080|NCT02130557|566898321|FG001|Overall Study|Withdrawal by Subject|12|||
157039081|NCT02130557|566898320|FG000|Overall Study|Investigator Request|0|||
157039082|NCT02130557|566898321|FG001|Overall Study|Investigator Request|2|||
157039083|NCT02130557|566898320|FG000|Overall Study|Deceased|14|||
157039084|NCT02130557|566898321|FG001|Overall Study|Deceased|14|||
157039085|NCT02130557|566898320|FG000|Overall Study|Lost to Follow-up|6|||
157039086|NCT02130557|566898321|FG001|Overall Study|Lost to Follow-up|7|||
157039087|NCT02130557|566898320|FG000|Overall Study|Other|2|||
157039088|NCT02130557|566898321|FG001|Overall Study|Other|1|||
157039089|NCT02130557|566898320|FG000|Overall Study|Missing|2|||
157039090|NCT02130557|566898321|FG001|Overall Study|Missing|1|||
157039091|NCT02928172|566898322|FG000|Overall Study|Device did not record data|1|||
157039092|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
157039093|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
157172106|NCT01392742|567371125|FG000|Overall Study|Adverse event/intercurrent illness|17|||
157172107|NCT01392742|567371125|FG000|Overall Study|Protocol Violation|14|||
157172108|NCT01392742|567371125|FG000|Overall Study|Other|3|||
157172109|NCT01392742|567371125|FG000|Overall Study|Missing information|13|||
157172110|NCT01998958|567371126|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172111|NCT01998958|567371127|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
157172112|NCT01998958|567371128|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172113|NCT01998958|567371129|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172114|NCT01998958|567371130|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172115|NCT01998958|567371131|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172116|NCT01998958|567371132|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172117|NCT01998958|567371133|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172118|NCT01998958|567371134|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172119|NCT01998958|567371135|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172120|NCT01998958|567371136|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172121|NCT01998958|567371137|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172122|NCT01998958|567371138|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172123|NCT01998958|567371139|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172124|NCT01998958|567371140|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
156962908|NCT00428090|566616059|FG001|Overall Study|Worsening of AD|0|||
156962909|NCT00428090|566616060|FG002|Overall Study|Worsening of AD|1|||
156962910|NCT00428090|566616061|FG003|Overall Study|Worsening of AD|0|||
156962911|NCT00428090|566616058|FG000|Overall Study|Excluded for concerning QTc value|0|||
156962912|NCT00428090|566616059|FG001|Overall Study|Excluded for concerning QTc value|0|||
156962913|NCT00428090|566616060|FG002|Overall Study|Excluded for concerning QTc value|1|||
156962914|NCT00428090|566616061|FG003|Overall Study|Excluded for concerning QTc value|0|||
156962915|NCT00428090|566616058|FG000|Overall Study|Insufficient AD documentation|0|||
156962916|NCT00428090|566616059|FG001|Overall Study|Insufficient AD documentation|0|||
156962917|NCT00428090|566616060|FG002|Overall Study|Insufficient AD documentation|1|||
156962918|NCT00428090|566616061|FG003|Overall Study|Insufficient AD documentation|0|||
156962919|NCT00428090|566616058|FG000|Overall Study|High MMSE scores|0|||
156962920|NCT00428090|566616059|FG001|Overall Study|High MMSE scores|0|||
156962921|NCT00428090|566616060|FG002|Overall Study|High MMSE scores|1|||
156962922|NCT00428090|566616061|FG003|Overall Study|High MMSE scores|0|||
156962923|NCT00428090|566616058|FG000|Overall Study|Deterioration of cognitive status|0|||
156962924|NCT00428090|566616059|FG001|Overall Study|Deterioration of cognitive status|0|||
156962925|NCT00428090|566616060|FG002|Overall Study|Deterioration of cognitive status|1|||
156962926|NCT00428090|566616061|FG003|Overall Study|Deterioration of cognitive status|0|||
156962927|NCT00428090|566616058|FG000|Overall Study|Serious adverse event|0|||
157039094|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
157039095|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
157039096|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
157039097|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
157039098|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
157039099|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
157039100|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
157039101|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
157039102|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
157039103|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
157039104|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
157039105|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
157039106|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
157039107|NCT03333109|566898323|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
157039108|NCT03333109|566898324|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
157039109|NCT03333109|566898325|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
157039110|NCT03333109|566898323|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
157039111|NCT03333109|566898324|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
157039112|NCT03333109|566898325|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
157039113|NCT03333109|566898323|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
157039114|NCT03333109|566898324|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
157039115|NCT03333109|566898325|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
157039116|NCT00309166|566898326|FG000|Overall Study|Adverse event, non-fatal|1|||
157039117|NCT00309166|566898327|FG001|Overall Study|Adverse event, non-fatal|0|||
157039118|NCT00309166|566898326|FG000|Overall Study|Withdrawal by Subject|4|||
157039119|NCT00309166|566898327|FG001|Overall Study|Withdrawal by Subject|3|||
157039120|NCT00701701|566898328|FG000|Overall Study|Withdrawal by Subject|0|||
157039121|NCT00701701|566898329|FG001|Overall Study|Withdrawal by Subject|1|||
157039122|NCT00701701|566898328|FG000|Overall Study|Adverse Event|0|||
157039123|NCT00701701|566898329|FG001|Overall Study|Adverse Event|1|||
157039124|NCT05827068|566898339|FG000|Overall Study|Lost to Follow-up|1|||
157039125|NCT05827068|566898340|FG001|Overall Study|Lost to Follow-up|4|||
157039126|NCT05827068|566898341|FG002|Overall Study|Lost to Follow-up|1|||
157039127|NCT05827068|566898342|FG003|Overall Study|Lost to Follow-up|1|||
157039128|NCT05827068|566898343|FG004|Overall Study|Lost to Follow-up|2|||
157039129|NCT05827068|566898344|FG005|Overall Study|Lost to Follow-up|4|||
157039130|NCT05827068|566898345|FG006|Overall Study|Lost to Follow-up|1|||
157039131|NCT05827068|566898339|FG000|Overall Study|Withdrawal by Subject|4|||
157039132|NCT05827068|566898340|FG001|Overall Study|Withdrawal by Subject|0|||
157172125|NCT01998958|567371141|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172126|NCT01998958|567371142|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172127|NCT01998958|567371143|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172128|NCT01998958|567371144|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172129|NCT01998958|567371145|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172130|NCT01998958|567371146|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172131|NCT01998958|567371147|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172132|NCT01998958|567371148|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172133|NCT01998958|567371149|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172134|NCT01998958|567371150|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172135|NCT01998958|567371151|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172136|NCT01998958|567371152|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172137|NCT01998958|567371153|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172138|NCT01998958|567371154|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172139|NCT01998958|567371155|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172140|NCT01998958|567371156|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172141|NCT01998958|567371157|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
157172142|NCT01998958|567371126|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172143|NCT01998958|567371127|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
157172144|NCT01998958|567371128|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172145|NCT01998958|567371129|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172146|NCT01998958|567371130|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172147|NCT01998958|567371131|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172148|NCT01998958|567371132|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172149|NCT01998958|567371133|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172150|NCT01998958|567371134|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157227853|NCT03008460|567579218|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
157039133|NCT05827068|566898341|FG002|Overall Study|Withdrawal by Subject|1|||
157039134|NCT05827068|566898342|FG003|Overall Study|Withdrawal by Subject|2|||
157039135|NCT05827068|566898343|FG004|Overall Study|Withdrawal by Subject|3|||
157039136|NCT05827068|566898344|FG005|Overall Study|Withdrawal by Subject|0|||
157039137|NCT05827068|566898345|FG006|Overall Study|Withdrawal by Subject|1|||
157039138|NCT05827068|566898339|FG000|Overall Study|Physician Decision|0|||
157039139|NCT05827068|566898340|FG001|Overall Study|Physician Decision|0|||
157039140|NCT05827068|566898341|FG002|Overall Study|Physician Decision|0|||
157039141|NCT05827068|566898342|FG003|Overall Study|Physician Decision|0|||
157039142|NCT05827068|566898343|FG004|Overall Study|Physician Decision|1|||
157039143|NCT05827068|566898344|FG005|Overall Study|Physician Decision|0|||
157039144|NCT05827068|566898345|FG006|Overall Study|Physician Decision|1|||
157039145|NCT05827068|566898339|FG000|Overall Study|Other Than Specified|0|||
157039146|NCT05827068|566898340|FG001|Overall Study|Other Than Specified|1|||
157039147|NCT05827068|566898341|FG002|Overall Study|Other Than Specified|0|||
157039148|NCT05827068|566898342|FG003|Overall Study|Other Than Specified|0|||
157039149|NCT05827068|566898343|FG004|Overall Study|Other Than Specified|0|||
157039150|NCT05827068|566898344|FG005|Overall Study|Other Than Specified|0|||
157039151|NCT05827068|566898345|FG006|Overall Study|Other Than Specified|0|||
157039152|NCT05464732|566898346|FG000|Overall Study|Lost to Follow-up|0|||
157039153|NCT05464732|566898347|FG001|Overall Study|Lost to Follow-up|1|||
157039154|NCT05464732|566898346|FG000|Overall Study|Adverse Event|1|||
157039155|NCT05464732|566898347|FG001|Overall Study|Adverse Event|0|||
157039156|NCT02678689|566898348|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
157039157|NCT02678689|566898349|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
157039158|NCT02761187|566898353|FG000|Overall Study|Too ill to Participate|13|||
157039159|NCT02761187|566898354|FG001|Overall Study|Too ill to Participate|8|||
157039160|NCT02761187|566898353|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
157039161|NCT02761187|566898354|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
157039162|NCT02761187|566898353|FG000|Overall Study|Patient withdrew consent|64|||
157039163|NCT02761187|566898354|FG001|Overall Study|Patient withdrew consent|58|||
157039164|NCT02761187|566898353|FG000|Overall Study|Physician discretion|4|||
157039165|NCT02761187|566898354|FG001|Overall Study|Physician discretion|8|||
157039166|NCT02761187|566898353|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
157039167|NCT02761187|566898354|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
157039168|NCT02761187|566898353|FG000|Overall Study|On Hospice|20|||
157039169|NCT02761187|566898354|FG001|Overall Study|On Hospice|26|||
157039170|NCT02761187|566898353|FG000|Overall Study|Deceased|474|||
157039171|NCT02761187|566898354|FG001|Overall Study|Deceased|642|||
157039172|NCT02761187|566898353|FG000|Overall Study|Lost to Follow-up|73|||
157039173|NCT02761187|566898354|FG001|Overall Study|Lost to Follow-up|63|||
157039174|NCT02761187|566898353|FG000|Overall Study|Due to study discontinued at site|100|||
157039175|NCT02761187|566898354|FG001|Overall Study|Due to study discontinued at site|85|||
157039176|NCT02761187|566898353|FG000|Overall Study|Reason not Specified|1484|||
157039177|NCT02761187|566898354|FG001|Overall Study|Reason not Specified|937|||
157039178|NCT05630833|566898359|FG000|Overall Study|Adverse Event|3|||
157039179|NCT05630833|566898360|FG001|Overall Study|Adverse Event|0|||
157039180|NCT05630833|566898359|FG000|Overall Study|Lack of Efficacy|0|||
157039181|NCT05630833|566898360|FG001|Overall Study|Lack of Efficacy|1|||
157039182|NCT05630833|566898359|FG000|Overall Study|Lost to Follow-up|1|||
157039183|NCT05630833|566898360|FG001|Overall Study|Lost to Follow-up|0|||
156962928|NCT00428090|566616059|FG001|Overall Study|Serious adverse event|0|||
156962929|NCT00428090|566616060|FG002|Overall Study|Serious adverse event|1|||
156962930|NCT00428090|566616061|FG003|Overall Study|Serious adverse event|0|||
156962931|NCT00428090|566616058|FG000|Overall Study|Excluded for heart insufficiency|0|||
156962932|NCT00428090|566616059|FG001|Overall Study|Excluded for heart insufficiency|0|||
156962933|NCT00428090|566616060|FG002|Overall Study|Excluded for heart insufficiency|1|||
156962934|NCT00428090|566616061|FG003|Overall Study|Excluded for heart insufficiency|0|||
156962935|NCT00428090|566616058|FG000|Overall Study|Raised Creatinine Value|0|||
156962936|NCT00428090|566616059|FG001|Overall Study|Raised Creatinine Value|0|||
156962937|NCT00428090|566616060|FG002|Overall Study|Raised Creatinine Value|0|||
156962938|NCT00428090|566616061|FG003|Overall Study|Raised Creatinine Value|1|||
156962939|NCT01791725|566616065|FG000|Overall Study|Withdrawal by Subject|0|||
156962940|NCT01791725|566616066|FG001|Overall Study|Withdrawal by Subject|1|||
156962941|NCT01791725|566616067|FG002|Overall Study|Withdrawal by Subject|0|||
156962942|NCT01615328|566616081|FG000|Overall Study|Lost to Follow-up|3|||
156962943|NCT01615328|566616082|FG001|Overall Study|Lost to Follow-up|5|||
156962944|NCT02157779|566616083|FG000|Overall Study|Logistical|9|||
156962945|NCT02157779|566616084|FG001|Overall Study|Logistical|3|||
156962946|NCT02157779|566616083|FG000|Overall Study|Stopped attending, reason unknown|11|||
156962947|NCT02157779|566616084|FG001|Overall Study|Stopped attending, reason unknown|7|||
157039184|NCT05630833|566898359|FG000|Overall Study|Withdrawal by Subject|3|||
157039185|NCT05630833|566898360|FG001|Overall Study|Withdrawal by Subject|1|||
157039186|NCT05704725|566898361|FG000|Overall Study|Lost to Follow-up|0|||
157039187|NCT05704725|566898362|FG001|Overall Study|Lost to Follow-up|1|||
157039188|NCT05704725|566898361|FG000|Overall Study|Withdrawal by Subject|1|||
157039189|NCT05704725|566898362|FG001|Overall Study|Withdrawal by Subject|0|||
157039190|NCT00490139|566898363|FG000|Overall Study|Lost to Follow-up|249|||
157039191|NCT00490139|566898364|FG001|Overall Study|Lost to Follow-up|216|||
157039192|NCT00490139|566898365|FG002|Overall Study|Lost to Follow-up|205|||
157172151|NCT01998958|567371135|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172152|NCT01998958|567371136|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172153|NCT01998958|567371137|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172154|NCT01998958|567371138|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172155|NCT01998958|567371139|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172156|NCT01998958|567371140|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172157|NCT01998958|567371141|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172158|NCT01998958|567371142|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172159|NCT01998958|567371143|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172160|NCT01998958|567371144|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172161|NCT01998958|567371145|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172162|NCT01998958|567371146|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172163|NCT01998958|567371147|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172164|NCT01998958|567371148|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172165|NCT01998958|567371149|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172166|NCT01998958|567371150|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172167|NCT01998958|567371151|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172168|NCT01998958|567371152|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172169|NCT01998958|567371153|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172170|NCT01998958|567371154|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172171|NCT01998958|567371155|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172172|NCT01998958|567371156|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172173|NCT01998958|567371157|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
157172174|NCT01998958|567371126|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
157172175|NCT01998958|567371127|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
157172176|NCT01998958|567371128|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
157172177|NCT01998958|567371129|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
157172178|NCT01998958|567371130|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
157172179|NCT01998958|567371131|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
157172180|NCT01998958|567371132|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
157172181|NCT01998958|567371133|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
157172182|NCT01998958|567371134|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
157172183|NCT01998958|567371135|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
157172184|NCT01998958|567371136|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
157172185|NCT01998958|567371137|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
157172186|NCT01998958|567371138|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
157172187|NCT01998958|567371139|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
157172188|NCT01998958|567371140|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
157172189|NCT01998958|567371141|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
157172190|NCT01998958|567371142|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
157172191|NCT01998958|567371143|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
157172192|NCT01998958|567371144|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
157172193|NCT01998958|567371145|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
157172194|NCT01998958|567371146|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
157172195|NCT01998958|567371147|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
157172196|NCT01998958|567371148|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
157172197|NCT01998958|567371149|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
157172198|NCT01998958|567371150|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
157172199|NCT01998958|567371151|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
157172200|NCT01998958|567371152|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
157172201|NCT01998958|567371153|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
157172202|NCT01998958|567371154|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
157172203|NCT01998958|567371155|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
157172204|NCT01998958|567371156|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
157172205|NCT01998958|567371157|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
157172206|NCT01998958|567371126|FG000|Period 1 (Panel A and B)|Other|1|||
157172207|NCT01998958|567371127|FG001|Period 1 (Panel A and B)|Other|0|||
157172208|NCT01998958|567371128|FG002|Period 1 (Panel A and B)|Other|0|||
157172209|NCT01998958|567371129|FG003|Period 1 (Panel A and B)|Other|0|||
157172210|NCT01998958|567371130|FG004|Period 1 (Panel A and B)|Other|0|||
157172211|NCT01998958|567371131|FG005|Period 1 (Panel A and B)|Other|0|||
157172212|NCT01998958|567371132|FG006|Period 1 (Panel A and B)|Other|0|||
157172213|NCT01998958|567371133|FG007|Period 1 (Panel A and B)|Other|0|||
157172214|NCT01998958|567371134|FG008|Period 1 (Panel A and B)|Other|0|||
157172215|NCT01998958|567371135|FG009|Period 1 (Panel A and B)|Other|0|||
157172216|NCT01998958|567371136|FG010|Period 1 (Panel A and B)|Other|0|||
157172217|NCT01998958|567371137|FG011|Period 1 (Panel A and B)|Other|0|||
157172218|NCT01998958|567371138|FG012|Period 1 (Panel A and B)|Other|0|||
157172219|NCT01998958|567371139|FG013|Period 1 (Panel A and B)|Other|0|||
157172220|NCT01998958|567371140|FG014|Period 1 (Panel A and B)|Other|0|||
157172221|NCT01998958|567371141|FG015|Period 1 (Panel A and B)|Other|0|||
157172222|NCT01998958|567371142|FG016|Period 1 (Panel A and B)|Other|0|||
157172223|NCT01998958|567371143|FG017|Period 1 (Panel A and B)|Other|0|||
157172224|NCT01998958|567371144|FG018|Period 1 (Panel A and B)|Other|0|||
157172225|NCT01998958|567371145|FG019|Period 1 (Panel A and B)|Other|0|||
157172226|NCT01998958|567371146|FG020|Period 1 (Panel A and B)|Other|0|||
157172227|NCT01998958|567371147|FG021|Period 1 (Panel A and B)|Other|0|||
157039193|NCT00490139|566898366|FG003|Overall Study|Lost to Follow-up|229|||
157039194|NCT00490139|566898363|FG000|Overall Study|Withdrawal by Subject|333|||
157039195|NCT00490139|566898364|FG001|Overall Study|Withdrawal by Subject|322|||
157039196|NCT00490139|566898365|FG002|Overall Study|Withdrawal by Subject|396|||
157039197|NCT00490139|566898366|FG003|Overall Study|Withdrawal by Subject|295|||
157039198|NCT00490139|566898363|FG000|Overall Study|Patient did not sign ICF 12|169|||
157039199|NCT00490139|566898364|FG001|Overall Study|Patient did not sign ICF 12|176|||
157039200|NCT00490139|566898365|FG002|Overall Study|Patient did not sign ICF 12|139|||
157039201|NCT00490139|566898366|FG003|Overall Study|Patient did not sign ICF 12|167|||
157039202|NCT00490139|566898363|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
157039203|NCT00490139|566898364|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
157039204|NCT00490139|566898365|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
157039205|NCT00490139|566898366|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
157039206|NCT00490139|566898363|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
157039207|NCT00490139|566898364|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
157039208|NCT00490139|566898365|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
157039209|NCT00490139|566898366|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
157039210|NCT00490139|566898363|FG000|Overall Study|Other reasons as defined per protocol|98|||
157039211|NCT00490139|566898364|FG001|Overall Study|Other reasons as defined per protocol|84|||
157039212|NCT00490139|566898365|FG002|Overall Study|Other reasons as defined per protocol|82|||
157039213|NCT00490139|566898366|FG003|Overall Study|Other reasons as defined per protocol|105|||
157039214|NCT03664804|566898368|FG000|Overall Study|Withdrawal by Subject|7|||
157172228|NCT01998958|567371148|FG022|Period 1 (Panel A and B)|Other|0|||
157172229|NCT01998958|567371149|FG023|Period 1 (Panel A and B)|Other|0|||
157172230|NCT01998958|567371150|FG024|Period 1 (Panel A and B)|Other|0|||
157172231|NCT01998958|567371151|FG025|Period 1 (Panel A and B)|Other|0|||
156977553|NCT02073097|566670741|FG000|Overall Study|Adverse Event|0|||
156977554|NCT02073097|566670742|FG001|Overall Study|Adverse Event|0|||
156977555|NCT02073097|566670743|FG002|Overall Study|Adverse Event|0|||
156977556|NCT02073097|566670744|FG003|Overall Study|Adverse Event|0|||
156977557|NCT02073097|566670745|FG004|Overall Study|Adverse Event|0|||
156977558|NCT02073097|566670746|FG005|Overall Study|Adverse Event|0|||
156977559|NCT02073097|566670747|FG006|Overall Study|Adverse Event|0|||
156977560|NCT02073097|566670748|FG007|Overall Study|Adverse Event|2|||
156977561|NCT02073097|566670741|FG000|Overall Study|Withdrawal by Subject|0|||
156977562|NCT02073097|566670742|FG001|Overall Study|Withdrawal by Subject|0|||
156977563|NCT02073097|566670743|FG002|Overall Study|Withdrawal by Subject|0|||
156977564|NCT02073097|566670744|FG003|Overall Study|Withdrawal by Subject|0|||
156977565|NCT02073097|566670745|FG004|Overall Study|Withdrawal by Subject|0|||
156977566|NCT02073097|566670746|FG005|Overall Study|Withdrawal by Subject|0|||
156977567|NCT02073097|566670747|FG006|Overall Study|Withdrawal by Subject|0|||
156977568|NCT02073097|566670748|FG007|Overall Study|Withdrawal by Subject|2|||
156977569|NCT02073097|566670741|FG000|Overall Study|Death|0|||
156977570|NCT02073097|566670742|FG001|Overall Study|Death|0|||
156977571|NCT02073097|566670743|FG002|Overall Study|Death|0|||
156977572|NCT02073097|566670744|FG003|Overall Study|Death|0|||
156977573|NCT02073097|566670745|FG004|Overall Study|Death|0|||
156977574|NCT02073097|566670746|FG005|Overall Study|Death|0|||
156977575|NCT02073097|566670747|FG006|Overall Study|Death|0|||
156977576|NCT02073097|566670748|FG007|Overall Study|Death|1|||
156977577|NCT02073097|566670741|FG000|Overall Study|Physician Decision|0|||
156977578|NCT02073097|566670742|FG001|Overall Study|Physician Decision|0|||
156977579|NCT02073097|566670743|FG002|Overall Study|Physician Decision|0|||
156977580|NCT02073097|566670744|FG003|Overall Study|Physician Decision|0|||
156977581|NCT02073097|566670745|FG004|Overall Study|Physician Decision|0|||
156977582|NCT02073097|566670746|FG005|Overall Study|Physician Decision|0|||
156977583|NCT02073097|566670747|FG006|Overall Study|Physician Decision|0|||
156977584|NCT02073097|566670748|FG007|Overall Study|Physician Decision|1|||
156977585|NCT01693692|566670751|FG000|Overall Study|Withdrawal by Subject|12|||
156977586|NCT01693692|566670752|FG001|Overall Study|Withdrawal by Subject|10|||
156977587|NCT01693692|566670753|FG002|Overall Study|Withdrawal by Subject|11|||
156977588|NCT01693692|566670751|FG000|Overall Study|Adverse Event|7|||
156977589|NCT01693692|566670752|FG001|Overall Study|Adverse Event|14|||
156977590|NCT01693692|566670753|FG002|Overall Study|Adverse Event|9|||
156977591|NCT01693692|566670751|FG000|Overall Study|Physician Decision|0|||
156977592|NCT01693692|566670752|FG001|Overall Study|Physician Decision|0|||
156977593|NCT01693692|566670753|FG002|Overall Study|Physician Decision|1|||
156977594|NCT01693692|566670751|FG000|Overall Study|Protocol Violation|5|||
156977595|NCT01693692|566670752|FG001|Overall Study|Protocol Violation|4|||
156977596|NCT01693692|566670753|FG002|Overall Study|Protocol Violation|6|||
156977597|NCT01693692|566670751|FG000|Overall Study|Lost to Follow-up|2|||
156977598|NCT01693692|566670752|FG001|Overall Study|Lost to Follow-up|2|||
156977599|NCT01693692|566670753|FG002|Overall Study|Lost to Follow-up|3|||
156977600|NCT01693692|566670751|FG000|Overall Study|Other|4|||
156977601|NCT01693692|566670752|FG001|Overall Study|Other|4|||
156977602|NCT01693692|566670753|FG002|Overall Study|Other|6|||
157172232|NCT01998958|567371152|FG026|Period 1 (Panel A and B)|Other|0|||
157172233|NCT01998958|567371153|FG027|Period 1 (Panel A and B)|Other|0|||
157172234|NCT01998958|567371154|FG028|Period 1 (Panel A and B)|Other|0|||
157172235|NCT01998958|567371155|FG029|Period 1 (Panel A and B)|Other|0|||
157172236|NCT01998958|567371156|FG030|Period 1 (Panel A and B)|Other|0|||
157172237|NCT01998958|567371157|FG031|Period 1 (Panel A and B)|Other|0|||
157172238|NCT01998958|567371126|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
157172239|NCT01998958|567371127|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
157172240|NCT01998958|567371128|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
157172241|NCT01998958|567371129|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
157172242|NCT01998958|567371130|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
157172243|NCT01998958|567371131|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
157172244|NCT01998958|567371132|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
157039215|NCT05529992|566898369|FG000|Overall Study|Withdrawal by Subject|1|||
157039216|NCT06140290|566898370|FG000|Period 1|Adverse Event|1|||
157039217|NCT06140290|566898371|FG001|Period 1|Adverse Event|0|||
157039218|NCT06140290|566898370|FG000|Period 2|Assigned but not treated|0|||
157039219|NCT06140290|566898371|FG001|Period 2|Assigned but not treated|1|||
157039220|NCT06140290|566898370|FG000|Period 2|Withdrawal by Subject|0|||
157039221|NCT06140290|566898371|FG001|Period 2|Withdrawal by Subject|1|||
157039222|NCT03459196|566899617|FG000|Overall Study|Subject didn't receive study catheter|2|||
157039223|NCT00092534|566899620|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
157039224|NCT00092534|566899621|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
157039225|NCT00092534|566899622|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
157039226|NCT00092534|566899623|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
157039227|NCT00092534|566899624|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
157039228|NCT00092534|566899620|FG000|Base Study Vaccination Period|Adverse Event|3|||
157039229|NCT00092534|566899621|FG001|Base Study Vaccination Period|Adverse Event|1|||
157039230|NCT00092534|566899622|FG002|Base Study Vaccination Period|Adverse Event|0|||
157039231|NCT00092534|566899623|FG003|Base Study Vaccination Period|Adverse Event|0|||
157039232|NCT00092534|566899624|FG004|Base Study Vaccination Period|Adverse Event|0|||
157039233|NCT00092534|566899620|FG000|Base Study Vaccination Period|Death|5|||
157039234|NCT00092534|566899621|FG001|Base Study Vaccination Period|Death|4|||
157039235|NCT00092534|566899622|FG002|Base Study Vaccination Period|Death|0|||
157039236|NCT00092534|566899623|FG003|Base Study Vaccination Period|Death|0|||
157039237|NCT00092534|566899624|FG004|Base Study Vaccination Period|Death|0|||
157039238|NCT00092534|566899620|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
157039239|NCT00092534|566899621|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
157039240|NCT00092534|566899622|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
157039241|NCT00092534|566899623|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
157039242|NCT00092534|566899624|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
157039243|NCT00092534|566899620|FG000|Base Study Vaccination Period|Physician Decision|1|||
157039244|NCT00092534|566899621|FG001|Base Study Vaccination Period|Physician Decision|0|||
157039245|NCT00092534|566899622|FG002|Base Study Vaccination Period|Physician Decision|0|||
157039246|NCT00092534|566899623|FG003|Base Study Vaccination Period|Physician Decision|0|||
157039247|NCT00092534|566899624|FG004|Base Study Vaccination Period|Physician Decision|0|||
157039248|NCT00092534|566899620|FG000|Base Study Vaccination Period|Pregnancy|9|||
157039249|NCT00092534|566899621|FG001|Base Study Vaccination Period|Pregnancy|7|||
157039250|NCT00092534|566899622|FG002|Base Study Vaccination Period|Pregnancy|0|||
157039251|NCT00092534|566899623|FG003|Base Study Vaccination Period|Pregnancy|0|||
157039252|NCT00092534|566899624|FG004|Base Study Vaccination Period|Pregnancy|0|||
157039253|NCT00092534|566899620|FG000|Base Study Vaccination Period|Protocol Violation|2|||
157039254|NCT00092534|566899621|FG001|Base Study Vaccination Period|Protocol Violation|1|||
157039255|NCT00092534|566899622|FG002|Base Study Vaccination Period|Protocol Violation|0|||
157039256|NCT00092534|566899623|FG003|Base Study Vaccination Period|Protocol Violation|0|||
157039257|NCT00092534|566899624|FG004|Base Study Vaccination Period|Protocol Violation|0|||
157039258|NCT00092534|566899620|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
157039259|NCT00092534|566899621|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
157039260|NCT00092534|566899622|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
157039261|NCT00092534|566899623|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
157039262|NCT00092534|566899624|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
157039263|NCT00092534|566899620|FG000|Base Study Vaccination Period|Moved|14|||
157039264|NCT00092534|566899621|FG001|Base Study Vaccination Period|Moved|12|||
157172245|NCT01998958|567371133|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
157172246|NCT01998958|567371134|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
157172247|NCT01998958|567371135|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
157172248|NCT01998958|567371136|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
157172249|NCT01998958|567371137|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
157172250|NCT01998958|567371138|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
157172251|NCT01998958|567371139|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
157172252|NCT01998958|567371140|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
157172253|NCT01998958|567371141|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
157172254|NCT01998958|567371142|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
157039265|NCT00092534|566899622|FG002|Base Study Vaccination Period|Moved|0|||
157039266|NCT00092534|566899623|FG003|Base Study Vaccination Period|Moved|0|||
157039267|NCT00092534|566899624|FG004|Base Study Vaccination Period|Moved|0|||
157039268|NCT00092534|566899620|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
157039269|NCT00092534|566899621|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
157039270|NCT00092534|566899622|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
157039271|NCT00092534|566899623|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
157039272|NCT00092534|566899624|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
157039273|NCT00092534|566899620|FG000|Base Study Vaccination Period|Travel|1|||
157039274|NCT00092534|566899621|FG001|Base Study Vaccination Period|Travel|0|||
157039275|NCT00092534|566899622|FG002|Base Study Vaccination Period|Travel|0|||
157039276|NCT00092534|566899623|FG003|Base Study Vaccination Period|Travel|0|||
157039277|NCT00092534|566899624|FG004|Base Study Vaccination Period|Travel|0|||
157039278|NCT00092534|566899620|FG000|Base Study Vaccination Period|Site Closed|0|||
157039279|NCT00092534|566899621|FG001|Base Study Vaccination Period|Site Closed|1|||
157039280|NCT00092534|566899622|FG002|Base Study Vaccination Period|Site Closed|0|||
157039281|NCT00092534|566899623|FG003|Base Study Vaccination Period|Site Closed|0|||
157039282|NCT00092534|566899624|FG004|Base Study Vaccination Period|Site Closed|0|||
157039283|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Adverse Event|2|||
157039284|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Adverse Event|4|||
157039285|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Adverse Event|0|||
157039286|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Adverse Event|0|||
157039287|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Adverse Event|0|||
157039288|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Death|2|||
157039289|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Death|1|||
157039290|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Death|0|||
157039291|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Death|0|||
157039292|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Death|0|||
157039293|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
157039294|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
157039295|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
157039296|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
157039297|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
157039298|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Pregnancy|6|||
157039299|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Pregnancy|10|||
157039300|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Pregnancy|0|||
157039301|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Pregnancy|0|||
157039302|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Pregnancy|0|||
157039303|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
157039304|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
157039305|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
157039306|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
157039307|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
157039308|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
157039309|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
157172255|NCT01998958|567371143|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
157172256|NCT01998958|567371144|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
157172257|NCT01998958|567371145|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
157172258|NCT01998958|567371146|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
157172259|NCT01998958|567371147|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
157172260|NCT01998958|567371148|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
157172261|NCT01998958|567371149|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
156962948|NCT02157779|566616083|FG000|Overall Study|No response to outreach after Baseline|1|||
156962949|NCT02157779|566616084|FG001|Overall Study|No response to outreach after Baseline|1|||
156962950|NCT02157779|566616083|FG000|Overall Study|Moved|1|||
156962951|NCT02157779|566616084|FG001|Overall Study|Moved|0|||
156962952|NCT02157779|566616083|FG000|Overall Study|Medical|1|||
156962953|NCT02157779|566616084|FG001|Overall Study|Medical|0|||
156962954|NCT02157779|566616083|FG000|Overall Study|Legal issue|1|||
156962955|NCT02157779|566616084|FG001|Overall Study|Legal issue|0|||
156962956|NCT02548455|566616085|FG000|Overall Study|Withdrawal by Subject|27|||
156962957|NCT02548455|566616085|FG000|Overall Study|Death|26|||
156962958|NCT02548455|566616085|FG000|Overall Study|Lost to Follow-up|14|||
156962959|NCT02548455|566616085|FG000|Overall Study|Visit not completed|173|||
156962960|NCT00487162|566616087|FG000|Overall Study|Adverse Event|0|||
156962961|NCT00487162|566616088|FG001|Overall Study|Adverse Event|1|||
156962962|NCT00487162|566616087|FG000|Overall Study|Physician Decision|0|||
156962963|NCT00487162|566616088|FG001|Overall Study|Physician Decision|1|||
156962964|NCT00487162|566616087|FG000|Overall Study|Withdrawal by Subject|2|||
156962965|NCT00487162|566616088|FG001|Overall Study|Withdrawal by Subject|3|||
156962966|NCT01292876|566616089|FG000|Overall Study|Physician Decision|4|||
156962967|NCT01627327|566616090|FG000|Overall Study|Adverse Event|6|||
156962968|NCT01627327|566616091|FG001|Overall Study|Adverse Event|12|||
156962969|NCT01627327|566616090|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
156962970|NCT01627327|566616091|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
157172262|NCT01998958|567371150|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
157172263|NCT01998958|567371151|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
157172264|NCT01998958|567371152|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
157172265|NCT01998958|567371153|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
156962971|NCT01627327|566616090|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
156962972|NCT01627327|566616091|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
156962973|NCT01627327|566616090|FG000|Overall Study|Protocol Violation|4|||
156962974|NCT01627327|566616091|FG001|Overall Study|Protocol Violation|10|||
156962975|NCT01627327|566616090|FG000|Overall Study|Lost to Follow-up|1|||
156962976|NCT01627327|566616091|FG001|Overall Study|Lost to Follow-up|3|||
157172266|NCT01998958|567371154|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
156962977|NCT01627327|566616090|FG000|Overall Study|Physician Decision|1|||
156962978|NCT01627327|566616091|FG001|Overall Study|Physician Decision|0|||
156962979|NCT01627327|566616090|FG000|Overall Study|Withdrawal by Subject|3|||
156962980|NCT01627327|566616091|FG001|Overall Study|Withdrawal by Subject|3|||
156962981|NCT01137474|566616095|FG000|Overall Study|Adverse Event|3|||
156962982|NCT01137474|566616096|FG001|Overall Study|Adverse Event|5|||
156962983|NCT01137474|566616097|FG002|Overall Study|Adverse Event|1|||
156962984|NCT01137474|566616098|FG003|Overall Study|Adverse Event|3|||
156962985|NCT01137474|566616095|FG000|Overall Study|Withdrawal by Subject|7|||
156962986|NCT01137474|566616096|FG001|Overall Study|Withdrawal by Subject|2|||
156962987|NCT01137474|566616097|FG002|Overall Study|Withdrawal by Subject|6|||
156962988|NCT01137474|566616098|FG003|Overall Study|Withdrawal by Subject|9|||
156962989|NCT01137474|566616095|FG000|Overall Study|No longer met study criteria|6|||
156962990|NCT01137474|566616096|FG001|Overall Study|No longer met study criteria|1|||
156962991|NCT01137474|566616097|FG002|Overall Study|No longer met study criteria|0|||
156962992|NCT01137474|566616098|FG003|Overall Study|No longer met study criteria|5|||
156962993|NCT01137474|566616095|FG000|Overall Study|Lost to Follow-up|5|||
156962994|NCT01137474|566616096|FG001|Overall Study|Lost to Follow-up|1|||
156962995|NCT01137474|566616097|FG002|Overall Study|Lost to Follow-up|0|||
156962996|NCT01137474|566616098|FG003|Overall Study|Lost to Follow-up|2|||
156962997|NCT01137474|566616095|FG000|Overall Study|Lack of Efficacy|0|||
156962998|NCT01137474|566616096|FG001|Overall Study|Lack of Efficacy|0|||
156962999|NCT01137474|566616097|FG002|Overall Study|Lack of Efficacy|0|||
156963000|NCT01137474|566616098|FG003|Overall Study|Lack of Efficacy|2|||
156963001|NCT01137474|566616095|FG000|Overall Study|Other|3|||
156963002|NCT01137474|566616096|FG001|Overall Study|Other|1|||
156963003|NCT01137474|566616097|FG002|Overall Study|Other|0|||
156963004|NCT01137474|566616098|FG003|Overall Study|Other|0|||
156963005|NCT01137474|566616095|FG000|Overall Study|Pregnancy|0|||
156963006|NCT01137474|566616096|FG001|Overall Study|Pregnancy|1|||
156963007|NCT01137474|566616097|FG002|Overall Study|Pregnancy|0|||
156963008|NCT01137474|566616098|FG003|Overall Study|Pregnancy|0|||
156963009|NCT01137474|566616095|FG000|Overall Study|Administrative reason by sponsor|0|||
156963010|NCT01137474|566616096|FG001|Overall Study|Administrative reason by sponsor|1|||
156963011|NCT01137474|566616097|FG002|Overall Study|Administrative reason by sponsor|0|||
156963012|NCT01137474|566616098|FG003|Overall Study|Administrative reason by sponsor|0|||
156963013|NCT02525874|566616099|FG000|Overall Study|Other|1|||
156963014|NCT02525874|566616099|FG000|Overall Study|Investigator Decision|1|||
156963015|NCT02525874|566616099|FG000|Overall Study|Consent withdrawn|22|||
156963016|NCT02525874|566616099|FG000|Overall Study|Non-compliance with study drug|3|||
156963017|NCT02525874|566616099|FG000|Overall Study|Adverse Event|17|||
156963018|NCT02525874|566616099|FG000|Overall Study|Lost to Follow-up|7|||
156963019|NCT02525874|566616099|FG000|Overall Study|Disease progression, defined by protocol|2|||
156963020|NCT02525874|566616099|FG000|Overall Study|Disease relapse|4|||
156963021|NCT02525874|566616099|FG000|Overall Study|Alternative Treatment for MS|2|||
156963022|NCT02525874|566616099|FG000|Overall Study|New lesions in Brain|1|||
156963023|NCT02308748|566616115|FG000|Period 1|Withdrawal by Subject|0|||
156963024|NCT02308748|566616116|FG001|Period 1|Withdrawal by Subject|0|||
156963025|NCT02308748|566616117|FG002|Period 1|Withdrawal by Subject|1|||
156963026|NCT02308748|566616118|FG003|Period 1|Withdrawal by Subject|0|||
156963027|NCT02308748|566616119|FG004|Period 1|Withdrawal by Subject|0|||
156963028|NCT02308748|566616120|FG005|Period 1|Withdrawal by Subject|0|||
156963029|NCT02308748|566616121|FG006|Period 1|Withdrawal by Subject|0|||
156963030|NCT02308748|566616122|FG007|Period 1|Withdrawal by Subject|0|||
156963031|NCT02308748|566616123|FG008|Period 1|Withdrawal by Subject|0|||
156963032|NCT02308748|566616124|FG009|Period 1|Withdrawal by Subject|0|||
156963033|NCT02308748|566616115|FG000|Period 2|Adverse Event|0|||
156963034|NCT02308748|566616116|FG001|Period 2|Adverse Event|0|||
156963035|NCT02308748|566616117|FG002|Period 2|Adverse Event|0|||
156963036|NCT02308748|566616118|FG003|Period 2|Adverse Event|0|||
156963037|NCT02308748|566616119|FG004|Period 2|Adverse Event|0|||
156963038|NCT02308748|566616120|FG005|Period 2|Adverse Event|0|||
156963039|NCT02308748|566616121|FG006|Period 2|Adverse Event|0|||
156963040|NCT02308748|566616122|FG007|Period 2|Adverse Event|1|||
156963041|NCT02308748|566616123|FG008|Period 2|Adverse Event|0|||
156963042|NCT02308748|566616124|FG009|Period 2|Adverse Event|0|||
156963043|NCT02308748|566616115|FG000|Period 3|Protocol Violation|0|||
156963044|NCT02308748|566616116|FG001|Period 3|Protocol Violation|0|||
156963045|NCT02308748|566616117|FG002|Period 3|Protocol Violation|0|||
156963046|NCT02308748|566616118|FG003|Period 3|Protocol Violation|0|||
156963047|NCT02308748|566616119|FG004|Period 3|Protocol Violation|0|||
156963048|NCT02308748|566616120|FG005|Period 3|Protocol Violation|0|||
156963049|NCT02308748|566616121|FG006|Period 3|Protocol Violation|0|||
156963050|NCT02308748|566616122|FG007|Period 3|Protocol Violation|0|||
156963051|NCT02308748|566616123|FG008|Period 3|Protocol Violation|0|||
156963052|NCT02308748|566616124|FG009|Period 3|Protocol Violation|1|||
156963053|NCT02308748|566616115|FG000|Period 5|Adverse Event|1|||
156963054|NCT02308748|566616116|FG001|Period 5|Adverse Event|0|||
156963055|NCT02308748|566616117|FG002|Period 5|Adverse Event|0|||
156963056|NCT02308748|566616118|FG003|Period 5|Adverse Event|0|||
156963057|NCT02308748|566616119|FG004|Period 5|Adverse Event|0|||
156963058|NCT02308748|566616120|FG005|Period 5|Adverse Event|0|||
156963059|NCT02308748|566616121|FG006|Period 5|Adverse Event|0|||
156963060|NCT02308748|566616122|FG007|Period 5|Adverse Event|0|||
156963061|NCT02308748|566616123|FG008|Period 5|Adverse Event|1|||
156963062|NCT02308748|566616124|FG009|Period 5|Adverse Event|0|||
156963063|NCT00675766|566616126|FG000|Overall Study|Lost to Follow-up|6|||
156963064|NCT00675766|566616127|FG001|Overall Study|Lost to Follow-up|5|||
156963065|NCT00675766|566616128|FG002|Overall Study|Lost to Follow-up|21|||
156963066|NCT00675766|566616129|FG003|Overall Study|Lost to Follow-up|26|||
156963067|NCT01749982|566616130|FG000|Overall Study|Physician Decision|0|||
156963068|NCT01749982|566616131|FG001|Overall Study|Physician Decision|0|||
156963069|NCT01749982|566616132|FG002|Overall Study|Physician Decision|0|||
156963070|NCT01749982|566616133|FG003|Overall Study|Physician Decision|1|||
156963071|NCT01749982|566616130|FG000|Overall Study|Lost to Follow-up|0|||
156963072|NCT01749982|566616131|FG001|Overall Study|Lost to Follow-up|0|||
156963073|NCT01749982|566616132|FG002|Overall Study|Lost to Follow-up|0|||
156963074|NCT01749982|566616133|FG003|Overall Study|Lost to Follow-up|1|||
156963075|NCT01749982|566616130|FG000|Overall Study|Withdrawal by Subject|0|||
156963076|NCT01749982|566616131|FG001|Overall Study|Withdrawal by Subject|0|||
156963077|NCT01749982|566616132|FG002|Overall Study|Withdrawal by Subject|0|||
156963078|NCT01749982|566616133|FG003|Overall Study|Withdrawal by Subject|1|||
156963079|NCT00113568|566616145|FG000|Overall Study|Adverse Event|97|||
156963080|NCT00113568|566616145|FG000|Overall Study|Death|1|||
156963081|NCT00113568|566616145|FG000|Overall Study|Lack of Efficacy|30|||
156963082|NCT00113568|566616145|FG000|Overall Study|Lost to Follow-up|156|||
156963083|NCT00113568|566616145|FG000|Overall Study|Protocol Violation|32|||
156963084|NCT00113568|566616145|FG000|Overall Study|Withdrawal by Subject|117|||
156963085|NCT00113568|566616145|FG000|Overall Study|Other|112|||
156963086|NCT01569438|566616151|FG000|Overall Study|Lack of Efficacy|1|||
156963087|NCT01569438|566616152|FG001|Overall Study|Lack of Efficacy|2|||
156963088|NCT01569438|566616151|FG000|Overall Study|Withdrawal by Subject|0|||
156963089|NCT01569438|566616152|FG001|Overall Study|Withdrawal by Subject|3|||
157172267|NCT01998958|567371155|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
157172268|NCT01998958|567371156|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
157172269|NCT01998958|567371157|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
157172270|NCT01998958|567371126|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172271|NCT01998958|567371127|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172272|NCT01998958|567371128|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172273|NCT01998958|567371129|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172274|NCT01998958|567371130|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172275|NCT01998958|567371131|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172276|NCT01998958|567371132|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172277|NCT01998958|567371133|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172278|NCT01998958|567371134|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172279|NCT01998958|567371135|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172280|NCT01998958|567371136|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172281|NCT01998958|567371137|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172282|NCT01998958|567371138|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172283|NCT01998958|567371139|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172284|NCT01998958|567371140|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
157172285|NCT01998958|567371141|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172286|NCT01998958|567371142|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172287|NCT01998958|567371143|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172288|NCT01998958|567371144|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
157172289|NCT01998958|567371145|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172290|NCT01998958|567371146|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172291|NCT01998958|567371147|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156963090|NCT01569438|566616151|FG000|Overall Study|Adverse Event|2|||
156963091|NCT01569438|566616152|FG001|Overall Study|Adverse Event|15|||
156963092|NCT01569438|566616151|FG000|Overall Study|Protocol Violation|2|||
156963093|NCT01569438|566616152|FG001|Overall Study|Protocol Violation|0|||
157172292|NCT01998958|567371148|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156963094|NCT01569438|566616151|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
156963095|NCT01569438|566616152|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
156963096|NCT01569438|566616151|FG000|Overall Study|Sponsor/Physician decision|1|||
156963097|NCT01569438|566616152|FG001|Overall Study|Sponsor/Physician decision|1|||
156963098|NCT01569438|566616151|FG000|Overall Study|Unable to adhere to study schedule|0|||
156963099|NCT01569438|566616152|FG001|Overall Study|Unable to adhere to study schedule|1|||
156963100|NCT00736645|566616155|FG000|Overall Study|Adverse Event|0|||
156963101|NCT00736645|566616156|FG001|Overall Study|Adverse Event|2|||
156963102|NCT00736645|566616157|FG002|Overall Study|Adverse Event|0|||
156963103|NCT00736645|566616158|FG003|Overall Study|Adverse Event|0|||
156963104|NCT01302847|566616159|FG000|Overall Study|Death|0|||
156963105|NCT01302847|566616160|FG001|Overall Study|Death|1|||
156963106|NCT01302847|566616161|FG002|Overall Study|Death|0|||
156963107|NCT01302847|566616162|FG003|Overall Study|Death|0|||
156963108|NCT01302847|566616163|FG004|Overall Study|Death|0|||
156963109|NCT01302847|566616164|FG005|Overall Study|Death|1|||
156963110|NCT01302847|566616165|FG006|Overall Study|Death|1|||
156963111|NCT01302847|566616166|FG007|Overall Study|Death|0|||
156963112|NCT01302847|566616159|FG000|Overall Study|Pregnancy|2|||
156963113|NCT01302847|566616160|FG001|Overall Study|Pregnancy|0|||
156963114|NCT01302847|566616161|FG002|Overall Study|Pregnancy|0|||
156963115|NCT01302847|566616162|FG003|Overall Study|Pregnancy|0|||
156963116|NCT01302847|566616163|FG004|Overall Study|Pregnancy|0|||
156963117|NCT01302847|566616164|FG005|Overall Study|Pregnancy|0|||
156963118|NCT01302847|566616165|FG006|Overall Study|Pregnancy|0|||
156963119|NCT01302847|566616166|FG007|Overall Study|Pregnancy|0|||
156963120|NCT01302847|566616159|FG000|Overall Study|Virologic failure|0|||
156963121|NCT01302847|566616160|FG001|Overall Study|Virologic failure|2|||
156963122|NCT01302847|566616161|FG002|Overall Study|Virologic failure|0|||
156963123|NCT01302847|566616162|FG003|Overall Study|Virologic failure|2|||
156963124|NCT01302847|566616163|FG004|Overall Study|Virologic failure|1|||
156963125|NCT01302847|566616164|FG005|Overall Study|Virologic failure|3|||
156963126|NCT01302847|566616165|FG006|Overall Study|Virologic failure|1|||
156963127|NCT01302847|566616166|FG007|Overall Study|Virologic failure|2|||
156963128|NCT01302847|566616159|FG000|Overall Study|Severe debilitation, unable to continue|0|||
156963129|NCT01302847|566616160|FG001|Overall Study|Severe debilitation, unable to continue|0|||
156963130|NCT01302847|566616161|FG002|Overall Study|Severe debilitation, unable to continue|0|||
156963131|NCT01302847|566616162|FG003|Overall Study|Severe debilitation, unable to continue|0|||
156963132|NCT01302847|566616163|FG004|Overall Study|Severe debilitation, unable to continue|0|||
156963133|NCT01302847|566616164|FG005|Overall Study|Severe debilitation, unable to continue|1|||
156963134|NCT01302847|566616165|FG006|Overall Study|Severe debilitation, unable to continue|1|||
156963135|NCT01302847|566616166|FG007|Overall Study|Severe debilitation, unable to continue|0|||
156963136|NCT01302847|566616159|FG000|Overall Study|Not able to get to clinic|1|||
156963137|NCT01302847|566616160|FG001|Overall Study|Not able to get to clinic|1|||
156963138|NCT01302847|566616161|FG002|Overall Study|Not able to get to clinic|0|||
156963139|NCT01302847|566616162|FG003|Overall Study|Not able to get to clinic|0|||
156963140|NCT01302847|566616163|FG004|Overall Study|Not able to get to clinic|0|||
156963141|NCT01302847|566616164|FG005|Overall Study|Not able to get to clinic|0|||
156963142|NCT01302847|566616165|FG006|Overall Study|Not able to get to clinic|0|||
156963143|NCT01302847|566616166|FG007|Overall Study|Not able to get to clinic|0|||
156963144|NCT01302847|566616159|FG000|Overall Study|Site closing|2|||
156963145|NCT01302847|566616160|FG001|Overall Study|Site closing|2|||
156963146|NCT01302847|566616161|FG002|Overall Study|Site closing|0|||
156963147|NCT01302847|566616162|FG003|Overall Study|Site closing|0|||
156963148|NCT01302847|566616163|FG004|Overall Study|Site closing|0|||
156963149|NCT01302847|566616164|FG005|Overall Study|Site closing|0|||
156963150|NCT01302847|566616165|FG006|Overall Study|Site closing|0|||
156963151|NCT01302847|566616166|FG007|Overall Study|Site closing|0|||
156963152|NCT01302847|566616159|FG000|Overall Study|Withdrawal by Subject|1|||
156963153|NCT01302847|566616160|FG001|Overall Study|Withdrawal by Subject|0|||
156963154|NCT01302847|566616161|FG002|Overall Study|Withdrawal by Subject|0|||
156963155|NCT01302847|566616162|FG003|Overall Study|Withdrawal by Subject|0|||
156963156|NCT01302847|566616163|FG004|Overall Study|Withdrawal by Subject|1|||
156963157|NCT01302847|566616164|FG005|Overall Study|Withdrawal by Subject|0|||
156963158|NCT01302847|566616165|FG006|Overall Study|Withdrawal by Subject|0|||
156963159|NCT01302847|566616166|FG007|Overall Study|Withdrawal by Subject|1|||
156963160|NCT01302847|566616159|FG000|Overall Study|Not willing to adhere to requirements|5|||
156963161|NCT01302847|566616160|FG001|Overall Study|Not willing to adhere to requirements|0|||
156963162|NCT01302847|566616161|FG002|Overall Study|Not willing to adhere to requirements|1|||
156963163|NCT01302847|566616162|FG003|Overall Study|Not willing to adhere to requirements|0|||
157172293|NCT01998958|567371149|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172294|NCT01998958|567371150|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156963164|NCT01302847|566616163|FG004|Overall Study|Not willing to adhere to requirements|0|||
156963165|NCT01302847|566616164|FG005|Overall Study|Not willing to adhere to requirements|0|||
157172295|NCT01998958|567371151|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
156963166|NCT01302847|566616165|FG006|Overall Study|Not willing to adhere to requirements|0|||
156963167|NCT01302847|566616166|FG007|Overall Study|Not willing to adhere to requirements|2|||
156963168|NCT01302847|566616159|FG000|Overall Study|Site unable to contact participant|2|||
157039310|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
157039311|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
157039312|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
157039313|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Moved|62|||
157039314|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Moved|58|||
157039315|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Moved|0|||
157039316|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Moved|0|||
157039317|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Moved|0|||
157039318|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Travel|10|||
157039319|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Travel|7|||
157039320|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Travel|0|||
157172296|NCT01998958|567371152|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172297|NCT01998958|567371153|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172298|NCT01998958|567371154|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172299|NCT01998958|567371155|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172300|NCT01998958|567371156|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172301|NCT01998958|567371157|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
157172302|NCT01998958|567371126|FG000|Open Label Phase (Optional)|Adverse Event|0|||
157172303|NCT01998958|567371127|FG001|Open Label Phase (Optional)|Adverse Event|0|||
157172304|NCT01998958|567371128|FG002|Open Label Phase (Optional)|Adverse Event|0|||
157172305|NCT01998958|567371129|FG003|Open Label Phase (Optional)|Adverse Event|0|||
157172306|NCT01998958|567371130|FG004|Open Label Phase (Optional)|Adverse Event|0|||
157172307|NCT01998958|567371131|FG005|Open Label Phase (Optional)|Adverse Event|0|||
157172308|NCT01998958|567371132|FG006|Open Label Phase (Optional)|Adverse Event|0|||
157172309|NCT01998958|567371133|FG007|Open Label Phase (Optional)|Adverse Event|0|||
157172310|NCT01998958|567371134|FG008|Open Label Phase (Optional)|Adverse Event|0|||
157172311|NCT01998958|567371135|FG009|Open Label Phase (Optional)|Adverse Event|0|||
157172312|NCT01998958|567371136|FG010|Open Label Phase (Optional)|Adverse Event|0|||
157172313|NCT01998958|567371137|FG011|Open Label Phase (Optional)|Adverse Event|0|||
157172314|NCT01998958|567371138|FG012|Open Label Phase (Optional)|Adverse Event|0|||
157172315|NCT01998958|567371139|FG013|Open Label Phase (Optional)|Adverse Event|0|||
157172316|NCT01998958|567371140|FG014|Open Label Phase (Optional)|Adverse Event|0|||
157172317|NCT01998958|567371141|FG015|Open Label Phase (Optional)|Adverse Event|0|||
157172318|NCT01998958|567371142|FG016|Open Label Phase (Optional)|Adverse Event|0|||
157172319|NCT01998958|567371143|FG017|Open Label Phase (Optional)|Adverse Event|0|||
157172320|NCT01998958|567371144|FG018|Open Label Phase (Optional)|Adverse Event|0|||
157172321|NCT01998958|567371145|FG019|Open Label Phase (Optional)|Adverse Event|0|||
157172322|NCT01998958|567371146|FG020|Open Label Phase (Optional)|Adverse Event|0|||
157172323|NCT01998958|567371147|FG021|Open Label Phase (Optional)|Adverse Event|0|||
157172324|NCT01998958|567371148|FG022|Open Label Phase (Optional)|Adverse Event|0|||
157172325|NCT01998958|567371149|FG023|Open Label Phase (Optional)|Adverse Event|1|||
157172326|NCT01998958|567371150|FG024|Open Label Phase (Optional)|Adverse Event|0|||
157172327|NCT01998958|567371151|FG025|Open Label Phase (Optional)|Adverse Event|0|||
157172328|NCT01998958|567371152|FG026|Open Label Phase (Optional)|Adverse Event|0|||
157172329|NCT01998958|567371153|FG027|Open Label Phase (Optional)|Adverse Event|0|||
157172330|NCT01998958|567371154|FG028|Open Label Phase (Optional)|Adverse Event|0|||
157172331|NCT01998958|567371155|FG029|Open Label Phase (Optional)|Adverse Event|0|||
157172332|NCT01998958|567371156|FG030|Open Label Phase (Optional)|Adverse Event|0|||
157172333|NCT01998958|567371157|FG031|Open Label Phase (Optional)|Adverse Event|0|||
157172334|NCT01998958|567371126|FG000|Open Label Phase (Optional)|Other|0|||
157172335|NCT01998958|567371127|FG001|Open Label Phase (Optional)|Other|0|||
157172336|NCT01998958|567371128|FG002|Open Label Phase (Optional)|Other|0|||
157172337|NCT01998958|567371129|FG003|Open Label Phase (Optional)|Other|0|||
157172338|NCT01998958|567371130|FG004|Open Label Phase (Optional)|Other|0|||
157039321|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Travel|0|||
157039322|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Travel|0|||
157039323|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Site Closed|0|||
157039324|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Site Closed|2|||
157039325|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Site Closed|0|||
157039326|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Site Closed|0|||
157039327|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Site Closed|0|||
157039328|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
157172339|NCT01998958|567371131|FG005|Open Label Phase (Optional)|Other|0|||
157172340|NCT01998958|567371132|FG006|Open Label Phase (Optional)|Other|0|||
157039329|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
157039330|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
157172341|NCT01998958|567371133|FG007|Open Label Phase (Optional)|Other|0|||
157172342|NCT01998958|567371134|FG008|Open Label Phase (Optional)|Other|0|||
157172343|NCT01998958|567371135|FG009|Open Label Phase (Optional)|Other|0|||
157172344|NCT01998958|567371136|FG010|Open Label Phase (Optional)|Other|0|||
157172345|NCT01998958|567371137|FG011|Open Label Phase (Optional)|Other|0|||
157172346|NCT01998958|567371138|FG012|Open Label Phase (Optional)|Other|0|||
157172347|NCT01998958|567371139|FG013|Open Label Phase (Optional)|Other|0|||
157039331|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
157172348|NCT01998958|567371140|FG014|Open Label Phase (Optional)|Other|0|||
157172349|NCT01998958|567371141|FG015|Open Label Phase (Optional)|Other|0|||
157039332|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
157039333|NCT00092534|566899620|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
157039334|NCT00092534|566899621|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
157039335|NCT00092534|566899622|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
157039336|NCT00092534|566899623|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
157039337|NCT00092534|566899624|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
157039338|NCT00092534|566899620|FG000|Base Study EXT|Lost to Follow-up|0|||
157039339|NCT00092534|566899621|FG001|Base Study EXT|Lost to Follow-up|0|||
157039340|NCT00092534|566899622|FG002|Base Study EXT|Lost to Follow-up|41|||
157039341|NCT00092534|566899623|FG003|Base Study EXT|Lost to Follow-up|0|||
157039342|NCT00092534|566899624|FG004|Base Study EXT|Lost to Follow-up|0|||
157039343|NCT00092534|566899620|FG000|Base Study EXT|Physician Decision|0|||
157039344|NCT00092534|566899621|FG001|Base Study EXT|Physician Decision|0|||
157039345|NCT00092534|566899622|FG002|Base Study EXT|Physician Decision|1|||
157039346|NCT00092534|566899623|FG003|Base Study EXT|Physician Decision|0|||
157039347|NCT00092534|566899624|FG004|Base Study EXT|Physician Decision|0|||
157039348|NCT00092534|566899620|FG000|Base Study EXT|Pregnancy|0|||
157039349|NCT00092534|566899621|FG001|Base Study EXT|Pregnancy|0|||
157039350|NCT00092534|566899622|FG002|Base Study EXT|Pregnancy|12|||
157039351|NCT00092534|566899623|FG003|Base Study EXT|Pregnancy|0|||
157039352|NCT00092534|566899624|FG004|Base Study EXT|Pregnancy|0|||
157039353|NCT00092534|566899620|FG000|Base Study EXT|Withdrawal by Subject|0|||
157039354|NCT00092534|566899621|FG001|Base Study EXT|Withdrawal by Subject|0|||
157039355|NCT00092534|566899622|FG002|Base Study EXT|Withdrawal by Subject|18|||
157039356|NCT00092534|566899623|FG003|Base Study EXT|Withdrawal by Subject|0|||
157039357|NCT00092534|566899624|FG004|Base Study EXT|Withdrawal by Subject|0|||
157039358|NCT00092534|566899620|FG000|Base Study EXT|Participant moved|0|||
157039359|NCT00092534|566899621|FG001|Base Study EXT|Participant moved|0|||
157039360|NCT00092534|566899622|FG002|Base Study EXT|Participant moved|6|||
157039361|NCT00092534|566899623|FG003|Base Study EXT|Participant moved|0|||
157039362|NCT00092534|566899624|FG004|Base Study EXT|Participant moved|0|||
157039363|NCT00092534|566899620|FG000|Base Study EXT|Travel|0|||
157039364|NCT00092534|566899621|FG001|Base Study EXT|Travel|0|||
157039365|NCT00092534|566899622|FG002|Base Study EXT|Travel|2|||
157039366|NCT00092534|566899623|FG003|Base Study EXT|Travel|0|||
157039367|NCT00092534|566899624|FG004|Base Study EXT|Travel|0|||
157039368|NCT00092534|566899620|FG000|Base Study EXT|Site closed|0|||
157039369|NCT00092534|566899621|FG001|Base Study EXT|Site closed|0|||
157039370|NCT00092534|566899622|FG002|Base Study EXT|Site closed|21|||
157039371|NCT00092534|566899623|FG003|Base Study EXT|Site closed|0|||
157039372|NCT00092534|566899624|FG004|Base Study EXT|Site closed|0|||
157039373|NCT00092534|566899620|FG000|Base Study EXT|Study ended|0|||
157039374|NCT00092534|566899621|FG001|Base Study EXT|Study ended|0|||
157039375|NCT00092534|566899622|FG002|Base Study EXT|Study ended|29|||
157039376|NCT00092534|566899623|FG003|Base Study EXT|Study ended|0|||
157039377|NCT00092534|566899624|FG004|Base Study EXT|Study ended|0|||
157039378|NCT00092534|566899620|FG000|Base Study EXT|Protocol Violation|0|||
157039379|NCT00092534|566899621|FG001|Base Study EXT|Protocol Violation|0|||
157039380|NCT00092534|566899622|FG002|Base Study EXT|Protocol Violation|15|||
157039381|NCT00092534|566899623|FG003|Base Study EXT|Protocol Violation|0|||
157039382|NCT00092534|566899624|FG004|Base Study EXT|Protocol Violation|0|||
157039383|NCT00092534|566899620|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
157039384|NCT00092534|566899621|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
157039385|NCT00092534|566899622|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
157039386|NCT00092534|566899623|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
157039387|NCT00092534|566899624|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
157039388|NCT03083366|566899625|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
157039389|NCT03083366|566899626|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
157039390|NCT03083366|566899625|FG000|Enrollment Period|Lack of Efficacy|1|||
157039391|NCT03083366|566899626|FG001|Enrollment Period|Lack of Efficacy|0|||
157039392|NCT02036970|566899632|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
157039393|NCT02036970|566899633|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
157039394|NCT02036970|566899634|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
157039395|NCT02036970|566899635|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
157172350|NCT01998958|567371142|FG016|Open Label Phase (Optional)|Other|0|||
157039396|NCT02036970|566899636|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
157039397|NCT02036970|566899637|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
157039398|NCT02036970|566899638|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
157039399|NCT02036970|566899639|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
157039400|NCT02036970|566899640|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
157039401|NCT02036970|566899641|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
157039402|NCT02036970|566899632|FG000|Part 1: Day 1 Through Week 16|Death|0|||
157039403|NCT02036970|566899633|FG001|Part 1: Day 1 Through Week 16|Death|0|||
157039404|NCT02036970|566899634|FG002|Part 1: Day 1 Through Week 16|Death|0|||
157039405|NCT02036970|566899635|FG003|Part 1: Day 1 Through Week 16|Death|0|||
157039406|NCT02036970|566899636|FG004|Part 1: Day 1 Through Week 16|Death|0|||
157039407|NCT02036970|566899637|FG005|Part 1: Day 1 Through Week 16|Death|0|||
157172351|NCT01998958|567371143|FG017|Open Label Phase (Optional)|Other|0|||
157172352|NCT01998958|567371144|FG018|Open Label Phase (Optional)|Other|0|||
157172353|NCT01998958|567371145|FG019|Open Label Phase (Optional)|Other|0|||
157172354|NCT01998958|567371146|FG020|Open Label Phase (Optional)|Other|0|||
157172355|NCT01998958|567371147|FG021|Open Label Phase (Optional)|Other|0|||
156963169|NCT01302847|566616160|FG001|Overall Study|Site unable to contact participant|1|||
156963170|NCT01302847|566616161|FG002|Overall Study|Site unable to contact participant|0|||
156963171|NCT01302847|566616162|FG003|Overall Study|Site unable to contact participant|0|||
156963172|NCT01302847|566616163|FG004|Overall Study|Site unable to contact participant|0|||
156963173|NCT01302847|566616164|FG005|Overall Study|Site unable to contact participant|0|||
156963174|NCT01302847|566616165|FG006|Overall Study|Site unable to contact participant|2|||
156963175|NCT01302847|566616166|FG007|Overall Study|Site unable to contact participant|0|||
156963176|NCT04302350|566616168|FG000|Overall Study|Physician Decision|1|||
156963177|NCT04302350|566616169|FG001|Overall Study|Physician Decision|1|||
156963178|NCT04302350|566616170|FG002|Overall Study|Physician Decision|2|||
156963179|NCT04302350|566616168|FG000|Overall Study|Lack of Efficacy|1|||
156963180|NCT04302350|566616169|FG001|Overall Study|Lack of Efficacy|1|||
156963181|NCT04302350|566616170|FG002|Overall Study|Lack of Efficacy|4|||
156963182|NCT04302350|566616168|FG000|Overall Study|Adverse Event|0|||
156963183|NCT04302350|566616169|FG001|Overall Study|Adverse Event|1|||
156963184|NCT04302350|566616170|FG002|Overall Study|Adverse Event|2|||
156963185|NCT02137369|566616173|FG000|Overall Study|Withdrawal by Subject|3|||
156963186|NCT02137369|566616174|FG001|Overall Study|Withdrawal by Subject|2|||
156963187|NCT02137369|566616173|FG000|Overall Study|Adverse Event|2|||
156963188|NCT02137369|566616174|FG001|Overall Study|Adverse Event|0|||
156963189|NCT02137369|566616173|FG000|Overall Study|Lost to Follow-up|1|||
156963190|NCT02137369|566616174|FG001|Overall Study|Lost to Follow-up|0|||
156963191|NCT02137369|566616173|FG000|Overall Study|Moved away|2|||
156963192|NCT02137369|566616174|FG001|Overall Study|Moved away|0|||
156963193|NCT03519854|566616175|FG000|Overall Study|Technical Error|0|||
156963194|NCT03519854|566616176|FG001|Overall Study|Technical Error|0|||
156963195|NCT03519854|566616177|FG002|Overall Study|Technical Error|1|||
156963196|NCT03519854|566616178|FG003|Overall Study|Technical Error|0|||
156963197|NCT03519854|566616179|FG004|Overall Study|Technical Error|0|||
156963198|NCT03519854|566616180|FG005|Overall Study|Technical Error|0|||
156963199|NCT03519854|566616181|FG006|Overall Study|Technical Error|0|||
156963200|NCT03519854|566616182|FG007|Overall Study|Technical Error|0|||
156963201|NCT03519854|566616183|FG008|Overall Study|Technical Error|0|||
156963202|NCT03519854|566616184|FG009|Overall Study|Technical Error|0|||
156963203|NCT03519854|566616185|FG010|Overall Study|Technical Error|0|||
156963204|NCT03519854|566616186|FG011|Overall Study|Technical Error|0|||
156963205|NCT03519854|566616187|FG012|Overall Study|Technical Error|0|||
156963206|NCT03519854|566616188|FG013|Overall Study|Technical Error|0|||
156963207|NCT03519854|566616189|FG014|Overall Study|Technical Error|0|||
156963208|NCT03519854|566616190|FG015|Overall Study|Technical Error|0|||
156963209|NCT03519854|566616191|FG016|Overall Study|Technical Error|0|||
156963210|NCT03519854|566616192|FG017|Overall Study|Technical Error|0|||
156963211|NCT00707031|566616193|FG000|Overall Study|Adverse Event|45|||
156963212|NCT00707031|566616194|FG001|Overall Study|Adverse Event|45|||
156963213|NCT00707031|566616193|FG000|Overall Study|Lack of Efficacy|19|||
156963214|NCT00707031|566616194|FG001|Overall Study|Lack of Efficacy|6|||
156963215|NCT00707031|566616193|FG000|Overall Study|Lost to Follow-up|2|||
156963216|NCT00707031|566616194|FG001|Overall Study|Lost to Follow-up|1|||
156963217|NCT00707031|566616193|FG000|Overall Study|Protocol Violation|1|||
156963218|NCT00707031|566616194|FG001|Overall Study|Protocol Violation|0|||
156963219|NCT00707031|566616193|FG000|Overall Study|Withdrawal by Subject|7|||
156963220|NCT00707031|566616194|FG001|Overall Study|Withdrawal by Subject|8|||
156963221|NCT00707031|566616193|FG000|Overall Study|Poor Compliance to Protocol|7|||
156963222|NCT00707031|566616194|FG001|Overall Study|Poor Compliance to Protocol|13|||
156963223|NCT00707031|566616193|FG000|Overall Study|Familial or Personal Reasons|12|||
156963224|NCT00707031|566616194|FG001|Overall Study|Familial or Personal Reasons|15|||
156963225|NCT00707031|566616193|FG000|Overall Study|Serious Noncompliance|2|||
156963226|NCT00707031|566616194|FG001|Overall Study|Serious Noncompliance|3|||
156963227|NCT00707031|566616193|FG000|Overall Study|Sponsor Decision|9|||
156963228|NCT00707031|566616194|FG001|Overall Study|Sponsor Decision|8|||
156963229|NCT02747238|566616195|FG000|Overall Study|Lack of Efficacy|0|||
156963230|NCT02747238|566616196|FG001|Overall Study|Lack of Efficacy|1|||
156963231|NCT02747238|566616195|FG000|Overall Study|Data lost|3|||
156963232|NCT02747238|566616196|FG001|Overall Study|Data lost|5|||
156963233|NCT01951625|566616201|FG000|Treatment Period|Protocol Violation|2|||
156963234|NCT01951625|566616202|FG001|Treatment Period|Protocol Violation|0|||
156963235|NCT01951625|566616203|FG002|Treatment Period|Protocol Violation|1|||
156963236|NCT01951625|566616204|FG003|Treatment Period|Protocol Violation|3|||
156963237|NCT01951625|566616205|FG004|Treatment Period|Protocol Violation|2|||
156963238|NCT01951625|566616201|FG000|Treatment Period|Physician Decision|0|||
156963239|NCT01951625|566616202|FG001|Treatment Period|Physician Decision|0|||
156963240|NCT01951625|566616203|FG002|Treatment Period|Physician Decision|0|||
156963241|NCT01951625|566616204|FG003|Treatment Period|Physician Decision|0|||
157172356|NCT01998958|567371148|FG022|Open Label Phase (Optional)|Other|5|||
157039408|NCT02036970|566899638|FG006|Part 1: Day 1 Through Week 16|Death|0|||
157039409|NCT02036970|566899639|FG007|Part 1: Day 1 Through Week 16|Death|0|||
157039410|NCT02036970|566899640|FG008|Part 1: Day 1 Through Week 16|Death|1|||
157039411|NCT02036970|566899641|FG009|Part 1: Day 1 Through Week 16|Death|0|||
157039412|NCT02036970|566899632|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
157039413|NCT02036970|566899633|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039414|NCT02036970|566899634|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
157039415|NCT02036970|566899635|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039416|NCT02036970|566899636|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039417|NCT02036970|566899637|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039418|NCT02036970|566899638|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039419|NCT02036970|566899639|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039420|NCT02036970|566899640|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
157039421|NCT02036970|566899641|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
157039422|NCT02036970|566899632|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039423|NCT02036970|566899633|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039424|NCT02036970|566899634|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039425|NCT02036970|566899635|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039426|NCT02036970|566899636|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
157039427|NCT02036970|566899637|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039428|NCT02036970|566899638|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039429|NCT02036970|566899639|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
157039430|NCT02036970|566899640|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
157039431|NCT02036970|566899641|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
157039432|NCT02036970|566899632|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039433|NCT02036970|566899633|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039434|NCT02036970|566899634|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039435|NCT02036970|566899635|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
157039436|NCT02036970|566899636|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039437|NCT02036970|566899637|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039438|NCT02036970|566899638|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039439|NCT02036970|566899639|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039440|NCT02036970|566899640|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039441|NCT02036970|566899641|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
157039442|NCT02036970|566899632|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
157039443|NCT02036970|566899633|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
157039444|NCT02036970|566899634|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
157039445|NCT02036970|566899635|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
157039446|NCT02036970|566899636|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
157039447|NCT02036970|566899637|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
157172357|NCT01998958|567371149|FG023|Open Label Phase (Optional)|Other|1|||
157172358|NCT01998958|567371150|FG024|Open Label Phase (Optional)|Other|0|||
156963242|NCT01951625|566616205|FG004|Treatment Period|Physician Decision|1|||
156963243|NCT01951625|566616201|FG000|Treatment Period|Protocol driven decision point|0|||
156963244|NCT01951625|566616202|FG001|Treatment Period|Protocol driven decision point|5|||
156963245|NCT01951625|566616203|FG002|Treatment Period|Protocol driven decision point|0|||
156963246|NCT01951625|566616204|FG003|Treatment Period|Protocol driven decision point|2|||
156963247|NCT01951625|566616205|FG004|Treatment Period|Protocol driven decision point|1|||
156963248|NCT01951625|566616201|FG000|Treatment Period|Non compliance with study drug|1|||
156963249|NCT01951625|566616202|FG001|Treatment Period|Non compliance with study drug|2|||
156963250|NCT01951625|566616203|FG002|Treatment Period|Non compliance with study drug|2|||
156963251|NCT01951625|566616204|FG003|Treatment Period|Non compliance with study drug|0|||
156963252|NCT01951625|566616205|FG004|Treatment Period|Non compliance with study drug|0|||
156963253|NCT01951625|566616201|FG000|Treatment Period|Death|3|||
156963254|NCT01951625|566616202|FG001|Treatment Period|Death|2|||
156963255|NCT01951625|566616203|FG002|Treatment Period|Death|2|||
156963256|NCT01951625|566616204|FG003|Treatment Period|Death|1|||
156963257|NCT01951625|566616205|FG004|Treatment Period|Death|2|||
156963258|NCT01951625|566616201|FG000|Treatment Period|Adverse Event|7|||
156963259|NCT01951625|566616202|FG001|Treatment Period|Adverse Event|10|||
156963260|NCT01951625|566616203|FG002|Treatment Period|Adverse Event|9|||
156963261|NCT01951625|566616204|FG003|Treatment Period|Adverse Event|8|||
156963262|NCT01951625|566616205|FG004|Treatment Period|Adverse Event|8|||
156963263|NCT01951625|566616201|FG000|Treatment Period|Withdrawal by Subject|5|||
156963264|NCT01951625|566616202|FG001|Treatment Period|Withdrawal by Subject|2|||
156963265|NCT01951625|566616203|FG002|Treatment Period|Withdrawal by Subject|1|||
156963266|NCT01951625|566616204|FG003|Treatment Period|Withdrawal by Subject|7|||
156963267|NCT01951625|566616205|FG004|Treatment Period|Withdrawal by Subject|3|||
156963268|NCT01951625|566616201|FG000|Treatment Period|Lost to Follow-up|1|||
157039448|NCT02036970|566899638|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
157172359|NCT01998958|567371151|FG025|Open Label Phase (Optional)|Other|0|||
156963269|NCT01951625|566616202|FG001|Treatment Period|Lost to Follow-up|0|||
156963270|NCT01951625|566616203|FG002|Treatment Period|Lost to Follow-up|0|||
156963271|NCT01951625|566616204|FG003|Treatment Period|Lost to Follow-up|1|||
156963272|NCT01951625|566616205|FG004|Treatment Period|Lost to Follow-up|0|||
156963273|NCT01951625|566616201|FG000|Follow Up Period|Non-compliance with study drug|1|||
156963274|NCT01951625|566616202|FG001|Follow Up Period|Non-compliance with study drug|0|||
156963275|NCT01951625|566616203|FG002|Follow Up Period|Non-compliance with study drug|0|||
156963276|NCT01951625|566616204|FG003|Follow Up Period|Non-compliance with study drug|0|||
156963277|NCT01951625|566616205|FG004|Follow Up Period|Non-compliance with study drug|0|||
156963278|NCT01951625|566616201|FG000|Follow Up Period|Death|1|||
156963279|NCT01951625|566616202|FG001|Follow Up Period|Death|3|||
156963280|NCT01951625|566616203|FG002|Follow Up Period|Death|2|||
156963281|NCT01951625|566616204|FG003|Follow Up Period|Death|2|||
156963282|NCT01951625|566616205|FG004|Follow Up Period|Death|1|||
156963283|NCT01951625|566616201|FG000|Follow Up Period|Logistical difficulties|1|||
156963284|NCT01951625|566616202|FG001|Follow Up Period|Logistical difficulties|2|||
156963285|NCT01951625|566616203|FG002|Follow Up Period|Logistical difficulties|0|||
156963286|NCT01951625|566616204|FG003|Follow Up Period|Logistical difficulties|0|||
156963287|NCT01951625|566616205|FG004|Follow Up Period|Logistical difficulties|0|||
156963288|NCT01951625|566616201|FG000|Follow Up Period|Adverse Event|0|||
156963289|NCT01951625|566616202|FG001|Follow Up Period|Adverse Event|3|||
156963290|NCT01951625|566616203|FG002|Follow Up Period|Adverse Event|2|||
156963291|NCT01951625|566616204|FG003|Follow Up Period|Adverse Event|3|||
156963292|NCT01951625|566616205|FG004|Follow Up Period|Adverse Event|5|||
156963293|NCT01951625|566616201|FG000|Follow Up Period|Withdrawal by Subject|4|||
156963294|NCT01951625|566616202|FG001|Follow Up Period|Withdrawal by Subject|1|||
156963295|NCT01951625|566616203|FG002|Follow Up Period|Withdrawal by Subject|0|||
156963296|NCT01951625|566616204|FG003|Follow Up Period|Withdrawal by Subject|5|||
156963297|NCT01951625|566616205|FG004|Follow Up Period|Withdrawal by Subject|3|||
156963298|NCT01951625|566616201|FG000|Follow Up Period|Lost to Follow-up|1|||
156963299|NCT01951625|566616202|FG001|Follow Up Period|Lost to Follow-up|0|||
156963300|NCT01951625|566616203|FG002|Follow Up Period|Lost to Follow-up|0|||
156963301|NCT01951625|566616204|FG003|Follow Up Period|Lost to Follow-up|1|||
156963302|NCT01951625|566616205|FG004|Follow Up Period|Lost to Follow-up|1|||
156963303|NCT04128293|566618452|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156963304|NCT04128293|566618453|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156963305|NCT04128293|566618454|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156963306|NCT04128293|566618455|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
156963307|NCT02035332|566618456|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
156963308|NCT02030015|566618459|FG000|Overall Study|Withdrawal by Subject|3|||
156963309|NCT02030015|566618459|FG000|Overall Study|Death|13|||
156963310|NCT03014674|566618461|FG000|Overall Study|Withdrawal by Subject|1|||
156963311|NCT03014674|566618462|FG001|Overall Study|Withdrawal by Subject|0|||
156963312|NCT03014674|566618463|FG002|Overall Study|Withdrawal by Subject|0|||
156963313|NCT00514943|566618464|FG000|Stage 1|Progressive disease|4|||
156963314|NCT00514943|566618465|FG001|Stage 1|Progressive disease|8|||
156963315|NCT00514943|566618464|FG000|Stage 1|Other Adverse Event|16|||
156963316|NCT00514943|566618465|FG001|Stage 1|Other Adverse Event|6|||
156963317|NCT00514943|566618464|FG000|Stage 1|Not treated|1|||
156963318|NCT00514943|566618465|FG001|Stage 1|Not treated|2|||
156963319|NCT00514943|566618464|FG000|Stage 1|Patient refused to continue study meds|8|||
156963320|NCT00514943|566618465|FG001|Stage 1|Patient refused to continue study meds|3|||
156963321|NCT00514943|566618464|FG000|Stage 1|Other than stated above|1|||
156963322|NCT00514943|566618465|FG001|Stage 1|Other than stated above|7|||
156963323|NCT00514943|566618464|FG000|Stage 2|Progressive disease|27|||
156963324|NCT00514943|566618465|FG001|Stage 2|Progressive disease|24|||
156963325|NCT00514943|566618464|FG000|Stage 2|Other Adverse Event|3|||
156963326|NCT00514943|566618465|FG001|Stage 2|Other Adverse Event|10|||
156963327|NCT00514943|566618464|FG000|Stage 2|Patient refused to continue study meds|2|||
156963328|NCT00514943|566618465|FG001|Stage 2|Patient refused to continue study meds|0|||
156963329|NCT00514943|566618464|FG000|Stage 2|Other than stated above|0|||
156963330|NCT00514943|566618465|FG001|Stage 2|Other than stated above|2|||
156963331|NCT00833560|566618471|FG000|Overall Study|Toxicity|13|||
156963332|NCT00833560|566618471|FG000|Overall Study|Adverse Event|11|||
156963333|NCT00833560|566618471|FG000|Overall Study|Protocol Violation|6|||
156963334|NCT00833560|566618471|FG000|Overall Study|Lack of Efficacy|4|||
156963335|NCT00833560|566618471|FG000|Overall Study|Death|2|||
156963336|NCT00833560|566618471|FG000|Overall Study|Pregression of other disease|1|||
156963337|NCT00833560|566618471|FG000|Overall Study|Other|5|||
156963338|NCT03382782|566618474|FG000|Cohort 1|Withdrawal by Subject|11|||
156963339|NCT03382782|566618475|FG001|Cohort 1|Withdrawal by Subject|5|||
156963340|NCT03382782|566618476|FG002|Cohort 1|Withdrawal by Subject|0|||
156963341|NCT03382782|566618474|FG000|Cohort 2|Withdrawal by Subject|1|||
156963342|NCT03382782|566618475|FG001|Cohort 2|Withdrawal by Subject|1|||
156963343|NCT03382782|566618476|FG002|Cohort 2|Withdrawal by Subject|0|||
156963344|NCT03382782|566618474|FG000|Cohort 3|Withdrawal by Subject|1|||
156963345|NCT03382782|566618475|FG001|Cohort 3|Withdrawal by Subject|2|||
156963346|NCT03382782|566618476|FG002|Cohort 3|Withdrawal by Subject|0|||
156963347|NCT02690974|566618481|FG000|Overall Study|Adverse Event|16|||
156963348|NCT02690974|566618481|FG000|Overall Study|Death|9|||
157039449|NCT02036970|566899639|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
157039450|NCT02036970|566899640|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
157039451|NCT02036970|566899641|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
157039452|NCT02036970|566899632|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039453|NCT02036970|566899633|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039454|NCT02036970|566899634|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039455|NCT02036970|566899635|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039456|NCT02036970|566899636|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039457|NCT02036970|566899637|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039458|NCT02036970|566899638|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039459|NCT02036970|566899639|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
157039460|NCT02036970|566899640|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039461|NCT02036970|566899641|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
157039462|NCT02036970|566899632|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039463|NCT02036970|566899633|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
157039464|NCT02036970|566899634|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
157039465|NCT02036970|566899635|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039466|NCT02036970|566899636|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039467|NCT02036970|566899637|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039468|NCT02036970|566899638|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039469|NCT02036970|566899639|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039470|NCT02036970|566899640|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
157039471|NCT02036970|566899641|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
157039472|NCT02036970|566899632|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039473|NCT02036970|566899633|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
157039474|NCT02036970|566899634|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
157039475|NCT02036970|566899635|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
157039476|NCT02036970|566899636|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039477|NCT02036970|566899637|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039478|NCT02036970|566899638|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039479|NCT02036970|566899639|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039480|NCT02036970|566899640|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
157039481|NCT02036970|566899641|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
157039482|NCT02702843|566899642|FG000|Overall Study|Insufficient data to analyze|15|||
157039483|NCT02702843|566899643|FG001|Overall Study|Insufficient data to analyze|23|||
157039484|NCT05802173|566899644|FG000|Overall Study|Withdrawal by Subject|2|||
157039485|NCT05802173|566899645|FG001|Overall Study|Withdrawal by Subject|0|||
157039486|NCT05802173|566899646|FG002|Overall Study|Withdrawal by Subject|0|||
157039487|NCT05802173|566899644|FG000|Overall Study|Protocol Violation|1|||
157039488|NCT05802173|566899645|FG001|Overall Study|Protocol Violation|0|||
157039489|NCT05802173|566899646|FG002|Overall Study|Protocol Violation|0|||
157039490|NCT05802173|566899644|FG000|Overall Study|Lost to Follow-up|0|||
157039491|NCT05802173|566899645|FG001|Overall Study|Lost to Follow-up|6|||
157039492|NCT05802173|566899646|FG002|Overall Study|Lost to Follow-up|4|||
157039493|NCT05802173|566899644|FG000|Overall Study|non-compliance|0|||
157039494|NCT05802173|566899645|FG001|Overall Study|non-compliance|1|||
157039495|NCT05802173|566899646|FG002|Overall Study|non-compliance|0|||
157039496|NCT03752684|566899648|FG000|Overall Study|Lost to Follow-up|4|||
157039497|NCT00360269|566899649|FG000|Overall Study|Lost to Follow-up|7|||
157039498|NCT00360269|566899650|FG001|Overall Study|Lost to Follow-up|9|||
157039499|NCT00360269|566899649|FG000|Overall Study|Physician Decision|1|||
157039500|NCT00360269|566899650|FG001|Overall Study|Physician Decision|2|||
157039501|NCT00360269|566899649|FG000|Overall Study|Adverse Event|1|||
157039502|NCT00360269|566899650|FG001|Overall Study|Adverse Event|0|||
157039503|NCT00360269|566899649|FG000|Overall Study|Withdrawal by Subject|1|||
157039504|NCT00360269|566899650|FG001|Overall Study|Withdrawal by Subject|1|||
157039505|NCT00048932|566899651|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
157039506|NCT00048932|566899652|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
157039507|NCT00048932|566899653|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
157039508|NCT00048932|566899651|FG000|Double Blind Period (DB)|Adverse Event|51|||
157039509|NCT00048932|566899652|FG001|Double Blind Period (DB)|Adverse Event|19|||
157039510|NCT00048932|566899653|FG002|Double Blind Period (DB)|Adverse Event|0|||
157039511|NCT00048932|566899651|FG000|Double Blind Period (DB)|Death|5|||
157039512|NCT00048932|566899652|FG001|Double Blind Period (DB)|Death|3|||
157039513|NCT00048932|566899653|FG002|Double Blind Period (DB)|Death|0|||
157039514|NCT00048932|566899651|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
157039515|NCT00048932|566899652|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
157039516|NCT00048932|566899653|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
157039517|NCT00048932|566899651|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
157039518|NCT00048932|566899652|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
157039519|NCT00048932|566899653|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
157039520|NCT00048932|566899651|FG000|Double Blind Period (DB)|Relocation|1|||
157039521|NCT00048932|566899652|FG001|Double Blind Period (DB)|Relocation|0|||
157039522|NCT00048932|566899653|FG002|Double Blind Period (DB)|Relocation|0|||
157172360|NCT01998958|567371152|FG026|Open Label Phase (Optional)|Other|0|||
157172361|NCT01998958|567371153|FG027|Open Label Phase (Optional)|Other|0|||
157172362|NCT01998958|567371154|FG028|Open Label Phase (Optional)|Other|0|||
156963349|NCT02690974|566618481|FG000|Overall Study|Subject/guardian decision|4|||
156963350|NCT02690974|566618481|FG000|Overall Study|Lost to Follow-up|3|||
156963351|NCT02690974|566618481|FG000|Overall Study|Withdrawal of Informed Consent|3|||
156963352|NCT02690974|566618481|FG000|Overall Study|Physician Decision|2|||
156963353|NCT02690974|566618481|FG000|Overall Study|Non-compliance with study treatment|1|||
156963354|NCT02690974|566618481|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156963355|NCT02690974|566618481|FG000|Overall Study|Protocol Deviation|1|||
156963356|NCT02623322|566618482|FG000|Overall Study|Lost to Follow-up|2|||
156963357|NCT02623322|566618483|FG001|Overall Study|Lost to Follow-up|1|||
156963358|NCT02623322|566618484|FG002|Overall Study|Lost to Follow-up|0|||
156963359|NCT01644734|566618485|FG000|Overall Study|Adverse Event|4|||
156963360|NCT01644734|566618485|FG000|Overall Study|Lost to Follow-up|17|||
156963361|NCT01644734|566618485|FG000|Overall Study|Reasons other than stated above|7|||
156963362|NCT01644734|566618485|FG000|Overall Study|Missing documentation|238|||
156963363|NCT01692782|566618486|FG000|Overall Study|Adverse Event|12|||
157039523|NCT00048932|566899651|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
157039524|NCT00048932|566899652|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
157039525|NCT00048932|566899653|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
157039526|NCT00048932|566899651|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
157039527|NCT00048932|566899652|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
157039528|NCT00048932|566899653|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
157039529|NCT00048932|566899651|FG000|Double Blind Period (DB)|Pregnancy|1|||
157039530|NCT00048932|566899652|FG001|Double Blind Period (DB)|Pregnancy|0|||
157039531|NCT00048932|566899653|FG002|Double Blind Period (DB)|Pregnancy|0|||
157039532|NCT00048932|566899651|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
157039533|NCT00048932|566899652|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
157039534|NCT00048932|566899653|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
157039535|NCT00048932|566899651|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
157039536|NCT00048932|566899652|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
157039537|NCT00048932|566899653|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
157039538|NCT00048932|566899651|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
157039539|NCT00048932|566899652|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
157039540|NCT00048932|566899653|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
157039541|NCT00048932|566899651|FG000|Open Label Period (OL)|Death|0|||
157039542|NCT00048932|566899652|FG001|Open Label Period (OL)|Death|0|||
157039543|NCT00048932|566899653|FG002|Open Label Period (OL)|Death|25|||
157039544|NCT00048932|566899651|FG000|Open Label Period (OL)|Adverse Event|0|||
157039545|NCT00048932|566899652|FG001|Open Label Period (OL)|Adverse Event|0|||
157039546|NCT00048932|566899653|FG002|Open Label Period (OL)|Adverse Event|103|||
157039547|NCT00048932|566899651|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
157039548|NCT00048932|566899652|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
157039549|NCT00048932|566899653|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
157039550|NCT00048932|566899651|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
157039551|NCT00048932|566899652|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
157039552|NCT00048932|566899653|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
157039553|NCT00048932|566899651|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
157039554|NCT00048932|566899652|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
157039555|NCT00048932|566899653|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
157039556|NCT00048932|566899651|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
157039557|NCT00048932|566899652|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
157039558|NCT00048932|566899653|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
157039559|NCT00048932|566899651|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
157039560|NCT00048932|566899652|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
157039561|NCT00048932|566899653|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
157039562|NCT00048932|566899651|FG000|Open Label Period (OL)|Pregnancy|0|||
157039563|NCT00048932|566899652|FG001|Open Label Period (OL)|Pregnancy|0|||
157039564|NCT00048932|566899653|FG002|Open Label Period (OL)|Pregnancy|6|||
157039565|NCT00048932|566899651|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
157039566|NCT00048932|566899652|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
157039567|NCT00048932|566899653|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
157039568|NCT00048932|566899651|FG000|Open Label Period (OL)|Investigator Retiring|0|||
157039569|NCT00048932|566899652|FG001|Open Label Period (OL)|Investigator Retiring|0|||
157039570|NCT00048932|566899653|FG002|Open Label Period (OL)|Investigator Retiring|2|||
157039571|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
157172363|NCT01998958|567371155|FG029|Open Label Phase (Optional)|Other|0|||
156963364|NCT01692782|566618487|FG001|Overall Study|Adverse Event|32|||
156963365|NCT01692782|566618488|FG002|Overall Study|Adverse Event|2|||
156963366|NCT01692782|566618486|FG000|Overall Study|Lack of Efficacy|1|||
156963367|NCT01692782|566618487|FG001|Overall Study|Lack of Efficacy|2|||
156963368|NCT01692782|566618488|FG002|Overall Study|Lack of Efficacy|0|||
157039572|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
157039573|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
157039574|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Relocated|0|||
157039575|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Relocated|0|||
157039576|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Relocated|6|||
157039577|NCT00048932|566899651|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
157039578|NCT00048932|566899652|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
157039579|NCT00048932|566899653|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
157039580|NCT00048932|566899651|FG000|Open Label Period (OL)|Site Closure|0|||
157039581|NCT00048932|566899652|FG001|Open Label Period (OL)|Site Closure|0|||
157039582|NCT00048932|566899653|FG002|Open Label Period (OL)|Site Closure|3|||
157039583|NCT00048932|566899651|FG000|Open Label Period (OL)|Trial Terminated|0|||
157039584|NCT00048932|566899652|FG001|Open Label Period (OL)|Trial Terminated|0|||
157039585|NCT00048932|566899653|FG002|Open Label Period (OL)|Trial Terminated|1|||
157039586|NCT00048932|566899651|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
157039587|NCT00048932|566899652|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
157039588|NCT00048932|566899653|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
157039589|NCT00048932|566899651|FG000|Open Label Period (OL)|Patient Decision|0|||
157039590|NCT00048932|566899652|FG001|Open Label Period (OL)|Patient Decision|0|||
157039591|NCT00048932|566899653|FG002|Open Label Period (OL)|Patient Decision|4|||
157039592|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
157039593|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
157039594|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
157039595|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
157039596|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
157039597|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
157039598|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
157039599|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
157039600|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
157039601|NCT00048932|566899651|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
157039602|NCT00048932|566899652|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
157039603|NCT00048932|566899653|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
157039604|NCT00048932|566899651|FG000|Open Label Period (OL)|Investigator Decision|0|||
157039605|NCT00048932|566899652|FG001|Open Label Period (OL)|Investigator Decision|0|||
157039606|NCT00048932|566899653|FG002|Open Label Period (OL)|Investigator Decision|4|||
157039607|NCT00048932|566899651|FG000|Open Label Period (OL)|Site Staff Issues|0|||
157039608|NCT00048932|566899652|FG001|Open Label Period (OL)|Site Staff Issues|0|||
157039609|NCT00048932|566899653|FG002|Open Label Period (OL)|Site Staff Issues|2|||
157039610|NCT00048932|566899651|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
157039611|NCT00048932|566899652|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
157039612|NCT00048932|566899653|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
157039613|NCT00048932|566899651|FG000|Open Label Period (OL)|Participant Surgery|0|||
157039614|NCT00048932|566899652|FG001|Open Label Period (OL)|Participant Surgery|0|||
157039615|NCT00048932|566899653|FG002|Open Label Period (OL)|Participant Surgery|1|||
157039616|NCT03244800|566899658|FG000|Overall Study|Adverse Event|0|||
157039617|NCT03244800|566899659|FG001|Overall Study|Adverse Event|1|||
157039618|NCT03244800|566899660|FG002|Overall Study|Adverse Event|0|||
157039619|NCT03244800|566899661|FG003|Overall Study|Adverse Event|1|||
157039620|NCT03244800|566899658|FG000|Overall Study|Withdrew treatment|0|||
157039621|NCT03244800|566899659|FG001|Overall Study|Withdrew treatment|0|||
157039622|NCT03244800|566899660|FG002|Overall Study|Withdrew treatment|0|||
157039623|NCT03244800|566899661|FG003|Overall Study|Withdrew treatment|1|||
157039624|NCT00890591|566899669|FG000|Overall Study|Lack of Efficacy|20|||
157039625|NCT03451422|566899676|FG000|Overall Study|Lost to Follow-up|0|||
157039626|NCT03451422|566899677|FG001|Overall Study|Lost to Follow-up|0|||
157039627|NCT03451422|566899678|FG002|Overall Study|Lost to Follow-up|0|||
157039628|NCT03451422|566899679|FG003|Overall Study|Lost to Follow-up|0|||
157039629|NCT03451422|566899680|FG004|Overall Study|Lost to Follow-up|0|||
157172364|NCT01998958|567371156|FG030|Open Label Phase (Optional)|Other|0|||
157039630|NCT03451422|566899681|FG005|Overall Study|Lost to Follow-up|1|||
157039631|NCT03451422|566899676|FG000|Overall Study|Decision by sponsor|1|||
157039632|NCT03451422|566899677|FG001|Overall Study|Decision by sponsor|0|||
157039633|NCT03451422|566899678|FG002|Overall Study|Decision by sponsor|1|||
157039634|NCT03451422|566899679|FG003|Overall Study|Decision by sponsor|0|||
157039635|NCT03451422|566899680|FG004|Overall Study|Decision by sponsor|0|||
157172365|NCT01998958|567371157|FG031|Open Label Phase (Optional)|Other|0|||
157172366|NCT01998958|567371126|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172367|NCT01998958|567371127|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
157039636|NCT03451422|566899681|FG005|Overall Study|Decision by sponsor|0|||
157172368|NCT01998958|567371128|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172369|NCT01998958|567371129|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
157039637|NCT03451422|566899676|FG000|Overall Study|Withdrawal by Subject|0|||
156963369|NCT01692782|566618486|FG000|Overall Study|Lost to Follow-up|2|||
156963370|NCT01692782|566618487|FG001|Overall Study|Lost to Follow-up|7|||
156963371|NCT01692782|566618488|FG002|Overall Study|Lost to Follow-up|1|||
156963372|NCT01692782|566618486|FG000|Overall Study|Pregnancy|1|||
156963373|NCT01692782|566618487|FG001|Overall Study|Pregnancy|0|||
156963374|NCT01692782|566618488|FG002|Overall Study|Pregnancy|0|||
156963375|NCT01692782|566618486|FG000|Overall Study|Protocol Violation|1|||
156963376|NCT01692782|566618487|FG001|Overall Study|Protocol Violation|0|||
156963377|NCT01692782|566618488|FG002|Overall Study|Protocol Violation|2|||
156963378|NCT01692782|566618486|FG000|Overall Study|Non-complance with study drug|0|||
156963379|NCT01692782|566618487|FG001|Overall Study|Non-complance with study drug|4|||
156963380|NCT01692782|566618488|FG002|Overall Study|Non-complance with study drug|1|||
156963381|NCT01692782|566618486|FG000|Overall Study|Non-compliant with study visits|0|||
156963382|NCT01692782|566618487|FG001|Overall Study|Non-compliant with study visits|0|||
156963383|NCT01692782|566618488|FG002|Overall Study|Non-compliant with study visits|1|||
156963384|NCT01692782|566618486|FG000|Overall Study|SAE not related to study drug|0|||
156963385|NCT01692782|566618487|FG001|Overall Study|SAE not related to study drug|1|||
156963386|NCT01692782|566618488|FG002|Overall Study|SAE not related to study drug|0|||
156963387|NCT01692782|566618486|FG000|Overall Study|Withdrawal by Subject|3|||
156963388|NCT01692782|566618487|FG001|Overall Study|Withdrawal by Subject|10|||
156963389|NCT01692782|566618488|FG002|Overall Study|Withdrawal by Subject|3|||
156963390|NCT00868439|566618489|FG000|Overall Study|Adverse Event|4|||
156963391|NCT00868439|566618490|FG001|Overall Study|Adverse Event|3|||
156963392|NCT00868439|566618489|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
156963393|NCT00868439|566618490|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
156963394|NCT00868439|566618489|FG000|Overall Study|Death|0|||
156963395|NCT00868439|566618490|FG001|Overall Study|Death|1|||
156963396|NCT00868439|566618489|FG000|Overall Study|Protocol Violation|1|||
156963397|NCT00868439|566618490|FG001|Overall Study|Protocol Violation|1|||
156963398|NCT00868439|566618489|FG000|Overall Study|Physician Decision|1|||
156963399|NCT00868439|566618490|FG001|Overall Study|Physician Decision|0|||
156963400|NCT00868439|566618489|FG000|Overall Study|Withdrawal by Subject|0|||
156963401|NCT00868439|566618490|FG001|Overall Study|Withdrawal by Subject|1|||
156963402|NCT01132326|566618491|FG000|Overall Study|Lack of Efficacy|25|||
156963403|NCT01132326|566618491|FG000|Overall Study|Adverse Event|37|||
156963404|NCT01132326|566618491|FG000|Overall Study|Protocol Violation|1|||
156963405|NCT01132326|566618491|FG000|Overall Study|Lost to Follow-up|16|||
156963406|NCT01132326|566618491|FG000|Overall Study|Withdrawal by Subject|40|||
156963407|NCT01132326|566618491|FG000|Overall Study|Physician Decision|10|||
156963408|NCT01132326|566618491|FG000|Overall Study|Study Termination|80|||
156963409|NCT01132326|566618491|FG000|Overall Study|Declining Health|1|||
156963410|NCT01132326|566618491|FG000|Overall Study|Pregnancy|1|||
156963411|NCT01132326|566618491|FG000|Overall Study|Caregiver Withdrew Consent|1|||
156963412|NCT01132326|566618491|FG000|Overall Study|Death|5|||
156963413|NCT01132326|566618491|FG000|Overall Study|Subject Unable to Come To Visits|1|||
156963414|NCT00338884|566618492|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
156963415|NCT00338884|566618492|FG000|Overall Study|Adverse Event|14|||
156963416|NCT00338884|566618492|FG000|Overall Study|Death|8|||
156963417|NCT00338884|566618492|FG000|Overall Study|Other|4|||
156963418|NCT00338884|566618492|FG000|Overall Study|Global Deterioration of Health Status|3|||
156963419|NCT00338884|566618492|FG000|Overall Study|Withdrawal by Subject|3|||
156963420|NCT00338884|566618492|FG000|Overall Study|Lost to Follow-up|1|||
156963421|NCT00338884|566618492|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
156963422|NCT00423176|566618493|FG000|Overall Study|Adverse Event|4|||
156963423|NCT00423176|566618494|FG001|Overall Study|Adverse Event|6|||
156963424|NCT00423176|566618493|FG000|Overall Study|Treatment Failure|1|||
156963425|NCT00423176|566618494|FG001|Overall Study|Treatment Failure|6|||
156963426|NCT00423176|566618493|FG000|Overall Study|Lost to Follow-up|4|||
156963427|NCT00423176|566618494|FG001|Overall Study|Lost to Follow-up|7|||
156963428|NCT00423176|566618493|FG000|Overall Study|Withdrawal by Subject|4|||
156963429|NCT00423176|566618494|FG001|Overall Study|Withdrawal by Subject|3|||
156963430|NCT00423176|566618493|FG000|Overall Study|Protocol Violation|1|||
156963431|NCT00423176|566618494|FG001|Overall Study|Protocol Violation|3|||
156963432|NCT00423176|566618493|FG000|Overall Study|Did not meet protocol eligibility|2|||
156963433|NCT00423176|566618494|FG001|Overall Study|Did not meet protocol eligibility|4|||
156963434|NCT00911534|566618495|FG000|Overall Study|Adverse Event|4|||
156963435|NCT00911534|566618496|FG001|Overall Study|Adverse Event|4|||
156963436|NCT00911534|566618495|FG000|Overall Study|Lost to Follow-up|2|||
156963437|NCT00911534|566618496|FG001|Overall Study|Lost to Follow-up|4|||
156963438|NCT00911534|566618495|FG000|Overall Study|Withdrawal by Subject|2|||
156963439|NCT00911534|566618496|FG001|Overall Study|Withdrawal by Subject|1|||
156963440|NCT00911534|566618495|FG000|Overall Study|Lack of Efficacy|4|||
156963441|NCT00911534|566618496|FG001|Overall Study|Lack of Efficacy|1|||
156963442|NCT00911534|566618495|FG000|Overall Study|Withdrawal of consent|1|||
156963443|NCT00911534|566618496|FG001|Overall Study|Withdrawal of consent|4|||
156963444|NCT00911534|566618495|FG000|Overall Study|Other|2|||
156963445|NCT00911534|566618496|FG001|Overall Study|Other|2|||
156963446|NCT03492281|566618499|FG000|Overall Study|Withdrawal by Subject|21|||
156963447|NCT03492281|566618500|FG001|Overall Study|Withdrawal by Subject|14|||
156963448|NCT03492281|566618501|FG002|Overall Study|Withdrawal by Subject|13|||
156963449|NCT03492281|566618499|FG000|Overall Study|Lost to Follow-up|14|||
156963450|NCT03492281|566618500|FG001|Overall Study|Lost to Follow-up|15|||
156963451|NCT03492281|566618501|FG002|Overall Study|Lost to Follow-up|10|||
156963452|NCT03492281|566618499|FG000|Overall Study|Adverse Event|6|||
156963453|NCT03492281|566618500|FG001|Overall Study|Adverse Event|8|||
156963454|NCT03492281|566618501|FG002|Overall Study|Adverse Event|13|||
156963455|NCT03492281|566618499|FG000|Overall Study|Lack of Efficacy|3|||
156963456|NCT03492281|566618500|FG001|Overall Study|Lack of Efficacy|0|||
156963457|NCT03492281|566618501|FG002|Overall Study|Lack of Efficacy|1|||
156963458|NCT03492281|566618499|FG000|Overall Study|Physician Decision|1|||
156963459|NCT03492281|566618500|FG001|Overall Study|Physician Decision|0|||
156963460|NCT03492281|566618501|FG002|Overall Study|Physician Decision|3|||
156963461|NCT03492281|566618499|FG000|Overall Study|Protocol Violation|0|||
156963462|NCT03492281|566618500|FG001|Overall Study|Protocol Violation|2|||
156963463|NCT03492281|566618501|FG002|Overall Study|Protocol Violation|1|||
156963464|NCT03492281|566618499|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
156963465|NCT03492281|566618500|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
156963466|NCT03492281|566618501|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
156963467|NCT03492281|566618499|FG000|Overall Study|Death|0|||
156963468|NCT03492281|566618500|FG001|Overall Study|Death|0|||
156963469|NCT03492281|566618501|FG002|Overall Study|Death|1|||
156963470|NCT03492281|566618499|FG000|Overall Study|Captured as Other in Database|8|||
156963471|NCT03492281|566618500|FG001|Overall Study|Captured as Other in Database|6|||
156963472|NCT03492281|566618501|FG002|Overall Study|Captured as Other in Database|3|||
156963473|NCT02677116|566618506|FG000|Overall Study|Adverse Event|0|||
156963474|NCT02677116|566618507|FG001|Overall Study|Adverse Event|1|||
156963475|NCT02677116|566618508|FG002|Overall Study|Adverse Event|0|||
156963476|NCT02677116|566618509|FG003|Overall Study|Adverse Event|0|||
156963477|NCT02677116|566618510|FG004|Overall Study|Adverse Event|0|||
156963478|NCT02677116|566618511|FG005|Overall Study|Adverse Event|1|||
156963479|NCT02677116|566618512|FG006|Overall Study|Adverse Event|1|||
156963480|NCT02677116|566618513|FG007|Overall Study|Adverse Event|0|||
156963481|NCT02677116|566618514|FG008|Overall Study|Adverse Event|0|||
156963482|NCT02677116|566618506|FG000|Overall Study|Physician Decision|0|||
156963483|NCT02677116|566618507|FG001|Overall Study|Physician Decision|2|||
156963484|NCT02677116|566618508|FG002|Overall Study|Physician Decision|3|||
156963485|NCT02677116|566618509|FG003|Overall Study|Physician Decision|2|||
156963486|NCT02677116|566618510|FG004|Overall Study|Physician Decision|1|||
156963487|NCT02677116|566618511|FG005|Overall Study|Physician Decision|3|||
156963488|NCT02677116|566618512|FG006|Overall Study|Physician Decision|1|||
156963489|NCT02677116|566618513|FG007|Overall Study|Physician Decision|1|||
156963490|NCT02677116|566618514|FG008|Overall Study|Physician Decision|2|||
156963491|NCT02677116|566618506|FG000|Overall Study|Withdrawal by parent or guardian|2|||
156963492|NCT02677116|566618507|FG001|Overall Study|Withdrawal by parent or guardian|1|||
156963493|NCT02677116|566618508|FG002|Overall Study|Withdrawal by parent or guardian|0|||
156963494|NCT02677116|566618509|FG003|Overall Study|Withdrawal by parent or guardian|1|||
156963495|NCT02677116|566618510|FG004|Overall Study|Withdrawal by parent or guardian|0|||
156963496|NCT02677116|566618511|FG005|Overall Study|Withdrawal by parent or guardian|0|||
156963497|NCT02677116|566618512|FG006|Overall Study|Withdrawal by parent or guardian|2|||
156963498|NCT02677116|566618513|FG007|Overall Study|Withdrawal by parent or guardian|1|||
156963499|NCT02677116|566618514|FG008|Overall Study|Withdrawal by parent or guardian|0|||
156963500|NCT02677116|566618506|FG000|Overall Study|Withdrawal by Subject|1|||
156963501|NCT02677116|566618507|FG001|Overall Study|Withdrawal by Subject|0|||
156963502|NCT02677116|566618508|FG002|Overall Study|Withdrawal by Subject|0|||
156963503|NCT02677116|566618509|FG003|Overall Study|Withdrawal by Subject|0|||
156963504|NCT02677116|566618510|FG004|Overall Study|Withdrawal by Subject|0|||
156963505|NCT02677116|566618511|FG005|Overall Study|Withdrawal by Subject|0|||
156963506|NCT02677116|566618512|FG006|Overall Study|Withdrawal by Subject|0|||
156963507|NCT02677116|566618513|FG007|Overall Study|Withdrawal by Subject|0|||
156963508|NCT02677116|566618514|FG008|Overall Study|Withdrawal by Subject|0|||
156963509|NCT03342638|566618515|FG000|Overall Study|Withdrawal by Subject|1|||
156963510|NCT03342638|566618516|FG001|Overall Study|Withdrawal by Subject|0|||
156963511|NCT03342638|566618515|FG000|Overall Study|Physician Decision|0|||
156963512|NCT03342638|566618516|FG001|Overall Study|Physician Decision|1|||
156963513|NCT01292239|566618521|FG000|Overall Study|Other|1|||
156963514|NCT01292239|566618522|FG001|Overall Study|Other|1|||
156963515|NCT01292239|566618521|FG000|Overall Study|Withdrawal by Subject|3|||
156963516|NCT01292239|566618522|FG001|Overall Study|Withdrawal by Subject|6|||
156963517|NCT03213158|566618523|FG000|Overall Study|Withdrawal by Subject|1|||
156963518|NCT03213158|566618523|FG000|Overall Study|Physician Decision|2|||
156963519|NCT03649230|566618525|FG000|Overall Study|Adverse Event|12|||
156963520|NCT03649230|566618525|FG000|Overall Study|Death|8|||
156963521|NCT03649230|566618525|FG000|Overall Study|Withdrawal by Subject|6|||
156963522|NCT03649230|566618525|FG000|Overall Study|Physician Decision|5|||
156963523|NCT03649230|566618525|FG000|Overall Study|Disease progression|5|||
156963524|NCT03649230|566618525|FG000|Overall Study|Switched to non-HEC|5|||
157172370|NCT01998958|567371130|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172371|NCT01998958|567371131|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172372|NCT01998958|567371132|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172373|NCT01998958|567371133|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172374|NCT01998958|567371134|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172375|NCT01998958|567371135|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172376|NCT01998958|567371136|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172377|NCT01998958|567371137|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172378|NCT01998958|567371138|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172379|NCT01998958|567371139|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172380|NCT01998958|567371140|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172381|NCT01998958|567371141|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172382|NCT01998958|567371142|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172383|NCT01998958|567371143|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172384|NCT01998958|567371144|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172385|NCT01998958|567371145|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172386|NCT01998958|567371146|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172387|NCT01998958|567371147|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172388|NCT01998958|567371148|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
157172389|NCT01998958|567371149|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172390|NCT01998958|567371150|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172391|NCT01998958|567371151|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172392|NCT01998958|567371152|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172393|NCT01998958|567371153|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172394|NCT01998958|567371154|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172395|NCT01998958|567371155|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172396|NCT01998958|567371156|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172397|NCT01998958|567371157|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
157172398|NCT01998958|567371126|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172399|NCT01998958|567371127|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172400|NCT01998958|567371128|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172401|NCT01998958|567371129|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172402|NCT01998958|567371130|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172403|NCT01998958|567371131|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172404|NCT01998958|567371132|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172405|NCT01998958|567371133|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172406|NCT01998958|567371134|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172407|NCT01998958|567371135|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172408|NCT01998958|567371136|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172409|NCT01998958|567371137|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172410|NCT01998958|567371138|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172411|NCT01998958|567371139|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172412|NCT01998958|567371140|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172413|NCT01998958|567371141|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172414|NCT01998958|567371142|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172415|NCT01998958|567371143|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172416|NCT01998958|567371144|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172417|NCT01998958|567371145|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172418|NCT01998958|567371146|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172419|NCT01998958|567371147|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
157172420|NCT01998958|567371148|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
157172421|NCT01998958|567371149|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172422|NCT01998958|567371150|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172423|NCT01998958|567371151|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
156963525|NCT03649230|566618525|FG000|Overall Study|Chemotherapy discontinued|4|||
156963526|NCT03649230|566618525|FG000|Overall Study|Received only 3 HEC cycles|4|||
156963527|NCT03649230|566618525|FG000|Overall Study|Screen Failure|3|||
156963528|NCT03649230|566618525|FG000|Overall Study|Patient stopped treatment|2|||
156963529|NCT03649230|566618525|FG000|Overall Study|Protocol Violation|1|||
156963530|NCT03649230|566618525|FG000|Overall Study|Non-compliance|1|||
156963531|NCT03649230|566618525|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
156963532|NCT01693068|566618526|FG000|Randomization Period|On-study|2|||
156963533|NCT01693068|566618527|FG001|Randomization Period|On-study|5|||
156963534|NCT01693068|566618528|FG002|Randomization Period|On-study|0|||
156963535|NCT01693068|566618526|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
156963536|NCT01693068|566618527|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
156963537|NCT01693068|566618528|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
156963538|NCT00295022|566618534|FG000|Overall Study|Adverse Event|1|||
156963539|NCT00295022|566618535|FG001|Overall Study|Adverse Event|1|||
156963540|NCT00295022|566618536|FG002|Overall Study|Adverse Event|2|||
156963541|NCT00295022|566618534|FG000|Overall Study|Lost to Follow-up|0|||
156963542|NCT00295022|566618535|FG001|Overall Study|Lost to Follow-up|0|||
156963543|NCT00295022|566618536|FG002|Overall Study|Lost to Follow-up|1|||
156963544|NCT00295022|566618534|FG000|Overall Study|Withdrawal by Subject|0|||
156963545|NCT00295022|566618535|FG001|Overall Study|Withdrawal by Subject|0|||
156963546|NCT00295022|566618536|FG002|Overall Study|Withdrawal by Subject|2|||
156963547|NCT04403698|566618538|FG000|Overall Study|Adverse Event|1|||
156963548|NCT04403698|566618539|FG001|Overall Study|Adverse Event|1|||
156963549|NCT04403698|566618538|FG000|Overall Study|Lost to Follow-up|1|||
156963550|NCT04403698|566618539|FG001|Overall Study|Lost to Follow-up|0|||
156963551|NCT04403698|566618538|FG000|Overall Study|Protocol Violation|0|||
156963552|NCT04403698|566618539|FG001|Overall Study|Protocol Violation|1|||
156963553|NCT00977665|566618540|FG000|Overall Study|Withdrawal by Subject|1|||
156963554|NCT00977665|566618541|FG001|Overall Study|Withdrawal by Subject|3|||
156963555|NCT00977665|566618540|FG000|Overall Study|Physician Decision|2|||
156963556|NCT00977665|566618541|FG001|Overall Study|Physician Decision|1|||
156963557|NCT00977665|566618540|FG000|Overall Study|Sponsor requested withdrawal|0|||
156963558|NCT00977665|566618541|FG001|Overall Study|Sponsor requested withdrawal|1|||
156963559|NCT00977665|566618540|FG000|Overall Study|Lost to Follow-up|1|||
156963560|NCT00977665|566618541|FG001|Overall Study|Lost to Follow-up|0|||
156963561|NCT00977665|566618540|FG000|Overall Study|Death|3|||
156963562|NCT00977665|566618541|FG001|Overall Study|Death|2|||
156963563|NCT00977665|566618540|FG000|Overall Study|Adverse Event|14|||
156963564|NCT00977665|566618541|FG001|Overall Study|Adverse Event|7|||
156963565|NCT00977665|566618540|FG000|Overall Study|Treatment failure|0|||
156963566|NCT00977665|566618541|FG001|Overall Study|Treatment failure|1|||
156963567|NCT01330433|566618542|FG000|Overall Study|Death|1|||
156963568|NCT01330433|566618543|FG001|Overall Study|Death|3|||
156963569|NCT01330433|566618542|FG000|Overall Study|Lost to Follow-up|1|||
156963570|NCT01330433|566618543|FG001|Overall Study|Lost to Follow-up|0|||
156963571|NCT02300220|566618546|FG000|Overall Study|Lost to Follow-up|1|||
156963572|NCT02300220|566618547|FG001|Overall Study|Lost to Follow-up|2|||
156963573|NCT02300220|566618546|FG000|Overall Study|Death|1|||
156963574|NCT02300220|566618547|FG001|Overall Study|Death|1|||
156963575|NCT02300220|566618546|FG000|Overall Study|Adverse Event|1|||
156963576|NCT02300220|566618547|FG001|Overall Study|Adverse Event|1|||
156963577|NCT02300220|566618546|FG000|Overall Study|Protocol Violation|1|||
156963578|NCT02300220|566618547|FG001|Overall Study|Protocol Violation|0|||
156963579|NCT02300220|566618546|FG000|Overall Study|Withdrawal by Subject|0|||
156963580|NCT02300220|566618547|FG001|Overall Study|Withdrawal by Subject|2|||
156963581|NCT02300220|566618546|FG000|Overall Study|Did not tolerate IMP|0|||
156963582|NCT02300220|566618547|FG001|Overall Study|Did not tolerate IMP|1|||
156963583|NCT04322682|566618548|FG000|Overall Study|Withdrawal by Subject|33|||
156963584|NCT04322682|566618549|FG001|Overall Study|Withdrawal by Subject|47|||
156963585|NCT04322682|566618548|FG000|Overall Study|Death|5|||
156963586|NCT04322682|566618549|FG001|Overall Study|Death|9|||
156963587|NCT04322682|566618548|FG000|Overall Study|Lost to Follow-up|4|||
156963588|NCT04322682|566618549|FG001|Overall Study|Lost to Follow-up|8|||
156963589|NCT04322682|566618548|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
156963590|NCT04322682|566618549|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
156963591|NCT04123067|566618550|FG000|Overall Study|Lost to Follow-up|0|||
156963592|NCT04123067|566618551|FG001|Overall Study|Lost to Follow-up|1|||
156963593|NCT02238379|566618552|FG000|Overall Study|Lost to Follow-up|1|||
156963594|NCT02238379|566618553|FG001|Overall Study|Lost to Follow-up|0|||
156963595|NCT00441090|566618554|FG000|Overall Study|Adverse Event|0|||
156963596|NCT00441090|566618555|FG001|Overall Study|Adverse Event|1|||
156963597|NCT00441090|566618556|FG002|Overall Study|Adverse Event|1|||
156963598|NCT00441090|566618557|FG003|Overall Study|Adverse Event|0|||
156963599|NCT00441090|566618558|FG004|Overall Study|Adverse Event|0|||
156963600|NCT00441090|566618554|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156963601|NCT00441090|566618555|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156963602|NCT00441090|566618556|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156963603|NCT00441090|566618557|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
156963604|NCT00441090|566618558|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
156963605|NCT00441090|566618554|FG000|Overall Study|Withdrawal by Subject|1|||
156963606|NCT00441090|566618555|FG001|Overall Study|Withdrawal by Subject|0|||
156963607|NCT00441090|566618556|FG002|Overall Study|Withdrawal by Subject|1|||
156963608|NCT00441090|566618557|FG003|Overall Study|Withdrawal by Subject|0|||
156963609|NCT00441090|566618558|FG004|Overall Study|Withdrawal by Subject|0|||
156963610|NCT00441090|566618554|FG000|Overall Study|Lack of Efficacy|1|||
156963611|NCT00441090|566618555|FG001|Overall Study|Lack of Efficacy|0|||
156963612|NCT00441090|566618556|FG002|Overall Study|Lack of Efficacy|0|||
156963613|NCT00441090|566618557|FG003|Overall Study|Lack of Efficacy|0|||
156963614|NCT00441090|566618558|FG004|Overall Study|Lack of Efficacy|0|||
156963615|NCT01441102|566618559|FG000|Overall Study|Adverse Event|1|||
156963616|NCT01441102|566618559|FG000|Overall Study|Withdrawal by Subject|2|||
156963617|NCT03085485|566618560|FG000|Overall Study|Death|1|||
156963618|NCT03085485|566618561|FG001|Overall Study|Death|0|||
156963619|NCT03085485|566618560|FG000|Overall Study|Lost to Follow-up|1|||
156963620|NCT03085485|566618561|FG001|Overall Study|Lost to Follow-up|0|||
156963621|NCT01022762|566618562|FG000|Overall Study|Adverse Event|3|||
156963622|NCT01022762|566618563|FG001|Overall Study|Adverse Event|1|||
156963623|NCT01022762|566618562|FG000|Overall Study|Lack of Efficacy|0|||
156963624|NCT01022762|566618563|FG001|Overall Study|Lack of Efficacy|1|||
156963625|NCT01022762|566618562|FG000|Overall Study|Protocol Violation|7|||
156963626|NCT01022762|566618563|FG001|Overall Study|Protocol Violation|6|||
156963627|NCT01022762|566618562|FG000|Overall Study|Unclassified|12|||
156963628|NCT01022762|566618563|FG001|Overall Study|Unclassified|20|||
156963629|NCT00605280|566618564|FG000|Year 1|Protocol Violation|0|||
156963630|NCT00605280|566618565|FG001|Year 1|Protocol Violation|0|||
156963631|NCT00605280|566618566|FG002|Year 1|Protocol Violation|0|||
156963632|NCT00605280|566618567|FG003|Year 1|Protocol Violation|1|||
156963633|NCT00605280|566618564|FG000|Year 1|Adverse Event|3|||
156963634|NCT00605280|566618565|FG001|Year 1|Adverse Event|1|||
156963635|NCT00605280|566618566|FG002|Year 1|Adverse Event|1|||
156963636|NCT00605280|566618567|FG003|Year 1|Adverse Event|5|||
156963637|NCT00605280|566618564|FG000|Year 1|Physician Decision|7|||
156963638|NCT00605280|566618565|FG001|Year 1|Physician Decision|4|||
156963639|NCT00605280|566618566|FG002|Year 1|Physician Decision|0|||
156963640|NCT00605280|566618567|FG003|Year 1|Physician Decision|6|||
156963641|NCT00605280|566618564|FG000|Year 1|Withdrawal by Subject|2|||
156963642|NCT00605280|566618565|FG001|Year 1|Withdrawal by Subject|4|||
156963643|NCT00605280|566618566|FG002|Year 1|Withdrawal by Subject|0|||
156963644|NCT00605280|566618567|FG003|Year 1|Withdrawal by Subject|4|||
156963645|NCT00605280|566618564|FG000|Year 1|Other|2|||
156963646|NCT00605280|566618565|FG001|Year 1|Other|1|||
156963647|NCT00605280|566618566|FG002|Year 1|Other|0|||
156963648|NCT00605280|566618567|FG003|Year 1|Other|1|||
156963649|NCT00605280|566618564|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
156963650|NCT00605280|566618565|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
156963651|NCT00605280|566618566|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
156963652|NCT00605280|566618567|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
156963653|NCT00605280|566618564|FG000|Year 2|Adverse Event|4|||
156963654|NCT00605280|566618565|FG001|Year 2|Adverse Event|0|||
156963655|NCT00605280|566618566|FG002|Year 2|Adverse Event|2|||
156963656|NCT00605280|566618567|FG003|Year 2|Adverse Event|4|||
156963657|NCT00605280|566618564|FG000|Year 2|Physician Decision|11|||
156963658|NCT00605280|566618565|FG001|Year 2|Physician Decision|6|||
156963659|NCT00605280|566618566|FG002|Year 2|Physician Decision|4|||
156963660|NCT00605280|566618567|FG003|Year 2|Physician Decision|11|||
156963661|NCT00605280|566618564|FG000|Year 2|Withdrawal by Subject|4|||
156963662|NCT00605280|566618565|FG001|Year 2|Withdrawal by Subject|0|||
156963663|NCT00605280|566618566|FG002|Year 2|Withdrawal by Subject|0|||
156963664|NCT00605280|566618567|FG003|Year 2|Withdrawal by Subject|4|||
156963665|NCT00605280|566618564|FG000|Year 2|Other|1|||
156963666|NCT00605280|566618565|FG001|Year 2|Other|0|||
156963667|NCT00605280|566618566|FG002|Year 2|Other|0|||
156963668|NCT00605280|566618567|FG003|Year 2|Other|1|||
156963669|NCT00605280|566618564|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
156963670|NCT00605280|566618565|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
156963671|NCT00605280|566618566|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
156963672|NCT00605280|566618567|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
156963673|NCT00605280|566618564|FG000|Year 3 Extension|Adverse Event|2|||
156963674|NCT00605280|566618565|FG001|Year 3 Extension|Adverse Event|0|||
156963675|NCT00605280|566618566|FG002|Year 3 Extension|Adverse Event|0|||
156963676|NCT00605280|566618567|FG003|Year 3 Extension|Adverse Event|2|||
156963677|NCT00605280|566618564|FG000|Year 3 Extension|Physician Decision|0|||
156963678|NCT00605280|566618565|FG001|Year 3 Extension|Physician Decision|0|||
156963679|NCT00605280|566618566|FG002|Year 3 Extension|Physician Decision|0|||
156963680|NCT00605280|566618567|FG003|Year 3 Extension|Physician Decision|2|||
156963681|NCT00605280|566618564|FG000|Year 3 Extension|Withdrawal by Subject|2|||
157172424|NCT01998958|567371152|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172425|NCT01998958|567371153|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172426|NCT01998958|567371154|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172427|NCT01998958|567371155|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
156963682|NCT00605280|566618565|FG001|Year 3 Extension|Withdrawal by Subject|0|||
156963683|NCT00605280|566618566|FG002|Year 3 Extension|Withdrawal by Subject|0|||
156963684|NCT00605280|566618567|FG003|Year 3 Extension|Withdrawal by Subject|5|||
156963685|NCT00605280|566618564|FG000|Year 3 Extension|Other|2|||
156963686|NCT00605280|566618565|FG001|Year 3 Extension|Other|0|||
156963687|NCT00605280|566618566|FG002|Year 3 Extension|Other|0|||
156963688|NCT00605280|566618567|FG003|Year 3 Extension|Other|0|||
156963689|NCT00605280|566618564|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
156963690|NCT00605280|566618565|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156963691|NCT00605280|566618566|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156963692|NCT00605280|566618567|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
156963693|NCT01302119|566618568|FG000|Overall Study|Withdrawal by Subject|30|||
156963694|NCT01302119|566618569|FG001|Overall Study|Withdrawal by Subject|20|||
156963695|NCT01302119|566618568|FG000|Overall Study|Lost to Follow-up|10|||
156963696|NCT01302119|566618569|FG001|Overall Study|Lost to Follow-up|4|||
156963697|NCT01302119|566618568|FG000|Overall Study|Adverse Event|2|||
157039638|NCT03451422|566899677|FG001|Overall Study|Withdrawal by Subject|0|||
157039639|NCT03451422|566899678|FG002|Overall Study|Withdrawal by Subject|2|||
157039640|NCT03451422|566899679|FG003|Overall Study|Withdrawal by Subject|3|||
157039641|NCT03451422|566899680|FG004|Overall Study|Withdrawal by Subject|2|||
157039642|NCT03451422|566899681|FG005|Overall Study|Withdrawal by Subject|1|||
157039643|NCT04545619|566899682|FG000|Overall Study|due to equipment challenges|1|||
157039644|NCT04384172|566899685|FG000|Overall Study|Lost to Follow-up|0|||
157039645|NCT04384172|566899686|FG001|Overall Study|Lost to Follow-up|2|||
157039646|NCT04384172|566899685|FG000|Overall Study|Pregnancy|1|||
157039647|NCT04384172|566899686|FG001|Overall Study|Pregnancy|0|||
157039648|NCT04384172|566899685|FG000|Overall Study|Withdrawal by Subject|0|||
157039649|NCT04384172|566899686|FG001|Overall Study|Withdrawal by Subject|1|||
157039650|NCT04949542|566899687|FG000|Overall Study|Lost to Follow-up|4|||
157039651|NCT04949542|566899688|FG001|Overall Study|Lost to Follow-up|1|||
157039652|NCT01536093|566899691|FG000|Overall Study|Death|1|||
157039653|NCT01536093|566899692|FG001|Overall Study|Death|2|||
157039654|NCT01536093|566899691|FG000|Overall Study|absence of maternal colostrum|2|||
157039655|NCT01536093|566899692|FG001|Overall Study|absence of maternal colostrum|0|||
157039656|NCT01536093|566899691|FG000|Overall Study|Withdrawal by Subject|0|||
157039657|NCT01536093|566899692|FG001|Overall Study|Withdrawal by Subject|1|||
157039658|NCT01211184|566899693|FG000|Overall Study|Withdrawal by Subject|0|||
157039659|NCT01211184|566899694|FG001|Overall Study|Withdrawal by Subject|2|||
157039660|NCT01211184|566899695|FG002|Overall Study|Withdrawal by Subject|1|||
157039661|NCT01421667|566899696|FG000|Overall Study|Withdrawal by Subject|0|||
157039662|NCT01421667|566899697|FG001|Overall Study|Withdrawal by Subject|1|||
157039663|NCT01421667|566899698|FG002|Overall Study|Withdrawal by Subject|2|||
157039664|NCT01421667|566899699|FG003|Overall Study|Withdrawal by Subject|1|||
157039665|NCT01421667|566899696|FG000|Overall Study|Lost to Follow-up|0|||
157039666|NCT01421667|566899697|FG001|Overall Study|Lost to Follow-up|1|||
157039667|NCT01421667|566899698|FG002|Overall Study|Lost to Follow-up|0|||
157039668|NCT01421667|566899699|FG003|Overall Study|Lost to Follow-up|0|||
157039669|NCT03802994|566899700|FG000|Overall Study|Lost to Follow-up|0|||
157039670|NCT03802994|566899701|FG001|Overall Study|Lost to Follow-up|2|||
157039671|NCT03802994|566899702|FG002|Overall Study|Lost to Follow-up|3|||
157039672|NCT03802994|566899703|FG003|Overall Study|Lost to Follow-up|2|||
157039673|NCT03802994|566899704|FG004|Overall Study|Lost to Follow-up|2|||
157039674|NCT00983294|566899705|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
157039675|NCT00983294|566899705|FG000|Colchicine With Azithromycin|Adverse Event|1|||
157039676|NCT00390884|566899706|FG000|Overall Study|Withdrawal by Subject|2|||
157039677|NCT00390884|566899707|FG001|Overall Study|Withdrawal by Subject|2|||
157039678|NCT00756574|566899708|FG000|Overall Study|Withdrawal by Subject|9|||
157039679|NCT00756574|566899709|FG001|Overall Study|Withdrawal by Subject|7|||
157039680|NCT00756574|566899708|FG000|Overall Study|Lost to Follow-up|4|||
157039681|NCT00756574|566899709|FG001|Overall Study|Lost to Follow-up|4|||
157039682|NCT04622332|566899710|FG000|Overall Study|Withdrawal by Subject|4|||
157039683|NCT04622332|566899711|FG001|Overall Study|Withdrawal by Subject|2|||
157039684|NCT04622332|566899710|FG000|Overall Study|Physician Decision|1|||
157039685|NCT04622332|566899711|FG001|Overall Study|Physician Decision|1|||
157039686|NCT04622332|566899710|FG000|Overall Study|Adverse Event|0|||
157039687|NCT04622332|566899711|FG001|Overall Study|Adverse Event|2|||
157039688|NCT04622332|566899710|FG000|Overall Study|Protocol Violation|0|||
157039689|NCT04622332|566899711|FG001|Overall Study|Protocol Violation|1|||
157039690|NCT05966155|566899712|FG000|Overall Study|Death|1|||
157039691|NCT05966155|566899713|FG001|Overall Study|Death|2|||
157039692|NCT05966155|566899712|FG000|Overall Study|Lost to Follow-up|63|||
157039693|NCT05966155|566899713|FG001|Overall Study|Lost to Follow-up|67|||
157039694|NCT05966155|566899712|FG000|Overall Study|Protocol Violation|1|||
157039695|NCT05966155|566899713|FG001|Overall Study|Protocol Violation|0|||
157039696|NCT05966155|566899712|FG000|Overall Study|Withdrawal by Subject|8|||
157039697|NCT05966155|566899713|FG001|Overall Study|Withdrawal by Subject|9|||
157039698|NCT05966155|566899712|FG000|Overall Study|Enrolled Erroneously|0|||
157039699|NCT05966155|566899713|FG001|Overall Study|Enrolled Erroneously|1|||
157039700|NCT05966155|566899712|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
157039701|NCT05966155|566899713|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
157039702|NCT03840902|566899718|FG000|Overall Study|Randomized but not treated|1|||
157039703|NCT03840902|566899719|FG001|Overall Study|Randomized but not treated|1|||
157039704|NCT02744066|566899721|FG000|Overall Study|Withdrawal by parent|0|||
157039705|NCT02744066|566899722|FG001|Overall Study|Withdrawal by parent|1|||
157039706|NCT02744066|566899721|FG000|Overall Study|Discharged from NICU prior to completion|0|||
157039707|NCT02744066|566899722|FG001|Overall Study|Discharged from NICU prior to completion|4|||
157039708|NCT04337931|566899723|FG000|Overall Study|Death|4|||
157039709|NCT04337931|566899724|FG001|Overall Study|Death|1|||
157039710|NCT04337931|566899725|FG002|Overall Study|Death|7|||
157039711|NCT04337931|566899723|FG000|Overall Study|Withdrawal by Subject|0|||
157039712|NCT04337931|566899724|FG001|Overall Study|Withdrawal by Subject|1|||
157039713|NCT04337931|566899725|FG002|Overall Study|Withdrawal by Subject|0|||
157039714|NCT04337931|566899723|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
157039715|NCT04337931|566899724|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
157039716|NCT04337931|566899725|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
157039717|NCT04337931|566899723|FG000|Overall Study|Study terminated by sponsor|3|||
157039718|NCT04337931|566899724|FG001|Overall Study|Study terminated by sponsor|6|||
157039719|NCT04337931|566899725|FG002|Overall Study|Study terminated by sponsor|2|||
157039720|NCT04337931|566899723|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
157039721|NCT04337931|566899724|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
157039722|NCT04337931|566899725|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
157039723|NCT04337931|566899723|FG000|Overall Study|Colorectal cancer treatment|1|||
157039724|NCT04337931|566899724|FG001|Overall Study|Colorectal cancer treatment|0|||
157039725|NCT04337931|566899725|FG002|Overall Study|Colorectal cancer treatment|0|||
157039726|NCT04337931|566899723|FG000|Overall Study|Participant decision|0|||
157039727|NCT04337931|566899724|FG001|Overall Study|Participant decision|1|||
157039728|NCT04337931|566899725|FG002|Overall Study|Participant decision|0|||
157039729|NCT01532999|566899726|FG000|Overall Study|Lost to Follow-up|14|||
157039730|NCT01532999|566899727|FG001|Overall Study|Lost to Follow-up|8|||
157039731|NCT01532999|566899726|FG000|Overall Study|Physician Decision|1|||
157039732|NCT01532999|566899727|FG001|Overall Study|Physician Decision|2|||
157039733|NCT01532999|566899726|FG000|Overall Study|Withdrawal by Subject|5|||
157039734|NCT01532999|566899727|FG001|Overall Study|Withdrawal by Subject|0|||
157039735|NCT01532999|566899726|FG000|Overall Study|Relocated|2|||
157039736|NCT01532999|566899727|FG001|Overall Study|Relocated|0|||
157039737|NCT01532999|566899726|FG000|Overall Study|should not have been randomized|1|||
157039738|NCT01532999|566899727|FG001|Overall Study|should not have been randomized|0|||
157039739|NCT01532999|566899726|FG000|Overall Study|substantial noncompliance|2|||
157039740|NCT01532999|566899727|FG001|Overall Study|substantial noncompliance|0|||
157039741|NCT01532999|566899726|FG000|Overall Study|no show for week 9 assessments|6|||
157039742|NCT01532999|566899727|FG001|Overall Study|no show for week 9 assessments|4|||
157039743|NCT01532999|566899726|FG000|Overall Study|Adverse Event|0|||
157039744|NCT01532999|566899727|FG001|Overall Study|Adverse Event|1|||
157039745|NCT01532999|566899726|FG000|Overall Study|incarcerated|0|||
157039746|NCT01532999|566899727|FG001|Overall Study|incarcerated|1|||
157039747|NCT01532999|566899726|FG000|Overall Study|New job|0|||
157039748|NCT01532999|566899727|FG001|Overall Study|New job|2|||
157039749|NCT02408887|566899728|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
157039750|NCT02408887|566899729|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
157039751|NCT02408887|566899728|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
157039752|NCT02408887|566899729|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
157039753|NCT04066075|566899731|FG000|Overall Study|Lost to Follow-up|3|||
157039754|NCT04066075|566899732|FG001|Overall Study|Lost to Follow-up|3|||
157039755|NCT04066075|566899731|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
157039756|NCT04066075|566899732|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
157039757|NCT04066075|566899731|FG000|Overall Study|Withdrawal by Subject|2|||
157039758|NCT04066075|566899732|FG001|Overall Study|Withdrawal by Subject|2|||
157039759|NCT01675492|566899739|FG000|Overall Study|study completed early - product approval|42|||
157039760|NCT03593226|566899756|FG000|Overall Study|Disease progression|6|||
157039761|NCT03593226|566899757|FG001|Overall Study|Disease progression|13|||
157039762|NCT03593226|566899758|FG002|Overall Study|Disease progression|5|||
157039763|NCT03593226|566899759|FG003|Overall Study|Disease progression|6|||
157039764|NCT03593226|566899756|FG000|Overall Study|Adverse Event|0|||
157039765|NCT03593226|566899757|FG001|Overall Study|Adverse Event|1|||
157039766|NCT03593226|566899758|FG002|Overall Study|Adverse Event|0|||
157039767|NCT03593226|566899759|FG003|Overall Study|Adverse Event|0|||
157039768|NCT03593226|566899756|FG000|Overall Study|Withdrawal by Subject|0|||
157039769|NCT03593226|566899757|FG001|Overall Study|Withdrawal by Subject|4|||
157039770|NCT03593226|566899758|FG002|Overall Study|Withdrawal by Subject|1|||
157039771|NCT03593226|566899759|FG003|Overall Study|Withdrawal by Subject|0|||
157039772|NCT03593226|566899756|FG000|Overall Study|Physician Decision|0|||
157039773|NCT03593226|566899757|FG001|Overall Study|Physician Decision|1|||
157039774|NCT03593226|566899758|FG002|Overall Study|Physician Decision|0|||
157039775|NCT03593226|566899759|FG003|Overall Study|Physician Decision|0|||
157039776|NCT03593226|566899756|FG000|Overall Study|Clinical disease progression|0|||
157039777|NCT03593226|566899757|FG001|Overall Study|Clinical disease progression|0|||
157039778|NCT03593226|566899758|FG002|Overall Study|Clinical disease progression|1|||
157039779|NCT03593226|566899759|FG003|Overall Study|Clinical disease progression|0|||
157039780|NCT04517435|566899760|FG000|Overall Study|Withdrawal by Subject|0|||
157039781|NCT04517435|566899761|FG001|Overall Study|Withdrawal by Subject|0|||
157039782|NCT04517435|566899762|FG002|Overall Study|Withdrawal by Subject|1|||
157039783|NCT04517435|566899760|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
157039784|NCT04517435|566899761|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
157039785|NCT04517435|566899762|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
157039786|NCT06191679|566899763|FG000|Baseline|Lost to Follow-up|1|||
157039787|NCT06191679|566899764|FG001|Baseline|Lost to Follow-up|0|||
157039788|NCT06191679|566899765|FG002|Baseline|Lost to Follow-up|1|||
157039789|NCT06191679|566899766|FG003|Baseline|Lost to Follow-up|0|||
157039790|NCT06191679|566899763|FG000|Allocation to Group|Withdrawal by Subject|0|||
157039791|NCT06191679|566899764|FG001|Allocation to Group|Withdrawal by Subject|1|||
157039792|NCT06191679|566899765|FG002|Allocation to Group|Withdrawal by Subject|2|||
157039793|NCT06191679|566899766|FG003|Allocation to Group|Withdrawal by Subject|0|||
157039794|NCT06191679|566899763|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
157039795|NCT06191679|566899764|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
157172428|NCT01998958|567371156|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
157039796|NCT06191679|566899765|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
157039797|NCT06191679|566899766|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
157039798|NCT06191679|566899763|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
157039799|NCT06191679|566899764|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
157039800|NCT06191679|566899765|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
157039801|NCT06191679|566899766|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
157039802|NCT06191679|566899763|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
157039803|NCT06191679|566899764|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
157039804|NCT06191679|566899765|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
157039805|NCT06191679|566899766|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
157039806|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
157039807|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
157039808|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
157039809|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
157039810|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
157039811|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
157039812|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
157039813|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
157039814|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
157039815|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
157039816|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
157039817|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
157039818|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
157039819|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
157039820|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
157039821|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
157039822|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
157039823|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
157039824|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
157039825|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
157039826|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
157039827|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
157039828|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
157039829|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
157039830|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
157039831|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
157039832|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
157039833|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
157039834|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
157039835|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
157039836|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
157039837|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
157172429|NCT01998958|567371157|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
157172430|NCT01998958|567371126|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172431|NCT01998958|567371127|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172432|NCT01998958|567371128|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172433|NCT01998958|567371129|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172434|NCT01998958|567371130|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172435|NCT01998958|567371131|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172436|NCT01998958|567371132|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172437|NCT01998958|567371133|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172438|NCT01998958|567371134|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172439|NCT01998958|567371135|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172440|NCT01998958|567371136|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172441|NCT01998958|567371137|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157039838|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
157039839|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
157039840|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
157039841|NCT03656718|566899767|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
157039842|NCT03656718|566899768|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
157039843|NCT03656718|566899769|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
157039844|NCT03656718|566899770|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
157039845|NCT03656718|566899771|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
157039846|NCT03656718|566899772|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
157039847|NCT03656718|566899773|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
157039848|NCT03656718|566899767|FG000|Treatment Period Part C|Disease progression|0|||
157039849|NCT03656718|566899768|FG001|Treatment Period Part C|Disease progression|0|||
157039850|NCT03656718|566899769|FG002|Treatment Period Part C|Disease progression|0|||
157039851|NCT03656718|566899770|FG003|Treatment Period Part C|Disease progression|0|||
157039852|NCT03656718|566899771|FG004|Treatment Period Part C|Disease progression|12|||
157039853|NCT03656718|566899772|FG005|Treatment Period Part C|Disease progression|0|||
157039854|NCT03656718|566899773|FG006|Treatment Period Part C|Disease progression|0|||
157039855|NCT03656718|566899767|FG000|Treatment Period Part C|Death|0|||
157039856|NCT03656718|566899768|FG001|Treatment Period Part C|Death|0|||
157039857|NCT03656718|566899769|FG002|Treatment Period Part C|Death|0|||
157039858|NCT03656718|566899770|FG003|Treatment Period Part C|Death|0|||
157039859|NCT03656718|566899771|FG004|Treatment Period Part C|Death|1|||
157039860|NCT03656718|566899772|FG005|Treatment Period Part C|Death|0|||
157039861|NCT03656718|566899773|FG006|Treatment Period Part C|Death|0|||
157039862|NCT03656718|566899767|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039863|NCT03656718|566899768|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039864|NCT03656718|566899769|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039865|NCT03656718|566899770|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039866|NCT03656718|566899771|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
157039867|NCT03656718|566899772|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039868|NCT03656718|566899773|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
157039869|NCT03656718|566899767|FG000|Treatment Period Part C|Other reasons|0|||
157039870|NCT03656718|566899768|FG001|Treatment Period Part C|Other reasons|0|||
157039871|NCT03656718|566899769|FG002|Treatment Period Part C|Other reasons|0|||
157039872|NCT03656718|566899770|FG003|Treatment Period Part C|Other reasons|0|||
157039873|NCT03656718|566899771|FG004|Treatment Period Part C|Other reasons|1|||
157039874|NCT03656718|566899772|FG005|Treatment Period Part C|Other reasons|0|||
157039875|NCT03656718|566899773|FG006|Treatment Period Part C|Other reasons|0|||
157039876|NCT03656718|566899767|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
157039877|NCT03656718|566899768|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
157039878|NCT03656718|566899769|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
157039879|NCT03656718|566899770|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
157039880|NCT03656718|566899771|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
157039881|NCT03656718|566899772|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
157039882|NCT03656718|566899773|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
157039883|NCT03277989|566899777|FG000|Overall Study|Lost to Follow-up|6|||
157039884|NCT03277989|566899777|FG000|Overall Study|Adverse Event|6|||
157039885|NCT03277989|566899777|FG000|Overall Study|Withdrawal by Subject|3|||
157039886|NCT03277989|566899777|FG000|Overall Study|Didn't Receive Study Device|7|||
157039887|NCT03277989|566899777|FG000|Overall Study|Site Closure|26|||
157039888|NCT03277989|566899777|FG000|Overall Study|Sponsor Closure|107|||
157039889|NCT03367156|566901481|FG000|Overall Study|Lack of interest|3|||
157039890|NCT03367156|566901482|FG001|Overall Study|Lack of interest|1|||
157039891|NCT03367156|566901481|FG000|Overall Study|Death|2|||
157039892|NCT03367156|566901482|FG001|Overall Study|Death|0|||
157039893|NCT03367156|566901481|FG000|Overall Study|Lost to Follow-up|2|||
157039894|NCT03367156|566901482|FG001|Overall Study|Lost to Follow-up|1|||
157039895|NCT03367156|566901481|FG000|Overall Study|Became ineligible|1|||
157039896|NCT03367156|566901482|FG001|Overall Study|Became ineligible|2|||
157039897|NCT03367156|566901481|FG000|Overall Study|Hospitalization|1|||
157039898|NCT03367156|566901482|FG001|Overall Study|Hospitalization|0|||
157039899|NCT03367156|566901481|FG000|Overall Study|Concerned about Treatment|11|||
157039900|NCT03367156|566901482|FG001|Overall Study|Concerned about Treatment|3|||
157039901|NCT03367156|566901481|FG000|Overall Study|Started new treatment|4|||
157039902|NCT03367156|566901482|FG001|Overall Study|Started new treatment|1|||
157227854|NCT03008460|567579217|FG000|Overall Study|End of study visit outside permitted time window|0|||
157039903|NCT03762850|566901483|FG000|Overall Study|Death|0|||
157039904|NCT03762850|566901484|FG001|Overall Study|Death|1|||
157039905|NCT03762850|566901483|FG000|Overall Study|Lost to Follow-up|0|||
157039906|NCT03762850|566901484|FG001|Overall Study|Lost to Follow-up|1|||
157039907|NCT03762850|566901483|FG000|Overall Study|Physician Decision|0|||
156963698|NCT01302119|566618569|FG001|Overall Study|Adverse Event|1|||
156963699|NCT01302119|566618568|FG000|Overall Study|Non-compliance|4|||
156963700|NCT01302119|566618569|FG001|Overall Study|Non-compliance|2|||
156963701|NCT01302119|566618568|FG000|Overall Study|Non-specific|4|||
156963702|NCT01302119|566618569|FG001|Overall Study|Non-specific|1|||
156963703|NCT01775904|566618573|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
156963704|NCT01775904|566618573|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
156963705|NCT00518115|566618574|FG000|Overall Study|Adverse Event|6|||
156963706|NCT00518115|566618575|FG001|Overall Study|Adverse Event|1|||
156963707|NCT00518115|566618576|FG002|Overall Study|Adverse Event|5|||
156963708|NCT00518115|566618577|FG003|Overall Study|Adverse Event|6|||
156963709|NCT00518115|566618578|FG004|Overall Study|Adverse Event|5|||
156963710|NCT00518115|566618579|FG005|Overall Study|Adverse Event|5|||
156963711|NCT00518115|566618580|FG006|Overall Study|Adverse Event|5|||
156963712|NCT00518115|566618581|FG007|Overall Study|Adverse Event|10|||
156963713|NCT00518115|566618582|FG008|Overall Study|Adverse Event|2|||
156963714|NCT00518115|566618583|FG009|Overall Study|Adverse Event|9|||
156963715|NCT00518115|566618574|FG000|Overall Study|Lost to Follow-up|0|||
156963716|NCT00518115|566618575|FG001|Overall Study|Lost to Follow-up|0|||
156963717|NCT00518115|566618576|FG002|Overall Study|Lost to Follow-up|2|||
156963718|NCT00518115|566618577|FG003|Overall Study|Lost to Follow-up|3|||
156963719|NCT00518115|566618578|FG004|Overall Study|Lost to Follow-up|1|||
156963720|NCT00518115|566618579|FG005|Overall Study|Lost to Follow-up|3|||
156963721|NCT00518115|566618580|FG006|Overall Study|Lost to Follow-up|0|||
156963722|NCT00518115|566618581|FG007|Overall Study|Lost to Follow-up|1|||
156963723|NCT00518115|566618582|FG008|Overall Study|Lost to Follow-up|1|||
156963724|NCT00518115|566618583|FG009|Overall Study|Lost to Follow-up|1|||
156963725|NCT00518115|566618574|FG000|Overall Study|Protocol Violation|1|||
156963726|NCT00518115|566618575|FG001|Overall Study|Protocol Violation|3|||
156963727|NCT00518115|566618576|FG002|Overall Study|Protocol Violation|1|||
156963728|NCT00518115|566618577|FG003|Overall Study|Protocol Violation|0|||
156963729|NCT00518115|566618578|FG004|Overall Study|Protocol Violation|0|||
156963730|NCT00518115|566618579|FG005|Overall Study|Protocol Violation|0|||
156963731|NCT00518115|566618580|FG006|Overall Study|Protocol Violation|0|||
156963732|NCT00518115|566618581|FG007|Overall Study|Protocol Violation|0|||
156963733|NCT00518115|566618582|FG008|Overall Study|Protocol Violation|0|||
156963734|NCT00518115|566618583|FG009|Overall Study|Protocol Violation|0|||
156963735|NCT00518115|566618574|FG000|Overall Study|Withdrawal by Subject|1|||
156963736|NCT00518115|566618575|FG001|Overall Study|Withdrawal by Subject|1|||
156963737|NCT00518115|566618576|FG002|Overall Study|Withdrawal by Subject|5|||
156963738|NCT00518115|566618577|FG003|Overall Study|Withdrawal by Subject|0|||
156963739|NCT00518115|566618578|FG004|Overall Study|Withdrawal by Subject|2|||
156963740|NCT00518115|566618579|FG005|Overall Study|Withdrawal by Subject|1|||
156963741|NCT00518115|566618580|FG006|Overall Study|Withdrawal by Subject|0|||
156963742|NCT00518115|566618581|FG007|Overall Study|Withdrawal by Subject|2|||
156963743|NCT00518115|566618582|FG008|Overall Study|Withdrawal by Subject|1|||
156963744|NCT00518115|566618583|FG009|Overall Study|Withdrawal by Subject|3|||
156963745|NCT00518115|566618574|FG000|Overall Study|Lack of Efficacy|1|||
156963746|NCT00518115|566618575|FG001|Overall Study|Lack of Efficacy|0|||
156963747|NCT00518115|566618576|FG002|Overall Study|Lack of Efficacy|1|||
156963748|NCT00518115|566618577|FG003|Overall Study|Lack of Efficacy|1|||
156963749|NCT00518115|566618578|FG004|Overall Study|Lack of Efficacy|0|||
156963750|NCT00518115|566618579|FG005|Overall Study|Lack of Efficacy|0|||
156963751|NCT00518115|566618580|FG006|Overall Study|Lack of Efficacy|0|||
156963752|NCT00518115|566618581|FG007|Overall Study|Lack of Efficacy|1|||
156963753|NCT00518115|566618582|FG008|Overall Study|Lack of Efficacy|0|||
156963754|NCT00518115|566618583|FG009|Overall Study|Lack of Efficacy|0|||
156963755|NCT00518115|566618574|FG000|Overall Study|Non-Compliance|1|||
156963756|NCT00518115|566618575|FG001|Overall Study|Non-Compliance|0|||
156963757|NCT00518115|566618576|FG002|Overall Study|Non-Compliance|1|||
156963758|NCT00518115|566618577|FG003|Overall Study|Non-Compliance|0|||
156963759|NCT00518115|566618578|FG004|Overall Study|Non-Compliance|1|||
156963760|NCT00518115|566618579|FG005|Overall Study|Non-Compliance|1|||
156963761|NCT00518115|566618580|FG006|Overall Study|Non-Compliance|1|||
156963762|NCT00518115|566618581|FG007|Overall Study|Non-Compliance|1|||
156963763|NCT00518115|566618582|FG008|Overall Study|Non-Compliance|0|||
156963764|NCT00518115|566618583|FG009|Overall Study|Non-Compliance|1|||
156963765|NCT00518115|566618574|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
156963766|NCT00518115|566618575|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
156963767|NCT00518115|566618576|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963768|NCT00518115|566618577|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963769|NCT00518115|566618578|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963770|NCT00518115|566618579|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
156963771|NCT00518115|566618580|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963772|NCT00518115|566618581|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963773|NCT00518115|566618582|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
156963774|NCT00518115|566618583|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
157039908|NCT03762850|566901484|FG001|Overall Study|Physician Decision|1|||
156963775|NCT00518115|566618574|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
156963776|NCT00518115|566618575|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963777|NCT00518115|566618576|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963778|NCT00518115|566618577|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963779|NCT00518115|566618578|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963780|NCT00518115|566618579|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963781|NCT00518115|566618580|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963782|NCT00518115|566618581|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963783|NCT00518115|566618582|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963784|NCT00518115|566618583|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
156963785|NCT00518115|566618574|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963786|NCT00518115|566618575|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963787|NCT00518115|566618576|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
156963788|NCT00518115|566618577|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963789|NCT00518115|566618578|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963790|NCT00518115|566618579|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963791|NCT00518115|566618580|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963792|NCT00518115|566618581|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963793|NCT00518115|566618582|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
156963794|NCT00518115|566618583|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
156963795|NCT00518115|566618574|FG000|Overall Study|Wrong Monotherapy Administered|0|||
156963796|NCT00518115|566618575|FG001|Overall Study|Wrong Monotherapy Administered|0|||
156963797|NCT00518115|566618576|FG002|Overall Study|Wrong Monotherapy Administered|1|||
156963798|NCT00518115|566618577|FG003|Overall Study|Wrong Monotherapy Administered|0|||
156963799|NCT00518115|566618578|FG004|Overall Study|Wrong Monotherapy Administered|0|||
156963800|NCT00518115|566618579|FG005|Overall Study|Wrong Monotherapy Administered|0|||
156963801|NCT00518115|566618580|FG006|Overall Study|Wrong Monotherapy Administered|1|||
156963802|NCT00518115|566618581|FG007|Overall Study|Wrong Monotherapy Administered|0|||
156963803|NCT00518115|566618582|FG008|Overall Study|Wrong Monotherapy Administered|0|||
156963804|NCT00518115|566618583|FG009|Overall Study|Wrong Monotherapy Administered|0|||
156963805|NCT00518115|566618574|FG000|Overall Study|Violation of Exclusion Criteria|0|||
156963806|NCT00518115|566618575|FG001|Overall Study|Violation of Exclusion Criteria|0|||
156963807|NCT00518115|566618576|FG002|Overall Study|Violation of Exclusion Criteria|0|||
156963808|NCT00518115|566618577|FG003|Overall Study|Violation of Exclusion Criteria|1|||
156963809|NCT00518115|566618578|FG004|Overall Study|Violation of Exclusion Criteria|0|||
156963810|NCT00518115|566618579|FG005|Overall Study|Violation of Exclusion Criteria|0|||
156963811|NCT00518115|566618580|FG006|Overall Study|Violation of Exclusion Criteria|1|||
156963812|NCT00518115|566618581|FG007|Overall Study|Violation of Exclusion Criteria|0|||
156963813|NCT00518115|566618582|FG008|Overall Study|Violation of Exclusion Criteria|0|||
156963814|NCT00518115|566618583|FG009|Overall Study|Violation of Exclusion Criteria|0|||
156963815|NCT00518115|566618574|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
156963816|NCT00518115|566618575|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
156963817|NCT00518115|566618576|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
156963818|NCT00518115|566618577|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
156963819|NCT00518115|566618578|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
156963820|NCT00518115|566618579|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
156963821|NCT00518115|566618580|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
156963822|NCT00518115|566618581|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
156963823|NCT00518115|566618582|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
156963824|NCT00518115|566618583|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
156963825|NCT00518115|566618574|FG000|Overall Study|Withdrew Consent|0|||
156963826|NCT00518115|566618575|FG001|Overall Study|Withdrew Consent|0|||
156963827|NCT00518115|566618576|FG002|Overall Study|Withdrew Consent|0|||
156963828|NCT00518115|566618577|FG003|Overall Study|Withdrew Consent|0|||
156963829|NCT00518115|566618578|FG004|Overall Study|Withdrew Consent|0|||
156963830|NCT00518115|566618579|FG005|Overall Study|Withdrew Consent|1|||
156963831|NCT00518115|566618580|FG006|Overall Study|Withdrew Consent|0|||
156963832|NCT00518115|566618581|FG007|Overall Study|Withdrew Consent|0|||
156963833|NCT00518115|566618582|FG008|Overall Study|Withdrew Consent|0|||
156963834|NCT00518115|566618583|FG009|Overall Study|Withdrew Consent|0|||
157172442|NCT01998958|567371138|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156963835|NCT00518115|566618574|FG000|Overall Study|Moved Out of State|0|||
156963836|NCT00518115|566618575|FG001|Overall Study|Moved Out of State|0|||
156963837|NCT00518115|566618576|FG002|Overall Study|Moved Out of State|0|||
156963838|NCT00518115|566618577|FG003|Overall Study|Moved Out of State|0|||
156963839|NCT00518115|566618578|FG004|Overall Study|Moved Out of State|0|||
156963840|NCT00518115|566618579|FG005|Overall Study|Moved Out of State|0|||
156963841|NCT00518115|566618580|FG006|Overall Study|Moved Out of State|0|||
156963842|NCT00518115|566618581|FG007|Overall Study|Moved Out of State|0|||
156963843|NCT00518115|566618582|FG008|Overall Study|Moved Out of State|0|||
156963844|NCT00518115|566618583|FG009|Overall Study|Moved Out of State|1|||
156963845|NCT04891419|566618584|FG000|Overall Study|Withdrawal by Subject|4|||
156963846|NCT04891419|566618585|FG001|Overall Study|Withdrawal by Subject|0|||
156963847|NCT04891419|566618584|FG000|Overall Study|Lost to Follow-up|1|||
156963848|NCT04891419|566618585|FG001|Overall Study|Lost to Follow-up|3|||
156963849|NCT02291614|566618589|FG000|Overall Study|Lost to Follow-up|0|||
156963850|NCT02291614|566618590|FG001|Overall Study|Lost to Follow-up|0|||
156963851|NCT02291614|566618591|FG002|Overall Study|Lost to Follow-up|0|||
156963852|NCT02291614|566618592|FG003|Overall Study|Lost to Follow-up|0|||
156963853|NCT02291614|566618593|FG004|Overall Study|Lost to Follow-up|0|||
156963854|NCT02291614|566618594|FG005|Overall Study|Lost to Follow-up|0|||
156963855|NCT02291614|566618595|FG006|Overall Study|Lost to Follow-up|0|||
156963856|NCT02291614|566618596|FG007|Overall Study|Lost to Follow-up|1|||
156963857|NCT02291614|566618597|FG008|Overall Study|Lost to Follow-up|0|||
156963858|NCT02291614|566618598|FG009|Overall Study|Lost to Follow-up|0|||
156963859|NCT02291614|566618599|FG010|Overall Study|Lost to Follow-up|0|||
156963860|NCT02291614|566618589|FG000|Overall Study|Withdrawal by Subject|0|||
156963861|NCT02291614|566618590|FG001|Overall Study|Withdrawal by Subject|1|||
156963862|NCT02291614|566618591|FG002|Overall Study|Withdrawal by Subject|0|||
156963863|NCT02291614|566618592|FG003|Overall Study|Withdrawal by Subject|0|||
156963864|NCT02291614|566618593|FG004|Overall Study|Withdrawal by Subject|0|||
156963865|NCT02291614|566618594|FG005|Overall Study|Withdrawal by Subject|0|||
156963866|NCT02291614|566618595|FG006|Overall Study|Withdrawal by Subject|0|||
156963867|NCT02291614|566618596|FG007|Overall Study|Withdrawal by Subject|0|||
156963868|NCT02291614|566618597|FG008|Overall Study|Withdrawal by Subject|0|||
156963869|NCT02291614|566618598|FG009|Overall Study|Withdrawal by Subject|2|||
156963870|NCT02291614|566618599|FG010|Overall Study|Withdrawal by Subject|2|||
156963871|NCT02291614|566618589|FG000|Overall Study|Decision by sponsor|0|||
156963872|NCT02291614|566618590|FG001|Overall Study|Decision by sponsor|0|||
156963873|NCT02291614|566618591|FG002|Overall Study|Decision by sponsor|0|||
156963874|NCT02291614|566618592|FG003|Overall Study|Decision by sponsor|1|||
156963875|NCT02291614|566618593|FG004|Overall Study|Decision by sponsor|0|||
156963876|NCT02291614|566618594|FG005|Overall Study|Decision by sponsor|0|||
156963877|NCT02291614|566618595|FG006|Overall Study|Decision by sponsor|0|||
156963878|NCT02291614|566618596|FG007|Overall Study|Decision by sponsor|0|||
156963879|NCT02291614|566618597|FG008|Overall Study|Decision by sponsor|0|||
156963880|NCT02291614|566618598|FG009|Overall Study|Decision by sponsor|0|||
156963881|NCT02291614|566618599|FG010|Overall Study|Decision by sponsor|0|||
156963882|NCT02291614|566618589|FG000|Overall Study|Death|0|||
156963883|NCT02291614|566618590|FG001|Overall Study|Death|0|||
156963884|NCT02291614|566618591|FG002|Overall Study|Death|1|||
156963885|NCT02291614|566618592|FG003|Overall Study|Death|0|||
156963886|NCT02291614|566618593|FG004|Overall Study|Death|1|||
156963887|NCT02291614|566618594|FG005|Overall Study|Death|1|||
156963888|NCT02291614|566618595|FG006|Overall Study|Death|1|||
156963889|NCT02291614|566618596|FG007|Overall Study|Death|0|||
156963890|NCT02291614|566618597|FG008|Overall Study|Death|0|||
156963891|NCT02291614|566618598|FG009|Overall Study|Death|0|||
156963892|NCT02291614|566618599|FG010|Overall Study|Death|0|||
156963893|NCT00843167|566618600|FG000|Treatment Period|Adverse Event|1|||
156963894|NCT00843167|566618601|FG001|Treatment Period|Adverse Event|5|||
156963895|NCT00843167|566618600|FG000|Treatment Period|Withdrawal by Subject|2|||
156963896|NCT00843167|566618601|FG001|Treatment Period|Withdrawal by Subject|3|||
156963897|NCT03743038|566618602|FG000|Overall Study|Physician Decision|1|||
156963898|NCT02432105|566618605|FG000|Overall Study|Lost to Follow-up|1|||
156963899|NCT02432105|566618606|FG001|Overall Study|Lost to Follow-up|1|||
156963900|NCT02432105|566618607|FG002|Overall Study|Lost to Follow-up|0|||
156963901|NCT02432105|566618605|FG000|Overall Study|Withdrawal by Subject|1|||
156963902|NCT02432105|566618606|FG001|Overall Study|Withdrawal by Subject|0|||
156963903|NCT02432105|566618607|FG002|Overall Study|Withdrawal by Subject|1|||
157172443|NCT01998958|567371139|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172444|NCT01998958|567371140|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172445|NCT01998958|567371141|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156963904|NCT02432105|566618605|FG000|Overall Study|Culture positive for yeast|0|||
156963905|NCT02432105|566618606|FG001|Overall Study|Culture positive for yeast|1|||
156963906|NCT02432105|566618607|FG002|Overall Study|Culture positive for yeast|0|||
156963907|NCT02432105|566618605|FG000|Overall Study|Randomized in error|0|||
156963908|NCT02432105|566618606|FG001|Overall Study|Randomized in error|0|||
156963909|NCT02432105|566618607|FG002|Overall Study|Randomized in error|2|||
156963910|NCT02130193|566618608|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
156963911|NCT02130193|566618609|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
156963912|NCT02130193|566618610|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
156963913|NCT02130193|566618608|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
156963914|NCT02130193|566618609|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
156963915|NCT02130193|566618610|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
156963916|NCT02130193|566618608|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
156963917|NCT02130193|566618609|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
156963918|NCT02130193|566618610|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
157172446|NCT01998958|567371142|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172447|NCT01998958|567371143|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172448|NCT01998958|567371144|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156963919|NCT02130193|566618608|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
156963920|NCT02130193|566618609|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
156963921|NCT02130193|566618610|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
156963922|NCT02693743|566618620|FG000|Overall Study|Physician Decision|1|||
156963923|NCT02693743|566618621|FG001|Overall Study|Physician Decision|0|||
156963924|NCT02626780|566618622|FG000|Overall Study|Withdrawal by Subject|3|||
156963925|NCT05338333|566618627|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
156963926|NCT05338333|566618628|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
156963927|NCT00680407|566618634|FG000|Overall Study|Lost to Follow-up|3|||
156963928|NCT00680407|566618635|FG001|Overall Study|Lost to Follow-up|3|||
156963929|NCT00680407|566618636|FG002|Overall Study|Lost to Follow-up|1|||
156963930|NCT00680407|566618634|FG000|Overall Study|Withdrawal by Subject|5|||
156963931|NCT00680407|566618635|FG001|Overall Study|Withdrawal by Subject|2|||
156963932|NCT00680407|566618636|FG002|Overall Study|Withdrawal by Subject|2|||
156963933|NCT00499031|566620474|FG000|Overall Study|Improper pre-protocol treatment|1|||
156963934|NCT00499031|566620474|FG000|Overall Study|Required test not done|1|||
156963935|NCT00499031|566620474|FG000|Overall Study|Never treated|1|||
156963936|NCT03409666|566620475|FG000|Overall Study|Physician Decision|0|||
156963937|NCT03409666|566620476|FG001|Overall Study|Physician Decision|1|||
156963938|NCT03409666|566620475|FG000|Overall Study|Protocol Violation|0|||
156963939|NCT03409666|566620476|FG001|Overall Study|Protocol Violation|3|||
156963940|NCT00512148|566620477|FG000|Primay Study Period|Withdrawal by Subject|1|||
156963941|NCT01666951|566620484|FG000|Overall Study|Not dosed|1|||
156963942|NCT01666951|566620485|FG001|Overall Study|Not dosed|1|||
156963943|NCT02366910|566620486|FG000|Overall Study|Withdrawal by Subject|2|||
156963944|NCT02366910|566620486|FG000|Overall Study|Screen Failure|3|||
156963945|NCT03284788|566620487|FG000|Overall Study|Withdrawal by Subject|2|||
156963946|NCT03563716|566620488|FG000|Overall Study|Death|20|||
156963947|NCT03563716|566620489|FG001|Overall Study|Death|14|||
156963948|NCT03563716|566620488|FG000|Overall Study|Withdrawal by Subject|3|||
156963949|NCT03563716|566620489|FG001|Overall Study|Withdrawal by Subject|3|||
156963950|NCT03563716|566620488|FG000|Overall Study|Still on Study|45|||
156963951|NCT03563716|566620489|FG001|Overall Study|Still on Study|50|||
156963952|NCT04605978|566620493|FG000|Overall Study|Adverse Event|2|||
156963953|NCT04605978|566620494|FG001|Overall Study|Adverse Event|1|||
156963954|NCT04605978|566620493|FG000|Overall Study|Withdrawal nonmedical reason|1|||
156963955|NCT04605978|566620494|FG001|Overall Study|Withdrawal nonmedical reason|1|||
156963956|NCT03813238|566620495|FG000|Overall Study|Adverse Event|0|||
156963957|NCT03813238|566620496|FG001|Overall Study|Adverse Event|6|||
156963958|NCT03813238|566620495|FG000|Overall Study|Withdrawal by parent/guardian|0|||
156963959|NCT03813238|566620496|FG001|Overall Study|Withdrawal by parent/guardian|2|||
156963960|NCT03813238|566620495|FG000|Overall Study|Lost to Follow-up|0|||
156963961|NCT03813238|566620496|FG001|Overall Study|Lost to Follow-up|1|||
156963962|NCT03813238|566620495|FG000|Overall Study|Other than specified|1|||
156963963|NCT03813238|566620496|FG001|Overall Study|Other than specified|2|||
156963964|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
156963965|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
156963966|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
156963967|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
156963968|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
156963969|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
156963970|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
156963971|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
156963972|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
156963973|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
156963974|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
156963975|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
156963976|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Death|6|||
156963977|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Death|3|||
156963978|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Death|0|||
156963979|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Death|1|||
157172449|NCT01998958|567371145|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156963980|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Death|1|||
156963981|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Death|0|||
156963982|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
156963983|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
156963984|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
156963985|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
156963986|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
156963987|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
156963988|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156963989|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
156963990|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
156963991|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156963992|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156963993|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
156963994|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
156963995|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
156963996|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
156963997|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
156963998|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
156963999|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
156964000|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
156964001|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
156964002|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
156964003|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
156964004|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
156964005|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
156964006|NCT03104699|566620497|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
156964007|NCT03104699|566620498|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
156964008|NCT03104699|566620499|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
156964009|NCT03104699|566620500|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
156964010|NCT03104699|566620501|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
156964011|NCT03104699|566620502|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
156964012|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156964013|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156964014|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156964015|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156964016|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
156964017|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
156964018|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Death|0|||
156964019|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Death|0|||
156964020|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Death|0|||
156964021|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Death|0|||
156964022|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Death|0|||
156964023|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Death|107|||
156964024|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156964025|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156964026|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156964027|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156964028|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
156964029|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
156964030|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156964031|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156964032|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156964033|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
157172450|NCT01998958|567371146|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172451|NCT01998958|567371147|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
156964034|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
156964035|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
156964036|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156964037|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156964038|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156964039|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156964040|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
156964041|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
156964042|NCT03104699|566620497|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
156964043|NCT03104699|566620498|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
156964044|NCT03104699|566620499|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
156964045|NCT03104699|566620500|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
156964046|NCT03104699|566620501|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
156964047|NCT03104699|566620502|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
156964048|NCT01690130|566620503|FG000|Overall Study|Subject have cancelled visit.|1|||
156964049|NCT01690130|566620504|FG001|Overall Study|Subject have cancelled visit.|0|||
156964050|NCT02450331|566620508|FG000|Overall Study|Death|162|||
156964051|NCT02450331|566620509|FG001|Overall Study|Death|171|||
156964052|NCT02450331|566620508|FG000|Overall Study|Lost to Follow-up|14|||
156964053|NCT02450331|566620509|FG001|Overall Study|Lost to Follow-up|12|||
156964054|NCT02450331|566620508|FG000|Overall Study|Withdrawal by Subject|55|||
156964055|NCT02450331|566620509|FG001|Overall Study|Withdrawal by Subject|44|||
156964056|NCT02450331|566620508|FG000|Overall Study|Non-specified other|1|||
156964057|NCT02450331|566620509|FG001|Overall Study|Non-specified other|1|||
156964058|NCT02080871|566620510|FG000|Overall Study|Death|1|||
156964059|NCT02080871|566620510|FG000|Overall Study|Lost to Follow-up|1|||
156964060|NCT00234052|566620511|FG000|Treatment|Withdrawal by Subject|3|||
156964061|NCT00234052|566620511|FG000|Treatment|Adverse Event|5|||
156964062|NCT00234052|566620511|FG000|Treatment|Death|2|||
156964063|NCT00234052|566620511|FG000|Treatment|Progressive Disease|11|||
156964064|NCT00234052|566620511|FG000|Follow-up for 5 Years|Death|41|||
156964065|NCT00234052|566620511|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
156964066|NCT00234052|566620511|FG000|Follow-up for 5 Years|Other|7|||
156964067|NCT01410474|566620512|FG000|Overall Study|Withdrawal by Subject|0|||
156964068|NCT01410474|566620513|FG001|Overall Study|Withdrawal by Subject|1|||
156964069|NCT02428296|566620514|FG000|Overall Study|Adverse Event|7|||
156964070|NCT02428296|566620514|FG000|Overall Study|Withdrawal by Subject|2|||
156964071|NCT00831779|566620519|FG000|Overall Study|Lost to Follow-up|1|||
156964072|NCT00831779|566620520|FG001|Overall Study|Lost to Follow-up|0|||
156964073|NCT00831779|566620519|FG000|Overall Study|No longer met criteria|0|||
156964074|NCT00831779|566620520|FG001|Overall Study|No longer met criteria|1|||
156964075|NCT04020341|566620521|FG000|Overall Study|Adverse Event|8|||
156964076|NCT04020341|566620522|FG001|Overall Study|Adverse Event|6|||
156964077|NCT04020341|566620521|FG000|Overall Study|Lost to Follow-up|8|||
156964078|NCT04020341|566620522|FG001|Overall Study|Lost to Follow-up|2|||
156964079|NCT04020341|566620521|FG000|Overall Study|Withdrawal by Subject|16|||
156964080|NCT04020341|566620522|FG001|Overall Study|Withdrawal by Subject|16|||
156964081|NCT04020341|566620521|FG000|Overall Study|Participant not able to swallow the tablet|1|||
156964082|NCT04020341|566620522|FG001|Overall Study|Participant not able to swallow the tablet|0|||
156964083|NCT04020341|566620521|FG000|Overall Study|Physician Decision|0|||
156964084|NCT04020341|566620522|FG001|Overall Study|Physician Decision|2|||
156964085|NCT04020341|566620521|FG000|Overall Study|Protocol Deviation|0|||
156964086|NCT04020341|566620522|FG001|Overall Study|Protocol Deviation|2|||
156964087|NCT05763628|566620523|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
156964088|NCT05763628|566620524|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
156964089|NCT05763628|566620523|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
156964090|NCT05763628|566620524|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
156964091|NCT05763628|566620523|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
156964092|NCT05763628|566620524|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
156964093|NCT04528069|566620525|FG000|Overall Study|Adverse Event|1|||
156964094|NCT04528069|566620525|FG000|Overall Study|Lost to Follow-up|1|||
156964095|NCT04528069|566620525|FG000|Overall Study|Patient Unable to Come|1|||
156964096|NCT04528069|566620525|FG000|Overall Study|Patient Unable to Attend|1|||
156964097|NCT01814371|566620527|FG000|Overall Study|Lost to Follow-up|30|||
156964098|NCT01814371|566620528|FG001|Overall Study|Lost to Follow-up|27|||
156964099|NCT04683926|566620529|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
156964100|NCT04683926|566620530|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
156964101|NCT04683926|566620531|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
156964102|NCT04683926|566620532|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
156964103|NCT04535947|566620536|FG000|Overall Study|Adverse Event|1|||
156964104|NCT04535947|566620537|FG001|Overall Study|Adverse Event|4|||
156964105|NCT04535947|566620536|FG000|Overall Study|Other reasons not specified|2|||
156964106|NCT04535947|566620537|FG001|Overall Study|Other reasons not specified|0|||
156964107|NCT04535947|566620536|FG000|Overall Study|Withdrawal by Subject|1|||
156964108|NCT04535947|566620537|FG001|Overall Study|Withdrawal by Subject|1|||
156964109|NCT05072080|566620542|FG000|Overall Study|Death|0|||
156964110|NCT05072080|566620543|FG001|Overall Study|Death|0|||
156964111|NCT05072080|566620544|FG002|Overall Study|Death|1|||
156964112|NCT05072080|566620545|FG003|Overall Study|Death|0|||
156964113|NCT05072080|566620542|FG000|Overall Study|Lost to Follow-up|65|||
156964114|NCT05072080|566620543|FG001|Overall Study|Lost to Follow-up|70|||
156964115|NCT05072080|566620544|FG002|Overall Study|Lost to Follow-up|58|||
156964116|NCT05072080|566620545|FG003|Overall Study|Lost to Follow-up|23|||
156964117|NCT05072080|566620542|FG000|Overall Study|Physician Decision|2|||
156964118|NCT05072080|566620543|FG001|Overall Study|Physician Decision|1|||
156964119|NCT05072080|566620544|FG002|Overall Study|Physician Decision|1|||
156964120|NCT05072080|566620545|FG003|Overall Study|Physician Decision|0|||
156964121|NCT05072080|566620542|FG000|Overall Study|Withdrawal by Subject|45|||
156964122|NCT05072080|566620543|FG001|Overall Study|Withdrawal by Subject|30|||
156964123|NCT05072080|566620544|FG002|Overall Study|Withdrawal by Subject|27|||
156964124|NCT05072080|566620545|FG003|Overall Study|Withdrawal by Subject|7|||
156964125|NCT05072080|566620542|FG000|Overall Study|Sponsor Decision|0|||
157172452|NCT01998958|567371148|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
157172453|NCT01998958|567371149|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
156964126|NCT05072080|566620543|FG001|Overall Study|Sponsor Decision|1|||
157172454|NCT01998958|567371150|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156964127|NCT05072080|566620544|FG002|Overall Study|Sponsor Decision|0|||
156964128|NCT05072080|566620545|FG003|Overall Study|Sponsor Decision|0|||
156964129|NCT05072080|566620542|FG000|Overall Study|Subject moved|1|||
156964130|NCT05072080|566620543|FG001|Overall Study|Subject moved|3|||
156964131|NCT05072080|566620544|FG002|Overall Study|Subject moved|5|||
156964132|NCT05072080|566620545|FG003|Overall Study|Subject moved|2|||
156964133|NCT05072080|566620542|FG000|Overall Study|Withdrawal by parent|0|||
156964134|NCT05072080|566620543|FG001|Overall Study|Withdrawal by parent|0|||
156964135|NCT05072080|566620544|FG002|Overall Study|Withdrawal by parent|1|||
156964136|NCT05072080|566620545|FG003|Overall Study|Withdrawal by parent|0|||
156964137|NCT05072080|566620542|FG000|Overall Study|Subject was deployed|0|||
156964138|NCT05072080|566620543|FG001|Overall Study|Subject was deployed|1|||
156964139|NCT05072080|566620544|FG002|Overall Study|Subject was deployed|0|||
157172455|NCT01998958|567371151|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172456|NCT01998958|567371152|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172457|NCT01998958|567371153|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156964140|NCT05072080|566620545|FG003|Overall Study|Subject was deployed|0|||
156964141|NCT05072080|566620542|FG000|Overall Study|Subject left site without receiving dose|0|||
156964142|NCT05072080|566620543|FG001|Overall Study|Subject left site without receiving dose|1|||
156964143|NCT05072080|566620544|FG002|Overall Study|Subject left site without receiving dose|0|||
156964144|NCT05072080|566620545|FG003|Overall Study|Subject left site without receiving dose|0|||
156964145|NCT05072080|566620542|FG000|Overall Study|Subject incarcerated|0|||
156964146|NCT05072080|566620543|FG001|Overall Study|Subject incarcerated|1|||
156964147|NCT05072080|566620544|FG002|Overall Study|Subject incarcerated|0|||
156964148|NCT05072080|566620545|FG003|Overall Study|Subject incarcerated|1|||
156964149|NCT05072080|566620542|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
156964150|NCT05072080|566620543|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
156964151|NCT05072080|566620544|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
156964152|NCT05072080|566620545|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
156964153|NCT05072080|566620542|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
156964154|NCT05072080|566620543|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
156964155|NCT05072080|566620544|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
156964156|NCT05072080|566620545|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
156964157|NCT04867369|566620548|FG000|Overall Study|Withdrawal by Subject|1|||
156964158|NCT04867369|566620549|FG001|Overall Study|Withdrawal by Subject|0|||
156964159|NCT04212091|566620550|FG000|Overall Study|Lost to Follow-up|0|||
156964160|NCT04212091|566620551|FG001|Overall Study|Lost to Follow-up|0|||
156964161|NCT04212091|566620552|FG002|Overall Study|Lost to Follow-up|0|||
156964162|NCT04212091|566620553|FG003|Overall Study|Lost to Follow-up|0|||
156964163|NCT04212091|566620554|FG004|Overall Study|Lost to Follow-up|1|||
156964164|NCT04212091|566620555|FG005|Overall Study|Lost to Follow-up|1|||
156964165|NCT04212091|566620550|FG000|Overall Study|Participant unable to adhere to visit|0|||
156964166|NCT04212091|566620551|FG001|Overall Study|Participant unable to adhere to visit|0|||
156964167|NCT04212091|566620552|FG002|Overall Study|Participant unable to adhere to visit|0|||
156964168|NCT04212091|566620553|FG003|Overall Study|Participant unable to adhere to visit|0|||
156964169|NCT04212091|566620554|FG004|Overall Study|Participant unable to adhere to visit|1|||
156964170|NCT04212091|566620555|FG005|Overall Study|Participant unable to adhere to visit|0|||
156964171|NCT03182868|566620556|FG000|Overall Study|Protocol Violation|3|||
156964172|NCT03182868|566620557|FG001|Overall Study|Protocol Violation|0|||
156964173|NCT03182868|566620558|FG002|Overall Study|Protocol Violation|4|||
156964174|NCT03182868|566620559|FG003|Overall Study|Protocol Violation|1|||
156964175|NCT03182868|566620560|FG004|Overall Study|Protocol Violation|8|||
156964176|NCT02191267|566620562|FG000|Overall Study|Withdrawal by Subject|1|||
156964177|NCT02191267|566620563|FG001|Overall Study|Withdrawal by Subject|0|||
156964178|NCT02191267|566620564|FG002|Overall Study|Withdrawal by Subject|0|||
156964179|NCT00587964|566620565|FG000|Overall Study|Withdrawal by Subject|1|||
156964180|NCT00587964|566620565|FG000|Overall Study|Lost to Follow-up|1|||
156964181|NCT00587964|566620565|FG000|Overall Study|Patient found to be ineligible|1|||
156964182|NCT00587964|566620565|FG000|Overall Study|Patient did not receive intervention|5|||
156964183|NCT00587964|566620565|FG000|Overall Study|Progression of Disease|4|||
156964184|NCT00734630|566620566|FG000|Overall Study|Lack of Efficacy|4|||
156964185|NCT00734630|566620567|FG001|Overall Study|Lack of Efficacy|4|||
156964186|NCT00734630|566620566|FG000|Overall Study|Withdrawal by Subject|7|||
156964187|NCT00734630|566620567|FG001|Overall Study|Withdrawal by Subject|9|||
156964188|NCT00734630|566620566|FG000|Overall Study|Lost to Follow-up|13|||
156964189|NCT00734630|566620567|FG001|Overall Study|Lost to Follow-up|7|||
156964190|NCT00734630|566620566|FG000|Overall Study|Protocol Violation|0|||
156964191|NCT00734630|566620567|FG001|Overall Study|Protocol Violation|3|||
157172458|NCT01998958|567371154|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172459|NCT01998958|567371155|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156964192|NCT00734630|566620566|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
157172460|NCT01998958|567371156|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
156964193|NCT00734630|566620567|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
156964194|NCT00734630|566620566|FG000|Overall Study|Adverse Event|3|||
156964195|NCT00734630|566620567|FG001|Overall Study|Adverse Event|6|||
156964196|NCT00734630|566620566|FG000|Overall Study|Randomized in Error|0|||
156964197|NCT00734630|566620567|FG001|Overall Study|Randomized in Error|1|||
156964198|NCT00734630|566620566|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
156964199|NCT00734630|566620567|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
156964200|NCT00734630|566620566|FG000|Overall Study|Poor Compliance|1|||
156964201|NCT00734630|566620567|FG001|Overall Study|Poor Compliance|1|||
156964202|NCT01239030|566620568|FG000|Double Blind|Adverse Event|0|||
156964203|NCT01239030|566620569|FG001|Double Blind|Adverse Event|1|||
156964204|NCT01239030|566620570|FG002|Double Blind|Adverse Event|0|||
156964205|NCT01239030|566620571|FG003|Double Blind|Adverse Event|2|||
156964206|NCT01239030|566620572|FG004|Double Blind|Adverse Event|0|||
156964207|NCT01239030|566620568|FG000|Double Blind|Withdrawal by Subject|0|||
156964208|NCT01239030|566620569|FG001|Double Blind|Withdrawal by Subject|1|||
156964209|NCT01239030|566620570|FG002|Double Blind|Withdrawal by Subject|1|||
156964210|NCT01239030|566620571|FG003|Double Blind|Withdrawal by Subject|0|||
156964211|NCT01239030|566620572|FG004|Double Blind|Withdrawal by Subject|1|||
156964212|NCT01239030|566620568|FG000|Double Blind|Lost to Follow-up|1|||
156964213|NCT01239030|566620569|FG001|Double Blind|Lost to Follow-up|1|||
156964214|NCT01239030|566620570|FG002|Double Blind|Lost to Follow-up|0|||
156964215|NCT01239030|566620571|FG003|Double Blind|Lost to Follow-up|0|||
156964216|NCT01239030|566620572|FG004|Double Blind|Lost to Follow-up|0|||
156964217|NCT01239030|566620568|FG000|Double Blind|Physician Decision|0|||
156964218|NCT01239030|566620569|FG001|Double Blind|Physician Decision|1|||
156964219|NCT01239030|566620570|FG002|Double Blind|Physician Decision|0|||
156964220|NCT01239030|566620571|FG003|Double Blind|Physician Decision|0|||
156964221|NCT01239030|566620572|FG004|Double Blind|Physician Decision|0|||
156964222|NCT01239030|566620568|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
156964223|NCT01239030|566620569|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
156964224|NCT01239030|566620570|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
156964225|NCT01239030|566620571|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
156964226|NCT01239030|566620572|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
156964227|NCT01239030|566620568|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
156964228|NCT01239030|566620569|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
156964229|NCT01239030|566620570|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
156964230|NCT01239030|566620571|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
156964231|NCT01239030|566620572|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
156964232|NCT01239030|566620568|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156964233|NCT01239030|566620569|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156964234|NCT01239030|566620570|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
156964235|NCT01239030|566620571|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
156964236|NCT01239030|566620572|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
156964237|NCT01239030|566620568|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
156964238|NCT01239030|566620569|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
156964239|NCT01239030|566620570|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
156964240|NCT01239030|566620571|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
156964241|NCT01239030|566620572|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
156964242|NCT00802074|566620576|FG000|Overall Study|Adverse Event|1|||
156964243|NCT00802074|566620577|FG001|Overall Study|Adverse Event|1|||
156964244|NCT00802074|566620578|FG002|Overall Study|Adverse Event|1|||
156964245|NCT00802074|566620579|FG003|Overall Study|Adverse Event|0|||
157039909|NCT03762850|566901483|FG000|Overall Study|Withdrawal by Subject|4|||
157039910|NCT03762850|566901484|FG001|Overall Study|Withdrawal by Subject|9|||
157039911|NCT02232737|566901489|FG000|Overall Study|Lost to Follow-up|18|||
157039912|NCT02232737|566901490|FG001|Overall Study|Lost to Follow-up|28|||
157039913|NCT02232737|566901491|FG002|Overall Study|Lost to Follow-up|33|||
157039914|NCT02232737|566901489|FG000|Overall Study|Personal reasons|7|||
157039915|NCT02232737|566901490|FG001|Overall Study|Personal reasons|8|||
157039916|NCT02232737|566901491|FG002|Overall Study|Personal reasons|14|||
157039917|NCT02232737|566901489|FG000|Overall Study|Adverse Event|6|||
157039918|NCT02232737|566901490|FG001|Overall Study|Adverse Event|3|||
156964246|NCT00802074|566620580|FG004|Overall Study|Adverse Event|0|||
156964247|NCT00802074|566620581|FG005|Overall Study|Adverse Event|0|||
156964248|NCT00802074|566620576|FG000|Overall Study|Withdrawal by Subject|1|||
156964249|NCT00802074|566620577|FG001|Overall Study|Withdrawal by Subject|0|||
156964250|NCT00802074|566620578|FG002|Overall Study|Withdrawal by Subject|0|||
156964251|NCT00802074|566620579|FG003|Overall Study|Withdrawal by Subject|0|||
156964252|NCT00802074|566620580|FG004|Overall Study|Withdrawal by Subject|0|||
156964253|NCT00802074|566620581|FG005|Overall Study|Withdrawal by Subject|0|||
156964254|NCT00827918|566620582|FG000|Overall Study|Adverse Event|4|||
156964255|NCT00827918|566620583|FG001|Overall Study|Adverse Event|0|||
156964256|NCT00827918|566620584|FG002|Overall Study|Adverse Event|0|||
157039919|NCT02232737|566901491|FG002|Overall Study|Adverse Event|8|||
157039920|NCT02232737|566901489|FG000|Overall Study|Incarcerated|2|||
157039921|NCT02232737|566901490|FG001|Overall Study|Incarcerated|1|||
157039922|NCT02232737|566901491|FG002|Overall Study|Incarcerated|2|||
156964257|NCT00827918|566620582|FG000|Overall Study|Lack of Efficacy|16|||
156964258|NCT00827918|566620583|FG001|Overall Study|Lack of Efficacy|4|||
156964259|NCT00827918|566620584|FG002|Overall Study|Lack of Efficacy|15|||
156964260|NCT00827918|566620582|FG000|Overall Study|Physician Decision|1|||
156964261|NCT00827918|566620583|FG001|Overall Study|Physician Decision|0|||
156964262|NCT00827918|566620584|FG002|Overall Study|Physician Decision|0|||
156964263|NCT00827918|566620582|FG000|Overall Study|Pregnancy|0|||
156964264|NCT00827918|566620583|FG001|Overall Study|Pregnancy|1|||
156964265|NCT00827918|566620584|FG002|Overall Study|Pregnancy|0|||
156964266|NCT00827918|566620582|FG000|Overall Study|Progressive Disease|1|||
156964267|NCT00827918|566620583|FG001|Overall Study|Progressive Disease|1|||
156964268|NCT00827918|566620584|FG002|Overall Study|Progressive Disease|0|||
156964269|NCT00827918|566620582|FG000|Overall Study|Protocol Violation|0|||
156964270|NCT00827918|566620583|FG001|Overall Study|Protocol Violation|1|||
156964271|NCT00827918|566620584|FG002|Overall Study|Protocol Violation|0|||
156964272|NCT00827918|566620582|FG000|Overall Study|Withdrawal by Subject|6|||
156964273|NCT00827918|566620583|FG001|Overall Study|Withdrawal by Subject|2|||
156964274|NCT00827918|566620584|FG002|Overall Study|Withdrawal by Subject|6|||
156964275|NCT00127101|566620587|FG000|Base Protocol|Adverse Event|0|||
156964276|NCT00127101|566620588|FG001|Base Protocol|Adverse Event|2|||
156964277|NCT00127101|566620589|FG002|Base Protocol|Adverse Event|1|||
156964278|NCT00127101|566620590|FG003|Base Protocol|Adverse Event|0|||
156964279|NCT00127101|566620591|FG004|Base Protocol|Adverse Event|0|||
156964280|NCT00127101|566620592|FG005|Base Protocol|Adverse Event|0|||
157039923|NCT02232737|566901489|FG000|Overall Study|Withdrawal by Subject|0|||
157039924|NCT02232737|566901490|FG001|Overall Study|Withdrawal by Subject|1|||
157039925|NCT02232737|566901491|FG002|Overall Study|Withdrawal by Subject|2|||
157039926|NCT02232737|566901489|FG000|Overall Study|Death|0|||
157039927|NCT02232737|566901490|FG001|Overall Study|Death|1|||
157039928|NCT02232737|566901491|FG002|Overall Study|Death|1|||
157039929|NCT02232737|566901489|FG000|Overall Study|Physician Decision|1|||
157039930|NCT02232737|566901490|FG001|Overall Study|Physician Decision|3|||
157039931|NCT02232737|566901491|FG002|Overall Study|Physician Decision|1|||
157039932|NCT02232737|566901489|FG000|Overall Study|Protocol Violation|1|||
157039933|NCT02232737|566901490|FG001|Overall Study|Protocol Violation|0|||
157039934|NCT02232737|566901491|FG002|Overall Study|Protocol Violation|1|||
157039935|NCT02232737|566901489|FG000|Overall Study|Reason unknown|1|||
157039936|NCT02232737|566901490|FG001|Overall Study|Reason unknown|0|||
157039937|NCT02232737|566901491|FG002|Overall Study|Reason unknown|0|||
157039938|NCT00065182|566901500|FG000|Overall Study|Adverse Event|24|||
157039939|NCT00065182|566901501|FG001|Overall Study|Adverse Event|17|||
157039940|NCT00065182|566901500|FG000|Overall Study|Lost to Follow-up|0|||
157039941|NCT00065182|566901501|FG001|Overall Study|Lost to Follow-up|4|||
157039942|NCT00065182|566901500|FG000|Overall Study|Protocol Violation|3|||
157039943|NCT00065182|566901501|FG001|Overall Study|Protocol Violation|4|||
157039944|NCT00065182|566901500|FG000|Overall Study|Serious adverse events (SAE)|1|||
157039945|NCT00065182|566901501|FG001|Overall Study|Serious adverse events (SAE)|0|||
157039946|NCT00065182|566901500|FG000|Overall Study|Sponsor Decision|11|||
157039947|NCT00065182|566901501|FG001|Overall Study|Sponsor Decision|7|||
157039948|NCT00065182|566901500|FG000|Overall Study|Withdrawal by Subject|8|||
157039949|NCT00065182|566901501|FG001|Overall Study|Withdrawal by Subject|3|||
157039950|NCT00065182|566901500|FG000|Overall Study|No clinical benefit|1|||
157039951|NCT00065182|566901501|FG001|Overall Study|No clinical benefit|0|||
157039952|NCT00065182|566901500|FG000|Overall Study|Death|0|||
157039953|NCT00065182|566901501|FG001|Overall Study|Death|1|||
157039954|NCT00065182|566901500|FG000|Overall Study|Decline in Status|0|||
157039955|NCT00065182|566901501|FG001|Overall Study|Decline in Status|1|||
157039956|NCT03738228|566901502|FG000|Overall Study|Never received study treatment|2|||
157227855|NCT03008460|567579218|FG001|Overall Study|End of study visit outside permitted time window|1|||
156964281|NCT00127101|566620587|FG000|Base Protocol|Lack of Efficacy|1|||
157039957|NCT03738228|566901503|FG001|Overall Study|Never received study treatment|2|||
157039958|NCT01641900|566901504|FG000|Overall Study|Withdrawal by Subject|2|||
157039959|NCT01641900|566901505|FG001|Overall Study|Withdrawal by Subject|2|||
157039960|NCT02568215|566901506|FG000|Overall Study|Death|1|||
157039961|NCT02568215|566901507|FG001|Overall Study|Death|2|||
157039962|NCT02568215|566901508|FG002|Overall Study|Death|0|||
157039963|NCT02568215|566901506|FG000|Overall Study|Physician Decision|2|||
157039964|NCT02568215|566901507|FG001|Overall Study|Physician Decision|2|||
157039965|NCT02568215|566901508|FG002|Overall Study|Physician Decision|2|||
157039966|NCT02568215|566901506|FG000|Overall Study|Lost to Follow-up|29|||
157227856|NCT03008460|567579217|FG000|Overall Study|Lost to Follow-up|1|||
156964282|NCT00127101|566620588|FG001|Base Protocol|Lack of Efficacy|0|||
156964283|NCT00127101|566620589|FG002|Base Protocol|Lack of Efficacy|0|||
157039967|NCT02568215|566901507|FG001|Overall Study|Lost to Follow-up|32|||
157039968|NCT02568215|566901508|FG002|Overall Study|Lost to Follow-up|41|||
157039969|NCT02568215|566901506|FG000|Overall Study|Withdrawal by Subject|21|||
157039970|NCT02568215|566901507|FG001|Overall Study|Withdrawal by Subject|19|||
157039971|NCT02568215|566901508|FG002|Overall Study|Withdrawal by Subject|22|||
157039972|NCT02568215|566901506|FG000|Overall Study|Protocol Violation|1|||
157039973|NCT02568215|566901507|FG001|Overall Study|Protocol Violation|1|||
156964284|NCT00127101|566620590|FG003|Base Protocol|Lack of Efficacy|0|||
156964285|NCT00127101|566620591|FG004|Base Protocol|Lack of Efficacy|2|||
156964286|NCT00127101|566620592|FG005|Base Protocol|Lack of Efficacy|0|||
157039974|NCT02568215|566901508|FG002|Overall Study|Protocol Violation|0|||
157039975|NCT02568215|566901506|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
157039976|NCT02568215|566901507|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
157039977|NCT02568215|566901508|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
157039978|NCT02568215|566901506|FG000|Overall Study|Other|0|||
157039979|NCT02568215|566901507|FG001|Overall Study|Other|1|||
157039980|NCT02568215|566901508|FG002|Overall Study|Other|4|||
157039981|NCT02941549|566901509|FG000|Overall Study|Adverse Event|1|||
157039982|NCT02941549|566901510|FG001|Overall Study|Adverse Event|0|||
157039983|NCT02941549|566901511|FG002|Overall Study|Adverse Event|0|||
157039984|NCT02941549|566901509|FG000|Overall Study|Withdrawal by Subject|2|||
157039985|NCT02941549|566901510|FG001|Overall Study|Withdrawal by Subject|1|||
157039986|NCT02941549|566901511|FG002|Overall Study|Withdrawal by Subject|2|||
157039987|NCT00713596|566901512|FG000|Overall Study|Study was terminated|2|||
157039988|NCT00713596|566901513|FG001|Overall Study|Study was terminated|3|||
157039989|NCT00713596|566901514|FG002|Overall Study|Study was terminated|2|||
157039990|NCT03712371|566901515|FG000|Overall Study|Lack of Efficacy|0|||
157039991|NCT03712371|566901516|FG001|Overall Study|Lack of Efficacy|0|||
157039992|NCT03712371|566901517|FG002|Overall Study|Lack of Efficacy|0|||
157039993|NCT03712371|566901518|FG003|Overall Study|Lack of Efficacy|1|||
157039994|NCT02463448|566901521|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
157039995|NCT02463448|566901521|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
157039996|NCT02463448|566901521|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
157039997|NCT02463448|566901521|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
157172461|NCT01998958|567371157|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
157172462|NCT01532570|567371160|FG000|Overall Study|Lack of Efficacy|1|||
157172463|NCT01532570|567371161|FG001|Overall Study|Lack of Efficacy|0|||
157172464|NCT01532570|567371162|FG002|Overall Study|Lack of Efficacy|0|||
157172465|NCT01532570|567371163|FG003|Overall Study|Lack of Efficacy|0|||
157172466|NCT01532570|567371160|FG000|Overall Study|Withdrawal by Subject|0|||
157172467|NCT01532570|567371161|FG001|Overall Study|Withdrawal by Subject|1|||
157172468|NCT01532570|567371162|FG002|Overall Study|Withdrawal by Subject|0|||
157172469|NCT01532570|567371163|FG003|Overall Study|Withdrawal by Subject|0|||
157172470|NCT05224076|567371172|FG000|Overall Study|Lost to Follow-up|24|||
156964287|NCT00127101|566620587|FG000|Base Protocol|Withdrawal by Subject|1|||
156964288|NCT00127101|566620588|FG001|Base Protocol|Withdrawal by Subject|2|||
156964289|NCT00127101|566620589|FG002|Base Protocol|Withdrawal by Subject|1|||
156964290|NCT00127101|566620590|FG003|Base Protocol|Withdrawal by Subject|0|||
156964291|NCT00127101|566620591|FG004|Base Protocol|Withdrawal by Subject|0|||
156964292|NCT00127101|566620592|FG005|Base Protocol|Withdrawal by Subject|1|||
156964293|NCT00127101|566620587|FG000|Continuation Phase|Adverse Event|0|||
156964294|NCT00127101|566620588|FG001|Continuation Phase|Adverse Event|0|||
156964295|NCT00127101|566620589|FG002|Continuation Phase|Adverse Event|0|||
156964296|NCT00127101|566620590|FG003|Continuation Phase|Adverse Event|0|||
156964297|NCT00127101|566620591|FG004|Continuation Phase|Adverse Event|1|||
156964298|NCT00127101|566620592|FG005|Continuation Phase|Adverse Event|1|||
156964299|NCT00127101|566620587|FG000|Continuation Phase|Lack of Efficacy|0|||
156964300|NCT00127101|566620588|FG001|Continuation Phase|Lack of Efficacy|0|||
156964301|NCT00127101|566620589|FG002|Continuation Phase|Lack of Efficacy|0|||
156964302|NCT00127101|566620590|FG003|Continuation Phase|Lack of Efficacy|0|||
156964303|NCT00127101|566620591|FG004|Continuation Phase|Lack of Efficacy|0|||
156964304|NCT00127101|566620592|FG005|Continuation Phase|Lack of Efficacy|1|||
156964305|NCT00127101|566620587|FG000|Continuation Phase|Withdrawal by Subject|0|||
156964306|NCT00127101|566620588|FG001|Continuation Phase|Withdrawal by Subject|0|||
156964307|NCT00127101|566620589|FG002|Continuation Phase|Withdrawal by Subject|1|||
156964308|NCT00127101|566620590|FG003|Continuation Phase|Withdrawal by Subject|0|||
156964309|NCT00127101|566620591|FG004|Continuation Phase|Withdrawal by Subject|2|||
156964310|NCT00127101|566620592|FG005|Continuation Phase|Withdrawal by Subject|1|||
156964311|NCT01830127|566620595|FG000|Overall Study|Adverse Event|1|||
156964312|NCT01830127|566620596|FG001|Overall Study|Adverse Event|6|||
156964313|NCT01830127|566620595|FG000|Overall Study|Lack of Efficacy|3|||
156964314|NCT01830127|566620596|FG001|Overall Study|Lack of Efficacy|0|||
156964315|NCT01830127|566620595|FG000|Overall Study|Withdrawal by Subject|1|||
156964316|NCT01830127|566620596|FG001|Overall Study|Withdrawal by Subject|1|||
156964317|NCT01830127|566620595|FG000|Overall Study|Other reason not defined above|0|||
156964318|NCT01830127|566620596|FG001|Overall Study|Other reason not defined above|2|||
156964319|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
157039998|NCT02275611|566901525|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
157039999|NCT02275611|566901526|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
157040000|NCT02275611|566901527|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
157040001|NCT02275611|566901528|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
157172471|NCT01807949|567371174|FG000|Overall Study|Adverse Event|1|||
157172472|NCT01807949|567371175|FG001|Overall Study|Adverse Event|2|||
157227857|NCT03008460|567579218|FG001|Overall Study|Lost to Follow-up|3|||
156964320|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
156964321|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
156964322|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
156964323|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
157040002|NCT02101775|566901529|FG000|Overall Study|Adverse Event|4|||
157040003|NCT02101775|566901530|FG001|Overall Study|Adverse Event|0|||
157040004|NCT02101775|566901531|FG002|Overall Study|Adverse Event|0|||
157040005|NCT02101775|566901529|FG000|Overall Study|Admission to Hospital|0|||
157040006|NCT02101775|566901530|FG001|Overall Study|Admission to Hospital|1|||
157040007|NCT02101775|566901531|FG002|Overall Study|Admission to Hospital|0|||
157040008|NCT00503906|566901532|FG000|Overall Study|Withdrawal by Subject|1|||
157040009|NCT03611556|566901533|FG000|Overall Study|Death|7|||
157040010|NCT03611556|566901534|FG001|Overall Study|Death|7|||
157040011|NCT03611556|566901535|FG002|Overall Study|Death|3|||
157040012|NCT03611556|566901536|FG003|Overall Study|Death|8|||
157040013|NCT03611556|566901537|FG004|Overall Study|Death|47|||
157040014|NCT03611556|566901538|FG005|Overall Study|Death|32|||
157040015|NCT03611556|566901539|FG006|Overall Study|Death|53|||
157040016|NCT03611556|566901533|FG000|Overall Study|Withdrawal by Subject|0|||
157040017|NCT03611556|566901534|FG001|Overall Study|Withdrawal by Subject|0|||
157040018|NCT03611556|566901535|FG002|Overall Study|Withdrawal by Subject|0|||
157040019|NCT03611556|566901536|FG003|Overall Study|Withdrawal by Subject|0|||
157040020|NCT03611556|566901537|FG004|Overall Study|Withdrawal by Subject|4|||
157040021|NCT03611556|566901538|FG005|Overall Study|Withdrawal by Subject|2|||
157040022|NCT03611556|566901539|FG006|Overall Study|Withdrawal by Subject|4|||
157040023|NCT03611556|566901533|FG000|Overall Study|Sponsor decision|0|||
157040024|NCT03611556|566901534|FG001|Overall Study|Sponsor decision|0|||
157040025|NCT03611556|566901535|FG002|Overall Study|Sponsor decision|0|||
157040026|NCT03611556|566901536|FG003|Overall Study|Sponsor decision|0|||
157040027|NCT03611556|566901537|FG004|Overall Study|Sponsor decision|9|||
157040028|NCT03611556|566901538|FG005|Overall Study|Sponsor decision|4|||
157040029|NCT03611556|566901539|FG006|Overall Study|Sponsor decision|12|||
157040030|NCT03611556|566901533|FG000|Overall Study|Reasons|0|||
157040031|NCT03611556|566901534|FG001|Overall Study|Reasons|0|||
157040032|NCT03611556|566901535|FG002|Overall Study|Reasons|0|||
157040033|NCT03611556|566901536|FG003|Overall Study|Reasons|0|||
157040034|NCT03611556|566901537|FG004|Overall Study|Reasons|2|||
157040035|NCT03611556|566901538|FG005|Overall Study|Reasons|0|||
157040036|NCT03611556|566901539|FG006|Overall Study|Reasons|1|||
157040037|NCT02844439|566901540|FG000|Overall Study|Withdrawal by Subject|1|||
157040038|NCT02844439|566901540|FG000|Overall Study|Lost to Follow-up|2|||
157040039|NCT02844439|566901540|FG000|Overall Study|Termination by Sponsor|4|||
157040040|NCT02844439|566901540|FG000|Overall Study|Death|28|||
157040041|NCT02844439|566901540|FG000|Overall Study|Other|5|||
157040042|NCT05036278|566901543|FG000|Overall Study|Withdrawal by Subject|1|||
156964324|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
156964325|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156964326|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156964327|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156964328|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
156964329|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
156964330|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156964331|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156964332|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156964333|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
156964334|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
156964335|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
156964336|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
156964337|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
156964338|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
156964339|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
156964340|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
156964341|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
157040043|NCT05036278|566901543|FG000|Overall Study|Adverse Event|1|||
157040044|NCT02787005|566901546|FG000|Overall Study|Adverse Event|24|||
157040045|NCT02787005|566901547|FG001|Overall Study|Adverse Event|9|||
157040046|NCT02787005|566901548|FG002|Overall Study|Adverse Event|9|||
157172473|NCT01807949|567371176|FG002|Overall Study|Adverse Event|2|||
156964342|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
157172474|NCT01807949|567371174|FG000|Overall Study|Withdrawal by Subject|1|||
157172475|NCT01807949|567371175|FG001|Overall Study|Withdrawal by Subject|2|||
157172476|NCT01807949|567371176|FG002|Overall Study|Withdrawal by Subject|2|||
156964343|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
157040047|NCT02787005|566901549|FG003|Overall Study|Adverse Event|7|||
157040048|NCT02787005|566901550|FG004|Overall Study|Adverse Event|2|||
157040049|NCT02787005|566901546|FG000|Overall Study|Death|100|||
157040050|NCT02787005|566901547|FG001|Overall Study|Death|53|||
157040051|NCT02787005|566901548|FG002|Overall Study|Death|48|||
157040052|NCT02787005|566901549|FG003|Overall Study|Death|69|||
157040053|NCT02787005|566901550|FG004|Overall Study|Death|38|||
157040054|NCT02787005|566901546|FG000|Overall Study|Sponsor Decision|7|||
157040055|NCT02787005|566901547|FG001|Overall Study|Sponsor Decision|4|||
156964344|NCT01662310|566620598|FG000|Run-In or Stabilization Phase|Other|1|||
156964345|NCT01662310|566620599|FG001|Run-In or Stabilization Phase|Other|0|||
156964346|NCT01662310|566620600|FG002|Run-In or Stabilization Phase|Other|0|||
156964347|NCT01662310|566620601|FG003|Run-In or Stabilization Phase|Other|0|||
156964348|NCT01662310|566620602|FG004|Run-In or Stabilization Phase|Other|0|||
156964349|NCT01662310|566620598|FG000|Double-Blind Phase|Adverse Event|0|||
156964350|NCT01662310|566620599|FG001|Double-Blind Phase|Adverse Event|0|||
156964351|NCT01662310|566620600|FG002|Double-Blind Phase|Adverse Event|1|||
156964352|NCT01662310|566620601|FG003|Double-Blind Phase|Adverse Event|0|||
156964353|NCT01662310|566620602|FG004|Double-Blind Phase|Adverse Event|0|||
156964354|NCT01662310|566620598|FG000|Double-Blind Phase|Lost to Follow-up|0|||
156964355|NCT01662310|566620599|FG001|Double-Blind Phase|Lost to Follow-up|3|||
156964356|NCT01662310|566620600|FG002|Double-Blind Phase|Lost to Follow-up|0|||
156964357|NCT01662310|566620601|FG003|Double-Blind Phase|Lost to Follow-up|0|||
156964358|NCT01662310|566620602|FG004|Double-Blind Phase|Lost to Follow-up|0|||
156964359|NCT01662310|566620598|FG000|Double-Blind Phase|Pregnancy|0|||
156964360|NCT01662310|566620599|FG001|Double-Blind Phase|Pregnancy|2|||
156964361|NCT01662310|566620600|FG002|Double-Blind Phase|Pregnancy|0|||
156964362|NCT01662310|566620601|FG003|Double-Blind Phase|Pregnancy|0|||
156964363|NCT01662310|566620602|FG004|Double-Blind Phase|Pregnancy|0|||
156964364|NCT01662310|566620598|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
156964365|NCT01662310|566620599|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
156964366|NCT01662310|566620600|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
156964367|NCT01662310|566620601|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
156964368|NCT01662310|566620602|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
156964369|NCT01662310|566620598|FG000|Double-Blind Phase|Other|0|||
156964370|NCT01662310|566620599|FG001|Double-Blind Phase|Other|0|||
156964371|NCT01662310|566620600|FG002|Double-Blind Phase|Other|1|||
156964372|NCT01662310|566620601|FG003|Double-Blind Phase|Other|0|||
156964373|NCT01662310|566620602|FG004|Double-Blind Phase|Other|0|||
156964374|NCT01662310|566620598|FG000|Double-Blind Phase|Randomized but not treated|0|||
156964375|NCT01662310|566620599|FG001|Double-Blind Phase|Randomized but not treated|1|||
156964376|NCT01662310|566620600|FG002|Double-Blind Phase|Randomized but not treated|0|||
156964377|NCT01662310|566620601|FG003|Double-Blind Phase|Randomized but not treated|0|||
156964378|NCT01662310|566620602|FG004|Double-Blind Phase|Randomized but not treated|0|||
156964379|NCT01662310|566620598|FG000|Open-Label Extension Phase|Adverse Event|0|||
156964380|NCT01662310|566620599|FG001|Open-Label Extension Phase|Adverse Event|0|||
156964381|NCT01662310|566620600|FG002|Open-Label Extension Phase|Adverse Event|0|||
156964382|NCT01662310|566620601|FG003|Open-Label Extension Phase|Adverse Event|3|||
156964383|NCT01662310|566620602|FG004|Open-Label Extension Phase|Adverse Event|0|||
156964384|NCT01662310|566620598|FG000|Open-Label Extension Phase|Death|0|||
156964385|NCT01662310|566620599|FG001|Open-Label Extension Phase|Death|0|||
156964386|NCT01662310|566620600|FG002|Open-Label Extension Phase|Death|0|||
156964387|NCT01662310|566620601|FG003|Open-Label Extension Phase|Death|1|||
156964388|NCT01662310|566620602|FG004|Open-Label Extension Phase|Death|0|||
156964389|NCT01662310|566620598|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
156964390|NCT01662310|566620599|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
156964391|NCT01662310|566620600|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
156964392|NCT01662310|566620601|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
157172477|NCT01807949|567371174|FG000|Overall Study|Non-Compliance|0|||
157172478|NCT01807949|567371175|FG001|Overall Study|Non-Compliance|0|||
157172479|NCT01807949|567371176|FG002|Overall Study|Non-Compliance|1|||
157172480|NCT01807949|567371174|FG000|Overall Study|Undefined|0|||
157172481|NCT01807949|567371175|FG001|Overall Study|Undefined|1|||
157172482|NCT01807949|567371176|FG002|Overall Study|Undefined|2|||
157172483|NCT01807949|567371174|FG000|Overall Study|Randomized But Not Treated|0|||
157172484|NCT01807949|567371175|FG001|Overall Study|Randomized But Not Treated|2|||
157172485|NCT01807949|567371176|FG002|Overall Study|Randomized But Not Treated|2|||
157172486|NCT00881361|567371177|FG000|Overall Study|Terminated prior to surgery|27|||
157172487|NCT00881361|567371178|FG001|Overall Study|Terminated prior to surgery|7|||
157172488|NCT00881361|567371179|FG002|Overall Study|Terminated prior to surgery|0|||
157172489|NCT00881361|567371177|FG000|Overall Study|Ineligible|17|||
157172490|NCT00881361|567371178|FG001|Overall Study|Ineligible|2|||
157172491|NCT00881361|567371179|FG002|Overall Study|Ineligible|2|||
157172492|NCT02141217|567371180|FG000|Overall Study|Adverse Event|1|||
157172493|NCT02141217|567371181|FG001|Overall Study|Adverse Event|2|||
157172494|NCT02141217|567371180|FG000|Overall Study|Protocol Violation|1|||
157172495|NCT02141217|567371181|FG001|Overall Study|Protocol Violation|4|||
157172496|NCT02141217|567371180|FG000|Overall Study|Withdrawal by Subject|6|||
157172497|NCT02141217|567371181|FG001|Overall Study|Withdrawal by Subject|0|||
157172498|NCT02141217|567371180|FG000|Overall Study|Lost to Follow-up|1|||
157172499|NCT02141217|567371181|FG001|Overall Study|Lost to Follow-up|1|||
157172500|NCT02141217|567371180|FG000|Overall Study|Physician Decision|1|||
157172501|NCT02141217|567371181|FG001|Overall Study|Physician Decision|0|||
157172502|NCT02141217|567371180|FG000|Overall Study|Surgical Intervention|1|||
157172503|NCT02141217|567371181|FG001|Overall Study|Surgical Intervention|1|||
157172504|NCT00448760|567371182|FG000|Overall Study|Death|3|||
157172505|NCT04603391|567371183|FG000|First Intervention (4 Days)|Adverse Event|1|||
156964393|NCT01662310|566620602|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
156964394|NCT01662310|566620598|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
156964395|NCT01662310|566620599|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
156964396|NCT01662310|566620600|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
156964397|NCT01662310|566620601|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
156964398|NCT01662310|566620602|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
156964399|NCT01662310|566620598|FG000|Open-Label Extension Phase|Pregnancy|0|||
156964400|NCT01662310|566620599|FG001|Open-Label Extension Phase|Pregnancy|0|||
156964401|NCT01662310|566620600|FG002|Open-Label Extension Phase|Pregnancy|0|||
156964402|NCT01662310|566620601|FG003|Open-Label Extension Phase|Pregnancy|1|||
156964403|NCT01662310|566620602|FG004|Open-Label Extension Phase|Pregnancy|0|||
156964404|NCT01662310|566620598|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
156964405|NCT01662310|566620599|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
156964406|NCT01662310|566620600|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
156964407|NCT01662310|566620601|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
156964408|NCT01662310|566620602|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
156964409|NCT01565707|566620607|FG000|Overall Study|Adverse Event|1|||
156964410|NCT01565707|566620608|FG001|Overall Study|Adverse Event|6|||
156964411|NCT01565707|566620609|FG002|Overall Study|Adverse Event|2|||
156964412|NCT01565707|566620610|FG003|Overall Study|Adverse Event|1|||
156964413|NCT01565707|566620607|FG000|Overall Study|Lost to Follow-up|1|||
156964414|NCT01565707|566620608|FG001|Overall Study|Lost to Follow-up|0|||
156964415|NCT01565707|566620609|FG002|Overall Study|Lost to Follow-up|0|||
156964416|NCT01565707|566620610|FG003|Overall Study|Lost to Follow-up|0|||
156964417|NCT01565707|566620607|FG000|Overall Study|Protocol Violation|1|||
156964418|NCT01565707|566620608|FG001|Overall Study|Protocol Violation|0|||
156964419|NCT01565707|566620609|FG002|Overall Study|Protocol Violation|0|||
156964420|NCT01565707|566620610|FG003|Overall Study|Protocol Violation|1|||
156964421|NCT01565707|566620607|FG000|Overall Study|Withdrawal by Subject|3|||
156964422|NCT01565707|566620608|FG001|Overall Study|Withdrawal by Subject|1|||
156964423|NCT01565707|566620609|FG002|Overall Study|Withdrawal by Subject|1|||
156964424|NCT01565707|566620610|FG003|Overall Study|Withdrawal by Subject|1|||
156964425|NCT01565707|566620607|FG000|Overall Study|Randomized but not evaluable|2|||
156964426|NCT01565707|566620608|FG001|Overall Study|Randomized but not evaluable|0|||
156964427|NCT01565707|566620609|FG002|Overall Study|Randomized but not evaluable|0|||
157172506|NCT04603391|567371184|FG001|First Intervention (4 Days)|Adverse Event|0|||
157172507|NCT04603391|567371183|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
157172508|NCT04603391|567371184|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
157172509|NCT02759861|567371187|FG000|Overall Study|Death|1|||
157172510|NCT00618995|567371188|FG000|Period 1|Adverse Event|0|||
157172511|NCT00618995|567371189|FG001|Period 1|Adverse Event|0|||
157172512|NCT00618995|567371190|FG002|Period 1|Adverse Event|1|||
157172513|NCT00618995|567371191|FG003|Period 1|Adverse Event|0|||
157172514|NCT00618995|567371188|FG000|Period 1|Protocol Violation|0|||
157172515|NCT00618995|567371189|FG001|Period 1|Protocol Violation|1|||
157172516|NCT00618995|567371190|FG002|Period 1|Protocol Violation|1|||
157172517|NCT00618995|567371191|FG003|Period 1|Protocol Violation|0|||
157227858|NCT00767325|567579222|FG000|Overall Study|Lack of Efficacy|2|||
156964428|NCT01565707|566620610|FG003|Overall Study|Randomized but not evaluable|0|||
156964429|NCT01565707|566620607|FG000|Overall Study|Miscellaneous|1|||
156964430|NCT01565707|566620608|FG001|Overall Study|Miscellaneous|1|||
156964431|NCT01565707|566620609|FG002|Overall Study|Miscellaneous|0|||
156964432|NCT01565707|566620610|FG003|Overall Study|Miscellaneous|2|||
156964433|NCT01371851|566620611|FG000|Overall Study|Lost to Follow-up|5|||
156964434|NCT01371851|566620612|FG001|Overall Study|Lost to Follow-up|8|||
156964435|NCT01371851|566620611|FG000|Overall Study|was arrested and put in jail|0|||
156964436|NCT01371851|566620612|FG001|Overall Study|was arrested and put in jail|1|||
156964437|NCT01371851|566620611|FG000|Overall Study|non study related adverse event|1|||
156964438|NCT01371851|566620612|FG001|Overall Study|non study related adverse event|0|||
156964439|NCT01371851|566620611|FG000|Overall Study|Blood Pressure outside study parameters|2|||
156964440|NCT01371851|566620612|FG001|Overall Study|Blood Pressure outside study parameters|0|||
156964441|NCT02012491|566620613|FG000|Overall Study|Lost to Follow-up|1|||
156964442|NCT02012491|566620614|FG001|Overall Study|Lost to Follow-up|0|||
156964443|NCT02012491|566620613|FG000|Overall Study|Protocol Violation|0|||
156964444|NCT02012491|566620614|FG001|Overall Study|Protocol Violation|1|||
156964445|NCT02012491|566620613|FG000|Overall Study|Withdrawal by Subject|1|||
156964446|NCT02012491|566620614|FG001|Overall Study|Withdrawal by Subject|0|||
156964447|NCT00450411|566620615|FG000|Overall Study|Protocol Violation|6|||
156964448|NCT00450411|566620615|FG000|Overall Study|No protocol treatment|2|||
156964449|NCT05608629|566620626|FG000|Overall Study|Lost to Follow-up|2|||
156964450|NCT03969719|566620627|FG000|Overall Study|Other reasons not specified|1|||
157040056|NCT02787005|566901548|FG002|Overall Study|Sponsor Decision|0|||
157172518|NCT00618995|567371188|FG000|Period 2|Protocol Violation|0|||
157172519|NCT00618995|567371189|FG001|Period 2|Protocol Violation|0|||
157172520|NCT00618995|567371190|FG002|Period 2|Protocol Violation|1|||
157172521|NCT00618995|567371191|FG003|Period 2|Protocol Violation|0|||
157172522|NCT00618995|567371188|FG000|Period 4|Adverse Event|1|||
157040057|NCT02787005|566901549|FG003|Overall Study|Sponsor Decision|4|||
157227859|NCT00767325|567579222|FG000|Overall Study|Adverse Event|7|||
157227860|NCT00767325|567579222|FG000|Overall Study|Lost to Follow-up|3|||
157040058|NCT02787005|566901550|FG004|Overall Study|Sponsor Decision|5|||
157040059|NCT02787005|566901546|FG000|Overall Study|Withdrawal by Subject|2|||
157040060|NCT02787005|566901547|FG001|Overall Study|Withdrawal by Subject|1|||
157040061|NCT02787005|566901548|FG002|Overall Study|Withdrawal by Subject|1|||
157040062|NCT02787005|566901549|FG003|Overall Study|Withdrawal by Subject|0|||
157040063|NCT02787005|566901550|FG004|Overall Study|Withdrawal by Subject|1|||
156964451|NCT03969719|566620628|FG001|Overall Study|Other reasons not specified|1|||
156964452|NCT03969719|566620629|FG002|Overall Study|Other reasons not specified|3|||
156964453|NCT03969719|566620627|FG000|Overall Study|Withdrawal by Subject|2|||
156964454|NCT03969719|566620628|FG001|Overall Study|Withdrawal by Subject|3|||
156964455|NCT03969719|566620629|FG002|Overall Study|Withdrawal by Subject|2|||
156964456|NCT03969719|566620627|FG000|Overall Study|Protocol Violation|1|||
156964457|NCT03969719|566620628|FG001|Overall Study|Protocol Violation|2|||
156964458|NCT03969719|566620629|FG002|Overall Study|Protocol Violation|0|||
156964459|NCT03969719|566620627|FG000|Overall Study|Adverse Event|0|||
156964460|NCT03969719|566620628|FG001|Overall Study|Adverse Event|2|||
157040064|NCT02787005|566901546|FG000|Overall Study|Screen Failure|0|||
157040065|NCT02787005|566901547|FG001|Overall Study|Screen Failure|2|||
157040066|NCT02787005|566901548|FG002|Overall Study|Screen Failure|0|||
157040067|NCT02787005|566901549|FG003|Overall Study|Screen Failure|0|||
156964461|NCT03969719|566620629|FG002|Overall Study|Adverse Event|0|||
156964462|NCT03969719|566620627|FG000|Overall Study|Lost to Follow-up|0|||
157172523|NCT00618995|567371189|FG001|Period 4|Adverse Event|0|||
157172524|NCT00618995|567371190|FG002|Period 4|Adverse Event|0|||
157172525|NCT00618995|567371191|FG003|Period 4|Adverse Event|0|||
157172526|NCT00067470|567371192|FG000|Overall Study|Withdrawal by Subject|0|||
157172527|NCT00067470|567371193|FG001|Overall Study|Withdrawal by Subject|1|||
157172528|NCT01342952|567371194|FG000|Overall Study|Adverse Event|0|||
157172529|NCT01342952|567371195|FG001|Overall Study|Adverse Event|5|||
157172530|NCT01342952|567371196|FG002|Overall Study|Adverse Event|1|||
157172531|NCT01342952|567371197|FG003|Overall Study|Adverse Event|0|||
157172532|NCT01342952|567371194|FG000|Overall Study|Lost to Follow-up|0|||
157172533|NCT01342952|567371195|FG001|Overall Study|Lost to Follow-up|2|||
157172534|NCT01342952|567371196|FG002|Overall Study|Lost to Follow-up|0|||
157172535|NCT01342952|567371197|FG003|Overall Study|Lost to Follow-up|0|||
157172536|NCT01342952|567371194|FG000|Overall Study|Withdrawal by Subject|1|||
157172537|NCT01342952|567371195|FG001|Overall Study|Withdrawal by Subject|1|||
157172538|NCT01342952|567371196|FG002|Overall Study|Withdrawal by Subject|0|||
157172539|NCT01342952|567371197|FG003|Overall Study|Withdrawal by Subject|0|||
157172540|NCT01342952|567371194|FG000|Overall Study|Physician Decision|3|||
157172541|NCT01342952|567371195|FG001|Overall Study|Physician Decision|3|||
157172542|NCT01342952|567371196|FG002|Overall Study|Physician Decision|1|||
157172543|NCT01342952|567371197|FG003|Overall Study|Physician Decision|0|||
157172544|NCT00416312|567371199|FG000|Overall Study|tumors not visible on imaging|2|||
157172545|NCT02727660|567371200|FG000|Overall Study|Lack of Efficacy|40|||
157172546|NCT02727660|567371201|FG001|Overall Study|Lack of Efficacy|40|||
157172547|NCT02727660|567371202|FG002|Overall Study|Lack of Efficacy|70|||
157172548|NCT02727660|567371200|FG000|Overall Study|Adverse Event|28|||
157172549|NCT02727660|567371201|FG001|Overall Study|Adverse Event|21|||
157172550|NCT02727660|567371202|FG002|Overall Study|Adverse Event|32|||
157172551|NCT02727660|567371200|FG000|Overall Study|Withdrawal by Subject|26|||
156964463|NCT03969719|566620628|FG001|Overall Study|Lost to Follow-up|1|||
156964464|NCT03969719|566620629|FG002|Overall Study|Lost to Follow-up|0|||
157040068|NCT02787005|566901550|FG004|Overall Study|Screen Failure|1|||
157040069|NCT02787005|566901546|FG000|Overall Study|Lost to Follow-up|0|||
157172552|NCT02727660|567371201|FG001|Overall Study|Withdrawal by Subject|25|||
157172553|NCT02727660|567371202|FG002|Overall Study|Withdrawal by Subject|30|||
157172554|NCT02727660|567371200|FG000|Overall Study|Physician Decision|3|||
157172555|NCT02727660|567371201|FG001|Overall Study|Physician Decision|8|||
157172556|NCT02727660|567371202|FG002|Overall Study|Physician Decision|14|||
157227861|NCT00767325|567579222|FG000|Overall Study|No longer met study criteria|2|||
157040070|NCT02787005|566901547|FG001|Overall Study|Lost to Follow-up|0|||
157172557|NCT02727660|567371200|FG000|Overall Study|Lost to Follow-up|5|||
157227862|NCT00767325|567579222|FG000|Overall Study|Missed visit due to family reasons|1|||
157040071|NCT02787005|566901548|FG002|Overall Study|Lost to Follow-up|0|||
157040072|NCT02787005|566901549|FG003|Overall Study|Lost to Follow-up|1|||
157172558|NCT02727660|567371201|FG001|Overall Study|Lost to Follow-up|9|||
157172559|NCT02727660|567371202|FG002|Overall Study|Lost to Follow-up|8|||
157172560|NCT02727660|567371200|FG000|Overall Study|Protocol Violation|7|||
157172561|NCT02727660|567371201|FG001|Overall Study|Protocol Violation|5|||
157172562|NCT02727660|567371202|FG002|Overall Study|Protocol Violation|5|||
157172563|NCT02727660|567371200|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
157172564|NCT02727660|567371201|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
156964465|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
156964466|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
157040073|NCT02787005|566901550|FG004|Overall Study|Lost to Follow-up|0|||
156964467|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
156964468|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964469|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964470|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964471|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964472|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964473|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
156964474|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
156964475|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
156964476|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
156964477|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156964478|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156964479|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156964480|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156964481|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
157040074|NCT05580003|566901556|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040075|NCT05580003|566901557|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040076|NCT05580003|566901558|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040077|NCT05580003|566901559|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040078|NCT05580003|566901560|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040079|NCT05580003|566901561|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040080|NCT05580003|566901562|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
157040081|NCT05580003|566901563|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040082|NCT05580003|566901564|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040083|NCT05580003|566901565|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040084|NCT05580003|566901566|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040085|NCT05580003|566901567|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040086|NCT05580003|566901568|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040087|NCT05580003|566901569|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040088|NCT05580003|566901570|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040089|NCT05580003|566901571|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040090|NCT05580003|566901572|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157227863|NCT03538756|567579223|FG000|Long-Term Follow-up|Adverse Event|0|||
157227864|NCT03538756|567579224|FG001|Long-Term Follow-up|Adverse Event|0|||
157227865|NCT03538756|567579225|FG002|Long-Term Follow-up|Adverse Event|6|||
157227866|NCT03538756|567579223|FG000|Long-Term Follow-up|Death|0|||
157227867|NCT03538756|567579224|FG001|Long-Term Follow-up|Death|0|||
157227868|NCT03538756|567579225|FG002|Long-Term Follow-up|Death|1|||
157227869|NCT03538756|567579223|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
157227870|NCT03538756|567579224|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
157227871|NCT03538756|567579225|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
157227872|NCT03538756|567579223|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
157227873|NCT03538756|567579224|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
157227874|NCT03538756|567579225|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
157227875|NCT03538756|567579223|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
157227876|NCT03538756|567579224|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
157227877|NCT03538756|567579225|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
157227878|NCT00752856|567579226|FG000|Overall Study|randomized but did not do viral kinetics|0|||
157227879|NCT00752856|567579227|FG001|Overall Study|randomized but did not do viral kinetics|1|||
157227880|NCT02688608|567579228|FG000|Overall Study|Lost to Follow-up|1|||
157227881|NCT04529109|567579230|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
157227882|NCT04529109|567579231|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
157227883|NCT01508936|567579233|FG000|Overall Study|Adverse Event|11|||
157227884|NCT01508936|567579234|FG001|Overall Study|Adverse Event|32|||
157227885|NCT01508936|567579233|FG000|Overall Study|Lack of Efficacy|0|||
157227886|NCT01508936|567579234|FG001|Overall Study|Lack of Efficacy|1|||
157227887|NCT01508936|567579233|FG000|Overall Study|Withdrawal by Subject|4|||
157227888|NCT01508936|567579234|FG001|Overall Study|Withdrawal by Subject|18|||
157227889|NCT01508936|567579233|FG000|Overall Study|Protocol Violation|2|||
157227890|NCT01508936|567579234|FG001|Overall Study|Protocol Violation|3|||
157227891|NCT01508936|567579233|FG000|Overall Study|Lost to Follow-up|2|||
156964482|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
156964483|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
157227892|NCT01508936|567579234|FG001|Overall Study|Lost to Follow-up|9|||
157227893|NCT01508936|567579233|FG000|Overall Study|Other|0|||
157227894|NCT01508936|567579234|FG001|Overall Study|Other|5|||
157227895|NCT01508936|567579233|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
157227896|NCT01508936|567579234|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
156964484|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
157172565|NCT02727660|567371202|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
157172566|NCT02727660|567371200|FG000|Overall Study|Administrative Reasons|2|||
157172567|NCT02727660|567371201|FG001|Overall Study|Administrative Reasons|3|||
157172568|NCT02727660|567371202|FG002|Overall Study|Administrative Reasons|4|||
157172569|NCT01192204|567371204|FG000|Overall Study|could not keep recall appointments|1|||
157172570|NCT01192204|567371205|FG001|Overall Study|could not keep recall appointments|0|||
157172571|NCT00964158|567371208|FG000|Overall Study|Lost to Follow-up|0|||
157172572|NCT00964158|567371209|FG001|Overall Study|Lost to Follow-up|1|||
157172573|NCT00964158|567371210|FG002|Overall Study|Lost to Follow-up|2|||
157172574|NCT00964158|567371208|FG000|Overall Study|Withdrawal by Subject|0|||
157172575|NCT00964158|567371209|FG001|Overall Study|Withdrawal by Subject|0|||
157172576|NCT00964158|567371210|FG002|Overall Study|Withdrawal by Subject|6|||
157172577|NCT00507416|567371211|FG000|Overall Study|Adverse Event|58|||
157172578|NCT00507416|567371212|FG001|Overall Study|Adverse Event|67|||
157172579|NCT00507416|567371213|FG002|Overall Study|Adverse Event|65|||
156964485|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
156964486|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
157172580|NCT00507416|567371211|FG000|Overall Study|Protocol Violation|1|||
157172581|NCT00507416|567371212|FG001|Overall Study|Protocol Violation|2|||
157172582|NCT00507416|567371213|FG002|Overall Study|Protocol Violation|0|||
157172583|NCT00507416|567371211|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
157172584|NCT00507416|567371212|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
157172585|NCT00507416|567371213|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
157172586|NCT00507416|567371211|FG000|Overall Study|Progressive Disease|20|||
157172587|NCT00507416|567371212|FG001|Overall Study|Progressive Disease|10|||
156964487|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156964488|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156964489|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156964490|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156964491|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
156964492|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
156964493|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964494|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
156964495|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964496|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964497|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964498|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964499|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964500|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
156964501|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964502|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964503|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
156964504|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964505|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
157172588|NCT00507416|567371213|FG002|Overall Study|Progressive Disease|13|||
156964506|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964507|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964508|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964509|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
156964510|NCT01212770|566620630|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
156964511|NCT01212770|566620631|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
156964512|NCT01212770|566620632|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
156964513|NCT01212770|566620633|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964514|NCT01212770|566620634|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964515|NCT01212770|566620635|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964516|NCT01212770|566620636|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964517|NCT01212770|566620637|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964518|NCT01212770|566620638|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
156964519|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156964520|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
156964521|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
156964522|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
156964523|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156964524|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156964525|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
156964526|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156964527|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
156964528|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
157040091|NCT05580003|566901573|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040092|NCT05580003|566901574|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040093|NCT05580003|566901575|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040094|NCT05580003|566901576|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040095|NCT05580003|566901577|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040096|NCT05580003|566901578|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040097|NCT05580003|566901579|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040098|NCT05580003|566901580|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040099|NCT05580003|566901581|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040100|NCT05580003|566901582|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040101|NCT05580003|566901583|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
157040102|NCT05580003|566901556|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040103|NCT05580003|566901557|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040104|NCT05580003|566901558|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040105|NCT05580003|566901559|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040106|NCT05580003|566901560|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040107|NCT05580003|566901561|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
157040108|NCT05580003|566901562|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040109|NCT05580003|566901563|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040110|NCT05580003|566901564|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040111|NCT05580003|566901565|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040112|NCT05580003|566901566|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040113|NCT05580003|566901567|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040114|NCT05580003|566901568|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040115|NCT05580003|566901569|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040116|NCT05580003|566901570|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040117|NCT05580003|566901571|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040118|NCT05580003|566901572|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040119|NCT05580003|566901573|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040120|NCT05580003|566901574|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040121|NCT05580003|566901575|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040122|NCT05580003|566901576|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040123|NCT05580003|566901577|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040124|NCT05580003|566901578|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040125|NCT05580003|566901579|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040126|NCT05580003|566901580|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040127|NCT05580003|566901581|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040128|NCT05580003|566901582|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040129|NCT05580003|566901583|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
157040130|NCT05580003|566901556|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040131|NCT05580003|566901557|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040132|NCT05580003|566901558|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040133|NCT05580003|566901559|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
157040134|NCT05580003|566901560|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040135|NCT05580003|566901561|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040136|NCT05580003|566901562|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040137|NCT05580003|566901563|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040138|NCT05580003|566901564|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040139|NCT05580003|566901565|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040140|NCT05580003|566901566|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040141|NCT05580003|566901567|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040142|NCT05580003|566901568|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040143|NCT05580003|566901569|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040144|NCT05580003|566901570|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040145|NCT05580003|566901571|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040146|NCT05580003|566901572|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040147|NCT05580003|566901573|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040148|NCT05580003|566901574|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040149|NCT05580003|566901575|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040150|NCT05580003|566901576|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157227897|NCT00679367|567579235|FG000|Overall Study|Adverse Event|7|||
157040151|NCT05580003|566901577|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040152|NCT05580003|566901578|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040153|NCT05580003|566901579|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040154|NCT05580003|566901580|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040155|NCT05580003|566901581|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040156|NCT05580003|566901582|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157040157|NCT05580003|566901583|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
157227898|NCT00679367|567579235|FG000|Overall Study|inability to swallow oral drugs|1|||
157040158|NCT05580003|566901556|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040159|NCT05580003|566901557|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
157040160|NCT05580003|566901558|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040161|NCT05580003|566901559|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040162|NCT05580003|566901560|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040163|NCT05580003|566901561|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
156964529|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
156964530|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
157040164|NCT05580003|566901562|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040165|NCT05580003|566901563|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040166|NCT05580003|566901564|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040167|NCT05580003|566901565|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040168|NCT05580003|566901566|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040169|NCT05580003|566901567|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040170|NCT05580003|566901568|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040171|NCT05580003|566901569|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040172|NCT05580003|566901570|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040173|NCT05580003|566901571|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040174|NCT05580003|566901572|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040175|NCT05580003|566901573|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040176|NCT05580003|566901574|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040177|NCT05580003|566901575|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040178|NCT05580003|566901576|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040179|NCT05580003|566901577|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040180|NCT05580003|566901578|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040181|NCT05580003|566901579|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040182|NCT05580003|566901580|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040183|NCT05580003|566901581|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040184|NCT05580003|566901582|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040185|NCT05580003|566901583|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
157040186|NCT05580003|566901556|FG000|Part 2 (up to 10 Days)|Other|0|||
157040187|NCT05580003|566901557|FG001|Part 2 (up to 10 Days)|Other|0|||
157040188|NCT05580003|566901558|FG002|Part 2 (up to 10 Days)|Other|0|||
157040189|NCT05580003|566901559|FG003|Part 2 (up to 10 Days)|Other|0|||
157040190|NCT05580003|566901560|FG004|Part 2 (up to 10 Days)|Other|0|||
157040191|NCT05580003|566901561|FG005|Part 2 (up to 10 Days)|Other|0|||
157040192|NCT05580003|566901562|FG006|Part 2 (up to 10 Days)|Other|0|||
157040193|NCT05580003|566901563|FG007|Part 2 (up to 10 Days)|Other|0|||
156964531|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
156964532|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
156964533|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
156964534|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156964535|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156964536|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
156964537|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
156964538|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
156964539|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
156964540|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
156964541|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156964542|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156964543|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
156964544|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
157040194|NCT05580003|566901564|FG008|Part 2 (up to 10 Days)|Other|0|||
157040195|NCT05580003|566901565|FG009|Part 2 (up to 10 Days)|Other|1|||
157040196|NCT05580003|566901566|FG010|Part 2 (up to 10 Days)|Other|0|||
157040197|NCT05580003|566901567|FG011|Part 2 (up to 10 Days)|Other|0|||
157040198|NCT05580003|566901568|FG012|Part 2 (up to 10 Days)|Other|0|||
157040199|NCT05580003|566901569|FG013|Part 2 (up to 10 Days)|Other|0|||
157040200|NCT05580003|566901570|FG014|Part 2 (up to 10 Days)|Other|0|||
157040201|NCT05580003|566901571|FG015|Part 2 (up to 10 Days)|Other|0|||
157040202|NCT05580003|566901572|FG016|Part 2 (up to 10 Days)|Other|0|||
157040203|NCT05580003|566901573|FG017|Part 2 (up to 10 Days)|Other|0|||
157040204|NCT05580003|566901574|FG018|Part 2 (up to 10 Days)|Other|0|||
157040205|NCT05580003|566901575|FG019|Part 2 (up to 10 Days)|Other|0|||
157040206|NCT05580003|566901576|FG020|Part 2 (up to 10 Days)|Other|0|||
157040207|NCT05580003|566901577|FG021|Part 2 (up to 10 Days)|Other|0|||
157040208|NCT05580003|566901578|FG022|Part 2 (up to 10 Days)|Other|0|||
157040209|NCT05580003|566901579|FG023|Part 2 (up to 10 Days)|Other|0|||
157040210|NCT05580003|566901580|FG024|Part 2 (up to 10 Days)|Other|0|||
157040211|NCT05580003|566901581|FG025|Part 2 (up to 10 Days)|Other|0|||
156964545|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
156964546|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964547|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964548|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
156964549|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964550|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964551|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964552|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964553|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964554|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
156964555|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964556|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964557|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964558|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
156964559|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964560|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964561|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964562|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964563|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
156964564|NCT01212770|566620630|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964565|NCT01212770|566620631|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964566|NCT01212770|566620632|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
156964567|NCT01212770|566620633|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
156964568|NCT01212770|566620634|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964569|NCT01212770|566620635|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964570|NCT01212770|566620636|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964571|NCT01212770|566620637|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964572|NCT01212770|566620638|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
156964573|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964574|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
156964575|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
156964576|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964577|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964578|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964579|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964580|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
156964581|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
156964582|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156964583|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
156964584|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
156964585|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156964586|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156964587|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156964588|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
156964589|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
156964590|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
156964591|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964592|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
156964593|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964594|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964595|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964596|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964597|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964598|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964599|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
156964600|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156964601|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
156964602|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
156964603|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156964604|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156964605|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156964606|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
156964607|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
156964608|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
156964609|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156964610|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
156964611|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156964612|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156964613|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156964614|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156964615|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
156964616|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156964617|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
156964618|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964619|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
156964620|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156964621|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964622|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964623|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964624|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964625|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
156964626|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
156964627|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156964628|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156964629|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156964630|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156964631|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156964632|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156964633|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
156964634|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
156964635|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
156964636|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156964637|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
156964638|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
156964639|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156964640|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156964641|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156964642|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
156964643|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156964644|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
156964645|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156964646|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
156964647|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
156964648|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156964649|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156964650|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156964651|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
156964652|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156964653|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
156964654|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964655|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
156964656|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964657|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964658|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964659|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964660|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964661|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964662|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
156964663|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964664|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964665|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964666|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964667|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964668|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964669|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964670|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
156964671|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
156964672|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156964673|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
156964674|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156964675|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156964676|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156964677|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
157040212|NCT05580003|566901582|FG026|Part 2 (up to 10 Days)|Other|0|||
157040213|NCT05580003|566901583|FG027|Part 2 (up to 10 Days)|Other|0|||
156964678|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
156964679|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156964680|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
156964681|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964682|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156964683|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156964684|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964685|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964686|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964687|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964688|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
156964689|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
156964690|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964691|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
156964692|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
156964693|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964694|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964695|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964696|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964697|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
156964698|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
156964699|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964700|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156964701|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156964702|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964703|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964704|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964705|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964706|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
156964707|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
156964708|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964709|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
156964710|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
156964711|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964712|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964713|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964714|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964715|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964716|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
156964717|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964718|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964719|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
156964720|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964721|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964722|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964723|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964724|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964725|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
156964726|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964727|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
156964728|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964729|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964730|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964731|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964732|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964733|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
156964734|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
156964735|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
156964736|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
156964737|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
156964738|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
156964739|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
157172589|NCT00507416|567371211|FG000|Overall Study|Patient declined further treatment|18|||
157172590|NCT00507416|567371212|FG001|Overall Study|Patient declined further treatment|14|||
157172591|NCT00507416|567371213|FG002|Overall Study|Patient declined further treatment|11|||
157172592|NCT00507416|567371211|FG000|Overall Study|Other|11|||
156964740|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
156964741|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
157172593|NCT00507416|567371212|FG001|Overall Study|Other|16|||
156964742|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
156964743|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
156964744|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964745|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964746|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
156964747|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964748|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964749|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964750|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964751|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964752|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
156964753|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964754|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964755|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
156964756|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964757|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964758|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964759|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964760|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
156964761|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
156964762|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964763|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964764|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
156964765|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964766|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964767|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964768|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964769|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964770|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
156964771|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964772|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
156964773|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156964774|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964775|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964776|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964777|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964778|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
156964779|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
156964780|NCT01212770|566620630|FG000|Long-term Safety Phase (Year 5)|Death|0|||
156964781|NCT01212770|566620631|FG001|Long-term Safety Phase (Year 5)|Death|0|||
156964782|NCT01212770|566620632|FG002|Long-term Safety Phase (Year 5)|Death|0|||
156964783|NCT01212770|566620633|FG003|Long-term Safety Phase (Year 5)|Death|0|||
156964784|NCT01212770|566620634|FG004|Long-term Safety Phase (Year 5)|Death|0|||
156964785|NCT01212770|566620635|FG005|Long-term Safety Phase (Year 5)|Death|0|||
156964786|NCT01212770|566620636|FG006|Long-term Safety Phase (Year 5)|Death|0|||
156964787|NCT01212770|566620637|FG007|Long-term Safety Phase (Year 5)|Death|1|||
156964788|NCT01212770|566620638|FG008|Long-term Safety Phase (Year 5)|Death|0|||
156964789|NCT00829387|566620641|FG000|Overall Study|Withdrawal by Subject|2|||
156964790|NCT00829387|566620642|FG001|Overall Study|Withdrawal by Subject|3|||
156964791|NCT00829387|566620641|FG000|Overall Study|Disqualified by PI|1|||
156964792|NCT00829387|566620642|FG001|Overall Study|Disqualified by PI|0|||
156964793|NCT04304833|566620643|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
156964794|NCT04304833|566620644|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
156964795|NCT02858895|566620645|FG000|Overall Study|Disease progression|31|||
156964796|NCT02858895|566620645|FG000|Overall Study|Death|2|||
156964797|NCT02858895|566620645|FG000|Overall Study|Adverse Event|1|||
156964798|NCT02858895|566620645|FG000|Overall Study|Withdrawal by Subject|3|||
156964799|NCT02858895|566620645|FG000|Overall Study|hospice,|1|||
156964800|NCT02858895|566620645|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
156964801|NCT01377480|566622852|FG000|Overall Study|Protocol Violation|0|||
156964802|NCT01377480|566622853|FG001|Overall Study|Protocol Violation|0|||
156964803|NCT01377480|566622854|FG002|Overall Study|Protocol Violation|0|||
156964804|NCT01377480|566622855|FG003|Overall Study|Protocol Violation|4|||
156964805|NCT01377480|566622852|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
156964806|NCT01377480|566622853|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
156964807|NCT01377480|566622854|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
156964808|NCT01377480|566622855|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
156964809|NCT01377480|566622852|FG000|Overall Study|Withdrawal by Subject|0|||
156964810|NCT01377480|566622853|FG001|Overall Study|Withdrawal by Subject|0|||
156964811|NCT01377480|566622854|FG002|Overall Study|Withdrawal by Subject|1|||
156964812|NCT01377480|566622855|FG003|Overall Study|Withdrawal by Subject|0|||
157172594|NCT00507416|567371213|FG002|Overall Study|Other|13|||
157172595|NCT00507416|567371211|FG000|Overall Study|Did not Receive Study Treatment|3|||
157172596|NCT00507416|567371212|FG001|Overall Study|Did not Receive Study Treatment|9|||
157172597|NCT00507416|567371213|FG002|Overall Study|Did not Receive Study Treatment|4|||
157172598|NCT03101514|567371214|FG000|Overall Study|Withdrawal by Subject|4|||
157172599|NCT03101514|567371214|FG000|Overall Study|Protocol Violation|2|||
157172600|NCT03101514|567371214|FG000|Overall Study|patient's information was incomplete|1|||
157172601|NCT03571256|567371215|FG000|Overall Study|Adverse Event|3|||
157172602|NCT03571256|567371216|FG001|Overall Study|Adverse Event|0|||
157172603|NCT03571256|567371217|FG002|Overall Study|Adverse Event|1|||
157172604|NCT03571256|567371215|FG000|Overall Study|Withdrawal by Subject|3|||
157172605|NCT03571256|567371216|FG001|Overall Study|Withdrawal by Subject|1|||
157172606|NCT03571256|567371217|FG002|Overall Study|Withdrawal by Subject|1|||
157172607|NCT03571256|567371215|FG000|Overall Study|Other than specified|0|||
157172608|NCT03571256|567371216|FG001|Overall Study|Other than specified|1|||
157172609|NCT03571256|567371217|FG002|Overall Study|Other than specified|1|||
157172610|NCT03571256|567371215|FG000|Overall Study|Protocol Violation|0|||
157172611|NCT03571256|567371216|FG001|Overall Study|Protocol Violation|1|||
157172612|NCT03571256|567371217|FG002|Overall Study|Protocol Violation|1|||
157172613|NCT02270684|567371218|FG000|Overall Study|Lost to Follow-up|0|||
157172614|NCT02270684|567371219|FG001|Overall Study|Lost to Follow-up|3|||
157172615|NCT02270684|567371218|FG000|Overall Study|Study terminated|1|||
157172616|NCT02270684|567371219|FG001|Overall Study|Study terminated|0|||
157172617|NCT02247401|567371222|FG000|Overall Study|Adverse Event|1|||
157172618|NCT02247401|567371223|FG001|Overall Study|Adverse Event|0|||
157172619|NCT02247401|567371224|FG002|Overall Study|Adverse Event|0|||
157172620|NCT02247401|567371222|FG000|Overall Study|Withdrawal by Subject|4|||
157172621|NCT02247401|567371223|FG001|Overall Study|Withdrawal by Subject|1|||
157172622|NCT02247401|567371224|FG002|Overall Study|Withdrawal by Subject|1|||
157172623|NCT02247401|567371222|FG000|Overall Study|Lost to Follow-up|1|||
157172624|NCT02247401|567371223|FG001|Overall Study|Lost to Follow-up|1|||
157172625|NCT02247401|567371224|FG002|Overall Study|Lost to Follow-up|1|||
156964813|NCT01377480|566622852|FG000|Overall Study|Serious adverse event|0|||
156964814|NCT01377480|566622853|FG001|Overall Study|Serious adverse event|0|||
156964815|NCT01377480|566622854|FG002|Overall Study|Serious adverse event|1|||
156964816|NCT01377480|566622855|FG003|Overall Study|Serious adverse event|1|||
156964817|NCT01377480|566622852|FG000|Overall Study|Other|0|||
156964818|NCT01377480|566622853|FG001|Overall Study|Other|0|||
156964819|NCT01377480|566622854|FG002|Overall Study|Other|7|||
156964820|NCT01377480|566622855|FG003|Overall Study|Other|6|||
156964821|NCT04098406|566622858|FG000|Overall Study|Adverse Event|2|||
156964822|NCT04098406|566622859|FG001|Overall Study|Adverse Event|1|||
156964823|NCT04098406|566622858|FG000|Overall Study|Withdrawal by Subject|1|||
156964824|NCT04098406|566622859|FG001|Overall Study|Withdrawal by Subject|0|||
156964825|NCT01786512|566622860|FG000|Overall Study|Lost to Follow-up|0|||
156964826|NCT01786512|566622861|FG001|Overall Study|Lost to Follow-up|0|||
156964827|NCT01786512|566622862|FG002|Overall Study|Lost to Follow-up|0|||
156964828|NCT01786512|566622863|FG003|Overall Study|Lost to Follow-up|0|||
156964829|NCT01786512|566622864|FG004|Overall Study|Lost to Follow-up|0|||
156964830|NCT01786512|566622865|FG005|Overall Study|Lost to Follow-up|0|||
156964831|NCT01786512|566622866|FG006|Overall Study|Lost to Follow-up|0|||
156964832|NCT01786512|566622867|FG007|Overall Study|Lost to Follow-up|0|||
156964833|NCT01786512|566622868|FG008|Overall Study|Lost to Follow-up|0|||
156964834|NCT01786512|566622869|FG009|Overall Study|Lost to Follow-up|1|||
156964835|NCT01786512|566622870|FG010|Overall Study|Lost to Follow-up|0|||
156964836|NCT01786512|566622860|FG000|Overall Study|Decision by sponsor|0|||
156964837|NCT01786512|566622861|FG001|Overall Study|Decision by sponsor|0|||
156964838|NCT01786512|566622862|FG002|Overall Study|Decision by sponsor|0|||
156964839|NCT01786512|566622863|FG003|Overall Study|Decision by sponsor|0|||
156964840|NCT01786512|566622864|FG004|Overall Study|Decision by sponsor|0|||
156964841|NCT01786512|566622865|FG005|Overall Study|Decision by sponsor|0|||
156964842|NCT01786512|566622866|FG006|Overall Study|Decision by sponsor|0|||
156964843|NCT01786512|566622867|FG007|Overall Study|Decision by sponsor|0|||
156964844|NCT01786512|566622868|FG008|Overall Study|Decision by sponsor|0|||
156964845|NCT01786512|566622869|FG009|Overall Study|Decision by sponsor|0|||
156964846|NCT01786512|566622870|FG010|Overall Study|Decision by sponsor|2|||
156964847|NCT01786512|566622860|FG000|Overall Study|Withdrawal by Subject|0|||
156964848|NCT01786512|566622861|FG001|Overall Study|Withdrawal by Subject|1|||
156964849|NCT01786512|566622862|FG002|Overall Study|Withdrawal by Subject|0|||
156964850|NCT01786512|566622863|FG003|Overall Study|Withdrawal by Subject|0|||
156964851|NCT01786512|566622864|FG004|Overall Study|Withdrawal by Subject|0|||
156964852|NCT01786512|566622865|FG005|Overall Study|Withdrawal by Subject|0|||
156964853|NCT01786512|566622866|FG006|Overall Study|Withdrawal by Subject|1|||
156964854|NCT01786512|566622867|FG007|Overall Study|Withdrawal by Subject|0|||
156964855|NCT01786512|566622868|FG008|Overall Study|Withdrawal by Subject|0|||
156964856|NCT01786512|566622869|FG009|Overall Study|Withdrawal by Subject|3|||
156964857|NCT01786512|566622870|FG010|Overall Study|Withdrawal by Subject|7|||
156964858|NCT01786512|566622860|FG000|Overall Study|Death|0|||
157172626|NCT03695393|567371225|FG000|Overall Study|Death|3|||
157040214|NCT05580003|566901556|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040215|NCT05580003|566901557|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040216|NCT05580003|566901558|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040217|NCT05580003|566901559|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040218|NCT05580003|566901560|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040219|NCT05580003|566901561|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040220|NCT05580003|566901562|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040221|NCT05580003|566901563|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040222|NCT05580003|566901564|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040223|NCT05580003|566901565|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040224|NCT05580003|566901566|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040225|NCT05580003|566901567|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040226|NCT05580003|566901568|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040227|NCT05580003|566901569|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040228|NCT05580003|566901570|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040229|NCT05580003|566901571|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040230|NCT05580003|566901572|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040231|NCT05580003|566901573|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040232|NCT05580003|566901574|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040233|NCT05580003|566901575|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
157040234|NCT05580003|566901576|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040235|NCT05580003|566901577|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040236|NCT05580003|566901578|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040237|NCT05580003|566901579|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040238|NCT05580003|566901580|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040239|NCT05580003|566901581|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040240|NCT05580003|566901582|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040241|NCT05580003|566901583|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
157040242|NCT05580003|566901556|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040243|NCT05580003|566901557|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040244|NCT05580003|566901558|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040245|NCT05580003|566901559|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040246|NCT05580003|566901560|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040247|NCT05580003|566901561|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040248|NCT05580003|566901562|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040249|NCT05580003|566901563|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040250|NCT05580003|566901564|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040251|NCT05580003|566901565|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040252|NCT05580003|566901566|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040253|NCT05580003|566901567|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040254|NCT05580003|566901568|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040255|NCT05580003|566901569|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040256|NCT05580003|566901570|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040257|NCT05580003|566901571|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040258|NCT05580003|566901572|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040259|NCT05580003|566901573|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040260|NCT05580003|566901574|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040261|NCT05580003|566901575|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040262|NCT05580003|566901576|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
157040263|NCT05580003|566901577|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040264|NCT05580003|566901578|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040265|NCT05580003|566901579|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040266|NCT05580003|566901580|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040267|NCT05580003|566901581|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040268|NCT05580003|566901582|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040269|NCT05580003|566901583|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
157040270|NCT05580003|566901556|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040271|NCT05580003|566901557|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040272|NCT05580003|566901558|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040273|NCT05580003|566901559|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040274|NCT05580003|566901560|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040275|NCT05580003|566901561|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040276|NCT05580003|566901562|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040277|NCT05580003|566901563|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040278|NCT05580003|566901564|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040279|NCT05580003|566901565|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040280|NCT05580003|566901566|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040281|NCT05580003|566901567|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040282|NCT05580003|566901568|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156964859|NCT01786512|566622861|FG001|Overall Study|Death|0|||
156964860|NCT01786512|566622862|FG002|Overall Study|Death|0|||
156964861|NCT01786512|566622863|FG003|Overall Study|Death|0|||
156964862|NCT01786512|566622864|FG004|Overall Study|Death|0|||
156964863|NCT01786512|566622865|FG005|Overall Study|Death|0|||
156964864|NCT01786512|566622866|FG006|Overall Study|Death|0|||
156964865|NCT01786512|566622867|FG007|Overall Study|Death|0|||
156964866|NCT01786512|566622868|FG008|Overall Study|Death|4|||
156964867|NCT01786512|566622869|FG009|Overall Study|Death|1|||
156964868|NCT01786512|566622870|FG010|Overall Study|Death|3|||
156964869|NCT00605293|566622871|FG000|Overall Study|Death|2|||
156964870|NCT00605293|566622872|FG001|Overall Study|Death|1|||
156964871|NCT00605293|566622871|FG000|Overall Study|Insufficient Therapeutic Response|2|||
156964872|NCT00605293|566622872|FG001|Overall Study|Insufficient Therapeutic Response|0|||
156964873|NCT00605293|566622871|FG000|Overall Study|Adverse Event|1|||
156964874|NCT00605293|566622872|FG001|Overall Study|Adverse Event|0|||
156964875|NCT00605293|566622871|FG000|Overall Study|Holidays Dialysis Out|1|||
156964876|NCT00605293|566622872|FG001|Overall Study|Holidays Dialysis Out|0|||
156964877|NCT00605293|566622871|FG000|Overall Study|Blood Transfusion|7|||
156964878|NCT00605293|566622872|FG001|Overall Study|Blood Transfusion|1|||
156964879|NCT00605293|566622871|FG000|Overall Study|Renal Transplantation|3|||
156964880|NCT00605293|566622872|FG001|Overall Study|Renal Transplantation|1|||
156964881|NCT00605293|566622871|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
156964882|NCT00605293|566622872|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
156964883|NCT00605293|566622871|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
156964884|NCT00605293|566622872|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
156964885|NCT00605293|566622871|FG000|Overall Study|Principal Investigator Decision|0|||
156964886|NCT00605293|566622872|FG001|Overall Study|Principal Investigator Decision|1|||
156964887|NCT03581981|566622873|FG000|Overall Study|Withdrawal by Subject|12|||
156964888|NCT03581981|566622874|FG001|Overall Study|Withdrawal by Subject|13|||
156964889|NCT03581981|566622873|FG000|Overall Study|Physician Decision|1|||
156964890|NCT03581981|566622874|FG001|Overall Study|Physician Decision|2|||
156964891|NCT03581981|566622873|FG000|Overall Study|Lost to Follow-up|0|||
156964892|NCT03581981|566622874|FG001|Overall Study|Lost to Follow-up|4|||
156964893|NCT00828984|566622875|FG000|Overall Study|Adverse Event|2|||
156964894|NCT00828984|566622876|FG001|Overall Study|Adverse Event|3|||
156964895|NCT00828984|566622877|FG002|Overall Study|Adverse Event|0|||
156964896|NCT00828984|566622875|FG000|Overall Study|Lost to Follow-up|5|||
156964897|NCT00828984|566622876|FG001|Overall Study|Lost to Follow-up|3|||
156964898|NCT00828984|566622877|FG002|Overall Study|Lost to Follow-up|1|||
156964899|NCT00828984|566622875|FG000|Overall Study|Withdrawal by Subject|4|||
156964900|NCT00828984|566622876|FG001|Overall Study|Withdrawal by Subject|4|||
156964901|NCT00828984|566622877|FG002|Overall Study|Withdrawal by Subject|4|||
156964902|NCT00828984|566622875|FG000|Overall Study|Ineligable|1|||
156964903|NCT00828984|566622876|FG001|Overall Study|Ineligable|2|||
156964904|NCT00828984|566622877|FG002|Overall Study|Ineligable|0|||
156964905|NCT00828984|566622875|FG000|Overall Study|Medical Contraindication|0|||
156964906|NCT00828984|566622876|FG001|Overall Study|Medical Contraindication|1|||
156964907|NCT00828984|566622877|FG002|Overall Study|Medical Contraindication|0|||
156964908|NCT00828984|566622875|FG000|Overall Study|Noncompliant|1|||
156964909|NCT00828984|566622876|FG001|Overall Study|Noncompliant|2|||
156964910|NCT00828984|566622877|FG002|Overall Study|Noncompliant|3|||
156964911|NCT00828984|566622875|FG000|Overall Study|ConMed|1|||
156964912|NCT00828984|566622876|FG001|Overall Study|ConMed|1|||
156964913|NCT00828984|566622877|FG002|Overall Study|ConMed|1|||
156964914|NCT04493931|566622882|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
156964915|NCT04493931|566622883|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964916|NCT04493931|566622884|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964917|NCT04493931|566622885|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964918|NCT04493931|566622886|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964919|NCT04493931|566622887|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964920|NCT04493931|566622888|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
156964921|NCT04493931|566622882|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964922|NCT04493931|566622883|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
156964923|NCT04493931|566622884|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964924|NCT04493931|566622885|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964925|NCT04493931|566622886|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964926|NCT04493931|566622887|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964927|NCT04493931|566622888|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
156964928|NCT04493931|566622882|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156964929|NCT04493931|566622883|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
156964930|NCT04493931|566622884|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156964931|NCT04493931|566622885|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156964932|NCT04493931|566622886|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
157172627|NCT03695393|567371226|FG001|Overall Study|Death|1|||
156964933|NCT04493931|566622887|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156964934|NCT04493931|566622888|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
156964935|NCT04493931|566622882|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964936|NCT04493931|566622883|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964937|NCT04493931|566622884|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
156964938|NCT04493931|566622885|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964939|NCT04493931|566622886|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964940|NCT04493931|566622887|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964941|NCT04493931|566622888|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
156964942|NCT03338894|566622889|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
156964943|NCT00863655|566622890|FG000|Overall Study|Protocol Violation|4|||
156964944|NCT00863655|566622891|FG001|Overall Study|Protocol Violation|0|||
156964945|NCT00863655|566622890|FG000|Overall Study|Adverse Event|52|||
156964946|NCT00863655|566622891|FG001|Overall Study|Adverse Event|8|||
156964947|NCT00863655|566622890|FG000|Overall Study|Withdrawal by Subject|47|||
156964948|NCT00863655|566622891|FG001|Overall Study|Withdrawal by Subject|7|||
156964949|NCT00863655|566622890|FG000|Overall Study|Administrative problems|1|||
156964950|NCT00863655|566622891|FG001|Overall Study|Administrative problems|0|||
156964951|NCT00863655|566622890|FG000|Overall Study|Death|7|||
156964952|NCT00863655|566622891|FG001|Overall Study|Death|1|||
156964953|NCT00863655|566622890|FG000|Overall Study|New cancer therapy|5|||
156964954|NCT00863655|566622891|FG001|Overall Study|New cancer therapy|1|||
156964955|NCT00863655|566622890|FG000|Overall Study|Disease progression|364|||
156964956|NCT00863655|566622891|FG001|Overall Study|Disease progression|221|||
156964957|NCT00863655|566622890|FG000|Overall Study|Treatment completed as per protocol|5|||
156964958|NCT00863655|566622891|FG001|Overall Study|Treatment completed as per protocol|1|||
156964959|NCT00420199|566622897|FG000|Overall Study|Participant no longer met study criteria|1|||
156964960|NCT00420199|566622898|FG001|Overall Study|Participant no longer met study criteria|0|||
156964961|NCT00002558|566622910|FG000|Overall Study|Withdrawal by Subject|0|||
156964962|NCT00002558|566622911|FG001|Overall Study|Withdrawal by Subject|1|||
156964963|NCT01260350|566622912|FG000|Overall Study|Lack of Efficacy|0|||
156964964|NCT01260350|566622913|FG001|Overall Study|Lack of Efficacy|0|||
156964965|NCT01260350|566622914|FG002|Overall Study|Lack of Efficacy|0|||
156964966|NCT01260350|566622915|FG003|Overall Study|Lack of Efficacy|0|||
156964967|NCT01260350|566622916|FG004|Overall Study|Lack of Efficacy|0|||
156964968|NCT01260350|566622917|FG005|Overall Study|Lack of Efficacy|0|||
156964969|NCT01260350|566622918|FG006|Overall Study|Lack of Efficacy|0|||
156964970|NCT01260350|566622919|FG007|Overall Study|Lack of Efficacy|0|||
156964971|NCT01260350|566622920|FG008|Overall Study|Lack of Efficacy|0|||
156964972|NCT01260350|566622921|FG009|Overall Study|Lack of Efficacy|0|||
156964973|NCT01260350|566622922|FG010|Overall Study|Lack of Efficacy|0|||
156964974|NCT01260350|566622923|FG011|Overall Study|Lack of Efficacy|0|||
156964975|NCT01260350|566622924|FG012|Overall Study|Lack of Efficacy|0|||
156964976|NCT01260350|566622925|FG013|Overall Study|Lack of Efficacy|0|||
156964977|NCT01260350|566622926|FG014|Overall Study|Lack of Efficacy|0|||
156964978|NCT01260350|566622927|FG015|Overall Study|Lack of Efficacy|0|||
156964979|NCT01260350|566622928|FG016|Overall Study|Lack of Efficacy|0|||
156964980|NCT01260350|566622929|FG017|Overall Study|Lack of Efficacy|1|||
156964981|NCT01260350|566622930|FG018|Overall Study|Lack of Efficacy|0|||
156964982|NCT01260350|566622931|FG019|Overall Study|Lack of Efficacy|0|||
156964983|NCT01260350|566622932|FG020|Overall Study|Lack of Efficacy|3|||
156964984|NCT01260350|566622933|FG021|Overall Study|Lack of Efficacy|0|||
156964985|NCT01260350|566622912|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964986|NCT01260350|566622913|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964987|NCT01260350|566622914|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964988|NCT01260350|566622915|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964989|NCT01260350|566622916|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964990|NCT01260350|566622917|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964991|NCT01260350|566622918|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964992|NCT01260350|566622919|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964993|NCT01260350|566622920|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
156964994|NCT01260350|566622921|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964995|NCT01260350|566622922|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964996|NCT01260350|566622923|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964997|NCT01260350|566622924|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964998|NCT01260350|566622925|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156964999|NCT01260350|566622926|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965000|NCT01260350|566622927|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965001|NCT01260350|566622928|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965002|NCT01260350|566622929|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965003|NCT01260350|566622930|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965004|NCT01260350|566622931|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965005|NCT01260350|566622932|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965006|NCT01260350|566622933|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
156965007|NCT00558428|566622936|FG000|Overall Study|Adverse Event|6|||
156965008|NCT00558428|566622937|FG001|Overall Study|Adverse Event|22|||
156965009|NCT00558428|566622938|FG002|Overall Study|Adverse Event|3|||
156965010|NCT00558428|566622939|FG003|Overall Study|Adverse Event|4|||
156965011|NCT00558428|566622936|FG000|Overall Study|Lost to Follow-up|0|||
156965012|NCT00558428|566622937|FG001|Overall Study|Lost to Follow-up|1|||
156965013|NCT00558428|566622938|FG002|Overall Study|Lost to Follow-up|0|||
156965014|NCT00558428|566622939|FG003|Overall Study|Lost to Follow-up|0|||
156965015|NCT00558428|566622936|FG000|Overall Study|Lack of Efficacy|0|||
156965016|NCT00558428|566622937|FG001|Overall Study|Lack of Efficacy|0|||
156965017|NCT00558428|566622938|FG002|Overall Study|Lack of Efficacy|1|||
156965018|NCT00558428|566622939|FG003|Overall Study|Lack of Efficacy|2|||
156965019|NCT00558428|566622936|FG000|Overall Study|Non compliant with protocol|1|||
156965020|NCT00558428|566622937|FG001|Overall Study|Non compliant with protocol|0|||
156965021|NCT00558428|566622938|FG002|Overall Study|Non compliant with protocol|0|||
156965022|NCT00558428|566622939|FG003|Overall Study|Non compliant with protocol|3|||
156965023|NCT00558428|566622936|FG000|Overall Study|Consent withdrawn|2|||
156965024|NCT00558428|566622937|FG001|Overall Study|Consent withdrawn|1|||
156965025|NCT00558428|566622938|FG002|Overall Study|Consent withdrawn|0|||
156965026|NCT00558428|566622939|FG003|Overall Study|Consent withdrawn|1|||
156965027|NCT00558428|566622936|FG000|Overall Study|Other|3|||
156965028|NCT00558428|566622937|FG001|Overall Study|Other|0|||
156965029|NCT00558428|566622938|FG002|Overall Study|Other|0|||
156965030|NCT00558428|566622939|FG003|Overall Study|Other|1|||
156965031|NCT02570126|566622940|FG000|Overall Study|Lost to Follow-up|2|||
156965032|NCT02570126|566622941|FG001|Overall Study|Lost to Follow-up|0|||
156965033|NCT02570126|566622940|FG000|Overall Study|Unable To Arrange Visit 3|1|||
156965034|NCT02570126|566622941|FG001|Overall Study|Unable To Arrange Visit 3|0|||
156965035|NCT02570126|566622940|FG000|Overall Study|Violation Of Procedures GSK|0|||
156965036|NCT02570126|566622941|FG001|Overall Study|Violation Of Procedures GSK|1|||
156965037|NCT02570126|566622940|FG000|Overall Study|Protocol Violation|0|||
156965038|NCT02570126|566622941|FG001|Overall Study|Protocol Violation|1|||
156965039|NCT02570126|566622940|FG000|Overall Study|Withdrawal by Subject|3|||
156965040|NCT02570126|566622941|FG001|Overall Study|Withdrawal by Subject|7|||
156965041|NCT00626028|566622942|FG000|Overall Study|Adverse Event|1|||
156965042|NCT00626028|566622943|FG001|Overall Study|Adverse Event|1|||
156965043|NCT00626028|566622942|FG000|Overall Study|Device Failure|0|||
156965044|NCT00626028|566622943|FG001|Overall Study|Device Failure|1|||
156965045|NCT00626028|566622942|FG000|Overall Study|Physician Decision|2|||
156965046|NCT00626028|566622943|FG001|Overall Study|Physician Decision|1|||
156965047|NCT00626028|566622942|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
156965048|NCT00626028|566622943|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
156965049|NCT05224050|566622944|FG000|Overall Study|Withdrawal by Subject|9|||
156965050|NCT05224050|566622944|FG000|Overall Study|Lost to Follow-up|3|||
156965051|NCT00917579|566622946|FG000|Washout >= 2 Weeks|Adverse Event|1|||
156965052|NCT00917579|566622947|FG001|Washout >= 2 Weeks|Adverse Event|0|||
156965053|NCT00917579|566622946|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
156965054|NCT00917579|566622947|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
156965055|NCT00754338|566622948|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156965056|NCT00754338|566622949|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
156965057|NCT00754338|566622950|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
156965058|NCT00754338|566622951|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156965059|NCT00754338|566622948|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156965060|NCT00754338|566622949|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
156965061|NCT00754338|566622950|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
156965062|NCT00754338|566622951|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
156965063|NCT04385368|566622958|FG000|Overall Study|Death|5|||
156965064|NCT04385368|566622959|FG001|Overall Study|Death|5|||
156965065|NCT04385368|566622958|FG000|Overall Study|Physician Decision|3|||
156965066|NCT04385368|566622959|FG001|Overall Study|Physician Decision|0|||
156965067|NCT04385368|566622958|FG000|Overall Study|Withdrawal by Subject|4|||
156965068|NCT04385368|566622959|FG001|Overall Study|Withdrawal by Subject|3|||
156965069|NCT02123108|566622964|FG000|Overall Study|Death|2|||
156965070|NCT02123108|566622965|FG001|Overall Study|Death|3|||
157040283|NCT05580003|566901569|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040284|NCT05580003|566901570|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040285|NCT05580003|566901571|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
156965071|NCT00716092|566622969|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
156965072|NCT00716092|566622970|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
157227899|NCT00679367|567579235|FG000|Overall Study|Lack of Efficacy|3|||
156965073|NCT00716092|566622971|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
156965074|NCT02219048|566622972|FG000|Overall Study|Adverse Event|2|||
156965075|NCT02219048|566622973|FG001|Overall Study|Adverse Event|5|||
156965076|NCT02219048|566622972|FG000|Overall Study|No longer meets eligibility criteria|1|||
156965077|NCT02219048|566622973|FG001|Overall Study|No longer meets eligibility criteria|0|||
156965078|NCT02219048|566622972|FG000|Overall Study|Study terminated by sponsor|16|||
156965079|NCT02219048|566622973|FG001|Overall Study|Study terminated by sponsor|15|||
156965080|NCT02219048|566622972|FG000|Overall Study|Withdrawal by Subject|2|||
156965081|NCT02219048|566622973|FG001|Overall Study|Withdrawal by Subject|0|||
156965082|NCT02219048|566622972|FG000|Overall Study|Other|0|||
156965083|NCT02219048|566622973|FG001|Overall Study|Other|1|||
156965084|NCT02436330|566622974|FG000|Cohort 1|Lost to Follow-up|5|||
156965085|NCT02436330|566622975|FG001|Cohort 1|Lost to Follow-up|2|||
156965086|NCT02436330|566622974|FG000|Cohort 1|Withdrawal by Subject|0|||
156965087|NCT02436330|566622975|FG001|Cohort 1|Withdrawal by Subject|1|||
156965088|NCT02436330|566622974|FG000|Cohort 2|Lost to Follow-up|2|||
156965089|NCT02436330|566622975|FG001|Cohort 2|Lost to Follow-up|0|||
156965090|NCT02436330|566622974|FG000|Cohort 2|Withdrawal by Subject|2|||
156965091|NCT02436330|566622975|FG001|Cohort 2|Withdrawal by Subject|3|||
156965092|NCT02436330|566622974|FG000|Cohort 3|Lost to Follow-up|1|||
156965093|NCT02436330|566622975|FG001|Cohort 3|Lost to Follow-up|0|||
156965094|NCT02436330|566622974|FG000|Cohort 3|Withdrawal by Subject|4|||
156965095|NCT02436330|566622975|FG001|Cohort 3|Withdrawal by Subject|0|||
156965096|NCT02436330|566622974|FG000|Cohort 4|Lost to Follow-up|1|||
156965097|NCT02436330|566622975|FG001|Cohort 4|Lost to Follow-up|0|||
156965098|NCT02436330|566622974|FG000|Cohort 4|Withdrawal by Subject|1|||
156965099|NCT02436330|566622975|FG001|Cohort 4|Withdrawal by Subject|0|||
156965100|NCT02436330|566622974|FG000|Cohort 5|Lost to Follow-up|3|||
156965101|NCT02436330|566622975|FG001|Cohort 5|Lost to Follow-up|2|||
156965102|NCT02436330|566622974|FG000|Cohort 5|Withdrawal by Subject|3|||
156965103|NCT02436330|566622975|FG001|Cohort 5|Withdrawal by Subject|2|||
156965104|NCT02436330|566622974|FG000|Cohort 6|Lost to Follow-up|2|||
156965105|NCT02436330|566622975|FG001|Cohort 6|Lost to Follow-up|0|||
156965106|NCT02436330|566622974|FG000|Cohort 6|Withdrawal by Subject|1|||
156965107|NCT02436330|566622975|FG001|Cohort 6|Withdrawal by Subject|1|||
157040286|NCT05580003|566901572|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040287|NCT05580003|566901573|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040288|NCT05580003|566901574|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040289|NCT05580003|566901575|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040290|NCT05580003|566901576|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040291|NCT05580003|566901577|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
157040292|NCT05580003|566901578|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040293|NCT05580003|566901579|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040294|NCT05580003|566901580|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040295|NCT05580003|566901581|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040296|NCT05580003|566901582|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040297|NCT05580003|566901583|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
157040298|NCT05580003|566901556|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040299|NCT05580003|566901557|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040300|NCT05580003|566901558|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040301|NCT05580003|566901559|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040302|NCT05580003|566901560|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040303|NCT05580003|566901561|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040304|NCT05580003|566901562|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040305|NCT05580003|566901563|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040306|NCT05580003|566901564|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040307|NCT05580003|566901565|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040308|NCT05580003|566901566|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040309|NCT05580003|566901567|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040310|NCT05580003|566901568|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040311|NCT05580003|566901569|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040312|NCT05580003|566901570|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040313|NCT05580003|566901571|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040314|NCT05580003|566901572|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040315|NCT05580003|566901573|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040316|NCT05580003|566901574|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040317|NCT05580003|566901575|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156965108|NCT02054806|566622976|FG000|Overall Study|Sponsor Decision|31|||
157040318|NCT05580003|566901576|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040319|NCT05580003|566901577|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040320|NCT05580003|566901578|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156965109|NCT02054806|566622976|FG000|Overall Study|Withdrawal by Subject|43|||
157040321|NCT05580003|566901579|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040322|NCT05580003|566901580|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157040323|NCT05580003|566901581|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
156965110|NCT02054806|566622976|FG000|Overall Study|Protocol Violation|2|||
156965111|NCT02054806|566622976|FG000|Overall Study|Lost to Follow-up|10|||
156965112|NCT02054806|566622976|FG000|Overall Study|Death|391|||
156965113|NCT04721925|566622977|FG000|2-Month Assessment|Lost to Follow-up|5|||
156965114|NCT04721925|566622978|FG001|2-Month Assessment|Lost to Follow-up|3|||
156965115|NCT04721925|566622977|FG000|4-Month Assessment|Lost to Follow-up|3|||
156965116|NCT04721925|566622978|FG001|4-Month Assessment|Lost to Follow-up|6|||
156965117|NCT00677235|566622979|FG000|Overall Study|Withdrawal by Subject|1|||
156965118|NCT00677235|566622980|FG001|Overall Study|Withdrawal by Subject|1|||
156965119|NCT00677235|566622979|FG000|Overall Study|Lost to Follow-up|2|||
157172628|NCT03695393|567371225|FG000|Overall Study|Lost to Follow-up|0|||
157172629|NCT03695393|567371226|FG001|Overall Study|Lost to Follow-up|1|||
156965120|NCT00677235|566622980|FG001|Overall Study|Lost to Follow-up|1|||
156965121|NCT00677235|566622979|FG000|Overall Study|Death|37|||
156965122|NCT00677235|566622980|FG001|Overall Study|Death|36|||
156965123|NCT00677235|566622979|FG000|Overall Study|Adverse Experience|1|||
156965124|NCT00677235|566622980|FG001|Overall Study|Adverse Experience|0|||
156965125|NCT00952367|566622981|FG000|Overall Study|Withdrawal by Subject|2|||
156965126|NCT00952367|566622981|FG000|Overall Study|Noncoordination|1|||
156965127|NCT00952367|566622981|FG000|Overall Study|Protocol Violation|3|||
156965128|NCT02835339|566622995|FG000|Overall Study|Did not receive allocated intervention|13|||
156965129|NCT02835339|566622996|FG001|Overall Study|Did not receive allocated intervention|16|||
156965130|NCT01077544|566622997|FG000|Overall Study|New Cancer Therapy|3|||
157172630|NCT04585451|567371227|FG000|Overall Study|Withdrawal by Subject|26|||
156965131|NCT01077544|566622998|FG001|Overall Study|New Cancer Therapy|3|||
156965132|NCT01077544|566622997|FG000|Overall Study|Adverse Event|0|||
156965133|NCT01077544|566622998|FG001|Overall Study|Adverse Event|1|||
156965134|NCT01077544|566622997|FG000|Overall Study|Disease Progression|0|||
156965135|NCT01077544|566622998|FG001|Overall Study|Disease Progression|1|||
156965136|NCT04918147|566623007|FG000|Overall Study|Disease flare as defined in protocol|0|||
156965137|NCT04918147|566623008|FG001|Overall Study|Disease flare as defined in protocol|2|||
156965138|NCT04575051|566623009|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
156965139|NCT04575051|566623010|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
156965140|NCT04575051|566623011|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
156965141|NCT04575051|566623012|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
156965142|NCT04575051|566623013|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
156965143|NCT04575051|566623009|FG000|Time Period 1|Missing follow up|1|||
156965144|NCT04575051|566623010|FG001|Time Period 1|Missing follow up|3|||
156965145|NCT04575051|566623011|FG002|Time Period 1|Missing follow up|1|||
156965146|NCT04575051|566623012|FG003|Time Period 1|Missing follow up|3|||
156965147|NCT04575051|566623013|FG004|Time Period 1|Missing follow up|2|||
156965148|NCT04575051|566623009|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
156965149|NCT04575051|566623010|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
156965150|NCT04575051|566623011|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
156965151|NCT04575051|566623012|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
156965152|NCT04575051|566623013|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
156965153|NCT04575051|566623009|FG000|Time Period 2|Missing follow up|1|||
156965154|NCT04575051|566623010|FG001|Time Period 2|Missing follow up|8|||
156965155|NCT04575051|566623011|FG002|Time Period 2|Missing follow up|7|||
156965156|NCT04575051|566623012|FG003|Time Period 2|Missing follow up|0|||
156965157|NCT04575051|566623013|FG004|Time Period 2|Missing follow up|1|||
156965158|NCT04575051|566623009|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
156965159|NCT04575051|566623010|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
156965160|NCT04575051|566623011|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
156965161|NCT04575051|566623012|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
156965162|NCT04575051|566623013|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
156965163|NCT04575051|566623009|FG000|Time Period 3|Missing follow up|8|||
156965164|NCT04575051|566623010|FG001|Time Period 3|Missing follow up|6|||
156965165|NCT04575051|566623011|FG002|Time Period 3|Missing follow up|4|||
156965166|NCT04575051|566623012|FG003|Time Period 3|Missing follow up|3|||
156965167|NCT04575051|566623013|FG004|Time Period 3|Missing follow up|0|||
156965168|NCT04575051|566623009|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
156965169|NCT04575051|566623010|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
156965170|NCT04575051|566623011|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
156965171|NCT04575051|566623012|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
156965172|NCT04575051|566623013|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
156965173|NCT04575051|566623009|FG000|Time Period 4|Missing follow up|17|||
156965174|NCT04575051|566623010|FG001|Time Period 4|Missing follow up|3|||
156965175|NCT04575051|566623011|FG002|Time Period 4|Missing follow up|4|||
156965176|NCT04575051|566623012|FG003|Time Period 4|Missing follow up|2|||
156965177|NCT04575051|566623013|FG004|Time Period 4|Missing follow up|1|||
156965178|NCT04575051|566623009|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
156965179|NCT04575051|566623010|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
156965180|NCT04575051|566623011|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
156965181|NCT04575051|566623012|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
157172631|NCT04585451|567371228|FG001|Overall Study|Withdrawal by Subject|0|||
156965182|NCT04575051|566623013|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
156965183|NCT04575051|566623009|FG000|Time Period 5|Missing follow up|11|||
156965184|NCT04575051|566623010|FG001|Time Period 5|Missing follow up|8|||
156965185|NCT04575051|566623011|FG002|Time Period 5|Missing follow up|12|||
156965186|NCT04575051|566623012|FG003|Time Period 5|Missing follow up|3|||
156965187|NCT04575051|566623013|FG004|Time Period 5|Missing follow up|11|||
156965188|NCT02862457|566623014|FG000|Overall Study|Death|1|||
156965189|NCT02862457|566623015|FG001|Overall Study|Death|3|||
156965190|NCT02862457|566623016|FG002|Overall Study|Death|2|||
156965191|NCT02862457|566623017|FG003|Overall Study|Death|3|||
156965192|NCT02862457|566623018|FG004|Overall Study|Death|0|||
156965193|NCT02862457|566623019|FG005|Overall Study|Death|2|||
156965194|NCT02862457|566623020|FG006|Overall Study|Death|1|||
156965195|NCT02862457|566623014|FG000|Overall Study|Lost to Follow-up|1|||
156965196|NCT02862457|566623015|FG001|Overall Study|Lost to Follow-up|0|||
156965197|NCT02862457|566623016|FG002|Overall Study|Lost to Follow-up|0|||
156965198|NCT02862457|566623017|FG003|Overall Study|Lost to Follow-up|1|||
156965199|NCT02862457|566623018|FG004|Overall Study|Lost to Follow-up|0|||
156965200|NCT02862457|566623019|FG005|Overall Study|Lost to Follow-up|0|||
156965201|NCT02862457|566623020|FG006|Overall Study|Lost to Follow-up|0|||
156965202|NCT02862457|566623014|FG000|Overall Study|Withdrawal by Subject|0|||
156965203|NCT02862457|566623015|FG001|Overall Study|Withdrawal by Subject|0|||
156965204|NCT02862457|566623016|FG002|Overall Study|Withdrawal by Subject|1|||
156965205|NCT02862457|566623017|FG003|Overall Study|Withdrawal by Subject|0|||
156965206|NCT02862457|566623018|FG004|Overall Study|Withdrawal by Subject|0|||
156965207|NCT02862457|566623019|FG005|Overall Study|Withdrawal by Subject|1|||
156965208|NCT02862457|566623020|FG006|Overall Study|Withdrawal by Subject|0|||
156965209|NCT02085252|566623025|FG000|Overall Study|Withdrawal of Consent|1|||
156965210|NCT02085252|566623026|FG001|Overall Study|Withdrawal of Consent|0|||
156965211|NCT02085252|566623025|FG000|Overall Study|Adverse Event|0|||
156965212|NCT02085252|566623026|FG001|Overall Study|Adverse Event|1|||
156965213|NCT02085252|566623025|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
156965214|NCT02085252|566623026|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
156965215|NCT02085252|566623025|FG000|Overall Study|Reason Not Specified|0|||
156965216|NCT02085252|566623026|FG001|Overall Study|Reason Not Specified|1|||
156965217|NCT02085252|566623025|FG000|Overall Study|Reason Unknown|0|||
156965218|NCT02085252|566623026|FG001|Overall Study|Reason Unknown|1|||
156965219|NCT00951275|566623027|FG000|Overall Study|Administrative Reason|1|||
156965220|NCT00951275|566623027|FG000|Overall Study|Adverse Event|7|||
156965221|NCT00951275|566623027|FG000|Overall Study|Withdrawal by Subject|4|||
156965222|NCT00951275|566623027|FG000|Overall Study|Protocol Violation|1|||
156965223|NCT03260868|566623028|FG000|Overall Study|Poor Compliance to Protocol|0|||
156965224|NCT03260868|566623029|FG001|Overall Study|Poor Compliance to Protocol|2|||
156965225|NCT03260868|566623028|FG000|Overall Study|Study Terminated By Sponsor|2|||
156965226|NCT03260868|566623029|FG001|Overall Study|Study Terminated By Sponsor|1|||
156965227|NCT03260868|566623028|FG000|Overall Study|Other than specified above|1|||
156965228|NCT03260868|566623029|FG001|Overall Study|Other than specified above|0|||
156965229|NCT01112579|566623030|FG000|Overall Study|Missed Visit|1|||
156965230|NCT01112579|566623031|FG001|Overall Study|Missed Visit|1|||
156965231|NCT01112579|566623030|FG000|Overall Study|Death|0|||
156965232|NCT01112579|566623031|FG001|Overall Study|Death|2|||
156965233|NCT03645759|566623032|FG000|Overall Study|Lost to Follow-up|3|||
157040324|NCT05580003|566901582|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
157172632|NCT00966693|567371229|FG000|Overall Study|Adverse Event|0|||
157172633|NCT00966693|567371230|FG001|Overall Study|Adverse Event|0|||
156965234|NCT03645759|566623033|FG001|Overall Study|Lost to Follow-up|2|||
156965235|NCT00818753|566623034|FG000|Overall Study|Protocol Violation|1|||
156965236|NCT00818753|566623035|FG001|Overall Study|Protocol Violation|0|||
156965237|NCT00818753|566623036|FG002|Overall Study|Protocol Violation|0|||
156965238|NCT00818753|566623034|FG000|Overall Study|Other reason (not specified)|0|||
156965239|NCT00818753|566623035|FG001|Overall Study|Other reason (not specified)|0|||
156965240|NCT00818753|566623036|FG002|Overall Study|Other reason (not specified)|1|||
156965241|NCT00818753|566623034|FG000|Overall Study|Randomised and not treated|2|||
156965242|NCT00818753|566623035|FG001|Overall Study|Randomised and not treated|0|||
156965243|NCT00818753|566623036|FG002|Overall Study|Randomised and not treated|0|||
156965244|NCT02459574|566623038|FG000|Overall Study|Withdrawal by Subject|6|||
156965245|NCT02459574|566623039|FG001|Overall Study|Withdrawal by Subject|6|||
156965246|NCT02459574|566623040|FG002|Overall Study|Withdrawal by Subject|2|||
156965247|NCT02459574|566623038|FG000|Overall Study|Lost to Follow-up|1|||
156965248|NCT02459574|566623039|FG001|Overall Study|Lost to Follow-up|1|||
156965249|NCT02459574|566623040|FG002|Overall Study|Lost to Follow-up|0|||
156965250|NCT02459574|566623038|FG000|Overall Study|Death|0|||
156965251|NCT02459574|566623039|FG001|Overall Study|Death|1|||
156965252|NCT02459574|566623040|FG002|Overall Study|Death|0|||
156965253|NCT00251745|566623041|FG000|Overall Study|Adverse Event|7|||
156965254|NCT00251745|566623042|FG001|Overall Study|Adverse Event|9|||
156965255|NCT00251745|566623043|FG002|Overall Study|Adverse Event|11|||
156965256|NCT00251745|566623041|FG000|Overall Study|Lost to Follow-up|4|||
157172634|NCT00966693|567371231|FG002|Overall Study|Adverse Event|1|||
156965257|NCT00251745|566623042|FG001|Overall Study|Lost to Follow-up|2|||
156965258|NCT00251745|566623043|FG002|Overall Study|Lost to Follow-up|5|||
156965259|NCT00251745|566623041|FG000|Overall Study|Withdrawal by Subject|13|||
156965260|NCT00251745|566623042|FG001|Overall Study|Withdrawal by Subject|7|||
156965261|NCT00251745|566623043|FG002|Overall Study|Withdrawal by Subject|3|||
156965262|NCT00251745|566623041|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
156965263|NCT00251745|566623042|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
156965264|NCT00251745|566623043|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
156965265|NCT00251745|566623041|FG000|Overall Study|Lack of Efficacy|3|||
156965266|NCT00251745|566623042|FG001|Overall Study|Lack of Efficacy|0|||
156965267|NCT00251745|566623043|FG002|Overall Study|Lack of Efficacy|0|||
156965268|NCT00251745|566623041|FG000|Overall Study|Noncompliant|0|||
156965269|NCT00251745|566623042|FG001|Overall Study|Noncompliant|2|||
156965270|NCT00251745|566623043|FG002|Overall Study|Noncompliant|2|||
156965271|NCT00251745|566623041|FG000|Overall Study|Pregnancy|0|||
156965272|NCT00251745|566623042|FG001|Overall Study|Pregnancy|1|||
156965273|NCT00251745|566623043|FG002|Overall Study|Pregnancy|0|||
156965274|NCT00251745|566623041|FG000|Overall Study|Per Subject Request|0|||
156965275|NCT00251745|566623042|FG001|Overall Study|Per Subject Request|0|||
156965276|NCT00251745|566623043|FG002|Overall Study|Per Subject Request|1|||
156965277|NCT00251745|566623041|FG000|Overall Study|Per Investigator Request|1|||
156965278|NCT00251745|566623042|FG001|Overall Study|Per Investigator Request|0|||
156965279|NCT00251745|566623043|FG002|Overall Study|Per Investigator Request|0|||
156965280|NCT04508699|566623046|FG000|Overall Study|Lack of Efficacy|2|||
156965281|NCT04508699|566623047|FG001|Overall Study|Lack of Efficacy|15|||
156965282|NCT04508699|566623046|FG000|Overall Study|Withdrawal by Subject|0|||
156965283|NCT04508699|566623047|FG001|Overall Study|Withdrawal by Subject|2|||
156965284|NCT01735201|566624552|FG000|Overall Study|Adverse Event|1|||
156965285|NCT01735201|566624553|FG001|Overall Study|Adverse Event|1|||
156965286|NCT01735201|566624554|FG002|Overall Study|Adverse Event|0|||
156965287|NCT01735201|566624555|FG003|Overall Study|Adverse Event|1|||
156965288|NCT01735201|566624556|FG004|Overall Study|Adverse Event|1|||
156965289|NCT01735201|566624557|FG005|Overall Study|Adverse Event|3|||
156965290|NCT01735201|566624558|FG006|Overall Study|Adverse Event|2|||
156965291|NCT01735201|566624559|FG007|Overall Study|Adverse Event|1|||
156965292|NCT01735201|566624552|FG000|Overall Study|Personal Reasons|1|||
156965293|NCT01735201|566624553|FG001|Overall Study|Personal Reasons|0|||
156965294|NCT01735201|566624554|FG002|Overall Study|Personal Reasons|0|||
156965295|NCT01735201|566624555|FG003|Overall Study|Personal Reasons|0|||
156965296|NCT01735201|566624556|FG004|Overall Study|Personal Reasons|0|||
156965297|NCT01735201|566624557|FG005|Overall Study|Personal Reasons|0|||
156965298|NCT01735201|566624558|FG006|Overall Study|Personal Reasons|0|||
156965299|NCT01735201|566624559|FG007|Overall Study|Personal Reasons|0|||
156965300|NCT01735201|566624552|FG000|Overall Study|Protocol Violation|1|||
156965301|NCT01735201|566624553|FG001|Overall Study|Protocol Violation|0|||
156965302|NCT01735201|566624554|FG002|Overall Study|Protocol Violation|0|||
156965303|NCT01735201|566624555|FG003|Overall Study|Protocol Violation|0|||
156965304|NCT01735201|566624556|FG004|Overall Study|Protocol Violation|0|||
156965305|NCT01735201|566624557|FG005|Overall Study|Protocol Violation|0|||
156965306|NCT01735201|566624558|FG006|Overall Study|Protocol Violation|0|||
156965307|NCT01735201|566624559|FG007|Overall Study|Protocol Violation|0|||
156965308|NCT01735201|566624552|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156965309|NCT01735201|566624553|FG001|Overall Study|Other Miscellaneous Reasons|0|||
156965310|NCT01735201|566624554|FG002|Overall Study|Other Miscellaneous Reasons|0|||
156965311|NCT01735201|566624555|FG003|Overall Study|Other Miscellaneous Reasons|1|||
156965312|NCT01735201|566624556|FG004|Overall Study|Other Miscellaneous Reasons|0|||
156965313|NCT01735201|566624557|FG005|Overall Study|Other Miscellaneous Reasons|2|||
156965314|NCT01735201|566624558|FG006|Overall Study|Other Miscellaneous Reasons|1|||
156965315|NCT01735201|566624559|FG007|Overall Study|Other Miscellaneous Reasons|1|||
156965316|NCT02178059|566624565|FG000|Washout|Physician Decision|1|||
156965317|NCT02178059|566624566|FG001|Washout|Physician Decision|0|||
156965318|NCT00289887|566624567|FG000|Overall Study|Adverse Event|3|||
156965319|NCT00289887|566624568|FG001|Overall Study|Adverse Event|3|||
156965320|NCT00289887|566624567|FG000|Overall Study|Lack of Efficacy|3|||
156965321|NCT00289887|566624568|FG001|Overall Study|Lack of Efficacy|11|||
156965322|NCT00289887|566624567|FG000|Overall Study|Lost to Follow-up|3|||
156965323|NCT00289887|566624568|FG001|Overall Study|Lost to Follow-up|3|||
156965324|NCT00289887|566624567|FG000|Overall Study|Protocol Violation|3|||
156965325|NCT00289887|566624568|FG001|Overall Study|Protocol Violation|1|||
156965326|NCT00289887|566624567|FG000|Overall Study|Withdrawal by Subject|3|||
156965327|NCT00289887|566624568|FG001|Overall Study|Withdrawal by Subject|8|||
156965328|NCT00289887|566624567|FG000|Overall Study|Other|7|||
156965329|NCT00289887|566624568|FG001|Overall Study|Other|3|||
156965330|NCT00175825|566624569|FG000|Overall Study|Adverse Event|3|||
156965331|NCT00175825|566624570|FG001|Overall Study|Adverse Event|2|||
156965332|NCT00175825|566624571|FG002|Overall Study|Adverse Event|1|||
156965333|NCT00175825|566624572|FG003|Overall Study|Adverse Event|1|||
156965334|NCT00175825|566624569|FG000|Overall Study|Lost to Follow-up|1|||
156965335|NCT00175825|566624570|FG001|Overall Study|Lost to Follow-up|2|||
156965336|NCT00175825|566624571|FG002|Overall Study|Lost to Follow-up|0|||
156965337|NCT00175825|566624572|FG003|Overall Study|Lost to Follow-up|0|||
156965338|NCT00175825|566624569|FG000|Overall Study|Withdrawal by Subject|1|||
156965339|NCT00175825|566624570|FG001|Overall Study|Withdrawal by Subject|0|||
156965340|NCT00175825|566624571|FG002|Overall Study|Withdrawal by Subject|0|||
156965341|NCT00175825|566624572|FG003|Overall Study|Withdrawal by Subject|0|||
156965342|NCT03255824|566624580|FG000|Overall Study|Under-sedation|2|||
156965343|NCT03255824|566624581|FG001|Overall Study|Under-sedation|1|||
156965344|NCT02001194|566624584|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
156965345|NCT02001194|566624585|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
156965346|NCT02001194|566624586|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
156965347|NCT02001194|566624587|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
156965348|NCT02001194|566624584|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
156965349|NCT02001194|566624585|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
156965350|NCT02001194|566624586|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
156965351|NCT02001194|566624587|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
156965352|NCT03432364|566624589|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
156965353|NCT00522301|566624590|FG000|Overall Study|Withdrawal by Subject|1|||
156965354|NCT00522301|566624590|FG000|Overall Study|Adverse Event|5|||
156965355|NCT03040713|566624591|FG000|Overall Study|Positive amyloid scan|3|||
156965356|NCT01699022|566624598|FG000|Overall Study|Early discontinuation from the study|3|||
156965357|NCT04539821|566624599|FG000|Overall Study|Withdrawal by Subject|2|||
156965358|NCT04539821|566624599|FG000|Overall Study|continued care with their physician|20|||
156965359|NCT04539821|566624599|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
156965360|NCT02066402|566624602|FG000|Overall Study|Adverse Event|1|||
156965361|NCT02066402|566624603|FG001|Overall Study|Adverse Event|2|||
156965362|NCT02066402|566624602|FG000|Overall Study|Lost to Follow-up|11|||
156965363|NCT02066402|566624603|FG001|Overall Study|Lost to Follow-up|8|||
156965364|NCT02066402|566624602|FG000|Overall Study|Withdrawal by Subject|14|||
156965365|NCT02066402|566624603|FG001|Overall Study|Withdrawal by Subject|11|||
156965366|NCT02066402|566624602|FG000|Overall Study|Progressive disease-clinical progression|0|||
156965367|NCT02066402|566624603|FG001|Overall Study|Progressive disease-clinical progression|1|||
156965368|NCT02066402|566624602|FG000|Overall Study|Protocol driven decision point|0|||
156965369|NCT02066402|566624603|FG001|Overall Study|Protocol driven decision point|1|||
156965370|NCT00152464|566624604|FG000|Overall Study|Adverse Event|3|||
156965371|NCT00152464|566624605|FG001|Overall Study|Adverse Event|6|||
156965372|NCT00152464|566624604|FG000|Overall Study|Lost to Follow-up|8|||
156965373|NCT00152464|566624605|FG001|Overall Study|Lost to Follow-up|4|||
156965374|NCT00152464|566624604|FG000|Overall Study|Protocol Violation|3|||
156965375|NCT00152464|566624605|FG001|Overall Study|Protocol Violation|1|||
156965376|NCT00152464|566624604|FG000|Overall Study|Withdrawal by Subject|21|||
156965377|NCT00152464|566624605|FG001|Overall Study|Withdrawal by Subject|22|||
156965378|NCT00152464|566624604|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
156965379|NCT00152464|566624605|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
156965380|NCT00152464|566624604|FG000|Overall Study|Eczema deterioration|0|||
156965381|NCT00152464|566624605|FG001|Overall Study|Eczema deterioration|1|||
156965382|NCT00152464|566624604|FG000|Overall Study|Parent decision|1|||
156965383|NCT00152464|566624605|FG001|Overall Study|Parent decision|1|||
156965384|NCT00152464|566624604|FG000|Overall Study|Investigator decision|1|||
156965385|NCT00152464|566624605|FG001|Overall Study|Investigator decision|0|||
156965386|NCT00152464|566624604|FG000|Overall Study|Lack of Efficacy|1|||
156965387|NCT00152464|566624605|FG001|Overall Study|Lack of Efficacy|0|||
156965388|NCT00152464|566624604|FG000|Overall Study|Eczema poorly controlled|1|||
156965389|NCT00152464|566624605|FG001|Overall Study|Eczema poorly controlled|0|||
156965390|NCT00152464|566624604|FG000|Overall Study|Patient relocated|1|||
156965391|NCT00152464|566624605|FG001|Overall Study|Patient relocated|0|||
156965392|NCT02462876|566624606|FG000|Overall Study|Death|3|||
156965393|NCT02462876|566624606|FG000|Overall Study|Lost to Follow-up|7|||
156965394|NCT02462876|566624606|FG000|Overall Study|Surgical Bypass|9|||
156965395|NCT02462876|566624606|FG000|Overall Study|Amputation Above the Metatarsals|1|||
156965396|NCT02462876|566624606|FG000|Overall Study|36 months follow-up visit missed|1|||
156965397|NCT02462876|566624606|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
156965398|NCT02462876|566624606|FG000|Overall Study|Patient did not come back to the vascular department|1|||
156965399|NCT02462876|566624606|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
156965400|NCT02462876|566624606|FG000|Overall Study|Patient refused to come back|1|||
156965401|NCT02462876|566624606|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
156965402|NCT02462876|566624606|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
156965403|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
156965404|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
156965405|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
156965406|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
156965407|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
157172635|NCT00966693|567371232|FG003|Overall Study|Adverse Event|2|||
156965408|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
156965409|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
156965410|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
156965411|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Other|18|||
156965412|NCT02565914|566624607|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
156965413|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
156965414|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Other|1|||
156965415|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
156965416|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
156965417|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
156965418|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
156965419|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
156965420|NCT02565914|566624607|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
156965421|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
156965422|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
156965423|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
156965424|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
156965425|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
156965426|NCT02565914|566624607|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
156965427|NCT04465357|566624608|FG000|Overall Study|Adverse Event|2|||
156965428|NCT04465357|566624608|FG000|Overall Study|Lack of Efficacy|1|||
156965429|NCT04465357|566624608|FG000|Overall Study|Lost to Follow-up|2|||
156965430|NCT04465357|566624608|FG000|Overall Study|Withdrawal by Subject|6|||
156965431|NCT04465357|566624608|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
156965432|NCT01040260|566624610|FG000|Overall Study|Withdrawal by Subject|12|||
156965433|NCT01040260|566624611|FG001|Overall Study|Withdrawal by Subject|6|||
156965434|NCT01040260|566624610|FG000|Overall Study|Lost to Follow-up|3|||
156965435|NCT01040260|566624611|FG001|Overall Study|Lost to Follow-up|5|||
156965436|NCT00781391|566624616|FG000|Overall Study|never received study drug|24|||
156965437|NCT00781391|566624617|FG001|Overall Study|never received study drug|23|||
156965438|NCT00781391|566624618|FG002|Overall Study|never received study drug|32|||
156965439|NCT00781391|566624616|FG000|Overall Study|Protocol Violation|19|||
156965440|NCT00781391|566624617|FG001|Overall Study|Protocol Violation|17|||
156965441|NCT00781391|566624618|FG002|Overall Study|Protocol Violation|20|||
156965442|NCT00781391|566624616|FG000|Overall Study|Death|789|||
156965443|NCT00781391|566624617|FG001|Overall Study|Death|730|||
156965444|NCT00781391|566624618|FG002|Overall Study|Death|706|||
156965445|NCT00781391|566624616|FG000|Overall Study|Withdrawal by Subject|47|||
156965446|NCT00781391|566624617|FG001|Overall Study|Withdrawal by Subject|37|||
156965447|NCT00781391|566624618|FG002|Overall Study|Withdrawal by Subject|25|||
156965448|NCT00781391|566624616|FG000|Overall Study|Lost to Follow-up|0|||
156965449|NCT00781391|566624617|FG001|Overall Study|Lost to Follow-up|0|||
156965450|NCT00781391|566624618|FG002|Overall Study|Lost to Follow-up|1|||
156965451|NCT00708916|566624620|FG000|Overall Study|Subject Noncompliance|2|||
156965452|NCT00708916|566624620|FG000|Overall Study|Adverse Event|2|||
156965453|NCT01984684|566624622|FG000|Overall Study|Lost to Follow-up|25|||
156965454|NCT01984684|566624623|FG001|Overall Study|Lost to Follow-up|24|||
156965455|NCT01984684|566624622|FG000|Overall Study|Adverse Event|8|||
156965456|NCT01984684|566624623|FG001|Overall Study|Adverse Event|12|||
156965457|NCT01984684|566624622|FG000|Overall Study|Withdrawal by Subject|9|||
156965458|NCT01984684|566624623|FG001|Overall Study|Withdrawal by Subject|9|||
156965459|NCT01984684|566624622|FG000|Overall Study|Lack of Efficacy|3|||
156965460|NCT01984684|566624623|FG001|Overall Study|Lack of Efficacy|6|||
156965461|NCT01984684|566624622|FG000|Overall Study|Physician Decision|4|||
156965462|NCT01984684|566624623|FG001|Overall Study|Physician Decision|2|||
156965463|NCT01984684|566624622|FG000|Overall Study|Protocol Violation|4|||
156965464|NCT01984684|566624623|FG001|Overall Study|Protocol Violation|2|||
156965465|NCT01984684|566624622|FG000|Overall Study|Death|0|||
156965466|NCT01984684|566624623|FG001|Overall Study|Death|1|||
156965467|NCT01984684|566624622|FG000|Overall Study|Noncompliance with study drug|2|||
156965468|NCT01984684|566624623|FG001|Overall Study|Noncompliance with study drug|1|||
156965469|NCT01984684|566624622|FG000|Overall Study|Subject incarcerated|1|||
156965470|NCT01984684|566624623|FG001|Overall Study|Subject incarcerated|0|||
156965471|NCT01984684|566624622|FG000|Overall Study|Study drug not available at site|1|||
156965472|NCT01984684|566624623|FG001|Overall Study|Study drug not available at site|1|||
156965473|NCT01984684|566624622|FG000|Overall Study|Subject had inadequate IV access|0|||
156965474|NCT01984684|566624623|FG001|Overall Study|Subject had inadequate IV access|1|||
156965475|NCT04555096|566624629|FG000|Overall Study|Death|4|||
156965476|NCT04555096|566624630|FG001|Overall Study|Death|4|||
156965477|NCT04555096|566624629|FG000|Overall Study|Withdrawal by Subject|1|||
156965478|NCT04555096|566624630|FG001|Overall Study|Withdrawal by Subject|0|||
156965479|NCT04555096|566624629|FG000|Overall Study|Other|0|||
156965480|NCT04555096|566624630|FG001|Overall Study|Other|1|||
156965481|NCT03205371|566624633|FG000|Overall Study|Withdrawal by Subject|4|||
157040325|NCT05580003|566901583|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
156965482|NCT03205371|566624634|FG001|Overall Study|Withdrawal by Subject|1|||
156965483|NCT03205371|566624635|FG002|Overall Study|Withdrawal by Subject|0|||
156965484|NCT03205371|566624636|FG003|Overall Study|Withdrawal by Subject|0|||
156965485|NCT03205371|566624637|FG004|Overall Study|Withdrawal by Subject|0|||
156965486|NCT03205371|566624638|FG005|Overall Study|Withdrawal by Subject|0|||
156965487|NCT03205371|566624639|FG006|Overall Study|Withdrawal by Subject|4|||
156965488|NCT03205371|566624640|FG007|Overall Study|Withdrawal by Subject|0|||
156965489|NCT03205371|566624641|FG008|Overall Study|Withdrawal by Subject|2|||
156965490|NCT03205371|566624642|FG009|Overall Study|Withdrawal by Subject|0|||
156965491|NCT03205371|566624643|FG010|Overall Study|Withdrawal by Subject|0|||
156965492|NCT03205371|566624644|FG011|Overall Study|Withdrawal by Subject|1|||
156965493|NCT03205371|566624633|FG000|Overall Study|Lost to Follow-up|0|||
156965494|NCT03205371|566624634|FG001|Overall Study|Lost to Follow-up|0|||
156965495|NCT03205371|566624635|FG002|Overall Study|Lost to Follow-up|0|||
156965496|NCT03205371|566624636|FG003|Overall Study|Lost to Follow-up|0|||
156965497|NCT03205371|566624637|FG004|Overall Study|Lost to Follow-up|0|||
156965498|NCT03205371|566624638|FG005|Overall Study|Lost to Follow-up|0|||
156965499|NCT03205371|566624639|FG006|Overall Study|Lost to Follow-up|5|||
156965500|NCT03205371|566624640|FG007|Overall Study|Lost to Follow-up|2|||
156965501|NCT03205371|566624641|FG008|Overall Study|Lost to Follow-up|3|||
156965502|NCT03205371|566624642|FG009|Overall Study|Lost to Follow-up|0|||
156965503|NCT03205371|566624643|FG010|Overall Study|Lost to Follow-up|0|||
156965504|NCT03205371|566624644|FG011|Overall Study|Lost to Follow-up|0|||
156965505|NCT03205371|566624633|FG000|Overall Study|Protocol Violation|0|||
156965506|NCT03205371|566624634|FG001|Overall Study|Protocol Violation|0|||
156965507|NCT03205371|566624635|FG002|Overall Study|Protocol Violation|0|||
156965508|NCT03205371|566624636|FG003|Overall Study|Protocol Violation|0|||
156965509|NCT03205371|566624637|FG004|Overall Study|Protocol Violation|0|||
156965510|NCT03205371|566624638|FG005|Overall Study|Protocol Violation|0|||
156965511|NCT03205371|566624639|FG006|Overall Study|Protocol Violation|1|||
156965512|NCT03205371|566624640|FG007|Overall Study|Protocol Violation|0|||
156965513|NCT03205371|566624641|FG008|Overall Study|Protocol Violation|0|||
156965514|NCT03205371|566624642|FG009|Overall Study|Protocol Violation|0|||
156965515|NCT03205371|566624643|FG010|Overall Study|Protocol Violation|0|||
156965516|NCT03205371|566624644|FG011|Overall Study|Protocol Violation|0|||
156965517|NCT03205371|566624633|FG000|Overall Study|Adverse Event|0|||
156965518|NCT03205371|566624634|FG001|Overall Study|Adverse Event|0|||
156965519|NCT03205371|566624635|FG002|Overall Study|Adverse Event|0|||
156965520|NCT03205371|566624636|FG003|Overall Study|Adverse Event|0|||
156965521|NCT03205371|566624637|FG004|Overall Study|Adverse Event|0|||
156965522|NCT03205371|566624638|FG005|Overall Study|Adverse Event|0|||
156965523|NCT03205371|566624639|FG006|Overall Study|Adverse Event|0|||
156965524|NCT03205371|566624640|FG007|Overall Study|Adverse Event|1|||
156965525|NCT03205371|566624641|FG008|Overall Study|Adverse Event|0|||
156965526|NCT03205371|566624642|FG009|Overall Study|Adverse Event|0|||
156965527|NCT03205371|566624643|FG010|Overall Study|Adverse Event|0|||
156965528|NCT03205371|566624644|FG011|Overall Study|Adverse Event|0|||
156965529|NCT03923959|566624645|FG000|Overall Study|Death|16|||
156965530|NCT03923959|566624646|FG001|Overall Study|Death|12|||
156965531|NCT03923959|566624645|FG000|Overall Study|Lost to Follow-up|56|||
156965532|NCT03923959|566624646|FG001|Overall Study|Lost to Follow-up|56|||
156965533|NCT03923959|566624645|FG000|Overall Study|Withdrawal by Subject|1|||
156965534|NCT03923959|566624646|FG001|Overall Study|Withdrawal by Subject|1|||
156965535|NCT03923959|566624645|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
156965536|NCT03923959|566624646|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
156965537|NCT05711641|566624648|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
156965538|NCT05711641|566624649|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
156965539|NCT05711641|566624648|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
156965540|NCT05711641|566624649|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
156965541|NCT03574597|566624650|FG000|Overall Study|Withdrawal by Subject|67|||
156965542|NCT03574597|566624651|FG001|Overall Study|Withdrawal by Subject|96|||
156965543|NCT03574597|566624650|FG000|Overall Study|Lost to Follow-up|192|||
156965544|NCT03574597|566624651|FG001|Overall Study|Lost to Follow-up|188|||
156965545|NCT03624504|566624652|FG000|Overall Study|Unsuccessful Implant|1|||
156965546|NCT00951483|566624653|FG000|Overall Study|Physician Decision|4|||
156965547|NCT00951483|566624654|FG001|Overall Study|Physician Decision|0|||
156965548|NCT00951483|566624653|FG000|Overall Study|Withdrawal by Subject|15|||
156965549|NCT00951483|566624654|FG001|Overall Study|Withdrawal by Subject|0|||
157040326|NCT05580003|566901556|FG000|Part 6 Period 2 (Day 1)|Other|0|||
156965550|NCT03565887|566624655|FG000|Overall Study|Adverse Event|1|||
156965551|NCT03565887|566624656|FG001|Overall Study|Adverse Event|0|||
156965552|NCT03565887|566624655|FG000|Overall Study|Withdrawal by Subject|0|||
156965553|NCT03565887|566624656|FG001|Overall Study|Withdrawal by Subject|2|||
156965554|NCT02975973|566624657|FG000|Overall Study|Adverse Event|1|||
156965555|NCT02975973|566624658|FG001|Overall Study|Adverse Event|1|||
156965556|NCT02975973|566624659|FG002|Overall Study|Adverse Event|1|||
156965557|NCT02975973|566624660|FG003|Overall Study|Adverse Event|0|||
156965558|NCT03804710|566624661|FG000|Overall Study|Adverse Event|0|||
156965559|NCT03804710|566624662|FG001|Overall Study|Adverse Event|3|||
157172636|NCT00966693|567371229|FG000|Overall Study|Death|0|||
157172637|NCT00966693|567371230|FG001|Overall Study|Death|0|||
157172638|NCT00966693|567371231|FG002|Overall Study|Death|1|||
157172639|NCT00966693|567371232|FG003|Overall Study|Death|0|||
157172640|NCT00966693|567371229|FG000|Overall Study|Withdrawal by Subject|1|||
156965560|NCT03804710|566624661|FG000|Overall Study|Withdrawal by Subject|2|||
157172641|NCT00966693|567371230|FG001|Overall Study|Withdrawal by Subject|0|||
157172642|NCT00966693|567371231|FG002|Overall Study|Withdrawal by Subject|0|||
156965561|NCT03804710|566624662|FG001|Overall Study|Withdrawal by Subject|1|||
156965562|NCT03804710|566624661|FG000|Overall Study|Other|0|||
156965563|NCT03804710|566624662|FG001|Overall Study|Other|1|||
156965564|NCT00689221|566624668|FG000|Overall Study|Ongoing at cut-off date|39|||
156965565|NCT00689221|566624669|FG001|Overall Study|Ongoing at cut-off date|36|||
156965566|NCT01939548|566624671|FG000|Overall Study|Non compliance|0|||
156965567|NCT01939548|566624672|FG001|Overall Study|Non compliance|2|||
156965568|NCT01939548|566624673|FG002|Overall Study|Non compliance|0|||
156965569|NCT01939548|566624671|FG000|Overall Study|Study Terminated by Sponsor|17|||
156965570|NCT01939548|566624672|FG001|Overall Study|Study Terminated by Sponsor|19|||
156965571|NCT01939548|566624673|FG002|Overall Study|Study Terminated by Sponsor|12|||
156965572|NCT01939548|566624671|FG000|Overall Study|Insufficient Clinical Response|1|||
156965573|NCT01939548|566624672|FG001|Overall Study|Insufficient Clinical Response|0|||
156965574|NCT01939548|566624673|FG002|Overall Study|Insufficient Clinical Response|0|||
156965575|NCT01939548|566624671|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
156965576|NCT01939548|566624672|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
156965577|NCT01939548|566624673|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
156965578|NCT01939548|566624671|FG000|Overall Study|Withdrawal by Subject|4|||
156965579|NCT01939548|566624672|FG001|Overall Study|Withdrawal by Subject|4|||
156965580|NCT01939548|566624673|FG002|Overall Study|Withdrawal by Subject|1|||
156965581|NCT01939548|566624671|FG000|Overall Study|Protocol Violation|7|||
156965582|NCT01939548|566624672|FG001|Overall Study|Protocol Violation|6|||
156965583|NCT01939548|566624673|FG002|Overall Study|Protocol Violation|5|||
156965584|NCT01939548|566624671|FG000|Overall Study|Lost to Follow-up|5|||
156965585|NCT01939548|566624672|FG001|Overall Study|Lost to Follow-up|5|||
156965586|NCT01939548|566624673|FG002|Overall Study|Lost to Follow-up|3|||
156965587|NCT01939548|566624671|FG000|Overall Study|Adverse Event|2|||
156965588|NCT01939548|566624672|FG001|Overall Study|Adverse Event|9|||
156965589|NCT01939548|566624673|FG002|Overall Study|Adverse Event|7|||
156965590|NCT01939548|566624671|FG000|Overall Study|Death|0|||
156965591|NCT01939548|566624672|FG001|Overall Study|Death|0|||
156965592|NCT01939548|566624673|FG002|Overall Study|Death|1|||
156965593|NCT01939548|566624671|FG000|Overall Study|Participant dropped|0|||
156965594|NCT01939548|566624672|FG001|Overall Study|Participant dropped|0|||
156965595|NCT01939548|566624673|FG002|Overall Study|Participant dropped|1|||
156965596|NCT01939548|566624671|FG000|Overall Study|Participant unwilling to continue|0|||
156965597|NCT01939548|566624672|FG001|Overall Study|Participant unwilling to continue|1|||
156965598|NCT01939548|566624673|FG002|Overall Study|Participant unwilling to continue|0|||
156965599|NCT01939548|566624671|FG000|Overall Study|Participant withdrew consent|0|||
156965600|NCT01939548|566624672|FG001|Overall Study|Participant withdrew consent|2|||
156965601|NCT01939548|566624673|FG002|Overall Study|Participant withdrew consent|0|||
156965602|NCT01939548|566624671|FG000|Overall Study|Did not complete follow-up|0|||
156965603|NCT01939548|566624672|FG001|Overall Study|Did not complete follow-up|1|||
156965604|NCT01939548|566624673|FG002|Overall Study|Did not complete follow-up|0|||
156965605|NCT03311373|566624674|FG000|Overall Study|Adverse Event|1|||
156965606|NCT03311373|566624674|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
156965607|NCT03311373|566624674|FG000|Overall Study|Lost to Follow-up|1|||
156965608|NCT03311373|566624674|FG000|Overall Study|Physician Decision|1|||
156965609|NCT03311373|566624674|FG000|Overall Study|Withdrawal by Subject|3|||
156965610|NCT01297959|566624679|FG000|Overall Study|Adverse Event|0|||
156965611|NCT01297959|566624680|FG001|Overall Study|Adverse Event|1|||
156965612|NCT01297959|566624679|FG000|Overall Study|Protocol Violation|2|||
156965613|NCT01297959|566624680|FG001|Overall Study|Protocol Violation|1|||
156965614|NCT01297959|566624679|FG000|Overall Study|Withdrawal by Subject|5|||
156965615|NCT01297959|566624680|FG001|Overall Study|Withdrawal by Subject|4|||
156965616|NCT01297959|566624679|FG000|Overall Study|Physician Decision|0|||
156965617|NCT01297959|566624680|FG001|Overall Study|Physician Decision|1|||
156965618|NCT01297959|566624679|FG000|Overall Study|Unrelated medical illness / complication|0|||
157172643|NCT00966693|567371232|FG003|Overall Study|Withdrawal by Subject|5|||
157172644|NCT00966693|567371229|FG000|Overall Study|Disease Progression|0|||
156965619|NCT01297959|566624680|FG001|Overall Study|Unrelated medical illness / complication|2|||
156965620|NCT01297959|566624679|FG000|Overall Study|Other|13|||
156965621|NCT01297959|566624680|FG001|Overall Study|Other|7|||
156965622|NCT00344461|566624681|FG000|Overall Study|Adverse Event|6|||
156965623|NCT00344461|566624681|FG000|Overall Study|Death|1|||
156965624|NCT00344461|566624681|FG000|Overall Study|Lack of Efficacy|2|||
156965625|NCT00344461|566624681|FG000|Overall Study|Lost to Follow-up|2|||
157172645|NCT00966693|567371230|FG001|Overall Study|Disease Progression|0|||
157040327|NCT05580003|566901557|FG001|Part 6 Period 2 (Day 1)|Other|0|||
157040328|NCT05580003|566901558|FG002|Part 6 Period 2 (Day 1)|Other|0|||
157227900|NCT00679367|567579235|FG000|Overall Study|Withdrawal by Subject|1|||
157227901|NCT03365947|567579236|FG000|Overall Study|Lost to Follow-up|0|||
156965626|NCT00344461|566624681|FG000|Overall Study|Physician Decision|2|||
156965627|NCT00344461|566624681|FG000|Overall Study|Protocol Violation|6|||
156965628|NCT00344461|566624681|FG000|Overall Study|Withdrawal by Subject|2|||
156965629|NCT00941330|566624686|FG000|Overall Study|Other|1|||
156965630|NCT00941330|566624687|FG001|Overall Study|Other|0|||
156965631|NCT00941330|566624686|FG000|Overall Study|Physician Decision|0|||
156965632|NCT00941330|566624687|FG001|Overall Study|Physician Decision|2|||
156965633|NCT00686881|566624688|FG000|Overall Study|Withdrawal by Subject|11|||
156965634|NCT00686881|566624689|FG001|Overall Study|Withdrawal by Subject|18|||
156965635|NCT00686881|566624688|FG000|Overall Study|Lost to Follow-up|0|||
156965636|NCT00686881|566624689|FG001|Overall Study|Lost to Follow-up|1|||
156965637|NCT00686881|566624688|FG000|Overall Study|Treatment-related adverse event|10|||
156965638|NCT00686881|566624689|FG001|Overall Study|Treatment-related adverse event|9|||
156965639|NCT00686881|566624688|FG000|Overall Study|Met discontinuation criteria|5|||
156965640|NCT00686881|566624689|FG001|Overall Study|Met discontinuation criteria|0|||
156965641|NCT00686881|566624688|FG000|Overall Study|Onset of malignant tumor|11|||
156965642|NCT00686881|566624689|FG001|Overall Study|Onset of malignant tumor|11|||
156965643|NCT00686881|566624688|FG000|Overall Study|Lack of Efficacy|4|||
156965644|NCT00686881|566624689|FG001|Overall Study|Lack of Efficacy|3|||
156965645|NCT00686881|566624688|FG000|Overall Study|Physician Decision|1|||
156965646|NCT00686881|566624689|FG001|Overall Study|Physician Decision|0|||
156965647|NCT00686881|566624688|FG000|Overall Study|Circumstances of site|1|||
156965648|NCT00686881|566624689|FG001|Overall Study|Circumstances of site|1|||
156965649|NCT00686881|566624688|FG000|Overall Study|Did not meet protocol eligibility|1|||
156965650|NCT00686881|566624689|FG001|Overall Study|Did not meet protocol eligibility|0|||
156965651|NCT00686881|566624688|FG000|Overall Study|Irregular visits|1|||
156965652|NCT00686881|566624689|FG001|Overall Study|Irregular visits|0|||
156965653|NCT00686881|566624688|FG000|Overall Study|Study discontinuation|35|||
156965654|NCT00686881|566624689|FG001|Overall Study|Study discontinuation|32|||
156965655|NCT00686881|566624688|FG000|Overall Study|Never received study drug|2|||
156965656|NCT00686881|566624689|FG001|Overall Study|Never received study drug|6|||
156965657|NCT00541450|566624693|FG000|Phase A|Adverse Event|3|||
156965658|NCT00541450|566624694|FG001|Phase A|Adverse Event|0|||
156965659|NCT00541450|566624693|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
156965660|NCT00541450|566624694|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
156965661|NCT00541450|566624693|FG000|Phase A|Hyperglycemia|0|||
156965662|NCT00541450|566624694|FG001|Phase A|Hyperglycemia|1|||
156965663|NCT00541450|566624693|FG000|Phase A|Lost to Follow-up|6|||
156965664|NCT00541450|566624694|FG001|Phase A|Lost to Follow-up|4|||
156965665|NCT00541450|566624693|FG000|Phase A|Physician Decision|2|||
156965666|NCT00541450|566624694|FG001|Phase A|Physician Decision|0|||
156965667|NCT00541450|566624693|FG000|Phase A|Protocol Violation|2|||
156965668|NCT00541450|566624694|FG001|Phase A|Protocol Violation|3|||
156965669|NCT00541450|566624693|FG000|Phase A|Withdrawal by Subject|7|||
156965670|NCT00541450|566624694|FG001|Phase A|Withdrawal by Subject|7|||
156965671|NCT00541450|566624693|FG000|Phase B|Adverse Event|6|||
156965672|NCT00541450|566624694|FG001|Phase B|Adverse Event|6|||
156965673|NCT00541450|566624693|FG000|Phase B|Hyperglycemia|10|||
156965674|NCT00541450|566624694|FG001|Phase B|Hyperglycemia|9|||
156965675|NCT00541450|566624693|FG000|Phase B|Lost to Follow-up|6|||
156965676|NCT00541450|566624694|FG001|Phase B|Lost to Follow-up|4|||
156965677|NCT00541450|566624693|FG000|Phase B|Physician Decision|4|||
156965678|NCT00541450|566624694|FG001|Phase B|Physician Decision|2|||
156965679|NCT00541450|566624693|FG000|Phase B|Pregnancy|0|||
156965680|NCT00541450|566624694|FG001|Phase B|Pregnancy|1|||
156965681|NCT00541450|566624693|FG000|Phase B|Protocol Violation|3|||
156965682|NCT00541450|566624694|FG001|Phase B|Protocol Violation|3|||
156965683|NCT00541450|566624693|FG000|Phase B|Withdrawal by Subject|8|||
156965684|NCT00541450|566624694|FG001|Phase B|Withdrawal by Subject|6|||
156965685|NCT02048072|566624695|FG000|Overall Study|Adverse Event|3|||
156965686|NCT02048072|566624695|FG000|Overall Study|Lost to Follow-up|1|||
156965687|NCT01648270|566624699|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
157040329|NCT05580003|566901559|FG003|Part 6 Period 2 (Day 1)|Other|0|||
157227902|NCT03365947|567579237|FG001|Overall Study|Lost to Follow-up|0|||
157227903|NCT03365947|567579238|FG002|Overall Study|Lost to Follow-up|0|||
157227904|NCT03365947|567579239|FG003|Overall Study|Lost to Follow-up|0|||
156965688|NCT01389973|566624700|FG000|Overall Study|Lost to Follow-up|1|||
156965689|NCT01389973|566624700|FG000|Overall Study|Trial Stopped by Sponsor|9|||
156965690|NCT01389973|566624700|FG000|Overall Study|Other|10|||
156965691|NCT04866017|566624704|FG000|Overall Study|Study Terminated by Sponsor|13|||
156965692|NCT04866017|566624705|FG001|Overall Study|Study Terminated by Sponsor|14|||
156965693|NCT04866017|566624706|FG002|Overall Study|Study Terminated by Sponsor|13|||
156965694|NCT04866017|566624704|FG000|Overall Study|Death|8|||
156965695|NCT04866017|566624705|FG001|Overall Study|Death|4|||
156965696|NCT04866017|566624706|FG002|Overall Study|Death|8|||
157040330|NCT05580003|566901560|FG004|Part 6 Period 2 (Day 1)|Other|0|||
157172646|NCT00966693|567371231|FG002|Overall Study|Disease Progression|1|||
156965697|NCT04866017|566624704|FG000|Overall Study|Withdrawal by Subject|1|||
156965698|NCT04866017|566624705|FG001|Overall Study|Withdrawal by Subject|0|||
156965699|NCT04866017|566624706|FG002|Overall Study|Withdrawal by Subject|1|||
156965700|NCT04866017|566624704|FG000|Overall Study|Physician Decision|0|||
156965701|NCT04866017|566624705|FG001|Overall Study|Physician Decision|1|||
156965702|NCT04866017|566624706|FG002|Overall Study|Physician Decision|0|||
156965703|NCT02543658|566626295|FG000|Overall Study|Lack of Efficacy|0|||
156965704|NCT02543658|566626296|FG001|Overall Study|Lack of Efficacy|4|||
156965705|NCT00789815|566626297|FG000|Overall Study|Protocol Violation|6|||
156965706|NCT00789815|566626298|FG001|Overall Study|Protocol Violation|1|||
156965707|NCT00789815|566626297|FG000|Overall Study|Intubation due to massive bleeding|1|||
156965708|NCT00789815|566626298|FG001|Overall Study|Intubation due to massive bleeding|0|||
156965709|NCT01787097|566626303|FG000|Overall Study|Withdrawal by Subject|1|||
156965710|NCT01787097|566626304|FG001|Overall Study|Withdrawal by Subject|0|||
156965711|NCT01787097|566626305|FG002|Overall Study|Withdrawal by Subject|0|||
156965712|NCT01787097|566626306|FG003|Overall Study|Withdrawal by Subject|0|||
156965713|NCT00999466|566626308|FG000|Main Part|Withdrawal by Subject|0|||
156965714|NCT00999466|566626309|FG001|Main Part|Withdrawal by Subject|0|||
156965715|NCT00999466|566626310|FG002|Main Part|Withdrawal by Subject|2|||
156965716|NCT00999466|566626308|FG000|Main Part|Adverse Event|0|||
156965717|NCT00999466|566626309|FG001|Main Part|Adverse Event|4|||
156965718|NCT00999466|566626310|FG002|Main Part|Adverse Event|2|||
156965719|NCT00430248|566626317|FG000|Overall Study|Adverse Event|49|||
156965720|NCT00430248|566626318|FG001|Overall Study|Adverse Event|61|||
156965721|NCT00430248|566626319|FG002|Overall Study|Adverse Event|64|||
156965722|NCT00430248|566626317|FG000|Overall Study|Protocol Violation|10|||
156965723|NCT00430248|566626318|FG001|Overall Study|Protocol Violation|2|||
156965724|NCT00430248|566626319|FG002|Overall Study|Protocol Violation|4|||
156965725|NCT00430248|566626317|FG000|Overall Study|Personal Reasons|12|||
156965726|NCT00430248|566626318|FG001|Overall Study|Personal Reasons|24|||
156965727|NCT00430248|566626319|FG002|Overall Study|Personal Reasons|9|||
156965728|NCT00430248|566626317|FG000|Overall Study|Lost to Follow-up|28|||
156965729|NCT00430248|566626318|FG001|Overall Study|Lost to Follow-up|33|||
156965730|NCT00430248|566626319|FG002|Overall Study|Lost to Follow-up|28|||
156965731|NCT00430248|566626317|FG000|Overall Study|Therapeutic Failure|1|||
156965732|NCT00430248|566626318|FG001|Overall Study|Therapeutic Failure|1|||
156965733|NCT00430248|566626319|FG002|Overall Study|Therapeutic Failure|1|||
156965734|NCT00430248|566626317|FG000|Overall Study|Withdrawal by Subject|14|||
156965735|NCT00430248|566626318|FG001|Overall Study|Withdrawal by Subject|20|||
156965736|NCT00430248|566626319|FG002|Overall Study|Withdrawal by Subject|16|||
156965737|NCT00430248|566626317|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156965738|NCT00430248|566626318|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
156965739|NCT00430248|566626319|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
156965740|NCT00430248|566626317|FG000|Overall Study|Gout Flare|3|||
156965741|NCT00430248|566626318|FG001|Overall Study|Gout Flare|7|||
156965742|NCT00430248|566626319|FG002|Overall Study|Gout Flare|2|||
156965743|NCT00430248|566626317|FG000|Overall Study|Reason Not Specified|8|||
156965744|NCT00430248|566626318|FG001|Overall Study|Reason Not Specified|8|||
156965745|NCT00430248|566626319|FG002|Overall Study|Reason Not Specified|11|||
156965746|NCT01113502|566626320|FG000|Overall Study|Withdrawal by Subject|1|||
156965747|NCT01113502|566626321|FG001|Overall Study|Withdrawal by Subject|0|||
156965748|NCT01113502|566626322|FG002|Overall Study|Withdrawal by Subject|1|||
156965749|NCT01113502|566626323|FG003|Overall Study|Withdrawal by Subject|1|||
156965750|NCT01113502|566626324|FG004|Overall Study|Withdrawal by Subject|0|||
156965751|NCT01113502|566626320|FG000|Overall Study|Adverse Event|0|||
156965752|NCT01113502|566626321|FG001|Overall Study|Adverse Event|0|||
156965753|NCT01113502|566626322|FG002|Overall Study|Adverse Event|3|||
156965754|NCT01113502|566626323|FG003|Overall Study|Adverse Event|2|||
156965755|NCT01113502|566626324|FG004|Overall Study|Adverse Event|0|||
156965756|NCT02230956|566626325|FG000|Overall Study|Adverse Event|1|||
156965757|NCT02230956|566626326|FG001|Overall Study|Adverse Event|1|||
156965758|NCT02230956|566626327|FG002|Overall Study|Adverse Event|0|||
156965759|NCT02230956|566626325|FG000|Overall Study|Lack of Efficacy|1|||
156965760|NCT02230956|566626326|FG001|Overall Study|Lack of Efficacy|1|||
156965761|NCT02230956|566626327|FG002|Overall Study|Lack of Efficacy|1|||
156965762|NCT02230956|566626325|FG000|Overall Study|Lost to Follow-up|1|||
157172647|NCT00966693|567371232|FG003|Overall Study|Disease Progression|16|||
156965763|NCT02230956|566626326|FG001|Overall Study|Lost to Follow-up|1|||
156965764|NCT02230956|566626327|FG002|Overall Study|Lost to Follow-up|2|||
156965765|NCT02230956|566626325|FG000|Overall Study|Personal Reasons|2|||
157172648|NCT01265420|567371235|FG000|Overall Study|Lost to Follow-up|1|||
157172649|NCT02554253|567371236|FG000|Overall Study|ineligible after enrollment|1|||
156965766|NCT02230956|566626326|FG001|Overall Study|Personal Reasons|1|||
156965767|NCT02230956|566626327|FG002|Overall Study|Personal Reasons|1|||
156965768|NCT02230956|566626325|FG000|Overall Study|Protocol Violation|0|||
156965769|NCT02230956|566626326|FG001|Overall Study|Protocol Violation|1|||
156965770|NCT02230956|566626327|FG002|Overall Study|Protocol Violation|1|||
157172650|NCT02554253|567371237|FG001|Overall Study|ineligible after enrollment|0|||
156965771|NCT02230956|566626325|FG000|Overall Study|Other Miscellaneous Reason|0|||
156965772|NCT02230956|566626326|FG001|Overall Study|Other Miscellaneous Reason|1|||
156965773|NCT02230956|566626327|FG002|Overall Study|Other Miscellaneous Reason|2|||
156965774|NCT00117676|566626330|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
156965775|NCT00117676|566626331|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
156965776|NCT00117676|566626330|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
156965777|NCT00117676|566626331|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
156965778|NCT00117676|566626330|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
156965779|NCT00117676|566626331|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
156965780|NCT00117676|566626330|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
156965781|NCT00117676|566626331|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
156965782|NCT00117676|566626330|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
156965783|NCT00117676|566626331|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
156965784|NCT00117676|566626330|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
156965785|NCT00117676|566626331|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
156965786|NCT00117676|566626330|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
156965787|NCT00117676|566626331|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
156965788|NCT00117676|566626330|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
156965789|NCT00117676|566626331|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
156965790|NCT00117676|566626330|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
156965791|NCT00117676|566626331|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
156965792|NCT00117676|566626330|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
156965793|NCT00117676|566626331|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
156965794|NCT00117676|566626330|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
156965795|NCT00117676|566626331|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
156965796|NCT00117676|566626330|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
156965797|NCT00117676|566626331|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
156965798|NCT00117676|566626330|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
156965799|NCT00117676|566626331|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
156965800|NCT00117676|566626330|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
156965801|NCT00117676|566626331|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
156965802|NCT00117676|566626330|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
156965803|NCT00117676|566626331|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
156965804|NCT00117676|566626330|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
156965805|NCT00117676|566626331|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
156965806|NCT00117676|566626330|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
156965807|NCT00117676|566626331|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
156965808|NCT00117676|566626330|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
156965809|NCT00117676|566626331|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
156965810|NCT00117676|566626330|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
156965811|NCT00117676|566626331|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
156965812|NCT00117676|566626330|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
156965813|NCT00117676|566626331|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
156965814|NCT00117676|566626330|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
156965815|NCT00117676|566626331|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
156965816|NCT00117676|566626330|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
156965817|NCT00117676|566626331|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
156965818|NCT00117676|566626330|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
156965819|NCT00117676|566626331|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
156965820|NCT00117676|566626330|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
156965821|NCT00117676|566626331|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
156965822|NCT00117676|566626330|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
156965823|NCT00117676|566626331|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
156965824|NCT00117676|566626330|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
156965825|NCT00117676|566626331|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
156965826|NCT00117676|566626330|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
156965827|NCT00117676|566626331|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
156965828|NCT00117676|566626330|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
157172651|NCT02554253|567371236|FG000|Overall Study|converted to transcatheter procedure|0|||
157172652|NCT02554253|567371237|FG001|Overall Study|converted to transcatheter procedure|1|||
157172653|NCT02554253|567371236|FG000|Overall Study|received both drugs|0|||
157172654|NCT02554253|567371237|FG001|Overall Study|received both drugs|1|||
157172655|NCT01736254|567371239|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
157172656|NCT01736254|567371239|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
156965829|NCT00117676|566626331|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
156965830|NCT00117676|566626330|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
156965831|NCT00117676|566626331|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
156965832|NCT00117676|566626330|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
156965833|NCT00117676|566626331|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
156965834|NCT00117676|566626330|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
156965835|NCT00117676|566626331|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
156965836|NCT00117676|566626330|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
156965837|NCT00117676|566626331|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
156965838|NCT00117676|566626330|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
156965839|NCT00117676|566626331|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
156965840|NCT00117676|566626330|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
156965841|NCT00117676|566626331|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
156965842|NCT00117676|566626330|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
156965843|NCT00117676|566626331|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
156965844|NCT00952822|566626332|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156965845|NCT00952822|566626333|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
156965846|NCT00952822|566626334|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156965847|NCT00952822|566626335|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
156965848|NCT00952822|566626332|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156965849|NCT00952822|566626333|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156965850|NCT00952822|566626334|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
156965851|NCT00952822|566626335|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
156965852|NCT01362439|566626337|FG000|Overall Study|Adverse Event|1|||
156965853|NCT01362439|566626337|FG000|Overall Study|Lack of Efficacy|3|||
156965854|NCT01362439|566626337|FG000|Overall Study|Lost to Follow-up|2|||
156965855|NCT01362439|566626337|FG000|Overall Study|Study medication non-compliant|1|||
157040331|NCT05580003|566901561|FG005|Part 6 Period 2 (Day 1)|Other|0|||
157040332|NCT05580003|566901562|FG006|Part 6 Period 2 (Day 1)|Other|0|||
156965856|NCT01362439|566626337|FG000|Overall Study|Participant who withdrew consent|8|||
157040333|NCT05580003|566901563|FG007|Part 6 Period 2 (Day 1)|Other|0|||
157040334|NCT05580003|566901564|FG008|Part 6 Period 2 (Day 1)|Other|0|||
157040335|NCT05580003|566901565|FG009|Part 6 Period 2 (Day 1)|Other|0|||
157040336|NCT05580003|566901566|FG010|Part 6 Period 2 (Day 1)|Other|0|||
157040337|NCT05580003|566901567|FG011|Part 6 Period 2 (Day 1)|Other|0|||
157040338|NCT05580003|566901568|FG012|Part 6 Period 2 (Day 1)|Other|0|||
157040339|NCT05580003|566901569|FG013|Part 6 Period 2 (Day 1)|Other|0|||
157040340|NCT05580003|566901570|FG014|Part 6 Period 2 (Day 1)|Other|0|||
157040341|NCT05580003|566901571|FG015|Part 6 Period 2 (Day 1)|Other|0|||
157040342|NCT05580003|566901572|FG016|Part 6 Period 2 (Day 1)|Other|0|||
157040343|NCT05580003|566901573|FG017|Part 6 Period 2 (Day 1)|Other|0|||
157040344|NCT05580003|566901574|FG018|Part 6 Period 2 (Day 1)|Other|0|||
157040345|NCT05580003|566901575|FG019|Part 6 Period 2 (Day 1)|Other|0|||
157040346|NCT05580003|566901576|FG020|Part 6 Period 2 (Day 1)|Other|0|||
157040347|NCT05580003|566901577|FG021|Part 6 Period 2 (Day 1)|Other|0|||
157040348|NCT05580003|566901578|FG022|Part 6 Period 2 (Day 1)|Other|0|||
157040349|NCT05580003|566901579|FG023|Part 6 Period 2 (Day 1)|Other|0|||
157040350|NCT05580003|566901580|FG024|Part 6 Period 2 (Day 1)|Other|1|||
157040351|NCT05580003|566901581|FG025|Part 6 Period 2 (Day 1)|Other|0|||
157172657|NCT02559206|567371240|FG000|Overall Study|Adverse Event|0|||
157172658|NCT02559206|567371241|FG001|Overall Study|Adverse Event|4|||
157172659|NCT02559206|567371242|FG002|Overall Study|Adverse Event|1|||
156965857|NCT04040751|566626338|FG000|Overall Study|Withdrawal by Subject|2|||
156965858|NCT04040751|566626339|FG001|Overall Study|Withdrawal by Subject|0|||
156965859|NCT04040751|566626340|FG002|Overall Study|Withdrawal by Subject|2|||
156965860|NCT04040751|566626341|FG003|Overall Study|Withdrawal by Subject|0|||
156965861|NCT02355743|566626342|FG000|Overall Study|Withdrawal by Subject|1|||
156965862|NCT02355743|566626342|FG000|Overall Study|Lost to Follow-up|1|||
157172660|NCT02559206|567371243|FG003|Overall Study|Adverse Event|5|||
157172661|NCT02559206|567371244|FG004|Overall Study|Adverse Event|3|||
157172662|NCT02559206|567371245|FG005|Overall Study|Adverse Event|0|||
157172663|NCT02559206|567371246|FG006|Overall Study|Adverse Event|1|||
157172664|NCT02559206|567371247|FG007|Overall Study|Adverse Event|0|||
156965863|NCT03364751|566626343|FG000|Overall Study|Withdrawal by Subject|1|||
156965864|NCT03364751|566626344|FG001|Overall Study|Withdrawal by Subject|0|||
156965865|NCT03364751|566626345|FG002|Overall Study|Withdrawal by Subject|0|||
157040352|NCT05580003|566901582|FG026|Part 6 Period 2 (Day 1)|Other|0|||
157040353|NCT05580003|566901583|FG027|Part 6 Period 2 (Day 1)|Other|0|||
156965866|NCT03364751|566626346|FG003|Overall Study|Withdrawal by Subject|0|||
157040354|NCT03516812|566901584|FG000|Overall Study|Adverse Event|4|||
157040355|NCT03516812|566901584|FG000|Overall Study|Lack of Efficacy|2|||
157172665|NCT02559206|567371240|FG000|Overall Study|Protocol Violation|1|||
157227905|NCT03365947|567579240|FG004|Overall Study|Lost to Follow-up|0|||
157040356|NCT04795167|566901585|FG000|Overall Study|Death|1|||
156965867|NCT03364751|566626343|FG000|Overall Study|Lost to Follow-up|0|||
156965868|NCT03364751|566626344|FG001|Overall Study|Lost to Follow-up|1|||
156965869|NCT03364751|566626345|FG002|Overall Study|Lost to Follow-up|0|||
156965870|NCT03364751|566626346|FG003|Overall Study|Lost to Follow-up|0|||
156965871|NCT04542018|566626348|FG000|Overall Study|Withdrawal by Subject|0|||
156965872|NCT04542018|566626349|FG001|Overall Study|Withdrawal by Subject|0|||
156965873|NCT04542018|566626350|FG002|Overall Study|Withdrawal by Subject|4|||
156965874|NCT04542018|566626348|FG000|Overall Study|Protocol Violation|0|||
156965875|NCT04542018|566626349|FG001|Overall Study|Protocol Violation|0|||
156965876|NCT04542018|566626350|FG002|Overall Study|Protocol Violation|2|||
156965877|NCT03583554|566626351|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
156965878|NCT03583554|566626352|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
156965879|NCT03583554|566626353|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
156965880|NCT01596582|566626360|FG000|Overall Study|Deemed ineligible after study visit|3|||
156965881|NCT01596582|566626361|FG001|Overall Study|Deemed ineligible after study visit|6|||
156965882|NCT01596582|566626360|FG000|Overall Study|Missing all outcome data|1|||
156965883|NCT01596582|566626361|FG001|Overall Study|Missing all outcome data|1|||
156965884|NCT01428076|566626362|FG000|Overall Study|Adverse Event|0|||
156965885|NCT01428076|566626363|FG001|Overall Study|Adverse Event|1|||
156965886|NCT00262821|566626364|FG000|Overall Study|Ineligible - wrong stage|0|||
156965887|NCT00262821|566626365|FG001|Overall Study|Ineligible - wrong stage|3|||
156965888|NCT00262821|566626364|FG000|Overall Study|Ineligible - wrong cell type|2|||
156965889|NCT00262821|566626365|FG001|Overall Study|Ineligible - wrong cell type|2|||
156965890|NCT00262821|566626364|FG000|Overall Study|Ineligible - wrong primary|0|||
156965891|NCT00262821|566626365|FG001|Overall Study|Ineligible - wrong primary|1|||
156965892|NCT00262821|566626364|FG000|Overall Study|Ineligible - inadequate pathology|1|||
156965893|NCT00262821|566626365|FG001|Overall Study|Ineligible - inadequate pathology|3|||
156965894|NCT00262821|566626364|FG000|Overall Study|Ineligible - elevated creatinine|0|||
156965895|NCT00262821|566626365|FG001|Overall Study|Ineligible - elevated creatinine|2|||
156965896|NCT00262821|566626364|FG000|Overall Study|Ineligible - required test not done|1|||
156965897|NCT00262821|566626365|FG001|Overall Study|Ineligible - required test not done|4|||
156965898|NCT00262821|566626364|FG000|Overall Study|Inevaluable - inadequate data|0|||
156965899|NCT00262821|566626365|FG001|Overall Study|Inevaluable - inadequate data|4|||
156965900|NCT00765388|566626366|FG000|Period 1|Lack of Efficacy|1|||
156965901|NCT00765388|566626367|FG001|Period 1|Lack of Efficacy|2|||
156965902|NCT00765388|566626366|FG000|Period 1|Lost to Follow-up|0|||
156965903|NCT00765388|566626367|FG001|Period 1|Lost to Follow-up|1|||
156965904|NCT00765388|566626366|FG000|Period 1|Herpes Zoster|0|||
156965905|NCT00765388|566626367|FG001|Period 1|Herpes Zoster|1|||
156965906|NCT00765388|566626366|FG000|Period 1|Hip operation|0|||
156965907|NCT00765388|566626367|FG001|Period 1|Hip operation|1|||
156965908|NCT03923933|566626371|FG000|Overall Study|Lost to Follow-up|1|||
156965909|NCT03923933|566626372|FG001|Overall Study|Lost to Follow-up|0|||
156965910|NCT03923933|566626371|FG000|Overall Study|Withdrawal by Subject|0|||
156965911|NCT03923933|566626372|FG001|Overall Study|Withdrawal by Subject|1|||
156965912|NCT02454101|566626373|FG000|Overall Study|Adverse Event|2|||
156965913|NCT02454101|566626374|FG001|Overall Study|Adverse Event|3|||
156965914|NCT02454101|566626373|FG000|Overall Study|Lost to Follow-up|3|||
156965915|NCT02454101|566626374|FG001|Overall Study|Lost to Follow-up|4|||
156965916|NCT01995461|566626375|FG000|Overall Study|Death|1|||
156965917|NCT01995461|566626375|FG000|Overall Study|Lost to Follow-up|2|||
156965918|NCT01995461|566626375|FG000|Overall Study|Withdrawal by Subject|2|||
156965919|NCT01777854|566626376|FG000|Overall Study|Physician Decision|3|||
156965920|NCT01777854|566626377|FG001|Overall Study|Physician Decision|3|||
156965921|NCT01667432|566626380|FG000|Overall Study|Premature Study Termination|26|||
156965922|NCT01667432|566626380|FG000|Overall Study|Failure to Return|10|||
156965923|NCT01667432|566626380|FG000|Overall Study|Moved to Another Center|3|||
156965924|NCT01667432|566626380|FG000|Overall Study|Lost to Follow-up|3|||
156965925|NCT01667432|566626380|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
156965926|NCT01667432|566626380|FG000|Overall Study|Insufficient Therapeutic Response|4|||
156965927|NCT01667432|566626380|FG000|Overall Study|Adverse Event|1|||
156965928|NCT01667432|566626380|FG000|Overall Study|Protocol Deviation|2|||
156965929|NCT01667432|566626380|FG000|Overall Study|Principal Investigator Decision|1|||
156965930|NCT01667432|566626380|FG000|Overall Study|Reason Not Specified|2|||
156965931|NCT01667432|566626380|FG000|Overall Study|Missing Information|4|||
156965932|NCT00553696|566626381|FG000|Overall Study|Adverse Event|2|||
156965933|NCT00553696|566626382|FG001|Overall Study|Adverse Event|4|||
156965934|NCT00553696|566626383|FG002|Overall Study|Adverse Event|0|||
156965935|NCT00553696|566626384|FG003|Overall Study|Adverse Event|1|||
156965936|NCT00553696|566626381|FG000|Overall Study|Global deterioration of health status|0|||
156965937|NCT00553696|566626382|FG001|Overall Study|Global deterioration of health status|2|||
156965938|NCT00553696|566626383|FG002|Overall Study|Global deterioration of health status|0|||
156965939|NCT00553696|566626384|FG003|Overall Study|Global deterioration of health status|0|||
156965940|NCT00553696|566626381|FG000|Overall Study|Objective progression or relapse|2|||
156965941|NCT00553696|566626382|FG001|Overall Study|Objective progression or relapse|9|||
156965942|NCT00553696|566626383|FG002|Overall Study|Objective progression or relapse|6|||
156965943|NCT00553696|566626384|FG003|Overall Study|Objective progression or relapse|0|||
156965944|NCT00553696|566626381|FG000|Overall Study|Withdrawal by Subject|0|||
156965945|NCT00553696|566626382|FG001|Overall Study|Withdrawal by Subject|1|||
156965946|NCT00553696|566626383|FG002|Overall Study|Withdrawal by Subject|0|||
156965947|NCT00553696|566626384|FG003|Overall Study|Withdrawal by Subject|0|||
156965948|NCT00671931|566626385|FG000|Overall Study|Physician Decision|1|||
156965949|NCT00671931|566626386|FG001|Overall Study|Physician Decision|0|||
156965950|NCT00671931|566626387|FG002|Overall Study|Physician Decision|0|||
156965951|NCT00671931|566626388|FG003|Overall Study|Physician Decision|2|||
156965952|NCT00671931|566626389|FG004|Overall Study|Physician Decision|1|||
156965953|NCT02925676|566626393|FG000|Overall Study|Withdrawal by Subject|1|||
156965954|NCT00981084|566626394|FG000|Post Intervention (Data Analysis)|poor effort|1|||
156965955|NCT00981084|566626395|FG001|Post Intervention (Data Analysis)|poor effort|1|||
156965956|NCT00981084|566626394|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
156965957|NCT00981084|566626395|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
156965958|NCT00902694|566626396|FG000|Overall Study|Death|1|||
156965959|NCT00902694|566626397|FG001|Overall Study|Death|3|||
156965960|NCT00902694|566626396|FG000|Overall Study|Lost to Follow-up|1|||
156965961|NCT00902694|566626397|FG001|Overall Study|Lost to Follow-up|0|||
156965962|NCT00902694|566626396|FG000|Overall Study|Censored per protocol|3|||
156965963|NCT00902694|566626397|FG001|Overall Study|Censored per protocol|1|||
156965964|NCT00902694|566626396|FG000|Overall Study|Pregnancy|1|||
156965965|NCT00902694|566626397|FG001|Overall Study|Pregnancy|1|||
156965966|NCT00902694|566626396|FG000|Overall Study|Incarceration|1|||
156965967|NCT00902694|566626397|FG001|Overall Study|Incarceration|0|||
156965968|NCT04969263|566626398|FG000|Overall Study|Death|1|||
156965969|NCT04969263|566626398|FG000|Overall Study|Lost to Follow-up|2|||
156965970|NCT04969263|566626398|FG000|Overall Study|Withdrawal by Subject|5|||
156965971|NCT04969263|566626398|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
156965972|NCT00725296|566626399|FG000|Overall Study|Adverse Event|11|||
156965973|NCT00725296|566626399|FG000|Overall Study|Lack of Efficacy|7|||
156965974|NCT00725296|566626399|FG000|Overall Study|Withdrawal by Subject|3|||
156965975|NCT00725296|566626399|FG000|Overall Study|Non-Compliance|2|||
156965976|NCT00725296|566626399|FG000|Overall Study|Lost to Follow-up|1|||
156965977|NCT00725296|566626399|FG000|Overall Study|Other|38|||
156965978|NCT03360942|566626400|FG000|Overall Study|Device explanted|2|||
156965979|NCT03360942|566626400|FG000|Overall Study|Study closure|1|||
156965980|NCT03360942|566626400|FG000|Overall Study|Withdrawal by Subject|2|||
156965981|NCT03456700|566626401|FG000|Overall Study|Withdrawal by Subject|1|||
156965982|NCT04154787|566626402|FG000|Overall Study|Adverse Event|0|||
156965983|NCT04154787|566626403|FG001|Overall Study|Adverse Event|1|||
156965984|NCT04154787|566626404|FG002|Overall Study|Adverse Event|0|||
156965985|NCT04154787|566626402|FG000|Overall Study|Patient Requires Other Treatment|0|||
156965986|NCT04154787|566626403|FG001|Overall Study|Patient Requires Other Treatment|1|||
156965987|NCT04154787|566626404|FG002|Overall Study|Patient Requires Other Treatment|0|||
156965988|NCT04154787|566626402|FG000|Overall Study|Study Terminated By Sponsor|0|||
156965989|NCT04154787|566626403|FG001|Overall Study|Study Terminated By Sponsor|6|||
156965990|NCT04154787|566626404|FG002|Overall Study|Study Terminated By Sponsor|1|||
156965991|NCT04154787|566626402|FG000|Overall Study|Subject Decision|0|||
156965992|NCT04154787|566626403|FG001|Overall Study|Subject Decision|1|||
156965993|NCT04154787|566626404|FG002|Overall Study|Subject Decision|0|||
156965994|NCT04154787|566626402|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
156965995|NCT04154787|566626403|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
156965996|NCT04154787|566626404|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
156965997|NCT00613951|566626408|FG000|Overall Study|Adverse Event|1|||
156965998|NCT00613951|566626409|FG001|Overall Study|Adverse Event|0|||
156965999|NCT00613951|566626410|FG002|Overall Study|Adverse Event|1|||
156966000|NCT00613951|566626408|FG000|Overall Study|Lack of Efficacy|0|||
156966001|NCT00613951|566626409|FG001|Overall Study|Lack of Efficacy|1|||
156966002|NCT00613951|566626410|FG002|Overall Study|Lack of Efficacy|1|||
156966003|NCT00613951|566626408|FG000|Overall Study|Protocol Violation|1|||
156966004|NCT00613951|566626409|FG001|Overall Study|Protocol Violation|1|||
156966005|NCT00613951|566626410|FG002|Overall Study|Protocol Violation|1|||
156966006|NCT00613951|566626408|FG000|Overall Study|Unclassified|5|||
156966007|NCT00613951|566626409|FG001|Overall Study|Unclassified|3|||
156966008|NCT00613951|566626410|FG002|Overall Study|Unclassified|2|||
156966009|NCT03053050|566626411|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
156966010|NCT03053050|566626412|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
156966011|NCT03053050|566626413|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
156966012|NCT03053050|566626414|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
156966013|NCT03053050|566626411|FG000|Randomized Phase|Withdrew Consent|16|||
156966014|NCT03053050|566626412|FG001|Randomized Phase|Withdrew Consent|8|||
156966015|NCT03053050|566626413|FG002|Randomized Phase|Withdrew Consent|9|||
156966016|NCT03053050|566626414|FG003|Randomized Phase|Withdrew Consent|0|||
156966017|NCT03053050|566626411|FG000|Randomized Phase|Investigator's Discretion|6|||
156966018|NCT03053050|566626412|FG001|Randomized Phase|Investigator's Discretion|6|||
156966019|NCT03053050|566626413|FG002|Randomized Phase|Investigator's Discretion|3|||
156966020|NCT03053050|566626414|FG003|Randomized Phase|Investigator's Discretion|0|||
156966021|NCT03053050|566626411|FG000|Randomized Phase|Lost to Follow-up|5|||
156966022|NCT03053050|566626412|FG001|Randomized Phase|Lost to Follow-up|1|||
156966023|NCT03053050|566626413|FG002|Randomized Phase|Lost to Follow-up|1|||
156966024|NCT03053050|566626414|FG003|Randomized Phase|Lost to Follow-up|0|||
156966025|NCT03053050|566626411|FG000|Randomized Phase|Adverse Event|0|||
156966026|NCT03053050|566626412|FG001|Randomized Phase|Adverse Event|1|||
156966027|NCT03053050|566626413|FG002|Randomized Phase|Adverse Event|0|||
156966028|NCT03053050|566626414|FG003|Randomized Phase|Adverse Event|0|||
156966029|NCT03053050|566626411|FG000|Randomized Phase|Randomized but Never Treated|2|||
156966030|NCT03053050|566626412|FG001|Randomized Phase|Randomized but Never Treated|2|||
156966031|NCT03053050|566626413|FG002|Randomized Phase|Randomized but Never Treated|2|||
156966032|NCT03053050|566626414|FG003|Randomized Phase|Randomized but Never Treated|0|||
156966033|NCT03053050|566626411|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
156966034|NCT03053050|566626412|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
156966035|NCT03053050|566626413|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
156966036|NCT03053050|566626414|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
156966037|NCT03053050|566626411|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
156966038|NCT03053050|566626412|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
156966039|NCT03053050|566626413|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
156966040|NCT03053050|566626414|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
156966041|NCT03053050|566626411|FG000|Open-label Phase|Withdrew Consent|0|||
156966042|NCT03053050|566626412|FG001|Open-label Phase|Withdrew Consent|0|||
156966043|NCT03053050|566626413|FG002|Open-label Phase|Withdrew Consent|0|||
156966044|NCT03053050|566626414|FG003|Open-label Phase|Withdrew Consent|6|||
156966045|NCT03053050|566626411|FG000|Open-label Phase|Investigator's Discretion|0|||
156966046|NCT03053050|566626412|FG001|Open-label Phase|Investigator's Discretion|0|||
156966047|NCT03053050|566626413|FG002|Open-label Phase|Investigator's Discretion|0|||
156966048|NCT03053050|566626414|FG003|Open-label Phase|Investigator's Discretion|4|||
156966049|NCT00655980|566626415|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
156966050|NCT00655980|566626416|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
156966051|NCT00655980|566626417|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
156966052|NCT05540522|566626418|FG000|Overall Study|Adverse Event|1|||
156966053|NCT05540522|566626419|FG001|Overall Study|Adverse Event|0|||
156966054|NCT05540522|566626420|FG002|Overall Study|Adverse Event|2|||
156966055|NCT05540522|566626421|FG003|Overall Study|Adverse Event|5|||
156966056|NCT05540522|566626418|FG000|Overall Study|Lost to Follow-up|487|||
156966057|NCT05540522|566626419|FG001|Overall Study|Lost to Follow-up|427|||
156966058|NCT05540522|566626420|FG002|Overall Study|Lost to Follow-up|146|||
156966059|NCT05540522|566626421|FG003|Overall Study|Lost to Follow-up|166|||
156966060|NCT05540522|566626418|FG000|Overall Study|Physician Decision|11|||
156966061|NCT05540522|566626419|FG001|Overall Study|Physician Decision|19|||
156966062|NCT05540522|566626420|FG002|Overall Study|Physician Decision|8|||
156966063|NCT05540522|566626421|FG003|Overall Study|Physician Decision|13|||
156966064|NCT05540522|566626418|FG000|Overall Study|Pregnancy|1|||
156966065|NCT05540522|566626419|FG001|Overall Study|Pregnancy|0|||
156966066|NCT05540522|566626420|FG002|Overall Study|Pregnancy|0|||
156966067|NCT05540522|566626421|FG003|Overall Study|Pregnancy|0|||
156966068|NCT05540522|566626418|FG000|Overall Study|Protocol Violation|3|||
156966069|NCT05540522|566626419|FG001|Overall Study|Protocol Violation|1|||
156966070|NCT05540522|566626420|FG002|Overall Study|Protocol Violation|9|||
156966071|NCT05540522|566626421|FG003|Overall Study|Protocol Violation|7|||
156966072|NCT05540522|566626418|FG000|Overall Study|Withdrawal by Subject|168|||
156966073|NCT05540522|566626419|FG001|Overall Study|Withdrawal by Subject|134|||
156966074|NCT05540522|566626420|FG002|Overall Study|Withdrawal by Subject|331|||
156966075|NCT05540522|566626421|FG003|Overall Study|Withdrawal by Subject|322|||
156966076|NCT05540522|566626418|FG000|Overall Study|Death|7|||
156966077|NCT05540522|566626419|FG001|Overall Study|Death|9|||
156966078|NCT05540522|566626420|FG002|Overall Study|Death|49|||
156966079|NCT05540522|566626421|FG003|Overall Study|Death|46|||
156966080|NCT05540522|566626418|FG000|Overall Study|Not vaccinated|34|||
156966081|NCT05540522|566626419|FG001|Overall Study|Not vaccinated|53|||
156966082|NCT05540522|566626420|FG002|Overall Study|Not vaccinated|57|||
156966083|NCT05540522|566626421|FG003|Overall Study|Not vaccinated|50|||
156966084|NCT05540522|566626418|FG000|Overall Study|No longer meets eligibility criteria|0|||
156966085|NCT05540522|566626419|FG001|Overall Study|No longer meets eligibility criteria|0|||
156966086|NCT05540522|566626420|FG002|Overall Study|No longer meets eligibility criteria|3|||
156966087|NCT05540522|566626421|FG003|Overall Study|No longer meets eligibility criteria|2|||
156966088|NCT05540522|566626418|FG000|Overall Study|Other (Unspecified)|8|||
156966089|NCT05540522|566626419|FG001|Overall Study|Other (Unspecified)|10|||
156966090|NCT05540522|566626420|FG002|Overall Study|Other (Unspecified)|4|||
156966091|NCT05540522|566626421|FG003|Overall Study|Other (Unspecified)|2|||
156966092|NCT00506493|566626425|FG000|Overall Study|Death|6|||
156966093|NCT00506493|566626425|FG000|Overall Study|Withdrawal by Subject|5|||
156966094|NCT01266642|566626426|FG000|Overall Study|Protocol Violation|0|||
156966095|NCT01266642|566626427|FG001|Overall Study|Protocol Violation|1|||
156966096|NCT01553318|566627945|FG000|Overall Study|Protocol Violation|3|||
156966097|NCT01553318|566627946|FG001|Overall Study|Protocol Violation|2|||
156966098|NCT00989092|566627952|FG000|Overall Study|Physician Decision|9|||
156966099|NCT00989092|566627953|FG001|Overall Study|Physician Decision|6|||
156966100|NCT00989092|566627952|FG000|Overall Study|Adverse Event|20|||
156966101|NCT00989092|566627953|FG001|Overall Study|Adverse Event|1|||
156966102|NCT00989092|566627952|FG000|Overall Study|Chemotherapy initiated|12|||
156966103|NCT00989092|566627953|FG001|Overall Study|Chemotherapy initiated|4|||
156966104|NCT00989092|566627952|FG000|Overall Study|Withdrawal by Subject|17|||
156966105|NCT00989092|566627953|FG001|Overall Study|Withdrawal by Subject|9|||
156966106|NCT00989092|566627952|FG000|Overall Study|Death|14|||
156966107|NCT00989092|566627953|FG001|Overall Study|Death|2|||
156966108|NCT00989092|566627952|FG000|Overall Study|Ineligibility determined|3|||
156966109|NCT00989092|566627953|FG001|Overall Study|Ineligibility determined|3|||
156966110|NCT00989092|566627952|FG000|Overall Study|Lost to Follow-up|6|||
156966111|NCT00989092|566627953|FG001|Overall Study|Lost to Follow-up|2|||
156966112|NCT00989092|566627952|FG000|Overall Study|Other|3|||
156966113|NCT00989092|566627953|FG001|Overall Study|Other|1|||
156966114|NCT00989092|566627952|FG000|Overall Study|Protocol deviation|2|||
156966115|NCT00989092|566627953|FG001|Overall Study|Protocol deviation|0|||
156966116|NCT00989092|566627952|FG000|Overall Study|Erythropoietin therapy initiated|2|||
156966117|NCT00989092|566627953|FG001|Overall Study|Erythropoietin therapy initiated|0|||
156966118|NCT00989092|566627952|FG000|Overall Study|Did not receive study drug|2|||
156966119|NCT00989092|566627953|FG001|Overall Study|Did not receive study drug|0|||
156966120|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
156966121|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
156966122|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
156966123|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
156966124|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
156966125|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
156966126|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Death|1|||
156966127|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Death|0|||
156966128|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Adverse Event|1|||
156966129|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Adverse Event|0|||
156966130|NCT02586025|566627955|FG000|Neoadjuvant Treatment|Physician Decision|2|||
156966131|NCT02586025|566627956|FG001|Neoadjuvant Treatment|Physician Decision|1|||
156966132|NCT02586025|566627955|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
156966133|NCT02586025|566627956|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
156966134|NCT02586025|566627955|FG000|Adjuvant Treatment|Recurrent Disease|4|||
156966135|NCT02586025|566627956|FG001|Adjuvant Treatment|Recurrent Disease|5|||
156966136|NCT02586025|566627955|FG000|Adjuvant Treatment|Physician Decision|0|||
156966137|NCT02586025|566627956|FG001|Adjuvant Treatment|Physician Decision|1|||
156966138|NCT02586025|566627955|FG000|Adjuvant Treatment|Pregnancy|1|||
156966139|NCT02586025|566627956|FG001|Adjuvant Treatment|Pregnancy|0|||
156966140|NCT02586025|566627955|FG000|Treatment-Free Follow-Up|Death|11|||
156966141|NCT02586025|566627956|FG001|Treatment-Free Follow-Up|Death|11|||
156966142|NCT02586025|566627955|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
156966143|NCT02586025|566627956|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
156966144|NCT02586025|566627955|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
156966145|NCT02586025|566627956|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
156966146|NCT02586025|566627955|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
156966147|NCT02586025|566627956|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
156966148|NCT02586025|566627955|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
156966149|NCT02586025|566627956|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
156966150|NCT03704584|566627957|FG000|Overall Study|Withdrawal by Subject|1|||
156966151|NCT03704584|566627958|FG001|Overall Study|Withdrawal by Subject|0|||
156966152|NCT01083641|566627960|FG000|Overall Study|Withdrawal by Subject|2|||
156966153|NCT03439189|566627961|FG000|Overall Study|Protocol Violation|19|||
156966154|NCT03439189|566627961|FG000|Overall Study|Lack of Efficacy|63|||
156966155|NCT03412812|566627962|FG000|Level 1|Death|3|||
156966156|NCT03412812|566627963|FG001|Level 1|Death|0|||
156966157|NCT03412812|566627962|FG000|Level 1|Adverse Event|0|||
156966158|NCT03412812|566627963|FG001|Level 1|Adverse Event|1|||
156966159|NCT02127372|566627964|FG000|Overall Study|Withdrawal by Subject|1|||
156966160|NCT02127372|566627965|FG001|Overall Study|Withdrawal by Subject|0|||
157227906|NCT03365947|567579241|FG005|Overall Study|Lost to Follow-up|1|||
156966161|NCT02173548|566627966|FG000|Overall Study|Lost to Follow-up|0|||
156966162|NCT02173548|566627967|FG001|Overall Study|Lost to Follow-up|2|||
156966163|NCT02173548|566627966|FG000|Overall Study|Withdrawal by Subject|1|||
156966164|NCT02173548|566627967|FG001|Overall Study|Withdrawal by Subject|0|||
156966165|NCT03597568|566627968|FG000|Overall Study|Withdrawal by Subject|1|||
156966166|NCT03597568|566627969|FG001|Overall Study|Withdrawal by Subject|1|||
156966167|NCT03597568|566627968|FG000|Overall Study|Unable to analyze vascular data|1|||
156966168|NCT03597568|566627969|FG001|Overall Study|Unable to analyze vascular data|1|||
157227907|NCT03365947|567579242|FG006|Overall Study|Lost to Follow-up|0|||
156966169|NCT03822117|566627972|FG000|Overall Study|Death|18|||
156966170|NCT03822117|566627973|FG001|Overall Study|Death|17|||
157227908|NCT03365947|567579243|FG007|Overall Study|Lost to Follow-up|0|||
156966171|NCT03822117|566627974|FG002|Overall Study|Death|12|||
156966172|NCT03822117|566627975|FG003|Overall Study|Death|4|||
156966173|NCT03822117|566627972|FG000|Overall Study|Lost to Follow-up|1|||
156966174|NCT03822117|566627973|FG001|Overall Study|Lost to Follow-up|2|||
156966175|NCT03822117|566627974|FG002|Overall Study|Lost to Follow-up|3|||
156966176|NCT03822117|566627975|FG003|Overall Study|Lost to Follow-up|0|||
156966177|NCT03822117|566627972|FG000|Overall Study|Study Terminated by Sponsor|25|||
156966178|NCT03822117|566627973|FG001|Overall Study|Study Terminated by Sponsor|11|||
156966179|NCT03822117|566627974|FG002|Overall Study|Study Terminated by Sponsor|6|||
156966180|NCT03822117|566627975|FG003|Overall Study|Study Terminated by Sponsor|0|||
156966181|NCT03822117|566627972|FG000|Overall Study|Withdrawal by Subject|4|||
156966182|NCT03822117|566627973|FG001|Overall Study|Withdrawal by Subject|0|||
156966183|NCT03822117|566627974|FG002|Overall Study|Withdrawal by Subject|3|||
156966184|NCT03822117|566627975|FG003|Overall Study|Withdrawal by Subject|0|||
156966185|NCT03822117|566627972|FG000|Overall Study|Disease Progression|1|||
156966186|NCT03822117|566627973|FG001|Overall Study|Disease Progression|2|||
156966187|NCT03822117|566627974|FG002|Overall Study|Disease Progression|1|||
156966188|NCT03822117|566627975|FG003|Overall Study|Disease Progression|0|||
156966189|NCT03822117|566627972|FG000|Overall Study|Never Returned to Hospital|0|||
156966190|NCT03822117|566627973|FG001|Overall Study|Never Returned to Hospital|0|||
156966191|NCT03822117|566627974|FG002|Overall Study|Never Returned to Hospital|1|||
156966192|NCT03822117|566627975|FG003|Overall Study|Never Returned to Hospital|0|||
156966193|NCT01357616|566627979|FG000|Overall Study|Adverse Event|1|||
156966194|NCT01357616|566627980|FG001|Overall Study|Adverse Event|1|||
156966195|NCT01357616|566627979|FG000|Overall Study|Lost to Follow-up|4|||
156966196|NCT01357616|566627980|FG001|Overall Study|Lost to Follow-up|3|||
156966197|NCT01357616|566627979|FG000|Overall Study|Protocol Violation|0|||
156966198|NCT01357616|566627980|FG001|Overall Study|Protocol Violation|2|||
156966199|NCT01357616|566627979|FG000|Overall Study|Inadequate Control of IOP|1|||
156966200|NCT01357616|566627980|FG001|Overall Study|Inadequate Control of IOP|2|||
156966201|NCT01357616|566627979|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
156966202|NCT01357616|566627980|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
156966203|NCT01357616|566627979|FG000|Overall Study|Withdrawal by Subject|1|||
156966204|NCT01357616|566627980|FG001|Overall Study|Withdrawal by Subject|0|||
156966205|NCT05131165|566627982|FG000|Overall Study|Death|1|||
156966206|NCT05131165|566627983|FG001|Overall Study|Death|1|||
156966207|NCT05131165|566627984|FG002|Overall Study|Death|0|||
156966208|NCT05131165|566627982|FG000|Overall Study|Lost to Follow-up|2|||
156966209|NCT05131165|566627983|FG001|Overall Study|Lost to Follow-up|2|||
156966210|NCT05131165|566627984|FG002|Overall Study|Lost to Follow-up|5|||
156966211|NCT05131165|566627982|FG000|Overall Study|Transferred out of clinic|1|||
156966212|NCT05131165|566627983|FG001|Overall Study|Transferred out of clinic|0|||
156966213|NCT05131165|566627984|FG002|Overall Study|Transferred out of clinic|3|||
156966214|NCT05131165|566627982|FG000|Overall Study|Dropped out|1|||
156966215|NCT05131165|566627983|FG001|Overall Study|Dropped out|2|||
156966216|NCT05131165|566627984|FG002|Overall Study|Dropped out|0|||
156966217|NCT03466086|566627991|FG000|Period 1|Sponsor decision due to study timeline|1|||
156966218|NCT03466086|566627992|FG001|Period 1|Sponsor decision due to study timeline|0|||
156966219|NCT03466086|566627991|FG000|Period 1|Withdrawal by Subject|1|||
156966220|NCT03466086|566627992|FG001|Period 1|Withdrawal by Subject|0|||
156966221|NCT01754467|566627996|FG000|Overall Study|Lost to Follow-up|1|||
156966222|NCT01970462|566627997|FG000|Overall Study|Lost to Follow-up|0|||
156966223|NCT01970462|566627998|FG001|Overall Study|Lost to Follow-up|2|||
156966224|NCT03002610|566627999|FG000|Overall Study|Withdrawal by Subject|6|||
156966225|NCT03002610|566628000|FG001|Overall Study|Withdrawal by Subject|25|||
156966226|NCT03002610|566628001|FG002|Overall Study|Withdrawal by Subject|13|||
156966227|NCT03802123|566628002|FG000|Overall Study|Withdrawal by Subject|3|||
156966228|NCT03802123|566628002|FG000|Overall Study|Physician Decision|1|||
156966229|NCT03802123|566628002|FG000|Overall Study|Subject moved to hospice care|1|||
156966230|NCT03802123|566628002|FG000|Overall Study|technician error|1|||
156966231|NCT03802123|566628002|FG000|Overall Study|Death|3|||
156966232|NCT01822587|566628003|FG000|Overall Study|Lost to Follow-up|7|||
156966233|NCT01822587|566628004|FG001|Overall Study|Lost to Follow-up|9|||
156966234|NCT01822587|566628005|FG002|Overall Study|Lost to Follow-up|12|||
156966235|NCT01822587|566628003|FG000|Overall Study|Physician Decision|9|||
157040357|NCT04795167|566901586|FG001|Overall Study|Death|18|||
156966236|NCT01822587|566628004|FG001|Overall Study|Physician Decision|6|||
156966237|NCT01822587|566628005|FG002|Overall Study|Physician Decision|6|||
156966238|NCT01274182|566628006|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
157040358|NCT04795167|566901587|FG002|Overall Study|Death|1|||
157040359|NCT04795167|566901585|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
156966239|NCT01274182|566628007|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
157040360|NCT04795167|566901586|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
157040361|NCT04795167|566901587|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
156966240|NCT01274182|566628008|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
156966241|NCT01274182|566628006|FG000|Overall Study|Adverse Event|4|||
156966242|NCT01274182|566628007|FG001|Overall Study|Adverse Event|5|||
156966243|NCT01274182|566628008|FG002|Overall Study|Adverse Event|3|||
157172666|NCT02559206|567371241|FG001|Overall Study|Protocol Violation|0|||
157172667|NCT02559206|567371242|FG002|Overall Study|Protocol Violation|1|||
157172668|NCT02559206|567371243|FG003|Overall Study|Protocol Violation|0|||
157172669|NCT02559206|567371244|FG004|Overall Study|Protocol Violation|0|||
157172670|NCT02559206|567371245|FG005|Overall Study|Protocol Violation|2|||
157172671|NCT02559206|567371246|FG006|Overall Study|Protocol Violation|0|||
157172672|NCT02559206|567371247|FG007|Overall Study|Protocol Violation|0|||
157172673|NCT02559206|567371240|FG000|Overall Study|Withdrawal by Subject|3|||
157172674|NCT02559206|567371241|FG001|Overall Study|Withdrawal by Subject|3|||
157172675|NCT02559206|567371242|FG002|Overall Study|Withdrawal by Subject|1|||
157172676|NCT02559206|567371243|FG003|Overall Study|Withdrawal by Subject|3|||
157172677|NCT02559206|567371244|FG004|Overall Study|Withdrawal by Subject|5|||
157172678|NCT02559206|567371245|FG005|Overall Study|Withdrawal by Subject|4|||
157172679|NCT02559206|567371246|FG006|Overall Study|Withdrawal by Subject|1|||
157172680|NCT02559206|567371247|FG007|Overall Study|Withdrawal by Subject|2|||
157172681|NCT02559206|567371240|FG000|Overall Study|Lost to Follow-up|3|||
157172682|NCT02559206|567371241|FG001|Overall Study|Lost to Follow-up|5|||
157172683|NCT02559206|567371242|FG002|Overall Study|Lost to Follow-up|3|||
157172684|NCT02559206|567371243|FG003|Overall Study|Lost to Follow-up|3|||
157172685|NCT02559206|567371244|FG004|Overall Study|Lost to Follow-up|2|||
157172686|NCT02559206|567371245|FG005|Overall Study|Lost to Follow-up|5|||
157172687|NCT02559206|567371246|FG006|Overall Study|Lost to Follow-up|1|||
157172688|NCT02559206|567371247|FG007|Overall Study|Lost to Follow-up|4|||
157172689|NCT02559206|567371240|FG000|Overall Study|Lack of Efficacy|1|||
157172690|NCT02559206|567371241|FG001|Overall Study|Lack of Efficacy|0|||
157172691|NCT02559206|567371242|FG002|Overall Study|Lack of Efficacy|3|||
157172692|NCT02559206|567371243|FG003|Overall Study|Lack of Efficacy|2|||
157172693|NCT02559206|567371244|FG004|Overall Study|Lack of Efficacy|2|||
157172694|NCT02559206|567371245|FG005|Overall Study|Lack of Efficacy|3|||
157172695|NCT02559206|567371246|FG006|Overall Study|Lack of Efficacy|3|||
157172696|NCT02559206|567371247|FG007|Overall Study|Lack of Efficacy|3|||
157172697|NCT02559206|567371240|FG000|Overall Study|Other Not Specified|0|||
157172698|NCT02559206|567371241|FG001|Overall Study|Other Not Specified|0|||
157172699|NCT02559206|567371242|FG002|Overall Study|Other Not Specified|0|||
157172700|NCT02559206|567371243|FG003|Overall Study|Other Not Specified|1|||
157172701|NCT02559206|567371244|FG004|Overall Study|Other Not Specified|0|||
157172702|NCT02559206|567371245|FG005|Overall Study|Other Not Specified|0|||
157172703|NCT02559206|567371246|FG006|Overall Study|Other Not Specified|0|||
157172704|NCT02559206|567371247|FG007|Overall Study|Other Not Specified|0|||
157172705|NCT01375647|567373400|FG000|Overall Study|Lost to Follow-up|3|||
157172706|NCT01375647|567373401|FG001|Overall Study|Lost to Follow-up|3|||
157172707|NCT01375647|567373402|FG002|Overall Study|Lost to Follow-up|7|||
157172708|NCT01375647|567373403|FG003|Overall Study|Lost to Follow-up|10|||
157172709|NCT01375647|567373400|FG000|Overall Study|Death|1|||
157172710|NCT01375647|567373401|FG001|Overall Study|Death|2|||
157172711|NCT01375647|567373402|FG002|Overall Study|Death|1|||
157172712|NCT01375647|567373403|FG003|Overall Study|Death|0|||
157172713|NCT01375647|567373400|FG000|Overall Study|Withdrawal by Subject|17|||
157172714|NCT01375647|567373401|FG001|Overall Study|Withdrawal by Subject|20|||
157172715|NCT01375647|567373402|FG002|Overall Study|Withdrawal by Subject|26|||
157172716|NCT01375647|567373403|FG003|Overall Study|Withdrawal by Subject|14|||
157172717|NCT01375647|567373400|FG000|Overall Study|Physician Decision|1|||
157172718|NCT01375647|567373401|FG001|Overall Study|Physician Decision|0|||
157172719|NCT01375647|567373402|FG002|Overall Study|Physician Decision|0|||
157172720|NCT01375647|567373403|FG003|Overall Study|Physician Decision|0|||
157172721|NCT01770145|567373404|FG000|Baseline|Adverse Event|20|||
157172722|NCT01770145|567373404|FG000|Baseline|Withdrawal by Subject|1|||
157172723|NCT01770145|567373404|FG000|Baseline|Lost to Follow-up|1|||
157172724|NCT01770145|567373404|FG000|Baseline|Unable to define optimal dose|4|||
157172725|NCT01770145|567373404|FG000|Treatment|Adverse Event|3|||
157172726|NCT01770145|567373404|FG000|Treatment|Withdrawal by Subject|1|||
157172727|NCT01102140|567373405|FG000|Overall Study|Lost to Follow-up|1|||
157172728|NCT01102140|567373406|FG001|Overall Study|Lost to Follow-up|0|||
157172729|NCT01102140|567373405|FG000|Overall Study|Investigator terminated study|2|||
157172730|NCT01102140|567373406|FG001|Overall Study|Investigator terminated study|2|||
157172731|NCT03788967|567373409|FG000|Overall Study|Lost to Follow-up|14|||
157172732|NCT03788967|567373410|FG001|Overall Study|Lost to Follow-up|10|||
157227909|NCT03365947|567579244|FG008|Overall Study|Lost to Follow-up|0|||
157227910|NCT03365947|567579245|FG009|Overall Study|Lost to Follow-up|0|||
157227911|NCT03365947|567579246|FG010|Overall Study|Lost to Follow-up|0|||
157227912|NCT03365947|567579247|FG011|Overall Study|Lost to Follow-up|0|||
157172733|NCT03788967|567373409|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
157172734|NCT03788967|567373410|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
157172735|NCT03788967|567373409|FG000|Overall Study|Participant Withdrawal of Consent|13|||
157172736|NCT03788967|567373410|FG001|Overall Study|Participant Withdrawal of Consent|5|||
157172737|NCT03788967|567373409|FG000|Overall Study|Adverse Event|1|||
157172738|NCT03788967|567373410|FG001|Overall Study|Adverse Event|1|||
157172739|NCT03788967|567373409|FG000|Overall Study|COVID-19|1|||
157172740|NCT03788967|567373410|FG001|Overall Study|COVID-19|2|||
157227913|NCT03365947|567579248|FG012|Overall Study|Lost to Follow-up|0|||
156966244|NCT01274182|566628006|FG000|Overall Study|Withdrawal by Subject|5|||
157172741|NCT04268303|567373411|FG000|Overall Study|Lost to Follow-up|1|||
156966245|NCT01274182|566628007|FG001|Overall Study|Withdrawal by Subject|5|||
156966246|NCT01274182|566628008|FG002|Overall Study|Withdrawal by Subject|3|||
156966247|NCT01274182|566628006|FG000|Overall Study|Lost to Follow-up|2|||
156966248|NCT01274182|566628007|FG001|Overall Study|Lost to Follow-up|3|||
156966249|NCT01274182|566628008|FG002|Overall Study|Lost to Follow-up|1|||
156966250|NCT01274182|566628006|FG000|Overall Study|Protocol Violation|3|||
156966251|NCT01274182|566628007|FG001|Overall Study|Protocol Violation|2|||
156966252|NCT01274182|566628008|FG002|Overall Study|Protocol Violation|0|||
156966253|NCT01274182|566628006|FG000|Overall Study|Death|1|||
156966254|NCT01274182|566628007|FG001|Overall Study|Death|0|||
156966255|NCT01274182|566628008|FG002|Overall Study|Death|1|||
156966256|NCT01970982|566628009|FG000|Overall Study|Withdrawal by Subject|0|||
156966257|NCT01970982|566628010|FG001|Overall Study|Withdrawal by Subject|0|||
156966258|NCT01970982|566628011|FG002|Overall Study|Withdrawal by Subject|2|||
156966259|NCT03575325|566628017|FG000|Overall Study|Death|1|||
156966260|NCT02712905|566628020|FG000|Monotherapy|Death|2|||
156966261|NCT02712905|566628021|FG001|Monotherapy|Death|5|||
156966262|NCT02712905|566628022|FG002|Monotherapy|Death|0|||
156966263|NCT02712905|566628023|FG003|Monotherapy|Death|3|||
156966264|NCT02712905|566628024|FG004|Monotherapy|Death|15|||
156966265|NCT02712905|566628025|FG005|Monotherapy|Death|1|||
156966266|NCT02712905|566628026|FG006|Monotherapy|Death|3|||
156966267|NCT02712905|566628027|FG007|Monotherapy|Death|3|||
156966268|NCT02712905|566628028|FG008|Monotherapy|Death|0|||
156966269|NCT02712905|566628029|FG009|Monotherapy|Death|27|||
156966270|NCT02712905|566628030|FG010|Monotherapy|Death|2|||
156966271|NCT02712905|566628031|FG011|Monotherapy|Death|5|||
156966272|NCT02712905|566628032|FG012|Monotherapy|Death|0|||
156966273|NCT02712905|566628033|FG013|Monotherapy|Death|0|||
156966274|NCT02712905|566628034|FG014|Monotherapy|Death|0|||
156966275|NCT02712905|566628035|FG015|Monotherapy|Death|0|||
156966276|NCT02712905|566628036|FG016|Monotherapy|Death|0|||
156966277|NCT02712905|566628037|FG017|Monotherapy|Death|0|||
156966278|NCT02712905|566628020|FG000|Monotherapy|Lost to Follow-up|0|||
156966279|NCT02712905|566628021|FG001|Monotherapy|Lost to Follow-up|1|||
156966280|NCT02712905|566628022|FG002|Monotherapy|Lost to Follow-up|0|||
156966281|NCT02712905|566628023|FG003|Monotherapy|Lost to Follow-up|1|||
156966282|NCT02712905|566628024|FG004|Monotherapy|Lost to Follow-up|0|||
156966283|NCT02712905|566628025|FG005|Monotherapy|Lost to Follow-up|0|||
156966284|NCT02712905|566628026|FG006|Monotherapy|Lost to Follow-up|0|||
156966285|NCT02712905|566628027|FG007|Monotherapy|Lost to Follow-up|0|||
156966286|NCT02712905|566628028|FG008|Monotherapy|Lost to Follow-up|0|||
156966287|NCT02712905|566628029|FG009|Monotherapy|Lost to Follow-up|2|||
156966288|NCT02712905|566628030|FG010|Monotherapy|Lost to Follow-up|0|||
156966289|NCT02712905|566628031|FG011|Monotherapy|Lost to Follow-up|0|||
156966290|NCT02712905|566628032|FG012|Monotherapy|Lost to Follow-up|0|||
156966291|NCT02712905|566628033|FG013|Monotherapy|Lost to Follow-up|0|||
156966292|NCT02712905|566628034|FG014|Monotherapy|Lost to Follow-up|0|||
156966293|NCT02712905|566628035|FG015|Monotherapy|Lost to Follow-up|0|||
156966294|NCT02712905|566628036|FG016|Monotherapy|Lost to Follow-up|0|||
156966295|NCT02712905|566628037|FG017|Monotherapy|Lost to Follow-up|0|||
156966296|NCT02712905|566628020|FG000|Monotherapy|Physician Decision|1|||
156966297|NCT02712905|566628021|FG001|Monotherapy|Physician Decision|0|||
156966298|NCT02712905|566628022|FG002|Monotherapy|Physician Decision|0|||
156966299|NCT02712905|566628023|FG003|Monotherapy|Physician Decision|1|||
156966300|NCT02712905|566628024|FG004|Monotherapy|Physician Decision|0|||
156966301|NCT02712905|566628025|FG005|Monotherapy|Physician Decision|0|||
156966302|NCT02712905|566628026|FG006|Monotherapy|Physician Decision|0|||
156966303|NCT02712905|566628027|FG007|Monotherapy|Physician Decision|0|||
156966304|NCT02712905|566628028|FG008|Monotherapy|Physician Decision|0|||
156966305|NCT02712905|566628029|FG009|Monotherapy|Physician Decision|1|||
156966306|NCT02712905|566628030|FG010|Monotherapy|Physician Decision|0|||
156966307|NCT02712905|566628031|FG011|Monotherapy|Physician Decision|0|||
156966308|NCT02712905|566628032|FG012|Monotherapy|Physician Decision|0|||
156966309|NCT02712905|566628033|FG013|Monotherapy|Physician Decision|0|||
156966310|NCT02712905|566628034|FG014|Monotherapy|Physician Decision|0|||
157172742|NCT04268303|567373412|FG001|Overall Study|Lost to Follow-up|1|||
157172743|NCT04268303|567373413|FG002|Overall Study|Lost to Follow-up|2|||
157172744|NCT04268303|567373411|FG000|Overall Study|Withdrawal by Subject|0|||
156966311|NCT02712905|566628035|FG015|Monotherapy|Physician Decision|0|||
156966312|NCT02712905|566628036|FG016|Monotherapy|Physician Decision|0|||
156966313|NCT02712905|566628037|FG017|Monotherapy|Physician Decision|0|||
156966314|NCT02712905|566628020|FG000|Monotherapy|Study Terminated by Sponsor|0|||
156966315|NCT02712905|566628021|FG001|Monotherapy|Study Terminated by Sponsor|0|||
156966316|NCT02712905|566628022|FG002|Monotherapy|Study Terminated by Sponsor|0|||
156966317|NCT02712905|566628023|FG003|Monotherapy|Study Terminated by Sponsor|0|||
156966318|NCT02712905|566628024|FG004|Monotherapy|Study Terminated by Sponsor|1|||
156966319|NCT02712905|566628025|FG005|Monotherapy|Study Terminated by Sponsor|0|||
156966320|NCT02712905|566628026|FG006|Monotherapy|Study Terminated by Sponsor|0|||
156966321|NCT02712905|566628027|FG007|Monotherapy|Study Terminated by Sponsor|0|||
156966322|NCT02712905|566628028|FG008|Monotherapy|Study Terminated by Sponsor|0|||
157040362|NCT01753999|566901588|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
157040363|NCT01753999|566901589|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
157040364|NCT01753999|566901588|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
157040365|NCT01753999|566901589|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
157040366|NCT01753999|566901588|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
157040367|NCT01753999|566901589|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
157040368|NCT01753999|566901588|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
157040369|NCT01753999|566901589|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
157040370|NCT01753999|566901588|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
157040371|NCT01753999|566901589|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
157040372|NCT01753999|566901588|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
157040373|NCT01753999|566901589|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
157040374|NCT03890289|566901590|FG000|Overall Study|Adverse Event|1|||
157040375|NCT03890289|566901590|FG000|Overall Study|Physician Decision|1|||
157040376|NCT03890289|566901590|FG000|Overall Study|Lack of Efficacy|2|||
157040377|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
157040378|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
157040379|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
157040380|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
157040381|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
157040382|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
157040383|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
157040384|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
157040385|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
157040386|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
157040387|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
157040388|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
157040389|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
157040390|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
157040391|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
157040392|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
157040393|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
157040394|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
157040395|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
157040396|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
157040397|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
157040398|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
157040399|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
157040400|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
157040401|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
157040402|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
157040403|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
157040404|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
157040405|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
157040406|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
157040407|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
156966323|NCT02712905|566628029|FG009|Monotherapy|Study Terminated by Sponsor|2|||
156966324|NCT02712905|566628030|FG010|Monotherapy|Study Terminated by Sponsor|0|||
156966325|NCT02712905|566628031|FG011|Monotherapy|Study Terminated by Sponsor|0|||
156966326|NCT02712905|566628032|FG012|Monotherapy|Study Terminated by Sponsor|0|||
156966327|NCT02712905|566628033|FG013|Monotherapy|Study Terminated by Sponsor|0|||
156966328|NCT02712905|566628034|FG014|Monotherapy|Study Terminated by Sponsor|0|||
156966329|NCT02712905|566628035|FG015|Monotherapy|Study Terminated by Sponsor|0|||
156966330|NCT02712905|566628036|FG016|Monotherapy|Study Terminated by Sponsor|0|||
156966331|NCT02712905|566628037|FG017|Monotherapy|Study Terminated by Sponsor|0|||
156966332|NCT02712905|566628020|FG000|Monotherapy|Withdrawal by Subject|0|||
156966333|NCT02712905|566628021|FG001|Monotherapy|Withdrawal by Subject|0|||
156966334|NCT02712905|566628022|FG002|Monotherapy|Withdrawal by Subject|1|||
156966335|NCT02712905|566628023|FG003|Monotherapy|Withdrawal by Subject|0|||
156966336|NCT02712905|566628024|FG004|Monotherapy|Withdrawal by Subject|2|||
156966337|NCT02712905|566628025|FG005|Monotherapy|Withdrawal by Subject|0|||
156966338|NCT02712905|566628026|FG006|Monotherapy|Withdrawal by Subject|0|||
156966339|NCT02712905|566628027|FG007|Monotherapy|Withdrawal by Subject|0|||
156966340|NCT02712905|566628028|FG008|Monotherapy|Withdrawal by Subject|0|||
157040408|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
157172745|NCT04268303|567373412|FG001|Overall Study|Withdrawal by Subject|1|||
157172746|NCT04268303|567373413|FG002|Overall Study|Withdrawal by Subject|1|||
156966341|NCT02712905|566628029|FG009|Monotherapy|Withdrawal by Subject|4|||
156966342|NCT02712905|566628030|FG010|Monotherapy|Withdrawal by Subject|1|||
156966343|NCT02712905|566628031|FG011|Monotherapy|Withdrawal by Subject|2|||
156966344|NCT02712905|566628032|FG012|Monotherapy|Withdrawal by Subject|0|||
157172747|NCT04268303|567373411|FG000|Overall Study|Adverse Event|2|||
156966345|NCT02712905|566628033|FG013|Monotherapy|Withdrawal by Subject|0|||
157227914|NCT03365947|567579249|FG013|Overall Study|Lost to Follow-up|0|||
157227915|NCT03365947|567579250|FG014|Overall Study|Lost to Follow-up|0|||
157227916|NCT03365947|567579251|FG015|Overall Study|Lost to Follow-up|0|||
157227917|NCT03365947|567579252|FG016|Overall Study|Lost to Follow-up|0|||
157227918|NCT03365947|567579253|FG017|Overall Study|Lost to Follow-up|0|||
157227919|NCT03365947|567579254|FG018|Overall Study|Lost to Follow-up|0|||
157227920|NCT01611090|567579255|FG000|Randomized Period|Lost to Follow-up|8|||
157227921|NCT01611090|567579256|FG001|Randomized Period|Lost to Follow-up|3|||
157227922|NCT01611090|567579257|FG002|Randomized Period|Lost to Follow-up|0|||
157227923|NCT01611090|567579255|FG000|Randomized Period|Withdrawal by Subject|22|||
157227924|NCT01611090|567579256|FG001|Randomized Period|Withdrawal by Subject|26|||
157227925|NCT01611090|567579257|FG002|Randomized Period|Withdrawal by Subject|0|||
157227926|NCT01611090|567579255|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
157227927|NCT01611090|567579256|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
157227928|NCT01611090|567579257|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
157227929|NCT01611090|567579255|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
157227930|NCT01611090|567579256|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
157227931|NCT01611090|567579257|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
157227932|NCT00788125|567580920|FG000|Overall Study|Death|6|||
157227933|NCT02999178|567580928|FG000|Overall Study|Adverse Event|85|||
157227934|NCT02999178|567580929|FG001|Overall Study|Adverse Event|62|||
157227935|NCT02999178|567580928|FG000|Overall Study|Protocol Violation|1|||
157227936|NCT02999178|567580929|FG001|Overall Study|Protocol Violation|2|||
157227937|NCT02999178|567580928|FG000|Overall Study|Lost to Follow-up|0|||
157227938|NCT02999178|567580929|FG001|Overall Study|Lost to Follow-up|2|||
157227939|NCT02999178|567580928|FG000|Overall Study|Withdrawal by Subject|21|||
157227940|NCT02999178|567580929|FG001|Overall Study|Withdrawal by Subject|21|||
157227941|NCT02999178|567580928|FG000|Overall Study|Other reason not defined above|7|||
157227942|NCT02999178|567580929|FG001|Overall Study|Other reason not defined above|13|||
157227943|NCT02473640|567580940|FG000|Treatment Period 1|Adverse Event|1|||
157227944|NCT00977106|567580943|FG000|Overall Study|Adverse Event|5|||
157227945|NCT00977106|567580944|FG001|Overall Study|Adverse Event|6|||
157227946|NCT00977106|567580943|FG000|Overall Study|Withdrawal by Subject|2|||
157227947|NCT00977106|567580944|FG001|Overall Study|Withdrawal by Subject|2|||
157227948|NCT00977106|567580943|FG000|Overall Study|Lack of Efficacy|2|||
157227949|NCT00977106|567580944|FG001|Overall Study|Lack of Efficacy|2|||
157227950|NCT00977106|567580943|FG000|Overall Study|Protocol Violation|0|||
157227951|NCT00977106|567580944|FG001|Overall Study|Protocol Violation|1|||
157227952|NCT00977106|567580943|FG000|Overall Study|Other|1|||
157227953|NCT00977106|567580944|FG001|Overall Study|Other|0|||
157227954|NCT01439165|567580951|FG000|Overall Study|Protocol Violation|3|||
157172748|NCT04268303|567373412|FG001|Overall Study|Adverse Event|0|||
157172749|NCT04268303|567373413|FG002|Overall Study|Adverse Event|0|||
157172750|NCT00355134|567373414|FG000|Core Phase|Withdrawal by Subject|35|||
157172751|NCT00355134|567373415|FG001|Core Phase|Withdrawal by Subject|24|||
157172752|NCT00355134|567373416|FG002|Core Phase|Withdrawal by Subject|35|||
157172753|NCT00355134|567373417|FG003|Core Phase|Withdrawal by Subject|0|||
157172754|NCT00355134|567373418|FG004|Core Phase|Withdrawal by Subject|0|||
157172755|NCT00355134|567373414|FG000|Core Phase|Adverse Event|28|||
157172756|NCT00355134|567373415|FG001|Core Phase|Adverse Event|22|||
157172757|NCT00355134|567373416|FG002|Core Phase|Adverse Event|16|||
157172758|NCT00355134|567373417|FG003|Core Phase|Adverse Event|0|||
157172759|NCT00355134|567373418|FG004|Core Phase|Adverse Event|0|||
157172760|NCT00355134|567373414|FG000|Core Phase|Lost to Follow-up|17|||
157172761|NCT00355134|567373415|FG001|Core Phase|Lost to Follow-up|13|||
157172762|NCT00355134|567373416|FG002|Core Phase|Lost to Follow-up|21|||
157172763|NCT00355134|567373417|FG003|Core Phase|Lost to Follow-up|0|||
157172764|NCT00355134|567373418|FG004|Core Phase|Lost to Follow-up|0|||
157172765|NCT00355134|567373414|FG000|Core Phase|Abnormal laboratory value(s)|19|||
157227955|NCT01439165|567580952|FG001|Overall Study|Protocol Violation|0|||
157227956|NCT01439165|567580951|FG000|Overall Study|Lost to Follow-up|11|||
157227957|NCT01439165|567580952|FG001|Overall Study|Lost to Follow-up|1|||
157227958|NCT01439165|567580951|FG000|Overall Study|Withdrawal by Subject|7|||
157227959|NCT01439165|567580952|FG001|Overall Study|Withdrawal by Subject|1|||
157227960|NCT02419313|567580953|FG000|First Intervention|Lost to Follow-up|2|||
157227961|NCT02419313|567580954|FG001|First Intervention|Lost to Follow-up|0|||
157172766|NCT00355134|567373415|FG001|Core Phase|Abnormal laboratory value(s)|14|||
157227962|NCT02419313|567580953|FG000|Second Intervention|Lost to Follow-up|1|||
157227963|NCT02419313|567580954|FG001|Second Intervention|Lost to Follow-up|0|||
157227964|NCT04557124|567580956|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
157227965|NCT04557124|567580957|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
157227966|NCT04557124|567580956|FG000|Mid-point (1 Month)|Missed testing|5|||
157227967|NCT04557124|567580957|FG001|Mid-point (1 Month)|Missed testing|4|||
157172767|NCT00355134|567373416|FG002|Core Phase|Abnormal laboratory value(s)|2|||
157172768|NCT00355134|567373417|FG003|Core Phase|Abnormal laboratory value(s)|0|||
157172769|NCT00355134|567373418|FG004|Core Phase|Abnormal laboratory value(s)|0|||
157172770|NCT00355134|567373414|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
157040409|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
157040410|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
157040411|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
157040412|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
157040413|NCT02392234|566901597|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
157040414|NCT02392234|566901598|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
157040415|NCT02392234|566901599|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
157040416|NCT02392234|566901600|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
157040417|NCT02392234|566901601|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
157040418|NCT02392234|566901602|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
157040419|NCT02392234|566901597|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
157040420|NCT02392234|566901598|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
157040421|NCT02392234|566901599|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
157040422|NCT02392234|566901600|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
157040423|NCT02392234|566901601|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
157040424|NCT02392234|566901602|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
157040425|NCT02029235|566901603|FG000|Overall Study|Non-compliance with study meds or diary|4|||
157040426|NCT02029235|566901604|FG001|Overall Study|Non-compliance with study meds or diary|1|||
157040427|NCT02816398|566901610|FG000|Overall Study|Death|5|||
157040428|NCT02816398|566901610|FG000|Overall Study|Lack of Efficacy|8|||
157040429|NCT02816398|566901610|FG000|Overall Study|Lost to Follow-up|1|||
157040430|NCT01387516|566901611|FG000|Overall Study|Lost to Follow-up|4|||
157040431|NCT01387516|566901612|FG001|Overall Study|Lost to Follow-up|4|||
157040432|NCT01387516|566901613|FG002|Overall Study|Lost to Follow-up|2|||
157040433|NCT01387516|566901614|FG003|Overall Study|Lost to Follow-up|3|||
157040434|NCT01387516|566901611|FG000|Overall Study|Withdrawal by Subject|1|||
157040435|NCT01387516|566901612|FG001|Overall Study|Withdrawal by Subject|1|||
157040436|NCT01387516|566901613|FG002|Overall Study|Withdrawal by Subject|2|||
157040437|NCT01387516|566901614|FG003|Overall Study|Withdrawal by Subject|0|||
157040438|NCT01387516|566901611|FG000|Overall Study|Death|0|||
157040439|NCT01387516|566901612|FG001|Overall Study|Death|0|||
157040440|NCT01387516|566901613|FG002|Overall Study|Death|0|||
157040441|NCT01387516|566901614|FG003|Overall Study|Death|1|||
157040442|NCT03582475|566901615|FG000|Treatment Period|Withdrawal by Subject|0|||
157040443|NCT03582475|566901616|FG001|Treatment Period|Withdrawal by Subject|1|||
157040444|NCT03582475|566901615|FG000|Follow-up Period|Withdrawal by Subject|0|||
157040445|NCT03582475|566901616|FG001|Follow-up Period|Withdrawal by Subject|1|||
157040446|NCT03170648|566901622|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
157040447|NCT03170648|566901622|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
157040448|NCT02052440|566901623|FG000|Overall Study|Withdrawal by Subject|0|||
157040449|NCT02052440|566901624|FG001|Overall Study|Withdrawal by Subject|1|||
157040450|NCT03509909|566901625|FG000|Overall Study|Withdrawal by Subject|16|||
157040451|NCT03509909|566901626|FG001|Overall Study|Withdrawal by Subject|9|||
157040452|NCT03509909|566901625|FG000|Overall Study|Lost to Follow-up|3|||
157040453|NCT03509909|566901626|FG001|Overall Study|Lost to Follow-up|4|||
157040454|NCT03509909|566901625|FG000|Overall Study|Adverse Event|2|||
157040455|NCT03509909|566901626|FG001|Overall Study|Adverse Event|0|||
157040456|NCT01400958|566901627|FG000|Overall Study|Physician Decision|0|||
157040457|NCT01400958|566901628|FG001|Overall Study|Physician Decision|1|||
157172771|NCT00355134|567373415|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
157172772|NCT00355134|567373416|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
156966346|NCT02712905|566628034|FG014|Monotherapy|Withdrawal by Subject|0|||
156966347|NCT02712905|566628035|FG015|Monotherapy|Withdrawal by Subject|0|||
156966348|NCT02712905|566628036|FG016|Monotherapy|Withdrawal by Subject|0|||
156966349|NCT02712905|566628037|FG017|Monotherapy|Withdrawal by Subject|0|||
156966350|NCT02712905|566628020|FG000|Monotherapy|Started New Cancer Drug|0|||
156966351|NCT02712905|566628021|FG001|Monotherapy|Started New Cancer Drug|0|||
156966352|NCT02712905|566628022|FG002|Monotherapy|Started New Cancer Drug|0|||
156966353|NCT02712905|566628023|FG003|Monotherapy|Started New Cancer Drug|0|||
156966354|NCT02712905|566628024|FG004|Monotherapy|Started New Cancer Drug|0|||
156966355|NCT02712905|566628025|FG005|Monotherapy|Started New Cancer Drug|1|||
156966356|NCT02712905|566628026|FG006|Monotherapy|Started New Cancer Drug|0|||
156966357|NCT02712905|566628027|FG007|Monotherapy|Started New Cancer Drug|0|||
157040458|NCT01400958|566901627|FG000|Overall Study|Withdrawal by Subject|0|||
157040459|NCT01400958|566901628|FG001|Overall Study|Withdrawal by Subject|1|||
157040460|NCT01400958|566901627|FG000|Overall Study|Adverse Event|1|||
157040461|NCT01400958|566901628|FG001|Overall Study|Adverse Event|0|||
157040462|NCT04436289|566901629|FG000|Overall Study|Death prior to hospital discharge|8|||
157040463|NCT04436289|566901630|FG001|Overall Study|Death prior to hospital discharge|5|||
157040464|NCT04436289|566901631|FG002|Overall Study|Death prior to hospital discharge|0|||
157040465|NCT04436289|566901632|FG003|Overall Study|Death prior to hospital discharge|1|||
157040466|NCT04436289|566901629|FG000|Overall Study|Withdrawal by Subject|0|||
157040467|NCT04436289|566901630|FG001|Overall Study|Withdrawal by Subject|1|||
156966358|NCT02712905|566628028|FG008|Monotherapy|Started New Cancer Drug|0|||
156966359|NCT02712905|566628029|FG009|Monotherapy|Started New Cancer Drug|0|||
156966360|NCT02712905|566628030|FG010|Monotherapy|Started New Cancer Drug|0|||
156966361|NCT02712905|566628031|FG011|Monotherapy|Started New Cancer Drug|0|||
156966362|NCT02712905|566628032|FG012|Monotherapy|Started New Cancer Drug|0|||
156966363|NCT02712905|566628033|FG013|Monotherapy|Started New Cancer Drug|0|||
156966364|NCT02712905|566628034|FG014|Monotherapy|Started New Cancer Drug|0|||
156966365|NCT02712905|566628035|FG015|Monotherapy|Started New Cancer Drug|0|||
156966366|NCT02712905|566628036|FG016|Monotherapy|Started New Cancer Drug|0|||
156966367|NCT02712905|566628037|FG017|Monotherapy|Started New Cancer Drug|0|||
156966368|NCT02712905|566628020|FG000|Monotherapy|Adverse Event|0|||
156966369|NCT02712905|566628021|FG001|Monotherapy|Adverse Event|0|||
156966370|NCT02712905|566628022|FG002|Monotherapy|Adverse Event|0|||
156966371|NCT02712905|566628023|FG003|Monotherapy|Adverse Event|0|||
156966372|NCT02712905|566628024|FG004|Monotherapy|Adverse Event|0|||
156966373|NCT02712905|566628025|FG005|Monotherapy|Adverse Event|0|||
156966374|NCT02712905|566628026|FG006|Monotherapy|Adverse Event|0|||
156966375|NCT02712905|566628027|FG007|Monotherapy|Adverse Event|0|||
156966376|NCT02712905|566628028|FG008|Monotherapy|Adverse Event|1|||
156966377|NCT02712905|566628029|FG009|Monotherapy|Adverse Event|0|||
156966378|NCT02712905|566628030|FG010|Monotherapy|Adverse Event|0|||
156966379|NCT02712905|566628031|FG011|Monotherapy|Adverse Event|0|||
156966380|NCT02712905|566628032|FG012|Monotherapy|Adverse Event|0|||
156966381|NCT02712905|566628033|FG013|Monotherapy|Adverse Event|0|||
156966382|NCT02712905|566628034|FG014|Monotherapy|Adverse Event|0|||
156966383|NCT02712905|566628035|FG015|Monotherapy|Adverse Event|0|||
156966384|NCT02712905|566628036|FG016|Monotherapy|Adverse Event|0|||
156966385|NCT02712905|566628037|FG017|Monotherapy|Adverse Event|0|||
156966386|NCT02712905|566628020|FG000|Combination Therapy|Death|0|||
156966387|NCT02712905|566628021|FG001|Combination Therapy|Death|0|||
156966388|NCT02712905|566628022|FG002|Combination Therapy|Death|0|||
156966389|NCT02712905|566628023|FG003|Combination Therapy|Death|0|||
156966390|NCT02712905|566628024|FG004|Combination Therapy|Death|0|||
156966391|NCT02712905|566628025|FG005|Combination Therapy|Death|0|||
156966392|NCT02712905|566628026|FG006|Combination Therapy|Death|0|||
156966393|NCT02712905|566628027|FG007|Combination Therapy|Death|0|||
156966394|NCT02712905|566628028|FG008|Combination Therapy|Death|0|||
156966395|NCT02712905|566628029|FG009|Combination Therapy|Death|0|||
156966396|NCT02712905|566628030|FG010|Combination Therapy|Death|0|||
156966397|NCT02712905|566628031|FG011|Combination Therapy|Death|0|||
156966398|NCT02712905|566628032|FG012|Combination Therapy|Death|5|||
156966399|NCT02712905|566628033|FG013|Combination Therapy|Death|6|||
156966400|NCT02712905|566628034|FG014|Combination Therapy|Death|1|||
156966401|NCT02712905|566628035|FG015|Combination Therapy|Death|3|||
156966402|NCT02712905|566628036|FG016|Combination Therapy|Death|1|||
156966403|NCT02712905|566628037|FG017|Combination Therapy|Death|3|||
156966404|NCT02712905|566628020|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
156966405|NCT02712905|566628021|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
156966406|NCT02712905|566628022|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
156966407|NCT02712905|566628023|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
156966408|NCT02712905|566628024|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
156966409|NCT02712905|566628025|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
156966410|NCT02712905|566628026|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
156966411|NCT02712905|566628027|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
156966412|NCT02712905|566628028|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
156966413|NCT02712905|566628029|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
156966414|NCT02712905|566628030|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
156966415|NCT02712905|566628031|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
156966416|NCT02712905|566628032|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
156966417|NCT02712905|566628033|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
156966418|NCT02712905|566628034|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
156966419|NCT02712905|566628035|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
156966420|NCT02712905|566628036|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
156966421|NCT02712905|566628037|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
156966422|NCT02712905|566628020|FG000|Combination Therapy|Withdrawal by Subject|0|||
156966423|NCT02712905|566628021|FG001|Combination Therapy|Withdrawal by Subject|0|||
156966424|NCT02712905|566628022|FG002|Combination Therapy|Withdrawal by Subject|0|||
156966425|NCT02712905|566628023|FG003|Combination Therapy|Withdrawal by Subject|0|||
156966426|NCT02712905|566628024|FG004|Combination Therapy|Withdrawal by Subject|0|||
156966427|NCT02712905|566628025|FG005|Combination Therapy|Withdrawal by Subject|0|||
156966428|NCT02712905|566628026|FG006|Combination Therapy|Withdrawal by Subject|0|||
156966429|NCT02712905|566628027|FG007|Combination Therapy|Withdrawal by Subject|0|||
156966430|NCT02712905|566628028|FG008|Combination Therapy|Withdrawal by Subject|0|||
156966431|NCT02712905|566628029|FG009|Combination Therapy|Withdrawal by Subject|0|||
156966432|NCT02712905|566628030|FG010|Combination Therapy|Withdrawal by Subject|0|||
156966433|NCT02712905|566628031|FG011|Combination Therapy|Withdrawal by Subject|0|||
156966434|NCT02712905|566628032|FG012|Combination Therapy|Withdrawal by Subject|0|||
156966435|NCT02712905|566628033|FG013|Combination Therapy|Withdrawal by Subject|0|||
156966436|NCT02712905|566628034|FG014|Combination Therapy|Withdrawal by Subject|0|||
156966437|NCT02712905|566628035|FG015|Combination Therapy|Withdrawal by Subject|1|||
156966438|NCT02712905|566628036|FG016|Combination Therapy|Withdrawal by Subject|0|||
156966439|NCT02712905|566628037|FG017|Combination Therapy|Withdrawal by Subject|2|||
156966440|NCT02712905|566628020|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966441|NCT02712905|566628021|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966442|NCT02712905|566628022|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966443|NCT02712905|566628023|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966444|NCT02712905|566628024|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966445|NCT02712905|566628025|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966446|NCT02712905|566628026|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966447|NCT02712905|566628027|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966448|NCT02712905|566628028|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966449|NCT02712905|566628029|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966450|NCT02712905|566628030|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966451|NCT02712905|566628031|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966452|NCT02712905|566628032|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966453|NCT02712905|566628033|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966454|NCT02712905|566628034|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966455|NCT02712905|566628035|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
156966456|NCT02712905|566628036|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966457|NCT02712905|566628037|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
156966458|NCT03178266|566628040|FG000|Overall Study|Death|0|||
156966459|NCT03178266|566628041|FG001|Overall Study|Death|1|||
156966460|NCT03178266|566628040|FG000|Overall Study|Disont. Early|0|||
156966461|NCT03178266|566628041|FG001|Overall Study|Disont. Early|1|||
156966462|NCT03178266|566628040|FG000|Overall Study|Withdrawal by Subject|0|||
156966463|NCT03178266|566628041|FG001|Overall Study|Withdrawal by Subject|2|||
156966464|NCT01812655|566628042|FG000|Overall Study|Protocol Violation|1|||
156966465|NCT01812655|566628043|FG001|Overall Study|Protocol Violation|1|||
156966466|NCT01812655|566628044|FG002|Overall Study|Protocol Violation|0|||
156966467|NCT02363946|566628045|FG000|Overall Study|Lost to Follow-up|0|||
156966468|NCT02363946|566628046|FG001|Overall Study|Lost to Follow-up|0|||
156966469|NCT02363946|566628047|FG002|Overall Study|Lost to Follow-up|0|||
156966470|NCT02363946|566628048|FG003|Overall Study|Lost to Follow-up|0|||
156966471|NCT02363946|566628049|FG004|Overall Study|Lost to Follow-up|0|||
156966472|NCT02363946|566628050|FG005|Overall Study|Lost to Follow-up|0|||
156966473|NCT02363946|566628051|FG006|Overall Study|Lost to Follow-up|0|||
156966474|NCT02363946|566628052|FG007|Overall Study|Lost to Follow-up|1|||
156966475|NCT02363946|566628053|FG008|Overall Study|Lost to Follow-up|0|||
156966476|NCT02363946|566628054|FG009|Overall Study|Lost to Follow-up|0|||
156966477|NCT02363946|566628055|FG010|Overall Study|Lost to Follow-up|0|||
156966478|NCT02363946|566628056|FG011|Overall Study|Lost to Follow-up|0|||
156966479|NCT02363946|566628057|FG012|Overall Study|Lost to Follow-up|0|||
156966480|NCT04435665|566628058|FG000|Overall Study|Lost to Follow-up|0|||
156966481|NCT04435665|566628059|FG001|Overall Study|Lost to Follow-up|0|||
156966482|NCT04435665|566628060|FG002|Overall Study|Lost to Follow-up|0|||
156966483|NCT04435665|566628061|FG003|Overall Study|Lost to Follow-up|1|||
156966484|NCT00419263|566628062|FG000|Overall Study|Lost to Follow-up|2|||
156966485|NCT00419263|566628063|FG001|Overall Study|Lost to Follow-up|1|||
156966486|NCT00419263|566628064|FG002|Overall Study|Lost to Follow-up|1|||
156966487|NCT00419263|566628062|FG000|Overall Study|Randomized in Error, Not Treated|1|||
156966488|NCT00419263|566628063|FG001|Overall Study|Randomized in Error, Not Treated|1|||
156966489|NCT00419263|566628064|FG002|Overall Study|Randomized in Error, Not Treated|0|||
156966490|NCT00419263|566628062|FG000|Overall Study|Adverse Event|0|||
156966491|NCT00419263|566628063|FG001|Overall Study|Adverse Event|0|||
156966492|NCT00419263|566628064|FG002|Overall Study|Adverse Event|1|||
156966493|NCT00419263|566628062|FG000|Overall Study|Withdrawal by Subject|0|||
156966494|NCT00419263|566628063|FG001|Overall Study|Withdrawal by Subject|0|||
156966495|NCT00419263|566628064|FG002|Overall Study|Withdrawal by Subject|1|||
156966496|NCT02342886|566628065|FG000|Overall Study|Treatment non-compliance|1|||
156966497|NCT02342886|566628066|FG001|Overall Study|Treatment non-compliance|0|||
156966498|NCT02342886|566628067|FG002|Overall Study|Treatment non-compliance|0|||
156966499|NCT02342886|566628068|FG003|Overall Study|Treatment non-compliance|1|||
156966500|NCT02342886|566628069|FG004|Overall Study|Treatment non-compliance|0|||
156966501|NCT02342886|566628065|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
156966502|NCT02342886|566628066|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
156966503|NCT02342886|566628067|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
156966504|NCT02342886|566628068|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
157172773|NCT00355134|567373417|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
156966505|NCT02342886|566628069|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
156966506|NCT02342886|566628065|FG000|Overall Study|Adverse event/specific toxicity|4|||
156966507|NCT02342886|566628066|FG001|Overall Study|Adverse event/specific toxicity|3|||
156966508|NCT02342886|566628067|FG002|Overall Study|Adverse event/specific toxicity|11|||
156966509|NCT02342886|566628068|FG003|Overall Study|Adverse event/specific toxicity|2|||
156966510|NCT02342886|566628069|FG004|Overall Study|Adverse event/specific toxicity|1|||
156966511|NCT02342886|566628065|FG000|Overall Study|Lost to Follow-up|1|||
156966512|NCT02342886|566628066|FG001|Overall Study|Lost to Follow-up|0|||
156966513|NCT02342886|566628067|FG002|Overall Study|Lost to Follow-up|0|||
156966514|NCT02342886|566628068|FG003|Overall Study|Lost to Follow-up|0|||
156966515|NCT02342886|566628069|FG004|Overall Study|Lost to Follow-up|0|||
156966516|NCT02342886|566628065|FG000|Overall Study|Death|1|||
156966517|NCT02342886|566628066|FG001|Overall Study|Death|2|||
156966518|NCT02342886|566628067|FG002|Overall Study|Death|1|||
156966519|NCT02342886|566628068|FG003|Overall Study|Death|0|||
156966520|NCT02342886|566628069|FG004|Overall Study|Death|1|||
156966521|NCT02342886|566628065|FG000|Overall Study|Withdrawal by Subject|0|||
156966522|NCT02342886|566628066|FG001|Overall Study|Withdrawal by Subject|1|||
156966523|NCT02342886|566628067|FG002|Overall Study|Withdrawal by Subject|0|||
156966524|NCT02342886|566628068|FG003|Overall Study|Withdrawal by Subject|1|||
156966525|NCT02342886|566628069|FG004|Overall Study|Withdrawal by Subject|0|||
156966526|NCT02342886|566628065|FG000|Overall Study|Investigator/sponsor decision|0|||
156966527|NCT02342886|566628066|FG001|Overall Study|Investigator/sponsor decision|2|||
156966528|NCT02342886|566628067|FG002|Overall Study|Investigator/sponsor decision|0|||
156966529|NCT02342886|566628068|FG003|Overall Study|Investigator/sponsor decision|3|||
156966530|NCT02342886|566628069|FG004|Overall Study|Investigator/sponsor decision|1|||
156966531|NCT02342886|566628065|FG000|Overall Study|Pregnancy|0|||
156966532|NCT02342886|566628066|FG001|Overall Study|Pregnancy|0|||
156966533|NCT02342886|566628067|FG002|Overall Study|Pregnancy|2|||
156966534|NCT02342886|566628068|FG003|Overall Study|Pregnancy|0|||
156966535|NCT02342886|566628069|FG004|Overall Study|Pregnancy|0|||
156966536|NCT02342886|566628065|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156966537|NCT02342886|566628066|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156966538|NCT02342886|566628067|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
156966539|NCT02342886|566628068|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156966540|NCT02342886|566628069|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
156966541|NCT02342886|566628065|FG000|Overall Study|Protocol Violation|0|||
156966542|NCT02342886|566628066|FG001|Overall Study|Protocol Violation|0|||
156966543|NCT02342886|566628067|FG002|Overall Study|Protocol Violation|0|||
156966544|NCT02342886|566628068|FG003|Overall Study|Protocol Violation|2|||
156966545|NCT02342886|566628069|FG004|Overall Study|Protocol Violation|0|||
156966546|NCT00862134|566628073|FG000|Overall Study|Death|1|||
156966547|NCT00862134|566628074|FG001|Overall Study|Death|0|||
156966548|NCT00862134|566628073|FG000|Overall Study|Physician Decision|0|||
156966549|NCT00862134|566628074|FG001|Overall Study|Physician Decision|1|||
156966550|NCT00862134|566628073|FG000|Overall Study|Withdrawal by Subject|1|||
156966551|NCT00862134|566628074|FG001|Overall Study|Withdrawal by Subject|2|||
156966552|NCT00862134|566628073|FG000|Overall Study|Sponsor terminated study|5|||
156966553|NCT00862134|566628074|FG001|Overall Study|Sponsor terminated study|7|||
156966554|NCT00862134|566628073|FG000|Overall Study|Adverse Event|2|||
156966555|NCT00862134|566628074|FG001|Overall Study|Adverse Event|2|||
156966556|NCT00862134|566628073|FG000|Overall Study|Withdrew prior to dosing|2|||
156966557|NCT00862134|566628074|FG001|Overall Study|Withdrew prior to dosing|0|||
156966558|NCT00765674|566628075|FG000|Overall Study|Adverse Event|7|||
156966559|NCT00765674|566628076|FG001|Overall Study|Adverse Event|2|||
156966560|NCT00765674|566628077|FG002|Overall Study|Adverse Event|8|||
156966561|NCT00765674|566628078|FG003|Overall Study|Adverse Event|11|||
156966562|NCT00765674|566628075|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
156966563|NCT00765674|566628076|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
156966564|NCT00765674|566628077|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
156966565|NCT00765674|566628078|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
156966566|NCT00765674|566628075|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
156966567|NCT00765674|566628076|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
156966568|NCT00765674|566628077|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
156966569|NCT00765674|566628078|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
156966570|NCT00765674|566628075|FG000|Overall Study|Lack of Efficacy|2|||
156966571|NCT00765674|566628076|FG001|Overall Study|Lack of Efficacy|3|||
156966572|NCT00765674|566628077|FG002|Overall Study|Lack of Efficacy|1|||
156966573|NCT00765674|566628078|FG003|Overall Study|Lack of Efficacy|2|||
156966574|NCT00765674|566628075|FG000|Overall Study|Protocol Violation|2|||
156966575|NCT00765674|566628076|FG001|Overall Study|Protocol Violation|0|||
156966576|NCT00765674|566628077|FG002|Overall Study|Protocol Violation|1|||
156966577|NCT00765674|566628078|FG003|Overall Study|Protocol Violation|0|||
156966578|NCT00765674|566628075|FG000|Overall Study|Withdrawal by Subject|5|||
156966579|NCT00765674|566628076|FG001|Overall Study|Withdrawal by Subject|7|||
156966580|NCT00765674|566628077|FG002|Overall Study|Withdrawal by Subject|3|||
156966581|NCT00765674|566628078|FG003|Overall Study|Withdrawal by Subject|8|||
157172774|NCT00355134|567373418|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
157172775|NCT00355134|567373414|FG000|Core Phase|Administrative problems|5|||
157172776|NCT00355134|567373415|FG001|Core Phase|Administrative problems|3|||
157172777|NCT00355134|567373416|FG002|Core Phase|Administrative problems|5|||
157172778|NCT00355134|567373417|FG003|Core Phase|Administrative problems|0|||
157172779|NCT00355134|567373418|FG004|Core Phase|Administrative problems|0|||
156966582|NCT00765674|566628075|FG000|Overall Study|Lost to Follow-up|4|||
156966583|NCT00765674|566628076|FG001|Overall Study|Lost to Follow-up|6|||
156966584|NCT00765674|566628077|FG002|Overall Study|Lost to Follow-up|2|||
156966585|NCT00765674|566628078|FG003|Overall Study|Lost to Follow-up|1|||
156966586|NCT00765674|566628075|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
156966587|NCT00765674|566628076|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
156966588|NCT00765674|566628077|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
156966589|NCT00765674|566628078|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
156966590|NCT01813474|566628084|FG000|Overall Study|Withdrawal by Subject|0|||
156966591|NCT01813474|566628085|FG001|Overall Study|Withdrawal by Subject|0|||
156966592|NCT01813474|566628086|FG002|Overall Study|Withdrawal by Subject|1|||
156966593|NCT01813474|566628084|FG000|Overall Study|Adverse Event|1|||
156966594|NCT01813474|566628085|FG001|Overall Study|Adverse Event|1|||
156966595|NCT01813474|566628086|FG002|Overall Study|Adverse Event|0|||
156966596|NCT01813474|566628084|FG000|Overall Study|Lack of Efficacy|2|||
156966597|NCT01813474|566628085|FG001|Overall Study|Lack of Efficacy|6|||
156966598|NCT01813474|566628086|FG002|Overall Study|Lack of Efficacy|9|||
156966599|NCT01813474|566628084|FG000|Overall Study|Death|0|||
156966600|NCT01813474|566628085|FG001|Overall Study|Death|0|||
156966601|NCT01813474|566628086|FG002|Overall Study|Death|1|||
156966602|NCT03015402|566628087|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
156966603|NCT03015402|566628088|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
156966604|NCT03015402|566628087|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
156966605|NCT03015402|566628088|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
156966606|NCT00316082|566628089|FG000|Overall Study|Lack of Efficacy|2|||
156966607|NCT00316082|566628090|FG001|Overall Study|Lack of Efficacy|3|||
156966608|NCT00316082|566628091|FG002|Overall Study|Lack of Efficacy|3|||
156966609|NCT00316082|566628092|FG003|Overall Study|Lack of Efficacy|4|||
156966610|NCT00316082|566628093|FG004|Overall Study|Lack of Efficacy|6|||
156966611|NCT00316082|566628089|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
156966612|NCT00316082|566628090|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
156966613|NCT00316082|566628091|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
156966614|NCT00316082|566628092|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
156966615|NCT00316082|566628093|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
156966616|NCT00316082|566628089|FG000|Overall Study|Lost to Follow-up|7|||
156966617|NCT00316082|566628090|FG001|Overall Study|Lost to Follow-up|6|||
156966618|NCT00316082|566628091|FG002|Overall Study|Lost to Follow-up|7|||
156966619|NCT00316082|566628092|FG003|Overall Study|Lost to Follow-up|8|||
156966620|NCT00316082|566628093|FG004|Overall Study|Lost to Follow-up|6|||
156966621|NCT00316082|566628089|FG000|Overall Study|Poor/noncompliance|6|||
156966622|NCT00316082|566628090|FG001|Overall Study|Poor/noncompliance|1|||
156966623|NCT00316082|566628091|FG002|Overall Study|Poor/noncompliance|4|||
156966624|NCT00316082|566628092|FG003|Overall Study|Poor/noncompliance|1|||
156966625|NCT00316082|566628093|FG004|Overall Study|Poor/noncompliance|4|||
156966626|NCT00316082|566628089|FG000|Overall Study|Adverse Event|4|||
156966627|NCT00316082|566628090|FG001|Overall Study|Adverse Event|2|||
156966628|NCT00316082|566628091|FG002|Overall Study|Adverse Event|5|||
156966629|NCT00316082|566628092|FG003|Overall Study|Adverse Event|1|||
156966630|NCT00316082|566628093|FG004|Overall Study|Adverse Event|3|||
156966631|NCT00316082|566628089|FG000|Overall Study|Subject no longer meets study criteria|3|||
156966632|NCT00316082|566628090|FG001|Overall Study|Subject no longer meets study criteria|1|||
156966633|NCT00316082|566628091|FG002|Overall Study|Subject no longer meets study criteria|2|||
156966634|NCT00316082|566628092|FG003|Overall Study|Subject no longer meets study criteria|2|||
156966635|NCT00316082|566628093|FG004|Overall Study|Subject no longer meets study criteria|1|||
156966636|NCT00316082|566628089|FG000|Overall Study|Physician Decision|1|||
156966637|NCT00316082|566628090|FG001|Overall Study|Physician Decision|1|||
156966638|NCT00316082|566628091|FG002|Overall Study|Physician Decision|2|||
156966639|NCT00316082|566628092|FG003|Overall Study|Physician Decision|1|||
156966640|NCT00316082|566628093|FG004|Overall Study|Physician Decision|1|||
157172780|NCT00355134|567373414|FG000|Core Phase|Protocol Violation|3|||
157172781|NCT00355134|567373415|FG001|Core Phase|Protocol Violation|2|||
156966641|NCT00316082|566628089|FG000|Overall Study|Death|0|||
156966642|NCT00316082|566628090|FG001|Overall Study|Death|0|||
156966643|NCT00316082|566628091|FG002|Overall Study|Death|1|||
156966644|NCT00316082|566628092|FG003|Overall Study|Death|0|||
156966645|NCT00316082|566628093|FG004|Overall Study|Death|0|||
156966646|NCT00316082|566628089|FG000|Overall Study|Administrative reason by sponsor|0|||
156966647|NCT00316082|566628090|FG001|Overall Study|Administrative reason by sponsor|0|||
156966648|NCT00316082|566628091|FG002|Overall Study|Administrative reason by sponsor|1|||
156966649|NCT00316082|566628092|FG003|Overall Study|Administrative reason by sponsor|0|||
156966650|NCT00316082|566628093|FG004|Overall Study|Administrative reason by sponsor|0|||
157040468|NCT04436289|566901631|FG002|Overall Study|Withdrawal by Subject|4|||
157040469|NCT04436289|566901632|FG003|Overall Study|Withdrawal by Subject|0|||
157040470|NCT04436289|566901629|FG000|Overall Study|Extended hospital stay|0|||
157040471|NCT04436289|566901630|FG001|Overall Study|Extended hospital stay|1|||
157040472|NCT04436289|566901631|FG002|Overall Study|Extended hospital stay|0|||
157040473|NCT04436289|566901632|FG003|Overall Study|Extended hospital stay|0|||
157040474|NCT04436289|566901629|FG000|Overall Study|Lost to Follow-up|0|||
156966651|NCT00528775|566628094|FG000|Overall Study|Other not specified|1|||
156966652|NCT02216773|566628095|FG000|Overall Study|Disease progression|4|||
156966653|NCT02216773|566628096|FG001|Overall Study|Disease progression|2|||
156966654|NCT02216773|566628095|FG000|Overall Study|Insufficient FLRV|4|||
156966655|NCT02216773|566628096|FG001|Overall Study|Insufficient FLRV|0|||
156966656|NCT02216773|566628095|FG000|Overall Study|Abandoned|4|||
156966657|NCT02216773|566628096|FG001|Overall Study|Abandoned|3|||
157040475|NCT04436289|566901630|FG001|Overall Study|Lost to Follow-up|4|||
157040476|NCT04436289|566901631|FG002|Overall Study|Lost to Follow-up|1|||
157040477|NCT04436289|566901632|FG003|Overall Study|Lost to Follow-up|3|||
157040478|NCT04801420|566901635|FG000|Overall Study|Other|1|||
157040479|NCT04801420|566901636|FG001|Overall Study|Other|2|||
157040480|NCT04801420|566901637|FG002|Overall Study|Other|1|||
157040481|NCT04801420|566901635|FG000|Overall Study|Lost to Follow-up|7|||
157040482|NCT04801420|566901636|FG001|Overall Study|Lost to Follow-up|9|||
157040483|NCT04801420|566901637|FG002|Overall Study|Lost to Follow-up|10|||
157040484|NCT04801420|566901635|FG000|Overall Study|Moved from study area|0|||
157040485|NCT04801420|566901636|FG001|Overall Study|Moved from study area|1|||
157040486|NCT04801420|566901637|FG002|Overall Study|Moved from study area|1|||
157040487|NCT04801420|566901635|FG000|Overall Study|Withdrawal by Subject|5|||
157040488|NCT04801420|566901636|FG001|Overall Study|Withdrawal by Subject|1|||
157040489|NCT04801420|566901637|FG002|Overall Study|Withdrawal by Subject|4|||
157040490|NCT04801420|566901635|FG000|Overall Study|Individual stopping criteria reached|0|||
157040491|NCT04801420|566901636|FG001|Overall Study|Individual stopping criteria reached|1|||
157040492|NCT04801420|566901637|FG002|Overall Study|Individual stopping criteria reached|0|||
157040493|NCT04801420|566901635|FG000|Overall Study|Ongoing in the study|195|||
157040494|NCT04801420|566901636|FG001|Overall Study|Ongoing in the study|195|||
157040495|NCT04801420|566901637|FG002|Overall Study|Ongoing in the study|192|||
157040496|NCT03598907|566901638|FG000|Overall Study|Physician Decision|14|||
157040497|NCT03598907|566901639|FG001|Overall Study|Physician Decision|19|||
157040498|NCT03211247|566901642|FG000|Overall Study|Adverse Event|8|||
157040499|NCT03211247|566901643|FG001|Overall Study|Adverse Event|0|||
157040500|NCT03211247|566901644|FG002|Overall Study|Adverse Event|1|||
157040501|NCT03211247|566901645|FG003|Overall Study|Adverse Event|0|||
157040502|NCT03211247|566901646|FG004|Overall Study|Adverse Event|0|||
157040503|NCT03211247|566901642|FG000|Overall Study|Lost to Follow-up|2|||
157040504|NCT03211247|566901643|FG001|Overall Study|Lost to Follow-up|1|||
157040505|NCT03211247|566901644|FG002|Overall Study|Lost to Follow-up|0|||
157040506|NCT03211247|566901645|FG003|Overall Study|Lost to Follow-up|0|||
157040507|NCT03211247|566901646|FG004|Overall Study|Lost to Follow-up|0|||
157040508|NCT03211247|566901642|FG000|Overall Study|Physician Decision|1|||
157040509|NCT03211247|566901643|FG001|Overall Study|Physician Decision|2|||
157040510|NCT03211247|566901644|FG002|Overall Study|Physician Decision|0|||
157040511|NCT03211247|566901645|FG003|Overall Study|Physician Decision|0|||
157040512|NCT03211247|566901646|FG004|Overall Study|Physician Decision|0|||
157040513|NCT03211247|566901642|FG000|Overall Study|Non-compliance with study drug|2|||
157040514|NCT03211247|566901643|FG001|Overall Study|Non-compliance with study drug|0|||
157040515|NCT03211247|566901644|FG002|Overall Study|Non-compliance with study drug|0|||
157040516|NCT03211247|566901645|FG003|Overall Study|Non-compliance with study drug|0|||
157040517|NCT03211247|566901646|FG004|Overall Study|Non-compliance with study drug|0|||
157040518|NCT03211247|566901642|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
157040519|NCT03211247|566901643|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
157040520|NCT03211247|566901644|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
157040521|NCT03211247|566901645|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
157040522|NCT03211247|566901646|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
156966658|NCT00540124|566628099|FG000|Overall Study|Adverse Event|0|||
156966659|NCT00540124|566628100|FG001|Overall Study|Adverse Event|2|||
156966660|NCT00540124|566628101|FG002|Overall Study|Adverse Event|1|||
157040523|NCT03211247|566901642|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
157040524|NCT03211247|566901643|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
157040525|NCT03211247|566901644|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
157040526|NCT03211247|566901645|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
157040527|NCT03211247|566901646|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
157040528|NCT03211247|566901642|FG000|Overall Study|Protocol Violation|0|||
157040529|NCT03211247|566901643|FG001|Overall Study|Protocol Violation|1|||
157040530|NCT03211247|566901644|FG002|Overall Study|Protocol Violation|0|||
157040531|NCT03211247|566901645|FG003|Overall Study|Protocol Violation|0|||
156966661|NCT00540124|566628099|FG000|Overall Study|Entry Criteria Not Met|2|||
156966662|NCT00540124|566628100|FG001|Overall Study|Entry Criteria Not Met|0|||
156966663|NCT00540124|566628101|FG002|Overall Study|Entry Criteria Not Met|0|||
156966664|NCT00540124|566628099|FG000|Overall Study|Lack of Efficacy|1|||
156966665|NCT00540124|566628100|FG001|Overall Study|Lack of Efficacy|0|||
156966666|NCT00540124|566628101|FG002|Overall Study|Lack of Efficacy|0|||
156966667|NCT00540124|566628099|FG000|Overall Study|Withdrawal by Subject|1|||
156966668|NCT00540124|566628100|FG001|Overall Study|Withdrawal by Subject|1|||
156966669|NCT00540124|566628101|FG002|Overall Study|Withdrawal by Subject|0|||
156966670|NCT02124265|566628111|FG000|Overall Study|Adverse Event|1|||
156966671|NCT00058123|566628113|FG000|Overall Study|Wrong histology|9|||
156966672|NCT00058123|566628113|FG000|Overall Study|Received >3 prior treatments|1|||
156966673|NCT01298999|566628116|FG000|Overall Study|Physician Decision|0|||
156966674|NCT01298999|566628117|FG001|Overall Study|Physician Decision|1|||
156966675|NCT01298999|566628116|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
156966676|NCT01298999|566628117|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
156966677|NCT02816138|566628120|FG000|Overall Study|Adverse Event|1|||
156966678|NCT04839965|566628121|FG000|Overall Study|Death|6|||
156966679|NCT04839965|566628122|FG001|Overall Study|Death|6|||
156966680|NCT04839965|566628121|FG000|Overall Study|Lost to Follow-up|1|||
156966681|NCT04839965|566628122|FG001|Overall Study|Lost to Follow-up|0|||
156966682|NCT02291679|566628123|FG000|Overall Study|Adverse Event|2|||
156966683|NCT02291679|566628124|FG001|Overall Study|Adverse Event|12|||
156966684|NCT02291679|566628125|FG002|Overall Study|Adverse Event|19|||
156966685|NCT02291679|566628123|FG000|Overall Study|Protocol Violation|5|||
156966686|NCT02291679|566628124|FG001|Overall Study|Protocol Violation|1|||
156966687|NCT02291679|566628125|FG002|Overall Study|Protocol Violation|7|||
156966688|NCT02291679|566628123|FG000|Overall Study|Withdrew Consent|18|||
156966689|NCT02291679|566628124|FG001|Overall Study|Withdrew Consent|10|||
156966690|NCT02291679|566628125|FG002|Overall Study|Withdrew Consent|15|||
156966691|NCT02291679|566628123|FG000|Overall Study|Lost to Follow-up|12|||
156966692|NCT02291679|566628124|FG001|Overall Study|Lost to Follow-up|10|||
156966693|NCT02291679|566628125|FG002|Overall Study|Lost to Follow-up|9|||
156966694|NCT02291679|566628123|FG000|Overall Study|Insufficient Therapeutic Response|5|||
156966695|NCT02291679|566628124|FG001|Overall Study|Insufficient Therapeutic Response|5|||
156966696|NCT02291679|566628125|FG002|Overall Study|Insufficient Therapeutic Response|7|||
156966697|NCT02291679|566628123|FG000|Overall Study|Other|2|||
156966698|NCT02291679|566628124|FG001|Overall Study|Other|4|||
156966699|NCT02291679|566628125|FG002|Overall Study|Other|2|||
156966700|NCT02532179|566629780|FG000|Overall Study|Lost to Follow-up|1|||
156966701|NCT02532179|566629780|FG000|Overall Study|Pregnancy|1|||
156966702|NCT02532179|566629780|FG000|Overall Study|Subject received depot steroid injection|1|||
156966703|NCT01337674|566629784|FG000|Treatment Period 1|Adverse Event|0|||
156966704|NCT01337674|566629785|FG001|Treatment Period 1|Adverse Event|1|||
156966705|NCT01337674|566629786|FG002|Treatment Period 1|Adverse Event|0|||
156966706|NCT01337674|566629787|FG003|Treatment Period 1|Adverse Event|0|||
156966707|NCT01337674|566629784|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
156966708|NCT01337674|566629785|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
156966709|NCT01337674|566629786|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
156966710|NCT01337674|566629787|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
156966711|NCT01337674|566629784|FG000|Treatment Period 2|Withdrawal by Subject|0|||
156966712|NCT01337674|566629785|FG001|Treatment Period 2|Withdrawal by Subject|0|||
156966713|NCT01337674|566629786|FG002|Treatment Period 2|Withdrawal by Subject|1|||
156966714|NCT01337674|566629787|FG003|Treatment Period 2|Withdrawal by Subject|0|||
156966715|NCT00119405|566629788|FG000|Overall Study|Withdrawal by Subject|1|||
156966716|NCT00939484|566629789|FG000|Overall Study|Progression/Relapse|8|||
156966717|NCT00939484|566629790|FG001|Overall Study|Progression/Relapse|20|||
156966718|NCT00939484|566629791|FG002|Overall Study|Progression/Relapse|3|||
156966719|NCT04233372|566629792|FG000|Overall Study|Lost to Follow-up|104|||
156966720|NCT04233372|566629792|FG000|Overall Study|Adverse Event|8|||
156966721|NCT04233372|566629792|FG000|Overall Study|Withdrawal by Subject|2|||
156966722|NCT04958785|566629793|FG000|Overall Study|Study Terminated by Sponsor|4|||
156966723|NCT04958785|566629794|FG001|Overall Study|Study Terminated by Sponsor|10|||
156966724|NCT04958785|566629795|FG002|Overall Study|Study Terminated by Sponsor|7|||
156966725|NCT04958785|566629796|FG003|Overall Study|Study Terminated by Sponsor|6|||
157172782|NCT00355134|567373416|FG002|Core Phase|Protocol Violation|2|||
157172783|NCT00355134|567373417|FG003|Core Phase|Protocol Violation|0|||
157172784|NCT00355134|567373418|FG004|Core Phase|Protocol Violation|0|||
157172785|NCT00355134|567373414|FG000|Core Phase|Abnormal test procedure result(s)|1|||
157172786|NCT00355134|567373415|FG001|Core Phase|Abnormal test procedure result(s)|2|||
157172787|NCT00355134|567373416|FG002|Core Phase|Abnormal test procedure result(s)|1|||
156966726|NCT04958785|566629797|FG004|Overall Study|Study Terminated by Sponsor|34|||
156966727|NCT04958785|566629793|FG000|Overall Study|Death|2|||
156966728|NCT04958785|566629794|FG001|Overall Study|Death|3|||
156966729|NCT04958785|566629795|FG002|Overall Study|Death|4|||
156966730|NCT04958785|566629796|FG003|Overall Study|Death|5|||
156966731|NCT04958785|566629797|FG004|Overall Study|Death|5|||
156966732|NCT04958785|566629793|FG000|Overall Study|Withdrew consent|2|||
156966733|NCT04958785|566629794|FG001|Overall Study|Withdrew consent|0|||
156966734|NCT04958785|566629795|FG002|Overall Study|Withdrew consent|3|||
156966735|NCT04958785|566629796|FG003|Overall Study|Withdrew consent|1|||
156966736|NCT04958785|566629797|FG004|Overall Study|Withdrew consent|0|||
156966737|NCT04958785|566629793|FG000|Overall Study|Investigator's discretion|0|||
156966738|NCT04958785|566629794|FG001|Overall Study|Investigator's discretion|1|||
156966739|NCT04958785|566629795|FG002|Overall Study|Investigator's discretion|0|||
156966740|NCT04958785|566629796|FG003|Overall Study|Investigator's discretion|1|||
156966741|NCT04958785|566629797|FG004|Overall Study|Investigator's discretion|2|||
156966742|NCT04958785|566629793|FG000|Overall Study|Adverse Event|0|||
156966743|NCT04958785|566629794|FG001|Overall Study|Adverse Event|0|||
156966744|NCT04958785|566629795|FG002|Overall Study|Adverse Event|0|||
156966745|NCT04958785|566629796|FG003|Overall Study|Adverse Event|0|||
156966746|NCT04958785|566629797|FG004|Overall Study|Adverse Event|1|||
156966747|NCT04958785|566629793|FG000|Overall Study|Lost to Follow-up|0|||
156966748|NCT04958785|566629794|FG001|Overall Study|Lost to Follow-up|0|||
156966749|NCT04958785|566629795|FG002|Overall Study|Lost to Follow-up|0|||
156966750|NCT04958785|566629796|FG003|Overall Study|Lost to Follow-up|0|||
156966751|NCT04958785|566629797|FG004|Overall Study|Lost to Follow-up|1|||
156966752|NCT03938454|566629798|FG000|Overall Study|Protocol Violation|1|||
156966753|NCT03938454|566629798|FG000|Overall Study|Withdrawal by Subject|2|||
156966754|NCT03938454|566629798|FG000|Overall Study|Lost to Follow-up|3|||
156966755|NCT01090310|566629799|FG000|Core Study|Adverse Event|2|||
156966756|NCT01090310|566629800|FG001|Core Study|Adverse Event|2|||
156966757|NCT01090310|566629801|FG002|Core Study|Adverse Event|1|||
156966758|NCT01090310|566629802|FG003|Core Study|Adverse Event|1|||
156966759|NCT01090310|566629799|FG000|Core Study|Subject withdrew consent|0|||
156966760|NCT01090310|566629800|FG001|Core Study|Subject withdrew consent|3|||
156966761|NCT01090310|566629801|FG002|Core Study|Subject withdrew consent|1|||
156966762|NCT01090310|566629802|FG003|Core Study|Subject withdrew consent|1|||
156966763|NCT01090310|566629799|FG000|Core Study|Abnormal test procedure result|0|||
156966764|NCT01090310|566629800|FG001|Core Study|Abnormal test procedure result|0|||
156966765|NCT01090310|566629801|FG002|Core Study|Abnormal test procedure result|1|||
156966766|NCT01090310|566629802|FG003|Core Study|Abnormal test procedure result|0|||
156966767|NCT01090310|566629799|FG000|Core Study|Administrative reasons|5|||
156966768|NCT01090310|566629800|FG001|Core Study|Administrative reasons|6|||
156966769|NCT01090310|566629801|FG002|Core Study|Administrative reasons|4|||
156966770|NCT01090310|566629802|FG003|Core Study|Administrative reasons|4|||
156966771|NCT01090310|566629799|FG000|Core Study|Protocol deviation|1|||
156966772|NCT01090310|566629800|FG001|Core Study|Protocol deviation|0|||
156966773|NCT01090310|566629801|FG002|Core Study|Protocol deviation|0|||
156966774|NCT01090310|566629802|FG003|Core Study|Protocol deviation|1|||
156966775|NCT01090310|566629799|FG000|Extension Study|Aministrative problems|13|||
156966776|NCT01090310|566629800|FG001|Extension Study|Aministrative problems|15|||
156966777|NCT01090310|566629801|FG002|Extension Study|Aministrative problems|14|||
156966778|NCT01090310|566629802|FG003|Extension Study|Aministrative problems|18|||
156966779|NCT01090310|566629799|FG000|Extension Study|Adverse Event|0|||
156966780|NCT01090310|566629800|FG001|Extension Study|Adverse Event|0|||
156966781|NCT01090310|566629801|FG002|Extension Study|Adverse Event|0|||
156966782|NCT01090310|566629802|FG003|Extension Study|Adverse Event|1|||
156966783|NCT01090310|566629799|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
156966784|NCT01090310|566629800|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
156966785|NCT01090310|566629801|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
156966786|NCT01090310|566629802|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
156966787|NCT01090310|566629799|FG000|Extension Study|Subject withdrew consent|0|||
156966788|NCT01090310|566629800|FG001|Extension Study|Subject withdrew consent|1|||
156966789|NCT01090310|566629801|FG002|Extension Study|Subject withdrew consent|0|||
156966790|NCT01090310|566629802|FG003|Extension Study|Subject withdrew consent|0|||
156966791|NCT00695786|566629803|FG000|Overall Study|Adverse Event|0|||
156966792|NCT00695786|566629804|FG001|Overall Study|Adverse Event|3|||
156966793|NCT00695786|566629805|FG002|Overall Study|Adverse Event|4|||
156966794|NCT00695786|566629806|FG003|Overall Study|Adverse Event|2|||
156966795|NCT00695786|566629803|FG000|Overall Study|Lost to Follow-up|0|||
156966796|NCT00695786|566629804|FG001|Overall Study|Lost to Follow-up|5|||
156966797|NCT00695786|566629805|FG002|Overall Study|Lost to Follow-up|1|||
156966798|NCT00695786|566629806|FG003|Overall Study|Lost to Follow-up|1|||
156966799|NCT00695786|566629803|FG000|Overall Study|Withdrawal by Subject|0|||
156966800|NCT00695786|566629804|FG001|Overall Study|Withdrawal by Subject|4|||
156966801|NCT00695786|566629805|FG002|Overall Study|Withdrawal by Subject|3|||
156966802|NCT00695786|566629806|FG003|Overall Study|Withdrawal by Subject|1|||
156966803|NCT00695786|566629803|FG000|Overall Study|Deemed Ineligible|1|||
156966804|NCT00695786|566629804|FG001|Overall Study|Deemed Ineligible|0|||
156966805|NCT00695786|566629805|FG002|Overall Study|Deemed Ineligible|0|||
156966806|NCT00695786|566629806|FG003|Overall Study|Deemed Ineligible|0|||
156966807|NCT00695786|566629803|FG000|Overall Study|Lack of Efficacy|0|||
156966808|NCT00695786|566629804|FG001|Overall Study|Lack of Efficacy|0|||
156966809|NCT00695786|566629805|FG002|Overall Study|Lack of Efficacy|0|||
156966810|NCT00695786|566629806|FG003|Overall Study|Lack of Efficacy|4|||
156966811|NCT01224925|566629807|FG000|Overall Study|Lost to Follow-up|3|||
157227968|NCT04557124|567580956|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
157227969|NCT04557124|567580957|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
157227970|NCT04557124|567580956|FG000|Post-testing (2 Months)|Missed testing|1|||
157227971|NCT04557124|567580957|FG001|Post-testing (2 Months)|Missed testing|5|||
157227972|NCT04557124|567580956|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
156966812|NCT01224925|566629808|FG001|Overall Study|Lost to Follow-up|2|||
156966813|NCT04244396|566629812|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
156966814|NCT04244396|566629812|FG000|Overall Study|Withdrawal by Subject|2|||
156966815|NCT04244396|566629812|FG000|Overall Study|Study termination|37|||
156966816|NCT00949884|566629813|FG000|Overall Study|Adverse Event|14|||
156966817|NCT00949884|566629814|FG001|Overall Study|Adverse Event|3|||
156966818|NCT00949884|566629815|FG002|Overall Study|Adverse Event|12|||
156966819|NCT00949884|566629813|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
156966820|NCT00949884|566629814|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
156966821|NCT00949884|566629815|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
156966822|NCT00949884|566629813|FG000|Overall Study|Lost to Follow-up|7|||
156966823|NCT00949884|566629814|FG001|Overall Study|Lost to Follow-up|5|||
156966824|NCT00949884|566629815|FG002|Overall Study|Lost to Follow-up|5|||
156966825|NCT00949884|566629813|FG000|Overall Study|Physician Decision|5|||
156966826|NCT00949884|566629814|FG001|Overall Study|Physician Decision|0|||
156966827|NCT00949884|566629815|FG002|Overall Study|Physician Decision|6|||
156966828|NCT00949884|566629813|FG000|Overall Study|Treatment non-compliance|5|||
156966829|NCT00949884|566629814|FG001|Overall Study|Treatment non-compliance|0|||
156966830|NCT00949884|566629815|FG002|Overall Study|Treatment non-compliance|8|||
156966831|NCT00949884|566629813|FG000|Overall Study|Withdrawal by Subject|13|||
156966832|NCT00949884|566629814|FG001|Overall Study|Withdrawal by Subject|4|||
156966833|NCT00949884|566629815|FG002|Overall Study|Withdrawal by Subject|16|||
156966834|NCT00949884|566629813|FG000|Overall Study|Lack of Efficacy|4|||
156966835|NCT00949884|566629814|FG001|Overall Study|Lack of Efficacy|2|||
156966836|NCT00949884|566629815|FG002|Overall Study|Lack of Efficacy|7|||
156966837|NCT00949884|566629813|FG000|Overall Study|Study terminated by sponsor|0|||
156966838|NCT00949884|566629814|FG001|Overall Study|Study terminated by sponsor|0|||
156966839|NCT00949884|566629815|FG002|Overall Study|Study terminated by sponsor|1|||
156966840|NCT00245102|566629816|FG000|Overall Study|Not Treated|1|||
156966841|NCT00245102|566629817|FG001|Overall Study|Not Treated|0|||
156966842|NCT00245102|566629818|FG002|Overall Study|Not Treated|1|||
156966843|NCT00245102|566629819|FG003|Overall Study|Not Treated|0|||
156966844|NCT00245102|566629820|FG004|Overall Study|Not Treated|0|||
156966845|NCT00245102|566629821|FG005|Overall Study|Not Treated|0|||
156966846|NCT00245102|566629816|FG000|Overall Study|Protocol Violation|1|||
156966847|NCT00245102|566629817|FG001|Overall Study|Protocol Violation|0|||
156966848|NCT00245102|566629818|FG002|Overall Study|Protocol Violation|0|||
156966849|NCT00245102|566629819|FG003|Overall Study|Protocol Violation|0|||
156966850|NCT00245102|566629820|FG004|Overall Study|Protocol Violation|0|||
156966851|NCT00245102|566629821|FG005|Overall Study|Protocol Violation|0|||
156966852|NCT00245102|566629816|FG000|Overall Study|Death|0|||
156966853|NCT00245102|566629817|FG001|Overall Study|Death|0|||
156966854|NCT00245102|566629818|FG002|Overall Study|Death|0|||
156966855|NCT00245102|566629819|FG003|Overall Study|Death|1|||
156966856|NCT00245102|566629820|FG004|Overall Study|Death|0|||
156966857|NCT00245102|566629821|FG005|Overall Study|Death|0|||
156966858|NCT00245102|566629816|FG000|Overall Study|Adverse Event|4|||
156966859|NCT00245102|566629817|FG001|Overall Study|Adverse Event|2|||
156966860|NCT00245102|566629818|FG002|Overall Study|Adverse Event|5|||
156966861|NCT00245102|566629819|FG003|Overall Study|Adverse Event|1|||
156966862|NCT00245102|566629820|FG004|Overall Study|Adverse Event|0|||
156966863|NCT00245102|566629821|FG005|Overall Study|Adverse Event|2|||
156966864|NCT00245102|566629816|FG000|Overall Study|Decline in performance|0|||
156966865|NCT00245102|566629817|FG001|Overall Study|Decline in performance|2|||
156966866|NCT00245102|566629818|FG002|Overall Study|Decline in performance|0|||
156966867|NCT00245102|566629819|FG003|Overall Study|Decline in performance|1|||
156966868|NCT00245102|566629820|FG004|Overall Study|Decline in performance|0|||
156966869|NCT00245102|566629821|FG005|Overall Study|Decline in performance|2|||
156966870|NCT00245102|566629816|FG000|Overall Study|Participant needed surgery|0|||
156966871|NCT00245102|566629817|FG001|Overall Study|Participant needed surgery|0|||
157227973|NCT04557124|567580957|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
156966872|NCT00245102|566629818|FG002|Overall Study|Participant needed surgery|1|||
156966873|NCT00245102|566629819|FG003|Overall Study|Participant needed surgery|0|||
156966874|NCT00245102|566629820|FG004|Overall Study|Participant needed surgery|0|||
156966875|NCT00245102|566629821|FG005|Overall Study|Participant needed surgery|0|||
156966876|NCT00245102|566629816|FG000|Overall Study|Clinical progression|1|||
156966877|NCT00245102|566629817|FG001|Overall Study|Clinical progression|0|||
156966878|NCT00245102|566629818|FG002|Overall Study|Clinical progression|0|||
156966879|NCT00245102|566629819|FG003|Overall Study|Clinical progression|0|||
156966880|NCT00245102|566629820|FG004|Overall Study|Clinical progression|0|||
156966881|NCT00245102|566629821|FG005|Overall Study|Clinical progression|0|||
157227974|NCT04557124|567580956|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
156966882|NCT02293395|566629826|FG000|Overall Study|Lost to Follow-up|1|||
157040532|NCT03211247|566901646|FG004|Overall Study|Protocol Violation|0|||
157040533|NCT02415127|566901647|FG000|Overall Study|Adverse Event|1|||
157040534|NCT02415127|566901648|FG001|Overall Study|Adverse Event|0|||
157040535|NCT04153890|566901649|FG000|Overall Study|Lost to Follow-up|9|||
157040536|NCT04153890|566901650|FG001|Overall Study|Lost to Follow-up|0|||
157040537|NCT04153890|566901651|FG002|Overall Study|Lost to Follow-up|9|||
157040538|NCT04153890|566901652|FG003|Overall Study|Lost to Follow-up|0|||
157040539|NCT04153890|566901649|FG000|Overall Study|Death|0|||
157040540|NCT04153890|566901650|FG001|Overall Study|Death|2|||
157040541|NCT04153890|566901651|FG002|Overall Study|Death|0|||
157040542|NCT04153890|566901652|FG003|Overall Study|Death|0|||
157040543|NCT04153890|566901649|FG000|Overall Study|Withdrawal by Subject|0|||
157040544|NCT04153890|566901650|FG001|Overall Study|Withdrawal by Subject|0|||
157040545|NCT04153890|566901651|FG002|Overall Study|Withdrawal by Subject|0|||
157040546|NCT04153890|566901652|FG003|Overall Study|Withdrawal by Subject|2|||
157040547|NCT03997474|566901655|FG000|Overall Study|Death|6|||
157040548|NCT03997474|566901656|FG001|Overall Study|Death|2|||
157040549|NCT03997474|566901657|FG002|Overall Study|Death|1|||
157040550|NCT03997474|566901655|FG000|Overall Study|Physician Decision|2|||
157040551|NCT03997474|566901656|FG001|Overall Study|Physician Decision|0|||
157040552|NCT03997474|566901657|FG002|Overall Study|Physician Decision|0|||
157040553|NCT03997474|566901655|FG000|Overall Study|study terminated by sponsor|1|||
157040554|NCT03997474|566901656|FG001|Overall Study|study terminated by sponsor|0|||
157040555|NCT03997474|566901657|FG002|Overall Study|study terminated by sponsor|1|||
157040556|NCT05037513|566901659|FG000|Intervention Period|Lost to Follow-up|1|||
157040557|NCT05037513|566901660|FG001|Intervention Period|Lost to Follow-up|2|||
157040558|NCT05037513|566901659|FG000|Follow Up Period|Lost to Follow-up|16|||
157040559|NCT05037513|566901660|FG001|Follow Up Period|Lost to Follow-up|21|||
157040560|NCT05037513|566901659|FG000|Follow Up Period|Death|0|||
157040561|NCT05037513|566901660|FG001|Follow Up Period|Death|1|||
157040562|NCT05037513|566901659|FG000|Follow Up Period|Incarcerated|4|||
157040563|NCT05037513|566901660|FG001|Follow Up Period|Incarcerated|2|||
157040564|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
157040565|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
157040566|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
157040567|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
157040568|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
157040569|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
157040570|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
157040571|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
157040572|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
157040573|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
157040574|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
157040575|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
157040576|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
157040577|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
157040578|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
156966883|NCT02293395|566629827|FG001|Overall Study|Lost to Follow-up|0|||
156966884|NCT02293395|566629826|FG000|Overall Study|Withdrawal by Subject|8|||
156966885|NCT02293395|566629827|FG001|Overall Study|Withdrawal by Subject|7|||
156966886|NCT00224770|566629833|FG000|Overall Study|Lost to Follow-up|4|||
156966887|NCT00224770|566629834|FG001|Overall Study|Lost to Follow-up|2|||
156966888|NCT00224770|566629835|FG002|Overall Study|Lost to Follow-up|0|||
156966889|NCT01106430|566629836|FG000|Overall Study|Adverse Event|8|||
156966890|NCT01106430|566629837|FG001|Overall Study|Adverse Event|10|||
156966891|NCT01106430|566629836|FG000|Overall Study|Lack of Efficacy|2|||
156966892|NCT01106430|566629837|FG001|Overall Study|Lack of Efficacy|13|||
156966893|NCT01106430|566629836|FG000|Overall Study|Lost to Follow-up|5|||
156966894|NCT01106430|566629837|FG001|Overall Study|Lost to Follow-up|1|||
156966895|NCT01106430|566629836|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
156966896|NCT01106430|566629837|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
156966897|NCT01106430|566629836|FG000|Overall Study|Moved Out Of State|0|||
156966898|NCT01106430|566629837|FG001|Overall Study|Moved Out Of State|1|||
156966899|NCT01106430|566629836|FG000|Overall Study|Refused To Take Medication|0|||
156966900|NCT01106430|566629837|FG001|Overall Study|Refused To Take Medication|1|||
156966901|NCT01106430|566629836|FG000|Overall Study|Noncompliance|0|||
157040579|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
157040580|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
157040581|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
157040582|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
157040583|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
157040584|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
157040585|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
157040586|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
157040587|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
157040588|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
156966902|NCT01106430|566629837|FG001|Overall Study|Noncompliance|1|||
156966903|NCT01106430|566629836|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
156966904|NCT01106430|566629837|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
156966905|NCT01106430|566629836|FG000|Overall Study|Previous Use Of Marijuana|1|||
156966906|NCT01106430|566629837|FG001|Overall Study|Previous Use Of Marijuana|0|||
156966907|NCT01106430|566629836|FG000|Overall Study|Protocol Violation|7|||
156966908|NCT01106430|566629837|FG001|Overall Study|Protocol Violation|2|||
156966909|NCT01106430|566629836|FG000|Overall Study|Withdrawal by Subject|8|||
156966910|NCT01106430|566629837|FG001|Overall Study|Withdrawal by Subject|4|||
156966911|NCT00437645|566629844|FG000|Overall Study|Adverse Event|15|||
156966912|NCT00437645|566629845|FG001|Overall Study|Adverse Event|84|||
156966913|NCT00437645|566629844|FG000|Overall Study|Withdrawal by Subject|10|||
156966914|NCT00437645|566629845|FG001|Overall Study|Withdrawal by Subject|22|||
156966915|NCT00437645|566629844|FG000|Overall Study|Protocol Violation|3|||
156966916|NCT00437645|566629845|FG001|Overall Study|Protocol Violation|3|||
156966917|NCT00437645|566629844|FG000|Overall Study|Lost to Follow-up|2|||
156966918|NCT00437645|566629845|FG001|Overall Study|Lost to Follow-up|3|||
156966919|NCT00437645|566629844|FG000|Overall Study|Administrative problems|2|||
156966920|NCT00437645|566629845|FG001|Overall Study|Administrative problems|1|||
156966921|NCT00437645|566629844|FG000|Overall Study|Lack of Efficacy|2|||
156966922|NCT00437645|566629845|FG001|Overall Study|Lack of Efficacy|1|||
156966923|NCT00437645|566629844|FG000|Overall Study|Condition no longer requires study drug|1|||
156966924|NCT00437645|566629845|FG001|Overall Study|Condition no longer requires study drug|1|||
156966925|NCT00662857|566629846|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
156966926|NCT00662857|566629847|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
156966927|NCT00662857|566629846|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
156966928|NCT00662857|566629847|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
156966929|NCT00662857|566629846|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
156966930|NCT00662857|566629847|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
156966931|NCT03966053|566629848|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
156966932|NCT02832622|566629853|FG000|Overall Study|MPP not programmed|1259|||
156966933|NCT02832622|566629853|FG000|Overall Study|Withdrawal by Subject|123|||
156966934|NCT02832622|566629853|FG000|Overall Study|Death|119|||
156966935|NCT02832622|566629853|FG000|Overall Study|Unsuccessful CRT implant|93|||
156966936|NCT02832622|566629853|FG000|Overall Study|Lost to Follow-up|45|||
156966937|NCT02832622|566629853|FG000|Overall Study|Patient non-compliance|42|||
156966938|NCT02832622|566629853|FG000|Overall Study|Withdrawal by other reasons|25|||
156966939|NCT02832622|566629853|FG000|Overall Study|System explant|24|||
156966940|NCT02832622|566629853|FG000|Overall Study|Physician Decision|6|||
156966941|NCT02472652|566629856|FG000|Overall Study|Lost to Follow-up|1|||
156966942|NCT04586569|566629861|FG000|Overall Study|Withdrawal by Subject|0|||
156966943|NCT04586569|566629862|FG001|Overall Study|Withdrawal by Subject|2|||
156966944|NCT04586569|566629861|FG000|Overall Study|No longer eligible|2|||
156966945|NCT04586569|566629862|FG001|Overall Study|No longer eligible|3|||
156966946|NCT04586569|566629861|FG000|Overall Study|Physician Decision|1|||
156966947|NCT04586569|566629862|FG001|Overall Study|Physician Decision|0|||
156966948|NCT00998400|566629863|FG000|Overall Study|Lack of interest/motivation|1|||
156966949|NCT00998400|566629864|FG001|Overall Study|Lack of interest/motivation|2|||
156966950|NCT00998400|566629863|FG000|Overall Study|Logistical problems|1|||
156966951|NCT00998400|566629864|FG001|Overall Study|Logistical problems|0|||
156966952|NCT03185832|566629865|FG000|Overall Study|Death|9|||
156966953|NCT03185832|566629866|FG001|Overall Study|Death|14|||
156966954|NCT03185832|566629867|FG002|Overall Study|Death|9|||
156966955|NCT03185832|566629868|FG003|Overall Study|Death|7|||
156966956|NCT03185832|566629865|FG000|Overall Study|Withdrawn - vital status available|0|||
156966957|NCT03185832|566629866|FG001|Overall Study|Withdrawn - vital status available|1|||
156966958|NCT03185832|566629867|FG002|Overall Study|Withdrawn - vital status available|1|||
156966959|NCT03185832|566629868|FG003|Overall Study|Withdrawn - vital status available|4|||
156966960|NCT01777321|566629870|FG000|Overall Study|Withdrawal by Subject|0|||
156966961|NCT01777321|566629871|FG001|Overall Study|Withdrawal by Subject|1|||
156966962|NCT03837509|566629872|FG000|Phase 1|Death|5|||
156966963|NCT03837509|566629873|FG001|Phase 1|Death|2|||
156966964|NCT03837509|566629874|FG002|Phase 1|Death|0|||
156966965|NCT03837509|566629875|FG003|Phase 1|Death|0|||
157172788|NCT00355134|567373417|FG003|Core Phase|Abnormal test procedure result(s)|0|||
157172789|NCT00355134|567373418|FG004|Core Phase|Abnormal test procedure result(s)|0|||
156966966|NCT03837509|566629876|FG004|Phase 1|Death|0|||
156966967|NCT03837509|566629872|FG000|Phase 2|Death|0|||
156966968|NCT03837509|566629873|FG001|Phase 2|Death|0|||
156966969|NCT03837509|566629874|FG002|Phase 2|Death|0|||
156966970|NCT03837509|566629875|FG003|Phase 2|Death|1|||
156966971|NCT03837509|566629876|FG004|Phase 2|Death|1|||
156966972|NCT03548207|566629881|FG000|Overall Study|Death|10|||
156966973|NCT03548207|566629882|FG001|Overall Study|Death|23|||
156966974|NCT03548207|566629883|FG002|Overall Study|Death|3|||
156966975|NCT03548207|566629881|FG000|Overall Study|Lost to Follow-up|0|||
156966976|NCT03548207|566629882|FG001|Overall Study|Lost to Follow-up|2|||
156966977|NCT03548207|566629883|FG002|Overall Study|Lost to Follow-up|0|||
156966978|NCT03548207|566629881|FG000|Overall Study|Withdrawal by Subject|0|||
156966979|NCT03548207|566629882|FG001|Overall Study|Withdrawal by Subject|3|||
156966980|NCT03548207|566629883|FG002|Overall Study|Withdrawal by Subject|0|||
156966981|NCT03548207|566629881|FG000|Overall Study|Sponsor decision|19|||
156966982|NCT03548207|566629882|FG001|Overall Study|Sponsor decision|40|||
156966983|NCT03548207|566629883|FG002|Overall Study|Sponsor decision|6|||
156966984|NCT03548207|566629881|FG000|Overall Study|Randomized but not treated|6|||
156966985|NCT03548207|566629882|FG001|Overall Study|Randomized but not treated|10|||
156966986|NCT03548207|566629883|FG002|Overall Study|Randomized but not treated|4|||
156966987|NCT01756352|566629884|FG000|Overall Study|moved away and lost to followup|1|||
156966988|NCT00415610|566629885|FG000|Overall Study|Death|3|||
156966989|NCT00415610|566629886|FG001|Overall Study|Death|2|||
156966990|NCT00415610|566629887|FG002|Overall Study|Death|5|||
156966991|NCT00526630|566629888|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
156966992|NCT00526630|566629889|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
156966993|NCT00526630|566629888|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
156966994|NCT00526630|566629889|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
156966995|NCT00337272|566629890|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
156966996|NCT00337272|566629891|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
156966997|NCT00337272|566629890|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
156966998|NCT00337272|566629891|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
156966999|NCT00337272|566629890|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
156967000|NCT00337272|566629891|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
156967001|NCT00337272|566629890|FG000|Treatment Period|Non-compliance|1|||
156967002|NCT00337272|566629891|FG001|Treatment Period|Non-compliance|1|||
156967003|NCT00337272|566629890|FG000|Treatment Period|Withdrawal by Subject|0|||
156967004|NCT00337272|566629891|FG001|Treatment Period|Withdrawal by Subject|1|||
156967005|NCT00337272|566629890|FG000|Withdrawal Period|Non-compliance|0|||
156967006|NCT00337272|566629891|FG001|Withdrawal Period|Non-compliance|1|||
156967007|NCT03320018|566629892|FG000|Treatment Period|Withdrawal by Subject|1|||
156967008|NCT03320018|566629893|FG001|Treatment Period|Withdrawal by Subject|0|||
156967009|NCT03320018|566629892|FG000|Day 90 Follow up|Death|0|||
156967010|NCT03320018|566629893|FG001|Day 90 Follow up|Death|1|||
156967011|NCT02641392|566629894|FG000|Overall Study|Lost to Follow-up|0|||
156967012|NCT02641392|566629895|FG001|Overall Study|Lost to Follow-up|0|||
156967013|NCT02641392|566629896|FG002|Overall Study|Lost to Follow-up|2|||
156967014|NCT02641392|566629894|FG000|Overall Study|Withdrawal by Subject|0|||
156967015|NCT02641392|566629895|FG001|Overall Study|Withdrawal by Subject|0|||
156967016|NCT02641392|566629896|FG002|Overall Study|Withdrawal by Subject|17|||
156967017|NCT02641392|566629894|FG000|Overall Study|Adverse Event|0|||
156967018|NCT02641392|566629895|FG001|Overall Study|Adverse Event|1|||
156967019|NCT02641392|566629896|FG002|Overall Study|Adverse Event|25|||
156967020|NCT02641392|566629894|FG000|Overall Study|Study Terminated by Sponsor|4|||
156967021|NCT02641392|566629895|FG001|Overall Study|Study Terminated by Sponsor|12|||
156967022|NCT02641392|566629896|FG002|Overall Study|Study Terminated by Sponsor|144|||
156967023|NCT02641392|566629894|FG000|Overall Study|Lack of Efficacy|0|||
156967024|NCT02641392|566629895|FG001|Overall Study|Lack of Efficacy|0|||
156967025|NCT02641392|566629896|FG002|Overall Study|Lack of Efficacy|101|||
156967026|NCT02641392|566629894|FG000|Overall Study|Miscellaneous|0|||
156967027|NCT02641392|566629895|FG001|Overall Study|Miscellaneous|0|||
156967028|NCT02641392|566629896|FG002|Overall Study|Miscellaneous|3|||
156967029|NCT02641392|566629894|FG000|Overall Study|Death|0|||
156967030|NCT02641392|566629895|FG001|Overall Study|Death|0|||
156967031|NCT02641392|566629896|FG002|Overall Study|Death|1|||
156967032|NCT02691182|566629897|FG000|Overall Study|Withdrawal by Subject|4|||
156967033|NCT02691182|566629898|FG001|Overall Study|Withdrawal by Subject|7|||
156967034|NCT02691182|566629899|FG002|Overall Study|Withdrawal by Subject|6|||
156967035|NCT02691182|566629900|FG003|Overall Study|Withdrawal by Subject|8|||
156967036|NCT02691182|566629897|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
156967037|NCT02691182|566629898|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
156967038|NCT02691182|566629899|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
156967039|NCT02691182|566629900|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
156967040|NCT02691182|566629897|FG000|Overall Study|Lost to Follow-up|8|||
156967041|NCT02691182|566629898|FG001|Overall Study|Lost to Follow-up|33|||
156967042|NCT02691182|566629899|FG002|Overall Study|Lost to Follow-up|19|||
156967043|NCT02691182|566629900|FG003|Overall Study|Lost to Follow-up|22|||
156967044|NCT02691182|566629897|FG000|Overall Study|Adverse Event|3|||
156967045|NCT02691182|566629898|FG001|Overall Study|Adverse Event|10|||
156967046|NCT02691182|566629899|FG002|Overall Study|Adverse Event|10|||
156967047|NCT02691182|566629900|FG003|Overall Study|Adverse Event|11|||
157172790|NCT00355134|567373414|FG000|Core Phase|Condition no longer requires study drug|1|||
156967048|NCT02691182|566629897|FG000|Overall Study|Physician Decision|3|||
156967049|NCT02691182|566629898|FG001|Overall Study|Physician Decision|7|||
156967050|NCT02691182|566629899|FG002|Overall Study|Physician Decision|14|||
156967051|NCT02691182|566629900|FG003|Overall Study|Physician Decision|8|||
156967052|NCT02691182|566629897|FG000|Overall Study|Lack of Efficacy|0|||
157172791|NCT00355134|567373415|FG001|Core Phase|Condition no longer requires study drug|0|||
156967053|NCT02691182|566629898|FG001|Overall Study|Lack of Efficacy|0|||
156967054|NCT02691182|566629899|FG002|Overall Study|Lack of Efficacy|0|||
156967055|NCT02691182|566629900|FG003|Overall Study|Lack of Efficacy|4|||
156967056|NCT02691182|566629897|FG000|Overall Study|Protocol Violation|2|||
156967057|NCT02691182|566629898|FG001|Overall Study|Protocol Violation|6|||
156967058|NCT02691182|566629899|FG002|Overall Study|Protocol Violation|6|||
156967059|NCT02691182|566629900|FG003|Overall Study|Protocol Violation|8|||
156967060|NCT02691182|566629897|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
156967061|NCT02691182|566629898|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
156967062|NCT02691182|566629899|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
156967063|NCT02691182|566629900|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
156967064|NCT02691182|566629897|FG000|Overall Study|Missing|0|||
156967065|NCT02691182|566629898|FG001|Overall Study|Missing|5|||
156967066|NCT02691182|566629899|FG002|Overall Study|Missing|1|||
156967067|NCT02691182|566629900|FG003|Overall Study|Missing|5|||
156967068|NCT00266825|566629903|FG000|Completed Follow-Up|Lost to Follow-up|14|||
156967069|NCT00266825|566629904|FG001|Completed Follow-Up|Lost to Follow-up|19|||
156967070|NCT00266825|566629903|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
156967071|NCT00266825|566629904|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
156967072|NCT02799784|566629905|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
156967073|NCT02799784|566629906|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
156967074|NCT02799784|566629905|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
156967075|NCT02799784|566629906|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
156967076|NCT02799784|566629905|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
156967077|NCT02799784|566629906|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
156967078|NCT02799784|566629905|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
156967079|NCT02799784|566629906|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
156967080|NCT02799784|566629905|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
156967081|NCT02799784|566629906|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
156967082|NCT02799784|566629905|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
156967083|NCT02799784|566629906|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
156967084|NCT01127646|566629907|FG000|Overall Study|Entry Criteria Not Met|1|||
156967085|NCT01127646|566629908|FG001|Overall Study|Entry Criteria Not Met|0|||
156967086|NCT01127646|566629907|FG000|Overall Study|Protocol Violation|0|||
156967087|NCT01127646|566629908|FG001|Overall Study|Protocol Violation|1|||
156967088|NCT01662063|566629912|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
156967089|NCT01662063|566629913|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
156967090|NCT01662063|566629914|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
156967091|NCT01662063|566629912|FG000|Overall Study|Lack of Efficacy|1|||
156967092|NCT01662063|566629913|FG001|Overall Study|Lack of Efficacy|6|||
156967093|NCT01662063|566629914|FG002|Overall Study|Lack of Efficacy|0|||
156967094|NCT01662063|566629912|FG000|Overall Study|Lost to Follow-up|0|||
156967095|NCT01662063|566629913|FG001|Overall Study|Lost to Follow-up|4|||
156967096|NCT01662063|566629914|FG002|Overall Study|Lost to Follow-up|0|||
156967097|NCT01662063|566629912|FG000|Overall Study|Protocol Violation|1|||
156967098|NCT01662063|566629913|FG001|Overall Study|Protocol Violation|0|||
156967099|NCT01662063|566629914|FG002|Overall Study|Protocol Violation|0|||
156967100|NCT01662063|566629912|FG000|Overall Study|Withdrawal by Subject|2|||
156967101|NCT01662063|566629913|FG001|Overall Study|Withdrawal by Subject|4|||
156967102|NCT01662063|566629914|FG002|Overall Study|Withdrawal by Subject|1|||
156967103|NCT01662063|566629912|FG000|Overall Study|Physician Decision|0|||
156967104|NCT01662063|566629913|FG001|Overall Study|Physician Decision|2|||
156967105|NCT01662063|566629914|FG002|Overall Study|Physician Decision|0|||
156967106|NCT01662063|566629912|FG000|Overall Study|Other|0|||
156967107|NCT01662063|566629913|FG001|Overall Study|Other|1|||
156967108|NCT01662063|566629914|FG002|Overall Study|Other|0|||
156967109|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
156967110|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
156967111|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156967112|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
156967113|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
156967114|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
156967115|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
156967116|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
156967117|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156967118|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
156967119|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156967120|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
156967121|NCT00293267|566629915|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
156967122|NCT00293267|566629916|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
156967123|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
157040589|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Other|1|||
157040590|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Other|0|||
157040591|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Other|0|||
157040592|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Other|0|||
157040593|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Other|0|||
157040594|NCT02386098|566903093|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
157040595|NCT02386098|566903094|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
157040596|NCT02386098|566903095|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
157040597|NCT02386098|566903096|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
157040598|NCT02386098|566903097|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
157040599|NCT03002194|566903100|FG000|Overall Study|Lost to Follow-up|6|||
157040600|NCT03002194|566903100|FG000|Overall Study|Adverse Event|1|||
157040601|NCT03002194|566903100|FG000|Overall Study|Lack of Efficacy|1|||
157040602|NCT03002194|566903100|FG000|Overall Study|Withdrawal by Subject|2|||
157040603|NCT02200705|566903101|FG000|Overall Study|Excluded|12|||
157040604|NCT02200705|566903101|FG000|Overall Study|Death|21|||
157040605|NCT02200705|566903101|FG000|Overall Study|Withdrawal by Subject|22|||
157040606|NCT02200705|566903101|FG000|Overall Study|Lost to Follow-up|13|||
157040607|NCT02200705|566903101|FG000|Overall Study|Physician Decision|5|||
157040608|NCT02200705|566903101|FG000|Overall Study|Adverse Event|2|||
157040609|NCT05250115|566903102|FG000|Overall Study|Premature study end|40|||
157040610|NCT05250115|566903102|FG000|Overall Study|Adverse Event|8|||
156967124|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
156967125|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
156967126|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
156967127|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
156967128|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
156967129|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
156967130|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
156967131|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Death|3|||
156967132|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Death|0|||
156967133|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
156967134|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
156967135|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
156967136|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
156967137|NCT00293267|566629915|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
156967138|NCT00293267|566629916|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
156967139|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
156967140|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
156967141|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
156967142|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
156967143|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
156967144|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
156967145|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
156967146|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
156967147|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
156967148|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
156967149|NCT00293267|566629915|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
156967150|NCT00293267|566629916|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
156967151|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
156967152|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
156967153|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
156967154|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
156967155|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
156967156|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
156967157|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
156967158|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
156967159|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
156967160|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
156967161|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
156967162|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
156967163|NCT00293267|566629915|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
156967164|NCT00293267|566629916|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
156967165|NCT01050816|566629917|FG000|Overall Study|Lost to Follow-up|2|||
156967166|NCT01050816|566629917|FG000|Overall Study|patient's refusal|2|||
157040611|NCT05250115|566903102|FG000|Overall Study|Lost to Follow-up|7|||
157040612|NCT05250115|566903102|FG000|Overall Study|Withdrawal by Subject|6|||
157040613|NCT05250115|566903102|FG000|Overall Study|Withdrawal of informed consent|1|||
157040614|NCT05250115|566903102|FG000|Overall Study|Other|7|||
157040615|NCT02633215|566903106|FG000|Overall Study|Lost to Follow-up|2|||
157040616|NCT02633215|566903107|FG001|Overall Study|Lost to Follow-up|3|||
157040617|NCT00754325|566903108|FG000|Initial Treatment|Continuing Active Treatment|4|||
157040618|NCT00754325|566903109|FG001|Initial Treatment|Continuing Active Treatment|5|||
157040619|NCT00754325|566903108|FG000|Initial Treatment|Adverse Event|7|||
157040620|NCT00754325|566903109|FG001|Initial Treatment|Adverse Event|6|||
157040621|NCT00754325|566903108|FG000|Initial Treatment|Withdrawal by Subject|2|||
157040622|NCT00754325|566903109|FG001|Initial Treatment|Withdrawal by Subject|2|||
157040623|NCT00754325|566903108|FG000|Initial Treatment|Physician Decision|2|||
157040624|NCT00754325|566903109|FG001|Initial Treatment|Physician Decision|0|||
157040625|NCT00754325|566903108|FG000|Initial Treatment|Sponsor Request|0|||
157040626|NCT00754325|566903109|FG001|Initial Treatment|Sponsor Request|1|||
157040627|NCT00754325|566903108|FG000|Initial Treatment|Disease Progression|35|||
157040628|NCT00754325|566903109|FG001|Initial Treatment|Disease Progression|35|||
157040629|NCT03801148|566903110|FG000|Period 1 (2 Days)|Adverse Event|1|||
157040630|NCT03801148|566903111|FG001|Period 1 (2 Days)|Adverse Event|1|||
157040631|NCT03801148|566903112|FG002|Period 1 (2 Days)|Adverse Event|0|||
157040632|NCT03801148|566903113|FG003|Period 1 (2 Days)|Adverse Event|0|||
157040633|NCT03801148|566903110|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
157040634|NCT03801148|566903111|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
157040635|NCT03801148|566903112|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
157040636|NCT03801148|566903113|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
157040637|NCT03801148|566903110|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157040638|NCT03801148|566903111|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157040639|NCT03801148|566903112|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
157040640|NCT03801148|566903113|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157040641|NCT03801148|566903110|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
157040642|NCT03801148|566903111|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
157040643|NCT03801148|566903112|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
157040644|NCT03801148|566903113|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
157040645|NCT06212752|566903114|FG000|Overall Study|Death|5|||
157040646|NCT06212752|566903115|FG001|Overall Study|Death|3|||
157040647|NCT06212752|566903114|FG000|Overall Study|Participants ongoing|23|||
157040648|NCT06212752|566903115|FG001|Overall Study|Participants ongoing|8|||
157040649|NCT04162210|566903116|FG000|Overall Study|Lost to Follow-up|4|||
157040650|NCT04162210|566903117|FG001|Overall Study|Lost to Follow-up|1|||
157040651|NCT04162210|566903116|FG000|Overall Study|Withdrawal by Subject|17|||
157040652|NCT04162210|566903117|FG001|Overall Study|Withdrawal by Subject|9|||
157040653|NCT04162210|566903116|FG000|Overall Study|Ongoing|113|||
157040654|NCT04162210|566903117|FG001|Overall Study|Ongoing|59|||
157040655|NCT00371345|566903118|FG000|Overall Study|Disease Progression|21|||
157040656|NCT00371345|566903119|FG001|Overall Study|Disease Progression|35|||
157040657|NCT00371345|566903118|FG000|Overall Study|Study Drug Toxicity|1|||
157040658|NCT00371345|566903119|FG001|Overall Study|Study Drug Toxicity|7|||
157040659|NCT00371345|566903118|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
157040660|NCT00371345|566903119|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
157040661|NCT00371345|566903118|FG000|Overall Study|Participant Request|1|||
157040662|NCT00371345|566903119|FG001|Overall Study|Participant Request|1|||
157040663|NCT00371345|566903118|FG000|Overall Study|Participant Withdrew Consent|0|||
157040664|NCT00371345|566903119|FG001|Overall Study|Participant Withdrew Consent|1|||
157040665|NCT00705406|566903120|FG000|Overall Study|Lost to Follow-up|3|||
157040666|NCT00705406|566903121|FG001|Overall Study|Lost to Follow-up|3|||
157040667|NCT00705406|566903120|FG000|Overall Study|Did not receive study drug|1|||
157040668|NCT00705406|566903121|FG001|Overall Study|Did not receive study drug|2|||
157040669|NCT01779700|566903122|FG000|Overall Study|Adverse Event|4|||
157040670|NCT01779700|566903123|FG001|Overall Study|Adverse Event|3|||
157040671|NCT01779700|566903122|FG000|Overall Study|Withdrawal by Subject|0|||
157040672|NCT01779700|566903123|FG001|Overall Study|Withdrawal by Subject|2|||
157040673|NCT00442104|566903124|FG000|Overall Study|Adverse Event|5|||
157040674|NCT00442104|566903124|FG000|Overall Study|Death|2|||
157040675|NCT00442104|566903124|FG000|Overall Study|Lost to Follow-up|3|||
157040676|NCT00442104|566903124|FG000|Overall Study|Withdrawal by Subject|5|||
157040677|NCT00442104|566903124|FG000|Overall Study|Insufficient Clinical Response|10|||
157040678|NCT00442104|566903124|FG000|Overall Study|Other|21|||
157040679|NCT00442104|566903124|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
157040680|NCT00918333|566903127|FG000|Overall Study|Drug not taken per protocol|1|||
157040681|NCT00918333|566903128|FG001|Overall Study|Drug not taken per protocol|0|||
157040682|NCT00918333|566903127|FG000|Overall Study|Inadequate amount of drugs provided|1|||
157040683|NCT00918333|566903128|FG001|Overall Study|Inadequate amount of drugs provided|4|||
157040684|NCT00918333|566903127|FG000|Overall Study|Ineligible|1|||
157040685|NCT00918333|566903128|FG001|Overall Study|Ineligible|0|||
157040686|NCT00918333|566903127|FG000|Overall Study|Withdrawal by Subject|0|||
157040687|NCT00918333|566903128|FG001|Overall Study|Withdrawal by Subject|1|||
157040688|NCT04497415|566903129|FG000|Overall Study|Lost to Follow-up|43|||
157040689|NCT04497415|566903130|FG001|Overall Study|Lost to Follow-up|27|||
157040690|NCT00263757|566903131|FG000|Overall Study|Withdrawal by Subject|5|||
157227975|NCT04557124|567580957|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
156967167|NCT01494584|566629919|FG000|Overall Study|Study Closed/Terminated|1|||
156967168|NCT00374322|566629924|FG000|Overall Study|Lost to Follow-up|92|||
156967169|NCT00374322|566629925|FG001|Overall Study|Lost to Follow-up|90|||
156967170|NCT00374322|566629924|FG000|Overall Study|Protocol Violation|8|||
156967171|NCT00374322|566629925|FG001|Overall Study|Protocol Violation|3|||
156967172|NCT00374322|566629924|FG000|Overall Study|Withdrawal by Subject|235|||
156967173|NCT00374322|566629925|FG001|Overall Study|Withdrawal by Subject|167|||
156967174|NCT00374322|566629924|FG000|Overall Study|Sponsor Terminated Study|866|||
156967175|NCT00374322|566629925|FG001|Overall Study|Sponsor Terminated Study|990|||
156967176|NCT00374322|566629924|FG000|Overall Study|Physician Decision|36|||
156967177|NCT00374322|566629925|FG001|Overall Study|Physician Decision|32|||
156967178|NCT00374322|566629924|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
156967179|NCT00374322|566629925|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
156967180|NCT00374322|566629924|FG000|Overall Study|Sponsor Decision|2|||
156967181|NCT00374322|566629925|FG001|Overall Study|Sponsor Decision|3|||
156967182|NCT00374322|566629924|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
156967183|NCT00374322|566629925|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
156967184|NCT00374322|566629924|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
156967185|NCT00374322|566629925|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
156967186|NCT00374322|566629924|FG000|Overall Study|Severe Toxicity|1|||
156967187|NCT00374322|566629925|FG001|Overall Study|Severe Toxicity|0|||
156967188|NCT00374322|566629924|FG000|Overall Study|Site Closed|2|||
156967189|NCT00374322|566629925|FG001|Overall Study|Site Closed|2|||
156967190|NCT00374322|566629924|FG000|Overall Study|Participant Changed Physician|1|||
156967191|NCT00374322|566629925|FG001|Overall Study|Participant Changed Physician|0|||
156967192|NCT00374322|566629924|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
156967193|NCT00374322|566629925|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
156967194|NCT00374322|566629924|FG000|Overall Study|Noncompliance with Study Requirements|0|||
156967195|NCT00374322|566629925|FG001|Overall Study|Noncompliance with Study Requirements|1|||
156967196|NCT00374322|566629924|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
156967197|NCT00374322|566629925|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
156967198|NCT00374322|566629924|FG000|Overall Study|Did Not Receive Study Medication|8|||
156967199|NCT00374322|566629925|FG001|Overall Study|Did Not Receive Study Medication|6|||
156967200|NCT02151266|566629930|FG000|Overall Study|Lost to Follow-up|1|||
156967201|NCT02151266|566629931|FG001|Overall Study|Lost to Follow-up|4|||
156967202|NCT02151266|566629932|FG002|Overall Study|Lost to Follow-up|1|||
156967203|NCT02151266|566629930|FG000|Overall Study|Did NOT receive intervention|3|||
156967204|NCT02151266|566629931|FG001|Overall Study|Did NOT receive intervention|6|||
156967205|NCT02151266|566629932|FG002|Overall Study|Did NOT receive intervention|2|||
156967206|NCT02151266|566629930|FG000|Overall Study|Not able to exercise|4|||
156967207|NCT02151266|566629931|FG001|Overall Study|Not able to exercise|5|||
156967208|NCT02151266|566629932|FG002|Overall Study|Not able to exercise|4|||
156967209|NCT01169675|566629933|FG000|Overall Study|Progressive disease|13|||
156967210|NCT01169675|566629934|FG001|Overall Study|Progressive disease|2|||
156967211|NCT01169675|566629935|FG002|Overall Study|Progressive disease|5|||
156967212|NCT01169675|566629936|FG003|Overall Study|Progressive disease|15|||
156967213|NCT01169675|566629937|FG004|Overall Study|Progressive disease|1|||
156967214|NCT01169675|566629933|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
156967215|NCT01169675|566629934|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156967216|NCT01169675|566629935|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156967217|NCT01169675|566629936|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
156967218|NCT01169675|566629937|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
156967219|NCT01169675|566629933|FG000|Overall Study|Adverse Event|5|||
156967220|NCT01169675|566629934|FG001|Overall Study|Adverse Event|1|||
156967221|NCT01169675|566629935|FG002|Overall Study|Adverse Event|2|||
156967222|NCT01169675|566629936|FG003|Overall Study|Adverse Event|0|||
156967223|NCT01169675|566629937|FG004|Overall Study|Adverse Event|0|||
156967224|NCT01169675|566629933|FG000|Overall Study|Withdrawal by Subject|1|||
156967225|NCT01169675|566629934|FG001|Overall Study|Withdrawal by Subject|0|||
156967226|NCT01169675|566629935|FG002|Overall Study|Withdrawal by Subject|0|||
156967227|NCT01169675|566629936|FG003|Overall Study|Withdrawal by Subject|1|||
156967228|NCT01169675|566629937|FG004|Overall Study|Withdrawal by Subject|2|||
156967229|NCT01169675|566629933|FG000|Overall Study|Other Reason Not Defined Above|0|||
156967230|NCT01169675|566629934|FG001|Overall Study|Other Reason Not Defined Above|0|||
156967231|NCT01169675|566629935|FG002|Overall Study|Other Reason Not Defined Above|0|||
156967232|NCT01169675|566629936|FG003|Overall Study|Other Reason Not Defined Above|1|||
157040691|NCT00263757|566903132|FG001|Overall Study|Withdrawal by Subject|4|||
157040692|NCT00263757|566903131|FG000|Overall Study|Screen failure|0|||
156967233|NCT01169675|566629937|FG004|Overall Study|Other Reason Not Defined Above|1|||
156967234|NCT02355028|566629940|FG000|Overall Study|Adverse Event|2|||
156967235|NCT02355028|566629941|FG001|Overall Study|Adverse Event|0|||
156967236|NCT02355028|566629940|FG000|Overall Study|Withdrawal by Subject|1|||
156967237|NCT02355028|566629941|FG001|Overall Study|Withdrawal by Subject|1|||
157227976|NCT00001849|567580958|FG000|Overall Study|Death|4|||
157172792|NCT00355134|567373416|FG002|Core Phase|Condition no longer requires study drug|1|||
157172793|NCT00355134|567373417|FG003|Core Phase|Condition no longer requires study drug|0|||
157172794|NCT00355134|567373418|FG004|Core Phase|Condition no longer requires study drug|0|||
157172795|NCT00355134|567373414|FG000|Extension Phase|Withdrawal by Subject|7|||
157172796|NCT00355134|567373415|FG001|Extension Phase|Withdrawal by Subject|11|||
156967238|NCT02355028|566629940|FG000|Overall Study|Deemed ineligible after randomization|8|||
156967239|NCT02355028|566629941|FG001|Overall Study|Deemed ineligible after randomization|4|||
156967240|NCT02276222|566629942|FG000|Overall Study|Adverse Event|62|||
156967241|NCT02276222|566629943|FG001|Overall Study|Adverse Event|11|||
156967242|NCT02276222|566629942|FG000|Overall Study|Death|3|||
156967243|NCT02276222|566629943|FG001|Overall Study|Death|4|||
156967244|NCT02276222|566629942|FG000|Overall Study|Lack of Efficacy|13|||
156967245|NCT02276222|566629943|FG001|Overall Study|Lack of Efficacy|3|||
156967246|NCT02276222|566629942|FG000|Overall Study|Protocol Violation|3|||
156967247|NCT02276222|566629943|FG001|Overall Study|Protocol Violation|2|||
156967248|NCT02276222|566629942|FG000|Overall Study|Withdrawal by Subject|79|||
156967249|NCT02276222|566629943|FG001|Overall Study|Withdrawal by Subject|33|||
156967250|NCT02276222|566629942|FG000|Overall Study|non compliance with study medication|6|||
156967251|NCT02276222|566629943|FG001|Overall Study|non compliance with study medication|2|||
156967252|NCT02276222|566629942|FG000|Overall Study|sponsor decision|0|||
156967253|NCT02276222|566629943|FG001|Overall Study|sponsor decision|3|||
156967254|NCT02276222|566629942|FG000|Overall Study|Lost to Follow-up|15|||
156967255|NCT02276222|566629943|FG001|Overall Study|Lost to Follow-up|5|||
156967256|NCT02276222|566629942|FG000|Overall Study|Physician Decision|2|||
156967257|NCT02276222|566629943|FG001|Overall Study|Physician Decision|1|||
156967258|NCT02276222|566629942|FG000|Overall Study|sheduling conflict|1|||
156967259|NCT02276222|566629943|FG001|Overall Study|sheduling conflict|0|||
156967260|NCT02276222|566629942|FG000|Overall Study|subject withdrew after randomization|1|||
156967261|NCT02276222|566629943|FG001|Overall Study|subject withdrew after randomization|0|||
156967262|NCT04102579|566629944|FG000|Overall Study|Withdrawal by Subject|3|||
156967263|NCT04102579|566629945|FG001|Overall Study|Withdrawal by Subject|4|||
156967264|NCT04102579|566629944|FG000|Overall Study|Lost to Follow-up|0|||
156967265|NCT04102579|566629945|FG001|Overall Study|Lost to Follow-up|1|||
156967266|NCT04102579|566629944|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
156967267|NCT04102579|566629945|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
156967268|NCT04102579|566629944|FG000|Overall Study|Other than Specified|1|||
156967269|NCT04102579|566629945|FG001|Overall Study|Other than Specified|0|||
156967270|NCT04102579|566629944|FG000|Overall Study|Not Dosed with Study Drug|0|||
156967271|NCT04102579|566629945|FG001|Overall Study|Not Dosed with Study Drug|1|||
156967272|NCT02240108|566631604|FG000|Overall Study|Other than specified|8|||
156967273|NCT02240108|566631605|FG001|Overall Study|Other than specified|6|||
156967274|NCT02240108|566631604|FG000|Overall Study|Adverse Event|1|||
156967275|NCT02240108|566631605|FG001|Overall Study|Adverse Event|9|||
156967276|NCT02240108|566631604|FG000|Overall Study|Pregnancy|1|||
156967277|NCT02240108|566631605|FG001|Overall Study|Pregnancy|0|||
156967278|NCT02240108|566631604|FG000|Overall Study|Withdrawal by Subject|4|||
156967279|NCT02240108|566631605|FG001|Overall Study|Withdrawal by Subject|9|||
156967280|NCT02240108|566631604|FG000|Overall Study|StudyTerminated by Sponsor|0|||
156967281|NCT02240108|566631605|FG001|Overall Study|StudyTerminated by Sponsor|1|||
156967282|NCT05178121|566631612|FG000|Overall Study|Other|4|||
156967283|NCT05178121|566631612|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
156967284|NCT01953003|566631613|FG000|Overall Study|Not treated|0|||
156967285|NCT01953003|566631614|FG001|Overall Study|Not treated|1|||
156967286|NCT01953003|566631613|FG000|Overall Study|Progressive disease|35|||
156967287|NCT01953003|566631614|FG001|Overall Study|Progressive disease|45|||
156967288|NCT01953003|566631613|FG000|Overall Study|Related Adverse events|7|||
156967289|NCT01953003|566631614|FG001|Overall Study|Related Adverse events|2|||
156967290|NCT01953003|566631613|FG000|Overall Study|Non-related adverse events|0|||
156967291|NCT01953003|566631614|FG001|Overall Study|Non-related adverse events|2|||
156967292|NCT01953003|566631613|FG000|Overall Study|Protocol Violation|0|||
156967293|NCT01953003|566631614|FG001|Overall Study|Protocol Violation|1|||
157172797|NCT00355134|567373416|FG002|Extension Phase|Withdrawal by Subject|0|||
157172798|NCT00355134|567373417|FG003|Extension Phase|Withdrawal by Subject|7|||
157172799|NCT00355134|567373418|FG004|Extension Phase|Withdrawal by Subject|5|||
156967294|NCT01953003|566631613|FG000|Overall Study|Withdrawal by Subject|14|||
156967295|NCT01953003|566631614|FG001|Overall Study|Withdrawal by Subject|4|||
156967296|NCT00553501|566631617|FG000|Overall Study|Adverse Event|2|||
156967297|NCT00553501|566631617|FG000|Overall Study|Death|1|||
156967298|NCT00553501|566631617|FG000|Overall Study|Progression|1|||
156967299|NCT01464021|566631621|FG000|Overall Study|Withdrawal by Subject|13|||
156967300|NCT01464021|566631621|FG000|Overall Study|Lost to Follow-up|1|||
156967301|NCT01464021|566631621|FG000|Overall Study|Lack of Efficacy|1|||
156967302|NCT01464021|566631621|FG000|Overall Study|various|11|||
156967303|NCT03391765|566631623|FG000|Overall Study|Adverse Event|2|||
156967304|NCT03391765|566631624|FG001|Overall Study|Adverse Event|0|||
156967305|NCT03391765|566631625|FG002|Overall Study|Adverse Event|0|||
156967306|NCT03391765|566631626|FG003|Overall Study|Adverse Event|2|||
157227977|NCT00001849|567580958|FG000|Overall Study|Lost to Follow-up|2|||
157227978|NCT00001849|567580958|FG000|Overall Study|Withdrawal by Subject|2|||
157227979|NCT00001849|567580958|FG000|Overall Study|tumor remained occult|6|||
157227980|NCT00442936|567580959|FG000|Overall Study|Protocol Violation|1|||
157227981|NCT00442936|567580960|FG001|Overall Study|Protocol Violation|0|||
157227982|NCT00442936|567580961|FG002|Overall Study|Protocol Violation|1|||
157227983|NCT00442936|567580962|FG003|Overall Study|Protocol Violation|1|||
157227984|NCT02428699|567580964|FG000|Washout Period 1|Screen Failure|1|||
157227985|NCT02428699|567580965|FG001|Washout Period 1|Screen Failure|2|||
157227986|NCT02460159|567580966|FG000|Overall Study|Adverse Event|4|||
157227987|NCT02460159|567580967|FG001|Overall Study|Adverse Event|1|||
157227988|NCT02460159|567580966|FG000|Overall Study|Withdrawal by Subject|2|||
157227989|NCT02460159|567580967|FG001|Overall Study|Withdrawal by Subject|0|||
157227990|NCT00243932|567580968|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
157227991|NCT00243932|567580969|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
157227992|NCT00243932|567580970|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
157227993|NCT05518487|567580971|FG000|Overall Study|Withdrawal by Subject|3|||
157227994|NCT01370408|567580972|FG000|Overall Study|treatment failure|9|||
157227995|NCT02780687|567580974|FG000|Overall Study|Adverse Event|1|||
157227996|NCT02780687|567580975|FG001|Overall Study|Adverse Event|1|||
157227997|NCT02780687|567580974|FG000|Overall Study|Withdrawal by Subject|2|||
157227998|NCT02780687|567580975|FG001|Overall Study|Withdrawal by Subject|1|||
157227999|NCT02780687|567580974|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
157228000|NCT02780687|567580975|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
157228001|NCT02780687|567580974|FG000|Overall Study|progressive disease|29|||
157228002|NCT02780687|567580975|FG001|Overall Study|progressive disease|6|||
157228003|NCT05014412|567580976|FG000|Overall Study|Death|11|||
157228004|NCT05014412|567580977|FG001|Overall Study|Death|7|||
157228005|NCT05014412|567580978|FG002|Overall Study|Death|4|||
157228006|NCT05014412|567580979|FG003|Overall Study|Death|7|||
157228007|NCT05014412|567580976|FG000|Overall Study|Withdrawal by Subject|1|||
157228008|NCT05014412|567580977|FG001|Overall Study|Withdrawal by Subject|1|||
157228009|NCT05014412|567580978|FG002|Overall Study|Withdrawal by Subject|1|||
157228010|NCT05014412|567580979|FG003|Overall Study|Withdrawal by Subject|2|||
157228011|NCT05014412|567580976|FG000|Overall Study|Ongoing|21|||
157228012|NCT05014412|567580977|FG001|Overall Study|Ongoing|4|||
157228013|NCT05014412|567580978|FG002|Overall Study|Ongoing|6|||
157228014|NCT05014412|567580979|FG003|Overall Study|Ongoing|20|||
157228015|NCT05295953|567580981|FG000|Overall Study|Withdrawal by Subject|0|||
157172800|NCT00355134|567373414|FG000|Extension Phase|Adverse Event|13|||
157172801|NCT00355134|567373415|FG001|Extension Phase|Adverse Event|9|||
157172802|NCT00355134|567373416|FG002|Extension Phase|Adverse Event|0|||
157172803|NCT00355134|567373417|FG003|Extension Phase|Adverse Event|3|||
157172804|NCT00355134|567373418|FG004|Extension Phase|Adverse Event|5|||
157172805|NCT00355134|567373414|FG000|Extension Phase|Lost to Follow-up|2|||
157172806|NCT00355134|567373415|FG001|Extension Phase|Lost to Follow-up|6|||
157172807|NCT00355134|567373416|FG002|Extension Phase|Lost to Follow-up|0|||
157172808|NCT00355134|567373417|FG003|Extension Phase|Lost to Follow-up|2|||
157172809|NCT00355134|567373418|FG004|Extension Phase|Lost to Follow-up|4|||
157228016|NCT05295953|567580982|FG001|Overall Study|Withdrawal by Subject|1|||
157228017|NCT01199861|567580984|FG000|Overall Study|Administrative problems|1|||
157228018|NCT01199861|567580985|FG001|Overall Study|Administrative problems|0|||
157228019|NCT01199861|567580984|FG000|Overall Study|Adverse Event|1|||
157228020|NCT01199861|567580985|FG001|Overall Study|Adverse Event|0|||
157228021|NCT04257929|567580986|FG000|Overall Study|Adverse Event|1|||
157172810|NCT00355134|567373414|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
157172811|NCT00355134|567373415|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
157172812|NCT00355134|567373416|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
157228022|NCT04257929|567580987|FG001|Overall Study|Adverse Event|0|||
157228023|NCT04257929|567580988|FG002|Overall Study|Adverse Event|1|||
157228024|NCT04257929|567580986|FG000|Overall Study|Withdrawal by Subject|1|||
157228025|NCT04257929|567580987|FG001|Overall Study|Withdrawal by Subject|0|||
157228026|NCT04257929|567580988|FG002|Overall Study|Withdrawal by Subject|0|||
157228027|NCT04257929|567580986|FG000|Overall Study|COVID-19|0|||
157228028|NCT04257929|567580987|FG001|Overall Study|COVID-19|1|||
157228029|NCT04257929|567580988|FG002|Overall Study|COVID-19|1|||
157228030|NCT04257929|567580986|FG000|Overall Study|Lost to Follow-up|0|||
157228031|NCT04257929|567580987|FG001|Overall Study|Lost to Follow-up|0|||
157228032|NCT04257929|567580988|FG002|Overall Study|Lost to Follow-up|1|||
157228033|NCT05630547|567580989|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
157228034|NCT05630547|567580990|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
157228035|NCT05630547|567580991|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
157172813|NCT00355134|567373417|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
157228036|NCT05630547|567580992|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
157228037|NCT05630547|567580989|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
157228038|NCT05630547|567580990|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
157228039|NCT05630547|567580991|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
156967307|NCT03391765|566631623|FG000|Overall Study|Withdrew consent|5|||
156967308|NCT03391765|566631624|FG001|Overall Study|Withdrew consent|7|||
156967309|NCT03391765|566631625|FG002|Overall Study|Withdrew consent|2|||
156967310|NCT03391765|566631626|FG003|Overall Study|Withdrew consent|5|||
156967311|NCT03391765|566631623|FG000|Overall Study|Other, not specified|44|||
156967312|NCT03391765|566631624|FG001|Overall Study|Other, not specified|38|||
156967313|NCT03391765|566631625|FG002|Overall Study|Other, not specified|21|||
156967314|NCT03391765|566631626|FG003|Overall Study|Other, not specified|16|||
156967315|NCT00944658|566631627|FG000|Treatment 12 Weeks|Adverse Event|0|||
156967316|NCT00944658|566631628|FG001|Treatment 12 Weeks|Adverse Event|2|||
156967317|NCT02563002|566631631|FG000|Overall Study|Death|72|||
156967318|NCT02563002|566631632|FG001|Overall Study|Death|87|||
156967319|NCT02563002|566631631|FG000|Overall Study|Lost to Follow-up|5|||
156967320|NCT02563002|566631632|FG001|Overall Study|Lost to Follow-up|0|||
156967321|NCT02563002|566631631|FG000|Overall Study|Physician Decision|0|||
156967322|NCT02563002|566631632|FG001|Overall Study|Physician Decision|2|||
156967323|NCT02563002|566631631|FG000|Overall Study|Withdrawal by Subject|2|||
156967324|NCT02563002|566631632|FG001|Overall Study|Withdrawal by Subject|10|||
156967325|NCT02563002|566631631|FG000|Overall Study|Sponsor decision|74|||
156967326|NCT02563002|566631632|FG001|Overall Study|Sponsor decision|55|||
156967327|NCT03518125|566631639|FG000|Overall Study|Lost to Follow-up|0|||
156967328|NCT03518125|566631640|FG001|Overall Study|Lost to Follow-up|2|||
156967329|NCT03518125|566631641|FG002|Overall Study|Lost to Follow-up|0|||
156967330|NCT03518125|566631642|FG003|Overall Study|Lost to Follow-up|0|||
156967331|NCT03518125|566631643|FG004|Overall Study|Lost to Follow-up|3|||
156967332|NCT03518125|566631644|FG005|Overall Study|Lost to Follow-up|5|||
156967333|NCT03518125|566631639|FG000|Overall Study|Physician Decision|0|||
156967334|NCT03518125|566631640|FG001|Overall Study|Physician Decision|1|||
156967335|NCT03518125|566631641|FG002|Overall Study|Physician Decision|0|||
156967336|NCT03518125|566631642|FG003|Overall Study|Physician Decision|0|||
156967337|NCT03518125|566631643|FG004|Overall Study|Physician Decision|0|||
156967338|NCT03518125|566631644|FG005|Overall Study|Physician Decision|0|||
156967339|NCT03518125|566631639|FG000|Overall Study|Withdrawal by Subject|1|||
156967340|NCT03518125|566631640|FG001|Overall Study|Withdrawal by Subject|1|||
157040693|NCT00263757|566903132|FG001|Overall Study|Screen failure|1|||
157040694|NCT00263757|566903131|FG000|Overall Study|Adverse Event|3|||
157040695|NCT00263757|566903132|FG001|Overall Study|Adverse Event|3|||
157040696|NCT03021993|566903140|FG000|Overall Study|Withdrawal by Subject|4|||
157040697|NCT03021993|566903140|FG000|Overall Study|Physician Decision|1|||
157040698|NCT03021993|566903140|FG000|Overall Study|enrolled but were not treated|1|||
157040699|NCT03021993|566903140|FG000|Overall Study|Death|3|||
157040700|NCT02499328|566903151|FG000|Overall Study|Withdrawal by Subject|1|||
157040701|NCT02499328|566903152|FG001|Overall Study|Withdrawal by Subject|1|||
157040702|NCT02499328|566903153|FG002|Overall Study|Withdrawal by Subject|5|||
157040703|NCT02499328|566903154|FG003|Overall Study|Withdrawal by Subject|3|||
157040704|NCT02499328|566903155|FG004|Overall Study|Withdrawal by Subject|5|||
157040705|NCT02499328|566903156|FG005|Overall Study|Withdrawal by Subject|0|||
157040706|NCT02499328|566903157|FG006|Overall Study|Withdrawal by Subject|0|||
157040707|NCT02499328|566903158|FG007|Overall Study|Withdrawal by Subject|0|||
157040708|NCT02499328|566903159|FG008|Overall Study|Withdrawal by Subject|2|||
157040709|NCT02499328|566903160|FG009|Overall Study|Withdrawal by Subject|2|||
157040710|NCT02499328|566903161|FG010|Overall Study|Withdrawal by Subject|0|||
157040711|NCT02499328|566903162|FG011|Overall Study|Withdrawal by Subject|3|||
157040712|NCT02499328|566903163|FG012|Overall Study|Withdrawal by Subject|7|||
157040713|NCT02499328|566903164|FG013|Overall Study|Withdrawal by Subject|3|||
157040714|NCT02499328|566903165|FG014|Overall Study|Withdrawal by Subject|1|||
157040715|NCT02499328|566903166|FG015|Overall Study|Withdrawal by Subject|0|||
157040716|NCT02499328|566903167|FG016|Overall Study|Withdrawal by Subject|0|||
157172814|NCT00355134|567373418|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
157172815|NCT00355134|567373414|FG000|Extension Phase|Administrative problems|2|||
157172816|NCT00355134|567373415|FG001|Extension Phase|Administrative problems|4|||
157172817|NCT00355134|567373416|FG002|Extension Phase|Administrative problems|0|||
157172818|NCT00355134|567373417|FG003|Extension Phase|Administrative problems|1|||
156967341|NCT03518125|566631641|FG002|Overall Study|Withdrawal by Subject|0|||
157040717|NCT02499328|566903168|FG017|Overall Study|Withdrawal by Subject|3|||
157040718|NCT02499328|566903169|FG018|Overall Study|Withdrawal by Subject|0|||
157040719|NCT02499328|566903151|FG000|Overall Study|Lost to Follow-up|0|||
157172819|NCT00355134|567373418|FG004|Extension Phase|Administrative problems|1|||
157172820|NCT00355134|567373414|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
157172821|NCT00355134|567373415|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
156967342|NCT03518125|566631642|FG003|Overall Study|Withdrawal by Subject|1|||
156967343|NCT03518125|566631643|FG004|Overall Study|Withdrawal by Subject|1|||
156967344|NCT03518125|566631644|FG005|Overall Study|Withdrawal by Subject|3|||
156967345|NCT03518125|566631639|FG000|Overall Study|Missed Day 394 Visit|1|||
156967346|NCT03518125|566631640|FG001|Overall Study|Missed Day 394 Visit|0|||
156967347|NCT03518125|566631641|FG002|Overall Study|Missed Day 394 Visit|0|||
156967348|NCT03518125|566631642|FG003|Overall Study|Missed Day 394 Visit|0|||
157228040|NCT05630547|567580992|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
157228041|NCT05630547|567580989|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
157228042|NCT05630547|567580990|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
157228043|NCT05630547|567580991|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
157228044|NCT05630547|567580992|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
157228045|NCT05630547|567580989|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
157228046|NCT05630547|567580990|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
157228047|NCT05630547|567580991|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
157228048|NCT05630547|567580992|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
157228049|NCT05630547|567580989|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
157228050|NCT05630547|567580990|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
157228051|NCT05630547|567580991|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
157228052|NCT05630547|567580992|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
157228053|NCT05630547|567580989|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
157228054|NCT05630547|567580990|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
157228055|NCT05630547|567580991|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
157228056|NCT05630547|567580992|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
157228057|NCT05630547|567580989|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
157228058|NCT05630547|567580990|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
157228059|NCT05630547|567580991|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
157228060|NCT05630547|567580992|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
157228061|NCT05630547|567580989|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
157228062|NCT05630547|567580990|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
157228063|NCT05630547|567580991|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
157228064|NCT05630547|567580992|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
157228065|NCT05630547|567580989|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
157228066|NCT05630547|567580990|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
157228067|NCT05630547|567580991|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
157228068|NCT05630547|567580992|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
157228069|NCT05630547|567580989|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
157228070|NCT05630547|567580990|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
157228071|NCT05630547|567580991|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
157228072|NCT05630547|567580992|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
157228073|NCT05049460|567580993|FG000|Overall Study|Withdrawal by Subject|2|||
157228074|NCT05049460|567580994|FG001|Overall Study|Withdrawal by Subject|2|||
157228075|NCT05049460|567580993|FG000|Overall Study|Lost to Follow-up|2|||
157228076|NCT05049460|567580994|FG001|Overall Study|Lost to Follow-up|2|||
157228077|NCT00918567|567580995|FG000|Overall Study|Lack of Efficacy|3|||
157228078|NCT00918567|567580996|FG001|Overall Study|Lack of Efficacy|1|||
157228079|NCT00918567|567580995|FG000|Overall Study|Withdrawal by Subject|1|||
157228080|NCT00918567|567580996|FG001|Overall Study|Withdrawal by Subject|1|||
157228081|NCT00918567|567580995|FG000|Overall Study|Adverse Event|1|||
157228082|NCT00918567|567580996|FG001|Overall Study|Adverse Event|0|||
157228083|NCT05275998|567580997|FG000|Overall Study|Adverse Event|0|||
157228084|NCT05275998|567580998|FG001|Overall Study|Adverse Event|0|||
157228085|NCT05275998|567580999|FG002|Overall Study|Adverse Event|0|||
157228086|NCT05275998|567581000|FG003|Overall Study|Adverse Event|1|||
157228087|NCT05275998|567580997|FG000|Overall Study|Withdrawal by Subject|0|||
157228088|NCT05275998|567580998|FG001|Overall Study|Withdrawal by Subject|0|||
157228089|NCT05275998|567580999|FG002|Overall Study|Withdrawal by Subject|0|||
157228090|NCT05275998|567581000|FG003|Overall Study|Withdrawal by Subject|1|||
157228091|NCT05275998|567580997|FG000|Overall Study|Physician Decision|0|||
157228092|NCT05275998|567580998|FG001|Overall Study|Physician Decision|0|||
157228093|NCT05275998|567580999|FG002|Overall Study|Physician Decision|0|||
157228094|NCT05275998|567581000|FG003|Overall Study|Physician Decision|1|||
157228095|NCT05275998|567580997|FG000|Overall Study|Protocol Violation|0|||
157228096|NCT05275998|567580998|FG001|Overall Study|Protocol Violation|0|||
157228097|NCT05275998|567580999|FG002|Overall Study|Protocol Violation|1|||
157228098|NCT05275998|567581000|FG003|Overall Study|Protocol Violation|0|||
157228099|NCT01867242|567581003|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
157228100|NCT01867242|567581004|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
157228101|NCT01867242|567581005|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
157228102|NCT03066999|567581006|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
157228103|NCT03066999|567581007|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
157228104|NCT00661999|567581008|FG000|Overall Study|Adverse Event|11|||
157228105|NCT00661999|567581009|FG001|Overall Study|Adverse Event|5|||
157228106|NCT00661999|567581010|FG002|Overall Study|Adverse Event|8|||
157228107|NCT00661999|567581008|FG000|Overall Study|Death|8|||
157228108|NCT00661999|567581009|FG001|Overall Study|Death|6|||
157228109|NCT00661999|567581010|FG002|Overall Study|Death|3|||
157172822|NCT00355134|567373416|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
157172823|NCT00355134|567373417|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
157172824|NCT00355134|567373418|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
157172825|NCT00355134|567373414|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
157172826|NCT00355134|567373415|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
156967349|NCT03518125|566631643|FG004|Overall Study|Missed Day 394 Visit|0|||
156967350|NCT03518125|566631644|FG005|Overall Study|Missed Day 394 Visit|0|||
156967351|NCT04452877|566631645|FG000|Overall Study|Adverse Event|5|||
156967352|NCT04452877|566631645|FG000|Overall Study|Lost to Follow-up|1|||
156967353|NCT04452877|566631645|FG000|Overall Study|Physician Decision|4|||
156967354|NCT04452877|566631645|FG000|Overall Study|Progressive Disease|18|||
156967355|NCT04452877|566631645|FG000|Overall Study|Withdrawal by Subject|3|||
156967356|NCT05453110|566631650|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
156967357|NCT05453110|566631651|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
156967358|NCT05453110|566631652|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
156967359|NCT05906368|566631653|FG000|Overall Study|Withdrawal by Subject|1|||
156967360|NCT05906368|566631654|FG001|Overall Study|Withdrawal by Subject|1|||
156967361|NCT05906368|566631653|FG000|Overall Study|Ineligibility criteria identified|2|||
156967362|NCT05906368|566631654|FG001|Overall Study|Ineligibility criteria identified|0|||
156967363|NCT00595504|566631657|FG000|Overall Study|Withdrawal by Subject|1|||
156967364|NCT00595504|566631658|FG001|Overall Study|Withdrawal by Subject|3|||
156967365|NCT00595504|566631657|FG000|Overall Study|Physician Decision|1|||
156967366|NCT00595504|566631658|FG001|Overall Study|Physician Decision|0|||
156967367|NCT01477853|566631659|FG000|Phase A|Adverse Event|1|||
156967368|NCT01477853|566631660|FG001|Phase A|Adverse Event|2|||
156967369|NCT01477853|566631661|FG002|Phase A|Adverse Event|2|||
156967370|NCT01477853|566631659|FG000|Phase A|Lost to Follow-up|4|||
156967371|NCT01477853|566631660|FG001|Phase A|Lost to Follow-up|3|||
156967372|NCT01477853|566631661|FG002|Phase A|Lost to Follow-up|2|||
156967373|NCT01477853|566631659|FG000|Phase A|Physician Decision|1|||
156967374|NCT01477853|566631660|FG001|Phase A|Physician Decision|0|||
156967375|NCT01477853|566631661|FG002|Phase A|Physician Decision|1|||
156967376|NCT01477853|566631659|FG000|Phase A|Study terminated by sponsor|37|||
156967377|NCT01477853|566631660|FG001|Phase A|Study terminated by sponsor|40|||
156967378|NCT01477853|566631661|FG002|Phase A|Study terminated by sponsor|39|||
156967379|NCT01477853|566631659|FG000|Phase B|Lost to Follow-up|0|||
156967380|NCT01477853|566631660|FG001|Phase B|Lost to Follow-up|1|||
156967381|NCT01477853|566631661|FG002|Phase B|Lost to Follow-up|0|||
156967382|NCT01477853|566631659|FG000|Phase B|Study terminated by sponsor|12|||
156967383|NCT01477853|566631660|FG001|Phase B|Study terminated by sponsor|10|||
156967384|NCT01477853|566631661|FG002|Phase B|Study terminated by sponsor|11|||
156967385|NCT01804816|566631662|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
156967386|NCT01804816|566631662|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
156967387|NCT01235546|566631665|FG000|Overall Study|Staff error, medication not administered|1|||
156967388|NCT01235546|566631666|FG001|Overall Study|Staff error, medication not administered|0|||
156967389|NCT01235546|566631665|FG000|Overall Study|Protocol Violation|1|||
156967390|NCT01235546|566631666|FG001|Overall Study|Protocol Violation|1|||
156967391|NCT01123382|566631667|FG000|Overall Study|Withdrawal by Subject|1|||
156967392|NCT01123382|566631668|FG001|Overall Study|Withdrawal by Subject|4|||
156967393|NCT01123382|566631667|FG000|Overall Study|Lost to Follow-up|1|||
156967394|NCT01123382|566631668|FG001|Overall Study|Lost to Follow-up|2|||
156967395|NCT01256411|566631669|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
156967396|NCT01256411|566631670|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
156967397|NCT01256411|566631671|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
156967398|NCT01256411|566631672|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
156967399|NCT01256411|566631673|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
156967400|NCT01256411|566631674|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
156967401|NCT01256411|566631669|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
156967402|NCT01256411|566631670|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
156967403|NCT01256411|566631671|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
156967404|NCT01256411|566631672|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
156967405|NCT01256411|566631673|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
156967406|NCT01256411|566631674|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
156967407|NCT01256411|566631669|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
156967408|NCT01256411|566631670|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
156967409|NCT01256411|566631671|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
156967410|NCT01256411|566631672|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156967411|NCT01256411|566631673|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156967412|NCT01256411|566631674|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
156967413|NCT01256411|566631669|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
156967414|NCT01256411|566631670|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
156967415|NCT01256411|566631671|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
156967416|NCT01256411|566631672|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
157040720|NCT02499328|566903152|FG001|Overall Study|Lost to Follow-up|1|||
157040721|NCT02499328|566903153|FG002|Overall Study|Lost to Follow-up|1|||
157172827|NCT00355134|567373416|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
157172828|NCT00355134|567373417|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
157172829|NCT00355134|567373418|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
157172830|NCT00355134|567373414|FG000|Extension Phase|Protocol Violation|0|||
157172831|NCT00355134|567373415|FG001|Extension Phase|Protocol Violation|0|||
157172832|NCT00355134|567373416|FG002|Extension Phase|Protocol Violation|0|||
157172833|NCT00355134|567373417|FG003|Extension Phase|Protocol Violation|1|||
157172834|NCT00355134|567373418|FG004|Extension Phase|Protocol Violation|0|||
157172835|NCT03621189|567373431|FG000|Overall Study|Withdrawal by Subject|0|||
157172836|NCT03621189|567373432|FG001|Overall Study|Withdrawal by Subject|3|||
157172837|NCT03621189|567373431|FG000|Overall Study|Physician Decision|0|||
157172838|NCT03621189|567373432|FG001|Overall Study|Physician Decision|2|||
157172839|NCT03488238|567373433|FG000|Overall Study|Equipment malfunction|1|||
157172840|NCT03488238|567373433|FG000|Overall Study|Adverse Event|1|||
157172841|NCT01316939|567373436|FG000|Overall Study|Study closed/terminated|26|||
157172842|NCT01316939|567373437|FG001|Overall Study|Study closed/terminated|25|||
157172843|NCT01316939|567373438|FG002|Overall Study|Study closed/terminated|23|||
157172844|NCT01316939|567373436|FG000|Overall Study|Lack of Efficacy|24|||
157172845|NCT01316939|567373437|FG001|Overall Study|Lack of Efficacy|25|||
157172846|NCT01316939|567373438|FG002|Overall Study|Lack of Efficacy|25|||
157172847|NCT01316939|567373436|FG000|Overall Study|Adverse Event|9|||
157172848|NCT01316939|567373437|FG001|Overall Study|Adverse Event|12|||
157172849|NCT01316939|567373438|FG002|Overall Study|Adverse Event|11|||
157172850|NCT01316939|567373436|FG000|Overall Study|Withdrawal by Subject|1|||
157172851|NCT01316939|567373437|FG001|Overall Study|Withdrawal by Subject|3|||
157172852|NCT01316939|567373438|FG002|Overall Study|Withdrawal by Subject|6|||
157172853|NCT01316939|567373436|FG000|Overall Study|Physician Decision|2|||
157172854|NCT01316939|567373437|FG001|Overall Study|Physician Decision|2|||
157172855|NCT01316939|567373438|FG002|Overall Study|Physician Decision|1|||
157172856|NCT01316939|567373436|FG000|Overall Study|Lost to Follow-up|0|||
157172857|NCT01316939|567373437|FG001|Overall Study|Lost to Follow-up|0|||
157172858|NCT01316939|567373438|FG002|Overall Study|Lost to Follow-up|2|||
157172859|NCT01316939|567373436|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
157172860|NCT01316939|567373437|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
157172861|NCT01316939|567373438|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
157172862|NCT01316939|567373436|FG000|Overall Study|Protocol Violation|0|||
157172863|NCT01316939|567373437|FG001|Overall Study|Protocol Violation|1|||
157172864|NCT01316939|567373438|FG002|Overall Study|Protocol Violation|0|||
157172865|NCT01432457|567373439|FG000|Overall Study|Adverse Event|7|||
157172866|NCT01432457|567373440|FG001|Overall Study|Adverse Event|10|||
157172867|NCT01432457|567373441|FG002|Overall Study|Adverse Event|16|||
157172868|NCT01432457|567373439|FG000|Overall Study|Lack of Efficacy|2|||
157172869|NCT01432457|567373440|FG001|Overall Study|Lack of Efficacy|1|||
157172870|NCT01432457|567373441|FG002|Overall Study|Lack of Efficacy|1|||
157172871|NCT01432457|567373439|FG000|Overall Study|Lost to Follow-up|11|||
157172872|NCT01432457|567373440|FG001|Overall Study|Lost to Follow-up|15|||
157172873|NCT01432457|567373441|FG002|Overall Study|Lost to Follow-up|20|||
157172874|NCT01432457|567373439|FG000|Overall Study|Protocol Violation|3|||
157172875|NCT01432457|567373440|FG001|Overall Study|Protocol Violation|2|||
157172876|NCT01432457|567373441|FG002|Overall Study|Protocol Violation|6|||
157172877|NCT01432457|567373439|FG000|Overall Study|Withdrawal by Subject|6|||
157172878|NCT01432457|567373440|FG001|Overall Study|Withdrawal by Subject|11|||
157172879|NCT01432457|567373441|FG002|Overall Study|Withdrawal by Subject|9|||
157172880|NCT01432457|567373439|FG000|Overall Study|Reasons not defined|2|||
157172881|NCT01432457|567373440|FG001|Overall Study|Reasons not defined|3|||
157172882|NCT01432457|567373441|FG002|Overall Study|Reasons not defined|4|||
157172883|NCT01432457|567373439|FG000|Overall Study|Did not take study drug|6|||
157172884|NCT01432457|567373440|FG001|Overall Study|Did not take study drug|6|||
157172885|NCT01432457|567373441|FG002|Overall Study|Did not take study drug|3|||
157172886|NCT04134728|567373442|FG000|Overall Study|Adverse Event|3|||
157172887|NCT04134728|567373443|FG001|Overall Study|Adverse Event|2|||
157040722|NCT02499328|566903154|FG003|Overall Study|Lost to Follow-up|2|||
157172888|NCT04134728|567373444|FG002|Overall Study|Adverse Event|9|||
157172889|NCT04134728|567373445|FG003|Overall Study|Adverse Event|0|||
157040723|NCT02499328|566903155|FG004|Overall Study|Lost to Follow-up|0|||
157040724|NCT02499328|566903156|FG005|Overall Study|Lost to Follow-up|0|||
157172890|NCT04134728|567373446|FG004|Overall Study|Adverse Event|0|||
157172891|NCT04134728|567373447|FG005|Overall Study|Adverse Event|0|||
157172892|NCT04134728|567373442|FG000|Overall Study|Lack of Efficacy|3|||
157172893|NCT04134728|567373443|FG001|Overall Study|Lack of Efficacy|3|||
157172894|NCT04134728|567373444|FG002|Overall Study|Lack of Efficacy|1|||
157172895|NCT04134728|567373445|FG003|Overall Study|Lack of Efficacy|2|||
157172896|NCT04134728|567373446|FG004|Overall Study|Lack of Efficacy|0|||
157172897|NCT04134728|567373447|FG005|Overall Study|Lack of Efficacy|0|||
157172898|NCT04134728|567373442|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
157172899|NCT04134728|567373443|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
156967417|NCT01256411|566631673|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
156967418|NCT01256411|566631674|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
156967419|NCT01256411|566631669|FG000|Extension by Maximum Treatment|Adverse Event|4|||
156967420|NCT01256411|566631670|FG001|Extension by Maximum Treatment|Adverse Event|2|||
156967421|NCT01256411|566631671|FG002|Extension by Maximum Treatment|Adverse Event|1|||
156967422|NCT01256411|566631672|FG003|Extension by Maximum Treatment|Adverse Event|0|||
156967423|NCT01256411|566631673|FG004|Extension by Maximum Treatment|Adverse Event|0|||
156967424|NCT01256411|566631674|FG005|Extension by Maximum Treatment|Adverse Event|0|||
156967425|NCT01256411|566631669|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
156967426|NCT01256411|566631670|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
156967427|NCT01256411|566631671|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
156967428|NCT01256411|566631672|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
156967429|NCT01256411|566631673|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
156967430|NCT01256411|566631674|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
156967431|NCT01256411|566631669|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156967432|NCT01256411|566631670|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156967433|NCT01256411|566631671|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156967434|NCT01256411|566631672|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156967435|NCT01256411|566631673|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
156967436|NCT01256411|566631674|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
156967437|NCT01256411|566631669|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156967438|NCT01256411|566631670|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156967439|NCT01256411|566631671|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156967440|NCT01256411|566631672|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156967441|NCT01256411|566631673|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
156967442|NCT01256411|566631674|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
156967443|NCT01256411|566631669|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156967444|NCT01256411|566631670|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156967445|NCT01256411|566631671|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156967446|NCT01256411|566631672|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
156967447|NCT01256411|566631673|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
156967448|NCT01256411|566631674|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
156967449|NCT01256411|566631669|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156967450|NCT01256411|566631670|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156967451|NCT01256411|566631671|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156967452|NCT01256411|566631672|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
156967453|NCT01256411|566631673|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
156967454|NCT01256411|566631674|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
156967455|NCT02740049|566631675|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
156967456|NCT02274857|566631676|FG000|Overall Study|Adverse Event|1|||
156967457|NCT02274857|566631677|FG001|Overall Study|Adverse Event|0|||
156967458|NCT02274857|566631676|FG000|Overall Study|Death|1|||
156967459|NCT02274857|566631677|FG001|Overall Study|Death|2|||
156967460|NCT02274857|566631676|FG000|Overall Study|Lost to Follow-up|3|||
156967461|NCT02274857|566631677|FG001|Overall Study|Lost to Follow-up|0|||
156967462|NCT02274857|566631676|FG000|Overall Study|Physician Decision|2|||
156967463|NCT02274857|566631677|FG001|Overall Study|Physician Decision|0|||
156967464|NCT02274857|566631676|FG000|Overall Study|Trial screen failure|0|||
156967465|NCT02274857|566631677|FG001|Overall Study|Trial screen failure|2|||
156967466|NCT02274857|566631676|FG000|Overall Study|Withdrawal by Subject|11|||
156967467|NCT02274857|566631677|FG001|Overall Study|Withdrawal by Subject|2|||
156967468|NCT02274857|566631676|FG000|Overall Study|Other|2|||
156967469|NCT02274857|566631677|FG001|Overall Study|Other|0|||
156967470|NCT02403180|566631680|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
156967471|NCT02403180|566631681|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
156967472|NCT02403180|566631680|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
156967473|NCT02403180|566631681|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
156967474|NCT01445652|566631688|FG000|Overall Study|Not comfortable in lenses|5|||
156967475|NCT01445652|566631689|FG001|Overall Study|Not comfortable in lenses|0|||
156967476|NCT01445652|566631688|FG000|Overall Study|Failed to attend scheduled visit|2|||
156967477|NCT01445652|566631689|FG001|Overall Study|Failed to attend scheduled visit|3|||
156967478|NCT01445652|566631688|FG000|Overall Study|Failed teach session|2|||
156967479|NCT01445652|566631689|FG001|Overall Study|Failed teach session|0|||
156967480|NCT01445652|566631688|FG000|Overall Study|Adverse Event|1|||
156967481|NCT01445652|566631689|FG001|Overall Study|Adverse Event|0|||
156967482|NCT04570436|566631690|FG000|Overall Study|Adverse Event|0|||
156967483|NCT04570436|566631691|FG001|Overall Study|Adverse Event|0|||
156967484|NCT04570436|566631692|FG002|Overall Study|Adverse Event|1|||
156967485|NCT04570436|566631693|FG003|Overall Study|Adverse Event|0|||
156967486|NCT04570436|566631694|FG004|Overall Study|Adverse Event|0|||
157040725|NCT02499328|566903157|FG006|Overall Study|Lost to Follow-up|0|||
157040726|NCT02499328|566903158|FG007|Overall Study|Lost to Follow-up|2|||
157040727|NCT02499328|566903159|FG008|Overall Study|Lost to Follow-up|3|||
157040728|NCT02499328|566903160|FG009|Overall Study|Lost to Follow-up|0|||
157040729|NCT02499328|566903161|FG010|Overall Study|Lost to Follow-up|0|||
157040730|NCT02499328|566903162|FG011|Overall Study|Lost to Follow-up|0|||
157040731|NCT02499328|566903163|FG012|Overall Study|Lost to Follow-up|0|||
157040732|NCT02499328|566903164|FG013|Overall Study|Lost to Follow-up|0|||
157040733|NCT02499328|566903165|FG014|Overall Study|Lost to Follow-up|0|||
157040734|NCT02499328|566903166|FG015|Overall Study|Lost to Follow-up|0|||
157040735|NCT02499328|566903167|FG016|Overall Study|Lost to Follow-up|0|||
157040736|NCT02499328|566903168|FG017|Overall Study|Lost to Follow-up|0|||
157040737|NCT02499328|566903169|FG018|Overall Study|Lost to Follow-up|1|||
157040738|NCT02499328|566903151|FG000|Overall Study|Death|0|||
157040739|NCT02499328|566903152|FG001|Overall Study|Death|3|||
157040740|NCT02499328|566903153|FG002|Overall Study|Death|3|||
157040741|NCT02499328|566903154|FG003|Overall Study|Death|2|||
157040742|NCT02499328|566903155|FG004|Overall Study|Death|4|||
157040743|NCT02499328|566903156|FG005|Overall Study|Death|7|||
157040744|NCT02499328|566903157|FG006|Overall Study|Death|3|||
157040745|NCT02499328|566903158|FG007|Overall Study|Death|0|||
157040746|NCT02499328|566903159|FG008|Overall Study|Death|2|||
157040747|NCT02499328|566903160|FG009|Overall Study|Death|6|||
157040748|NCT02499328|566903161|FG010|Overall Study|Death|6|||
157040749|NCT02499328|566903162|FG011|Overall Study|Death|20|||
157040750|NCT02499328|566903163|FG012|Overall Study|Death|9|||
157040751|NCT02499328|566903164|FG013|Overall Study|Death|7|||
157040752|NCT02499328|566903165|FG014|Overall Study|Death|3|||
157040753|NCT02499328|566903166|FG015|Overall Study|Death|1|||
157040754|NCT02499328|566903167|FG016|Overall Study|Death|1|||
157040755|NCT02499328|566903168|FG017|Overall Study|Death|16|||
157040756|NCT02499328|566903169|FG018|Overall Study|Death|5|||
157040757|NCT02499328|566903151|FG000|Overall Study|"Other"|2|||
157040758|NCT02499328|566903152|FG001|Overall Study|"Other"|2|||
157040759|NCT02499328|566903153|FG002|Overall Study|"Other"|1|||
157040760|NCT02499328|566903154|FG003|Overall Study|"Other"|3|||
157040761|NCT02499328|566903155|FG004|Overall Study|"Other"|6|||
157040762|NCT02499328|566903156|FG005|Overall Study|"Other"|2|||
157040763|NCT02499328|566903157|FG006|Overall Study|"Other"|3|||
157040764|NCT02499328|566903158|FG007|Overall Study|"Other"|4|||
157040765|NCT02499328|566903159|FG008|Overall Study|"Other"|6|||
157040766|NCT02499328|566903160|FG009|Overall Study|"Other"|16|||
157040767|NCT02499328|566903161|FG010|Overall Study|"Other"|13|||
157040768|NCT02499328|566903162|FG011|Overall Study|"Other"|31|||
157040769|NCT02499328|566903163|FG012|Overall Study|"Other"|8|||
157040770|NCT02499328|566903164|FG013|Overall Study|"Other"|7|||
157040771|NCT02499328|566903165|FG014|Overall Study|"Other"|6|||
157040772|NCT02499328|566903166|FG015|Overall Study|"Other"|0|||
157040773|NCT02499328|566903167|FG016|Overall Study|"Other"|0|||
157040774|NCT02499328|566903168|FG017|Overall Study|"Other"|34|||
157040775|NCT02499328|566903169|FG018|Overall Study|"Other"|43|||
157040776|NCT02499328|566903151|FG000|Overall Study|Disease Progression|0|||
157040777|NCT02499328|566903152|FG001|Overall Study|Disease Progression|0|||
157040778|NCT02499328|566903153|FG002|Overall Study|Disease Progression|0|||
157040779|NCT02499328|566903154|FG003|Overall Study|Disease Progression|0|||
157040780|NCT02499328|566903155|FG004|Overall Study|Disease Progression|0|||
157040781|NCT02499328|566903156|FG005|Overall Study|Disease Progression|0|||
157040782|NCT02499328|566903157|FG006|Overall Study|Disease Progression|1|||
157040783|NCT02499328|566903158|FG007|Overall Study|Disease Progression|0|||
157040784|NCT02499328|566903159|FG008|Overall Study|Disease Progression|1|||
157040785|NCT02499328|566903160|FG009|Overall Study|Disease Progression|0|||
157040786|NCT02499328|566903161|FG010|Overall Study|Disease Progression|1|||
157040787|NCT02499328|566903162|FG011|Overall Study|Disease Progression|0|||
157040788|NCT02499328|566903163|FG012|Overall Study|Disease Progression|0|||
157040789|NCT02499328|566903164|FG013|Overall Study|Disease Progression|0|||
157040790|NCT02499328|566903165|FG014|Overall Study|Disease Progression|0|||
157040791|NCT02499328|566903166|FG015|Overall Study|Disease Progression|0|||
157040792|NCT02499328|566903167|FG016|Overall Study|Disease Progression|0|||
157040793|NCT02499328|566903168|FG017|Overall Study|Disease Progression|2|||
157040794|NCT02499328|566903169|FG018|Overall Study|Disease Progression|0|||
157040795|NCT02499328|566903151|FG000|Overall Study|Adverse Event|1|||
157040796|NCT02499328|566903152|FG001|Overall Study|Adverse Event|0|||
157172900|NCT04134728|567373444|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
157172901|NCT04134728|567373445|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
157040797|NCT02499328|566903153|FG002|Overall Study|Adverse Event|0|||
157172902|NCT04134728|567373446|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
157040798|NCT02499328|566903154|FG003|Overall Study|Adverse Event|1|||
157040799|NCT02499328|566903155|FG004|Overall Study|Adverse Event|0|||
157040800|NCT02499328|566903156|FG005|Overall Study|Adverse Event|0|||
157040801|NCT02499328|566903157|FG006|Overall Study|Adverse Event|0|||
157040802|NCT02499328|566903158|FG007|Overall Study|Adverse Event|0|||
157040803|NCT02499328|566903159|FG008|Overall Study|Adverse Event|0|||
157040804|NCT02499328|566903160|FG009|Overall Study|Adverse Event|0|||
157172903|NCT04134728|567373447|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
157172904|NCT04134728|567373442|FG000|Overall Study|Protocol Deviation|0|||
157172905|NCT04134728|567373443|FG001|Overall Study|Protocol Deviation|0|||
157172906|NCT04134728|567373444|FG002|Overall Study|Protocol Deviation|1|||
157172907|NCT04134728|567373445|FG003|Overall Study|Protocol Deviation|0|||
157172908|NCT04134728|567373446|FG004|Overall Study|Protocol Deviation|0|||
157172909|NCT04134728|567373447|FG005|Overall Study|Protocol Deviation|0|||
157172910|NCT04134728|567373442|FG000|Overall Study|Informed Consent Withdrawn|3|||
157172911|NCT04134728|567373443|FG001|Overall Study|Informed Consent Withdrawn|6|||
157172912|NCT04134728|567373444|FG002|Overall Study|Informed Consent Withdrawn|8|||
157172913|NCT04134728|567373445|FG003|Overall Study|Informed Consent Withdrawn|1|||
157172914|NCT04134728|567373446|FG004|Overall Study|Informed Consent Withdrawn|1|||
157172915|NCT04134728|567373447|FG005|Overall Study|Informed Consent Withdrawn|0|||
157172916|NCT04134728|567373442|FG000|Overall Study|Physician Decision|2|||
157172917|NCT04134728|567373443|FG001|Overall Study|Physician Decision|0|||
157172918|NCT04134728|567373444|FG002|Overall Study|Physician Decision|0|||
157172919|NCT04134728|567373445|FG003|Overall Study|Physician Decision|0|||
157172920|NCT04134728|567373446|FG004|Overall Study|Physician Decision|0|||
157172921|NCT04134728|567373447|FG005|Overall Study|Physician Decision|0|||
157172922|NCT04134728|567373442|FG000|Overall Study|Lost to Follow-up|1|||
157172923|NCT04134728|567373443|FG001|Overall Study|Lost to Follow-up|2|||
157172924|NCT04134728|567373444|FG002|Overall Study|Lost to Follow-up|1|||
157172925|NCT04134728|567373445|FG003|Overall Study|Lost to Follow-up|0|||
157172926|NCT04134728|567373446|FG004|Overall Study|Lost to Follow-up|0|||
157172927|NCT04134728|567373447|FG005|Overall Study|Lost to Follow-up|1|||
157172928|NCT04134728|567373442|FG000|Overall Study|Investigator Site Closed|0|||
157172929|NCT04134728|567373443|FG001|Overall Study|Investigator Site Closed|1|||
157172930|NCT04134728|567373444|FG002|Overall Study|Investigator Site Closed|1|||
157172931|NCT04134728|567373445|FG003|Overall Study|Investigator Site Closed|0|||
157172932|NCT04134728|567373446|FG004|Overall Study|Investigator Site Closed|0|||
157172933|NCT04134728|567373447|FG005|Overall Study|Investigator Site Closed|0|||
157172934|NCT03382262|567373448|FG000|Overall Study|Physician Decision|0|||
157172935|NCT03382262|567373449|FG001|Overall Study|Physician Decision|0|||
157172936|NCT03382262|567373450|FG002|Overall Study|Physician Decision|1|||
157172937|NCT03382262|567373451|FG003|Overall Study|Physician Decision|0|||
157172938|NCT03382262|567373448|FG000|Overall Study|Withdrawal by Subject|0|||
156967487|NCT04570436|566631695|FG005|Overall Study|Adverse Event|0|||
156967488|NCT04570436|566631696|FG006|Overall Study|Adverse Event|0|||
156967489|NCT04570436|566631697|FG007|Overall Study|Adverse Event|0|||
156967490|NCT04570436|566631698|FG008|Overall Study|Adverse Event|0|||
156967491|NCT04570436|566631699|FG009|Overall Study|Adverse Event|0|||
156967492|NCT04570436|566631690|FG000|Overall Study|Physician Decision|1|||
156967493|NCT04570436|566631691|FG001|Overall Study|Physician Decision|0|||
156967494|NCT04570436|566631692|FG002|Overall Study|Physician Decision|0|||
156967495|NCT04570436|566631693|FG003|Overall Study|Physician Decision|0|||
156967496|NCT04570436|566631694|FG004|Overall Study|Physician Decision|0|||
156967497|NCT04570436|566631695|FG005|Overall Study|Physician Decision|0|||
156967498|NCT04570436|566631696|FG006|Overall Study|Physician Decision|0|||
156967499|NCT04570436|566631697|FG007|Overall Study|Physician Decision|0|||
156967500|NCT04570436|566631698|FG008|Overall Study|Physician Decision|0|||
156967501|NCT04570436|566631699|FG009|Overall Study|Physician Decision|0|||
156967502|NCT00929162|566631700|FG000|Overall Study|Adverse Event|8|||
156967503|NCT00929162|566631701|FG001|Overall Study|Adverse Event|5|||
156967504|NCT00929162|566631700|FG000|Overall Study|Withdrawal by Subject|3|||
156967505|NCT00929162|566631701|FG001|Overall Study|Withdrawal by Subject|1|||
156967506|NCT00929162|566631700|FG000|Overall Study|Protocol Violation|32|||
156967507|NCT00929162|566631701|FG001|Overall Study|Protocol Violation|30|||
156967508|NCT00929162|566631700|FG000|Overall Study|Other termination reason|5|||
156967509|NCT00929162|566631701|FG001|Overall Study|Other termination reason|6|||
156967510|NCT00658567|566631703|FG000|Overall Study|Adverse Event|5|||
156967511|NCT00658567|566631704|FG001|Overall Study|Adverse Event|2|||
156967512|NCT00658567|566631705|FG002|Overall Study|Adverse Event|3|||
156967513|NCT00658567|566631703|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
156967514|NCT00658567|566631704|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
156967515|NCT00658567|566631705|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
156967516|NCT00658567|566631703|FG000|Overall Study|Physician Decision|0|||
156967517|NCT00658567|566631704|FG001|Overall Study|Physician Decision|1|||
156967518|NCT00658567|566631705|FG002|Overall Study|Physician Decision|0|||
156967519|NCT00658567|566631703|FG000|Overall Study|At Discretion of Sponsor|1|||
156967520|NCT00658567|566631704|FG001|Overall Study|At Discretion of Sponsor|1|||
156967521|NCT00658567|566631705|FG002|Overall Study|At Discretion of Sponsor|1|||
156967522|NCT01755702|566631706|FG000|Wash Out Period I|Other Reason|3|||
156967523|NCT01755702|566631706|FG000|Washout Period II|Other Reason|5|||
157172939|NCT03382262|567373449|FG001|Overall Study|Withdrawal by Subject|0|||
156967524|NCT00691938|566631707|FG000|Overall Study|QTc prolongation|1|||
156967525|NCT00691938|566631708|FG001|Overall Study|QTc prolongation|0|||
157172940|NCT03382262|567373450|FG002|Overall Study|Withdrawal by Subject|0|||
156967526|NCT00691938|566631709|FG002|Overall Study|QTc prolongation|0|||
157172941|NCT03382262|567373451|FG003|Overall Study|Withdrawal by Subject|1|||
157040805|NCT02499328|566903161|FG010|Overall Study|Adverse Event|0|||
157040806|NCT02499328|566903162|FG011|Overall Study|Adverse Event|0|||
157040807|NCT02499328|566903163|FG012|Overall Study|Adverse Event|1|||
157040808|NCT02499328|566903164|FG013|Overall Study|Adverse Event|0|||
157040809|NCT02499328|566903165|FG014|Overall Study|Adverse Event|0|||
157040810|NCT02499328|566903166|FG015|Overall Study|Adverse Event|0|||
157040811|NCT02499328|566903167|FG016|Overall Study|Adverse Event|0|||
157040812|NCT02499328|566903168|FG017|Overall Study|Adverse Event|0|||
157040813|NCT02499328|566903169|FG018|Overall Study|Adverse Event|0|||
157040814|NCT03414684|566903170|FG000|First-course Treatment|Complete response|0|||
157040815|NCT03414684|566903171|FG001|First-course Treatment|Complete response|1|||
157040816|NCT03414684|566903170|FG000|First-course Treatment|Intercurrent illness|1|||
157040817|NCT03414684|566903171|FG001|First-course Treatment|Intercurrent illness|0|||
157040818|NCT03414684|566903170|FG000|First-course Treatment|Progressive Disease|31|||
157040819|NCT03414684|566903171|FG001|First-course Treatment|Progressive Disease|32|||
157040820|NCT03414684|566903170|FG000|First-course Treatment|Adverse Event|1|||
157040821|NCT03414684|566903171|FG001|First-course Treatment|Adverse Event|2|||
157040822|NCT03414684|566903170|FG000|First-course Treatment|Physician Decision|0|||
157040823|NCT03414684|566903171|FG001|First-course Treatment|Physician Decision|1|||
157040824|NCT03414684|566903170|FG000|First-course Treatment|Withdrawal by Subject|0|||
157040825|NCT03414684|566903171|FG001|First-course Treatment|Withdrawal by Subject|1|||
157040826|NCT03414684|566903170|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
157040827|NCT03414684|566903171|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
157040828|NCT03414684|566903170|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
157040829|NCT03414684|566903171|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
157040830|NCT03414684|566903170|FG000|First-course Treatment|Still on treatment|3|||
157040831|NCT03414684|566903171|FG001|First-course Treatment|Still on treatment|0|||
157040832|NCT03414684|566903170|FG000|First-course Treatment|Never started protocol therapy|2|||
157040833|NCT03414684|566903171|FG001|First-course Treatment|Never started protocol therapy|1|||
157040834|NCT03414684|566903170|FG000|Crossover Treatment|Progressive disease|0|||
157040835|NCT03414684|566903171|FG001|Crossover Treatment|Progressive disease|12|||
157040836|NCT03414684|566903170|FG000|Crossover Treatment|Adverse Event|0|||
157040837|NCT03414684|566903171|FG001|Crossover Treatment|Adverse Event|3|||
157040838|NCT03414684|566903170|FG000|Crossover Treatment|Physician Decision|0|||
157040839|NCT03414684|566903171|FG001|Crossover Treatment|Physician Decision|1|||
157040840|NCT03414684|566903170|FG000|Crossover Treatment|Still on treatment|0|||
157040841|NCT03414684|566903171|FG001|Crossover Treatment|Still on treatment|2|||
157040842|NCT02078648|566903172|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
157040843|NCT02078648|566903173|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
157040844|NCT02078648|566903172|FG000|Overall Study|Adverse Event|0|||
157040845|NCT02078648|566903173|FG001|Overall Study|Adverse Event|1|||
157040846|NCT02078648|566903172|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
157040847|NCT02078648|566903173|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
157040848|NCT02078648|566903172|FG000|Overall Study|Withdrawal by Subject|3|||
157040849|NCT02078648|566903173|FG001|Overall Study|Withdrawal by Subject|1|||
157040850|NCT02078648|566903172|FG000|Overall Study|Investigator Decision|5|||
157040851|NCT02078648|566903173|FG001|Overall Study|Investigator Decision|7|||
157040852|NCT02078648|566903172|FG000|Overall Study|Death|1|||
157040853|NCT02078648|566903173|FG001|Overall Study|Death|1|||
157040854|NCT02078648|566903172|FG000|Overall Study|Undefined|0|||
157040855|NCT02078648|566903173|FG001|Overall Study|Undefined|1|||
157040856|NCT04088227|566903174|FG000|Overall Study|Withdrawal by Subject|1|||
157040857|NCT04088227|566903175|FG001|Overall Study|Withdrawal by Subject|0|||
157040858|NCT04088227|566903174|FG000|Overall Study|Surgery postponed >5weeks|1|||
157040859|NCT04088227|566903175|FG001|Overall Study|Surgery postponed >5weeks|0|||
157040860|NCT01855750|566903176|FG000|Overall Study|Death|78|||
157040861|NCT01855750|566903177|FG001|Overall Study|Death|78|||
157040862|NCT01855750|566903176|FG000|Overall Study|Lost to Follow-up|9|||
157040863|NCT01855750|566903177|FG001|Overall Study|Lost to Follow-up|23|||
157040864|NCT01855750|566903176|FG000|Overall Study|Withdrawal by Subject|35|||
157040865|NCT01855750|566903177|FG001|Overall Study|Withdrawal by Subject|28|||
157040866|NCT01855750|566903176|FG000|Overall Study|Sponsor ends the study|297|||
157040867|NCT01855750|566903177|FG001|Overall Study|Sponsor ends the study|290|||
157040868|NCT05379270|566903178|FG000|Overall Study|Withdrawal by Subject|1|||
157040869|NCT05379270|566903179|FG001|Overall Study|Withdrawal by Subject|1|||
157040870|NCT03160885|566903180|FG000|Initial Treatment Period|Not dosed|2|||
157040871|NCT03160885|566903181|FG001|Initial Treatment Period|Not dosed|0|||
157172942|NCT00233324|567373452|FG000|Main Study|Death|68|||
157040872|NCT03160885|566903182|FG002|Initial Treatment Period|Not dosed|0|||
157040873|NCT03160885|566903183|FG003|Initial Treatment Period|Not dosed|0|||
157172943|NCT00233324|567373453|FG001|Main Study|Death|60|||
157172944|NCT00233324|567373454|FG002|Main Study|Death|62|||
157172945|NCT00233324|567373455|FG003|Main Study|Death|47|||
157172946|NCT00233324|567373452|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
157228110|NCT00661999|567581008|FG000|Overall Study|Other Reasons|5|||
157228111|NCT00661999|567581009|FG001|Overall Study|Other Reasons|12|||
157228112|NCT00661999|567581010|FG002|Overall Study|Other Reasons|23|||
157228113|NCT00661999|567581008|FG000|Overall Study|Withdrawal by Subject|30|||
157228114|NCT00661999|567581009|FG001|Overall Study|Withdrawal by Subject|23|||
157228115|NCT00661999|567581010|FG002|Overall Study|Withdrawal by Subject|14|||
157228116|NCT00661999|567581008|FG000|Overall Study|Alternative Treatment|1|||
157228117|NCT00661999|567581009|FG001|Overall Study|Alternative Treatment|0|||
157228118|NCT00661999|567581010|FG002|Overall Study|Alternative Treatment|0|||
157228119|NCT00661999|567581008|FG000|Overall Study|Other Medical Problems|4|||
157228120|NCT00661999|567581009|FG001|Overall Study|Other Medical Problems|4|||
157228121|NCT00661999|567581010|FG002|Overall Study|Other Medical Problems|9|||
157228122|NCT01361126|567581013|FG000|Overall Study|Sponsor decision|0|||
157228123|NCT01361126|567581014|FG001|Overall Study|Sponsor decision|2|||
157228124|NCT00264810|567581015|FG000|Baseline|Withdrawal by Subject|10|||
157228125|NCT00264810|567581016|FG001|Baseline|Withdrawal by Subject|10|||
157228126|NCT00264810|567581015|FG000|Baseline|Physician Decision|7|||
157228127|NCT00264810|567581016|FG001|Baseline|Physician Decision|8|||
157228128|NCT00264810|567581015|FG000|Baseline|Subject Compliance Failure|3|||
157228129|NCT00264810|567581016|FG001|Baseline|Subject Compliance Failure|3|||
157228130|NCT00264810|567581015|FG000|Baseline|Insufficient Seizure Frequency|2|||
157228131|NCT00264810|567581016|FG001|Baseline|Insufficient Seizure Frequency|2|||
157228132|NCT00264810|567581015|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
157228133|NCT00264810|567581016|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
157228134|NCT00264810|567581015|FG000|Baseline|Other|0|||
157228135|NCT00264810|567581016|FG001|Baseline|Other|1|||
157228136|NCT00264810|567581015|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
157228137|NCT00264810|567581016|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
157228138|NCT00264810|567581015|FG000|Stimulation Optimization Period|Death|0|||
157228139|NCT00264810|567581016|FG001|Stimulation Optimization Period|Death|1|||
157228140|NCT00264810|567581015|FG000|Blinded Evaluation Period|Explant due to infection|1|||
157228141|NCT00264810|567581016|FG001|Blinded Evaluation Period|Explant due to infection|1|||
157228142|NCT00264810|567581015|FG000|Open Label Evaluation Period|Explant due to infection|1|||
157228143|NCT00264810|567581016|FG001|Open Label Evaluation Period|Explant due to infection|1|||
157228144|NCT00264810|567581015|FG000|Open Label Evaluation Period|Death|3|||
157228145|NCT00264810|567581016|FG001|Open Label Evaluation Period|Death|2|||
157228146|NCT00264810|567581015|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
157228147|NCT00264810|567581016|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
157228148|NCT02199509|567581020|FG000|Overall Study|Suicidal Ideation|0|||
157228149|NCT02199509|567581021|FG001|Overall Study|Suicidal Ideation|1|||
157228150|NCT02199509|567581020|FG000|Overall Study|Misunderstood titration schedule|1|||
157228151|NCT02199509|567581021|FG001|Overall Study|Misunderstood titration schedule|0|||
157228152|NCT01658943|567581023|FG000|Overall Study|Adverse Event|6|||
157228153|NCT01658943|567581024|FG001|Overall Study|Adverse Event|13|||
157228154|NCT01658943|567581023|FG000|Overall Study|Withdrawal by Subject|9|||
157228155|NCT01658943|567581024|FG001|Overall Study|Withdrawal by Subject|2|||
157228156|NCT01658943|567581023|FG000|Overall Study|Progression/Relapse|39|||
157228157|NCT01658943|567581024|FG001|Overall Study|Progression/Relapse|40|||
157228158|NCT01658943|567581023|FG000|Overall Study|Death|4|||
157228159|NCT01658943|567581024|FG001|Overall Study|Death|2|||
157228160|NCT01658943|567581023|FG000|Overall Study|not protocol specified|4|||
157228161|NCT01658943|567581024|FG001|Overall Study|not protocol specified|1|||
157228162|NCT01658943|567581023|FG000|Overall Study|Not eligible|7|||
157228163|NCT01658943|567581024|FG001|Overall Study|Not eligible|9|||
157228164|NCT01658943|567581023|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
157228165|NCT01658943|567581024|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
157228166|NCT01346410|567581026|FG000|Overall Study|Death|1|||
157228167|NCT02576990|567581027|FG000|Overall Study|Death|29|||
157228168|NCT02576990|567581028|FG001|Overall Study|Death|18|||
157228169|NCT02576990|567581027|FG000|Overall Study|Physician Decision|1|||
157228170|NCT02576990|567581028|FG001|Overall Study|Physician Decision|0|||
156967527|NCT00691938|566631710|FG003|Overall Study|QTc prolongation|0|||
156967528|NCT00691938|566631711|FG004|Overall Study|QTc prolongation|0|||
156967529|NCT00691938|566631712|FG005|Overall Study|QTc prolongation|0|||
156967530|NCT00691938|566631713|FG006|Overall Study|QTc prolongation|0|||
156967531|NCT04860518|566631715|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
156967532|NCT04860518|566631716|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
156967533|NCT00594854|566631720|FG000|Overall Study|Study terminated|7|||
156967534|NCT00594854|566631721|FG001|Overall Study|Study terminated|10|||
157228171|NCT02576990|567581027|FG000|Overall Study|Screen failure|2|||
157228172|NCT02576990|567581028|FG001|Overall Study|Screen failure|0|||
157228173|NCT02576990|567581027|FG000|Overall Study|Sponsor's decision|24|||
157228174|NCT02576990|567581028|FG001|Overall Study|Sponsor's decision|4|||
156967535|NCT03172702|566631724|FG000|Overall Study|Adverse Event|9|||
157228175|NCT02576990|567581027|FG000|Overall Study|Withdrawal by Subject|0|||
157228176|NCT02576990|567581028|FG001|Overall Study|Withdrawal by Subject|2|||
156967536|NCT03172702|566631724|FG000|Overall Study|Death|2|||
156967537|NCT03172702|566631724|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
156967538|NCT03172702|566631724|FG000|Overall Study|Withdrawal by Subject|5|||
156967539|NCT03172702|566631724|FG000|Overall Study|Other|2|||
156967540|NCT03292146|566631725|FG000|Baseline to 12 months|Relocation|1|||
156967541|NCT03292146|566631726|FG001|Baseline to 12 months|Relocation|0|||
156967542|NCT03292146|566631725|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
156967543|NCT03292146|566631726|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
156967544|NCT03292146|566631725|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
156967545|NCT03292146|566631726|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
156967546|NCT03292146|566631725|FG000|12 months to 24 months|Planning pregnancy|2|||
156967547|NCT03292146|566631726|FG001|12 months to 24 months|Planning pregnancy|2|||
156967548|NCT03292146|566631725|FG000|12 months to 24 months|Personal reasons|1|||
156967549|NCT03292146|566631726|FG001|12 months to 24 months|Personal reasons|0|||
156967550|NCT03292146|566631725|FG000|12 months to 24 months|Lost to Follow-up|0|||
156967551|NCT03292146|566631726|FG001|12 months to 24 months|Lost to Follow-up|1|||
156967552|NCT02954354|566631727|FG000|Overall Study|Adverse Event|2|||
156967553|NCT02954354|566631728|FG001|Overall Study|Adverse Event|2|||
156967554|NCT02954354|566631729|FG002|Overall Study|Adverse Event|4|||
156967555|NCT02954354|566631727|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
156967556|NCT02954354|566631728|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
156967557|NCT02954354|566631729|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
156967558|NCT02954354|566631727|FG000|Overall Study|Lack of Efficacy|0|||
156967559|NCT02954354|566631728|FG001|Overall Study|Lack of Efficacy|2|||
156967560|NCT02954354|566631729|FG002|Overall Study|Lack of Efficacy|0|||
156967561|NCT02954354|566631727|FG000|Overall Study|Withdrawal by Subject|17|||
156967562|NCT02954354|566631728|FG001|Overall Study|Withdrawal by Subject|9|||
156967563|NCT02954354|566631729|FG002|Overall Study|Withdrawal by Subject|11|||
156967564|NCT02954354|566631727|FG000|Overall Study|Lost to Follow-up|12|||
156967565|NCT02954354|566631728|FG001|Overall Study|Lost to Follow-up|5|||
156967566|NCT02954354|566631729|FG002|Overall Study|Lost to Follow-up|0|||
156967567|NCT02954354|566631727|FG000|Overall Study|Miscellaneous|2|||
156967568|NCT02954354|566631728|FG001|Overall Study|Miscellaneous|2|||
156967569|NCT02954354|566631729|FG002|Overall Study|Miscellaneous|1|||
156967570|NCT06134180|566631732|FG000|Overall Study|Lost to Follow-up|4|||
156967571|NCT03440372|566631733|FG000|Treatment|Adverse Event|16|||
156967572|NCT03440372|566631734|FG001|Treatment|Adverse Event|8|||
156967573|NCT03440372|566631733|FG000|Treatment|Lack of Efficacy|4|||
156967574|NCT03440372|566631734|FG001|Treatment|Lack of Efficacy|2|||
156967575|NCT03440372|566631733|FG000|Treatment|Withdrawal by Subject|12|||
156967576|NCT03440372|566631734|FG001|Treatment|Withdrawal by Subject|8|||
156967577|NCT03440372|566631733|FG000|Treatment|Lost to Follow-up|1|||
156967578|NCT03440372|566631734|FG001|Treatment|Lost to Follow-up|0|||
156967579|NCT03440372|566631733|FG000|Treatment|Pregnancy|1|||
156967580|NCT03440372|566631734|FG001|Treatment|Pregnancy|0|||
156967581|NCT03440372|566631733|FG000|Treatment|Study Terminated by Sponsor|2|||
156967582|NCT03440372|566631734|FG001|Treatment|Study Terminated by Sponsor|1|||
156967583|NCT03440372|566631733|FG000|Treatment|Other Reason|2|||
156967584|NCT03440372|566631734|FG001|Treatment|Other Reason|3|||
156967585|NCT04642898|566631735|FG000|Overall Study|Withdrawal by Subject|2|||
156967586|NCT04642898|566631736|FG001|Overall Study|Withdrawal by Subject|4|||
156967587|NCT04642898|566631737|FG002|Overall Study|Withdrawal by Subject|4|||
156967588|NCT04642898|566631738|FG003|Overall Study|Withdrawal by Subject|6|||
156967589|NCT04642898|566631739|FG004|Overall Study|Withdrawal by Subject|2|||
156967590|NCT04642898|566631740|FG005|Overall Study|Withdrawal by Subject|6|||
156967591|NCT04642898|566631735|FG000|Overall Study|Lost to Follow-up|0|||
156967592|NCT04642898|566631736|FG001|Overall Study|Lost to Follow-up|0|||
156967593|NCT04642898|566631737|FG002|Overall Study|Lost to Follow-up|0|||
156967594|NCT04642898|566631738|FG003|Overall Study|Lost to Follow-up|2|||
157040874|NCT03160885|566903184|FG004|Initial Treatment Period|Not dosed|0|||
157040875|NCT03160885|566903185|FG005|Initial Treatment Period|Not dosed|0|||
156967595|NCT04642898|566631739|FG004|Overall Study|Lost to Follow-up|0|||
156967596|NCT04642898|566631740|FG005|Overall Study|Lost to Follow-up|1|||
156967597|NCT04642898|566631735|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
156967598|NCT04642898|566631736|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
156967599|NCT04642898|566631737|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
156967600|NCT04642898|566631738|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
156967601|NCT04642898|566631739|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
156967602|NCT04642898|566631740|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
156967603|NCT04642898|566631735|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156967604|NCT04642898|566631736|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156967605|NCT04642898|566631737|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156967606|NCT04642898|566631738|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
157040876|NCT03160885|566903186|FG006|Initial Treatment Period|Not dosed|0|||
157040877|NCT03160885|566903180|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
157040878|NCT03160885|566903181|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
157040879|NCT03160885|566903182|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157040880|NCT03160885|566903183|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157040881|NCT03160885|566903184|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157040882|NCT03160885|566903185|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157040883|NCT03160885|566903186|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
157040884|NCT03160885|566903180|FG000|Open-label Treatment|Not dosed|0|||
157040885|NCT03160885|566903181|FG001|Open-label Treatment|Not dosed|0|||
157040886|NCT03160885|566903182|FG002|Open-label Treatment|Not dosed|0|||
157040887|NCT03160885|566903183|FG003|Open-label Treatment|Not dosed|0|||
157040888|NCT03160885|566903184|FG004|Open-label Treatment|Not dosed|0|||
157040889|NCT03160885|566903185|FG005|Open-label Treatment|Not dosed|0|||
157040890|NCT03160885|566903186|FG006|Open-label Treatment|Not dosed|2|||
157040891|NCT03160885|566903180|FG000|Open-label Treatment|Discontinued IMP|0|||
157040892|NCT03160885|566903181|FG001|Open-label Treatment|Discontinued IMP|0|||
157040893|NCT03160885|566903182|FG002|Open-label Treatment|Discontinued IMP|0|||
157040894|NCT03160885|566903183|FG003|Open-label Treatment|Discontinued IMP|0|||
157040895|NCT03160885|566903184|FG004|Open-label Treatment|Discontinued IMP|0|||
157040896|NCT03160885|566903185|FG005|Open-label Treatment|Discontinued IMP|0|||
157040897|NCT03160885|566903186|FG006|Open-label Treatment|Discontinued IMP|131|||
157040898|NCT03160885|566903180|FG000|Open-label Treatment|Completed Week 50|0|||
157040899|NCT03160885|566903181|FG001|Open-label Treatment|Completed Week 50|0|||
157040900|NCT03160885|566903182|FG002|Open-label Treatment|Completed Week 50|0|||
157040901|NCT03160885|566903183|FG003|Open-label Treatment|Completed Week 50|0|||
157040902|NCT03160885|566903184|FG004|Open-label Treatment|Completed Week 50|0|||
157040903|NCT03160885|566903185|FG005|Open-label Treatment|Completed Week 50|0|||
157040904|NCT03160885|566903186|FG006|Open-label Treatment|Completed Week 50|4|||
157040905|NCT03160885|566903180|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040906|NCT03160885|566903181|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040907|NCT03160885|566903182|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040908|NCT03160885|566903183|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
157040909|NCT03160885|566903184|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040910|NCT03160885|566903185|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040911|NCT03160885|566903186|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
157040912|NCT03160885|566903180|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
157040913|NCT03160885|566903181|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
157040914|NCT03160885|566903182|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
157040915|NCT03160885|566903183|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
157040916|NCT03160885|566903184|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
157040917|NCT03160885|566903185|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
157040918|NCT03160885|566903186|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
157040919|NCT03160885|566903180|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157040920|NCT03160885|566903181|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157040921|NCT03160885|566903182|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
157040922|NCT03160885|566903183|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
157040923|NCT03160885|566903184|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
157040924|NCT03160885|566903185|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
157040925|NCT03160885|566903186|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
157040926|NCT03160885|566903180|FG000|Maintenance Treatment Period|Completed Week 50|0|||
157040927|NCT03160885|566903181|FG001|Maintenance Treatment Period|Completed Week 50|0|||
157040928|NCT03160885|566903182|FG002|Maintenance Treatment Period|Completed Week 50|1|||
157040929|NCT03160885|566903183|FG003|Maintenance Treatment Period|Completed Week 50|0|||
157040930|NCT03160885|566903184|FG004|Maintenance Treatment Period|Completed Week 50|0|||
157040931|NCT03160885|566903185|FG005|Maintenance Treatment Period|Completed Week 50|0|||
157040932|NCT03160885|566903186|FG006|Maintenance Treatment Period|Completed Week 50|0|||
157040933|NCT03425682|566903187|FG000|Overall Study|Lost to Follow-up|2|||
157040934|NCT03425682|566903188|FG001|Overall Study|Lost to Follow-up|4|||
157040935|NCT03425682|566903187|FG000|Overall Study|Withdrawal by Subject|0|||
157040936|NCT03425682|566903188|FG001|Overall Study|Withdrawal by Subject|3|||
157040937|NCT03425682|566903187|FG000|Overall Study|Subject did not meet I/E|4|||
157040938|NCT03425682|566903188|FG001|Overall Study|Subject did not meet I/E|10|||
157040939|NCT03610581|566903189|FG000|Overall Study|Study terminated by sponsor|2|||
157040940|NCT03610581|566903190|FG001|Overall Study|Study terminated by sponsor|0|||
157040941|NCT03610581|566903189|FG000|Overall Study|Other|0|||
157040942|NCT03610581|566903190|FG001|Overall Study|Other|1|||
157040943|NCT03610581|566903189|FG000|Overall Study|Withdrawal by Subject|1|||
157172947|NCT00233324|567373453|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
157040944|NCT03610581|566903190|FG001|Overall Study|Withdrawal by Subject|0|||
157040945|NCT02307682|566903191|FG000|Overall Study|Adverse Event|9|||
157172948|NCT00233324|567373454|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
157228177|NCT00936390|567581029|FG000|Overall Study|Protocol Violation|21|||
157228178|NCT00936390|567581030|FG001|Overall Study|Protocol Violation|25|||
156967607|NCT04642898|566631739|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
156967608|NCT04642898|566631740|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
156967609|NCT04495179|566631741|FG000|Overall Study|Lost to Follow-up|0|||
156967610|NCT04495179|566631742|FG001|Overall Study|Lost to Follow-up|1|||
156967611|NCT04495179|566631741|FG000|Overall Study|Withdrawal by Subject|2|||
156967612|NCT04495179|566631742|FG001|Overall Study|Withdrawal by Subject|4|||
156967613|NCT04495179|566631741|FG000|Overall Study|Study terminated by sponsor|0|||
156967614|NCT04495179|566631742|FG001|Overall Study|Study terminated by sponsor|18|||
156967615|NCT04495179|566631741|FG000|Overall Study|Death|0|||
156967616|NCT04495179|566631742|FG001|Overall Study|Death|4|||
156967617|NCT04495179|566631741|FG000|Overall Study|Adverse Event|0|||
156967618|NCT04495179|566631742|FG001|Overall Study|Adverse Event|1|||
156967619|NCT04280562|566631743|FG000|Study|Adverse Event|2|||
156967620|NCT04280562|566631744|FG001|Study|Adverse Event|0|||
156967621|NCT04280562|566631743|FG000|Study|Lost to Follow-up|3|||
156967622|NCT04280562|566631744|FG001|Study|Lost to Follow-up|3|||
156967623|NCT00162370|566631748|FG000|Efficacy Population|Lost to Follow-up|51|||
156967624|NCT00569582|566631749|FG000|Overall Study|Withdrawal by Subject|5|||
156967625|NCT00569582|566631749|FG000|Overall Study|Death|2|||
156967626|NCT00569582|566631749|FG000|Overall Study|Adverse Event|7|||
156967627|NCT00569582|566631749|FG000|Overall Study|Subject was too ill to travel.|1|||
156967628|NCT00569582|566631749|FG000|Overall Study|Subject was non-compliant.|1|||
156967629|NCT01328080|566631754|FG000|Overall Study|Lost to Follow-up|5|||
156967630|NCT03266770|566631755|FG000|Overall Study|Physician Decision|3|||
156967631|NCT03266770|566631755|FG000|Overall Study|Insufficient study supplies|1|||
156967632|NCT03266770|566631755|FG000|Overall Study|Adverse Event|1|||
156967633|NCT01936857|566631756|FG000|Overall Study|Sent to prison or 06 center|11|||
156967634|NCT01936857|566631757|FG001|Overall Study|Sent to prison or 06 center|12|||
156967635|NCT01936857|566631756|FG000|Overall Study|Lost to Follow-up|10|||
156967636|NCT01936857|566631757|FG001|Overall Study|Lost to Follow-up|7|||
156967637|NCT01936857|566631756|FG000|Overall Study|Death|7|||
156967638|NCT01936857|566631757|FG001|Overall Study|Death|3|||
156967639|NCT01936857|566631756|FG000|Overall Study|Moved|2|||
156967640|NCT01936857|566631757|FG001|Overall Study|Moved|1|||
156967641|NCT01936857|566631756|FG000|Overall Study|Withdrawal by Subject|1|||
156967642|NCT01936857|566631757|FG001|Overall Study|Withdrawal by Subject|0|||
156967643|NCT01936857|566631756|FG000|Overall Study|Side effect of medication|1|||
156967644|NCT01936857|566631757|FG001|Overall Study|Side effect of medication|0|||
156967645|NCT01936857|566631756|FG000|Overall Study|Other|2|||
156967646|NCT01936857|566631757|FG001|Overall Study|Other|2|||
156967647|NCT00490282|566631758|FG000|Overall Study|Withdrawal by Subject|3|||
156967648|NCT05380947|566631763|FG000|Washout Period 1|Not attend visit|1|||
156967649|NCT05380947|566631764|FG001|Washout Period 1|Not attend visit|0|||
156967650|NCT05380947|566631765|FG002|Washout Period 1|Not attend visit|0|||
156967651|NCT05380947|566631766|FG003|Washout Period 1|Not attend visit|0|||
156967652|NCT05380947|566631763|FG000|Washout Period 2|Adverse Event|1|||
156967653|NCT05380947|566631764|FG001|Washout Period 2|Adverse Event|0|||
156967654|NCT05380947|566631765|FG002|Washout Period 2|Adverse Event|0|||
156967655|NCT05380947|566631766|FG003|Washout Period 2|Adverse Event|0|||
156967656|NCT05380947|566631763|FG000|Washout Period 3|Adverse Event|0|||
156967657|NCT05380947|566631764|FG001|Washout Period 3|Adverse Event|1|||
156967658|NCT05380947|566631765|FG002|Washout Period 3|Adverse Event|0|||
156967659|NCT05380947|566631766|FG003|Washout Period 3|Adverse Event|0|||
156967660|NCT05380947|566631763|FG000|Washout Period 3|Not attend visit|0|||
156967661|NCT05380947|566631764|FG001|Washout Period 3|Not attend visit|1|||
156967662|NCT05380947|566631765|FG002|Washout Period 3|Not attend visit|0|||
156967663|NCT05380947|566631766|FG003|Washout Period 3|Not attend visit|1|||
156967664|NCT01563536|566631767|FG000|Overall Study|Withdrawal by Subject|0|||
156967665|NCT01563536|566631768|FG001|Overall Study|Withdrawal by Subject|2|||
156967666|NCT01563536|566631767|FG000|Overall Study|Lost to Follow-up|1|||
156967667|NCT01563536|566631768|FG001|Overall Study|Lost to Follow-up|0|||
156967668|NCT02170025|566631771|FG000|Overall Study|Adverse Event|2|||
156967669|NCT02170025|566631772|FG001|Overall Study|Adverse Event|0|||
156967670|NCT00572195|566631773|FG000|Overall Study|Withdrawal by Subject|50|||
156967671|NCT00572195|566631773|FG000|Overall Study|Death|9|||
156967672|NCT00572195|566631773|FG000|Overall Study|Adverse Event|4|||
156967673|NCT00572195|566631773|FG000|Overall Study|Lost to Follow-up|5|||
156967674|NCT01525602|566631774|FG000|Overall Study|Adverse Event|1|||
156967675|NCT01525602|566631775|FG001|Overall Study|Adverse Event|0|||
156967676|NCT01525602|566631776|FG002|Overall Study|Adverse Event|1|||
157228179|NCT05905783|567581031|FG000|Overall Study|Lost to Follow-up|12|||
156967677|NCT01525602|566631777|FG003|Overall Study|Adverse Event|1|||
156967678|NCT01525602|566631778|FG004|Overall Study|Adverse Event|3|||
156967679|NCT01525602|566631779|FG005|Overall Study|Adverse Event|3|||
156967680|NCT01525602|566631780|FG006|Overall Study|Adverse Event|0|||
156967681|NCT01525602|566631781|FG007|Overall Study|Adverse Event|1|||
156967682|NCT01525602|566631774|FG000|Overall Study|Disease progression|6|||
156967683|NCT01525602|566631775|FG001|Overall Study|Disease progression|3|||
157172949|NCT00233324|567373455|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
157172950|NCT00233324|567373452|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
157172951|NCT00233324|567373453|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
157172952|NCT00233324|567373454|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
157172953|NCT00233324|567373455|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
157172954|NCT00801892|567373456|FG000|Main Study Period|Withdrawal by Subject|0|||
157172955|NCT00801892|567373457|FG001|Main Study Period|Withdrawal by Subject|1|||
157172956|NCT00801892|567373456|FG000|Sham Crossover Period|Lost to Follow-up|0|||
157172957|NCT00801892|567373457|FG001|Sham Crossover Period|Lost to Follow-up|2|||
157172958|NCT01711541|567373458|FG000|Overall Study|Cancel prior to treatment|0|||
157172959|NCT01711541|567373459|FG001|Overall Study|Cancel prior to treatment|0|||
157172960|NCT01711541|567373460|FG002|Overall Study|Cancel prior to treatment|0|||
157172961|NCT01711541|567373461|FG003|Overall Study|Cancel prior to treatment|1|||
157172962|NCT01711541|567373462|FG004|Overall Study|Cancel prior to treatment|0|||
157172963|NCT01711541|567373458|FG000|Overall Study|Ineligible|0|||
157172964|NCT01711541|567373459|FG001|Overall Study|Ineligible|1|||
157172965|NCT01711541|567373460|FG002|Overall Study|Ineligible|0|||
157172966|NCT01711541|567373461|FG003|Overall Study|Ineligible|0|||
157172967|NCT01711541|567373462|FG004|Overall Study|Ineligible|0|||
157172968|NCT00728936|567373463|FG000|Overall Study|Withdrawal by Subject|0|||
157172969|NCT00728936|567373464|FG001|Overall Study|Withdrawal by Subject|0|||
157172970|NCT00728936|567373465|FG002|Overall Study|Withdrawal by Subject|0|||
157172971|NCT00728936|567373466|FG003|Overall Study|Withdrawal by Subject|0|||
157172972|NCT00728936|567373467|FG004|Overall Study|Withdrawal by Subject|0|||
157172973|NCT00728936|567373468|FG005|Overall Study|Withdrawal by Subject|1|||
157172974|NCT00728936|567373469|FG006|Overall Study|Withdrawal by Subject|0|||
157172975|NCT00438464|567373470|FG000|Overall Study|Terminated Early|14|||
157172976|NCT00438464|567373471|FG001|Overall Study|Terminated Early|5|||
157172977|NCT00438464|567373470|FG000|Overall Study|Incomplete data submission|0|||
157172978|NCT00438464|567373471|FG001|Overall Study|Incomplete data submission|2|||
157172979|NCT03943446|567373472|FG000|Overall Study|Lost to Follow-up|0|||
157172980|NCT03943446|567373473|FG001|Overall Study|Lost to Follow-up|0|||
157172981|NCT03943446|567373474|FG002|Overall Study|Lost to Follow-up|1|||
157172982|NCT03943446|567373472|FG000|Overall Study|Withdrawal by Subject|1|||
157172983|NCT03943446|567373473|FG001|Overall Study|Withdrawal by Subject|1|||
157172984|NCT03943446|567373474|FG002|Overall Study|Withdrawal by Subject|2|||
157172985|NCT03943446|567373472|FG000|Overall Study|Study Terminated by Sponsor|1|||
157172986|NCT03943446|567373473|FG001|Overall Study|Study Terminated by Sponsor|2|||
157172987|NCT03943446|567373474|FG002|Overall Study|Study Terminated by Sponsor|1|||
157172988|NCT03943446|567373472|FG000|Overall Study|Reason not Specified|5|||
157172989|NCT03943446|567373473|FG001|Overall Study|Reason not Specified|1|||
157172990|NCT03943446|567373474|FG002|Overall Study|Reason not Specified|3|||
157172991|NCT01281189|567373486|FG000|Overall Study|Adverse Event|7|||
157172992|NCT01281189|567373487|FG001|Overall Study|Adverse Event|9|||
157172993|NCT01281189|567373486|FG000|Overall Study|Lost to Follow-up|6|||
156967684|NCT01525602|566631776|FG002|Overall Study|Disease progression|2|||
156967685|NCT01525602|566631777|FG003|Overall Study|Disease progression|5|||
156967686|NCT01525602|566631778|FG004|Overall Study|Disease progression|22|||
156967687|NCT01525602|566631779|FG005|Overall Study|Disease progression|2|||
156967688|NCT01525602|566631780|FG006|Overall Study|Disease progression|3|||
156967689|NCT01525602|566631781|FG007|Overall Study|Disease progression|3|||
156967690|NCT01525602|566631774|FG000|Overall Study|Clinical progression|2|||
156967691|NCT01525602|566631775|FG001|Overall Study|Clinical progression|0|||
156967692|NCT01525602|566631776|FG002|Overall Study|Clinical progression|0|||
156967693|NCT01525602|566631777|FG003|Overall Study|Clinical progression|0|||
156967694|NCT01525602|566631778|FG004|Overall Study|Clinical progression|0|||
156967695|NCT01525602|566631779|FG005|Overall Study|Clinical progression|0|||
156967696|NCT01525602|566631780|FG006|Overall Study|Clinical progression|1|||
156967697|NCT01525602|566631781|FG007|Overall Study|Clinical progression|1|||
156967698|NCT01525602|566631774|FG000|Overall Study|Non-compliance|0|||
156967699|NCT01525602|566631775|FG001|Overall Study|Non-compliance|0|||
156967700|NCT01525602|566631776|FG002|Overall Study|Non-compliance|0|||
156967701|NCT01525602|566631777|FG003|Overall Study|Non-compliance|0|||
156967702|NCT01525602|566631778|FG004|Overall Study|Non-compliance|1|||
156967703|NCT01525602|566631779|FG005|Overall Study|Non-compliance|0|||
156967704|NCT01525602|566631780|FG006|Overall Study|Non-compliance|0|||
156967705|NCT01525602|566631781|FG007|Overall Study|Non-compliance|0|||
156967706|NCT01525602|566631774|FG000|Overall Study|Withdrawal by Subject|0|||
157172994|NCT01281189|567373487|FG001|Overall Study|Lost to Follow-up|4|||
156967707|NCT01525602|566631775|FG001|Overall Study|Withdrawal by Subject|0|||
157172995|NCT01281189|567373486|FG000|Overall Study|Withdrawal by Subject|21|||
157228180|NCT05905783|567581032|FG001|Overall Study|Lost to Follow-up|18|||
156967708|NCT01525602|566631776|FG002|Overall Study|Withdrawal by Subject|0|||
156967709|NCT01525602|566631777|FG003|Overall Study|Withdrawal by Subject|0|||
157172996|NCT01281189|567373487|FG001|Overall Study|Withdrawal by Subject|24|||
157172997|NCT01281189|567373486|FG000|Overall Study|Physician Decision|2|||
157040946|NCT02307682|566903192|FG001|Overall Study|Adverse Event|8|||
157040947|NCT02307682|566903193|FG002|Overall Study|Adverse Event|12|||
157040948|NCT02307682|566903191|FG000|Overall Study|Lack of Efficacy|1|||
157040949|NCT02307682|566903192|FG001|Overall Study|Lack of Efficacy|0|||
157040950|NCT02307682|566903193|FG002|Overall Study|Lack of Efficacy|1|||
157040951|NCT02307682|566903191|FG000|Overall Study|Physician Decision|2|||
157040952|NCT02307682|566903192|FG001|Overall Study|Physician Decision|2|||
157040953|NCT02307682|566903193|FG002|Overall Study|Physician Decision|8|||
157040954|NCT02307682|566903191|FG000|Overall Study|Progressive Disease|1|||
157040955|NCT02307682|566903192|FG001|Overall Study|Progressive Disease|0|||
157040956|NCT02307682|566903193|FG002|Overall Study|Progressive Disease|0|||
157040957|NCT02307682|566903191|FG000|Overall Study|Withdrawal by Subject|26|||
157040958|NCT02307682|566903192|FG001|Overall Study|Withdrawal by Subject|34|||
157040959|NCT02307682|566903193|FG002|Overall Study|Withdrawal by Subject|23|||
157040960|NCT02307682|566903191|FG000|Overall Study|Death|9|||
157040961|NCT02307682|566903192|FG001|Overall Study|Death|7|||
157040962|NCT02307682|566903193|FG002|Overall Study|Death|12|||
157040963|NCT02307682|566903191|FG000|Overall Study|Lost to Follow-up|1|||
157040964|NCT02307682|566903192|FG001|Overall Study|Lost to Follow-up|5|||
157040965|NCT02307682|566903193|FG002|Overall Study|Lost to Follow-up|6|||
157040966|NCT02307682|566903191|FG000|Overall Study|Protocol Deviation|0|||
157040967|NCT02307682|566903192|FG001|Overall Study|Protocol Deviation|0|||
157040968|NCT02307682|566903193|FG002|Overall Study|Protocol Deviation|2|||
157040969|NCT02307682|566903191|FG000|Overall Study|Other|1|||
157040970|NCT02307682|566903192|FG001|Overall Study|Other|1|||
157040971|NCT02307682|566903193|FG002|Overall Study|Other|0|||
157040972|NCT04218357|566903196|FG000|1st Allocation|Withdrawal by Subject|1|||
157040973|NCT04218357|566903197|FG001|1st Allocation|Withdrawal by Subject|0|||
157040974|NCT05349838|566903198|FG000|Overall Study|Virological Failure|1|||
157040975|NCT05349838|566903199|FG001|Overall Study|Virological Failure|2|||
157040976|NCT05349838|566903198|FG000|Overall Study|Withdrawal by Subject|2|||
157040977|NCT05349838|566903199|FG001|Overall Study|Withdrawal by Subject|3|||
157040978|NCT05349838|566903198|FG000|Overall Study|Adverse Event|3|||
157040979|NCT05349838|566903199|FG001|Overall Study|Adverse Event|1|||
157040980|NCT05349838|566903198|FG000|Overall Study|Lost to Follow-up|1|||
157040981|NCT05349838|566903199|FG001|Overall Study|Lost to Follow-up|2|||
157040982|NCT05349838|566903198|FG000|Overall Study|Other reasons|5|||
157172998|NCT01281189|567373487|FG001|Overall Study|Physician Decision|3|||
157172999|NCT01281189|567373486|FG000|Overall Study|Death|103|||
157173000|NCT01281189|567373487|FG001|Overall Study|Death|91|||
157173001|NCT01281189|567373486|FG000|Overall Study|Other|8|||
157173002|NCT01281189|567373487|FG001|Overall Study|Other|12|||
157173003|NCT05355818|567373488|FG000|Overall Study|Adverse Event|1|||
157173004|NCT05355818|567373489|FG001|Overall Study|Adverse Event|1|||
157228181|NCT05905783|567581031|FG000|Overall Study|Withdrawal by Subject|29|||
156967710|NCT01525602|566631778|FG004|Overall Study|Withdrawal by Subject|3|||
157040983|NCT05349838|566903199|FG001|Overall Study|Other reasons|1|||
157173005|NCT05355818|567373488|FG000|Overall Study|Lack of Efficacy|2|||
157173006|NCT05355818|567373489|FG001|Overall Study|Lack of Efficacy|1|||
157173007|NCT05355818|567373488|FG000|Overall Study|Lost to Follow-up|0|||
156967711|NCT01525602|566631779|FG005|Overall Study|Withdrawal by Subject|1|||
156967712|NCT01525602|566631780|FG006|Overall Study|Withdrawal by Subject|0|||
156967713|NCT01525602|566631781|FG007|Overall Study|Withdrawal by Subject|1|||
156967714|NCT01525602|566631774|FG000|Overall Study|Physician Decision|0|||
156967715|NCT01525602|566631775|FG001|Overall Study|Physician Decision|0|||
156967716|NCT01525602|566631776|FG002|Overall Study|Physician Decision|0|||
156967717|NCT01525602|566631777|FG003|Overall Study|Physician Decision|0|||
156967718|NCT01525602|566631778|FG004|Overall Study|Physician Decision|3|||
156967719|NCT01525602|566631779|FG005|Overall Study|Physician Decision|0|||
156967720|NCT01525602|566631780|FG006|Overall Study|Physician Decision|1|||
156967721|NCT01525602|566631781|FG007|Overall Study|Physician Decision|0|||
156967722|NCT01525602|566631774|FG000|Overall Study|Death|0|||
156967723|NCT01525602|566631775|FG001|Overall Study|Death|0|||
157040984|NCT05071430|566903201|FG000|Overall Study|Adverse Event|1|||
157173008|NCT05355818|567373489|FG001|Overall Study|Lost to Follow-up|1|||
157173009|NCT01601704|567373491|FG000|Overall Study|Randomized but not dispensed study med|1|||
157173010|NCT01601704|567373492|FG001|Overall Study|Randomized but not dispensed study med|4|||
156967724|NCT01525602|566631776|FG002|Overall Study|Death|0|||
157040985|NCT05071430|566903202|FG001|Overall Study|Adverse Event|2|||
157040986|NCT05071430|566903201|FG000|Overall Study|Lost to Follow-up|4|||
157040987|NCT05071430|566903202|FG001|Overall Study|Lost to Follow-up|4|||
157040988|NCT05071430|566903201|FG000|Overall Study|Protocol Violation|1|||
156967725|NCT01525602|566631777|FG003|Overall Study|Death|0|||
157040989|NCT05071430|566903202|FG001|Overall Study|Protocol Violation|0|||
157040990|NCT05071430|566903201|FG000|Overall Study|Withdrawal by Subject|3|||
157040991|NCT05071430|566903202|FG001|Overall Study|Withdrawal by Subject|2|||
157173011|NCT04897594|567373495|FG000|Overall Study|Lost to Follow-up|0|||
157173012|NCT04897594|567373496|FG001|Overall Study|Lost to Follow-up|1|||
157173013|NCT04897594|567373497|FG002|Overall Study|Lost to Follow-up|1|||
157040992|NCT05071430|566903201|FG000|Overall Study|Other|1|||
157040993|NCT05071430|566903202|FG001|Overall Study|Other|1|||
157040994|NCT01958021|566903203|FG000|Treatment|Progressive disease|206|||
157040995|NCT01958021|566903204|FG001|Treatment|Progressive disease|265|||
157040996|NCT01958021|566903203|FG000|Treatment|Adverse Event|38|||
157040997|NCT01958021|566903204|FG001|Treatment|Adverse Event|10|||
157040998|NCT01958021|566903203|FG000|Treatment|Subject/guardian decision|29|||
157040999|NCT01958021|566903204|FG001|Treatment|Subject/guardian decision|25|||
157041000|NCT01958021|566903203|FG000|Treatment|Physician Decision|28|||
157041001|NCT01958021|566903204|FG001|Treatment|Physician Decision|21|||
157041002|NCT01958021|566903203|FG000|Treatment|Death|6|||
157041003|NCT01958021|566903204|FG001|Treatment|Death|1|||
157041004|NCT01958021|566903203|FG000|Treatment|Protocol deviation|3|||
157041005|NCT01958021|566903204|FG001|Treatment|Protocol deviation|1|||
157041006|NCT01958021|566903203|FG000|Treatment|Sponsor decision|24|||
157041007|NCT01958021|566903204|FG001|Treatment|Sponsor decision|11|||
157041008|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
157041009|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
157041010|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Death|1|||
157041011|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Death|0|||
157041012|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
157041013|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
157041014|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
157041015|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
157041016|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
157041017|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
157041018|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
157041019|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
157041020|NCT01958021|566903203|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
157041021|NCT01958021|566903204|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
157041022|NCT02157116|566904573|FG000|Overall Study|Withdrawal by Subject|4|||
157041023|NCT02157116|566904573|FG000|Overall Study|Physician Decision|3|||
157041024|NCT02157116|566904573|FG000|Overall Study|Failed Screening|2|||
157041025|NCT00975585|566904574|FG000|Overall Study|Adverse Event|0|||
157041026|NCT00975585|566904575|FG001|Overall Study|Adverse Event|4|||
157041027|NCT00975585|566904574|FG000|Overall Study|Lost to Follow-up|3|||
157041028|NCT00975585|566904575|FG001|Overall Study|Lost to Follow-up|5|||
157041029|NCT00975585|566904574|FG000|Overall Study|Withdrawal by Subject|2|||
157041030|NCT00975585|566904575|FG001|Overall Study|Withdrawal by Subject|1|||
157041031|NCT00975585|566904574|FG000|Overall Study|Lens issue|2|||
157041032|NCT00975585|566904575|FG001|Overall Study|Lens issue|2|||
157041033|NCT01953224|566904576|FG000|Overall Study|Lost to Follow-up|1|||
157041034|NCT01953224|566904577|FG001|Overall Study|Lost to Follow-up|1|||
157041035|NCT01953224|566904576|FG000|Overall Study|Withdrawal by Subject|1|||
157041036|NCT01953224|566904577|FG001|Overall Study|Withdrawal by Subject|2|||
157041037|NCT00683800|566904578|FG000|Overall Study|Adverse Event|195|||
157041038|NCT00683800|566904579|FG001|Overall Study|Adverse Event|102|||
157041039|NCT00683800|566904578|FG000|Overall Study|Death|0|||
157041040|NCT00683800|566904579|FG001|Overall Study|Death|1|||
157041041|NCT00683800|566904578|FG000|Overall Study|Lost to Follow-up|57|||
157041042|NCT00683800|566904579|FG001|Overall Study|Lost to Follow-up|44|||
157041043|NCT00683800|566904578|FG000|Overall Study|Other|5|||
157041044|NCT00683800|566904579|FG001|Overall Study|Other|2|||
157041045|NCT00683800|566904578|FG000|Overall Study|Protocol Violation|13|||
157041046|NCT00683800|566904579|FG001|Overall Study|Protocol Violation|16|||
157041047|NCT00683800|566904578|FG000|Overall Study|Withdrawal by Subject|66|||
157041048|NCT00683800|566904579|FG001|Overall Study|Withdrawal by Subject|64|||
157041049|NCT00683800|566904578|FG000|Overall Study|Lack of Efficacy|61|||
157041050|NCT00683800|566904579|FG001|Overall Study|Lack of Efficacy|104|||
157041051|NCT00683800|566904578|FG000|Overall Study|Randomized, not treated|35|||
157041052|NCT00683800|566904579|FG001|Overall Study|Randomized, not treated|33|||
157041053|NCT01359150|566904580|FG000|Overall Study|Lack of Efficacy|1|||
157041054|NCT01359150|566904581|FG001|Overall Study|Lack of Efficacy|1|||
157041055|NCT01359150|566904580|FG000|Overall Study|Withdrawal by Subject|1|||
157041056|NCT01359150|566904581|FG001|Overall Study|Withdrawal by Subject|1|||
157041057|NCT01359150|566904580|FG000|Overall Study|Adverse Event|4|||
157041058|NCT01359150|566904581|FG001|Overall Study|Adverse Event|3|||
157041059|NCT01359150|566904580|FG000|Overall Study|Other|1|||
157041060|NCT01359150|566904581|FG001|Overall Study|Other|0|||
157041061|NCT01619059|566904586|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
157041062|NCT01619059|566904587|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
157041063|NCT01619059|566904586|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
157041064|NCT01619059|566904587|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
157041065|NCT01619059|566904586|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
157041066|NCT01619059|566904587|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
157041067|NCT01619059|566904586|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
157228182|NCT05905783|567581032|FG001|Overall Study|Withdrawal by Subject|37|||
157228183|NCT05905783|567581031|FG000|Overall Study|Decision by sponsor|69|||
157041068|NCT01619059|566904587|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
157173014|NCT04897594|567373495|FG000|Overall Study|Sponsor Decision|0|||
156967726|NCT01525602|566631778|FG004|Overall Study|Death|1|||
156967727|NCT01525602|566631779|FG005|Overall Study|Death|1|||
156967728|NCT01525602|566631780|FG006|Overall Study|Death|0|||
156967729|NCT01525602|566631781|FG007|Overall Study|Death|0|||
156967730|NCT01525602|566631774|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967731|NCT01525602|566631775|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967732|NCT01525602|566631776|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967733|NCT01525602|566631777|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967734|NCT01525602|566631778|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967735|NCT01525602|566631779|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
156967736|NCT01525602|566631780|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
156967737|NCT01525602|566631781|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
156967738|NCT03703466|566631782|FG000|Overall Study|Death|2|||
156967739|NCT03703466|566631783|FG001|Overall Study|Death|1|||
156967740|NCT03703466|566631784|FG002|Overall Study|Death|0|||
156967741|NCT03703466|566631782|FG000|Overall Study|Withdrawal by Subject|0|||
156967742|NCT03703466|566631783|FG001|Overall Study|Withdrawal by Subject|3|||
156967743|NCT03703466|566631784|FG002|Overall Study|Withdrawal by Subject|0|||
156967744|NCT03703466|566631782|FG000|Overall Study|Completed < 3 Cycles|2|||
156967745|NCT03703466|566631783|FG001|Overall Study|Completed < 3 Cycles|2|||
156967746|NCT03703466|566631784|FG002|Overall Study|Completed < 3 Cycles|2|||
156967747|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
156967748|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
156967749|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
156967750|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
156967751|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
156967752|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
156967753|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
156967754|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
156967755|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
156967756|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
156967757|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
156967758|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
157041069|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
157041070|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
157041071|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
157041072|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
157041073|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
157041074|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
157041075|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Death|1|||
157041076|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Death|0|||
157041077|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
157041078|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
157041079|NCT01619059|566904586|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
157041080|NCT01619059|566904587|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
157041081|NCT03229408|566904588|FG000|Overall Study|Withdrawal by Subject|4|||
157041082|NCT03229408|566904589|FG001|Overall Study|Withdrawal by Subject|1|||
157041083|NCT03229408|566904588|FG000|Overall Study|Adverse Event|2|||
157041084|NCT03229408|566904589|FG001|Overall Study|Adverse Event|0|||
157041085|NCT03229408|566904588|FG000|Overall Study|Pregnancy|0|||
157041086|NCT03229408|566904589|FG001|Overall Study|Pregnancy|1|||
157041087|NCT03229408|566904588|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
157041088|NCT03229408|566904589|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
157041089|NCT03683576|566904597|FG000|Overall Study|Withdrawal by Subject|2|||
157041090|NCT03683576|566904598|FG001|Overall Study|Withdrawal by Subject|0|||
157041091|NCT03683576|566904599|FG002|Overall Study|Withdrawal by Subject|8|||
157041092|NCT03683576|566904600|FG003|Overall Study|Withdrawal by Subject|3|||
157041093|NCT03683576|566904597|FG000|Overall Study|Adverse Event|3|||
157041094|NCT03683576|566904598|FG001|Overall Study|Adverse Event|0|||
156967759|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
156967760|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
157041095|NCT03683576|566904599|FG002|Overall Study|Adverse Event|0|||
156967761|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
156967762|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
157041096|NCT03683576|566904600|FG003|Overall Study|Adverse Event|4|||
157041097|NCT03683576|566904597|FG000|Overall Study|Lack of Efficacy|1|||
157041098|NCT03683576|566904598|FG001|Overall Study|Lack of Efficacy|0|||
157041099|NCT03683576|566904599|FG002|Overall Study|Lack of Efficacy|1|||
157041100|NCT03683576|566904600|FG003|Overall Study|Lack of Efficacy|1|||
157041101|NCT03683576|566904597|FG000|Overall Study|Lost to Follow-up|0|||
157041102|NCT03683576|566904598|FG001|Overall Study|Lost to Follow-up|1|||
157041103|NCT03683576|566904599|FG002|Overall Study|Lost to Follow-up|2|||
157041104|NCT03683576|566904600|FG003|Overall Study|Lost to Follow-up|0|||
157041105|NCT03683576|566904597|FG000|Overall Study|Other, Not Specified|0|||
157041106|NCT03683576|566904598|FG001|Overall Study|Other, Not Specified|2|||
157041107|NCT03683576|566904599|FG002|Overall Study|Other, Not Specified|0|||
157041108|NCT03683576|566904600|FG003|Overall Study|Other, Not Specified|0|||
157041109|NCT03683576|566904597|FG000|Overall Study|Protocol Violation|0|||
157041110|NCT03683576|566904598|FG001|Overall Study|Protocol Violation|1|||
157041111|NCT03683576|566904599|FG002|Overall Study|Protocol Violation|1|||
157041112|NCT03683576|566904600|FG003|Overall Study|Protocol Violation|0|||
157173015|NCT04897594|567373496|FG001|Overall Study|Sponsor Decision|0|||
157173016|NCT04897594|567373497|FG002|Overall Study|Sponsor Decision|1|||
157173017|NCT04897594|567373495|FG000|Overall Study|Withdrawal by Subject|1|||
157173018|NCT04897594|567373496|FG001|Overall Study|Withdrawal by Subject|0|||
157173019|NCT04897594|567373497|FG002|Overall Study|Withdrawal by Subject|1|||
157173020|NCT00511108|567373498|FG000|Overall Study|Adverse Event|2|||
157173021|NCT00511108|567373499|FG001|Overall Study|Adverse Event|0|||
157173022|NCT00511108|567373500|FG002|Overall Study|Adverse Event|1|||
157173023|NCT00511108|567373501|FG003|Overall Study|Adverse Event|2|||
157173024|NCT00511108|567373498|FG000|Overall Study|Lost to Follow-up|0|||
157173025|NCT00511108|567373499|FG001|Overall Study|Lost to Follow-up|2|||
157173026|NCT00511108|567373500|FG002|Overall Study|Lost to Follow-up|1|||
157173027|NCT00511108|567373501|FG003|Overall Study|Lost to Follow-up|0|||
157173028|NCT00511108|567373498|FG000|Overall Study|Physician Decision|0|||
157173029|NCT00511108|567373499|FG001|Overall Study|Physician Decision|0|||
157173030|NCT00511108|567373500|FG002|Overall Study|Physician Decision|0|||
157173031|NCT00511108|567373501|FG003|Overall Study|Physician Decision|1|||
157173032|NCT00511108|567373498|FG000|Overall Study|Withdrawal by Subject|4|||
157173033|NCT00511108|567373499|FG001|Overall Study|Withdrawal by Subject|0|||
157173034|NCT00511108|567373500|FG002|Overall Study|Withdrawal by Subject|3|||
157173035|NCT00511108|567373501|FG003|Overall Study|Withdrawal by Subject|2|||
157173036|NCT02147691|567373502|FG000|Overall Study|Withdrawal by Subject|2|||
157173037|NCT02147691|567373503|FG001|Overall Study|Withdrawal by Subject|0|||
157173038|NCT02147691|567373502|FG000|Overall Study|Adverse Event|2|||
157173039|NCT02147691|567373503|FG001|Overall Study|Adverse Event|0|||
157173040|NCT02147691|567373502|FG000|Overall Study|Lost to Follow-up|0|||
157173041|NCT02147691|567373503|FG001|Overall Study|Lost to Follow-up|1|||
157173042|NCT02432703|567373506|FG000|Overall Study|Adverse Event|1|||
157173043|NCT02432703|567373507|FG001|Overall Study|Adverse Event|4|||
157173044|NCT02432703|567373506|FG000|Overall Study|Lack of Efficacy|1|||
157173045|NCT02432703|567373507|FG001|Overall Study|Lack of Efficacy|0|||
157173046|NCT02432703|567373506|FG000|Overall Study|Lost to Follow-up|5|||
157173047|NCT02432703|567373507|FG001|Overall Study|Lost to Follow-up|3|||
157173048|NCT02432703|567373506|FG000|Overall Study|Withdrawal by Subject|9|||
157173049|NCT02432703|567373507|FG001|Overall Study|Withdrawal by Subject|6|||
157173050|NCT02432703|567373506|FG000|Overall Study|Other|6|||
157173051|NCT02432703|567373507|FG001|Overall Study|Other|5|||
157173052|NCT04325906|567373511|FG000|Overall Study|Withdrawal by Subject|2|||
157173053|NCT04325906|567373512|FG001|Overall Study|Withdrawal by Subject|0|||
157173054|NCT01628393|567373517|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
157041113|NCT01588951|566904601|FG000|Overall Study|Ineligible in retrospect|0|||
157041114|NCT01588951|566904602|FG001|Overall Study|Ineligible in retrospect|0|||
157041115|NCT01588951|566904603|FG002|Overall Study|Ineligible in retrospect|1|||
157041116|NCT03488719|566904606|FG000|Overall Study|Adverse Event|0|||
157041117|NCT03488719|566904607|FG001|Overall Study|Adverse Event|4|||
157173055|NCT01628393|567373518|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157173056|NCT01628393|567373519|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157173057|NCT01628393|567373520|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157173058|NCT01628393|567373521|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
157173059|NCT01628393|567373517|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
157173060|NCT01628393|567373518|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
157173061|NCT01628393|567373519|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
157173062|NCT01628393|567373520|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
157173063|NCT01628393|567373521|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
157173064|NCT01628393|567373517|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
157173065|NCT01628393|567373518|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
157173066|NCT01628393|567373519|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
157173067|NCT01628393|567373520|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
157173068|NCT01628393|567373521|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
157173069|NCT01628393|567373517|FG000|Blinded Active Extension Period|Adverse Event|0|||
157173070|NCT01628393|567373518|FG001|Blinded Active Extension Period|Adverse Event|1|||
157173071|NCT01628393|567373519|FG002|Blinded Active Extension Period|Adverse Event|0|||
157173072|NCT01628393|567373520|FG003|Blinded Active Extension Period|Adverse Event|2|||
157041118|NCT03488719|566904608|FG002|Overall Study|Adverse Event|2|||
157041119|NCT03488719|566904606|FG000|Overall Study|Other|0|||
157041120|NCT03488719|566904607|FG001|Overall Study|Other|0|||
157041121|NCT03488719|566904608|FG002|Overall Study|Other|5|||
157041122|NCT04038580|566904612|FG000|Washout 1|Death|0|||
157041123|NCT04038580|566904613|FG001|Washout 1|Death|0|||
157041124|NCT04038580|566904614|FG002|Washout 1|Death|0|||
157041125|NCT04038580|566904615|FG003|Washout 1|Death|1|||
157041126|NCT04038580|566904616|FG004|Washout 1|Death|0|||
157041127|NCT04038580|566904617|FG005|Washout 1|Death|0|||
157041128|NCT04038580|566904612|FG000|Washout 1|Withdrawal by Subject|0|||
157041129|NCT04038580|566904613|FG001|Washout 1|Withdrawal by Subject|0|||
157041130|NCT04038580|566904614|FG002|Washout 1|Withdrawal by Subject|0|||
157041131|NCT04038580|566904615|FG003|Washout 1|Withdrawal by Subject|0|||
157041132|NCT04038580|566904616|FG004|Washout 1|Withdrawal by Subject|1|||
157041133|NCT04038580|566904617|FG005|Washout 1|Withdrawal by Subject|0|||
157041134|NCT04038580|566904612|FG000|Wash-out 2|Withdrawal by Subject|1|||
157041135|NCT04038580|566904613|FG001|Wash-out 2|Withdrawal by Subject|0|||
157041136|NCT04038580|566904614|FG002|Wash-out 2|Withdrawal by Subject|0|||
157041137|NCT04038580|566904615|FG003|Wash-out 2|Withdrawal by Subject|2|||
157041138|NCT04038580|566904616|FG004|Wash-out 2|Withdrawal by Subject|0|||
157041139|NCT04038580|566904617|FG005|Wash-out 2|Withdrawal by Subject|1|||
157041140|NCT04038580|566904612|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
157041141|NCT04038580|566904613|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
157041142|NCT04038580|566904614|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
157041143|NCT04038580|566904615|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
157041144|NCT04038580|566904616|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
157041145|NCT04038580|566904617|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
157041146|NCT04038580|566904612|FG000|Wash-out 3|Withdrawal by Subject|1|||
157041147|NCT04038580|566904613|FG001|Wash-out 3|Withdrawal by Subject|0|||
157041148|NCT04038580|566904614|FG002|Wash-out 3|Withdrawal by Subject|2|||
157173073|NCT01628393|567373521|FG004|Blinded Active Extension Period|Adverse Event|2|||
157173074|NCT01628393|567373517|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
157173075|NCT01628393|567373518|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
157173076|NCT01628393|567373519|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
156967763|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
156967764|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
156967765|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
156967766|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
156967767|NCT00549757|566633688|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
156967768|NCT00549757|566633689|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
156967769|NCT00549757|566633688|FG000|Extension Period (in Average 9 Months)|Death|143|||
156967770|NCT00549757|566633689|FG001|Extension Period (in Average 9 Months)|Death|136|||
156967771|NCT00549757|566633688|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
157173077|NCT01628393|567373520|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
157173078|NCT01628393|567373521|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
157173079|NCT01628393|567373517|FG000|Blinded Active Extension Period|Physician Decision|0|||
157173080|NCT01628393|567373518|FG001|Blinded Active Extension Period|Physician Decision|3|||
157173081|NCT01628393|567373519|FG002|Blinded Active Extension Period|Physician Decision|0|||
157173082|NCT01628393|567373520|FG003|Blinded Active Extension Period|Physician Decision|1|||
156967772|NCT00549757|566633689|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
156967773|NCT00549757|566633688|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
156967774|NCT00549757|566633689|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
156967775|NCT00549757|566633688|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
156967776|NCT00549757|566633689|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
156967777|NCT00105235|566633690|FG000|Overall Study|Death|4|||
156967778|NCT00105235|566633690|FG000|Overall Study|Physician Decision|1|||
156967779|NCT00105235|566633690|FG000|Overall Study|Withdrawal by Subject|2|||
156967780|NCT02052310|566633691|FG000|Overall Study|Death|64|||
156967781|NCT02052310|566633692|FG001|Overall Study|Death|54|||
157041149|NCT04038580|566904615|FG003|Wash-out 3|Withdrawal by Subject|0|||
157041150|NCT04038580|566904616|FG004|Wash-out 3|Withdrawal by Subject|0|||
157041151|NCT04038580|566904617|FG005|Wash-out 3|Withdrawal by Subject|0|||
157041152|NCT03477175|566904618|FG000|Overall Study|Unable to travel due to COVID-19|0|||
157173083|NCT01628393|567373521|FG004|Blinded Active Extension Period|Physician Decision|0|||
157173084|NCT01628393|567373517|FG000|Blinded Active Extension Period|Protocol Violation|0|||
157173085|NCT01628393|567373518|FG001|Blinded Active Extension Period|Protocol Violation|0|||
157173086|NCT01628393|567373519|FG002|Blinded Active Extension Period|Protocol Violation|2|||
157228184|NCT05905783|567581032|FG001|Overall Study|Decision by sponsor|65|||
157041153|NCT03477175|566904619|FG001|Overall Study|Unable to travel due to COVID-19|1|||
157041154|NCT03477175|566904618|FG000|Overall Study|Physician Decision|1|||
157041155|NCT03477175|566904619|FG001|Overall Study|Physician Decision|0|||
157041156|NCT03477175|566904618|FG000|Overall Study|Transitioned to commercial drug|6|||
157041157|NCT03477175|566904619|FG001|Overall Study|Transitioned to commercial drug|6|||
157041158|NCT03477175|566904618|FG000|Overall Study|Lost to Follow-up|1|||
156967782|NCT02052310|566633691|FG000|Overall Study|Withdrawal by Subject|37|||
156967783|NCT02052310|566633692|FG001|Overall Study|Withdrawal by Subject|49|||
156967784|NCT02052310|566633691|FG000|Overall Study|Other than specified|32|||
156967785|NCT02052310|566633692|FG001|Overall Study|Other than specified|29|||
156967786|NCT02052310|566633691|FG000|Overall Study|Adverse Event|29|||
156967787|NCT02052310|566633692|FG001|Overall Study|Adverse Event|22|||
156967788|NCT02052310|566633691|FG000|Overall Study|Kidney Transplant|23|||
156967789|NCT02052310|566633692|FG001|Overall Study|Kidney Transplant|29|||
156967790|NCT02052310|566633691|FG000|Overall Study|Physician Decision|14|||
156967791|NCT02052310|566633692|FG001|Overall Study|Physician Decision|7|||
156967792|NCT02052310|566633691|FG000|Overall Study|Lack of Efficacy|6|||
156967793|NCT02052310|566633692|FG001|Overall Study|Lack of Efficacy|1|||
156967794|NCT02052310|566633691|FG000|Overall Study|Site Terminated by Sponsor|5|||
156967795|NCT02052310|566633692|FG001|Overall Study|Site Terminated by Sponsor|13|||
156967796|NCT02052310|566633691|FG000|Overall Study|Lost to Follow-up|4|||
156967797|NCT02052310|566633692|FG001|Overall Study|Lost to Follow-up|2|||
156967798|NCT02052310|566633691|FG000|Overall Study|Protocol Violation|1|||
156967799|NCT02052310|566633692|FG001|Overall Study|Protocol Violation|6|||
156967800|NCT01964326|566633693|FG000|Overall Study|Adverse Event|48|||
156967801|NCT01964326|566633693|FG000|Overall Study|Death|2|||
156967802|NCT01964326|566633693|FG000|Overall Study|Protocol Violation|4|||
156967803|NCT01964326|566633693|FG000|Overall Study|Lost to Follow-up|88|||
156967804|NCT01964326|566633693|FG000|Overall Study|Withdrawal by Subject|87|||
156967805|NCT01964326|566633693|FG000|Overall Study|Pregnancy|1|||
156967806|NCT01964326|566633693|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
156967807|NCT01964326|566633693|FG000|Overall Study|Physician Decision|55|||
156967808|NCT01964326|566633693|FG000|Overall Study|Investigator Discretion|1|||
156967809|NCT01964326|566633693|FG000|Overall Study|Other|9|||
156967810|NCT01964326|566633693|FG000|Overall Study|Did not meet eligibility criteria|1|||
156967811|NCT02093663|566633702|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
156967812|NCT02093663|566633703|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156967813|NCT02093663|566633704|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156967814|NCT02093663|566633705|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156967815|NCT02093663|566633706|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
156967816|NCT02093663|566633702|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
156967817|NCT02093663|566633703|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967818|NCT02093663|566633704|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967819|NCT02093663|566633705|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967820|NCT02093663|566633706|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967821|NCT02093663|566633702|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
156967822|NCT02093663|566633703|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
156967823|NCT02093663|566633704|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156967824|NCT02093663|566633705|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156967825|NCT02093663|566633706|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
156967826|NCT02093663|566633702|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156967827|NCT02093663|566633703|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156967828|NCT02093663|566633704|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
156967829|NCT02093663|566633705|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156967830|NCT02093663|566633706|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
156967831|NCT02093663|566633702|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967832|NCT02093663|566633703|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967833|NCT02093663|566633704|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
156967834|NCT02093663|566633705|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967835|NCT02093663|566633706|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
156967836|NCT02093663|566633702|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156967837|NCT02093663|566633703|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156967838|NCT02093663|566633704|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
156967839|NCT02093663|566633705|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
156967840|NCT02093663|566633706|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
156967841|NCT02093663|566633702|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156967842|NCT02093663|566633703|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156967843|NCT02093663|566633704|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
156967844|NCT02093663|566633705|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
156967845|NCT02093663|566633706|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
156967846|NCT02093663|566633702|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156967847|NCT02093663|566633703|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156967848|NCT02093663|566633704|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
156967849|NCT02093663|566633705|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
156967850|NCT02093663|566633706|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
156967851|NCT02093663|566633702|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
157041159|NCT03477175|566904619|FG001|Overall Study|Lost to Follow-up|1|||
157041160|NCT03477175|566904618|FG000|Overall Study|Withdrawal by Subject|3|||
157041161|NCT03477175|566904619|FG001|Overall Study|Withdrawal by Subject|1|||
157041162|NCT03477175|566904618|FG000|Overall Study|Adverse Event|1|||
157041163|NCT03477175|566904619|FG001|Overall Study|Adverse Event|5|||
157041164|NCT03477175|566904618|FG000|Overall Study|Disease Progression|7|||
157041165|NCT03477175|566904619|FG001|Overall Study|Disease Progression|7|||
157041166|NCT04021862|566904620|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
157041167|NCT04021862|566904621|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
157041168|NCT04021862|566904622|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
157041169|NCT04021862|566904623|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
157041170|NCT04021862|566904624|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
157041171|NCT04021862|566904625|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
157041172|NCT04021862|566904620|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
157041173|NCT04021862|566904621|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
157041174|NCT04021862|566904622|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
157041175|NCT04021862|566904623|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
157041176|NCT04021862|566904624|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
157041177|NCT04021862|566904625|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
157041178|NCT04021862|566904620|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
157041179|NCT04021862|566904621|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
157041180|NCT04021862|566904622|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
157041181|NCT04021862|566904623|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
157041182|NCT04021862|566904624|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
157041183|NCT04021862|566904625|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
157041184|NCT04021862|566904620|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
157041185|NCT04021862|566904621|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
157041186|NCT04021862|566904622|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
157041187|NCT04021862|566904623|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
157041188|NCT04021862|566904624|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
157041189|NCT04021862|566904625|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
157041190|NCT04021862|566904620|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
156967852|NCT02093663|566633703|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156967853|NCT02093663|566633704|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156967854|NCT02093663|566633705|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
156967855|NCT02093663|566633706|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
156967856|NCT03086330|566633713|FG000|Overall Study|Withdrawal by Subject|3|||
156967857|NCT03086330|566633714|FG001|Overall Study|Withdrawal by Subject|2|||
156967858|NCT03086330|566633713|FG000|Overall Study|Lost to Follow-up|1|||
156967859|NCT03086330|566633714|FG001|Overall Study|Lost to Follow-up|2|||
156967860|NCT00645164|566633715|FG000|Overall Study|Lost to Follow-up|2|||
156967861|NCT00645164|566633715|FG000|Overall Study|Withdrawal by Subject|4|||
156967862|NCT00645164|566633715|FG000|Overall Study|Protocol Violation|1|||
156967863|NCT03039023|566633718|FG000|Overall Study|Withdrawal by Subject|1|||
156967864|NCT03039023|566633719|FG001|Overall Study|Withdrawal by Subject|0|||
156967865|NCT03039023|566633720|FG002|Overall Study|Withdrawal by Subject|1|||
156967866|NCT03039023|566633721|FG003|Overall Study|Withdrawal by Subject|1|||
156967867|NCT03039023|566633722|FG004|Overall Study|Withdrawal by Subject|0|||
156967868|NCT03039023|566633718|FG000|Overall Study|Physician Decision|0|||
156967869|NCT03039023|566633719|FG001|Overall Study|Physician Decision|0|||
156967870|NCT03039023|566633720|FG002|Overall Study|Physician Decision|0|||
156967871|NCT03039023|566633721|FG003|Overall Study|Physician Decision|1|||
156967872|NCT03039023|566633722|FG004|Overall Study|Physician Decision|0|||
156967873|NCT03338829|566633724|FG000|Overall Study|Lost to Follow-up|4|||
156967874|NCT03338829|566633725|FG001|Overall Study|Lost to Follow-up|2|||
156967875|NCT03338829|566633726|FG002|Overall Study|Lost to Follow-up|4|||
156967876|NCT03338829|566633724|FG000|Overall Study|Pregnancy loss|1|||
156967877|NCT03338829|566633725|FG001|Overall Study|Pregnancy loss|1|||
156967878|NCT03338829|566633726|FG002|Overall Study|Pregnancy loss|0|||
157041191|NCT04021862|566904621|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
157041192|NCT04021862|566904622|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
157041193|NCT04021862|566904623|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
157041194|NCT04021862|566904624|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
157041195|NCT04021862|566904625|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
157173087|NCT01628393|567373520|FG003|Blinded Active Extension Period|Protocol Violation|1|||
157173088|NCT01628393|567373521|FG004|Blinded Active Extension Period|Protocol Violation|0|||
157173089|NCT01628393|567373517|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
156967879|NCT03338829|566633724|FG000|Overall Study|Protocol Violation|0|||
156967880|NCT03338829|566633725|FG001|Overall Study|Protocol Violation|1|||
156967881|NCT03338829|566633726|FG002|Overall Study|Protocol Violation|0|||
156967882|NCT03701399|566633730|FG000|Overall Study|Adverse Event|3|||
157228185|NCT02093689|567581033|FG000|Overall Study|Physician Decision|4|||
156967883|NCT03701399|566633731|FG001|Overall Study|Adverse Event|5|||
156967884|NCT03701399|566633730|FG000|Overall Study|Withdrawal by Subject|6|||
156967885|NCT03701399|566633731|FG001|Overall Study|Withdrawal by Subject|3|||
156967886|NCT03701399|566633730|FG000|Overall Study|Investigators decision|1|||
156967887|NCT03701399|566633731|FG001|Overall Study|Investigators decision|2|||
156967888|NCT03701399|566633730|FG000|Overall Study|Lost to Follow-up|1|||
156967889|NCT03701399|566633731|FG001|Overall Study|Lost to Follow-up|2|||
156967890|NCT03701399|566633730|FG000|Overall Study|Death|1|||
156967891|NCT03701399|566633731|FG001|Overall Study|Death|1|||
156967892|NCT03701399|566633730|FG000|Overall Study|Randomized but not treated|1|||
156967893|NCT03701399|566633731|FG001|Overall Study|Randomized but not treated|0|||
156967894|NCT00448448|566633732|FG000|Overall Study|Withdrawal by Subject|13|||
156967895|NCT00448448|566633733|FG001|Overall Study|Withdrawal by Subject|2|||
156967896|NCT00448448|566633732|FG000|Overall Study|On protocol when study ended|83|||
156967897|NCT00448448|566633733|FG001|Overall Study|On protocol when study ended|36|||
156967898|NCT00448448|566633732|FG000|Overall Study|Lost to Follow-up|2|||
156967899|NCT00448448|566633733|FG001|Overall Study|Lost to Follow-up|1|||
156967900|NCT00448448|566633732|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
156967901|NCT00448448|566633733|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
156967902|NCT00448448|566633732|FG000|Overall Study|Signed consent lost|0|||
156967903|NCT00448448|566633733|FG001|Overall Study|Signed consent lost|1|||
156967904|NCT02340026|566633734|FG000|Treatment Phase|Withdrawal by Subject|2|||
156967905|NCT02340026|566633735|FG001|Treatment Phase|Withdrawal by Subject|2|||
156967906|NCT02340026|566633734|FG000|Follow-up Phase|Lost to Follow-up|1|||
156967907|NCT02340026|566633735|FG001|Follow-up Phase|Lost to Follow-up|0|||
156967908|NCT03945292|566633736|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
156967909|NCT03945292|566633737|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967910|NCT03945292|566633738|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
156967911|NCT03945292|566633739|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967912|NCT03945292|566633740|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967913|NCT03945292|566633741|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967914|NCT03945292|566633742|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967915|NCT03945292|566633743|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
156967916|NCT03945292|566633736|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967917|NCT03945292|566633737|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967918|NCT03945292|566633738|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
156967919|NCT03945292|566633739|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967920|NCT03945292|566633740|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967921|NCT03945292|566633741|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967922|NCT03945292|566633742|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967923|NCT03945292|566633743|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
156967924|NCT03945292|566633736|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967925|NCT03945292|566633737|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967926|NCT03945292|566633738|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967927|NCT03945292|566633739|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967928|NCT03945292|566633740|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967929|NCT03945292|566633741|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967930|NCT03945292|566633742|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
156967931|NCT03945292|566633743|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
156967932|NCT02684006|566633744|FG000|Overall Study|Other|18|||
156967933|NCT02684006|566633745|FG001|Overall Study|Other|6|||
156967934|NCT02684006|566633744|FG000|Overall Study|Protocol Violation|2|||
156967935|NCT02684006|566633745|FG001|Overall Study|Protocol Violation|1|||
156967936|NCT02684006|566633744|FG000|Overall Study|Non-compliance with study drug|1|||
156967937|NCT02684006|566633745|FG001|Overall Study|Non-compliance with study drug|1|||
156967938|NCT02684006|566633744|FG000|Overall Study|No longer met eligibility criteria|6|||
156967939|NCT02684006|566633745|FG001|Overall Study|No longer met eligibility criteria|2|||
156967940|NCT02684006|566633744|FG000|Overall Study|Lost to Follow-up|0|||
156967941|NCT02684006|566633745|FG001|Overall Study|Lost to Follow-up|1|||
156967942|NCT02684006|566633744|FG000|Overall Study|Death|25|||
156967943|NCT02684006|566633745|FG001|Overall Study|Death|22|||
156967944|NCT02684006|566633744|FG000|Overall Study|Global deterioration of health status|18|||
156967945|NCT02684006|566633745|FG001|Overall Study|Global deterioration of health status|20|||
156967946|NCT02684006|566633744|FG000|Overall Study|Physician Decision|15|||
156967947|NCT02684006|566633745|FG001|Overall Study|Physician Decision|8|||
156967948|NCT02684006|566633744|FG000|Overall Study|Adverse Event|86|||
156967949|NCT02684006|566633745|FG001|Overall Study|Adverse Event|65|||
156967950|NCT02684006|566633744|FG000|Overall Study|Withdrawal by Subject|29|||
156967951|NCT02684006|566633745|FG001|Overall Study|Withdrawal by Subject|43|||
156967952|NCT02684006|566633744|FG000|Overall Study|Progressive disease|236|||
156967953|NCT02684006|566633745|FG001|Overall Study|Progressive disease|266|||
156967954|NCT02684006|566633744|FG000|Overall Study|Participation terminated by sponsor|6|||
156967955|NCT02684006|566633745|FG001|Overall Study|Participation terminated by sponsor|9|||
156967956|NCT00946296|566633746|FG000|Overall Study|Physician Decision|3|||
156967957|NCT00946296|566633747|FG001|Overall Study|Physician Decision|0|||
156967958|NCT03434678|566633750|FG000|Overall Study|Withdrawal by Subject|13|||
156967959|NCT03434678|566633751|FG001|Overall Study|Withdrawal by Subject|13|||
156967960|NCT03434678|566633750|FG000|Overall Study|Found to be ineligible post randomization|2|||
156967961|NCT03434678|566633751|FG001|Overall Study|Found to be ineligible post randomization|1|||
156967962|NCT01368965|566633752|FG000|Overall Study|Lost to Follow-up|12|||
156967963|NCT06060457|566633753|FG000|Overall Study|Adverse Event|1|||
156967964|NCT06060457|566633754|FG001|Overall Study|Adverse Event|1|||
156967965|NCT06060457|566633753|FG000|Overall Study|Death|2|||
156967966|NCT06060457|566633754|FG001|Overall Study|Death|2|||
156967967|NCT06060457|566633753|FG000|Overall Study|Lost to Follow-up|17|||
156967968|NCT06060457|566633754|FG001|Overall Study|Lost to Follow-up|19|||
156967969|NCT06060457|566633753|FG000|Overall Study|Physician Decision|0|||
156967970|NCT06060457|566633754|FG001|Overall Study|Physician Decision|1|||
156967971|NCT06060457|566633753|FG000|Overall Study|Protocol Violation|1|||
156967972|NCT06060457|566633754|FG001|Overall Study|Protocol Violation|1|||
156967973|NCT06060457|566633753|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
156967974|NCT06060457|566633754|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
156967975|NCT06060457|566633753|FG000|Overall Study|Withdrawal by Subject|12|||
156967976|NCT06060457|566633754|FG001|Overall Study|Withdrawal by Subject|15|||
156967977|NCT06060457|566633753|FG000|Overall Study|Other Than Specified|2|||
156967978|NCT06060457|566633754|FG001|Overall Study|Other Than Specified|1|||
156967979|NCT02061202|566633755|FG000|Overall Study|Lost to Follow-up|1|||
156967980|NCT02061202|566633756|FG001|Overall Study|Lost to Follow-up|1|||
156967981|NCT04559568|566633773|FG000|Overall Study|Physician Decision|0|||
156967982|NCT04559568|566633774|FG001|Overall Study|Physician Decision|0|||
156967983|NCT04559568|566633775|FG002|Overall Study|Physician Decision|0|||
157041196|NCT03371017|566904626|FG000|Overall Study|Physician Decision|0|||
157041197|NCT03371017|566904627|FG001|Overall Study|Physician Decision|1|||
157041198|NCT03371017|566904626|FG000|Overall Study|Reason not Specified|0|||
157041199|NCT03371017|566904627|FG001|Overall Study|Reason not Specified|1|||
157041200|NCT03371017|566904626|FG000|Overall Study|Lost to Follow-up|13|||
157041201|NCT03371017|566904627|FG001|Overall Study|Lost to Follow-up|16|||
157041202|NCT03371017|566904626|FG000|Overall Study|Death|228|||
157041203|NCT03371017|566904627|FG001|Overall Study|Death|215|||
157041204|NCT03371017|566904626|FG000|Overall Study|Withdrawal by Subject|20|||
157041205|NCT03371017|566904627|FG001|Overall Study|Withdrawal by Subject|25|||
157041206|NCT03371017|566904626|FG000|Overall Study|Study Ended by Sponsor|37|||
157041207|NCT03371017|566904627|FG001|Overall Study|Study Ended by Sponsor|38|||
157041208|NCT03371017|566904626|FG000|Overall Study|Protocol Deviation|0|||
157041209|NCT03371017|566904627|FG001|Overall Study|Protocol Deviation|1|||
157041210|NCT05525572|566904628|FG000|Overall Study|Lost to Follow-up|2|||
157041211|NCT05251363|566904629|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
157041212|NCT05251363|566904629|FG000|Overall Study After Implant Period|Death|9|||
157041213|NCT05251363|566904629|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
157041214|NCT05251363|566904629|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
157041215|NCT05251363|566904629|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
157041216|NCT05251363|566904629|FG000|Overall Study After Implant Period|Physician Decision|1|||
157041217|NCT05251363|566904629|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
157041218|NCT00489307|566904632|FG000|Overall Study|Death|1|||
157041219|NCT00489307|566904633|FG001|Overall Study|Death|1|||
157041220|NCT00489307|566904632|FG000|Overall Study|Lost to Follow-up|2|||
157041221|NCT00489307|566904633|FG001|Overall Study|Lost to Follow-up|2|||
157041222|NCT00489307|566904632|FG000|Overall Study|Physician Decision|1|||
157041223|NCT00489307|566904633|FG001|Overall Study|Physician Decision|0|||
157041224|NCT00489307|566904632|FG000|Overall Study|Withdrawal by Subject|2|||
157041225|NCT00489307|566904633|FG001|Overall Study|Withdrawal by Subject|4|||
157041226|NCT00489307|566904632|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
157041227|NCT00489307|566904633|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
157041228|NCT00489307|566904632|FG000|Overall Study|Surgery after assignment|1|||
157041229|NCT00489307|566904633|FG001|Overall Study|Surgery after assignment|0|||
156967984|NCT04559568|566633776|FG003|Overall Study|Physician Decision|0|||
156967985|NCT04559568|566633777|FG004|Overall Study|Physician Decision|0|||
156967986|NCT04559568|566633778|FG005|Overall Study|Physician Decision|0|||
156967987|NCT04559568|566633779|FG006|Overall Study|Physician Decision|0|||
157041230|NCT00489307|566904632|FG000|Overall Study|Did not fill up the forms|2|||
156967988|NCT04559568|566633780|FG007|Overall Study|Physician Decision|0|||
157041231|NCT00489307|566904633|FG001|Overall Study|Did not fill up the forms|1|||
157041232|NCT00489307|566904632|FG000|Overall Study|Patient or family refusal|5|||
157041233|NCT00489307|566904633|FG001|Overall Study|Patient or family refusal|9|||
156967989|NCT04559568|566633781|FG008|Overall Study|Physician Decision|0|||
157041234|NCT03835754|566904634|FG000|Overall Study|Death|4|||
157041235|NCT04306367|566904635|FG000|Overall Study|Progression of Disease|9|||
156967990|NCT04559568|566633782|FG009|Overall Study|Physician Decision|1|||
156967991|NCT04559568|566633783|FG010|Overall Study|Physician Decision|0|||
157041236|NCT04306367|566904635|FG000|Overall Study|Adverse Event|3|||
157041237|NCT04306367|566904635|FG000|Overall Study|Withdrawal by Subject|1|||
157041238|NCT03227861|566904636|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
157041239|NCT03227861|566904636|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
157041240|NCT03227861|566904636|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
157041241|NCT03227861|566904636|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
157041242|NCT03227861|566904636|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
157041243|NCT03227861|566904636|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
157041244|NCT03227861|566904636|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
157041245|NCT03227861|566904636|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
157041246|NCT03227861|566904636|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
157041247|NCT03227861|566904636|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
157041248|NCT02751528|566904643|FG000|Overall Study|Withdrawal by Subject|1|||
157041249|NCT02751528|566904643|FG000|Overall Study|Adverse Event|1|||
157041250|NCT05485805|566904644|FG000|Overall Study|Withdrawal by Subject|1|||
157041251|NCT05485805|566904645|FG001|Overall Study|Withdrawal by Subject|2|||
157041252|NCT05485805|566904646|FG002|Overall Study|Withdrawal by Subject|2|||
157041253|NCT05485805|566904647|FG003|Overall Study|Withdrawal by Subject|0|||
157041254|NCT05485805|566904648|FG004|Overall Study|Withdrawal by Subject|2|||
157041255|NCT05485805|566904644|FG000|Overall Study|Adverse Event|0|||
157041256|NCT05485805|566904645|FG001|Overall Study|Adverse Event|1|||
157041257|NCT05485805|566904646|FG002|Overall Study|Adverse Event|0|||
157041258|NCT05485805|566904647|FG003|Overall Study|Adverse Event|0|||
157041259|NCT05485805|566904648|FG004|Overall Study|Adverse Event|0|||
157041260|NCT05485805|566904644|FG000|Overall Study|Lost to Follow-up|1|||
157041261|NCT05485805|566904645|FG001|Overall Study|Lost to Follow-up|1|||
157041262|NCT05485805|566904646|FG002|Overall Study|Lost to Follow-up|3|||
157041263|NCT05485805|566904647|FG003|Overall Study|Lost to Follow-up|1|||
157041264|NCT05485805|566904648|FG004|Overall Study|Lost to Follow-up|0|||
157041265|NCT05810285|566904652|FG000|Overall Study|Death|4|||
157041266|NCT05810285|566904653|FG001|Overall Study|Death|21|||
157041267|NCT05810285|566904652|FG000|Overall Study|Adverse Event|18|||
157041268|NCT05810285|566904653|FG001|Overall Study|Adverse Event|16|||
157041269|NCT04484623|566904654|FG000|Overall Study|Lost to Follow-up|0|||
157041270|NCT04484623|566904655|FG001|Overall Study|Lost to Follow-up|1|||
157041271|NCT04484623|566904654|FG000|Overall Study|Protocol Deviation|1|||
157041272|NCT04484623|566904655|FG001|Overall Study|Protocol Deviation|0|||
157041273|NCT04484623|566904654|FG000|Overall Study|Physician Decision|1|||
157041274|NCT04484623|566904655|FG001|Overall Study|Physician Decision|0|||
157041275|NCT04484623|566904654|FG000|Overall Study|Withdrawal by Subject|11|||
157041276|NCT04484623|566904655|FG001|Overall Study|Withdrawal by Subject|8|||
157041277|NCT04484623|566904654|FG000|Overall Study|Ongoing|94|||
157041278|NCT04484623|566904655|FG001|Overall Study|Ongoing|84|||
157041279|NCT05470114|566904656|FG000|Overall Study|Withdrawal by Subject|1|||
157041280|NCT05470114|566904657|FG001|Overall Study|Withdrawal by Subject|0|||
157041281|NCT05470114|566904656|FG000|Overall Study|Lost to Follow-up|1|||
157041282|NCT05470114|566904657|FG001|Overall Study|Lost to Follow-up|0|||
157041283|NCT02488408|566904662|FG000|Part A|Adverse Event|2|||
157041284|NCT02488408|566904663|FG001|Part A|Adverse Event|0|||
157041285|NCT02488408|566904664|FG002|Part A|Adverse Event|0|||
157041286|NCT02488408|566904665|FG003|Part A|Adverse Event|0|||
157041287|NCT02488408|566904666|FG004|Part A|Adverse Event|0|||
157041288|NCT02488408|566904667|FG005|Part A|Adverse Event|0|||
157173090|NCT01628393|567373518|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
157173091|NCT01628393|567373519|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
157173092|NCT01628393|567373520|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
157173093|NCT01628393|567373521|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
157173094|NCT01665768|567373522|FG000|Overall Study|Adverse Event|3|||
157173095|NCT01665768|567373522|FG000|Overall Study|Lack of Efficacy|19|||
157173096|NCT01665768|567373522|FG000|Overall Study|Withdrawal by Subject|1|||
157041289|NCT02488408|566904668|FG006|Part A|Adverse Event|0|||
157041290|NCT02488408|566904669|FG007|Part A|Adverse Event|0|||
157173097|NCT01329341|567373523|FG000|Overall Study|Withdrawal by Subject|44|||
157173098|NCT00561340|567373524|FG000|Overall Study|refused to drink pediasure|6|||
157173099|NCT00561340|567373525|FG001|Overall Study|refused to drink pediasure|0|||
157173100|NCT02988219|567373531|FG000|Overall Study|Lack of Efficacy|1|||
157041291|NCT02488408|566904670|FG008|Part A|Adverse Event|0|||
157041292|NCT02488408|566904671|FG009|Part A|Adverse Event|0|||
157041293|NCT02488408|566904662|FG000|Part A|Death|1|||
157041294|NCT02488408|566904663|FG001|Part A|Death|5|||
157041295|NCT02488408|566904664|FG002|Part A|Death|0|||
157041296|NCT02488408|566904665|FG003|Part A|Death|0|||
157041297|NCT02488408|566904666|FG004|Part A|Death|3|||
157173101|NCT02988219|567373532|FG001|Overall Study|Lack of Efficacy|1|||
157173102|NCT02988219|567373531|FG000|Overall Study|Withdrawal by Subject|0|||
157173103|NCT02988219|567373532|FG001|Overall Study|Withdrawal by Subject|2|||
157041298|NCT02488408|566904667|FG005|Part A|Death|0|||
157041299|NCT02488408|566904668|FG006|Part A|Death|0|||
157041300|NCT02488408|566904669|FG007|Part A|Death|0|||
157041301|NCT02488408|566904670|FG008|Part A|Death|0|||
157041302|NCT02488408|566904671|FG009|Part A|Death|0|||
157041303|NCT02488408|566904662|FG000|Part A|Disease Progression|2|||
157041304|NCT02488408|566904663|FG001|Part A|Disease Progression|8|||
157041305|NCT02488408|566904664|FG002|Part A|Disease Progression|2|||
157041306|NCT02488408|566904665|FG003|Part A|Disease Progression|3|||
157041307|NCT02488408|566904666|FG004|Part A|Disease Progression|4|||
157041308|NCT02488408|566904667|FG005|Part A|Disease Progression|0|||
157041309|NCT02488408|566904668|FG006|Part A|Disease Progression|0|||
157041310|NCT02488408|566904669|FG007|Part A|Disease Progression|0|||
157041311|NCT02488408|566904670|FG008|Part A|Disease Progression|0|||
157041312|NCT02488408|566904671|FG009|Part A|Disease Progression|0|||
157041313|NCT02488408|566904662|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
157041314|NCT02488408|566904663|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
157041315|NCT02488408|566904664|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
157041316|NCT02488408|566904665|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
157041317|NCT02488408|566904666|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
157041318|NCT02488408|566904667|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
157041319|NCT02488408|566904668|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
157041320|NCT02488408|566904669|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
157041321|NCT02488408|566904670|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
157041322|NCT02488408|566904671|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
157041323|NCT02488408|566904662|FG000|Part A|Investigator Decision|0|||
157041324|NCT02488408|566904663|FG001|Part A|Investigator Decision|1|||
157041325|NCT02488408|566904664|FG002|Part A|Investigator Decision|1|||
157041326|NCT02488408|566904665|FG003|Part A|Investigator Decision|0|||
157041327|NCT02488408|566904666|FG004|Part A|Investigator Decision|0|||
157041328|NCT02488408|566904667|FG005|Part A|Investigator Decision|0|||
157041329|NCT02488408|566904668|FG006|Part A|Investigator Decision|0|||
157041330|NCT02488408|566904669|FG007|Part A|Investigator Decision|0|||
157041331|NCT02488408|566904670|FG008|Part A|Investigator Decision|0|||
157041332|NCT02488408|566904671|FG009|Part A|Investigator Decision|0|||
157041333|NCT02488408|566904662|FG000|Part A|Withdrawal by Subject|0|||
157041334|NCT02488408|566904663|FG001|Part A|Withdrawal by Subject|0|||
157041335|NCT02488408|566904664|FG002|Part A|Withdrawal by Subject|2|||
157041336|NCT02488408|566904665|FG003|Part A|Withdrawal by Subject|0|||
157041337|NCT02488408|566904666|FG004|Part A|Withdrawal by Subject|0|||
157041338|NCT02488408|566904667|FG005|Part A|Withdrawal by Subject|0|||
157041339|NCT02488408|566904668|FG006|Part A|Withdrawal by Subject|0|||
157041340|NCT02488408|566904669|FG007|Part A|Withdrawal by Subject|0|||
157041341|NCT02488408|566904670|FG008|Part A|Withdrawal by Subject|0|||
157041342|NCT02488408|566904671|FG009|Part A|Withdrawal by Subject|0|||
157041343|NCT02488408|566904662|FG000|Part A|Other|1|||
157041344|NCT02488408|566904663|FG001|Part A|Other|0|||
157041345|NCT02488408|566904664|FG002|Part A|Other|0|||
157041346|NCT02488408|566904665|FG003|Part A|Other|0|||
157041347|NCT02488408|566904666|FG004|Part A|Other|0|||
157041348|NCT02488408|566904667|FG005|Part A|Other|0|||
157041349|NCT02488408|566904668|FG006|Part A|Other|0|||
157041350|NCT02488408|566904669|FG007|Part A|Other|0|||
157041351|NCT02488408|566904670|FG008|Part A|Other|0|||
157041352|NCT02488408|566904671|FG009|Part A|Other|0|||
157041353|NCT02488408|566904662|FG000|Part B|Adverse Event|0|||
157041354|NCT02488408|566904663|FG001|Part B|Adverse Event|0|||
157041355|NCT02488408|566904664|FG002|Part B|Adverse Event|0|||
157041356|NCT02488408|566904665|FG003|Part B|Adverse Event|0|||
157173104|NCT01522443|567373536|FG000|Overall Study|No longer receiving clinical benefit|36|||
157173105|NCT01522443|567373537|FG001|Overall Study|No longer receiving clinical benefit|28|||
157173106|NCT01522443|567373536|FG000|Overall Study|Adverse Event|10|||
157173107|NCT01522443|567373537|FG001|Overall Study|Adverse Event|15|||
157173108|NCT01522443|567373536|FG000|Overall Study|Withdrawal by Subject|5|||
157041357|NCT02488408|566904666|FG004|Part B|Adverse Event|0|||
157041358|NCT02488408|566904667|FG005|Part B|Adverse Event|2|||
157041359|NCT02488408|566904668|FG006|Part B|Adverse Event|2|||
157173109|NCT01522443|567373537|FG001|Overall Study|Withdrawal by Subject|8|||
157173110|NCT01522443|567373536|FG000|Overall Study|No study treatment given|1|||
157173111|NCT01522443|567373537|FG001|Overall Study|No study treatment given|1|||
157041360|NCT02488408|566904669|FG007|Part B|Adverse Event|7|||
157041361|NCT02488408|566904670|FG008|Part B|Adverse Event|2|||
157041362|NCT02488408|566904671|FG009|Part B|Adverse Event|2|||
157041363|NCT02488408|566904662|FG000|Part B|Death|0|||
157041364|NCT02488408|566904663|FG001|Part B|Death|0|||
157041365|NCT02488408|566904664|FG002|Part B|Death|0|||
157041366|NCT02488408|566904665|FG003|Part B|Death|0|||
157041367|NCT02488408|566904666|FG004|Part B|Death|0|||
157041368|NCT02488408|566904667|FG005|Part B|Death|3|||
157041369|NCT02488408|566904668|FG006|Part B|Death|1|||
157041370|NCT02488408|566904669|FG007|Part B|Death|2|||
157041371|NCT02488408|566904670|FG008|Part B|Death|2|||
157041372|NCT02488408|566904671|FG009|Part B|Death|2|||
157041373|NCT02488408|566904662|FG000|Part B|Death due to Disease Progression|0|||
157041374|NCT02488408|566904663|FG001|Part B|Death due to Disease Progression|0|||
157173112|NCT01522443|567373536|FG000|Overall Study|Other|1|||
157228186|NCT02093689|567581034|FG001|Overall Study|Physician Decision|0|||
157228187|NCT02093689|567581035|FG002|Overall Study|Physician Decision|0|||
157228188|NCT04947579|567581040|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
157228189|NCT04947579|567581041|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
157228190|NCT04947579|567581042|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
157228191|NCT04947579|567581043|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
157228192|NCT04947579|567581044|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
157228193|NCT04947579|567581045|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
157228194|NCT04947579|567581040|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
157228195|NCT04947579|567581041|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
157228196|NCT04947579|567581042|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
157228197|NCT04947579|567581043|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
157228198|NCT04947579|567581044|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
157228199|NCT04947579|567581045|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
157228200|NCT04947579|567581040|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
157228201|NCT04947579|567581041|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
157228202|NCT04947579|567581042|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
157228203|NCT04947579|567581043|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
157228204|NCT04947579|567581044|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
157228205|NCT04947579|567581045|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
157228206|NCT04947579|567581040|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
157228207|NCT04947579|567581041|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
157228208|NCT04947579|567581042|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
157228209|NCT04947579|567581043|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
157228210|NCT04947579|567581044|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
157228211|NCT04947579|567581045|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
157228212|NCT04947579|567581040|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
157228213|NCT04947579|567581041|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
157228214|NCT04947579|567581042|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
157228215|NCT04947579|567581043|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
157228216|NCT04947579|567581044|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
157228217|NCT04947579|567581045|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
157228218|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
157228219|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
157228220|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
157228221|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
157228222|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
157228223|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
157228224|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
157228225|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
157228226|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
157228227|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
157228228|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
157228229|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
156967992|NCT04559568|566633773|FG000|Overall Study|Withdrawal by Subject|0|||
156967993|NCT04559568|566633774|FG001|Overall Study|Withdrawal by Subject|0|||
156967994|NCT04559568|566633775|FG002|Overall Study|Withdrawal by Subject|0|||
156967995|NCT04559568|566633776|FG003|Overall Study|Withdrawal by Subject|0|||
156967996|NCT04559568|566633777|FG004|Overall Study|Withdrawal by Subject|0|||
156967997|NCT04559568|566633778|FG005|Overall Study|Withdrawal by Subject|0|||
156967998|NCT04559568|566633779|FG006|Overall Study|Withdrawal by Subject|0|||
156967999|NCT04559568|566633780|FG007|Overall Study|Withdrawal by Subject|0|||
156968000|NCT04559568|566633781|FG008|Overall Study|Withdrawal by Subject|0|||
156968001|NCT04559568|566633782|FG009|Overall Study|Withdrawal by Subject|0|||
156968002|NCT04559568|566633783|FG010|Overall Study|Withdrawal by Subject|1|||
156968003|NCT03721965|566633784|FG000|Overall Study|Death|1|||
156968004|NCT03721965|566633784|FG000|Overall Study|Study Terminated by Sponsor|1|||
156968005|NCT05103384|566633785|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
156968006|NCT02612311|566633786|FG000|Overall Study|Adverse Event|16|||
156968007|NCT02612311|566633787|FG001|Overall Study|Adverse Event|12|||
156968008|NCT02612311|566633788|FG002|Overall Study|Adverse Event|7|||
156968009|NCT02612311|566633789|FG003|Overall Study|Adverse Event|13|||
156968010|NCT02612311|566633786|FG000|Overall Study|Death|29|||
156968011|NCT02612311|566633787|FG001|Overall Study|Death|10|||
156968012|NCT02612311|566633788|FG002|Overall Study|Death|11|||
156968013|NCT02612311|566633789|FG003|Overall Study|Death|11|||
156968014|NCT02612311|566633786|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
156968015|NCT02612311|566633787|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
156968016|NCT02612311|566633788|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
157173113|NCT01522443|567373537|FG001|Overall Study|Other|3|||
157173114|NCT03260894|567373538|FG000|Overall Study|Death|6|||
157173115|NCT03260894|567373539|FG001|Overall Study|Death|8|||
157173116|NCT03260894|567373538|FG000|Overall Study|Withdrawal by Subject|4|||
157173117|NCT03260894|567373539|FG001|Overall Study|Withdrawal by Subject|11|||
157173118|NCT03260894|567373538|FG000|Overall Study|On-going at clinical cut off date|36|||
157173119|NCT03260894|567373539|FG001|Overall Study|On-going at clinical cut off date|31|||
157173120|NCT00290589|567373541|FG000|Overall Study|Lost to Follow-up|2|||
157173121|NCT00290589|567373542|FG001|Overall Study|Lost to Follow-up|2|||
157173122|NCT05014542|567373543|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
157173123|NCT05014542|567373544|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
157173124|NCT05014542|567373543|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
157173125|NCT05014542|567373544|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
157173126|NCT05014542|567373543|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
157173127|NCT05014542|567373544|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
157173128|NCT05014542|567373543|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
157173129|NCT05014542|567373544|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
157173130|NCT00691093|567373545|FG000|Overall Study|Adverse Event|1|||
157173131|NCT00691093|567373545|FG000|Overall Study|Lost to Follow-up|1|||
157173132|NCT00691093|567373545|FG000|Overall Study|Lack of Efficacy|1|||
157173133|NCT00691093|567373545|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
157041375|NCT02488408|566904664|FG002|Part B|Death due to Disease Progression|0|||
157041376|NCT02488408|566904665|FG003|Part B|Death due to Disease Progression|0|||
157041377|NCT02488408|566904666|FG004|Part B|Death due to Disease Progression|0|||
157041378|NCT02488408|566904667|FG005|Part B|Death due to Disease Progression|2|||
157041379|NCT02488408|566904668|FG006|Part B|Death due to Disease Progression|2|||
157041380|NCT02488408|566904669|FG007|Part B|Death due to Disease Progression|1|||
157041381|NCT02488408|566904670|FG008|Part B|Death due to Disease Progression|1|||
157041382|NCT02488408|566904671|FG009|Part B|Death due to Disease Progression|1|||
157041383|NCT02488408|566904662|FG000|Part B|Disease Progression|0|||
157041384|NCT02488408|566904663|FG001|Part B|Disease Progression|0|||
157041385|NCT02488408|566904664|FG002|Part B|Disease Progression|0|||
157041386|NCT02488408|566904665|FG003|Part B|Disease Progression|0|||
157041387|NCT02488408|566904666|FG004|Part B|Disease Progression|0|||
157041388|NCT02488408|566904667|FG005|Part B|Disease Progression|6|||
157041389|NCT02488408|566904668|FG006|Part B|Disease Progression|9|||
157041390|NCT02488408|566904669|FG007|Part B|Disease Progression|7|||
157041391|NCT02488408|566904670|FG008|Part B|Disease Progression|9|||
157041392|NCT02488408|566904671|FG009|Part B|Disease Progression|11|||
157041393|NCT02488408|566904662|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
157041394|NCT02488408|566904663|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
157041395|NCT02488408|566904664|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
157041396|NCT02488408|566904665|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
157041397|NCT02488408|566904666|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
157041398|NCT02488408|566904667|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
157041399|NCT02488408|566904668|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
157041400|NCT02488408|566904669|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
157041401|NCT02488408|566904670|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
157041402|NCT02488408|566904671|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
157041403|NCT02488408|566904662|FG000|Part B|Investigator Decision|0|||
157041404|NCT02488408|566904663|FG001|Part B|Investigator Decision|0|||
157041405|NCT02488408|566904664|FG002|Part B|Investigator Decision|0|||
157041406|NCT02488408|566904665|FG003|Part B|Investigator Decision|0|||
157041407|NCT02488408|566904666|FG004|Part B|Investigator Decision|0|||
157041408|NCT02488408|566904667|FG005|Part B|Investigator Decision|0|||
157041409|NCT02488408|566904668|FG006|Part B|Investigator Decision|1|||
157041410|NCT02488408|566904669|FG007|Part B|Investigator Decision|0|||
157041411|NCT02488408|566904670|FG008|Part B|Investigator Decision|2|||
157041412|NCT02488408|566904671|FG009|Part B|Investigator Decision|1|||
157041413|NCT00719888|566904672|FG000|Overall Study|Death|24|||
157041414|NCT00719888|566904673|FG001|Overall Study|Death|9|||
157041415|NCT00719888|566904672|FG000|Overall Study|Relapse|8|||
157173134|NCT01700985|567373547|FG000|Overall Study|Incarcerated|0|||
157173135|NCT01700985|567373548|FG001|Overall Study|Incarcerated|1|||
157173136|NCT00965146|567373549|FG000|Overall Study|Death|7|||
157173137|NCT00965146|567373549|FG000|Overall Study|Lost to Follow-up|22|||
157173138|NCT00965146|567373549|FG000|Overall Study|Withdrawal by Subject|17|||
157041416|NCT00719888|566904673|FG001|Overall Study|Relapse|3|||
157041417|NCT00719888|566904672|FG000|Overall Study|Physician Decision|1|||
157041418|NCT00719888|566904673|FG001|Overall Study|Physician Decision|0|||
157041419|NCT00719888|566904672|FG000|Overall Study|Withdrawal by Subject|1|||
157041420|NCT00719888|566904673|FG001|Overall Study|Withdrawal by Subject|0|||
157173139|NCT00965146|567373549|FG000|Overall Study|Unable to return|1|||
157173140|NCT00965146|567373549|FG000|Overall Study|Unwilling to return|11|||
157173141|NCT00965146|567373549|FG000|Overall Study|Intercurrent illness|1|||
157173142|NCT00965146|567373549|FG000|Overall Study|Revision / Removal of Study Implant|6|||
157173143|NCT00965146|567373549|FG000|Overall Study|Overall Study Termination|145|||
157041421|NCT05886777|566904674|FG000|Overall Study|Lost to Follow-up|1|||
157041422|NCT05886777|566904675|FG001|Overall Study|Lost to Follow-up|0|||
157041423|NCT05886777|566904676|FG002|Overall Study|Lost to Follow-up|2|||
157041424|NCT05886777|566904677|FG003|Overall Study|Lost to Follow-up|1|||
157041425|NCT05886777|566904678|FG004|Overall Study|Lost to Follow-up|0|||
157041426|NCT05886777|566904679|FG005|Overall Study|Lost to Follow-up|2|||
157041427|NCT05886777|566904680|FG006|Overall Study|Lost to Follow-up|0|||
157041428|NCT05886777|566904674|FG000|Overall Study|Other|0|||
157041429|NCT05886777|566904675|FG001|Overall Study|Other|2|||
157041430|NCT05886777|566904676|FG002|Overall Study|Other|1|||
157041431|NCT05886777|566904677|FG003|Overall Study|Other|0|||
157041432|NCT05886777|566904678|FG004|Overall Study|Other|0|||
157041433|NCT05886777|566904679|FG005|Overall Study|Other|0|||
157041434|NCT05886777|566904680|FG006|Overall Study|Other|0|||
157041435|NCT05886777|566904674|FG000|Overall Study|Withdrawal by Subject|1|||
157041436|NCT05886777|566904675|FG001|Overall Study|Withdrawal by Subject|0|||
157041437|NCT05886777|566904676|FG002|Overall Study|Withdrawal by Subject|1|||
157041438|NCT05886777|566904677|FG003|Overall Study|Withdrawal by Subject|4|||
157041439|NCT05886777|566904678|FG004|Overall Study|Withdrawal by Subject|3|||
157041440|NCT05886777|566904679|FG005|Overall Study|Withdrawal by Subject|1|||
157041441|NCT05886777|566904680|FG006|Overall Study|Withdrawal by Subject|1|||
157041442|NCT05886777|566904674|FG000|Overall Study|Protocol Violation|0|||
157041443|NCT05886777|566904675|FG001|Overall Study|Protocol Violation|0|||
157041444|NCT05886777|566904676|FG002|Overall Study|Protocol Violation|1|||
157041445|NCT05886777|566904677|FG003|Overall Study|Protocol Violation|0|||
157041446|NCT05886777|566904678|FG004|Overall Study|Protocol Violation|0|||
157041447|NCT05886777|566904679|FG005|Overall Study|Protocol Violation|0|||
157041448|NCT05886777|566904680|FG006|Overall Study|Protocol Violation|0|||
157041449|NCT05886777|566904674|FG000|Overall Study|No longer met eligibility criteria|0|||
157041450|NCT05886777|566904675|FG001|Overall Study|No longer met eligibility criteria|1|||
157041451|NCT05886777|566904676|FG002|Overall Study|No longer met eligibility criteria|0|||
157041452|NCT05886777|566904677|FG003|Overall Study|No longer met eligibility criteria|0|||
157041453|NCT05886777|566904678|FG004|Overall Study|No longer met eligibility criteria|0|||
157041454|NCT05886777|566904679|FG005|Overall Study|No longer met eligibility criteria|0|||
157041455|NCT05886777|566904680|FG006|Overall Study|No longer met eligibility criteria|0|||
157041456|NCT03773107|566904681|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
157041457|NCT03773107|566904682|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
157041458|NCT03773107|566904683|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
157041459|NCT03773107|566904684|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
157041460|NCT05199571|566906237|FG000|Treatment Period|Participant decision|3|||
157041461|NCT05199571|566906237|FG000|Treatment Period|Physician Decision|1|||
157041462|NCT05199571|566906237|FG000|Post-treatment Follow up Period|Participant decision|3|||
157041463|NCT05029284|566906240|FG000|Overall Study|Lost to Follow-up|1|||
157041464|NCT02972034|566906241|FG000|Overall Study|Death|11|||
157041465|NCT02972034|566906242|FG001|Overall Study|Death|1|||
157041466|NCT02972034|566906243|FG002|Overall Study|Death|3|||
157041467|NCT02972034|566906244|FG003|Overall Study|Death|3|||
157041468|NCT02972034|566906245|FG004|Overall Study|Death|2|||
157041469|NCT02972034|566906246|FG005|Overall Study|Death|2|||
157041470|NCT02972034|566906247|FG006|Overall Study|Death|3|||
157041471|NCT02972034|566906248|FG007|Overall Study|Death|4|||
157041472|NCT02972034|566906249|FG008|Overall Study|Death|8|||
157041473|NCT02972034|566906250|FG009|Overall Study|Death|11|||
157041474|NCT02972034|566906251|FG010|Overall Study|Death|3|||
157041475|NCT02972034|566906252|FG011|Overall Study|Death|2|||
157041476|NCT02972034|566906253|FG012|Overall Study|Death|11|||
157041477|NCT02972034|566906254|FG013|Overall Study|Death|10|||
157041478|NCT02972034|566906255|FG014|Overall Study|Death|9|||
157041479|NCT02972034|566906241|FG000|Overall Study|Lost to Follow-up|0|||
157173144|NCT01148693|567373550|FG000|Overall Study|Attempts for cannulation were failed|13|||
157173145|NCT01148693|567373551|FG001|Overall Study|Attempts for cannulation were failed|10|||
157173146|NCT01135017|567373552|FG000|Overall Study|Adverse Event|3|||
157041480|NCT02972034|566906242|FG001|Overall Study|Lost to Follow-up|0|||
157041481|NCT02972034|566906243|FG002|Overall Study|Lost to Follow-up|0|||
157041482|NCT02972034|566906244|FG003|Overall Study|Lost to Follow-up|0|||
157041483|NCT02972034|566906245|FG004|Overall Study|Lost to Follow-up|1|||
157173147|NCT01135017|567373553|FG001|Overall Study|Adverse Event|8|||
157041484|NCT02972034|566906246|FG005|Overall Study|Lost to Follow-up|0|||
157041485|NCT02972034|566906247|FG006|Overall Study|Lost to Follow-up|0|||
157041486|NCT02972034|566906248|FG007|Overall Study|Lost to Follow-up|1|||
157041487|NCT02972034|566906249|FG008|Overall Study|Lost to Follow-up|0|||
157041488|NCT02972034|566906250|FG009|Overall Study|Lost to Follow-up|0|||
157041489|NCT02972034|566906251|FG010|Overall Study|Lost to Follow-up|0|||
157041490|NCT02972034|566906252|FG011|Overall Study|Lost to Follow-up|0|||
157041491|NCT02972034|566906253|FG012|Overall Study|Lost to Follow-up|0|||
157041492|NCT02972034|566906254|FG013|Overall Study|Lost to Follow-up|0|||
157041493|NCT02972034|566906255|FG014|Overall Study|Lost to Follow-up|1|||
157041494|NCT02972034|566906241|FG000|Overall Study|Physician Decision|0|||
157173148|NCT01135017|567373552|FG000|Overall Study|Other than above|3|||
157173149|NCT01135017|567373553|FG001|Overall Study|Other than above|4|||
157173150|NCT02146248|567373555|FG000|Overall Study|Withdrawal by Subject|2|||
157173151|NCT00425100|567373556|FG000|Overall Study|Adverse Event|36|||
157173152|NCT00425100|567373556|FG000|Overall Study|Lack of Efficacy|4|||
157173153|NCT00425100|567373556|FG000|Overall Study|Lost to Follow-up|2|||
157173154|NCT00425100|567373556|FG000|Overall Study|Protocol Violation|4|||
157173155|NCT00425100|567373556|FG000|Overall Study|Withdrawal by Subject|7|||
157173156|NCT03699631|567373558|FG000|Overall Study|Adverse Event|3|||
157173157|NCT01769469|567373562|FG000|Overall Study|Consent Withdrawn|5|||
157173158|NCT01769469|567373562|FG000|Overall Study|Moved Out Of Area|3|||
157173159|NCT01769469|567373562|FG000|Overall Study|Lost to Follow-up|17|||
157173160|NCT01769469|567373562|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
157173161|NCT01769469|567373562|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
157173162|NCT04021706|567375355|FG000|Overall Study|Adverse Event|2|||
157173163|NCT04021706|567375356|FG001|Overall Study|Adverse Event|0|||
157173164|NCT04021706|567375355|FG000|Overall Study|Withdrawal by Subject|1|||
157173165|NCT04021706|567375356|FG001|Overall Study|Withdrawal by Subject|2|||
157173166|NCT04021706|567375355|FG000|Overall Study|Physician Decision|1|||
157173167|NCT04021706|567375356|FG001|Overall Study|Physician Decision|0|||
157173168|NCT02332798|567375359|FG000|Overall Study|Unwilling to Participate in Study|0|||
157173169|NCT02332798|567375360|FG001|Overall Study|Unwilling to Participate in Study|1|||
157173170|NCT02332798|567375361|FG002|Overall Study|Unwilling to Participate in Study|1|||
157173171|NCT02332798|567375359|FG000|Overall Study|Positive Urine Drug Test|0|||
157173172|NCT02332798|567375360|FG001|Overall Study|Positive Urine Drug Test|1|||
157173173|NCT02332798|567375361|FG002|Overall Study|Positive Urine Drug Test|0|||
157173174|NCT02332798|567375359|FG000|Overall Study|Abnormal Laboratory Findings|1|||
157173175|NCT02332798|567375360|FG001|Overall Study|Abnormal Laboratory Findings|0|||
157173176|NCT02332798|567375361|FG002|Overall Study|Abnormal Laboratory Findings|0|||
157173177|NCT00107172|567375362|FG000|Overall Study|Withdrawal by Subject|1|||
157173178|NCT00107172|567375363|FG001|Overall Study|Withdrawal by Subject|0|||
157173179|NCT00107172|567375362|FG000|Overall Study|Death|0|||
157173180|NCT00107172|567375363|FG001|Overall Study|Death|2|||
157173181|NCT00107172|567375362|FG000|Overall Study|Other Reason|4|||
157173182|NCT00107172|567375363|FG001|Overall Study|Other Reason|3|||
157173183|NCT00595868|567375364|FG000|Overall Study|Lost to Follow-up|45|||
157173184|NCT00595868|567375365|FG001|Overall Study|Lost to Follow-up|50|||
157173185|NCT02688153|567375366|FG000|Overall Study|Death|7|||
157173186|NCT02688153|567375367|FG001|Overall Study|Death|5|||
157173187|NCT02688153|567375366|FG000|Overall Study|Withdrawal by Subject|4|||
157173188|NCT02688153|567375367|FG001|Overall Study|Withdrawal by Subject|2|||
157173189|NCT02688153|567375366|FG000|Overall Study|Valve Explant|1|||
157173190|NCT02688153|567375367|FG001|Overall Study|Valve Explant|0|||
157173191|NCT02688153|567375366|FG000|Overall Study|Conversion to Commercial Valve|3|||
157173192|NCT02688153|567375367|FG001|Overall Study|Conversion to Commercial Valve|0|||
157173193|NCT00859573|567375368|FG000|Overall Study|Withdrawal by Subject|4|||
157173194|NCT00859573|567375369|FG001|Overall Study|Withdrawal by Subject|1|||
157173195|NCT00859573|567375368|FG000|Overall Study|Physician Decision|1|||
157173196|NCT00859573|567375369|FG001|Overall Study|Physician Decision|1|||
157173197|NCT00439725|567375370|FG000|Treatment Period|Withdrawal by Subject|22|||
157173198|NCT00439725|567375371|FG001|Treatment Period|Withdrawal by Subject|19|||
157173199|NCT00439725|567375370|FG000|Treatment Period|Study terminated by sponsor|156|||
157173200|NCT00439725|567375371|FG001|Treatment Period|Study terminated by sponsor|148|||
157173201|NCT00439725|567375370|FG000|Treatment Period|Site closed by investigator|1|||
157041495|NCT02972034|566906242|FG001|Overall Study|Physician Decision|0|||
157041496|NCT02972034|566906243|FG002|Overall Study|Physician Decision|0|||
157041497|NCT02972034|566906244|FG003|Overall Study|Physician Decision|0|||
157041498|NCT02972034|566906245|FG004|Overall Study|Physician Decision|0|||
157041499|NCT02972034|566906246|FG005|Overall Study|Physician Decision|0|||
157041500|NCT02972034|566906247|FG006|Overall Study|Physician Decision|0|||
157041501|NCT02972034|566906248|FG007|Overall Study|Physician Decision|1|||
157041502|NCT02972034|566906249|FG008|Overall Study|Physician Decision|0|||
157041503|NCT02972034|566906250|FG009|Overall Study|Physician Decision|0|||
157041504|NCT02972034|566906251|FG010|Overall Study|Physician Decision|1|||
157041505|NCT02972034|566906252|FG011|Overall Study|Physician Decision|0|||
157041506|NCT02972034|566906253|FG012|Overall Study|Physician Decision|0|||
157173202|NCT00439725|567375371|FG001|Treatment Period|Site closed by investigator|2|||
157173203|NCT00439725|567375370|FG000|Treatment Period|Adverse Event|39|||
157173204|NCT00439725|567375371|FG001|Treatment Period|Adverse Event|18|||
157173205|NCT00439725|567375370|FG000|Treatment Period|Physician Decision|1|||
157173206|NCT00439725|567375371|FG001|Treatment Period|Physician Decision|1|||
157173207|NCT00439725|567375370|FG000|Treatment Period|Protocol Violation|2|||
157173208|NCT00439725|567375371|FG001|Treatment Period|Protocol Violation|1|||
157041507|NCT02972034|566906254|FG013|Overall Study|Physician Decision|0|||
157173209|NCT00439725|567375370|FG000|Treatment Period|Clinical endpoint reached|6|||
157173210|NCT00439725|567375371|FG001|Treatment Period|Clinical endpoint reached|50|||
157173211|NCT00439725|567375370|FG000|Treatment Period|Technical problems|1|||
157173212|NCT00439725|567375371|FG001|Treatment Period|Technical problems|0|||
157041508|NCT02972034|566906255|FG014|Overall Study|Physician Decision|0|||
157041509|NCT02972034|566906241|FG000|Overall Study|Sponsor Decision|0|||
157041510|NCT02972034|566906242|FG001|Overall Study|Sponsor Decision|0|||
157173213|NCT00439725|567375370|FG000|Treatment Period|Lost to Follow-up|1|||
157173214|NCT00439725|567375371|FG001|Treatment Period|Lost to Follow-up|1|||
157173215|NCT00439725|567375370|FG000|Treatment Period|Participant convenience|1|||
157173216|NCT00439725|567375371|FG001|Treatment Period|Participant convenience|0|||
157173217|NCT00439725|567375370|FG000|Treatment Period|Protocol driven decision point|1|||
157173218|NCT00439725|567375371|FG001|Treatment Period|Protocol driven decision point|1|||
157173219|NCT00439725|567375370|FG000|Treatment Period|Death|1|||
157173220|NCT00439725|567375371|FG001|Treatment Period|Death|1|||
157173221|NCT00439725|567375370|FG000|Treatment Period|Participant did not receive treatment|4|||
157173222|NCT00439725|567375371|FG001|Treatment Period|Participant did not receive treatment|4|||
157173223|NCT00439725|567375370|FG000|Observational Period|Withdrawal by Subject|2|||
157173224|NCT00439725|567375371|FG001|Observational Period|Withdrawal by Subject|2|||
157173225|NCT00439725|567375370|FG000|Observational Period|Lost to Follow-up|0|||
157173226|NCT00439725|567375371|FG001|Observational Period|Lost to Follow-up|1|||
157173227|NCT00439725|567375370|FG000|Observational Period|Death|0|||
157173228|NCT00439725|567375371|FG001|Observational Period|Death|2|||
157173229|NCT00439725|567375370|FG000|Observational Period|Study termination by sponsor|1|||
157173230|NCT00439725|567375371|FG001|Observational Period|Study termination by sponsor|1|||
157173231|NCT00439725|567375370|FG000|Observational Period|Clinical endpoint reached|3|||
157173232|NCT00439725|567375371|FG001|Observational Period|Clinical endpoint reached|1|||
157173233|NCT00439725|567375370|FG000|Observational Period|Technical problems|1|||
157173234|NCT00439725|567375371|FG001|Observational Period|Technical problems|0|||
157173235|NCT00439725|567375370|FG000|Observational Period|Participant convenience|1|||
157173236|NCT00439725|567375371|FG001|Observational Period|Participant convenience|0|||
157173237|NCT02848313|567375372|FG000|Overall Study|Adverse Event|1|||
157173238|NCT02848313|567375373|FG001|Overall Study|Adverse Event|2|||
157173239|NCT02848313|567375372|FG000|Overall Study|Lack of Efficacy|0|||
157173240|NCT02848313|567375373|FG001|Overall Study|Lack of Efficacy|1|||
157173241|NCT02848313|567375372|FG000|Overall Study|Withdrawal by Subject|1|||
157173242|NCT02848313|567375373|FG001|Overall Study|Withdrawal by Subject|1|||
157173243|NCT02848313|567375372|FG000|Overall Study|Lost to follow up|1|||
157173244|NCT02848313|567375373|FG001|Overall Study|Lost to follow up|0|||
157173245|NCT03510910|567375374|FG000|Overall Study|Incomplete Survey|2|||
157173246|NCT03510910|567375375|FG001|Overall Study|Incomplete Survey|3|||
157173247|NCT01673490|567375376|FG000|Overall Study|Lost to Follow-up|1|||
157173248|NCT01673490|567375376|FG000|Overall Study|Adverse Event|3|||
157173249|NCT01673490|567375376|FG000|Overall Study|Withdrawal by Subject|3|||
157173250|NCT00379236|567375377|FG000|Double-blind|Adverse Event|11|||
157173251|NCT00379236|567375378|FG001|Double-blind|Adverse Event|6|||
157173252|NCT00379236|567375379|FG002|Double-blind|Adverse Event|0|||
157173253|NCT00379236|567375377|FG000|Double-blind|Protocol Violation|3|||
157173254|NCT00379236|567375378|FG001|Double-blind|Protocol Violation|3|||
157173255|NCT00379236|567375379|FG002|Double-blind|Protocol Violation|0|||
157173256|NCT00379236|567375377|FG000|Double-blind|Withdrawal by Subject|12|||
157173257|NCT00379236|567375378|FG001|Double-blind|Withdrawal by Subject|13|||
157173258|NCT00379236|567375379|FG002|Double-blind|Withdrawal by Subject|0|||
157173259|NCT00379236|567375377|FG000|Double-blind|Lost to Follow-up|4|||
157173260|NCT00379236|567375378|FG001|Double-blind|Lost to Follow-up|3|||
157173261|NCT00379236|567375379|FG002|Double-blind|Lost to Follow-up|0|||
157173262|NCT00379236|567375377|FG000|Double-blind|Use of exclusionary medication|1|||
157173263|NCT00379236|567375378|FG001|Double-blind|Use of exclusionary medication|2|||
157173264|NCT00379236|567375379|FG002|Double-blind|Use of exclusionary medication|0|||
157173265|NCT00379236|567375377|FG000|Double-blind|Other|3|||
157173266|NCT00379236|567375378|FG001|Double-blind|Other|7|||
157173267|NCT00379236|567375379|FG002|Double-blind|Other|0|||
157173268|NCT00379236|567375377|FG000|Double-blind|Data could not be retrieved|2|||
157173269|NCT00379236|567375378|FG001|Double-blind|Data could not be retrieved|2|||
157041511|NCT02972034|566906243|FG002|Overall Study|Sponsor Decision|0|||
157173270|NCT00379236|567375379|FG002|Double-blind|Data could not be retrieved|0|||
157173271|NCT00379236|567375377|FG000|Open-label Extension|Adverse Event|0|||
157173272|NCT00379236|567375378|FG001|Open-label Extension|Adverse Event|0|||
157173273|NCT00379236|567375379|FG002|Open-label Extension|Adverse Event|13|||
157173274|NCT00379236|567375377|FG000|Open-label Extension|Protocol Violation|0|||
157173275|NCT00379236|567375378|FG001|Open-label Extension|Protocol Violation|0|||
157173276|NCT00379236|567375379|FG002|Open-label Extension|Protocol Violation|7|||
157173277|NCT00379236|567375377|FG000|Open-label Extension|Withdrawal by Subject|0|||
157173278|NCT00379236|567375378|FG001|Open-label Extension|Withdrawal by Subject|0|||
157173279|NCT00379236|567375379|FG002|Open-label Extension|Withdrawal by Subject|13|||
157173280|NCT00379236|567375377|FG000|Open-label Extension|Lost to Follow-up|0|||
157173281|NCT00379236|567375378|FG001|Open-label Extension|Lost to Follow-up|0|||
157173282|NCT00379236|567375379|FG002|Open-label Extension|Lost to Follow-up|12|||
157041512|NCT02972034|566906244|FG003|Overall Study|Sponsor Decision|1|||
157041513|NCT02972034|566906245|FG004|Overall Study|Sponsor Decision|0|||
157173283|NCT00379236|567375377|FG000|Open-label Extension|Use of exclusionary medication|0|||
157173284|NCT00379236|567375378|FG001|Open-label Extension|Use of exclusionary medication|0|||
157173285|NCT00379236|567375379|FG002|Open-label Extension|Use of exclusionary medication|3|||
157173286|NCT00379236|567375377|FG000|Open-label Extension|Other|0|||
157173287|NCT00379236|567375378|FG001|Open-label Extension|Other|0|||
157173288|NCT00379236|567375379|FG002|Open-label Extension|Other|7|||
157041514|NCT02972034|566906246|FG005|Overall Study|Sponsor Decision|0|||
157041515|NCT02972034|566906247|FG006|Overall Study|Sponsor Decision|1|||
157041516|NCT02972034|566906248|FG007|Overall Study|Sponsor Decision|1|||
157041517|NCT02972034|566906249|FG008|Overall Study|Sponsor Decision|1|||
157041518|NCT02972034|566906250|FG009|Overall Study|Sponsor Decision|2|||
157041519|NCT02972034|566906251|FG010|Overall Study|Sponsor Decision|2|||
157041520|NCT02972034|566906252|FG011|Overall Study|Sponsor Decision|0|||
157041521|NCT02972034|566906253|FG012|Overall Study|Sponsor Decision|1|||
157041522|NCT02972034|566906254|FG013|Overall Study|Sponsor Decision|0|||
157041523|NCT02972034|566906255|FG014|Overall Study|Sponsor Decision|1|||
157041524|NCT02972034|566906241|FG000|Overall Study|Withdrawal by Subject|3|||
157041525|NCT02972034|566906242|FG001|Overall Study|Withdrawal by Subject|0|||
157041526|NCT02972034|566906243|FG002|Overall Study|Withdrawal by Subject|0|||
157041527|NCT02972034|566906244|FG003|Overall Study|Withdrawal by Subject|0|||
157041528|NCT02972034|566906245|FG004|Overall Study|Withdrawal by Subject|1|||
157041529|NCT02972034|566906246|FG005|Overall Study|Withdrawal by Subject|1|||
157041530|NCT02972034|566906247|FG006|Overall Study|Withdrawal by Subject|0|||
157041531|NCT02972034|566906248|FG007|Overall Study|Withdrawal by Subject|0|||
157041532|NCT02972034|566906249|FG008|Overall Study|Withdrawal by Subject|1|||
157041533|NCT02972034|566906250|FG009|Overall Study|Withdrawal by Subject|1|||
157041534|NCT02972034|566906251|FG010|Overall Study|Withdrawal by Subject|2|||
157041535|NCT02972034|566906252|FG011|Overall Study|Withdrawal by Subject|1|||
157041536|NCT02972034|566906253|FG012|Overall Study|Withdrawal by Subject|1|||
157041537|NCT02972034|566906254|FG013|Overall Study|Withdrawal by Subject|1|||
157041538|NCT02972034|566906255|FG014|Overall Study|Withdrawal by Subject|0|||
157041539|NCT02972034|566906241|FG000|Overall Study|Screen Failure|0|||
157041540|NCT02972034|566906242|FG001|Overall Study|Screen Failure|0|||
157041541|NCT02972034|566906243|FG002|Overall Study|Screen Failure|0|||
157041542|NCT02972034|566906244|FG003|Overall Study|Screen Failure|0|||
157041543|NCT02972034|566906245|FG004|Overall Study|Screen Failure|0|||
157041544|NCT02972034|566906246|FG005|Overall Study|Screen Failure|0|||
157041545|NCT02972034|566906247|FG006|Overall Study|Screen Failure|0|||
157041546|NCT02972034|566906248|FG007|Overall Study|Screen Failure|0|||
157041547|NCT02972034|566906249|FG008|Overall Study|Screen Failure|0|||
157041548|NCT02972034|566906250|FG009|Overall Study|Screen Failure|0|||
157041549|NCT02972034|566906251|FG010|Overall Study|Screen Failure|0|||
157041550|NCT02972034|566906252|FG011|Overall Study|Screen Failure|0|||
157041551|NCT02972034|566906253|FG012|Overall Study|Screen Failure|1|||
157041552|NCT02972034|566906254|FG013|Overall Study|Screen Failure|0|||
157041553|NCT02972034|566906255|FG014|Overall Study|Screen Failure|0|||
157041554|NCT03861052|566906256|FG000|Overall Study|Adverse Event|1|||
157041555|NCT03861052|566906257|FG001|Overall Study|Adverse Event|1|||
157041556|NCT03861052|566906258|FG002|Overall Study|Adverse Event|2|||
157041557|NCT03861052|566906259|FG003|Overall Study|Adverse Event|4|||
157041558|NCT03861052|566906256|FG000|Overall Study|Lost to Follow-up|0|||
157041559|NCT03861052|566906257|FG001|Overall Study|Lost to Follow-up|0|||
157041560|NCT03861052|566906258|FG002|Overall Study|Lost to Follow-up|0|||
157041561|NCT03861052|566906259|FG003|Overall Study|Lost to Follow-up|1|||
157041562|NCT03861052|566906256|FG000|Overall Study|Physician Decision|0|||
157041563|NCT03861052|566906257|FG001|Overall Study|Physician Decision|1|||
157041564|NCT03861052|566906258|FG002|Overall Study|Physician Decision|0|||
157041565|NCT03861052|566906259|FG003|Overall Study|Physician Decision|0|||
157041566|NCT03861052|566906256|FG000|Overall Study|Withdrawal by Subject|2|||
157041567|NCT03861052|566906257|FG001|Overall Study|Withdrawal by Subject|5|||
157173289|NCT04914819|567375385|FG000|Overall Study|Pregnancy|3|||
157173290|NCT04914819|567375386|FG001|Overall Study|Pregnancy|1|||
157173291|NCT04914819|567375385|FG000|Overall Study|Discontinued study|4|||
157041568|NCT03861052|566906258|FG002|Overall Study|Withdrawal by Subject|3|||
157041569|NCT03861052|566906259|FG003|Overall Study|Withdrawal by Subject|0|||
157041570|NCT03861052|566906256|FG000|Overall Study|Relocation to other city|1|||
157041571|NCT03861052|566906257|FG001|Overall Study|Relocation to other city|0|||
157041572|NCT03861052|566906258|FG002|Overall Study|Relocation to other city|0|||
157041573|NCT03861052|566906259|FG003|Overall Study|Relocation to other city|0|||
157041574|NCT03009344|566906260|FG000|Overall Study|Lack of Efficacy|5|||
157041575|NCT03009344|566906260|FG000|Overall Study|Withdrawal by Subject|1|||
157041576|NCT03009344|566906260|FG000|Overall Study|Adverse Event|1|||
157041577|NCT00378898|566906261|FG000|Overall Study|Withdrawal by Subject|10|||
157041578|NCT00378898|566906262|FG001|Overall Study|Withdrawal by Subject|5|||
157041579|NCT00378898|566906261|FG000|Overall Study|Protocol Violation|1|||
157041580|NCT00378898|566906262|FG001|Overall Study|Protocol Violation|1|||
157041581|NCT03116464|566906266|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
157041582|NCT00454194|566906274|FG000|Overall Study|Adverse Event|7|||
157173292|NCT04914819|567375386|FG001|Overall Study|Discontinued study|1|||
157173293|NCT04914819|567375385|FG000|Overall Study|Lost to Follow-up|7|||
157173294|NCT04914819|567375386|FG001|Overall Study|Lost to Follow-up|0|||
157173295|NCT02715804|567375387|FG000|Overall Study|Death|222|||
157173296|NCT02715804|567375388|FG001|Overall Study|Death|106|||
157173297|NCT02715804|567375387|FG000|Overall Study|Withdrawal by Subject|5|||
157173298|NCT02715804|567375388|FG001|Overall Study|Withdrawal by Subject|4|||
157173299|NCT02715804|567375387|FG000|Overall Study|Other than specified|2|||
157173300|NCT02715804|567375388|FG001|Overall Study|Other than specified|3|||
157173301|NCT01625611|567375391|FG000|Overall Study|No adlib drinks Lab 1|3|||
157173302|NCT01625611|567375392|FG001|Overall Study|No adlib drinks Lab 1|0|||
157173303|NCT01625611|567375391|FG000|Overall Study|Technical issues with PET|1|||
157173304|NCT01625611|567375392|FG001|Overall Study|Technical issues with PET|0|||
157173305|NCT01625611|567375391|FG000|Overall Study|Unable to complete study procedures|1|||
157173306|NCT01625611|567375392|FG001|Overall Study|Unable to complete study procedures|0|||
157173307|NCT01625611|567375391|FG000|Overall Study|Withdrawal by Subject|3|||
157173308|NCT01625611|567375392|FG001|Overall Study|Withdrawal by Subject|0|||
157173309|NCT00948194|567375393|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
157173310|NCT00948194|567375394|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
157173311|NCT02905825|567375403|FG000|Overall Study|Protocol Violation|11|||
157173312|NCT02905825|567375403|FG000|Overall Study|Device Malfunction|1|||
157173313|NCT00527072|567375404|FG000|Overall Study|Adverse Event|13|||
157173314|NCT00527072|567375404|FG000|Overall Study|Lack of Efficacy|11|||
157173315|NCT00527072|567375404|FG000|Overall Study|Lost to Follow-up|3|||
157173316|NCT00527072|567375404|FG000|Overall Study|Protocol Violation|2|||
157173317|NCT00527072|567375404|FG000|Overall Study|Withdrawal by Subject|7|||
157173318|NCT02657434|567375405|FG000|Overall Study|Study Terminated By Sponsor|64|||
157173319|NCT02657434|567375406|FG001|Overall Study|Study Terminated By Sponsor|82|||
157173320|NCT02657434|567375405|FG000|Overall Study|Death|189|||
157173321|NCT02657434|567375406|FG001|Overall Study|Death|190|||
157173322|NCT02657434|567375405|FG000|Overall Study|Lost to Follow-up|2|||
157173323|NCT02657434|567375406|FG001|Overall Study|Lost to Follow-up|2|||
157173324|NCT02657434|567375405|FG000|Overall Study|Randomization by Error|2|||
157173325|NCT02657434|567375406|FG001|Overall Study|Randomization by Error|0|||
157173326|NCT02657434|567375405|FG000|Overall Study|Withdrawal by Subject|28|||
157173327|NCT02657434|567375406|FG001|Overall Study|Withdrawal by Subject|17|||
157173328|NCT02657434|567375405|FG000|Overall Study|Protocol Violation|1|||
157173329|NCT02657434|567375406|FG001|Overall Study|Protocol Violation|0|||
157173330|NCT02657434|567375405|FG000|Overall Study|Physician Decision|0|||
157173331|NCT02657434|567375406|FG001|Overall Study|Physician Decision|1|||
157173332|NCT02137837|567375413|FG000|Overall Study|Adverse Event|0|||
157173333|NCT02137837|567375414|FG001|Overall Study|Adverse Event|2|||
157173334|NCT02137837|567375415|FG002|Overall Study|Adverse Event|1|||
157173335|NCT02137837|567375413|FG000|Overall Study|Refusal unrelated to adverse event|2|||
157173336|NCT02137837|567375414|FG001|Overall Study|Refusal unrelated to adverse event|2|||
157173337|NCT02137837|567375415|FG002|Overall Study|Refusal unrelated to adverse event|1|||
157173338|NCT02137837|567375413|FG000|Overall Study|Progression/relapse|9|||
157173339|NCT02137837|567375414|FG001|Overall Study|Progression/relapse|7|||
157173340|NCT02137837|567375415|FG002|Overall Study|Progression/relapse|7|||
157173341|NCT02137837|567375413|FG000|Overall Study|Not protocol specified|2|||
157173342|NCT02137837|567375414|FG001|Overall Study|Not protocol specified|1|||
157228230|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
157228231|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
157228232|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
157173343|NCT02137837|567375415|FG002|Overall Study|Not protocol specified|3|||
157173344|NCT01181141|567375416|FG000|Overall Study|Adverse Event|2|||
157173345|NCT01181141|567375417|FG001|Overall Study|Adverse Event|1|||
157173346|NCT01181141|567375416|FG000|Overall Study|Lack of Efficacy|1|||
157173347|NCT01181141|567375417|FG001|Overall Study|Lack of Efficacy|0|||
157173348|NCT01181141|567375416|FG000|Overall Study|Lost to Follow-up|1|||
157173349|NCT01181141|567375417|FG001|Overall Study|Lost to Follow-up|1|||
157173350|NCT01181141|567375416|FG000|Overall Study|Physician Decision|2|||
157173351|NCT01181141|567375417|FG001|Overall Study|Physician Decision|0|||
157173352|NCT01181141|567375416|FG000|Overall Study|Protocol Violation|3|||
157173353|NCT01181141|567375417|FG001|Overall Study|Protocol Violation|1|||
157173354|NCT01181141|567375416|FG000|Overall Study|Withdrawal by Subject|3|||
157173355|NCT01181141|567375417|FG001|Overall Study|Withdrawal by Subject|1|||
157173356|NCT00118911|567375418|FG000|Overall Study|Withdrawal by Subject|2|||
157173357|NCT00118911|567375419|FG001|Overall Study|Withdrawal by Subject|5|||
157173358|NCT03496662|567375421|FG000|Overall Study|Adverse Event|0|||
157173359|NCT03496662|567375422|FG001|Overall Study|Adverse Event|0|||
157173360|NCT03496662|567375423|FG002|Overall Study|Adverse Event|4|||
157173361|NCT03496662|567375421|FG000|Overall Study|Withdrawal by Subject|1|||
157173362|NCT03496662|567375422|FG001|Overall Study|Withdrawal by Subject|0|||
157173363|NCT03496662|567375423|FG002|Overall Study|Withdrawal by Subject|2|||
157173364|NCT03496662|567375421|FG000|Overall Study|Death|0|||
157173365|NCT03496662|567375422|FG001|Overall Study|Death|0|||
157228233|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
157228234|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
157228235|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
157041583|NCT00454194|566906275|FG001|Overall Study|Adverse Event|2|||
157041584|NCT00454194|566906274|FG000|Overall Study|Withdrawal by Subject|12|||
157041585|NCT00454194|566906275|FG001|Overall Study|Withdrawal by Subject|8|||
157041586|NCT00454194|566906274|FG000|Overall Study|Other Medical Problems|1|||
157041587|NCT00454194|566906275|FG001|Overall Study|Other Medical Problems|2|||
157041588|NCT00454194|566906274|FG000|Overall Study|Other Unspecified Reason|2|||
157041589|NCT00454194|566906275|FG001|Overall Study|Other Unspecified Reason|2|||
157041590|NCT00229658|566906293|FG000|Overall Study|Administrative|2|||
157041591|NCT00229658|566906294|FG001|Overall Study|Administrative|1|||
157041592|NCT00229658|566906293|FG000|Overall Study|Investigator decision|13|||
157041593|NCT00229658|566906294|FG001|Overall Study|Investigator decision|10|||
157041594|NCT00229658|566906293|FG000|Overall Study|Other|80|||
157041595|NCT00229658|566906294|FG001|Overall Study|Other|60|||
157041596|NCT00229658|566906293|FG000|Overall Study|Lost to Follow-up|82|||
157041597|NCT00229658|566906294|FG001|Overall Study|Lost to Follow-up|55|||
157041598|NCT00229658|566906293|FG000|Overall Study|Serious Adverse Event|2|||
157041599|NCT00229658|566906294|FG001|Overall Study|Serious Adverse Event|2|||
157041600|NCT00229658|566906293|FG000|Overall Study|Withdrawal of consent|46|||
157041601|NCT00229658|566906294|FG001|Overall Study|Withdrawal of consent|39|||
157041602|NCT00205179|566906295|FG000|Overall Study|Death|0|||
157041603|NCT00205179|566906296|FG001|Overall Study|Death|2|||
157041604|NCT00205179|566906295|FG000|Overall Study|Physician Decision|1|||
157041605|NCT00205179|566906296|FG001|Overall Study|Physician Decision|1|||
157041606|NCT00205179|566906295|FG000|Overall Study|Adverse Event|1|||
157041607|NCT00205179|566906296|FG001|Overall Study|Adverse Event|1|||
157041608|NCT00463229|566906297|FG000|Overall Study|Lost to Follow-up|5|||
157041609|NCT00463229|566906298|FG001|Overall Study|Lost to Follow-up|7|||
157041610|NCT00463229|566906297|FG000|Overall Study|Death|4|||
157041611|NCT00463229|566906298|FG001|Overall Study|Death|3|||
157041612|NCT01700205|566906305|FG000|Overall Study|Withdrawal by Subject|13|||
157041613|NCT01700205|566906306|FG001|Overall Study|Withdrawal by Subject|13|||
157041614|NCT01700205|566906305|FG000|Overall Study|Protocol Violation|2|||
157041615|NCT01700205|566906306|FG001|Overall Study|Protocol Violation|2|||
157041616|NCT01728324|566906307|FG000|Termination of DBV|Adverse Event|14|||
157041617|NCT01728324|566906308|FG001|Termination of DBV|Adverse Event|13|||
157041618|NCT01728324|566906309|FG002|Termination of DBV|Adverse Event|4|||
157041619|NCT01728324|566906307|FG000|Termination of DBV|Lack of Efficacy|14|||
157041620|NCT01728324|566906308|FG001|Termination of DBV|Lack of Efficacy|12|||
157041621|NCT01728324|566906309|FG002|Termination of DBV|Lack of Efficacy|8|||
157041622|NCT01728324|566906307|FG000|Termination of DBV|Withdrawal by Subject|9|||
157041623|NCT01728324|566906308|FG001|Termination of DBV|Withdrawal by Subject|6|||
157041624|NCT01728324|566906309|FG002|Termination of DBV|Withdrawal by Subject|2|||
157041625|NCT01728324|566906307|FG000|Termination of DBV|Other than stated|1|||
157041626|NCT01728324|566906308|FG001|Termination of DBV|Other than stated|3|||
157041627|NCT01728324|566906309|FG002|Termination of DBV|Other than stated|0|||
157041628|NCT01728324|566906307|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
157041629|NCT01728324|566906308|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
157041630|NCT01728324|566906309|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
157041631|NCT01728324|566906307|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
157041632|NCT01728324|566906308|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
157041633|NCT01728324|566906309|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
157041634|NCT01728324|566906307|FG000|Termination of FDV|Adverse Event|14|||
157041635|NCT01728324|566906308|FG001|Termination of FDV|Adverse Event|13|||
157041636|NCT01728324|566906309|FG002|Termination of FDV|Adverse Event|4|||
157041637|NCT01728324|566906307|FG000|Termination of FDV|Lack of Efficacy|14|||
157041638|NCT01728324|566906308|FG001|Termination of FDV|Lack of Efficacy|12|||
157041639|NCT01728324|566906309|FG002|Termination of FDV|Lack of Efficacy|8|||
157041640|NCT01728324|566906307|FG000|Termination of FDV|Withdrawal by Subject|9|||
157041641|NCT01728324|566906308|FG001|Termination of FDV|Withdrawal by Subject|6|||
157041642|NCT01728324|566906309|FG002|Termination of FDV|Withdrawal by Subject|2|||
157041643|NCT01728324|566906307|FG000|Termination of FDV|Other than stated|1|||
157041644|NCT01728324|566906308|FG001|Termination of FDV|Other than stated|3|||
157041645|NCT01728324|566906309|FG002|Termination of FDV|Other than stated|0|||
157041646|NCT01728324|566906307|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
157041647|NCT01728324|566906308|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
157041648|NCT01728324|566906309|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
157041649|NCT01728324|566906307|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
157041650|NCT01728324|566906308|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
157041651|NCT01728324|566906309|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
157041652|NCT01728324|566906307|FG000|Termination of RBV|Adverse Event|15|||
157041653|NCT01728324|566906308|FG001|Termination of RBV|Adverse Event|16|||
157041654|NCT01728324|566906309|FG002|Termination of RBV|Adverse Event|5|||
157041655|NCT01728324|566906307|FG000|Termination of RBV|Lack of Efficacy|14|||
157041656|NCT01728324|566906308|FG001|Termination of RBV|Lack of Efficacy|11|||
157041657|NCT01728324|566906309|FG002|Termination of RBV|Lack of Efficacy|7|||
157041658|NCT01728324|566906307|FG000|Termination of RBV|Withdrawal by Subject|9|||
157041659|NCT01728324|566906308|FG001|Termination of RBV|Withdrawal by Subject|5|||
157041660|NCT01728324|566906309|FG002|Termination of RBV|Withdrawal by Subject|2|||
157041661|NCT01728324|566906307|FG000|Termination of RBV|Other than stated|1|||
157041662|NCT01728324|566906308|FG001|Termination of RBV|Other than stated|3|||
157041663|NCT01728324|566906309|FG002|Termination of RBV|Other than stated|1|||
157041664|NCT01728324|566906307|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
157041665|NCT01728324|566906308|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
157041666|NCT01728324|566906309|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
157041667|NCT01728324|566906307|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
157041668|NCT01728324|566906308|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
157041669|NCT01728324|566906309|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
157041670|NCT01170208|566906310|FG000|Overall Study|Withdrawal by Subject|5|||
157041671|NCT01170208|566906311|FG001|Overall Study|Withdrawal by Subject|0|||
157041672|NCT01170208|566906312|FG002|Overall Study|Withdrawal by Subject|1|||
157041673|NCT01170208|566906310|FG000|Overall Study|Protocol Violation|1|||
157041674|NCT01170208|566906311|FG001|Overall Study|Protocol Violation|0|||
157041675|NCT01170208|566906312|FG002|Overall Study|Protocol Violation|1|||
157041676|NCT03113409|566906315|FG000|Overall Study|Withdrawal by Subject|5|||
157041677|NCT03113409|566906316|FG001|Overall Study|Withdrawal by Subject|0|||
157041678|NCT03113409|566906317|FG002|Overall Study|Withdrawal by Subject|0|||
157041679|NCT00388726|566906320|FG000|Overall Study|Adverse Event|50|||
157041680|NCT00388726|566906321|FG001|Overall Study|Adverse Event|24|||
157041681|NCT00388726|566906320|FG000|Overall Study|Progressive Disease|336|||
157041682|NCT00388726|566906321|FG001|Overall Study|Progressive Disease|153|||
157041683|NCT00388726|566906320|FG000|Overall Study|Clinical Progression|61|||
157041684|NCT00388726|566906321|FG001|Overall Study|Clinical Progression|36|||
157041685|NCT00388726|566906320|FG000|Overall Study|Withdrawal by Subject|10|||
157041686|NCT00388726|566906321|FG001|Overall Study|Withdrawal by Subject|7|||
157041687|NCT00388726|566906320|FG000|Overall Study|Administrative|6|||
157041688|NCT00388726|566906321|FG001|Overall Study|Administrative|9|||
157041689|NCT00388726|566906320|FG000|Overall Study|Physician Decision|18|||
157041690|NCT00388726|566906321|FG001|Overall Study|Physician Decision|13|||
157041691|NCT00388726|566906320|FG000|Overall Study|Death|3|||
157041692|NCT00388726|566906321|FG001|Overall Study|Death|2|||
157041693|NCT02406092|566906322|FG000|Overall Study|Screen failure|10|||
157041694|NCT02406092|566906323|FG001|Overall Study|Screen failure|7|||
157041695|NCT02406092|566906322|FG000|Overall Study|Death|22|||
157041696|NCT02406092|566906323|FG001|Overall Study|Death|5|||
157041697|NCT02406092|566906322|FG000|Overall Study|Lost to Follow-up|4|||
157041698|NCT02406092|566906323|FG001|Overall Study|Lost to Follow-up|1|||
157041699|NCT02406092|566906322|FG000|Overall Study|Adverse Event|1|||
157041700|NCT02406092|566906323|FG001|Overall Study|Adverse Event|0|||
157041701|NCT02406092|566906322|FG000|Overall Study|Withdrawal by Subject|1|||
157041702|NCT02406092|566906323|FG001|Overall Study|Withdrawal by Subject|0|||
157041703|NCT03041233|566906324|FG000|Overall Study|Death|5|||
157041704|NCT03041233|566906324|FG000|Overall Study|Physician Decision|1|||
157041705|NCT03041233|566906324|FG000|Overall Study|Lost to Follow-up|16|||
157041706|NCT03041233|566906324|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
157041707|NCT03041233|566906324|FG000|Overall Study|Sponsor Request|1|||
157041708|NCT03041233|566906324|FG000|Overall Study|Duplicate subject|1|||
157041709|NCT03041233|566906324|FG000|Overall Study|Re-ablation|1|||
157041710|NCT00853593|566906328|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
157041711|NCT00853593|566906328|FG000|Overall Study|Model 4396 lead not attempted|29|||
157041712|NCT00853593|566906328|FG000|Overall Study|Implant not attempted|4|||
157041713|NCT00641537|566906331|FG000|96-week Period|Adverse Event|0|||
157041714|NCT00641537|566906332|FG001|96-week Period|Adverse Event|1|||
157041715|NCT00641537|566906333|FG002|96-week Period|Adverse Event|3|||
157041716|NCT00641537|566906334|FG003|96-week Period|Adverse Event|0|||
157041717|NCT00641537|566906335|FG004|96-week Period|Adverse Event|2|||
157041718|NCT00641537|566906336|FG005|96-week Period|Adverse Event|0|||
157041719|NCT00641537|566906337|FG006|96-week Period|Adverse Event|0|||
157173366|NCT03496662|567375423|FG002|Overall Study|Death|2|||
157173367|NCT03496662|567375421|FG000|Overall Study|Noncompliance|0|||
157041720|NCT00641537|566906338|FG007|96-week Period|Adverse Event|0|||
157041721|NCT00641537|566906331|FG000|96-week Period|Lost to Follow-up|3|||
157041722|NCT00641537|566906332|FG001|96-week Period|Lost to Follow-up|1|||
157041723|NCT00641537|566906333|FG002|96-week Period|Lost to Follow-up|2|||
157041724|NCT00641537|566906334|FG003|96-week Period|Lost to Follow-up|2|||
157041725|NCT00641537|566906335|FG004|96-week Period|Lost to Follow-up|4|||
157041726|NCT00641537|566906336|FG005|96-week Period|Lost to Follow-up|0|||
157041727|NCT00641537|566906337|FG006|96-week Period|Lost to Follow-up|1|||
157041728|NCT00641537|566906338|FG007|96-week Period|Lost to Follow-up|0|||
157041729|NCT00641537|566906331|FG000|96-week Period|Protocol Violation|0|||
157041730|NCT00641537|566906332|FG001|96-week Period|Protocol Violation|1|||
157041731|NCT00641537|566906333|FG002|96-week Period|Protocol Violation|0|||
157173368|NCT03496662|567375422|FG001|Overall Study|Noncompliance|0|||
157173369|NCT03496662|567375423|FG002|Overall Study|Noncompliance|1|||
157173370|NCT01467661|567375424|FG000|Overall Study|Adverse Event|16|||
157173371|NCT01467661|567375424|FG000|Overall Study|Withdrawal by Subject|1|||
157173372|NCT01467661|567375424|FG000|Overall Study|Lack of Efficacy|3|||
157173373|NCT01467661|567375424|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
157173374|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
157228236|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
157228237|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
157228238|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
156968017|NCT02612311|566633789|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
156968018|NCT02612311|566633786|FG000|Overall Study|Investigator's Decision|11|||
156968019|NCT02612311|566633787|FG001|Overall Study|Investigator's Decision|15|||
156968020|NCT02612311|566633788|FG002|Overall Study|Investigator's Decision|6|||
156968021|NCT02612311|566633789|FG003|Overall Study|Investigator's Decision|6|||
156968022|NCT02612311|566633786|FG000|Overall Study|Lack of Efficacy|0|||
156968023|NCT02612311|566633787|FG001|Overall Study|Lack of Efficacy|0|||
156968024|NCT02612311|566633788|FG002|Overall Study|Lack of Efficacy|1|||
156968025|NCT02612311|566633789|FG003|Overall Study|Lack of Efficacy|1|||
156968026|NCT02612311|566633786|FG000|Overall Study|Lost to Follow-up|2|||
156968027|NCT02612311|566633787|FG001|Overall Study|Lost to Follow-up|2|||
156968028|NCT02612311|566633788|FG002|Overall Study|Lost to Follow-up|1|||
156968029|NCT02612311|566633789|FG003|Overall Study|Lost to Follow-up|2|||
156968030|NCT02612311|566633786|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
156968031|NCT02612311|566633787|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
156968032|NCT02612311|566633788|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
156968033|NCT02612311|566633789|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
156968034|NCT02612311|566633786|FG000|Overall Study|Site Terminated by Sponsor|29|||
156968035|NCT02612311|566633787|FG001|Overall Study|Site Terminated by Sponsor|12|||
156968036|NCT02612311|566633788|FG002|Overall Study|Site Terminated by Sponsor|13|||
156968037|NCT02612311|566633789|FG003|Overall Study|Site Terminated by Sponsor|5|||
156968038|NCT02612311|566633786|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
156968039|NCT02612311|566633787|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
156968040|NCT02612311|566633788|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
156968041|NCT02612311|566633789|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
156968042|NCT02612311|566633786|FG000|Overall Study|Reason Not Specified|3|||
156968043|NCT02612311|566633787|FG001|Overall Study|Reason Not Specified|7|||
156968044|NCT02612311|566633788|FG002|Overall Study|Reason Not Specified|4|||
156968045|NCT02612311|566633789|FG003|Overall Study|Reason Not Specified|5|||
156968046|NCT02612311|566633786|FG000|Overall Study|Unknown/Missing|10|||
156968047|NCT02612311|566633787|FG001|Overall Study|Unknown/Missing|13|||
156968048|NCT02612311|566633788|FG002|Overall Study|Unknown/Missing|4|||
156968049|NCT02612311|566633789|FG003|Overall Study|Unknown/Missing|0|||
156968050|NCT02612311|566633786|FG000|Overall Study|Non-Compliance with Study|1|||
156968051|NCT02612311|566633787|FG001|Overall Study|Non-Compliance with Study|0|||
156968052|NCT02612311|566633788|FG002|Overall Study|Non-Compliance with Study|0|||
156968053|NCT02612311|566633789|FG003|Overall Study|Non-Compliance with Study|0|||
156968054|NCT04085328|566633793|FG000|Overall Study|Witihdrew Consent|16|||
156968055|NCT04085328|566633794|FG001|Overall Study|Witihdrew Consent|16|||
156968056|NCT04085328|566633793|FG000|Overall Study|Adverse Event|8|||
156968057|NCT04085328|566633794|FG001|Overall Study|Adverse Event|7|||
156968058|NCT04085328|566633793|FG000|Overall Study|Lost to Follow-up|7|||
156968059|NCT04085328|566633794|FG001|Overall Study|Lost to Follow-up|2|||
156968060|NCT04085328|566633793|FG000|Overall Study|Physician Decision|0|||
156968061|NCT04085328|566633794|FG001|Overall Study|Physician Decision|1|||
156968062|NCT04085328|566633793|FG000|Overall Study|Pregnancy|0|||
157173375|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
157228239|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
157228240|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
157228241|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
157228242|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
157173376|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
157173377|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
157173378|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
157173379|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
157173380|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
157173381|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
157173382|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
157173383|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
156968063|NCT04085328|566633794|FG001|Overall Study|Pregnancy|1|||
157173384|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
157173385|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
157173386|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
157173387|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
157173388|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
157173389|NCT03814005|567375427|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
157173390|NCT03814005|567375428|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
157173391|NCT03814005|567375429|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
157173392|NCT03395223|567375430|FG000|Overall Study|Lost to Follow-up|3|||
156968064|NCT04085328|566633793|FG000|Overall Study|Reasons Related to COVID-19|5|||
156968065|NCT04085328|566633794|FG001|Overall Study|Reasons Related to COVID-19|8|||
156968066|NCT04085328|566633793|FG000|Overall Study|Did not meet inclusion criteria|1|||
156968067|NCT04085328|566633794|FG001|Overall Study|Did not meet inclusion criteria|1|||
156968068|NCT04085328|566633793|FG000|Overall Study|Early termination|1|||
156968069|NCT04085328|566633794|FG001|Overall Study|Early termination|0|||
156968070|NCT00514735|566633795|FG000|Overall Study|Withdrawal by Subject|13|||
156968071|NCT00514735|566633796|FG001|Overall Study|Withdrawal by Subject|5|||
156968072|NCT00514735|566633795|FG000|Overall Study|Death|1|||
156968073|NCT00514735|566633796|FG001|Overall Study|Death|0|||
156968074|NCT00514735|566633795|FG000|Overall Study|Lost to Follow-up|0|||
156968075|NCT00514735|566633796|FG001|Overall Study|Lost to Follow-up|1|||
156968076|NCT04751942|566633798|FG000|Overall Study|Lost to Follow-up|9|||
156968077|NCT04751942|566633799|FG001|Overall Study|Lost to Follow-up|6|||
156968078|NCT01422408|566633800|FG000|Overall Study|Adverse Event|1|||
156968079|NCT01422408|566633800|FG000|Overall Study|Withdrawal by Subject|3|||
156968080|NCT00724152|566633807|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
156968081|NCT00724152|566633808|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
156968082|NCT00724152|566633809|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
156968083|NCT00724152|566633807|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
156968084|NCT00724152|566633808|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
156968085|NCT00724152|566633809|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
156968086|NCT04274894|566633813|FG000|Overall Study|Adverse Event|7|||
156968087|NCT04274894|566633813|FG000|Overall Study|Withdrew consent|5|||
156968088|NCT04274894|566633813|FG000|Overall Study|Lost to Follow-up|9|||
156968089|NCT04274894|566633813|FG000|Overall Study|COVID-19 infection|1|||
156968090|NCT04274894|566633813|FG000|Overall Study|Other, not specified|20|||
156968091|NCT02279043|566633814|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
156968092|NCT02279043|566633815|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
156968093|NCT02279043|566633816|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
156968094|NCT02279043|566633814|FG000|Overall Study|Lost to Follow-up|46|||
156968095|NCT02279043|566633815|FG001|Overall Study|Lost to Follow-up|88|||
156968096|NCT02279043|566633816|FG002|Overall Study|Lost to Follow-up|0|||
156968097|NCT04510675|566633821|FG000|Overall Study|Withdrawal by Subject|5|||
156968098|NCT01499082|566633826|FG000|Overall Study|Randomized but not Treated|0|||
156968099|NCT01499082|566633827|FG001|Overall Study|Randomized but not Treated|1|||
156968100|NCT01499082|566633826|FG000|Overall Study|Adverse Event|12|||
156968101|NCT01499082|566633827|FG001|Overall Study|Adverse Event|16|||
156968102|NCT01499082|566633826|FG000|Overall Study|Lack of Efficacy|1|||
156968103|NCT01499082|566633827|FG001|Overall Study|Lack of Efficacy|1|||
156968104|NCT01499082|566633826|FG000|Overall Study|Protocol Violation|6|||
156968105|NCT01499082|566633827|FG001|Overall Study|Protocol Violation|8|||
156968106|NCT01499082|566633826|FG000|Overall Study|Diverse Reasons|18|||
156968107|NCT01499082|566633827|FG001|Overall Study|Diverse Reasons|14|||
156968108|NCT01499082|566633826|FG000|Overall Study|Site Closure for Noncompliance|5|||
156968109|NCT01499082|566633827|FG001|Overall Study|Site Closure for Noncompliance|2|||
156968110|NCT01499082|566633826|FG000|Overall Study|Hypoglycemia|2|||
156968111|NCT01499082|566633827|FG001|Overall Study|Hypoglycemia|3|||
156968112|NCT01499082|566633826|FG000|Overall Study|Lost to Follow-up|1|||
156968113|NCT01499082|566633827|FG001|Overall Study|Lost to Follow-up|3|||
156968114|NCT06213701|566633831|FG000|Overall Study|Withdrawal by Subject|2|||
156968115|NCT06213701|566633832|FG001|Overall Study|Withdrawal by Subject|1|||
156968116|NCT06213701|566633833|FG002|Overall Study|Withdrawal by Subject|0|||
156968117|NCT00538590|566633834|FG000|Overall Study|Death|1|||
156968118|NCT00538590|566633835|FG001|Overall Study|Death|0|||
156968119|NCT01256567|566633836|FG000|Overall Study|Withdrawal by Subject|1|||
156968120|NCT00567190|566633842|FG000|Overall Study|Death|235|||
156968121|NCT00567190|566633843|FG001|Overall Study|Death|280|||
156968122|NCT00567190|566633842|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
156968123|NCT00567190|566633843|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
156968124|NCT03184792|566633847|FG000|Overall Study|Pandemic|2|||
157173393|NCT03395223|567375430|FG000|Overall Study|Other|1|||
156968125|NCT03184792|566633848|FG001|Overall Study|Pandemic|2|||
156968126|NCT00636610|566633851|FG000|Overall Study|Adverse Event|4|||
156968127|NCT00636610|566633852|FG001|Overall Study|Adverse Event|4|||
156968128|NCT00636610|566633851|FG000|Overall Study|Death|6|||
156968129|NCT00636610|566633852|FG001|Overall Study|Death|3|||
156968130|NCT00636610|566633851|FG000|Overall Study|Physician decision to withdraw patient|15|||
157041732|NCT00641537|566906334|FG003|96-week Period|Protocol Violation|1|||
157041733|NCT00641537|566906335|FG004|96-week Period|Protocol Violation|0|||
157041734|NCT00641537|566906336|FG005|96-week Period|Protocol Violation|1|||
157041735|NCT00641537|566906337|FG006|96-week Period|Protocol Violation|0|||
157041736|NCT00641537|566906338|FG007|96-week Period|Protocol Violation|0|||
157041737|NCT00641537|566906331|FG000|96-week Period|Death|2|||
157041738|NCT00641537|566906332|FG001|96-week Period|Death|0|||
157041739|NCT00641537|566906333|FG002|96-week Period|Death|1|||
157041740|NCT00641537|566906334|FG003|96-week Period|Death|0|||
157041741|NCT00641537|566906335|FG004|96-week Period|Death|0|||
157041742|NCT00641537|566906336|FG005|96-week Period|Death|0|||
157041743|NCT00641537|566906337|FG006|96-week Period|Death|0|||
157041744|NCT00641537|566906338|FG007|96-week Period|Death|0|||
157041745|NCT00641537|566906331|FG000|96-week Period|Other|4|||
157041746|NCT00641537|566906332|FG001|96-week Period|Other|7|||
157041747|NCT00641537|566906333|FG002|96-week Period|Other|14|||
157041748|NCT00641537|566906334|FG003|96-week Period|Other|9|||
157041749|NCT00641537|566906335|FG004|96-week Period|Other|11|||
157041750|NCT00641537|566906336|FG005|96-week Period|Other|6|||
157041751|NCT00641537|566906337|FG006|96-week Period|Other|4|||
157041752|NCT00641537|566906338|FG007|96-week Period|Other|6|||
157041753|NCT00641537|566906331|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
157041754|NCT00641537|566906332|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
157041755|NCT00641537|566906333|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
157041756|NCT00641537|566906334|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
157041757|NCT00641537|566906335|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
157041758|NCT00641537|566906336|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
157041759|NCT00641537|566906337|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
157041760|NCT00641537|566906338|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
157041761|NCT00641537|566906331|FG000|24-Week Supplemental Follow-up Period|Other|0|||
157041762|NCT00641537|566906332|FG001|24-Week Supplemental Follow-up Period|Other|2|||
157041763|NCT00641537|566906333|FG002|24-Week Supplemental Follow-up Period|Other|2|||
157041764|NCT00641537|566906334|FG003|24-Week Supplemental Follow-up Period|Other|1|||
157041765|NCT00641537|566906335|FG004|24-Week Supplemental Follow-up Period|Other|3|||
157041766|NCT00641537|566906336|FG005|24-Week Supplemental Follow-up Period|Other|0|||
157041767|NCT00641537|566906337|FG006|24-Week Supplemental Follow-up Period|Other|1|||
157041768|NCT00641537|566906338|FG007|24-Week Supplemental Follow-up Period|Other|1|||
157041769|NCT03745313|566906341|FG000|At 30 Days Follow-up|Death|2|||
157041770|NCT03745313|566906341|FG000|At 6 Months Follow-up|Death|1|||
157041771|NCT03745313|566906341|FG000|At 6 Months Follow-up|Missed Visit|1|||
157041772|NCT03745313|566906341|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
157041773|NCT03745313|566906341|FG000|At 1 Year Follow-up|Death|2|||
157041774|NCT03745313|566906341|FG000|At 1 Year Follow-up|Missed Visit|2|||
157041775|NCT03745313|566906341|FG000|At 2 Year Follow-up|Missed Visit|1|||
157041776|NCT01706159|566906342|FG000|Overall Study|Withdrawal Criteria|2|||
157041777|NCT01706159|566906343|FG001|Overall Study|Withdrawal Criteria|1|||
157041778|NCT01706159|566906342|FG000|Overall Study|Unclassified|6|||
157041779|NCT01706159|566906343|FG001|Overall Study|Unclassified|1|||
157041780|NCT03362190|566906344|FG000|Overall Study|Adverse Event|0|||
157041781|NCT03362190|566906345|FG001|Overall Study|Adverse Event|0|||
157041782|NCT03362190|566906346|FG002|Overall Study|Adverse Event|0|||
157041783|NCT03362190|566906347|FG003|Overall Study|Adverse Event|1|||
157041784|NCT03362190|566906344|FG000|Overall Study|Withdrawal by Subject|0|||
157041785|NCT03362190|566906345|FG001|Overall Study|Withdrawal by Subject|0|||
157041786|NCT03362190|566906346|FG002|Overall Study|Withdrawal by Subject|0|||
157041787|NCT03362190|566906347|FG003|Overall Study|Withdrawal by Subject|1|||
157041788|NCT02235298|566906355|FG000|Overall Study|Lost to Follow-up|6|||
157041789|NCT02235298|566906356|FG001|Overall Study|Lost to Follow-up|5|||
157041790|NCT02235298|566906355|FG000|Overall Study|Adverse Event|2|||
157041791|NCT02235298|566906356|FG001|Overall Study|Adverse Event|2|||
157041792|NCT02235298|566906355|FG000|Overall Study|Withdrawal by Subject|0|||
157041793|NCT02235298|566906356|FG001|Overall Study|Withdrawal by Subject|1|||
157041794|NCT02628626|566906359|FG000|Overall Study|Withdrawal by Subject|2|||
157041795|NCT02628626|566906360|FG001|Overall Study|Withdrawal by Subject|2|||
157041796|NCT01593020|566906361|FG000|Overall Study|Adverse Event|1|||
157041797|NCT01593020|566906362|FG001|Overall Study|Adverse Event|1|||
157041798|NCT01593020|566906361|FG000|Overall Study|Death|0|||
157041799|NCT01593020|566906362|FG001|Overall Study|Death|1|||
157041800|NCT01593020|566906361|FG000|Overall Study|Ineligible|1|||
157041801|NCT01593020|566906362|FG001|Overall Study|Ineligible|0|||
157041802|NCT02454959|566906363|FG000|Overall Study|Protocol-Specified Criteria|3|||
157041803|NCT02454959|566906363|FG000|Overall Study|Physician Decision|1|||
157041804|NCT02454959|566906363|FG000|Overall Study|Withdrawal by Subject|3|||
157041805|NCT02454959|566906363|FG000|Overall Study|Adverse Event|2|||
157041806|NCT02350634|566906364|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
157041807|NCT03611075|566906373|FG000|Overall Study|Physician Decision|0|||
157041808|NCT03611075|566906374|FG001|Overall Study|Physician Decision|1|||
157041809|NCT03611075|566906375|FG002|Overall Study|Physician Decision|1|||
157041810|NCT03611075|566906376|FG003|Overall Study|Physician Decision|0|||
157041811|NCT03611075|566906377|FG004|Overall Study|Physician Decision|0|||
157041812|NCT03611075|566906378|FG005|Overall Study|Physician Decision|0|||
157041813|NCT03611075|566906379|FG006|Overall Study|Physician Decision|0|||
157041814|NCT03611075|566906380|FG007|Overall Study|Physician Decision|0|||
157041815|NCT03611075|566906381|FG008|Overall Study|Physician Decision|0|||
157041816|NCT03611075|566906373|FG000|Overall Study|Lost to Follow-up|1|||
157041817|NCT03611075|566906374|FG001|Overall Study|Lost to Follow-up|0|||
157041818|NCT03611075|566906375|FG002|Overall Study|Lost to Follow-up|0|||
157041819|NCT03611075|566906376|FG003|Overall Study|Lost to Follow-up|2|||
157041820|NCT03611075|566906377|FG004|Overall Study|Lost to Follow-up|0|||
157041821|NCT03611075|566906378|FG005|Overall Study|Lost to Follow-up|0|||
157041822|NCT03611075|566906379|FG006|Overall Study|Lost to Follow-up|0|||
157041823|NCT03611075|566906380|FG007|Overall Study|Lost to Follow-up|0|||
157041824|NCT03611075|566906381|FG008|Overall Study|Lost to Follow-up|0|||
157041825|NCT03611075|566906373|FG000|Overall Study|Withdrawal by Subject|0|||
157041826|NCT03611075|566906374|FG001|Overall Study|Withdrawal by Subject|1|||
157041827|NCT03611075|566906375|FG002|Overall Study|Withdrawal by Subject|1|||
157041828|NCT03611075|566906376|FG003|Overall Study|Withdrawal by Subject|1|||
157041829|NCT03611075|566906377|FG004|Overall Study|Withdrawal by Subject|0|||
157041830|NCT03611075|566906378|FG005|Overall Study|Withdrawal by Subject|0|||
157041831|NCT03611075|566906379|FG006|Overall Study|Withdrawal by Subject|1|||
157041832|NCT03611075|566906380|FG007|Overall Study|Withdrawal by Subject|0|||
157041833|NCT03611075|566906381|FG008|Overall Study|Withdrawal by Subject|0|||
157041834|NCT03611075|566906373|FG000|Overall Study|Reason unknown|0|||
157041835|NCT03611075|566906374|FG001|Overall Study|Reason unknown|0|||
157041836|NCT03611075|566906375|FG002|Overall Study|Reason unknown|0|||
157041837|NCT03611075|566906376|FG003|Overall Study|Reason unknown|1|||
157041838|NCT03611075|566906377|FG004|Overall Study|Reason unknown|0|||
157041839|NCT03611075|566906378|FG005|Overall Study|Reason unknown|0|||
157041840|NCT03611075|566906379|FG006|Overall Study|Reason unknown|1|||
157041841|NCT03611075|566906380|FG007|Overall Study|Reason unknown|0|||
157041842|NCT03611075|566906381|FG008|Overall Study|Reason unknown|0|||
157041843|NCT05025384|566906392|FG000|Overall Study|Physician Decision|5|||
157041844|NCT05025384|566906393|FG001|Overall Study|Physician Decision|6|||
157041845|NCT02517268|566906396|FG000|Overall Study|Withdrawal by Subject|1|||
157041846|NCT02517268|566906397|FG001|Overall Study|Withdrawal by Subject|0|||
157041847|NCT04649047|566906400|FG000|Overall Study|Withdrawal by Subject|3|||
157041848|NCT07204444|566906402|FG000|Overall Study|Medical/Hospitalization|6|||
157041849|NCT07204444|566906403|FG001|Overall Study|Medical/Hospitalization|9|||
157041850|NCT07204444|566906404|FG002|Overall Study|Medical/Hospitalization|6|||
157041851|NCT07204444|566906402|FG000|Overall Study|Treatment Provider Issue|1|||
157041852|NCT07204444|566906403|FG001|Overall Study|Treatment Provider Issue|3|||
157041853|NCT07204444|566906404|FG002|Overall Study|Treatment Provider Issue|0|||
157041854|NCT07204444|566906402|FG000|Overall Study|Withdrawal by Subject|11|||
157041855|NCT07204444|566906403|FG001|Overall Study|Withdrawal by Subject|5|||
157041856|NCT07204444|566906404|FG002|Overall Study|Withdrawal by Subject|5|||
157041857|NCT07204444|566906402|FG000|Overall Study|Death|3|||
157041858|NCT07204444|566906403|FG001|Overall Study|Death|6|||
157041859|NCT07204444|566906404|FG002|Overall Study|Death|1|||
157041860|NCT07204444|566906402|FG000|Overall Study|Unable To Reach|29|||
157041861|NCT07204444|566906403|FG001|Overall Study|Unable To Reach|26|||
157041862|NCT07204444|566906404|FG002|Overall Study|Unable To Reach|17|||
157041863|NCT07204444|566906402|FG000|Overall Study|Protocol Deviation|3|||
157041864|NCT07204444|566906403|FG001|Overall Study|Protocol Deviation|2|||
157041865|NCT07204444|566906404|FG002|Overall Study|Protocol Deviation|0|||
157041866|NCT05815342|566907558|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
157041867|NCT05815342|566907558|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
157041868|NCT05815342|566907558|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
157041869|NCT05815342|566907558|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
157041870|NCT05815342|566907558|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
157041871|NCT00345046|566907561|FG000|Overall Study|Protocol Violation|1|||
157041872|NCT00345046|566907562|FG001|Overall Study|Protocol Violation|1|||
157041873|NCT00345046|566907563|FG002|Overall Study|Protocol Violation|2|||
157173394|NCT00810810|567375431|FG000|Overall Study|Withdrawal by Subject|0|||
157173395|NCT00810810|567375432|FG001|Overall Study|Withdrawal by Subject|8|||
157041874|NCT03689946|566907564|FG000|Overall Study|Withdrawal by Subject|3|||
157041875|NCT03689946|566907564|FG000|Overall Study|Lost to Follow-up|3|||
157041876|NCT03689946|566907564|FG000|Overall Study|Data corruption|2|||
157041877|NCT01555138|566907565|FG000|Overall Study|Death|0|||
157041878|NCT01555138|566907566|FG001|Overall Study|Death|1|||
157041879|NCT01555138|566907565|FG000|Overall Study|Lost to Follow-up|1|||
157041880|NCT01555138|566907566|FG001|Overall Study|Lost to Follow-up|0|||
157041881|NCT01555138|566907565|FG000|Overall Study|Abnormal Lab reults|1|||
157041882|NCT01555138|566907566|FG001|Overall Study|Abnormal Lab reults|3|||
157041883|NCT01555138|566907565|FG000|Overall Study|Lack of Efficacy|2|||
157041884|NCT01555138|566907566|FG001|Overall Study|Lack of Efficacy|2|||
157041885|NCT01555138|566907565|FG000|Overall Study|Protocol Violation|5|||
157041886|NCT01555138|566907566|FG001|Overall Study|Protocol Violation|3|||
157041887|NCT01555138|566907565|FG000|Overall Study|Administrative problems|8|||
157041888|NCT01555138|566907566|FG001|Overall Study|Administrative problems|0|||
157041889|NCT01555138|566907565|FG000|Overall Study|Withdrawal by Subject|16|||
157041890|NCT01555138|566907566|FG001|Overall Study|Withdrawal by Subject|15|||
157041891|NCT01555138|566907565|FG000|Overall Study|Adverse Event|14|||
157041892|NCT01555138|566907566|FG001|Overall Study|Adverse Event|14|||
157041893|NCT00512252|566907570|FG000|Overall Study|Lost to Follow-up|0|||
157041894|NCT00512252|566907571|FG001|Overall Study|Lost to Follow-up|0|||
157041895|NCT00512252|566907572|FG002|Overall Study|Lost to Follow-up|1|||
157041896|NCT00512252|566907570|FG000|Overall Study|Protocol Violation|0|||
157041897|NCT00512252|566907571|FG001|Overall Study|Protocol Violation|0|||
157041898|NCT00512252|566907572|FG002|Overall Study|Protocol Violation|1|||
157041899|NCT00512252|566907570|FG000|Overall Study|Death|0|||
157041900|NCT00512252|566907571|FG001|Overall Study|Death|0|||
157041901|NCT00512252|566907572|FG002|Overall Study|Death|1|||
157041902|NCT02357966|566907573|FG000|Overall Study|Death|0|||
157041903|NCT02357966|566907574|FG001|Overall Study|Death|0|||
157041904|NCT02357966|566907575|FG002|Overall Study|Death|1|||
157041905|NCT02357966|566907576|FG003|Overall Study|Death|0|||
157041906|NCT02357966|566907577|FG004|Overall Study|Death|2|||
157041907|NCT02357966|566907578|FG005|Overall Study|Death|0|||
157041908|NCT02357966|566907573|FG000|Overall Study|Physician Decision|1|||
157041909|NCT02357966|566907574|FG001|Overall Study|Physician Decision|0|||
157041910|NCT02357966|566907575|FG002|Overall Study|Physician Decision|0|||
157041911|NCT02357966|566907576|FG003|Overall Study|Physician Decision|0|||
157041912|NCT02357966|566907577|FG004|Overall Study|Physician Decision|1|||
157041913|NCT02357966|566907578|FG005|Overall Study|Physician Decision|0|||
157041914|NCT04608409|566907581|FG000|Overall Study|Physician Decision|1|||
157041915|NCT04608409|566907582|FG001|Overall Study|Physician Decision|1|||
157041916|NCT04608409|566907583|FG002|Overall Study|Physician Decision|2|||
157041917|NCT01787032|566907584|FG000|Overall Study|Protocol Violation|0|||
157041918|NCT01787032|566907585|FG001|Overall Study|Protocol Violation|0|||
157041919|NCT01787032|566907586|FG002|Overall Study|Protocol Violation|0|||
157041920|NCT01787032|566907587|FG003|Overall Study|Protocol Violation|0|||
157041921|NCT01787032|566907588|FG004|Overall Study|Protocol Violation|1|||
157041922|NCT01787032|566907589|FG005|Overall Study|Protocol Violation|1|||
157041923|NCT02040870|566907590|FG000|Overall Study|Completed treatment phase|6|||
157041924|NCT02040870|566907590|FG000|Overall Study|Adverse Event|7|||
157041925|NCT02040870|566907590|FG000|Overall Study|Progressive disease|58|||
157041926|NCT02040870|566907590|FG000|Overall Study|Physician Decision|6|||
157041927|NCT02040870|566907590|FG000|Overall Study|Subject/guardian decision|10|||
157041928|NCT02040870|566907590|FG000|Overall Study|Lost to Follow-up|3|||
157041929|NCT02040870|566907590|FG000|Overall Study|Death|13|||
157041930|NCT04941482|566907598|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
157041931|NCT04941482|566907599|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
157041932|NCT00687219|566907601|FG000|Overall Study|Adverse Event|8|||
157041933|NCT00687219|566907601|FG000|Overall Study|Discontinuance criteria met|7|||
157041934|NCT00687219|566907601|FG000|Overall Study|HCV-RNA positive conversion|34|||
157041935|NCT00687219|566907601|FG000|Overall Study|Withdrawal by Subject|1|||
157041936|NCT00687219|566907601|FG000|Overall Study|Lack of Efficacy|1|||
157041937|NCT01367236|566907602|FG000|Overall Study|Withdrawal by Subject|3|||
157041938|NCT01367236|566907603|FG001|Overall Study|Withdrawal by Subject|1|||
157041939|NCT03102034|566907609|FG000|Overall Study|Withdrawal by Subject|1|||
157041940|NCT03102034|566907610|FG001|Overall Study|Withdrawal by Subject|0|||
157228243|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
157228244|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
157228245|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
157228246|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
157041941|NCT02063659|566907614|FG000|Double-Blind Treatment Period|Adverse Event|1|||
157041942|NCT02063659|566907615|FG001|Double-Blind Treatment Period|Adverse Event|2|||
157041943|NCT02063659|566907616|FG002|Double-Blind Treatment Period|Adverse Event|0|||
157041944|NCT02063659|566907617|FG003|Double-Blind Treatment Period|Adverse Event|0|||
157041945|NCT02063659|566907614|FG000|Double-Blind Treatment Period|Physician Decision|1|||
157041946|NCT02063659|566907615|FG001|Double-Blind Treatment Period|Physician Decision|0|||
157041947|NCT02063659|566907616|FG002|Double-Blind Treatment Period|Physician Decision|0|||
157041948|NCT02063659|566907617|FG003|Double-Blind Treatment Period|Physician Decision|0|||
157041949|NCT02063659|566907614|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
157041950|NCT02063659|566907615|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
157041951|NCT02063659|566907616|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
157041952|NCT02063659|566907617|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
157041953|NCT02063659|566907614|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
157041954|NCT02063659|566907615|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
157041955|NCT02063659|566907616|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
157041956|NCT02063659|566907617|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
157228247|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
157173396|NCT00810810|567375433|FG002|Overall Study|Withdrawal by Subject|10|||
157173397|NCT00810810|567375434|FG003|Overall Study|Withdrawal by Subject|8|||
157173398|NCT00810810|567375431|FG000|Overall Study|Physician Decision|0|||
157173399|NCT00810810|567375432|FG001|Overall Study|Physician Decision|3|||
157173400|NCT00810810|567375433|FG002|Overall Study|Physician Decision|1|||
157173401|NCT00810810|567375434|FG003|Overall Study|Physician Decision|5|||
157173402|NCT01156532|567375435|FG000|Overall Study|Family Reasons|1|||
157173403|NCT01156532|567375435|FG000|Overall Study|Lost to Follow-up|1|||
157173404|NCT02563925|567375438|FG000|Overall Study|Withdrawal by Subject|2|||
157173405|NCT00282867|567375442|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
157173406|NCT00282867|567375443|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
157173407|NCT00282867|567375444|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
157173408|NCT05067452|567375445|FG000|Overall Study|Lost to Follow-up|0|||
157173409|NCT05067452|567375446|FG001|Overall Study|Lost to Follow-up|4|||
157173410|NCT01074658|567375447|FG000|Overall Study|No implant attempted|19|||
157173411|NCT00426556|567375448|FG000|Phase I - Core Phase|Disease Progression|0|||
157173412|NCT00426556|567375449|FG001|Phase I - Core Phase|Disease Progression|6|||
157173413|NCT00426556|567375450|FG002|Phase I - Core Phase|Disease Progression|2|||
157173414|NCT00426556|567375451|FG003|Phase I - Core Phase|Disease Progression|0|||
157173415|NCT00426556|567375448|FG000|Phase I - Core Phase|Adverse Event|1|||
157173416|NCT00426556|567375449|FG001|Phase I - Core Phase|Adverse Event|3|||
157173417|NCT00426556|567375450|FG002|Phase I - Core Phase|Adverse Event|1|||
157173418|NCT00426556|567375451|FG003|Phase I - Core Phase|Adverse Event|0|||
157173419|NCT00426556|567375448|FG000|Phase I - Core Phase|Death|0|||
157173420|NCT00426556|567375449|FG001|Phase I - Core Phase|Death|1|||
157173421|NCT00426556|567375450|FG002|Phase I - Core Phase|Death|0|||
157173422|NCT00426556|567375451|FG003|Phase I - Core Phase|Death|0|||
157173423|NCT00426556|567375448|FG000|Phase I - Extension Phase|Adverse Event|0|||
157173424|NCT00426556|567375449|FG001|Phase I - Extension Phase|Adverse Event|1|||
157173425|NCT00426556|567375450|FG002|Phase I - Extension Phase|Adverse Event|1|||
157173426|NCT00426556|567375451|FG003|Phase I - Extension Phase|Adverse Event|0|||
157173427|NCT00426556|567375448|FG000|Phase I - Extension Phase|Disease Progression|5|||
157173428|NCT00426556|567375449|FG001|Phase I - Extension Phase|Disease Progression|5|||
157173429|NCT00426556|567375450|FG002|Phase I - Extension Phase|Disease Progression|6|||
157173430|NCT00426556|567375451|FG003|Phase I - Extension Phase|Disease Progression|0|||
157173431|NCT00426556|567375448|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
157173432|NCT00426556|567375449|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
157173433|NCT00426556|567375450|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
157173434|NCT00426556|567375451|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
157173435|NCT00426556|567375448|FG000|Phase II - Core Phase|Disease Progression|0|||
157173436|NCT00426556|567375449|FG001|Phase II - Core Phase|Disease Progression|0|||
157173437|NCT00426556|567375450|FG002|Phase II - Core Phase|Disease Progression|0|||
157173438|NCT00426556|567375451|FG003|Phase II - Core Phase|Disease Progression|16|||
157173439|NCT00426556|567375448|FG000|Phase II - Core Phase|Adverse Event|0|||
157173440|NCT00426556|567375449|FG001|Phase II - Core Phase|Adverse Event|0|||
157173441|NCT00426556|567375450|FG002|Phase II - Core Phase|Adverse Event|0|||
157173442|NCT00426556|567375451|FG003|Phase II - Core Phase|Adverse Event|8|||
157173443|NCT00426556|567375448|FG000|Phase II - Extension Phase|Disease Progression|0|||
157173444|NCT00426556|567375449|FG001|Phase II - Extension Phase|Disease Progression|0|||
157173445|NCT00426556|567375450|FG002|Phase II - Extension Phase|Disease Progression|0|||
157173446|NCT00426556|567375451|FG003|Phase II - Extension Phase|Disease Progression|21|||
157173447|NCT00426556|567375448|FG000|Phase II - Extension Phase|Adverse Event|0|||
157173448|NCT00426556|567375449|FG001|Phase II - Extension Phase|Adverse Event|0|||
157173449|NCT00426556|567375450|FG002|Phase II - Extension Phase|Adverse Event|0|||
157173450|NCT00426556|567375451|FG003|Phase II - Extension Phase|Adverse Event|2|||
157173451|NCT00432562|567375457|FG000|Overall Study|Death|3|||
157173452|NCT00432562|567375458|FG001|Overall Study|Death|0|||
157173453|NCT03970824|567375459|FG000|Overall Study|Withdrawal by Subject|1|||
157173454|NCT03970824|567375460|FG001|Overall Study|Withdrawal by Subject|1|||
157173455|NCT03970824|567375461|FG002|Overall Study|Withdrawal by Subject|3|||
157173456|NCT03970824|567375459|FG000|Overall Study|Lost to Follow-up|0|||
157173457|NCT03970824|567375460|FG001|Overall Study|Lost to Follow-up|2|||
157173458|NCT03970824|567375461|FG002|Overall Study|Lost to Follow-up|1|||
157173459|NCT03970824|567375459|FG000|Overall Study|Adverse Event|1|||
157228248|NCT04947579|567581040|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
157173460|NCT03970824|567375460|FG001|Overall Study|Adverse Event|0|||
157173461|NCT03970824|567375461|FG002|Overall Study|Adverse Event|0|||
157173462|NCT01767519|567375466|FG000|Overall Study|Other Reasons|4|||
157173463|NCT01767519|567375467|FG001|Overall Study|Other Reasons|4|||
157173464|NCT01767519|567375468|FG002|Overall Study|Other Reasons|2|||
157173465|NCT01767519|567375466|FG000|Overall Study|Protocol Violation|0|||
157173466|NCT01767519|567375467|FG001|Overall Study|Protocol Violation|3|||
157173467|NCT01767519|567375468|FG002|Overall Study|Protocol Violation|0|||
157173468|NCT01767519|567375466|FG000|Overall Study|Personal Reasons|1|||
157173469|NCT01767519|567375467|FG001|Overall Study|Personal Reasons|0|||
157228249|NCT04947579|567581041|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
157041957|NCT02063659|566907614|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157041958|NCT02063659|566907615|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157041959|NCT02063659|566907616|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
157041960|NCT02063659|566907617|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
157041961|NCT02063659|566907614|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157041962|NCT02063659|566907615|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157041963|NCT02063659|566907616|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
157041964|NCT02063659|566907617|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
157041965|NCT02063659|566907614|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
157173470|NCT01767519|567375468|FG002|Overall Study|Personal Reasons|0|||
157173471|NCT01767519|567375466|FG000|Overall Study|Lost to Follow-up|3|||
157173472|NCT01767519|567375467|FG001|Overall Study|Lost to Follow-up|1|||
157173473|NCT01767519|567375468|FG002|Overall Study|Lost to Follow-up|2|||
157173474|NCT01767519|567375466|FG000|Overall Study|Lack of Efficacy|1|||
157173475|NCT01767519|567375467|FG001|Overall Study|Lack of Efficacy|0|||
157173476|NCT01767519|567375468|FG002|Overall Study|Lack of Efficacy|0|||
157173477|NCT01767519|567375466|FG000|Overall Study|Adverse Event|5|||
157173478|NCT01767519|567375467|FG001|Overall Study|Adverse Event|5|||
157173479|NCT01767519|567375468|FG002|Overall Study|Adverse Event|1|||
157173480|NCT00493974|567375471|FG000|Overall Study|Death|1|||
157173481|NCT00493974|567375472|FG001|Overall Study|Death|2|||
157173482|NCT00493974|567375471|FG000|Overall Study|Withdrawal by Subject|8|||
157173483|NCT00493974|567375472|FG001|Overall Study|Withdrawal by Subject|6|||
157173484|NCT00493974|567375471|FG000|Overall Study|Lost to Follow-up|4|||
157173485|NCT00493974|567375472|FG001|Overall Study|Lost to Follow-up|6|||
157173486|NCT00862654|567375473|FG000|Overall Study|Lack of Efficacy|1|||
157173487|NCT00862654|567375474|FG001|Overall Study|Lack of Efficacy|0|||
157173488|NCT00862654|567375475|FG002|Overall Study|Lack of Efficacy|1|||
157173489|NCT00862654|567375476|FG003|Overall Study|Lack of Efficacy|0|||
157173490|NCT00862654|567375473|FG000|Overall Study|Lost to Follow-up|1|||
156968131|NCT00636610|566633852|FG001|Overall Study|Physician decision to withdraw patient|9|||
156968132|NCT00636610|566633851|FG000|Overall Study|Subject decision to withdraw|15|||
156968133|NCT00636610|566633852|FG001|Overall Study|Subject decision to withdraw|11|||
156968134|NCT00636610|566633851|FG000|Overall Study|Disease progression - radiographic|41|||
156968135|NCT00636610|566633852|FG001|Overall Study|Disease progression - radiographic|51|||
156968136|NCT00636610|566633851|FG000|Overall Study|Disease progression - clinical|8|||
156968137|NCT00636610|566633852|FG001|Overall Study|Disease progression - clinical|3|||
156968138|NCT00636610|566633851|FG000|Overall Study|Reason for discontinuation not available|3|||
156968139|NCT00636610|566633852|FG001|Overall Study|Reason for discontinuation not available|2|||
156968140|NCT02495025|566633853|FG000|Overall Study|Lost to Follow-up|21|||
156968141|NCT02495025|566633854|FG001|Overall Study|Lost to Follow-up|14|||
156968142|NCT02495025|566633853|FG000|Overall Study|Withdrawal by Subject|5|||
156968143|NCT02495025|566633854|FG001|Overall Study|Withdrawal by Subject|0|||
156968144|NCT05899686|566633857|FG000|Overall Study|Protocol Violation|1|||
156968145|NCT02412137|566633866|FG000|Overall Study|Withdrawal by Subject|2|||
156968146|NCT02412137|566633867|FG001|Overall Study|Withdrawal by Subject|0|||
156968147|NCT02412137|566633866|FG000|Overall Study|Lost to Follow-up|21|||
156968148|NCT02412137|566633867|FG001|Overall Study|Lost to Follow-up|14|||
156968149|NCT02412137|566633866|FG000|Overall Study|Physician Decision|28|||
156968150|NCT02412137|566633867|FG001|Overall Study|Physician Decision|9|||
156968151|NCT03355326|566633876|FG000|Overall Study|Protocol Violation|3|||
156968152|NCT03355326|566633877|FG001|Overall Study|Protocol Violation|3|||
156968153|NCT05809596|566633878|FG000|Overall Study|Death|16|||
156968154|NCT05809596|566633878|FG000|Overall Study|Withdrawal by Subject|4|||
156968155|NCT05809596|566633878|FG000|Overall Study|Physician Decision|1|||
156968156|NCT05809596|566633878|FG000|Overall Study|Missed Visit|2|||
156968157|NCT05809596|566633878|FG000|Overall Study|Other|3|||
156968158|NCT03076970|566635769|FG000|Washout Period 2|Adverse Event|0|||
156968159|NCT03076970|566635770|FG001|Washout Period 2|Adverse Event|0|||
156968160|NCT03076970|566635771|FG002|Washout Period 2|Adverse Event|0|||
156968161|NCT03076970|566635772|FG003|Washout Period 2|Adverse Event|0|||
157041966|NCT02063659|566907615|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
157041967|NCT02063659|566907616|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
157173491|NCT00862654|567375474|FG001|Overall Study|Lost to Follow-up|2|||
157173492|NCT00862654|567375475|FG002|Overall Study|Lost to Follow-up|1|||
157173493|NCT00862654|567375476|FG003|Overall Study|Lost to Follow-up|3|||
157173494|NCT00862654|567375473|FG000|Overall Study|Adverse Event|0|||
157173495|NCT00862654|567375474|FG001|Overall Study|Adverse Event|1|||
157173496|NCT00862654|567375475|FG002|Overall Study|Adverse Event|1|||
156968162|NCT03076970|566635773|FG004|Washout Period 2|Adverse Event|1|||
156968163|NCT03076970|566635774|FG005|Washout Period 2|Adverse Event|0|||
157173497|NCT00862654|567375476|FG003|Overall Study|Adverse Event|0|||
156968164|NCT03076970|566635769|FG000|Period 3|Withdrawal by Subject|0|||
156968165|NCT03076970|566635770|FG001|Period 3|Withdrawal by Subject|0|||
157173498|NCT00862654|567375473|FG000|Overall Study|Pregnancy|1|||
157173499|NCT00862654|567375474|FG001|Overall Study|Pregnancy|1|||
157173500|NCT00862654|567375475|FG002|Overall Study|Pregnancy|0|||
157228250|NCT04947579|567581042|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
157228251|NCT04947579|567581043|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
157228252|NCT04947579|567581044|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
157228253|NCT04947579|567581045|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
157228254|NCT00634179|567581046|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
157228255|NCT04272801|567581047|FG000|Overall Study|Withdrawal by Subject|4|||
157228256|NCT04272801|567581047|FG000|Overall Study|Lost to Follow-up|4|||
157228257|NCT04272801|567581047|FG000|Overall Study|Ineligible|1|||
157228258|NCT00475020|567581048|FG000|Overall Study|Physician Decision|3|||
157228259|NCT00475020|567581048|FG000|Overall Study|Insurance Denial|1|||
157228260|NCT00475020|567581048|FG000|Overall Study|Donor not able to donate the last minute|1|||
157228261|NCT03481309|567581049|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
157228262|NCT03481309|567581050|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
157173501|NCT00862654|567375476|FG003|Overall Study|Pregnancy|0|||
157173502|NCT00862654|567375473|FG000|Overall Study|Withdrawal by Subject|2|||
157173503|NCT00862654|567375474|FG001|Overall Study|Withdrawal by Subject|2|||
157173504|NCT00862654|567375475|FG002|Overall Study|Withdrawal by Subject|2|||
157173505|NCT00862654|567375476|FG003|Overall Study|Withdrawal by Subject|3|||
157173506|NCT00862654|567375473|FG000|Overall Study|Subject mistake|0|||
157173507|NCT00862654|567375474|FG001|Overall Study|Subject mistake|1|||
157173508|NCT00862654|567375475|FG002|Overall Study|Subject mistake|0|||
157173509|NCT00862654|567375476|FG003|Overall Study|Subject mistake|0|||
157173510|NCT00862654|567375473|FG000|Overall Study|Familly constraint|0|||
157173511|NCT00862654|567375474|FG001|Overall Study|Familly constraint|1|||
157173512|NCT00862654|567375475|FG002|Overall Study|Familly constraint|0|||
157173513|NCT00862654|567375476|FG003|Overall Study|Familly constraint|0|||
157173514|NCT00862654|567375473|FG000|Overall Study|Never used study drugs|1|||
157173515|NCT00862654|567375474|FG001|Overall Study|Never used study drugs|0|||
157173516|NCT00862654|567375475|FG002|Overall Study|Never used study drugs|0|||
157173517|NCT00862654|567375476|FG003|Overall Study|Never used study drugs|0|||
157173518|NCT00862654|567375473|FG000|Overall Study|Included after end of inclusions|0|||
157173519|NCT00862654|567375474|FG001|Overall Study|Included after end of inclusions|0|||
157173520|NCT00862654|567375475|FG002|Overall Study|Included after end of inclusions|1|||
157173521|NCT00862654|567375476|FG003|Overall Study|Included after end of inclusions|0|||
157173522|NCT03219567|567375477|FG000|Overall Study|Withdrawal by Subject|0|||
157173523|NCT03219567|567375478|FG001|Overall Study|Withdrawal by Subject|1|||
157173524|NCT01181778|567375484|FG000|Overall Study|Physician Decision|48|||
157173525|NCT02713789|567375485|FG000|Overall Study|Lost to Follow-up|0|||
157173526|NCT02713789|567375486|FG001|Overall Study|Lost to Follow-up|1|||
157173527|NCT02713789|567375487|FG002|Overall Study|Lost to Follow-up|1|||
157173528|NCT02726113|567375488|FG000|Total Enrollment|Physician Decision|0|||
157173529|NCT02726113|567375489|FG001|Total Enrollment|Physician Decision|1|||
157173530|NCT02726113|567375488|FG000|Total Enrollment|Protocol Violation|1|||
157173531|NCT02726113|567375489|FG001|Total Enrollment|Protocol Violation|0|||
157173532|NCT02726113|567375488|FG000|Total Enrollment|Withdrawal by Subject|2|||
157173533|NCT02726113|567375489|FG001|Total Enrollment|Withdrawal by Subject|1|||
157173534|NCT02726113|567375488|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
157173535|NCT02726113|567375489|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
157173536|NCT02726113|567375488|FG000|Genomic Analysis|Protocol Violation|1|||
157173537|NCT02726113|567375489|FG001|Genomic Analysis|Protocol Violation|0|||
157173538|NCT02726113|567375488|FG000|Genomic Analysis|Withdrawal by Subject|2|||
157173539|NCT02726113|567375489|FG001|Genomic Analysis|Withdrawal by Subject|1|||
157173540|NCT02726113|567375488|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
157173541|NCT02726113|567375489|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
157228263|NCT03481309|567581051|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
157228264|NCT03481309|567581052|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
157228265|NCT03481309|567581053|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
157228266|NCT03481309|567581054|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
157228267|NCT01575054|567581055|FG000|Overall Study|Other Reasons|5|||
157228268|NCT01575054|567581056|FG001|Overall Study|Other Reasons|3|||
156968166|NCT03076970|566635771|FG002|Period 3|Withdrawal by Subject|0|||
156968167|NCT03076970|566635772|FG003|Period 3|Withdrawal by Subject|0|||
156968168|NCT03076970|566635773|FG004|Period 3|Withdrawal by Subject|0|||
156968169|NCT03076970|566635774|FG005|Period 3|Withdrawal by Subject|1|||
156968170|NCT03076970|566635769|FG000|Period 3|Failure to meet I/E criteria|0|||
157173542|NCT03549117|567375496|FG000|Overall Study|Withdrawal by Subject|1|||
157173543|NCT03549117|567375497|FG001|Overall Study|Withdrawal by Subject|0|||
157173544|NCT03148756|567375498|FG000|Overall Study|Study Terminated|0|||
157228269|NCT01575054|567581055|FG000|Overall Study|Protocol Violation|2|||
157228270|NCT01575054|567581056|FG001|Overall Study|Protocol Violation|1|||
157173545|NCT03148756|567375499|FG001|Overall Study|Study Terminated|1|||
157173546|NCT00637377|567375505|FG000|Overall Study|Adverse Event|2|||
157173547|NCT00637377|567375506|FG001|Overall Study|Adverse Event|6|||
157173548|NCT00637377|567375507|FG002|Overall Study|Adverse Event|8|||
157173549|NCT00637377|567375508|FG003|Overall Study|Adverse Event|9|||
156968171|NCT03076970|566635770|FG001|Period 3|Failure to meet I/E criteria|0|||
156968172|NCT03076970|566635771|FG002|Period 3|Failure to meet I/E criteria|0|||
156968173|NCT03076970|566635772|FG003|Period 3|Failure to meet I/E criteria|0|||
156968174|NCT03076970|566635773|FG004|Period 3|Failure to meet I/E criteria|1|||
156968175|NCT03076970|566635774|FG005|Period 3|Failure to meet I/E criteria|0|||
156968176|NCT01984697|566635775|FG000|Overall Study|Adverse Event|0|||
156968177|NCT01984697|566635776|FG001|Overall Study|Adverse Event|0|||
156968178|NCT01984697|566635777|FG002|Overall Study|Adverse Event|2|||
156968179|NCT01984697|566635778|FG003|Overall Study|Adverse Event|0|||
156968180|NCT01984697|566635779|FG004|Overall Study|Adverse Event|0|||
156968181|NCT01984697|566635775|FG000|Overall Study|Lost to Follow-up|14|||
156968182|NCT01984697|566635776|FG001|Overall Study|Lost to Follow-up|5|||
156968183|NCT01984697|566635777|FG002|Overall Study|Lost to Follow-up|10|||
156968184|NCT01984697|566635778|FG003|Overall Study|Lost to Follow-up|6|||
156968185|NCT01984697|566635779|FG004|Overall Study|Lost to Follow-up|21|||
156968186|NCT01984697|566635775|FG000|Overall Study|Physician Decision|3|||
156968187|NCT01984697|566635776|FG001|Overall Study|Physician Decision|0|||
156968188|NCT01984697|566635777|FG002|Overall Study|Physician Decision|0|||
156968189|NCT01984697|566635778|FG003|Overall Study|Physician Decision|1|||
156968190|NCT01984697|566635779|FG004|Overall Study|Physician Decision|0|||
156968191|NCT01984697|566635775|FG000|Overall Study|Protocol Violation|8|||
156968192|NCT01984697|566635776|FG001|Overall Study|Protocol Violation|5|||
156968193|NCT01984697|566635777|FG002|Overall Study|Protocol Violation|3|||
156968194|NCT01984697|566635778|FG003|Overall Study|Protocol Violation|2|||
156968195|NCT01984697|566635779|FG004|Overall Study|Protocol Violation|0|||
156968196|NCT01984697|566635775|FG000|Overall Study|Withdrawal by Subject|15|||
156968197|NCT01984697|566635776|FG001|Overall Study|Withdrawal by Subject|21|||
156968198|NCT01984697|566635777|FG002|Overall Study|Withdrawal by Subject|13|||
156968199|NCT01984697|566635778|FG003|Overall Study|Withdrawal by Subject|11|||
156968200|NCT01984697|566635779|FG004|Overall Study|Withdrawal by Subject|13|||
156968201|NCT01984697|566635775|FG000|Overall Study|Missed last follow-up visit|1|||
156968202|NCT01984697|566635776|FG001|Overall Study|Missed last follow-up visit|0|||
156968203|NCT01984697|566635777|FG002|Overall Study|Missed last follow-up visit|0|||
156968204|NCT01984697|566635778|FG003|Overall Study|Missed last follow-up visit|0|||
156968205|NCT01984697|566635779|FG004|Overall Study|Missed last follow-up visit|0|||
156968206|NCT01984697|566635775|FG000|Overall Study|Death|0|||
156968207|NCT01984697|566635776|FG001|Overall Study|Death|0|||
156968208|NCT01984697|566635777|FG002|Overall Study|Death|0|||
156968209|NCT01984697|566635778|FG003|Overall Study|Death|1|||
156968210|NCT01984697|566635779|FG004|Overall Study|Death|0|||
156968211|NCT01984697|566635775|FG000|Overall Study|Pregnancy|2|||
156968212|NCT01984697|566635776|FG001|Overall Study|Pregnancy|0|||
156968213|NCT01984697|566635777|FG002|Overall Study|Pregnancy|1|||
156968214|NCT01984697|566635778|FG003|Overall Study|Pregnancy|0|||
156968215|NCT01984697|566635779|FG004|Overall Study|Pregnancy|1|||
156968216|NCT01345630|566635780|FG000|Overall Study|Adverse Event|22|||
156968217|NCT01345630|566635781|FG001|Overall Study|Adverse Event|23|||
156968218|NCT01345630|566635780|FG000|Overall Study|Lost to Follow-up|17|||
156968219|NCT01345630|566635781|FG001|Overall Study|Lost to Follow-up|16|||
156968220|NCT01345630|566635780|FG000|Overall Study|Protocol Violation|4|||
156968221|NCT01345630|566635781|FG001|Overall Study|Protocol Violation|1|||
156968222|NCT01345630|566635780|FG000|Overall Study|Medication error without associated AE|0|||
156968223|NCT01345630|566635781|FG001|Overall Study|Medication error without associated AE|1|||
156968224|NCT01345630|566635780|FG000|Overall Study|Study terminated by sponsor|254|||
156968225|NCT01345630|566635781|FG001|Overall Study|Study terminated by sponsor|285|||
156968226|NCT01345630|566635780|FG000|Overall Study|Other reasons|6|||
156968227|NCT01345630|566635781|FG001|Overall Study|Other reasons|8|||
156968228|NCT01345630|566635780|FG000|Overall Study|Withdrawn due to pregnancy|1|||
156968229|NCT01345630|566635781|FG001|Overall Study|Withdrawn due to pregnancy|2|||
156968230|NCT01345630|566635780|FG000|Overall Study|No longer willing to participate|9|||
156968231|NCT01345630|566635781|FG001|Overall Study|No longer willing to participate|12|||
156968232|NCT01345630|566635780|FG000|Overall Study|Insufficient clinical response|48|||
156968233|NCT01345630|566635781|FG001|Overall Study|Insufficient clinical response|11|||
156968234|NCT01364922|566635784|FG000|Open-label (OL) Period|Adverse Event|7|||
156968235|NCT01364922|566635785|FG001|Open-label (OL) Period|Adverse Event|0|||
156968236|NCT01364922|566635786|FG002|Open-label (OL) Period|Adverse Event|0|||
156968237|NCT01364922|566635784|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
156968238|NCT01364922|566635785|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
156968239|NCT01364922|566635786|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
156968240|NCT01364922|566635784|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
156968241|NCT01364922|566635785|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
156968242|NCT01364922|566635786|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
156968243|NCT01364922|566635784|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
156968244|NCT01364922|566635785|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
156968245|NCT01364922|566635786|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
156968246|NCT01364922|566635784|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
156968247|NCT01364922|566635785|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
157041968|NCT02063659|566907617|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
157041969|NCT02063659|566907614|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
157041970|NCT02063659|566907615|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
157041971|NCT02063659|566907616|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
157041972|NCT02063659|566907617|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
157041973|NCT02972359|566907618|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
157041974|NCT02972359|566907618|FG000|Overall Study|Lack of Efficacy|1|||
157041975|NCT02972359|566907618|FG000|Overall Study|Adverse Event|4|||
157041976|NCT02972359|566907618|FG000|Overall Study|Death|1|||
157041977|NCT02972359|566907618|FG000|Overall Study|Withdrawal by Subject|30|||
157041978|NCT02972359|566907618|FG000|Overall Study|Protocol Violation|1|||
157041979|NCT02972359|566907618|FG000|Overall Study|Lost to Follow-up|26|||
157041980|NCT02972359|566907618|FG000|Overall Study|Other reasons|5|||
157041981|NCT02972359|566907618|FG000|Overall Study|Missing|1|||
157041982|NCT04827732|566907625|FG000|Overall Study|Did not start treatment|0|||
157041983|NCT04827732|566907626|FG001|Overall Study|Did not start treatment|1|||
157041984|NCT04827732|566907627|FG002|Overall Study|Did not start treatment|0|||
157041985|NCT04827732|566907628|FG003|Overall Study|Did not start treatment|1|||
157041986|NCT04300023|566907631|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
157041987|NCT04300023|566907632|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
157041988|NCT04057131|566907633|FG000|Overall Study|Protocol Violation|24|||
157041989|NCT02830204|566907634|FG000|Overall Study|Death|9|||
157041990|NCT02830204|566907634|FG000|Overall Study|Withdrawal by Subject|1|||
157041991|NCT04686266|566907637|FG000|Overall Study|Withdrawal by Subject|0|||
157041992|NCT04686266|566907638|FG001|Overall Study|Withdrawal by Subject|1|||
157041993|NCT02401815|566907643|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157041994|NCT02401815|566907644|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157041995|NCT02401815|566907645|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157041996|NCT02401815|566907646|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
157041997|NCT02401815|566907647|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157041998|NCT02401815|566907648|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157041999|NCT02401815|566907649|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157042000|NCT02401815|566907650|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157042001|NCT02401815|566907651|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157042002|NCT02401815|566907652|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
157042003|NCT02401815|566907643|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
157042004|NCT02401815|566907644|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042005|NCT02401815|566907645|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042006|NCT02401815|566907646|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
157042007|NCT02401815|566907647|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042008|NCT02401815|566907648|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042009|NCT02401815|566907649|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042010|NCT02401815|566907650|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042011|NCT02401815|566907651|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042012|NCT02401815|566907652|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
157042013|NCT02401815|566907643|FG000|Dose Escalation (up to 670 Days)|Death|1|||
157042014|NCT02401815|566907644|FG001|Dose Escalation (up to 670 Days)|Death|2|||
157042015|NCT02401815|566907645|FG002|Dose Escalation (up to 670 Days)|Death|3|||
157042016|NCT02401815|566907646|FG003|Dose Escalation (up to 670 Days)|Death|5|||
157042017|NCT02401815|566907647|FG004|Dose Escalation (up to 670 Days)|Death|4|||
157042018|NCT02401815|566907648|FG005|Dose Escalation (up to 670 Days)|Death|0|||
157042019|NCT02401815|566907649|FG006|Dose Escalation (up to 670 Days)|Death|0|||
157042020|NCT02401815|566907650|FG007|Dose Escalation (up to 670 Days)|Death|0|||
157042021|NCT02401815|566907651|FG008|Dose Escalation (up to 670 Days)|Death|0|||
157042022|NCT02401815|566907652|FG009|Dose Escalation (up to 670 Days)|Death|0|||
157042023|NCT02401815|566907643|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042024|NCT02401815|566907644|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
157042025|NCT02401815|566907645|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042026|NCT02401815|566907646|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042027|NCT02401815|566907647|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
157042028|NCT02401815|566907648|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042029|NCT02401815|566907649|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042030|NCT02401815|566907650|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042031|NCT02401815|566907651|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042032|NCT02401815|566907652|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
157042033|NCT02401815|566907643|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
157042034|NCT02401815|566907644|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042035|NCT02401815|566907645|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042036|NCT02401815|566907646|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042037|NCT02401815|566907647|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
157173550|NCT00637377|567375505|FG000|Overall Study|Death|1|||
157173551|NCT00637377|567375506|FG001|Overall Study|Death|3|||
156968248|NCT01364922|566635786|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
156968249|NCT01364922|566635784|FG000|Open-label (OL) Period|Other, Unspecified|1|||
156968250|NCT01364922|566635785|FG001|Open-label (OL) Period|Other, Unspecified|0|||
156968251|NCT01364922|566635786|FG002|Open-label (OL) Period|Other, Unspecified|0|||
156968252|NCT01364922|566635784|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
156968253|NCT01364922|566635785|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
156968254|NCT01364922|566635786|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
156968255|NCT01364922|566635784|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
156968256|NCT01364922|566635785|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
156968257|NCT01364922|566635786|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
156968258|NCT01364922|566635784|FG000|Double-Blind (DB) Period|Adverse Event|0|||
156968259|NCT01364922|566635785|FG001|Double-Blind (DB) Period|Adverse Event|0|||
156968260|NCT01364922|566635786|FG002|Double-Blind (DB) Period|Adverse Event|1|||
156968261|NCT01364922|566635784|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
156968262|NCT01364922|566635785|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
156968263|NCT01364922|566635786|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
156968264|NCT00949715|566635787|FG000|Overall Study|Physician Decision|1|||
156968265|NCT00949715|566635788|FG001|Overall Study|Physician Decision|0|||
156968266|NCT00949715|566635787|FG000|Overall Study|Lost to Follow-up|1|||
156968267|NCT00949715|566635788|FG001|Overall Study|Lost to Follow-up|0|||
156968268|NCT00949715|566635787|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
156968269|NCT00949715|566635788|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
156968270|NCT01289418|566635792|FG000|Day 8 Survey|email address invalid|283|||
156968271|NCT01289418|566635792|FG000|Day 8 Survey|participants did not complete the survey|1935|||
156968272|NCT01289418|566635792|FG000|Day 29 Survey|email address invalid|283|||
156968273|NCT01289418|566635792|FG000|Day 29 Survey|participants did not complete the survey|2185|||
156968274|NCT01352585|566635793|FG000|Overall Study|Adverse Event|2|||
156968275|NCT01352585|566635794|FG001|Overall Study|Adverse Event|1|||
156968276|NCT01352585|566635793|FG000|Overall Study|Lost to Follow-up|1|||
156968277|NCT01352585|566635794|FG001|Overall Study|Lost to Follow-up|0|||
156968278|NCT01352585|566635793|FG000|Overall Study|Other|5|||
156968279|NCT01352585|566635794|FG001|Overall Study|Other|2|||
156968280|NCT00838682|566635797|FG000|Overall Study|Lost to Follow-up|21|||
156968281|NCT00838682|566635798|FG001|Overall Study|Lost to Follow-up|14|||
156968282|NCT00838682|566635797|FG000|Overall Study|detection of exclusion criteria|4|||
156968283|NCT00838682|566635798|FG001|Overall Study|detection of exclusion criteria|3|||
156968284|NCT00838682|566635797|FG000|Overall Study|Protocol Violation|0|||
156968285|NCT00838682|566635798|FG001|Overall Study|Protocol Violation|1|||
156968286|NCT00838682|566635797|FG000|Overall Study|Withdrawal by Subject|0|||
156968287|NCT00838682|566635798|FG001|Overall Study|Withdrawal by Subject|1|||
156968288|NCT03928028|566635810|FG000|Overall Study|Physician Decision|9|||
156968289|NCT03928028|566635811|FG001|Overall Study|Physician Decision|6|||
156968290|NCT03928028|566635812|FG002|Overall Study|Physician Decision|3|||
156968291|NCT03928028|566635810|FG000|Overall Study|Withdrawal by Subject|12|||
156968292|NCT03928028|566635811|FG001|Overall Study|Withdrawal by Subject|3|||
156968293|NCT03928028|566635812|FG002|Overall Study|Withdrawal by Subject|3|||
156968294|NCT04525547|566635818|FG000|Overall Study|Not treated with Ofev|2|||
156968295|NCT04525547|566635818|FG000|Overall Study|Off-label use|2|||
156968296|NCT04525547|566635818|FG000|Overall Study|Lost to Follow-up|1|||
156968297|NCT00800202|566635819|FG000|Overall Study|Adverse Event|7|||
156968298|NCT00800202|566635820|FG001|Overall Study|Adverse Event|6|||
156968299|NCT00800202|566635819|FG000|Overall Study|Death|1|||
156968300|NCT00800202|566635820|FG001|Overall Study|Death|0|||
156968301|NCT00800202|566635819|FG000|Overall Study|Other|5|||
156968302|NCT00800202|566635820|FG001|Overall Study|Other|0|||
156968303|NCT00800202|566635819|FG000|Overall Study|Disease Progression|54|||
156968304|NCT00800202|566635820|FG001|Overall Study|Disease Progression|18|||
156968305|NCT00180479|566635828|FG000|Overall Study|Death|4|||
156968306|NCT00180479|566635829|FG001|Overall Study|Death|2|||
156968307|NCT00180479|566635828|FG000|Overall Study|Lost to Follow-up|9|||
156968308|NCT00180479|566635829|FG001|Overall Study|Lost to Follow-up|7|||
156968309|NCT00180479|566635828|FG000|Overall Study|Withdrawal by Subject|3|||
156968310|NCT00180479|566635829|FG001|Overall Study|Withdrawal by Subject|3|||
156968311|NCT00180479|566635828|FG000|Overall Study|Informed consent not signed|0|||
156968312|NCT00180479|566635829|FG001|Overall Study|Informed consent not signed|1|||
156968313|NCT03315143|566635834|FG000|Overall Study|Death|240|||
156968314|NCT03315143|566635835|FG001|Overall Study|Death|246|||
157173552|NCT00637377|567375507|FG002|Overall Study|Death|2|||
157173553|NCT00637377|567375508|FG003|Overall Study|Death|1|||
156968315|NCT03315143|566635834|FG000|Overall Study|Withdrawal by Subject|57|||
156968316|NCT03315143|566635835|FG001|Overall Study|Withdrawal by Subject|68|||
156968317|NCT03315143|566635834|FG000|Overall Study|Site Terminated by Sponsor|256|||
156968318|NCT03315143|566635835|FG001|Overall Study|Site Terminated by Sponsor|282|||
156968319|NCT03315143|566635834|FG000|Overall Study|Study Terminated by Sponsor|4723|||
156968320|NCT03315143|566635835|FG001|Overall Study|Study Terminated by Sponsor|4664|||
157173554|NCT00637377|567375505|FG000|Overall Study|Lack of Efficacy|0|||
157228271|NCT01575054|567581055|FG000|Overall Study|Personal Reasons|10|||
157228272|NCT01575054|567581056|FG001|Overall Study|Personal Reasons|11|||
157228273|NCT01575054|567581055|FG000|Overall Study|Lost to Follow-up|3|||
157228274|NCT01575054|567581056|FG001|Overall Study|Lost to Follow-up|3|||
157228275|NCT01575054|567581055|FG000|Overall Study|Adverse Event|9|||
157228276|NCT01575054|567581056|FG001|Overall Study|Adverse Event|8|||
157228277|NCT02768298|567581059|FG000|Overall Study|Adverse Event|1|||
157228278|NCT02768298|567581060|FG001|Overall Study|Adverse Event|4|||
157228279|NCT02768298|567581059|FG000|Overall Study|Death|2|||
157228280|NCT02768298|567581060|FG001|Overall Study|Death|1|||
157228281|NCT02768298|567581059|FG000|Overall Study|Non-compliance with study treatment|0|||
157228282|NCT02768298|567581060|FG001|Overall Study|Non-compliance with study treatment|1|||
157228283|NCT02768298|567581059|FG000|Overall Study|Subject/guardian decision|1|||
157228284|NCT02768298|567581060|FG001|Overall Study|Subject/guardian decision|0|||
157228285|NCT02768298|567581059|FG000|Overall Study|Withdrawal of informed consent|0|||
157042038|NCT02401815|566907648|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157228286|NCT02768298|567581060|FG001|Overall Study|Withdrawal of informed consent|1|||
157228287|NCT02130466|567581061|FG000|Overall Study|Death|4|||
157228288|NCT02130466|567581062|FG001|Overall Study|Death|1|||
157228289|NCT02130466|567581063|FG002|Overall Study|Death|1|||
157228290|NCT02130466|567581064|FG003|Overall Study|Death|3|||
157228291|NCT02130466|567581065|FG004|Overall Study|Death|2|||
157228292|NCT02130466|567581066|FG005|Overall Study|Death|30|||
157228293|NCT02130466|567581067|FG006|Overall Study|Death|45|||
157228294|NCT02130466|567581068|FG007|Overall Study|Death|2|||
157228295|NCT02130466|567581069|FG008|Overall Study|Death|3|||
157228296|NCT02130466|567581070|FG009|Overall Study|Death|4|||
157228297|NCT02130466|567581071|FG010|Overall Study|Death|5|||
157228298|NCT02130466|567581072|FG011|Overall Study|Death|3|||
157228299|NCT02130466|567581073|FG012|Overall Study|Death|11|||
157228300|NCT02130466|567581074|FG013|Overall Study|Death|7|||
157228301|NCT02130466|567581061|FG000|Overall Study|Lost to Follow-up|1|||
157228302|NCT02130466|567581062|FG001|Overall Study|Lost to Follow-up|0|||
157228303|NCT02130466|567581063|FG002|Overall Study|Lost to Follow-up|0|||
157228304|NCT02130466|567581064|FG003|Overall Study|Lost to Follow-up|0|||
157228305|NCT02130466|567581065|FG004|Overall Study|Lost to Follow-up|0|||
157228306|NCT02130466|567581066|FG005|Overall Study|Lost to Follow-up|1|||
157228307|NCT02130466|567581067|FG006|Overall Study|Lost to Follow-up|0|||
157228308|NCT02130466|567581068|FG007|Overall Study|Lost to Follow-up|0|||
157228309|NCT02130466|567581069|FG008|Overall Study|Lost to Follow-up|0|||
157228310|NCT02130466|567581070|FG009|Overall Study|Lost to Follow-up|0|||
157228311|NCT02130466|567581071|FG010|Overall Study|Lost to Follow-up|0|||
157228312|NCT02130466|567581072|FG011|Overall Study|Lost to Follow-up|0|||
157228313|NCT02130466|567581073|FG012|Overall Study|Lost to Follow-up|1|||
157228314|NCT02130466|567581074|FG013|Overall Study|Lost to Follow-up|0|||
157228315|NCT02130466|567581061|FG000|Overall Study|Physician Decision|0|||
157228316|NCT02130466|567581062|FG001|Overall Study|Physician Decision|0|||
157228317|NCT02130466|567581063|FG002|Overall Study|Physician Decision|0|||
157228318|NCT02130466|567581064|FG003|Overall Study|Physician Decision|0|||
157228319|NCT02130466|567581065|FG004|Overall Study|Physician Decision|0|||
157228320|NCT02130466|567581066|FG005|Overall Study|Physician Decision|1|||
157042039|NCT02401815|566907649|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042040|NCT02401815|566907650|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042041|NCT02401815|566907651|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042042|NCT02401815|566907652|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
157042043|NCT02401815|566907643|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042044|NCT02401815|566907644|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042045|NCT02401815|566907645|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042046|NCT02401815|566907646|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042047|NCT02401815|566907647|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042048|NCT02401815|566907648|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
157042049|NCT02401815|566907649|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157228321|NCT02130466|567581067|FG006|Overall Study|Physician Decision|1|||
157228322|NCT02130466|567581068|FG007|Overall Study|Physician Decision|0|||
157228323|NCT02130466|567581069|FG008|Overall Study|Physician Decision|0|||
157228324|NCT02130466|567581070|FG009|Overall Study|Physician Decision|0|||
157228325|NCT02130466|567581071|FG010|Overall Study|Physician Decision|0|||
157228326|NCT02130466|567581072|FG011|Overall Study|Physician Decision|0|||
157228327|NCT02130466|567581073|FG012|Overall Study|Physician Decision|0|||
157228328|NCT02130466|567581074|FG013|Overall Study|Physician Decision|0|||
157228329|NCT02130466|567581061|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
157228330|NCT02130466|567581062|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
157228331|NCT02130466|567581063|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
157228332|NCT02130466|567581064|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
157228333|NCT02130466|567581065|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
157228334|NCT02130466|567581066|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
157228335|NCT02130466|567581067|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
157042050|NCT02401815|566907650|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042051|NCT02401815|566907651|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042052|NCT02401815|566907652|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
157042053|NCT02401815|566907643|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042054|NCT02401815|566907644|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042055|NCT02401815|566907645|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042056|NCT02401815|566907646|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042057|NCT02401815|566907647|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042058|NCT02401815|566907648|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042059|NCT02401815|566907649|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
157173555|NCT00637377|567375506|FG001|Overall Study|Lack of Efficacy|0|||
157173556|NCT00637377|567375507|FG002|Overall Study|Lack of Efficacy|1|||
157173557|NCT00637377|567375508|FG003|Overall Study|Lack of Efficacy|1|||
157173558|NCT00637377|567375505|FG000|Overall Study|Lost to Follow-up|4|||
157173559|NCT00637377|567375506|FG001|Overall Study|Lost to Follow-up|1|||
157173560|NCT00637377|567375507|FG002|Overall Study|Lost to Follow-up|2|||
157042060|NCT02401815|566907650|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042061|NCT02401815|566907651|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042062|NCT02401815|566907652|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042063|NCT02401815|566907643|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042064|NCT02401815|566907644|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042065|NCT02401815|566907645|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042066|NCT02401815|566907646|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042067|NCT02401815|566907647|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042068|NCT02401815|566907648|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
157042069|NCT02401815|566907649|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
157042070|NCT02401815|566907650|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042071|NCT02401815|566907651|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042072|NCT02401815|566907652|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
157042073|NCT02401815|566907643|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042074|NCT02401815|566907644|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042075|NCT02401815|566907645|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042076|NCT02401815|566907646|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042077|NCT02401815|566907647|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042078|NCT02401815|566907648|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
157042079|NCT02401815|566907649|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042080|NCT02401815|566907650|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042081|NCT02401815|566907651|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042082|NCT02401815|566907652|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
157042083|NCT02401815|566907643|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042084|NCT02401815|566907644|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042085|NCT02401815|566907645|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042086|NCT02401815|566907646|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042087|NCT02401815|566907647|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042088|NCT02401815|566907648|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042089|NCT02401815|566907649|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
157042090|NCT02401815|566907650|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
157042091|NCT02401815|566907651|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
157042092|NCT02401815|566907652|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
157042093|NCT02401815|566907643|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157173561|NCT00637377|567375508|FG003|Overall Study|Lost to Follow-up|2|||
157173562|NCT00637377|567375505|FG000|Overall Study|Protocol Violation|2|||
157173563|NCT00637377|567375506|FG001|Overall Study|Protocol Violation|1|||
157173564|NCT00637377|567375507|FG002|Overall Study|Protocol Violation|1|||
157173565|NCT00637377|567375508|FG003|Overall Study|Protocol Violation|0|||
157173566|NCT00637377|567375505|FG000|Overall Study|Withdrawal by Subject|11|||
157173567|NCT00637377|567375506|FG001|Overall Study|Withdrawal by Subject|15|||
157173568|NCT00637377|567375507|FG002|Overall Study|Withdrawal by Subject|13|||
157173569|NCT00637377|567375508|FG003|Overall Study|Withdrawal by Subject|11|||
157173570|NCT00637377|567375505|FG000|Overall Study|Other (no further information available)|7|||
157228336|NCT02130466|567581068|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
157173571|NCT00637377|567375506|FG001|Overall Study|Other (no further information available)|6|||
157173572|NCT00637377|567375507|FG002|Overall Study|Other (no further information available)|10|||
157173573|NCT00637377|567375508|FG003|Overall Study|Other (no further information available)|5|||
157173574|NCT01293084|567375510|FG000|Overall Study|Physician Decision|3|||
157228337|NCT02130466|567581069|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
157173575|NCT01293084|567375510|FG000|Overall Study|Withdrawal by Subject|2|||
157173576|NCT04186663|567375511|FG000|Overall Study|Lost to Follow-up|1|||
157173577|NCT04186663|567375511|FG000|Overall Study|Unable to complete blood draw|3|||
157173578|NCT00719862|567375516|FG000|Overall Study|Adverse Event|1|||
156968321|NCT03315143|566635834|FG000|Overall Study|Reason not Specified|16|||
156968322|NCT03315143|566635835|FG001|Overall Study|Reason not Specified|32|||
156968323|NCT02459262|566635836|FG000|Overall Study|Withdrawal by Subject|0|||
156968324|NCT02459262|566635837|FG001|Overall Study|Withdrawal by Subject|0|||
156968325|NCT02459262|566635838|FG002|Overall Study|Withdrawal by Subject|0|||
156968326|NCT02459262|566635839|FG003|Overall Study|Withdrawal by Subject|0|||
156968327|NCT02459262|566635840|FG004|Overall Study|Withdrawal by Subject|0|||
156968328|NCT02459262|566635841|FG005|Overall Study|Withdrawal by Subject|0|||
156968329|NCT02459262|566635842|FG006|Overall Study|Withdrawal by Subject|0|||
156968330|NCT02459262|566635843|FG007|Overall Study|Withdrawal by Subject|0|||
156968331|NCT02459262|566635844|FG008|Overall Study|Withdrawal by Subject|0|||
156968332|NCT02459262|566635845|FG009|Overall Study|Withdrawal by Subject|1|||
156968333|NCT02459262|566635846|FG010|Overall Study|Withdrawal by Subject|0|||
156968334|NCT05168579|566635847|FG000|Overall Study|Lack of Consent|1|||
156968335|NCT05168579|566635848|FG001|Overall Study|Lack of Consent|0|||
156968336|NCT05168579|566635847|FG000|Overall Study|Conflicts with time|2|||
156968337|NCT05168579|566635848|FG001|Overall Study|Conflicts with time|0|||
156968338|NCT05168579|566635847|FG000|Overall Study|Time slots were full|3|||
156968339|NCT05168579|566635848|FG001|Overall Study|Time slots were full|0|||
156968340|NCT05168579|566635847|FG000|Overall Study|Lost to Follow-up|0|||
156968341|NCT05168579|566635848|FG001|Overall Study|Lost to Follow-up|15|||
156968342|NCT01242748|566635849|FG000|Overall Study|Adverse Event|10|||
156968343|NCT01242748|566635850|FG001|Overall Study|Adverse Event|5|||
156968344|NCT01242748|566635849|FG000|Overall Study|Lost to Follow-up|6|||
156968345|NCT01242748|566635850|FG001|Overall Study|Lost to Follow-up|2|||
156968346|NCT01242748|566635849|FG000|Overall Study|Physician Decision|3|||
156968347|NCT01242748|566635850|FG001|Overall Study|Physician Decision|2|||
156968348|NCT01242748|566635849|FG000|Overall Study|Protocol Violation|1|||
156968349|NCT01242748|566635850|FG001|Overall Study|Protocol Violation|0|||
156968350|NCT01242748|566635849|FG000|Overall Study|Withdrawal by Subject|10|||
156968351|NCT01242748|566635850|FG001|Overall Study|Withdrawal by Subject|2|||
156968352|NCT01242748|566635849|FG000|Overall Study|Miscellaneous reasons|8|||
156968353|NCT01242748|566635850|FG001|Overall Study|Miscellaneous reasons|3|||
156968354|NCT00840801|566635851|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
156968355|NCT00840801|566635852|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
156968356|NCT00840801|566635853|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
156968357|NCT00840801|566635851|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
156968358|NCT00840801|566635852|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
156968359|NCT00840801|566635853|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
156968360|NCT00840801|566635851|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
156968361|NCT00840801|566635852|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
156968362|NCT00840801|566635853|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
156968363|NCT00840801|566635851|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
156968364|NCT00840801|566635852|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
156968365|NCT00840801|566635853|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
156968366|NCT00508404|566635856|FG000|Overall Study|Ongoing at Data Cut-off|12|||
156968367|NCT00508404|566635856|FG000|Overall Study|Adverse Event|2|||
156968368|NCT00508404|566635856|FG000|Overall Study|Death|16|||
156968369|NCT00508404|566635856|FG000|Overall Study|Physician Decision|2|||
156968370|NCT00508404|566635856|FG000|Overall Study|Withdrawal by Subject|3|||
156968371|NCT00508404|566635856|FG000|Overall Study|Protocol-specified Criteria|2|||
156968372|NCT00508404|566635856|FG000|Overall Study|Lost to Follow-up|2|||
156968373|NCT00508404|566635856|FG000|Overall Study|Other - Not Specified|3|||
156968374|NCT01505387|566635857|FG000|Overall Study|Protocol Violation|1|||
156968375|NCT01505387|566635858|FG001|Overall Study|Protocol Violation|0|||
156968376|NCT01505387|566635857|FG000|Overall Study|Withdrawal by Subject|1|||
156968377|NCT01505387|566635858|FG001|Overall Study|Withdrawal by Subject|1|||
156968378|NCT01424930|566635859|FG000|Overall Study|Adverse Event|0|||
156968379|NCT01424930|566635860|FG001|Overall Study|Adverse Event|1|||
156968380|NCT01424930|566635859|FG000|Overall Study|Death|1|||
156968381|NCT01424930|566635860|FG001|Overall Study|Death|0|||
156968382|NCT01424930|566635859|FG000|Overall Study|Progressive Disease|3|||
156968383|NCT01424930|566635860|FG001|Overall Study|Progressive Disease|6|||
156968384|NCT01424930|566635859|FG000|Overall Study|Screen Failure|0|||
156968385|NCT01424930|566635860|FG001|Overall Study|Screen Failure|1|||
156968386|NCT01424930|566635859|FG000|Overall Study|Reason not specified|0|||
156968387|NCT01424930|566635860|FG001|Overall Study|Reason not specified|6|||
156968388|NCT01197508|566635863|FG000|Overall Study|Withdrawal by Subject|8|||
156968389|NCT01197508|566635864|FG001|Overall Study|Withdrawal by Subject|7|||
156968390|NCT01197508|566635865|FG002|Overall Study|Withdrawal by Subject|15|||
156968391|NCT01197508|566635866|FG003|Overall Study|Withdrawal by Subject|4|||
157173579|NCT00719862|567375517|FG001|Overall Study|Adverse Event|2|||
157042094|NCT02401815|566907644|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042095|NCT02401815|566907645|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042096|NCT02401815|566907646|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042097|NCT02401815|566907647|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042098|NCT02401815|566907648|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042099|NCT02401815|566907649|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042100|NCT02401815|566907650|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
157042101|NCT02401815|566907651|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
157042102|NCT02401815|566907652|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
157042103|NCT02401815|566907643|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042104|NCT02401815|566907644|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042105|NCT02401815|566907645|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042106|NCT02401815|566907646|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042107|NCT02401815|566907647|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042108|NCT02401815|566907648|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042109|NCT02401815|566907649|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042110|NCT02401815|566907650|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042111|NCT02401815|566907651|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
157042112|NCT02401815|566907652|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
157042113|NCT02401815|566907643|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042114|NCT02401815|566907644|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042115|NCT02401815|566907645|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042116|NCT02401815|566907646|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042117|NCT02401815|566907647|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042118|NCT02401815|566907648|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042119|NCT02401815|566907649|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042120|NCT02401815|566907650|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042121|NCT02401815|566907651|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
157042122|NCT02401815|566907652|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
157042123|NCT02401815|566907643|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042124|NCT02401815|566907644|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042125|NCT02401815|566907645|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042126|NCT02401815|566907646|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042127|NCT02401815|566907647|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042128|NCT02401815|566907648|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042129|NCT02401815|566907649|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042130|NCT02401815|566907650|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
157042131|NCT02401815|566907651|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
157042132|NCT02401815|566907652|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
157042133|NCT05613907|566907653|FG000|Overall Study|Lost to Follow-up|5|||
157042134|NCT05613907|566907653|FG000|Overall Study|Death|3|||
157042135|NCT05613907|566907653|FG000|Overall Study|Withdrawal by Subject|2|||
157042136|NCT00748709|566907663|FG000|Overall Study|Progressive disease|15|||
157042137|NCT00748709|566907663|FG000|Overall Study|Drug reducing Toxity|2|||
157042138|NCT00748709|566907663|FG000|Overall Study|Other Adverse Event|1|||
157042139|NCT00748709|566907663|FG000|Overall Study|Withdrawal by Subject|1|||
157042140|NCT00748709|566907663|FG000|Overall Study|Other Reasons|1|||
157042141|NCT03789656|566907664|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
157042142|NCT03789656|566907665|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
157042143|NCT03789656|566907666|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
157042144|NCT03789656|566907667|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
157042145|NCT03789656|566907668|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
157042146|NCT03789656|566907664|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
157042147|NCT03789656|566907665|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
157042148|NCT03789656|566907666|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
157042149|NCT03789656|566907667|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
157042150|NCT03789656|566907668|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
157042151|NCT03789656|566907664|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
157042152|NCT03789656|566907665|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
157042153|NCT03789656|566907666|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
157042154|NCT03789656|566907667|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
157042155|NCT03789656|566907668|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
157042156|NCT03789656|566907664|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
157042157|NCT03789656|566907665|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
157173580|NCT00719862|567375516|FG000|Overall Study|Lack of Efficacy|3|||
157173581|NCT00719862|567375517|FG001|Overall Study|Lack of Efficacy|0|||
157173582|NCT00719862|567375516|FG000|Overall Study|Non-Compliance|1|||
157173583|NCT00719862|567375517|FG001|Overall Study|Non-Compliance|0|||
157173584|NCT00719862|567375516|FG000|Overall Study|Withdrawal by Subject|1|||
157173585|NCT00719862|567375517|FG001|Overall Study|Withdrawal by Subject|0|||
157173586|NCT00719862|567375516|FG000|Overall Study|Lost to Follow-up|0|||
157173587|NCT00719862|567375517|FG001|Overall Study|Lost to Follow-up|1|||
157173588|NCT00719862|567375516|FG000|Overall Study|Other|2|||
157173589|NCT00719862|567375517|FG001|Overall Study|Other|3|||
157173590|NCT01135394|567377447|FG000|Screening|Lost to Follow-up|2|||
157173591|NCT01135394|567377447|FG000|Screening|Withdrawal by Subject|10|||
157173592|NCT01135394|567377447|FG000|Screening|Screening failure|16|||
157173593|NCT01135394|567377447|FG000|Screening|Physician Decision|5|||
156968392|NCT01197508|566635863|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
156968393|NCT01197508|566635864|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
156968394|NCT01197508|566635865|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
156968395|NCT01197508|566635866|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
156968396|NCT01197508|566635863|FG000|Overall Study|Adverse Event|10|||
156968397|NCT01197508|566635864|FG001|Overall Study|Adverse Event|13|||
156968398|NCT01197508|566635865|FG002|Overall Study|Adverse Event|23|||
156968399|NCT01197508|566635866|FG003|Overall Study|Adverse Event|3|||
156968400|NCT01197508|566635863|FG000|Overall Study|Severe non-compliance to protocol|0|||
156968401|NCT01197508|566635864|FG001|Overall Study|Severe non-compliance to protocol|3|||
156968402|NCT01197508|566635865|FG002|Overall Study|Severe non-compliance to protocol|1|||
156968403|NCT01197508|566635866|FG003|Overall Study|Severe non-compliance to protocol|3|||
156968404|NCT01197508|566635863|FG000|Overall Study|Condition under investigation worsened|1|||
156968405|NCT01197508|566635864|FG001|Overall Study|Condition under investigation worsened|1|||
156968406|NCT01197508|566635865|FG002|Overall Study|Condition under investigation worsened|1|||
156968407|NCT01197508|566635866|FG003|Overall Study|Condition under investigation worsened|1|||
156968408|NCT01197508|566635863|FG000|Overall Study|Lack of Efficacy|1|||
156968409|NCT01197508|566635864|FG001|Overall Study|Lack of Efficacy|2|||
156968410|NCT01197508|566635865|FG002|Overall Study|Lack of Efficacy|2|||
156968411|NCT01197508|566635866|FG003|Overall Study|Lack of Efficacy|1|||
156968412|NCT01197508|566635863|FG000|Overall Study|Study-specific withdrawal criteria|0|||
156968413|NCT01197508|566635864|FG001|Overall Study|Study-specific withdrawal criteria|0|||
156968414|NCT01197508|566635865|FG002|Overall Study|Study-specific withdrawal criteria|1|||
156968415|NCT01197508|566635866|FG003|Overall Study|Study-specific withdrawal criteria|2|||
156968416|NCT01197508|566635863|FG000|Overall Study|Lost to Follow-up|1|||
156968417|NCT01197508|566635864|FG001|Overall Study|Lost to Follow-up|1|||
156968418|NCT01197508|566635865|FG002|Overall Study|Lost to Follow-up|2|||
156968419|NCT01197508|566635866|FG003|Overall Study|Lost to Follow-up|0|||
156968420|NCT01197508|566635863|FG000|Overall Study|Other|2|||
156968421|NCT01197508|566635864|FG001|Overall Study|Other|3|||
156968422|NCT01197508|566635865|FG002|Overall Study|Other|2|||
156968423|NCT01197508|566635866|FG003|Overall Study|Other|2|||
156968424|NCT01078155|566635867|FG000|Overall Study|Adverse Event|7|||
156968425|NCT01078155|566635867|FG000|Overall Study|Lack of Efficacy|16|||
156968426|NCT01078155|566635867|FG000|Overall Study|Participant's Decision|6|||
156968427|NCT01078155|566635867|FG000|Overall Study|Lost to Follow-up|15|||
156968428|NCT03286751|566635868|FG000|Washout Period 1|Withdrawal by Subject|0|||
156968429|NCT03286751|566635869|FG001|Washout Period 1|Withdrawal by Subject|0|||
156968430|NCT03286751|566635870|FG002|Washout Period 1|Withdrawal by Subject|0|||
156968431|NCT03286751|566635871|FG003|Washout Period 1|Withdrawal by Subject|0|||
156968432|NCT03286751|566635872|FG004|Washout Period 1|Withdrawal by Subject|1|||
156968433|NCT03286751|566635873|FG005|Washout Period 1|Withdrawal by Subject|0|||
156968434|NCT03286751|566635868|FG000|Washout Period 2|Personal Reasons|0|||
156968435|NCT03286751|566635869|FG001|Washout Period 2|Personal Reasons|1|||
156968436|NCT03286751|566635870|FG002|Washout Period 2|Personal Reasons|0|||
156968437|NCT03286751|566635871|FG003|Washout Period 2|Personal Reasons|0|||
156968438|NCT03286751|566635872|FG004|Washout Period 2|Personal Reasons|0|||
156968439|NCT03286751|566635873|FG005|Washout Period 2|Personal Reasons|0|||
156968440|NCT03286751|566635868|FG000|Washout Period 5|Adverse Event|0|||
156968441|NCT03286751|566635869|FG001|Washout Period 5|Adverse Event|0|||
156968442|NCT03286751|566635870|FG002|Washout Period 5|Adverse Event|0|||
156968443|NCT03286751|566635871|FG003|Washout Period 5|Adverse Event|0|||
156968444|NCT03286751|566635872|FG004|Washout Period 5|Adverse Event|1|||
156968445|NCT03286751|566635873|FG005|Washout Period 5|Adverse Event|0|||
156968446|NCT01119768|566635874|FG000|Treatment Period|Lack of Efficacy|18|||
156968447|NCT01119768|566635875|FG001|Treatment Period|Lack of Efficacy|25|||
156968448|NCT01301391|566635876|FG000|Overall Study|Death|13|||
156968449|NCT01301391|566635876|FG000|Overall Study|Lost to Follow-up|3|||
156968450|NCT01301391|566635876|FG000|Overall Study|Physician Decision|2|||
156968451|NCT01301391|566635876|FG000|Overall Study|Sponsor's decision|8|||
156968452|NCT01059643|566635877|FG000|Overall Study|Adverse Event|3|||
157173594|NCT01135394|567377447|FG000|Baseline Assessment|Withdrawal by Subject|9|||
157173595|NCT01135394|567377447|FG000|Baseline Assessment|Physician Decision|3|||
157173596|NCT01135394|567377447|FG000|Baseline Assessment|Lost to Follow-up|2|||
157042158|NCT03789656|566907666|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
157042159|NCT03789656|566907667|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
157042160|NCT03789656|566907668|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
157042161|NCT05325294|566907674|FG000|Overall Study|Adverse Event|3|||
157042162|NCT05325294|566907675|FG001|Overall Study|Adverse Event|3|||
157042163|NCT05325294|566907674|FG000|Overall Study|Physician Decision|0|||
157042164|NCT05325294|566907675|FG001|Overall Study|Physician Decision|1|||
157042165|NCT05325294|566907674|FG000|Overall Study|Withdrawal by Subject|0|||
157042166|NCT05325294|566907675|FG001|Overall Study|Withdrawal by Subject|3|||
157042167|NCT05325294|566907674|FG000|Overall Study|Lost to Follow-up|1|||
157042168|NCT05325294|566907675|FG001|Overall Study|Lost to Follow-up|0|||
157042169|NCT05325294|566907674|FG000|Overall Study|Sponsor Request|0|||
157042170|NCT05325294|566907675|FG001|Overall Study|Sponsor Request|2|||
157042171|NCT05422339|566908785|FG000|Overall Study|Withdrawal by Subject|17|||
157042172|NCT05422339|566908786|FG001|Overall Study|Withdrawal by Subject|15|||
157042173|NCT04172675|566908787|FG000|Overall Study|Withdrawal by Subject|7|||
157042174|NCT04172675|566908788|FG001|Overall Study|Withdrawal by Subject|5|||
157042175|NCT04172675|566908789|FG002|Overall Study|Withdrawal by Subject|1|||
157042176|NCT04172675|566908790|FG003|Overall Study|Withdrawal by Subject|4|||
157042177|NCT03070392|566908797|FG000|Overall Study|Not Treated|7|||
157042178|NCT03070392|566908798|FG001|Overall Study|Not Treated|0|||
157042179|NCT03070392|566908799|FG002|Overall Study|Not Treated|3|||
157042180|NCT03070392|566908800|FG003|Overall Study|Not Treated|12|||
157042181|NCT03070392|566908797|FG000|Overall Study|Death|3|||
157042182|NCT03070392|566908798|FG001|Overall Study|Death|0|||
157042183|NCT03070392|566908799|FG002|Overall Study|Death|0|||
157042184|NCT03070392|566908800|FG003|Overall Study|Death|1|||
157042185|NCT03070392|566908797|FG000|Overall Study|Withdrawal by Subject|7|||
157042186|NCT03070392|566908798|FG001|Overall Study|Withdrawal by Subject|0|||
157042187|NCT03070392|566908799|FG002|Overall Study|Withdrawal by Subject|0|||
157042188|NCT03070392|566908800|FG003|Overall Study|Withdrawal by Subject|3|||
157042189|NCT03070392|566908797|FG000|Overall Study|Physician Decision|1|||
157042190|NCT03070392|566908798|FG001|Overall Study|Physician Decision|0|||
157042191|NCT03070392|566908799|FG002|Overall Study|Physician Decision|0|||
157042192|NCT03070392|566908800|FG003|Overall Study|Physician Decision|2|||
157042193|NCT03070392|566908797|FG000|Overall Study|Progressive Disease|154|||
157042194|NCT03070392|566908798|FG001|Overall Study|Progressive Disease|6|||
157042195|NCT03070392|566908799|FG002|Overall Study|Progressive Disease|2|||
157042196|NCT03070392|566908800|FG003|Overall Study|Progressive Disease|70|||
157042197|NCT03070392|566908797|FG000|Overall Study|Adverse Event|6|||
157042198|NCT03070392|566908798|FG001|Overall Study|Adverse Event|1|||
157042199|NCT03070392|566908799|FG002|Overall Study|Adverse Event|1|||
157042200|NCT03070392|566908800|FG003|Overall Study|Adverse Event|3|||
157042201|NCT03070392|566908797|FG000|Overall Study|Alternate anticancer treatment|1|||
157042202|NCT03070392|566908798|FG001|Overall Study|Alternate anticancer treatment|0|||
157042203|NCT03070392|566908799|FG002|Overall Study|Alternate anticancer treatment|0|||
157042204|NCT03070392|566908800|FG003|Overall Study|Alternate anticancer treatment|1|||
157042205|NCT03070392|566908797|FG000|Overall Study|Ongoing|73|||
157042206|NCT03070392|566908798|FG001|Overall Study|Ongoing|0|||
157042207|NCT03070392|566908799|FG002|Overall Study|Ongoing|0|||
157042208|NCT03070392|566908800|FG003|Overall Study|Ongoing|11|||
157042209|NCT02534233|566908806|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
157228338|NCT02130466|567581070|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
157228339|NCT02130466|567581071|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
157228340|NCT02130466|567581072|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
157228341|NCT02130466|567581073|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
157228342|NCT02130466|567581074|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
157228343|NCT02130466|567581061|FG000|Overall Study|Withdrawal by Subject|1|||
157228344|NCT02130466|567581062|FG001|Overall Study|Withdrawal by Subject|0|||
157228345|NCT02130466|567581063|FG002|Overall Study|Withdrawal by Subject|0|||
157228346|NCT02130466|567581064|FG003|Overall Study|Withdrawal by Subject|0|||
157228347|NCT02130466|567581065|FG004|Overall Study|Withdrawal by Subject|0|||
157228348|NCT02130466|567581066|FG005|Overall Study|Withdrawal by Subject|1|||
157228349|NCT02130466|567581067|FG006|Overall Study|Withdrawal by Subject|0|||
157042210|NCT00925548|566908807|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
157042211|NCT00925548|566908808|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
157042212|NCT00458783|566908810|FG000|Overall Study|Protocol Violation|1228|||
157042213|NCT00458783|566908811|FG001|Overall Study|Protocol Violation|1220|||
157042214|NCT01737398|566908812|FG000|Overall Study|Adverse event or SAE|16|||
157042215|NCT01737398|566908813|FG001|Overall Study|Adverse event or SAE|1|||
157042216|NCT01737398|566908812|FG000|Overall Study|Stopping rule met|2|||
157042217|NCT01737398|566908813|FG001|Overall Study|Stopping rule met|1|||
157042218|NCT01737398|566908812|FG000|Overall Study|Voluntary withdrawal|2|||
157042219|NCT01737398|566908813|FG001|Overall Study|Voluntary withdrawal|3|||
157042220|NCT01737398|566908812|FG000|Overall Study|Ineligibility|1|||
157042221|NCT01737398|566908813|FG001|Overall Study|Ineligibility|0|||
157042222|NCT01737398|566908812|FG000|Overall Study|Liver transplant|1|||
157228350|NCT02130466|567581068|FG007|Overall Study|Withdrawal by Subject|0|||
157228351|NCT02130466|567581069|FG008|Overall Study|Withdrawal by Subject|1|||
157228352|NCT02130466|567581070|FG009|Overall Study|Withdrawal by Subject|0|||
157228353|NCT02130466|567581071|FG010|Overall Study|Withdrawal by Subject|0|||
157228354|NCT02130466|567581072|FG011|Overall Study|Withdrawal by Subject|0|||
157228355|NCT02130466|567581073|FG012|Overall Study|Withdrawal by Subject|0|||
157228356|NCT02130466|567581074|FG013|Overall Study|Withdrawal by Subject|0|||
157228357|NCT01922349|567581075|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
157228358|NCT01922349|567581076|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
157228359|NCT01922349|567581077|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
157228360|NCT01922349|567581078|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
157228361|NCT00922779|567581079|FG000|Overall Study|Adverse Event|67|||
157228362|NCT00922779|567581079|FG000|Overall Study|Pregnancy|7|||
157228363|NCT00922779|567581079|FG000|Overall Study|Withdrawal by Subject|308|||
157042223|NCT01737398|566908813|FG001|Overall Study|Liver transplant|0|||
157042224|NCT01737398|566908812|FG000|Overall Study|Disease progression|2|||
157042225|NCT01737398|566908813|FG001|Overall Study|Disease progression|3|||
157042226|NCT01737398|566908812|FG000|Overall Study|Sponsor's decision|2|||
157042227|NCT01737398|566908813|FG001|Overall Study|Sponsor's decision|0|||
157042228|NCT03220724|566908820|FG000|Overall Study|Lost to Follow-up|2|||
157042229|NCT03220724|566908821|FG001|Overall Study|Lost to Follow-up|2|||
157042230|NCT03220724|566908822|FG002|Overall Study|Lost to Follow-up|0|||
157042231|NCT03220724|566908823|FG003|Overall Study|Lost to Follow-up|3|||
157042232|NCT03220724|566908824|FG004|Overall Study|Lost to Follow-up|1|||
157042233|NCT03220724|566908825|FG005|Overall Study|Lost to Follow-up|0|||
157042234|NCT03220724|566908826|FG006|Overall Study|Lost to Follow-up|2|||
157042235|NCT03220724|566908827|FG007|Overall Study|Lost to Follow-up|1|||
157042236|NCT03220724|566908828|FG008|Overall Study|Lost to Follow-up|0|||
157042237|NCT03220724|566908820|FG000|Overall Study|Withdrawal by Subject|1|||
157042238|NCT03220724|566908821|FG001|Overall Study|Withdrawal by Subject|0|||
157042239|NCT03220724|566908822|FG002|Overall Study|Withdrawal by Subject|1|||
157042240|NCT03220724|566908823|FG003|Overall Study|Withdrawal by Subject|0|||
157042241|NCT03220724|566908824|FG004|Overall Study|Withdrawal by Subject|0|||
157042242|NCT03220724|566908825|FG005|Overall Study|Withdrawal by Subject|0|||
157042243|NCT03220724|566908826|FG006|Overall Study|Withdrawal by Subject|0|||
157042244|NCT03220724|566908827|FG007|Overall Study|Withdrawal by Subject|0|||
157042245|NCT03220724|566908828|FG008|Overall Study|Withdrawal by Subject|0|||
157042246|NCT01613417|566908829|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
157042247|NCT01613417|566908830|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
157042248|NCT00047385|566908832|FG000|Overall Study|Death before any screening|2|||
157042249|NCT00047385|566908833|FG001|Overall Study|Death before any screening|5|||
157042250|NCT00047385|566908832|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
157042251|NCT00047385|566908833|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
157042252|NCT00047385|566908832|FG000|Overall Study|Eligible for screening but had no screen|260|||
157042253|NCT00047385|566908833|FG001|Overall Study|Eligible for screening but had no screen|492|||
157042254|NCT03865732|566908834|FG000|Overall Study|Adverse Event|0|||
157042255|NCT03865732|566908835|FG001|Overall Study|Adverse Event|1|||
157042256|NCT03392194|566908836|FG000|Overall Study|Withdrawal by Subject|1|||
157042257|NCT03392194|566908837|FG001|Overall Study|Withdrawal by Subject|2|||
157042258|NCT03392194|566908836|FG000|Overall Study|Conflicts with personal schedule|1|||
157042259|NCT03392194|566908837|FG001|Overall Study|Conflicts with personal schedule|0|||
157042260|NCT00620854|566908840|FG000|Washout 1|Withdrawal by Subject|0|||
157042261|NCT00620854|566908841|FG001|Washout 1|Withdrawal by Subject|0|||
157042262|NCT00620854|566908842|FG002|Washout 1|Withdrawal by Subject|1|||
157042263|NCT00620854|566908843|FG003|Washout 1|Withdrawal by Subject|1|||
157042264|NCT00620854|566908844|FG004|Washout 1|Withdrawal by Subject|0|||
157042265|NCT00620854|566908845|FG005|Washout 1|Withdrawal by Subject|0|||
157042266|NCT02095145|566908848|FG000|Overall Study|Withdrawal by Subject|1|||
157042267|NCT02095145|566908849|FG001|Overall Study|Withdrawal by Subject|0|||
157042268|NCT00093496|566908854|FG000|Overall Study|Protocol Violation|1|||
157042269|NCT00093496|566908855|FG001|Overall Study|Protocol Violation|3|||
157042270|NCT00586313|566908856|FG000|Overall Study|Lack of Efficacy|2|||
157228364|NCT00922779|567581079|FG000|Overall Study|Lost to Follow-up|44|||
157228365|NCT00922779|567581079|FG000|Overall Study|Other|27|||
157042271|NCT03205566|566908861|FG000|Phase 1|Protocol Violation|1|||
157042272|NCT03205566|566908862|FG001|Phase 1|Protocol Violation|1|||
157042273|NCT03184987|566908863|FG000|Overall Study|Withdrawal by Subject|0|||
157042274|NCT03184987|566908864|FG001|Overall Study|Withdrawal by Subject|1|||
157042275|NCT03184987|566908865|FG002|Overall Study|Withdrawal by Subject|2|||
157042276|NCT03184987|566908863|FG000|Overall Study|Physician Decision|0|||
157042277|NCT03184987|566908864|FG001|Overall Study|Physician Decision|0|||
157042278|NCT03184987|566908865|FG002|Overall Study|Physician Decision|1|||
157228366|NCT00922779|567581079|FG000|Overall Study|Missing|1874|||
157228367|NCT00336024|567581081|FG000|Overall Study|Death|2|||
157228368|NCT00336024|567581082|FG001|Overall Study|Death|1|||
157042279|NCT03184987|566908863|FG000|Overall Study|Adverse Event|1|||
157042280|NCT03184987|566908864|FG001|Overall Study|Adverse Event|0|||
157042281|NCT03184987|566908865|FG002|Overall Study|Adverse Event|1|||
157042282|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
157042283|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
157042284|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
157042285|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
157042286|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
157042287|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
157042288|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
157042289|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
157042290|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
157042291|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
157042292|NCT01767467|566908866|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
157042293|NCT01767467|566908867|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
157042294|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
157042295|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
157042296|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
157042297|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
157042298|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
157042299|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
157042300|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
157042301|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
157042302|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
157042303|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
157042304|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
157042305|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
157042306|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
157042307|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
157042308|NCT01767467|566908866|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
157042309|NCT01767467|566908867|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
157042310|NCT00853580|566908868|FG000|Overall Study|Lost to Follow-up|3|||
157042311|NCT00853580|566908869|FG001|Overall Study|Lost to Follow-up|5|||
157042312|NCT00853580|566908868|FG000|Overall Study|Protocol Violation|2|||
157042313|NCT00853580|566908869|FG001|Overall Study|Protocol Violation|1|||
157042314|NCT00853580|566908868|FG000|Overall Study|Withdrawal by Subject|2|||
157042315|NCT00853580|566908869|FG001|Overall Study|Withdrawal by Subject|8|||
157042316|NCT00853580|566908868|FG000|Overall Study|Commenced contraindicated therapy|0|||
157042317|NCT00853580|566908869|FG001|Overall Study|Commenced contraindicated therapy|2|||
157042318|NCT04971733|566908872|FG000|Overall Study|Adverse Event|1|||
157042319|NCT04971733|566908873|FG001|Overall Study|Adverse Event|1|||
157042320|NCT04971733|566908872|FG000|Overall Study|Subject choice|2|||
157042321|NCT04971733|566908873|FG001|Overall Study|Subject choice|0|||
157042322|NCT04971733|566908872|FG000|Overall Study|Withdrawal by Subject|1|||
157042323|NCT04971733|566908873|FG001|Overall Study|Withdrawal by Subject|0|||
157042324|NCT04971733|566908872|FG000|Overall Study|Other|1|||
157042325|NCT04971733|566908873|FG001|Overall Study|Other|0|||
157042326|NCT01160354|566908874|FG000|Overall Study|Death|0|||
157042327|NCT01160354|566908875|FG001|Overall Study|Death|1|||
157042328|NCT01160354|566908876|FG002|Overall Study|Death|1|||
157042329|NCT00600353|566908880|FG000|Overall Study|history of malignancy within 5 years|1|||
157042330|NCT00600353|566908881|FG001|Overall Study|history of malignancy within 5 years|0|||
157042331|NCT00600353|566908880|FG000|Overall Study|History of prepartive regimen|0|||
157042332|NCT00600353|566908881|FG001|Overall Study|History of prepartive regimen|1|||
157042333|NCT04200664|566908882|FG000|Overall Study|Withdrawal by Subject|1|||
157042334|NCT04200664|566908883|FG001|Overall Study|Withdrawal by Subject|0|||
157042335|NCT04200664|566908884|FG002|Overall Study|Withdrawal by Subject|0|||
157042336|NCT00491894|566908887|FG000|Overall Study|Adverse Event|14|||
157042337|NCT00491894|566908887|FG000|Overall Study|Withdrawal by Subject|5|||
157042338|NCT00491894|566908887|FG000|Overall Study|Death|3|||
157042339|NCT00491894|566908887|FG000|Overall Study|Lost to Follow-up|3|||
157042340|NCT00491894|566908887|FG000|Overall Study|Lack of Efficacy|2|||
157042341|NCT00491894|566908887|FG000|Overall Study|Other-Failed to meet any criteria|2|||
157042342|NCT00491894|566908887|FG000|Overall Study|Physician Decision|2|||
157042343|NCT00491894|566908887|FG000|Overall Study|Protocol Violation|2|||
157042344|NCT00491894|566908887|FG000|Overall Study|Other-Intake of prohibited medication|1|||
157042345|NCT01563185|566908888|FG000|Overall Study|Withdrawal by Subject|1|||
157042346|NCT01563185|566908888|FG000|Overall Study|Non-Compliance with study drug|1|||
157042347|NCT04577651|566908889|FG000|Overall Study|Screen Failure|7|||
157042348|NCT04577651|566908889|FG000|Overall Study|Adverse Event|1|||
157042349|NCT04577651|566908889|FG000|Overall Study|Death|1|||
157042350|NCT04577651|566908889|FG000|Overall Study|Physician Decision|1|||
157042351|NCT04577651|566908889|FG000|Overall Study|Withdrawal by Subject|3|||
157042352|NCT03678688|566910135|FG000|Overall Study|Reason not Specified|0|||
157042353|NCT03678688|566910136|FG001|Overall Study|Reason not Specified|0|||
157173597|NCT01135394|567377447|FG000|Baseline Assessment|Adverse Event|1|||
157173598|NCT01135394|567377447|FG000|Study Treatment|Withdrawal by Subject|1|||
157173599|NCT01135394|567377447|FG000|Study Treatment|Physician Decision|1|||
157173600|NCT01135394|567377447|FG000|Study Treatment|Adverse Event|2|||
157173601|NCT04432376|567377448|FG000|Double-blind Treatment Period|Adverse Event|2|||
157173602|NCT04432376|567377449|FG001|Double-blind Treatment Period|Adverse Event|6|||
157173603|NCT04432376|567377450|FG002|Double-blind Treatment Period|Adverse Event|0|||
157173604|NCT04432376|567377448|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
157173605|NCT04432376|567377449|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
157173606|NCT04432376|567377450|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
157173607|NCT04432376|567377448|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
157173608|NCT04432376|567377449|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
157173609|NCT04432376|567377450|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157173610|NCT04432376|567377448|FG000|Double-blind Treatment Period|Protocol Violation|0|||
157173611|NCT04432376|567377449|FG001|Double-blind Treatment Period|Protocol Violation|1|||
157042354|NCT03678688|566910137|FG002|Overall Study|Reason not Specified|3|||
157042355|NCT03678688|566910138|FG003|Overall Study|Reason not Specified|0|||
157042356|NCT03678688|566910139|FG004|Overall Study|Reason not Specified|1|||
157042357|NCT03678688|566910140|FG005|Overall Study|Reason not Specified|0|||
157042358|NCT03678688|566910141|FG006|Overall Study|Reason not Specified|0|||
157042359|NCT03678688|566910142|FG007|Overall Study|Reason not Specified|0|||
157042360|NCT03678688|566910143|FG008|Overall Study|Reason not Specified|0|||
157042361|NCT03678688|566910135|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
157042362|NCT03678688|566910136|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
157042363|NCT03678688|566910137|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
157042364|NCT03678688|566910138|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
157042365|NCT03678688|566910139|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
157042366|NCT03678688|566910140|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
157042367|NCT03678688|566910141|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
157042368|NCT03678688|566910142|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
157042369|NCT03678688|566910143|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
157042370|NCT03678688|566910135|FG000|Overall Study|Covid Related Adverse Event|0|||
157042371|NCT03678688|566910136|FG001|Overall Study|Covid Related Adverse Event|0|||
157042372|NCT03678688|566910137|FG002|Overall Study|Covid Related Adverse Event|0|||
157042373|NCT03678688|566910138|FG003|Overall Study|Covid Related Adverse Event|0|||
157042374|NCT03678688|566910139|FG004|Overall Study|Covid Related Adverse Event|0|||
157042375|NCT03678688|566910140|FG005|Overall Study|Covid Related Adverse Event|3|||
157042376|NCT03678688|566910141|FG006|Overall Study|Covid Related Adverse Event|1|||
157042377|NCT03678688|566910142|FG007|Overall Study|Covid Related Adverse Event|1|||
157042378|NCT03678688|566910143|FG008|Overall Study|Covid Related Adverse Event|0|||
157042379|NCT03678688|566910135|FG000|Overall Study|Physician Decision|0|||
157042380|NCT03678688|566910136|FG001|Overall Study|Physician Decision|0|||
157042381|NCT03678688|566910137|FG002|Overall Study|Physician Decision|0|||
157042382|NCT03678688|566910138|FG003|Overall Study|Physician Decision|0|||
157042383|NCT03678688|566910139|FG004|Overall Study|Physician Decision|0|||
157042384|NCT03678688|566910140|FG005|Overall Study|Physician Decision|1|||
157042385|NCT03678688|566910141|FG006|Overall Study|Physician Decision|0|||
157042386|NCT03678688|566910142|FG007|Overall Study|Physician Decision|0|||
157042387|NCT03678688|566910143|FG008|Overall Study|Physician Decision|0|||
157042388|NCT03678688|566910135|FG000|Overall Study|Withdrawal by Subject|0|||
157042389|NCT03678688|566910136|FG001|Overall Study|Withdrawal by Subject|0|||
157042390|NCT03678688|566910137|FG002|Overall Study|Withdrawal by Subject|0|||
157042391|NCT03678688|566910138|FG003|Overall Study|Withdrawal by Subject|0|||
157042392|NCT03678688|566910139|FG004|Overall Study|Withdrawal by Subject|0|||
157042393|NCT03678688|566910140|FG005|Overall Study|Withdrawal by Subject|0|||
157042394|NCT03678688|566910141|FG006|Overall Study|Withdrawal by Subject|2|||
157042395|NCT03678688|566910142|FG007|Overall Study|Withdrawal by Subject|1|||
157042396|NCT03678688|566910143|FG008|Overall Study|Withdrawal by Subject|0|||
157042397|NCT00551421|566910144|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
157042398|NCT03136159|566910145|FG000|Overall Study|chorioamnionitis|2|||
157173612|NCT04432376|567377450|FG002|Double-blind Treatment Period|Protocol Violation|0|||
157228369|NCT00336024|567581081|FG000|Overall Study|Physician Decision|4|||
157042399|NCT03136159|566910146|FG001|Overall Study|chorioamnionitis|0|||
157042400|NCT03136159|566910145|FG000|Overall Study|vertical skin incision|1|||
157042401|NCT03136159|566910146|FG001|Overall Study|vertical skin incision|0|||
157042402|NCT03136159|566910145|FG000|Overall Study|additional dressing|1|||
157042403|NCT03136159|566910146|FG001|Overall Study|additional dressing|0|||
157042404|NCT03136159|566910145|FG000|Overall Study|never got dressing placed|1|||
157042405|NCT03136159|566910146|FG001|Overall Study|never got dressing placed|0|||
157042406|NCT03823703|566910147|FG000|Overall Study|Sponsor request|0|||
157042407|NCT03823703|566910148|FG001|Overall Study|Sponsor request|3|||
157042408|NCT03823703|566910149|FG002|Overall Study|Sponsor request|4|||
157042409|NCT03823703|566910147|FG000|Overall Study|Adverse Event|3|||
157042410|NCT03823703|566910148|FG001|Overall Study|Adverse Event|1|||
157042411|NCT03823703|566910149|FG002|Overall Study|Adverse Event|0|||
157042412|NCT03823703|566910147|FG000|Overall Study|Withdrawal by Subject|0|||
157042413|NCT03823703|566910148|FG001|Overall Study|Withdrawal by Subject|1|||
157042414|NCT03823703|566910149|FG002|Overall Study|Withdrawal by Subject|0|||
157042415|NCT01278030|566910150|FG000|Overall Study|Withdrawal by Subject|8|||
157042416|NCT01278030|566910151|FG001|Overall Study|Withdrawal by Subject|4|||
157042417|NCT02372799|566910152|FG000|Treatment Period|Adverse Event|3|||
157042418|NCT02372799|566910153|FG001|Treatment Period|Adverse Event|10|||
157042419|NCT02372799|566910154|FG002|Treatment Period|Adverse Event|6|||
157042420|NCT02372799|566910152|FG000|Treatment Period|Insufficient therapeutic response|2|||
157042421|NCT02372799|566910153|FG001|Treatment Period|Insufficient therapeutic response|2|||
157042422|NCT02372799|566910154|FG002|Treatment Period|Insufficient therapeutic response|0|||
157042423|NCT02372799|566910152|FG000|Treatment Period|Withdrawal by Subject|10|||
157042424|NCT02372799|566910153|FG001|Treatment Period|Withdrawal by Subject|10|||
157042425|NCT02372799|566910154|FG002|Treatment Period|Withdrawal by Subject|2|||
157042426|NCT02372799|566910152|FG000|Treatment Period|Lost to Follow-up|11|||
157042427|NCT02372799|566910153|FG001|Treatment Period|Lost to Follow-up|5|||
157042428|NCT02372799|566910154|FG002|Treatment Period|Lost to Follow-up|3|||
157042429|NCT02372799|566910152|FG000|Treatment Period|Protocol Violation|3|||
157042430|NCT02372799|566910153|FG001|Treatment Period|Protocol Violation|0|||
157042431|NCT02372799|566910154|FG002|Treatment Period|Protocol Violation|0|||
157042432|NCT02372799|566910152|FG000|Treatment Period|Non-compliance with study drug|4|||
157042433|NCT02372799|566910153|FG001|Treatment Period|Non-compliance with study drug|4|||
157042434|NCT02372799|566910154|FG002|Treatment Period|Non-compliance with study drug|4|||
157042435|NCT02372799|566910152|FG000|Treatment Period|Miscellaneous Reasons|1|||
157042436|NCT02372799|566910153|FG001|Treatment Period|Miscellaneous Reasons|1|||
157042437|NCT02372799|566910154|FG002|Treatment Period|Miscellaneous Reasons|0|||
157042438|NCT02372799|566910152|FG000|Down-taper Period|Lost to Follow-up|1|||
157042439|NCT02372799|566910153|FG001|Down-taper Period|Lost to Follow-up|2|||
157042440|NCT02372799|566910154|FG002|Down-taper Period|Lost to Follow-up|2|||
157042441|NCT00089609|566910155|FG000|Overall Study|Withdrawal by Subject|3|||
157042442|NCT00089609|566910156|FG001|Overall Study|Withdrawal by Subject|1|||
157042443|NCT00357994|566910158|FG000|Overall Study|Adverse Event|1|||
157042444|NCT00357994|566910159|FG001|Overall Study|Adverse Event|2|||
157042445|NCT00357994|566910158|FG000|Overall Study|Lack of Efficacy|0|||
157042446|NCT00357994|566910159|FG001|Overall Study|Lack of Efficacy|1|||
157042447|NCT00357994|566910158|FG000|Overall Study|Protocol Violation|1|||
157042448|NCT00357994|566910159|FG001|Overall Study|Protocol Violation|0|||
157042449|NCT00745875|566910166|FG000|Overall Study|Continuing study treatment|4|||
157042450|NCT00745875|566910167|FG001|Overall Study|Continuing study treatment|4|||
157042451|NCT01833455|566910168|FG000|Overall Study|Withdrawal by Subject|1|||
157042452|NCT01833455|566910169|FG001|Overall Study|Withdrawal by Subject|0|||
157042453|NCT02000752|566910174|FG000|Overall Study|Dystocic delivery|19|||
157042454|NCT02000752|566910175|FG001|Overall Study|Dystocic delivery|8|||
157042455|NCT02000752|566910174|FG000|Overall Study|Shift Changes|12|||
157042456|NCT02000752|566910175|FG001|Overall Study|Shift Changes|5|||
157042457|NCT00019604|566910177|FG000|Overall Study|Death|1|||
157042458|NCT00019604|566910177|FG000|Overall Study|Progressive disease|23|||
157042459|NCT00019604|566910177|FG000|Overall Study|Refused treatment|1|||
157042460|NCT00019604|566910177|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
157042461|NCT00019604|566910177|FG000|Overall Study|Going to have liver transplant|1|||
157042462|NCT00019604|566910177|FG000|Overall Study|Move to a different study|1|||
157042463|NCT00019604|566910177|FG000|Overall Study|Non compliant on systemic CH|1|||
157042464|NCT00019604|566910177|FG000|Overall Study|Non compliant|1|||
157042465|NCT00019604|566910177|FG000|Overall Study|Resectable disease|1|||
157042466|NCT00019604|566910177|FG000|Overall Study|Started new chemo regimen|1|||
157042467|NCT00019604|566910177|FG000|Overall Study|Pt going to immunotherapy study|1|||
157042468|NCT00019604|566910177|FG000|Overall Study|Too much disease|1|||
157042469|NCT00019604|566910177|FG000|Overall Study|Unable to evaluate|1|||
157042470|NCT00019604|566910177|FG000|Overall Study|Details for other not available|4|||
157042471|NCT03345979|566910194|FG000|Overall Study|Withdrawal by Subject|20|||
157042472|NCT03345979|566910195|FG001|Overall Study|Withdrawal by Subject|31|||
157042473|NCT03345979|566910194|FG000|Overall Study|Adverse Event|10|||
157042474|NCT03345979|566910195|FG001|Overall Study|Adverse Event|11|||
157042475|NCT03345979|566910194|FG000|Overall Study|Lost to Follow-up|8|||
157042476|NCT03345979|566910195|FG001|Overall Study|Lost to Follow-up|9|||
157042477|NCT03345979|566910194|FG000|Overall Study|Lack of Efficacy|4|||
157042478|NCT03345979|566910195|FG001|Overall Study|Lack of Efficacy|2|||
157042479|NCT03345979|566910194|FG000|Overall Study|Protocol Violation|1|||
157042480|NCT03345979|566910195|FG001|Overall Study|Protocol Violation|3|||
157042481|NCT03345979|566910194|FG000|Overall Study|Physician Decision|0|||
157042482|NCT03345979|566910195|FG001|Overall Study|Physician Decision|2|||
157042483|NCT00734578|566910196|FG000|Overall Study|Adverse Event|4|||
157042484|NCT00734578|566910197|FG001|Overall Study|Adverse Event|6|||
157042485|NCT00734578|566910198|FG002|Overall Study|Adverse Event|1|||
157042486|NCT00734578|566910196|FG000|Overall Study|Protocol Violation|8|||
157042487|NCT00734578|566910197|FG001|Overall Study|Protocol Violation|6|||
157173613|NCT04432376|567377448|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
157173614|NCT04432376|567377449|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
157173615|NCT04432376|567377450|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
157173616|NCT00462488|567377451|FG000|Overall Study|Protocol Violation|1|||
157173617|NCT00462488|567377452|FG001|Overall Study|Protocol Violation|0|||
157173618|NCT00462488|567377451|FG000|Overall Study|Lack of Efficacy|19|||
157173619|NCT00462488|567377452|FG001|Overall Study|Lack of Efficacy|17|||
157173620|NCT01742091|567377457|FG000|Overall Study|Adverse Event|0|||
157173621|NCT01742091|567377458|FG001|Overall Study|Adverse Event|0|||
157173622|NCT01742091|567377459|FG002|Overall Study|Adverse Event|0|||
157173623|NCT01742091|567377460|FG003|Overall Study|Adverse Event|0|||
157173624|NCT01742091|567377461|FG004|Overall Study|Adverse Event|1|||
157173625|NCT01742091|567377462|FG005|Overall Study|Adverse Event|0|||
157173626|NCT01742091|567377457|FG000|Overall Study|Physician Decision|0|||
157173627|NCT01742091|567377458|FG001|Overall Study|Physician Decision|0|||
157173628|NCT01742091|567377459|FG002|Overall Study|Physician Decision|0|||
157173629|NCT01742091|567377460|FG003|Overall Study|Physician Decision|0|||
157173630|NCT01742091|567377461|FG004|Overall Study|Physician Decision|0|||
157173631|NCT01742091|567377462|FG005|Overall Study|Physician Decision|1|||
157173632|NCT01742091|567377457|FG000|Overall Study|Withdrawal by Subject|0|||
157173633|NCT01742091|567377458|FG001|Overall Study|Withdrawal by Subject|0|||
157173634|NCT01742091|567377459|FG002|Overall Study|Withdrawal by Subject|0|||
157173635|NCT01742091|567377460|FG003|Overall Study|Withdrawal by Subject|1|||
157173636|NCT01742091|567377461|FG004|Overall Study|Withdrawal by Subject|0|||
157173637|NCT01742091|567377462|FG005|Overall Study|Withdrawal by Subject|0|||
157173638|NCT01742091|567377457|FG000|Overall Study|Lost to Follow-up|0|||
157173639|NCT01742091|567377458|FG001|Overall Study|Lost to Follow-up|0|||
157173640|NCT01742091|567377459|FG002|Overall Study|Lost to Follow-up|0|||
157173641|NCT01742091|567377460|FG003|Overall Study|Lost to Follow-up|0|||
157173642|NCT01742091|567377461|FG004|Overall Study|Lost to Follow-up|0|||
157173643|NCT01742091|567377462|FG005|Overall Study|Lost to Follow-up|1|||
157173644|NCT05742841|567377463|FG000|Overall Study|Withdrawal by Subject|1|||
157173645|NCT05742841|567377463|FG000|Overall Study|Lost to Follow-up|1|||
157173646|NCT02088541|567377464|FG000|Overall Study|Adverse Event|3|||
157173647|NCT02088541|567377465|FG001|Overall Study|Adverse Event|0|||
157173648|NCT02088541|567377466|FG002|Overall Study|Adverse Event|3|||
157173649|NCT02088541|567377467|FG003|Overall Study|Adverse Event|3|||
157173650|NCT02088541|567377468|FG004|Overall Study|Adverse Event|0|||
157173651|NCT02088541|567377464|FG000|Overall Study|Death|51|||
157173652|NCT02088541|567377465|FG001|Overall Study|Death|21|||
157173653|NCT02088541|567377466|FG002|Overall Study|Death|85|||
157173654|NCT02088541|567377467|FG003|Overall Study|Death|28|||
157173655|NCT02088541|567377468|FG004|Overall Study|Death|38|||
157173656|NCT02088541|567377464|FG000|Overall Study|Lost to Follow-up|2|||
157173657|NCT02088541|567377465|FG001|Overall Study|Lost to Follow-up|0|||
157173658|NCT02088541|567377466|FG002|Overall Study|Lost to Follow-up|1|||
157173659|NCT02088541|567377467|FG003|Overall Study|Lost to Follow-up|0|||
157173660|NCT02088541|567377468|FG004|Overall Study|Lost to Follow-up|0|||
157173661|NCT02088541|567377464|FG000|Overall Study|Physician Decision|2|||
157173662|NCT02088541|567377465|FG001|Overall Study|Physician Decision|1|||
157173663|NCT02088541|567377466|FG002|Overall Study|Physician Decision|2|||
157173664|NCT02088541|567377467|FG003|Overall Study|Physician Decision|0|||
157173665|NCT02088541|567377468|FG004|Overall Study|Physician Decision|2|||
157173666|NCT02088541|567377464|FG000|Overall Study|Disease progression|7|||
157173667|NCT02088541|567377465|FG001|Overall Study|Disease progression|1|||
157173668|NCT02088541|567377466|FG002|Overall Study|Disease progression|2|||
157173669|NCT02088541|567377467|FG003|Overall Study|Disease progression|3|||
157173670|NCT02088541|567377468|FG004|Overall Study|Disease progression|1|||
157173671|NCT02088541|567377464|FG000|Overall Study|Study terminated by sponsor|1|||
157173672|NCT02088541|567377465|FG001|Overall Study|Study terminated by sponsor|1|||
157173673|NCT02088541|567377466|FG002|Overall Study|Study terminated by sponsor|12|||
157173674|NCT02088541|567377467|FG003|Overall Study|Study terminated by sponsor|2|||
157173675|NCT02088541|567377468|FG004|Overall Study|Study terminated by sponsor|6|||
157173676|NCT02088541|567377464|FG000|Overall Study|Withdrawal by Subject|3|||
157173677|NCT02088541|567377465|FG001|Overall Study|Withdrawal by Subject|2|||
157173678|NCT02088541|567377466|FG002|Overall Study|Withdrawal by Subject|9|||
157173679|NCT02088541|567377467|FG003|Overall Study|Withdrawal by Subject|7|||
157173680|NCT02088541|567377468|FG004|Overall Study|Withdrawal by Subject|10|||
157173681|NCT02088541|567377464|FG000|Overall Study|Other|2|||
157173682|NCT02088541|567377465|FG001|Overall Study|Other|1|||
157042488|NCT00734578|566910198|FG002|Overall Study|Protocol Violation|3|||
157173683|NCT02088541|567377466|FG002|Overall Study|Other|3|||
157173684|NCT02088541|567377467|FG003|Overall Study|Other|1|||
157173685|NCT02088541|567377468|FG004|Overall Study|Other|1|||
157173686|NCT03750240|567377470|FG000|Overall Study|Technical Difficulties|2|||
157173687|NCT03706040|567377471|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
157173688|NCT03706040|567377472|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
157042489|NCT00734578|566910196|FG000|Overall Study|Withdrawal by Subject|7|||
157173689|NCT03706040|567377473|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
157173690|NCT03706040|567377474|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
157173691|NCT03706040|567377475|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
157173692|NCT03706040|567377476|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
157173693|NCT03706040|567377477|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
157173694|NCT03706040|567377471|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
157173695|NCT03706040|567377472|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
157173696|NCT03706040|567377473|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
157173697|NCT03706040|567377474|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
157173698|NCT03706040|567377475|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
157173699|NCT03706040|567377476|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
157173700|NCT03706040|567377477|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
157173701|NCT03706040|567377471|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
157173702|NCT03706040|567377472|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
157173703|NCT03706040|567377473|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
157173704|NCT03706040|567377474|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
157173705|NCT03706040|567377475|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
157173706|NCT03706040|567377476|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
157173707|NCT03706040|567377477|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
157173708|NCT03706040|567377471|FG000|Period A (Week 0 to Week 16)|Other|2|||
157173709|NCT03706040|567377472|FG001|Period A (Week 0 to Week 16)|Other|0|||
157173710|NCT03706040|567377473|FG002|Period A (Week 0 to Week 16)|Other|2|||
157173711|NCT03706040|567377474|FG003|Period A (Week 0 to Week 16)|Other|0|||
157173712|NCT03706040|567377475|FG004|Period A (Week 0 to Week 16)|Other|0|||
157173713|NCT03706040|567377476|FG005|Period A (Week 0 to Week 16)|Other|0|||
157173714|NCT03706040|567377477|FG006|Period A (Week 0 to Week 16)|Other|0|||
157173715|NCT03706040|567377471|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
157173716|NCT03706040|567377472|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
157173717|NCT03706040|567377473|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
157173718|NCT03706040|567377474|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
157173719|NCT03706040|567377475|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
157173720|NCT03706040|567377476|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
157173721|NCT03706040|567377477|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
157173722|NCT03706040|567377471|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
157173723|NCT03706040|567377472|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
157173724|NCT03706040|567377473|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
157173725|NCT03706040|567377474|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
157173726|NCT03706040|567377475|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
157173727|NCT03706040|567377476|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
157173728|NCT03706040|567377477|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
157173729|NCT03706040|567377471|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
157173730|NCT03706040|567377472|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
157173731|NCT03706040|567377473|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
157173732|NCT03706040|567377474|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
157173733|NCT03706040|567377475|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
157173734|NCT03706040|567377476|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
157173735|NCT03706040|567377477|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
157173736|NCT03706040|567377471|FG000|Period B (Week 16 to Week 52)|Other|0|||
157173737|NCT03706040|567377472|FG001|Period B (Week 16 to Week 52)|Other|0|||
157173738|NCT03706040|567377473|FG002|Period B (Week 16 to Week 52)|Other|0|||
157173739|NCT03706040|567377474|FG003|Period B (Week 16 to Week 52)|Other|4|||
157173740|NCT03706040|567377475|FG004|Period B (Week 16 to Week 52)|Other|5|||
157173741|NCT03706040|567377476|FG005|Period B (Week 16 to Week 52)|Other|23|||
157173742|NCT03706040|567377477|FG006|Period B (Week 16 to Week 52)|Other|17|||
157173743|NCT00927758|567377478|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
157173744|NCT00927758|567377479|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
157173745|NCT00927758|567377480|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
157173746|NCT00927758|567377481|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
157173747|NCT00927758|567377482|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
157173748|NCT00927758|567377483|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
157173749|NCT00927758|567377478|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
157173750|NCT00927758|567377479|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
157173751|NCT00927758|567377480|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
157173752|NCT00927758|567377481|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
157173753|NCT00927758|567377482|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
157173754|NCT00927758|567377483|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
157173755|NCT02940860|567377486|FG000|Overall Study|Non-serious AE|1|||
157042490|NCT00734578|566910197|FG001|Overall Study|Withdrawal by Subject|8|||
157173756|NCT02940860|567377487|FG001|Overall Study|Non-serious AE|2|||
157173757|NCT02940860|567377486|FG000|Overall Study|Serious AE|7|||
157173758|NCT02940860|567377487|FG001|Overall Study|Serious AE|3|||
157228370|NCT00336024|567581082|FG001|Overall Study|Physician Decision|1|||
157042491|NCT00734578|566910198|FG002|Overall Study|Withdrawal by Subject|11|||
157173759|NCT02940860|567377486|FG000|Overall Study|Withdrawal by Subject|19|||
157173760|NCT02940860|567377487|FG001|Overall Study|Withdrawal by Subject|9|||
157173761|NCT02940860|567377486|FG000|Overall Study|Lost to Follow-up|13|||
156968453|NCT01059643|566635877|FG000|Overall Study|Withdrawal by Subject|2|||
156968454|NCT01059643|566635877|FG000|Overall Study|Physician Decision|1|||
156968455|NCT01621880|566635878|FG000|Overall Study|Adverse Event|5|||
156968456|NCT01621880|566635879|FG001|Overall Study|Adverse Event|1|||
156968457|NCT01621880|566635878|FG000|Overall Study|Withdrawal by Subject|5|||
156968458|NCT01621880|566635879|FG001|Overall Study|Withdrawal by Subject|4|||
156968459|NCT01949870|566635880|FG000|Overall Study|Lack of Efficacy|2|||
156968460|NCT01949870|566635880|FG000|Overall Study|Adverse Event|1|||
156968461|NCT01949870|566635880|FG000|Overall Study|Study termination|1|||
156968462|NCT01949870|566635880|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
156968463|NCT04044456|566635886|FG000|Overall Study|Lost to Follow-up|4|||
156968464|NCT04044456|566635887|FG001|Overall Study|Lost to Follow-up|1|||
156968465|NCT04044456|566635886|FG000|Overall Study|Withdrawal by Subject|1|||
156968466|NCT04044456|566635887|FG001|Overall Study|Withdrawal by Subject|0|||
156968467|NCT00330174|566635888|FG000|Overall Study|Withdrawal by Subject|7|||
156968468|NCT00330174|566635889|FG001|Overall Study|Withdrawal by Subject|7|||
156968469|NCT00330174|566635888|FG000|Overall Study|Lost to Follow-up|4|||
156968470|NCT00330174|566635889|FG001|Overall Study|Lost to Follow-up|1|||
156968471|NCT00330174|566635888|FG000|Overall Study|Clinical deterioration|1|||
156968472|NCT00330174|566635889|FG001|Overall Study|Clinical deterioration|2|||
156968473|NCT00330174|566635888|FG000|Overall Study|Excessive missed visits|3|||
156968474|NCT00330174|566635889|FG001|Overall Study|Excessive missed visits|8|||
156968475|NCT00330174|566635888|FG000|Overall Study|Miscellaneous reasons|7|||
156968476|NCT00330174|566635889|FG001|Overall Study|Miscellaneous reasons|1|||
156968477|NCT02316769|566635892|FG000|Overall Study|Physician Decision|1|||
156968478|NCT02316769|566635893|FG001|Overall Study|Physician Decision|0|||
156968479|NCT02316769|566635892|FG000|Overall Study|Withdrawal by Subject|1|||
156968480|NCT02316769|566635893|FG001|Overall Study|Withdrawal by Subject|0|||
156968481|NCT01281644|566635896|FG000|Overall Study|Lost to Follow-up|3|||
156968482|NCT01281644|566635896|FG000|Overall Study|Withdrawal by Subject|2|||
156968483|NCT05608499|566635901|FG000|Overall Study|Lack of Efficacy|1|||
156968484|NCT05608499|566635902|FG001|Overall Study|Lack of Efficacy|0|||
156968485|NCT05608499|566635901|FG000|Overall Study|Lost to Follow-up|0|||
156968486|NCT05608499|566635902|FG001|Overall Study|Lost to Follow-up|1|||
156968487|NCT02660827|566635905|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
156968488|NCT02660827|566635905|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
156968489|NCT02660827|566635905|FG000|From Study to End of Continued Access|Adverse Event|3|||
156968490|NCT02660827|566635905|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
156968491|NCT02660827|566635905|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
156968492|NCT02660827|566635905|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
156968493|NCT02660827|566635905|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
156968494|NCT02660827|566635905|FG000|Period 2: Continued Access Period|Adverse Event|3|||
156968495|NCT04672941|566635906|FG000|Overall Study|Investigator decision|1|||
156968496|NCT04672941|566635906|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
156968497|NCT04672941|566635906|FG000|Overall Study|COVID-19 related but no adverse event|1|||
156968498|NCT04672941|566635906|FG000|Overall Study|Adverse Event|2|||
156968499|NCT04672941|566635906|FG000|Overall Study|Lost to Follow-up|2|||
156968500|NCT00045305|566635907|FG000|Overall Study|Lack of Efficacy|6|||
156968501|NCT00045305|566635907|FG000|Overall Study|Adverse Event|3|||
156968502|NCT00045305|566635907|FG000|Overall Study|Death|3|||
156968503|NCT00045305|566635907|FG000|Overall Study|site error|2|||
156968504|NCT03848403|566635908|FG000|Period 2 (Day 8)|Adverse Event|1|||
156968505|NCT03848403|566635909|FG001|Period 2 (Day 8)|Adverse Event|2|||
156968506|NCT03848403|566635910|FG002|Period 2 (Day 8)|Adverse Event|2|||
156968507|NCT03848403|566635908|FG000|Period 2 (Day 8)|Physician Decision|0|||
156968508|NCT03848403|566635909|FG001|Period 2 (Day 8)|Physician Decision|1|||
156968509|NCT03848403|566635910|FG002|Period 2 (Day 8)|Physician Decision|0|||
156968510|NCT03848403|566635908|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
156968511|NCT03848403|566635909|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
157042492|NCT00734578|566910196|FG000|Overall Study|Lost to Follow-up|9|||
156968512|NCT03848403|566635910|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
156968513|NCT00168038|566635911|FG000|Overall Study|Adverse Event|1|||
156968514|NCT00168038|566635911|FG000|Overall Study|Therapy failure|1|||
156968515|NCT02657031|566635915|FG000|Overall Study|Adverse Event|1|||
156968516|NCT02657031|566635916|FG001|Overall Study|Adverse Event|2|||
156968517|NCT04198805|566635917|FG000|Overall Study|Death|0|||
156968518|NCT04198805|566635918|FG001|Overall Study|Death|0|||
156968519|NCT04198805|566635919|FG002|Overall Study|Death|0|||
156968520|NCT04198805|566635920|FG003|Overall Study|Death|1|||
156968521|NCT04198805|566635917|FG000|Overall Study|Early Termination|8|||
156968522|NCT04198805|566635918|FG001|Overall Study|Early Termination|4|||
156968523|NCT04198805|566635919|FG002|Overall Study|Early Termination|6|||
156968524|NCT04198805|566635920|FG003|Overall Study|Early Termination|9|||
157228371|NCT00336024|567581081|FG000|Overall Study|Protocol Violation|1|||
157228372|NCT00336024|567581082|FG001|Overall Study|Protocol Violation|0|||
157228373|NCT00336024|567581081|FG000|Overall Study|Withdrawal by Subject|1|||
157228374|NCT00336024|567581082|FG001|Overall Study|Withdrawal by Subject|2|||
157228375|NCT00336024|567581081|FG000|Overall Study|Failure to fulfill consolidation|1|||
157228376|NCT00336024|567581082|FG001|Overall Study|Failure to fulfill consolidation|1|||
157228377|NCT00336024|567581081|FG000|Overall Study|Progressive Disease|4|||
157228378|NCT00336024|567581082|FG001|Overall Study|Progressive Disease|7|||
157228379|NCT00336024|567581081|FG000|Overall Study|Ineligible|7|||
157228380|NCT00336024|567581082|FG001|Overall Study|Ineligible|7|||
157228381|NCT05067504|567581083|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
157228382|NCT05067504|567581084|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
157228383|NCT05067504|567581083|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
157228384|NCT05067504|567581084|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
157228385|NCT05067504|567581083|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
157228386|NCT05067504|567581084|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
157228387|NCT05771428|567583240|FG000|Overall Study|Adverse Event|0|||
157228388|NCT05771428|567583241|FG001|Overall Study|Adverse Event|1|||
157228389|NCT05771428|567583242|FG002|Overall Study|Adverse Event|1|||
157228390|NCT05771428|567583243|FG003|Overall Study|Adverse Event|1|||
157228391|NCT05771428|567583240|FG000|Overall Study|Withdrawal by Subject|3|||
157228392|NCT05771428|567583241|FG001|Overall Study|Withdrawal by Subject|2|||
157228393|NCT05771428|567583242|FG002|Overall Study|Withdrawal by Subject|1|||
157228394|NCT05771428|567583243|FG003|Overall Study|Withdrawal by Subject|4|||
157228395|NCT05771428|567583240|FG000|Overall Study|Other|0|||
157228396|NCT05771428|567583241|FG001|Overall Study|Other|1|||
157228397|NCT05771428|567583242|FG002|Overall Study|Other|2|||
157228398|NCT05771428|567583243|FG003|Overall Study|Other|1|||
157228399|NCT05771428|567583240|FG000|Overall Study|Randomized but Not Treated|0|||
157228400|NCT05771428|567583241|FG001|Overall Study|Randomized but Not Treated|0|||
157228401|NCT05771428|567583242|FG002|Overall Study|Randomized but Not Treated|1|||
157228402|NCT05771428|567583243|FG003|Overall Study|Randomized but Not Treated|0|||
157228403|NCT01210001|567583244|FG000|Overall Study|Not treated|1|||
157228404|NCT01210001|567583245|FG001|Overall Study|Not treated|0|||
157228405|NCT01210001|567583246|FG002|Overall Study|Not treated|0|||
157228406|NCT01210001|567583244|FG000|Overall Study|Adverse Event|4|||
157228407|NCT01210001|567583245|FG001|Overall Study|Adverse Event|2|||
157228408|NCT01210001|567583246|FG002|Overall Study|Adverse Event|5|||
157228409|NCT01210001|567583244|FG000|Overall Study|Non compliant with protocol|2|||
157228410|NCT01210001|567583245|FG001|Overall Study|Non compliant with protocol|2|||
157228411|NCT01210001|567583246|FG002|Overall Study|Non compliant with protocol|3|||
157228412|NCT01210001|567583244|FG000|Overall Study|Lost to Follow-up|4|||
157228413|NCT01210001|567583245|FG001|Overall Study|Lost to Follow-up|3|||
157228414|NCT01210001|567583246|FG002|Overall Study|Lost to Follow-up|2|||
157228415|NCT01210001|567583244|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
157228416|NCT01210001|567583245|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
157228417|NCT01210001|567583246|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
157228418|NCT01210001|567583244|FG000|Overall Study|Other reason not defined above|2|||
157228419|NCT01210001|567583245|FG001|Overall Study|Other reason not defined above|2|||
157228420|NCT01210001|567583246|FG002|Overall Study|Other reason not defined above|1|||
157228421|NCT02684344|567583249|FG000|Overall Study|Withdrawal by Subject|0|||
157228422|NCT02684344|567583250|FG001|Overall Study|Withdrawal by Subject|1|||
157228423|NCT01451762|567583251|FG000|Overall Study|Lost to Follow-up|3|||
157228424|NCT01451762|567583252|FG001|Overall Study|Lost to Follow-up|6|||
157228425|NCT01451762|567583253|FG002|Overall Study|Lost to Follow-up|6|||
157228426|NCT00630305|567583254|FG000|Overall Study|Withdrawal by Subject|1|||
157228427|NCT00630305|567583254|FG000|Overall Study|Inability to insert contact lens|1|||
157228428|NCT01085045|567583255|FG000|Part A|Withdrawal by Subject|4|||
157228429|NCT01085045|567583255|FG000|Part A|Adverse Event|6|||
157228430|NCT01085045|567583255|FG000|Part A|Protocol Violation|1|||
157228431|NCT01085045|567583255|FG000|Part A|Protocol Specified Criteria|7|||
157228432|NCT01085045|567583255|FG000|Part B|Withdrawal by Subject|2|||
157228433|NCT01085045|567583255|FG000|Part B|Protocol Specified Criteria|6|||
157228434|NCT01085045|567583255|FG000|Part B|Lost to Follow-up|1|||
157228435|NCT01085045|567583255|FG000|Part B|Adverse Event|6|||
157228436|NCT01494506|567583256|FG000|Overall Study|Lack of Efficacy|77|||
157228437|NCT01494506|567583257|FG001|Overall Study|Lack of Efficacy|83|||
157228438|NCT01494506|567583258|FG002|Overall Study|Lack of Efficacy|57|||
157228439|NCT01494506|567583256|FG000|Overall Study|Adverse Event|17|||
157228440|NCT01494506|567583257|FG001|Overall Study|Adverse Event|10|||
157228441|NCT01494506|567583258|FG002|Overall Study|Adverse Event|11|||
156968525|NCT03599349|566635925|FG000|Overall Study|Lost to Follow-up|1|||
157228442|NCT01494506|567583256|FG000|Overall Study|Death|9|||
157228443|NCT01494506|567583257|FG001|Overall Study|Death|5|||
157228444|NCT01494506|567583258|FG002|Overall Study|Death|2|||
157228445|NCT01494506|567583256|FG000|Overall Study|Physician Decision|7|||
157228446|NCT01494506|567583257|FG001|Overall Study|Physician Decision|5|||
156968526|NCT00810264|566635930|FG000|Overall Study|Lost to Follow-up|191|||
157228447|NCT01494506|567583258|FG002|Overall Study|Physician Decision|4|||
157228448|NCT01494506|567583256|FG000|Overall Study|Withdrawal by Subject|17|||
157228449|NCT01494506|567583257|FG001|Overall Study|Withdrawal by Subject|20|||
157228450|NCT01494506|567583258|FG002|Overall Study|Withdrawal by Subject|14|||
157228451|NCT01494506|567583256|FG000|Overall Study|Clinical Deterioration|21|||
157228452|NCT01494506|567583257|FG001|Overall Study|Clinical Deterioration|17|||
157228453|NCT01494506|567583258|FG002|Overall Study|Clinical Deterioration|13|||
157228454|NCT01494506|567583256|FG000|Overall Study|Sponsor Decision|0|||
157228455|NCT01494506|567583257|FG001|Overall Study|Sponsor Decision|0|||
157228456|NCT01494506|567583258|FG002|Overall Study|Sponsor Decision|1|||
157228457|NCT01494506|567583256|FG000|Overall Study|Other|0|||
157228458|NCT01494506|567583257|FG001|Overall Study|Other|3|||
157228459|NCT01494506|567583258|FG002|Overall Study|Other|1|||
157228460|NCT02924038|567583259|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
157228461|NCT02924038|567583260|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
157228462|NCT02777528|567583264|FG000|Overall Study|Still in study|24|||
157228463|NCT02777528|567583265|FG001|Overall Study|Still in study|10|||
157228464|NCT02777528|567583266|FG002|Overall Study|Still in study|1|||
157228465|NCT02777528|567583264|FG000|Overall Study|Study Device Explanted|1|||
157228466|NCT02777528|567583265|FG001|Overall Study|Study Device Explanted|0|||
157228467|NCT02777528|567583266|FG002|Overall Study|Study Device Explanted|0|||
157228468|NCT02777528|567583264|FG000|Overall Study|Death|14|||
157228469|NCT02777528|567583265|FG001|Overall Study|Death|7|||
157228470|NCT02777528|567583266|FG002|Overall Study|Death|1|||
157228471|NCT02777528|567583264|FG000|Overall Study|Withdrawal by Subject|2|||
157228472|NCT02777528|567583265|FG001|Overall Study|Withdrawal by Subject|2|||
157228473|NCT02777528|567583266|FG002|Overall Study|Withdrawal by Subject|1|||
157173762|NCT02940860|567377487|FG001|Overall Study|Lost to Follow-up|7|||
157173763|NCT02940860|567377486|FG000|Overall Study|Physician Decision|5|||
157173764|NCT02940860|567377487|FG001|Overall Study|Physician Decision|3|||
157173765|NCT02940860|567377486|FG000|Overall Study|Sponsor Decision|0|||
157173766|NCT02940860|567377487|FG001|Overall Study|Sponsor Decision|1|||
157173767|NCT02940860|567377486|FG000|Overall Study|Protocol Violation|0|||
157173768|NCT02940860|567377487|FG001|Overall Study|Protocol Violation|2|||
157173769|NCT02940860|567377486|FG000|Overall Study|Death|3|||
157173770|NCT02940860|567377487|FG001|Overall Study|Death|2|||
157173771|NCT02940860|567377486|FG000|Overall Study|Moved, poor venous access, transport|6|||
157173772|NCT02940860|567377487|FG001|Overall Study|Moved, poor venous access, transport|4|||
157173773|NCT02940860|567377486|FG000|Overall Study|Not treated|2|||
157173774|NCT02940860|567377487|FG001|Overall Study|Not treated|2|||
157173775|NCT02431793|567377489|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
157173776|NCT02431793|567377490|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
157173777|NCT02431793|567377491|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
157173778|NCT02431793|567377489|FG000|Overall Study|Withdrawal by Subject|7|||
157173779|NCT02431793|567377490|FG001|Overall Study|Withdrawal by Subject|5|||
157173780|NCT02431793|567377491|FG002|Overall Study|Withdrawal by Subject|5|||
157173781|NCT02431793|567377489|FG000|Overall Study|Lost to Follow-up|101|||
157173782|NCT02431793|567377490|FG001|Overall Study|Lost to Follow-up|122|||
157173783|NCT02431793|567377491|FG002|Overall Study|Lost to Follow-up|104|||
157173784|NCT01563107|567377496|FG000|Overall Study|Physician Decision|0|||
157173785|NCT01563107|567377497|FG001|Overall Study|Physician Decision|1|||
157173786|NCT01563107|567377498|FG002|Overall Study|Physician Decision|1|||
157173787|NCT01563107|567377499|FG003|Overall Study|Physician Decision|3|||
157173788|NCT01563107|567377496|FG000|Overall Study|Withdrawal by Subject|1|||
157173789|NCT01563107|567377497|FG001|Overall Study|Withdrawal by Subject|2|||
157173790|NCT01563107|567377498|FG002|Overall Study|Withdrawal by Subject|1|||
157173791|NCT01563107|567377499|FG003|Overall Study|Withdrawal by Subject|2|||
157173792|NCT02707601|567377500|FG000|Overall Study|Death|0|||
157173793|NCT02707601|567377501|FG001|Overall Study|Death|1|||
157173794|NCT02707601|567377500|FG000|Overall Study|Lack of Efficacy|0|||
157173795|NCT02707601|567377501|FG001|Overall Study|Lack of Efficacy|1|||
157173796|NCT02707601|567377500|FG000|Overall Study|Investigator's Discretion|1|||
157173797|NCT02707601|567377501|FG001|Overall Study|Investigator's Discretion|0|||
157042493|NCT00734578|566910197|FG001|Overall Study|Lost to Follow-up|3|||
157173798|NCT02707601|567377500|FG000|Overall Study|Withdrew Consent|0|||
157173799|NCT02707601|567377501|FG001|Overall Study|Withdrew Consent|1|||
157173800|NCT02707601|567377500|FG000|Overall Study|Lost to Follow-up|1|||
157173801|NCT02707601|567377501|FG001|Overall Study|Lost to Follow-up|1|||
157173802|NCT02707601|567377500|FG000|Overall Study|Participants Randomized but Not Treated|2|||
157173803|NCT02707601|567377501|FG001|Overall Study|Participants Randomized but Not Treated|0|||
157228474|NCT02777528|567583264|FG000|Overall Study|Physician Decision|2|||
157228475|NCT02777528|567583265|FG001|Overall Study|Physician Decision|1|||
157228476|NCT02777528|567583266|FG002|Overall Study|Physician Decision|0|||
157228477|NCT02777528|567583264|FG000|Overall Study|Lost to Follow-up|2|||
157228478|NCT02777528|567583265|FG001|Overall Study|Lost to Follow-up|0|||
157228479|NCT02777528|567583266|FG002|Overall Study|Lost to Follow-up|0|||
157173804|NCT00063986|567377503|FG000|Overall Study|Withdrawal by Subject|1|||
157173805|NCT00063986|567377503|FG000|Overall Study|Ineligible|1|||
157228480|NCT02777528|567583264|FG000|Overall Study|Discontinued due to Other|1|||
157228481|NCT02777528|567583265|FG001|Overall Study|Discontinued due to Other|0|||
157228482|NCT02777528|567583266|FG002|Overall Study|Discontinued due to Other|0|||
157228483|NCT00453362|567583267|FG000|Overall Study|Adverse Event|5|||
157228484|NCT00453362|567583267|FG000|Overall Study|Death|7|||
157228485|NCT00453362|567583267|FG000|Overall Study|Physician Decision|2|||
157228486|NCT00453362|567583267|FG000|Overall Study|Withdrawal by Subject|3|||
157228487|NCT00453362|567583267|FG000|Overall Study|Progression of disease|56|||
157228488|NCT00453362|567583267|FG000|Overall Study|Screening Failure|14|||
157228489|NCT02127281|567583268|FG000|Overall Study|Lost to Follow-up|1|||
157228490|NCT02127281|567583269|FG001|Overall Study|Lost to Follow-up|0|||
157228491|NCT04885296|567583270|FG000|Period 1|Covid-19 Related|1|||
157228492|NCT04885296|567583271|FG001|Period 1|Covid-19 Related|0|||
157228493|NCT04885296|567583270|FG000|Period 1|Adverse Event|0|||
157228494|NCT04885296|567583271|FG001|Period 1|Adverse Event|1|||
157228495|NCT04885296|567583270|FG000|Period 1|Withdrawal by Subject|1|||
157228496|NCT04885296|567583271|FG001|Period 1|Withdrawal by Subject|1|||
157228497|NCT04885296|567583270|FG000|Period 1|Test Article No Longer Available|1|||
157228498|NCT04885296|567583271|FG001|Period 1|Test Article No Longer Available|0|||
157228499|NCT04885296|567583270|FG000|Period 1|Dispensed Study lens in Error|1|||
157228500|NCT04885296|567583271|FG001|Period 1|Dispensed Study lens in Error|0|||
157228501|NCT04885296|567583270|FG000|Period 1|Lost to Follow-up|1|||
157228502|NCT04885296|567583271|FG001|Period 1|Lost to Follow-up|0|||
157228503|NCT04885296|567583270|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
157228504|NCT04885296|567583271|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
157228505|NCT00433147|567583272|FG000|Overall Study|Adverse Event|0|||
157228506|NCT00433147|567583273|FG001|Overall Study|Adverse Event|1|||
157228507|NCT00433147|567583274|FG002|Overall Study|Adverse Event|0|||
157228508|NCT00433147|567583275|FG003|Overall Study|Adverse Event|0|||
157228509|NCT01882647|567583276|FG000|Overall Study|Lost to Follow-up|2|||
157228510|NCT01882647|567583277|FG001|Overall Study|Lost to Follow-up|2|||
157228511|NCT01882647|567583276|FG000|Overall Study|Withdrawal by Subject|0|||
157228512|NCT01882647|567583277|FG001|Overall Study|Withdrawal by Subject|4|||
157228513|NCT00376220|567583281|FG000|Overall Study|Lost to Follow-up|7|||
157228514|NCT00376220|567583282|FG001|Overall Study|Lost to Follow-up|10|||
157228515|NCT00376220|567583281|FG000|Overall Study|Withdrawal by Subject|3|||
157228516|NCT00376220|567583282|FG001|Overall Study|Withdrawal by Subject|2|||
157228517|NCT02564263|567583283|FG000|Overall Study|Adverse Event|31|||
157228518|NCT02564263|567583284|FG001|Overall Study|Adverse Event|29|||
157228519|NCT02564263|567583283|FG000|Overall Study|Death|270|||
157228520|NCT02564263|567583284|FG001|Overall Study|Death|262|||
157228521|NCT02564263|567583283|FG000|Overall Study|Withdrawal by Subject|4|||
157228522|NCT02564263|567583284|FG001|Overall Study|Withdrawal by Subject|19|||
157228523|NCT02564263|567583283|FG000|Overall Study|Sponsor's decision|9|||
157228524|NCT02564263|567583284|FG001|Overall Study|Sponsor's decision|4|||
157228525|NCT02906709|567583285|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
157228526|NCT02906709|567583286|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
157228527|NCT02906709|567583285|FG000|Phase A (Week 0 to Week 16)|Death|0|||
156968527|NCT00810264|566635930|FG000|Overall Study|Withdrawal by subject or physician|721|||
156968528|NCT00810264|566635930|FG000|Overall Study|Death|641|||
156968529|NCT01860703|566635941|FG000|Overall Study|Adverse Event|1|||
156968530|NCT01860703|566635942|FG001|Overall Study|Adverse Event|4|||
156968531|NCT01860703|566635943|FG002|Overall Study|Adverse Event|0|||
156968532|NCT01860703|566635944|FG003|Overall Study|Adverse Event|2|||
156968533|NCT01860703|566635941|FG000|Overall Study|Withdrawal by Subject|0|||
156968534|NCT01860703|566635942|FG001|Overall Study|Withdrawal by Subject|1|||
156968535|NCT01860703|566635943|FG002|Overall Study|Withdrawal by Subject|0|||
156968536|NCT01860703|566635944|FG003|Overall Study|Withdrawal by Subject|0|||
156968537|NCT01860703|566635941|FG000|Overall Study|Personal reason|1|||
156968538|NCT01860703|566635942|FG001|Overall Study|Personal reason|0|||
156968539|NCT01860703|566635943|FG002|Overall Study|Personal reason|1|||
156968540|NCT01860703|566635944|FG003|Overall Study|Personal reason|0|||
156968541|NCT03770494|566635945|FG000|Overall Study|Lost to Follow-up|0|||
156968542|NCT03770494|566635946|FG001|Overall Study|Lost to Follow-up|0|||
157042494|NCT00734578|566910198|FG002|Overall Study|Lost to Follow-up|5|||
156968543|NCT03770494|566635947|FG002|Overall Study|Lost to Follow-up|1|||
156968544|NCT03770494|566635948|FG003|Overall Study|Lost to Follow-up|1|||
156968545|NCT03770494|566635949|FG004|Overall Study|Lost to Follow-up|1|||
157228528|NCT02906709|567583286|FG001|Phase A (Week 0 to Week 16)|Death|1|||
157228529|NCT02906709|567583285|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
157228530|NCT02906709|567583286|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
157228531|NCT02906709|567583285|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
157228532|NCT02906709|567583286|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
157228533|NCT00920140|567583287|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
157228534|NCT00920140|567583288|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
157228535|NCT00920140|567583289|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
156968546|NCT03770494|566635950|FG005|Overall Study|Lost to Follow-up|0|||
156968547|NCT03770494|566635951|FG006|Overall Study|Lost to Follow-up|0|||
157228536|NCT00920140|567583290|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
157173806|NCT00063986|567377503|FG000|Overall Study|Intra-operatively ineligible|4|||
157173807|NCT00247273|567377504|FG000|Overall Study|Adverse Event|85|||
157173808|NCT00247273|567377505|FG001|Overall Study|Adverse Event|80|||
157173809|NCT00247273|567377504|FG000|Overall Study|Physician Decision|6|||
157173810|NCT00247273|567377505|FG001|Overall Study|Physician Decision|3|||
157228537|NCT00920140|567583291|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
157228538|NCT00920140|567583287|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
157228539|NCT00920140|567583288|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
157228540|NCT00920140|567583289|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
157228541|NCT00920140|567583290|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
157228542|NCT00920140|567583291|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
157228543|NCT00920140|567583287|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157228544|NCT00920140|567583288|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
157228545|NCT00920140|567583289|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157228546|NCT00920140|567583290|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157228547|NCT00920140|567583291|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
157228548|NCT00920140|567583287|FG000|Phase 2|Adverse Event|0|||
157228549|NCT00920140|567583288|FG001|Phase 2|Adverse Event|0|||
157228550|NCT00920140|567583289|FG002|Phase 2|Adverse Event|14|||
157228551|NCT00920140|567583290|FG003|Phase 2|Adverse Event|2|||
157228552|NCT00920140|567583291|FG004|Phase 2|Adverse Event|3|||
157228553|NCT00920140|567583287|FG000|Phase 2|Lack of Efficacy|0|||
157228554|NCT00920140|567583288|FG001|Phase 2|Lack of Efficacy|0|||
157228555|NCT00920140|567583289|FG002|Phase 2|Lack of Efficacy|29|||
157228556|NCT00920140|567583290|FG003|Phase 2|Lack of Efficacy|14|||
157173811|NCT00247273|567377504|FG000|Overall Study|Lost to Follow-up|7|||
157173812|NCT00247273|567377505|FG001|Overall Study|Lost to Follow-up|7|||
157173813|NCT00247273|567377504|FG000|Overall Study|Withdrawal by Subject|46|||
157173814|NCT00247273|567377505|FG001|Overall Study|Withdrawal by Subject|47|||
157173815|NCT00247273|567377504|FG000|Overall Study|Did not take any study drug|2|||
157173816|NCT00247273|567377505|FG001|Overall Study|Did not take any study drug|0|||
157173817|NCT01709708|567377506|FG000|Overall Study|Protocol Violation|1|||
156968548|NCT03770494|566635952|FG007|Overall Study|Lost to Follow-up|0|||
156968549|NCT03770494|566635953|FG008|Overall Study|Lost to Follow-up|0|||
156968550|NCT03770494|566635954|FG009|Overall Study|Lost to Follow-up|0|||
156968551|NCT03770494|566635955|FG010|Overall Study|Lost to Follow-up|0|||
156968552|NCT03770494|566635956|FG011|Overall Study|Lost to Follow-up|0|||
156968553|NCT03770494|566635957|FG012|Overall Study|Lost to Follow-up|0|||
156968554|NCT03770494|566635958|FG013|Overall Study|Lost to Follow-up|0|||
156968555|NCT03770494|566635945|FG000|Overall Study|Study terminated by sponsor|1|||
156968556|NCT03770494|566635946|FG001|Overall Study|Study terminated by sponsor|2|||
156968557|NCT03770494|566635947|FG002|Overall Study|Study terminated by sponsor|1|||
156968558|NCT03770494|566635948|FG003|Overall Study|Study terminated by sponsor|1|||
156968559|NCT03770494|566635949|FG004|Overall Study|Study terminated by sponsor|1|||
156968560|NCT03770494|566635950|FG005|Overall Study|Study terminated by sponsor|2|||
156968561|NCT03770494|566635951|FG006|Overall Study|Study terminated by sponsor|1|||
156968562|NCT03770494|566635952|FG007|Overall Study|Study terminated by sponsor|2|||
156968563|NCT03770494|566635953|FG008|Overall Study|Study terminated by sponsor|1|||
156968564|NCT03770494|566635954|FG009|Overall Study|Study terminated by sponsor|2|||
156968565|NCT03770494|566635955|FG010|Overall Study|Study terminated by sponsor|1|||
156968566|NCT03770494|566635956|FG011|Overall Study|Study terminated by sponsor|2|||
156968567|NCT03770494|566635957|FG012|Overall Study|Study terminated by sponsor|0|||
156968568|NCT03770494|566635958|FG013|Overall Study|Study terminated by sponsor|0|||
156968569|NCT03770494|566635945|FG000|Overall Study|Withdrawal by Subject|1|||
156968570|NCT03770494|566635946|FG001|Overall Study|Withdrawal by Subject|1|||
156968571|NCT03770494|566635947|FG002|Overall Study|Withdrawal by Subject|0|||
156968572|NCT03770494|566635948|FG003|Overall Study|Withdrawal by Subject|0|||
156968573|NCT03770494|566635949|FG004|Overall Study|Withdrawal by Subject|2|||
156968574|NCT03770494|566635950|FG005|Overall Study|Withdrawal by Subject|2|||
156968575|NCT03770494|566635951|FG006|Overall Study|Withdrawal by Subject|2|||
156968576|NCT03770494|566635952|FG007|Overall Study|Withdrawal by Subject|0|||
156968577|NCT03770494|566635953|FG008|Overall Study|Withdrawal by Subject|2|||
156968578|NCT03770494|566635954|FG009|Overall Study|Withdrawal by Subject|3|||
156968579|NCT03770494|566635955|FG010|Overall Study|Withdrawal by Subject|1|||
156968580|NCT03770494|566635956|FG011|Overall Study|Withdrawal by Subject|0|||
156968581|NCT03770494|566635957|FG012|Overall Study|Withdrawal by Subject|0|||
156968582|NCT03770494|566635958|FG013|Overall Study|Withdrawal by Subject|0|||
156968583|NCT01582789|566637610|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
156968584|NCT01582789|566637611|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
156968585|NCT00861614|566637612|FG000|Overall Study|Disease Progression|182|||
157173818|NCT01709708|567377507|FG001|Overall Study|Protocol Violation|2|||
157173819|NCT00270998|567377509|FG000|3 Month Follow-up|Adverse Event|1|||
157173820|NCT00270998|567377510|FG001|3 Month Follow-up|Adverse Event|0|||
157228557|NCT00920140|567583291|FG004|Phase 2|Lack of Efficacy|5|||
157228558|NCT00920140|567583287|FG000|Phase 2|Lost to Follow-up|0|||
157228559|NCT00920140|567583288|FG001|Phase 2|Lost to Follow-up|0|||
157228560|NCT00920140|567583289|FG002|Phase 2|Lost to Follow-up|0|||
157042495|NCT00734578|566910196|FG000|Overall Study|Lack of Efficacy|3|||
157042496|NCT00734578|566910197|FG001|Overall Study|Lack of Efficacy|2|||
157042497|NCT00734578|566910198|FG002|Overall Study|Lack of Efficacy|5|||
157042498|NCT00734578|566910196|FG000|Overall Study|Randomized in error|1|||
157042499|NCT00734578|566910197|FG001|Overall Study|Randomized in error|0|||
157042500|NCT00734578|566910198|FG002|Overall Study|Randomized in error|0|||
157042501|NCT00734578|566910196|FG000|Overall Study|Exclusion criteria|1|||
157042502|NCT00734578|566910197|FG001|Overall Study|Exclusion criteria|0|||
157042503|NCT00734578|566910198|FG002|Overall Study|Exclusion criteria|0|||
157042504|NCT00999596|566910199|FG000|Overall Study|Statistical population not required|101|||
157042505|NCT02085941|566910204|FG000|Overall Study|Lack of Efficacy|1|||
157042506|NCT02085941|566910205|FG001|Overall Study|Lack of Efficacy|0|||
157042507|NCT02085941|566910204|FG000|Overall Study|Death|6|||
157042508|NCT02085941|566910205|FG001|Overall Study|Death|1|||
157042509|NCT02085941|566910204|FG000|Overall Study|Lost to Follow-up|1|||
157042510|NCT02085941|566910205|FG001|Overall Study|Lost to Follow-up|0|||
157042511|NCT02085941|566910204|FG000|Overall Study|Physician Decision|0|||
157042512|NCT02085941|566910205|FG001|Overall Study|Physician Decision|2|||
157042513|NCT01932970|566910206|FG000|Overall Study|Withdrawal by Subject|5|||
157042514|NCT01932970|566910206|FG000|Overall Study|Death|1|||
157042515|NCT01932970|566910206|FG000|Overall Study|Lost to Follow-up|2|||
157042516|NCT01932970|566910206|FG000|Overall Study|Protocol Specified Criteria|10|||
157042517|NCT02203799|566910211|FG000|Overall Study|Withdrawal by Subject|3|||
157042518|NCT03335488|566910212|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
157042519|NCT03335488|566910213|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
157042520|NCT03335488|566910212|FG000|Safety Extension Period|Adverse Event|1|||
157042521|NCT03335488|566910213|FG001|Safety Extension Period|Adverse Event|0|||
157042522|NCT03335488|566910212|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
157042523|NCT03335488|566910213|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
157042524|NCT01953692|566910214|FG000|Overall Study|Adverse Event|5|||
157042525|NCT01953692|566910215|FG001|Overall Study|Adverse Event|2|||
157042526|NCT01953692|566910216|FG002|Overall Study|Adverse Event|4|||
157042527|NCT01953692|566910217|FG003|Overall Study|Adverse Event|2|||
157042528|NCT01953692|566910218|FG004|Overall Study|Adverse Event|1|||
157042529|NCT01953692|566910219|FG005|Overall Study|Adverse Event|2|||
157042530|NCT01953692|566910220|FG006|Overall Study|Adverse Event|0|||
157042531|NCT01953692|566910221|FG007|Overall Study|Adverse Event|0|||
157042532|NCT01953692|566910222|FG008|Overall Study|Adverse Event|0|||
157042533|NCT01953692|566910214|FG000|Overall Study|Clinical Progression|0|||
157042534|NCT01953692|566910215|FG001|Overall Study|Clinical Progression|15|||
157042535|NCT01953692|566910216|FG002|Overall Study|Clinical Progression|7|||
157042536|NCT01953692|566910217|FG003|Overall Study|Clinical Progression|5|||
157042537|NCT01953692|566910218|FG004|Overall Study|Clinical Progression|0|||
157042538|NCT01953692|566910219|FG005|Overall Study|Clinical Progression|7|||
157042539|NCT01953692|566910220|FG006|Overall Study|Clinical Progression|20|||
157042540|NCT01953692|566910221|FG007|Overall Study|Clinical Progression|3|||
157042541|NCT01953692|566910222|FG008|Overall Study|Clinical Progression|3|||
157042542|NCT01953692|566910214|FG000|Overall Study|Death|5|||
157042543|NCT01953692|566910215|FG001|Overall Study|Death|0|||
157042544|NCT01953692|566910216|FG002|Overall Study|Death|2|||
157042545|NCT01953692|566910217|FG003|Overall Study|Death|2|||
157042546|NCT01953692|566910218|FG004|Overall Study|Death|1|||
157042547|NCT01953692|566910219|FG005|Overall Study|Death|3|||
157042548|NCT01953692|566910220|FG006|Overall Study|Death|6|||
157042549|NCT01953692|566910221|FG007|Overall Study|Death|2|||
157042550|NCT01953692|566910222|FG008|Overall Study|Death|1|||
157042551|NCT01953692|566910214|FG000|Overall Study|Excluded Medication|1|||
157042552|NCT01953692|566910215|FG001|Overall Study|Excluded Medication|0|||
157042553|NCT01953692|566910216|FG002|Overall Study|Excluded Medication|0|||
157042554|NCT01953692|566910217|FG003|Overall Study|Excluded Medication|0|||
157173821|NCT00270998|567377511|FG002|3 Month Follow-up|Adverse Event|0|||
157173822|NCT00270998|567377509|FG000|3 Month Follow-up|Lack of Efficacy|1|||
157173823|NCT00270998|567377510|FG001|3 Month Follow-up|Lack of Efficacy|2|||
157042555|NCT01953692|566910218|FG004|Overall Study|Excluded Medication|0|||
157042556|NCT01953692|566910219|FG005|Overall Study|Excluded Medication|0|||
157042557|NCT01953692|566910220|FG006|Overall Study|Excluded Medication|0|||
157042558|NCT01953692|566910221|FG007|Overall Study|Excluded Medication|0|||
157042559|NCT01953692|566910222|FG008|Overall Study|Excluded Medication|0|||
157042560|NCT01953692|566910214|FG000|Overall Study|Lost to Follow-up|1|||
157173824|NCT00270998|567377511|FG002|3 Month Follow-up|Lack of Efficacy|1|||
157042561|NCT01953692|566910215|FG001|Overall Study|Lost to Follow-up|0|||
157042562|NCT01953692|566910216|FG002|Overall Study|Lost to Follow-up|3|||
157042563|NCT01953692|566910217|FG003|Overall Study|Lost to Follow-up|1|||
157042564|NCT01953692|566910218|FG004|Overall Study|Lost to Follow-up|0|||
157042565|NCT01953692|566910219|FG005|Overall Study|Lost to Follow-up|1|||
157042566|NCT01953692|566910220|FG006|Overall Study|Lost to Follow-up|0|||
157042567|NCT01953692|566910221|FG007|Overall Study|Lost to Follow-up|0|||
157042568|NCT01953692|566910222|FG008|Overall Study|Lost to Follow-up|0|||
157042569|NCT01953692|566910214|FG000|Overall Study|Physician Decision|11|||
157173825|NCT00270998|567377509|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
157042570|NCT01953692|566910215|FG001|Overall Study|Physician Decision|4|||
157042571|NCT01953692|566910216|FG002|Overall Study|Physician Decision|2|||
157042572|NCT01953692|566910217|FG003|Overall Study|Physician Decision|2|||
157042573|NCT01953692|566910218|FG004|Overall Study|Physician Decision|1|||
157042574|NCT01953692|566910219|FG005|Overall Study|Physician Decision|2|||
157042575|NCT01953692|566910220|FG006|Overall Study|Physician Decision|4|||
157042576|NCT01953692|566910221|FG007|Overall Study|Physician Decision|1|||
157042577|NCT01953692|566910222|FG008|Overall Study|Physician Decision|0|||
157042578|NCT01953692|566910214|FG000|Overall Study|Protocol Violation|0|||
157042579|NCT01953692|566910215|FG001|Overall Study|Protocol Violation|2|||
157042580|NCT01953692|566910216|FG002|Overall Study|Protocol Violation|1|||
157042581|NCT01953692|566910217|FG003|Overall Study|Protocol Violation|0|||
157042582|NCT01953692|566910218|FG004|Overall Study|Protocol Violation|0|||
156968586|NCT00861614|566637613|FG001|Overall Study|Disease Progression|263|||
156968587|NCT00861614|566637612|FG000|Overall Study|Study Drug Toxicity|79|||
156968588|NCT00861614|566637613|FG001|Overall Study|Study Drug Toxicity|6|||
156968589|NCT00861614|566637612|FG000|Overall Study|Death|32|||
156968590|NCT00861614|566637613|FG001|Overall Study|Death|19|||
156968591|NCT00861614|566637612|FG000|Overall Study|Adverse Event|27|||
156968592|NCT00861614|566637613|FG001|Overall Study|Adverse Event|23|||
157042583|NCT01953692|566910219|FG005|Overall Study|Protocol Violation|0|||
157042584|NCT01953692|566910220|FG006|Overall Study|Protocol Violation|0|||
157042585|NCT01953692|566910221|FG007|Overall Study|Protocol Violation|1|||
157042586|NCT01953692|566910222|FG008|Overall Study|Protocol Violation|0|||
157042587|NCT01953692|566910214|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042588|NCT01953692|566910215|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042589|NCT01953692|566910216|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042590|NCT01953692|566910217|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042591|NCT01953692|566910218|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042592|NCT01953692|566910219|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042593|NCT01953692|566910220|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042594|NCT01953692|566910221|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
157042595|NCT01953692|566910222|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
157042596|NCT01953692|566910214|FG000|Overall Study|Withdrawal by Subject|4|||
157042597|NCT01953692|566910215|FG001|Overall Study|Withdrawal by Subject|2|||
157042598|NCT01953692|566910216|FG002|Overall Study|Withdrawal by Subject|1|||
157042599|NCT01953692|566910217|FG003|Overall Study|Withdrawal by Subject|2|||
157042600|NCT01953692|566910218|FG004|Overall Study|Withdrawal by Subject|0|||
157042601|NCT01953692|566910219|FG005|Overall Study|Withdrawal by Subject|3|||
157042602|NCT01953692|566910220|FG006|Overall Study|Withdrawal by Subject|2|||
157042603|NCT01953692|566910221|FG007|Overall Study|Withdrawal by Subject|1|||
157042604|NCT01953692|566910222|FG008|Overall Study|Withdrawal by Subject|1|||
157042605|NCT01801007|566910227|FG000|Overall Study|Adverse Event|2|||
157042606|NCT01801007|566910227|FG000|Overall Study|Lost to Follow-up|4|||
157042607|NCT01801007|566910227|FG000|Overall Study|Withdrawal by Subject|5|||
157042608|NCT02743819|566910228|FG000|Overall Study|Lack of Efficacy|5|||
157042609|NCT02743819|566910228|FG000|Overall Study|Death|2|||
157042610|NCT02743819|566910228|FG000|Overall Study|Adverse Event|1|||
157042611|NCT00145470|566910229|FG000|Overall Study|Adverse Event|19|||
157042612|NCT00145470|566910230|FG001|Overall Study|Adverse Event|25|||
157042613|NCT00145470|566910229|FG000|Overall Study|Lack of Efficacy|27|||
157042614|NCT00145470|566910230|FG001|Overall Study|Lack of Efficacy|13|||
157042615|NCT00145470|566910229|FG000|Overall Study|Withdrawal by Subject|36|||
157042616|NCT00145470|566910230|FG001|Overall Study|Withdrawal by Subject|34|||
157042617|NCT00145470|566910229|FG000|Overall Study|Lost to Follow-up|21|||
157042618|NCT00145470|566910230|FG001|Overall Study|Lost to Follow-up|17|||
157042619|NCT00145470|566910229|FG000|Overall Study|Reason Not Reported|9|||
157042620|NCT00145470|566910230|FG001|Overall Study|Reason Not Reported|9|||
157042621|NCT00676091|566910232|FG000|Infant Series|Parent or legal guardian request|10|||
157042622|NCT00676091|566910233|FG001|Infant Series|Parent or legal guardian request|8|||
157042623|NCT00676091|566910232|FG000|Infant Series|Protocol Violation|6|||
157042624|NCT00676091|566910233|FG001|Infant Series|Protocol Violation|3|||
157042625|NCT00676091|566910232|FG000|Infant Series|Adverse Event|2|||
157042626|NCT00676091|566910233|FG001|Infant Series|Adverse Event|3|||
157042627|NCT00676091|566910232|FG000|Infant Series|Failed to return|1|||
157042628|NCT00676091|566910233|FG001|Infant Series|Failed to return|3|||
157042629|NCT00676091|566910232|FG000|Infant Series|Lost to Follow-up|1|||
156968593|NCT00861614|566637612|FG000|Overall Study|Withdrawal by Subject|34|||
156968594|NCT00861614|566637613|FG001|Overall Study|Withdrawal by Subject|35|||
157042630|NCT00676091|566910233|FG001|Infant Series|Lost to Follow-up|0|||
157042631|NCT00676091|566910232|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
157042632|NCT00676091|566910233|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
157042633|NCT00676091|566910232|FG000|After Infant Series|Adverse Event|0|||
157042634|NCT00676091|566910233|FG001|After Infant Series|Adverse Event|1|||
157228561|NCT00920140|567583290|FG003|Phase 2|Lost to Follow-up|1|||
156968595|NCT00861614|566637612|FG000|Overall Study|Other|17|||
157042635|NCT00676091|566910232|FG000|After Infant Series|Protocol Violation|0|||
157228562|NCT00920140|567583291|FG004|Phase 2|Lost to Follow-up|0|||
157173826|NCT00270998|567377510|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
157173827|NCT00270998|567377511|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
157173828|NCT00270998|567377509|FG000|3 Month Follow-up|Pessary did not fit|12|||
157173829|NCT00270998|567377510|FG001|3 Month Follow-up|Pessary did not fit|0|||
157173830|NCT00270998|567377511|FG002|3 Month Follow-up|Pessary did not fit|0|||
157173831|NCT00270998|567377509|FG000|3 Month Follow-up|Personal/family health|1|||
157173832|NCT00270998|567377510|FG001|3 Month Follow-up|Personal/family health|1|||
157173833|NCT00270998|567377511|FG002|3 Month Follow-up|Personal/family health|0|||
157173834|NCT00270998|567377509|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
157173835|NCT00270998|567377510|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
157173836|NCT00270998|567377511|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
157173837|NCT00270998|567377509|FG000|12 Month Follow-up|Lack of Efficacy|5|||
157173838|NCT00270998|567377510|FG001|12 Month Follow-up|Lack of Efficacy|4|||
157173839|NCT00270998|567377511|FG002|12 Month Follow-up|Lack of Efficacy|3|||
157173840|NCT00270998|567377509|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
157173841|NCT00270998|567377510|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
157173842|NCT00270998|567377511|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
157173843|NCT00270998|567377509|FG000|12 Month Follow-up|Pessary did not fit|1|||
157173844|NCT00270998|567377510|FG001|12 Month Follow-up|Pessary did not fit|0|||
157173845|NCT00270998|567377511|FG002|12 Month Follow-up|Pessary did not fit|0|||
157173846|NCT00270998|567377509|FG000|12 Month Follow-up|Personal/family health|0|||
157173847|NCT00270998|567377510|FG001|12 Month Follow-up|Personal/family health|5|||
157173848|NCT00270998|567377511|FG002|12 Month Follow-up|Personal/family health|1|||
157173849|NCT00270998|567377509|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
157173850|NCT00270998|567377510|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
157173851|NCT00270998|567377511|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
157173852|NCT04075396|567377514|FG000|Overall Study|Death|11|||
157173853|NCT04075396|567377515|FG001|Overall Study|Death|9|||
157173854|NCT04075396|567377514|FG000|Overall Study|Withdrawal by Subject|1|||
157173855|NCT04075396|567377515|FG001|Overall Study|Withdrawal by Subject|2|||
157173856|NCT04075396|567377514|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
157173857|NCT04075396|567377515|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
157173858|NCT04075396|567377514|FG000|Overall Study|Enrolled but not-treated|0|||
157173859|NCT04075396|567377515|FG001|Overall Study|Enrolled but not-treated|1|||
157173860|NCT01896856|567377516|FG000|Overall Study|Transportation issues / Non-compliance|0|||
157173861|NCT01896856|567377517|FG001|Overall Study|Transportation issues / Non-compliance|0|||
157173862|NCT01896856|567377518|FG002|Overall Study|Transportation issues / Non-compliance|1|||
157173863|NCT01896856|567377519|FG003|Overall Study|Transportation issues / Non-compliance|0|||
157173864|NCT01896856|567377520|FG004|Overall Study|Transportation issues / Non-compliance|0|||
157173865|NCT01896856|567377521|FG005|Overall Study|Transportation issues / Non-compliance|0|||
157173866|NCT00105560|567377529|FG000|Overall Study|Lost to Follow-up|1|||
157173867|NCT01248364|567377530|FG000|Overall Study|Adverse Event|0|||
157173868|NCT01248364|567377531|FG001|Overall Study|Adverse Event|1|||
157173869|NCT01248364|567377532|FG002|Overall Study|Adverse Event|0|||
157173870|NCT01248364|567377533|FG003|Overall Study|Adverse Event|0|||
157173871|NCT02559713|567377536|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
157173872|NCT01021813|567377537|FG000|DB Treatment Phase|Adverse Event|60|||
157173873|NCT01021813|567377538|FG001|DB Treatment Phase|Adverse Event|22|||
157173874|NCT01021813|567377539|FG002|DB Treatment Phase|Adverse Event|0|||
157173875|NCT01021813|567377540|FG003|DB Treatment Phase|Adverse Event|0|||
157173876|NCT01021813|567377541|FG004|DB Treatment Phase|Adverse Event|0|||
157173877|NCT01021813|567377537|FG000|DB Treatment Phase|Lack of Efficacy|44|||
157173878|NCT01021813|567377538|FG001|DB Treatment Phase|Lack of Efficacy|28|||
157173879|NCT01021813|567377539|FG002|DB Treatment Phase|Lack of Efficacy|0|||
157173880|NCT01021813|567377540|FG003|DB Treatment Phase|Lack of Efficacy|0|||
157173881|NCT01021813|567377541|FG004|DB Treatment Phase|Lack of Efficacy|0|||
157173882|NCT01021813|567377537|FG000|DB Treatment Phase|Lost to Follow-up|14|||
157173883|NCT01021813|567377538|FG001|DB Treatment Phase|Lost to Follow-up|12|||
157173884|NCT01021813|567377539|FG002|DB Treatment Phase|Lost to Follow-up|0|||
157173885|NCT01021813|567377540|FG003|DB Treatment Phase|Lost to Follow-up|0|||
157173886|NCT01021813|567377541|FG004|DB Treatment Phase|Lost to Follow-up|0|||
157173887|NCT01021813|567377537|FG000|DB Treatment Phase|Physician Decision|17|||
157173888|NCT01021813|567377538|FG001|DB Treatment Phase|Physician Decision|8|||
157173889|NCT01021813|567377539|FG002|DB Treatment Phase|Physician Decision|0|||
157173890|NCT01021813|567377540|FG003|DB Treatment Phase|Physician Decision|0|||
157173891|NCT01021813|567377541|FG004|DB Treatment Phase|Physician Decision|0|||
157173892|NCT01021813|567377537|FG000|DB Treatment Phase|Pregnancy|1|||
157173893|NCT01021813|567377538|FG001|DB Treatment Phase|Pregnancy|0|||
157173894|NCT01021813|567377539|FG002|DB Treatment Phase|Pregnancy|0|||
157173895|NCT01021813|567377540|FG003|DB Treatment Phase|Pregnancy|0|||
157173896|NCT01021813|567377541|FG004|DB Treatment Phase|Pregnancy|0|||
157173897|NCT01021813|567377537|FG000|DB Treatment Phase|Protocol Violation|4|||
157173898|NCT01021813|567377538|FG001|DB Treatment Phase|Protocol Violation|3|||
157042636|NCT00676091|566910233|FG001|After Infant Series|Protocol Violation|1|||
157042637|NCT00676091|566910232|FG000|After Infant Series|Failed to return|1|||
157042638|NCT00676091|566910233|FG001|After Infant Series|Failed to return|1|||
157042639|NCT00676091|566910232|FG000|Toddler Dose|Failed to return|2|||
157042640|NCT00676091|566910233|FG001|Toddler Dose|Failed to return|0|||
157042641|NCT00676091|566910232|FG000|Toddler Dose|Parent or legal guardian request|1|||
157042642|NCT00676091|566910233|FG001|Toddler Dose|Parent or legal guardian request|0|||
157042643|NCT00914966|566910239|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
157042644|NCT00914966|566910239|FG000|Step 1: 1500 Units|Physician Decision|1|||
157042645|NCT00914966|566910239|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
157042646|NCT01701401|566910240|FG000|Overall Study|Randomized But Not Treated|3|||
157042647|NCT01701401|566910241|FG001|Overall Study|Randomized But Not Treated|1|||
157042648|NCT01701401|566910242|FG002|Overall Study|Randomized But Not Treated|0|||
157042649|NCT01701401|566910243|FG003|Overall Study|Randomized But Not Treated|1|||
157042650|NCT01701401|566910240|FG000|Overall Study|Lost to Follow-up|5|||
157042651|NCT01701401|566910241|FG001|Overall Study|Lost to Follow-up|5|||
157042652|NCT01701401|566910242|FG002|Overall Study|Lost to Follow-up|1|||
157042653|NCT01701401|566910243|FG003|Overall Study|Lost to Follow-up|3|||
157042654|NCT01701401|566910240|FG000|Overall Study|Withdrew Consent|0|||
157042655|NCT01701401|566910241|FG001|Overall Study|Withdrew Consent|3|||
157042656|NCT01701401|566910242|FG002|Overall Study|Withdrew Consent|1|||
157042657|NCT01701401|566910243|FG003|Overall Study|Withdrew Consent|2|||
157042658|NCT01701401|566910240|FG000|Overall Study|Lack of Efficacy|1|||
157042659|NCT01701401|566910241|FG001|Overall Study|Lack of Efficacy|0|||
157042660|NCT01701401|566910242|FG002|Overall Study|Lack of Efficacy|2|||
157042661|NCT01701401|566910243|FG003|Overall Study|Lack of Efficacy|0|||
157042662|NCT01701401|566910240|FG000|Overall Study|Adverse Event|1|||
157042663|NCT01701401|566910241|FG001|Overall Study|Adverse Event|0|||
157042664|NCT01701401|566910242|FG002|Overall Study|Adverse Event|0|||
157042665|NCT01701401|566910243|FG003|Overall Study|Adverse Event|0|||
157042666|NCT01701401|566910240|FG000|Overall Study|Protocol Violation|0|||
157042667|NCT01701401|566910241|FG001|Overall Study|Protocol Violation|0|||
157042668|NCT01701401|566910242|FG002|Overall Study|Protocol Violation|1|||
157042669|NCT01701401|566910243|FG003|Overall Study|Protocol Violation|0|||
157042670|NCT04762277|566910247|FG000|Overall Study|Withdrawal by Subject|0|||
157042671|NCT04762277|566910248|FG001|Overall Study|Withdrawal by Subject|2|||
157042672|NCT04762277|566910247|FG000|Overall Study|Protocol Violation|0|||
157042673|NCT04762277|566910248|FG001|Overall Study|Protocol Violation|1|||
157042674|NCT04762277|566910247|FG000|Overall Study|Adverse Event|1|||
157042675|NCT04762277|566910248|FG001|Overall Study|Adverse Event|0|||
157042676|NCT04701203|566910255|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
157042677|NCT04701203|566910256|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
157042678|NCT04701203|566910257|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
157042679|NCT04701203|566910255|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
157042680|NCT04701203|566910256|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
157042681|NCT04701203|566910257|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
157042682|NCT04701203|566910255|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
157042683|NCT04701203|566910256|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
157042684|NCT04701203|566910257|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
157042685|NCT04701203|566910255|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
157042686|NCT04701203|566910256|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
157042687|NCT04701203|566910257|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
157173899|NCT01021813|567377539|FG002|DB Treatment Phase|Protocol Violation|0|||
157173900|NCT01021813|567377540|FG003|DB Treatment Phase|Protocol Violation|0|||
157173901|NCT01021813|567377541|FG004|DB Treatment Phase|Protocol Violation|0|||
157173902|NCT01021813|567377537|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
157173903|NCT01021813|567377538|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
157173904|NCT01021813|567377539|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
157173905|NCT01021813|567377540|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
157173906|NCT01021813|567377541|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
157173907|NCT01021813|567377537|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
157173908|NCT01021813|567377538|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
157173909|NCT01021813|567377539|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
157173910|NCT01021813|567377540|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
157173911|NCT01021813|567377541|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
157173912|NCT01021813|567377537|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
157173913|NCT01021813|567377538|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
157173914|NCT01021813|567377539|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
157228563|NCT00920140|567583287|FG000|Phase 2|Physician Decision|0|||
157042688|NCT02434328|566910258|FG000|Overall Study|Adverse Event|9|||
157042689|NCT02434328|566910259|FG001|Overall Study|Adverse Event|4|||
157042690|NCT02434328|566910258|FG000|Overall Study|Lack of Efficacy|0|||
157042691|NCT02434328|566910259|FG001|Overall Study|Lack of Efficacy|2|||
157042692|NCT02434328|566910258|FG000|Overall Study|Physician Decision|0|||
157042693|NCT02434328|566910259|FG001|Overall Study|Physician Decision|1|||
157042694|NCT02434328|566910258|FG000|Overall Study|Withdrawal by Subject|12|||
157042695|NCT02434328|566910259|FG001|Overall Study|Withdrawal by Subject|21|||
157173915|NCT01021813|567377540|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
157173916|NCT01021813|567377541|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
157173917|NCT01021813|567377537|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
157173918|NCT01021813|567377538|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
157173919|NCT01021813|567377539|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
157173920|NCT01021813|567377540|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
157173921|NCT01021813|567377541|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
157173922|NCT01021813|567377537|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
157173923|NCT01021813|567377538|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
157173924|NCT01021813|567377539|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
157173925|NCT01021813|567377540|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
157173926|NCT01021813|567377541|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
157173927|NCT01021813|567377537|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
157173928|NCT01021813|567377538|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
157173929|NCT01021813|567377539|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
157173930|NCT01021813|567377540|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
157173931|NCT01021813|567377541|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
157173932|NCT01117012|567377545|FG000|Overall Study|Adverse Event|0|||
157173933|NCT01117012|567377546|FG001|Overall Study|Adverse Event|1|||
157173934|NCT01117012|567377545|FG000|Overall Study|Death|1|||
157173935|NCT01117012|567377546|FG001|Overall Study|Death|1|||
157173936|NCT01117012|567377545|FG000|Overall Study|Withdrawal by Subject|3|||
157173937|NCT01117012|567377546|FG001|Overall Study|Withdrawal by Subject|0|||
157042696|NCT02434328|566910258|FG000|Overall Study|Death|4|||
157042697|NCT02434328|566910259|FG001|Overall Study|Death|7|||
157042698|NCT02434328|566910258|FG000|Overall Study|Lost to Follow-up|1|||
157042699|NCT02434328|566910259|FG001|Overall Study|Lost to Follow-up|6|||
157042700|NCT02434328|566910258|FG000|Overall Study|Other|4|||
157042701|NCT02434328|566910259|FG001|Overall Study|Other|1|||
157042702|NCT05293717|566910261|FG000|Overall Study|Physician Decision|1|||
157042703|NCT04323800|566911954|FG000|Overall Study|Withdrawal by Subject|4|||
157042704|NCT04323800|566911955|FG001|Overall Study|Withdrawal by Subject|4|||
157042705|NCT04323800|566911954|FG000|Overall Study|Incomplete transfusion|1|||
157042706|NCT04323800|566911955|FG001|Overall Study|Incomplete transfusion|0|||
157042707|NCT04323800|566911954|FG000|Overall Study|Other|0|||
157042708|NCT04323800|566911955|FG001|Overall Study|Other|1|||
157042709|NCT04323800|566911954|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
157042710|NCT04323800|566911955|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
157042711|NCT00489554|566911956|FG000|Overall Study|Adverse Event|2|||
157173938|NCT01117012|567377545|FG000|Overall Study|Undefined|4|||
157173939|NCT01117012|567377546|FG001|Overall Study|Undefined|3|||
157173940|NCT00673894|567377550|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
157173941|NCT00673894|567377551|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
157173942|NCT00673894|567377550|FG000|First Intervention 4 Weeks|Adverse Event|1|||
157173943|NCT00673894|567377551|FG001|First Intervention 4 Weeks|Adverse Event|0|||
157173944|NCT00326417|567377552|FG000|Overall Study|Withdrawal by Subject|0|||
157173945|NCT00326417|567377553|FG001|Overall Study|Withdrawal by Subject|0|||
157173946|NCT00326417|567377554|FG002|Overall Study|Withdrawal by Subject|1|||
157173947|NCT00326417|567377555|FG003|Overall Study|Withdrawal by Subject|0|||
157173948|NCT00326417|567377552|FG000|Overall Study|Arm Closed|7|||
157173949|NCT00326417|567377553|FG001|Overall Study|Arm Closed|0|||
157173950|NCT00326417|567377554|FG002|Overall Study|Arm Closed|0|||
157173951|NCT00326417|567377555|FG003|Overall Study|Arm Closed|3|||
157173952|NCT00326417|567377552|FG000|Overall Study|Death|7|||
157173953|NCT00326417|567377553|FG001|Overall Study|Death|0|||
157173954|NCT00326417|567377554|FG002|Overall Study|Death|0|||
157173955|NCT00326417|567377555|FG003|Overall Study|Death|0|||
157173956|NCT00844285|567377556|FG000|Overall Study|Other|0|||
157173957|NCT00844285|567377557|FG001|Overall Study|Other|1|||
157042712|NCT00489554|566911956|FG000|Overall Study|Withdrawal by Subject|1|||
157042713|NCT00489554|566911956|FG000|Overall Study|Lost to Follow-up|1|||
157042714|NCT01732757|566911957|FG000|Overall Study|Lost to Follow-up|1|||
157228564|NCT00920140|567583288|FG001|Phase 2|Physician Decision|0|||
157042715|NCT01732757|566911958|FG001|Overall Study|Lost to Follow-up|0|||
157173958|NCT00844285|567377558|FG002|Overall Study|Other|0|||
157173959|NCT00844285|567377556|FG000|Overall Study|Other than specified|95|||
157173960|NCT00844285|567377557|FG001|Overall Study|Other than specified|129|||
157173961|NCT00844285|567377558|FG002|Overall Study|Other than specified|12|||
157173962|NCT00844285|567377556|FG000|Overall Study|Site closure|256|||
157042716|NCT01732757|566911959|FG002|Overall Study|Lost to Follow-up|0|||
157042717|NCT00731692|566911960|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
157173963|NCT00844285|567377557|FG001|Overall Study|Site closure|450|||
157173964|NCT00844285|567377558|FG002|Overall Study|Site closure|50|||
157173965|NCT00844285|567377556|FG000|Overall Study|Follow-up < 8 years|16|||
157173966|NCT00844285|567377557|FG001|Overall Study|Follow-up < 8 years|23|||
157173967|NCT00844285|567377558|FG002|Overall Study|Follow-up < 8 years|4|||
157173968|NCT00844285|567377556|FG000|Overall Study|Protocol Violation|26|||
157173969|NCT00844285|567377557|FG001|Overall Study|Protocol Violation|28|||
157173970|NCT00844285|567377558|FG002|Overall Study|Protocol Violation|54|||
157173971|NCT00844285|567377556|FG000|Overall Study|Death|22|||
157173972|NCT00844285|567377557|FG001|Overall Study|Death|21|||
157173973|NCT00844285|567377558|FG002|Overall Study|Death|8|||
157173974|NCT00844285|567377556|FG000|Overall Study|Withdrew Consent|344|||
157173975|NCT00844285|567377557|FG001|Overall Study|Withdrew Consent|466|||
157173976|NCT00844285|567377558|FG002|Overall Study|Withdrew Consent|70|||
157173977|NCT00844285|567377556|FG000|Overall Study|Lost to Follow-up|330|||
157173978|NCT00844285|567377557|FG001|Overall Study|Lost to Follow-up|486|||
157173979|NCT00844285|567377558|FG002|Overall Study|Lost to Follow-up|74|||
157173980|NCT04682353|567377561|FG000|Overall Study|Lost to Follow-up|0|||
157173981|NCT04682353|567377562|FG001|Overall Study|Lost to Follow-up|1|||
157173982|NCT04682353|567377563|FG002|Overall Study|Lost to Follow-up|0|||
157173983|NCT04682353|567377564|FG003|Overall Study|Lost to Follow-up|1|||
157173984|NCT04682353|567377561|FG000|Overall Study|Personal reasons|0|||
157173985|NCT04682353|567377562|FG001|Overall Study|Personal reasons|1|||
157173986|NCT04682353|567377563|FG002|Overall Study|Personal reasons|0|||
157173987|NCT04682353|567377564|FG003|Overall Study|Personal reasons|0|||
157173988|NCT01586806|567377565|FG000|Overall Study|Protocol Violation|0|||
157173989|NCT01586806|567377566|FG001|Overall Study|Protocol Violation|1|||
157173990|NCT01586806|567377567|FG002|Overall Study|Protocol Violation|0|||
157173991|NCT01586806|567377565|FG000|Overall Study|Withdrawal by Subject|1|||
157173992|NCT01586806|567377566|FG001|Overall Study|Withdrawal by Subject|0|||
157173993|NCT01586806|567377567|FG002|Overall Study|Withdrawal by Subject|0|||
157173994|NCT01586806|567377565|FG000|Overall Study|Lost to Follow-up|2|||
157173995|NCT01586806|567377566|FG001|Overall Study|Lost to Follow-up|3|||
157173996|NCT01586806|567377567|FG002|Overall Study|Lost to Follow-up|2|||
157173997|NCT01313208|567377568|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
157173998|NCT01313208|567377569|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
157173999|NCT01313208|567377568|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
157174000|NCT01313208|567377569|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
157174001|NCT01313208|567377568|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
157174002|NCT01313208|567377569|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
157174003|NCT01313208|567377568|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
157174004|NCT01313208|567377569|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
157174005|NCT01313208|567377568|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
157174006|NCT01313208|567377569|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
157174007|NCT01313208|567377568|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
157174008|NCT01313208|567377569|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
157174009|NCT01313208|567377568|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
157174010|NCT01313208|567377569|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
157174011|NCT01313208|567377568|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
157174012|NCT01313208|567377569|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
157174013|NCT01313208|567377568|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
157174014|NCT01313208|567377569|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
157174015|NCT00187889|567377570|FG000|Overall Study|Withdrawal by Subject|6|||
157174016|NCT00187889|567377571|FG001|Overall Study|Withdrawal by Subject|4|||
157174017|NCT02671461|567377576|FG000|Treatment|Adverse Event|0|||
157174018|NCT02671461|567377577|FG001|Treatment|Adverse Event|0|||
157174019|NCT02671461|567377578|FG002|Treatment|Adverse Event|1|||
157174020|NCT02671461|567377576|FG000|Treatment|Administrative Reason by Sponsor|1|||
157174021|NCT02671461|567377577|FG001|Treatment|Administrative Reason by Sponsor|3|||
157174022|NCT02671461|567377578|FG002|Treatment|Administrative Reason by Sponsor|4|||
157174023|NCT02671461|567377576|FG000|Treatment|Randomized, not treated|1|||
157174024|NCT02671461|567377577|FG001|Treatment|Randomized, not treated|0|||
157174025|NCT02671461|567377578|FG002|Treatment|Randomized, not treated|0|||
157174026|NCT02671461|567377576|FG000|Follow-up|Withdrawal by Subject|1|||
157174027|NCT02671461|567377577|FG001|Follow-up|Withdrawal by Subject|0|||
157174028|NCT02671461|567377578|FG002|Follow-up|Withdrawal by Subject|0|||
157174029|NCT02671461|567377576|FG000|Follow-up|Lost to Follow-up|0|||
157174030|NCT02671461|567377577|FG001|Follow-up|Lost to Follow-up|0|||
157174031|NCT02671461|567377578|FG002|Follow-up|Lost to Follow-up|1|||
157174032|NCT02671461|567377576|FG000|Follow-up|Administrative Reason by Sponsor|0|||
157174033|NCT02671461|567377577|FG001|Follow-up|Administrative Reason by Sponsor|1|||
157174034|NCT02671461|567377578|FG002|Follow-up|Administrative Reason by Sponsor|0|||
157174035|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
157174036|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
157174037|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
157174038|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
157174039|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
157174040|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
157174041|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
157174042|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
157042718|NCT00731692|566911961|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
157042719|NCT00731692|566911962|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
157042720|NCT00731692|566911960|FG000|Core Study (36 Months)|Physician Decision|1|||
157042721|NCT00731692|566911961|FG001|Core Study (36 Months)|Physician Decision|0|||
157042722|NCT00731692|566911962|FG002|Core Study (36 Months)|Physician Decision|2|||
157042723|NCT00731692|566911960|FG000|Core Study (36 Months)|Death|2|||
157042724|NCT00731692|566911961|FG001|Core Study (36 Months)|Death|1|||
157042725|NCT00731692|566911962|FG002|Core Study (36 Months)|Death|2|||
157042726|NCT00731692|566911960|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
157042727|NCT00731692|566911961|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
157042728|NCT00731692|566911962|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
157042729|NCT00731692|566911960|FG000|Core Study (36 Months)|Administrative|2|||
157042730|NCT00731692|566911961|FG001|Core Study (36 Months)|Administrative|2|||
157042731|NCT00731692|566911962|FG002|Core Study (36 Months)|Administrative|6|||
157042732|NCT00731692|566911960|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
157042733|NCT00731692|566911961|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
157042734|NCT00731692|566911962|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
157042735|NCT00731692|566911960|FG000|Core Study (36 Months)|Protocol Violation|4|||
157042736|NCT00731692|566911961|FG001|Core Study (36 Months)|Protocol Violation|5|||
157042737|NCT00731692|566911962|FG002|Core Study (36 Months)|Protocol Violation|8|||
157042738|NCT00731692|566911960|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
157042739|NCT00731692|566911961|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
157042740|NCT00731692|566911962|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
157042741|NCT00731692|566911960|FG000|Core Study (36 Months)|Adverse Event|25|||
157042742|NCT00731692|566911961|FG001|Core Study (36 Months)|Adverse Event|28|||
157042743|NCT00731692|566911962|FG002|Core Study (36 Months)|Adverse Event|29|||
157042744|NCT00731692|566911960|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
157042745|NCT00731692|566911961|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
157042746|NCT00731692|566911962|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
157042747|NCT00731692|566911960|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
157042748|NCT00731692|566911961|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
157042749|NCT00731692|566911962|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
157042750|NCT00731692|566911960|FG000|Extension Phase|Abnormal test procedure|0|||
157042751|NCT00731692|566911961|FG001|Extension Phase|Abnormal test procedure|0|||
157042752|NCT00731692|566911962|FG002|Extension Phase|Abnormal test procedure|1|||
157042753|NCT00731692|566911960|FG000|Extension Phase|Abnormal lab values|0|||
157042754|NCT00731692|566911961|FG001|Extension Phase|Abnormal lab values|0|||
157042755|NCT00731692|566911962|FG002|Extension Phase|Abnormal lab values|1|||
157042756|NCT00731692|566911960|FG000|Extension Phase|Lost to Follow-up|0|||
157042757|NCT00731692|566911961|FG001|Extension Phase|Lost to Follow-up|1|||
157042758|NCT00731692|566911962|FG002|Extension Phase|Lost to Follow-up|4|||
157042759|NCT00731692|566911960|FG000|Extension Phase|Withdrawal by Subject|4|||
157042760|NCT00731692|566911961|FG001|Extension Phase|Withdrawal by Subject|5|||
157042761|NCT00731692|566911962|FG002|Extension Phase|Withdrawal by Subject|3|||
157042762|NCT00731692|566911960|FG000|Extension Phase|Adverse Event|1|||
157042763|NCT00731692|566911961|FG001|Extension Phase|Adverse Event|1|||
157042764|NCT00731692|566911962|FG002|Extension Phase|Adverse Event|15|||
157042765|NCT00747006|566911963|FG000|Overall Study|Adverse Event|1|||
157042766|NCT00747006|566911964|FG001|Overall Study|Adverse Event|0|||
157042767|NCT00747006|566911965|FG002|Overall Study|Adverse Event|0|||
157042768|NCT00747006|566911963|FG000|Overall Study|Lost to Follow-up|0|||
157042769|NCT00747006|566911964|FG001|Overall Study|Lost to Follow-up|1|||
157042770|NCT00747006|566911965|FG002|Overall Study|Lost to Follow-up|0|||
157042771|NCT00747006|566911963|FG000|Overall Study|Physician Decision|2|||
157174043|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
157174044|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
157174045|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
157174046|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
157174047|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
157174048|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
157174049|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
157042772|NCT00747006|566911964|FG001|Overall Study|Physician Decision|0|||
157174050|NCT01412060|567377579|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
157174051|NCT01412060|567377580|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
157174052|NCT01412060|567377581|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
157042773|NCT00747006|566911965|FG002|Overall Study|Physician Decision|1|||
157042774|NCT02132949|566911970|FG000|Overall Study|Death|7|||
157042775|NCT02132949|566911971|FG001|Overall Study|Death|13|||
157042776|NCT02132949|566911970|FG000|Overall Study|Lost to Follow-up|14|||
157042777|NCT02132949|566911971|FG001|Overall Study|Lost to Follow-up|4|||
157042778|NCT02132949|566911970|FG000|Overall Study|Withdrawal by Subject|6|||
157042779|NCT02132949|566911971|FG001|Overall Study|Withdrawal by Subject|5|||
157042780|NCT02132949|566911970|FG000|Overall Study|Noncompliance|5|||
157042781|NCT02132949|566911971|FG001|Overall Study|Noncompliance|1|||
157042782|NCT02132949|566911970|FG000|Overall Study|Physician Decision|3|||
157042783|NCT02132949|566911971|FG001|Overall Study|Physician Decision|1|||
157042784|NCT02132949|566911970|FG000|Overall Study|Disease Progression|3|||
157042785|NCT02132949|566911971|FG001|Overall Study|Disease Progression|0|||
157042786|NCT02132949|566911970|FG000|Overall Study|Adverse Event|2|||
157042787|NCT02132949|566911971|FG001|Overall Study|Adverse Event|1|||
157042788|NCT02132949|566911970|FG000|Overall Study|Withdrew Prior to Treatment|1|||
157042789|NCT02132949|566911971|FG001|Overall Study|Withdrew Prior to Treatment|2|||
157042790|NCT02132949|566911970|FG000|Overall Study|Reason Unspecified|0|||
157042791|NCT02132949|566911971|FG001|Overall Study|Reason Unspecified|1|||
157042792|NCT01583166|566911972|FG000|Overall Study|Withdrawal by Subject|4|||
157042793|NCT01583166|566911973|FG001|Overall Study|Withdrawal by Subject|6|||
157042794|NCT04652869|566911974|FG000|Overall Study|Withdrawal by Subject|0|||
157042795|NCT04652869|566911975|FG001|Overall Study|Withdrawal by Subject|2|||
157042796|NCT04652869|566911976|FG002|Overall Study|Withdrawal by Subject|0|||
157042797|NCT01372085|566911977|FG000|Washout Period 2|Physician Decision|0|||
157042798|NCT01372085|566911978|FG001|Washout Period 2|Physician Decision|0|||
157042799|NCT01372085|566911979|FG002|Washout Period 2|Physician Decision|0|||
157042800|NCT01372085|566911980|FG003|Washout Period 2|Physician Decision|0|||
157042801|NCT01372085|566911981|FG004|Washout Period 2|Physician Decision|1|||
157042802|NCT01372085|566911982|FG005|Washout Period 2|Physician Decision|0|||
157042803|NCT01372085|566911983|FG006|Washout Period 2|Physician Decision|0|||
157042804|NCT01372085|566911984|FG007|Washout Period 2|Physician Decision|0|||
157042805|NCT01372085|566911985|FG008|Washout Period 2|Physician Decision|0|||
157042806|NCT01372085|566911986|FG009|Washout Period 2|Physician Decision|0|||
157042807|NCT01372085|566911977|FG000|Washout Period 3|Withdrawal by Subject|0|||
157042808|NCT01372085|566911978|FG001|Washout Period 3|Withdrawal by Subject|0|||
157042809|NCT01372085|566911979|FG002|Washout Period 3|Withdrawal by Subject|0|||
157042810|NCT01372085|566911980|FG003|Washout Period 3|Withdrawal by Subject|0|||
157042811|NCT01372085|566911981|FG004|Washout Period 3|Withdrawal by Subject|0|||
157042812|NCT01372085|566911982|FG005|Washout Period 3|Withdrawal by Subject|2|||
157042813|NCT01372085|566911983|FG006|Washout Period 3|Withdrawal by Subject|0|||
157042814|NCT01372085|566911984|FG007|Washout Period 3|Withdrawal by Subject|0|||
157042815|NCT01372085|566911985|FG008|Washout Period 3|Withdrawal by Subject|0|||
157042816|NCT01372085|566911986|FG009|Washout Period 3|Withdrawal by Subject|0|||
157042817|NCT00562094|566911987|FG000|Overall Study|Lost to Follow-up|62|||
157042818|NCT03960645|566911988|FG000|Overall Study|Protocol Violation|1|||
157042819|NCT03960645|566911989|FG001|Overall Study|Protocol Violation|0|||
157042820|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
157042821|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
157042822|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
157042823|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
157042824|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
157042825|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
157042826|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
157042827|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
157042828|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
157042829|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
157042830|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
157042831|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
157042832|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
157042833|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
157042834|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
157042835|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
157042836|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
157042837|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
157042838|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
157042839|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
157042840|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
157042841|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
157042842|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
157042843|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
157174053|NCT01412060|567377579|FG000|Period Between RIP and SP|Adverse Event|4|||
157042844|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
157042845|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
157042846|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
157042847|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
157042848|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
157042849|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
157042850|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
157042851|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
157174054|NCT01412060|567377580|FG001|Period Between RIP and SP|Adverse Event|0|||
157042852|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
157042853|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
157042854|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
157042855|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
157042856|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
157042857|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
157042858|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
157042859|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
157042860|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
157042861|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
157042862|NCT03732807|566911994|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042863|NCT03732807|566911995|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042864|NCT03732807|566911996|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042865|NCT03732807|566911997|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042866|NCT03732807|566911998|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042867|NCT03732807|566911999|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
157042868|NCT03732807|566912000|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
157042869|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
157042870|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
157042871|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
157042872|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
157042873|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
157042874|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
157042875|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
157042876|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
157042877|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
157042878|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
157042879|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
157042880|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
157042881|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
157042882|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
157042883|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
157042884|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
157042885|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
157042886|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
157042887|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
157042888|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
157042889|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
157042890|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042891|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
157042892|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042893|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042894|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042895|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042896|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
157042897|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
157042898|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
157042899|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
157042900|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
157042901|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
157042902|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
157042903|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
157042904|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
157042905|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
157042906|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
157042907|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
157042908|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
157042909|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
157042910|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
157042911|NCT03732807|566911994|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
157174055|NCT01412060|567377581|FG002|Period Between RIP and SP|Adverse Event|0|||
157174056|NCT01412060|567377579|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
157174057|NCT01412060|567377580|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
157042912|NCT03732807|566911995|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
157042913|NCT03732807|566911996|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
157228565|NCT00920140|567583289|FG002|Phase 2|Physician Decision|3|||
157228566|NCT00920140|567583290|FG003|Phase 2|Physician Decision|3|||
157228567|NCT00920140|567583291|FG004|Phase 2|Physician Decision|2|||
157228568|NCT00920140|567583287|FG000|Phase 2|Withdrawal by Subject|0|||
157228569|NCT00920140|567583288|FG001|Phase 2|Withdrawal by Subject|0|||
157228570|NCT00920140|567583289|FG002|Phase 2|Withdrawal by Subject|4|||
157228571|NCT00920140|567583290|FG003|Phase 2|Withdrawal by Subject|2|||
157228572|NCT00920140|567583291|FG004|Phase 2|Withdrawal by Subject|1|||
157228573|NCT01124149|567583292|FG000|Acute Phase|Withdrawal by Subject|22|||
157228574|NCT01124149|567583292|FG000|Acute Phase|Adverse Event|21|||
157228575|NCT01124149|567583292|FG000|Acute Phase|Lack of Efficacy|17|||
157228576|NCT01124149|567583292|FG000|Acute Phase|Protocol Violation|14|||
157228577|NCT01124149|567583292|FG000|Acute Phase|Lost to Follow-up|2|||
157228578|NCT01124149|567583292|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
157228579|NCT01124149|567583292|FG000|Acute Phase|Sponsor request|1|||
157228580|NCT01124149|567583292|FG000|Acute Phase|UC symptoms not ameliorated|1|||
157228581|NCT01124149|567583292|FG000|Acute Phase|Non-compliance|1|||
157228582|NCT01124149|567583292|FG000|Acute Phase|Low hemoglobin|1|||
157228583|NCT01124149|567583292|FG000|Acute Phase|Travelling to another country|1|||
157228584|NCT01124149|567583292|FG000|Acute Phase|Sponsor decision|1|||
157228585|NCT01124149|567583292|FG000|Maintenance Phase|Lack of Efficacy|40|||
157228586|NCT01124149|567583292|FG000|Maintenance Phase|Adverse Event|24|||
157228587|NCT01124149|567583292|FG000|Maintenance Phase|Lost to Follow-up|15|||
157228588|NCT01124149|567583292|FG000|Maintenance Phase|Withdrawal by Subject|10|||
157228589|NCT01124149|567583292|FG000|Maintenance Phase|Protocol Violation|5|||
157228590|NCT01124149|567583292|FG000|Maintenance Phase|Coordinator error|1|||
157228591|NCT01124149|567583292|FG000|Maintenance Phase|Non-compliance|1|||
157228592|NCT01644500|567583293|FG000|Overall Study|Adverse Event|6|||
157228593|NCT01644500|567583294|FG001|Overall Study|Adverse Event|1|||
157228594|NCT01644500|567583295|FG002|Overall Study|Adverse Event|2|||
157228595|NCT01644500|567583293|FG000|Overall Study|Death|0|||
157228596|NCT01644500|567583294|FG001|Overall Study|Death|1|||
157228597|NCT01644500|567583295|FG002|Overall Study|Death|0|||
157228598|NCT01644500|567583293|FG000|Overall Study|Lost to Follow-up|3|||
157228599|NCT01644500|567583294|FG001|Overall Study|Lost to Follow-up|8|||
157228600|NCT01644500|567583295|FG002|Overall Study|Lost to Follow-up|0|||
157228601|NCT01644500|567583293|FG000|Overall Study|Protocol Violation|1|||
157228602|NCT01644500|567583294|FG001|Overall Study|Protocol Violation|1|||
157228603|NCT01644500|567583295|FG002|Overall Study|Protocol Violation|0|||
157228604|NCT01644500|567583293|FG000|Overall Study|Withdrawal by Subject|11|||
157228605|NCT01644500|567583294|FG001|Overall Study|Withdrawal by Subject|12|||
157228606|NCT01644500|567583295|FG002|Overall Study|Withdrawal by Subject|12|||
157228607|NCT01644500|567583293|FG000|Overall Study|Physician Decision|1|||
157228608|NCT01644500|567583294|FG001|Overall Study|Physician Decision|1|||
157228609|NCT01644500|567583295|FG002|Overall Study|Physician Decision|1|||
157228610|NCT00322491|567583299|FG000|Overall Study|Adverse Event|1|||
157228611|NCT00322491|567583300|FG001|Overall Study|Adverse Event|0|||
157228612|NCT00322491|567583299|FG000|Overall Study|Death|1|||
157228613|NCT00322491|567583300|FG001|Overall Study|Death|2|||
157042914|NCT03732807|566911997|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
157042915|NCT03732807|566911998|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
157042916|NCT03732807|566911999|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
157042917|NCT03732807|566912000|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
157042918|NCT03737110|566912001|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
157042919|NCT03737110|566912002|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
157042920|NCT03737110|566912003|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
157042921|NCT03737110|566912004|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
157042922|NCT03737110|566912005|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
157042923|NCT03737110|566912006|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
157042924|NCT03737110|566912001|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
157042925|NCT03737110|566912002|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
157228614|NCT01400425|567583301|FG000|Overall Study|Withdrawal by Subject|10|||
157228615|NCT00688064|567583302|FG000|Overall Study|Protocol Violation|0|||
157228616|NCT00688064|567583303|FG001|Overall Study|Protocol Violation|1|||
157228617|NCT00688064|567583302|FG000|Overall Study|Adverse Event|2|||
157228618|NCT00688064|567583303|FG001|Overall Study|Adverse Event|4|||
157228619|NCT00688064|567583302|FG000|Overall Study|Withdrawal by Subject|7|||
157042926|NCT03737110|566912003|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
157228620|NCT00688064|567583303|FG001|Overall Study|Withdrawal by Subject|7|||
157228621|NCT00688064|567583302|FG000|Overall Study|Lost to Follow-up|10|||
157228622|NCT00688064|567583303|FG001|Overall Study|Lost to Follow-up|10|||
157228623|NCT00688064|567583302|FG000|Overall Study|Lack of Efficacy|0|||
157228624|NCT00688064|567583303|FG001|Overall Study|Lack of Efficacy|1|||
157228625|NCT00688064|567583302|FG000|Overall Study|Pregnancy|1|||
157228626|NCT00688064|567583303|FG001|Overall Study|Pregnancy|0|||
157228627|NCT00688064|567583302|FG000|Overall Study|Any other reasons|1|||
157228628|NCT00688064|567583303|FG001|Overall Study|Any other reasons|3|||
157228629|NCT00720096|567583306|FG000|Overall Study|Withdrawal by Subject|0|||
157042927|NCT03737110|566912004|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
157042928|NCT03737110|566912005|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
157042929|NCT03737110|566912006|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
157042930|NCT03737110|566912001|FG000|Run-in (RI) Period|Adverse Event|4|||
157042931|NCT03737110|566912002|FG001|Run-in (RI) Period|Adverse Event|0|||
157042932|NCT03737110|566912003|FG002|Run-in (RI) Period|Adverse Event|0|||
157042933|NCT03737110|566912004|FG003|Run-in (RI) Period|Adverse Event|0|||
157042934|NCT03737110|566912005|FG004|Run-in (RI) Period|Adverse Event|0|||
157042935|NCT03737110|566912006|FG005|Run-in (RI) Period|Adverse Event|0|||
157042936|NCT03737110|566912001|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
157042937|NCT03737110|566912002|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
157042938|NCT03737110|566912003|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
157042939|NCT03737110|566912004|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
157042940|NCT03737110|566912005|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
156968596|NCT00861614|566637613|FG001|Overall Study|Other|22|||
156968597|NCT01255592|566637614|FG000|Overall Study|Adverse Event|5|||
156968598|NCT01255592|566637615|FG001|Overall Study|Adverse Event|0|||
156968599|NCT01255592|566637614|FG000|Overall Study|Withdrawal by Subject|1|||
157042941|NCT03737110|566912006|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
157042942|NCT03737110|566912001|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157042943|NCT03737110|566912002|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157042944|NCT03737110|566912003|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
157042945|NCT03737110|566912004|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157042946|NCT03737110|566912005|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157042947|NCT03737110|566912006|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157174058|NCT01412060|567377581|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
157174059|NCT01412060|567377579|FG000|Period Between RIP and SP|Protocol Violation|2|||
157174060|NCT01412060|567377580|FG001|Period Between RIP and SP|Protocol Violation|0|||
157174061|NCT01412060|567377581|FG002|Period Between RIP and SP|Protocol Violation|0|||
157174062|NCT01412060|567377579|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
157174063|NCT01412060|567377580|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
157174064|NCT01412060|567377581|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
157174065|NCT01412060|567377579|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
157174066|NCT01412060|567377580|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
157174067|NCT01412060|567377581|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
157174068|NCT01412060|567377579|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
157174069|NCT01412060|567377580|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
157174070|NCT01412060|567377581|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
157174071|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
157174072|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
157174073|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
157174074|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
156968600|NCT01255592|566637615|FG001|Overall Study|Withdrawal by Subject|0|||
156968601|NCT01255592|566637614|FG000|Overall Study|Other|0|||
156968602|NCT01255592|566637615|FG001|Overall Study|Other|1|||
156968603|NCT02259517|566637616|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
156968604|NCT02259517|566637617|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
156968605|NCT02259517|566637618|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
156968606|NCT02259517|566637616|FG000|Overall Study|Withdrawal by Subject|0|||
156968607|NCT02259517|566637617|FG001|Overall Study|Withdrawal by Subject|0|||
156968608|NCT02259517|566637618|FG002|Overall Study|Withdrawal by Subject|3|||
156968609|NCT02364180|566637623|FG000|Overall Study|Screen Fail|1|||
156968610|NCT02323646|566637624|FG000|Treatment Course 1|Adverse Event|1|||
156968611|NCT02323646|566637625|FG001|Treatment Course 1|Adverse Event|0|||
156968612|NCT02323646|566637626|FG002|Treatment Course 1|Adverse Event|1|||
156968613|NCT02323646|566637624|FG000|Treatment Course 1|Heavy Bleeding|1|||
156968614|NCT02323646|566637625|FG001|Treatment Course 1|Heavy Bleeding|1|||
156968615|NCT02323646|566637626|FG002|Treatment Course 1|Heavy Bleeding|0|||
156968616|NCT02323646|566637624|FG000|Treatment Course 1|Lost to Follow-up|1|||
156968617|NCT02323646|566637625|FG001|Treatment Course 1|Lost to Follow-up|0|||
156968618|NCT02323646|566637626|FG002|Treatment Course 1|Lost to Follow-up|2|||
156968619|NCT02323646|566637624|FG000|Treatment Course 1|Withdrawal by Subject|0|||
156968620|NCT02323646|566637625|FG001|Treatment Course 1|Withdrawal by Subject|2|||
156968621|NCT02323646|566637626|FG002|Treatment Course 1|Withdrawal by Subject|0|||
156968622|NCT02323646|566637624|FG000|Treatment Course 2|Adverse Event|1|||
156968623|NCT02323646|566637625|FG001|Treatment Course 2|Adverse Event|0|||
156968624|NCT02323646|566637626|FG002|Treatment Course 2|Adverse Event|1|||
156968625|NCT02323646|566637624|FG000|Treatment Course 2|Lost to Follow-up|0|||
156968626|NCT02323646|566637625|FG001|Treatment Course 2|Lost to Follow-up|0|||
156968627|NCT02323646|566637626|FG002|Treatment Course 2|Lost to Follow-up|1|||
157042948|NCT03737110|566912001|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157042949|NCT03737110|566912002|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157042950|NCT03737110|566912003|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157042951|NCT03737110|566912004|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
157042952|NCT03737110|566912005|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157042953|NCT03737110|566912006|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
157042954|NCT03737110|566912001|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
157042955|NCT03737110|566912002|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
157042956|NCT03737110|566912003|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
157042957|NCT03737110|566912004|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
157042958|NCT03737110|566912005|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
157042959|NCT03737110|566912006|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
157042960|NCT03737110|566912001|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
157042961|NCT03737110|566912002|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
157042962|NCT03737110|566912003|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
157042963|NCT03737110|566912004|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
157042964|NCT03737110|566912005|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
157042965|NCT03737110|566912006|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
157042966|NCT00599196|566912011|FG000|Overall Study|Lack of Efficacy|22|||
157042967|NCT00599196|566912011|FG000|Overall Study|Adverse Event|93|||
157042968|NCT00599196|566912011|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
157042969|NCT00599196|566912011|FG000|Overall Study|Subject withdrew consent|43|||
157042970|NCT00599196|566912011|FG000|Overall Study|Study ended per sponsor|197|||
157042971|NCT00599196|566912011|FG000|Overall Study|Lost to Follow-up|17|||
157042972|NCT00599196|566912011|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
157042973|NCT00599196|566912011|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
157042974|NCT00599196|566912011|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
157042975|NCT00599196|566912011|FG000|Overall Study|Other: Pt Moved To Australia|1|||
157042976|NCT00599196|566912011|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
157042977|NCT00599196|566912011|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
157042978|NCT01009645|566912012|FG000|Overall Study|Lost to Follow-up|2|||
157042979|NCT01009645|566912013|FG001|Overall Study|Lost to Follow-up|8|||
157042980|NCT01009645|566912014|FG002|Overall Study|Lost to Follow-up|4|||
157042981|NCT01009645|566912015|FG003|Overall Study|Lost to Follow-up|5|||
157042982|NCT01079806|566912020|FG000|Day 1 to Week 96|Adverse Event|0|||
157042983|NCT01079806|566912021|FG001|Day 1 to Week 96|Adverse Event|3|||
157042984|NCT01079806|566912020|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
157042985|NCT01079806|566912021|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
157042986|NCT01079806|566912020|FG000|Day 1 to Week 96|Pregnancy|0|||
157042987|NCT01079806|566912021|FG001|Day 1 to Week 96|Pregnancy|1|||
157042988|NCT01079806|566912020|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
157042989|NCT01079806|566912021|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
157042990|NCT01079806|566912020|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
157042991|NCT01079806|566912021|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
157042992|NCT01079806|566912020|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
157042993|NCT01079806|566912021|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
157042994|NCT01079806|566912020|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
157042995|NCT01079806|566912021|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
157042996|NCT01079806|566912020|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
157042997|NCT01079806|566912021|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
157042998|NCT01079806|566912020|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
157042999|NCT01079806|566912021|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
157043000|NCT01079806|566912020|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
157043001|NCT01079806|566912021|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
157043002|NCT02788981|566912022|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
157043003|NCT02788981|566912023|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
157043004|NCT02384382|566912027|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
157043005|NCT02384382|566912027|FG000|Overall Study|Death|1|||
157228630|NCT00720096|567583307|FG001|Overall Study|Withdrawal by Subject|2|||
157228631|NCT00524459|567583311|FG000|Overall Study|Withdrawal by Subject|1|||
157043006|NCT02384382|566912027|FG000|Overall Study|Adverse Event|1|||
157043007|NCT02384382|566912027|FG000|Overall Study|Disease progression|16|||
157228632|NCT00524459|567583311|FG000|Overall Study|Other|1|||
157043008|NCT01822756|566912030|FG000|Overall Study|Adverse Event|0|||
157043009|NCT01822756|566912031|FG001|Overall Study|Adverse Event|0|||
157043010|NCT01822756|566912032|FG002|Overall Study|Adverse Event|0|||
157043011|NCT01822756|566912033|FG003|Overall Study|Adverse Event|2|||
157043012|NCT01822756|566912034|FG004|Overall Study|Adverse Event|0|||
157043013|NCT01822756|566912030|FG000|Overall Study|Disease progression|11|||
157043014|NCT01822756|566912031|FG001|Overall Study|Disease progression|1|||
157043015|NCT01822756|566912032|FG002|Overall Study|Disease progression|7|||
157228633|NCT03127137|567583312|FG000|Overall Study|Requested sedation after consent|1|||
157228634|NCT03127137|567583313|FG001|Overall Study|Requested sedation after consent|0|||
157228635|NCT03127137|567583312|FG000|Overall Study|Malfunction in electronic data collection|1|||
157228636|NCT03127137|567583313|FG001|Overall Study|Malfunction in electronic data collection|0|||
157228637|NCT03127137|567583312|FG000|Overall Study|Post procedure testing could not be obtained|0|||
157228638|NCT03127137|567583313|FG001|Overall Study|Post procedure testing could not be obtained|1|||
157228639|NCT04424407|567583314|FG000|Overall Study|Withdrawal by Subject|2|||
157228640|NCT04424407|567583314|FG000|Overall Study|Lost to Follow-up|1|||
157228641|NCT01574248|567583317|FG000|Overall Study|Withdrawal by Subject|2|||
157228642|NCT01574248|567583318|FG001|Overall Study|Withdrawal by Subject|0|||
157228643|NCT01574248|567583317|FG000|Overall Study|Missing primary endpoint data|1|||
157228644|NCT01574248|567583318|FG001|Overall Study|Missing primary endpoint data|0|||
157228645|NCT01458405|567583321|FG000|Phase 1 (up to 12 Months)|Other|0|||
157228646|NCT01458405|567583322|FG001|Phase 1 (up to 12 Months)|Other|1|||
157228647|NCT01458405|567583323|FG002|Phase 1 (up to 12 Months)|Other|0|||
157228648|NCT01458405|567583324|FG003|Phase 1 (up to 12 Months)|Other|0|||
157228649|NCT01458405|567583321|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
157228650|NCT01458405|567583322|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
157228651|NCT01458405|567583323|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
157228652|NCT01458405|567583324|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
157228653|NCT01458405|567583321|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
157228654|NCT01458405|567583322|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
157228655|NCT01458405|567583323|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
157228656|NCT01458405|567583324|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
157228657|NCT01458405|567583321|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
157228658|NCT01458405|567583322|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
157228659|NCT01458405|567583323|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
157228660|NCT01458405|567583324|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
157228661|NCT02497781|567583327|FG000|Overall Study|Withdrawal by Subject|2|||
157228662|NCT02497781|567583328|FG001|Overall Study|Withdrawal by Subject|0|||
157228663|NCT02497781|567583327|FG000|Overall Study|Lack of Efficacy|0|||
157228664|NCT02497781|567583328|FG001|Overall Study|Lack of Efficacy|1|||
157228665|NCT02497781|567583327|FG000|Overall Study|Randomised but not treated|1|||
157228666|NCT02497781|567583328|FG001|Overall Study|Randomised but not treated|1|||
157228667|NCT02497781|567583327|FG000|Overall Study|Lost to Follow-up|1|||
157228668|NCT02497781|567583328|FG001|Overall Study|Lost to Follow-up|1|||
157228669|NCT01193608|567583329|FG000|Overall Study|Other|0|||
157228670|NCT01193608|567583330|FG001|Overall Study|Other|1|||
157228671|NCT01193608|567583331|FG002|Overall Study|Other|0|||
157228672|NCT01193608|567583332|FG003|Overall Study|Other|0|||
157228673|NCT01193608|567583333|FG004|Overall Study|Other|0|||
157228674|NCT01193608|567583334|FG005|Overall Study|Other|0|||
157228675|NCT01193608|567583329|FG000|Overall Study|Withdrawal by Subject|0|||
157228676|NCT01193608|567583330|FG001|Overall Study|Withdrawal by Subject|1|||
157228677|NCT01193608|567583331|FG002|Overall Study|Withdrawal by Subject|2|||
157043016|NCT01822756|566912033|FG003|Overall Study|Disease progression|2|||
157043017|NCT01822756|566912034|FG004|Overall Study|Disease progression|6|||
157043018|NCT01822756|566912030|FG000|Overall Study|Death|2|||
157043019|NCT01822756|566912031|FG001|Overall Study|Death|2|||
157043020|NCT01822756|566912032|FG002|Overall Study|Death|1|||
157043021|NCT01822756|566912033|FG003|Overall Study|Death|0|||
157043022|NCT01822756|566912034|FG004|Overall Study|Death|0|||
157043023|NCT01822756|566912030|FG000|Overall Study|Lost to Follow-up|1|||
157043024|NCT01822756|566912031|FG001|Overall Study|Lost to Follow-up|0|||
157043025|NCT01822756|566912032|FG002|Overall Study|Lost to Follow-up|1|||
157043026|NCT01822756|566912033|FG003|Overall Study|Lost to Follow-up|0|||
157043027|NCT01822756|566912034|FG004|Overall Study|Lost to Follow-up|1|||
157228678|NCT01193608|567583332|FG003|Overall Study|Withdrawal by Subject|3|||
157228679|NCT01193608|567583333|FG004|Overall Study|Withdrawal by Subject|3|||
157228680|NCT01193608|567583334|FG005|Overall Study|Withdrawal by Subject|0|||
157043028|NCT01822756|566912030|FG000|Overall Study|Physician Decision|0|||
157228681|NCT01193608|567583329|FG000|Overall Study|Lost to Follow-up|0|||
157043029|NCT01822756|566912031|FG001|Overall Study|Physician Decision|1|||
157043030|NCT01822756|566912032|FG002|Overall Study|Physician Decision|0|||
157043031|NCT01822756|566912033|FG003|Overall Study|Physician Decision|0|||
157043032|NCT01822756|566912034|FG004|Overall Study|Physician Decision|0|||
157043033|NCT01822756|566912030|FG000|Overall Study|disease progression & patient preference|2|||
157043034|NCT01822756|566912031|FG001|Overall Study|disease progression & patient preference|0|||
157228682|NCT01193608|567583330|FG001|Overall Study|Lost to Follow-up|0|||
157228683|NCT01193608|567583331|FG002|Overall Study|Lost to Follow-up|0|||
157043035|NCT01822756|566912032|FG002|Overall Study|disease progression & patient preference|1|||
157228684|NCT01193608|567583332|FG003|Overall Study|Lost to Follow-up|0|||
157228685|NCT01193608|567583333|FG004|Overall Study|Lost to Follow-up|1|||
157043036|NCT01822756|566912033|FG003|Overall Study|disease progression & patient preference|0|||
157043037|NCT01822756|566912034|FG004|Overall Study|disease progression & patient preference|0|||
157043038|NCT02630966|566912035|FG000|Overall Study|Adverse Event|1|||
157043039|NCT02630966|566912036|FG001|Overall Study|Adverse Event|3|||
157043040|NCT02630966|566912035|FG000|Overall Study|Significant Protocol Deviation|0|||
157043041|NCT02630966|566912036|FG001|Overall Study|Significant Protocol Deviation|2|||
157043042|NCT02630966|566912035|FG000|Overall Study|Voluntary Withdrawal|1|||
157043043|NCT02630966|566912036|FG001|Overall Study|Voluntary Withdrawal|1|||
157043044|NCT02630966|566912035|FG000|Overall Study|Lack of Efficacy|0|||
157043045|NCT02630966|566912036|FG001|Overall Study|Lack of Efficacy|2|||
157043046|NCT00665392|566912037|FG000|Overall Study|not treated|1|||
157043047|NCT00243867|566912043|FG000|Overall Study|Adverse Event|24|||
157043048|NCT00243867|566912044|FG001|Overall Study|Adverse Event|34|||
157043049|NCT00243867|566912043|FG000|Overall Study|Lack of Efficacy|115|||
157043050|NCT00243867|566912044|FG001|Overall Study|Lack of Efficacy|78|||
157043051|NCT00243867|566912043|FG000|Overall Study|Withdrawal by Subject|11|||
157043052|NCT00243867|566912044|FG001|Overall Study|Withdrawal by Subject|23|||
157043053|NCT00243867|566912043|FG000|Overall Study|Lost to Follow-up|2|||
157043054|NCT00243867|566912044|FG001|Overall Study|Lost to Follow-up|1|||
157043055|NCT00243867|566912043|FG000|Overall Study|Physician Decision|2|||
157043056|NCT00243867|566912044|FG001|Overall Study|Physician Decision|7|||
157043057|NCT00243867|566912043|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
157043058|NCT00243867|566912044|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
157043059|NCT03389802|566912056|FG000|Overall Study|Lack of Efficacy|3|||
157043060|NCT03389802|566912057|FG001|Overall Study|Lack of Efficacy|3|||
157043061|NCT03389802|566912058|FG002|Overall Study|Lack of Efficacy|13|||
157043062|NCT03389802|566912059|FG003|Overall Study|Lack of Efficacy|6|||
157043063|NCT03389802|566912060|FG004|Overall Study|Lack of Efficacy|1|||
157043064|NCT03389802|566912056|FG000|Overall Study|Adverse Event|0|||
157043065|NCT03389802|566912057|FG001|Overall Study|Adverse Event|0|||
157043066|NCT03389802|566912058|FG002|Overall Study|Adverse Event|1|||
157043067|NCT03389802|566912059|FG003|Overall Study|Adverse Event|0|||
157043068|NCT03389802|566912060|FG004|Overall Study|Adverse Event|4|||
157043069|NCT03389802|566912056|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
157043070|NCT03389802|566912057|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
157043071|NCT03389802|566912058|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
157043072|NCT03389802|566912059|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
157043073|NCT03389802|566912060|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
157043074|NCT02426138|566912061|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
157043075|NCT02426138|566912062|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
157043076|NCT04677738|566912063|FG000|Overall Study|Withdrawal by Subject|4|||
157043077|NCT04677738|566912064|FG001|Overall Study|Withdrawal by Subject|2|||
157043078|NCT01683409|566912070|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
157043079|NCT01683409|566912071|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
157043080|NCT01683409|566912072|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
157043081|NCT01683409|566912073|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
157043082|NCT01683409|566912074|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
157043083|NCT01683409|566912070|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
157043084|NCT01683409|566912071|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
157043085|NCT01683409|566912072|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
157043086|NCT01683409|566912073|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
157043087|NCT01683409|566912074|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
157043088|NCT01683409|566912070|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
157043089|NCT01683409|566912071|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
157043090|NCT01683409|566912072|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
157043091|NCT01683409|566912073|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
157043092|NCT01683409|566912074|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
157043093|NCT01683409|566912070|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
157043094|NCT01683409|566912071|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
157043095|NCT01683409|566912072|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
157043096|NCT01683409|566912073|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
157043097|NCT01683409|566912074|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
157043098|NCT01683409|566912070|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
157043099|NCT01683409|566912071|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
157043100|NCT01683409|566912072|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
157043101|NCT01683409|566912073|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
157043102|NCT01683409|566912074|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
157043103|NCT01683409|566912070|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
157043104|NCT01683409|566912071|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
157043105|NCT01683409|566912072|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
157043106|NCT01683409|566912073|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
157043107|NCT01683409|566912074|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
157043108|NCT01683409|566912070|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
157228686|NCT01193608|567583334|FG005|Overall Study|Lost to Follow-up|2|||
157043109|NCT01683409|566912071|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
157043110|NCT01683409|566912072|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
157043111|NCT01683409|566912073|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
157043112|NCT01683409|566912074|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
157043113|NCT01683409|566912070|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
157043114|NCT01683409|566912071|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
157043115|NCT01683409|566912072|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
157043116|NCT01683409|566912073|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
157043117|NCT01683409|566912074|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
157043118|NCT01683409|566912070|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
157043119|NCT01683409|566912071|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
157043120|NCT01683409|566912072|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
157043121|NCT01683409|566912073|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
157043122|NCT01683409|566912074|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
157043123|NCT01683409|566912070|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
157043124|NCT01683409|566912071|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
157043125|NCT01683409|566912072|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
157043126|NCT01683409|566912073|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
157043127|NCT01683409|566912074|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
157043128|NCT01683409|566912070|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
157043129|NCT01683409|566912071|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
157043130|NCT01683409|566912072|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
157043131|NCT01683409|566912073|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
157043132|NCT01683409|566912074|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
157043133|NCT00553332|566912076|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
157043134|NCT00467272|566912083|FG000|Overall Study|Pneumonia|2|||
157043135|NCT00467272|566912083|FG000|Overall Study|Thrombophlebitis|1|||
157043136|NCT04745676|566912086|FG000|Overall Study|Death|1|||
157043137|NCT04745676|566912087|FG001|Overall Study|Death|0|||
157043138|NCT04745676|566912088|FG002|Overall Study|Death|0|||
157043139|NCT00989196|566912089|FG000|Treatment Period|Lost to Follow-up|1|||
157043140|NCT00989196|566912090|FG001|Treatment Period|Lost to Follow-up|0|||
157043141|NCT05824559|566912091|FG000|Overall Study|Adverse Event|2|||
157043142|NCT05824559|566912091|FG000|Overall Study|Physician Decision|2|||
157043143|NCT05824559|566912091|FG000|Overall Study|Progressive Disease|16|||
157043144|NCT05824559|566912091|FG000|Overall Study|Study Terminated by Sponsor|1|||
157043145|NCT05824559|566912091|FG000|Overall Study|Withdrawal by Subject|2|||
157043146|NCT01690624|566912092|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
157043147|NCT01690624|566912093|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
157043148|NCT01690624|566912094|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
157043149|NCT01690624|566912095|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
157043150|NCT01690624|566912092|FG000|Overall Study|Adverse event (other than DLT)|3|||
157043151|NCT01690624|566912093|FG001|Overall Study|Adverse event (other than DLT)|1|||
157043152|NCT01690624|566912094|FG002|Overall Study|Adverse event (other than DLT)|1|||
157043153|NCT01690624|566912095|FG003|Overall Study|Adverse event (other than DLT)|1|||
157043154|NCT01690624|566912092|FG000|Overall Study|Withdrawal by Subject|0|||
157043155|NCT01690624|566912093|FG001|Overall Study|Withdrawal by Subject|0|||
157043156|NCT01690624|566912094|FG002|Overall Study|Withdrawal by Subject|1|||
157043157|NCT01690624|566912095|FG003|Overall Study|Withdrawal by Subject|0|||
157043158|NCT01690624|566912092|FG000|Overall Study|Sponsor is ending trial|0|||
157043159|NCT01690624|566912093|FG001|Overall Study|Sponsor is ending trial|0|||
157043160|NCT01690624|566912094|FG002|Overall Study|Sponsor is ending trial|0|||
157043161|NCT01690624|566912095|FG003|Overall Study|Sponsor is ending trial|1|||
157043162|NCT01690624|566912092|FG000|Overall Study|Physician Decision|0|||
157043163|NCT01690624|566912093|FG001|Overall Study|Physician Decision|0|||
157043164|NCT01690624|566912094|FG002|Overall Study|Physician Decision|0|||
157043165|NCT01690624|566912095|FG003|Overall Study|Physician Decision|1|||
157043166|NCT01690624|566912092|FG000|Overall Study|Withdrawal by Subject|0|||
157043167|NCT01690624|566912093|FG001|Overall Study|Withdrawal by Subject|1|||
157043168|NCT01690624|566912094|FG002|Overall Study|Withdrawal by Subject|0|||
157043169|NCT01690624|566912095|FG003|Overall Study|Withdrawal by Subject|0|||
157043170|NCT01690624|566912092|FG000|Overall Study|Lack of Efficacy|1|||
157043171|NCT01690624|566912093|FG001|Overall Study|Lack of Efficacy|1|||
157043172|NCT01690624|566912094|FG002|Overall Study|Lack of Efficacy|3|||
157043173|NCT01690624|566912095|FG003|Overall Study|Lack of Efficacy|0|||
157043174|NCT04445831|566912096|FG000|Overall Study|Withdrawal by Subject|2|||
157043175|NCT04445831|566912097|FG001|Overall Study|Withdrawal by Subject|1|||
157043176|NCT04445831|566912098|FG002|Overall Study|Withdrawal by Subject|1|||
157228687|NCT01193608|567583329|FG000|Overall Study|Adverse Event|0|||
157043177|NCT04445831|566912099|FG003|Overall Study|Withdrawal by Subject|0|||
157043178|NCT04445831|566912100|FG004|Overall Study|Withdrawal by Subject|0|||
157043179|NCT04445831|566912101|FG005|Overall Study|Withdrawal by Subject|0|||
157043180|NCT04445831|566912102|FG006|Overall Study|Withdrawal by Subject|0|||
157228688|NCT01193608|567583330|FG001|Overall Study|Adverse Event|0|||
157174075|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
157174076|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
157174077|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
157174078|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
157174079|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
157174080|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
157174081|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
157174082|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
157174083|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
157174084|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
157174085|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
157174086|NCT01412060|567377579|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
157174087|NCT01412060|567377580|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
157174088|NCT01412060|567377581|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
157174089|NCT01412060|567377579|FG000|Period Between SP and DBP|Protocol Violation|2|||
157174090|NCT01412060|567377580|FG001|Period Between SP and DBP|Protocol Violation|0|||
157174091|NCT01412060|567377581|FG002|Period Between SP and DBP|Protocol Violation|0|||
157174092|NCT01412060|567377579|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
157174093|NCT01412060|567377580|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
157174094|NCT01412060|567377581|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
157174095|NCT01412060|567377579|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
157174096|NCT01412060|567377580|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
157174097|NCT01412060|567377581|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
157174098|NCT01412060|567377579|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
157174099|NCT01412060|567377580|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
157174100|NCT01412060|567377581|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
157174101|NCT01412060|567377579|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
157174102|NCT01412060|567377580|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
157174103|NCT01412060|567377581|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
157174104|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
157174105|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
157174106|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
157174107|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
157174108|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
157174109|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
157174110|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
157174111|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
157174112|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
157174113|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
157174114|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
157174115|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
157174116|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
157174117|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
157174118|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
157174119|NCT01412060|567377579|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
157174120|NCT01412060|567377580|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
157174121|NCT01412060|567377581|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
157174122|NCT00004732|567377582|FG000|Overall Study|Withdrawal by Subject|36|||
157174123|NCT00004732|567377583|FG001|Overall Study|Withdrawal by Subject|64|||
157174124|NCT00004732|567377582|FG000|Overall Study|Lost to Follow-up|33|||
157174125|NCT00004732|567377583|FG001|Overall Study|Lost to Follow-up|47|||
157174126|NCT01688635|567377587|FG000|Washout 1|Withdrawal by Subject|1|||
157174127|NCT01688635|567377588|FG001|Washout 1|Withdrawal by Subject|0|||
157174128|NCT01688635|567377587|FG000|Washout 1|Adverse Event|0|||
157174129|NCT01688635|567377588|FG001|Washout 1|Adverse Event|1|||
157174130|NCT01688635|567377587|FG000|Washout 1|Physician Decision|0|||
157174131|NCT01688635|567377588|FG001|Washout 1|Physician Decision|1|||
157174132|NCT01688635|567377587|FG000|Washout 2|Physician Decision|1|||
157174133|NCT01688635|567377588|FG001|Washout 2|Physician Decision|0|||
157174134|NCT01688635|567377587|FG000|Washout 2|Withdrawal by Subject|1|||
157174135|NCT01688635|567377588|FG001|Washout 2|Withdrawal by Subject|0|||
157174136|NCT01688635|567377587|FG000|Washout 2|Sponsor Decision|1|||
157174137|NCT01688635|567377588|FG001|Washout 2|Sponsor Decision|2|||
157174138|NCT01688635|567377587|FG000|Washout 3|Withdrawal by Subject|1|||
157174139|NCT01688635|567377588|FG001|Washout 3|Withdrawal by Subject|0|||
157174140|NCT02674685|567377589|FG000|Overall Study|Withdrawal by Subject|4|||
157174141|NCT02661464|567377592|FG000|Overall Study|Lost to Follow-up|28|||
157174142|NCT02661464|567377593|FG001|Overall Study|Lost to Follow-up|0|||
157174143|NCT02661464|567377594|FG002|Overall Study|Lost to Follow-up|0|||
157174144|NCT02661464|567377595|FG003|Overall Study|Lost to Follow-up|0|||
157043181|NCT04445831|566912096|FG000|Overall Study|Subject withdrawal by caregiver|0|||
157043182|NCT04445831|566912097|FG001|Overall Study|Subject withdrawal by caregiver|1|||
157043183|NCT04445831|566912098|FG002|Overall Study|Subject withdrawal by caregiver|0|||
157043184|NCT04445831|566912099|FG003|Overall Study|Subject withdrawal by caregiver|0|||
157043185|NCT04445831|566912100|FG004|Overall Study|Subject withdrawal by caregiver|0|||
157043186|NCT04445831|566912101|FG005|Overall Study|Subject withdrawal by caregiver|0|||
157043187|NCT04445831|566912102|FG006|Overall Study|Subject withdrawal by caregiver|0|||
157043188|NCT03147287|566912105|FG000|Overall Study|Randomized Not Treated|2|||
157043189|NCT03147287|566912106|FG001|Overall Study|Randomized Not Treated|1|||
157043190|NCT03147287|566912107|FG002|Overall Study|Randomized Not Treated|1|||
157043191|NCT03147287|566912105|FG000|Overall Study|Progressive Disease RECIST|31|||
157043192|NCT03147287|566912106|FG001|Overall Study|Progressive Disease RECIST|72|||
157043193|NCT03147287|566912107|FG002|Overall Study|Progressive Disease RECIST|32|||
157043194|NCT03147287|566912105|FG000|Overall Study|Progressive Disease not RECIST|13|||
157043195|NCT03147287|566912106|FG001|Overall Study|Progressive Disease not RECIST|21|||
157043196|NCT03147287|566912107|FG002|Overall Study|Progressive Disease not RECIST|13|||
157043197|NCT03147287|566912105|FG000|Overall Study|Physician Decision|1|||
157043198|NCT03147287|566912106|FG001|Overall Study|Physician Decision|2|||
157043199|NCT03147287|566912107|FG002|Overall Study|Physician Decision|1|||
157043200|NCT03147287|566912105|FG000|Overall Study|Intercurrent illness|0|||
157043201|NCT03147287|566912106|FG001|Overall Study|Intercurrent illness|1|||
157043202|NCT03147287|566912107|FG002|Overall Study|Intercurrent illness|0|||
157043203|NCT03147287|566912105|FG000|Overall Study|Withdrawal by Subject|2|||
157043204|NCT03147287|566912106|FG001|Overall Study|Withdrawal by Subject|3|||
157043205|NCT03147287|566912107|FG002|Overall Study|Withdrawal by Subject|2|||
157043206|NCT03147287|566912105|FG000|Overall Study|Patient Non-Compliance|0|||
157043207|NCT03147287|566912106|FG001|Overall Study|Patient Non-Compliance|2|||
157043208|NCT03147287|566912107|FG002|Overall Study|Patient Non-Compliance|0|||
157043209|NCT03147287|566912105|FG000|Overall Study|Patient moved|0|||
157043210|NCT03147287|566912106|FG001|Overall Study|Patient moved|1|||
157043211|NCT03147287|566912107|FG002|Overall Study|Patient moved|0|||
157043212|NCT03147287|566912105|FG000|Overall Study|Arm A crossover without PD|1|||
157043213|NCT03147287|566912106|FG001|Overall Study|Arm A crossover without PD|0|||
157043214|NCT03147287|566912107|FG002|Overall Study|Arm A crossover without PD|0|||
157043215|NCT03147287|566912105|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
157043216|NCT03147287|566912106|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
157043217|NCT03147287|566912107|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
157043218|NCT02556918|566913793|FG000|Overall Study|Protocol Violation|5|||
157043219|NCT02556918|566913794|FG001|Overall Study|Protocol Violation|6|||
157043220|NCT02556918|566913793|FG000|Overall Study|Withdrawal by Subject|4|||
157043221|NCT02556918|566913794|FG001|Overall Study|Withdrawal by Subject|4|||
157043222|NCT04511702|566913804|FG000|Overall Study|Lost to Follow-up|3|||
157043223|NCT04511702|566913805|FG001|Overall Study|Lost to Follow-up|0|||
157043224|NCT04511702|566913806|FG002|Overall Study|Lost to Follow-up|4|||
157043225|NCT04511702|566913804|FG000|Overall Study|Withdrawal by Subject|17|||
157043226|NCT04511702|566913805|FG001|Overall Study|Withdrawal by Subject|1|||
157043227|NCT04511702|566913806|FG002|Overall Study|Withdrawal by Subject|8|||
157043228|NCT05349721|566913807|FG000|Part A (24 Weeks)|Adverse Event|9|||
157043229|NCT05349721|566913808|FG001|Part A (24 Weeks)|Adverse Event|2|||
157043230|NCT05349721|566913807|FG000|Part A (24 Weeks)|Death|8|||
157043231|NCT05349721|566913808|FG001|Part A (24 Weeks)|Death|3|||
157043232|NCT05349721|566913807|FG000|Part A (24 Weeks)|Disease Progression|1|||
157043233|NCT05349721|566913808|FG001|Part A (24 Weeks)|Disease Progression|1|||
157043234|NCT05349721|566913807|FG000|Part A (24 Weeks)|Screen Failure|2|||
157043235|NCT05349721|566913808|FG001|Part A (24 Weeks)|Screen Failure|0|||
157043236|NCT05349721|566913807|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
157043237|NCT05349721|566913808|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
157043238|NCT05349721|566913807|FG000|Part A (24 Weeks)|Other Than Specified|5|||
157043239|NCT05349721|566913808|FG001|Part A (24 Weeks)|Other Than Specified|1|||
157043240|NCT05349721|566913807|FG000|Part B (28 Weeks)|Adverse Event|3|||
157043241|NCT05349721|566913808|FG001|Part B (28 Weeks)|Adverse Event|0|||
157043242|NCT05349721|566913807|FG000|Part B (28 Weeks)|Death|21|||
157043243|NCT05349721|566913808|FG001|Part B (28 Weeks)|Death|11|||
157043244|NCT05349721|566913807|FG000|Part B (28 Weeks)|Disease Progression|2|||
157043245|NCT05349721|566913808|FG001|Part B (28 Weeks)|Disease Progression|1|||
157043246|NCT05349721|566913807|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
157043247|NCT05349721|566913808|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
157043248|NCT05349721|566913807|FG000|Part B (28 Weeks)|Physician Decision|1|||
157043249|NCT05349721|566913808|FG001|Part B (28 Weeks)|Physician Decision|0|||
157043250|NCT05349721|566913807|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
157043251|NCT05349721|566913808|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
157043252|NCT05349721|566913807|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
157043253|NCT05349721|566913808|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
157043254|NCT05349721|566913807|FG000|Part B (28 Weeks)|Other Than Specified|4|||
157043255|NCT05349721|566913808|FG001|Part B (28 Weeks)|Other Than Specified|2|||
157043256|NCT05349721|566913807|FG000|Part C (108 Weeks)|Death|0|||
157043257|NCT05349721|566913808|FG001|Part C (108 Weeks)|Death|1|||
157043258|NCT05349721|566913807|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
157043259|NCT05349721|566913808|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
157043260|NCT05349721|566913807|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
157043261|NCT05349721|566913808|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
157043262|NCT05349721|566913807|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
157043263|NCT05349721|566913808|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
157043264|NCT00799409|566913811|FG000|Overall Study|Withdrawal by Subject|1|||
157043265|NCT00799409|566913812|FG001|Overall Study|Withdrawal by Subject|0|||
157043266|NCT00799409|566913813|FG002|Overall Study|Withdrawal by Subject|0|||
157043267|NCT00799409|566913811|FG000|Overall Study|Lost to Follow-up|1|||
157043268|NCT00799409|566913812|FG001|Overall Study|Lost to Follow-up|0|||
157043269|NCT00799409|566913813|FG002|Overall Study|Lost to Follow-up|0|||
157043270|NCT00799409|566913811|FG000|Overall Study|Optimal Dose Not Achieved|2|||
157043271|NCT00799409|566913812|FG001|Overall Study|Optimal Dose Not Achieved|0|||
157043272|NCT00799409|566913813|FG002|Overall Study|Optimal Dose Not Achieved|0|||
157043273|NCT00799409|566913811|FG000|Overall Study|Failure to follow study protocol)|1|||
157043274|NCT00799409|566913812|FG001|Overall Study|Failure to follow study protocol)|0|||
157043275|NCT00799409|566913813|FG002|Overall Study|Failure to follow study protocol)|0|||
157043276|NCT00799409|566913811|FG000|Overall Study|Did not attend lab school day 1|1|||
157043277|NCT00799409|566913812|FG001|Overall Study|Did not attend lab school day 1|0|||
157043278|NCT00799409|566913813|FG002|Overall Study|Did not attend lab school day 1|0|||
157043279|NCT00799409|566913811|FG000|Overall Study|medication compliance|1|||
157043280|NCT00799409|566913812|FG001|Overall Study|medication compliance|0|||
157043281|NCT00799409|566913813|FG002|Overall Study|medication compliance|0|||
157043282|NCT05553366|566913818|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
157043283|NCT05553366|566913819|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
157043284|NCT05553366|566913820|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
157043285|NCT05553366|566913818|FG000|Overall Study|Lost to Follow-up|3|||
157043286|NCT05553366|566913819|FG001|Overall Study|Lost to Follow-up|3|||
157043287|NCT05553366|566913820|FG002|Overall Study|Lost to Follow-up|3|||
157043288|NCT05553366|566913818|FG000|Overall Study|Other non-compliance|1|||
157043289|NCT05553366|566913819|FG001|Overall Study|Other non-compliance|1|||
157043290|NCT05553366|566913820|FG002|Overall Study|Other non-compliance|0|||
157043291|NCT05553366|566913818|FG000|Overall Study|Randomized but not dosed|0|||
157043292|NCT05553366|566913819|FG001|Overall Study|Randomized but not dosed|0|||
157043293|NCT05553366|566913820|FG002|Overall Study|Randomized but not dosed|2|||
157043294|NCT00249769|566913821|FG000|Overall Study|Withdrawal by Subject|1|||
157043295|NCT00249769|566913822|FG001|Overall Study|Withdrawal by Subject|10|||
157043296|NCT00249769|566913823|FG002|Overall Study|Withdrawal by Subject|6|||
157043297|NCT00249769|566913821|FG000|Overall Study|Migration from Study Area|1|||
157043298|NCT00249769|566913822|FG001|Overall Study|Migration from Study Area|3|||
157043299|NCT00249769|566913823|FG002|Overall Study|Migration from Study Area|14|||
157043300|NCT00249769|566913821|FG000|Overall Study|Miscellaneous|0|||
157043301|NCT00249769|566913822|FG001|Overall Study|Miscellaneous|2|||
157043302|NCT00249769|566913823|FG002|Overall Study|Miscellaneous|2|||
157043303|NCT00249769|566913821|FG000|Overall Study|Adverse Event|0|||
157043304|NCT00249769|566913822|FG001|Overall Study|Adverse Event|0|||
157043305|NCT00249769|566913823|FG002|Overall Study|Adverse Event|1|||
157174145|NCT02661464|567377592|FG000|Overall Study|Withdrawal by Subject|3|||
157174146|NCT02661464|567377593|FG001|Overall Study|Withdrawal by Subject|1|||
157174147|NCT02661464|567377594|FG002|Overall Study|Withdrawal by Subject|0|||
157174148|NCT02661464|567377595|FG003|Overall Study|Withdrawal by Subject|0|||
157174149|NCT02661464|567377592|FG000|Overall Study|Participants terminated prematurely|288|||
157174150|NCT02661464|567377593|FG001|Overall Study|Participants terminated prematurely|52|||
157174151|NCT02661464|567377594|FG002|Overall Study|Participants terminated prematurely|1|||
157174152|NCT02661464|567377595|FG003|Overall Study|Participants terminated prematurely|1|||
157174153|NCT02661464|567377592|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
157174154|NCT02661464|567377593|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
157174155|NCT02661464|567377594|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
157174156|NCT02661464|567377595|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
157174157|NCT05567393|567377597|FG000|Overall Study|Voluntary Withdrawal|0|||
157043306|NCT00249769|566913821|FG000|Overall Study|Physician Decision|0|||
157043307|NCT00249769|566913822|FG001|Overall Study|Physician Decision|0|||
157043308|NCT00249769|566913823|FG002|Overall Study|Physician Decision|2|||
157174158|NCT05567393|567377598|FG001|Overall Study|Voluntary Withdrawal|0|||
157043309|NCT00249769|566913821|FG000|Overall Study|Lost to Follow-up|0|||
157043310|NCT00249769|566913822|FG001|Overall Study|Lost to Follow-up|0|||
157043311|NCT00249769|566913823|FG002|Overall Study|Lost to Follow-up|3|||
157043312|NCT02022657|566913828|FG000|Overall Study|Withdrawal by Subject|2|||
157043313|NCT02022657|566913829|FG001|Overall Study|Withdrawal by Subject|0|||
157043314|NCT02022657|566913830|FG002|Overall Study|Withdrawal by Subject|1|||
157043315|NCT02022657|566913831|FG003|Overall Study|Withdrawal by Subject|0|||
157043316|NCT02022657|566913832|FG004|Overall Study|Withdrawal by Subject|0|||
157043317|NCT02022657|566913833|FG005|Overall Study|Withdrawal by Subject|0|||
157043318|NCT02022657|566913828|FG000|Overall Study|Physician Decision|0|||
157043319|NCT02022657|566913829|FG001|Overall Study|Physician Decision|0|||
157043320|NCT02022657|566913830|FG002|Overall Study|Physician Decision|0|||
157043321|NCT02022657|566913831|FG003|Overall Study|Physician Decision|0|||
157043322|NCT02022657|566913832|FG004|Overall Study|Physician Decision|0|||
157043323|NCT02022657|566913833|FG005|Overall Study|Physician Decision|1|||
157043324|NCT00795184|566913835|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
157043325|NCT00795184|566913836|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
157043326|NCT01629589|566913837|FG000|Overall Study|Protocol Violation|4|||
157043327|NCT01629589|566913838|FG001|Overall Study|Protocol Violation|2|||
157043328|NCT01629589|566913837|FG000|Overall Study|Lost to Follow-up|2|||
157043329|NCT01629589|566913838|FG001|Overall Study|Lost to Follow-up|1|||
157043330|NCT01629589|566913837|FG000|Overall Study|Withdrawal by Subject|2|||
157043331|NCT01629589|566913838|FG001|Overall Study|Withdrawal by Subject|3|||
157043332|NCT01629589|566913837|FG000|Overall Study|Did not receive study vaccine|0|||
157043333|NCT01629589|566913838|FG001|Overall Study|Did not receive study vaccine|1|||
157043334|NCT01530334|566913839|FG000|Overall Study|Adverse Event|3|||
157043335|NCT01530334|566913839|FG000|Overall Study|unknown reason|1|||
157043336|NCT01530334|566913839|FG000|Overall Study|Progressive disease|47|||
157043337|NCT03781375|566913840|FG000|Double-blind Phase|Adverse Event|0|||
157043338|NCT03781375|566913841|FG001|Double-blind Phase|Adverse Event|1|||
157043339|NCT03781375|566913840|FG000|Double-blind Phase|Lack of Response|6|||
157043340|NCT03781375|566913841|FG001|Double-blind Phase|Lack of Response|2|||
157043341|NCT03781375|566913840|FG000|Double-blind Phase|Other|1|||
157043342|NCT03781375|566913841|FG001|Double-blind Phase|Other|3|||
157043343|NCT03781375|566913840|FG000|Open-label Phase|Protocol Issues|0|||
157043344|NCT03781375|566913841|FG001|Open-label Phase|Protocol Issues|1|||
157043345|NCT03781375|566913840|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
157043346|NCT03781375|566913841|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
157043347|NCT03781375|566913840|FG000|Open-label Phase|Other|2|||
157043348|NCT03781375|566913841|FG001|Open-label Phase|Other|2|||
156968628|NCT02323646|566637624|FG000|Treatment Course 2|Non-compliance|0|||
156968629|NCT02323646|566637625|FG001|Treatment Course 2|Non-compliance|1|||
156968630|NCT02323646|566637626|FG002|Treatment Course 2|Non-compliance|1|||
156968631|NCT00521144|566637627|FG000|Overall Study|Not Treated|0|||
156968632|NCT00521144|566637628|FG001|Overall Study|Not Treated|0|||
156968633|NCT00521144|566637629|FG002|Overall Study|Not Treated|0|||
156968634|NCT00521144|566637630|FG003|Overall Study|Not Treated|1|||
156968635|NCT00521144|566637631|FG004|Overall Study|Not Treated|0|||
156968636|NCT00521144|566637627|FG000|Overall Study|Adverse Event|0|||
156968637|NCT00521144|566637628|FG001|Overall Study|Adverse Event|1|||
156968638|NCT00521144|566637629|FG002|Overall Study|Adverse Event|0|||
156968639|NCT00521144|566637630|FG003|Overall Study|Adverse Event|0|||
156968640|NCT00521144|566637631|FG004|Overall Study|Adverse Event|1|||
156968641|NCT00521144|566637627|FG000|Overall Study|Progressive Disease|4|||
156968642|NCT00521144|566637628|FG001|Overall Study|Progressive Disease|2|||
156968643|NCT00521144|566637629|FG002|Overall Study|Progressive Disease|2|||
156968644|NCT00521144|566637630|FG003|Overall Study|Progressive Disease|0|||
156968645|NCT00521144|566637631|FG004|Overall Study|Progressive Disease|6|||
156968646|NCT02901626|566637632|FG000|Overall Study|Lost to Follow-up|1|||
156968647|NCT02901626|566637633|FG001|Overall Study|Lost to Follow-up|1|||
156968648|NCT00659490|566637634|FG000|Overall Study|Lost to Follow-up|2|||
156968649|NCT00659490|566637635|FG001|Overall Study|Lost to Follow-up|0|||
156968650|NCT00659490|566637636|FG002|Overall Study|Lost to Follow-up|1|||
156968651|NCT05674890|566637637|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
156968652|NCT05674890|566637638|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
156968653|NCT05674890|566637637|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
156968654|NCT05674890|566637638|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
156968655|NCT05674890|566637637|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
156968656|NCT05674890|566637638|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
156968657|NCT01750879|566637639|FG000|Overall Study|Adverse Event|8|||
156968658|NCT01750879|566637640|FG001|Overall Study|Adverse Event|0|||
156968659|NCT01750879|566637639|FG000|Overall Study|Lack of Efficacy|1|||
156968660|NCT01750879|566637640|FG001|Overall Study|Lack of Efficacy|0|||
156968661|NCT01750879|566637639|FG000|Overall Study|Withdrawal by Subject|1|||
156968662|NCT01750879|566637640|FG001|Overall Study|Withdrawal by Subject|0|||
156968663|NCT01750879|566637639|FG000|Overall Study|Did not complete per protocol|0|||
156968664|NCT01750879|566637640|FG001|Overall Study|Did not complete per protocol|3|||
156968665|NCT02421666|566637641|FG000|6-month Follow-up|Lost to Follow-up|8|||
156968666|NCT02421666|566637642|FG001|6-month Follow-up|Lost to Follow-up|7|||
156968667|NCT02421666|566637641|FG000|6-month Follow-up|Withdrawal by Subject|5|||
156968668|NCT02421666|566637642|FG001|6-month Follow-up|Withdrawal by Subject|6|||
156968669|NCT02421666|566637641|FG000|12-month Follow-up|Lost to Follow-up|5|||
157043349|NCT02079649|566913843|FG000|Overall Study|Lost to Follow-up|0|||
157043350|NCT02079649|566913844|FG001|Overall Study|Lost to Follow-up|0|||
157043351|NCT02079649|566913845|FG002|Overall Study|Lost to Follow-up|0|||
157043352|NCT02079649|566913846|FG003|Overall Study|Lost to Follow-up|1|||
157043353|NCT02079649|566913843|FG000|Overall Study|Withdrawal by Subject|0|||
157043354|NCT02079649|566913844|FG001|Overall Study|Withdrawal by Subject|0|||
157043355|NCT02079649|566913845|FG002|Overall Study|Withdrawal by Subject|0|||
157043356|NCT02079649|566913846|FG003|Overall Study|Withdrawal by Subject|1|||
157043357|NCT02079649|566913843|FG000|Overall Study|Randomization error (prior to treatment)|1|||
157043358|NCT02079649|566913844|FG001|Overall Study|Randomization error (prior to treatment)|0|||
157043359|NCT02079649|566913845|FG002|Overall Study|Randomization error (prior to treatment)|1|||
157043360|NCT02079649|566913846|FG003|Overall Study|Randomization error (prior to treatment)|0|||
157043361|NCT03739866|566913870|FG000|Overall Study|Lost to Follow-up|0|||
157043362|NCT03739866|566913871|FG001|Overall Study|Lost to Follow-up|0|||
157043363|NCT03739866|566913872|FG002|Overall Study|Lost to Follow-up|0|||
157043364|NCT03739866|566913873|FG003|Overall Study|Lost to Follow-up|1|||
157043365|NCT03739866|566913874|FG004|Overall Study|Lost to Follow-up|0|||
157043366|NCT03739866|566913875|FG005|Overall Study|Lost to Follow-up|0|||
157043367|NCT03739866|566913876|FG006|Overall Study|Lost to Follow-up|0|||
157043368|NCT03739866|566913877|FG007|Overall Study|Lost to Follow-up|0|||
157043369|NCT03739866|566913870|FG000|Overall Study|Enrolled but not treated|0|||
157043370|NCT03739866|566913871|FG001|Overall Study|Enrolled but not treated|0|||
157043371|NCT03739866|566913872|FG002|Overall Study|Enrolled but not treated|1|||
157043372|NCT03739866|566913873|FG003|Overall Study|Enrolled but not treated|0|||
157043373|NCT03739866|566913874|FG004|Overall Study|Enrolled but not treated|1|||
157043374|NCT03739866|566913875|FG005|Overall Study|Enrolled but not treated|0|||
157043375|NCT03739866|566913876|FG006|Overall Study|Enrolled but not treated|0|||
157043376|NCT03739866|566913877|FG007|Overall Study|Enrolled but not treated|0|||
157043377|NCT01034306|566913878|FG000|Overall Study|Adverse Event|1|||
157043378|NCT01034306|566913879|FG001|Overall Study|Adverse Event|0|||
157043379|NCT01034306|566913878|FG000|Overall Study|Lost to Follow-up|0|||
157043380|NCT01034306|566913879|FG001|Overall Study|Lost to Follow-up|1|||
157043381|NCT01034306|566913878|FG000|Overall Study|Withdrawal by Subject|2|||
157043382|NCT01034306|566913879|FG001|Overall Study|Withdrawal by Subject|2|||
157043383|NCT01034306|566913878|FG000|Overall Study|hospitalized and decided to stop|1|||
157043384|NCT01034306|566913879|FG001|Overall Study|hospitalized and decided to stop|0|||
157043385|NCT01034306|566913878|FG000|Overall Study|Noncomplience|1|||
157043386|NCT01034306|566913879|FG001|Overall Study|Noncomplience|0|||
157043387|NCT00836498|566913880|FG000|Overall Study|Adverse Event|1|||
157043388|NCT00836498|566913881|FG001|Overall Study|Adverse Event|0|||
157043389|NCT00836498|566913880|FG000|Overall Study|Lost to Follow-up|1|||
157043390|NCT00836498|566913881|FG001|Overall Study|Lost to Follow-up|0|||
157043391|NCT00836498|566913880|FG000|Overall Study|Withdrawal by Subject|2|||
157043392|NCT00836498|566913881|FG001|Overall Study|Withdrawal by Subject|1|||
157043393|NCT03057600|566913882|FG000|Overall Study|Adverse Event|0|||
157043394|NCT03057600|566913883|FG001|Overall Study|Adverse Event|0|||
157043395|NCT03057600|566913884|FG002|Overall Study|Adverse Event|4|||
157043396|NCT03057600|566913885|FG003|Overall Study|Adverse Event|0|||
157043397|NCT03057600|566913882|FG000|Overall Study|Radiologic Disease Progression|8|||
157043398|NCT03057600|566913883|FG001|Overall Study|Radiologic Disease Progression|7|||
157043399|NCT03057600|566913884|FG002|Overall Study|Radiologic Disease Progression|13|||
157043400|NCT03057600|566913885|FG003|Overall Study|Radiologic Disease Progression|10|||
157043401|NCT03057600|566913882|FG000|Overall Study|Symptomatic Deterioration|0|||
157043402|NCT03057600|566913883|FG001|Overall Study|Symptomatic Deterioration|1|||
157043403|NCT03057600|566913884|FG002|Overall Study|Symptomatic Deterioration|1|||
157043404|NCT03057600|566913885|FG003|Overall Study|Symptomatic Deterioration|0|||
157043405|NCT03057600|566913882|FG000|Overall Study|Investigator Decision|0|||
157043406|NCT03057600|566913883|FG001|Overall Study|Investigator Decision|0|||
157043407|NCT03057600|566913884|FG002|Overall Study|Investigator Decision|1|||
157043408|NCT03057600|566913885|FG003|Overall Study|Investigator Decision|0|||
157043409|NCT03057600|566913882|FG000|Overall Study|Study Termination by Sponsor|0|||
157043410|NCT03057600|566913883|FG001|Overall Study|Study Termination by Sponsor|0|||
157043411|NCT03057600|566913884|FG002|Overall Study|Study Termination by Sponsor|0|||
157043412|NCT03057600|566913885|FG003|Overall Study|Study Termination by Sponsor|2|||
157043413|NCT03057600|566913882|FG000|Overall Study|Withdrawal by Subject|0|||
157043414|NCT03057600|566913883|FG001|Overall Study|Withdrawal by Subject|1|||
157043415|NCT03057600|566913884|FG002|Overall Study|Withdrawal by Subject|0|||
157043416|NCT03057600|566913885|FG003|Overall Study|Withdrawal by Subject|0|||
157043417|NCT03057600|566913882|FG000|Overall Study|Other, Not Specified|1|||
157043418|NCT03057600|566913883|FG001|Overall Study|Other, Not Specified|1|||
157043419|NCT03057600|566913884|FG002|Overall Study|Other, Not Specified|1|||
157043420|NCT03057600|566913885|FG003|Overall Study|Other, Not Specified|1|||
157043421|NCT03489369|566913886|FG000|Overall Study|Documented Progressive Disease|3|||
157043422|NCT03489369|566913887|FG001|Overall Study|Documented Progressive Disease|2|||
157043423|NCT03489369|566913888|FG002|Overall Study|Documented Progressive Disease|3|||
157228689|NCT01193608|567583331|FG002|Overall Study|Adverse Event|0|||
157043424|NCT03489369|566913889|FG003|Overall Study|Documented Progressive Disease|6|||
157043425|NCT03489369|566913886|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
157043426|NCT03489369|566913887|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
157043427|NCT03489369|566913888|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
157043428|NCT03489369|566913889|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
157043429|NCT01968967|566913890|FG000|Treatment Period|Other|22|||
157043430|NCT01968967|566913891|FG001|Treatment Period|Other|22|||
157043431|NCT01968967|566913892|FG002|Treatment Period|Other|0|||
157043432|NCT01968967|566913893|FG003|Treatment Period|Other|0|||
157043433|NCT01968967|566913894|FG004|Treatment Period|Other|0|||
157043434|NCT01968967|566913890|FG000|Treatment Period|Withdrawal by Subject|71|||
157043435|NCT01968967|566913891|FG001|Treatment Period|Withdrawal by Subject|61|||
157043436|NCT01968967|566913892|FG002|Treatment Period|Withdrawal by Subject|0|||
157043437|NCT01968967|566913893|FG003|Treatment Period|Withdrawal by Subject|0|||
157043438|NCT01968967|566913894|FG004|Treatment Period|Withdrawal by Subject|0|||
157043439|NCT01968967|566913890|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
157043440|NCT01968967|566913891|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
157043441|NCT01968967|566913892|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
157043442|NCT01968967|566913893|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
157043443|NCT01968967|566913894|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
157043444|NCT01968967|566913890|FG000|Treatment Period|Lost to Follow-up|26|||
157043445|NCT01968967|566913891|FG001|Treatment Period|Lost to Follow-up|31|||
157043446|NCT01968967|566913892|FG002|Treatment Period|Lost to Follow-up|0|||
157043447|NCT01968967|566913893|FG003|Treatment Period|Lost to Follow-up|0|||
157043448|NCT01968967|566913894|FG004|Treatment Period|Lost to Follow-up|0|||
157043449|NCT01968967|566913890|FG000|Treatment Period|Protocol Violation|1|||
157043450|NCT01968967|566913891|FG001|Treatment Period|Protocol Violation|2|||
157043451|NCT01968967|566913892|FG002|Treatment Period|Protocol Violation|0|||
157043452|NCT01968967|566913893|FG003|Treatment Period|Protocol Violation|0|||
157043453|NCT01968967|566913894|FG004|Treatment Period|Protocol Violation|0|||
157043454|NCT01968967|566913890|FG000|Treatment Period|Adverse Event|9|||
157043455|NCT01968967|566913891|FG001|Treatment Period|Adverse Event|8|||
157043456|NCT01968967|566913892|FG002|Treatment Period|Adverse Event|0|||
157043457|NCT01968967|566913893|FG003|Treatment Period|Adverse Event|0|||
157043458|NCT01968967|566913894|FG004|Treatment Period|Adverse Event|0|||
157043459|NCT01968967|566913890|FG000|Treatment Period|Death|9|||
157043460|NCT01968967|566913891|FG001|Treatment Period|Death|2|||
157043461|NCT01968967|566913892|FG002|Treatment Period|Death|0|||
157043462|NCT01968967|566913893|FG003|Treatment Period|Death|0|||
157043463|NCT01968967|566913894|FG004|Treatment Period|Death|0|||
157043464|NCT01968967|566913890|FG000|Treatment Period|Randomized Not Treated|6|||
157043465|NCT01968967|566913891|FG001|Treatment Period|Randomized Not Treated|5|||
157043466|NCT01968967|566913892|FG002|Treatment Period|Randomized Not Treated|0|||
157043467|NCT01968967|566913893|FG003|Treatment Period|Randomized Not Treated|0|||
157043468|NCT01968967|566913894|FG004|Treatment Period|Randomized Not Treated|0|||
157043469|NCT01968967|566913890|FG000|Extension Period|Withdrew Consent|0|||
157043470|NCT01968967|566913891|FG001|Extension Period|Withdrew Consent|0|||
157043471|NCT01968967|566913892|FG002|Extension Period|Withdrew Consent|2|||
157043472|NCT01968967|566913893|FG003|Extension Period|Withdrew Consent|0|||
157043473|NCT01968967|566913894|FG004|Extension Period|Withdrew Consent|5|||
157043474|NCT02106884|566913897|FG000|Overall Study|Change of diagnosis/exclusion|0|||
157043475|NCT02106884|566913898|FG001|Overall Study|Change of diagnosis/exclusion|1|||
157043476|NCT00109031|566913899|FG000|Overall Study|Adverse Event|0|||
157043477|NCT00109031|566913900|FG001|Overall Study|Adverse Event|0|||
157043478|NCT00109031|566913901|FG002|Overall Study|Adverse Event|1|||
157043479|NCT00109031|566913902|FG003|Overall Study|Adverse Event|0|||
157043480|NCT00109031|566913899|FG000|Overall Study|Withdrawal by Subject|0|||
157043481|NCT00109031|566913900|FG001|Overall Study|Withdrawal by Subject|1|||
157043482|NCT00109031|566913901|FG002|Overall Study|Withdrawal by Subject|0|||
157043483|NCT00109031|566913902|FG003|Overall Study|Withdrawal by Subject|0|||
157043484|NCT00109031|566913899|FG000|Overall Study|Physician Decision|0|||
157043485|NCT00109031|566913900|FG001|Overall Study|Physician Decision|1|||
157043486|NCT00109031|566913901|FG002|Overall Study|Physician Decision|0|||
157043487|NCT00109031|566913902|FG003|Overall Study|Physician Decision|0|||
157043488|NCT00109031|566913899|FG000|Overall Study|Protocol Violation|0|||
157043489|NCT00109031|566913900|FG001|Overall Study|Protocol Violation|0|||
157043490|NCT00109031|566913901|FG002|Overall Study|Protocol Violation|1|||
157043491|NCT00109031|566913902|FG003|Overall Study|Protocol Violation|0|||
157043492|NCT02091752|566913903|FG000|Overall Study|Study terminated by Sponsor|2|||
157043493|NCT02091752|566913903|FG000|Overall Study|Adverse Event|1|||
157043494|NCT04029090|566913910|FG000|Overall Study|Protocol Violation|1|||
157043495|NCT04029090|566913911|FG001|Overall Study|Protocol Violation|0|||
157043496|NCT04029090|566913912|FG002|Overall Study|Protocol Violation|0|||
157043497|NCT04029090|566913910|FG000|Overall Study|Withdrawal by Subject|0|||
157043498|NCT04029090|566913911|FG001|Overall Study|Withdrawal by Subject|1|||
157043499|NCT04029090|566913912|FG002|Overall Study|Withdrawal by Subject|0|||
157043500|NCT01065779|566913913|FG000|Overall Study|Duplicate Investigation|1|||
157043501|NCT01065779|566913913|FG000|Overall Study|Investigation Before Contract Date|37|||
157043502|NCT01065779|566913913|FG000|Overall Study|Non-enrollment Period Administration|10|||
157043503|NCT01065779|566913913|FG000|Overall Study|Not Administered With Study Drug|17|||
157043504|NCT01065779|566913913|FG000|Overall Study|Failed to Follow-up|10|||
157043505|NCT01065779|566913913|FG000|Overall Study|Inclusion Criteria Violation|7|||
157043506|NCT02157948|566913914|FG000|Overall Study|Withdrawal by Subject|4|||
157043507|NCT02157948|566913915|FG001|Overall Study|Withdrawal by Subject|5|||
157043508|NCT02157948|566913914|FG000|Overall Study|Lost to Follow-up|3|||
157043509|NCT02157948|566913915|FG001|Overall Study|Lost to Follow-up|2|||
157043510|NCT02157948|566913914|FG000|Overall Study|Protocol Specified Criteria|2|||
157043511|NCT02157948|566913915|FG001|Overall Study|Protocol Specified Criteria|1|||
157043512|NCT02157948|566913914|FG000|Overall Study|Decision by Sponsor|0|||
157043513|NCT02157948|566913915|FG001|Overall Study|Decision by Sponsor|1|||
157043514|NCT01604824|566913916|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
157043515|NCT01604824|566913917|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
157043516|NCT01604824|566913918|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
157043517|NCT01604824|566913919|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
157043518|NCT01604824|566913920|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
157043519|NCT01604824|566913921|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
157043520|NCT01604824|566913916|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
157043521|NCT01604824|566913917|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
157043522|NCT01604824|566913918|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
157043523|NCT01604824|566913919|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
157043524|NCT01604824|566913920|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
157043525|NCT01604824|566913921|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
157043526|NCT04218864|566913938|FG000|Overall Study|Lost to Follow-up|8|||
157043527|NCT04218864|566913939|FG001|Overall Study|Lost to Follow-up|4|||
157043528|NCT04218864|566913938|FG000|Overall Study|Withdrawal by Subject|1|||
157043529|NCT04218864|566913939|FG001|Overall Study|Withdrawal by Subject|3|||
157043530|NCT00933270|566913940|FG000|Overall Study|Withdrawal by Subject|26|||
157043531|NCT00933270|566913940|FG000|Overall Study|Insufficient Follow-up|10|||
157043532|NCT00933270|566913940|FG000|Overall Study|Lost to Follow-up|14|||
157043533|NCT00933270|566913940|FG000|Overall Study|Adverse Event|1|||
157043534|NCT00933270|566913940|FG000|Overall Study|Missed Visit|2|||
157043535|NCT00933270|566913940|FG000|Overall Study|Death|24|||
157043536|NCT00933270|566913940|FG000|Overall Study|Moved or would not return|10|||
157043537|NCT02409680|566913941|FG000|Overall Study|Lost to Follow-up|15|||
157043538|NCT02409680|566913942|FG001|Overall Study|Lost to Follow-up|30|||
157043539|NCT05366751|566913943|FG000|Overall Study|Adverse Event|25|||
157043540|NCT05366751|566913943|FG000|Overall Study|Physician Decision|3|||
157043541|NCT05366751|566913943|FG000|Overall Study|Lost to Follow-up|2|||
157043542|NCT05366751|566913943|FG000|Overall Study|Withdrawal by Subject|14|||
157043543|NCT05366751|566913943|FG000|Overall Study|Study Terminated by Sponsor|50|||
157043544|NCT05366751|566913943|FG000|Overall Study|Site Terminated by Sponsor|3|||
157043545|NCT04912856|566913950|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
157043546|NCT04912856|566913951|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
157043547|NCT04912856|566913950|FG000|Overall Study|Not reported in synoptic CSR.|0|||
157043548|NCT04912856|566913951|FG001|Overall Study|Not reported in synoptic CSR.|1|||
157043549|NCT00647387|566913954|FG000|Overall Study|Lost to Follow-up|6|||
157043550|NCT00647387|566913954|FG000|Overall Study|Unsuccessful implant|5|||
157043551|NCT00647387|566913954|FG000|Overall Study|Device explanted|3|||
157043552|NCT00647387|566913954|FG000|Overall Study|Other Reason|3|||
157043553|NCT00647387|566913954|FG000|Overall Study|Death|2|||
157043554|NCT00302211|566913955|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
157043555|NCT00302211|566913956|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
157043556|NCT00302211|566913957|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
157043557|NCT00302211|566913958|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
157043558|NCT00302211|566913959|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
157043559|NCT00302211|566913955|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
157174159|NCT05567393|567377599|FG002|Overall Study|Voluntary Withdrawal|0|||
157174160|NCT05567393|567377600|FG003|Overall Study|Voluntary Withdrawal|0|||
157043560|NCT00302211|566913956|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
157043561|NCT00302211|566913957|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
157043562|NCT00302211|566913958|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
157043563|NCT00302211|566913959|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
157043564|NCT00302211|566913955|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
157174161|NCT05567393|567377601|FG004|Overall Study|Voluntary Withdrawal|0|||
157174162|NCT05567393|567377602|FG005|Overall Study|Voluntary Withdrawal|0|||
157043565|NCT00302211|566913956|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
157043566|NCT00302211|566913957|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
157174163|NCT05567393|567377603|FG006|Overall Study|Voluntary Withdrawal|0|||
157174164|NCT05567393|567377604|FG007|Overall Study|Voluntary Withdrawal|0|||
157043567|NCT00302211|566913958|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
157043568|NCT00302211|566913959|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
157043569|NCT00302211|566913955|FG000|Double Blind Period (New Patients)|Disease progression|0|||
157043570|NCT00302211|566913956|FG001|Double Blind Period (New Patients)|Disease progression|1|||
157043571|NCT00302211|566913957|FG002|Double Blind Period (New Patients)|Disease progression|1|||
157043572|NCT00302211|566913958|FG003|Double Blind Period (New Patients)|Disease progression|0|||
157043573|NCT00302211|566913959|FG004|Double Blind Period (New Patients)|Disease progression|0|||
157043574|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
157043575|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
157043576|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
157043577|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
157043578|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
157043579|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
157043580|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
157043581|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
157043582|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
157043583|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
157043584|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
157043585|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
157043586|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
157043587|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
157043588|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
157043589|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
157043590|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
157043591|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
157043592|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
157043593|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
157043594|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Death|0|||
157043595|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Death|0|||
157043596|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Death|0|||
157043597|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Death|1|||
157043598|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Death|1|||
157043599|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
157043600|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
157043601|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
157043602|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
157043603|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
157043604|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
157043605|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
157043606|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
157043607|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
157043608|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
157043609|NCT00302211|566913955|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
157043610|NCT00302211|566913956|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
157043611|NCT00302211|566913957|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
157043612|NCT00302211|566913958|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
157043613|NCT00302211|566913959|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
157043614|NCT03137459|566915923|FG000|2-month Assessment|Withdrawal by Subject|13|||
157043615|NCT03137459|566915924|FG001|2-month Assessment|Withdrawal by Subject|3|||
157043616|NCT03137459|566915923|FG000|2-month Assessment|Unable to reach|42|||
157043617|NCT03137459|566915924|FG001|2-month Assessment|Unable to reach|32|||
157043618|NCT03137459|566915923|FG000|2-month Assessment|Refused assessment|7|||
157043619|NCT03137459|566915924|FG001|2-month Assessment|Refused assessment|5|||
157043620|NCT03137459|566915923|FG000|2-month Assessment|Acutely ill|6|||
157043621|NCT03137459|566915924|FG001|2-month Assessment|Acutely ill|2|||
157043622|NCT03137459|566915923|FG000|4-month Assessment|Death|4|||
157043623|NCT03137459|566915924|FG001|4-month Assessment|Death|2|||
157043624|NCT03137459|566915923|FG000|4-month Assessment|Withdrawal by Subject|4|||
157043625|NCT03137459|566915924|FG001|4-month Assessment|Withdrawal by Subject|2|||
157174165|NCT05567393|567377605|FG008|Overall Study|Voluntary Withdrawal|0|||
157174166|NCT05567393|567377606|FG009|Overall Study|Voluntary Withdrawal|0|||
157043626|NCT03137459|566915923|FG000|4-month Assessment|Unable to reach|44|||
157043627|NCT03137459|566915924|FG001|4-month Assessment|Unable to reach|29|||
157043628|NCT03137459|566915923|FG000|4-month Assessment|Refused assessment|24|||
157043629|NCT03137459|566915924|FG001|4-month Assessment|Refused assessment|10|||
157043630|NCT03137459|566915923|FG000|4-month Assessment|Acutely ill|2|||
157174167|NCT05567393|567377607|FG010|Overall Study|Voluntary Withdrawal|0|||
157174168|NCT05567393|567377608|FG011|Overall Study|Voluntary Withdrawal|0|||
157043631|NCT03137459|566915924|FG001|4-month Assessment|Acutely ill|3|||
157043632|NCT03137459|566915923|FG000|6-months|Lost to Follow-up|14|||
157043633|NCT03137459|566915924|FG001|6-months|Lost to Follow-up|11|||
157043634|NCT03137459|566915923|FG000|6-months|Death|0|||
157043635|NCT03137459|566915924|FG001|6-months|Death|2|||
157043636|NCT03137459|566915923|FG000|6-months|Refused assessment|6|||
157043637|NCT03137459|566915924|FG001|6-months|Refused assessment|3|||
157043638|NCT03137459|566915923|FG000|6-months|Acutely ill|1|||
157043639|NCT03137459|566915924|FG001|6-months|Acutely ill|1|||
157043640|NCT04921358|566915926|FG000|Overall Study|Withdrawal by Subject|6|||
157043641|NCT04921358|566915927|FG001|Overall Study|Withdrawal by Subject|13|||
157043642|NCT04921358|566915926|FG000|Overall Study|Lost to Follow-up|3|||
157043643|NCT04921358|566915927|FG001|Overall Study|Lost to Follow-up|6|||
157043644|NCT04921358|566915926|FG000|Overall Study|Study Terminated by Sponsor|86|||
157043645|NCT04921358|566915927|FG001|Overall Study|Study Terminated by Sponsor|89|||
157043646|NCT04921358|566915926|FG000|Overall Study|Death|92|||
157043647|NCT04921358|566915927|FG001|Overall Study|Death|82|||
157043648|NCT02278796|566915928|FG000|Overall Study|Death|2|||
157043649|NCT02278796|566915929|FG001|Overall Study|Death|3|||
157043650|NCT04926857|566915930|FG000|Overall Study|Withdrawal by Subject|40|||
157043651|NCT04926857|566915930|FG000|Overall Study|Death|9|||
157043652|NCT04926857|566915930|FG000|Overall Study|Study product no longer in use|44|||
157043653|NCT04926857|566915930|FG000|Overall Study|Inadequate data to address primary objective|16|||
157043654|NCT02634307|566915931|FG000|Overall Study|Adverse Event|50|||
157043655|NCT02634307|566915932|FG001|Overall Study|Adverse Event|24|||
157043656|NCT02634307|566915933|FG002|Overall Study|Adverse Event|14|||
157043657|NCT02634307|566915931|FG000|Overall Study|Lost to Follow-up|21|||
157043658|NCT02634307|566915932|FG001|Overall Study|Lost to Follow-up|5|||
157043659|NCT02634307|566915933|FG002|Overall Study|Lost to Follow-up|6|||
157043660|NCT02634307|566915931|FG000|Overall Study|Pregnancy|5|||
157043661|NCT02634307|566915932|FG001|Overall Study|Pregnancy|1|||
157043662|NCT02634307|566915933|FG002|Overall Study|Pregnancy|3|||
157043663|NCT02634307|566915931|FG000|Overall Study|Withdrawal by Subject|38|||
157043664|NCT02634307|566915932|FG001|Overall Study|Withdrawal by Subject|24|||
157043665|NCT02634307|566915933|FG002|Overall Study|Withdrawal by Subject|18|||
157043666|NCT02634307|566915931|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157043667|NCT02634307|566915932|FG001|Overall Study|Non-Compliance with Study Drug|2|||
157043668|NCT02634307|566915933|FG002|Overall Study|Non-Compliance with Study Drug|2|||
157043669|NCT02634307|566915931|FG000|Overall Study|Lack of Efficacy|1|||
157043670|NCT02634307|566915932|FG001|Overall Study|Lack of Efficacy|5|||
157043671|NCT02634307|566915933|FG002|Overall Study|Lack of Efficacy|3|||
157043672|NCT02634307|566915931|FG000|Overall Study|Physician Decision|7|||
157043673|NCT02634307|566915932|FG001|Overall Study|Physician Decision|5|||
157043674|NCT02634307|566915933|FG002|Overall Study|Physician Decision|5|||
157043675|NCT02634307|566915931|FG000|Overall Study|Reason not Specified|3|||
157043676|NCT02634307|566915932|FG001|Overall Study|Reason not Specified|5|||
157043677|NCT02634307|566915933|FG002|Overall Study|Reason not Specified|10|||
157043678|NCT02310581|566915934|FG000|Overall Study|Adverse Event|1|||
157043679|NCT02310581|566915935|FG001|Overall Study|Adverse Event|1|||
157043680|NCT02310581|566915936|FG002|Overall Study|Adverse Event|1|||
157043681|NCT02310581|566915937|FG003|Overall Study|Adverse Event|0|||
157043682|NCT02310581|566915934|FG000|Overall Study|Withdrawal by Subject|2|||
157043683|NCT02310581|566915935|FG001|Overall Study|Withdrawal by Subject|1|||
157043684|NCT02310581|566915936|FG002|Overall Study|Withdrawal by Subject|0|||
157043685|NCT02310581|566915937|FG003|Overall Study|Withdrawal by Subject|1|||
157043686|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
157043687|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
157043688|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
157043689|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
157174169|NCT05567393|567377609|FG012|Overall Study|Voluntary Withdrawal|0|||
157174170|NCT05567393|567377610|FG013|Overall Study|Voluntary Withdrawal|1|||
157043690|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
157043691|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
157043692|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
157043693|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
157174171|NCT05567393|567377611|FG014|Overall Study|Voluntary Withdrawal|0|||
157174172|NCT05567393|567377612|FG015|Overall Study|Voluntary Withdrawal|0|||
157174173|NCT05567393|567377613|FG016|Overall Study|Voluntary Withdrawal|0|||
157043694|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
157043695|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
157043696|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
157043697|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
157174174|NCT05567393|567377614|FG017|Overall Study|Voluntary Withdrawal|0|||
157043698|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Other|1|||
157043699|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Other|0|||
157043700|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Other|0|||
157043701|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
157043702|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
157043703|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
157043704|NCT00887224|566915938|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
157043705|NCT00887224|566915939|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
157043706|NCT00887224|566915940|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
157043707|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
157043708|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
157043709|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
157043710|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
157043711|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
157043712|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
157043713|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
157043714|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
157043715|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
157043716|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
157043717|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
157043718|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
157043719|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Other|1|||
157043720|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Other|0|||
157043721|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Other|0|||
157043722|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
157043723|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
157043724|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
157043725|NCT00887224|566915938|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
157043726|NCT00887224|566915939|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
157043727|NCT00887224|566915940|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
157043728|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
157043729|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
157043730|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
157043731|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
157043732|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
157043733|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
157043734|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
157043735|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
157043736|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
157043737|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
157043738|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
157043739|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
157043740|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Other|30|||
157043741|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Other|0|||
157043742|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Other|0|||
157043743|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
157043744|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
157043745|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
157043746|NCT00887224|566915938|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
157043747|NCT00887224|566915939|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
157043748|NCT00887224|566915940|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
157043749|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Adverse Event|0|||
157043750|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Adverse Event|7|||
157043751|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Adverse Event|2|||
157043752|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Failed to return|0|||
157043753|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Failed to return|2|||
157043754|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Failed to return|2|||
157043755|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
157043756|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
157174175|NCT02177175|567377617|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
157174176|NCT02177175|567377618|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
157174177|NCT01924299|567377619|FG000|Period 2|Withdrawal by Subject|1|||
157174178|NCT01924299|567377620|FG001|Period 2|Withdrawal by Subject|0|||
157043757|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
157043758|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
157043759|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
157043760|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
157043761|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Other|0|||
157043762|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Other|2|||
157174179|NCT01924299|567377619|FG000|Period 2|Adverse Event|0|||
157174180|NCT01924299|567377620|FG001|Period 2|Adverse Event|1|||
157043763|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Other|0|||
157043764|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
157174181|NCT04199793|567377621|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
157174182|NCT04199793|567377622|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
157174183|NCT04199793|567377621|FG000|Overall Study|Withdrawal by Subject|1|||
157174184|NCT04199793|567377622|FG001|Overall Study|Withdrawal by Subject|1|||
157174185|NCT03820726|567377623|FG000|Overall Study|Other than listed|23|||
157174186|NCT03820726|567377623|FG000|Overall Study|Withdrawal by Subject|37|||
157174187|NCT03820726|567377623|FG000|Overall Study|Lost to Follow-up|3|||
157174188|NCT03820726|567377623|FG000|Overall Study|Protocol deviation|1|||
157174189|NCT03820726|567377623|FG000|Overall Study|Adverse Event|146|||
157174190|NCT03820726|567377623|FG000|Overall Study|Not treated|1|||
157174191|NCT00888615|567377627|FG000|Overall Study|No treatment|2|||
157174192|NCT00861380|567377628|FG000|Overall Study|Withdrawal Information not recorded|8427|||
157174193|NCT00861380|567377629|FG001|Overall Study|Withdrawal Information not recorded|9112|||
157174194|NCT00861380|567377630|FG002|Overall Study|Withdrawal Information not recorded|8872|||
157174195|NCT00861380|567377631|FG003|Overall Study|Withdrawal Information not recorded|3689|||
157174196|NCT00861380|567377632|FG004|Overall Study|Withdrawal Information not recorded|1812|||
157174197|NCT00861380|567377633|FG005|Overall Study|Withdrawal Information not recorded|6249|||
157174198|NCT00861380|567377634|FG006|Overall Study|Withdrawal Information not recorded|3020|||
157174199|NCT00628758|567377635|FG000|Overall Study|Adverse Event|2|||
157174200|NCT00628758|567377636|FG001|Overall Study|Adverse Event|3|||
157174201|NCT00628758|567377635|FG000|Overall Study|Withdrawal by Subject|6|||
157174202|NCT00628758|567377636|FG001|Overall Study|Withdrawal by Subject|3|||
157174203|NCT00628758|567377635|FG000|Overall Study|Death|1|||
157174204|NCT00628758|567377636|FG001|Overall Study|Death|0|||
157174205|NCT00628758|567377635|FG000|Overall Study|Protocol Violation|5|||
157174206|NCT00628758|567377636|FG001|Overall Study|Protocol Violation|1|||
157174207|NCT00628758|567377635|FG000|Overall Study|Lost to Follow-up|25|||
157174208|NCT00628758|567377636|FG001|Overall Study|Lost to Follow-up|31|||
157174209|NCT00628758|567377635|FG000|Overall Study|Pregnancy|2|||
157174210|NCT00628758|567377636|FG001|Overall Study|Pregnancy|2|||
157174211|NCT00628758|567377635|FG000|Overall Study|Investigator Moved|3|||
157174212|NCT00628758|567377636|FG001|Overall Study|Investigator Moved|0|||
157174213|NCT00628758|567377635|FG000|Overall Study|Treatment Failure|0|||
157174214|NCT00628758|567377636|FG001|Overall Study|Treatment Failure|2|||
157174215|NCT01184846|567377637|FG000|Overall Study|Adverse Event|2|||
157174216|NCT01184846|567377637|FG000|Overall Study|Insufficient response|1|||
157174217|NCT03984812|567379722|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174218|NCT03984812|567379723|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174219|NCT03984812|567379724|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
157174220|NCT03984812|567379725|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174221|NCT03984812|567379726|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174222|NCT03984812|567379727|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174223|NCT03984812|567379728|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174224|NCT03984812|567379729|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174225|NCT03984812|567379730|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174226|NCT03984812|567379731|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174227|NCT03984812|567379732|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
157174228|NCT02971007|567379733|FG000|Overall Study|Adverse Event|1|||
157174229|NCT02971007|567379734|FG001|Overall Study|Adverse Event|0|||
157174230|NCT02971007|567379735|FG002|Overall Study|Adverse Event|0|||
157174231|NCT02971007|567379733|FG000|Overall Study|Lost to Follow-up|0|||
157174232|NCT02971007|567379734|FG001|Overall Study|Lost to Follow-up|1|||
157174233|NCT02971007|567379735|FG002|Overall Study|Lost to Follow-up|1|||
157174234|NCT02971007|567379733|FG000|Overall Study|Withdrawal by Subject|0|||
157174235|NCT02971007|567379734|FG001|Overall Study|Withdrawal by Subject|1|||
157174236|NCT02971007|567379735|FG002|Overall Study|Withdrawal by Subject|0|||
157174237|NCT02971007|567379733|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
157174238|NCT02971007|567379734|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
157174239|NCT02971007|567379735|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
157043765|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
157043766|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
157043767|NCT00887224|566915938|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
157043768|NCT00887224|566915939|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
157043769|NCT00887224|566915940|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
157174240|NCT02971007|567379733|FG000|Overall Study|Patient discontinued study drug|0|||
157174241|NCT02971007|567379734|FG001|Overall Study|Patient discontinued study drug|1|||
157174242|NCT02971007|567379735|FG002|Overall Study|Patient discontinued study drug|0|||
157174243|NCT00607919|567379739|FG000|Acute Phase|Adverse Event|9|||
157174244|NCT00607919|567379740|FG001|Acute Phase|Adverse Event|2|||
157043770|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
157174245|NCT00607919|567379739|FG000|Acute Phase|Entry Criteria Not Met|1|||
157174246|NCT00607919|567379740|FG001|Acute Phase|Entry Criteria Not Met|1|||
157174247|NCT00607919|567379739|FG000|Acute Phase|Lack of Efficacy|1|||
157174248|NCT00607919|567379740|FG001|Acute Phase|Lack of Efficacy|2|||
157174249|NCT00607919|567379739|FG000|Acute Phase|Lost to Follow-up|9|||
157043771|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
157043772|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
157043773|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
157043774|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
157043775|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
157043776|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
157043777|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
157043778|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
157043779|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
157043780|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
157043781|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
157043782|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
157043783|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
157043784|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
157043785|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
157043786|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
157043787|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
157043788|NCT00887224|566915938|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
157043789|NCT00887224|566915939|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
157043790|NCT00887224|566915940|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
157043791|NCT03883828|566915941|FG000|Overall Study|Did not start radiotherapy|1|||
157043792|NCT03883828|566915942|FG001|Overall Study|Did not start radiotherapy|2|||
157043793|NCT04938453|566915943|FG000|Washout Period 1|Adverse Event|1|||
157043794|NCT04938453|566915944|FG001|Washout Period 1|Adverse Event|0|||
157043795|NCT04938453|566915943|FG000|Washout Period 1|Physician Decision|0|||
157043796|NCT04938453|566915944|FG001|Washout Period 1|Physician Decision|1|||
157043797|NCT02575365|566915945|FG000|Overall Study|Lost to Follow-up|4|||
157043798|NCT00487240|566915947|FG000|Overall Study|Withdrawal by Subject|12|||
157043799|NCT00487240|566915948|FG001|Overall Study|Withdrawal by Subject|6|||
157043800|NCT00487240|566915947|FG000|Overall Study|Lost to Follow-up|7|||
157043801|NCT00487240|566915948|FG001|Overall Study|Lost to Follow-up|6|||
157043802|NCT00487240|566915947|FG000|Overall Study|Adverse Event|0|||
157043803|NCT00487240|566915948|FG001|Overall Study|Adverse Event|4|||
157043804|NCT00487240|566915947|FG000|Overall Study|Protocol Violation|5|||
157043805|NCT00487240|566915948|FG001|Overall Study|Protocol Violation|5|||
157174250|NCT00607919|567379740|FG001|Acute Phase|Lost to Follow-up|3|||
157174251|NCT00607919|567379739|FG000|Acute Phase|Parent/Caregiver Decision|6|||
157174252|NCT00607919|567379740|FG001|Acute Phase|Parent/Caregiver Decision|4|||
157174253|NCT00607919|567379739|FG000|Acute Phase|Protocol Violation|5|||
157174254|NCT00607919|567379740|FG001|Acute Phase|Protocol Violation|1|||
157174255|NCT00607919|567379739|FG000|Acute Phase|Withdrawal by Subject|3|||
157174256|NCT00607919|567379740|FG001|Acute Phase|Withdrawal by Subject|3|||
157174257|NCT00607919|567379739|FG000|Open-Label Phase|Adverse Event|1|||
157174258|NCT00607919|567379740|FG001|Open-Label Phase|Adverse Event|5|||
157174259|NCT00607919|567379739|FG000|Open-Label Phase|Lost to Follow-up|4|||
157174260|NCT00607919|567379740|FG001|Open-Label Phase|Lost to Follow-up|1|||
157174261|NCT00607919|567379739|FG000|Open-Label Phase|Protocol Violation|2|||
157174262|NCT00607919|567379740|FG001|Open-Label Phase|Protocol Violation|2|||
157174263|NCT00607919|567379739|FG000|Open-Label Phase|Withdrawal by Subject|2|||
157174264|NCT00607919|567379740|FG001|Open-Label Phase|Withdrawal by Subject|2|||
157174265|NCT00607919|567379739|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
157174266|NCT00607919|567379740|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
157174267|NCT02580240|567379741|FG000|Overall Study|Physician Decision|2|||
157174268|NCT02580240|567379742|FG001|Overall Study|Physician Decision|0|||
157174269|NCT02001688|567379743|FG000|Overall Study|Withdrawal by Subject|0|||
157174270|NCT02001688|567379744|FG001|Overall Study|Withdrawal by Subject|0|||
157174271|NCT02001688|567379745|FG002|Overall Study|Withdrawal by Subject|1|||
157174272|NCT02001688|567379743|FG000|Overall Study|Adverse Event|0|||
157174273|NCT02001688|567379744|FG001|Overall Study|Adverse Event|1|||
157174274|NCT02001688|567379745|FG002|Overall Study|Adverse Event|0|||
157174275|NCT01675141|567379747|FG000|Overall Study|Lenalidomide outside NIH|3|||
157174276|NCT01675141|567379747|FG000|Overall Study|Withdrawal by Subject|3|||
157174277|NCT01675141|567379747|FG000|Overall Study|Physician Decision|4|||
157174278|NCT01675141|567379747|FG000|Overall Study|No treatment, per protocol|1|||
157174279|NCT00105183|567379751|FG000|Overall Study|Death|19|||
157174280|NCT00105183|567379752|FG001|Overall Study|Death|13|||
157174281|NCT00105183|567379753|FG002|Overall Study|Death|15|||
157174282|NCT00105183|567379751|FG000|Overall Study|Withdrawal by Subject|1|||
157174283|NCT00105183|567379752|FG001|Overall Study|Withdrawal by Subject|1|||
157174284|NCT00105183|567379753|FG002|Overall Study|Withdrawal by Subject|4|||
157174285|NCT00105183|567379751|FG000|Overall Study|Physician Decision|1|||
157174286|NCT00105183|567379752|FG001|Overall Study|Physician Decision|2|||
157174287|NCT00105183|567379753|FG002|Overall Study|Physician Decision|3|||
157174288|NCT00105183|567379751|FG000|Overall Study|Lost to Follow-up|0|||
157043806|NCT00487240|566915947|FG000|Overall Study|Entry Criteria Not Met|3|||
157043807|NCT00487240|566915948|FG001|Overall Study|Entry Criteria Not Met|4|||
157043808|NCT00487240|566915947|FG000|Overall Study|Sponsor Decision|2|||
157043809|NCT00487240|566915948|FG001|Overall Study|Sponsor Decision|1|||
157043810|NCT00487240|566915947|FG000|Overall Study|Physician Decision|2|||
157043811|NCT00487240|566915948|FG001|Overall Study|Physician Decision|0|||
157043812|NCT01698918|566915949|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
157043813|NCT01698918|566915949|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
157043814|NCT01698918|566915949|FG000|First Line Treatment (Core+Extension)|Death|2|||
157043815|NCT01698918|566915949|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
157043816|NCT01698918|566915949|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
157043817|NCT01698918|566915949|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
157043818|NCT01698918|566915949|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
157043819|NCT01698918|566915949|FG000|Second Line Treatment (Core+Extension)|Death|1|||
157043820|NCT01698918|566915949|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
157043821|NCT01698918|566915949|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
157043822|NCT03176407|566915950|FG000|Overall Study|Protocol Violation|1|||
157043823|NCT03176407|566915950|FG000|Overall Study|human failure|1|||
157043824|NCT03176407|566915950|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
157043825|NCT01428583|566915952|FG000|Overall Study|Adverse Event|75|||
157043826|NCT01428583|566915952|FG000|Overall Study|Withdrawal by Subject|51|||
157043827|NCT01428583|566915952|FG000|Overall Study|Lack of Efficacy|37|||
157043828|NCT01428583|566915952|FG000|Overall Study|Lost to Follow-up|17|||
157043829|NCT01428583|566915952|FG000|Overall Study|Death|1|||
157043830|NCT01428583|566915952|FG000|Overall Study|Pregnancy|1|||
157043831|NCT01428583|566915952|FG000|Overall Study|Protocol Violation|1|||
157043832|NCT01428583|566915952|FG000|Overall Study|Physician Decision|12|||
157043833|NCT01428583|566915952|FG000|Overall Study|Non-compliant|25|||
157043834|NCT01428583|566915952|FG000|Overall Study|Confirmed positive urine drug test|8|||
157043835|NCT01428583|566915952|FG000|Overall Study|Sponsor's request|3|||
157043836|NCT01428583|566915952|FG000|Overall Study|Other|6|||
157043837|NCT00768755|566915956|FG000|Phase 1|Death|6|||
157043838|NCT00768755|566915957|FG001|Phase 1|Death|0|||
157043839|NCT00768755|566915958|FG002|Phase 1|Death|0|||
157043840|NCT00768755|566915959|FG003|Phase 1|Death|0|||
157043841|NCT00768755|566915956|FG000|Phase 1|Other|4|||
157043842|NCT00768755|566915957|FG001|Phase 1|Other|0|||
157043843|NCT00768755|566915958|FG002|Phase 1|Other|0|||
157043844|NCT00768755|566915959|FG003|Phase 1|Other|0|||
157043845|NCT00768755|566915956|FG000|Phase 2|Death|0|||
157043846|NCT00768755|566915957|FG001|Phase 2|Death|37|||
157043847|NCT00768755|566915958|FG002|Phase 2|Death|48|||
157043848|NCT00768755|566915959|FG003|Phase 2|Death|31|||
157043849|NCT00768755|566915956|FG000|Phase 2|Protocol Violation|0|||
157043850|NCT00768755|566915957|FG001|Phase 2|Protocol Violation|2|||
157043851|NCT00768755|566915958|FG002|Phase 2|Protocol Violation|0|||
157043852|NCT00768755|566915959|FG003|Phase 2|Protocol Violation|1|||
157043853|NCT00768755|566915956|FG000|Phase 2|Lost to Follow-up|0|||
157043854|NCT00768755|566915957|FG001|Phase 2|Lost to Follow-up|1|||
157043855|NCT00768755|566915958|FG002|Phase 2|Lost to Follow-up|1|||
157043856|NCT00768755|566915959|FG003|Phase 2|Lost to Follow-up|4|||
157043857|NCT00768755|566915956|FG000|Phase 2|Withdrawal by Subject|0|||
157043858|NCT00768755|566915957|FG001|Phase 2|Withdrawal by Subject|1|||
157043859|NCT00768755|566915958|FG002|Phase 2|Withdrawal by Subject|0|||
157043860|NCT00768755|566915959|FG003|Phase 2|Withdrawal by Subject|1|||
157043861|NCT00768755|566915956|FG000|Phase 2|Other|0|||
157043862|NCT00768755|566915957|FG001|Phase 2|Other|1|||
157043863|NCT00768755|566915958|FG002|Phase 2|Other|2|||
157043864|NCT00768755|566915959|FG003|Phase 2|Other|4|||
157043865|NCT00768755|566915956|FG000|Phase 2|Study Terminated by Sponsor|0|||
157043866|NCT00768755|566915957|FG001|Phase 2|Study Terminated by Sponsor|13|||
157043867|NCT00768755|566915958|FG002|Phase 2|Study Terminated by Sponsor|7|||
157043868|NCT00768755|566915959|FG003|Phase 2|Study Terminated by Sponsor|14|||
157043869|NCT00768755|566915956|FG000|Phase 2|Randomized but not treated|0|||
157043870|NCT00768755|566915957|FG001|Phase 2|Randomized but not treated|0|||
157043871|NCT00768755|566915958|FG002|Phase 2|Randomized but not treated|0|||
157043872|NCT00768755|566915959|FG003|Phase 2|Randomized but not treated|2|||
157043873|NCT00670488|566915960|FG000|Overall Study|Adverse Event|0|||
157043874|NCT00670488|566915961|FG001|Overall Study|Adverse Event|7|||
157174289|NCT00105183|567379752|FG001|Overall Study|Lost to Follow-up|1|||
157043875|NCT00670488|566915962|FG002|Overall Study|Adverse Event|0|||
157043876|NCT00670488|566915963|FG003|Overall Study|Adverse Event|3|||
157043877|NCT00670488|566915964|FG004|Overall Study|Adverse Event|1|||
157043878|NCT00670488|566915965|FG005|Overall Study|Adverse Event|1|||
157043879|NCT00670488|566915966|FG006|Overall Study|Adverse Event|5|||
157043880|NCT00670488|566915967|FG007|Overall Study|Adverse Event|1|||
157043881|NCT00670488|566915968|FG008|Overall Study|Adverse Event|0|||
157043882|NCT00670488|566915969|FG009|Overall Study|Adverse Event|1|||
157043883|NCT00670488|566915960|FG000|Overall Study|Physician Decision|1|||
157043884|NCT00670488|566915961|FG001|Overall Study|Physician Decision|9|||
157043885|NCT00670488|566915962|FG002|Overall Study|Physician Decision|0|||
157043886|NCT00670488|566915963|FG003|Overall Study|Physician Decision|1|||
157043887|NCT00670488|566915964|FG004|Overall Study|Physician Decision|0|||
157043888|NCT00670488|566915965|FG005|Overall Study|Physician Decision|0|||
157043889|NCT00670488|566915966|FG006|Overall Study|Physician Decision|0|||
157043890|NCT00670488|566915967|FG007|Overall Study|Physician Decision|0|||
157043891|NCT00670488|566915968|FG008|Overall Study|Physician Decision|0|||
157043892|NCT00670488|566915969|FG009|Overall Study|Physician Decision|0|||
157043893|NCT00670488|566915960|FG000|Overall Study|Progressive Disease|2|||
157043894|NCT00670488|566915961|FG001|Overall Study|Progressive Disease|41|||
157043895|NCT00670488|566915962|FG002|Overall Study|Progressive Disease|3|||
157043896|NCT00670488|566915963|FG003|Overall Study|Progressive Disease|2|||
157043897|NCT00670488|566915964|FG004|Overall Study|Progressive Disease|2|||
157043898|NCT00670488|566915965|FG005|Overall Study|Progressive Disease|4|||
157043899|NCT00670488|566915966|FG006|Overall Study|Progressive Disease|11|||
157043900|NCT00670488|566915967|FG007|Overall Study|Progressive Disease|2|||
157043901|NCT00670488|566915968|FG008|Overall Study|Progressive Disease|2|||
157043902|NCT00670488|566915969|FG009|Overall Study|Progressive Disease|1|||
157043903|NCT00670488|566915960|FG000|Overall Study|Withdrawal by Subject|0|||
157043904|NCT00670488|566915961|FG001|Overall Study|Withdrawal by Subject|1|||
157043905|NCT00670488|566915962|FG002|Overall Study|Withdrawal by Subject|0|||
157043906|NCT00670488|566915963|FG003|Overall Study|Withdrawal by Subject|1|||
157043907|NCT00670488|566915964|FG004|Overall Study|Withdrawal by Subject|0|||
157043908|NCT00670488|566915965|FG005|Overall Study|Withdrawal by Subject|0|||
157043909|NCT00670488|566915966|FG006|Overall Study|Withdrawal by Subject|1|||
157043910|NCT00670488|566915967|FG007|Overall Study|Withdrawal by Subject|0|||
157043911|NCT00670488|566915968|FG008|Overall Study|Withdrawal by Subject|1|||
157043912|NCT00670488|566915969|FG009|Overall Study|Withdrawal by Subject|0|||
157043913|NCT00878189|566915970|FG000|Overall Study|Death|0|||
157043914|NCT00878189|566915971|FG001|Overall Study|Death|1|||
157043915|NCT00878189|566915972|FG002|Overall Study|Death|0|||
157043916|NCT00878189|566915973|FG003|Overall Study|Death|1|||
157043917|NCT00878189|566915974|FG004|Overall Study|Death|0|||
157043918|NCT00878189|566915975|FG005|Overall Study|Death|0|||
157043919|NCT00878189|566915976|FG006|Overall Study|Death|0|||
157043920|NCT00878189|566915977|FG007|Overall Study|Death|0|||
157043921|NCT00878189|566915978|FG008|Overall Study|Death|1|||
157043922|NCT00878189|566915970|FG000|Overall Study|Participant Refused to Follow-up|0|||
157043923|NCT00878189|566915971|FG001|Overall Study|Participant Refused to Follow-up|0|||
157043924|NCT00878189|566915972|FG002|Overall Study|Participant Refused to Follow-up|0|||
157043925|NCT00878189|566915973|FG003|Overall Study|Participant Refused to Follow-up|0|||
157043926|NCT00878189|566915974|FG004|Overall Study|Participant Refused to Follow-up|0|||
157043927|NCT00878189|566915975|FG005|Overall Study|Participant Refused to Follow-up|4|||
157043928|NCT00878189|566915976|FG006|Overall Study|Participant Refused to Follow-up|0|||
157043929|NCT00878189|566915977|FG007|Overall Study|Participant Refused to Follow-up|0|||
157043930|NCT00878189|566915978|FG008|Overall Study|Participant Refused to Follow-up|0|||
157043931|NCT00878189|566915970|FG000|Overall Study|Other|3|||
157043932|NCT00878189|566915971|FG001|Overall Study|Other|2|||
157043933|NCT00878189|566915972|FG002|Overall Study|Other|4|||
157043934|NCT00878189|566915973|FG003|Overall Study|Other|7|||
157043935|NCT00878189|566915974|FG004|Overall Study|Other|4|||
157043936|NCT00878189|566915975|FG005|Overall Study|Other|18|||
157043937|NCT00878189|566915976|FG006|Overall Study|Other|15|||
157043938|NCT00878189|566915977|FG007|Overall Study|Other|3|||
157043939|NCT00878189|566915978|FG008|Overall Study|Other|4|||
157043940|NCT00878189|566915970|FG000|Overall Study|Lost to Follow-up|0|||
157043941|NCT00878189|566915971|FG001|Overall Study|Lost to Follow-up|0|||
157043942|NCT00878189|566915972|FG002|Overall Study|Lost to Follow-up|0|||
157043943|NCT00878189|566915973|FG003|Overall Study|Lost to Follow-up|0|||
157043944|NCT00878189|566915974|FG004|Overall Study|Lost to Follow-up|0|||
157043945|NCT00878189|566915975|FG005|Overall Study|Lost to Follow-up|1|||
157043946|NCT00878189|566915976|FG006|Overall Study|Lost to Follow-up|1|||
157043947|NCT00878189|566915977|FG007|Overall Study|Lost to Follow-up|0|||
157043948|NCT00878189|566915978|FG008|Overall Study|Lost to Follow-up|0|||
157043949|NCT00878189|566915970|FG000|Overall Study|Objection Progression or Relapse|0|||
157043950|NCT00878189|566915971|FG001|Overall Study|Objection Progression or Relapse|0|||
157043951|NCT00878189|566915972|FG002|Overall Study|Objection Progression or Relapse|0|||
157043952|NCT00878189|566915973|FG003|Overall Study|Objection Progression or Relapse|0|||
157043953|NCT00878189|566915974|FG004|Overall Study|Objection Progression or Relapse|0|||
157043954|NCT00878189|566915975|FG005|Overall Study|Objection Progression or Relapse|0|||
157043955|NCT00878189|566915976|FG006|Overall Study|Objection Progression or Relapse|0|||
157043956|NCT00878189|566915977|FG007|Overall Study|Objection Progression or Relapse|0|||
157043957|NCT00878189|566915978|FG008|Overall Study|Objection Progression or Relapse|3|||
157043958|NCT04693637|566915979|FG000|Overall Study|Death|4|||
157043959|NCT04693637|566915979|FG000|Overall Study|Withdrawal by Subject|3|||
157043960|NCT04693637|566915979|FG000|Overall Study|Physician Decision|2|||
157043961|NCT04693637|566915979|FG000|Overall Study|Lost to Follow-up|1|||
157174290|NCT00105183|567379753|FG002|Overall Study|Lost to Follow-up|1|||
157043962|NCT04237792|566915980|FG000|Treatment (Day 1)|Adverse Event|1|||
157043963|NCT04237792|566915981|FG001|Treatment (Day 1)|Adverse Event|0|||
157043964|NCT04237792|566915982|FG002|Treatment (Day 1)|Adverse Event|0|||
157043965|NCT04237792|566915983|FG003|Treatment (Day 1)|Adverse Event|0|||
157043966|NCT04237792|566915984|FG004|Treatment (Day 1)|Adverse Event|1|||
157043967|NCT04237792|566915985|FG005|Treatment (Day 1)|Adverse Event|1|||
157043968|NCT04237792|566915980|FG000|Treatment (Day 1)|Other|0|||
157043969|NCT04237792|566915981|FG001|Treatment (Day 1)|Other|0|||
157043970|NCT04237792|566915982|FG002|Treatment (Day 1)|Other|1|||
157043971|NCT04237792|566915983|FG003|Treatment (Day 1)|Other|0|||
157043972|NCT04237792|566915984|FG004|Treatment (Day 1)|Other|0|||
157043973|NCT04237792|566915985|FG005|Treatment (Day 1)|Other|1|||
157043974|NCT04237792|566915980|FG000|Treatment (Day 1)|Not treated|1|||
157043975|NCT04237792|566915981|FG001|Treatment (Day 1)|Not treated|1|||
157043976|NCT04237792|566915982|FG002|Treatment (Day 1)|Not treated|2|||
157043977|NCT04237792|566915983|FG003|Treatment (Day 1)|Not treated|1|||
157043978|NCT04237792|566915984|FG004|Treatment (Day 1)|Not treated|0|||
157043979|NCT04237792|566915985|FG005|Treatment (Day 1)|Not treated|1|||
157043980|NCT04885998|566915986|FG000|Overall Study|Withdrawal by Subject|0|||
157043981|NCT04885998|566915987|FG001|Overall Study|Withdrawal by Subject|2|||
157043982|NCT04885998|566915988|FG002|Overall Study|Withdrawal by Subject|0|||
157043983|NCT04885998|566915989|FG003|Overall Study|Withdrawal by Subject|3|||
157043984|NCT04885998|566915986|FG000|Overall Study|Lost to Follow-up|1|||
157043985|NCT04885998|566915987|FG001|Overall Study|Lost to Follow-up|1|||
157043986|NCT04885998|566915988|FG002|Overall Study|Lost to Follow-up|0|||
157043987|NCT04885998|566915989|FG003|Overall Study|Lost to Follow-up|0|||
157043988|NCT04885998|566915986|FG000|Overall Study|Death|2|||
157043989|NCT04885998|566915987|FG001|Overall Study|Death|1|||
157043990|NCT04885998|566915988|FG002|Overall Study|Death|2|||
157043991|NCT04885998|566915989|FG003|Overall Study|Death|2|||
157043992|NCT04885998|566915986|FG000|Overall Study|Decision by sponsor|1|||
157043993|NCT04885998|566915987|FG001|Overall Study|Decision by sponsor|1|||
157043994|NCT04885998|566915988|FG002|Overall Study|Decision by sponsor|0|||
157043995|NCT04885998|566915989|FG003|Overall Study|Decision by sponsor|0|||
157043996|NCT05260437|566915990|FG000|Overall Study|Lost to Follow-up|5|||
157043997|NCT05260437|566915991|FG001|Overall Study|Lost to Follow-up|2|||
157043998|NCT05260437|566915992|FG002|Overall Study|Lost to Follow-up|1|||
157043999|NCT05260437|566915993|FG003|Overall Study|Lost to Follow-up|2|||
157044000|NCT05260437|566915994|FG004|Overall Study|Lost to Follow-up|2|||
157044001|NCT05260437|566915990|FG000|Overall Study|Withdrawal by Subject|3|||
157044002|NCT05260437|566915991|FG001|Overall Study|Withdrawal by Subject|0|||
157044003|NCT05260437|566915992|FG002|Overall Study|Withdrawal by Subject|4|||
157044004|NCT05260437|566915993|FG003|Overall Study|Withdrawal by Subject|5|||
157044005|NCT05260437|566915994|FG004|Overall Study|Withdrawal by Subject|0|||
157044006|NCT05260437|566915990|FG000|Overall Study|Vaccine Not Administered|0|||
157044007|NCT05260437|566915991|FG001|Overall Study|Vaccine Not Administered|1|||
157044008|NCT05260437|566915992|FG002|Overall Study|Vaccine Not Administered|0|||
157044009|NCT05260437|566915993|FG003|Overall Study|Vaccine Not Administered|0|||
157044010|NCT05260437|566915994|FG004|Overall Study|Vaccine Not Administered|0|||
157044011|NCT00910962|566915995|FG000|Overall Study|Adverse Event|5|||
157044012|NCT00910962|566915996|FG001|Overall Study|Adverse Event|20|||
157044013|NCT00910962|566915997|FG002|Overall Study|Adverse Event|17|||
157044014|NCT00910962|566915995|FG000|Overall Study|Protocol Violation|1|||
157044015|NCT00910962|566915996|FG001|Overall Study|Protocol Violation|3|||
157044016|NCT00910962|566915997|FG002|Overall Study|Protocol Violation|3|||
157044017|NCT00910962|566915995|FG000|Overall Study|Lost to Follow-up|0|||
157044018|NCT00910962|566915996|FG001|Overall Study|Lost to Follow-up|3|||
157044019|NCT00910962|566915997|FG002|Overall Study|Lost to Follow-up|1|||
157044020|NCT00910962|566915995|FG000|Overall Study|Physician Decision|0|||
157044021|NCT00910962|566915996|FG001|Overall Study|Physician Decision|6|||
157044022|NCT00910962|566915997|FG002|Overall Study|Physician Decision|6|||
157044023|NCT00910962|566915995|FG000|Overall Study|Withdrawal by Subject|25|||
157044024|NCT00910962|566915996|FG001|Overall Study|Withdrawal by Subject|32|||
157044025|NCT00910962|566915997|FG002|Overall Study|Withdrawal by Subject|32|||
157044026|NCT00910962|566915995|FG000|Overall Study|Reached defined stopping criteria|12|||
157044027|NCT00910962|566915996|FG001|Overall Study|Reached defined stopping criteria|14|||
157174291|NCT00105183|567379751|FG000|Overall Study|Other reason|1|||
157174292|NCT00105183|567379752|FG001|Overall Study|Other reason|2|||
157044028|NCT00910962|566915997|FG002|Overall Study|Reached defined stopping criteria|17|||
157044029|NCT00195819|566915998|FG000|Double-Blind|Withdrawal by Subject|1|||
157044030|NCT00195819|566915999|FG001|Double-Blind|Withdrawal by Subject|0|||
157044031|NCT00195819|566915998|FG000|Double-Blind|Moved|1|||
157044032|NCT00195819|566915999|FG001|Double-Blind|Moved|0|||
157044033|NCT00195819|566915998|FG000|Open-label|Adverse Event|0|||
157044034|NCT00195819|566915999|FG001|Open-label|Adverse Event|9|||
157044035|NCT00195819|566915998|FG000|Open-label|Lack of Efficacy|0|||
157044036|NCT00195819|566915999|FG001|Open-label|Lack of Efficacy|2|||
157044037|NCT00195819|566915998|FG000|Open-label|Pregnancy|0|||
157044038|NCT00195819|566915999|FG001|Open-label|Pregnancy|1|||
157044039|NCT00195819|566915998|FG000|Open-label|Protocol Violation|0|||
157044040|NCT00195819|566915999|FG001|Open-label|Protocol Violation|2|||
157044041|NCT00195819|566915998|FG000|Open-label|Moved|0|||
157044042|NCT00195819|566915999|FG001|Open-label|Moved|1|||
157044043|NCT00195819|566915998|FG000|Open-label|Withdrawal by Subject|0|||
157044044|NCT00195819|566915999|FG001|Open-label|Withdrawal by Subject|5|||
157044045|NCT00787176|566916000|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
157044046|NCT00787176|566916001|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
157044047|NCT00787176|566916002|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
157044048|NCT00787176|566916003|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
157044049|NCT01124045|566916004|FG000|Overall Study|Lost to Follow-up|0|||
157044050|NCT01124045|566916005|FG001|Overall Study|Lost to Follow-up|1|||
157044051|NCT01124045|566916004|FG000|Overall Study|Physician Decision|0|||
157044052|NCT01124045|566916005|FG001|Overall Study|Physician Decision|2|||
157044053|NCT03298087|566916009|FG000|Overall Study|Withdrawal by Subject|4|||
157044054|NCT03274076|566916010|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
157044055|NCT03274076|566916011|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
157044056|NCT03274076|566916012|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
157044057|NCT03274076|566916013|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
157044058|NCT03274076|566916010|FG000|24 Weeks Open Label|Adverse Event|0|||
157044059|NCT03274076|566916011|FG001|24 Weeks Open Label|Adverse Event|0|||
157044060|NCT03274076|566916012|FG002|24 Weeks Open Label|Adverse Event|2|||
157044061|NCT03274076|566916013|FG003|24 Weeks Open Label|Adverse Event|0|||
157044062|NCT03274076|566916010|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
157044063|NCT03274076|566916011|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
157044064|NCT03274076|566916012|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
157044065|NCT03274076|566916013|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
157044066|NCT01303510|566916014|FG000|Overall Study|Lost to Follow-up|1|||
157044067|NCT01303510|566916015|FG001|Overall Study|Lost to Follow-up|0|||
157044068|NCT00701415|566916020|FG000|Overall Study|Adverse Event|0|||
157044069|NCT00701415|566916021|FG001|Overall Study|Adverse Event|1|||
157044070|NCT00701415|566916020|FG000|Overall Study|Social/family issues and needle phobia|1|||
157044071|NCT00701415|566916021|FG001|Overall Study|Social/family issues and needle phobia|0|||
157044072|NCT02022670|566916024|FG000|Overall Study|Adverse Event|1|||
157044073|NCT02022670|566916025|FG001|Overall Study|Adverse Event|0|||
157044074|NCT02022670|566916026|FG002|Overall Study|Adverse Event|1|||
157044075|NCT02113449|566916027|FG000|Overall Study|Adverse Event|4|||
157044076|NCT04638816|566916028|FG000|Overall Study|Withdrawal by Subject|0|||
157044077|NCT04638816|566916029|FG001|Overall Study|Withdrawal by Subject|1|||
157044078|NCT04638816|566916028|FG000|Overall Study|Lost to Follow-up|0|||
157044079|NCT04638816|566916029|FG001|Overall Study|Lost to Follow-up|1|||
157044080|NCT01328496|566916032|FG000|Overall Study|Significant Change in Health Status|1|||
157044081|NCT01328496|566916033|FG001|Overall Study|Significant Change in Health Status|0|||
157044082|NCT02208843|566916036|FG000|Overall Study|Clinical symptoms of progression|2|||
157044083|NCT02208843|566916036|FG000|Overall Study|Progression disease according to RECIST|24|||
157044084|NCT02208843|566916036|FG000|Overall Study|Adverse Event|12|||
157044085|NCT02208843|566916036|FG000|Overall Study|Protocol Violation|1|||
157044086|NCT02208843|566916036|FG000|Overall Study|Withdrawal by Subject|1|||
157044087|NCT02208843|566916036|FG000|Overall Study|Switched to commercial afatinib|20|||
157044088|NCT03822832|566916042|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
157044089|NCT03822832|566916043|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
157044090|NCT03822832|566916042|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
157044091|NCT03822832|566916043|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
157044092|NCT03822832|566916042|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
157044093|NCT03822832|566916043|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
157044094|NCT03822832|566916042|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
157044095|NCT03822832|566916043|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
157044096|NCT03822832|566916042|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
157044097|NCT03822832|566916043|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
157044098|NCT03822832|566916042|FG000|Re-allocation|Not re-allocated to open label period|2|||
157044099|NCT03822832|566916043|FG001|Re-allocation|Not re-allocated to open label period|6|||
157044100|NCT03822832|566916042|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
157044101|NCT03822832|566916043|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
157044102|NCT03822832|566916042|FG000|Period 2 - Open Label Period|Adverse Event|0|||
157044103|NCT03822832|566916043|FG001|Period 2 - Open Label Period|Adverse Event|3|||
157044104|NCT04248803|566916044|FG000|Overall Study|Lost to Follow-up|7|||
157044105|NCT04248803|566916045|FG001|Overall Study|Lost to Follow-up|7|||
157044106|NCT04248803|566916046|FG002|Overall Study|Lost to Follow-up|7|||
157044107|NCT04248803|566916047|FG003|Overall Study|Lost to Follow-up|7|||
157044108|NCT04248803|566916048|FG004|Overall Study|Lost to Follow-up|7|||
157044109|NCT04248803|566916049|FG005|Overall Study|Lost to Follow-up|7|||
157044110|NCT05352230|566916050|FG000|First Intervention (3 Months)|study terminated|2|||
157044111|NCT05352230|566916051|FG001|First Intervention (3 Months)|study terminated|2|||
157044112|NCT04399837|566916052|FG000|Overall Study|Other than listed|0|||
157044113|NCT04399837|566916053|FG001|Overall Study|Other than listed|2|||
157044114|NCT04399837|566916054|FG002|Overall Study|Other than listed|2|||
157044115|NCT04399837|566916055|FG003|Overall Study|Other than listed|3|||
157044116|NCT04399837|566916052|FG000|Overall Study|Withdrawal by Subject|1|||
157228690|NCT01193608|567583332|FG003|Overall Study|Adverse Event|0|||
157228691|NCT01193608|567583333|FG004|Overall Study|Adverse Event|1|||
157228692|NCT01193608|567583334|FG005|Overall Study|Adverse Event|0|||
157228693|NCT02674334|567583339|FG000|Overall Study|Lost to Follow-up|5|||
157228694|NCT02674334|567583340|FG001|Overall Study|Lost to Follow-up|3|||
157228695|NCT02674334|567583339|FG000|Overall Study|participant difficulty breathing|1|||
157228696|NCT02674334|567583340|FG001|Overall Study|participant difficulty breathing|0|||
157228697|NCT02674334|567583339|FG000|Overall Study|NIRS not recording|1|||
157228698|NCT02674334|567583340|FG001|Overall Study|NIRS not recording|0|||
157228699|NCT00860405|567583345|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
157228700|NCT00860405|567583346|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
157228701|NCT00864097|567583347|FG000|Overall Study|Death|0|||
157228702|NCT00864097|567583348|FG001|Overall Study|Death|1|||
157228703|NCT00864097|567583349|FG002|Overall Study|Death|0|||
157228704|NCT00864097|567583350|FG003|Overall Study|Death|0|||
157228705|NCT00864097|567583347|FG000|Overall Study|Adverse Event|6|||
157228706|NCT00864097|567583348|FG001|Overall Study|Adverse Event|8|||
157228707|NCT00864097|567583349|FG002|Overall Study|Adverse Event|11|||
157228708|NCT00864097|567583350|FG003|Overall Study|Adverse Event|9|||
157228709|NCT00864097|567583347|FG000|Overall Study|Lack of Efficacy|9|||
157228710|NCT00864097|567583348|FG001|Overall Study|Lack of Efficacy|3|||
157228711|NCT00864097|567583349|FG002|Overall Study|Lack of Efficacy|7|||
157228712|NCT00864097|567583350|FG003|Overall Study|Lack of Efficacy|2|||
157228713|NCT00864097|567583347|FG000|Overall Study|Lost to Follow-up|0|||
157228714|NCT00864097|567583348|FG001|Overall Study|Lost to Follow-up|1|||
157228715|NCT00864097|567583349|FG002|Overall Study|Lost to Follow-up|0|||
157228716|NCT00864097|567583350|FG003|Overall Study|Lost to Follow-up|1|||
157228717|NCT00864097|567583347|FG000|Overall Study|Withdrawal by Subject|15|||
156968670|NCT02421666|566637642|FG001|12-month Follow-up|Lost to Follow-up|5|||
156968671|NCT02421666|566637641|FG000|12-month Follow-up|Withdrawal by Subject|6|||
156968672|NCT02421666|566637642|FG001|12-month Follow-up|Withdrawal by Subject|11|||
156968673|NCT04681729|566637658|FG000|Overall Study|Lack of Efficacy|2|||
156968674|NCT04681729|566637659|FG001|Overall Study|Lack of Efficacy|2|||
156968675|NCT04681729|566637658|FG000|Overall Study|Withdrawal by Subject|8|||
156968676|NCT04681729|566637659|FG001|Overall Study|Withdrawal by Subject|9|||
156968677|NCT02436811|566637660|FG000|Overall Study|Lost to Follow-up|2|||
156968678|NCT02436811|566637661|FG001|Overall Study|Lost to Follow-up|9|||
156968679|NCT02436811|566637662|FG002|Overall Study|Lost to Follow-up|7|||
156968680|NCT04209725|566637663|FG000|Overall Study|Adverse Event|1|||
156968681|NCT03494166|566637666|FG000|Overall Study|Death|0|||
156968682|NCT03494166|566637667|FG001|Overall Study|Death|0|||
156968683|NCT03494166|566637668|FG002|Overall Study|Death|0|||
156968684|NCT03494166|566637669|FG003|Overall Study|Death|1|||
156968685|NCT03494166|566637670|FG004|Overall Study|Death|3|||
156968686|NCT03494166|566637671|FG005|Overall Study|Death|0|||
156968687|NCT03494166|566637666|FG000|Overall Study|Lost to Follow-up|2|||
156968688|NCT03494166|566637667|FG001|Overall Study|Lost to Follow-up|2|||
156968689|NCT03494166|566637668|FG002|Overall Study|Lost to Follow-up|2|||
156968690|NCT03494166|566637669|FG003|Overall Study|Lost to Follow-up|2|||
156968691|NCT03494166|566637670|FG004|Overall Study|Lost to Follow-up|14|||
156968692|NCT03494166|566637671|FG005|Overall Study|Lost to Follow-up|0|||
156968693|NCT03494166|566637666|FG000|Overall Study|Withdrawal by Subject|10|||
156968694|NCT03494166|566637667|FG001|Overall Study|Withdrawal by Subject|7|||
156968695|NCT03494166|566637668|FG002|Overall Study|Withdrawal by Subject|0|||
156968696|NCT03494166|566637669|FG003|Overall Study|Withdrawal by Subject|5|||
156968697|NCT03494166|566637670|FG004|Overall Study|Withdrawal by Subject|3|||
156968698|NCT03494166|566637671|FG005|Overall Study|Withdrawal by Subject|17|||
156968699|NCT03494166|566637666|FG000|Overall Study|Screen failure|1|||
156968700|NCT03494166|566637667|FG001|Overall Study|Screen failure|0|||
156968701|NCT03494166|566637668|FG002|Overall Study|Screen failure|0|||
156968702|NCT03494166|566637669|FG003|Overall Study|Screen failure|0|||
156968703|NCT03494166|566637670|FG004|Overall Study|Screen failure|1|||
156968704|NCT03494166|566637671|FG005|Overall Study|Screen failure|0|||
156968705|NCT02277990|566637672|FG000|Overall Study|Death|170|||
156968706|NCT02277990|566637673|FG001|Overall Study|Death|188|||
156968707|NCT02277990|566637672|FG000|Overall Study|Withdrawal by Subject|64|||
156968708|NCT02277990|566637673|FG001|Overall Study|Withdrawal by Subject|53|||
156968709|NCT02277990|566637672|FG000|Overall Study|Physician Decision|40|||
156968710|NCT02277990|566637673|FG001|Overall Study|Physician Decision|34|||
156968711|NCT02277990|566637672|FG000|Overall Study|Lost to Follow-up|66|||
156968712|NCT02277990|566637673|FG001|Overall Study|Lost to Follow-up|69|||
156968713|NCT02277990|566637672|FG000|Overall Study|Had other reason|26|||
156968714|NCT02277990|566637673|FG001|Overall Study|Had other reason|32|||
156968715|NCT04179032|566637676|FG000|Part B (Up to Week 52)|Adverse Event|1|||
157228718|NCT00864097|567583348|FG001|Overall Study|Withdrawal by Subject|11|||
156968716|NCT04179032|566637676|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
156968717|NCT04179032|566637676|FG000|Access Extension Phase|Ongoing|11|||
156968718|NCT04393441|566637678|FG000|Overall Study|Adverse Event|0|||
156968719|NCT04393441|566637679|FG001|Overall Study|Adverse Event|3|||
156968720|NCT04393441|566637678|FG000|Overall Study|Withdrawal by Subject|5|||
157044117|NCT04399837|566916053|FG001|Overall Study|Withdrawal by Subject|2|||
157044118|NCT04399837|566916054|FG002|Overall Study|Withdrawal by Subject|1|||
157044119|NCT04399837|566916055|FG003|Overall Study|Withdrawal by Subject|1|||
157044120|NCT02060487|566916056|FG000|Overall Study|Other|1|||
157044121|NCT02060487|566916057|FG001|Overall Study|Other|2|||
157044122|NCT02060487|566916058|FG002|Overall Study|Other|1|||
157044123|NCT02060487|566916056|FG000|Overall Study|Lack of Efficacy|0|||
157044124|NCT02060487|566916057|FG001|Overall Study|Lack of Efficacy|1|||
157044125|NCT02060487|566916058|FG002|Overall Study|Lack of Efficacy|0|||
157044126|NCT02060487|566916056|FG000|Overall Study|Withdrawal by Subject|3|||
157044127|NCT02060487|566916057|FG001|Overall Study|Withdrawal by Subject|10|||
157044128|NCT02060487|566916058|FG002|Overall Study|Withdrawal by Subject|4|||
157044129|NCT02060487|566916056|FG000|Overall Study|Study Terminated By Sponsor|87|||
157044130|NCT02060487|566916057|FG001|Overall Study|Study Terminated By Sponsor|89|||
157044131|NCT02060487|566916058|FG002|Overall Study|Study Terminated By Sponsor|100|||
157044132|NCT02060487|566916056|FG000|Overall Study|Randomized in error|1|||
157044133|NCT02060487|566916057|FG001|Overall Study|Randomized in error|0|||
157044134|NCT02060487|566916058|FG002|Overall Study|Randomized in error|0|||
157044135|NCT02060487|566916056|FG000|Overall Study|Protocol Violation|0|||
157044136|NCT02060487|566916057|FG001|Overall Study|Protocol Violation|1|||
157044137|NCT02060487|566916058|FG002|Overall Study|Protocol Violation|1|||
157044138|NCT02060487|566916056|FG000|Overall Study|Lost to Follow-up|3|||
157044139|NCT02060487|566916057|FG001|Overall Study|Lost to Follow-up|0|||
157044140|NCT02060487|566916058|FG002|Overall Study|Lost to Follow-up|2|||
157044141|NCT02060487|566916056|FG000|Overall Study|Death|34|||
157044142|NCT02060487|566916057|FG001|Overall Study|Death|25|||
157044143|NCT02060487|566916058|FG002|Overall Study|Death|19|||
157044144|NCT02060487|566916056|FG000|Overall Study|Adverse Event|0|||
157044145|NCT02060487|566916057|FG001|Overall Study|Adverse Event|0|||
157044146|NCT02060487|566916058|FG002|Overall Study|Adverse Event|1|||
157044147|NCT03697603|566916059|FG000|Overall Study|Adverse Event|3|||
157044148|NCT03697603|566916060|FG001|Overall Study|Adverse Event|18|||
157044149|NCT03697603|566916061|FG002|Overall Study|Adverse Event|3|||
157044150|NCT03697603|566916059|FG000|Overall Study|Physician Decision|1|||
157044151|NCT03697603|566916060|FG001|Overall Study|Physician Decision|0|||
157044152|NCT03697603|566916061|FG002|Overall Study|Physician Decision|2|||
157044153|NCT03697603|566916059|FG000|Overall Study|Protocol Violation|3|||
157044154|NCT03697603|566916060|FG001|Overall Study|Protocol Violation|8|||
157044155|NCT03697603|566916061|FG002|Overall Study|Protocol Violation|5|||
157044156|NCT03697603|566916059|FG000|Overall Study|Withdrawal by Subject|5|||
157044157|NCT03697603|566916060|FG001|Overall Study|Withdrawal by Subject|1|||
157044158|NCT03697603|566916061|FG002|Overall Study|Withdrawal by Subject|1|||
157044159|NCT03697603|566916059|FG000|Overall Study|Protocol Violation|0|||
157044160|NCT03697603|566916060|FG001|Overall Study|Protocol Violation|0|||
157044161|NCT03697603|566916061|FG002|Overall Study|Protocol Violation|1|||
157044162|NCT05182606|566916062|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
157044163|NCT02309294|566916063|FG000|Overall Study|Withdrawal by Subject|2|||
157044164|NCT03683030|566916066|FG000|Overall Study|Enrolled but screen failures|12|||
157044165|NCT03683030|566916067|FG001|Overall Study|Enrolled but screen failures|7|||
157044166|NCT03683030|566916066|FG000|Overall Study|Enrolled but no catheter inserted|11|||
157044167|NCT03683030|566916067|FG001|Overall Study|Enrolled but no catheter inserted|13|||
157044168|NCT03683030|566916066|FG000|Overall Study|Withdrawal by Subject|0|||
157044169|NCT03683030|566916067|FG001|Overall Study|Withdrawal by Subject|2|||
157044170|NCT03683030|566916066|FG000|Overall Study|Early termination by subject|1|||
157044171|NCT03683030|566916067|FG001|Overall Study|Early termination by subject|0|||
157044172|NCT03683030|566916066|FG000|Overall Study|Lost to Follow-up|0|||
157044173|NCT03683030|566916067|FG001|Overall Study|Lost to Follow-up|6|||
157044174|NCT03683030|566916066|FG000|Overall Study|Death|0|||
157044175|NCT03683030|566916067|FG001|Overall Study|Death|2|||
157044176|NCT03683030|566916066|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
157044177|NCT03683030|566916067|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
157044178|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
157044179|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
157044180|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
157044181|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
157044182|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
157044183|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
157044184|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
157044185|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
157044186|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
157044187|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
157044188|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
157044189|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
157174293|NCT00105183|567379753|FG002|Overall Study|Other reason|0|||
157174294|NCT00615914|567379757|FG000|Overall Study|Adverse Event|274|||
157044190|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
157044191|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
157044192|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
157044193|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
157044194|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
157044195|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
157044196|NCT02222493|566916070|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
157044197|NCT02222493|566916071|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
157044198|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
157044199|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
157044200|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
157044201|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
157044202|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
157044203|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
157044204|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
157044205|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
157044206|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
157044207|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
157044208|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
157044209|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
157044210|NCT02222493|566916070|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
157044211|NCT02222493|566916071|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
157044212|NCT02222493|566916070|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
157044213|NCT02222493|566916071|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
157044214|NCT02222493|566916070|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
157044215|NCT02222493|566916071|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
157044216|NCT02222493|566916070|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
157044217|NCT02222493|566916071|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
157044218|NCT02222493|566916070|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
157044219|NCT02222493|566916071|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
157044220|NCT02222493|566916070|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
157044221|NCT02222493|566916071|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
157044222|NCT02542943|566916074|FG000|Overall Study|Lost to Follow-up|1|||
157044223|NCT02542943|566916075|FG001|Overall Study|Lost to Follow-up|0|||
157044224|NCT02542943|566916076|FG002|Overall Study|Lost to Follow-up|0|||
157044225|NCT02542943|566916074|FG000|Overall Study|Withdrawal by Subject|0|||
157044226|NCT02542943|566916075|FG001|Overall Study|Withdrawal by Subject|1|||
157044227|NCT02542943|566916076|FG002|Overall Study|Withdrawal by Subject|0|||
157044228|NCT03476798|566916080|FG000|Overall Study|Death|1|||
157044229|NCT03476798|566916080|FG000|Overall Study|Withdrawal by Subject|2|||
157044230|NCT03476798|566916080|FG000|Overall Study|Protocol Violation|2|||
157044231|NCT06269003|566916081|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
157044232|NCT06269003|566916082|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
157044233|NCT06269003|566916083|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
157044234|NCT06269003|566916084|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
157044235|NCT00985088|566917743|FG000|Overall Study|Serious Adverse Event|1|||
157044236|NCT00985088|566917744|FG001|Overall Study|Serious Adverse Event|1|||
157044237|NCT00985088|566917745|FG002|Overall Study|Serious Adverse Event|0|||
157044238|NCT00985088|566917746|FG003|Overall Study|Serious Adverse Event|0|||
157044239|NCT00985088|566917747|FG004|Overall Study|Serious Adverse Event|0|||
157044240|NCT00985088|566917748|FG005|Overall Study|Serious Adverse Event|0|||
157044241|NCT00985088|566917749|FG006|Overall Study|Serious Adverse Event|0|||
157044242|NCT00985088|566917750|FG007|Overall Study|Serious Adverse Event|1|||
157044243|NCT00985088|566917743|FG000|Overall Study|Adverse Event|0|||
157044244|NCT00985088|566917744|FG001|Overall Study|Adverse Event|0|||
157044245|NCT00985088|566917745|FG002|Overall Study|Adverse Event|1|||
157044246|NCT00985088|566917746|FG003|Overall Study|Adverse Event|0|||
157044247|NCT00985088|566917747|FG004|Overall Study|Adverse Event|0|||
157044248|NCT00985088|566917748|FG005|Overall Study|Adverse Event|0|||
157044249|NCT00985088|566917749|FG006|Overall Study|Adverse Event|0|||
157044250|NCT00985088|566917750|FG007|Overall Study|Adverse Event|0|||
157044251|NCT00985088|566917743|FG000|Overall Study|Withdrawal by Subject|4|||
157044252|NCT00985088|566917744|FG001|Overall Study|Withdrawal by Subject|0|||
157044253|NCT00985088|566917745|FG002|Overall Study|Withdrawal by Subject|0|||
157044254|NCT00985088|566917746|FG003|Overall Study|Withdrawal by Subject|1|||
157044255|NCT00985088|566917747|FG004|Overall Study|Withdrawal by Subject|3|||
157044256|NCT00985088|566917748|FG005|Overall Study|Withdrawal by Subject|2|||
157044257|NCT00985088|566917749|FG006|Overall Study|Withdrawal by Subject|1|||
157044258|NCT00985088|566917750|FG007|Overall Study|Withdrawal by Subject|2|||
157044259|NCT00985088|566917743|FG000|Overall Study|Migrated/moved from study area|0|||
157044260|NCT00985088|566917744|FG001|Overall Study|Migrated/moved from study area|0|||
157044261|NCT00985088|566917745|FG002|Overall Study|Migrated/moved from study area|1|||
157044262|NCT00985088|566917746|FG003|Overall Study|Migrated/moved from study area|0|||
157044263|NCT00985088|566917747|FG004|Overall Study|Migrated/moved from study area|0|||
157044264|NCT00985088|566917748|FG005|Overall Study|Migrated/moved from study area|0|||
157044265|NCT00985088|566917749|FG006|Overall Study|Migrated/moved from study area|0|||
157044266|NCT00985088|566917750|FG007|Overall Study|Migrated/moved from study area|1|||
157174295|NCT00615914|567379757|FG000|Overall Study|Death|20|||
157174296|NCT00615914|567379757|FG000|Overall Study|Lack of Efficacy|59|||
157174297|NCT00615914|567379757|FG000|Overall Study|Lost to Follow-up|187|||
157174298|NCT00615914|567379757|FG000|Overall Study|Withdrawal by Subject|16|||
157174299|NCT00615914|567379757|FG000|Overall Study|Physician Decision|4|||
157174300|NCT00615914|567379757|FG000|Overall Study|No data was collected.|65|||
157174301|NCT00615914|567379757|FG000|Overall Study|No treatment|2|||
157174302|NCT00615914|567379757|FG000|Overall Study|Irregularly enrolled patients|10|||
157174303|NCT03673956|567379758|FG000|Overall Study|Lost to Follow-up|1|||
157174304|NCT03673956|567379759|FG001|Overall Study|Lost to Follow-up|0|||
157174305|NCT03673956|567379760|FG002|Overall Study|Lost to Follow-up|0|||
157174306|NCT03673956|567379761|FG003|Overall Study|Lost to Follow-up|0|||
157174307|NCT03673956|567379758|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
157174308|NCT03673956|567379759|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
157174309|NCT03673956|567379760|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
157174310|NCT03673956|567379761|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
157174311|NCT01855945|567379766|FG000|Overall Study|Adverse Event|0|||
157174312|NCT01855945|567379767|FG001|Overall Study|Adverse Event|0|||
157174313|NCT01855945|567379768|FG002|Overall Study|Adverse Event|0|||
157174314|NCT01855945|567379769|FG003|Overall Study|Adverse Event|0|||
157174315|NCT01855945|567379770|FG004|Overall Study|Adverse Event|0|||
157174316|NCT01855945|567379771|FG005|Overall Study|Adverse Event|0|||
157174317|NCT01855945|567379772|FG006|Overall Study|Adverse Event|1|||
157174318|NCT01855945|567379773|FG007|Overall Study|Adverse Event|0|||
157174319|NCT01855945|567379774|FG008|Overall Study|Adverse Event|0|||
157174320|NCT01855945|567379775|FG009|Overall Study|Adverse Event|0|||
157174321|NCT01855945|567379776|FG010|Overall Study|Adverse Event|0|||
157174322|NCT01855945|567379777|FG011|Overall Study|Adverse Event|0|||
157174323|NCT01855945|567379766|FG000|Overall Study|Death|0|||
157174324|NCT01855945|567379767|FG001|Overall Study|Death|0|||
157174325|NCT01855945|567379768|FG002|Overall Study|Death|0|||
157174326|NCT01855945|567379769|FG003|Overall Study|Death|0|||
157174327|NCT01855945|567379770|FG004|Overall Study|Death|0|||
157174328|NCT01855945|567379771|FG005|Overall Study|Death|0|||
157174329|NCT01855945|567379772|FG006|Overall Study|Death|2|||
157174330|NCT01855945|567379773|FG007|Overall Study|Death|0|||
157174331|NCT01855945|567379774|FG008|Overall Study|Death|0|||
157174332|NCT01855945|567379775|FG009|Overall Study|Death|0|||
157174333|NCT01855945|567379776|FG010|Overall Study|Death|0|||
157174334|NCT01855945|567379777|FG011|Overall Study|Death|0|||
157174335|NCT01855945|567379766|FG000|Overall Study|Lost to Follow-up|11|||
157174336|NCT01855945|567379767|FG001|Overall Study|Lost to Follow-up|10|||
157174337|NCT01855945|567379768|FG002|Overall Study|Lost to Follow-up|7|||
157174338|NCT01855945|567379769|FG003|Overall Study|Lost to Follow-up|3|||
157174339|NCT01855945|567379770|FG004|Overall Study|Lost to Follow-up|0|||
157174340|NCT01855945|567379771|FG005|Overall Study|Lost to Follow-up|3|||
157174341|NCT01855945|567379772|FG006|Overall Study|Lost to Follow-up|4|||
157174342|NCT01855945|567379773|FG007|Overall Study|Lost to Follow-up|7|||
157174343|NCT01855945|567379774|FG008|Overall Study|Lost to Follow-up|2|||
157174344|NCT01855945|567379775|FG009|Overall Study|Lost to Follow-up|0|||
157174345|NCT01855945|567379776|FG010|Overall Study|Lost to Follow-up|0|||
157174346|NCT01855945|567379777|FG011|Overall Study|Lost to Follow-up|2|||
157174347|NCT01855945|567379766|FG000|Overall Study|Other - Unclassified|1|||
157174348|NCT01855945|567379767|FG001|Overall Study|Other - Unclassified|1|||
157174349|NCT01855945|567379768|FG002|Overall Study|Other - Unclassified|1|||
157174350|NCT01855945|567379769|FG003|Overall Study|Other - Unclassified|0|||
157174351|NCT01855945|567379770|FG004|Overall Study|Other - Unclassified|0|||
157174352|NCT01855945|567379771|FG005|Overall Study|Other - Unclassified|0|||
157174353|NCT01855945|567379772|FG006|Overall Study|Other - Unclassified|2|||
157174354|NCT01855945|567379773|FG007|Overall Study|Other - Unclassified|1|||
157174355|NCT01855945|567379774|FG008|Overall Study|Other - Unclassified|0|||
157174356|NCT01855945|567379775|FG009|Overall Study|Other - Unclassified|0|||
157174357|NCT01855945|567379776|FG010|Overall Study|Other - Unclassified|1|||
157174358|NCT01855945|567379777|FG011|Overall Study|Other - Unclassified|0|||
157174359|NCT01855945|567379766|FG000|Overall Study|Withdrawal by Subject|4|||
157174360|NCT01855945|567379767|FG001|Overall Study|Withdrawal by Subject|0|||
157174361|NCT01855945|567379768|FG002|Overall Study|Withdrawal by Subject|4|||
157174362|NCT01855945|567379769|FG003|Overall Study|Withdrawal by Subject|1|||
157174363|NCT01855945|567379770|FG004|Overall Study|Withdrawal by Subject|1|||
157228719|NCT00864097|567583349|FG002|Overall Study|Withdrawal by Subject|11|||
157228720|NCT00864097|567583350|FG003|Overall Study|Withdrawal by Subject|12|||
157044267|NCT00985088|566917743|FG000|Overall Study|Lost to Follow-up|6|||
157044268|NCT00985088|566917744|FG001|Overall Study|Lost to Follow-up|1|||
157044269|NCT00985088|566917745|FG002|Overall Study|Lost to Follow-up|2|||
157044270|NCT00985088|566917746|FG003|Overall Study|Lost to Follow-up|6|||
157044271|NCT00985088|566917747|FG004|Overall Study|Lost to Follow-up|6|||
157044272|NCT00985088|566917748|FG005|Overall Study|Lost to Follow-up|5|||
157044273|NCT00985088|566917749|FG006|Overall Study|Lost to Follow-up|3|||
157044274|NCT00985088|566917750|FG007|Overall Study|Lost to Follow-up|2|||
157044275|NCT01970878|566917751|FG000|Overall Study|Withdrawal by Subject|11|||
157044276|NCT01970878|566917752|FG001|Overall Study|Withdrawal by Subject|10|||
157044277|NCT01970878|566917753|FG002|Overall Study|Withdrawal by Subject|14|||
157044278|NCT01970878|566917754|FG003|Overall Study|Withdrawal by Subject|7|||
157044279|NCT01970878|566917751|FG000|Overall Study|Lost to Follow-up|1|||
157044280|NCT01970878|566917752|FG001|Overall Study|Lost to Follow-up|3|||
157044281|NCT01970878|566917753|FG002|Overall Study|Lost to Follow-up|2|||
157044282|NCT01970878|566917754|FG003|Overall Study|Lost to Follow-up|4|||
157044283|NCT01970878|566917751|FG000|Overall Study|Administrative Reasons|1|||
157044284|NCT01970878|566917752|FG001|Overall Study|Administrative Reasons|0|||
157044285|NCT01970878|566917753|FG002|Overall Study|Administrative Reasons|0|||
157044286|NCT01970878|566917754|FG003|Overall Study|Administrative Reasons|4|||
157044287|NCT01970878|566917751|FG000|Overall Study|Lack of Efficacy|2|||
157044288|NCT01970878|566917752|FG001|Overall Study|Lack of Efficacy|1|||
157044289|NCT01970878|566917753|FG002|Overall Study|Lack of Efficacy|2|||
157044290|NCT01970878|566917754|FG003|Overall Study|Lack of Efficacy|0|||
157044291|NCT01970878|566917751|FG000|Overall Study|Adverse Event|12|||
157044292|NCT01970878|566917752|FG001|Overall Study|Adverse Event|7|||
157044293|NCT01970878|566917753|FG002|Overall Study|Adverse Event|4|||
157044294|NCT01970878|566917754|FG003|Overall Study|Adverse Event|3|||
157044295|NCT01970878|566917751|FG000|Overall Study|Protocol Specified Criteria|10|||
157044296|NCT01970878|566917752|FG001|Overall Study|Protocol Specified Criteria|4|||
157044297|NCT01970878|566917753|FG002|Overall Study|Protocol Specified Criteria|3|||
157044298|NCT01970878|566917754|FG003|Overall Study|Protocol Specified Criteria|6|||
157044299|NCT01970878|566917751|FG000|Overall Study|Physician Decision|0|||
157044300|NCT01970878|566917752|FG001|Overall Study|Physician Decision|1|||
157044301|NCT01970878|566917753|FG002|Overall Study|Physician Decision|1|||
157044302|NCT01970878|566917754|FG003|Overall Study|Physician Decision|0|||
157044303|NCT01970878|566917751|FG000|Overall Study|No Completion Status|0|||
157044304|NCT01970878|566917752|FG001|Overall Study|No Completion Status|1|||
157044305|NCT01970878|566917753|FG002|Overall Study|No Completion Status|0|||
157044306|NCT01970878|566917754|FG003|Overall Study|No Completion Status|0|||
157044307|NCT06571695|566917759|FG000|Overall Study|Lost to Follow-up|1|||
157044308|NCT06571695|566917760|FG001|Overall Study|Lost to Follow-up|6|||
157044309|NCT00108355|566917761|FG000|Overall Study|Peritonitis at index paracentesis|1|||
157044310|NCT00108355|566917762|FG001|Overall Study|Peritonitis at index paracentesis|1|||
157044311|NCT00108355|566917761|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
157044312|NCT00108355|566917762|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
157044313|NCT03214081|566917763|FG000|Overall Study|Case Report Forms Uncollected|9|||
157044314|NCT03214081|566917763|FG000|Overall Study|Protocol Deviation|54|||
157044315|NCT02962284|566917764|FG000|Overall Study|Death|2|||
157044316|NCT02962284|566917765|FG001|Overall Study|Death|0|||
157044317|NCT02962284|566917764|FG000|Overall Study|Progressive disease|2|||
157044318|NCT02962284|566917765|FG001|Overall Study|Progressive disease|3|||
157044319|NCT02962284|566917764|FG000|Overall Study|Withdrawal by Subject|1|||
157044320|NCT02962284|566917765|FG001|Overall Study|Withdrawal by Subject|0|||
157044321|NCT02637063|566917766|FG000|Overall Study|Lost to Follow-up|3|||
157044322|NCT02637063|566917767|FG001|Overall Study|Lost to Follow-up|2|||
157228721|NCT00864097|567583347|FG000|Overall Study|Protocol Violation|2|||
157228722|NCT00864097|567583348|FG001|Overall Study|Protocol Violation|1|||
157228723|NCT00864097|567583349|FG002|Overall Study|Protocol Violation|0|||
157044323|NCT02637063|566917768|FG002|Overall Study|Lost to Follow-up|3|||
157044324|NCT02637063|566917766|FG000|Overall Study|Withdrawal by Subject|2|||
157044325|NCT02637063|566917767|FG001|Overall Study|Withdrawal by Subject|2|||
157044326|NCT02637063|566917768|FG002|Overall Study|Withdrawal by Subject|3|||
157228724|NCT00864097|567583350|FG003|Overall Study|Protocol Violation|1|||
157044327|NCT00491400|566917769|FG000|Overall Study|Withdrawal by Subject|5|||
157044328|NCT00491400|566917770|FG001|Overall Study|Withdrawal by Subject|4|||
157044329|NCT00597376|566917771|FG000|Overall Study|Withdrawal by Subject|4|||
157044330|NCT00597376|566917772|FG001|Overall Study|Withdrawal by Subject|3|||
157044331|NCT00597376|566917771|FG000|Overall Study|Adverse Event|4|||
157044332|NCT00597376|566917772|FG001|Overall Study|Adverse Event|1|||
157044333|NCT02698475|566917773|FG000|Main Study Period|Lack of Efficacy|1|||
157044334|NCT02698475|566917773|FG000|Main Study Period|Protocol Violation|2|||
157044335|NCT02698475|566917773|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
157044336|NCT02698475|566917773|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
157044337|NCT02698475|566917773|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
157044338|NCT02698475|566917773|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
157044339|NCT02698475|566917773|FG000|Long-Term Extension Period|Other|1|||
157044340|NCT01214200|566917778|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
157044341|NCT01214200|566917778|FG000|Overall Study|Withdrawal by Subject|2|||
157044342|NCT00587171|566917779|FG000|Overall Study|Lost to Follow-up|1|||
157044343|NCT00587171|566917780|FG001|Overall Study|Lost to Follow-up|1|||
157044344|NCT01532648|566917789|FG000|Overall Study|Lost to Follow-up|3|||
157044345|NCT01532648|566917790|FG001|Overall Study|Lost to Follow-up|4|||
157044346|NCT01532648|566917789|FG000|Overall Study|Lack of Efficacy|4|||
157044347|NCT01532648|566917790|FG001|Overall Study|Lack of Efficacy|1|||
157044348|NCT01532648|566917789|FG000|Overall Study|Protocol Violation|1|||
157044349|NCT01532648|566917790|FG001|Overall Study|Protocol Violation|1|||
157044350|NCT01532648|566917789|FG000|Overall Study|Adverse Event|12|||
157044351|NCT01532648|566917790|FG001|Overall Study|Adverse Event|9|||
157044352|NCT01532648|566917789|FG000|Overall Study|Withdrawal by Subject|16|||
157044353|NCT01532648|566917790|FG001|Overall Study|Withdrawal by Subject|2|||
157044354|NCT02148705|566917791|FG000|Overall Study|Death|2|||
157044355|NCT02148705|566917792|FG001|Overall Study|Death|0|||
157044356|NCT02148705|566917793|FG002|Overall Study|Death|0|||
157044357|NCT02148705|566917791|FG000|Overall Study|Lost to Follow-up|13|||
157044358|NCT02148705|566917792|FG001|Overall Study|Lost to Follow-up|4|||
157044359|NCT02148705|566917793|FG002|Overall Study|Lost to Follow-up|10|||
157044360|NCT02148705|566917791|FG000|Overall Study|Withdrawal by Subject|3|||
157044361|NCT02148705|566917792|FG001|Overall Study|Withdrawal by Subject|0|||
157044362|NCT02148705|566917793|FG002|Overall Study|Withdrawal by Subject|2|||
157044363|NCT02148705|566917791|FG000|Overall Study|Not Treated|0|||
157044364|NCT02148705|566917792|FG001|Overall Study|Not Treated|1|||
157044365|NCT02148705|566917793|FG002|Overall Study|Not Treated|5|||
157044366|NCT01737021|566917796|FG000|Overall Study|Lost to Follow-up|5|||
157044367|NCT01737021|566917797|FG001|Overall Study|Lost to Follow-up|3|||
157044368|NCT01673594|566917798|FG000|Overall Study|Adverse Event|3|||
157044369|NCT01673594|566917799|FG001|Overall Study|Adverse Event|1|||
157044370|NCT01673594|566917798|FG000|Overall Study|Lost to Follow-up|1|||
157044371|NCT01673594|566917799|FG001|Overall Study|Lost to Follow-up|0|||
157044372|NCT01673594|566917798|FG000|Overall Study|Physician Decision|2|||
157044373|NCT01673594|566917799|FG001|Overall Study|Physician Decision|4|||
157044374|NCT01673594|566917798|FG000|Overall Study|Withdrawal by Subject|0|||
157044375|NCT01673594|566917799|FG001|Overall Study|Withdrawal by Subject|1|||
157044376|NCT02824198|566917800|FG000|Overall Study|Non-compliance with the protocol|5|||
157044377|NCT02824198|566917801|FG001|Overall Study|Non-compliance with the protocol|1|||
157044378|NCT02824198|566917800|FG000|Overall Study|Lost to Follow-up|5|||
157044379|NCT02824198|566917801|FG001|Overall Study|Lost to Follow-up|2|||
157044380|NCT02824198|566917800|FG000|Overall Study|Withdrawal by Subject|5|||
157044381|NCT02824198|566917801|FG001|Overall Study|Withdrawal by Subject|0|||
157044382|NCT02605174|566917802|FG000|Overall Study|Adverse Event|0|||
157044383|NCT02605174|566917803|FG001|Overall Study|Adverse Event|0|||
157044384|NCT02605174|566917804|FG002|Overall Study|Adverse Event|1|||
157044385|NCT02605174|566917805|FG003|Overall Study|Adverse Event|0|||
157044386|NCT02605174|566917806|FG004|Overall Study|Adverse Event|4|||
157044387|NCT02605174|566917807|FG005|Overall Study|Adverse Event|0|||
157044388|NCT02605174|566917808|FG006|Overall Study|Adverse Event|0|||
157044389|NCT02605174|566917802|FG000|Overall Study|Lost to Follow-up|20|||
157044390|NCT02605174|566917803|FG001|Overall Study|Lost to Follow-up|7|||
157044391|NCT02605174|566917804|FG002|Overall Study|Lost to Follow-up|27|||
157044392|NCT02605174|566917805|FG003|Overall Study|Lost to Follow-up|10|||
157044393|NCT02605174|566917806|FG004|Overall Study|Lost to Follow-up|20|||
157044394|NCT02605174|566917807|FG005|Overall Study|Lost to Follow-up|10|||
157044395|NCT02605174|566917808|FG006|Overall Study|Lost to Follow-up|29|||
157044396|NCT02605174|566917802|FG000|Overall Study|Protocol Violation|10|||
157044397|NCT02605174|566917803|FG001|Overall Study|Protocol Violation|4|||
157044398|NCT02605174|566917804|FG002|Overall Study|Protocol Violation|14|||
157044399|NCT02605174|566917805|FG003|Overall Study|Protocol Violation|6|||
157044400|NCT02605174|566917806|FG004|Overall Study|Protocol Violation|7|||
157044401|NCT02605174|566917807|FG005|Overall Study|Protocol Violation|7|||
157174364|NCT01855945|567379771|FG005|Overall Study|Withdrawal by Subject|0|||
157174365|NCT01855945|567379772|FG006|Overall Study|Withdrawal by Subject|1|||
157174366|NCT01855945|567379773|FG007|Overall Study|Withdrawal by Subject|0|||
157174367|NCT01855945|567379774|FG008|Overall Study|Withdrawal by Subject|0|||
157174368|NCT01855945|567379775|FG009|Overall Study|Withdrawal by Subject|2|||
157174369|NCT01855945|567379776|FG010|Overall Study|Withdrawal by Subject|4|||
157174370|NCT01855945|567379777|FG011|Overall Study|Withdrawal by Subject|1|||
157174371|NCT02156804|567379778|FG000|Overall Study|Withdrawal by Subject|1|||
157174372|NCT03228394|567379779|FG000|Overall Study|Lost to Follow-up|0|||
157044402|NCT02605174|566917808|FG006|Overall Study|Protocol Violation|12|||
157044403|NCT02605174|566917802|FG000|Overall Study|Pregnancy|1|||
157044404|NCT02605174|566917803|FG001|Overall Study|Pregnancy|0|||
157044405|NCT02605174|566917804|FG002|Overall Study|Pregnancy|0|||
157044406|NCT02605174|566917805|FG003|Overall Study|Pregnancy|2|||
157174373|NCT03228394|567379780|FG001|Overall Study|Lost to Follow-up|0|||
157174374|NCT03228394|567379781|FG002|Overall Study|Lost to Follow-up|1|||
157174375|NCT03228394|567379782|FG003|Overall Study|Lost to Follow-up|1|||
156968721|NCT04393441|566637679|FG001|Overall Study|Withdrawal by Subject|7|||
156968722|NCT04393441|566637678|FG000|Overall Study|Lost to Follow-up|0|||
156968723|NCT04393441|566637679|FG001|Overall Study|Lost to Follow-up|2|||
156968724|NCT04393441|566637678|FG000|Overall Study|Protocol Deviation|2|||
156968725|NCT04393441|566637679|FG001|Overall Study|Protocol Deviation|1|||
156968726|NCT04393441|566637678|FG000|Overall Study|Reason not Specified|1|||
156968727|NCT04393441|566637679|FG001|Overall Study|Reason not Specified|1|||
156968728|NCT02782169|566637680|FG000|Overall Study|Lost to Follow-up|1|||
156968729|NCT02782169|566637681|FG001|Overall Study|Lost to Follow-up|2|||
156968730|NCT00771810|566637682|FG000|Overall Study|Adverse Event|3|||
156968731|NCT00771810|566637683|FG001|Overall Study|Adverse Event|0|||
156968732|NCT00771810|566637684|FG002|Overall Study|Adverse Event|2|||
156968733|NCT00771810|566637682|FG000|Overall Study|Lost to Follow-up|0|||
156968734|NCT00771810|566637683|FG001|Overall Study|Lost to Follow-up|0|||
156968735|NCT00771810|566637684|FG002|Overall Study|Lost to Follow-up|1|||
156968736|NCT00771810|566637682|FG000|Overall Study|Physician Decision|1|||
156968737|NCT00771810|566637683|FG001|Overall Study|Physician Decision|2|||
156968738|NCT00771810|566637684|FG002|Overall Study|Physician Decision|2|||
156968739|NCT00771810|566637682|FG000|Overall Study|Protocol Violation|0|||
156968740|NCT00771810|566637683|FG001|Overall Study|Protocol Violation|1|||
156968741|NCT00771810|566637684|FG002|Overall Study|Protocol Violation|1|||
156968742|NCT00771810|566637682|FG000|Overall Study|Withdrawal by Subject|1|||
156968743|NCT00771810|566637683|FG001|Overall Study|Withdrawal by Subject|2|||
156968744|NCT00771810|566637684|FG002|Overall Study|Withdrawal by Subject|0|||
156968745|NCT00771810|566637682|FG000|Overall Study|Other|0|||
156968746|NCT00771810|566637683|FG001|Overall Study|Other|0|||
156968747|NCT00771810|566637684|FG002|Overall Study|Other|1|||
156968748|NCT02953938|566637689|FG000|Overall Study|Adverse Event|0|||
156968749|NCT02953938|566637690|FG001|Overall Study|Adverse Event|1|||
156968750|NCT02953938|566637689|FG000|Overall Study|Withdrawal by Subject|1|||
156968751|NCT02953938|566637690|FG001|Overall Study|Withdrawal by Subject|1|||
156968752|NCT02638948|566637695|FG000|Overall Study|Withdrawal by Subject|4|||
156968753|NCT02638948|566637696|FG001|Overall Study|Withdrawal by Subject|5|||
156968754|NCT02638948|566637697|FG002|Overall Study|Withdrawal by Subject|3|||
156968755|NCT02638948|566637698|FG003|Overall Study|Withdrawal by Subject|1|||
156968756|NCT02638948|566637695|FG000|Overall Study|Administrative Reason by Sponsor|0|||
156968757|NCT02638948|566637696|FG001|Overall Study|Administrative Reason by Sponsor|1|||
156968758|NCT02638948|566637697|FG002|Overall Study|Administrative Reason by Sponsor|0|||
156968759|NCT02638948|566637698|FG003|Overall Study|Administrative Reason by Sponsor|4|||
156968760|NCT02638948|566637695|FG000|Overall Study|Adverse Event|0|||
156968761|NCT02638948|566637696|FG001|Overall Study|Adverse Event|0|||
156968762|NCT02638948|566637697|FG002|Overall Study|Adverse Event|1|||
156968763|NCT02638948|566637698|FG003|Overall Study|Adverse Event|1|||
156968764|NCT02638948|566637695|FG000|Overall Study|Lack of Efficacy|1|||
156968765|NCT02638948|566637696|FG001|Overall Study|Lack of Efficacy|1|||
156968766|NCT02638948|566637697|FG002|Overall Study|Lack of Efficacy|0|||
156968767|NCT02638948|566637698|FG003|Overall Study|Lack of Efficacy|0|||
156968768|NCT02638948|566637695|FG000|Overall Study|Lost to Follow-up|0|||
156968769|NCT02638948|566637696|FG001|Overall Study|Lost to Follow-up|0|||
156968770|NCT02638948|566637697|FG002|Overall Study|Lost to Follow-up|1|||
156968771|NCT02638948|566637698|FG003|Overall Study|Lost to Follow-up|1|||
156968772|NCT02638948|566637695|FG000|Overall Study|Poor/Non-Compliance|0|||
156968773|NCT02638948|566637696|FG001|Overall Study|Poor/Non-Compliance|2|||
156968774|NCT02638948|566637697|FG002|Overall Study|Poor/Non-Compliance|1|||
156968775|NCT02638948|566637698|FG003|Overall Study|Poor/Non-Compliance|0|||
156968776|NCT02638948|566637695|FG000|Overall Study|Participant no longer met study criteria|0|||
156968777|NCT02638948|566637696|FG001|Overall Study|Participant no longer met study criteria|1|||
156968778|NCT02638948|566637697|FG002|Overall Study|Participant no longer met study criteria|0|||
156968779|NCT02638948|566637698|FG003|Overall Study|Participant no longer met study criteria|0|||
156968780|NCT02638948|566637695|FG000|Overall Study|Other than specified above|4|||
156968781|NCT02638948|566637696|FG001|Overall Study|Other than specified above|1|||
156968782|NCT02638948|566637697|FG002|Overall Study|Other than specified above|1|||
156968783|NCT02638948|566637698|FG003|Overall Study|Other than specified above|1|||
156968784|NCT05007392|566637699|FG000|Overall Study|Randomized but not treated|1|||
156968785|NCT05007392|566637700|FG001|Overall Study|Randomized but not treated|2|||
156968786|NCT05007392|566637699|FG000|Overall Study|Other|5|||
156968787|NCT05007392|566637700|FG001|Overall Study|Other|4|||
156968788|NCT05007392|566637699|FG000|Overall Study|Lost to Follow-up|1|||
156968789|NCT05007392|566637700|FG001|Overall Study|Lost to Follow-up|2|||
156968790|NCT05007392|566637699|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
156968791|NCT05007392|566637700|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
156968792|NCT05007392|566637699|FG000|Overall Study|Use of prohibited concomitant drug|1|||
156968793|NCT05007392|566637700|FG001|Overall Study|Use of prohibited concomitant drug|1|||
156968794|NCT05007392|566637699|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
156968795|NCT05007392|566637700|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
157228725|NCT00864097|567583347|FG000|Overall Study|Terminated by sponsor|105|||
157228726|NCT00864097|567583348|FG001|Overall Study|Terminated by sponsor|112|||
157228727|NCT00864097|567583349|FG002|Overall Study|Terminated by sponsor|102|||
157228728|NCT00864097|567583350|FG003|Overall Study|Terminated by sponsor|99|||
157228729|NCT00864097|567583347|FG000|Overall Study|Randomized but not treated|2|||
157228730|NCT00864097|567583348|FG001|Overall Study|Randomized but not treated|0|||
157228731|NCT00864097|567583349|FG002|Overall Study|Randomized but not treated|1|||
157228732|NCT00864097|567583350|FG003|Overall Study|Randomized but not treated|0|||
157228733|NCT00864097|567583347|FG000|Overall Study|Other|0|||
157228734|NCT00864097|567583348|FG001|Overall Study|Other|0|||
157228735|NCT00864097|567583349|FG002|Overall Study|Other|0|||
157228736|NCT00864097|567583350|FG003|Overall Study|Other|1|||
157228737|NCT00320112|567583352|FG000|Overall Study|Lost to Follow-up|3|||
157228738|NCT00320112|567583353|FG001|Overall Study|Lost to Follow-up|4|||
157228739|NCT00320112|567583352|FG000|Overall Study|Withdrawal by Subject|3|||
157228740|NCT00320112|567583353|FG001|Overall Study|Withdrawal by Subject|0|||
157228741|NCT00320112|567583352|FG000|Overall Study|Death|2|||
157228742|NCT00320112|567583353|FG001|Overall Study|Death|1|||
157228743|NCT00486837|567583357|FG000|Overall Study|Withdrawal by Subject|1|||
157228744|NCT00486837|567583358|FG001|Overall Study|Withdrawal by Subject|0|||
157228745|NCT00486837|567583357|FG000|Overall Study|Adverse Event|1|||
157228746|NCT00486837|567583358|FG001|Overall Study|Adverse Event|1|||
157228747|NCT00486837|567583357|FG000|Overall Study|Protocol Violation|4|||
157228748|NCT00486837|567583358|FG001|Overall Study|Protocol Violation|2|||
157228749|NCT00486837|567583357|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
157228750|NCT00486837|567583358|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
157228751|NCT04534283|567583359|FG000|Overall Study|Physician Decision|2|||
157228752|NCT04534283|567583359|FG000|Overall Study|Withdrawal by Subject|1|||
157228753|NCT04534283|567583359|FG000|Overall Study|Disease Progression|12|||
157228754|NCT04534283|567583359|FG000|Overall Study|Adverse Event|1|||
157228755|NCT00661505|567583360|FG000|Overall Study|Adverse Event|3|||
157228756|NCT00661505|567583360|FG000|Overall Study|Protocol Violation|14|||
157228757|NCT00661505|567583360|FG000|Overall Study|Withdrawal by Subject|8|||
157228758|NCT00661505|567583360|FG000|Overall Study|Lost to Follow-up|3|||
157228759|NCT00661505|567583360|FG000|Overall Study|Other|2|||
157228760|NCT00977470|567583363|FG000|Overall Study|Lack of Efficacy|32|||
157228761|NCT00977470|567583364|FG001|Overall Study|Lack of Efficacy|30|||
157228762|NCT00977470|567583363|FG000|Overall Study|Physician Decision|2|||
157228763|NCT00977470|567583364|FG001|Overall Study|Physician Decision|0|||
157228764|NCT00977470|567583363|FG000|Overall Study|Adverse Event|1|||
157228765|NCT00977470|567583364|FG001|Overall Study|Adverse Event|2|||
157228766|NCT00977470|567583363|FG000|Overall Study|Protocol Violation|1|||
157228767|NCT00977470|567583364|FG001|Overall Study|Protocol Violation|0|||
157228768|NCT00977470|567583363|FG000|Overall Study|Withdrawal by Subject|0|||
157228769|NCT00977470|567583364|FG001|Overall Study|Withdrawal by Subject|2|||
157228770|NCT00977470|567583363|FG000|Overall Study|Death|0|||
157228771|NCT00977470|567583364|FG001|Overall Study|Death|2|||
157228772|NCT00977470|567583363|FG000|Overall Study|clinical decline|0|||
157228773|NCT00977470|567583364|FG001|Overall Study|clinical decline|1|||
157228774|NCT00977470|567583363|FG000|Overall Study|prolonged recovery post-surgery|0|||
157228775|NCT00977470|567583364|FG001|Overall Study|prolonged recovery post-surgery|1|||
157228776|NCT00977470|567583363|FG000|Overall Study|Still on-study|2|||
157228777|NCT00977470|567583364|FG001|Overall Study|Still on-study|0|||
157228778|NCT03257462|567583367|FG000|Cohort A|Lost to Follow-up|1|||
157228779|NCT03257462|567583368|FG001|Cohort A|Lost to Follow-up|0|||
157228780|NCT03257462|567583369|FG002|Cohort A|Lost to Follow-up|0|||
157228781|NCT03257462|567583370|FG003|Cohort A|Lost to Follow-up|0|||
157228782|NCT03257462|567583367|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
157228783|NCT03257462|567583368|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
157228784|NCT03257462|567583369|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
157228785|NCT03257462|567583370|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
157228786|NCT00796822|567583371|FG000|Overall Study|Lost to Follow-up|2|||
157228787|NCT00796822|567583372|FG001|Overall Study|Lost to Follow-up|0|||
157228788|NCT00796822|567583371|FG000|Overall Study|Adverse Event|1|||
157228789|NCT00796822|567583372|FG001|Overall Study|Adverse Event|0|||
157228790|NCT00368277|567583373|FG000|Overall Study|Adverse Event|33|||
157228791|NCT00368277|567583374|FG001|Overall Study|Adverse Event|49|||
157228792|NCT00368277|567583373|FG000|Overall Study|Death|2|||
157228793|NCT00368277|567583374|FG001|Overall Study|Death|1|||
157228794|NCT00368277|567583373|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
157228795|NCT00368277|567583374|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
157228796|NCT00368277|567583373|FG000|Overall Study|Protocol deviation|7|||
157228797|NCT00368277|567583374|FG001|Overall Study|Protocol deviation|0|||
157228798|NCT00368277|567583373|FG000|Overall Study|Patient withdrew consent|32|||
157228799|NCT00368277|567583374|FG001|Overall Study|Patient withdrew consent|28|||
157228800|NCT00368277|567583373|FG000|Overall Study|Lost to Follow-up|8|||
157228801|NCT00368277|567583374|FG001|Overall Study|Lost to Follow-up|6|||
157228802|NCT05097989|567583375|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157044407|NCT02605174|566917806|FG004|Overall Study|Pregnancy|0|||
157044408|NCT02605174|566917807|FG005|Overall Study|Pregnancy|0|||
157044409|NCT02605174|566917808|FG006|Overall Study|Pregnancy|0|||
157044410|NCT02605174|566917802|FG000|Overall Study|Withdrawal by Subject|9|||
157044411|NCT02605174|566917803|FG001|Overall Study|Withdrawal by Subject|6|||
157044412|NCT02605174|566917804|FG002|Overall Study|Withdrawal by Subject|14|||
157044413|NCT02605174|566917805|FG003|Overall Study|Withdrawal by Subject|11|||
157044414|NCT02605174|566917806|FG004|Overall Study|Withdrawal by Subject|6|||
157044415|NCT02605174|566917807|FG005|Overall Study|Withdrawal by Subject|4|||
157044416|NCT02605174|566917808|FG006|Overall Study|Withdrawal by Subject|15|||
157044417|NCT02605174|566917802|FG000|Overall Study|Physician Decision|2|||
157044418|NCT02605174|566917803|FG001|Overall Study|Physician Decision|0|||
157044419|NCT02605174|566917804|FG002|Overall Study|Physician Decision|0|||
157044420|NCT02605174|566917805|FG003|Overall Study|Physician Decision|0|||
157044421|NCT02605174|566917806|FG004|Overall Study|Physician Decision|0|||
157044422|NCT02605174|566917807|FG005|Overall Study|Physician Decision|0|||
157044423|NCT02605174|566917808|FG006|Overall Study|Physician Decision|3|||
157044424|NCT02605174|566917802|FG000|Overall Study|Randomization Failure|22|||
157044425|NCT02605174|566917803|FG001|Overall Study|Randomization Failure|6|||
157044426|NCT02605174|566917804|FG002|Overall Study|Randomization Failure|20|||
157044427|NCT02605174|566917805|FG003|Overall Study|Randomization Failure|7|||
157044428|NCT02605174|566917806|FG004|Overall Study|Randomization Failure|16|||
157044429|NCT02605174|566917807|FG005|Overall Study|Randomization Failure|11|||
157044430|NCT02605174|566917808|FG006|Overall Study|Randomization Failure|30|||
157044431|NCT01256359|566917812|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
157044432|NCT01256359|566917813|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
157044433|NCT01256359|566917812|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
157044434|NCT01256359|566917813|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
157044435|NCT03292406|566917816|FG000|Overall Study|Progressive Disease|6|||
157044436|NCT03292406|566917817|FG001|Overall Study|Progressive Disease|3|||
157044437|NCT03292406|566917818|FG002|Overall Study|Progressive Disease|4|||
157044438|NCT03292406|566917816|FG000|Overall Study|Adverse Event|7|||
157044439|NCT03292406|566917817|FG001|Overall Study|Adverse Event|1|||
157044440|NCT03292406|566917818|FG002|Overall Study|Adverse Event|4|||
157044441|NCT03292406|566917816|FG000|Overall Study|Withdrawal by Subject|0|||
157044442|NCT03292406|566917817|FG001|Overall Study|Withdrawal by Subject|7|||
157044443|NCT03292406|566917818|FG002|Overall Study|Withdrawal by Subject|2|||
157044444|NCT03292406|566917816|FG000|Overall Study|Protocol Violation|0|||
157044445|NCT03292406|566917817|FG001|Overall Study|Protocol Violation|1|||
157044446|NCT03292406|566917818|FG002|Overall Study|Protocol Violation|1|||
157044447|NCT03292406|566917816|FG000|Overall Study|Other|0|||
157044448|NCT03292406|566917817|FG001|Overall Study|Other|1|||
157044449|NCT03292406|566917818|FG002|Overall Study|Other|2|||
157044450|NCT02736188|566917821|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
157044451|NCT02736188|566917821|FG000|Overall Study|Adverse Event|1|||
157044452|NCT02736188|566917821|FG000|Overall Study|Withdrawal by Subject|1|||
157044453|NCT02736188|566917821|FG000|Overall Study|Other|6|||
157174376|NCT03228394|567379783|FG004|Overall Study|Lost to Follow-up|0|||
157174377|NCT03228394|567379784|FG005|Overall Study|Lost to Follow-up|0|||
156968796|NCT05007392|566637699|FG000|Overall Study|Adverse Event|10|||
156968797|NCT05007392|566637700|FG001|Overall Study|Adverse Event|6|||
156968798|NCT05007392|566637699|FG000|Overall Study|Participant choice|5|||
156968799|NCT05007392|566637700|FG001|Overall Study|Participant choice|10|||
156968800|NCT05007392|566637699|FG000|Overall Study|Withdrawal of consent|5|||
156968801|NCT05007392|566637700|FG001|Overall Study|Withdrawal of consent|4|||
156968802|NCT01218126|566637703|FG000|Overall Study|Adverse Event|8|||
156968803|NCT01218126|566637704|FG001|Overall Study|Adverse Event|10|||
156968804|NCT01218126|566637705|FG002|Overall Study|Adverse Event|12|||
156968805|NCT01218126|566637706|FG003|Overall Study|Adverse Event|16|||
156968806|NCT01218126|566637703|FG000|Overall Study|Lack of Efficacy|7|||
156968807|NCT01218126|566637704|FG001|Overall Study|Lack of Efficacy|2|||
156968808|NCT01218126|566637705|FG002|Overall Study|Lack of Efficacy|2|||
156968809|NCT01218126|566637706|FG003|Overall Study|Lack of Efficacy|6|||
156968810|NCT01218126|566637703|FG000|Overall Study|Protocol Violation|5|||
156968811|NCT01218126|566637704|FG001|Overall Study|Protocol Violation|2|||
156968812|NCT01218126|566637705|FG002|Overall Study|Protocol Violation|2|||
156968813|NCT01218126|566637706|FG003|Overall Study|Protocol Violation|3|||
156968814|NCT01218126|566637703|FG000|Overall Study|Protocol-defined stopping criteria|1|||
156968815|NCT01218126|566637704|FG001|Overall Study|Protocol-defined stopping criteria|1|||
156968816|NCT01218126|566637705|FG002|Overall Study|Protocol-defined stopping criteria|0|||
156968817|NCT01218126|566637706|FG003|Overall Study|Protocol-defined stopping criteria|0|||
156968818|NCT01218126|566637703|FG000|Overall Study|Lost to Follow-up|0|||
156968819|NCT01218126|566637704|FG001|Overall Study|Lost to Follow-up|0|||
156968820|NCT01218126|566637705|FG002|Overall Study|Lost to Follow-up|0|||
156968821|NCT01218126|566637706|FG003|Overall Study|Lost to Follow-up|2|||
156968822|NCT01218126|566637703|FG000|Overall Study|Physician Decision|1|||
156968823|NCT01218126|566637704|FG001|Overall Study|Physician Decision|2|||
156968824|NCT01218126|566637705|FG002|Overall Study|Physician Decision|4|||
156968825|NCT01218126|566637706|FG003|Overall Study|Physician Decision|2|||
156968826|NCT01218126|566637703|FG000|Overall Study|Withdrawal by Subject|2|||
156968827|NCT01218126|566637704|FG001|Overall Study|Withdrawal by Subject|5|||
156968828|NCT01218126|566637705|FG002|Overall Study|Withdrawal by Subject|4|||
156968829|NCT01218126|566637706|FG003|Overall Study|Withdrawal by Subject|6|||
156968830|NCT00313820|566637710|FG000|Assigned to Treatment|Other|1|||
156968831|NCT00313820|566637711|FG001|Assigned to Treatment|Other|0|||
156968832|NCT00313820|566637710|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
156968833|NCT00313820|566637711|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
156968834|NCT00313820|566637710|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
156968835|NCT00313820|566637711|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
156968836|NCT00313820|566637710|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
156968837|NCT00313820|566637711|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
156968838|NCT00313820|566637710|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
156968839|NCT00313820|566637711|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
156968840|NCT00313820|566637710|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
156968841|NCT00313820|566637711|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
156968842|NCT02453685|566637715|FG000|Overall Study|Adverse Event|0|||
156968843|NCT02453685|566637716|FG001|Overall Study|Adverse Event|1|||
156968844|NCT02453685|566637715|FG000|Overall Study|Protocol Violation|7|||
156968845|NCT02453685|566637716|FG001|Overall Study|Protocol Violation|4|||
156968846|NCT02453685|566637715|FG000|Overall Study|Lost to Follow-up|0|||
156968847|NCT02453685|566637716|FG001|Overall Study|Lost to Follow-up|1|||
156968848|NCT02453685|566637715|FG000|Overall Study|Withdrawal by Subject|8|||
156968849|NCT02453685|566637716|FG001|Overall Study|Withdrawal by Subject|4|||
156968850|NCT02453685|566637715|FG000|Overall Study|Unclassified|4|||
156968851|NCT02453685|566637716|FG001|Overall Study|Unclassified|2|||
156968852|NCT00265889|566637717|FG000|Overall Study|Physician Decision|1|||
156968853|NCT00265889|566637717|FG000|Overall Study|Protocol Violation|1|||
156968854|NCT00265889|566637717|FG000|Overall Study|Insurance denied the request|3|||
156968855|NCT02134587|566637718|FG000|Overall Study|Did not completed all meetings|30|||
156968856|NCT00453986|566637722|FG000|Overall Study|Lost to Follow-up|6|||
156968857|NCT00453986|566637723|FG001|Overall Study|Lost to Follow-up|5|||
156968858|NCT00453986|566637724|FG002|Overall Study|Lost to Follow-up|6|||
156968859|NCT00453986|566637725|FG003|Overall Study|Lost to Follow-up|2|||
156968860|NCT00453986|566637726|FG004|Overall Study|Lost to Follow-up|0|||
156968861|NCT02778100|566637729|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
156968862|NCT02778100|566637730|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
156968863|NCT01515748|566637738|FG000|Overall Study|Withdrawal by Subject|32|||
156968864|NCT01515748|566637739|FG001|Overall Study|Withdrawal by Subject|41|||
156968865|NCT01515748|566637738|FG000|Overall Study|Lost to Follow-up|2|||
156968866|NCT01515748|566637739|FG001|Overall Study|Lost to Follow-up|4|||
156968867|NCT01515748|566637738|FG000|Overall Study|Other than specified above|5|||
156968868|NCT01515748|566637739|FG001|Overall Study|Other than specified above|10|||
156968869|NCT03221387|566637740|FG000|Overall Study|Lost to Follow-up|1|||
156968870|NCT03221387|566637740|FG000|Overall Study|Lung transplant|1|||
156968871|NCT00522626|566637741|FG000|Overall Study|Lost to Follow-up|7|||
156968872|NCT00803452|566637742|FG000|Overall Study|Adverse Event|0|||
156968873|NCT00803452|566637743|FG001|Overall Study|Adverse Event|2|||
156968874|NCT00803452|566637742|FG000|Overall Study|Lost to Follow-up|0|||
156968875|NCT00803452|566637743|FG001|Overall Study|Lost to Follow-up|3|||
156968876|NCT02365519|566637745|FG000|Randomized and Treated|Adverse Event|0|||
156968877|NCT02365519|566637746|FG001|Randomized and Treated|Adverse Event|1|||
156968878|NCT02365519|566637747|FG002|Randomized and Treated|Adverse Event|0|||
156968879|NCT02365519|566637745|FG000|Randomized and Treated|Withdrawal by Subject|0|||
156968880|NCT02365519|566637746|FG001|Randomized and Treated|Withdrawal by Subject|1|||
156968881|NCT02365519|566637747|FG002|Randomized and Treated|Withdrawal by Subject|1|||
156968882|NCT01971723|566637748|FG000|Overall Study|Withdrawal by Subject|1|||
156968883|NCT01971723|566637749|FG001|Overall Study|Withdrawal by Subject|1|||
156968884|NCT01971723|566637748|FG000|Overall Study|Protocol Violation|1|||
156968885|NCT01971723|566637749|FG001|Overall Study|Protocol Violation|2|||
156968886|NCT03017079|566637750|FG000|Overall Study|Physician Decision|1|||
156968887|NCT03017079|566637751|FG001|Overall Study|Physician Decision|1|||
156968888|NCT03017079|566637750|FG000|Overall Study|Death|3|||
156968889|NCT03017079|566637751|FG001|Overall Study|Death|2|||
156968890|NCT03017079|566637750|FG000|Overall Study|Lack of Efficacy|2|||
156968891|NCT03017079|566637751|FG001|Overall Study|Lack of Efficacy|2|||
156968892|NCT03017079|566637750|FG000|Overall Study|Protocol Violation|0|||
156968893|NCT03017079|566637751|FG001|Overall Study|Protocol Violation|1|||
156968894|NCT04120233|566637757|FG000|Overall Study|Adverse Event|0|||
156968895|NCT04120233|566637758|FG001|Overall Study|Adverse Event|0|||
156968896|NCT04120233|566637759|FG002|Overall Study|Adverse Event|0|||
156968897|NCT04120233|566637760|FG003|Overall Study|Adverse Event|0|||
156968898|NCT04120233|566637761|FG004|Overall Study|Adverse Event|1|||
156968899|NCT04120233|566637762|FG005|Overall Study|Adverse Event|0|||
156968900|NCT00608582|566637775|FG000|Overall Study|Lost to Follow-up|2|||
157044454|NCT02708498|566917822|FG000|Overall Study|Death|20|||
157044455|NCT02708498|566917823|FG001|Overall Study|Death|19|||
157044456|NCT02708498|566917824|FG002|Overall Study|Death|0|||
157044457|NCT02708498|566917825|FG003|Overall Study|Death|0|||
157044458|NCT02708498|566917826|FG004|Overall Study|Death|1|||
157044459|NCT02708498|566917827|FG005|Overall Study|Death|0|||
157044460|NCT02708498|566917828|FG006|Overall Study|Death|0|||
157044461|NCT02708498|566917829|FG007|Overall Study|Death|0|||
157044462|NCT02708498|566917822|FG000|Overall Study|Unknown reason, missing data|0|||
157044463|NCT02708498|566917823|FG001|Overall Study|Unknown reason, missing data|0|||
157044464|NCT02708498|566917824|FG002|Overall Study|Unknown reason, missing data|62|||
157044465|NCT02708498|566917825|FG003|Overall Study|Unknown reason, missing data|51|||
157044466|NCT02708498|566917826|FG004|Overall Study|Unknown reason, missing data|195|||
157044467|NCT02708498|566917827|FG005|Overall Study|Unknown reason, missing data|132|||
157044468|NCT02708498|566917828|FG006|Overall Study|Unknown reason, missing data|0|||
157044469|NCT02708498|566917829|FG007|Overall Study|Unknown reason, missing data|0|||
157044470|NCT03052517|566917830|FG000|Overall Study|Study Terminated By Sponsor|928|||
157044471|NCT03052517|566917831|FG001|Overall Study|Study Terminated By Sponsor|938|||
157044472|NCT03052517|566917832|FG002|Overall Study|Study Terminated By Sponsor|296|||
157044473|NCT03052517|566917830|FG000|Overall Study|Subject/Guardian Decision|50|||
157044474|NCT03052517|566917831|FG001|Overall Study|Subject/Guardian Decision|45|||
157044475|NCT03052517|566917832|FG002|Overall Study|Subject/Guardian Decision|22|||
157044476|NCT03052517|566917830|FG000|Overall Study|Lack of Efficacy|23|||
157044477|NCT03052517|566917831|FG001|Overall Study|Lack of Efficacy|14|||
157044478|NCT03052517|566917832|FG002|Overall Study|Lack of Efficacy|7|||
157044479|NCT03052517|566917830|FG000|Overall Study|Adverse Event|6|||
157044480|NCT03052517|566917831|FG001|Overall Study|Adverse Event|5|||
157044481|NCT03052517|566917832|FG002|Overall Study|Adverse Event|0|||
157044482|NCT03052517|566917830|FG000|Overall Study|Physician Decision|4|||
157044483|NCT03052517|566917831|FG001|Overall Study|Physician Decision|5|||
157044484|NCT03052517|566917832|FG002|Overall Study|Physician Decision|1|||
157044485|NCT03052517|566917830|FG000|Overall Study|Death|3|||
157044486|NCT03052517|566917831|FG001|Overall Study|Death|0|||
157044487|NCT03052517|566917832|FG002|Overall Study|Death|1|||
157044488|NCT03052517|566917830|FG000|Overall Study|Lost to Follow-up|2|||
157044489|NCT03052517|566917831|FG001|Overall Study|Lost to Follow-up|4|||
157044490|NCT03052517|566917832|FG002|Overall Study|Lost to Follow-up|0|||
157044491|NCT03052517|566917830|FG000|Overall Study|Pregnancy|1|||
157044492|NCT03052517|566917831|FG001|Overall Study|Pregnancy|0|||
157044493|NCT03052517|566917832|FG002|Overall Study|Pregnancy|1|||
157044494|NCT03052517|566917830|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
157044495|NCT03052517|566917831|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
157044496|NCT03052517|566917832|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
157044497|NCT03052517|566917830|FG000|Overall Study|Technical Problems|0|||
157044498|NCT03052517|566917831|FG001|Overall Study|Technical Problems|1|||
157044499|NCT03052517|566917832|FG002|Overall Study|Technical Problems|0|||
157044500|NCT01858688|566917833|FG000|Overall Study|Withdrawal by Subject|8|||
157044501|NCT01858688|566917833|FG000|Overall Study|Participant began another therapy|3|||
157044502|NCT01858688|566917833|FG000|Overall Study|Physician Decision|2|||
157044503|NCT01858688|566917833|FG000|Overall Study|Progressive Disease|2|||
157044504|NCT01858688|566917833|FG000|Overall Study|Reason not reproted|5|||
157044505|NCT00822900|566917839|FG000|Overall Study|Withdrawal by Subject|14|||
157044506|NCT00822900|566917840|FG001|Overall Study|Withdrawal by Subject|14|||
157044507|NCT00822900|566917839|FG000|Overall Study|Lost to Follow-up|9|||
157044508|NCT00822900|566917840|FG001|Overall Study|Lost to Follow-up|9|||
157044509|NCT00822900|566917839|FG000|Overall Study|Death|83|||
157044510|NCT00822900|566917840|FG001|Overall Study|Death|69|||
157044511|NCT00822900|566917839|FG000|Overall Study|Became a ward of the state|2|||
157044512|NCT00822900|566917840|FG001|Overall Study|Became a ward of the state|1|||
157044513|NCT00659373|566917852|FG000|Overall Study|Withdrawal by Subject|3|||
157044514|NCT00659373|566917853|FG001|Overall Study|Withdrawal by Subject|5|||
157044515|NCT00659373|566917852|FG000|Overall Study|Assessment Missed|2|||
157044516|NCT00659373|566917853|FG001|Overall Study|Assessment Missed|2|||
157044517|NCT03042767|566917856|FG000|Overall Study|Lost to Follow-up|1|||
157044518|NCT03042767|566917857|FG001|Overall Study|Lost to Follow-up|2|||
157044519|NCT02686658|566917864|FG000|Overall Study|Adverse Event|0|||
157044520|NCT02686658|566917865|FG001|Overall Study|Adverse Event|0|||
157044521|NCT02686658|566917866|FG002|Overall Study|Adverse Event|1|||
157044522|NCT02686658|566917867|FG003|Overall Study|Adverse Event|1|||
157044523|NCT02686658|566917868|FG004|Overall Study|Adverse Event|2|||
157044524|NCT02686658|566917869|FG005|Overall Study|Adverse Event|1|||
157044525|NCT02686658|566917864|FG000|Overall Study|Investigator decision|0|||
157044526|NCT02686658|566917865|FG001|Overall Study|Investigator decision|0|||
157044527|NCT02686658|566917866|FG002|Overall Study|Investigator decision|0|||
157044528|NCT02686658|566917867|FG003|Overall Study|Investigator decision|1|||
157044529|NCT02686658|566917868|FG004|Overall Study|Investigator decision|2|||
157044530|NCT02686658|566917869|FG005|Overall Study|Investigator decision|1|||
157044531|NCT02686658|566917864|FG000|Overall Study|Sponsor decision|1|||
157044532|NCT02686658|566917865|FG001|Overall Study|Sponsor decision|2|||
157044533|NCT02686658|566917866|FG002|Overall Study|Sponsor decision|1|||
157044534|NCT02686658|566917867|FG003|Overall Study|Sponsor decision|5|||
157044535|NCT02686658|566917868|FG004|Overall Study|Sponsor decision|13|||
157044536|NCT02686658|566917869|FG005|Overall Study|Sponsor decision|2|||
157044537|NCT02686658|566917864|FG000|Overall Study|Lost to Follow-up|0|||
157044538|NCT02686658|566917865|FG001|Overall Study|Lost to Follow-up|0|||
157044539|NCT02686658|566917866|FG002|Overall Study|Lost to Follow-up|2|||
157044540|NCT02686658|566917867|FG003|Overall Study|Lost to Follow-up|0|||
157044541|NCT02686658|566917868|FG004|Overall Study|Lost to Follow-up|0|||
157044542|NCT02686658|566917869|FG005|Overall Study|Lost to Follow-up|1|||
157044543|NCT02686658|566917864|FG000|Overall Study|Death|1|||
157044544|NCT02686658|566917865|FG001|Overall Study|Death|0|||
157044545|NCT02686658|566917866|FG002|Overall Study|Death|0|||
157044546|NCT02686658|566917867|FG003|Overall Study|Death|1|||
157044547|NCT02686658|566917868|FG004|Overall Study|Death|1|||
157044548|NCT02686658|566917869|FG005|Overall Study|Death|1|||
157044549|NCT02686658|566917864|FG000|Overall Study|Withdrawal by Subject|2|||
157044550|NCT02686658|566917865|FG001|Overall Study|Withdrawal by Subject|5|||
157044551|NCT02686658|566917866|FG002|Overall Study|Withdrawal by Subject|4|||
157044552|NCT02686658|566917867|FG003|Overall Study|Withdrawal by Subject|4|||
157044553|NCT02686658|566917868|FG004|Overall Study|Withdrawal by Subject|17|||
157044554|NCT02686658|566917869|FG005|Overall Study|Withdrawal by Subject|8|||
157044555|NCT02686658|566917864|FG000|Overall Study|Placed in hospice care|0|||
157044556|NCT02686658|566917865|FG001|Overall Study|Placed in hospice care|0|||
157044557|NCT02686658|566917866|FG002|Overall Study|Placed in hospice care|1|||
157044558|NCT02686658|566917867|FG003|Overall Study|Placed in hospice care|0|||
157044559|NCT02686658|566917868|FG004|Overall Study|Placed in hospice care|0|||
157044560|NCT02686658|566917869|FG005|Overall Study|Placed in hospice care|0|||
157044561|NCT02686658|566917864|FG000|Overall Study|Participant non-compliance|0|||
157044562|NCT02686658|566917865|FG001|Overall Study|Participant non-compliance|0|||
157044563|NCT02686658|566917866|FG002|Overall Study|Participant non-compliance|0|||
157044564|NCT02686658|566917867|FG003|Overall Study|Participant non-compliance|0|||
157044565|NCT02686658|566917868|FG004|Overall Study|Participant non-compliance|0|||
157044566|NCT02686658|566917869|FG005|Overall Study|Participant non-compliance|1|||
157044567|NCT02686658|566917864|FG000|Overall Study|Concern over coronavirus disease care|0|||
157044568|NCT02686658|566917865|FG001|Overall Study|Concern over coronavirus disease care|0|||
157044569|NCT02686658|566917866|FG002|Overall Study|Concern over coronavirus disease care|0|||
157044570|NCT02686658|566917867|FG003|Overall Study|Concern over coronavirus disease care|0|||
157044571|NCT02686658|566917868|FG004|Overall Study|Concern over coronavirus disease care|2|||
157044572|NCT02686658|566917869|FG005|Overall Study|Concern over coronavirus disease care|1|||
157044573|NCT01227421|566917872|FG000|Overall Study|Lost to Follow-up|6|||
157044574|NCT01227421|566917873|FG001|Overall Study|Lost to Follow-up|7|||
157044575|NCT01227421|566917874|FG002|Overall Study|Lost to Follow-up|5|||
157044576|NCT01227421|566917872|FG000|Overall Study|Adverse Event|2|||
157044577|NCT01227421|566917873|FG001|Overall Study|Adverse Event|7|||
157044578|NCT01227421|566917874|FG002|Overall Study|Adverse Event|2|||
157044579|NCT01227421|566917872|FG000|Overall Study|Withdrawal by Subject|1|||
157044580|NCT01227421|566917873|FG001|Overall Study|Withdrawal by Subject|2|||
157044581|NCT01227421|566917874|FG002|Overall Study|Withdrawal by Subject|1|||
157044582|NCT01227421|566917872|FG000|Overall Study|Protocol Violation|1|||
157044583|NCT01227421|566917873|FG001|Overall Study|Protocol Violation|1|||
157044584|NCT01227421|566917874|FG002|Overall Study|Protocol Violation|2|||
157044585|NCT01227421|566917872|FG000|Overall Study|Randomized in error|1|||
157044586|NCT01227421|566917873|FG001|Overall Study|Randomized in error|1|||
157044587|NCT01227421|566917874|FG002|Overall Study|Randomized in error|0|||
157044588|NCT01827839|566917877|FG000|Overall Study|Adverse Event|1|||
157044589|NCT01827839|566917877|FG000|Overall Study|Consent Withdrawal|2|||
157044590|NCT00614614|566917878|FG000|Primary Vaccination Phase|Adverse Event|6|||
157044591|NCT00614614|566917879|FG001|Primary Vaccination Phase|Adverse Event|0|||
157044592|NCT00614614|566917880|FG002|Primary Vaccination Phase|Adverse Event|0|||
157044593|NCT00614614|566917881|FG003|Primary Vaccination Phase|Adverse Event|0|||
157044594|NCT00614614|566917882|FG004|Primary Vaccination Phase|Adverse Event|0|||
157044595|NCT00614614|566917878|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
157044596|NCT00614614|566917879|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
157044597|NCT00614614|566917880|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
157044598|NCT00614614|566917881|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
157174378|NCT03228394|567379785|FG006|Overall Study|Lost to Follow-up|2|||
157174379|NCT03228394|567379786|FG007|Overall Study|Lost to Follow-up|0|||
157044599|NCT00614614|566917882|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
157044600|NCT00614614|566917878|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
157044601|NCT00614614|566917879|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
157044602|NCT00614614|566917880|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
157044603|NCT00614614|566917881|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
157044604|NCT00614614|566917882|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
157044605|NCT00614614|566917878|FG000|Primary Vaccination Phase|Protocol Violation|9|||
157044606|NCT00614614|566917879|FG001|Primary Vaccination Phase|Protocol Violation|3|||
157044607|NCT00614614|566917880|FG002|Primary Vaccination Phase|Protocol Violation|0|||
157044608|NCT00614614|566917881|FG003|Primary Vaccination Phase|Protocol Violation|0|||
157044609|NCT00614614|566917882|FG004|Primary Vaccination Phase|Protocol Violation|0|||
157044610|NCT00614614|566917878|FG000|Primary Vaccination Phase|Other|4|||
157044611|NCT00614614|566917879|FG001|Primary Vaccination Phase|Other|0|||
157044612|NCT00614614|566917880|FG002|Primary Vaccination Phase|Other|0|||
157044613|NCT00614614|566917881|FG003|Primary Vaccination Phase|Other|0|||
157044614|NCT00614614|566917882|FG004|Primary Vaccination Phase|Other|0|||
157044615|NCT00614614|566917878|FG000|Booster Vaccination Phase|Adverse Event|0|||
157044616|NCT00614614|566917879|FG001|Booster Vaccination Phase|Adverse Event|0|||
157044617|NCT00614614|566917880|FG002|Booster Vaccination Phase|Adverse Event|1|||
157044618|NCT00614614|566917881|FG003|Booster Vaccination Phase|Adverse Event|1|||
157044619|NCT00614614|566917882|FG004|Booster Vaccination Phase|Adverse Event|0|||
157044620|NCT00614614|566917878|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
157044621|NCT00614614|566917879|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
157044622|NCT00614614|566917880|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
157044623|NCT00614614|566917881|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
157044624|NCT00614614|566917882|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
157044625|NCT00614614|566917878|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
157044626|NCT00614614|566917879|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
157044627|NCT00614614|566917880|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
157044628|NCT00614614|566917881|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
157044629|NCT00614614|566917882|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
157044630|NCT00614614|566917878|FG000|Booster Vaccination Phase|Protocol Violation|0|||
157044631|NCT00614614|566917879|FG001|Booster Vaccination Phase|Protocol Violation|0|||
157044632|NCT00614614|566917880|FG002|Booster Vaccination Phase|Protocol Violation|2|||
157044633|NCT00614614|566917881|FG003|Booster Vaccination Phase|Protocol Violation|3|||
157044634|NCT00614614|566917882|FG004|Booster Vaccination Phase|Protocol Violation|0|||
157044635|NCT00614614|566917878|FG000|Booster Vaccination Phase|Other|0|||
157044636|NCT00614614|566917879|FG001|Booster Vaccination Phase|Other|1|||
157044637|NCT00614614|566917880|FG002|Booster Vaccination Phase|Other|3|||
157044638|NCT00614614|566917881|FG003|Booster Vaccination Phase|Other|2|||
157044639|NCT00614614|566917882|FG004|Booster Vaccination Phase|Other|1|||
157044640|NCT05426109|566917883|FG000|Overall Study|Withdrawal by Subject|0|||
157044641|NCT05426109|566917884|FG001|Overall Study|Withdrawal by Subject|1|||
157044642|NCT05212285|566917885|FG000|Overall Study|Lack of Efficacy|12|||
157044643|NCT05212285|566917886|FG001|Overall Study|Lack of Efficacy|8|||
157044644|NCT05212285|566917885|FG000|Overall Study|Withdrawal by Subject|8|||
157044645|NCT05212285|566917886|FG001|Overall Study|Withdrawal by Subject|1|||
157044646|NCT05212285|566917885|FG000|Overall Study|Lost to Follow-up|13|||
157044647|NCT05212285|566917886|FG001|Overall Study|Lost to Follow-up|1|||
157044648|NCT05212285|566917885|FG000|Overall Study|miss data|21|||
157044649|NCT05212285|566917886|FG001|Overall Study|miss data|2|||
157044650|NCT01000805|566917888|FG000|Overall Study|Adverse Event|21|||
157044651|NCT01000805|566917889|FG001|Overall Study|Adverse Event|9|||
157044652|NCT01000805|566917888|FG000|Overall Study|Lack of Efficacy|5|||
157044653|NCT01000805|566917889|FG001|Overall Study|Lack of Efficacy|16|||
157044654|NCT01000805|566917888|FG000|Overall Study|Lost to Follow-up|16|||
157044655|NCT01000805|566917889|FG001|Overall Study|Lost to Follow-up|21|||
157044656|NCT01000805|566917888|FG000|Overall Study|Physician Decision|0|||
157044657|NCT01000805|566917889|FG001|Overall Study|Physician Decision|1|||
157044658|NCT01000805|566917888|FG000|Overall Study|Protocol Violation|12|||
157044659|NCT01000805|566917889|FG001|Overall Study|Protocol Violation|8|||
157044660|NCT01000805|566917888|FG000|Overall Study|Withdrawal by Subject|16|||
157044661|NCT01000805|566917889|FG001|Overall Study|Withdrawal by Subject|6|||
157044662|NCT01000805|566917888|FG000|Overall Study|Sponsor Decision|0|||
157044663|NCT01000805|566917889|FG001|Overall Study|Sponsor Decision|1|||
157044664|NCT00949117|566919087|FG000|Overall Study|Lack of Efficacy|2|||
157044665|NCT00949117|566919088|FG001|Overall Study|Lack of Efficacy|3|||
157044666|NCT00949117|566919087|FG000|Overall Study|Protocol Violation|1|||
157044667|NCT00949117|566919088|FG001|Overall Study|Protocol Violation|1|||
157044668|NCT00949117|566919087|FG000|Overall Study|Adverse Event|0|||
157044669|NCT00949117|566919088|FG001|Overall Study|Adverse Event|1|||
157044670|NCT03964974|566919089|FG000|Overall Study|Lost to Follow-up|3|||
157044671|NCT03964974|566919090|FG001|Overall Study|Lost to Follow-up|2|||
157228803|NCT05097989|567583376|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228804|NCT05097989|567583377|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157044672|NCT03964974|566919089|FG000|Overall Study|Withdrawal by Subject|0|||
157044673|NCT03964974|566919090|FG001|Overall Study|Withdrawal by Subject|3|||
157044674|NCT02014402|566919091|FG000|Overall Study|Adverse Event|1|||
157044675|NCT02014402|566919092|FG001|Overall Study|Adverse Event|0|||
157044676|NCT02014402|566919093|FG002|Overall Study|Adverse Event|0|||
157044677|NCT02014402|566919094|FG003|Overall Study|Adverse Event|0|||
157044678|NCT02014402|566919091|FG000|Overall Study|Withdrawal by Subject|1|||
157044679|NCT02014402|566919092|FG001|Overall Study|Withdrawal by Subject|2|||
157044680|NCT02014402|566919093|FG002|Overall Study|Withdrawal by Subject|2|||
157044681|NCT02014402|566919094|FG003|Overall Study|Withdrawal by Subject|1|||
157228805|NCT05097989|567583378|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228806|NCT05097989|567583379|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228807|NCT05097989|567583380|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
157228808|NCT05097989|567583381|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228809|NCT05097989|567583382|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228810|NCT05097989|567583383|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
157228811|NCT05097989|567583375|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
157228812|NCT05097989|567583376|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
157228813|NCT05097989|567583377|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
157228814|NCT05097989|567583378|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
157228815|NCT05097989|567583379|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
157228816|NCT05097989|567583380|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
157228817|NCT05097989|567583381|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
157228818|NCT05097989|567583382|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
157174380|NCT03228394|567379779|FG000|Overall Study|Withdrawal by Subject|0|||
157174381|NCT03228394|567379780|FG001|Overall Study|Withdrawal by Subject|0|||
157174382|NCT03228394|567379781|FG002|Overall Study|Withdrawal by Subject|1|||
157174383|NCT03228394|567379782|FG003|Overall Study|Withdrawal by Subject|0|||
157174384|NCT03228394|567379783|FG004|Overall Study|Withdrawal by Subject|0|||
157174385|NCT03228394|567379784|FG005|Overall Study|Withdrawal by Subject|0|||
157174386|NCT03228394|567379785|FG006|Overall Study|Withdrawal by Subject|1|||
157174387|NCT03228394|567379786|FG007|Overall Study|Withdrawal by Subject|3|||
157174388|NCT03228394|567379779|FG000|Overall Study|Protocol Violation|0|||
157174389|NCT03228394|567379780|FG001|Overall Study|Protocol Violation|0|||
157174390|NCT03228394|567379781|FG002|Overall Study|Protocol Violation|0|||
157228819|NCT05097989|567583383|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
157228820|NCT05097989|567583375|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228821|NCT05097989|567583376|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228822|NCT05097989|567583377|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228823|NCT05097989|567583378|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228824|NCT05097989|567583379|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228825|NCT05097989|567583380|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
157228826|NCT05097989|567583381|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
157228827|NCT05097989|567583382|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
157228828|NCT05097989|567583383|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
157228829|NCT05097989|567583375|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157174391|NCT03228394|567379782|FG003|Overall Study|Protocol Violation|1|||
157174392|NCT03228394|567379783|FG004|Overall Study|Protocol Violation|0|||
157174393|NCT03228394|567379784|FG005|Overall Study|Protocol Violation|0|||
157174394|NCT03228394|567379785|FG006|Overall Study|Protocol Violation|0|||
157174395|NCT03228394|567379786|FG007|Overall Study|Protocol Violation|0|||
157174396|NCT03228394|567379779|FG000|Overall Study|Physician Decision|0|||
157174397|NCT03228394|567379780|FG001|Overall Study|Physician Decision|0|||
157174398|NCT03228394|567379781|FG002|Overall Study|Physician Decision|0|||
157174399|NCT03228394|567379782|FG003|Overall Study|Physician Decision|0|||
157174400|NCT03228394|567379783|FG004|Overall Study|Physician Decision|0|||
157174401|NCT03228394|567379784|FG005|Overall Study|Physician Decision|0|||
157174402|NCT03228394|567379785|FG006|Overall Study|Physician Decision|1|||
157174403|NCT03228394|567379786|FG007|Overall Study|Physician Decision|0|||
157174404|NCT03228394|567379779|FG000|Overall Study|Noncompliance|0|||
157174405|NCT03228394|567379780|FG001|Overall Study|Noncompliance|0|||
157174406|NCT03228394|567379781|FG002|Overall Study|Noncompliance|0|||
157044682|NCT02014402|566919091|FG000|Overall Study|Subject did not have transportation|0|||
157044683|NCT02014402|566919092|FG001|Overall Study|Subject did not have transportation|1|||
157044684|NCT02014402|566919093|FG002|Overall Study|Subject did not have transportation|0|||
157044685|NCT02014402|566919094|FG003|Overall Study|Subject did not have transportation|0|||
157044686|NCT02014402|566919091|FG000|Overall Study|Lost to Follow-up|0|||
157044687|NCT02014402|566919092|FG001|Overall Study|Lost to Follow-up|0|||
157044688|NCT02014402|566919093|FG002|Overall Study|Lost to Follow-up|1|||
157044689|NCT02014402|566919094|FG003|Overall Study|Lost to Follow-up|2|||
157044690|NCT04992273|566919098|FG000|Overall Study|Lost to Follow-up|0|||
157044691|NCT04992273|566919099|FG001|Overall Study|Lost to Follow-up|1|||
157174407|NCT03228394|567379782|FG003|Overall Study|Noncompliance|0|||
157174408|NCT03228394|567379783|FG004|Overall Study|Noncompliance|0|||
157174409|NCT03228394|567379784|FG005|Overall Study|Noncompliance|0|||
157174410|NCT03228394|567379785|FG006|Overall Study|Noncompliance|1|||
157174411|NCT03228394|567379786|FG007|Overall Study|Noncompliance|0|||
157174412|NCT02443805|567379789|FG000|Overall Study|Adverse Event|100|||
157174413|NCT02443805|567379790|FG001|Overall Study|Adverse Event|18|||
157174414|NCT02443805|567379789|FG000|Overall Study|Withdrawal by Subject|73|||
157044692|NCT01364597|566919100|FG000|Overall Study|Adverse Event|4|||
157174415|NCT02443805|567379790|FG001|Overall Study|Withdrawal by Subject|74|||
157174416|NCT02443805|567379789|FG000|Overall Study|Lost to Follow-up|19|||
157044693|NCT01364597|566919101|FG001|Overall Study|Adverse Event|5|||
157174417|NCT02443805|567379790|FG001|Overall Study|Lost to Follow-up|14|||
157174418|NCT02443805|567379789|FG000|Overall Study|Pregnancy|6|||
157174419|NCT02443805|567379790|FG001|Overall Study|Pregnancy|5|||
157174420|NCT02443805|567379789|FG000|Overall Study|Protocol Violation|2|||
157174421|NCT02443805|567379790|FG001|Overall Study|Protocol Violation|4|||
157174422|NCT02443805|567379789|FG000|Overall Study|Lack of Efficacy|1|||
157174423|NCT02443805|567379790|FG001|Overall Study|Lack of Efficacy|1|||
157174424|NCT02443805|567379789|FG000|Overall Study|Non-compliance with study drug|6|||
157174425|NCT02443805|567379790|FG001|Overall Study|Non-compliance with study drug|4|||
157174426|NCT02443805|567379789|FG000|Overall Study|Withdrawal by parent/guardian|3|||
157174427|NCT02443805|567379790|FG001|Overall Study|Withdrawal by parent/guardian|5|||
157174428|NCT02443805|567379789|FG000|Overall Study|Any other reason not above-mentioned|3|||
157174429|NCT02443805|567379790|FG001|Overall Study|Any other reason not above-mentioned|2|||
156968901|NCT00608582|566637776|FG001|Overall Study|Lost to Follow-up|0|||
156968902|NCT00608582|566637775|FG000|Overall Study|No Best Response in Phase 1 located|1|||
156968903|NCT00608582|566637776|FG001|Overall Study|No Best Response in Phase 1 located|1|||
156968904|NCT00608582|566637775|FG000|Overall Study|Illicit Drug Use|1|||
156968905|NCT00608582|566637776|FG001|Overall Study|Illicit Drug Use|0|||
156968906|NCT00608582|566637775|FG000|Overall Study|Early stage Design Change|0|||
156968907|NCT00608582|566637776|FG001|Overall Study|Early stage Design Change|3|||
156968908|NCT04922554|566637777|FG000|Overall Study|Adverse Event|4|||
156968909|NCT04922554|566637778|FG001|Overall Study|Adverse Event|0|||
156968910|NCT04922554|566637777|FG000|Overall Study|Withdrawal by Subject|1|||
156968911|NCT04922554|566637778|FG001|Overall Study|Withdrawal by Subject|0|||
156968912|NCT02276066|566639044|FG000|Overall Study|Lost to Follow-up|21|||
156968913|NCT02276066|566639045|FG001|Overall Study|Lost to Follow-up|11|||
156968914|NCT05050578|566639046|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
156968915|NCT05050578|566639047|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
156968916|NCT05050578|566639046|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
156968917|NCT05050578|566639047|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
156968918|NCT05050578|566639046|FG000|Period 2, 30 Days|Protocol Violation|0|||
156968919|NCT05050578|566639047|FG001|Period 2, 30 Days|Protocol Violation|1|||
156968920|NCT02243280|566639048|FG000|Treated|Adverse Event|1|||
156968921|NCT02243280|566639049|FG001|Treated|Adverse Event|0|||
156968922|NCT02243280|566639050|FG002|Treated|Adverse Event|0|||
156968923|NCT02243280|566639051|FG003|Treated|Adverse Event|0|||
156968924|NCT02243280|566639052|FG004|Treated|Adverse Event|0|||
156968925|NCT02243280|566639053|FG005|Treated|Adverse Event|0|||
156968926|NCT02243280|566639054|FG006|Treated|Adverse Event|0|||
156968927|NCT02243280|566639055|FG007|Treated|Adverse Event|0|||
156968928|NCT02243280|566639056|FG008|Treated|Adverse Event|0|||
156968929|NCT02243280|566639057|FG009|Treated|Adverse Event|0|||
156968930|NCT02243280|566639058|FG010|Treated|Adverse Event|1|||
156968931|NCT02243280|566639048|FG000|Treated|Lost to Follow-up|0|||
156968932|NCT02243280|566639049|FG001|Treated|Lost to Follow-up|0|||
156968933|NCT02243280|566639050|FG002|Treated|Lost to Follow-up|0|||
156968934|NCT02243280|566639051|FG003|Treated|Lost to Follow-up|0|||
156968935|NCT02243280|566639052|FG004|Treated|Lost to Follow-up|0|||
156968936|NCT02243280|566639053|FG005|Treated|Lost to Follow-up|0|||
156968937|NCT02243280|566639054|FG006|Treated|Lost to Follow-up|0|||
156968938|NCT02243280|566639055|FG007|Treated|Lost to Follow-up|0|||
156968939|NCT02243280|566639056|FG008|Treated|Lost to Follow-up|1|||
156968940|NCT02243280|566639057|FG009|Treated|Lost to Follow-up|0|||
156968941|NCT02243280|566639058|FG010|Treated|Lost to Follow-up|2|||
156968942|NCT03386032|566639060|FG000|Overall Study|Lack of Efficacy|6|||
156968943|NCT03386032|566639061|FG001|Overall Study|Lack of Efficacy|2|||
156968944|NCT03386032|566639062|FG002|Overall Study|Lack of Efficacy|0|||
156968945|NCT03386032|566639060|FG000|Overall Study|Adverse Event|2|||
156968946|NCT03386032|566639061|FG001|Overall Study|Adverse Event|2|||
156968947|NCT03386032|566639062|FG002|Overall Study|Adverse Event|0|||
156968948|NCT03386032|566639060|FG000|Overall Study|Withdrawal by Subject|1|||
156968949|NCT03386032|566639061|FG001|Overall Study|Withdrawal by Subject|0|||
156968950|NCT03386032|566639062|FG002|Overall Study|Withdrawal by Subject|0|||
156968951|NCT03386032|566639060|FG000|Overall Study|Lost to Follow-up|9|||
156968952|NCT03386032|566639061|FG001|Overall Study|Lost to Follow-up|3|||
156968953|NCT03386032|566639062|FG002|Overall Study|Lost to Follow-up|0|||
156968954|NCT01807156|566639063|FG000|Overall Study|Physician Decision|1|||
156968955|NCT02710292|566639068|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
156968956|NCT02710292|566639069|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
156968957|NCT02710292|566639068|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
156968958|NCT02710292|566639069|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
156968959|NCT03122119|566639070|FG000|Overall Study|Did not meet eligibility critria|1|||
156968960|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
156968961|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
156968962|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
156968963|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
157044694|NCT01364597|566919102|FG002|Overall Study|Adverse Event|16|||
157044695|NCT01364597|566919103|FG003|Overall Study|Adverse Event|7|||
157044696|NCT01364597|566919100|FG000|Overall Study|Lack of Efficacy|4|||
157044697|NCT01364597|566919101|FG001|Overall Study|Lack of Efficacy|4|||
157044698|NCT01364597|566919102|FG002|Overall Study|Lack of Efficacy|23|||
157044699|NCT01364597|566919103|FG003|Overall Study|Lack of Efficacy|8|||
157044700|NCT01364597|566919100|FG000|Overall Study|Protocol Violation|0|||
157044701|NCT01364597|566919101|FG001|Overall Study|Protocol Violation|0|||
157044702|NCT01364597|566919102|FG002|Overall Study|Protocol Violation|2|||
157044703|NCT01364597|566919103|FG003|Overall Study|Protocol Violation|0|||
157044704|NCT01364597|566919100|FG000|Overall Study|Lost to Follow-up|0|||
157044705|NCT01364597|566919101|FG001|Overall Study|Lost to Follow-up|0|||
157044706|NCT01364597|566919102|FG002|Overall Study|Lost to Follow-up|5|||
157044707|NCT01364597|566919103|FG003|Overall Study|Lost to Follow-up|3|||
157044708|NCT01364597|566919100|FG000|Overall Study|Withdrawal by Subject|4|||
157044709|NCT01364597|566919101|FG001|Overall Study|Withdrawal by Subject|1|||
157044710|NCT01364597|566919102|FG002|Overall Study|Withdrawal by Subject|18|||
157044711|NCT01364597|566919103|FG003|Overall Study|Withdrawal by Subject|6|||
157044712|NCT01364597|566919100|FG000|Overall Study|Non compliance|1|||
157044713|NCT01364597|566919101|FG001|Overall Study|Non compliance|0|||
157044714|NCT01364597|566919102|FG002|Overall Study|Non compliance|1|||
157044715|NCT01364597|566919103|FG003|Overall Study|Non compliance|0|||
157044716|NCT01364597|566919100|FG000|Overall Study|Lack of compliance|1|||
157044717|NCT01364597|566919101|FG001|Overall Study|Lack of compliance|0|||
157044718|NCT01364597|566919102|FG002|Overall Study|Lack of compliance|0|||
157044719|NCT01364597|566919103|FG003|Overall Study|Lack of compliance|0|||
157044720|NCT01364597|566919100|FG000|Overall Study|End of treatment epilepsy|1|||
157044721|NCT01364597|566919101|FG001|Overall Study|End of treatment epilepsy|0|||
157044722|NCT01364597|566919102|FG002|Overall Study|End of treatment epilepsy|0|||
157044723|NCT01364597|566919103|FG003|Overall Study|End of treatment epilepsy|0|||
157044724|NCT01364597|566919100|FG000|Overall Study|No Seizures|1|||
157044725|NCT01364597|566919101|FG001|Overall Study|No Seizures|0|||
157044726|NCT01364597|566919102|FG002|Overall Study|No Seizures|0|||
157044727|NCT01364597|566919103|FG003|Overall Study|No Seizures|0|||
157044728|NCT01364597|566919100|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
157044729|NCT01364597|566919101|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
157044730|NCT01364597|566919102|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
157044731|NCT01364597|566919103|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
157044732|NCT01364597|566919100|FG000|Overall Study|Cure|1|||
157044733|NCT01364597|566919101|FG001|Overall Study|Cure|0|||
157044734|NCT01364597|566919102|FG002|Overall Study|Cure|0|||
157044735|NCT01364597|566919103|FG003|Overall Study|Cure|0|||
157044736|NCT01364597|566919100|FG000|Overall Study|Patient was moving|0|||
157044737|NCT01364597|566919101|FG001|Overall Study|Patient was moving|1|||
157044738|NCT01364597|566919102|FG002|Overall Study|Patient was moving|0|||
157044739|NCT01364597|566919103|FG003|Overall Study|Patient was moving|0|||
157044740|NCT01364597|566919100|FG000|Overall Study|Seizures resolved|0|||
157044741|NCT01364597|566919101|FG001|Overall Study|Seizures resolved|0|||
157044742|NCT01364597|566919102|FG002|Overall Study|Seizures resolved|1|||
157044743|NCT01364597|566919103|FG003|Overall Study|Seizures resolved|0|||
157044744|NCT01364597|566919100|FG000|Overall Study|Patient became seizure-free after surgery|0|||
157044745|NCT01364597|566919101|FG001|Overall Study|Patient became seizure-free after surgery|0|||
157044746|NCT01364597|566919102|FG002|Overall Study|Patient became seizure-free after surgery|1|||
157044747|NCT01364597|566919103|FG003|Overall Study|Patient became seizure-free after surgery|0|||
157044748|NCT01364597|566919100|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
157044749|NCT01364597|566919101|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
157044750|NCT01364597|566919102|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
157044751|NCT01364597|566919103|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
157044752|NCT01364597|566919100|FG000|Overall Study|Patient cured from Epilepsy|0|||
157044753|NCT01364597|566919101|FG001|Overall Study|Patient cured from Epilepsy|0|||
157044754|NCT01364597|566919102|FG002|Overall Study|Patient cured from Epilepsy|1|||
157044755|NCT01364597|566919103|FG003|Overall Study|Patient cured from Epilepsy|0|||
157044756|NCT01364597|566919100|FG000|Overall Study|Investigator decision|0|||
157044757|NCT01364597|566919101|FG001|Overall Study|Investigator decision|0|||
157044758|NCT01364597|566919102|FG002|Overall Study|Investigator decision|1|||
157044759|NCT01364597|566919103|FG003|Overall Study|Investigator decision|0|||
157044760|NCT01364597|566919100|FG000|Overall Study|Sponsor recommended discontinuation|0|||
157044761|NCT01364597|566919101|FG001|Overall Study|Sponsor recommended discontinuation|0|||
157044762|NCT01364597|566919102|FG002|Overall Study|Sponsor recommended discontinuation|0|||
157044763|NCT01364597|566919103|FG003|Overall Study|Sponsor recommended discontinuation|1|||
157044764|NCT01364597|566919100|FG000|Overall Study|Parents went abroad with the patient|0|||
157044765|NCT01364597|566919101|FG001|Overall Study|Parents went abroad with the patient|0|||
157044766|NCT01364597|566919102|FG002|Overall Study|Parents went abroad with the patient|1|||
157044767|NCT01364597|566919103|FG003|Overall Study|Parents went abroad with the patient|0|||
157044768|NCT01364597|566919100|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
157044769|NCT01364597|566919101|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
157044770|NCT01364597|566919102|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
157044771|NCT01364597|566919103|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
157044772|NCT01364597|566919100|FG000|Overall Study|BRV administration dropout|0|||
157044773|NCT01364597|566919101|FG001|Overall Study|BRV administration dropout|0|||
157044774|NCT01364597|566919102|FG002|Overall Study|BRV administration dropout|1|||
157044775|NCT01364597|566919103|FG003|Overall Study|BRV administration dropout|0|||
157044776|NCT01364597|566919100|FG000|Overall Study|Dropout|0|||
157044777|NCT01364597|566919101|FG001|Overall Study|Dropout|0|||
157044778|NCT01364597|566919102|FG002|Overall Study|Dropout|3|||
157044779|NCT01364597|566919103|FG003|Overall Study|Dropout|1|||
157044780|NCT01364597|566919100|FG000|Overall Study|Unreliable subject|0|||
157044781|NCT01364597|566919101|FG001|Overall Study|Unreliable subject|0|||
157044782|NCT01364597|566919102|FG002|Overall Study|Unreliable subject|0|||
157044783|NCT01364597|566919103|FG003|Overall Study|Unreliable subject|1|||
157044784|NCT01364597|566919100|FG000|Overall Study|Other|0|||
157044785|NCT01364597|566919101|FG001|Overall Study|Other|0|||
157044786|NCT01364597|566919102|FG002|Overall Study|Other|0|||
157044787|NCT01364597|566919103|FG003|Overall Study|Other|1|||
157044788|NCT03493282|566919107|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
157044789|NCT03493282|566919108|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
157044790|NCT03493282|566919109|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
157044791|NCT03493282|566919107|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
157044792|NCT03493282|566919108|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
157044793|NCT03493282|566919109|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
157044794|NCT01380145|566919110|FG000|Overall Study|Progressive disease|4|||
157044795|NCT02038049|566919111|FG000|Overall Study|Lost to Follow-up|1|||
157044796|NCT02038049|566919112|FG001|Overall Study|Lost to Follow-up|0|||
157044797|NCT02660086|566919114|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
157044798|NCT02660086|566919115|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
157044799|NCT02660086|566919114|FG000|Overall Study- 12-month|Left full-time employment|12|||
157044800|NCT02660086|566919115|FG001|Overall Study- 12-month|Left full-time employment|20|||
157044801|NCT02660086|566919114|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
157044802|NCT02660086|566919115|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
157044803|NCT02660086|566919114|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
157044804|NCT02660086|566919115|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
157044805|NCT02660086|566919114|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
157044806|NCT02660086|566919115|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
157044807|NCT02660086|566919114|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
157044808|NCT02660086|566919115|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
157044809|NCT04250636|566919121|FG000|Overall Study|Lost to Follow-up|2|||
157044810|NCT05005247|566919123|FG000|Overall Study|Withdrawal by Subject|0|||
157044811|NCT05005247|566919124|FG001|Overall Study|Withdrawal by Subject|1|||
157044812|NCT05005247|566919125|FG002|Overall Study|Withdrawal by Subject|0|||
157044813|NCT02827201|566919132|FG000|Overall Study|Death|1|||
157044814|NCT02827201|566919133|FG001|Overall Study|Death|2|||
157044815|NCT02827201|566919132|FG000|Overall Study|Patients not treated|1|||
157044816|NCT02827201|566919133|FG001|Overall Study|Patients not treated|1|||
157044817|NCT02630186|566919134|FG000|Overall Study|Withdrawal by Subject|1|||
157044818|NCT00439218|566919135|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
157044819|NCT02128269|566919138|FG000|Treatment Period|Adverse Event|1|||
157044820|NCT02128269|566919138|FG000|Treatment Period|Physician Decision|1|||
157044821|NCT01021748|566919139|FG000|Overall Study|Adverse Event|2|||
157044822|NCT01021748|566919140|FG001|Overall Study|Adverse Event|1|||
157044823|NCT01021748|566919141|FG002|Overall Study|Adverse Event|2|||
157174430|NCT00961116|567379791|FG000|Washout Period of 7 Days|Adverse Event|1|||
157174431|NCT00961116|567379792|FG001|Washout Period of 7 Days|Adverse Event|1|||
157174432|NCT00961116|567379791|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
157174433|NCT00961116|567379792|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
157174434|NCT00961116|567379791|FG000|Washout Period of 7 Days|Protocol Violation|0|||
157174435|NCT00961116|567379792|FG001|Washout Period of 7 Days|Protocol Violation|1|||
157174436|NCT00968708|567379793|FG000|Overall Study|Adverse Event|169|||
157174437|NCT00968708|567379794|FG001|Overall Study|Adverse Event|150|||
157174438|NCT00968708|567379793|FG000|Overall Study|Major Protocol Deviation|0|||
157174439|NCT00968708|567379794|FG001|Overall Study|Major Protocol Deviation|1|||
157174440|NCT00968708|567379793|FG000|Overall Study|Lost to Follow-up|19|||
157174441|NCT00968708|567379794|FG001|Overall Study|Lost to Follow-up|11|||
157044824|NCT01021748|566919142|FG003|Overall Study|Adverse Event|0|||
157044825|NCT01021748|566919143|FG004|Overall Study|Adverse Event|2|||
157044826|NCT01021748|566919144|FG005|Overall Study|Adverse Event|0|||
157044827|NCT01021748|566919145|FG006|Overall Study|Adverse Event|1|||
157044828|NCT01021748|566919146|FG007|Overall Study|Adverse Event|0|||
157044829|NCT01021748|566919147|FG008|Overall Study|Adverse Event|7|||
157044830|NCT01021748|566919139|FG000|Overall Study|Physician Decision|1|||
157044831|NCT01021748|566919140|FG001|Overall Study|Physician Decision|0|||
157044832|NCT01021748|566919141|FG002|Overall Study|Physician Decision|1|||
157044833|NCT01021748|566919142|FG003|Overall Study|Physician Decision|1|||
157044834|NCT01021748|566919143|FG004|Overall Study|Physician Decision|0|||
157044835|NCT01021748|566919144|FG005|Overall Study|Physician Decision|0|||
157044836|NCT01021748|566919145|FG006|Overall Study|Physician Decision|1|||
157044837|NCT01021748|566919146|FG007|Overall Study|Physician Decision|1|||
157044838|NCT01021748|566919147|FG008|Overall Study|Physician Decision|2|||
157044839|NCT01021748|566919139|FG000|Overall Study|Progressive Disease|3|||
157044840|NCT01021748|566919140|FG001|Overall Study|Progressive Disease|3|||
157044841|NCT01021748|566919141|FG002|Overall Study|Progressive Disease|4|||
157044842|NCT01021748|566919142|FG003|Overall Study|Progressive Disease|6|||
157044843|NCT01021748|566919143|FG004|Overall Study|Progressive Disease|7|||
157044844|NCT01021748|566919144|FG005|Overall Study|Progressive Disease|3|||
157044845|NCT01021748|566919145|FG006|Overall Study|Progressive Disease|0|||
157044846|NCT01021748|566919146|FG007|Overall Study|Progressive Disease|5|||
157044847|NCT01021748|566919147|FG008|Overall Study|Progressive Disease|6|||
157044848|NCT01021748|566919139|FG000|Overall Study|Withdrawal by Subject|0|||
157044849|NCT01021748|566919140|FG001|Overall Study|Withdrawal by Subject|0|||
157044850|NCT01021748|566919141|FG002|Overall Study|Withdrawal by Subject|0|||
157044851|NCT01021748|566919142|FG003|Overall Study|Withdrawal by Subject|0|||
157174442|NCT00968708|567379793|FG000|Overall Study|Voluntary Withdrawal|104|||
157174443|NCT00968708|567379794|FG001|Overall Study|Voluntary Withdrawal|101|||
157174444|NCT00968708|567379793|FG000|Overall Study|Investigator Discretion|0|||
157174445|NCT00968708|567379794|FG001|Overall Study|Investigator Discretion|1|||
157044852|NCT01021748|566919143|FG004|Overall Study|Withdrawal by Subject|0|||
157044853|NCT01021748|566919144|FG005|Overall Study|Withdrawal by Subject|0|||
157044854|NCT01021748|566919145|FG006|Overall Study|Withdrawal by Subject|1|||
157044855|NCT01021748|566919146|FG007|Overall Study|Withdrawal by Subject|0|||
157044856|NCT01021748|566919147|FG008|Overall Study|Withdrawal by Subject|1|||
157044857|NCT01021748|566919139|FG000|Overall Study|Not Treated|0|||
157044858|NCT01021748|566919140|FG001|Overall Study|Not Treated|1|||
157044859|NCT01021748|566919141|FG002|Overall Study|Not Treated|0|||
157044860|NCT01021748|566919142|FG003|Overall Study|Not Treated|0|||
157044861|NCT01021748|566919143|FG004|Overall Study|Not Treated|0|||
157044862|NCT01021748|566919144|FG005|Overall Study|Not Treated|0|||
157044863|NCT01021748|566919145|FG006|Overall Study|Not Treated|0|||
157044864|NCT01021748|566919146|FG007|Overall Study|Not Treated|0|||
157044865|NCT01021748|566919147|FG008|Overall Study|Not Treated|0|||
157044866|NCT01829711|566919148|FG000|Overall Study|Lost to Follow-up|2|||
157044867|NCT01829711|566919148|FG000|Overall Study|Withdrawal by Subject|3|||
157044868|NCT01829711|566919148|FG000|Overall Study|Death|4|||
157044869|NCT01829711|566919148|FG000|Overall Study|Started new therapies|17|||
157044870|NCT01829711|566919148|FG000|Overall Study|Adverse Event|3|||
157044871|NCT01829711|566919148|FG000|Overall Study|Due to progression of disease|13|||
157044872|NCT01829711|566919148|FG000|Overall Study|Due to lack of response|1|||
157044873|NCT01480258|566919149|FG000|Infant Series|Protocol Violation|2|||
157044874|NCT01480258|566919150|FG001|Infant Series|Protocol Violation|0|||
157044875|NCT01480258|566919149|FG000|Infant Series|Physician Decision|0|||
157044876|NCT01480258|566919150|FG001|Infant Series|Physician Decision|1|||
157044877|NCT01480258|566919149|FG000|Infant Series|Not Vaccinated|3|||
157044878|NCT01480258|566919150|FG001|Infant Series|Not Vaccinated|0|||
157044879|NCT01480258|566919149|FG000|Infant Series|Adverse Event|1|||
157044880|NCT01480258|566919150|FG001|Infant Series|Adverse Event|1|||
157044881|NCT01480258|566919149|FG000|Infant Series|Withdrawal by Subject|1|||
157044882|NCT01480258|566919150|FG001|Infant Series|Withdrawal by Subject|6|||
157044883|NCT01480258|566919149|FG000|Interim Period|Lost to Follow-up|0|||
157044884|NCT01480258|566919150|FG001|Interim Period|Lost to Follow-up|2|||
157044885|NCT01480258|566919149|FG000|Interim Period|Physician Decision|1|||
157044886|NCT01480258|566919150|FG001|Interim Period|Physician Decision|0|||
157044887|NCT01480258|566919149|FG000|Interim Period|Protocol Violation|0|||
157174446|NCT00968708|567379793|FG000|Overall Study|Other|26|||
157044888|NCT01480258|566919150|FG001|Interim Period|Protocol Violation|1|||
157044889|NCT01480258|566919149|FG000|Interim Period|Withdrawal by Subject|9|||
157044890|NCT01480258|566919150|FG001|Interim Period|Withdrawal by Subject|6|||
157044891|NCT01640288|566919153|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
157174447|NCT00968708|567379794|FG001|Overall Study|Other|34|||
157044892|NCT01640288|566919154|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
157044893|NCT01640288|566919153|FG000|Overall Study|Screen Failure|20|||
157044894|NCT01640288|566919154|FG001|Overall Study|Screen Failure|18|||
157044895|NCT01640288|566919153|FG000|Overall Study|Withdrawn by PI|5|||
157044896|NCT01640288|566919154|FG001|Overall Study|Withdrawn by PI|0|||
157044897|NCT01640288|566919153|FG000|Overall Study|Withdrawal by Subject|1|||
157044898|NCT01640288|566919154|FG001|Overall Study|Withdrawal by Subject|0|||
157044899|NCT01485887|566919158|FG000|Overall Study|Withdrawal by Subject|2|||
157044900|NCT01485887|566919158|FG000|Overall Study|Adverse Event|8|||
157044901|NCT01485887|566919158|FG000|Overall Study|Deterioration of primary disease|1|||
157044902|NCT01485887|566919158|FG000|Overall Study|Primary disease markedly improved|1|||
157044903|NCT02234141|566919159|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044904|NCT02234141|566919160|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044905|NCT02234141|566919161|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044906|NCT02234141|566919162|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
157044907|NCT02234141|566919163|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044908|NCT02234141|566919164|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044909|NCT02234141|566919165|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
157044910|NCT02234141|566919159|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044911|NCT02234141|566919160|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
157044912|NCT02234141|566919161|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044913|NCT02234141|566919162|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044914|NCT02234141|566919163|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044915|NCT02234141|566919164|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044916|NCT02234141|566919165|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
157044917|NCT02234141|566919159|FG000|Treatment Period (24 Weeks)|Death|1|||
157044918|NCT02234141|566919160|FG001|Treatment Period (24 Weeks)|Death|2|||
157044919|NCT02234141|566919161|FG002|Treatment Period (24 Weeks)|Death|0|||
157044920|NCT02234141|566919162|FG003|Treatment Period (24 Weeks)|Death|1|||
157044921|NCT02234141|566919163|FG004|Treatment Period (24 Weeks)|Death|0|||
157044922|NCT02234141|566919164|FG005|Treatment Period (24 Weeks)|Death|0|||
157044923|NCT02234141|566919165|FG006|Treatment Period (24 Weeks)|Death|0|||
157044924|NCT02234141|566919159|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
157044925|NCT02234141|566919160|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
157044926|NCT02234141|566919161|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
157044927|NCT02234141|566919162|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
157044928|NCT02234141|566919163|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
157044929|NCT02234141|566919164|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
157044930|NCT02234141|566919165|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
157044931|NCT02234141|566919159|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044932|NCT02234141|566919160|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
157044933|NCT02234141|566919161|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044934|NCT02234141|566919162|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044935|NCT02234141|566919163|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044936|NCT02234141|566919164|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044937|NCT02234141|566919165|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
157044938|NCT02234141|566919159|FG000|Long-Term Treatment Period|Death|0|||
157044939|NCT02234141|566919160|FG001|Long-Term Treatment Period|Death|0|||
157044940|NCT02234141|566919161|FG002|Long-Term Treatment Period|Death|0|||
157044941|NCT02234141|566919162|FG003|Long-Term Treatment Period|Death|0|||
157044942|NCT02234141|566919163|FG004|Long-Term Treatment Period|Death|0|||
157044943|NCT02234141|566919164|FG005|Long-Term Treatment Period|Death|1|||
157044944|NCT02234141|566919165|FG006|Long-Term Treatment Period|Death|0|||
157044945|NCT02234141|566919159|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
157044946|NCT02234141|566919160|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
157044947|NCT02234141|566919161|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
157044948|NCT02234141|566919162|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
157044949|NCT02234141|566919163|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
157044950|NCT02234141|566919164|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
157044951|NCT02234141|566919165|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
157044952|NCT02234141|566919159|FG000|Long-Term Treatment Period|Adverse Event|4|||
157044953|NCT02234141|566919160|FG001|Long-Term Treatment Period|Adverse Event|0|||
157044954|NCT02234141|566919161|FG002|Long-Term Treatment Period|Adverse Event|5|||
157044955|NCT02234141|566919162|FG003|Long-Term Treatment Period|Adverse Event|0|||
157044956|NCT02234141|566919163|FG004|Long-Term Treatment Period|Adverse Event|1|||
157044957|NCT02234141|566919164|FG005|Long-Term Treatment Period|Adverse Event|1|||
157044958|NCT02234141|566919165|FG006|Long-Term Treatment Period|Adverse Event|1|||
157044959|NCT02234141|566919159|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
157044960|NCT02234141|566919160|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
157044961|NCT02234141|566919161|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
157044962|NCT02234141|566919162|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
157174448|NCT02708966|567379795|FG000|Overall Study|Lost to Follow-up|2|||
157174449|NCT02708966|567379796|FG001|Overall Study|Lost to Follow-up|2|||
157174450|NCT00389441|567379799|FG000|Overall Study|Adverse Event|7|||
157044963|NCT02234141|566919163|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
157044964|NCT02234141|566919164|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
157044965|NCT02234141|566919165|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
157044966|NCT02234141|566919159|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
157044967|NCT02234141|566919160|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
157044968|NCT02234141|566919161|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
157044969|NCT02234141|566919162|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
157044970|NCT02234141|566919163|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
157044971|NCT02234141|566919164|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
157174451|NCT00389441|567379799|FG000|Overall Study|Death|4|||
157044972|NCT02234141|566919165|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
157044973|NCT00895245|566919166|FG000|Overall Study|Lack of Efficacy|6|||
157044974|NCT02095678|566919167|FG000|Overall Study|Withdrawal by Subject|0|||
157044975|NCT02095678|566919168|FG001|Overall Study|Withdrawal by Subject|1|||
157044976|NCT02095678|566919167|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
157044977|NCT02095678|566919168|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
157044978|NCT02095678|566919167|FG000|Overall Study|lesion impacted by previous treatment|1|||
157044979|NCT02095678|566919168|FG001|Overall Study|lesion impacted by previous treatment|1|||
157044980|NCT02095678|566919167|FG000|Overall Study|No Confirmed Diagnosis|0|||
157044981|NCT02095678|566919168|FG001|Overall Study|No Confirmed Diagnosis|3|||
157044982|NCT02095678|566919167|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
157044983|NCT02095678|566919168|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
157044984|NCT02095678|566919167|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
157044985|NCT02095678|566919168|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
157044986|NCT03418545|566919169|FG000|Overall Study|Withdrawal by Participant|2|||
157044987|NCT03418545|566919170|FG001|Overall Study|Withdrawal by Participant|4|||
157044988|NCT03418545|566919169|FG000|Overall Study|Lost to Follow-up|3|||
157044989|NCT03418545|566919170|FG001|Overall Study|Lost to Follow-up|5|||
157044990|NCT03418545|566919169|FG000|Overall Study|Reason Not Specified|0|||
157044991|NCT03418545|566919170|FG001|Overall Study|Reason Not Specified|1|||
157044992|NCT03418545|566919169|FG000|Overall Study|Missing Completion Status|0|||
157044993|NCT03418545|566919170|FG001|Overall Study|Missing Completion Status|1|||
157044994|NCT01220999|566919173|FG000|Overall Study|Progressive disease|0|||
157044995|NCT01220999|566919174|FG001|Overall Study|Progressive disease|0|||
157044996|NCT01220999|566919175|FG002|Overall Study|Progressive disease|1|||
157044997|NCT01220999|566919176|FG003|Overall Study|Progressive disease|0|||
157044998|NCT01220999|566919177|FG004|Overall Study|Progressive disease|0|||
157044999|NCT01560429|566919178|FG000|Overall Study|Protocol Violation|3|||
157045000|NCT01560429|566919179|FG001|Overall Study|Protocol Violation|6|||
157045001|NCT01365546|566919180|FG000|Overall Study|Withdrawal by Subject|1|||
157045002|NCT01365546|566919180|FG000|Overall Study|Screen failure|9|||
157045003|NCT01365546|566919180|FG000|Overall Study|Study termination|1|||
157045004|NCT03343704|566919185|FG000|Overall Study|Refused to complete follow up|0|||
157045005|NCT03343704|566919186|FG001|Overall Study|Refused to complete follow up|1|||
157045006|NCT03343704|566919185|FG000|Overall Study|Death|0|||
157045007|NCT03343704|566919186|FG001|Overall Study|Death|1|||
157045008|NCT03343704|566919185|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
157045009|NCT03343704|566919186|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
157045010|NCT04224272|566919187|FG000|Part 1 - Dose Finding|Death|4|||
157045011|NCT04224272|566919187|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
157045012|NCT04224272|566919187|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
157045013|NCT04224272|566919187|FG000|Part 2 - Dose Expansion|Death|10|||
157045014|NCT04224272|566919187|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
157045015|NCT02609048|566919188|FG000|Overall Study|Adverse Event|3|||
157045016|NCT02609048|566919189|FG001|Overall Study|Adverse Event|0|||
157045017|NCT02609048|566919190|FG002|Overall Study|Adverse Event|0|||
157045018|NCT02609048|566919188|FG000|Overall Study|Randomized but never treated|1|||
157045019|NCT02609048|566919189|FG001|Overall Study|Randomized but never treated|1|||
157045020|NCT02609048|566919190|FG002|Overall Study|Randomized but never treated|1|||
157045021|NCT02609048|566919188|FG000|Overall Study|Withdrawal of informed consent|1|||
157045022|NCT02609048|566919189|FG001|Overall Study|Withdrawal of informed consent|0|||
157045023|NCT02609048|566919190|FG002|Overall Study|Withdrawal of informed consent|0|||
157045024|NCT02609048|566919188|FG000|Overall Study|Reason not specified|6|||
157045025|NCT02609048|566919189|FG001|Overall Study|Reason not specified|9|||
157045026|NCT02609048|566919190|FG002|Overall Study|Reason not specified|9|||
157045027|NCT05432986|566919196|FG000|Overall Study|Withdrawal by Subject|2|||
157045028|NCT05432986|566919196|FG000|Overall Study|incomplete measurement|7|||
157045029|NCT00670449|566920806|FG000|Overall Study|Adverse Event|6|||
157045030|NCT00670449|566920807|FG001|Overall Study|Adverse Event|2|||
157045031|NCT00670449|566920808|FG002|Overall Study|Adverse Event|8|||
157045032|NCT00670449|566920809|FG003|Overall Study|Adverse Event|5|||
157045033|NCT00670449|566920806|FG000|Overall Study|Protocol Deviation|1|||
157045034|NCT00670449|566920807|FG001|Overall Study|Protocol Deviation|2|||
157045035|NCT00670449|566920808|FG002|Overall Study|Protocol Deviation|0|||
157045036|NCT00670449|566920809|FG003|Overall Study|Protocol Deviation|1|||
157045037|NCT00670449|566920806|FG000|Overall Study|Administrative Problems|0|||
157045038|NCT00670449|566920807|FG001|Overall Study|Administrative Problems|2|||
157174452|NCT00389441|567379799|FG000|Overall Study|Lost to Follow-up|2|||
157045039|NCT00670449|566920808|FG002|Overall Study|Administrative Problems|0|||
157045040|NCT00670449|566920809|FG003|Overall Study|Administrative Problems|1|||
157045041|NCT00670449|566920806|FG000|Overall Study|Subject Withdrew Consent|0|||
157045042|NCT00670449|566920807|FG001|Overall Study|Subject Withdrew Consent|2|||
157045043|NCT00670449|566920808|FG002|Overall Study|Subject Withdrew Consent|0|||
157174453|NCT00389441|567379799|FG000|Overall Study|Withdrawal by Subject|4|||
157045044|NCT00670449|566920809|FG003|Overall Study|Subject Withdrew Consent|1|||
157045045|NCT00670449|566920806|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
157045046|NCT00670449|566920807|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
157045047|NCT00670449|566920808|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
157045048|NCT00670449|566920809|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
157045049|NCT00670449|566920806|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
157045050|NCT00670449|566920807|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
157045051|NCT00670449|566920808|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
157045052|NCT00670449|566920809|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
157045053|NCT00413283|566920810|FG000|Overall Study|Withdrawal by Subject|1|||
157045054|NCT00413283|566920811|FG001|Overall Study|Withdrawal by Subject|0|||
157045055|NCT00413283|566920812|FG002|Overall Study|Withdrawal by Subject|0|||
157045056|NCT00413283|566920813|FG003|Overall Study|Withdrawal by Subject|1|||
157045057|NCT00413283|566920810|FG000|Overall Study|Death|0|||
157045058|NCT00413283|566920811|FG001|Overall Study|Death|0|||
157045059|NCT00413283|566920812|FG002|Overall Study|Death|1|||
157045060|NCT00413283|566920813|FG003|Overall Study|Death|1|||
157045061|NCT00413283|566920810|FG000|Overall Study|Adverse Event|0|||
157045062|NCT00413283|566920811|FG001|Overall Study|Adverse Event|0|||
157045063|NCT00413283|566920812|FG002|Overall Study|Adverse Event|0|||
157045064|NCT00413283|566920813|FG003|Overall Study|Adverse Event|1|||
157045065|NCT00413283|566920810|FG000|Overall Study|Ineligibility determined|0|||
157045066|NCT00413283|566920811|FG001|Overall Study|Ineligibility determined|0|||
157045067|NCT00413283|566920812|FG002|Overall Study|Ineligibility determined|0|||
157045068|NCT00413283|566920813|FG003|Overall Study|Ineligibility determined|1|||
157045069|NCT00413283|566920810|FG000|Overall Study|Protocol deviation|0|||
157045070|NCT00413283|566920811|FG001|Overall Study|Protocol deviation|1|||
157045071|NCT00413283|566920812|FG002|Overall Study|Protocol deviation|0|||
157045072|NCT00413283|566920813|FG003|Overall Study|Protocol deviation|0|||
157045073|NCT00413283|566920810|FG000|Overall Study|Requirement for alternative therapy|0|||
157045074|NCT00413283|566920811|FG001|Overall Study|Requirement for alternative therapy|2|||
157045075|NCT00413283|566920812|FG002|Overall Study|Requirement for alternative therapy|0|||
157045076|NCT00413283|566920813|FG003|Overall Study|Requirement for alternative therapy|0|||
157045077|NCT00413283|566920810|FG000|Overall Study|Other|0|||
157045078|NCT00413283|566920811|FG001|Overall Study|Other|0|||
157045079|NCT00413283|566920812|FG002|Overall Study|Other|1|||
157045080|NCT00413283|566920813|FG003|Overall Study|Other|0|||
157045081|NCT02771366|566920814|FG000|Period 1|Withdrawal by Subject|0|||
157045082|NCT02771366|566920815|FG001|Period 1|Withdrawal by Subject|2|||
157045083|NCT02771366|566920814|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
157045084|NCT02771366|566920815|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
157045085|NCT01823224|566920816|FG000|Overall Study|Lost to Follow-up|5|||
157045086|NCT01823224|566920817|FG001|Overall Study|Lost to Follow-up|6|||
157045087|NCT01823224|566920816|FG000|Overall Study|didn't qualify|1|||
157045088|NCT01823224|566920817|FG001|Overall Study|didn't qualify|2|||
157045089|NCT01823224|566920816|FG000|Overall Study|pharmacy error|0|||
157045090|NCT01823224|566920817|FG001|Overall Study|pharmacy error|1|||
157045091|NCT01823224|566920816|FG000|Overall Study|missed med dose|0|||
157045092|NCT01823224|566920817|FG001|Overall Study|missed med dose|1|||
157045093|NCT01823224|566920816|FG000|Overall Study|Withdrawal by Subject|0|||
157045094|NCT01823224|566920817|FG001|Overall Study|Withdrawal by Subject|1|||
157045095|NCT01779050|566920818|FG000|Overall Study|Withdrawal by Subject|1|||
157045096|NCT01779050|566920819|FG001|Overall Study|Withdrawal by Subject|0|||
157045097|NCT01409837|566920820|FG000|Overall Study|Withdrawal by Subject|2|||
157045098|NCT01409837|566920821|FG001|Overall Study|Withdrawal by Subject|1|||
157045099|NCT01409837|566920820|FG000|Overall Study|Lost to Follow-up|1|||
157045100|NCT01409837|566920821|FG001|Overall Study|Lost to Follow-up|0|||
157045101|NCT01409837|566920820|FG000|Overall Study|Physician Decision|0|||
157045102|NCT01409837|566920821|FG001|Overall Study|Physician Decision|1|||
157045103|NCT00022672|566920825|FG000|Main Phase: 24 Months|Adverse Event|6|||
157045104|NCT00022672|566920826|FG001|Main Phase: 24 Months|Adverse Event|0|||
157045105|NCT00022672|566920825|FG000|Main Phase: 24 Months|Death|0|||
157045106|NCT00022672|566920826|FG001|Main Phase: 24 Months|Death|3|||
157045107|NCT00022672|566920825|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
157045108|NCT00022672|566920826|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
157045109|NCT00022672|566920825|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
157045110|NCT00022672|566920826|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
157045111|NCT00022672|566920825|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
157045112|NCT00022672|566920826|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
157045113|NCT00022672|566920825|FG000|Main Phase: 24 Months|Refused Treatment|3|||
157045114|NCT00022672|566920826|FG001|Main Phase: 24 Months|Refused Treatment|4|||
157045115|NCT00022672|566920825|FG000|Main Phase: 24 Months|Failure to Return|1|||
157045116|NCT00022672|566920826|FG001|Main Phase: 24 Months|Failure to Return|1|||
157045117|NCT00022672|566920825|FG000|Main Phase: 24 Months|Other|1|||
157045118|NCT00022672|566920826|FG001|Main Phase: 24 Months|Other|0|||
157045119|NCT00022672|566920825|FG000|Extension Phase|Adverse Event|1|||
157045120|NCT00022672|566920826|FG001|Extension Phase|Adverse Event|3|||
157045121|NCT00022672|566920825|FG000|Extension Phase|Death|0|||
157045122|NCT00022672|566920826|FG001|Extension Phase|Death|1|||
157045123|NCT00022672|566920825|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
157045124|NCT00022672|566920826|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
157045125|NCT00022672|566920825|FG000|Extension Phase|Refused Treatment|0|||
157045126|NCT00022672|566920826|FG001|Extension Phase|Refused Treatment|2|||
157045127|NCT00022672|566920825|FG000|Extension Phase|Other|1|||
157045128|NCT00022672|566920826|FG001|Extension Phase|Other|1|||
157045129|NCT00403494|566920827|FG000|Overall Study|Adverse Event|10|||
157045130|NCT00403494|566920828|FG001|Overall Study|Adverse Event|8|||
157045131|NCT00403494|566920827|FG000|Overall Study|Withdrew Consent|3|||
157045132|NCT00403494|566920828|FG001|Overall Study|Withdrew Consent|2|||
157045133|NCT00403494|566920827|FG000|Overall Study|Inappropriately enrolled|0|||
157045134|NCT00403494|566920828|FG001|Overall Study|Inappropriately enrolled|1|||
157045135|NCT00403494|566920827|FG000|Overall Study|Lost to Follow-up|0|||
157045136|NCT00403494|566920828|FG001|Overall Study|Lost to Follow-up|2|||
157045137|NCT00403494|566920827|FG000|Overall Study|Protocol noncompliance|0|||
157045138|NCT00403494|566920828|FG001|Overall Study|Protocol noncompliance|1|||
157045139|NCT00403494|566920827|FG000|Overall Study|Death|1|||
157045140|NCT00403494|566920828|FG001|Overall Study|Death|0|||
157045141|NCT00403494|566920827|FG000|Overall Study|Sponsor Request|1|||
157045142|NCT00403494|566920828|FG001|Overall Study|Sponsor Request|0|||
157045143|NCT03648541|566920830|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
157045144|NCT03648541|566920831|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
157045145|NCT03648541|566920830|FG000|Re-induction Period Only|Lack of Efficacy|7|||
157045146|NCT03648541|566920831|FG001|Re-induction Period Only|Lack of Efficacy|0|||
157045147|NCT03648541|566920830|FG000|Maintenance Period Only|Missing|0|||
157045148|NCT03648541|566920831|FG001|Maintenance Period Only|Missing|1|||
157045149|NCT03648541|566920830|FG000|Maintenance Period Only|Other not listed below|0|||
157045150|NCT03648541|566920831|FG001|Maintenance Period Only|Other not listed below|4|||
157045151|NCT03648541|566920830|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
157045152|NCT03648541|566920831|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
157045153|NCT03648541|566920830|FG000|Maintenance Period Only|Protocol Violation|0|||
157045154|NCT03648541|566920831|FG001|Maintenance Period Only|Protocol Violation|1|||
157045155|NCT03648541|566920830|FG000|Maintenance Period Only|Lack of Efficacy|0|||
157045156|NCT03648541|566920831|FG001|Maintenance Period Only|Lack of Efficacy|18|||
157045157|NCT03648541|566920830|FG000|Maintenance Period Only|Adverse Event|0|||
157045158|NCT03648541|566920831|FG001|Maintenance Period Only|Adverse Event|4|||
157045159|NCT03648541|566920830|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
157045160|NCT03648541|566920831|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
157045161|NCT03490032|566920832|FG000|Overall Study|family issue (child custody)|1|||
157045162|NCT03490032|566920833|FG001|Overall Study|family issue (child custody)|0|||
157045163|NCT03490032|566920834|FG002|Overall Study|family issue (child custody)|0|||
157045164|NCT00308308|566920835|FG000|Overall Study|Adverse Event|17|||
157045165|NCT00308308|566920836|FG001|Overall Study|Adverse Event|2|||
157045166|NCT00308308|566920835|FG000|Overall Study|Lost to Follow-up|5|||
157045167|NCT00308308|566920836|FG001|Overall Study|Lost to Follow-up|5|||
157045168|NCT00308308|566920835|FG000|Overall Study|Physician Decision|15|||
157045169|NCT00308308|566920836|FG001|Overall Study|Physician Decision|7|||
157045170|NCT00308308|566920835|FG000|Overall Study|Protocol Violation|3|||
157045171|NCT00308308|566920836|FG001|Overall Study|Protocol Violation|14|||
157045172|NCT00308308|566920835|FG000|Overall Study|Withdrawal by Subject|47|||
157045173|NCT00308308|566920836|FG001|Overall Study|Withdrawal by Subject|19|||
157045174|NCT00308308|566920835|FG000|Overall Study|Various|7|||
157045175|NCT00308308|566920836|FG001|Overall Study|Various|5|||
157045176|NCT00308308|566920835|FG000|Overall Study|Randomized but not dosed|8|||
157174454|NCT00389441|567379799|FG000|Overall Study|Physician Decision|1|||
157174455|NCT00389441|567379799|FG000|Overall Study|Protocol Violation|1|||
157174456|NCT00389441|567379799|FG000|Overall Study|Global deterioration of health status|4|||
157174457|NCT00389441|567379799|FG000|Overall Study|Objective progression or relapse|26|||
157045177|NCT00308308|566920836|FG001|Overall Study|Randomized but not dosed|16|||
157174458|NCT00389441|567379799|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
157174459|NCT00389441|567379799|FG000|Overall Study|Clinical progression|1|||
157174460|NCT02260388|567379800|FG000|Overall Study|Lost to Follow-up|2|||
157174461|NCT02260388|567379801|FG001|Overall Study|Lost to Follow-up|8|||
157045178|NCT00308308|566920835|FG000|Overall Study|Other|1|||
157045179|NCT00308308|566920836|FG001|Overall Study|Other|0|||
157174462|NCT02260388|567379802|FG002|Overall Study|Lost to Follow-up|3|||
157045180|NCT00273052|566920839|FG000|Overall Study|Withdrawal by Subject|16|||
157045181|NCT00273052|566920840|FG001|Overall Study|Withdrawal by Subject|19|||
157045182|NCT00273052|566920839|FG000|Overall Study|Adverse Event|21|||
157045183|NCT00273052|566920840|FG001|Overall Study|Adverse Event|19|||
157045184|NCT00273052|566920839|FG000|Overall Study|Protocol Violation|14|||
157045185|NCT00273052|566920840|FG001|Overall Study|Protocol Violation|18|||
157045186|NCT00273052|566920839|FG000|Overall Study|Lost to Follow-up|7|||
157045187|NCT00273052|566920840|FG001|Overall Study|Lost to Follow-up|25|||
157045188|NCT00273052|566920839|FG000|Overall Study|Lack of Efficacy|6|||
157045189|NCT00273052|566920840|FG001|Overall Study|Lack of Efficacy|4|||
157045190|NCT00273052|566920839|FG000|Overall Study|Non-Compliance|3|||
157045191|NCT00273052|566920840|FG001|Overall Study|Non-Compliance|1|||
157045192|NCT00273052|566920839|FG000|Overall Study|Other|2|||
157045193|NCT00273052|566920840|FG001|Overall Study|Other|0|||
157045194|NCT00273052|566920839|FG000|Overall Study|Worsening serum lipid levels|0|||
157045195|NCT00273052|566920840|FG001|Overall Study|Worsening serum lipid levels|2|||
157045196|NCT01852045|566920841|FG000|Overall Study|Adverse Event|1|||
157045197|NCT01852045|566920842|FG001|Overall Study|Adverse Event|0|||
157045198|NCT01852045|566920843|FG002|Overall Study|Adverse Event|0|||
157045199|NCT01852045|566920841|FG000|Overall Study|Lack of Efficacy|3|||
157045200|NCT01852045|566920842|FG001|Overall Study|Lack of Efficacy|0|||
157045201|NCT01852045|566920843|FG002|Overall Study|Lack of Efficacy|0|||
157045202|NCT01852045|566920841|FG000|Overall Study|Lost to Follow-up|0|||
157045203|NCT01852045|566920842|FG001|Overall Study|Lost to Follow-up|1|||
157045204|NCT01852045|566920843|FG002|Overall Study|Lost to Follow-up|1|||
157045205|NCT01852045|566920841|FG000|Overall Study|Withdrawal by Subject|1|||
157045206|NCT01852045|566920842|FG001|Overall Study|Withdrawal by Subject|0|||
157045207|NCT01852045|566920843|FG002|Overall Study|Withdrawal by Subject|1|||
157045208|NCT01852045|566920841|FG000|Overall Study|Other Miscellaneous Reasons|1|||
157045209|NCT01852045|566920842|FG001|Overall Study|Other Miscellaneous Reasons|3|||
157045210|NCT01852045|566920843|FG002|Overall Study|Other Miscellaneous Reasons|2|||
157045211|NCT00240994|566920844|FG000|Overall Study|Lost to Follow-up|1|||
157045212|NCT00240994|566920844|FG000|Overall Study|Protocol Violation|1|||
157045213|NCT00240994|566920844|FG000|Overall Study|Graft failure|1|||
157045214|NCT03142932|566920846|FG000|Overall Study|Lost to Follow-up|2|||
157045215|NCT03142932|566920847|FG001|Overall Study|Lost to Follow-up|11|||
157045216|NCT00703092|566920848|FG000|Overall Study|Withdrawal by Subject|2|||
157045217|NCT00681109|566920849|FG000|Overall Study|Lost to Follow-up|2|||
157045218|NCT00681109|566920850|FG001|Overall Study|Lost to Follow-up|6|||
157045219|NCT00681109|566920851|FG002|Overall Study|Lost to Follow-up|0|||
157045220|NCT02706483|566920852|FG000|Overall Study|Adverse Event|97|||
157045221|NCT02706483|566920852|FG000|Overall Study|Death|1|||
157045222|NCT02706483|566920852|FG000|Overall Study|Lack of Efficacy|39|||
157045223|NCT02706483|566920852|FG000|Overall Study|Lost to Follow-up|101|||
157045224|NCT02706483|566920852|FG000|Overall Study|Non-compliance with study drug|15|||
157045225|NCT02706483|566920852|FG000|Overall Study|Physician Decision|6|||
157045226|NCT02706483|566920852|FG000|Overall Study|Pregnancy|6|||
157045227|NCT02706483|566920852|FG000|Overall Study|Protocol Violation|18|||
157045228|NCT02706483|566920852|FG000|Overall Study|Withdrawal by Subject|136|||
157045229|NCT02706483|566920852|FG000|Overall Study|Non-compliance with visits|6|||
157045230|NCT02706483|566920852|FG000|Overall Study|Site closure|4|||
157045231|NCT02706483|566920852|FG000|Overall Study|Subject moved|1|||
157045232|NCT04248868|566920853|FG000|Overall Study|Death|1|||
157045233|NCT04248868|566920853|FG000|Overall Study|Lost to Follow-up|3|||
157045234|NCT04248868|566920853|FG000|Overall Study|Protocol Violation|2|||
157045235|NCT04660799|566920854|FG000|Overall Study|Progressive Disease|1|||
157045236|NCT04660799|566920855|FG001|Overall Study|Progressive Disease|1|||
157045237|NCT04660799|566920854|FG000|Overall Study|Death|2|||
157045238|NCT04660799|566920855|FG001|Overall Study|Death|1|||
157045239|NCT04660799|566920854|FG000|Overall Study|Adverse Event|2|||
157045240|NCT04660799|566920855|FG001|Overall Study|Adverse Event|1|||
157045241|NCT04660799|566920854|FG000|Overall Study|Withdrawal by Subject|2|||
157045242|NCT04660799|566920855|FG001|Overall Study|Withdrawal by Subject|5|||
157045243|NCT03131713|566920858|FG000|Overall Study|Lost to Follow-up|5|||
157045244|NCT03131713|566920859|FG001|Overall Study|Lost to Follow-up|0|||
157045245|NCT01972776|566920860|FG000|Part 1|Withdrawal by Subject|0|||
157045246|NCT01972776|566920861|FG001|Part 1|Withdrawal by Subject|0|||
157045247|NCT01972776|566920862|FG002|Part 1|Withdrawal by Subject|1|||
157045248|NCT01972776|566920863|FG003|Part 1|Withdrawal by Subject|0|||
157045249|NCT01972776|566920864|FG004|Part 1|Withdrawal by Subject|0|||
157045250|NCT01972776|566920865|FG005|Part 1|Withdrawal by Subject|0|||
157045251|NCT01972776|566920860|FG000|Part 1|Adverse Event|0|||
157174463|NCT02260388|567379803|FG003|Overall Study|Lost to Follow-up|4|||
157174464|NCT01981109|567379804|FG000|Overall Study|Death|36|||
157174465|NCT01981109|567379804|FG000|Overall Study|Withdrawal by Subject|40|||
157045252|NCT01972776|566920861|FG001|Part 1|Adverse Event|0|||
157174466|NCT01981109|567379804|FG000|Overall Study|Lost to Follow-up|9|||
157174467|NCT01981109|567379804|FG000|Overall Study|No Discontinuation Documentation|37|||
157045253|NCT01972776|566920862|FG002|Part 1|Adverse Event|1|||
157045254|NCT01972776|566920863|FG003|Part 1|Adverse Event|1|||
157045255|NCT01972776|566920864|FG004|Part 1|Adverse Event|0|||
157045256|NCT01972776|566920865|FG005|Part 1|Adverse Event|0|||
157045257|NCT01972776|566920860|FG000|Part 2|Adverse Event|0|||
157045258|NCT01972776|566920861|FG001|Part 2|Adverse Event|0|||
157174468|NCT01981109|567379804|FG000|Overall Study|Study Termination|100|||
157045259|NCT01972776|566920862|FG002|Part 2|Adverse Event|0|||
157045260|NCT01972776|566920863|FG003|Part 2|Adverse Event|0|||
157045261|NCT01972776|566920864|FG004|Part 2|Adverse Event|3|||
157045262|NCT01972776|566920865|FG005|Part 2|Adverse Event|0|||
157045263|NCT01972776|566920860|FG000|Part 2|Administrative problems|0|||
157045264|NCT01972776|566920861|FG001|Part 2|Administrative problems|0|||
157045265|NCT01972776|566920862|FG002|Part 2|Administrative problems|0|||
157045266|NCT01972776|566920863|FG003|Part 2|Administrative problems|0|||
157045267|NCT01972776|566920864|FG004|Part 2|Administrative problems|10|||
157045268|NCT01972776|566920865|FG005|Part 2|Administrative problems|7|||
157045269|NCT01228734|566920869|FG000|Overall Study|Randomized, but not treated|0|||
157045270|NCT01228734|566920870|FG001|Overall Study|Randomized, but not treated|4|||
157045271|NCT02382640|566920874|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
157045272|NCT02382640|566920875|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
157045273|NCT02382640|566920876|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
157045274|NCT02382640|566920877|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
157045275|NCT01543204|566920878|FG000|Overall Study|Non-compliance|1|||
157045276|NCT01543204|566920878|FG000|Overall Study|Adverse Event|1|||
157045277|NCT01543204|566920878|FG000|Overall Study|Withdrawal by Subject|4|||
157045278|NCT01543204|566920878|FG000|Overall Study|Requirement for Alternative Therapy|1|||
157045279|NCT01543204|566920878|FG000|Overall Study|Lost to Follow-up|1|||
157045280|NCT02449902|566920882|FG000|Overall Study|Adverse Event|0|||
157045281|NCT02449902|566920883|FG001|Overall Study|Adverse Event|1|||
157045282|NCT02449902|566920882|FG000|Overall Study|Withdrawal by Subject|0|||
157045283|NCT02449902|566920883|FG001|Overall Study|Withdrawal by Subject|1|||
157045284|NCT03326856|566920884|FG000|Overall Study|Lost to Follow-up|1|||
157045285|NCT03326856|566920885|FG001|Overall Study|Lost to Follow-up|1|||
157045286|NCT03326856|566920886|FG002|Overall Study|Lost to Follow-up|0|||
157045287|NCT03326856|566920887|FG003|Overall Study|Lost to Follow-up|0|||
157045288|NCT03326856|566920888|FG004|Overall Study|Lost to Follow-up|0|||
157045289|NCT02037568|566920889|FG000|Overall Study|Withdrawal by Subject|17|||
157045290|NCT02037568|566920890|FG001|Overall Study|Withdrawal by Subject|24|||
157045291|NCT02037568|566920889|FG000|Overall Study|Lost to Follow-up|16|||
157045292|NCT02037568|566920890|FG001|Overall Study|Lost to Follow-up|13|||
157045293|NCT02037568|566920889|FG000|Overall Study|Screen Failure|3|||
157045294|NCT02037568|566920890|FG001|Overall Study|Screen Failure|1|||
157045295|NCT02037568|566920889|FG000|Overall Study|Patient did not receive transplant|0|||
157045296|NCT02037568|566920890|FG001|Overall Study|Patient did not receive transplant|1|||
157045297|NCT00721734|566920891|FG000|Overall Study|Progressive Disease|3|||
157045298|NCT00721734|566920892|FG001|Overall Study|Progressive Disease|10|||
157045299|NCT00721734|566920893|FG002|Overall Study|Progressive Disease|4|||
157045300|NCT00721734|566920894|FG003|Overall Study|Progressive Disease|5|||
157045301|NCT00721734|566920895|FG004|Overall Study|Progressive Disease|2|||
157045302|NCT00721734|566920891|FG000|Overall Study|Adverse Event|3|||
157045303|NCT00721734|566920892|FG001|Overall Study|Adverse Event|1|||
157045304|NCT00721734|566920893|FG002|Overall Study|Adverse Event|4|||
157174469|NCT01981109|567379804|FG000|Overall Study|No data available|2|||
157174470|NCT03407170|567379805|FG000|Overall Study|Adverse Event|1|||
157174471|NCT00305604|567379808|FG000|Overall Study|Adverse Event|6|||
157174472|NCT00305604|567379809|FG001|Overall Study|Adverse Event|3|||
157174473|NCT00305604|567379808|FG000|Overall Study|Lack of Efficacy|11|||
157174474|NCT00305604|567379809|FG001|Overall Study|Lack of Efficacy|18|||
157174475|NCT00305604|567379808|FG000|Overall Study|Lost to Follow-up|0|||
157174476|NCT00305604|567379809|FG001|Overall Study|Lost to Follow-up|4|||
157174477|NCT00305604|567379808|FG000|Overall Study|Protocol Violation|2|||
157174478|NCT00305604|567379809|FG001|Overall Study|Protocol Violation|1|||
157174479|NCT00305604|567379808|FG000|Overall Study|Withdrawal by Subject|12|||
157174480|NCT00305604|567379809|FG001|Overall Study|Withdrawal by Subject|21|||
157045305|NCT00721734|566920894|FG003|Overall Study|Adverse Event|0|||
157045306|NCT00721734|566920895|FG004|Overall Study|Adverse Event|3|||
157045307|NCT00721734|566920891|FG000|Overall Study|Withdrawal by Subject|2|||
157174481|NCT00305604|567379808|FG000|Overall Study|Patient moved|1|||
157174482|NCT00305604|567379809|FG001|Overall Study|Patient moved|0|||
157174483|NCT00636441|567379810|FG000|Overall Study|Adverse Event|0|||
157174484|NCT00636441|567379811|FG001|Overall Study|Adverse Event|1|||
157174485|NCT00636441|567379812|FG002|Overall Study|Adverse Event|1|||
157045308|NCT00721734|566920892|FG001|Overall Study|Withdrawal by Subject|1|||
157045309|NCT00721734|566920893|FG002|Overall Study|Withdrawal by Subject|0|||
157045310|NCT00721734|566920894|FG003|Overall Study|Withdrawal by Subject|0|||
157045311|NCT00721734|566920895|FG004|Overall Study|Withdrawal by Subject|1|||
157045312|NCT00721734|566920891|FG000|Overall Study|Other|0|||
157045313|NCT00721734|566920892|FG001|Overall Study|Other|0|||
157045314|NCT00721734|566920893|FG002|Overall Study|Other|0|||
157045315|NCT00721734|566920894|FG003|Overall Study|Other|1|||
157045316|NCT00721734|566920895|FG004|Overall Study|Other|0|||
157045317|NCT03162614|566920896|FG000|Overall Study|Lost to Follow-up|2|||
157045318|NCT03162614|566920897|FG001|Overall Study|Lost to Follow-up|1|||
157045319|NCT03162614|566920898|FG002|Overall Study|Lost to Follow-up|1|||
157045320|NCT03162614|566920899|FG003|Overall Study|Lost to Follow-up|1|||
157174486|NCT00636441|567379813|FG003|Overall Study|Adverse Event|0|||
157174487|NCT00636441|567379814|FG004|Overall Study|Adverse Event|0|||
157174488|NCT00636441|567379815|FG005|Overall Study|Adverse Event|1|||
157174489|NCT00636441|567379816|FG006|Overall Study|Adverse Event|0|||
157045321|NCT03162614|566920900|FG004|Overall Study|Lost to Follow-up|2|||
157045322|NCT03162614|566920901|FG005|Overall Study|Lost to Follow-up|0|||
157045323|NCT03162614|566920896|FG000|Overall Study|Protocol Violation|0|||
157045324|NCT03162614|566920897|FG001|Overall Study|Protocol Violation|1|||
157045325|NCT03162614|566920898|FG002|Overall Study|Protocol Violation|0|||
157045326|NCT03162614|566920899|FG003|Overall Study|Protocol Violation|1|||
157045327|NCT03162614|566920900|FG004|Overall Study|Protocol Violation|0|||
157045328|NCT03162614|566920901|FG005|Overall Study|Protocol Violation|0|||
157045329|NCT03162614|566920896|FG000|Overall Study|Withdrawal by Subject|2|||
157045330|NCT03162614|566920897|FG001|Overall Study|Withdrawal by Subject|1|||
157045331|NCT03162614|566920898|FG002|Overall Study|Withdrawal by Subject|1|||
157045332|NCT03162614|566920899|FG003|Overall Study|Withdrawal by Subject|1|||
157045333|NCT03162614|566920900|FG004|Overall Study|Withdrawal by Subject|0|||
157045334|NCT03162614|566920901|FG005|Overall Study|Withdrawal by Subject|0|||
157045335|NCT03162614|566920896|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
157045336|NCT03162614|566920897|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
157045337|NCT03162614|566920898|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
157045338|NCT03162614|566920899|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
157045339|NCT03162614|566920900|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
157045340|NCT03162614|566920901|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
157045341|NCT03861234|566920902|FG000|Overall Study|Not treated|0|||
157045342|NCT03861234|566920903|FG001|Overall Study|Not treated|0|||
157045343|NCT03861234|566920904|FG002|Overall Study|Not treated|0|||
157045344|NCT03861234|566920905|FG003|Overall Study|Not treated|0|||
157045345|NCT03861234|566920906|FG004|Overall Study|Not treated|0|||
157045346|NCT03861234|566920907|FG005|Overall Study|Not treated|1|||
157045347|NCT03861234|566920908|FG006|Overall Study|Not treated|0|||
157045348|NCT03861234|566920909|FG007|Overall Study|Not treated|0|||
157045349|NCT03861234|566920902|FG000|Overall Study|Adverse Event|0|||
157045350|NCT03861234|566920903|FG001|Overall Study|Adverse Event|0|||
157045351|NCT03861234|566920904|FG002|Overall Study|Adverse Event|0|||
157045352|NCT03861234|566920905|FG003|Overall Study|Adverse Event|0|||
157045353|NCT03861234|566920906|FG004|Overall Study|Adverse Event|0|||
157045354|NCT03861234|566920907|FG005|Overall Study|Adverse Event|1|||
157045355|NCT03861234|566920908|FG006|Overall Study|Adverse Event|0|||
157045356|NCT03861234|566920909|FG007|Overall Study|Adverse Event|0|||
157045357|NCT03861234|566920902|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
157045358|NCT03861234|566920903|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
157045359|NCT03861234|566920904|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
157045360|NCT03861234|566920905|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
157045361|NCT03861234|566920906|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
157045362|NCT03861234|566920907|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
157045363|NCT03861234|566920908|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
157045364|NCT03861234|566920909|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
157045365|NCT03861234|566920902|FG000|Overall Study|As per sponsor decision|0|||
157045366|NCT03861234|566920903|FG001|Overall Study|As per sponsor decision|0|||
157045367|NCT03861234|566920904|FG002|Overall Study|As per sponsor decision|0|||
157045368|NCT03861234|566920905|FG003|Overall Study|As per sponsor decision|0|||
157045369|NCT03861234|566920906|FG004|Overall Study|As per sponsor decision|0|||
157045370|NCT03861234|566920907|FG005|Overall Study|As per sponsor decision|0|||
157045371|NCT03861234|566920908|FG006|Overall Study|As per sponsor decision|1|||
157045372|NCT03861234|566920909|FG007|Overall Study|As per sponsor decision|0|||
157045373|NCT03861234|566920902|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
157045374|NCT03861234|566920903|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
157045375|NCT03861234|566920904|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
157045376|NCT03861234|566920905|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
157045377|NCT03861234|566920906|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
157045378|NCT03861234|566920907|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
157045379|NCT03861234|566920908|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
157045380|NCT03861234|566920909|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
157045381|NCT00621842|566920910|FG000|Overall Study|Adverse Event|6|||
157045382|NCT00621842|566920910|FG000|Overall Study|Withdrawal by Subject|7|||
157045383|NCT00621842|566920910|FG000|Overall Study|Protocol Violation|4|||
157045384|NCT00621842|566920910|FG000|Overall Study|Lack of Efficacy|2|||
157045385|NCT01074242|566920913|FG000|Overall Study|Case report before date of contract|40|||
157045386|NCT01074242|566920913|FG000|Overall Study|Lost to Follow-up|1|||
157045387|NCT01074242|566920913|FG000|Overall Study|Case report unclear|6|||
157045388|NCT01074242|566920913|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
157045389|NCT01074242|566920913|FG000|Overall Study|Duplicate Case Report Form|5|||
157045390|NCT01957163|566920914|FG000|Overall Study|Adverse Event|5|||
157045391|NCT01957163|566920915|FG001|Overall Study|Adverse Event|2|||
157045392|NCT01957163|566920916|FG002|Overall Study|Adverse Event|4|||
157045393|NCT01957163|566920914|FG000|Overall Study|Lack of Efficacy|5|||
157045394|NCT01957163|566920915|FG001|Overall Study|Lack of Efficacy|4|||
157045395|NCT01957163|566920916|FG002|Overall Study|Lack of Efficacy|9|||
157045396|NCT01957163|566920914|FG000|Overall Study|Protocol Violation|1|||
157045397|NCT01957163|566920915|FG001|Overall Study|Protocol Violation|2|||
157045398|NCT01957163|566920916|FG002|Overall Study|Protocol Violation|0|||
157045399|NCT01957163|566920914|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
157045400|NCT01957163|566920915|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
157045401|NCT01957163|566920916|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
157045402|NCT01957163|566920914|FG000|Overall Study|Lost to Follow-up|0|||
157045403|NCT01957163|566920915|FG001|Overall Study|Lost to Follow-up|1|||
157045404|NCT01957163|566920916|FG002|Overall Study|Lost to Follow-up|0|||
157045405|NCT01957163|566920914|FG000|Overall Study|Withdrawal by Subject|4|||
157045406|NCT01957163|566920915|FG001|Overall Study|Withdrawal by Subject|2|||
157045407|NCT01957163|566920916|FG002|Overall Study|Withdrawal by Subject|4|||
157045408|NCT01668719|566920917|FG000|Phase I|On treatment|1|||
157045409|NCT01668719|566920918|FG001|Phase I|On treatment|0|||
157045410|NCT01668719|566920919|FG002|Phase I|On treatment|0|||
157045411|NCT01668719|566920917|FG000|Phase I|Adverse Event|2|||
157045412|NCT01668719|566920918|FG001|Phase I|Adverse Event|0|||
157045413|NCT01668719|566920919|FG002|Phase I|Adverse Event|0|||
157045414|NCT01668719|566920917|FG000|Phase I|Progression/relapse|1|||
157045415|NCT01668719|566920918|FG001|Phase I|Progression/relapse|0|||
157045416|NCT01668719|566920919|FG002|Phase I|Progression/relapse|0|||
157045417|NCT01668719|566920917|FG000|Phase I|not protocol specified|2|||
157045418|NCT01668719|566920918|FG001|Phase I|not protocol specified|0|||
157045419|NCT01668719|566920919|FG002|Phase I|not protocol specified|0|||
157045420|NCT01668719|566920917|FG000|Phase II|On treatment|0|||
157045421|NCT01668719|566920918|FG001|Phase II|On treatment|4|||
157045422|NCT01668719|566920919|FG002|Phase II|On treatment|3|||
157045423|NCT01668719|566920917|FG000|Phase II|Adverse Event|0|||
157045424|NCT01668719|566920918|FG001|Phase II|Adverse Event|18|||
157045425|NCT01668719|566920919|FG002|Phase II|Adverse Event|18|||
157045426|NCT01668719|566920917|FG000|Phase II|Refusal unrelated to adverse event|0|||
157045427|NCT01668719|566920918|FG001|Phase II|Refusal unrelated to adverse event|4|||
157045428|NCT01668719|566920919|FG002|Phase II|Refusal unrelated to adverse event|1|||
157045429|NCT01668719|566920917|FG000|Phase II|Progression/relapse|0|||
157045430|NCT01668719|566920918|FG001|Phase II|Progression/relapse|13|||
157045431|NCT01668719|566920919|FG002|Phase II|Progression/relapse|17|||
157045432|NCT01668719|566920917|FG000|Phase II|Death|0|||
157045433|NCT01668719|566920918|FG001|Phase II|Death|0|||
157045434|NCT01668719|566920919|FG002|Phase II|Death|2|||
157045435|NCT01668719|566920917|FG000|Phase II|not protocol specified|0|||
157045436|NCT01668719|566920918|FG001|Phase II|not protocol specified|13|||
157045437|NCT01668719|566920919|FG002|Phase II|not protocol specified|7|||
157045438|NCT01321073|566920920|FG000|Overall Study|Did not attempt implant|4|||
157045439|NCT01321073|566920920|FG000|Overall Study|Death|3|||
157045440|NCT01638000|566920921|FG000|Overall Study|Randomized but Never Received Drug|7|||
157045441|NCT01638000|566920922|FG001|Overall Study|Randomized but Never Received Drug|10|||
157045442|NCT01638000|566920921|FG000|Overall Study|Adverse Event|14|||
157045443|NCT01638000|566920922|FG001|Overall Study|Adverse Event|16|||
157045444|NCT01638000|566920921|FG000|Overall Study|Lack of Efficacy|5|||
157045445|NCT01638000|566920922|FG001|Overall Study|Lack of Efficacy|6|||
157045446|NCT01638000|566920921|FG000|Overall Study|Protocol Violation|11|||
157045447|NCT01638000|566920922|FG001|Overall Study|Protocol Violation|13|||
157045448|NCT01638000|566920921|FG000|Overall Study|Withdrawal by Subject|21|||
157045449|NCT01638000|566920922|FG001|Overall Study|Withdrawal by Subject|24|||
157045450|NCT01638000|566920921|FG000|Overall Study|Miscellaneous|2|||
157045451|NCT01638000|566920922|FG001|Overall Study|Miscellaneous|2|||
157045452|NCT00875706|566920923|FG000|Overall Study|Withdrawal by Subject|1|||
157045453|NCT00875706|566920924|FG001|Overall Study|Withdrawal by Subject|0|||
157045454|NCT00875706|566920925|FG002|Overall Study|Withdrawal by Subject|0|||
157045455|NCT03652610|566920926|FG000|Overall Study|Lost to Follow-up|1|||
157045456|NCT03652610|566920927|FG001|Overall Study|Lost to Follow-up|0|||
157045457|NCT03652610|566920926|FG000|Overall Study|Withdrawal by Subject|3|||
157045458|NCT03652610|566920927|FG001|Overall Study|Withdrawal by Subject|5|||
157045459|NCT00786188|566920928|FG000|Overall Study|Adverse Event|3|||
157045460|NCT00786188|566920929|FG001|Overall Study|Adverse Event|1|||
157045461|NCT00786188|566920928|FG000|Overall Study|Withdrawal by Subject|2|||
157045462|NCT00786188|566920929|FG001|Overall Study|Withdrawal by Subject|0|||
157045463|NCT00326183|566920930|FG000|Overall Study|Lost to Follow-up|104|||
157045464|NCT00326183|566920931|FG001|Overall Study|Lost to Follow-up|56|||
157045465|NCT00326183|566920930|FG000|Overall Study|Protocol Violation|6|||
157045466|NCT00326183|566920931|FG001|Overall Study|Protocol Violation|3|||
157045467|NCT00326183|566920930|FG000|Overall Study|Withdrawal by Subject|35|||
157045468|NCT00326183|566920931|FG001|Overall Study|Withdrawal by Subject|7|||
157045469|NCT00326183|566920930|FG000|Overall Study|Subject Moved|7|||
157045470|NCT00326183|566920931|FG001|Overall Study|Subject Moved|4|||
157045471|NCT00326183|566920930|FG000|Overall Study|Other|47|||
157045472|NCT00326183|566920931|FG001|Overall Study|Other|13|||
157045473|NCT00326183|566920930|FG000|Overall Study|Adverse Event|1|||
157045474|NCT00326183|566920931|FG001|Overall Study|Adverse Event|0|||
157045475|NCT00570505|566920934|FG000|Overall Study|Adverse Event|7|||
157045476|NCT00570505|566920934|FG000|Overall Study|Withdrawal by Subject|7|||
157045477|NCT00570505|566920934|FG000|Overall Study|Lost to Follow-up|23|||
157045478|NCT00570505|566920934|FG000|Overall Study|Other loss to follow-up|4|||
157045479|NCT02334215|566920937|FG000|Overall Study|Death|1|||
157045480|NCT02334215|566920938|FG001|Overall Study|Death|1|||
157045481|NCT02334215|566920939|FG002|Overall Study|Death|0|||
157045482|NCT02334215|566920937|FG000|Overall Study|Lost to Follow-up|1|||
157045483|NCT02334215|566920938|FG001|Overall Study|Lost to Follow-up|0|||
157045484|NCT02334215|566920939|FG002|Overall Study|Lost to Follow-up|4|||
157045485|NCT02334215|566920937|FG000|Overall Study|Withdrawal by Subject|2|||
157045486|NCT02334215|566920938|FG001|Overall Study|Withdrawal by Subject|2|||
157045487|NCT02334215|566920939|FG002|Overall Study|Withdrawal by Subject|1|||
157045488|NCT02334215|566920937|FG000|Overall Study|Not released from incarceration on time|3|||
157045489|NCT02334215|566920938|FG001|Overall Study|Not released from incarceration on time|3|||
157045490|NCT02334215|566920939|FG002|Overall Study|Not released from incarceration on time|3|||
157045491|NCT02334215|566920937|FG000|Overall Study|Incarcerated|0|||
157045492|NCT02334215|566920938|FG001|Overall Study|Incarcerated|0|||
157045493|NCT02334215|566920939|FG002|Overall Study|Incarcerated|7|||
157045494|NCT05865392|566920942|FG000|Overall Study|Withdrawal by Subject|4|||
157045495|NCT05865392|566920943|FG001|Overall Study|Withdrawal by Subject|0|||
157045496|NCT05865392|566920942|FG000|Overall Study|Didn't meet inclusion criteria|4|||
157045497|NCT05865392|566920943|FG001|Overall Study|Didn't meet inclusion criteria|0|||
157045498|NCT04447027|566920944|FG000|Dose Escalation|Withdrawal by Subject|1|||
157045499|NCT04447027|566920945|FG001|Dose Escalation|Withdrawal by Subject|4|||
157045500|NCT04447027|566920946|FG002|Dose Escalation|Withdrawal by Subject|3|||
157045501|NCT04447027|566920947|FG003|Dose Escalation|Withdrawal by Subject|3|||
157045502|NCT04447027|566920948|FG004|Dose Escalation|Withdrawal by Subject|1|||
157045503|NCT04447027|566920949|FG005|Dose Escalation|Withdrawal by Subject|0|||
157045504|NCT04447027|566920950|FG006|Dose Escalation|Withdrawal by Subject|0|||
157045505|NCT04447027|566920951|FG007|Dose Escalation|Withdrawal by Subject|0|||
157045506|NCT04447027|566920952|FG008|Dose Escalation|Withdrawal by Subject|0|||
157045507|NCT04447027|566920944|FG000|Dose Escalation|Refused further treatment|0|||
157045508|NCT04447027|566920945|FG001|Dose Escalation|Refused further treatment|1|||
157045509|NCT04447027|566920946|FG002|Dose Escalation|Refused further treatment|1|||
157045510|NCT04447027|566920947|FG003|Dose Escalation|Refused further treatment|0|||
157045511|NCT04447027|566920948|FG004|Dose Escalation|Refused further treatment|0|||
157045512|NCT04447027|566920949|FG005|Dose Escalation|Refused further treatment|0|||
157045513|NCT04447027|566920950|FG006|Dose Escalation|Refused further treatment|0|||
157045514|NCT04447027|566920951|FG007|Dose Escalation|Refused further treatment|0|||
157045515|NCT04447027|566920952|FG008|Dose Escalation|Refused further treatment|0|||
157045516|NCT04447027|566920944|FG000|Dose Expansion|Withdrawal by Subject|0|||
157045517|NCT04447027|566920945|FG001|Dose Expansion|Withdrawal by Subject|0|||
157045518|NCT04447027|566920946|FG002|Dose Expansion|Withdrawal by Subject|0|||
157045519|NCT04447027|566920947|FG003|Dose Expansion|Withdrawal by Subject|0|||
157045520|NCT04447027|566920948|FG004|Dose Expansion|Withdrawal by Subject|0|||
157045521|NCT04447027|566920949|FG005|Dose Expansion|Withdrawal by Subject|2|||
157045522|NCT04447027|566920950|FG006|Dose Expansion|Withdrawal by Subject|0|||
157045523|NCT04447027|566920951|FG007|Dose Expansion|Withdrawal by Subject|2|||
157045524|NCT04447027|566920952|FG008|Dose Expansion|Withdrawal by Subject|0|||
157045525|NCT02485925|566920953|FG000|Overall Study|Withdrawal by Subject|3|||
157045526|NCT02485925|566920953|FG000|Overall Study|Death|1|||
157045527|NCT02485925|566920953|FG000|Overall Study|Lost to Follow-up|11|||
157045528|NCT04118894|566920957|FG000|Overall Study|Lost to Follow-up|21|||
157045529|NCT04118894|566920957|FG000|Overall Study|Withdrawal by Subject|10|||
157045530|NCT04118894|566920957|FG000|Overall Study|Adverse Event|4|||
157045531|NCT02969356|566920962|FG000|Overall Study|Adverse Event|7|||
157045532|NCT02969356|566920962|FG000|Overall Study|Consent withdrawn|2|||
157045533|NCT02969356|566920962|FG000|Overall Study|Lost to Follow-up|3|||
157045534|NCT02969356|566920962|FG000|Overall Study|Did not need to be reinjected|6|||
157045535|NCT02969356|566920962|FG000|Overall Study|Personal reasons|5|||
157045536|NCT04924608|566922158|FG000|Overall Study|Adverse Event|10|||
157045537|NCT04924608|566922159|FG001|Overall Study|Adverse Event|6|||
157045538|NCT04924608|566922158|FG000|Overall Study|Lost to Follow-up|1|||
157045539|NCT04924608|566922159|FG001|Overall Study|Lost to Follow-up|1|||
157045540|NCT04924608|566922158|FG000|Overall Study|Ongoing at the data cut-off date|54|||
157045541|NCT04924608|566922159|FG001|Overall Study|Ongoing at the data cut-off date|60|||
157045542|NCT04924608|566922158|FG000|Overall Study|Progressive Disease|2|||
157045543|NCT04924608|566922159|FG001|Overall Study|Progressive Disease|0|||
157045544|NCT04924608|566922158|FG000|Overall Study|Withdrawal by Subject|3|||
157045545|NCT04924608|566922159|FG001|Overall Study|Withdrawal by Subject|6|||
157045546|NCT04924608|566922158|FG000|Overall Study|Other reason|1|||
157045547|NCT04924608|566922159|FG001|Overall Study|Other reason|1|||
157045548|NCT01276509|566922160|FG000|Overall Study|Adverse Event|9|||
157045549|NCT01276509|566922161|FG001|Overall Study|Adverse Event|8|||
157045550|NCT01276509|566922162|FG002|Overall Study|Adverse Event|4|||
157045551|NCT01276509|566922163|FG003|Overall Study|Adverse Event|3|||
157045552|NCT01276509|566922160|FG000|Overall Study|Lack of Efficacy|2|||
157045553|NCT01276509|566922161|FG001|Overall Study|Lack of Efficacy|1|||
157045554|NCT01276509|566922162|FG002|Overall Study|Lack of Efficacy|1|||
157045555|NCT01276509|566922163|FG003|Overall Study|Lack of Efficacy|2|||
157045556|NCT01276509|566922160|FG000|Overall Study|Pregnancy|1|||
157045557|NCT01276509|566922161|FG001|Overall Study|Pregnancy|0|||
157045558|NCT01276509|566922162|FG002|Overall Study|Pregnancy|0|||
157045559|NCT01276509|566922163|FG003|Overall Study|Pregnancy|0|||
157045560|NCT01276509|566922160|FG000|Overall Study|Withdrawal by Subject|1|||
157045561|NCT01276509|566922161|FG001|Overall Study|Withdrawal by Subject|2|||
157045562|NCT01276509|566922162|FG002|Overall Study|Withdrawal by Subject|0|||
157045563|NCT01276509|566922163|FG003|Overall Study|Withdrawal by Subject|0|||
157045564|NCT01276509|566922160|FG000|Overall Study|Other|0|||
157045565|NCT01276509|566922161|FG001|Overall Study|Other|1|||
157045566|NCT01276509|566922162|FG002|Overall Study|Other|0|||
157045567|NCT01276509|566922163|FG003|Overall Study|Other|0|||
157045568|NCT04493424|566922165|FG000|Overall Study|Termination of the trial by the sponsor|89|||
157045569|NCT04493424|566922165|FG000|Overall Study|Withdrawal by Subject|9|||
157045570|NCT04493424|566922165|FG000|Overall Study|Lost to Follow-up|2|||
157045571|NCT04493424|566922165|FG000|Overall Study|Lack of Efficacy|3|||
157045572|NCT04493424|566922165|FG000|Overall Study|Adverse Event|5|||
157045573|NCT03769090|566922166|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
157045574|NCT03769090|566922167|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
157045575|NCT03769090|566922168|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
157045576|NCT03769090|566922166|FG000|Overall Study|Withdrawal by Subject|52|||
157045577|NCT03769090|566922167|FG001|Overall Study|Withdrawal by Subject|62|||
157045578|NCT03769090|566922168|FG002|Overall Study|Withdrawal by Subject|74|||
157045579|NCT03769090|566922166|FG000|Overall Study|Death|4|||
157045580|NCT03769090|566922167|FG001|Overall Study|Death|2|||
157045581|NCT03769090|566922168|FG002|Overall Study|Death|2|||
157045582|NCT03769090|566922166|FG000|Overall Study|Adverse Event|7|||
157045583|NCT03769090|566922167|FG001|Overall Study|Adverse Event|7|||
157045584|NCT03769090|566922168|FG002|Overall Study|Adverse Event|8|||
157045585|NCT03769090|566922166|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
157045586|NCT03769090|566922167|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
157045587|NCT03769090|566922168|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
157045588|NCT03769090|566922166|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
157045589|NCT03769090|566922167|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
157045590|NCT03769090|566922168|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
157045591|NCT03769090|566922166|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
157045592|NCT03769090|566922167|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
157045593|NCT03769090|566922168|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
157045594|NCT03769090|566922166|FG000|Overall Study|Protocol Violation|5|||
157045595|NCT03769090|566922167|FG001|Overall Study|Protocol Violation|6|||
157045596|NCT03769090|566922168|FG002|Overall Study|Protocol Violation|8|||
157045597|NCT03769090|566922166|FG000|Overall Study|Pregnancy|1|||
157045598|NCT03769090|566922167|FG001|Overall Study|Pregnancy|0|||
157045599|NCT03769090|566922168|FG002|Overall Study|Pregnancy|3|||
157045600|NCT03769090|566922166|FG000|Overall Study|Lost to Follow-up|19|||
157045601|NCT03769090|566922167|FG001|Overall Study|Lost to Follow-up|25|||
157045602|NCT03769090|566922168|FG002|Overall Study|Lost to Follow-up|21|||
157045603|NCT03769090|566922166|FG000|Overall Study|Condition under investigation worsened|2|||
157045604|NCT03769090|566922167|FG001|Overall Study|Condition under investigation worsened|0|||
157045605|NCT03769090|566922168|FG002|Overall Study|Condition under investigation worsened|1|||
157045606|NCT03769090|566922166|FG000|Overall Study|Lack of Efficacy|1|||
157045607|NCT03769090|566922167|FG001|Overall Study|Lack of Efficacy|2|||
157045608|NCT03769090|566922168|FG002|Overall Study|Lack of Efficacy|2|||
157045609|NCT03769090|566922166|FG000|Overall Study|Other reasons|8|||
157045610|NCT03769090|566922167|FG001|Overall Study|Other reasons|12|||
157045611|NCT03769090|566922168|FG002|Overall Study|Other reasons|15|||
157045612|NCT01190124|566922175|FG000|Overall Study|Death|3|||
157045613|NCT01190124|566922176|FG001|Overall Study|Death|0|||
157045614|NCT01190124|566922177|FG002|Overall Study|Death|0|||
157045615|NCT01190124|566922175|FG000|Overall Study|Therapeutic Failure|12|||
157045616|NCT01190124|566922176|FG001|Overall Study|Therapeutic Failure|0|||
157045617|NCT01190124|566922177|FG002|Overall Study|Therapeutic Failure|1|||
157045618|NCT01190124|566922175|FG000|Overall Study|Lost to Follow-up|2|||
157045619|NCT01190124|566922176|FG001|Overall Study|Lost to Follow-up|0|||
157045620|NCT01190124|566922177|FG002|Overall Study|Lost to Follow-up|0|||
157045621|NCT02713594|566922178|FG000|Overall Study|Withdrawal by Subject|32|||
157045622|NCT02713594|566922179|FG001|Overall Study|Withdrawal by Subject|22|||
157045623|NCT02713594|566922178|FG000|Overall Study|Lost to Follow-up|358|||
157045624|NCT02713594|566922179|FG001|Overall Study|Lost to Follow-up|374|||
157045625|NCT00671853|566922181|FG000|Overall Study|Lack of Efficacy|3|||
157045626|NCT00671853|566922182|FG001|Overall Study|Lack of Efficacy|7|||
157045627|NCT00671853|566922181|FG000|Overall Study|Adverse Event|7|||
157045628|NCT00671853|566922182|FG001|Overall Study|Adverse Event|1|||
157045629|NCT00671853|566922181|FG000|Overall Study|Withdrawal by Subject|1|||
157045630|NCT00671853|566922182|FG001|Overall Study|Withdrawal by Subject|5|||
157045631|NCT00671853|566922181|FG000|Overall Study|Lost to Follow-up|8|||
157045632|NCT00671853|566922182|FG001|Overall Study|Lost to Follow-up|8|||
157045633|NCT00671853|566922181|FG000|Overall Study|Physician Decision|0|||
157045634|NCT00671853|566922182|FG001|Overall Study|Physician Decision|2|||
157045635|NCT00671853|566922181|FG000|Overall Study|Non-adherence with study procedures|1|||
157045636|NCT00671853|566922182|FG001|Overall Study|Non-adherence with study procedures|4|||
157045637|NCT01377844|566922183|FG000|Overall Study|Withdrawal by Subject|25|||
157045638|NCT01377844|566922184|FG001|Overall Study|Withdrawal by Subject|28|||
157045639|NCT01377844|566922183|FG000|Overall Study|Protocol Violation|2|||
157045640|NCT01377844|566922184|FG001|Overall Study|Protocol Violation|3|||
157045641|NCT01377844|566922183|FG000|Overall Study|Adverse Event|3|||
157045642|NCT01377844|566922184|FG001|Overall Study|Adverse Event|0|||
157045643|NCT01377844|566922183|FG000|Overall Study|Physician Decision|6|||
157045644|NCT01377844|566922184|FG001|Overall Study|Physician Decision|3|||
157045645|NCT01377844|566922183|FG000|Overall Study|Study terminated by Sponsor|0|||
157045646|NCT01377844|566922184|FG001|Overall Study|Study terminated by Sponsor|1|||
157045647|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
157045648|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157045649|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157045650|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157045651|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
157045652|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157045653|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157045654|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157045655|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
157045656|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157045657|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157045658|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157045659|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
157045660|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157045661|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157045662|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157045663|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
157045664|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157045665|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157045666|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157045667|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
157045668|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157045669|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157045670|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157045671|NCT01185340|566922188|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
157045672|NCT01185340|566922189|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157045673|NCT01185340|566922190|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157045674|NCT01185340|566922191|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157045675|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
157045676|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
157045677|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
157045678|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
157045679|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
157045680|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
157045681|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
157045682|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
157045683|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
157045684|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
157045685|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
157174490|NCT00636441|567379810|FG000|Overall Study|Late, ineligible|0|||
157174491|NCT00636441|567379811|FG001|Overall Study|Late, ineligible|0|||
157174492|NCT00636441|567379812|FG002|Overall Study|Late, ineligible|0|||
157174493|NCT00636441|567379813|FG003|Overall Study|Late, ineligible|0|||
157174494|NCT00636441|567379814|FG004|Overall Study|Late, ineligible|0|||
157174495|NCT00636441|567379815|FG005|Overall Study|Late, ineligible|0|||
157174496|NCT00636441|567379816|FG006|Overall Study|Late, ineligible|1|||
157045686|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
157045687|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
157045688|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
157045689|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
157174497|NCT00636441|567379810|FG000|Overall Study|Screen Failure|0|||
157174498|NCT00636441|567379811|FG001|Overall Study|Screen Failure|0|||
157174499|NCT00636441|567379812|FG002|Overall Study|Screen Failure|0|||
157174500|NCT00636441|567379813|FG003|Overall Study|Screen Failure|0|||
157174501|NCT00636441|567379814|FG004|Overall Study|Screen Failure|0|||
157174502|NCT00636441|567379815|FG005|Overall Study|Screen Failure|0|||
157174503|NCT00636441|567379816|FG006|Overall Study|Screen Failure|17|||
157174504|NCT00555906|567379819|FG000|Phase 1|Objective Progression or Relapse|3|||
157174505|NCT00555906|567379820|FG001|Phase 1|Objective Progression or Relapse|5|||
157174506|NCT00555906|567379821|FG002|Phase 1|Objective Progression or Relapse|3|||
157174507|NCT00555906|567379822|FG003|Phase 1|Objective Progression or Relapse|1|||
157174508|NCT00555906|567379823|FG004|Phase 1|Objective Progression or Relapse|0|||
157174509|NCT00555906|567379819|FG000|Phase 1|Global Deterioration of Health Status|0|||
157174510|NCT00555906|567379820|FG001|Phase 1|Global Deterioration of Health Status|1|||
157174511|NCT00555906|567379821|FG002|Phase 1|Global Deterioration of Health Status|1|||
157174512|NCT00555906|567379822|FG003|Phase 1|Global Deterioration of Health Status|1|||
157174513|NCT00555906|567379823|FG004|Phase 1|Global Deterioration of Health Status|0|||
157174514|NCT00555906|567379819|FG000|Phase 1|Adverse Event|0|||
157174515|NCT00555906|567379820|FG001|Phase 1|Adverse Event|0|||
157174516|NCT00555906|567379821|FG002|Phase 1|Adverse Event|3|||
157174517|NCT00555906|567379822|FG003|Phase 1|Adverse Event|2|||
157174518|NCT00555906|567379823|FG004|Phase 1|Adverse Event|0|||
157174519|NCT00555906|567379819|FG000|Phase 1|Withdrawal by Subject|0|||
157174520|NCT00555906|567379820|FG001|Phase 1|Withdrawal by Subject|0|||
157174521|NCT00555906|567379821|FG002|Phase 1|Withdrawal by Subject|0|||
157174522|NCT00555906|567379822|FG003|Phase 1|Withdrawal by Subject|1|||
157174523|NCT00555906|567379823|FG004|Phase 1|Withdrawal by Subject|0|||
157174524|NCT00555906|567379819|FG000|Phase 2|Adverse Event|0|||
157174525|NCT00555906|567379820|FG001|Phase 2|Adverse Event|0|||
157174526|NCT00555906|567379821|FG002|Phase 2|Adverse Event|0|||
157174527|NCT00555906|567379822|FG003|Phase 2|Adverse Event|0|||
157174528|NCT00555906|567379823|FG004|Phase 2|Adverse Event|4|||
157174529|NCT00555906|567379819|FG000|Phase 2|Global Deterioration of Health Status|0|||
157174530|NCT00555906|567379820|FG001|Phase 2|Global Deterioration of Health Status|0|||
157174531|NCT00555906|567379821|FG002|Phase 2|Global Deterioration of Health Status|0|||
157174532|NCT00555906|567379822|FG003|Phase 2|Global Deterioration of Health Status|0|||
157174533|NCT00555906|567379823|FG004|Phase 2|Global Deterioration of Health Status|2|||
157174534|NCT00555906|567379819|FG000|Phase 2|Objective Progression or Relapse|0|||
157174535|NCT00555906|567379820|FG001|Phase 2|Objective Progression or Relapse|0|||
157174536|NCT00555906|567379821|FG002|Phase 2|Objective Progression or Relapse|0|||
157174537|NCT00555906|567379822|FG003|Phase 2|Objective Progression or Relapse|0|||
157174538|NCT00555906|567379823|FG004|Phase 2|Objective Progression or Relapse|16|||
157174539|NCT00555906|567379819|FG000|Phase 2|Withdrawal by Subject|0|||
157174540|NCT00555906|567379820|FG001|Phase 2|Withdrawal by Subject|0|||
157174541|NCT00555906|567379821|FG002|Phase 2|Withdrawal by Subject|0|||
157174542|NCT00555906|567379822|FG003|Phase 2|Withdrawal by Subject|0|||
157174543|NCT00555906|567379823|FG004|Phase 2|Withdrawal by Subject|2|||
157174544|NCT00555906|567379819|FG000|Phase 2|Other|0|||
157174545|NCT00555906|567379820|FG001|Phase 2|Other|0|||
157174546|NCT00555906|567379821|FG002|Phase 2|Other|0|||
157174547|NCT00555906|567379822|FG003|Phase 2|Other|0|||
157174548|NCT00555906|567379823|FG004|Phase 2|Other|6|||
157174549|NCT00555906|567379819|FG000|Phase 2|Randomized but not Treated|0|||
157174550|NCT00555906|567379820|FG001|Phase 2|Randomized but not Treated|0|||
157174551|NCT00555906|567379821|FG002|Phase 2|Randomized but not Treated|0|||
157174552|NCT00555906|567379822|FG003|Phase 2|Randomized but not Treated|0|||
157174553|NCT00555906|567379823|FG004|Phase 2|Randomized but not Treated|2|||
157174554|NCT02849626|567379824|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
157174555|NCT02849626|567379825|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
157174556|NCT02849626|567379826|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
157174557|NCT02849626|567379827|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
157174558|NCT02849626|567379824|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
157174559|NCT02849626|567379825|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
157174560|NCT02849626|567379826|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
157174561|NCT02849626|567379827|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
157174562|NCT02849626|567379824|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
157174563|NCT02849626|567379825|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
157174564|NCT02849626|567379826|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
157174565|NCT02849626|567379827|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
157174566|NCT02849626|567379824|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
157174567|NCT02849626|567379825|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
157174568|NCT02849626|567379826|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
157174569|NCT02849626|567379827|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
157174570|NCT02849626|567379824|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
157174571|NCT02849626|567379825|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
157174572|NCT02849626|567379826|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
157174573|NCT02849626|567379827|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
157174574|NCT02849626|567379824|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
157174575|NCT02849626|567379825|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
157174576|NCT02849626|567379826|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
157174577|NCT02849626|567379827|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
157174578|NCT02849626|567379824|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
157174579|NCT02849626|567379825|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
157174580|NCT02849626|567379826|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
157174581|NCT02849626|567379827|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
157174582|NCT02849626|567379824|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
157174583|NCT02849626|567379825|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
157174584|NCT02849626|567379826|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
157174585|NCT02849626|567379827|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
157174586|NCT02849626|567379824|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
157174587|NCT02849626|567379825|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
157174588|NCT02849626|567379826|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
157174589|NCT02849626|567379827|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
157174590|NCT02849626|567379824|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
157174591|NCT02849626|567379825|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
157174592|NCT02849626|567379826|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
157174593|NCT02849626|567379827|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
157174594|NCT02849626|567379824|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
157174595|NCT02849626|567379825|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
157174596|NCT02849626|567379826|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
157174597|NCT02849626|567379827|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
157174598|NCT01185704|567379828|FG000|Overall Study|Randomized but not treated|3|||
157174599|NCT01185704|567379829|FG001|Overall Study|Randomized but not treated|3|||
157174600|NCT01185704|567379828|FG000|Overall Study|Lack of ovarian response|5|||
157174601|NCT01185704|567379829|FG001|Overall Study|Lack of ovarian response|1|||
157174602|NCT01185704|567379828|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
157174603|NCT01185704|567379829|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
157174604|NCT01185704|567379828|FG000|Overall Study|Ectopic pregnancy|0|||
157174605|NCT01185704|567379829|FG001|Overall Study|Ectopic pregnancy|1|||
157174606|NCT04046341|567379830|FG000|Overall Study|Lost to Follow-up|2|||
157174607|NCT04046341|567379830|FG000|Overall Study|Withdrawal by Subject|1|||
157174608|NCT02447458|567379831|FG000|Overall Study|Other|0|||
157174609|NCT02447458|567379832|FG001|Overall Study|Other|0|||
157174610|NCT02447458|567379833|FG002|Overall Study|Other|1|||
157174611|NCT02447458|567379834|FG003|Overall Study|Other|0|||
157174612|NCT02447458|567379835|FG004|Overall Study|Other|0|||
157174613|NCT02447458|567379836|FG005|Overall Study|Other|0|||
157174614|NCT03505749|567379837|FG000|Overall Study|Lost to Follow-up|7|||
157174615|NCT03505749|567379838|FG001|Overall Study|Lost to Follow-up|11|||
157174616|NCT03505749|567379837|FG000|Overall Study|Withdrawal by Subject|6|||
157174617|NCT03505749|567379838|FG001|Overall Study|Withdrawal by Subject|0|||
157174618|NCT03505749|567379837|FG000|Overall Study|Discharged from treatment|3|||
157174619|NCT03505749|567379838|FG001|Overall Study|Discharged from treatment|6|||
157174620|NCT01151540|567379839|FG000|Overall Study|Other|2|||
157174621|NCT01151540|567379839|FG000|Overall Study|Adverse event, non-fatal|4|||
157174622|NCT01151540|567379839|FG000|Overall Study|Withdrawal by Subject|7|||
157174623|NCT03846219|567379841|FG000|Overall Study|Withdrawal by Subject|3|||
157174624|NCT03846219|567379842|FG001|Overall Study|Withdrawal by Subject|2|||
157174625|NCT03846219|567379843|FG002|Overall Study|Withdrawal by Subject|2|||
157174626|NCT03846219|567379841|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
157174627|NCT03846219|567379842|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
157174628|NCT03846219|567379843|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
157174629|NCT03846219|567379841|FG000|Overall Study|Physician Decision|0|||
157174630|NCT03846219|567379842|FG001|Overall Study|Physician Decision|0|||
157174631|NCT03846219|567379843|FG002|Overall Study|Physician Decision|2|||
157174632|NCT01392378|567379844|FG000|Infant Series|Adverse Event|0|||
157174633|NCT01392378|567379845|FG001|Infant Series|Adverse Event|0|||
157174634|NCT01392378|567379846|FG002|Infant Series|Adverse Event|0|||
157174635|NCT01392378|567379847|FG003|Infant Series|Adverse Event|1|||
157174636|NCT01392378|567379848|FG004|Infant Series|Adverse Event|0|||
157174637|NCT01392378|567379844|FG000|Infant Series|Lost to Follow-up|0|||
157174638|NCT01392378|567379845|FG001|Infant Series|Lost to Follow-up|0|||
156968964|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
156968965|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
156968966|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
156968967|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
157174639|NCT01392378|567379846|FG002|Infant Series|Lost to Follow-up|0|||
157174640|NCT01392378|567379847|FG003|Infant Series|Lost to Follow-up|1|||
157174641|NCT01392378|567379848|FG004|Infant Series|Lost to Follow-up|0|||
157174642|NCT01392378|567379844|FG000|Infant Series|Protocol Violation|0|||
157174643|NCT01392378|567379845|FG001|Infant Series|Protocol Violation|1|||
157174644|NCT01392378|567379846|FG002|Infant Series|Protocol Violation|0|||
157174645|NCT01392378|567379847|FG003|Infant Series|Protocol Violation|0|||
157174646|NCT01392378|567379848|FG004|Infant Series|Protocol Violation|0|||
157174647|NCT01392378|567379844|FG000|Infant Series|Withdrawal by Parent|4|||
157174648|NCT01392378|567379845|FG001|Infant Series|Withdrawal by Parent|1|||
157174649|NCT01392378|567379846|FG002|Infant Series|Withdrawal by Parent|0|||
157174650|NCT01392378|567379847|FG003|Infant Series|Withdrawal by Parent|0|||
157174651|NCT01392378|567379848|FG004|Infant Series|Withdrawal by Parent|0|||
157174652|NCT01392378|567379844|FG000|After Infant Series|Lost to Follow-up|0|||
157174653|NCT01392378|567379845|FG001|After Infant Series|Lost to Follow-up|0|||
157174654|NCT01392378|567379846|FG002|After Infant Series|Lost to Follow-up|1|||
157174655|NCT01392378|567379847|FG003|After Infant Series|Lost to Follow-up|0|||
157174656|NCT01392378|567379848|FG004|After Infant Series|Lost to Follow-up|0|||
157174657|NCT01392378|567379844|FG000|After Infant Series|Withdrawal by Parent|0|||
157174658|NCT01392378|567379845|FG001|After Infant Series|Withdrawal by Parent|1|||
157174659|NCT01392378|567379846|FG002|After Infant Series|Withdrawal by Parent|1|||
157174660|NCT01392378|567379847|FG003|After Infant Series|Withdrawal by Parent|0|||
157174661|NCT01392378|567379848|FG004|After Infant Series|Withdrawal by Parent|1|||
157174662|NCT01392378|567379844|FG000|Toddler Dose|Lost to Follow-up|0|||
157174663|NCT01392378|567379845|FG001|Toddler Dose|Lost to Follow-up|0|||
157174664|NCT01392378|567379846|FG002|Toddler Dose|Lost to Follow-up|0|||
157174665|NCT01392378|567379847|FG003|Toddler Dose|Lost to Follow-up|1|||
157174666|NCT01392378|567379848|FG004|Toddler Dose|Lost to Follow-up|0|||
157174667|NCT01392378|567379844|FG000|Toddler Dose|Withdrawal by Parent|0|||
157174668|NCT01392378|567379845|FG001|Toddler Dose|Withdrawal by Parent|1|||
157174669|NCT01392378|567379846|FG002|Toddler Dose|Withdrawal by Parent|0|||
157174670|NCT01392378|567379847|FG003|Toddler Dose|Withdrawal by Parent|1|||
157174671|NCT01392378|567379848|FG004|Toddler Dose|Withdrawal by Parent|1|||
157174672|NCT02322411|567379851|FG000|Overall Study|Lost to Follow-up|4|||
157174673|NCT02322411|567379852|FG001|Overall Study|Lost to Follow-up|7|||
157174674|NCT02322411|567379851|FG000|Overall Study|Withdrawal by Subject|1|||
157174675|NCT02322411|567379852|FG001|Overall Study|Withdrawal by Subject|0|||
157174676|NCT01998880|567379853|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
157174677|NCT01998880|567379854|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
157174678|NCT01998880|567379853|FG000|Overall Study|Disease Progression|1|||
157174679|NCT01998880|567379854|FG001|Overall Study|Disease Progression|8|||
157174680|NCT01998880|567379853|FG000|Overall Study|Withdrew Consent|2|||
157174681|NCT01998880|567379854|FG001|Overall Study|Withdrew Consent|1|||
157174682|NCT01998880|567379853|FG000|Overall Study|Death|3|||
157174683|NCT01998880|567379854|FG001|Overall Study|Death|6|||
157174684|NCT01998880|567379853|FG000|Overall Study|Insufficient Therapeutic Response|1|||
157174685|NCT01998880|567379854|FG001|Overall Study|Insufficient Therapeutic Response|5|||
157174686|NCT01998880|567379853|FG000|Overall Study|Administrative/Other|1|||
157174687|NCT01998880|567379854|FG001|Overall Study|Administrative/Other|1|||
157174688|NCT01998880|567379853|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
157174689|NCT01998880|567379854|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
157174690|NCT01998880|567379853|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
157174691|NCT01998880|567379854|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
157174692|NCT01998880|567379853|FG000|Overall Study|Did Not Receive Treatment|3|||
157174693|NCT01998880|567379854|FG001|Overall Study|Did Not Receive Treatment|2|||
157174694|NCT02248857|567379855|FG000|3 Month|Withdrawal by Subject|9|||
157174695|NCT02248857|567379856|FG001|3 Month|Withdrawal by Subject|3|||
157045690|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
157045691|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
157045692|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
157045693|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
157045694|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
157045695|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
157045696|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
157045697|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
157045698|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
157174696|NCT02248857|567379857|FG002|3 Month|Withdrawal by Subject|4|||
157174697|NCT02248857|567379855|FG000|3 Month|Unable to reach for 3 month|35|||
157174698|NCT02248857|567379856|FG001|3 Month|Unable to reach for 3 month|29|||
157174699|NCT02248857|567379857|FG002|3 Month|Unable to reach for 3 month|26|||
157174700|NCT02248857|567379855|FG000|3 Month|Partially completed, unable to finish|2|||
157045699|NCT01185340|566922188|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
157045700|NCT01185340|566922189|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
157174701|NCT02248857|567379856|FG001|3 Month|Partially completed, unable to finish|2|||
157174702|NCT02248857|567379857|FG002|3 Month|Partially completed, unable to finish|1|||
157174703|NCT02248857|567379855|FG000|6 Month|Lost to Follow-up|27|||
157174704|NCT02248857|567379856|FG001|6 Month|Lost to Follow-up|26|||
157174705|NCT02248857|567379857|FG002|6 Month|Lost to Follow-up|15|||
157174706|NCT02248857|567379855|FG000|6 Month|Partially completed, unable to finish|0|||
157174707|NCT02248857|567379856|FG001|6 Month|Partially completed, unable to finish|1|||
157174708|NCT02248857|567379857|FG002|6 Month|Partially completed, unable to finish|0|||
157174709|NCT02248857|567379855|FG000|6 Month|Withdrawal by Subject|0|||
157174710|NCT02248857|567379856|FG001|6 Month|Withdrawal by Subject|2|||
157174711|NCT02248857|567379857|FG002|6 Month|Withdrawal by Subject|2|||
157174712|NCT02248857|567379855|FG000|6 Month|Death|1|||
157174713|NCT02248857|567379856|FG001|6 Month|Death|0|||
157174714|NCT02248857|567379857|FG002|6 Month|Death|0|||
157174715|NCT02261883|567379858|FG000|Overall Study|Death|3|||
157174716|NCT02261883|567379859|FG001|Overall Study|Death|2|||
157174717|NCT02261883|567379858|FG000|Overall Study|Physician Decision|1|||
157174718|NCT02261883|567379859|FG001|Overall Study|Physician Decision|0|||
157174719|NCT02261883|567379858|FG000|Overall Study|Protocol Violation|1|||
157174720|NCT02261883|567379859|FG001|Overall Study|Protocol Violation|0|||
157174721|NCT02261883|567379858|FG000|Overall Study|Withdrawal by Subject|0|||
157174722|NCT02261883|567379859|FG001|Overall Study|Withdrawal by Subject|1|||
157174723|NCT02261883|567379858|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
157174724|NCT02261883|567379859|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
157174725|NCT00903370|567379861|FG000|Overall Study|Death|13|||
157174726|NCT00903370|567379862|FG001|Overall Study|Death|10|||
157174727|NCT00903370|567379861|FG000|Overall Study|Withdrawal by Subject|9|||
157174728|NCT00903370|567379862|FG001|Overall Study|Withdrawal by Subject|6|||
157174729|NCT00903370|567379861|FG000|Overall Study|Lost to Follow-up|6|||
157174730|NCT00903370|567379862|FG001|Overall Study|Lost to Follow-up|8|||
157174731|NCT00345540|567379867|FG000|Overall Study|Withdrawal by Subject|1|||
157174732|NCT00141037|567379869|FG000|Overall Study|Physician Decision|1|||
157174733|NCT00141037|567379870|FG001|Overall Study|Physician Decision|2|||
157174734|NCT00141037|567379869|FG000|Overall Study|Lost to Follow-up|3|||
157174735|NCT00141037|567379870|FG001|Overall Study|Lost to Follow-up|1|||
157174736|NCT00141037|567379869|FG000|Overall Study|Protocol Violation|0|||
157174737|NCT00141037|567379870|FG001|Overall Study|Protocol Violation|2|||
157174738|NCT00141037|567379869|FG000|Overall Study|Withdrawal by Subject|2|||
157174739|NCT00141037|567379870|FG001|Overall Study|Withdrawal by Subject|1|||
157174740|NCT00141037|567379869|FG000|Overall Study|Other|0|||
157174741|NCT00141037|567379870|FG001|Overall Study|Other|1|||
157174742|NCT00141037|567379869|FG000|Overall Study|Moved from area|1|||
157174743|NCT00141037|567379870|FG001|Overall Study|Moved from area|7|||
157174744|NCT00141037|567379869|FG000|Overall Study|Graft Failure|3|||
157174745|NCT00141037|567379870|FG001|Overall Study|Graft Failure|4|||
157174746|NCT01938001|567379871|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
157174747|NCT01938001|567379872|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
157174748|NCT01938001|567379871|FG000|Pre-Treatment|Death|1|||
156968968|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
156968969|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
156968970|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
156968971|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
156968972|NCT01493687|566639074|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
156968973|NCT01493687|566639075|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
156968974|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
156968975|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
156968976|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
156968977|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
156968978|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
156968979|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
156968980|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
156968981|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
156968982|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
156968983|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
156968984|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
156968985|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
156968986|NCT01493687|566639074|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
156968987|NCT01493687|566639075|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
156968988|NCT01493687|566639074|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
156968989|NCT01493687|566639075|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
156968990|NCT01783418|566639077|FG000|Overall Study|Withdrawal by Subject|1|||
156968991|NCT01783418|566639078|FG001|Overall Study|Withdrawal by Subject|0|||
156968992|NCT00089141|566639079|FG000|Overall Study|Termination of trial|18|||
156968993|NCT00089141|566639080|FG001|Overall Study|Termination of trial|24|||
156968994|NCT00508261|566639083|FG000|Overall Study|Other|0|||
156968995|NCT00508261|566639084|FG001|Overall Study|Other|1|||
156968996|NCT00508261|566639085|FG002|Overall Study|Other|1|||
157174749|NCT01938001|567379872|FG001|Pre-Treatment|Death|0|||
157174750|NCT01938001|567379871|FG000|Treatment|Death|2|||
157174751|NCT01938001|567379872|FG001|Treatment|Death|0|||
157174752|NCT01938001|567379871|FG000|Treatment|Adverse Event|14|||
157174753|NCT01938001|567379872|FG001|Treatment|Adverse Event|8|||
156968997|NCT00508261|566639086|FG003|Overall Study|Other|0|||
156968998|NCT00508261|566639083|FG000|Overall Study|Serious Adverse Event|0|||
156968999|NCT00508261|566639084|FG001|Overall Study|Serious Adverse Event|1|||
156969000|NCT00508261|566639085|FG002|Overall Study|Serious Adverse Event|0|||
156969001|NCT00508261|566639086|FG003|Overall Study|Serious Adverse Event|0|||
156969002|NCT00508261|566639083|FG000|Overall Study|Withdrawal by Subject|3|||
156969003|NCT00508261|566639084|FG001|Overall Study|Withdrawal by Subject|4|||
156969004|NCT00508261|566639085|FG002|Overall Study|Withdrawal by Subject|4|||
156969005|NCT00508261|566639086|FG003|Overall Study|Withdrawal by Subject|0|||
156969006|NCT00508261|566639083|FG000|Overall Study|Migrated/ moved from study area|0|||
156969007|NCT00508261|566639084|FG001|Overall Study|Migrated/ moved from study area|1|||
156969008|NCT00508261|566639085|FG002|Overall Study|Migrated/ moved from study area|0|||
156969009|NCT00508261|566639086|FG003|Overall Study|Migrated/ moved from study area|0|||
156969010|NCT00508261|566639083|FG000|Overall Study|Lost to Follow-up|0|||
156969011|NCT00508261|566639084|FG001|Overall Study|Lost to Follow-up|1|||
156969012|NCT00508261|566639085|FG002|Overall Study|Lost to Follow-up|1|||
156969013|NCT00508261|566639086|FG003|Overall Study|Lost to Follow-up|1|||
156969014|NCT00335452|566639087|FG000|Overall Study|Death|156|||
156969015|NCT00335452|566639088|FG001|Overall Study|Death|144|||
156969016|NCT00335452|566639089|FG002|Overall Study|Death|158|||
156969017|NCT00335452|566639090|FG003|Overall Study|Death|129|||
156969018|NCT00335452|566639087|FG000|Overall Study|Lost to Follow-up|2|||
156969019|NCT00335452|566639088|FG001|Overall Study|Lost to Follow-up|3|||
156969020|NCT00335452|566639089|FG002|Overall Study|Lost to Follow-up|1|||
156969021|NCT00335452|566639090|FG003|Overall Study|Lost to Follow-up|2|||
156969022|NCT02736825|566639091|FG000|Overall Study|Lost to Follow-up|10|||
156969023|NCT02736825|566639092|FG001|Overall Study|Lost to Follow-up|11|||
156969024|NCT02736825|566639091|FG000|Overall Study|Early Termination|0|||
156969025|NCT02736825|566639092|FG001|Overall Study|Early Termination|1|||
156969026|NCT00790452|566639093|FG000|Overall Study|Drug supply issue|1|||
156969027|NCT00790452|566639094|FG001|Overall Study|Drug supply issue|0|||
156969028|NCT04082884|566639095|FG000|Overall Study|Withdrawal by Subject|1|||
156969029|NCT00387894|566639096|FG000|Overall Study|Withdrawal by Subject|1|||
156969030|NCT00827541|566639099|FG000|Overall Study|Exitus|1|||
156969031|NCT00827541|566639100|FG001|Overall Study|Exitus|8|||
156969032|NCT00827541|566639099|FG000|Overall Study|Other|1|||
156969033|NCT00827541|566639100|FG001|Overall Study|Other|3|||
156969034|NCT00827541|566639099|FG000|Overall Study|Pathogen not susceptible|1|||
156969035|NCT00827541|566639100|FG001|Overall Study|Pathogen not susceptible|0|||
156969036|NCT00827541|566639099|FG000|Overall Study|Lack of effectiveness|1|||
156969037|NCT00827541|566639100|FG001|Overall Study|Lack of effectiveness|0|||
156969038|NCT01649232|566639101|FG000|Overall Study|Physician Decision|2|||
156969039|NCT01649232|566639102|FG001|Overall Study|Physician Decision|0|||
156969040|NCT02347657|566639103|FG000|Overall Study|Physician Decision|0|||
156969041|NCT02347657|566639104|FG001|Overall Study|Physician Decision|1|||
156969042|NCT02347657|566639103|FG000|Overall Study|Adverse Event|8|||
156969043|NCT02347657|566639104|FG001|Overall Study|Adverse Event|4|||
156969044|NCT02347657|566639103|FG000|Overall Study|Withdrawal by Subject|6|||
156969045|NCT02347657|566639104|FG001|Overall Study|Withdrawal by Subject|7|||
156969046|NCT02347657|566639103|FG000|Overall Study|Randomized but not treated|1|||
156969047|NCT02347657|566639104|FG001|Overall Study|Randomized but not treated|0|||
156969048|NCT02347657|566639103|FG000|Overall Study|Other|3|||
156969049|NCT02347657|566639104|FG001|Overall Study|Other|3|||
156969050|NCT00677352|566639114|FG000|Treatment Phase|Adverse Event|14|||
156969051|NCT00677352|566639115|FG001|Treatment Phase|Adverse Event|22|||
156969052|NCT00677352|566639114|FG000|Treatment Phase|Lack of Efficacy|2|||
156969053|NCT00677352|566639115|FG001|Treatment Phase|Lack of Efficacy|3|||
156969054|NCT00677352|566639114|FG000|Treatment Phase|Lost to Follow-up|0|||
156969055|NCT00677352|566639115|FG001|Treatment Phase|Lost to Follow-up|1|||
156969056|NCT00677352|566639114|FG000|Treatment Phase|Withdrawal by Subject|7|||
156969057|NCT00677352|566639115|FG001|Treatment Phase|Withdrawal by Subject|7|||
156969058|NCT00677352|566639114|FG000|Treatment Phase|Physician Decision|1|||
156969059|NCT00677352|566639115|FG001|Treatment Phase|Physician Decision|0|||
156969060|NCT00677352|566639114|FG000|Treatment Phase|Pregnancy|0|||
156969061|NCT00677352|566639115|FG001|Treatment Phase|Pregnancy|1|||
156969062|NCT00677352|566639114|FG000|Treatment Phase|Protocol Violation|1|||
156969063|NCT00677352|566639115|FG001|Treatment Phase|Protocol Violation|1|||
156969064|NCT00677352|566639114|FG000|Treatment Phase|Transference or work related matter|0|||
156969065|NCT00677352|566639115|FG001|Treatment Phase|Transference or work related matter|5|||
156969066|NCT00677352|566639114|FG000|Treatment Phase|Not treated|0|||
156969067|NCT00677352|566639115|FG001|Treatment Phase|Not treated|2|||
156969068|NCT00677352|566639114|FG000|Tapering Phase|Adverse Event|1|||
156969069|NCT00677352|566639115|FG001|Tapering Phase|Adverse Event|5|||
156969070|NCT00677352|566639114|FG000|Tapering Phase|Withdrawal by Subject|5|||
156969071|NCT00677352|566639115|FG001|Tapering Phase|Withdrawal by Subject|3|||
156969072|NCT00677352|566639114|FG000|Tapering Phase|Pregnancy|0|||
156969073|NCT00677352|566639115|FG001|Tapering Phase|Pregnancy|1|||
156969074|NCT00677352|566639114|FG000|Tapering Phase|Job transfer|0|||
156969075|NCT00677352|566639115|FG001|Tapering Phase|Job transfer|1|||
157045701|NCT01185340|566922190|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
157045702|NCT01185340|566922191|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
157174754|NCT01938001|567379871|FG000|Treatment|Progressive Disease|21|||
156969076|NCT01972529|566639117|FG000|Overall Study|Adverse Event|0|||
156969077|NCT01972529|566639118|FG001|Overall Study|Adverse Event|1|||
156969078|NCT01972529|566639119|FG002|Overall Study|Adverse Event|0|||
156969079|NCT01972529|566639120|FG003|Overall Study|Adverse Event|0|||
156969080|NCT01972529|566639117|FG000|Overall Study|Lost to Follow-up|1|||
156969081|NCT01972529|566639118|FG001|Overall Study|Lost to Follow-up|0|||
156969082|NCT01972529|566639119|FG002|Overall Study|Lost to Follow-up|0|||
156969083|NCT01972529|566639120|FG003|Overall Study|Lost to Follow-up|0|||
156969084|NCT01972529|566639117|FG000|Overall Study|Participant Choice|0|||
156969085|NCT01972529|566639118|FG001|Overall Study|Participant Choice|1|||
156969086|NCT01972529|566639119|FG002|Overall Study|Participant Choice|0|||
156969087|NCT01972529|566639120|FG003|Overall Study|Participant Choice|0|||
156969088|NCT01972529|566639117|FG000|Overall Study|Withdrawl of Consent|1|||
156969089|NCT01972529|566639118|FG001|Overall Study|Withdrawl of Consent|2|||
156969090|NCT01972529|566639119|FG002|Overall Study|Withdrawl of Consent|0|||
156969091|NCT01972529|566639120|FG003|Overall Study|Withdrawl of Consent|1|||
156969092|NCT01972529|566639117|FG000|Overall Study|Other|0|||
156969093|NCT01972529|566639118|FG001|Overall Study|Other|0|||
156969094|NCT01972529|566639119|FG002|Overall Study|Other|0|||
156969095|NCT01972529|566639120|FG003|Overall Study|Other|2|||
156969096|NCT01972529|566639117|FG000|Overall Study|Not treated|0|||
156969097|NCT01972529|566639118|FG001|Overall Study|Not treated|1|||
156969098|NCT01972529|566639119|FG002|Overall Study|Not treated|2|||
156969099|NCT01972529|566639120|FG003|Overall Study|Not treated|1|||
156969100|NCT02618967|566639121|FG000|Overall Study|Lost to Follow-up|0|||
156969101|NCT02618967|566639122|FG001|Overall Study|Lost to Follow-up|0|||
156969102|NCT02618967|566639123|FG002|Overall Study|Lost to Follow-up|1|||
156969103|NCT02618967|566639124|FG003|Overall Study|Lost to Follow-up|0|||
156969104|NCT02618967|566639125|FG004|Overall Study|Lost to Follow-up|2|||
156969105|NCT02618967|566639126|FG005|Overall Study|Lost to Follow-up|0|||
156969106|NCT02618967|566639127|FG006|Overall Study|Lost to Follow-up|0|||
156969107|NCT02618967|566639128|FG007|Overall Study|Lost to Follow-up|0|||
156969108|NCT02618967|566639121|FG000|Overall Study|Withdrawal by Subject|1|||
156969109|NCT02618967|566639122|FG001|Overall Study|Withdrawal by Subject|0|||
156969110|NCT02618967|566639123|FG002|Overall Study|Withdrawal by Subject|0|||
156969111|NCT02618967|566639124|FG003|Overall Study|Withdrawal by Subject|0|||
156969112|NCT02618967|566639125|FG004|Overall Study|Withdrawal by Subject|0|||
156969113|NCT02618967|566639126|FG005|Overall Study|Withdrawal by Subject|0|||
156969114|NCT02618967|566639127|FG006|Overall Study|Withdrawal by Subject|0|||
156969115|NCT02618967|566639128|FG007|Overall Study|Withdrawal by Subject|0|||
156969116|NCT00715429|566639130|FG000|Overall Study|Did not complete the study diary|0|||
156969117|NCT00715429|566639131|FG001|Overall Study|Did not complete the study diary|1|||
156969118|NCT04003610|566639137|FG000|Overall Study|Lost to Follow-up|0|||
156969119|NCT04003610|566639138|FG001|Overall Study|Lost to Follow-up|1|||
156969120|NCT04003610|566639139|FG002|Overall Study|Lost to Follow-up|0|||
156969121|NCT04003610|566639137|FG000|Overall Study|Death|0|||
156969122|NCT04003610|566639138|FG001|Overall Study|Death|0|||
156969123|NCT04003610|566639139|FG002|Overall Study|Death|3|||
156969124|NCT04003610|566639137|FG000|Overall Study|Study Terminated by Sponsor|0|||
156969125|NCT04003610|566639138|FG001|Overall Study|Study Terminated by Sponsor|0|||
156969126|NCT04003610|566639139|FG002|Overall Study|Study Terminated by Sponsor|3|||
156969127|NCT00386022|566639145|FG000|Plus Estrogen|Lost to Follow-up|2|||
156969128|NCT00386022|566639146|FG001|Plus Estrogen|Lost to Follow-up|0|||
156969129|NCT00386022|566639145|FG000|Plus Estrogen|Adverse Event|0|||
156969130|NCT00386022|566639146|FG001|Plus Estrogen|Adverse Event|1|||
156969131|NCT03078816|566639147|FG000|Overall Study|Withdrawal by Subject|1|||
156969132|NCT02114151|566639148|FG000|Overall Study|Death|1|||
156969133|NCT02114151|566639148|FG000|Overall Study|Lost to Follow-up|1|||
156969134|NCT02114151|566639148|FG000|Overall Study|Withdrawal by Subject|5|||
156969135|NCT03933826|566639149|FG000|Overall Study|Withdrawal by Subject|8|||
156969136|NCT03933826|566639150|FG001|Overall Study|Withdrawal by Subject|1|||
156969137|NCT03933826|566639149|FG000|Overall Study|Death|19|||
156969138|NCT03933826|566639150|FG001|Overall Study|Death|11|||
156969139|NCT03933826|566639149|FG000|Overall Study|Lost to Follow-up|41|||
156969140|NCT03933826|566639150|FG001|Overall Study|Lost to Follow-up|13|||
156969141|NCT04992546|566639151|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
156969142|NCT04992546|566639151|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
156969143|NCT04992546|566639151|FG000|Open-Label Treatment Period|Adverse Event|3|||
156969144|NCT04992546|566639151|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
156969145|NCT03419364|566639155|FG000|Overall Study|Delivery due to maternal condition|2|||
156969146|NCT03419364|566639156|FG001|Overall Study|Delivery due to maternal condition|0|||
156969147|NCT03419364|566639157|FG002|Overall Study|Delivery due to maternal condition|0|||
156969148|NCT03188055|566639161|FG000|Overall Study|Unavailable for training|0|||
156969149|NCT03188055|566639162|FG001|Overall Study|Unavailable for training|0|||
156969150|NCT03188055|566639163|FG002|Overall Study|Unavailable for training|19|||
157045703|NCT00667017|566922192|FG000|Overall Study|Withdrawal by Subject|1|||
157045704|NCT01848483|566922193|FG000|Overall Study|Death|2|||
157045705|NCT01848483|566922194|FG001|Overall Study|Death|1|||
157045706|NCT01848483|566922193|FG000|Overall Study|Lost to Follow-up|6|||
157045707|NCT01848483|566922194|FG001|Overall Study|Lost to Follow-up|8|||
157045708|NCT01848483|566922193|FG000|Overall Study|Withdrawal by Subject|1|||
157045709|NCT01848483|566922194|FG001|Overall Study|Withdrawal by Subject|0|||
157045710|NCT01848483|566922193|FG000|Overall Study|Incarceration|2|||
157045711|NCT01848483|566922194|FG001|Overall Study|Incarceration|2|||
157045712|NCT00246129|566922199|FG000|Overall Study|Lost to Follow-up|1|||
157045713|NCT00246129|566922200|FG001|Overall Study|Lost to Follow-up|0|||
157045714|NCT00246129|566922199|FG000|Overall Study|Death|2|||
157045715|NCT00246129|566922200|FG001|Overall Study|Death|1|||
157045716|NCT00246129|566922199|FG000|Overall Study|suffered primary non-function|1|||
157045717|NCT00246129|566922200|FG001|Overall Study|suffered primary non-function|0|||
157045718|NCT00246129|566922199|FG000|Overall Study|grafts failed|3|||
157045719|NCT00246129|566922200|FG001|Overall Study|grafts failed|1|||
157045720|NCT03469258|566922201|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
157045721|NCT02202317|566922207|FG000|Overall Study|Lost to Follow-up|1|||
157045722|NCT03403036|566922208|FG000|Overall Study|Lack of Efficacy|5|||
157045723|NCT01353274|566922209|FG000|Overall Study|No case report form (CRF) collected|28|||
157045724|NCT01128959|566922210|FG000|Lead in Period|Adverse Event|3|||
157045725|NCT01128959|566922210|FG000|Treatment Period|Adverse Event|3|||
157045726|NCT01128959|566922210|FG000|Treatment Period|Withdrawal by Subject|1|||
157045727|NCT02338999|566922211|FG000|First Intervention|Withdrawal by Subject|3|||
157045728|NCT02338999|566922212|FG001|First Intervention|Withdrawal by Subject|1|||
157045729|NCT02338999|566922211|FG000|Washout Period|Withdrawal by Subject|0|||
157045730|NCT02338999|566922212|FG001|Washout Period|Withdrawal by Subject|2|||
157045731|NCT02338999|566922211|FG000|Second Intervention|Withdrawal by Subject|0|||
157045732|NCT02338999|566922212|FG001|Second Intervention|Withdrawal by Subject|2|||
157045733|NCT03851094|566922213|FG000|Overall Study|Withdrawal by Subject|0|||
157045734|NCT03851094|566922214|FG001|Overall Study|Withdrawal by Subject|1|||
157045735|NCT03851094|566922213|FG000|Overall Study|Participant lost device|0|||
157045736|NCT03851094|566922214|FG001|Overall Study|Participant lost device|1|||
157045737|NCT03851094|566922213|FG000|Overall Study|Participant returned device|0|||
157045738|NCT03851094|566922214|FG001|Overall Study|Participant returned device|2|||
157045739|NCT04658784|566922215|FG000|6-month Follow-up|Lost to Follow-up|2|||
157045740|NCT04658784|566922216|FG001|6-month Follow-up|Lost to Follow-up|5|||
157045741|NCT02392507|566922217|FG000|Induction Regimen|Death|3|||
157045742|NCT02392507|566922217|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
157045743|NCT02392507|566922217|FG000|Induction Regimen|Physician Decision|1|||
157045744|NCT02392507|566922217|FG000|Induction Regimen|Withdrawal by Subject|2|||
157045745|NCT02392507|566922217|FG000|Maintenance Regimen|Death|1|||
157045746|NCT02392507|566922217|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
157045747|NCT01951703|566922218|FG000|First Intervention|Withdrawal by Subject|1|||
157045748|NCT01951703|566922219|FG001|First Intervention|Withdrawal by Subject|0|||
157045749|NCT01951703|566922218|FG000|First Intervention|Subject was not compliant|1|||
157045750|NCT01951703|566922219|FG001|First Intervention|Subject was not compliant|1|||
157045751|NCT01951703|566922218|FG000|First Intervention|Physician Decision|1|||
157045752|NCT01951703|566922219|FG001|First Intervention|Physician Decision|0|||
157045753|NCT01951703|566922218|FG000|Second Intervention|Protocol Violation|0|||
157045754|NCT01951703|566922219|FG001|Second Intervention|Protocol Violation|1|||
157045755|NCT01951703|566922218|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
157174755|NCT01938001|567379872|FG001|Treatment|Progressive Disease|54|||
157174756|NCT01938001|567379871|FG000|Treatment|Withdrawal by Subject|13|||
157174757|NCT01938001|567379872|FG001|Treatment|Withdrawal by Subject|7|||
157174758|NCT01938001|567379871|FG000|Treatment|Other reasons|2|||
156969151|NCT03188055|566639164|FG003|Overall Study|Unavailable for training|0|||
156969152|NCT03188055|566639165|FG004|Overall Study|Unavailable for training|0|||
156969153|NCT03188055|566639166|FG005|Overall Study|Unavailable for training|0|||
156969154|NCT03188055|566639161|FG000|Overall Study|Lost to Follow-up|0|||
156969155|NCT03188055|566639162|FG001|Overall Study|Lost to Follow-up|18|||
156969156|NCT03188055|566639163|FG002|Overall Study|Lost to Follow-up|0|||
156969157|NCT03188055|566639164|FG003|Overall Study|Lost to Follow-up|11|||
156969158|NCT03188055|566639165|FG004|Overall Study|Lost to Follow-up|0|||
156969159|NCT03188055|566639166|FG005|Overall Study|Lost to Follow-up|0|||
156969160|NCT03188055|566639161|FG000|Overall Study|Withdrawal by Subject|0|||
156969161|NCT03188055|566639162|FG001|Overall Study|Withdrawal by Subject|1|||
156969162|NCT03188055|566639163|FG002|Overall Study|Withdrawal by Subject|0|||
156969163|NCT03188055|566639164|FG003|Overall Study|Withdrawal by Subject|1|||
156969164|NCT03188055|566639165|FG004|Overall Study|Withdrawal by Subject|0|||
156969165|NCT03188055|566639166|FG005|Overall Study|Withdrawal by Subject|0|||
156969166|NCT03657277|566639167|FG000|Overall Study|Physician Decision|2|||
156969167|NCT03657277|566639167|FG000|Overall Study|Lost to Follow-up|1|||
157045756|NCT01951703|566922219|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
157045757|NCT02007070|566922220|FG000|Overall Study|Adverse Event|4|||
156969168|NCT03657277|566639167|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
157045758|NCT02007070|566922220|FG000|Overall Study|Clinical Progression|4|||
157045759|NCT02007070|566922220|FG000|Overall Study|Death|1|||
157045760|NCT02007070|566922220|FG000|Overall Study|Protocol Violation|2|||
157045761|NCT02007070|566922220|FG000|Overall Study|Physician Decision|1|||
157045762|NCT02007070|566922220|FG000|Overall Study|Progressive Disease|21|||
157045763|NCT03128099|566922223|FG000|Overall Study|High dose task was too long|0|||
157045764|NCT03128099|566922224|FG001|Overall Study|High dose task was too long|4|||
157045765|NCT03128099|566922225|FG002|Overall Study|High dose task was too long|0|||
157045766|NCT03128099|566922223|FG000|Overall Study|Participant got a full time job.|1|||
157045767|NCT03128099|566922224|FG001|Overall Study|Participant got a full time job.|0|||
157045768|NCT03128099|566922225|FG002|Overall Study|Participant got a full time job.|0|||
157045769|NCT03128099|566922223|FG000|Overall Study|Became homeless and lost contact|1|||
157045770|NCT03128099|566922224|FG001|Overall Study|Became homeless and lost contact|0|||
157045771|NCT03128099|566922225|FG002|Overall Study|Became homeless and lost contact|0|||
157045772|NCT03128099|566922223|FG000|Overall Study|Did not complete all the assessments|0|||
157045773|NCT03128099|566922224|FG001|Overall Study|Did not complete all the assessments|0|||
157045774|NCT03128099|566922225|FG002|Overall Study|Did not complete all the assessments|1|||
157045775|NCT02362789|566922235|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
157045776|NCT02362789|566922236|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
157045777|NCT02362789|566922237|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
157045778|NCT02362789|566922235|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
157045779|NCT02362789|566922236|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
157045780|NCT02362789|566922237|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
157045781|NCT02362789|566922235|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
157045782|NCT02362789|566922236|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
157045783|NCT02362789|566922237|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
157045784|NCT02362789|566922235|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
157045785|NCT02362789|566922236|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
157045786|NCT02362789|566922237|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
157045787|NCT02362789|566922235|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
157045788|NCT02362789|566922236|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
157045789|NCT02362789|566922237|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
157045790|NCT04397263|566922241|FG000|Overall Study|Withdrawal by Subject|2|||
157045791|NCT02251652|566922242|FG000|Overall Study|Withdrawal by Subject|1|||
157045792|NCT05169684|566922244|FG000|Overall Study|Adverse Event|1|||
157045793|NCT05169684|566922245|FG001|Overall Study|Adverse Event|3|||
157045794|NCT05169684|566922244|FG000|Overall Study|Physician Decision|0|||
157045795|NCT05169684|566922245|FG001|Overall Study|Physician Decision|1|||
157045796|NCT05169684|566922244|FG000|Overall Study|Progressive Disease|1|||
157045797|NCT05169684|566922245|FG001|Overall Study|Progressive Disease|1|||
157045798|NCT05169684|566922244|FG000|Overall Study|Participant request to discontinue treatment|0|||
157045799|NCT05169684|566922245|FG001|Overall Study|Participant request to discontinue treatment|1|||
157045800|NCT05169684|566922244|FG000|Overall Study|Other Reason|0|||
157045801|NCT05169684|566922245|FG001|Overall Study|Other Reason|1|||
157045802|NCT03539055|566922246|FG000|Overall Study|Death|4|||
157045803|NCT03539055|566922246|FG000|Overall Study|Lost to Follow-up|1|||
157045804|NCT03539055|566922246|FG000|Overall Study|Withdrawal by Subject|2|||
157045805|NCT03539055|566922246|FG000|Overall Study|Screen Fail|7|||
157045806|NCT03539055|566922246|FG000|Overall Study|Drug Intolerance|2|||
157045807|NCT05484661|566922253|FG000|Overall Study|Withdrawal by Subject|1|||
157045808|NCT05484661|566922254|FG001|Overall Study|Withdrawal by Subject|0|||
157045809|NCT03205488|566922260|FG000|Overall Study|Adverse Event|1|||
157045810|NCT03205488|566922261|FG001|Overall Study|Adverse Event|2|||
157045811|NCT03205488|566922262|FG002|Overall Study|Adverse Event|4|||
157045812|NCT03205488|566922260|FG000|Overall Study|Protocol Violation|0|||
157045813|NCT03205488|566922261|FG001|Overall Study|Protocol Violation|0|||
157045814|NCT03205488|566922262|FG002|Overall Study|Protocol Violation|1|||
157045815|NCT03775213|566922263|FG000|Overall Study|Withdrawal by Subject|51|||
157045816|NCT03775213|566922264|FG001|Overall Study|Withdrawal by Subject|53|||
157045817|NCT03775213|566922263|FG000|Overall Study|Incomplete Survey|7|||
157045818|NCT03775213|566922264|FG001|Overall Study|Incomplete Survey|7|||
157045819|NCT04748341|566922268|FG000|Overall Study|Lost to Follow-up|1|||
157045820|NCT04748341|566922269|FG001|Overall Study|Lost to Follow-up|1|||
157045821|NCT05615363|566922270|FG000|Overall Study|Adverse Event|0|||
157045822|NCT05615363|566922271|FG001|Overall Study|Adverse Event|4|||
157045823|NCT05615363|566922272|FG002|Overall Study|Adverse Event|4|||
157045824|NCT05615363|566922273|FG003|Overall Study|Adverse Event|3|||
157045825|NCT05615363|566922274|FG004|Overall Study|Adverse Event|1|||
157045826|NCT05615363|566922270|FG000|Overall Study|Physician Decision|2|||
157045827|NCT05615363|566922271|FG001|Overall Study|Physician Decision|0|||
157045828|NCT05615363|566922272|FG002|Overall Study|Physician Decision|4|||
157045829|NCT05615363|566922273|FG003|Overall Study|Physician Decision|1|||
157045830|NCT05615363|566922274|FG004|Overall Study|Physician Decision|3|||
157045831|NCT05615363|566922270|FG000|Overall Study|Protocol Violation|2|||
157045832|NCT05615363|566922271|FG001|Overall Study|Protocol Violation|0|||
157045833|NCT05615363|566922272|FG002|Overall Study|Protocol Violation|0|||
157045834|NCT05615363|566922273|FG003|Overall Study|Protocol Violation|0|||
157045835|NCT05615363|566922274|FG004|Overall Study|Protocol Violation|1|||
157045836|NCT05615363|566922270|FG000|Overall Study|Withdrawal by Subject|0|||
157045837|NCT05615363|566922271|FG001|Overall Study|Withdrawal by Subject|0|||
157045838|NCT05615363|566922272|FG002|Overall Study|Withdrawal by Subject|1|||
157045839|NCT05615363|566922273|FG003|Overall Study|Withdrawal by Subject|0|||
157045840|NCT05615363|566922274|FG004|Overall Study|Withdrawal by Subject|0|||
157045841|NCT02159989|566922275|FG000|Overall Study|Adverse Event|1|||
157045842|NCT02159989|566922276|FG001|Overall Study|Adverse Event|0|||
157045843|NCT02159989|566922277|FG002|Overall Study|Adverse Event|0|||
157045844|NCT02159989|566922278|FG003|Overall Study|Adverse Event|0|||
157045845|NCT02159989|566922279|FG004|Overall Study|Adverse Event|1|||
157045846|NCT02159989|566922280|FG005|Overall Study|Adverse Event|0|||
157045847|NCT02159989|566922281|FG006|Overall Study|Adverse Event|1|||
157045848|NCT02159989|566922282|FG007|Overall Study|Adverse Event|2|||
157045849|NCT02159989|566922283|FG008|Overall Study|Adverse Event|0|||
157045850|NCT02159989|566922284|FG009|Overall Study|Adverse Event|2|||
157045851|NCT02159989|566922285|FG010|Overall Study|Adverse Event|1|||
157045852|NCT02159989|566922275|FG000|Overall Study|Death|0|||
157045853|NCT02159989|566922276|FG001|Overall Study|Death|0|||
157045854|NCT02159989|566922277|FG002|Overall Study|Death|0|||
157045855|NCT02159989|566922278|FG003|Overall Study|Death|0|||
157045856|NCT02159989|566922279|FG004|Overall Study|Death|0|||
157045857|NCT02159989|566922280|FG005|Overall Study|Death|0|||
157045858|NCT02159989|566922281|FG006|Overall Study|Death|0|||
157045859|NCT02159989|566922282|FG007|Overall Study|Death|0|||
157045860|NCT02159989|566922283|FG008|Overall Study|Death|0|||
157045861|NCT02159989|566922284|FG009|Overall Study|Death|0|||
157045862|NCT02159989|566922285|FG010|Overall Study|Death|1|||
157045863|NCT02159989|566922275|FG000|Overall Study|Lack of Efficacy|2|||
157045864|NCT02159989|566922276|FG001|Overall Study|Lack of Efficacy|3|||
157045865|NCT02159989|566922277|FG002|Overall Study|Lack of Efficacy|3|||
157045866|NCT02159989|566922278|FG003|Overall Study|Lack of Efficacy|0|||
157045867|NCT02159989|566922279|FG004|Overall Study|Lack of Efficacy|2|||
157045868|NCT02159989|566922280|FG005|Overall Study|Lack of Efficacy|3|||
157045869|NCT02159989|566922281|FG006|Overall Study|Lack of Efficacy|3|||
157045870|NCT02159989|566922282|FG007|Overall Study|Lack of Efficacy|1|||
157045871|NCT02159989|566922283|FG008|Overall Study|Lack of Efficacy|3|||
157045872|NCT02159989|566922284|FG009|Overall Study|Lack of Efficacy|6|||
157045873|NCT02159989|566922285|FG010|Overall Study|Lack of Efficacy|7|||
157045874|NCT02159989|566922275|FG000|Overall Study|Lost to Follow-up|0|||
157045875|NCT02159989|566922276|FG001|Overall Study|Lost to Follow-up|0|||
157045876|NCT02159989|566922277|FG002|Overall Study|Lost to Follow-up|0|||
157045877|NCT02159989|566922278|FG003|Overall Study|Lost to Follow-up|1|||
157045878|NCT02159989|566922279|FG004|Overall Study|Lost to Follow-up|0|||
157045879|NCT02159989|566922280|FG005|Overall Study|Lost to Follow-up|0|||
157045880|NCT02159989|566922281|FG006|Overall Study|Lost to Follow-up|0|||
157045881|NCT02159989|566922282|FG007|Overall Study|Lost to Follow-up|0|||
157045882|NCT02159989|566922283|FG008|Overall Study|Lost to Follow-up|0|||
157045883|NCT02159989|566922284|FG009|Overall Study|Lost to Follow-up|0|||
157045884|NCT02159989|566922285|FG010|Overall Study|Lost to Follow-up|1|||
157045885|NCT02159989|566922275|FG000|Overall Study|Withdrawal by Subject|2|||
157045886|NCT02159989|566922276|FG001|Overall Study|Withdrawal by Subject|0|||
157045887|NCT02159989|566922277|FG002|Overall Study|Withdrawal by Subject|0|||
157045888|NCT02159989|566922278|FG003|Overall Study|Withdrawal by Subject|2|||
157045889|NCT02159989|566922279|FG004|Overall Study|Withdrawal by Subject|1|||
157045890|NCT02159989|566922280|FG005|Overall Study|Withdrawal by Subject|0|||
157045891|NCT02159989|566922281|FG006|Overall Study|Withdrawal by Subject|3|||
157045892|NCT02159989|566922282|FG007|Overall Study|Withdrawal by Subject|1|||
157045893|NCT02159989|566922283|FG008|Overall Study|Withdrawal by Subject|0|||
157045894|NCT02159989|566922284|FG009|Overall Study|Withdrawal by Subject|0|||
157045895|NCT02159989|566922285|FG010|Overall Study|Withdrawal by Subject|0|||
157045896|NCT02159989|566922275|FG000|Overall Study|New treatment|0|||
157045897|NCT02159989|566922276|FG001|Overall Study|New treatment|1|||
157045898|NCT02159989|566922277|FG002|Overall Study|New treatment|0|||
157045899|NCT02159989|566922278|FG003|Overall Study|New treatment|0|||
157045900|NCT02159989|566922279|FG004|Overall Study|New treatment|0|||
157045901|NCT02159989|566922280|FG005|Overall Study|New treatment|0|||
157045902|NCT02159989|566922281|FG006|Overall Study|New treatment|0|||
157045903|NCT02159989|566922282|FG007|Overall Study|New treatment|0|||
157045904|NCT02159989|566922283|FG008|Overall Study|New treatment|0|||
157045905|NCT02159989|566922284|FG009|Overall Study|New treatment|0|||
157045906|NCT02159989|566922285|FG010|Overall Study|New treatment|0|||
157045907|NCT02159989|566922275|FG000|Overall Study|Insurance Issues|0|||
157045908|NCT02159989|566922276|FG001|Overall Study|Insurance Issues|0|||
157045909|NCT02159989|566922277|FG002|Overall Study|Insurance Issues|0|||
157045910|NCT02159989|566922278|FG003|Overall Study|Insurance Issues|0|||
157045911|NCT02159989|566922279|FG004|Overall Study|Insurance Issues|0|||
157045912|NCT02159989|566922280|FG005|Overall Study|Insurance Issues|0|||
157045913|NCT02159989|566922281|FG006|Overall Study|Insurance Issues|0|||
157045914|NCT02159989|566922282|FG007|Overall Study|Insurance Issues|0|||
157045915|NCT02159989|566922283|FG008|Overall Study|Insurance Issues|0|||
157045916|NCT02159989|566922284|FG009|Overall Study|Insurance Issues|1|||
157045917|NCT02159989|566922285|FG010|Overall Study|Insurance Issues|0|||
157045918|NCT01719172|566923971|FG000|Overall Study|Lost to Follow-up|1|||
157045919|NCT01719172|566923971|FG000|Overall Study|Death|1|||
157045920|NCT03041090|566923972|FG000|Overall Study|technical error|0|||
157045921|NCT03041090|566923973|FG001|Overall Study|technical error|3|||
157045922|NCT02701296|566923974|FG000|Overall Study|Incomplete Data|0|||
157045923|NCT02701296|566923975|FG001|Overall Study|Incomplete Data|2|||
157045924|NCT00484198|566923977|FG000|Overall Study|Participant Withdrew Consent|12|||
157045925|NCT00484198|566923978|FG001|Overall Study|Participant Withdrew Consent|21|||
157045926|NCT00484198|566923979|FG002|Overall Study|Participant Withdrew Consent|47|||
157045927|NCT00484198|566923980|FG003|Overall Study|Participant Withdrew Consent|59|||
157045928|NCT00484198|566923977|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
157045929|NCT00484198|566923978|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
157045930|NCT00484198|566923979|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
157045931|NCT00484198|566923980|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
157045932|NCT00484198|566923977|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
157045933|NCT00484198|566923978|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
157045934|NCT00484198|566923979|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
157045935|NCT00484198|566923980|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
157045936|NCT00484198|566923977|FG000|Overall Study|Adverse Event|3|||
157045937|NCT00484198|566923978|FG001|Overall Study|Adverse Event|11|||
157045938|NCT00484198|566923979|FG002|Overall Study|Adverse Event|32|||
157045939|NCT00484198|566923980|FG003|Overall Study|Adverse Event|31|||
157045940|NCT00484198|566923977|FG000|Overall Study|Protocol Violation|0|||
157045941|NCT00484198|566923978|FG001|Overall Study|Protocol Violation|5|||
157045942|NCT00484198|566923979|FG002|Overall Study|Protocol Violation|6|||
157045943|NCT00484198|566923980|FG003|Overall Study|Protocol Violation|8|||
157045944|NCT00484198|566923977|FG000|Overall Study|Other|7|||
157045945|NCT00484198|566923978|FG001|Overall Study|Other|10|||
157045946|NCT00484198|566923979|FG002|Overall Study|Other|31|||
157045947|NCT00484198|566923980|FG003|Overall Study|Other|28|||
157045948|NCT02958553|566923981|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
157045949|NCT02958553|566923981|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
157045950|NCT01802333|566923991|FG000|Overall Study|Ineligible|2|||
157045951|NCT01802333|566923992|FG001|Overall Study|Ineligible|6|||
157045952|NCT01802333|566923993|FG002|Overall Study|Ineligible|8|||
157045953|NCT01802333|566923991|FG000|Overall Study|Adverse Event|1|||
157045954|NCT01802333|566923992|FG001|Overall Study|Adverse Event|8|||
157045955|NCT01802333|566923993|FG002|Overall Study|Adverse Event|8|||
157045956|NCT01802333|566923991|FG000|Overall Study|Withdrawal by Subject|6|||
157045957|NCT01802333|566923992|FG001|Overall Study|Withdrawal by Subject|6|||
157045958|NCT01802333|566923993|FG002|Overall Study|Withdrawal by Subject|5|||
157045959|NCT01802333|566923991|FG000|Overall Study|Progression/relapse|1|||
157045960|NCT01802333|566923992|FG001|Overall Study|Progression/relapse|3|||
157045961|NCT01802333|566923993|FG002|Overall Study|Progression/relapse|0|||
157045962|NCT01802333|566923991|FG000|Overall Study|Death|7|||
157045963|NCT01802333|566923992|FG001|Overall Study|Death|14|||
157045964|NCT01802333|566923993|FG002|Overall Study|Death|13|||
157045965|NCT01802333|566923991|FG000|Overall Study|Other - not protocol specified|32|||
157045966|NCT01802333|566923992|FG001|Overall Study|Other - not protocol specified|22|||
157045967|NCT01802333|566923993|FG002|Overall Study|Other - not protocol specified|24|||
157045968|NCT01802333|566923991|FG000|Overall Study|Did not start treatment|0|||
157045969|NCT01802333|566923992|FG001|Overall Study|Did not start treatment|2|||
157045970|NCT01802333|566923993|FG002|Overall Study|Did not start treatment|5|||
157045971|NCT02224755|566923995|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
157045972|NCT02224755|566923996|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
157045973|NCT02224755|566923995|FG000|Two Year Follow up Post-implant|Death|103|||
157045974|NCT02224755|566923996|FG001|Two Year Follow up Post-implant|Death|98|||
157045975|NCT02224755|566923995|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
157045976|NCT02224755|566923996|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
157045977|NCT02224755|566923995|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
157045978|NCT02224755|566923996|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
157045979|NCT02224755|566923995|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
157045980|NCT02224755|566923996|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
157045981|NCT00704340|566923997|FG000|Overall Study|Lost to Follow-up|2|||
157045982|NCT00704340|566923998|FG001|Overall Study|Lost to Follow-up|1|||
157045983|NCT00704340|566923997|FG000|Overall Study|Death|0|||
157045984|NCT00704340|566923998|FG001|Overall Study|Death|1|||
157045985|NCT01019135|566924004|FG000|Overall Study|Did not receive allocated intervention|12|||
157045986|NCT01019135|566924005|FG001|Overall Study|Did not receive allocated intervention|6|||
157045987|NCT01019135|566924006|FG002|Overall Study|Did not receive allocated intervention|25|||
157045988|NCT01019135|566924004|FG000|Overall Study|Did not attend CR|8|||
157045989|NCT01019135|566924005|FG001|Overall Study|Did not attend CR|13|||
157045990|NCT01019135|566924006|FG002|Overall Study|Did not attend CR|6|||
157045991|NCT05124210|566924007|FG000|Overall Study|Lost to Follow-up|1|||
157045992|NCT05124210|566924008|FG001|Overall Study|Lost to Follow-up|0|||
157045993|NCT05124210|566924007|FG000|Overall Study|Withdrawal by Subject|1|||
157045994|NCT05124210|566924008|FG001|Overall Study|Withdrawal by Subject|0|||
157045995|NCT00638456|566924010|FG000|Overall Study|Withdrawal by Subject|6|||
157045996|NCT00638456|566924011|FG001|Overall Study|Withdrawal by Subject|2|||
157045997|NCT00403845|566924015|FG000|Treatment Period 1|Subject withdrew consent|1|||
157045998|NCT00403845|566924016|FG001|Treatment Period 1|Subject withdrew consent|0|||
157045999|NCT00403845|566924017|FG002|Treatment Period 1|Subject withdrew consent|0|||
157046000|NCT00403845|566924018|FG003|Treatment Period 1|Subject withdrew consent|0|||
157046001|NCT00403845|566924015|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
157046002|NCT00403845|566924016|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
157046003|NCT00403845|566924017|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
157046004|NCT00403845|566924018|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
157046005|NCT00403845|566924015|FG000|Treatment Period 2|Subject withdrew consent|1|||
157046006|NCT00403845|566924016|FG001|Treatment Period 2|Subject withdrew consent|0|||
157046007|NCT00403845|566924017|FG002|Treatment Period 2|Subject withdrew consent|0|||
157046008|NCT00403845|566924018|FG003|Treatment Period 2|Subject withdrew consent|0|||
157046009|NCT00403845|566924015|FG000|Treatment Period 3|Subject withdrew consent|0|||
157046010|NCT00403845|566924016|FG001|Treatment Period 3|Subject withdrew consent|0|||
157046011|NCT00403845|566924017|FG002|Treatment Period 3|Subject withdrew consent|0|||
157046012|NCT00403845|566924018|FG003|Treatment Period 3|Subject withdrew consent|1|||
157046013|NCT00403845|566924015|FG000|Treatment Period 3|Adverse Event|0|||
157046014|NCT00403845|566924016|FG001|Treatment Period 3|Adverse Event|0|||
157046015|NCT00403845|566924017|FG002|Treatment Period 3|Adverse Event|0|||
157046016|NCT00403845|566924018|FG003|Treatment Period 3|Adverse Event|1|||
157046017|NCT00624377|566924021|FG000|Overall Study|Lost to Follow-up|355|||
157046018|NCT00624377|566924021|FG000|Overall Study|Withdrawal by Subject|100|||
157046019|NCT00624377|566924021|FG000|Overall Study|Adverse Event|14|||
157046020|NCT00624377|566924021|FG000|Overall Study|Other|91|||
157046021|NCT00624377|566924021|FG000|Overall Study|Non-evaluable population|84|||
157046022|NCT00148122|566924023|FG000|Overall Study|Withdrawal by Subject|2|||
157046023|NCT05074433|566924025|FG000|Overall Study|Adverse Event|0|||
157046024|NCT05074433|566924026|FG001|Overall Study|Adverse Event|2|||
157046025|NCT05074433|566924027|FG002|Overall Study|Adverse Event|0|||
157046026|NCT05074433|566924028|FG003|Overall Study|Adverse Event|1|||
157046027|NCT05074433|566924025|FG000|Overall Study|Sponsor Request|0|||
157046028|NCT05074433|566924026|FG001|Overall Study|Sponsor Request|1|||
157046029|NCT05074433|566924027|FG002|Overall Study|Sponsor Request|1|||
157046030|NCT05074433|566924028|FG003|Overall Study|Sponsor Request|0|||
157046031|NCT05074433|566924025|FG000|Overall Study|Death|1|||
157046032|NCT05074433|566924026|FG001|Overall Study|Death|0|||
157046033|NCT05074433|566924027|FG002|Overall Study|Death|0|||
157046034|NCT05074433|566924028|FG003|Overall Study|Death|0|||
157046035|NCT05074433|566924025|FG000|Overall Study|Lost to Follow-up|0|||
157046036|NCT05074433|566924026|FG001|Overall Study|Lost to Follow-up|0|||
157046037|NCT05074433|566924027|FG002|Overall Study|Lost to Follow-up|2|||
157046038|NCT05074433|566924028|FG003|Overall Study|Lost to Follow-up|0|||
157046039|NCT05074433|566924025|FG000|Overall Study|Subject Decision|8|||
157046040|NCT05074433|566924026|FG001|Overall Study|Subject Decision|6|||
157046041|NCT05074433|566924027|FG002|Overall Study|Subject Decision|4|||
157046042|NCT05074433|566924028|FG003|Overall Study|Subject Decision|5|||
157046043|NCT04492475|566924029|FG000|Overall Study|Enrolled but not treated|8|||
157046044|NCT04492475|566924030|FG001|Overall Study|Enrolled but not treated|8|||
157046045|NCT04492475|566924029|FG000|Overall Study|Withdrawal by Subject|4|||
157046046|NCT04492475|566924030|FG001|Overall Study|Withdrawal by Subject|0|||
157046047|NCT04492475|566924029|FG000|Overall Study|Became ineligible after enrollment|2|||
157046048|NCT04492475|566924030|FG001|Overall Study|Became ineligible after enrollment|0|||
157046049|NCT02066636|566924031|FG000|Overall Study|Disease progression|51|||
157046050|NCT02066636|566924032|FG001|Overall Study|Disease progression|60|||
157046051|NCT02066636|566924033|FG002|Overall Study|Disease progression|700|||
157046052|NCT02066636|566924031|FG000|Overall Study|Study drug toxicity|13|||
157046053|NCT02066636|566924032|FG001|Overall Study|Study drug toxicity|2|||
157046054|NCT02066636|566924033|FG002|Overall Study|Study drug toxicity|58|||
157046055|NCT02066636|566924031|FG000|Overall Study|Death|4|||
157046056|NCT02066636|566924032|FG001|Overall Study|Death|2|||
157046057|NCT02066636|566924033|FG002|Overall Study|Death|158|||
157046058|NCT02066636|566924031|FG000|Overall Study|Adverse event unrelated to study drug|6|||
157046059|NCT02066636|566924032|FG001|Overall Study|Adverse event unrelated to study drug|4|||
157046060|NCT02066636|566924033|FG002|Overall Study|Adverse event unrelated to study drug|45|||
157046061|NCT02066636|566924031|FG000|Overall Study|Participant request to discontinue treatment|12|||
157046062|NCT02066636|566924032|FG001|Overall Study|Participant request to discontinue treatment|12|||
157046063|NCT02066636|566924033|FG002|Overall Study|Participant request to discontinue treatment|70|||
157046064|NCT02066636|566924031|FG000|Overall Study|Participant withdrew consent|10|||
157174759|NCT01938001|567379872|FG001|Treatment|Other reasons|1|||
157174760|NCT02983799|567379880|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
156969169|NCT01024608|566639170|FG000|Overall Study|Adverse Event|1|||
156969170|NCT01024608|566639171|FG001|Overall Study|Adverse Event|0|||
156969171|NCT01024608|566639170|FG000|Overall Study|Withdrawal by Subject|1|||
156969172|NCT01024608|566639171|FG001|Overall Study|Withdrawal by Subject|0|||
156969173|NCT01024608|566639170|FG000|Overall Study|Lost to Follow-up|0|||
156969174|NCT01024608|566639171|FG001|Overall Study|Lost to Follow-up|1|||
156969175|NCT01024608|566639170|FG000|Overall Study|Protocol Violation|0|||
156969176|NCT01024608|566639171|FG001|Overall Study|Protocol Violation|3|||
156969177|NCT01024608|566639170|FG000|Overall Study|Never received study treatment|2|||
156969178|NCT01024608|566639171|FG001|Overall Study|Never received study treatment|0|||
156969179|NCT04349280|566639172|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
156969180|NCT04349280|566639173|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
156969181|NCT04349280|566639172|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
156969182|NCT04349280|566639173|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
156969183|NCT04349280|566639172|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
156969184|NCT04349280|566639173|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
156969185|NCT00657618|566639176|FG000|Overall Study|Adverse Event|32|||
156969186|NCT00657618|566639176|FG000|Overall Study|Withdrawal by Subject|8|||
156969187|NCT00657618|566639176|FG000|Overall Study|negative for leishmaniasis|2|||
156969188|NCT00657618|566639176|FG000|Overall Study|didn't start due to schedule conflicts|1|||
156969189|NCT01659151|566639177|FG000|Overall Study|Inadequate TIL growth|1|||
156969190|NCT05774197|566639178|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
156969191|NCT06223373|566639181|FG000|Overall Study|Lost to Follow-up|1|||
156969192|NCT06223373|566639182|FG001|Overall Study|Lost to Follow-up|2|||
156969193|NCT01370525|566640899|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
156969194|NCT01370525|566640900|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
156969195|NCT01370525|566640899|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
156969196|NCT01370525|566640900|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
156969197|NCT01370525|566640899|FG000|Overall Study|Adverse Event|0|||
156969198|NCT01370525|566640900|FG001|Overall Study|Adverse Event|1|||
156969199|NCT01370525|566640899|FG000|Overall Study|Protocol Violation|2|||
156969200|NCT01370525|566640900|FG001|Overall Study|Protocol Violation|1|||
156969201|NCT01370525|566640899|FG000|Overall Study|Lost to follow up|2|||
156969202|NCT01370525|566640900|FG001|Overall Study|Lost to follow up|6|||
156969203|NCT04791761|566640901|FG000|Overall Study|Lost to Follow-up|8|||
156969204|NCT04791761|566640902|FG001|Overall Study|Lost to Follow-up|6|||
156969205|NCT04791761|566640903|FG002|Overall Study|Lost to Follow-up|10|||
156969206|NCT04791761|566640901|FG000|Overall Study|Withdrawal by Subject|0|||
156969207|NCT04791761|566640902|FG001|Overall Study|Withdrawal by Subject|1|||
156969208|NCT04791761|566640903|FG002|Overall Study|Withdrawal by Subject|1|||
156969209|NCT04791761|566640901|FG000|Overall Study|Protocol Violation|0|||
156969210|NCT04791761|566640902|FG001|Overall Study|Protocol Violation|1|||
156969211|NCT04791761|566640903|FG002|Overall Study|Protocol Violation|1|||
156969212|NCT02940574|566640906|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
156969213|NCT02940574|566640907|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
156969214|NCT02940574|566640906|FG000|1-year Follow-up|Lost to Follow-up|3|||
156969215|NCT02940574|566640907|FG001|1-year Follow-up|Lost to Follow-up|4|||
156969216|NCT00520975|566640908|FG000|Overall Study|Disease progression|31|||
156969217|NCT00520975|566640909|FG001|Overall Study|Disease progression|23|||
156969218|NCT00520975|566640908|FG000|Overall Study|Adverse Event|7|||
156969219|NCT00520975|566640909|FG001|Overall Study|Adverse Event|10|||
156969220|NCT00520975|566640908|FG000|Overall Study|Death|0|||
156969221|NCT00520975|566640909|FG001|Overall Study|Death|2|||
156969222|NCT00520975|566640908|FG000|Overall Study|Withdrawal by Subject|3|||
156969223|NCT00520975|566640909|FG001|Overall Study|Withdrawal by Subject|5|||
156969224|NCT00520975|566640908|FG000|Overall Study|Other therapy|2|||
156969225|NCT00520975|566640909|FG001|Overall Study|Other therapy|4|||
156969226|NCT00520975|566640908|FG000|Overall Study|Other reasons|4|||
156969227|NCT00520975|566640909|FG001|Overall Study|Other reasons|2|||
156969228|NCT00520975|566640908|FG000|Overall Study|Not start protocol therapy|1|||
156969229|NCT00520975|566640909|FG001|Overall Study|Not start protocol therapy|2|||
156969230|NCT04810221|566640910|FG000|Overall Study|Physician Decision|3|||
156969231|NCT03642938|566640911|FG000|Overall Study|Withdrawal by Subject|0|||
156969232|NCT03642938|566640912|FG001|Overall Study|Withdrawal by Subject|0|||
156969233|NCT03642938|566640913|FG002|Overall Study|Withdrawal by Subject|0|||
156969234|NCT03642938|566640914|FG003|Overall Study|Withdrawal by Subject|1|||
156969235|NCT00642902|566640915|FG000|Overall Study|Adverse Event|0|||
156969236|NCT00642902|566640916|FG001|Overall Study|Adverse Event|1|||
156969237|NCT00642902|566640917|FG002|Overall Study|Adverse Event|3|||
156969238|NCT00642902|566640918|FG003|Overall Study|Adverse Event|1|||
156969239|NCT00642902|566640915|FG000|Overall Study|Lost to Follow-up|1|||
156969240|NCT00642902|566640916|FG001|Overall Study|Lost to Follow-up|1|||
156969241|NCT00642902|566640917|FG002|Overall Study|Lost to Follow-up|0|||
156969242|NCT00642902|566640918|FG003|Overall Study|Lost to Follow-up|0|||
156969243|NCT00642902|566640915|FG000|Overall Study|Lack of Efficacy|0|||
157174761|NCT02983799|567379881|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
157174762|NCT02983799|567379882|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
156969244|NCT00642902|566640916|FG001|Overall Study|Lack of Efficacy|3|||
157046065|NCT02066636|566924032|FG001|Overall Study|Participant withdrew consent|18|||
157046066|NCT02066636|566924033|FG002|Overall Study|Participant withdrew consent|61|||
157046067|NCT02066636|566924031|FG000|Overall Study|Lost to Follow-up|0|||
157046068|NCT02066636|566924032|FG001|Overall Study|Lost to Follow-up|2|||
157046069|NCT02066636|566924033|FG002|Overall Study|Lost to Follow-up|2|||
157046070|NCT02066636|566924031|FG000|Overall Study|Maximum clinical benefit|2|||
157046071|NCT02066636|566924032|FG001|Overall Study|Maximum clinical benefit|2|||
157046072|NCT02066636|566924033|FG002|Overall Study|Maximum clinical benefit|3|||
157046073|NCT02066636|566924031|FG000|Overall Study|Poor/non-compliance|2|||
157046074|NCT02066636|566924032|FG001|Overall Study|Poor/non-compliance|1|||
157046075|NCT02066636|566924033|FG002|Overall Study|Poor/non-compliance|1|||
157046076|NCT02066636|566924031|FG000|Overall Study|Participant no loner meets study criteria|3|||
157046077|NCT02066636|566924032|FG001|Overall Study|Participant no loner meets study criteria|2|||
157046078|NCT02066636|566924033|FG002|Overall Study|Participant no loner meets study criteria|28|||
157046079|NCT02066636|566924031|FG000|Overall Study|Administrative reasons by sponsor|8|||
157046080|NCT02066636|566924032|FG001|Overall Study|Administrative reasons by sponsor|5|||
157046081|NCT02066636|566924033|FG002|Overall Study|Administrative reasons by sponsor|0|||
157046082|NCT02066636|566924031|FG000|Overall Study|Other reasons|16|||
157046083|NCT02066636|566924032|FG001|Overall Study|Other reasons|15|||
157046084|NCT02066636|566924033|FG002|Overall Study|Other reasons|50|||
157046085|NCT00391170|566924034|FG000|Overall Study|Withdrawal by Subject|1|||
157046086|NCT00391170|566924035|FG001|Overall Study|Withdrawal by Subject|0|||
157046087|NCT00391170|566924034|FG000|Overall Study|Adverse Event|3|||
157046088|NCT00391170|566924035|FG001|Overall Study|Adverse Event|2|||
156969245|NCT00642902|566640917|FG002|Overall Study|Lack of Efficacy|3|||
156969246|NCT00642902|566640918|FG003|Overall Study|Lack of Efficacy|0|||
156969247|NCT00642902|566640915|FG000|Overall Study|Death|1|||
156969248|NCT00642902|566640916|FG001|Overall Study|Death|0|||
156969249|NCT00642902|566640917|FG002|Overall Study|Death|0|||
156969250|NCT00642902|566640918|FG003|Overall Study|Death|0|||
156969251|NCT00642902|566640915|FG000|Overall Study|Premature termination of clinical trial|37|||
156969252|NCT00642902|566640916|FG001|Overall Study|Premature termination of clinical trial|32|||
156969253|NCT00642902|566640917|FG002|Overall Study|Premature termination of clinical trial|35|||
156969254|NCT00642902|566640918|FG003|Overall Study|Premature termination of clinical trial|35|||
156969255|NCT00642902|566640915|FG000|Overall Study|Randomized, but not treated|0|||
156969256|NCT00642902|566640916|FG001|Overall Study|Randomized, but not treated|0|||
156969257|NCT00642902|566640917|FG002|Overall Study|Randomized, but not treated|1|||
156969258|NCT00642902|566640918|FG003|Overall Study|Randomized, but not treated|0|||
156969259|NCT00642902|566640915|FG000|Overall Study|Other|1|||
156969260|NCT00642902|566640916|FG001|Overall Study|Other|5|||
156969261|NCT00642902|566640917|FG002|Overall Study|Other|1|||
156969262|NCT00642902|566640918|FG003|Overall Study|Other|4|||
156969263|NCT02182973|566640921|FG000|Overall Study|Withdrawal by Subject|3|||
156969264|NCT02182973|566640922|FG001|Overall Study|Withdrawal by Subject|0|||
156969265|NCT00238433|566640923|FG000|Overall Study|Screen failure|1|||
156969266|NCT00238433|566640923|FG000|Overall Study|Lost to Follow-up|1|||
156969267|NCT00238433|566640923|FG000|Overall Study|Death|1|||
156969268|NCT01814748|566640924|FG000|Overall Study|Lost to Follow-up|1|||
156969269|NCT01814748|566640925|FG001|Overall Study|Lost to Follow-up|2|||
156969270|NCT01814748|566640924|FG000|Overall Study|Study site terminated by sponsor|1|||
156969271|NCT01814748|566640925|FG001|Overall Study|Study site terminated by sponsor|1|||
156969272|NCT01814748|566640924|FG000|Overall Study|Withdrawal by Subject|6|||
156969273|NCT01814748|566640925|FG001|Overall Study|Withdrawal by Subject|4|||
156969274|NCT01889186|566640926|FG000|Overall Study|Adverse event- not related to progression|18|||
156969275|NCT01889186|566640927|FG001|Overall Study|Adverse event- not related to progression|5|||
156969276|NCT01889186|566640926|FG000|Overall Study|Adverse event- related to progression|7|||
156969277|NCT01889186|566640927|FG001|Overall Study|Adverse event- related to progression|2|||
156969278|NCT01889186|566640926|FG000|Overall Study|COVID-19 logistical restrictions|1|||
156969279|NCT01889186|566640927|FG001|Overall Study|COVID-19 logistical restrictions|0|||
156969280|NCT01889186|566640926|FG000|Overall Study|Investigator request|1|||
156969281|NCT01889186|566640927|FG001|Overall Study|Investigator request|1|||
156969282|NCT01889186|566640926|FG000|Overall Study|Progressive disease- Richter's|12|||
156969283|NCT01889186|566640927|FG001|Overall Study|Progressive disease- Richter's|7|||
156969284|NCT01889186|566640926|FG000|Overall Study|Progressive disease per protocol|46|||
157046089|NCT00391170|566924034|FG000|Overall Study|Physician Decision|2|||
157046090|NCT00391170|566924035|FG001|Overall Study|Physician Decision|2|||
157046091|NCT03567616|566924038|FG000|Overall Study|Disease progression|4|||
157046092|NCT03567616|566924038|FG000|Overall Study|Withdrawal by Subject|1|||
156969285|NCT01889186|566640927|FG001|Overall Study|Progressive disease per protocol|17|||
156969286|NCT01889186|566640926|FG000|Overall Study|Stem cell transplant|2|||
156969287|NCT01889186|566640927|FG001|Overall Study|Stem cell transplant|1|||
156969288|NCT01889186|566640926|FG000|Overall Study|Withdrew consent|2|||
157174763|NCT02983799|567379883|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
157174764|NCT02983799|567379884|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
157174765|NCT02983799|567379880|FG000|Overall Study|Death|20|||
157174766|NCT02983799|567379881|FG001|Overall Study|Death|5|||
157174767|NCT02983799|567379882|FG002|Overall Study|Death|23|||
157174768|NCT02983799|567379883|FG003|Overall Study|Death|47|||
157174769|NCT02983799|567379884|FG004|Overall Study|Death|7|||
157174770|NCT02983799|567379880|FG000|Overall Study|Withdrawal by Subject|1|||
157174771|NCT02983799|567379881|FG001|Overall Study|Withdrawal by Subject|0|||
157174772|NCT02983799|567379882|FG002|Overall Study|Withdrawal by Subject|3|||
157174773|NCT02983799|567379883|FG003|Overall Study|Withdrawal by Subject|4|||
157174774|NCT02983799|567379884|FG004|Overall Study|Withdrawal by Subject|1|||
157174775|NCT02983799|567379880|FG000|Overall Study|Protocol Violation|0|||
157174776|NCT02983799|567379881|FG001|Overall Study|Protocol Violation|1|||
157174777|NCT02983799|567379882|FG002|Overall Study|Protocol Violation|0|||
157174778|NCT02983799|567379883|FG003|Overall Study|Protocol Violation|0|||
157174779|NCT02983799|567379884|FG004|Overall Study|Protocol Violation|1|||
157174780|NCT02983799|567379880|FG000|Overall Study|Lost to Follow-up|1|||
157174781|NCT02983799|567379881|FG001|Overall Study|Lost to Follow-up|0|||
157174782|NCT02983799|567379882|FG002|Overall Study|Lost to Follow-up|1|||
157174783|NCT02983799|567379883|FG003|Overall Study|Lost to Follow-up|0|||
157174784|NCT02983799|567379884|FG004|Overall Study|Lost to Follow-up|0|||
157174785|NCT02293902|567379890|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
157174786|NCT02293902|567379891|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
157174787|NCT02293902|567379892|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
157174788|NCT02293902|567379893|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
157174789|NCT02293902|567379894|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
157174790|NCT02293902|567379890|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
157174791|NCT02293902|567379891|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
157174792|NCT02293902|567379892|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
157174793|NCT02293902|567379893|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
157174794|NCT02293902|567379894|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
157174795|NCT02293902|567379890|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
157174796|NCT02293902|567379891|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
157174797|NCT02293902|567379892|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
157174798|NCT02293902|567379893|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
157174799|NCT02293902|567379894|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
157174800|NCT02293902|567379890|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
157174801|NCT02293902|567379891|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
157174802|NCT02293902|567379892|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
157174803|NCT02293902|567379893|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
157174804|NCT02293902|567379894|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
157174805|NCT02293902|567379890|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
157174806|NCT02293902|567379891|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
157174807|NCT02293902|567379892|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
157174808|NCT02293902|567379893|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
157174809|NCT02293902|567379894|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
157174810|NCT03366844|567381756|FG000|Overall Study|Physician Decision|1|||
157174811|NCT03366844|567381756|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
157174812|NCT02687711|567381759|FG000|Overall Study|Adverse Event|89|||
157174813|NCT02687711|567381759|FG000|Overall Study|Lack of Efficacy|70|||
157174814|NCT02687711|567381759|FG000|Overall Study|Lost to Follow-up|20|||
157174815|NCT02687711|567381759|FG000|Overall Study|Consent withdrawn|15|||
157174816|NCT02687711|567381759|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
157174817|NCT02687711|567381759|FG000|Overall Study|Too expensive|4|||
157174818|NCT02687711|567381759|FG000|Overall Study|Participant moved abroad|1|||
157174819|NCT02687711|567381759|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
157174820|NCT02687711|567381759|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
157174821|NCT02687711|567381759|FG000|Overall Study|Disliked taste|1|||
157174822|NCT02687711|567381759|FG000|Overall Study|Low mood|1|||
157174823|NCT02687711|567381759|FG000|Overall Study|Side effects|1|||
157174824|NCT02687711|567381759|FG000|Overall Study|Change of Hospital|1|||
157174825|NCT02687711|567381759|FG000|Overall Study|Liver Encephalopathy|1|||
156969289|NCT01889186|566640927|FG001|Overall Study|Withdrew consent|3|||
157174826|NCT02687711|567381759|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
157174827|NCT02687711|567381759|FG000|Overall Study|Withdrawn due to intake interruption|1|||
157174828|NCT02687711|567381759|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
157174829|NCT02687711|567381759|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
156969290|NCT01889186|566640926|FG000|Overall Study|Other, not specified|18|||
156969291|NCT01889186|566640927|FG001|Overall Study|Other, not specified|15|||
157174830|NCT02687711|567381759|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
157174831|NCT01105936|567381763|FG000|Period 1|Adverse Event|0|||
157174832|NCT01105936|567381764|FG001|Period 1|Adverse Event|0|||
157174833|NCT01105936|567381765|FG002|Period 1|Adverse Event|0|||
157174834|NCT01105936|567381766|FG003|Period 1|Adverse Event|1|||
157174835|NCT01105936|567381763|FG000|Period 2|Adverse Event|1|||
157174836|NCT01105936|567381764|FG001|Period 2|Adverse Event|0|||
157174837|NCT01105936|567381765|FG002|Period 2|Adverse Event|0|||
157174838|NCT01105936|567381766|FG003|Period 2|Adverse Event|0|||
157174839|NCT01105936|567381763|FG000|Period 3|Protocol Violation|0|||
157174840|NCT01105936|567381764|FG001|Period 3|Protocol Violation|2|||
157174841|NCT01105936|567381765|FG002|Period 3|Protocol Violation|0|||
157174842|NCT01105936|567381766|FG003|Period 3|Protocol Violation|0|||
157174843|NCT03170258|567381771|FG000|Overall Study|Physician Decision|4|||
157174844|NCT03170258|567381772|FG001|Overall Study|Physician Decision|0|||
157174845|NCT03170258|567381771|FG000|Overall Study|Equipment issues|1|||
157174846|NCT03170258|567381772|FG001|Overall Study|Equipment issues|0|||
157174847|NCT03170258|567381771|FG000|Overall Study|Medication|1|||
157174848|NCT03170258|567381772|FG001|Overall Study|Medication|0|||
157174849|NCT03170258|567381771|FG000|Overall Study|Sleep issues|1|||
157174850|NCT03170258|567381772|FG001|Overall Study|Sleep issues|0|||
157174851|NCT03276572|567381775|FG000|Overall Study|In follow-up|0|||
157174852|NCT03276572|567381776|FG001|Overall Study|In follow-up|0|||
157174853|NCT03276572|567381777|FG002|Overall Study|In follow-up|0|||
157174854|NCT03276572|567381778|FG003|Overall Study|In follow-up|0|||
157174855|NCT03276572|567381779|FG004|Overall Study|In follow-up|0|||
157174856|NCT03276572|567381780|FG005|Overall Study|In follow-up|1|||
157174857|NCT03276572|567381781|FG006|Overall Study|In follow-up|1|||
157174858|NCT03276572|567381775|FG000|Overall Study|Lost to Follow-up|0|||
157174859|NCT03276572|567381776|FG001|Overall Study|Lost to Follow-up|0|||
157174860|NCT03276572|567381777|FG002|Overall Study|Lost to Follow-up|0|||
157174861|NCT03276572|567381778|FG003|Overall Study|Lost to Follow-up|0|||
157174862|NCT03276572|567381779|FG004|Overall Study|Lost to Follow-up|0|||
157174863|NCT03276572|567381780|FG005|Overall Study|Lost to Follow-up|0|||
157174864|NCT03276572|567381781|FG006|Overall Study|Lost to Follow-up|1|||
157174865|NCT02954952|567381796|FG000|Overall Study|Withdrawal by Subject|1|||
157174866|NCT02954952|567381797|FG001|Overall Study|Withdrawal by Subject|0|||
157174867|NCT02954952|567381798|FG002|Overall Study|Withdrawal by Subject|0|||
156969292|NCT01896869|566640928|FG000|Overall Study|Withdrawal by Subject|0|||
156969293|NCT01896869|566640929|FG001|Overall Study|Withdrawal by Subject|6|||
156969294|NCT01896869|566640928|FG000|Overall Study|Lost to Follow-up|1|||
156969295|NCT01896869|566640929|FG001|Overall Study|Lost to Follow-up|0|||
156969296|NCT04710927|566640935|FG000|Overall Study|Lost to Follow-up|7|||
156969297|NCT04710927|566640936|FG001|Overall Study|Lost to Follow-up|6|||
156969298|NCT04710927|566640937|FG002|Overall Study|Lost to Follow-up|5|||
156969299|NCT00454571|566640942|FG000|Overall Study|Adverse Event|2|||
156969300|NCT00454571|566640943|FG001|Overall Study|Adverse Event|0|||
156969301|NCT00454571|566640942|FG000|Overall Study|Physician Decision|0|||
156969302|NCT00454571|566640943|FG001|Overall Study|Physician Decision|1|||
156969303|NCT00454571|566640942|FG000|Overall Study|Protocol Violation|1|||
156969304|NCT00454571|566640943|FG001|Overall Study|Protocol Violation|0|||
156969305|NCT00454571|566640942|FG000|Overall Study|Withdrawal by Subject|10|||
156969306|NCT00454571|566640943|FG001|Overall Study|Withdrawal by Subject|5|||
156969307|NCT01376323|566640944|FG000|Overall Study|Adverse Event|1|||
156969308|NCT01376323|566640945|FG001|Overall Study|Adverse Event|0|||
156969309|NCT01376323|566640946|FG002|Overall Study|Adverse Event|0|||
156969310|NCT01376323|566640947|FG003|Overall Study|Adverse Event|2|||
156969311|NCT01376323|566640948|FG004|Overall Study|Adverse Event|0|||
156969312|NCT01376323|566640944|FG000|Overall Study|Lost to Follow-up|0|||
156969313|NCT01376323|566640945|FG001|Overall Study|Lost to Follow-up|0|||
156969314|NCT01376323|566640946|FG002|Overall Study|Lost to Follow-up|0|||
156969315|NCT01376323|566640947|FG003|Overall Study|Lost to Follow-up|2|||
156969316|NCT01376323|566640948|FG004|Overall Study|Lost to Follow-up|0|||
156969317|NCT01376323|566640944|FG000|Overall Study|Physician Decision|1|||
156969318|NCT01376323|566640945|FG001|Overall Study|Physician Decision|0|||
156969319|NCT01376323|566640946|FG002|Overall Study|Physician Decision|2|||
157046093|NCT03567616|566924038|FG000|Overall Study|Physician Decision|1|||
157174868|NCT02954952|567381796|FG000|Overall Study|No data collected|0|||
157174869|NCT02954952|567381797|FG001|Overall Study|No data collected|1|||
157174870|NCT02954952|567381798|FG002|Overall Study|No data collected|0|||
157174871|NCT02911519|567381799|FG000|Overall Study|Lost to Follow-up|2|||
156969320|NCT01376323|566640947|FG003|Overall Study|Physician Decision|1|||
156969321|NCT01376323|566640948|FG004|Overall Study|Physician Decision|1|||
156969322|NCT01376323|566640944|FG000|Overall Study|Withdrawal by Subject|0|||
156969323|NCT01376323|566640945|FG001|Overall Study|Withdrawal by Subject|1|||
156969324|NCT01376323|566640946|FG002|Overall Study|Withdrawal by Subject|1|||
156969325|NCT01376323|566640947|FG003|Overall Study|Withdrawal by Subject|0|||
156969326|NCT01376323|566640948|FG004|Overall Study|Withdrawal by Subject|0|||
157174872|NCT02911519|567381800|FG001|Overall Study|Lost to Follow-up|2|||
157174873|NCT02911519|567381799|FG000|Overall Study|Death|0|||
157174874|NCT02911519|567381800|FG001|Overall Study|Death|2|||
157174875|NCT00724815|567381803|FG000|Overall Study|Randomized, not treated|31|||
157174876|NCT00724815|567381804|FG001|Overall Study|Randomized, not treated|30|||
157174877|NCT00724815|567381803|FG000|Overall Study|Adverse Event|5|||
157174878|NCT00724815|567381804|FG001|Overall Study|Adverse Event|3|||
157174879|NCT00724815|567381803|FG000|Overall Study|Lost to Follow-up|4|||
157174880|NCT00724815|567381804|FG001|Overall Study|Lost to Follow-up|1|||
157174881|NCT00724815|567381803|FG000|Overall Study|Other Various|3|||
157174882|NCT00724815|567381804|FG001|Overall Study|Other Various|5|||
157174883|NCT00810043|567381805|FG000|Overall Study|Withdrawal by Subject|1|||
157174884|NCT00810043|567381806|FG001|Overall Study|Withdrawal by Subject|0|||
157174885|NCT00810043|567381807|FG002|Overall Study|Withdrawal by Subject|2|||
157174886|NCT00810043|567381805|FG000|Overall Study|Lost to Follow-up|1|||
157174887|NCT00810043|567381806|FG001|Overall Study|Lost to Follow-up|0|||
157174888|NCT00810043|567381807|FG002|Overall Study|Lost to Follow-up|0|||
157174889|NCT00810043|567381805|FG000|Overall Study|Physician Decision|0|||
157174890|NCT00810043|567381806|FG001|Overall Study|Physician Decision|0|||
157174891|NCT00810043|567381807|FG002|Overall Study|Physician Decision|2|||
157174892|NCT00810043|567381805|FG000|Overall Study|Death|2|||
157174893|NCT00810043|567381806|FG001|Overall Study|Death|0|||
157174894|NCT00810043|567381807|FG002|Overall Study|Death|0|||
157174895|NCT00810043|567381805|FG000|Overall Study|Unrelated medical problem|0|||
157174896|NCT00810043|567381806|FG001|Overall Study|Unrelated medical problem|1|||
157174897|NCT00810043|567381807|FG002|Overall Study|Unrelated medical problem|0|||
157174898|NCT00810043|567381805|FG000|Overall Study|Non-medical problem|0|||
157174899|NCT00810043|567381806|FG001|Overall Study|Non-medical problem|0|||
157174900|NCT00810043|567381807|FG002|Overall Study|Non-medical problem|1|||
157174901|NCT00810043|567381805|FG000|Overall Study|No longer met enrollment criteria|0|||
157174902|NCT00810043|567381806|FG001|Overall Study|No longer met enrollment criteria|0|||
157174903|NCT00810043|567381807|FG002|Overall Study|No longer met enrollment criteria|3|||
156969327|NCT03595332|566640949|FG000|Overall Study|Lost to Follow-up|16|||
156969328|NCT03595332|566640950|FG001|Overall Study|Lost to Follow-up|22|||
156969329|NCT03595332|566640949|FG000|Overall Study|Unable to retrieve ID from school|0|||
156969330|NCT03595332|566640950|FG001|Overall Study|Unable to retrieve ID from school|2|||
156969331|NCT02227875|566640951|FG000|Overall Study|Protocol Violation|10|||
156969332|NCT02227875|566640952|FG001|Overall Study|Protocol Violation|7|||
156969333|NCT02227875|566640951|FG000|Overall Study|Other|1|||
156969334|NCT02227875|566640952|FG001|Overall Study|Other|3|||
156969335|NCT02227875|566640951|FG000|Overall Study|Physician Decision|1|||
156969336|NCT02227875|566640952|FG001|Overall Study|Physician Decision|0|||
156969337|NCT02227875|566640951|FG000|Overall Study|Adverse Event|3|||
156969338|NCT02227875|566640952|FG001|Overall Study|Adverse Event|0|||
156969339|NCT02227875|566640951|FG000|Overall Study|Withdrawal by Subject|12|||
156969340|NCT02227875|566640952|FG001|Overall Study|Withdrawal by Subject|13|||
156969341|NCT02227875|566640951|FG000|Overall Study|Lost to Follow-up|10|||
156969342|NCT02227875|566640952|FG001|Overall Study|Lost to Follow-up|10|||
156969343|NCT01201811|566640953|FG000|Overall Study|Adverse Event|6|||
156969344|NCT01201811|566640953|FG000|Overall Study|Disease progression|3|||
156969345|NCT01201811|566640953|FG000|Overall Study|Withdrawal by Subject|3|||
156969346|NCT01201811|566640953|FG000|Overall Study|Death|4|||
156969347|NCT01201811|566640953|FG000|Overall Study|Treatment Failure|2|||
156969348|NCT01201811|566640953|FG000|Overall Study|Physician Decision|1|||
156969349|NCT02856113|566640954|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
156969350|NCT02856113|566640955|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
156969351|NCT02856113|566640954|FG000|Overall Study|Significant Protocol Deviation|1|||
156969352|NCT02856113|566640955|FG001|Overall Study|Significant Protocol Deviation|0|||
156969353|NCT02856113|566640954|FG000|Overall Study|Lost to Follow-up|3|||
156969354|NCT02856113|566640955|FG001|Overall Study|Lost to Follow-up|5|||
156969355|NCT02856113|566640954|FG000|Overall Study|Voluntary Withdrawal|3|||
156969356|NCT02856113|566640955|FG001|Overall Study|Voluntary Withdrawal|5|||
156969357|NCT02856113|566640954|FG000|Overall Study|Pregnancy|0|||
156969358|NCT02856113|566640955|FG001|Overall Study|Pregnancy|1|||
156969359|NCT02856113|566640954|FG000|Overall Study|Principal Investigator Discretion|2|||
156969360|NCT02856113|566640955|FG001|Overall Study|Principal Investigator Discretion|1|||
156969361|NCT02856113|566640954|FG000|Overall Study|Randomized but not Treated|1|||
156969362|NCT02856113|566640955|FG001|Overall Study|Randomized but not Treated|0|||
156969363|NCT02856113|566640954|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
156969364|NCT02856113|566640955|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
157046094|NCT03567616|566924038|FG000|Overall Study|Death|1|||
156969365|NCT01960725|566640956|FG000|Overall Study|Lost to Follow-up|4|||
156969366|NCT01960725|566640957|FG001|Overall Study|Lost to Follow-up|3|||
156969367|NCT01960725|566640956|FG000|Overall Study|Withdrawal by Subject|1|||
156969368|NCT01960725|566640957|FG001|Overall Study|Withdrawal by Subject|0|||
156969369|NCT01960725|566640956|FG000|Overall Study|unable to obtain blood sample|1|||
156969370|NCT01960725|566640957|FG001|Overall Study|unable to obtain blood sample|2|||
157174904|NCT00445341|567381811|FG000|Overall Study|refused further treatment|1|||
157174905|NCT00445341|567381811|FG000|Overall Study|taken off treatment too early|1|||
157174906|NCT03051217|567381812|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
157046095|NCT03567616|566924038|FG000|Overall Study|Adverse Event|1|||
157046096|NCT03035942|566924040|FG000|Overall Study|Adverse Event|8|||
157046097|NCT03035942|566924041|FG001|Overall Study|Adverse Event|4|||
157046098|NCT03035942|566924042|FG002|Overall Study|Adverse Event|5|||
157046099|NCT05270460|566924043|FG000|Overall Study|Adverse Event|0|||
157046100|NCT05270460|566924044|FG001|Overall Study|Adverse Event|1|||
157046101|NCT05270460|566924045|FG002|Overall Study|Adverse Event|0|||
157046102|NCT05270460|566924043|FG000|Overall Study|Early Termination|0|||
157046103|NCT05270460|566924044|FG001|Overall Study|Early Termination|1|||
157046104|NCT05270460|566924045|FG002|Overall Study|Early Termination|0|||
157046105|NCT00380250|566924046|FG000|Overall Study|Withdrawal by Subject|39|||
157046106|NCT00380250|566924047|FG001|Overall Study|Withdrawal by Subject|28|||
157046107|NCT00380250|566924046|FG000|Overall Study|Adverse Event|20|||
157046108|NCT00380250|566924047|FG001|Overall Study|Adverse Event|9|||
157046109|NCT00380250|566924046|FG000|Overall Study|Lack of Efficacy|10|||
157046110|NCT00380250|566924047|FG001|Overall Study|Lack of Efficacy|8|||
157046111|NCT00380250|566924046|FG000|Overall Study|Protocol Violation|15|||
157046112|NCT00380250|566924047|FG001|Overall Study|Protocol Violation|5|||
157046113|NCT00380250|566924046|FG000|Overall Study|Lost to Follow-up|14|||
157046114|NCT00380250|566924047|FG001|Overall Study|Lost to Follow-up|5|||
157046115|NCT00380250|566924046|FG000|Overall Study|Physician Decision|1|||
157046116|NCT00380250|566924047|FG001|Overall Study|Physician Decision|0|||
157046117|NCT01989104|566924048|FG000|Overall Study|Withdrawal by Subject|3|||
157046118|NCT01989104|566924049|FG001|Overall Study|Withdrawal by Subject|0|||
157046119|NCT01989104|566924050|FG002|Overall Study|Withdrawal by Subject|0|||
157046120|NCT01989104|566924051|FG003|Overall Study|Withdrawal by Subject|0|||
157046121|NCT01989104|566924052|FG004|Overall Study|Withdrawal by Subject|0|||
157046122|NCT02833948|566924054|FG000|Overall Study|Death|2|||
157046123|NCT02833948|566924055|FG001|Overall Study|Death|3|||
157046124|NCT02833948|566924054|FG000|Overall Study|were not scanned|8|||
157046125|NCT02833948|566924055|FG001|Overall Study|were not scanned|13|||
157046126|NCT02833948|566924054|FG000|Overall Study|scans could not be evaluated|5|||
157046127|NCT02833948|566924055|FG001|Overall Study|scans could not be evaluated|2|||
157046128|NCT00680771|566924059|FG000|Overall Study|Withdrawal by Subject|1|||
157046129|NCT00680771|566924060|FG001|Overall Study|Withdrawal by Subject|0|||
157046130|NCT00680771|566924059|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
157046131|NCT00680771|566924060|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
157046132|NCT00680771|566924059|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
157046133|NCT00680771|566924060|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
157046134|NCT02691702|566924061|FG000|Overall Study|Adverse Event|1|||
157046135|NCT02691702|566924062|FG001|Overall Study|Adverse Event|0|||
157046136|NCT02691702|566924063|FG002|Overall Study|Adverse Event|0|||
157046137|NCT02691702|566924064|FG003|Overall Study|Adverse Event|0|||
157046138|NCT02691702|566924065|FG004|Overall Study|Adverse Event|0|||
157046139|NCT02691702|566924066|FG005|Overall Study|Adverse Event|0|||
157046140|NCT02691702|566924067|FG006|Overall Study|Adverse Event|0|||
157046141|NCT02691702|566924068|FG007|Overall Study|Adverse Event|0|||
157046142|NCT02691702|566924069|FG008|Overall Study|Adverse Event|1|||
157046143|NCT02691702|566924070|FG009|Overall Study|Adverse Event|0|||
157046144|NCT02691702|566924071|FG010|Overall Study|Adverse Event|1|||
157046145|NCT02691702|566924061|FG000|Overall Study|Lost to Follow-up|0|||
157046146|NCT02691702|566924062|FG001|Overall Study|Lost to Follow-up|0|||
157046147|NCT02691702|566924063|FG002|Overall Study|Lost to Follow-up|1|||
157046148|NCT02691702|566924064|FG003|Overall Study|Lost to Follow-up|0|||
157046149|NCT02691702|566924065|FG004|Overall Study|Lost to Follow-up|0|||
157046150|NCT02691702|566924066|FG005|Overall Study|Lost to Follow-up|2|||
157046151|NCT02691702|566924067|FG006|Overall Study|Lost to Follow-up|0|||
157046152|NCT02691702|566924068|FG007|Overall Study|Lost to Follow-up|0|||
157046153|NCT02691702|566924069|FG008|Overall Study|Lost to Follow-up|0|||
157046154|NCT02691702|566924070|FG009|Overall Study|Lost to Follow-up|0|||
157046155|NCT02691702|566924071|FG010|Overall Study|Lost to Follow-up|1|||
157046156|NCT02691702|566924061|FG000|Overall Study|Withdrawal by Subject|1|||
157046157|NCT02691702|566924062|FG001|Overall Study|Withdrawal by Subject|1|||
157046158|NCT02691702|566924063|FG002|Overall Study|Withdrawal by Subject|0|||
157046159|NCT02691702|566924064|FG003|Overall Study|Withdrawal by Subject|0|||
157046160|NCT02691702|566924065|FG004|Overall Study|Withdrawal by Subject|0|||
157046161|NCT02691702|566924066|FG005|Overall Study|Withdrawal by Subject|1|||
157046162|NCT02691702|566924067|FG006|Overall Study|Withdrawal by Subject|2|||
157046163|NCT02691702|566924068|FG007|Overall Study|Withdrawal by Subject|0|||
157046164|NCT02691702|566924069|FG008|Overall Study|Withdrawal by Subject|0|||
157046165|NCT02691702|566924070|FG009|Overall Study|Withdrawal by Subject|0|||
157046166|NCT02691702|566924071|FG010|Overall Study|Withdrawal by Subject|0|||
157046167|NCT02691702|566924061|FG000|Overall Study|Other|0|||
157046168|NCT02691702|566924062|FG001|Overall Study|Other|0|||
157046169|NCT02691702|566924063|FG002|Overall Study|Other|0|||
157046170|NCT02691702|566924064|FG003|Overall Study|Other|0|||
157046171|NCT02691702|566924065|FG004|Overall Study|Other|0|||
157046172|NCT02691702|566924066|FG005|Overall Study|Other|0|||
157046173|NCT02691702|566924067|FG006|Overall Study|Other|1|||
157046174|NCT02691702|566924068|FG007|Overall Study|Other|0|||
157046175|NCT02691702|566924069|FG008|Overall Study|Other|1|||
157046176|NCT02691702|566924070|FG009|Overall Study|Other|0|||
157046177|NCT02691702|566924071|FG010|Overall Study|Other|0|||
157046178|NCT02691702|566924061|FG000|Overall Study|Protocol Violation|0|||
157046179|NCT02691702|566924062|FG001|Overall Study|Protocol Violation|0|||
157046180|NCT02691702|566924063|FG002|Overall Study|Protocol Violation|0|||
157046181|NCT02691702|566924064|FG003|Overall Study|Protocol Violation|0|||
157046182|NCT02691702|566924065|FG004|Overall Study|Protocol Violation|0|||
157046183|NCT02691702|566924066|FG005|Overall Study|Protocol Violation|0|||
157046184|NCT02691702|566924067|FG006|Overall Study|Protocol Violation|0|||
157046185|NCT02691702|566924068|FG007|Overall Study|Protocol Violation|0|||
157046186|NCT02691702|566924069|FG008|Overall Study|Protocol Violation|0|||
157046187|NCT02691702|566924070|FG009|Overall Study|Protocol Violation|2|||
157046188|NCT02691702|566924071|FG010|Overall Study|Protocol Violation|0|||
157046189|NCT05613088|566924072|FG000|Treatment|Ongoing Study Treatment|9|||
157046190|NCT05613088|566924073|FG001|Treatment|Ongoing Study Treatment|2|||
157046191|NCT05613088|566924072|FG000|Treatment|Adverse Event|3|||
157046192|NCT05613088|566924073|FG001|Treatment|Adverse Event|1|||
157046193|NCT05613088|566924072|FG000|Treatment|Other Reasons|0|||
157046194|NCT05613088|566924073|FG001|Treatment|Other Reasons|1|||
157046195|NCT05613088|566924072|FG000|Treatment|Progressive Disease|58|||
157046196|NCT05613088|566924073|FG001|Treatment|Progressive Disease|26|||
157046197|NCT05613088|566924072|FG000|Treatment|Withdrawal by Subject|0|||
157046198|NCT05613088|566924073|FG001|Treatment|Withdrawal by Subject|4|||
157046199|NCT05163353|566924076|FG000|Overall Study|Adverse Event|1|||
157046200|NCT05163353|566924077|FG001|Overall Study|Adverse Event|0|||
157046201|NCT05163353|566924076|FG000|Overall Study|Withdrawal by Subject|21|||
157046202|NCT05163353|566924077|FG001|Overall Study|Withdrawal by Subject|6|||
157046203|NCT05163353|566924076|FG000|Overall Study|Protocol Violation|0|||
157046204|NCT05163353|566924077|FG001|Overall Study|Protocol Violation|1|||
157046205|NCT05163353|566924076|FG000|Overall Study|Lost to Follow-up|13|||
157046206|NCT05163353|566924077|FG001|Overall Study|Lost to Follow-up|2|||
157046207|NCT06086028|566924079|FG000|Overall Study|Withdrawal by Subject|1|||
157046208|NCT06086028|566924080|FG001|Overall Study|Withdrawal by Subject|1|||
157046209|NCT06086028|566924079|FG000|Overall Study|Lost to Follow-up|2|||
157046210|NCT06086028|566924080|FG001|Overall Study|Lost to Follow-up|3|||
157046211|NCT00824408|566924081|FG000|Run-in Phase|Progressive disease|4|||
157046212|NCT00824408|566924082|FG001|Run-in Phase|Progressive disease|4|||
157046213|NCT00824408|566924083|FG002|Run-in Phase|Progressive disease|0|||
157046214|NCT00824408|566924084|FG003|Run-in Phase|Progressive disease|0|||
157046215|NCT00824408|566924085|FG004|Run-in Phase|Progressive disease|0|||
157046216|NCT00824408|566924081|FG000|Run-in Phase|Adverse Event|1|||
157046217|NCT00824408|566924082|FG001|Run-in Phase|Adverse Event|1|||
157046218|NCT00824408|566924083|FG002|Run-in Phase|Adverse Event|0|||
157046219|NCT00824408|566924084|FG003|Run-in Phase|Adverse Event|0|||
157046220|NCT00824408|566924085|FG004|Run-in Phase|Adverse Event|0|||
157046221|NCT00824408|566924081|FG000|Run-in Phase|Refused to continue medication|1|||
157046222|NCT00824408|566924082|FG001|Run-in Phase|Refused to continue medication|0|||
157046223|NCT00824408|566924083|FG002|Run-in Phase|Refused to continue medication|0|||
157046224|NCT00824408|566924084|FG003|Run-in Phase|Refused to continue medication|0|||
157046225|NCT00824408|566924085|FG004|Run-in Phase|Refused to continue medication|0|||
157046226|NCT00824408|566924081|FG000|Run-in Phase|Other reason not defined above|0|||
157046227|NCT00824408|566924082|FG001|Run-in Phase|Other reason not defined above|1|||
157046228|NCT00824408|566924083|FG002|Run-in Phase|Other reason not defined above|0|||
157046229|NCT00824408|566924084|FG003|Run-in Phase|Other reason not defined above|0|||
157046230|NCT00824408|566924085|FG004|Run-in Phase|Other reason not defined above|0|||
157046231|NCT00824408|566924081|FG000|Randomized Phase|Not treated|0|||
157046232|NCT00824408|566924082|FG001|Randomized Phase|Not treated|0|||
157046233|NCT00824408|566924083|FG002|Randomized Phase|Not treated|1|||
157046234|NCT00824408|566924084|FG003|Randomized Phase|Not treated|1|||
157046235|NCT00824408|566924085|FG004|Randomized Phase|Not treated|1|||
157046236|NCT00824408|566924081|FG000|Randomized Phase|Progressive disease|0|||
157046237|NCT00824408|566924082|FG001|Randomized Phase|Progressive disease|0|||
157046238|NCT00824408|566924083|FG002|Randomized Phase|Progressive disease|25|||
157046239|NCT00824408|566924084|FG003|Randomized Phase|Progressive disease|36|||
157046240|NCT00824408|566924085|FG004|Randomized Phase|Progressive disease|34|||
157046241|NCT00824408|566924081|FG000|Randomized Phase|Adverse Event|0|||
157046242|NCT00824408|566924082|FG001|Randomized Phase|Adverse Event|0|||
157046243|NCT00824408|566924083|FG002|Randomized Phase|Adverse Event|4|||
157046244|NCT00824408|566924084|FG003|Randomized Phase|Adverse Event|5|||
157046245|NCT00824408|566924085|FG004|Randomized Phase|Adverse Event|5|||
157046246|NCT00824408|566924081|FG000|Randomized Phase|Refused to continue medication|0|||
157046247|NCT00824408|566924082|FG001|Randomized Phase|Refused to continue medication|0|||
157046248|NCT00824408|566924083|FG002|Randomized Phase|Refused to continue medication|2|||
157046249|NCT00824408|566924084|FG003|Randomized Phase|Refused to continue medication|2|||
157046250|NCT00824408|566924085|FG004|Randomized Phase|Refused to continue medication|2|||
157046251|NCT00824408|566924081|FG000|Randomized Phase|Other reason not defined above|0|||
157046252|NCT00824408|566924082|FG001|Randomized Phase|Other reason not defined above|0|||
157046253|NCT00824408|566924083|FG002|Randomized Phase|Other reason not defined above|4|||
157046254|NCT00824408|566924084|FG003|Randomized Phase|Other reason not defined above|2|||
157046255|NCT00824408|566924085|FG004|Randomized Phase|Other reason not defined above|4|||
157046256|NCT01218594|566924088|FG000|Overall Study|Death|1|||
157046257|NCT01218594|566924088|FG000|Overall Study|Withdrawal by Subject|3|||
157046258|NCT01218594|566924088|FG000|Overall Study|Adverse Event|2|||
157046259|NCT01218594|566924088|FG000|Overall Study|Physician Decision|6|||
157046260|NCT04602728|566924091|FG000|Overall Study|Lost to Follow-up|4|||
157046261|NCT04602728|566924092|FG001|Overall Study|Lost to Follow-up|4|||
157046262|NCT04181788|566924093|FG000|TREATMENT|Adverse Event|0|||
157046263|NCT04181788|566924094|FG001|TREATMENT|Adverse Event|2|||
157046264|NCT04181788|566924095|FG002|TREATMENT|Adverse Event|1|||
157046265|NCT04181788|566924096|FG003|TREATMENT|Adverse Event|0|||
157046266|NCT04181788|566924097|FG004|TREATMENT|Adverse Event|1|||
157046267|NCT04181788|566924098|FG005|TREATMENT|Adverse Event|3|||
157046268|NCT04181788|566924093|FG000|TREATMENT|Death|0|||
157046269|NCT04181788|566924094|FG001|TREATMENT|Death|0|||
157046270|NCT04181788|566924095|FG002|TREATMENT|Death|0|||
157046271|NCT04181788|566924096|FG003|TREATMENT|Death|0|||
157046272|NCT04181788|566924097|FG004|TREATMENT|Death|8|||
157046273|NCT04181788|566924098|FG005|TREATMENT|Death|8|||
157046274|NCT04181788|566924093|FG000|TREATMENT|Physician Decision|0|||
157046275|NCT04181788|566924094|FG001|TREATMENT|Physician Decision|0|||
157046276|NCT04181788|566924095|FG002|TREATMENT|Physician Decision|0|||
157046277|NCT04181788|566924096|FG003|TREATMENT|Physician Decision|0|||
157046278|NCT04181788|566924097|FG004|TREATMENT|Physician Decision|0|||
157046279|NCT04181788|566924098|FG005|TREATMENT|Physician Decision|1|||
157046280|NCT04181788|566924093|FG000|TREATMENT|Progressive disease|3|||
157046281|NCT04181788|566924094|FG001|TREATMENT|Progressive disease|3|||
157046282|NCT04181788|566924095|FG002|TREATMENT|Progressive disease|5|||
157046283|NCT04181788|566924096|FG003|TREATMENT|Progressive disease|7|||
157046284|NCT04181788|566924097|FG004|TREATMENT|Progressive disease|20|||
157046285|NCT04181788|566924098|FG005|TREATMENT|Progressive disease|38|||
157046286|NCT04181788|566924093|FG000|TREATMENT|Global deterioration of health status|0|||
157046287|NCT04181788|566924094|FG001|TREATMENT|Global deterioration of health status|2|||
157046288|NCT04181788|566924095|FG002|TREATMENT|Global deterioration of health status|0|||
157174907|NCT03051217|567381813|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
157174908|NCT03051217|567381814|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
157174909|NCT03051217|567381815|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
157174910|NCT03051217|567381816|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
157174911|NCT03051217|567381817|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
157174912|NCT03051217|567381818|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
157174913|NCT03051217|567381812|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174914|NCT03051217|567381813|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
157174915|NCT03051217|567381814|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174916|NCT03051217|567381815|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174917|NCT03051217|567381816|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174918|NCT03051217|567381817|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174919|NCT03051217|567381818|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
157174920|NCT03051217|567381812|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
157174921|NCT03051217|567381813|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
157174922|NCT03051217|567381814|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
157174923|NCT03051217|567381815|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
157174924|NCT03051217|567381816|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
157174925|NCT03051217|567381817|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
157174926|NCT03051217|567381818|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
157174927|NCT03051217|567381812|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
157174928|NCT03051217|567381813|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
157174929|NCT03051217|567381814|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
157174930|NCT03051217|567381815|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
157174931|NCT03051217|567381816|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
157174932|NCT03051217|567381817|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
157174933|NCT03051217|567381818|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
157174934|NCT03051217|567381812|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174935|NCT03051217|567381813|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174936|NCT03051217|567381814|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174937|NCT03051217|567381815|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
157228830|NCT05097989|567583376|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157046289|NCT04181788|566924096|FG003|TREATMENT|Global deterioration of health status|0|||
157046290|NCT04181788|566924097|FG004|TREATMENT|Global deterioration of health status|2|||
157046291|NCT04181788|566924098|FG005|TREATMENT|Global deterioration of health status|8|||
157046292|NCT04181788|566924093|FG000|TREATMENT|Withdrawal by Subject|1|||
157174938|NCT03051217|567381816|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174939|NCT03051217|567381817|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174940|NCT03051217|567381818|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
157174941|NCT03051217|567381812|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174942|NCT03051217|567381813|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174943|NCT03051217|567381814|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174944|NCT03051217|567381815|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
157174945|NCT03051217|567381816|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174946|NCT03051217|567381817|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174947|NCT03051217|567381818|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
157174948|NCT03051217|567381812|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174949|NCT03051217|567381813|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174950|NCT03051217|567381814|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174951|NCT03051217|567381815|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174952|NCT03051217|567381816|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
157174953|NCT03051217|567381817|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174954|NCT03051217|567381818|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
157174955|NCT03051217|567381812|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174956|NCT03051217|567381813|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174957|NCT03051217|567381814|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174958|NCT03051217|567381815|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174959|NCT03051217|567381816|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174960|NCT03051217|567381817|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
157174961|NCT03051217|567381818|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
157174962|NCT00641706|567381821|FG000|Overall Study|Adverse Event|2|||
157174963|NCT00641706|567381822|FG001|Overall Study|Adverse Event|1|||
157174964|NCT00641706|567381821|FG000|Overall Study|Withdrawal by Subject|6|||
157174965|NCT00641706|567381822|FG001|Overall Study|Withdrawal by Subject|1|||
157174966|NCT00641706|567381821|FG000|Overall Study|Clinical Decline|1|||
157174967|NCT00641706|567381822|FG001|Overall Study|Clinical Decline|0|||
157174968|NCT00641706|567381821|FG000|Overall Study|Lead Investigator Decision|0|||
157174969|NCT00641706|567381822|FG001|Overall Study|Lead Investigator Decision|1|||
157174970|NCT00109772|567381823|FG000|Double-blind Treatment|Adverse Event|14|||
157174971|NCT00109772|567381824|FG001|Double-blind Treatment|Adverse Event|5|||
157174972|NCT00109772|567381823|FG000|Double-blind Treatment|Lack of Efficacy|1|||
157174973|NCT00109772|567381824|FG001|Double-blind Treatment|Lack of Efficacy|0|||
157174974|NCT00109772|567381823|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
157174975|NCT00109772|567381824|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
157174976|NCT00109772|567381823|FG000|Double-blind Treatment|Lost to Follow-up|2|||
157174977|NCT00109772|567381824|FG001|Double-blind Treatment|Lost to Follow-up|3|||
157174978|NCT00109772|567381823|FG000|Double-blind Treatment|Protocol Violation|0|||
157174979|NCT00109772|567381824|FG001|Double-blind Treatment|Protocol Violation|1|||
157174980|NCT00109772|567381823|FG000|Double-blind Treatment|Other|0|||
157174981|NCT00109772|567381824|FG001|Double-blind Treatment|Other|4|||
157174982|NCT00109772|567381823|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
157174983|NCT00109772|567381824|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
157174984|NCT00109772|567381823|FG000|Open-label Extension|Adverse Event|10|||
157174985|NCT00109772|567381824|FG001|Open-label Extension|Adverse Event|19|||
157174986|NCT00109772|567381823|FG000|Open-label Extension|Lack of Efficacy|19|||
157174987|NCT00109772|567381824|FG001|Open-label Extension|Lack of Efficacy|11|||
157174988|NCT00109772|567381823|FG000|Open-label Extension|Withdrawal by Subject|9|||
156969371|NCT02831257|566640962|FG000|Overall Study|Lack of Efficacy|3|||
156969372|NCT02831257|566640962|FG000|Overall Study|Adverse Event|2|||
156969373|NCT02831257|566640962|FG000|Overall Study|Physician Decision|1|||
156969374|NCT02831257|566640962|FG000|Overall Study|Withdrawal by Subject|6|||
156969375|NCT01058304|566640964|FG000|Overall Study|Withdrawal by Subject|8|||
156969376|NCT01058304|566640965|FG001|Overall Study|Withdrawal by Subject|5|||
156969377|NCT01058304|566640964|FG000|Overall Study|Lost to Follow-up|13|||
156969378|NCT01058304|566640965|FG001|Overall Study|Lost to Follow-up|16|||
156969379|NCT01058304|566640964|FG000|Overall Study|Developed exclusion criterion|6|||
156969380|NCT01058304|566640965|FG001|Overall Study|Developed exclusion criterion|12|||
156969381|NCT02496767|566640967|FG000|Open-label Lead-in Phase|Adverse Event|176|||
156969382|NCT02496767|566640968|FG001|Open-label Lead-in Phase|Adverse Event|0|||
156969383|NCT02496767|566640969|FG002|Open-label Lead-in Phase|Adverse Event|0|||
157174989|NCT00109772|567381824|FG001|Open-label Extension|Withdrawal by Subject|6|||
157174990|NCT00109772|567381823|FG000|Open-label Extension|Lost to Follow-up|1|||
156969384|NCT02496767|566640970|FG003|Open-label Lead-in Phase|Adverse Event|0|||
156969385|NCT02496767|566640971|FG004|Open-label Lead-in Phase|Adverse Event|0|||
156969386|NCT02496767|566640972|FG005|Open-label Lead-in Phase|Adverse Event|0|||
156969387|NCT02496767|566640973|FG006|Open-label Lead-in Phase|Adverse Event|0|||
156969388|NCT02496767|566640974|FG007|Open-label Lead-in Phase|Adverse Event|0|||
156969389|NCT02496767|566640967|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
156969390|NCT02496767|566640968|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
156969391|NCT02496767|566640969|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
156969392|NCT02496767|566640970|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
156969393|NCT02496767|566640971|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
156969394|NCT02496767|566640972|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
156969395|NCT02496767|566640973|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
156969396|NCT02496767|566640974|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
157174991|NCT00109772|567381824|FG001|Open-label Extension|Lost to Follow-up|0|||
157174992|NCT00109772|567381823|FG000|Open-label Extension|Death|0|||
157174993|NCT00109772|567381824|FG001|Open-label Extension|Death|1|||
157174994|NCT00109772|567381823|FG000|Open-label Extension|Protocol Violation|2|||
157174995|NCT00109772|567381824|FG001|Open-label Extension|Protocol Violation|2|||
157174996|NCT00109772|567381823|FG000|Open-label Extension|Other|4|||
157174997|NCT00109772|567381824|FG001|Open-label Extension|Other|10|||
157174998|NCT01989754|567381825|FG000|Overall Study|Withdrawal by Subject|10|||
157174999|NCT01989754|567381826|FG001|Overall Study|Withdrawal by Subject|14|||
157175000|NCT01989754|567381825|FG000|Overall Study|Lost to Follow-up|28|||
157175001|NCT01989754|567381826|FG001|Overall Study|Lost to Follow-up|20|||
157175002|NCT01989754|567381825|FG000|Overall Study|Closed Site|1|||
157175003|NCT01989754|567381826|FG001|Overall Study|Closed Site|1|||
157175004|NCT01359046|567381827|FG000|Overall Study|Did not receive allocated intervention|6|||
157175005|NCT01359046|567381828|FG001|Overall Study|Did not receive allocated intervention|6|||
157175006|NCT01359046|567381827|FG000|Overall Study|Physician Decision|1|||
157175007|NCT01359046|567381828|FG001|Overall Study|Physician Decision|11|||
157175008|NCT01369225|567381832|FG000|Overall Study|Withdrawal by Subject|1|||
157175009|NCT01369225|567381833|FG001|Overall Study|Withdrawal by Subject|0|||
157175010|NCT01369225|567381834|FG002|Overall Study|Withdrawal by Subject|2|||
157175011|NCT01369225|567381835|FG003|Overall Study|Withdrawal by Subject|1|||
157175012|NCT01369225|567381836|FG004|Overall Study|Withdrawal by Subject|0|||
157175013|NCT01369225|567381837|FG005|Overall Study|Withdrawal by Subject|0|||
157175014|NCT01369225|567381832|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
157175015|NCT01369225|567381833|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
157175016|NCT01369225|567381834|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
157175017|NCT01369225|567381835|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
157175018|NCT01369225|567381836|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
157175019|NCT01369225|567381837|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
157175020|NCT01369225|567381832|FG000|Overall Study|Other|1|||
157175021|NCT01369225|567381833|FG001|Overall Study|Other|0|||
157175022|NCT01369225|567381834|FG002|Overall Study|Other|0|||
157175023|NCT01369225|567381835|FG003|Overall Study|Other|0|||
157175024|NCT01369225|567381836|FG004|Overall Study|Other|1|||
157175025|NCT01369225|567381837|FG005|Overall Study|Other|0|||
157175026|NCT01369225|567381832|FG000|Overall Study|Adverse Event|0|||
157175027|NCT01369225|567381833|FG001|Overall Study|Adverse Event|0|||
157175028|NCT01369225|567381834|FG002|Overall Study|Adverse Event|0|||
157175029|NCT01369225|567381835|FG003|Overall Study|Adverse Event|1|||
157175030|NCT01369225|567381836|FG004|Overall Study|Adverse Event|1|||
157175031|NCT01369225|567381837|FG005|Overall Study|Adverse Event|0|||
157175032|NCT00792701|567381838|FG000|Overall Study|Adverse Event|0|||
157175033|NCT00792701|567381839|FG001|Overall Study|Adverse Event|22|||
157175034|NCT00792701|567381838|FG000|Overall Study|Ineligible|1|||
157175035|NCT00792701|567381839|FG001|Overall Study|Ineligible|3|||
157175036|NCT00792701|567381838|FG000|Overall Study|Withdrawal by Subject|1|||
157175037|NCT00792701|567381839|FG001|Overall Study|Withdrawal by Subject|19|||
157175038|NCT00792701|567381838|FG000|Overall Study|Not protocol specified|17|||
157175039|NCT00792701|567381839|FG001|Overall Study|Not protocol specified|0|||
157175040|NCT05507580|567381840|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
157175041|NCT05507580|567381841|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
157175042|NCT05507580|567381842|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
157175043|NCT05507580|567381843|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
157175044|NCT05507580|567381844|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
157175045|NCT05507580|567381845|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
157175046|NCT05507580|567381840|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
157175047|NCT05507580|567381841|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
157175048|NCT05507580|567381842|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157175049|NCT05507580|567381843|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157175050|NCT05507580|567381844|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157175051|NCT05507580|567381845|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
157175052|NCT05507580|567381840|FG000|Double-Blind Treatment Period|Other, not specified|5|||
157175053|NCT05507580|567381841|FG001|Double-Blind Treatment Period|Other, not specified|4|||
156969397|NCT02496767|566640967|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
157046293|NCT04181788|566924094|FG001|TREATMENT|Withdrawal by Subject|2|||
157046294|NCT04181788|566924095|FG002|TREATMENT|Withdrawal by Subject|0|||
157046295|NCT04181788|566924096|FG003|TREATMENT|Withdrawal by Subject|0|||
157046296|NCT04181788|566924097|FG004|TREATMENT|Withdrawal by Subject|3|||
157046297|NCT04181788|566924098|FG005|TREATMENT|Withdrawal by Subject|5|||
157046298|NCT04181788|566924093|FG000|TREATMENT|Other unspecified|0|||
157046299|NCT04181788|566924094|FG001|TREATMENT|Other unspecified|0|||
157046300|NCT04181788|566924095|FG002|TREATMENT|Other unspecified|0|||
157046301|NCT04181788|566924096|FG003|TREATMENT|Other unspecified|0|||
157046302|NCT04181788|566924097|FG004|TREATMENT|Other unspecified|0|||
157046303|NCT04181788|566924098|FG005|TREATMENT|Other unspecified|2|||
157046304|NCT04181788|566924093|FG000|TREATMENT|Ongoing|0|||
157046305|NCT04181788|566924094|FG001|TREATMENT|Ongoing|3|||
157046306|NCT04181788|566924095|FG002|TREATMENT|Ongoing|0|||
157046307|NCT04181788|566924096|FG003|TREATMENT|Ongoing|5|||
157046308|NCT04181788|566924097|FG004|TREATMENT|Ongoing|7|||
157046309|NCT04181788|566924098|FG005|TREATMENT|Ongoing|15|||
157046310|NCT04181788|566924093|FG000|FOLLOW-UP|Death|0|||
157046311|NCT04181788|566924094|FG001|FOLLOW-UP|Death|0|||
157046312|NCT04181788|566924095|FG002|FOLLOW-UP|Death|1|||
157046313|NCT04181788|566924096|FG003|FOLLOW-UP|Death|2|||
157046314|NCT04181788|566924097|FG004|FOLLOW-UP|Death|8|||
157046315|NCT04181788|566924098|FG005|FOLLOW-UP|Death|20|||
157046316|NCT04181788|566924093|FG000|FOLLOW-UP|Lost to Follow-up|0|||
157046317|NCT04181788|566924094|FG001|FOLLOW-UP|Lost to Follow-up|0|||
157046318|NCT04181788|566924095|FG002|FOLLOW-UP|Lost to Follow-up|0|||
157046319|NCT04181788|566924096|FG003|FOLLOW-UP|Lost to Follow-up|0|||
157046320|NCT04181788|566924097|FG004|FOLLOW-UP|Lost to Follow-up|0|||
157046321|NCT04181788|566924098|FG005|FOLLOW-UP|Lost to Follow-up|2|||
157046322|NCT04181788|566924093|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
157046323|NCT04181788|566924094|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
157046324|NCT04181788|566924095|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
157046325|NCT04181788|566924096|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
157046326|NCT04181788|566924097|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
157046327|NCT04181788|566924098|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
157046328|NCT04181788|566924093|FG000|FOLLOW-UP|Other unspecified|0|||
157046329|NCT04181788|566924094|FG001|FOLLOW-UP|Other unspecified|1|||
157046330|NCT04181788|566924095|FG002|FOLLOW-UP|Other unspecified|0|||
157046331|NCT04181788|566924096|FG003|FOLLOW-UP|Other unspecified|0|||
157046332|NCT04181788|566924097|FG004|FOLLOW-UP|Other unspecified|0|||
157046333|NCT04181788|566924098|FG005|FOLLOW-UP|Other unspecified|3|||
157046334|NCT04181788|566924093|FG000|FOLLOW-UP|Ongoing|0|||
157046335|NCT04181788|566924094|FG001|FOLLOW-UP|Ongoing|0|||
157046336|NCT04181788|566924095|FG002|FOLLOW-UP|Ongoing|1|||
157046337|NCT04181788|566924096|FG003|FOLLOW-UP|Ongoing|3|||
157046338|NCT04181788|566924097|FG004|FOLLOW-UP|Ongoing|2|||
157046339|NCT04181788|566924098|FG005|FOLLOW-UP|Ongoing|2|||
157046340|NCT04937504|566924099|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
157046341|NCT04937504|566924100|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
157046342|NCT04937504|566924099|FG000|9 Months Assessment|Lost to Follow-up|3|||
157046343|NCT04937504|566924100|FG001|9 Months Assessment|Lost to Follow-up|2|||
157046344|NCT04535414|566924101|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
157046345|NCT04535414|566924102|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
157046346|NCT04535414|566924101|FG000|Overall Study|Cancelled appointment|1|||
157046347|NCT04535414|566924102|FG001|Overall Study|Cancelled appointment|0|||
156969398|NCT02496767|566640968|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969399|NCT02496767|566640969|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969400|NCT02496767|566640970|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969401|NCT02496767|566640971|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969402|NCT02496767|566640972|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969403|NCT02496767|566640973|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969404|NCT02496767|566640974|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
156969405|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156969406|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
156969407|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
156969408|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
156969409|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
156969410|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156969411|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
156969412|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
157046348|NCT04535414|566924101|FG000|Overall Study|cancelled - food in stomach|2|||
157046349|NCT04535414|566924102|FG001|Overall Study|cancelled - food in stomach|0|||
157046350|NCT04535414|566924101|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
157046351|NCT04535414|566924102|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
157046352|NCT04535414|566924101|FG000|Overall Study|Withdrawal by Subject|0|||
157046353|NCT04535414|566924102|FG001|Overall Study|Withdrawal by Subject|1|||
157046354|NCT04186247|566924103|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
157046355|NCT04186247|566924104|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
157046356|NCT04186247|566924105|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
157175054|NCT05507580|567381842|FG002|Double-Blind Treatment Period|Other, not specified|0|||
157046357|NCT04186247|566924106|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
157046358|NCT04186247|566924107|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
157046359|NCT03662659|566924108|FG000|Pre-treatment|Participant no longer met study criteria|1|||
157046360|NCT03662659|566924109|FG001|Pre-treatment|Participant no longer met study criteria|1|||
157046361|NCT03662659|566924108|FG000|Pre-treatment|Other reasons|1|||
157046362|NCT03662659|566924109|FG001|Pre-treatment|Other reasons|0|||
157046363|NCT03662659|566924108|FG000|Treatment|Completed Treatment|0|||
157046364|NCT03662659|566924109|FG001|Treatment|Completed Treatment|2|||
157046365|NCT03662659|566924108|FG000|Treatment|Disease Progression|85|||
157046366|NCT03662659|566924109|FG001|Treatment|Disease Progression|97|||
157046367|NCT03662659|566924108|FG000|Treatment|Study Drug Toxicity|19|||
157046368|NCT03662659|566924109|FG001|Treatment|Study Drug Toxicity|9|||
157046369|NCT03662659|566924108|FG000|Treatment|Death|11|||
157046370|NCT03662659|566924109|FG001|Treatment|Death|9|||
157046371|NCT03662659|566924108|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
157046372|NCT03662659|566924109|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
157046373|NCT03662659|566924108|FG000|Treatment|Withdrawal by Subject|1|||
157046374|NCT03662659|566924109|FG001|Treatment|Withdrawal by Subject|1|||
157046375|NCT03662659|566924108|FG000|Treatment|Poor/Non-compliance|1|||
157046376|NCT03662659|566924109|FG001|Treatment|Poor/Non-compliance|0|||
157046377|NCT03662659|566924108|FG000|Treatment|Participant no longer meets study criteria|1|||
157046378|NCT03662659|566924109|FG001|Treatment|Participant no longer meets study criteria|0|||
157046379|NCT03662659|566924108|FG000|Treatment|Other reasons|10|||
157046380|NCT03662659|566924109|FG001|Treatment|Other reasons|8|||
157046381|NCT03662659|566924108|FG000|Treatment|Administrative reasons by sponsor|1|||
157046382|NCT03662659|566924109|FG001|Treatment|Administrative reasons by sponsor|0|||
157046383|NCT03662659|566924108|FG000|Treatment|maximum clinical benefit|0|||
157046384|NCT03662659|566924109|FG001|Treatment|maximum clinical benefit|2|||
157046385|NCT04369664|566926011|FG000|Overall Study|Physician Decision|1|||
157046386|NCT04369664|566926012|FG001|Overall Study|Physician Decision|0|||
157046387|NCT01668355|566926015|FG000|Overall Study|Death|3|||
157046388|NCT01668355|566926016|FG001|Overall Study|Death|1|||
157046389|NCT01668355|566926015|FG000|Overall Study|Withdrawal by Subject|6|||
157046390|NCT01668355|566926016|FG001|Overall Study|Withdrawal by Subject|1|||
157046391|NCT00535626|566926017|FG000|Overall Study|Death|15|||
157046392|NCT00535626|566926017|FG000|Overall Study|Lost to Follow-up|29|||
157046393|NCT00535626|566926017|FG000|Overall Study|Withdrawal by Subject|20|||
157046394|NCT00535626|566926017|FG000|Overall Study|Removal/revision of study component|8|||
157046395|NCT00535626|566926017|FG000|Overall Study|Subject terminated|31|||
157046396|NCT00535626|566926017|FG000|Overall Study|Unable to return|2|||
157046397|NCT02830893|566926018|FG000|Overall Study|Relocation to out of the country|1|||
157046398|NCT02830893|566926019|FG001|Overall Study|Relocation to out of the country|0|||
157046399|NCT02830893|566926018|FG000|Overall Study|Lost to Follow-up|0|||
157046400|NCT02830893|566926019|FG001|Overall Study|Lost to Follow-up|2|||
157046401|NCT02830893|566926018|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
157046402|NCT02830893|566926019|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
157046403|NCT01277302|566926020|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
157046404|NCT01277302|566926021|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
157046405|NCT01277302|566926022|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
157046406|NCT01277302|566926020|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
157046407|NCT01277302|566926021|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
157046408|NCT01277302|566926022|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
157046409|NCT01277302|566926020|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
157046410|NCT01277302|566926021|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
157046411|NCT01277302|566926022|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
157046412|NCT01277302|566926020|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
157046413|NCT01277302|566926021|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
157046414|NCT01277302|566926022|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
157046415|NCT01277302|566926020|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
157046416|NCT01277302|566926021|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
157175055|NCT05507580|567381843|FG003|Double-Blind Treatment Period|Other, not specified|0|||
157175056|NCT05507580|567381844|FG004|Double-Blind Treatment Period|Other, not specified|0|||
157175057|NCT05507580|567381845|FG005|Double-Blind Treatment Period|Other, not specified|0|||
157046417|NCT01277302|566926022|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
157046418|NCT01277302|566926020|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
157046419|NCT01277302|566926021|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
157046420|NCT01277302|566926022|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
157046421|NCT01277302|566926020|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
157046422|NCT01277302|566926021|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
157046423|NCT01277302|566926022|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
157175058|NCT05507580|567381840|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
157228831|NCT05097989|567583377|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
157228832|NCT05097989|567583378|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157228833|NCT05097989|567583379|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157228834|NCT05097989|567583380|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
157228835|NCT05097989|567583381|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157228836|NCT05097989|567583382|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
157228837|NCT05097989|567583383|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
157228838|NCT05097989|567583375|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157046424|NCT01277302|566926020|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
157046425|NCT01277302|566926021|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
157046426|NCT01277302|566926022|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
157046427|NCT01277302|566926020|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
157046428|NCT01277302|566926021|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
157046429|NCT01277302|566926022|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
157046430|NCT02710669|566926025|FG000|Overall Study|Physician Decision|2|||
157046431|NCT02710669|566926026|FG001|Overall Study|Physician Decision|1|||
157046432|NCT02710669|566926027|FG002|Overall Study|Physician Decision|0|||
157046433|NCT02710669|566926025|FG000|Overall Study|Institutional delays (including COVID)|2|||
157046434|NCT02710669|566926026|FG001|Overall Study|Institutional delays (including COVID)|2|||
157046435|NCT02710669|566926027|FG002|Overall Study|Institutional delays (including COVID)|0|||
157046436|NCT02710669|566926025|FG000|Overall Study|arrived in afib/aflutter|10|||
157046437|NCT02710669|566926026|FG001|Overall Study|arrived in afib/aflutter|8|||
157046438|NCT02710669|566926027|FG002|Overall Study|arrived in afib/aflutter|2|||
157046439|NCT01567852|566926028|FG000|Overall Study|Withdrawal by Subject|3|||
157046440|NCT01567852|566926029|FG001|Overall Study|Withdrawal by Subject|6|||
157046441|NCT01567852|566926028|FG000|Overall Study|ECT discontinued|1|||
157046442|NCT01567852|566926029|FG001|Overall Study|ECT discontinued|1|||
157175059|NCT05507580|567381841|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
157175060|NCT05507580|567381842|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
157175061|NCT05507580|567381843|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
157175062|NCT05507580|567381844|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
157175063|NCT05507580|567381845|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
157175064|NCT05507580|567381840|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
157175065|NCT05507580|567381841|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
157175066|NCT05507580|567381842|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
157175067|NCT05507580|567381843|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
157175068|NCT05507580|567381844|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
157175069|NCT05507580|567381845|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
157175070|NCT05507580|567381840|FG000|Single-Blind Treatment Period|Other, not specified|0|||
157175071|NCT05507580|567381841|FG001|Single-Blind Treatment Period|Other, not specified|0|||
157175072|NCT05507580|567381842|FG002|Single-Blind Treatment Period|Other, not specified|2|||
157175073|NCT05507580|567381843|FG003|Single-Blind Treatment Period|Other, not specified|7|||
157175074|NCT05507580|567381844|FG004|Single-Blind Treatment Period|Other, not specified|3|||
157175075|NCT05507580|567381845|FG005|Single-Blind Treatment Period|Other, not specified|5|||
157175076|NCT03037307|567381846|FG000|Period 1|Did Not Meet Study Criteria|0|||
157175077|NCT03037307|567381847|FG001|Period 1|Did Not Meet Study Criteria|0|||
157175078|NCT03037307|567381848|FG002|Period 1|Did Not Meet Study Criteria|0|||
157175079|NCT03037307|567381849|FG003|Period 1|Did Not Meet Study Criteria|1|||
157175080|NCT03037307|567381850|FG004|Period 1|Did Not Meet Study Criteria|0|||
157175081|NCT03037307|567381851|FG005|Period 1|Did Not Meet Study Criteria|0|||
157175082|NCT00802867|567381852|FG000|Overall Study|Lost to Follow-up|6|||
157175083|NCT00802867|567381852|FG000|Overall Study|Protocol Violation|6|||
157175084|NCT00802867|567381852|FG000|Overall Study|Withdrawal by Subject|1|||
157175085|NCT03000686|567381859|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
157175086|NCT03000686|567381860|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
157175087|NCT03000686|567381861|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
157175088|NCT03000686|567381862|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
157175089|NCT02920450|567381863|FG000|Overall Study|Death|1|||
157175090|NCT02920450|567381864|FG001|Overall Study|Death|0|||
157175091|NCT02920450|567381865|FG002|Overall Study|Death|0|||
157175092|NCT02920450|567381866|FG003|Overall Study|Death|0|||
157175093|NCT02920450|567381863|FG000|Overall Study|Withdrawal by Subject|1|||
157228839|NCT05097989|567583376|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157228840|NCT05097989|567583377|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
157046443|NCT03332589|566926030|FG000|Overall Study|Lack of Efficacy|2|||
157046444|NCT03332589|566926031|FG001|Overall Study|Lack of Efficacy|0|||
157046445|NCT03332589|566926032|FG002|Overall Study|Lack of Efficacy|0|||
157175094|NCT02920450|567381864|FG001|Overall Study|Withdrawal by Subject|0|||
157046446|NCT03332589|566926030|FG000|Overall Study|Adverse Event|1|||
157175095|NCT02920450|567381865|FG002|Overall Study|Withdrawal by Subject|0|||
157228841|NCT05097989|567583378|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157046447|NCT03332589|566926031|FG001|Overall Study|Adverse Event|0|||
157046448|NCT03332589|566926032|FG002|Overall Study|Adverse Event|0|||
157046449|NCT03332589|566926030|FG000|Overall Study|Death|1|||
157046450|NCT03332589|566926031|FG001|Overall Study|Death|0|||
157046451|NCT03332589|566926032|FG002|Overall Study|Death|0|||
157046452|NCT04633200|566926033|FG000|Overall Study|Lost to Follow-up|3|||
157046453|NCT04633200|566926034|FG001|Overall Study|Lost to Follow-up|5|||
157046454|NCT03690219|566926035|FG000|Overall Study|no injuries|9|||
157046455|NCT03690219|566926036|FG001|Overall Study|no injuries|20|||
157046456|NCT03690219|566926035|FG000|Overall Study|missing information|7|||
157046457|NCT03690219|566926036|FG001|Overall Study|missing information|7|||
157046458|NCT01523392|566926037|FG000|Treatment Period 1|Withdrawal by Subject|2|||
157046459|NCT01523392|566926038|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157046460|NCT01523392|566926037|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
157046461|NCT01523392|566926038|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
157046462|NCT01523392|566926037|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
157046463|NCT01523392|566926038|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
157046464|NCT04809623|566926039|FG000|Overall Study|Study Terminated by Sponsor|1|||
157046465|NCT04809623|566926040|FG001|Overall Study|Study Terminated by Sponsor|0|||
157046466|NCT02002689|566926041|FG000|Overall Study|Disease Progression|7|||
157046467|NCT02002689|566926041|FG000|Overall Study|Adverse Event|3|||
157046468|NCT02354417|566926042|FG000|Overall Study|Physician Decision|1|||
157046469|NCT02092285|566926043|FG000|Induction Phase|Adverse Event|7|||
157046470|NCT02092285|566926043|FG000|Induction Phase|Physician Decision|4|||
157046471|NCT02092285|566926043|FG000|Induction Phase|Pregnancy|1|||
157046472|NCT02092285|566926043|FG000|Induction Phase|Relapse/Recurrence|7|||
157046473|NCT02092285|566926043|FG000|Induction Phase|Withdrawal by Subject|2|||
157046474|NCT02092285|566926043|FG000|Induction Phase|Lack of Efficacy|14|||
157046475|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
157046476|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
157046477|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
157046478|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
157046479|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
157046480|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
157046481|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
157046482|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
157046483|NCT02092285|566926043|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
157046484|NCT00087516|566926044|FG000|Overall Study|Adverse Event|10|||
157046485|NCT00087516|566926045|FG001|Overall Study|Adverse Event|10|||
157046486|NCT00087516|566926046|FG002|Overall Study|Adverse Event|3|||
157046487|NCT00087516|566926047|FG003|Overall Study|Adverse Event|6|||
157046488|NCT00087516|566926044|FG000|Overall Study|Lack of Efficacy|82|||
157046489|NCT00087516|566926045|FG001|Overall Study|Lack of Efficacy|80|||
157046490|NCT00087516|566926046|FG002|Overall Study|Lack of Efficacy|39|||
157046491|NCT00087516|566926047|FG003|Overall Study|Lack of Efficacy|29|||
157046492|NCT00087516|566926044|FG000|Overall Study|Lost to Follow-up|8|||
157046493|NCT00087516|566926045|FG001|Overall Study|Lost to Follow-up|6|||
157046494|NCT00087516|566926046|FG002|Overall Study|Lost to Follow-up|5|||
157046495|NCT00087516|566926047|FG003|Overall Study|Lost to Follow-up|5|||
157046496|NCT00087516|566926044|FG000|Overall Study|Protocol Violation|4|||
157046497|NCT00087516|566926045|FG001|Overall Study|Protocol Violation|8|||
157046498|NCT00087516|566926046|FG002|Overall Study|Protocol Violation|3|||
157046499|NCT00087516|566926047|FG003|Overall Study|Protocol Violation|6|||
157046500|NCT00087516|566926044|FG000|Overall Study|Withdrawal by Subject|16|||
157046501|NCT00087516|566926045|FG001|Overall Study|Withdrawal by Subject|27|||
157046502|NCT00087516|566926046|FG002|Overall Study|Withdrawal by Subject|11|||
157046503|NCT00087516|566926047|FG003|Overall Study|Withdrawal by Subject|12|||
157046504|NCT00087516|566926044|FG000|Overall Study|Site terminated|0|||
157175096|NCT02920450|567381866|FG003|Overall Study|Withdrawal by Subject|0|||
157175097|NCT00770224|567381873|FG000|Step 1: Induction|Adverse Event|3|||
157175098|NCT00770224|567381874|FG001|Step 1: Induction|Adverse Event|0|||
157175099|NCT00770224|567381873|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
157046505|NCT00087516|566926045|FG001|Overall Study|Site terminated|2|||
157175100|NCT00770224|567381874|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
157175101|NCT00770224|567381873|FG000|Step 1: Induction|Other reason not protocol specified|2|||
157046506|NCT00087516|566926046|FG002|Overall Study|Site terminated|1|||
157046507|NCT00087516|566926047|FG003|Overall Study|Site terminated|0|||
157046508|NCT00087516|566926044|FG000|Overall Study|Protocol specified discontinuation|35|||
157046509|NCT00087516|566926045|FG001|Overall Study|Protocol specified discontinuation|33|||
157046510|NCT00087516|566926046|FG002|Overall Study|Protocol specified discontinuation|33|||
157175102|NCT00770224|567381874|FG001|Step 1: Induction|Other reason not protocol specified|0|||
157175103|NCT00770224|567381873|FG000|Step 1: Induction|Ineligible|2|||
157175104|NCT00770224|567381874|FG001|Step 1: Induction|Ineligible|0|||
157046511|NCT00087516|566926047|FG003|Overall Study|Protocol specified discontinuation|26|||
157046512|NCT00087516|566926044|FG000|Overall Study|Patient moved|3|||
157046513|NCT00087516|566926045|FG001|Overall Study|Patient moved|2|||
157046514|NCT00087516|566926046|FG002|Overall Study|Patient moved|1|||
157228842|NCT05097989|567583379|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157228843|NCT05097989|567583380|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157228844|NCT05097989|567583381|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157046515|NCT00087516|566926047|FG003|Overall Study|Patient moved|0|||
157046516|NCT00087516|566926044|FG000|Overall Study|Patient was non-compliant|3|||
157046517|NCT00087516|566926045|FG001|Overall Study|Patient was non-compliant|1|||
157046518|NCT00087516|566926046|FG002|Overall Study|Patient was non-compliant|0|||
157046519|NCT00087516|566926047|FG003|Overall Study|Patient was non-compliant|0|||
157046520|NCT00087516|566926044|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
157046521|NCT00087516|566926045|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
157046522|NCT00087516|566926046|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
157046523|NCT00087516|566926047|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
157228845|NCT05097989|567583382|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157228846|NCT05097989|567583383|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
157228847|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157046524|NCT00087516|566926044|FG000|Overall Study|Other|0|||
157046525|NCT00087516|566926045|FG001|Overall Study|Other|0|||
157046526|NCT00087516|566926046|FG002|Overall Study|Other|1|||
157046527|NCT00087516|566926047|FG003|Overall Study|Other|0|||
157046528|NCT02236611|566926048|FG000|Overall Study|Adverse Event|10|||
157046529|NCT02236611|566926049|FG001|Overall Study|Adverse Event|16|||
157046530|NCT02236611|566926048|FG000|Overall Study|Lack of Efficacy|4|||
157046531|NCT02236611|566926049|FG001|Overall Study|Lack of Efficacy|7|||
157046532|NCT02236611|566926048|FG000|Overall Study|Lost to Follow-up|0|||
157046533|NCT02236611|566926049|FG001|Overall Study|Lost to Follow-up|2|||
157228848|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
157228849|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228850|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228851|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228852|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228853|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228854|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228855|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
157228856|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228857|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228858|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228859|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228860|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157228861|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228862|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228863|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228864|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157228865|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228866|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228867|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228868|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228869|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
157228870|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228871|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228872|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228873|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
157228874|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228875|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157046534|NCT02236611|566926048|FG000|Overall Study|Protocol deviation|3|||
157046535|NCT02236611|566926049|FG001|Overall Study|Protocol deviation|5|||
157046536|NCT02236611|566926048|FG000|Overall Study|Withdrew consent|9|||
157046537|NCT02236611|566926049|FG001|Overall Study|Withdrew consent|4|||
157046538|NCT01450007|566926050|FG000|Overall Study|Late exclusion before treatment|2|||
157046539|NCT01450007|566926051|FG001|Overall Study|Late exclusion before treatment|3|||
157046540|NCT01450007|566926052|FG002|Overall Study|Late exclusion before treatment|2|||
157046541|NCT01450007|566926050|FG000|Overall Study|Protocol Violation|0|||
157046542|NCT01450007|566926051|FG001|Overall Study|Protocol Violation|1|||
157046543|NCT01450007|566926052|FG002|Overall Study|Protocol Violation|1|||
157228876|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228877|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
157228878|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228879|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157046544|NCT01450007|566926050|FG000|Overall Study|Adverse Event|0|||
157046545|NCT01450007|566926051|FG001|Overall Study|Adverse Event|1|||
157046546|NCT01450007|566926052|FG002|Overall Study|Adverse Event|0|||
157046547|NCT01332266|566926053|FG000|Phase 1b|Death|3|||
157175105|NCT00770224|567381873|FG000|Step 1: Induction|No protocol treatment given|1|||
157175106|NCT00770224|567381874|FG001|Step 1: Induction|No protocol treatment given|0|||
157175107|NCT00770224|567381873|FG000|Step 2: Maintenance|Adverse Event|0|||
157175108|NCT00770224|567381874|FG001|Step 2: Maintenance|Adverse Event|10|||
157175109|NCT00770224|567381873|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
156969413|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156969414|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
156969415|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
156969416|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
156969417|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
156969418|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156969419|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156969420|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
156969421|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
156969422|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
156969423|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
156969424|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
156969425|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
156969426|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
156969427|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
156969428|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
156969429|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
156969430|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
156969431|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
156969432|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
156969433|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
156969434|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
156969435|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
156969436|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
156969437|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156969438|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
156969439|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
156969440|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
156969441|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
156969442|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156969443|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156969444|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
156969445|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969446|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
156969447|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
156969448|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969449|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969450|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969451|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969452|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
156969453|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156969454|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
156969455|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156969456|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
156969457|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
156969458|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156969459|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156969460|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
156969461|NCT02496767|566640967|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969462|NCT02496767|566640968|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
156969463|NCT02496767|566640969|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969464|NCT02496767|566640970|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969465|NCT02496767|566640971|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969466|NCT02496767|566640972|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969467|NCT02496767|566640973|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969468|NCT02496767|566640974|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
156969469|NCT02496767|566640967|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
156969470|NCT02496767|566640968|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
157175110|NCT00770224|567381874|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
157175111|NCT00770224|567381873|FG000|Step 2: Maintenance|Progression/relapse|0|||
157175112|NCT00770224|567381874|FG001|Step 2: Maintenance|Progression/relapse|1|||
157175113|NCT00770224|567381873|FG000|Step 2: Maintenance|Death|0|||
157175114|NCT00770224|567381874|FG001|Step 2: Maintenance|Death|2|||
157175115|NCT00770224|567381873|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
157175116|NCT00770224|567381874|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
157175117|NCT00770224|567381873|FG000|Step 2: Maintenance|Ineligible|0|||
157175118|NCT00770224|567381874|FG001|Step 2: Maintenance|Ineligible|2|||
157175119|NCT04737759|567381875|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
157175120|NCT04737759|567381876|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
157175121|NCT04737759|567381875|FG000|Overall Study|Death|2|||
157175122|NCT04737759|567381876|FG001|Overall Study|Death|0|||
157175123|NCT04737759|567381875|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
157175124|NCT04737759|567381876|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
157175125|NCT04737759|567381875|FG000|Overall Study|Lost to Follow-up|4|||
157175126|NCT04737759|567381876|FG001|Overall Study|Lost to Follow-up|12|||
157175127|NCT01484561|567381877|FG000|Overall Study|Lack of Efficacy|3|||
157175128|NCT01484561|567381878|FG001|Overall Study|Lack of Efficacy|1|||
157175129|NCT01484561|567381877|FG000|Overall Study|Lost to Follow-up|1|||
157175130|NCT01484561|567381878|FG001|Overall Study|Lost to Follow-up|0|||
157175131|NCT01484561|567381877|FG000|Overall Study|Withdrawal by Subject|3|||
157175132|NCT01484561|567381878|FG001|Overall Study|Withdrawal by Subject|0|||
157175133|NCT01484561|567381877|FG000|Overall Study|Other|1|||
157175134|NCT01484561|567381878|FG001|Overall Study|Other|1|||
157175135|NCT01484561|567381877|FG000|Overall Study|Adverse Event|1|||
157175136|NCT01484561|567381878|FG001|Overall Study|Adverse Event|4|||
157175137|NCT01112982|567381879|FG000|Overall Study|Withdrawal by Subject|1|||
157175138|NCT01112982|567381879|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
157175139|NCT03371251|567381880|FG000|Overall Study|Withdrawal by Subject|1|||
157175140|NCT03371251|567381881|FG001|Overall Study|Withdrawal by Subject|0|||
157175141|NCT03371251|567381882|FG002|Overall Study|Withdrawal by Subject|1|||
157175142|NCT03371251|567381883|FG003|Overall Study|Withdrawal by Subject|0|||
157175143|NCT03371251|567381884|FG004|Overall Study|Withdrawal by Subject|2|||
157175144|NCT03371251|567381885|FG005|Overall Study|Withdrawal by Subject|2|||
157175145|NCT03371251|567381880|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
157175146|NCT03371251|567381881|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
157175147|NCT03371251|567381882|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
157175148|NCT03371251|567381883|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
157175149|NCT03371251|567381884|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
157175150|NCT03371251|567381885|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
157175151|NCT03371251|567381880|FG000|Overall Study|Adverse Event|0|||
157175152|NCT03371251|567381881|FG001|Overall Study|Adverse Event|0|||
157175153|NCT03371251|567381882|FG002|Overall Study|Adverse Event|0|||
157175154|NCT03371251|567381883|FG003|Overall Study|Adverse Event|0|||
157175155|NCT03371251|567381884|FG004|Overall Study|Adverse Event|1|||
157175156|NCT03371251|567381885|FG005|Overall Study|Adverse Event|0|||
157175157|NCT03371251|567381880|FG000|Overall Study|Decision by Sponsor|0|||
157175158|NCT03371251|567381881|FG001|Overall Study|Decision by Sponsor|0|||
157175159|NCT03371251|567381882|FG002|Overall Study|Decision by Sponsor|0|||
157175160|NCT03371251|567381883|FG003|Overall Study|Decision by Sponsor|0|||
157175161|NCT03371251|567381884|FG004|Overall Study|Decision by Sponsor|2|||
157175162|NCT03371251|567381885|FG005|Overall Study|Decision by Sponsor|0|||
157175163|NCT00294684|567381886|FG000|Overall Study|Lost to Follow-up|5|||
157175164|NCT00294684|567381887|FG001|Overall Study|Lost to Follow-up|8|||
157175165|NCT05425719|567381888|FG000|Overall Study|Lost to Follow-up|4|||
157175166|NCT05425719|567381889|FG001|Overall Study|Lost to Follow-up|0|||
157175167|NCT05425719|567381888|FG000|Overall Study|Withdrew consent|1|||
157175168|NCT05425719|567381889|FG001|Overall Study|Withdrew consent|1|||
157175169|NCT01033487|567381892|FG000|Fourth Intervention Period|Adverse Event|0|||
157175170|NCT01033487|567381893|FG001|Fourth Intervention Period|Adverse Event|0|||
157175171|NCT01033487|567381894|FG002|Fourth Intervention Period|Adverse Event|0|||
157175172|NCT01033487|567381895|FG003|Fourth Intervention Period|Adverse Event|0|||
157175173|NCT01033487|567381896|FG004|Fourth Intervention Period|Adverse Event|0|||
157175174|NCT01033487|567381897|FG005|Fourth Intervention Period|Adverse Event|0|||
157046548|NCT01332266|566926054|FG001|Phase 1b|Death|3|||
157175175|NCT01033487|567381898|FG006|Fourth Intervention Period|Adverse Event|0|||
157046549|NCT01332266|566926055|FG002|Phase 1b|Death|2|||
157046550|NCT01332266|566926056|FG003|Phase 1b|Death|0|||
157175176|NCT01033487|567381899|FG007|Fourth Intervention Period|Adverse Event|0|||
157175177|NCT01033487|567381900|FG008|Fourth Intervention Period|Adverse Event|1|||
157046551|NCT01332266|566926057|FG004|Phase 1b|Death|0|||
157175178|NCT01033487|567381901|FG009|Fourth Intervention Period|Adverse Event|0|||
157175179|NCT02193828|567381902|FG000|Overall Study|Withdrawal by Subject|0|||
157175180|NCT02193828|567381903|FG001|Overall Study|Withdrawal by Subject|0|||
157046552|NCT01332266|566926053|FG000|Phase 1b|Lost to Follow-up|0|||
157046553|NCT01332266|566926054|FG001|Phase 1b|Lost to Follow-up|1|||
157175181|NCT02193828|567381904|FG002|Overall Study|Withdrawal by Subject|1|||
157175182|NCT02193828|567381905|FG003|Overall Study|Withdrawal by Subject|1|||
157175183|NCT04176445|567381906|FG000|Overall Study|Adverse Event|0|||
157175184|NCT04176445|567381907|FG001|Overall Study|Adverse Event|1|||
157175185|NCT04176445|567381906|FG000|Overall Study|change plans weaning after first intervention|0|||
157175186|NCT04176445|567381907|FG001|Overall Study|change plans weaning after first intervention|1|||
157175187|NCT04377672|567381908|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
157175188|NCT03954444|567381909|FG000|Overall Study|Withdrawal by Subject|5|||
157175189|NCT03954444|567381910|FG001|Overall Study|Withdrawal by Subject|5|||
157175190|NCT03954444|567381911|FG002|Overall Study|Withdrawal by Subject|5|||
157175191|NCT03954444|567381909|FG000|Overall Study|Adverse Event|1|||
157175192|NCT03954444|567381910|FG001|Overall Study|Adverse Event|3|||
157175193|NCT03954444|567381911|FG002|Overall Study|Adverse Event|2|||
157175194|NCT03954444|567381909|FG000|Overall Study|Protocol Violation|0|||
157175195|NCT03954444|567381910|FG001|Overall Study|Protocol Violation|3|||
157175196|NCT03954444|567381911|FG002|Overall Study|Protocol Violation|5|||
157175197|NCT03954444|567381909|FG000|Overall Study|Use of prohibited therapy|1|||
157175198|NCT03954444|567381910|FG001|Overall Study|Use of prohibited therapy|1|||
157175199|NCT03954444|567381911|FG002|Overall Study|Use of prohibited therapy|2|||
157175200|NCT03954444|567381909|FG000|Overall Study|Lost to Follow-up|1|||
157175201|NCT03954444|567381910|FG001|Overall Study|Lost to Follow-up|0|||
157175202|NCT03954444|567381911|FG002|Overall Study|Lost to Follow-up|1|||
157175203|NCT03954444|567381909|FG000|Overall Study|Non-compliant with study drug application|2|||
157175204|NCT03954444|567381910|FG001|Overall Study|Non-compliant with study drug application|2|||
157175205|NCT03954444|567381911|FG002|Overall Study|Non-compliant with study drug application|0|||
157175206|NCT03954444|567381909|FG000|Overall Study|Administrative reasons|0|||
157175207|NCT03954444|567381910|FG001|Overall Study|Administrative reasons|0|||
157175208|NCT03954444|567381911|FG002|Overall Study|Administrative reasons|1|||
157175209|NCT03954444|567381909|FG000|Overall Study|Miscellaneous|3|||
157175210|NCT03954444|567381910|FG001|Overall Study|Miscellaneous|2|||
157175211|NCT03954444|567381911|FG002|Overall Study|Miscellaneous|1|||
157175212|NCT00435994|567381913|FG000|Overall Study|Lost to Follow-up|7|||
157175213|NCT00435994|567381914|FG001|Overall Study|Lost to Follow-up|0|||
157175214|NCT00435994|567381915|FG002|Overall Study|Lost to Follow-up|0|||
157175215|NCT05109702|567381917|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
157175216|NCT05109702|567381918|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
157175217|NCT05109702|567381919|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
157175218|NCT05109702|567381917|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
157175219|NCT05109702|567381918|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
157175220|NCT05109702|567381919|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
157175221|NCT05109702|567381917|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
157175222|NCT05109702|567381918|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
157175223|NCT05109702|567381919|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
157175224|NCT05109702|567381917|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
157175225|NCT05109702|567381918|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
157175226|NCT05109702|567381919|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
157175227|NCT05109702|567381917|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
157175228|NCT05109702|567381918|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
157175229|NCT05109702|567381919|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
157175230|NCT03094832|567381920|FG000|Overall Study|Lost to Follow-up|0|||
157175231|NCT03094832|567381921|FG001|Overall Study|Lost to Follow-up|0|||
157175232|NCT03094832|567381922|FG002|Overall Study|Lost to Follow-up|0|||
157175233|NCT03094832|567381923|FG003|Overall Study|Lost to Follow-up|1|||
157175234|NCT03094832|567381924|FG004|Overall Study|Lost to Follow-up|1|||
157175235|NCT03094832|567381920|FG000|Overall Study|Death|1|||
157175236|NCT03094832|567381921|FG001|Overall Study|Death|0|||
157175237|NCT03094832|567381922|FG002|Overall Study|Death|0|||
157175238|NCT03094832|567381923|FG003|Overall Study|Death|0|||
157175239|NCT03094832|567381924|FG004|Overall Study|Death|0|||
157175240|NCT03094832|567381920|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
157175241|NCT03094832|567381921|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157175242|NCT03094832|567381922|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
157175243|NCT03094832|567381923|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
157175244|NCT03094832|567381924|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
157175245|NCT03094832|567381920|FG000|Overall Study|Other|13|||
157175246|NCT03094832|567381921|FG001|Overall Study|Other|20|||
157175247|NCT03094832|567381922|FG002|Overall Study|Other|1|||
157175248|NCT03094832|567381923|FG003|Overall Study|Other|7|||
157175249|NCT03094832|567381924|FG004|Overall Study|Other|1|||
157175250|NCT00788697|567381931|FG000|Overall Study|No study drug administered|12|||
157175251|NCT00788697|567381931|FG000|Overall Study|Training Patients|74|||
157175252|NCT00788697|567381931|FG000|Overall Study|no truth standard procedure available|5|||
157175253|NCT00788697|567381931|FG000|Overall Study|Technically inadequate truth standard|1|||
157175254|NCT00788697|567381931|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
157175255|NCT00367432|567381932|FG000|First Period (16 Weeks)|Adverse Event|6|||
157175256|NCT00367432|567381933|FG001|First Period (16 Weeks)|Adverse Event|0|||
157228880|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228881|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228882|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157228883|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
157228884|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
157046554|NCT01332266|566926055|FG002|Phase 1b|Lost to Follow-up|0|||
157046555|NCT01332266|566926056|FG003|Phase 1b|Lost to Follow-up|0|||
157046556|NCT01332266|566926057|FG004|Phase 1b|Lost to Follow-up|0|||
157046557|NCT01332266|566926053|FG000|Phase 1b|Withdrawal by Subject|1|||
157046558|NCT01332266|566926054|FG001|Phase 1b|Withdrawal by Subject|1|||
157046559|NCT01332266|566926055|FG002|Phase 1b|Withdrawal by Subject|1|||
157046560|NCT01332266|566926056|FG003|Phase 1b|Withdrawal by Subject|0|||
157046561|NCT01332266|566926057|FG004|Phase 1b|Withdrawal by Subject|0|||
157046562|NCT01332266|566926053|FG000|Phase 2|Death|0|||
157046563|NCT01332266|566926054|FG001|Phase 2|Death|0|||
157046564|NCT01332266|566926055|FG002|Phase 2|Death|0|||
157046565|NCT01332266|566926056|FG003|Phase 2|Death|33|||
157046566|NCT01332266|566926057|FG004|Phase 2|Death|36|||
157046567|NCT01332266|566926053|FG000|Phase 2|Lost to Follow-up|0|||
157046568|NCT01332266|566926054|FG001|Phase 2|Lost to Follow-up|0|||
157046569|NCT01332266|566926055|FG002|Phase 2|Lost to Follow-up|0|||
157046570|NCT01332266|566926056|FG003|Phase 2|Lost to Follow-up|2|||
157046571|NCT01332266|566926057|FG004|Phase 2|Lost to Follow-up|0|||
157046572|NCT01332266|566926053|FG000|Phase 2|Physician Decision|0|||
157046573|NCT01332266|566926054|FG001|Phase 2|Physician Decision|0|||
157046574|NCT01332266|566926055|FG002|Phase 2|Physician Decision|0|||
157046575|NCT01332266|566926056|FG003|Phase 2|Physician Decision|3|||
157046576|NCT01332266|566926057|FG004|Phase 2|Physician Decision|1|||
157046577|NCT01332266|566926053|FG000|Phase 2|Symptomatic deterioration|0|||
157046578|NCT01332266|566926054|FG001|Phase 2|Symptomatic deterioration|0|||
157046579|NCT01332266|566926055|FG002|Phase 2|Symptomatic deterioration|0|||
157046580|NCT01332266|566926056|FG003|Phase 2|Symptomatic deterioration|0|||
157046581|NCT01332266|566926057|FG004|Phase 2|Symptomatic deterioration|1|||
157046582|NCT01332266|566926053|FG000|Phase 2|Progression Disease|0|||
157046583|NCT01332266|566926054|FG001|Phase 2|Progression Disease|0|||
157046584|NCT01332266|566926055|FG002|Phase 2|Progression Disease|0|||
157046585|NCT01332266|566926056|FG003|Phase 2|Progression Disease|2|||
157046586|NCT01332266|566926057|FG004|Phase 2|Progression Disease|1|||
157046587|NCT01332266|566926053|FG000|Phase 2|Withdrawal by Subject|0|||
157046588|NCT01332266|566926054|FG001|Phase 2|Withdrawal by Subject|0|||
157046589|NCT01332266|566926055|FG002|Phase 2|Withdrawal by Subject|0|||
157046590|NCT01332266|566926056|FG003|Phase 2|Withdrawal by Subject|2|||
157046591|NCT01332266|566926057|FG004|Phase 2|Withdrawal by Subject|2|||
157046592|NCT01536704|566926060|FG000|Washout Period 1|Withdrawal by Subject|1|||
157046593|NCT01536704|566926061|FG001|Washout Period 1|Withdrawal by Subject|2|||
157046594|NCT01536704|566926062|FG002|Washout Period 1|Withdrawal by Subject|0|||
157046595|NCT01536704|566926063|FG003|Washout Period 1|Withdrawal by Subject|0|||
157046596|NCT01536704|566926060|FG000|Washout Period 2|Adverse Event|1|||
157046597|NCT01536704|566926061|FG001|Washout Period 2|Adverse Event|0|||
157046598|NCT01536704|566926062|FG002|Washout Period 2|Adverse Event|0|||
157228885|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
157228886|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
157228887|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
157228888|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
157228889|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
157228890|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
157228891|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
157228892|NCT05097989|567583375|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
157228893|NCT05097989|567583376|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
157046599|NCT01536704|566926063|FG003|Washout Period 2|Adverse Event|0|||
157046600|NCT01536704|566926060|FG000|Washout Period 2|Withdrawal by Subject|0|||
157046601|NCT01536704|566926061|FG001|Washout Period 2|Withdrawal by Subject|0|||
157046602|NCT01536704|566926062|FG002|Washout Period 2|Withdrawal by Subject|0|||
157046603|NCT01536704|566926063|FG003|Washout Period 2|Withdrawal by Subject|1|||
157046604|NCT01536704|566926060|FG000|Period 3|Adverse Event|0|||
157046605|NCT01536704|566926061|FG001|Period 3|Adverse Event|0|||
157046606|NCT01536704|566926062|FG002|Period 3|Adverse Event|0|||
157046607|NCT01536704|566926063|FG003|Period 3|Adverse Event|1|||
157046608|NCT01536704|566926060|FG000|Washout Period 3|Adverse Event|0|||
157046609|NCT01536704|566926061|FG001|Washout Period 3|Adverse Event|0|||
157046610|NCT01536704|566926062|FG002|Washout Period 3|Adverse Event|1|||
157046611|NCT01536704|566926063|FG003|Washout Period 3|Adverse Event|0|||
157228894|NCT05097989|567583377|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
157046612|NCT01947491|566926064|FG000|Overall Study|Lost to Follow-up|5|||
157046613|NCT01947491|566926065|FG001|Overall Study|Lost to Follow-up|3|||
157046614|NCT01947491|566926066|FG002|Overall Study|Lost to Follow-up|1|||
157046615|NCT01947491|566926067|FG003|Overall Study|Lost to Follow-up|2|||
157046616|NCT01947491|566926064|FG000|Overall Study|Lack of Efficacy|1|||
156969471|NCT02496767|566640969|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
156969472|NCT02496767|566640970|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
156969473|NCT02496767|566640971|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
156969474|NCT02496767|566640972|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
156969475|NCT02496767|566640973|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
156969476|NCT02496767|566640974|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
156969477|NCT02496767|566640967|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
156969478|NCT02496767|566640968|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
156969479|NCT02496767|566640969|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
156969480|NCT02496767|566640970|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
156969481|NCT02496767|566640971|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
156969482|NCT02496767|566640972|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
156969483|NCT02496767|566640973|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
156969484|NCT02496767|566640974|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
156969485|NCT02496767|566640967|FG000|Double-blind, Withdrawal Phase|Death|0|||
156969486|NCT02496767|566640968|FG001|Double-blind, Withdrawal Phase|Death|0|||
156969487|NCT02496767|566640969|FG002|Double-blind, Withdrawal Phase|Death|0|||
156969488|NCT02496767|566640970|FG003|Double-blind, Withdrawal Phase|Death|0|||
156969489|NCT02496767|566640971|FG004|Double-blind, Withdrawal Phase|Death|0|||
156969490|NCT02496767|566640972|FG005|Double-blind, Withdrawal Phase|Death|0|||
156969491|NCT02496767|566640973|FG006|Double-blind, Withdrawal Phase|Death|1|||
156969492|NCT02496767|566640974|FG007|Double-blind, Withdrawal Phase|Death|2|||
156969493|NCT02496767|566640967|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156969494|NCT02496767|566640968|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156969495|NCT02496767|566640969|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156969496|NCT02496767|566640970|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156969497|NCT02496767|566640971|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
156969498|NCT02496767|566640972|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156969499|NCT02496767|566640973|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156969500|NCT02496767|566640974|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
156969501|NCT04035200|566640980|FG000|Overall Study|Lost to Follow-up|0|||
156969502|NCT04035200|566640981|FG001|Overall Study|Lost to Follow-up|1|||
156969503|NCT04035200|566640982|FG002|Overall Study|Lost to Follow-up|0|||
156969504|NCT04035200|566640980|FG000|Overall Study|Withdrawal by Subject|1|||
156969505|NCT04035200|566640981|FG001|Overall Study|Withdrawal by Subject|4|||
156969506|NCT04035200|566640982|FG002|Overall Study|Withdrawal by Subject|4|||
156969507|NCT04035200|566640980|FG000|Overall Study|COVID-19|1|||
156969508|NCT04035200|566640981|FG001|Overall Study|COVID-19|0|||
156969509|NCT04035200|566640982|FG002|Overall Study|COVID-19|0|||
156969510|NCT04035200|566640980|FG000|Overall Study|Early Termination|0|||
156969511|NCT04035200|566640981|FG001|Overall Study|Early Termination|1|||
156969512|NCT04035200|566640982|FG002|Overall Study|Early Termination|0|||
156969513|NCT04035200|566640980|FG000|Overall Study|Non-compliance|0|||
156969514|NCT04035200|566640981|FG001|Overall Study|Non-compliance|1|||
156969515|NCT04035200|566640982|FG002|Overall Study|Non-compliance|0|||
156969516|NCT03138733|566640985|FG000|Overall Study|Death|17|||
156969517|NCT03138733|566640986|FG001|Overall Study|Death|18|||
156969518|NCT03138733|566640985|FG000|Overall Study|Withdrawal by Subject|11|||
156969519|NCT03138733|566640986|FG001|Overall Study|Withdrawal by Subject|6|||
156969520|NCT03138733|566640985|FG000|Overall Study|Lost to Follow-up|3|||
156969521|NCT03138733|566640986|FG001|Overall Study|Lost to Follow-up|2|||
156969522|NCT03138733|566640985|FG000|Overall Study|Adverse Event|1|||
156969523|NCT03138733|566640986|FG001|Overall Study|Adverse Event|0|||
156969524|NCT03138733|566640985|FG000|Overall Study|Protocol Violation|1|||
156969525|NCT03138733|566640986|FG001|Overall Study|Protocol Violation|3|||
156969526|NCT03138733|566640985|FG000|Overall Study|Administrative or logistical reason|1|||
156969527|NCT03138733|566640986|FG001|Overall Study|Administrative or logistical reason|0|||
156969528|NCT03138733|566640985|FG000|Overall Study|The patient was transferred to another hospital|1|||
156969529|NCT03138733|566640986|FG001|Overall Study|The patient was transferred to another hospital|0|||
156969530|NCT01089374|566640987|FG000|Overall Study|Lost to Follow-up|3|||
156969531|NCT01089374|566640988|FG001|Overall Study|Lost to Follow-up|0|||
156969532|NCT01089374|566640987|FG000|Overall Study|Withdrawal by Subject|1|||
156969533|NCT01089374|566640988|FG001|Overall Study|Withdrawal by Subject|0|||
156969534|NCT01089374|566640987|FG000|Overall Study|Study closed early - low accrual|6|||
156969535|NCT01089374|566640988|FG001|Overall Study|Study closed early - low accrual|0|||
156969536|NCT03641313|566641002|FG000|Overall Study|Death|1|||
156969537|NCT03641313|566641002|FG000|Overall Study|Withdrawal by Subject|2|||
156969538|NCT03641313|566641002|FG000|Overall Study|Declining health|1|||
156969539|NCT03641313|566641002|FG000|Overall Study|Adverse Event|1|||
156969540|NCT03033225|566641003|FG000|Overall Study|Withdrawal by Subject|5|||
156969541|NCT01533493|566641006|FG000|Overall Study|Adverse Event|2|||
156969542|NCT01533493|566641007|FG001|Overall Study|Adverse Event|1|||
156969543|NCT01533493|566641006|FG000|Overall Study|Withdrawal by Subject|1|||
156969544|NCT01533493|566641007|FG001|Overall Study|Withdrawal by Subject|2|||
156969545|NCT01533493|566641006|FG000|Overall Study|Lost to Follow-up|2|||
156969546|NCT01533493|566641007|FG001|Overall Study|Lost to Follow-up|0|||
156969547|NCT05614089|566641013|FG000|Overall Study|Pregnancy|5|||
156969548|NCT05614089|566641014|FG001|Overall Study|Pregnancy|2|||
156969549|NCT05614089|566641013|FG000|Overall Study|Lost to Follow-up|5|||
156969550|NCT05614089|566641014|FG001|Overall Study|Lost to Follow-up|1|||
156969551|NCT05614089|566641013|FG000|Overall Study|Death|0|||
156969552|NCT05614089|566641014|FG001|Overall Study|Death|1|||
156969553|NCT05614089|566641013|FG000|Overall Study|Adverse Event|1|||
156969554|NCT05614089|566641014|FG001|Overall Study|Adverse Event|0|||
156969555|NCT05163522|566641015|FG000|Overall Study|Withdrawal by Subject|0|||
156969556|NCT05163522|566641016|FG001|Overall Study|Withdrawal by Subject|0|||
156969557|NCT05163522|566641017|FG002|Overall Study|Withdrawal by Subject|1|||
156969558|NCT05163522|566641018|FG003|Overall Study|Withdrawal by Subject|0|||
156969559|NCT05163522|566641019|FG004|Overall Study|Withdrawal by Subject|0|||
156969560|NCT05163522|566641020|FG005|Overall Study|Withdrawal by Subject|0|||
156969561|NCT05163522|566641021|FG006|Overall Study|Withdrawal by Subject|0|||
156969562|NCT05163522|566641022|FG007|Overall Study|Withdrawal by Subject|0|||
156969563|NCT05163522|566641023|FG008|Overall Study|Withdrawal by Subject|0|||
156969564|NCT05163522|566641024|FG009|Overall Study|Withdrawal by Subject|0|||
156969565|NCT05163522|566641025|FG010|Overall Study|Withdrawal by Subject|0|||
156969566|NCT02521285|566641027|FG000|Overall Study|Lost to Follow-up|1|||
156969567|NCT02521285|566641028|FG001|Overall Study|Lost to Follow-up|1|||
156969568|NCT02521285|566641027|FG000|Overall Study|Withdrawal by Subject|1|||
156969569|NCT02521285|566641028|FG001|Overall Study|Withdrawal by Subject|1|||
156969570|NCT02521285|566641027|FG000|Overall Study|Adverse Event|0|||
156969571|NCT02521285|566641028|FG001|Overall Study|Adverse Event|1|||
156969572|NCT05701995|566641029|FG000|Pre-Treatment|Randomization Error|1|||
156969573|NCT05701995|566641030|FG001|Pre-Treatment|Randomization Error|1|||
156969574|NCT05701995|566641029|FG000|Treatment|Withdrawal by Subject|8|||
156969575|NCT05701995|566641030|FG001|Treatment|Withdrawal by Subject|4|||
156969576|NCT05701995|566641029|FG000|Treatment|Lost to Follow-up|2|||
156969577|NCT05701995|566641030|FG001|Treatment|Lost to Follow-up|3|||
156969578|NCT05701995|566641029|FG000|Treatment|Adverse Event|3|||
156969579|NCT05701995|566641030|FG001|Treatment|Adverse Event|1|||
156969580|NCT05701995|566641029|FG000|Treatment|Other Reason|1|||
156969581|NCT05701995|566641030|FG001|Treatment|Other Reason|1|||
156969582|NCT05701995|566641029|FG000|Treatment|Death|1|||
156969583|NCT05701995|566641030|FG001|Treatment|Death|0|||
156969584|NCT05701995|566641029|FG000|Treatment|Physician Decision|0|||
156969585|NCT05701995|566641030|FG001|Treatment|Physician Decision|1|||
156969586|NCT04899245|566641035|FG000|Overall Study|Withdrawal by Subject|3|||
156969587|NCT04899245|566641036|FG001|Overall Study|Withdrawal by Subject|5|||
156969588|NCT04899245|566641037|FG002|Overall Study|Withdrawal by Subject|2|||
156969589|NCT04899245|566641035|FG000|Overall Study|No longer eligible - Left staff position|0|||
156969590|NCT04899245|566641036|FG001|Overall Study|No longer eligible - Left staff position|0|||
156969591|NCT04899245|566641037|FG002|Overall Study|No longer eligible - Left staff position|1|||
156969592|NCT04899245|566641035|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
156969593|NCT04899245|566641036|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
156969594|NCT04899245|566641037|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
156969595|NCT04899245|566641035|FG000|Overall Study|No longer eligible - Moved away from area|2|||
156969596|NCT04899245|566641036|FG001|Overall Study|No longer eligible - Moved away from area|2|||
156969597|NCT04899245|566641037|FG002|Overall Study|No longer eligible - Moved away from area|0|||
156969598|NCT03937219|566641041|FG000|Overall Study|Death|223|||
156969599|NCT03937219|566641042|FG001|Overall Study|Death|211|||
156969600|NCT03937219|566641041|FG000|Overall Study|Withdrawal by Subject|17|||
156969601|NCT03937219|566641042|FG001|Overall Study|Withdrawal by Subject|25|||
156969602|NCT03937219|566641041|FG000|Overall Study|Lost to Follow-up|3|||
156969603|NCT03937219|566641042|FG001|Overall Study|Lost to Follow-up|4|||
156969604|NCT00500903|566641043|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
156969605|NCT00500903|566641044|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
156969606|NCT00500903|566641045|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
156969607|NCT00500903|566641043|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
156969608|NCT00500903|566641044|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
156969609|NCT00500903|566641045|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
156969610|NCT00500903|566641043|FG000|Overall Study|Progressive Disease|41|||
156969611|NCT00500903|566641044|FG001|Overall Study|Progressive Disease|2|||
156969612|NCT00500903|566641045|FG002|Overall Study|Progressive Disease|15|||
156969613|NCT00500903|566641043|FG000|Overall Study|Patient Declined Further Treatment|0|||
157228895|NCT05097989|567583378|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
157228896|NCT05097989|567583379|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
157228897|NCT05097989|567583380|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
156969614|NCT00500903|566641044|FG001|Overall Study|Patient Declined Further Treatment|0|||
156969615|NCT00500903|566641045|FG002|Overall Study|Patient Declined Further Treatment|3|||
156969616|NCT00500903|566641043|FG000|Overall Study|Symptomatic Deterioration|2|||
156969617|NCT00500903|566641044|FG001|Overall Study|Symptomatic Deterioration|0|||
156969618|NCT00500903|566641045|FG002|Overall Study|Symptomatic Deterioration|0|||
156969619|NCT00500903|566641043|FG000|Overall Study|Reason Not Specified|10|||
156969620|NCT00500903|566641044|FG001|Overall Study|Reason Not Specified|0|||
156969621|NCT00500903|566641045|FG002|Overall Study|Reason Not Specified|2|||
156969622|NCT01648348|566641046|FG000|Overall Study|Cancel|1|||
156969623|NCT01648348|566641047|FG001|Overall Study|Cancel|0|||
156969624|NCT01648348|566641048|FG002|Overall Study|Cancel|0|||
156969625|NCT01648348|566641049|FG003|Overall Study|Cancel|0|||
156969626|NCT01648348|566641050|FG004|Overall Study|Cancel|3|||
156969627|NCT01648348|566641051|FG005|Overall Study|Cancel|6|||
156969628|NCT01648348|566641046|FG000|Overall Study|Replaced for MTD analysis|1|||
156969629|NCT01648348|566641047|FG001|Overall Study|Replaced for MTD analysis|0|||
156969630|NCT01648348|566641048|FG002|Overall Study|Replaced for MTD analysis|1|||
156969631|NCT01648348|566641049|FG003|Overall Study|Replaced for MTD analysis|0|||
156969632|NCT01648348|566641050|FG004|Overall Study|Replaced for MTD analysis|0|||
156969633|NCT01648348|566641051|FG005|Overall Study|Replaced for MTD analysis|0|||
156969634|NCT00696410|566641052|FG000|Overall Study|Lost to Follow-up|2|||
156969635|NCT00696410|566641053|FG001|Overall Study|Lost to Follow-up|0|||
156969636|NCT00696410|566641052|FG000|Overall Study|Withdrawal by Subject|8|||
156969637|NCT00696410|566641053|FG001|Overall Study|Withdrawal by Subject|0|||
156969638|NCT00696410|566641052|FG000|Overall Study|Physician Decision|3|||
156969639|NCT00696410|566641053|FG001|Overall Study|Physician Decision|0|||
156969640|NCT04981678|566641054|FG000|Overall Study|Lost to Follow-up|0|||
156969641|NCT04981678|566641055|FG001|Overall Study|Lost to Follow-up|1|||
156969642|NCT03421808|566641056|FG000|Overall Study|COVID related problems|2|||
156969643|NCT03421808|566641057|FG001|Overall Study|COVID related problems|0|||
156969644|NCT03421808|566641056|FG000|Overall Study|Withdrawal by Subject|1|||
156969645|NCT03421808|566641057|FG001|Overall Study|Withdrawal by Subject|0|||
156969646|NCT03421808|566641056|FG000|Overall Study|Protocol Violation|0|||
156969647|NCT03421808|566641057|FG001|Overall Study|Protocol Violation|1|||
156969648|NCT03764774|566641060|FG000|Overall Study|Withdrawal by Subject|0|||
156969649|NCT03764774|566641061|FG001|Overall Study|Withdrawal by Subject|0|||
156969650|NCT03764774|566641062|FG002|Overall Study|Withdrawal by Subject|0|||
156969651|NCT03764774|566641063|FG003|Overall Study|Withdrawal by Subject|0|||
156969652|NCT03764774|566641064|FG004|Overall Study|Withdrawal by Subject|0|||
156969653|NCT03764774|566641065|FG005|Overall Study|Withdrawal by Subject|0|||
156969654|NCT03764774|566641066|FG006|Overall Study|Withdrawal by Subject|0|||
156969655|NCT03764774|566641067|FG007|Overall Study|Withdrawal by Subject|0|||
156969656|NCT03764774|566641068|FG008|Overall Study|Withdrawal by Subject|0|||
156969657|NCT03764774|566641069|FG009|Overall Study|Withdrawal by Subject|0|||
156969658|NCT03764774|566641070|FG010|Overall Study|Withdrawal by Subject|1|||
156969659|NCT03764774|566641071|FG011|Overall Study|Withdrawal by Subject|0|||
156969660|NCT03764774|566641072|FG012|Overall Study|Withdrawal by Subject|0|||
156969661|NCT03764774|566641073|FG013|Overall Study|Withdrawal by Subject|0|||
156969662|NCT03764774|566641060|FG000|Overall Study|Adverse Event|0|||
156969663|NCT03764774|566641061|FG001|Overall Study|Adverse Event|0|||
156969664|NCT03764774|566641062|FG002|Overall Study|Adverse Event|0|||
156969665|NCT03764774|566641063|FG003|Overall Study|Adverse Event|0|||
156969666|NCT03764774|566641064|FG004|Overall Study|Adverse Event|0|||
156969667|NCT03764774|566641065|FG005|Overall Study|Adverse Event|0|||
156969668|NCT03764774|566641066|FG006|Overall Study|Adverse Event|0|||
156969669|NCT03764774|566641067|FG007|Overall Study|Adverse Event|0|||
156969670|NCT03764774|566641068|FG008|Overall Study|Adverse Event|0|||
156969671|NCT03764774|566641069|FG009|Overall Study|Adverse Event|0|||
156969672|NCT03764774|566641070|FG010|Overall Study|Adverse Event|0|||
156969673|NCT03764774|566641071|FG011|Overall Study|Adverse Event|0|||
156969674|NCT03764774|566641072|FG012|Overall Study|Adverse Event|2|||
156969675|NCT03764774|566641073|FG013|Overall Study|Adverse Event|0|||
156969676|NCT03764774|566641060|FG000|Overall Study|Lost to Follow-up|0|||
156969677|NCT03764774|566641061|FG001|Overall Study|Lost to Follow-up|0|||
156969678|NCT03764774|566641062|FG002|Overall Study|Lost to Follow-up|0|||
156969679|NCT03764774|566641063|FG003|Overall Study|Lost to Follow-up|0|||
156969680|NCT03764774|566641064|FG004|Overall Study|Lost to Follow-up|0|||
156969681|NCT03764774|566641065|FG005|Overall Study|Lost to Follow-up|0|||
156969682|NCT03764774|566641066|FG006|Overall Study|Lost to Follow-up|0|||
156969683|NCT03764774|566641067|FG007|Overall Study|Lost to Follow-up|0|||
156969684|NCT03764774|566641068|FG008|Overall Study|Lost to Follow-up|0|||
156969685|NCT03764774|566641069|FG009|Overall Study|Lost to Follow-up|0|||
156969686|NCT03764774|566641070|FG010|Overall Study|Lost to Follow-up|0|||
156969687|NCT03764774|566641071|FG011|Overall Study|Lost to Follow-up|0|||
156969688|NCT03764774|566641072|FG012|Overall Study|Lost to Follow-up|0|||
156969689|NCT03764774|566641073|FG013|Overall Study|Lost to Follow-up|1|||
156969690|NCT03764774|566641060|FG000|Overall Study|Physician Decision|0|||
156969691|NCT03764774|566641061|FG001|Overall Study|Physician Decision|0|||
157046617|NCT01947491|566926065|FG001|Overall Study|Lack of Efficacy|0|||
156969692|NCT03764774|566641062|FG002|Overall Study|Physician Decision|0|||
156969693|NCT03764774|566641063|FG003|Overall Study|Physician Decision|0|||
156969694|NCT03764774|566641064|FG004|Overall Study|Physician Decision|0|||
156969695|NCT03764774|566641065|FG005|Overall Study|Physician Decision|0|||
157175257|NCT00367432|567381932|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
157175258|NCT00367432|567381933|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
157175259|NCT00367432|567381932|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
157175260|NCT00367432|567381933|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
157175261|NCT00367432|567381932|FG000|First Period (16 Weeks)|Other Reason|2|||
157175262|NCT00367432|567381933|FG001|First Period (16 Weeks)|Other Reason|0|||
157175263|NCT00367432|567381932|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
157175264|NCT00367432|567381933|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
157175265|NCT00367432|567381932|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
157175266|NCT00367432|567381933|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
157175267|NCT00367432|567381932|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
157175268|NCT00367432|567381933|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
157175269|NCT00367432|567381932|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
157175270|NCT00367432|567381933|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
157175271|NCT00367432|567381932|FG000|Second Period (up to 54 Months)|Other Reason|6|||
157175272|NCT00367432|567381933|FG001|Second Period (up to 54 Months)|Other Reason|2|||
157175273|NCT00014911|567381934|FG000|Overall Study|Adverse Event|1|||
157175274|NCT00014911|567381934|FG000|Overall Study|Lost to Follow-up|1|||
157175275|NCT00014911|567381934|FG000|Overall Study|Withdrawal by Subject|6|||
157175276|NCT00014911|567381934|FG000|Overall Study|Unknown Reasons|2|||
157175277|NCT00014911|567381934|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
157175278|NCT04179786|567381935|FG000|Overall Study|Withdrawal by Subject|8|||
157175279|NCT03310580|567381936|FG000|Overall Study|Adverse Event|0|||
157175280|NCT03310580|567381937|FG001|Overall Study|Adverse Event|1|||
157175281|NCT03310580|567381938|FG002|Overall Study|Adverse Event|0|||
157175282|NCT03205982|567381940|FG000|Overall Study|Lost to Follow-up|20|||
157175283|NCT03205982|567381941|FG001|Overall Study|Lost to Follow-up|19|||
157175284|NCT03205982|567381940|FG000|Overall Study|Withdrawal by Subject|4|||
157175285|NCT03205982|567381941|FG001|Overall Study|Withdrawal by Subject|3|||
157175286|NCT03205982|567381940|FG000|Overall Study|Withdrawal by PI|0|||
157175287|NCT03205982|567381941|FG001|Overall Study|Withdrawal by PI|1|||
157175288|NCT01626989|567381949|FG000|Screening Period|Screen Failure|15|||
157175289|NCT01626989|567381950|FG001|Screening Period|Screen Failure|0|||
157175290|NCT01626989|567381951|FG002|Screening Period|Screen Failure|0|||
157175291|NCT01626989|567381949|FG000|Screening Period|Withdrawal by Subject|2|||
157175292|NCT01626989|567381950|FG001|Screening Period|Withdrawal by Subject|0|||
157175293|NCT01626989|567381951|FG002|Screening Period|Withdrawal by Subject|0|||
157175294|NCT02947022|567381960|FG000|Overall Study|Study Stopped|1|||
157175295|NCT03077243|567383674|FG000|Overall Study|Death|1|||
157175296|NCT03077243|567383675|FG001|Overall Study|Death|2|||
157175297|NCT03077243|567383676|FG002|Overall Study|Death|0|||
157175298|NCT03077243|567383677|FG003|Overall Study|Death|0|||
157175299|NCT03077243|567383674|FG000|Overall Study|Withdrawal by Subject|1|||
157175300|NCT03077243|567383675|FG001|Overall Study|Withdrawal by Subject|3|||
157175301|NCT03077243|567383676|FG002|Overall Study|Withdrawal by Subject|0|||
157175302|NCT03077243|567383677|FG003|Overall Study|Withdrawal by Subject|0|||
157175303|NCT03077243|567383674|FG000|Overall Study|Physician Decision|1|||
157175304|NCT03077243|567383675|FG001|Overall Study|Physician Decision|0|||
157175305|NCT03077243|567383676|FG002|Overall Study|Physician Decision|0|||
157175306|NCT03077243|567383677|FG003|Overall Study|Physician Decision|0|||
157175307|NCT03077243|567383674|FG000|Overall Study|Research at two study sites terminated early|0|||
157175308|NCT03077243|567383675|FG001|Overall Study|Research at two study sites terminated early|0|||
157175309|NCT03077243|567383676|FG002|Overall Study|Research at two study sites terminated early|0|||
157175310|NCT03077243|567383677|FG003|Overall Study|Research at two study sites terminated early|69|||
157175311|NCT01544478|567383678|FG000|Overall Study|Adverse Event|1|||
157175312|NCT01544478|567383678|FG000|Overall Study|Death|1|||
157175313|NCT01544478|567383678|FG000|Overall Study|Lost to Follow-up|48|||
157175314|NCT01544478|567383678|FG000|Overall Study|Physician Decision|15|||
157175315|NCT01544478|567383678|FG000|Overall Study|Pregnancy|1|||
157175316|NCT01544478|567383678|FG000|Overall Study|Withdrawal by Subject|52|||
157175317|NCT00212758|567383679|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
157175318|NCT00212758|567383680|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
157175319|NCT00212758|567383679|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
157175320|NCT00212758|567383680|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
157175321|NCT02574481|567383681|FG000|Overall Study|Withdrawal by Subject|29|||
157175322|NCT02574481|567383682|FG001|Overall Study|Withdrawal by Subject|15|||
157175323|NCT02574481|567383683|FG002|Overall Study|Withdrawal by Subject|4|||
156969696|NCT03764774|566641066|FG006|Overall Study|Physician Decision|0|||
156969697|NCT03764774|566641067|FG007|Overall Study|Physician Decision|0|||
156969698|NCT03764774|566641068|FG008|Overall Study|Physician Decision|0|||
156969699|NCT03764774|566641069|FG009|Overall Study|Physician Decision|4|||
156969700|NCT03764774|566641070|FG010|Overall Study|Physician Decision|1|||
156969701|NCT03764774|566641071|FG011|Overall Study|Physician Decision|4|||
157175324|NCT02574481|567383684|FG003|Overall Study|Withdrawal by Subject|1|||
156969702|NCT03764774|566641072|FG012|Overall Study|Physician Decision|9|||
156969703|NCT03764774|566641073|FG013|Overall Study|Physician Decision|0|||
156969704|NCT03764774|566641060|FG000|Overall Study|Study Termination|0|||
156969705|NCT03764774|566641061|FG001|Overall Study|Study Termination|0|||
156969706|NCT03764774|566641062|FG002|Overall Study|Study Termination|0|||
156969707|NCT03764774|566641063|FG003|Overall Study|Study Termination|0|||
157046618|NCT01947491|566926066|FG002|Overall Study|Lack of Efficacy|0|||
157046619|NCT01947491|566926067|FG003|Overall Study|Lack of Efficacy|1|||
157175325|NCT02574481|567383681|FG000|Overall Study|Adverse Event|5|||
157046620|NCT01947491|566926064|FG000|Overall Study|Protocol Violation|1|||
157046621|NCT01947491|566926065|FG001|Overall Study|Protocol Violation|0|||
157046622|NCT01947491|566926066|FG002|Overall Study|Protocol Violation|0|||
157046623|NCT01947491|566926067|FG003|Overall Study|Protocol Violation|0|||
157046624|NCT01947491|566926064|FG000|Overall Study|Withdrawal by Subject|1|||
157046625|NCT01947491|566926065|FG001|Overall Study|Withdrawal by Subject|1|||
157046626|NCT01947491|566926066|FG002|Overall Study|Withdrawal by Subject|1|||
157046627|NCT01947491|566926067|FG003|Overall Study|Withdrawal by Subject|0|||
157046628|NCT01947491|566926064|FG000|Overall Study|Worsening of condition|0|||
157046629|NCT01947491|566926065|FG001|Overall Study|Worsening of condition|1|||
157046630|NCT01947491|566926066|FG002|Overall Study|Worsening of condition|0|||
157046631|NCT01947491|566926067|FG003|Overall Study|Worsening of condition|0|||
157175326|NCT02574481|567383682|FG001|Overall Study|Adverse Event|1|||
157175327|NCT02574481|567383683|FG002|Overall Study|Adverse Event|1|||
157175328|NCT02574481|567383684|FG003|Overall Study|Adverse Event|0|||
157175329|NCT02574481|567383681|FG000|Overall Study|Visit Missed|15|||
157175330|NCT02574481|567383682|FG001|Overall Study|Visit Missed|7|||
156969708|NCT03764774|566641064|FG004|Overall Study|Study Termination|0|||
156969709|NCT03764774|566641065|FG005|Overall Study|Study Termination|0|||
156969710|NCT03764774|566641066|FG006|Overall Study|Study Termination|0|||
156969711|NCT03764774|566641067|FG007|Overall Study|Study Termination|0|||
156969712|NCT03764774|566641068|FG008|Overall Study|Study Termination|0|||
156969713|NCT03764774|566641069|FG009|Overall Study|Study Termination|1|||
156969714|NCT03764774|566641070|FG010|Overall Study|Study Termination|0|||
156969715|NCT03764774|566641071|FG011|Overall Study|Study Termination|0|||
156969716|NCT03764774|566641072|FG012|Overall Study|Study Termination|0|||
156969717|NCT03764774|566641073|FG013|Overall Study|Study Termination|2|||
156969718|NCT00847405|566642277|FG000|First Intervention|Adverse Event|0|||
156969719|NCT00847405|566642278|FG001|First Intervention|Adverse Event|1|||
156969720|NCT00847405|566642277|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
156969721|NCT00847405|566642278|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
156969722|NCT01728792|566642279|FG000|Overall Study|Withdrawal of Consent|1|||
156969723|NCT01728792|566642280|FG001|Overall Study|Withdrawal of Consent|1|||
156969724|NCT01728792|566642281|FG002|Overall Study|Withdrawal of Consent|0|||
156969725|NCT01728792|566642282|FG003|Overall Study|Withdrawal of Consent|1|||
156969726|NCT01728792|566642283|FG004|Overall Study|Withdrawal of Consent|0|||
156969727|NCT01728792|566642279|FG000|Overall Study|Lost to Follow-up|2|||
156969728|NCT01728792|566642280|FG001|Overall Study|Lost to Follow-up|1|||
156969729|NCT01728792|566642281|FG002|Overall Study|Lost to Follow-up|4|||
156969730|NCT01728792|566642282|FG003|Overall Study|Lost to Follow-up|2|||
156969731|NCT01728792|566642283|FG004|Overall Study|Lost to Follow-up|0|||
156969732|NCT03559218|566642284|FG000|Overall Study|Withdrawal by Subject|1|||
156969733|NCT03559218|566642285|FG001|Overall Study|Withdrawal by Subject|0|||
156969734|NCT04277455|566642286|FG000|Overall Study|Lost to Follow-up|1|||
156969735|NCT04737109|566642294|FG000|Study Treatment|Disease Progression|5|||
156969736|NCT04737109|566642295|FG001|Study Treatment|Disease Progression|0|||
156969737|NCT04737109|566642296|FG002|Study Treatment|Disease Progression|0|||
156969738|NCT04737109|566642297|FG003|Study Treatment|Disease Progression|0|||
156969739|NCT04737109|566642294|FG000|Study Treatment|Death on study|1|||
156969740|NCT04737109|566642295|FG001|Study Treatment|Death on study|0|||
156969741|NCT04737109|566642296|FG002|Study Treatment|Death on study|0|||
156969742|NCT04737109|566642297|FG003|Study Treatment|Death on study|0|||
156969743|NCT03092375|566642298|FG000|Overall Study|Lack of Efficacy|0|||
156969744|NCT03092375|566642299|FG001|Overall Study|Lack of Efficacy|1|||
156969745|NCT03092375|566642300|FG002|Overall Study|Lack of Efficacy|1|||
156969746|NCT03092375|566642301|FG003|Overall Study|Lack of Efficacy|0|||
156969747|NCT01679301|566642302|FG000|Screening Period|screen failure|3|||
156969748|NCT01679301|566642303|FG001|Screening Period|screen failure|0|||
156969749|NCT01679301|566642304|FG002|Screening Period|screen failure|0|||
156969750|NCT02305381|566642307|FG000|Overall Study|Unclassified|5|||
156969751|NCT02305381|566642308|FG001|Overall Study|Unclassified|5|||
156969752|NCT02305381|566642309|FG002|Overall Study|Unclassified|7|||
157175331|NCT02574481|567383683|FG002|Overall Study|Visit Missed|5|||
156969753|NCT02882282|566642310|FG000|Overall Study|Adverse Event|1|||
156969754|NCT02882282|566642311|FG001|Overall Study|Adverse Event|0|||
156969755|NCT03953898|566642312|FG000|Overall Study|Lack of Efficacy|8|||
156969756|NCT03953898|566642312|FG000|Overall Study|Death|3|||
156969757|NCT03953898|566642312|FG000|Overall Study|Withdrawal by Subject|2|||
156969758|NCT03953898|566642312|FG000|Overall Study|Adverse Event|1|||
156969759|NCT00246337|566642313|FG000|Overall Study|Lost to Follow-up|3|||
156969760|NCT00246337|566642314|FG001|Overall Study|Lost to Follow-up|0|||
156969761|NCT00246337|566642315|FG002|Overall Study|Lost to Follow-up|0|||
157228898|NCT05097989|567583381|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
157228899|NCT05097989|567583382|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
157228900|NCT05097989|567583383|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
157228901|NCT05097989|567583375|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228902|NCT05097989|567583376|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228903|NCT05097989|567583377|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228904|NCT05097989|567583378|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228905|NCT05097989|567583379|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
157228906|NCT05097989|567583380|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228907|NCT05097989|567583381|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228908|NCT05097989|567583382|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228909|NCT05097989|567583383|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
157228910|NCT05097989|567583375|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
157228911|NCT05097989|567583376|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
157228912|NCT05097989|567583377|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228913|NCT05097989|567583378|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228914|NCT05097989|567583379|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228915|NCT05097989|567583380|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228916|NCT05097989|567583381|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228917|NCT05097989|567583382|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228918|NCT05097989|567583383|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
157228919|NCT05097989|567583375|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
157228920|NCT05097989|567583376|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
157228921|NCT05097989|567583377|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
157228922|NCT05097989|567583378|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
157228923|NCT05097989|567583379|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
157228924|NCT05097989|567583380|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
157228925|NCT05097989|567583381|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
157228926|NCT05097989|567583382|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
157228927|NCT05097989|567583383|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
157228928|NCT03283709|567583393|FG000|Overall Study|trial terminated|0|||
157228929|NCT03283709|567583394|FG001|Overall Study|trial terminated|1|||
157228930|NCT00117949|567583395|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
157228931|NCT00117949|567583396|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
157228932|NCT00117949|567583397|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
157228933|NCT00117949|567583398|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
157228934|NCT00117949|567583395|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
157228935|NCT00117949|567583396|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
157228936|NCT00117949|567583397|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
157228937|NCT00117949|567583398|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
157228938|NCT00117949|567583395|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
157228939|NCT00117949|567583396|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
157228940|NCT00117949|567583397|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
157228941|NCT00117949|567583398|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
157228942|NCT00117949|567583395|FG000|Overall Study|PSA increase >=10ng/mL|0|||
157228943|NCT00117949|567583396|FG001|Overall Study|PSA increase >=10ng/mL|1|||
157228944|NCT00117949|567583397|FG002|Overall Study|PSA increase >=10ng/mL|1|||
157228945|NCT00117949|567583398|FG003|Overall Study|PSA increase >=10ng/mL|0|||
157228946|NCT00117949|567583395|FG000|Overall Study|PSA reduction <=50%|0|||
157228947|NCT00117949|567583396|FG001|Overall Study|PSA reduction <=50%|2|||
157228948|NCT00117949|567583397|FG002|Overall Study|PSA reduction <=50%|2|||
157228949|NCT00117949|567583398|FG003|Overall Study|PSA reduction <=50%|4|||
157228950|NCT00117949|567583395|FG000|Overall Study|Hepatic abnormalities|0|||
157228951|NCT00117949|567583396|FG001|Overall Study|Hepatic abnormalities|1|||
157228952|NCT00117949|567583397|FG002|Overall Study|Hepatic abnormalities|0|||
157228953|NCT00117949|567583398|FG003|Overall Study|Hepatic abnormalities|1|||
157228954|NCT01004172|567583401|FG000|Overall Study|Progressive Disease in CNS Only|16|||
157228955|NCT01004172|567583401|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
157228956|NCT01004172|567583401|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
157228957|NCT01004172|567583401|FG000|Overall Study|Adverse Event|1|||
157228958|NCT01004172|567583401|FG000|Overall Study|Physician Decision|1|||
157228959|NCT01004172|567583401|FG000|Overall Study|Symptomatic Deterioration|2|||
157228960|NCT00406848|567583405|FG000|Overall Study|Withdrawal by Subject|27|||
157228961|NCT00406848|567583406|FG001|Overall Study|Withdrawal by Subject|22|||
157228962|NCT00406848|567583405|FG000|Overall Study|Adverse Event|38|||
157228963|NCT00406848|567583406|FG001|Overall Study|Adverse Event|7|||
157228964|NCT00406848|567583405|FG000|Overall Study|Lack of Efficacy|9|||
157228965|NCT00406848|567583406|FG001|Overall Study|Lack of Efficacy|14|||
157228966|NCT00406848|567583405|FG000|Overall Study|Protocol Violation|10|||
157046632|NCT01947491|566926064|FG000|Overall Study|Adverse Event|0|||
157046633|NCT01947491|566926065|FG001|Overall Study|Adverse Event|1|||
157046634|NCT01947491|566926066|FG002|Overall Study|Adverse Event|0|||
157046635|NCT01947491|566926067|FG003|Overall Study|Adverse Event|2|||
157046636|NCT02067663|566926068|FG000|Overall Study|Lost to Follow-up|13|||
157046637|NCT02067663|566926069|FG001|Overall Study|Lost to Follow-up|14|||
157046638|NCT00486954|566926070|FG000|Pilot Part|Adverse Event|4|||
157046639|NCT00486954|566926071|FG001|Pilot Part|Adverse Event|0|||
157046640|NCT00486954|566926072|FG002|Pilot Part|Adverse Event|5|||
157046641|NCT00486954|566926073|FG003|Pilot Part|Adverse Event|0|||
157046642|NCT00486954|566926074|FG004|Pilot Part|Adverse Event|0|||
157046643|NCT00486954|566926070|FG000|Pilot Part|Disease Progression|2|||
157046644|NCT00486954|566926071|FG001|Pilot Part|Disease Progression|0|||
157046645|NCT00486954|566926072|FG002|Pilot Part|Disease Progression|1|||
157046646|NCT00486954|566926073|FG003|Pilot Part|Disease Progression|0|||
157046647|NCT00486954|566926074|FG004|Pilot Part|Disease Progression|0|||
157046648|NCT00486954|566926070|FG000|Randomized Part|Lost to Follow-up|0|||
157046649|NCT00486954|566926071|FG001|Randomized Part|Lost to Follow-up|0|||
157046650|NCT00486954|566926072|FG002|Randomized Part|Lost to Follow-up|0|||
157046651|NCT00486954|566926073|FG003|Randomized Part|Lost to Follow-up|0|||
157046652|NCT00486954|566926074|FG004|Randomized Part|Lost to Follow-up|1|||
157046653|NCT00486954|566926070|FG000|Randomized Part|Withdrawal by Subject|0|||
157046654|NCT00486954|566926071|FG001|Randomized Part|Withdrawal by Subject|0|||
157046655|NCT00486954|566926072|FG002|Randomized Part|Withdrawal by Subject|0|||
157046656|NCT00486954|566926073|FG003|Randomized Part|Withdrawal by Subject|1|||
157046657|NCT00486954|566926074|FG004|Randomized Part|Withdrawal by Subject|0|||
157046658|NCT00486954|566926070|FG000|Randomized Part|Sponsor Terminated Study|0|||
157046659|NCT00486954|566926071|FG001|Randomized Part|Sponsor Terminated Study|0|||
157046660|NCT00486954|566926072|FG002|Randomized Part|Sponsor Terminated Study|0|||
157046661|NCT00486954|566926073|FG003|Randomized Part|Sponsor Terminated Study|19|||
157046662|NCT00486954|566926074|FG004|Randomized Part|Sponsor Terminated Study|13|||
157046663|NCT03236779|566926077|FG000|Overall Study|Lost to Follow-up|13|||
157046664|NCT03236779|566926078|FG001|Overall Study|Lost to Follow-up|21|||
157046665|NCT03316170|566926080|FG000|Overall Study|Death|1|||
157046666|NCT03316170|566926081|FG001|Overall Study|Death|0|||
157046667|NCT03316170|566926080|FG000|Overall Study|Lost to Follow-up|6|||
157046668|NCT03316170|566926081|FG001|Overall Study|Lost to Follow-up|7|||
157175332|NCT02574481|567383684|FG003|Overall Study|Visit Missed|0|||
157046669|NCT01836523|566926082|FG000|Overall Study|Adverse Event|15|||
157046670|NCT01836523|566926083|FG001|Overall Study|Adverse Event|41|||
157046671|NCT01836523|566926084|FG002|Overall Study|Adverse Event|49|||
157046672|NCT01836523|566926085|FG003|Overall Study|Adverse Event|14|||
157046673|NCT01836523|566926082|FG000|Overall Study|Protocol Violation|6|||
157046674|NCT01836523|566926083|FG001|Overall Study|Protocol Violation|3|||
157046675|NCT01836523|566926084|FG002|Overall Study|Protocol Violation|2|||
157046676|NCT01836523|566926085|FG003|Overall Study|Protocol Violation|4|||
157046677|NCT01836523|566926082|FG000|Overall Study|Met Withdrawal Criteria|13|||
157046678|NCT01836523|566926083|FG001|Overall Study|Met Withdrawal Criteria|13|||
157046679|NCT01836523|566926084|FG002|Overall Study|Met Withdrawal Criteria|21|||
157046680|NCT01836523|566926085|FG003|Overall Study|Met Withdrawal Criteria|27|||
157046681|NCT01836523|566926082|FG000|Overall Study|Unclassified|17|||
157046682|NCT01836523|566926083|FG001|Overall Study|Unclassified|28|||
157046683|NCT01836523|566926084|FG002|Overall Study|Unclassified|19|||
157046684|NCT01836523|566926085|FG003|Overall Study|Unclassified|29|||
157046685|NCT02935673|566926086|FG000|Overall Study|Adverse Event|0|||
157046686|NCT02935673|566926087|FG001|Overall Study|Adverse Event|1|||
157046687|NCT02935673|566926088|FG002|Overall Study|Adverse Event|0|||
157046688|NCT02935673|566926086|FG000|Overall Study|Withdrawal by Subject|1|||
157046689|NCT02935673|566926087|FG001|Overall Study|Withdrawal by Subject|2|||
157046690|NCT02935673|566926088|FG002|Overall Study|Withdrawal by Subject|0|||
157046691|NCT00749944|566926089|FG000|Overall Study|Lost to Follow-up|2|||
157175333|NCT02574481|567383681|FG000|Overall Study|Other|7|||
157175334|NCT02574481|567383682|FG001|Overall Study|Other|2|||
157175335|NCT02574481|567383683|FG002|Overall Study|Other|0|||
157175336|NCT02574481|567383684|FG003|Overall Study|Other|0|||
157046692|NCT00749944|566926090|FG001|Overall Study|Lost to Follow-up|1|||
157046693|NCT00749944|566926089|FG000|Overall Study|Other|1|||
157046694|NCT00749944|566926090|FG001|Overall Study|Other|0|||
157046695|NCT00749944|566926089|FG000|Overall Study|Withdrawal by Subject|2|||
157046696|NCT00749944|566926090|FG001|Overall Study|Withdrawal by Subject|0|||
157046697|NCT02547974|566926091|FG000|Overall Study|Withdrawal by Subject|1|||
157046698|NCT02547974|566926092|FG001|Overall Study|Withdrawal by Subject|0|||
157175337|NCT02574481|567383681|FG000|Overall Study|Death|48|||
157175338|NCT02574481|567383682|FG001|Overall Study|Death|26|||
157046699|NCT02547974|566926093|FG002|Overall Study|Withdrawal by Subject|0|||
157175339|NCT02574481|567383683|FG002|Overall Study|Death|12|||
157046700|NCT02547974|566926094|FG003|Overall Study|Withdrawal by Subject|0|||
157046701|NCT01102426|566926095|FG000|Overall Study|Randomized but not treated|4|||
157046702|NCT01102426|566926096|FG001|Overall Study|Randomized but not treated|1|||
157175340|NCT02574481|567383684|FG003|Overall Study|Death|4|||
157175341|NCT02574481|567383681|FG000|Overall Study|Physician Decision|5|||
157046703|NCT01102426|566926095|FG000|Overall Study|Adverse Events (treatment-related)|15|||
157046704|NCT01102426|566926096|FG001|Overall Study|Adverse Events (treatment-related)|8|||
157046705|NCT01102426|566926095|FG000|Overall Study|Physician Decision|9|||
157046706|NCT01102426|566926096|FG001|Overall Study|Physician Decision|6|||
157046707|NCT01102426|566926095|FG000|Overall Study|Progressive Disease|85|||
157046708|NCT01102426|566926096|FG001|Overall Study|Progressive Disease|44|||
157046709|NCT01102426|566926095|FG000|Overall Study|Adverse Events (unrelated to|9|||
157046710|NCT01102426|566926096|FG001|Overall Study|Adverse Events (unrelated to|1|||
157046711|NCT01102426|566926095|FG000|Overall Study|Patient Refusal|24|||
157046712|NCT01102426|566926096|FG001|Overall Study|Patient Refusal|12|||
157046713|NCT01102426|566926095|FG000|Overall Study|Death (due to adverse events|0|||
157046714|NCT01102426|566926096|FG001|Overall Study|Death (due to adverse events|1|||
157046715|NCT01102426|566926095|FG000|Overall Study|Death (non-related to the study|19|||
157046716|NCT01102426|566926096|FG001|Overall Study|Death (non-related to the study|8|||
157046717|NCT03265132|566926097|FG000|Overall Study|Adverse Event|0|||
157046718|NCT03265132|566926098|FG001|Overall Study|Adverse Event|1|||
157046719|NCT03265132|566926097|FG000|Overall Study|Lack of Efficacy|0|||
157046720|NCT03265132|566926098|FG001|Overall Study|Lack of Efficacy|2|||
157046721|NCT03265132|566926097|FG000|Overall Study|Progressive disease|0|||
157046722|NCT03265132|566926098|FG001|Overall Study|Progressive disease|2|||
157046723|NCT03265132|566926097|FG000|Overall Study|Withdrawal by Subject|0|||
157175342|NCT02574481|567383682|FG001|Overall Study|Physician Decision|2|||
157175343|NCT02574481|567383683|FG002|Overall Study|Physician Decision|0|||
157175344|NCT02574481|567383684|FG003|Overall Study|Physician Decision|0|||
157175345|NCT02574481|567383681|FG000|Overall Study|Lost to Follow-up|5|||
157175346|NCT02574481|567383682|FG001|Overall Study|Lost to Follow-up|1|||
157175347|NCT02574481|567383683|FG002|Overall Study|Lost to Follow-up|3|||
157175348|NCT02574481|567383684|FG003|Overall Study|Lost to Follow-up|0|||
157175349|NCT02038790|567383688|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
157175350|NCT02038790|567383689|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
157175351|NCT02431702|567383690|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
157175352|NCT02431702|567383691|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175353|NCT02431702|567383692|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175354|NCT02431702|567383693|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175355|NCT02431702|567383694|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175356|NCT02431702|567383695|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175357|NCT02431702|567383696|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
157175358|NCT02431702|567383690|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
157175359|NCT02431702|567383691|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
157175360|NCT02431702|567383692|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
157175361|NCT02431702|567383693|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
157175362|NCT02431702|567383694|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
157175363|NCT02431702|567383695|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
157175364|NCT02431702|567383696|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
157175365|NCT02431702|567383690|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
157175366|NCT02431702|567383691|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
157175367|NCT02431702|567383692|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
157175368|NCT02431702|567383693|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
157175369|NCT02431702|567383694|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
157175370|NCT02431702|567383695|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
157175371|NCT02431702|567383696|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
157175372|NCT02431702|567383690|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
157175373|NCT02431702|567383691|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
157175374|NCT02431702|567383692|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
157175375|NCT02431702|567383693|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
157175376|NCT02431702|567383694|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
157175377|NCT02431702|567383695|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
157175378|NCT02431702|567383696|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
157175379|NCT02431702|567383690|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
157175380|NCT02431702|567383691|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175381|NCT02431702|567383692|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175382|NCT02431702|567383693|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175383|NCT02431702|567383694|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175384|NCT02431702|567383695|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175385|NCT02431702|567383696|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
157175386|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
157175387|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
157175388|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
157228967|NCT00406848|567583406|FG001|Overall Study|Protocol Violation|6|||
157046724|NCT03265132|566926098|FG001|Overall Study|Withdrawal by Subject|1|||
157046725|NCT03259568|566926104|FG000|Overall Study|Participant performance was low|3|||
157046726|NCT00089791|566926105|FG000|Overall Study|Physician Decision|6|||
157046727|NCT00089791|566926106|FG001|Overall Study|Physician Decision|3|||
157046728|NCT00089791|566926105|FG000|Overall Study|Adverse Event|81|||
157046729|NCT00089791|566926106|FG001|Overall Study|Adverse Event|93|||
157046730|NCT00089791|566926105|FG000|Overall Study|Withdrawal by Subject|403|||
157046731|NCT00089791|566926106|FG001|Overall Study|Withdrawal by Subject|344|||
157046732|NCT00089791|566926105|FG000|Overall Study|Death|78|||
157046733|NCT00089791|566926106|FG001|Overall Study|Death|62|||
157046734|NCT00089791|566926105|FG000|Overall Study|Disease progression|7|||
157046735|NCT00089791|566926106|FG001|Overall Study|Disease progression|3|||
157046736|NCT00089791|566926105|FG000|Overall Study|Ineligibility determined|12|||
157046737|NCT00089791|566926106|FG001|Overall Study|Ineligibility determined|9|||
157046738|NCT00089791|566926105|FG000|Overall Study|Lost to Follow-up|57|||
157046739|NCT00089791|566926106|FG001|Overall Study|Lost to Follow-up|57|||
157046740|NCT00089791|566926105|FG000|Overall Study|Noncompliance|17|||
157046741|NCT00089791|566926106|FG001|Overall Study|Noncompliance|13|||
157046742|NCT00089791|566926105|FG000|Overall Study|Other|20|||
157046743|NCT00089791|566926106|FG001|Overall Study|Other|32|||
157046744|NCT00089791|566926105|FG000|Overall Study|Protocol deviation|12|||
157046745|NCT00089791|566926106|FG001|Overall Study|Protocol deviation|10|||
157046746|NCT00089791|566926105|FG000|Overall Study|Requirement for alternative therapy|7|||
157046747|NCT00089791|566926106|FG001|Overall Study|Requirement for alternative therapy|4|||
157046748|NCT02161458|566926107|FG000|Overall Study|Withdrawal by Subject|0|||
157046749|NCT02161458|566926108|FG001|Overall Study|Withdrawal by Subject|4|||
157046750|NCT02161458|566926109|FG002|Overall Study|Withdrawal by Subject|4|||
157046751|NCT02161458|566926110|FG003|Overall Study|Withdrawal by Subject|0|||
157046752|NCT02161458|566926107|FG000|Overall Study|Lost to Follow-up|0|||
157046753|NCT02161458|566926108|FG001|Overall Study|Lost to Follow-up|2|||
157046754|NCT02161458|566926109|FG002|Overall Study|Lost to Follow-up|1|||
157046755|NCT02161458|566926110|FG003|Overall Study|Lost to Follow-up|0|||
157046756|NCT01989689|566926111|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
157046757|NCT01989689|566926112|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
157046758|NCT01989689|566926111|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
157046759|NCT01989689|566926112|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
157046760|NCT03200574|566926132|FG000|Overall Study|Death|4|||
157046761|NCT03200574|566926132|FG000|Overall Study|Withdrawal by Subject|8|||
157046762|NCT03200574|566926132|FG000|Overall Study|Long-Term need for anticoagulation|1|||
157046763|NCT03200574|566926132|FG000|Overall Study|Relocation|2|||
157046764|NCT03200574|566926132|FG000|Overall Study|Lost to Follow-up|2|||
157046765|NCT00705159|566926133|FG000|Overall Study|Withdrawal by Subject|0|||
157046766|NCT00705159|566926134|FG001|Overall Study|Withdrawal by Subject|1|||
157046767|NCT00705159|566926135|FG002|Overall Study|Withdrawal by Subject|1|||
157046768|NCT00705159|566926136|FG003|Overall Study|Withdrawal by Subject|1|||
157046769|NCT00705159|566926133|FG000|Overall Study|Protocol Violation|0|||
157046770|NCT00705159|566926134|FG001|Overall Study|Protocol Violation|1|||
157046771|NCT00705159|566926135|FG002|Overall Study|Protocol Violation|0|||
157046772|NCT00705159|566926136|FG003|Overall Study|Protocol Violation|0|||
157046773|NCT00705159|566926133|FG000|Overall Study|Adverse Event|0|||
157046774|NCT00705159|566926134|FG001|Overall Study|Adverse Event|0|||
157046775|NCT00705159|566926135|FG002|Overall Study|Adverse Event|1|||
157046776|NCT00705159|566926136|FG003|Overall Study|Adverse Event|0|||
157046777|NCT00705159|566926133|FG000|Overall Study|Lost to Follow-up|0|||
157046778|NCT00705159|566926134|FG001|Overall Study|Lost to Follow-up|0|||
157046779|NCT00705159|566926135|FG002|Overall Study|Lost to Follow-up|3|||
157046780|NCT00705159|566926136|FG003|Overall Study|Lost to Follow-up|2|||
157046781|NCT00705159|566926133|FG000|Overall Study|Screen Failure|0|||
157046782|NCT00705159|566926134|FG001|Overall Study|Screen Failure|0|||
157046783|NCT00705159|566926135|FG002|Overall Study|Screen Failure|0|||
157046784|NCT00705159|566926136|FG003|Overall Study|Screen Failure|1|||
157046785|NCT00526994|566926137|FG000|Overall Study|Lost to Follow-up|98|||
157046786|NCT00526994|566926138|FG001|Overall Study|Lost to Follow-up|108|||
157046787|NCT00526994|566926139|FG002|Overall Study|Lost to Follow-up|96|||
157046788|NCT00526994|566926137|FG000|Overall Study|Death|4|||
157046789|NCT00526994|566926138|FG001|Overall Study|Death|3|||
157046790|NCT00526994|566926139|FG002|Overall Study|Death|3|||
157046791|NCT00526994|566926137|FG000|Overall Study|Withdrawal by Subject|2|||
157046792|NCT00526994|566926138|FG001|Overall Study|Withdrawal by Subject|7|||
157046793|NCT00526994|566926139|FG002|Overall Study|Withdrawal by Subject|5|||
157046794|NCT00526994|566926137|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
157046795|NCT00526994|566926138|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
157046796|NCT00526994|566926139|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
157046797|NCT03026166|566926140|FG000|Overall Study|Death|22|||
157046798|NCT03026166|566926141|FG001|Overall Study|Death|7|||
157046799|NCT03026166|566926140|FG000|Overall Study|Physician Decision|2|||
157046800|NCT03026166|566926141|FG001|Overall Study|Physician Decision|0|||
157046801|NCT03026166|566926140|FG000|Overall Study|Withdrawal by Subject|1|||
157046802|NCT03026166|566926141|FG001|Overall Study|Withdrawal by Subject|2|||
157046803|NCT03026166|566926140|FG000|Overall Study|Lost to Follow-up|1|||
157046804|NCT03026166|566926141|FG001|Overall Study|Lost to Follow-up|0|||
157046805|NCT03026166|566926140|FG000|Overall Study|Study Terminated by Sponsor|3|||
157046806|NCT03026166|566926141|FG001|Overall Study|Study Terminated by Sponsor|3|||
157046807|NCT03026166|566926140|FG000|Overall Study|Other|1|||
157046808|NCT03026166|566926141|FG001|Overall Study|Other|0|||
157046809|NCT04821271|566926146|FG000|Period 1|Withdrawal by Subject|2|||
157046810|NCT04821271|566926147|FG001|Period 1|Withdrawal by Subject|0|||
157046811|NCT02521493|566926151|FG000|Overall Study|Death|3|||
157046812|NCT02521493|566926152|FG001|Overall Study|Death|4|||
157046813|NCT02521493|566926153|FG002|Overall Study|Death|1|||
157046814|NCT02521493|566926151|FG000|Overall Study|Physician Decision|19|||
157046815|NCT02521493|566926152|FG001|Overall Study|Physician Decision|1|||
157046816|NCT02521493|566926153|FG002|Overall Study|Physician Decision|2|||
157046817|NCT02521493|566926151|FG000|Overall Study|Withdrawal by Subject|3|||
157046818|NCT02521493|566926152|FG001|Overall Study|Withdrawal by Subject|0|||
157046819|NCT02521493|566926153|FG002|Overall Study|Withdrawal by Subject|0|||
157046820|NCT02521493|566926151|FG000|Overall Study|Ineligible|0|||
157046821|NCT02521493|566926152|FG001|Overall Study|Ineligible|1|||
157046822|NCT02521493|566926153|FG002|Overall Study|Ineligible|0|||
157046823|NCT02521493|566926151|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
157046824|NCT02521493|566926152|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
157046825|NCT02521493|566926153|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
157046826|NCT02521493|566926151|FG000|Overall Study|No MRD result|0|||
157046827|NCT02521493|566926152|FG001|Overall Study|No MRD result|0|||
157046828|NCT02521493|566926153|FG002|Overall Study|No MRD result|4|||
157046829|NCT04083781|566926154|FG000|Main Part|Physician Decision|0|||
157046830|NCT04083781|566926155|FG001|Main Part|Physician Decision|1|||
157046831|NCT04083781|566926156|FG002|Main Part|Physician Decision|2|||
157046832|NCT04083781|566926157|FG003|Main Part|Physician Decision|0|||
157046833|NCT04083781|566926154|FG000|Main Part|Death|1|||
157046834|NCT04083781|566926155|FG001|Main Part|Death|3|||
157046835|NCT04083781|566926156|FG002|Main Part|Death|1|||
157046836|NCT04083781|566926157|FG003|Main Part|Death|0|||
157046837|NCT04083781|566926154|FG000|Main Part|Withdrawal by Subject|5|||
157046838|NCT04083781|566926155|FG001|Main Part|Withdrawal by Subject|2|||
157046839|NCT04083781|566926156|FG002|Main Part|Withdrawal by Subject|3|||
157046840|NCT04083781|566926157|FG003|Main Part|Withdrawal by Subject|7|||
157046841|NCT04083781|566926154|FG000|Extension Part|Physician Decision|0|||
157046842|NCT04083781|566926155|FG001|Extension Part|Physician Decision|0|||
157046843|NCT04083781|566926156|FG002|Extension Part|Physician Decision|0|||
157046844|NCT04083781|566926157|FG003|Extension Part|Physician Decision|1|||
157046845|NCT04083781|566926154|FG000|Extension Part|Death|0|||
157046846|NCT04083781|566926155|FG001|Extension Part|Death|1|||
157046847|NCT04083781|566926156|FG002|Extension Part|Death|0|||
157046848|NCT04083781|566926157|FG003|Extension Part|Death|1|||
157046849|NCT04083781|566926154|FG000|Extension Part|Withdrawal by Subject|0|||
157046850|NCT04083781|566926155|FG001|Extension Part|Withdrawal by Subject|1|||
157046851|NCT04083781|566926156|FG002|Extension Part|Withdrawal by Subject|0|||
157175389|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
157175390|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
157175391|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
157175392|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
156969762|NCT00246337|566642316|FG003|Overall Study|Lost to Follow-up|0|||
156969763|NCT00246337|566642317|FG004|Overall Study|Lost to Follow-up|2|||
156969764|NCT00246337|566642318|FG005|Overall Study|Lost to Follow-up|2|||
156969765|NCT00246337|566642319|FG006|Overall Study|Lost to Follow-up|1|||
156969766|NCT00246337|566642320|FG007|Overall Study|Lost to Follow-up|2|||
156969767|NCT00246337|566642321|FG008|Overall Study|Lost to Follow-up|0|||
156969768|NCT00246337|566642313|FG000|Overall Study|Protocol Violation|1|||
156969769|NCT00246337|566642314|FG001|Overall Study|Protocol Violation|0|||
156969770|NCT00246337|566642315|FG002|Overall Study|Protocol Violation|0|||
156969771|NCT00246337|566642316|FG003|Overall Study|Protocol Violation|0|||
156969772|NCT00246337|566642317|FG004|Overall Study|Protocol Violation|1|||
156969773|NCT00246337|566642318|FG005|Overall Study|Protocol Violation|0|||
157046852|NCT04083781|566926157|FG003|Extension Part|Withdrawal by Subject|0|||
157046853|NCT04083781|566926154|FG000|Extension Part|Ongoing|13|||
157046854|NCT04083781|566926155|FG001|Extension Part|Ongoing|25|||
157046855|NCT04083781|566926156|FG002|Extension Part|Ongoing|15|||
157046856|NCT04083781|566926157|FG003|Extension Part|Ongoing|51|||
157046857|NCT01263496|566926158|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
157046858|NCT01263496|566926159|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046859|NCT01263496|566926160|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046860|NCT01263496|566926161|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046861|NCT01263496|566926162|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046862|NCT01263496|566926163|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046863|NCT01263496|566926164|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046864|NCT01263496|566926165|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046865|NCT01263496|566926166|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
157046866|NCT01263496|566926158|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
156969774|NCT00246337|566642319|FG006|Overall Study|Protocol Violation|1|||
157046867|NCT01263496|566926159|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046868|NCT01263496|566926160|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046869|NCT01263496|566926161|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
157046870|NCT01263496|566926162|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
157046871|NCT01263496|566926163|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046872|NCT01263496|566926164|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046873|NCT01263496|566926165|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046874|NCT01263496|566926166|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
157046875|NCT01263496|566926158|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
157046876|NCT01263496|566926159|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
157046877|NCT01263496|566926160|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
157046878|NCT01263496|566926161|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
157046879|NCT01263496|566926162|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
157046880|NCT01263496|566926163|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
157046881|NCT01263496|566926164|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
157046882|NCT01263496|566926165|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
157046883|NCT01263496|566926166|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
157046884|NCT01263496|566926158|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046885|NCT01263496|566926159|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
157046886|NCT01263496|566926160|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046887|NCT01263496|566926161|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046888|NCT01263496|566926162|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046889|NCT01263496|566926163|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046890|NCT01263496|566926164|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046891|NCT01263496|566926165|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046892|NCT01263496|566926166|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
157046893|NCT01263496|566926158|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157046894|NCT01263496|566926159|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
157046895|NCT01263496|566926160|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
157046896|NCT01263496|566926161|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
157046897|NCT01263496|566926162|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
157046898|NCT01263496|566926163|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157046899|NCT01263496|566926164|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157046900|NCT01263496|566926165|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
157046901|NCT01263496|566926166|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157046902|NCT01263496|566926158|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
157046903|NCT01263496|566926159|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
157046904|NCT01263496|566926160|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
157046905|NCT01263496|566926161|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
157046906|NCT01263496|566926162|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
157046907|NCT01263496|566926163|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157046908|NCT01263496|566926164|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157046909|NCT01263496|566926165|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157046910|NCT01263496|566926166|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
157046911|NCT01263496|566926158|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046912|NCT01263496|566926159|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157175393|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
157175394|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
157175395|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
157175396|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
157175397|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
157175398|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
157175399|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
157175400|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
157175401|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
157175402|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
157228968|NCT00406848|567583405|FG000|Overall Study|Lost to Follow-up|6|||
157228969|NCT00406848|567583406|FG001|Overall Study|Lost to Follow-up|2|||
157228970|NCT00406848|567583405|FG000|Overall Study|Physician Decision|2|||
157228971|NCT00406848|567583406|FG001|Overall Study|Physician Decision|2|||
157228972|NCT00406848|567583405|FG000|Overall Study|Sponsor Decision|1|||
157228973|NCT00406848|567583406|FG001|Overall Study|Sponsor Decision|1|||
157228974|NCT01355081|567583407|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
157228975|NCT01355081|567583408|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
157046913|NCT01263496|566926160|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046914|NCT01263496|566926161|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046915|NCT01263496|566926162|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046916|NCT01263496|566926163|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046917|NCT01263496|566926164|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046918|NCT01263496|566926165|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
157046919|NCT01263496|566926166|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157046920|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
157046921|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
157046922|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
157046923|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
157046924|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
157046925|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
157046926|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
157046927|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
157046928|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
157046929|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
157046930|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
157046931|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
157046932|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
157046933|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
157175403|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
157175404|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
157175405|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
157175406|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
157175407|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157046934|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
157046935|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
157046936|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
157046937|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
157046938|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
157046939|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
157046940|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
157046941|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
157046942|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
157046943|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
157046944|NCT02203032|566926168|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
157175408|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
157175409|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157175410|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157175411|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157175412|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157175413|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
157175414|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
157175415|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
157175416|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
157175417|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
157175418|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
157175419|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
157175420|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
157175421|NCT02431702|567383690|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175422|NCT02431702|567383691|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175423|NCT02431702|567383692|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
157175424|NCT02431702|567383693|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175425|NCT02431702|567383694|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175426|NCT02431702|567383695|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175427|NCT02431702|567383696|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
157175428|NCT02431702|567383690|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
157175429|NCT02431702|567383691|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
157175430|NCT02431702|567383692|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
157175431|NCT02431702|567383693|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
157175432|NCT02431702|567383694|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
157175433|NCT02431702|567383695|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
157175434|NCT02431702|567383696|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
157046945|NCT02203032|566926169|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
157046946|NCT02203032|566926170|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
157046947|NCT02203032|566926171|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
157046948|NCT02203032|566926168|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
157046949|NCT02203032|566926169|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
157046950|NCT02203032|566926170|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
157046951|NCT02203032|566926171|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
157046952|NCT02203032|566926168|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
157046953|NCT02203032|566926169|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
157046954|NCT02203032|566926170|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
157046955|NCT02203032|566926171|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
157046956|NCT02203032|566926168|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
157046957|NCT02203032|566926169|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
157046958|NCT02203032|566926170|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
157046959|NCT02203032|566926171|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
157046960|NCT02203032|566926168|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
157046961|NCT02203032|566926169|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
157046962|NCT02203032|566926170|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
157046963|NCT02203032|566926171|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
157046964|NCT02203032|566926168|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
157046965|NCT02203032|566926169|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
157046966|NCT02203032|566926170|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
157046967|NCT02203032|566926171|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
157046968|NCT02241785|566926172|FG000|Overall Study|Sponsor Termination|43|||
157046969|NCT02241785|566926172|FG000|Overall Study|Withdrawal by Subject|1|||
157046970|NCT02241785|566926172|FG000|Overall Study|Lost to Follow-up|2|||
157046971|NCT02241785|566926172|FG000|Overall Study|Adverse Event|1|||
157046972|NCT03905642|566926175|FG000|Overall Study|Withdrawal by Subject|3|||
157046973|NCT03905642|566926175|FG000|Overall Study|Pregnancy|1|||
157046974|NCT03905642|566926175|FG000|Overall Study|Adverse Event|1|||
157046975|NCT03905642|566926175|FG000|Overall Study|Lack of Efficacy|1|||
157046976|NCT03905642|566926175|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
157046977|NCT05995977|566926176|FG000|Overall Study|Withdrawal by Subject|1|||
157046978|NCT05995977|566926177|FG001|Overall Study|Withdrawal by Subject|4|||
157046979|NCT05995977|566926176|FG000|Overall Study|Lost to Follow-up|2|||
157046980|NCT05995977|566926177|FG001|Overall Study|Lost to Follow-up|0|||
157046981|NCT03840200|566928394|FG000|Overall Study|Death|6|||
157046982|NCT03840200|566928395|FG001|Overall Study|Death|3|||
157046983|NCT03840200|566928396|FG002|Overall Study|Death|6|||
157046984|NCT03840200|566928397|FG003|Overall Study|Death|10|||
157046985|NCT03840200|566928394|FG000|Overall Study|Reason Not Specified|2|||
157046986|NCT03840200|566928395|FG001|Overall Study|Reason Not Specified|2|||
157046987|NCT03840200|566928396|FG002|Overall Study|Reason Not Specified|1|||
157046988|NCT03840200|566928397|FG003|Overall Study|Reason Not Specified|15|||
157046989|NCT03840200|566928394|FG000|Overall Study|Physician Decision|0|||
157046990|NCT03840200|566928395|FG001|Overall Study|Physician Decision|0|||
157046991|NCT03840200|566928396|FG002|Overall Study|Physician Decision|0|||
157046992|NCT03840200|566928397|FG003|Overall Study|Physician Decision|2|||
157046993|NCT03840200|566928394|FG000|Overall Study|Progressive Disease|0|||
157046994|NCT03840200|566928395|FG001|Overall Study|Progressive Disease|0|||
157046995|NCT03840200|566928396|FG002|Overall Study|Progressive Disease|0|||
157046996|NCT03840200|566928397|FG003|Overall Study|Progressive Disease|1|||
157046997|NCT03840200|566928394|FG000|Overall Study|Withdrawal by Subject|0|||
157046998|NCT03840200|566928395|FG001|Overall Study|Withdrawal by Subject|1|||
157046999|NCT03840200|566928396|FG002|Overall Study|Withdrawal by Subject|0|||
157047000|NCT03840200|566928397|FG003|Overall Study|Withdrawal by Subject|2|||
157047001|NCT02196259|566928400|FG000|Overall Study|Researcher choice|0|||
157047002|NCT02196259|566928401|FG001|Overall Study|Researcher choice|0|||
157047003|NCT02196259|566928402|FG002|Overall Study|Researcher choice|1|||
157047004|NCT02196259|566928400|FG000|Overall Study|Partial data analysis|0|||
157175435|NCT02431702|567383690|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
157047005|NCT02196259|566928401|FG001|Overall Study|Partial data analysis|3|||
157047006|NCT02196259|566928402|FG002|Overall Study|Partial data analysis|0|||
157047007|NCT01808534|566928403|FG000|Overall Study|Disease progression|3|||
157175436|NCT02431702|567383691|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
157047008|NCT01808534|566928403|FG000|Overall Study|Physician Decision|1|||
157047009|NCT01148017|566928406|FG000|Overall Study|Withdrawal by Subject|31|||
157175437|NCT02431702|567383692|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
157047010|NCT01148017|566928407|FG001|Overall Study|Withdrawal by Subject|14|||
157047011|NCT01148017|566928408|FG002|Overall Study|Withdrawal by Subject|0|||
157047012|NCT01148017|566928409|FG003|Overall Study|Withdrawal by Subject|0|||
157047013|NCT01148017|566928406|FG000|Overall Study|Lost to Follow-up|23|||
157047014|NCT01148017|566928407|FG001|Overall Study|Lost to Follow-up|10|||
157047015|NCT01148017|566928408|FG002|Overall Study|Lost to Follow-up|0|||
157047016|NCT01148017|566928409|FG003|Overall Study|Lost to Follow-up|0|||
157047017|NCT01148017|566928406|FG000|Overall Study|Inappropriate enrollment|1|||
157047018|NCT01148017|566928407|FG001|Overall Study|Inappropriate enrollment|0|||
157047019|NCT01148017|566928408|FG002|Overall Study|Inappropriate enrollment|0|||
157047020|NCT01148017|566928409|FG003|Overall Study|Inappropriate enrollment|0|||
157047021|NCT01148017|566928406|FG000|Overall Study|Administrative reason|22|||
157047022|NCT01148017|566928407|FG001|Overall Study|Administrative reason|9|||
157047023|NCT01148017|566928408|FG002|Overall Study|Administrative reason|0|||
157047024|NCT01148017|566928409|FG003|Overall Study|Administrative reason|0|||
157047025|NCT01148017|566928406|FG000|Overall Study|Unable to classify|3|||
157047026|NCT01148017|566928407|FG001|Overall Study|Unable to classify|1|||
157047027|NCT01148017|566928408|FG002|Overall Study|Unable to classify|0|||
157047028|NCT01148017|566928409|FG003|Overall Study|Unable to classify|0|||
157047029|NCT00569166|566928411|FG000|Overall Study|Withdrawal by Subject|7|||
157047030|NCT00569166|566928412|FG001|Overall Study|Withdrawal by Subject|5|||
157047031|NCT00569166|566928413|FG002|Overall Study|Withdrawal by Subject|3|||
157047032|NCT00569166|566928411|FG000|Overall Study|Lost to Follow-up|2|||
157047033|NCT00569166|566928412|FG001|Overall Study|Lost to Follow-up|1|||
157047034|NCT00569166|566928413|FG002|Overall Study|Lost to Follow-up|1|||
157047035|NCT01686152|566928414|FG000|Overall Study|Withdrawal by Subject|11|||
157047036|NCT01686152|566928415|FG001|Overall Study|Withdrawal by Subject|11|||
157047037|NCT01686152|566928416|FG002|Overall Study|Withdrawal by Subject|3|||
157047038|NCT01686152|566928414|FG000|Overall Study|Drug Code Unblinded|0|||
157047039|NCT01686152|566928415|FG001|Overall Study|Drug Code Unblinded|1|||
157047040|NCT01686152|566928416|FG002|Overall Study|Drug Code Unblinded|0|||
157047041|NCT01686152|566928414|FG000|Overall Study|Protocol Violation|6|||
157047042|NCT01686152|566928415|FG001|Overall Study|Protocol Violation|1|||
157047043|NCT01686152|566928416|FG002|Overall Study|Protocol Violation|0|||
157047044|NCT01686152|566928414|FG000|Overall Study|Adverse Event|12|||
157047045|NCT01686152|566928415|FG001|Overall Study|Adverse Event|11|||
157047046|NCT01686152|566928416|FG002|Overall Study|Adverse Event|0|||
157047047|NCT01686152|566928414|FG000|Overall Study|Lack of Efficacy|0|||
157047048|NCT01686152|566928415|FG001|Overall Study|Lack of Efficacy|0|||
157047049|NCT01686152|566928416|FG002|Overall Study|Lack of Efficacy|1|||
157047050|NCT01686152|566928414|FG000|Overall Study|IP Non-compliance|5|||
157047051|NCT01686152|566928415|FG001|Overall Study|IP Non-compliance|5|||
157047052|NCT01686152|566928416|FG002|Overall Study|IP Non-compliance|0|||
157047053|NCT01686152|566928414|FG000|Overall Study|Lost to Follow-up|7|||
157047054|NCT01686152|566928415|FG001|Overall Study|Lost to Follow-up|6|||
157047055|NCT01686152|566928416|FG002|Overall Study|Lost to Follow-up|5|||
157047056|NCT01853384|566928417|FG000|Randomized|Adverse Event|5|||
157047057|NCT01853384|566928418|FG001|Randomized|Adverse Event|3|||
157047058|NCT01853384|566928417|FG000|Randomized|Death|1|||
157047059|NCT01853384|566928418|FG001|Randomized|Death|2|||
157047060|NCT01853384|566928417|FG000|Randomized|Lost to Follow-up|1|||
157047061|NCT01853384|566928418|FG001|Randomized|Lost to Follow-up|1|||
157047062|NCT01853384|566928417|FG000|Randomized|Withdrawal by Subject|5|||
157047063|NCT01853384|566928418|FG001|Randomized|Withdrawal by Subject|3|||
157047064|NCT01853384|566928417|FG000|Randomized|Sponsor Decision|47|||
157047065|NCT01853384|566928418|FG001|Randomized|Sponsor Decision|34|||
157047066|NCT01853384|566928417|FG000|Randomized|Other|3|||
157047067|NCT01853384|566928418|FG001|Randomized|Other|3|||
157047068|NCT01853384|566928417|FG000|Completed Follow up Visit 1|Early Termination|13|||
157047069|NCT01853384|566928418|FG001|Completed Follow up Visit 1|Early Termination|9|||
157047070|NCT01853384|566928417|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
157047071|NCT01853384|566928418|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
157047072|NCT01853384|566928417|FG000|Completed Follow up Visit 2|Adverse Event|1|||
157047073|NCT01853384|566928418|FG001|Completed Follow up Visit 2|Adverse Event|0|||
157047074|NCT01853384|566928417|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
157047075|NCT01853384|566928418|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
157047076|NCT01853384|566928417|FG000|Completed Follow up Visit 2|Death|1|||
157047077|NCT01853384|566928418|FG001|Completed Follow up Visit 2|Death|0|||
157047078|NCT01853384|566928417|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
157047079|NCT01853384|566928418|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
157047080|NCT04311983|566928419|FG000|Overall Study|Lost to Follow-up|421|||
157047081|NCT04311983|566928420|FG001|Overall Study|Lost to Follow-up|456|||
157047082|NCT04311983|566928419|FG000|Overall Study|Incomplete survey|7|||
157047083|NCT04311983|566928420|FG001|Overall Study|Incomplete survey|9|||
157047084|NCT04311983|566928419|FG000|Overall Study|Death|1|||
157047085|NCT04311983|566928420|FG001|Overall Study|Death|0|||
157047086|NCT01205126|566928421|FG000|Titration Phase|Adverse Event|5|||
157047087|NCT01205126|566928422|FG001|Titration Phase|Adverse Event|3|||
157047088|NCT01205126|566928421|FG000|Titration Phase|Withdrawal by Subject|5|||
157047089|NCT01205126|566928422|FG001|Titration Phase|Withdrawal by Subject|5|||
157047090|NCT01205126|566928421|FG000|Titration Phase|Lost to Follow-up|2|||
157047091|NCT01205126|566928422|FG001|Titration Phase|Lost to Follow-up|2|||
157047092|NCT01205126|566928421|FG000|Titration Phase|No stable titration dose|1|||
157047093|NCT01205126|566928422|FG001|Titration Phase|No stable titration dose|0|||
157047094|NCT01205126|566928421|FG000|Titration Phase|More than maximum dosage required|2|||
157047095|NCT01205126|566928422|FG001|Titration Phase|More than maximum dosage required|3|||
157228976|NCT01355081|567583409|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
157228977|NCT01355081|567583407|FG000|Overall Study|Major Protocol Deviation|0|||
157228978|NCT01355081|567583408|FG001|Overall Study|Major Protocol Deviation|1|||
157228979|NCT01355081|567583409|FG002|Overall Study|Major Protocol Deviation|0|||
157175438|NCT02431702|567383693|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
157175439|NCT02431702|567383694|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
157175440|NCT02431702|567383695|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
157175441|NCT02431702|567383696|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
157175442|NCT02431702|567383690|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
157175443|NCT02431702|567383691|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
157175444|NCT02431702|567383692|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
157175445|NCT02431702|567383693|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
157175446|NCT02431702|567383694|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
157175447|NCT02431702|567383695|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
157175448|NCT02431702|567383696|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
157175449|NCT02431702|567383690|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
157175450|NCT02431702|567383691|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
157175451|NCT02431702|567383692|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
157175452|NCT02431702|567383693|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
157175453|NCT02431702|567383694|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
157175454|NCT02431702|567383695|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
157175455|NCT02431702|567383696|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
157175456|NCT03907969|567383697|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
157175457|NCT03907969|567383698|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
157175458|NCT03907969|567383699|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
157175459|NCT03907969|567383700|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
157175460|NCT03907969|567383701|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
157175461|NCT03907969|567383702|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
157175462|NCT03907969|567383703|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
157175463|NCT03907969|567383704|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
157175464|NCT03907969|567383705|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
157175465|NCT03907969|567383706|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
157175466|NCT03907969|567383707|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
157175467|NCT03907969|567383697|FG000|Monotherapy Part A|Progressive Disease|0|||
157175468|NCT03907969|567383698|FG001|Monotherapy Part A|Progressive Disease|1|||
157175469|NCT03907969|567383699|FG002|Monotherapy Part A|Progressive Disease|0|||
157175470|NCT03907969|567383700|FG003|Monotherapy Part A|Progressive Disease|0|||
157175471|NCT03907969|567383701|FG004|Monotherapy Part A|Progressive Disease|0|||
157175472|NCT03907969|567383702|FG005|Monotherapy Part A|Progressive Disease|1|||
157175473|NCT03907969|567383703|FG006|Monotherapy Part A|Progressive Disease|2|||
157175474|NCT03907969|567383704|FG007|Monotherapy Part A|Progressive Disease|0|||
157175475|NCT03907969|567383705|FG008|Monotherapy Part A|Progressive Disease|0|||
157175476|NCT03907969|567383706|FG009|Monotherapy Part A|Progressive Disease|0|||
157175477|NCT03907969|567383707|FG010|Monotherapy Part A|Progressive Disease|0|||
157175478|NCT03907969|567383697|FG000|Monotherapy Part A|Death|0|||
157175479|NCT03907969|567383698|FG001|Monotherapy Part A|Death|0|||
157175480|NCT03907969|567383699|FG002|Monotherapy Part A|Death|1|||
157175481|NCT03907969|567383700|FG003|Monotherapy Part A|Death|1|||
157175482|NCT03907969|567383701|FG004|Monotherapy Part A|Death|0|||
157175483|NCT03907969|567383702|FG005|Monotherapy Part A|Death|1|||
157175484|NCT03907969|567383703|FG006|Monotherapy Part A|Death|0|||
157175485|NCT03907969|567383704|FG007|Monotherapy Part A|Death|0|||
157175486|NCT03907969|567383705|FG008|Monotherapy Part A|Death|0|||
157175487|NCT03907969|567383706|FG009|Monotherapy Part A|Death|0|||
157175488|NCT03907969|567383707|FG010|Monotherapy Part A|Death|0|||
157175489|NCT03907969|567383697|FG000|Combination Therapy Part A|Adverse Event|0|||
157175490|NCT03907969|567383698|FG001|Combination Therapy Part A|Adverse Event|0|||
157175491|NCT03907969|567383699|FG002|Combination Therapy Part A|Adverse Event|0|||
157175492|NCT03907969|567383700|FG003|Combination Therapy Part A|Adverse Event|0|||
156969775|NCT00246337|566642320|FG007|Overall Study|Protocol Violation|1|||
156969776|NCT00246337|566642321|FG008|Overall Study|Protocol Violation|0|||
157175493|NCT03907969|567383701|FG004|Combination Therapy Part A|Adverse Event|0|||
157175494|NCT03907969|567383702|FG005|Combination Therapy Part A|Adverse Event|0|||
157175495|NCT03907969|567383703|FG006|Combination Therapy Part A|Adverse Event|0|||
157175496|NCT03907969|567383704|FG007|Combination Therapy Part A|Adverse Event|0|||
157175497|NCT03907969|567383705|FG008|Combination Therapy Part A|Adverse Event|0|||
157175498|NCT03907969|567383706|FG009|Combination Therapy Part A|Adverse Event|1|||
157175499|NCT03907969|567383707|FG010|Combination Therapy Part A|Adverse Event|1|||
157175500|NCT03907969|567383697|FG000|Combination Therapy Part A|Progressive disease|0|||
157228980|NCT01355081|567583407|FG000|Overall Study|Lost to Follow-up|0|||
157228981|NCT01355081|567583408|FG001|Overall Study|Lost to Follow-up|0|||
156969777|NCT00246337|566642313|FG000|Overall Study|Withdrawal by Subject|2|||
156969778|NCT00246337|566642314|FG001|Overall Study|Withdrawal by Subject|0|||
156969779|NCT00246337|566642315|FG002|Overall Study|Withdrawal by Subject|0|||
157228982|NCT01355081|567583409|FG002|Overall Study|Lost to Follow-up|1|||
157228983|NCT01355081|567583407|FG000|Overall Study|Withdrawal of Consent|2|||
156969780|NCT00246337|566642316|FG003|Overall Study|Withdrawal by Subject|0|||
156969781|NCT00246337|566642317|FG004|Overall Study|Withdrawal by Subject|0|||
156969782|NCT00246337|566642318|FG005|Overall Study|Withdrawal by Subject|0|||
156969783|NCT00246337|566642319|FG006|Overall Study|Withdrawal by Subject|1|||
156969784|NCT00246337|566642320|FG007|Overall Study|Withdrawal by Subject|1|||
156969785|NCT00246337|566642321|FG008|Overall Study|Withdrawal by Subject|0|||
156969786|NCT00246337|566642313|FG000|Overall Study|Lack of Qualifying Event|8|||
156969787|NCT00246337|566642314|FG001|Overall Study|Lack of Qualifying Event|2|||
156969788|NCT00246337|566642315|FG002|Overall Study|Lack of Qualifying Event|1|||
156969789|NCT00246337|566642316|FG003|Overall Study|Lack of Qualifying Event|1|||
156969790|NCT00246337|566642317|FG004|Overall Study|Lack of Qualifying Event|1|||
156969791|NCT00246337|566642318|FG005|Overall Study|Lack of Qualifying Event|3|||
156969792|NCT00246337|566642319|FG006|Overall Study|Lack of Qualifying Event|3|||
156969793|NCT00246337|566642320|FG007|Overall Study|Lack of Qualifying Event|2|||
156969794|NCT00246337|566642321|FG008|Overall Study|Lack of Qualifying Event|5|||
156969795|NCT00246337|566642313|FG000|Overall Study|Site Terminated|10|||
156969796|NCT00246337|566642314|FG001|Overall Study|Site Terminated|0|||
156969797|NCT00246337|566642315|FG002|Overall Study|Site Terminated|0|||
156969798|NCT00246337|566642316|FG003|Overall Study|Site Terminated|0|||
156969799|NCT00246337|566642317|FG004|Overall Study|Site Terminated|0|||
156969800|NCT00246337|566642318|FG005|Overall Study|Site Terminated|7|||
156969801|NCT00246337|566642319|FG006|Overall Study|Site Terminated|1|||
156969802|NCT00246337|566642320|FG007|Overall Study|Site Terminated|6|||
156969803|NCT00246337|566642321|FG008|Overall Study|Site Terminated|2|||
156969804|NCT00246337|566642313|FG000|Overall Study|Abnormal baseline lab values|7|||
156969805|NCT00246337|566642314|FG001|Overall Study|Abnormal baseline lab values|0|||
156969806|NCT00246337|566642315|FG002|Overall Study|Abnormal baseline lab values|2|||
156969807|NCT00246337|566642316|FG003|Overall Study|Abnormal baseline lab values|0|||
156969808|NCT00246337|566642317|FG004|Overall Study|Abnormal baseline lab values|0|||
156969809|NCT00246337|566642318|FG005|Overall Study|Abnormal baseline lab values|2|||
156969810|NCT00246337|566642319|FG006|Overall Study|Abnormal baseline lab values|2|||
156969811|NCT00246337|566642320|FG007|Overall Study|Abnormal baseline lab values|0|||
156969812|NCT00246337|566642321|FG008|Overall Study|Abnormal baseline lab values|4|||
156969813|NCT00246337|566642313|FG000|Overall Study|Overwhelmed|0|||
156969814|NCT00246337|566642314|FG001|Overall Study|Overwhelmed|0|||
156969815|NCT00246337|566642315|FG002|Overall Study|Overwhelmed|0|||
156969816|NCT00246337|566642316|FG003|Overall Study|Overwhelmed|0|||
156969817|NCT00246337|566642317|FG004|Overall Study|Overwhelmed|0|||
156969818|NCT00246337|566642318|FG005|Overall Study|Overwhelmed|1|||
156969819|NCT00246337|566642319|FG006|Overall Study|Overwhelmed|0|||
156969820|NCT00246337|566642320|FG007|Overall Study|Overwhelmed|0|||
156969821|NCT00246337|566642321|FG008|Overall Study|Overwhelmed|0|||
156969822|NCT00246337|566642313|FG000|Overall Study|Protocol Violator|1|||
156969823|NCT00246337|566642314|FG001|Overall Study|Protocol Violator|0|||
156969824|NCT00246337|566642315|FG002|Overall Study|Protocol Violator|0|||
156969825|NCT00246337|566642316|FG003|Overall Study|Protocol Violator|0|||
156969826|NCT00246337|566642317|FG004|Overall Study|Protocol Violator|0|||
156969827|NCT00246337|566642318|FG005|Overall Study|Protocol Violator|0|||
156969828|NCT00246337|566642319|FG006|Overall Study|Protocol Violator|0|||
156969829|NCT00246337|566642320|FG007|Overall Study|Protocol Violator|0|||
156969830|NCT00246337|566642321|FG008|Overall Study|Protocol Violator|0|||
156969831|NCT00246337|566642313|FG000|Overall Study|Reported as completing trial in error|0|||
156969832|NCT00246337|566642314|FG001|Overall Study|Reported as completing trial in error|0|||
156969833|NCT00246337|566642315|FG002|Overall Study|Reported as completing trial in error|0|||
156969834|NCT00246337|566642316|FG003|Overall Study|Reported as completing trial in error|0|||
156969835|NCT00246337|566642317|FG004|Overall Study|Reported as completing trial in error|0|||
156969836|NCT00246337|566642318|FG005|Overall Study|Reported as completing trial in error|0|||
156969837|NCT00246337|566642319|FG006|Overall Study|Reported as completing trial in error|0|||
156969838|NCT00246337|566642320|FG007|Overall Study|Reported as completing trial in error|1|||
156969839|NCT00246337|566642321|FG008|Overall Study|Reported as completing trial in error|0|||
156969840|NCT01226511|566642324|FG000|Acute Treatment Period|Adverse Event|7|||
156969841|NCT01226511|566642325|FG001|Acute Treatment Period|Adverse Event|6|||
156969842|NCT01226511|566642324|FG000|Acute Treatment Period|Lack of Efficacy|2|||
156969843|NCT01226511|566642325|FG001|Acute Treatment Period|Lack of Efficacy|1|||
156969844|NCT01226511|566642324|FG000|Acute Treatment Period|Lost to Follow-up|3|||
156969845|NCT01226511|566642325|FG001|Acute Treatment Period|Lost to Follow-up|6|||
156969846|NCT01226511|566642324|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
156969847|NCT01226511|566642325|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
156969848|NCT01226511|566642324|FG000|Acute Treatment Period|Protocol Violation|5|||
156969849|NCT01226511|566642325|FG001|Acute Treatment Period|Protocol Violation|5|||
156969850|NCT01226511|566642324|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
156969851|NCT01226511|566642325|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
156969852|NCT01226511|566642324|FG000|Extension Treatment Period|Adverse Event|8|||
156969853|NCT01226511|566642325|FG001|Extension Treatment Period|Adverse Event|8|||
157175501|NCT03907969|567383698|FG001|Combination Therapy Part A|Progressive disease|0|||
157175502|NCT03907969|567383699|FG002|Combination Therapy Part A|Progressive disease|0|||
157175503|NCT03907969|567383700|FG003|Combination Therapy Part A|Progressive disease|0|||
157175504|NCT03907969|567383701|FG004|Combination Therapy Part A|Progressive disease|0|||
157175505|NCT03907969|567383702|FG005|Combination Therapy Part A|Progressive disease|0|||
157175506|NCT03907969|567383703|FG006|Combination Therapy Part A|Progressive disease|0|||
157175507|NCT03907969|567383704|FG007|Combination Therapy Part A|Progressive disease|1|||
157175508|NCT03907969|567383705|FG008|Combination Therapy Part A|Progressive disease|0|||
156969854|NCT01226511|566642324|FG000|Extension Treatment Period|Lack of Efficacy|3|||
156969855|NCT01226511|566642325|FG001|Extension Treatment Period|Lack of Efficacy|2|||
156969856|NCT01226511|566642324|FG000|Extension Treatment Period|Lost to Follow-up|4|||
156969857|NCT01226511|566642325|FG001|Extension Treatment Period|Lost to Follow-up|3|||
156969858|NCT01226511|566642324|FG000|Extension Treatment Period|Protocol Violation|2|||
156969859|NCT01226511|566642325|FG001|Extension Treatment Period|Protocol Violation|2|||
156969860|NCT01226511|566642324|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
156969861|NCT01226511|566642325|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
156969862|NCT01226511|566642324|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
156969863|NCT01226511|566642325|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
156969864|NCT01226511|566642324|FG000|Extension Treatment Period|Sponsor Decision|1|||
156969865|NCT01226511|566642325|FG001|Extension Treatment Period|Sponsor Decision|1|||
156969866|NCT01226511|566642324|FG000|Taper Period|Adverse Event|1|||
156969867|NCT01226511|566642325|FG001|Taper Period|Adverse Event|0|||
156969868|NCT01226511|566642324|FG000|Taper Period|Lost to Follow-up|2|||
156969869|NCT01226511|566642325|FG001|Taper Period|Lost to Follow-up|2|||
156969870|NCT01226511|566642324|FG000|Taper Period|Protocol Violation|1|||
156969871|NCT01226511|566642325|FG001|Taper Period|Protocol Violation|0|||
156969872|NCT01226511|566642324|FG000|Taper Period|Parent/Caregiver Decision|1|||
156969873|NCT01226511|566642325|FG001|Taper Period|Parent/Caregiver Decision|1|||
156969874|NCT05267600|566642330|FG000|Overall Study|Adverse Event|1|||
156969875|NCT05267600|566642331|FG001|Overall Study|Adverse Event|4|||
156969876|NCT05267600|566642330|FG000|Overall Study|Death|1|||
156969877|NCT05267600|566642331|FG001|Overall Study|Death|2|||
156969878|NCT05267600|566642330|FG000|Overall Study|Lack of Efficacy|1|||
156969879|NCT05267600|566642331|FG001|Overall Study|Lack of Efficacy|2|||
156969880|NCT05267600|566642330|FG000|Overall Study|Lost to Follow-up|3|||
156969881|NCT05267600|566642331|FG001|Overall Study|Lost to Follow-up|0|||
156969882|NCT05267600|566642330|FG000|Overall Study|Physician Decision|4|||
156969883|NCT05267600|566642331|FG001|Overall Study|Physician Decision|0|||
156969884|NCT05267600|566642330|FG000|Overall Study|Treatment Unblinded|0|||
156969885|NCT05267600|566642331|FG001|Overall Study|Treatment Unblinded|1|||
156969886|NCT05267600|566642330|FG000|Overall Study|Withdrawal by Subject|5|||
156969887|NCT05267600|566642331|FG001|Overall Study|Withdrawal by Subject|4|||
156969888|NCT01722162|566642336|FG000|Overall Study|Withdrawal by Subject|1|||
156969889|NCT01722162|566642337|FG001|Overall Study|Withdrawal by Subject|1|||
156969890|NCT01722162|566642336|FG000|Overall Study|Found ineligible|1|||
156969891|NCT01722162|566642337|FG001|Overall Study|Found ineligible|0|||
156969892|NCT01722162|566642336|FG000|Overall Study|Unrelated to study adverse event|2|||
156969893|NCT01722162|566642337|FG001|Overall Study|Unrelated to study adverse event|2|||
156969894|NCT01722162|566642336|FG000|Overall Study|Adverse Event|1|||
156969895|NCT01722162|566642337|FG001|Overall Study|Adverse Event|1|||
156969896|NCT01722162|566642336|FG000|Overall Study|Insurance denial post enrollment|0|||
156969897|NCT01722162|566642337|FG001|Overall Study|Insurance denial post enrollment|1|||
156969898|NCT01722162|566642336|FG000|Overall Study|Noncompliance|0|||
156969899|NCT01722162|566642337|FG001|Overall Study|Noncompliance|1|||
156969900|NCT00643123|566642338|FG000|Overall Study|Lost to Follow-up|4|||
156969901|NCT00643123|566642339|FG001|Overall Study|Lost to Follow-up|0|||
156969902|NCT00643123|566642338|FG000|Overall Study|Withdrawal by Subject|1|||
156969903|NCT00643123|566642339|FG001|Overall Study|Withdrawal by Subject|1|||
156969904|NCT05292534|566642340|FG000|Overall Study|Protocol Violation|3|||
156969905|NCT05292534|566642341|FG001|Overall Study|Protocol Violation|4|||
156969906|NCT05292534|566642340|FG000|Overall Study|Withdrawal by Subject|0|||
156969907|NCT05292534|566642341|FG001|Overall Study|Withdrawal by Subject|1|||
156969908|NCT01538472|566642343|FG000|Overall Study|Disease Progression|3|||
156969909|NCT01538472|566642343|FG000|Overall Study|Death|1|||
156969910|NCT02309112|566642344|FG000|Overall Study|Withdrawal by Subject|1|||
156969911|NCT02309112|566642345|FG001|Overall Study|Withdrawal by Subject|0|||
157175509|NCT03907969|567383706|FG009|Combination Therapy Part A|Progressive disease|2|||
156969912|NCT02309112|566642346|FG002|Overall Study|Withdrawal by Subject|1|||
156969913|NCT02309112|566642344|FG000|Overall Study|Lost to Follow-up|0|||
156969914|NCT02309112|566642345|FG001|Overall Study|Lost to Follow-up|1|||
156969915|NCT02309112|566642346|FG002|Overall Study|Lost to Follow-up|0|||
156969916|NCT02133872|566642347|FG000|Overall Study|Withdrawal by Subject|5|||
156969917|NCT02133872|566642348|FG001|Overall Study|Withdrawal by Subject|3|||
156969918|NCT02133872|566642349|FG002|Overall Study|Withdrawal by Subject|0|||
156969919|NCT02923739|566642350|FG000|Overall Study|Withdrawal by Subject|2|||
156969920|NCT02923739|566642351|FG001|Overall Study|Withdrawal by Subject|0|||
157175510|NCT03907969|567383707|FG010|Combination Therapy Part A|Progressive disease|3|||
156969921|NCT02923739|566642352|FG002|Overall Study|Withdrawal by Subject|0|||
156969922|NCT02923739|566642353|FG003|Overall Study|Withdrawal by Subject|0|||
156969923|NCT02923739|566642350|FG000|Overall Study|Failed Screening|3|||
156969924|NCT02923739|566642351|FG001|Overall Study|Failed Screening|0|||
156969925|NCT02923739|566642352|FG002|Overall Study|Failed Screening|0|||
156969926|NCT02923739|566642353|FG003|Overall Study|Failed Screening|0|||
156969927|NCT00948974|566642358|FG000|Overall Study|Lost to Follow-up|23|||
156969928|NCT00948974|566642359|FG001|Overall Study|Lost to Follow-up|20|||
156969929|NCT00409682|566642361|FG000|Open-label Induction Period|Adverse Event|1|||
156969930|NCT00409682|566642362|FG001|Open-label Induction Period|Adverse Event|0|||
156969931|NCT00409682|566642363|FG002|Open-label Induction Period|Adverse Event|0|||
156969932|NCT00409682|566642361|FG000|Open-label Induction Period|Lack of Efficacy|1|||
156969933|NCT00409682|566642362|FG001|Open-label Induction Period|Lack of Efficacy|0|||
156969934|NCT00409682|566642363|FG002|Open-label Induction Period|Lack of Efficacy|0|||
156969935|NCT00409682|566642361|FG000|Open-label Induction Period|Protocol Violation|1|||
156969936|NCT00409682|566642362|FG001|Open-label Induction Period|Protocol Violation|0|||
156969937|NCT00409682|566642363|FG002|Open-label Induction Period|Protocol Violation|0|||
156969938|NCT00409682|566642361|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
156969939|NCT00409682|566642362|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
156969940|NCT00409682|566642363|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
156969941|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
156969942|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
156969943|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
156969944|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
156969945|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
156969946|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
156969947|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
156969948|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
156969949|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
156969950|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
156969951|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
156969952|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
156969953|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
156969954|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
156969955|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
156969956|NCT00409682|566642361|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
156969957|NCT00409682|566642362|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
156969958|NCT00409682|566642363|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
156969959|NCT00118716|566642367|FG000|Overall Study|Adverse Event|2|||
156969960|NCT00118716|566642368|FG001|Overall Study|Adverse Event|7|||
156969961|NCT00118716|566642367|FG000|Overall Study|Protocol Violation|5|||
156969962|NCT00118716|566642368|FG001|Overall Study|Protocol Violation|4|||
156969963|NCT00118716|566642367|FG000|Overall Study|Withdrawal by Subject|0|||
156969964|NCT00118716|566642368|FG001|Overall Study|Withdrawal by Subject|1|||
156969965|NCT00118716|566642367|FG000|Overall Study|Exacerbation|2|||
156969966|NCT00118716|566642368|FG001|Overall Study|Exacerbation|2|||
156969967|NCT00118716|566642367|FG000|Overall Study|Discontinued by sponsor|1|||
156969968|NCT00118716|566642368|FG001|Overall Study|Discontinued by sponsor|1|||
156969969|NCT00118716|566642367|FG000|Overall Study|Non-compliance|1|||
156969970|NCT00118716|566642368|FG001|Overall Study|Non-compliance|3|||
156969971|NCT00118716|566642367|FG000|Overall Study|misrandomized|1|||
156969972|NCT00118716|566642368|FG001|Overall Study|misrandomized|1|||
156969973|NCT00118716|566642367|FG000|Overall Study|Expired drug use|1|||
156969974|NCT00118716|566642368|FG001|Overall Study|Expired drug use|2|||
156969975|NCT00118716|566642367|FG000|Overall Study|Investigator discretion|0|||
156969976|NCT00118716|566642368|FG001|Overall Study|Investigator discretion|1|||
156969977|NCT00855062|566642369|FG000|Step1|Early Study Closure|5|||
156969978|NCT00855062|566642370|FG001|Step1|Early Study Closure|7|||
156969979|NCT00855062|566642369|FG000|Step1|Adverse Event|1|||
156969980|NCT00855062|566642370|FG001|Step1|Adverse Event|1|||
156969981|NCT00855062|566642369|FG000|Step1|Protocol Violation|1|||
156969982|NCT00855062|566642370|FG001|Step1|Protocol Violation|0|||
156969983|NCT00855062|566642369|FG000|Step1|Pregnancy|1|||
156969984|NCT00855062|566642370|FG001|Step1|Pregnancy|0|||
156969985|NCT00855062|566642369|FG000|Step1|Withdrawal by Subject|2|||
156969986|NCT00855062|566642370|FG001|Step1|Withdrawal by Subject|3|||
156969987|NCT00855062|566642369|FG000|Step2|Early Study Closure|6|||
156969988|NCT00855062|566642370|FG001|Step2|Early Study Closure|2|||
156969989|NCT00855062|566642369|FG000|Step2|Adverse Event|0|||
156969990|NCT00855062|566642370|FG001|Step2|Adverse Event|3|||
156969991|NCT00855062|566642369|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
156969992|NCT00855062|566642370|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
156969993|NCT02857426|566642373|FG000|Overall Study|Disease progression|34|||
156969994|NCT02857426|566642374|FG001|Overall Study|Disease progression|13|||
157228984|NCT01355081|567583408|FG001|Overall Study|Withdrawal of Consent|3|||
157228985|NCT01355081|567583409|FG002|Overall Study|Withdrawal of Consent|3|||
157228986|NCT01355081|567583407|FG000|Overall Study|Lack of Efficacy|2|||
157228987|NCT01355081|567583408|FG001|Overall Study|Lack of Efficacy|1|||
157228988|NCT01355081|567583409|FG002|Overall Study|Lack of Efficacy|1|||
157228989|NCT01355081|567583407|FG000|Overall Study|Non Compliance with Study Medication|0|||
157228990|NCT01355081|567583408|FG001|Overall Study|Non Compliance with Study Medication|1|||
157228991|NCT01355081|567583409|FG002|Overall Study|Non Compliance with Study Medication|0|||
157228992|NCT02719522|567583410|FG000|Overall Study|Implant Failure|4|||
157228993|NCT02719522|567583410|FG000|Overall Study|Death|2|||
157228994|NCT02719522|567583410|FG000|Overall Study|Lost to Follow-up|5|||
157228995|NCT04803357|567583411|FG000|Overall Study|Withdrawal by Subject|31|||
157228996|NCT04803357|567583412|FG001|Overall Study|Withdrawal by Subject|5|||
157228997|NCT02879643|567583414|FG000|Overall Study|Adverse Event|0|||
157228998|NCT02879643|567583415|FG001|Overall Study|Adverse Event|0|||
157228999|NCT02879643|567583416|FG002|Overall Study|Adverse Event|1|||
157229000|NCT02879643|567583417|FG003|Overall Study|Adverse Event|1|||
157229001|NCT02879643|567583418|FG004|Overall Study|Adverse Event|0|||
157229002|NCT00182091|567583419|FG000|Overall Study|Withdrawal by Subject|1|||
157229003|NCT00182091|567583420|FG001|Overall Study|Withdrawal by Subject|0|||
157229004|NCT00182091|567583421|FG002|Overall Study|Withdrawal by Subject|0|||
157229005|NCT00182091|567583422|FG003|Overall Study|Withdrawal by Subject|0|||
157229006|NCT02456909|567583423|FG000|Overall Study|Did not receive allocated intervention|24|||
157229007|NCT02456909|567583424|FG001|Overall Study|Did not receive allocated intervention|26|||
157229008|NCT02456909|567583423|FG000|Overall Study|Did not complete the primary outcome|0|||
157229009|NCT02456909|567583424|FG001|Overall Study|Did not complete the primary outcome|1|||
157229010|NCT03309956|567583425|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
157229011|NCT04603937|567583426|FG000|Overall Study|Adverse Event|9|||
157229012|NCT04603937|567583427|FG001|Overall Study|Adverse Event|10|||
157229013|NCT04603937|567583426|FG000|Overall Study|Withdrawal by Subject|7|||
157229014|NCT04603937|567583427|FG001|Overall Study|Withdrawal by Subject|6|||
157229015|NCT04603937|567583426|FG000|Overall Study|Lost to Follow-up|5|||
157229016|NCT04603937|567583427|FG001|Overall Study|Lost to Follow-up|6|||
157229017|NCT04603937|567583426|FG000|Overall Study|Physician Decision|0|||
157229018|NCT04603937|567583427|FG001|Overall Study|Physician Decision|1|||
157229019|NCT04603937|567583426|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
157229020|NCT04603937|567583427|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
157229021|NCT02518685|567583428|FG000|Overall Study|Adverse Event|29|||
157229022|NCT02518685|567583429|FG001|Overall Study|Adverse Event|1|||
157229023|NCT02518685|567583428|FG000|Overall Study|Withdrawal by Subject|10|||
157229024|NCT02518685|567583429|FG001|Overall Study|Withdrawal by Subject|3|||
157229025|NCT02518685|567583428|FG000|Overall Study|relocation, study fatigue|7|||
157229026|NCT02518685|567583429|FG001|Overall Study|relocation, study fatigue|2|||
157229027|NCT02518685|567583428|FG000|Overall Study|Pregnancy|1|||
157229028|NCT02518685|567583429|FG001|Overall Study|Pregnancy|0|||
157229029|NCT02518685|567583428|FG000|Overall Study|Physician Decision|1|||
157229030|NCT02518685|567583429|FG001|Overall Study|Physician Decision|0|||
157229031|NCT02518685|567583428|FG000|Overall Study|Lost to Follow-up|1|||
157229032|NCT02518685|567583429|FG001|Overall Study|Lost to Follow-up|4|||
157229033|NCT05109234|567583430|FG000|Overall Study|Adverse Event|2|||
157229034|NCT05109234|567583431|FG001|Overall Study|Adverse Event|2|||
157229035|NCT05109234|567583430|FG000|Overall Study|Lack of Efficacy|5|||
157229036|NCT05109234|567583431|FG001|Overall Study|Lack of Efficacy|0|||
157229037|NCT05109234|567583430|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
157229038|NCT05109234|567583431|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
157229039|NCT05109234|567583430|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
157229040|NCT05109234|567583431|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
157229041|NCT05109234|567583430|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
157229042|NCT05109234|567583431|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
157229043|NCT05109234|567583430|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
157229044|NCT05109234|567583431|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
157229045|NCT00993616|567583432|FG000|Overall Study|No tumor at entry|1|||
157229046|NCT00993616|567583432|FG000|Overall Study|Never treated|1|||
157229047|NCT03946449|567583433|FG000|Treatment Extension II|Rolled over to another study|0|||
157229048|NCT03946449|567583434|FG001|Treatment Extension II|Rolled over to another study|0|||
157229049|NCT03946449|567583435|FG002|Treatment Extension II|Rolled over to another study|2|||
157229050|NCT03946449|567583433|FG000|Treatment Extension II|Withdrawal by Subject|0|||
157229051|NCT03946449|567583434|FG001|Treatment Extension II|Withdrawal by Subject|0|||
157229052|NCT03946449|567583435|FG002|Treatment Extension II|Withdrawal by Subject|1|||
157229053|NCT03805438|567585108|FG000|Overall Study|Lack of Efficacy|1|||
157229054|NCT03805438|567585108|FG000|Overall Study|Protocol Violation|1|||
157229055|NCT01374919|567585109|FG000|Overall Study|Withdrawal by Subject|2|||
156969995|NCT02857426|566642373|FG000|Overall Study|Study drug toxicity|4|||
157229056|NCT00366899|567585110|FG000|Infant Series|Withdrawal by Subject|4|||
157229057|NCT00366899|567585111|FG001|Infant Series|Withdrawal by Subject|7|||
157229058|NCT00366899|567585110|FG000|Infant Series|Protocol Violation|2|||
157229059|NCT00366899|567585111|FG001|Infant Series|Protocol Violation|1|||
156969996|NCT02857426|566642374|FG001|Overall Study|Study drug toxicity|1|||
157175511|NCT03907969|567383697|FG000|Combination Therapy Part A|Death|0|||
157175512|NCT03907969|567383698|FG001|Combination Therapy Part A|Death|0|||
157175513|NCT03907969|567383699|FG002|Combination Therapy Part A|Death|0|||
157175514|NCT03907969|567383700|FG003|Combination Therapy Part A|Death|0|||
157175515|NCT03907969|567383701|FG004|Combination Therapy Part A|Death|0|||
157175516|NCT03907969|567383702|FG005|Combination Therapy Part A|Death|0|||
157175517|NCT03907969|567383703|FG006|Combination Therapy Part A|Death|0|||
157175518|NCT03907969|567383704|FG007|Combination Therapy Part A|Death|0|||
157175519|NCT03907969|567383705|FG008|Combination Therapy Part A|Death|1|||
157175520|NCT03907969|567383706|FG009|Combination Therapy Part A|Death|0|||
157175521|NCT03907969|567383707|FG010|Combination Therapy Part A|Death|1|||
157175522|NCT03907969|567383697|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
157175523|NCT03907969|567383698|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
157175524|NCT03907969|567383699|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
157175525|NCT03907969|567383700|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
157175526|NCT03907969|567383701|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
157175527|NCT03907969|567383702|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
157175528|NCT03907969|567383703|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
157175529|NCT03907969|567383704|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
157175530|NCT03907969|567383705|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
157175531|NCT03907969|567383706|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
157175532|NCT03907969|567383707|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
157175533|NCT03907969|567383697|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
157175534|NCT03907969|567383698|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
157175535|NCT03907969|567383699|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
157175536|NCT03907969|567383700|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
157175537|NCT03907969|567383701|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
157175538|NCT03907969|567383702|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
157175539|NCT03907969|567383703|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
157175540|NCT03907969|567383704|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
157175541|NCT03907969|567383705|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
157175542|NCT03907969|567383706|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
157175543|NCT03907969|567383707|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
157175544|NCT03907969|567383697|FG000|Combination Therapy Part A|Physician Decision|0|||
157175545|NCT03907969|567383698|FG001|Combination Therapy Part A|Physician Decision|0|||
157175546|NCT03907969|567383699|FG002|Combination Therapy Part A|Physician Decision|0|||
157175547|NCT03907969|567383700|FG003|Combination Therapy Part A|Physician Decision|0|||
157175548|NCT03907969|567383701|FG004|Combination Therapy Part A|Physician Decision|0|||
157175549|NCT03907969|567383702|FG005|Combination Therapy Part A|Physician Decision|0|||
157175550|NCT03907969|567383703|FG006|Combination Therapy Part A|Physician Decision|0|||
157175551|NCT03907969|567383704|FG007|Combination Therapy Part A|Physician Decision|1|||
157175552|NCT03907969|567383705|FG008|Combination Therapy Part A|Physician Decision|0|||
157175553|NCT03907969|567383706|FG009|Combination Therapy Part A|Physician Decision|0|||
157229060|NCT00366899|567585110|FG000|Infant Series|Failed to return|1|||
157229061|NCT00366899|567585111|FG001|Infant Series|Failed to return|1|||
156969997|NCT02857426|566642373|FG000|Overall Study|Death|1|||
156969998|NCT02857426|566642374|FG001|Overall Study|Death|0|||
156969999|NCT02857426|566642373|FG000|Overall Study|Adverse event unrelated to study drug|6|||
156970000|NCT02857426|566642374|FG001|Overall Study|Adverse event unrelated to study drug|2|||
156970001|NCT02857426|566642373|FG000|Overall Study|Participant withdrew consent|1|||
156970002|NCT02857426|566642374|FG001|Overall Study|Participant withdrew consent|1|||
156970003|NCT02857426|566642373|FG000|Overall Study|Maximum clinical benefit|1|||
156970004|NCT02857426|566642374|FG001|Overall Study|Maximum clinical benefit|0|||
156970005|NCT02857426|566642373|FG000|Overall Study|Completed treatment|0|||
156970006|NCT02857426|566642374|FG001|Overall Study|Completed treatment|2|||
156970007|NCT02110901|566642375|FG000|Overall Study|Death|6|||
156970008|NCT02110901|566642376|FG001|Overall Study|Death|3|||
156970009|NCT02110901|566642375|FG000|Overall Study|Lost to Follow-up|12|||
156970010|NCT02110901|566642376|FG001|Overall Study|Lost to Follow-up|8|||
156970011|NCT02110901|566642375|FG000|Overall Study|Withdrawal by Subject|7|||
156970012|NCT02110901|566642376|FG001|Overall Study|Withdrawal by Subject|3|||
156970013|NCT02110901|566642375|FG000|Overall Study|received a kidney transplant|5|||
156970014|NCT02110901|566642376|FG001|Overall Study|received a kidney transplant|0|||
156970015|NCT00701038|566642383|FG000|Overall Study|study amended pilot group of patients|4|||
156970016|NCT00701038|566642384|FG001|Overall Study|study amended pilot group of patients|4|||
156970017|NCT03988166|566642388|FG000|Overall Study|Lost to Follow-up|2|||
156970018|NCT03988166|566642388|FG000|Overall Study|Death|1|||
157175554|NCT03907969|567383707|FG010|Combination Therapy Part A|Physician Decision|1|||
157175555|NCT04209530|567383709|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
157175556|NCT04209530|567383710|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
157175557|NCT04209530|567383709|FG000|Overall Study|Withdrawal by Subject|0|||
157175558|NCT04209530|567383710|FG001|Overall Study|Withdrawal by Subject|1|||
157175559|NCT01510028|567383711|FG000|Overall Study|Lack of Efficacy|1|||
157175560|NCT01510028|567383712|FG001|Overall Study|Lack of Efficacy|0|||
157175561|NCT01510028|567383713|FG002|Overall Study|Lack of Efficacy|0|||
157175562|NCT01510028|567383714|FG003|Overall Study|Lack of Efficacy|0|||
157175563|NCT00633893|567383715|FG000|Overall Study|Death|1|||
156970019|NCT02703922|566642390|FG000|Overall Study|Death|5|||
156970020|NCT02703922|566642391|FG001|Overall Study|Death|8|||
156970021|NCT02703922|566642390|FG000|Overall Study|Lost to Follow-up|10|||
156970022|NCT02703922|566642391|FG001|Overall Study|Lost to Follow-up|10|||
156970023|NCT05805657|566642394|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
156970024|NCT05805657|566642395|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
156970025|NCT00316173|566642399|FG000|Run-in Phase|Adverse Event|1|||
156970026|NCT00316173|566642400|FG001|Run-in Phase|Adverse Event|0|||
156970027|NCT00316173|566642399|FG000|Run-in Phase|Protocol Violation|1|||
156970028|NCT00316173|566642400|FG001|Run-in Phase|Protocol Violation|0|||
156970029|NCT00316173|566642399|FG000|Run-in Phase|Study Follow-up Stopped|5|||
156970030|NCT00316173|566642400|FG001|Run-in Phase|Study Follow-up Stopped|0|||
156970031|NCT00316173|566642399|FG000|Treatment Phase|Adverse Event|0|||
156970032|NCT00316173|566642400|FG001|Treatment Phase|Adverse Event|1|||
156970033|NCT00316173|566642399|FG000|Treatment Phase|Lack of Efficacy|0|||
156970034|NCT00316173|566642400|FG001|Treatment Phase|Lack of Efficacy|3|||
156970035|NCT00316173|566642399|FG000|Treatment Phase|Lost to Follow-up|0|||
156970036|NCT00316173|566642400|FG001|Treatment Phase|Lost to Follow-up|3|||
156970037|NCT00316173|566642399|FG000|Treatment Phase|Withdrawal by Subject|0|||
156970038|NCT00316173|566642400|FG001|Treatment Phase|Withdrawal by Subject|1|||
156970039|NCT00316173|566642399|FG000|Treatment Phase|Study Follow-up Stopped|0|||
156970040|NCT00316173|566642400|FG001|Treatment Phase|Study Follow-up Stopped|34|||
156970041|NCT01951638|566642404|FG000|Treatment Period|Protocol Violation|0|||
156970042|NCT01951638|566642405|FG001|Treatment Period|Protocol Violation|0|||
156970043|NCT01951638|566642406|FG002|Treatment Period|Protocol Violation|0|||
156970044|NCT01951638|566642407|FG003|Treatment Period|Protocol Violation|2|||
156970045|NCT01951638|566642408|FG004|Treatment Period|Protocol Violation|0|||
156970046|NCT01951638|566642404|FG000|Treatment Period|Protocol-driven decision point|1|||
156970047|NCT01951638|566642405|FG001|Treatment Period|Protocol-driven decision point|3|||
156970048|NCT01951638|566642406|FG002|Treatment Period|Protocol-driven decision point|0|||
156970049|NCT01951638|566642407|FG003|Treatment Period|Protocol-driven decision point|0|||
156970050|NCT01951638|566642408|FG004|Treatment Period|Protocol-driven decision point|0|||
156970051|NCT01951638|566642404|FG000|Treatment Period|Logistical difficulties|0|||
156970052|NCT01951638|566642405|FG001|Treatment Period|Logistical difficulties|1|||
156970053|NCT01951638|566642406|FG002|Treatment Period|Logistical difficulties|1|||
156970054|NCT01951638|566642407|FG003|Treatment Period|Logistical difficulties|0|||
156970055|NCT01951638|566642408|FG004|Treatment Period|Logistical difficulties|0|||
156970056|NCT01951638|566642404|FG000|Treatment Period|Withdrawal by Subject|9|||
156970057|NCT01951638|566642405|FG001|Treatment Period|Withdrawal by Subject|6|||
156970058|NCT01951638|566642406|FG002|Treatment Period|Withdrawal by Subject|4|||
156970059|NCT01951638|566642407|FG003|Treatment Period|Withdrawal by Subject|5|||
156970060|NCT01951638|566642408|FG004|Treatment Period|Withdrawal by Subject|4|||
156970061|NCT01951638|566642404|FG000|Treatment Period|Death|0|||
156970062|NCT01951638|566642405|FG001|Treatment Period|Death|0|||
156970063|NCT01951638|566642406|FG002|Treatment Period|Death|0|||
156970064|NCT01951638|566642407|FG003|Treatment Period|Death|3|||
156970065|NCT01951638|566642408|FG004|Treatment Period|Death|1|||
156970066|NCT01951638|566642404|FG000|Treatment Period|Adverse Event|3|||
156970067|NCT01951638|566642405|FG001|Treatment Period|Adverse Event|4|||
156970068|NCT01951638|566642406|FG002|Treatment Period|Adverse Event|8|||
156970069|NCT01951638|566642407|FG003|Treatment Period|Adverse Event|6|||
156970070|NCT01951638|566642408|FG004|Treatment Period|Adverse Event|5|||
156970071|NCT01951638|566642404|FG000|Follow-up Period|Protocol Violation|0|||
156970072|NCT01951638|566642405|FG001|Follow-up Period|Protocol Violation|0|||
156970073|NCT01951638|566642406|FG002|Follow-up Period|Protocol Violation|0|||
156970074|NCT01951638|566642407|FG003|Follow-up Period|Protocol Violation|1|||
156970075|NCT01951638|566642408|FG004|Follow-up Period|Protocol Violation|0|||
156970076|NCT01951638|566642404|FG000|Follow-up Period|Logistical difficulties|0|||
156970077|NCT01951638|566642405|FG001|Follow-up Period|Logistical difficulties|2|||
156970078|NCT01951638|566642406|FG002|Follow-up Period|Logistical difficulties|0|||
156970079|NCT01951638|566642407|FG003|Follow-up Period|Logistical difficulties|0|||
156970080|NCT01951638|566642408|FG004|Follow-up Period|Logistical difficulties|1|||
156970081|NCT01951638|566642404|FG000|Follow-up Period|Withdrawal by Subject|1|||
157047096|NCT01205126|566928421|FG000|Titration Phase|Other|8|||
157047097|NCT01205126|566928422|FG001|Titration Phase|Other|6|||
157047098|NCT01205126|566928421|FG000|Between Titration & Maintenance Phase|Other|0|||
157047099|NCT01205126|566928422|FG001|Between Titration & Maintenance Phase|Other|4|||
157047100|NCT01205126|566928421|FG000|Maintenance Phase|Adverse Event|3|||
157047101|NCT01205126|566928422|FG001|Maintenance Phase|Adverse Event|7|||
157047102|NCT01205126|566928421|FG000|Maintenance Phase|Death|4|||
157047103|NCT01205126|566928422|FG001|Maintenance Phase|Death|4|||
157047104|NCT01205126|566928421|FG000|Maintenance Phase|More than the maximum dosage required|5|||
157047105|NCT01205126|566928422|FG001|Maintenance Phase|More than the maximum dosage required|5|||
157047106|NCT01205126|566928421|FG000|Maintenance Phase|Prohibited drugs used|1|||
157047107|NCT01205126|566928422|FG001|Maintenance Phase|Prohibited drugs used|0|||
157047108|NCT01205126|566928421|FG000|Maintenance Phase|Other|11|||
157047109|NCT01205126|566928422|FG001|Maintenance Phase|Other|8|||
157047110|NCT01205126|566928421|FG000|Maintenance Phase|Lost to Follow-up|5|||
157047111|NCT01205126|566928422|FG001|Maintenance Phase|Lost to Follow-up|5|||
157047112|NCT01205126|566928421|FG000|Maintenance Phase|Withdrawal by Subject|8|||
157047113|NCT01205126|566928422|FG001|Maintenance Phase|Withdrawal by Subject|11|||
157047114|NCT00929526|566928423|FG000|Overall Study|Withdrawal by Subject|1|||
157047115|NCT00929526|566928424|FG001|Overall Study|Withdrawal by Subject|11|||
157047116|NCT00929526|566928423|FG000|Overall Study|Lost to Follow-up|8|||
157047117|NCT00929526|566928424|FG001|Overall Study|Lost to Follow-up|12|||
157047118|NCT00929526|566928423|FG000|Overall Study|Other|8|||
157047119|NCT00929526|566928424|FG001|Overall Study|Other|6|||
157047120|NCT00578344|566928427|FG000|Overall Study|Insurance problems|1|||
157047121|NCT00578344|566928427|FG000|Overall Study|Graft failure|1|||
157047122|NCT02169414|566928428|FG000|Overall Study|Withdrawal by Subject|1|||
157047123|NCT02169414|566928429|FG001|Overall Study|Withdrawal by Subject|0|||
157047124|NCT02169414|566928430|FG002|Overall Study|Withdrawal by Subject|0|||
157047125|NCT02169414|566928431|FG003|Overall Study|Withdrawal by Subject|0|||
157047126|NCT02169414|566928428|FG000|Overall Study|Adverse Event|0|||
157047127|NCT02169414|566928429|FG001|Overall Study|Adverse Event|1|||
157047128|NCT02169414|566928430|FG002|Overall Study|Adverse Event|0|||
157047129|NCT02169414|566928431|FG003|Overall Study|Adverse Event|0|||
157047130|NCT03374254|566928434|FG000|Overall Study|Death|5|||
157047131|NCT03374254|566928435|FG001|Overall Study|Death|16|||
157047132|NCT03374254|566928436|FG002|Overall Study|Death|13|||
157047133|NCT03374254|566928437|FG003|Overall Study|Death|11|||
157047134|NCT03374254|566928438|FG004|Overall Study|Death|9|||
157047135|NCT03374254|566928439|FG005|Overall Study|Death|12|||
157047136|NCT03374254|566928440|FG006|Overall Study|Death|11|||
157047137|NCT03374254|566928441|FG007|Overall Study|Death|6|||
157047138|NCT03374254|566928442|FG008|Overall Study|Death|7|||
157047139|NCT03374254|566928434|FG000|Overall Study|Lost to Follow-up|0|||
157047140|NCT03374254|566928435|FG001|Overall Study|Lost to Follow-up|0|||
157047141|NCT03374254|566928436|FG002|Overall Study|Lost to Follow-up|0|||
157047142|NCT03374254|566928437|FG003|Overall Study|Lost to Follow-up|0|||
157047143|NCT03374254|566928438|FG004|Overall Study|Lost to Follow-up|0|||
157047144|NCT03374254|566928439|FG005|Overall Study|Lost to Follow-up|0|||
157047145|NCT03374254|566928440|FG006|Overall Study|Lost to Follow-up|2|||
157047146|NCT03374254|566928441|FG007|Overall Study|Lost to Follow-up|0|||
157047147|NCT03374254|566928442|FG008|Overall Study|Lost to Follow-up|0|||
157047148|NCT03374254|566928434|FG000|Overall Study|Sponsor Decision|1|||
157047149|NCT03374254|566928435|FG001|Overall Study|Sponsor Decision|0|||
157047150|NCT03374254|566928436|FG002|Overall Study|Sponsor Decision|2|||
157047151|NCT03374254|566928437|FG003|Overall Study|Sponsor Decision|3|||
157047152|NCT03374254|566928438|FG004|Overall Study|Sponsor Decision|2|||
157047153|NCT03374254|566928439|FG005|Overall Study|Sponsor Decision|3|||
157047154|NCT03374254|566928440|FG006|Overall Study|Sponsor Decision|3|||
157047155|NCT03374254|566928441|FG007|Overall Study|Sponsor Decision|3|||
157047156|NCT03374254|566928442|FG008|Overall Study|Sponsor Decision|4|||
157047157|NCT03374254|566928434|FG000|Overall Study|Withdrawal by Subject|0|||
157047158|NCT03374254|566928435|FG001|Overall Study|Withdrawal by Subject|0|||
157047159|NCT03374254|566928436|FG002|Overall Study|Withdrawal by Subject|0|||
157047160|NCT03374254|566928437|FG003|Overall Study|Withdrawal by Subject|2|||
157047161|NCT03374254|566928438|FG004|Overall Study|Withdrawal by Subject|0|||
157047162|NCT03374254|566928439|FG005|Overall Study|Withdrawal by Subject|1|||
157047163|NCT03374254|566928440|FG006|Overall Study|Withdrawal by Subject|0|||
157047164|NCT03374254|566928441|FG007|Overall Study|Withdrawal by Subject|0|||
157047165|NCT03374254|566928442|FG008|Overall Study|Withdrawal by Subject|0|||
157047166|NCT02309515|566928444|FG000|Overall Study|Withdrawal by Subject|0|||
157047167|NCT02309515|566928445|FG001|Overall Study|Withdrawal by Subject|1|||
157047168|NCT04070105|566928446|FG000|Overall Study|Lost to Follow-up|0|||
157047169|NCT04070105|566928447|FG001|Overall Study|Lost to Follow-up|0|||
157047170|NCT04070105|566928448|FG002|Overall Study|Lost to Follow-up|0|||
157047171|NCT04070105|566928449|FG003|Overall Study|Lost to Follow-up|0|||
157047172|NCT04070105|566928450|FG004|Overall Study|Lost to Follow-up|0|||
157047173|NCT04070105|566928451|FG005|Overall Study|Lost to Follow-up|1|||
157175564|NCT00633893|567383716|FG001|Overall Study|Death|3|||
157175565|NCT00633893|567383717|FG002|Overall Study|Death|9|||
157229062|NCT00366899|567585110|FG000|Infant Series|Lost to Follow-up|0|||
157229063|NCT00366899|567585111|FG001|Infant Series|Lost to Follow-up|2|||
157229064|NCT00366899|567585110|FG000|Infant Series|Adverse Event|0|||
157229065|NCT00366899|567585111|FG001|Infant Series|Adverse Event|1|||
157229066|NCT00366899|567585110|FG000|Infant Series|Physician Decision|1|||
157229067|NCT00366899|567585111|FG001|Infant Series|Physician Decision|0|||
157229068|NCT00366899|567585110|FG000|Infant Series|Randomized but not consented|1|||
157229069|NCT00366899|567585111|FG001|Infant Series|Randomized but not consented|0|||
157229070|NCT00366899|567585110|FG000|After Infant Series|Lost to Follow-up|4|||
157229071|NCT00366899|567585111|FG001|After Infant Series|Lost to Follow-up|3|||
157229072|NCT00366899|567585110|FG000|After Infant Series|Withdrawal by Subject|1|||
157229073|NCT00366899|567585111|FG001|After Infant Series|Withdrawal by Subject|4|||
157229074|NCT00366899|567585110|FG000|After Infant Series|Adverse Event|1|||
157229075|NCT00366899|567585111|FG001|After Infant Series|Adverse Event|2|||
157229076|NCT00366899|567585110|FG000|After Infant Series|Protocol Violation|1|||
157229077|NCT00366899|567585111|FG001|After Infant Series|Protocol Violation|0|||
157229078|NCT00366899|567585110|FG000|Toddler Dose|Withdrawal by Subject|1|||
157229079|NCT00366899|567585111|FG001|Toddler Dose|Withdrawal by Subject|1|||
157229080|NCT00366899|567585110|FG000|Toddler Dose|Protocol Violation|1|||
157229081|NCT00366899|567585111|FG001|Toddler Dose|Protocol Violation|0|||
157229082|NCT00419770|567585115|FG000|Overall Study|Withdrawal by Subject|5|||
157229083|NCT00419770|567585116|FG001|Overall Study|Withdrawal by Subject|1|||
157229084|NCT02424188|567585125|FG000|Overall Study|Death|2|||
157229085|NCT02424188|567585126|FG001|Overall Study|Death|2|||
157229086|NCT02424188|567585125|FG000|Overall Study|Lost to Follow-up|1|||
157229087|NCT02424188|567585126|FG001|Overall Study|Lost to Follow-up|3|||
157229088|NCT02424188|567585125|FG000|Overall Study|Incarceration|1|||
157229089|NCT02424188|567585126|FG001|Overall Study|Incarceration|0|||
157229090|NCT03601637|567585127|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
157229091|NCT03601637|567585128|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
157229092|NCT03601637|567585127|FG000|Overall Study|Adverse Event|1|||
157229093|NCT03601637|567585128|FG001|Overall Study|Adverse Event|1|||
157229094|NCT03601637|567585127|FG000|Overall Study|Other|0|||
157229095|NCT03601637|567585128|FG001|Overall Study|Other|1|||
157229096|NCT05037097|567585130|FG000|Overall Study|Withdrawal by Subject|0|||
157229097|NCT05037097|567585131|FG001|Overall Study|Withdrawal by Subject|1|||
157229098|NCT05037097|567585132|FG002|Overall Study|Withdrawal by Subject|0|||
157229099|NCT05037097|567585133|FG003|Overall Study|Withdrawal by Subject|1|||
157229100|NCT05037097|567585134|FG004|Overall Study|Withdrawal by Subject|0|||
157229101|NCT05037097|567585135|FG005|Overall Study|Withdrawal by Subject|2|||
157229102|NCT05037097|567585136|FG006|Overall Study|Withdrawal by Subject|0|||
157229103|NCT05037097|567585137|FG007|Overall Study|Withdrawal by Subject|0|||
157229104|NCT05037097|567585130|FG000|Overall Study|Lost to Follow-up|0|||
157229105|NCT05037097|567585131|FG001|Overall Study|Lost to Follow-up|1|||
157229106|NCT05037097|567585132|FG002|Overall Study|Lost to Follow-up|0|||
156970082|NCT01951638|566642405|FG001|Follow-up Period|Withdrawal by Subject|5|||
156970083|NCT01951638|566642406|FG002|Follow-up Period|Withdrawal by Subject|2|||
156970084|NCT01951638|566642407|FG003|Follow-up Period|Withdrawal by Subject|1|||
156970085|NCT01951638|566642408|FG004|Follow-up Period|Withdrawal by Subject|2|||
156970086|NCT01951638|566642404|FG000|Follow-up Period|Lost to Follow-up|0|||
156970087|NCT01951638|566642405|FG001|Follow-up Period|Lost to Follow-up|1|||
156970088|NCT01951638|566642406|FG002|Follow-up Period|Lost to Follow-up|0|||
156970089|NCT01951638|566642407|FG003|Follow-up Period|Lost to Follow-up|1|||
156970090|NCT01951638|566642408|FG004|Follow-up Period|Lost to Follow-up|0|||
156970091|NCT01951638|566642404|FG000|Follow-up Period|Death|1|||
156970092|NCT01951638|566642405|FG001|Follow-up Period|Death|0|||
156970093|NCT01951638|566642406|FG002|Follow-up Period|Death|1|||
156970094|NCT01951638|566642407|FG003|Follow-up Period|Death|4|||
156970095|NCT01951638|566642408|FG004|Follow-up Period|Death|1|||
156970096|NCT01951638|566642404|FG000|Follow-up Period|Adverse Event|0|||
156970097|NCT01951638|566642405|FG001|Follow-up Period|Adverse Event|1|||
156970098|NCT01951638|566642406|FG002|Follow-up Period|Adverse Event|2|||
156970099|NCT01951638|566642407|FG003|Follow-up Period|Adverse Event|1|||
156970100|NCT01951638|566642408|FG004|Follow-up Period|Adverse Event|1|||
156970101|NCT03764072|566642409|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156970102|NCT03764072|566642410|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156970103|NCT03764072|566642411|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
157229107|NCT05037097|567585133|FG003|Overall Study|Lost to Follow-up|0|||
157229108|NCT05037097|567585134|FG004|Overall Study|Lost to Follow-up|1|||
157229109|NCT05037097|567585135|FG005|Overall Study|Lost to Follow-up|1|||
157229110|NCT05037097|567585136|FG006|Overall Study|Lost to Follow-up|0|||
157229111|NCT05037097|567585137|FG007|Overall Study|Lost to Follow-up|0|||
157229112|NCT02322047|567585138|FG000|Overall Study|Physician Decision|1|||
157229113|NCT02322047|567585139|FG001|Overall Study|Physician Decision|0|||
157229114|NCT02322047|567585140|FG002|Overall Study|Physician Decision|0|||
157229115|NCT02322047|567585141|FG003|Overall Study|Physician Decision|0|||
157229116|NCT02322047|567585138|FG000|Overall Study|Withdrawal by Subject|1|||
157229117|NCT02322047|567585139|FG001|Overall Study|Withdrawal by Subject|0|||
157047174|NCT00923078|566928454|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
157047175|NCT00923078|566928455|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
157047176|NCT00923078|566928456|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
157047177|NCT00923078|566928454|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
157047178|NCT00923078|566928455|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
157047179|NCT00923078|566928456|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
157047180|NCT01072149|566928463|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047181|NCT01072149|566928464|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047182|NCT01072149|566928465|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
157047183|NCT01072149|566928466|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047184|NCT01072149|566928467|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047185|NCT01072149|566928468|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047186|NCT01072149|566928469|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047187|NCT01072149|566928470|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047188|NCT01072149|566928471|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047189|NCT01072149|566928472|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047190|NCT01072149|566928473|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047191|NCT01072149|566928474|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156970104|NCT03764072|566642412|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156970105|NCT03764072|566642413|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156970106|NCT03764072|566642414|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
156970107|NCT03764072|566642409|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
156970108|NCT03764072|566642410|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
156970109|NCT03764072|566642411|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
156970110|NCT03764072|566642412|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
156970111|NCT03764072|566642413|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
156970112|NCT03764072|566642414|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
156970113|NCT03764072|566642409|FG000|Overall Study|Lost to Follow-up|0|||
156970114|NCT03764072|566642410|FG001|Overall Study|Lost to Follow-up|0|||
156970115|NCT03764072|566642411|FG002|Overall Study|Lost to Follow-up|0|||
156970116|NCT03764072|566642412|FG003|Overall Study|Lost to Follow-up|0|||
156970117|NCT03764072|566642413|FG004|Overall Study|Lost to Follow-up|1|||
156970118|NCT03764072|566642414|FG005|Overall Study|Lost to Follow-up|0|||
156970119|NCT00552084|566642415|FG000|Overall Study|Adverse Event|2|||
156970120|NCT00552084|566642416|FG001|Overall Study|Adverse Event|3|||
156970121|NCT00552084|566642415|FG000|Overall Study|Withdrawal by Subject|4|||
156970122|NCT00552084|566642416|FG001|Overall Study|Withdrawal by Subject|5|||
156970123|NCT00552084|566642415|FG000|Overall Study|Protocol Violation|1|||
156970124|NCT00552084|566642416|FG001|Overall Study|Protocol Violation|0|||
156970125|NCT00552084|566642415|FG000|Overall Study|change in anti-arrythmic drug|1|||
156970126|NCT00552084|566642416|FG001|Overall Study|change in anti-arrythmic drug|1|||
156970127|NCT01338025|566642417|FG000|Overall Study|Unexpected closure of study|10|||
156970128|NCT01338025|566642418|FG001|Overall Study|Unexpected closure of study|9|||
156970129|NCT01338025|566642417|FG000|Overall Study|Withdrawal by Subject|0|||
156970130|NCT01338025|566642418|FG001|Overall Study|Withdrawal by Subject|2|||
156970131|NCT01338025|566642417|FG000|Overall Study|Found ineligible after starting|1|||
156970132|NCT01338025|566642418|FG001|Overall Study|Found ineligible after starting|0|||
156970133|NCT02286089|566642421|FG000|Overall Study|Ongoing in Study|1|||
156970134|NCT02286089|566642422|FG001|Overall Study|Ongoing in Study|1|||
156970135|NCT02286089|566642423|FG002|Overall Study|Ongoing in Study|4|||
156970136|NCT02286089|566642424|FG003|Overall Study|Ongoing in Study|10|||
156970137|NCT02286089|566642421|FG000|Overall Study|Withdrawal by Subject|0|||
156970138|NCT02286089|566642422|FG001|Overall Study|Withdrawal by Subject|0|||
156970139|NCT02286089|566642423|FG002|Overall Study|Withdrawal by Subject|2|||
156970140|NCT02286089|566642424|FG003|Overall Study|Withdrawal by Subject|2|||
156970141|NCT05073133|566642426|FG000|Overall Study|Death|2|||
156970142|NCT05002218|566642430|FG000|Overall Study|Lost to Follow-up|5|||
156970143|NCT05002218|566642431|FG001|Overall Study|Lost to Follow-up|6|||
156970144|NCT02790073|566644171|FG000|Overall Study|Death|1|||
156970145|NCT02790073|566644171|FG000|Overall Study|Withdrawal from HD|1|||
156970146|NCT02790073|566644171|FG000|Overall Study|Withdrawal by Subject|1|||
156970147|NCT03328143|566644172|FG000|Overall Study|Declined|3|||
156970148|NCT03328143|566644172|FG000|Overall Study|Required increased sedation|4|||
157047192|NCT01072149|566928475|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
156970149|NCT03328143|566644172|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
156970150|NCT03328143|566644172|FG000|Overall Study|Surgery cancelled|1|||
156970151|NCT00514683|566644174|FG000|Overall Study|Not treated|2|||
156970152|NCT00514683|566644175|FG001|Overall Study|Not treated|1|||
156970153|NCT00514683|566644176|FG002|Overall Study|Not treated|0|||
156970154|NCT00514683|566644177|FG003|Overall Study|Not treated|0|||
156970155|NCT00514683|566644178|FG004|Overall Study|Not treated|1|||
156970156|NCT00514683|566644174|FG000|Overall Study|Adverse Event|21|||
156970157|NCT00514683|566644175|FG001|Overall Study|Adverse Event|20|||
157047193|NCT01072149|566928476|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047194|NCT01072149|566928477|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047195|NCT01072149|566928478|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047196|NCT01072149|566928479|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047197|NCT01072149|566928480|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
157047198|NCT01072149|566928463|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047199|NCT01072149|566928464|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047200|NCT01072149|566928465|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047201|NCT01072149|566928466|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047202|NCT01072149|566928467|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047203|NCT01072149|566928468|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047204|NCT01072149|566928469|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047205|NCT01072149|566928470|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047206|NCT01072149|566928471|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047207|NCT01072149|566928472|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047208|NCT01072149|566928473|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047209|NCT01072149|566928474|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047210|NCT01072149|566928475|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047211|NCT01072149|566928476|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047212|NCT01072149|566928477|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047213|NCT01072149|566928478|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047214|NCT01072149|566928479|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
157047215|NCT01072149|566928480|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
157047216|NCT01072149|566928463|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047217|NCT01072149|566928464|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047218|NCT01072149|566928465|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047219|NCT01072149|566928466|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047220|NCT01072149|566928467|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047221|NCT01072149|566928468|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047222|NCT01072149|566928469|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047223|NCT01072149|566928470|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047224|NCT01072149|566928471|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047225|NCT01072149|566928472|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047226|NCT01072149|566928473|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
157047227|NCT01072149|566928474|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047228|NCT01072149|566928475|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047229|NCT01072149|566928476|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047230|NCT01072149|566928477|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047231|NCT01072149|566928478|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047232|NCT01072149|566928479|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047233|NCT01072149|566928480|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
157047234|NCT01072149|566928463|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047235|NCT01072149|566928464|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
157047236|NCT01072149|566928465|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047237|NCT01072149|566928466|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047238|NCT01072149|566928467|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047239|NCT01072149|566928468|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047240|NCT01072149|566928469|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047241|NCT01072149|566928470|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047242|NCT01072149|566928471|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047243|NCT01072149|566928472|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047244|NCT01072149|566928473|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047245|NCT01072149|566928474|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047246|NCT01072149|566928475|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047247|NCT01072149|566928476|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047248|NCT01072149|566928477|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047249|NCT01072149|566928478|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047250|NCT01072149|566928479|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047251|NCT01072149|566928480|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
157047252|NCT01072149|566928463|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047253|NCT01072149|566928464|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047254|NCT01072149|566928465|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
157175566|NCT00633893|567383715|FG000|Overall Study|Adverse Event|65|||
157175567|NCT00633893|567383716|FG001|Overall Study|Adverse Event|58|||
157175568|NCT00633893|567383717|FG002|Overall Study|Adverse Event|126|||
157175569|NCT00633893|567383715|FG000|Overall Study|Withdrawal by Subject|7|||
157175570|NCT00633893|567383716|FG001|Overall Study|Withdrawal by Subject|12|||
157175571|NCT00633893|567383717|FG002|Overall Study|Withdrawal by Subject|6|||
157175572|NCT00633893|567383715|FG000|Overall Study|Lost to Follow-up|2|||
157175573|NCT00633893|567383716|FG001|Overall Study|Lost to Follow-up|4|||
157047255|NCT01072149|566928466|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047256|NCT01072149|566928467|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047257|NCT01072149|566928468|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047258|NCT01072149|566928469|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047259|NCT01072149|566928470|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047260|NCT01072149|566928471|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047261|NCT01072149|566928472|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047262|NCT01072149|566928473|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047263|NCT01072149|566928474|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047264|NCT01072149|566928475|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047265|NCT01072149|566928476|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047266|NCT01072149|566928477|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047267|NCT01072149|566928478|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047268|NCT01072149|566928479|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047269|NCT01072149|566928480|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
157047270|NCT01072149|566928463|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047271|NCT01072149|566928464|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047272|NCT01072149|566928465|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047273|NCT01072149|566928466|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047274|NCT01072149|566928467|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047275|NCT01072149|566928468|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047276|NCT01072149|566928469|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047277|NCT01072149|566928470|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
157047278|NCT01072149|566928471|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047279|NCT01072149|566928472|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047280|NCT01072149|566928473|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047281|NCT01072149|566928474|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047282|NCT01072149|566928475|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047283|NCT01072149|566928476|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047284|NCT01072149|566928477|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047285|NCT01072149|566928478|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047286|NCT01072149|566928479|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047287|NCT01072149|566928480|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
157047288|NCT01072149|566928463|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
157047289|NCT01072149|566928464|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
157047290|NCT01072149|566928465|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
157047291|NCT01072149|566928466|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
157047292|NCT01072149|566928467|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
157047293|NCT01072149|566928468|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
157047294|NCT01072149|566928469|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
157047295|NCT01072149|566928470|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
157047296|NCT01072149|566928471|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
157047297|NCT01072149|566928472|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
157047298|NCT01072149|566928473|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
157047299|NCT01072149|566928474|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
157047300|NCT01072149|566928475|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
157047301|NCT01072149|566928476|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
157047302|NCT01072149|566928477|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
157047303|NCT01072149|566928478|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
157047304|NCT01072149|566928479|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
157047305|NCT01072149|566928480|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
157047306|NCT01072149|566928463|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047307|NCT01072149|566928464|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047308|NCT01072149|566928465|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047309|NCT01072149|566928466|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047310|NCT01072149|566928467|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047311|NCT01072149|566928468|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157175574|NCT00633893|567383717|FG002|Overall Study|Lost to Follow-up|8|||
157175575|NCT00633893|567383715|FG000|Overall Study|Poor/non-compliance|5|||
157175576|NCT00633893|567383716|FG001|Overall Study|Poor/non-compliance|12|||
157175577|NCT00633893|567383717|FG002|Overall Study|Poor/non-compliance|3|||
157175578|NCT00633893|567383715|FG000|Overall Study|Pregnancy|2|||
157175579|NCT00633893|567383716|FG001|Overall Study|Pregnancy|1|||
157175580|NCT00633893|567383717|FG002|Overall Study|Pregnancy|1|||
157175581|NCT00633893|567383715|FG000|Overall Study|Not meet/no longer meets criteria|4|||
157047312|NCT01072149|566928469|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047313|NCT01072149|566928470|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047314|NCT01072149|566928471|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047315|NCT01072149|566928472|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047316|NCT01072149|566928473|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047317|NCT01072149|566928474|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047318|NCT01072149|566928475|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047319|NCT01072149|566928476|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047320|NCT01072149|566928477|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047321|NCT01072149|566928478|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
157047322|NCT01072149|566928479|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047323|NCT01072149|566928480|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
157047324|NCT01072149|566928463|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
157047325|NCT01072149|566928464|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
157047326|NCT01072149|566928465|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
157047327|NCT01072149|566928466|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
157047328|NCT01072149|566928467|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
157047329|NCT01072149|566928468|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
157047330|NCT01072149|566928469|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
157047331|NCT01072149|566928470|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
157047332|NCT01072149|566928471|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
157047333|NCT01072149|566928472|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
157047334|NCT01072149|566928473|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
157047335|NCT01072149|566928474|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
157047336|NCT01072149|566928475|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
157047337|NCT01072149|566928476|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
157047338|NCT01072149|566928477|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
157047339|NCT01072149|566928478|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
157047340|NCT01072149|566928479|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
157047341|NCT01072149|566928480|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
157047342|NCT01072149|566928463|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047343|NCT01072149|566928464|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047344|NCT01072149|566928465|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047345|NCT01072149|566928466|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047346|NCT01072149|566928467|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047347|NCT01072149|566928468|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047348|NCT01072149|566928469|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047349|NCT01072149|566928470|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047350|NCT01072149|566928471|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047351|NCT01072149|566928472|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047352|NCT01072149|566928473|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047353|NCT01072149|566928474|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047354|NCT01072149|566928475|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
157047355|NCT01072149|566928476|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047356|NCT01072149|566928477|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047357|NCT01072149|566928478|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047358|NCT01072149|566928479|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047359|NCT01072149|566928480|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
157047360|NCT01072149|566928463|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047361|NCT01072149|566928464|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047362|NCT01072149|566928465|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
157047363|NCT01072149|566928466|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047364|NCT01072149|566928467|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047365|NCT01072149|566928468|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047366|NCT01072149|566928469|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047367|NCT01072149|566928470|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047368|NCT01072149|566928471|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047369|NCT01072149|566928472|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047370|NCT01072149|566928473|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047371|NCT01072149|566928474|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047372|NCT01072149|566928475|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047373|NCT01072149|566928476|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
157175582|NCT00633893|567383716|FG001|Overall Study|Not meet/no longer meets criteria|6|||
157175583|NCT00633893|567383717|FG002|Overall Study|Not meet/no longer meets criteria|4|||
157175584|NCT00633893|567383715|FG000|Overall Study|Other|28|||
157175585|NCT00633893|567383716|FG001|Overall Study|Other|33|||
157047374|NCT01072149|566928477|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047375|NCT01072149|566928478|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157175586|NCT00633893|567383717|FG002|Overall Study|Other|31|||
157047376|NCT01072149|566928479|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157047377|NCT01072149|566928480|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
157175587|NCT02741310|567383718|FG000|Overall Study|Sponsor Decision|2|||
157047378|NCT01768572|566928481|FG000|Overall Study|Adverse Event|7|||
157047379|NCT01768572|566928482|FG001|Overall Study|Adverse Event|8|||
157175588|NCT02741310|567383719|FG001|Overall Study|Sponsor Decision|2|||
157175589|NCT01784211|567383724|FG000|Part A (Days 1-15)|Adverse Event|1|||
157175590|NCT01784211|567383725|FG001|Part A (Days 1-15)|Adverse Event|1|||
157175591|NCT01784211|567383726|FG002|Part A (Days 1-15)|Adverse Event|0|||
157175592|NCT01784211|567383727|FG003|Part A (Days 1-15)|Adverse Event|0|||
157175593|NCT01784211|567383728|FG004|Part A (Days 1-15)|Adverse Event|0|||
157175594|NCT01784211|567383729|FG005|Part A (Days 1-15)|Adverse Event|0|||
157047380|NCT01768572|566928483|FG002|Overall Study|Adverse Event|4|||
157047381|NCT01768572|566928481|FG000|Overall Study|Lack of Efficacy|1|||
157047382|NCT01768572|566928482|FG001|Overall Study|Lack of Efficacy|3|||
157047383|NCT01768572|566928483|FG002|Overall Study|Lack of Efficacy|1|||
157047384|NCT01768572|566928481|FG000|Overall Study|Other, Not due to an adverse event|1|||
157047385|NCT01768572|566928482|FG001|Overall Study|Other, Not due to an adverse event|1|||
157047386|NCT01768572|566928483|FG002|Overall Study|Other, Not due to an adverse event|1|||
157047387|NCT02245620|566928484|FG000|Overall Study|Physician Decision|1|||
157047388|NCT02245620|566928485|FG001|Overall Study|Physician Decision|1|||
157047389|NCT04766996|566928488|FG000|Overall Study|Withdrawal by Subject|1|||
157047390|NCT04766996|566928489|FG001|Overall Study|Withdrawal by Subject|0|||
157047391|NCT04766996|566928490|FG002|Overall Study|Withdrawal by Subject|13|||
157047392|NCT01322386|566928491|FG000|Overall Study|Protocol Violation|0|||
157047393|NCT01322386|566928492|FG001|Overall Study|Protocol Violation|1|||
157047394|NCT01322386|566928491|FG000|Overall Study|Physician Decision|0|||
157047395|NCT01322386|566928492|FG001|Overall Study|Physician Decision|1|||
157047396|NCT00871494|566928500|FG000|Overall Study|Protocol Violation|5|||
157047397|NCT00871494|566928500|FG000|Overall Study|Lack of Efficacy|4|||
157047398|NCT00871494|566928500|FG000|Overall Study|Adverse Event|4|||
157047399|NCT00871494|566928500|FG000|Overall Study|Lost to Follow-up|1|||
157047400|NCT02988713|566928512|FG000|Overall Study|Withdrawal by Subject|1|||
157047401|NCT02988713|566928512|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
157047402|NCT02404441|566928513|FG000|Phase 1 Part|Adverse Event|1|||
157047403|NCT02404441|566928514|FG001|Phase 1 Part|Adverse Event|0|||
157047404|NCT02404441|566928515|FG002|Phase 1 Part|Adverse Event|0|||
157047405|NCT02404441|566928516|FG003|Phase 1 Part|Adverse Event|0|||
157047406|NCT02404441|566928517|FG004|Phase 1 Part|Adverse Event|0|||
157047407|NCT02404441|566928518|FG005|Phase 1 Part|Adverse Event|0|||
157047408|NCT02404441|566928519|FG006|Phase 1 Part|Adverse Event|0|||
157047409|NCT02404441|566928520|FG007|Phase 1 Part|Adverse Event|0|||
157047410|NCT02404441|566928521|FG008|Phase 1 Part|Adverse Event|0|||
157047411|NCT02404441|566928522|FG009|Phase 1 Part|Adverse Event|0|||
157047412|NCT02404441|566928513|FG000|Phase 1 Part|Physician Decision|0|||
157047413|NCT02404441|566928514|FG001|Phase 1 Part|Physician Decision|1|||
157047414|NCT02404441|566928515|FG002|Phase 1 Part|Physician Decision|0|||
157047415|NCT02404441|566928516|FG003|Phase 1 Part|Physician Decision|0|||
157047416|NCT02404441|566928517|FG004|Phase 1 Part|Physician Decision|0|||
157047417|NCT02404441|566928518|FG005|Phase 1 Part|Physician Decision|0|||
157047418|NCT02404441|566928519|FG006|Phase 1 Part|Physician Decision|0|||
157047419|NCT02404441|566928520|FG007|Phase 1 Part|Physician Decision|0|||
157047420|NCT02404441|566928521|FG008|Phase 1 Part|Physician Decision|0|||
157047421|NCT02404441|566928522|FG009|Phase 1 Part|Physician Decision|0|||
157047422|NCT02404441|566928513|FG000|Phase 1 Part|Progressive Disease|14|||
157047423|NCT02404441|566928514|FG001|Phase 1 Part|Progressive Disease|11|||
157047424|NCT02404441|566928515|FG002|Phase 1 Part|Progressive Disease|7|||
157047425|NCT02404441|566928516|FG003|Phase 1 Part|Progressive Disease|6|||
157047426|NCT02404441|566928517|FG004|Phase 1 Part|Progressive Disease|9|||
157047427|NCT02404441|566928518|FG005|Phase 1 Part|Progressive Disease|0|||
157047428|NCT02404441|566928519|FG006|Phase 1 Part|Progressive Disease|0|||
157047429|NCT02404441|566928520|FG007|Phase 1 Part|Progressive Disease|0|||
157047430|NCT02404441|566928521|FG008|Phase 1 Part|Progressive Disease|0|||
157047431|NCT02404441|566928522|FG009|Phase 1 Part|Progressive Disease|0|||
157047432|NCT02404441|566928513|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
157047433|NCT02404441|566928514|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
157047434|NCT02404441|566928515|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
157175595|NCT01784211|567383724|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
157175596|NCT01784211|567383725|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
157175597|NCT01784211|567383726|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
157047435|NCT02404441|566928516|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
157047436|NCT02404441|566928517|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
157047437|NCT02404441|566928518|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
157047438|NCT02404441|566928519|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
157047439|NCT02404441|566928520|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
157047440|NCT02404441|566928521|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
157047441|NCT02404441|566928522|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
157047442|NCT02404441|566928513|FG000|Phase 1 Part|Death|1|||
157047443|NCT02404441|566928514|FG001|Phase 1 Part|Death|1|||
157047444|NCT02404441|566928515|FG002|Phase 1 Part|Death|1|||
157047445|NCT02404441|566928516|FG003|Phase 1 Part|Death|0|||
157175598|NCT01784211|567383727|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
157047446|NCT02404441|566928517|FG004|Phase 1 Part|Death|1|||
157047447|NCT02404441|566928518|FG005|Phase 1 Part|Death|0|||
157047448|NCT02404441|566928519|FG006|Phase 1 Part|Death|0|||
157047449|NCT02404441|566928520|FG007|Phase 1 Part|Death|0|||
157229118|NCT02322047|567585140|FG002|Overall Study|Withdrawal by Subject|0|||
157229119|NCT02322047|567585141|FG003|Overall Study|Withdrawal by Subject|1|||
157229120|NCT02322047|567585138|FG000|Overall Study|Adverse Event|0|||
157229121|NCT02322047|567585139|FG001|Overall Study|Adverse Event|1|||
157229122|NCT02322047|567585140|FG002|Overall Study|Adverse Event|0|||
157229123|NCT02322047|567585141|FG003|Overall Study|Adverse Event|0|||
157229124|NCT02322047|567585138|FG000|Overall Study|Lost to Follow-up|0|||
157229125|NCT02322047|567585139|FG001|Overall Study|Lost to Follow-up|0|||
157229126|NCT02322047|567585140|FG002|Overall Study|Lost to Follow-up|1|||
157229127|NCT02322047|567585141|FG003|Overall Study|Lost to Follow-up|1|||
157229128|NCT00088829|567585142|FG000|Overall Study|PI left institution and study was close|22|||
157229129|NCT05818137|567585143|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
157229130|NCT05818137|567585143|FG000|Extension Treatment Period|Ongoing participants|44|||
157229131|NCT01367275|567585144|FG000|Overall Study|Ineligible|1|||
157229132|NCT01367275|567585144|FG000|Overall Study|Disease Progression|2|||
157229133|NCT04510857|567585145|FG000|Overall Study|Withdrawal by Subject|1|||
157229134|NCT04510857|567585146|FG001|Overall Study|Withdrawal by Subject|2|||
157229135|NCT02319148|567585149|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
157229136|NCT02319148|567585150|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
157229137|NCT02319148|567585151|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
157229138|NCT02319148|567585152|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
157229139|NCT02319148|567585149|FG000|Second Intervention Period|No longer willing to participate|0|||
157229140|NCT02319148|567585150|FG001|Second Intervention Period|No longer willing to participate|1|||
157229141|NCT02319148|567585151|FG002|Second Intervention Period|No longer willing to participate|0|||
157229142|NCT02319148|567585152|FG003|Second Intervention Period|No longer willing to participate|0|||
157229143|NCT02319148|567585149|FG000|Second Intervention Period|Other|0|||
157229144|NCT02319148|567585150|FG001|Second Intervention Period|Other|0|||
157229145|NCT02319148|567585151|FG002|Second Intervention Period|Other|0|||
157229146|NCT02319148|567585152|FG003|Second Intervention Period|Other|1|||
157229147|NCT00264797|567585155|FG000|Overall Study|Withdrawal by Subject|11|||
157229148|NCT00264797|567585156|FG001|Overall Study|Withdrawal by Subject|11|||
157229149|NCT00264797|567585155|FG000|Overall Study|Lost to Follow-up|9|||
157229150|NCT00264797|567585156|FG001|Overall Study|Lost to Follow-up|17|||
157229151|NCT00264797|567585155|FG000|Overall Study|Moved from area|3|||
157229152|NCT00264797|567585156|FG001|Overall Study|Moved from area|1|||
157229153|NCT00264797|567585155|FG000|Overall Study|Practical Problems|2|||
157229154|NCT00264797|567585156|FG001|Overall Study|Practical Problems|3|||
157229155|NCT00264797|567585155|FG000|Overall Study|Incarceration|4|||
157229156|NCT00264797|567585156|FG001|Overall Study|Incarceration|5|||
157229157|NCT00264797|567585155|FG000|Overall Study|Pressure/advice from Outsiders|1|||
157229158|NCT00264797|567585156|FG001|Overall Study|Pressure/advice from Outsiders|1|||
157229159|NCT00264797|567585155|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
157229160|NCT00264797|567585156|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
157229161|NCT00264797|567585155|FG000|Overall Study|Other|3|||
157229162|NCT00264797|567585156|FG001|Overall Study|Other|4|||
157229163|NCT00048048|567585157|FG000|Core Treatment|Withdrawal by Subject|0|||
157229164|NCT00048048|567585158|FG001|Core Treatment|Withdrawal by Subject|0|||
157229165|NCT00048048|567585159|FG002|Core Treatment|Withdrawal by Subject|1|||
156970158|NCT00514683|566644176|FG002|Overall Study|Adverse Event|15|||
156970159|NCT00514683|566644177|FG003|Overall Study|Adverse Event|13|||
156970160|NCT00514683|566644178|FG004|Overall Study|Adverse Event|27|||
156970161|NCT00514683|566644174|FG000|Overall Study|Protocol Violation|1|||
156970162|NCT00514683|566644175|FG001|Overall Study|Protocol Violation|1|||
156970163|NCT00514683|566644176|FG002|Overall Study|Protocol Violation|0|||
156970164|NCT00514683|566644177|FG003|Overall Study|Protocol Violation|1|||
156970165|NCT00514683|566644178|FG004|Overall Study|Protocol Violation|0|||
156970166|NCT00514683|566644174|FG000|Overall Study|Withdrawal by Subject|2|||
156970167|NCT00514683|566644175|FG001|Overall Study|Withdrawal by Subject|2|||
156970168|NCT00514683|566644176|FG002|Overall Study|Withdrawal by Subject|1|||
156970169|NCT00514683|566644177|FG003|Overall Study|Withdrawal by Subject|0|||
156970170|NCT00514683|566644178|FG004|Overall Study|Withdrawal by Subject|4|||
156970171|NCT00514683|566644174|FG000|Overall Study|Reason other than listed above|0|||
156970172|NCT00514683|566644175|FG001|Overall Study|Reason other than listed above|1|||
156970173|NCT00514683|566644176|FG002|Overall Study|Reason other than listed above|2|||
156970174|NCT00514683|566644177|FG003|Overall Study|Reason other than listed above|0|||
156970175|NCT00514683|566644178|FG004|Overall Study|Reason other than listed above|1|||
156970176|NCT02487498|566644179|FG000|Period: Period 1|Adverse Event|2|||
156970177|NCT02487498|566644180|FG001|Period: Period 1|Adverse Event|4|||
156970178|NCT02487498|566644179|FG000|Period: Period 1|Subject/guardian decision|2|||
156970179|NCT02487498|566644180|FG001|Period: Period 1|Subject/guardian decision|4|||
156970180|NCT02487498|566644179|FG000|Period: Period 1|Lost to Follow-up|0|||
157229166|NCT00048048|567585160|FG003|Core Treatment|Withdrawal by Subject|0|||
157229167|NCT00048048|567585161|FG004|Core Treatment|Withdrawal by Subject|0|||
157229168|NCT00048048|567585162|FG005|Core Treatment|Withdrawal by Subject|0|||
157229169|NCT00048048|567585163|FG006|Core Treatment|Withdrawal by Subject|0|||
157175599|NCT01784211|567383728|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
157175600|NCT01784211|567383729|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
157175601|NCT02044822|567383730|FG000|Overall Study|Study Terminated by Sponsor|77|||
157175602|NCT02044822|567383730|FG000|Overall Study|Investigator's Discretion|10|||
157175603|NCT02044822|567383730|FG000|Overall Study|Withdrew Consent|3|||
157175604|NCT02044822|567383730|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
157175605|NCT02044822|567383730|FG000|Overall Study|Lost to Follow-up|1|||
157175606|NCT02025530|567383733|FG000|Overall Study|No longer met elligibility criteria|5|||
157175607|NCT02025530|567383734|FG001|Overall Study|No longer met elligibility criteria|1|||
157175608|NCT03551626|567383735|FG000|Overall Study|Adverse Event|88|||
157175609|NCT03551626|567383735|FG000|Overall Study|Disease relapse|18|||
157175610|NCT03551626|567383735|FG000|Overall Study|Withdrawal of informed consent|6|||
157175611|NCT03551626|567383735|FG000|Overall Study|Patient decision|5|||
157175612|NCT03551626|567383735|FG000|Overall Study|Physician Decision|4|||
157175613|NCT03551626|567383735|FG000|Overall Study|Lost to Follow-up|3|||
157175614|NCT03551626|567383735|FG000|Overall Study|Pregnancy|1|||
157175615|NCT03551626|567383735|FG000|Overall Study|Protocol deviation|1|||
157175616|NCT03551626|567383735|FG000|Overall Study|Technical problems|1|||
157175617|NCT00653328|567383736|FG000|Overall Study|Withdrawal by Subject|1|||
157047450|NCT02404441|566928521|FG008|Phase 1 Part|Death|0|||
157047451|NCT02404441|566928522|FG009|Phase 1 Part|Death|0|||
157047452|NCT02404441|566928513|FG000|Phase 2 Part|Adverse Event|0|||
157047453|NCT02404441|566928514|FG001|Phase 2 Part|Adverse Event|0|||
157047454|NCT02404441|566928515|FG002|Phase 2 Part|Adverse Event|0|||
157047455|NCT02404441|566928516|FG003|Phase 2 Part|Adverse Event|0|||
157047456|NCT02404441|566928517|FG004|Phase 2 Part|Adverse Event|0|||
157047457|NCT02404441|566928518|FG005|Phase 2 Part|Adverse Event|2|||
157047458|NCT02404441|566928519|FG006|Phase 2 Part|Adverse Event|3|||
157047459|NCT02404441|566928520|FG007|Phase 2 Part|Adverse Event|3|||
157047460|NCT02404441|566928521|FG008|Phase 2 Part|Adverse Event|6|||
157047461|NCT02404441|566928522|FG009|Phase 2 Part|Adverse Event|1|||
157047462|NCT02404441|566928513|FG000|Phase 2 Part|Physician Decision|0|||
157047463|NCT02404441|566928514|FG001|Phase 2 Part|Physician Decision|0|||
157047464|NCT02404441|566928515|FG002|Phase 2 Part|Physician Decision|0|||
157047465|NCT02404441|566928516|FG003|Phase 2 Part|Physician Decision|0|||
157047466|NCT02404441|566928517|FG004|Phase 2 Part|Physician Decision|0|||
157047467|NCT02404441|566928518|FG005|Phase 2 Part|Physician Decision|7|||
157047468|NCT02404441|566928519|FG006|Phase 2 Part|Physician Decision|9|||
157047469|NCT02404441|566928520|FG007|Phase 2 Part|Physician Decision|2|||
157047470|NCT02404441|566928521|FG008|Phase 2 Part|Physician Decision|1|||
157047471|NCT02404441|566928522|FG009|Phase 2 Part|Physician Decision|3|||
157047472|NCT02404441|566928513|FG000|Phase 2 Part|Progressive disease|0|||
157047473|NCT02404441|566928514|FG001|Phase 2 Part|Progressive disease|0|||
157047474|NCT02404441|566928515|FG002|Phase 2 Part|Progressive disease|0|||
157047475|NCT02404441|566928516|FG003|Phase 2 Part|Progressive disease|0|||
157047476|NCT02404441|566928517|FG004|Phase 2 Part|Progressive disease|0|||
157047477|NCT02404441|566928518|FG005|Phase 2 Part|Progressive disease|43|||
157047478|NCT02404441|566928519|FG006|Phase 2 Part|Progressive disease|32|||
157047479|NCT02404441|566928520|FG007|Phase 2 Part|Progressive disease|31|||
157047480|NCT02404441|566928521|FG008|Phase 2 Part|Progressive disease|39|||
157047481|NCT02404441|566928522|FG009|Phase 2 Part|Progressive disease|27|||
157047482|NCT02404441|566928513|FG000|Phase 2 Part|Subject/guardian decision|0|||
157047483|NCT02404441|566928514|FG001|Phase 2 Part|Subject/guardian decision|0|||
157047484|NCT02404441|566928515|FG002|Phase 2 Part|Subject/guardian decision|0|||
157047485|NCT02404441|566928516|FG003|Phase 2 Part|Subject/guardian decision|0|||
157047486|NCT02404441|566928517|FG004|Phase 2 Part|Subject/guardian decision|0|||
157047487|NCT02404441|566928518|FG005|Phase 2 Part|Subject/guardian decision|3|||
157047488|NCT02404441|566928519|FG006|Phase 2 Part|Subject/guardian decision|9|||
157047489|NCT02404441|566928520|FG007|Phase 2 Part|Subject/guardian decision|0|||
157047490|NCT02404441|566928521|FG008|Phase 2 Part|Subject/guardian decision|3|||
157047491|NCT02404441|566928522|FG009|Phase 2 Part|Subject/guardian decision|2|||
157047492|NCT02404441|566928513|FG000|Phase 2 Part|Death|0|||
157047493|NCT02404441|566928514|FG001|Phase 2 Part|Death|0|||
157175618|NCT00653328|567383736|FG000|Overall Study|Adverse Event|2|||
157175619|NCT00653328|567383736|FG000|Overall Study|Disease progression|10|||
157175620|NCT00653328|567383736|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
157175621|NCT01237223|567383743|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
157175622|NCT01237223|567383744|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
157047494|NCT02404441|566928515|FG002|Phase 2 Part|Death|0|||
157047495|NCT02404441|566928516|FG003|Phase 2 Part|Death|0|||
157175623|NCT01237223|567383745|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
157175624|NCT01237223|567383746|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
157047496|NCT02404441|566928517|FG004|Phase 2 Part|Death|0|||
157047497|NCT02404441|566928518|FG005|Phase 2 Part|Death|4|||
157047498|NCT02404441|566928519|FG006|Phase 2 Part|Death|8|||
157047499|NCT02404441|566928520|FG007|Phase 2 Part|Death|4|||
157047500|NCT02404441|566928521|FG008|Phase 2 Part|Death|10|||
157047501|NCT02404441|566928522|FG009|Phase 2 Part|Death|9|||
157047502|NCT00088166|566928523|FG000|Overall Study|Adverse Event|11|||
157047503|NCT00088166|566928524|FG001|Overall Study|Adverse Event|9|||
157047504|NCT00088166|566928523|FG000|Overall Study|Death|3|||
157047505|NCT00088166|566928524|FG001|Overall Study|Death|1|||
157047506|NCT00088166|566928523|FG000|Overall Study|Lost to Follow-up|0|||
157047507|NCT00088166|566928524|FG001|Overall Study|Lost to Follow-up|1|||
157047508|NCT00088166|566928523|FG000|Overall Study|Physician Decision|4|||
157047509|NCT00088166|566928524|FG001|Overall Study|Physician Decision|1|||
157047510|NCT00088166|566928523|FG000|Overall Study|Protocol Violation|1|||
157047511|NCT00088166|566928524|FG001|Overall Study|Protocol Violation|5|||
157047512|NCT00088166|566928523|FG000|Overall Study|Patient deterioration|29|||
157047513|NCT00088166|566928524|FG001|Overall Study|Patient deterioration|39|||
157047514|NCT00088166|566928523|FG000|Overall Study|Withdrawal by Subject|5|||
157047515|NCT00088166|566928524|FG001|Overall Study|Withdrawal by Subject|5|||
157047516|NCT02671266|566928525|FG000|Overall Study|Withdrawal by Subject|1|||
157047517|NCT02671266|566928526|FG001|Overall Study|Withdrawal by Subject|1|||
157047518|NCT00666705|566928527|FG000|Overall Study|Withdrawal by Subject|1|||
157047519|NCT01976507|566928530|FG000|Overall Study|Adverse Event|6|||
157047520|NCT01976507|566928530|FG000|Overall Study|ablation not done, drug not given|1|||
157047521|NCT01029704|566928532|FG000|Overall Study|Adverse Event|0|||
157047522|NCT01029704|566928533|FG001|Overall Study|Adverse Event|0|||
157047523|NCT01029704|566928534|FG002|Overall Study|Adverse Event|0|||
157047524|NCT01029704|566928535|FG003|Overall Study|Adverse Event|0|||
157047525|NCT01029704|566928536|FG004|Overall Study|Adverse Event|0|||
157047526|NCT01029704|566928537|FG005|Overall Study|Adverse Event|0|||
157047527|NCT01029704|566928538|FG006|Overall Study|Adverse Event|1|||
157047528|NCT01029704|566928539|FG007|Overall Study|Adverse Event|1|||
157047529|NCT01029704|566928540|FG008|Overall Study|Adverse Event|0|||
157047530|NCT01029704|566928532|FG000|Overall Study|Withdrawal by Subject|0|||
157047531|NCT01029704|566928533|FG001|Overall Study|Withdrawal by Subject|0|||
157047532|NCT01029704|566928534|FG002|Overall Study|Withdrawal by Subject|0|||
157047533|NCT01029704|566928535|FG003|Overall Study|Withdrawal by Subject|0|||
157047534|NCT01029704|566928536|FG004|Overall Study|Withdrawal by Subject|2|||
157047535|NCT01029704|566928537|FG005|Overall Study|Withdrawal by Subject|1|||
157047536|NCT01029704|566928538|FG006|Overall Study|Withdrawal by Subject|1|||
157047537|NCT01029704|566928539|FG007|Overall Study|Withdrawal by Subject|1|||
157047538|NCT01029704|566928540|FG008|Overall Study|Withdrawal by Subject|0|||
157047539|NCT01029704|566928532|FG000|Overall Study|Lost to Follow-up|0|||
157047540|NCT01029704|566928533|FG001|Overall Study|Lost to Follow-up|0|||
157047541|NCT01029704|566928534|FG002|Overall Study|Lost to Follow-up|0|||
157047542|NCT01029704|566928535|FG003|Overall Study|Lost to Follow-up|0|||
157047543|NCT01029704|566928536|FG004|Overall Study|Lost to Follow-up|0|||
157047544|NCT01029704|566928537|FG005|Overall Study|Lost to Follow-up|0|||
157047545|NCT01029704|566928538|FG006|Overall Study|Lost to Follow-up|1|||
157047546|NCT01029704|566928539|FG007|Overall Study|Lost to Follow-up|1|||
157047547|NCT01029704|566928540|FG008|Overall Study|Lost to Follow-up|1|||
157047548|NCT01029704|566928532|FG000|Overall Study|Lack of Efficacy|0|||
157047549|NCT01029704|566928533|FG001|Overall Study|Lack of Efficacy|0|||
157047550|NCT01029704|566928534|FG002|Overall Study|Lack of Efficacy|0|||
157047551|NCT01029704|566928535|FG003|Overall Study|Lack of Efficacy|0|||
157047552|NCT01029704|566928536|FG004|Overall Study|Lack of Efficacy|2|||
157047553|NCT01029704|566928537|FG005|Overall Study|Lack of Efficacy|3|||
157047554|NCT01029704|566928538|FG006|Overall Study|Lack of Efficacy|1|||
157047555|NCT01029704|566928539|FG007|Overall Study|Lack of Efficacy|2|||
157047556|NCT01029704|566928540|FG008|Overall Study|Lack of Efficacy|0|||
157047557|NCT01029704|566928532|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
157047558|NCT01029704|566928533|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
157047559|NCT01029704|566928534|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
157047560|NCT01029704|566928535|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
157047561|NCT01029704|566928536|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
157047562|NCT01029704|566928537|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
157047563|NCT01029704|566928538|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
157175625|NCT01237223|567383747|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
157175626|NCT01237223|567383748|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
157175627|NCT01237223|567383743|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
157175628|NCT01237223|567383744|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
157175629|NCT01237223|567383745|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
157047564|NCT01029704|566928539|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
157047565|NCT01029704|566928540|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
157175630|NCT01237223|567383746|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
157175631|NCT01237223|567383747|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
157047566|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
157047567|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
157047568|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
157047569|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
157047570|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Death|0|||
157047571|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Death|0|||
157047572|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Death|1|||
157047573|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Death|0|||
157047574|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
157047575|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
157047576|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
157047577|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
157047578|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
157047579|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
157047580|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
157047581|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
157047582|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
157047583|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
157047584|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
157047585|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
157047586|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
157047587|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
157047588|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
157047589|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
157047590|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
157047591|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
157047592|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
157047593|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
157047594|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Other|2|||
157047595|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Other|0|||
157047596|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Other|0|||
157047597|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Other|0|||
157047598|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
157047599|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
157047600|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
157047601|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
157047602|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
157047603|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
157047604|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
157047605|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
157047606|NCT03845517|566928541|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
157047607|NCT03845517|566928542|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
157047608|NCT03845517|566928543|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
157047609|NCT03845517|566928544|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
157047610|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
157047611|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
157047612|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
157047613|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
157047614|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Death|0|||
157047615|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Death|0|||
157047616|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Death|1|||
157047617|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Death|1|||
157047618|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
157047619|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
157047620|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
157047621|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
157047622|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
157047623|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
157047624|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
157047625|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
157047626|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
157047627|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
157047628|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
157047629|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
157047630|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Other|1|||
157047631|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Other|0|||
157047632|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Other|1|||
157047633|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Other|0|||
157047634|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
157047635|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
157047636|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
157047637|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
157047638|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
157047639|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
157047640|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
157047641|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
157047642|NCT03845517|566928541|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
157175632|NCT01237223|567383748|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
157175633|NCT01237223|567383743|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
157175634|NCT01237223|567383744|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
157175635|NCT01237223|567383745|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
157175636|NCT01237223|567383746|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
157175637|NCT01237223|567383747|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
157175638|NCT01237223|567383748|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
157175639|NCT01237223|567383743|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
157175640|NCT01237223|567383744|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
157175641|NCT01237223|567383745|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
157175642|NCT01237223|567383746|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
157175643|NCT01237223|567383747|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
157175644|NCT01237223|567383748|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
157175645|NCT01237223|567383743|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
157175646|NCT01237223|567383744|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
157175647|NCT01237223|567383745|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
157175648|NCT01237223|567383746|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
157175649|NCT01237223|567383747|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
157175650|NCT01237223|567383748|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
157175651|NCT01237223|567383743|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
157175652|NCT01237223|567383744|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
157175653|NCT01237223|567383745|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
157175654|NCT01237223|567383746|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
157175655|NCT01237223|567383747|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
157175656|NCT01237223|567383748|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
157175657|NCT01237223|567383743|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
157175658|NCT01237223|567383744|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
157175659|NCT01237223|567383745|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
157175660|NCT01237223|567383746|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
157175661|NCT01237223|567383747|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
157175662|NCT01237223|567383748|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
157175663|NCT01237223|567383743|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
157175664|NCT01237223|567383744|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
157175665|NCT01237223|567383745|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
157175666|NCT01237223|567383746|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
157175667|NCT01237223|567383747|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
157175668|NCT01237223|567383748|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
157175669|NCT01237223|567383743|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
157175670|NCT01237223|567383744|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
157175671|NCT01237223|567383745|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
157175672|NCT01237223|567383746|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
157175673|NCT01237223|567383747|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
157175674|NCT01237223|567383748|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
156970181|NCT02487498|566644180|FG001|Period: Period 1|Lost to Follow-up|2|||
156970182|NCT02487498|566644179|FG000|Period: Period 1|Lack of Efficacy|1|||
156970183|NCT02487498|566644180|FG001|Period: Period 1|Lack of Efficacy|0|||
156970184|NCT02487498|566644179|FG000|Period: Period 1|Physician Decision|0|||
156970185|NCT02487498|566644180|FG001|Period: Period 1|Physician Decision|1|||
156970186|NCT02487498|566644179|FG000|Period: Period 1|Protocol deviation|1|||
156970187|NCT02487498|566644180|FG001|Period: Period 1|Protocol deviation|0|||
156970188|NCT02487498|566644179|FG000|Period: Washout|Subject/guardian decision|0|||
156970189|NCT02487498|566644180|FG001|Period: Washout|Subject/guardian decision|5|||
156970190|NCT02487498|566644179|FG000|Period: Washout|Lack of Efficacy|1|||
156970191|NCT02487498|566644180|FG001|Period: Washout|Lack of Efficacy|1|||
156970192|NCT02487498|566644179|FG000|Period: Washout|Physician Decision|1|||
156970193|NCT02487498|566644180|FG001|Period: Washout|Physician Decision|0|||
156970194|NCT02487498|566644179|FG000|Period: Washout|Non-compliance with study treatment|0|||
156970195|NCT02487498|566644180|FG001|Period: Washout|Non-compliance with study treatment|1|||
156970196|NCT02487498|566644179|FG000|Period: Period 2|Adverse Event|2|||
156970197|NCT02487498|566644180|FG001|Period: Period 2|Adverse Event|2|||
156970198|NCT02487498|566644179|FG000|Period: Period 2|Subject/guardian decision|2|||
156970199|NCT02487498|566644180|FG001|Period: Period 2|Subject/guardian decision|1|||
156970200|NCT02487498|566644179|FG000|Period: Period 2|Lost to Follow-up|1|||
156970201|NCT02487498|566644180|FG001|Period: Period 2|Lost to Follow-up|1|||
156970202|NCT02487498|566644179|FG000|Period: Period 2|Death|0|||
156970203|NCT02487498|566644180|FG001|Period: Period 2|Death|1|||
156970204|NCT02487498|566644179|FG000|Period: Period 2|Physician Decision|1|||
156970205|NCT02487498|566644180|FG001|Period: Period 2|Physician Decision|0|||
156970206|NCT00676130|566644187|FG000|Overall Study|Lost to Follow-up|0|||
156970207|NCT00676130|566644188|FG001|Overall Study|Lost to Follow-up|1|||
156970208|NCT00676130|566644187|FG000|Overall Study|Found ineligible|3|||
156970209|NCT00676130|566644188|FG001|Overall Study|Found ineligible|2|||
156970210|NCT00676130|566644187|FG000|Overall Study|Withdrawal by Subject|0|||
156970211|NCT00676130|566644188|FG001|Overall Study|Withdrawal by Subject|1|||
156970212|NCT01564368|566644189|FG000|Overall Study|Ineligible|18|||
156970213|NCT01564368|566644189|FG000|Overall Study|Not Randomized in Parent study|116|||
156970214|NCT01564368|566644189|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
156970215|NCT01564368|566644189|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
156970216|NCT01802437|566644190|FG000|Overall Study|Lost to Follow-up|1|||
156970217|NCT01802437|566644191|FG001|Overall Study|Lost to Follow-up|0|||
156970218|NCT01802437|566644190|FG000|Overall Study|Withdrawal by Subject|3|||
156970219|NCT01802437|566644191|FG001|Overall Study|Withdrawal by Subject|4|||
156970220|NCT04857034|566644192|FG000|Placebo-Controlled Period|Request to discontinue|2|||
156970221|NCT04857034|566644193|FG001|Placebo-Controlled Period|Request to discontinue|2|||
156970222|NCT04857034|566644194|FG002|Placebo-Controlled Period|Request to discontinue|0|||
156970223|NCT04857034|566644195|FG003|Placebo-Controlled Period|Request to discontinue|0|||
156970224|NCT04857034|566644196|FG004|Placebo-Controlled Period|Request to discontinue|0|||
156970225|NCT04857034|566644192|FG000|Placebo-Controlled Period|withdrew consent|1|||
156970226|NCT04857034|566644193|FG001|Placebo-Controlled Period|withdrew consent|1|||
156970227|NCT04857034|566644194|FG002|Placebo-Controlled Period|withdrew consent|2|||
156970228|NCT04857034|566644195|FG003|Placebo-Controlled Period|withdrew consent|0|||
156970229|NCT04857034|566644196|FG004|Placebo-Controlled Period|withdrew consent|0|||
156970230|NCT04857034|566644192|FG000|Placebo-Controlled Period|Pregnancy|1|||
156970231|NCT04857034|566644193|FG001|Placebo-Controlled Period|Pregnancy|1|||
156970232|NCT04857034|566644194|FG002|Placebo-Controlled Period|Pregnancy|0|||
156970233|NCT04857034|566644195|FG003|Placebo-Controlled Period|Pregnancy|0|||
156970234|NCT04857034|566644196|FG004|Placebo-Controlled Period|Pregnancy|0|||
156970235|NCT04857034|566644192|FG000|Placebo-Controlled Period|Ongoing study period|0|||
156970236|NCT04857034|566644193|FG001|Placebo-Controlled Period|Ongoing study period|1|||
156970237|NCT04857034|566644194|FG002|Placebo-Controlled Period|Ongoing study period|0|||
156970238|NCT04857034|566644195|FG003|Placebo-Controlled Period|Ongoing study period|0|||
156970239|NCT04857034|566644196|FG004|Placebo-Controlled Period|Ongoing study period|0|||
156970240|NCT04857034|566644192|FG000|Active Treatment Period|Lack of Efficacy|1|||
156970241|NCT04857034|566644193|FG001|Active Treatment Period|Lack of Efficacy|0|||
156970242|NCT04857034|566644194|FG002|Active Treatment Period|Lack of Efficacy|0|||
156970243|NCT04857034|566644195|FG003|Active Treatment Period|Lack of Efficacy|0|||
156970244|NCT04857034|566644196|FG004|Active Treatment Period|Lack of Efficacy|0|||
156970245|NCT04857034|566644192|FG000|Active Treatment Period|request to discontinue|0|||
156970246|NCT04857034|566644193|FG001|Active Treatment Period|request to discontinue|1|||
156970247|NCT04857034|566644194|FG002|Active Treatment Period|request to discontinue|0|||
156970248|NCT04857034|566644195|FG003|Active Treatment Period|request to discontinue|1|||
156970249|NCT04857034|566644196|FG004|Active Treatment Period|request to discontinue|0|||
156970250|NCT04857034|566644192|FG000|Active Treatment Period|administrative reason by sponsor|1|||
156970251|NCT04857034|566644193|FG001|Active Treatment Period|administrative reason by sponsor|5|||
156970252|NCT04857034|566644194|FG002|Active Treatment Period|administrative reason by sponsor|0|||
156970253|NCT04857034|566644195|FG003|Active Treatment Period|administrative reason by sponsor|2|||
156970254|NCT04857034|566644196|FG004|Active Treatment Period|administrative reason by sponsor|2|||
156970255|NCT04857034|566644192|FG000|Active Treatment Period|other reasons|1|||
156970256|NCT04857034|566644193|FG001|Active Treatment Period|other reasons|1|||
156970257|NCT04857034|566644194|FG002|Active Treatment Period|other reasons|0|||
156970258|NCT04857034|566644195|FG003|Active Treatment Period|other reasons|0|||
156970259|NCT04857034|566644196|FG004|Active Treatment Period|other reasons|1|||
156970260|NCT04857034|566644192|FG000|Active Treatment Period|Ongoing Study Period|2|||
156970261|NCT04857034|566644193|FG001|Active Treatment Period|Ongoing Study Period|4|||
156970262|NCT04857034|566644194|FG002|Active Treatment Period|Ongoing Study Period|0|||
156970263|NCT04857034|566644195|FG003|Active Treatment Period|Ongoing Study Period|1|||
156970264|NCT04857034|566644196|FG004|Active Treatment Period|Ongoing Study Period|0|||
156970265|NCT01682213|566644199|FG000|Overall Study|Withdrawal by Subject|2|||
156970266|NCT01181726|566644200|FG000|First Intervention|Adverse Event|1|||
156970267|NCT01181726|566644201|FG001|First Intervention|Adverse Event|0|||
156970268|NCT04998604|566644202|FG000|Overall Study|Adverse Event|3|||
156970269|NCT04998604|566644203|FG001|Overall Study|Adverse Event|2|||
156970270|NCT04998604|566644202|FG000|Overall Study|Withdrawal by Subject|2|||
156970271|NCT04998604|566644203|FG001|Overall Study|Withdrawal by Subject|4|||
156970272|NCT04998604|566644202|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
156970273|NCT04998604|566644203|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
156970274|NCT00429663|566644204|FG000|Overall Study|Lost to Follow-up|24|||
156970275|NCT00429663|566644205|FG001|Overall Study|Lost to Follow-up|31|||
156970276|NCT00429663|566644204|FG000|Overall Study|Physician Decision|6|||
156970277|NCT00429663|566644205|FG001|Overall Study|Physician Decision|3|||
156970278|NCT00429663|566644204|FG000|Overall Study|Withdrawal by Subject|2|||
156970279|NCT00429663|566644205|FG001|Overall Study|Withdrawal by Subject|5|||
156970280|NCT00429663|566644204|FG000|Overall Study|Death|4|||
156970281|NCT00429663|566644205|FG001|Overall Study|Death|0|||
156970282|NCT03243422|566644211|FG000|Overall Study|Death|20|||
156970283|NCT03243422|566644212|FG001|Overall Study|Death|21|||
156970284|NCT03243422|566644211|FG000|Overall Study|Lost to Follow-up|9|||
156970285|NCT03243422|566644212|FG001|Overall Study|Lost to Follow-up|21|||
156970286|NCT03243422|566644211|FG000|Overall Study|Withdrawal by Subject|22|||
156970287|NCT03243422|566644212|FG001|Overall Study|Withdrawal by Subject|8|||
156970288|NCT03261271|566644213|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
156970289|NCT03261271|566644214|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
156970290|NCT02173054|566644215|FG000|Overall Study|lack of compliance|1|||
156970291|NCT02173054|566644216|FG001|Overall Study|lack of compliance|0|||
156970292|NCT02173054|566644217|FG002|Overall Study|lack of compliance|0|||
156970293|NCT02173054|566644215|FG000|Overall Study|Withdrawal by Subject|0|||
156970294|NCT02173054|566644216|FG001|Overall Study|Withdrawal by Subject|0|||
156970295|NCT02173054|566644217|FG002|Overall Study|Withdrawal by Subject|1|||
156970296|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
156970297|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
156970298|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
156970299|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
156970300|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
156970301|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
156970302|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
156970303|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156970304|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156970305|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
156970306|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
156970307|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
156970308|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156970309|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156970310|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
156970311|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
156970312|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
156970313|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156970314|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156970315|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
156970316|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Death|2|||
156970317|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Death|2|||
156970318|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Death|0|||
156970319|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Death|0|||
156970320|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Death|0|||
156970321|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
156970322|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
156970323|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
156970324|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
156970325|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
156970326|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156970327|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
156970328|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156970329|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156970330|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
156970331|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
156970332|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
156970333|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156970334|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156970335|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
156970336|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
156970337|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156970338|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156970339|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156970340|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
156970341|NCT03420781|566644218|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
156970342|NCT03420781|566644219|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156970343|NCT03420781|566644220|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156970344|NCT03420781|566644221|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
157047643|NCT03845517|566928542|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
157047644|NCT03845517|566928543|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
157047645|NCT03845517|566928544|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
157047646|NCT01109979|566928545|FG000|Overall Study|Physician Decision|2|||
157047647|NCT01109979|566928546|FG001|Overall Study|Physician Decision|0|||
157047648|NCT01109979|566928545|FG000|Overall Study|Withdrawal by Subject|0|||
157047649|NCT01109979|566928546|FG001|Overall Study|Withdrawal by Subject|1|||
157047650|NCT03136861|566928549|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
157047651|NCT03136861|566928550|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
157047652|NCT03136861|566928551|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
157047653|NCT03136861|566928552|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
157047654|NCT03136861|566928553|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
157047655|NCT03136861|566928554|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
157047656|NCT03136861|566928555|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
157047657|NCT03136861|566928549|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
157047658|NCT03136861|566928550|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
157047659|NCT03136861|566928551|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
157047660|NCT03136861|566928552|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
157047661|NCT03136861|566928553|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
157047662|NCT03136861|566928554|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
157047663|NCT03136861|566928555|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
157047664|NCT03136861|566928549|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
157047665|NCT03136861|566928550|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
157047666|NCT03136861|566928551|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
157047667|NCT03136861|566928552|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
157047668|NCT03136861|566928553|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
157047669|NCT03136861|566928554|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
157047670|NCT03136861|566928555|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
157047671|NCT03136861|566928549|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047672|NCT03136861|566928550|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
157047673|NCT03136861|566928551|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047674|NCT03136861|566928552|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047675|NCT03136861|566928553|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047676|NCT03136861|566928554|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047677|NCT03136861|566928555|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
157047678|NCT03136861|566928549|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
157047679|NCT03136861|566928550|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
157047680|NCT03136861|566928551|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
157047681|NCT03136861|566928552|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
157047682|NCT03136861|566928553|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
157047683|NCT03136861|566928554|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
157047684|NCT03136861|566928555|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
157047685|NCT03136861|566928549|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
157047686|NCT03136861|566928550|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
157047687|NCT03136861|566928551|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
157047688|NCT03136861|566928552|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
157047689|NCT03136861|566928553|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
157047690|NCT03136861|566928554|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
157047691|NCT03136861|566928555|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
157047692|NCT03136861|566928549|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157047693|NCT03136861|566928550|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157047694|NCT03136861|566928551|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
157047695|NCT03136861|566928552|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157047696|NCT03136861|566928553|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157047697|NCT03136861|566928554|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157047698|NCT03136861|566928555|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
157175675|NCT01237223|567383743|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
157175676|NCT01237223|567383744|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
157175677|NCT01237223|567383745|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
157175678|NCT01237223|567383746|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
157175679|NCT01237223|567383747|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
157175680|NCT01237223|567383748|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
157175681|NCT01017549|567383751|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
157175682|NCT01017549|567383751|FG000|One-year Follow-up|Lost to Follow-up|2|||
157175683|NCT01017549|567383751|FG000|One-year Follow-up|Withdrawal by Subject|5|||
157047699|NCT03136861|566928549|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047700|NCT03136861|566928550|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047701|NCT03136861|566928551|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
157047702|NCT03136861|566928552|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047703|NCT03136861|566928553|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047704|NCT03136861|566928554|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047705|NCT03136861|566928555|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
157047706|NCT03390166|566928556|FG000|Overall Study|Death|0|||
157047707|NCT03390166|566928557|FG001|Overall Study|Death|1|||
157047708|NCT03390166|566928556|FG000|Overall Study|Lost to Follow-up|6|||
157047709|NCT03390166|566928557|FG001|Overall Study|Lost to Follow-up|4|||
157047710|NCT03390166|566928556|FG000|Overall Study|Physician Decision|2|||
157047711|NCT03390166|566928557|FG001|Overall Study|Physician Decision|1|||
157047712|NCT03390166|566928556|FG000|Overall Study|Move from study area|3|||
157047713|NCT03390166|566928557|FG001|Overall Study|Move from study area|2|||
157047714|NCT03390166|566928556|FG000|Overall Study|To militarycamp for conscript|1|||
157047715|NCT03390166|566928557|FG001|Overall Study|To militarycamp for conscript|0|||
157047716|NCT03390166|566928556|FG000|Overall Study|To drug therapy course|0|||
157047717|NCT03390166|566928557|FG001|Overall Study|To drug therapy course|1|||
157047718|NCT03390166|566928556|FG000|Overall Study|Move to work oversea|0|||
157047719|NCT03390166|566928557|FG001|Overall Study|Move to work oversea|1|||
157047720|NCT00274287|566928560|FG000|Overall Study|Withdrawal by Subject|1|||
157047721|NCT00274287|566928560|FG000|Overall Study|subject non-compliance|1|||
157047722|NCT01262456|566928566|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
157047723|NCT01262456|566928567|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
157047724|NCT01262456|566928568|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
157047725|NCT01262456|566928566|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
157047726|NCT01262456|566928567|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
157047727|NCT01262456|566928568|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
157047728|NCT01262456|566928566|FG000|3-Month Double-Blind Period|Adverse Event|6|||
157047729|NCT01262456|566928567|FG001|3-Month Double-Blind Period|Adverse Event|4|||
157047730|NCT01262456|566928568|FG002|3-Month Double-Blind Period|Adverse Event|8|||
157047731|NCT01262456|566928566|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
157047732|NCT01262456|566928567|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
157047733|NCT01262456|566928568|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
157047734|NCT01262456|566928566|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
157047735|NCT01262456|566928567|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
157047736|NCT01262456|566928568|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
157047737|NCT01262456|566928566|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
157047738|NCT01262456|566928567|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
157047739|NCT01262456|566928568|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
157047740|NCT01262456|566928566|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
157047741|NCT01262456|566928567|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
157047742|NCT01262456|566928568|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
157047743|NCT01262456|566928566|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
157047744|NCT01262456|566928567|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
157047745|NCT01262456|566928568|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
157047746|NCT01262456|566928566|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
157047747|NCT01262456|566928567|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
157047748|NCT01262456|566928568|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
157047749|NCT03938272|566928569|FG000|Overall Study|Withdrawal by Subject|1|||
157047750|NCT03938272|566928570|FG001|Overall Study|Withdrawal by Subject|0|||
157047751|NCT03938272|566928569|FG000|Overall Study|Physician Decision|0|||
157047752|NCT03938272|566928570|FG001|Overall Study|Physician Decision|2|||
157047753|NCT03938272|566928569|FG000|Overall Study|Study termination by sponsor|10|||
157047754|NCT03938272|566928570|FG001|Overall Study|Study termination by sponsor|8|||
157047755|NCT01880736|566928576|FG000|Overall Study|Adverse Event|0|||
157047756|NCT01880736|566928577|FG001|Overall Study|Adverse Event|0|||
157047757|NCT01880736|566928578|FG002|Overall Study|Adverse Event|0|||
157047758|NCT01880736|566928579|FG003|Overall Study|Adverse Event|1|||
157047759|NCT01880736|566928576|FG000|Overall Study|Withdrawal Criteria|1|||
157047760|NCT01880736|566928577|FG001|Overall Study|Withdrawal Criteria|2|||
157047761|NCT01880736|566928578|FG002|Overall Study|Withdrawal Criteria|1|||
157047762|NCT01880736|566928579|FG003|Overall Study|Withdrawal Criteria|5|||
157047763|NCT05289037|566928585|FG000|Overall Study|Withdrawal by Subject|7|||
157047764|NCT05289037|566928586|FG001|Overall Study|Withdrawal by Subject|0|||
157047765|NCT05289037|566928587|FG002|Overall Study|Withdrawal by Subject|3|||
157047766|NCT05289037|566928588|FG003|Overall Study|Withdrawal by Subject|3|||
157047767|NCT05289037|566928589|FG004|Overall Study|Withdrawal by Subject|1|||
157047768|NCT05289037|566928590|FG005|Overall Study|Withdrawal by Subject|5|||
157047769|NCT05289037|566928591|FG006|Overall Study|Withdrawal by Subject|2|||
157047770|NCT05289037|566928592|FG007|Overall Study|Withdrawal by Subject|1|||
156970345|NCT03420781|566644222|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
156970346|NCT03420781|566644218|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156970347|NCT03420781|566644219|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156970348|NCT03420781|566644220|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156970349|NCT03420781|566644221|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
156970350|NCT03420781|566644222|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
156970351|NCT03420781|566644218|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156970352|NCT03420781|566644219|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156970353|NCT03420781|566644220|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156970354|NCT03420781|566644221|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
156970355|NCT03420781|566644222|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
156970356|NCT03420781|566644218|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
156970357|NCT03420781|566644219|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
156970358|NCT03420781|566644220|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
156970359|NCT03420781|566644221|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
156970360|NCT03420781|566644222|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
156970361|NCT01330316|566644223|FG000|Overall Study|Adverse Event|2|||
156970362|NCT01330316|566644224|FG001|Overall Study|Adverse Event|2|||
156970363|NCT01330316|566644223|FG000|Overall Study|Lack of Efficacy|0|||
156970364|NCT01330316|566644224|FG001|Overall Study|Lack of Efficacy|10|||
156970365|NCT01330316|566644223|FG000|Overall Study|Lost to Follow-up|0|||
156970366|NCT01330316|566644224|FG001|Overall Study|Lost to Follow-up|1|||
156970367|NCT01330316|566644223|FG000|Overall Study|Withdrawal by Subject|0|||
156970368|NCT01330316|566644224|FG001|Overall Study|Withdrawal by Subject|1|||
156970369|NCT01330316|566644223|FG000|Overall Study|other than above|0|||
156970370|NCT01330316|566644224|FG001|Overall Study|other than above|1|||
156970371|NCT02696564|566644227|FG000|Overall Study|Death|1|||
156970372|NCT02696564|566644228|FG001|Overall Study|Death|2|||
156970373|NCT02696564|566644227|FG000|Overall Study|Withdrawal by Subject|3|||
156970374|NCT02696564|566644228|FG001|Overall Study|Withdrawal by Subject|2|||
156970375|NCT02696564|566644227|FG000|Overall Study|Lost to Follow-up|3|||
156970376|NCT02696564|566644228|FG001|Overall Study|Lost to Follow-up|3|||
156970377|NCT02696564|566644227|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
156970378|NCT02696564|566644228|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
156970379|NCT02696564|566644227|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
156970380|NCT02696564|566644228|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
156970381|NCT02696564|566644227|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
156970382|NCT02696564|566644228|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
156970383|NCT02696564|566644227|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
156970384|NCT02696564|566644228|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
156970385|NCT02696564|566644227|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
156970386|NCT02696564|566644228|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
156970387|NCT01337986|566644229|FG000|Overall Study|Adverse Event|2|||
156970388|NCT01337986|566644230|FG001|Overall Study|Adverse Event|2|||
156970389|NCT01337986|566644229|FG000|Overall Study|Lost to Follow-up|1|||
156970390|NCT01337986|566644230|FG001|Overall Study|Lost to Follow-up|0|||
156970391|NCT01337986|566644229|FG000|Overall Study|Protocol Violation|0|||
156970392|NCT01337986|566644230|FG001|Overall Study|Protocol Violation|3|||
156970393|NCT04067401|566644231|FG000|Overall Study|Withdrawal by Subject|7|||
156970394|NCT04067401|566644232|FG001|Overall Study|Withdrawal by Subject|0|||
156970395|NCT04067401|566644231|FG000|Overall Study|no data provided|1|||
156970396|NCT04067401|566644232|FG001|Overall Study|no data provided|0|||
156970397|NCT03633929|566644233|FG000|Overall Study|Lost to Follow-up|1|||
156970398|NCT03633929|566644233|FG000|Overall Study|Did not login to software. Did not participate|3|||
156970399|NCT01520402|566644235|FG000|Overall Study|Withdrawal by Subject|2|||
156970400|NCT01520402|566644235|FG000|Overall Study|Physician Decision|3|||
156970401|NCT02287584|566644236|FG000|the Double-blind Phase|Adverse Event|17|||
156970402|NCT02287584|566644237|FG001|the Double-blind Phase|Adverse Event|17|||
156970403|NCT02287584|566644238|FG002|the Double-blind Phase|Adverse Event|12|||
156970404|NCT02287584|566644239|FG003|the Double-blind Phase|Adverse Event|0|||
156970405|NCT02287584|566644240|FG004|the Double-blind Phase|Adverse Event|0|||
156970406|NCT02287584|566644241|FG005|the Double-blind Phase|Adverse Event|0|||
156970407|NCT02287584|566644236|FG000|the Double-blind Phase|Lack of Efficacy|18|||
156970408|NCT02287584|566644237|FG001|the Double-blind Phase|Lack of Efficacy|8|||
156970409|NCT02287584|566644238|FG002|the Double-blind Phase|Lack of Efficacy|8|||
156970410|NCT02287584|566644239|FG003|the Double-blind Phase|Lack of Efficacy|0|||
156970411|NCT02287584|566644240|FG004|the Double-blind Phase|Lack of Efficacy|0|||
156970412|NCT02287584|566644241|FG005|the Double-blind Phase|Lack of Efficacy|0|||
156970413|NCT02287584|566644236|FG000|the Double-blind Phase|Lost to Follow-up|0|||
157047771|NCT05289037|566928593|FG008|Overall Study|Withdrawal by Subject|2|||
157047772|NCT05289037|566928594|FG009|Overall Study|Withdrawal by Subject|2|||
157047773|NCT05289037|566928595|FG010|Overall Study|Withdrawal by Subject|1|||
157047774|NCT05289037|566928596|FG011|Overall Study|Withdrawal by Subject|0|||
157047775|NCT05289037|566928597|FG012|Overall Study|Withdrawal by Subject|1|||
157047776|NCT05289037|566928598|FG013|Overall Study|Withdrawal by Subject|2|||
157047777|NCT05289037|566928599|FG014|Overall Study|Withdrawal by Subject|0|||
157047778|NCT05289037|566928600|FG015|Overall Study|Withdrawal by Subject|3|||
157047779|NCT05289037|566928601|FG016|Overall Study|Withdrawal by Subject|3|||
157047780|NCT05289037|566928585|FG000|Overall Study|Lost to Follow-up|1|||
157047781|NCT05289037|566928586|FG001|Overall Study|Lost to Follow-up|4|||
157047782|NCT05289037|566928587|FG002|Overall Study|Lost to Follow-up|3|||
157047783|NCT05289037|566928588|FG003|Overall Study|Lost to Follow-up|3|||
157047784|NCT05289037|566928589|FG004|Overall Study|Lost to Follow-up|3|||
157047785|NCT05289037|566928590|FG005|Overall Study|Lost to Follow-up|2|||
157047786|NCT05289037|566928591|FG006|Overall Study|Lost to Follow-up|3|||
157047787|NCT05289037|566928592|FG007|Overall Study|Lost to Follow-up|2|||
157047788|NCT05289037|566928593|FG008|Overall Study|Lost to Follow-up|2|||
157047789|NCT05289037|566928594|FG009|Overall Study|Lost to Follow-up|1|||
157047790|NCT05289037|566928595|FG010|Overall Study|Lost to Follow-up|3|||
157047791|NCT05289037|566928596|FG011|Overall Study|Lost to Follow-up|4|||
157047792|NCT05289037|566928597|FG012|Overall Study|Lost to Follow-up|2|||
157047793|NCT05289037|566928598|FG013|Overall Study|Lost to Follow-up|7|||
157047794|NCT05289037|566928599|FG014|Overall Study|Lost to Follow-up|4|||
157047795|NCT05289037|566928600|FG015|Overall Study|Lost to Follow-up|6|||
157047796|NCT05289037|566928601|FG016|Overall Study|Lost to Follow-up|4|||
157047797|NCT05289037|566928585|FG000|Overall Study|Death|0|||
157047798|NCT05289037|566928586|FG001|Overall Study|Death|0|||
157047799|NCT05289037|566928587|FG002|Overall Study|Death|0|||
157047800|NCT05289037|566928588|FG003|Overall Study|Death|0|||
157047801|NCT05289037|566928589|FG004|Overall Study|Death|0|||
157047802|NCT05289037|566928590|FG005|Overall Study|Death|1|||
157047803|NCT05289037|566928591|FG006|Overall Study|Death|0|||
157047804|NCT05289037|566928592|FG007|Overall Study|Death|0|||
157047805|NCT05289037|566928593|FG008|Overall Study|Death|0|||
157047806|NCT05289037|566928594|FG009|Overall Study|Death|0|||
157047807|NCT05289037|566928595|FG010|Overall Study|Death|0|||
157047808|NCT05289037|566928596|FG011|Overall Study|Death|0|||
157047809|NCT05289037|566928597|FG012|Overall Study|Death|0|||
157047810|NCT05289037|566928598|FG013|Overall Study|Death|0|||
157047811|NCT05289037|566928599|FG014|Overall Study|Death|1|||
157047812|NCT05289037|566928600|FG015|Overall Study|Death|0|||
157047813|NCT05289037|566928601|FG016|Overall Study|Death|0|||
157047814|NCT05289037|566928585|FG000|Overall Study|Did not receive vaccine|0|||
157047815|NCT05289037|566928586|FG001|Overall Study|Did not receive vaccine|3|||
157047816|NCT05289037|566928587|FG002|Overall Study|Did not receive vaccine|0|||
157047817|NCT05289037|566928588|FG003|Overall Study|Did not receive vaccine|0|||
157047818|NCT05289037|566928589|FG004|Overall Study|Did not receive vaccine|1|||
157047819|NCT05289037|566928590|FG005|Overall Study|Did not receive vaccine|1|||
157047820|NCT05289037|566928591|FG006|Overall Study|Did not receive vaccine|1|||
157047821|NCT05289037|566928592|FG007|Overall Study|Did not receive vaccine|0|||
157047822|NCT05289037|566928593|FG008|Overall Study|Did not receive vaccine|0|||
157047823|NCT05289037|566928594|FG009|Overall Study|Did not receive vaccine|0|||
157047824|NCT05289037|566928595|FG010|Overall Study|Did not receive vaccine|0|||
157047825|NCT05289037|566928596|FG011|Overall Study|Did not receive vaccine|0|||
157047826|NCT05289037|566928597|FG012|Overall Study|Did not receive vaccine|0|||
157047827|NCT05289037|566928598|FG013|Overall Study|Did not receive vaccine|0|||
157047828|NCT05289037|566928599|FG014|Overall Study|Did not receive vaccine|1|||
157047829|NCT05289037|566928600|FG015|Overall Study|Did not receive vaccine|0|||
157047830|NCT05289037|566928601|FG016|Overall Study|Did not receive vaccine|0|||
157047831|NCT05289037|566928585|FG000|Overall Study|Unable to make last visit|0|||
157047832|NCT05289037|566928586|FG001|Overall Study|Unable to make last visit|0|||
157047833|NCT05289037|566928587|FG002|Overall Study|Unable to make last visit|1|||
157047834|NCT05289037|566928588|FG003|Overall Study|Unable to make last visit|0|||
157047835|NCT05289037|566928589|FG004|Overall Study|Unable to make last visit|0|||
157047836|NCT05289037|566928590|FG005|Overall Study|Unable to make last visit|0|||
157047837|NCT05289037|566928591|FG006|Overall Study|Unable to make last visit|0|||
157047838|NCT05289037|566928592|FG007|Overall Study|Unable to make last visit|0|||
157047839|NCT05289037|566928593|FG008|Overall Study|Unable to make last visit|0|||
157047840|NCT05289037|566928594|FG009|Overall Study|Unable to make last visit|0|||
157047841|NCT05289037|566928595|FG010|Overall Study|Unable to make last visit|0|||
157047842|NCT05289037|566928596|FG011|Overall Study|Unable to make last visit|0|||
157047843|NCT05289037|566928597|FG012|Overall Study|Unable to make last visit|0|||
157047844|NCT05289037|566928598|FG013|Overall Study|Unable to make last visit|0|||
157047845|NCT05289037|566928599|FG014|Overall Study|Unable to make last visit|0|||
157047846|NCT05289037|566928600|FG015|Overall Study|Unable to make last visit|0|||
157047847|NCT05289037|566928601|FG016|Overall Study|Unable to make last visit|0|||
157047848|NCT05289037|566928585|FG000|Overall Study|Protocol deviation|0|||
157047849|NCT05289037|566928586|FG001|Overall Study|Protocol deviation|0|||
157047850|NCT05289037|566928587|FG002|Overall Study|Protocol deviation|0|||
157047851|NCT05289037|566928588|FG003|Overall Study|Protocol deviation|0|||
157047852|NCT05289037|566928589|FG004|Overall Study|Protocol deviation|0|||
157047853|NCT05289037|566928590|FG005|Overall Study|Protocol deviation|0|||
157047854|NCT05289037|566928591|FG006|Overall Study|Protocol deviation|0|||
157047855|NCT05289037|566928592|FG007|Overall Study|Protocol deviation|0|||
157047856|NCT05289037|566928593|FG008|Overall Study|Protocol deviation|0|||
157047857|NCT05289037|566928594|FG009|Overall Study|Protocol deviation|0|||
157047858|NCT05289037|566928595|FG010|Overall Study|Protocol deviation|0|||
157047859|NCT05289037|566928596|FG011|Overall Study|Protocol deviation|0|||
157047860|NCT05289037|566928597|FG012|Overall Study|Protocol deviation|0|||
157047861|NCT05289037|566928598|FG013|Overall Study|Protocol deviation|0|||
157047862|NCT05289037|566928599|FG014|Overall Study|Protocol deviation|0|||
157047863|NCT05289037|566928600|FG015|Overall Study|Protocol deviation|1|||
157047864|NCT05289037|566928601|FG016|Overall Study|Protocol deviation|0|||
157047865|NCT02831049|566928602|FG000|Overall Study|Lost to Follow-up|0|||
157047866|NCT02831049|566928603|FG001|Overall Study|Lost to Follow-up|0|||
157047867|NCT02831049|566928604|FG002|Overall Study|Lost to Follow-up|1|||
157047868|NCT02831049|566928602|FG000|Overall Study|Withdrawal by Subject|0|||
157047869|NCT02831049|566928603|FG001|Overall Study|Withdrawal by Subject|1|||
157047870|NCT02831049|566928604|FG002|Overall Study|Withdrawal by Subject|1|||
157047871|NCT02831049|566928602|FG000|Overall Study|Pandemic shutdown|1|||
157047872|NCT02831049|566928603|FG001|Overall Study|Pandemic shutdown|0|||
157047873|NCT02831049|566928604|FG002|Overall Study|Pandemic shutdown|0|||
157047874|NCT04852978|566928606|FG000|Overall Study|Physician Decision|0|||
157047875|NCT04852978|566928607|FG001|Overall Study|Physician Decision|1|||
157047876|NCT04852978|566928608|FG002|Overall Study|Physician Decision|0|||
157047877|NCT04852978|566928609|FG003|Overall Study|Physician Decision|0|||
157047878|NCT04852978|566928610|FG004|Overall Study|Physician Decision|0|||
157047879|NCT04852978|566928611|FG005|Overall Study|Physician Decision|0|||
157047880|NCT04852978|566928612|FG006|Overall Study|Physician Decision|0|||
157047881|NCT04852978|566928613|FG007|Overall Study|Physician Decision|2|||
157047882|NCT04852978|566928614|FG008|Overall Study|Physician Decision|0|||
157047883|NCT04852978|566928606|FG000|Overall Study|Sponsor request|0|||
157047884|NCT04852978|566928607|FG001|Overall Study|Sponsor request|0|||
157047885|NCT04852978|566928608|FG002|Overall Study|Sponsor request|1|||
157047886|NCT04852978|566928609|FG003|Overall Study|Sponsor request|0|||
157047887|NCT04852978|566928610|FG004|Overall Study|Sponsor request|0|||
157047888|NCT04852978|566928611|FG005|Overall Study|Sponsor request|0|||
157047889|NCT04852978|566928612|FG006|Overall Study|Sponsor request|0|||
157047890|NCT04852978|566928613|FG007|Overall Study|Sponsor request|0|||
157047891|NCT04852978|566928614|FG008|Overall Study|Sponsor request|0|||
157047892|NCT04852978|566928606|FG000|Overall Study|Death|0|||
157047893|NCT04852978|566928607|FG001|Overall Study|Death|0|||
157047894|NCT04852978|566928608|FG002|Overall Study|Death|0|||
157047895|NCT04852978|566928609|FG003|Overall Study|Death|0|||
157047896|NCT04852978|566928610|FG004|Overall Study|Death|0|||
157047897|NCT04852978|566928611|FG005|Overall Study|Death|0|||
157047898|NCT04852978|566928612|FG006|Overall Study|Death|1|||
157047899|NCT04852978|566928613|FG007|Overall Study|Death|0|||
157047900|NCT04852978|566928614|FG008|Overall Study|Death|0|||
157047901|NCT04852978|566928606|FG000|Overall Study|Lost to Follow-up|3|||
157047902|NCT04852978|566928607|FG001|Overall Study|Lost to Follow-up|2|||
157047903|NCT04852978|566928608|FG002|Overall Study|Lost to Follow-up|2|||
157047904|NCT04852978|566928609|FG003|Overall Study|Lost to Follow-up|0|||
157047905|NCT04852978|566928610|FG004|Overall Study|Lost to Follow-up|2|||
157047906|NCT04852978|566928611|FG005|Overall Study|Lost to Follow-up|4|||
157047907|NCT04852978|566928612|FG006|Overall Study|Lost to Follow-up|1|||
157047908|NCT04852978|566928613|FG007|Overall Study|Lost to Follow-up|2|||
157047909|NCT04852978|566928614|FG008|Overall Study|Lost to Follow-up|2|||
157047910|NCT04852978|566928606|FG000|Overall Study|Withdrawal by Subject|4|||
157047911|NCT04852978|566928607|FG001|Overall Study|Withdrawal by Subject|2|||
157047912|NCT04852978|566928608|FG002|Overall Study|Withdrawal by Subject|2|||
157047913|NCT04852978|566928609|FG003|Overall Study|Withdrawal by Subject|1|||
157175684|NCT01017549|567383751|FG000|5 Year Follow-up|Lost to Follow-up|9|||
157175685|NCT01017549|567383751|FG000|5 Year Follow-up|Mastectomy|3|||
157175686|NCT00443846|567383753|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
157175687|NCT00443846|567383754|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
157175688|NCT00443846|567383753|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
157175689|NCT00443846|567383754|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
157175690|NCT00443846|567383753|FG000|Overall Study|Adverse Event|0|||
157175691|NCT00443846|567383754|FG001|Overall Study|Adverse Event|1|||
157175692|NCT00443846|567383753|FG000|Overall Study|Personal reason|8|||
157175693|NCT00443846|567383754|FG001|Overall Study|Personal reason|3|||
157047914|NCT04852978|566928610|FG004|Overall Study|Withdrawal by Subject|5|||
157047915|NCT04852978|566928611|FG005|Overall Study|Withdrawal by Subject|3|||
157047916|NCT04852978|566928612|FG006|Overall Study|Withdrawal by Subject|2|||
157047917|NCT04852978|566928613|FG007|Overall Study|Withdrawal by Subject|2|||
157047918|NCT04852978|566928614|FG008|Overall Study|Withdrawal by Subject|1|||
157047919|NCT00747149|566930026|FG000|Overall Study|Adverse Event|0|||
157047920|NCT00747149|566930027|FG001|Overall Study|Adverse Event|15|||
157047921|NCT00747149|566930026|FG000|Overall Study|Lost to Follow-up|0|||
157047922|NCT00747149|566930027|FG001|Overall Study|Lost to Follow-up|10|||
157047923|NCT00747149|566930026|FG000|Overall Study|Withdrawal by Subject|0|||
157047924|NCT00747149|566930027|FG001|Overall Study|Withdrawal by Subject|6|||
157047925|NCT00747149|566930026|FG000|Overall Study|Did not receive treatment|0|||
157047926|NCT00747149|566930027|FG001|Overall Study|Did not receive treatment|1|||
157047927|NCT00747149|566930026|FG000|Overall Study|Incorrect enrollment|0|||
157047928|NCT00747149|566930027|FG001|Overall Study|Incorrect enrollment|6|||
157047929|NCT00747149|566930026|FG000|Overall Study|Severe non-compliance to protocol|0|||
157047930|NCT00747149|566930027|FG001|Overall Study|Severe non-compliance to protocol|1|||
157047931|NCT00747149|566930026|FG000|Overall Study|Not reported|1|||
157047932|NCT00747149|566930027|FG001|Overall Study|Not reported|4|||
157047933|NCT00070707|566930028|FG000|Overall Study|Adverse Event|1|||
157047934|NCT00070707|566930029|FG001|Overall Study|Adverse Event|2|||
157047935|NCT00070707|566930028|FG000|Overall Study|Lack of Efficacy|4|||
157047936|NCT00070707|566930029|FG001|Overall Study|Lack of Efficacy|1|||
157047937|NCT00070707|566930028|FG000|Overall Study|Protocol Violation|8|||
157047938|NCT00070707|566930029|FG001|Overall Study|Protocol Violation|4|||
157047939|NCT00070707|566930028|FG000|Overall Study|Unrelated to Study Medication|1|||
157047940|NCT00070707|566930029|FG001|Overall Study|Unrelated to Study Medication|0|||
157047941|NCT01304940|566930039|FG000|Overall Study|not meet symptom severity requirement|3|||
157047942|NCT01304940|566930040|FG001|Overall Study|not meet symptom severity requirement|0|||
157047943|NCT00278395|566930041|FG000|Overall Study|Adverse Event|2|||
157047944|NCT00278395|566930041|FG000|Overall Study|Nonevaluable|1|||
157047945|NCT03740737|566930042|FG000|Overall Study|Protocol deviation|13|||
157047946|NCT03740737|566930043|FG001|Overall Study|Protocol deviation|0|||
157047947|NCT03740737|566930042|FG000|Overall Study|Adverse Event|2|||
157047948|NCT03740737|566930043|FG001|Overall Study|Adverse Event|0|||
157047949|NCT03740737|566930042|FG000|Overall Study|Lost to Follow-up|1|||
157047950|NCT03740737|566930043|FG001|Overall Study|Lost to Follow-up|0|||
157047951|NCT03740737|566930042|FG000|Overall Study|Randomization failure|1|||
157047952|NCT03740737|566930043|FG001|Overall Study|Randomization failure|0|||
157047953|NCT03740737|566930042|FG000|Overall Study|Participant withdrew consent|1|||
157047954|NCT03740737|566930043|FG001|Overall Study|Participant withdrew consent|0|||
157047955|NCT03740737|566930042|FG000|Overall Study|Participant withdrew from trial|2|||
157047956|NCT03740737|566930043|FG001|Overall Study|Participant withdrew from trial|1|||
157047957|NCT02753075|566930050|FG000|Overall Study|Adverse Event|2|||
157047958|NCT02753075|566930051|FG001|Overall Study|Adverse Event|1|||
157047959|NCT02753075|566930052|FG002|Overall Study|Adverse Event|0|||
157047960|NCT02753075|566930050|FG000|Overall Study|Lost to Follow-up|2|||
157047961|NCT02753075|566930051|FG001|Overall Study|Lost to Follow-up|0|||
157047962|NCT02753075|566930052|FG002|Overall Study|Lost to Follow-up|0|||
157047963|NCT02753075|566930050|FG000|Overall Study|Withdrawal of Consent|1|||
157047964|NCT02753075|566930051|FG001|Overall Study|Withdrawal of Consent|1|||
157047965|NCT02753075|566930052|FG002|Overall Study|Withdrawal of Consent|3|||
157047966|NCT02753075|566930050|FG000|Overall Study|Physician Decision|3|||
157047967|NCT02753075|566930051|FG001|Overall Study|Physician Decision|1|||
157047968|NCT02753075|566930052|FG002|Overall Study|Physician Decision|0|||
157047969|NCT02784834|566930054|FG000|Overall Study|Lack of Efficacy|1|||
157047970|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
157047971|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
157047972|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
157047973|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
157047974|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Adverse Event|7|||
157047975|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Adverse Event|8|||
157047976|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Adverse Event|8|||
157047977|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Adverse Event|9|||
157047978|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
157047979|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
157047980|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
157047981|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
157047982|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
157047983|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
157047984|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
157047985|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
157047986|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Pregnancy|0|||
157047987|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Pregnancy|2|||
157047988|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Pregnancy|2|||
157047989|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Pregnancy|0|||
157047990|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Non-compliance|1|||
157047991|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Non-compliance|0|||
157047992|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Non-compliance|0|||
157047993|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Non-compliance|3|||
157047994|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Other|3|||
157047995|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Other|0|||
157047996|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Other|3|||
157047997|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Other|2|||
157047998|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
157047999|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
157048000|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
157048001|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
157048002|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
157048003|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
157048004|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
157048005|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
157048006|NCT02143713|566930055|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
157048007|NCT02143713|566930056|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
157048008|NCT02143713|566930057|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
157048009|NCT02143713|566930058|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
157048010|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
157048011|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
157048012|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
157048013|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
157048014|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
157048015|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
157048016|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
157048017|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
157048018|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
157048019|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
157048020|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
157048021|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
157048022|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
157048023|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
157048024|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
157048025|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
157048026|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
157048027|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
157048028|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
157048029|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
157048030|NCT02143713|566930055|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
157048031|NCT02143713|566930056|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
157048032|NCT02143713|566930057|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
157048033|NCT02143713|566930058|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
157048034|NCT01999335|566930059|FG000|Overall Study|Discontinued before receiving treatment|0|||
157048035|NCT01999335|566930060|FG001|Overall Study|Discontinued before receiving treatment|0|||
157048036|NCT01999335|566930061|FG002|Overall Study|Discontinued before receiving treatment|0|||
157048037|NCT01999335|566930062|FG003|Overall Study|Discontinued before receiving treatment|0|||
157048038|NCT01999335|566930063|FG004|Overall Study|Discontinued before receiving treatment|2|||
157048039|NCT00080119|566930064|FG000|Overall Study|Discontinued because of study closure|0|||
157048040|NCT00080119|566930065|FG001|Overall Study|Discontinued because of study closure|0|||
157048041|NCT00080119|566930066|FG002|Overall Study|Discontinued because of study closure|130|||
157048042|NCT00080119|566930067|FG003|Overall Study|Discontinued because of study closure|141|||
157048043|NCT00080119|566930064|FG000|Overall Study|Unable to get to clinic|24|||
157048044|NCT00080119|566930065|FG001|Overall Study|Unable to get to clinic|24|||
157048045|NCT00080119|566930066|FG002|Overall Study|Unable to get to clinic|7|||
157048046|NCT00080119|566930067|FG003|Overall Study|Unable to get to clinic|1|||
157048047|NCT00080119|566930064|FG000|Overall Study|Consent withdrawn|13|||
157048048|NCT00080119|566930065|FG001|Overall Study|Consent withdrawn|17|||
157048049|NCT00080119|566930066|FG002|Overall Study|Consent withdrawn|4|||
157048050|NCT00080119|566930067|FG003|Overall Study|Consent withdrawn|6|||
157048051|NCT00080119|566930064|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
157048052|NCT00080119|566930065|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
157048053|NCT00080119|566930066|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
157048054|NCT00080119|566930067|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
157048055|NCT00080119|566930064|FG000|Overall Study|Lost to Follow-up|16|||
157048056|NCT00080119|566930065|FG001|Overall Study|Lost to Follow-up|19|||
157048057|NCT00080119|566930066|FG002|Overall Study|Lost to Follow-up|19|||
157048058|NCT00080119|566930067|FG003|Overall Study|Lost to Follow-up|14|||
157048059|NCT00889863|566930075|FG000|Part I: Open Label|Death|1|||
157048060|NCT00889863|566930076|FG001|Part I: Open Label|Death|0|||
157048061|NCT00889863|566930075|FG000|Part I: Open Label|Adverse Event|4|||
157048062|NCT00889863|566930076|FG001|Part I: Open Label|Adverse Event|0|||
157175694|NCT00443846|567383753|FG000|Overall Study|Lost to Follow-up|1|||
157175695|NCT00443846|567383754|FG001|Overall Study|Lost to Follow-up|2|||
157175696|NCT00391807|567383765|FG000|Overall Study|Did not receive study medication|23|||
157175697|NCT00391807|567383765|FG000|Overall Study|Adverse Event|177|||
157175698|NCT00391807|567383765|FG000|Overall Study|Pregnancy|25|||
157175699|NCT00391807|567383765|FG000|Overall Study|Lost to Follow-up|227|||
157175700|NCT00391807|567383765|FG000|Overall Study|Withdrawal by Subject|147|||
157175701|NCT00391807|567383765|FG000|Overall Study|Protocol Violation|20|||
157175702|NCT00391807|567383765|FG000|Overall Study|Various|96|||
157175703|NCT05441540|567383766|FG000|Overall Study|Withdrawal by Subject|2|||
157175704|NCT00813917|567383767|FG000|Overall Study|Adverse Event|0|||
157175705|NCT00813917|567383768|FG001|Overall Study|Adverse Event|1|||
157175706|NCT00813917|567383767|FG000|Overall Study|Withdrawal by Subject|3|||
157175707|NCT00813917|567383768|FG001|Overall Study|Withdrawal by Subject|4|||
157175708|NCT00813917|567383767|FG000|Overall Study|Lost to Follow-up|3|||
157175709|NCT00813917|567383768|FG001|Overall Study|Lost to Follow-up|1|||
157175710|NCT04539262|567383771|FG000|Overall Study|Adverse Event|0|||
157175711|NCT04539262|567383772|FG001|Overall Study|Adverse Event|0|||
157175712|NCT04539262|567383773|FG002|Overall Study|Adverse Event|1|||
157175713|NCT04539262|567383774|FG003|Overall Study|Adverse Event|0|||
157175714|NCT04539262|567383775|FG004|Overall Study|Adverse Event|0|||
157175715|NCT04539262|567383776|FG005|Overall Study|Adverse Event|0|||
157175716|NCT04539262|567383777|FG006|Overall Study|Adverse Event|0|||
157175717|NCT04539262|567383778|FG007|Overall Study|Adverse Event|0|||
157175718|NCT04539262|567383771|FG000|Overall Study|Withdrew Consent|0|||
157175719|NCT04539262|567383772|FG001|Overall Study|Withdrew Consent|0|||
157175720|NCT04539262|567383773|FG002|Overall Study|Withdrew Consent|0|||
157175721|NCT04539262|567383774|FG003|Overall Study|Withdrew Consent|1|||
157175722|NCT04539262|567383775|FG004|Overall Study|Withdrew Consent|0|||
157175723|NCT04539262|567383776|FG005|Overall Study|Withdrew Consent|0|||
157175724|NCT04539262|567383777|FG006|Overall Study|Withdrew Consent|0|||
157175725|NCT04539262|567383778|FG007|Overall Study|Withdrew Consent|0|||
157175726|NCT04539262|567383771|FG000|Overall Study|Randomized, Not treated|0|||
157175727|NCT04539262|567383772|FG001|Overall Study|Randomized, Not treated|1|||
157175728|NCT04539262|567383773|FG002|Overall Study|Randomized, Not treated|0|||
157175729|NCT04539262|567383774|FG003|Overall Study|Randomized, Not treated|0|||
157175730|NCT04539262|567383775|FG004|Overall Study|Randomized, Not treated|0|||
157175731|NCT04539262|567383776|FG005|Overall Study|Randomized, Not treated|0|||
157175732|NCT04539262|567383777|FG006|Overall Study|Randomized, Not treated|1|||
157175733|NCT04539262|567383778|FG007|Overall Study|Randomized, Not treated|0|||
157175734|NCT03862495|567383783|FG000|Overall Study|Lost to Follow-up|37|||
157175735|NCT03862495|567383784|FG001|Overall Study|Lost to Follow-up|35|||
157175736|NCT04397796|567383785|FG000|Overall Study|Death|3|||
157175737|NCT04397796|567383786|FG001|Overall Study|Death|1|||
157175738|NCT03363165|567383787|FG000|3-month Follow-up|Death|0|||
157175739|NCT03363165|567383788|FG001|3-month Follow-up|Death|1|||
157175740|NCT03363165|567383787|FG000|6-month Follow-up|Death|0|||
157175741|NCT03363165|567383788|FG001|6-month Follow-up|Death|1|||
157175742|NCT03363165|567383787|FG000|6-month Follow-up|Withdrawal by Subject|1|||
157175743|NCT03363165|567383788|FG001|6-month Follow-up|Withdrawal by Subject|1|||
157175744|NCT03363165|567383787|FG000|12-month Follow-up|Death|1|||
157175745|NCT03363165|567383788|FG001|12-month Follow-up|Death|1|||
157175746|NCT03363165|567383787|FG000|12-month Follow-up|Withdrawal by Subject|1|||
157175747|NCT03363165|567383788|FG001|12-month Follow-up|Withdrawal by Subject|1|||
157175748|NCT00126672|567383789|FG000|Overall Study|Adverse Event|4|||
157175749|NCT00126672|567383789|FG000|Overall Study|Lost to Follow-up|4|||
157175750|NCT01001234|567383790|FG000|Overall Study|Withdrawal by Subject|2|||
157175751|NCT01001234|567383791|FG001|Overall Study|Withdrawal by Subject|0|||
157175752|NCT01001234|567383792|FG002|Overall Study|Withdrawal by Subject|3|||
157175753|NCT01001234|567383793|FG003|Overall Study|Withdrawal by Subject|0|||
157175754|NCT01001234|567383794|FG004|Overall Study|Withdrawal by Subject|0|||
157175755|NCT01001234|567383790|FG000|Overall Study|Protocol Violation|34|||
156970414|NCT02287584|566644237|FG001|the Double-blind Phase|Lost to Follow-up|1|||
156970415|NCT02287584|566644238|FG002|the Double-blind Phase|Lost to Follow-up|1|||
156970416|NCT02287584|566644239|FG003|the Double-blind Phase|Lost to Follow-up|0|||
157229170|NCT00048048|567585164|FG007|Core Treatment|Withdrawal by Subject|0|||
157175756|NCT01001234|567383791|FG001|Overall Study|Protocol Violation|3|||
157175757|NCT01001234|567383792|FG002|Overall Study|Protocol Violation|19|||
157175758|NCT01001234|567383793|FG003|Overall Study|Protocol Violation|18|||
157175759|NCT01001234|567383794|FG004|Overall Study|Protocol Violation|0|||
157175760|NCT01001234|567383790|FG000|Overall Study|Lost to Follow-up|0|||
157175761|NCT01001234|567383791|FG001|Overall Study|Lost to Follow-up|0|||
157175762|NCT01001234|567383792|FG002|Overall Study|Lost to Follow-up|1|||
157175763|NCT01001234|567383793|FG003|Overall Study|Lost to Follow-up|2|||
157175764|NCT01001234|567383794|FG004|Overall Study|Lost to Follow-up|0|||
157175765|NCT01001234|567383790|FG000|Overall Study|Physician Decision|1|||
157175766|NCT01001234|567383791|FG001|Overall Study|Physician Decision|0|||
157175767|NCT01001234|567383792|FG002|Overall Study|Physician Decision|0|||
157175768|NCT01001234|567383793|FG003|Overall Study|Physician Decision|0|||
157175769|NCT01001234|567383794|FG004|Overall Study|Physician Decision|0|||
157048063|NCT00889863|566930075|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
157048064|NCT00889863|566930076|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
157048065|NCT00889863|566930075|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
157048066|NCT00889863|566930076|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
157048067|NCT00889863|566930075|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
157048068|NCT00889863|566930076|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
157048069|NCT00889863|566930075|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
157048070|NCT00889863|566930076|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
157048071|NCT00889863|566930075|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
157048072|NCT00889863|566930076|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
157048073|NCT01090739|566930077|FG000|Enrollment|Withdrawal by Subject|24|||
157048074|NCT01090739|566930077|FG000|Enrollment|Protocol Violation|14|||
157048075|NCT01090739|566930077|FG000|Enrollment|Lost to Follow-up|5|||
157048076|NCT01090739|566930077|FG000|Enrollment|Physician Decision|5|||
157048077|NCT01090739|566930077|FG000|Enrollment|Sponsor termination of site|4|||
157048078|NCT01090739|566930077|FG000|Enrollment|Study implant limit reached|2|||
157048079|NCT01090739|566930077|FG000|Enrollment|Adverse Event|1|||
157048080|NCT01090739|566930077|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
157048081|NCT01090739|566930077|FG000|12 Month Follow-up|Lost to Follow-up|1|||
157048082|NCT01090739|566930077|FG000|12 Month Follow-up|Physician Decision|1|||
157048083|NCT01090739|566930077|FG000|12 Month Follow-up|Death|1|||
157048084|NCT01090739|566930077|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
157048085|NCT01090739|566930077|FG000|24 Month Follow-up|Lost to Follow-up|1|||
157048086|NCT01090739|566930077|FG000|24 Month Follow-up|Death|1|||
157048087|NCT01090739|566930077|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
157048088|NCT01090739|566930077|FG000|36 Month Follow-up|Visit still pending|17|||
157048089|NCT00441168|566930078|FG000|Treatment Period|Death|3|||
157048090|NCT00441168|566930079|FG001|Treatment Period|Death|0|||
157048091|NCT00441168|566930078|FG000|Treatment Period|Adverse Event|1|||
157048092|NCT00441168|566930079|FG001|Treatment Period|Adverse Event|2|||
157048093|NCT00441168|566930078|FG000|Treatment Period|Progressive Disease|0|||
157048094|NCT00441168|566930079|FG001|Treatment Period|Progressive Disease|2|||
157048095|NCT00441168|566930078|FG000|Treatment Period|Protocol Violation|0|||
157048096|NCT00441168|566930079|FG001|Treatment Period|Protocol Violation|1|||
157048097|NCT00441168|566930078|FG000|Treatment Period|Lost to Follow-up|0|||
157048098|NCT00441168|566930079|FG001|Treatment Period|Lost to Follow-up|1|||
157048099|NCT00441168|566930078|FG000|Treatment Period|Withdrawal by Subject|3|||
157048100|NCT00441168|566930079|FG001|Treatment Period|Withdrawal by Subject|0|||
157048101|NCT00441168|566930078|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
157048102|NCT00441168|566930079|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
157048103|NCT00441168|566930078|FG000|Treatment Period|refractory disease|1|||
157048104|NCT00441168|566930079|FG001|Treatment Period|refractory disease|0|||
157048105|NCT00441168|566930078|FG000|Follow-up Period|Death|3|||
157048106|NCT00441168|566930079|FG001|Follow-up Period|Death|0|||
157048107|NCT00441168|566930078|FG000|Follow-up Period|Lost to Follow-up|5|||
157048108|NCT00441168|566930079|FG001|Follow-up Period|Lost to Follow-up|6|||
157048109|NCT00441168|566930078|FG000|Follow-up Period|Withdrawal by Subject|3|||
157048110|NCT00441168|566930079|FG001|Follow-up Period|Withdrawal by Subject|0|||
157048111|NCT00441168|566930078|FG000|Follow-up Period|Other|1|||
157048112|NCT00441168|566930079|FG001|Follow-up Period|Other|3|||
157048113|NCT04410445|566930081|FG000|Overall Study|Lost to Follow-up|3|||
157048114|NCT04410445|566930082|FG001|Overall Study|Lost to Follow-up|9|||
157048115|NCT04410445|566930081|FG000|Overall Study|Withdrawal by Subject|27|||
157048116|NCT04410445|566930082|FG001|Overall Study|Withdrawal by Subject|15|||
157048117|NCT03547154|566930087|FG000|Overall Study|Disease Progression/Recurrence|6|||
157048118|NCT03547154|566930088|FG001|Overall Study|Disease Progression/Recurrence|14|||
157048119|NCT03547154|566930087|FG000|Overall Study|Adverse Event|26|||
157048120|NCT03547154|566930088|FG001|Overall Study|Adverse Event|31|||
157048121|NCT03547154|566930087|FG000|Overall Study|Protocol Violation|6|||
157048122|NCT03547154|566930088|FG001|Overall Study|Protocol Violation|1|||
157048123|NCT03547154|566930087|FG000|Overall Study|Physician Decision|4|||
157048124|NCT03547154|566930088|FG001|Overall Study|Physician Decision|3|||
157048125|NCT03547154|566930087|FG000|Overall Study|Insufficient Therapeutic Response|13|||
157048126|NCT03547154|566930088|FG001|Overall Study|Insufficient Therapeutic Response|10|||
157048127|NCT03547154|566930087|FG000|Overall Study|Withdrawal by Subject|10|||
157048128|NCT03547154|566930088|FG001|Overall Study|Withdrawal by Subject|6|||
157048129|NCT03547154|566930087|FG000|Overall Study|Not Selected|0|||
157048130|NCT03547154|566930088|FG001|Overall Study|Not Selected|1|||
157175770|NCT01001234|567383790|FG000|Overall Study|Not Treated: Adverse Event|1|||
157175771|NCT01001234|567383791|FG001|Overall Study|Not Treated: Adverse Event|0|||
157175772|NCT01001234|567383792|FG002|Overall Study|Not Treated: Adverse Event|0|||
157048131|NCT03547154|566930087|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
157048132|NCT03547154|566930088|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
157048133|NCT03909100|566930090|FG000|Overall Study|Protocol Deviation|2|||
157175773|NCT01001234|567383793|FG003|Overall Study|Not Treated: Adverse Event|0|||
157048134|NCT03909100|566930090|FG000|Overall Study|Technical Problems|4|||
157048135|NCT03909100|566930090|FG000|Overall Study|Withdrawal by Subject|4|||
157048136|NCT03909100|566930090|FG000|Overall Study|Lost to Follow-up|1|||
157048137|NCT03909100|566930090|FG000|Overall Study|Reason not Specified|4|||
157048138|NCT01794299|566930091|FG000|Overall Study|ATIR manufacturing not possible|1|||
157048139|NCT01794299|566930091|FG000|Overall Study|Death|14|||
157048140|NCT01794299|566930091|FG000|Overall Study|Graft failure|1|||
157048141|NCT01794299|566930091|FG000|Overall Study|ATIR batch rejected|2|||
157048142|NCT01794299|566930091|FG000|Overall Study|Relapse|2|||
157048143|NCT01794299|566930091|FG000|Overall Study|Discontinued from active follow-up|1|||
157048144|NCT01794299|566930091|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
157048145|NCT04867382|566930092|FG000|Overall Study|Did not complete the survey|2|||
157048146|NCT04867382|566930093|FG001|Overall Study|Did not complete the survey|1|||
157048147|NCT03803475|566930094|FG000|Overall Study|Physician Decision|1|||
157048148|NCT00266656|566930095|FG000|Overall Study|Death|1|||
157048149|NCT00266656|566930096|FG001|Overall Study|Death|0|||
157048150|NCT00266656|566930095|FG000|Overall Study|Lost to Follow-up|4|||
157048151|NCT00266656|566930096|FG001|Overall Study|Lost to Follow-up|1|||
157048152|NCT00266656|566930095|FG000|Overall Study|Withdrawal by Subject|4|||
157048153|NCT00266656|566930096|FG001|Overall Study|Withdrawal by Subject|2|||
157048154|NCT00266656|566930095|FG000|Overall Study|Did Not Reach Final Height|4|||
157048155|NCT00266656|566930096|FG001|Overall Study|Did Not Reach Final Height|8|||
157048156|NCT00266656|566930095|FG000|Overall Study|Parent/Caregiver Decision|1|||
157048157|NCT00266656|566930096|FG001|Overall Study|Parent/Caregiver Decision|2|||
157048158|NCT00428714|566930099|FG000|Overall Study|Progressive Disease|28|||
157048159|NCT00428714|566930100|FG001|Overall Study|Progressive Disease|36|||
157048160|NCT00428714|566930099|FG000|Overall Study|Withdrawal by Subject|0|||
157048161|NCT00428714|566930100|FG001|Overall Study|Withdrawal by Subject|3|||
157048162|NCT00428714|566930099|FG000|Overall Study|Adverse Event|0|||
157048163|NCT00428714|566930100|FG001|Overall Study|Adverse Event|2|||
157048164|NCT00428714|566930099|FG000|Overall Study|Physician Decision|1|||
157048165|NCT00428714|566930100|FG001|Overall Study|Physician Decision|1|||
157175774|NCT01001234|567383794|FG004|Overall Study|Not Treated: Adverse Event|0|||
157175775|NCT01001234|567383790|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
157175776|NCT01001234|567383791|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
157175777|NCT01001234|567383792|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
157175778|NCT01001234|567383793|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
157175779|NCT01001234|567383794|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
157175780|NCT01001234|567383790|FG000|Overall Study|Not Treated: Protocol Violation|3|||
156970417|NCT02287584|566644240|FG004|the Double-blind Phase|Lost to Follow-up|0|||
156970418|NCT02287584|566644241|FG005|the Double-blind Phase|Lost to Follow-up|0|||
156970419|NCT02287584|566644236|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
156970420|NCT02287584|566644237|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
156970421|NCT02287584|566644238|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
156970422|NCT02287584|566644239|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
156970423|NCT02287584|566644240|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
156970424|NCT02287584|566644241|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
156970425|NCT02287584|566644236|FG000|the Double-blind Phase|Pregnancy|0|||
156970426|NCT02287584|566644237|FG001|the Double-blind Phase|Pregnancy|1|||
156970427|NCT02287584|566644238|FG002|the Double-blind Phase|Pregnancy|0|||
156970428|NCT02287584|566644239|FG003|the Double-blind Phase|Pregnancy|0|||
156970429|NCT02287584|566644240|FG004|the Double-blind Phase|Pregnancy|0|||
156970430|NCT02287584|566644241|FG005|the Double-blind Phase|Pregnancy|0|||
156970431|NCT02287584|566644236|FG000|the Double-blind Phase|Protocol Violation|0|||
156970432|NCT02287584|566644237|FG001|the Double-blind Phase|Protocol Violation|3|||
156970433|NCT02287584|566644238|FG002|the Double-blind Phase|Protocol Violation|0|||
156970434|NCT02287584|566644239|FG003|the Double-blind Phase|Protocol Violation|0|||
156970435|NCT02287584|566644240|FG004|the Double-blind Phase|Protocol Violation|0|||
156970436|NCT02287584|566644241|FG005|the Double-blind Phase|Protocol Violation|0|||
156970437|NCT02287584|566644236|FG000|the Double-blind Phase|other reasons|0|||
156970438|NCT02287584|566644237|FG001|the Double-blind Phase|other reasons|0|||
156970439|NCT02287584|566644238|FG002|the Double-blind Phase|other reasons|1|||
156970440|NCT02287584|566644239|FG003|the Double-blind Phase|other reasons|0|||
156970441|NCT02287584|566644240|FG004|the Double-blind Phase|other reasons|0|||
156970442|NCT02287584|566644241|FG005|the Double-blind Phase|other reasons|0|||
156970443|NCT02287584|566644236|FG000|the Open-label Phase|Did not receive drug|0|||
156970444|NCT02287584|566644237|FG001|the Open-label Phase|Did not receive drug|0|||
156970445|NCT02287584|566644238|FG002|the Open-label Phase|Did not receive drug|0|||
156970446|NCT02287584|566644239|FG003|the Open-label Phase|Did not receive drug|7|||
156970447|NCT02287584|566644240|FG004|the Open-label Phase|Did not receive drug|6|||
156970448|NCT02287584|566644241|FG005|the Open-label Phase|Did not receive drug|4|||
156970449|NCT02287584|566644236|FG000|the Open-label Phase|Adverse Event|0|||
156970450|NCT02287584|566644237|FG001|the Open-label Phase|Adverse Event|0|||
157048166|NCT00428714|566930099|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
156970451|NCT02287584|566644238|FG002|the Open-label Phase|Adverse Event|0|||
157048167|NCT00428714|566930100|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
157175781|NCT01001234|567383791|FG001|Overall Study|Not Treated: Protocol Violation|0|||
157175782|NCT01001234|567383792|FG002|Overall Study|Not Treated: Protocol Violation|0|||
157175783|NCT01001234|567383793|FG003|Overall Study|Not Treated: Protocol Violation|0|||
156970452|NCT02287584|566644239|FG003|the Open-label Phase|Adverse Event|15|||
156970453|NCT02287584|566644240|FG004|the Open-label Phase|Adverse Event|12|||
156970454|NCT02287584|566644241|FG005|the Open-label Phase|Adverse Event|16|||
156970455|NCT02287584|566644236|FG000|the Open-label Phase|Lack of Efficacy|0|||
156970456|NCT02287584|566644237|FG001|the Open-label Phase|Lack of Efficacy|0|||
156970457|NCT02287584|566644238|FG002|the Open-label Phase|Lack of Efficacy|0|||
156970458|NCT02287584|566644239|FG003|the Open-label Phase|Lack of Efficacy|8|||
156970459|NCT02287584|566644240|FG004|the Open-label Phase|Lack of Efficacy|3|||
156970460|NCT02287584|566644241|FG005|the Open-label Phase|Lack of Efficacy|7|||
156970461|NCT02287584|566644236|FG000|the Open-label Phase|Lost to Follow-up|0|||
156970462|NCT02287584|566644237|FG001|the Open-label Phase|Lost to Follow-up|0|||
156970463|NCT02287584|566644238|FG002|the Open-label Phase|Lost to Follow-up|0|||
156970464|NCT02287584|566644239|FG003|the Open-label Phase|Lost to Follow-up|4|||
156970465|NCT02287584|566644240|FG004|the Open-label Phase|Lost to Follow-up|1|||
156970466|NCT02287584|566644241|FG005|the Open-label Phase|Lost to Follow-up|2|||
156970467|NCT02287584|566644236|FG000|the Open-label Phase|Withdrawal by Subject|0|||
156970468|NCT02287584|566644237|FG001|the Open-label Phase|Withdrawal by Subject|0|||
156970469|NCT02287584|566644238|FG002|the Open-label Phase|Withdrawal by Subject|0|||
156970470|NCT02287584|566644239|FG003|the Open-label Phase|Withdrawal by Subject|18|||
156970471|NCT02287584|566644240|FG004|the Open-label Phase|Withdrawal by Subject|29|||
156970472|NCT02287584|566644241|FG005|the Open-label Phase|Withdrawal by Subject|21|||
156970473|NCT02287584|566644236|FG000|the Open-label Phase|non-compliance|0|||
156970474|NCT02287584|566644237|FG001|the Open-label Phase|non-compliance|0|||
156970475|NCT02287584|566644238|FG002|the Open-label Phase|non-compliance|0|||
156970476|NCT02287584|566644239|FG003|the Open-label Phase|non-compliance|2|||
156970477|NCT02287584|566644240|FG004|the Open-label Phase|non-compliance|5|||
156970478|NCT02287584|566644241|FG005|the Open-label Phase|non-compliance|1|||
156970479|NCT02287584|566644236|FG000|the Open-label Phase|other reasons|0|||
156970480|NCT02287584|566644237|FG001|the Open-label Phase|other reasons|0|||
156970481|NCT02287584|566644238|FG002|the Open-label Phase|other reasons|0|||
156970482|NCT02287584|566644239|FG003|the Open-label Phase|other reasons|3|||
156970483|NCT02287584|566644240|FG004|the Open-label Phase|other reasons|6|||
156970484|NCT02287584|566644241|FG005|the Open-label Phase|other reasons|6|||
156970485|NCT00106184|566644244|FG000|Overall Study|Withdrawal by Subject|3|||
156970486|NCT00106184|566644245|FG001|Overall Study|Withdrawal by Subject|2|||
156970487|NCT00792103|566644247|FG000|Overall Study|Enrolled, not treated|15|||
156970488|NCT00792103|566644247|FG000|Overall Study|Lost to Follow-up|17|||
156970489|NCT00792103|566644247|FG000|Overall Study|Adverse Event|25|||
156970490|NCT00792103|566644247|FG000|Overall Study|Withdrawal by Subject|52|||
156970491|NCT00792103|566644247|FG000|Overall Study|Protocol Violation|10|||
156970492|NCT00792103|566644247|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
156970493|NCT00758459|566644248|FG000|Overall Study|Adverse Event|3|||
156970494|NCT00758459|566644249|FG001|Overall Study|Adverse Event|2|||
156970495|NCT00758459|566644248|FG000|Overall Study|Protocol Violation|0|||
156970496|NCT00758459|566644249|FG001|Overall Study|Protocol Violation|1|||
156970497|NCT00758459|566644248|FG000|Overall Study|Withdrawal by Subject|0|||
156970498|NCT00758459|566644249|FG001|Overall Study|Withdrawal by Subject|1|||
156970499|NCT00855595|566644250|FG000|Overall Study|Withdrawal by Subject|1|||
156970500|NCT00855595|566644251|FG001|Overall Study|Withdrawal by Subject|2|||
156970501|NCT00855595|566644250|FG000|Overall Study|Lost to Follow-up|3|||
156970502|NCT00855595|566644251|FG001|Overall Study|Lost to Follow-up|3|||
156970503|NCT00855595|566644250|FG000|Overall Study|Adverse Event|1|||
156970504|NCT00855595|566644251|FG001|Overall Study|Adverse Event|1|||
156970505|NCT00855595|566644250|FG000|Overall Study|patient moved out of state|1|||
156970506|NCT00855595|566644251|FG001|Overall Study|patient moved out of state|0|||
156970507|NCT00855595|566644250|FG000|Overall Study|patient left country|0|||
156970508|NCT00855595|566644251|FG001|Overall Study|patient left country|1|||
156970509|NCT00611858|566644252|FG000|Overall Study|Adverse Event|2|||
156970510|NCT00611858|566644252|FG000|Overall Study|Withdrawal by Subject|2|||
156970511|NCT01844284|566644253|FG000|Overall Study|Lost to Follow-up|12|||
156970512|NCT01844284|566644254|FG001|Overall Study|Lost to Follow-up|7|||
157048168|NCT00428714|566930099|FG000|Overall Study|Death due to other then PD|1|||
157048169|NCT00428714|566930100|FG001|Overall Study|Death due to other then PD|0|||
156970513|NCT01820559|566644255|FG000|Overall Study|Adverse Event|4|||
156970514|NCT01820559|566644256|FG001|Overall Study|Adverse Event|6|||
156970515|NCT01820559|566644257|FG002|Overall Study|Adverse Event|13|||
156970516|NCT01820559|566644255|FG000|Overall Study|Withdrawal by Subject|1|||
156970517|NCT01820559|566644256|FG001|Overall Study|Withdrawal by Subject|2|||
156970518|NCT01820559|566644257|FG002|Overall Study|Withdrawal by Subject|5|||
156970519|NCT01820559|566644255|FG000|Overall Study|Protocol Violation|2|||
157048170|NCT02807857|566930103|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
157048171|NCT02807857|566930103|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
157175784|NCT01001234|567383794|FG004|Overall Study|Not Treated: Protocol Violation|0|||
157048172|NCT02807857|566930103|FG000|Follow-Up Set|Withdrawal by Subject|8|||
157048173|NCT02807857|566930103|FG000|Follow-Up Set|Lost to Follow-up|7|||
157048174|NCT02807857|566930103|FG000|Follow-Up Set|Physician Decision|6|||
157048175|NCT02807857|566930103|FG000|Follow-Up Set|Adverse Event|3|||
157048176|NCT02807857|566930103|FG000|Follow-Up Set|Death|27|||
157048177|NCT02807857|566930103|FG000|Follow-Up Set|Relocation|2|||
157048178|NCT00513071|566930105|FG000|Overall Study|Adverse Event|1|||
157048179|NCT00513071|566930105|FG000|Overall Study|Withdrawal by Subject|1|||
157048180|NCT00513071|566930105|FG000|Overall Study|Physician Decision|3|||
157048181|NCT00667732|566930107|FG000|Run -In (8 Weeks)|Adverse Event|4|||
157048182|NCT00667732|566930108|FG001|Run -In (8 Weeks)|Adverse Event|0|||
157048183|NCT00667732|566930109|FG002|Run -In (8 Weeks)|Adverse Event|0|||
157048184|NCT00667732|566930107|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
157048185|NCT00667732|566930108|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
157048186|NCT00667732|566930109|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
157175785|NCT01001234|567383790|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
157175786|NCT01001234|567383791|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
157175787|NCT01001234|567383792|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
157175788|NCT01001234|567383793|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
157175789|NCT01001234|567383794|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
157175790|NCT01001234|567383790|FG000|Overall Study|Not Treated: Pregnancy|3|||
157175791|NCT01001234|567383791|FG001|Overall Study|Not Treated: Pregnancy|0|||
157175792|NCT01001234|567383792|FG002|Overall Study|Not Treated: Pregnancy|0|||
157175793|NCT01001234|567383793|FG003|Overall Study|Not Treated: Pregnancy|0|||
157175794|NCT01001234|567383794|FG004|Overall Study|Not Treated: Pregnancy|0|||
157175795|NCT01001234|567383790|FG000|Overall Study|Not Treated: Physician Decision|37|||
157175796|NCT01001234|567383791|FG001|Overall Study|Not Treated: Physician Decision|4|||
157175797|NCT01001234|567383792|FG002|Overall Study|Not Treated: Physician Decision|0|||
157175798|NCT01001234|567383793|FG003|Overall Study|Not Treated: Physician Decision|0|||
157175799|NCT01001234|567383794|FG004|Overall Study|Not Treated: Physician Decision|0|||
157175800|NCT01001234|567383790|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
157175801|NCT01001234|567383791|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
157175802|NCT01001234|567383792|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
157175803|NCT01001234|567383793|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
157175804|NCT01001234|567383794|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
157175805|NCT01851863|567383796|FG000|Overall Study|Did not receive study medication|2|||
157175806|NCT01851863|567383797|FG001|Overall Study|Did not receive study medication|5|||
157175807|NCT01851863|567383798|FG002|Overall Study|Did not receive study medication|3|||
157175808|NCT01851863|567383799|FG003|Overall Study|Did not receive study medication|0|||
157175809|NCT01851863|567383796|FG000|Overall Study|Lost to Follow-up|3|||
157175810|NCT01851863|567383797|FG001|Overall Study|Lost to Follow-up|4|||
157175811|NCT01851863|567383798|FG002|Overall Study|Lost to Follow-up|2|||
157175812|NCT01851863|567383799|FG003|Overall Study|Lost to Follow-up|3|||
157175813|NCT00753623|567383800|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
157175814|NCT00753623|567383801|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
157175815|NCT00753623|567383800|FG000|Phase I (14 Days)|Physician Decision|1|||
157175816|NCT00753623|567383801|FG001|Phase I (14 Days)|Physician Decision|2|||
157175817|NCT00753623|567383800|FG000|Phase I (14 Days)|Adverse Event|0|||
157175818|NCT00753623|567383801|FG001|Phase I (14 Days)|Adverse Event|1|||
157175819|NCT00753623|567383800|FG000|Washout (7 Days)|Physician Decision|1|||
157175820|NCT00753623|567383801|FG001|Washout (7 Days)|Physician Decision|0|||
157175821|NCT00753623|567383800|FG000|Phase II (14 Days)|Physician Decision|0|||
157175822|NCT00753623|567383801|FG001|Phase II (14 Days)|Physician Decision|1|||
157175823|NCT03332303|567383802|FG000|Overall Study|Participant did not dose|1|||
157175824|NCT03332303|567383803|FG001|Overall Study|Participant did not dose|2|||
157175825|NCT03332303|567383804|FG002|Overall Study|Participant did not dose|0|||
157175826|NCT03332303|567383802|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
157048187|NCT00667732|566930107|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
157048188|NCT00667732|566930108|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
157048189|NCT00667732|566930109|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
157048190|NCT02106325|566930112|FG000|Phase 1|Lost to Follow-up|2|||
157048191|NCT02106325|566930113|FG001|Phase 1|Lost to Follow-up|2|||
157048192|NCT02106325|566930112|FG000|Phase 2|Lost to Follow-up|2|||
157048193|NCT02106325|566930113|FG001|Phase 2|Lost to Follow-up|3|||
157048194|NCT02106325|566930112|FG000|Phase 3|Lost to Follow-up|2|||
157048195|NCT02106325|566930113|FG001|Phase 3|Lost to Follow-up|1|||
157048196|NCT00452114|566930114|FG000|Overall Study|Physician Decision|3|||
157048197|NCT00452114|566930115|FG001|Overall Study|Physician Decision|3|||
157175827|NCT03332303|567383803|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
157175828|NCT03332303|567383804|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
157175829|NCT03332303|567383802|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
157175830|NCT03332303|567383803|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
157175831|NCT03332303|567383804|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
157048198|NCT04197713|566930117|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
157048199|NCT04197713|566930118|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
157048200|NCT03242863|566930119|FG000|Study Week 1|Withdrawal by Subject|0|||
157048201|NCT03242863|566930120|FG001|Study Week 1|Withdrawal by Subject|1|||
157048202|NCT03242863|566930121|FG002|Study Week 1|Withdrawal by Subject|0|||
157048203|NCT03242863|566930122|FG003|Study Week 1|Withdrawal by Subject|0|||
157048204|NCT03242863|566930123|FG004|Study Week 1|Withdrawal by Subject|3|||
157048205|NCT03242863|566930124|FG005|Study Week 1|Withdrawal by Subject|0|||
157048206|NCT05338476|566930137|FG000|Period 2|Adverse Event|0|||
157048207|NCT05338476|566930138|FG001|Period 2|Adverse Event|1|||
157048208|NCT03786471|566930141|FG000|Overall Study|Death|254|||
157048209|NCT03786471|566930142|FG001|Overall Study|Death|223|||
157048210|NCT03786471|566930143|FG002|Overall Study|Death|37|||
157048211|NCT03786471|566930141|FG000|Overall Study|Lost to Follow-up|63|||
157048212|NCT03786471|566930142|FG001|Overall Study|Lost to Follow-up|50|||
157048213|NCT03786471|566930143|FG002|Overall Study|Lost to Follow-up|15|||
157048214|NCT03786471|566930141|FG000|Overall Study|Withdrawal by Subject|99|||
157048215|NCT03786471|566930142|FG001|Overall Study|Withdrawal by Subject|81|||
157048216|NCT03786471|566930143|FG002|Overall Study|Withdrawal by Subject|11|||
157048217|NCT00443820|566931643|FG000|Overall Study|Adverse Event|1|||
157048218|NCT00443820|566931644|FG001|Overall Study|Adverse Event|1|||
157048219|NCT00443820|566931645|FG002|Overall Study|Adverse Event|0|||
157048220|NCT00443820|566931646|FG003|Overall Study|Adverse Event|0|||
157048221|NCT00443820|566931643|FG000|Overall Study|Lack of Efficacy|3|||
157048222|NCT00443820|566931644|FG001|Overall Study|Lack of Efficacy|2|||
157048223|NCT00443820|566931645|FG002|Overall Study|Lack of Efficacy|1|||
157048224|NCT00443820|566931646|FG003|Overall Study|Lack of Efficacy|1|||
157048225|NCT00443820|566931643|FG000|Overall Study|Protocol Violation|2|||
157048226|NCT00443820|566931644|FG001|Overall Study|Protocol Violation|1|||
157048227|NCT00443820|566931645|FG002|Overall Study|Protocol Violation|2|||
157048228|NCT00443820|566931646|FG003|Overall Study|Protocol Violation|1|||
157048229|NCT00443820|566931643|FG000|Overall Study|Withdrawal by Subject|6|||
157048230|NCT00443820|566931644|FG001|Overall Study|Withdrawal by Subject|7|||
157048231|NCT00443820|566931645|FG002|Overall Study|Withdrawal by Subject|8|||
157048232|NCT00443820|566931646|FG003|Overall Study|Withdrawal by Subject|9|||
157048233|NCT00443820|566931643|FG000|Overall Study|Lost to Follow-up|9|||
157048234|NCT00443820|566931644|FG001|Overall Study|Lost to Follow-up|8|||
157048235|NCT00443820|566931645|FG002|Overall Study|Lost to Follow-up|6|||
157048236|NCT00443820|566931646|FG003|Overall Study|Lost to Follow-up|5|||
157048237|NCT00443820|566931643|FG000|Overall Study|Administrative problems|0|||
157048238|NCT00443820|566931644|FG001|Overall Study|Administrative problems|0|||
157048239|NCT00443820|566931645|FG002|Overall Study|Administrative problems|0|||
157048240|NCT00443820|566931646|FG003|Overall Study|Administrative problems|1|||
157048241|NCT00443820|566931643|FG000|Overall Study|Death|0|||
157048242|NCT00443820|566931644|FG001|Overall Study|Death|0|||
157048243|NCT00443820|566931645|FG002|Overall Study|Death|1|||
157048244|NCT00443820|566931646|FG003|Overall Study|Death|0|||
157048245|NCT02507297|566931647|FG000|Overall Study|Withdrawal by Subject|1|||
157048246|NCT02507297|566931648|FG001|Overall Study|Withdrawal by Subject|0|||
157048247|NCT02507297|566931647|FG000|Overall Study|Lost to Follow-up|0|||
157048248|NCT02507297|566931648|FG001|Overall Study|Lost to Follow-up|1|||
157048249|NCT02489799|566931649|FG000|Overall Study|Lost to Follow-up|4|||
157048250|NCT02489799|566931650|FG001|Overall Study|Lost to Follow-up|1|||
157048251|NCT02489799|566931649|FG000|Overall Study|Failure to Maintain Eligibility|4|||
157048252|NCT02489799|566931650|FG001|Overall Study|Failure to Maintain Eligibility|6|||
157048253|NCT02489799|566931649|FG000|Overall Study|Withdrawal by Subject|1|||
157048254|NCT02489799|566931650|FG001|Overall Study|Withdrawal by Subject|1|||
157048255|NCT02489799|566931649|FG000|Overall Study|Death|0|||
157048256|NCT02489799|566931650|FG001|Overall Study|Death|1|||
157048257|NCT01241448|566931651|FG000|Overall Study|Adverse Event|1|||
157048258|NCT01241448|566931652|FG001|Overall Study|Adverse Event|0|||
157048259|NCT01241448|566931653|FG002|Overall Study|Adverse Event|2|||
157048260|NCT01241448|566931654|FG003|Overall Study|Adverse Event|2|||
157048261|NCT01241448|566931651|FG000|Overall Study|Lost to Follow-up|2|||
157048262|NCT01241448|566931652|FG001|Overall Study|Lost to Follow-up|1|||
157048263|NCT01241448|566931653|FG002|Overall Study|Lost to Follow-up|1|||
157048264|NCT01241448|566931654|FG003|Overall Study|Lost to Follow-up|1|||
157048265|NCT01241448|566931651|FG000|Overall Study|Physician Decision|0|||
157048266|NCT01241448|566931652|FG001|Overall Study|Physician Decision|2|||
157048267|NCT01241448|566931653|FG002|Overall Study|Physician Decision|0|||
157048268|NCT01241448|566931654|FG003|Overall Study|Physician Decision|0|||
157048269|NCT01241448|566931651|FG000|Overall Study|Protocol Violation|10|||
157048270|NCT01241448|566931652|FG001|Overall Study|Protocol Violation|5|||
157048271|NCT01241448|566931653|FG002|Overall Study|Protocol Violation|3|||
157048272|NCT01241448|566931654|FG003|Overall Study|Protocol Violation|6|||
157048273|NCT01241448|566931651|FG000|Overall Study|Sponsor Decision|17|||
157048274|NCT01241448|566931652|FG001|Overall Study|Sponsor Decision|14|||
157048275|NCT01241448|566931653|FG002|Overall Study|Sponsor Decision|12|||
157048276|NCT01241448|566931654|FG003|Overall Study|Sponsor Decision|6|||
157048277|NCT01241448|566931651|FG000|Overall Study|Withdrawal by Subject|4|||
157048278|NCT01241448|566931652|FG001|Overall Study|Withdrawal by Subject|5|||
157048279|NCT01241448|566931653|FG002|Overall Study|Withdrawal by Subject|3|||
157048280|NCT01241448|566931654|FG003|Overall Study|Withdrawal by Subject|6|||
157048281|NCT01241448|566931651|FG000|Overall Study|Excluded due to data integrity issues|3|||
157048282|NCT01241448|566931652|FG001|Overall Study|Excluded due to data integrity issues|2|||
157048283|NCT01241448|566931653|FG002|Overall Study|Excluded due to data integrity issues|2|||
157048284|NCT01241448|566931654|FG003|Overall Study|Excluded due to data integrity issues|2|||
157048285|NCT04803734|566931664|FG000|Overall Study|Withdrawal by Subject|0|||
157048286|NCT04803734|566931665|FG001|Overall Study|Withdrawal by Subject|1|||
157048287|NCT04803734|566931664|FG000|Overall Study|Protocol Violation|0|||
157048288|NCT04803734|566931665|FG001|Overall Study|Protocol Violation|1|||
157048289|NCT02152384|566931673|FG000|Period 1|Withdrawal by Subject|0|||
157048290|NCT02152384|566931674|FG001|Period 1|Withdrawal by Subject|1|||
157048291|NCT02152384|566931673|FG000|Period 1|Adverse Event|1|||
157048292|NCT02152384|566931674|FG001|Period 1|Adverse Event|1|||
157048293|NCT01215253|566931675|FG000|Overall Study|Withdrawal by Subject|57|||
157048294|NCT01215253|566931676|FG001|Overall Study|Withdrawal by Subject|35|||
157048295|NCT01215253|566931675|FG000|Overall Study|Physician Decision|9|||
157048296|NCT01215253|566931676|FG001|Overall Study|Physician Decision|12|||
157048297|NCT01215253|566931675|FG000|Overall Study|Lost to Follow-up|6|||
157048298|NCT01215253|566931676|FG001|Overall Study|Lost to Follow-up|4|||
157048299|NCT01215253|566931675|FG000|Overall Study|Other|14|||
157048300|NCT01215253|566931676|FG001|Overall Study|Other|12|||
157048301|NCT01320683|566931680|FG000|Overall Study|Positive antibody response|1|||
157048302|NCT02291861|566931681|FG000|Overall Study|Adverse Event|2|||
157048303|NCT02291861|566931682|FG001|Overall Study|Adverse Event|4|||
157048304|NCT02291861|566931683|FG002|Overall Study|Adverse Event|1|||
157048305|NCT02291861|566931684|FG003|Overall Study|Adverse Event|2|||
157048306|NCT02291861|566931681|FG000|Overall Study|Death|0|||
157048307|NCT02291861|566931682|FG001|Overall Study|Death|0|||
157048308|NCT02291861|566931683|FG002|Overall Study|Death|1|||
157048309|NCT02291861|566931684|FG003|Overall Study|Death|1|||
157048310|NCT02291861|566931681|FG000|Overall Study|Protocol Violation|1|||
157048311|NCT02291861|566931682|FG001|Overall Study|Protocol Violation|0|||
157048312|NCT02291861|566931683|FG002|Overall Study|Protocol Violation|0|||
157048313|NCT02291861|566931684|FG003|Overall Study|Protocol Violation|1|||
157048314|NCT02291861|566931681|FG000|Overall Study|Withdrawal by Subject|1|||
157048315|NCT02291861|566931682|FG001|Overall Study|Withdrawal by Subject|2|||
157048316|NCT02291861|566931683|FG002|Overall Study|Withdrawal by Subject|1|||
157048317|NCT02291861|566931684|FG003|Overall Study|Withdrawal by Subject|4|||
157048318|NCT02291861|566931681|FG000|Overall Study|Noncompliance|1|||
156970520|NCT01820559|566644256|FG001|Overall Study|Protocol Violation|1|||
156970521|NCT01820559|566644257|FG002|Overall Study|Protocol Violation|3|||
156970522|NCT01820559|566644255|FG000|Overall Study|Subject's non-compliance|1|||
156970523|NCT01820559|566644256|FG001|Overall Study|Subject's non-compliance|0|||
156970524|NCT01820559|566644257|FG002|Overall Study|Subject's non-compliance|2|||
156970525|NCT01820559|566644255|FG000|Overall Study|Lost to Follow-up|3|||
156970526|NCT01820559|566644256|FG001|Overall Study|Lost to Follow-up|2|||
156970527|NCT01820559|566644257|FG002|Overall Study|Lost to Follow-up|2|||
156970528|NCT01820559|566644255|FG000|Overall Study|At sponsor request|0|||
156970529|NCT01820559|566644256|FG001|Overall Study|At sponsor request|0|||
156970530|NCT01820559|566644257|FG002|Overall Study|At sponsor request|1|||
156970531|NCT01820559|566644255|FG000|Overall Study|Lack of Efficacy|3|||
156970532|NCT01820559|566644256|FG001|Overall Study|Lack of Efficacy|2|||
156970533|NCT01820559|566644257|FG002|Overall Study|Lack of Efficacy|3|||
156970534|NCT02755597|566644258|FG000|Overall Study|Withdrew consent|27|||
156970535|NCT02755597|566644259|FG001|Overall Study|Withdrew consent|11|||
156970536|NCT02755597|566644258|FG000|Overall Study|Lost to Follow-up|1|||
156970537|NCT02755597|566644259|FG001|Overall Study|Lost to Follow-up|0|||
156970538|NCT02755597|566644258|FG000|Overall Study|Death|78|||
156970539|NCT02755597|566644259|FG001|Overall Study|Death|36|||
156970540|NCT02755597|566644258|FG000|Overall Study|Study terminated by Sponsor|67|||
156970541|NCT02755597|566644259|FG001|Overall Study|Study terminated by Sponsor|47|||
156970542|NCT02755597|566644258|FG000|Overall Study|Other, not specified|20|||
156970543|NCT02755597|566644259|FG001|Overall Study|Other, not specified|3|||
156970544|NCT02755597|566644258|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
156970545|NCT02755597|566644259|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
156970546|NCT00166296|566644260|FG000|Overall Study|Withdrawal by Subject|1|||
156970547|NCT00166296|566644261|FG001|Overall Study|Withdrawal by Subject|3|||
157048319|NCT02291861|566931682|FG001|Overall Study|Noncompliance|1|||
156970548|NCT00166296|566644260|FG000|Overall Study|Adverse Event|2|||
156970549|NCT00166296|566644261|FG001|Overall Study|Adverse Event|4|||
157048320|NCT02291861|566931683|FG002|Overall Study|Noncompliance|2|||
157048321|NCT02291861|566931684|FG003|Overall Study|Noncompliance|1|||
157048322|NCT02291861|566931681|FG000|Overall Study|Lost to Follow-up|2|||
157048323|NCT02291861|566931682|FG001|Overall Study|Lost to Follow-up|1|||
157048324|NCT02291861|566931683|FG002|Overall Study|Lost to Follow-up|4|||
157229171|NCT00048048|567585165|FG008|Core Treatment|Withdrawal by Subject|0|||
157229172|NCT00048048|567585166|FG009|Core Treatment|Withdrawal by Subject|0|||
156970550|NCT00166296|566644260|FG000|Overall Study|Lost to Follow-up|4|||
156970551|NCT00166296|566644261|FG001|Overall Study|Lost to Follow-up|2|||
156970552|NCT03351738|566644262|FG000|Overall Study|Withdrawal by Subject|0|||
156970553|NCT03351738|566644263|FG001|Overall Study|Withdrawal by Subject|1|||
156970554|NCT03351738|566644264|FG002|Overall Study|Withdrawal by Subject|0|||
156970555|NCT03351738|566644265|FG003|Overall Study|Withdrawal by Subject|1|||
156970556|NCT03351738|566644266|FG004|Overall Study|Withdrawal by Subject|0|||
156970557|NCT03351738|566644267|FG005|Overall Study|Withdrawal by Subject|0|||
156970558|NCT02597036|566644270|FG000|Overall Study|Progressive Disease|0|||
156970559|NCT02597036|566644271|FG001|Overall Study|Progressive Disease|0|||
156970560|NCT02597036|566644272|FG002|Overall Study|Progressive Disease|0|||
156970561|NCT02597036|566644273|FG003|Overall Study|Progressive Disease|0|||
156970562|NCT02597036|566644274|FG004|Overall Study|Progressive Disease|1|||
156970563|NCT02597036|566644275|FG005|Overall Study|Progressive Disease|1|||
156970564|NCT02597036|566644276|FG006|Overall Study|Progressive Disease|1|||
156970565|NCT02597036|566644277|FG007|Overall Study|Progressive Disease|0|||
156970566|NCT02597036|566644278|FG008|Overall Study|Progressive Disease|0|||
156970567|NCT02597036|566644279|FG009|Overall Study|Progressive Disease|0|||
156970568|NCT02597036|566644280|FG010|Overall Study|Progressive Disease|0|||
156970569|NCT02597036|566644281|FG011|Overall Study|Progressive Disease|0|||
156970570|NCT02597036|566644270|FG000|Overall Study|Adverse Event|0|||
156970571|NCT02597036|566644271|FG001|Overall Study|Adverse Event|0|||
156970572|NCT02597036|566644272|FG002|Overall Study|Adverse Event|0|||
156970573|NCT02597036|566644273|FG003|Overall Study|Adverse Event|0|||
156970574|NCT02597036|566644274|FG004|Overall Study|Adverse Event|0|||
156970575|NCT02597036|566644275|FG005|Overall Study|Adverse Event|0|||
156970576|NCT02597036|566644276|FG006|Overall Study|Adverse Event|0|||
156970577|NCT02597036|566644277|FG007|Overall Study|Adverse Event|1|||
156970578|NCT02597036|566644278|FG008|Overall Study|Adverse Event|0|||
156970579|NCT02597036|566644279|FG009|Overall Study|Adverse Event|0|||
156970580|NCT02597036|566644280|FG010|Overall Study|Adverse Event|0|||
156970581|NCT02597036|566644281|FG011|Overall Study|Adverse Event|1|||
156970582|NCT02597036|566644270|FG000|Overall Study|Death|0|||
156970583|NCT02597036|566644271|FG001|Overall Study|Death|0|||
156970584|NCT02597036|566644272|FG002|Overall Study|Death|0|||
156970585|NCT02597036|566644273|FG003|Overall Study|Death|0|||
156970586|NCT02597036|566644274|FG004|Overall Study|Death|0|||
156970587|NCT02597036|566644275|FG005|Overall Study|Death|0|||
156970588|NCT02597036|566644276|FG006|Overall Study|Death|0|||
156970589|NCT02597036|566644277|FG007|Overall Study|Death|0|||
156970590|NCT02597036|566644278|FG008|Overall Study|Death|0|||
156970591|NCT02597036|566644279|FG009|Overall Study|Death|1|||
156970592|NCT02597036|566644280|FG010|Overall Study|Death|1|||
156970593|NCT02597036|566644281|FG011|Overall Study|Death|0|||
156970594|NCT02597036|566644270|FG000|Overall Study|Lost to Follow-up|0|||
156970595|NCT02597036|566644271|FG001|Overall Study|Lost to Follow-up|0|||
156970596|NCT02597036|566644272|FG002|Overall Study|Lost to Follow-up|0|||
156970597|NCT02597036|566644273|FG003|Overall Study|Lost to Follow-up|0|||
156970598|NCT02597036|566644274|FG004|Overall Study|Lost to Follow-up|0|||
156970599|NCT02597036|566644275|FG005|Overall Study|Lost to Follow-up|0|||
156970600|NCT02597036|566644276|FG006|Overall Study|Lost to Follow-up|0|||
156970601|NCT02597036|566644277|FG007|Overall Study|Lost to Follow-up|0|||
156970602|NCT02597036|566644278|FG008|Overall Study|Lost to Follow-up|0|||
156970603|NCT02597036|566644279|FG009|Overall Study|Lost to Follow-up|0|||
156970604|NCT02597036|566644280|FG010|Overall Study|Lost to Follow-up|1|||
156970605|NCT02597036|566644281|FG011|Overall Study|Lost to Follow-up|0|||
156970606|NCT02597036|566644270|FG000|Overall Study|Withdrawal by Subject|0|||
156970607|NCT02597036|566644271|FG001|Overall Study|Withdrawal by Subject|0|||
156970608|NCT02597036|566644272|FG002|Overall Study|Withdrawal by Subject|0|||
156970609|NCT02597036|566644273|FG003|Overall Study|Withdrawal by Subject|0|||
156970610|NCT02597036|566644274|FG004|Overall Study|Withdrawal by Subject|0|||
156970611|NCT02597036|566644275|FG005|Overall Study|Withdrawal by Subject|0|||
156970612|NCT02597036|566644276|FG006|Overall Study|Withdrawal by Subject|0|||
156970613|NCT02597036|566644277|FG007|Overall Study|Withdrawal by Subject|0|||
156970614|NCT02597036|566644278|FG008|Overall Study|Withdrawal by Subject|0|||
156970615|NCT02597036|566644279|FG009|Overall Study|Withdrawal by Subject|0|||
156970616|NCT02597036|566644280|FG010|Overall Study|Withdrawal by Subject|0|||
156970617|NCT02597036|566644281|FG011|Overall Study|Withdrawal by Subject|1|||
157229173|NCT00048048|567585167|FG010|Core Treatment|Withdrawal by Subject|0|||
156970618|NCT06351371|566644282|FG000|Overall Study|Mutation Status Not Confirmed|9|||
156970619|NCT06351371|566644282|FG000|Overall Study|Ineligible|1|||
156970620|NCT06351371|566644282|FG000|Overall Study|Adverse Event|4|||
156970621|NCT06351371|566644282|FG000|Overall Study|Death|1|||
156970622|NCT06351371|566644282|FG000|Overall Study|Disease progression|14|||
156970623|NCT06351371|566644282|FG000|Overall Study|Withdrawal by Subject|3|||
156970624|NCT06351371|566644282|FG000|Overall Study|Physician Decision|3|||
156970625|NCT03759834|566644283|FG000|Overall Study|Withdrawal by Subject|1|||
156970626|NCT02515279|566644284|FG000|Overall Study|Adverse Event|7|||
157229174|NCT00048048|567585168|FG011|Core Treatment|Withdrawal by Subject|0|||
157229175|NCT00048048|567585157|FG000|Core Treatment|Adverse Event|0|||
157229176|NCT00048048|567585158|FG001|Core Treatment|Adverse Event|0|||
157229177|NCT00048048|567585159|FG002|Core Treatment|Adverse Event|0|||
157229178|NCT00048048|567585160|FG003|Core Treatment|Adverse Event|0|||
157229179|NCT00048048|567585161|FG004|Core Treatment|Adverse Event|0|||
157229180|NCT00048048|567585162|FG005|Core Treatment|Adverse Event|0|||
157229181|NCT00048048|567585163|FG006|Core Treatment|Adverse Event|0|||
157229182|NCT00048048|567585164|FG007|Core Treatment|Adverse Event|1|||
157229183|NCT00048048|567585165|FG008|Core Treatment|Adverse Event|0|||
157229184|NCT00048048|567585166|FG009|Core Treatment|Adverse Event|0|||
157229185|NCT00048048|567585167|FG010|Core Treatment|Adverse Event|0|||
157229186|NCT00048048|567585168|FG011|Core Treatment|Adverse Event|0|||
157229187|NCT00048048|567585157|FG000|Extension Year 1|Early withdrawals|0|||
157229188|NCT00048048|567585158|FG001|Extension Year 1|Early withdrawals|0|||
157229189|NCT00048048|567585159|FG002|Extension Year 1|Early withdrawals|0|||
157229190|NCT00048048|567585160|FG003|Extension Year 1|Early withdrawals|0|||
157229191|NCT00048048|567585161|FG004|Extension Year 1|Early withdrawals|0|||
157229192|NCT00048048|567585162|FG005|Extension Year 1|Early withdrawals|0|||
157229193|NCT00048048|567585163|FG006|Extension Year 1|Early withdrawals|0|||
156970627|NCT02515279|566644284|FG000|Overall Study|Lack of Efficacy|31|||
156970628|NCT02515279|566644284|FG000|Overall Study|Lost to Follow-up|9|||
156970629|NCT02515279|566644284|FG000|Overall Study|Withdrawal by Subject|18|||
156970630|NCT02515279|566644284|FG000|Overall Study|End-of-treatment visit not attended|17|||
156970631|NCT02515279|566644284|FG000|Overall Study|Other|22|||
156970632|NCT01800968|566644285|FG000|Overall Study|Death|23|||
156970633|NCT01800968|566644286|FG001|Overall Study|Death|16|||
156970634|NCT01800968|566644285|FG000|Overall Study|Lost to Follow-up|5|||
156970635|NCT01800968|566644286|FG001|Overall Study|Lost to Follow-up|7|||
156970636|NCT01800968|566644285|FG000|Overall Study|Withdrawal by Subject|7|||
156970637|NCT01800968|566644286|FG001|Overall Study|Withdrawal by Subject|9|||
156970638|NCT01800968|566644285|FG000|Overall Study|Physician Decision|1|||
156970639|NCT01800968|566644286|FG001|Overall Study|Physician Decision|0|||
156970640|NCT04987762|566644288|FG000|Overall Study|Study was Terminated by Sponsor|103|||
156970641|NCT03185481|566644289|FG000|Overall Study|Adverse Event|1|||
156970642|NCT03185481|566644289|FG000|Overall Study|Study Terminated by Sponsor|4|||
156970643|NCT03371940|566644292|FG000|Overall Study|Withdrawal by Subject|8|||
156970644|NCT03371940|566644293|FG001|Overall Study|Withdrawal by Subject|1|||
156970645|NCT03371940|566644294|FG002|Overall Study|Withdrawal by Subject|3|||
156970646|NCT03371940|566644295|FG003|Overall Study|Withdrawal by Subject|4|||
156970647|NCT05099926|566644296|FG000|Overall Study|Lost to Follow-up|1|||
156970648|NCT00031486|566644302|FG000|Overall Study|Adverse Event|1|||
156970649|NCT00031486|566644303|FG001|Overall Study|Adverse Event|0|||
156970650|NCT00031486|566644302|FG000|Overall Study|Lost to Follow-up|0|||
156970651|NCT00031486|566644303|FG001|Overall Study|Lost to Follow-up|1|||
156970652|NCT00031486|566644302|FG000|Overall Study|Withdrawal by Subject|3|||
156970653|NCT00031486|566644303|FG001|Overall Study|Withdrawal by Subject|2|||
156970654|NCT00031486|566644302|FG000|Overall Study|Death|0|||
156970655|NCT00031486|566644303|FG001|Overall Study|Death|3|||
156970656|NCT00031486|566644302|FG000|Overall Study|Non-compliant|0|||
156970657|NCT00031486|566644303|FG001|Overall Study|Non-compliant|4|||
156970658|NCT00031486|566644302|FG000|Overall Study|Did not meet eligibility requirement|2|||
156970659|NCT00031486|566644303|FG001|Overall Study|Did not meet eligibility requirement|1|||
156970660|NCT00031486|566644302|FG000|Overall Study|Other|1|||
156970661|NCT00031486|566644303|FG001|Overall Study|Other|1|||
156970662|NCT00689026|566644304|FG000|Overall Study|Withdrawal by Subject|13|||
156970663|NCT00689026|566644305|FG001|Overall Study|Withdrawal by Subject|6|||
156970664|NCT04058353|566644310|FG000|Overall Study|Adverse Event|2|||
156970665|NCT04058353|566644311|FG001|Overall Study|Adverse Event|1|||
156970666|NCT04058353|566644310|FG000|Overall Study|Physician Decision|1|||
156970667|NCT04058353|566644311|FG001|Overall Study|Physician Decision|0|||
156970668|NCT04058353|566644310|FG000|Overall Study|Other|1|||
156970669|NCT04058353|566644311|FG001|Overall Study|Other|0|||
156970670|NCT02390531|566644312|FG000|Overall Study|Death|0|||
156970671|NCT02390531|566644313|FG001|Overall Study|Death|2|||
156970672|NCT02390531|566644314|FG002|Overall Study|Death|0|||
156970673|NCT02390531|566644315|FG003|Overall Study|Death|1|||
156970674|NCT02390531|566644316|FG004|Overall Study|Death|0|||
156970675|NCT02390531|566644317|FG005|Overall Study|Death|0|||
156970676|NCT02390531|566644318|FG006|Overall Study|Death|0|||
156970677|NCT02390531|566644319|FG007|Overall Study|Death|1|||
156970678|NCT02390531|566644312|FG000|Overall Study|Protocol Violation|0|||
156970679|NCT02390531|566644313|FG001|Overall Study|Protocol Violation|0|||
156970680|NCT02390531|566644314|FG002|Overall Study|Protocol Violation|0|||
156970681|NCT02390531|566644315|FG003|Overall Study|Protocol Violation|0|||
156970682|NCT02390531|566644316|FG004|Overall Study|Protocol Violation|1|||
157229194|NCT00048048|567585164|FG007|Extension Year 1|Early withdrawals|0|||
157229195|NCT00048048|567585165|FG008|Extension Year 1|Early withdrawals|0|||
157229196|NCT00048048|567585166|FG009|Extension Year 1|Early withdrawals|2|||
157229197|NCT00048048|567585167|FG010|Extension Year 1|Early withdrawals|2|||
157175832|NCT03332303|567383802|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
157175833|NCT03332303|567383803|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
156970683|NCT02390531|566644317|FG005|Overall Study|Protocol Violation|0|||
156970684|NCT02390531|566644318|FG006|Overall Study|Protocol Violation|2|||
156970685|NCT02390531|566644319|FG007|Overall Study|Protocol Violation|0|||
156970686|NCT03779906|566644320|FG000|Overall Study|Lost to Follow-up|7|||
156970687|NCT03779906|566644320|FG000|Overall Study|COVID pandemic|1|||
156970688|NCT00766675|566646130|FG000|Overall Study|Adverse Event|16|||
156970689|NCT00766675|566646130|FG000|Overall Study|Lost to Follow-up|2|||
156970690|NCT00766675|566646130|FG000|Overall Study|Withdrawal by Subject|11|||
156970691|NCT00766675|566646130|FG000|Overall Study|Protocol Violation|8|||
156970692|NCT00766675|566646130|FG000|Overall Study|Participant took prohibited medication|1|||
156970693|NCT00766675|566646130|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
156970694|NCT00766675|566646130|FG000|Overall Study|Insufficient therapy|1|||
156970695|NCT03308825|566646131|FG000|Overall Study|Lost to Follow-up|2|||
156970696|NCT03308825|566646132|FG001|Overall Study|Lost to Follow-up|2|||
156970697|NCT03308825|566646133|FG002|Overall Study|Lost to Follow-up|1|||
156970698|NCT03308825|566646134|FG003|Overall Study|Lost to Follow-up|0|||
156970699|NCT03308825|566646131|FG000|Overall Study|Protocol Violation|0|||
156970700|NCT03308825|566646132|FG001|Overall Study|Protocol Violation|2|||
156970701|NCT03308825|566646133|FG002|Overall Study|Protocol Violation|0|||
156970702|NCT03308825|566646134|FG003|Overall Study|Protocol Violation|0|||
156970703|NCT02044848|566646136|FG000|Overall Study|Administrative Problems|2|||
156970704|NCT02044848|566646137|FG001|Overall Study|Administrative Problems|3|||
156970705|NCT00045708|566646138|FG000|Phase 1|early progressive disease|0|||
156970706|NCT00045708|566646139|FG001|Phase 1|early progressive disease|1|||
156970707|NCT00045708|566646140|FG002|Phase 1|early progressive disease|0|||
156970708|NCT00685945|566646142|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
156970709|NCT03183388|566646143|FG000|Overall Study|Lost to Follow-up|3|||
156970710|NCT03183388|566646144|FG001|Overall Study|Lost to Follow-up|5|||
156970711|NCT03183388|566646143|FG000|Overall Study|Physician Decision|1|||
156970712|NCT03183388|566646144|FG001|Overall Study|Physician Decision|4|||
156970713|NCT03183388|566646143|FG000|Overall Study|Withdrawal by Subject|4|||
156970714|NCT03183388|566646144|FG001|Overall Study|Withdrawal by Subject|1|||
156970715|NCT03183388|566646143|FG000|Overall Study|Moved|1|||
156970716|NCT03183388|566646144|FG001|Overall Study|Moved|0|||
156970717|NCT03183388|566646143|FG000|Overall Study|Met Exclusion Criteria|2|||
156970718|NCT03183388|566646144|FG001|Overall Study|Met Exclusion Criteria|2|||
156970719|NCT03183388|566646143|FG000|Overall Study|COVID Pandemic Related|2|||
156970720|NCT03183388|566646144|FG001|Overall Study|COVID Pandemic Related|4|||
156970721|NCT01679236|566646149|FG000|Overall Study|Lost to Follow-up|15|||
156970722|NCT01679236|566646150|FG001|Overall Study|Lost to Follow-up|15|||
156970723|NCT00284141|566646151|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
156970724|NCT00284141|566646151|FG000|Overall Study|Adverse Event|19|||
156970725|NCT00284141|566646151|FG000|Overall Study|Participant's request|9|||
156970726|NCT00284141|566646151|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
156970727|NCT00284141|566646151|FG000|Overall Study|Clinical deterioration / death|2|||
156970728|NCT00284141|566646151|FG000|Overall Study|General decline|1|||
156970729|NCT00284141|566646151|FG000|Overall Study|Pneumonia|1|||
156970730|NCT00284141|566646151|FG000|Overall Study|Did not take study medication|2|||
156970731|NCT00284141|566646151|FG000|Overall Study|Ongoing treatment|2|||
156970732|NCT00803101|566646162|FG000|Overall Study|Death / Serious Adverse Event|4|||
156970733|NCT00803101|566646163|FG001|Overall Study|Death / Serious Adverse Event|6|||
156970734|NCT00803101|566646162|FG000|Overall Study|Withdrawal by Subject|6|||
156970735|NCT00803101|566646163|FG001|Overall Study|Withdrawal by Subject|4|||
156970736|NCT00803101|566646162|FG000|Overall Study|Lost to Follow-up|2|||
156970737|NCT00803101|566646163|FG001|Overall Study|Lost to Follow-up|2|||
156970738|NCT00803101|566646162|FG000|Overall Study|Protocol Violation|1|||
156970739|NCT00803101|566646163|FG001|Overall Study|Protocol Violation|7|||
156970740|NCT00803101|566646162|FG000|Overall Study|Surgery finished outside protocol window|1|||
156970741|NCT00803101|566646163|FG001|Overall Study|Surgery finished outside protocol window|1|||
156970742|NCT00803101|566646162|FG000|Overall Study|Patient died outside SAE report period|1|||
156970743|NCT00803101|566646163|FG001|Overall Study|Patient died outside SAE report period|0|||
156970744|NCT00803101|566646162|FG000|Overall Study|Patient did not attend scheduled visit|2|||
156970745|NCT00803101|566646163|FG001|Overall Study|Patient did not attend scheduled visit|1|||
156970746|NCT00803101|566646162|FG000|Overall Study|Patient did not have surgery|1|||
156970747|NCT00803101|566646163|FG001|Overall Study|Patient did not have surgery|1|||
156970748|NCT01782742|566646164|FG000|Double-blind Treatment Phase|Adverse Event|1|||
156970749|NCT01782742|566646165|FG001|Double-blind Treatment Phase|Adverse Event|0|||
156970750|NCT01529008|566646166|FG000|Bone Marrow Harvesting|Physician Decision|1|||
156970751|NCT01529008|566646167|FG001|Bone Marrow Harvesting|Physician Decision|1|||
156970752|NCT01529008|566646166|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
156970753|NCT01529008|566646167|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
156970754|NCT01529008|566646166|FG000|Treatment|Adverse Event|6|||
156970755|NCT01529008|566646167|FG001|Treatment|Adverse Event|0|||
157048325|NCT02291861|566931684|FG003|Overall Study|Lost to Follow-up|0|||
157048326|NCT02291861|566931681|FG000|Overall Study|Other|0|||
157048327|NCT02291861|566931682|FG001|Overall Study|Other|0|||
157048328|NCT02291861|566931683|FG002|Overall Study|Other|0|||
157048329|NCT02291861|566931684|FG003|Overall Study|Other|1|||
157048330|NCT00267956|566931687|FG000|Controlled Period|Adverse Event|4|||
157048331|NCT00267956|566931688|FG001|Controlled Period|Adverse Event|1|||
157048332|NCT00267956|566931689|FG002|Controlled Period|Adverse Event|0|||
157048333|NCT00267956|566931690|FG003|Controlled Period|Adverse Event|0|||
157048334|NCT00267956|566931687|FG000|Controlled Period|Lack of Efficacy|4|||
157048335|NCT00267956|566931688|FG001|Controlled Period|Lack of Efficacy|2|||
157048336|NCT00267956|566931689|FG002|Controlled Period|Lack of Efficacy|0|||
157048337|NCT00267956|566931690|FG003|Controlled Period|Lack of Efficacy|0|||
157048338|NCT00267956|566931687|FG000|Controlled Period|Lost to Follow-up|2|||
157048339|NCT00267956|566931688|FG001|Controlled Period|Lost to Follow-up|0|||
157048340|NCT00267956|566931689|FG002|Controlled Period|Lost to Follow-up|0|||
157048341|NCT00267956|566931690|FG003|Controlled Period|Lost to Follow-up|0|||
157048342|NCT00267956|566931687|FG000|Controlled Period|Withdrew consent|3|||
157048343|NCT00267956|566931688|FG001|Controlled Period|Withdrew consent|1|||
157048344|NCT00267956|566931689|FG002|Controlled Period|Withdrew consent|0|||
157048345|NCT00267956|566931690|FG003|Controlled Period|Withdrew consent|0|||
157048346|NCT00267956|566931687|FG000|After Controlled Period|Adverse Event|0|||
157048347|NCT00267956|566931688|FG001|After Controlled Period|Adverse Event|0|||
157048348|NCT00267956|566931689|FG002|After Controlled Period|Adverse Event|2|||
157048349|NCT00267956|566931690|FG003|After Controlled Period|Adverse Event|1|||
157048350|NCT00267956|566931687|FG000|After Controlled Period|Lack of Efficacy|0|||
157048351|NCT00267956|566931688|FG001|After Controlled Period|Lack of Efficacy|0|||
157048352|NCT00267956|566931689|FG002|After Controlled Period|Lack of Efficacy|1|||
157048353|NCT00267956|566931690|FG003|After Controlled Period|Lack of Efficacy|1|||
157175834|NCT03332303|567383804|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
157175835|NCT03332303|567383802|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
157175836|NCT03332303|567383803|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
157175837|NCT03332303|567383804|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
157175838|NCT03332303|567383802|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
157175839|NCT03332303|567383803|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
157175840|NCT03332303|567383804|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
157175841|NCT03332303|567383802|FG000|Overall Study|Participant had a significant protocol deviation|0|||
157175842|NCT03332303|567383803|FG001|Overall Study|Participant had a significant protocol deviation|1|||
157175843|NCT03332303|567383804|FG002|Overall Study|Participant had a significant protocol deviation|0|||
157175844|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
157175845|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
157175846|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
157175847|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
157175848|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
157175849|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
157175850|NCT00996593|567383805|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
157175851|NCT00996593|567383805|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
157175852|NCT00996593|567383805|FG000|Long-Term Follow-Up|Site Closed|1|||
157175853|NCT00889681|567383806|FG000|Overall Study|Not meeting qualification Criteria|2|||
157175854|NCT00889681|567383806|FG000|Overall Study|Insurance disapproval|1|||
157175855|NCT00871572|567383807|FG000|Overall Study|Adverse Event|0|||
157175856|NCT00871572|567383808|FG001|Overall Study|Adverse Event|2|||
157175857|NCT00871572|567383809|FG002|Overall Study|Adverse Event|0|||
157175858|NCT00871572|567383810|FG003|Overall Study|Adverse Event|3|||
157175859|NCT00871572|567383807|FG000|Overall Study|Investigator Decision|0|||
157175860|NCT00871572|567383808|FG001|Overall Study|Investigator Decision|1|||
157175861|NCT00871572|567383809|FG002|Overall Study|Investigator Decision|0|||
157175862|NCT00871572|567383810|FG003|Overall Study|Investigator Decision|1|||
157175863|NCT00871572|567383807|FG000|Overall Study|Lost to Follow-up|0|||
157048354|NCT00267956|566931687|FG000|After Controlled Period|Lost to Follow-up|0|||
157175864|NCT00871572|567383808|FG001|Overall Study|Lost to Follow-up|1|||
157175865|NCT00871572|567383809|FG002|Overall Study|Lost to Follow-up|0|||
157175866|NCT00871572|567383810|FG003|Overall Study|Lost to Follow-up|1|||
157175867|NCT00871572|567383807|FG000|Overall Study|Protocol Violation|0|||
157175868|NCT00871572|567383808|FG001|Overall Study|Protocol Violation|0|||
157175869|NCT00871572|567383809|FG002|Overall Study|Protocol Violation|1|||
157048355|NCT00267956|566931688|FG001|After Controlled Period|Lost to Follow-up|0|||
157048356|NCT00267956|566931689|FG002|After Controlled Period|Lost to Follow-up|1|||
157175870|NCT00871572|567383810|FG003|Overall Study|Protocol Violation|1|||
157175871|NCT00871572|567383807|FG000|Overall Study|Sponsor Decision|1|||
157175872|NCT00871572|567383808|FG001|Overall Study|Sponsor Decision|0|||
157048357|NCT00267956|566931690|FG003|After Controlled Period|Lost to Follow-up|0|||
157048358|NCT00267956|566931687|FG000|After Controlled Period|Withdrew consent|0|||
157048359|NCT00267956|566931688|FG001|After Controlled Period|Withdrew consent|0|||
157048360|NCT00267956|566931689|FG002|After Controlled Period|Withdrew consent|1|||
157048361|NCT00267956|566931690|FG003|After Controlled Period|Withdrew consent|0|||
157048362|NCT01263223|566931691|FG000|Period 2|Withdrawal by Subject|0|||
157048363|NCT01263223|566931692|FG001|Period 2|Withdrawal by Subject|1|||
157048364|NCT01263223|566931691|FG000|7-day Follow-up|Withdrawal by Subject|0|||
157048365|NCT01263223|566931692|FG001|7-day Follow-up|Withdrawal by Subject|1|||
157048366|NCT01263223|566931691|FG000|7-day Follow-up|Lost to Follow-up|1|||
157048367|NCT01263223|566931692|FG001|7-day Follow-up|Lost to Follow-up|0|||
157048368|NCT02005484|566931695|FG000|Overall Study|Death|1|||
157048369|NCT02005484|566931695|FG000|Overall Study|Disease progression|1|||
157048370|NCT02005484|566931695|FG000|Overall Study|Changed to a Different Study|1|||
157048371|NCT02005484|566931695|FG000|Overall Study|Sponsor decision|1|||
157048372|NCT02246647|566931696|FG000|Overall Study|Withdrawal by Subject|1|||
157048373|NCT02246647|566931697|FG001|Overall Study|Withdrawal by Subject|1|||
157048374|NCT01393964|566931698|FG000|Overall Study|Disease Progression|4|||
157048375|NCT01393964|566931699|FG001|Overall Study|Disease Progression|3|||
157048376|NCT01393964|566931700|FG002|Overall Study|Disease Progression|5|||
157048377|NCT01393964|566931698|FG000|Overall Study|Study drug toxicity|1|||
157048378|NCT01393964|566931699|FG001|Overall Study|Study drug toxicity|0|||
157175873|NCT00871572|567383809|FG002|Overall Study|Sponsor Decision|0|||
157175874|NCT00871572|567383810|FG003|Overall Study|Sponsor Decision|0|||
157175875|NCT00871572|567383807|FG000|Overall Study|Withdrawal by Subject|1|||
157175876|NCT00871572|567383808|FG001|Overall Study|Withdrawal by Subject|2|||
157175877|NCT00871572|567383809|FG002|Overall Study|Withdrawal by Subject|3|||
157175878|NCT00871572|567383810|FG003|Overall Study|Withdrawal by Subject|1|||
157175879|NCT01957787|567383815|FG000|Overall Study|Death|18|||
157175880|NCT01957787|567383815|FG000|Overall Study|Lost to Follow-up|3|||
157175881|NCT01957787|567383815|FG000|Overall Study|Withdrawal by Subject|3|||
157175882|NCT01957787|567383815|FG000|Overall Study|Entered Hospice or Similar Program|2|||
157175883|NCT01957787|567383815|FG000|Overall Study|Index Tumor(s) Resected|2|||
157175884|NCT01957787|567383815|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
157175885|NCT01957787|567383815|FG000|Overall Study|Local therapy, not cryoablation|6|||
157175886|NCT00405652|567383816|FG000|Overall Study|Adverse Event|4|||
157175887|NCT00418717|567383817|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
157175888|NCT00418717|567383817|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
157175889|NCT02762708|567383822|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
157175890|NCT02762708|567383823|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
157175891|NCT02762708|567383824|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
157175892|NCT02762708|567383825|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
157175893|NCT01468701|567383826|FG000|Overall Study|Not eligible|91|||
157175894|NCT01468701|567383827|FG001|Overall Study|Not eligible|140|||
157175895|NCT01468701|567383828|FG002|Overall Study|Not eligible|29|||
157175896|NCT01468701|567383829|FG003|Overall Study|Not eligible|12|||
157175897|NCT01468701|567383830|FG004|Overall Study|Not eligible|22|||
157175898|NCT01468701|567383831|FG005|Overall Study|Not eligible|2|||
157175899|NCT01468701|567383832|FG006|Overall Study|Not eligible|39|||
157175900|NCT01468701|567383833|FG007|Overall Study|Not eligible|1|||
157175901|NCT01468701|567383834|FG008|Overall Study|Not eligible|40|||
157175902|NCT01468701|567383835|FG009|Overall Study|Not eligible|126|||
157175903|NCT01468701|567383836|FG010|Overall Study|Not eligible|39|||
157175904|NCT01468701|567383837|FG011|Overall Study|Not eligible|33|||
157175905|NCT01468701|567383838|FG012|Overall Study|Not eligible|1|||
157175906|NCT01468701|567383839|FG013|Overall Study|Not eligible|19|||
157175907|NCT01468701|567383840|FG014|Overall Study|Not eligible|1|||
157175908|NCT01468701|567383841|FG015|Overall Study|Not eligible|32|||
157175909|NCT01468701|567383842|FG016|Overall Study|Not eligible|0|||
157175910|NCT01468701|567383826|FG000|Overall Study|Lost to Follow-up|306|||
157175911|NCT01468701|567383827|FG001|Overall Study|Lost to Follow-up|0|||
157175912|NCT01468701|567383828|FG002|Overall Study|Lost to Follow-up|0|||
157175913|NCT01468701|567383829|FG003|Overall Study|Lost to Follow-up|0|||
157175914|NCT01468701|567383830|FG004|Overall Study|Lost to Follow-up|0|||
157175915|NCT01468701|567383831|FG005|Overall Study|Lost to Follow-up|0|||
157175916|NCT01468701|567383832|FG006|Overall Study|Lost to Follow-up|0|||
157175917|NCT01468701|567383833|FG007|Overall Study|Lost to Follow-up|0|||
157175918|NCT01468701|567383834|FG008|Overall Study|Lost to Follow-up|215|||
157048379|NCT01393964|566931700|FG002|Overall Study|Study drug toxicity|0|||
157048380|NCT01393964|566931698|FG000|Overall Study|Withdrawal by Subject|0|||
157048381|NCT01393964|566931699|FG001|Overall Study|Withdrawal by Subject|0|||
157048382|NCT01393964|566931700|FG002|Overall Study|Withdrawal by Subject|1|||
157175919|NCT01468701|567383835|FG009|Overall Study|Lost to Follow-up|309|||
157048383|NCT01393964|566931698|FG000|Overall Study|Adverse event unrelated to study drug|0|||
157048384|NCT01393964|566931699|FG001|Overall Study|Adverse event unrelated to study drug|3|||
157175920|NCT01468701|567383836|FG010|Overall Study|Lost to Follow-up|224|||
157175921|NCT01468701|567383837|FG011|Overall Study|Lost to Follow-up|212|||
157048385|NCT01393964|566931700|FG002|Overall Study|Adverse event unrelated to study drug|0|||
157048386|NCT01393964|566931698|FG000|Overall Study|Subject request stop study treatment|0|||
157048387|NCT01393964|566931699|FG001|Overall Study|Subject request stop study treatment|1|||
157048388|NCT01393964|566931700|FG002|Overall Study|Subject request stop study treatment|0|||
157048389|NCT01393964|566931698|FG000|Overall Study|Subject decided to move to transplant|1|||
157048390|NCT01393964|566931699|FG001|Overall Study|Subject decided to move to transplant|0|||
157048391|NCT01393964|566931700|FG002|Overall Study|Subject decided to move to transplant|0|||
157048392|NCT01393964|566931698|FG000|Overall Study|Subject switched to commercial supply|1|||
157048393|NCT01393964|566931699|FG001|Overall Study|Subject switched to commercial supply|0|||
157048394|NCT01393964|566931700|FG002|Overall Study|Subject switched to commercial supply|2|||
157048395|NCT01393964|566931698|FG000|Overall Study|Subject plateaued in terms of effect|1|||
157048396|NCT01393964|566931699|FG001|Overall Study|Subject plateaued in terms of effect|0|||
157048397|NCT01393964|566931700|FG002|Overall Study|Subject plateaued in terms of effect|0|||
157048398|NCT01393964|566931698|FG000|Overall Study|Investigator removed subject from study|0|||
157048399|NCT01393964|566931699|FG001|Overall Study|Investigator removed subject from study|1|||
157048400|NCT01393964|566931700|FG002|Overall Study|Investigator removed subject from study|0|||
157048401|NCT01393964|566931698|FG000|Overall Study|Subject converted to roll-over study|0|||
157048402|NCT01393964|566931699|FG001|Overall Study|Subject converted to roll-over study|1|||
157048403|NCT01393964|566931700|FG002|Overall Study|Subject converted to roll-over study|0|||
157048404|NCT01393964|566931698|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
157048405|NCT01393964|566931699|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
157048406|NCT01393964|566931700|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
157048407|NCT01113541|566931701|FG000|Overall Study|Withdrawal by Subject|1|||
157048408|NCT01113541|566931701|FG000|Overall Study|Protocol Violation|1|||
157048409|NCT01113541|566931701|FG000|Overall Study|Study Terminated by Sponsor|7|||
157048410|NCT01113541|566931701|FG000|Overall Study|Adverse Event|4|||
157048411|NCT01918033|566931702|FG000|Overall Study|Adverse Event|1|||
157048412|NCT01918033|566931703|FG001|Overall Study|Adverse Event|0|||
157048413|NCT01918033|566931704|FG002|Overall Study|Adverse Event|2|||
157048414|NCT01918033|566931702|FG000|Overall Study|Lost to Follow-up|0|||
157048415|NCT01918033|566931703|FG001|Overall Study|Lost to Follow-up|1|||
157048416|NCT01918033|566931704|FG002|Overall Study|Lost to Follow-up|0|||
157048417|NCT01918033|566931702|FG000|Overall Study|Protocol Violation|2|||
157048418|NCT01918033|566931703|FG001|Overall Study|Protocol Violation|0|||
157048419|NCT01918033|566931704|FG002|Overall Study|Protocol Violation|1|||
157048420|NCT01918033|566931702|FG000|Overall Study|Withdrawal by Subject|2|||
157048421|NCT01918033|566931703|FG001|Overall Study|Withdrawal by Subject|1|||
157048422|NCT01918033|566931704|FG002|Overall Study|Withdrawal by Subject|0|||
157048423|NCT04679675|566931705|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
157048424|NCT04679675|566931706|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
157048425|NCT04679675|566931707|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
157048426|NCT04679675|566931708|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
157048427|NCT04679675|566931705|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
157048428|NCT04679675|566931706|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
157048429|NCT04679675|566931707|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
157048430|NCT04679675|566931708|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
157048431|NCT03006393|566931717|FG000|Overall Study|Withdrawal by Subject|1|||
157048432|NCT03006393|566931718|FG001|Overall Study|Withdrawal by Subject|1|||
157048433|NCT03006393|566931717|FG000|Overall Study|Pregnancy|0|||
157048434|NCT03006393|566931718|FG001|Overall Study|Pregnancy|1|||
157048435|NCT03006393|566931717|FG000|Overall Study|Lost to Follow-up|0|||
157048436|NCT03006393|566931718|FG001|Overall Study|Lost to Follow-up|1|||
157048437|NCT00807599|566931721|FG000|Overall Study|Not treated on protocol study|0|||
157048438|NCT00807599|566931722|FG001|Overall Study|Not treated on protocol study|0|||
157048439|NCT00807599|566931723|FG002|Overall Study|Not treated on protocol study|2|||
157048440|NCT00807599|566931721|FG000|Overall Study|Adverse Event|0|||
157048441|NCT00807599|566931722|FG001|Overall Study|Adverse Event|0|||
157048442|NCT00807599|566931723|FG002|Overall Study|Adverse Event|5|||
157048443|NCT00807599|566931721|FG000|Overall Study|Inadequate response to induction|0|||
157048444|NCT00807599|566931722|FG001|Overall Study|Inadequate response to induction|0|||
157048445|NCT00807599|566931723|FG002|Overall Study|Inadequate response to induction|9|||
157175922|NCT01468701|567383838|FG012|Overall Study|Lost to Follow-up|11|||
157175923|NCT01468701|567383839|FG013|Overall Study|Lost to Follow-up|164|||
157175924|NCT01468701|567383840|FG014|Overall Study|Lost to Follow-up|17|||
157175925|NCT01468701|567383841|FG015|Overall Study|Lost to Follow-up|127|||
157175926|NCT01468701|567383842|FG016|Overall Study|Lost to Follow-up|1|||
157048446|NCT00807599|566931721|FG000|Overall Study|Withdrawal by Subject|0|||
157048447|NCT00807599|566931722|FG001|Overall Study|Withdrawal by Subject|0|||
157048448|NCT00807599|566931723|FG002|Overall Study|Withdrawal by Subject|1|||
157048449|NCT03695185|566931724|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
157048450|NCT03695185|566931724|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
157175927|NCT01468701|567383826|FG000|Overall Study|Withdrawal by Subject|165|||
156970756|NCT01529008|566646166|FG000|Treatment|Other|3|||
156970757|NCT01529008|566646167|FG001|Treatment|Other|1|||
156970758|NCT01529008|566646166|FG000|Efficacy Analysis|Protocol Violation|2|||
156970759|NCT01529008|566646167|FG001|Efficacy Analysis|Protocol Violation|0|||
156970760|NCT01529008|566646166|FG000|Efficacy Analysis|Physician Decision|0|||
156970761|NCT01529008|566646167|FG001|Efficacy Analysis|Physician Decision|1|||
156970762|NCT01529008|566646166|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
156970763|NCT01529008|566646167|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
156970764|NCT04170686|566646168|FG000|Screening|Physician Decision|12|||
156970765|NCT04170686|566646169|FG001|Screening|Physician Decision|13|||
156970766|NCT04170686|566646168|FG000|Randomization and Treatment|Lost to Follow-up|26|||
156970767|NCT04170686|566646169|FG001|Randomization and Treatment|Lost to Follow-up|15|||
156970768|NCT04425902|566646172|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
156970769|NCT01191840|566646173|FG000|Overall Study|withdrew consent|2|||
156970770|NCT01191840|566646174|FG001|Overall Study|withdrew consent|1|||
156970771|NCT01191840|566646173|FG000|Overall Study|Subject discontinued treatment|1|||
156970772|NCT01191840|566646174|FG001|Overall Study|Subject discontinued treatment|2|||
156970773|NCT01191840|566646173|FG000|Overall Study|Lost to Follow-up|4|||
156970774|NCT01191840|566646174|FG001|Overall Study|Lost to Follow-up|6|||
156970775|NCT01191840|566646173|FG000|Overall Study|Non Staph Infection|4|||
156970776|NCT01191840|566646174|FG001|Overall Study|Non Staph Infection|3|||
156970777|NCT01191840|566646173|FG000|Overall Study|ineligible at enrollment|1|||
156970778|NCT01191840|566646174|FG001|Overall Study|ineligible at enrollment|0|||
156970779|NCT01191840|566646173|FG000|Overall Study|IRB approval lapse|0|||
156970780|NCT01191840|566646174|FG001|Overall Study|IRB approval lapse|2|||
156970781|NCT01191840|566646173|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
156970782|NCT01191840|566646174|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
156970783|NCT01191840|566646173|FG000|Overall Study|Withdrawal by Subject|2|||
156970784|NCT01191840|566646174|FG001|Overall Study|Withdrawal by Subject|0|||
156970785|NCT04669600|566646175|FG000|Overall Study|Withdrawal by Subject|1|||
156970786|NCT04669600|566646175|FG000|Overall Study|Other|6|||
156970787|NCT00331344|566646185|FG000|Phase I|Adverse Event|0|||
156970788|NCT00331344|566646186|FG001|Phase I|Adverse Event|0|||
156970789|NCT00331344|566646187|FG002|Phase I|Adverse Event|0|||
156970790|NCT00331344|566646188|FG003|Phase I|Adverse Event|1|||
156970791|NCT00331344|566646189|FG004|Phase I|Adverse Event|2|||
156970792|NCT00331344|566646190|FG005|Phase I|Adverse Event|2|||
156970793|NCT00331344|566646191|FG006|Phase I|Adverse Event|0|||
156970794|NCT00331344|566646192|FG007|Phase I|Adverse Event|1|||
156970795|NCT00331344|566646193|FG008|Phase I|Adverse Event|0|||
156970796|NCT00331344|566646185|FG000|Phase II|Death|0|||
156970797|NCT00331344|566646186|FG001|Phase II|Death|0|||
156970798|NCT00331344|566646187|FG002|Phase II|Death|0|||
156970799|NCT00331344|566646188|FG003|Phase II|Death|0|||
156970800|NCT00331344|566646189|FG004|Phase II|Death|0|||
156970801|NCT00331344|566646190|FG005|Phase II|Death|0|||
156970802|NCT00331344|566646191|FG006|Phase II|Death|0|||
156970803|NCT00331344|566646192|FG007|Phase II|Death|0|||
156970804|NCT00331344|566646193|FG008|Phase II|Death|4|||
156970805|NCT04538144|566646194|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
156970806|NCT04538144|566646195|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
156970807|NCT04538144|566646196|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
156970808|NCT04538144|566646197|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
156970809|NCT02228967|566646198|FG000|Overall Study|Lost to Follow-up|146|||
156970810|NCT02228967|566646199|FG001|Overall Study|Lost to Follow-up|142|||
156970811|NCT02228967|566646198|FG000|Overall Study|Withdrawal by Subject|13|||
156970812|NCT02228967|566646199|FG001|Overall Study|Withdrawal by Subject|18|||
156970813|NCT01264380|566646200|FG000|Period C|Disease Progression|0|||
156970814|NCT01264380|566646201|FG001|Period C|Disease Progression|0|||
156970815|NCT01264380|566646202|FG002|Period C|Disease Progression|4|||
156970816|NCT01264380|566646200|FG000|Period C|Death|0|||
156970817|NCT01264380|566646201|FG001|Period C|Death|0|||
156970818|NCT01264380|566646202|FG002|Period C|Death|2|||
156970819|NCT01264380|566646200|FG000|Period C|Follow-up for survival status|0|||
156970820|NCT01264380|566646201|FG001|Period C|Follow-up for survival status|0|||
156970821|NCT01264380|566646202|FG002|Period C|Follow-up for survival status|6|||
156970822|NCT01264380|566646200|FG000|Period C|Withdrawal by Subject|0|||
156970823|NCT01264380|566646201|FG001|Period C|Withdrawal by Subject|0|||
156970824|NCT01264380|566646202|FG002|Period C|Withdrawal by Subject|1|||
156970825|NCT01264380|566646200|FG000|Period C|Adverse Event|0|||
156970826|NCT01264380|566646201|FG001|Period C|Adverse Event|0|||
156970827|NCT01264380|566646202|FG002|Period C|Adverse Event|1|||
156970828|NCT03474107|566646204|FG000|Overall Study|Adverse Event|42|||
156970829|NCT03474107|566646205|FG001|Overall Study|Adverse Event|46|||
156970830|NCT03474107|566646204|FG000|Overall Study|Death|2|||
156970831|NCT03474107|566646205|FG001|Overall Study|Death|2|||
156970832|NCT03474107|566646204|FG000|Overall Study|Lost to Follow-up|0|||
156970833|NCT03474107|566646205|FG001|Overall Study|Lost to Follow-up|1|||
157048451|NCT03695185|566931724|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
157048452|NCT03695185|566931724|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
157048453|NCT03695185|566931724|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
157048454|NCT03695185|566931724|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
157048455|NCT01328756|566931728|FG000|Overall Study|Protocol Violation|4|||
157048456|NCT01328756|566931728|FG000|Overall Study|Adverse Event|39|||
157048457|NCT01328756|566931728|FG000|Overall Study|Lack of Efficacy|5|||
157048458|NCT01328756|566931728|FG000|Overall Study|Withdrawal by Subject|41|||
157048459|NCT01328756|566931728|FG000|Overall Study|Lost to Follow-up|5|||
157048460|NCT01328756|566931728|FG000|Overall Study|Other|29|||
157048461|NCT04183491|566931734|FG000|Overall Study|Withdrawal by Subject|0|||
157048462|NCT04183491|566931735|FG001|Overall Study|Withdrawal by Subject|0|||
157048463|NCT04183491|566931736|FG002|Overall Study|Withdrawal by Subject|1|||
157048464|NCT04183491|566931737|FG003|Overall Study|Withdrawal by Subject|0|||
157048465|NCT04183491|566931738|FG004|Overall Study|Withdrawal by Subject|0|||
157048466|NCT04183491|566931739|FG005|Overall Study|Withdrawal by Subject|1|||
157048467|NCT04183491|566931740|FG006|Overall Study|Withdrawal by Subject|0|||
157048468|NCT02538094|566931741|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
157048469|NCT02538094|566931742|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
157048470|NCT02538094|566931741|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
157048471|NCT02538094|566931742|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
157048472|NCT03288506|566931743|FG000|Overall Study|Withdrawal by Subject|52|||
157048473|NCT03692871|566931744|FG000|Overall Study|Death|1|||
157048474|NCT03692871|566931745|FG001|Overall Study|Death|1|||
157048475|NCT03692871|566931744|FG000|Overall Study|Lost to Follow-up|24|||
157048476|NCT03692871|566931745|FG001|Overall Study|Lost to Follow-up|9|||
157048477|NCT03692871|566931744|FG000|Overall Study|Physician Decision|22|||
157048478|NCT03692871|566931745|FG001|Overall Study|Physician Decision|7|||
157048479|NCT03692871|566931744|FG000|Overall Study|Protocol Deviation|1|||
157048480|NCT03692871|566931745|FG001|Overall Study|Protocol Deviation|0|||
157048481|NCT03692871|566931744|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
157048482|NCT03692871|566931745|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
157048483|NCT02852824|566931748|FG000|Overall Study|Withdrawal by Subject|1|||
157048484|NCT02852824|566931749|FG001|Overall Study|Withdrawal by Subject|0|||
157048485|NCT02852824|566931750|FG002|Overall Study|Withdrawal by Subject|0|||
157048486|NCT02852824|566931751|FG003|Overall Study|Withdrawal by Subject|0|||
157048487|NCT02852824|566931752|FG004|Overall Study|Withdrawal by Subject|0|||
157048488|NCT02852824|566931753|FG005|Overall Study|Withdrawal by Subject|0|||
157048489|NCT02852824|566931754|FG006|Overall Study|Withdrawal by Subject|0|||
157048490|NCT02852824|566931748|FG000|Overall Study|Adverse Event|0|||
157048491|NCT02852824|566931749|FG001|Overall Study|Adverse Event|0|||
157048492|NCT02852824|566931750|FG002|Overall Study|Adverse Event|0|||
157048493|NCT02852824|566931751|FG003|Overall Study|Adverse Event|0|||
157048494|NCT02852824|566931752|FG004|Overall Study|Adverse Event|2|||
157048495|NCT02852824|566931753|FG005|Overall Study|Adverse Event|0|||
157048496|NCT02852824|566931754|FG006|Overall Study|Adverse Event|0|||
157048497|NCT01316913|566931755|FG000|Overall Study|Adverse Event|17|||
157048498|NCT01316913|566931756|FG001|Overall Study|Adverse Event|20|||
157048499|NCT01316913|566931757|FG002|Overall Study|Adverse Event|15|||
157048500|NCT01316913|566931758|FG003|Overall Study|Adverse Event|11|||
157048501|NCT01316913|566931755|FG000|Overall Study|Lack of Efficacy|22|||
157048502|NCT01316913|566931756|FG001|Overall Study|Lack of Efficacy|12|||
157048503|NCT01316913|566931757|FG002|Overall Study|Lack of Efficacy|9|||
157048504|NCT01316913|566931758|FG003|Overall Study|Lack of Efficacy|13|||
157048505|NCT01316913|566931755|FG000|Overall Study|Protocol Violation|1|||
157048506|NCT01316913|566931756|FG001|Overall Study|Protocol Violation|4|||
157048507|NCT01316913|566931757|FG002|Overall Study|Protocol Violation|4|||
157048508|NCT01316913|566931758|FG003|Overall Study|Protocol Violation|1|||
157048509|NCT01316913|566931755|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
157048510|NCT01316913|566931756|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
157229198|NCT00048048|567585168|FG011|Extension Year 1|Early withdrawals|4|||
157048511|NCT01316913|566931757|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
157048512|NCT01316913|566931758|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
157048513|NCT01316913|566931755|FG000|Overall Study|Lost to Follow-up|0|||
157048514|NCT01316913|566931756|FG001|Overall Study|Lost to Follow-up|1|||
157048515|NCT01316913|566931757|FG002|Overall Study|Lost to Follow-up|0|||
157048516|NCT01316913|566931758|FG003|Overall Study|Lost to Follow-up|2|||
157048517|NCT01316913|566931755|FG000|Overall Study|Withdrawal by Subject|10|||
157048518|NCT01316913|566931756|FG001|Overall Study|Withdrawal by Subject|9|||
157048519|NCT01316913|566931757|FG002|Overall Study|Withdrawal by Subject|10|||
157048520|NCT01316913|566931758|FG003|Overall Study|Withdrawal by Subject|6|||
157048521|NCT01860079|566931759|FG000|Overall Study|Physician Decision|14|||
157048522|NCT01860079|566931760|FG001|Overall Study|Physician Decision|22|||
157048523|NCT02102724|566931761|FG000|Overall Study|Lost to Follow-up|1|||
157048524|NCT02102724|566931762|FG001|Overall Study|Lost to Follow-up|0|||
157048525|NCT02102724|566931761|FG000|Overall Study|surgery for brain aneurysm|1|||
157048526|NCT02102724|566931762|FG001|Overall Study|surgery for brain aneurysm|1|||
157048527|NCT05445557|566931763|FG000|Double Blind Part|Lost to Follow-up|1|||
157048528|NCT02008916|566931764|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
157048529|NCT02008916|566931765|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
157048530|NCT02008916|566931766|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
157048531|NCT02008916|566931764|FG000|Week 16 - 156|Adverse Event|4|||
157048532|NCT02008916|566931765|FG001|Week 16 - 156|Adverse Event|2|||
157048533|NCT02008916|566931766|FG002|Week 16 - 156|Adverse Event|3|||
157048534|NCT02008916|566931764|FG000|Week 16 - 156|Withdrawal by Subject|7|||
157048535|NCT02008916|566931765|FG001|Week 16 - 156|Withdrawal by Subject|3|||
157048536|NCT02008916|566931766|FG002|Week 16 - 156|Withdrawal by Subject|5|||
157048537|NCT02008916|566931764|FG000|Week 16 - 156|No longer requires treatment|0|||
157048538|NCT02008916|566931765|FG001|Week 16 - 156|No longer requires treatment|1|||
157048539|NCT02008916|566931766|FG002|Week 16 - 156|No longer requires treatment|0|||
157048540|NCT02008916|566931764|FG000|Week 16 - 156|Lost to Follow-up|5|||
157048541|NCT02008916|566931765|FG001|Week 16 - 156|Lost to Follow-up|0|||
157048542|NCT02008916|566931766|FG002|Week 16 - 156|Lost to Follow-up|0|||
157048543|NCT02008916|566931764|FG000|Week 16 - 156|Lack of Efficacy|3|||
157048544|NCT02008916|566931765|FG001|Week 16 - 156|Lack of Efficacy|5|||
157048545|NCT02008916|566931766|FG002|Week 16 - 156|Lack of Efficacy|2|||
157048546|NCT02008916|566931764|FG000|Week 16 - 156|Pregnancy|0|||
157048547|NCT02008916|566931765|FG001|Week 16 - 156|Pregnancy|1|||
157048548|NCT02008916|566931766|FG002|Week 16 - 156|Pregnancy|0|||
157048549|NCT02008916|566931764|FG000|Week 16 - 156|Physician Decision|0|||
157048550|NCT02008916|566931765|FG001|Week 16 - 156|Physician Decision|1|||
157048551|NCT02008916|566931766|FG002|Week 16 - 156|Physician Decision|0|||
157048552|NCT01323790|566931767|FG000|Overall Study|Other|3|||
157048553|NCT01323790|566931768|FG001|Overall Study|Other|2|||
157048554|NCT01323790|566931769|FG002|Overall Study|Other|1|||
157048555|NCT01323790|566931767|FG000|Overall Study|Lost to Follow-up|11|||
157048556|NCT01323790|566931768|FG001|Overall Study|Lost to Follow-up|9|||
157175928|NCT01468701|567383827|FG001|Overall Study|Withdrawal by Subject|0|||
157175929|NCT01468701|567383828|FG002|Overall Study|Withdrawal by Subject|0|||
157175930|NCT01468701|567383829|FG003|Overall Study|Withdrawal by Subject|0|||
157175931|NCT01468701|567383830|FG004|Overall Study|Withdrawal by Subject|0|||
157175932|NCT01468701|567383831|FG005|Overall Study|Withdrawal by Subject|0|||
157175933|NCT01468701|567383832|FG006|Overall Study|Withdrawal by Subject|0|||
157175934|NCT01468701|567383833|FG007|Overall Study|Withdrawal by Subject|0|||
156970834|NCT03474107|566646204|FG000|Overall Study|Progressive Disease|177|||
156970835|NCT03474107|566646205|FG001|Overall Study|Progressive Disease|180|||
156970836|NCT03474107|566646204|FG000|Overall Study|Protocol Violation|1|||
156970837|NCT03474107|566646205|FG001|Overall Study|Protocol Violation|1|||
156970838|NCT03474107|566646204|FG000|Overall Study|Withdrawal by Subject|15|||
156970839|NCT03474107|566646205|FG001|Overall Study|Withdrawal by Subject|27|||
156970840|NCT03474107|566646204|FG000|Overall Study|Physician Decision|7|||
156970841|NCT03474107|566646205|FG001|Overall Study|Physician Decision|22|||
156970842|NCT03474107|566646204|FG000|Overall Study|Miscellaneous|1|||
156970843|NCT03474107|566646205|FG001|Overall Study|Miscellaneous|6|||
156970844|NCT04207840|566646206|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
156970845|NCT04207840|566646207|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
156970846|NCT04207840|566646208|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
156970847|NCT04207840|566646206|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
156970848|NCT04207840|566646207|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
156970849|NCT04207840|566646208|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
156970850|NCT03430063|566646212|FG000|Overall Study|Adverse Event|0|||
156970851|NCT03430063|566646213|FG001|Overall Study|Adverse Event|1|||
156970852|NCT03430063|566646214|FG002|Overall Study|Adverse Event|0|||
156970853|NCT03430063|566646212|FG000|Overall Study|Death|3|||
156970854|NCT03430063|566646213|FG001|Overall Study|Death|2|||
156970855|NCT03430063|566646214|FG002|Overall Study|Death|3|||
156970856|NCT03430063|566646212|FG000|Overall Study|Lost to Follow-up|0|||
156970857|NCT03430063|566646213|FG001|Overall Study|Lost to Follow-up|1|||
156970858|NCT03430063|566646214|FG002|Overall Study|Lost to Follow-up|0|||
156970859|NCT03430063|566646212|FG000|Overall Study|Withdrawal by Subject|0|||
156970860|NCT03430063|566646213|FG001|Overall Study|Withdrawal by Subject|0|||
156970861|NCT03430063|566646214|FG002|Overall Study|Withdrawal by Subject|1|||
157048557|NCT01323790|566931769|FG002|Overall Study|Lost to Follow-up|9|||
157048558|NCT01323790|566931767|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
157048559|NCT01323790|566931768|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
157048560|NCT01323790|566931769|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
157048561|NCT01323790|566931767|FG000|Overall Study|Lack of Efficacy|3|||
157175935|NCT01468701|567383834|FG008|Overall Study|Withdrawal by Subject|83|||
156970862|NCT03430063|566646212|FG000|Overall Study|Withdrawal of consent|3|||
157048562|NCT01323790|566931768|FG001|Overall Study|Lack of Efficacy|0|||
156970863|NCT03430063|566646213|FG001|Overall Study|Withdrawal of consent|1|||
156970864|NCT03430063|566646214|FG002|Overall Study|Withdrawal of consent|2|||
156970865|NCT03430063|566646212|FG000|Overall Study|Progressive disease|1|||
156970866|NCT03430063|566646213|FG001|Overall Study|Progressive disease|2|||
156970867|NCT03430063|566646214|FG002|Overall Study|Progressive disease|1|||
156970868|NCT03430063|566646212|FG000|Overall Study|Other un-specified|1|||
156970869|NCT03430063|566646213|FG001|Overall Study|Other un-specified|1|||
156970870|NCT03430063|566646214|FG002|Overall Study|Other un-specified|0|||
156970871|NCT03430063|566646212|FG000|Overall Study|Randomized, but never treated|0|||
156970872|NCT03430063|566646213|FG001|Overall Study|Randomized, but never treated|0|||
156970873|NCT03430063|566646214|FG002|Overall Study|Randomized, but never treated|1|||
156970874|NCT03124199|566646215|FG000|Overall Study|Lost to Follow-up|4|||
156970875|NCT03086018|566646216|FG000|Final Testing for End of Trial|Adverse Event|1|||
156970876|NCT03086018|566646216|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
156970877|NCT01892345|566646217|FG000|Overall Study|Adverse Event|0|||
156970878|NCT01892345|566646218|FG001|Overall Study|Adverse Event|2|||
156970879|NCT01892345|566646217|FG000|Overall Study|Death|1|||
156970880|NCT01892345|566646218|FG001|Overall Study|Death|0|||
156970881|NCT01892345|566646217|FG000|Overall Study|Lost to Follow-up|3|||
156970882|NCT01892345|566646218|FG001|Overall Study|Lost to Follow-up|0|||
156970883|NCT01892345|566646217|FG000|Overall Study|Withdrawal by Subject|12|||
156970884|NCT01892345|566646218|FG001|Overall Study|Withdrawal by Subject|1|||
156970885|NCT00659984|566646222|FG000|Overall Study|Adverse Event|1|||
156970886|NCT00621543|566646223|FG000|Overall Study|Lost to Follow-up|23|||
156970887|NCT01287611|566646225|FG000|Overall Study|Lost to Follow-up|29|||
156970888|NCT01287611|566646226|FG001|Overall Study|Lost to Follow-up|16|||
156970889|NCT01287611|566646225|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
156970890|NCT01287611|566646226|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
156970891|NCT02192970|566646227|FG000|Overall Study|Lost to Follow-up|6|||
156970892|NCT02192970|566646228|FG001|Overall Study|Lost to Follow-up|0|||
157048563|NCT01323790|566931769|FG002|Overall Study|Lack of Efficacy|3|||
157048564|NCT01323790|566931767|FG000|Overall Study|Adverse Event|11|||
157048565|NCT01323790|566931768|FG001|Overall Study|Adverse Event|24|||
157048566|NCT01323790|566931769|FG002|Overall Study|Adverse Event|12|||
157048567|NCT01323790|566931767|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
157048568|NCT01323790|566931768|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
157048569|NCT01323790|566931769|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
157048570|NCT01323790|566931767|FG000|Overall Study|Withdrawal by Subject|23|||
157048571|NCT01323790|566931768|FG001|Overall Study|Withdrawal by Subject|20|||
157048572|NCT01323790|566931769|FG002|Overall Study|Withdrawal by Subject|13|||
157048573|NCT01323790|566931767|FG000|Overall Study|Did Not Receive Treatment|2|||
156970893|NCT03745222|566646229|FG000|Overall Study|Withdrawal by Subject|0|||
156970894|NCT03745222|566646230|FG001|Overall Study|Withdrawal by Subject|1|||
156970895|NCT03745222|566646231|FG002|Overall Study|Withdrawal by Subject|0|||
156970896|NCT02657317|566646232|FG000|Overall Study|Withdrawal by Subject|2|||
156970897|NCT02657317|566646233|FG001|Overall Study|Withdrawal by Subject|0|||
156970898|NCT02657317|566646232|FG000|Overall Study|Lost to Follow-up|3|||
156970899|NCT02657317|566646233|FG001|Overall Study|Lost to Follow-up|3|||
156970900|NCT02634788|566646234|FG000|Overall Study|Adverse Event|0|||
157048574|NCT01323790|566931768|FG001|Overall Study|Did Not Receive Treatment|0|||
157048575|NCT01323790|566931769|FG002|Overall Study|Did Not Receive Treatment|1|||
157048576|NCT01323790|566931767|FG000|Overall Study|Severe non-compliance with protocol|2|||
157048577|NCT01323790|566931768|FG001|Overall Study|Severe non-compliance with protocol|2|||
157048578|NCT01323790|566931769|FG002|Overall Study|Severe non-compliance with protocol|2|||
157048579|NCT02915783|566931777|FG000|Overall Study|Death|21|||
157048580|NCT02915783|566931777|FG000|Overall Study|Lost to Follow-up|1|||
157048581|NCT02915783|566931777|FG000|Overall Study|Withdrawal by Subject|2|||
157048582|NCT02950961|566931778|FG000|Overall Study|Study had to stop due to COVID.|7|||
157048583|NCT01915914|566931779|FG000|Acute Phase|Withdrawal by Subject|4|||
157048584|NCT01915914|566931780|FG001|Acute Phase|Withdrawal by Subject|0|||
157048585|NCT01915914|566931781|FG002|Acute Phase|Withdrawal by Subject|0|||
157048586|NCT01915914|566931782|FG003|Acute Phase|Withdrawal by Subject|0|||
157048587|NCT01915914|566931779|FG000|Acute Phase|Lost to Follow-up|4|||
157048588|NCT01915914|566931780|FG001|Acute Phase|Lost to Follow-up|0|||
157048589|NCT01915914|566931781|FG002|Acute Phase|Lost to Follow-up|0|||
157048590|NCT01915914|566931782|FG003|Acute Phase|Lost to Follow-up|0|||
157048591|NCT01915914|566931779|FG000|Acute Phase|Physician Decision|1|||
157048592|NCT01915914|566931780|FG001|Acute Phase|Physician Decision|0|||
157175936|NCT01468701|567383835|FG009|Overall Study|Withdrawal by Subject|88|||
157175937|NCT01468701|567383836|FG010|Overall Study|Withdrawal by Subject|100|||
157175938|NCT01468701|567383837|FG011|Overall Study|Withdrawal by Subject|114|||
157175939|NCT01468701|567383838|FG012|Overall Study|Withdrawal by Subject|9|||
157048593|NCT01915914|566931781|FG002|Acute Phase|Physician Decision|0|||
157048594|NCT01915914|566931782|FG003|Acute Phase|Physician Decision|0|||
157048595|NCT01915914|566931779|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
157048596|NCT01915914|566931780|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
157048597|NCT01915914|566931781|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
156970901|NCT02634788|566646235|FG001|Overall Study|Adverse Event|8|||
156970902|NCT02634788|566646236|FG002|Overall Study|Adverse Event|3|||
156970903|NCT02634788|566646237|FG003|Overall Study|Adverse Event|1|||
156970904|NCT02634788|566646234|FG000|Overall Study|Lack of Efficacy|4|||
156970905|NCT02634788|566646235|FG001|Overall Study|Lack of Efficacy|0|||
157048598|NCT01915914|566931782|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
157048599|NCT01915914|566931779|FG000|Acute Phase|"Not Achieved treatment success"|1|||
157048600|NCT01915914|566931780|FG001|Acute Phase|"Not Achieved treatment success"|0|||
157048601|NCT01915914|566931781|FG002|Acute Phase|"Not Achieved treatment success"|0|||
157048602|NCT01915914|566931782|FG003|Acute Phase|"Not Achieved treatment success"|0|||
157048603|NCT01915914|566931779|FG000|Acute Phase|Missing|1|||
157048604|NCT01915914|566931780|FG001|Acute Phase|Missing|0|||
157048605|NCT01915914|566931781|FG002|Acute Phase|Missing|0|||
157048606|NCT01915914|566931782|FG003|Acute Phase|Missing|0|||
157048607|NCT01915914|566931779|FG000|Maintenance Phase|Withdrawal by Subject|0|||
157048608|NCT01915914|566931780|FG001|Maintenance Phase|Withdrawal by Subject|1|||
157048609|NCT01915914|566931781|FG002|Maintenance Phase|Withdrawal by Subject|1|||
157048610|NCT01915914|566931782|FG003|Maintenance Phase|Withdrawal by Subject|0|||
157048611|NCT01915914|566931779|FG000|Maintenance Phase|Lost to Follow-up|0|||
157048612|NCT01915914|566931780|FG001|Maintenance Phase|Lost to Follow-up|4|||
157048613|NCT01915914|566931781|FG002|Maintenance Phase|Lost to Follow-up|1|||
157048614|NCT01915914|566931782|FG003|Maintenance Phase|Lost to Follow-up|0|||
157048615|NCT01915914|566931779|FG000|Maintenance Phase|Missing|0|||
157048616|NCT01915914|566931780|FG001|Maintenance Phase|Missing|1|||
157048617|NCT01915914|566931781|FG002|Maintenance Phase|Missing|0|||
157048618|NCT01915914|566931782|FG003|Maintenance Phase|Missing|0|||
157048619|NCT01915914|566931779|FG000|Follow-up Phase|Withdrawal by Subject|0|||
157048620|NCT01915914|566931780|FG001|Follow-up Phase|Withdrawal by Subject|0|||
157048621|NCT01915914|566931781|FG002|Follow-up Phase|Withdrawal by Subject|0|||
157048622|NCT01915914|566931782|FG003|Follow-up Phase|Withdrawal by Subject|1|||
157048623|NCT01915914|566931779|FG000|Follow-up Phase|Physician Decision|0|||
157048624|NCT01915914|566931780|FG001|Follow-up Phase|Physician Decision|0|||
157048625|NCT01915914|566931781|FG002|Follow-up Phase|Physician Decision|0|||
157048626|NCT01915914|566931782|FG003|Follow-up Phase|Physician Decision|1|||
157048627|NCT02432274|566931784|FG000|Overall Study|Death|2|||
157048628|NCT02432274|566931785|FG001|Overall Study|Death|6|||
157048629|NCT02432274|566931786|FG002|Overall Study|Death|7|||
157048630|NCT02432274|566931787|FG003|Overall Study|Death|0|||
157048631|NCT02432274|566931788|FG004|Overall Study|Death|27|||
157048632|NCT02432274|566931789|FG005|Overall Study|Death|7|||
157048633|NCT02432274|566931790|FG006|Overall Study|Death|9|||
157048634|NCT02432274|566931791|FG007|Overall Study|Death|14|||
157048635|NCT02432274|566931784|FG000|Overall Study|Withdrawal of Consent|0|||
157048636|NCT02432274|566931785|FG001|Overall Study|Withdrawal of Consent|0|||
157048637|NCT02432274|566931786|FG002|Overall Study|Withdrawal of Consent|0|||
157048638|NCT02432274|566931787|FG003|Overall Study|Withdrawal of Consent|0|||
157048639|NCT02432274|566931788|FG004|Overall Study|Withdrawal of Consent|2|||
157048640|NCT02432274|566931789|FG005|Overall Study|Withdrawal of Consent|0|||
156970906|NCT02634788|566646236|FG002|Overall Study|Lack of Efficacy|1|||
156970907|NCT02634788|566646237|FG003|Overall Study|Lack of Efficacy|4|||
156970908|NCT02634788|566646234|FG000|Overall Study|Lost to Follow-up|0|||
156970909|NCT02634788|566646235|FG001|Overall Study|Lost to Follow-up|1|||
156970910|NCT02634788|566646236|FG002|Overall Study|Lost to Follow-up|0|||
156970911|NCT02634788|566646237|FG003|Overall Study|Lost to Follow-up|0|||
156970912|NCT02634788|566646234|FG000|Overall Study|Withdrawal by Subject|0|||
156970913|NCT02634788|566646235|FG001|Overall Study|Withdrawal by Subject|1|||
156970914|NCT02634788|566646236|FG002|Overall Study|Withdrawal by Subject|1|||
156970915|NCT02634788|566646237|FG003|Overall Study|Withdrawal by Subject|0|||
157048641|NCT02432274|566931790|FG006|Overall Study|Withdrawal of Consent|1|||
157048642|NCT02432274|566931791|FG007|Overall Study|Withdrawal of Consent|2|||
157048643|NCT01736475|566931792|FG000|Overall Study|Adverse Event|4|||
157175940|NCT01468701|567383839|FG013|Overall Study|Withdrawal by Subject|47|||
156970916|NCT01780935|566646250|FG000|Overall Study|Admin problems due to early termination|321|||
156970917|NCT01780935|566646251|FG001|Overall Study|Admin problems due to early termination|309|||
156970918|NCT01780935|566646250|FG000|Overall Study|Adverse Event|2|||
156970919|NCT01780935|566646251|FG001|Overall Study|Adverse Event|4|||
156970920|NCT01780935|566646250|FG000|Overall Study|Death|1|||
156970921|NCT01780935|566646251|FG001|Overall Study|Death|6|||
156970922|NCT01780935|566646250|FG000|Overall Study|Lost to Follow-up|2|||
157048644|NCT01736475|566931793|FG001|Overall Study|Adverse Event|0|||
157048645|NCT01736475|566931792|FG000|Overall Study|Withdrawal by Subject|2|||
156970923|NCT01780935|566646251|FG001|Overall Study|Lost to Follow-up|6|||
156970924|NCT01780935|566646250|FG000|Overall Study|Physician Decision|1|||
156970925|NCT01780935|566646251|FG001|Overall Study|Physician Decision|1|||
157048646|NCT01736475|566931793|FG001|Overall Study|Withdrawal by Subject|0|||
157048647|NCT01736475|566931792|FG000|Overall Study|Protocol Violation|4|||
157048648|NCT01736475|566931793|FG001|Overall Study|Protocol Violation|0|||
157048649|NCT01736475|566931792|FG000|Overall Study|Other - Screen failure|1|||
157048650|NCT01736475|566931793|FG001|Overall Study|Other - Screen failure|0|||
157048651|NCT01736475|566931792|FG000|Overall Study|Other - Surgical procedure|1|||
157048652|NCT01736475|566931793|FG001|Overall Study|Other - Surgical procedure|0|||
157048653|NCT02114515|566931795|FG000|Overall Study|Lost to Follow-up|52|||
156970926|NCT01780935|566646250|FG000|Overall Study|Protocol deviation|0|||
157048654|NCT02114515|566931796|FG001|Overall Study|Lost to Follow-up|55|||
157048655|NCT02114515|566931795|FG000|Overall Study|Death|12|||
157048656|NCT02114515|566931796|FG001|Overall Study|Death|12|||
157048657|NCT02114515|566931795|FG000|Overall Study|Withdrawal by Subject|4|||
157048658|NCT02114515|566931796|FG001|Overall Study|Withdrawal by Subject|22|||
157048659|NCT02114515|566931795|FG000|Overall Study|Other|65|||
157048660|NCT02114515|566931796|FG001|Overall Study|Other|61|||
157048661|NCT05487300|566933261|FG000|Overall Study|Withdrawal by Subject|1|||
157048662|NCT05487300|566933262|FG001|Overall Study|Withdrawal by Subject|0|||
157048663|NCT03141177|566933263|FG000|Overall Study|Death|62|||
157048664|NCT03141177|566933264|FG001|Overall Study|Death|13|||
157048665|NCT03141177|566933265|FG002|Overall Study|Death|84|||
157048666|NCT03141177|566933263|FG000|Overall Study|Participant withdrew consent|9|||
157048667|NCT03141177|566933264|FG001|Overall Study|Participant withdrew consent|2|||
157048668|NCT03141177|566933265|FG002|Overall Study|Participant withdrew consent|13|||
157048669|NCT03141177|566933263|FG000|Overall Study|Not reported|1|||
157048670|NCT03141177|566933264|FG001|Overall Study|Not reported|0|||
157048671|NCT03141177|566933265|FG002|Overall Study|Not reported|1|||
156970927|NCT01780935|566646251|FG001|Overall Study|Protocol deviation|1|||
156970928|NCT01780935|566646250|FG000|Overall Study|Patient withdrew consent|8|||
156970929|NCT01780935|566646251|FG001|Overall Study|Patient withdrew consent|9|||
156970930|NCT01281202|566646252|FG000|Overall Study|Adverse Event|2|||
156970931|NCT01281202|566646253|FG001|Overall Study|Adverse Event|0|||
156970932|NCT01281202|566646252|FG000|Overall Study|Withdrawal by Subject|2|||
156970933|NCT01281202|566646253|FG001|Overall Study|Withdrawal by Subject|2|||
156970934|NCT01281202|566646252|FG000|Overall Study|Protocol Violation|11|||
156970935|NCT01281202|566646253|FG001|Overall Study|Protocol Violation|10|||
156970936|NCT01281202|566646252|FG000|Overall Study|Administrative|2|||
156970937|NCT01281202|566646253|FG001|Overall Study|Administrative|8|||
156970938|NCT01281202|566646252|FG000|Overall Study|Lost to Follow-up|11|||
156970939|NCT01281202|566646253|FG001|Overall Study|Lost to Follow-up|13|||
156970940|NCT01281202|566646252|FG000|Overall Study|Incarceration|0|||
156970941|NCT01281202|566646253|FG001|Overall Study|Incarceration|3|||
156970942|NCT04581200|566646254|FG000|Overall Study|Lost to Follow-up|6|||
156970943|NCT04581200|566646255|FG001|Overall Study|Lost to Follow-up|5|||
156970944|NCT04711603|566646256|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
156970945|NCT04711603|566646257|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
156970946|NCT04711603|566646258|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
156970947|NCT04711603|566646259|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
156970948|NCT04711603|566646256|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156970949|NCT04711603|566646257|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
156970950|NCT04711603|566646258|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156970951|NCT04711603|566646259|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
156970952|NCT04711603|566646256|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
156970953|NCT04711603|566646257|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
157048672|NCT03141177|566933263|FG000|Overall Study|Lost to Follow-up|2|||
157048673|NCT03141177|566933264|FG001|Overall Study|Lost to Follow-up|1|||
157048674|NCT03141177|566933265|FG002|Overall Study|Lost to Follow-up|1|||
157048675|NCT03141177|566933263|FG000|Overall Study|Other reasons|4|||
157048676|NCT03141177|566933264|FG001|Overall Study|Other reasons|0|||
157048677|NCT03141177|566933265|FG002|Overall Study|Other reasons|11|||
157048678|NCT03141177|566933263|FG000|Overall Study|Participants did not start treatment period|3|||
157048679|NCT03141177|566933264|FG001|Overall Study|Participants did not start treatment period|0|||
157048680|NCT03141177|566933265|FG002|Overall Study|Participants did not start treatment period|8|||
157048681|NCT05006703|566933266|FG000|Overall Study|Withdrawal by Subject|1|||
157048682|NCT05006703|566933267|FG001|Overall Study|Withdrawal by Subject|0|||
157048683|NCT05006703|566933266|FG000|Overall Study|Lost to Follow-up|13|||
157048684|NCT05006703|566933267|FG001|Overall Study|Lost to Follow-up|5|||
157175941|NCT01468701|567383840|FG014|Overall Study|Withdrawal by Subject|6|||
157175942|NCT01468701|567383841|FG015|Overall Study|Withdrawal by Subject|31|||
157175943|NCT01468701|567383842|FG016|Overall Study|Withdrawal by Subject|0|||
157175944|NCT01468701|567383826|FG000|Overall Study|Other reasons than listed|437|||
157175945|NCT01468701|567383827|FG001|Overall Study|Other reasons than listed|0|||
156970954|NCT04711603|566646258|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
156970955|NCT04711603|566646259|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
157048685|NCT00264576|566933272|FG000|Overall Study|Lost to Follow-up|1|||
157048686|NCT00264576|566933273|FG001|Overall Study|Lost to Follow-up|1|||
157048687|NCT02659059|566933274|FG000|Overall Study|Other reasons|6|||
157175946|NCT01468701|567383828|FG002|Overall Study|Other reasons than listed|0|||
157175947|NCT01468701|567383829|FG003|Overall Study|Other reasons than listed|0|||
157175948|NCT01468701|567383830|FG004|Overall Study|Other reasons than listed|0|||
156970956|NCT04711603|566646256|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156970957|NCT04711603|566646257|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
157048688|NCT02659059|566933275|FG001|Overall Study|Other reasons|1|||
157048689|NCT02659059|566933274|FG000|Overall Study|Disease Progression|143|||
157048690|NCT02659059|566933275|FG001|Overall Study|Disease Progression|16|||
157048691|NCT02659059|566933274|FG000|Overall Study|Study Drug toxicity|56|||
157048692|NCT02659059|566933275|FG001|Overall Study|Study Drug toxicity|9|||
157048693|NCT02659059|566933274|FG000|Overall Study|Death|3|||
157048694|NCT02659059|566933275|FG001|Overall Study|Death|1|||
157048695|NCT02659059|566933274|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
157048696|NCT02659059|566933275|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
157048697|NCT02659059|566933274|FG000|Overall Study|Participant request to discontinue study treatment|5|||
157048698|NCT02659059|566933275|FG001|Overall Study|Participant request to discontinue study treatment|0|||
157048699|NCT02659059|566933274|FG000|Overall Study|Participant withdrew consent|6|||
157048700|NCT02659059|566933275|FG001|Overall Study|Participant withdrew consent|1|||
157048701|NCT00092456|566933278|FG000|Overall Study|Adverse Event|0|||
157048702|NCT00092456|566933279|FG001|Overall Study|Adverse Event|0|||
157048703|NCT00092456|566933280|FG002|Overall Study|Adverse Event|1|||
156970958|NCT04711603|566646258|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156970959|NCT04711603|566646259|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
156970960|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
156970961|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
156970962|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
156970963|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
156970964|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156970965|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156970966|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
156970967|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
156970968|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
156970969|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
156970970|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
156970971|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
156970972|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
156970973|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
156970974|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
156970975|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
156970976|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156970977|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156970978|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
156970979|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
156970980|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156970981|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156970982|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
156970983|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
156970984|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
156970985|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
157048704|NCT00092456|566933281|FG003|Overall Study|Adverse Event|1|||
157048705|NCT00092456|566933278|FG000|Overall Study|Lost to Follow-up|2|||
157048706|NCT00092456|566933279|FG001|Overall Study|Lost to Follow-up|2|||
157048707|NCT00092456|566933280|FG002|Overall Study|Lost to Follow-up|1|||
157048708|NCT00092456|566933281|FG003|Overall Study|Lost to Follow-up|2|||
157048709|NCT00092456|566933278|FG000|Overall Study|Protocol Violation|5|||
157048710|NCT00092456|566933279|FG001|Overall Study|Protocol Violation|7|||
157048711|NCT00092456|566933280|FG002|Overall Study|Protocol Violation|8|||
157048712|NCT00092456|566933281|FG003|Overall Study|Protocol Violation|6|||
157048713|NCT00092456|566933278|FG000|Overall Study|Withdrawal by Subject|13|||
157048714|NCT00092456|566933279|FG001|Overall Study|Withdrawal by Subject|5|||
157048715|NCT00092456|566933280|FG002|Overall Study|Withdrawal by Subject|16|||
157048716|NCT00092456|566933281|FG003|Overall Study|Withdrawal by Subject|6|||
157048717|NCT00092456|566933278|FG000|Overall Study|Moved|1|||
157048718|NCT00092456|566933279|FG001|Overall Study|Moved|1|||
157048719|NCT00092456|566933280|FG002|Overall Study|Moved|0|||
157048720|NCT00092456|566933281|FG003|Overall Study|Moved|1|||
157048721|NCT00092456|566933278|FG000|Overall Study|Other|4|||
157175949|NCT01468701|567383831|FG005|Overall Study|Other reasons than listed|0|||
157175950|NCT01468701|567383832|FG006|Overall Study|Other reasons than listed|0|||
157048722|NCT00092456|566933279|FG001|Overall Study|Other|2|||
157048723|NCT00092456|566933280|FG002|Overall Study|Other|3|||
157048724|NCT00092456|566933281|FG003|Overall Study|Other|0|||
157048725|NCT04783389|566933282|FG000|Overall Study|Withdrawal by Subject|2|||
157048726|NCT04783389|566933283|FG001|Overall Study|Withdrawal by Subject|0|||
157048727|NCT04783389|566933284|FG002|Overall Study|Withdrawal by Subject|0|||
157048728|NCT04783389|566933282|FG000|Overall Study|Termination of Study by Sponsor|10|||
157175951|NCT01468701|567383833|FG007|Overall Study|Other reasons than listed|0|||
157048729|NCT04783389|566933283|FG001|Overall Study|Termination of Study by Sponsor|12|||
157229199|NCT00048048|567585157|FG000|Extension Year 2|Early withdrawals|0|||
156970986|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
156970987|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
156970988|NCT04711603|566646256|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156970989|NCT04711603|566646257|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156970990|NCT04711603|566646258|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
156970991|NCT04711603|566646259|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
156970992|NCT05479604|566646260|FG000|Overall Study|Lost to Follow-up|1|||
156970993|NCT05479604|566646261|FG001|Overall Study|Lost to Follow-up|5|||
156970994|NCT01591382|566646262|FG000|Overall Study|Discharged Prior to Study Completion|2|||
156970995|NCT01591382|566646263|FG001|Overall Study|Discharged Prior to Study Completion|1|||
156970996|NCT01591382|566646262|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
156970997|NCT01591382|566646263|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
156970998|NCT04252742|566646265|FG000|Overall Study|Decision by sponsor|0|||
156970999|NCT04252742|566646266|FG001|Overall Study|Decision by sponsor|2|||
156971000|NCT04252742|566646265|FG000|Overall Study|Withdrawal by Subject|15|||
156971001|NCT04252742|566646266|FG001|Overall Study|Withdrawal by Subject|9|||
156971002|NCT04252742|566646265|FG000|Overall Study|Lost to Follow-up|0|||
156971003|NCT04252742|566646266|FG001|Overall Study|Lost to Follow-up|1|||
156971004|NCT04359784|566646268|FG000|Overall Study|Death|2|||
156971005|NCT00504426|566646274|FG000|Overall Study|Adverse Event|0|||
156971006|NCT00504426|566646275|FG001|Overall Study|Adverse Event|0|||
156971007|NCT00504426|566646276|FG002|Overall Study|Adverse Event|2|||
156971008|NCT00504426|566646277|FG003|Overall Study|Adverse Event|0|||
156971009|NCT00504426|566646274|FG000|Overall Study|Protocol Violation|1|||
156971010|NCT00504426|566646275|FG001|Overall Study|Protocol Violation|1|||
156971011|NCT00504426|566646276|FG002|Overall Study|Protocol Violation|2|||
156971012|NCT00504426|566646277|FG003|Overall Study|Protocol Violation|0|||
156971013|NCT00504426|566646274|FG000|Overall Study|Withdrawal by Subject|2|||
156971014|NCT00504426|566646275|FG001|Overall Study|Withdrawal by Subject|0|||
156971015|NCT00504426|566646276|FG002|Overall Study|Withdrawal by Subject|0|||
156971016|NCT00504426|566646277|FG003|Overall Study|Withdrawal by Subject|0|||
156971017|NCT03685591|566646280|FG000|Overall Study|Global Deterioration of Health Status|0|||
156971018|NCT03685591|566646281|FG001|Overall Study|Global Deterioration of Health Status|0|||
156971019|NCT03685591|566646282|FG002|Overall Study|Global Deterioration of Health Status|0|||
156971020|NCT03685591|566646283|FG003|Overall Study|Global Deterioration of Health Status|1|||
156971021|NCT03685591|566646284|FG004|Overall Study|Global Deterioration of Health Status|2|||
156971022|NCT03685591|566646285|FG005|Overall Study|Global Deterioration of Health Status|4|||
156971023|NCT03685591|566646286|FG006|Overall Study|Global Deterioration of Health Status|1|||
156971024|NCT03685591|566646287|FG007|Overall Study|Global Deterioration of Health Status|1|||
156971025|NCT03685591|566646288|FG008|Overall Study|Global Deterioration of Health Status|0|||
156971026|NCT03685591|566646280|FG000|Overall Study|Progressive Disease|1|||
156971027|NCT03685591|566646281|FG001|Overall Study|Progressive Disease|1|||
156971028|NCT03685591|566646282|FG002|Overall Study|Progressive Disease|0|||
156971029|NCT03685591|566646283|FG003|Overall Study|Progressive Disease|3|||
156971030|NCT03685591|566646284|FG004|Overall Study|Progressive Disease|5|||
156971031|NCT03685591|566646285|FG005|Overall Study|Progressive Disease|4|||
156971032|NCT03685591|566646286|FG006|Overall Study|Progressive Disease|3|||
156971033|NCT03685591|566646287|FG007|Overall Study|Progressive Disease|2|||
156971034|NCT03685591|566646288|FG008|Overall Study|Progressive Disease|1|||
156971035|NCT03685591|566646280|FG000|Overall Study|Other|0|||
156971036|NCT03685591|566646281|FG001|Overall Study|Other|0|||
156971037|NCT03685591|566646282|FG002|Overall Study|Other|1|||
156971038|NCT03685591|566646283|FG003|Overall Study|Other|0|||
156971039|NCT03685591|566646284|FG004|Overall Study|Other|2|||
156971040|NCT03685591|566646285|FG005|Overall Study|Other|3|||
156971041|NCT03685591|566646286|FG006|Overall Study|Other|0|||
156971042|NCT03685591|566646287|FG007|Overall Study|Other|0|||
156971043|NCT03685591|566646288|FG008|Overall Study|Other|0|||
156971044|NCT03685591|566646280|FG000|Overall Study|Withdrawal by Subject|0|||
156971045|NCT03685591|566646281|FG001|Overall Study|Withdrawal by Subject|0|||
156971046|NCT03685591|566646282|FG002|Overall Study|Withdrawal by Subject|0|||
156971047|NCT03685591|566646283|FG003|Overall Study|Withdrawal by Subject|0|||
156971048|NCT03685591|566646284|FG004|Overall Study|Withdrawal by Subject|3|||
156971049|NCT03685591|566646285|FG005|Overall Study|Withdrawal by Subject|2|||
156971050|NCT03685591|566646286|FG006|Overall Study|Withdrawal by Subject|0|||
156971051|NCT03685591|566646287|FG007|Overall Study|Withdrawal by Subject|0|||
156971052|NCT03685591|566646288|FG008|Overall Study|Withdrawal by Subject|1|||
156971053|NCT03685591|566646280|FG000|Overall Study|Adverse Event|0|||
156971054|NCT03685591|566646281|FG001|Overall Study|Adverse Event|0|||
156971055|NCT03685591|566646282|FG002|Overall Study|Adverse Event|0|||
157048730|NCT04783389|566933284|FG002|Overall Study|Termination of Study by Sponsor|14|||
156971056|NCT03685591|566646283|FG003|Overall Study|Adverse Event|1|||
156971057|NCT03685591|566646284|FG004|Overall Study|Adverse Event|1|||
157048731|NCT00215943|566933285|FG000|Overall Study|Disease Progression|3|||
156971058|NCT03685591|566646285|FG005|Overall Study|Adverse Event|4|||
156971059|NCT03685591|566646286|FG006|Overall Study|Adverse Event|0|||
156971060|NCT03685591|566646287|FG007|Overall Study|Adverse Event|1|||
156971061|NCT03685591|566646288|FG008|Overall Study|Adverse Event|1|||
156971062|NCT01685138|566646291|FG000|Overall Study|Lost to Follow-up|1|||
156971063|NCT01685138|566646291|FG000|Overall Study|Protocol Violation|1|||
156971064|NCT01685138|566646291|FG000|Overall Study|No longer requires treatment|1|||
156971065|NCT01685138|566646291|FG000|Overall Study|Subject/guardian decision|2|||
156971066|NCT01685138|566646291|FG000|Overall Study|Physician Decision|6|||
156971067|NCT01685138|566646291|FG000|Overall Study|Death|10|||
156971068|NCT01685138|566646291|FG000|Overall Study|Adverse Event|18|||
156971069|NCT01685138|566646291|FG000|Overall Study|Progressive disease|53|||
156971070|NCT02220894|566646298|FG000|Overall Study|Adverse Event|127|||
156971071|NCT02220894|566646299|FG001|Overall Study|Adverse Event|74|||
156971072|NCT02220894|566646298|FG000|Overall Study|Death|418|||
156971073|NCT02220894|566646299|FG001|Overall Study|Death|508|||
156971074|NCT02220894|566646298|FG000|Overall Study|Lost to Follow-up|0|||
156971075|NCT02220894|566646299|FG001|Overall Study|Lost to Follow-up|4|||
156971076|NCT02220894|566646298|FG000|Overall Study|Site Terminated by Sponsor|2|||
156971077|NCT02220894|566646299|FG001|Overall Study|Site Terminated by Sponsor|0|||
156971078|NCT02220894|566646298|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
156971079|NCT02220894|566646299|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
156971080|NCT02220894|566646298|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
156971081|NCT02220894|566646299|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
156971082|NCT02220894|566646298|FG000|Overall Study|Withdrawal by Subject|10|||
156971083|NCT02220894|566646299|FG001|Overall Study|Withdrawal by Subject|9|||
156971084|NCT03217747|566646300|FG000|Overall Study|Adverse Event|0|||
156971085|NCT03217747|566646301|FG001|Overall Study|Adverse Event|1|||
156971086|NCT03217747|566646302|FG002|Overall Study|Adverse Event|0|||
156971087|NCT03217747|566646303|FG003|Overall Study|Adverse Event|0|||
156971088|NCT03217747|566646304|FG004|Overall Study|Adverse Event|0|||
156971089|NCT03217747|566646305|FG005|Overall Study|Adverse Event|0|||
156971090|NCT03217747|566646306|FG006|Overall Study|Adverse Event|0|||
156971091|NCT03217747|566646307|FG007|Overall Study|Adverse Event|0|||
156971092|NCT03217747|566646308|FG008|Overall Study|Adverse Event|0|||
156971093|NCT03217747|566646309|FG009|Overall Study|Adverse Event|0|||
156971094|NCT03217747|566646310|FG010|Overall Study|Adverse Event|0|||
156971095|NCT03217747|566646311|FG011|Overall Study|Adverse Event|0|||
156971096|NCT03217747|566646312|FG012|Overall Study|Adverse Event|1|||
156971097|NCT03217747|566646313|FG013|Overall Study|Adverse Event|1|||
156971098|NCT03217747|566646300|FG000|Overall Study|Death|0|||
156971099|NCT03217747|566646301|FG001|Overall Study|Death|0|||
156971100|NCT03217747|566646302|FG002|Overall Study|Death|0|||
156971101|NCT03217747|566646303|FG003|Overall Study|Death|0|||
156971102|NCT03217747|566646304|FG004|Overall Study|Death|0|||
156971103|NCT03217747|566646305|FG005|Overall Study|Death|0|||
156971104|NCT03217747|566646306|FG006|Overall Study|Death|0|||
156971105|NCT03217747|566646307|FG007|Overall Study|Death|0|||
156971106|NCT03217747|566646308|FG008|Overall Study|Death|1|||
156971107|NCT03217747|566646309|FG009|Overall Study|Death|0|||
156971108|NCT03217747|566646310|FG010|Overall Study|Death|0|||
156971109|NCT03217747|566646311|FG011|Overall Study|Death|0|||
156971110|NCT03217747|566646312|FG012|Overall Study|Death|0|||
156971111|NCT03217747|566646313|FG013|Overall Study|Death|0|||
156971112|NCT03217747|566646300|FG000|Overall Study|Lack of Efficacy|12|||
156971113|NCT03217747|566646301|FG001|Overall Study|Lack of Efficacy|6|||
156971114|NCT03217747|566646302|FG002|Overall Study|Lack of Efficacy|15|||
156971115|NCT03217747|566646303|FG003|Overall Study|Lack of Efficacy|11|||
156971116|NCT03217747|566646304|FG004|Overall Study|Lack of Efficacy|3|||
156971117|NCT03217747|566646305|FG005|Overall Study|Lack of Efficacy|14|||
156971118|NCT03217747|566646306|FG006|Overall Study|Lack of Efficacy|10|||
157048732|NCT00215943|566933286|FG001|Overall Study|Disease Progression|5|||
157048733|NCT00215943|566933285|FG000|Overall Study|Alternate therapy|0|||
157048734|NCT00215943|566933286|FG001|Overall Study|Alternate therapy|1|||
157048735|NCT00215943|566933285|FG000|Overall Study|Adverse Event|3|||
156971119|NCT03217747|566646307|FG007|Overall Study|Lack of Efficacy|4|||
156971120|NCT03217747|566646308|FG008|Overall Study|Lack of Efficacy|2|||
156971121|NCT03217747|566646309|FG009|Overall Study|Lack of Efficacy|7|||
156971122|NCT03217747|566646310|FG010|Overall Study|Lack of Efficacy|3|||
156971123|NCT03217747|566646311|FG011|Overall Study|Lack of Efficacy|1|||
156971124|NCT03217747|566646312|FG012|Overall Study|Lack of Efficacy|3|||
157048736|NCT00215943|566933286|FG001|Overall Study|Adverse Event|6|||
157048737|NCT00215943|566933285|FG000|Overall Study|Other disease|0|||
156971125|NCT03217747|566646313|FG013|Overall Study|Lack of Efficacy|1|||
156971126|NCT03217747|566646300|FG000|Overall Study|Withdrawal by Subject|2|||
156971127|NCT03217747|566646301|FG001|Overall Study|Withdrawal by Subject|1|||
156971128|NCT03217747|566646302|FG002|Overall Study|Withdrawal by Subject|1|||
156971129|NCT03217747|566646303|FG003|Overall Study|Withdrawal by Subject|1|||
156971130|NCT03217747|566646304|FG004|Overall Study|Withdrawal by Subject|1|||
156971131|NCT03217747|566646305|FG005|Overall Study|Withdrawal by Subject|2|||
157048738|NCT00215943|566933286|FG001|Overall Study|Other disease|1|||
157048739|NCT00215943|566933285|FG000|Overall Study|Other complications|3|||
157048740|NCT00215943|566933286|FG001|Overall Study|Other complications|1|||
157048741|NCT02121808|566933287|FG000|Overall Study|Technical problem|3|||
157048742|NCT03924193|566933288|FG000|Overall Study|Adverse Event|10|||
157048743|NCT03924193|566933289|FG001|Overall Study|Adverse Event|0|||
156971132|NCT03217747|566646306|FG006|Overall Study|Withdrawal by Subject|1|||
156971133|NCT03217747|566646307|FG007|Overall Study|Withdrawal by Subject|0|||
156971134|NCT03217747|566646308|FG008|Overall Study|Withdrawal by Subject|0|||
156971135|NCT03217747|566646309|FG009|Overall Study|Withdrawal by Subject|0|||
156971136|NCT03217747|566646310|FG010|Overall Study|Withdrawal by Subject|0|||
156971137|NCT03217747|566646311|FG011|Overall Study|Withdrawal by Subject|1|||
156971138|NCT03217747|566646312|FG012|Overall Study|Withdrawal by Subject|0|||
156971139|NCT03217747|566646313|FG013|Overall Study|Withdrawal by Subject|1|||
156971140|NCT03217747|566646300|FG000|Overall Study|Toxicity and progression|1|||
156971141|NCT03217747|566646301|FG001|Overall Study|Toxicity and progression|0|||
157048744|NCT03924193|566933290|FG002|Overall Study|Adverse Event|10|||
157048745|NCT03924193|566933288|FG000|Overall Study|Withdrawal by Subject|5|||
157048746|NCT03924193|566933289|FG001|Overall Study|Withdrawal by Subject|10|||
157048747|NCT03924193|566933290|FG002|Overall Study|Withdrawal by Subject|2|||
157048748|NCT01562275|566933291|FG000|Stage 1|Adverse Event|0|||
157048749|NCT01562275|566933292|FG001|Stage 1|Adverse Event|0|||
157048750|NCT01562275|566933293|FG002|Stage 1|Adverse Event|0|||
157048751|NCT01562275|566933294|FG003|Stage 1|Adverse Event|1|||
157048752|NCT01562275|566933295|FG004|Stage 1|Adverse Event|1|||
157048753|NCT01562275|566933296|FG005|Stage 1|Adverse Event|0|||
157048754|NCT01562275|566933297|FG006|Stage 1|Adverse Event|0|||
157048755|NCT01562275|566933298|FG007|Stage 1|Adverse Event|0|||
157048756|NCT01562275|566933299|FG008|Stage 1|Adverse Event|0|||
157048757|NCT01562275|566933300|FG009|Stage 1|Adverse Event|1|||
157048758|NCT01562275|566933301|FG010|Stage 1|Adverse Event|0|||
157048759|NCT01562275|566933302|FG011|Stage 1|Adverse Event|0|||
157048760|NCT01562275|566933303|FG012|Stage 1|Adverse Event|0|||
157048761|NCT01562275|566933291|FG000|Stage 1|Death|1|||
157048762|NCT01562275|566933292|FG001|Stage 1|Death|0|||
157048763|NCT01562275|566933293|FG002|Stage 1|Death|0|||
157048764|NCT01562275|566933294|FG003|Stage 1|Death|0|||
157048765|NCT01562275|566933295|FG004|Stage 1|Death|0|||
157048766|NCT01562275|566933296|FG005|Stage 1|Death|0|||
157048767|NCT01562275|566933297|FG006|Stage 1|Death|0|||
157048768|NCT01562275|566933298|FG007|Stage 1|Death|0|||
157048769|NCT01562275|566933299|FG008|Stage 1|Death|0|||
157048770|NCT01562275|566933300|FG009|Stage 1|Death|0|||
157048771|NCT01562275|566933301|FG010|Stage 1|Death|0|||
157048772|NCT01562275|566933302|FG011|Stage 1|Death|0|||
157048773|NCT01562275|566933303|FG012|Stage 1|Death|0|||
157048774|NCT01562275|566933291|FG000|Stage 1|Non Compliance|0|||
157048775|NCT01562275|566933292|FG001|Stage 1|Non Compliance|0|||
157048776|NCT01562275|566933293|FG002|Stage 1|Non Compliance|1|||
157048777|NCT01562275|566933294|FG003|Stage 1|Non Compliance|0|||
157048778|NCT01562275|566933295|FG004|Stage 1|Non Compliance|0|||
157048779|NCT01562275|566933296|FG005|Stage 1|Non Compliance|0|||
157048780|NCT01562275|566933297|FG006|Stage 1|Non Compliance|0|||
157048781|NCT01562275|566933298|FG007|Stage 1|Non Compliance|0|||
157048782|NCT01562275|566933299|FG008|Stage 1|Non Compliance|0|||
157048783|NCT01562275|566933300|FG009|Stage 1|Non Compliance|0|||
157048784|NCT01562275|566933301|FG010|Stage 1|Non Compliance|0|||
157048785|NCT01562275|566933302|FG011|Stage 1|Non Compliance|0|||
157048786|NCT01562275|566933303|FG012|Stage 1|Non Compliance|0|||
157048787|NCT01562275|566933291|FG000|Stage 1|Physician Decision|0|||
157048788|NCT01562275|566933292|FG001|Stage 1|Physician Decision|0|||
157048789|NCT01562275|566933293|FG002|Stage 1|Physician Decision|0|||
157048790|NCT01562275|566933294|FG003|Stage 1|Physician Decision|0|||
157048791|NCT01562275|566933295|FG004|Stage 1|Physician Decision|1|||
157048792|NCT01562275|566933296|FG005|Stage 1|Physician Decision|0|||
157048793|NCT01562275|566933297|FG006|Stage 1|Physician Decision|1|||
157048794|NCT01562275|566933298|FG007|Stage 1|Physician Decision|0|||
157048795|NCT01562275|566933299|FG008|Stage 1|Physician Decision|1|||
157048796|NCT01562275|566933300|FG009|Stage 1|Physician Decision|0|||
157048797|NCT01562275|566933301|FG010|Stage 1|Physician Decision|0|||
157048798|NCT01562275|566933302|FG011|Stage 1|Physician Decision|0|||
157048799|NCT01562275|566933303|FG012|Stage 1|Physician Decision|0|||
157048800|NCT01562275|566933291|FG000|Stage 1|Progression of Disease|2|||
157048801|NCT01562275|566933292|FG001|Stage 1|Progression of Disease|6|||
156971142|NCT03217747|566646302|FG002|Overall Study|Toxicity and progression|0|||
157048802|NCT01562275|566933293|FG002|Stage 1|Progression of Disease|2|||
157048803|NCT01562275|566933294|FG003|Stage 1|Progression of Disease|1|||
157048804|NCT01562275|566933295|FG004|Stage 1|Progression of Disease|2|||
157048805|NCT01562275|566933296|FG005|Stage 1|Progression of Disease|4|||
157048806|NCT01562275|566933297|FG006|Stage 1|Progression of Disease|1|||
157048807|NCT01562275|566933298|FG007|Stage 1|Progression of Disease|7|||
157048808|NCT01562275|566933299|FG008|Stage 1|Progression of Disease|2|||
157048809|NCT01562275|566933300|FG009|Stage 1|Progression of Disease|5|||
157048810|NCT01562275|566933301|FG010|Stage 1|Progression of Disease|3|||
157048811|NCT01562275|566933302|FG011|Stage 1|Progression of Disease|0|||
157048812|NCT01562275|566933303|FG012|Stage 1|Progression of Disease|0|||
157048813|NCT01562275|566933291|FG000|Stage 1|Withdrawal by Subject|0|||
156971143|NCT03217747|566646303|FG003|Overall Study|Toxicity and progression|0|||
156971144|NCT03217747|566646304|FG004|Overall Study|Toxicity and progression|0|||
156971145|NCT03217747|566646305|FG005|Overall Study|Toxicity and progression|0|||
156971146|NCT03217747|566646306|FG006|Overall Study|Toxicity and progression|0|||
156971147|NCT03217747|566646307|FG007|Overall Study|Toxicity and progression|0|||
156971148|NCT03217747|566646308|FG008|Overall Study|Toxicity and progression|0|||
156971149|NCT03217747|566646309|FG009|Overall Study|Toxicity and progression|0|||
156971150|NCT03217747|566646310|FG010|Overall Study|Toxicity and progression|0|||
156971151|NCT03217747|566646311|FG011|Overall Study|Toxicity and progression|0|||
156971152|NCT03217747|566646312|FG012|Overall Study|Toxicity and progression|0|||
156971153|NCT03217747|566646313|FG013|Overall Study|Toxicity and progression|0|||
156971154|NCT03217747|566646300|FG000|Overall Study|Removal of sole target lesion|1|||
156971155|NCT03217747|566646301|FG001|Overall Study|Removal of sole target lesion|0|||
156971156|NCT03217747|566646302|FG002|Overall Study|Removal of sole target lesion|0|||
156971157|NCT03217747|566646303|FG003|Overall Study|Removal of sole target lesion|0|||
156971158|NCT03217747|566646304|FG004|Overall Study|Removal of sole target lesion|0|||
156971159|NCT03217747|566646305|FG005|Overall Study|Removal of sole target lesion|0|||
156971160|NCT03217747|566646306|FG006|Overall Study|Removal of sole target lesion|0|||
156971161|NCT03217747|566646307|FG007|Overall Study|Removal of sole target lesion|0|||
156971162|NCT03217747|566646308|FG008|Overall Study|Removal of sole target lesion|0|||
156971163|NCT03217747|566646309|FG009|Overall Study|Removal of sole target lesion|0|||
156971164|NCT03217747|566646310|FG010|Overall Study|Removal of sole target lesion|0|||
156971165|NCT03217747|566646311|FG011|Overall Study|Removal of sole target lesion|0|||
156971166|NCT03217747|566646312|FG012|Overall Study|Removal of sole target lesion|0|||
156971167|NCT03217747|566646313|FG013|Overall Study|Removal of sole target lesion|0|||
156971168|NCT03217747|566646300|FG000|Overall Study|Stroke|0|||
156971169|NCT03217747|566646301|FG001|Overall Study|Stroke|0|||
156971170|NCT03217747|566646302|FG002|Overall Study|Stroke|0|||
156971171|NCT03217747|566646303|FG003|Overall Study|Stroke|0|||
156971172|NCT03217747|566646304|FG004|Overall Study|Stroke|0|||
156971173|NCT03217747|566646305|FG005|Overall Study|Stroke|1|||
156971174|NCT03217747|566646306|FG006|Overall Study|Stroke|0|||
156971175|NCT03217747|566646307|FG007|Overall Study|Stroke|0|||
156971176|NCT03217747|566646308|FG008|Overall Study|Stroke|0|||
157048814|NCT01562275|566933292|FG001|Stage 1|Withdrawal by Subject|1|||
157048815|NCT01562275|566933293|FG002|Stage 1|Withdrawal by Subject|0|||
157048816|NCT01562275|566933294|FG003|Stage 1|Withdrawal by Subject|2|||
157048817|NCT01562275|566933295|FG004|Stage 1|Withdrawal by Subject|0|||
157048818|NCT01562275|566933296|FG005|Stage 1|Withdrawal by Subject|0|||
157175952|NCT01468701|567383834|FG008|Overall Study|Other reasons than listed|318|||
157175953|NCT01468701|567383835|FG009|Overall Study|Other reasons than listed|658|||
157175954|NCT01468701|567383836|FG010|Overall Study|Other reasons than listed|433|||
157175955|NCT01468701|567383837|FG011|Overall Study|Other reasons than listed|504|||
157175956|NCT01468701|567383838|FG012|Overall Study|Other reasons than listed|28|||
157175957|NCT01468701|567383839|FG013|Overall Study|Other reasons than listed|239|||
156971177|NCT03217747|566646309|FG009|Overall Study|Stroke|0|||
156971178|NCT03217747|566646310|FG010|Overall Study|Stroke|0|||
156971179|NCT03217747|566646311|FG011|Overall Study|Stroke|1|||
156971180|NCT03217747|566646312|FG012|Overall Study|Stroke|0|||
156971181|NCT03217747|566646313|FG013|Overall Study|Stroke|0|||
156971182|NCT03996291|566646314|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
156971183|NCT03996291|566646315|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
156971184|NCT03996291|566646316|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
156971185|NCT03996291|566646317|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
156971186|NCT03996291|566646318|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
156971187|NCT03996291|566646319|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
156971188|NCT03996291|566646320|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
156971189|NCT03996291|566646321|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
156971190|NCT03996291|566646314|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156971191|NCT03996291|566646315|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156971192|NCT03996291|566646316|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156971193|NCT03996291|566646317|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156971194|NCT03996291|566646318|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
156971195|NCT03996291|566646319|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
156971196|NCT03996291|566646320|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
157048819|NCT01562275|566933297|FG006|Stage 1|Withdrawal by Subject|1|||
157048820|NCT01562275|566933298|FG007|Stage 1|Withdrawal by Subject|0|||
157175958|NCT01468701|567383840|FG014|Overall Study|Other reasons than listed|39|||
157175959|NCT01468701|567383841|FG015|Overall Study|Other reasons than listed|172|||
157175960|NCT01468701|567383842|FG016|Overall Study|Other reasons than listed|0|||
156971197|NCT03996291|566646321|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
157048821|NCT01562275|566933299|FG008|Stage 1|Withdrawal by Subject|0|||
157048822|NCT01562275|566933300|FG009|Stage 1|Withdrawal by Subject|1|||
156971198|NCT03996291|566646314|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971199|NCT03996291|566646315|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971200|NCT03996291|566646316|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971201|NCT03996291|566646317|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971202|NCT03996291|566646318|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
156971203|NCT03996291|566646319|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971204|NCT03996291|566646320|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
156971205|NCT03996291|566646321|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
156971206|NCT03996291|566646314|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
156971207|NCT03996291|566646315|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
156971208|NCT03996291|566646316|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
156971209|NCT03996291|566646317|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
156971210|NCT03996291|566646318|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
156971211|NCT03996291|566646319|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
156971212|NCT03996291|566646320|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
156971213|NCT03996291|566646321|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
156971214|NCT03996291|566646314|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971215|NCT03996291|566646315|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971216|NCT03996291|566646316|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971217|NCT03996291|566646317|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971218|NCT03996291|566646318|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
156971219|NCT03996291|566646319|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971220|NCT03996291|566646320|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971221|NCT03996291|566646321|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
156971222|NCT01995539|566647602|FG000|Overall Study|Screening Failure|1|||
156971223|NCT01995539|566647602|FG000|Overall Study|Withdrawal by Investigator|15|||
156971224|NCT01995539|566647602|FG000|Overall Study|Withdrawal by Subject|11|||
156971225|NCT01995539|566647602|FG000|Overall Study|Lost to Follow-up|5|||
156971226|NCT01995539|566647602|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
156971227|NCT04382924|566647603|FG000|Overall Study|Death|2|||
156971228|NCT04382924|566647604|FG001|Overall Study|Death|5|||
156971229|NCT04382924|566647605|FG002|Overall Study|Death|4|||
156971230|NCT04382924|566647603|FG000|Overall Study|Protocol Violation|0|||
156971231|NCT04382924|566647604|FG001|Overall Study|Protocol Violation|1|||
156971232|NCT04382924|566647605|FG002|Overall Study|Protocol Violation|1|||
156971233|NCT04382924|566647603|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
156971234|NCT04382924|566647604|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
156971235|NCT04382924|566647605|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
156971236|NCT04382924|566647603|FG000|Overall Study|Withdrawal by Subject|6|||
156971237|NCT04382924|566647604|FG001|Overall Study|Withdrawal by Subject|3|||
156971238|NCT04382924|566647605|FG002|Overall Study|Withdrawal by Subject|6|||
156971239|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
156971240|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
156971241|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
156971242|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
156971243|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
156971244|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
156971245|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
156971246|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
156971247|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
156971248|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
156971249|NCT00261495|566647610|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
156971250|NCT00261495|566647611|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
156971251|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
156971252|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
156971253|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
156971254|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
156971255|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
157229200|NCT00048048|567585158|FG001|Extension Year 2|Early withdrawals|0|||
157229201|NCT00048048|567585159|FG002|Extension Year 2|Early withdrawals|0|||
157229202|NCT00048048|567585160|FG003|Extension Year 2|Early withdrawals|0|||
156971256|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
157229203|NCT00048048|567585161|FG004|Extension Year 2|Early withdrawals|0|||
157229204|NCT00048048|567585162|FG005|Extension Year 2|Early withdrawals|0|||
157229205|NCT00048048|567585163|FG006|Extension Year 2|Early withdrawals|0|||
157229206|NCT00048048|567585164|FG007|Extension Year 2|Early withdrawals|0|||
156971257|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
157229207|NCT00048048|567585165|FG008|Extension Year 2|Early withdrawals|0|||
157229208|NCT00048048|567585166|FG009|Extension Year 2|Early withdrawals|0|||
157229209|NCT00048048|567585167|FG010|Extension Year 2|Early withdrawals|4|||
156971258|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
156971259|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
156971260|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
156971261|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
156971262|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
156971263|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
156971264|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
156971265|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
156971266|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
156971267|NCT00261495|566647610|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
156971268|NCT00261495|566647611|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
156971269|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
156971270|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
156971271|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
156971272|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
156971273|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
156971274|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
156971275|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
156971276|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
156971277|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
156971278|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
156971279|NCT00261495|566647610|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
156971280|NCT00261495|566647611|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
156971281|NCT01932697|566647612|FG000|Overall Study|Received a different amount of tx|1|||
156971282|NCT01932697|566647613|FG001|Overall Study|Received a different amount of tx|0|||
156971283|NCT01932697|566647612|FG000|Overall Study|Ineligible|1|||
156971284|NCT01932697|566647613|FG001|Overall Study|Ineligible|0|||
156971285|NCT00215540|566647623|FG000|Overall Study|Withdrew from study medication|1|||
156971286|NCT00215540|566647624|FG001|Overall Study|Withdrew from study medication|0|||
156971287|NCT00215540|566647625|FG002|Overall Study|Withdrew from study medication|0|||
156971288|NCT03010462|566647626|FG000|Overall Study|Withdrawal by Subject|3|||
156971289|NCT03010462|566647627|FG001|Overall Study|Withdrawal by Subject|1|||
156971290|NCT02487810|566647628|FG000|Overall Study|Withdrawal by Subject|1|||
156971291|NCT02487810|566647629|FG001|Overall Study|Withdrawal by Subject|0|||
156971292|NCT00763958|566647630|FG000|Overall Study|did not meet final criteria|4|||
156971293|NCT00763958|566647631|FG001|Overall Study|did not meet final criteria|4|||
156971294|NCT00763958|566647630|FG000|Overall Study|Lost to Follow-up|10|||
156971295|NCT00763958|566647631|FG001|Overall Study|Lost to Follow-up|2|||
156971296|NCT00763958|566647630|FG000|Overall Study|Believed they were receiving placebo|0|||
156971297|NCT00763958|566647631|FG001|Overall Study|Believed they were receiving placebo|5|||
156971298|NCT04074590|566647632|FG000|Overall Study|Adverse Event|1|||
156971299|NCT04074590|566647633|FG001|Overall Study|Adverse Event|0|||
156971300|NCT04074590|566647632|FG000|Overall Study|Physician Decision|1|||
156971301|NCT04074590|566647633|FG001|Overall Study|Physician Decision|0|||
156971302|NCT04074590|566647632|FG000|Overall Study|Withdrawal by Subject|2|||
156971303|NCT04074590|566647633|FG001|Overall Study|Withdrawal by Subject|0|||
156971304|NCT02063828|566647640|FG000|Overall Study|Withdrawal by Subject|4|||
156971305|NCT02063828|566647641|FG001|Overall Study|Withdrawal by Subject|6|||
156971306|NCT02063828|566647642|FG002|Overall Study|Withdrawal by Subject|3|||
156971307|NCT02063828|566647640|FG000|Overall Study|Death|0|||
156971308|NCT02063828|566647641|FG001|Overall Study|Death|0|||
156971309|NCT02063828|566647642|FG002|Overall Study|Death|1|||
156971310|NCT02753595|566647643|FG000|Overall Study|Sponsor termination|2|||
156971311|NCT02753595|566647644|FG001|Overall Study|Sponsor termination|2|||
156971312|NCT01064297|566647648|FG000|Overall Study|Lost to Follow-up|791|||
156971313|NCT01064297|566647649|FG001|Overall Study|Lost to Follow-up|48|||
156971314|NCT01064297|566647650|FG002|Overall Study|Lost to Follow-up|133|||
156971315|NCT02068495|566647653|FG000|Overall Study|Case Report Forms Uncollected|60|||
156971316|NCT02068495|566647653|FG000|Overall Study|Protocol Deviation|49|||
156971317|NCT01666808|566647661|FG000|Overall Study|Lost to Follow-up|9|||
156971318|NCT01666808|566647662|FG001|Overall Study|Lost to Follow-up|15|||
156971319|NCT01666808|566647661|FG000|Overall Study|Withdrawal by Subject|3|||
157048823|NCT01562275|566933301|FG010|Stage 1|Withdrawal by Subject|0|||
157048824|NCT01562275|566933302|FG011|Stage 1|Withdrawal by Subject|0|||
156971320|NCT01666808|566647662|FG001|Overall Study|Withdrawal by Subject|1|||
156971321|NCT01666808|566647661|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
156971322|NCT01666808|566647662|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
156971323|NCT03248375|566647663|FG000|Overall Study|Lost to Follow-up|5|||
156971324|NCT04098250|566647666|FG000|Overall Study|Withdrawal by Subject|1|||
156971325|NCT04098250|566647667|FG001|Overall Study|Withdrawal by Subject|0|||
156971326|NCT04098250|566647666|FG000|Overall Study|Lost to Follow-up|0|||
156971327|NCT04098250|566647667|FG001|Overall Study|Lost to Follow-up|1|||
156971328|NCT00633464|566647672|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
156971329|NCT00633464|566647673|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
156971330|NCT00633464|566647672|FG000|Overall Study|Never Treated (Randomized in error)|0|||
156971331|NCT00633464|566647673|FG001|Overall Study|Never Treated (Randomized in error)|1|||
156971332|NCT00394355|566647674|FG000|Overall Study|Adverse Event|10|||
156971333|NCT00394355|566647675|FG001|Overall Study|Adverse Event|6|||
156971334|NCT00394355|566647676|FG002|Overall Study|Adverse Event|7|||
156971335|NCT00394355|566647677|FG003|Overall Study|Adverse Event|8|||
156971336|NCT00394355|566647674|FG000|Overall Study|Did not meet protocol eligibility|1|||
156971337|NCT00394355|566647675|FG001|Overall Study|Did not meet protocol eligibility|5|||
156971338|NCT00394355|566647676|FG002|Overall Study|Did not meet protocol eligibility|4|||
156971339|NCT00394355|566647677|FG003|Overall Study|Did not meet protocol eligibility|2|||
156971340|NCT00394355|566647674|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
156971341|NCT00394355|566647675|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
156971342|NCT00394355|566647676|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
156971343|NCT00394355|566647677|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
156971344|NCT00394355|566647674|FG000|Overall Study|Subject withdrawal - related to drug|1|||
156971345|NCT00394355|566647675|FG001|Overall Study|Subject withdrawal - related to drug|0|||
156971346|NCT00394355|566647676|FG002|Overall Study|Subject withdrawal - related to drug|0|||
156971347|NCT00394355|566647677|FG003|Overall Study|Subject withdrawal - related to drug|0|||
156971348|NCT00394355|566647674|FG000|Overall Study|Lost to Follow-up|7|||
156971349|NCT00394355|566647675|FG001|Overall Study|Lost to Follow-up|5|||
156971350|NCT00394355|566647676|FG002|Overall Study|Lost to Follow-up|4|||
156971351|NCT00394355|566647677|FG003|Overall Study|Lost to Follow-up|3|||
157048825|NCT01562275|566933303|FG012|Stage 1|Withdrawal by Subject|0|||
157048826|NCT01562275|566933291|FG000|Stage 2|Death|0|||
157048827|NCT01562275|566933292|FG001|Stage 2|Death|0|||
157048828|NCT01562275|566933293|FG002|Stage 2|Death|0|||
157175961|NCT01468701|567383826|FG000|Overall Study|No end of study case report form|0|||
157175962|NCT01468701|567383827|FG001|Overall Study|No end of study case report form|0|||
156971352|NCT00394355|566647674|FG000|Overall Study|Noncompliance with protocol|4|||
156971353|NCT00394355|566647675|FG001|Overall Study|Noncompliance with protocol|3|||
156971354|NCT00394355|566647676|FG002|Overall Study|Noncompliance with protocol|10|||
156971355|NCT00394355|566647677|FG003|Overall Study|Noncompliance with protocol|8|||
156971356|NCT00394355|566647674|FG000|Overall Study|Administrative|0|||
156971357|NCT00394355|566647675|FG001|Overall Study|Administrative|1|||
156971358|NCT00394355|566647676|FG002|Overall Study|Administrative|1|||
156971359|NCT00394355|566647677|FG003|Overall Study|Administrative|1|||
156971360|NCT00394355|566647674|FG000|Overall Study|Lack of Efficacy|0|||
156971361|NCT00394355|566647675|FG001|Overall Study|Lack of Efficacy|0|||
156971362|NCT00394355|566647676|FG002|Overall Study|Lack of Efficacy|2|||
156971363|NCT00394355|566647677|FG003|Overall Study|Lack of Efficacy|3|||
156971364|NCT02612064|566647681|FG000|Overall Study|Withdrawal by Subject|1|||
156971365|NCT02612064|566647682|FG001|Overall Study|Withdrawal by Subject|1|||
156971366|NCT02612064|566647681|FG000|Overall Study|Other|0|||
156971367|NCT02612064|566647682|FG001|Overall Study|Other|2|||
156971368|NCT00717860|566647683|FG000|Overall Study|Clinical adverse experience|5|||
156971369|NCT00717860|566647684|FG001|Overall Study|Clinical adverse experience|9|||
156971370|NCT00717860|566647683|FG000|Overall Study|Laboratory adverse experience|2|||
156971371|NCT00717860|566647684|FG001|Overall Study|Laboratory adverse experience|2|||
156971372|NCT00717860|566647683|FG000|Overall Study|Lack of Efficacy|7|||
156971373|NCT00717860|566647684|FG001|Overall Study|Lack of Efficacy|13|||
156971374|NCT00717860|566647683|FG000|Overall Study|Discontinued for other reason|6|||
156971375|NCT00717860|566647684|FG001|Overall Study|Discontinued for other reason|1|||
156971376|NCT00717860|566647683|FG000|Overall Study|Withdrew consent|7|||
156971377|NCT00717860|566647684|FG001|Overall Study|Withdrew consent|3|||
156971378|NCT00698646|566647688|FG000|Overall Study|Adverse Event|8|||
156971379|NCT00698646|566647689|FG001|Overall Study|Adverse Event|7|||
156971380|NCT00698646|566647690|FG002|Overall Study|Adverse Event|8|||
156971381|NCT00698646|566647688|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
156971382|NCT00698646|566647689|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
156971383|NCT00698646|566647690|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
156971384|NCT00698646|566647688|FG000|Overall Study|Protocol Deviation|6|||
156971385|NCT00698646|566647689|FG001|Overall Study|Protocol Deviation|2|||
156971386|NCT00698646|566647690|FG002|Overall Study|Protocol Deviation|3|||
157048829|NCT01562275|566933294|FG003|Stage 2|Death|0|||
157048830|NCT01562275|566933295|FG004|Stage 2|Death|0|||
156971387|NCT00698646|566647688|FG000|Overall Study|Withdrawal by Subject|10|||
156971388|NCT00698646|566647689|FG001|Overall Study|Withdrawal by Subject|11|||
157048831|NCT01562275|566933296|FG005|Stage 2|Death|0|||
157175963|NCT01468701|567383828|FG002|Overall Study|No end of study case report form|0|||
156971389|NCT00698646|566647690|FG002|Overall Study|Withdrawal by Subject|8|||
156971390|NCT00698646|566647688|FG000|Overall Study|Lost to Follow-up|0|||
156971391|NCT00698646|566647689|FG001|Overall Study|Lost to Follow-up|0|||
156971392|NCT00698646|566647690|FG002|Overall Study|Lost to Follow-up|2|||
157048832|NCT01562275|566933297|FG006|Stage 2|Death|0|||
157048833|NCT01562275|566933298|FG007|Stage 2|Death|0|||
157048834|NCT01562275|566933299|FG008|Stage 2|Death|0|||
156971393|NCT00698646|566647688|FG000|Overall Study|Administrative problems|1|||
156971394|NCT00698646|566647689|FG001|Overall Study|Administrative problems|0|||
156971395|NCT00698646|566647690|FG002|Overall Study|Administrative problems|1|||
156971396|NCT00511875|566647696|FG000|Overall Study|Lost to Follow-up|4|||
156971397|NCT00511875|566647697|FG001|Overall Study|Lost to Follow-up|0|||
156971398|NCT00511875|566647696|FG000|Overall Study|Missing variables|1|||
156971399|NCT00511875|566647697|FG001|Overall Study|Missing variables|0|||
156971400|NCT02618616|566647698|FG000|Overall Study|Lack of Efficacy|4|||
156971401|NCT02618616|566647699|FG001|Overall Study|Lack of Efficacy|0|||
156971402|NCT02618616|566647698|FG000|Overall Study|Pregnancy|0|||
156971403|NCT02618616|566647699|FG001|Overall Study|Pregnancy|1|||
156971404|NCT02618616|566647698|FG000|Overall Study|Adverse Event|8|||
156971405|NCT02618616|566647699|FG001|Overall Study|Adverse Event|0|||
156971406|NCT02618616|566647698|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
156971407|NCT02618616|566647699|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
156971408|NCT02618616|566647698|FG000|Overall Study|Consent withdrawn by subject|8|||
156971409|NCT02618616|566647699|FG001|Overall Study|Consent withdrawn by subject|5|||
156971410|NCT02618616|566647698|FG000|Overall Study|Lost to Follow-up|0|||
156971411|NCT02618616|566647699|FG001|Overall Study|Lost to Follow-up|1|||
156971412|NCT00459342|566647703|FG000|Overall Study|Not eligible|1|||
156971413|NCT02686034|566647704|FG000|Run-In Period 1|Eligibility|12|||
156971414|NCT02686034|566647705|FG001|Run-In Period 1|Eligibility|10|||
156971415|NCT02686034|566647704|FG000|Run-In Period 1|Withdrawal by Subject|4|||
156971416|NCT02686034|566647705|FG001|Run-In Period 1|Withdrawal by Subject|3|||
156971417|NCT02686034|566647704|FG000|Run-In Period 1|Lost to Follow-up|4|||
156971418|NCT02686034|566647705|FG001|Run-In Period 1|Lost to Follow-up|4|||
156971419|NCT02686034|566647704|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
156971420|NCT02686034|566647705|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
156971421|NCT02686034|566647704|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
156971422|NCT02686034|566647705|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
156971423|NCT02686034|566647704|FG000|Randomized Controlled Period 2|Adverse Event|0|||
156971424|NCT02686034|566647705|FG001|Randomized Controlled Period 2|Adverse Event|2|||
156971425|NCT02686034|566647704|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
156971426|NCT02686034|566647705|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
156971427|NCT02686034|566647704|FG000|Open Label Period 3|Lost to Follow-up|0|||
156971428|NCT02686034|566647705|FG001|Open Label Period 3|Lost to Follow-up|1|||
156971429|NCT00542880|566647706|FG000|Period 1|Eligibility criteria not fulfilled|2|||
156971430|NCT00542880|566647707|FG001|Period 1|Eligibility criteria not fulfilled|6|||
156971431|NCT00542880|566647706|FG000|Period 1|Adverse Event|2|||
156971432|NCT00542880|566647707|FG001|Period 1|Adverse Event|2|||
156971433|NCT00542880|566647706|FG000|Period 1|Development of study-specific criteria|1|||
156971434|NCT00542880|566647707|FG001|Period 1|Development of study-specific criteria|2|||
156971435|NCT00542880|566647706|FG000|Period 1|Withdrawal by Subject|1|||
156971436|NCT00542880|566647707|FG001|Period 1|Withdrawal by Subject|1|||
156971437|NCT00542880|566647706|FG000|Period 1|Protocol Violation|0|||
156971438|NCT00542880|566647707|FG001|Period 1|Protocol Violation|1|||
156971439|NCT00542880|566647706|FG000|Period 2|Adverse Event|5|||
156971440|NCT00542880|566647707|FG001|Period 2|Adverse Event|7|||
156971441|NCT00542880|566647706|FG000|Period 2|Eligibility not fulfilled|0|||
156971442|NCT00542880|566647707|FG001|Period 2|Eligibility not fulfilled|1|||
156971443|NCT00542880|566647706|FG000|Period 2|Discontinuation criteria|2|||
156971444|NCT00542880|566647707|FG001|Period 2|Discontinuation criteria|0|||
156971445|NCT00542880|566647706|FG000|Period 2|Severe non-compliance|0|||
156971446|NCT00542880|566647707|FG001|Period 2|Severe non-compliance|1|||
156971447|NCT00542880|566647706|FG000|Period 2|Other|0|||
156971448|NCT00542880|566647707|FG001|Period 2|Other|1|||
156971449|NCT00542880|566647706|FG000|Period 3|Adverse Event|0|||
156971450|NCT00542880|566647707|FG001|Period 3|Adverse Event|2|||
156971451|NCT02027402|566647710|FG000|Overall Study|Withdrawal by Subject|4|||
156971452|NCT02027402|566647711|FG001|Overall Study|Withdrawal by Subject|1|||
156971453|NCT03904043|566647716|FG000|Overall Study|Adverse Event|1|||
156971454|NCT03904043|566647717|FG001|Overall Study|Adverse Event|1|||
156971455|NCT03904043|566647716|FG000|Overall Study|Withdrawal by Subject|1|||
156971456|NCT03904043|566647717|FG001|Overall Study|Withdrawal by Subject|0|||
156971457|NCT03904043|566647716|FG000|Overall Study|Non-compliance|1|||
156971458|NCT03904043|566647717|FG001|Overall Study|Non-compliance|0|||
156971459|NCT03904043|566647716|FG000|Overall Study|Did not start treatment|1|||
156971460|NCT03904043|566647717|FG001|Overall Study|Did not start treatment|0|||
156971461|NCT03750006|566647718|FG000|Overall Study|Withdrawal by Subject|8|||
156971462|NCT03750006|566647718|FG000|Overall Study|COVID PANDEMIC|11|||
156971463|NCT00755222|566649918|FG000|Overall Study|Withdrawal by Subject|4|||
156971464|NCT00755222|566649919|FG001|Overall Study|Withdrawal by Subject|2|||
156971465|NCT00755222|566649918|FG000|Overall Study|Adverse Event|2|||
156971466|NCT00755222|566649919|FG001|Overall Study|Adverse Event|0|||
156971467|NCT00755222|566649918|FG000|Overall Study|Protocol Violation|2|||
156971468|NCT00755222|566649919|FG001|Overall Study|Protocol Violation|0|||
156971469|NCT01147822|566649926|FG000|Overall Study|Lost to Follow-up|14|||
156971470|NCT01147822|566649927|FG001|Overall Study|Lost to Follow-up|6|||
156971471|NCT01147822|566649926|FG000|Overall Study|Withdrawal by Subject|10|||
156971472|NCT01147822|566649927|FG001|Overall Study|Withdrawal by Subject|16|||
156971473|NCT01147822|566649926|FG000|Overall Study|Physician Decision|9|||
156971474|NCT01147822|566649927|FG001|Overall Study|Physician Decision|8|||
156971475|NCT01147822|566649926|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
156971476|NCT01147822|566649927|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
156971477|NCT01147822|566649926|FG000|Overall Study|Protocol Violation|1|||
156971478|NCT01147822|566649927|FG001|Overall Study|Protocol Violation|1|||
156971479|NCT02798211|566649934|FG000|Period 1|Adverse Event|1|||
156971480|NCT02798211|566649935|FG001|Period 1|Adverse Event|1|||
156971481|NCT02798211|566649936|FG002|Period 1|Adverse Event|0|||
156971482|NCT02798211|566649937|FG003|Period 1|Adverse Event|0|||
156971483|NCT02798211|566649938|FG004|Period 1|Adverse Event|0|||
156971484|NCT02798211|566649939|FG005|Period 1|Adverse Event|0|||
156971485|NCT02798211|566649934|FG000|Period 1|Lost to Follow-up|2|||
156971486|NCT02798211|566649935|FG001|Period 1|Lost to Follow-up|1|||
156971487|NCT02798211|566649936|FG002|Period 1|Lost to Follow-up|0|||
156971488|NCT02798211|566649937|FG003|Period 1|Lost to Follow-up|0|||
156971489|NCT02798211|566649938|FG004|Period 1|Lost to Follow-up|0|||
156971490|NCT02798211|566649939|FG005|Period 1|Lost to Follow-up|0|||
156971491|NCT02798211|566649934|FG000|Period 1|Protocol Violation|0|||
156971492|NCT02798211|566649935|FG001|Period 1|Protocol Violation|0|||
156971493|NCT02798211|566649936|FG002|Period 1|Protocol Violation|2|||
156971494|NCT02798211|566649937|FG003|Period 1|Protocol Violation|0|||
156971495|NCT02798211|566649938|FG004|Period 1|Protocol Violation|0|||
156971496|NCT02798211|566649939|FG005|Period 1|Protocol Violation|0|||
156971497|NCT02798211|566649934|FG000|Period 1|Withdrawal by Subject|1|||
156971498|NCT02798211|566649935|FG001|Period 1|Withdrawal by Subject|1|||
156971499|NCT02798211|566649936|FG002|Period 1|Withdrawal by Subject|0|||
156971500|NCT02798211|566649937|FG003|Period 1|Withdrawal by Subject|0|||
156971501|NCT02798211|566649938|FG004|Period 1|Withdrawal by Subject|0|||
156971502|NCT02798211|566649939|FG005|Period 1|Withdrawal by Subject|0|||
156971503|NCT02798211|566649934|FG000|Period 1|Death|0|||
156971504|NCT02798211|566649935|FG001|Period 1|Death|0|||
156971505|NCT02798211|566649936|FG002|Period 1|Death|1|||
156971506|NCT02798211|566649937|FG003|Period 1|Death|0|||
156971507|NCT02798211|566649938|FG004|Period 1|Death|0|||
156971508|NCT02798211|566649939|FG005|Period 1|Death|0|||
156971509|NCT02798211|566649934|FG000|Period 1|Withdrawal of Informed Consent|2|||
156971510|NCT02798211|566649935|FG001|Period 1|Withdrawal of Informed Consent|7|||
156971511|NCT02798211|566649936|FG002|Period 1|Withdrawal of Informed Consent|3|||
156971512|NCT02798211|566649937|FG003|Period 1|Withdrawal of Informed Consent|0|||
156971513|NCT02798211|566649938|FG004|Period 1|Withdrawal of Informed Consent|0|||
156971514|NCT02798211|566649939|FG005|Period 1|Withdrawal of Informed Consent|0|||
156971515|NCT02798211|566649934|FG000|Period 2|Withdrawal by Subject|2|||
156971516|NCT02798211|566649935|FG001|Period 2|Withdrawal by Subject|0|||
156971517|NCT02798211|566649936|FG002|Period 2|Withdrawal by Subject|0|||
156971518|NCT02798211|566649937|FG003|Period 2|Withdrawal by Subject|0|||
156971519|NCT02798211|566649938|FG004|Period 2|Withdrawal by Subject|2|||
156971520|NCT02798211|566649939|FG005|Period 2|Withdrawal by Subject|2|||
156971521|NCT02798211|566649934|FG000|Period 2|Adverse Event|5|||
156971522|NCT02798211|566649935|FG001|Period 2|Adverse Event|0|||
156971523|NCT02798211|566649936|FG002|Period 2|Adverse Event|0|||
156971524|NCT02798211|566649937|FG003|Period 2|Adverse Event|0|||
156971525|NCT02798211|566649938|FG004|Period 2|Adverse Event|1|||
156971526|NCT02798211|566649939|FG005|Period 2|Adverse Event|0|||
156971527|NCT02798211|566649934|FG000|Period 2|Lack of Efficacy|1|||
156971528|NCT02798211|566649935|FG001|Period 2|Lack of Efficacy|0|||
156971529|NCT02798211|566649936|FG002|Period 2|Lack of Efficacy|0|||
156971530|NCT02798211|566649937|FG003|Period 2|Lack of Efficacy|1|||
156971531|NCT02798211|566649938|FG004|Period 2|Lack of Efficacy|0|||
156971532|NCT02798211|566649939|FG005|Period 2|Lack of Efficacy|1|||
156971533|NCT02798211|566649934|FG000|Period 2|Lost to Follow-up|3|||
156971534|NCT02798211|566649935|FG001|Period 2|Lost to Follow-up|0|||
156971535|NCT02798211|566649936|FG002|Period 2|Lost to Follow-up|0|||
156971536|NCT02798211|566649937|FG003|Period 2|Lost to Follow-up|0|||
156971537|NCT02798211|566649938|FG004|Period 2|Lost to Follow-up|2|||
156971538|NCT02798211|566649939|FG005|Period 2|Lost to Follow-up|0|||
157229210|NCT00048048|567585168|FG011|Extension Year 2|Early withdrawals|2|||
156971539|NCT02798211|566649934|FG000|Period 2|Physician Decision|1|||
156971540|NCT02798211|566649935|FG001|Period 2|Physician Decision|0|||
157229211|NCT03992196|567585169|FG000|Enrollment|lost to follow-up prior dosing|1|||
156971541|NCT02798211|566649936|FG002|Period 2|Physician Decision|0|||
156971542|NCT02798211|566649937|FG003|Period 2|Physician Decision|1|||
156971543|NCT02798211|566649938|FG004|Period 2|Physician Decision|1|||
156971544|NCT02798211|566649939|FG005|Period 2|Physician Decision|0|||
156971545|NCT02798211|566649934|FG000|Period 2|Pregnancy|0|||
156971546|NCT02798211|566649935|FG001|Period 2|Pregnancy|0|||
156971547|NCT02798211|566649936|FG002|Period 2|Pregnancy|0|||
156971548|NCT02798211|566649937|FG003|Period 2|Pregnancy|2|||
156971549|NCT02798211|566649938|FG004|Period 2|Pregnancy|0|||
157229212|NCT03992196|567585170|FG001|Enrollment|lost to follow-up prior dosing|0|||
156971550|NCT02798211|566649939|FG005|Period 2|Pregnancy|0|||
156971551|NCT02798211|566649934|FG000|Period 2|Technical problems|1|||
156971552|NCT02798211|566649935|FG001|Period 2|Technical problems|0|||
156971553|NCT02798211|566649936|FG002|Period 2|Technical problems|0|||
156971554|NCT02798211|566649937|FG003|Period 2|Technical problems|1|||
156971555|NCT02798211|566649938|FG004|Period 2|Technical problems|0|||
156971556|NCT02798211|566649939|FG005|Period 2|Technical problems|0|||
156971557|NCT02798211|566649934|FG000|Period 2|Withdrawal of Informed Consent|1|||
156971558|NCT02798211|566649935|FG001|Period 2|Withdrawal of Informed Consent|0|||
156971559|NCT02798211|566649936|FG002|Period 2|Withdrawal of Informed Consent|0|||
156971560|NCT02798211|566649937|FG003|Period 2|Withdrawal of Informed Consent|2|||
156971561|NCT02798211|566649938|FG004|Period 2|Withdrawal of Informed Consent|2|||
156971562|NCT02798211|566649939|FG005|Period 2|Withdrawal of Informed Consent|3|||
156971563|NCT01782872|566649940|FG000|Overall Study|Protocol Violation|0|||
156971564|NCT01782872|566649941|FG001|Overall Study|Protocol Violation|0|||
156971565|NCT01782872|566649942|FG002|Overall Study|Protocol Violation|0|||
156971566|NCT01782872|566649943|FG003|Overall Study|Protocol Violation|1|||
156971567|NCT01782872|566649940|FG000|Overall Study|Withdrawal by Subject|0|||
156971568|NCT01782872|566649941|FG001|Overall Study|Withdrawal by Subject|1|||
156971569|NCT01782872|566649942|FG002|Overall Study|Withdrawal by Subject|0|||
156971570|NCT01782872|566649943|FG003|Overall Study|Withdrawal by Subject|0|||
156971571|NCT02748694|566649944|FG000|Overall Study|Voluntary Withdrawal|0|||
156971572|NCT02748694|566649945|FG001|Overall Study|Voluntary Withdrawal|0|||
156971573|NCT02748694|566649946|FG002|Overall Study|Voluntary Withdrawal|0|||
156971574|NCT02748694|566649947|FG003|Overall Study|Voluntary Withdrawal|0|||
156971575|NCT02748694|566649948|FG004|Overall Study|Voluntary Withdrawal|0|||
156971576|NCT02748694|566649949|FG005|Overall Study|Voluntary Withdrawal|0|||
156971577|NCT02748694|566649950|FG006|Overall Study|Voluntary Withdrawal|0|||
156971578|NCT02748694|566649951|FG007|Overall Study|Voluntary Withdrawal|0|||
156971579|NCT02748694|566649952|FG008|Overall Study|Voluntary Withdrawal|0|||
156971580|NCT02748694|566649953|FG009|Overall Study|Voluntary Withdrawal|0|||
156971581|NCT02748694|566649954|FG010|Overall Study|Voluntary Withdrawal|0|||
156971582|NCT02748694|566649955|FG011|Overall Study|Voluntary Withdrawal|0|||
156971583|NCT02748694|566649956|FG012|Overall Study|Voluntary Withdrawal|0|||
156971584|NCT02748694|566649957|FG013|Overall Study|Voluntary Withdrawal|0|||
156971585|NCT02748694|566649958|FG014|Overall Study|Voluntary Withdrawal|2|||
156971586|NCT04026165|566649961|FG000|Run-in Placebo Period|Enrollment Error|13|||
156971587|NCT04026165|566649962|FG001|Run-in Placebo Period|Enrollment Error|0|||
156971588|NCT04026165|566649963|FG002|Run-in Placebo Period|Enrollment Error|0|||
156971589|NCT04026165|566649964|FG003|Run-in Placebo Period|Enrollment Error|0|||
156971590|NCT04026165|566649961|FG000|Run-in Placebo Period|Run-in Failure|4|||
156971591|NCT04026165|566649962|FG001|Run-in Placebo Period|Run-in Failure|0|||
156971592|NCT04026165|566649963|FG002|Run-in Placebo Period|Run-in Failure|0|||
156971593|NCT04026165|566649964|FG003|Run-in Placebo Period|Run-in Failure|0|||
156971594|NCT04026165|566649961|FG000|Run-in Placebo Period|Protocol Violation|2|||
156971595|NCT04026165|566649962|FG001|Run-in Placebo Period|Protocol Violation|0|||
156971596|NCT04026165|566649963|FG002|Run-in Placebo Period|Protocol Violation|0|||
156971597|NCT04026165|566649964|FG003|Run-in Placebo Period|Protocol Violation|0|||
156971598|NCT04026165|566649961|FG000|Run-in Placebo Period|Withdrew Consent|2|||
156971599|NCT04026165|566649962|FG001|Run-in Placebo Period|Withdrew Consent|0|||
156971600|NCT04026165|566649963|FG002|Run-in Placebo Period|Withdrew Consent|0|||
156971601|NCT04026165|566649964|FG003|Run-in Placebo Period|Withdrew Consent|0|||
156971602|NCT04026165|566649961|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
157175964|NCT01468701|567383829|FG003|Overall Study|No end of study case report form|0|||
157175965|NCT01468701|567383830|FG004|Overall Study|No end of study case report form|0|||
157175966|NCT01468701|567383831|FG005|Overall Study|No end of study case report form|0|||
157175967|NCT01468701|567383832|FG006|Overall Study|No end of study case report form|0|||
157175968|NCT01468701|567383833|FG007|Overall Study|No end of study case report form|0|||
156971603|NCT04026165|566649962|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156971604|NCT04026165|566649963|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156971605|NCT04026165|566649964|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
156971606|NCT04026165|566649961|FG000|Run-in SEL Period|Run-in Failure|0|||
156971607|NCT04026165|566649962|FG001|Run-in SEL Period|Run-in Failure|26|||
156971608|NCT04026165|566649963|FG002|Run-in SEL Period|Run-in Failure|0|||
156971609|NCT04026165|566649964|FG003|Run-in SEL Period|Run-in Failure|0|||
156971610|NCT04026165|566649961|FG000|Run-in SEL Period|Withdrew Consent|0|||
157175969|NCT01468701|567383834|FG008|Overall Study|No end of study case report form|4|||
156971611|NCT04026165|566649962|FG001|Run-in SEL Period|Withdrew Consent|10|||
156971612|NCT04026165|566649963|FG002|Run-in SEL Period|Withdrew Consent|0|||
156971613|NCT04026165|566649964|FG003|Run-in SEL Period|Withdrew Consent|0|||
157175970|NCT01468701|567383835|FG009|Overall Study|No end of study case report form|1|||
156971614|NCT04026165|566649961|FG000|Run-in SEL Period|Enrollment Error|0|||
156971615|NCT04026165|566649962|FG001|Run-in SEL Period|Enrollment Error|4|||
156971616|NCT04026165|566649963|FG002|Run-in SEL Period|Enrollment Error|0|||
157175971|NCT01468701|567383836|FG010|Overall Study|No end of study case report form|2|||
156971617|NCT04026165|566649964|FG003|Run-in SEL Period|Enrollment Error|0|||
156971618|NCT04026165|566649961|FG000|Run-in SEL Period|Protocol Violation|0|||
156971619|NCT04026165|566649962|FG001|Run-in SEL Period|Protocol Violation|3|||
156971620|NCT04026165|566649963|FG002|Run-in SEL Period|Protocol Violation|0|||
156971621|NCT04026165|566649964|FG003|Run-in SEL Period|Protocol Violation|0|||
156971622|NCT04026165|566649961|FG000|Run-in SEL Period|Investigator's Discretion|0|||
156971623|NCT04026165|566649962|FG001|Run-in SEL Period|Investigator's Discretion|2|||
156971624|NCT04026165|566649963|FG002|Run-in SEL Period|Investigator's Discretion|0|||
156971625|NCT04026165|566649964|FG003|Run-in SEL Period|Investigator's Discretion|0|||
156971626|NCT04026165|566649961|FG000|Run-in SEL Period|Death|0|||
156971627|NCT04026165|566649962|FG001|Run-in SEL Period|Death|1|||
156971628|NCT04026165|566649963|FG002|Run-in SEL Period|Death|0|||
156971629|NCT04026165|566649964|FG003|Run-in SEL Period|Death|0|||
157175972|NCT01468701|567383837|FG011|Overall Study|No end of study case report form|3|||
157175973|NCT01468701|567383838|FG012|Overall Study|No end of study case report form|0|||
157175974|NCT01468701|567383839|FG013|Overall Study|No end of study case report form|1|||
157175975|NCT01468701|567383840|FG014|Overall Study|No end of study case report form|0|||
157175976|NCT01468701|567383841|FG015|Overall Study|No end of study case report form|0|||
157175977|NCT01468701|567383842|FG016|Overall Study|No end of study case report form|0|||
157175978|NCT01468701|567383826|FG000|Overall Study|Not being followed up|0|||
157175979|NCT01468701|567383827|FG001|Overall Study|Not being followed up|4963|||
157175980|NCT01468701|567383828|FG002|Overall Study|Not being followed up|1755|||
157175981|NCT01468701|567383829|FG003|Overall Study|Not being followed up|703|||
157175982|NCT01468701|567383830|FG004|Overall Study|Not being followed up|1714|||
157175983|NCT01468701|567383831|FG005|Overall Study|Not being followed up|126|||
157175984|NCT01468701|567383832|FG006|Overall Study|Not being followed up|1170|||
157175985|NCT01468701|567383833|FG007|Overall Study|Not being followed up|4|||
157175986|NCT01468701|567383834|FG008|Overall Study|Not being followed up|0|||
157175987|NCT01468701|567383835|FG009|Overall Study|Not being followed up|0|||
157175988|NCT01468701|567383836|FG010|Overall Study|Not being followed up|0|||
157175989|NCT01468701|567383837|FG011|Overall Study|Not being followed up|0|||
157175990|NCT01468701|567383838|FG012|Overall Study|Not being followed up|0|||
157175991|NCT01468701|567383839|FG013|Overall Study|Not being followed up|0|||
157175992|NCT01468701|567383840|FG014|Overall Study|Not being followed up|0|||
157175993|NCT01468701|567383841|FG015|Overall Study|Not being followed up|0|||
157175994|NCT01468701|567383842|FG016|Overall Study|Not being followed up|0|||
157175995|NCT00631540|567383843|FG000|Overall Study|Withdrawal by Subject|5|||
157175996|NCT00631540|567383843|FG000|Overall Study|Death|4|||
157175997|NCT00631540|567383843|FG000|Overall Study|Lost to Follow-up|2|||
157175998|NCT00631540|567383843|FG000|Overall Study|Core Lab Data Unavailable|3|||
157175999|NCT00970268|567383844|FG000|Overall Study|Withdrawal by Subject|12|||
157176000|NCT00970268|567383845|FG001|Overall Study|Withdrawal by Subject|19|||
157176001|NCT00970268|567383844|FG000|Overall Study|Adverse Event|15|||
157176002|NCT00970268|567383845|FG001|Overall Study|Adverse Event|12|||
157176003|NCT00970268|567383844|FG000|Overall Study|Lack of Efficacy|3|||
157176004|NCT00970268|567383845|FG001|Overall Study|Lack of Efficacy|6|||
156971630|NCT04026165|566649961|FG000|Randomized Period|Withdrew Consent|0|||
156971631|NCT04026165|566649962|FG001|Randomized Period|Withdrew Consent|0|||
156971632|NCT04026165|566649963|FG002|Randomized Period|Withdrew Consent|5|||
157176005|NCT00970268|567383844|FG000|Overall Study|Protocol Violation|4|||
157176006|NCT00970268|567383845|FG001|Overall Study|Protocol Violation|7|||
157176007|NCT00970268|567383844|FG000|Overall Study|Other Reason|3|||
157176008|NCT00970268|567383845|FG001|Overall Study|Other Reason|1|||
157176009|NCT00970268|567383844|FG000|Overall Study|COPD Exacerbation|4|||
157176010|NCT00970268|567383845|FG001|Overall Study|COPD Exacerbation|2|||
157176011|NCT00970268|567383844|FG000|Overall Study|Lost to Follow-up|1|||
157176012|NCT00970268|567383845|FG001|Overall Study|Lost to Follow-up|2|||
157176013|NCT00970268|567383844|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
157176014|NCT00970268|567383845|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
157176015|NCT01079195|567383846|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
157176016|NCT01079195|567383846|FG000|Overall Study|No Documentation Available|437|||
156971633|NCT04026165|566649964|FG003|Randomized Period|Withdrew Consent|8|||
156971634|NCT04026165|566649961|FG000|Randomized Period|Death|0|||
156971635|NCT04026165|566649962|FG001|Randomized Period|Death|0|||
157176017|NCT01079195|567383846|FG000|Overall Study|Adverse Event|157|||
157176018|NCT01079195|567383846|FG000|Overall Study|Reason Unknown|39|||
157176019|NCT01079195|567383846|FG000|Overall Study|Withdrawal by Subject|18|||
157176020|NCT01079195|567383846|FG000|Overall Study|Financial Reasons|15|||
157176021|NCT01079195|567383846|FG000|Overall Study|Lack of Effectiveness|12|||
157176022|NCT01079195|567383846|FG000|Overall Study|Physician Decision|4|||
157176023|NCT01079195|567383846|FG000|Overall Study|Improved Status of Participant|4|||
157176024|NCT01079195|567383846|FG000|Overall Study|No Follow-up Documentation Available|4|||
157176025|NCT01079195|567383846|FG000|Overall Study|Non-compliance|2|||
157176026|NCT01999946|567383850|FG000|Overall Study|Participant not released from jail|2|||
157176027|NCT01999946|567383851|FG001|Overall Study|Participant not released from jail|2|||
157176028|NCT01999946|567383852|FG002|Overall Study|Participant not released from jail|0|||
156971636|NCT04026165|566649963|FG002|Randomized Period|Death|5|||
156971637|NCT04026165|566649964|FG003|Randomized Period|Death|7|||
156971638|NCT04026165|566649961|FG000|Randomized Period|Investigator's Discretion|0|||
156971639|NCT04026165|566649962|FG001|Randomized Period|Investigator's Discretion|0|||
156971640|NCT04026165|566649963|FG002|Randomized Period|Investigator's Discretion|2|||
156971641|NCT04026165|566649964|FG003|Randomized Period|Investigator's Discretion|2|||
156971642|NCT04026165|566649961|FG000|Randomized Period|Lost to Follow-up|0|||
156971643|NCT04026165|566649962|FG001|Randomized Period|Lost to Follow-up|0|||
156971644|NCT04026165|566649963|FG002|Randomized Period|Lost to Follow-up|2|||
156971645|NCT04026165|566649964|FG003|Randomized Period|Lost to Follow-up|2|||
156971646|NCT01059630|566649967|FG000|Overall Study|Death|100|||
156971647|NCT01059630|566649968|FG001|Overall Study|Death|84|||
156971648|NCT01059630|566649967|FG000|Overall Study|Lost to Follow-up|4|||
156971649|NCT01059630|566649968|FG001|Overall Study|Lost to Follow-up|1|||
156971650|NCT01059630|566649967|FG000|Overall Study|Physician Decision|2|||
156971651|NCT01059630|566649968|FG001|Overall Study|Physician Decision|4|||
156971652|NCT01059630|566649967|FG000|Overall Study|Withdrawal by Subject|21|||
156971653|NCT01059630|566649968|FG001|Overall Study|Withdrawal by Subject|14|||
156971654|NCT03170375|566649969|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
156971655|NCT03170375|566649970|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
156971656|NCT03170375|566649971|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
156971657|NCT03170375|566649969|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
156971658|NCT03170375|566649970|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
156971659|NCT03170375|566649971|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
156971660|NCT00441701|566649972|FG000|Overall Study|Adverse Event|3|||
156971661|NCT00441701|566649973|FG001|Overall Study|Adverse Event|2|||
156971662|NCT00441701|566649974|FG002|Overall Study|Adverse Event|1|||
156971663|NCT00441701|566649975|FG003|Overall Study|Adverse Event|0|||
156971664|NCT00441701|566649976|FG004|Overall Study|Adverse Event|2|||
156971665|NCT00441701|566649977|FG005|Overall Study|Adverse Event|2|||
156971666|NCT00441701|566649978|FG006|Overall Study|Adverse Event|0|||
156971667|NCT00441701|566649979|FG007|Overall Study|Adverse Event|0|||
156971668|NCT00441701|566649980|FG008|Overall Study|Adverse Event|0|||
156971669|NCT00441701|566649981|FG009|Overall Study|Adverse Event|0|||
156971670|NCT00441701|566649972|FG000|Overall Study|Lack of Efficacy|2|||
156971671|NCT00441701|566649973|FG001|Overall Study|Lack of Efficacy|0|||
156971672|NCT00441701|566649974|FG002|Overall Study|Lack of Efficacy|2|||
156971673|NCT00441701|566649975|FG003|Overall Study|Lack of Efficacy|2|||
156971674|NCT00441701|566649976|FG004|Overall Study|Lack of Efficacy|0|||
156971675|NCT00441701|566649977|FG005|Overall Study|Lack of Efficacy|1|||
156971676|NCT00441701|566649978|FG006|Overall Study|Lack of Efficacy|0|||
156971677|NCT00441701|566649979|FG007|Overall Study|Lack of Efficacy|0|||
156971678|NCT00441701|566649980|FG008|Overall Study|Lack of Efficacy|0|||
156971679|NCT00441701|566649981|FG009|Overall Study|Lack of Efficacy|0|||
156971680|NCT00441701|566649972|FG000|Overall Study|Withdrawal by Subject|0|||
156971681|NCT00441701|566649973|FG001|Overall Study|Withdrawal by Subject|2|||
156971682|NCT00441701|566649974|FG002|Overall Study|Withdrawal by Subject|1|||
156971683|NCT00441701|566649975|FG003|Overall Study|Withdrawal by Subject|1|||
156971684|NCT00441701|566649976|FG004|Overall Study|Withdrawal by Subject|0|||
156971685|NCT00441701|566649977|FG005|Overall Study|Withdrawal by Subject|0|||
156971686|NCT00441701|566649978|FG006|Overall Study|Withdrawal by Subject|0|||
156971687|NCT00441701|566649979|FG007|Overall Study|Withdrawal by Subject|0|||
156971688|NCT00441701|566649980|FG008|Overall Study|Withdrawal by Subject|0|||
156971689|NCT00441701|566649981|FG009|Overall Study|Withdrawal by Subject|0|||
156971690|NCT00077064|566649982|FG000|Overall Study|Adverse Event|0|||
156971691|NCT00077064|566649983|FG001|Overall Study|Adverse Event|4|||
156971692|NCT00077064|566649982|FG000|Overall Study|Patient refusal|0|||
156971693|NCT00077064|566649983|FG001|Overall Study|Patient refusal|2|||
156971694|NCT02007434|566649989|FG000|Overall Study|Lost to Follow-up|0|||
156971695|NCT02007434|566649990|FG001|Overall Study|Lost to Follow-up|1|||
156971696|NCT02007434|566649991|FG002|Overall Study|Lost to Follow-up|0|||
156971697|NCT02007434|566649992|FG003|Overall Study|Lost to Follow-up|0|||
156971698|NCT02007434|566649993|FG004|Overall Study|Lost to Follow-up|0|||
156971699|NCT02007434|566649994|FG005|Overall Study|Lost to Follow-up|0|||
156971700|NCT02007434|566649995|FG006|Overall Study|Lost to Follow-up|0|||
156971701|NCT02007434|566649996|FG007|Overall Study|Lost to Follow-up|0|||
156971702|NCT02007434|566649989|FG000|Overall Study|Non-compliance|1|||
156971703|NCT02007434|566649990|FG001|Overall Study|Non-compliance|0|||
156971704|NCT02007434|566649991|FG002|Overall Study|Non-compliance|1|||
156971705|NCT02007434|566649992|FG003|Overall Study|Non-compliance|0|||
156971706|NCT02007434|566649993|FG004|Overall Study|Non-compliance|0|||
156971707|NCT02007434|566649994|FG005|Overall Study|Non-compliance|0|||
156971708|NCT02007434|566649995|FG006|Overall Study|Non-compliance|0|||
156971709|NCT02007434|566649996|FG007|Overall Study|Non-compliance|0|||
156971710|NCT02255357|566649999|FG000|Overall Study|Physician Decision|10|||
156971711|NCT02255357|566650000|FG001|Overall Study|Physician Decision|24|||
156971712|NCT00509236|566650005|FG000|Overall Study|Adverse Event|7|||
156971713|NCT00509236|566650006|FG001|Overall Study|Adverse Event|9|||
156971714|NCT00509236|566650005|FG000|Overall Study|Withdrawal by Subject|5|||
156971715|NCT00509236|566650006|FG001|Overall Study|Withdrawal by Subject|10|||
156971716|NCT00509236|566650005|FG000|Overall Study|Protocol Violation|3|||
156971717|NCT00509236|566650006|FG001|Overall Study|Protocol Violation|0|||
156971718|NCT00509236|566650005|FG000|Overall Study|Excluded Medication|1|||
156971719|NCT00509236|566650006|FG001|Overall Study|Excluded Medication|1|||
156971720|NCT00509236|566650005|FG000|Overall Study|Scheduled Kidney Transplant|1|||
156971721|NCT00509236|566650006|FG001|Overall Study|Scheduled Kidney Transplant|0|||
156971722|NCT00927355|566650007|FG000|Overall Study|Adverse Event|1|||
156971723|NCT00927355|566650008|FG001|Overall Study|Adverse Event|1|||
156971724|NCT03299686|566650020|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
156971725|NCT03299686|566650021|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
156971726|NCT03299686|566650020|FG000|Treatment Epoch|Physician Decision|1|||
156971727|NCT03299686|566650021|FG001|Treatment Epoch|Physician Decision|0|||
156971728|NCT03299686|566650020|FG000|Treatment Epoch|Adverse Event|8|||
156971729|NCT03299686|566650021|FG001|Treatment Epoch|Adverse Event|4|||
156971730|NCT03299686|566650020|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
156971731|NCT03299686|566650021|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
156971732|NCT02709005|566650022|FG000|Overall Study|Lost to Follow-up|1|||
156971733|NCT02709005|566650023|FG001|Overall Study|Lost to Follow-up|1|||
156971734|NCT02709005|566650022|FG000|Overall Study|Withdrawal by Subject|3|||
156971735|NCT02709005|566650023|FG001|Overall Study|Withdrawal by Subject|0|||
156971736|NCT01572389|566650025|FG000|Overall Study|Death|1|||
157176029|NCT01999946|567383850|FG000|Overall Study|Not included in primary outcome analysis|0|||
157176030|NCT01999946|567383851|FG001|Overall Study|Not included in primary outcome analysis|0|||
157176031|NCT01999946|567383852|FG002|Overall Study|Not included in primary outcome analysis|79|||
157176032|NCT03906136|567385387|FG000|Overall Study|Adverse Event|1|||
157176033|NCT03906136|567385388|FG001|Overall Study|Adverse Event|0|||
157176034|NCT03906136|567385387|FG000|Overall Study|Lost to Follow-up|7|||
157176035|NCT03906136|567385388|FG001|Overall Study|Lost to Follow-up|4|||
157176036|NCT03906136|567385387|FG000|Overall Study|Physician Decision|1|||
157176037|NCT03906136|567385388|FG001|Overall Study|Physician Decision|0|||
157176038|NCT03906136|567385387|FG000|Overall Study|Withdrawal by Subject|3|||
156971737|NCT01572389|566650026|FG001|Overall Study|Death|3|||
156971738|NCT01572389|566650025|FG000|Overall Study|Withdrawal by Subject|14|||
156971739|NCT01572389|566650026|FG001|Overall Study|Withdrawal by Subject|2|||
156971740|NCT01572389|566650025|FG000|Overall Study|Lost to Follow-up|25|||
156971741|NCT01572389|566650026|FG001|Overall Study|Lost to Follow-up|14|||
156971742|NCT01572389|566650025|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
156971743|NCT01572389|566650026|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
156971744|NCT00499863|566650031|FG000|Overall Study|Lack of Efficacy|21|||
156971745|NCT00499863|566650032|FG001|Overall Study|Lack of Efficacy|27|||
157176039|NCT03906136|567385388|FG001|Overall Study|Withdrawal by Subject|7|||
157176040|NCT02371980|567385398|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
157176041|NCT02371980|567385399|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
157176042|NCT02371980|567385400|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
157176043|NCT02371980|567385401|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
157176044|NCT02371980|567385402|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
157176045|NCT02371980|567385398|FG000|Open-label Period|Significant Protocol Deviation|19|||
157176046|NCT02371980|567385399|FG001|Open-label Period|Significant Protocol Deviation|0|||
157176047|NCT02371980|567385400|FG002|Open-label Period|Significant Protocol Deviation|0|||
157176048|NCT02371980|567385401|FG003|Open-label Period|Significant Protocol Deviation|0|||
157176049|NCT02371980|567385402|FG004|Open-label Period|Significant Protocol Deviation|0|||
157176050|NCT02371980|567385398|FG000|Open-label Period|Noncompliance with Study Drug|10|||
157176051|NCT02371980|567385399|FG001|Open-label Period|Noncompliance with Study Drug|0|||
157176052|NCT02371980|567385400|FG002|Open-label Period|Noncompliance with Study Drug|0|||
157176053|NCT02371980|567385401|FG003|Open-label Period|Noncompliance with Study Drug|0|||
157176054|NCT02371980|567385402|FG004|Open-label Period|Noncompliance with Study Drug|0|||
157176055|NCT02371980|567385398|FG000|Open-label Period|Lost to Follow-up|55|||
157176056|NCT02371980|567385399|FG001|Open-label Period|Lost to Follow-up|0|||
156971746|NCT00499863|566650031|FG000|Overall Study|Protocol Violation|12|||
156971747|NCT00499863|566650032|FG001|Overall Study|Protocol Violation|7|||
156971748|NCT00499863|566650031|FG000|Overall Study|Withdrawal by Subject|6|||
156971749|NCT00499863|566650032|FG001|Overall Study|Withdrawal by Subject|4|||
156971750|NCT00499863|566650031|FG000|Overall Study|Adverse Event|8|||
156971751|NCT00499863|566650032|FG001|Overall Study|Adverse Event|2|||
156971752|NCT00499863|566650031|FG000|Overall Study|Sponsor decision|2|||
156971753|NCT00499863|566650032|FG001|Overall Study|Sponsor decision|2|||
156971754|NCT00499863|566650031|FG000|Overall Study|Lost to Follow-up|1|||
156971755|NCT00499863|566650032|FG001|Overall Study|Lost to Follow-up|1|||
156971756|NCT02535364|566650033|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
156971757|NCT02535364|566650033|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
156971758|NCT02535364|566650033|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
157176057|NCT02371980|567385400|FG002|Open-label Period|Lost to Follow-up|0|||
157176058|NCT02371980|567385401|FG003|Open-label Period|Lost to Follow-up|0|||
156971759|NCT02535364|566650033|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
156971760|NCT02535364|566650033|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
156971761|NCT02535364|566650033|FG000|Part B Screening|Death|2|||
156971762|NCT02535364|566650033|FG000|Part B Screening|Physician Decision|1|||
156971763|NCT02535364|566650033|FG000|Part B Screening|Withdrawal by Subject|1|||
156971764|NCT02535364|566650033|FG000|Part B Screening|Adverse Event|1|||
156971765|NCT02535364|566650033|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
156971766|NCT02535364|566650033|FG000|Study Treatment|Death|1|||
157176059|NCT02371980|567385402|FG004|Open-label Period|Lost to Follow-up|0|||
157176060|NCT02371980|567385398|FG000|Open-label Period|Voluntary Withdrawal|91|||
157176061|NCT02371980|567385399|FG001|Open-label Period|Voluntary Withdrawal|0|||
157176062|NCT02371980|567385400|FG002|Open-label Period|Voluntary Withdrawal|0|||
157176063|NCT02371980|567385401|FG003|Open-label Period|Voluntary Withdrawal|0|||
157176064|NCT02371980|567385402|FG004|Open-label Period|Voluntary Withdrawal|0|||
157176065|NCT02371980|567385398|FG000|Open-label Period|Pregnancy|1|||
157176066|NCT02371980|567385399|FG001|Open-label Period|Pregnancy|0|||
157176067|NCT02371980|567385400|FG002|Open-label Period|Pregnancy|0|||
157176068|NCT02371980|567385401|FG003|Open-label Period|Pregnancy|0|||
157176069|NCT02371980|567385402|FG004|Open-label Period|Pregnancy|0|||
157176070|NCT02371980|567385398|FG000|Open-label Period|Lack of Efficacy|116|||
157176071|NCT02371980|567385399|FG001|Open-label Period|Lack of Efficacy|0|||
157176072|NCT02371980|567385400|FG002|Open-label Period|Lack of Efficacy|0|||
157176073|NCT02371980|567385401|FG003|Open-label Period|Lack of Efficacy|0|||
157176074|NCT02371980|567385402|FG004|Open-label Period|Lack of Efficacy|0|||
157176075|NCT02371980|567385398|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
157176076|NCT02371980|567385399|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
157176077|NCT02371980|567385400|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
157176078|NCT02371980|567385401|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
157176079|NCT02371980|567385402|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
157176080|NCT02371980|567385398|FG000|Open-label Period|Reason not Specified|9|||
157176081|NCT02371980|567385399|FG001|Open-label Period|Reason not Specified|0|||
157176082|NCT02371980|567385400|FG002|Open-label Period|Reason not Specified|0|||
157176083|NCT02371980|567385401|FG003|Open-label Period|Reason not Specified|0|||
157176084|NCT02371980|567385402|FG004|Open-label Period|Reason not Specified|0|||
157176085|NCT02371980|567385398|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
157176086|NCT02371980|567385399|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
157176087|NCT02371980|567385400|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
157176088|NCT02371980|567385401|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
157176089|NCT02371980|567385402|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
157176090|NCT02371980|567385398|FG000|Double-blind Period|Significant Protocol Deviation|0|||
157176091|NCT02371980|567385399|FG001|Double-blind Period|Significant Protocol Deviation|2|||
157176092|NCT02371980|567385400|FG002|Double-blind Period|Significant Protocol Deviation|7|||
157176093|NCT02371980|567385401|FG003|Double-blind Period|Significant Protocol Deviation|3|||
157176094|NCT02371980|567385402|FG004|Double-blind Period|Significant Protocol Deviation|3|||
157176095|NCT02371980|567385398|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
157176096|NCT02371980|567385399|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
157176097|NCT02371980|567385400|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
157176098|NCT02371980|567385401|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
157176099|NCT02371980|567385402|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
157176100|NCT02371980|567385398|FG000|Double-blind Period|Lost to Follow-up|0|||
157176101|NCT02371980|567385399|FG001|Double-blind Period|Lost to Follow-up|8|||
157176102|NCT02371980|567385400|FG002|Double-blind Period|Lost to Follow-up|8|||
157176103|NCT02371980|567385401|FG003|Double-blind Period|Lost to Follow-up|6|||
157176104|NCT02371980|567385402|FG004|Double-blind Period|Lost to Follow-up|5|||
157176105|NCT02371980|567385398|FG000|Double-blind Period|Voluntary Withdrawal|0|||
157176106|NCT02371980|567385399|FG001|Double-blind Period|Voluntary Withdrawal|12|||
157176107|NCT02371980|567385400|FG002|Double-blind Period|Voluntary Withdrawal|8|||
157176108|NCT02371980|567385401|FG003|Double-blind Period|Voluntary Withdrawal|9|||
157176109|NCT02371980|567385402|FG004|Double-blind Period|Voluntary Withdrawal|11|||
157176110|NCT02371980|567385398|FG000|Double-blind Period|Relapse|0|||
157176111|NCT02371980|567385399|FG001|Double-blind Period|Relapse|50|||
157176112|NCT02371980|567385400|FG002|Double-blind Period|Relapse|25|||
157176113|NCT02371980|567385401|FG003|Double-blind Period|Relapse|25|||
156971767|NCT02535364|566650033|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
156971768|NCT02535364|566650033|FG000|12-Month Follow-up Period|Disease progression|22|||
157176114|NCT02371980|567385402|FG004|Double-blind Period|Relapse|26|||
157176115|NCT02371980|567385398|FG000|Double-blind Period|Reason not Specified|0|||
157176116|NCT02371980|567385399|FG001|Double-blind Period|Reason not Specified|3|||
157176117|NCT02371980|567385400|FG002|Double-blind Period|Reason not Specified|3|||
157176118|NCT02371980|567385401|FG003|Double-blind Period|Reason not Specified|2|||
157176119|NCT02371980|567385402|FG004|Double-blind Period|Reason not Specified|1|||
156971769|NCT02535364|566650033|FG000|12-Month Follow-up Period|Death|5|||
157048835|NCT01562275|566933300|FG009|Stage 2|Death|0|||
157229213|NCT03992196|567585171|FG002|Enrollment|lost to follow-up prior dosing|0|||
157229214|NCT03992196|567585169|FG000|Treatment|Protocol Violation|0|||
157229215|NCT03992196|567585170|FG001|Treatment|Protocol Violation|0|||
157229216|NCT03992196|567585171|FG002|Treatment|Protocol Violation|1|||
157229217|NCT03992196|567585169|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
157229218|NCT03992196|567585170|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
157229219|NCT03992196|567585171|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
157229220|NCT03992196|567585169|FG000|Treatment|Withdrawal due to non-compliance|0|||
157229221|NCT03992196|567585170|FG001|Treatment|Withdrawal due to non-compliance|0|||
157229222|NCT03992196|567585171|FG002|Treatment|Withdrawal due to non-compliance|1|||
157229223|NCT03992196|567585169|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
157229224|NCT03992196|567585170|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
157229225|NCT03992196|567585171|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
157229226|NCT03992196|567585169|FG000|Treatment|Withdrawal by parent/guardian|0|||
157229227|NCT03992196|567585170|FG001|Treatment|Withdrawal by parent/guardian|0|||
157229228|NCT03992196|567585171|FG002|Treatment|Withdrawal by parent/guardian|2|||
157229229|NCT00755196|567585175|FG000|Overall Study|Lost to Follow-up|1|||
157229230|NCT00755196|567585175|FG000|Overall Study|Lack of Efficiency|1|||
157229231|NCT02388763|567585176|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
157229232|NCT02388763|567585177|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
157229233|NCT02388763|567585176|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
157229234|NCT02388763|567585177|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
157229235|NCT01604850|567585178|FG000|Overall Study|Enrolled but never treated|0|||
157229236|NCT01604850|567585179|FG001|Overall Study|Enrolled but never treated|1|||
157229237|NCT01604850|567585178|FG000|Overall Study|Efficacy Failure|50|||
157229238|NCT01604850|567585179|FG001|Overall Study|Efficacy Failure|29|||
157229239|NCT01604850|567585178|FG000|Overall Study|Lost to Follow-up|1|||
157229240|NCT01604850|567585179|FG001|Overall Study|Lost to Follow-up|0|||
157229241|NCT01604850|567585178|FG000|Overall Study|Subject withdrew consent|1|||
157229242|NCT01604850|567585179|FG001|Overall Study|Subject withdrew consent|0|||
157229243|NCT01703832|567585180|FG000|Overall Study|Withdrawal by Subject|1|||
157229244|NCT01703832|567585181|FG001|Overall Study|Withdrawal by Subject|0|||
157229245|NCT00543309|567585182|FG000|Overall Study|Physician Decision|0|||
157229246|NCT00543309|567585183|FG001|Overall Study|Physician Decision|1|||
157229247|NCT00543309|567585184|FG002|Overall Study|Physician Decision|0|||
157229248|NCT02194998|567585190|FG000|On-HCV Treatment|Did not pick up study medication|0|||
157229249|NCT02194998|567585191|FG001|On-HCV Treatment|Did not pick up study medication|1|||
157229250|NCT02194998|567585192|FG002|On-HCV Treatment|Did not pick up study medication|0|||
157229251|NCT02194998|567585193|FG003|On-HCV Treatment|Did not pick up study medication|0|||
157229252|NCT02194998|567585190|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
157229253|NCT02194998|567585191|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
157229254|NCT02194998|567585192|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
157229255|NCT02194998|567585193|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
157229256|NCT01249664|567585194|FG000|Overall Study|Withdrawal by Subject|5|||
157229257|NCT01249664|567585195|FG001|Overall Study|Withdrawal by Subject|0|||
157229258|NCT01249664|567585194|FG000|Overall Study|Adverse Event|1|||
157229259|NCT01249664|567585195|FG001|Overall Study|Adverse Event|0|||
157229260|NCT00525590|567585196|FG000|Overall Study|Adverse Event|3|||
157229261|NCT00525590|567585196|FG000|Overall Study|Physician Decision|3|||
157229262|NCT00525590|567585196|FG000|Overall Study|Withdrawal by Subject|16|||
157229263|NCT00525590|567585196|FG000|Overall Study|Lost to Follow-up|1|||
157229264|NCT00525590|567585196|FG000|Overall Study|Death|9|||
157229265|NCT00525590|567585196|FG000|Overall Study|Other|13|||
157229266|NCT00762086|567585201|FG000|Overall Study|Adverse Event|2|||
157229267|NCT00762086|567585202|FG001|Overall Study|Adverse Event|0|||
157229268|NCT00762086|567585201|FG000|Overall Study|Lost to Follow-up|0|||
157229269|NCT00762086|567585202|FG001|Overall Study|Lost to Follow-up|2|||
157229270|NCT00762086|567585201|FG000|Overall Study|Non compliance|1|||
157229271|NCT00762086|567585202|FG001|Overall Study|Non compliance|0|||
157229272|NCT00762086|567585201|FG000|Overall Study|Withdrawal by Subject|2|||
157229273|NCT00762086|567585202|FG001|Overall Study|Withdrawal by Subject|2|||
157229274|NCT00762086|567585201|FG000|Overall Study|Ineligible to participate in the study|1|||
157229275|NCT00762086|567585202|FG001|Overall Study|Ineligible to participate in the study|0|||
157229276|NCT03661528|567585203|FG000|Overall Study|Death|1|||
157229277|NCT03661528|567585204|FG001|Overall Study|Death|0|||
157229278|NCT03661528|567585203|FG000|Overall Study|Physician Decision|3|||
157229279|NCT03661528|567585204|FG001|Overall Study|Physician Decision|1|||
157229280|NCT03661528|567585203|FG000|Overall Study|Other than Specified|5|||
157229281|NCT03661528|567585204|FG001|Overall Study|Other than Specified|2|||
156971770|NCT02535364|566650033|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
157229282|NCT03661528|567585203|FG000|Overall Study|Withdrawal by Subject|5|||
157229283|NCT03661528|567585204|FG001|Overall Study|Withdrawal by Subject|3|||
157229284|NCT03661528|567585203|FG000|Overall Study|Disease Progression|8|||
157229285|NCT03661528|567585204|FG001|Overall Study|Disease Progression|13|||
156971771|NCT02535364|566650033|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
156971772|NCT02535364|566650033|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
156971773|NCT00571701|566650034|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
156971774|NCT00571701|566650035|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
156971775|NCT00571701|566650034|FG000|First Intervention 12 Months|Death|1|||
156971776|NCT00571701|566650035|FG001|First Intervention 12 Months|Death|0|||
156971777|NCT00571701|566650034|FG000|Second Intervention 12 Months|Adverse Event|0|||
156971778|NCT00571701|566650035|FG001|Second Intervention 12 Months|Adverse Event|1|||
156971779|NCT00571701|566650034|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
156971780|NCT00571701|566650035|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
156971781|NCT00691132|566650037|FG000|Overall Study|Adverse Event|2|||
156971782|NCT00691132|566650038|FG001|Overall Study|Adverse Event|3|||
156971783|NCT00691132|566650037|FG000|Overall Study|Withdrawal by Subject|10|||
156971784|NCT00691132|566650038|FG001|Overall Study|Withdrawal by Subject|10|||
156971785|NCT01959347|566650040|FG000|Overall Study|Protocol Violation|9|||
156971786|NCT01959347|566650041|FG001|Overall Study|Protocol Violation|7|||
156971787|NCT03541044|566650042|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
156971788|NCT03541044|566650043|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
156971789|NCT03541044|566650042|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
156971790|NCT03541044|566650043|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
156971791|NCT02889133|566650049|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
156971792|NCT02889133|566650050|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
156971793|NCT02889133|566650049|FG000|Completed Primary Outcome|Manufacturing error|3|||
156971794|NCT02889133|566650050|FG001|Completed Primary Outcome|Manufacturing error|8|||
156971795|NCT02889133|566650049|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
156971796|NCT02889133|566650050|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
156971797|NCT02889133|566650049|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
156971798|NCT02889133|566650050|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
156971799|NCT02889133|566650049|FG000|Completed Primary Outcome|Protocol Violation|1|||
156971800|NCT02889133|566650050|FG001|Completed Primary Outcome|Protocol Violation|0|||
156971801|NCT02889133|566650049|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
156971802|NCT02889133|566650050|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
156971803|NCT02889133|566650049|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
156971804|NCT02889133|566650050|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
156971805|NCT02889133|566650049|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
156971806|NCT02889133|566650050|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
156971807|NCT02889133|566650049|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
156971808|NCT02889133|566650050|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
156971809|NCT02889133|566650049|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
156971810|NCT02889133|566650050|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
156971811|NCT03131960|566650051|FG000|Overall Study|Adverse Event|0|||
156971812|NCT03131960|566650052|FG001|Overall Study|Adverse Event|1|||
156971813|NCT01215357|566650055|FG000|Overall Study|Withdrawal by Subject|3|||
156971814|NCT01215357|566650055|FG000|Overall Study|Protocol Violation|9|||
156971815|NCT01375205|566650060|FG000|Overall Study|Lost to Follow-up|15|||
156971816|NCT01375205|566650061|FG001|Overall Study|Lost to Follow-up|12|||
156971817|NCT01375205|566650060|FG000|Overall Study|Withdrawal by Subject|6|||
156971818|NCT01375205|566650061|FG001|Overall Study|Withdrawal by Subject|1|||
156971819|NCT01859793|566650062|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
156971820|NCT01859793|566650063|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
156971821|NCT01859793|566650062|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
156971822|NCT01859793|566650063|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
156971823|NCT01859793|566650062|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
156971824|NCT01859793|566650063|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
156971825|NCT01859793|566650062|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
156971826|NCT01859793|566650063|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
156971827|NCT01148862|566650064|FG000|Second Intervention|Withdrawal by Subject|0|||
156971828|NCT01148862|566650065|FG001|Second Intervention|Withdrawal by Subject|2|||
156971829|NCT04543188|566650066|FG000|Phase 1a|Adverse Event|0|||
156971830|NCT04543188|566650067|FG001|Phase 1a|Adverse Event|0|||
156971831|NCT04543188|566650068|FG002|Phase 1a|Adverse Event|0|||
156971832|NCT04543188|566650069|FG003|Phase 1a|Adverse Event|1|||
156971833|NCT04543188|566650070|FG004|Phase 1a|Adverse Event|0|||
156971834|NCT04543188|566650071|FG005|Phase 1a|Adverse Event|0|||
156971835|NCT04543188|566650072|FG006|Phase 1a|Adverse Event|1|||
156971836|NCT04543188|566650073|FG007|Phase 1a|Adverse Event|0|||
156971837|NCT04543188|566650074|FG008|Phase 1a|Adverse Event|0|||
156971838|NCT04543188|566650075|FG009|Phase 1a|Adverse Event|0|||
156971839|NCT04543188|566650076|FG010|Phase 1a|Adverse Event|0|||
156971840|NCT04543188|566650077|FG011|Phase 1a|Adverse Event|0|||
156971841|NCT04543188|566650078|FG012|Phase 1a|Adverse Event|0|||
156971842|NCT04543188|566650079|FG013|Phase 1a|Adverse Event|0|||
156971843|NCT04543188|566650080|FG014|Phase 1a|Adverse Event|0|||
156971844|NCT04543188|566650066|FG000|Phase 1a|Other (Death)|0|||
156971845|NCT04543188|566650067|FG001|Phase 1a|Other (Death)|1|||
156971846|NCT04543188|566650068|FG002|Phase 1a|Other (Death)|0|||
156971847|NCT04543188|566650069|FG003|Phase 1a|Other (Death)|0|||
156971848|NCT04543188|566650070|FG004|Phase 1a|Other (Death)|1|||
156971849|NCT04543188|566650071|FG005|Phase 1a|Other (Death)|0|||
156971850|NCT04543188|566650072|FG006|Phase 1a|Other (Death)|0|||
156971851|NCT04543188|566650073|FG007|Phase 1a|Other (Death)|0|||
156971852|NCT04543188|566650074|FG008|Phase 1a|Other (Death)|0|||
156971853|NCT04543188|566650075|FG009|Phase 1a|Other (Death)|1|||
156971854|NCT04543188|566650076|FG010|Phase 1a|Other (Death)|0|||
156971855|NCT04543188|566650077|FG011|Phase 1a|Other (Death)|0|||
156971856|NCT04543188|566650078|FG012|Phase 1a|Other (Death)|0|||
156971857|NCT04543188|566650079|FG013|Phase 1a|Other (Death)|0|||
156971858|NCT04543188|566650080|FG014|Phase 1a|Other (Death)|0|||
156971859|NCT04543188|566650066|FG000|Phase 1a|Lost to Follow-up|0|||
156971860|NCT04543188|566650067|FG001|Phase 1a|Lost to Follow-up|0|||
156971861|NCT04543188|566650068|FG002|Phase 1a|Lost to Follow-up|0|||
156971862|NCT04543188|566650069|FG003|Phase 1a|Lost to Follow-up|0|||
156971863|NCT04543188|566650070|FG004|Phase 1a|Lost to Follow-up|0|||
156971864|NCT04543188|566650071|FG005|Phase 1a|Lost to Follow-up|0|||
156971865|NCT04543188|566650072|FG006|Phase 1a|Lost to Follow-up|0|||
156971866|NCT04543188|566650073|FG007|Phase 1a|Lost to Follow-up|0|||
156971867|NCT04543188|566650074|FG008|Phase 1a|Lost to Follow-up|0|||
156971868|NCT04543188|566650075|FG009|Phase 1a|Lost to Follow-up|0|||
156971869|NCT04543188|566650076|FG010|Phase 1a|Lost to Follow-up|1|||
156971870|NCT04543188|566650077|FG011|Phase 1a|Lost to Follow-up|0|||
156971871|NCT04543188|566650078|FG012|Phase 1a|Lost to Follow-up|0|||
156971872|NCT04543188|566650079|FG013|Phase 1a|Lost to Follow-up|0|||
156971873|NCT04543188|566650080|FG014|Phase 1a|Lost to Follow-up|0|||
156971874|NCT04543188|566650066|FG000|Phase 1a|Progressive Disease|2|||
156971875|NCT04543188|566650067|FG001|Phase 1a|Progressive Disease|2|||
156971876|NCT04543188|566650068|FG002|Phase 1a|Progressive Disease|3|||
156971877|NCT04543188|566650069|FG003|Phase 1a|Progressive Disease|1|||
156971878|NCT04543188|566650070|FG004|Phase 1a|Progressive Disease|4|||
156971879|NCT04543188|566650071|FG005|Phase 1a|Progressive Disease|2|||
156971880|NCT04543188|566650072|FG006|Phase 1a|Progressive Disease|3|||
156971881|NCT04543188|566650073|FG007|Phase 1a|Progressive Disease|4|||
156971882|NCT04543188|566650074|FG008|Phase 1a|Progressive Disease|1|||
156971883|NCT04543188|566650075|FG009|Phase 1a|Progressive Disease|0|||
156971884|NCT04543188|566650076|FG010|Phase 1a|Progressive Disease|4|||
156971885|NCT04543188|566650077|FG011|Phase 1a|Progressive Disease|0|||
156971886|NCT04543188|566650078|FG012|Phase 1a|Progressive Disease|0|||
156971887|NCT04543188|566650079|FG013|Phase 1a|Progressive Disease|0|||
156971888|NCT04543188|566650080|FG014|Phase 1a|Progressive Disease|0|||
156971889|NCT04543188|566650066|FG000|Phase 1a|Study terminated by sponsor|0|||
156971890|NCT04543188|566650067|FG001|Phase 1a|Study terminated by sponsor|0|||
156971891|NCT04543188|566650068|FG002|Phase 1a|Study terminated by sponsor|0|||
156971892|NCT04543188|566650069|FG003|Phase 1a|Study terminated by sponsor|0|||
156971893|NCT04543188|566650070|FG004|Phase 1a|Study terminated by sponsor|1|||
156971894|NCT04543188|566650071|FG005|Phase 1a|Study terminated by sponsor|0|||
156971895|NCT04543188|566650072|FG006|Phase 1a|Study terminated by sponsor|0|||
156971896|NCT04543188|566650073|FG007|Phase 1a|Study terminated by sponsor|0|||
156971897|NCT04543188|566650074|FG008|Phase 1a|Study terminated by sponsor|0|||
156971898|NCT04543188|566650075|FG009|Phase 1a|Study terminated by sponsor|0|||
156971899|NCT04543188|566650076|FG010|Phase 1a|Study terminated by sponsor|1|||
156971900|NCT04543188|566650077|FG011|Phase 1a|Study terminated by sponsor|0|||
156971901|NCT04543188|566650078|FG012|Phase 1a|Study terminated by sponsor|0|||
156971902|NCT04543188|566650079|FG013|Phase 1a|Study terminated by sponsor|0|||
156971903|NCT04543188|566650080|FG014|Phase 1a|Study terminated by sponsor|0|||
156971904|NCT04543188|566650066|FG000|Phase 1a|Withdrawal by Subject|0|||
156971905|NCT04543188|566650067|FG001|Phase 1a|Withdrawal by Subject|0|||
156971906|NCT04543188|566650068|FG002|Phase 1a|Withdrawal by Subject|0|||
156971907|NCT04543188|566650069|FG003|Phase 1a|Withdrawal by Subject|0|||
156971908|NCT04543188|566650070|FG004|Phase 1a|Withdrawal by Subject|3|||
156971909|NCT04543188|566650071|FG005|Phase 1a|Withdrawal by Subject|0|||
156971910|NCT04543188|566650072|FG006|Phase 1a|Withdrawal by Subject|0|||
156971911|NCT04543188|566650073|FG007|Phase 1a|Withdrawal by Subject|0|||
156971912|NCT04543188|566650074|FG008|Phase 1a|Withdrawal by Subject|1|||
156971913|NCT04543188|566650075|FG009|Phase 1a|Withdrawal by Subject|1|||
156971914|NCT04543188|566650076|FG010|Phase 1a|Withdrawal by Subject|2|||
156971915|NCT04543188|566650077|FG011|Phase 1a|Withdrawal by Subject|0|||
156971916|NCT04543188|566650078|FG012|Phase 1a|Withdrawal by Subject|0|||
156971917|NCT04543188|566650079|FG013|Phase 1a|Withdrawal by Subject|0|||
156971918|NCT04543188|566650080|FG014|Phase 1a|Withdrawal by Subject|0|||
156971919|NCT04543188|566650066|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
156971920|NCT04543188|566650067|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
156971921|NCT04543188|566650068|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
156971922|NCT04543188|566650069|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
156971923|NCT04543188|566650070|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
156971924|NCT04543188|566650071|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
157048836|NCT01562275|566933301|FG010|Stage 2|Death|0|||
157048837|NCT01562275|566933302|FG011|Stage 2|Death|2|||
157048838|NCT01562275|566933303|FG012|Stage 2|Death|1|||
156971925|NCT04543188|566650072|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
156971926|NCT04543188|566650073|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
156971927|NCT04543188|566650074|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
156971928|NCT04543188|566650075|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
156971929|NCT04543188|566650076|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
156971930|NCT04543188|566650077|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
156971931|NCT04543188|566650078|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
156971932|NCT04543188|566650079|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
156971933|NCT04543188|566650080|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
156971934|NCT04543188|566650066|FG000|Phase 1a|Other|0|||
156971935|NCT04543188|566650067|FG001|Phase 1a|Other|0|||
156971936|NCT04543188|566650068|FG002|Phase 1a|Other|0|||
156971937|NCT04543188|566650069|FG003|Phase 1a|Other|0|||
156971938|NCT04543188|566650070|FG004|Phase 1a|Other|0|||
156971939|NCT04543188|566650071|FG005|Phase 1a|Other|0|||
156971940|NCT04543188|566650072|FG006|Phase 1a|Other|0|||
156971941|NCT04543188|566650073|FG007|Phase 1a|Other|0|||
156971942|NCT04543188|566650074|FG008|Phase 1a|Other|0|||
156971943|NCT04543188|566650075|FG009|Phase 1a|Other|1|||
156971944|NCT04543188|566650076|FG010|Phase 1a|Other|0|||
156971945|NCT04543188|566650077|FG011|Phase 1a|Other|0|||
156971946|NCT04543188|566650078|FG012|Phase 1a|Other|0|||
156971947|NCT04543188|566650079|FG013|Phase 1a|Other|0|||
156971948|NCT04543188|566650080|FG014|Phase 1a|Other|0|||
156971949|NCT04543188|566650066|FG000|Phase 1b|Adverse Event|0|||
156971950|NCT04543188|566650067|FG001|Phase 1b|Adverse Event|0|||
156971951|NCT04543188|566650068|FG002|Phase 1b|Adverse Event|0|||
156971952|NCT04543188|566650069|FG003|Phase 1b|Adverse Event|0|||
156971953|NCT04543188|566650070|FG004|Phase 1b|Adverse Event|0|||
156971954|NCT04543188|566650071|FG005|Phase 1b|Adverse Event|0|||
156971955|NCT04543188|566650072|FG006|Phase 1b|Adverse Event|0|||
156971956|NCT04543188|566650073|FG007|Phase 1b|Adverse Event|0|||
156971957|NCT04543188|566650074|FG008|Phase 1b|Adverse Event|0|||
156971958|NCT04543188|566650075|FG009|Phase 1b|Adverse Event|0|||
156971959|NCT04543188|566650076|FG010|Phase 1b|Adverse Event|0|||
156971960|NCT04543188|566650077|FG011|Phase 1b|Adverse Event|0|||
156971961|NCT04543188|566650078|FG012|Phase 1b|Adverse Event|0|||
156971962|NCT04543188|566650079|FG013|Phase 1b|Adverse Event|0|||
156971963|NCT04543188|566650080|FG014|Phase 1b|Adverse Event|2|||
156971964|NCT04543188|566650066|FG000|Phase 1b|Other (Death)|0|||
156971965|NCT04543188|566650067|FG001|Phase 1b|Other (Death)|0|||
156971966|NCT04543188|566650068|FG002|Phase 1b|Other (Death)|0|||
156971967|NCT04543188|566650069|FG003|Phase 1b|Other (Death)|0|||
156971968|NCT04543188|566650070|FG004|Phase 1b|Other (Death)|0|||
156971969|NCT04543188|566650071|FG005|Phase 1b|Other (Death)|0|||
156971970|NCT04543188|566650072|FG006|Phase 1b|Other (Death)|0|||
156971971|NCT04543188|566650073|FG007|Phase 1b|Other (Death)|0|||
156971972|NCT04543188|566650074|FG008|Phase 1b|Other (Death)|0|||
156971973|NCT04543188|566650075|FG009|Phase 1b|Other (Death)|0|||
156971974|NCT04543188|566650076|FG010|Phase 1b|Other (Death)|0|||
156971975|NCT04543188|566650077|FG011|Phase 1b|Other (Death)|0|||
156971976|NCT04543188|566650078|FG012|Phase 1b|Other (Death)|1|||
156971977|NCT04543188|566650079|FG013|Phase 1b|Other (Death)|0|||
156971978|NCT04543188|566650080|FG014|Phase 1b|Other (Death)|1|||
156971979|NCT04543188|566650066|FG000|Phase 1b|Progressive Disease|0|||
156971980|NCT04543188|566650067|FG001|Phase 1b|Progressive Disease|0|||
156971981|NCT04543188|566650068|FG002|Phase 1b|Progressive Disease|0|||
156971982|NCT04543188|566650069|FG003|Phase 1b|Progressive Disease|0|||
156971983|NCT04543188|566650070|FG004|Phase 1b|Progressive Disease|0|||
156971984|NCT04543188|566650071|FG005|Phase 1b|Progressive Disease|0|||
156971985|NCT04543188|566650072|FG006|Phase 1b|Progressive Disease|0|||
157048839|NCT01562275|566933291|FG000|Stage 2|Progression of Disease|0|||
157048840|NCT01562275|566933292|FG001|Stage 2|Progression of Disease|0|||
157048841|NCT01562275|566933293|FG002|Stage 2|Progression of Disease|0|||
156971986|NCT04543188|566650073|FG007|Phase 1b|Progressive Disease|0|||
157048842|NCT01562275|566933294|FG003|Stage 2|Progression of Disease|0|||
156971987|NCT04543188|566650074|FG008|Phase 1b|Progressive Disease|0|||
156971988|NCT04543188|566650075|FG009|Phase 1b|Progressive Disease|0|||
156971989|NCT04543188|566650076|FG010|Phase 1b|Progressive Disease|0|||
156971990|NCT04543188|566650077|FG011|Phase 1b|Progressive Disease|0|||
156971991|NCT04543188|566650078|FG012|Phase 1b|Progressive Disease|2|||
156971992|NCT04543188|566650079|FG013|Phase 1b|Progressive Disease|1|||
156971993|NCT04543188|566650080|FG014|Phase 1b|Progressive Disease|5|||
156971994|NCT04543188|566650066|FG000|Phase 1b|Study Terminated By Sponsor|0|||
156971995|NCT04543188|566650067|FG001|Phase 1b|Study Terminated By Sponsor|0|||
156971996|NCT04543188|566650068|FG002|Phase 1b|Study Terminated By Sponsor|0|||
156971997|NCT04543188|566650069|FG003|Phase 1b|Study Terminated By Sponsor|0|||
156971998|NCT04543188|566650070|FG004|Phase 1b|Study Terminated By Sponsor|0|||
156971999|NCT04543188|566650071|FG005|Phase 1b|Study Terminated By Sponsor|0|||
156972000|NCT04543188|566650072|FG006|Phase 1b|Study Terminated By Sponsor|0|||
157048843|NCT01562275|566933295|FG004|Stage 2|Progression of Disease|0|||
157048844|NCT01562275|566933296|FG005|Stage 2|Progression of Disease|0|||
157048845|NCT01562275|566933297|FG006|Stage 2|Progression of Disease|0|||
157048846|NCT01562275|566933298|FG007|Stage 2|Progression of Disease|0|||
157048847|NCT01562275|566933299|FG008|Stage 2|Progression of Disease|0|||
157048848|NCT01562275|566933300|FG009|Stage 2|Progression of Disease|0|||
157048849|NCT01562275|566933301|FG010|Stage 2|Progression of Disease|0|||
157048850|NCT01562275|566933302|FG011|Stage 2|Progression of Disease|12|||
157048851|NCT01562275|566933303|FG012|Stage 2|Progression of Disease|4|||
157048852|NCT01863368|566933304|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
157048853|NCT01863368|566933305|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
157048854|NCT01863368|566933304|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
157048855|NCT01863368|566933305|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
157048856|NCT01863368|566933304|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
157048857|NCT01863368|566933305|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
157048858|NCT01863368|566933304|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
157048859|NCT01863368|566933305|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
157048860|NCT01863368|566933304|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
157176120|NCT02371980|567385398|FG000|Double-blind Period|Missing|0|||
157176121|NCT02371980|567385399|FG001|Double-blind Period|Missing|1|||
157048861|NCT01863368|566933305|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
157048862|NCT01863368|566933304|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
157048863|NCT01863368|566933305|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
157048864|NCT00647699|566933306|FG000|Overall Study|Lost to Follow-up|5|||
157048865|NCT00647699|566933307|FG001|Overall Study|Lost to Follow-up|4|||
157048866|NCT00647699|566933306|FG000|Overall Study|Withdrawal by Subject|3|||
157048867|NCT00647699|566933307|FG001|Overall Study|Withdrawal by Subject|8|||
157048868|NCT04909593|566933308|FG000|Overall Study|Withdrawal by Subject|1|||
157048869|NCT01018992|566933309|FG000|Overall Study|Adverse Event|8|||
157048870|NCT01018992|566933310|FG001|Overall Study|Adverse Event|3|||
157048871|NCT01018992|566933309|FG000|Overall Study|Withdrawal by Subject|3|||
157048872|NCT01018992|566933310|FG001|Overall Study|Withdrawal by Subject|8|||
157048873|NCT01018992|566933309|FG000|Overall Study|Protocol Violation|0|||
157048874|NCT01018992|566933310|FG001|Overall Study|Protocol Violation|4|||
157048875|NCT01018992|566933309|FG000|Overall Study|Lost to Follow-up|5|||
157048876|NCT01018992|566933310|FG001|Overall Study|Lost to Follow-up|1|||
156972001|NCT04543188|566650073|FG007|Phase 1b|Study Terminated By Sponsor|0|||
156972002|NCT04543188|566650074|FG008|Phase 1b|Study Terminated By Sponsor|0|||
156972003|NCT04543188|566650075|FG009|Phase 1b|Study Terminated By Sponsor|0|||
156972004|NCT04543188|566650076|FG010|Phase 1b|Study Terminated By Sponsor|0|||
156972005|NCT04543188|566650077|FG011|Phase 1b|Study Terminated By Sponsor|1|||
156972006|NCT04543188|566650078|FG012|Phase 1b|Study Terminated By Sponsor|1|||
156972007|NCT04543188|566650079|FG013|Phase 1b|Study Terminated By Sponsor|0|||
157048877|NCT00515112|566933312|FG000|Overall Study|Death|0|||
157048878|NCT00515112|566933313|FG001|Overall Study|Death|1|||
157048879|NCT00515112|566933312|FG000|Overall Study|The study was terminated|3|||
157048880|NCT00515112|566933313|FG001|Overall Study|The study was terminated|2|||
157048881|NCT04425252|566933314|FG000|Overall Study|Withdrawal by Subject|2|||
157048882|NCT04425252|566933315|FG001|Overall Study|Withdrawal by Subject|1|||
157176122|NCT02371980|567385400|FG002|Double-blind Period|Missing|0|||
157176123|NCT02371980|567385401|FG003|Double-blind Period|Missing|0|||
157176124|NCT02371980|567385402|FG004|Double-blind Period|Missing|0|||
157176125|NCT01280812|567385404|FG000|Overall Study|Withdrawal by Subject|2|||
157176126|NCT01280812|567385405|FG001|Overall Study|Withdrawal by Subject|1|||
156972008|NCT04543188|566650080|FG014|Phase 1b|Study Terminated By Sponsor|1|||
156972009|NCT04543188|566650066|FG000|Phase 1b|Withdrawal by Subject|0|||
156972010|NCT04543188|566650067|FG001|Phase 1b|Withdrawal by Subject|0|||
156972011|NCT04543188|566650068|FG002|Phase 1b|Withdrawal by Subject|0|||
156972012|NCT04543188|566650069|FG003|Phase 1b|Withdrawal by Subject|0|||
156972013|NCT04543188|566650070|FG004|Phase 1b|Withdrawal by Subject|0|||
156972014|NCT04543188|566650071|FG005|Phase 1b|Withdrawal by Subject|0|||
156972015|NCT04543188|566650072|FG006|Phase 1b|Withdrawal by Subject|0|||
156972016|NCT04543188|566650073|FG007|Phase 1b|Withdrawal by Subject|0|||
156972017|NCT04543188|566650074|FG008|Phase 1b|Withdrawal by Subject|0|||
156972018|NCT04543188|566650075|FG009|Phase 1b|Withdrawal by Subject|0|||
156972019|NCT04543188|566650076|FG010|Phase 1b|Withdrawal by Subject|0|||
156972020|NCT04543188|566650077|FG011|Phase 1b|Withdrawal by Subject|0|||
156972021|NCT04543188|566650078|FG012|Phase 1b|Withdrawal by Subject|0|||
156972022|NCT04543188|566650079|FG013|Phase 1b|Withdrawal by Subject|0|||
157048883|NCT04425252|566933314|FG000|Overall Study|Lost to Follow-up|1|||
157048884|NCT04425252|566933315|FG001|Overall Study|Lost to Follow-up|0|||
157176127|NCT01280812|567385406|FG002|Overall Study|Withdrawal by Subject|0|||
157176128|NCT01280812|567385404|FG000|Overall Study|Lost to Follow-up|1|||
156972023|NCT04543188|566650080|FG014|Phase 1b|Withdrawal by Subject|2|||
156972024|NCT04270747|566650081|FG000|Through Week 16|Adverse Event|1|||
156972025|NCT04270747|566650082|FG001|Through Week 16|Adverse Event|2|||
156972026|NCT04270747|566650083|FG002|Through Week 16|Adverse Event|0|||
157048885|NCT04425252|566933314|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
156972027|NCT04270747|566650081|FG000|Through Week 16|Death|0|||
156972028|NCT04270747|566650082|FG001|Through Week 16|Death|2|||
156972029|NCT04270747|566650083|FG002|Through Week 16|Death|0|||
156972030|NCT04270747|566650081|FG000|Through Week 16|Consent Withdrawn|3|||
156972031|NCT04270747|566650082|FG001|Through Week 16|Consent Withdrawn|3|||
156972032|NCT04270747|566650083|FG002|Through Week 16|Consent Withdrawn|0|||
156972033|NCT04270747|566650081|FG000|Through Week 16|Physician Decision|1|||
156972034|NCT04270747|566650082|FG001|Through Week 16|Physician Decision|1|||
157048886|NCT04425252|566933315|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
157048887|NCT01825785|566933316|FG000|Overall Study|Adverse Event|0|||
157048888|NCT01825785|566933317|FG001|Overall Study|Adverse Event|0|||
157048889|NCT01825785|566933318|FG002|Overall Study|Adverse Event|0|||
157048890|NCT01825785|566933319|FG003|Overall Study|Adverse Event|0|||
157048891|NCT01825785|566933320|FG004|Overall Study|Adverse Event|1|||
157048892|NCT01825785|566933321|FG005|Overall Study|Adverse Event|0|||
157048893|NCT01825785|566933322|FG006|Overall Study|Adverse Event|0|||
157048894|NCT01825785|566933316|FG000|Overall Study|Withdrawal by Subject|0|||
157048895|NCT01825785|566933317|FG001|Overall Study|Withdrawal by Subject|0|||
157048896|NCT01825785|566933318|FG002|Overall Study|Withdrawal by Subject|0|||
157048897|NCT01825785|566933319|FG003|Overall Study|Withdrawal by Subject|0|||
157048898|NCT01825785|566933320|FG004|Overall Study|Withdrawal by Subject|1|||
157048899|NCT01825785|566933321|FG005|Overall Study|Withdrawal by Subject|1|||
157048900|NCT01825785|566933322|FG006|Overall Study|Withdrawal by Subject|0|||
157048901|NCT00307489|566933323|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
157048902|NCT00307489|566933324|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
157048903|NCT00307489|566933323|FG000|Baseline Through Week 48|Physician Decision|1|||
157048904|NCT00307489|566933324|FG001|Baseline Through Week 48|Physician Decision|0|||
157048905|NCT00307489|566933323|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
157048906|NCT00307489|566933324|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
156972035|NCT04270747|566650083|FG002|Through Week 16|Physician Decision|0|||
156972036|NCT04270747|566650081|FG000|Through Week 16|Lost to Follow-up|2|||
156972037|NCT04270747|566650082|FG001|Through Week 16|Lost to Follow-up|0|||
156972038|NCT04270747|566650083|FG002|Through Week 16|Lost to Follow-up|0|||
156972039|NCT04270747|566650081|FG000|Through Week 16|Protocol Violation|1|||
156972040|NCT04270747|566650082|FG001|Through Week 16|Protocol Violation|2|||
156972041|NCT04270747|566650083|FG002|Through Week 16|Protocol Violation|0|||
156972042|NCT04270747|566650081|FG000|Through Week 16|Protocol Specified Criteria|6|||
157048907|NCT00307489|566933323|FG000|Week 48 Through Week 168|Adverse Event|1|||
157048908|NCT00307489|566933324|FG001|Week 48 Through Week 168|Adverse Event|0|||
157048909|NCT00307489|566933323|FG000|Week 48 Through Week 168|Physician Decision|1|||
157048910|NCT00307489|566933324|FG001|Week 48 Through Week 168|Physician Decision|0|||
157048911|NCT00307489|566933323|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
157048912|NCT00307489|566933324|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
157048913|NCT00307489|566933323|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
157048914|NCT00307489|566933324|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
157048915|NCT00307489|566933323|FG000|Week 48 Through Week 168|Death|0|||
157048916|NCT00307489|566933324|FG001|Week 48 Through Week 168|Death|1|||
157048917|NCT00307489|566933323|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
157176129|NCT01280812|567385405|FG001|Overall Study|Lost to Follow-up|1|||
157176130|NCT01280812|567385406|FG002|Overall Study|Lost to Follow-up|1|||
157176131|NCT00959894|567385412|FG000|Overall Study|Lost to Follow-up|10|||
157176132|NCT00959894|567385412|FG000|Overall Study|Adverse Event|3|||
157176133|NCT00959894|567385412|FG000|Overall Study|Withdrawal by Subject|1|||
156972043|NCT04270747|566650082|FG001|Through Week 16|Protocol Specified Criteria|7|||
156972044|NCT04270747|566650083|FG002|Through Week 16|Protocol Specified Criteria|0|||
156972045|NCT04270747|566650081|FG000|Through Week 16|Miscellaneous|1|||
157176134|NCT00959894|567385412|FG000|Overall Study|Need for contraindicated medication|1|||
157176135|NCT00959894|567385412|FG000|Overall Study|Subject moved out of town|1|||
157176136|NCT00922974|567385413|FG000|Phase II Component|Protocol Violation|2|||
157176137|NCT00922974|567385414|FG001|Phase II Component|Protocol Violation|0|||
157176138|NCT00922974|567385413|FG000|Phase II Component|Not evaluable for treatment review|5|||
157176139|NCT00922974|567385414|FG001|Phase II Component|Not evaluable for treatment review|0|||
157229286|NCT03661528|567585203|FG000|Overall Study|Adverse Event|61|||
156972046|NCT04270747|566650082|FG001|Through Week 16|Miscellaneous|1|||
156972047|NCT04270747|566650083|FG002|Through Week 16|Miscellaneous|0|||
156972048|NCT04270747|566650081|FG000|Post Week 16|Adverse Event|7|||
156972049|NCT04270747|566650082|FG001|Post Week 16|Adverse Event|5|||
156972050|NCT04270747|566650083|FG002|Post Week 16|Adverse Event|1|||
157048918|NCT00307489|566933324|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
157048919|NCT00307489|566933323|FG000|Week 48 Through Week 168|Seroconversion|1|||
157048920|NCT00307489|566933324|FG001|Week 48 Through Week 168|Seroconversion|0|||
157048921|NCT00304278|566933327|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
157048922|NCT00304278|566933327|FG000|Overall Study|PT had medical condition preventing TX|1|||
157048923|NCT02065895|566933328|FG000|Overall Study|Protocol Violation|1|||
157048924|NCT02065895|566933329|FG001|Overall Study|Protocol Violation|0|||
157229287|NCT03661528|567585204|FG001|Overall Study|Adverse Event|55|||
156972051|NCT04270747|566650081|FG000|Post Week 16|Death|2|||
156972052|NCT04270747|566650082|FG001|Post Week 16|Death|0|||
156972053|NCT04270747|566650083|FG002|Post Week 16|Death|2|||
156972054|NCT04270747|566650081|FG000|Post Week 16|Consent Withdrawn|4|||
156972055|NCT04270747|566650082|FG001|Post Week 16|Consent Withdrawn|3|||
156972056|NCT04270747|566650083|FG002|Post Week 16|Consent Withdrawn|6|||
156972057|NCT04270747|566650081|FG000|Post Week 16|Physician Decision|3|||
156972058|NCT04270747|566650082|FG001|Post Week 16|Physician Decision|1|||
156972059|NCT04270747|566650083|FG002|Post Week 16|Physician Decision|1|||
156972060|NCT04270747|566650081|FG000|Post Week 16|Lost to Follow-up|2|||
157229288|NCT02468778|567585214|FG000|Overall Study|Death|2|||
157229289|NCT02468778|567585215|FG001|Overall Study|Death|1|||
157229290|NCT02468778|567585216|FG002|Overall Study|Death|0|||
157229291|NCT02468778|567585214|FG000|Overall Study|Lost to Follow-up|1|||
157229292|NCT02468778|567585215|FG001|Overall Study|Lost to Follow-up|2|||
157229293|NCT02468778|567585216|FG002|Overall Study|Lost to Follow-up|2|||
157229294|NCT02468778|567585214|FG000|Overall Study|Withdrawal by Subject|0|||
156972061|NCT04270747|566650082|FG001|Post Week 16|Lost to Follow-up|1|||
156972062|NCT04270747|566650083|FG002|Post Week 16|Lost to Follow-up|0|||
156972063|NCT04270747|566650081|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
156972064|NCT04270747|566650082|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
156972065|NCT04270747|566650083|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
157048925|NCT02065895|566933330|FG002|Overall Study|Protocol Violation|0|||
157048926|NCT02065895|566933331|FG003|Overall Study|Protocol Violation|1|||
157048927|NCT02065895|566933332|FG004|Overall Study|Protocol Violation|0|||
157048928|NCT02065895|566933333|FG005|Overall Study|Protocol Violation|0|||
157048929|NCT02065895|566933328|FG000|Overall Study|Scheduling conflicts|0|||
157048930|NCT02065895|566933329|FG001|Overall Study|Scheduling conflicts|1|||
157048931|NCT02065895|566933330|FG002|Overall Study|Scheduling conflicts|0|||
157048932|NCT02065895|566933331|FG003|Overall Study|Scheduling conflicts|0|||
157048933|NCT02065895|566933332|FG004|Overall Study|Scheduling conflicts|0|||
157048934|NCT02065895|566933333|FG005|Overall Study|Scheduling conflicts|0|||
157048935|NCT03137784|566933336|FG000|Overall Study|Adverse Event|1|||
157048936|NCT03137784|566933337|FG001|Overall Study|Adverse Event|1|||
157048937|NCT03137784|566933338|FG002|Overall Study|Adverse Event|0|||
157048938|NCT03137784|566933339|FG003|Overall Study|Adverse Event|0|||
157048939|NCT03137784|566933340|FG004|Overall Study|Adverse Event|0|||
157048940|NCT03137784|566933341|FG005|Overall Study|Adverse Event|0|||
157048941|NCT03137784|566933336|FG000|Overall Study|Subject/guardian decision|1|||
157229295|NCT02468778|567585215|FG001|Overall Study|Withdrawal by Subject|1|||
156972066|NCT04270747|566650081|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
156972067|NCT04270747|566650082|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
156972068|NCT04270747|566650083|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
156972069|NCT04270747|566650081|FG000|Post Week 16|Miscellaneous|1|||
156972070|NCT04270747|566650082|FG001|Post Week 16|Miscellaneous|0|||
156972071|NCT04270747|566650083|FG002|Post Week 16|Miscellaneous|1|||
156972072|NCT01784068|566650085|FG000|NTCS Phase|Adverse Event|5|||
156972073|NCT01784068|566650086|FG001|NTCS Phase|Adverse Event|0|||
156972074|NCT01784068|566650085|FG000|NTCS Phase|Physician Decision|2|||
156972075|NCT01784068|566650086|FG001|NTCS Phase|Physician Decision|0|||
156972076|NCT01784068|566650085|FG000|NTCS Phase|Patient/guardian decision|3|||
156972077|NCT01784068|566650086|FG001|NTCS Phase|Patient/guardian decision|0|||
156972078|NCT01784068|566650085|FG000|NTCS Phase|Death|2|||
156972079|NCT01784068|566650086|FG001|NTCS Phase|Death|0|||
156972080|NCT01784068|566650085|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
156972081|NCT01784068|566650086|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
156972082|NCT01784068|566650085|FG000|TFR Phase|Physician Decision|0|||
156972083|NCT01784068|566650086|FG001|TFR Phase|Physician Decision|1|||
156972084|NCT01784068|566650085|FG000|TFR Phase|Patient/guardian decision|0|||
156972085|NCT01784068|566650086|FG001|TFR Phase|Patient/guardian decision|3|||
156972086|NCT01784068|566650085|FG000|TFR Phase|Death|0|||
156972087|NCT01784068|566650086|FG001|TFR Phase|Death|1|||
156972088|NCT01784068|566650085|FG000|TFR Phase|Lack of Efficacy|0|||
156972089|NCT01784068|566650086|FG001|TFR Phase|Lack of Efficacy|88|||
157048942|NCT03137784|566933337|FG001|Overall Study|Subject/guardian decision|0|||
157048943|NCT03137784|566933338|FG002|Overall Study|Subject/guardian decision|0|||
157048944|NCT03137784|566933339|FG003|Overall Study|Subject/guardian decision|0|||
157229296|NCT02468778|567585216|FG002|Overall Study|Withdrawal by Subject|1|||
156972090|NCT00696384|566650091|FG000|Open Label Phase|Adverse Event|27|||
156972091|NCT00696384|566650092|FG001|Open Label Phase|Adverse Event|0|||
156972092|NCT00696384|566650093|FG002|Open Label Phase|Adverse Event|0|||
156972093|NCT00696384|566650091|FG000|Open Label Phase|Protocol Violation|18|||
156972094|NCT00696384|566650092|FG001|Open Label Phase|Protocol Violation|0|||
156972095|NCT00696384|566650093|FG002|Open Label Phase|Protocol Violation|0|||
156972096|NCT00696384|566650091|FG000|Open Label Phase|Lost to Follow-up|24|||
156972097|NCT00696384|566650092|FG001|Open Label Phase|Lost to Follow-up|0|||
157229297|NCT02458469|567585219|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
157229298|NCT02458469|567585220|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
157176140|NCT00922974|567385413|FG000|Phase III Component|Protocol Violation|8|||
157176141|NCT00922974|567385414|FG001|Phase III Component|Protocol Violation|6|||
156972098|NCT00696384|566650093|FG002|Open Label Phase|Lost to Follow-up|0|||
156972099|NCT00696384|566650091|FG000|Open Label Phase|Withdrawal by Subject|37|||
156972100|NCT00696384|566650092|FG001|Open Label Phase|Withdrawal by Subject|0|||
156972101|NCT00696384|566650093|FG002|Open Label Phase|Withdrawal by Subject|0|||
156972102|NCT00696384|566650091|FG000|Open Label Phase|Other|6|||
156972103|NCT00696384|566650092|FG001|Open Label Phase|Other|0|||
156972104|NCT00696384|566650093|FG002|Open Label Phase|Other|0|||
156972105|NCT00696384|566650091|FG000|Open Label Phase|Lack of Efficacy|3|||
156972106|NCT00696384|566650092|FG001|Open Label Phase|Lack of Efficacy|0|||
156972107|NCT00696384|566650093|FG002|Open Label Phase|Lack of Efficacy|0|||
156972108|NCT00696384|566650091|FG000|Open Label Phase|Physician Decision|4|||
156972109|NCT00696384|566650092|FG001|Open Label Phase|Physician Decision|0|||
156972110|NCT00696384|566650093|FG002|Open Label Phase|Physician Decision|0|||
156972111|NCT00696384|566650091|FG000|Double Blind Phase|Adverse Event|0|||
156972112|NCT00696384|566650092|FG001|Double Blind Phase|Adverse Event|2|||
156972113|NCT00696384|566650093|FG002|Double Blind Phase|Adverse Event|2|||
156972114|NCT00696384|566650091|FG000|Double Blind Phase|Lost to Follow-up|0|||
156972115|NCT00696384|566650092|FG001|Double Blind Phase|Lost to Follow-up|2|||
156972116|NCT00696384|566650093|FG002|Double Blind Phase|Lost to Follow-up|1|||
156972117|NCT00696384|566650091|FG000|Double Blind Phase|Withdrawal by Subject|0|||
156972118|NCT00696384|566650092|FG001|Double Blind Phase|Withdrawal by Subject|4|||
156972119|NCT00696384|566650093|FG002|Double Blind Phase|Withdrawal by Subject|3|||
156972120|NCT00696384|566650091|FG000|Double Blind Phase|Lack of Efficacy|0|||
156972121|NCT00696384|566650092|FG001|Double Blind Phase|Lack of Efficacy|1|||
156972122|NCT00696384|566650093|FG002|Double Blind Phase|Lack of Efficacy|0|||
156972123|NCT00696384|566650091|FG000|Double Blind Phase|Physician Decision|0|||
156972124|NCT00696384|566650092|FG001|Double Blind Phase|Physician Decision|2|||
156972125|NCT00696384|566650093|FG002|Double Blind Phase|Physician Decision|0|||
156972126|NCT01678131|566650094|FG000|Overall Study|Adverse Event|0|||
156972127|NCT01678131|566650095|FG001|Overall Study|Adverse Event|1|||
156972128|NCT01678131|566650096|FG002|Overall Study|Adverse Event|0|||
156972129|NCT01678131|566650094|FG000|Overall Study|Withdrawal by Subject|0|||
156972130|NCT01678131|566650095|FG001|Overall Study|Withdrawal by Subject|0|||
156972131|NCT01678131|566650096|FG002|Overall Study|Withdrawal by Subject|2|||
156972132|NCT00558064|566650098|FG000|Overall Study|Adverse Event|3|||
156972133|NCT00558064|566650099|FG001|Overall Study|Adverse Event|2|||
156972134|NCT00558064|566650098|FG000|Overall Study|Lack of Efficacy|0|||
156972135|NCT00558064|566650099|FG001|Overall Study|Lack of Efficacy|1|||
156972136|NCT00558064|566650098|FG000|Overall Study|Protocol Violation|1|||
156972137|NCT00558064|566650099|FG001|Overall Study|Protocol Violation|0|||
156972138|NCT00558064|566650098|FG000|Overall Study|Lost to Follow-up|0|||
156972139|NCT00558064|566650099|FG001|Overall Study|Lost to Follow-up|1|||
156972140|NCT00558064|566650098|FG000|Overall Study|Withdrawal by Subject|0|||
156972141|NCT00558064|566650099|FG001|Overall Study|Withdrawal by Subject|1|||
156972142|NCT00558064|566650098|FG000|Overall Study|No visit within allowance period|1|||
156972143|NCT00558064|566650099|FG001|Overall Study|No visit within allowance period|0|||
156972144|NCT00982930|566650100|FG000|Overall Study|Adverse Event|1|||
156972145|NCT00982930|566650100|FG000|Overall Study|Withdrawal by Subject|1|||
156972146|NCT00982930|566650100|FG000|Overall Study|Administrative Problems|2|||
156972147|NCT00941798|566650101|FG000|Overall Study|Withdrawal by Subject|72|||
156972148|NCT00941798|566650102|FG001|Overall Study|Withdrawal by Subject|74|||
156972149|NCT00941798|566650101|FG000|Overall Study|Adverse Event|43|||
156972150|NCT00941798|566650102|FG001|Overall Study|Adverse Event|23|||
156972151|NCT00941798|566650101|FG000|Overall Study|Lost to Follow-up|29|||
156972152|NCT00941798|566650102|FG001|Overall Study|Lost to Follow-up|23|||
156972153|NCT00941798|566650101|FG000|Overall Study|Protocol Violation|17|||
156972154|NCT00941798|566650102|FG001|Overall Study|Protocol Violation|20|||
156972155|NCT00941798|566650101|FG000|Overall Study|Administrative problems|13|||
156972156|NCT00941798|566650102|FG001|Overall Study|Administrative problems|23|||
156972157|NCT00941798|566650101|FG000|Overall Study|Lack of Efficacy|10|||
156972158|NCT00941798|566650102|FG001|Overall Study|Lack of Efficacy|17|||
156972159|NCT00941798|566650101|FG000|Overall Study|Patient's inability to use device|6|||
156972160|NCT00941798|566650102|FG001|Overall Study|Patient's inability to use device|1|||
157176142|NCT03682055|567385415|FG000|Overall Study|Lack of Efficacy|1|||
156972161|NCT00941798|566650101|FG000|Overall Study|Abnormal test procedure results|3|||
156972162|NCT00941798|566650102|FG001|Overall Study|Abnormal test procedure results|1|||
156972163|NCT00941798|566650101|FG000|Overall Study|Abnormal laboratory values|1|||
156972164|NCT00941798|566650102|FG001|Overall Study|Abnormal laboratory values|2|||
156972165|NCT00941798|566650101|FG000|Overall Study|Death|0|||
156972166|NCT00941798|566650102|FG001|Overall Study|Death|1|||
157176143|NCT03682055|567385416|FG001|Overall Study|Lack of Efficacy|2|||
157176144|NCT03682055|567385417|FG002|Overall Study|Lack of Efficacy|1|||
156972167|NCT04179721|566650105|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
156972168|NCT04179721|566650106|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
156972169|NCT04179721|566650105|FG000|Overall Study|Lost to Follow-up|0|||
157176145|NCT03682055|567385418|FG003|Overall Study|Lack of Efficacy|2|||
156972170|NCT04179721|566650106|FG001|Overall Study|Lost to Follow-up|1|||
156972171|NCT04225988|566650107|FG000|Overall Study|Withdrawal by Subject|2|||
156972172|NCT04225988|566650108|FG001|Overall Study|Withdrawal by Subject|0|||
156972173|NCT05597722|566650109|FG000|Overall Study|Study was terminated|6|||
156972174|NCT05597722|566650110|FG001|Overall Study|Study was terminated|1|||
156972175|NCT00404495|566650111|FG000|Overall Study|Death|37|||
156972176|NCT00404495|566650112|FG001|Overall Study|Death|11|||
156972177|NCT00404495|566650111|FG000|Overall Study|Lost to Follow-up|5|||
156972178|NCT00404495|566650112|FG001|Overall Study|Lost to Follow-up|0|||
156972179|NCT00404495|566650111|FG000|Overall Study|Other|1|||
156972180|NCT00404495|566650112|FG001|Overall Study|Other|0|||
156972181|NCT00404495|566650111|FG000|Overall Study|Withdrawal by Subject|1|||
156972182|NCT00404495|566650112|FG001|Overall Study|Withdrawal by Subject|0|||
157048945|NCT03137784|566933340|FG004|Overall Study|Subject/guardian decision|0|||
157048946|NCT03137784|566933341|FG005|Overall Study|Subject/guardian decision|0|||
157048947|NCT03137784|566933336|FG000|Overall Study|Non-compliance with study treatment|0|||
157048948|NCT03137784|566933337|FG001|Overall Study|Non-compliance with study treatment|0|||
157048949|NCT03137784|566933338|FG002|Overall Study|Non-compliance with study treatment|0|||
157048950|NCT03137784|566933339|FG003|Overall Study|Non-compliance with study treatment|0|||
157048951|NCT03137784|566933340|FG004|Overall Study|Non-compliance with study treatment|1|||
157048952|NCT03137784|566933341|FG005|Overall Study|Non-compliance with study treatment|0|||
157048953|NCT01381549|566933344|FG000|Overall Study|Ineligible: No organisms isolated|0|||
157048954|NCT01381549|566933345|FG001|Overall Study|Ineligible: No organisms isolated|0|||
157048955|NCT01381549|566933346|FG002|Overall Study|Ineligible: No organisms isolated|1|||
157048956|NCT02981953|566933347|FG000|Overall Study|Death|9|||
157048957|NCT02981953|566933347|FG000|Overall Study|Withdrawal by Subject|1|||
157048958|NCT02981953|566933347|FG000|Overall Study|Withdrawal to non-compliance|1|||
157048959|NCT00805792|566933352|FG000|Overall Study|Death|3|||
157048960|NCT00805792|566933352|FG000|Overall Study|Lost to Follow-up|2|||
157048961|NCT02165202|566933357|FG000|Oral Phase|Refused further participation|5|||
157048962|NCT02165202|566933358|FG001|Oral Phase|Refused further participation|1|||
157048963|NCT02165202|566933357|FG000|Oral Phase|Study product Related Toxicity|1|||
157048964|NCT02165202|566933358|FG001|Oral Phase|Study product Related Toxicity|0|||
157048965|NCT02165202|566933357|FG000|Oral Phase|Unable to contact Participant|1|||
157048966|NCT02165202|566933358|FG001|Oral Phase|Unable to contact Participant|1|||
157048967|NCT02165202|566933357|FG000|Oral Phase|Clinical reasons|1|||
157048968|NCT02165202|566933358|FG001|Oral Phase|Clinical reasons|0|||
157048969|NCT02165202|566933357|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
157048970|NCT02165202|566933358|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
157048971|NCT02165202|566933357|FG000|Oral Phase|CMC advised termination|1|||
157048972|NCT02165202|566933358|FG001|Oral Phase|CMC advised termination|0|||
157048973|NCT02165202|566933357|FG000|Oral Phase|Relocated, no follow-up planned|1|||
157048974|NCT02165202|566933358|FG001|Oral Phase|Relocated, no follow-up planned|0|||
157048975|NCT02165202|566933357|FG000|Oral Phase|Abnormal EKG|0|||
157048976|NCT02165202|566933358|FG001|Oral Phase|Abnormal EKG|1|||
157048977|NCT02165202|566933357|FG000|Injection Phase|Abnormal Lab Value|5|||
157048978|NCT02165202|566933358|FG001|Injection Phase|Abnormal Lab Value|1|||
157048979|NCT02165202|566933357|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
157048980|NCT02165202|566933358|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
157048981|NCT02165202|566933357|FG000|Injection Phase|Unable to attend within Visit Window|1|||
157048982|NCT02165202|566933358|FG001|Injection Phase|Unable to attend within Visit Window|0|||
157048983|NCT02165202|566933357|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
157048984|NCT02165202|566933358|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
157048985|NCT02165202|566933357|FG000|Injection Phase|End of Study|2|||
157048986|NCT02165202|566933358|FG001|Injection Phase|End of Study|1|||
157048987|NCT02165202|566933357|FG000|Injection Phase|Study Product related Toxicity|1|||
157048988|NCT02165202|566933358|FG001|Injection Phase|Study Product related Toxicity|0|||
157048989|NCT02165202|566933357|FG000|Injection Phase|No longer interested|0|||
157048990|NCT02165202|566933358|FG001|Injection Phase|No longer interested|1|||
157048991|NCT02165202|566933357|FG000|Injection Phase|Participant unwilling to comply|1|||
157048992|NCT02165202|566933358|FG001|Injection Phase|Participant unwilling to comply|0|||
157048993|NCT00990184|566933364|FG000|Overall Study|Physician Decision|1|||
157048994|NCT01655498|566933365|FG000|Overall Study|Unrelated health issue|2|||
157048995|NCT01655498|566933365|FG000|Overall Study|Protocol Violation|2|||
157048996|NCT01655498|566933365|FG000|Overall Study|Withdrawal by Subject|1|||
157048997|NCT00603798|566933367|FG000|Overall Study|Adverse Event|4|||
157048998|NCT00603798|566933368|FG001|Overall Study|Adverse Event|2|||
157048999|NCT00603798|566933369|FG002|Overall Study|Adverse Event|1|||
156972183|NCT04108000|566650113|FG000|Overall Study|Death of patient|1|||
157049000|NCT00603798|566933367|FG000|Overall Study|Withdrawal by Subject|4|||
157176146|NCT03682055|567385419|FG004|Overall Study|Lack of Efficacy|1|||
156972184|NCT04108000|566650114|FG001|Overall Study|Death of patient|0|||
156972185|NCT04108000|566650115|FG002|Overall Study|Death of patient|1|||
156972186|NCT04108000|566650116|FG003|Overall Study|Death of patient|0|||
156972187|NCT04108000|566650113|FG000|Overall Study|Withdrawal by Subject|2|||
156972188|NCT04108000|566650114|FG001|Overall Study|Withdrawal by Subject|2|||
157049001|NCT00603798|566933368|FG001|Overall Study|Withdrawal by Subject|3|||
157049002|NCT00603798|566933369|FG002|Overall Study|Withdrawal by Subject|4|||
157049003|NCT00603798|566933367|FG000|Overall Study|Lost to Follow-up|1|||
157049004|NCT00603798|566933368|FG001|Overall Study|Lost to Follow-up|0|||
157049005|NCT00603798|566933369|FG002|Overall Study|Lost to Follow-up|1|||
157049006|NCT00603798|566933367|FG000|Overall Study|Non-compliance with study procedures|0|||
157049007|NCT00603798|566933368|FG001|Overall Study|Non-compliance with study procedures|1|||
157049008|NCT00603798|566933369|FG002|Overall Study|Non-compliance with study procedures|0|||
157049009|NCT00603798|566933367|FG000|Overall Study|Not due to AE|1|||
157049010|NCT00603798|566933368|FG001|Overall Study|Not due to AE|1|||
157049011|NCT00603798|566933369|FG002|Overall Study|Not due to AE|4|||
157049012|NCT00988429|566933372|FG000|Overall Study|Adverse Event|9|||
157049013|NCT00988429|566933373|FG001|Overall Study|Adverse Event|21|||
157049014|NCT00988429|566933374|FG002|Overall Study|Adverse Event|45|||
157049015|NCT00988429|566933372|FG000|Overall Study|Lack of Efficacy|0|||
157049016|NCT00988429|566933373|FG001|Overall Study|Lack of Efficacy|0|||
157049017|NCT00988429|566933374|FG002|Overall Study|Lack of Efficacy|1|||
157049018|NCT00988429|566933372|FG000|Overall Study|Non-Compliance with Study Drug|5|||
157049019|NCT00988429|566933373|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157049020|NCT00988429|566933374|FG002|Overall Study|Non-Compliance with Study Drug|3|||
157049021|NCT00988429|566933372|FG000|Overall Study|Physician Decision|1|||
157049022|NCT00988429|566933373|FG001|Overall Study|Physician Decision|0|||
157049023|NCT00988429|566933374|FG002|Overall Study|Physician Decision|3|||
157049024|NCT00988429|566933372|FG000|Overall Study|Pregnancy|2|||
157049025|NCT00988429|566933373|FG001|Overall Study|Pregnancy|1|||
157049026|NCT00988429|566933374|FG002|Overall Study|Pregnancy|0|||
157049027|NCT00988429|566933372|FG000|Overall Study|Protocol Violation|4|||
157049028|NCT00988429|566933373|FG001|Overall Study|Protocol Violation|3|||
157049029|NCT00988429|566933374|FG002|Overall Study|Protocol Violation|3|||
157049030|NCT00988429|566933372|FG000|Overall Study|Withdrawal by Subject|7|||
157049031|NCT00988429|566933373|FG001|Overall Study|Withdrawal by Subject|7|||
157049032|NCT00988429|566933374|FG002|Overall Study|Withdrawal by Subject|12|||
157049033|NCT00988429|566933372|FG000|Overall Study|Administrative Reasons|1|||
157049034|NCT00988429|566933373|FG001|Overall Study|Administrative Reasons|2|||
157049035|NCT00988429|566933374|FG002|Overall Study|Administrative Reasons|1|||
157049036|NCT00988429|566933372|FG000|Overall Study|other reasons|8|||
157049037|NCT00988429|566933373|FG001|Overall Study|other reasons|8|||
157049038|NCT00988429|566933374|FG002|Overall Study|other reasons|1|||
157049039|NCT02964234|566933375|FG000|Overall Study|Lost to Follow-up|22|||
157049040|NCT02964234|566933376|FG001|Overall Study|Lost to Follow-up|13|||
157049041|NCT01799993|566933377|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
157049042|NCT01799993|566933378|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
157049043|NCT01799993|566933377|FG000|Overall Study|Death|61|||
157049044|NCT01799993|566933378|FG001|Overall Study|Death|45|||
157049045|NCT01799993|566933377|FG000|Overall Study|Withdrawal by Subject|23|||
157049046|NCT01799993|566933378|FG001|Overall Study|Withdrawal by Subject|24|||
157049047|NCT01799993|566933377|FG000|Overall Study|Lost to Follow-up|5|||
157049048|NCT01799993|566933378|FG001|Overall Study|Lost to Follow-up|8|||
157049049|NCT01799993|566933377|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
157049050|NCT01799993|566933378|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
157049051|NCT01799993|566933377|FG000|Overall Study|Protocol driven decision point|0|||
157049052|NCT01799993|566933378|FG001|Overall Study|Protocol driven decision point|3|||
157049053|NCT01799993|566933377|FG000|Overall Study|Protocol Violation|1|||
157049054|NCT01799993|566933378|FG001|Overall Study|Protocol Violation|1|||
157049055|NCT01799993|566933377|FG000|Overall Study|Deterioration of general conditions|2|||
157049056|NCT01799993|566933378|FG001|Overall Study|Deterioration of general conditions|0|||
157049057|NCT01799993|566933377|FG000|Overall Study|Screen failure|0|||
157049058|NCT01799993|566933378|FG001|Overall Study|Screen failure|1|||
157049059|NCT01799993|566933377|FG000|Overall Study|Adverse Event|1|||
157049060|NCT01799993|566933378|FG001|Overall Study|Adverse Event|0|||
157049061|NCT01799993|566933377|FG000|Overall Study|Lack of Efficacy|1|||
157049062|NCT01799993|566933378|FG001|Overall Study|Lack of Efficacy|0|||
157049063|NCT01799993|566933377|FG000|Overall Study|Recovery|0|||
157049064|NCT01799993|566933378|FG001|Overall Study|Recovery|1|||
157049065|NCT01799993|566933377|FG000|Overall Study|Logistical difficulties|1|||
157049066|NCT01799993|566933378|FG001|Overall Study|Logistical difficulties|0|||
157049067|NCT01799993|566933377|FG000|Overall Study|Protocol deviation|1|||
157049068|NCT01799993|566933378|FG001|Overall Study|Protocol deviation|0|||
157049069|NCT01799993|566933377|FG000|Overall Study|Non-compliance with medical device|1|||
157049070|NCT01799993|566933378|FG001|Overall Study|Non-compliance with medical device|0|||
157049071|NCT01799993|566933377|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157049072|NCT01799993|566933378|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157049073|NCT01799993|566933377|FG000|Overall Study|Other|1|||
157049074|NCT01799993|566933378|FG001|Overall Study|Other|0|||
157049075|NCT01799993|566933377|FG000|Overall Study|Subject didn't return for follow-up|0|||
157049076|NCT01799993|566933378|FG001|Overall Study|Subject didn't return for follow-up|1|||
157049077|NCT04361617|566933379|FG000|Overall Study|Withdrawal by Subject|0|||
157049078|NCT04361617|566933380|FG001|Overall Study|Withdrawal by Subject|1|||
157049079|NCT00687297|566933386|FG000|Randomization|Withdrawal by Subject|2|||
157049080|NCT00687297|566933387|FG001|Randomization|Withdrawal by Subject|0|||
157049081|NCT00687297|566933386|FG000|Randomization|Withdrew before treatment, ineligible|1|||
156972189|NCT04108000|566650115|FG002|Overall Study|Withdrawal by Subject|0|||
156972190|NCT04108000|566650116|FG003|Overall Study|Withdrawal by Subject|0|||
156972191|NCT04108000|566650113|FG000|Overall Study|Death of surrogate partner|0|||
156972192|NCT04108000|566650114|FG001|Overall Study|Death of surrogate partner|1|||
156972193|NCT04108000|566650115|FG002|Overall Study|Death of surrogate partner|0|||
156972194|NCT04108000|566650116|FG003|Overall Study|Death of surrogate partner|1|||
156972195|NCT05559866|566650119|FG000|Overall Study|Withdrawal by Subject|1|||
156972196|NCT05559866|566650120|FG001|Overall Study|Withdrawal by Subject|0|||
156972197|NCT03538951|566650121|FG000|Overall Study|Withdrawal by Subject|1|||
157049082|NCT00687297|566933387|FG001|Randomization|Withdrew before treatment, ineligible|1|||
157049083|NCT00687297|566933386|FG000|Induction|Withdrawal by Subject|4|||
157049084|NCT00687297|566933387|FG001|Induction|Withdrawal by Subject|4|||
157176147|NCT03682055|567385420|FG005|Overall Study|Lack of Efficacy|3|||
157176148|NCT03682055|567385415|FG000|Overall Study|Withdrawal by Subject|0|||
157176149|NCT03682055|567385416|FG001|Overall Study|Withdrawal by Subject|0|||
157176150|NCT03682055|567385417|FG002|Overall Study|Withdrawal by Subject|0|||
157049085|NCT00687297|566933386|FG000|Induction|Adverse Event|16|||
157049086|NCT00687297|566933387|FG001|Induction|Adverse Event|15|||
157049087|NCT00687297|566933386|FG000|Induction|Death|7|||
157049088|NCT00687297|566933387|FG001|Induction|Death|11|||
157049089|NCT00687297|566933386|FG000|Induction|Lack of Efficacy|17|||
157049090|NCT00687297|566933387|FG001|Induction|Lack of Efficacy|21|||
157049091|NCT00687297|566933386|FG000|Induction|Ineligible|0|||
157049092|NCT00687297|566933387|FG001|Induction|Ineligible|1|||
157049093|NCT00687297|566933386|FG000|Induction|Patient Noncompliance|1|||
157049094|NCT00687297|566933387|FG001|Induction|Patient Noncompliance|0|||
157049095|NCT00687297|566933386|FG000|Induction|Physician Decision|0|||
157049096|NCT00687297|566933387|FG001|Induction|Physician Decision|2|||
157049097|NCT00687297|566933386|FG000|Induction|Other|0|||
157049098|NCT00687297|566933387|FG001|Induction|Other|1|||
157049099|NCT02525744|566933390|FG000|Period 1|Physician Decision|0|||
157049100|NCT02525744|566933391|FG001|Period 1|Physician Decision|0|||
157049101|NCT02525744|566933392|FG002|Period 1|Physician Decision|1|||
157049102|NCT02525744|566933393|FG003|Period 1|Physician Decision|0|||
157049103|NCT02525744|566933390|FG000|Period 3|Adverse Event|0|||
157049104|NCT02525744|566933391|FG001|Period 3|Adverse Event|1|||
157049105|NCT02525744|566933392|FG002|Period 3|Adverse Event|0|||
157049106|NCT02525744|566933393|FG003|Period 3|Adverse Event|0|||
157049107|NCT02525744|566933390|FG000|Period 4|Withdrawal by Subject|1|||
157049108|NCT02525744|566933391|FG001|Period 4|Withdrawal by Subject|0|||
157049109|NCT02525744|566933392|FG002|Period 4|Withdrawal by Subject|0|||
157049110|NCT02525744|566933393|FG003|Period 4|Withdrawal by Subject|0|||
157049111|NCT02525744|566933390|FG000|Period 5|Physician Decision|1|||
157049112|NCT02525744|566933391|FG001|Period 5|Physician Decision|0|||
157049113|NCT02525744|566933392|FG002|Period 5|Physician Decision|0|||
157049114|NCT02525744|566933393|FG003|Period 5|Physician Decision|0|||
157049115|NCT01182285|566933394|FG000|First Intervention Week 1-10|Disease progression|1|||
157049116|NCT01182285|566933395|FG001|First Intervention Week 1-10|Disease progression|0|||
157049117|NCT01182285|566933396|FG002|First Intervention Week 1-10|Disease progression|0|||
157049118|NCT01182285|566933394|FG000|First Intervention Week 1-10|Adverse Event|1|||
157049119|NCT01182285|566933395|FG001|First Intervention Week 1-10|Adverse Event|0|||
157049120|NCT01182285|566933396|FG002|First Intervention Week 1-10|Adverse Event|0|||
157049121|NCT01182285|566933394|FG000|First Intervention Week 1-10|Non-compliance|1|||
157049122|NCT01182285|566933395|FG001|First Intervention Week 1-10|Non-compliance|0|||
157049123|NCT01182285|566933396|FG002|First Intervention Week 1-10|Non-compliance|0|||
157049124|NCT01182285|566933394|FG000|Third Intervention Week 11-52|Disease Progression|0|||
157049125|NCT01182285|566933395|FG001|Third Intervention Week 11-52|Disease Progression|0|||
157176151|NCT03682055|567385418|FG003|Overall Study|Withdrawal by Subject|0|||
157176152|NCT03682055|567385419|FG004|Overall Study|Withdrawal by Subject|0|||
157049126|NCT01182285|566933396|FG002|Third Intervention Week 11-52|Disease Progression|6|||
157049127|NCT01182285|566933394|FG000|Third Intervention Week 11-52|Other|0|||
157049128|NCT01182285|566933395|FG001|Third Intervention Week 11-52|Other|0|||
157176153|NCT03682055|567385420|FG005|Overall Study|Withdrawal by Subject|1|||
157176154|NCT03682055|567385415|FG000|Overall Study|Termination of Study by Sponsor|0|||
156972198|NCT03538951|566650122|FG001|Overall Study|Withdrawal by Subject|2|||
157049129|NCT01182285|566933396|FG002|Third Intervention Week 11-52|Other|2|||
157049130|NCT00472082|566933397|FG000|Overall Study|Study prematurely terminated|5|||
157049131|NCT02069379|566933398|FG000|Baseline Measurements|Lost to Follow-up|1|||
157049132|NCT02069379|566933399|FG001|Baseline Measurements|Lost to Follow-up|0|||
157049133|NCT02069379|566933400|FG002|Baseline Measurements|Lost to Follow-up|0|||
157049134|NCT02069379|566933401|FG003|Baseline Measurements|Lost to Follow-up|0|||
157049135|NCT02069379|566933398|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
157176155|NCT03682055|567385416|FG001|Overall Study|Termination of Study by Sponsor|0|||
157049136|NCT02069379|566933399|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
157049137|NCT02069379|566933400|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
157049138|NCT02069379|566933401|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
157049139|NCT02069379|566933398|FG000|First Treatment Arm|Lost to Follow-up|0|||
157049140|NCT02069379|566933399|FG001|First Treatment Arm|Lost to Follow-up|1|||
157049141|NCT02069379|566933400|FG002|First Treatment Arm|Lost to Follow-up|1|||
157049142|NCT02069379|566933401|FG003|First Treatment Arm|Lost to Follow-up|0|||
157049143|NCT02069379|566933398|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
156972199|NCT03444376|566650124|FG000|Part A|Disease relapse or Progression|1|||
156972200|NCT03444376|566650124|FG000|Part A|Withdrawal by Subject|2|||
156972201|NCT03444376|566650124|FG000|Part A|Adverse Event|1|||
156972202|NCT03444376|566650124|FG000|Part B|Disease relapse or Progression|18|||
156972203|NCT03444376|566650124|FG000|Part B|Withdrawal by Subject|2|||
156972204|NCT03444376|566650124|FG000|Part B|Adverse Event|2|||
156972205|NCT03444376|566650124|FG000|Part B|Physician Decision|1|||
156972206|NCT03444376|566650124|FG000|Part C|Disease relapse or Progression|43|||
156972207|NCT03444376|566650124|FG000|Part C|Withdrawal by Subject|5|||
156972208|NCT03444376|566650124|FG000|Part C|Adverse Event|2|||
156972209|NCT03444376|566650124|FG000|Part C|Physician Decision|2|||
156972210|NCT03444376|566650124|FG000|Part C|Death|1|||
156972211|NCT01493960|566651485|FG000|Overall Study|Adverse Event|0|||
156972212|NCT01493960|566651486|FG001|Overall Study|Adverse Event|1|||
156972213|NCT01493960|566651485|FG000|Overall Study|Lack of Efficacy|15|||
156972214|NCT01493960|566651486|FG001|Overall Study|Lack of Efficacy|9|||
156972215|NCT01493960|566651485|FG000|Overall Study|Protocol Violation|3|||
156972216|NCT01493960|566651486|FG001|Overall Study|Protocol Violation|0|||
156972217|NCT01493960|566651485|FG000|Overall Study|Withdrawal by Subject|10|||
156972218|NCT01493960|566651486|FG001|Overall Study|Withdrawal by Subject|4|||
156972219|NCT01493960|566651485|FG000|Overall Study|Non-specified|4|||
156972220|NCT01493960|566651486|FG001|Overall Study|Non-specified|4|||
156972221|NCT03935217|566651487|FG000|Overall Study|Adverse Event|1|||
156972222|NCT03935217|566651488|FG001|Overall Study|Adverse Event|0|||
156972223|NCT03935217|566651487|FG000|Overall Study|Lost to Follow-up|0|||
156972224|NCT03935217|566651488|FG001|Overall Study|Lost to Follow-up|1|||
156972225|NCT03935217|566651487|FG000|Overall Study|Withdrawal by Subject|0|||
156972226|NCT03935217|566651488|FG001|Overall Study|Withdrawal by Subject|2|||
156972227|NCT03237858|566651489|FG000|Overall Study|Death|19|||
156972228|NCT03237858|566651489|FG000|Overall Study|Withdrawal by Subject|37|||
156972229|NCT01160484|566651491|FG000|Overall Study|Lack of Efficacy|9|||
156972230|NCT01160484|566651491|FG000|Overall Study|Adverse Event|6|||
156972231|NCT01160484|566651491|FG000|Overall Study|Withdrawal by Subject|2|||
156972232|NCT01160484|566651491|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
156972233|NCT02026232|566651494|FG000|Overall Study|incomplete visit/missing data|3|||
156972234|NCT02026232|566651495|FG001|Overall Study|incomplete visit/missing data|2|||
156972235|NCT00332332|566651496|FG000|Overall Study|Adverse Event|13|||
156972236|NCT00332332|566651496|FG000|Overall Study|Death|1|||
156972237|NCT00332332|566651496|FG000|Overall Study|Withdrawal by Subject|8|||
156972238|NCT00332332|566651496|FG000|Overall Study|Physician Decision|1|||
156972239|NCT00332332|566651496|FG000|Overall Study|Lost to Follow-up|3|||
156972240|NCT00332332|566651496|FG000|Overall Study|Protocol deviation|4|||
156972241|NCT00332332|566651496|FG000|Overall Study|Noncompliance|2|||
156972242|NCT00332332|566651496|FG000|Overall Study|Disease progression|2|||
156972243|NCT00332332|566651496|FG000|Overall Study|Other|18|||
156972244|NCT00332332|566651496|FG000|Overall Study|Did not receive study treatment|16|||
156972245|NCT01108458|566651497|FG000|Overall Study|Withdrawal by Subject|1|||
156972246|NCT01382602|566651498|FG000|Overall Study|Protocol Violation|0|||
156972247|NCT01382602|566651499|FG001|Overall Study|Protocol Violation|3|||
156972248|NCT01382602|566651498|FG000|Overall Study|Withdrawal by Subject|0|||
156972249|NCT01382602|566651499|FG001|Overall Study|Withdrawal by Subject|1|||
156972250|NCT01392300|566651507|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
156972251|NCT01392300|566651508|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
156972252|NCT01392300|566651509|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
156972253|NCT01392300|566651507|FG000|Main Period (MP)|Withdrawal by Subject|5|||
156972254|NCT01392300|566651508|FG001|Main Period (MP)|Withdrawal by Subject|1|||
156972255|NCT01392300|566651509|FG002|Main Period (MP)|Withdrawal by Subject|0|||
156972256|NCT01392300|566651507|FG000|Main Period (MP)|Lost to Follow-up|3|||
156972257|NCT01392300|566651508|FG001|Main Period (MP)|Lost to Follow-up|3|||
156972258|NCT01392300|566651509|FG002|Main Period (MP)|Lost to Follow-up|0|||
156972259|NCT01392300|566651507|FG000|Main Period (MP)|Non-compliance|1|||
156972260|NCT01392300|566651508|FG001|Main Period (MP)|Non-compliance|0|||
156972261|NCT01392300|566651509|FG002|Main Period (MP)|Non-compliance|0|||
156972262|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
156972263|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
156972264|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
156972265|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
156972266|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
157176156|NCT03682055|567385417|FG002|Overall Study|Termination of Study by Sponsor|0|||
157176157|NCT03682055|567385418|FG003|Overall Study|Termination of Study by Sponsor|0|||
157176158|NCT03682055|567385419|FG004|Overall Study|Termination of Study by Sponsor|0|||
157176159|NCT03682055|567385420|FG005|Overall Study|Termination of Study by Sponsor|3|||
157176160|NCT00191386|567385421|FG000|Overall Study|Adverse Event|16|||
157176161|NCT00191386|567385421|FG000|Overall Study|Lost to Follow-up|1|||
157176162|NCT00191386|567385421|FG000|Overall Study|Entry Criteria Exclusion|3|||
157176163|NCT00191386|567385421|FG000|Overall Study|Protocol Violation|18|||
156972267|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
156972268|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
156972269|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
156972270|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
156972271|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Death|0|||
156972272|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Death|0|||
156972273|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Death|4|||
156972274|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
156972275|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
156972276|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
156972277|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
156972278|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
156972279|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
156972280|NCT01392300|566651507|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
156972281|NCT01392300|566651508|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
156972282|NCT01392300|566651509|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
156972283|NCT05056870|566651514|FG000|Period 1|Site COVID-19 Related|3|||
156972284|NCT05056870|566651515|FG001|Period 1|Site COVID-19 Related|3|||
156972285|NCT05056870|566651514|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
156972286|NCT05056870|566651515|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
156972287|NCT05056870|566651514|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
156972288|NCT05056870|566651515|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
156972289|NCT05056870|566651514|FG000|Period 2|COVID-19 Related|1|||
156972290|NCT05056870|566651515|FG001|Period 2|COVID-19 Related|0|||
156972291|NCT05056870|566651514|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
156972292|NCT05056870|566651515|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
156972293|NCT02799472|566651518|FG000|Overall Study|Withdrawal by Subject|2|||
156972294|NCT02799472|566651519|FG001|Overall Study|Withdrawal by Subject|4|||
156972295|NCT02799472|566651518|FG000|Overall Study|Lack of Efficacy|2|||
156972296|NCT02799472|566651519|FG001|Overall Study|Lack of Efficacy|0|||
156972297|NCT02799472|566651518|FG000|Overall Study|Lost to Follow-up|0|||
156972298|NCT02799472|566651519|FG001|Overall Study|Lost to Follow-up|1|||
156972299|NCT01966003|566651520|FG000|Overall Study|Death|43|||
156972300|NCT01966003|566651521|FG001|Overall Study|Death|36|||
156972301|NCT01966003|566651520|FG000|Overall Study|Protocol Violation|6|||
156972302|NCT01966003|566651521|FG001|Overall Study|Protocol Violation|4|||
156972303|NCT01966003|566651520|FG000|Overall Study|Lost to Follow-up|4|||
156972304|NCT01966003|566651521|FG001|Overall Study|Lost to Follow-up|3|||
156972305|NCT01966003|566651520|FG000|Overall Study|Physician Decision|12|||
156972306|NCT01966003|566651521|FG001|Overall Study|Physician Decision|13|||
156972307|NCT01966003|566651520|FG000|Overall Study|Withdrawal by Subject|29|||
156972308|NCT01966003|566651521|FG001|Overall Study|Withdrawal by Subject|19|||
156972309|NCT01966003|566651520|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
156972310|NCT01966003|566651521|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
156972311|NCT01966003|566651520|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
156972312|NCT01966003|566651521|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
156972313|NCT01966003|566651520|FG000|Overall Study|Other|1|||
156972314|NCT01966003|566651521|FG001|Overall Study|Other|1|||
156972315|NCT00674570|566651522|FG000|Overall Study|Withdrawal by Subject|0|||
156972316|NCT00674570|566651523|FG001|Overall Study|Withdrawal by Subject|2|||
156972317|NCT00674570|566651524|FG002|Overall Study|Withdrawal by Subject|0|||
156972318|NCT01492686|566651526|FG000|Double-blind Phase|Adverse Event|0|||
156972319|NCT01492686|566651527|FG001|Double-blind Phase|Adverse Event|2|||
156972320|NCT01492686|566651526|FG000|Double-blind Phase|Physician Decision|0|||
156972321|NCT01492686|566651527|FG001|Double-blind Phase|Physician Decision|1|||
156972322|NCT01492686|566651526|FG000|Double-blind Phase|Withdrawal by Subject|0|||
156972323|NCT01492686|566651527|FG001|Double-blind Phase|Withdrawal by Subject|2|||
156972324|NCT01492686|566651526|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
156972325|NCT01492686|566651527|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
156972326|NCT01492686|566651526|FG000|Open-label Phase|Adverse Event|1|||
156972327|NCT01492686|566651527|FG001|Open-label Phase|Adverse Event|2|||
156972328|NCT01492686|566651526|FG000|Open-label Phase|Physician Decision|1|||
156972329|NCT01492686|566651527|FG001|Open-label Phase|Physician Decision|0|||
157176164|NCT00191386|567385421|FG000|Overall Study|Withdrawal by Subject|96|||
157176165|NCT00191386|567385421|FG000|Overall Study|Physician Decision|11|||
157176166|NCT00191386|567385421|FG000|Overall Study|Lack of Efficacy|15|||
157229299|NCT02458469|567585221|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
157229300|NCT02458469|567585222|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
157229301|NCT02458469|567585223|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
157229302|NCT02458469|567585224|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
156972330|NCT01492686|566651526|FG000|Open-label Phase|Withdrawal by Subject|6|||
156972331|NCT01492686|566651527|FG001|Open-label Phase|Withdrawal by Subject|7|||
156972332|NCT01492686|566651526|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
156972333|NCT01492686|566651527|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
157229303|NCT02458469|567585219|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
157229304|NCT02458469|567585220|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
157229305|NCT02458469|567585221|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
157229306|NCT02458469|567585222|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
157229307|NCT02458469|567585223|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
157229308|NCT02458469|567585224|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
157229309|NCT02458469|567585219|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
157229310|NCT02458469|567585220|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
157229311|NCT02458469|567585221|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
157229312|NCT02458469|567585222|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156972334|NCT02313909|566651528|FG000|Overall Study|Consent withdrawn by participant|33|||
156972335|NCT02313909|566651529|FG001|Overall Study|Consent withdrawn by participant|33|||
156972336|NCT02313909|566651528|FG000|Overall Study|Lost to Follow-up|24|||
156972337|NCT02313909|566651529|FG001|Overall Study|Lost to Follow-up|17|||
156972338|NCT03505476|566651530|FG000|Overall Study|Physician Decision|18|||
156972339|NCT03505476|566651530|FG000|Overall Study|Device Malfunctioned|101|||
156972340|NCT03505476|566651530|FG000|Overall Study|Data Corrupt|6|||
156972341|NCT03505476|566651530|FG000|Overall Study|Device application insufficiant|3|||
156972342|NCT02569437|566651531|FG000|Overall Study|Lost to Follow-up|12|||
156972343|NCT02569437|566651532|FG001|Overall Study|Lost to Follow-up|14|||
156972344|NCT00985985|566651533|FG000|Overall Study|Adverse Event|4|||
156972345|NCT00985985|566651534|FG001|Overall Study|Adverse Event|2|||
156972346|NCT00985985|566651535|FG002|Overall Study|Adverse Event|2|||
156972347|NCT00985985|566651536|FG003|Overall Study|Adverse Event|2|||
156972348|NCT00985985|566651533|FG000|Overall Study|Lost to Follow-up|4|||
156972349|NCT00985985|566651534|FG001|Overall Study|Lost to Follow-up|11|||
156972350|NCT00985985|566651535|FG002|Overall Study|Lost to Follow-up|2|||
156972351|NCT00985985|566651536|FG003|Overall Study|Lost to Follow-up|3|||
156972352|NCT00985985|566651533|FG000|Overall Study|Protocol Violation|1|||
156972353|NCT00985985|566651534|FG001|Overall Study|Protocol Violation|2|||
156972354|NCT00985985|566651535|FG002|Overall Study|Protocol Violation|0|||
156972355|NCT00985985|566651536|FG003|Overall Study|Protocol Violation|1|||
156972356|NCT00985985|566651533|FG000|Overall Study|Lack of Efficacy|5|||
156972357|NCT00985985|566651534|FG001|Overall Study|Lack of Efficacy|6|||
156972358|NCT00985985|566651535|FG002|Overall Study|Lack of Efficacy|1|||
156972359|NCT00985985|566651536|FG003|Overall Study|Lack of Efficacy|3|||
156972360|NCT00985985|566651533|FG000|Overall Study|Withdrawal by Subject|4|||
156972361|NCT00985985|566651534|FG001|Overall Study|Withdrawal by Subject|2|||
156972362|NCT00985985|566651535|FG002|Overall Study|Withdrawal by Subject|2|||
156972363|NCT00985985|566651536|FG003|Overall Study|Withdrawal by Subject|2|||
156972364|NCT00985985|566651533|FG000|Overall Study|Other Reason|6|||
156972365|NCT00985985|566651534|FG001|Overall Study|Other Reason|1|||
156972366|NCT00985985|566651535|FG002|Overall Study|Other Reason|4|||
156972367|NCT00985985|566651536|FG003|Overall Study|Other Reason|2|||
156972368|NCT01282801|566651538|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
156972369|NCT01282801|566651539|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
156972370|NCT01060553|566651540|FG000|Overall Study|Lost to Follow-up|3|||
156972371|NCT01060553|566651541|FG001|Overall Study|Lost to Follow-up|5|||
156972372|NCT01060553|566651540|FG000|Overall Study|Withdrawal by Subject|5|||
156972373|NCT01060553|566651541|FG001|Overall Study|Withdrawal by Subject|5|||
156972374|NCT01060553|566651540|FG000|Overall Study|Lack of Efficacy|1|||
156972375|NCT01060553|566651541|FG001|Overall Study|Lack of Efficacy|0|||
157229313|NCT02458469|567585223|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
156972376|NCT03592277|566651546|FG000|Overall Study|Withdrawal by Subject|6|||
156972377|NCT03592277|566651547|FG001|Overall Study|Withdrawal by Subject|8|||
156972378|NCT01781390|566651548|FG000|Overall Study|Withdrawal of Consent|0|||
156972379|NCT01781390|566651549|FG001|Overall Study|Withdrawal of Consent|3|||
156972380|NCT01781390|566651550|FG002|Overall Study|Withdrawal of Consent|1|||
156972381|NCT01781390|566651548|FG000|Overall Study|Lost to Follow-up|1|||
156972382|NCT01781390|566651549|FG001|Overall Study|Lost to Follow-up|1|||
156972383|NCT01781390|566651550|FG002|Overall Study|Lost to Follow-up|1|||
156972384|NCT01781390|566651548|FG000|Overall Study|Adverse Event|1|||
156972385|NCT01781390|566651549|FG001|Overall Study|Adverse Event|2|||
157229314|NCT02458469|567585224|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
156972386|NCT01781390|566651550|FG002|Overall Study|Adverse Event|1|||
156972387|NCT01781390|566651548|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
156972388|NCT01781390|566651549|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
156972389|NCT01781390|566651550|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
156972390|NCT04707196|566651551|FG000|Overall Study|Withdrawal by Subject|9|||
156972391|NCT04707196|566651552|FG001|Overall Study|Withdrawal by Subject|6|||
156972392|NCT04707196|566651551|FG000|Overall Study|Lost to Follow-up|1|||
156972393|NCT04707196|566651552|FG001|Overall Study|Lost to Follow-up|0|||
156972394|NCT04707196|566651551|FG000|Overall Study|Protocol Violation|4|||
156972395|NCT04707196|566651552|FG001|Overall Study|Protocol Violation|1|||
156972396|NCT04707196|566651551|FG000|Overall Study|Adverse Event|2|||
156972397|NCT04707196|566651552|FG001|Overall Study|Adverse Event|2|||
156972398|NCT04707196|566651551|FG000|Overall Study|Death|3|||
156972399|NCT04707196|566651552|FG001|Overall Study|Death|1|||
156972400|NCT04707196|566651551|FG000|Overall Study|Non-compliance with study drug|1|||
156972401|NCT04707196|566651552|FG001|Overall Study|Non-compliance with study drug|0|||
156972402|NCT04707196|566651551|FG000|Overall Study|Progressive disease|9|||
156972403|NCT04707196|566651552|FG001|Overall Study|Progressive disease|10|||
156972404|NCT01862796|566651554|FG000|Overall Study|Prohibited medications|0|||
156972405|NCT01862796|566651555|FG001|Overall Study|Prohibited medications|0|||
156972406|NCT01862796|566651556|FG002|Overall Study|Prohibited medications|1|||
156972407|NCT01462162|566651557|FG000|Overall Study|Adverse Event|5|||
156972408|NCT01462162|566651557|FG000|Overall Study|Lack of Efficacy|4|||
156972409|NCT01462162|566651557|FG000|Overall Study|Abnormal laboratory parameters|1|||
156972410|NCT01462162|566651557|FG000|Overall Study|Other|2|||
156972411|NCT04404478|566651558|FG000|Overall Study|Withdrawal by Subject|1|||
157049144|NCT02069379|566933399|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
157049145|NCT02069379|566933400|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
157049146|NCT02069379|566933401|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
157049147|NCT02069379|566933398|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
156972412|NCT04404478|566651559|FG001|Overall Study|Withdrawal by Subject|3|||
156972413|NCT03485911|566651560|FG000|Part 1|Perceived lack of efficacy|1|||
156972414|NCT03485911|566651561|FG001|Part 1|Perceived lack of efficacy|1|||
156972415|NCT03485911|566651562|FG002|Part 1|Perceived lack of efficacy|2|||
156972416|NCT03485911|566651563|FG003|Part 1|Perceived lack of efficacy|0|||
156972417|NCT03485911|566651560|FG000|Part 1|Subject withdrew consent|0|||
156972418|NCT03485911|566651561|FG001|Part 1|Subject withdrew consent|1|||
156972419|NCT03485911|566651562|FG002|Part 1|Subject withdrew consent|0|||
156972420|NCT03485911|566651563|FG003|Part 1|Subject withdrew consent|1|||
156972421|NCT03485911|566651560|FG000|Part 1|Lab abnormalities/AEs|3|||
156972422|NCT03485911|566651561|FG001|Part 1|Lab abnormalities/AEs|1|||
156972423|NCT03485911|566651562|FG002|Part 1|Lab abnormalities/AEs|1|||
156972424|NCT03485911|566651563|FG003|Part 1|Lab abnormalities/AEs|0|||
156972425|NCT03485911|566651560|FG000|Part 1|Withdrew Consent prior to dosing|0|||
156972426|NCT03485911|566651561|FG001|Part 1|Withdrew Consent prior to dosing|0|||
156972427|NCT03485911|566651562|FG002|Part 1|Withdrew Consent prior to dosing|0|||
156972428|NCT03485911|566651563|FG003|Part 1|Withdrew Consent prior to dosing|1|||
156972429|NCT03485911|566651560|FG000|Part 1|Other NOS|0|||
156972430|NCT03485911|566651561|FG001|Part 1|Other NOS|0|||
156972431|NCT03485911|566651562|FG002|Part 1|Other NOS|0|||
156972432|NCT03485911|566651563|FG003|Part 1|Other NOS|1|||
156972433|NCT03485911|566651560|FG000|Part 2|Perceived lack of efficacy|5|||
156972434|NCT03485911|566651561|FG001|Part 2|Perceived lack of efficacy|3|||
156972435|NCT03485911|566651562|FG002|Part 2|Perceived lack of efficacy|0|||
156972436|NCT03485911|566651563|FG003|Part 2|Perceived lack of efficacy|2|||
156972437|NCT03485911|566651560|FG000|Part 2|Subject withdrew consent|1|||
156972438|NCT03485911|566651561|FG001|Part 2|Subject withdrew consent|0|||
156972439|NCT03485911|566651562|FG002|Part 2|Subject withdrew consent|2|||
156972440|NCT03485911|566651563|FG003|Part 2|Subject withdrew consent|1|||
156972441|NCT03485911|566651560|FG000|Part 2|Lab abnormalities/AEs|1|||
156972442|NCT03485911|566651561|FG001|Part 2|Lab abnormalities/AEs|2|||
156972443|NCT03485911|566651562|FG002|Part 2|Lab abnormalities/AEs|0|||
156972444|NCT03485911|566651563|FG003|Part 2|Lab abnormalities/AEs|0|||
156972445|NCT03485911|566651560|FG000|Part 2|Other NOS|0|||
156972446|NCT03485911|566651561|FG001|Part 2|Other NOS|1|||
156972447|NCT03485911|566651562|FG002|Part 2|Other NOS|0|||
156972448|NCT03485911|566651563|FG003|Part 2|Other NOS|0|||
156972449|NCT03485911|566651560|FG000|Part 2|Intercurrent illness/new medical condition|1|||
156972450|NCT03485911|566651561|FG001|Part 2|Intercurrent illness/new medical condition|0|||
156972451|NCT03485911|566651562|FG002|Part 2|Intercurrent illness/new medical condition|0|||
156972452|NCT03485911|566651563|FG003|Part 2|Intercurrent illness/new medical condition|0|||
156972453|NCT03485911|566651560|FG000|Part 2|Investigator judgement|1|||
156972454|NCT03485911|566651561|FG001|Part 2|Investigator judgement|0|||
156972455|NCT03485911|566651562|FG002|Part 2|Investigator judgement|0|||
156972456|NCT03485911|566651563|FG003|Part 2|Investigator judgement|0|||
156972457|NCT03485911|566651560|FG000|Part 3|Perceived lack of efficacy|2|||
156972458|NCT03485911|566651561|FG001|Part 3|Perceived lack of efficacy|2|||
156972459|NCT03485911|566651562|FG002|Part 3|Perceived lack of efficacy|2|||
156972460|NCT03485911|566651563|FG003|Part 3|Perceived lack of efficacy|0|||
156972461|NCT03485911|566651560|FG000|Part 3|Subject withdrew consent|1|||
156972462|NCT03485911|566651561|FG001|Part 3|Subject withdrew consent|4|||
156972463|NCT03485911|566651562|FG002|Part 3|Subject withdrew consent|0|||
157049148|NCT02069379|566933399|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
156972464|NCT03485911|566651563|FG003|Part 3|Subject withdrew consent|1|||
156972465|NCT03485911|566651560|FG000|Part 3|Lab abnormalities/AEs|1|||
156972466|NCT03485911|566651561|FG001|Part 3|Lab abnormalities/AEs|1|||
156972467|NCT03485911|566651562|FG002|Part 3|Lab abnormalities/AEs|0|||
156972468|NCT03485911|566651563|FG003|Part 3|Lab abnormalities/AEs|2|||
156972469|NCT03485911|566651560|FG000|Part 3|Other NOS|1|||
156972470|NCT03485911|566651561|FG001|Part 3|Other NOS|1|||
156972471|NCT03485911|566651562|FG002|Part 3|Other NOS|0|||
156972472|NCT03485911|566651563|FG003|Part 3|Other NOS|0|||
156972473|NCT03485911|566651560|FG000|Part 3|Intercurrent illness/new medical condition|0|||
156972474|NCT03485911|566651561|FG001|Part 3|Intercurrent illness/new medical condition|1|||
156972475|NCT03485911|566651562|FG002|Part 3|Intercurrent illness/new medical condition|1|||
156972476|NCT03485911|566651563|FG003|Part 3|Intercurrent illness/new medical condition|0|||
156972477|NCT03485911|566651560|FG000|Part 3|Sponsor discontinuation|1|||
156972478|NCT03485911|566651561|FG001|Part 3|Sponsor discontinuation|0|||
156972479|NCT03485911|566651562|FG002|Part 3|Sponsor discontinuation|0|||
156972480|NCT03485911|566651563|FG003|Part 3|Sponsor discontinuation|0|||
156972481|NCT03485911|566651560|FG000|Part 3|Berotralstat provided by alternative means|13|||
156972482|NCT03485911|566651561|FG001|Part 3|Berotralstat provided by alternative means|13|||
156972483|NCT03485911|566651562|FG002|Part 3|Berotralstat provided by alternative means|7|||
156972484|NCT03485911|566651563|FG003|Part 3|Berotralstat provided by alternative means|7|||
156972485|NCT03333928|566651564|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
156972486|NCT03333928|566651565|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
157176167|NCT01826448|567385422|FG000|Overall Study|Adverse Event|1|||
157176168|NCT01826448|567385423|FG001|Overall Study|Adverse Event|3|||
157176169|NCT01826448|567385422|FG000|Overall Study|Disease progression|2|||
157176170|NCT01826448|567385423|FG001|Overall Study|Disease progression|4|||
156972487|NCT03333928|566651566|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
156972488|NCT03333928|566651564|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
156972489|NCT03333928|566651565|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
156972490|NCT03333928|566651566|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
156972491|NCT03333928|566651564|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
156972492|NCT03333928|566651565|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
156972493|NCT03333928|566651566|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
156972494|NCT03333928|566651564|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
156972495|NCT03333928|566651565|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
156972496|NCT03333928|566651566|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
156972497|NCT03333928|566651564|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
156972498|NCT03333928|566651565|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
156972499|NCT03333928|566651566|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
156972500|NCT03333928|566651564|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
156972501|NCT03333928|566651565|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
156972502|NCT03333928|566651566|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
156972503|NCT03333928|566651564|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
156972504|NCT03333928|566651565|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
157049149|NCT02069379|566933400|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
157049150|NCT02069379|566933401|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
157049151|NCT02069379|566933398|FG000|Second Treatment Arm|Lost to Follow-up|0|||
157049152|NCT02069379|566933399|FG001|Second Treatment Arm|Lost to Follow-up|0|||
156972505|NCT03333928|566651566|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
156972506|NCT03333928|566651564|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
156972507|NCT03333928|566651565|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
156972508|NCT03333928|566651566|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
156972509|NCT01674621|566651567|FG000|Overall Study|Adverse Event|3|||
156972510|NCT01674621|566651568|FG001|Overall Study|Adverse Event|2|||
156972511|NCT01674621|566651569|FG002|Overall Study|Adverse Event|5|||
156972512|NCT01674621|566651570|FG003|Overall Study|Adverse Event|5|||
156972513|NCT01674621|566651571|FG004|Overall Study|Adverse Event|1|||
156972514|NCT01674621|566651567|FG000|Overall Study|Inability to Complete Study Procedures|0|||
156972515|NCT01674621|566651568|FG001|Overall Study|Inability to Complete Study Procedures|0|||
156972516|NCT01674621|566651569|FG002|Overall Study|Inability to Complete Study Procedures|0|||
156972517|NCT01674621|566651570|FG003|Overall Study|Inability to Complete Study Procedures|0|||
156972518|NCT01674621|566651571|FG004|Overall Study|Inability to Complete Study Procedures|2|||
156972519|NCT01674621|566651567|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
157049153|NCT02069379|566933400|FG002|Second Treatment Arm|Lost to Follow-up|1|||
157176171|NCT01826448|567385422|FG000|Overall Study|Withdrawal by Subject|1|||
156972520|NCT01674621|566651568|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156972521|NCT01674621|566651569|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156972522|NCT01674621|566651570|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
157049154|NCT02069379|566933401|FG003|Second Treatment Arm|Lost to Follow-up|0|||
157176172|NCT01826448|567385423|FG001|Overall Study|Withdrawal by Subject|0|||
156972523|NCT01674621|566651571|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
156972524|NCT01674621|566651567|FG000|Overall Study|Withdrawal by Subject|2|||
156972525|NCT01674621|566651568|FG001|Overall Study|Withdrawal by Subject|5|||
156972526|NCT01674621|566651569|FG002|Overall Study|Withdrawal by Subject|2|||
156972527|NCT01674621|566651570|FG003|Overall Study|Withdrawal by Subject|0|||
156972528|NCT01674621|566651571|FG004|Overall Study|Withdrawal by Subject|1|||
157176173|NCT01826448|567385422|FG000|Overall Study|Physician Decision|0|||
157176174|NCT01826448|567385423|FG001|Overall Study|Physician Decision|1|||
157176175|NCT01826448|567385422|FG000|Overall Study|2 active cancers|0|||
157176176|NCT01826448|567385423|FG001|Overall Study|2 active cancers|1|||
157176177|NCT04038385|567385424|FG000|Overall Study|Completed baseline assessment only|7|||
157176178|NCT04038385|567385425|FG001|Overall Study|Completed baseline assessment only|4|||
157176179|NCT04038385|567385424|FG000|Overall Study|Moved out of area|4|||
157176180|NCT04038385|567385425|FG001|Overall Study|Moved out of area|2|||
156972529|NCT01674621|566651567|FG000|Overall Study|Other than specified|0|||
156972530|NCT01674621|566651568|FG001|Overall Study|Other than specified|1|||
156972531|NCT01674621|566651569|FG002|Overall Study|Other than specified|0|||
156972532|NCT01674621|566651570|FG003|Overall Study|Other than specified|0|||
156972533|NCT01674621|566651571|FG004|Overall Study|Other than specified|2|||
156972534|NCT03815019|566651574|FG000|Overall Study|Withdrawal by Subject|6|||
156972535|NCT03815019|566651575|FG001|Overall Study|Withdrawal by Subject|8|||
156972536|NCT05398796|566651576|FG000|Overall Study|Participant moved from the area|0|||
156972537|NCT05398796|566651577|FG001|Overall Study|Participant moved from the area|1|||
156972538|NCT05398796|566651578|FG002|Overall Study|Participant moved from the area|0|||
156972539|NCT05398796|566651579|FG003|Overall Study|Participant moved from the area|0|||
156972540|NCT05960097|566651581|FG000|Overall Study|Lost to Follow-up|3|||
156972541|NCT05960097|566651582|FG001|Overall Study|Lost to Follow-up|1|||
156972542|NCT05960097|566651583|FG002|Overall Study|Lost to Follow-up|1|||
156972543|NCT05960097|566651584|FG003|Overall Study|Lost to Follow-up|2|||
156972544|NCT05960097|566651585|FG004|Overall Study|Lost to Follow-up|1|||
156972545|NCT05960097|566651586|FG005|Overall Study|Lost to Follow-up|1|||
156972546|NCT05960097|566651587|FG006|Overall Study|Lost to Follow-up|2|||
156972547|NCT05960097|566651588|FG007|Overall Study|Lost to Follow-up|3|||
156972548|NCT05960097|566651581|FG000|Overall Study|Physician Decision|0|||
156972549|NCT05960097|566651582|FG001|Overall Study|Physician Decision|0|||
156972550|NCT05960097|566651583|FG002|Overall Study|Physician Decision|0|||
156972551|NCT05960097|566651584|FG003|Overall Study|Physician Decision|0|||
156972552|NCT05960097|566651585|FG004|Overall Study|Physician Decision|0|||
156972553|NCT05960097|566651586|FG005|Overall Study|Physician Decision|0|||
156972554|NCT05960097|566651587|FG006|Overall Study|Physician Decision|1|||
156972555|NCT05960097|566651588|FG007|Overall Study|Physician Decision|0|||
156972556|NCT05960097|566651581|FG000|Overall Study|Withdrawal by Subject|1|||
156972557|NCT05960097|566651582|FG001|Overall Study|Withdrawal by Subject|0|||
156972558|NCT05960097|566651583|FG002|Overall Study|Withdrawal by Subject|0|||
156972559|NCT05960097|566651584|FG003|Overall Study|Withdrawal by Subject|1|||
156972560|NCT05960097|566651585|FG004|Overall Study|Withdrawal by Subject|1|||
156972561|NCT05960097|566651586|FG005|Overall Study|Withdrawal by Subject|0|||
157176181|NCT04038385|567385424|FG000|Overall Study|Discontinued study involvement|6|||
157176182|NCT04038385|567385425|FG001|Overall Study|Discontinued study involvement|1|||
157176183|NCT00784459|567385429|FG000|Overall Study|Adverse Event|0|||
157176184|NCT00784459|567385430|FG001|Overall Study|Adverse Event|2|||
157176185|NCT02009930|567385431|FG000|Overall Study|withdrawn|5|||
157176186|NCT00666536|567385434|FG000|Overall Study|Adverse Event|9|||
157176187|NCT00666536|567385435|FG001|Overall Study|Adverse Event|19|||
157176188|NCT00666536|567385434|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
157176189|NCT00666536|567385435|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
156972562|NCT05960097|566651587|FG006|Overall Study|Withdrawal by Subject|0|||
156972563|NCT05960097|566651588|FG007|Overall Study|Withdrawal by Subject|0|||
156972564|NCT05960097|566651581|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972565|NCT05960097|566651582|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972566|NCT05960097|566651583|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
156972567|NCT05960097|566651584|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972568|NCT05960097|566651585|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972569|NCT05960097|566651586|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972570|NCT05960097|566651587|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972571|NCT05960097|566651588|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
156972572|NCT00728962|566651589|FG000|Implant Placement Surgery|Adverse Event|8|||
156972573|NCT00728962|566651589|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
156972574|NCT00728962|566651589|FG000|Implant Placement Surgery|Protocol Violation|1|||
156972575|NCT00728962|566651589|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
156972576|NCT00728962|566651589|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
156972577|NCT05918978|566651600|FG000|Overall Study|Study Terminated by Sponsor|17|||
157176190|NCT00666536|567385434|FG000|Overall Study|Protocol deviation(s)|8|||
156972578|NCT05918978|566651601|FG001|Overall Study|Study Terminated by Sponsor|11|||
156972579|NCT05918978|566651600|FG000|Overall Study|Withdrawal by Subject|1|||
156972580|NCT05918978|566651601|FG001|Overall Study|Withdrawal by Subject|1|||
157176191|NCT00666536|567385435|FG001|Overall Study|Protocol deviation(s)|6|||
156972581|NCT05918978|566651600|FG000|Overall Study|Adverse Event|1|||
156972582|NCT05918978|566651601|FG001|Overall Study|Adverse Event|0|||
156972583|NCT05918978|566651600|FG000|Overall Study|Other|0|||
156972584|NCT05918978|566651601|FG001|Overall Study|Other|1|||
156972585|NCT00622180|566651602|FG000|Overall Study|Lost to Follow-up|1|||
156972586|NCT00622180|566651603|FG001|Overall Study|Lost to Follow-up|2|||
156972587|NCT05619003|566651605|FG000|Overall Study|Adverse Event|1|||
156972588|NCT07018999|566651610|FG000|Overall Study|Protocol Violation|0|||
156972589|NCT07018999|566651611|FG001|Overall Study|Protocol Violation|1|||
156972590|NCT07018999|566651610|FG000|Overall Study|Incomplete data entry|4|||
156972591|NCT07018999|566651611|FG001|Overall Study|Incomplete data entry|7|||
156972592|NCT01114204|566653037|FG000|Overall Study|Adverse Event|3|||
156972593|NCT01114204|566653038|FG001|Overall Study|Adverse Event|2|||
156972594|NCT01114204|566653037|FG000|Overall Study|Lost to Follow-up|1|||
156972595|NCT01114204|566653038|FG001|Overall Study|Lost to Follow-up|0|||
156972596|NCT01114204|566653037|FG000|Overall Study|Withdrawal by Subject|10|||
156972597|NCT01114204|566653038|FG001|Overall Study|Withdrawal by Subject|6|||
156972598|NCT01114204|566653037|FG000|Overall Study|Death|1|||
156972599|NCT01114204|566653038|FG001|Overall Study|Death|0|||
156972600|NCT01114204|566653037|FG000|Overall Study|Other-Personal reasons|2|||
156972601|NCT01114204|566653038|FG001|Overall Study|Other-Personal reasons|0|||
156972602|NCT01114204|566653037|FG000|Overall Study|Other-Medical monitor request|1|||
156972603|NCT01114204|566653038|FG001|Overall Study|Other-Medical monitor request|0|||
156972604|NCT01114204|566653037|FG000|Overall Study|Other-Participant request|2|||
156972605|NCT01114204|566653038|FG001|Overall Study|Other-Participant request|0|||
156972606|NCT01114204|566653037|FG000|Overall Study|Other-Protocol Violation|1|||
156972607|NCT01114204|566653038|FG001|Overall Study|Other-Protocol Violation|0|||
156972608|NCT02207725|566653039|FG000|Overall Study|Did Not Receive Treatment|0|||
156972609|NCT02207725|566653040|FG001|Overall Study|Did Not Receive Treatment|1|||
156972610|NCT02207725|566653041|FG002|Overall Study|Did Not Receive Treatment|1|||
156972611|NCT02207725|566653042|FG003|Overall Study|Did Not Receive Treatment|1|||
156972612|NCT02801669|566653045|FG000|Overall Study|Death|66|||
156972613|NCT02801669|566653046|FG001|Overall Study|Death|69|||
156972614|NCT02801669|566653045|FG000|Overall Study|Withdrawal by Subject|81|||
156972615|NCT02801669|566653046|FG001|Overall Study|Withdrawal by Subject|77|||
156972616|NCT02801669|566653045|FG000|Overall Study|Other|4|||
156972617|NCT02801669|566653046|FG001|Overall Study|Other|6|||
156972618|NCT00615264|566653047|FG000|Overall Study|Withdrawal by Subject|17|||
156972619|NCT00615264|566653048|FG001|Overall Study|Withdrawal by Subject|19|||
156972620|NCT00615264|566653047|FG000|Overall Study|Lost to Follow-up|6|||
156972621|NCT00615264|566653048|FG001|Overall Study|Lost to Follow-up|13|||
156972622|NCT00615264|566653047|FG000|Overall Study|Adverse Event|8|||
156972623|NCT00615264|566653048|FG001|Overall Study|Adverse Event|5|||
156972624|NCT00615264|566653047|FG000|Overall Study|Death|1|||
156972625|NCT00615264|566653048|FG001|Overall Study|Death|1|||
156972626|NCT00615264|566653047|FG000|Overall Study|Protocol Violation|11|||
156972627|NCT00615264|566653048|FG001|Overall Study|Protocol Violation|7|||
156972628|NCT00615264|566653047|FG000|Overall Study|Not defined|7|||
156972629|NCT00615264|566653048|FG001|Overall Study|Not defined|4|||
156972630|NCT00615264|566653047|FG000|Overall Study|Dermal Hypersensitivity|0|||
156972631|NCT00615264|566653048|FG001|Overall Study|Dermal Hypersensitivity|3|||
156972632|NCT00871403|566653054|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
156972633|NCT00871403|566653055|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
156972634|NCT00871403|566653056|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
156972635|NCT00871403|566653054|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
156972636|NCT00871403|566653055|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
156972637|NCT00871403|566653056|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
156972638|NCT00871403|566653054|FG000|Combination Treatment Phase|Adverse Event|0|||
156972639|NCT00871403|566653055|FG001|Combination Treatment Phase|Adverse Event|17|||
156972640|NCT00871403|566653056|FG002|Combination Treatment Phase|Adverse Event|2|||
156972641|NCT00871403|566653054|FG000|Combination Treatment Phase|Disease Progression|0|||
156972642|NCT00871403|566653055|FG001|Combination Treatment Phase|Disease Progression|8|||
156972643|NCT00871403|566653056|FG002|Combination Treatment Phase|Disease Progression|5|||
156972644|NCT00871403|566653054|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
156972645|NCT00871403|566653055|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
156972646|NCT00871403|566653056|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
156972647|NCT00871403|566653054|FG000|Combination Treatment Phase|Physician Decision|0|||
156972648|NCT00871403|566653055|FG001|Combination Treatment Phase|Physician Decision|1|||
156972649|NCT00871403|566653056|FG002|Combination Treatment Phase|Physician Decision|3|||
157176192|NCT00666536|567385434|FG000|Overall Study|Withdrawal by Subject|10|||
156972650|NCT00871403|566653054|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
156972651|NCT00871403|566653055|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
156972652|NCT00871403|566653056|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
156972653|NCT00871403|566653054|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
156972654|NCT00871403|566653055|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
156972655|NCT00871403|566653056|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
156972656|NCT00708435|566653057|FG000|Overall Study|Death / Serious Adverse Event|10|||
156972657|NCT00708435|566653058|FG001|Overall Study|Death / Serious Adverse Event|5|||
156972658|NCT00708435|566653057|FG000|Overall Study|Lost to Follow-up|9|||
156972659|NCT00708435|566653058|FG001|Overall Study|Lost to Follow-up|4|||
156972660|NCT00708435|566653057|FG000|Overall Study|Withdrawal by Subject|3|||
156972661|NCT00708435|566653058|FG001|Overall Study|Withdrawal by Subject|7|||
156972662|NCT00708435|566653057|FG000|Overall Study|Adverse Event|1|||
156972663|NCT00708435|566653058|FG001|Overall Study|Adverse Event|0|||
156972664|NCT00708435|566653057|FG000|Overall Study|Protocol Violation|0|||
156972665|NCT00708435|566653058|FG001|Overall Study|Protocol Violation|1|||
156972666|NCT00708435|566653057|FG000|Overall Study|Intervention by primary care physician|1|||
156972667|NCT00708435|566653058|FG001|Overall Study|Intervention by primary care physician|0|||
156972668|NCT00708435|566653057|FG000|Overall Study|Refused hospitalization|1|||
156972669|NCT00708435|566653058|FG001|Overall Study|Refused hospitalization|0|||
156972670|NCT04766086|566653059|FG000|Overall Study|Lost to Follow-up|3|||
156972671|NCT04766086|566653060|FG001|Overall Study|Lost to Follow-up|5|||
156972672|NCT04766086|566653061|FG002|Overall Study|Lost to Follow-up|3|||
156972673|NCT04766086|566653059|FG000|Overall Study|Withdrawal by Subject|1|||
157229315|NCT03130699|567585225|FG000|Overall Study|Lost to Follow-up|34|||
156972674|NCT04766086|566653060|FG001|Overall Study|Withdrawal by Subject|1|||
156972675|NCT04766086|566653061|FG002|Overall Study|Withdrawal by Subject|2|||
156972676|NCT04766086|566653059|FG000|Overall Study|Other|0|||
156972677|NCT04766086|566653060|FG001|Overall Study|Other|0|||
156972678|NCT04766086|566653061|FG002|Overall Study|Other|1|||
156972679|NCT02343003|566653064|FG000|Overall Study|Withdrawal by Subject|9|||
156972680|NCT02343003|566653065|FG001|Overall Study|Withdrawal by Subject|4|||
156972681|NCT02343003|566653064|FG000|Overall Study|Lost to Follow-up|5|||
156972682|NCT02343003|566653065|FG001|Overall Study|Lost to Follow-up|1|||
156972683|NCT02343003|566653064|FG000|Overall Study|Protocol Violation|1|||
156972684|NCT02343003|566653065|FG001|Overall Study|Protocol Violation|0|||
156972685|NCT02343003|566653064|FG000|Overall Study|Death|0|||
156972686|NCT02343003|566653065|FG001|Overall Study|Death|1|||
156972687|NCT02343003|566653064|FG000|Overall Study|exclusion criteria met|1|||
156972688|NCT02343003|566653065|FG001|Overall Study|exclusion criteria met|1|||
156972689|NCT02343003|566653064|FG000|Overall Study|terminated by sponsor|2|||
156972690|NCT02343003|566653065|FG001|Overall Study|terminated by sponsor|0|||
156972691|NCT01153269|566653066|FG000|Overall Study|Withdrawal by Subject|1|||
156972692|NCT01153269|566653066|FG000|Overall Study|Antiretroviral therapy break|1|||
156972693|NCT02635724|566653077|FG000|Overall Study|Withdrawal by Subject|0|||
156972694|NCT02635724|566653078|FG001|Overall Study|Withdrawal by Subject|1|||
156972695|NCT02635724|566653079|FG002|Overall Study|Withdrawal by Subject|0|||
156972696|NCT02424591|566653084|FG000|Overall Study|Protocol Violation|2|||
156972697|NCT02424591|566653085|FG001|Overall Study|Protocol Violation|3|||
156972698|NCT00770432|566653086|FG000|Overall Study|Other|4|||
156972699|NCT00770432|566653087|FG001|Overall Study|Other|6|||
156972700|NCT00770432|566653086|FG000|Overall Study|Non-compliance|0|||
156972701|NCT00770432|566653087|FG001|Overall Study|Non-compliance|1|||
156972702|NCT00312702|566653088|FG000|Immunization Phase|Lost to Follow-up|0|||
156972703|NCT00312702|566653089|FG001|Immunization Phase|Lost to Follow-up|1|||
156972704|NCT00312702|566653090|FG002|Immunization Phase|Lost to Follow-up|0|||
156972705|NCT01453348|566653091|FG000|Overall Study|Death|0|||
156972706|NCT01453348|566653092|FG001|Overall Study|Death|0|||
156972707|NCT01453348|566653093|FG002|Overall Study|Death|1|||
156972708|NCT01453348|566653091|FG000|Overall Study|Withdrawal by Subject|0|||
156972709|NCT01453348|566653092|FG001|Overall Study|Withdrawal by Subject|1|||
156972710|NCT01453348|566653093|FG002|Overall Study|Withdrawal by Subject|0|||
156972711|NCT01453348|566653091|FG000|Overall Study|Protocol Violation|1|||
156972712|NCT01453348|566653092|FG001|Overall Study|Protocol Violation|0|||
156972713|NCT01453348|566653093|FG002|Overall Study|Protocol Violation|0|||
156972714|NCT01498822|566653095|FG000|Overall Study|Protocol Violation|8|||
156972715|NCT01498822|566653096|FG001|Overall Study|Protocol Violation|4|||
156972716|NCT01498822|566653095|FG000|Overall Study|Other Reason|5|||
156972717|NCT01498822|566653096|FG001|Overall Study|Other Reason|2|||
156972718|NCT01498822|566653095|FG000|Overall Study|Lack of Efficacy|7|||
156972719|NCT01498822|566653096|FG001|Overall Study|Lack of Efficacy|2|||
156972720|NCT01498822|566653095|FG000|Overall Study|AE, non-serious non-fatal|8|||
156972721|NCT01498822|566653096|FG001|Overall Study|AE, non-serious non-fatal|17|||
156972722|NCT01498822|566653095|FG000|Overall Study|SAE, non-fatal|2|||
156972723|NCT01498822|566653096|FG001|Overall Study|SAE, non-fatal|2|||
156972724|NCT01498822|566653095|FG000|Overall Study|Adverse Event, serious fatal|1|||
157229316|NCT03130699|567585226|FG001|Overall Study|Lost to Follow-up|37|||
156972725|NCT01498822|566653096|FG001|Overall Study|Adverse Event, serious fatal|1|||
156972726|NCT01498822|566653095|FG000|Overall Study|Withdrawal by Subject|15|||
156972727|NCT01498822|566653096|FG001|Overall Study|Withdrawal by Subject|25|||
157049155|NCT04617847|566933404|FG000|Overall Study|Withdrawal by Subject|1|||
157049156|NCT04617847|566933405|FG001|Overall Study|Withdrawal by Subject|0|||
157049157|NCT04617847|566933404|FG000|Overall Study|Adverse Event|0|||
157049158|NCT04617847|566933405|FG001|Overall Study|Adverse Event|2|||
157049159|NCT04617847|566933404|FG000|Overall Study|Death|0|||
157049160|NCT04617847|566933405|FG001|Overall Study|Death|1|||
157049161|NCT04617847|566933404|FG000|Overall Study|Termination of Study by Sponsor|2|||
157049162|NCT04617847|566933405|FG001|Overall Study|Termination of Study by Sponsor|21|||
157049163|NCT01525875|566933406|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
157049164|NCT01525875|566933407|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
157049165|NCT01525875|566933406|FG000|Open-label Period|Lost to Follow-up|0|||
157049166|NCT01525875|566933407|FG001|Open-label Period|Lost to Follow-up|2|||
157049167|NCT00700999|566933408|FG000|Overall Study|Lost to Follow-up|7|||
157049168|NCT00700999|566933409|FG001|Overall Study|Lost to Follow-up|7|||
157049169|NCT00700999|566933408|FG000|Overall Study|Excluded - did not meet study criteria|0|||
157049170|NCT00700999|566933409|FG001|Overall Study|Excluded - did not meet study criteria|1|||
157049171|NCT00700999|566933408|FG000|Overall Study|Withdrawal by Subject|8|||
157049172|NCT00700999|566933409|FG001|Overall Study|Withdrawal by Subject|1|||
157049173|NCT00244751|566933410|FG000|Overall Study|Adverse Event|7|||
157049174|NCT00244751|566933411|FG001|Overall Study|Adverse Event|7|||
157049175|NCT00244751|566933412|FG002|Overall Study|Adverse Event|5|||
157049176|NCT00244751|566933410|FG000|Overall Study|Lost to Follow-up|0|||
157049177|NCT00244751|566933411|FG001|Overall Study|Lost to Follow-up|1|||
157049178|NCT00244751|566933412|FG002|Overall Study|Lost to Follow-up|0|||
157049179|NCT00244751|566933410|FG000|Overall Study|Protocol Violation|1|||
157049180|NCT00244751|566933411|FG001|Overall Study|Protocol Violation|0|||
157049181|NCT00244751|566933412|FG002|Overall Study|Protocol Violation|1|||
157049182|NCT00244751|566933410|FG000|Overall Study|Withdrawal by Subject|7|||
157049183|NCT00244751|566933411|FG001|Overall Study|Withdrawal by Subject|5|||
157049184|NCT00244751|566933412|FG002|Overall Study|Withdrawal by Subject|3|||
157049185|NCT00244751|566933410|FG000|Overall Study|Elevated liver enzymes|1|||
157049186|NCT00244751|566933411|FG001|Overall Study|Elevated liver enzymes|0|||
157049187|NCT00244751|566933412|FG002|Overall Study|Elevated liver enzymes|0|||
157049188|NCT00244751|566933410|FG000|Overall Study|Lack of compliance with protocol|0|||
157049189|NCT00244751|566933411|FG001|Overall Study|Lack of compliance with protocol|1|||
157049190|NCT00244751|566933412|FG002|Overall Study|Lack of compliance with protocol|0|||
157049191|NCT00244751|566933410|FG000|Overall Study|Safety reasons|0|||
157049192|NCT00244751|566933411|FG001|Overall Study|Safety reasons|1|||
157049193|NCT00244751|566933412|FG002|Overall Study|Safety reasons|0|||
157049194|NCT00244751|566933410|FG000|Overall Study|Participant randomized by mistake|0|||
157049195|NCT00244751|566933411|FG001|Overall Study|Participant randomized by mistake|0|||
157049196|NCT00244751|566933412|FG002|Overall Study|Participant randomized by mistake|1|||
157049197|NCT05522777|566934964|FG000|Overall Study|Lack of Efficacy|1|||
157049198|NCT05522777|566934964|FG000|Overall Study|Withdrawal by Subject|1|||
157049199|NCT03029585|566934970|FG000|Overall Study|Death|1|||
157049200|NCT03029585|566934971|FG001|Overall Study|Death|1|||
157049201|NCT03029585|566934970|FG000|Overall Study|Withdrawal by Subject|1|||
157049202|NCT03029585|566934971|FG001|Overall Study|Withdrawal by Subject|0|||
157049203|NCT04025762|566934972|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
157049204|NCT04025762|566934973|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
157049205|NCT03340961|566934975|FG000|Overall Study|Adverse Event|1|||
157049206|NCT03340961|566934976|FG001|Overall Study|Adverse Event|3|||
157049207|NCT03340961|566934977|FG002|Overall Study|Adverse Event|2|||
157049208|NCT03340961|566934978|FG003|Overall Study|Adverse Event|4|||
157049209|NCT03340961|566934975|FG000|Overall Study|Lost to Follow-up|0|||
157049210|NCT03340961|566934976|FG001|Overall Study|Lost to Follow-up|1|||
157049211|NCT03340961|566934977|FG002|Overall Study|Lost to Follow-up|0|||
157176193|NCT00666536|567385435|FG001|Overall Study|Withdrawal by Subject|9|||
157176194|NCT00666536|567385434|FG000|Overall Study|Lost to Follow-up|4|||
157176195|NCT00666536|567385435|FG001|Overall Study|Lost to Follow-up|3|||
157176196|NCT02853123|567385439|FG000|Treatment Period 1|Adverse Event|0|||
157049212|NCT03340961|566934978|FG003|Overall Study|Lost to Follow-up|1|||
157176197|NCT02853123|567385440|FG001|Treatment Period 1|Adverse Event|3|||
157049213|NCT03340961|566934975|FG000|Overall Study|Withdrawal by Subject|3|||
157049214|NCT03340961|566934976|FG001|Overall Study|Withdrawal by Subject|2|||
157049215|NCT03340961|566934977|FG002|Overall Study|Withdrawal by Subject|4|||
157049216|NCT03340961|566934978|FG003|Overall Study|Withdrawal by Subject|7|||
157049217|NCT03340961|566934975|FG000|Overall Study|Use of prohibited treatment|0|||
157049218|NCT03340961|566934976|FG001|Overall Study|Use of prohibited treatment|3|||
157049219|NCT03340961|566934977|FG002|Overall Study|Use of prohibited treatment|2|||
157176198|NCT02853123|567385439|FG000|Washout Period|Worsening of COPD|0|||
157176199|NCT02853123|567385440|FG001|Washout Period|Worsening of COPD|3|||
157176200|NCT02853123|567385439|FG000|Washout Period|Adverse Event|1|||
157049220|NCT03340961|566934978|FG003|Overall Study|Use of prohibited treatment|4|||
157049221|NCT03340961|566934975|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
157049222|NCT03340961|566934976|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
157176201|NCT02853123|567385440|FG001|Washout Period|Adverse Event|0|||
157176202|NCT02471586|567385446|FG000|Overall Study|Lost to Follow-up|3|||
157176203|NCT02471586|567385447|FG001|Overall Study|Lost to Follow-up|8|||
157176204|NCT02471586|567385448|FG002|Overall Study|Lost to Follow-up|4|||
157176205|NCT02471586|567385446|FG000|Overall Study|Death|2|||
157176206|NCT02471586|567385447|FG001|Overall Study|Death|2|||
157176207|NCT02471586|567385448|FG002|Overall Study|Death|0|||
157176208|NCT01419015|567385453|FG000|Overall Study|Death|2|||
157176209|NCT04839393|567385454|FG000|Overall Study|Adverse Event|0|||
157176210|NCT04839393|567385455|FG001|Overall Study|Adverse Event|0|||
157176211|NCT04839393|567385456|FG002|Overall Study|Adverse Event|2|||
157176212|NCT04839393|567385454|FG000|Overall Study|Withdrawal by participant|0|||
157176213|NCT04839393|567385455|FG001|Overall Study|Withdrawal by participant|0|||
157176214|NCT04839393|567385456|FG002|Overall Study|Withdrawal by participant|1|||
157176215|NCT05091918|567385459|FG000|Overall Study|Adverse Event|1|||
157176216|NCT05091918|567385459|FG000|Overall Study|Withdrawal by Subject|81|||
157176217|NCT01100658|567385460|FG000|Overall Study|Withdrawal by Subject|1|||
157176218|NCT00239356|567385463|FG000|Overall Study|Lack of Efficacy|1|||
157176219|NCT00239356|567385464|FG001|Overall Study|Lack of Efficacy|0|||
157176220|NCT00239356|567385463|FG000|Overall Study|Adverse Event|6|||
157176221|NCT00239356|567385464|FG001|Overall Study|Adverse Event|0|||
157176222|NCT00239356|567385463|FG000|Overall Study|Withdrawal by Subject|15|||
157176223|NCT00239356|567385464|FG001|Overall Study|Withdrawal by Subject|6|||
157176224|NCT00239356|567385463|FG000|Overall Study|Lost to Follow-up|3|||
157176225|NCT00239356|567385464|FG001|Overall Study|Lost to Follow-up|0|||
157176226|NCT00239356|567385463|FG000|Overall Study|poor/non-compliance|2|||
157049223|NCT03340961|566934977|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
157049224|NCT03340961|566934978|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
157049225|NCT03340961|566934975|FG000|Overall Study|Subject developed an exclusion criterion|0|||
157049226|NCT03340961|566934976|FG001|Overall Study|Subject developed an exclusion criterion|1|||
157049227|NCT03340961|566934977|FG002|Overall Study|Subject developed an exclusion criterion|0|||
157049228|NCT03340961|566934978|FG003|Overall Study|Subject developed an exclusion criterion|0|||
157049229|NCT03340961|566934975|FG000|Overall Study|Protocol Violation|1|||
157049230|NCT03340961|566934976|FG001|Overall Study|Protocol Violation|0|||
157049231|NCT03340961|566934977|FG002|Overall Study|Protocol Violation|1|||
157049232|NCT03340961|566934978|FG003|Overall Study|Protocol Violation|0|||
157049233|NCT03340961|566934975|FG000|Overall Study|Adverse Event|1|||
157049234|NCT03340961|566934976|FG001|Overall Study|Adverse Event|1|||
157049235|NCT03340961|566934977|FG002|Overall Study|Adverse Event|0|||
157049236|NCT03340961|566934978|FG003|Overall Study|Adverse Event|0|||
157049237|NCT03340961|566934975|FG000|Overall Study|Lack of Efficacy|0|||
157049238|NCT03340961|566934976|FG001|Overall Study|Lack of Efficacy|0|||
157049239|NCT03340961|566934977|FG002|Overall Study|Lack of Efficacy|0|||
157049240|NCT03340961|566934978|FG003|Overall Study|Lack of Efficacy|1|||
157049241|NCT01286311|566934979|FG000|Overall Study|Physician did not want outreach sent|14|||
157049242|NCT01286311|566934980|FG001|Overall Study|Physician did not want outreach sent|0|||
157049243|NCT01437540|566934981|FG000|Overall Study|Not listed below|7|||
157049244|NCT01437540|566934982|FG001|Overall Study|Not listed below|6|||
157049245|NCT01437540|566934981|FG000|Overall Study|COPD exacerbation|13|||
157049246|NCT01437540|566934982|FG001|Overall Study|COPD exacerbation|3|||
157049247|NCT01437540|566934981|FG000|Overall Study|Lost to Follow-up|3|||
157049248|NCT01437540|566934982|FG001|Overall Study|Lost to Follow-up|5|||
157049249|NCT01437540|566934981|FG000|Overall Study|Lack of Efficacy|23|||
157049250|NCT01437540|566934982|FG001|Overall Study|Lack of Efficacy|11|||
157049251|NCT01437540|566934981|FG000|Overall Study|Protocol Violation|24|||
157049252|NCT01437540|566934982|FG001|Overall Study|Protocol Violation|12|||
157049253|NCT01437540|566934981|FG000|Overall Study|Adverse Event|26|||
157049254|NCT01437540|566934982|FG001|Overall Study|Adverse Event|13|||
157049255|NCT01437540|566934981|FG000|Overall Study|Withdrawal by Subject|31|||
157049256|NCT01437540|566934982|FG001|Overall Study|Withdrawal by Subject|15|||
157049257|NCT04328467|566934987|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
157049258|NCT04328467|566934988|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
157049259|NCT04328467|566934989|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
157176227|NCT00239356|567385464|FG001|Overall Study|poor/non-compliance|0|||
157049260|NCT01975701|566934990|FG000|Overall Study|Lost to Follow-up|1|||
157049261|NCT01975701|566934990|FG000|Overall Study|Death|23|||
157049262|NCT01975701|566934990|FG000|Overall Study|Physician Decision|1|||
157176228|NCT00239356|567385463|FG000|Overall Study|Pregnancy|1|||
157176229|NCT00239356|567385464|FG001|Overall Study|Pregnancy|0|||
157176230|NCT00239356|567385463|FG000|Overall Study|Administrative reason|0|||
157049263|NCT01393600|566934993|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
157049264|NCT01393600|566934994|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
157176231|NCT00239356|567385464|FG001|Overall Study|Administrative reason|1|||
157176232|NCT00239356|567385463|FG000|Overall Study|Drug available on market|11|||
157176233|NCT00239356|567385464|FG001|Overall Study|Drug available on market|2|||
157176234|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
157176235|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
157176236|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
157176237|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
156972728|NCT01498822|566653095|FG000|Overall Study|Lost to Follow-up|8|||
156972729|NCT01498822|566653096|FG001|Overall Study|Lost to Follow-up|3|||
156972730|NCT03056534|566653105|FG000|Overall Study|Participant withdrew consent|8|||
156972731|NCT03056534|566653105|FG000|Overall Study|Participant not able to return|6|||
156972732|NCT03056534|566653105|FG000|Overall Study|Lost to Follow-up|37|||
156972733|NCT03056534|566653105|FG000|Overall Study|Investigator judgment|1|||
156972734|NCT03056534|566653105|FG000|Overall Study|Death|4|||
156972735|NCT03056534|566653105|FG000|Overall Study|Adverse Event|1|||
156972736|NCT03056534|566653105|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
156972737|NCT05004688|566653106|FG000|Overall Study|Protocol Violation|7|||
156972738|NCT05004688|566653106|FG000|Overall Study|Physician Decision|2|||
156972739|NCT05004688|566653106|FG000|Overall Study|Withdrawal by Subject|2|||
156972740|NCT04954586|566653107|FG000|Overall Study|Withdrawal by Subject|5|||
156972741|NCT02134925|566653108|FG000|Overall Study|Withdrawal by Subject|1|||
156972742|NCT02134925|566653109|FG001|Overall Study|Withdrawal by Subject|0|||
156972743|NCT02134925|566653108|FG000|Overall Study|Cancel|1|||
156972744|NCT02134925|566653109|FG001|Overall Study|Cancel|6|||
156972745|NCT02158884|566653110|FG000|Baseline Assessment|Missed performance assessment|3|||
156972746|NCT02158884|566653110|FG000|Baseline Assessment|Missed SMFA|1|||
156972747|NCT02158884|566653110|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
156972748|NCT02158884|566653110|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
156972749|NCT02158884|566653110|FG000|6 Month Assessment|Missed SMFA|20|||
156972750|NCT02158884|566653110|FG000|12 Month Assessment|Missed SMFA|17|||
156972751|NCT05158296|566653111|FG000|Overall Study|Sponsor Decision|2|||
156972752|NCT05158296|566653112|FG001|Overall Study|Sponsor Decision|3|||
156972753|NCT05158296|566653113|FG002|Overall Study|Sponsor Decision|2|||
156972754|NCT02552238|566653114|FG000|Overall Study|Withdrawal by Subject|2|||
156972755|NCT02552238|566653114|FG000|Overall Study|Adverse Event|2|||
156972756|NCT06387472|566653117|FG000|Overall Study|Withdrawal by Subject|1|||
156972757|NCT06387472|566653117|FG000|Overall Study|Lost to Follow-up|2|||
156972758|NCT06387472|566653117|FG000|Overall Study|Physician Decision|1|||
156972759|NCT04182880|566653118|FG000|Overall Study|Pregnancy|1|||
156972760|NCT04182880|566653119|FG001|Overall Study|Pregnancy|0|||
156972761|NCT02036645|566653120|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972762|NCT02036645|566653121|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972763|NCT02036645|566653122|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972764|NCT02036645|566653123|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972765|NCT02036645|566653124|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972766|NCT02036645|566653125|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972767|NCT02036645|566653126|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
156972768|NCT02036645|566653127|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972769|NCT02036645|566653128|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972770|NCT02036645|566653129|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972771|NCT02036645|566653130|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972772|NCT02036645|566653131|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
156972773|NCT02036645|566653120|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972774|NCT02036645|566653121|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972775|NCT02036645|566653122|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972776|NCT02036645|566653123|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
156972777|NCT02036645|566653124|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972778|NCT02036645|566653125|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972779|NCT02036645|566653126|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972780|NCT02036645|566653127|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972781|NCT02036645|566653128|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972782|NCT02036645|566653129|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972783|NCT02036645|566653130|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972784|NCT02036645|566653131|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
156972785|NCT02332590|566653136|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
156972786|NCT02332590|566653137|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
156972787|NCT02332590|566653136|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
156972788|NCT02332590|566653137|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
156972789|NCT02332590|566653136|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
156972790|NCT02332590|566653137|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
156972791|NCT02332590|566653136|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
156972792|NCT02332590|566653137|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
156972793|NCT02332590|566653136|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
156972794|NCT02332590|566653137|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
156972795|NCT02332590|566653136|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
156972796|NCT02332590|566653137|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
157049265|NCT01393600|566934995|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
157049266|NCT01393600|566934996|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
157049267|NCT01393600|566934993|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
157049268|NCT01393600|566934994|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
157049269|NCT01393600|566934995|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
157049270|NCT01393600|566934996|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
157049271|NCT01393600|566934993|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
157049272|NCT01393600|566934994|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
157049273|NCT01393600|566934995|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
157049274|NCT01393600|566934996|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
157049275|NCT01393600|566934993|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
157049276|NCT01393600|566934994|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
157049277|NCT01393600|566934995|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
157049278|NCT01393600|566934996|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
157049279|NCT01393600|566934993|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
157049280|NCT01393600|566934994|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
157049281|NCT01393600|566934995|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
157049282|NCT01393600|566934996|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
157049283|NCT01393600|566934993|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
157049284|NCT01393600|566934994|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
157049285|NCT01393600|566934995|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
157049286|NCT01393600|566934996|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
157049287|NCT01393600|566934993|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
157049288|NCT01393600|566934994|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
157176238|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
157176239|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
157049289|NCT01393600|566934995|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
157049290|NCT01393600|566934996|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
157049291|NCT02410278|566934997|FG000|Run-in Period|Adverse Event|5|||
157049292|NCT02410278|566934998|FG001|Run-in Period|Adverse Event|0|||
157049293|NCT02410278|566934999|FG002|Run-in Period|Adverse Event|0|||
157049294|NCT02410278|566934997|FG000|Run-in Period|GSRS Threshold Not Met|30|||
157049295|NCT02410278|566934998|FG001|Run-in Period|GSRS Threshold Not Met|0|||
157049296|NCT02410278|566934999|FG002|Run-in Period|GSRS Threshold Not Met|0|||
157049297|NCT02410278|566934997|FG000|Run-in Period|Lost to Follow-up|1|||
157049298|NCT02410278|566934998|FG001|Run-in Period|Lost to Follow-up|0|||
157049299|NCT02410278|566934999|FG002|Run-in Period|Lost to Follow-up|0|||
157049300|NCT02410278|566934997|FG000|Run-in Period|Withdrawal by Subject|1|||
157049301|NCT02410278|566934998|FG001|Run-in Period|Withdrawal by Subject|0|||
157049302|NCT02410278|566934999|FG002|Run-in Period|Withdrawal by Subject|0|||
157049303|NCT02410278|566934997|FG000|Run-in Period|Pregnancy|1|||
157049304|NCT02410278|566934998|FG001|Run-in Period|Pregnancy|0|||
157049305|NCT02410278|566934999|FG002|Run-in Period|Pregnancy|0|||
157049306|NCT02410278|566934997|FG000|Study Treatment Period|Adverse Event|0|||
157049307|NCT02410278|566934998|FG001|Study Treatment Period|Adverse Event|6|||
157049308|NCT02410278|566934999|FG002|Study Treatment Period|Adverse Event|3|||
157049309|NCT02410278|566934997|FG000|Study Treatment Period|Physician Decision|0|||
157049310|NCT02410278|566934998|FG001|Study Treatment Period|Physician Decision|0|||
157176240|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
157176241|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
157176242|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
157176243|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
157176244|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
157176245|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
157176246|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
157176247|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
157176248|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
157176249|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
157176250|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
157176251|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
157176252|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
157176253|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
157229317|NCT03130699|567585227|FG002|Overall Study|Lost to Follow-up|26|||
157049311|NCT02410278|566934999|FG002|Study Treatment Period|Physician Decision|1|||
157049312|NCT02410278|566934997|FG000|Study Treatment Period|Withdrawal by Subject|0|||
157049313|NCT02410278|566934998|FG001|Study Treatment Period|Withdrawal by Subject|1|||
157049314|NCT02410278|566934999|FG002|Study Treatment Period|Withdrawal by Subject|0|||
157049315|NCT02410278|566934997|FG000|Study Treatment Period|Other|0|||
157049316|NCT02410278|566934998|FG001|Study Treatment Period|Other|3|||
157049317|NCT02410278|566934999|FG002|Study Treatment Period|Other|0|||
157049318|NCT02410278|566934997|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
157049319|NCT02410278|566934998|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
157049320|NCT02410278|566934999|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
157049321|NCT01670877|566935000|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
157049322|NCT01670877|566935001|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
157049323|NCT01670877|566935002|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
157049324|NCT01670877|566935003|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
157049325|NCT01670877|566935004|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
157049326|NCT01670877|566935005|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
157049327|NCT01670877|566935000|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
157049328|NCT01670877|566935001|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
157049329|NCT01670877|566935002|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
157049330|NCT01670877|566935003|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
157049331|NCT01670877|566935004|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
157049332|NCT01670877|566935005|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
157049333|NCT01670877|566935000|FG000|Part I and Part 2|Grade 2 vomiting|0|||
157049334|NCT01670877|566935001|FG001|Part I and Part 2|Grade 2 vomiting|0|||
157049335|NCT01670877|566935002|FG002|Part I and Part 2|Grade 2 vomiting|0|||
157049336|NCT01670877|566935003|FG003|Part I and Part 2|Grade 2 vomiting|1|||
157049337|NCT01670877|566935004|FG004|Part I and Part 2|Grade 2 vomiting|0|||
157049338|NCT01670877|566935005|FG005|Part I and Part 2|Grade 2 vomiting|0|||
157049339|NCT01670877|566935000|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
157049340|NCT01670877|566935001|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
157049341|NCT01670877|566935002|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
157049342|NCT01670877|566935003|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
157049343|NCT01670877|566935004|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
157049344|NCT01670877|566935005|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
157049345|NCT01670877|566935000|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
156972797|NCT02332590|566653136|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
156972798|NCT02332590|566653137|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
156972799|NCT02332590|566653136|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
156972800|NCT02332590|566653137|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
156972801|NCT02332590|566653136|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
156972802|NCT02332590|566653137|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
156972803|NCT00279201|566653138|FG000|Initiation|Death|1|||
156972804|NCT00279201|566653139|FG001|Initiation|Death|5|||
156972805|NCT00279201|566653140|FG002|Initiation|Death|0|||
156972806|NCT00279201|566653141|FG003|Initiation|Death|0|||
156972807|NCT00279201|566653142|FG004|Initiation|Death|0|||
156972808|NCT00279201|566653143|FG005|Initiation|Death|0|||
156972809|NCT00279201|566653138|FG000|Initiation|Adverse Event|6|||
156972810|NCT00279201|566653139|FG001|Initiation|Adverse Event|15|||
156972811|NCT00279201|566653140|FG002|Initiation|Adverse Event|0|||
156972812|NCT00279201|566653141|FG003|Initiation|Adverse Event|0|||
156972813|NCT00279201|566653142|FG004|Initiation|Adverse Event|0|||
156972814|NCT00279201|566653143|FG005|Initiation|Adverse Event|0|||
156972815|NCT00279201|566653138|FG000|Initiation|Lost to Follow-up|42|||
156972816|NCT00279201|566653139|FG001|Initiation|Lost to Follow-up|41|||
156972817|NCT00279201|566653140|FG002|Initiation|Lost to Follow-up|0|||
156972818|NCT00279201|566653141|FG003|Initiation|Lost to Follow-up|0|||
156972819|NCT00279201|566653142|FG004|Initiation|Lost to Follow-up|0|||
156972820|NCT00279201|566653143|FG005|Initiation|Lost to Follow-up|0|||
156972821|NCT00279201|566653138|FG000|Initiation|Entry Criteria Exclusion|7|||
156972822|NCT00279201|566653139|FG001|Initiation|Entry Criteria Exclusion|9|||
156972823|NCT00279201|566653140|FG002|Initiation|Entry Criteria Exclusion|0|||
156972824|NCT00279201|566653141|FG003|Initiation|Entry Criteria Exclusion|0|||
156972825|NCT00279201|566653142|FG004|Initiation|Entry Criteria Exclusion|0|||
156972826|NCT00279201|566653143|FG005|Initiation|Entry Criteria Exclusion|0|||
156972827|NCT00279201|566653138|FG000|Initiation|Protocol Violation|9|||
156972828|NCT00279201|566653139|FG001|Initiation|Protocol Violation|10|||
156972829|NCT00279201|566653140|FG002|Initiation|Protocol Violation|0|||
156972830|NCT00279201|566653141|FG003|Initiation|Protocol Violation|0|||
156972831|NCT00279201|566653142|FG004|Initiation|Protocol Violation|0|||
156972832|NCT00279201|566653143|FG005|Initiation|Protocol Violation|0|||
156972833|NCT00279201|566653138|FG000|Initiation|Withdrawal by Subject|35|||
156972834|NCT00279201|566653139|FG001|Initiation|Withdrawal by Subject|41|||
157049346|NCT01670877|566935001|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
157049347|NCT01670877|566935002|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
157176254|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
156972835|NCT00279201|566653140|FG002|Initiation|Withdrawal by Subject|0|||
156972836|NCT00279201|566653141|FG003|Initiation|Withdrawal by Subject|0|||
156972837|NCT00279201|566653142|FG004|Initiation|Withdrawal by Subject|0|||
156972838|NCT00279201|566653143|FG005|Initiation|Withdrawal by Subject|0|||
156972839|NCT00279201|566653138|FG000|Initiation|Physician Decision|15|||
157049348|NCT01670877|566935003|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
157049349|NCT01670877|566935004|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
157049350|NCT01670877|566935005|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
157049351|NCT00042939|566935006|FG000|Overall Study|Adverse Event|6|||
157049352|NCT00042939|566935007|FG001|Overall Study|Adverse Event|7|||
157049353|NCT00042939|566935006|FG000|Overall Study|Death|3|||
157049354|NCT00042939|566935007|FG001|Overall Study|Death|2|||
157049355|NCT00042939|566935006|FG000|Overall Study|Withdrawal by Subject|3|||
157049356|NCT00042939|566935007|FG001|Overall Study|Withdrawal by Subject|4|||
157049357|NCT00042939|566935006|FG000|Overall Study|Other disease|1|||
157049358|NCT00042939|566935007|FG001|Overall Study|Other disease|0|||
157049359|NCT00042939|566935006|FG000|Overall Study|Ineligible|2|||
157049360|NCT00042939|566935007|FG001|Overall Study|Ineligible|2|||
157049361|NCT00042939|566935006|FG000|Overall Study|Deterioration of health|3|||
157049362|NCT00042939|566935007|FG001|Overall Study|Deterioration of health|4|||
157049363|NCT00042939|566935006|FG000|Overall Study|QOL diminished|1|||
157049364|NCT00042939|566935007|FG001|Overall Study|QOL diminished|0|||
157049365|NCT00042939|566935006|FG000|Overall Study|Rising ca 19-9|1|||
157049366|NCT00042939|566935007|FG001|Overall Study|Rising ca 19-9|0|||
157049367|NCT00042939|566935006|FG000|Overall Study|Patient non-compliance|1|||
157049368|NCT00042939|566935007|FG001|Overall Study|Patient non-compliance|0|||
157049369|NCT00042939|566935006|FG000|Overall Study|Still on treatment|1|||
157049370|NCT00042939|566935007|FG001|Overall Study|Still on treatment|0|||
157049371|NCT00042939|566935006|FG000|Overall Study|Treatment break > 4 weeks|0|||
157049372|NCT00042939|566935007|FG001|Overall Study|Treatment break > 4 weeks|1|||
157049373|NCT00042939|566935006|FG000|Overall Study|Did not start treatment|2|||
157049374|NCT00042939|566935007|FG001|Overall Study|Did not start treatment|1|||
157049375|NCT00795639|566935008|FG000|Overall Study|Death|1|||
157049376|NCT00795639|566935009|FG001|Overall Study|Death|6|||
157049377|NCT00795639|566935008|FG000|Overall Study|Withdrawal by Subject|1|||
157049378|NCT00795639|566935009|FG001|Overall Study|Withdrawal by Subject|3|||
157049379|NCT00795639|566935008|FG000|Overall Study|Pregnancy|1|||
157049380|NCT00795639|566935009|FG001|Overall Study|Pregnancy|0|||
157049381|NCT00795639|566935008|FG000|Overall Study|Adverse Event|5|||
157049382|NCT00795639|566935009|FG001|Overall Study|Adverse Event|2|||
157049383|NCT00795639|566935008|FG000|Overall Study|Other|0|||
157049384|NCT00795639|566935009|FG001|Overall Study|Other|2|||
157049385|NCT00795639|566935008|FG000|Overall Study|Terminated by sponsor|13|||
157049386|NCT00795639|566935009|FG001|Overall Study|Terminated by sponsor|12|||
157049387|NCT00795639|566935008|FG000|Overall Study|Randomized and not treated|0|||
157049388|NCT00795639|566935009|FG001|Overall Study|Randomized and not treated|1|||
157049389|NCT03349476|566935010|FG000|Overall Study|Physician Decision|3|||
157049390|NCT01762345|566935011|FG000|Overall Study|Adverse Event|5|||
157049391|NCT01762345|566935011|FG000|Overall Study|Protocol Violation|2|||
157049392|NCT02379078|566935012|FG000|Overall Study|Lost to Follow-up|33|||
157049393|NCT02379078|566935013|FG001|Overall Study|Lost to Follow-up|30|||
157049394|NCT02379078|566935012|FG000|Overall Study|Withdrawal by Subject|6|||
157049395|NCT02379078|566935013|FG001|Overall Study|Withdrawal by Subject|5|||
157049396|NCT00761267|566935014|FG000|Overall Study|Death|1|||
157049397|NCT00761267|566935015|FG001|Overall Study|Death|2|||
157049398|NCT00761267|566935016|FG002|Overall Study|Death|5|||
157049399|NCT00761267|566935014|FG000|Overall Study|Lost to Follow-up|0|||
157049400|NCT00761267|566935015|FG001|Overall Study|Lost to Follow-up|0|||
157049401|NCT00761267|566935016|FG002|Overall Study|Lost to Follow-up|1|||
157049402|NCT00761267|566935014|FG000|Overall Study|Randomized but not treated|1|||
157049403|NCT00761267|566935015|FG001|Overall Study|Randomized but not treated|1|||
157049404|NCT00761267|566935016|FG002|Overall Study|Randomized but not treated|0|||
157049405|NCT00761267|566935014|FG000|Overall Study|Withdrawal by Subject|0|||
157229318|NCT03130699|567585225|FG000|Overall Study|Withdrawal by Subject|5|||
157229319|NCT03130699|567585226|FG001|Overall Study|Withdrawal by Subject|1|||
157049406|NCT00761267|566935015|FG001|Overall Study|Withdrawal by Subject|1|||
157049407|NCT00761267|566935016|FG002|Overall Study|Withdrawal by Subject|0|||
157049408|NCT01777932|566935017|FG000|Overall Study|Disease progression|136|||
157049409|NCT01777932|566935017|FG000|Overall Study|Death|3|||
157049410|NCT01777932|566935017|FG000|Overall Study|Adverse Event|34|||
157049411|NCT01777932|566935017|FG000|Overall Study|Lost to Follow-up|3|||
157049412|NCT01777932|566935017|FG000|Overall Study|Investigator decision|10|||
157049413|NCT01777932|566935017|FG000|Overall Study|Reimbursement limit|9|||
157049414|NCT01777932|566935017|FG000|Overall Study|Patient refused further treatment|10|||
157049415|NCT00068107|566935023|FG000|Overall Study|end-stage renal disease|6|||
157049416|NCT00068107|566935023|FG000|Overall Study|Death|2|||
157049417|NCT00068107|566935023|FG000|Overall Study|Withdrawal by Subject|1|||
157049418|NCT01419184|566935024|FG000|Overall Study|Site data not available|3|||
157049419|NCT01419184|566935025|FG001|Overall Study|Site data not available|2|||
157049420|NCT01419184|566935024|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
157049421|NCT01419184|566935025|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
157049422|NCT01419184|566935024|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
157049423|NCT01419184|566935025|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
157049424|NCT01419184|566935024|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
157049425|NCT01419184|566935025|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
157049426|NCT01419184|566935024|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
157049427|NCT01419184|566935025|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
157049428|NCT01419184|566935024|FG000|Overall Study|Participant randomized, not treated|1|||
157049429|NCT01419184|566935025|FG001|Overall Study|Participant randomized, not treated|0|||
157049430|NCT03989232|566935032|FG000|Overall Study|Lost to Follow-up|3|||
157049431|NCT03989232|566935033|FG001|Overall Study|Lost to Follow-up|10|||
157049432|NCT03989232|566935032|FG000|Overall Study|Withdrawal by Subject|6|||
157049433|NCT03989232|566935033|FG001|Overall Study|Withdrawal by Subject|6|||
157049434|NCT03989232|566935032|FG000|Overall Study|Death|1|||
157049435|NCT03989232|566935033|FG001|Overall Study|Death|2|||
157049436|NCT03031782|566935035|FG000|Treatment Period 1|Lack of Efficacy|3|||
157049437|NCT03031782|566935036|FG001|Treatment Period 1|Lack of Efficacy|0|||
157049438|NCT03031782|566935037|FG002|Treatment Period 1|Lack of Efficacy|0|||
157049439|NCT03031782|566935038|FG003|Treatment Period 1|Lack of Efficacy|0|||
157049440|NCT03031782|566935039|FG004|Treatment Period 1|Lack of Efficacy|0|||
157049441|NCT03031782|566935035|FG000|Treatment Period 2|Physician Decision|0|||
157049442|NCT03031782|566935036|FG001|Treatment Period 2|Physician Decision|1|||
157049443|NCT03031782|566935037|FG002|Treatment Period 2|Physician Decision|0|||
157049444|NCT03031782|566935038|FG003|Treatment Period 2|Physician Decision|0|||
157049445|NCT03031782|566935039|FG004|Treatment Period 2|Physician Decision|3|||
157049446|NCT03031782|566935035|FG000|Treatment Period 2|Lack of Efficacy|0|||
157049447|NCT03031782|566935036|FG001|Treatment Period 2|Lack of Efficacy|1|||
157049448|NCT03031782|566935037|FG002|Treatment Period 2|Lack of Efficacy|0|||
157049449|NCT03031782|566935038|FG003|Treatment Period 2|Lack of Efficacy|0|||
157049450|NCT03031782|566935039|FG004|Treatment Period 2|Lack of Efficacy|1|||
157049451|NCT03031782|566935035|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157049452|NCT03031782|566935036|FG001|Treatment Period 2|Withdrawal by Subject|3|||
157049453|NCT03031782|566935037|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157049454|NCT03031782|566935038|FG003|Treatment Period 2|Withdrawal by Subject|0|||
157049455|NCT03031782|566935039|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157049456|NCT03031782|566935035|FG000|Treatment Period 2|Adverse Event|0|||
157049457|NCT03031782|566935036|FG001|Treatment Period 2|Adverse Event|1|||
157049458|NCT03031782|566935037|FG002|Treatment Period 2|Adverse Event|2|||
157049459|NCT03031782|566935038|FG003|Treatment Period 2|Adverse Event|0|||
157049460|NCT03031782|566935039|FG004|Treatment Period 2|Adverse Event|0|||
157049461|NCT03031782|566935035|FG000|Treatment Period 3|Withdrawal by Subject|0|||
157049462|NCT03031782|566935036|FG001|Treatment Period 3|Withdrawal by Subject|0|||
157049463|NCT03031782|566935037|FG002|Treatment Period 3|Withdrawal by Subject|0|||
157049464|NCT03031782|566935038|FG003|Treatment Period 3|Withdrawal by Subject|1|||
157049465|NCT03031782|566935039|FG004|Treatment Period 3|Withdrawal by Subject|0|||
157049466|NCT02644122|566935042|FG000|Overall Study|Withdrawal by Subject|1|||
157049467|NCT01930188|566935043|FG000|Overall Study|unclassified|4|||
157049468|NCT01930188|566935044|FG001|Overall Study|unclassified|5|||
157049469|NCT01930188|566935045|FG002|Overall Study|unclassified|3|||
157049470|NCT01930188|566935043|FG000|Overall Study|Missing follow-up information|2|||
157049471|NCT01930188|566935044|FG001|Overall Study|Missing follow-up information|2|||
157049472|NCT01930188|566935045|FG002|Overall Study|Missing follow-up information|3|||
157049473|NCT01930188|566935043|FG000|Overall Study|Lost to Follow-up|5|||
157049474|NCT01930188|566935044|FG001|Overall Study|Lost to Follow-up|2|||
157049475|NCT01930188|566935045|FG002|Overall Study|Lost to Follow-up|2|||
157049476|NCT01930188|566935043|FG000|Overall Study|Death|2|||
157049477|NCT01930188|566935044|FG001|Overall Study|Death|1|||
157049478|NCT01930188|566935045|FG002|Overall Study|Death|3|||
157049479|NCT01930188|566935043|FG000|Overall Study|Withdrawal by Subject|9|||
157049480|NCT01930188|566935044|FG001|Overall Study|Withdrawal by Subject|11|||
157049481|NCT01930188|566935045|FG002|Overall Study|Withdrawal by Subject|8|||
157049482|NCT02514824|566935046|FG000|Overall Study|Withdrawal by Subject|1|||
157049483|NCT02514824|566935047|FG001|Overall Study|Withdrawal by Subject|0|||
157049484|NCT02514824|566935048|FG002|Overall Study|Withdrawal by Subject|0|||
157049485|NCT02514824|566935049|FG003|Overall Study|Withdrawal by Subject|0|||
157049486|NCT02514824|566935046|FG000|Overall Study|Dose-Limiting Toxicity|0|||
157049487|NCT02514824|566935047|FG001|Overall Study|Dose-Limiting Toxicity|1|||
157049488|NCT02514824|566935048|FG002|Overall Study|Dose-Limiting Toxicity|0|||
157049489|NCT02514824|566935049|FG003|Overall Study|Dose-Limiting Toxicity|0|||
157049490|NCT02170207|566935052|FG000|Overall Study|Case report forms unavailable|5|||
157049491|NCT03122860|566935053|FG000|Overall Study|Discontinued Before Treatment|1|||
157049492|NCT03122860|566935054|FG001|Overall Study|Discontinued Before Treatment|1|||
157049493|NCT03122860|566935055|FG002|Overall Study|Discontinued Before Treatment|2|||
157049494|NCT03122860|566935056|FG003|Overall Study|Discontinued Before Treatment|0|||
157049495|NCT03122860|566935057|FG004|Overall Study|Discontinued Before Treatment|1|||
157049496|NCT03122860|566935058|FG005|Overall Study|Discontinued Before Treatment|0|||
157049497|NCT03122860|566935053|FG000|Overall Study|Adverse Event|1|||
157049498|NCT03122860|566935054|FG001|Overall Study|Adverse Event|0|||
157049499|NCT03122860|566935055|FG002|Overall Study|Adverse Event|1|||
157049500|NCT03122860|566935056|FG003|Overall Study|Adverse Event|1|||
157049501|NCT03122860|566935057|FG004|Overall Study|Adverse Event|0|||
157049502|NCT03122860|566935058|FG005|Overall Study|Adverse Event|0|||
157049503|NCT03122860|566935053|FG000|Overall Study|Lost to Follow-up|5|||
157049504|NCT03122860|566935054|FG001|Overall Study|Lost to Follow-up|2|||
157049505|NCT03122860|566935055|FG002|Overall Study|Lost to Follow-up|3|||
157049506|NCT03122860|566935056|FG003|Overall Study|Lost to Follow-up|3|||
157049507|NCT03122860|566935057|FG004|Overall Study|Lost to Follow-up|5|||
157049508|NCT03122860|566935058|FG005|Overall Study|Lost to Follow-up|4|||
157049509|NCT03122860|566935053|FG000|Overall Study|Subject Non-Compliance|0|||
157049510|NCT03122860|566935054|FG001|Overall Study|Subject Non-Compliance|0|||
157049511|NCT03122860|566935055|FG002|Overall Study|Subject Non-Compliance|1|||
157049512|NCT03122860|566935056|FG003|Overall Study|Subject Non-Compliance|0|||
157049513|NCT03122860|566935057|FG004|Overall Study|Subject Non-Compliance|0|||
157049514|NCT03122860|566935058|FG005|Overall Study|Subject Non-Compliance|0|||
157049515|NCT03122860|566935053|FG000|Overall Study|Withdrawal by Subject|3|||
157049516|NCT03122860|566935054|FG001|Overall Study|Withdrawal by Subject|2|||
157049517|NCT03122860|566935055|FG002|Overall Study|Withdrawal by Subject|5|||
157049518|NCT03122860|566935056|FG003|Overall Study|Withdrawal by Subject|7|||
157049519|NCT03122860|566935057|FG004|Overall Study|Withdrawal by Subject|9|||
157049520|NCT03122860|566935058|FG005|Overall Study|Withdrawal by Subject|8|||
157049521|NCT01138657|566935059|FG000|Overall Study|Adverse Event|3|||
157049522|NCT01138657|566935060|FG001|Overall Study|Adverse Event|10|||
157049523|NCT01138657|566935059|FG000|Overall Study|Lack of Efficacy|2|||
157049524|NCT01138657|566935060|FG001|Overall Study|Lack of Efficacy|1|||
157049525|NCT01138657|566935059|FG000|Overall Study|Lost to Follow-up|0|||
157049526|NCT01138657|566935060|FG001|Overall Study|Lost to Follow-up|3|||
157049527|NCT01138657|566935059|FG000|Overall Study|Miscellaneous Reasons|3|||
157049528|NCT01138657|566935060|FG001|Overall Study|Miscellaneous Reasons|4|||
157049529|NCT02399449|566935063|FG000|Overall Study|Withdrawal by Subject|3|||
157049530|NCT02399449|566935064|FG001|Overall Study|Withdrawal by Subject|9|||
157049531|NCT02399449|566935063|FG000|Overall Study|Physician Decision|0|||
157049532|NCT02399449|566935064|FG001|Overall Study|Physician Decision|1|||
157049533|NCT01020435|566935065|FG000|Overall Study|Lost to Follow-up|0|||
157049534|NCT01020435|566935066|FG001|Overall Study|Lost to Follow-up|1|||
157049535|NCT00337610|566935067|FG000|Overall Study|Adverse Event|2|||
157049536|NCT00337610|566935068|FG001|Overall Study|Adverse Event|2|||
157049537|NCT00337610|566935067|FG000|Overall Study|Death|0|||
157049538|NCT00337610|566935068|FG001|Overall Study|Death|1|||
157049539|NCT00337610|566935067|FG000|Overall Study|Lack of Efficacy|6|||
157049540|NCT00337610|566935068|FG001|Overall Study|Lack of Efficacy|3|||
157049541|NCT00337610|566935067|FG000|Overall Study|Lost to Follow-up|3|||
157049542|NCT00337610|566935068|FG001|Overall Study|Lost to Follow-up|3|||
157049543|NCT00337610|566935067|FG000|Overall Study|Withdrawal by Subject|6|||
157049544|NCT00337610|566935068|FG001|Overall Study|Withdrawal by Subject|5|||
157049545|NCT00346398|566935069|FG000|Overall Study|Lost to Follow-up|3|||
157049546|NCT00346398|566935070|FG001|Overall Study|Lost to Follow-up|0|||
157049547|NCT00346398|566935069|FG000|Overall Study|Withdrawal by Subject|0|||
157049548|NCT00346398|566935070|FG001|Overall Study|Withdrawal by Subject|2|||
157049549|NCT03979040|566935071|FG000|Overall Study|Withdrawal by Subject|24|||
157049550|NCT03979040|566935072|FG001|Overall Study|Withdrawal by Subject|32|||
157049551|NCT03979040|566935071|FG000|Overall Study|randomized but never started treatment|32|||
157049552|NCT03979040|566935072|FG001|Overall Study|randomized but never started treatment|39|||
157049553|NCT03979040|566935071|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
157049554|NCT03979040|566935072|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
157049555|NCT02607956|566935073|FG000|Double-Blinded Phase|Withdrew Consent|17|||
157049556|NCT02607956|566935074|FG001|Double-Blinded Phase|Withdrew Consent|19|||
157049557|NCT02607956|566935075|FG002|Double-Blinded Phase|Withdrew Consent|0|||
157049558|NCT02607956|566935076|FG003|Double-Blinded Phase|Withdrew Consent|0|||
157049559|NCT02607956|566935073|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
157049560|NCT02607956|566935074|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
157049561|NCT02607956|566935075|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
157049562|NCT02607956|566935076|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
157049563|NCT02607956|566935073|FG000|Double-Blinded Phase|Randomized but never treated|7|||
157049564|NCT02607956|566935074|FG001|Double-Blinded Phase|Randomized but never treated|5|||
157049565|NCT02607956|566935075|FG002|Double-Blinded Phase|Randomized but never treated|0|||
157049566|NCT02607956|566935076|FG003|Double-Blinded Phase|Randomized but never treated|0|||
157049567|NCT02607956|566935073|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
157049568|NCT02607956|566935074|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
157049569|NCT02607956|566935075|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
157049570|NCT02607956|566935076|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
157049571|NCT02607956|566935073|FG000|Double-Blinded Phase|Death|4|||
157049572|NCT02607956|566935074|FG001|Double-Blinded Phase|Death|4|||
157049573|NCT02607956|566935075|FG002|Double-Blinded Phase|Death|0|||
157049574|NCT02607956|566935076|FG003|Double-Blinded Phase|Death|0|||
157049575|NCT02607956|566935073|FG000|Double-Blinded Phase|Adverse Event|4|||
157049576|NCT02607956|566935074|FG001|Double-Blinded Phase|Adverse Event|3|||
157049577|NCT02607956|566935075|FG002|Double-Blinded Phase|Adverse Event|0|||
157049578|NCT02607956|566935076|FG003|Double-Blinded Phase|Adverse Event|0|||
157049579|NCT02607956|566935073|FG000|Double-Blinded Phase|Protocol Violation|3|||
157049580|NCT02607956|566935074|FG001|Double-Blinded Phase|Protocol Violation|1|||
157049581|NCT02607956|566935075|FG002|Double-Blinded Phase|Protocol Violation|0|||
157049582|NCT02607956|566935076|FG003|Double-Blinded Phase|Protocol Violation|0|||
157049583|NCT02607956|566935073|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
157049584|NCT02607956|566935074|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
157049585|NCT02607956|566935075|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
157049586|NCT02607956|566935076|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
157049587|NCT02607956|566935073|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
157049588|NCT02607956|566935074|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
157049589|NCT02607956|566935075|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
157049590|NCT02607956|566935076|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
157049591|NCT02607956|566935073|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
157049592|NCT02607956|566935074|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
157049593|NCT02607956|566935075|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
157049594|NCT02607956|566935076|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
157049595|NCT02607956|566935073|FG000|Open-Label Extension Phase|Death|0|||
157049596|NCT02607956|566935074|FG001|Open-Label Extension Phase|Death|0|||
157049597|NCT02607956|566935075|FG002|Open-Label Extension Phase|Death|1|||
157049598|NCT02607956|566935076|FG003|Open-Label Extension Phase|Death|3|||
157049599|NCT02607956|566935073|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
157049600|NCT02607956|566935074|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
157049601|NCT02607956|566935075|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
157049602|NCT02607956|566935076|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
157049603|NCT02607956|566935073|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
157049604|NCT02607956|566935074|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
157049605|NCT02607956|566935075|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
157049606|NCT02607956|566935076|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
157049607|NCT02607956|566935073|FG000|Open-Label Extension Phase|Protocol Violation|0|||
157049608|NCT02607956|566935074|FG001|Open-Label Extension Phase|Protocol Violation|0|||
157049609|NCT02607956|566935075|FG002|Open-Label Extension Phase|Protocol Violation|0|||
157049610|NCT02607956|566935076|FG003|Open-Label Extension Phase|Protocol Violation|2|||
157049611|NCT02607956|566935073|FG000|Open-Label Extension Phase|Pregnancy|0|||
157049612|NCT02607956|566935074|FG001|Open-Label Extension Phase|Pregnancy|0|||
157049613|NCT02607956|566935075|FG002|Open-Label Extension Phase|Pregnancy|0|||
157049614|NCT02607956|566935076|FG003|Open-Label Extension Phase|Pregnancy|1|||
157049615|NCT02326220|566935090|FG000|Double-blind Treatment Period|Adverse Event|1|||
157049616|NCT02326220|566935091|FG001|Double-blind Treatment Period|Adverse Event|2|||
157049617|NCT02326220|566935092|FG002|Double-blind Treatment Period|Adverse Event|0|||
157049618|NCT02326220|566935090|FG000|Double-blind Treatment Period|Protocol Violation|0|||
157049619|NCT02326220|566935091|FG001|Double-blind Treatment Period|Protocol Violation|1|||
157049620|NCT02326220|566935092|FG002|Double-blind Treatment Period|Protocol Violation|0|||
157049621|NCT02326220|566935090|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
157049622|NCT02326220|566935091|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
157049623|NCT02326220|566935092|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157049624|NCT02326220|566935090|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
157049625|NCT02326220|566935091|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
157049626|NCT02326220|566935092|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
157049627|NCT02326220|566935090|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
157049628|NCT02326220|566935091|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
157049629|NCT02326220|566935092|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
157049630|NCT02699099|566935093|FG000|Overall Study|Adverse Event|1|||
157049631|NCT02699099|566935094|FG001|Overall Study|Adverse Event|0|||
157049632|NCT02699099|566935095|FG002|Overall Study|Adverse Event|2|||
157049633|NCT02699099|566935093|FG000|Overall Study|Lost to Follow-up|0|||
157049634|NCT02699099|566935094|FG001|Overall Study|Lost to Follow-up|1|||
157049635|NCT02699099|566935095|FG002|Overall Study|Lost to Follow-up|0|||
157049636|NCT02699099|566935093|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
157049637|NCT02699099|566935094|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
157049638|NCT02699099|566935095|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
157176255|NCT01001572|567385465|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
157176256|NCT01001572|567385466|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
157176257|NCT01001572|567385467|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
157176258|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
157049639|NCT01240590|566935098|FG000|Phase I|Refused further treatment|0|||
157049640|NCT01240590|566935099|FG001|Phase I|Refused further treatment|0|||
157049641|NCT01240590|566935100|FG002|Phase I|Refused further treatment|3|||
157049642|NCT01240590|566935101|FG003|Phase I|Refused further treatment|0|||
157049643|NCT01240590|566935102|FG004|Phase I|Refused further treatment|0|||
157049644|NCT01240590|566935098|FG000|Phase II|Refused further treatment|0|||
157049645|NCT01240590|566935099|FG001|Phase II|Refused further treatment|0|||
157049646|NCT01240590|566935100|FG002|Phase II|Refused further treatment|0|||
157049647|NCT01240590|566935101|FG003|Phase II|Refused further treatment|2|||
157049648|NCT01240590|566935102|FG004|Phase II|Refused further treatment|1|||
157049649|NCT00824850|566935105|FG000|Overall Study|Withdrawal by Subject|0|||
157049650|NCT00824850|566935106|FG001|Overall Study|Withdrawal by Subject|1|||
157049651|NCT01075152|566935110|FG000|Overall Study|Withdrawal by Subject|1|||
157049652|NCT01075152|566935111|FG001|Overall Study|Withdrawal by Subject|0|||
157049653|NCT04820491|566935112|FG000|Overall Study|Withdrawal by Subject|1|||
157049654|NCT04820491|566935113|FG001|Overall Study|Withdrawal by Subject|0|||
157049655|NCT01079949|566935116|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
157049656|NCT01079949|566935117|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
157049657|NCT01079949|566935116|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
157049658|NCT01079949|566935117|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
157049659|NCT01079949|566935116|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
157049660|NCT01079949|566935117|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
157049661|NCT01079949|566935116|FG000|Overall Study|Randomized but not treated|1|||
157049662|NCT01079949|566935117|FG001|Overall Study|Randomized but not treated|0|||
157049663|NCT02144285|566935118|FG000|Overall Study|Withdrawal by Subject|0|||
157049664|NCT02144285|566935119|FG001|Overall Study|Withdrawal by Subject|0|||
157049665|NCT02144285|566935120|FG002|Overall Study|Withdrawal by Subject|0|||
157049666|NCT02144285|566935121|FG003|Overall Study|Withdrawal by Subject|0|||
157049667|NCT02144285|566935122|FG004|Overall Study|Withdrawal by Subject|1|||
157049668|NCT02144285|566935123|FG005|Overall Study|Withdrawal by Subject|0|||
157049669|NCT02144285|566935124|FG006|Overall Study|Withdrawal by Subject|0|||
157049670|NCT02144285|566935125|FG007|Overall Study|Withdrawal by Subject|0|||
157049671|NCT02144285|566935126|FG008|Overall Study|Withdrawal by Subject|0|||
157049672|NCT02144285|566935127|FG009|Overall Study|Withdrawal by Subject|0|||
157049673|NCT01529632|566935128|FG000|Overall Study|Administrative problem|2|||
157049674|NCT01529632|566935129|FG001|Overall Study|Administrative problem|1|||
157049675|NCT01529632|566935128|FG000|Overall Study|Protocol Violation|0|||
157049676|NCT01529632|566935129|FG001|Overall Study|Protocol Violation|1|||
157049677|NCT01529632|566935128|FG000|Overall Study|Adverse Event|1|||
157049678|NCT01529632|566935129|FG001|Overall Study|Adverse Event|1|||
157049679|NCT05184062|566935131|FG000|Overall Study|Lost to Follow-up|5|||
157049680|NCT05184062|566935132|FG001|Overall Study|Lost to Follow-up|1|||
157049681|NCT05184062|566935131|FG000|Overall Study|Withdrawal by Subject|1|||
157049682|NCT05184062|566935132|FG001|Overall Study|Withdrawal by Subject|0|||
157049683|NCT03659136|566935137|FG000|Overall Study|Not treated|2|||
157049684|NCT03659136|566935138|FG001|Overall Study|Not treated|0|||
157049685|NCT03659136|566935137|FG000|Overall Study|Covid-19 related|1|||
157049686|NCT03659136|566935138|FG001|Overall Study|Covid-19 related|1|||
157049687|NCT03659136|566935137|FG000|Overall Study|Withdrawal by Subject|1|||
157049688|NCT03659136|566935138|FG001|Overall Study|Withdrawal by Subject|6|||
157049689|NCT03659136|566935137|FG000|Overall Study|Adverse Event|4|||
157049690|NCT03659136|566935138|FG001|Overall Study|Adverse Event|6|||
157049691|NCT03659136|566935137|FG000|Overall Study|Progressive disease|37|||
157049692|NCT03659136|566935138|FG001|Overall Study|Progressive disease|31|||
157049693|NCT03659136|566935137|FG000|Overall Study|Study closure|2|||
157049694|NCT03659136|566935138|FG001|Overall Study|Study closure|2|||
157049695|NCT03659136|566935137|FG000|Overall Study|Sponsor decision/recommendation|3|||
157049696|NCT03659136|566935138|FG001|Overall Study|Sponsor decision/recommendation|2|||
157049697|NCT03659136|566935137|FG000|Overall Study|Switched to other drug/therapy|2|||
157049698|NCT03659136|566935138|FG001|Overall Study|Switched to other drug/therapy|2|||
157049699|NCT03659136|566935137|FG000|Overall Study|Lack of clinical benefit|0|||
157049700|NCT03659136|566935138|FG001|Overall Study|Lack of clinical benefit|1|||
157049701|NCT04620733|566937128|FG000|Overall Study|Adverse Event|4|||
157049702|NCT04620733|566937129|FG001|Overall Study|Adverse Event|3|||
157049703|NCT04620733|566937128|FG000|Overall Study|Withdrawal by Subject|2|||
157049704|NCT04620733|566937129|FG001|Overall Study|Withdrawal by Subject|5|||
157049705|NCT04620733|566937128|FG000|Overall Study|Lost to Follow-up|1|||
157049706|NCT04620733|566937129|FG001|Overall Study|Lost to Follow-up|1|||
157049707|NCT04620733|566937128|FG000|Overall Study|Protocol Deviation|1|||
157049708|NCT04620733|566937129|FG001|Overall Study|Protocol Deviation|1|||
157049709|NCT04620733|566937128|FG000|Overall Study|Reason Not Specified|0|||
157049710|NCT04620733|566937129|FG001|Overall Study|Reason Not Specified|1|||
157049711|NCT03976102|566937130|FG000|Overall Study|Withdrawal by Subject|4|||
157049712|NCT03976102|566937131|FG001|Overall Study|Withdrawal by Subject|4|||
157049713|NCT03976102|566937130|FG000|Overall Study|Adverse Event|2|||
157049714|NCT03976102|566937131|FG001|Overall Study|Adverse Event|4|||
157049715|NCT03976102|566937130|FG000|Overall Study|Not related to Covid-19|9|||
157049716|NCT03976102|566937131|FG001|Overall Study|Not related to Covid-19|13|||
157049717|NCT03976102|566937130|FG000|Overall Study|Lost to Follow-up|0|||
157176259|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
157049718|NCT03976102|566937131|FG001|Overall Study|Lost to Follow-up|2|||
157049719|NCT03976102|566937130|FG000|Overall Study|Death|3|||
157049720|NCT03976102|566937131|FG001|Overall Study|Death|2|||
157049721|NCT03976102|566937130|FG000|Overall Study|Physician Decision|1|||
157049722|NCT03976102|566937131|FG001|Overall Study|Physician Decision|1|||
157049723|NCT02164578|566937139|FG000|Treatment Period|Withdrawal by Subject|3|||
157049724|NCT02164578|566937140|FG001|Treatment Period|Withdrawal by Subject|3|||
157049725|NCT02164578|566937139|FG000|Treatment Period|Adverse Event|13|||
157049726|NCT02164578|566937140|FG001|Treatment Period|Adverse Event|6|||
157049727|NCT02164578|566937139|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
157049728|NCT02164578|566937140|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
157049729|NCT02164578|566937139|FG000|Treatment Period|Protocol Violation|0|||
157049730|NCT02164578|566937140|FG001|Treatment Period|Protocol Violation|2|||
157049731|NCT02164578|566937139|FG000|Extension Period|Withdrawal by Subject|2|||
157049732|NCT02164578|566937140|FG001|Extension Period|Withdrawal by Subject|0|||
157049733|NCT02164578|566937139|FG000|Extension Period|Adverse Event|4|||
157049734|NCT02164578|566937140|FG001|Extension Period|Adverse Event|0|||
157049735|NCT02164578|566937139|FG000|Extension Period|Expiry of study medication|1|||
157049736|NCT02164578|566937140|FG001|Extension Period|Expiry of study medication|0|||
157049737|NCT02164578|566937139|FG000|Extension Period|Protocol Violation|0|||
157049738|NCT02164578|566937140|FG001|Extension Period|Protocol Violation|1|||
157049739|NCT02400749|566937148|FG000|Week 0 -16|Withdrawal by Subject|5|||
157049740|NCT02400749|566937149|FG001|Week 0 -16|Withdrawal by Subject|5|||
157049741|NCT02400749|566937148|FG000|Week 0 -16|Adverse Event|3|||
157049742|NCT02400749|566937149|FG001|Week 0 -16|Adverse Event|1|||
157049743|NCT02400749|566937148|FG000|Week 0 -16|Lost to Follow-up|2|||
157049744|NCT02400749|566937149|FG001|Week 0 -16|Lost to Follow-up|0|||
157049745|NCT02400749|566937148|FG000|Week 0 -16|Protocol Violation|1|||
157049746|NCT02400749|566937149|FG001|Week 0 -16|Protocol Violation|0|||
157049747|NCT02400749|566937148|FG000|Week 17 - 32|Withdrawal by Subject|3|||
157049748|NCT02400749|566937149|FG001|Week 17 - 32|Withdrawal by Subject|2|||
157049749|NCT02400749|566937148|FG000|Week 17 - 32|Adverse Event|2|||
157049750|NCT02400749|566937149|FG001|Week 17 - 32|Adverse Event|1|||
157049751|NCT00507429|566937152|FG000|Treatment Phase|Disease Progression|12|||
157049752|NCT00507429|566937153|FG001|Treatment Phase|Disease Progression|5|||
157049753|NCT00507429|566937152|FG000|Treatment Phase|Adverse Event|12|||
157049754|NCT00507429|566937153|FG001|Treatment Phase|Adverse Event|5|||
157049755|NCT00507429|566937152|FG000|Treatment Phase|Withdrawal by Subject|3|||
157049756|NCT00507429|566937153|FG001|Treatment Phase|Withdrawal by Subject|3|||
157049757|NCT00507429|566937152|FG000|Treatment Phase|Physician Decision|4|||
157049758|NCT00507429|566937153|FG001|Treatment Phase|Physician Decision|2|||
157049759|NCT00507429|566937152|FG000|Treatment Phase|Other|6|||
157049760|NCT00507429|566937153|FG001|Treatment Phase|Other|3|||
157049761|NCT00507429|566937152|FG000|Maintenance Phase|Progressive Disease|14|||
157049762|NCT00507429|566937153|FG001|Maintenance Phase|Progressive Disease|0|||
157049763|NCT00813709|566937154|FG000|Double Blind Period|Adverse Event|4|||
157049764|NCT00813709|566937155|FG001|Double Blind Period|Adverse Event|1|||
157049765|NCT00813709|566937156|FG002|Double Blind Period|Adverse Event|4|||
157049766|NCT00813709|566937157|FG003|Double Blind Period|Adverse Event|0|||
157049767|NCT00813709|566937158|FG004|Double Blind Period|Adverse Event|0|||
157049768|NCT00813709|566937159|FG005|Double Blind Period|Adverse Event|0|||
157049769|NCT00813709|566937154|FG000|Double Blind Period|Lost to Follow-up|3|||
157049770|NCT00813709|566937155|FG001|Double Blind Period|Lost to Follow-up|2|||
157049771|NCT00813709|566937156|FG002|Double Blind Period|Lost to Follow-up|2|||
157049772|NCT00813709|566937157|FG003|Double Blind Period|Lost to Follow-up|0|||
157049773|NCT00813709|566937158|FG004|Double Blind Period|Lost to Follow-up|0|||
157049774|NCT00813709|566937159|FG005|Double Blind Period|Lost to Follow-up|0|||
157049775|NCT00813709|566937154|FG000|Double Blind Period|Switched to open label phase|9|||
157049776|NCT00813709|566937155|FG001|Double Blind Period|Switched to open label phase|26|||
157049777|NCT00813709|566937156|FG002|Double Blind Period|Switched to open label phase|18|||
157049778|NCT00813709|566937157|FG003|Double Blind Period|Switched to open label phase|0|||
157049779|NCT00813709|566937158|FG004|Double Blind Period|Switched to open label phase|0|||
157049780|NCT00813709|566937159|FG005|Double Blind Period|Switched to open label phase|0|||
157049781|NCT00813709|566937154|FG000|Double Blind Period|Randomized but not treated|1|||
157049782|NCT00813709|566937155|FG001|Double Blind Period|Randomized but not treated|3|||
157049783|NCT00813709|566937156|FG002|Double Blind Period|Randomized but not treated|1|||
157049784|NCT00813709|566937157|FG003|Double Blind Period|Randomized but not treated|0|||
157049785|NCT00813709|566937158|FG004|Double Blind Period|Randomized but not treated|0|||
157049786|NCT00813709|566937159|FG005|Double Blind Period|Randomized but not treated|0|||
157049787|NCT00813709|566937154|FG000|Double Blind Period|Other|14|||
157049788|NCT00813709|566937155|FG001|Double Blind Period|Other|9|||
157049789|NCT00813709|566937156|FG002|Double Blind Period|Other|6|||
157049790|NCT00813709|566937157|FG003|Double Blind Period|Other|0|||
157049791|NCT00813709|566937158|FG004|Double Blind Period|Other|0|||
157049792|NCT00813709|566937159|FG005|Double Blind Period|Other|0|||
157049793|NCT00813709|566937154|FG000|Open Label Period|Adverse Event|0|||
157049794|NCT00813709|566937155|FG001|Open Label Period|Adverse Event|0|||
157049795|NCT00813709|566937156|FG002|Open Label Period|Adverse Event|0|||
157049796|NCT00813709|566937157|FG003|Open Label Period|Adverse Event|5|||
157049797|NCT00813709|566937158|FG004|Open Label Period|Adverse Event|4|||
157049798|NCT00813709|566937159|FG005|Open Label Period|Adverse Event|3|||
157049799|NCT00813709|566937154|FG000|Open Label Period|Lack of Efficacy|0|||
157049800|NCT00813709|566937155|FG001|Open Label Period|Lack of Efficacy|0|||
157049801|NCT00813709|566937156|FG002|Open Label Period|Lack of Efficacy|0|||
157049802|NCT00813709|566937157|FG003|Open Label Period|Lack of Efficacy|3|||
157049803|NCT00813709|566937158|FG004|Open Label Period|Lack of Efficacy|1|||
157049804|NCT00813709|566937159|FG005|Open Label Period|Lack of Efficacy|1|||
157049805|NCT00813709|566937154|FG000|Open Label Period|Randomized but not treated|0|||
157049806|NCT00813709|566937155|FG001|Open Label Period|Randomized but not treated|0|||
157049807|NCT00813709|566937156|FG002|Open Label Period|Randomized but not treated|0|||
157049808|NCT00813709|566937157|FG003|Open Label Period|Randomized but not treated|1|||
157049809|NCT00813709|566937158|FG004|Open Label Period|Randomized but not treated|0|||
157049810|NCT00813709|566937159|FG005|Open Label Period|Randomized but not treated|1|||
157049811|NCT00813709|566937154|FG000|Open Label Period|Other|0|||
157049812|NCT00813709|566937155|FG001|Open Label Period|Other|0|||
157049813|NCT00813709|566937156|FG002|Open Label Period|Other|0|||
157049814|NCT00813709|566937157|FG003|Open Label Period|Other|11|||
157049815|NCT00813709|566937158|FG004|Open Label Period|Other|5|||
157049816|NCT00813709|566937159|FG005|Open Label Period|Other|6|||
157049817|NCT02446015|566937160|FG000|Overall Study|Adverse Event|0|||
157049818|NCT02446015|566937161|FG001|Overall Study|Adverse Event|1|||
157049819|NCT02446015|566937160|FG000|Overall Study|Withdrawal by Subject|1|||
157049820|NCT02446015|566937161|FG001|Overall Study|Withdrawal by Subject|0|||
157049821|NCT01919489|566937162|FG000|Overall Study|Rejected the need of injections|4|||
157049822|NCT01919489|566937163|FG001|Overall Study|Rejected the need of injections|7|||
157049823|NCT01919489|566937162|FG000|Overall Study|Adverse Event|10|||
157049824|NCT01919489|566937163|FG001|Overall Study|Adverse Event|0|||
157049825|NCT01919489|566937162|FG000|Overall Study|Hospital readmission|2|||
157049826|NCT01919489|566937163|FG001|Overall Study|Hospital readmission|9|||
157049827|NCT01919489|566937162|FG000|Overall Study|Death|2|||
157049828|NCT01919489|566937163|FG001|Overall Study|Death|1|||
157049829|NCT01919489|566937162|FG000|Overall Study|Lost to Follow-up|38|||
157049830|NCT01919489|566937163|FG001|Overall Study|Lost to Follow-up|27|||
157049831|NCT00857311|566937164|FG000|Overall Study|Lost to Follow-up|1|||
157049832|NCT00857311|566937165|FG001|Overall Study|Lost to Follow-up|0|||
157049833|NCT00857311|566937166|FG002|Overall Study|Lost to Follow-up|0|||
157049834|NCT00857311|566937167|FG003|Overall Study|Lost to Follow-up|0|||
157049835|NCT01587703|566937168|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
157049836|NCT01587703|566937169|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049837|NCT01587703|566937170|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049838|NCT01587703|566937171|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049839|NCT01587703|566937172|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049840|NCT01587703|566937173|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049841|NCT01587703|566937174|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049842|NCT01587703|566937175|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049843|NCT01587703|566937176|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049844|NCT01587703|566937177|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049845|NCT01587703|566937178|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049846|NCT01587703|566937179|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049847|NCT01587703|566937180|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049848|NCT01587703|566937181|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049849|NCT01587703|566937182|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049850|NCT01587703|566937183|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049851|NCT01587703|566937184|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049852|NCT01587703|566937185|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049853|NCT01587703|566937186|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
157049854|NCT01587703|566937168|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049855|NCT01587703|566937169|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157176260|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
157176261|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
157176262|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
157176263|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
157176264|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
157049856|NCT01587703|566937170|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049857|NCT01587703|566937171|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049858|NCT01587703|566937172|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049859|NCT01587703|566937173|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
157049860|NCT01587703|566937174|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049861|NCT01587703|566937175|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
157049862|NCT01587703|566937176|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049863|NCT01587703|566937177|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049864|NCT01587703|566937178|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049865|NCT01587703|566937179|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049866|NCT01587703|566937180|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049867|NCT01587703|566937181|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049868|NCT01587703|566937182|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049869|NCT01587703|566937183|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049870|NCT01587703|566937184|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049871|NCT01587703|566937185|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049872|NCT01587703|566937186|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
157049873|NCT01587703|566937168|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049874|NCT01587703|566937169|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049875|NCT01587703|566937170|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049876|NCT01587703|566937171|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049877|NCT01587703|566937172|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049878|NCT01587703|566937173|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049879|NCT01587703|566937174|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
157049880|NCT01587703|566937175|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049881|NCT01587703|566937176|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049882|NCT01587703|566937177|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049883|NCT01587703|566937178|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049884|NCT01587703|566937179|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049885|NCT01587703|566937180|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049886|NCT01587703|566937181|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049887|NCT01587703|566937182|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049888|NCT01587703|566937183|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049889|NCT01587703|566937184|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049890|NCT01587703|566937185|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049891|NCT01587703|566937186|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
157049892|NCT01587703|566937168|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
157049893|NCT01587703|566937169|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
157049894|NCT01587703|566937170|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
157049895|NCT01587703|566937171|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
157049896|NCT01587703|566937172|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
157049897|NCT01587703|566937173|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
157049898|NCT01587703|566937174|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
157049899|NCT01587703|566937175|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
157049900|NCT01587703|566937176|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049901|NCT01587703|566937177|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049902|NCT01587703|566937178|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049903|NCT01587703|566937179|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049904|NCT01587703|566937180|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049905|NCT01587703|566937181|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049906|NCT01587703|566937182|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049907|NCT01587703|566937183|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049908|NCT01587703|566937184|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049909|NCT01587703|566937185|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049910|NCT01587703|566937186|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
157049911|NCT01587703|566937168|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049912|NCT01587703|566937169|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049913|NCT01587703|566937170|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049914|NCT01587703|566937171|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049915|NCT01587703|566937172|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049916|NCT01587703|566937173|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049917|NCT01587703|566937174|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049918|NCT01587703|566937175|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049919|NCT01587703|566937176|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
157049920|NCT01587703|566937177|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
157176265|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
157049921|NCT01587703|566937178|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
157176266|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
157049922|NCT01587703|566937179|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049923|NCT01587703|566937180|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049924|NCT01587703|566937181|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157176267|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
157049925|NCT01587703|566937182|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049926|NCT01587703|566937183|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049927|NCT01587703|566937184|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049928|NCT01587703|566937185|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049929|NCT01587703|566937186|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
157049930|NCT01587703|566937168|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049931|NCT01587703|566937169|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049932|NCT01587703|566937170|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049933|NCT01587703|566937171|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049934|NCT01587703|566937172|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049935|NCT01587703|566937173|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049936|NCT01587703|566937174|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049937|NCT01587703|566937175|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049938|NCT01587703|566937176|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
157049939|NCT01587703|566937177|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049940|NCT01587703|566937178|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
157049941|NCT01587703|566937179|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049942|NCT01587703|566937180|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049943|NCT01587703|566937181|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049944|NCT01587703|566937182|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049945|NCT01587703|566937183|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049946|NCT01587703|566937184|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049947|NCT01587703|566937185|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049948|NCT01587703|566937186|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
157049949|NCT01587703|566937168|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049950|NCT01587703|566937169|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049951|NCT01587703|566937170|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049952|NCT01587703|566937171|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049953|NCT01587703|566937172|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049954|NCT01587703|566937173|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049955|NCT01587703|566937174|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049956|NCT01587703|566937175|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049957|NCT01587703|566937176|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049958|NCT01587703|566937177|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
157049959|NCT01587703|566937178|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
157049960|NCT01587703|566937179|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049961|NCT01587703|566937180|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049962|NCT01587703|566937181|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049963|NCT01587703|566937182|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049964|NCT01587703|566937183|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049965|NCT01587703|566937184|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049966|NCT01587703|566937185|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049967|NCT01587703|566937186|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
157049968|NCT01587703|566937168|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049969|NCT01587703|566937169|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049970|NCT01587703|566937170|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049971|NCT01587703|566937171|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049972|NCT01587703|566937172|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049973|NCT01587703|566937173|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049974|NCT01587703|566937174|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049975|NCT01587703|566937175|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049976|NCT01587703|566937176|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
157049977|NCT01587703|566937177|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049978|NCT01587703|566937178|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049979|NCT01587703|566937179|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049980|NCT01587703|566937180|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049981|NCT01587703|566937181|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049982|NCT01587703|566937182|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049983|NCT01587703|566937183|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049984|NCT01587703|566937184|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049985|NCT01587703|566937185|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157176268|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
157176269|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
157049986|NCT01587703|566937186|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
157049987|NCT01587703|566937168|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049988|NCT01587703|566937169|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049989|NCT01587703|566937170|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049990|NCT01587703|566937171|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049991|NCT01587703|566937172|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049992|NCT01587703|566937173|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049993|NCT01587703|566937174|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049994|NCT01587703|566937175|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049995|NCT01587703|566937176|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049996|NCT01587703|566937177|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049997|NCT01587703|566937178|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049998|NCT01587703|566937179|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157049999|NCT01587703|566937180|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050000|NCT01587703|566937181|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050001|NCT01587703|566937182|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050002|NCT01587703|566937183|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050003|NCT01587703|566937184|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050004|NCT01587703|566937185|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
157050005|NCT01587703|566937186|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
157050006|NCT01587703|566937168|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050007|NCT01587703|566937169|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050008|NCT01587703|566937170|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050009|NCT01587703|566937171|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050010|NCT01587703|566937172|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050011|NCT01587703|566937173|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050012|NCT01587703|566937174|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050013|NCT01587703|566937175|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050014|NCT01587703|566937176|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050015|NCT01587703|566937177|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050016|NCT01587703|566937178|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050017|NCT01587703|566937179|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050018|NCT01587703|566937180|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050019|NCT01587703|566937181|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050020|NCT01587703|566937182|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050021|NCT01587703|566937183|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050022|NCT01587703|566937184|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
157050023|NCT01587703|566937185|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
157050024|NCT01587703|566937186|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
157050025|NCT01587703|566937168|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050026|NCT01587703|566937169|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050027|NCT01587703|566937170|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050028|NCT01587703|566937171|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050029|NCT01587703|566937172|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050030|NCT01587703|566937173|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050031|NCT01587703|566937174|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050032|NCT01587703|566937175|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050033|NCT01587703|566937176|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050034|NCT01587703|566937177|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157176270|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
157176271|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
157050035|NCT01587703|566937178|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050036|NCT01587703|566937179|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050037|NCT01587703|566937180|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157176272|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
157176273|NCT01001572|567385465|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157176274|NCT01001572|567385466|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157176275|NCT01001572|567385467|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
157176276|NCT01094808|567385468|FG000|Overall Study|Withdrawal by Subject|1|||
157176277|NCT01094808|567385469|FG001|Overall Study|Withdrawal by Subject|1|||
157176278|NCT01094808|567385470|FG002|Overall Study|Withdrawal by Subject|0|||
157176279|NCT00369278|567385471|FG000|Overall Study|Adverse Event|14|||
157176280|NCT00369278|567385472|FG001|Overall Study|Adverse Event|11|||
157176281|NCT00369278|567385471|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157176282|NCT00369278|567385472|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
157176283|NCT00369278|567385471|FG000|Overall Study|Protocol Violation|2|||
157176284|NCT00369278|567385472|FG001|Overall Study|Protocol Violation|1|||
157176285|NCT00369278|567385471|FG000|Overall Study|Withdrawal by Subject|2|||
157176286|NCT00369278|567385472|FG001|Overall Study|Withdrawal by Subject|2|||
157050038|NCT01587703|566937181|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050039|NCT01587703|566937182|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050040|NCT01587703|566937183|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
157050041|NCT01587703|566937184|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050042|NCT01587703|566937185|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050043|NCT01587703|566937186|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
157050044|NCT01587703|566937168|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050045|NCT01587703|566937169|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050046|NCT01587703|566937170|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050047|NCT01587703|566937171|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050048|NCT01587703|566937172|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050049|NCT01587703|566937173|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050050|NCT01587703|566937174|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050051|NCT01587703|566937175|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050052|NCT01587703|566937176|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050053|NCT01587703|566937177|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050054|NCT01587703|566937178|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050055|NCT01587703|566937179|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
157050056|NCT01587703|566937180|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050057|NCT01587703|566937181|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050058|NCT01587703|566937182|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
157050059|NCT01587703|566937183|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050060|NCT01587703|566937184|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050061|NCT01587703|566937185|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050062|NCT01587703|566937186|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
157050063|NCT01587703|566937168|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050064|NCT01587703|566937169|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050065|NCT01587703|566937170|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050066|NCT01587703|566937171|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050067|NCT01587703|566937172|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050068|NCT01587703|566937173|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050069|NCT01587703|566937174|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050070|NCT01587703|566937175|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050071|NCT01587703|566937176|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050072|NCT01587703|566937177|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050073|NCT01587703|566937178|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050074|NCT01587703|566937179|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
157050075|NCT01587703|566937180|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
157050076|NCT01587703|566937181|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
157050077|NCT01587703|566937182|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
157050078|NCT01587703|566937183|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
157050079|NCT01587703|566937184|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
157050080|NCT01587703|566937185|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050081|NCT01587703|566937186|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
157050082|NCT01587703|566937168|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050083|NCT01587703|566937169|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050084|NCT01587703|566937170|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050085|NCT01587703|566937171|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050086|NCT01587703|566937172|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050087|NCT01587703|566937173|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050088|NCT01587703|566937174|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050089|NCT01587703|566937175|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050090|NCT01587703|566937176|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050091|NCT01587703|566937177|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050092|NCT01587703|566937178|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050093|NCT01587703|566937179|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
157050094|NCT01587703|566937180|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
157050095|NCT01587703|566937181|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
157176287|NCT00369278|567385471|FG000|Overall Study|Lost to Follow-up|1|||
157176288|NCT00369278|567385472|FG001|Overall Study|Lost to Follow-up|0|||
157050096|NCT01587703|566937182|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
157050097|NCT01587703|566937183|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
157050098|NCT01587703|566937184|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
157050099|NCT01587703|566937185|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
157176289|NCT00369278|567385471|FG000|Overall Study|Graft loss|1|||
157176290|NCT00369278|567385472|FG001|Overall Study|Graft loss|2|||
157050100|NCT01587703|566937186|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
157050101|NCT01587703|566937168|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050102|NCT01587703|566937169|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050103|NCT01587703|566937170|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050104|NCT01587703|566937171|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050105|NCT01587703|566937172|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050106|NCT01587703|566937173|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050107|NCT01587703|566937174|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050108|NCT01587703|566937175|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050109|NCT01587703|566937176|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050110|NCT01587703|566937177|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050111|NCT01587703|566937178|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050112|NCT01587703|566937179|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
157050113|NCT01587703|566937180|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050114|NCT01587703|566937181|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050115|NCT01587703|566937182|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050116|NCT01587703|566937183|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050117|NCT01587703|566937184|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050118|NCT01587703|566937185|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050119|NCT01587703|566937186|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
157050120|NCT01714947|566937187|FG000|Part B|Progressive Disease|3|||
157050121|NCT04751929|566937188|FG000|Overall Study|Withdrawal by Subject|2|||
157050122|NCT04751929|566937189|FG001|Overall Study|Withdrawal by Subject|0|||
157050123|NCT04751929|566937190|FG002|Overall Study|Withdrawal by Subject|0|||
157050124|NCT04751929|566937191|FG003|Overall Study|Withdrawal by Subject|0|||
157050125|NCT04751929|566937188|FG000|Overall Study|Rising PSA|0|||
157050126|NCT04751929|566937189|FG001|Overall Study|Rising PSA|1|||
157050127|NCT04751929|566937190|FG002|Overall Study|Rising PSA|0|||
157050128|NCT04751929|566937191|FG003|Overall Study|Rising PSA|0|||
157050129|NCT04751929|566937188|FG000|Overall Study|Adverse Event|1|||
157050130|NCT04751929|566937189|FG001|Overall Study|Adverse Event|2|||
157050131|NCT04751929|566937190|FG002|Overall Study|Adverse Event|0|||
157050132|NCT04751929|566937191|FG003|Overall Study|Adverse Event|0|||
157050133|NCT04751929|566937188|FG000|Overall Study|Progressive Disease|3|||
157050134|NCT04751929|566937189|FG001|Overall Study|Progressive Disease|4|||
157050135|NCT04751929|566937190|FG002|Overall Study|Progressive Disease|4|||
157050136|NCT04751929|566937191|FG003|Overall Study|Progressive Disease|0|||
157050137|NCT04751929|566937188|FG000|Overall Study|Death|1|||
157050138|NCT04751929|566937189|FG001|Overall Study|Death|1|||
157050139|NCT04751929|566937190|FG002|Overall Study|Death|0|||
157050140|NCT04751929|566937191|FG003|Overall Study|Death|0|||
157050141|NCT01123356|566937192|FG000|Overall Study|Adverse Event|2|||
157050142|NCT01123356|566937192|FG000|Overall Study|Lack of Efficacy|4|||
157050143|NCT01123356|566937192|FG000|Overall Study|Withdrawal by Subject|1|||
157050144|NCT00376259|566937195|FG000|Overall Study|Sponsor request - study termination|21|||
157176291|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
157176292|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
157176293|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
157176294|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
157176295|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
157176296|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
157176297|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
157050145|NCT00376259|566937196|FG001|Overall Study|Sponsor request - study termination|21|||
157050146|NCT00376259|566937195|FG000|Overall Study|Patient request|1|||
157050147|NCT00376259|566937196|FG001|Overall Study|Patient request|0|||
157050148|NCT00759681|566937198|FG000|Overall Study|Death|2|||
157050149|NCT00759681|566937199|FG001|Overall Study|Death|5|||
157050150|NCT00759681|566937198|FG000|Overall Study|Lost to Follow-up|8|||
157050151|NCT00759681|566937199|FG001|Overall Study|Lost to Follow-up|5|||
157050152|NCT00930644|566937200|FG000|Overall Study|Withdrawal by Subject|4|||
157050153|NCT00930644|566937200|FG000|Overall Study|Physician Decision|2|||
157050154|NCT00930644|566937200|FG000|Overall Study|Death|1|||
157050155|NCT00930644|566937200|FG000|Overall Study|Adverse Event|16|||
157050156|NCT01877720|566937201|FG000|Overall Study|Adverse Event|1|||
157176298|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
157050157|NCT01877720|566937202|FG001|Overall Study|Adverse Event|0|||
157050158|NCT00473512|566937205|FG000|Period 1 (Phase 1)|Adverse Event|0|||
157050159|NCT00473512|566937206|FG001|Period 1 (Phase 1)|Adverse Event|0|||
157050160|NCT00473512|566937207|FG002|Period 1 (Phase 1)|Adverse Event|0|||
157050161|NCT00473512|566937208|FG003|Period 1 (Phase 1)|Adverse Event|5|||
157050162|NCT00473512|566937209|FG004|Period 1 (Phase 1)|Adverse Event|0|||
157050163|NCT00473512|566937205|FG000|Period 1 (Phase 1)|Death|0|||
157050164|NCT00473512|566937206|FG001|Period 1 (Phase 1)|Death|0|||
157050165|NCT00473512|566937207|FG002|Period 1 (Phase 1)|Death|0|||
157050166|NCT00473512|566937208|FG003|Period 1 (Phase 1)|Death|1|||
157050167|NCT00473512|566937209|FG004|Period 1 (Phase 1)|Death|0|||
157050168|NCT00473512|566937205|FG000|Period 1 (Phase 1)|Disease Progression|1|||
157050169|NCT00473512|566937206|FG001|Period 1 (Phase 1)|Disease Progression|1|||
157050170|NCT00473512|566937207|FG002|Period 1 (Phase 1)|Disease Progression|0|||
157050171|NCT00473512|566937208|FG003|Period 1 (Phase 1)|Disease Progression|10|||
157050172|NCT00473512|566937209|FG004|Period 1 (Phase 1)|Disease Progression|1|||
157050173|NCT00473512|566937205|FG000|Period 1 (Phase 1)|Other|0|||
157050174|NCT00473512|566937206|FG001|Period 1 (Phase 1)|Other|0|||
157050175|NCT00473512|566937207|FG002|Period 1 (Phase 1)|Other|0|||
157050176|NCT00473512|566937208|FG003|Period 1 (Phase 1)|Other|1|||
157050177|NCT00473512|566937209|FG004|Period 1 (Phase 1)|Other|0|||
157050178|NCT00473512|566937205|FG000|Period 2 (Phase 2)|Adverse Event|0|||
157050179|NCT00473512|566937206|FG001|Period 2 (Phase 2)|Adverse Event|0|||
157050180|NCT00473512|566937207|FG002|Period 2 (Phase 2)|Adverse Event|0|||
157050181|NCT00473512|566937208|FG003|Period 2 (Phase 2)|Adverse Event|1|||
157050182|NCT00473512|566937209|FG004|Period 2 (Phase 2)|Adverse Event|0|||
157050183|NCT00473512|566937205|FG000|Period 2 (Phase 2)|Death|0|||
157050184|NCT00473512|566937206|FG001|Period 2 (Phase 2)|Death|0|||
157050185|NCT00473512|566937207|FG002|Period 2 (Phase 2)|Death|0|||
157050186|NCT00473512|566937208|FG003|Period 2 (Phase 2)|Death|1|||
157050187|NCT00473512|566937209|FG004|Period 2 (Phase 2)|Death|1|||
157050188|NCT00473512|566937205|FG000|Period 2 (Phase 2)|Disease Progression|0|||
157050189|NCT00473512|566937206|FG001|Period 2 (Phase 2)|Disease Progression|2|||
157050190|NCT00473512|566937207|FG002|Period 2 (Phase 2)|Disease Progression|2|||
157050191|NCT00473512|566937208|FG003|Period 2 (Phase 2)|Disease Progression|17|||
157050192|NCT00473512|566937209|FG004|Period 2 (Phase 2)|Disease Progression|1|||
157050193|NCT00473512|566937205|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
157050194|NCT00473512|566937206|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
157050195|NCT00473512|566937207|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
157050196|NCT00473512|566937208|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
157050197|NCT00473512|566937209|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
157050198|NCT00473512|566937205|FG000|Period 2 (Phase 2)|Other|1|||
157050199|NCT00473512|566937206|FG001|Period 2 (Phase 2)|Other|0|||
157050200|NCT00473512|566937207|FG002|Period 2 (Phase 2)|Other|0|||
157050201|NCT00473512|566937208|FG003|Period 2 (Phase 2)|Other|3|||
157050202|NCT00473512|566937209|FG004|Period 2 (Phase 2)|Other|0|||
157050203|NCT01129011|566937210|FG000|Overall Study|Adverse Event|20|||
157050204|NCT01129011|566937211|FG001|Overall Study|Adverse Event|30|||
157050205|NCT01129011|566937210|FG000|Overall Study|Withdrawal by Subject|24|||
157050206|NCT01129011|566937211|FG001|Overall Study|Withdrawal by Subject|8|||
157050207|NCT01129011|566937210|FG000|Overall Study|Lost to Follow-up|6|||
157050208|NCT01129011|566937211|FG001|Overall Study|Lost to Follow-up|7|||
157050209|NCT01129011|566937210|FG000|Overall Study|Duodenal Ulcer|2|||
157050210|NCT01129011|566937211|FG001|Overall Study|Duodenal Ulcer|8|||
157050211|NCT01129011|566937210|FG000|Overall Study|misc|7|||
157050212|NCT01129011|566937211|FG001|Overall Study|misc|4|||
157050213|NCT01012999|566937217|FG000|Overall Study|Protocol Violation|1|||
157050214|NCT01369147|566937218|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
157050215|NCT01369147|566937219|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
157050216|NCT01369147|566937220|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
157050217|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
157050218|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
157050219|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
157050220|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
157050221|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
157050222|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
157050223|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
157050224|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
157050225|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
157176299|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
157176300|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
157176301|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
157176302|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
157050226|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
157050227|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
157050228|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
157050229|NCT01494467|566937225|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
157050230|NCT01494467|566937226|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
157050231|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
157050232|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
157050233|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
157050234|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
157050235|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
157050236|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
157229320|NCT03130699|567585227|FG002|Overall Study|Withdrawal by Subject|0|||
157229321|NCT03130699|567585225|FG000|Overall Study|Withdrawal by PI|1|||
157229322|NCT03130699|567585226|FG001|Overall Study|Withdrawal by PI|2|||
157229323|NCT03130699|567585227|FG002|Overall Study|Withdrawal by PI|5|||
157229324|NCT03130699|567585225|FG000|Overall Study|Death|0|||
157229325|NCT03130699|567585226|FG001|Overall Study|Death|0|||
157229326|NCT03130699|567585227|FG002|Overall Study|Death|1|||
157229327|NCT03561883|567585230|FG000|Overall Study|Adverse Event|10|||
157229328|NCT03561883|567585231|FG001|Overall Study|Adverse Event|13|||
157229329|NCT03561883|567585230|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157050237|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
157050238|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
157050239|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
157050240|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
157050241|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
157050242|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
157050243|NCT01494467|566937225|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
157050244|NCT01494467|566937226|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
157050245|NCT02584257|566937229|FG000|Period 1|Withdrawal by Subject|0|||
157050246|NCT02584257|566937230|FG001|Period 1|Withdrawal by Subject|0|||
157050247|NCT02584257|566937231|FG002|Period 1|Withdrawal by Subject|0|||
157050248|NCT02584257|566937232|FG003|Period 1|Withdrawal by Subject|0|||
157176303|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
157176304|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
157176305|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
157176306|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
157176307|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
157176308|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
157176309|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
157176310|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
157176311|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
157176312|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
157176313|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
157176314|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
157176315|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
157176316|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Other|1|||
157176317|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Other|0|||
157176318|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Other|0|||
157176319|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Other|0|||
157176320|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Other|1|||
157176321|NCT02980692|567385479|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
157176322|NCT02980692|567385480|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
157176323|NCT02980692|567385481|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
157176324|NCT02980692|567385482|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
157176325|NCT02980692|567385483|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
157176326|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Adverse Event|0|||
157176327|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Adverse Event|0|||
157176328|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Adverse Event|0|||
157176329|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Adverse Event|1|||
157176330|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Adverse Event|1|||
157176331|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
157176332|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
157176333|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
157176334|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
157176335|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
157176336|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
157176337|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
157176338|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
157176339|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
157176340|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
157176341|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Pregnancy|0|||
157229330|NCT03561883|567585231|FG001|Overall Study|Non-Compliance With Study Drug|2|||
157229331|NCT03561883|567585230|FG000|Overall Study|Protocol Violation|2|||
157229332|NCT03561883|567585231|FG001|Overall Study|Protocol Violation|3|||
157050249|NCT02584257|566937233|FG004|Period 1|Withdrawal by Subject|0|||
157050250|NCT02584257|566937234|FG005|Period 1|Withdrawal by Subject|0|||
157176342|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Pregnancy|0|||
157176343|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Pregnancy|1|||
157176344|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Pregnancy|1|||
157176345|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Pregnancy|0|||
157176346|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
157176347|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
157176348|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
157176349|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
157176350|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
157176351|NCT02980692|567385479|FG000|Double-blind Follow-up Period|Other|0|||
157176352|NCT02980692|567385480|FG001|Double-blind Follow-up Period|Other|0|||
157176353|NCT02980692|567385481|FG002|Double-blind Follow-up Period|Other|1|||
157176354|NCT02980692|567385482|FG003|Double-blind Follow-up Period|Other|1|||
157176355|NCT02980692|567385483|FG004|Double-blind Follow-up Period|Other|3|||
157176356|NCT04702984|567385493|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
156972840|NCT00279201|566653139|FG001|Initiation|Physician Decision|18|||
156972841|NCT00279201|566653140|FG002|Initiation|Physician Decision|0|||
156972842|NCT00279201|566653141|FG003|Initiation|Physician Decision|0|||
156972843|NCT00279201|566653142|FG004|Initiation|Physician Decision|0|||
156972844|NCT00279201|566653143|FG005|Initiation|Physician Decision|0|||
156972845|NCT00279201|566653138|FG000|Initiation|Sponsor Decision|13|||
156972846|NCT00279201|566653139|FG001|Initiation|Sponsor Decision|5|||
156972847|NCT00279201|566653140|FG002|Initiation|Sponsor Decision|0|||
156972848|NCT00279201|566653141|FG003|Initiation|Sponsor Decision|0|||
156972849|NCT00279201|566653142|FG004|Initiation|Sponsor Decision|0|||
156972850|NCT00279201|566653143|FG005|Initiation|Sponsor Decision|0|||
156972851|NCT00279201|566653138|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156972852|NCT00279201|566653139|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
156972853|NCT00279201|566653140|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156972854|NCT00279201|566653141|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156972855|NCT00279201|566653142|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156972856|NCT00279201|566653143|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
156972857|NCT00279201|566653138|FG000|Maintenance|Lack of Efficacy|32|||
156972858|NCT00279201|566653139|FG001|Maintenance|Lack of Efficacy|30|||
156972859|NCT00279201|566653140|FG002|Maintenance|Lack of Efficacy|0|||
156972860|NCT00279201|566653141|FG003|Maintenance|Lack of Efficacy|0|||
156972861|NCT00279201|566653142|FG004|Maintenance|Lack of Efficacy|0|||
156972862|NCT00279201|566653143|FG005|Maintenance|Lack of Efficacy|0|||
156972863|NCT00279201|566653138|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
156972864|NCT00279201|566653139|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
156972865|NCT00279201|566653140|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156972866|NCT00279201|566653141|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156972867|NCT00279201|566653142|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156972868|NCT00279201|566653143|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
156972869|NCT00279201|566653138|FG000|Maintenance|Adverse Event|4|||
156972870|NCT00279201|566653139|FG001|Maintenance|Adverse Event|4|||
156972871|NCT00279201|566653140|FG002|Maintenance|Adverse Event|0|||
156972872|NCT00279201|566653141|FG003|Maintenance|Adverse Event|0|||
156972873|NCT00279201|566653142|FG004|Maintenance|Adverse Event|0|||
156972874|NCT00279201|566653143|FG005|Maintenance|Adverse Event|0|||
156972875|NCT00279201|566653138|FG000|Maintenance|Death|4|||
156972876|NCT00279201|566653139|FG001|Maintenance|Death|4|||
156972877|NCT00279201|566653140|FG002|Maintenance|Death|0|||
156972878|NCT00279201|566653141|FG003|Maintenance|Death|0|||
156972879|NCT00279201|566653142|FG004|Maintenance|Death|0|||
156972880|NCT00279201|566653143|FG005|Maintenance|Death|0|||
156972881|NCT00279201|566653138|FG000|Maintenance|Lost to Follow-up|17|||
156972882|NCT00279201|566653139|FG001|Maintenance|Lost to Follow-up|13|||
156972883|NCT00279201|566653140|FG002|Maintenance|Lost to Follow-up|0|||
156972884|NCT00279201|566653141|FG003|Maintenance|Lost to Follow-up|0|||
156972885|NCT00279201|566653142|FG004|Maintenance|Lost to Follow-up|0|||
156972886|NCT00279201|566653143|FG005|Maintenance|Lost to Follow-up|0|||
156972887|NCT00279201|566653138|FG000|Maintenance|Entry Criteria Exclusion|1|||
156972888|NCT00279201|566653139|FG001|Maintenance|Entry Criteria Exclusion|4|||
156972889|NCT00279201|566653140|FG002|Maintenance|Entry Criteria Exclusion|0|||
156972890|NCT00279201|566653141|FG003|Maintenance|Entry Criteria Exclusion|0|||
156972891|NCT00279201|566653142|FG004|Maintenance|Entry Criteria Exclusion|0|||
156972892|NCT00279201|566653143|FG005|Maintenance|Entry Criteria Exclusion|0|||
156972893|NCT00279201|566653138|FG000|Maintenance|Protocol Violation|16|||
156972894|NCT00279201|566653139|FG001|Maintenance|Protocol Violation|24|||
156972895|NCT00279201|566653140|FG002|Maintenance|Protocol Violation|0|||
156972896|NCT00279201|566653141|FG003|Maintenance|Protocol Violation|0|||
156972897|NCT00279201|566653142|FG004|Maintenance|Protocol Violation|0|||
156972898|NCT00279201|566653143|FG005|Maintenance|Protocol Violation|0|||
156972899|NCT00279201|566653138|FG000|Maintenance|Withdrawal by Subject|18|||
156972900|NCT00279201|566653139|FG001|Maintenance|Withdrawal by Subject|18|||
157176357|NCT03725293|567385494|FG000|Overall Study|Physician Decision|9|||
157050251|NCT02584257|566937235|FG006|Period 1|Withdrawal by Subject|1|||
157050252|NCT02584257|566937236|FG007|Period 1|Withdrawal by Subject|0|||
157050253|NCT02584257|566937237|FG008|Period 1|Withdrawal by Subject|0|||
157050254|NCT02584257|566937229|FG000|Period 2|Physician Decision|1|||
157050255|NCT02584257|566937230|FG001|Period 2|Physician Decision|0|||
157050256|NCT02584257|566937231|FG002|Period 2|Physician Decision|0|||
157050257|NCT02584257|566937232|FG003|Period 2|Physician Decision|0|||
157050258|NCT02584257|566937233|FG004|Period 2|Physician Decision|0|||
157050259|NCT02584257|566937234|FG005|Period 2|Physician Decision|0|||
157050260|NCT02584257|566937235|FG006|Period 2|Physician Decision|0|||
157050261|NCT02584257|566937236|FG007|Period 2|Physician Decision|0|||
157050262|NCT02584257|566937237|FG008|Period 2|Physician Decision|0|||
157050263|NCT02584257|566937229|FG000|Period 2|Adverse Event|0|||
157050264|NCT02584257|566937230|FG001|Period 2|Adverse Event|1|||
157050265|NCT02584257|566937231|FG002|Period 2|Adverse Event|0|||
157050266|NCT02584257|566937232|FG003|Period 2|Adverse Event|0|||
157050267|NCT02584257|566937233|FG004|Period 2|Adverse Event|0|||
157050268|NCT02584257|566937234|FG005|Period 2|Adverse Event|0|||
157050269|NCT02584257|566937235|FG006|Period 2|Adverse Event|0|||
157050270|NCT02584257|566937236|FG007|Period 2|Adverse Event|0|||
157050271|NCT02584257|566937237|FG008|Period 2|Adverse Event|0|||
157050272|NCT02309892|566937238|FG000|Overall Study|Physician Decision|1|||
157050273|NCT02309892|566937239|FG001|Overall Study|Physician Decision|0|||
157050274|NCT02309892|566937240|FG002|Overall Study|Physician Decision|0|||
157050275|NCT02309892|566937241|FG003|Overall Study|Physician Decision|0|||
157050276|NCT02309892|566937242|FG004|Overall Study|Physician Decision|0|||
157050277|NCT02309892|566937243|FG005|Overall Study|Physician Decision|0|||
157050278|NCT02309892|566937244|FG006|Overall Study|Physician Decision|0|||
157050279|NCT02309892|566937238|FG000|Overall Study|Adverse Event|1|||
157050280|NCT02309892|566937239|FG001|Overall Study|Adverse Event|0|||
157050281|NCT02309892|566937240|FG002|Overall Study|Adverse Event|1|||
157050282|NCT02309892|566937241|FG003|Overall Study|Adverse Event|0|||
157050283|NCT02309892|566937242|FG004|Overall Study|Adverse Event|0|||
157050284|NCT02309892|566937243|FG005|Overall Study|Adverse Event|0|||
157050285|NCT02309892|566937244|FG006|Overall Study|Adverse Event|0|||
157050286|NCT02309892|566937238|FG000|Overall Study|Progressive Disease|0|||
157050287|NCT02309892|566937239|FG001|Overall Study|Progressive Disease|1|||
157050288|NCT02309892|566937240|FG002|Overall Study|Progressive Disease|0|||
157050289|NCT02309892|566937241|FG003|Overall Study|Progressive Disease|0|||
157050290|NCT02309892|566937242|FG004|Overall Study|Progressive Disease|1|||
157050291|NCT02309892|566937243|FG005|Overall Study|Progressive Disease|0|||
157050292|NCT02309892|566937244|FG006|Overall Study|Progressive Disease|0|||
157050293|NCT02309892|566937238|FG000|Overall Study|Death|0|||
157050294|NCT02309892|566937239|FG001|Overall Study|Death|0|||
157050295|NCT02309892|566937240|FG002|Overall Study|Death|0|||
157050296|NCT02309892|566937241|FG003|Overall Study|Death|0|||
157050297|NCT02309892|566937242|FG004|Overall Study|Death|0|||
157050298|NCT02309892|566937243|FG005|Overall Study|Death|1|||
157050299|NCT02309892|566937244|FG006|Overall Study|Death|0|||
157050300|NCT02721147|566937247|FG000|Overall Study|Lost to Follow-up|2|||
157050301|NCT02721147|566937248|FG001|Overall Study|Lost to Follow-up|0|||
157050302|NCT02721147|566937249|FG002|Overall Study|Lost to Follow-up|0|||
157050303|NCT05376397|566937250|FG000|Overall Study|Lost to Follow-up|1|||
157050304|NCT01722097|566937251|FG000|Overall Study|Patient sheets not returned|6|||
157050305|NCT01722097|566937252|FG001|Overall Study|Patient sheets not returned|5|||
157050306|NCT01535261|566937254|FG000|Overall Study|Physician Decision|8|||
157050307|NCT01535261|566937254|FG000|Overall Study|Protocol Violation|3|||
157050308|NCT01535261|566937254|FG000|Overall Study|Death|5|||
157050309|NCT01535261|566937254|FG000|Overall Study|Lost to Follow-up|8|||
157050310|NCT01535261|566937254|FG000|Overall Study|Withdrawal by Subject|14|||
157050311|NCT01535261|566937254|FG000|Overall Study|Adverse Event|12|||
157050312|NCT01137682|566937257|FG000|Overall Study|Adverse Event-CORE|2|||
157050313|NCT01137682|566937258|FG001|Overall Study|Adverse Event-CORE|4|||
157050314|NCT01137682|566937259|FG002|Overall Study|Adverse Event-CORE|0|||
157050315|NCT01137682|566937257|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
157050316|NCT01137682|566937258|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
157050317|NCT01137682|566937259|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
157050318|NCT01137682|566937257|FG000|Overall Study|Administrative problems-CORE|2|||
157050319|NCT01137682|566937258|FG001|Overall Study|Administrative problems-CORE|1|||
157050320|NCT01137682|566937259|FG002|Overall Study|Administrative problems-CORE|0|||
157050321|NCT01137682|566937257|FG000|Overall Study|Protocol Violation-CORE|0|||
157050322|NCT01137682|566937258|FG001|Overall Study|Protocol Violation-CORE|1|||
157050323|NCT01137682|566937259|FG002|Overall Study|Protocol Violation-CORE|1|||
157050324|NCT01137682|566937257|FG000|Overall Study|Adverse Event-Extension|4|||
157050325|NCT01137682|566937258|FG001|Overall Study|Adverse Event-Extension|8|||
157050326|NCT01137682|566937259|FG002|Overall Study|Adverse Event-Extension|7|||
157050327|NCT01137682|566937257|FG000|Overall Study|Lack of Efficacy-Extension|15|||
157050328|NCT01137682|566937258|FG001|Overall Study|Lack of Efficacy-Extension|9|||
157050329|NCT01137682|566937259|FG002|Overall Study|Lack of Efficacy-Extension|13|||
157050330|NCT01137682|566937257|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
157050331|NCT01137682|566937258|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
157176358|NCT03725293|567385495|FG001|Overall Study|Physician Decision|6|||
157176359|NCT03725293|567385494|FG000|Overall Study|alternative vascular access needs|1|||
157176360|NCT03725293|567385495|FG001|Overall Study|alternative vascular access needs|2|||
157176361|NCT03725293|567385494|FG000|Overall Study|venous anatomy screen failures|2|||
157176362|NCT03725293|567385495|FG001|Overall Study|venous anatomy screen failures|1|||
157176363|NCT02143141|567385496|FG000|Overall Study|pain scores at 24 hours not collected|1|||
157176364|NCT02143141|567385497|FG001|Overall Study|pain scores at 24 hours not collected|0|||
157176365|NCT00064077|567385498|FG000|Overall Study|Improper prior treatment|1|||
157176366|NCT00064077|567385499|FG001|Overall Study|Improper prior treatment|0|||
157176367|NCT00064077|567385500|FG002|Overall Study|Improper prior treatment|0|||
156972901|NCT00279201|566653140|FG002|Maintenance|Withdrawal by Subject|0|||
156972902|NCT00279201|566653141|FG003|Maintenance|Withdrawal by Subject|0|||
156972903|NCT00279201|566653142|FG004|Maintenance|Withdrawal by Subject|0|||
156972904|NCT00279201|566653143|FG005|Maintenance|Withdrawal by Subject|0|||
156972905|NCT00279201|566653138|FG000|Maintenance|Physician Decision|9|||
156972906|NCT00279201|566653139|FG001|Maintenance|Physician Decision|9|||
156972907|NCT00279201|566653140|FG002|Maintenance|Physician Decision|0|||
156972908|NCT00279201|566653141|FG003|Maintenance|Physician Decision|0|||
156972909|NCT00279201|566653142|FG004|Maintenance|Physician Decision|0|||
156972910|NCT00279201|566653143|FG005|Maintenance|Physician Decision|0|||
156972911|NCT00279201|566653138|FG000|Maintenance|Sponsor Decision|4|||
156972912|NCT00279201|566653139|FG001|Maintenance|Sponsor Decision|0|||
156972913|NCT00279201|566653140|FG002|Maintenance|Sponsor Decision|0|||
156972914|NCT00279201|566653141|FG003|Maintenance|Sponsor Decision|0|||
156972915|NCT00279201|566653142|FG004|Maintenance|Sponsor Decision|0|||
156972916|NCT00279201|566653143|FG005|Maintenance|Sponsor Decision|0|||
156972917|NCT00279201|566653138|FG000|Maintenance|HbA1c>7.5%|123|||
156972918|NCT00279201|566653139|FG001|Maintenance|HbA1c>7.5%|126|||
156972919|NCT00279201|566653140|FG002|Maintenance|HbA1c>7.5%|0|||
156972920|NCT00279201|566653141|FG003|Maintenance|HbA1c>7.5%|0|||
156972921|NCT00279201|566653142|FG004|Maintenance|HbA1c>7.5%|0|||
156972922|NCT00279201|566653143|FG005|Maintenance|HbA1c>7.5%|0|||
156972923|NCT00279201|566653138|FG000|Intensification Addendum|Withdrawal by Subject|0|||
156972924|NCT00279201|566653139|FG001|Intensification Addendum|Withdrawal by Subject|0|||
156972925|NCT00279201|566653140|FG002|Intensification Addendum|Withdrawal by Subject|12|||
156972926|NCT00279201|566653141|FG003|Intensification Addendum|Withdrawal by Subject|14|||
156972927|NCT00279201|566653142|FG004|Intensification Addendum|Withdrawal by Subject|9|||
156972928|NCT00279201|566653143|FG005|Intensification Addendum|Withdrawal by Subject|18|||
156972929|NCT00279201|566653138|FG000|Intensification Addendum|Lost to Follow-up|0|||
156972930|NCT00279201|566653139|FG001|Intensification Addendum|Lost to Follow-up|0|||
156972931|NCT00279201|566653140|FG002|Intensification Addendum|Lost to Follow-up|4|||
156972932|NCT00279201|566653141|FG003|Intensification Addendum|Lost to Follow-up|6|||
156972933|NCT00279201|566653142|FG004|Intensification Addendum|Lost to Follow-up|7|||
156972934|NCT00279201|566653143|FG005|Intensification Addendum|Lost to Follow-up|7|||
156972935|NCT00279201|566653138|FG000|Intensification Addendum|Protocol Violation|0|||
156972936|NCT00279201|566653139|FG001|Intensification Addendum|Protocol Violation|0|||
156972937|NCT00279201|566653140|FG002|Intensification Addendum|Protocol Violation|2|||
156972938|NCT00279201|566653141|FG003|Intensification Addendum|Protocol Violation|2|||
156972939|NCT00279201|566653142|FG004|Intensification Addendum|Protocol Violation|6|||
156972940|NCT00279201|566653143|FG005|Intensification Addendum|Protocol Violation|6|||
156972941|NCT00279201|566653138|FG000|Intensification Addendum|Adverse Event|0|||
156972942|NCT00279201|566653139|FG001|Intensification Addendum|Adverse Event|0|||
156972943|NCT00279201|566653140|FG002|Intensification Addendum|Adverse Event|0|||
156972944|NCT00279201|566653141|FG003|Intensification Addendum|Adverse Event|4|||
156972945|NCT00279201|566653142|FG004|Intensification Addendum|Adverse Event|1|||
156972946|NCT00279201|566653143|FG005|Intensification Addendum|Adverse Event|3|||
156972947|NCT00279201|566653138|FG000|Intensification Addendum|Physician Decision|0|||
156972948|NCT00279201|566653139|FG001|Intensification Addendum|Physician Decision|0|||
156972949|NCT00279201|566653140|FG002|Intensification Addendum|Physician Decision|4|||
156972950|NCT00279201|566653141|FG003|Intensification Addendum|Physician Decision|1|||
156972951|NCT00279201|566653142|FG004|Intensification Addendum|Physician Decision|3|||
156972952|NCT00279201|566653143|FG005|Intensification Addendum|Physician Decision|2|||
156972953|NCT00279201|566653138|FG000|Intensification Addendum|Sponsor Decision|0|||
156972954|NCT00279201|566653139|FG001|Intensification Addendum|Sponsor Decision|0|||
156972955|NCT00279201|566653140|FG002|Intensification Addendum|Sponsor Decision|0|||
156972956|NCT00279201|566653141|FG003|Intensification Addendum|Sponsor Decision|0|||
156972957|NCT00279201|566653142|FG004|Intensification Addendum|Sponsor Decision|1|||
156972958|NCT00279201|566653143|FG005|Intensification Addendum|Sponsor Decision|1|||
156972959|NCT00279201|566653138|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
156972960|NCT00279201|566653139|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
156972961|NCT00279201|566653140|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
156972962|NCT00279201|566653141|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
156972963|NCT00279201|566653142|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
157176368|NCT00064077|567385501|FG003|Overall Study|Improper prior treatment|0|||
157176369|NCT00064077|567385498|FG000|Overall Study|Poor risk|2|||
157176370|NCT00064077|567385499|FG001|Overall Study|Poor risk|0|||
157176371|NCT00064077|567385500|FG002|Overall Study|Poor risk|1|||
157176372|NCT00064077|567385501|FG003|Overall Study|Poor risk|1|||
157176373|NCT00064077|567385498|FG000|Overall Study|Pathology|10|||
157176374|NCT00064077|567385499|FG001|Overall Study|Pathology|7|||
157176375|NCT00064077|567385500|FG002|Overall Study|Pathology|3|||
157176376|NCT00064077|567385501|FG003|Overall Study|Pathology|4|||
157176377|NCT00064077|567385498|FG000|Overall Study|No surgery|0|||
157176378|NCT00064077|567385499|FG001|Overall Study|No surgery|0|||
157176379|NCT00064077|567385500|FG002|Overall Study|No surgery|1|||
157176380|NCT00064077|567385501|FG003|Overall Study|No surgery|0|||
157176381|NCT00064077|567385498|FG000|Overall Study|No tumor|0|||
157176382|NCT00064077|567385499|FG001|Overall Study|No tumor|0|||
157176383|NCT00064077|567385500|FG002|Overall Study|No tumor|1|||
157176384|NCT00064077|567385501|FG003|Overall Study|No tumor|0|||
157176385|NCT00064077|567385498|FG000|Overall Study|Other reasons|2|||
157176386|NCT00064077|567385499|FG001|Overall Study|Other reasons|2|||
157050332|NCT01137682|566937259|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
157050333|NCT01137682|566937257|FG000|Overall Study|Lost to Follow Up-Extension|0|||
157050334|NCT01137682|566937258|FG001|Overall Study|Lost to Follow Up-Extension|1|||
157050335|NCT01137682|566937259|FG002|Overall Study|Lost to Follow Up-Extension|0|||
157050336|NCT01137682|566937257|FG000|Overall Study|Administrative problems-Extension|0|||
157050337|NCT01137682|566937258|FG001|Overall Study|Administrative problems-Extension|2|||
157050338|NCT01137682|566937259|FG002|Overall Study|Administrative problems-Extension|0|||
157050339|NCT01137682|566937257|FG000|Overall Study|Death-Extension|2|||
157050340|NCT01137682|566937258|FG001|Overall Study|Death-Extension|0|||
157050341|NCT01137682|566937259|FG002|Overall Study|Death-Extension|0|||
157050342|NCT01137682|566937257|FG000|Overall Study|Protocol Violation-Extension|2|||
157050343|NCT01137682|566937258|FG001|Overall Study|Protocol Violation-Extension|1|||
157050344|NCT01137682|566937259|FG002|Overall Study|Protocol Violation-Extension|0|||
157050345|NCT01137682|566937257|FG000|Overall Study|Did not enter extension|2|||
157050346|NCT01137682|566937258|FG001|Overall Study|Did not enter extension|3|||
157050347|NCT01137682|566937259|FG002|Overall Study|Did not enter extension|2|||
157050348|NCT01137682|566937257|FG000|Overall Study|Did not receive treatment in extension|0|||
157050349|NCT01137682|566937258|FG001|Overall Study|Did not receive treatment in extension|0|||
157050350|NCT01137682|566937259|FG002|Overall Study|Did not receive treatment in extension|1|||
157050351|NCT02009332|566937260|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
157050352|NCT02009332|566937261|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
157050353|NCT02009332|566937262|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
157050354|NCT02009332|566937263|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
157050355|NCT02009332|566937264|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
157050356|NCT02009332|566937265|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
157050357|NCT02009332|566937260|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
157050358|NCT02009332|566937261|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
157050359|NCT02009332|566937262|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
157176387|NCT00064077|567385500|FG002|Overall Study|Other reasons|1|||
157176388|NCT00064077|567385501|FG003|Overall Study|Other reasons|2|||
157176389|NCT01057862|567385502|FG000|Overall Study|Withdrawal by Subject|1|||
157176390|NCT01057862|567385503|FG001|Overall Study|Withdrawal by Subject|2|||
157176391|NCT02255760|567385504|FG000|Overall Study|Lost to Follow-up|0|||
157176392|NCT02255760|567385505|FG001|Overall Study|Lost to Follow-up|1|||
157176393|NCT02255760|567385506|FG002|Overall Study|Lost to Follow-up|0|||
157176394|NCT02255760|567385507|FG003|Overall Study|Lost to Follow-up|0|||
157176395|NCT02255760|567385508|FG004|Overall Study|Lost to Follow-up|0|||
157176396|NCT00003838|567385509|FG000|Overall Study|Death|0|||
157176397|NCT00003838|567385510|FG001|Overall Study|Death|12|||
157176398|NCT00003838|567385511|FG002|Overall Study|Death|7|||
157176399|NCT00003838|567385509|FG000|Overall Study|Lost to Follow-up|0|||
157176400|NCT00003838|567385510|FG001|Overall Study|Lost to Follow-up|1|||
157176401|NCT00003838|567385511|FG002|Overall Study|Lost to Follow-up|1|||
157176402|NCT00003838|567385509|FG000|Overall Study|Disease Progression|0|||
157176403|NCT00003838|567385510|FG001|Overall Study|Disease Progression|12|||
157176404|NCT00003838|567385511|FG002|Overall Study|Disease Progression|0|||
157176405|NCT00618813|567385512|FG000|Overall Study|Lack of Efficacy|1|||
157176406|NCT00618813|567385512|FG000|Overall Study|Physician Decision|2|||
157176407|NCT00618813|567385512|FG000|Overall Study|Withdrawal by Subject|1|||
157176408|NCT01809197|567385513|FG000|Overall Study|Lost to Follow-up|4|||
157050360|NCT02009332|566937263|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
157050361|NCT02009332|566937264|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
157176409|NCT01809197|567385514|FG001|Overall Study|Lost to Follow-up|2|||
157176410|NCT01809197|567385513|FG000|Overall Study|Adverse Event|2|||
157176411|NCT01809197|567385514|FG001|Overall Study|Adverse Event|3|||
157176412|NCT01809197|567385513|FG000|Overall Study|Failed slit lamp exam|1|||
157176413|NCT01809197|567385514|FG001|Overall Study|Failed slit lamp exam|0|||
157176414|NCT01809197|567385513|FG000|Overall Study|Non-Compliance|1|||
157176415|NCT01809197|567385514|FG001|Overall Study|Non-Compliance|1|||
157176416|NCT01809197|567385513|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
157176417|NCT01809197|567385514|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
157176418|NCT01809197|567385513|FG000|Overall Study|Withdrawal by Subject|1|||
157176419|NCT01809197|567385514|FG001|Overall Study|Withdrawal by Subject|1|||
156972964|NCT00279201|566653143|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
156972965|NCT00279201|566653138|FG000|Intensification Addendum|Lack of Efficacy|0|||
156972966|NCT00279201|566653139|FG001|Intensification Addendum|Lack of Efficacy|0|||
156972967|NCT00279201|566653140|FG002|Intensification Addendum|Lack of Efficacy|0|||
156972968|NCT00279201|566653141|FG003|Intensification Addendum|Lack of Efficacy|1|||
156972969|NCT00279201|566653142|FG004|Intensification Addendum|Lack of Efficacy|1|||
156972970|NCT00279201|566653143|FG005|Intensification Addendum|Lack of Efficacy|0|||
156972971|NCT00279201|566653138|FG000|Intensification Addendum|Death|0|||
156972972|NCT00279201|566653139|FG001|Intensification Addendum|Death|0|||
156972973|NCT00279201|566653140|FG002|Intensification Addendum|Death|0|||
156972974|NCT00279201|566653141|FG003|Intensification Addendum|Death|0|||
156972975|NCT00279201|566653142|FG004|Intensification Addendum|Death|1|||
156972976|NCT00279201|566653143|FG005|Intensification Addendum|Death|0|||
156972977|NCT04739761|566653154|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
156972978|NCT04739761|566653155|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
156972979|NCT04739761|566653154|FG000|Overall Study|By complete response from the participant|1|||
156972980|NCT04739761|566653155|FG001|Overall Study|By complete response from the participant|0|||
156972981|NCT04739761|566653154|FG000|Overall Study|Lost to Follow-up|3|||
156972982|NCT04739761|566653155|FG001|Overall Study|Lost to Follow-up|3|||
156972983|NCT04739761|566653154|FG000|Overall Study|Death|13|||
156972984|NCT04739761|566653155|FG001|Overall Study|Death|13|||
156972985|NCT04739761|566653154|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
156972986|NCT04739761|566653155|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
156972987|NCT04739761|566653154|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
156972988|NCT04739761|566653155|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
156972989|NCT04739761|566653154|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
156972990|NCT04739761|566653155|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
156972991|NCT04739761|566653154|FG000|Overall Study|Adverse Event|0|||
156972992|NCT04739761|566653155|FG001|Overall Study|Adverse Event|3|||
156972993|NCT04739761|566653154|FG000|Overall Study|Participant decision|1|||
156972994|NCT04739761|566653155|FG001|Overall Study|Participant decision|0|||
156972995|NCT04739761|566653154|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
156972996|NCT04739761|566653155|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
156972997|NCT04739761|566653154|FG000|Overall Study|Participant immediately started next line of treatment|1|||
156972998|NCT04739761|566653155|FG001|Overall Study|Participant immediately started next line of treatment|0|||
156972999|NCT04739761|566653154|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
156973000|NCT04739761|566653155|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
156973001|NCT04739761|566653154|FG000|Overall Study|Lack of clinical benefit|1|||
156973002|NCT04739761|566653155|FG001|Overall Study|Lack of clinical benefit|0|||
156973003|NCT04739761|566653154|FG000|Overall Study|Disease progression|5|||
156973004|NCT04739761|566653155|FG001|Overall Study|Disease progression|5|||
156973005|NCT04739761|566653154|FG000|Overall Study|Withdrawal by Subject|14|||
156973006|NCT04739761|566653155|FG001|Overall Study|Withdrawal by Subject|13|||
156973007|NCT04739761|566653154|FG000|Overall Study|Protocol Violation|1|||
156973008|NCT04739761|566653155|FG001|Overall Study|Protocol Violation|0|||
156973009|NCT04739761|566653154|FG000|Overall Study|Physician Decision|2|||
156973010|NCT04739761|566653155|FG001|Overall Study|Physician Decision|0|||
156973011|NCT03881696|566653156|FG000|Overall Study|Adverse Event|2|||
156973012|NCT03881696|566653157|FG001|Overall Study|Adverse Event|0|||
156973013|NCT03881696|566653156|FG000|Overall Study|Withdrawal by Subject|2|||
156973014|NCT03881696|566653157|FG001|Overall Study|Withdrawal by Subject|0|||
156973015|NCT03881696|566653156|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
156973016|NCT03881696|566653157|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
156973017|NCT03881696|566653156|FG000|Overall Study|Failure to meet continuation criteria|1|||
156973018|NCT03881696|566653157|FG001|Overall Study|Failure to meet continuation criteria|0|||
156973019|NCT00856167|566653159|FG000|Period 1|Withdrawal by Subject|1|||
156973020|NCT00856167|566653160|FG001|Period 1|Withdrawal by Subject|4|||
156973021|NCT00856167|566653161|FG002|Period 1|Withdrawal by Subject|0|||
156973022|NCT00856167|566653162|FG003|Period 1|Withdrawal by Subject|0|||
156973023|NCT00856167|566653159|FG000|Period 1|Lost to Follow-up|2|||
156973024|NCT00856167|566653160|FG001|Period 1|Lost to Follow-up|1|||
156973025|NCT00856167|566653161|FG002|Period 1|Lost to Follow-up|0|||
156973026|NCT00856167|566653162|FG003|Period 1|Lost to Follow-up|0|||
156973027|NCT00856167|566653159|FG000|Period 2|Lost to Follow-up|0|||
156973028|NCT00856167|566653160|FG001|Period 2|Lost to Follow-up|0|||
157176420|NCT01809197|567385513|FG000|Overall Study|Product not available|0|||
156973029|NCT00856167|566653161|FG002|Period 2|Lost to Follow-up|3|||
156973030|NCT00856167|566653162|FG003|Period 2|Lost to Follow-up|1|||
156973031|NCT00856167|566653159|FG000|Period 2|Withdrawal by Subject|0|||
157050362|NCT02009332|566937265|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
157050363|NCT02009332|566937260|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
157050364|NCT02009332|566937261|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
157050365|NCT02009332|566937262|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
157050366|NCT02009332|566937263|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
157050367|NCT02009332|566937264|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
157050368|NCT02009332|566937265|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
157050369|NCT01912599|566937266|FG000|Overall Study|Withdrawal by Subject|0|||
157229333|NCT03561883|567585230|FG000|Overall Study|Withdrawal by Subject|14|||
157050370|NCT01912599|566937267|FG001|Overall Study|Withdrawal by Subject|1|||
157050371|NCT01280721|566937271|FG000|Overall Study|Adverse Event|4|||
157050372|NCT01280721|566937271|FG000|Overall Study|Physician Decision|3|||
157050373|NCT01280721|566937271|FG000|Overall Study|Withdrawal by Subject|6|||
157050374|NCT01280721|566937271|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
157050375|NCT01280721|566937271|FG000|Overall Study|No tolerability for the lowest dose|2|||
157050376|NCT01180400|566937272|FG000|Overall Study|Withdrawal by Subject|5|||
157050377|NCT01180400|566937273|FG001|Overall Study|Withdrawal by Subject|6|||
157050378|NCT01180400|566937272|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157050379|NCT01180400|566937273|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
157050380|NCT01180400|566937272|FG000|Overall Study|Adverse Event|12|||
157050381|NCT01180400|566937273|FG001|Overall Study|Adverse Event|10|||
157050382|NCT01180400|566937272|FG000|Overall Study|Severe non-compliance to protocol|1|||
157050383|NCT01180400|566937273|FG001|Overall Study|Severe non-compliance to protocol|2|||
157050384|NCT01180400|566937272|FG000|Overall Study|Condition under investigation worsened|2|||
157050385|NCT01180400|566937273|FG001|Overall Study|Condition under investigation worsened|1|||
157050386|NCT01180400|566937272|FG000|Overall Study|Lack of Efficacy|2|||
157050387|NCT01180400|566937273|FG001|Overall Study|Lack of Efficacy|0|||
157050388|NCT01180400|566937272|FG000|Overall Study|Study-specific withdrawal criteria|1|||
157050389|NCT01180400|566937273|FG001|Overall Study|Study-specific withdrawal criteria|2|||
157050390|NCT01180400|566937272|FG000|Overall Study|Lost to Follow-up|2|||
157050391|NCT01180400|566937273|FG001|Overall Study|Lost to Follow-up|3|||
157050392|NCT01180400|566937272|FG000|Overall Study|Other|0|||
157050393|NCT01180400|566937273|FG001|Overall Study|Other|1|||
157050394|NCT03449979|566937275|FG000|Overall Study|Technical difficulty|0|||
157050395|NCT03449979|566937276|FG001|Overall Study|Technical difficulty|0|||
157050396|NCT03449979|566937277|FG002|Overall Study|Technical difficulty|0|||
157050397|NCT03449979|566937278|FG003|Overall Study|Technical difficulty|1|||
157050398|NCT03481725|566937279|FG000|Overall Study|Withdrawal by Subject|1|||
157050399|NCT03481725|566937280|FG001|Overall Study|Withdrawal by Subject|0|||
157050400|NCT02206607|566937283|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
157050401|NCT02206607|566937284|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
157050402|NCT02206607|566937285|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
157050403|NCT02206607|566937286|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
157050404|NCT02206607|566937287|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
157050405|NCT02206607|566937283|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
157050406|NCT02206607|566937284|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
157050407|NCT02206607|566937285|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
157050408|NCT02206607|566937286|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
157050409|NCT02206607|566937287|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
157050410|NCT00424476|566937298|FG000|Overall Study|Withdrawal by Subject|7|||
157050411|NCT00424476|566937299|FG001|Overall Study|Withdrawal by Subject|6|||
157050412|NCT00424476|566937300|FG002|Overall Study|Withdrawal by Subject|3|||
157050413|NCT00424476|566937298|FG000|Overall Study|Adverse Event|19|||
157050414|NCT00424476|566937299|FG001|Overall Study|Adverse Event|16|||
157050415|NCT00424476|566937300|FG002|Overall Study|Adverse Event|15|||
157050416|NCT00424476|566937298|FG000|Overall Study|Lack of Efficacy|16|||
157050417|NCT00424476|566937299|FG001|Overall Study|Lack of Efficacy|12|||
157050418|NCT00424476|566937300|FG002|Overall Study|Lack of Efficacy|12|||
157050419|NCT00424476|566937298|FG000|Overall Study|Lack of Compliance|1|||
157050420|NCT00424476|566937299|FG001|Overall Study|Lack of Compliance|1|||
157050421|NCT00424476|566937300|FG002|Overall Study|Lack of Compliance|1|||
157050422|NCT00424476|566937298|FG000|Overall Study|Lost to Follow-up|4|||
157050423|NCT00424476|566937299|FG001|Overall Study|Lost to Follow-up|6|||
157050424|NCT00424476|566937300|FG002|Overall Study|Lost to Follow-up|3|||
157050425|NCT00424476|566937298|FG000|Overall Study|Protocol Violation|7|||
157050426|NCT00424476|566937299|FG001|Overall Study|Protocol Violation|2|||
157050427|NCT00424476|566937300|FG002|Overall Study|Protocol Violation|3|||
157050428|NCT00424476|566937298|FG000|Overall Study|Physician Decision|3|||
157050429|NCT00424476|566937299|FG001|Overall Study|Physician Decision|2|||
157050430|NCT00424476|566937300|FG002|Overall Study|Physician Decision|3|||
157050431|NCT00424476|566937298|FG000|Overall Study|Other|4|||
157050432|NCT00424476|566937299|FG001|Overall Study|Other|3|||
157050433|NCT00424476|566937300|FG002|Overall Study|Other|9|||
157050434|NCT00657709|566937301|FG000|Overall Study|AE or Death|7|||
157050435|NCT00657709|566937302|FG001|Overall Study|AE or Death|7|||
157050436|NCT00657709|566937303|FG002|Overall Study|AE or Death|6|||
157176421|NCT01809197|567385514|FG001|Overall Study|Product not available|1|||
157176422|NCT00425113|567385515|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
157176423|NCT00425113|567385516|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
157176424|NCT00425113|567385515|FG000|Overall Study|diagnosis of abdominal TB|0|||
157176425|NCT00425113|567385516|FG001|Overall Study|diagnosis of abdominal TB|1|||
157176426|NCT00425113|567385515|FG000|Overall Study|missing study drug more than 14 days|0|||
157176427|NCT00425113|567385516|FG001|Overall Study|missing study drug more than 14 days|1|||
157176428|NCT00425113|567385515|FG000|Overall Study|Withdrawal by Subject|1|||
157176429|NCT00425113|567385516|FG001|Overall Study|Withdrawal by Subject|0|||
157176430|NCT00268463|567385517|FG000|Overall Study|study terminated due to low accrual|10|||
157176431|NCT00268463|567385518|FG001|Overall Study|study terminated due to low accrual|12|||
157176432|NCT03495817|567385519|FG000|26 Week Open Label|Adverse Event|3|||
157176433|NCT03495817|567385519|FG000|26 Week Open Label|Withdrawal by Subject|4|||
157176434|NCT03495817|567385519|FG000|26 Week Open Label|Lost to Follow-up|1|||
157050437|NCT00657709|566937304|FG003|Overall Study|AE or Death|7|||
157050438|NCT00657709|566937305|FG004|Overall Study|AE or Death|1|||
157050439|NCT00657709|566937301|FG000|Overall Study|Withdrawal by Subject|7|||
157050440|NCT00657709|566937302|FG001|Overall Study|Withdrawal by Subject|15|||
157050441|NCT00657709|566937303|FG002|Overall Study|Withdrawal by Subject|15|||
157050442|NCT00657709|566937304|FG003|Overall Study|Withdrawal by Subject|5|||
157050443|NCT00657709|566937305|FG004|Overall Study|Withdrawal by Subject|9|||
157050444|NCT00657709|566937301|FG000|Overall Study|Lost to Follow-up|9|||
157050445|NCT00657709|566937302|FG001|Overall Study|Lost to Follow-up|9|||
157050446|NCT00657709|566937303|FG002|Overall Study|Lost to Follow-up|7|||
157050447|NCT00657709|566937304|FG003|Overall Study|Lost to Follow-up|1|||
157050448|NCT00657709|566937305|FG004|Overall Study|Lost to Follow-up|21|||
157050449|NCT00657709|566937301|FG000|Overall Study|Protocol Violation|0|||
157050450|NCT00657709|566937302|FG001|Overall Study|Protocol Violation|2|||
157050451|NCT00657709|566937303|FG002|Overall Study|Protocol Violation|0|||
157050452|NCT00657709|566937304|FG003|Overall Study|Protocol Violation|1|||
157050453|NCT00657709|566937305|FG004|Overall Study|Protocol Violation|2|||
157050454|NCT01441596|566937306|FG000|Overall Study|Other reason not defined below|0|||
157050455|NCT01441596|566937307|FG001|Overall Study|Other reason not defined below|2|||
157050456|NCT01441596|566937308|FG002|Overall Study|Other reason not defined below|1|||
157050457|NCT01441596|566937306|FG000|Overall Study|Withdrawal by Subject|4|||
157050458|NCT01441596|566937307|FG001|Overall Study|Withdrawal by Subject|0|||
157050459|NCT01441596|566937308|FG002|Overall Study|Withdrawal by Subject|2|||
157050460|NCT01441596|566937306|FG000|Overall Study|Not treated|0|||
157050461|NCT01441596|566937307|FG001|Overall Study|Not treated|1|||
157050462|NCT01441596|566937308|FG002|Overall Study|Not treated|1|||
157050463|NCT03055988|566937309|FG000|Period 1|Adverse Event|0|||
157050464|NCT03055988|566937310|FG001|Period 1|Adverse Event|1|||
157050465|NCT03055988|566937309|FG000|Period 1|Lost to Follow-up|1|||
157050466|NCT03055988|566937310|FG001|Period 1|Lost to Follow-up|0|||
157050467|NCT03055988|566937309|FG000|Period 1|Withdrawal by Subject|0|||
157050468|NCT03055988|566937310|FG001|Period 1|Withdrawal by Subject|4|||
157050469|NCT03055988|566937309|FG000|Period 2|Adverse Event|0|||
157050470|NCT03055988|566937310|FG001|Period 2|Adverse Event|1|||
157050471|NCT03055988|566937309|FG000|Period 2|Other than listed|1|||
157050472|NCT03055988|566937310|FG001|Period 2|Other than listed|1|||
157050473|NCT01528605|566937311|FG000|Overall Study|Lost to Follow-up|1|||
157050474|NCT01528605|566937312|FG001|Overall Study|Lost to Follow-up|0|||
157050475|NCT01528605|566937313|FG002|Overall Study|Lost to Follow-up|1|||
157050476|NCT01528605|566937314|FG003|Overall Study|Lost to Follow-up|1|||
157050477|NCT01528605|566937315|FG004|Overall Study|Lost to Follow-up|0|||
157050478|NCT01528605|566937316|FG005|Overall Study|Lost to Follow-up|0|||
157176435|NCT03495817|567385519|FG000|26 Week Extension|Lost to Follow-up|2|||
157176436|NCT01686958|567385520|FG000|Overall Study|Withdrawal by Subject|1|||
157176437|NCT02224638|567385532|FG000|Overall Study|Adverse Event|1|||
157050479|NCT01528605|566937311|FG000|Overall Study|Death|1|||
157050480|NCT01528605|566937312|FG001|Overall Study|Death|0|||
157050481|NCT01528605|566937313|FG002|Overall Study|Death|0|||
157050482|NCT01528605|566937314|FG003|Overall Study|Death|0|||
157050483|NCT01528605|566937315|FG004|Overall Study|Death|0|||
157050484|NCT01528605|566937316|FG005|Overall Study|Death|0|||
157176438|NCT02224638|567385533|FG001|Overall Study|Adverse Event|1|||
157176439|NCT01406652|567385534|FG000|Overall Study|Lost-to-follow-up|3|||
157176440|NCT01406652|567385535|FG001|Overall Study|Lost-to-follow-up|4|||
157050485|NCT01681511|566937317|FG000|Overall Study|No Treatment Received|1|||
157050486|NCT01681511|566937318|FG001|Overall Study|No Treatment Received|3|||
157176441|NCT01406652|567385534|FG000|Overall Study|Withdrawal by Subject|2|||
157176442|NCT01406652|567385535|FG001|Overall Study|Withdrawal by Subject|2|||
157176443|NCT01406652|567385534|FG000|Overall Study|Insufficient follow-up|5|||
157176444|NCT01406652|567385535|FG001|Overall Study|Insufficient follow-up|4|||
157050487|NCT01681511|566937317|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
157050488|NCT01681511|566937318|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
157050489|NCT01681511|566937317|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
157050490|NCT01681511|566937318|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
157050491|NCT01681511|566937317|FG000|Overall Study|No Daily Urine Sample Collected|0|||
157050492|NCT01681511|566937318|FG001|Overall Study|No Daily Urine Sample Collected|1|||
157050493|NCT01681511|566937317|FG000|Overall Study|No post-catheter sample collected|11|||
157050494|NCT01681511|566937318|FG001|Overall Study|No post-catheter sample collected|4|||
157050495|NCT01156675|566937319|FG000|Overall Study|Death|5|||
157050496|NCT01156675|566937320|FG001|Overall Study|Death|3|||
157050497|NCT01156675|566937321|FG002|Overall Study|Death|0|||
157050498|NCT01156675|566937319|FG000|Overall Study|No data|29|||
157050499|NCT01156675|566937320|FG001|Overall Study|No data|22|||
157050500|NCT01156675|566937321|FG002|Overall Study|No data|2|||
157050501|NCT00090519|566937335|FG000|Overall Study|Adverse Event|5|||
157050502|NCT00090519|566937336|FG001|Overall Study|Adverse Event|4|||
157050503|NCT00090519|566937335|FG000|Overall Study|Death|9|||
157050504|NCT00090519|566937336|FG001|Overall Study|Death|9|||
157050505|NCT00090519|566937335|FG000|Overall Study|Lost to Follow-up|26|||
157050506|NCT00090519|566937336|FG001|Overall Study|Lost to Follow-up|29|||
157050507|NCT00090519|566937335|FG000|Overall Study|Withdrawal by Subject|28|||
157050508|NCT00090519|566937336|FG001|Overall Study|Withdrawal by Subject|29|||
157050509|NCT00090519|566937335|FG000|Overall Study|Physician Decision|2|||
157050510|NCT00090519|566937336|FG001|Overall Study|Physician Decision|3|||
157050511|NCT00090519|566937335|FG000|Overall Study|Sponsor Decision|3|||
157050512|NCT00090519|566937336|FG001|Overall Study|Sponsor Decision|1|||
157050513|NCT00116649|566937337|FG000|Overall Study|Adverse Event|20|||
157050514|NCT00116649|566937337|FG000|Overall Study|Lack of Efficacy|1|||
157050515|NCT00116649|566937337|FG000|Overall Study|Lost to Follow-up|32|||
157050516|NCT00116649|566937337|FG000|Overall Study|Withdrawal by Subject|68|||
157050517|NCT00116649|566937337|FG000|Overall Study|Local Skin Reaction|9|||
157050518|NCT00116649|566937337|FG000|Overall Study|Various Reasons|18|||
157050519|NCT00116649|566937337|FG000|Overall Study|Protocol Specified|7|||
157050520|NCT02161146|566937338|FG000|Overall Study|Adverse Event|1|||
157050521|NCT02161146|566937339|FG001|Overall Study|Adverse Event|1|||
157050522|NCT02161146|566937340|FG002|Overall Study|Adverse Event|0|||
157050523|NCT02161146|566937341|FG003|Overall Study|Adverse Event|1|||
157050524|NCT02161146|566937342|FG004|Overall Study|Adverse Event|0|||
157050525|NCT02161146|566937338|FG000|Overall Study|Lost to Follow-up|0|||
157050526|NCT02161146|566937339|FG001|Overall Study|Lost to Follow-up|1|||
157050527|NCT02161146|566937340|FG002|Overall Study|Lost to Follow-up|0|||
157050528|NCT02161146|566937341|FG003|Overall Study|Lost to Follow-up|0|||
157050529|NCT02161146|566937342|FG004|Overall Study|Lost to Follow-up|0|||
157050530|NCT02161146|566937338|FG000|Overall Study|Personal Reasons|0|||
157050531|NCT02161146|566937339|FG001|Overall Study|Personal Reasons|1|||
157050532|NCT02161146|566937340|FG002|Overall Study|Personal Reasons|0|||
157050533|NCT02161146|566937341|FG003|Overall Study|Personal Reasons|2|||
157050534|NCT02161146|566937342|FG004|Overall Study|Personal Reasons|1|||
157050535|NCT02161146|566937338|FG000|Overall Study|Other Miscellaneous Reasons|0|||
157050536|NCT02161146|566937339|FG001|Overall Study|Other Miscellaneous Reasons|1|||
157050537|NCT02161146|566937340|FG002|Overall Study|Other Miscellaneous Reasons|0|||
157050538|NCT02161146|566937341|FG003|Overall Study|Other Miscellaneous Reasons|0|||
157050539|NCT02161146|566937342|FG004|Overall Study|Other Miscellaneous Reasons|0|||
157050540|NCT00845520|566937343|FG000|Overall Study|Death|1|||
157050541|NCT00845520|566937344|FG001|Overall Study|Death|2|||
157050542|NCT00845520|566937345|FG002|Overall Study|Death|0|||
157050543|NCT00845520|566937343|FG000|Overall Study|Lost to Follow-up|1|||
157050544|NCT00845520|566937344|FG001|Overall Study|Lost to Follow-up|0|||
157050545|NCT00845520|566937345|FG002|Overall Study|Lost to Follow-up|0|||
157050546|NCT00845520|566937343|FG000|Overall Study|Adverse Event|0|||
157050547|NCT00845520|566937344|FG001|Overall Study|Adverse Event|0|||
157050548|NCT00845520|566937345|FG002|Overall Study|Adverse Event|1|||
157050549|NCT02613403|566937346|FG000|Overall Study|Lost to Follow-up|0|||
157050550|NCT02613403|566937347|FG001|Overall Study|Lost to Follow-up|1|||
157176445|NCT01406652|567385534|FG000|Overall Study|Infection not sure|10|||
157176446|NCT01406652|567385535|FG001|Overall Study|Infection not sure|10|||
157050551|NCT02613403|566937348|FG002|Overall Study|Lost to Follow-up|0|||
157050552|NCT02613403|566937349|FG003|Overall Study|Lost to Follow-up|0|||
157176447|NCT01400139|567385542|FG000|HYD Core Study|Adverse Event|210|||
157050553|NCT02613403|566937350|FG004|Overall Study|Lost to Follow-up|0|||
157050554|NCT02613403|566937346|FG000|Overall Study|Withdrawal by Subject|2|||
157050555|NCT02613403|566937347|FG001|Overall Study|Withdrawal by Subject|0|||
157050556|NCT02613403|566937348|FG002|Overall Study|Withdrawal by Subject|0|||
157050557|NCT02613403|566937349|FG003|Overall Study|Withdrawal by Subject|0|||
157050558|NCT02613403|566937350|FG004|Overall Study|Withdrawal by Subject|0|||
157050559|NCT00800176|566937351|FG000|Overall Study|Adverse Event|2|||
157050560|NCT00800176|566937352|FG001|Overall Study|Adverse Event|1|||
157050561|NCT00800176|566937353|FG002|Overall Study|Adverse Event|0|||
157050562|NCT00800176|566937354|FG003|Overall Study|Adverse Event|2|||
157050563|NCT00800176|566937355|FG004|Overall Study|Adverse Event|1|||
157050564|NCT00800176|566937356|FG005|Overall Study|Adverse Event|1|||
157050565|NCT00800176|566937351|FG000|Overall Study|Refused treatment|3|||
157050566|NCT00800176|566937352|FG001|Overall Study|Refused treatment|2|||
157176448|NCT01400139|567385542|FG000|HYD Core Study|Lack of Efficacy|59|||
157050567|NCT00800176|566937353|FG002|Overall Study|Refused treatment|0|||
157050568|NCT00800176|566937354|FG003|Overall Study|Refused treatment|0|||
157050569|NCT00800176|566937355|FG004|Overall Study|Refused treatment|1|||
157050570|NCT00800176|566937356|FG005|Overall Study|Refused treatment|4|||
157050571|NCT00800176|566937351|FG000|Overall Study|Failure to return|3|||
157050572|NCT00800176|566937352|FG001|Overall Study|Failure to return|3|||
157050573|NCT00800176|566937353|FG002|Overall Study|Failure to return|0|||
157050574|NCT00800176|566937354|FG003|Overall Study|Failure to return|2|||
157050575|NCT00800176|566937355|FG004|Overall Study|Failure to return|0|||
157050576|NCT00800176|566937356|FG005|Overall Study|Failure to return|0|||
157050577|NCT00800176|566937351|FG000|Overall Study|Other|1|||
157050578|NCT00800176|566937352|FG001|Overall Study|Other|0|||
157050579|NCT00800176|566937353|FG002|Overall Study|Other|0|||
157050580|NCT00800176|566937354|FG003|Overall Study|Other|0|||
157050581|NCT00800176|566937355|FG004|Overall Study|Other|2|||
157050582|NCT00800176|566937356|FG005|Overall Study|Other|0|||
157050583|NCT02659540|566937359|FG000|Overall Study|Adverse Event|3|||
157050584|NCT02659540|566937360|FG001|Overall Study|Adverse Event|2|||
157050585|NCT02659540|566937359|FG000|Overall Study|Death|1|||
157050586|NCT02659540|566937360|FG001|Overall Study|Death|0|||
157050587|NCT02659540|566937359|FG000|Overall Study|Progressive disease|2|||
157050588|NCT02659540|566937360|FG001|Overall Study|Progressive disease|6|||
157050589|NCT04914897|566938922|FG000|Overall Study|Withdrawal by Subject|3|||
157050590|NCT04914897|566938923|FG001|Overall Study|Withdrawal by Subject|1|||
157050591|NCT04914897|566938924|FG002|Overall Study|Withdrawal by Subject|1|||
157050592|NCT04914897|566938925|FG003|Overall Study|Withdrawal by Subject|1|||
157050593|NCT04914897|566938922|FG000|Overall Study|Poor compliance to protocol|0|||
157050594|NCT04914897|566938923|FG001|Overall Study|Poor compliance to protocol|0|||
157050595|NCT04914897|566938924|FG002|Overall Study|Poor compliance to protocol|1|||
157050596|NCT04914897|566938925|FG003|Overall Study|Poor compliance to protocol|0|||
157050597|NCT04914897|566938922|FG000|Overall Study|Progressive disease|5|||
157050598|NCT04914897|566938923|FG001|Overall Study|Progressive disease|14|||
157050599|NCT04914897|566938924|FG002|Overall Study|Progressive disease|30|||
157050600|NCT04914897|566938925|FG003|Overall Study|Progressive disease|21|||
157050601|NCT04914897|566938922|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
157050602|NCT04914897|566938923|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
157050603|NCT04914897|566938924|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
157050604|NCT04914897|566938925|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
157050605|NCT04914897|566938922|FG000|Overall Study|Other|1|||
157050606|NCT04914897|566938923|FG001|Overall Study|Other|0|||
157050607|NCT04914897|566938924|FG002|Overall Study|Other|0|||
157050608|NCT04914897|566938925|FG003|Overall Study|Other|1|||
157050609|NCT03020914|566938926|FG000|Overall Study|Surgery Cancelled|1|||
157050610|NCT03020914|566938927|FG001|Overall Study|Surgery Cancelled|0|||
157050611|NCT00451906|566938934|FG000|Overall Study|Adverse Event|515|||
157050612|NCT00451906|566938934|FG000|Overall Study|Lost to Follow-up|31|||
157050613|NCT00451906|566938934|FG000|Overall Study|Withdrawal by Subject|111|||
157050614|NCT00451906|566938934|FG000|Overall Study|Protocol Violation|21|||
157050615|NCT00451906|566938934|FG000|Overall Study|Progressive disease|1328|||
157050616|NCT00451906|566938934|FG000|Overall Study|Termination of the study|108|||
157050617|NCT00451906|566938934|FG000|Overall Study|Other Reasons|121|||
157050618|NCT00451906|566938934|FG000|Overall Study|Did not complete final visit|4|||
157050619|NCT05066230|566938935|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
157050620|NCT05066230|566938936|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
157050621|NCT05066230|566938935|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
157050622|NCT05066230|566938936|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
157050623|NCT05066230|566938935|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
157176449|NCT01400139|567385542|FG000|HYD Core Study|Withdrawal by Subject|114|||
157176450|NCT01400139|567385542|FG000|HYD Core Study|Lost to Follow-up|39|||
157176451|NCT01400139|567385542|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
157176452|NCT01400139|567385542|FG000|HYD Core Study|Administrative|56|||
157176453|NCT01400139|567385542|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
157176454|NCT01400139|567385542|FG000|HYD Extension Period|Adverse Event|8|||
157050624|NCT05066230|566938936|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
157050625|NCT05066230|566938935|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
157050626|NCT05066230|566938936|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
157050627|NCT05066230|566938935|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
157050628|NCT05066230|566938936|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
157176455|NCT01400139|567385542|FG000|HYD Extension Period|Withdrawal by Subject|5|||
157176456|NCT01400139|567385542|FG000|HYD Extension Period|Administrative|10|||
157050629|NCT05066230|566938935|FG000|After Week 48|Adverse Event|1|||
157050630|NCT05066230|566938936|FG001|After Week 48|Adverse Event|0|||
157050631|NCT05066230|566938935|FG000|After Week 48|Non-compliance with study schedule|1|||
157050632|NCT05066230|566938936|FG001|After Week 48|Non-compliance with study schedule|0|||
157176457|NCT00994162|567385543|FG000|Overall Study|Withdrawal by Subject|1|||
157176458|NCT00994162|567385543|FG000|Overall Study|Lost to Follow-up|2|||
157050633|NCT05066230|566938935|FG000|After Week 48|Withdrawal by Subject|0|||
157050634|NCT05066230|566938936|FG001|After Week 48|Withdrawal by Subject|1|||
157050635|NCT05066230|566938935|FG000|After Week 48|Lost to Follow-up|3|||
157050636|NCT05066230|566938936|FG001|After Week 48|Lost to Follow-up|3|||
157050637|NCT05066230|566938935|FG000|After Week 48|Sponsor Request|115|||
157050638|NCT05066230|566938936|FG001|After Week 48|Sponsor Request|111|||
157050639|NCT03072238|566938937|FG000|Overall Study|Withdrawal by Subject|44|||
157050640|NCT03072238|566938938|FG001|Overall Study|Withdrawal by Subject|64|||
157050641|NCT03072238|566938937|FG000|Overall Study|Lost to Follow-up|14|||
157050642|NCT03072238|566938938|FG001|Overall Study|Lost to Follow-up|5|||
157050643|NCT03072238|566938937|FG000|Overall Study|Physician Decision|4|||
157050644|NCT03072238|566938938|FG001|Overall Study|Physician Decision|6|||
157050645|NCT03072238|566938937|FG000|Overall Study|Death|351|||
157050646|NCT03072238|566938938|FG001|Overall Study|Death|318|||
157050647|NCT03072238|566938937|FG000|Overall Study|Progressive Disease|3|||
157050648|NCT03072238|566938938|FG001|Overall Study|Progressive Disease|4|||
157050649|NCT03072238|566938937|FG000|Overall Study|Reason Not Specified|138|||
157050650|NCT03072238|566938938|FG001|Overall Study|Reason Not Specified|150|||
157050651|NCT02889900|566938942|FG000|Overall Study|Adverse Event|11|||
157050652|NCT02889900|566938942|FG000|Overall Study|Condition under investigation worsened|32|||
157050653|NCT02889900|566938942|FG000|Overall Study|Other|5|||
157050654|NCT02889900|566938942|FG000|Overall Study|Withdrawal by Subject|7|||
157050655|NCT02889900|566938942|FG000|Overall Study|Not treated|2|||
157050656|NCT01416285|566938943|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
157050657|NCT01416285|566938944|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
157050658|NCT01005602|566938945|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
157050659|NCT01005602|566938946|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
157050660|NCT01131325|566938949|FG000|Overall Study|Adverse Event|1|||
157050661|NCT01131325|566938949|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
157050662|NCT03761849|566938950|FG000|Overall Study|transferred to OpenLabelExtension|35|||
157050663|NCT03761849|566938951|FG001|Overall Study|transferred to OpenLabelExtension|34|||
157050664|NCT03761849|566938952|FG002|Overall Study|transferred to OpenLabelExtension|36|||
157050665|NCT03761849|566938953|FG003|Overall Study|transferred to OpenLabelExtension|0|||
157050666|NCT03761849|566938954|FG004|Overall Study|transferred to OpenLabelExtension|0|||
157050667|NCT03761849|566938955|FG005|Overall Study|transferred to OpenLabelExtension|0|||
157050668|NCT03761849|566938950|FG000|Overall Study|Adverse Event|1|||
157050669|NCT03761849|566938951|FG001|Overall Study|Adverse Event|0|||
157050670|NCT03761849|566938952|FG002|Overall Study|Adverse Event|0|||
157050671|NCT03761849|566938953|FG003|Overall Study|Adverse Event|0|||
157050672|NCT03761849|566938954|FG004|Overall Study|Adverse Event|2|||
157050673|NCT03761849|566938955|FG005|Overall Study|Adverse Event|3|||
157050674|NCT03761849|566938950|FG000|Overall Study|Withdrawal by Subject|0|||
157050675|NCT03761849|566938951|FG001|Overall Study|Withdrawal by Subject|0|||
157050676|NCT03761849|566938952|FG002|Overall Study|Withdrawal by Subject|0|||
157050677|NCT03761849|566938953|FG003|Overall Study|Withdrawal by Subject|41|||
157050678|NCT03761849|566938954|FG004|Overall Study|Withdrawal by Subject|43|||
157050679|NCT03761849|566938955|FG005|Overall Study|Withdrawal by Subject|35|||
157050680|NCT03761849|566938950|FG000|Overall Study|Lost to Follow-up|0|||
157050681|NCT03761849|566938951|FG001|Overall Study|Lost to Follow-up|1|||
157050682|NCT03761849|566938952|FG002|Overall Study|Lost to Follow-up|0|||
157050683|NCT03761849|566938953|FG003|Overall Study|Lost to Follow-up|2|||
157050684|NCT03761849|566938954|FG004|Overall Study|Lost to Follow-up|4|||
157050685|NCT03761849|566938955|FG005|Overall Study|Lost to Follow-up|5|||
157050686|NCT03761849|566938950|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
157050687|NCT03761849|566938951|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
157050688|NCT03761849|566938952|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
157050689|NCT03761849|566938953|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
157050690|NCT03761849|566938954|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
157050691|NCT03761849|566938955|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
157050692|NCT03761849|566938950|FG000|Overall Study|Physician Decision|0|||
157050693|NCT03761849|566938951|FG001|Overall Study|Physician Decision|0|||
157050694|NCT03761849|566938952|FG002|Overall Study|Physician Decision|0|||
157050695|NCT03761849|566938953|FG003|Overall Study|Physician Decision|1|||
157050696|NCT03761849|566938954|FG004|Overall Study|Physician Decision|4|||
157050697|NCT03761849|566938955|FG005|Overall Study|Physician Decision|4|||
157050698|NCT03761849|566938950|FG000|Overall Study|Death|0|||
157050699|NCT03761849|566938951|FG001|Overall Study|Death|0|||
157050700|NCT03761849|566938952|FG002|Overall Study|Death|0|||
157050701|NCT03761849|566938953|FG003|Overall Study|Death|1|||
157050702|NCT03761849|566938954|FG004|Overall Study|Death|1|||
157050703|NCT03761849|566938955|FG005|Overall Study|Death|3|||
157050704|NCT03761849|566938950|FG000|Overall Study|Protocol Violation|0|||
157050705|NCT03761849|566938951|FG001|Overall Study|Protocol Violation|0|||
157050706|NCT03761849|566938952|FG002|Overall Study|Protocol Violation|0|||
157050707|NCT03761849|566938953|FG003|Overall Study|Protocol Violation|2|||
157050708|NCT03761849|566938954|FG004|Overall Study|Protocol Violation|2|||
157050709|NCT03761849|566938955|FG005|Overall Study|Protocol Violation|1|||
157050710|NCT03761849|566938950|FG000|Overall Study|Participant could not come to site|0|||
157050711|NCT03761849|566938951|FG001|Overall Study|Participant could not come to site|0|||
157050712|NCT03761849|566938952|FG002|Overall Study|Participant could not come to site|0|||
157050713|NCT03761849|566938953|FG003|Overall Study|Participant could not come to site|0|||
157050714|NCT03761849|566938954|FG004|Overall Study|Participant could not come to site|1|||
157050715|NCT03761849|566938955|FG005|Overall Study|Participant could not come to site|0|||
157050716|NCT03761849|566938950|FG000|Overall Study|SF- safety Finding|0|||
157050717|NCT03761849|566938951|FG001|Overall Study|SF- safety Finding|0|||
157050718|NCT03761849|566938952|FG002|Overall Study|SF- safety Finding|0|||
157050719|NCT03761849|566938953|FG003|Overall Study|SF- safety Finding|0|||
157050720|NCT03761849|566938954|FG004|Overall Study|SF- safety Finding|0|||
157050721|NCT03761849|566938955|FG005|Overall Study|SF- safety Finding|1|||
157050722|NCT03761849|566938950|FG000|Overall Study|Patient did not attend visit|0|||
157050723|NCT03761849|566938951|FG001|Overall Study|Patient did not attend visit|0|||
157050724|NCT03761849|566938952|FG002|Overall Study|Patient did not attend visit|0|||
157050725|NCT03761849|566938953|FG003|Overall Study|Patient did not attend visit|0|||
157050726|NCT03761849|566938954|FG004|Overall Study|Patient did not attend visit|0|||
157050727|NCT03761849|566938955|FG005|Overall Study|Patient did not attend visit|1|||
157050728|NCT03884478|566938956|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
157050729|NCT03884478|566938957|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
157050730|NCT03884478|566938958|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
157050731|NCT03884478|566938956|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
157050732|NCT03884478|566938957|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
157050733|NCT03884478|566938958|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
157050734|NCT03884478|566938956|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
157050735|NCT03884478|566938957|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
157050736|NCT03884478|566938958|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
157050737|NCT03884478|566938956|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
157050738|NCT03884478|566938957|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
157050739|NCT03884478|566938958|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
157050740|NCT01540474|566938959|FG000|Vaccination Period|Lost to Follow-up|0|||
157050741|NCT01540474|566938960|FG001|Vaccination Period|Lost to Follow-up|1|||
157050742|NCT01540474|566938961|FG002|Vaccination Period|Lost to Follow-up|0|||
157050743|NCT01540474|566938962|FG003|Vaccination Period|Lost to Follow-up|0|||
157050744|NCT00828139|566938963|FG000|Overall Study|Adverse Event|8|||
157050745|NCT00828139|566938964|FG001|Overall Study|Adverse Event|1|||
157050746|NCT00828139|566938965|FG002|Overall Study|Adverse Event|10|||
157050747|NCT00828139|566938966|FG003|Overall Study|Adverse Event|5|||
157050748|NCT00828139|566938963|FG000|Overall Study|Death|2|||
157050749|NCT00828139|566938964|FG001|Overall Study|Death|1|||
157050750|NCT00828139|566938965|FG002|Overall Study|Death|0|||
157050751|NCT00828139|566938966|FG003|Overall Study|Death|2|||
157050752|NCT00828139|566938963|FG000|Overall Study|Refusal unrelated to toxicity|3|||
157050753|NCT00828139|566938964|FG001|Overall Study|Refusal unrelated to toxicity|4|||
157050754|NCT00828139|566938965|FG002|Overall Study|Refusal unrelated to toxicity|5|||
157050755|NCT00828139|566938966|FG003|Overall Study|Refusal unrelated to toxicity|3|||
157050756|NCT00828139|566938963|FG000|Overall Study|Disease Progression|24|||
157050757|NCT00828139|566938964|FG001|Overall Study|Disease Progression|33|||
157050758|NCT00828139|566938965|FG002|Overall Study|Disease Progression|35|||
157050759|NCT00828139|566938966|FG003|Overall Study|Disease Progression|39|||
157050760|NCT00828139|566938963|FG000|Overall Study|Other|4|||
157050761|NCT00828139|566938964|FG001|Overall Study|Other|2|||
157050762|NCT00828139|566938965|FG002|Overall Study|Other|5|||
157050763|NCT00828139|566938966|FG003|Overall Study|Other|2|||
157050764|NCT04271254|566938970|FG000|Overall Study|Withdrawal by Subject|3|||
157050765|NCT00417885|566938973|FG000|Overall Study|Adverse Event|1|||
157050766|NCT00417885|566938973|FG000|Overall Study|Objective Progression or Relapse|3|||
157050767|NCT00417885|566938973|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
157050768|NCT02825550|566938980|FG000|Overall Study|Physician Decision|1|||
157050769|NCT00248794|566938983|FG000|Overall Study|Lost to Follow-up|6|||
157050770|NCT00248794|566938984|FG001|Overall Study|Lost to Follow-up|8|||
157050771|NCT00248794|566938985|FG002|Overall Study|Lost to Follow-up|3|||
157050772|NCT03444155|566938988|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
157050773|NCT03444155|566938989|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
157050774|NCT01894620|566938990|FG000|Overall Study|Withdrawal by Subject|0|||
157050775|NCT01894620|566938991|FG001|Overall Study|Withdrawal by Subject|1|||
157050776|NCT02877680|566938992|FG000|Overall Study|Lost to Follow-up|1|||
157176459|NCT00994162|567385543|FG000|Overall Study|Product Complaint|1|||
157176460|NCT00994162|567385543|FG000|Overall Study|Poor Compliance|5|||
157176461|NCT00994162|567385543|FG000|Overall Study|Lack of Response|3|||
157050777|NCT02877680|566938993|FG001|Overall Study|Lost to Follow-up|1|||
157050778|NCT01133678|566938994|FG000|Overall Study|Death|1|||
157050779|NCT01133678|566938995|FG001|Overall Study|Death|1|||
157176462|NCT00994162|567385543|FG000|Overall Study|Discharged from Hospital|4|||
157176463|NCT00994162|567385543|FG000|Overall Study|Death|2|||
157050780|NCT01124916|566938996|FG000|Overall Study|Lost to Follow-up|3|||
157050781|NCT01124916|566938997|FG001|Overall Study|Lost to Follow-up|2|||
157050782|NCT01864200|566938998|FG000|Overall Study|Lost to Follow-up|1|||
157050783|NCT01864200|566938999|FG001|Overall Study|Lost to Follow-up|3|||
157050784|NCT01864200|566938998|FG000|Overall Study|Protocol Violation|1|||
157050785|NCT01864200|566938999|FG001|Overall Study|Protocol Violation|0|||
157050786|NCT02077374|566939002|FG000|Overall Study|Withdrawal by Subject|0|||
157050787|NCT02077374|566939003|FG001|Overall Study|Withdrawal by Subject|1|||
157050788|NCT02077374|566939002|FG000|Overall Study|Protocol Violation|0|||
157050789|NCT02077374|566939003|FG001|Overall Study|Protocol Violation|1|||
157050790|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
157050791|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
157050792|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
157050793|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
157050794|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
157050795|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Adverse Event|0|||
157050796|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Adverse Event|1|||
157050797|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Adverse Event|1|||
157050798|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Adverse Event|0|||
157050799|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Adverse Event|0|||
157050800|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
157050801|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
157050802|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
157050803|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
157050804|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
157050805|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Physician Decision|1|||
157050806|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Physician Decision|0|||
157050807|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Physician Decision|0|||
157050808|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Physician Decision|0|||
157050809|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Physician Decision|0|||
157050810|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
157050811|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
157050812|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
157050813|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
157050814|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
157050815|NCT00446095|566939004|FG000|Phase II (8 Weeks)|Ongoing|0|||
157050816|NCT00446095|566939005|FG001|Phase II (8 Weeks)|Ongoing|0|||
157050817|NCT00446095|566939006|FG002|Phase II (8 Weeks)|Ongoing|1|||
157050818|NCT00446095|566939007|FG003|Phase II (8 Weeks)|Ongoing|0|||
157050819|NCT00446095|566939008|FG004|Phase II (8 Weeks)|Ongoing|0|||
157050820|NCT00446095|566939004|FG000|Phase I (28 Days)|Adverse Event|0|||
157050821|NCT00446095|566939005|FG001|Phase I (28 Days)|Adverse Event|0|||
157050822|NCT00446095|566939006|FG002|Phase I (28 Days)|Adverse Event|0|||
157050823|NCT00446095|566939007|FG003|Phase I (28 Days)|Adverse Event|1|||
157050824|NCT00446095|566939008|FG004|Phase I (28 Days)|Adverse Event|0|||
157050825|NCT00446095|566939004|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
157050826|NCT00446095|566939005|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
157050827|NCT00446095|566939006|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
157050828|NCT00446095|566939007|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
157050829|NCT00446095|566939008|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
157050830|NCT00886834|566939009|FG000|Overall Study|Protocol Violation|0|||
157050831|NCT00886834|566939010|FG001|Overall Study|Protocol Violation|3|||
157050832|NCT02574286|566939011|FG000|Overall Study|Adverse Event|3|||
157050833|NCT02574286|566939011|FG000|Overall Study|Withdrawal by Subject|2|||
157050834|NCT01029925|566939014|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
157050835|NCT01029925|566939014|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
157050836|NCT01029925|566939014|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
157050837|NCT02159352|566939015|FG000|Overall Study|Adverse Event|3|||
157050838|NCT02159352|566939016|FG001|Overall Study|Adverse Event|1|||
157050839|NCT02159352|566939015|FG000|Overall Study|Withdrawal by Subject|0|||
157050840|NCT02159352|566939016|FG001|Overall Study|Withdrawal by Subject|1|||
157050841|NCT00529529|566939017|FG000|Overall Study|Adverse Event|12|||
157050842|NCT00529529|566939018|FG001|Overall Study|Adverse Event|17|||
157050843|NCT00529529|566939019|FG002|Overall Study|Adverse Event|8|||
157050844|NCT00529529|566939017|FG000|Overall Study|Subject withdrew consent|12|||
157050845|NCT00529529|566939018|FG001|Overall Study|Subject withdrew consent|9|||
157050846|NCT00529529|566939019|FG002|Overall Study|Subject withdrew consent|12|||
157050847|NCT00529529|566939017|FG000|Overall Study|Protocol deviation|8|||
157229334|NCT03561883|567585231|FG001|Overall Study|Withdrawal by Subject|6|||
157050848|NCT00529529|566939018|FG001|Overall Study|Protocol deviation|12|||
157050849|NCT00529529|566939019|FG002|Overall Study|Protocol deviation|5|||
157050850|NCT00529529|566939017|FG000|Overall Study|Lost to Follow-up|5|||
157050851|NCT00529529|566939018|FG001|Overall Study|Lost to Follow-up|3|||
157050852|NCT00529529|566939019|FG002|Overall Study|Lost to Follow-up|1|||
157050853|NCT00529529|566939017|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
157050854|NCT00529529|566939018|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157050855|NCT00529529|566939019|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
157176464|NCT00994162|567385543|FG000|Overall Study|Care Transferred to Another Physician|2|||
157176465|NCT00994162|567385543|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
156973032|NCT00856167|566653160|FG001|Period 2|Withdrawal by Subject|0|||
156973033|NCT00856167|566653161|FG002|Period 2|Withdrawal by Subject|2|||
156973034|NCT00856167|566653162|FG003|Period 2|Withdrawal by Subject|4|||
156973035|NCT06027619|566653163|FG000|Overall Study|Adverse Event|0|||
156973036|NCT06027619|566653164|FG001|Overall Study|Adverse Event|0|||
156973037|NCT06027619|566653165|FG002|Overall Study|Adverse Event|1|||
156973038|NCT01061333|566653166|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
156973039|NCT01061333|566653167|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
156973040|NCT01816763|566654679|FG000|Overall Study|The main reason for an incomplete survey|4|||
156973041|NCT01816763|566654680|FG001|Overall Study|The main reason for an incomplete survey|15|||
156973042|NCT01816763|566654681|FG002|Overall Study|The main reason for an incomplete survey|11|||
156973043|NCT01186328|566654686|FG000|Overall Study|Death|1|||
156973044|NCT01186328|566654687|FG001|Overall Study|Death|0|||
156973045|NCT01186328|566654688|FG002|Overall Study|Death|0|||
156973046|NCT03075501|566654689|FG000|Overall Study|Scheduling difficulties|15|||
156973047|NCT03075501|566654690|FG001|Overall Study|Scheduling difficulties|9|||
156973048|NCT03610737|566654697|FG000|Overall Study|Withdrawal by Subject|1|||
156973049|NCT03610737|566654698|FG001|Overall Study|Withdrawal by Subject|5|||
156973050|NCT03610737|566654697|FG000|Overall Study|Death|1|||
156973051|NCT03610737|566654698|FG001|Overall Study|Death|0|||
156973052|NCT03610737|566654697|FG000|Overall Study|Not treated|5|||
156973053|NCT03610737|566654698|FG001|Overall Study|Not treated|2|||
156973054|NCT03610737|566654697|FG000|Overall Study|Missed Visit|1|||
156973055|NCT03610737|566654698|FG001|Overall Study|Missed Visit|2|||
156973056|NCT02670538|566654699|FG000|Overall Study|Withdrawal of Consent|8|||
156973057|NCT02670538|566654700|FG001|Overall Study|Withdrawal of Consent|6|||
156973058|NCT02670538|566654701|FG002|Overall Study|Withdrawal of Consent|5|||
156973059|NCT02670538|566654699|FG000|Overall Study|Lost to Follow-up|8|||
156973060|NCT02670538|566654700|FG001|Overall Study|Lost to Follow-up|12|||
156973061|NCT02670538|566654701|FG002|Overall Study|Lost to Follow-up|7|||
156973062|NCT02670538|566654699|FG000|Overall Study|Adverse Event|5|||
156973063|NCT02670538|566654700|FG001|Overall Study|Adverse Event|5|||
156973064|NCT02670538|566654701|FG002|Overall Study|Adverse Event|11|||
156973065|NCT02670538|566654699|FG000|Overall Study|Lack of Efficacy|7|||
156973066|NCT02670538|566654700|FG001|Overall Study|Lack of Efficacy|1|||
156973067|NCT02670538|566654701|FG002|Overall Study|Lack of Efficacy|2|||
156973068|NCT02670538|566654699|FG000|Overall Study|Protocol Violation|3|||
156973069|NCT02670538|566654700|FG001|Overall Study|Protocol Violation|4|||
156973070|NCT02670538|566654701|FG002|Overall Study|Protocol Violation|1|||
156973071|NCT02670538|566654699|FG000|Overall Study|Noncompliance with Study Drug|1|||
156973072|NCT02670538|566654700|FG001|Overall Study|Noncompliance with Study Drug|3|||
156973073|NCT02670538|566654701|FG002|Overall Study|Noncompliance with Study Drug|2|||
156973074|NCT02670538|566654699|FG000|Overall Study|Other Miscellaneous Reasons|0|||
156973075|NCT02670538|566654700|FG001|Overall Study|Other Miscellaneous Reasons|1|||
156973076|NCT02670538|566654701|FG002|Overall Study|Other Miscellaneous Reasons|2|||
156973077|NCT01373931|566654702|FG000|Lead-in Period|Adverse Event|2|||
156973078|NCT01373931|566654703|FG001|Lead-in Period|Adverse Event|0|||
156973079|NCT01373931|566654702|FG000|Period 1|Adverse Event|2|||
156973080|NCT01373931|566654703|FG001|Period 1|Adverse Event|0|||
156973081|NCT01373931|566654702|FG000|Period 1|Withdrawal by Subject|0|||
156973082|NCT01373931|566654703|FG001|Period 1|Withdrawal by Subject|2|||
156973083|NCT00742079|566654704|FG000|Overall Study|Lost to Follow-up|0|||
156973084|NCT00742079|566654705|FG001|Overall Study|Lost to Follow-up|1|||
156973085|NCT02243202|566654707|FG000|Overall Study|Adverse Event|5|||
156973086|NCT02243202|566654708|FG001|Overall Study|Adverse Event|6|||
156973087|NCT02243202|566654709|FG002|Overall Study|Adverse Event|10|||
156973088|NCT02243202|566654710|FG003|Overall Study|Adverse Event|4|||
156973089|NCT02243202|566654707|FG000|Overall Study|Lost to Follow-up|9|||
156973090|NCT02243202|566654708|FG001|Overall Study|Lost to Follow-up|9|||
156973091|NCT02243202|566654709|FG002|Overall Study|Lost to Follow-up|14|||
156973092|NCT02243202|566654710|FG003|Overall Study|Lost to Follow-up|11|||
156973093|NCT02243202|566654707|FG000|Overall Study|Protocol Violation|3|||
156973094|NCT02243202|566654708|FG001|Overall Study|Protocol Violation|1|||
156973095|NCT02243202|566654709|FG002|Overall Study|Protocol Violation|2|||
157176466|NCT00994162|567385543|FG000|Overall Study|Physician Decision|2|||
156973096|NCT02243202|566654710|FG003|Overall Study|Protocol Violation|1|||
156973097|NCT02243202|566654707|FG000|Overall Study|Withdrawal by Subject|7|||
156973098|NCT02243202|566654708|FG001|Overall Study|Withdrawal by Subject|6|||
156973099|NCT02243202|566654709|FG002|Overall Study|Withdrawal by Subject|4|||
156973100|NCT02243202|566654710|FG003|Overall Study|Withdrawal by Subject|4|||
156973101|NCT02243202|566654707|FG000|Overall Study|Other|1|||
156973102|NCT02243202|566654708|FG001|Overall Study|Other|3|||
156973103|NCT02243202|566654709|FG002|Overall Study|Other|1|||
156973104|NCT02243202|566654710|FG003|Overall Study|Other|2|||
156973105|NCT02243202|566654707|FG000|Overall Study|Randomized but not received treatment|0|||
156973106|NCT02243202|566654708|FG001|Overall Study|Randomized but not received treatment|0|||
157050856|NCT00529529|566939017|FG000|Overall Study|Death|2|||
157050857|NCT00529529|566939018|FG001|Overall Study|Death|0|||
157050858|NCT00529529|566939019|FG002|Overall Study|Death|0|||
157050859|NCT00529529|566939017|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157050860|NCT00529529|566939018|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157050861|NCT00529529|566939019|FG002|Overall Study|Abnormal test procedure result(s)|0|||
157050862|NCT00529529|566939017|FG000|Overall Study|Administrative problems|1|||
157050863|NCT00529529|566939018|FG001|Overall Study|Administrative problems|0|||
157050864|NCT00529529|566939019|FG002|Overall Study|Administrative problems|3|||
157050865|NCT02279732|566939020|FG000|Overall Study|Death|23|||
157050866|NCT02279732|566939021|FG001|Overall Study|Death|20|||
157050867|NCT02279732|566939020|FG000|Overall Study|Disease Progression|13|||
157050868|NCT02279732|566939021|FG001|Overall Study|Disease Progression|3|||
157050869|NCT02279732|566939020|FG000|Overall Study|Withdrawal by Subject|2|||
157050870|NCT02279732|566939021|FG001|Overall Study|Withdrawal by Subject|7|||
157050871|NCT02279732|566939020|FG000|Overall Study|Adverse Event|1|||
157050872|NCT02279732|566939021|FG001|Overall Study|Adverse Event|2|||
157050873|NCT02279732|566939020|FG000|Overall Study|Administrative Reason By Sponsor|0|||
157050874|NCT02279732|566939021|FG001|Overall Study|Administrative Reason By Sponsor|2|||
157050875|NCT02279732|566939020|FG000|Overall Study|Study Drug Toxicity|2|||
157050876|NCT02279732|566939021|FG001|Overall Study|Study Drug Toxicity|0|||
157050877|NCT02279732|566939020|FG000|Overall Study|Lost to Follow-up|0|||
157050878|NCT02279732|566939021|FG001|Overall Study|Lost to Follow-up|1|||
157050879|NCT02279732|566939020|FG000|Overall Study|Maximum Clinical Benefit|1|||
157050880|NCT02279732|566939021|FG001|Overall Study|Maximum Clinical Benefit|0|||
157050881|NCT02279732|566939020|FG000|Overall Study|Subject Requested to Discontinue|0|||
157050882|NCT02279732|566939021|FG001|Overall Study|Subject Requested to Discontinue|1|||
157050883|NCT02279732|566939020|FG000|Overall Study|Other|53|||
157050884|NCT02279732|566939021|FG001|Overall Study|Other|67|||
157050885|NCT02279732|566939020|FG000|Overall Study|Other|3|||
157050886|NCT02279732|566939021|FG001|Overall Study|Other|3|||
157050887|NCT02203513|566939022|FG000|Overall Study|Refused further treatment|2|||
157050888|NCT02203513|566939023|FG001|Overall Study|Refused further treatment|0|||
157050889|NCT02203513|566939024|FG002|Overall Study|Refused further treatment|1|||
157050890|NCT02203513|566939025|FG003|Overall Study|Refused further treatment|0|||
157050891|NCT02203513|566939026|FG004|Overall Study|Refused further treatment|0|||
157050892|NCT02203513|566939022|FG000|Overall Study|Switched to alternative treatment|3|||
157050893|NCT02203513|566939023|FG001|Overall Study|Switched to alternative treatment|4|||
157050894|NCT02203513|566939024|FG002|Overall Study|Switched to alternative treatment|0|||
157050895|NCT02203513|566939025|FG003|Overall Study|Switched to alternative treatment|0|||
157050896|NCT02203513|566939026|FG004|Overall Study|Switched to alternative treatment|4|||
157050897|NCT02203513|566939022|FG000|Overall Study|Did not receive investigational product (IP)|0|||
157176467|NCT00994162|567385543|FG000|Overall Study|Surrounding Wound Erythematous|1|||
157050898|NCT02203513|566939023|FG001|Overall Study|Did not receive investigational product (IP)|1|||
157050899|NCT02203513|566939024|FG002|Overall Study|Did not receive investigational product (IP)|0|||
157050900|NCT02203513|566939025|FG003|Overall Study|Did not receive investigational product (IP)|0|||
157050901|NCT02203513|566939026|FG004|Overall Study|Did not receive investigational product (IP)|0|||
157050902|NCT02203513|566939022|FG000|Overall Study|Death (unrelated to study therapy)|1|||
157050903|NCT02203513|566939023|FG001|Overall Study|Death (unrelated to study therapy)|3|||
157050904|NCT02203513|566939024|FG002|Overall Study|Death (unrelated to study therapy)|1|||
157050905|NCT02203513|566939025|FG003|Overall Study|Death (unrelated to study therapy)|0|||
157050906|NCT02203513|566939026|FG004|Overall Study|Death (unrelated to study therapy)|2|||
157050907|NCT02203513|566939022|FG000|Overall Study|Lost to Follow-up|0|||
157050908|NCT02203513|566939023|FG001|Overall Study|Lost to Follow-up|0|||
157050909|NCT02203513|566939024|FG002|Overall Study|Lost to Follow-up|1|||
157050910|NCT02203513|566939025|FG003|Overall Study|Lost to Follow-up|1|||
157050911|NCT02203513|566939026|FG004|Overall Study|Lost to Follow-up|0|||
157050912|NCT03060525|566939028|FG000|Overall Study|moved out of state|1|||
157050913|NCT03060525|566939029|FG001|Overall Study|moved out of state|1|||
157050914|NCT03060525|566939030|FG002|Overall Study|moved out of state|1|||
157050915|NCT03060525|566939031|FG003|Overall Study|moved out of state|1|||
157050916|NCT03060525|566939028|FG000|Overall Study|unable to meet time commitment required of study|2|||
157050917|NCT03060525|566939029|FG001|Overall Study|unable to meet time commitment required of study|3|||
157050918|NCT03060525|566939030|FG002|Overall Study|unable to meet time commitment required of study|3|||
157050919|NCT03060525|566939031|FG003|Overall Study|unable to meet time commitment required of study|1|||
157050920|NCT03060525|566939028|FG000|Overall Study|no longer interested in doing intervention|0|||
157050921|NCT03060525|566939029|FG001|Overall Study|no longer interested in doing intervention|0|||
157050922|NCT03060525|566939030|FG002|Overall Study|no longer interested in doing intervention|0|||
157176468|NCT00994162|567385543|FG000|Overall Study|Machine Losing Vaccum|1|||
157176469|NCT00994162|567385543|FG000|Overall Study|Patient Lived Too Far Away|1|||
157050923|NCT03060525|566939031|FG003|Overall Study|no longer interested in doing intervention|1|||
157050924|NCT02978716|566939032|FG000|Overall Study|Death|25|||
157050925|NCT02978716|566939033|FG001|Overall Study|Death|13|||
157050926|NCT02978716|566939034|FG002|Overall Study|Death|20|||
157050927|NCT02978716|566939032|FG000|Overall Study|Lost to Follow-up|0|||
157050928|NCT02978716|566939033|FG001|Overall Study|Lost to Follow-up|0|||
157050929|NCT02978716|566939034|FG002|Overall Study|Lost to Follow-up|1|||
157050930|NCT02978716|566939032|FG000|Overall Study|Withdrawal by Subject|6|||
157050931|NCT02978716|566939033|FG001|Overall Study|Withdrawal by Subject|4|||
157050932|NCT02978716|566939034|FG002|Overall Study|Withdrawal by Subject|5|||
157050933|NCT02978716|566939032|FG000|Overall Study|Sponsor terminated|2|||
157050934|NCT02978716|566939033|FG001|Overall Study|Sponsor terminated|13|||
157050935|NCT02978716|566939034|FG002|Overall Study|Sponsor terminated|9|||
157050936|NCT02978716|566939032|FG000|Overall Study|Other|1|||
157050937|NCT02978716|566939033|FG001|Overall Study|Other|3|||
157050938|NCT02978716|566939034|FG002|Overall Study|Other|0|||
157050939|NCT00960206|566939035|FG000|Overall Study|Death|7|||
157050940|NCT00960206|566939036|FG001|Overall Study|Death|4|||
157050941|NCT00960206|566939037|FG002|Overall Study|Death|1|||
157050942|NCT00960206|566939035|FG000|Overall Study|Unwilling/Unable to return|1|||
157050943|NCT00960206|566939036|FG001|Overall Study|Unwilling/Unable to return|2|||
157050944|NCT00960206|566939037|FG002|Overall Study|Unwilling/Unable to return|0|||
157050945|NCT00960206|566939035|FG000|Overall Study|Lost to Follow-up|8|||
157050946|NCT00960206|566939036|FG001|Overall Study|Lost to Follow-up|14|||
157050947|NCT00960206|566939037|FG002|Overall Study|Lost to Follow-up|8|||
157050948|NCT00960206|566939035|FG000|Overall Study|Withdrawal by Subject|2|||
157050949|NCT00960206|566939036|FG001|Overall Study|Withdrawal by Subject|4|||
157050950|NCT00960206|566939037|FG002|Overall Study|Withdrawal by Subject|0|||
157050951|NCT00960206|566939035|FG000|Overall Study|Revision of study component|2|||
157050952|NCT00960206|566939036|FG001|Overall Study|Revision of study component|2|||
157050953|NCT00960206|566939037|FG002|Overall Study|Revision of study component|2|||
157050954|NCT00960206|566939035|FG000|Overall Study|Missing 10 year data|20|||
157050955|NCT00960206|566939036|FG001|Overall Study|Missing 10 year data|1|||
157050956|NCT00960206|566939037|FG002|Overall Study|Missing 10 year data|1|||
157050957|NCT02548585|566939050|FG000|Overall Study|Withdrawal by Subject|0|||
157050958|NCT02548585|566939051|FG001|Overall Study|Withdrawal by Subject|0|||
157050959|NCT02548585|566939052|FG002|Overall Study|Withdrawal by Subject|0|||
157050960|NCT02548585|566939053|FG003|Overall Study|Withdrawal by Subject|0|||
157050961|NCT02548585|566939054|FG004|Overall Study|Withdrawal by Subject|0|||
157050962|NCT02548585|566939055|FG005|Overall Study|Withdrawal by Subject|1|||
157050963|NCT02548585|566939056|FG006|Overall Study|Withdrawal by Subject|0|||
157050964|NCT02548585|566939050|FG000|Overall Study|Lost to Follow-up|1|||
157050965|NCT02548585|566939051|FG001|Overall Study|Lost to Follow-up|0|||
157050966|NCT02548585|566939052|FG002|Overall Study|Lost to Follow-up|0|||
157050967|NCT02548585|566939053|FG003|Overall Study|Lost to Follow-up|0|||
157050968|NCT02548585|566939054|FG004|Overall Study|Lost to Follow-up|0|||
157050969|NCT02548585|566939055|FG005|Overall Study|Lost to Follow-up|0|||
157050970|NCT02548585|566939056|FG006|Overall Study|Lost to Follow-up|0|||
157050971|NCT02548585|566939050|FG000|Overall Study|Other|1|||
157050972|NCT02548585|566939051|FG001|Overall Study|Other|0|||
157050973|NCT02548585|566939052|FG002|Overall Study|Other|0|||
157050974|NCT02548585|566939053|FG003|Overall Study|Other|2|||
157050975|NCT02548585|566939054|FG004|Overall Study|Other|3|||
157050976|NCT02548585|566939055|FG005|Overall Study|Other|0|||
157050977|NCT02548585|566939056|FG006|Overall Study|Other|1|||
157050978|NCT02548585|566939050|FG000|Overall Study|Randomized but not treated|0|||
157050979|NCT02548585|566939051|FG001|Overall Study|Randomized but not treated|0|||
157050980|NCT02548585|566939052|FG002|Overall Study|Randomized but not treated|0|||
157050981|NCT02548585|566939053|FG003|Overall Study|Randomized but not treated|0|||
157050982|NCT02548585|566939054|FG004|Overall Study|Randomized but not treated|0|||
157050983|NCT02548585|566939055|FG005|Overall Study|Randomized but not treated|1|||
157050984|NCT02548585|566939056|FG006|Overall Study|Randomized but not treated|0|||
157050985|NCT00452452|566939057|FG000|Overall Study|Protocol Violation|0|||
157050986|NCT00452452|566939058|FG001|Overall Study|Protocol Violation|0|||
157050987|NCT00452452|566939059|FG002|Overall Study|Protocol Violation|1|||
157050988|NCT00452452|566939057|FG000|Overall Study|Withdrawal by Subject|1|||
157050989|NCT00452452|566939058|FG001|Overall Study|Withdrawal by Subject|0|||
157050990|NCT00452452|566939059|FG002|Overall Study|Withdrawal by Subject|0|||
157050991|NCT00452452|566939057|FG000|Overall Study|Lost to Follow-up|1|||
157050992|NCT00452452|566939058|FG001|Overall Study|Lost to Follow-up|0|||
157050993|NCT00452452|566939059|FG002|Overall Study|Lost to Follow-up|0|||
157050994|NCT00711555|566940857|FG000|Overall Study|Adverse Event|3|||
157050995|NCT00608959|566940860|FG000|Part 1|Did not meet eligibility criteria|1|||
157050996|NCT01248715|566940861|FG000|Overall Study|Not influenza positive|501|||
157050997|NCT01248715|566940862|FG001|Overall Study|Not influenza positive|510|||
157050998|NCT01807234|566940866|FG000|Overall Study|Lost to Follow-up|2|||
157050999|NCT01807234|566940867|FG001|Overall Study|Lost to Follow-up|5|||
157051000|NCT01807234|566940868|FG002|Overall Study|Lost to Follow-up|1|||
157051001|NCT01807234|566940869|FG003|Overall Study|Lost to Follow-up|1|||
157051002|NCT01807234|566940870|FG004|Overall Study|Lost to Follow-up|1|||
157051003|NCT01807234|566940871|FG005|Overall Study|Lost to Follow-up|2|||
157051004|NCT01807234|566940866|FG000|Overall Study|Withdrawal by Subject|3|||
157051005|NCT01807234|566940867|FG001|Overall Study|Withdrawal by Subject|1|||
157051006|NCT01807234|566940868|FG002|Overall Study|Withdrawal by Subject|1|||
157051007|NCT01807234|566940869|FG003|Overall Study|Withdrawal by Subject|1|||
157051008|NCT01807234|566940870|FG004|Overall Study|Withdrawal by Subject|2|||
157051009|NCT01807234|566940871|FG005|Overall Study|Withdrawal by Subject|1|||
157051010|NCT01807234|566940866|FG000|Overall Study|Lack of Efficacy|0|||
157051011|NCT01807234|566940867|FG001|Overall Study|Lack of Efficacy|0|||
157051012|NCT01807234|566940868|FG002|Overall Study|Lack of Efficacy|0|||
157051013|NCT01807234|566940869|FG003|Overall Study|Lack of Efficacy|0|||
157051014|NCT01807234|566940870|FG004|Overall Study|Lack of Efficacy|1|||
157051015|NCT01807234|566940871|FG005|Overall Study|Lack of Efficacy|1|||
157051016|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
157051017|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
157051018|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
157051019|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
157051020|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
157051021|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
157051022|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
157051023|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
157051024|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
157051025|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
157051026|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
157051027|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
157051028|NCT01345253|566940872|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
157051029|NCT01345253|566940873|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
157051030|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
157051031|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
157051032|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
157051033|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
157051034|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
157051035|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
157051036|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
157051037|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
157051038|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
157051039|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
157051040|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
157051041|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
157051042|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
157051043|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
157051044|NCT01345253|566940872|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
157051045|NCT01345253|566940873|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
157051046|NCT00476151|566940874|FG000|Overall Study|Adverse Event|0|||
157051047|NCT00476151|566940875|FG001|Overall Study|Adverse Event|2|||
157051048|NCT00476151|566940874|FG000|Overall Study|Protocol Violation|1|||
157051049|NCT00476151|566940875|FG001|Overall Study|Protocol Violation|3|||
157051050|NCT00476151|566940874|FG000|Overall Study|Withdrawal by Subject|2|||
157051051|NCT00476151|566940875|FG001|Overall Study|Withdrawal by Subject|0|||
157051052|NCT00476151|566940874|FG000|Overall Study|Physician Decision|0|||
157051053|NCT00476151|566940875|FG001|Overall Study|Physician Decision|2|||
157051054|NCT02068352|566940876|FG000|Overall Study|Lost to Follow-up|0|||
157051055|NCT02068352|566940877|FG001|Overall Study|Lost to Follow-up|2|||
157051056|NCT02068352|566940878|FG002|Overall Study|Lost to Follow-up|0|||
157051057|NCT02068352|566940876|FG000|Overall Study|Adverse Event|4|||
157051058|NCT02068352|566940877|FG001|Overall Study|Adverse Event|2|||
157051059|NCT02068352|566940878|FG002|Overall Study|Adverse Event|7|||
157051060|NCT02068352|566940876|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
157051061|NCT02068352|566940877|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
157051062|NCT02068352|566940878|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
157051063|NCT02068352|566940876|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
157051064|NCT02068352|566940877|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
157051065|NCT02068352|566940878|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
157051066|NCT02068352|566940876|FG000|Overall Study|Protocol Deviation|0|||
157051067|NCT02068352|566940877|FG001|Overall Study|Protocol Deviation|0|||
157051068|NCT02068352|566940878|FG002|Overall Study|Protocol Deviation|1|||
157176470|NCT00994162|567385543|FG000|Overall Study|Above Knee Amputation|1|||
157051069|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
157051070|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
157051071|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
157051072|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
157051073|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
157176471|NCT00994162|567385543|FG000|Overall Study|Reason Not Reported By Site|1|||
157051074|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
157051075|NCT03557307|566940884|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
157051076|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
157051077|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Death|3|||
157051078|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
157051079|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
157051080|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
157051081|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
157051082|NCT03557307|566940884|FG000|Period 2: Maintenance Phase|other|3|||
157051083|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
157051084|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
157051085|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
157051086|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
157051087|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
157051088|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
157051089|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
157051090|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
157051091|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
157051092|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
157051093|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
157051094|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
157051095|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
157051096|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
157051097|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
157051098|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
157051099|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
157051100|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
157051101|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
157051102|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
157051103|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
157051104|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051105|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
157051106|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051107|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051108|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051109|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051110|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
157051111|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
157051112|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
157051113|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
157051114|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
157051115|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
157051116|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
157051117|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
157051118|NCT03745651|566940885|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
157051119|NCT03745651|566940886|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
157051120|NCT03745651|566940887|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
157051121|NCT03745651|566940888|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
157051122|NCT03745651|566940889|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
157051123|NCT03745651|566940890|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
157051124|NCT03745651|566940891|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
157051125|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051126|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051127|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051128|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051129|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051130|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
157051131|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
157051132|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
157051133|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
157051134|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
157051135|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
157051136|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
157051137|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
157051138|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
157051139|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
157051140|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
157051141|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
157051142|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
157051143|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
157051144|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
157051145|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
157051146|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
157051147|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
157051148|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
157051149|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
157051150|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
157051151|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
157051152|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
157051153|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
157051154|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
157051155|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
157051156|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
157051157|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
157051158|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
157051159|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
157051160|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051161|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051162|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051163|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051164|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051165|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
157051166|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
157051167|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
157051168|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
157051169|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
157051170|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
157051171|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
157051172|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
157051173|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
157051174|NCT03745651|566940885|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
157051175|NCT03745651|566940886|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
157051176|NCT03745651|566940887|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
157051177|NCT03745651|566940888|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
157051178|NCT03745651|566940889|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
157051179|NCT03745651|566940890|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
157051180|NCT03745651|566940891|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
157051181|NCT04175834|566940892|FG000|Overall Study|Withdrawal by Subject|1|||
157051182|NCT04175834|566940893|FG001|Overall Study|Withdrawal by Subject|0|||
157051183|NCT04239911|566940897|FG000|Overall Study|Lost to Follow-up|2|||
157051184|NCT04239911|566940898|FG001|Overall Study|Lost to Follow-up|1|||
157051185|NCT03456856|566940899|FG000|Overall Study|Lost to Follow-up|2|||
157051186|NCT03456856|566940899|FG000|Overall Study|Withdrawal by Subject|1|||
157051187|NCT02137785|566940900|FG000|Overall Study|Lost to Follow-up|1|||
157051188|NCT02137785|566940901|FG001|Overall Study|Lost to Follow-up|0|||
157051189|NCT02137785|566940900|FG000|Overall Study|Withdrawal by Subject|1|||
157051190|NCT02137785|566940901|FG001|Overall Study|Withdrawal by Subject|4|||
157051191|NCT02137785|566940900|FG000|Overall Study|subject moved out of state|1|||
157051192|NCT02137785|566940901|FG001|Overall Study|subject moved out of state|0|||
157051193|NCT01584648|566940902|FG000|Overall Study|Death|136|||
157051194|NCT01584648|566940903|FG001|Overall Study|Death|146|||
157051195|NCT01584648|566940902|FG000|Overall Study|Lost to Follow-up|9|||
157051196|NCT01584648|566940903|FG001|Overall Study|Lost to Follow-up|9|||
157051197|NCT01584648|566940902|FG000|Overall Study|Investigator discretion|3|||
157051198|NCT01584648|566940903|FG001|Overall Study|Investigator discretion|2|||
157051199|NCT01584648|566940902|FG000|Overall Study|Withdrew consent|13|||
157051200|NCT01584648|566940903|FG001|Overall Study|Withdrew consent|4|||
157051201|NCT01584648|566940902|FG000|Overall Study|Study closed/terminated|50|||
157051202|NCT01584648|566940903|FG001|Overall Study|Study closed/terminated|23|||
157051203|NCT01584648|566940902|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
157051204|NCT01584648|566940903|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
157051205|NCT01190436|566940904|FG000|Overall Study|Lost to Follow-up|35|||
156973107|NCT02243202|566654709|FG002|Overall Study|Randomized but not received treatment|0|||
156973108|NCT02243202|566654710|FG003|Overall Study|Randomized but not received treatment|1|||
156973109|NCT00991341|566654712|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
156973110|NCT00991341|566654713|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
156973111|NCT00991341|566654712|FG000|Overall Study|Death|3|||
156973112|NCT00991341|566654713|FG001|Overall Study|Death|0|||
156973113|NCT00991341|566654712|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
156973114|NCT00991341|566654713|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
156973115|NCT00991341|566654712|FG000|Overall Study|Physician Decision|1|||
156973116|NCT00991341|566654713|FG001|Overall Study|Physician Decision|2|||
156973117|NCT00991341|566654712|FG000|Overall Study|Withdrawal by Subject|3|||
156973118|NCT00991341|566654713|FG001|Overall Study|Withdrawal by Subject|4|||
156973119|NCT03954743|566654725|FG000|Overall Study|Adverse Event|1|||
156973120|NCT03954743|566654726|FG001|Overall Study|Adverse Event|0|||
156973121|NCT03954743|566654725|FG000|Overall Study|Lost to Follow-up|6|||
156973122|NCT03954743|566654726|FG001|Overall Study|Lost to Follow-up|4|||
156973123|NCT03954743|566654725|FG000|Overall Study|Protocol Violation|1|||
156973124|NCT03954743|566654726|FG001|Overall Study|Protocol Violation|0|||
156973125|NCT03954743|566654725|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
156973126|NCT03954743|566654726|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
156973127|NCT03954743|566654725|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
156973128|NCT03954743|566654726|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
156973129|NCT00860067|566654729|FG000|Overall Study|Lost to Follow-up|46|||
156973130|NCT00860067|566654730|FG001|Overall Study|Lost to Follow-up|9|||
156973131|NCT00860067|566654731|FG002|Overall Study|Lost to Follow-up|9|||
156973132|NCT00860067|566654729|FG000|Overall Study|Withdrawal by Subject|4|||
156973133|NCT00860067|566654730|FG001|Overall Study|Withdrawal by Subject|0|||
156973134|NCT00860067|566654731|FG002|Overall Study|Withdrawal by Subject|0|||
156973135|NCT00860067|566654729|FG000|Overall Study|Pregnancy|1|||
156973136|NCT00860067|566654730|FG001|Overall Study|Pregnancy|0|||
156973137|NCT00860067|566654731|FG002|Overall Study|Pregnancy|0|||
156973138|NCT00100932|566654732|FG000|Overall Study|Adverse Event|11|||
156973139|NCT00100932|566654733|FG001|Overall Study|Adverse Event|2|||
156973140|NCT00100932|566654732|FG000|Overall Study|Withdrawal by Subject|6|||
156973141|NCT00100932|566654733|FG001|Overall Study|Withdrawal by Subject|0|||
156973142|NCT00100932|566654732|FG000|Overall Study|Progressive Disease|44|||
156973143|NCT00100932|566654733|FG001|Overall Study|Progressive Disease|18|||
156973144|NCT00100932|566654732|FG000|Overall Study|Physician Decision|7|||
156973145|NCT00100932|566654733|FG001|Overall Study|Physician Decision|5|||
156973146|NCT00100932|566654732|FG000|Overall Study|Other|5|||
156973147|NCT00100932|566654733|FG001|Overall Study|Other|2|||
156973148|NCT02387996|566654734|FG000|Overall Study|Disease Progression|167|||
156973149|NCT02387996|566654734|FG000|Overall Study|Study Drug Toxicity|31|||
156973150|NCT02387996|566654734|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
156973151|NCT02387996|566654734|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
156973152|NCT02387996|566654734|FG000|Overall Study|Subject Withdrew Consent|5|||
156973153|NCT02387996|566654734|FG000|Overall Study|Lost to Follow-up|1|||
156973154|NCT02387996|566654734|FG000|Overall Study|Poor/Non-Compliance|1|||
156973155|NCT02387996|566654734|FG000|Overall Study|Other Reasons|5|||
156973156|NCT02387996|566654734|FG000|Overall Study|Death|1|||
156973157|NCT01446796|566654735|FG000|Overall Study|Withdrawal by Subject|1|||
156973158|NCT01446796|566654736|FG001|Overall Study|Withdrawal by Subject|0|||
156973159|NCT00988221|566654739|FG000|Part I|Adverse Event|0|||
156973160|NCT00988221|566654740|FG001|Part I|Adverse Event|1|||
156973161|NCT00988221|566654741|FG002|Part I|Adverse Event|2|||
156973162|NCT00988221|566654742|FG003|Part I|Adverse Event|0|||
156973163|NCT00988221|566654739|FG000|Part I|Insufficient Therapeutic Response|4|||
156973164|NCT00988221|566654740|FG001|Part I|Insufficient Therapeutic Response|6|||
156973165|NCT00988221|566654741|FG002|Part I|Insufficient Therapeutic Response|5|||
156973166|NCT00988221|566654742|FG003|Part I|Insufficient Therapeutic Response|0|||
156973167|NCT00988221|566654739|FG000|Part I|Refused Treatment|0|||
156973168|NCT00988221|566654740|FG001|Part I|Refused Treatment|2|||
156973169|NCT00988221|566654741|FG002|Part I|Refused Treatment|1|||
156973170|NCT00988221|566654742|FG003|Part I|Refused Treatment|0|||
156973171|NCT00988221|566654739|FG000|Part I|Lost to Follow-up|0|||
156973172|NCT00988221|566654740|FG001|Part I|Lost to Follow-up|1|||
156973173|NCT00988221|566654741|FG002|Part I|Lost to Follow-up|0|||
156973174|NCT00988221|566654742|FG003|Part I|Lost to Follow-up|0|||
156973175|NCT00988221|566654739|FG000|Part II|Adverse Event|1|||
156973176|NCT00988221|566654740|FG001|Part II|Adverse Event|0|||
156973177|NCT00988221|566654741|FG002|Part II|Adverse Event|0|||
156973178|NCT00988221|566654742|FG003|Part II|Adverse Event|1|||
156973179|NCT00988221|566654739|FG000|Part II|Withdrawal by Subject|0|||
156973180|NCT00988221|566654740|FG001|Part II|Withdrawal by Subject|0|||
156973181|NCT00988221|566654741|FG002|Part II|Withdrawal by Subject|2|||
156973182|NCT00988221|566654742|FG003|Part II|Withdrawal by Subject|2|||
156973183|NCT00988221|566654739|FG000|Part II|Reason not Specified|0|||
156973184|NCT00988221|566654740|FG001|Part II|Reason not Specified|0|||
156973185|NCT00988221|566654741|FG002|Part II|Reason not Specified|1|||
157051206|NCT01190436|566940904|FG000|Overall Study|Other|4|||
157051207|NCT03146845|566940905|FG000|Overall Study|Reference ulcer healed|1|||
157051208|NCT03146845|566940906|FG001|Overall Study|Reference ulcer healed|0|||
157051209|NCT03146845|566940905|FG000|Overall Study|Physician Decision|1|||
157051210|NCT03146845|566940906|FG001|Overall Study|Physician Decision|0|||
157051211|NCT03146845|566940905|FG000|Overall Study|Adverse Event|1|||
157051212|NCT03146845|566940906|FG001|Overall Study|Adverse Event|0|||
157051213|NCT03146845|566940905|FG000|Overall Study|Withdrawal by Subject|2|||
157051214|NCT03146845|566940906|FG001|Overall Study|Withdrawal by Subject|0|||
157051215|NCT03146845|566940905|FG000|Overall Study|Noncompliance|0|||
157051216|NCT03146845|566940906|FG001|Overall Study|Noncompliance|1|||
157051217|NCT03146845|566940905|FG000|Overall Study|Protocol Violation|0|||
157051218|NCT03146845|566940906|FG001|Overall Study|Protocol Violation|2|||
157051219|NCT03146845|566940905|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
157051220|NCT03146845|566940906|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
157051221|NCT00113529|566940909|FG000|Overall Study|Adverse Event|4|||
157051222|NCT00113529|566940909|FG000|Overall Study|Lack of Efficacy|20|||
157051223|NCT00113529|566940909|FG000|Overall Study|Decision of sponsor|6|||
157051224|NCT00113529|566940909|FG000|Overall Study|Withdrawal by Subject|4|||
157051225|NCT01757288|566940911|FG000|Overall Study|Consent withdrawal|0|||
157051226|NCT01757288|566940912|FG001|Overall Study|Consent withdrawal|4|||
157051227|NCT01757288|566940913|FG002|Overall Study|Consent withdrawal|4|||
157051228|NCT01757288|566940911|FG000|Overall Study|Patient off study, IRB hold.|0|||
157051229|NCT01757288|566940912|FG001|Overall Study|Patient off study, IRB hold.|0|||
157051230|NCT01757288|566940913|FG002|Overall Study|Patient off study, IRB hold.|1|||
157051231|NCT01757288|566940911|FG000|Overall Study|Patient death prior to starting treatment|0|||
157051232|NCT01757288|566940912|FG001|Overall Study|Patient death prior to starting treatment|0|||
157051233|NCT01757288|566940913|FG002|Overall Study|Patient death prior to starting treatment|1|||
157051234|NCT01757288|566940911|FG000|Overall Study|Wrong medication administered|0|||
157051235|NCT01757288|566940912|FG001|Overall Study|Wrong medication administered|1|||
157051236|NCT01757288|566940913|FG002|Overall Study|Wrong medication administered|0|||
157051237|NCT01757288|566940911|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
157051238|NCT01757288|566940912|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
157051239|NCT01757288|566940913|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
157051240|NCT01757288|566940911|FG000|Overall Study|Not meeting protocol constraints|0|||
157051241|NCT01757288|566940912|FG001|Overall Study|Not meeting protocol constraints|1|||
157051242|NCT01757288|566940913|FG002|Overall Study|Not meeting protocol constraints|1|||
157051243|NCT01757288|566940911|FG000|Overall Study|Multiple missed appointments|0|||
157051244|NCT01757288|566940912|FG001|Overall Study|Multiple missed appointments|1|||
157051245|NCT01757288|566940913|FG002|Overall Study|Multiple missed appointments|0|||
157051246|NCT01757288|566940911|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
157051247|NCT01757288|566940912|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
157051248|NCT01757288|566940913|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
157051249|NCT01757288|566940911|FG000|Overall Study|>2 weeks treatment break|0|||
157051250|NCT01757288|566940912|FG001|Overall Study|>2 weeks treatment break|0|||
157051251|NCT01757288|566940913|FG002|Overall Study|>2 weeks treatment break|1|||
157051252|NCT03386344|566940914|FG000|Overall Study|Adverse Event|6|||
157051253|NCT03386344|566940915|FG001|Overall Study|Adverse Event|3|||
157051254|NCT03386344|566940916|FG002|Overall Study|Adverse Event|1|||
157051255|NCT03386344|566940914|FG000|Overall Study|Poor Compliance to Protocol|0|||
157051256|NCT03386344|566940915|FG001|Overall Study|Poor Compliance to Protocol|1|||
157051257|NCT03386344|566940916|FG002|Overall Study|Poor Compliance to Protocol|0|||
157051258|NCT03386344|566940914|FG000|Overall Study|Study Terminated by Sponsor|101|||
157051259|NCT03386344|566940915|FG001|Overall Study|Study Terminated by Sponsor|102|||
157051260|NCT03386344|566940916|FG002|Overall Study|Study Terminated by Sponsor|106|||
157051261|NCT03386344|566940914|FG000|Overall Study|Lost to Follow-up|3|||
157051262|NCT03386344|566940915|FG001|Overall Study|Lost to Follow-up|2|||
157051263|NCT03386344|566940916|FG002|Overall Study|Lost to Follow-up|1|||
157051264|NCT03386344|566940914|FG000|Overall Study|At the Participant's own Request|7|||
157051265|NCT03386344|566940915|FG001|Overall Study|At the Participant's own Request|7|||
157051266|NCT03386344|566940916|FG002|Overall Study|At the Participant's own Request|8|||
157051267|NCT03386344|566940914|FG000|Overall Study|Reason not Specified|0|||
157051268|NCT03386344|566940915|FG001|Overall Study|Reason not Specified|1|||
157051269|NCT03386344|566940916|FG002|Overall Study|Reason not Specified|0|||
157051270|NCT01077284|566940919|FG000|Overall Study|Adverse Event|2|||
157051271|NCT01077284|566940920|FG001|Overall Study|Adverse Event|0|||
157051272|NCT01077284|566940921|FG002|Overall Study|Adverse Event|1|||
157051273|NCT01077284|566940919|FG000|Overall Study|Lost to Follow-up|1|||
157051274|NCT01077284|566940920|FG001|Overall Study|Lost to Follow-up|2|||
157051275|NCT01077284|566940921|FG002|Overall Study|Lost to Follow-up|0|||
157051276|NCT01077284|566940919|FG000|Overall Study|Withdrawal by Subject|2|||
157051277|NCT01077284|566940920|FG001|Overall Study|Withdrawal by Subject|3|||
157176472|NCT00795509|567385544|FG000|Overall Study|Protocol Violation|31|||
157051278|NCT01077284|566940921|FG002|Overall Study|Withdrawal by Subject|1|||
157051279|NCT01077284|566940919|FG000|Overall Study|Other|0|||
157051280|NCT01077284|566940920|FG001|Overall Study|Other|0|||
157051281|NCT01077284|566940921|FG002|Overall Study|Other|1|||
157051282|NCT04626128|566940922|FG000|Overall Study|Withdrawal by Subject|0|||
157051283|NCT04626128|566940923|FG001|Overall Study|Withdrawal by Subject|1|||
157051284|NCT04626128|566940924|FG002|Overall Study|Withdrawal by Subject|0|||
157051285|NCT04626128|566940925|FG003|Overall Study|Withdrawal by Subject|0|||
157051286|NCT00841321|566940930|FG000|Overall Study|Lost to Follow-up|1|||
157051287|NCT00841321|566940931|FG001|Overall Study|Lost to Follow-up|1|||
157051288|NCT00841321|566940930|FG000|Overall Study|Adverse Event|0|||
157051289|NCT00841321|566940931|FG001|Overall Study|Adverse Event|2|||
157051290|NCT02632747|566940932|FG000|Wash-out Period|Adverse Event|1|||
157051291|NCT02632747|566940933|FG001|Wash-out Period|Adverse Event|0|||
157051292|NCT04421456|566940934|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
157051293|NCT04421456|566940935|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
157051294|NCT04421456|566940936|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
157051295|NCT04421456|566940934|FG000|Randomized Treatment Period|Adverse Event|0|||
157051296|NCT04421456|566940935|FG001|Randomized Treatment Period|Adverse Event|1|||
157051297|NCT04421456|566940936|FG002|Randomized Treatment Period|Adverse Event|0|||
157051298|NCT04421456|566940934|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
157051299|NCT04421456|566940935|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
157051300|NCT04421456|566940936|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
157051301|NCT04421456|566940934|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
157051302|NCT04421456|566940935|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
157051303|NCT04421456|566940936|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
157051304|NCT04421456|566940934|FG000|Randomized Treatment Period|Participant non-compliance|1|||
157051305|NCT04421456|566940935|FG001|Randomized Treatment Period|Participant non-compliance|1|||
157051306|NCT04421456|566940936|FG002|Randomized Treatment Period|Participant non-compliance|2|||
157051307|NCT04421456|566940934|FG000|Randomized Treatment Period|Other|0|||
157051308|NCT04421456|566940935|FG001|Randomized Treatment Period|Other|1|||
157051309|NCT04421456|566940936|FG002|Randomized Treatment Period|Other|3|||
157051310|NCT03209492|566940937|FG000|Overall Study|Case Report Forms Uncollected|5|||
157051311|NCT04908488|566940938|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
157051312|NCT04908488|566940939|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
157051313|NCT04908488|566940938|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
157051314|NCT04908488|566940939|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
157051315|NCT01107912|566940940|FG000|Period 1|Adverse Event|0|||
157051316|NCT01107912|566940941|FG001|Period 1|Adverse Event|0|||
157051317|NCT01107912|566940942|FG002|Period 1|Adverse Event|0|||
157051318|NCT01107912|566940943|FG003|Period 1|Adverse Event|0|||
157051319|NCT01107912|566940944|FG004|Period 1|Adverse Event|2|||
157051320|NCT01107912|566940945|FG005|Period 1|Adverse Event|0|||
157051321|NCT01107912|566940940|FG000|Period 1|Physician Decision|0|||
157051322|NCT01107912|566940941|FG001|Period 1|Physician Decision|0|||
157051323|NCT01107912|566940942|FG002|Period 1|Physician Decision|0|||
157051324|NCT01107912|566940943|FG003|Period 1|Physician Decision|0|||
157051325|NCT01107912|566940944|FG004|Period 1|Physician Decision|1|||
157051326|NCT01107912|566940945|FG005|Period 1|Physician Decision|0|||
157051327|NCT01107912|566940940|FG000|Period 1|Withdrawal by Subject|1|||
157051328|NCT01107912|566940941|FG001|Period 1|Withdrawal by Subject|0|||
157051329|NCT01107912|566940942|FG002|Period 1|Withdrawal by Subject|0|||
157051330|NCT01107912|566940943|FG003|Period 1|Withdrawal by Subject|0|||
157051331|NCT01107912|566940944|FG004|Period 1|Withdrawal by Subject|0|||
157051332|NCT01107912|566940945|FG005|Period 1|Withdrawal by Subject|0|||
157051333|NCT01107912|566940940|FG000|Period 2|Physician Decision|0|||
157051334|NCT01107912|566940941|FG001|Period 2|Physician Decision|0|||
157051335|NCT01107912|566940942|FG002|Period 2|Physician Decision|1|||
157051336|NCT01107912|566940943|FG003|Period 2|Physician Decision|0|||
157051337|NCT01107912|566940944|FG004|Period 2|Physician Decision|0|||
157051338|NCT01107912|566940945|FG005|Period 2|Physician Decision|0|||
157051339|NCT01107912|566940940|FG000|Period 3|Adverse Event|0|||
157051340|NCT01107912|566940941|FG001|Period 3|Adverse Event|1|||
157051341|NCT01107912|566940942|FG002|Period 3|Adverse Event|1|||
157051342|NCT01107912|566940943|FG003|Period 3|Adverse Event|0|||
157051343|NCT01107912|566940944|FG004|Period 3|Adverse Event|0|||
157051344|NCT01107912|566940945|FG005|Period 3|Adverse Event|0|||
157051345|NCT01107912|566940940|FG000|Period 3|Withdrawal by Subject|0|||
157051346|NCT01107912|566940941|FG001|Period 3|Withdrawal by Subject|0|||
157051347|NCT01107912|566940942|FG002|Period 3|Withdrawal by Subject|0|||
157051348|NCT01107912|566940943|FG003|Period 3|Withdrawal by Subject|1|||
157051349|NCT01107912|566940944|FG004|Period 3|Withdrawal by Subject|0|||
157051350|NCT01107912|566940945|FG005|Period 3|Withdrawal by Subject|0|||
157051351|NCT00879710|566940950|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
157051352|NCT00879710|566940951|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
157051353|NCT00879710|566940952|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
157051354|NCT00879710|566940953|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
157051355|NCT00879710|566940950|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
157176473|NCT00719953|567385547|FG000|Overall Study|Adverse Event|4|||
157176474|NCT03175562|567385548|FG000|Overall Study|Adverse Event|1|||
157176475|NCT03175562|567385548|FG000|Overall Study|Lost to Follow-up|3|||
157176476|NCT03175562|567385548|FG000|Overall Study|Withdrawal by Subject|7|||
157176477|NCT03175562|567385548|FG000|Overall Study|Other (Not Specified)|5|||
157176478|NCT01230749|567385550|FG000|Overall Study|Adverse Event|0|||
157176479|NCT01230749|567385551|FG001|Overall Study|Adverse Event|0|||
157176480|NCT01230749|567385552|FG002|Overall Study|Adverse Event|0|||
157176481|NCT01230749|567385553|FG003|Overall Study|Adverse Event|1|||
157176482|NCT01230749|567385550|FG000|Overall Study|Physician Decision|0|||
157176483|NCT01230749|567385551|FG001|Overall Study|Physician Decision|0|||
157176484|NCT01230749|567385552|FG002|Overall Study|Physician Decision|1|||
157176485|NCT01230749|567385553|FG003|Overall Study|Physician Decision|0|||
157176486|NCT01230749|567385550|FG000|Overall Study|Withdrawal by Subject|0|||
157176487|NCT01230749|567385551|FG001|Overall Study|Withdrawal by Subject|1|||
157176488|NCT01230749|567385552|FG002|Overall Study|Withdrawal by Subject|0|||
157176489|NCT01230749|567385553|FG003|Overall Study|Withdrawal by Subject|0|||
157176490|NCT01230749|567385550|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
157176491|NCT01230749|567385551|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
157176492|NCT01230749|567385552|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
157176493|NCT01230749|567385553|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
157176494|NCT00402285|567387055|FG000|Overall Study|insufficient RNA quality|7|||
157176495|NCT00402285|567387056|FG001|Overall Study|insufficient RNA quality|6|||
157176496|NCT00402285|567387057|FG002|Overall Study|insufficient RNA quality|2|||
157051356|NCT00879710|566940951|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
157051357|NCT00879710|566940952|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
157051358|NCT00879710|566940953|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
157051359|NCT00595959|566940954|FG000|Overall Study|Withdrawal by Subject|1|||
157051360|NCT00595959|566940954|FG000|Overall Study|Lost to Follow-up|1|||
157051361|NCT00963924|566940955|FG000|Overall Study|Adverse Event|1|||
157051362|NCT00963924|566940956|FG001|Overall Study|Adverse Event|0|||
157051363|NCT00963924|566940955|FG000|Overall Study|Withdrawal by Subject|0|||
157051364|NCT00963924|566940956|FG001|Overall Study|Withdrawal by Subject|1|||
157051365|NCT00963924|566940955|FG000|Overall Study|Changed antipsychotic|0|||
157051366|NCT00963924|566940956|FG001|Overall Study|Changed antipsychotic|1|||
157051367|NCT00963924|566940955|FG000|Overall Study|Lost to Follow-up|0|||
157051368|NCT00963924|566940956|FG001|Overall Study|Lost to Follow-up|1|||
157051369|NCT03875729|566940958|FG000|Overall Study|Adverse Event|0|||
157051370|NCT03875729|566940959|FG001|Overall Study|Adverse Event|5|||
157051371|NCT03875729|566940958|FG000|Overall Study|Withdrawal by Subject|8|||
157051372|NCT03875729|566940959|FG001|Overall Study|Withdrawal by Subject|11|||
157051373|NCT03875729|566940958|FG000|Overall Study|Pregnancy|0|||
157051374|NCT03875729|566940959|FG001|Overall Study|Pregnancy|1|||
157051375|NCT03875729|566940958|FG000|Overall Study|Lost to Follow-up|0|||
157051376|NCT03875729|566940959|FG001|Overall Study|Lost to Follow-up|5|||
157051377|NCT03875729|566940958|FG000|Overall Study|Personal reasons|2|||
157051378|NCT03875729|566940959|FG001|Overall Study|Personal reasons|0|||
157051379|NCT00753896|566940960|FG000|Overall Study|Adverse Event|4|||
157051380|NCT00753896|566940960|FG000|Overall Study|Death|1|||
157051381|NCT00753896|566940960|FG000|Overall Study|Lost to Follow-up|2|||
157051382|NCT00753896|566940960|FG000|Overall Study|Protocol Violation|1|||
157051383|NCT00753896|566940960|FG000|Overall Study|Withdrawal by Subject|4|||
157051384|NCT00753896|566940960|FG000|Overall Study|Entry Criteria Not Met|4|||
157051385|NCT01280656|566940961|FG000|Overall Study|Adverse Event|1|||
157051386|NCT01280656|566940962|FG001|Overall Study|Adverse Event|14|||
157176497|NCT03417505|567387061|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
157176498|NCT03417505|567387062|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
157176499|NCT03235726|567387067|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176500|NCT03235726|567387068|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176501|NCT03235726|567387069|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157229335|NCT03561883|567585230|FG000|Overall Study|Lost to Follow-up|2|||
157176502|NCT03235726|567387070|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176503|NCT03235726|567387071|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
157176504|NCT03235726|567387072|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176505|NCT03235726|567387073|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176506|NCT03235726|567387074|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157051387|NCT01280656|566940963|FG002|Overall Study|Adverse Event|13|||
157051388|NCT01280656|566940961|FG000|Overall Study|Lack of Efficacy|1|||
157051389|NCT01280656|566940962|FG001|Overall Study|Lack of Efficacy|22|||
157051390|NCT01280656|566940963|FG002|Overall Study|Lack of Efficacy|38|||
157051391|NCT01280656|566940961|FG000|Overall Study|Treatment shortening (RGT)|0|||
157051392|NCT01280656|566940962|FG001|Overall Study|Treatment shortening (RGT)|4|||
157051393|NCT01280656|566940963|FG002|Overall Study|Treatment shortening (RGT)|5|||
157176507|NCT03235726|567387075|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157051394|NCT01280656|566940961|FG000|Overall Study|Other|1|||
157176508|NCT03235726|567387076|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
157176509|NCT03235726|567387067|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176510|NCT03235726|567387068|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176511|NCT03235726|567387069|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176512|NCT03235726|567387070|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157051395|NCT01280656|566940962|FG001|Overall Study|Other|7|||
157051396|NCT01280656|566940963|FG002|Overall Study|Other|7|||
157051397|NCT00952523|566940964|FG000|Overall Study|Withdrawal by Subject|7|||
157051398|NCT05265247|566940965|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
157051399|NCT05265247|566940966|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
157051400|NCT05265247|566940965|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
157051401|NCT05265247|566940966|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
157051402|NCT05265247|566940965|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
157051403|NCT05265247|566940966|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
157051404|NCT01856569|566940973|FG000|Overall Study|Other|1|||
157051405|NCT01856569|566940973|FG000|Overall Study|Changed Site/Structure|1|||
157051406|NCT01856569|566940973|FG000|Overall Study|Lost to Follow-up|3|||
157051407|NCT01856569|566940973|FG000|Overall Study|Did not met inclusion criteria|8|||
157051408|NCT02707952|566940974|FG000|Overall Study|Adverse Event|1|||
157176513|NCT03235726|567387071|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
157051409|NCT02707952|566940975|FG001|Overall Study|Adverse Event|0|||
157051410|NCT02707952|566940976|FG002|Overall Study|Adverse Event|0|||
157051411|NCT02707952|566940977|FG003|Overall Study|Adverse Event|0|||
157051412|NCT02707952|566940974|FG000|Overall Study|Lost to Follow-up|1|||
157051413|NCT02707952|566940975|FG001|Overall Study|Lost to Follow-up|0|||
157051414|NCT02707952|566940976|FG002|Overall Study|Lost to Follow-up|0|||
157051415|NCT02707952|566940977|FG003|Overall Study|Lost to Follow-up|0|||
157051416|NCT02707952|566940974|FG000|Overall Study|Withdrawal by Subject|0|||
157051417|NCT02707952|566940975|FG001|Overall Study|Withdrawal by Subject|1|||
157051418|NCT02707952|566940976|FG002|Overall Study|Withdrawal by Subject|2|||
157051419|NCT02707952|566940977|FG003|Overall Study|Withdrawal by Subject|0|||
157051420|NCT01287832|566940979|FG000|Overall Study|Adverse Event|1|||
157051421|NCT01287832|566940980|FG001|Overall Study|Adverse Event|0|||
157051422|NCT01287832|566940979|FG000|Overall Study|Death|0|||
157051423|NCT01287832|566940980|FG001|Overall Study|Death|1|||
157051424|NCT03065400|566940983|FG000|Overall Study|Adverse Event|1|||
157051425|NCT03065400|566940983|FG000|Overall Study|Physician Decision|3|||
157051426|NCT03065400|566940983|FG000|Overall Study|Withdrawal by Subject|1|||
157051427|NCT03065400|566940983|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
157051428|NCT03072862|566940984|FG000|Overall Study|Withdrawal by Subject|4|||
157051429|NCT03072862|566940984|FG000|Overall Study|Lost to Follow-up|6|||
157051430|NCT03072862|566940984|FG000|Overall Study|Protocol Violation|4|||
157051431|NCT03072862|566940984|FG000|Overall Study|Physician Decision|2|||
157051432|NCT03072862|566940984|FG000|Overall Study|Death|1|||
157051433|NCT03072862|566940984|FG000|Overall Study|Adverse Event|1|||
157051434|NCT00632736|566940985|FG000|Overall Study|Adverse Event|104|||
157051435|NCT00632736|566940985|FG000|Overall Study|Lost to Follow-up|15|||
157051436|NCT00632736|566940985|FG000|Overall Study|Protocol Violation|14|||
157051437|NCT00632736|566940985|FG000|Overall Study|Withdrawal by Subject|99|||
157051438|NCT00632736|566940985|FG000|Overall Study|Lack of Efficacy|5|||
157051439|NCT00632736|566940985|FG000|Overall Study|Sponsor terminated study|5|||
157051440|NCT00632736|566940985|FG000|Overall Study|Non-compliance|10|||
157051441|NCT00632736|566940985|FG000|Overall Study|Other|16|||
157051442|NCT03347396|566940986|FG000|Part A (26 Weeks)|Adverse Event|1|||
157051443|NCT03347396|566940987|FG001|Part A (26 Weeks)|Adverse Event|0|||
157051444|NCT03347396|566940986|FG000|Part A (26 Weeks)|Death|0|||
157051445|NCT03347396|566940987|FG001|Part A (26 Weeks)|Death|1|||
157051446|NCT03347396|566940986|FG000|Part B (149 Weeks)|Adverse Event|1|||
157051447|NCT03347396|566940987|FG001|Part B (149 Weeks)|Adverse Event|1|||
157051448|NCT03347396|566940986|FG000|Part B (149 Weeks)|Death|1|||
157176514|NCT03235726|567387072|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157051449|NCT03347396|566940987|FG001|Part B (149 Weeks)|Death|0|||
157176515|NCT03235726|567387073|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176516|NCT03235726|567387074|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176517|NCT03235726|567387075|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157176518|NCT03235726|567387076|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
157051450|NCT03015220|566940990|FG000|Overall Study|Withdrawal by Subject|3|||
157051451|NCT03015220|566940991|FG001|Overall Study|Withdrawal by Subject|2|||
157051452|NCT03015220|566940992|FG002|Overall Study|Withdrawal by Subject|2|||
157051453|NCT03015220|566940993|FG003|Overall Study|Withdrawal by Subject|2|||
157051454|NCT03015220|566940990|FG000|Overall Study|Lost to Follow-up|0|||
157051455|NCT03015220|566940991|FG001|Overall Study|Lost to Follow-up|0|||
157051456|NCT03015220|566940992|FG002|Overall Study|Lost to Follow-up|1|||
157051457|NCT03015220|566940993|FG003|Overall Study|Lost to Follow-up|0|||
157051458|NCT01670526|566940994|FG000|Overall Study|Withdrawal by Subject|3|||
157051459|NCT01670526|566940995|FG001|Overall Study|Withdrawal by Subject|1|||
157051460|NCT01670526|566940994|FG000|Overall Study|Lost to Follow-up|9|||
157051461|NCT01670526|566940995|FG001|Overall Study|Lost to Follow-up|5|||
157051462|NCT00392197|566940996|FG000|Overall Study|Adverse Event|4|||
157051463|NCT00392197|566940997|FG001|Overall Study|Adverse Event|12|||
157051464|NCT00392197|566940996|FG000|Overall Study|Lack of Efficacy|3|||
157051465|NCT00392197|566940997|FG001|Overall Study|Lack of Efficacy|4|||
157051466|NCT00392197|566940996|FG000|Overall Study|Lost to Follow-up|0|||
157051467|NCT00392197|566940997|FG001|Overall Study|Lost to Follow-up|1|||
157051468|NCT00392197|566940996|FG000|Overall Study|Physician Decision|3|||
157051469|NCT00392197|566940997|FG001|Overall Study|Physician Decision|2|||
157051470|NCT00392197|566940996|FG000|Overall Study|Protocol Violation|7|||
157176519|NCT00879437|567387077|FG000|Overall Study|Protocol Violation|0|||
157176520|NCT00879437|567387078|FG001|Overall Study|Protocol Violation|1|||
157176521|NCT00879437|567387077|FG000|Overall Study|Death|1|||
157176522|NCT00879437|567387078|FG001|Overall Study|Death|0|||
157176523|NCT04685538|567387079|FG000|Overall Study|Adverse Event|0|||
157176524|NCT04685538|567387080|FG001|Overall Study|Adverse Event|1|||
157176525|NCT04685538|567387079|FG000|Overall Study|Lost to Follow-up|0|||
157176526|NCT04685538|567387080|FG001|Overall Study|Lost to Follow-up|2|||
157229336|NCT03561883|567585231|FG001|Overall Study|Lost to Follow-up|6|||
157229337|NCT03561883|567585230|FG000|Overall Study|Study Terminated by Sponsor|12|||
157229338|NCT03561883|567585231|FG001|Overall Study|Study Terminated by Sponsor|11|||
157051471|NCT00392197|566940997|FG001|Overall Study|Protocol Violation|5|||
157051472|NCT00392197|566940996|FG000|Overall Study|Withdrawal by Subject|4|||
157051473|NCT00392197|566940997|FG001|Overall Study|Withdrawal by Subject|6|||
157051474|NCT01794689|566940998|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
157051475|NCT01794689|566940999|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
157051476|NCT01794689|566941000|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
157051477|NCT01794689|566941001|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
157051478|NCT01794689|566940998|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
157051479|NCT01794689|566940999|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
157051480|NCT01794689|566941000|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
157051481|NCT01794689|566941001|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
157051482|NCT01794689|566940998|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
157051483|NCT01794689|566940999|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
157051484|NCT01794689|566941000|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
157051485|NCT01794689|566941001|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
157051486|NCT01794689|566940998|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
157051487|NCT01794689|566940999|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
157051488|NCT01794689|566941000|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
157051489|NCT01794689|566941001|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
157051490|NCT02312258|566941002|FG000|Overall Study|Lost to Follow-up|8|||
157051491|NCT02312258|566941003|FG001|Overall Study|Lost to Follow-up|8|||
157051492|NCT02312258|566941002|FG000|Overall Study|Withdrawal by Patient|49|||
157051493|NCT02312258|566941003|FG001|Overall Study|Withdrawal by Patient|76|||
157051494|NCT02312258|566941002|FG000|Overall Study|Reason not Specified|107|||
157051495|NCT02312258|566941003|FG001|Overall Study|Reason not Specified|159|||
157051496|NCT02312258|566941002|FG000|Overall Study|Missing|2|||
157051497|NCT02312258|566941003|FG001|Overall Study|Missing|1|||
157051498|NCT02312258|566941002|FG000|Overall Study|Death|115|||
157051499|NCT02312258|566941003|FG001|Overall Study|Death|181|||
157051500|NCT01970527|566941004|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
157051501|NCT01970527|566941005|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
157176527|NCT00291187|567387081|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
157176528|NCT00291187|567387082|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
157176529|NCT00291187|567387083|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
157176530|NCT00291187|567387084|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
157176531|NCT01040845|567387085|FG000|Overall Study|Withdrawal by Subject|1|||
157176532|NCT01040845|567387086|FG001|Overall Study|Withdrawal by Subject|1|||
157176533|NCT01040845|567387085|FG000|Overall Study|Physician Decision|1|||
157176534|NCT01040845|567387086|FG001|Overall Study|Physician Decision|0|||
157176535|NCT04362813|567387087|FG000|Overall Study|Death|12|||
157051502|NCT01970527|566941004|FG000|Treatment|Disease progression|0|||
157051503|NCT01970527|566941005|FG001|Treatment|Disease progression|1|||
157176536|NCT04362813|567387088|FG001|Overall Study|Death|16|||
157176537|NCT04362813|567387087|FG000|Overall Study|Withdrawal by Subject|3|||
157229339|NCT03561883|567585230|FG000|Overall Study|Physician Decision|1|||
157229340|NCT03561883|567585231|FG001|Overall Study|Physician Decision|0|||
157229341|NCT03561883|567585230|FG000|Overall Study|Randomized by Mistake|1|||
157051504|NCT01970527|566941004|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
157051505|NCT01970527|566941005|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
157051506|NCT01970527|566941004|FG000|Treatment|Death|0|||
157051507|NCT01970527|566941005|FG001|Treatment|Death|1|||
157051508|NCT01970527|566941004|FG000|Follow-up Clinic Visit|Disease progression|1|||
157051509|NCT01970527|566941005|FG001|Follow-up Clinic Visit|Disease progression|1|||
157176538|NCT04362813|567387088|FG001|Overall Study|Withdrawal by Subject|1|||
157176539|NCT04362813|567387087|FG000|Overall Study|Protocol Violation|0|||
157176540|NCT04362813|567387088|FG001|Overall Study|Protocol Violation|3|||
157176541|NCT04362813|567387087|FG000|Overall Study|Lost to Follow-up|1|||
157176542|NCT04362813|567387088|FG001|Overall Study|Lost to Follow-up|1|||
156973186|NCT00988221|566654742|FG003|Part II|Reason not Specified|0|||
156973187|NCT00988221|566654739|FG000|Part III|Adverse Event|1|||
156973188|NCT00988221|566654740|FG001|Part III|Adverse Event|0|||
156973189|NCT00988221|566654741|FG002|Part III|Adverse Event|1|||
156973190|NCT00988221|566654742|FG003|Part III|Adverse Event|0|||
156973191|NCT00988221|566654739|FG000|Part III|Insufficient Therapeutic Response|0|||
156973192|NCT00988221|566654740|FG001|Part III|Insufficient Therapeutic Response|1|||
156973193|NCT00988221|566654741|FG002|Part III|Insufficient Therapeutic Response|1|||
156973194|NCT00988221|566654742|FG003|Part III|Insufficient Therapeutic Response|0|||
156973195|NCT00988221|566654739|FG000|Part III|Refused Treatment|0|||
156973196|NCT00988221|566654740|FG001|Part III|Refused Treatment|0|||
156973197|NCT00988221|566654741|FG002|Part III|Refused Treatment|1|||
156973198|NCT00988221|566654742|FG003|Part III|Refused Treatment|0|||
156973199|NCT02756832|566654745|FG000|Overall Study|Lost for Observation after Baseline|6|||
156973200|NCT02756832|566654745|FG000|Overall Study|Lost for Observation|13|||
156973201|NCT02756832|566654745|FG000|Overall Study|Patient's Unwillingness|12|||
156973202|NCT02756832|566654745|FG000|Overall Study|Insufficient Efficacy|2|||
156973203|NCT02756832|566654745|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
156973204|NCT02756832|566654745|FG000|Overall Study|Reason not Specified|9|||
156973205|NCT02756832|566654745|FG000|Overall Study|Protocol Deviation|10|||
156973206|NCT04146896|566654755|FG000|Overall Study|Adverse Event|5|||
156973207|NCT04146896|566654756|FG001|Overall Study|Adverse Event|8|||
156973208|NCT04146896|566654755|FG000|Overall Study|Lack of Efficacy|3|||
156973209|NCT04146896|566654756|FG001|Overall Study|Lack of Efficacy|2|||
156973210|NCT04146896|566654755|FG000|Overall Study|Lost to Follow-up|0|||
156973211|NCT04146896|566654756|FG001|Overall Study|Lost to Follow-up|1|||
156973212|NCT04146896|566654755|FG000|Overall Study|Non-compliance|5|||
156973213|NCT04146896|566654756|FG001|Overall Study|Non-compliance|4|||
156973214|NCT04146896|566654755|FG000|Overall Study|Withdrawal by Subject|3|||
156973215|NCT04146896|566654756|FG001|Overall Study|Withdrawal by Subject|5|||
156973216|NCT04146896|566654755|FG000|Overall Study|Randomized in error|1|||
156973217|NCT04146896|566654756|FG001|Overall Study|Randomized in error|2|||
156973218|NCT01597505|566654757|FG000|Overall Study|Physician Decision|5|||
156973219|NCT01597505|566654758|FG001|Overall Study|Physician Decision|0|||
156973220|NCT01597505|566654757|FG000|Overall Study|Adverse Event|19|||
156973221|NCT01597505|566654758|FG001|Overall Study|Adverse Event|7|||
156973222|NCT01597505|566654757|FG000|Overall Study|Lost to Follow-up|4|||
156973223|NCT01597505|566654758|FG001|Overall Study|Lost to Follow-up|2|||
156973224|NCT01597505|566654757|FG000|Overall Study|Withdrawal by Subject|10|||
156973225|NCT01597505|566654758|FG001|Overall Study|Withdrawal by Subject|18|||
156973226|NCT01597505|566654757|FG000|Overall Study|Other|5|||
156973227|NCT01597505|566654758|FG001|Overall Study|Other|6|||
156973228|NCT01597505|566654757|FG000|Overall Study|Missing|1|||
156973229|NCT01597505|566654758|FG001|Overall Study|Missing|0|||
156973230|NCT02675465|566654759|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
156973231|NCT02675465|566654760|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
156973232|NCT02675465|566654761|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
156973233|NCT02675465|566654762|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
156973234|NCT02675465|566654763|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
156973235|NCT02675465|566654764|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
156973236|NCT02675465|566654759|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156973237|NCT02675465|566654760|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156973238|NCT02675465|566654761|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
156973239|NCT02675465|566654762|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156973240|NCT02675465|566654763|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156973241|NCT02675465|566654764|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
156973242|NCT02675465|566654759|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
156973243|NCT02675465|566654760|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
156973244|NCT02675465|566654761|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
156973245|NCT02675465|566654762|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
156973246|NCT02675465|566654763|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
156973247|NCT02675465|566654764|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
156973248|NCT02675465|566654759|FG000|Stage 4: Long Term Extension|Death|0|||
156973249|NCT02675465|566654760|FG001|Stage 4: Long Term Extension|Death|0|||
156973250|NCT02675465|566654761|FG002|Stage 4: Long Term Extension|Death|0|||
156973251|NCT02675465|566654762|FG003|Stage 4: Long Term Extension|Death|1|||
156973252|NCT02675465|566654763|FG004|Stage 4: Long Term Extension|Death|0|||
156973253|NCT02675465|566654764|FG005|Stage 4: Long Term Extension|Death|0|||
156973254|NCT05031078|566654765|FG000|Overall Study|Withdrawal by Subject|0|||
156973255|NCT05031078|566654766|FG001|Overall Study|Withdrawal by Subject|1|||
156973256|NCT05031078|566654767|FG002|Overall Study|Withdrawal by Subject|0|||
156973257|NCT03728972|566654768|FG000|Overall Study|Death|1|||
156973258|NCT03728972|566654769|FG001|Overall Study|Death|0|||
156973259|NCT03728972|566654768|FG000|Overall Study|Lack of Efficacy|1|||
156973260|NCT03728972|566654769|FG001|Overall Study|Lack of Efficacy|0|||
156973261|NCT03728972|566654768|FG000|Overall Study|Physician Decision|3|||
156973262|NCT03728972|566654769|FG001|Overall Study|Physician Decision|0|||
156973263|NCT03728972|566654768|FG000|Overall Study|Disease progression|4|||
156973264|NCT03728972|566654769|FG001|Overall Study|Disease progression|3|||
156973265|NCT00895622|566654777|FG000|Overall Study|Protocol Violation|5|||
156973266|NCT00895622|566654778|FG001|Overall Study|Protocol Violation|4|||
156973267|NCT00895622|566654779|FG002|Overall Study|Protocol Violation|4|||
156973268|NCT00532155|566654780|FG000|Overall Study|Adverse Event|66|||
156973269|NCT00532155|566654781|FG001|Overall Study|Adverse Event|123|||
156973270|NCT00532155|566654780|FG000|Overall Study|Lack of Efficacy|332|||
156973271|NCT00532155|566654781|FG001|Overall Study|Lack of Efficacy|255|||
156973272|NCT00532155|566654780|FG000|Overall Study|Protocol Violation|1|||
156973273|NCT00532155|566654781|FG001|Overall Study|Protocol Violation|3|||
156973274|NCT00532155|566654780|FG000|Overall Study|Lost to Follow-up|2|||
156973275|NCT00532155|566654781|FG001|Overall Study|Lost to Follow-up|0|||
156973276|NCT00532155|566654780|FG000|Overall Study|Physician Decision|16|||
156973277|NCT00532155|566654781|FG001|Overall Study|Physician Decision|15|||
156973278|NCT00532155|566654780|FG000|Overall Study|Withdrawal by Subject|23|||
156973279|NCT00532155|566654781|FG001|Overall Study|Withdrawal by Subject|44|||
156973280|NCT00532155|566654780|FG000|Overall Study|Consent withdrawn|5|||
156973281|NCT00532155|566654781|FG001|Overall Study|Consent withdrawn|7|||
156973282|NCT00532155|566654780|FG000|Overall Study|Moved|1|||
156973283|NCT00532155|566654781|FG001|Overall Study|Moved|0|||
156973284|NCT00532155|566654780|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
156973285|NCT00532155|566654781|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
156973286|NCT00532155|566654780|FG000|Overall Study|Occurence of a second cancer|0|||
156973287|NCT00532155|566654781|FG001|Overall Study|Occurence of a second cancer|1|||
156973288|NCT00532155|566654780|FG000|Overall Study|Occurence of a secondary cancer|0|||
156973289|NCT00532155|566654781|FG001|Overall Study|Occurence of a secondary cancer|1|||
156973290|NCT00532155|566654780|FG000|Overall Study|Promotor ended study|1|||
156973291|NCT00532155|566654781|FG001|Overall Study|Promotor ended study|0|||
156973292|NCT00532155|566654780|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
156973293|NCT00532155|566654781|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
156973294|NCT00532155|566654780|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
156973295|NCT00532155|566654781|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
156973296|NCT00532155|566654780|FG000|Overall Study|Study stopped|1|||
156973297|NCT00532155|566654781|FG001|Overall Study|Study stopped|0|||
156973298|NCT00532155|566654780|FG000|Overall Study|Study terminated by sponsor|1|||
156973299|NCT00532155|566654781|FG001|Overall Study|Study terminated by sponsor|0|||
156973300|NCT00532155|566654780|FG000|Overall Study|Study termination stop further treatment|4|||
156973301|NCT00532155|566654781|FG001|Overall Study|Study termination stop further treatment|0|||
156973302|NCT00532155|566654780|FG000|Overall Study|Did not receive study medication|2|||
156973303|NCT00532155|566654781|FG001|Overall Study|Did not receive study medication|6|||
156973304|NCT03483038|566654782|FG000|Overall Study|Subjects still in follow-up|18|||
156973305|NCT04027348|566654783|FG000|Overall Study|Adverse Event|2|||
156973306|NCT02487472|566654784|FG000|Overall Study|Did not complete telephonic interviews|9|||
156973307|NCT02487472|566654784|FG000|Overall Study|Other|2|||
156973308|NCT01313286|566654785|FG000|Period 1|Withdrawal by Subject|2|||
156973309|NCT01313286|566654786|FG001|Period 1|Withdrawal by Subject|0|||
156973310|NCT04843930|566654788|FG000|Randomization|Withdrawal by Subject|6|||
156973311|NCT04843930|566654789|FG001|Randomization|Withdrawal by Subject|6|||
156973312|NCT04843930|566654790|FG002|Randomization|Withdrawal by Subject|0|||
156973313|NCT04843930|566654791|FG003|Randomization|Withdrawal by Subject|0|||
156973314|NCT04843930|566654788|FG000|Week 6 Assessment|Adverse Event|3|||
156973315|NCT04843930|566654789|FG001|Week 6 Assessment|Adverse Event|0|||
156973316|NCT04843930|566654790|FG002|Week 6 Assessment|Adverse Event|0|||
156973317|NCT04843930|566654791|FG003|Week 6 Assessment|Adverse Event|0|||
156973318|NCT04843930|566654788|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
156973319|NCT04843930|566654789|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
156973320|NCT04843930|566654790|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
156973321|NCT04843930|566654791|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
156973322|NCT04843930|566654788|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
156973323|NCT04843930|566654789|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
156973324|NCT04843930|566654790|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
156973325|NCT04843930|566654791|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
156973326|NCT02010632|566654795|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
156973327|NCT02010632|566654796|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
156973328|NCT01987817|566654798|FG000|Overall Study|Adverse Event|4|||
156973329|NCT01987817|566654799|FG001|Overall Study|Adverse Event|0|||
156973330|NCT01987817|566654798|FG000|Overall Study|Withdrawal by Subject|1|||
157051510|NCT01970527|566941004|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
157051511|NCT01970527|566941005|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
157051512|NCT01970527|566941004|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
157051513|NCT01970527|566941005|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
157051514|NCT01964547|566941006|FG000|Overall Study|Adverse Event|8|||
157051515|NCT01964547|566941007|FG001|Overall Study|Adverse Event|2|||
157051516|NCT01964547|566941006|FG000|Overall Study|Withdrawal by Subject|4|||
157051517|NCT01964547|566941007|FG001|Overall Study|Withdrawal by Subject|7|||
157051518|NCT01964547|566941006|FG000|Overall Study|Lost to Follow-up|0|||
157051519|NCT01964547|566941007|FG001|Overall Study|Lost to Follow-up|1|||
157051520|NCT01964547|566941006|FG000|Overall Study|Withdrawal by Investigator|0|||
157051521|NCT01964547|566941007|FG001|Overall Study|Withdrawal by Investigator|1|||
157051522|NCT04447287|566941008|FG000|Period 1: Run-in Period|Adverse Event|3|||
157051523|NCT04447287|566941009|FG001|Period 1: Run-in Period|Adverse Event|0|||
157051524|NCT04447287|566941010|FG002|Period 1: Run-in Period|Adverse Event|0|||
157051525|NCT04447287|566941008|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
157051526|NCT04447287|566941009|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
157051527|NCT04447287|566941010|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
157051528|NCT04447287|566941008|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
157051529|NCT04447287|566941009|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
157051530|NCT04447287|566941010|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
157051531|NCT05700851|566941011|FG000|Overall Study|Received a kidney transplant|1|||
157051532|NCT05700851|566941011|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
157051533|NCT05700851|566941011|FG000|Overall Study|Withdrawal by Subject|1|||
157051534|NCT02147093|566941014|FG000|Period 1|Lost to Follow-up|0|||
157051535|NCT02147093|566941015|FG001|Period 1|Lost to Follow-up|1|||
157051536|NCT02147093|566941014|FG000|Period 2|Protocol Violation|2|||
157051537|NCT02147093|566941015|FG001|Period 2|Protocol Violation|0|||
157051538|NCT03246724|566941016|FG000|Overall Study|Withdrawal by Subject|5|||
157051539|NCT03246724|566941017|FG001|Overall Study|Withdrawal by Subject|2|||
157051540|NCT03246724|566941018|FG002|Overall Study|Withdrawal by Subject|4|||
157051541|NCT03246724|566941019|FG003|Overall Study|Withdrawal by Subject|2|||
157051542|NCT03246724|566941016|FG000|Overall Study|Ineligible on day of surgery|7|||
157051543|NCT03246724|566941017|FG001|Overall Study|Ineligible on day of surgery|2|||
157051544|NCT03246724|566941018|FG002|Overall Study|Ineligible on day of surgery|0|||
157051545|NCT03246724|566941019|FG003|Overall Study|Ineligible on day of surgery|3|||
157051546|NCT03246724|566941016|FG000|Overall Study|Study completed before surgical date|2|||
157051547|NCT03246724|566941017|FG001|Overall Study|Study completed before surgical date|1|||
157051548|NCT03246724|566941018|FG002|Overall Study|Study completed before surgical date|8|||
157051549|NCT03246724|566941019|FG003|Overall Study|Study completed before surgical date|1|||
157051550|NCT03246724|566941016|FG000|Overall Study|Transferred to other arm|0|||
157051551|NCT03246724|566941017|FG001|Overall Study|Transferred to other arm|0|||
157051552|NCT03246724|566941018|FG002|Overall Study|Transferred to other arm|1|||
157051553|NCT03246724|566941019|FG003|Overall Study|Transferred to other arm|0|||
157176543|NCT04362813|567387087|FG000|Overall Study|Enrolled but did not receive treatment|2|||
157176544|NCT04362813|567387088|FG001|Overall Study|Enrolled but did not receive treatment|4|||
157176545|NCT01732107|567387093|FG000|Overall Study|Adverse Event|2|||
157176546|NCT01732107|567387093|FG000|Overall Study|Disease Progression|8|||
157176547|NCT01732107|567387093|FG000|Overall Study|Physician Decision|1|||
157176548|NCT01732107|567387093|FG000|Overall Study|Withdrawal by Subject|2|||
157176549|NCT02023268|567387094|FG000|Overall Study|Lack of Efficacy|0|||
157176550|NCT02023268|567387095|FG001|Overall Study|Lack of Efficacy|1|||
157176551|NCT02023268|567387094|FG000|Overall Study|Adverse Event|0|||
157176552|NCT02023268|567387095|FG001|Overall Study|Adverse Event|2|||
157176553|NCT02023268|567387094|FG000|Overall Study|Withdrawal by Subject|0|||
157176554|NCT02023268|567387095|FG001|Overall Study|Withdrawal by Subject|1|||
157176555|NCT04445688|567387096|FG000|Washout (One Week)|Adverse Event|2|||
157176556|NCT04445688|567387096|FG000|Washout (One Week)|Withdrawal by Subject|1|||
157176557|NCT00615459|567387098|FG000|Period I|Adverse Event|2|||
157176558|NCT00615459|567387099|FG001|Period I|Adverse Event|0|||
157176559|NCT00615459|567387100|FG002|Period I|Adverse Event|1|||
157176560|NCT00615459|567387101|FG003|Period I|Adverse Event|0|||
157176561|NCT00615459|567387098|FG000|Period I|Subject withdrew consent|1|||
157176562|NCT00615459|567387099|FG001|Period I|Subject withdrew consent|0|||
157176563|NCT00615459|567387100|FG002|Period I|Subject withdrew consent|0|||
157176564|NCT00615459|567387101|FG003|Period I|Subject withdrew consent|1|||
157051554|NCT03246724|566941016|FG000|Overall Study|Unable to obtain medication timely|0|||
157176565|NCT00615459|567387098|FG000|Period I|Abnormal test procedure results|1|||
157176566|NCT00615459|567387099|FG001|Period I|Abnormal test procedure results|1|||
157176567|NCT00615459|567387100|FG002|Period I|Abnormal test procedure results|1|||
157051555|NCT03246724|566941017|FG001|Overall Study|Unable to obtain medication timely|2|||
157176568|NCT00615459|567387101|FG003|Period I|Abnormal test procedure results|0|||
157176569|NCT00615459|567387098|FG000|Period II|Adverse Event|1|||
157051556|NCT03246724|566941018|FG002|Overall Study|Unable to obtain medication timely|2|||
157051557|NCT03246724|566941019|FG003|Overall Study|Unable to obtain medication timely|1|||
157051558|NCT03246724|566941016|FG000|Overall Study|Re-consented to participate|0|||
157051559|NCT03246724|566941017|FG001|Overall Study|Re-consented to participate|0|||
157051560|NCT03246724|566941018|FG002|Overall Study|Re-consented to participate|0|||
157176570|NCT00615459|567387099|FG001|Period II|Adverse Event|0|||
157176571|NCT00615459|567387100|FG002|Period II|Adverse Event|0|||
157176572|NCT00615459|567387101|FG003|Period II|Adverse Event|0|||
157176573|NCT00615459|567387098|FG000|Period II|Lost to Follow-up|0|||
157176574|NCT00615459|567387099|FG001|Period II|Lost to Follow-up|0|||
157176575|NCT00615459|567387100|FG002|Period II|Lost to Follow-up|0|||
157176576|NCT00615459|567387101|FG003|Period II|Lost to Follow-up|1|||
157176577|NCT00615459|567387098|FG000|Period III|Adverse Event|0|||
157176578|NCT00615459|567387099|FG001|Period III|Adverse Event|1|||
157176579|NCT00615459|567387100|FG002|Period III|Adverse Event|0|||
157176580|NCT00615459|567387101|FG003|Period III|Adverse Event|0|||
157176581|NCT00615459|567387098|FG000|Period III|Administrative problems|0|||
157176582|NCT00615459|567387099|FG001|Period III|Administrative problems|1|||
157176583|NCT00615459|567387100|FG002|Period III|Administrative problems|1|||
157176584|NCT00615459|567387101|FG003|Period III|Administrative problems|0|||
156973331|NCT01987817|566654799|FG001|Overall Study|Withdrawal by Subject|1|||
156973332|NCT01987817|566654798|FG000|Overall Study|Physician Decision|1|||
156973333|NCT01987817|566654799|FG001|Overall Study|Physician Decision|0|||
156973334|NCT01576718|566654802|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
156973335|NCT01576718|566654803|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973336|NCT01576718|566654804|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973337|NCT01576718|566654805|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973338|NCT01576718|566654806|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973339|NCT01576718|566654807|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973340|NCT01576718|566654808|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
156973341|NCT01576718|566654802|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
156973342|NCT01576718|566654803|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156973343|NCT01576718|566654804|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156973344|NCT01576718|566654805|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
157051561|NCT03246724|566941019|FG003|Overall Study|Re-consented to participate|1|||
157176585|NCT00615459|567387098|FG000|Period III|Unsatisfactory therapeutic effect|0|||
157176586|NCT00615459|567387099|FG001|Period III|Unsatisfactory therapeutic effect|1|||
157176587|NCT00615459|567387100|FG002|Period III|Unsatisfactory therapeutic effect|0|||
157176588|NCT00615459|567387101|FG003|Period III|Unsatisfactory therapeutic effect|0|||
157176589|NCT03379376|567387113|FG000|Overall Study|Lost to Follow-up|2|||
157176590|NCT03379376|567387113|FG000|Overall Study|Did not wish to complete follow up|1|||
157176591|NCT03379376|567387113|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
157176592|NCT03379376|567387113|FG000|Overall Study|Death|1|||
157176593|NCT02475629|567387114|FG000|Overall Study|Adverse Event|1|||
157176594|NCT02475629|567387114|FG000|Overall Study|Death|4|||
157176595|NCT02475629|567387114|FG000|Overall Study|Physician Decision|1|||
157176596|NCT02475629|567387114|FG000|Overall Study|Withdrawal by Subject|1|||
157176597|NCT02475629|567387114|FG000|Overall Study|Lost to Follow-up|1|||
157176598|NCT02475629|567387114|FG000|Overall Study|Subject non-compliance|1|||
157176599|NCT01611298|567387115|FG000|Overall Study|Relapsed|2|||
157176600|NCT01963780|567387116|FG000|Overall Study|Death|7|||
157176601|NCT04083794|567387117|FG000|Overall Study|Lost to Follow-up|9|||
157176602|NCT03383614|567387118|FG000|Overall Study|Withdrawal by Subject|0|||
157176603|NCT03383614|567387119|FG001|Overall Study|Withdrawal by Subject|1|||
157176604|NCT03383614|567387120|FG002|Overall Study|Withdrawal by Subject|0|||
157176605|NCT03383614|567387121|FG003|Overall Study|Withdrawal by Subject|0|||
157176606|NCT04294095|567387123|FG000|Overall Study|Adverse Event|1|||
157176607|NCT04294095|567387124|FG001|Overall Study|Adverse Event|0|||
157176608|NCT00293241|567387125|FG000|Overall Study|Lost to Follow-up|9|||
157176609|NCT00293241|567387126|FG001|Overall Study|Lost to Follow-up|16|||
157176610|NCT00293241|567387125|FG000|Overall Study|Physician Decision|23|||
157176611|NCT00293241|567387126|FG001|Overall Study|Physician Decision|17|||
157176612|NCT00293241|567387125|FG000|Overall Study|Withdrawal by Subject|4|||
157176613|NCT00293241|567387126|FG001|Overall Study|Withdrawal by Subject|8|||
157176614|NCT03803202|567387127|FG000|Overall Study|Other|0|||
157176615|NCT03803202|567387128|FG001|Overall Study|Other|1|||
157176616|NCT03803202|567387129|FG002|Overall Study|Other|0|||
157176617|NCT03803202|567387130|FG003|Overall Study|Other|0|||
157176618|NCT03803202|567387131|FG004|Overall Study|Other|0|||
157176619|NCT03803202|567387132|FG005|Overall Study|Other|0|||
157176620|NCT03803202|567387133|FG006|Overall Study|Other|0|||
157176621|NCT03803202|567387134|FG007|Overall Study|Other|0|||
157176622|NCT03803202|567387135|FG008|Overall Study|Other|0|||
157176623|NCT03803202|567387127|FG000|Overall Study|Death|0|||
157176624|NCT03803202|567387128|FG001|Overall Study|Death|0|||
157176625|NCT03803202|567387129|FG002|Overall Study|Death|0|||
157051562|NCT01229176|566941022|FG000|Overall Study|Withdrawal by Subject|0|||
157051563|NCT01229176|566941023|FG001|Overall Study|Withdrawal by Subject|0|||
157051564|NCT01229176|566941024|FG002|Overall Study|Withdrawal by Subject|0|||
157051565|NCT01229176|566941025|FG003|Overall Study|Withdrawal by Subject|1|||
157051566|NCT01229176|566941026|FG004|Overall Study|Withdrawal by Subject|1|||
157051567|NCT01229176|566941027|FG005|Overall Study|Withdrawal by Subject|1|||
157051568|NCT01229176|566941028|FG006|Overall Study|Withdrawal by Subject|0|||
157051569|NCT01229176|566941029|FG007|Overall Study|Withdrawal by Subject|1|||
157051570|NCT01229176|566941022|FG000|Overall Study|Lost to Follow-up|0|||
157051571|NCT01229176|566941023|FG001|Overall Study|Lost to Follow-up|3|||
157051572|NCT01229176|566941024|FG002|Overall Study|Lost to Follow-up|0|||
157051573|NCT01229176|566941025|FG003|Overall Study|Lost to Follow-up|0|||
157051574|NCT01229176|566941026|FG004|Overall Study|Lost to Follow-up|1|||
157051575|NCT01229176|566941027|FG005|Overall Study|Lost to Follow-up|1|||
157051576|NCT01229176|566941028|FG006|Overall Study|Lost to Follow-up|0|||
157051577|NCT01229176|566941029|FG007|Overall Study|Lost to Follow-up|2|||
157051578|NCT03890484|566941030|FG000|Overall Study|Lost to Follow-up|1|||
157051579|NCT03890484|566941031|FG001|Overall Study|Lost to Follow-up|1|||
157051580|NCT00518206|566941032|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
157051581|NCT00518206|566941033|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
157051582|NCT00518206|566941032|FG000|Overall Study|Withdrawal by Subject|2|||
157051583|NCT00518206|566941033|FG001|Overall Study|Withdrawal by Subject|0|||
157051584|NCT00518206|566941032|FG000|Overall Study|Drug Supply Issue|1|||
157051585|NCT00518206|566941033|FG001|Overall Study|Drug Supply Issue|0|||
157051586|NCT00518206|566941032|FG000|Overall Study|Reason Unknown|1|||
157051587|NCT00518206|566941033|FG001|Overall Study|Reason Unknown|0|||
157051588|NCT00518206|566941032|FG000|Overall Study|Completion Status Unknown|1|||
157051589|NCT00518206|566941033|FG001|Overall Study|Completion Status Unknown|0|||
157051590|NCT03075878|566941034|FG000|Overall Study|Physician Decision|1|||
157051591|NCT02188459|566941035|FG000|Overall Study|Lost to Follow-up|3|||
157051592|NCT02188459|566941036|FG001|Overall Study|Lost to Follow-up|4|||
157051593|NCT02188459|566941035|FG000|Overall Study|Early Termination|0|||
157051594|NCT02188459|566941036|FG001|Overall Study|Early Termination|3|||
157051595|NCT00882050|566941041|FG000|Overall Study|Physician Decision|1|||
157051596|NCT00882050|566941042|FG001|Overall Study|Physician Decision|0|||
157051597|NCT00882050|566941043|FG002|Overall Study|Physician Decision|0|||
157051598|NCT02612285|566941044|FG000|Overall Study|Withdrawal by Subject|1|||
157051599|NCT01322347|566942879|FG000|Overall Study|Adverse Event|7|||
157051600|NCT01322347|566942880|FG001|Overall Study|Adverse Event|2|||
157051601|NCT01322347|566942879|FG000|Overall Study|Death|5|||
157051602|NCT01322347|566942880|FG001|Overall Study|Death|3|||
157051603|NCT01322347|566942879|FG000|Overall Study|Physician Decision|2|||
157051604|NCT01322347|566942880|FG001|Overall Study|Physician Decision|1|||
157051605|NCT01322347|566942879|FG000|Overall Study|Protocol Violation|5|||
157051606|NCT01322347|566942880|FG001|Overall Study|Protocol Violation|2|||
157051607|NCT01322347|566942879|FG000|Overall Study|Withdrawal by Subject|1|||
157051608|NCT01322347|566942880|FG001|Overall Study|Withdrawal by Subject|4|||
157051609|NCT01322347|566942879|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
157051610|NCT01322347|566942880|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
157051611|NCT01322347|566942879|FG000|Overall Study|blood transfusion|5|||
157051612|NCT01322347|566942880|FG001|Overall Study|blood transfusion|5|||
157051613|NCT01322347|566942879|FG000|Overall Study|sponsor decision|1|||
157051614|NCT01322347|566942880|FG001|Overall Study|sponsor decision|3|||
157051615|NCT01322347|566942879|FG000|Overall Study|ineligible|6|||
157051616|NCT01322347|566942880|FG001|Overall Study|ineligible|3|||
157051617|NCT01322347|566942879|FG000|Overall Study|kidney transplant|3|||
157051618|NCT01322347|566942880|FG001|Overall Study|kidney transplant|1|||
157051619|NCT01322347|566942879|FG000|Overall Study|study drug withheld > 12 wks|0|||
157051620|NCT01322347|566942880|FG001|Overall Study|study drug withheld > 12 wks|1|||
157051621|NCT01322347|566942879|FG000|Overall Study|moved/changed dialysis|2|||
157051622|NCT01322347|566942880|FG001|Overall Study|moved/changed dialysis|4|||
157051623|NCT01193283|566942881|FG000|Overall Study|Death|1|||
157051624|NCT04883541|566942882|FG000|Overall Study|Not attending regular yoga class|16|||
157051625|NCT04883541|566942883|FG001|Overall Study|Not attending regular yoga class|0|||
157051626|NCT04883541|566942882|FG000|Overall Study|Not attending the pregnancy school|0|||
157051627|NCT04883541|566942883|FG001|Overall Study|Not attending the pregnancy school|9|||
157051628|NCT03693989|566942885|FG000|Overall Study|Protocol Violation|3|||
157051629|NCT03693989|566942886|FG001|Overall Study|Protocol Violation|4|||
157051630|NCT01052272|566942887|FG000|Overall Study|Death|0|||
157051631|NCT01052272|566942888|FG001|Overall Study|Death|0|||
157051632|NCT01052272|566942889|FG002|Overall Study|Death|1|||
157051633|NCT01052272|566942890|FG003|Overall Study|Death|1|||
157051634|NCT01052272|566942887|FG000|Overall Study|Physician Decision|0|||
157051635|NCT01052272|566942888|FG001|Overall Study|Physician Decision|1|||
157051636|NCT01052272|566942889|FG002|Overall Study|Physician Decision|0|||
157051637|NCT01052272|566942890|FG003|Overall Study|Physician Decision|0|||
157051638|NCT01052272|566942887|FG000|Overall Study|patient refuses follow-up|5|||
157051639|NCT01052272|566942888|FG001|Overall Study|patient refuses follow-up|4|||
157051640|NCT01052272|566942889|FG002|Overall Study|patient refuses follow-up|2|||
157051641|NCT01052272|566942890|FG003|Overall Study|patient refuses follow-up|4|||
157051642|NCT01052272|566942887|FG000|Overall Study|Withdrawal by Subject|0|||
157051643|NCT01052272|566942888|FG001|Overall Study|Withdrawal by Subject|2|||
157051644|NCT01052272|566942889|FG002|Overall Study|Withdrawal by Subject|3|||
157051645|NCT01052272|566942890|FG003|Overall Study|Withdrawal by Subject|2|||
157051646|NCT01052272|566942887|FG000|Overall Study|placed in long-term care|0|||
157051647|NCT01052272|566942888|FG001|Overall Study|placed in long-term care|0|||
157051648|NCT01052272|566942889|FG002|Overall Study|placed in long-term care|1|||
157051649|NCT01052272|566942890|FG003|Overall Study|placed in long-term care|0|||
157051650|NCT01052272|566942887|FG000|Overall Study|decline in health|0|||
157051651|NCT01052272|566942888|FG001|Overall Study|decline in health|0|||
157051652|NCT01052272|566942889|FG002|Overall Study|decline in health|1|||
157051653|NCT01052272|566942890|FG003|Overall Study|decline in health|0|||
157051654|NCT00648895|566942891|FG000|Overall Study|Lack of Efficacy|0|||
157051655|NCT00648895|566942892|FG001|Overall Study|Lack of Efficacy|1|||
157051656|NCT00379210|566942895|FG000|Overall Study|Withdrawal by Subject|10|||
157051657|NCT00379210|566942896|FG001|Overall Study|Withdrawal by Subject|7|||
157051658|NCT01358175|566942897|FG000|Overall Study|Death|1|||
157051659|NCT01358175|566942898|FG001|Overall Study|Death|0|||
157051660|NCT01358175|566942899|FG002|Overall Study|Death|1|||
157051661|NCT01358175|566942897|FG000|Overall Study|Withdrawal by Subject|9|||
157051662|NCT01358175|566942898|FG001|Overall Study|Withdrawal by Subject|5|||
157051663|NCT01358175|566942899|FG002|Overall Study|Withdrawal by Subject|10|||
157051664|NCT01358175|566942897|FG000|Overall Study|Technical issues|0|||
157051665|NCT01358175|566942898|FG001|Overall Study|Technical issues|1|||
157051666|NCT01358175|566942899|FG002|Overall Study|Technical issues|0|||
157051667|NCT01358175|566942897|FG000|Overall Study|Pregnancy|0|||
157051668|NCT01358175|566942898|FG001|Overall Study|Pregnancy|1|||
157051669|NCT01358175|566942899|FG002|Overall Study|Pregnancy|0|||
157051670|NCT01358175|566942897|FG000|Overall Study|Physician Decision|1|||
157051671|NCT01358175|566942898|FG001|Overall Study|Physician Decision|0|||
157051672|NCT01358175|566942899|FG002|Overall Study|Physician Decision|0|||
157051673|NCT01358175|566942897|FG000|Overall Study|Non Compliance with Study Treatment|0|||
157051674|NCT01358175|566942898|FG001|Overall Study|Non Compliance with Study Treatment|1|||
157051675|NCT01358175|566942899|FG002|Overall Study|Non Compliance with Study Treatment|1|||
157051676|NCT01358175|566942897|FG000|Overall Study|Lost to Follow-up|1|||
157051677|NCT01358175|566942898|FG001|Overall Study|Lost to Follow-up|1|||
157051678|NCT01358175|566942899|FG002|Overall Study|Lost to Follow-up|3|||
157051679|NCT01358175|566942897|FG000|Overall Study|Lack of Efficacy|3|||
157051680|NCT01358175|566942898|FG001|Overall Study|Lack of Efficacy|8|||
157051681|NCT01358175|566942899|FG002|Overall Study|Lack of Efficacy|6|||
157051682|NCT01358175|566942897|FG000|Overall Study|Adverse Event|6|||
157051683|NCT01358175|566942898|FG001|Overall Study|Adverse Event|11|||
157051684|NCT01358175|566942899|FG002|Overall Study|Adverse Event|11|||
157051685|NCT02991118|566942900|FG000|Overall Study|Death|3|||
157051686|NCT02991118|566942901|FG001|Overall Study|Death|8|||
157051687|NCT02991118|566942900|FG000|Overall Study|Protocol Violation|0|||
157051688|NCT02991118|566942901|FG001|Overall Study|Protocol Violation|3|||
157051689|NCT02991118|566942900|FG000|Overall Study|Physician Decision|0|||
157051690|NCT02991118|566942901|FG001|Overall Study|Physician Decision|1|||
157051691|NCT02991118|566942900|FG000|Overall Study|Moved out of the country|0|||
157051692|NCT02991118|566942901|FG001|Overall Study|Moved out of the country|1|||
157176626|NCT03803202|567387130|FG003|Overall Study|Death|0|||
157176627|NCT03803202|567387131|FG004|Overall Study|Death|0|||
157176628|NCT03803202|567387132|FG005|Overall Study|Death|1|||
157176629|NCT03803202|567387133|FG006|Overall Study|Death|0|||
157176630|NCT03803202|567387134|FG007|Overall Study|Death|0|||
157176631|NCT03803202|567387135|FG008|Overall Study|Death|0|||
157176632|NCT03803202|567387127|FG000|Overall Study|Withdrawal by Subject|0|||
157176633|NCT03803202|567387128|FG001|Overall Study|Withdrawal by Subject|0|||
157176634|NCT03803202|567387129|FG002|Overall Study|Withdrawal by Subject|1|||
157176635|NCT03803202|567387130|FG003|Overall Study|Withdrawal by Subject|0|||
157176636|NCT03803202|567387131|FG004|Overall Study|Withdrawal by Subject|0|||
157176637|NCT03803202|567387132|FG005|Overall Study|Withdrawal by Subject|0|||
157176638|NCT03803202|567387133|FG006|Overall Study|Withdrawal by Subject|0|||
157176639|NCT03803202|567387134|FG007|Overall Study|Withdrawal by Subject|1|||
157176640|NCT03803202|567387135|FG008|Overall Study|Withdrawal by Subject|0|||
157176641|NCT03803202|567387127|FG000|Overall Study|Lost to Follow-up|0|||
157051693|NCT02991118|566942900|FG000|Overall Study|Adverse Event|2|||
157051694|NCT02991118|566942901|FG001|Overall Study|Adverse Event|2|||
157051695|NCT02991118|566942900|FG000|Overall Study|Withdrawal by Subject|1|||
157051696|NCT02991118|566942901|FG001|Overall Study|Withdrawal by Subject|7|||
157051697|NCT02991118|566942900|FG000|Overall Study|Could not attend study visits|0|||
157051698|NCT02991118|566942901|FG001|Overall Study|Could not attend study visits|1|||
157051699|NCT02991118|566942900|FG000|Overall Study|Lost to Follow-up|1|||
157051700|NCT02991118|566942901|FG001|Overall Study|Lost to Follow-up|9|||
157051701|NCT04085614|566942903|FG000|Overall Study|Protocol Violation|9|||
157051702|NCT04085614|566942904|FG001|Overall Study|Protocol Violation|6|||
157051703|NCT00476957|566942909|FG000|Overall Study|Lost to Follow-up|176|||
157051704|NCT00476957|566942910|FG001|Overall Study|Lost to Follow-up|193|||
157051705|NCT00409747|566942915|FG000|Overall Study|Withdrawal by Subject|1|||
157051706|NCT01989156|566942918|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
157051707|NCT01989156|566942919|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
157051708|NCT01989156|566942920|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
157051709|NCT01989156|566942918|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
157051710|NCT01989156|566942919|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
157051711|NCT01989156|566942920|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
157051712|NCT01989156|566942918|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
157051713|NCT01989156|566942919|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
157051714|NCT01989156|566942920|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
157051715|NCT01989156|566942918|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
157051716|NCT01989156|566942919|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
157051717|NCT01989156|566942920|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
157051718|NCT01989156|566942918|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
157051719|NCT01989156|566942919|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
157051720|NCT01989156|566942920|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
157051721|NCT01989156|566942918|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
157051722|NCT01989156|566942919|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
157051723|NCT01989156|566942920|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
157051724|NCT01989156|566942918|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
157051725|NCT01989156|566942919|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
157051726|NCT01989156|566942920|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
157051727|NCT01989156|566942918|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
157051728|NCT01989156|566942919|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
157051729|NCT01989156|566942920|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
157051730|NCT03839355|566942921|FG000|Overall Study|Withdrawal by Subject|1|||
157051731|NCT03839355|566942922|FG001|Overall Study|Withdrawal by Subject|0|||
157051732|NCT01916109|566942923|FG000|Overall Study|Withdrawal by Subject|1|||
157051733|NCT00103857|566942924|FG000|54-Week Base Study|Adverse Event|12|||
157051734|NCT00103857|566942925|FG001|54-Week Base Study|Adverse Event|9|||
157051735|NCT00103857|566942926|FG002|54-Week Base Study|Adverse Event|11|||
157051736|NCT00103857|566942927|FG003|54-Week Base Study|Adverse Event|6|||
157051737|NCT00103857|566942928|FG004|54-Week Base Study|Adverse Event|5|||
157051738|NCT00103857|566942929|FG005|54-Week Base Study|Adverse Event|11|||
157051739|NCT00103857|566942930|FG006|54-Week Base Study|Adverse Event|3|||
157051740|NCT00103857|566942924|FG000|54-Week Base Study|Death|0|||
157051741|NCT00103857|566942925|FG001|54-Week Base Study|Death|0|||
157051742|NCT00103857|566942926|FG002|54-Week Base Study|Death|0|||
157051743|NCT00103857|566942927|FG003|54-Week Base Study|Death|0|||
157051744|NCT00103857|566942928|FG004|54-Week Base Study|Death|1|||
157051745|NCT00103857|566942929|FG005|54-Week Base Study|Death|1|||
157051746|NCT00103857|566942930|FG006|54-Week Base Study|Death|0|||
157051747|NCT00103857|566942924|FG000|54-Week Base Study|Lack of Efficacy|11|||
157051748|NCT00103857|566942925|FG001|54-Week Base Study|Lack of Efficacy|14|||
157051749|NCT00103857|566942926|FG002|54-Week Base Study|Lack of Efficacy|8|||
157051750|NCT00103857|566942927|FG003|54-Week Base Study|Lack of Efficacy|4|||
157051751|NCT00103857|566942928|FG004|54-Week Base Study|Lack of Efficacy|3|||
157051752|NCT00103857|566942929|FG005|54-Week Base Study|Lack of Efficacy|14|||
157051753|NCT00103857|566942930|FG006|54-Week Base Study|Lack of Efficacy|19|||
157051754|NCT00103857|566942924|FG000|54-Week Base Study|Lost to Follow-up|5|||
157051755|NCT00103857|566942925|FG001|54-Week Base Study|Lost to Follow-up|4|||
157051756|NCT00103857|566942926|FG002|54-Week Base Study|Lost to Follow-up|7|||
157051757|NCT00103857|566942927|FG003|54-Week Base Study|Lost to Follow-up|5|||
157051758|NCT00103857|566942928|FG004|54-Week Base Study|Lost to Follow-up|10|||
157051759|NCT00103857|566942929|FG005|54-Week Base Study|Lost to Follow-up|9|||
157051760|NCT00103857|566942930|FG006|54-Week Base Study|Lost to Follow-up|3|||
157051761|NCT00103857|566942924|FG000|54-Week Base Study|Physician Decision|1|||
157051762|NCT00103857|566942925|FG001|54-Week Base Study|Physician Decision|1|||
157051763|NCT00103857|566942926|FG002|54-Week Base Study|Physician Decision|0|||
157051764|NCT00103857|566942927|FG003|54-Week Base Study|Physician Decision|0|||
157051765|NCT00103857|566942928|FG004|54-Week Base Study|Physician Decision|1|||
157051766|NCT00103857|566942929|FG005|54-Week Base Study|Physician Decision|0|||
157051767|NCT00103857|566942930|FG006|54-Week Base Study|Physician Decision|0|||
157051768|NCT00103857|566942924|FG000|54-Week Base Study|Pregnancy|1|||
157051769|NCT00103857|566942925|FG001|54-Week Base Study|Pregnancy|0|||
157051770|NCT00103857|566942926|FG002|54-Week Base Study|Pregnancy|0|||
157051771|NCT00103857|566942927|FG003|54-Week Base Study|Pregnancy|0|||
157176642|NCT03803202|567387128|FG001|Overall Study|Lost to Follow-up|0|||
157176643|NCT03803202|567387129|FG002|Overall Study|Lost to Follow-up|0|||
157051772|NCT00103857|566942928|FG004|54-Week Base Study|Pregnancy|1|||
157051773|NCT00103857|566942929|FG005|54-Week Base Study|Pregnancy|0|||
157051774|NCT00103857|566942930|FG006|54-Week Base Study|Pregnancy|1|||
157051775|NCT00103857|566942924|FG000|54-Week Base Study|Protocol Violation|6|||
157051776|NCT00103857|566942925|FG001|54-Week Base Study|Protocol Violation|4|||
157051777|NCT00103857|566942926|FG002|54-Week Base Study|Protocol Violation|2|||
157051778|NCT00103857|566942927|FG003|54-Week Base Study|Protocol Violation|4|||
157051779|NCT00103857|566942928|FG004|54-Week Base Study|Protocol Violation|0|||
157051780|NCT00103857|566942929|FG005|54-Week Base Study|Protocol Violation|3|||
157051781|NCT00103857|566942930|FG006|54-Week Base Study|Protocol Violation|3|||
157051782|NCT00103857|566942924|FG000|54-Week Base Study|Withdrawal by Subject|17|||
157051783|NCT00103857|566942925|FG001|54-Week Base Study|Withdrawal by Subject|16|||
157051784|NCT00103857|566942926|FG002|54-Week Base Study|Withdrawal by Subject|16|||
157051785|NCT00103857|566942927|FG003|54-Week Base Study|Withdrawal by Subject|15|||
157051786|NCT00103857|566942928|FG004|54-Week Base Study|Withdrawal by Subject|10|||
157051787|NCT00103857|566942929|FG005|54-Week Base Study|Withdrawal by Subject|15|||
157051788|NCT00103857|566942930|FG006|54-Week Base Study|Withdrawal by Subject|4|||
157051789|NCT00103857|566942924|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
157051790|NCT00103857|566942925|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
157051791|NCT00103857|566942926|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
157051792|NCT00103857|566942927|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
157051793|NCT00103857|566942928|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
157051794|NCT00103857|566942929|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
157051795|NCT00103857|566942930|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
157051796|NCT00103857|566942924|FG000|54-Week Base Study|patient moved|0|||
157051797|NCT00103857|566942925|FG001|54-Week Base Study|patient moved|1|||
157051798|NCT00103857|566942926|FG002|54-Week Base Study|patient moved|1|||
157051799|NCT00103857|566942927|FG003|54-Week Base Study|patient moved|2|||
157051800|NCT00103857|566942928|FG004|54-Week Base Study|patient moved|3|||
157051801|NCT00103857|566942929|FG005|54-Week Base Study|patient moved|1|||
157051802|NCT00103857|566942930|FG006|54-Week Base Study|patient moved|0|||
157051803|NCT00103857|566942924|FG000|54-Week Base Study|non-compliance with study procedures|1|||
157051804|NCT00103857|566942925|FG001|54-Week Base Study|non-compliance with study procedures|2|||
157051805|NCT00103857|566942926|FG002|54-Week Base Study|non-compliance with study procedures|0|||
157051806|NCT00103857|566942927|FG003|54-Week Base Study|non-compliance with study procedures|0|||
157051807|NCT00103857|566942928|FG004|54-Week Base Study|non-compliance with study procedures|0|||
157051808|NCT00103857|566942929|FG005|54-Week Base Study|non-compliance with study procedures|2|||
157051809|NCT00103857|566942930|FG006|54-Week Base Study|non-compliance with study procedures|0|||
157051810|NCT00103857|566942924|FG000|54-Week Base Study|patient incarcerated|0|||
157051811|NCT00103857|566942925|FG001|54-Week Base Study|patient incarcerated|0|||
157051812|NCT00103857|566942926|FG002|54-Week Base Study|patient incarcerated|0|||
157051813|NCT00103857|566942927|FG003|54-Week Base Study|patient incarcerated|0|||
157051814|NCT00103857|566942928|FG004|54-Week Base Study|patient incarcerated|1|||
157051815|NCT00103857|566942929|FG005|54-Week Base Study|patient incarcerated|1|||
157051816|NCT00103857|566942930|FG006|54-Week Base Study|patient incarcerated|0|||
157051817|NCT00103857|566942924|FG000|54-Week Base Study|laboratory reporting error|0|||
157051818|NCT00103857|566942925|FG001|54-Week Base Study|laboratory reporting error|0|||
157051819|NCT00103857|566942926|FG002|54-Week Base Study|laboratory reporting error|0|||
157051820|NCT00103857|566942927|FG003|54-Week Base Study|laboratory reporting error|0|||
157051821|NCT00103857|566942928|FG004|54-Week Base Study|laboratory reporting error|1|||
157051822|NCT00103857|566942929|FG005|54-Week Base Study|laboratory reporting error|0|||
157051823|NCT00103857|566942930|FG006|54-Week Base Study|laboratory reporting error|0|||
157051824|NCT00103857|566942924|FG000|54-Week Base Study|site error|0|||
157051825|NCT00103857|566942925|FG001|54-Week Base Study|site error|0|||
157051826|NCT00103857|566942926|FG002|54-Week Base Study|site error|0|||
157051827|NCT00103857|566942927|FG003|54-Week Base Study|site error|0|||
157051828|NCT00103857|566942928|FG004|54-Week Base Study|site error|0|||
157051829|NCT00103857|566942929|FG005|54-Week Base Study|site error|1|||
157051830|NCT00103857|566942930|FG006|54-Week Base Study|site error|0|||
157051831|NCT00103857|566942924|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
157051832|NCT00103857|566942925|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051833|NCT00103857|566942926|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051834|NCT00103857|566942927|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051835|NCT00103857|566942928|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051836|NCT00103857|566942929|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051837|NCT00103857|566942930|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
157051838|NCT00103857|566942924|FG000|50-Week Extension Study|Adverse Event|2|||
157051839|NCT00103857|566942925|FG001|50-Week Extension Study|Adverse Event|3|||
157051840|NCT00103857|566942926|FG002|50-Week Extension Study|Adverse Event|2|||
157051841|NCT00103857|566942927|FG003|50-Week Extension Study|Adverse Event|0|||
157051842|NCT00103857|566942928|FG004|50-Week Extension Study|Adverse Event|1|||
157051843|NCT00103857|566942929|FG005|50-Week Extension Study|Adverse Event|1|||
157051844|NCT00103857|566942930|FG006|50-Week Extension Study|Adverse Event|0|||
157051845|NCT00103857|566942924|FG000|50-Week Extension Study|Death|0|||
157051846|NCT00103857|566942925|FG001|50-Week Extension Study|Death|0|||
157051847|NCT00103857|566942926|FG002|50-Week Extension Study|Death|0|||
157229342|NCT03561883|567585231|FG001|Overall Study|Randomized by Mistake|0|||
157229343|NCT03561883|567585230|FG000|Overall Study|Other, Not Specified|3|||
157229344|NCT03561883|567585231|FG001|Overall Study|Other, Not Specified|2|||
157051848|NCT00103857|566942927|FG003|50-Week Extension Study|Death|1|||
157051849|NCT00103857|566942928|FG004|50-Week Extension Study|Death|0|||
157051850|NCT00103857|566942929|FG005|50-Week Extension Study|Death|1|||
157051851|NCT00103857|566942930|FG006|50-Week Extension Study|Death|0|||
157051852|NCT00103857|566942924|FG000|50-Week Extension Study|Lack of Efficacy|26|||
157051853|NCT00103857|566942925|FG001|50-Week Extension Study|Lack of Efficacy|15|||
157051854|NCT00103857|566942926|FG002|50-Week Extension Study|Lack of Efficacy|13|||
157051855|NCT00103857|566942927|FG003|50-Week Extension Study|Lack of Efficacy|16|||
157051856|NCT00103857|566942928|FG004|50-Week Extension Study|Lack of Efficacy|8|||
157051857|NCT00103857|566942929|FG005|50-Week Extension Study|Lack of Efficacy|8|||
157051858|NCT00103857|566942930|FG006|50-Week Extension Study|Lack of Efficacy|0|||
157051859|NCT00103857|566942924|FG000|50-Week Extension Study|Lost to Follow-up|4|||
157051860|NCT00103857|566942925|FG001|50-Week Extension Study|Lost to Follow-up|0|||
157051861|NCT00103857|566942926|FG002|50-Week Extension Study|Lost to Follow-up|1|||
157051862|NCT00103857|566942927|FG003|50-Week Extension Study|Lost to Follow-up|4|||
157051863|NCT00103857|566942928|FG004|50-Week Extension Study|Lost to Follow-up|3|||
157051864|NCT00103857|566942929|FG005|50-Week Extension Study|Lost to Follow-up|3|||
157051865|NCT00103857|566942930|FG006|50-Week Extension Study|Lost to Follow-up|0|||
157051866|NCT00103857|566942924|FG000|50-Week Extension Study|Physician Decision|0|||
157051867|NCT00103857|566942925|FG001|50-Week Extension Study|Physician Decision|1|||
157051868|NCT00103857|566942926|FG002|50-Week Extension Study|Physician Decision|1|||
157051869|NCT00103857|566942927|FG003|50-Week Extension Study|Physician Decision|0|||
157051870|NCT00103857|566942928|FG004|50-Week Extension Study|Physician Decision|0|||
157051871|NCT00103857|566942929|FG005|50-Week Extension Study|Physician Decision|0|||
157051872|NCT00103857|566942930|FG006|50-Week Extension Study|Physician Decision|0|||
157051873|NCT00103857|566942924|FG000|50-Week Extension Study|Pregnancy|0|||
157051874|NCT00103857|566942925|FG001|50-Week Extension Study|Pregnancy|0|||
157051875|NCT00103857|566942926|FG002|50-Week Extension Study|Pregnancy|1|||
157051876|NCT00103857|566942927|FG003|50-Week Extension Study|Pregnancy|0|||
157051877|NCT00103857|566942928|FG004|50-Week Extension Study|Pregnancy|1|||
157051878|NCT00103857|566942929|FG005|50-Week Extension Study|Pregnancy|0|||
157051879|NCT00103857|566942930|FG006|50-Week Extension Study|Pregnancy|0|||
157051880|NCT00103857|566942924|FG000|50-Week Extension Study|Protocol Violation|1|||
157051881|NCT00103857|566942925|FG001|50-Week Extension Study|Protocol Violation|1|||
157051882|NCT00103857|566942926|FG002|50-Week Extension Study|Protocol Violation|1|||
157051883|NCT00103857|566942927|FG003|50-Week Extension Study|Protocol Violation|2|||
157051884|NCT00103857|566942928|FG004|50-Week Extension Study|Protocol Violation|0|||
157051885|NCT00103857|566942929|FG005|50-Week Extension Study|Protocol Violation|1|||
157051886|NCT00103857|566942930|FG006|50-Week Extension Study|Protocol Violation|0|||
157051887|NCT00103857|566942924|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
157051888|NCT00103857|566942925|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
157051889|NCT00103857|566942926|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
157051890|NCT00103857|566942927|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
157051891|NCT00103857|566942928|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
157051892|NCT00103857|566942929|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
157051893|NCT00103857|566942930|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
157051894|NCT00103857|566942924|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
157051895|NCT00103857|566942925|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
157051896|NCT00103857|566942926|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
157051897|NCT00103857|566942927|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
157051898|NCT00103857|566942928|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
157051899|NCT00103857|566942929|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
157051900|NCT00103857|566942930|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
157051901|NCT00103857|566942924|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
157051902|NCT00103857|566942925|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
157051903|NCT00103857|566942926|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
157051904|NCT00103857|566942927|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
157051905|NCT00103857|566942928|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
157051906|NCT00103857|566942929|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
157051907|NCT00103857|566942930|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
157051908|NCT00103857|566942924|FG000|50-Week Extension Study|patient moved|0|||
157051909|NCT00103857|566942925|FG001|50-Week Extension Study|patient moved|0|||
157051910|NCT00103857|566942926|FG002|50-Week Extension Study|patient moved|1|||
157051911|NCT00103857|566942927|FG003|50-Week Extension Study|patient moved|2|||
157051912|NCT00103857|566942928|FG004|50-Week Extension Study|patient moved|0|||
157051913|NCT00103857|566942929|FG005|50-Week Extension Study|patient moved|0|||
157051914|NCT00103857|566942930|FG006|50-Week Extension Study|patient moved|0|||
157051915|NCT00103857|566942924|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
157229345|NCT05956665|567585232|FG000|Overall Study|Death|1|||
157051916|NCT00103857|566942925|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
157051917|NCT00103857|566942926|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
157051918|NCT00103857|566942927|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
157051919|NCT00103857|566942928|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
157051920|NCT00103857|566942929|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
157051921|NCT00103857|566942930|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
157051922|NCT00103857|566942924|FG000|50-Week Extension Study|reason unspecified|0|||
157051923|NCT00103857|566942925|FG001|50-Week Extension Study|reason unspecified|0|||
157051924|NCT00103857|566942926|FG002|50-Week Extension Study|reason unspecified|0|||
157051925|NCT00103857|566942927|FG003|50-Week Extension Study|reason unspecified|0|||
157051926|NCT00103857|566942928|FG004|50-Week Extension Study|reason unspecified|1|||
157051927|NCT00103857|566942929|FG005|50-Week Extension Study|reason unspecified|0|||
157051928|NCT00103857|566942930|FG006|50-Week Extension Study|reason unspecified|0|||
157051929|NCT00636168|566942933|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
157051930|NCT00636168|566942934|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
157051931|NCT00636168|566942933|FG000|Randomized to Study Drug|Adverse Event|1|||
157051932|NCT00636168|566942934|FG001|Randomized to Study Drug|Adverse Event|0|||
157051933|NCT00636168|566942933|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
157051934|NCT00636168|566942934|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
157051935|NCT00636168|566942933|FG000|Treated With Study Drug|Recurrence of disease|135|||
157051936|NCT00636168|566942934|FG001|Treated With Study Drug|Recurrence of disease|282|||
157051937|NCT00636168|566942933|FG000|Treated With Study Drug|Adverse Event|250|||
157051938|NCT00636168|566942934|FG001|Treated With Study Drug|Adverse Event|22|||
157051939|NCT00636168|566942933|FG000|Treated With Study Drug|Participant withdrew consent|16|||
157051940|NCT00636168|566942934|FG001|Treated With Study Drug|Participant withdrew consent|21|||
157051941|NCT00636168|566942933|FG000|Treated With Study Drug|Poor/non-compliance|1|||
157051942|NCT00636168|566942934|FG001|Treated With Study Drug|Poor/non-compliance|3|||
157051943|NCT00636168|566942933|FG000|Treated With Study Drug|Death|3|||
157051944|NCT00636168|566942934|FG001|Treated With Study Drug|Death|0|||
157051945|NCT00636168|566942933|FG000|Treated With Study Drug|Pregnancy|1|||
157051946|NCT00636168|566942934|FG001|Treated With Study Drug|Pregnancy|0|||
157051947|NCT00636168|566942933|FG000|Treated With Study Drug|No longer meets study criteria|1|||
157051948|NCT00636168|566942934|FG001|Treated With Study Drug|No longer meets study criteria|0|||
157051949|NCT00636168|566942933|FG000|Treated With Study Drug|Other reason|1|||
157051950|NCT00636168|566942934|FG001|Treated With Study Drug|Other reason|3|||
157051951|NCT00636168|566942933|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
157051952|NCT00636168|566942934|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
157051953|NCT00636168|566942933|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
157051954|NCT00636168|566942934|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
157051955|NCT00636168|566942933|FG000|Long Term Follow-Up|Death|8|||
157051956|NCT00636168|566942934|FG001|Long Term Follow-Up|Death|9|||
157051957|NCT03541369|566942938|FG000|Overall Study|Death|0|||
157051958|NCT03541369|566942939|FG001|Overall Study|Death|0|||
157051959|NCT03541369|566942940|FG002|Overall Study|Death|0|||
157051960|NCT03541369|566942941|FG003|Overall Study|Death|0|||
157051961|NCT03541369|566942942|FG004|Overall Study|Death|1|||
157051962|NCT03541369|566942943|FG005|Overall Study|Death|1|||
157051963|NCT03541369|566942944|FG006|Overall Study|Death|0|||
157051964|NCT03541369|566942945|FG007|Overall Study|Death|2|||
157051965|NCT03541369|566942946|FG008|Overall Study|Death|1|||
157051966|NCT03541369|566942947|FG009|Overall Study|Death|2|||
157051967|NCT03541369|566942948|FG010|Overall Study|Death|1|||
157051968|NCT03541369|566942949|FG011|Overall Study|Death|0|||
157051969|NCT03541369|566942950|FG012|Overall Study|Death|2|||
157051970|NCT03541369|566942951|FG013|Overall Study|Death|1|||
157051971|NCT03541369|566942952|FG014|Overall Study|Death|1|||
157051972|NCT03541369|566942953|FG015|Overall Study|Death|1|||
157051973|NCT03541369|566942954|FG016|Overall Study|Death|0|||
157176644|NCT03803202|567387130|FG003|Overall Study|Lost to Follow-up|1|||
157176645|NCT03803202|567387131|FG004|Overall Study|Lost to Follow-up|1|||
157176646|NCT03803202|567387132|FG005|Overall Study|Lost to Follow-up|0|||
157176647|NCT03803202|567387133|FG006|Overall Study|Lost to Follow-up|1|||
157176648|NCT03803202|567387134|FG007|Overall Study|Lost to Follow-up|0|||
157176649|NCT03803202|567387135|FG008|Overall Study|Lost to Follow-up|0|||
157176650|NCT03595384|567387136|FG000|Overall Study|Other time commitments|8|||
157176651|NCT03595384|567387136|FG000|Overall Study|Changes to session time|7|||
157176652|NCT03595384|567387136|FG000|Overall Study|Relocation out of country|1|||
157051974|NCT03541369|566942955|FG017|Overall Study|Death|1|||
157051975|NCT03541369|566942938|FG000|Overall Study|Decision by sponsor|0|||
157051976|NCT03541369|566942939|FG001|Overall Study|Decision by sponsor|0|||
157051977|NCT03541369|566942940|FG002|Overall Study|Decision by sponsor|0|||
157051978|NCT03541369|566942941|FG003|Overall Study|Decision by sponsor|1|||
157051979|NCT03541369|566942942|FG004|Overall Study|Decision by sponsor|0|||
157051980|NCT03541369|566942943|FG005|Overall Study|Decision by sponsor|2|||
157176653|NCT01125293|567387137|FG000|Overall Study|Disease Progression|1|||
157229346|NCT05956665|567585232|FG000|Overall Study|Withdrawal by Subject|1|||
157051981|NCT03541369|566942944|FG006|Overall Study|Decision by sponsor|0|||
157051982|NCT03541369|566942945|FG007|Overall Study|Decision by sponsor|1|||
157051983|NCT03541369|566942946|FG008|Overall Study|Decision by sponsor|2|||
157051984|NCT03541369|566942947|FG009|Overall Study|Decision by sponsor|0|||
157051985|NCT03541369|566942948|FG010|Overall Study|Decision by sponsor|0|||
157051986|NCT03541369|566942949|FG011|Overall Study|Decision by sponsor|0|||
157051987|NCT03541369|566942950|FG012|Overall Study|Decision by sponsor|2|||
157051988|NCT03541369|566942951|FG013|Overall Study|Decision by sponsor|2|||
157051989|NCT03541369|566942952|FG014|Overall Study|Decision by sponsor|0|||
157051990|NCT03541369|566942953|FG015|Overall Study|Decision by sponsor|1|||
157051991|NCT03541369|566942954|FG016|Overall Study|Decision by sponsor|1|||
157051992|NCT03541369|566942955|FG017|Overall Study|Decision by sponsor|1|||
157051993|NCT03541369|566942938|FG000|Overall Study|Withdrawal by Subject|0|||
157051994|NCT03541369|566942939|FG001|Overall Study|Withdrawal by Subject|0|||
157051995|NCT03541369|566942940|FG002|Overall Study|Withdrawal by Subject|0|||
157051996|NCT03541369|566942941|FG003|Overall Study|Withdrawal by Subject|0|||
157051997|NCT03541369|566942942|FG004|Overall Study|Withdrawal by Subject|0|||
157051998|NCT03541369|566942943|FG005|Overall Study|Withdrawal by Subject|0|||
157051999|NCT03541369|566942944|FG006|Overall Study|Withdrawal by Subject|1|||
157052000|NCT03541369|566942945|FG007|Overall Study|Withdrawal by Subject|0|||
157052001|NCT03541369|566942946|FG008|Overall Study|Withdrawal by Subject|0|||
157052002|NCT03541369|566942947|FG009|Overall Study|Withdrawal by Subject|0|||
157052003|NCT03541369|566942948|FG010|Overall Study|Withdrawal by Subject|0|||
157052004|NCT03541369|566942949|FG011|Overall Study|Withdrawal by Subject|1|||
157052005|NCT03541369|566942950|FG012|Overall Study|Withdrawal by Subject|0|||
157052006|NCT03541369|566942951|FG013|Overall Study|Withdrawal by Subject|0|||
157052007|NCT03541369|566942952|FG014|Overall Study|Withdrawal by Subject|3|||
157052008|NCT03541369|566942953|FG015|Overall Study|Withdrawal by Subject|0|||
157052009|NCT03541369|566942954|FG016|Overall Study|Withdrawal by Subject|4|||
157052010|NCT03541369|566942955|FG017|Overall Study|Withdrawal by Subject|2|||
157052011|NCT03541369|566942938|FG000|Overall Study|Lost to Follow-up|0|||
157052012|NCT03541369|566942939|FG001|Overall Study|Lost to Follow-up|0|||
157052013|NCT03541369|566942940|FG002|Overall Study|Lost to Follow-up|0|||
157052014|NCT03541369|566942941|FG003|Overall Study|Lost to Follow-up|0|||
157052015|NCT03541369|566942942|FG004|Overall Study|Lost to Follow-up|1|||
157052016|NCT03541369|566942943|FG005|Overall Study|Lost to Follow-up|0|||
157052017|NCT03541369|566942944|FG006|Overall Study|Lost to Follow-up|0|||
157052018|NCT03541369|566942945|FG007|Overall Study|Lost to Follow-up|0|||
157052019|NCT03541369|566942946|FG008|Overall Study|Lost to Follow-up|1|||
157052020|NCT03541369|566942947|FG009|Overall Study|Lost to Follow-up|0|||
157052021|NCT03541369|566942948|FG010|Overall Study|Lost to Follow-up|0|||
157052022|NCT03541369|566942949|FG011|Overall Study|Lost to Follow-up|0|||
157052023|NCT03541369|566942950|FG012|Overall Study|Lost to Follow-up|1|||
157052024|NCT03541369|566942951|FG013|Overall Study|Lost to Follow-up|0|||
157052025|NCT03541369|566942952|FG014|Overall Study|Lost to Follow-up|0|||
157052026|NCT03541369|566942953|FG015|Overall Study|Lost to Follow-up|0|||
157052027|NCT03541369|566942954|FG016|Overall Study|Lost to Follow-up|0|||
157052028|NCT03541369|566942955|FG017|Overall Study|Lost to Follow-up|0|||
157052029|NCT00696241|566942956|FG000|Overall Study|Adverse Event|11|||
157052030|NCT00696241|566942957|FG001|Overall Study|Adverse Event|3|||
157052031|NCT00696241|566942958|FG002|Overall Study|Adverse Event|6|||
157052032|NCT00696241|566942959|FG003|Overall Study|Adverse Event|4|||
157052033|NCT00696241|566942960|FG004|Overall Study|Adverse Event|5|||
157052034|NCT00696241|566942956|FG000|Overall Study|Protocol Violation|1|||
157052035|NCT00696241|566942957|FG001|Overall Study|Protocol Violation|1|||
157052036|NCT00696241|566942958|FG002|Overall Study|Protocol Violation|2|||
157052037|NCT00696241|566942959|FG003|Overall Study|Protocol Violation|0|||
157052038|NCT00696241|566942960|FG004|Overall Study|Protocol Violation|3|||
157052039|NCT00696241|566942956|FG000|Overall Study|Lost to Follow-up|1|||
157052040|NCT00696241|566942957|FG001|Overall Study|Lost to Follow-up|4|||
157052041|NCT00696241|566942958|FG002|Overall Study|Lost to Follow-up|1|||
157052042|NCT00696241|566942959|FG003|Overall Study|Lost to Follow-up|2|||
157052043|NCT00696241|566942960|FG004|Overall Study|Lost to Follow-up|0|||
157052044|NCT00696241|566942956|FG000|Overall Study|Withdrawal by Subject|4|||
157052045|NCT00696241|566942957|FG001|Overall Study|Withdrawal by Subject|8|||
157052046|NCT00696241|566942958|FG002|Overall Study|Withdrawal by Subject|6|||
157052047|NCT00696241|566942959|FG003|Overall Study|Withdrawal by Subject|1|||
157052048|NCT00696241|566942960|FG004|Overall Study|Withdrawal by Subject|0|||
157052049|NCT00696241|566942956|FG000|Overall Study|Lack of Efficacy|1|||
157052050|NCT00696241|566942957|FG001|Overall Study|Lack of Efficacy|5|||
157052051|NCT00696241|566942958|FG002|Overall Study|Lack of Efficacy|4|||
157052052|NCT00696241|566942959|FG003|Overall Study|Lack of Efficacy|5|||
157052053|NCT00696241|566942960|FG004|Overall Study|Lack of Efficacy|3|||
157052054|NCT00696241|566942956|FG000|Overall Study|Other|6|||
157052055|NCT00696241|566942957|FG001|Overall Study|Other|1|||
157052056|NCT00696241|566942958|FG002|Overall Study|Other|5|||
157052057|NCT00696241|566942959|FG003|Overall Study|Other|2|||
157052058|NCT00696241|566942960|FG004|Overall Study|Other|1|||
157052059|NCT04749797|566942962|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
157176654|NCT01125293|567387138|FG001|Overall Study|Disease Progression|3|||
157052060|NCT04749797|566942963|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
157052061|NCT04749797|566942964|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
157052062|NCT02513667|566942965|FG000|Overall Study|Withdrawal by Subject|0|||
157052063|NCT02513667|566942966|FG001|Overall Study|Withdrawal by Subject|1|||
157052064|NCT00871715|566942969|FG000|Overall Study|Withdrawal by Subject|6|||
157052065|NCT00871715|566942970|FG001|Overall Study|Withdrawal by Subject|10|||
157052066|NCT00871715|566942971|FG002|Overall Study|Withdrawal by Subject|15|||
157052067|NCT00871715|566942969|FG000|Overall Study|Physician Decision|6|||
157052068|NCT00871715|566942970|FG001|Overall Study|Physician Decision|0|||
157052069|NCT00871715|566942971|FG002|Overall Study|Physician Decision|2|||
157052070|NCT00871715|566942969|FG000|Overall Study|Lost to Follow-up|3|||
157052071|NCT00871715|566942970|FG001|Overall Study|Lost to Follow-up|6|||
157052072|NCT00871715|566942971|FG002|Overall Study|Lost to Follow-up|9|||
157052073|NCT02291549|566942974|FG000|Overall Study|Lost to Follow-up|1|||
157052074|NCT02291549|566942975|FG001|Overall Study|Lost to Follow-up|0|||
157052075|NCT02291549|566942974|FG000|Overall Study|Withdrawal by Subject|0|||
157052076|NCT02291549|566942975|FG001|Overall Study|Withdrawal by Subject|1|||
157052077|NCT00537914|566942976|FG000|Overall Study|Death|1|||
157052078|NCT00537914|566942976|FG000|Overall Study|Adverse Event|7|||
157052079|NCT00537914|566942976|FG000|Overall Study|Treatment failure|10|||
157052080|NCT00537914|566942976|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
157052081|NCT00537914|566942976|FG000|Overall Study|Lost to Follow-up|19|||
157052082|NCT00537914|566942976|FG000|Overall Study|Withdrawal of informed consent|59|||
157052083|NCT01697956|566942978|FG000|Overall Study|Protocol Violation|1|||
157052084|NCT01697956|566942979|FG001|Overall Study|Protocol Violation|1|||
157052085|NCT01115309|566942980|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
157052086|NCT01115309|566942980|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
157052087|NCT01115309|566942980|FG000|Long-term Follow-up|Lost to Follow-up|6|||
157052088|NCT00655824|566942981|FG000|Overall Study|Adverse Event|3|||
157052089|NCT00655824|566942981|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
157052090|NCT00655824|566942981|FG000|Overall Study|Protocol Violation|1|||
157052091|NCT00655824|566942981|FG000|Overall Study|Withdrawal by Subject|4|||
157052092|NCT00655824|566942981|FG000|Overall Study|Deterioration of Trial Disease|2|||
157052093|NCT00589628|566942982|FG000|Overall Study|Lost to Follow-up|0|||
157052094|NCT00589628|566942983|FG001|Overall Study|Lost to Follow-up|1|||
157052095|NCT02189759|566942991|FG000|Overall Study|Lost to Follow-up|0|||
157052096|NCT02189759|566942992|FG001|Overall Study|Lost to Follow-up|0|||
157052097|NCT02189759|566942993|FG002|Overall Study|Lost to Follow-up|2|||
157052098|NCT02189759|566942994|FG003|Overall Study|Lost to Follow-up|5|||
157052099|NCT03032198|566942995|FG000|Overall Study|Screen Fail|1|||
157052100|NCT02470806|566942996|FG000|Overall Study|Lost to Follow-up|1|||
157052101|NCT02470806|566942997|FG001|Overall Study|Lost to Follow-up|1|||
157052102|NCT02470806|566942996|FG000|Overall Study|Adverse Event|5|||
157052103|NCT02470806|566942997|FG001|Overall Study|Adverse Event|2|||
157052104|NCT02470806|566942996|FG000|Overall Study|Protocol Violation|4|||
157052105|NCT02470806|566942997|FG001|Overall Study|Protocol Violation|11|||
157052106|NCT02470806|566942996|FG000|Overall Study|Physician Decision|0|||
157052107|NCT02470806|566942997|FG001|Overall Study|Physician Decision|3|||
157052108|NCT02470806|566942996|FG000|Overall Study|Withdrawal by Subject|3|||
157052109|NCT02470806|566942997|FG001|Overall Study|Withdrawal by Subject|10|||
157052110|NCT02470806|566942996|FG000|Overall Study|Lack of Efficacy|5|||
157052111|NCT02470806|566942997|FG001|Overall Study|Lack of Efficacy|15|||
157052112|NCT00866619|566942998|FG000|Overall Study|Adverse Event|112|||
157052113|NCT00866619|566942999|FG001|Overall Study|Adverse Event|106|||
157052114|NCT00866619|566943000|FG002|Overall Study|Adverse Event|47|||
157052115|NCT00866619|566943001|FG003|Overall Study|Adverse Event|44|||
157052116|NCT00866619|566942998|FG000|Overall Study|Protocol Violation|2|||
157052117|NCT00866619|566942999|FG001|Overall Study|Protocol Violation|39|||
157052118|NCT00866619|566943000|FG002|Overall Study|Protocol Violation|2|||
157052119|NCT00866619|566943001|FG003|Overall Study|Protocol Violation|17|||
157052120|NCT00866619|566942998|FG000|Overall Study|Withdrawal by Subject|587|||
157052121|NCT00866619|566942999|FG001|Overall Study|Withdrawal by Subject|295|||
157052122|NCT00866619|566943000|FG002|Overall Study|Withdrawal by Subject|272|||
157052123|NCT00866619|566943001|FG003|Overall Study|Withdrawal by Subject|144|||
157052124|NCT00866619|566942998|FG000|Overall Study|Lost to Follow-up|1145|||
157052125|NCT00866619|566942999|FG001|Overall Study|Lost to Follow-up|830|||
157052126|NCT00866619|566943000|FG002|Overall Study|Lost to Follow-up|568|||
157052127|NCT00866619|566943001|FG003|Overall Study|Lost to Follow-up|425|||
157052128|NCT01147471|566943002|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
157052129|NCT01147471|566943003|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
157052130|NCT01147471|566943002|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
157052131|NCT01147471|566943003|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
157052132|NCT01147471|566943002|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
157052133|NCT01147471|566943003|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
157052134|NCT01147471|566943002|FG000|3 Month Follow Up|Lost to Follow-up|1|||
157052135|NCT01147471|566943003|FG001|3 Month Follow Up|Lost to Follow-up|1|||
157176655|NCT01125293|567387139|FG002|Overall Study|Disease Progression|4|||
157176656|NCT01125293|567387140|FG003|Overall Study|Disease Progression|3|||
157052136|NCT01147471|566943002|FG000|3 Month Follow Up|Physician Decision|0|||
157052137|NCT01147471|566943003|FG001|3 Month Follow Up|Physician Decision|1|||
157052138|NCT01147471|566943002|FG000|6 Month Follow Up|Lost to Follow-up|4|||
157052139|NCT01147471|566943003|FG001|6 Month Follow Up|Lost to Follow-up|2|||
157052140|NCT02892019|566943006|FG000|Overall Study|randomized but not treated|0|||
157052141|NCT02892019|566943007|FG001|Overall Study|randomized but not treated|1|||
157052142|NCT02892019|566943006|FG000|Overall Study|Withdrawal by Subject|0|||
157052143|NCT02892019|566943007|FG001|Overall Study|Withdrawal by Subject|1|||
157052144|NCT02892019|566943006|FG000|Overall Study|Adverse Event|1|||
157052145|NCT02892019|566943007|FG001|Overall Study|Adverse Event|1|||
157052146|NCT00805441|566943008|FG000|Overall Study|Adverse Event|5|||
157052147|NCT00805441|566943009|FG001|Overall Study|Adverse Event|2|||
157052148|NCT00805441|566943008|FG000|Overall Study|Lack of Efficacy|0|||
157052149|NCT00805441|566943009|FG001|Overall Study|Lack of Efficacy|2|||
157052150|NCT00805441|566943008|FG000|Overall Study|Protocol Violation|4|||
157052151|NCT00805441|566943009|FG001|Overall Study|Protocol Violation|8|||
157052152|NCT00805441|566943008|FG000|Overall Study|Lost to Follow-up|10|||
157052153|NCT00805441|566943009|FG001|Overall Study|Lost to Follow-up|13|||
157052154|NCT00805441|566943008|FG000|Overall Study|Withdrawal by Subject|15|||
157052155|NCT00805441|566943009|FG001|Overall Study|Withdrawal by Subject|9|||
157052156|NCT00805441|566943008|FG000|Overall Study|Physician Decision|0|||
157052157|NCT00805441|566943009|FG001|Overall Study|Physician Decision|1|||
157052158|NCT00805441|566943008|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
157052159|NCT00805441|566943009|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
157052160|NCT02935894|566943014|FG000|Overall Study|Subject dismissed|1|||
157052161|NCT00853957|566943015|FG000|Overall Study|Adverse Event|9|||
157052162|NCT00853957|566943016|FG001|Overall Study|Adverse Event|3|||
157052163|NCT00853957|566943015|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157052164|NCT00853957|566943016|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157052165|NCT00853957|566943015|FG000|Overall Study|Subject withdrew consent|4|||
157052166|NCT00853957|566943016|FG001|Overall Study|Subject withdrew consent|5|||
157052167|NCT00853957|566943015|FG000|Overall Study|Lost to Follow-up|1|||
157052168|NCT00853957|566943016|FG001|Overall Study|Lost to Follow-up|6|||
157052169|NCT00853957|566943015|FG000|Overall Study|Protocol deviation|0|||
157052170|NCT00853957|566943016|FG001|Overall Study|Protocol deviation|3|||
157052171|NCT02942771|566943017|FG000|Overall Study|Adverse Event|1|||
157052172|NCT02942771|566943018|FG001|Overall Study|Adverse Event|0|||
157052173|NCT02942771|566943019|FG002|Overall Study|Adverse Event|0|||
157052174|NCT02942771|566943020|FG003|Overall Study|Adverse Event|0|||
157052175|NCT02942771|566943021|FG004|Overall Study|Adverse Event|2|||
157052176|NCT02942771|566943017|FG000|Overall Study|Lost to Follow-up|1|||
157052177|NCT02942771|566943018|FG001|Overall Study|Lost to Follow-up|0|||
157052178|NCT02942771|566943019|FG002|Overall Study|Lost to Follow-up|0|||
157052179|NCT02942771|566943020|FG003|Overall Study|Lost to Follow-up|0|||
157052180|NCT02942771|566943021|FG004|Overall Study|Lost to Follow-up|0|||
157052181|NCT02942771|566943017|FG000|Overall Study|Withdrawal by Subject|1|||
157052182|NCT02942771|566943018|FG001|Overall Study|Withdrawal by Subject|0|||
157052183|NCT02942771|566943019|FG002|Overall Study|Withdrawal by Subject|0|||
157052184|NCT02942771|566943020|FG003|Overall Study|Withdrawal by Subject|0|||
157052185|NCT02942771|566943021|FG004|Overall Study|Withdrawal by Subject|2|||
157052186|NCT01186809|566943022|FG000|Overall Study|Death|30|||
157052187|NCT04895085|566943023|FG000|Overall Study|Death|1|||
157052188|NCT04895085|566943023|FG000|Overall Study|Withdrawal by Subject|1|||
157052189|NCT04895085|566943023|FG000|Overall Study|No longer eligible: Moved from area|1|||
157052190|NCT04919499|566943028|FG000|Overall Study|Adverse Event|0|||
157052191|NCT04919499|566943029|FG001|Overall Study|Adverse Event|0|||
157052192|NCT04919499|566943030|FG002|Overall Study|Adverse Event|0|||
157052193|NCT04919499|566943031|FG003|Overall Study|Adverse Event|0|||
157052194|NCT04919499|566943032|FG004|Overall Study|Adverse Event|2|||
157052195|NCT04919499|566943028|FG000|Overall Study|Not treated|0|||
157176657|NCT01125293|567387141|FG004|Overall Study|Disease Progression|5|||
157052196|NCT04919499|566943029|FG001|Overall Study|Not treated|0|||
157052197|NCT04919499|566943030|FG002|Overall Study|Not treated|0|||
157052198|NCT04919499|566943031|FG003|Overall Study|Not treated|1|||
157052199|NCT04919499|566943032|FG004|Overall Study|Not treated|0|||
157052200|NCT00946998|566944486|FG000|Overall Study|Exited prior to first outcome assessment|5|||
157052201|NCT00946998|566944487|FG001|Overall Study|Exited prior to first outcome assessment|3|||
157052202|NCT01945593|566944488|FG000|Overall Study|Adverse Event|0|||
157052203|NCT01945593|566944489|FG001|Overall Study|Adverse Event|0|||
157052204|NCT01945593|566944490|FG002|Overall Study|Adverse Event|0|||
157052205|NCT01945593|566944491|FG003|Overall Study|Adverse Event|5|||
157052206|NCT01945593|566944488|FG000|Overall Study|Physician Decision|0|||
157052207|NCT01945593|566944489|FG001|Overall Study|Physician Decision|0|||
157052208|NCT01945593|566944490|FG002|Overall Study|Physician Decision|1|||
157052209|NCT01945593|566944491|FG003|Overall Study|Physician Decision|1|||
157052210|NCT01945593|566944488|FG000|Overall Study|Withdrawal by Subject|0|||
157052211|NCT01945593|566944489|FG001|Overall Study|Withdrawal by Subject|2|||
157052212|NCT01945593|566944490|FG002|Overall Study|Withdrawal by Subject|0|||
157176658|NCT01125293|567387142|FG005|Overall Study|Disease Progression|12|||
157176659|NCT01125293|567387137|FG000|Overall Study|Adverse Event|1|||
157176660|NCT01125293|567387138|FG001|Overall Study|Adverse Event|0|||
157052213|NCT01945593|566944491|FG003|Overall Study|Withdrawal by Subject|4|||
157052214|NCT01945593|566944488|FG000|Overall Study|Protocol Violation|0|||
157052215|NCT01945593|566944489|FG001|Overall Study|Protocol Violation|2|||
157052216|NCT01945593|566944490|FG002|Overall Study|Protocol Violation|1|||
157052217|NCT01945593|566944491|FG003|Overall Study|Protocol Violation|3|||
157052218|NCT01945593|566944488|FG000|Overall Study|Death|0|||
157052219|NCT01945593|566944489|FG001|Overall Study|Death|0|||
157052220|NCT01945593|566944490|FG002|Overall Study|Death|1|||
157052221|NCT01945593|566944491|FG003|Overall Study|Death|0|||
157052222|NCT01945593|566944488|FG000|Overall Study|Other: Terminated|0|||
157052223|NCT01945593|566944489|FG001|Overall Study|Other: Terminated|0|||
157052224|NCT01945593|566944490|FG002|Overall Study|Other: Terminated|0|||
157052225|NCT01945593|566944491|FG003|Overall Study|Other: Terminated|1|||
157052226|NCT01945593|566944488|FG000|Overall Study|Other: Surgical Procedure|0|||
157052227|NCT01945593|566944489|FG001|Overall Study|Other: Surgical Procedure|2|||
157052228|NCT01945593|566944490|FG002|Overall Study|Other: Surgical Procedure|0|||
157052229|NCT01945593|566944491|FG003|Overall Study|Other: Surgical Procedure|6|||
157052230|NCT01945593|566944488|FG000|Overall Study|Other: Screen Failure|0|||
157052231|NCT01945593|566944489|FG001|Overall Study|Other: Screen Failure|2|||
157052232|NCT01945593|566944490|FG002|Overall Study|Other: Screen Failure|0|||
157052233|NCT01945593|566944491|FG003|Overall Study|Other: Screen Failure|0|||
157052234|NCT00228813|566944492|FG000|Overall Study|Death|4|||
157052235|NCT02163499|566944498|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
157052236|NCT02163499|566944498|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
157052237|NCT02163499|566944498|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
157052238|NCT02163499|566944498|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
157052239|NCT02163499|566944498|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
157052240|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
157052241|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
157052242|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
157052243|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
157052244|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
157052245|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
157052246|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
157052247|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
157052248|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
157052249|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Death|8|||
157052250|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
157052251|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
157052252|NCT02163499|566944498|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
157052253|NCT01767376|566944501|FG000|Overall Study|Lost to Follow-up|3|||
157052254|NCT01767376|566944502|FG001|Overall Study|Lost to Follow-up|2|||
157052255|NCT01767376|566944503|FG002|Overall Study|Lost to Follow-up|0|||
157052256|NCT01767376|566944501|FG000|Overall Study|Withdrawal by Subject|1|||
157052257|NCT01767376|566944502|FG001|Overall Study|Withdrawal by Subject|1|||
157052258|NCT01767376|566944503|FG002|Overall Study|Withdrawal by Subject|0|||
157052259|NCT00946088|566944504|FG000|Overall Study|Withdrawal by Subject|0|||
157052260|NCT00946088|566944505|FG001|Overall Study|Withdrawal by Subject|1|||
157052261|NCT02542696|566944513|FG000|Overall Study|Adverse Event|167|||
157052262|NCT02542696|566944513|FG000|Overall Study|Lack of Efficacy|26|||
157052263|NCT02542696|566944513|FG000|Overall Study|Lost to Follow-up|6|||
157052264|NCT02542696|566944513|FG000|Overall Study|Withdrawal by Subject|104|||
157052265|NCT02542696|566944513|FG000|Overall Study|Protocol Violation|5|||
157052266|NCT02542696|566944513|FG000|Overall Study|Death|8|||
157052267|NCT02542696|566944513|FG000|Overall Study|DECREASED OFF TIME|1|||
157052268|NCT02542696|566944513|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
157052269|NCT02542696|566944513|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
157052270|NCT02542696|566944513|FG000|Overall Study|MEDICAL HISTORY|1|||
157052271|NCT02542696|566944513|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
157052272|NCT02542696|566944513|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
157052273|NCT02542696|566944513|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
157052274|NCT02542696|566944513|FG000|Overall Study|SPONSOR DECISION|3|||
157052275|NCT02542696|566944513|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
157052276|NCT02542696|566944513|FG000|Overall Study|SUBJECT DECISION|2|||
157052277|NCT03345407|566944514|FG000|Overall Study|Withdrawal by Subject|11|||
157052278|NCT03345407|566944515|FG001|Overall Study|Withdrawal by Subject|1|||
157052279|NCT03345407|566944516|FG002|Overall Study|Withdrawal by Subject|5|||
157052280|NCT03345407|566944517|FG003|Overall Study|Withdrawal by Subject|6|||
157052281|NCT03345407|566944518|FG004|Overall Study|Withdrawal by Subject|3|||
157052282|NCT03345407|566944519|FG005|Overall Study|Withdrawal by Subject|6|||
157052283|NCT03345407|566944520|FG006|Overall Study|Withdrawal by Subject|16|||
157052284|NCT03345407|566944514|FG000|Overall Study|Physician Decision|3|||
157052285|NCT03345407|566944515|FG001|Overall Study|Physician Decision|1|||
157052286|NCT03345407|566944516|FG002|Overall Study|Physician Decision|0|||
157052287|NCT03345407|566944517|FG003|Overall Study|Physician Decision|0|||
157052288|NCT03345407|566944518|FG004|Overall Study|Physician Decision|1|||
157052289|NCT03345407|566944519|FG005|Overall Study|Physician Decision|2|||
157052290|NCT03345407|566944520|FG006|Overall Study|Physician Decision|3|||
157052291|NCT03345407|566944514|FG000|Overall Study|Lost to Follow-up|2|||
157052292|NCT03345407|566944515|FG001|Overall Study|Lost to Follow-up|0|||
157052293|NCT03345407|566944516|FG002|Overall Study|Lost to Follow-up|1|||
157052294|NCT03345407|566944517|FG003|Overall Study|Lost to Follow-up|0|||
157052295|NCT03345407|566944518|FG004|Overall Study|Lost to Follow-up|1|||
157052296|NCT03345407|566944519|FG005|Overall Study|Lost to Follow-up|2|||
157052297|NCT03345407|566944520|FG006|Overall Study|Lost to Follow-up|3|||
157052298|NCT03345407|566944514|FG000|Overall Study|Protocol-defined stopping criteria|9|||
157052299|NCT03345407|566944515|FG001|Overall Study|Protocol-defined stopping criteria|0|||
157052300|NCT03345407|566944516|FG002|Overall Study|Protocol-defined stopping criteria|0|||
157052301|NCT03345407|566944517|FG003|Overall Study|Protocol-defined stopping criteria|0|||
157052302|NCT03345407|566944518|FG004|Overall Study|Protocol-defined stopping criteria|2|||
157052303|NCT03345407|566944519|FG005|Overall Study|Protocol-defined stopping criteria|1|||
157052304|NCT03345407|566944520|FG006|Overall Study|Protocol-defined stopping criteria|1|||
157052305|NCT03345407|566944514|FG000|Overall Study|Protocol Violation|2|||
157052306|NCT03345407|566944515|FG001|Overall Study|Protocol Violation|0|||
157052307|NCT03345407|566944516|FG002|Overall Study|Protocol Violation|0|||
157052308|NCT03345407|566944517|FG003|Overall Study|Protocol Violation|0|||
157052309|NCT03345407|566944518|FG004|Overall Study|Protocol Violation|1|||
157052310|NCT03345407|566944519|FG005|Overall Study|Protocol Violation|0|||
157052311|NCT03345407|566944520|FG006|Overall Study|Protocol Violation|3|||
157052312|NCT03345407|566944514|FG000|Overall Study|Lack of Efficacy|1|||
157052313|NCT03345407|566944515|FG001|Overall Study|Lack of Efficacy|1|||
157052314|NCT03345407|566944516|FG002|Overall Study|Lack of Efficacy|1|||
157052315|NCT03345407|566944517|FG003|Overall Study|Lack of Efficacy|1|||
157176661|NCT01125293|567387139|FG002|Overall Study|Adverse Event|0|||
157176662|NCT01125293|567387140|FG003|Overall Study|Adverse Event|0|||
157176663|NCT01125293|567387141|FG004|Overall Study|Adverse Event|2|||
157176664|NCT01125293|567387142|FG005|Overall Study|Adverse Event|8|||
157176665|NCT01125293|567387137|FG000|Overall Study|Symptomatic Deterioration|1|||
157176666|NCT01125293|567387138|FG001|Overall Study|Symptomatic Deterioration|0|||
157176667|NCT01125293|567387139|FG002|Overall Study|Symptomatic Deterioration|0|||
157176668|NCT01125293|567387140|FG003|Overall Study|Symptomatic Deterioration|0|||
157176669|NCT01125293|567387141|FG004|Overall Study|Symptomatic Deterioration|0|||
157176670|NCT01125293|567387142|FG005|Overall Study|Symptomatic Deterioration|0|||
157176671|NCT01125293|567387137|FG000|Overall Study|Death|0|||
157176672|NCT01125293|567387138|FG001|Overall Study|Death|0|||
157176673|NCT01125293|567387139|FG002|Overall Study|Death|0|||
157176674|NCT01125293|567387140|FG003|Overall Study|Death|0|||
157176675|NCT01125293|567387141|FG004|Overall Study|Death|1|||
157176676|NCT01125293|567387142|FG005|Overall Study|Death|0|||
157176677|NCT01125293|567387137|FG000|Overall Study|Withdrawal by Subject|0|||
157176678|NCT01125293|567387138|FG001|Overall Study|Withdrawal by Subject|0|||
157176679|NCT01125293|567387139|FG002|Overall Study|Withdrawal by Subject|0|||
157176680|NCT01125293|567387140|FG003|Overall Study|Withdrawal by Subject|0|||
157176681|NCT01125293|567387141|FG004|Overall Study|Withdrawal by Subject|2|||
157176682|NCT01125293|567387142|FG005|Overall Study|Withdrawal by Subject|1|||
157176683|NCT01125293|567387137|FG000|Overall Study|Physician Decision|0|||
157176684|NCT01125293|567387138|FG001|Overall Study|Physician Decision|0|||
157176685|NCT01125293|567387139|FG002|Overall Study|Physician Decision|0|||
157176686|NCT01125293|567387140|FG003|Overall Study|Physician Decision|0|||
157176687|NCT01125293|567387141|FG004|Overall Study|Physician Decision|0|||
157176688|NCT01125293|567387142|FG005|Overall Study|Physician Decision|2|||
157176689|NCT01270958|567387145|FG000|Overall Study|Lost to Follow-up|2|||
157176690|NCT01270958|567387145|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
157176691|NCT00260429|567387148|FG000|Overall Study|failure to follow appointments|1|||
157176692|NCT00260429|567387149|FG001|Overall Study|failure to follow appointments|0|||
157176693|NCT00260429|567387148|FG000|Overall Study|scheduled hand surgery|1|||
157176694|NCT00260429|567387149|FG001|Overall Study|scheduled hand surgery|0|||
157176695|NCT00659126|567387150|FG000|Overall Study|Adverse Event|2|||
157176696|NCT00659126|567387151|FG001|Overall Study|Adverse Event|2|||
157176697|NCT00659126|567387150|FG000|Overall Study|Screen failure|1|||
157176698|NCT00659126|567387151|FG001|Overall Study|Screen failure|1|||
157052316|NCT03345407|566944518|FG004|Overall Study|Lack of Efficacy|1|||
157052317|NCT03345407|566944519|FG005|Overall Study|Lack of Efficacy|0|||
157052318|NCT03345407|566944520|FG006|Overall Study|Lack of Efficacy|3|||
157052319|NCT03345407|566944514|FG000|Overall Study|Adverse Event|4|||
157052320|NCT03345407|566944515|FG001|Overall Study|Adverse Event|0|||
157052321|NCT03345407|566944516|FG002|Overall Study|Adverse Event|5|||
157052322|NCT03345407|566944517|FG003|Overall Study|Adverse Event|4|||
157052323|NCT03345407|566944518|FG004|Overall Study|Adverse Event|6|||
157052324|NCT03345407|566944519|FG005|Overall Study|Adverse Event|5|||
157176699|NCT00659126|567387150|FG000|Overall Study|Technical problems with MRI|0|||
157176700|NCT00659126|567387151|FG001|Overall Study|Technical problems with MRI|1|||
157052325|NCT03345407|566944520|FG006|Overall Study|Adverse Event|16|||
157052326|NCT03262389|566944523|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
157052327|NCT03262389|566944523|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
157052328|NCT03262389|566944523|FG000|Overall Study|opted out of PET/MR|1|||
157052329|NCT02256553|566944525|FG000|Period I|Adverse Event|5|||
157052330|NCT02256553|566944525|FG000|Period I|Protocol Violation|1|||
157052331|NCT02256553|566944525|FG000|Period II|Adverse Event|1|||
157052332|NCT02256553|566944525|FG000|Period II|Subject Moved|1|||
157052333|NCT02256553|566944525|FG000|Period III|Adverse Event|3|||
157052334|NCT02865083|566944528|FG000|Overall Study|Early Termination|3|||
157052335|NCT02865083|566944529|FG001|Overall Study|Early Termination|1|||
157052336|NCT00096278|566944530|FG000|Overall Study|No follow-up data|15|||
157052337|NCT00096278|566944531|FG001|Overall Study|No follow-up data|18|||
157052338|NCT00096278|566944530|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
157052339|NCT00096278|566944531|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
157052340|NCT03651271|566944532|FG000|Overall Study|Death|4|||
157052341|NCT03651271|566944533|FG001|Overall Study|Death|37|||
157052342|NCT03651271|566944534|FG002|Overall Study|Death|0|||
157052343|NCT03651271|566944535|FG003|Overall Study|Death|2|||
157052344|NCT03651271|566944536|FG004|Overall Study|Death|6|||
157052345|NCT03651271|566944532|FG000|Overall Study|Lost to Follow-up|1|||
157052346|NCT03651271|566944533|FG001|Overall Study|Lost to Follow-up|5|||
157052347|NCT03651271|566944534|FG002|Overall Study|Lost to Follow-up|0|||
157052348|NCT03651271|566944535|FG003|Overall Study|Lost to Follow-up|1|||
157052349|NCT03651271|566944536|FG004|Overall Study|Lost to Follow-up|0|||
157052350|NCT03651271|566944532|FG000|Overall Study|Physician Decision|0|||
157052351|NCT03651271|566944533|FG001|Overall Study|Physician Decision|2|||
157052352|NCT03651271|566944534|FG002|Overall Study|Physician Decision|0|||
157052353|NCT03651271|566944535|FG003|Overall Study|Physician Decision|0|||
157052354|NCT03651271|566944536|FG004|Overall Study|Physician Decision|0|||
157052355|NCT03651271|566944532|FG000|Overall Study|Withdrawal by Subject|1|||
157052356|NCT03651271|566944533|FG001|Overall Study|Withdrawal by Subject|15|||
157052357|NCT03651271|566944534|FG002|Overall Study|Withdrawal by Subject|0|||
157052358|NCT03651271|566944535|FG003|Overall Study|Withdrawal by Subject|0|||
157052359|NCT03651271|566944536|FG004|Overall Study|Withdrawal by Subject|1|||
157052360|NCT03651271|566944532|FG000|Overall Study|Patient medically unable to continue|0|||
157052361|NCT03651271|566944533|FG001|Overall Study|Patient medically unable to continue|0|||
157052362|NCT03651271|566944534|FG002|Overall Study|Patient medically unable to continue|0|||
157052363|NCT03651271|566944535|FG003|Overall Study|Patient medically unable to continue|1|||
157052364|NCT03651271|566944536|FG004|Overall Study|Patient medically unable to continue|0|||
157052365|NCT00821093|566944538|FG000|Overall Study|Adverse Event|20|||
157052366|NCT00821093|566944539|FG001|Overall Study|Adverse Event|12|||
157052367|NCT00821093|566944538|FG000|Overall Study|Withdrawal by Subject|9|||
157052368|NCT00821093|566944539|FG001|Overall Study|Withdrawal by Subject|13|||
157052369|NCT00821093|566944538|FG000|Overall Study|Lost to Follow-up|9|||
157052370|NCT00821093|566944539|FG001|Overall Study|Lost to Follow-up|3|||
157052371|NCT00821093|566944538|FG000|Overall Study|Protocol deviation|3|||
157052372|NCT00821093|566944539|FG001|Overall Study|Protocol deviation|6|||
157052373|NCT00821093|566944538|FG000|Overall Study|Abnormal laboratory value(s)|2|||
157052374|NCT00821093|566944539|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157052375|NCT00821093|566944538|FG000|Overall Study|Lack of Efficacy|2|||
157052376|NCT00821093|566944539|FG001|Overall Study|Lack of Efficacy|2|||
157052377|NCT00821093|566944538|FG000|Overall Study|Death|2|||
157052378|NCT00821093|566944539|FG001|Overall Study|Death|1|||
157052379|NCT00821093|566944538|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157052380|NCT00821093|566944539|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157052381|NCT00821093|566944538|FG000|Overall Study|Administrative problems|1|||
157052382|NCT00821093|566944539|FG001|Overall Study|Administrative problems|2|||
157052383|NCT05104242|566944544|FG000|Overall Study|Withdrawal by Subject|1|||
157052384|NCT05104242|566944545|FG001|Overall Study|Withdrawal by Subject|5|||
157052385|NCT05104242|566944544|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
157052386|NCT05104242|566944545|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
157052387|NCT02469155|566944550|FG000|Overall Study|Adverse Event|6|||
157052388|NCT02469155|566944551|FG001|Overall Study|Adverse Event|0|||
157052389|NCT02469155|566944552|FG002|Overall Study|Adverse Event|1|||
157052390|NCT02469155|566944553|FG003|Overall Study|Adverse Event|10|||
157052391|NCT02469155|566944550|FG000|Overall Study|Lack of Efficacy|13|||
157052392|NCT02469155|566944551|FG001|Overall Study|Lack of Efficacy|10|||
157052393|NCT02469155|566944552|FG002|Overall Study|Lack of Efficacy|10|||
157052394|NCT02469155|566944553|FG003|Overall Study|Lack of Efficacy|8|||
157052395|NCT02469155|566944550|FG000|Overall Study|Death|0|||
157052396|NCT02469155|566944551|FG001|Overall Study|Death|0|||
157052397|NCT02469155|566944552|FG002|Overall Study|Death|0|||
157052398|NCT02469155|566944553|FG003|Overall Study|Death|1|||
157052399|NCT02469155|566944550|FG000|Overall Study|Lost to Follow-up|5|||
157052400|NCT02469155|566944551|FG001|Overall Study|Lost to Follow-up|2|||
157052401|NCT02469155|566944552|FG002|Overall Study|Lost to Follow-up|7|||
157052402|NCT02469155|566944553|FG003|Overall Study|Lost to Follow-up|2|||
157052403|NCT02469155|566944550|FG000|Overall Study|Physician Decision|0|||
157052404|NCT02469155|566944551|FG001|Overall Study|Physician Decision|0|||
157052405|NCT02469155|566944552|FG002|Overall Study|Physician Decision|1|||
157052406|NCT02469155|566944553|FG003|Overall Study|Physician Decision|0|||
157052407|NCT02469155|566944550|FG000|Overall Study|Withdrawal by Subject|34|||
157052408|NCT02469155|566944551|FG001|Overall Study|Withdrawal by Subject|30|||
157052409|NCT02469155|566944552|FG002|Overall Study|Withdrawal by Subject|20|||
157052410|NCT02469155|566944553|FG003|Overall Study|Withdrawal by Subject|37|||
157052411|NCT02469155|566944550|FG000|Overall Study|Other|3|||
157052412|NCT02469155|566944551|FG001|Overall Study|Other|3|||
157052413|NCT02469155|566944552|FG002|Overall Study|Other|2|||
157052414|NCT02469155|566944553|FG003|Overall Study|Other|10|||
157052415|NCT02469155|566944550|FG000|Overall Study|Protocol Violation|0|||
157052416|NCT02469155|566944551|FG001|Overall Study|Protocol Violation|1|||
157052417|NCT02469155|566944552|FG002|Overall Study|Protocol Violation|0|||
157052418|NCT02469155|566944553|FG003|Overall Study|Protocol Violation|1|||
157052419|NCT02764320|566944560|FG000|Overall Study|Withdrawal by Subject|35|||
157052420|NCT02764320|566944561|FG001|Overall Study|Withdrawal by Subject|38|||
157052421|NCT02764320|566944560|FG000|Overall Study|Protocol Violation|11|||
157052422|NCT02764320|566944561|FG001|Overall Study|Protocol Violation|6|||
157176701|NCT00587301|567387155|FG000|Overall Study|Screen Failure|9|||
157176702|NCT00587301|567387155|FG000|Overall Study|Lost to Follow-up|22|||
157176703|NCT00587301|567387155|FG000|Overall Study|Withdrawal by Subject|7|||
157229347|NCT03978624|567585238|FG000|Overall Study|Protocol Violation|1|||
157229348|NCT03978624|567585239|FG001|Overall Study|Protocol Violation|0|||
157229349|NCT01606306|567585241|FG000|Overall Study|Lack of Efficacy|2|||
157229350|NCT01606306|567585242|FG001|Overall Study|Lack of Efficacy|1|||
157229351|NCT01606306|567585243|FG002|Overall Study|Lack of Efficacy|4|||
157229352|NCT01606306|567585244|FG003|Overall Study|Lack of Efficacy|4|||
157229353|NCT01606306|567585245|FG004|Overall Study|Lack of Efficacy|1|||
157229354|NCT01606306|567585246|FG005|Overall Study|Lack of Efficacy|2|||
157229355|NCT01606306|567585241|FG000|Overall Study|Adverse Event|1|||
157229356|NCT01606306|567585242|FG001|Overall Study|Adverse Event|0|||
157229357|NCT01606306|567585243|FG002|Overall Study|Adverse Event|1|||
157229358|NCT01606306|567585244|FG003|Overall Study|Adverse Event|1|||
157176704|NCT00587301|567387155|FG000|Overall Study|Protocol Violation|7|||
157229359|NCT01606306|567585245|FG004|Overall Study|Adverse Event|2|||
157229360|NCT01606306|567585246|FG005|Overall Study|Adverse Event|0|||
157229361|NCT01606306|567585241|FG000|Overall Study|Lost to Follow-up|7|||
157229362|NCT01606306|567585242|FG001|Overall Study|Lost to Follow-up|4|||
157176705|NCT01142193|567387157|FG000|Overall Study|Adverse Event|12|||
157176706|NCT01142193|567387158|FG001|Overall Study|Adverse Event|4|||
157176707|NCT01142193|567387157|FG000|Overall Study|Lack of Efficacy|2|||
157176708|NCT01142193|567387158|FG001|Overall Study|Lack of Efficacy|1|||
157176709|NCT01142193|567387157|FG000|Overall Study|Physician Decision|1|||
157176710|NCT01142193|567387158|FG001|Overall Study|Physician Decision|1|||
157176711|NCT01142193|567387157|FG000|Overall Study|Withdrawal by Subject|4|||
157176712|NCT01142193|567387158|FG001|Overall Study|Withdrawal by Subject|3|||
157176713|NCT01142193|567387157|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
157176714|NCT01142193|567387158|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
157176715|NCT01142193|567387157|FG000|Overall Study|Other|1|||
157176716|NCT01142193|567387158|FG001|Overall Study|Other|2|||
157176717|NCT03136367|567387174|FG000|T1 Consultation|discontinued mistakenly included|2|||
157176718|NCT03136367|567387175|FG001|T1 Consultation|discontinued mistakenly included|6|||
157176719|NCT03136367|567387176|FG002|T1 Consultation|discontinued mistakenly included|1|||
157176720|NCT03136367|567387174|FG000|T1 Consultation|Discontinued other|0|||
157176721|NCT03136367|567387175|FG001|T1 Consultation|Discontinued other|1|||
157176722|NCT03136367|567387176|FG002|T1 Consultation|Discontinued other|0|||
157176723|NCT03136367|567387174|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
157176724|NCT03136367|567387175|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
157229363|NCT01606306|567585243|FG002|Overall Study|Lost to Follow-up|5|||
157229364|NCT01606306|567585244|FG003|Overall Study|Lost to Follow-up|4|||
157052423|NCT02764320|566944560|FG000|Overall Study|Adverse Event|2|||
157176725|NCT03136367|567387176|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
157176726|NCT03136367|567387174|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
157176727|NCT03136367|567387175|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
157176728|NCT03136367|567387176|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
157229365|NCT01606306|567585245|FG004|Overall Study|Lost to Follow-up|3|||
157052424|NCT02764320|566944561|FG001|Overall Study|Adverse Event|0|||
157052425|NCT02764320|566944560|FG000|Overall Study|Health Issues unable to continue|2|||
157052426|NCT02764320|566944561|FG001|Overall Study|Health Issues unable to continue|0|||
157229366|NCT01606306|567585246|FG005|Overall Study|Lost to Follow-up|5|||
157052427|NCT02764320|566944560|FG000|Overall Study|Did not meet inclusion criteria|1|||
157052428|NCT02764320|566944561|FG001|Overall Study|Did not meet inclusion criteria|0|||
157229367|NCT01606306|567585241|FG000|Overall Study|Withdrawal by Subject|4|||
157229368|NCT01606306|567585242|FG001|Overall Study|Withdrawal by Subject|3|||
157229369|NCT01606306|567585243|FG002|Overall Study|Withdrawal by Subject|4|||
157052429|NCT02764320|566944560|FG000|Overall Study|Subject moved|0|||
157052430|NCT02764320|566944561|FG001|Overall Study|Subject moved|2|||
157052431|NCT02764320|566944560|FG000|Overall Study|Overused medication unavailable|0|||
157052432|NCT02764320|566944561|FG001|Overall Study|Overused medication unavailable|1|||
157052433|NCT02764320|566944560|FG000|Overall Study|Seeking care outside site|0|||
157052434|NCT02764320|566944561|FG001|Overall Study|Seeking care outside site|1|||
157052435|NCT02764320|566944560|FG000|Overall Study|Technology barriers|0|||
157052436|NCT02764320|566944561|FG001|Overall Study|Technology barriers|1|||
157052437|NCT03150589|566944563|FG000|Overall Study|Withdrawal by Subject|16|||
157052438|NCT03150589|566944564|FG001|Overall Study|Withdrawal by Subject|9|||
157052439|NCT03150589|566944563|FG000|Overall Study|Adverse Event|7|||
157052440|NCT03150589|566944564|FG001|Overall Study|Adverse Event|6|||
157052441|NCT03150589|566944563|FG000|Overall Study|Protocol Violation|4|||
157052442|NCT03150589|566944564|FG001|Overall Study|Protocol Violation|3|||
157052443|NCT03150589|566944563|FG000|Overall Study|Lost to Follow-up|3|||
157052444|NCT03150589|566944564|FG001|Overall Study|Lost to Follow-up|3|||
157052445|NCT03150589|566944563|FG000|Overall Study|Death|2|||
157052446|NCT03150589|566944564|FG001|Overall Study|Death|3|||
157052447|NCT03150589|566944563|FG000|Overall Study|IP non-compliance and other reasons|12|||
157052448|NCT03150589|566944564|FG001|Overall Study|IP non-compliance and other reasons|3|||
157052449|NCT01405508|566944565|FG000|Overall Study|AE, non-serious non-fatal|1|||
157052450|NCT01405508|566944566|FG001|Overall Study|AE, non-serious non-fatal|1|||
157052451|NCT01405508|566944567|FG002|Overall Study|AE, non-serious non-fatal|0|||
157052452|NCT01405508|566944568|FG003|Overall Study|AE, non-serious non-fatal|0|||
157052453|NCT03529942|566944569|FG000|Overall Study|Withdrawal by Subject|13|||
157052454|NCT03529942|566944569|FG000|Overall Study|Physician Decision|1|||
157052455|NCT03529942|566944569|FG000|Overall Study|Lost to Follow-up|7|||
157052456|NCT03529942|566944569|FG000|Overall Study|Needle inserted but no drug administered|1|||
157052457|NCT03529942|566944569|FG000|Overall Study|Personal reasons|1|||
157052458|NCT02516202|566944572|FG000|Overall Study|Withdrawal by Subject|1|||
157052459|NCT02516202|566944573|FG001|Overall Study|Withdrawal by Subject|0|||
157052460|NCT02516202|566944574|FG002|Overall Study|Withdrawal by Subject|1|||
157052461|NCT02516202|566944572|FG000|Overall Study|Lost to Follow-up|1|||
157052462|NCT02516202|566944573|FG001|Overall Study|Lost to Follow-up|1|||
157052463|NCT02516202|566944574|FG002|Overall Study|Lost to Follow-up|1|||
157052464|NCT02516202|566944572|FG000|Overall Study|Stopped Follow-up|0|||
157052465|NCT02516202|566944573|FG001|Overall Study|Stopped Follow-up|0|||
157052466|NCT02516202|566944574|FG002|Overall Study|Stopped Follow-up|1|||
157052467|NCT01000649|566944575|FG000|Overall Study|Adverse Event|5|||
157052468|NCT01000649|566944576|FG001|Overall Study|Adverse Event|1|||
157052469|NCT01000649|566944577|FG002|Overall Study|Adverse Event|2|||
157052470|NCT01000649|566944578|FG003|Overall Study|Adverse Event|4|||
157052471|NCT01000649|566944575|FG000|Overall Study|Lost to Follow-up|0|||
157052472|NCT01000649|566944576|FG001|Overall Study|Lost to Follow-up|2|||
157052473|NCT01000649|566944577|FG002|Overall Study|Lost to Follow-up|0|||
157052474|NCT01000649|566944578|FG003|Overall Study|Lost to Follow-up|2|||
157052475|NCT00689351|566944579|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
157052476|NCT00689351|566944580|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
157052477|NCT00689351|566944579|FG000|Infant Series of Dosing|Adverse Event|1|||
157052478|NCT00689351|566944580|FG001|Infant Series of Dosing|Adverse Event|0|||
157052479|NCT00689351|566944579|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
157052480|NCT00689351|566944580|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
157052481|NCT00689351|566944579|FG000|After Infant Series|Parent/legal guardian request|1|||
157052482|NCT00689351|566944580|FG001|After Infant Series|Parent/legal guardian request|0|||
157052483|NCT01766206|566944581|FG000|Overall Study|Withdrawal by Subject|22|||
157052484|NCT01766206|566944581|FG000|Overall Study|Lost to Follow-up|10|||
157052485|NCT01766206|566944581|FG000|Overall Study|Inappropriate enrollment|18|||
157052486|NCT01766206|566944581|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
157052487|NCT01662505|566944582|FG000|Overall Study|Progressive disease|6|||
157052488|NCT01662505|566944583|FG001|Overall Study|Progressive disease|1|||
157052489|NCT01662505|566944584|FG002|Overall Study|Progressive disease|5|||
157052490|NCT01662505|566944582|FG000|Overall Study|Refused cont. medication|0|||
157176729|NCT03136367|567387174|FG000|T2 Post-consultation|Discontinued other|0|||
157176730|NCT03136367|567387175|FG001|T2 Post-consultation|Discontinued other|2|||
157176731|NCT03136367|567387176|FG002|T2 Post-consultation|Discontinued other|6|||
157052491|NCT01662505|566944583|FG001|Overall Study|Refused cont. medication|0|||
157052492|NCT01662505|566944584|FG002|Overall Study|Refused cont. medication|1|||
157052493|NCT01662505|566944582|FG000|Overall Study|Not specified above|1|||
157052494|NCT01662505|566944583|FG001|Overall Study|Not specified above|3|||
157052495|NCT01662505|566944584|FG002|Overall Study|Not specified above|2|||
157052496|NCT01313663|566944585|FG000|Overall Study|Study Closed/Terminated|2|||
157052497|NCT01313663|566944586|FG001|Overall Study|Study Closed/Terminated|4|||
157052498|NCT01313663|566944585|FG000|Overall Study|Lost to Follow-up|0|||
157052499|NCT01313663|566944586|FG001|Overall Study|Lost to Follow-up|1|||
157052500|NCT01313663|566944585|FG000|Overall Study|Physician Decision|0|||
157052501|NCT01313663|566944586|FG001|Overall Study|Physician Decision|2|||
157052502|NCT01313663|566944585|FG000|Overall Study|Withdrawal by Subject|2|||
157052503|NCT01313663|566944586|FG001|Overall Study|Withdrawal by Subject|1|||
157052504|NCT01661972|566944587|FG000|Overall Study|Adverse Event|1|||
157052505|NCT01661972|566944588|FG001|Overall Study|Adverse Event|2|||
157052506|NCT01661972|566944587|FG000|Overall Study|Death during Treatment period|1|||
157052507|NCT01661972|566944588|FG001|Overall Study|Death during Treatment period|1|||
157052508|NCT01661972|566944587|FG000|Overall Study|Withdrawal by Subject|0|||
157052509|NCT01661972|566944588|FG001|Overall Study|Withdrawal by Subject|1|||
157052510|NCT02138838|566944594|FG000|Overall Study|Study Closure|7|||
157052511|NCT02138838|566944595|FG001|Overall Study|Study Closure|6|||
157052512|NCT02138838|566944594|FG000|Overall Study|Withdrawal by Subject|1|||
157052513|NCT02138838|566944595|FG001|Overall Study|Withdrawal by Subject|5|||
157052514|NCT01294644|566944597|FG000|Overall Study|Adverse Event|2|||
157052515|NCT01294644|566944598|FG001|Overall Study|Adverse Event|0|||
157052516|NCT01294644|566944599|FG002|Overall Study|Adverse Event|1|||
157052517|NCT01294644|566944597|FG000|Overall Study|Withdrawal by Subject|3|||
157052518|NCT01294644|566944598|FG001|Overall Study|Withdrawal by Subject|7|||
157052519|NCT01294644|566944599|FG002|Overall Study|Withdrawal by Subject|4|||
157052520|NCT01294644|566944597|FG000|Overall Study|Lost to Follow-up|3|||
157052521|NCT01294644|566944598|FG001|Overall Study|Lost to Follow-up|2|||
157052522|NCT01294644|566944599|FG002|Overall Study|Lost to Follow-up|5|||
157052523|NCT01294644|566944597|FG000|Overall Study|Miscellaneous Reason|2|||
157052524|NCT01294644|566944598|FG001|Overall Study|Miscellaneous Reason|1|||
157052525|NCT01294644|566944599|FG002|Overall Study|Miscellaneous Reason|4|||
157052526|NCT02367794|566944600|FG000|Overall Study|Death|252|||
157052527|NCT02367794|566944601|FG001|Overall Study|Death|245|||
157052528|NCT02367794|566944602|FG002|Overall Study|Death|243|||
157052529|NCT02367794|566944600|FG000|Overall Study|Lost to Follow-up|1|||
157052530|NCT02367794|566944601|FG001|Overall Study|Lost to Follow-up|2|||
157052531|NCT02367794|566944602|FG002|Overall Study|Lost to Follow-up|2|||
157052532|NCT02367794|566944600|FG000|Overall Study|Physician Decision|0|||
157052533|NCT02367794|566944601|FG001|Overall Study|Physician Decision|5|||
157052534|NCT02367794|566944602|FG002|Overall Study|Physician Decision|3|||
157052535|NCT02367794|566944600|FG000|Overall Study|Protocol Violation|1|||
157052536|NCT02367794|566944601|FG001|Overall Study|Protocol Violation|0|||
157052537|NCT02367794|566944602|FG002|Overall Study|Protocol Violation|1|||
157052538|NCT02367794|566944600|FG000|Overall Study|Withdrawal by Subject|25|||
157052539|NCT02367794|566944601|FG001|Overall Study|Withdrawal by Subject|12|||
157052540|NCT02367794|566944602|FG002|Overall Study|Withdrawal by Subject|20|||
157052541|NCT02367794|566944600|FG000|Overall Study|Brain metastasis|1|||
157052542|NCT02367794|566944601|FG001|Overall Study|Brain metastasis|0|||
157052543|NCT02367794|566944602|FG002|Overall Study|Brain metastasis|0|||
157052544|NCT02367794|566944600|FG000|Overall Study|Randomized in error|0|||
157052545|NCT02367794|566944601|FG001|Overall Study|Randomized in error|0|||
157052546|NCT02367794|566944602|FG002|Overall Study|Randomized in error|1|||
157052547|NCT02367794|566944600|FG000|Overall Study|Patient unable to receive carboplatin|0|||
157052548|NCT02367794|566944601|FG001|Overall Study|Patient unable to receive carboplatin|0|||
157052549|NCT02367794|566944602|FG002|Overall Study|Patient unable to receive carboplatin|1|||
157052550|NCT02367794|566944600|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
157052551|NCT02367794|566944601|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
157052552|NCT02367794|566944602|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
157052553|NCT02367794|566944600|FG000|Overall Study|Adverse Event|0|||
157052554|NCT02367794|566944601|FG001|Overall Study|Adverse Event|0|||
157052555|NCT02367794|566944602|FG002|Overall Study|Adverse Event|2|||
157052556|NCT02367794|566944600|FG000|Overall Study|Study Terminated By Sponsor|0|||
157052557|NCT02367794|566944601|FG001|Overall Study|Study Terminated By Sponsor|1|||
157052558|NCT02367794|566944602|FG002|Overall Study|Study Terminated By Sponsor|1|||
157052559|NCT02367794|566944600|FG000|Overall Study|Moved to Roll-Over Study|0|||
157052560|NCT02367794|566944601|FG001|Overall Study|Moved to Roll-Over Study|15|||
157052561|NCT02367794|566944602|FG002|Overall Study|Moved to Roll-Over Study|13|||
157052562|NCT02367794|566944600|FG000|Overall Study|Sponsor Request|60|||
157229370|NCT01606306|567585244|FG003|Overall Study|Withdrawal by Subject|4|||
157229371|NCT01606306|567585245|FG004|Overall Study|Withdrawal by Subject|5|||
157052563|NCT02367794|566944601|FG001|Overall Study|Sponsor Request|57|||
157052564|NCT02367794|566944602|FG002|Overall Study|Sponsor Request|45|||
157052565|NCT02367794|566944600|FG000|Overall Study|Moved into PTAP Study|0|||
157052566|NCT02367794|566944601|FG001|Overall Study|Moved into PTAP Study|2|||
157052567|NCT02367794|566944602|FG002|Overall Study|Moved into PTAP Study|3|||
157052568|NCT02367794|566944600|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
157052569|NCT02367794|566944601|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
157052570|NCT02367794|566944602|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
157052571|NCT02367794|566944600|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
157052572|NCT02367794|566944601|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
157052573|NCT02367794|566944602|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
157052574|NCT02367794|566944600|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
157052575|NCT02367794|566944601|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
157229372|NCT01606306|567585246|FG005|Overall Study|Withdrawal by Subject|4|||
157052576|NCT02367794|566944602|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
157052577|NCT02367794|566944600|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
157052578|NCT02367794|566944601|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
157229373|NCT01606306|567585241|FG000|Overall Study|Physician Decision|1|||
157229374|NCT01606306|567585242|FG001|Overall Study|Physician Decision|2|||
157229375|NCT01606306|567585243|FG002|Overall Study|Physician Decision|0|||
157229376|NCT01606306|567585244|FG003|Overall Study|Physician Decision|0|||
157229377|NCT01606306|567585245|FG004|Overall Study|Physician Decision|0|||
157229378|NCT01606306|567585246|FG005|Overall Study|Physician Decision|0|||
157229379|NCT02003183|567585249|FG000|Overall Study|Lost to Follow-up|0|||
157229380|NCT02003183|567585250|FG001|Overall Study|Lost to Follow-up|2|||
157052579|NCT02367794|566944602|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
157052580|NCT02010684|566944603|FG000|Overall Study|Lost to Follow-up|8|||
157052581|NCT02010684|566944604|FG001|Overall Study|Lost to Follow-up|18|||
157052582|NCT02010684|566944603|FG000|Overall Study|Withdrawal by Subject|4|||
157052583|NCT02010684|566944604|FG001|Overall Study|Withdrawal by Subject|5|||
157052584|NCT01986348|566944605|FG000|Overall Study|Death|8|||
157052585|NCT01986348|566944606|FG001|Overall Study|Death|22|||
157052586|NCT01986348|566944607|FG002|Overall Study|Death|10|||
157052587|NCT01986348|566944608|FG003|Overall Study|Death|21|||
157052588|NCT01986348|566944605|FG000|Overall Study|Lost to Follow-up|0|||
157052589|NCT01986348|566944606|FG001|Overall Study|Lost to Follow-up|0|||
157052590|NCT01986348|566944607|FG002|Overall Study|Lost to Follow-up|0|||
157052591|NCT01986348|566944608|FG003|Overall Study|Lost to Follow-up|2|||
157052592|NCT01986348|566944605|FG000|Overall Study|Physician Decision|0|||
157052593|NCT01986348|566944606|FG001|Overall Study|Physician Decision|0|||
157052594|NCT01986348|566944607|FG002|Overall Study|Physician Decision|0|||
157052595|NCT01986348|566944608|FG003|Overall Study|Physician Decision|1|||
157052596|NCT01986348|566944605|FG000|Overall Study|Progressive Disease|0|||
157052597|NCT01986348|566944606|FG001|Overall Study|Progressive Disease|0|||
157052598|NCT01986348|566944607|FG002|Overall Study|Progressive Disease|2|||
157052599|NCT01986348|566944608|FG003|Overall Study|Progressive Disease|0|||
157052600|NCT01986348|566944605|FG000|Overall Study|Withdrawal by Participant|0|||
157052601|NCT01986348|566944606|FG001|Overall Study|Withdrawal by Participant|1|||
157052602|NCT01986348|566944607|FG002|Overall Study|Withdrawal by Participant|2|||
157052603|NCT01986348|566944608|FG003|Overall Study|Withdrawal by Participant|1|||
157052604|NCT01986348|566944605|FG000|Overall Study|Study Terminated by Sponsor|0|||
157052605|NCT01986348|566944606|FG001|Overall Study|Study Terminated by Sponsor|0|||
157052606|NCT01986348|566944607|FG002|Overall Study|Study Terminated by Sponsor|0|||
157052607|NCT01986348|566944608|FG003|Overall Study|Study Terminated by Sponsor|3|||
157052608|NCT01986348|566944605|FG000|Overall Study|Other-unspecified|0|||
157052609|NCT01986348|566944606|FG001|Overall Study|Other-unspecified|1|||
157052610|NCT01986348|566944607|FG002|Overall Study|Other-unspecified|0|||
157052611|NCT01986348|566944608|FG003|Overall Study|Other-unspecified|2|||
157052612|NCT01884571|566944613|FG000|Overall Study|Adverse Event|1|||
157052613|NCT01884571|566944613|FG000|Overall Study|Death|2|||
157052614|NCT01884571|566944613|FG000|Overall Study|Withdrawal by Subject|2|||
157052615|NCT01884571|566944613|FG000|Overall Study|Disease progression|3|||
157052616|NCT02158806|566944618|FG000|Overall Study|Death|2|||
157052617|NCT02158806|566944619|FG001|Overall Study|Death|0|||
157052618|NCT02158806|566944618|FG000|Overall Study|Withdrawal by Subject|2|||
157052619|NCT02158806|566944619|FG001|Overall Study|Withdrawal by Subject|0|||
157052620|NCT02158806|566944618|FG000|Overall Study|Lost to Follow-up|0|||
157052621|NCT02158806|566944619|FG001|Overall Study|Lost to Follow-up|3|||
157052622|NCT02158806|566944618|FG000|Overall Study|Moved out of area|0|||
157052623|NCT02158806|566944619|FG001|Overall Study|Moved out of area|1|||
157229381|NCT01759290|567585253|FG000|Overall Study|Subjects withdrawn consent|5|||
157052624|NCT02158806|566944618|FG000|Overall Study|Transferred to palliative care|0|||
157052625|NCT02158806|566944619|FG001|Overall Study|Transferred to palliative care|1|||
157052626|NCT01898299|566944620|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
157052627|NCT01898299|566944621|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
157052628|NCT02340806|566944625|FG000|Overall Study|Protocol Violation|2|||
157052629|NCT02340806|566944626|FG001|Overall Study|Protocol Violation|0|||
157052630|NCT02340806|566944625|FG000|Overall Study|epidural catheter replaced|2|||
157052631|NCT02340806|566944626|FG001|Overall Study|epidural catheter replaced|1|||
157052632|NCT02340806|566944625|FG000|Overall Study|history of chronic pain medication|1|||
157052633|NCT02340806|566944626|FG001|Overall Study|history of chronic pain medication|0|||
157052634|NCT02340806|566944625|FG000|Overall Study|re-dose < 90 min of CSE|1|||
157052635|NCT02340806|566944626|FG001|Overall Study|re-dose < 90 min of CSE|3|||
157052636|NCT01159600|566944628|FG000|Overall Study|Not treated|0|||
157052637|NCT01159600|566944629|FG001|Overall Study|Not treated|0|||
157052638|NCT01159600|566944630|FG002|Overall Study|Not treated|1|||
157052639|NCT01159600|566944631|FG003|Overall Study|Not treated|0|||
157052640|NCT01159600|566944632|FG004|Overall Study|Not treated|0|||
157052641|NCT01159600|566944633|FG005|Overall Study|Not treated|1|||
157229382|NCT01759290|567585253|FG000|Overall Study|Physician Decision|2|||
157229383|NCT01759290|567585253|FG000|Overall Study|Death|17|||
157229384|NCT01759290|567585253|FG000|Overall Study|Lost to Follow-up|53|||
157229385|NCT01759290|567585253|FG000|Overall Study|Unknown reason|4|||
157229386|NCT00841100|567585254|FG000|Phase 1 (28 Days)|Adverse Event|1|||
156973345|NCT01576718|566654806|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156973346|NCT01576718|566654807|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156973347|NCT01576718|566654808|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
156973348|NCT01576718|566654802|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
156973349|NCT01576718|566654803|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973350|NCT01576718|566654804|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973351|NCT01576718|566654805|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973352|NCT01576718|566654806|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973353|NCT01576718|566654807|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973354|NCT01576718|566654808|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
156973355|NCT01576718|566654802|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
156973356|NCT01576718|566654803|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973357|NCT01576718|566654804|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973358|NCT01576718|566654805|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973359|NCT01576718|566654806|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973360|NCT01576718|566654807|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973361|NCT01576718|566654808|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
156973362|NCT01576718|566654802|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
156973363|NCT01576718|566654803|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973364|NCT01576718|566654804|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973365|NCT01576718|566654805|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973366|NCT01576718|566654806|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973367|NCT01576718|566654807|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973368|NCT01576718|566654808|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
156973369|NCT01576718|566654802|FG000|Treatment Period|Adverse Event|0|||
156973370|NCT01576718|566654803|FG001|Treatment Period|Adverse Event|1|||
156973371|NCT01576718|566654804|FG002|Treatment Period|Adverse Event|1|||
156973372|NCT01576718|566654805|FG003|Treatment Period|Adverse Event|1|||
156973373|NCT01576718|566654806|FG004|Treatment Period|Adverse Event|1|||
156973374|NCT01576718|566654807|FG005|Treatment Period|Adverse Event|1|||
156973375|NCT01576718|566654808|FG006|Treatment Period|Adverse Event|0|||
156973376|NCT01576718|566654802|FG000|Treatment Period|Withdrawal by Subject|0|||
156973377|NCT01576718|566654803|FG001|Treatment Period|Withdrawal by Subject|1|||
156973378|NCT01576718|566654804|FG002|Treatment Period|Withdrawal by Subject|1|||
156973379|NCT01576718|566654805|FG003|Treatment Period|Withdrawal by Subject|0|||
156973380|NCT01576718|566654806|FG004|Treatment Period|Withdrawal by Subject|2|||
156973381|NCT01576718|566654807|FG005|Treatment Period|Withdrawal by Subject|4|||
156973382|NCT01576718|566654808|FG006|Treatment Period|Withdrawal by Subject|2|||
156973383|NCT01576718|566654802|FG000|Treatment Period|Physician Decision|0|||
156973384|NCT01576718|566654803|FG001|Treatment Period|Physician Decision|1|||
156973385|NCT01576718|566654804|FG002|Treatment Period|Physician Decision|1|||
156973386|NCT01576718|566654805|FG003|Treatment Period|Physician Decision|1|||
156973387|NCT01576718|566654806|FG004|Treatment Period|Physician Decision|1|||
156973388|NCT01576718|566654807|FG005|Treatment Period|Physician Decision|0|||
156973389|NCT01576718|566654808|FG006|Treatment Period|Physician Decision|0|||
156973390|NCT01576718|566654802|FG000|Treatment Period|Protocol Violation|0|||
156973391|NCT01576718|566654803|FG001|Treatment Period|Protocol Violation|5|||
156973392|NCT01576718|566654804|FG002|Treatment Period|Protocol Violation|4|||
156973393|NCT01576718|566654805|FG003|Treatment Period|Protocol Violation|10|||
156973394|NCT01576718|566654806|FG004|Treatment Period|Protocol Violation|6|||
156973395|NCT01576718|566654807|FG005|Treatment Period|Protocol Violation|8|||
156973396|NCT01576718|566654808|FG006|Treatment Period|Protocol Violation|12|||
156973397|NCT01576718|566654802|FG000|Treatment Period|Sponsor request|0|||
156973398|NCT01576718|566654803|FG001|Treatment Period|Sponsor request|1|||
156973399|NCT01576718|566654804|FG002|Treatment Period|Sponsor request|0|||
156973400|NCT01576718|566654805|FG003|Treatment Period|Sponsor request|0|||
156973401|NCT01576718|566654806|FG004|Treatment Period|Sponsor request|0|||
156973402|NCT01576718|566654807|FG005|Treatment Period|Sponsor request|1|||
156973403|NCT01576718|566654808|FG006|Treatment Period|Sponsor request|0|||
156973404|NCT01576718|566654802|FG000|Treatment Period|Met stopping criteria|0|||
156973405|NCT01576718|566654803|FG001|Treatment Period|Met stopping criteria|16|||
156973406|NCT01576718|566654804|FG002|Treatment Period|Met stopping criteria|13|||
156973407|NCT01576718|566654805|FG003|Treatment Period|Met stopping criteria|19|||
156973408|NCT01576718|566654806|FG004|Treatment Period|Met stopping criteria|16|||
156973409|NCT01576718|566654807|FG005|Treatment Period|Met stopping criteria|33|||
156973410|NCT01576718|566654808|FG006|Treatment Period|Met stopping criteria|15|||
156973411|NCT01576718|566654802|FG000|Treatment Period|Lost to Follow-up|0|||
156973412|NCT01576718|566654803|FG001|Treatment Period|Lost to Follow-up|0|||
156973413|NCT01576718|566654804|FG002|Treatment Period|Lost to Follow-up|0|||
156973414|NCT01576718|566654805|FG003|Treatment Period|Lost to Follow-up|0|||
156973415|NCT01576718|566654806|FG004|Treatment Period|Lost to Follow-up|1|||
157176732|NCT03136367|567387174|FG000|T2 Post-consultation|Discontinued transferred care|0|||
157176733|NCT03136367|567387175|FG001|T2 Post-consultation|Discontinued transferred care|0|||
157176734|NCT03136367|567387176|FG002|T2 Post-consultation|Discontinued transferred care|3|||
157176735|NCT03136367|567387174|FG000|T2 Post-consultation|Discontinued lost contact|0|||
157176736|NCT03136367|567387175|FG001|T2 Post-consultation|Discontinued lost contact|1|||
157176737|NCT03136367|567387176|FG002|T2 Post-consultation|Discontinued lost contact|0|||
157176738|NCT03136367|567387174|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
157229387|NCT00841100|567585254|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
156973416|NCT01576718|566654807|FG005|Treatment Period|Lost to Follow-up|0|||
156973417|NCT01576718|566654808|FG006|Treatment Period|Lost to Follow-up|0|||
156973418|NCT01576718|566654802|FG000|Treatment Period|Noncompliance to study medication|0|||
156973419|NCT01576718|566654803|FG001|Treatment Period|Noncompliance to study medication|0|||
156973420|NCT01576718|566654804|FG002|Treatment Period|Noncompliance to study medication|0|||
156973421|NCT01576718|566654805|FG003|Treatment Period|Noncompliance to study medication|0|||
156973422|NCT01576718|566654806|FG004|Treatment Period|Noncompliance to study medication|0|||
156973423|NCT01576718|566654807|FG005|Treatment Period|Noncompliance to study medication|1|||
156973424|NCT01576718|566654808|FG006|Treatment Period|Noncompliance to study medication|1|||
156973425|NCT04631705|566654809|FG000|Overall Study|Withdrawal by Subject|0|||
156973426|NCT04631705|566654810|FG001|Overall Study|Withdrawal by Subject|0|||
156973427|NCT04631705|566654811|FG002|Overall Study|Withdrawal by Subject|0|||
156973428|NCT04631705|566654812|FG003|Overall Study|Withdrawal by Subject|0|||
156973429|NCT04631705|566654813|FG004|Overall Study|Withdrawal by Subject|0|||
156973430|NCT04631705|566654814|FG005|Overall Study|Withdrawal by Subject|0|||
156973431|NCT04631705|566654815|FG006|Overall Study|Withdrawal by Subject|1|||
156973432|NCT04631705|566654816|FG007|Overall Study|Withdrawal by Subject|0|||
156973433|NCT04631705|566654817|FG008|Overall Study|Withdrawal by Subject|0|||
156973434|NCT02070484|566654819|FG000|Overall Study|Withdrawal by Subject|1|||
156973435|NCT02070484|566654820|FG001|Overall Study|Withdrawal by Subject|0|||
156973436|NCT01521884|566654825|FG000|Overall Study|Non Responders|10|||
156973437|NCT01521884|566654825|FG000|Overall Study|Adverse Event|5|||
156973438|NCT01521884|566654825|FG000|Overall Study|Pregnancy|1|||
156973439|NCT01521884|566654825|FG000|Overall Study|Withdrawal by Subject|1|||
156973440|NCT01521884|566654825|FG000|Overall Study|Physician Decision|2|||
156973441|NCT01521884|566654825|FG000|Overall Study|Protocol Violation|3|||
156973442|NCT01521884|566654825|FG000|Overall Study|Participant non-eligible|1|||
156973443|NCT01521884|566654825|FG000|Overall Study|Lost to Follow-up|4|||
156973444|NCT02821819|566654826|FG000|Overall Study|Protocol Violation|1|||
156973445|NCT04241094|566654827|FG000|Overall Study|Dropped out of treatment|4|||
156973446|NCT04241094|566654827|FG000|Overall Study|Ineligible after clinical assessment|2|||
156973447|NCT04241094|566654827|FG000|Overall Study|Lost to Follow-up|2|||
156973448|NCT01669798|566654828|FG000|Overall Study|Physician Decision|5|||
156973449|NCT01806584|566654832|FG000|Overall Study|Adverse Event|2|||
156973450|NCT01806584|566654833|FG001|Overall Study|Adverse Event|1|||
156973451|NCT01806584|566654832|FG000|Overall Study|Death|1|||
156973452|NCT01806584|566654833|FG001|Overall Study|Death|0|||
156973453|NCT01806584|566654832|FG000|Overall Study|Lost to Follow-up|0|||
156973454|NCT01806584|566654833|FG001|Overall Study|Lost to Follow-up|2|||
156973455|NCT01806584|566654832|FG000|Overall Study|Study terminated by sponsor|9|||
156973456|NCT01806584|566654833|FG001|Overall Study|Study terminated by sponsor|14|||
156973457|NCT01806584|566654832|FG000|Overall Study|Withdrawal by Subject|1|||
156973458|NCT01806584|566654833|FG001|Overall Study|Withdrawal by Subject|1|||
156973459|NCT01806584|566654832|FG000|Overall Study|Other unspecified|1|||
156973460|NCT01806584|566654833|FG001|Overall Study|Other unspecified|0|||
156973461|NCT03995784|566654835|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
156973462|NCT01489189|566654836|FG000|Overall Study|Withdrawal by Subject|20|||
156973463|NCT01489189|566654837|FG001|Overall Study|Withdrawal by Subject|23|||
156973464|NCT01489189|566654836|FG000|Overall Study|Death|10|||
156973465|NCT01489189|566654837|FG001|Overall Study|Death|8|||
156973466|NCT01489189|566654836|FG000|Overall Study|Missed Visit|1|||
156973467|NCT01489189|566654837|FG001|Overall Study|Missed Visit|4|||
156973468|NCT00112580|566654838|FG000|Overall Study|Adverse Event|1|||
156973469|NCT00112580|566654839|FG001|Overall Study|Adverse Event|2|||
156973470|NCT00112580|566654838|FG000|Overall Study|Disease progression|5|||
156973471|NCT00112580|566654839|FG001|Overall Study|Disease progression|16|||
156973472|NCT00112580|566654838|FG000|Overall Study|Participant withdrew consent|2|||
156973473|NCT00112580|566654839|FG001|Overall Study|Participant withdrew consent|1|||
156973474|NCT02272725|566654843|FG000|Overall Study|equipment malfunction|2|||
156973475|NCT02272725|566654844|FG001|Overall Study|equipment malfunction|0|||
157229388|NCT03338972|567585257|FG000|Overall Study|Death|1|||
156973476|NCT02202434|566656662|FG000|Overall Study|Death|70|||
156973477|NCT02202434|566656663|FG001|Overall Study|Death|39|||
156973478|NCT02202434|566656664|FG002|Overall Study|Death|13|||
156973479|NCT02202434|566656665|FG003|Overall Study|Death|27|||
156973480|NCT02202434|566656662|FG000|Overall Study|Lost to Follow-up|1|||
156973481|NCT02202434|566656663|FG001|Overall Study|Lost to Follow-up|1|||
157052642|NCT01159600|566944634|FG006|Overall Study|Not treated|2|||
157052643|NCT01159600|566944635|FG007|Overall Study|Not treated|2|||
157052644|NCT01159600|566944628|FG000|Overall Study|Adverse Event|7|||
157052645|NCT01159600|566944629|FG001|Overall Study|Adverse Event|2|||
157052646|NCT01159600|566944630|FG002|Overall Study|Adverse Event|5|||
157052647|NCT01159600|566944631|FG003|Overall Study|Adverse Event|1|||
157052648|NCT01159600|566944632|FG004|Overall Study|Adverse Event|8|||
157052649|NCT01159600|566944633|FG005|Overall Study|Adverse Event|6|||
157052650|NCT01159600|566944634|FG006|Overall Study|Adverse Event|7|||
157052651|NCT01159600|566944635|FG007|Overall Study|Adverse Event|5|||
157052652|NCT01159600|566944628|FG000|Overall Study|Lack of Efficacy|0|||
157052653|NCT01159600|566944629|FG001|Overall Study|Lack of Efficacy|0|||
157052654|NCT01159600|566944630|FG002|Overall Study|Lack of Efficacy|0|||
157052655|NCT01159600|566944631|FG003|Overall Study|Lack of Efficacy|0|||
157052656|NCT01159600|566944632|FG004|Overall Study|Lack of Efficacy|2|||
157052657|NCT01159600|566944633|FG005|Overall Study|Lack of Efficacy|0|||
157052658|NCT01159600|566944634|FG006|Overall Study|Lack of Efficacy|0|||
157052659|NCT01159600|566944635|FG007|Overall Study|Lack of Efficacy|1|||
157052660|NCT01159600|566944628|FG000|Overall Study|Non compliant with protocol|2|||
157052661|NCT01159600|566944629|FG001|Overall Study|Non compliant with protocol|1|||
157052662|NCT01159600|566944630|FG002|Overall Study|Non compliant with protocol|0|||
157052663|NCT01159600|566944631|FG003|Overall Study|Non compliant with protocol|0|||
157052664|NCT01159600|566944632|FG004|Overall Study|Non compliant with protocol|2|||
157052665|NCT01159600|566944633|FG005|Overall Study|Non compliant with protocol|0|||
157052666|NCT01159600|566944634|FG006|Overall Study|Non compliant with protocol|2|||
157052667|NCT01159600|566944635|FG007|Overall Study|Non compliant with protocol|0|||
157052668|NCT01159600|566944628|FG000|Overall Study|Lost to Follow-up|2|||
157052669|NCT01159600|566944629|FG001|Overall Study|Lost to Follow-up|3|||
157052670|NCT01159600|566944630|FG002|Overall Study|Lost to Follow-up|4|||
157052671|NCT01159600|566944631|FG003|Overall Study|Lost to Follow-up|3|||
157052672|NCT01159600|566944632|FG004|Overall Study|Lost to Follow-up|3|||
157052673|NCT01159600|566944633|FG005|Overall Study|Lost to Follow-up|0|||
157052674|NCT01159600|566944634|FG006|Overall Study|Lost to Follow-up|3|||
157052675|NCT01159600|566944635|FG007|Overall Study|Lost to Follow-up|2|||
157052676|NCT01159600|566944628|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
157052677|NCT01159600|566944629|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
157052678|NCT01159600|566944630|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
157052679|NCT01159600|566944631|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
157052680|NCT01159600|566944632|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
157052681|NCT01159600|566944633|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
157052682|NCT01159600|566944634|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
157052683|NCT01159600|566944635|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
157052684|NCT01159600|566944628|FG000|Overall Study|Other reason not defined above|3|||
157052685|NCT01159600|566944629|FG001|Overall Study|Other reason not defined above|0|||
157052686|NCT01159600|566944630|FG002|Overall Study|Other reason not defined above|4|||
157052687|NCT01159600|566944631|FG003|Overall Study|Other reason not defined above|2|||
157052688|NCT01159600|566944632|FG004|Overall Study|Other reason not defined above|5|||
157052689|NCT01159600|566944633|FG005|Overall Study|Other reason not defined above|7|||
157052690|NCT01159600|566944634|FG006|Overall Study|Other reason not defined above|3|||
157052691|NCT01159600|566944635|FG007|Overall Study|Other reason not defined above|3|||
157052692|NCT04851587|566945879|FG000|Overall Study|Lost to Follow-up|18|||
157052693|NCT02101554|566945882|FG000|Overall Study|Protocol Violation|0|||
157052694|NCT02101554|566945883|FG001|Overall Study|Protocol Violation|1|||
157052695|NCT02101554|566945884|FG002|Overall Study|Protocol Violation|0|||
157052696|NCT02101554|566945882|FG000|Overall Study|Insufficient Clinical Response|0|||
157052697|NCT02101554|566945883|FG001|Overall Study|Insufficient Clinical Response|2|||
157052698|NCT02101554|566945884|FG002|Overall Study|Insufficient Clinical Response|0|||
157176739|NCT03136367|567387175|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
157052699|NCT02101554|566945882|FG000|Overall Study|Adverse Event|2|||
157052700|NCT02101554|566945883|FG001|Overall Study|Adverse Event|1|||
157052701|NCT02101554|566945884|FG002|Overall Study|Adverse Event|1|||
157052702|NCT02101554|566945882|FG000|Overall Study|Lost to Follow-up|0|||
157052703|NCT02101554|566945883|FG001|Overall Study|Lost to Follow-up|1|||
157052704|NCT02101554|566945884|FG002|Overall Study|Lost to Follow-up|0|||
157052705|NCT02101554|566945882|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
157052706|NCT02101554|566945883|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
157052707|NCT02101554|566945884|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
157052708|NCT04820023|566945885|FG000|Overall Study|Death|0|||
157052709|NCT04820023|566945886|FG001|Overall Study|Death|0|||
157052710|NCT04820023|566945887|FG002|Overall Study|Death|0|||
157052711|NCT04820023|566945888|FG003|Overall Study|Death|0|||
157052712|NCT04820023|566945889|FG004|Overall Study|Death|0|||
157052713|NCT04820023|566945890|FG005|Overall Study|Death|0|||
157052714|NCT04820023|566945891|FG006|Overall Study|Death|1|||
157052715|NCT04820023|566945892|FG007|Overall Study|Death|0|||
157052716|NCT04820023|566945893|FG008|Overall Study|Death|1|||
157052717|NCT04820023|566945885|FG000|Overall Study|Withdrawal by Subject|1|||
157176740|NCT03136367|567387176|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
157176741|NCT03136367|567387174|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
157176742|NCT03136367|567387175|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
157176743|NCT03136367|567387176|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
157176744|NCT03136367|567387174|FG000|T3 1 Week After Surgery|other discontinued|2|||
157176745|NCT03136367|567387175|FG001|T3 1 Week After Surgery|other discontinued|4|||
157176746|NCT03136367|567387176|FG002|T3 1 Week After Surgery|other discontinued|3|||
157229389|NCT03338972|567585258|FG001|Overall Study|Death|1|||
156973482|NCT02202434|566656664|FG002|Overall Study|Lost to Follow-up|1|||
156973483|NCT02202434|566656665|FG003|Overall Study|Lost to Follow-up|0|||
156973484|NCT02202434|566656662|FG000|Overall Study|Physician Decision|2|||
156973485|NCT02202434|566656663|FG001|Overall Study|Physician Decision|3|||
156973486|NCT02202434|566656664|FG002|Overall Study|Physician Decision|0|||
156973487|NCT02202434|566656665|FG003|Overall Study|Physician Decision|0|||
156973488|NCT02202434|566656662|FG000|Overall Study|Withdrawal by Subject|13|||
156973489|NCT02202434|566656663|FG001|Overall Study|Withdrawal by Subject|14|||
156973490|NCT02202434|566656664|FG002|Overall Study|Withdrawal by Subject|1|||
156973491|NCT02202434|566656665|FG003|Overall Study|Withdrawal by Subject|4|||
156973492|NCT02202434|566656662|FG000|Overall Study|Completed Study|1|||
156973493|NCT02202434|566656663|FG001|Overall Study|Completed Study|0|||
156973494|NCT02202434|566656664|FG002|Overall Study|Completed Study|0|||
156973495|NCT02202434|566656665|FG003|Overall Study|Completed Study|0|||
156973496|NCT02202434|566656662|FG000|Overall Study|Visit Missed|21|||
156973497|NCT02202434|566656663|FG001|Overall Study|Visit Missed|12|||
156973498|NCT02202434|566656664|FG002|Overall Study|Visit Missed|0|||
156973499|NCT02202434|566656665|FG003|Overall Study|Visit Missed|5|||
156973500|NCT02202434|566656662|FG000|Overall Study|Other|1|||
156973501|NCT02202434|566656663|FG001|Overall Study|Other|0|||
156973502|NCT02202434|566656664|FG002|Overall Study|Other|0|||
156973503|NCT02202434|566656665|FG003|Overall Study|Other|1|||
156973504|NCT01862991|566656666|FG000|Overall Study|Lost to Follow-up|2|||
156973505|NCT01862991|566656667|FG001|Overall Study|Lost to Follow-up|1|||
156973506|NCT01862991|566656668|FG002|Overall Study|Lost to Follow-up|1|||
156973507|NCT01862991|566656666|FG000|Overall Study|Protocol Violation|1|||
156973508|NCT01862991|566656667|FG001|Overall Study|Protocol Violation|0|||
156973509|NCT01862991|566656668|FG002|Overall Study|Protocol Violation|0|||
156973510|NCT04858802|566656669|FG000|Overall Study|Lost to Follow-up|1|||
156973511|NCT04858802|566656670|FG001|Overall Study|Lost to Follow-up|1|||
156973512|NCT04858802|566656669|FG000|Overall Study|Withdrawal by Subject|1|||
156973513|NCT04858802|566656670|FG001|Overall Study|Withdrawal by Subject|1|||
156973514|NCT00674323|566656672|FG000|Overall Study|Adverse Event|0|||
156973515|NCT00674323|566656673|FG001|Overall Study|Adverse Event|1|||
156973516|NCT00674323|566656674|FG002|Overall Study|Adverse Event|0|||
156973517|NCT00674323|566656672|FG000|Overall Study|Protocol Violation|1|||
156973518|NCT00674323|566656673|FG001|Overall Study|Protocol Violation|0|||
156973519|NCT00674323|566656674|FG002|Overall Study|Protocol Violation|0|||
156973520|NCT02013388|566656677|FG000|Overall Study|work emergency|1|||
156973521|NCT02013388|566656678|FG001|Overall Study|work emergency|0|||
156973522|NCT02013388|566656679|FG002|Overall Study|work emergency|0|||
156973523|NCT02013388|566656680|FG003|Overall Study|work emergency|0|||
156973524|NCT02013388|566656681|FG004|Overall Study|work emergency|1|||
156973525|NCT02013388|566656682|FG005|Overall Study|work emergency|0|||
156973526|NCT02013388|566656683|FG006|Overall Study|work emergency|0|||
156973527|NCT02013388|566656684|FG007|Overall Study|work emergency|0|||
156973528|NCT03145766|566656685|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156973529|NCT03145766|566656686|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156973530|NCT03145766|566656687|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
156973531|NCT03145766|566656688|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
156973532|NCT03145766|566656689|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
156973533|NCT03145766|566656685|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
156973534|NCT03145766|566656686|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
156973535|NCT03145766|566656687|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
156973536|NCT03145766|566656688|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
156973537|NCT03145766|566656689|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
156973538|NCT03145766|566656685|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
156973539|NCT03145766|566656686|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
156973540|NCT03145766|566656687|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
156973541|NCT03145766|566656688|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
156973542|NCT03145766|566656689|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
156973543|NCT03145766|566656685|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
156973544|NCT03145766|566656686|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
156973545|NCT03145766|566656687|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
157052718|NCT04820023|566945886|FG001|Overall Study|Withdrawal by Subject|2|||
157052719|NCT04820023|566945887|FG002|Overall Study|Withdrawal by Subject|2|||
157052720|NCT04820023|566945888|FG003|Overall Study|Withdrawal by Subject|1|||
157052721|NCT04820023|566945889|FG004|Overall Study|Withdrawal by Subject|4|||
157052722|NCT04820023|566945890|FG005|Overall Study|Withdrawal by Subject|3|||
157052723|NCT04820023|566945891|FG006|Overall Study|Withdrawal by Subject|3|||
157052724|NCT04820023|566945892|FG007|Overall Study|Withdrawal by Subject|6|||
157052725|NCT04820023|566945893|FG008|Overall Study|Withdrawal by Subject|5|||
157052726|NCT04820023|566945885|FG000|Overall Study|Progressive Disease|3|||
157052727|NCT04820023|566945886|FG001|Overall Study|Progressive Disease|0|||
157052728|NCT04820023|566945887|FG002|Overall Study|Progressive Disease|2|||
157052729|NCT04820023|566945888|FG003|Overall Study|Progressive Disease|2|||
157052730|NCT04820023|566945889|FG004|Overall Study|Progressive Disease|2|||
157052731|NCT04820023|566945890|FG005|Overall Study|Progressive Disease|0|||
157052732|NCT04820023|566945891|FG006|Overall Study|Progressive Disease|1|||
157052733|NCT04820023|566945892|FG007|Overall Study|Progressive Disease|1|||
157052734|NCT04820023|566945893|FG008|Overall Study|Progressive Disease|0|||
157052735|NCT04820023|566945885|FG000|Overall Study|New anti-cancer therapy|0|||
157052736|NCT04820023|566945886|FG001|Overall Study|New anti-cancer therapy|0|||
157052737|NCT04820023|566945887|FG002|Overall Study|New anti-cancer therapy|0|||
157052738|NCT04820023|566945888|FG003|Overall Study|New anti-cancer therapy|0|||
157052739|NCT04820023|566945889|FG004|Overall Study|New anti-cancer therapy|2|||
157052740|NCT04820023|566945890|FG005|Overall Study|New anti-cancer therapy|0|||
157052741|NCT04820023|566945891|FG006|Overall Study|New anti-cancer therapy|0|||
157052742|NCT04820023|566945892|FG007|Overall Study|New anti-cancer therapy|0|||
157052743|NCT04820023|566945893|FG008|Overall Study|New anti-cancer therapy|0|||
157052744|NCT04820023|566945885|FG000|Overall Study|Other|0|||
157052745|NCT04820023|566945886|FG001|Overall Study|Other|1|||
157052746|NCT04820023|566945887|FG002|Overall Study|Other|0|||
157052747|NCT04820023|566945888|FG003|Overall Study|Other|0|||
157052748|NCT04820023|566945889|FG004|Overall Study|Other|0|||
157052749|NCT04820023|566945890|FG005|Overall Study|Other|0|||
157052750|NCT04820023|566945891|FG006|Overall Study|Other|0|||
157052751|NCT04820023|566945892|FG007|Overall Study|Other|2|||
157052752|NCT04820023|566945893|FG008|Overall Study|Other|0|||
157052753|NCT01020487|566945895|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
157052754|NCT01020487|566945896|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
157052755|NCT01020487|566945897|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
157052756|NCT01020487|566945895|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
157052757|NCT01020487|566945896|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
157052758|NCT01020487|566945897|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
157052759|NCT01020487|566945895|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
157052760|NCT01020487|566945896|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
157052761|NCT01020487|566945897|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
157052762|NCT01020487|566945895|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
157052763|NCT01020487|566945896|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
157052764|NCT01020487|566945897|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
157052765|NCT01020487|566945895|FG000|Part 2 Open-label Period|Adverse Event|0|||
157052766|NCT01020487|566945896|FG001|Part 2 Open-label Period|Adverse Event|4|||
157052767|NCT01020487|566945897|FG002|Part 2 Open-label Period|Adverse Event|1|||
157052768|NCT04049578|566945898|FG000|Overall Study|Physician Decision|1|||
157052769|NCT02109172|566945909|FG000|Overall Study|Withdrawal by Subject|1|||
157052770|NCT02109172|566945910|FG001|Overall Study|Withdrawal by Subject|0|||
157052771|NCT02109172|566945911|FG002|Overall Study|Withdrawal by Subject|0|||
157052772|NCT02109172|566945912|FG003|Overall Study|Withdrawal by Subject|1|||
157052773|NCT02109172|566945913|FG004|Overall Study|Withdrawal by Subject|0|||
157052774|NCT02109172|566945914|FG005|Overall Study|Withdrawal by Subject|0|||
157052775|NCT02109172|566945909|FG000|Overall Study|Adverse Event|0|||
157052776|NCT02109172|566945910|FG001|Overall Study|Adverse Event|0|||
157052777|NCT02109172|566945911|FG002|Overall Study|Adverse Event|1|||
157052778|NCT02109172|566945912|FG003|Overall Study|Adverse Event|0|||
157229390|NCT03338972|567585259|FG002|Overall Study|Death|0|||
157052779|NCT02109172|566945913|FG004|Overall Study|Adverse Event|0|||
157052780|NCT02109172|566945914|FG005|Overall Study|Adverse Event|1|||
157052781|NCT02109172|566945909|FG000|Overall Study|Death|0|||
157052782|NCT02109172|566945910|FG001|Overall Study|Death|0|||
157229391|NCT03338972|567585260|FG003|Overall Study|Death|0|||
157052783|NCT02109172|566945911|FG002|Overall Study|Death|0|||
157052784|NCT02109172|566945912|FG003|Overall Study|Death|0|||
157052785|NCT02109172|566945913|FG004|Overall Study|Death|1|||
157052786|NCT02109172|566945914|FG005|Overall Study|Death|0|||
157052787|NCT03605745|566945915|FG000|Overall Study|Study was terminated for business reasons|47|||
157052788|NCT01279447|566945916|FG000|Overall Study|Lost to Follow-up|3|||
157052789|NCT01279447|566945917|FG001|Overall Study|Lost to Follow-up|1|||
157052790|NCT02213094|566945919|FG000|Overall Study|Adverse Event|1|||
157052791|NCT02213094|566945920|FG001|Overall Study|Adverse Event|0|||
157052792|NCT01074229|566945921|FG000|Overall Study|Lost to Follow-up|1|||
157229392|NCT03338972|567585257|FG000|Overall Study|Withdrawal by Subject|1|||
157229393|NCT03338972|567585258|FG001|Overall Study|Withdrawal by Subject|0|||
157229394|NCT03338972|567585259|FG002|Overall Study|Withdrawal by Subject|0|||
157229395|NCT03338972|567585260|FG003|Overall Study|Withdrawal by Subject|0|||
157229396|NCT06096168|567585263|FG000|Overall Study|Death|30|||
157229397|NCT06096168|567585263|FG000|Overall Study|Revision|2|||
157229398|NCT01868009|567585264|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
157229399|NCT01868009|567585265|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
157229400|NCT01868009|567585264|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
157229401|NCT01868009|567585265|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
157229402|NCT01868009|567585264|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
157229403|NCT01868009|567585265|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
157229404|NCT01046253|567585266|FG000|Second Intervention|Adverse Event|0|||
157229405|NCT01046253|567585267|FG001|Second Intervention|Adverse Event|1|||
156973546|NCT03145766|566656688|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
156973547|NCT03145766|566656689|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
156973548|NCT03145766|566656685|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
156973549|NCT03145766|566656686|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156973550|NCT03145766|566656687|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156973551|NCT03145766|566656688|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
156973552|NCT03145766|566656689|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
156973553|NCT03145766|566656685|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
156973554|NCT03145766|566656686|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
156973555|NCT03145766|566656687|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
156973556|NCT03145766|566656688|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
156973557|NCT03145766|566656689|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
156973558|NCT03145766|566656685|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156973559|NCT03145766|566656686|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156973560|NCT03145766|566656687|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
156973561|NCT03145766|566656688|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
156973562|NCT03145766|566656689|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
156973563|NCT04461795|566656691|FG000|Overall Study|Lost to Follow-up|2|||
156973564|NCT04461795|566656691|FG000|Overall Study|Withdrawal by Subject|2|||
156973565|NCT04461795|566656691|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
156973566|NCT00185640|566656693|FG000|Overall Study|Not Eligible|4|||
156973567|NCT00185640|566656693|FG000|Overall Study|Withdrawal by Subject|3|||
156973568|NCT00185640|566656693|FG000|Overall Study|Death|138|||
156973569|NCT00058422|566656694|FG000|Overall Study|Not treated|2|||
156973570|NCT02110732|566656697|FG000|Overall Study|Physician Decision|5|||
156973571|NCT02110732|566656698|FG001|Overall Study|Physician Decision|2|||
156973572|NCT02110732|566656697|FG000|Overall Study|Lost to Follow-up|1|||
156973573|NCT02110732|566656698|FG001|Overall Study|Lost to Follow-up|1|||
156973574|NCT00633932|566656699|FG000|Overall Study|Adverse Event|1|||
156973575|NCT00633932|566656700|FG001|Overall Study|Adverse Event|3|||
156973576|NCT00633932|566656701|FG002|Overall Study|Adverse Event|4|||
156973577|NCT00633932|566656699|FG000|Overall Study|Withdrawal by Subject|3|||
156973578|NCT00633932|566656700|FG001|Overall Study|Withdrawal by Subject|9|||
156973579|NCT00633932|566656701|FG002|Overall Study|Withdrawal by Subject|1|||
156973580|NCT00633932|566656699|FG000|Overall Study|Lost to Follow-up|1|||
156973581|NCT00633932|566656700|FG001|Overall Study|Lost to Follow-up|0|||
156973582|NCT00633932|566656701|FG002|Overall Study|Lost to Follow-up|2|||
156973583|NCT00633932|566656699|FG000|Overall Study|Protocol Violation|5|||
156973584|NCT00633932|566656700|FG001|Overall Study|Protocol Violation|2|||
156973585|NCT00633932|566656701|FG002|Overall Study|Protocol Violation|3|||
156973586|NCT00633932|566656699|FG000|Overall Study|Physician Decision|0|||
156973587|NCT00633932|566656700|FG001|Overall Study|Physician Decision|0|||
156973588|NCT00633932|566656701|FG002|Overall Study|Physician Decision|1|||
156973589|NCT00633932|566656699|FG000|Overall Study|Doctor's judgement|1|||
156973590|NCT00633932|566656700|FG001|Overall Study|Doctor's judgement|0|||
156973591|NCT00633932|566656701|FG002|Overall Study|Doctor's judgement|0|||
156973592|NCT00633932|566656699|FG000|Overall Study|Moved Away|1|||
156973593|NCT00633932|566656700|FG001|Overall Study|Moved Away|0|||
156973594|NCT00633932|566656701|FG002|Overall Study|Moved Away|0|||
156973595|NCT04836858|566656702|FG000|Overall Study|Adverse Event|0|||
156973596|NCT04836858|566656703|FG001|Overall Study|Adverse Event|0|||
156973597|NCT04836858|566656704|FG002|Overall Study|Adverse Event|0|||
156973598|NCT04836858|566656705|FG003|Overall Study|Adverse Event|1|||
156973599|NCT04836858|566656702|FG000|Overall Study|Lost to Follow-up|1|||
156973600|NCT04836858|566656703|FG001|Overall Study|Lost to Follow-up|0|||
156973601|NCT04836858|566656704|FG002|Overall Study|Lost to Follow-up|0|||
156973602|NCT04836858|566656705|FG003|Overall Study|Lost to Follow-up|0|||
157229406|NCT01046253|567585266|FG000|Second Intervention|Protocol Violation|0|||
157229407|NCT01046253|567585267|FG001|Second Intervention|Protocol Violation|1|||
157229408|NCT02339909|567585268|FG000|Overall Study|Became ineligible after randomisation|89|||
157052793|NCT01074229|566945922|FG001|Overall Study|Lost to Follow-up|0|||
157052794|NCT01074229|566945923|FG002|Overall Study|Lost to Follow-up|0|||
157052795|NCT01074229|566945921|FG000|Overall Study|Change to open surgical procedure|1|||
157052796|NCT01074229|566945922|FG001|Overall Study|Change to open surgical procedure|3|||
157052797|NCT01074229|566945923|FG002|Overall Study|Change to open surgical procedure|4|||
157052798|NCT00538629|566945926|FG000|Overall Study|At subject's request|1|||
157052799|NCT00538629|566945926|FG000|Overall Study|Adverse Event|2|||
157052800|NCT00538629|566945926|FG000|Overall Study|Lack of Efficacy|12|||
157052801|NCT00538629|566945926|FG000|Overall Study|Lost to Follow-up|6|||
157052802|NCT00538629|566945926|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
157052803|NCT04454125|566945929|FG000|Overall Study|Lost to Follow-up|0|||
157052804|NCT04454125|566945930|FG001|Overall Study|Lost to Follow-up|1|||
157052805|NCT00555620|566945932|FG000|Overall Study|Death|0|||
157052806|NCT00555620|566945933|FG001|Overall Study|Death|1|||
157052807|NCT00555620|566945934|FG002|Overall Study|Death|0|||
157052808|NCT00555620|566945935|FG003|Overall Study|Death|0|||
157052809|NCT00555620|566945936|FG004|Overall Study|Death|0|||
157052810|NCT00555620|566945937|FG005|Overall Study|Death|1|||
157052811|NCT00555620|566945932|FG000|Overall Study|Study terminated by sponsor|0|||
157052812|NCT00555620|566945933|FG001|Overall Study|Study terminated by sponsor|0|||
157052813|NCT00555620|566945934|FG002|Overall Study|Study terminated by sponsor|1|||
157052814|NCT00555620|566945935|FG003|Overall Study|Study terminated by sponsor|0|||
157052815|NCT00555620|566945936|FG004|Overall Study|Study terminated by sponsor|0|||
157052816|NCT00555620|566945937|FG005|Overall Study|Study terminated by sponsor|0|||
157052817|NCT00555620|566945932|FG000|Overall Study|Adverse Event|0|||
157052818|NCT00555620|566945933|FG001|Overall Study|Adverse Event|0|||
157052819|NCT00555620|566945934|FG002|Overall Study|Adverse Event|1|||
157052820|NCT00555620|566945935|FG003|Overall Study|Adverse Event|5|||
157052821|NCT00555620|566945936|FG004|Overall Study|Adverse Event|0|||
157052822|NCT00555620|566945937|FG005|Overall Study|Adverse Event|1|||
157052823|NCT00555620|566945932|FG000|Overall Study|Objective progression or relapse|6|||
157052824|NCT00555620|566945933|FG001|Overall Study|Objective progression or relapse|5|||
157052825|NCT00555620|566945934|FG002|Overall Study|Objective progression or relapse|12|||
157052826|NCT00555620|566945935|FG003|Overall Study|Objective progression or relapse|17|||
157052827|NCT00555620|566945936|FG004|Overall Study|Objective progression or relapse|3|||
157052828|NCT00555620|566945937|FG005|Overall Study|Objective progression or relapse|16|||
157052829|NCT00555620|566945932|FG000|Overall Study|Participant refused treatment|0|||
157052830|NCT00555620|566945933|FG001|Overall Study|Participant refused treatment|1|||
157052831|NCT00555620|566945934|FG002|Overall Study|Participant refused treatment|1|||
157052832|NCT00555620|566945935|FG003|Overall Study|Participant refused treatment|0|||
157052833|NCT00555620|566945936|FG004|Overall Study|Participant refused treatment|0|||
157052834|NCT00555620|566945937|FG005|Overall Study|Participant refused treatment|1|||
157052835|NCT00555620|566945932|FG000|Overall Study|Other|0|||
157052836|NCT00555620|566945933|FG001|Overall Study|Other|0|||
157052837|NCT00555620|566945934|FG002|Overall Study|Other|0|||
157052838|NCT00555620|566945935|FG003|Overall Study|Other|1|||
157052839|NCT00555620|566945936|FG004|Overall Study|Other|0|||
157052840|NCT00555620|566945937|FG005|Overall Study|Other|3|||
157052841|NCT01922102|566945938|FG000|Overall Study|Withdrawal by Subject|7|||
157052842|NCT01922102|566945939|FG001|Overall Study|Withdrawal by Subject|3|||
157052843|NCT01922102|566945940|FG002|Overall Study|Withdrawal by Subject|7|||
157052844|NCT01922102|566945938|FG000|Overall Study|Physician Decision|0|||
157052845|NCT01922102|566945939|FG001|Overall Study|Physician Decision|2|||
157052846|NCT01922102|566945940|FG002|Overall Study|Physician Decision|1|||
157052847|NCT01922102|566945938|FG000|Overall Study|Adverse Event|1|||
157052848|NCT01922102|566945939|FG001|Overall Study|Adverse Event|2|||
157052849|NCT01922102|566945940|FG002|Overall Study|Adverse Event|0|||
157176747|NCT03136367|567387174|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
157176748|NCT03136367|567387175|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
157176749|NCT03136367|567387176|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
157176750|NCT03136367|567387174|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
157052850|NCT01922102|566945938|FG000|Overall Study|Lost to Follow-up|1|||
157052851|NCT01922102|566945939|FG001|Overall Study|Lost to Follow-up|0|||
157176751|NCT03136367|567387175|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
157052852|NCT01922102|566945940|FG002|Overall Study|Lost to Follow-up|0|||
157052853|NCT01922102|566945938|FG000|Overall Study|Administrative problems|0|||
157052854|NCT01922102|566945939|FG001|Overall Study|Administrative problems|2|||
157052855|NCT01922102|566945940|FG002|Overall Study|Administrative problems|0|||
157052856|NCT05203822|566945941|FG000|Overall Study|Adverse Event|1|||
157052857|NCT05203822|566945941|FG000|Overall Study|Withdrawal by Subject|1|||
157052858|NCT05361304|566945946|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
157052859|NCT05361304|566945947|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
157052860|NCT05361304|566945946|FG000|Overall Study|COVID-19 Related|1|||
157052861|NCT05361304|566945947|FG001|Overall Study|COVID-19 Related|2|||
157052862|NCT05361304|566945946|FG000|Overall Study|Withdrawal by Subject|1|||
157052863|NCT05361304|566945947|FG001|Overall Study|Withdrawal by Subject|0|||
157052864|NCT03320941|566945948|FG000|Overall Study|subject/guardian decision|0|||
157052865|NCT03320941|566945949|FG001|Overall Study|subject/guardian decision|0|||
157052866|NCT03320941|566945950|FG002|Overall Study|subject/guardian decision|0|||
157052867|NCT03320941|566945951|FG003|Overall Study|subject/guardian decision|1|||
157052868|NCT03320941|566945952|FG004|Overall Study|subject/guardian decision|0|||
157052869|NCT00447499|566945953|FG000|Overall Study|Adverse Event|1|||
157052870|NCT00447499|566945953|FG000|Overall Study|Patient Decision|4|||
157052871|NCT00447499|566945953|FG000|Overall Study|Sponsor Decision|1|||
157052872|NCT00447499|566945953|FG000|Overall Study|Physician Decision|1|||
157052873|NCT03360071|566945956|FG000|Overall Study|Lost to Follow-up|1|||
157052874|NCT03360071|566945957|FG001|Overall Study|Lost to Follow-up|0|||
157052875|NCT03184519|566945962|FG000|Overall Study|Lost to Follow-up|6|||
157052876|NCT03184519|566945962|FG000|Overall Study|Physician Decision|21|||
157052877|NCT02823574|566945966|FG000|Randomization|Disease Progression|0|||
157052878|NCT02823574|566945967|FG001|Randomization|Disease Progression|0|||
157052879|NCT02823574|566945968|FG002|Randomization|Disease Progression|1|||
157052880|NCT02823574|566945969|FG003|Randomization|Disease Progression|0|||
157052881|NCT02823574|566945966|FG000|Randomization|AE unrelated to Study Drug|1|||
157052882|NCT02823574|566945967|FG001|Randomization|AE unrelated to Study Drug|0|||
157052883|NCT02823574|566945968|FG002|Randomization|AE unrelated to Study Drug|0|||
157052884|NCT02823574|566945969|FG003|Randomization|AE unrelated to Study Drug|0|||
157052885|NCT02823574|566945966|FG000|Treatment Period|Poor/Non Compliance|1|||
157052886|NCT02823574|566945967|FG001|Treatment Period|Poor/Non Compliance|0|||
157052887|NCT02823574|566945968|FG002|Treatment Period|Poor/Non Compliance|0|||
157052888|NCT02823574|566945969|FG003|Treatment Period|Poor/Non Compliance|1|||
157052889|NCT02823574|566945966|FG000|Treatment Period|Maximum Clinical Benefit|8|||
157052890|NCT02823574|566945967|FG001|Treatment Period|Maximum Clinical Benefit|4|||
157052891|NCT02823574|566945968|FG002|Treatment Period|Maximum Clinical Benefit|7|||
157052892|NCT02823574|566945969|FG003|Treatment Period|Maximum Clinical Benefit|1|||
157052893|NCT02823574|566945966|FG000|Treatment Period|Lost to Follow-up|1|||
157052894|NCT02823574|566945967|FG001|Treatment Period|Lost to Follow-up|1|||
157052895|NCT02823574|566945968|FG002|Treatment Period|Lost to Follow-up|0|||
157052896|NCT02823574|566945969|FG003|Treatment Period|Lost to Follow-up|0|||
157052897|NCT02823574|566945966|FG000|Treatment Period|Participant withdrew consent|4|||
157052898|NCT02823574|566945967|FG001|Treatment Period|Participant withdrew consent|0|||
157052899|NCT02823574|566945968|FG002|Treatment Period|Participant withdrew consent|0|||
157052900|NCT02823574|566945969|FG003|Treatment Period|Participant withdrew consent|1|||
157052901|NCT02823574|566945966|FG000|Treatment Period|Participant request to discontinue|5|||
157052902|NCT02823574|566945967|FG001|Treatment Period|Participant request to discontinue|0|||
157052903|NCT02823574|566945968|FG002|Treatment Period|Participant request to discontinue|3|||
157052904|NCT02823574|566945969|FG003|Treatment Period|Participant request to discontinue|2|||
157052905|NCT02823574|566945966|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
157052906|NCT02823574|566945967|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
157052907|NCT02823574|566945968|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
157176752|NCT03136367|567387176|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
157176753|NCT03136367|567387174|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
157176754|NCT03136367|567387175|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
157176755|NCT03136367|567387176|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
157176756|NCT03136367|567387174|FG000|T4 12 Weeks After Surgery|Death|0|||
157176757|NCT03136367|567387175|FG001|T4 12 Weeks After Surgery|Death|1|||
157176758|NCT03136367|567387176|FG002|T4 12 Weeks After Surgery|Death|3|||
157176759|NCT03136367|567387174|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
157176760|NCT03136367|567387175|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
157176761|NCT03136367|567387176|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
157176762|NCT03136367|567387174|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
157176763|NCT03136367|567387175|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
157176764|NCT03136367|567387176|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
157176765|NCT03136367|567387174|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
157176766|NCT03136367|567387175|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
157176767|NCT03136367|567387176|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
157052908|NCT02823574|566945969|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
157176768|NCT03136367|567387174|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
157176769|NCT03136367|567387175|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
157052909|NCT02823574|566945966|FG000|Treatment Period|Study Drug Toxicity|11|||
157052910|NCT02823574|566945967|FG001|Treatment Period|Study Drug Toxicity|2|||
157052911|NCT02823574|566945968|FG002|Treatment Period|Study Drug Toxicity|14|||
157052912|NCT02823574|566945969|FG003|Treatment Period|Study Drug Toxicity|4|||
157052913|NCT02823574|566945966|FG000|Treatment Period|Disease Progression|113|||
157052914|NCT02823574|566945967|FG001|Treatment Period|Disease Progression|64|||
157052915|NCT02823574|566945968|FG002|Treatment Period|Disease Progression|82|||
157052916|NCT02823574|566945969|FG003|Treatment Period|Disease Progression|43|||
157052917|NCT02823574|566945966|FG000|Treatment Period|Other reasons|5|||
157052918|NCT02823574|566945967|FG001|Treatment Period|Other reasons|9|||
157229409|NCT02339909|567585269|FG001|Overall Study|Became ineligible after randomisation|63|||
157229410|NCT02339909|567585270|FG002|Overall Study|Became ineligible after randomisation|71|||
157229411|NCT02585258|567585271|FG000|Overall Study|Adverse Event|28|||
157229412|NCT02585258|567585272|FG001|Overall Study|Adverse Event|29|||
157229413|NCT02585258|567585271|FG000|Overall Study|Death|3|||
157229414|NCT02585258|567585272|FG001|Overall Study|Death|2|||
157229415|NCT02585258|567585271|FG000|Overall Study|Lack of Efficacy|7|||
157229416|NCT02585258|567585272|FG001|Overall Study|Lack of Efficacy|9|||
157229417|NCT02585258|567585271|FG000|Overall Study|includes covid-related access problems|42|||
157229418|NCT02585258|567585272|FG001|Overall Study|includes covid-related access problems|46|||
157229419|NCT02585258|567585271|FG000|Overall Study|Lost to Follow-up|5|||
157229420|NCT02585258|567585272|FG001|Overall Study|Lost to Follow-up|2|||
157229421|NCT05125952|567585273|FG000|Overall Study|Physician Decision|1|||
157229422|NCT02848326|567586448|FG000|Treatment Period|Adverse Event|5|||
157229423|NCT02848326|567586449|FG001|Treatment Period|Adverse Event|4|||
157229424|NCT02848326|567586450|FG002|Treatment Period|Adverse Event|11|||
157229425|NCT02848326|567586451|FG003|Treatment Period|Adverse Event|6|||
157229426|NCT02848326|567586452|FG004|Treatment Period|Adverse Event|5|||
157229427|NCT02848326|567586453|FG005|Treatment Period|Adverse Event|7|||
157229428|NCT02848326|567586448|FG000|Treatment Period|Withdrawal of Consent|20|||
157229429|NCT02848326|567586449|FG001|Treatment Period|Withdrawal of Consent|6|||
157229430|NCT02848326|567586450|FG002|Treatment Period|Withdrawal of Consent|9|||
157229431|NCT02848326|567586451|FG003|Treatment Period|Withdrawal of Consent|6|||
157229432|NCT02848326|567586452|FG004|Treatment Period|Withdrawal of Consent|9|||
157229433|NCT02848326|567586453|FG005|Treatment Period|Withdrawal of Consent|6|||
157229434|NCT02848326|567586448|FG000|Treatment Period|Lost to Follow-up|5|||
157229435|NCT02848326|567586449|FG001|Treatment Period|Lost to Follow-up|1|||
157229436|NCT02848326|567586450|FG002|Treatment Period|Lost to Follow-up|11|||
157229437|NCT02848326|567586451|FG003|Treatment Period|Lost to Follow-up|7|||
157229438|NCT02848326|567586452|FG004|Treatment Period|Lost to Follow-up|2|||
157229439|NCT02848326|567586453|FG005|Treatment Period|Lost to Follow-up|3|||
157229440|NCT02848326|567586448|FG000|Treatment Period|Pregnancy|0|||
157229441|NCT02848326|567586449|FG001|Treatment Period|Pregnancy|0|||
157229442|NCT02848326|567586450|FG002|Treatment Period|Pregnancy|1|||
157229443|NCT02848326|567586451|FG003|Treatment Period|Pregnancy|1|||
157229444|NCT02848326|567586452|FG004|Treatment Period|Pregnancy|0|||
157229445|NCT02848326|567586453|FG005|Treatment Period|Pregnancy|1|||
157229446|NCT02848326|567586448|FG000|Treatment Period|Protocol Violation|4|||
157229447|NCT02848326|567586449|FG001|Treatment Period|Protocol Violation|3|||
157229448|NCT02848326|567586450|FG002|Treatment Period|Protocol Violation|4|||
157229449|NCT02848326|567586451|FG003|Treatment Period|Protocol Violation|2|||
157229450|NCT02848326|567586452|FG004|Treatment Period|Protocol Violation|3|||
157229451|NCT02848326|567586453|FG005|Treatment Period|Protocol Violation|3|||
157229452|NCT02848326|567586448|FG000|Treatment Period|Non-compliance with Study Drug|4|||
157229453|NCT02848326|567586449|FG001|Treatment Period|Non-compliance with Study Drug|0|||
157229454|NCT02848326|567586450|FG002|Treatment Period|Non-compliance with Study Drug|0|||
157229455|NCT02848326|567586451|FG003|Treatment Period|Non-compliance with Study Drug|1|||
157229456|NCT02848326|567586452|FG004|Treatment Period|Non-compliance with Study Drug|0|||
157229457|NCT02848326|567586453|FG005|Treatment Period|Non-compliance with Study Drug|0|||
157229458|NCT02848326|567586448|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
157229459|NCT02848326|567586449|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
157229460|NCT02848326|567586450|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
157229461|NCT02848326|567586451|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
157229462|NCT02848326|567586452|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
157229463|NCT02848326|567586453|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
157229464|NCT02848326|567586448|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
157229465|NCT02848326|567586449|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
157229466|NCT02848326|567586450|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
157229467|NCT02848326|567586451|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
157229468|NCT02848326|567586452|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
157229469|NCT02848326|567586453|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
157229470|NCT02937701|567586463|FG000|Day 1 to Week 22|Adverse Event|11|||
157229471|NCT02937701|567586464|FG001|Day 1 to Week 22|Adverse Event|14|||
157229472|NCT02937701|567586465|FG002|Day 1 to Week 22|Adverse Event|0|||
157229473|NCT02937701|567586466|FG003|Day 1 to Week 22|Adverse Event|0|||
157229474|NCT02937701|567586467|FG004|Day 1 to Week 22|Adverse Event|0|||
157229475|NCT02937701|567586463|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
157229476|NCT02937701|567586464|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
157229477|NCT02937701|567586465|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
157229478|NCT02937701|567586466|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
157229479|NCT02937701|567586467|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
157229480|NCT02937701|567586463|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
157229481|NCT02937701|567586464|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
157229482|NCT02937701|567586465|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
157229483|NCT02937701|567586466|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
157052919|NCT02823574|566945968|FG002|Treatment Period|Other reasons|3|||
157052920|NCT02823574|566945969|FG003|Treatment Period|Other reasons|6|||
157052921|NCT02823574|566945966|FG000|Treatment Period|Participant no longer meets study criteria|0|||
157052922|NCT02823574|566945967|FG001|Treatment Period|Participant no longer meets study criteria|0|||
157052923|NCT02823574|566945968|FG002|Treatment Period|Participant no longer meets study criteria|1|||
157052924|NCT02823574|566945969|FG003|Treatment Period|Participant no longer meets study criteria|0|||
157052925|NCT02823574|566945966|FG000|Treatment Period|Death|0|||
157052926|NCT02823574|566945967|FG001|Treatment Period|Death|0|||
157052927|NCT02823574|566945968|FG002|Treatment Period|Death|3|||
157052928|NCT02823574|566945969|FG003|Treatment Period|Death|1|||
157052929|NCT00590759|566945970|FG000|Overall Study|Death|52|||
157052930|NCT00590759|566945970|FG000|Overall Study|Lost to Follow-up|28|||
157052931|NCT00901459|566945975|FG000|Overall Study|Withdrawal by Subject|6|||
157052932|NCT04765046|566945976|FG000|Overall Study|Screen Failure|2|||
157052933|NCT04765046|566945976|FG000|Overall Study|Withdrawal by Subject|4|||
157052934|NCT04765046|566945976|FG000|Overall Study|Physician Decision|4|||
157052935|NCT04765046|566945976|FG000|Overall Study|Surgery Cancelled|8|||
157052936|NCT02959866|566945980|FG000|Overall Study|Withdrawal by Subject|1|||
157052937|NCT04529941|566945984|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
157052938|NCT04529941|566945985|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
157052939|NCT01005914|566945986|FG000|Overall Study|Adverse Event|4|||
157052940|NCT01005914|566945986|FG000|Overall Study|Death|4|||
157052941|NCT01005914|566945986|FG000|Overall Study|Lack of Efficacy|1|||
157052942|NCT01005914|566945986|FG000|Overall Study|Withdrawal by Subject|1|||
157052943|NCT01240785|566945987|FG000|Overall Study|Lost to Follow-up|1|||
157176770|NCT03136367|567387176|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
157176771|NCT03136367|567387174|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
157176772|NCT03136367|567387175|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
157176773|NCT03136367|567387176|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
157176774|NCT03136367|567387174|FG000|T5 1 Year After Surgery|Death|0|||
157176775|NCT03136367|567387175|FG001|T5 1 Year After Surgery|Death|0|||
157176776|NCT03136367|567387176|FG002|T5 1 Year After Surgery|Death|1|||
157176777|NCT03136367|567387174|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
157176778|NCT03136367|567387175|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
157176779|NCT03136367|567387176|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
157176780|NCT03136367|567387174|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
157176781|NCT03136367|567387175|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
157176782|NCT03136367|567387176|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
157176783|NCT03136367|567387174|FG000|T5 1 Year After Surgery|study ended before due|31|||
157176784|NCT03136367|567387175|FG001|T5 1 Year After Surgery|study ended before due|103|||
157176785|NCT03136367|567387176|FG002|T5 1 Year After Surgery|study ended before due|110|||
157176786|NCT03136367|567387174|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
157176787|NCT03136367|567387175|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
157176788|NCT03136367|567387176|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
157176789|NCT02146833|567387180|FG000|Overall Study|Death|10|||
157176790|NCT02146833|567387180|FG000|Overall Study|No longer consented to study treatment|1|||
157176791|NCT03726333|567387181|FG000|Overall Study|Progressive Disease|0|||
157176792|NCT03726333|567387182|FG001|Overall Study|Progressive Disease|0|||
157176793|NCT03726333|567387183|FG002|Overall Study|Progressive Disease|1|||
157176794|NCT03726333|567387184|FG003|Overall Study|Progressive Disease|0|||
157176795|NCT03726333|567387185|FG004|Overall Study|Progressive Disease|0|||
157176796|NCT00446641|567389577|FG000|Overall Study|Withdrawal by Subject|8|||
157176797|NCT00446641|567389578|FG001|Overall Study|Withdrawal by Subject|3|||
157176798|NCT00446641|567389577|FG000|Overall Study|poor compliance|8|||
157176799|NCT00446641|567389578|FG001|Overall Study|poor compliance|6|||
157176800|NCT00446641|567389577|FG000|Overall Study|Lost to Follow-up|1|||
157176801|NCT00446641|567389578|FG001|Overall Study|Lost to Follow-up|1|||
157176802|NCT00405275|567389585|FG000|Overall Study|Death|1|||
157176803|NCT00405275|567389586|FG001|Overall Study|Death|0|||
157052944|NCT01240785|566945988|FG001|Overall Study|Lost to Follow-up|0|||
157176804|NCT00405275|567389585|FG000|Overall Study|Lost to Follow-up|5|||
157176805|NCT00405275|567389586|FG001|Overall Study|Lost to Follow-up|1|||
157176806|NCT00405275|567389585|FG000|Overall Study|Withdrawal by Subject|7|||
157176807|NCT00405275|567389586|FG001|Overall Study|Withdrawal by Subject|9|||
157176808|NCT00405275|567389585|FG000|Overall Study|Unwilling to continue|10|||
157176809|NCT00405275|567389586|FG001|Overall Study|Unwilling to continue|9|||
157229484|NCT02937701|567586467|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
157176810|NCT00088595|567389587|FG000|Overall Study|Adverse Event|11|||
157052945|NCT01240785|566945987|FG000|Overall Study|Protocol Violation|0|||
157052946|NCT01240785|566945988|FG001|Overall Study|Protocol Violation|3|||
157052947|NCT00321555|566945993|FG000|Overall Study|Developed antibodies|1|||
157052948|NCT00321555|566945993|FG000|Overall Study|Switched to alternative treatment|3|||
157052949|NCT00321555|566945993|FG000|Overall Study|Physician Decision|1|||
157052950|NCT00321555|566945993|FG000|Overall Study|Disease progression on study|1|||
157052951|NCT04520256|566945996|FG000|Overall Study|Lost to Follow-up|6|||
157052952|NCT04520256|566945997|FG001|Overall Study|Lost to Follow-up|4|||
157052953|NCT04520256|566945998|FG002|Overall Study|Lost to Follow-up|2|||
157052954|NCT04520256|566945999|FG003|Overall Study|Lost to Follow-up|3|||
157052955|NCT04520256|566946000|FG004|Overall Study|Lost to Follow-up|6|||
157052956|NCT04520256|566946001|FG005|Overall Study|Lost to Follow-up|6|||
157052957|NCT04520256|566946002|FG006|Overall Study|Lost to Follow-up|4|||
157052958|NCT04520256|566946003|FG007|Overall Study|Lost to Follow-up|6|||
157052959|NCT04520256|566946004|FG008|Overall Study|Lost to Follow-up|1|||
157052960|NCT04520256|566946005|FG009|Overall Study|Lost to Follow-up|3|||
157052961|NCT04520256|566946006|FG010|Overall Study|Lost to Follow-up|3|||
157052962|NCT04520256|566946007|FG011|Overall Study|Lost to Follow-up|2|||
157052963|NCT04520256|566946008|FG012|Overall Study|Lost to Follow-up|5|||
157052964|NCT04520256|566946009|FG013|Overall Study|Lost to Follow-up|3|||
157052965|NCT04520256|566946010|FG014|Overall Study|Lost to Follow-up|3|||
157052966|NCT04520256|566946011|FG015|Overall Study|Lost to Follow-up|6|||
157052967|NCT04520256|566946012|FG016|Overall Study|Lost to Follow-up|6|||
157052968|NCT04520256|566946013|FG017|Overall Study|Lost to Follow-up|4|||
157052969|NCT04520256|566946014|FG018|Overall Study|Lost to Follow-up|3|||
157052970|NCT04520256|566946015|FG019|Overall Study|Lost to Follow-up|3|||
157052971|NCT04520256|566946016|FG020|Overall Study|Lost to Follow-up|7|||
157052972|NCT04520256|566946017|FG021|Overall Study|Lost to Follow-up|3|||
157052973|NCT04520256|566946018|FG022|Overall Study|Lost to Follow-up|3|||
157052974|NCT04520256|566946019|FG023|Overall Study|Lost to Follow-up|8|||
157052975|NCT04520256|566946020|FG024|Overall Study|Lost to Follow-up|5|||
157052976|NCT04520256|566946021|FG025|Overall Study|Lost to Follow-up|4|||
157052977|NCT04520256|566946022|FG026|Overall Study|Lost to Follow-up|3|||
157052978|NCT04520256|566946023|FG027|Overall Study|Lost to Follow-up|4|||
157052979|NCT04520256|566946024|FG028|Overall Study|Lost to Follow-up|3|||
157052980|NCT04520256|566946025|FG029|Overall Study|Lost to Follow-up|4|||
157052981|NCT04520256|566946026|FG030|Overall Study|Lost to Follow-up|4|||
157052982|NCT04520256|566946027|FG031|Overall Study|Lost to Follow-up|4|||
157052983|NCT00760877|566947458|FG000|Overall Study|Protocol Violation|1|||
157052984|NCT00760877|566947459|FG001|Overall Study|Protocol Violation|0|||
157052985|NCT00760877|566947458|FG000|Overall Study|Non-compliance with protocol treatment|2|||
157052986|NCT00760877|566947459|FG001|Overall Study|Non-compliance with protocol treatment|1|||
157052987|NCT00760877|566947458|FG000|Overall Study|Pregnancy|1|||
157052988|NCT00760877|566947459|FG001|Overall Study|Pregnancy|4|||
157052989|NCT00760877|566947458|FG000|Overall Study|Death|2|||
157052990|NCT00760877|566947459|FG001|Overall Study|Death|1|||
157052991|NCT00760877|566947458|FG000|Overall Study|Withdrawal by Subject|7|||
157052992|NCT00760877|566947459|FG001|Overall Study|Withdrawal by Subject|3|||
157052993|NCT00760877|566947458|FG000|Overall Study|Adverse Event|19|||
157052994|NCT00760877|566947459|FG001|Overall Study|Adverse Event|12|||
157052995|NCT00760877|566947458|FG000|Overall Study|Participant diagnosed with AML|0|||
157052996|NCT00760877|566947459|FG001|Overall Study|Participant diagnosed with AML|1|||
157052997|NCT00760877|566947458|FG000|Overall Study|Participant not eligible to cross-over|0|||
157052998|NCT00760877|566947459|FG001|Overall Study|Participant not eligible to cross-over|1|||
157052999|NCT00760877|566947458|FG000|Overall Study|Physician Decision|1|||
157053000|NCT00760877|566947459|FG001|Overall Study|Physician Decision|2|||
157053001|NCT00760877|566947458|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
157053002|NCT00760877|566947459|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
157053003|NCT00760877|566947458|FG000|Overall Study|Treatment failure|1|||
157053004|NCT00760877|566947459|FG001|Overall Study|Treatment failure|0|||
157053005|NCT01730118|566947460|FG000|Dose Escalation|Death on study|5|||
157053006|NCT01730118|566947461|FG001|Dose Escalation|Death on study|7|||
157053007|NCT01730118|566947462|FG002|Dose Escalation|Death on study|2|||
157053008|NCT01730118|566947463|FG003|Dose Escalation|Death on study|6|||
157053009|NCT01730118|566947464|FG004|Dose Escalation|Death on study|0|||
157053010|NCT01730118|566947465|FG005|Dose Escalation|Death on study|0|||
157053011|NCT01730118|566947466|FG006|Dose Escalation|Death on study|0|||
157053012|NCT01730118|566947460|FG000|Dose Escalation|Died before treatment|0|||
157053013|NCT01730118|566947461|FG001|Dose Escalation|Died before treatment|0|||
157053014|NCT01730118|566947462|FG002|Dose Escalation|Died before treatment|0|||
157053015|NCT01730118|566947463|FG003|Dose Escalation|Died before treatment|0|||
157053016|NCT01730118|566947464|FG004|Dose Escalation|Died before treatment|0|||
157053017|NCT01730118|566947465|FG005|Dose Escalation|Died before treatment|0|||
157053018|NCT01730118|566947466|FG006|Dose Escalation|Died before treatment|1|||
157053019|NCT01730118|566947460|FG000|Dose Escalation|Chose to start a different treatment|1|||
157053020|NCT01730118|566947461|FG001|Dose Escalation|Chose to start a different treatment|0|||
157053021|NCT01730118|566947462|FG002|Dose Escalation|Chose to start a different treatment|0|||
157053022|NCT01730118|566947463|FG003|Dose Escalation|Chose to start a different treatment|0|||
157053023|NCT01730118|566947464|FG004|Dose Escalation|Chose to start a different treatment|0|||
157053024|NCT01730118|566947465|FG005|Dose Escalation|Chose to start a different treatment|0|||
157053025|NCT01730118|566947466|FG006|Dose Escalation|Chose to start a different treatment|0|||
157053026|NCT01730118|566947460|FG000|Dose Escalation|Withdrawal by Subject|0|||
157053027|NCT01730118|566947461|FG001|Dose Escalation|Withdrawal by Subject|0|||
157053028|NCT01730118|566947462|FG002|Dose Escalation|Withdrawal by Subject|1|||
157053029|NCT01730118|566947463|FG003|Dose Escalation|Withdrawal by Subject|0|||
157229485|NCT02937701|567586463|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
157229486|NCT02937701|567586464|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
156973603|NCT04836858|566656702|FG000|Overall Study|Subject/Guardian decision|3|||
156973604|NCT04836858|566656703|FG001|Overall Study|Subject/Guardian decision|0|||
156973605|NCT04836858|566656704|FG002|Overall Study|Subject/Guardian decision|0|||
156973606|NCT04836858|566656705|FG003|Overall Study|Subject/Guardian decision|1|||
156973607|NCT04836858|566656702|FG000|Overall Study|Randomized but not treated|4|||
156973608|NCT04836858|566656703|FG001|Overall Study|Randomized but not treated|0|||
156973609|NCT04836858|566656704|FG002|Overall Study|Randomized but not treated|0|||
156973610|NCT04836858|566656705|FG003|Overall Study|Randomized but not treated|0|||
156973611|NCT02396537|566656708|FG000|Overall Study|Protocol Violation|0|||
156973612|NCT02396537|566656709|FG001|Overall Study|Protocol Violation|1|||
156973613|NCT01982435|566656710|FG000|Overall Study|Adverse Event|1|||
156973614|NCT01982435|566656711|FG001|Overall Study|Adverse Event|0|||
156973615|NCT01691521|566656715|FG000|Overall Study|Adverse Event|4|||
156973616|NCT01691521|566656716|FG001|Overall Study|Adverse Event|0|||
156973617|NCT01691521|566656717|FG002|Overall Study|Adverse Event|1|||
156973618|NCT01691521|566656715|FG000|Overall Study|Lack of Efficacy|1|||
156973619|NCT01691521|566656716|FG001|Overall Study|Lack of Efficacy|1|||
156973620|NCT01691521|566656717|FG002|Overall Study|Lack of Efficacy|2|||
156973621|NCT01691521|566656715|FG000|Overall Study|Protocol Violation|0|||
156973622|NCT01691521|566656716|FG001|Overall Study|Protocol Violation|3|||
156973623|NCT01691521|566656717|FG002|Overall Study|Protocol Violation|0|||
156973624|NCT01691521|566656715|FG000|Overall Study|Lost to Follow-up|0|||
156973625|NCT01691521|566656716|FG001|Overall Study|Lost to Follow-up|2|||
156973626|NCT01691521|566656717|FG002|Overall Study|Lost to Follow-up|2|||
156973627|NCT01691521|566656715|FG000|Overall Study|Physician Decision|2|||
156973628|NCT01691521|566656716|FG001|Overall Study|Physician Decision|1|||
156973629|NCT01691521|566656717|FG002|Overall Study|Physician Decision|0|||
156973630|NCT01691521|566656715|FG000|Overall Study|Withdrawal by Subject|5|||
156973631|NCT01691521|566656716|FG001|Overall Study|Withdrawal by Subject|9|||
156973632|NCT01691521|566656717|FG002|Overall Study|Withdrawal by Subject|4|||
156973633|NCT02281760|566656718|FG000|Overall Study|Withdrawal by Subject|1|||
156973634|NCT00954733|566656719|FG000|Overall Study|blood gas machine did not work|1|||
156973635|NCT03579290|566656720|FG000|Overall Study|Lost to Follow-up|9|||
156973636|NCT00622713|566656723|FG000|Overall Study|Adverse Event|35|||
156973637|NCT00622713|566656723|FG000|Overall Study|Administrative problems|4|||
156973638|NCT00622713|566656723|FG000|Overall Study|Withdrawal by Subject|11|||
156973639|NCT00622713|566656723|FG000|Overall Study|Lost to Follow-up|5|||
156973640|NCT00622713|566656723|FG000|Overall Study|Death|2|||
156973641|NCT00622713|566656723|FG000|Overall Study|Subject no longer required study drug|1|||
156973642|NCT00622713|566656723|FG000|Overall Study|Did not meet eligibility criteria|1|||
156973643|NCT01725386|566656732|FG000|Overall Study|Death|84|||
156973644|NCT01725386|566656733|FG001|Overall Study|Death|40|||
156973645|NCT01725386|566656732|FG000|Overall Study|Lost to Follow-up|81|||
156973646|NCT01725386|566656733|FG001|Overall Study|Lost to Follow-up|6|||
156973647|NCT01725386|566656732|FG000|Overall Study|Withdrawal by Subject|10|||
156973648|NCT01725386|566656733|FG001|Overall Study|Withdrawal by Subject|0|||
156973649|NCT00879996|566656737|FG000|Overall Study|Lost to Follow-up|7|||
156973650|NCT00879996|566656738|FG001|Overall Study|Lost to Follow-up|6|||
156973651|NCT00879996|566656737|FG000|Overall Study|non-compliance|6|||
156973652|NCT00879996|566656738|FG001|Overall Study|non-compliance|4|||
156973653|NCT00879996|566656737|FG000|Overall Study|Physician Decision|1|||
156973654|NCT00879996|566656738|FG001|Overall Study|Physician Decision|2|||
156973655|NCT00879996|566656737|FG000|Overall Study|psychiatric problem|0|||
156973656|NCT00879996|566656738|FG001|Overall Study|psychiatric problem|1|||
156973657|NCT00879996|566656737|FG000|Overall Study|put on parole|1|||
156973658|NCT00879996|566656738|FG001|Overall Study|put on parole|0|||
156973659|NCT01216163|566656743|FG000|Overall Study|Withdrawal by Subject|1|||
156973660|NCT01216163|566656744|FG001|Overall Study|Withdrawal by Subject|1|||
156973661|NCT01216163|566656745|FG002|Overall Study|Withdrawal by Subject|0|||
156973662|NCT02914314|566656746|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156973663|NCT02914314|566656747|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156973664|NCT02914314|566656748|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
156973665|NCT02914314|566656749|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
156973666|NCT02914314|566656746|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156973667|NCT02914314|566656747|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156973668|NCT02914314|566656748|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
156973669|NCT02914314|566656749|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
156973670|NCT02914314|566656746|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156973671|NCT02914314|566656747|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156973672|NCT02914314|566656748|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
156973673|NCT02914314|566656749|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
156973674|NCT02914314|566656746|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156973675|NCT02914314|566656747|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156973676|NCT02914314|566656748|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
157053030|NCT01730118|566947464|FG004|Dose Escalation|Withdrawal by Subject|0|||
157053031|NCT01730118|566947465|FG005|Dose Escalation|Withdrawal by Subject|0|||
157053032|NCT01730118|566947466|FG006|Dose Escalation|Withdrawal by Subject|0|||
157053033|NCT01730118|566947460|FG000|Dose Escalation|Disease progression prior to treatment|0|||
157053034|NCT01730118|566947461|FG001|Dose Escalation|Disease progression prior to treatment|0|||
157053035|NCT01730118|566947462|FG002|Dose Escalation|Disease progression prior to treatment|0|||
157053036|NCT01730118|566947463|FG003|Dose Escalation|Disease progression prior to treatment|0|||
157176811|NCT00088595|567389587|FG000|Overall Study|Withdrawal by Subject|8|||
157176812|NCT00088595|567389587|FG000|Overall Study|Ongoing (After Core)|7|||
157176813|NCT00088595|567389587|FG000|Overall Study|New Cancer Therapy|2|||
157176814|NCT01308853|567389598|FG000|Overall Study|Adverse Event|1|||
157176815|NCT01308853|567389598|FG000|Overall Study|Lost to Follow-up|2|||
157176816|NCT01308853|567389598|FG000|Overall Study|Insertion of permanent implants|1|||
157176817|NCT01376388|567389603|FG000|Overall Study|Adverse Event|13|||
157176818|NCT01376388|567389603|FG000|Overall Study|Lack of Efficacy|2|||
157176819|NCT01376388|567389603|FG000|Overall Study|Withdrawal by Subject|3|||
157176820|NCT02959970|567389611|FG000|Overall Study|Adverse Event|1|||
157176821|NCT02959970|567389612|FG001|Overall Study|Adverse Event|0|||
157176822|NCT02959970|567389611|FG000|Overall Study|Withdrawal by Subject|0|||
157176823|NCT02959970|567389612|FG001|Overall Study|Withdrawal by Subject|2|||
157053037|NCT01730118|566947464|FG004|Dose Escalation|Disease progression prior to treatment|0|||
157053038|NCT01730118|566947465|FG005|Dose Escalation|Disease progression prior to treatment|0|||
157053039|NCT01730118|566947466|FG006|Dose Escalation|Disease progression prior to treatment|1|||
157053040|NCT01730118|566947460|FG000|Dose Expansion|Death|0|||
157053041|NCT01730118|566947461|FG001|Dose Expansion|Death|0|||
157053042|NCT01730118|566947462|FG002|Dose Expansion|Death|0|||
157053043|NCT01730118|566947463|FG003|Dose Expansion|Death|0|||
157053044|NCT01730118|566947464|FG004|Dose Expansion|Death|1|||
157053045|NCT01730118|566947465|FG005|Dose Expansion|Death|0|||
157053046|NCT01730118|566947466|FG006|Dose Expansion|Death|0|||
157053047|NCT01730118|566947460|FG000|Dose Expansion|Other medical condition|0|||
157053048|NCT01730118|566947461|FG001|Dose Expansion|Other medical condition|0|||
157053049|NCT01730118|566947462|FG002|Dose Expansion|Other medical condition|0|||
157053050|NCT01730118|566947463|FG003|Dose Expansion|Other medical condition|0|||
157053051|NCT01730118|566947464|FG004|Dose Expansion|Other medical condition|1|||
157053052|NCT01730118|566947465|FG005|Dose Expansion|Other medical condition|0|||
157053053|NCT01730118|566947466|FG006|Dose Expansion|Other medical condition|0|||
157053054|NCT01730118|566947460|FG000|Dose Expansion|Withdrawal by Subject|0|||
157053055|NCT01730118|566947461|FG001|Dose Expansion|Withdrawal by Subject|0|||
157053056|NCT01730118|566947462|FG002|Dose Expansion|Withdrawal by Subject|0|||
157053057|NCT01730118|566947463|FG003|Dose Expansion|Withdrawal by Subject|0|||
157053058|NCT01730118|566947464|FG004|Dose Expansion|Withdrawal by Subject|1|||
157053059|NCT01730118|566947465|FG005|Dose Expansion|Withdrawal by Subject|0|||
157053060|NCT01730118|566947466|FG006|Dose Expansion|Withdrawal by Subject|0|||
157053061|NCT01730118|566947460|FG000|Dose Expansion|Disease progression|0|||
157053062|NCT01730118|566947461|FG001|Dose Expansion|Disease progression|0|||
157053063|NCT01730118|566947462|FG002|Dose Expansion|Disease progression|0|||
157053064|NCT01730118|566947463|FG003|Dose Expansion|Disease progression|0|||
157053065|NCT01730118|566947464|FG004|Dose Expansion|Disease progression|0|||
157053066|NCT01730118|566947465|FG005|Dose Expansion|Disease progression|1|||
157053067|NCT01730118|566947466|FG006|Dose Expansion|Disease progression|0|||
157053068|NCT01730118|566947460|FG000|Dose Expansion|Inability to return|0|||
157053069|NCT01730118|566947461|FG001|Dose Expansion|Inability to return|0|||
157053070|NCT01730118|566947462|FG002|Dose Expansion|Inability to return|0|||
157053071|NCT01730118|566947463|FG003|Dose Expansion|Inability to return|0|||
157176824|NCT02959970|567389611|FG000|Overall Study|Lost to Follow-up|1|||
157053072|NCT01730118|566947464|FG004|Dose Expansion|Inability to return|0|||
157176825|NCT02959970|567389612|FG001|Overall Study|Lost to Follow-up|5|||
157176826|NCT01473355|567389617|FG000|Overall Study|Protocol Violation|2|||
157176827|NCT01473355|567389617|FG000|Overall Study|Adverse Event|2|||
157176828|NCT01473355|567389617|FG000|Overall Study|Lost to Follow-up|2|||
157176829|NCT02017704|567389619|FG000|Overall Study|Withdrawal by Subject|2|||
157053073|NCT01730118|566947465|FG005|Dose Expansion|Inability to return|1|||
157053074|NCT01730118|566947466|FG006|Dose Expansion|Inability to return|0|||
157053075|NCT01730118|566947460|FG000|Dose Expansion|Physician Decision|0|||
157053076|NCT01730118|566947461|FG001|Dose Expansion|Physician Decision|0|||
157053077|NCT01730118|566947462|FG002|Dose Expansion|Physician Decision|0|||
157053078|NCT01730118|566947463|FG003|Dose Expansion|Physician Decision|0|||
157053079|NCT01730118|566947464|FG004|Dose Expansion|Physician Decision|0|||
157053080|NCT01730118|566947465|FG005|Dose Expansion|Physician Decision|1|||
157176830|NCT02017704|567389620|FG001|Overall Study|Withdrawal by Subject|0|||
157176831|NCT00918346|567389621|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
157176832|NCT00918346|567389622|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
157176833|NCT02076334|567389623|FG000|Overall Study|Protocol Violation|1|||
157053081|NCT01730118|566947466|FG006|Dose Expansion|Physician Decision|0|||
157053082|NCT05379400|566947470|FG000|Overall Study|Lost to Follow-up|1|||
157053083|NCT05379400|566947471|FG001|Overall Study|Lost to Follow-up|1|||
157053084|NCT05356130|566947473|FG000|Overall Study|Withdrawal by Subject|0|||
157053085|NCT05356130|566947474|FG001|Overall Study|Withdrawal by Subject|0|||
157053086|NCT05356130|566947475|FG002|Overall Study|Withdrawal by Subject|3|||
157053087|NCT01816165|566947478|FG000|Overall Study|Adverse Event|1|||
157053088|NCT01816165|566947479|FG001|Overall Study|Adverse Event|0|||
157053089|NCT01816165|566947480|FG002|Overall Study|Adverse Event|0|||
157053090|NCT01816165|566947481|FG003|Overall Study|Adverse Event|0|||
157053091|NCT01183013|566947484|FG000|Overall Study|Adverse Event|6|||
157053092|NCT01183013|566947485|FG001|Overall Study|Adverse Event|8|||
157053093|NCT01183013|566947486|FG002|Overall Study|Adverse Event|5|||
157053094|NCT01183013|566947487|FG003|Overall Study|Adverse Event|5|||
157053095|NCT01183013|566947488|FG004|Overall Study|Adverse Event|10|||
157053096|NCT01183013|566947489|FG005|Overall Study|Adverse Event|10|||
157053097|NCT01183013|566947490|FG006|Overall Study|Adverse Event|6|||
157053098|NCT01183013|566947484|FG000|Overall Study|Lack of Efficacy|3|||
157053099|NCT01183013|566947485|FG001|Overall Study|Lack of Efficacy|2|||
157053100|NCT01183013|566947486|FG002|Overall Study|Lack of Efficacy|1|||
157053101|NCT01183013|566947487|FG003|Overall Study|Lack of Efficacy|2|||
157053102|NCT01183013|566947488|FG004|Overall Study|Lack of Efficacy|1|||
157053103|NCT01183013|566947489|FG005|Overall Study|Lack of Efficacy|2|||
157053104|NCT01183013|566947490|FG006|Overall Study|Lack of Efficacy|0|||
157053105|NCT01183013|566947484|FG000|Overall Study|Protocol Violation|5|||
157053106|NCT01183013|566947485|FG001|Overall Study|Protocol Violation|2|||
157053107|NCT01183013|566947486|FG002|Overall Study|Protocol Violation|4|||
157053108|NCT01183013|566947487|FG003|Overall Study|Protocol Violation|0|||
157053109|NCT01183013|566947488|FG004|Overall Study|Protocol Violation|4|||
157053110|NCT01183013|566947489|FG005|Overall Study|Protocol Violation|3|||
157053111|NCT01183013|566947490|FG006|Overall Study|Protocol Violation|3|||
157053112|NCT01183013|566947484|FG000|Overall Study|Lost to Follow-up|7|||
157053113|NCT01183013|566947485|FG001|Overall Study|Lost to Follow-up|3|||
157053114|NCT01183013|566947486|FG002|Overall Study|Lost to Follow-up|4|||
157053115|NCT01183013|566947487|FG003|Overall Study|Lost to Follow-up|3|||
157053116|NCT01183013|566947488|FG004|Overall Study|Lost to Follow-up|2|||
157053117|NCT01183013|566947489|FG005|Overall Study|Lost to Follow-up|6|||
157053118|NCT01183013|566947490|FG006|Overall Study|Lost to Follow-up|5|||
157053119|NCT01183013|566947484|FG000|Overall Study|Withdrawal by Subject|9|||
157053120|NCT01183013|566947485|FG001|Overall Study|Withdrawal by Subject|13|||
157053121|NCT01183013|566947486|FG002|Overall Study|Withdrawal by Subject|10|||
157053122|NCT01183013|566947487|FG003|Overall Study|Withdrawal by Subject|8|||
157053123|NCT01183013|566947488|FG004|Overall Study|Withdrawal by Subject|7|||
157053124|NCT01183013|566947489|FG005|Overall Study|Withdrawal by Subject|9|||
157053125|NCT01183013|566947490|FG006|Overall Study|Withdrawal by Subject|10|||
157053126|NCT01183013|566947484|FG000|Overall Study|Reasons other than stated above|15|||
157053127|NCT01183013|566947485|FG001|Overall Study|Reasons other than stated above|11|||
157053128|NCT01183013|566947486|FG002|Overall Study|Reasons other than stated above|17|||
157053129|NCT01183013|566947487|FG003|Overall Study|Reasons other than stated above|12|||
157053130|NCT01183013|566947488|FG004|Overall Study|Reasons other than stated above|12|||
157053131|NCT01183013|566947489|FG005|Overall Study|Reasons other than stated above|15|||
157053132|NCT01183013|566947490|FG006|Overall Study|Reasons other than stated above|13|||
157053133|NCT00584909|566947491|FG000|Overall Study|Adverse Event|4|||
157053134|NCT02092909|566947492|FG000|Overall Study|Adverse Event|0|||
157053135|NCT02092909|566947493|FG001|Overall Study|Adverse Event|0|||
157053136|NCT02092909|566947494|FG002|Overall Study|Adverse Event|4|||
157053137|NCT02092909|566947495|FG003|Overall Study|Adverse Event|2|||
157053138|NCT02092909|566947492|FG000|Overall Study|Lack of Efficacy|0|||
157053139|NCT02092909|566947493|FG001|Overall Study|Lack of Efficacy|2|||
157053140|NCT02092909|566947494|FG002|Overall Study|Lack of Efficacy|1|||
157176834|NCT02076334|567389624|FG001|Overall Study|Protocol Violation|0|||
157176835|NCT02076334|567389625|FG002|Overall Study|Protocol Violation|0|||
157176836|NCT02076334|567389626|FG003|Overall Study|Protocol Violation|0|||
157176837|NCT02076334|567389623|FG000|Overall Study|Lost to Follow-up|0|||
157176838|NCT02076334|567389624|FG001|Overall Study|Lost to Follow-up|1|||
157053141|NCT02092909|566947495|FG003|Overall Study|Lack of Efficacy|0|||
157053142|NCT02092909|566947492|FG000|Overall Study|Withdrawal by Subject|0|||
157053143|NCT02092909|566947493|FG001|Overall Study|Withdrawal by Subject|0|||
157053144|NCT02092909|566947494|FG002|Overall Study|Withdrawal by Subject|2|||
157053145|NCT02092909|566947495|FG003|Overall Study|Withdrawal by Subject|1|||
157053146|NCT02092909|566947492|FG000|Overall Study|Study terminated by Sponsor|0|||
157053147|NCT02092909|566947493|FG001|Overall Study|Study terminated by Sponsor|0|||
157053148|NCT02092909|566947494|FG002|Overall Study|Study terminated by Sponsor|0|||
157053149|NCT02092909|566947495|FG003|Overall Study|Study terminated by Sponsor|2|||
157053150|NCT02092909|566947492|FG000|Overall Study|Miscellaneous|1|||
157053151|NCT02092909|566947493|FG001|Overall Study|Miscellaneous|1|||
157053152|NCT02092909|566947494|FG002|Overall Study|Miscellaneous|2|||
157053153|NCT02092909|566947495|FG003|Overall Study|Miscellaneous|1|||
157053154|NCT04175392|566947496|FG000|Overall Study|Withdrawal by Subject|3|||
157053155|NCT04175392|566947497|FG001|Overall Study|Withdrawal by Subject|2|||
157053156|NCT02727998|566947498|FG000|Overall Study|Lost to Follow-up|3|||
157053157|NCT02727998|566947499|FG001|Overall Study|Lost to Follow-up|3|||
157053158|NCT02727998|566947498|FG000|Overall Study|Withdrawal by Subject|0|||
157053159|NCT02727998|566947499|FG001|Overall Study|Withdrawal by Subject|1|||
157053160|NCT02105688|566947500|FG000|Part A: Double-Blind|Adverse Event|1|||
157053161|NCT02105688|566947501|FG001|Part A: Double-Blind|Adverse Event|0|||
157053162|NCT02105688|566947500|FG000|Part A: Double-Blind|Death|0|||
157053163|NCT02105688|566947501|FG001|Part A: Double-Blind|Death|1|||
157053164|NCT02105688|566947500|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
157053165|NCT02105688|566947501|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
157053166|NCT02105688|566947500|FG000|Part A: Double-Blind|Physician Decision|0|||
157053167|NCT02105688|566947501|FG001|Part A: Double-Blind|Physician Decision|1|||
157053168|NCT02105688|566947500|FG000|Part A: Double-Blind|Status Unknown|0|||
157053169|NCT02105688|566947501|FG001|Part A: Double-Blind|Status Unknown|2|||
157053170|NCT02105688|566947500|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
157053171|NCT02105688|566947501|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
157053172|NCT02105688|566947500|FG000|Part B: Observational Follow-up|Death|2|||
157053173|NCT02105688|566947501|FG001|Part B: Observational Follow-up|Death|1|||
157053174|NCT02105688|566947500|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
157053175|NCT02105688|566947501|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
157053176|NCT02105688|566947500|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
157053177|NCT02105688|566947501|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
157053178|NCT02105688|566947500|FG000|Part B: Observational Follow-up|Physician Decision|3|||
157053179|NCT02105688|566947501|FG001|Part B: Observational Follow-up|Physician Decision|1|||
157053180|NCT01103141|566947502|FG000|Overall Study|Death|0|||
157053181|NCT01103141|566947503|FG001|Overall Study|Death|1|||
157053182|NCT01103141|566947502|FG000|Overall Study|Lost to Follow-up|2|||
157053183|NCT01103141|566947503|FG001|Overall Study|Lost to Follow-up|1|||
157053184|NCT05072795|566947504|FG000|Overall Study|Lost to Follow-up|5|||
157053185|NCT00910871|566947513|FG000|Overall Study|Adverse Event|5|||
157053186|NCT00910871|566947513|FG000|Overall Study|Death|12|||
157053187|NCT00910871|566947513|FG000|Overall Study|Lost to Follow-up|8|||
157053188|NCT00910871|566947513|FG000|Overall Study|Protocol Violation|11|||
157053189|NCT00910871|566947513|FG000|Overall Study|Withdrawal by Subject|12|||
157053190|NCT00910871|566947513|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
157053191|NCT00910871|566947513|FG000|Overall Study|Undefined|1|||
157053192|NCT00850993|566947514|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
157053193|NCT00850993|566947515|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
157053194|NCT00850993|566947516|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
157053195|NCT00850993|566947517|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
157053196|NCT04501614|566947522|FG000|Overall Study|Study Terminated by Sponsor|6|||
157053197|NCT04501614|566947523|FG001|Overall Study|Study Terminated by Sponsor|3|||
157053198|NCT04501614|566947522|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
157053199|NCT04501614|566947523|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
157053200|NCT02555397|566947527|FG000|Overall Study|Withdrawal by Subject|1|||
157053201|NCT02555397|566947528|FG001|Overall Study|Withdrawal by Subject|0|||
157053202|NCT02555397|566947529|FG002|Overall Study|Withdrawal by Subject|0|||
157053203|NCT02555397|566947530|FG003|Overall Study|Withdrawal by Subject|0|||
157053204|NCT02555397|566947531|FG004|Overall Study|Withdrawal by Subject|0|||
157053205|NCT00237809|566947537|FG000|Overall Study|Lost to Follow-up|11|||
157053206|NCT00237809|566947538|FG001|Overall Study|Lost to Follow-up|10|||
157053207|NCT00237809|566947539|FG002|Overall Study|Lost to Follow-up|9|||
157053208|NCT00237809|566947540|FG003|Overall Study|Lost to Follow-up|9|||
157053209|NCT02006641|566947541|FG000|Overall Study|Withdrawal before treatment|2|||
157053210|NCT02006641|566947542|FG001|Overall Study|Withdrawal before treatment|5|||
157053211|NCT02006641|566947543|FG002|Overall Study|Withdrawal before treatment|3|||
157053212|NCT02006641|566947541|FG000|Overall Study|Adverse Event|15|||
157053213|NCT02006641|566947542|FG001|Overall Study|Adverse Event|11|||
157053214|NCT02006641|566947543|FG002|Overall Study|Adverse Event|15|||
157053215|NCT02006641|566947541|FG000|Overall Study|Protocol Violation|0|||
157053216|NCT02006641|566947542|FG001|Overall Study|Protocol Violation|2|||
157053217|NCT02006641|566947543|FG002|Overall Study|Protocol Violation|2|||
157053218|NCT02006641|566947541|FG000|Overall Study|Lost to Follow-up|0|||
157053219|NCT02006641|566947542|FG001|Overall Study|Lost to Follow-up|1|||
157053220|NCT02006641|566947543|FG002|Overall Study|Lost to Follow-up|0|||
157053221|NCT02006641|566947541|FG000|Overall Study|Withdrawal by Subject|7|||
157053222|NCT02006641|566947542|FG001|Overall Study|Withdrawal by Subject|12|||
157053223|NCT02006641|566947543|FG002|Overall Study|Withdrawal by Subject|11|||
157053224|NCT02006641|566947541|FG000|Overall Study|Other reason: patient didn't show up|1|||
157053225|NCT02006641|566947542|FG001|Overall Study|Other reason: patient didn't show up|0|||
157053226|NCT02006641|566947543|FG002|Overall Study|Other reason: patient didn't show up|0|||
157053227|NCT02006641|566947541|FG000|Overall Study|Other reason:patient didn't want to come|0|||
157053228|NCT02006641|566947542|FG001|Overall Study|Other reason:patient didn't want to come|0|||
157053229|NCT02006641|566947543|FG002|Overall Study|Other reason:patient didn't want to come|1|||
157053230|NCT02006641|566947541|FG000|Overall Study|Other reason: patient has moved|1|||
157053231|NCT02006641|566947542|FG001|Overall Study|Other reason: patient has moved|0|||
157053232|NCT02006641|566947543|FG002|Overall Study|Other reason: patient has moved|1|||
157053233|NCT02006641|566947541|FG000|Overall Study|Other reason: caregiver in hospital|0|||
157053234|NCT02006641|566947542|FG001|Overall Study|Other reason: caregiver in hospital|1|||
157053235|NCT02006641|566947543|FG002|Overall Study|Other reason: caregiver in hospital|0|||
157053236|NCT02006641|566947541|FG000|Overall Study|Other reason: patient's wife has died|0|||
157053237|NCT02006641|566947542|FG001|Overall Study|Other reason: patient's wife has died|0|||
157053238|NCT02006641|566947543|FG002|Overall Study|Other reason: patient's wife has died|1|||
157053239|NCT02006641|566947541|FG000|Overall Study|Other reason: hospitalisation|0|||
157053240|NCT02006641|566947542|FG001|Overall Study|Other reason: hospitalisation|1|||
157053241|NCT02006641|566947543|FG002|Overall Study|Other reason: hospitalisation|0|||
157053242|NCT02006641|566947541|FG000|Overall Study|Other reason: caregiver impossibility|0|||
157053243|NCT02006641|566947542|FG001|Overall Study|Other reason: caregiver impossibility|0|||
157053244|NCT02006641|566947543|FG002|Overall Study|Other reason: caregiver impossibility|1|||
157053245|NCT02006641|566947541|FG000|Overall Study|Other reason: protocol non-compliance|0|||
157053246|NCT02006641|566947542|FG001|Overall Study|Other reason: protocol non-compliance|0|||
157053247|NCT02006641|566947543|FG002|Overall Study|Other reason: protocol non-compliance|1|||
157053248|NCT01613599|566947544|FG000|Overall Study|Death|9|||
157053249|NCT01613599|566947544|FG000|Overall Study|Lost to Follow-up|5|||
157053250|NCT01613599|566947544|FG000|Overall Study|Withdrawal by Subject|8|||
157053251|NCT01613599|566947544|FG000|Overall Study|Reason not specified|3|||
157053252|NCT02132195|566947547|FG000|Initial Assignment|Relapsed|14|||
157053253|NCT02132195|566947548|FG001|Initial Assignment|Relapsed|0|||
157053254|NCT02132195|566947549|FG002|Initial Assignment|Relapsed|0|||
157053255|NCT02132195|566947547|FG000|Rescue Therapy|Relapsed|0|||
157053256|NCT02132195|566947548|FG001|Rescue Therapy|Relapsed|0|||
157053257|NCT02132195|566947549|FG002|Rescue Therapy|Relapsed|7|||
156973677|NCT02914314|566656749|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
156973678|NCT02914314|566656746|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156973679|NCT02914314|566656747|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156973680|NCT02914314|566656748|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
156973681|NCT02914314|566656749|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
156973682|NCT02002182|566656761|FG000|Overall Study|Withdraw from study|3|||
156973683|NCT02002182|566656762|FG001|Overall Study|Withdraw from study|1|||
156973684|NCT02002182|566656761|FG000|Overall Study|Health Reasons|1|||
156973685|NCT02002182|566656762|FG001|Overall Study|Health Reasons|0|||
156973686|NCT02002182|566656761|FG000|Overall Study|Death|1|||
156973687|NCT02002182|566656762|FG001|Overall Study|Death|0|||
156973688|NCT04772053|566656763|FG000|Overall Study|Physician Decision|2|||
156973689|NCT04772053|566656763|FG000|Overall Study|Withdrawal by Subject|3|||
156973690|NCT04772053|566656763|FG000|Overall Study|Study Terminated by Sponsor|1|||
156973691|NCT03107377|566656764|FG000|Overall Study|Adverse Event|3|||
156973692|NCT03107377|566656765|FG001|Overall Study|Adverse Event|3|||
156973693|NCT03107377|566656764|FG000|Overall Study|Protocol Violation|9|||
156973694|NCT03107377|566656765|FG001|Overall Study|Protocol Violation|12|||
156973695|NCT03107377|566656764|FG000|Overall Study|Physician Decision|3|||
156973696|NCT03107377|566656765|FG001|Overall Study|Physician Decision|6|||
156973697|NCT03107377|566656764|FG000|Overall Study|Pregnancy|7|||
156973698|NCT03107377|566656765|FG001|Overall Study|Pregnancy|7|||
156973699|NCT03107377|566656764|FG000|Overall Study|Withdrawal by Subject|16|||
156973700|NCT03107377|566656765|FG001|Overall Study|Withdrawal by Subject|22|||
156973701|NCT03107377|566656764|FG000|Overall Study|Lost to Follow-up|37|||
156973702|NCT03107377|566656765|FG001|Overall Study|Lost to Follow-up|34|||
156973703|NCT03107377|566656764|FG000|Overall Study|Other reason not specified|16|||
156973704|NCT03107377|566656765|FG001|Overall Study|Other reason not specified|15|||
156973705|NCT03787680|566656767|FG000|Overall Study|Physician Decision|2|||
156973706|NCT03787680|566656768|FG001|Overall Study|Physician Decision|3|||
156973707|NCT03787680|566656767|FG000|Overall Study|Adverse Event|7|||
156973708|NCT03787680|566656768|FG001|Overall Study|Adverse Event|3|||
156973709|NCT03787680|566656767|FG000|Overall Study|Withdrawal by Subject|2|||
156973710|NCT03787680|566656768|FG001|Overall Study|Withdrawal by Subject|1|||
156973711|NCT05454410|566656771|FG000|Overall Study|Withdrawal by Subject|0|||
156973712|NCT05454410|566656772|FG001|Overall Study|Withdrawal by Subject|0|||
156973713|NCT05454410|566656773|FG002|Overall Study|Withdrawal by Subject|1|||
156973714|NCT05454410|566656774|FG003|Overall Study|Withdrawal by Subject|1|||
156973715|NCT03635489|566656782|FG000|Overall Study|Death|19|||
156973716|NCT03635489|566656783|FG001|Overall Study|Death|13|||
156973717|NCT03635489|566656782|FG000|Overall Study|Lost to Follow-up|1|||
156973718|NCT03635489|566656783|FG001|Overall Study|Lost to Follow-up|2|||
156973719|NCT03635489|566656782|FG000|Overall Study|Withdrawal by Subject|1|||
157053258|NCT02132195|566947547|FG000|Rescue Therapy|Physician Decision|0|||
157053259|NCT02132195|566947548|FG001|Rescue Therapy|Physician Decision|0|||
157053260|NCT02132195|566947549|FG002|Rescue Therapy|Physician Decision|1|||
157053261|NCT02132195|566947547|FG000|Rescue Therapy|Withdrawal by Subject|0|||
157053262|NCT02132195|566947548|FG001|Rescue Therapy|Withdrawal by Subject|0|||
157053263|NCT02132195|566947549|FG002|Rescue Therapy|Withdrawal by Subject|1|||
157053264|NCT02132195|566947547|FG000|Rescue Therapy|Adverse Event|0|||
157053265|NCT02132195|566947548|FG001|Rescue Therapy|Adverse Event|0|||
157053266|NCT02132195|566947549|FG002|Rescue Therapy|Adverse Event|2|||
157053267|NCT02066389|566947551|FG000|Overall Study|Adverse Event|1|||
157053268|NCT02066389|566947552|FG001|Overall Study|Adverse Event|1|||
157053269|NCT02066389|566947553|FG002|Overall Study|Adverse Event|1|||
157053270|NCT02066389|566947554|FG003|Overall Study|Adverse Event|1|||
157053271|NCT02066389|566947555|FG004|Overall Study|Adverse Event|5|||
157053272|NCT02066389|566947556|FG005|Overall Study|Adverse Event|1|||
157053273|NCT02066389|566947551|FG000|Overall Study|Withdrawal by Subject|4|||
157053274|NCT02066389|566947552|FG001|Overall Study|Withdrawal by Subject|0|||
157053275|NCT02066389|566947553|FG002|Overall Study|Withdrawal by Subject|5|||
157053276|NCT02066389|566947554|FG003|Overall Study|Withdrawal by Subject|1|||
157053277|NCT02066389|566947555|FG004|Overall Study|Withdrawal by Subject|1|||
157053278|NCT02066389|566947556|FG005|Overall Study|Withdrawal by Subject|2|||
157053279|NCT02066389|566947551|FG000|Overall Study|Lost to Follow-up|0|||
157053280|NCT02066389|566947552|FG001|Overall Study|Lost to Follow-up|0|||
157053281|NCT02066389|566947553|FG002|Overall Study|Lost to Follow-up|0|||
157053282|NCT02066389|566947554|FG003|Overall Study|Lost to Follow-up|1|||
157053283|NCT02066389|566947555|FG004|Overall Study|Lost to Follow-up|1|||
157053284|NCT02066389|566947556|FG005|Overall Study|Lost to Follow-up|1|||
157053285|NCT02066389|566947551|FG000|Overall Study|Randomized in Error|0|||
157053286|NCT02066389|566947552|FG001|Overall Study|Randomized in Error|0|||
157053287|NCT02066389|566947553|FG002|Overall Study|Randomized in Error|0|||
157053288|NCT02066389|566947554|FG003|Overall Study|Randomized in Error|0|||
157053289|NCT02066389|566947555|FG004|Overall Study|Randomized in Error|0|||
157053290|NCT02066389|566947556|FG005|Overall Study|Randomized in Error|1|||
157053291|NCT01468597|566947565|FG000|Overall Study|Found ineligible|17|||
157053292|NCT01468597|566947565|FG000|Overall Study|concomitant valves|12|||
157053293|NCT01468597|566947565|FG000|Overall Study|off-pump CABG|1|||
157053294|NCT01468597|566947565|FG000|Overall Study|no platelet function data|5|||
157053295|NCT02561195|566947567|FG000|Vaccination 1 to 3|Adverse Event|4|||
157053296|NCT02561195|566947568|FG001|Vaccination 1 to 3|Adverse Event|5|||
157053297|NCT02561195|566947569|FG002|Vaccination 1 to 3|Adverse Event|0|||
157053298|NCT02561195|566947570|FG003|Vaccination 1 to 3|Adverse Event|3|||
157053299|NCT02561195|566947571|FG004|Vaccination 1 to 3|Adverse Event|4|||
157053300|NCT02561195|566947572|FG005|Vaccination 1 to 3|Adverse Event|0|||
157053301|NCT02561195|566947573|FG006|Vaccination 1 to 3|Adverse Event|0|||
157053302|NCT02561195|566947574|FG007|Vaccination 1 to 3|Adverse Event|0|||
157053303|NCT02561195|566947575|FG008|Vaccination 1 to 3|Adverse Event|0|||
157053304|NCT02561195|566947576|FG009|Vaccination 1 to 3|Adverse Event|0|||
157053305|NCT02561195|566947577|FG010|Vaccination 1 to 3|Adverse Event|0|||
157053306|NCT02561195|566947578|FG011|Vaccination 1 to 3|Adverse Event|0|||
157053307|NCT02561195|566947579|FG012|Vaccination 1 to 3|Adverse Event|0|||
157053308|NCT02561195|566947580|FG013|Vaccination 1 to 3|Adverse Event|0|||
157053309|NCT02561195|566947567|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
157053310|NCT02561195|566947568|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
157053311|NCT02561195|566947569|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
157053312|NCT02561195|566947570|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
157053313|NCT02561195|566947571|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
157053314|NCT02561195|566947572|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
157053315|NCT02561195|566947573|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
157053316|NCT02561195|566947574|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
157053317|NCT02561195|566947575|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
157053318|NCT02561195|566947576|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
157053319|NCT02561195|566947577|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
157176839|NCT02076334|567389625|FG002|Overall Study|Lost to Follow-up|1|||
157176840|NCT02076334|567389626|FG003|Overall Study|Lost to Follow-up|0|||
157053320|NCT02561195|566947578|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
157053321|NCT02561195|566947579|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
157053322|NCT02561195|566947580|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
157053323|NCT02561195|566947567|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053324|NCT02561195|566947568|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
157053325|NCT02561195|566947569|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053326|NCT02561195|566947570|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
157053327|NCT02561195|566947571|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
157053328|NCT02561195|566947572|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
157053329|NCT02561195|566947573|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053330|NCT02561195|566947574|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053331|NCT02561195|566947575|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053332|NCT02561195|566947576|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053333|NCT02561195|566947577|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053334|NCT02561195|566947578|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053335|NCT02561195|566947579|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053336|NCT02561195|566947580|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
157053337|NCT02561195|566947567|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
156973720|NCT03635489|566656783|FG001|Overall Study|Withdrawal by Subject|2|||
156973721|NCT03635489|566656782|FG000|Overall Study|Study Ended by Sponsor|28|||
156973722|NCT03635489|566656783|FG001|Overall Study|Study Ended by Sponsor|34|||
156973723|NCT01368900|566656784|FG000|Overall Study|Lost to Follow-up|7|||
156973724|NCT00654901|566656791|FG000|Overall Study|Lost to Follow-up|1|||
156973725|NCT00654901|566656792|FG001|Overall Study|Lost to Follow-up|0|||
156973726|NCT00654901|566656793|FG002|Overall Study|Lost to Follow-up|1|||
156973727|NCT00654901|566656794|FG003|Overall Study|Lost to Follow-up|0|||
156973728|NCT00654901|566656791|FG000|Overall Study|Withdrawal by Subject|3|||
156973729|NCT00654901|566656792|FG001|Overall Study|Withdrawal by Subject|0|||
156973730|NCT00654901|566656793|FG002|Overall Study|Withdrawal by Subject|1|||
156973731|NCT00654901|566656794|FG003|Overall Study|Withdrawal by Subject|0|||
156973732|NCT02404389|566656795|FG000|Overall Study|Adverse Event|1|||
156973733|NCT02404389|566656796|FG001|Overall Study|Adverse Event|0|||
156973734|NCT02404389|566656797|FG002|Overall Study|Adverse Event|1|||
156973735|NCT02404389|566656798|FG003|Overall Study|Adverse Event|0|||
156973736|NCT02404389|566656799|FG004|Overall Study|Adverse Event|2|||
156973737|NCT02404389|566656795|FG000|Overall Study|Subject/guardian decision|1|||
156973738|NCT02404389|566656796|FG001|Overall Study|Subject/guardian decision|0|||
156973739|NCT02404389|566656797|FG002|Overall Study|Subject/guardian decision|0|||
156973740|NCT02404389|566656798|FG003|Overall Study|Subject/guardian decision|1|||
156973741|NCT02404389|566656799|FG004|Overall Study|Subject/guardian decision|1|||
156973742|NCT00652938|566656806|FG000|Overall Study|Adverse Event|1|||
156973743|NCT00652938|566656807|FG001|Overall Study|Adverse Event|0|||
156973744|NCT00652938|566656808|FG002|Overall Study|Adverse Event|2|||
156973745|NCT00652938|566656806|FG000|Overall Study|Withdrawal by Subject|0|||
156973746|NCT00652938|566656807|FG001|Overall Study|Withdrawal by Subject|6|||
156973747|NCT00652938|566656808|FG002|Overall Study|Withdrawal by Subject|1|||
156973748|NCT00652938|566656806|FG000|Overall Study|Lost to Follow-up|0|||
156973749|NCT00652938|566656807|FG001|Overall Study|Lost to Follow-up|0|||
156973750|NCT00652938|566656808|FG002|Overall Study|Lost to Follow-up|2|||
156973751|NCT00652938|566656806|FG000|Overall Study|fear of blood sampling|0|||
156973752|NCT00652938|566656807|FG001|Overall Study|fear of blood sampling|1|||
156973753|NCT00652938|566656808|FG002|Overall Study|fear of blood sampling|0|||
156973754|NCT01412801|566656809|FG000|Overall Study|Death|0|||
156973755|NCT01412801|566656810|FG001|Overall Study|Death|1|||
156973756|NCT01412801|566656811|FG002|Overall Study|Death|0|||
156973757|NCT01412801|566656812|FG003|Overall Study|Death|4|||
156973758|NCT01412801|566656813|FG004|Overall Study|Death|2|||
156973759|NCT01412801|566656814|FG005|Overall Study|Death|2|||
156973760|NCT01412801|566656809|FG000|Overall Study|Lost to Follow-up|1|||
156973761|NCT01412801|566656810|FG001|Overall Study|Lost to Follow-up|2|||
156973762|NCT01412801|566656811|FG002|Overall Study|Lost to Follow-up|4|||
156973763|NCT01412801|566656812|FG003|Overall Study|Lost to Follow-up|0|||
156973764|NCT01412801|566656813|FG004|Overall Study|Lost to Follow-up|1|||
156973765|NCT01412801|566656814|FG005|Overall Study|Lost to Follow-up|1|||
156973766|NCT01412801|566656809|FG000|Overall Study|Withdrawal by Subject|3|||
156973767|NCT01412801|566656810|FG001|Overall Study|Withdrawal by Subject|2|||
156973768|NCT01412801|566656811|FG002|Overall Study|Withdrawal by Subject|1|||
156973769|NCT01412801|566656812|FG003|Overall Study|Withdrawal by Subject|0|||
156973770|NCT01412801|566656813|FG004|Overall Study|Withdrawal by Subject|0|||
156973771|NCT01412801|566656814|FG005|Overall Study|Withdrawal by Subject|0|||
156973772|NCT01412801|566656809|FG000|Overall Study|Relocated to another area|0|||
156973773|NCT01412801|566656810|FG001|Overall Study|Relocated to another area|0|||
156973774|NCT01412801|566656811|FG002|Overall Study|Relocated to another area|2|||
156973775|NCT01412801|566656812|FG003|Overall Study|Relocated to another area|0|||
156973776|NCT01412801|566656813|FG004|Overall Study|Relocated to another area|0|||
156973777|NCT01412801|566656814|FG005|Overall Study|Relocated to another area|0|||
156973778|NCT01547299|566656815|FG000|Overall Study|Withdrawal by Subject|2|||
156973779|NCT01547299|566656816|FG001|Overall Study|Withdrawal by Subject|2|||
156973780|NCT00782496|566656817|FG000|Overall Study|Lost to Follow-up|14|||
156973781|NCT00782496|566656818|FG001|Overall Study|Lost to Follow-up|15|||
156973782|NCT01483937|566656822|FG000|Overall Study|Withdrawal by Subject|4|||
156973783|NCT01483937|566656823|FG001|Overall Study|Withdrawal by Subject|3|||
156973784|NCT00117156|566656824|FG000|Overall Study|Adverse Event|9|||
156973785|NCT00117156|566656824|FG000|Overall Study|Physician Decision|1|||
156973786|NCT00117156|566656824|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
156973787|NCT01919970|566656825|FG000|Overall Study|Withdrawal by Subject|3|||
156973788|NCT01919970|566656826|FG001|Overall Study|Withdrawal by Subject|0|||
156973789|NCT01874145|566656827|FG000|Core Period|Non-compliance|1|||
156973790|NCT01874145|566656828|FG001|Core Period|Non-compliance|0|||
156973791|NCT01874145|566656827|FG000|Core Period|Protocol Violation|1|||
156973792|NCT01874145|566656828|FG001|Core Period|Protocol Violation|1|||
156973793|NCT01874145|566656827|FG000|Core Period|Physician Decision|1|||
156973794|NCT01874145|566656828|FG001|Core Period|Physician Decision|1|||
156973795|NCT01874145|566656827|FG000|Core Period|Adverse Event|0|||
156973796|NCT01874145|566656828|FG001|Core Period|Adverse Event|1|||
156973797|NCT01874145|566656827|FG000|Core Period|Withdrawal by Subject|0|||
156973798|NCT01874145|566656828|FG001|Core Period|Withdrawal by Subject|4|||
157053338|NCT02561195|566947568|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
157053339|NCT02561195|566947569|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
157053340|NCT02561195|566947570|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
157053341|NCT02561195|566947571|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
157053342|NCT02561195|566947572|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
157053343|NCT02561195|566947573|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
157053344|NCT02561195|566947574|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
157053345|NCT02561195|566947575|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
157053346|NCT02561195|566947576|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
157053347|NCT02561195|566947577|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
157053348|NCT02561195|566947578|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
157053349|NCT02561195|566947579|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
157053350|NCT02561195|566947580|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
157053351|NCT02561195|566947567|FG000|Vaccination 1 to 3|Other|7|||
157053352|NCT02561195|566947568|FG001|Vaccination 1 to 3|Other|3|||
157053353|NCT02561195|566947569|FG002|Vaccination 1 to 3|Other|1|||
157053354|NCT02561195|566947570|FG003|Vaccination 1 to 3|Other|7|||
157053355|NCT02561195|566947571|FG004|Vaccination 1 to 3|Other|5|||
157053356|NCT02561195|566947572|FG005|Vaccination 1 to 3|Other|1|||
157053357|NCT02561195|566947573|FG006|Vaccination 1 to 3|Other|0|||
157053358|NCT02561195|566947574|FG007|Vaccination 1 to 3|Other|0|||
157053359|NCT02561195|566947575|FG008|Vaccination 1 to 3|Other|0|||
157053360|NCT02561195|566947576|FG009|Vaccination 1 to 3|Other|0|||
157053361|NCT02561195|566947577|FG010|Vaccination 1 to 3|Other|0|||
157053362|NCT02561195|566947578|FG011|Vaccination 1 to 3|Other|0|||
157053363|NCT02561195|566947579|FG012|Vaccination 1 to 3|Other|0|||
157053364|NCT02561195|566947580|FG013|Vaccination 1 to 3|Other|0|||
157053365|NCT02561195|566947567|FG000|Vaccination 1 to 3|Protocol Violation|1|||
157053366|NCT02561195|566947568|FG001|Vaccination 1 to 3|Protocol Violation|0|||
157053367|NCT02561195|566947569|FG002|Vaccination 1 to 3|Protocol Violation|1|||
157053368|NCT02561195|566947570|FG003|Vaccination 1 to 3|Protocol Violation|2|||
157053369|NCT02561195|566947571|FG004|Vaccination 1 to 3|Protocol Violation|5|||
157053370|NCT02561195|566947572|FG005|Vaccination 1 to 3|Protocol Violation|2|||
157053371|NCT02561195|566947573|FG006|Vaccination 1 to 3|Protocol Violation|0|||
157053372|NCT02561195|566947574|FG007|Vaccination 1 to 3|Protocol Violation|0|||
157053373|NCT02561195|566947575|FG008|Vaccination 1 to 3|Protocol Violation|0|||
157053374|NCT02561195|566947576|FG009|Vaccination 1 to 3|Protocol Violation|0|||
157053375|NCT02561195|566947577|FG010|Vaccination 1 to 3|Protocol Violation|0|||
157053376|NCT02561195|566947578|FG011|Vaccination 1 to 3|Protocol Violation|0|||
157053377|NCT02561195|566947579|FG012|Vaccination 1 to 3|Protocol Violation|0|||
157053378|NCT02561195|566947580|FG013|Vaccination 1 to 3|Protocol Violation|0|||
157053379|NCT02561195|566947567|FG000|Vaccination 1 to 3|Death|2|||
157053380|NCT02561195|566947568|FG001|Vaccination 1 to 3|Death|1|||
157053381|NCT02561195|566947569|FG002|Vaccination 1 to 3|Death|0|||
157176841|NCT02076334|567389623|FG000|Overall Study|muscle soreness|0|||
157176842|NCT02076334|567389624|FG001|Overall Study|muscle soreness|0|||
157176843|NCT02076334|567389625|FG002|Overall Study|muscle soreness|0|||
157176844|NCT02076334|567389626|FG003|Overall Study|muscle soreness|1|||
157176845|NCT03238352|567389627|FG000|Overall Study|Lost to Follow-up|0|||
157176846|NCT03238352|567389628|FG001|Overall Study|Lost to Follow-up|2|||
157176847|NCT03238352|567389629|FG002|Overall Study|Lost to Follow-up|1|||
157176848|NCT03238352|567389627|FG000|Overall Study|Withdrawal by Subject|0|||
157176849|NCT03238352|567389628|FG001|Overall Study|Withdrawal by Subject|1|||
157176850|NCT03238352|567389629|FG002|Overall Study|Withdrawal by Subject|0|||
157176851|NCT00928512|567389630|FG000|Overall Study|Adverse Event|4|||
157176852|NCT00928512|567389631|FG001|Overall Study|Adverse Event|3|||
157176853|NCT00928512|567389632|FG002|Overall Study|Adverse Event|2|||
157176854|NCT00928512|567389633|FG003|Overall Study|Adverse Event|8|||
157176855|NCT00928512|567389634|FG004|Overall Study|Adverse Event|6|||
157176856|NCT00928512|567389630|FG000|Overall Study|Lack of Efficacy|2|||
157176857|NCT00928512|567389631|FG001|Overall Study|Lack of Efficacy|0|||
157176858|NCT00928512|567389632|FG002|Overall Study|Lack of Efficacy|4|||
157176859|NCT00928512|567389633|FG003|Overall Study|Lack of Efficacy|7|||
157176860|NCT00928512|567389634|FG004|Overall Study|Lack of Efficacy|3|||
157176861|NCT00928512|567389630|FG000|Overall Study|Protocol Violation|0|||
157053382|NCT02561195|566947570|FG003|Vaccination 1 to 3|Death|2|||
157053383|NCT02561195|566947571|FG004|Vaccination 1 to 3|Death|0|||
157053384|NCT02561195|566947572|FG005|Vaccination 1 to 3|Death|0|||
157053385|NCT02561195|566947573|FG006|Vaccination 1 to 3|Death|0|||
157053386|NCT02561195|566947574|FG007|Vaccination 1 to 3|Death|0|||
157053387|NCT02561195|566947575|FG008|Vaccination 1 to 3|Death|0|||
157053388|NCT02561195|566947576|FG009|Vaccination 1 to 3|Death|0|||
157053389|NCT02561195|566947577|FG010|Vaccination 1 to 3|Death|0|||
157053390|NCT02561195|566947578|FG011|Vaccination 1 to 3|Death|0|||
157053391|NCT02561195|566947579|FG012|Vaccination 1 to 3|Death|0|||
157053392|NCT02561195|566947580|FG013|Vaccination 1 to 3|Death|0|||
157176862|NCT00928512|567389631|FG001|Overall Study|Protocol Violation|1|||
157176863|NCT00928512|567389632|FG002|Overall Study|Protocol Violation|0|||
157176864|NCT00928512|567389633|FG003|Overall Study|Protocol Violation|1|||
157053393|NCT02561195|566947567|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
157053394|NCT02561195|566947568|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
157053395|NCT02561195|566947569|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
157053396|NCT02561195|566947570|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
157053397|NCT02561195|566947571|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
157053398|NCT02561195|566947572|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053399|NCT02561195|566947573|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053400|NCT02561195|566947574|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053401|NCT02561195|566947575|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053402|NCT02561195|566947576|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053403|NCT02561195|566947577|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053404|NCT02561195|566947578|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053405|NCT02561195|566947579|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053406|NCT02561195|566947580|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
157053407|NCT02561195|566947567|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
157053408|NCT02561195|566947568|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
157053409|NCT02561195|566947569|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
157053410|NCT02561195|566947570|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
157053411|NCT02561195|566947571|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
157053412|NCT02561195|566947572|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
157053413|NCT02561195|566947573|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
157053414|NCT02561195|566947574|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
157053415|NCT02561195|566947575|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
157053416|NCT02561195|566947576|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
157053417|NCT02561195|566947577|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
157053418|NCT02561195|566947578|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
157053419|NCT02561195|566947579|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
157053420|NCT02561195|566947580|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
157053421|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053422|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053423|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053424|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053425|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053426|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053427|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053428|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053429|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
157053430|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
157053431|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
157053432|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
157053433|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
157053434|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
157053435|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053436|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053437|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053438|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053439|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053440|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053441|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053442|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053443|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053444|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053445|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053446|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053447|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
157053448|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
157053449|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Death|0|||
157053450|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Death|0|||
157053451|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Death|0|||
157053452|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Death|0|||
157053453|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Death|0|||
157053454|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Death|0|||
157053455|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Death|0|||
157053456|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Death|0|||
157053457|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Death|0|||
157053458|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Death|1|||
157053459|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Death|0|||
157053460|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Death|0|||
157053461|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Death|0|||
157053462|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Death|0|||
157053463|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053464|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157176865|NCT00928512|567389634|FG004|Overall Study|Protocol Violation|3|||
157176866|NCT00928512|567389630|FG000|Overall Study|Withdrawal by Subject|3|||
157176867|NCT00928512|567389631|FG001|Overall Study|Withdrawal by Subject|0|||
157176868|NCT00928512|567389632|FG002|Overall Study|Withdrawal by Subject|3|||
157176869|NCT00928512|567389633|FG003|Overall Study|Withdrawal by Subject|4|||
157176870|NCT00928512|567389634|FG004|Overall Study|Withdrawal by Subject|0|||
157176871|NCT00928512|567389630|FG000|Overall Study|Lost to Follow-up|1|||
157176872|NCT00928512|567389631|FG001|Overall Study|Lost to Follow-up|1|||
157176873|NCT00928512|567389632|FG002|Overall Study|Lost to Follow-up|2|||
157176874|NCT00928512|567389633|FG003|Overall Study|Lost to Follow-up|1|||
157176875|NCT00928512|567389634|FG004|Overall Study|Lost to Follow-up|3|||
157176876|NCT00928512|567389630|FG000|Overall Study|Administrative Problems|0|||
157176877|NCT00928512|567389631|FG001|Overall Study|Administrative Problems|1|||
157176878|NCT00928512|567389632|FG002|Overall Study|Administrative Problems|0|||
157176879|NCT00928512|567389633|FG003|Overall Study|Administrative Problems|0|||
157176880|NCT00928512|567389634|FG004|Overall Study|Administrative Problems|0|||
157176881|NCT04153929|567389635|FG000|Overall Study|Other than listed|2|||
157176882|NCT04153929|567389636|FG001|Overall Study|Other than listed|2|||
157176883|NCT04153929|567389637|FG002|Overall Study|Other than listed|0|||
157176884|NCT04153929|567389638|FG003|Overall Study|Other than listed|1|||
157053465|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053466|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053467|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053468|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053469|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
157053470|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
157053471|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053472|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
157053473|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
157053474|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
157053475|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
157053476|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
157053477|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053478|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053479|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053480|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053481|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053482|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053483|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053484|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053485|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053486|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053487|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
157053488|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
157053489|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
157053490|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
157053491|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Other|0|||
157053492|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Other|0|||
157053493|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Other|0|||
157053494|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Other|0|||
157053495|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Other|0|||
157053496|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Other|0|||
157053497|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Other|0|||
157053498|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Other|0|||
157053499|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Other|0|||
157053500|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Other|0|||
157053501|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Other|2|||
157053502|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Other|2|||
157176885|NCT04153929|567389639|FG004|Overall Study|Other than listed|0|||
157176886|NCT04153929|567389640|FG005|Overall Study|Other than listed|2|||
157176887|NCT04153929|567389641|FG006|Overall Study|Other than listed|2|||
157176888|NCT04153929|567389642|FG007|Overall Study|Other than listed|1|||
157176889|NCT04153929|567389635|FG000|Overall Study|Lost to Follow-up|2|||
157176890|NCT04153929|567389636|FG001|Overall Study|Lost to Follow-up|1|||
157176891|NCT04153929|567389637|FG002|Overall Study|Lost to Follow-up|0|||
157053503|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Other|1|||
157176892|NCT04153929|567389638|FG003|Overall Study|Lost to Follow-up|1|||
157176893|NCT04153929|567389639|FG004|Overall Study|Lost to Follow-up|1|||
157176894|NCT04153929|567389640|FG005|Overall Study|Lost to Follow-up|0|||
157176895|NCT04153929|567389641|FG006|Overall Study|Lost to Follow-up|0|||
157176896|NCT04153929|567389642|FG007|Overall Study|Lost to Follow-up|0|||
157176897|NCT04153929|567389635|FG000|Overall Study|Withdrawal by Subject|3|||
157053504|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Other|0|||
157053505|NCT02561195|566947567|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053506|NCT02561195|566947568|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053507|NCT02561195|566947569|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053508|NCT02561195|566947570|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053509|NCT02561195|566947571|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053510|NCT02561195|566947572|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053511|NCT02561195|566947573|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
157053512|NCT02561195|566947574|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053513|NCT02561195|566947575|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053514|NCT02561195|566947576|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053515|NCT02561195|566947577|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
157053516|NCT02561195|566947578|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
157053517|NCT02561195|566947579|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
157053518|NCT02561195|566947580|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
157053519|NCT03905512|566947581|FG000|Overall Study|Withdrawal by Subject|9|||
157053520|NCT03905512|566947582|FG001|Overall Study|Withdrawal by Subject|8|||
157053521|NCT03905512|566947581|FG000|Overall Study|Adverse Event|1|||
157053522|NCT03905512|566947582|FG001|Overall Study|Adverse Event|2|||
157053523|NCT03905512|566947581|FG000|Overall Study|Lost to Follow-up|4|||
157053524|NCT03905512|566947582|FG001|Overall Study|Lost to Follow-up|3|||
157053525|NCT03905512|566947581|FG000|Overall Study|Other than Specified|7|||
157053526|NCT03905512|566947582|FG001|Overall Study|Other than Specified|4|||
157053527|NCT00736502|566947589|FG000|Overall Study|Adverse Event|22|||
157053528|NCT00736502|566947589|FG000|Overall Study|Lack of Efficacy|16|||
157053529|NCT00736502|566947589|FG000|Overall Study|Lost to Follow-up|27|||
157053530|NCT03987074|566947591|FG000|Overall Study|Withdrew Consent|1|||
157053531|NCT03987074|566947592|FG001|Overall Study|Withdrew Consent|1|||
157053532|NCT03987074|566947593|FG002|Overall Study|Withdrew Consent|0|||
157053533|NCT03987074|566947594|FG003|Overall Study|Withdrew Consent|2|||
157053534|NCT03987074|566947595|FG004|Overall Study|Withdrew Consent|1|||
157053535|NCT03987074|566947591|FG000|Overall Study|Adverse Event|2|||
157053536|NCT03987074|566947592|FG001|Overall Study|Adverse Event|1|||
157053537|NCT03987074|566947593|FG002|Overall Study|Adverse Event|0|||
157053538|NCT03987074|566947594|FG003|Overall Study|Adverse Event|0|||
157053539|NCT03987074|566947595|FG004|Overall Study|Adverse Event|1|||
157053540|NCT03987074|566947591|FG000|Overall Study|Lost to Follow-up|0|||
157053541|NCT03987074|566947592|FG001|Overall Study|Lost to Follow-up|0|||
157053542|NCT03987074|566947593|FG002|Overall Study|Lost to Follow-up|1|||
157053543|NCT03987074|566947594|FG003|Overall Study|Lost to Follow-up|1|||
157053544|NCT03987074|566947595|FG004|Overall Study|Lost to Follow-up|0|||
157053545|NCT03987074|566947591|FG000|Overall Study|Investigator's Discretion|0|||
157053546|NCT03987074|566947592|FG001|Overall Study|Investigator's Discretion|0|||
157053547|NCT03987074|566947593|FG002|Overall Study|Investigator's Discretion|0|||
157053548|NCT03987074|566947594|FG003|Overall Study|Investigator's Discretion|1|||
157053549|NCT03987074|566947595|FG004|Overall Study|Investigator's Discretion|0|||
157053550|NCT01307800|566947598|FG000|Overall Study|Adverse Event|9|||
157053551|NCT01307800|566947599|FG001|Overall Study|Adverse Event|8|||
157053552|NCT01307800|566947600|FG002|Overall Study|Adverse Event|10|||
157053553|NCT01307800|566947601|FG003|Overall Study|Adverse Event|14|||
157053554|NCT01307800|566947598|FG000|Overall Study|Entry Criteria Not Met|0|||
157053555|NCT01307800|566947599|FG001|Overall Study|Entry Criteria Not Met|0|||
157053556|NCT01307800|566947600|FG002|Overall Study|Entry Criteria Not Met|0|||
157053557|NCT01307800|566947601|FG003|Overall Study|Entry Criteria Not Met|2|||
157053558|NCT01307800|566947598|FG000|Overall Study|Lost to Follow-up|5|||
157053559|NCT01307800|566947599|FG001|Overall Study|Lost to Follow-up|6|||
157053560|NCT01307800|566947600|FG002|Overall Study|Lost to Follow-up|2|||
157053561|NCT01307800|566947601|FG003|Overall Study|Lost to Follow-up|8|||
157053562|NCT01307800|566947598|FG000|Overall Study|Perceived Lack of Efficacy|24|||
157053563|NCT01307800|566947599|FG001|Overall Study|Perceived Lack of Efficacy|23|||
157053564|NCT01307800|566947600|FG002|Overall Study|Perceived Lack of Efficacy|20|||
157053565|NCT01307800|566947601|FG003|Overall Study|Perceived Lack of Efficacy|33|||
157053566|NCT01307800|566947598|FG000|Overall Study|Protocol Violation|0|||
157053567|NCT01307800|566947599|FG001|Overall Study|Protocol Violation|3|||
157053568|NCT01307800|566947600|FG002|Overall Study|Protocol Violation|4|||
157053569|NCT01307800|566947601|FG003|Overall Study|Protocol Violation|5|||
157053570|NCT01307800|566947598|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
157053571|NCT01307800|566947599|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
157176898|NCT04153929|567389636|FG001|Overall Study|Withdrawal by Subject|1|||
157176899|NCT04153929|567389637|FG002|Overall Study|Withdrawal by Subject|0|||
157176900|NCT04153929|567389638|FG003|Overall Study|Withdrawal by Subject|3|||
157176901|NCT04153929|567389639|FG004|Overall Study|Withdrawal by Subject|1|||
157176902|NCT04153929|567389640|FG005|Overall Study|Withdrawal by Subject|0|||
157176903|NCT04153929|567389641|FG006|Overall Study|Withdrawal by Subject|1|||
157053572|NCT01307800|566947600|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
157176904|NCT04153929|567389642|FG007|Overall Study|Withdrawal by Subject|0|||
156973799|NCT01874145|566656827|FG000|Extension Period|Adverse Event|3|||
156973800|NCT01874145|566656828|FG001|Extension Period|Adverse Event|2|||
156973801|NCT01874145|566656827|FG000|Extension Period|Withdrawal by Subject|2|||
156973802|NCT01874145|566656828|FG001|Extension Period|Withdrawal by Subject|1|||
156973803|NCT01874145|566656827|FG000|Extension Period|Lost to Follow-up|1|||
156973804|NCT01874145|566656828|FG001|Extension Period|Lost to Follow-up|1|||
156973805|NCT02764775|566659389|FG000|Overall Study|Death|1|||
156973806|NCT02764775|566659389|FG000|Overall Study|Lost to Follow-up|2|||
156973807|NCT02764775|566659389|FG000|Overall Study|Withdrawal by Subject|3|||
156973808|NCT00976703|566659392|FG000|Overall Study|Physician Decision|1|||
156973809|NCT00976703|566659393|FG001|Overall Study|Physician Decision|1|||
156973810|NCT00976703|566659392|FG000|Overall Study|ineligible for study|2|||
156973811|NCT00976703|566659393|FG001|Overall Study|ineligible for study|2|||
156973812|NCT00975221|566659396|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
156973813|NCT00975221|566659397|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
156973814|NCT00975221|566659396|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
156973815|NCT00975221|566659397|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
156973816|NCT00975221|566659396|FG000|Titration Phase (Weeks 1-12)|Other|0|||
156973817|NCT00975221|566659397|FG001|Titration Phase (Weeks 1-12)|Other|1|||
156973818|NCT00975221|566659396|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
156973819|NCT00975221|566659397|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
156973820|NCT00975221|566659396|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
156973821|NCT00975221|566659397|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
156973822|NCT00975221|566659396|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
156973823|NCT00975221|566659397|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
156973824|NCT02243631|566659400|FG000|Overall Study|no synovial fluid on second aspirate|0|||
156973825|NCT02243631|566659401|FG001|Overall Study|no synovial fluid on second aspirate|1|||
156973826|NCT01992549|566659402|FG000|Overall Study|Lost to Follow-up|2|||
156973827|NCT01992549|566659402|FG000|Overall Study|Serious Adverse Event|1|||
156973828|NCT01992549|566659402|FG000|Overall Study|Product Switch to Extend Half Life|1|||
156973829|NCT00857805|566659405|FG000|Overall Study|Withdrawal by Subject|1|||
156973830|NCT00857805|566659406|FG001|Overall Study|Withdrawal by Subject|1|||
156973831|NCT01289041|566659407|FG000|Overall Study|Adverse Event|24|||
156973832|NCT01289041|566659407|FG000|Overall Study|Physician Decision|1|||
156973833|NCT01289041|566659407|FG000|Overall Study|Progressive Disease|41|||
156973834|NCT01289041|566659407|FG000|Overall Study|Withdrawal by Subject|3|||
156973835|NCT01289041|566659407|FG000|Overall Study|Death|1|||
156973836|NCT02714868|566659412|FG000|Overall Study|Withdrawal by Subject|3|||
156973837|NCT02714868|566659413|FG001|Overall Study|Withdrawal by Subject|0|||
156973838|NCT02714868|566659412|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
156973839|NCT02714868|566659413|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
156973840|NCT02714868|566659412|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
156973841|NCT02714868|566659413|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
156973842|NCT00710606|566659419|FG000|Overall Study|Adverse Event|0|||
156973843|NCT00710606|566659420|FG001|Overall Study|Adverse Event|2|||
156973844|NCT05044325|566659421|FG000|Part A:Treatment Period 1|Adverse Event|0|||
156973845|NCT05044325|566659422|FG001|Part A:Treatment Period 1|Adverse Event|0|||
156973846|NCT05044325|566659423|FG002|Part A:Treatment Period 1|Adverse Event|0|||
156973847|NCT05044325|566659424|FG003|Part A:Treatment Period 1|Adverse Event|0|||
156973848|NCT05044325|566659425|FG004|Part A:Treatment Period 1|Adverse Event|0|||
156973849|NCT05044325|566659426|FG005|Part A:Treatment Period 1|Adverse Event|1|||
156973850|NCT05044325|566659427|FG006|Part A:Treatment Period 1|Adverse Event|0|||
156973851|NCT05044325|566659428|FG007|Part A:Treatment Period 1|Adverse Event|1|||
156973852|NCT05044325|566659429|FG008|Part A:Treatment Period 1|Adverse Event|0|||
156973853|NCT05044325|566659430|FG009|Part A:Treatment Period 1|Adverse Event|0|||
156973854|NCT05044325|566659421|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973855|NCT05044325|566659422|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973856|NCT05044325|566659423|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973857|NCT05044325|566659424|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156973858|NCT05044325|566659425|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156973859|NCT05044325|566659426|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
156973860|NCT05044325|566659427|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973861|NCT05044325|566659428|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973862|NCT05044325|566659429|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973863|NCT05044325|566659430|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
156973864|NCT05044325|566659421|FG000|Part A:Treatment Period 1|Physician Decision|0|||
156973865|NCT05044325|566659422|FG001|Part A:Treatment Period 1|Physician Decision|0|||
156973866|NCT05044325|566659423|FG002|Part A:Treatment Period 1|Physician Decision|0|||
156973867|NCT05044325|566659424|FG003|Part A:Treatment Period 1|Physician Decision|0|||
156973868|NCT05044325|566659425|FG004|Part A:Treatment Period 1|Physician Decision|0|||
157053573|NCT01307800|566947601|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
157053574|NCT01307800|566947598|FG000|Overall Study|Sponsor Decision|6|||
157053575|NCT01307800|566947599|FG001|Overall Study|Sponsor Decision|9|||
157053576|NCT01307800|566947600|FG002|Overall Study|Sponsor Decision|12|||
157053577|NCT01307800|566947601|FG003|Overall Study|Sponsor Decision|28|||
157053578|NCT01307800|566947598|FG000|Overall Study|Withdrawal by Subject|10|||
157176905|NCT04153929|567389635|FG000|Overall Study|Protocol Violation|0|||
157176906|NCT04153929|567389636|FG001|Overall Study|Protocol Violation|0|||
157176907|NCT04153929|567389637|FG002|Overall Study|Protocol Violation|0|||
157176908|NCT04153929|567389638|FG003|Overall Study|Protocol Violation|0|||
157176909|NCT04153929|567389639|FG004|Overall Study|Protocol Violation|0|||
157176910|NCT04153929|567389640|FG005|Overall Study|Protocol Violation|0|||
157176911|NCT04153929|567389641|FG006|Overall Study|Protocol Violation|1|||
157176912|NCT04153929|567389642|FG007|Overall Study|Protocol Violation|2|||
157176913|NCT04153929|567389635|FG000|Overall Study|Adverse Event|3|||
157176914|NCT04153929|567389636|FG001|Overall Study|Adverse Event|5|||
157176915|NCT04153929|567389637|FG002|Overall Study|Adverse Event|5|||
157176916|NCT04153929|567389638|FG003|Overall Study|Adverse Event|11|||
157176917|NCT04153929|567389639|FG004|Overall Study|Adverse Event|15|||
157176918|NCT04153929|567389640|FG005|Overall Study|Adverse Event|4|||
157176919|NCT04153929|567389641|FG006|Overall Study|Adverse Event|8|||
157176920|NCT04153929|567389642|FG007|Overall Study|Adverse Event|2|||
157176921|NCT04153929|567389635|FG000|Overall Study|Not treated|1|||
157176922|NCT04153929|567389636|FG001|Overall Study|Not treated|0|||
157176923|NCT04153929|567389637|FG002|Overall Study|Not treated|0|||
157176924|NCT04153929|567389638|FG003|Overall Study|Not treated|0|||
157176925|NCT04153929|567389639|FG004|Overall Study|Not treated|0|||
157176926|NCT04153929|567389640|FG005|Overall Study|Not treated|0|||
157176927|NCT04153929|567389641|FG006|Overall Study|Not treated|1|||
157176928|NCT04153929|567389642|FG007|Overall Study|Not treated|0|||
157176929|NCT01749800|567389645|FG000|Overall Study|not meeting inclusion criteria|3|||
157176930|NCT01749800|567389646|FG001|Overall Study|not meeting inclusion criteria|0|||
157176931|NCT01749800|567389647|FG002|Overall Study|not meeting inclusion criteria|0|||
157176932|NCT01749800|567389645|FG000|Overall Study|Withdrawal by Subject|0|||
157176933|NCT01749800|567389646|FG001|Overall Study|Withdrawal by Subject|1|||
157176934|NCT01749800|567389647|FG002|Overall Study|Withdrawal by Subject|0|||
157176935|NCT01296698|567389648|FG000|Overall Study|Adverse Event|1|||
157229487|NCT02937701|567586465|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
157229488|NCT02937701|567586466|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
157229489|NCT02937701|567586467|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
157053579|NCT01307800|566947599|FG001|Overall Study|Withdrawal by Subject|11|||
157053580|NCT01307800|566947600|FG002|Overall Study|Withdrawal by Subject|8|||
157053581|NCT01307800|566947601|FG003|Overall Study|Withdrawal by Subject|15|||
157053582|NCT01307800|566947598|FG000|Overall Study|Participant Moved|0|||
157053583|NCT01307800|566947599|FG001|Overall Study|Participant Moved|2|||
157053584|NCT01307800|566947600|FG002|Overall Study|Participant Moved|1|||
157053585|NCT01307800|566947601|FG003|Overall Study|Participant Moved|3|||
157053586|NCT00508144|566947602|FG000|Overall Study|Not eligible|6|||
157053587|NCT00508144|566947602|FG000|Overall Study|Death|5|||
157053588|NCT01084772|566947606|FG000|Baseline|Withdrawal by Subject|7|||
157053589|NCT01084772|566947607|FG001|Baseline|Withdrawal by Subject|6|||
157053590|NCT01084772|566947606|FG000|3 Months|Death|1|||
157053591|NCT01084772|566947607|FG001|3 Months|Death|0|||
157053592|NCT01084772|566947606|FG000|3 Months|Study Termination|2|||
157053593|NCT01084772|566947607|FG001|3 Months|Study Termination|2|||
157053594|NCT01084772|566947606|FG000|1 Year|Withdrawal by Subject|0|||
157053595|NCT01084772|566947607|FG001|1 Year|Withdrawal by Subject|1|||
157053596|NCT01084772|566947606|FG000|1 Year|Lost to Follow-up|3|||
157053597|NCT01084772|566947607|FG001|1 Year|Lost to Follow-up|0|||
157053598|NCT01084772|566947606|FG000|1 Year|Study Termination|0|||
157053599|NCT01084772|566947607|FG001|1 Year|Study Termination|7|||
157053600|NCT01084772|566947606|FG000|2 Years|Withdrawal by Subject|1|||
157176936|NCT01296698|567389649|FG001|Overall Study|Adverse Event|0|||
157176937|NCT01296698|567389648|FG000|Overall Study|Death|1|||
157176938|NCT01296698|567389649|FG001|Overall Study|Death|0|||
157176939|NCT01296698|567389648|FG000|Overall Study|Lost to Follow-up|19|||
157176940|NCT01296698|567389649|FG001|Overall Study|Lost to Follow-up|1|||
157176941|NCT01296698|567389648|FG000|Overall Study|Withdrawal by Subject|12|||
157176942|NCT01296698|567389649|FG001|Overall Study|Withdrawal by Subject|0|||
157176943|NCT01296698|567389648|FG000|Overall Study|Difficulty Contacting Subject|2|||
157229490|NCT02937701|567586463|FG000|Day 1 to Week 22|Death|1|||
157176944|NCT01296698|567389649|FG001|Overall Study|Difficulty Contacting Subject|0|||
157053601|NCT01084772|566947607|FG001|2 Years|Withdrawal by Subject|0|||
157053602|NCT01084772|566947606|FG000|2 Years|Lost to Follow-up|5|||
157053603|NCT01084772|566947607|FG001|2 Years|Lost to Follow-up|2|||
157053604|NCT01084772|566947606|FG000|2 Years|Study Termination|3|||
157053605|NCT01084772|566947607|FG001|2 Years|Study Termination|2|||
157053606|NCT01517282|566947608|FG000|Overall Study|Consent withdrawn|0|||
157176945|NCT01296698|567389648|FG000|Overall Study|Study Terminated by Sponsor|209|||
157176946|NCT01296698|567389649|FG001|Overall Study|Study Terminated by Sponsor|12|||
157176947|NCT01975675|567389656|FG000|Overall Study|Death|0|||
157053607|NCT01517282|566947609|FG001|Overall Study|Consent withdrawn|1|||
157053608|NCT01517282|566947610|FG002|Overall Study|Consent withdrawn|1|||
157053609|NCT01517282|566947611|FG003|Overall Study|Consent withdrawn|1|||
157053610|NCT01517282|566947608|FG000|Overall Study|Physician Decision|1|||
157053611|NCT01517282|566947609|FG001|Overall Study|Physician Decision|0|||
157053612|NCT01517282|566947610|FG002|Overall Study|Physician Decision|0|||
157053613|NCT01517282|566947611|FG003|Overall Study|Physician Decision|0|||
157053614|NCT04413149|566948829|FG000|Overall Study|Death|10|||
157053615|NCT04413149|566948830|FG001|Overall Study|Death|5|||
157053616|NCT04413149|566948829|FG000|Overall Study|Lung transplantation|1|||
157053617|NCT04413149|566948830|FG001|Overall Study|Lung transplantation|0|||
157053618|NCT02878590|566948831|FG000|Overall Study|Withdrawal by Subject|2|||
157053619|NCT00814632|566948832|FG000|Overall Study|Lack of Efficacy|2|||
157053620|NCT04198428|566948833|FG000|Overall Study|Withdrawal by Subject|150|||
157053621|NCT04198428|566948834|FG001|Overall Study|Withdrawal by Subject|156|||
157053622|NCT05878990|566948836|FG000|Overall Study|Lost to Follow-up|7|||
157053623|NCT05878990|566948836|FG000|Overall Study|Withdrawal by Subject|1|||
157053624|NCT00668746|566948837|FG000|Overall Study|Lost to Follow-up|2|||
157053625|NCT00668746|566948838|FG001|Overall Study|Lost to Follow-up|1|||
157053626|NCT03409276|566948839|FG000|Overall Study|Withdrawal by Subject|0|||
157053627|NCT03409276|566948840|FG001|Overall Study|Withdrawal by Subject|0|||
157053628|NCT03409276|566948841|FG002|Overall Study|Withdrawal by Subject|0|||
157053629|NCT03409276|566948842|FG003|Overall Study|Withdrawal by Subject|0|||
157053630|NCT03409276|566948843|FG004|Overall Study|Withdrawal by Subject|1|||
157053631|NCT03409276|566948839|FG000|Overall Study|Lost to Follow-up|0|||
157053632|NCT03409276|566948840|FG001|Overall Study|Lost to Follow-up|0|||
157053633|NCT03409276|566948841|FG002|Overall Study|Lost to Follow-up|0|||
157053634|NCT03409276|566948842|FG003|Overall Study|Lost to Follow-up|2|||
157053635|NCT03409276|566948843|FG004|Overall Study|Lost to Follow-up|2|||
157053636|NCT03960437|566948849|FG000|Overall Study|Removed by PI|4|||
157053637|NCT03960437|566948849|FG000|Overall Study|Lost to Follow-up|2|||
157053638|NCT03960437|566948849|FG000|Overall Study|Withdrawal by Subject|1|||
157053639|NCT03960437|566948849|FG000|Overall Study|Death|2|||
157053640|NCT02368691|566948850|FG000|Overall Study|Death|13|||
157053641|NCT02368691|566948850|FG000|Overall Study|Lack of Efficacy|15|||
157053642|NCT02368691|566948850|FG000|Overall Study|Physician Decision|4|||
157053643|NCT01838447|566948851|FG000|Overall Study|Change in surgical plan|1|||
157053644|NCT01838447|566948852|FG001|Overall Study|Change in surgical plan|2|||
157053645|NCT01838447|566948851|FG000|Overall Study|Withdrawal by Subject|1|||
157053646|NCT01838447|566948852|FG001|Overall Study|Withdrawal by Subject|1|||
157053647|NCT01114217|566948853|FG000|Overall Study|Adverse Event|5|||
157053648|NCT01114217|566948854|FG001|Overall Study|Adverse Event|3|||
157053649|NCT01114217|566948853|FG000|Overall Study|Lost to Follow-up|17|||
157053650|NCT01114217|566948854|FG001|Overall Study|Lost to Follow-up|33|||
157053651|NCT01114217|566948853|FG000|Overall Study|Withdrawal by Subject|21|||
157053652|NCT01114217|566948854|FG001|Overall Study|Withdrawal by Subject|28|||
157053653|NCT01114217|566948853|FG000|Overall Study|Other-Clerical Error|3|||
157053654|NCT01114217|566948854|FG001|Overall Study|Other-Clerical Error|0|||
157053655|NCT01114217|566948853|FG000|Overall Study|Other-Early termination|6|||
157053656|NCT01114217|566948854|FG001|Overall Study|Other-Early termination|10|||
157053657|NCT01114217|566948853|FG000|Overall Study|Other-Procedure|1|||
157053658|NCT01114217|566948854|FG001|Overall Study|Other-Procedure|1|||
157053659|NCT01114217|566948853|FG000|Overall Study|Other-Pregnancy|2|||
157053660|NCT01114217|566948854|FG001|Overall Study|Other-Pregnancy|4|||
157053661|NCT01114217|566948853|FG000|Overall Study|Other-Protocol Violation|1|||
157053662|NCT01114217|566948854|FG001|Overall Study|Other-Protocol Violation|3|||
157176948|NCT01975675|567389657|FG001|Overall Study|Death|1|||
157176949|NCT01975675|567389658|FG002|Overall Study|Death|0|||
157176950|NCT01975675|567389659|FG003|Overall Study|Death|0|||
157176951|NCT00224003|567389660|FG000|Overall Study|Adverse Event|1|||
157176952|NCT00224003|567389660|FG000|Overall Study|Protocol Violation|2|||
157053663|NCT01114217|566948853|FG000|Overall Study|Other-Lack of Efficacy|1|||
157053664|NCT01114217|566948854|FG001|Overall Study|Other-Lack of Efficacy|0|||
157053665|NCT01114217|566948853|FG000|Overall Study|Other-Non Compliance|2|||
157053666|NCT01114217|566948854|FG001|Overall Study|Other-Non Compliance|0|||
157053667|NCT01114217|566948853|FG000|Overall Study|Other-Physician Decision|1|||
157176953|NCT00224003|567389660|FG000|Overall Study|Withdrawal by Subject|1|||
157053668|NCT01114217|566948854|FG001|Overall Study|Other-Physician Decision|1|||
157053669|NCT01114217|566948853|FG000|Overall Study|Other-Sponsor Decision|10|||
157053670|NCT01114217|566948854|FG001|Overall Study|Other-Sponsor Decision|12|||
157176954|NCT00224003|567389660|FG000|Overall Study|unk|3|||
157053671|NCT01114217|566948853|FG000|Overall Study|Other-Study Termination|0|||
157053672|NCT01114217|566948854|FG001|Overall Study|Other-Study Termination|1|||
157053673|NCT01114217|566948853|FG000|Overall Study|Other-Study Withdrawn|1|||
157053674|NCT01114217|566948854|FG001|Overall Study|Other-Study Withdrawn|1|||
157053675|NCT01114217|566948853|FG000|Overall Study|Other-Site Stopped Communicating|2|||
157176955|NCT03639987|567389661|FG000|Overall Study|Study terminated by sponsor|26|||
157053676|NCT01114217|566948854|FG001|Overall Study|Other-Site Stopped Communicating|0|||
157229491|NCT02937701|567586464|FG001|Day 1 to Week 22|Death|1|||
157053677|NCT01114217|566948853|FG000|Overall Study|Other-Lost to Follow-up|1|||
157053678|NCT01114217|566948854|FG001|Overall Study|Other-Lost to Follow-up|0|||
157053679|NCT01114217|566948853|FG000|Overall Study|Other-Withdrawal by Subject|1|||
157053680|NCT01114217|566948854|FG001|Overall Study|Other-Withdrawal by Subject|1|||
157053681|NCT06247488|566948855|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
157053682|NCT06247488|566948856|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
157053683|NCT06247488|566948857|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
157053684|NCT06247488|566948858|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
157053685|NCT06247488|566948859|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
157053686|NCT06247488|566948860|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
157053687|NCT06247488|566948855|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
157053688|NCT06247488|566948856|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
157053689|NCT06247488|566948857|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
157053690|NCT06247488|566948858|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
157053691|NCT06247488|566948859|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
157053692|NCT06247488|566948860|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
157053693|NCT06247488|566948855|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
157053694|NCT06247488|566948856|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
157053695|NCT06247488|566948857|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
157053696|NCT06247488|566948858|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
157053697|NCT06247488|566948859|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
157053698|NCT06247488|566948860|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
157053699|NCT06247488|566948855|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
157053700|NCT06247488|566948856|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
157053701|NCT06247488|566948857|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
157053702|NCT06247488|566948858|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
157053703|NCT06247488|566948859|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
157053704|NCT06247488|566948860|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
157053705|NCT06247488|566948855|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
157053706|NCT06247488|566948856|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
157053707|NCT06247488|566948857|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
157053708|NCT06247488|566948858|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
157053709|NCT06247488|566948859|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
157053710|NCT06247488|566948860|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
157053711|NCT06247488|566948855|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
157053712|NCT06247488|566948856|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
157053713|NCT06247488|566948857|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
157053714|NCT06247488|566948858|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
157053715|NCT06247488|566948859|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
157053716|NCT06247488|566948860|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
157053717|NCT06247488|566948855|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
157053718|NCT06247488|566948856|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
157053719|NCT06247488|566948857|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
157053720|NCT06247488|566948858|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
157053721|NCT06247488|566948859|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
157053722|NCT06247488|566948860|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
157053723|NCT03436797|566948864|FG000|Main Study|Withdrawal by Subject|2|||
157053724|NCT03436797|566948864|FG000|Main Study|Adverse Event|4|||
157053725|NCT03436797|566948864|FG000|Main Study|Lost to Follow-up|1|||
157053726|NCT03436797|566948864|FG000|Main Study|Death|1|||
157053727|NCT03436797|566948864|FG000|Main Study|Non-Specific|2|||
157053728|NCT03436797|566948864|FG000|Extended Dosing|Patient decision|1|||
157053729|NCT04739306|566948865|FG000|Main Study Period|Adverse Event|6|||
157053730|NCT04739306|566948866|FG001|Main Study Period|Adverse Event|7|||
157053731|NCT04739306|566948865|FG000|Main Study Period|Lost to Follow-up|4|||
157053732|NCT04739306|566948866|FG001|Main Study Period|Lost to Follow-up|6|||
157053733|NCT04739306|566948865|FG000|Main Study Period|Physician Decision|1|||
157053734|NCT04739306|566948866|FG001|Main Study Period|Physician Decision|1|||
157053735|NCT04739306|566948865|FG000|Main Study Period|Withdrawal by Subject|8|||
157053736|NCT04739306|566948866|FG001|Main Study Period|Withdrawal by Subject|6|||
157053737|NCT04739306|566948865|FG000|Main Study Period|Protocol Violation|0|||
157176956|NCT03639987|567389662|FG001|Overall Study|Study terminated by sponsor|25|||
157053738|NCT04739306|566948866|FG001|Main Study Period|Protocol Violation|1|||
157053739|NCT04739306|566948865|FG000|Main Study Period|War in Ukraine|1|||
157053740|NCT04739306|566948866|FG001|Main Study Period|War in Ukraine|1|||
157053741|NCT01951105|566948871|FG000|Overall Study|Adverse Event|0|||
157053742|NCT01951105|566948872|FG001|Overall Study|Adverse Event|5|||
157053743|NCT01951105|566948873|FG002|Overall Study|Adverse Event|0|||
157053744|NCT01951105|566948871|FG000|Overall Study|Lost to Follow-up|0|||
157053745|NCT01951105|566948872|FG001|Overall Study|Lost to Follow-up|1|||
157053746|NCT01951105|566948873|FG002|Overall Study|Lost to Follow-up|0|||
157053747|NCT01951105|566948871|FG000|Overall Study|Protocol Violation|1|||
157053748|NCT01951105|566948872|FG001|Overall Study|Protocol Violation|1|||
157053749|NCT01951105|566948873|FG002|Overall Study|Protocol Violation|1|||
157053750|NCT01951105|566948871|FG000|Overall Study|Withdrawal by Subject|0|||
157053751|NCT01951105|566948872|FG001|Overall Study|Withdrawal by Subject|3|||
157053752|NCT01951105|566948873|FG002|Overall Study|Withdrawal by Subject|1|||
157053753|NCT00561678|566948874|FG000|Overall Study|Withdrawal by Subject|4|||
157053754|NCT00561678|566948875|FG001|Overall Study|Withdrawal by Subject|3|||
157053755|NCT00561678|566948874|FG000|Overall Study|surgery cancelled|1|||
157053756|NCT00561678|566948875|FG001|Overall Study|surgery cancelled|1|||
157053757|NCT00561678|566948874|FG000|Overall Study|surgery rescheduled to different site|2|||
157053758|NCT00561678|566948875|FG001|Overall Study|surgery rescheduled to different site|2|||
157053759|NCT00561678|566948874|FG000|Overall Study|anesthesia provider refusal|1|||
157053760|NCT00561678|566948875|FG001|Overall Study|anesthesia provider refusal|0|||
157053761|NCT00422162|566948883|FG000|Overall Study|Adverse Event|11|||
157053762|NCT00422162|566948884|FG001|Overall Study|Adverse Event|9|||
157053763|NCT00422162|566948883|FG000|Overall Study|Lack of Efficacy|4|||
157053764|NCT00422162|566948884|FG001|Overall Study|Lack of Efficacy|10|||
157053765|NCT00422162|566948883|FG000|Overall Study|Withdrawal by Subject|7|||
157053766|NCT00422162|566948884|FG001|Overall Study|Withdrawal by Subject|6|||
157053767|NCT00422162|566948883|FG000|Overall Study|Lost to Follow-up|1|||
157053768|NCT00422162|566948884|FG001|Overall Study|Lost to Follow-up|2|||
157053769|NCT00422162|566948883|FG000|Overall Study|Non-Compliant with Protocol|1|||
157053770|NCT00422162|566948884|FG001|Overall Study|Non-Compliant with Protocol|1|||
157053771|NCT00422162|566948883|FG000|Overall Study|Other|0|||
157053772|NCT00422162|566948884|FG001|Overall Study|Other|1|||
157053773|NCT00422162|566948883|FG000|Overall Study|Didn't Receive Treatment|0|||
157053774|NCT00422162|566948884|FG001|Overall Study|Didn't Receive Treatment|1|||
157053775|NCT05274906|566948885|FG000|Overall Study|Withdrawal by Subject|2|||
157053776|NCT05274906|566948886|FG001|Overall Study|Withdrawal by Subject|1|||
157053777|NCT00848198|566948887|FG000|Overall Study|Incomplete Case Report Forms|15|||
157053778|NCT04930263|566948888|FG000|Overall Study|Withdrawal by Subject|3|||
157053779|NCT04930263|566948889|FG001|Overall Study|Withdrawal by Subject|5|||
157053780|NCT02812706|566948890|FG000|Phase 1|Adverse Event|0|||
157053781|NCT02812706|566948891|FG001|Phase 1|Adverse Event|2|||
157053782|NCT02812706|566948892|FG002|Phase 1|Adverse Event|0|||
157053783|NCT02812706|566948890|FG000|Phase 1|Progressive disease|3|||
157053784|NCT02812706|566948891|FG001|Phase 1|Progressive disease|3|||
157053785|NCT02812706|566948892|FG002|Phase 1|Progressive disease|0|||
157053786|NCT02812706|566948890|FG000|Phase 2|Adverse Event|0|||
157053787|NCT02812706|566948891|FG001|Phase 2|Adverse Event|0|||
157053788|NCT02812706|566948892|FG002|Phase 2|Adverse Event|2|||
157053789|NCT02812706|566948890|FG000|Phase 2|Progressive disease|0|||
157053790|NCT02812706|566948891|FG001|Phase 2|Progressive disease|0|||
157053791|NCT02812706|566948892|FG002|Phase 2|Progressive disease|22|||
157053792|NCT02812706|566948890|FG000|Phase 2|Other-Unspecified|0|||
157053793|NCT02812706|566948891|FG001|Phase 2|Other-Unspecified|0|||
157053794|NCT02812706|566948892|FG002|Phase 2|Other-Unspecified|4|||
157053795|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
157053796|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
157053797|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
157053798|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
157053799|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
157053800|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
157053801|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
157053802|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
157053803|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
157053804|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
157053805|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
157053806|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
157176957|NCT03639987|567389661|FG000|Overall Study|Lost to Follow-up|0|||
157053807|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
157053808|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
157053809|NCT02971683|566948893|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
157053810|NCT02971683|566948894|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
157053811|NCT02971683|566948893|FG000|Open-Label|Lost to Follow-up|1|||
157053812|NCT02971683|566948894|FG001|Open-Label|Lost to Follow-up|0|||
157053813|NCT02971683|566948893|FG000|Open-Label|Participants withdrew consent|0|||
157053814|NCT02971683|566948894|FG001|Open-Label|Participants withdrew consent|2|||
157176958|NCT03639987|567389662|FG001|Overall Study|Lost to Follow-up|1|||
157053815|NCT02971683|566948893|FG000|Open-Label|Participant request to discontinue study treatment|1|||
157176959|NCT03549429|567389663|FG000|Overall Study|Protocol Violation|5|||
157053816|NCT02971683|566948894|FG001|Open-Label|Participant request to discontinue study treatment|0|||
157053817|NCT02971683|566948893|FG000|Open-Label|Lack of Efficacy|2|||
157053818|NCT02971683|566948894|FG001|Open-Label|Lack of Efficacy|0|||
157053819|NCT02971683|566948893|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
157053820|NCT02971683|566948894|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
157176960|NCT03549429|567389664|FG001|Overall Study|Protocol Violation|3|||
157053821|NCT02971683|566948893|FG000|Long-Term Open Label|Participant withdrew consent|1|||
157053822|NCT02971683|566948894|FG001|Long-Term Open Label|Participant withdrew consent|0|||
157053823|NCT02971683|566948893|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
157053824|NCT02971683|566948894|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
157053825|NCT02971683|566948893|FG000|Long-Term Open Label|Adverse Event|1|||
157053826|NCT02971683|566948894|FG001|Long-Term Open Label|Adverse Event|2|||
157053827|NCT02971683|566948893|FG000|Long-Term Open Label|Lack of Efficacy|1|||
157053828|NCT02971683|566948894|FG001|Long-Term Open Label|Lack of Efficacy|1|||
157053829|NCT01699178|566948895|FG000|Overall Study|Adverse Event|1|||
157053830|NCT01699178|566948896|FG001|Overall Study|Adverse Event|5|||
157053831|NCT01699178|566948895|FG000|Overall Study|Lost to Follow-up|1|||
157053832|NCT01699178|566948896|FG001|Overall Study|Lost to Follow-up|6|||
157053833|NCT01699178|566948895|FG000|Overall Study|Non-compliance with Study Drug|3|||
157053834|NCT01699178|566948896|FG001|Overall Study|Non-compliance with Study Drug|1|||
157053835|NCT01699178|566948895|FG000|Overall Study|Physician Decision|1|||
157053836|NCT01699178|566948896|FG001|Overall Study|Physician Decision|0|||
157053837|NCT01699178|566948895|FG000|Overall Study|Withdrawal by Subject|4|||
157053838|NCT01699178|566948896|FG001|Overall Study|Withdrawal by Subject|12|||
157053839|NCT01699178|566948895|FG000|Overall Study|Hematocrit >54%|1|||
157053840|NCT01699178|566948896|FG001|Overall Study|Hematocrit >54%|1|||
157053841|NCT01699178|566948895|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
157053842|NCT01699178|566948896|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
157053843|NCT01699178|566948895|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
157053844|NCT01699178|566948896|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
157053845|NCT04016415|566948897|FG000|Overall Study|Adverse Event|2|||
157053846|NCT04016415|566948898|FG001|Overall Study|Adverse Event|1|||
157053847|NCT04016415|566948897|FG000|Overall Study|Lost to Follow-up|6|||
157053848|NCT04016415|566948898|FG001|Overall Study|Lost to Follow-up|2|||
157053849|NCT04016415|566948897|FG000|Overall Study|Physician Decision|5|||
157053850|NCT04016415|566948898|FG001|Overall Study|Physician Decision|1|||
157053851|NCT04016415|566948897|FG000|Overall Study|Pregnancy|0|||
157053852|NCT04016415|566948898|FG001|Overall Study|Pregnancy|1|||
157053853|NCT04016415|566948897|FG000|Overall Study|Withdrawal by Subject|24|||
157053854|NCT04016415|566948898|FG001|Overall Study|Withdrawal by Subject|27|||
157053855|NCT04016415|566948897|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
157053856|NCT04016415|566948898|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
157053857|NCT00912964|566948901|FG000|Overall Study|Eligibility criterion not met|1|||
157053858|NCT00912964|566948902|FG001|Overall Study|Eligibility criterion not met|1|||
157053859|NCT00912964|566948903|FG002|Overall Study|Eligibility criterion not met|0|||
157053860|NCT00912964|566948901|FG000|Overall Study|Adverse Event|15|||
157053861|NCT00912964|566948902|FG001|Overall Study|Adverse Event|18|||
157053862|NCT00912964|566948903|FG002|Overall Study|Adverse Event|12|||
157053863|NCT00912964|566948901|FG000|Overall Study|Lack of Efficacy|11|||
157053864|NCT00912964|566948902|FG001|Overall Study|Lack of Efficacy|4|||
157053865|NCT00912964|566948903|FG002|Overall Study|Lack of Efficacy|3|||
157053866|NCT00912964|566948901|FG000|Overall Study|Withdrawal by Subject|20|||
157053867|NCT00912964|566948902|FG001|Overall Study|Withdrawal by Subject|12|||
157053868|NCT00912964|566948903|FG002|Overall Study|Withdrawal by Subject|18|||
157053869|NCT00912964|566948901|FG000|Overall Study|Lost to Follow-up|4|||
157053870|NCT00912964|566948902|FG001|Overall Study|Lost to Follow-up|3|||
157053871|NCT00912964|566948903|FG002|Overall Study|Lost to Follow-up|3|||
157053872|NCT00912964|566948901|FG000|Overall Study|Protocol Violation|5|||
157176961|NCT00729326|567389674|FG000|Overall Study|Lost to Follow-up|2|||
157176962|NCT00729326|567389675|FG001|Overall Study|Lost to Follow-up|0|||
157176963|NCT00729326|567389674|FG000|Overall Study|Physician Decision|0|||
157176964|NCT00729326|567389675|FG001|Overall Study|Physician Decision|1|||
157176965|NCT00729326|567389674|FG000|Overall Study|Protocol Violation|3|||
157176966|NCT00729326|567389675|FG001|Overall Study|Protocol Violation|2|||
157176967|NCT00729326|567389674|FG000|Overall Study|Subject Decision|4|||
157053873|NCT00912964|566948902|FG001|Overall Study|Protocol Violation|3|||
157053874|NCT00912964|566948903|FG002|Overall Study|Protocol Violation|8|||
157053875|NCT00912964|566948901|FG000|Overall Study|Taking exclusionary medications|7|||
157053876|NCT00912964|566948902|FG001|Overall Study|Taking exclusionary medications|4|||
157053877|NCT00912964|566948903|FG002|Overall Study|Taking exclusionary medications|8|||
157053878|NCT00912964|566948901|FG000|Overall Study|Medical History|1|||
157053879|NCT00912964|566948902|FG001|Overall Study|Medical History|0|||
157053880|NCT00912964|566948903|FG002|Overall Study|Medical History|0|||
157053881|NCT00912964|566948901|FG000|Overall Study|Non-compliance with study procedures|2|||
157176968|NCT00729326|567389675|FG001|Overall Study|Subject Decision|4|||
157176969|NCT00729326|567389674|FG000|Overall Study|Sponsor Decision|1|||
157176970|NCT00729326|567389675|FG001|Overall Study|Sponsor Decision|2|||
157053882|NCT00912964|566948902|FG001|Overall Study|Non-compliance with study procedures|0|||
157053883|NCT00912964|566948903|FG002|Overall Study|Non-compliance with study procedures|0|||
157053884|NCT00912964|566948901|FG000|Overall Study|Violation of exclusion criterion|0|||
157176971|NCT01235728|567389676|FG000|Overall Study|Protocol Violation|0|||
157176972|NCT01235728|567389677|FG001|Overall Study|Protocol Violation|0|||
157176973|NCT01235728|567389678|FG002|Overall Study|Protocol Violation|0|||
157176974|NCT01235728|567389679|FG003|Overall Study|Protocol Violation|1|||
157176975|NCT01235728|567389680|FG004|Overall Study|Protocol Violation|0|||
157176976|NCT01235728|567389681|FG005|Overall Study|Protocol Violation|0|||
157176977|NCT01235728|567389682|FG006|Overall Study|Protocol Violation|0|||
157176978|NCT01235728|567389683|FG007|Overall Study|Protocol Violation|0|||
157176979|NCT01000025|567389684|FG000|Overall Study|Adverse Event|43|||
157176980|NCT01000025|567389685|FG001|Overall Study|Adverse Event|2|||
157176981|NCT01000025|567389684|FG000|Overall Study|Withdrawal by Subject|13|||
157176982|NCT01000025|567389685|FG001|Overall Study|Withdrawal by Subject|8|||
157176983|NCT01000025|567389684|FG000|Overall Study|Death|23|||
157176984|NCT01000025|567389685|FG001|Overall Study|Death|13|||
157176985|NCT01000025|567389684|FG000|Overall Study|Lack of Efficacy|363|||
157176986|NCT01000025|567389685|FG001|Overall Study|Lack of Efficacy|208|||
157176987|NCT01000025|567389684|FG000|Overall Study|Intercurrent Illness|26|||
157176988|NCT01000025|567389685|FG001|Overall Study|Intercurrent Illness|7|||
157176989|NCT01654523|567389686|FG000|Overall Study|Withdrawal by Subject|1|||
157176990|NCT04354155|567389687|FG000|Overall Study|Withdrawal by Subject|1|||
157176991|NCT04354155|567389687|FG000|Overall Study|Did not meet criteria for study intervention|1|||
157176992|NCT03199638|567389692|FG000|Overall Study|inability to drink glutamine during regularly|0|||
157176993|NCT03199638|567389693|FG001|Overall Study|inability to drink glutamine during regularly|2|||
157176994|NCT01575899|567389694|FG000|Overall Study|Lost to Follow-up|3|||
157176995|NCT01575899|567389695|FG001|Overall Study|Lost to Follow-up|4|||
157176996|NCT01575899|567389696|FG002|Overall Study|Lost to Follow-up|2|||
157176997|NCT01575899|567389694|FG000|Overall Study|Protocol Violation|2|||
157176998|NCT01575899|567389695|FG001|Overall Study|Protocol Violation|1|||
157176999|NCT01575899|567389696|FG002|Overall Study|Protocol Violation|0|||
157177000|NCT03097029|567389697|FG000|Overall Study|Withdrawal by Subject|1|||
157177001|NCT02807844|567389698|FG000|Overall Study|Physician Decision|0|||
157177002|NCT02807844|567389699|FG001|Overall Study|Physician Decision|0|||
157177003|NCT02807844|567389700|FG002|Overall Study|Physician Decision|0|||
157177004|NCT02807844|567389701|FG003|Overall Study|Physician Decision|0|||
157177005|NCT02807844|567389702|FG004|Overall Study|Physician Decision|0|||
157177006|NCT02807844|567389703|FG005|Overall Study|Physician Decision|0|||
157177007|NCT02807844|567389704|FG006|Overall Study|Physician Decision|3|||
157177008|NCT02807844|567389705|FG007|Overall Study|Physician Decision|0|||
157177009|NCT02807844|567389706|FG008|Overall Study|Physician Decision|1|||
157177010|NCT02807844|567389707|FG009|Overall Study|Physician Decision|2|||
157177011|NCT02807844|567389698|FG000|Overall Study|Death|0|||
157229492|NCT02937701|567586465|FG002|Day 1 to Week 22|Death|0|||
157229493|NCT02937701|567586466|FG003|Day 1 to Week 22|Death|0|||
157053885|NCT00912964|566948902|FG001|Overall Study|Violation of exclusion criterion|0|||
157053886|NCT00912964|566948903|FG002|Overall Study|Violation of exclusion criterion|2|||
157053887|NCT00912964|566948901|FG000|Overall Study|Randomized but never received study drug|0|||
157053888|NCT00912964|566948902|FG001|Overall Study|Randomized but never received study drug|1|||
157053889|NCT00912964|566948903|FG002|Overall Study|Randomized but never received study drug|0|||
157053890|NCT03547167|566948906|FG000|Overall Study|Withdrawal by Subject|34|||
157053891|NCT03547167|566948907|FG001|Overall Study|Withdrawal by Subject|12|||
157053892|NCT03547167|566948906|FG000|Overall Study|Screen Failure|0|||
157053893|NCT03547167|566948907|FG001|Overall Study|Screen Failure|1|||
157053894|NCT03547167|566948906|FG000|Overall Study|Lost to Follow-up|59|||
157053895|NCT03547167|566948907|FG001|Overall Study|Lost to Follow-up|15|||
157053896|NCT03547167|566948906|FG000|Overall Study|Death|4|||
157053897|NCT03547167|566948907|FG001|Overall Study|Death|2|||
157053898|NCT00070317|566948908|FG000|Overall Study|Inevaluable (Never Treated)|1|||
157053899|NCT00070317|566948908|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
157053900|NCT00070317|566948908|FG000|Overall Study|Ineligible required test not done|1|||
157053901|NCT00070317|566948908|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
157053902|NCT00070317|566948908|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
157177012|NCT02807844|567389699|FG001|Overall Study|Death|0|||
157053903|NCT03100370|566948909|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
157177013|NCT02807844|567389700|FG002|Overall Study|Death|2|||
157177014|NCT02807844|567389701|FG003|Overall Study|Death|4|||
157177015|NCT02807844|567389702|FG004|Overall Study|Death|1|||
157177016|NCT02807844|567389703|FG005|Overall Study|Death|2|||
157177017|NCT02807844|567389704|FG006|Overall Study|Death|1|||
157177018|NCT02807844|567389705|FG007|Overall Study|Death|2|||
157177019|NCT02807844|567389706|FG008|Overall Study|Death|0|||
157177020|NCT02807844|567389707|FG009|Overall Study|Death|1|||
157177021|NCT02807844|567389698|FG000|Overall Study|Withdrawal by Subject|0|||
157177022|NCT02807844|567389699|FG001|Overall Study|Withdrawal by Subject|0|||
157177023|NCT02807844|567389700|FG002|Overall Study|Withdrawal by Subject|2|||
157177024|NCT02807844|567389701|FG003|Overall Study|Withdrawal by Subject|1|||
157177025|NCT02807844|567389702|FG004|Overall Study|Withdrawal by Subject|1|||
157053904|NCT03100370|566948910|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
157177026|NCT02807844|567389703|FG005|Overall Study|Withdrawal by Subject|0|||
157053905|NCT03100370|566948911|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
157053906|NCT03100370|566948912|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
157053907|NCT03100370|566948913|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
157053908|NCT03100370|566948914|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
157053909|NCT02674399|566948915|FG000|Overall Study|Lost to Follow-up|2|||
157053910|NCT02674399|566948916|FG001|Overall Study|Lost to Follow-up|0|||
157053911|NCT01199302|566948936|FG000|Overall Study|Adverse Event|1|||
157053912|NCT01199302|566948937|FG001|Overall Study|Adverse Event|1|||
157053913|NCT01199302|566948938|FG002|Overall Study|Adverse Event|2|||
157053914|NCT01199302|566948939|FG003|Overall Study|Adverse Event|0|||
157053915|NCT01199302|566948936|FG000|Overall Study|Withdrawal by Subject|2|||
157053916|NCT01199302|566948937|FG001|Overall Study|Withdrawal by Subject|2|||
157053917|NCT01199302|566948938|FG002|Overall Study|Withdrawal by Subject|3|||
157053918|NCT01199302|566948939|FG003|Overall Study|Withdrawal by Subject|0|||
157053919|NCT01199302|566948936|FG000|Overall Study|Disease Progression|3|||
157053920|NCT01199302|566948937|FG001|Overall Study|Disease Progression|4|||
157053921|NCT01199302|566948938|FG002|Overall Study|Disease Progression|4|||
157053922|NCT01199302|566948939|FG003|Overall Study|Disease Progression|2|||
157053923|NCT01199302|566948936|FG000|Overall Study|Study Termination|13|||
157053924|NCT01199302|566948937|FG001|Overall Study|Study Termination|8|||
157053925|NCT01199302|566948938|FG002|Overall Study|Study Termination|11|||
157053926|NCT01199302|566948939|FG003|Overall Study|Study Termination|9|||
157053927|NCT01199302|566948936|FG000|Overall Study|Lost to Follow-up|0|||
157053928|NCT01199302|566948937|FG001|Overall Study|Lost to Follow-up|1|||
157053929|NCT01199302|566948938|FG002|Overall Study|Lost to Follow-up|0|||
157053930|NCT01199302|566948939|FG003|Overall Study|Lost to Follow-up|0|||
157053931|NCT01199302|566948936|FG000|Overall Study|Other|1|||
157053932|NCT01199302|566948937|FG001|Overall Study|Other|0|||
157053933|NCT01199302|566948938|FG002|Overall Study|Other|0|||
157053934|NCT01199302|566948939|FG003|Overall Study|Other|0|||
157053935|NCT04433091|566948940|FG000|Overall Study|Lost to Follow-up|1|||
157053936|NCT04433091|566948941|FG001|Overall Study|Lost to Follow-up|0|||
157053937|NCT04433091|566948940|FG000|Overall Study|Withdrawn .|2|||
157053938|NCT04433091|566948941|FG001|Overall Study|Withdrawn .|4|||
157053939|NCT03070301|566948942|FG000|Overall Study|Progression of disease|16|||
157053940|NCT03070301|566948942|FG000|Overall Study|Physician Decision|3|||
157053941|NCT03070301|566948942|FG000|Overall Study|Withdrawal by Subject|1|||
157053942|NCT03820024|566948943|FG000|Overall Study|Physician Decision|1|||
157053943|NCT03820024|566948944|FG001|Overall Study|Physician Decision|2|||
157053944|NCT02514577|566950106|FG000|Overall Study|Lost to Follow-up|6|||
157053945|NCT02514577|566950107|FG001|Overall Study|Lost to Follow-up|6|||
157053946|NCT02514577|566950106|FG000|Overall Study|Protocol Violation|1|||
157053947|NCT02514577|566950107|FG001|Overall Study|Protocol Violation|0|||
157053948|NCT02514577|566950106|FG000|Overall Study|Withdrawal by Subject|6|||
157053949|NCT02514577|566950107|FG001|Overall Study|Withdrawal by Subject|6|||
157053950|NCT02514577|566950106|FG000|Overall Study|Adverse Event|1|||
157053951|NCT02514577|566950107|FG001|Overall Study|Adverse Event|1|||
157053952|NCT00489489|566950108|FG000|Overall Study|Not treated due to protocol violation|0|||
157053953|NCT00489489|566950109|FG001|Overall Study|Not treated due to protocol violation|1|||
157053954|NCT00489489|566950110|FG002|Overall Study|Not treated due to protocol violation|1|||
157053955|NCT00489489|566950108|FG000|Overall Study|Adverse Event|1|||
157053956|NCT00489489|566950109|FG001|Overall Study|Adverse Event|1|||
157053957|NCT00489489|566950110|FG002|Overall Study|Adverse Event|1|||
157053958|NCT00489489|566950108|FG000|Overall Study|Protocol Violation|1|||
157053959|NCT00489489|566950109|FG001|Overall Study|Protocol Violation|0|||
157053960|NCT00489489|566950110|FG002|Overall Study|Protocol Violation|1|||
157053961|NCT00489489|566950108|FG000|Overall Study|Progressive disease|0|||
157053962|NCT00489489|566950109|FG001|Overall Study|Progressive disease|1|||
157053963|NCT00489489|566950110|FG002|Overall Study|Progressive disease|0|||
157053964|NCT00489489|566950108|FG000|Overall Study|Participant did not wish to continue|1|||
157053965|NCT00489489|566950109|FG001|Overall Study|Participant did not wish to continue|1|||
157053966|NCT00489489|566950110|FG002|Overall Study|Participant did not wish to continue|0|||
157177027|NCT02807844|567389704|FG006|Overall Study|Withdrawal by Subject|1|||
157177028|NCT02807844|567389705|FG007|Overall Study|Withdrawal by Subject|0|||
157177029|NCT02807844|567389706|FG008|Overall Study|Withdrawal by Subject|0|||
157177030|NCT02807844|567389707|FG009|Overall Study|Withdrawal by Subject|0|||
157053967|NCT00489489|566950108|FG000|Overall Study|Other than above|0|||
157053968|NCT00489489|566950109|FG001|Overall Study|Other than above|1|||
157053969|NCT00489489|566950110|FG002|Overall Study|Other than above|0|||
157053970|NCT03978130|566950115|FG000|Overall Study|Lost to Follow-up|13|||
157053971|NCT03978130|566950116|FG001|Overall Study|Lost to Follow-up|14|||
157053972|NCT03978130|566950115|FG000|Overall Study|Withdrawal by Subject|12|||
157053973|NCT03978130|566950116|FG001|Overall Study|Withdrawal by Subject|2|||
157053974|NCT03978130|566950115|FG000|Overall Study|Adverse Event|2|||
157177031|NCT02807844|567389698|FG000|Overall Study|Progressive disease|5|||
157177032|NCT02807844|567389699|FG001|Overall Study|Progressive disease|12|||
157177033|NCT02807844|567389700|FG002|Overall Study|Progressive disease|8|||
157053975|NCT03978130|566950116|FG001|Overall Study|Adverse Event|1|||
157177034|NCT02807844|567389701|FG003|Overall Study|Progressive disease|8|||
157177035|NCT02807844|567389702|FG004|Overall Study|Progressive disease|3|||
157177036|NCT02807844|567389703|FG005|Overall Study|Progressive disease|8|||
157177037|NCT02807844|567389704|FG006|Overall Study|Progressive disease|14|||
157177038|NCT02807844|567389705|FG007|Overall Study|Progressive disease|17|||
157177039|NCT02807844|567389706|FG008|Overall Study|Progressive disease|19|||
157177040|NCT02807844|567389707|FG009|Overall Study|Progressive disease|15|||
157177041|NCT02807844|567389698|FG000|Overall Study|Adverse Event|1|||
157177042|NCT02807844|567389699|FG001|Overall Study|Adverse Event|0|||
157177043|NCT02807844|567389700|FG002|Overall Study|Adverse Event|0|||
157177044|NCT02807844|567389701|FG003|Overall Study|Adverse Event|0|||
157177045|NCT02807844|567389702|FG004|Overall Study|Adverse Event|1|||
157177046|NCT02807844|567389703|FG005|Overall Study|Adverse Event|1|||
157177047|NCT02807844|567389704|FG006|Overall Study|Adverse Event|1|||
157177048|NCT02807844|567389705|FG007|Overall Study|Adverse Event|1|||
157177049|NCT02807844|567389706|FG008|Overall Study|Adverse Event|1|||
157177050|NCT02807844|567389707|FG009|Overall Study|Adverse Event|2|||
157177051|NCT00709124|567389708|FG000|Overall Study|Death|3|||
157177052|NCT00709124|567389709|FG001|Overall Study|Death|1|||
157177053|NCT00709124|567389708|FG000|Overall Study|encephalopathy; can't do assessment|1|||
157177054|NCT00709124|567389709|FG001|Overall Study|encephalopathy; can't do assessment|0|||
157177055|NCT00373490|567389710|FG000|Overall Study|Adverse Event|0|||
157177056|NCT00373490|567389711|FG001|Overall Study|Adverse Event|1|||
157177057|NCT00373490|567389710|FG000|Overall Study|Lack of Efficacy|9|||
157177058|NCT00373490|567389711|FG001|Overall Study|Lack of Efficacy|4|||
157177059|NCT00373490|567389710|FG000|Overall Study|Withdrawal by Subject|0|||
157177060|NCT00373490|567389711|FG001|Overall Study|Withdrawal by Subject|1|||
157177061|NCT00108953|567389718|FG000|Follow-up|Death|18|||
157177062|NCT00108953|567389719|FG001|Follow-up|Death|26|||
157177063|NCT00108953|567389718|FG000|Follow-up|Lost to Follow-up|1|||
156973869|NCT05044325|566659426|FG005|Part A:Treatment Period 1|Physician Decision|0|||
157177064|NCT00108953|567389719|FG001|Follow-up|Lost to Follow-up|1|||
156973870|NCT05044325|566659427|FG006|Part A:Treatment Period 1|Physician Decision|1|||
156973871|NCT05044325|566659428|FG007|Part A:Treatment Period 1|Physician Decision|0|||
156973872|NCT05044325|566659429|FG008|Part A:Treatment Period 1|Physician Decision|0|||
156973873|NCT05044325|566659430|FG009|Part A:Treatment Period 1|Physician Decision|0|||
156973874|NCT05044325|566659421|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973875|NCT05044325|566659422|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973876|NCT05044325|566659423|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
156973877|NCT05044325|566659424|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973878|NCT05044325|566659425|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973879|NCT05044325|566659426|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973880|NCT05044325|566659427|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973881|NCT05044325|566659428|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973882|NCT05044325|566659429|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973883|NCT05044325|566659430|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
156973884|NCT05044325|566659421|FG000|Part A:Treatment Period 2|Adverse Event|0|||
156973885|NCT05044325|566659422|FG001|Part A:Treatment Period 2|Adverse Event|1|||
156973886|NCT05044325|566659423|FG002|Part A:Treatment Period 2|Adverse Event|0|||
156973887|NCT05044325|566659424|FG003|Part A:Treatment Period 2|Adverse Event|0|||
156973888|NCT05044325|566659425|FG004|Part A:Treatment Period 2|Adverse Event|1|||
156973889|NCT05044325|566659426|FG005|Part A:Treatment Period 2|Adverse Event|1|||
156973890|NCT05044325|566659427|FG006|Part A:Treatment Period 2|Adverse Event|0|||
156973891|NCT05044325|566659428|FG007|Part A:Treatment Period 2|Adverse Event|0|||
156973892|NCT05044325|566659429|FG008|Part A:Treatment Period 2|Adverse Event|0|||
156973893|NCT05044325|566659430|FG009|Part A:Treatment Period 2|Adverse Event|0|||
156973894|NCT05044325|566659421|FG000|Part A:Treatment Period 2|Physician Decision|0|||
156973895|NCT05044325|566659422|FG001|Part A:Treatment Period 2|Physician Decision|0|||
156973896|NCT05044325|566659423|FG002|Part A:Treatment Period 2|Physician Decision|0|||
156973897|NCT05044325|566659424|FG003|Part A:Treatment Period 2|Physician Decision|0|||
156973898|NCT05044325|566659425|FG004|Part A:Treatment Period 2|Physician Decision|0|||
156973899|NCT05044325|566659426|FG005|Part A:Treatment Period 2|Physician Decision|1|||
156973900|NCT05044325|566659427|FG006|Part A:Treatment Period 2|Physician Decision|0|||
156973901|NCT05044325|566659428|FG007|Part A:Treatment Period 2|Physician Decision|0|||
156973902|NCT05044325|566659429|FG008|Part A:Treatment Period 2|Physician Decision|0|||
156973903|NCT05044325|566659430|FG009|Part A:Treatment Period 2|Physician Decision|0|||
156973904|NCT05044325|566659421|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973905|NCT05044325|566659422|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973906|NCT05044325|566659423|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973907|NCT05044325|566659424|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
157053976|NCT02880293|566950117|FG000|Overall Study|Inevaluable|5|||
157053977|NCT01038128|566950120|FG000|Overall Study|Lack of Efficacy|1|||
157177065|NCT00108953|567389718|FG000|Follow-up|Study terminated by sponsor|10|||
157177066|NCT00108953|567389719|FG001|Follow-up|Study terminated by sponsor|6|||
157177067|NCT00753688|567389720|FG000|Overall Study|Death|102|||
157053978|NCT01038128|566950120|FG000|Overall Study|Lost to Follow-up|1|||
157053979|NCT01038128|566950120|FG000|Overall Study|Withdrawal by Subject|2|||
157053980|NCT04203199|566950127|FG000|First Intervention Period|Lost to Follow-up|0|||
157053981|NCT04203199|566950128|FG001|First Intervention Period|Lost to Follow-up|1|||
157053982|NCT04203199|566950127|FG000|Second Intervention Period|Medication change|1|||
157053983|NCT04203199|566950128|FG001|Second Intervention Period|Medication change|0|||
157053984|NCT01838499|566950132|FG000|Overall Study|Protocol Violation|0|||
157053985|NCT01838499|566950133|FG001|Overall Study|Protocol Violation|1|||
157053986|NCT01838499|566950132|FG000|Overall Study|Lost to Follow-up|2|||
157053987|NCT01838499|566950133|FG001|Overall Study|Lost to Follow-up|4|||
157053988|NCT01838499|566950132|FG000|Overall Study|Lack of Efficacy|1|||
157053989|NCT01838499|566950133|FG001|Overall Study|Lack of Efficacy|2|||
157053990|NCT01838499|566950132|FG000|Overall Study|Adverse Event|2|||
157053991|NCT01838499|566950133|FG001|Overall Study|Adverse Event|1|||
157053992|NCT01838499|566950132|FG000|Overall Study|Withdrawal by Subject|19|||
157053993|NCT01838499|566950133|FG001|Overall Study|Withdrawal by Subject|9|||
157053994|NCT03614923|566950134|FG000|Overall Study|Withdrawal by Subject|2|||
157053995|NCT03614923|566950135|FG001|Overall Study|Withdrawal by Subject|1|||
157053996|NCT03614923|566950136|FG002|Overall Study|Withdrawal by Subject|1|||
157053997|NCT03614923|566950134|FG000|Overall Study|Adverse Event|0|||
157053998|NCT03614923|566950135|FG001|Overall Study|Adverse Event|2|||
157053999|NCT03614923|566950136|FG002|Overall Study|Adverse Event|1|||
157054000|NCT03614923|566950134|FG000|Overall Study|Lost to Follow-up|1|||
157054001|NCT03614923|566950135|FG001|Overall Study|Lost to Follow-up|0|||
157054002|NCT03614923|566950136|FG002|Overall Study|Lost to Follow-up|1|||
157054003|NCT03614923|566950134|FG000|Overall Study|Lack of Efficacy|2|||
157054004|NCT03614923|566950135|FG001|Overall Study|Lack of Efficacy|0|||
157054005|NCT03614923|566950136|FG002|Overall Study|Lack of Efficacy|1|||
157054006|NCT03614923|566950134|FG000|Overall Study|Non-compliance|0|||
157054007|NCT03614923|566950135|FG001|Overall Study|Non-compliance|1|||
157054008|NCT03614923|566950136|FG002|Overall Study|Non-compliance|0|||
157054009|NCT03614923|566950134|FG000|Overall Study|Other|0|||
157054010|NCT03614923|566950135|FG001|Overall Study|Other|1|||
157054011|NCT03614923|566950136|FG002|Overall Study|Other|1|||
157054012|NCT01136733|566950137|FG000|Phase 1b|Adverse Event|0|||
157054013|NCT01136733|566950138|FG001|Phase 1b|Adverse Event|3|||
157054014|NCT01136733|566950139|FG002|Phase 1b|Adverse Event|1|||
157054015|NCT01136733|566950140|FG003|Phase 1b|Adverse Event|0|||
157054016|NCT01136733|566950141|FG004|Phase 1b|Adverse Event|0|||
157054017|NCT01136733|566950142|FG005|Phase 1b|Adverse Event|0|||
157054018|NCT01136733|566950143|FG006|Phase 1b|Adverse Event|0|||
157054019|NCT01136733|566950137|FG000|Phase 1b|Participant Choice|0|||
157054020|NCT01136733|566950138|FG001|Phase 1b|Participant Choice|0|||
157054021|NCT01136733|566950139|FG002|Phase 1b|Participant Choice|1|||
157054022|NCT01136733|566950140|FG003|Phase 1b|Participant Choice|0|||
157054023|NCT01136733|566950141|FG004|Phase 1b|Participant Choice|0|||
157054024|NCT01136733|566950142|FG005|Phase 1b|Participant Choice|0|||
157054025|NCT01136733|566950143|FG006|Phase 1b|Participant Choice|0|||
157054026|NCT01136733|566950137|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
157054027|NCT01136733|566950138|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
157054028|NCT01136733|566950139|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
157054029|NCT01136733|566950140|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
157054030|NCT01136733|566950141|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
157054031|NCT01136733|566950142|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
157054032|NCT01136733|566950143|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
157054033|NCT01136733|566950137|FG000|Phase 1b|Clinical Progression|1|||
157054034|NCT01136733|566950138|FG001|Phase 1b|Clinical Progression|1|||
157054035|NCT01136733|566950139|FG002|Phase 1b|Clinical Progression|0|||
157054036|NCT01136733|566950140|FG003|Phase 1b|Clinical Progression|0|||
157054037|NCT01136733|566950141|FG004|Phase 1b|Clinical Progression|0|||
157054038|NCT01136733|566950142|FG005|Phase 1b|Clinical Progression|0|||
157054039|NCT01136733|566950143|FG006|Phase 1b|Clinical Progression|0|||
157177068|NCT00753688|567389721|FG001|Overall Study|Death|203|||
157177069|NCT00753688|567389720|FG000|Overall Study|Missing|4|||
157177070|NCT00753688|567389721|FG001|Overall Study|Missing|9|||
157054040|NCT01136733|566950137|FG000|Phase 2|Disease Progression|0|||
157054041|NCT01136733|566950138|FG001|Phase 2|Disease Progression|0|||
157054042|NCT01136733|566950139|FG002|Phase 2|Disease Progression|0|||
157054043|NCT01136733|566950140|FG003|Phase 2|Disease Progression|0|||
157054044|NCT01136733|566950141|FG004|Phase 2|Disease Progression|30|||
157177071|NCT00753688|567389720|FG000|Overall Study|Participant Withdrew Consent|2|||
157177072|NCT00753688|567389721|FG001|Overall Study|Participant Withdrew Consent|2|||
157054045|NCT01136733|566950142|FG005|Phase 2|Disease Progression|32|||
157054046|NCT01136733|566950143|FG006|Phase 2|Disease Progression|38|||
157054047|NCT01136733|566950137|FG000|Phase 2|Adverse Event|0|||
157054048|NCT01136733|566950138|FG001|Phase 2|Adverse Event|0|||
157054049|NCT01136733|566950139|FG002|Phase 2|Adverse Event|0|||
157054050|NCT01136733|566950140|FG003|Phase 2|Adverse Event|0|||
157054051|NCT01136733|566950141|FG004|Phase 2|Adverse Event|11|||
157054052|NCT01136733|566950142|FG005|Phase 2|Adverse Event|13|||
157054053|NCT01136733|566950143|FG006|Phase 2|Adverse Event|5|||
157054054|NCT01136733|566950137|FG000|Phase 2|Participant Choice|0|||
157054055|NCT01136733|566950138|FG001|Phase 2|Participant Choice|0|||
157054056|NCT01136733|566950139|FG002|Phase 2|Participant Choice|0|||
157229494|NCT02937701|567586467|FG004|Day 1 to Week 22|Death|0|||
157229495|NCT02937701|567586463|FG000|Day 1 to Week 22|Protocol Violation|1|||
157054057|NCT01136733|566950140|FG003|Phase 2|Participant Choice|0|||
157054058|NCT01136733|566950141|FG004|Phase 2|Participant Choice|3|||
157054059|NCT01136733|566950142|FG005|Phase 2|Participant Choice|0|||
157054060|NCT01136733|566950143|FG006|Phase 2|Participant Choice|1|||
157054061|NCT01136733|566950137|FG000|Phase 2|Administrative-Withdrew Consent|0|||
157054062|NCT01136733|566950138|FG001|Phase 2|Administrative-Withdrew Consent|0|||
157054063|NCT01136733|566950139|FG002|Phase 2|Administrative-Withdrew Consent|0|||
157054064|NCT01136733|566950140|FG003|Phase 2|Administrative-Withdrew Consent|0|||
157054065|NCT01136733|566950141|FG004|Phase 2|Administrative-Withdrew Consent|1|||
157054066|NCT01136733|566950142|FG005|Phase 2|Administrative-Withdrew Consent|0|||
157054067|NCT01136733|566950143|FG006|Phase 2|Administrative-Withdrew Consent|0|||
157054068|NCT01136733|566950137|FG000|Phase 2|Other|0|||
157229496|NCT02937701|567586464|FG001|Day 1 to Week 22|Protocol Violation|1|||
156973908|NCT05044325|566659425|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
156973909|NCT05044325|566659426|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973910|NCT05044325|566659427|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973911|NCT05044325|566659428|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973912|NCT05044325|566659429|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973913|NCT05044325|566659430|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
156973914|NCT01250119|566659433|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
156973915|NCT01250119|566659434|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
156973916|NCT01250119|566659433|FG000|Diagnostic Phase|Participants Not Tested|44|||
156973917|NCT01250119|566659434|FG001|Diagnostic Phase|Participants Not Tested|0|||
156973918|NCT01250119|566659433|FG000|Treatment Phase|Progressive Disease|0|||
156973919|NCT01250119|566659434|FG001|Treatment Phase|Progressive Disease|32|||
156973920|NCT01250119|566659433|FG000|Treatment Phase|Death|0|||
156973921|NCT01250119|566659434|FG001|Treatment Phase|Death|2|||
156973922|NCT01250119|566659433|FG000|Treatment Phase|Withdrawal by Subject|0|||
156973923|NCT01250119|566659434|FG001|Treatment Phase|Withdrawal by Subject|1|||
156973924|NCT01250119|566659433|FG000|Treatment Phase|Adverse Event|0|||
156973925|NCT01250119|566659434|FG001|Treatment Phase|Adverse Event|2|||
156973926|NCT01250119|566659433|FG000|Treatment Phase|Unknown reason|0|||
156973927|NCT01250119|566659434|FG001|Treatment Phase|Unknown reason|4|||
156973928|NCT05648357|566659437|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
156973929|NCT01559454|566659440|FG000|Overall Study|Lost to Follow-up|3|||
156973930|NCT01559454|566659441|FG001|Overall Study|Lost to Follow-up|2|||
156973931|NCT01559454|566659440|FG000|Overall Study|Withdrawal by Subject|0|||
156973932|NCT01559454|566659441|FG001|Overall Study|Withdrawal by Subject|1|||
156973933|NCT01559454|566659440|FG000|Overall Study|Physician Decision|0|||
156973934|NCT01559454|566659441|FG001|Overall Study|Physician Decision|1|||
156973935|NCT01559454|566659440|FG000|Overall Study|Protocol Violation|0|||
156973936|NCT01559454|566659441|FG001|Overall Study|Protocol Violation|1|||
156973937|NCT01559454|566659440|FG000|Overall Study|Lack of Efficacy|0|||
156973938|NCT01559454|566659441|FG001|Overall Study|Lack of Efficacy|1|||
156973939|NCT00462670|566659446|FG000|Overall Study|Adverse Event|3|||
156973940|NCT00462670|566659447|FG001|Overall Study|Adverse Event|5|||
156973941|NCT00462670|566659446|FG000|Overall Study|Lack of Efficacy|1|||
156973942|NCT00462670|566659447|FG001|Overall Study|Lack of Efficacy|0|||
156973943|NCT00462670|566659446|FG000|Overall Study|Protocol Violation|1|||
156973944|NCT00462670|566659447|FG001|Overall Study|Protocol Violation|0|||
156973945|NCT00462670|566659446|FG000|Overall Study|Resolution of signs and symptoms|0|||
156973946|NCT00462670|566659447|FG001|Overall Study|Resolution of signs and symptoms|2|||
156973947|NCT00482274|566659448|FG000|Overall Study|Adverse Event|1|||
156973948|NCT04887948|566659449|FG000|Overall Study|Death|1|||
156973949|NCT04887948|566659450|FG001|Overall Study|Death|0|||
156973950|NCT04887948|566659451|FG002|Overall Study|Death|0|||
156973951|NCT04887948|566659449|FG000|Overall Study|Lost to Follow-up|1|||
156973952|NCT04887948|566659450|FG001|Overall Study|Lost to Follow-up|0|||
157054069|NCT01136733|566950138|FG001|Phase 2|Other|0|||
157054070|NCT01136733|566950139|FG002|Phase 2|Other|0|||
156973953|NCT04887948|566659451|FG002|Overall Study|Lost to Follow-up|3|||
156973954|NCT04887948|566659449|FG000|Overall Study|Physician Decision|0|||
156973955|NCT04887948|566659450|FG001|Overall Study|Physician Decision|4|||
156973956|NCT04887948|566659451|FG002|Overall Study|Physician Decision|1|||
156973957|NCT04887948|566659449|FG000|Overall Study|Protocol Violation|1|||
156973958|NCT04887948|566659450|FG001|Overall Study|Protocol Violation|1|||
156973959|NCT04887948|566659451|FG002|Overall Study|Protocol Violation|0|||
156973960|NCT04887948|566659449|FG000|Overall Study|Withdrawal by Subject|0|||
156973961|NCT04887948|566659450|FG001|Overall Study|Withdrawal by Subject|6|||
156973962|NCT04887948|566659451|FG002|Overall Study|Withdrawal by Subject|1|||
157054071|NCT01136733|566950140|FG003|Phase 2|Other|0|||
157054072|NCT01136733|566950141|FG004|Phase 2|Other|6|||
157229497|NCT02937701|567586465|FG002|Day 1 to Week 22|Protocol Violation|0|||
157177073|NCT00753688|567389720|FG000|Overall Study|Ongoing - in Follow-up|15|||
157177074|NCT00753688|567389721|FG001|Overall Study|Ongoing - in Follow-up|31|||
157177075|NCT00753688|567389720|FG000|Overall Study|Adverse Event|0|||
157177076|NCT00753688|567389721|FG001|Overall Study|Adverse Event|1|||
156973963|NCT04887948|566659449|FG000|Overall Study|No longer met eligibility criteria|1|||
156973964|NCT04887948|566659450|FG001|Overall Study|No longer met eligibility criteria|2|||
156973965|NCT04887948|566659451|FG002|Overall Study|No longer met eligibility criteria|1|||
156973966|NCT04887948|566659449|FG000|Overall Study|Other|2|||
156973967|NCT04887948|566659450|FG001|Overall Study|Other|1|||
156973968|NCT04887948|566659451|FG002|Overall Study|Other|1|||
156973969|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
156973970|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
156973971|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Adverse Event|2|||
156973972|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Adverse Event|5|||
156973973|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
156973974|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
156973975|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
156973976|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
156973977|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Randomized by error|0|||
156973978|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Randomized by error|5|||
156973979|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
156973980|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
156973981|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
156973982|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
156973983|NCT02948959|566659452|FG000|52 Weeks Treatment Period|Change of residence location|0|||
156973984|NCT02948959|566659453|FG001|52 Weeks Treatment Period|Change of residence location|1|||
156973985|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
156973986|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
156973987|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
156973988|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
156973989|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
156973990|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
156973991|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
156973992|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
156973993|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
156973994|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
156973995|NCT02948959|566659452|FG000|12 Weeks Follow-up Period|Study site closure|1|||
156973996|NCT02948959|566659453|FG001|12 Weeks Follow-up Period|Study site closure|0|||
156973997|NCT00787319|566659454|FG000|Overall Study|Lost to Follow-up|2|||
156973998|NCT00787319|566659454|FG000|Overall Study|Withdrawal by Subject|15|||
156973999|NCT00787319|566659454|FG000|Overall Study|Adverse Event|3|||
156974000|NCT00787319|566659454|FG000|Overall Study|Objective progression or relapse|30|||
156974001|NCT00787319|566659454|FG000|Overall Study|Lack of Efficacy|1|||
156974002|NCT00787319|566659454|FG000|Overall Study|Budget exhausted/exceeded|1|||
156974003|NCT00787319|566659454|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
156974004|NCT00787319|566659454|FG000|Overall Study|No health insurance reimbursement|2|||
156974005|NCT00787319|566659454|FG000|Overall Study|Stabilized disease findings|3|||
156974006|NCT00787319|566659454|FG000|Overall Study|Inactive disease|5|||
156974007|NCT02312856|566659455|FG000|Overall Study|Death|1|||
156974008|NCT02312856|566659455|FG000|Overall Study|Lost to Follow-up|3|||
156974009|NCT01932294|566659456|FG000|Overall Study|Death|43|||
156974010|NCT01932294|566659456|FG000|Overall Study|Lost to Follow-up|8|||
156974011|NCT01932294|566659456|FG000|Overall Study|VAD Implantation|20|||
156974012|NCT01932294|566659456|FG000|Overall Study|Heart Transplantation|16|||
156974013|NCT01932294|566659456|FG000|Overall Study|Transferred to other hospitals|12|||
156974014|NCT04415151|566659457|FG000|Overall Study|Death|1|||
156974015|NCT04415151|566659458|FG001|Overall Study|Death|1|||
156974016|NCT04415151|566659457|FG000|Overall Study|Withdrawal by Subject|1|||
156974017|NCT04415151|566659458|FG001|Overall Study|Withdrawal by Subject|0|||
156974018|NCT00409786|566659461|FG000|Overall Study|Withdrawal by Subject|3|||
156974019|NCT00638235|566659462|FG000|Overall Study|Lost to Follow-up|31|||
156974020|NCT00638235|566659463|FG001|Overall Study|Lost to Follow-up|3|||
156974021|NCT00638235|566659464|FG002|Overall Study|Lost to Follow-up|18|||
156974022|NCT00638235|566659465|FG003|Overall Study|Lost to Follow-up|10|||
156974023|NCT00638235|566659466|FG004|Overall Study|Lost to Follow-up|13|||
156974024|NCT00638235|566659467|FG005|Overall Study|Lost to Follow-up|26|||
156974025|NCT00638235|566659468|FG006|Overall Study|Lost to Follow-up|0|||
156974026|NCT00638235|566659469|FG007|Overall Study|Lost to Follow-up|1|||
156974027|NCT00638235|566659470|FG008|Overall Study|Lost to Follow-up|18|||
156974028|NCT03075904|566659475|FG000|Overall Study|Physician Decision|3|||
156974029|NCT03075904|566659475|FG000|Overall Study|Need for Medication not Permitted|1|||
156974030|NCT00597714|566659476|FG000|Overall Study|Death|56|||
156974031|NCT00597714|566659477|FG001|Overall Study|Death|46|||
156974032|NCT00597714|566659478|FG002|Overall Study|Death|0|||
157177077|NCT02999100|567389722|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
157177078|NCT02999100|567389723|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
157177079|NCT02999100|567389724|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
157177080|NCT02999100|567389725|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
157177081|NCT02999100|567389726|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
157177082|NCT02999100|567389727|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
157177083|NCT02999100|567389722|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
157177084|NCT02999100|567389723|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
157177085|NCT02999100|567389724|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
157177086|NCT02999100|567389725|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
157177087|NCT02999100|567389726|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
157177088|NCT02999100|567389727|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
157177089|NCT02999100|567389722|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
157177090|NCT02999100|567389723|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
157177091|NCT02999100|567389724|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
157177092|NCT02999100|567389725|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
157177093|NCT02999100|567389726|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
157177094|NCT02999100|567389727|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
157177095|NCT02228564|567389728|FG000|Overall Study|Withdrawal by Subject|10|||
157177096|NCT02228564|567389728|FG000|Overall Study|Death|11|||
157177097|NCT02228564|567389728|FG000|Overall Study|Physician Decision|5|||
157177098|NCT02228564|567389728|FG000|Overall Study|Lost to Follow-up|17|||
157177099|NCT02228564|567389728|FG000|Overall Study|Other|6|||
157177100|NCT02633046|567389734|FG000|Overall Study|Adverse Event|8|||
157177101|NCT02633046|567389734|FG000|Overall Study|Physician Decision|7|||
157177102|NCT02633046|567389734|FG000|Overall Study|Withdrawal by Subject|8|||
157177103|NCT02633046|567389734|FG000|Overall Study|Increased proteinuria|2|||
157177104|NCT02633046|567389734|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
157177105|NCT02633046|567389734|FG000|Overall Study|Mutual decision patient and physician|1|||
157177106|NCT02142504|567389735|FG000|Overall Study|Protocol Violation|2|||
156974033|NCT00597714|566659476|FG000|Overall Study|Recipient death|0|||
156974034|NCT00597714|566659477|FG001|Overall Study|Recipient death|0|||
156974035|NCT00597714|566659478|FG002|Overall Study|Recipient death|10|||
156974036|NCT00539643|566659485|FG000|Overall Study|Adverse Event|1|||
156974037|NCT00539643|566659486|FG001|Overall Study|Adverse Event|0|||
156974038|NCT00539643|566659485|FG000|Overall Study|Death|2|||
156974039|NCT00539643|566659486|FG001|Overall Study|Death|1|||
156974040|NCT00539643|566659485|FG000|Overall Study|Physician Decision|3|||
156974041|NCT00539643|566659486|FG001|Overall Study|Physician Decision|1|||
156974042|NCT00539643|566659485|FG000|Overall Study|Withdrawal by Subject|0|||
156974043|NCT00539643|566659486|FG001|Overall Study|Withdrawal by Subject|1|||
156974044|NCT02228395|566659487|FG000|First Intervention Period|No longer willing to participate|1|||
156974045|NCT02228395|566659488|FG001|First Intervention Period|No longer willing to participate|0|||
156974046|NCT02228395|566659489|FG002|First Intervention Period|No longer willing to participate|0|||
156974047|NCT02228395|566659487|FG000|First Intervention Period|Unable to comply with study dates|0|||
156974048|NCT02228395|566659488|FG001|First Intervention Period|Unable to comply with study dates|1|||
156974049|NCT02228395|566659489|FG002|First Intervention Period|Unable to comply with study dates|1|||
156974050|NCT01480596|566659492|FG000|Overall Study|Adverse Event|3|||
156974051|NCT01480596|566659493|FG001|Overall Study|Adverse Event|0|||
156974052|NCT01480596|566659492|FG000|Overall Study|MG exacerbation or change in medication|2|||
156974053|NCT01480596|566659493|FG001|Overall Study|MG exacerbation or change in medication|2|||
156974054|NCT02917265|566659500|FG000|Overall Study|Physician Decision|1|||
156974055|NCT02917265|566659501|FG001|Overall Study|Physician Decision|0|||
156974056|NCT02917265|566659500|FG000|Overall Study|Withdrawal by Subject|1|||
156974057|NCT02917265|566659501|FG001|Overall Study|Withdrawal by Subject|0|||
156974058|NCT00979602|566659514|FG000|Overall Study|Serious Adverse Event|5|||
156974059|NCT00979602|566659515|FG001|Overall Study|Serious Adverse Event|3|||
156974060|NCT00979602|566659514|FG000|Overall Study|Protocol Violation|3|||
156974061|NCT00979602|566659515|FG001|Overall Study|Protocol Violation|0|||
156974062|NCT00979602|566659514|FG000|Overall Study|Withdrawal by Subject|31|||
156974063|NCT00979602|566659515|FG001|Overall Study|Withdrawal by Subject|25|||
156974064|NCT00979602|566659514|FG000|Overall Study|Lost to Follow-up|100|||
156974065|NCT00979602|566659515|FG001|Overall Study|Lost to Follow-up|96|||
156974066|NCT00979602|566659514|FG000|Overall Study|Migrated/moved from study area|3|||
156974067|NCT00979602|566659515|FG001|Overall Study|Migrated/moved from study area|6|||
156974068|NCT00979602|566659514|FG000|Overall Study|Others|3|||
156974069|NCT00979602|566659515|FG001|Overall Study|Others|3|||
156974070|NCT02904902|566659516|FG000|Overall Study|Withdrawal by Subject|1|||
157177107|NCT02142504|567389736|FG001|Overall Study|Protocol Violation|1|||
157177108|NCT02142504|567389737|FG002|Overall Study|Protocol Violation|2|||
156974071|NCT01719237|566659520|FG000|Overall Study|Physician Decision|0|||
156974072|NCT01719237|566659521|FG001|Overall Study|Physician Decision|1|||
156974073|NCT02712398|566659522|FG000|Overall Study|Withdrawal by Subject|6|||
156974074|NCT02712398|566659522|FG000|Overall Study|Lost to Follow-up|6|||
157054073|NCT01136733|566950142|FG005|Phase 2|Other|7|||
157054074|NCT01136733|566950143|FG006|Phase 2|Other|6|||
157054075|NCT01882088|566950145|FG000|Overall Study|Intolerance of esophageal manometry|1|||
157054076|NCT01882088|566950145|FG000|Overall Study|no possibility to place the catheter|1|||
157054077|NCT01882088|566950145|FG000|Overall Study|Protocol Violation|1|||
157054078|NCT01882088|566950145|FG000|Overall Study|inadequate pH-impedance tracings|2|||
157054079|NCT02186015|566950146|FG000|Overall Study|Physician Decision|1|||
157054080|NCT02186015|566950147|FG001|Overall Study|Physician Decision|0|||
157054081|NCT02069366|566950150|FG000|Overall Study|Lost to Follow-up|0|||
157054082|NCT02069366|566950151|FG001|Overall Study|Lost to Follow-up|0|||
157054083|NCT02069366|566950152|FG002|Overall Study|Lost to Follow-up|1|||
157054084|NCT02069366|566950153|FG003|Overall Study|Lost to Follow-up|0|||
157054085|NCT02069366|566950154|FG004|Overall Study|Lost to Follow-up|0|||
157054086|NCT02069366|566950155|FG005|Overall Study|Lost to Follow-up|2|||
157054087|NCT02069366|566950150|FG000|Overall Study|Protocol Violation|0|||
157054088|NCT02069366|566950151|FG001|Overall Study|Protocol Violation|0|||
157054089|NCT02069366|566950152|FG002|Overall Study|Protocol Violation|1|||
157054090|NCT02069366|566950153|FG003|Overall Study|Protocol Violation|0|||
157054091|NCT02069366|566950154|FG004|Overall Study|Protocol Violation|0|||
157054092|NCT02069366|566950155|FG005|Overall Study|Protocol Violation|0|||
157054093|NCT02069366|566950150|FG000|Overall Study|Withdrawal by Subject|1|||
157054094|NCT02069366|566950151|FG001|Overall Study|Withdrawal by Subject|0|||
157054095|NCT02069366|566950152|FG002|Overall Study|Withdrawal by Subject|1|||
157054096|NCT02069366|566950153|FG003|Overall Study|Withdrawal by Subject|2|||
157054097|NCT02069366|566950154|FG004|Overall Study|Withdrawal by Subject|0|||
157054098|NCT02069366|566950155|FG005|Overall Study|Withdrawal by Subject|0|||
157054099|NCT00168805|566950158|FG000|Overall Study|Adverse Event|7|||
157054100|NCT00168805|566950159|FG001|Overall Study|Adverse Event|11|||
157054101|NCT00168805|566950160|FG002|Overall Study|Adverse Event|16|||
157054102|NCT00168805|566950158|FG000|Overall Study|Protocol Violation|12|||
157054103|NCT00168805|566950159|FG001|Overall Study|Protocol Violation|11|||
157054104|NCT00168805|566950160|FG002|Overall Study|Protocol Violation|8|||
157054105|NCT00168805|566950158|FG000|Overall Study|Lost to Follow-up|12|||
157177109|NCT02142504|567389735|FG000|Overall Study|Adverse Event|2|||
157177110|NCT02142504|567389736|FG001|Overall Study|Adverse Event|3|||
157177111|NCT02142504|567389737|FG002|Overall Study|Adverse Event|4|||
157177112|NCT02142504|567389735|FG000|Overall Study|Lost to Follow-up|12|||
157177113|NCT02142504|567389736|FG001|Overall Study|Lost to Follow-up|19|||
157177114|NCT02142504|567389737|FG002|Overall Study|Lost to Follow-up|17|||
157177115|NCT02142504|567389735|FG000|Overall Study|Withdrawal by Subject|7|||
157177116|NCT02142504|567389736|FG001|Overall Study|Withdrawal by Subject|9|||
157177117|NCT02142504|567389737|FG002|Overall Study|Withdrawal by Subject|11|||
157177118|NCT02142504|567389735|FG000|Overall Study|Pregnancy|4|||
157177119|NCT02142504|567389736|FG001|Overall Study|Pregnancy|4|||
157177120|NCT02142504|567389737|FG002|Overall Study|Pregnancy|2|||
157177121|NCT02142504|567389735|FG000|Overall Study|Physician Decision|0|||
157177122|NCT02142504|567389736|FG001|Overall Study|Physician Decision|1|||
157177123|NCT02142504|567389737|FG002|Overall Study|Physician Decision|3|||
157177124|NCT02142504|567389735|FG000|Overall Study|Reason Not Specified|4|||
157177125|NCT02142504|567389736|FG001|Overall Study|Reason Not Specified|5|||
157177126|NCT02142504|567389737|FG002|Overall Study|Reason Not Specified|4|||
157177127|NCT01998399|567389744|FG000|Overall Study|Lost to Follow-up|1|||
157177128|NCT01998399|567389745|FG001|Overall Study|Lost to Follow-up|3|||
157177129|NCT01998399|567389744|FG000|Overall Study|Death|4|||
157177130|NCT01998399|567389745|FG001|Overall Study|Death|2|||
157177131|NCT01998399|567389744|FG000|Overall Study|Study stopped before dosing completed|3|||
157177132|NCT01998399|567389745|FG001|Overall Study|Study stopped before dosing completed|3|||
157177133|NCT01998399|567389744|FG000|Overall Study|Withdrawal by Subject|0|||
157177134|NCT01998399|567389745|FG001|Overall Study|Withdrawal by Subject|1|||
157054106|NCT00168805|566950159|FG001|Overall Study|Lost to Follow-up|17|||
157177135|NCT04114539|567389746|FG000|Overall Study|Adverse Event|14|||
157177136|NCT04114539|567389746|FG000|Overall Study|Lost to Follow-up|2|||
157054107|NCT00168805|566950160|FG002|Overall Study|Lost to Follow-up|11|||
157054108|NCT00168805|566950158|FG000|Overall Study|Withdrawal by Subject|16|||
157054109|NCT00168805|566950159|FG001|Overall Study|Withdrawal by Subject|18|||
157177137|NCT04114539|567389746|FG000|Overall Study|Non-compliance with Protocol|2|||
157177138|NCT04114539|567389746|FG000|Overall Study|Non-compliance with Study Drug|1|||
157177139|NCT04114539|567389746|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
157177140|NCT04114539|567389746|FG000|Overall Study|Withdrew consent|10|||
157177141|NCT04114539|567389746|FG000|Overall Study|Others not specified|5|||
157177142|NCT04114539|567389746|FG000|Overall Study|Investigator Decision|2|||
157177143|NCT00617591|567389747|FG000|Overall Study|Withdrew consent during Induction|4|||
157177144|NCT00617591|567389747|FG000|Overall Study|Withdrew consent during Maintenance|6|||
157054110|NCT00168805|566950160|FG002|Overall Study|Withdrawal by Subject|21|||
157054111|NCT00168805|566950158|FG000|Overall Study|Other|24|||
157054112|NCT00168805|566950159|FG001|Overall Study|Other|21|||
157054113|NCT00168805|566950160|FG002|Overall Study|Other|22|||
157054114|NCT00168805|566950158|FG000|Treatment|Adverse Event|25|||
157054115|NCT00168805|566950159|FG001|Treatment|Adverse Event|26|||
157229498|NCT02937701|567586466|FG003|Day 1 to Week 22|Protocol Violation|0|||
157229499|NCT02937701|567586467|FG004|Day 1 to Week 22|Protocol Violation|0|||
157229500|NCT02937701|567586463|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
157229501|NCT02937701|567586464|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
157229502|NCT02937701|567586465|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
157229503|NCT02937701|567586466|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
157229504|NCT02937701|567586467|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
157229505|NCT02937701|567586463|FG000|Day 1 to Week 22|Physician Decision|2|||
157229506|NCT02937701|567586464|FG001|Day 1 to Week 22|Physician Decision|0|||
157229507|NCT02937701|567586465|FG002|Day 1 to Week 22|Physician Decision|0|||
157229508|NCT02937701|567586466|FG003|Day 1 to Week 22|Physician Decision|0|||
157229509|NCT02937701|567586467|FG004|Day 1 to Week 22|Physician Decision|0|||
157229510|NCT02937701|567586463|FG000|Day 1 to Week 22|Other|1|||
157229511|NCT02937701|567586464|FG001|Day 1 to Week 22|Other|0|||
157229512|NCT02937701|567586465|FG002|Day 1 to Week 22|Other|0|||
157229513|NCT02937701|567586466|FG003|Day 1 to Week 22|Other|0|||
157229514|NCT02937701|567586467|FG004|Day 1 to Week 22|Other|0|||
157229515|NCT02937701|567586463|FG000|Week 22 to Week 50|Adverse Event|0|||
157229516|NCT02937701|567586464|FG001|Week 22 to Week 50|Adverse Event|0|||
157229517|NCT02937701|567586465|FG002|Week 22 to Week 50|Adverse Event|10|||
157229518|NCT02937701|567586466|FG003|Week 22 to Week 50|Adverse Event|3|||
157229519|NCT02937701|567586467|FG004|Week 22 to Week 50|Adverse Event|3|||
157229520|NCT02937701|567586463|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
157229521|NCT02937701|567586464|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
157229522|NCT02937701|567586465|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
157054116|NCT00168805|566950160|FG002|Treatment|Adverse Event|32|||
157054117|NCT00168805|566950158|FG000|Treatment|Protocol Violation|3|||
157054118|NCT00168805|566950159|FG001|Treatment|Protocol Violation|5|||
157054119|NCT00168805|566950160|FG002|Treatment|Protocol Violation|5|||
157054120|NCT00168805|566950158|FG000|Treatment|Withdrawal by Subject|3|||
157054121|NCT00168805|566950159|FG001|Treatment|Withdrawal by Subject|7|||
157054122|NCT00168805|566950160|FG002|Treatment|Withdrawal by Subject|8|||
157054123|NCT00168805|566950158|FG000|Treatment|Other|18|||
157054124|NCT00168805|566950159|FG001|Treatment|Other|18|||
157054125|NCT00168805|566950160|FG002|Treatment|Other|17|||
157054126|NCT01837719|566950161|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
157054127|NCT01837719|566950161|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
157054128|NCT02023099|566950162|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
157054129|NCT02023099|566950163|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
157054130|NCT02023099|566950164|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
157054131|NCT02023099|566950162|FG000|Overall Study|Withdrawn Consent|3|||
157054132|NCT02023099|566950163|FG001|Overall Study|Withdrawn Consent|0|||
157054133|NCT02023099|566950164|FG002|Overall Study|Withdrawn Consent|1|||
157054134|NCT02023099|566950162|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
157054135|NCT02023099|566950163|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
157054136|NCT02023099|566950164|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
157054137|NCT02062827|566950165|FG000|Overall Study|Death|1|||
157054138|NCT02062827|566950166|FG001|Overall Study|Death|0|||
157054139|NCT02062827|566950167|FG002|Overall Study|Death|0|||
157054140|NCT02062827|566950168|FG003|Overall Study|Death|0|||
157054141|NCT02062827|566950169|FG004|Overall Study|Death|0|||
157054142|NCT02062827|566950170|FG005|Overall Study|Death|0|||
157054143|NCT02062827|566950171|FG006|Overall Study|Death|0|||
157054144|NCT02062827|566950172|FG007|Overall Study|Death|0|||
157054145|NCT02062827|566950165|FG000|Overall Study|Withdrawal by Subject|3|||
157054146|NCT02062827|566950166|FG001|Overall Study|Withdrawal by Subject|1|||
157054147|NCT02062827|566950167|FG002|Overall Study|Withdrawal by Subject|1|||
157054148|NCT02062827|566950168|FG003|Overall Study|Withdrawal by Subject|2|||
157054149|NCT02062827|566950169|FG004|Overall Study|Withdrawal by Subject|6|||
157054150|NCT02062827|566950170|FG005|Overall Study|Withdrawal by Subject|0|||
157054151|NCT02062827|566950171|FG006|Overall Study|Withdrawal by Subject|5|||
157229523|NCT02937701|567586466|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
157229524|NCT02937701|567586467|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
157229525|NCT02937701|567586463|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
157054152|NCT02062827|566950172|FG007|Overall Study|Withdrawal by Subject|0|||
157054153|NCT02062827|566950165|FG000|Overall Study|Screen Fail|0|||
157054154|NCT02062827|566950166|FG001|Overall Study|Screen Fail|0|||
157054155|NCT02062827|566950167|FG002|Overall Study|Screen Fail|0|||
157054156|NCT02062827|566950168|FG003|Overall Study|Screen Fail|0|||
157054157|NCT02062827|566950169|FG004|Overall Study|Screen Fail|0|||
157229526|NCT02937701|567586464|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
157054158|NCT02062827|566950170|FG005|Overall Study|Screen Fail|0|||
157054159|NCT02062827|566950171|FG006|Overall Study|Screen Fail|0|||
157054160|NCT02062827|566950172|FG007|Overall Study|Screen Fail|8|||
157054161|NCT03708744|566950173|FG000|Overall Study|Withdrawal by Subject|0|||
157054162|NCT03708744|566950174|FG001|Overall Study|Withdrawal by Subject|0|||
157054163|NCT03708744|566950175|FG002|Overall Study|Withdrawal by Subject|1|||
157229527|NCT02937701|567586465|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
157054164|NCT03708744|566950176|FG003|Overall Study|Withdrawal by Subject|0|||
157054165|NCT02604199|566950178|FG000|Overall Study|Pregnancy|0|||
157054166|NCT02604199|566950179|FG001|Overall Study|Pregnancy|0|||
157054167|NCT02604199|566950180|FG002|Overall Study|Pregnancy|0|||
157054168|NCT02604199|566950181|FG003|Overall Study|Pregnancy|1|||
157054169|NCT02604199|566950178|FG000|Overall Study|Study terminated by sponsor|0|||
157054170|NCT02604199|566950179|FG001|Overall Study|Study terminated by sponsor|2|||
157054171|NCT02604199|566950180|FG002|Overall Study|Study terminated by sponsor|0|||
157054172|NCT02604199|566950181|FG003|Overall Study|Study terminated by sponsor|2|||
157054173|NCT02604199|566950178|FG000|Overall Study|Withdrawal by Subject|0|||
157054174|NCT02604199|566950179|FG001|Overall Study|Withdrawal by Subject|1|||
157054175|NCT02604199|566950180|FG002|Overall Study|Withdrawal by Subject|0|||
157054176|NCT02604199|566950181|FG003|Overall Study|Withdrawal by Subject|0|||
157054177|NCT00460577|566950186|FG000|Overall Study|Protocol Violation|2|||
157054178|NCT00460577|566950187|FG001|Overall Study|Protocol Violation|6|||
157054179|NCT02213458|566950188|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
157054180|NCT02213458|566950189|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
157054181|NCT02213458|566950188|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
157054182|NCT02213458|566950189|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
157054183|NCT02213458|566950188|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
157054184|NCT02213458|566950189|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
157054185|NCT02213458|566950188|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
157054186|NCT02213458|566950189|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
157054187|NCT02213458|566950188|FG000|Overall Study|Refused re-consent|6|||
157054188|NCT02213458|566950189|FG001|Overall Study|Refused re-consent|0|||
157054189|NCT02213458|566950188|FG000|Overall Study|Lost to Follow-up|2|||
157054190|NCT02213458|566950189|FG001|Overall Study|Lost to Follow-up|2|||
157054191|NCT02213458|566950188|FG000|Overall Study|Withdrawal by Subject|26|||
157054192|NCT02213458|566950189|FG001|Overall Study|Withdrawal by Subject|8|||
157054193|NCT04043806|566950190|FG000|Overall Study|Commercial drug is available for participants|13|||
157054194|NCT04043806|566950190|FG000|Overall Study|Physician Decision|2|||
157054195|NCT04043806|566950190|FG000|Overall Study|Other|12|||
157054196|NCT04043806|566950190|FG000|Overall Study|Adverse Event|2|||
157054197|NCT04043806|566950190|FG000|Overall Study|Lost to Follow-up|6|||
157054198|NCT04043806|566950190|FG000|Overall Study|Other non-compliance|2|||
157054199|NCT04043806|566950190|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
157054200|NCT04043806|566950190|FG000|Overall Study|Never Dosed|1|||
157054201|NCT01622088|566950191|FG000|Overall Study|Adverse Event|20|||
157054202|NCT01622088|566950191|FG000|Overall Study|Lost to Follow-up|1|||
157054203|NCT01622088|566950191|FG000|Overall Study|Withdrawal by Subject|20|||
157054204|NCT01622088|566950191|FG000|Overall Study|Investigator Decision|1|||
157054205|NCT01622088|566950191|FG000|Overall Study|Death|53|||
157054206|NCT01622088|566950191|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
157054207|NCT04362176|566950198|FG000|Overall Study|Lost to Follow-up|5|||
157054208|NCT04362176|566950199|FG001|Overall Study|Lost to Follow-up|8|||
157054209|NCT04362176|566950198|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
157054210|NCT04362176|566950199|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
157054211|NCT06312566|566950200|FG000|Overall Study|Protocol Violation|0|||
157054212|NCT06312566|566950201|FG001|Overall Study|Protocol Violation|1|||
157054213|NCT02260154|566950205|FG000|Overall Study|Screening failure|2|||
157054214|NCT01885559|566950206|FG000|Overall Study|Lost to Follow-up|15|||
157054215|NCT01885559|566950207|FG001|Overall Study|Lost to Follow-up|16|||
157054216|NCT01885559|566950206|FG000|Overall Study|Less than full participation|9|||
157054217|NCT01885559|566950207|FG001|Overall Study|Less than full participation|19|||
157054218|NCT01885559|566950206|FG000|Overall Study|Protocol Violation|0|||
157054219|NCT01885559|566950207|FG001|Overall Study|Protocol Violation|1|||
157054220|NCT00645411|566950208|FG000|Overall Study|Adverse Event|0|||
157054221|NCT00645411|566950209|FG001|Overall Study|Adverse Event|0|||
157054222|NCT00645411|566950210|FG002|Overall Study|Adverse Event|0|||
157054223|NCT00645411|566950211|FG003|Overall Study|Adverse Event|2|||
157054224|NCT00645411|566950208|FG000|Overall Study|Withdrawal by Subject|2|||
157054225|NCT00645411|566950209|FG001|Overall Study|Withdrawal by Subject|1|||
157054226|NCT00645411|566950210|FG002|Overall Study|Withdrawal by Subject|19|||
157177145|NCT01455415|567389749|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
157177146|NCT01455415|567389750|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
157177147|NCT01455415|567389749|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
157054227|NCT00645411|566950211|FG003|Overall Study|Withdrawal by Subject|21|||
157054228|NCT00645411|566950208|FG000|Overall Study|Lost to Follow-up|10|||
157054229|NCT00645411|566950209|FG001|Overall Study|Lost to Follow-up|5|||
157054230|NCT00645411|566950210|FG002|Overall Study|Lost to Follow-up|124|||
157054231|NCT00645411|566950211|FG003|Overall Study|Lost to Follow-up|75|||
157054232|NCT00645411|566950208|FG000|Overall Study|Protocol Violation|1|||
157054233|NCT00645411|566950209|FG001|Overall Study|Protocol Violation|0|||
157054234|NCT00645411|566950210|FG002|Overall Study|Protocol Violation|1|||
157054235|NCT00645411|566950211|FG003|Overall Study|Protocol Violation|0|||
156974075|NCT02712398|566659522|FG000|Overall Study|Sponsor Decision|1|||
156974076|NCT02712398|566659522|FG000|Overall Study|Physician Decision|1|||
156974077|NCT02712398|566659522|FG000|Overall Study|Death|2|||
156974078|NCT02712398|566659522|FG000|Overall Study|Re-operation|21|||
156974079|NCT00453102|566659526|FG000|Overall Study|Withdrawal by Subject|2|||
156974080|NCT05400746|566659531|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
156974081|NCT05400746|566659532|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
156974082|NCT05400746|566659533|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
156974083|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
156974084|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
156974085|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
156974086|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
156974087|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
156974088|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
156974089|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
156974090|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Physician Decision|4|||
156974091|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Physician Decision|1|||
156974092|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Physician Decision|3|||
156974093|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Physician Decision|0|||
156974094|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Physician Decision|0|||
156974095|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Physician Decision|1|||
156974096|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Physician Decision|0|||
156974097|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Other|0|||
156974098|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Other|1|||
156974099|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Other|0|||
156974100|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Other|0|||
156974101|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Other|0|||
156974102|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Other|0|||
156974103|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Other|0|||
156974104|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974105|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974106|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974107|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974108|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974109|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
156974110|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
156974111|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
156974112|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
156974113|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
156974114|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
156974115|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
156974116|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
156974117|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
156974118|NCT05375955|566659534|FG000|Treatment (12 Weeks)|Pregnancy|0|||
156974119|NCT05375955|566659535|FG001|Treatment (12 Weeks)|Pregnancy|0|||
156974120|NCT05375955|566659536|FG002|Treatment (12 Weeks)|Pregnancy|1|||
156974121|NCT05375955|566659537|FG003|Treatment (12 Weeks)|Pregnancy|0|||
156974122|NCT05375955|566659538|FG004|Treatment (12 Weeks)|Pregnancy|0|||
156974123|NCT05375955|566659539|FG005|Treatment (12 Weeks)|Pregnancy|0|||
156974124|NCT05375955|566659540|FG006|Treatment (12 Weeks)|Pregnancy|0|||
156974125|NCT05375955|566659534|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974126|NCT05375955|566659535|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974127|NCT05375955|566659536|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
156974128|NCT05375955|566659537|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974129|NCT05375955|566659538|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974130|NCT05375955|566659539|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974131|NCT05375955|566659540|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
156974132|NCT05375955|566659534|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156974133|NCT05375955|566659535|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156974134|NCT05375955|566659536|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156974135|NCT05375955|566659537|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156974136|NCT05375955|566659538|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156974137|NCT05375955|566659539|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
156974138|NCT05375955|566659540|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
156974139|NCT05375955|566659534|FG000|Follow-up (up to 5 Weeks)|Other|0|||
156974140|NCT05375955|566659535|FG001|Follow-up (up to 5 Weeks)|Other|1|||
156974141|NCT05375955|566659536|FG002|Follow-up (up to 5 Weeks)|Other|0|||
156974142|NCT05375955|566659537|FG003|Follow-up (up to 5 Weeks)|Other|0|||
156974143|NCT05375955|566659538|FG004|Follow-up (up to 5 Weeks)|Other|0|||
156974144|NCT05375955|566659539|FG005|Follow-up (up to 5 Weeks)|Other|0|||
156974145|NCT05375955|566659540|FG006|Follow-up (up to 5 Weeks)|Other|0|||
156974146|NCT05375955|566659534|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
156974147|NCT05375955|566659535|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156974148|NCT05375955|566659536|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
157054236|NCT00645411|566950208|FG000|Overall Study|Inappropriate enrollment|0|||
157054237|NCT00645411|566950209|FG001|Overall Study|Inappropriate enrollment|0|||
157054238|NCT00645411|566950210|FG002|Overall Study|Inappropriate enrollment|4|||
157054239|NCT00645411|566950211|FG003|Overall Study|Inappropriate enrollment|1|||
157177148|NCT01455415|567389750|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
157177149|NCT01455415|567389749|FG000|Period 1|Drug Error not Associated to AE|0|||
157177150|NCT01455415|567389750|FG001|Period 1|Drug Error not Associated to AE|1|||
157177151|NCT01455415|567389749|FG000|Period 1|AE Not Related to Study Drug|2|||
157177152|NCT01455415|567389750|FG001|Period 1|AE Not Related to Study Drug|6|||
157177153|NCT01455415|567389749|FG000|Period 1|Withdrawal by Subject|4|||
157177154|NCT01455415|567389750|FG001|Period 1|Withdrawal by Subject|5|||
157177155|NCT01455415|567389749|FG000|Period 1|Unspecified Reason|1|||
157177156|NCT01455415|567389750|FG001|Period 1|Unspecified Reason|1|||
157177157|NCT01455415|567389749|FG000|Period 1|Protocol Violation|0|||
157177158|NCT01455415|567389750|FG001|Period 1|Protocol Violation|2|||
157177159|NCT01455415|567389749|FG000|Washout|AE Related to Study Drug|2|||
157177160|NCT01455415|567389750|FG001|Washout|AE Related to Study Drug|0|||
157177161|NCT01455415|567389749|FG000|Washout|Lost to Follow-up|1|||
157177162|NCT01455415|567389750|FG001|Washout|Lost to Follow-up|0|||
157177163|NCT01455415|567389749|FG000|Washout|Drug Error not Associated to AE|2|||
157177164|NCT01455415|567389750|FG001|Washout|Drug Error not Associated to AE|1|||
157177165|NCT01455415|567389749|FG000|Washout|AE Not Related to Study Drug|2|||
157177166|NCT01455415|567389750|FG001|Washout|AE Not Related to Study Drug|3|||
157177167|NCT01455415|567389749|FG000|Washout|Unspecified Reason|1|||
157177168|NCT01455415|567389750|FG001|Washout|Unspecified Reason|2|||
157177169|NCT01455415|567389749|FG000|Washout|Protocol Violation|0|||
157177170|NCT01455415|567389750|FG001|Washout|Protocol Violation|1|||
157177171|NCT01455415|567389749|FG000|Period 2|AE Related to Study Drug|1|||
157177172|NCT01455415|567389750|FG001|Period 2|AE Related to Study Drug|2|||
157177173|NCT01455415|567389749|FG000|Period 2|Lost to Follow-up|2|||
157177174|NCT01455415|567389750|FG001|Period 2|Lost to Follow-up|1|||
157177175|NCT01455415|567389749|FG000|Period 2|AE Not Related to Study Drug|2|||
157177176|NCT01455415|567389750|FG001|Period 2|AE Not Related to Study Drug|1|||
157054240|NCT00645411|566950208|FG000|Overall Study|Unable to classify|0|||
157054241|NCT00645411|566950209|FG001|Overall Study|Unable to classify|0|||
157054242|NCT00645411|566950210|FG002|Overall Study|Unable to classify|3|||
157054243|NCT00645411|566950211|FG003|Overall Study|Unable to classify|4|||
157054244|NCT03560206|566950212|FG000|Overall Study|Lost to Follow-up|19|||
157054245|NCT03560206|566950213|FG001|Overall Study|Lost to Follow-up|11|||
157054246|NCT03560206|566950212|FG000|Overall Study|Withdrawal by Subject|2|||
157054247|NCT03560206|566950213|FG001|Overall Study|Withdrawal by Subject|4|||
157054248|NCT03560206|566950212|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
157054249|NCT03560206|566950213|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
157054250|NCT03560206|566950212|FG000|Overall Study|Busy schedule|14|||
157054251|NCT03560206|566950213|FG001|Overall Study|Busy schedule|2|||
157054252|NCT03560206|566950212|FG000|Overall Study|patients' new health condition such as cancer|10|||
157054253|NCT03560206|566950213|FG001|Overall Study|patients' new health condition such as cancer|1|||
157054254|NCT00738400|566950214|FG000|Overall Study|Adverse Event|3|||
157054255|NCT00738400|566950215|FG001|Overall Study|Adverse Event|1|||
157054256|NCT00738400|566950214|FG000|Overall Study|Withdrawal by Subject|0|||
157054257|NCT00738400|566950215|FG001|Overall Study|Withdrawal by Subject|1|||
157054258|NCT00738400|566950214|FG000|Overall Study|Lack of Efficacy|0|||
157054259|NCT00738400|566950215|FG001|Overall Study|Lack of Efficacy|1|||
157054260|NCT00738400|566950214|FG000|Overall Study|Lost to Follow-up|0|||
157054261|NCT00738400|566950215|FG001|Overall Study|Lost to Follow-up|3|||
157054262|NCT00738400|566950214|FG000|Overall Study|Protocol Violation|1|||
157054263|NCT00738400|566950215|FG001|Overall Study|Protocol Violation|0|||
157054264|NCT00738400|566950214|FG000|Overall Study|Non-compliant with study medication|0|||
157054265|NCT00738400|566950215|FG001|Overall Study|Non-compliant with study medication|1|||
157054266|NCT02255474|566950216|FG000|Overall Study|Lost to Follow-up|1|||
157054267|NCT02255474|566950217|FG001|Overall Study|Lost to Follow-up|1|||
157054268|NCT02255474|566950218|FG002|Overall Study|Lost to Follow-up|3|||
157177177|NCT01455415|567389749|FG000|Period 2|Lack of Efficacy|2|||
157177178|NCT01455415|567389750|FG001|Period 2|Lack of Efficacy|0|||
157177179|NCT01455415|567389749|FG000|Period 2|Withdrawal by Subject|2|||
157177180|NCT01455415|567389750|FG001|Period 2|Withdrawal by Subject|3|||
157177181|NCT01455415|567389749|FG000|Period 2|Unspecified Reason|2|||
157054269|NCT02255474|566950216|FG000|Overall Study|Withdrawal by Subject|1|||
157054270|NCT02255474|566950217|FG001|Overall Study|Withdrawal by Subject|1|||
157054271|NCT02255474|566950218|FG002|Overall Study|Withdrawal by Subject|0|||
157054272|NCT01867307|566950219|FG000|Overall Study|Protocol Violation|2|||
157054273|NCT01867307|566950220|FG001|Overall Study|Protocol Violation|0|||
157177182|NCT01455415|567389750|FG001|Period 2|Unspecified Reason|3|||
157177183|NCT01455415|567389749|FG000|Period 2|Protocol Violation|2|||
157177184|NCT01455415|567389750|FG001|Period 2|Protocol Violation|0|||
157177185|NCT01455415|567389749|FG000|Follow-up|AE Related to Study Drug|0|||
157177186|NCT01455415|567389750|FG001|Follow-up|AE Related to Study Drug|1|||
157054274|NCT01867307|566950219|FG000|Overall Study|Other Adverse Event|1|||
157054275|NCT01867307|566950220|FG001|Overall Study|Other Adverse Event|3|||
157054276|NCT00091572|566950222|FG000|Overall Study|Lost to Follow-up|1|||
157054277|NCT00091572|566950223|FG001|Overall Study|Lost to Follow-up|1|||
157054278|NCT00091572|566950222|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
157054279|NCT00091572|566950223|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
157054280|NCT00091572|566950222|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
157054281|NCT00091572|566950223|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
157054282|NCT00091572|566950222|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
157054283|NCT00091572|566950223|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
157054284|NCT00091572|566950222|FG000|Overall Study|Other Reason|6|||
157054285|NCT00091572|566950223|FG001|Overall Study|Other Reason|13|||
157054286|NCT00091572|566950222|FG000|Overall Study|Ongoing (still on treatment)|8|||
157054287|NCT00091572|566950223|FG001|Overall Study|Ongoing (still on treatment)|12|||
157054288|NCT00091572|566950222|FG000|Overall Study|Major Protocol Violation|2|||
157054289|NCT00091572|566950223|FG001|Overall Study|Major Protocol Violation|0|||
157054290|NCT00091572|566950222|FG000|Overall Study|Toxicity (Related AE)|53|||
157054291|NCT00091572|566950223|FG001|Overall Study|Toxicity (Related AE)|9|||
157054292|NCT03122548|566950226|FG000|Overall Study|Death|2|||
157054293|NCT03122548|566950226|FG000|Overall Study|Progression - subject went into hospice|1|||
157054294|NCT03122548|566950226|FG000|Overall Study|Study Terminated by Sponsor|2|||
157054295|NCT01634165|566950229|FG000|Period 2|Adverse Event|0|||
157054296|NCT01634165|566950230|FG001|Period 2|Adverse Event|1|||
157054297|NCT01634165|566950231|FG002|Period 2|Adverse Event|0|||
157054298|NCT01634165|566950232|FG003|Period 2|Adverse Event|0|||
157054299|NCT04097535|566950235|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
157054300|NCT00676195|566951516|FG000|Overall Study|Lost to Follow-up|1|||
157054301|NCT00676195|566951516|FG000|Overall Study|Adverse Event|1|||
157054302|NCT00676195|566951516|FG000|Overall Study|Physician Decision|1|||
157054303|NCT03322514|566951517|FG000|Overall Study|Withdrawal by Subject|1|||
157054304|NCT03322514|566951518|FG001|Overall Study|Withdrawal by Subject|1|||
157054305|NCT02136797|566951519|FG000|Overall Study|Not Treated|8|||
157054306|NCT04523571|566951520|FG000|Received 2 Doses|Withdrawal by Subject|0|||
157054307|NCT04523571|566951521|FG001|Received 2 Doses|Withdrawal by Subject|0|||
157054308|NCT04523571|566951522|FG002|Received 2 Doses|Withdrawal by Subject|0|||
157054309|NCT04523571|566951523|FG003|Received 2 Doses|Withdrawal by Subject|1|||
157054310|NCT04523571|566951524|FG004|Received 2 Doses|Withdrawal by Subject|1|||
157177187|NCT01455415|567389749|FG000|Follow-up|Lack of Efficacy|0|||
157177188|NCT01455415|567389750|FG001|Follow-up|Lack of Efficacy|1|||
157177189|NCT01455415|567389749|FG000|Follow-up|Withdrawal by Subject|2|||
157177190|NCT01455415|567389750|FG001|Follow-up|Withdrawal by Subject|0|||
157177191|NCT01455415|567389749|FG000|Follow-up|Unspecified Reason|1|||
157177192|NCT01455415|567389750|FG001|Follow-up|Unspecified Reason|0|||
157177193|NCT00719537|567389751|FG000|Overall Study|Withdrawal by Subject|1|||
157177194|NCT00719537|567389752|FG001|Overall Study|Withdrawal by Subject|0|||
157177195|NCT00719537|567389751|FG000|Overall Study|Lost to Follow-up|0|||
157177196|NCT00719537|567389752|FG001|Overall Study|Lost to Follow-up|1|||
157177197|NCT02460978|567389753|FG000|Overall Study|Adverse Event|17|||
157177198|NCT02460978|567389754|FG001|Overall Study|Adverse Event|11|||
157177199|NCT02460978|567389755|FG002|Overall Study|Adverse Event|11|||
157177200|NCT02460978|567389753|FG000|Overall Study|Withdrawal by Subject|5|||
157177201|NCT02460978|567389754|FG001|Overall Study|Withdrawal by Subject|5|||
157177202|NCT02460978|567389755|FG002|Overall Study|Withdrawal by Subject|14|||
157177203|NCT02460978|567389753|FG000|Overall Study|Lost to Follow-up|2|||
157177204|NCT02460978|567389754|FG001|Overall Study|Lost to Follow-up|3|||
157054311|NCT04523571|566951525|FG005|Received 2 Doses|Withdrawal by Subject|0|||
157054312|NCT04523571|566951520|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
157054313|NCT04523571|566951521|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
157054314|NCT04523571|566951522|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
157054315|NCT04523571|566951523|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
157054316|NCT04523571|566951524|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
157054317|NCT04523571|566951525|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
157054318|NCT04523571|566951520|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
157054319|NCT04523571|566951521|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
157054320|NCT04523571|566951522|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
157054321|NCT04523571|566951523|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
157177205|NCT02460978|567389755|FG002|Overall Study|Lost to Follow-up|1|||
157177206|NCT02460978|567389753|FG000|Overall Study|Protocol Violation|1|||
157177207|NCT02460978|567389754|FG001|Overall Study|Protocol Violation|1|||
157177208|NCT02460978|567389755|FG002|Overall Study|Protocol Violation|1|||
157177209|NCT02460978|567389753|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
157177210|NCT02460978|567389754|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
157177211|NCT02460978|567389755|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
157054322|NCT04523571|566951524|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
157054323|NCT04523571|566951525|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
157054324|NCT04523571|566951520|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
157054325|NCT04523571|566951521|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
157054326|NCT04523571|566951522|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
157054327|NCT04523571|566951523|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
157054328|NCT04523571|566951524|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
157054329|NCT04523571|566951525|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
157054330|NCT00627523|566951526|FG000|Overall Study|Lack of Efficacy|1|||
157054331|NCT00627523|566951527|FG001|Overall Study|Lack of Efficacy|0|||
157054332|NCT00627523|566951526|FG000|Overall Study|Withdrawal by Subject|0|||
157054333|NCT00627523|566951527|FG001|Overall Study|Withdrawal by Subject|2|||
157054334|NCT00627523|566951526|FG000|Overall Study|Other|1|||
157054335|NCT00627523|566951527|FG001|Overall Study|Other|0|||
157054336|NCT02011568|566951532|FG000|Overall Study|Withdrawal by Subject|8|||
157054337|NCT02011568|566951533|FG001|Overall Study|Withdrawal by Subject|10|||
157054338|NCT02011568|566951532|FG000|Overall Study|Physician Decision|1|||
157054339|NCT02011568|566951533|FG001|Overall Study|Physician Decision|3|||
157054340|NCT03344458|566951534|FG000|Overall Study|Physician Decision|1|||
157054341|NCT03344458|566951534|FG000|Overall Study|Withdrawal by Subject|16|||
157054342|NCT03344458|566951534|FG000|Overall Study|Other reasons|10|||
157054343|NCT03344458|566951534|FG000|Overall Study|Lost to Follow-up|9|||
157054344|NCT03344458|566951534|FG000|Overall Study|Protocol Violation|3|||
157054345|NCT00396409|566951540|FG000|Period 1 - 2007|Adverse Event|0|||
157054346|NCT00396409|566951541|FG001|Period 1 - 2007|Adverse Event|1|||
157054347|NCT00396409|566951540|FG000|Period 1 - 2007|Lack of Efficacy|0|||
157054348|NCT00396409|566951541|FG001|Period 1 - 2007|Lack of Efficacy|1|||
157054349|NCT00396409|566951540|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
157054350|NCT00396409|566951541|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
157054351|NCT00396409|566951540|FG000|Period 1 - 2007|Lost to Follow-up|2|||
157054352|NCT00396409|566951541|FG001|Period 1 - 2007|Lost to Follow-up|3|||
157054353|NCT00396409|566951540|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
157054354|NCT00396409|566951541|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
157054355|NCT00396409|566951540|FG000|Period 2 - 2008|Protocol Violation|1|||
157054356|NCT00396409|566951541|FG001|Period 2 - 2008|Protocol Violation|0|||
157054357|NCT00396409|566951540|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
157054358|NCT00396409|566951541|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
157054359|NCT00396409|566951540|FG000|Period 2 - 2008|Lost to Follow-up|3|||
157054360|NCT00396409|566951541|FG001|Period 2 - 2008|Lost to Follow-up|1|||
157054361|NCT00331799|566951542|FG000|Overall Study|Withdrawal by Subject|2|||
157054362|NCT00331799|566951542|FG000|Overall Study|Sedation|1|||
157054363|NCT02889809|566951543|FG000|Overall Study|Withdrawal by Subject|30|||
157054364|NCT02889809|566951544|FG001|Overall Study|Withdrawal by Subject|21|||
157054365|NCT02889809|566951543|FG000|Overall Study|Lost to Follow-up|1|||
157054366|NCT02889809|566951544|FG001|Overall Study|Lost to Follow-up|1|||
157054367|NCT02889809|566951543|FG000|Overall Study|Site Closed|12|||
157054368|NCT02889809|566951544|FG001|Overall Study|Site Closed|11|||
157054369|NCT03696342|566951545|FG000|Overall Study|Lost to Follow-up|1|||
157054370|NCT03696342|566951546|FG001|Overall Study|Lost to Follow-up|0|||
157054371|NCT02409732|566951547|FG000|Overall Study|Withdrawal by Subject|4|||
157054372|NCT02409732|566951547|FG000|Overall Study|Lost to Follow-up|2|||
157054373|NCT03314233|566951554|FG000|Overall Study|No longer eligible at time of delivery|1|||
157177212|NCT02460978|567389753|FG000|Overall Study|Pregnancy|0|||
157054374|NCT01797705|566951555|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
157054375|NCT01797705|566951555|FG000|Overall Study|Withdrawal by Subject|1|||
157054376|NCT01533181|566951556|FG000|Overall Study|Disease progression pre-active treatment|0|||
157054377|NCT01533181|566951557|FG001|Overall Study|Disease progression pre-active treatment|1|||
157054378|NCT01533181|566951556|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
157054379|NCT01533181|566951557|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
157054380|NCT02030847|566951558|FG000|Overall Study|Death|10|||
157054381|NCT02030847|566951558|FG000|Overall Study|Disease Progression|15|||
157177213|NCT02460978|567389754|FG001|Overall Study|Pregnancy|0|||
157054382|NCT02030847|566951558|FG000|Overall Study|New Cancer Therapy|8|||
157054383|NCT02030847|566951558|FG000|Overall Study|Physician Decision|3|||
157054384|NCT02030847|566951558|FG000|Overall Study|Withdrawal by Subject|1|||
157054385|NCT01703988|566951559|FG000|Overall Study|Investigator Judgment|0|||
157054386|NCT01703988|566951560|FG001|Overall Study|Investigator Judgment|0|||
157054387|NCT01703988|566951561|FG002|Overall Study|Investigator Judgment|0|||
157054388|NCT01703988|566951562|FG003|Overall Study|Investigator Judgment|1|||
157054389|NCT03785210|566951565|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
157054390|NCT03785210|566951566|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
157177214|NCT02460978|567389755|FG002|Overall Study|Pregnancy|2|||
157177215|NCT00588523|567389761|FG000|Overall Study|Not treated|3|||
157054391|NCT04468633|566951569|FG000|Overall Study|Withdrawal by Subject|4|||
157054392|NCT04468633|566951570|FG001|Overall Study|Withdrawal by Subject|0|||
157054393|NCT00460434|566951571|FG000|Overall Study|Lost to Follow-up|3|||
157054394|NCT00460434|566951572|FG001|Overall Study|Lost to Follow-up|7|||
157054395|NCT01498445|566951573|FG000|Overall Study|Lack of Efficacy|0|||
157054396|NCT01498445|566951574|FG001|Overall Study|Lack of Efficacy|0|||
157054397|NCT01498445|566951575|FG002|Overall Study|Lack of Efficacy|1|||
157054398|NCT01498445|566951576|FG003|Overall Study|Lack of Efficacy|2|||
157054399|NCT01498445|566951577|FG004|Overall Study|Lack of Efficacy|0|||
157054400|NCT01498445|566951578|FG005|Overall Study|Lack of Efficacy|0|||
157054401|NCT01498445|566951573|FG000|Overall Study|Screen Failure|0|||
157054402|NCT01498445|566951574|FG001|Overall Study|Screen Failure|0|||
157054403|NCT01498445|566951575|FG002|Overall Study|Screen Failure|0|||
157054404|NCT01498445|566951576|FG003|Overall Study|Screen Failure|0|||
157054405|NCT01498445|566951577|FG004|Overall Study|Screen Failure|1|||
157054406|NCT01498445|566951578|FG005|Overall Study|Screen Failure|1|||
157054407|NCT02722278|566951579|FG000|Overall Study|Withdrawal by Subject|5|||
157054408|NCT02722278|566951580|FG001|Overall Study|Withdrawal by Subject|3|||
157054409|NCT02722278|566951579|FG000|Overall Study|Adverse Event|4|||
157054410|NCT02722278|566951580|FG001|Overall Study|Adverse Event|1|||
157054411|NCT02722278|566951579|FG000|Overall Study|Lost to Follow-up|2|||
157054412|NCT02722278|566951580|FG001|Overall Study|Lost to Follow-up|0|||
157054413|NCT02722278|566951579|FG000|Overall Study|Protocol Violation|1|||
157054414|NCT02722278|566951580|FG001|Overall Study|Protocol Violation|0|||
157054415|NCT02722278|566951579|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
157054416|NCT02722278|566951580|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
157054417|NCT02722278|566951579|FG000|Overall Study|Subject declined after tx assignment|0|||
157054418|NCT02722278|566951580|FG001|Overall Study|Subject declined after tx assignment|1|||
157054419|NCT02722278|566951579|FG000|Overall Study|Site closure not study related|0|||
157054420|NCT02722278|566951580|FG001|Overall Study|Site closure not study related|1|||
157054421|NCT02465866|566951581|FG000|Period 3|Withdrawal by Subject|0|||
157054422|NCT02465866|566951582|FG001|Period 3|Withdrawal by Subject|1|||
157054423|NCT02465866|566951583|FG002|Period 3|Withdrawal by Subject|0|||
157054424|NCT02465866|566951584|FG003|Period 3|Withdrawal by Subject|0|||
157054425|NCT00203502|566951585|FG000|Overall Study|Death|1|||
157054426|NCT01469819|566951586|FG000|Overall Study|Withdrawal by Subject|1|||
157054427|NCT01469819|566951586|FG000|Overall Study|Did not meet inclusionary criteria|2|||
157054428|NCT01469819|566951586|FG000|Overall Study|Could not swallow SmartPill|2|||
157054429|NCT01469819|566951586|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
157054430|NCT01403805|566951589|FG000|Overall Study|Withdrawal by Subject|0|||
157054431|NCT01403805|566951590|FG001|Overall Study|Withdrawal by Subject|4|||
157054432|NCT01403805|566951589|FG000|Overall Study|Lost to Follow-up|0|||
157054433|NCT01403805|566951590|FG001|Overall Study|Lost to Follow-up|2|||
157054434|NCT01403805|566951589|FG000|Overall Study|Death|0|||
157054435|NCT01403805|566951590|FG001|Overall Study|Death|1|||
157054436|NCT01695993|566951591|FG000|Overall Study|Lost to Follow-up|2|||
157054437|NCT01695993|566951592|FG001|Overall Study|Lost to Follow-up|1|||
157054438|NCT01695993|566951593|FG002|Overall Study|Lost to Follow-up|3|||
157054439|NCT01695993|566951591|FG000|Overall Study|Withdrawal by Subject|2|||
157054440|NCT01695993|566951592|FG001|Overall Study|Withdrawal by Subject|2|||
157054441|NCT01695993|566951593|FG002|Overall Study|Withdrawal by Subject|2|||
157054442|NCT01695993|566951591|FG000|Overall Study|To ill to continue|1|||
157054443|NCT01695993|566951592|FG001|Overall Study|To ill to continue|2|||
157054444|NCT01695993|566951593|FG002|Overall Study|To ill to continue|0|||
157054445|NCT01695993|566951591|FG000|Overall Study|Changed Medical Facility|0|||
157054446|NCT01695993|566951592|FG001|Overall Study|Changed Medical Facility|0|||
157054447|NCT01695993|566951593|FG002|Overall Study|Changed Medical Facility|1|||
157054448|NCT01601821|566951594|FG000|Overall Study|Death|2|||
157054449|NCT01601821|566951595|FG001|Overall Study|Death|5|||
157054450|NCT01601821|566951594|FG000|Overall Study|Protocol Violation|2|||
157054451|NCT01601821|566951595|FG001|Overall Study|Protocol Violation|2|||
157054452|NCT01601821|566951594|FG000|Overall Study|Lost to Follow-up|6|||
157054453|NCT01601821|566951595|FG001|Overall Study|Lost to Follow-up|14|||
157054454|NCT01601821|566951594|FG000|Overall Study|Withdrawal by Subject|1|||
157054455|NCT01601821|566951595|FG001|Overall Study|Withdrawal by Subject|0|||
157054456|NCT01601821|566951594|FG000|Overall Study|Graft Loss|6|||
157054457|NCT01601821|566951595|FG001|Overall Study|Graft Loss|6|||
157054458|NCT01601821|566951594|FG000|Overall Study|Study Events|7|||
157054459|NCT01601821|566951595|FG001|Overall Study|Study Events|1|||
157054460|NCT01601821|566951594|FG000|Overall Study|Other|5|||
157054461|NCT01601821|566951595|FG001|Overall Study|Other|1|||
157177216|NCT01459068|567389764|FG000|Overall Study|Withdrawal by Subject|8|||
157177217|NCT01459068|567389765|FG001|Overall Study|Withdrawal by Subject|18|||
157177218|NCT01459068|567389764|FG000|Overall Study|Lost to Follow-up|31|||
157054462|NCT00147745|566951596|FG000|Overall Study|Withdrawal by Subject|1|||
157054463|NCT00147745|566951597|FG001|Overall Study|Withdrawal by Subject|0|||
157054464|NCT00147745|566951598|FG002|Overall Study|Withdrawal by Subject|0|||
157177219|NCT01459068|567389765|FG001|Overall Study|Lost to Follow-up|15|||
157054465|NCT01901302|566951599|FG000|Overall Study|Adverse Event|2|||
157054466|NCT01901302|566951600|FG001|Overall Study|Adverse Event|1|||
157177220|NCT01459068|567389764|FG000|Overall Study|Death|0|||
157054467|NCT01901302|566951599|FG000|Overall Study|Lack of Efficacy|0|||
157054468|NCT01901302|566951600|FG001|Overall Study|Lack of Efficacy|2|||
157054469|NCT01901302|566951599|FG000|Overall Study|Study Terminated by Sponsor|23|||
157054470|NCT01901302|566951600|FG001|Overall Study|Study Terminated by Sponsor|20|||
157054471|NCT01901302|566951599|FG000|Overall Study|Withdrawal by Subject|2|||
157054472|NCT01901302|566951600|FG001|Overall Study|Withdrawal by Subject|0|||
157054473|NCT00510783|566951602|FG000|Overall Study|Lost to Follow-up|29|||
157054474|NCT00510783|566951603|FG001|Overall Study|Lost to Follow-up|25|||
157054475|NCT00510783|566951602|FG000|Overall Study|Withdrawal by Subject|2|||
157054476|NCT00510783|566951603|FG001|Overall Study|Withdrawal by Subject|3|||
157054477|NCT00510783|566951602|FG000|Overall Study|Protocol Violation|0|||
157054478|NCT00510783|566951603|FG001|Overall Study|Protocol Violation|1|||
157054479|NCT00316121|566951604|FG000|Overall Study|Death|1|||
157054480|NCT00316121|566951605|FG001|Overall Study|Death|0|||
157054481|NCT00316121|566951604|FG000|Overall Study|Lost to Follow-up|14|||
157054482|NCT00316121|566951605|FG001|Overall Study|Lost to Follow-up|8|||
157054483|NCT00316121|566951604|FG000|Overall Study|Withdrawal by Subject|2|||
157054484|NCT00316121|566951605|FG001|Overall Study|Withdrawal by Subject|0|||
157054485|NCT00316121|566951604|FG000|Overall Study|Reason is missing|1|||
157054486|NCT00316121|566951605|FG001|Overall Study|Reason is missing|0|||
157054487|NCT00316121|566951604|FG000|Overall Study|Subject relocated|1|||
157054488|NCT00316121|566951605|FG001|Overall Study|Subject relocated|1|||
157054489|NCT00316121|566951604|FG000|Overall Study|Subject refused to return|1|||
157054490|NCT00316121|566951605|FG001|Overall Study|Subject refused to return|0|||
157054491|NCT00316121|566951604|FG000|Overall Study|Subject no show for visit x 3|1|||
157054492|NCT00316121|566951605|FG001|Overall Study|Subject no show for visit x 3|0|||
157054493|NCT00316121|566951604|FG000|Overall Study|Subject did not have 24 month visit|1|||
157054494|NCT00316121|566951605|FG001|Overall Study|Subject did not have 24 month visit|0|||
157054495|NCT03166215|566951611|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
157054496|NCT03166215|566951612|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
157054497|NCT03166215|566951613|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
157054498|NCT03166215|566951611|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
157054499|NCT03166215|566951612|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
157054500|NCT03166215|566951613|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
157054501|NCT04985604|566951615|FG000|Overall Study|Death|4|||
157054502|NCT04985604|566951616|FG001|Overall Study|Death|6|||
157054503|NCT04985604|566951615|FG000|Overall Study|Withdrawal by Subject|0|||
157054504|NCT04985604|566951616|FG001|Overall Study|Withdrawal by Subject|1|||
157054505|NCT04598776|566951617|FG000|Overall Study|Protocol Violation|5|||
157054506|NCT04598776|566951617|FG000|Overall Study|Physician Decision|4|||
157054507|NCT02282761|566951618|FG000|Overall Study|Death|0|||
157054508|NCT02282761|566951619|FG001|Overall Study|Death|0|||
157054509|NCT02282761|566951620|FG002|Overall Study|Death|1|||
157054510|NCT02282761|566951618|FG000|Overall Study|Adverse Event|6|||
157054511|NCT02282761|566951619|FG001|Overall Study|Adverse Event|2|||
157054512|NCT02282761|566951620|FG002|Overall Study|Adverse Event|0|||
157054513|NCT02282761|566951618|FG000|Overall Study|Lack of Efficacy|11|||
157054514|NCT02282761|566951619|FG001|Overall Study|Lack of Efficacy|6|||
157054515|NCT02282761|566951620|FG002|Overall Study|Lack of Efficacy|17|||
157054516|NCT02282761|566951618|FG000|Overall Study|Lost to Follow-up|2|||
157054517|NCT02282761|566951619|FG001|Overall Study|Lost to Follow-up|2|||
157054518|NCT02282761|566951620|FG002|Overall Study|Lost to Follow-up|1|||
157054519|NCT02282761|566951618|FG000|Overall Study|Physician Decision|0|||
157054520|NCT02282761|566951619|FG001|Overall Study|Physician Decision|0|||
157054521|NCT02282761|566951620|FG002|Overall Study|Physician Decision|2|||
157054522|NCT02282761|566951618|FG000|Overall Study|Withdrawal by Subject|8|||
157054523|NCT02282761|566951619|FG001|Overall Study|Withdrawal by Subject|10|||
157054524|NCT02282761|566951620|FG002|Overall Study|Withdrawal by Subject|16|||
157054525|NCT02282761|566951618|FG000|Overall Study|Other|3|||
157054526|NCT02282761|566951619|FG001|Overall Study|Other|2|||
157054527|NCT02282761|566951620|FG002|Overall Study|Other|1|||
157054528|NCT00658632|566951621|FG000|Overall Study|Adverse Event|13|||
157054529|NCT00658632|566951622|FG001|Overall Study|Adverse Event|11|||
157054530|NCT00658632|566951621|FG000|Overall Study|Lost to Follow-up|25|||
157054531|NCT00658632|566951622|FG001|Overall Study|Lost to Follow-up|23|||
157054532|NCT00658632|566951621|FG000|Overall Study|Withdrawal by Subject|10|||
157054533|NCT00658632|566951622|FG001|Overall Study|Withdrawal by Subject|7|||
157054534|NCT00658632|566951621|FG000|Overall Study|Lack of Efficacy|0|||
157054535|NCT00658632|566951622|FG001|Overall Study|Lack of Efficacy|1|||
157054536|NCT00658632|566951621|FG000|Overall Study|Withdrawal of consent|8|||
157054537|NCT00658632|566951622|FG001|Overall Study|Withdrawal of consent|14|||
157054538|NCT00658632|566951621|FG000|Overall Study|Pregnancy|1|||
157054539|NCT00658632|566951622|FG001|Overall Study|Pregnancy|1|||
157054540|NCT00658632|566951621|FG000|Overall Study|Other|7|||
157054541|NCT00658632|566951622|FG001|Overall Study|Other|8|||
157054542|NCT02632045|566951623|FG000|Overall Study|Withdrawal by Subject|1|||
157054543|NCT02632045|566951624|FG001|Overall Study|Withdrawal by Subject|2|||
157054544|NCT04551053|566951625|FG000|Overall Study|Death|10|||
157054545|NCT04551053|566951626|FG001|Overall Study|Death|9|||
157054546|NCT04551053|566951625|FG000|Overall Study|Lost to Follow-up|0|||
157054547|NCT04551053|566951626|FG001|Overall Study|Lost to Follow-up|2|||
157054548|NCT04551053|566951625|FG000|Overall Study|Study Terminated by Sponsor|57|||
157054549|NCT04551053|566951626|FG001|Overall Study|Study Terminated by Sponsor|65|||
157054550|NCT04551053|566951625|FG000|Overall Study|Withdrawal by Subject|12|||
157054551|NCT04551053|566951626|FG001|Overall Study|Withdrawal by Subject|5|||
157054552|NCT04551053|566951625|FG000|Overall Study|Adverse Event|2|||
157054553|NCT04551053|566951626|FG001|Overall Study|Adverse Event|0|||
157054554|NCT04551053|566951625|FG000|Overall Study|Lack of Efficacy|2|||
157054555|NCT04551053|566951626|FG001|Overall Study|Lack of Efficacy|1|||
157054556|NCT04551053|566951625|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
157054557|NCT04551053|566951626|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
157054558|NCT04551053|566951625|FG000|Overall Study|Splenapendectomi|1|||
157054559|NCT04551053|566951626|FG001|Overall Study|Splenapendectomi|0|||
157054560|NCT04551053|566951625|FG000|Overall Study|Medical Decision|1|||
157054561|NCT04551053|566951626|FG001|Overall Study|Medical Decision|1|||
157054562|NCT03861078|566951627|FG000|Overall Study|COVID-19 shut down|4|||
157054563|NCT03861078|566951627|FG000|Overall Study|Lost to Follow-up|1|||
157054564|NCT03861078|566951627|FG000|Overall Study|Protocol Violation|2|||
157054565|NCT03861078|566951627|FG000|Overall Study|lack of venous access|1|||
157054566|NCT00596960|566951629|FG000|Overall Study|Death|1|||
157054567|NCT00596960|566951630|FG001|Overall Study|Death|2|||
157054568|NCT00596960|566951629|FG000|Overall Study|Lost to Follow-up|6|||
157054569|NCT00596960|566951630|FG001|Overall Study|Lost to Follow-up|5|||
157054570|NCT00596960|566951629|FG000|Overall Study|Withdrawal by Subject|1|||
157054571|NCT00596960|566951630|FG001|Overall Study|Withdrawal by Subject|0|||
157054572|NCT00596960|566951629|FG000|Overall Study|Incarcerated|2|||
157054573|NCT00596960|566951630|FG001|Overall Study|Incarcerated|0|||
157054574|NCT00596960|566951629|FG000|Overall Study|Physician Decision|1|||
157054575|NCT00596960|566951630|FG001|Overall Study|Physician Decision|0|||
157054576|NCT00596960|566951629|FG000|Overall Study|Protocol Violation|0|||
157054577|NCT00596960|566951630|FG001|Overall Study|Protocol Violation|1|||
157054578|NCT00596960|566951629|FG000|Overall Study|No alcohol use data|0|||
157054579|NCT00596960|566951630|FG001|Overall Study|No alcohol use data|1|||
157054580|NCT03503188|566951631|FG000|Overall Study|Non eligible in the sub study|0|||
157054581|NCT03503188|566951632|FG001|Overall Study|Non eligible in the sub study|1|||
157054582|NCT02993926|566951636|FG000|Enantone Treatment Phase|Adverse Event|1|||
157054583|NCT02993926|566951637|FG001|Enantone Treatment Phase|Adverse Event|0|||
157054584|NCT02993926|566951638|FG002|Enantone Treatment Phase|Adverse Event|0|||
157054585|NCT02993926|566951636|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
157054586|NCT02993926|566951637|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
157054587|NCT02993926|566951638|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
157054588|NCT02993926|566951636|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
157054589|NCT02993926|566951637|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
157054590|NCT02993926|566951638|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
157054591|NCT02993926|566951636|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
157054592|NCT02993926|566951637|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
157054593|NCT02993926|566951638|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
157054594|NCT02009865|566951641|FG000|Overall Study|Adverse Event|0|||
157054595|NCT02009865|566951642|FG001|Overall Study|Adverse Event|2|||
157054596|NCT02009865|566951641|FG000|Overall Study|Protocol Violation|0|||
157054597|NCT02009865|566951642|FG001|Overall Study|Protocol Violation|2|||
157177221|NCT01459068|567389765|FG001|Overall Study|Death|1|||
157177222|NCT02023112|567389768|FG000|Overall Study|Withdrawal by Subject|2|||
157177223|NCT02023112|567389769|FG001|Overall Study|Withdrawal by Subject|1|||
157177224|NCT02910219|567389770|FG000|Overall Study|Withdrawal by Subject|1|||
157177225|NCT02910219|567389771|FG001|Overall Study|Withdrawal by Subject|1|||
157177226|NCT01425749|567389772|FG000|Overall Study|progression of melanoma|0|||
157177227|NCT01425749|567389773|FG001|Overall Study|progression of melanoma|1|||
157054598|NCT02009865|566951641|FG000|Overall Study|Withdrawal by Subject|1|||
157054599|NCT02009865|566951642|FG001|Overall Study|Withdrawal by Subject|1|||
157054600|NCT01760876|566951643|FG000|Overall Study|Non-cardiac death (head injury)|1|||
157177228|NCT00701441|567389776|FG000|Overall Study|failure in cpap compliance|0|||
157177229|NCT00701441|567389777|FG001|Overall Study|failure in cpap compliance|4|||
157177230|NCT01225172|567389782|FG000|Overall Study|Subject decision to stop|1|||
157054601|NCT01760876|566951643|FG000|Overall Study|Carcinoma of prostate|1|||
157054602|NCT01760876|566951643|FG000|Overall Study|Impaired renal function|1|||
157177231|NCT01225172|567389783|FG001|Overall Study|Subject decision to stop|0|||
157177232|NCT01225172|567389782|FG000|Overall Study|Subject request to discontinue treatment|3|||
157054603|NCT01760876|566951643|FG000|Overall Study|Major depression|1|||
157177233|NCT01225172|567389783|FG001|Overall Study|Subject request to discontinue treatment|1|||
157177234|NCT01225172|567389782|FG000|Overall Study|Subject no longer meets study criteria|1|||
157177235|NCT01225172|567389783|FG001|Overall Study|Subject no longer meets study criteria|0|||
157177236|NCT01225172|567389782|FG000|Overall Study|Withdrawal by Subject|1|||
157229528|NCT02937701|567586466|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
157054604|NCT01760876|566951643|FG000|Overall Study|Very poor baseline OCT quality|2|||
157054605|NCT00525915|566951647|FG000|Overall Study|Non-Compliance|0|||
157054606|NCT00525915|566951648|FG001|Overall Study|Non-Compliance|1|||
157054607|NCT00525915|566951647|FG000|Overall Study|Disease Progression|5|||
157054608|NCT00525915|566951648|FG001|Overall Study|Disease Progression|6|||
157054609|NCT00525915|566951647|FG000|Overall Study|Withdrawal by Subject|1|||
157054610|NCT00525915|566951648|FG001|Overall Study|Withdrawal by Subject|0|||
157054611|NCT00525915|566951647|FG000|Overall Study|Refused Surgery|1|||
157054612|NCT00525915|566951648|FG001|Overall Study|Refused Surgery|2|||
157054613|NCT00525915|566951647|FG000|Overall Study|Unrelated illness|1|||
157054614|NCT00525915|566951648|FG001|Overall Study|Unrelated illness|0|||
157054615|NCT00732498|566951649|FG000|Overall Study|Ineligible|1|||
157054616|NCT00732498|566951649|FG000|Overall Study|Adverse Event|2|||
157054617|NCT00732498|566951649|FG000|Overall Study|Physician Decision|3|||
157054618|NCT03394508|566951650|FG000|Overall Study|Protocol Violation|0|||
157054619|NCT03394508|566951651|FG001|Overall Study|Protocol Violation|3|||
157054620|NCT03394508|566951650|FG000|Overall Study|Lost to Follow-up|1|||
157054621|NCT03394508|566951651|FG001|Overall Study|Lost to Follow-up|0|||
157054622|NCT00267865|566951652|FG000|Induction Treatment|Died before completing.|2|||
157054623|NCT00267865|566951652|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
157054624|NCT04295499|566951654|FG000|Overall Study|moving out of state|1|||
157054625|NCT04295499|566951655|FG001|Overall Study|moving out of state|0|||
157054626|NCT04295499|566951654|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
157054627|NCT04295499|566951655|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
157054628|NCT01755598|566951656|FG000|Overall Study|Other|109|||
157054629|NCT01755598|566951657|FG001|Overall Study|Other|109|||
157054630|NCT01755598|566951656|FG000|Overall Study|Lost to Follow-up|32|||
157054631|NCT01755598|566951657|FG001|Overall Study|Lost to Follow-up|43|||
157054632|NCT01755598|566951656|FG000|Overall Study|Migrated/moved from study area|76|||
157054633|NCT01755598|566951657|FG001|Overall Study|Migrated/moved from study area|65|||
157054634|NCT01755598|566951656|FG000|Overall Study|Withdrawal by Subject|22|||
157054635|NCT01755598|566951657|FG001|Overall Study|Withdrawal by Subject|31|||
157054636|NCT01755598|566951656|FG000|Overall Study|Protocol Violation|7|||
157054637|NCT01755598|566951657|FG001|Overall Study|Protocol Violation|7|||
157054638|NCT01755598|566951656|FG000|Overall Study|Adverse Event|19|||
157054639|NCT01755598|566951657|FG001|Overall Study|Adverse Event|28|||
157054640|NCT00308113|566951658|FG000|Overall Study|Protocol closure|0|||
157054641|NCT00308113|566951659|FG001|Overall Study|Protocol closure|0|||
157054642|NCT00308113|566951660|FG002|Overall Study|Protocol closure|0|||
157054643|NCT00308113|566951661|FG003|Overall Study|Protocol closure|1|||
157054644|NCT02332889|566951662|FG000|Overall Study|Physician Decision|1|||
157054645|NCT02135445|566951666|FG000|Overall Study|Lost to Follow-up|1|||
157054646|NCT02135445|566951667|FG001|Overall Study|Lost to Follow-up|0|||
157054647|NCT02135445|566951666|FG000|Overall Study|Withdrawal by Subject|1|||
157054648|NCT02135445|566951667|FG001|Overall Study|Withdrawal by Subject|0|||
157054649|NCT03556891|566951668|FG000|Initial Pivotal Study|Adverse Event|4|||
157054650|NCT03556891|566951668|FG000|Initial Pivotal Study|MRI Need|3|||
157054651|NCT03556891|566951668|FG000|Initial Pivotal Study|Device Failure|1|||
157054652|NCT03556891|566951668|FG000|Initial Pivotal Study|Death|1|||
157054653|NCT03556891|566951668|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
157054654|NCT03556891|566951668|FG000|Initial Pivotal Study|Missing at random|1|||
157054655|NCT03556891|566951668|FG000|Initial Pivotal Study|Missing due to COVID|1|||
157054656|NCT03556891|566951668|FG000|Initial Pivotal Study|Protocol Violation|1|||
157054657|NCT02661490|566954016|FG000|Overall Study|Lost to Follow-up|0|||
157054658|NCT02661490|566954017|FG001|Overall Study|Lost to Follow-up|1|||
157054659|NCT02661490|566954018|FG002|Overall Study|Lost to Follow-up|0|||
157054660|NCT02661490|566954019|FG003|Overall Study|Lost to Follow-up|0|||
157054661|NCT02661490|566954020|FG004|Overall Study|Lost to Follow-up|2|||
157054662|NCT02661490|566954016|FG000|Overall Study|Withdrawal by Subject|2|||
157054663|NCT02661490|566954017|FG001|Overall Study|Withdrawal by Subject|0|||
157054664|NCT02661490|566954018|FG002|Overall Study|Withdrawal by Subject|2|||
157054665|NCT02661490|566954019|FG003|Overall Study|Withdrawal by Subject|0|||
157054666|NCT02661490|566954020|FG004|Overall Study|Withdrawal by Subject|0|||
157054667|NCT02661490|566954016|FG000|Overall Study|Death|1|||
157054668|NCT02661490|566954017|FG001|Overall Study|Death|1|||
157054669|NCT02661490|566954018|FG002|Overall Study|Death|0|||
157054670|NCT02661490|566954019|FG003|Overall Study|Death|1|||
157054671|NCT02661490|566954020|FG004|Overall Study|Death|0|||
157054672|NCT02661490|566954016|FG000|Overall Study|Reason not Specified|0|||
157054673|NCT02661490|566954017|FG001|Overall Study|Reason not Specified|0|||
157054674|NCT02661490|566954018|FG002|Overall Study|Reason not Specified|0|||
157054675|NCT02661490|566954019|FG003|Overall Study|Reason not Specified|0|||
157054676|NCT02661490|566954020|FG004|Overall Study|Reason not Specified|1|||
157054677|NCT00961298|566954021|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
157054678|NCT00961298|566954021|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
157054679|NCT00961298|566954021|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
157054680|NCT02388932|566954028|FG000|Overall Study|Death|1|||
157054681|NCT05927753|566954031|FG000|Overall Study|Withdrawal by Subject|0|||
157054682|NCT05927753|566954032|FG001|Overall Study|Withdrawal by Subject|2|||
157054683|NCT05927753|566954031|FG000|Overall Study|Physician Decision|0|||
157054684|NCT05927753|566954032|FG001|Overall Study|Physician Decision|1|||
157054685|NCT00409006|566954035|FG000|Overall Study|Death|15|||
157054686|NCT00409006|566954036|FG001|Overall Study|Death|6|||
157054687|NCT00409006|566954035|FG000|Overall Study|Lost to Follow-up|1|||
157054688|NCT00409006|566954036|FG001|Overall Study|Lost to Follow-up|2|||
157054689|NCT00409006|566954035|FG000|Overall Study|Withdrawal by Subject|3|||
157054690|NCT00409006|566954036|FG001|Overall Study|Withdrawal by Subject|2|||
157054691|NCT00409006|566954035|FG000|Overall Study|Physician Decision|1|||
157054692|NCT00409006|566954036|FG001|Overall Study|Physician Decision|2|||
157054693|NCT02123797|566954037|FG000|Baseline Intervention|Death|9|||
157054694|NCT02123797|566954038|FG001|Baseline Intervention|Death|16|||
157054695|NCT02123797|566954039|FG002|Baseline Intervention|Death|0|||
157054696|NCT02123797|566954040|FG003|Baseline Intervention|Death|0|||
157054697|NCT02123797|566954041|FG004|Baseline Intervention|Death|0|||
157054698|NCT02123797|566954037|FG000|Baseline Intervention|Withdrawal by Subject|2|||
157054699|NCT02123797|566954038|FG001|Baseline Intervention|Withdrawal by Subject|8|||
157054700|NCT02123797|566954039|FG002|Baseline Intervention|Withdrawal by Subject|0|||
157054701|NCT02123797|566954040|FG003|Baseline Intervention|Withdrawal by Subject|0|||
157054702|NCT02123797|566954041|FG004|Baseline Intervention|Withdrawal by Subject|0|||
157054703|NCT02123797|566954037|FG000|Baseline Intervention|Relocation|2|||
157054704|NCT02123797|566954038|FG001|Baseline Intervention|Relocation|0|||
157054705|NCT02123797|566954039|FG002|Baseline Intervention|Relocation|0|||
157054706|NCT02123797|566954040|FG003|Baseline Intervention|Relocation|0|||
157054707|NCT02123797|566954041|FG004|Baseline Intervention|Relocation|0|||
157054708|NCT02123797|566954037|FG000|Baseline Intervention|Out of window for initial survey|6|||
157054709|NCT02123797|566954038|FG001|Baseline Intervention|Out of window for initial survey|13|||
157054710|NCT02123797|566954039|FG002|Baseline Intervention|Out of window for initial survey|0|||
157054711|NCT02123797|566954040|FG003|Baseline Intervention|Out of window for initial survey|0|||
157054712|NCT02123797|566954041|FG004|Baseline Intervention|Out of window for initial survey|0|||
157054713|NCT02123797|566954037|FG000|Baseline Intervention|Lost to Follow-up|0|||
157054714|NCT02123797|566954038|FG001|Baseline Intervention|Lost to Follow-up|5|||
157054715|NCT02123797|566954039|FG002|Baseline Intervention|Lost to Follow-up|0|||
157054716|NCT02123797|566954040|FG003|Baseline Intervention|Lost to Follow-up|0|||
157054717|NCT02123797|566954041|FG004|Baseline Intervention|Lost to Follow-up|0|||
157054718|NCT02123797|566954037|FG000|Baseline Intervention|Other Disease|3|||
157054719|NCT02123797|566954038|FG001|Baseline Intervention|Other Disease|0|||
157054720|NCT02123797|566954039|FG002|Baseline Intervention|Other Disease|0|||
157054721|NCT02123797|566954040|FG003|Baseline Intervention|Other Disease|0|||
157054722|NCT02123797|566954041|FG004|Baseline Intervention|Other Disease|0|||
157054723|NCT02123797|566954037|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
157054724|NCT02123797|566954038|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
157054725|NCT02123797|566954039|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
157054726|NCT02123797|566954040|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
157054727|NCT02123797|566954041|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
157054728|NCT02123797|566954037|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
157054729|NCT02123797|566954038|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
157054730|NCT02123797|566954039|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
157054731|NCT02123797|566954040|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
157054732|NCT02123797|566954041|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
157054733|NCT02123797|566954037|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
157054734|NCT02123797|566954038|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
157054735|NCT02123797|566954039|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157054736|NCT02123797|566954040|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157054737|NCT02123797|566954041|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157177237|NCT01225172|567389783|FG001|Overall Study|Withdrawal by Subject|0|||
157177238|NCT01068717|567389784|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
157177239|NCT01068717|567389785|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
157177240|NCT01068717|567389786|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
157054738|NCT02123797|566954037|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
157054739|NCT02123797|566954038|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
157054740|NCT02123797|566954039|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
157054741|NCT02123797|566954040|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
157054742|NCT02123797|566954041|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
157054743|NCT02123797|566954037|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
157054744|NCT02123797|566954038|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
157054745|NCT02123797|566954039|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
157177241|NCT01068717|567389787|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
157177242|NCT02679781|567389788|FG000|Overall Study|Lost to Follow-up|1|||
157177243|NCT02679781|567389789|FG001|Overall Study|Lost to Follow-up|2|||
157177244|NCT02679781|567389788|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
157177245|NCT02679781|567389789|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
157177246|NCT01822223|567389790|FG000|Overall Study|Death|0|||
157177247|NCT01822223|567389791|FG001|Overall Study|Death|1|||
157177248|NCT04209400|567389794|FG000|Overall Study|Withdrawal by Subject|0|||
157177249|NCT04209400|567389795|FG001|Overall Study|Withdrawal by Subject|1|||
157177250|NCT03700736|567389800|FG000|Overall Study|Pregnancy|1|||
157177251|NCT03700736|567389801|FG001|Overall Study|Pregnancy|1|||
157177252|NCT03700736|567389800|FG000|Overall Study|Withdrawal by Subject|2|||
157177253|NCT03700736|567389801|FG001|Overall Study|Withdrawal by Subject|6|||
157177254|NCT01696396|567391851|FG000|Overall Study|Withdrawal by Subject|19|||
157177255|NCT01696396|567391852|FG001|Overall Study|Withdrawal by Subject|5|||
157177256|NCT01696396|567391853|FG002|Overall Study|Withdrawal by Subject|19|||
157177257|NCT01696396|567391854|FG003|Overall Study|Withdrawal by Subject|11|||
157177258|NCT01696396|567391851|FG000|Overall Study|Decision by Sponsor|3|||
157177259|NCT01696396|567391852|FG001|Overall Study|Decision by Sponsor|1|||
157177260|NCT01696396|567391853|FG002|Overall Study|Decision by Sponsor|2|||
157177261|NCT01696396|567391854|FG003|Overall Study|Decision by Sponsor|2|||
157177262|NCT01696396|567391851|FG000|Overall Study|Lost to Follow-up|9|||
157177263|NCT01696396|567391852|FG001|Overall Study|Lost to Follow-up|1|||
157177264|NCT01696396|567391853|FG002|Overall Study|Lost to Follow-up|4|||
157177265|NCT01696396|567391854|FG003|Overall Study|Lost to Follow-up|1|||
157177266|NCT01696396|567391851|FG000|Overall Study|Death|0|||
157177267|NCT01696396|567391852|FG001|Overall Study|Death|0|||
157177268|NCT01696396|567391853|FG002|Overall Study|Death|1|||
157177269|NCT01696396|567391854|FG003|Overall Study|Death|0|||
157177270|NCT00880100|567391857|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
157177271|NCT00880100|567391857|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
157177272|NCT00880100|567391857|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
157177273|NCT03424044|567391858|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177274|NCT03424044|567391859|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177275|NCT03424044|567391860|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
157177276|NCT03424044|567391861|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177277|NCT03424044|567391862|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177278|NCT03424044|567391863|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177279|NCT03424044|567391864|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177280|NCT03424044|567391865|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177281|NCT03424044|567391866|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
157177282|NCT03424044|567391858|FG000|First Intervention (76 Hours)|Adverse Event|0|||
157177283|NCT03424044|567391859|FG001|First Intervention (76 Hours)|Adverse Event|0|||
157177284|NCT03424044|567391860|FG002|First Intervention (76 Hours)|Adverse Event|0|||
157177285|NCT03424044|567391861|FG003|First Intervention (76 Hours)|Adverse Event|0|||
157177286|NCT03424044|567391862|FG004|First Intervention (76 Hours)|Adverse Event|1|||
157177287|NCT03424044|567391863|FG005|First Intervention (76 Hours)|Adverse Event|0|||
157177288|NCT03424044|567391864|FG006|First Intervention (76 Hours)|Adverse Event|0|||
157177289|NCT03424044|567391865|FG007|First Intervention (76 Hours)|Adverse Event|0|||
157177290|NCT03424044|567391866|FG008|First Intervention (76 Hours)|Adverse Event|0|||
157177291|NCT03424044|567391858|FG000|First Intervention (76 Hours)|device issues|0|||
157177292|NCT03424044|567391859|FG001|First Intervention (76 Hours)|device issues|0|||
157177293|NCT03424044|567391860|FG002|First Intervention (76 Hours)|device issues|0|||
157177294|NCT03424044|567391861|FG003|First Intervention (76 Hours)|device issues|0|||
157177295|NCT03424044|567391862|FG004|First Intervention (76 Hours)|device issues|0|||
157177296|NCT03424044|567391863|FG005|First Intervention (76 Hours)|device issues|0|||
157177297|NCT03424044|567391864|FG006|First Intervention (76 Hours)|device issues|1|||
157177298|NCT03424044|567391865|FG007|First Intervention (76 Hours)|device issues|1|||
157177299|NCT03424044|567391866|FG008|First Intervention (76 Hours)|device issues|1|||
157177300|NCT03424044|567391858|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
157177301|NCT03424044|567391859|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
157177302|NCT03424044|567391860|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
157177303|NCT03424044|567391861|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
157177304|NCT03424044|567391862|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
157177305|NCT03424044|567391863|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
157177306|NCT03424044|567391864|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
157177307|NCT03424044|567391865|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
157229529|NCT02937701|567586467|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
157229530|NCT02937701|567586463|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
157177308|NCT03424044|567391866|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
157177309|NCT03424044|567391858|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177310|NCT03424044|567391859|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177311|NCT03424044|567391860|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157229531|NCT02937701|567586464|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
157177312|NCT03424044|567391861|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
157177313|NCT03424044|567391862|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177314|NCT03424044|567391863|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177315|NCT03424044|567391864|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177316|NCT03424044|567391865|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177317|NCT03424044|567391866|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
157177318|NCT00106249|567391867|FG000|Overall Study|Lost to Follow-up|3|||
157177319|NCT00106249|567391868|FG001|Overall Study|Lost to Follow-up|2|||
157177320|NCT00114218|567391883|FG000|Overall Study|Wrong Cell Type|2|||
157177321|NCT00114218|567391883|FG000|Overall Study|Wrong Primary|1|||
157177322|NCT00114218|567391883|FG000|Overall Study|Never Treated|1|||
157177323|NCT01505114|567391884|FG000|Overall Study|Withdrawal by Subject|5|||
157177324|NCT01505114|567391885|FG001|Overall Study|Withdrawal by Subject|4|||
157177325|NCT01505114|567391886|FG002|Overall Study|Withdrawal by Subject|4|||
157177326|NCT01505114|567391887|FG003|Overall Study|Withdrawal by Subject|7|||
157177327|NCT01505114|567391884|FG000|Overall Study|Death|1|||
157177328|NCT01505114|567391885|FG001|Overall Study|Death|0|||
157177329|NCT01505114|567391886|FG002|Overall Study|Death|0|||
157177330|NCT01505114|567391887|FG003|Overall Study|Death|1|||
157177331|NCT01505114|567391884|FG000|Overall Study|unable to adhere to visit schedule|3|||
157177332|NCT01505114|567391885|FG001|Overall Study|unable to adhere to visit schedule|2|||
157177333|NCT01505114|567391886|FG002|Overall Study|unable to adhere to visit schedule|3|||
157177334|NCT01505114|567391887|FG003|Overall Study|unable to adhere to visit schedule|3|||
157177335|NCT01505114|567391884|FG000|Overall Study|Lost to Follow-up|11|||
157177336|NCT01505114|567391885|FG001|Overall Study|Lost to Follow-up|5|||
157177337|NCT01505114|567391886|FG002|Overall Study|Lost to Follow-up|8|||
157177338|NCT01505114|567391887|FG003|Overall Study|Lost to Follow-up|7|||
157177339|NCT01505114|567391884|FG000|Overall Study|relocated|4|||
157177340|NCT01505114|567391885|FG001|Overall Study|relocated|2|||
157177341|NCT01505114|567391886|FG002|Overall Study|relocated|2|||
157177342|NCT01505114|567391887|FG003|Overall Study|relocated|3|||
157177343|NCT01505114|567391884|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
157177344|NCT01505114|567391885|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
157177345|NCT01505114|567391886|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
157177346|NCT01505114|567391887|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
157177347|NCT01505114|567391884|FG000|Overall Study|staff safety concerns|0|||
157177348|NCT01505114|567391885|FG001|Overall Study|staff safety concerns|0|||
157177349|NCT01505114|567391886|FG002|Overall Study|staff safety concerns|0|||
157177350|NCT01505114|567391887|FG003|Overall Study|staff safety concerns|1|||
157177351|NCT01505114|567391884|FG000|Overall Study|investigator decision|1|||
157177352|NCT01505114|567391885|FG001|Overall Study|investigator decision|0|||
157177353|NCT01505114|567391886|FG002|Overall Study|investigator decision|1|||
157177354|NCT01505114|567391887|FG003|Overall Study|investigator decision|0|||
157177355|NCT01421069|567391889|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
157177356|NCT01421069|567391889|FG000|Parent Study|Failed to return|3|||
157177357|NCT01421069|567391889|FG000|Parent Study|Withdrawal by Subject|1|||
157177358|NCT01421069|567391889|FG000|Parent Study|Lost to Follow-up|2|||
157177359|NCT01421069|567391889|FG000|Parent Study|Lack of Efficacy|1|||
157177360|NCT01421069|567391889|FG000|Overall Period for Extension Study|Other|2|||
157177361|NCT01421069|567391889|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
157177362|NCT01421069|567391889|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
157177363|NCT01421069|567391889|FG000|Overall Period for Extension Study|Pregnancy|1|||
157177364|NCT01421069|567391889|FG000|Overall Period for Extension Study|Adverse Event|1|||
157177365|NCT01421069|567391889|FG000|Overall Period for Extension Study|Protocol Violation|1|||
157229532|NCT02937701|567586465|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
157229533|NCT02937701|567586466|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
157229534|NCT02937701|567586467|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
157229535|NCT02937701|567586463|FG000|Week 22 to Week 50|Physician Decision|0|||
157229536|NCT02937701|567586464|FG001|Week 22 to Week 50|Physician Decision|0|||
157229537|NCT02937701|567586465|FG002|Week 22 to Week 50|Physician Decision|2|||
157229538|NCT02937701|567586466|FG003|Week 22 to Week 50|Physician Decision|0|||
157229539|NCT02937701|567586467|FG004|Week 22 to Week 50|Physician Decision|1|||
157229540|NCT02937701|567586463|FG000|Week 22 to Week 50|Other|0|||
157229541|NCT02937701|567586464|FG001|Week 22 to Week 50|Other|0|||
157229542|NCT02937701|567586465|FG002|Week 22 to Week 50|Other|0|||
157229543|NCT02937701|567586466|FG003|Week 22 to Week 50|Other|0|||
157229544|NCT02937701|567586467|FG004|Week 22 to Week 50|Other|1|||
157177366|NCT01421069|567391889|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
157177367|NCT01421069|567391889|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
157177368|NCT01421069|567391889|FG000|Active Treatment Period|Other|1|||
157177369|NCT01421069|567391889|FG000|Active Treatment Period|No longer willing to participate in study|8|||
157177370|NCT01421069|567391889|FG000|Active Treatment Period|Insufficient clinical response|1|||
157229545|NCT00416520|567586469|FG000|Open-label Period|Adverse Event|28|||
157229546|NCT00416520|567586470|FG001|Open-label Period|Adverse Event|10|||
157229547|NCT00416520|567586471|FG002|Open-label Period|Adverse Event|0|||
157177371|NCT01421069|567391889|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
157177372|NCT01421069|567391889|FG000|Active Treatment Period|Pregnancy|1|||
157177373|NCT01421069|567391889|FG000|Active Treatment Period|Adverse Event|1|||
157177374|NCT01421069|567391889|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
157177375|NCT01421069|567391889|FG000|Active Treatment Period|Enrolled in observational period|29|||
157177376|NCT01421069|567391889|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
157177377|NCT01421069|567391889|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
157177378|NCT01421069|567391889|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
157177379|NCT01421069|567391889|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
157177380|NCT01421069|567391889|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
157177381|NCT01421069|567391889|FG000|2b. Retreatment Period|Protocol Violation|1|||
157177382|NCT01421069|567391889|FG000|Observational Period|Other|1|||
157177383|NCT01421069|567391889|FG000|Observational Period|No longer willing to participate in study|4|||
157177384|NCT01421069|567391889|FG000|Observational Period|Lost to Follow-up|3|||
157177385|NCT01641081|567391890|FG000|Period 1|Sponsor request (potential unblinding)|0|||
157177386|NCT01641081|567391891|FG001|Period 1|Sponsor request (potential unblinding)|0|||
157177387|NCT01641081|567391892|FG002|Period 1|Sponsor request (potential unblinding)|0|||
157177388|NCT01641081|567391893|FG003|Period 1|Sponsor request (potential unblinding)|0|||
157177389|NCT01641081|567391894|FG004|Period 1|Sponsor request (potential unblinding)|0|||
157177390|NCT01641081|567391895|FG005|Period 1|Sponsor request (potential unblinding)|0|||
157177391|NCT01641081|567391896|FG006|Period 1|Sponsor request (potential unblinding)|1|||
157177392|NCT01641081|567391897|FG007|Period 1|Sponsor request (potential unblinding)|0|||
157177393|NCT01641081|567391898|FG008|Period 1|Sponsor request (potential unblinding)|0|||
157177394|NCT01641081|567391899|FG009|Period 1|Sponsor request (potential unblinding)|0|||
157177395|NCT01641081|567391890|FG000|Period 1|Protocol Violation|0|||
157177396|NCT01641081|567391891|FG001|Period 1|Protocol Violation|0|||
157177397|NCT01641081|567391892|FG002|Period 1|Protocol Violation|0|||
157177398|NCT01641081|567391893|FG003|Period 1|Protocol Violation|0|||
157177399|NCT01641081|567391894|FG004|Period 1|Protocol Violation|1|||
157177400|NCT01641081|567391895|FG005|Period 1|Protocol Violation|0|||
157177401|NCT01641081|567391896|FG006|Period 1|Protocol Violation|0|||
157177402|NCT01641081|567391897|FG007|Period 1|Protocol Violation|1|||
157177403|NCT01641081|567391898|FG008|Period 1|Protocol Violation|0|||
157177404|NCT01641081|567391899|FG009|Period 1|Protocol Violation|0|||
157177405|NCT01641081|567391890|FG000|Period 1|Adverse Event|1|||
157177406|NCT01641081|567391891|FG001|Period 1|Adverse Event|0|||
157177407|NCT01641081|567391892|FG002|Period 1|Adverse Event|0|||
157177408|NCT01641081|567391893|FG003|Period 1|Adverse Event|0|||
157177409|NCT01641081|567391894|FG004|Period 1|Adverse Event|0|||
157177410|NCT01641081|567391895|FG005|Period 1|Adverse Event|0|||
157177411|NCT01641081|567391896|FG006|Period 1|Adverse Event|0|||
157177412|NCT01641081|567391897|FG007|Period 1|Adverse Event|2|||
157177413|NCT01641081|567391898|FG008|Period 1|Adverse Event|0|||
157177414|NCT01641081|567391899|FG009|Period 1|Adverse Event|0|||
157177415|NCT01641081|567391890|FG000|Period 2|Adverse Event|0|||
157177416|NCT01641081|567391891|FG001|Period 2|Adverse Event|0|||
157177417|NCT01641081|567391892|FG002|Period 2|Adverse Event|0|||
157177418|NCT01641081|567391893|FG003|Period 2|Adverse Event|0|||
157054746|NCT02123797|566954040|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
157054747|NCT02123797|566954041|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
157054748|NCT02123797|566954037|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
157054749|NCT02123797|566954038|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
157054750|NCT02123797|566954039|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
157054751|NCT02123797|566954040|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
157054752|NCT02123797|566954041|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
157054753|NCT02123797|566954037|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
157054754|NCT02123797|566954038|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
157054755|NCT02123797|566954039|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
157177419|NCT01641081|567391894|FG004|Period 2|Adverse Event|0|||
157177420|NCT01641081|567391895|FG005|Period 2|Adverse Event|1|||
157177421|NCT01641081|567391896|FG006|Period 2|Adverse Event|0|||
157177422|NCT01641081|567391897|FG007|Period 2|Adverse Event|0|||
157177423|NCT01641081|567391898|FG008|Period 2|Adverse Event|0|||
157177424|NCT01641081|567391899|FG009|Period 2|Adverse Event|0|||
157177425|NCT01641081|567391890|FG000|Period 2|Withdrawal by Subject|0|||
157177426|NCT01641081|567391891|FG001|Period 2|Withdrawal by Subject|0|||
157054756|NCT02123797|566954040|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
157177427|NCT01641081|567391892|FG002|Period 2|Withdrawal by Subject|0|||
157054757|NCT02123797|566954041|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
157177428|NCT01641081|567391893|FG003|Period 2|Withdrawal by Subject|1|||
157177429|NCT01641081|567391894|FG004|Period 2|Withdrawal by Subject|0|||
157177430|NCT01641081|567391895|FG005|Period 2|Withdrawal by Subject|0|||
157177431|NCT01641081|567391896|FG006|Period 2|Withdrawal by Subject|2|||
157177432|NCT01641081|567391897|FG007|Period 2|Withdrawal by Subject|0|||
157177433|NCT01641081|567391898|FG008|Period 2|Withdrawal by Subject|0|||
157177434|NCT01641081|567391899|FG009|Period 2|Withdrawal by Subject|0|||
157177435|NCT01641081|567391890|FG000|Period 2|Protocol Violation|1|||
157177436|NCT01641081|567391891|FG001|Period 2|Protocol Violation|0|||
157177437|NCT01641081|567391892|FG002|Period 2|Protocol Violation|0|||
157177438|NCT01641081|567391893|FG003|Period 2|Protocol Violation|0|||
157177439|NCT01641081|567391894|FG004|Period 2|Protocol Violation|0|||
157177440|NCT01641081|567391895|FG005|Period 2|Protocol Violation|0|||
157177441|NCT01641081|567391896|FG006|Period 2|Protocol Violation|0|||
157177442|NCT01641081|567391897|FG007|Period 2|Protocol Violation|0|||
157177443|NCT01641081|567391898|FG008|Period 2|Protocol Violation|0|||
157177444|NCT01641081|567391899|FG009|Period 2|Protocol Violation|0|||
157177445|NCT01641081|567391890|FG000|Period 3|Adverse Event|0|||
157177446|NCT01641081|567391891|FG001|Period 3|Adverse Event|0|||
157177447|NCT01641081|567391892|FG002|Period 3|Adverse Event|1|||
157177448|NCT01641081|567391893|FG003|Period 3|Adverse Event|0|||
157177449|NCT01641081|567391894|FG004|Period 3|Adverse Event|0|||
157177450|NCT01641081|567391895|FG005|Period 3|Adverse Event|0|||
157177451|NCT01641081|567391896|FG006|Period 3|Adverse Event|0|||
157177452|NCT01641081|567391897|FG007|Period 3|Adverse Event|0|||
157177453|NCT01641081|567391898|FG008|Period 3|Adverse Event|0|||
157177454|NCT01641081|567391899|FG009|Period 3|Adverse Event|0|||
157177455|NCT01641081|567391890|FG000|Period 3|Withdrawal by Subject|0|||
157177456|NCT01641081|567391891|FG001|Period 3|Withdrawal by Subject|0|||
157177457|NCT01641081|567391892|FG002|Period 3|Withdrawal by Subject|0|||
157177458|NCT01641081|567391893|FG003|Period 3|Withdrawal by Subject|0|||
157177459|NCT01641081|567391894|FG004|Period 3|Withdrawal by Subject|0|||
157177460|NCT01641081|567391895|FG005|Period 3|Withdrawal by Subject|0|||
157177461|NCT01641081|567391896|FG006|Period 3|Withdrawal by Subject|0|||
157177462|NCT01641081|567391897|FG007|Period 3|Withdrawal by Subject|0|||
157177463|NCT01641081|567391898|FG008|Period 3|Withdrawal by Subject|1|||
157177464|NCT01641081|567391899|FG009|Period 3|Withdrawal by Subject|0|||
157177465|NCT01641081|567391890|FG000|Period 4|Adverse Event|0|||
157177466|NCT01641081|567391891|FG001|Period 4|Adverse Event|1|||
157177467|NCT01641081|567391892|FG002|Period 4|Adverse Event|0|||
157177468|NCT01641081|567391893|FG003|Period 4|Adverse Event|1|||
157177469|NCT01641081|567391894|FG004|Period 4|Adverse Event|0|||
157177470|NCT01641081|567391895|FG005|Period 4|Adverse Event|0|||
157177471|NCT01641081|567391896|FG006|Period 4|Adverse Event|0|||
157177472|NCT01641081|567391897|FG007|Period 4|Adverse Event|0|||
157177473|NCT01641081|567391898|FG008|Period 4|Adverse Event|0|||
157177474|NCT01641081|567391899|FG009|Period 4|Adverse Event|0|||
157177475|NCT01641081|567391890|FG000|Period 5|Adverse Event|0|||
157177476|NCT01641081|567391891|FG001|Period 5|Adverse Event|0|||
157177477|NCT01641081|567391892|FG002|Period 5|Adverse Event|2|||
157177478|NCT01641081|567391893|FG003|Period 5|Adverse Event|0|||
157177479|NCT01641081|567391894|FG004|Period 5|Adverse Event|0|||
157177480|NCT01641081|567391895|FG005|Period 5|Adverse Event|0|||
157177481|NCT01641081|567391896|FG006|Period 5|Adverse Event|0|||
157177482|NCT01641081|567391897|FG007|Period 5|Adverse Event|0|||
157177483|NCT01641081|567391898|FG008|Period 5|Adverse Event|0|||
157177484|NCT01641081|567391899|FG009|Period 5|Adverse Event|0|||
157177485|NCT01095666|567391903|FG000|Overall Study|Lack of Efficacy|0|||
157177486|NCT01095666|567391904|FG001|Overall Study|Lack of Efficacy|0|||
157177487|NCT01095666|567391905|FG002|Overall Study|Lack of Efficacy|1|||
157177488|NCT01095666|567391903|FG000|Overall Study|Adverse Event|2|||
157177489|NCT01095666|567391904|FG001|Overall Study|Adverse Event|1|||
157177490|NCT01095666|567391905|FG002|Overall Study|Adverse Event|3|||
157177491|NCT01095666|567391903|FG000|Overall Study|Lost to Follow-up|2|||
157177492|NCT01095666|567391904|FG001|Overall Study|Lost to Follow-up|2|||
157177493|NCT01095666|567391905|FG002|Overall Study|Lost to Follow-up|0|||
157177494|NCT01095666|567391903|FG000|Overall Study|Withdrawal by Subject|6|||
157177495|NCT01095666|567391904|FG001|Overall Study|Withdrawal by Subject|6|||
157177496|NCT01095666|567391905|FG002|Overall Study|Withdrawal by Subject|1|||
157177497|NCT01095666|567391903|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
157177498|NCT01095666|567391904|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
157177499|NCT01095666|567391905|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
157177500|NCT04423757|567391908|FG000|Overall Study|Adverse Event|2|||
157229548|NCT00416520|567586472|FG003|Open-label Period|Adverse Event|0|||
157177501|NCT04423757|567391909|FG001|Overall Study|Adverse Event|0|||
157177502|NCT04423757|567391908|FG000|Overall Study|Not treated|1|||
157177503|NCT04423757|567391909|FG001|Overall Study|Not treated|1|||
157177504|NCT02738580|567391910|FG000|Overall Study|Adverse Event|1|||
157177505|NCT02738580|567391911|FG001|Overall Study|Adverse Event|0|||
157177506|NCT02738580|567391910|FG000|Overall Study|Lack of Efficacy|3|||
157177507|NCT02738580|567391911|FG001|Overall Study|Lack of Efficacy|2|||
157177508|NCT02738580|567391910|FG000|Overall Study|Withdrawal by Subject|0|||
157177509|NCT02738580|567391911|FG001|Overall Study|Withdrawal by Subject|1|||
157177510|NCT02738580|567391910|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
157177511|NCT02738580|567391911|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
157177512|NCT01202760|567391912|FG000|Overall Study|Entry Criteria Not Met|0|||
157177513|NCT01202760|567391913|FG001|Overall Study|Entry Criteria Not Met|3|||
157177514|NCT01202760|567391914|FG002|Overall Study|Entry Criteria Not Met|1|||
157177515|NCT01202760|567391912|FG000|Overall Study|Adverse Event|11|||
157054758|NCT02123797|566954037|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
157054759|NCT02123797|566954038|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
157054760|NCT02123797|566954039|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157054761|NCT02123797|566954040|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157054762|NCT02123797|566954041|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
157054763|NCT02123797|566954037|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
157054764|NCT02123797|566954038|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
157054765|NCT02123797|566954039|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
157054766|NCT02123797|566954040|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
157054767|NCT02123797|566954041|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
157054768|NCT04385849|566954045|FG000|Overall Study|Lost to Follow-up|1|||
157054769|NCT04385849|566954046|FG001|Overall Study|Lost to Follow-up|0|||
157054770|NCT01375777|566954047|FG000|Overall Study|Withdrawal by Subject|0|||
157054771|NCT01375777|566954048|FG001|Overall Study|Withdrawal by Subject|2|||
157054772|NCT01375777|566954049|FG002|Overall Study|Withdrawal by Subject|1|||
157054773|NCT01375777|566954050|FG003|Overall Study|Withdrawal by Subject|0|||
157054774|NCT01375777|566954051|FG004|Overall Study|Withdrawal by Subject|1|||
157054775|NCT01375777|566954052|FG005|Overall Study|Withdrawal by Subject|1|||
157054776|NCT01375777|566954053|FG006|Overall Study|Withdrawal by Subject|1|||
157054777|NCT01375777|566954054|FG007|Overall Study|Withdrawal by Subject|2|||
157054778|NCT01375777|566954055|FG008|Overall Study|Withdrawal by Subject|1|||
157054779|NCT01375777|566954047|FG000|Overall Study|Lost to Follow-up|1|||
157054780|NCT01375777|566954048|FG001|Overall Study|Lost to Follow-up|0|||
157054781|NCT01375777|566954049|FG002|Overall Study|Lost to Follow-up|0|||
157054782|NCT01375777|566954050|FG003|Overall Study|Lost to Follow-up|0|||
157054783|NCT01375777|566954051|FG004|Overall Study|Lost to Follow-up|0|||
157054784|NCT01375777|566954052|FG005|Overall Study|Lost to Follow-up|0|||
157054785|NCT01375777|566954053|FG006|Overall Study|Lost to Follow-up|1|||
157054786|NCT01375777|566954054|FG007|Overall Study|Lost to Follow-up|0|||
157054787|NCT01375777|566954055|FG008|Overall Study|Lost to Follow-up|0|||
157054788|NCT01375777|566954047|FG000|Overall Study|Other|1|||
157054789|NCT01375777|566954048|FG001|Overall Study|Other|1|||
157054790|NCT01375777|566954049|FG002|Overall Study|Other|0|||
157054791|NCT01375777|566954050|FG003|Overall Study|Other|0|||
157054792|NCT01375777|566954051|FG004|Overall Study|Other|0|||
157054793|NCT01375777|566954052|FG005|Overall Study|Other|0|||
157054794|NCT01375777|566954053|FG006|Overall Study|Other|0|||
157054795|NCT01375777|566954054|FG007|Overall Study|Other|0|||
157054796|NCT01375777|566954055|FG008|Overall Study|Other|1|||
157054797|NCT00355784|566954056|FG000|Overall Study|Withdrawal by Subject|0|||
157054798|NCT00355784|566954057|FG001|Overall Study|Withdrawal by Subject|0|||
157054799|NCT00355784|566954058|FG002|Overall Study|Withdrawal by Subject|2|||
157054800|NCT03602053|566954065|FG000|Overall Study|Withdrawal by Subject|7|||
157054801|NCT03602053|566954066|FG001|Overall Study|Withdrawal by Subject|9|||
157054802|NCT03602053|566954067|FG002|Overall Study|Withdrawal by Subject|7|||
157054803|NCT03602053|566954065|FG000|Overall Study|Lost to Follow-up|5|||
157054804|NCT03602053|566954066|FG001|Overall Study|Lost to Follow-up|6|||
157054805|NCT03602053|566954067|FG002|Overall Study|Lost to Follow-up|0|||
157054806|NCT03602053|566954065|FG000|Overall Study|Protocol Violation|3|||
157054807|NCT03602053|566954066|FG001|Overall Study|Protocol Violation|0|||
157054808|NCT03602053|566954067|FG002|Overall Study|Protocol Violation|4|||
157054809|NCT03602053|566954065|FG000|Overall Study|Physician Decision|1|||
157054810|NCT03602053|566954066|FG001|Overall Study|Physician Decision|0|||
157054811|NCT03602053|566954067|FG002|Overall Study|Physician Decision|0|||
157054812|NCT03602053|566954065|FG000|Overall Study|migration|2|||
157054813|NCT03602053|566954066|FG001|Overall Study|migration|3|||
157054814|NCT03602053|566954067|FG002|Overall Study|migration|0|||
157054815|NCT03602053|566954065|FG000|Overall Study|Other|1|||
157054816|NCT03602053|566954066|FG001|Overall Study|Other|0|||
157054817|NCT03602053|566954067|FG002|Overall Study|Other|0|||
157054818|NCT03672188|566954078|FG000|Overall Study|Withdrawal by Subject|0|||
157054819|NCT03672188|566954079|FG001|Overall Study|Withdrawal by Subject|0|||
157054820|NCT03672188|566954080|FG002|Overall Study|Withdrawal by Subject|0|||
157054821|NCT03672188|566954081|FG003|Overall Study|Withdrawal by Subject|3|||
157054822|NCT03672188|566954082|FG004|Overall Study|Withdrawal by Subject|0|||
157054823|NCT03672188|566954083|FG005|Overall Study|Withdrawal by Subject|0|||
157054824|NCT03672188|566954084|FG006|Overall Study|Withdrawal by Subject|0|||
157054825|NCT03672188|566954085|FG007|Overall Study|Withdrawal by Subject|0|||
157054826|NCT03672188|566954086|FG008|Overall Study|Withdrawal by Subject|0|||
157054827|NCT03672188|566954087|FG009|Overall Study|Withdrawal by Subject|0|||
157054828|NCT03672188|566954088|FG010|Overall Study|Withdrawal by Subject|0|||
157177516|NCT01202760|567391913|FG001|Overall Study|Adverse Event|9|||
157054829|NCT03672188|566954089|FG011|Overall Study|Withdrawal by Subject|0|||
157054830|NCT03672188|566954090|FG012|Overall Study|Withdrawal by Subject|0|||
157054831|NCT03672188|566954091|FG013|Overall Study|Withdrawal by Subject|0|||
157054832|NCT03672188|566954092|FG014|Overall Study|Withdrawal by Subject|0|||
157054833|NCT03672188|566954078|FG000|Overall Study|Death|0|||
157054834|NCT03672188|566954079|FG001|Overall Study|Death|0|||
157177517|NCT01202760|567391914|FG002|Overall Study|Adverse Event|10|||
157177518|NCT01202760|567391912|FG000|Overall Study|Death|2|||
157177519|NCT01202760|567391913|FG001|Overall Study|Death|1|||
157177520|NCT01202760|567391914|FG002|Overall Study|Death|0|||
157177521|NCT01202760|567391912|FG000|Overall Study|Lack of Efficacy|6|||
157177522|NCT01202760|567391913|FG001|Overall Study|Lack of Efficacy|8|||
157177523|NCT01202760|567391914|FG002|Overall Study|Lack of Efficacy|7|||
157177524|NCT01202760|567391912|FG000|Overall Study|Lost to Follow-up|0|||
157177525|NCT01202760|567391913|FG001|Overall Study|Lost to Follow-up|2|||
157177526|NCT01202760|567391914|FG002|Overall Study|Lost to Follow-up|1|||
157177527|NCT01202760|567391912|FG000|Overall Study|Parent / Caregiver Decision|0|||
157177528|NCT01202760|567391913|FG001|Overall Study|Parent / Caregiver Decision|1|||
157177529|NCT01202760|567391914|FG002|Overall Study|Parent / Caregiver Decision|0|||
157177530|NCT01202760|567391912|FG000|Overall Study|Withdrawal by Subject|17|||
157177531|NCT01202760|567391913|FG001|Overall Study|Withdrawal by Subject|18|||
157177532|NCT01202760|567391914|FG002|Overall Study|Withdrawal by Subject|14|||
157177533|NCT01202760|567391912|FG000|Overall Study|Physician Decision|0|||
157177534|NCT01202760|567391913|FG001|Overall Study|Physician Decision|1|||
157177535|NCT01202760|567391914|FG002|Overall Study|Physician Decision|0|||
157177536|NCT01202760|567391912|FG000|Overall Study|Protocol Violation|7|||
157177537|NCT01202760|567391913|FG001|Overall Study|Protocol Violation|5|||
157177538|NCT01202760|567391914|FG002|Overall Study|Protocol Violation|2|||
157177539|NCT01202760|567391912|FG000|Overall Study|Sponsor Decision|4|||
157177540|NCT01202760|567391913|FG001|Overall Study|Sponsor Decision|4|||
157177541|NCT01202760|567391914|FG002|Overall Study|Sponsor Decision|0|||
157177542|NCT02810951|567391915|FG000|Overall Study|Adverse Event|1|||
157177543|NCT01250756|567391916|FG000|Infant Series|Withdrawal by Subject|4|||
157177544|NCT01250756|567391917|FG001|Infant Series|Withdrawal by Subject|5|||
157177545|NCT01250756|567391916|FG000|Infant Series|Randomized, Not Vaccinated|2|||
157177546|NCT01250756|567391917|FG001|Infant Series|Randomized, Not Vaccinated|2|||
157177547|NCT01250756|567391916|FG000|Infant Series|Other|22|||
157177548|NCT01250756|567391917|FG001|Infant Series|Other|0|||
157177549|NCT01250756|567391916|FG000|After Infant Series|Adverse Event|5|||
157177550|NCT01250756|567391917|FG001|After Infant Series|Adverse Event|2|||
157177551|NCT01250756|567391916|FG000|After Infant Series|Withdrawal by Subject|4|||
157177552|NCT01250756|567391917|FG001|After Infant Series|Withdrawal by Subject|1|||
157177553|NCT01250756|567391916|FG000|After Infant Series|Other|2|||
157177554|NCT01250756|567391917|FG001|After Infant Series|Other|1|||
157177555|NCT01250756|567391916|FG000|Toddler Dose|Adverse Event|0|||
157177556|NCT01250756|567391917|FG001|Toddler Dose|Adverse Event|1|||
157177557|NCT01250756|567391916|FG000|After Toddler Dose|Adverse Event|0|||
157177558|NCT01250756|567391917|FG001|After Toddler Dose|Adverse Event|1|||
157177559|NCT02925312|567391921|FG000|Overall Study|Lost to Follow-up|25|||
157177560|NCT02925312|567391922|FG001|Overall Study|Lost to Follow-up|0|||
157177561|NCT02925312|567391921|FG000|Overall Study|Adverse Event|2|||
157229549|NCT00416520|567586469|FG000|Open-label Period|Death|2|||
156974149|NCT05375955|566659537|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
157177562|NCT02925312|567391922|FG001|Overall Study|Adverse Event|0|||
157177563|NCT00376246|567391923|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
157177564|NCT00376246|567391924|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
157177565|NCT00376246|567391923|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
157177566|NCT00376246|567391924|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
157177567|NCT00376246|567391923|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
157177568|NCT00376246|567391924|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
157177569|NCT00166517|567391929|FG000|Overall Study|Lost to Follow-up|1|||
157177570|NCT00166517|567391930|FG001|Overall Study|Lost to Follow-up|0|||
157177571|NCT00166517|567391929|FG000|Overall Study|Protocol Violation|4|||
157177572|NCT00166517|567391930|FG001|Overall Study|Protocol Violation|1|||
157177573|NCT00166517|567391929|FG000|Overall Study|Withdrawal by Subject|0|||
157177574|NCT00166517|567391930|FG001|Overall Study|Withdrawal by Subject|1|||
157177575|NCT03094611|567391934|FG000|Overall Study|Lack of Efficacy|1|||
157177576|NCT03094611|567391934|FG000|Overall Study|Stem Cell Transplant|1|||
157177577|NCT04285853|567391935|FG000|Overall Study|Withdrawal by Subject|1|||
157177578|NCT04285853|567391936|FG001|Overall Study|Withdrawal by Subject|0|||
157177579|NCT04285853|567391935|FG000|Overall Study|Lost to Follow-up|9|||
157177580|NCT04285853|567391936|FG001|Overall Study|Lost to Follow-up|5|||
157177581|NCT01496274|567391938|FG000|Overall Study|Protocol Violation|0|||
157177582|NCT01496274|567391939|FG001|Overall Study|Protocol Violation|1|||
156974150|NCT05375955|566659538|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156974151|NCT05375955|566659539|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156974152|NCT05375955|566659540|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
156974153|NCT05375955|566659534|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156974154|NCT05375955|566659535|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
156974155|NCT05375955|566659536|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156974156|NCT05375955|566659537|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
156974157|NCT05375955|566659538|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
156974158|NCT05375955|566659539|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
157177583|NCT01496274|567391938|FG000|Overall Study|Adverse Event|1|||
157054835|NCT03672188|566954080|FG002|Overall Study|Death|0|||
157054836|NCT03672188|566954081|FG003|Overall Study|Death|0|||
157054837|NCT03672188|566954082|FG004|Overall Study|Death|0|||
157054838|NCT03672188|566954083|FG005|Overall Study|Death|0|||
157054839|NCT03672188|566954084|FG006|Overall Study|Death|0|||
157054840|NCT03672188|566954085|FG007|Overall Study|Death|0|||
157054841|NCT03672188|566954086|FG008|Overall Study|Death|0|||
157054842|NCT03672188|566954087|FG009|Overall Study|Death|0|||
157054843|NCT03672188|566954088|FG010|Overall Study|Death|0|||
157054844|NCT03672188|566954089|FG011|Overall Study|Death|0|||
157054845|NCT03672188|566954090|FG012|Overall Study|Death|1|||
157054846|NCT03672188|566954091|FG013|Overall Study|Death|0|||
157054847|NCT03672188|566954092|FG014|Overall Study|Death|0|||
157054848|NCT03672188|566954078|FG000|Overall Study|Lost to Follow-up|0|||
157054849|NCT03672188|566954079|FG001|Overall Study|Lost to Follow-up|0|||
157054850|NCT03672188|566954080|FG002|Overall Study|Lost to Follow-up|1|||
157054851|NCT03672188|566954081|FG003|Overall Study|Lost to Follow-up|0|||
157054852|NCT03672188|566954082|FG004|Overall Study|Lost to Follow-up|0|||
157054853|NCT03672188|566954083|FG005|Overall Study|Lost to Follow-up|0|||
157054854|NCT03672188|566954084|FG006|Overall Study|Lost to Follow-up|0|||
157054855|NCT03672188|566954085|FG007|Overall Study|Lost to Follow-up|0|||
157054856|NCT03672188|566954086|FG008|Overall Study|Lost to Follow-up|0|||
157054857|NCT03672188|566954087|FG009|Overall Study|Lost to Follow-up|0|||
157054858|NCT03672188|566954088|FG010|Overall Study|Lost to Follow-up|0|||
157054859|NCT03672188|566954089|FG011|Overall Study|Lost to Follow-up|0|||
157054860|NCT03672188|566954090|FG012|Overall Study|Lost to Follow-up|0|||
157054861|NCT03672188|566954091|FG013|Overall Study|Lost to Follow-up|0|||
157054862|NCT03672188|566954092|FG014|Overall Study|Lost to Follow-up|0|||
157054863|NCT01234675|566954093|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
157054864|NCT01234675|566954094|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
157054865|NCT01234675|566954093|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
157054866|NCT01234675|566954094|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
157054867|NCT03997409|566954095|FG000|Overall Study|Protocol Violation|1|||
157054868|NCT03997409|566954096|FG001|Overall Study|Protocol Violation|1|||
157054869|NCT03997409|566954097|FG002|Overall Study|Protocol Violation|0|||
157054870|NCT03997409|566954095|FG000|Overall Study|Withdrawal by Subject|3|||
157054871|NCT03997409|566954096|FG001|Overall Study|Withdrawal by Subject|0|||
157054872|NCT03997409|566954097|FG002|Overall Study|Withdrawal by Subject|0|||
157054873|NCT03997409|566954095|FG000|Overall Study|Lost to Follow-up|0|||
157054874|NCT03997409|566954096|FG001|Overall Study|Lost to Follow-up|0|||
157054875|NCT03997409|566954097|FG002|Overall Study|Lost to Follow-up|1|||
157054876|NCT01753323|566954098|FG000|Overall Study|Lack of Efficacy|0|||
157054877|NCT01753323|566954099|FG001|Overall Study|Lack of Efficacy|0|||
157054878|NCT01753323|566954100|FG002|Overall Study|Lack of Efficacy|8|||
157054879|NCT01753323|566954098|FG000|Overall Study|Protocol deviation|1|||
157054880|NCT01753323|566954099|FG001|Overall Study|Protocol deviation|0|||
157054881|NCT01753323|566954100|FG002|Overall Study|Protocol deviation|0|||
157054882|NCT01753323|566954098|FG000|Overall Study|Adverse Event|0|||
157054883|NCT01753323|566954099|FG001|Overall Study|Adverse Event|0|||
157054884|NCT01753323|566954100|FG002|Overall Study|Adverse Event|1|||
157054885|NCT01870999|566954101|FG000|Overall Study|Adverse Event|0|||
157054886|NCT01870999|566954102|FG001|Overall Study|Adverse Event|4|||
157054887|NCT01870999|566954103|FG002|Overall Study|Adverse Event|1|||
157054888|NCT01870999|566954101|FG000|Overall Study|Subject met withdrawal criteria|3|||
157054889|NCT01870999|566954102|FG001|Overall Study|Subject met withdrawal criteria|2|||
157054890|NCT01870999|566954103|FG002|Overall Study|Subject met withdrawal criteria|0|||
157054891|NCT01870999|566954101|FG000|Overall Study|Subject withdrawn by Investigator|1|||
157054892|NCT01870999|566954102|FG001|Overall Study|Subject withdrawn by Investigator|0|||
157054893|NCT01870999|566954103|FG002|Overall Study|Subject withdrawn by Investigator|0|||
157177584|NCT01496274|567391939|FG001|Overall Study|Adverse Event|1|||
157177585|NCT01496274|567391938|FG000|Overall Study|Withdrawal by Subject|2|||
157177586|NCT01496274|567391939|FG001|Overall Study|Withdrawal by Subject|0|||
157177587|NCT01496274|567391938|FG000|Overall Study|Lost to Follow-up|0|||
157177588|NCT01496274|567391939|FG001|Overall Study|Lost to Follow-up|3|||
157054894|NCT01870999|566954101|FG000|Overall Study|Withdrawal by Subject|0|||
157054895|NCT01870999|566954102|FG001|Overall Study|Withdrawal by Subject|2|||
157054896|NCT01870999|566954103|FG002|Overall Study|Withdrawal by Subject|5|||
157054897|NCT01870999|566954101|FG000|Overall Study|Protocol Violation|0|||
157054898|NCT01870999|566954102|FG001|Overall Study|Protocol Violation|0|||
157054899|NCT01870999|566954103|FG002|Overall Study|Protocol Violation|1|||
157054900|NCT00116584|566954114|FG000|Overall Study|Withdrawal by Subject|1|||
157177589|NCT02758613|567391940|FG000|Treatment|Physician and Sponsor Decision|1|||
157054901|NCT00116584|566954115|FG001|Overall Study|Withdrawal by Subject|0|||
157054902|NCT00116584|566954114|FG000|Overall Study|Protocol Violation|1|||
157054903|NCT00116584|566954115|FG001|Overall Study|Protocol Violation|1|||
157054904|NCT03034772|566954116|FG000|Overall Study|Adverse Event|0|||
157054905|NCT03034772|566954117|FG001|Overall Study|Adverse Event|1|||
157054906|NCT03034772|566954116|FG000|Overall Study|Withdrawal by Subject|0|||
157177590|NCT02758613|567391941|FG001|Treatment|Physician and Sponsor Decision|0|||
157177591|NCT02758613|567391942|FG002|Treatment|Physician and Sponsor Decision|0|||
157177592|NCT02758613|567391943|FG003|Treatment|Physician and Sponsor Decision|0|||
157177593|NCT02758613|567391940|FG000|Treatment|Withdrawal by Subject|1|||
157177594|NCT02758613|567391941|FG001|Treatment|Withdrawal by Subject|0|||
157177595|NCT02758613|567391942|FG002|Treatment|Withdrawal by Subject|1|||
157177596|NCT02758613|567391943|FG003|Treatment|Withdrawal by Subject|0|||
157177597|NCT00351819|567391944|FG000|Overall Study|Lost to Follow-up|4|||
157177598|NCT00351819|567391945|FG001|Overall Study|Lost to Follow-up|4|||
157177599|NCT00351819|567391944|FG000|Overall Study|Withdrawal by Subject|0|||
157177600|NCT00351819|567391945|FG001|Overall Study|Withdrawal by Subject|4|||
157177601|NCT00351819|567391944|FG000|Overall Study|Elevated PSA|1|||
157177602|NCT00351819|567391945|FG001|Overall Study|Elevated PSA|1|||
157177603|NCT00351819|567391944|FG000|Overall Study|Traumatic ankle fracture|1|||
157177604|NCT00351819|567391945|FG001|Overall Study|Traumatic ankle fracture|0|||
157177605|NCT00351819|567391944|FG000|Overall Study|Unprofessional behavior|1|||
157177606|NCT00351819|567391945|FG001|Overall Study|Unprofessional behavior|0|||
157177607|NCT00351819|567391944|FG000|Overall Study|Non-compliance|0|||
157177608|NCT00351819|567391945|FG001|Overall Study|Non-compliance|1|||
157177609|NCT00351819|567391944|FG000|Overall Study|Incarcerated|0|||
157177610|NCT00351819|567391945|FG001|Overall Study|Incarcerated|1|||
157177611|NCT00351819|567391944|FG000|Overall Study|Enrolled in another trial|0|||
157177612|NCT00351819|567391945|FG001|Overall Study|Enrolled in another trial|1|||
157177613|NCT00249795|567391948|FG000|Overall Study|Not treated|16|||
157177614|NCT00249795|567391949|FG001|Overall Study|Not treated|14|||
157177615|NCT00249795|567391948|FG000|Overall Study|Symptomatic hypotension|127|||
157177616|NCT00249795|567391949|FG001|Overall Study|Symptomatic hypotension|64|||
157177617|NCT00249795|567391948|FG000|Overall Study|Other Serious Adverse Event|84|||
157177618|NCT00249795|567391949|FG001|Overall Study|Other Serious Adverse Event|93|||
157177619|NCT00249795|567391948|FG000|Overall Study|Qualifying condition not present|26|||
157177620|NCT00249795|567391949|FG001|Overall Study|Qualifying condition not present|29|||
157177621|NCT00249795|567391948|FG000|Overall Study|Withdrawal by Subject|678|||
157177622|NCT00249795|567391949|FG001|Overall Study|Withdrawal by Subject|742|||
157177623|NCT00249795|567391948|FG000|Overall Study|Thromboembolic / outcome event|39|||
157177624|NCT00249795|567391949|FG001|Overall Study|Thromboembolic / outcome event|45|||
157177625|NCT00249795|567391948|FG000|Overall Study|Oral anticoagulant required|2|||
157177626|NCT00249795|567391949|FG001|Overall Study|Oral anticoagulant required|0|||
157177627|NCT00249795|567391948|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
157177628|NCT00249795|567391949|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
157177629|NCT00249795|567391948|FG000|Overall Study|Non-compliance|71|||
157177630|NCT00249795|567391949|FG001|Overall Study|Non-compliance|69|||
157177631|NCT00249795|567391948|FG000|Overall Study|Study drug intolerance|3|||
157177632|NCT00249795|567391949|FG001|Overall Study|Study drug intolerance|3|||
157177633|NCT00249795|567391948|FG000|Overall Study|Other adverse events (non-serious)|188|||
157177634|NCT00249795|567391949|FG001|Overall Study|Other adverse events (non-serious)|159|||
157177635|NCT00249795|567391948|FG000|Overall Study|Physician withdrew consent|71|||
157177636|NCT00249795|567391949|FG001|Overall Study|Physician withdrew consent|63|||
157177637|NCT00249795|567391948|FG000|Overall Study|Surgery / procedure|4|||
157177638|NCT00249795|567391949|FG001|Overall Study|Surgery / procedure|5|||
157177639|NCT00249795|567391948|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
157054907|NCT03034772|566954117|FG001|Overall Study|Withdrawal by Subject|1|||
157054908|NCT01745380|566954118|FG000|Overall Study|Lost to Follow-up|1|||
157054909|NCT01745380|566954119|FG001|Overall Study|Lost to Follow-up|0|||
157054910|NCT01745380|566954118|FG000|Overall Study|Lack of Efficacy|0|||
157054911|NCT01745380|566954119|FG001|Overall Study|Lack of Efficacy|1|||
157177640|NCT00249795|567391949|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
157177641|NCT00249795|567391948|FG000|Overall Study|Lightheadedness / dizziness|15|||
157177642|NCT00249795|567391949|FG001|Overall Study|Lightheadedness / dizziness|11|||
157177643|NCT00249795|567391948|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
157177644|NCT00249795|567391949|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
157177645|NCT00249795|567391948|FG000|Overall Study|Other contraindicated medication|1|||
157177646|NCT00249795|567391949|FG001|Overall Study|Other contraindicated medication|1|||
157177647|NCT00249795|567391948|FG000|Overall Study|Event related to cardiac condition|17|||
157177648|NCT00249795|567391949|FG001|Overall Study|Event related to cardiac condition|16|||
157177649|NCT00249795|567391948|FG000|Overall Study|Patient not wish to continue after May08|4|||
157177650|NCT00249795|567391949|FG001|Overall Study|Patient not wish to continue after May08|6|||
157177651|NCT00249795|567391948|FG000|Overall Study|Site not agree to continue after May08|1|||
157177652|NCT00249795|567391949|FG001|Overall Study|Site not agree to continue after May08|1|||
157177653|NCT00249795|567391948|FG000|Overall Study|Lost to Follow-up|0|||
157177654|NCT00249795|567391949|FG001|Overall Study|Lost to Follow-up|2|||
157177655|NCT00249795|567391948|FG000|Overall Study|Missing|0|||
157177656|NCT00249795|567391949|FG001|Overall Study|Missing|1|||
157177657|NCT00196196|567391951|FG000|Overall Study|Withdrawal by Subject|2|||
157177658|NCT00196196|567391951|FG000|Overall Study|Did not have required condition (hydroce|5|||
157177659|NCT02096042|567391954|FG000|Overall Study|Disease Progression|1|||
157177660|NCT02096042|567391955|FG001|Overall Study|Disease Progression|0|||
157177661|NCT02096042|567391956|FG002|Overall Study|Disease Progression|0|||
157177662|NCT01015820|567391958|FG000|Overall Study|Suboptimal measurements|1|||
157177663|NCT01015820|567391959|FG001|Overall Study|Suboptimal measurements|0|||
157177664|NCT03034057|567391960|FG000|Overall Study|Withdrawal by Subject|10|||
157177665|NCT03034057|567391960|FG000|Overall Study|Protocol Violation|1|||
157177666|NCT03034057|567391960|FG000|Overall Study|Not defined|2|||
157177667|NCT03034057|567391960|FG000|Overall Study|Lost to Follow-up|19|||
157177668|NCT03034057|567391960|FG000|Overall Study|Adverse Event|22|||
157177669|NCT03034057|567391960|FG000|Overall Study|Medication error without associated AE|1|||
157177670|NCT03339401|567391961|FG000|Overall Study|Death|2|||
157177671|NCT03339401|567391962|FG001|Overall Study|Death|1|||
157177672|NCT03339401|567391961|FG000|Overall Study|Withdrawal by Subject|2|||
157177673|NCT03339401|567391962|FG001|Overall Study|Withdrawal by Subject|0|||
157177674|NCT03339401|567391961|FG000|Overall Study|Study terminated|4|||
157177675|NCT03339401|567391962|FG001|Overall Study|Study terminated|3|||
157177676|NCT03339401|567391961|FG000|Overall Study|Investigator Decision|1|||
157177677|NCT03339401|567391962|FG001|Overall Study|Investigator Decision|0|||
157177678|NCT00718523|567391963|FG000|Overall Study|Withdrawal by Subject|5|||
157177679|NCT00718523|567391964|FG001|Overall Study|Withdrawal by Subject|7|||
157177680|NCT00718523|567391963|FG000|Overall Study|Death|13|||
157177681|NCT00718523|567391964|FG001|Overall Study|Death|17|||
157177682|NCT01313078|567391965|FG000|Overall Study|Death|1|||
157177683|NCT01313078|567391965|FG000|Overall Study|Discontinued study drug|1|||
157177684|NCT01313078|567391965|FG000|Overall Study|Withdrawal by Subject|1|||
157177685|NCT00910728|567391966|FG000|Overall Study|Lack of Efficacy|2|||
157177686|NCT00910728|567391967|FG001|Overall Study|Lack of Efficacy|3|||
157177687|NCT00910728|567391968|FG002|Overall Study|Lack of Efficacy|1|||
157177688|NCT00910728|567391969|FG003|Overall Study|Lack of Efficacy|2|||
157177689|NCT00910728|567391970|FG004|Overall Study|Lack of Efficacy|1|||
157177690|NCT00910728|567391971|FG005|Overall Study|Lack of Efficacy|0|||
157177691|NCT00910728|567391972|FG006|Overall Study|Lack of Efficacy|2|||
157177692|NCT00910728|567391973|FG007|Overall Study|Lack of Efficacy|2|||
157177693|NCT00910728|567391974|FG008|Overall Study|Lack of Efficacy|2|||
157177694|NCT00910728|567391966|FG000|Overall Study|Withdrawal by Subject|0|||
157177695|NCT00910728|567391967|FG001|Overall Study|Withdrawal by Subject|0|||
157177696|NCT00910728|567391968|FG002|Overall Study|Withdrawal by Subject|0|||
157177697|NCT00910728|567391969|FG003|Overall Study|Withdrawal by Subject|0|||
157177698|NCT00910728|567391970|FG004|Overall Study|Withdrawal by Subject|3|||
157177699|NCT00910728|567391971|FG005|Overall Study|Withdrawal by Subject|1|||
157177700|NCT00910728|567391972|FG006|Overall Study|Withdrawal by Subject|2|||
157177701|NCT00910728|567391973|FG007|Overall Study|Withdrawal by Subject|0|||
157177702|NCT00910728|567391974|FG008|Overall Study|Withdrawal by Subject|0|||
157177703|NCT00910728|567391966|FG000|Overall Study|(not specified)|2|||
157177704|NCT00910728|567391967|FG001|Overall Study|(not specified)|0|||
157177705|NCT00910728|567391968|FG002|Overall Study|(not specified)|1|||
157177706|NCT00910728|567391969|FG003|Overall Study|(not specified)|0|||
157177707|NCT00910728|567391970|FG004|Overall Study|(not specified)|1|||
157177708|NCT00910728|567391971|FG005|Overall Study|(not specified)|0|||
157177709|NCT00910728|567391972|FG006|Overall Study|(not specified)|0|||
157177710|NCT00910728|567391973|FG007|Overall Study|(not specified)|0|||
157177711|NCT00910728|567391974|FG008|Overall Study|(not specified)|0|||
157177712|NCT00910728|567391966|FG000|Overall Study|Adverse Event|2|||
157177713|NCT00910728|567391967|FG001|Overall Study|Adverse Event|0|||
157177714|NCT00910728|567391968|FG002|Overall Study|Adverse Event|1|||
157177715|NCT00910728|567391969|FG003|Overall Study|Adverse Event|1|||
157177716|NCT00910728|567391970|FG004|Overall Study|Adverse Event|0|||
157177717|NCT00910728|567391971|FG005|Overall Study|Adverse Event|0|||
157177718|NCT00910728|567391972|FG006|Overall Study|Adverse Event|2|||
157177719|NCT00910728|567391973|FG007|Overall Study|Adverse Event|1|||
157177720|NCT00910728|567391974|FG008|Overall Study|Adverse Event|1|||
157177721|NCT03404518|567391975|FG000|Overall Study|Lost to Follow-up|28|||
157229550|NCT00416520|567586470|FG001|Open-label Period|Death|1|||
157177722|NCT03404518|567391976|FG001|Overall Study|Lost to Follow-up|30|||
157177723|NCT03404518|567391975|FG000|Overall Study|Protocol Violation|13|||
157177724|NCT03404518|567391976|FG001|Overall Study|Protocol Violation|6|||
157177725|NCT05041062|567391977|FG000|Overall Study|Adverse Event|2|||
157177726|NCT03693404|567391981|FG000|Overall Study|Withdrawal by Subject|1|||
157177727|NCT03693404|567391982|FG001|Overall Study|Withdrawal by Subject|0|||
157177728|NCT03693404|567391981|FG000|Overall Study|Lost to Follow-up|0|||
157177729|NCT03693404|567391982|FG001|Overall Study|Lost to Follow-up|5|||
157177730|NCT03693404|567391981|FG000|Overall Study|Excluded from Analysis|0|||
157177731|NCT03693404|567391982|FG001|Overall Study|Excluded from Analysis|1|||
157177732|NCT01176240|567391983|FG000|Study 306A|Lack of Efficacy|2|||
157177733|NCT01176240|567391984|FG001|Study 306A|Lack of Efficacy|1|||
157177734|NCT01176240|567391983|FG000|Study 306A|Protocol Violation|0|||
157177735|NCT01176240|567391984|FG001|Study 306A|Protocol Violation|1|||
157177736|NCT01176240|567391983|FG000|Study 306A|Withdrawal by Subject|0|||
157177737|NCT01176240|567391984|FG001|Study 306A|Withdrawal by Subject|1|||
157177738|NCT01176240|567391983|FG000|Study 306A|Stop due to diverse problems|1|||
157229551|NCT00416520|567586471|FG002|Open-label Period|Death|0|||
157177739|NCT01176240|567391984|FG001|Study 306A|Stop due to diverse problems|0|||
157177740|NCT01176240|567391983|FG000|Study 306B|Lack of Efficacy|5|||
157177741|NCT01176240|567391984|FG001|Study 306B|Lack of Efficacy|3|||
157177742|NCT01176240|567391983|FG000|Study 306B|Adverse Event|10|||
157177743|NCT01176240|567391984|FG001|Study 306B|Adverse Event|5|||
157177744|NCT01176240|567391983|FG000|Study 306B|Protocol Violation|2|||
157177745|NCT01176240|567391984|FG001|Study 306B|Protocol Violation|3|||
157177746|NCT01176240|567391983|FG000|Study 306B|Withdrawal by Subject|4|||
157177747|NCT01176240|567391984|FG001|Study 306B|Withdrawal by Subject|1|||
157177748|NCT01176240|567391983|FG000|Study 306B|Physician Decision|2|||
157177749|NCT01176240|567391984|FG001|Study 306B|Physician Decision|1|||
157177750|NCT01176240|567391983|FG000|Study 306B|Supine Hypertension|1|||
157177751|NCT01176240|567391984|FG001|Study 306B|Supine Hypertension|2|||
157177752|NCT01176240|567391983|FG000|Study 306B|Lost to Follow-up|0|||
157177753|NCT01176240|567391984|FG001|Study 306B|Lost to Follow-up|1|||
157177754|NCT01176240|567391983|FG000|Study 306B|withdrew prior to dosing|2|||
157177755|NCT01176240|567391984|FG001|Study 306B|withdrew prior to dosing|1|||
157177756|NCT05200455|567391985|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
157177757|NCT00807014|567391988|FG000|Overall Study|Participant Considered Disease Cured|13|||
157177758|NCT00807014|567391989|FG001|Overall Study|Participant Considered Disease Cured|2|||
157177759|NCT00807014|567391988|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
157177760|NCT00807014|567391989|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
157177761|NCT00807014|567391988|FG000|Overall Study|Protocol Violation|2|||
157177762|NCT00807014|567391989|FG001|Overall Study|Protocol Violation|8|||
157177763|NCT00807014|567391988|FG000|Overall Study|Adverse Event|0|||
157177764|NCT00807014|567391989|FG001|Overall Study|Adverse Event|2|||
157177765|NCT00807014|567391988|FG000|Overall Study|Lost to Follow-up|9|||
157177766|NCT00807014|567391989|FG001|Overall Study|Lost to Follow-up|7|||
157177767|NCT00807014|567391988|FG000|Overall Study|Recovery|1|||
157177768|NCT00807014|567391989|FG001|Overall Study|Recovery|0|||
157177769|NCT00807014|567391988|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
157177770|NCT00807014|567391989|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
157177771|NCT00651313|567391990|FG000|Overall Study|Adverse Event|0|||
157177772|NCT00651313|567391991|FG001|Overall Study|Adverse Event|1|||
157177773|NCT00651313|567391990|FG000|Overall Study|Withdrawal by Subject|3|||
157177774|NCT00651313|567391991|FG001|Overall Study|Withdrawal by Subject|1|||
157177775|NCT00651313|567391990|FG000|Overall Study|Lost to Follow-up|1|||
157177776|NCT00651313|567391991|FG001|Overall Study|Lost to Follow-up|1|||
157177777|NCT00651313|567391990|FG000|Overall Study|Adminstrative Discontinuation|2|||
157177778|NCT00651313|567391991|FG001|Overall Study|Adminstrative Discontinuation|3|||
157177779|NCT00892957|567391993|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
157177780|NCT00892957|567391994|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
157177781|NCT00892957|567391993|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
157177782|NCT00892957|567391994|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
157177783|NCT03307629|567392000|FG000|Overall Study|Withdrawal by Subject|0|||
157177784|NCT03307629|567392001|FG001|Overall Study|Withdrawal by Subject|0|||
157177785|NCT03307629|567392002|FG002|Overall Study|Withdrawal by Subject|0|||
157177786|NCT03307629|567392003|FG003|Overall Study|Withdrawal by Subject|2|||
157177787|NCT03307629|567392000|FG000|Overall Study|Disease Progression|0|||
157177788|NCT03307629|567392001|FG001|Overall Study|Disease Progression|0|||
157177789|NCT03307629|567392002|FG002|Overall Study|Disease Progression|0|||
157177790|NCT03307629|567392003|FG003|Overall Study|Disease Progression|3|||
157177791|NCT03307629|567392000|FG000|Overall Study|Death|0|||
157177792|NCT03307629|567392001|FG001|Overall Study|Death|3|||
157177793|NCT03307629|567392002|FG002|Overall Study|Death|0|||
157177794|NCT03307629|567392003|FG003|Overall Study|Death|1|||
157177795|NCT02853032|567392008|FG000|Overall Study|Adverse Event|4|||
157177796|NCT02853032|567392009|FG001|Overall Study|Adverse Event|0|||
157177797|NCT02853032|567392008|FG000|Overall Study|Withdrawal by Subject|3|||
157177798|NCT02853032|567392009|FG001|Overall Study|Withdrawal by Subject|1|||
157177799|NCT02853032|567392008|FG000|Overall Study|Requested to withdraw from all treatment|2|||
157177800|NCT02853032|567392009|FG001|Overall Study|Requested to withdraw from all treatment|2|||
157177801|NCT04876599|567392010|FG000|Overall Study|Missed|2|||
157177802|NCT04876599|567392011|FG001|Overall Study|Missed|0|||
157177803|NCT04876599|567392010|FG000|Overall Study|Declined|2|||
157177804|NCT04876599|567392011|FG001|Overall Study|Declined|3|||
157177805|NCT00676208|567392018|FG000|Overall Study|Lost to Follow-up|0|||
157177806|NCT00676208|567392019|FG001|Overall Study|Lost to Follow-up|2|||
157177807|NCT00676208|567392018|FG000|Overall Study|Incomplete data|2|||
157177808|NCT00676208|567392019|FG001|Overall Study|Incomplete data|4|||
157177809|NCT00669032|567392020|FG000|Overall Study|Lost to Follow-up|6|||
157177810|NCT00669032|567392021|FG001|Overall Study|Lost to Follow-up|5|||
157177811|NCT00669032|567392020|FG000|Overall Study|Lack of Efficacy|8|||
157177812|NCT00669032|567392021|FG001|Overall Study|Lack of Efficacy|19|||
157177813|NCT00669032|567392020|FG000|Overall Study|Withdrawal by Subject|12|||
157177814|NCT00669032|567392021|FG001|Overall Study|Withdrawal by Subject|13|||
157177815|NCT00669032|567392020|FG000|Overall Study|Adverse Event|12|||
157177816|NCT00669032|567392021|FG001|Overall Study|Adverse Event|16|||
157177817|NCT00669032|567392020|FG000|Overall Study|Physician Decision|1|||
157177818|NCT00669032|567392021|FG001|Overall Study|Physician Decision|1|||
157177819|NCT00669032|567392020|FG000|Overall Study|No fulfilment of the selection criteria|5|||
157177820|NCT00669032|567392021|FG001|Overall Study|No fulfilment of the selection criteria|5|||
157177821|NCT00642018|567392024|FG000|Overall Study|Adverse Event|11|||
157177822|NCT00642018|567392025|FG001|Overall Study|Adverse Event|36|||
157177823|NCT00642018|567392024|FG000|Overall Study|Withdrawal by Subject|4|||
157177824|NCT00642018|567392025|FG001|Overall Study|Withdrawal by Subject|10|||
157177825|NCT00642018|567392024|FG000|Overall Study|Progressive Disease|13|||
157177826|NCT00642018|567392025|FG001|Overall Study|Progressive Disease|18|||
157177827|NCT00642018|567392024|FG000|Overall Study|Physician Decision|0|||
157177828|NCT00642018|567392025|FG001|Overall Study|Physician Decision|10|||
157177829|NCT00642018|567392024|FG000|Overall Study|Protocol Violation|0|||
157177830|NCT00642018|567392025|FG001|Overall Study|Protocol Violation|1|||
157177831|NCT00642018|567392024|FG000|Overall Study|Death|0|||
157177832|NCT00642018|567392025|FG001|Overall Study|Death|3|||
157177833|NCT00642018|567392024|FG000|Overall Study|Entry Criteria Not Met|0|||
157177834|NCT00642018|567392025|FG001|Overall Study|Entry Criteria Not Met|1|||
157177835|NCT01607073|567392026|FG000|Overall Study|Adverse Event|1|||
157177836|NCT01410799|567392027|FG000|Overall Study|PI decision|13|||
157177837|NCT04126031|567392029|FG000|Part A|Withdrawal by Subject|0|||
157177838|NCT04126031|567392030|FG001|Part A|Withdrawal by Subject|0|||
157177839|NCT04126031|567392031|FG002|Part A|Withdrawal by Subject|1|||
157177840|NCT04126031|567392032|FG003|Part A|Withdrawal by Subject|0|||
157177841|NCT04126031|567392033|FG004|Part A|Withdrawal by Subject|0|||
157177842|NCT04126031|567392034|FG005|Part A|Withdrawal by Subject|0|||
157177843|NCT04126031|567392029|FG000|Part A|Other|1|||
157177844|NCT04126031|567392030|FG001|Part A|Other|0|||
157177845|NCT04126031|567392031|FG002|Part A|Other|0|||
157177846|NCT04126031|567392032|FG003|Part A|Other|0|||
157177847|NCT04126031|567392033|FG004|Part A|Other|0|||
157177848|NCT04126031|567392034|FG005|Part A|Other|0|||
157177849|NCT04126031|567392029|FG000|Part B|Adverse Event|0|||
157177850|NCT04126031|567392030|FG001|Part B|Adverse Event|0|||
157177851|NCT04126031|567392031|FG002|Part B|Adverse Event|0|||
157177852|NCT04126031|567392032|FG003|Part B|Adverse Event|0|||
157177853|NCT04126031|567392033|FG004|Part B|Adverse Event|0|||
157177854|NCT04126031|567392034|FG005|Part B|Adverse Event|2|||
157177855|NCT04126031|567392029|FG000|Part B|Pre-existing hypertransaminasemia|0|||
157177856|NCT04126031|567392030|FG001|Part B|Pre-existing hypertransaminasemia|0|||
157177857|NCT04126031|567392031|FG002|Part B|Pre-existing hypertransaminasemia|0|||
157177858|NCT04126031|567392032|FG003|Part B|Pre-existing hypertransaminasemia|0|||
157177859|NCT04126031|567392033|FG004|Part B|Pre-existing hypertransaminasemia|1|||
157177860|NCT04126031|567392034|FG005|Part B|Pre-existing hypertransaminasemia|0|||
157177861|NCT01946412|567392035|FG000|Overall Study|Adverse Event|1|||
157177862|NCT01946412|567392035|FG000|Overall Study|Non-Compliance|1|||
157177863|NCT01946412|567392035|FG000|Overall Study|Continued with commercial Kalydeco|2|||
157177864|NCT01946412|567392035|FG000|Overall Study|Difficulty in swallowing|1|||
157177865|NCT00131664|567392036|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
157177866|NCT00131664|567392037|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
157177867|NCT00131664|567392038|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
157177868|NCT00131664|567392039|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
157177869|NCT00131664|567392040|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
157177870|NCT00131664|567392041|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
157177871|NCT00131664|567392036|FG000|First Period (First 6 Months)|Death|0|||
157177872|NCT00131664|567392037|FG001|First Period (First 6 Months)|Death|1|||
157177873|NCT00131664|567392038|FG002|First Period (First 6 Months)|Death|0|||
157177874|NCT00131664|567392039|FG003|First Period (First 6 Months)|Death|0|||
157177875|NCT00131664|567392040|FG004|First Period (First 6 Months)|Death|0|||
157177876|NCT00131664|567392041|FG005|First Period (First 6 Months)|Death|0|||
157177877|NCT00131664|567392036|FG000|First Period (First 6 Months)|Protocol Violation|2|||
157177878|NCT00131664|567392037|FG001|First Period (First 6 Months)|Protocol Violation|2|||
157177879|NCT00131664|567392038|FG002|First Period (First 6 Months)|Protocol Violation|1|||
157177880|NCT00131664|567392039|FG003|First Period (First 6 Months)|Protocol Violation|0|||
157177881|NCT00131664|567392040|FG004|First Period (First 6 Months)|Protocol Violation|0|||
157177882|NCT00131664|567392041|FG005|First Period (First 6 Months)|Protocol Violation|0|||
157177883|NCT00131664|567392036|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
157177884|NCT00131664|567392037|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
157177885|NCT00131664|567392038|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
157177886|NCT00131664|567392039|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
157177887|NCT00131664|567392040|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
157177888|NCT00131664|567392041|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
157177889|NCT00131664|567392036|FG000|First Period (First 6 Months)|Adverse Event|9|||
157177890|NCT00131664|567392037|FG001|First Period (First 6 Months)|Adverse Event|4|||
157177891|NCT00131664|567392038|FG002|First Period (First 6 Months)|Adverse Event|5|||
157177892|NCT00131664|567392039|FG003|First Period (First 6 Months)|Adverse Event|0|||
157177893|NCT00131664|567392040|FG004|First Period (First 6 Months)|Adverse Event|0|||
157177894|NCT00131664|567392041|FG005|First Period (First 6 Months)|Adverse Event|0|||
157177895|NCT00131664|567392036|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
157177896|NCT00131664|567392037|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
157177897|NCT00131664|567392038|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
157177898|NCT00131664|567392039|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
157177899|NCT00131664|567392040|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
157177900|NCT00131664|567392041|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
157177901|NCT00131664|567392036|FG000|First Period (First 6 Months)|Administrative reasons|2|||
157177902|NCT00131664|567392037|FG001|First Period (First 6 Months)|Administrative reasons|0|||
157177903|NCT00131664|567392038|FG002|First Period (First 6 Months)|Administrative reasons|5|||
157177904|NCT00131664|567392039|FG003|First Period (First 6 Months)|Administrative reasons|0|||
157177905|NCT00131664|567392040|FG004|First Period (First 6 Months)|Administrative reasons|0|||
157177906|NCT00131664|567392041|FG005|First Period (First 6 Months)|Administrative reasons|0|||
157177907|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
157177908|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
157177909|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
157177910|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
157177911|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
157177912|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
157177913|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
157177914|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
157177915|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
157177916|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
157177917|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
157177918|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
157177919|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
157177920|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
157177921|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
157177922|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
157177923|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
157177924|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
157177925|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
157177926|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
157177927|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
157177928|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
157177929|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
157177930|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
157177931|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
157177932|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
157177933|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
157177934|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
157177935|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
157177936|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
157177937|NCT00131664|567392036|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
157177938|NCT00131664|567392037|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
157177939|NCT00131664|567392038|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
157177940|NCT00131664|567392039|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
157177941|NCT00131664|567392040|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
157177942|NCT00131664|567392041|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
157177943|NCT01594749|567393842|FG000|Overall Study|Adverse Event|2|||
157177944|NCT01594749|567393843|FG001|Overall Study|Adverse Event|1|||
157177945|NCT01594749|567393842|FG000|Overall Study|Withdrawal by Subject|2|||
157177946|NCT01594749|567393843|FG001|Overall Study|Withdrawal by Subject|2|||
157177947|NCT01594749|567393842|FG000|Overall Study|Protocol Violation|2|||
157177948|NCT01594749|567393843|FG001|Overall Study|Protocol Violation|0|||
157177949|NCT01594749|567393842|FG000|Overall Study|Physician Decision|1|||
157177950|NCT01594749|567393843|FG001|Overall Study|Physician Decision|1|||
157177951|NCT01594749|567393842|FG000|Overall Study|Non-compliance with Protocol|0|||
157177952|NCT01594749|567393843|FG001|Overall Study|Non-compliance with Protocol|1|||
157177953|NCT01594749|567393842|FG000|Overall Study|Lost to Follow-up|1|||
157229552|NCT00416520|567586472|FG003|Open-label Period|Death|0|||
157054912|NCT02660034|566954120|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
157054913|NCT02660034|566954121|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
157054914|NCT02660034|566954122|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
157054915|NCT02660034|566954123|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
157054916|NCT02660034|566954124|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
157054917|NCT02660034|566954125|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
157054918|NCT02660034|566954126|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
157054919|NCT02660034|566954127|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
157054920|NCT02660034|566954128|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
157054921|NCT02660034|566954129|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
157054922|NCT02660034|566954130|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
157054923|NCT02660034|566954131|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
157054924|NCT02660034|566954132|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
157054925|NCT02660034|566954133|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
157054926|NCT02660034|566954120|FG000|Overall Study|Progressive Disease (Clinical)|7|||
157054927|NCT02660034|566954121|FG001|Overall Study|Progressive Disease (Clinical)|8|||
157054928|NCT02660034|566954122|FG002|Overall Study|Progressive Disease (Clinical)|3|||
157054929|NCT02660034|566954123|FG003|Overall Study|Progressive Disease (Clinical)|9|||
157054930|NCT02660034|566954124|FG004|Overall Study|Progressive Disease (Clinical)|3|||
157054931|NCT02660034|566954125|FG005|Overall Study|Progressive Disease (Clinical)|0|||
157054932|NCT02660034|566954126|FG006|Overall Study|Progressive Disease (Clinical)|0|||
157054933|NCT02660034|566954127|FG007|Overall Study|Progressive Disease (Clinical)|0|||
157054934|NCT02660034|566954128|FG008|Overall Study|Progressive Disease (Clinical)|0|||
157054935|NCT02660034|566954129|FG009|Overall Study|Progressive Disease (Clinical)|0|||
157054936|NCT02660034|566954130|FG010|Overall Study|Progressive Disease (Clinical)|0|||
157054937|NCT02660034|566954131|FG011|Overall Study|Progressive Disease (Clinical)|0|||
157054938|NCT02660034|566954132|FG012|Overall Study|Progressive Disease (Clinical)|0|||
157054939|NCT02660034|566954133|FG013|Overall Study|Progressive Disease (Clinical)|0|||
157054940|NCT02660034|566954120|FG000|Overall Study|Lost to Follow-up|0|||
157054941|NCT02660034|566954121|FG001|Overall Study|Lost to Follow-up|0|||
157054942|NCT02660034|566954122|FG002|Overall Study|Lost to Follow-up|1|||
157054943|NCT02660034|566954123|FG003|Overall Study|Lost to Follow-up|1|||
157054944|NCT02660034|566954124|FG004|Overall Study|Lost to Follow-up|0|||
157054945|NCT02660034|566954125|FG005|Overall Study|Lost to Follow-up|0|||
157054946|NCT02660034|566954126|FG006|Overall Study|Lost to Follow-up|0|||
157054947|NCT02660034|566954127|FG007|Overall Study|Lost to Follow-up|0|||
157054948|NCT02660034|566954128|FG008|Overall Study|Lost to Follow-up|0|||
157054949|NCT02660034|566954129|FG009|Overall Study|Lost to Follow-up|1|||
157054950|NCT02660034|566954130|FG010|Overall Study|Lost to Follow-up|1|||
157054951|NCT02660034|566954131|FG011|Overall Study|Lost to Follow-up|1|||
157054952|NCT02660034|566954132|FG012|Overall Study|Lost to Follow-up|0|||
157054953|NCT02660034|566954133|FG013|Overall Study|Lost to Follow-up|0|||
157054954|NCT02660034|566954120|FG000|Overall Study|Participant moved into special access scheme|1|||
157054955|NCT02660034|566954121|FG001|Overall Study|Participant moved into special access scheme|2|||
157054956|NCT02660034|566954122|FG002|Overall Study|Participant moved into special access scheme|0|||
157054957|NCT02660034|566954123|FG003|Overall Study|Participant moved into special access scheme|0|||
157054958|NCT02660034|566954124|FG004|Overall Study|Participant moved into special access scheme|0|||
157054959|NCT02660034|566954125|FG005|Overall Study|Participant moved into special access scheme|0|||
157054960|NCT02660034|566954126|FG006|Overall Study|Participant moved into special access scheme|0|||
157054961|NCT02660034|566954127|FG007|Overall Study|Participant moved into special access scheme|0|||
157054962|NCT02660034|566954128|FG008|Overall Study|Participant moved into special access scheme|0|||
157054963|NCT02660034|566954129|FG009|Overall Study|Participant moved into special access scheme|0|||
157054964|NCT02660034|566954130|FG010|Overall Study|Participant moved into special access scheme|0|||
157054965|NCT02660034|566954131|FG011|Overall Study|Participant moved into special access scheme|0|||
157054966|NCT02660034|566954132|FG012|Overall Study|Participant moved into special access scheme|0|||
157054967|NCT02660034|566954133|FG013|Overall Study|Participant moved into special access scheme|0|||
157054968|NCT02660034|566954120|FG000|Overall Study|Adverse Event|1|||
157177954|NCT01594749|567393843|FG001|Overall Study|Lost to Follow-up|0|||
157177955|NCT01594749|567393842|FG000|Overall Study|Death|9|||
156974159|NCT05375955|566659540|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
156974160|NCT04615182|566659553|FG000|Overall Study|Re-transplanted|2|||
156974161|NCT04615182|566659553|FG000|Overall Study|Protocol Violation|6|||
156974162|NCT04615182|566659553|FG000|Overall Study|Death|6|||
156974163|NCT04615182|566659553|FG000|Overall Study|Death and protocol violation|1|||
156974164|NCT01126060|566659554|FG000|Overall Study|Protocol Violation|0|||
156974165|NCT01126060|566659555|FG001|Overall Study|Protocol Violation|2|||
156974166|NCT00402337|566659556|FG000|Overall Study|Adverse Event|0|||
156974167|NCT00402337|566659557|FG001|Overall Study|Adverse Event|2|||
156974168|NCT00402337|566659558|FG002|Overall Study|Adverse Event|2|||
156974169|NCT00402337|566659559|FG003|Overall Study|Adverse Event|3|||
157177956|NCT01594749|567393843|FG001|Overall Study|Death|3|||
156974170|NCT00402337|566659560|FG004|Overall Study|Adverse Event|2|||
156974171|NCT00402337|566659556|FG000|Overall Study|Noncompliance|0|||
156974172|NCT00402337|566659557|FG001|Overall Study|Noncompliance|0|||
156974173|NCT00402337|566659558|FG002|Overall Study|Noncompliance|0|||
157177957|NCT01594749|567393842|FG000|Overall Study|Not Treated|4|||
157177958|NCT01594749|567393843|FG001|Overall Study|Not Treated|10|||
157177959|NCT01594749|567393842|FG000|Overall Study|Lost Source Documentation|1|||
156974174|NCT00402337|566659559|FG003|Overall Study|Noncompliance|0|||
156974175|NCT00402337|566659560|FG004|Overall Study|Noncompliance|2|||
156974176|NCT00402337|566659556|FG000|Overall Study|Withdrawal by Subject|5|||
156974177|NCT00402337|566659557|FG001|Overall Study|Withdrawal by Subject|3|||
156974178|NCT00402337|566659558|FG002|Overall Study|Withdrawal by Subject|1|||
156974179|NCT00402337|566659559|FG003|Overall Study|Withdrawal by Subject|6|||
156974180|NCT00402337|566659560|FG004|Overall Study|Withdrawal by Subject|4|||
156974181|NCT00402337|566659556|FG000|Overall Study|Lost to Follow-up|0|||
157177960|NCT01594749|567393843|FG001|Overall Study|Lost Source Documentation|0|||
157177961|NCT00323310|567393844|FG000|Overall Study|Withdrawal by Subject|1|||
157177962|NCT00323310|567393844|FG000|Overall Study|a parent refused blood draw|1|||
157177963|NCT00323310|567393844|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
157177964|NCT03565991|567393845|FG000|Overall Study|Other|11|||
157177965|NCT03565991|567393846|FG001|Overall Study|Other|0|||
157177966|NCT03565991|567393845|FG000|Overall Study|Global deterioration of health status|14|||
157177967|NCT03565991|567393846|FG001|Overall Study|Global deterioration of health status|4|||
157177968|NCT03565991|567393845|FG000|Overall Study|Withdrawal by Subject|2|||
157177969|NCT03565991|567393846|FG001|Overall Study|Withdrawal by Subject|6|||
157177970|NCT03565991|567393845|FG000|Overall Study|Progressive disease|121|||
156974182|NCT00402337|566659557|FG001|Overall Study|Lost to Follow-up|0|||
156974183|NCT00402337|566659558|FG002|Overall Study|Lost to Follow-up|1|||
156974184|NCT00402337|566659559|FG003|Overall Study|Lost to Follow-up|2|||
156974185|NCT00402337|566659560|FG004|Overall Study|Lost to Follow-up|0|||
156974186|NCT00402337|566659556|FG000|Overall Study|Physician Decision|0|||
156974187|NCT00402337|566659557|FG001|Overall Study|Physician Decision|0|||
156974188|NCT00402337|566659558|FG002|Overall Study|Physician Decision|0|||
156974189|NCT00402337|566659559|FG003|Overall Study|Physician Decision|1|||
156974190|NCT00402337|566659560|FG004|Overall Study|Physician Decision|0|||
156974191|NCT00402337|566659556|FG000|Overall Study|Other Reason|0|||
156974192|NCT00402337|566659557|FG001|Overall Study|Other Reason|1|||
156974193|NCT00402337|566659558|FG002|Overall Study|Other Reason|0|||
156974194|NCT00402337|566659559|FG003|Overall Study|Other Reason|0|||
156974195|NCT00402337|566659560|FG004|Overall Study|Other Reason|0|||
156974196|NCT03565068|566659561|FG000|Overall Study|Protocol Violation|0|||
156974197|NCT03565068|566659562|FG001|Overall Study|Protocol Violation|0|||
156974198|NCT03565068|566659563|FG002|Overall Study|Protocol Violation|0|||
156974199|NCT03565068|566659564|FG003|Overall Study|Protocol Violation|0|||
156974200|NCT03565068|566659565|FG004|Overall Study|Protocol Violation|1|||
156974201|NCT03565068|566659566|FG005|Overall Study|Protocol Violation|0|||
156974202|NCT03565068|566659567|FG006|Overall Study|Protocol Violation|0|||
156974203|NCT03565068|566659568|FG007|Overall Study|Protocol Violation|1|||
156974204|NCT03565068|566659569|FG008|Overall Study|Protocol Violation|0|||
156974205|NCT03565068|566659561|FG000|Overall Study|Sponsor decision|0|||
156974206|NCT03565068|566659562|FG001|Overall Study|Sponsor decision|0|||
156974207|NCT03565068|566659563|FG002|Overall Study|Sponsor decision|0|||
156974208|NCT03565068|566659564|FG003|Overall Study|Sponsor decision|0|||
156974209|NCT03565068|566659565|FG004|Overall Study|Sponsor decision|1|||
156974210|NCT03565068|566659566|FG005|Overall Study|Sponsor decision|1|||
156974211|NCT03565068|566659567|FG006|Overall Study|Sponsor decision|0|||
156974212|NCT03565068|566659568|FG007|Overall Study|Sponsor decision|0|||
156974213|NCT03565068|566659569|FG008|Overall Study|Sponsor decision|0|||
156974214|NCT03565068|566659561|FG000|Overall Study|Withdrawal by Subject|0|||
156974215|NCT03565068|566659562|FG001|Overall Study|Withdrawal by Subject|0|||
156974216|NCT03565068|566659563|FG002|Overall Study|Withdrawal by Subject|1|||
156974217|NCT03565068|566659564|FG003|Overall Study|Withdrawal by Subject|0|||
156974218|NCT03565068|566659565|FG004|Overall Study|Withdrawal by Subject|2|||
156974219|NCT03565068|566659566|FG005|Overall Study|Withdrawal by Subject|0|||
156974220|NCT03565068|566659567|FG006|Overall Study|Withdrawal by Subject|1|||
156974221|NCT03565068|566659568|FG007|Overall Study|Withdrawal by Subject|5|||
156974222|NCT03565068|566659569|FG008|Overall Study|Withdrawal by Subject|1|||
157177971|NCT03565991|567393846|FG001|Overall Study|Progressive disease|29|||
157177972|NCT03565991|567393845|FG000|Overall Study|Death|3|||
157177973|NCT03565991|567393846|FG001|Overall Study|Death|0|||
157177974|NCT03565991|567393845|FG000|Overall Study|Adverse Event|7|||
157177975|NCT03565991|567393846|FG001|Overall Study|Adverse Event|2|||
157177976|NCT02944513|567393847|FG000|Overall Study|Withdrawal by Subject|4|||
156974223|NCT03565068|566659561|FG000|Overall Study|Physician Decision|0|||
157177977|NCT02944513|567393848|FG001|Overall Study|Withdrawal by Subject|1|||
156974224|NCT03565068|566659562|FG001|Overall Study|Physician Decision|0|||
156974225|NCT03565068|566659563|FG002|Overall Study|Physician Decision|0|||
157177978|NCT00937326|567393850|FG000|Overall Study|Adverse Event|0|||
157177979|NCT00937326|567393851|FG001|Overall Study|Adverse Event|3|||
156974226|NCT03565068|566659564|FG003|Overall Study|Physician Decision|0|||
156974227|NCT03565068|566659565|FG004|Overall Study|Physician Decision|0|||
156974228|NCT03565068|566659566|FG005|Overall Study|Physician Decision|0|||
156974229|NCT03565068|566659567|FG006|Overall Study|Physician Decision|0|||
157177980|NCT00937326|567393852|FG002|Overall Study|Adverse Event|1|||
157177981|NCT00937326|567393853|FG003|Overall Study|Adverse Event|1|||
157177982|NCT00937326|567393854|FG004|Overall Study|Adverse Event|2|||
157177983|NCT00937326|567393850|FG000|Overall Study|Death|0|||
157177984|NCT00937326|567393851|FG001|Overall Study|Death|0|||
157177985|NCT00937326|567393852|FG002|Overall Study|Death|1|||
157177986|NCT00937326|567393853|FG003|Overall Study|Death|0|||
157177987|NCT00937326|567393854|FG004|Overall Study|Death|0|||
157177988|NCT00937326|567393850|FG000|Overall Study|Withdrawal by Subject|3|||
157177989|NCT00937326|567393851|FG001|Overall Study|Withdrawal by Subject|4|||
157177990|NCT00937326|567393852|FG002|Overall Study|Withdrawal by Subject|1|||
157177991|NCT00937326|567393853|FG003|Overall Study|Withdrawal by Subject|4|||
157177992|NCT00937326|567393854|FG004|Overall Study|Withdrawal by Subject|3|||
157177993|NCT00937326|567393850|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
157177994|NCT00937326|567393851|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
157177995|NCT00937326|567393852|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
157177996|NCT00937326|567393853|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
157177997|NCT00937326|567393854|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
157177998|NCT00790218|567393855|FG000|Overall Study|Death|1|||
157177999|NCT00790218|567393856|FG001|Overall Study|Death|0|||
157178000|NCT00790218|567393857|FG002|Overall Study|Death|0|||
157178001|NCT00086385|567393858|FG000|Overall Study|Death|2|||
157178002|NCT00086385|567393859|FG001|Overall Study|Death|2|||
157178003|NCT00086385|567393860|FG002|Overall Study|Death|1|||
157178004|NCT00086385|567393861|FG003|Overall Study|Death|1|||
157178005|NCT04402385|567393870|FG000|Overall Study|Withdrawal by Subject|4|||
157178006|NCT04402385|567393871|FG001|Overall Study|Withdrawal by Subject|4|||
157178007|NCT04402385|567393870|FG000|Overall Study|Lost to Follow-up|1|||
157178008|NCT04402385|567393871|FG001|Overall Study|Lost to Follow-up|1|||
157178009|NCT04402385|567393870|FG000|Overall Study|Physician Decision|0|||
157178010|NCT04402385|567393871|FG001|Overall Study|Physician Decision|1|||
157178011|NCT00731666|567393872|FG000|Overall Study|Adverse Event|2|||
157178012|NCT00731666|567393872|FG000|Overall Study|Lost to Follow-up|8|||
157178013|NCT00731666|567393872|FG000|Overall Study|Withdrawal by Subject|2|||
157178014|NCT03250624|567393874|FG000|Overall Study|Lack of Efficacy|1|||
157178015|NCT03250624|567393875|FG001|Overall Study|Lack of Efficacy|4|||
157178016|NCT03250624|567393874|FG000|Overall Study|Adverse Event|0|||
157178017|NCT03250624|567393875|FG001|Overall Study|Adverse Event|1|||
157178018|NCT03250624|567393874|FG000|Overall Study|Other|1|||
157178019|NCT03250624|567393875|FG001|Overall Study|Other|2|||
157178020|NCT00948428|567393878|FG000|Overall Study|Withdrawal by Subject|6|||
157178021|NCT00948428|567393879|FG001|Overall Study|Withdrawal by Subject|12|||
157178022|NCT00948428|567393880|FG002|Overall Study|Withdrawal by Subject|7|||
157178023|NCT00948428|567393878|FG000|Overall Study|Adverse Event|6|||
157178024|NCT00948428|567393879|FG001|Overall Study|Adverse Event|3|||
157178025|NCT00948428|567393880|FG002|Overall Study|Adverse Event|0|||
157178026|NCT00948428|567393878|FG000|Overall Study|Lost to Follow-up|2|||
157178027|NCT00948428|567393879|FG001|Overall Study|Lost to Follow-up|1|||
157178028|NCT00948428|567393880|FG002|Overall Study|Lost to Follow-up|1|||
157178029|NCT00948428|567393878|FG000|Overall Study|Death|2|||
157178030|NCT00948428|567393879|FG001|Overall Study|Death|0|||
157178031|NCT00948428|567393880|FG002|Overall Study|Death|0|||
157178032|NCT00948428|567393878|FG000|Overall Study|Intercurrent Illness|1|||
157178033|NCT00948428|567393879|FG001|Overall Study|Intercurrent Illness|0|||
157178034|NCT00948428|567393880|FG002|Overall Study|Intercurrent Illness|0|||
157178035|NCT00948428|567393878|FG000|Overall Study|Non-compliance|1|||
157178036|NCT00948428|567393879|FG001|Overall Study|Non-compliance|2|||
157178037|NCT00948428|567393880|FG002|Overall Study|Non-compliance|0|||
157178038|NCT01843205|567393893|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
157178039|NCT01843205|567393894|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
157178040|NCT00606177|567393895|FG000|Overall Study|Adverse Event|9|||
157178041|NCT00606177|567393896|FG001|Overall Study|Adverse Event|5|||
157178042|NCT00606177|567393895|FG000|Overall Study|Lack of Efficacy|3|||
157178043|NCT00606177|567393896|FG001|Overall Study|Lack of Efficacy|7|||
157178044|NCT00606177|567393895|FG000|Overall Study|Physician Decision|1|||
157178045|NCT00606177|567393896|FG001|Overall Study|Physician Decision|0|||
157178046|NCT00606177|567393895|FG000|Overall Study|Protocol Violation|1|||
157178047|NCT00606177|567393896|FG001|Overall Study|Protocol Violation|4|||
157178048|NCT00606177|567393895|FG000|Overall Study|Withdrawal by Subject|5|||
157178049|NCT00606177|567393896|FG001|Overall Study|Withdrawal by Subject|6|||
157178050|NCT00606177|567393895|FG000|Overall Study|Progression to depressive phase|6|||
157178051|NCT00606177|567393896|FG001|Overall Study|Progression to depressive phase|1|||
157178052|NCT00606177|567393895|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
157178053|NCT00606177|567393896|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
157178054|NCT00606177|567393895|FG000|Overall Study|Change of residence or other commitments|1|||
157178055|NCT00606177|567393896|FG001|Overall Study|Change of residence or other commitments|1|||
157178056|NCT01355497|567393897|FG000|Overall Study|Death|19|||
157178057|NCT01355497|567393898|FG001|Overall Study|Death|18|||
157178058|NCT01355497|567393897|FG000|Overall Study|Lost to Follow-up|3|||
157178059|NCT01355497|567393898|FG001|Overall Study|Lost to Follow-up|0|||
157178060|NCT01355497|567393897|FG000|Overall Study|Protocol Violation|0|||
157178061|NCT01355497|567393898|FG001|Overall Study|Protocol Violation|1|||
157178062|NCT01355497|567393897|FG000|Overall Study|other-not provided|9|||
157178063|NCT01355497|567393898|FG001|Overall Study|other-not provided|4|||
157178064|NCT01355497|567393897|FG000|Overall Study|Withdrawal by Subject|12|||
157178065|NCT01355497|567393898|FG001|Overall Study|Withdrawal by Subject|20|||
157178066|NCT01355497|567393897|FG000|Overall Study|noncompliance|1|||
157178067|NCT01355497|567393898|FG001|Overall Study|noncompliance|2|||
157178068|NCT01355497|567393897|FG000|Overall Study|progressive disease|11|||
157178069|NCT01355497|567393898|FG001|Overall Study|progressive disease|8|||
157178070|NCT01355497|567393897|FG000|Overall Study|Adverse Event|11|||
157178071|NCT01355497|567393898|FG001|Overall Study|Adverse Event|10|||
157178072|NCT01518309|567393899|FG000|Overall Study|Adverse Event|6|||
157178073|NCT01518309|567393899|FG000|Overall Study|Death|6|||
157178074|NCT01518309|567393899|FG000|Overall Study|Lack of Efficacy|7|||
157178075|NCT01518309|567393899|FG000|Overall Study|Withdrawal by Subject|6|||
157178076|NCT01518309|567393899|FG000|Overall Study|Physician Decision|3|||
157178077|NCT01518309|567393899|FG000|Overall Study|Sponsor Decision|2|||
157178078|NCT01518309|567393899|FG000|Overall Study|Not in Predefined Categories|9|||
157178079|NCT02603172|567393901|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178080|NCT02603172|567393902|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178081|NCT02603172|567393903|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
157178082|NCT02603172|567393904|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178083|NCT02603172|567393905|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178084|NCT02603172|567393906|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178085|NCT02603172|567393907|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178086|NCT02603172|567393908|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
157178087|NCT00863317|567393909|FG000|Overall Study|Lost to Follow-up|8|||
157178088|NCT00863317|567393910|FG001|Overall Study|Lost to Follow-up|9|||
157178089|NCT00038142|567393913|FG000|Overall Study|Ineligible|1|||
157178090|NCT00038142|567393914|FG001|Overall Study|Ineligible|0|||
157178091|NCT00038142|567393913|FG000|Overall Study|Progressive Disease|11|||
157178092|NCT00038142|567393914|FG001|Overall Study|Progressive Disease|7|||
157178093|NCT00038142|567393913|FG000|Overall Study|Death|1|||
157178094|NCT00038142|567393914|FG001|Overall Study|Death|0|||
157178095|NCT00038142|567393913|FG000|Overall Study|Adverse Event|1|||
157178096|NCT00038142|567393914|FG001|Overall Study|Adverse Event|0|||
157178097|NCT00038142|567393913|FG000|Overall Study|Unknown Reason|8|||
157178098|NCT00038142|567393914|FG001|Overall Study|Unknown Reason|0|||
157178099|NCT00441727|567393915|FG000|Overall Study|Protocol Violation|19|||
157178100|NCT00441727|567393916|FG001|Overall Study|Protocol Violation|28|||
157178101|NCT00441727|567393917|FG002|Overall Study|Protocol Violation|32|||
157178102|NCT00441727|567393915|FG000|Overall Study|Adverse Event|26|||
157178103|NCT00441727|567393916|FG001|Overall Study|Adverse Event|33|||
157178104|NCT00441727|567393917|FG002|Overall Study|Adverse Event|28|||
157178105|NCT00441727|567393915|FG000|Overall Study|Lack of Efficacy|7|||
157178106|NCT00441727|567393916|FG001|Overall Study|Lack of Efficacy|8|||
157178107|NCT00441727|567393917|FG002|Overall Study|Lack of Efficacy|48|||
157178108|NCT00441727|567393915|FG000|Overall Study|Withdrawal by Subject|40|||
157178109|NCT00441727|567393916|FG001|Overall Study|Withdrawal by Subject|34|||
157178110|NCT00441727|567393917|FG002|Overall Study|Withdrawal by Subject|47|||
157178111|NCT00441727|567393915|FG000|Overall Study|Lost to Follow-up|5|||
157178112|NCT00441727|567393916|FG001|Overall Study|Lost to Follow-up|6|||
157178113|NCT00441727|567393917|FG002|Overall Study|Lost to Follow-up|5|||
157178114|NCT00441727|567393915|FG000|Overall Study|Safety Reasons|3|||
157178115|NCT00441727|567393916|FG001|Overall Study|Safety Reasons|1|||
157178116|NCT00441727|567393917|FG002|Overall Study|Safety Reasons|3|||
157178117|NCT00441727|567393915|FG000|Overall Study|Various reason specified|6|||
157178118|NCT00441727|567393916|FG001|Overall Study|Various reason specified|8|||
157178119|NCT00441727|567393917|FG002|Overall Study|Various reason specified|5|||
157178120|NCT02133001|567393922|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
157178121|NCT02133001|567393923|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
157178122|NCT02133001|567393922|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
157178123|NCT02133001|567393923|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
157178124|NCT02133001|567393922|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
157178125|NCT02133001|567393923|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
157178126|NCT02133001|567393922|FG000|Double Blind (Day 1-25)|Other|2|||
157178127|NCT02133001|567393923|FG001|Double Blind (Day 1-25)|Other|2|||
157178128|NCT02133001|567393922|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
157178129|NCT02133001|567393923|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
157178130|NCT02133001|567393922|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
157178131|NCT02133001|567393923|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
157178132|NCT02133001|567393922|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
157178133|NCT02133001|567393923|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
157178134|NCT02133001|567393922|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
157178135|NCT02133001|567393923|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
157178136|NCT04211961|567393924|FG000|Overall Study|Death|0|||
156974230|NCT03565068|566659568|FG007|Overall Study|Physician Decision|1|||
156974231|NCT03565068|566659569|FG008|Overall Study|Physician Decision|0|||
156974232|NCT03565068|566659561|FG000|Overall Study|Lost to Follow-up|0|||
156974233|NCT03565068|566659562|FG001|Overall Study|Lost to Follow-up|0|||
156974234|NCT03565068|566659563|FG002|Overall Study|Lost to Follow-up|0|||
156974235|NCT03565068|566659564|FG003|Overall Study|Lost to Follow-up|0|||
156974236|NCT03565068|566659565|FG004|Overall Study|Lost to Follow-up|0|||
156974237|NCT03565068|566659566|FG005|Overall Study|Lost to Follow-up|0|||
156974238|NCT03565068|566659567|FG006|Overall Study|Lost to Follow-up|0|||
156974239|NCT03565068|566659568|FG007|Overall Study|Lost to Follow-up|1|||
156974240|NCT03565068|566659569|FG008|Overall Study|Lost to Follow-up|0|||
156974241|NCT00311155|566662054|FG000|Overall Study|Adverse Event|21|||
156974242|NCT00311155|566662054|FG000|Overall Study|Withdrawal by Subject|17|||
156974243|NCT00311155|566662054|FG000|Overall Study|Did not meet entry criteria|55|||
156974244|NCT00429494|566662057|FG000|Overall Study|Withdrawal by Subject|9|||
156974245|NCT00429494|566662057|FG000|Overall Study|Death|6|||
156974246|NCT01590771|566662065|FG000|Overall Study|Other Protocol Specified Criteria|5|||
156974247|NCT01590771|566662066|FG001|Overall Study|Other Protocol Specified Criteria|14|||
156974248|NCT01590771|566662065|FG000|Overall Study|Withdrawal by Subject|8|||
156974249|NCT01590771|566662066|FG001|Overall Study|Withdrawal by Subject|15|||
156974250|NCT01590771|566662065|FG000|Overall Study|Protocol Violation|1|||
156974251|NCT01590771|566662066|FG001|Overall Study|Protocol Violation|2|||
156974252|NCT01590771|566662065|FG000|Overall Study|Lost to Follow-up|1|||
156974253|NCT01590771|566662066|FG001|Overall Study|Lost to Follow-up|1|||
156974254|NCT01590771|566662065|FG000|Overall Study|Lack of Efficacy|1|||
156974255|NCT01590771|566662066|FG001|Overall Study|Lack of Efficacy|0|||
156974256|NCT01590771|566662065|FG000|Overall Study|Adverse Event|3|||
156974257|NCT01590771|566662066|FG001|Overall Study|Adverse Event|7|||
156974258|NCT01785628|566662070|FG000|Overall Study|Lost to Follow-up|2|||
156974259|NCT01785628|566662071|FG001|Overall Study|Lost to Follow-up|3|||
156974260|NCT00767104|566662074|FG000|Overall Study|Lost to Follow-up|1|||
156974261|NCT00767104|566662075|FG001|Overall Study|Lost to Follow-up|2|||
156974262|NCT00840996|566662076|FG000|Overall Study|Withdrawal by Subject|1|||
156974263|NCT00840996|566662077|FG001|Overall Study|Withdrawal by Subject|0|||
156974264|NCT04022889|566662078|FG000|Stage 1: Period 1|Adverse Event|1|||
156974265|NCT04022889|566662079|FG001|Stage 1: Period 1|Adverse Event|0|||
156974266|NCT04022889|566662080|FG002|Stage 1: Period 1|Adverse Event|0|||
156974267|NCT04022889|566662078|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
156974268|NCT04022889|566662079|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
156974269|NCT04022889|566662080|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
156974270|NCT04022889|566662078|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
156974271|NCT04022889|566662079|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
156974272|NCT04022889|566662080|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
156974273|NCT04022889|566662078|FG000|Stage 2|Screen Failure|0|||
156974274|NCT04022889|566662079|FG001|Stage 2|Screen Failure|0|||
156974275|NCT04022889|566662080|FG002|Stage 2|Screen Failure|3|||
156974276|NCT04022889|566662078|FG000|Stage 2|Ineligible for apheresis donation|0|||
156974277|NCT04022889|566662079|FG001|Stage 2|Ineligible for apheresis donation|0|||
156974278|NCT04022889|566662080|FG002|Stage 2|Ineligible for apheresis donation|2|||
156974279|NCT04022889|566662078|FG000|Stage 2|Adverse Event|0|||
156974280|NCT04022889|566662079|FG001|Stage 2|Adverse Event|0|||
156974281|NCT04022889|566662080|FG002|Stage 2|Adverse Event|2|||
156974282|NCT04022889|566662078|FG000|Stage 2|Protocol Violation|0|||
156974283|NCT04022889|566662079|FG001|Stage 2|Protocol Violation|0|||
156974284|NCT04022889|566662080|FG002|Stage 2|Protocol Violation|1|||
156974285|NCT04022889|566662078|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
157178137|NCT04211961|567393925|FG001|Overall Study|Death|1|||
157178138|NCT04211961|567393924|FG000|Overall Study|Lost to Follow-up|0|||
157178139|NCT04211961|567393925|FG001|Overall Study|Lost to Follow-up|1|||
157178140|NCT04211961|567393924|FG000|Overall Study|Withdrawal by Subject|0|||
157178141|NCT04211961|567393925|FG001|Overall Study|Withdrawal by Subject|1|||
157178142|NCT03933215|567393928|FG000|Overall Study|Other|6|||
157178143|NCT03933215|567393928|FG000|Overall Study|Sponsor decision|5|||
156974286|NCT04022889|566662079|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
157054969|NCT02660034|566954121|FG001|Overall Study|Adverse Event|0|||
157178144|NCT03933215|567393928|FG000|Overall Study|Protocol Violation|5|||
156974287|NCT04022889|566662080|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
156974288|NCT01900054|566662084|FG000|Overall Study|Physician Decision|1|||
156974289|NCT01900054|566662084|FG000|Overall Study|Withdrawal by Subject|1|||
157178145|NCT03933215|567393928|FG000|Overall Study|Withdrawal by Subject|6|||
156974290|NCT03285295|566662089|FG000|Alinity s HBsAg|Protocol Violation|11|||
157054970|NCT02660034|566954122|FG002|Overall Study|Adverse Event|0|||
157178146|NCT03933215|567393928|FG000|Overall Study|Lost to Follow-up|6|||
156974291|NCT03285295|566662090|FG001|Alinity s HBsAg|Protocol Violation|0|||
156974292|NCT03285295|566662091|FG002|Alinity s HBsAg|Protocol Violation|0|||
156974293|NCT03285295|566662092|FG003|Alinity s HBsAg|Protocol Violation|0|||
156974294|NCT03285295|566662093|FG004|Alinity s HBsAg|Protocol Violation|0|||
157054971|NCT02660034|566954123|FG003|Overall Study|Adverse Event|0|||
157178147|NCT03933215|567393928|FG000|Overall Study|Enrolled but not treated|38|||
157178148|NCT05784129|567393931|FG000|Overall Study|Study terminated by sponsor|2|||
157178149|NCT05784129|567393932|FG001|Overall Study|Study terminated by sponsor|2|||
157178150|NCT00407550|567393933|FG000|Overall Study|Adverse Event|0|||
157178151|NCT00407550|567393934|FG001|Overall Study|Adverse Event|1|||
157178152|NCT00407550|567393933|FG000|Overall Study|Withdrawal by Subject|0|||
157178153|NCT00407550|567393934|FG001|Overall Study|Withdrawal by Subject|2|||
157178154|NCT00407550|567393933|FG000|Overall Study|Death|1|||
157178155|NCT00407550|567393934|FG001|Overall Study|Death|0|||
157178156|NCT00407550|567393933|FG000|Overall Study|Insurance or Other medical condition|2|||
157178157|NCT00407550|567393934|FG001|Overall Study|Insurance or Other medical condition|1|||
157178158|NCT01831804|567393939|FG000|Overall Study|Adverse Event|0|||
157178159|NCT01831804|567393940|FG001|Overall Study|Adverse Event|0|||
157178160|NCT01831804|567393941|FG002|Overall Study|Adverse Event|0|||
157178161|NCT01831804|567393942|FG003|Overall Study|Adverse Event|0|||
157178162|NCT01831804|567393943|FG004|Overall Study|Adverse Event|0|||
157178163|NCT01831804|567393944|FG005|Overall Study|Adverse Event|0|||
157178164|NCT01831804|567393945|FG006|Overall Study|Adverse Event|1|||
157178165|NCT01831804|567393946|FG007|Overall Study|Adverse Event|0|||
157178166|NCT01831804|567393947|FG008|Overall Study|Adverse Event|1|||
157178167|NCT01831804|567393939|FG000|Overall Study|Protocol Violation|0|||
157178168|NCT01831804|567393940|FG001|Overall Study|Protocol Violation|0|||
157178169|NCT01831804|567393941|FG002|Overall Study|Protocol Violation|2|||
157178170|NCT01831804|567393942|FG003|Overall Study|Protocol Violation|0|||
157178171|NCT01831804|567393943|FG004|Overall Study|Protocol Violation|0|||
157178172|NCT01831804|567393944|FG005|Overall Study|Protocol Violation|0|||
157178173|NCT01831804|567393945|FG006|Overall Study|Protocol Violation|0|||
157178174|NCT01831804|567393946|FG007|Overall Study|Protocol Violation|0|||
157178175|NCT01831804|567393947|FG008|Overall Study|Protocol Violation|0|||
157178176|NCT01831804|567393939|FG000|Overall Study|Protocol defined stopping criteria|1|||
157178177|NCT01831804|567393940|FG001|Overall Study|Protocol defined stopping criteria|1|||
157178178|NCT01831804|567393941|FG002|Overall Study|Protocol defined stopping criteria|3|||
157178179|NCT01831804|567393942|FG003|Overall Study|Protocol defined stopping criteria|0|||
157178180|NCT01831804|567393943|FG004|Overall Study|Protocol defined stopping criteria|1|||
157178181|NCT01831804|567393944|FG005|Overall Study|Protocol defined stopping criteria|0|||
157178182|NCT01831804|567393945|FG006|Overall Study|Protocol defined stopping criteria|0|||
157178183|NCT01831804|567393946|FG007|Overall Study|Protocol defined stopping criteria|0|||
157178184|NCT01831804|567393947|FG008|Overall Study|Protocol defined stopping criteria|0|||
157178185|NCT01831804|567393939|FG000|Overall Study|Lost to Follow-up|0|||
157178186|NCT01831804|567393940|FG001|Overall Study|Lost to Follow-up|0|||
157178187|NCT01831804|567393941|FG002|Overall Study|Lost to Follow-up|1|||
157178188|NCT01831804|567393942|FG003|Overall Study|Lost to Follow-up|0|||
157178189|NCT01831804|567393943|FG004|Overall Study|Lost to Follow-up|0|||
157178190|NCT01831804|567393944|FG005|Overall Study|Lost to Follow-up|0|||
157178191|NCT01831804|567393945|FG006|Overall Study|Lost to Follow-up|0|||
157178192|NCT01831804|567393946|FG007|Overall Study|Lost to Follow-up|0|||
157178193|NCT01831804|567393947|FG008|Overall Study|Lost to Follow-up|1|||
157178194|NCT01831804|567393939|FG000|Overall Study|Investigator discretion|0|||
157178195|NCT01831804|567393940|FG001|Overall Study|Investigator discretion|0|||
157178196|NCT01831804|567393941|FG002|Overall Study|Investigator discretion|0|||
157178197|NCT01831804|567393942|FG003|Overall Study|Investigator discretion|0|||
157178198|NCT01831804|567393943|FG004|Overall Study|Investigator discretion|1|||
157178199|NCT01831804|567393944|FG005|Overall Study|Investigator discretion|0|||
157178200|NCT01831804|567393945|FG006|Overall Study|Investigator discretion|0|||
157178201|NCT01831804|567393946|FG007|Overall Study|Investigator discretion|1|||
157178202|NCT01831804|567393947|FG008|Overall Study|Investigator discretion|0|||
157178203|NCT01831804|567393939|FG000|Overall Study|Withdrew Consent|0|||
157178204|NCT01831804|567393940|FG001|Overall Study|Withdrew Consent|1|||
157178205|NCT01831804|567393941|FG002|Overall Study|Withdrew Consent|0|||
157178206|NCT01831804|567393942|FG003|Overall Study|Withdrew Consent|0|||
157178207|NCT01831804|567393943|FG004|Overall Study|Withdrew Consent|0|||
157178208|NCT01831804|567393944|FG005|Overall Study|Withdrew Consent|0|||
157178209|NCT01831804|567393945|FG006|Overall Study|Withdrew Consent|0|||
157178210|NCT01831804|567393946|FG007|Overall Study|Withdrew Consent|2|||
157178211|NCT01831804|567393947|FG008|Overall Study|Withdrew Consent|0|||
157178212|NCT01819506|567393948|FG000|Overall Study|Physician Decision|5|||
157178213|NCT01819506|567393949|FG001|Overall Study|Physician Decision|2|||
157178214|NCT01819506|567393948|FG000|Overall Study|Withdrawal by Subject|3|||
157178215|NCT01819506|567393949|FG001|Overall Study|Withdrawal by Subject|3|||
157178216|NCT03168555|567393951|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
157178217|NCT03168555|567393951|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
157178218|NCT03168555|567393951|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
157178219|NCT03168555|567393951|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
157178220|NCT01235507|567393952|FG000|Overall Study|Adverse Event|1|||
157178221|NCT01235507|567393952|FG000|Overall Study|Withdrawal by Subject|1|||
157178222|NCT01587274|567393955|FG000|Overall Study|Lost to Follow-up|4|||
157178223|NCT01587274|567393956|FG001|Overall Study|Lost to Follow-up|5|||
157178224|NCT01587274|567393957|FG002|Overall Study|Lost to Follow-up|3|||
157178225|NCT01042938|567393960|FG000|Overall Study|Withdrawal by Subject|1|||
157178226|NCT01042938|567393961|FG001|Overall Study|Withdrawal by Subject|1|||
157178227|NCT01042938|567393960|FG000|Overall Study|Protocol Violation|1|||
157178228|NCT01042938|567393961|FG001|Overall Study|Protocol Violation|1|||
157178229|NCT01042938|567393960|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
157178230|NCT01042938|567393961|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
157178231|NCT03136484|567393962|FG000|Overall Study|Withdrawal by Subject|19|||
157178232|NCT03136484|567393963|FG001|Overall Study|Withdrawal by Subject|14|||
157178233|NCT03136484|567393962|FG000|Overall Study|Lost to Follow-up|7|||
157178234|NCT03136484|567393963|FG001|Overall Study|Lost to Follow-up|8|||
157178235|NCT03136484|567393962|FG000|Overall Study|Death|1|||
157178236|NCT03136484|567393963|FG001|Overall Study|Death|0|||
157178237|NCT01449955|567393968|FG000|Overall Study|Withdrawal by Subject|1|||
157178238|NCT01449955|567393969|FG001|Overall Study|Withdrawal by Subject|2|||
157178239|NCT04018612|567393972|FG000|Overall Study|Withdrawal by Subject|1|||
157178240|NCT04018612|567393973|FG001|Overall Study|Withdrawal by Subject|0|||
157178241|NCT04018612|567393974|FG002|Overall Study|Withdrawal by Subject|1|||
157178242|NCT00361218|567393975|FG000|Overall Study|Lost to Follow-up|11|||
157178243|NCT00361218|567393975|FG000|Overall Study|Personal Reasons|7|||
157178244|NCT00361218|567393975|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
157178245|NCT02566109|567393976|FG000|Overall Study|Withdrawal by Subject|1|||
157178246|NCT00318370|567393981|FG000|Period 1|Lack of Efficacy|5|||
157178247|NCT00318370|567393982|FG001|Period 1|Lack of Efficacy|0|||
157178248|NCT00318370|567393983|FG002|Period 1|Lack of Efficacy|0|||
157178249|NCT00318370|567393981|FG000|Period 1|Physician Decision|1|||
157178250|NCT00318370|567393982|FG001|Period 1|Physician Decision|0|||
157178251|NCT00318370|567393983|FG002|Period 1|Physician Decision|0|||
157178252|NCT00318370|567393981|FG000|Period 1|Withdrawal by Subject|1|||
157178253|NCT00318370|567393982|FG001|Period 1|Withdrawal by Subject|0|||
157178254|NCT00318370|567393983|FG002|Period 1|Withdrawal by Subject|0|||
157178255|NCT00318370|567393981|FG000|Period 2|Adverse Event|0|||
157178256|NCT00318370|567393982|FG001|Period 2|Adverse Event|3|||
157178257|NCT00318370|567393983|FG002|Period 2|Adverse Event|0|||
157178258|NCT00318370|567393981|FG000|Period 2|Lack of Efficacy|0|||
157178259|NCT00318370|567393982|FG001|Period 2|Lack of Efficacy|5|||
157178260|NCT00318370|567393983|FG002|Period 2|Lack of Efficacy|0|||
157178261|NCT00318370|567393981|FG000|Period 2|Physician Decision|0|||
157178262|NCT00318370|567393982|FG001|Period 2|Physician Decision|1|||
157178263|NCT00318370|567393983|FG002|Period 2|Physician Decision|0|||
157178264|NCT00318370|567393981|FG000|Period 2|Withdrawal by Subject|0|||
157178265|NCT00318370|567393982|FG001|Period 2|Withdrawal by Subject|1|||
157178266|NCT00318370|567393983|FG002|Period 2|Withdrawal by Subject|0|||
157178267|NCT00318370|567393981|FG000|Period 2|Other|0|||
157178268|NCT00318370|567393982|FG001|Period 2|Other|1|||
157178269|NCT00318370|567393983|FG002|Period 2|Other|0|||
157178270|NCT00318370|567393981|FG000|Period 3|Adverse Event|0|||
157178271|NCT00318370|567393982|FG001|Period 3|Adverse Event|0|||
157178272|NCT00318370|567393983|FG002|Period 3|Adverse Event|1|||
157178273|NCT00318370|567393981|FG000|Period 3|Lack of Efficacy|0|||
157178274|NCT00318370|567393982|FG001|Period 3|Lack of Efficacy|0|||
157178275|NCT00318370|567393983|FG002|Period 3|Lack of Efficacy|24|||
157178276|NCT00318370|567393981|FG000|Period 3|Death|0|||
157178277|NCT00318370|567393982|FG001|Period 3|Death|0|||
157178278|NCT00318370|567393983|FG002|Period 3|Death|1|||
157178279|NCT00318370|567393981|FG000|Period 3|Physician Decision|0|||
157178280|NCT00318370|567393982|FG001|Period 3|Physician Decision|0|||
157178281|NCT00318370|567393983|FG002|Period 3|Physician Decision|1|||
157178282|NCT00318370|567393981|FG000|Period 3|Withdrawal by Subject|0|||
157178283|NCT00318370|567393982|FG001|Period 3|Withdrawal by Subject|0|||
157178284|NCT00318370|567393983|FG002|Period 3|Withdrawal by Subject|3|||
157178285|NCT00318370|567393981|FG000|Period 3|Other|0|||
157178286|NCT00318370|567393982|FG001|Period 3|Other|0|||
157178287|NCT00318370|567393983|FG002|Period 3|Other|3|||
157178288|NCT00617656|567393988|FG000|Overall Study|Inclusion error|4|||
157178289|NCT00617656|567393989|FG001|Overall Study|Inclusion error|4|||
157178290|NCT00617656|567393990|FG002|Overall Study|Inclusion error|0|||
157178291|NCT00617656|567393991|FG003|Overall Study|Inclusion error|0|||
157178292|NCT00617656|567393988|FG000|Overall Study|Missing data|44|||
157178293|NCT00617656|567393989|FG001|Overall Study|Missing data|30|||
157178294|NCT00617656|567393990|FG002|Overall Study|Missing data|13|||
157178295|NCT00617656|567393991|FG003|Overall Study|Missing data|6|||
157178296|NCT00617656|567393988|FG000|Overall Study|Withdrawal by Subject|0|||
157178297|NCT00617656|567393989|FG001|Overall Study|Withdrawal by Subject|2|||
157178298|NCT00617656|567393990|FG002|Overall Study|Withdrawal by Subject|0|||
157178299|NCT00617656|567393991|FG003|Overall Study|Withdrawal by Subject|0|||
157178300|NCT01731990|567395659|FG000|Overall Study|Adverse Event|1|||
157178301|NCT01731990|567395660|FG001|Overall Study|Adverse Event|5|||
157178302|NCT01731990|567395659|FG000|Overall Study|Withdrawal by Subject|1|||
157178303|NCT01731990|567395660|FG001|Overall Study|Withdrawal by Subject|1|||
157178304|NCT01731990|567395659|FG000|Overall Study|Protocol deviation|1|||
157178305|NCT01731990|567395660|FG001|Overall Study|Protocol deviation|2|||
157178306|NCT01731990|567395659|FG000|Overall Study|Death|1|||
157178307|NCT01731990|567395660|FG001|Overall Study|Death|0|||
157178308|NCT01183104|567395663|FG000|Overall Study|Adverse Event|8|||
157178309|NCT01183104|567395664|FG001|Overall Study|Adverse Event|6|||
157178310|NCT01183104|567395663|FG000|Overall Study|Death|0|||
157178311|NCT01183104|567395664|FG001|Overall Study|Death|1|||
157178312|NCT01183104|567395663|FG000|Overall Study|Lost to Follow-up|14|||
157178313|NCT01183104|567395664|FG001|Overall Study|Lost to Follow-up|7|||
157178314|NCT01183104|567395663|FG000|Overall Study|Physician Decision|5|||
157178315|NCT01183104|567395664|FG001|Overall Study|Physician Decision|8|||
157178316|NCT01183104|567395663|FG000|Overall Study|Withdrawal by Subject|6|||
157178317|NCT01183104|567395664|FG001|Overall Study|Withdrawal by Subject|11|||
157178318|NCT01183104|567395663|FG000|Overall Study|Nonparticipation in Extension Study|39|||
157178319|NCT01183104|567395664|FG001|Overall Study|Nonparticipation in Extension Study|50|||
157178320|NCT01183104|567395663|FG000|Overall Study|Did not receive study drug|5|||
157178321|NCT01183104|567395664|FG001|Overall Study|Did not receive study drug|9|||
157178322|NCT01957215|567395669|FG000|Overall Study|Adverse Event|2|||
157178323|NCT01957215|567395670|FG001|Overall Study|Adverse Event|2|||
157178324|NCT01957215|567395669|FG000|Overall Study|Lost to Follow-up|3|||
157178325|NCT01957215|567395670|FG001|Overall Study|Lost to Follow-up|3|||
157178326|NCT01957215|567395669|FG000|Overall Study|Protocol Violation|1|||
157178327|NCT01957215|567395670|FG001|Overall Study|Protocol Violation|2|||
157178328|NCT01957215|567395669|FG000|Overall Study|Withdrawal by Subject|7|||
157178329|NCT01957215|567395670|FG001|Overall Study|Withdrawal by Subject|5|||
157178330|NCT03597503|567395674|FG000|Overall Study|Withdrawal by Subject|0|||
157178331|NCT03597503|567395675|FG001|Overall Study|Withdrawal by Subject|2|||
157178332|NCT03597503|567395674|FG000|Overall Study|Lost to Follow-up|1|||
157178333|NCT03597503|567395675|FG001|Overall Study|Lost to Follow-up|2|||
157178334|NCT03597503|567395674|FG000|Overall Study|Protocol Violation|1|||
157178335|NCT03597503|567395675|FG001|Overall Study|Protocol Violation|0|||
157178336|NCT02578992|567395678|FG000|Overall Study|equipment not available or malfunction|3|||
157178337|NCT02578992|567395679|FG001|Overall Study|equipment not available or malfunction|3|||
157178338|NCT00693420|567395680|FG000|Overall Study|Adverse Event|4|||
157178339|NCT00693420|567395681|FG001|Overall Study|Adverse Event|4|||
157178340|NCT00693420|567395680|FG000|Overall Study|Lost to Follow-up|0|||
157178341|NCT00693420|567395681|FG001|Overall Study|Lost to Follow-up|3|||
157178342|NCT00693420|567395680|FG000|Overall Study|Withdrawal by Subject|1|||
157178343|NCT00693420|567395681|FG001|Overall Study|Withdrawal by Subject|0|||
157178344|NCT00693420|567395680|FG000|Overall Study|Protocol Violation|0|||
157178345|NCT00693420|567395681|FG001|Overall Study|Protocol Violation|2|||
157178346|NCT00693420|567395680|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
157178347|NCT00693420|567395681|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
157178348|NCT00693420|567395680|FG000|Overall Study|Personal Reasons|1|||
157178349|NCT00693420|567395681|FG001|Overall Study|Personal Reasons|4|||
157178350|NCT00509028|567395682|FG000|Overall Study|Adverse Event|2|||
157178351|NCT00509028|567395683|FG001|Overall Study|Adverse Event|0|||
157178352|NCT00509028|567395682|FG000|Overall Study|Withdrawal by Subject|4|||
157178353|NCT00509028|567395683|FG001|Overall Study|Withdrawal by Subject|3|||
157178354|NCT00509028|567395682|FG000|Overall Study|Lost to Follow-up|0|||
157178355|NCT00509028|567395683|FG001|Overall Study|Lost to Follow-up|1|||
157178356|NCT00509028|567395682|FG000|Overall Study|Protocol Violation|4|||
157178357|NCT00509028|567395683|FG001|Overall Study|Protocol Violation|2|||
157178358|NCT00509028|567395682|FG000|Overall Study|Non-compliance|2|||
157178359|NCT00509028|567395683|FG001|Overall Study|Non-compliance|1|||
157178360|NCT05516134|567395684|FG000|Overall Study|Lost to Follow-up|1|||
157178361|NCT05516134|567395685|FG001|Overall Study|Lost to Follow-up|0|||
157178362|NCT05516134|567395686|FG002|Overall Study|Lost to Follow-up|0|||
157178363|NCT00136357|567395691|FG000|Overall Study|Withdrawal by Subject|3|||
157178364|NCT00136357|567395692|FG001|Overall Study|Withdrawal by Subject|2|||
157178365|NCT00420342|567395697|FG000|Overall Study|Lost to Follow-up|1|||
157178366|NCT00420342|567395698|FG001|Overall Study|Lost to Follow-up|0|||
157178367|NCT00420342|567395699|FG002|Overall Study|Lost to Follow-up|1|||
157178368|NCT00420342|567395697|FG000|Overall Study|Withdrawal by Subject|0|||
157178369|NCT00420342|567395698|FG001|Overall Study|Withdrawal by Subject|2|||
157178370|NCT00420342|567395699|FG002|Overall Study|Withdrawal by Subject|0|||
157178371|NCT00839436|567395704|FG000|Overall Study|Developed exclusionary condition|1|||
157178372|NCT00839436|567395705|FG001|Overall Study|Developed exclusionary condition|0|||
157178373|NCT00839436|567395706|FG002|Overall Study|Developed exclusionary condition|0|||
157178374|NCT00839436|567395704|FG000|Overall Study|Withdrawal by Subject|0|||
157178375|NCT00839436|567395705|FG001|Overall Study|Withdrawal by Subject|1|||
157178376|NCT00839436|567395706|FG002|Overall Study|Withdrawal by Subject|0|||
157178377|NCT00839436|567395704|FG000|Overall Study|Study drug no longer available|0|||
157178378|NCT00839436|567395705|FG001|Overall Study|Study drug no longer available|0|||
157178379|NCT00839436|567395706|FG002|Overall Study|Study drug no longer available|1|||
157178380|NCT01440972|567395707|FG000|Overall Study|Withdrawal by Subject|3|||
157178381|NCT01440972|567395708|FG001|Overall Study|Withdrawal by Subject|2|||
157178382|NCT04072575|567395709|FG000|Overall Study|Physician Decision|1|||
157178383|NCT04072575|567395709|FG000|Overall Study|Adverse Event|7|||
157178384|NCT04072575|567395709|FG000|Overall Study|Withdrawal by Subject|14|||
157178385|NCT04072575|567395709|FG000|Overall Study|Other|2|||
157178386|NCT01444898|567395710|FG000|Overall Study|Withdrawal by Subject|1|||
157178387|NCT02580591|567395711|FG000|Overall Study|Adverse Event|0|||
157178388|NCT02580591|567395712|FG001|Overall Study|Adverse Event|1|||
157178389|NCT02580591|567395713|FG002|Overall Study|Adverse Event|2|||
157178390|NCT02580591|567395714|FG003|Overall Study|Adverse Event|5|||
157178391|NCT02580591|567395711|FG000|Overall Study|Protocol Violation|3|||
157178392|NCT02580591|567395712|FG001|Overall Study|Protocol Violation|2|||
157178393|NCT02580591|567395713|FG002|Overall Study|Protocol Violation|1|||
157178394|NCT02580591|567395714|FG003|Overall Study|Protocol Violation|1|||
157178395|NCT02580591|567395711|FG000|Overall Study|Lost to Follow-up|5|||
157178396|NCT02580591|567395712|FG001|Overall Study|Lost to Follow-up|3|||
157178397|NCT02580591|567395713|FG002|Overall Study|Lost to Follow-up|3|||
157178398|NCT02580591|567395714|FG003|Overall Study|Lost to Follow-up|1|||
157178399|NCT02580591|567395711|FG000|Overall Study|Withdrawal by Subject|6|||
157178400|NCT02580591|567395712|FG001|Overall Study|Withdrawal by Subject|1|||
157178401|NCT02580591|567395713|FG002|Overall Study|Withdrawal by Subject|2|||
157178402|NCT02580591|567395714|FG003|Overall Study|Withdrawal by Subject|3|||
157178403|NCT02580591|567395711|FG000|Overall Study|Not treated|1|||
157178404|NCT02580591|567395712|FG001|Overall Study|Not treated|1|||
157178405|NCT02580591|567395713|FG002|Overall Study|Not treated|0|||
157178406|NCT02580591|567395714|FG003|Overall Study|Not treated|0|||
157178407|NCT02580591|567395711|FG000|Overall Study|Other than specified|3|||
157178408|NCT02580591|567395712|FG001|Overall Study|Other than specified|2|||
157178409|NCT02580591|567395713|FG002|Overall Study|Other than specified|5|||
157178410|NCT02580591|567395714|FG003|Overall Study|Other than specified|2|||
157178411|NCT01599806|567395717|FG000|Overall Study|Lost to Follow-up|20|||
157229553|NCT00416520|567586469|FG000|Open-label Period|Lack of Efficacy|8|||
157229554|NCT00416520|567586470|FG001|Open-label Period|Lack of Efficacy|1|||
157229555|NCT00416520|567586471|FG002|Open-label Period|Lack of Efficacy|0|||
157229556|NCT00416520|567586472|FG003|Open-label Period|Lack of Efficacy|0|||
157229557|NCT00416520|567586469|FG000|Open-label Period|Protocol Violation|3|||
157229558|NCT00416520|567586470|FG001|Open-label Period|Protocol Violation|3|||
157229559|NCT00416520|567586471|FG002|Open-label Period|Protocol Violation|0|||
157229560|NCT00416520|567586472|FG003|Open-label Period|Protocol Violation|0|||
157229561|NCT00416520|567586469|FG000|Open-label Period|Withdrawal by Subject|16|||
157229562|NCT00416520|567586470|FG001|Open-label Period|Withdrawal by Subject|5|||
157229563|NCT00416520|567586471|FG002|Open-label Period|Withdrawal by Subject|0|||
157229564|NCT00416520|567586472|FG003|Open-label Period|Withdrawal by Subject|0|||
157229565|NCT00416520|567586469|FG000|Open-label Period|Other Reasons|3|||
157229566|NCT00416520|567586470|FG001|Open-label Period|Other Reasons|12|||
157229567|NCT00416520|567586471|FG002|Open-label Period|Other Reasons|0|||
157229568|NCT00416520|567586472|FG003|Open-label Period|Other Reasons|0|||
157229569|NCT00416520|567586469|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
157229570|NCT00416520|567586470|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
157229571|NCT00416520|567586471|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
157229572|NCT00416520|567586472|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
157229573|NCT00416520|567586469|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
157229574|NCT00416520|567586470|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
157229575|NCT00416520|567586471|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
157229576|NCT00416520|567586472|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
157229577|NCT00416520|567586469|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
157229578|NCT00416520|567586470|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
157229579|NCT00416520|567586471|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
157229580|NCT00416520|567586472|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
157229581|NCT01108094|567586476|FG000|Overall Study|Adverse Event|2|||
157229582|NCT01108094|567586477|FG001|Overall Study|Adverse Event|0|||
157229583|NCT01108094|567586478|FG002|Overall Study|Adverse Event|0|||
157229584|NCT01108094|567586479|FG003|Overall Study|Adverse Event|0|||
157229585|NCT01108094|567586476|FG000|Overall Study|Withdrawal by Subject|1|||
157229586|NCT01108094|567586477|FG001|Overall Study|Withdrawal by Subject|0|||
157229587|NCT01108094|567586478|FG002|Overall Study|Withdrawal by Subject|0|||
157229588|NCT01108094|567586479|FG003|Overall Study|Withdrawal by Subject|0|||
157229589|NCT02918877|567586484|FG000|Overall Study|Withdrawal by Subject|2|||
157229590|NCT02918877|567586485|FG001|Overall Study|Withdrawal by Subject|2|||
157229591|NCT02918877|567586484|FG000|Overall Study|Surgery cancelled|1|||
157229592|NCT02918877|567586485|FG001|Overall Study|Surgery cancelled|0|||
157229593|NCT02918877|567586484|FG000|Overall Study|Physician Decision|1|||
157229594|NCT02918877|567586485|FG001|Overall Study|Physician Decision|0|||
157229595|NCT02918877|567586484|FG000|Overall Study|Received intraoperative steroids|1|||
157229596|NCT02918877|567586485|FG001|Overall Study|Received intraoperative steroids|0|||
157229597|NCT02918877|567586484|FG000|Overall Study|Unable to obtain lab samples|1|||
157229598|NCT02918877|567586485|FG001|Overall Study|Unable to obtain lab samples|0|||
157178412|NCT01599806|567395718|FG001|Overall Study|Lost to Follow-up|20|||
157178413|NCT01599806|567395717|FG000|Overall Study|Withdrawal by Subject|12|||
157178414|NCT01599806|567395718|FG001|Overall Study|Withdrawal by Subject|12|||
157178415|NCT01599806|567395717|FG000|Overall Study|Other Eligibility criteria|11|||
157178416|NCT01599806|567395718|FG001|Overall Study|Other Eligibility criteria|9|||
157178417|NCT03006926|567395719|FG000|Overall Study|Adverse Event|0|||
157178418|NCT03006926|567395720|FG001|Overall Study|Adverse Event|27|||
157178419|NCT03006926|567395719|FG000|Overall Study|Withdrawal by Subject|0|||
157178420|NCT03006926|567395720|FG001|Overall Study|Withdrawal by Subject|1|||
157178421|NCT03006926|567395719|FG000|Overall Study|Radiological Disease Progression|0|||
157178422|NCT03006926|567395720|FG001|Overall Study|Radiological Disease Progression|52|||
157178423|NCT03006926|567395719|FG000|Overall Study|Clinical Disease Progression|0|||
157178424|NCT03006926|567395720|FG001|Overall Study|Clinical Disease Progression|10|||
157178425|NCT03006926|567395719|FG000|Overall Study|Other|0|||
157178426|NCT03006926|567395720|FG001|Overall Study|Other|8|||
157178427|NCT01838213|567395721|FG000|Overall Study|Ineligible|166|||
157178428|NCT01838213|567395722|FG001|Overall Study|Ineligible|191|||
157178429|NCT04882072|567395727|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
157178430|NCT04882072|567395728|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
157178431|NCT04882072|567395727|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
157178432|NCT04882072|567395728|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
157178433|NCT04882072|567395727|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
157178434|NCT04882072|567395728|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
157178435|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
157178436|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
157178437|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
157178438|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
157178439|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
157178440|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
157178441|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
157178442|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
157178443|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
157178444|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
157178445|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
157178446|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
157178447|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
157178448|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
157178449|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
157178450|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
157178451|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
157178452|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
157178453|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
157178454|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
157178455|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
157178456|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
157178457|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
157178458|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
157178459|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
157178460|NCT02918318|567395729|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
157178461|NCT02918318|567395730|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
157178462|NCT02918318|567395731|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
157178463|NCT02918318|567395732|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
157178464|NCT02918318|567395733|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
157178465|NCT02918318|567395729|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
157178466|NCT02918318|567395730|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
157178467|NCT02918318|567395731|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
157178468|NCT02918318|567395732|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
157178469|NCT02918318|567395733|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
157178470|NCT02918318|567395729|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
157178471|NCT02918318|567395730|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178472|NCT02918318|567395731|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
157178473|NCT02918318|567395732|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
157178474|NCT02918318|567395733|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178475|NCT02918318|567395729|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
157178476|NCT02918318|567395730|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
157178477|NCT02918318|567395731|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
157178478|NCT02918318|567395732|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
157178479|NCT02918318|567395733|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
157054972|NCT02660034|566954124|FG004|Overall Study|Adverse Event|0|||
157178480|NCT02918318|567395729|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
157178481|NCT02918318|567395730|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
156974295|NCT03285295|566662089|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
156974296|NCT03285295|566662090|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
157178482|NCT02918318|567395731|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
157178483|NCT02918318|567395732|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
157178484|NCT02918318|567395733|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
157178485|NCT02918318|567395729|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
156974297|NCT03285295|566662091|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
156974298|NCT03285295|566662092|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
156974299|NCT03285295|566662093|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
156974300|NCT03285295|566662089|FG000|Alinity s HBsAg|No Results Generated|74|||
156974301|NCT03285295|566662090|FG001|Alinity s HBsAg|No Results Generated|6|||
156974302|NCT03285295|566662091|FG002|Alinity s HBsAg|No Results Generated|0|||
156974303|NCT03285295|566662092|FG003|Alinity s HBsAg|No Results Generated|0|||
156974304|NCT03285295|566662093|FG004|Alinity s HBsAg|No Results Generated|0|||
156974305|NCT03285295|566662089|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
156974306|NCT03285295|566662090|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
156974307|NCT03285295|566662091|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
156974308|NCT03285295|566662092|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
156974309|NCT03285295|566662093|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
156974310|NCT03285295|566662089|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
156974311|NCT03285295|566662090|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156974312|NCT03285295|566662091|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156974313|NCT03285295|566662092|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156974314|NCT03285295|566662093|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
156974315|NCT03285295|566662089|FG000|Alinity s HTLV I/II|No Results Generated|70|||
156974316|NCT03285295|566662090|FG001|Alinity s HTLV I/II|No Results Generated|0|||
156974317|NCT03285295|566662091|FG002|Alinity s HTLV I/II|No Results Generated|0|||
156974318|NCT03285295|566662092|FG003|Alinity s HTLV I/II|No Results Generated|0|||
156974319|NCT03285295|566662093|FG004|Alinity s HTLV I/II|No Results Generated|0|||
156974320|NCT03285295|566662089|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
156974321|NCT03285295|566662090|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156974322|NCT03285295|566662091|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156974323|NCT03285295|566662092|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156974324|NCT03285295|566662093|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
156974325|NCT03285295|566662089|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
156974326|NCT03285295|566662090|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
156974327|NCT03285295|566662091|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
156974328|NCT03285295|566662092|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
156974329|NCT03285295|566662093|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
156974330|NCT03285295|566662089|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
156974331|NCT03285295|566662090|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156974332|NCT03285295|566662091|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156974333|NCT03285295|566662092|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156974334|NCT03285295|566662093|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
156974335|NCT03285295|566662089|FG000|Alinity s Anti-HCV|No Results Generated|71|||
156974336|NCT03285295|566662090|FG001|Alinity s Anti-HCV|No Results Generated|0|||
156974337|NCT03285295|566662091|FG002|Alinity s Anti-HCV|No Results Generated|0|||
156974338|NCT03285295|566662092|FG003|Alinity s Anti-HCV|No Results Generated|0|||
156974339|NCT03285295|566662093|FG004|Alinity s Anti-HCV|No Results Generated|0|||
156974340|NCT03285295|566662089|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
156974341|NCT03285295|566662090|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156974342|NCT03285295|566662091|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156974343|NCT03285295|566662092|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156974344|NCT03285295|566662093|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
156974345|NCT03285295|566662089|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
156974346|NCT03285295|566662090|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156974347|NCT03285295|566662091|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156974348|NCT03285295|566662092|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156974349|NCT03285295|566662093|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
156974350|NCT03285295|566662089|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
156974351|NCT03285295|566662090|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156974352|NCT03285295|566662091|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156974353|NCT03285295|566662092|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156974354|NCT03285295|566662093|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
156974355|NCT03285295|566662089|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
156974356|NCT03285295|566662090|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156974357|NCT03285295|566662091|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156974358|NCT03285295|566662092|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
156974359|NCT03285295|566662093|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
157054973|NCT02660034|566954125|FG005|Overall Study|Adverse Event|0|||
157178486|NCT02918318|567395730|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
157178487|NCT02918318|567395731|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
157178488|NCT02918318|567395732|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
157178489|NCT02918318|567395733|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
157178490|NCT02918318|567395729|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178491|NCT02918318|567395730|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178492|NCT02918318|567395731|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178493|NCT02918318|567395732|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
157178494|NCT02918318|567395733|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
157178495|NCT00990249|567395734|FG000|Overall Study|Disease Progression|8|||
157178496|NCT00990249|567395734|FG000|Overall Study|Non-Compliance|1|||
157178497|NCT00990249|567395734|FG000|Overall Study|Death|2|||
157178498|NCT00990249|567395734|FG000|Overall Study|Not treated|2|||
157178499|NCT01548417|567395735|FG000|Overall Study|Withdrawal by Subject|0|||
157178500|NCT01548417|567395736|FG001|Overall Study|Withdrawal by Subject|2|||
157178501|NCT04583969|567395737|FG000|Overall Study|Death|31|||
157178502|NCT04583969|567395738|FG001|Overall Study|Death|38|||
157178503|NCT04583969|567395737|FG000|Overall Study|Lost to Follow-up|16|||
157178504|NCT04583969|567395738|FG001|Overall Study|Lost to Follow-up|13|||
157178505|NCT04583969|567395737|FG000|Overall Study|Protocol Violation|1|||
157178506|NCT04583969|567395738|FG001|Overall Study|Protocol Violation|0|||
157178507|NCT04583969|567395737|FG000|Overall Study|Withdrawal by Subject|3|||
157178508|NCT04583969|567395738|FG001|Overall Study|Withdrawal by Subject|3|||
157178509|NCT04583969|567395737|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
157178510|NCT04583969|567395738|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
157178511|NCT04583969|567395737|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
157178512|NCT04583969|567395738|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
157178513|NCT04583969|567395737|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
157178514|NCT04583969|567395738|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
157178515|NCT04583969|567395737|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
157178516|NCT04583969|567395738|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
157178517|NCT04583969|567395737|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
157178518|NCT04583969|567395738|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
157178519|NCT02873208|567395739|FG000|Overall Study|Withdrawal by Subject|36|||
157178520|NCT02873208|567395739|FG000|Overall Study|Lost to Follow-up|22|||
157178521|NCT02873208|567395739|FG000|Overall Study|Adverse Event|15|||
157178522|NCT02873208|567395739|FG000|Overall Study|Non-compliance with study drug|12|||
157178523|NCT02873208|567395739|FG000|Overall Study|Protocol Violation|8|||
157178524|NCT02873208|567395739|FG000|Overall Study|Pregnancy|2|||
157178525|NCT02873208|567395739|FG000|Overall Study|Incarceration|1|||
157178526|NCT02873208|567395739|FG000|Overall Study|Lack of Efficacy|1|||
157178527|NCT02873208|567395739|FG000|Overall Study|Physician Decision|1|||
157178528|NCT00415584|567395740|FG000|Overall Study|Withdrawal by Subject|1|||
157178529|NCT01061567|567395741|FG000|Overall Study|Adverse Event|32|||
157178530|NCT01061567|567395741|FG000|Overall Study|Death|2|||
157178531|NCT01061567|567395741|FG000|Overall Study|Lack of Efficacy|3|||
157178532|NCT01061567|567395741|FG000|Overall Study|Lost to Follow-up|24|||
157178533|NCT01061567|567395741|FG000|Overall Study|Protocol Violation|1|||
157178534|NCT01061567|567395741|FG000|Overall Study|Withdrawal by Subject|11|||
157178535|NCT01061567|567395741|FG000|Overall Study|Other reason than stated above|3|||
157178536|NCT00563368|567395742|FG000|Overall Study|Lost to Follow-up|14|||
157178537|NCT00563368|567395743|FG001|Overall Study|Lost to Follow-up|14|||
157178538|NCT00563368|567395744|FG002|Overall Study|Lost to Follow-up|12|||
157178539|NCT00563368|567395745|FG003|Overall Study|Lost to Follow-up|6|||
157178540|NCT00563368|567395746|FG004|Overall Study|Lost to Follow-up|9|||
157178541|NCT00563368|567395747|FG005|Overall Study|Lost to Follow-up|8|||
157178542|NCT00563368|567395748|FG006|Overall Study|Lost to Follow-up|9|||
157178543|NCT00563368|567395742|FG000|Overall Study|Adverse Event|3|||
157178544|NCT00563368|567395743|FG001|Overall Study|Adverse Event|4|||
157178545|NCT00563368|567395744|FG002|Overall Study|Adverse Event|5|||
157178546|NCT00563368|567395745|FG003|Overall Study|Adverse Event|9|||
157178547|NCT00563368|567395746|FG004|Overall Study|Adverse Event|6|||
157178548|NCT00563368|567395747|FG005|Overall Study|Adverse Event|10|||
157178549|NCT00563368|567395748|FG006|Overall Study|Adverse Event|17|||
157178550|NCT00563368|567395742|FG000|Overall Study|Withdrawal by Subject|11|||
157178551|NCT00563368|567395743|FG001|Overall Study|Withdrawal by Subject|6|||
157178552|NCT00563368|567395744|FG002|Overall Study|Withdrawal by Subject|5|||
157178553|NCT00563368|567395745|FG003|Overall Study|Withdrawal by Subject|7|||
157178554|NCT00563368|567395746|FG004|Overall Study|Withdrawal by Subject|8|||
157178555|NCT00563368|567395747|FG005|Overall Study|Withdrawal by Subject|5|||
157229599|NCT02918877|567586484|FG000|Overall Study|Unsafe to perform BAL|0|||
157229600|NCT02918877|567586485|FG001|Overall Study|Unsafe to perform BAL|1|||
157178556|NCT00563368|567395748|FG006|Overall Study|Withdrawal by Subject|4|||
157178557|NCT00563368|567395742|FG000|Overall Study|protocol non-compliance|1|||
157178558|NCT00563368|567395743|FG001|Overall Study|protocol non-compliance|1|||
157178559|NCT00563368|567395744|FG002|Overall Study|protocol non-compliance|2|||
157178560|NCT00563368|567395745|FG003|Overall Study|protocol non-compliance|1|||
157178561|NCT00563368|567395746|FG004|Overall Study|protocol non-compliance|0|||
157178562|NCT00563368|567395747|FG005|Overall Study|protocol non-compliance|1|||
157178563|NCT00563368|567395748|FG006|Overall Study|protocol non-compliance|3|||
157178564|NCT00563368|567395742|FG000|Overall Study|Pregnancy|1|||
157178565|NCT00563368|567395743|FG001|Overall Study|Pregnancy|0|||
157178566|NCT00563368|567395744|FG002|Overall Study|Pregnancy|1|||
157178567|NCT00563368|567395745|FG003|Overall Study|Pregnancy|2|||
157178568|NCT00563368|567395746|FG004|Overall Study|Pregnancy|1|||
157178569|NCT00563368|567395747|FG005|Overall Study|Pregnancy|2|||
157178570|NCT00563368|567395748|FG006|Overall Study|Pregnancy|0|||
157178571|NCT00563368|567395742|FG000|Overall Study|requirement for restricted medication|0|||
157178572|NCT00563368|567395743|FG001|Overall Study|requirement for restricted medication|0|||
157178573|NCT00563368|567395744|FG002|Overall Study|requirement for restricted medication|2|||
157178574|NCT00563368|567395745|FG003|Overall Study|requirement for restricted medication|0|||
157178575|NCT00563368|567395746|FG004|Overall Study|requirement for restricted medication|0|||
157178576|NCT00563368|567395747|FG005|Overall Study|requirement for restricted medication|0|||
157178577|NCT00563368|567395748|FG006|Overall Study|requirement for restricted medication|0|||
157178578|NCT00563368|567395742|FG000|Overall Study|Other|5|||
157178579|NCT00563368|567395743|FG001|Overall Study|Other|5|||
157178580|NCT00563368|567395744|FG002|Overall Study|Other|3|||
157178581|NCT00563368|567395745|FG003|Overall Study|Other|4|||
157178582|NCT00563368|567395746|FG004|Overall Study|Other|4|||
157178583|NCT00563368|567395747|FG005|Overall Study|Other|4|||
157178584|NCT00563368|567395748|FG006|Overall Study|Other|0|||
157178585|NCT02640755|567395749|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
157178586|NCT02640755|567395750|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
157178587|NCT02640755|567395749|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
157178588|NCT02640755|567395750|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
157178589|NCT02640755|567395749|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
157178590|NCT02640755|567395750|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
157178591|NCT01192100|567395757|FG000|Overall Study|Withdrawal by Subject|0|||
157178592|NCT01192100|567395758|FG001|Overall Study|Withdrawal by Subject|0|||
157178593|NCT01192100|567395759|FG002|Overall Study|Withdrawal by Subject|0|||
157178594|NCT01192100|567395760|FG003|Overall Study|Withdrawal by Subject|0|||
157178595|NCT01192100|567395761|FG004|Overall Study|Withdrawal by Subject|1|||
157178596|NCT01192100|567395762|FG005|Overall Study|Withdrawal by Subject|0|||
157178597|NCT01192100|567395757|FG000|Overall Study|Protocol Violation|0|||
157178598|NCT01192100|567395758|FG001|Overall Study|Protocol Violation|0|||
157178599|NCT01192100|567395759|FG002|Overall Study|Protocol Violation|0|||
157178600|NCT01192100|567395760|FG003|Overall Study|Protocol Violation|1|||
157178601|NCT01192100|567395761|FG004|Overall Study|Protocol Violation|0|||
157178602|NCT01192100|567395762|FG005|Overall Study|Protocol Violation|0|||
157178603|NCT02057068|567395763|FG000|Overall Study|Withdrawal by Subject|2|||
157178604|NCT02057068|567395764|FG001|Overall Study|Withdrawal by Subject|2|||
157178605|NCT02057068|567395763|FG000|Overall Study|Caregiver (CG) Health|0|||
157178606|NCT02057068|567395764|FG001|Overall Study|Caregiver (CG) Health|2|||
157178607|NCT02057068|567395763|FG000|Overall Study|Carepartner (CP) Health|4|||
157178608|NCT02057068|567395764|FG001|Overall Study|Carepartner (CP) Health|2|||
157178609|NCT02057068|567395763|FG000|Overall Study|Lost to Follow-up|2|||
157178610|NCT02057068|567395764|FG001|Overall Study|Lost to Follow-up|2|||
157178611|NCT00841672|567395766|FG000|Overall Study|Adverse Event|7|||
157178612|NCT00841672|567395767|FG001|Overall Study|Adverse Event|16|||
157178613|NCT00841672|567395766|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157178614|NCT00841672|567395767|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157178615|NCT00841672|567395766|FG000|Overall Study|Subject withdrew consent|2|||
157178616|NCT00841672|567395767|FG001|Overall Study|Subject withdrew consent|4|||
157178617|NCT00841672|567395766|FG000|Overall Study|Lost to Follow-up|1|||
157178618|NCT00841672|567395767|FG001|Overall Study|Lost to Follow-up|1|||
157178619|NCT00841672|567395766|FG000|Overall Study|Administrative problems|9|||
157178620|NCT00841672|567395767|FG001|Overall Study|Administrative problems|9|||
157178621|NCT00841672|567395766|FG000|Overall Study|Misrandomized|1|||
157178622|NCT00841672|567395767|FG001|Overall Study|Misrandomized|0|||
157178623|NCT00841672|567395766|FG000|Overall Study|Protocol Deviation|0|||
157178624|NCT00841672|567395767|FG001|Overall Study|Protocol Deviation|1|||
157178625|NCT02186561|567395770|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
157178626|NCT02186561|567395770|FG000|Enrollment|Enrollment Cap Reached|5|||
157178627|NCT02186561|567395770|FG000|Enrollment|Insurance Denial|2|||
157178628|NCT02186561|567395770|FG000|Enrollment|Withdrawal by Subject|2|||
157229601|NCT05346055|567586488|FG000|Overall Study|Withdrawal by Subject|1|||
157229602|NCT05346055|567586488|FG000|Overall Study|Protocol Violation|1|||
157229603|NCT05346055|567586488|FG000|Overall Study|Therapist decision|1|||
157178629|NCT02186561|567395770|FG000|Enrollment|Investigator Withdrew Consent|1|||
157178630|NCT02186561|567395770|FG000|30-Day Post Index Procedure Visit|Death|1|||
157178631|NCT02186561|567395770|FG000|1- Year Post Index Procedure Visit|Death|1|||
157178632|NCT02186561|567395770|FG000|1- Year Post Index Procedure Visit|Missed|1|||
156974360|NCT03285295|566662089|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
156974361|NCT03285295|566662090|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156974362|NCT03285295|566662091|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156974363|NCT03285295|566662092|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156974364|NCT03285295|566662093|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
156974365|NCT03285295|566662089|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
156974366|NCT03285295|566662090|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
156974367|NCT03285295|566662091|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
156974368|NCT03285295|566662092|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
156974369|NCT03285295|566662093|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
156974370|NCT03285295|566662089|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
156974371|NCT03285295|566662090|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
156974372|NCT03285295|566662091|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156974373|NCT03285295|566662092|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156974374|NCT03285295|566662093|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
156974375|NCT03285295|566662089|FG000|Alinity s Anti-HBc|No Results Generated|70|||
156974376|NCT03285295|566662090|FG001|Alinity s Anti-HBc|No Results Generated|0|||
156974377|NCT03285295|566662091|FG002|Alinity s Anti-HBc|No Results Generated|0|||
156974378|NCT03285295|566662092|FG003|Alinity s Anti-HBc|No Results Generated|0|||
156974379|NCT03285295|566662093|FG004|Alinity s Anti-HBc|No Results Generated|0|||
156974380|NCT03285295|566662089|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
156974381|NCT03285295|566662090|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156974382|NCT03285295|566662091|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156974383|NCT03285295|566662092|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156974384|NCT03285295|566662093|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
156974385|NCT03285295|566662089|FG000|Alinity s Chagas|Protocol Violation|76|||
156974386|NCT03285295|566662090|FG001|Alinity s Chagas|Protocol Violation|0|||
157178633|NCT00842361|567395771|FG000|Overall Study|Protocol Violation|1|||
156974387|NCT03285295|566662091|FG002|Alinity s Chagas|Protocol Violation|0|||
156974388|NCT03285295|566662092|FG003|Alinity s Chagas|Protocol Violation|0|||
156974389|NCT03285295|566662093|FG004|Alinity s Chagas|Protocol Violation|0|||
156974390|NCT03285295|566662089|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
156974391|NCT03285295|566662090|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
156974392|NCT03285295|566662091|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
156974393|NCT03285295|566662092|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
156974394|NCT03285295|566662093|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
156974395|NCT03285295|566662089|FG000|Alinity s Chagas|No Results Generated|105|||
156974396|NCT03285295|566662090|FG001|Alinity s Chagas|No Results Generated|0|||
156974397|NCT03285295|566662091|FG002|Alinity s Chagas|No Results Generated|0|||
156974398|NCT03285295|566662092|FG003|Alinity s Chagas|No Results Generated|0|||
156974399|NCT03285295|566662093|FG004|Alinity s Chagas|No Results Generated|0|||
156974400|NCT03285295|566662089|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
156974401|NCT03285295|566662090|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156974402|NCT03285295|566662091|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156974403|NCT03285295|566662092|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156974404|NCT03285295|566662093|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
156974405|NCT03015116|566662094|FG000|Overall Study|Lost to Follow-up|3|||
156974406|NCT03015116|566662095|FG001|Overall Study|Lost to Follow-up|0|||
156974407|NCT03015116|566662096|FG002|Overall Study|Lost to Follow-up|2|||
156974408|NCT03015116|566662094|FG000|Overall Study|Withdrawal by Subject|3|||
156974409|NCT03015116|566662095|FG001|Overall Study|Withdrawal by Subject|1|||
156974410|NCT03015116|566662096|FG002|Overall Study|Withdrawal by Subject|0|||
156974411|NCT03015116|566662094|FG000|Overall Study|Subject has New Medical Status|1|||
156974412|NCT03015116|566662095|FG001|Overall Study|Subject has New Medical Status|0|||
156974413|NCT03015116|566662096|FG002|Overall Study|Subject has New Medical Status|0|||
156974414|NCT03015116|566662094|FG000|Overall Study|Physician Decision|0|||
156974415|NCT03015116|566662095|FG001|Overall Study|Physician Decision|1|||
156974416|NCT03015116|566662096|FG002|Overall Study|Physician Decision|0|||
156974417|NCT02200939|566662100|FG000|Overall Study|Participant withdrew consent|0|||
156974418|NCT02200939|566662101|FG001|Overall Study|Participant withdrew consent|1|||
156974419|NCT02200939|566662100|FG000|Overall Study|Lost to Follow-up|2|||
157178634|NCT00842361|567395772|FG001|Overall Study|Protocol Violation|0|||
157178635|NCT00842361|567395771|FG000|Overall Study|Unclassified|0|||
156974420|NCT02200939|566662101|FG001|Overall Study|Lost to Follow-up|9|||
156974421|NCT02200939|566662100|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
156974422|NCT02200939|566662101|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
156974423|NCT04567693|566662102|FG000|Overall Study|Death|0|||
156974424|NCT04567693|566662103|FG001|Overall Study|Death|0|||
156974425|NCT04567693|566662104|FG002|Overall Study|Death|2|||
156974426|NCT04567693|566662102|FG000|Overall Study|Lost to Follow-up|1|||
156974427|NCT04567693|566662103|FG001|Overall Study|Lost to Follow-up|0|||
156974428|NCT04567693|566662104|FG002|Overall Study|Lost to Follow-up|2|||
156974429|NCT04567693|566662102|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
156974430|NCT04567693|566662103|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
156974431|NCT04567693|566662104|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
156974432|NCT02762981|566662105|FG000|Overall Study|Adverse Event|2|||
156974433|NCT02762981|566662106|FG001|Overall Study|Adverse Event|3|||
156974434|NCT02762981|566662107|FG002|Overall Study|Adverse Event|1|||
156974435|NCT02762981|566662108|FG003|Overall Study|Adverse Event|1|||
156974436|NCT02762981|566662109|FG004|Overall Study|Adverse Event|3|||
156974437|NCT02762981|566662105|FG000|Overall Study|Physician Decision|0|||
156974438|NCT02762981|566662106|FG001|Overall Study|Physician Decision|1|||
156974439|NCT02762981|566662107|FG002|Overall Study|Physician Decision|0|||
156974440|NCT02762981|566662108|FG003|Overall Study|Physician Decision|0|||
156974441|NCT02762981|566662109|FG004|Overall Study|Physician Decision|1|||
156974442|NCT02762981|566662105|FG000|Overall Study|Disease progression|11|||
156974443|NCT02762981|566662106|FG001|Overall Study|Disease progression|23|||
156974444|NCT02762981|566662107|FG002|Overall Study|Disease progression|4|||
156974445|NCT02762981|566662108|FG003|Overall Study|Disease progression|10|||
156974446|NCT02762981|566662109|FG004|Overall Study|Disease progression|1|||
156974447|NCT02762981|566662105|FG000|Overall Study|Enrolled not treated|1|||
156974448|NCT02762981|566662106|FG001|Overall Study|Enrolled not treated|5|||
156974449|NCT02762981|566662107|FG002|Overall Study|Enrolled not treated|0|||
156974450|NCT02762981|566662108|FG003|Overall Study|Enrolled not treated|2|||
156974451|NCT02762981|566662109|FG004|Overall Study|Enrolled not treated|0|||
156974452|NCT02762981|566662105|FG000|Overall Study|Other|2|||
156974453|NCT02762981|566662106|FG001|Overall Study|Other|3|||
156974454|NCT02762981|566662107|FG002|Overall Study|Other|1|||
156974455|NCT02762981|566662108|FG003|Overall Study|Other|0|||
156974456|NCT02762981|566662109|FG004|Overall Study|Other|0|||
156974457|NCT02762981|566662105|FG000|Overall Study|Missing|1|||
156974458|NCT02762981|566662106|FG001|Overall Study|Missing|0|||
156974459|NCT02762981|566662107|FG002|Overall Study|Missing|0|||
156974460|NCT02762981|566662108|FG003|Overall Study|Missing|0|||
156974461|NCT02762981|566662109|FG004|Overall Study|Missing|0|||
156974462|NCT02762981|566662105|FG000|Overall Study|Withdrawal by Subject|0|||
156974463|NCT02762981|566662106|FG001|Overall Study|Withdrawal by Subject|5|||
156974464|NCT02762981|566662107|FG002|Overall Study|Withdrawal by Subject|1|||
156974465|NCT02762981|566662108|FG003|Overall Study|Withdrawal by Subject|3|||
156974466|NCT02762981|566662109|FG004|Overall Study|Withdrawal by Subject|0|||
156974467|NCT02991482|566662110|FG000|Overall Study|Disease progression|56|||
156974468|NCT02991482|566662111|FG001|Overall Study|Disease progression|47|||
156974469|NCT02991482|566662110|FG000|Overall Study|Death|4|||
156974470|NCT02991482|566662111|FG001|Overall Study|Death|4|||
156974471|NCT02991482|566662110|FG000|Overall Study|Adverse Event|1|||
156974472|NCT02991482|566662111|FG001|Overall Study|Adverse Event|6|||
156974473|NCT02991482|566662110|FG000|Overall Study|Patient decision|1|||
156974474|NCT02991482|566662111|FG001|Overall Study|Patient decision|1|||
156974475|NCT02991482|566662110|FG000|Overall Study|Physician Decision|0|||
156974476|NCT02991482|566662111|FG001|Overall Study|Physician Decision|6|||
156974477|NCT02991482|566662110|FG000|Overall Study|Clinical deterioration|1|||
156974478|NCT02991482|566662111|FG001|Overall Study|Clinical deterioration|0|||
156974479|NCT02991482|566662110|FG000|Overall Study|Patient feeling too unwell|1|||
156974480|NCT02991482|566662111|FG001|Overall Study|Patient feeling too unwell|0|||
156974481|NCT02991482|566662110|FG000|Overall Study|Worsening of performance status|0|||
156974482|NCT02991482|566662111|FG001|Overall Study|Worsening of performance status|1|||
156974483|NCT02991482|566662110|FG000|Overall Study|Death prior to study drug initiation|1|||
156974484|NCT02991482|566662111|FG001|Overall Study|Death prior to study drug initiation|0|||
156974485|NCT02991482|566662110|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
156974486|NCT02991482|566662111|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
156974487|NCT02887989|566662115|FG000|Overall Study|Withdrawal by Subject|8|||
156974488|NCT02887989|566662116|FG001|Overall Study|Withdrawal by Subject|11|||
156974489|NCT02887989|566662115|FG000|Overall Study|Death|1|||
156974490|NCT02887989|566662116|FG001|Overall Study|Death|0|||
156974491|NCT01588990|566662126|FG000|Phase A|Withdrawal by Subject|5|||
156974492|NCT01588990|566662126|FG000|Phase A|Physician Decision|11|||
156974493|NCT01588990|566662126|FG000|Phase A|Other|14|||
156974494|NCT01588990|566662126|FG000|Phase A|Lost to Follow-up|1|||
156974495|NCT01588990|566662126|FG000|Phase A|Death|5|||
156974496|NCT01588990|566662126|FG000|Phase A|Adverse Event|28|||
156974497|NCT01588990|566662126|FG000|Phase A|Still on therapy at end of study|6|||
156974498|NCT01588990|566662126|FG000|Phase B|Adverse Event|2|||
156974499|NCT01588990|566662126|FG000|Phase B|Still on therapy at end of study|5|||
156974500|NCT01588990|566662126|FG000|Phase B|Withdrawal by Subject|3|||
156974501|NCT01588990|566662126|FG000|Phase B|Physician Decision|4|||
156974502|NCT01588990|566662126|FG000|Phase B|Other|2|||
156974503|NCT01641926|566662129|FG000|Overall Study|Adverse Event|5|||
156974504|NCT01641926|566662130|FG001|Overall Study|Adverse Event|2|||
156974505|NCT01641926|566662131|FG002|Overall Study|Adverse Event|3|||
156974506|NCT01641926|566662132|FG003|Overall Study|Adverse Event|1|||
156974507|NCT01641926|566662129|FG000|Overall Study|Lost to Follow-up|2|||
156974508|NCT01641926|566662130|FG001|Overall Study|Lost to Follow-up|2|||
157178636|NCT00842361|567395772|FG001|Overall Study|Unclassified|2|||
157178637|NCT01072448|567395775|FG000|Overall Study|Adverse Event|9|||
157178638|NCT01072448|567395776|FG001|Overall Study|Adverse Event|10|||
157178639|NCT01072448|567395775|FG000|Overall Study|Subject withdrew consent|4|||
157178640|NCT01072448|567395776|FG001|Overall Study|Subject withdrew consent|9|||
157178641|NCT01072448|567395775|FG000|Overall Study|Protocol deviation|3|||
157178642|NCT01072448|567395776|FG001|Overall Study|Protocol deviation|4|||
157178643|NCT01072448|567395775|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157178644|NCT01072448|567395776|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157178645|NCT01072448|567395775|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157178646|NCT01072448|567395776|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
157178647|NCT01072448|567395775|FG000|Overall Study|Lost to Follow-up|1|||
157178648|NCT01072448|567395776|FG001|Overall Study|Lost to Follow-up|1|||
157178649|NCT01072448|567395775|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157178650|NCT01072448|567395776|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157178651|NCT01072448|567395775|FG000|Overall Study|Death|0|||
157178652|NCT01072448|567395776|FG001|Overall Study|Death|2|||
157178653|NCT01814826|567395779|FG000|Overall Study|Other|3|||
157178654|NCT01814826|567395780|FG001|Overall Study|Other|5|||
157178655|NCT01814826|567395781|FG002|Overall Study|Other|0|||
157178656|NCT01814826|567395779|FG000|Overall Study|Death|29|||
157178657|NCT01814826|567395780|FG001|Overall Study|Death|24|||
157178658|NCT01814826|567395781|FG002|Overall Study|Death|3|||
157178659|NCT02917629|567395782|FG000|Overall Study|Withdrawal by Subject|0|||
157178660|NCT02917629|567395783|FG001|Overall Study|Withdrawal by Subject|1|||
157178661|NCT03271307|567395784|FG000|Overall Study|Lost to Follow-up|0|||
157178662|NCT03271307|567395785|FG001|Overall Study|Lost to Follow-up|0|||
157178663|NCT03271307|567395786|FG002|Overall Study|Lost to Follow-up|0|||
157178664|NCT03271307|567395787|FG003|Overall Study|Lost to Follow-up|28|||
157178665|NCT03271307|567395788|FG004|Overall Study|Lost to Follow-up|91|||
157178666|NCT01601470|567395789|FG000|Period 2 - LCZ696|Physician Decision|1|||
157178667|NCT03032510|567395790|FG000|Overall Study|Adverse Event|5|||
157178668|NCT03032510|567395791|FG001|Overall Study|Adverse Event|2|||
157178669|NCT03032510|567395790|FG000|Overall Study|Lost to Follow-up|8|||
157178670|NCT03032510|567395791|FG001|Overall Study|Lost to Follow-up|7|||
157178671|NCT03032510|567395790|FG000|Overall Study|Withdrawal by Subject|8|||
157178672|NCT03032510|567395791|FG001|Overall Study|Withdrawal by Subject|7|||
157178673|NCT03032510|567395790|FG000|Overall Study|Subject noncompliance|4|||
157178674|NCT03032510|567395791|FG001|Overall Study|Subject noncompliance|2|||
157178675|NCT03032510|567395790|FG000|Overall Study|Physician Decision|2|||
157178676|NCT03032510|567395791|FG001|Overall Study|Physician Decision|0|||
157178677|NCT01203787|567395792|FG000|Overall Study|Death|12|||
157178678|NCT01203787|567395793|FG001|Overall Study|Death|10|||
157178679|NCT01203787|567395792|FG000|Overall Study|Withdrawal by Subject|6|||
157178680|NCT01203787|567395793|FG001|Overall Study|Withdrawal by Subject|2|||
157178681|NCT01203787|567395792|FG000|Overall Study|Lost to Follow-up|2|||
157178682|NCT01203787|567395793|FG001|Overall Study|Lost to Follow-up|0|||
157178683|NCT01203787|567395792|FG000|Overall Study|Adverse Event|11|||
157178684|NCT01203787|567395793|FG001|Overall Study|Adverse Event|15|||
157178685|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
157178686|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
157178687|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
157178688|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
157178689|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
157178690|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
157178691|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
157178692|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
157178693|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
157178694|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
157178695|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
157178696|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
157229604|NCT00728949|567586495|FG000|Overall Study|Adverse Event|8|||
157229605|NCT00728949|567586496|FG001|Overall Study|Adverse Event|0|||
157178697|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
157178698|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
157178699|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
157178700|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
157178701|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
157178702|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
157178703|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
157178704|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
157178705|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
157178706|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
157178707|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
157178708|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
157178709|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
156974509|NCT01641926|566662131|FG002|Overall Study|Lost to Follow-up|1|||
156974510|NCT01641926|566662132|FG003|Overall Study|Lost to Follow-up|0|||
156974511|NCT01641926|566662129|FG000|Overall Study|Physician Decision|6|||
156974512|NCT01641926|566662130|FG001|Overall Study|Physician Decision|5|||
156974513|NCT01641926|566662131|FG002|Overall Study|Physician Decision|0|||
156974514|NCT01641926|566662132|FG003|Overall Study|Physician Decision|1|||
156974515|NCT01641926|566662129|FG000|Overall Study|Protocol Violation|1|||
156974516|NCT01641926|566662130|FG001|Overall Study|Protocol Violation|0|||
156974517|NCT01641926|566662131|FG002|Overall Study|Protocol Violation|0|||
156974518|NCT01641926|566662132|FG003|Overall Study|Protocol Violation|1|||
156974519|NCT01641926|566662129|FG000|Overall Study|Withdrawal by Subject|13|||
156974520|NCT01641926|566662130|FG001|Overall Study|Withdrawal by Subject|5|||
156974521|NCT01641926|566662131|FG002|Overall Study|Withdrawal by Subject|6|||
156974522|NCT01641926|566662132|FG003|Overall Study|Withdrawal by Subject|1|||
156974523|NCT01641926|566662129|FG000|Overall Study|Not Treated|1|||
156974524|NCT01641926|566662130|FG001|Overall Study|Not Treated|1|||
156974525|NCT01641926|566662131|FG002|Overall Study|Not Treated|1|||
156974526|NCT01641926|566662132|FG003|Overall Study|Not Treated|0|||
156974527|NCT01287520|566662133|FG000|Overall Study|Adverse Event|2|||
156974528|NCT01287520|566662134|FG001|Overall Study|Adverse Event|2|||
156974529|NCT01287520|566662135|FG002|Overall Study|Adverse Event|2|||
156974530|NCT01287520|566662136|FG003|Overall Study|Adverse Event|1|||
156974531|NCT01287520|566662137|FG004|Overall Study|Adverse Event|1|||
156974532|NCT01287520|566662138|FG005|Overall Study|Adverse Event|2|||
156974533|NCT01287520|566662139|FG006|Overall Study|Adverse Event|0|||
156974534|NCT01287520|566662140|FG007|Overall Study|Adverse Event|2|||
156974535|NCT01287520|566662141|FG008|Overall Study|Adverse Event|0|||
156974536|NCT01287520|566662133|FG000|Overall Study|Physician Decision|1|||
156974537|NCT01287520|566662134|FG001|Overall Study|Physician Decision|1|||
156974538|NCT01287520|566662135|FG002|Overall Study|Physician Decision|2|||
156974539|NCT01287520|566662136|FG003|Overall Study|Physician Decision|0|||
156974540|NCT01287520|566662137|FG004|Overall Study|Physician Decision|1|||
156974541|NCT01287520|566662138|FG005|Overall Study|Physician Decision|1|||
156974542|NCT01287520|566662139|FG006|Overall Study|Physician Decision|0|||
156974543|NCT01287520|566662140|FG007|Overall Study|Physician Decision|1|||
156974544|NCT01287520|566662141|FG008|Overall Study|Physician Decision|0|||
156974545|NCT01287520|566662133|FG000|Overall Study|Progressive disease|0|||
156974546|NCT01287520|566662134|FG001|Overall Study|Progressive disease|4|||
156974547|NCT01287520|566662135|FG002|Overall Study|Progressive disease|1|||
156974548|NCT01287520|566662136|FG003|Overall Study|Progressive disease|6|||
156974549|NCT01287520|566662137|FG004|Overall Study|Progressive disease|1|||
156974550|NCT01287520|566662138|FG005|Overall Study|Progressive disease|0|||
156974551|NCT01287520|566662139|FG006|Overall Study|Progressive disease|2|||
156974552|NCT01287520|566662140|FG007|Overall Study|Progressive disease|2|||
156974553|NCT01287520|566662141|FG008|Overall Study|Progressive disease|4|||
156974554|NCT01287520|566662133|FG000|Overall Study|Withdrawal by Subject|0|||
156974555|NCT01287520|566662134|FG001|Overall Study|Withdrawal by Subject|0|||
156974556|NCT01287520|566662135|FG002|Overall Study|Withdrawal by Subject|0|||
156974557|NCT01287520|566662136|FG003|Overall Study|Withdrawal by Subject|0|||
156974558|NCT01287520|566662137|FG004|Overall Study|Withdrawal by Subject|0|||
156974559|NCT01287520|566662138|FG005|Overall Study|Withdrawal by Subject|1|||
156974560|NCT01287520|566662139|FG006|Overall Study|Withdrawal by Subject|0|||
156974561|NCT01287520|566662140|FG007|Overall Study|Withdrawal by Subject|0|||
156974562|NCT01287520|566662141|FG008|Overall Study|Withdrawal by Subject|1|||
157229606|NCT00728949|567586495|FG000|Overall Study|Withdrawal by Subject|2|||
157229607|NCT00728949|567586496|FG001|Overall Study|Withdrawal by Subject|2|||
156974563|NCT03587142|566662142|FG000|Overall Study|Lost to Follow-up|5|||
156974564|NCT03587142|566662143|FG001|Overall Study|Lost to Follow-up|3|||
156974565|NCT03587142|566662142|FG000|Overall Study|Did not complete the f4 visit|3|||
156974566|NCT03587142|566662143|FG001|Overall Study|Did not complete the f4 visit|7|||
156974567|NCT01800201|566662144|FG000|Overall Study|Withdrawal by Subject|2|||
156974568|NCT01800201|566662145|FG001|Overall Study|Withdrawal by Subject|0|||
156974569|NCT01800201|566662144|FG000|Overall Study|patient privacy concerns|1|||
156974570|NCT01800201|566662145|FG001|Overall Study|patient privacy concerns|1|||
156974571|NCT01800201|566662144|FG000|Overall Study|did not want to use device|0|||
156974572|NCT01800201|566662145|FG001|Overall Study|did not want to use device|1|||
156974573|NCT01800201|566662144|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
156974574|NCT01800201|566662145|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
156974575|NCT02387216|566662149|FG000|Overall Study|Progressive disease|2|||
156974576|NCT02387216|566662150|FG001|Overall Study|Progressive disease|0|||
156974577|NCT02387216|566662149|FG000|Overall Study|Withdrawal by Subject|3|||
156974578|NCT02387216|566662150|FG001|Overall Study|Withdrawal by Subject|5|||
156974579|NCT02387216|566662149|FG000|Overall Study|Physician Decision|2|||
156974580|NCT02387216|566662150|FG001|Overall Study|Physician Decision|0|||
156974581|NCT02387216|566662149|FG000|Overall Study|Sponsor Decision|28|||
156974582|NCT02387216|566662150|FG001|Overall Study|Sponsor Decision|12|||
156974583|NCT02387216|566662149|FG000|Overall Study|Death|60|||
156974584|NCT02387216|566662150|FG001|Overall Study|Death|23|||
156974585|NCT02387216|566662149|FG000|Overall Study|Other|5|||
157178710|NCT00856986|567395794|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
157178711|NCT00856986|567395795|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
157178712|NCT00856986|567395796|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
157178713|NCT00856986|567395797|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
157178714|NCT00856986|567395798|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
157178715|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
157178716|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
157178717|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
157178718|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
157178719|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
157178720|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
157178721|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
157178722|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
157178723|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
157178724|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
157178725|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
157178726|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
157178727|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
157178728|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
157178729|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
157178730|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
157178731|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
157178732|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
157178733|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
157178734|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
157178735|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
157178736|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
157178737|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
157178738|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
157178739|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
157178740|NCT00856986|567395794|FG000|Main Period, Weeks 0-26|Unclassified|7|||
157178741|NCT00856986|567395795|FG001|Main Period, Weeks 0-26|Unclassified|6|||
157178742|NCT00856986|567395796|FG002|Main Period, Weeks 0-26|Unclassified|7|||
157178743|NCT00856986|567395797|FG003|Main Period, Weeks 0-26|Unclassified|0|||
157178744|NCT00856986|567395798|FG004|Main Period, Weeks 0-26|Unclassified|0|||
157178745|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
157178746|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
157178747|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
157178748|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
157178749|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
157178750|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
157178751|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
157178752|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
157178753|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
157178754|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
157178755|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
157178756|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
157178757|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
157178758|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
157178759|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
157178760|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
157178761|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
157178762|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
157178763|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
157178764|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
157178765|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
157178766|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
157178767|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
157178768|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
157178769|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
157178770|NCT00856986|567395794|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
157178771|NCT00856986|567395795|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
157178772|NCT00856986|567395796|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
157178773|NCT00856986|567395797|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
157178774|NCT00856986|567395798|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
157178775|NCT01041404|567395803|FG000|Overall Study|Adverse Event|45|||
157178776|NCT01041404|567395804|FG001|Overall Study|Adverse Event|35|||
157178777|NCT01041404|567395803|FG000|Overall Study|Lack of Efficacy|200|||
157229608|NCT00728949|567586495|FG000|Overall Study|Abnormal Lab Results|0|||
157178778|NCT01041404|567395804|FG001|Overall Study|Lack of Efficacy|210|||
157178779|NCT01041404|567395803|FG000|Overall Study|Violation of Selection Criteria|0|||
157178780|NCT01041404|567395804|FG001|Overall Study|Violation of Selection Criteria|1|||
156974586|NCT02387216|566662150|FG001|Overall Study|Other|4|||
156974587|NCT02387216|566662149|FG000|Overall Study|Lost to Follow-up|0|||
156974588|NCT02387216|566662150|FG001|Overall Study|Lost to Follow-up|3|||
156974589|NCT00909480|566662151|FG000|Overall Study|Adverse Event|5|||
156974590|NCT00909480|566662152|FG001|Overall Study|Adverse Event|3|||
156974591|NCT00909480|566662151|FG000|Overall Study|Protocol Violation|6|||
156974592|NCT00909480|566662152|FG001|Overall Study|Protocol Violation|8|||
156974593|NCT00909480|566662151|FG000|Overall Study|Withdrawal criteria|9|||
156974594|NCT00909480|566662152|FG001|Overall Study|Withdrawal criteria|11|||
156974595|NCT00909480|566662151|FG000|Overall Study|Unclassified|18|||
156974596|NCT00909480|566662152|FG001|Overall Study|Unclassified|19|||
156974597|NCT03528174|566662155|FG000|Overall Study|Adverse Event|1|||
156974598|NCT03528174|566662155|FG000|Overall Study|sensors dislodged|1|||
156974599|NCT02118337|566662156|FG000|Overall Study|Other|1|||
156974600|NCT02118337|566662157|FG001|Overall Study|Other|0|||
156974601|NCT02118337|566662158|FG002|Overall Study|Other|0|||
156974602|NCT02118337|566662159|FG003|Overall Study|Other|0|||
156974603|NCT02118337|566662160|FG004|Overall Study|Other|2|||
156974604|NCT02118337|566662161|FG005|Overall Study|Other|3|||
156974605|NCT02118337|566662162|FG006|Overall Study|Other|1|||
156974606|NCT02118337|566662163|FG007|Overall Study|Other|28|||
156974607|NCT02118337|566662164|FG008|Overall Study|Other|15|||
156974608|NCT02118337|566662156|FG000|Overall Study|Lost to Follow-up|0|||
156974609|NCT02118337|566662157|FG001|Overall Study|Lost to Follow-up|0|||
156974610|NCT02118337|566662158|FG002|Overall Study|Lost to Follow-up|0|||
156974611|NCT02118337|566662159|FG003|Overall Study|Lost to Follow-up|0|||
156974612|NCT02118337|566662160|FG004|Overall Study|Lost to Follow-up|0|||
156974613|NCT02118337|566662161|FG005|Overall Study|Lost to Follow-up|0|||
156974614|NCT02118337|566662162|FG006|Overall Study|Lost to Follow-up|0|||
156974615|NCT02118337|566662163|FG007|Overall Study|Lost to Follow-up|1|||
156974616|NCT02118337|566662164|FG008|Overall Study|Lost to Follow-up|0|||
156974617|NCT02118337|566662156|FG000|Overall Study|Withdrawal by Subject|1|||
156974618|NCT02118337|566662157|FG001|Overall Study|Withdrawal by Subject|3|||
156974619|NCT02118337|566662158|FG002|Overall Study|Withdrawal by Subject|2|||
156974620|NCT02118337|566662159|FG003|Overall Study|Withdrawal by Subject|1|||
156974621|NCT02118337|566662160|FG004|Overall Study|Withdrawal by Subject|2|||
156974622|NCT02118337|566662161|FG005|Overall Study|Withdrawal by Subject|2|||
156974623|NCT02118337|566662162|FG006|Overall Study|Withdrawal by Subject|1|||
156974624|NCT02118337|566662163|FG007|Overall Study|Withdrawal by Subject|4|||
156974625|NCT02118337|566662164|FG008|Overall Study|Withdrawal by Subject|2|||
156974626|NCT02118337|566662156|FG000|Overall Study|Death|2|||
156974627|NCT02118337|566662157|FG001|Overall Study|Death|2|||
156974628|NCT02118337|566662158|FG002|Overall Study|Death|1|||
156974629|NCT02118337|566662159|FG003|Overall Study|Death|2|||
156974630|NCT02118337|566662160|FG004|Overall Study|Death|5|||
156974631|NCT02118337|566662161|FG005|Overall Study|Death|1|||
156974632|NCT02118337|566662162|FG006|Overall Study|Death|2|||
156974633|NCT02118337|566662163|FG007|Overall Study|Death|9|||
156974634|NCT02118337|566662164|FG008|Overall Study|Death|4|||
156974635|NCT03724396|566662166|FG000|Overall Study|Lost to Follow-up|1|||
156974636|NCT03724396|566662167|FG001|Overall Study|Lost to Follow-up|1|||
156974637|NCT03724396|566662166|FG000|Overall Study|Withdrawal by Subject|1|||
156974638|NCT03724396|566662167|FG001|Overall Study|Withdrawal by Subject|0|||
156974639|NCT03879408|566662168|FG000|Overall Study|Lost to Follow-up|0|||
156974640|NCT03879408|566662169|FG001|Overall Study|Lost to Follow-up|3|||
156974641|NCT03879408|566662170|FG002|Overall Study|Lost to Follow-up|2|||
156974642|NCT03879408|566662171|FG003|Overall Study|Lost to Follow-up|1|||
156974643|NCT03879408|566662172|FG004|Overall Study|Lost to Follow-up|0|||
156974644|NCT03879408|566662168|FG000|Overall Study|Withdrawal by Subject|2|||
156974645|NCT03879408|566662169|FG001|Overall Study|Withdrawal by Subject|1|||
157178781|NCT01041404|567395803|FG000|Overall Study|Protocol Violation|4|||
157178782|NCT01041404|567395804|FG001|Overall Study|Protocol Violation|0|||
157178783|NCT01041404|567395803|FG000|Overall Study|Withdrawal by Subject|29|||
157178784|NCT01041404|567395804|FG001|Overall Study|Withdrawal by Subject|23|||
157178785|NCT01041404|567395803|FG000|Overall Study|Failure to Return|1|||
156974646|NCT03879408|566662170|FG002|Overall Study|Withdrawal by Subject|1|||
156974647|NCT03879408|566662171|FG003|Overall Study|Withdrawal by Subject|0|||
156974648|NCT03879408|566662172|FG004|Overall Study|Withdrawal by Subject|1|||
156974649|NCT01490125|566662173|FG000|Period I|Adverse Event|4|||
156974650|NCT01490125|566662174|FG001|Period I|Adverse Event|1|||
156974651|NCT01490125|566662175|FG002|Period I|Adverse Event|1|||
156974652|NCT01490125|566662176|FG003|Period I|Adverse Event|3|||
156974653|NCT01490125|566662177|FG004|Period I|Adverse Event|2|||
156974654|NCT01490125|566662178|FG005|Period I|Adverse Event|4|||
156974655|NCT01490125|566662173|FG000|Period I|Protocol Violation|1|||
156974656|NCT01490125|566662174|FG001|Period I|Protocol Violation|1|||
156974657|NCT01490125|566662175|FG002|Period I|Protocol Violation|1|||
156974658|NCT01490125|566662176|FG003|Period I|Protocol Violation|1|||
157178786|NCT01041404|567395804|FG001|Overall Study|Failure to Return|2|||
156974659|NCT01490125|566662177|FG004|Period I|Protocol Violation|0|||
156974660|NCT01490125|566662178|FG005|Period I|Protocol Violation|0|||
156974661|NCT01490125|566662173|FG000|Period I|Withdrawal by Subject|1|||
156974662|NCT01490125|566662174|FG001|Period I|Withdrawal by Subject|3|||
156974663|NCT01490125|566662175|FG002|Period I|Withdrawal by Subject|2|||
156974664|NCT01490125|566662176|FG003|Period I|Withdrawal by Subject|1|||
156974665|NCT01490125|566662177|FG004|Period I|Withdrawal by Subject|2|||
156974666|NCT01490125|566662178|FG005|Period I|Withdrawal by Subject|1|||
156974667|NCT01490125|566662173|FG000|Period II|Adverse Event|2|||
156974668|NCT01490125|566662174|FG001|Period II|Adverse Event|3|||
156974669|NCT01490125|566662175|FG002|Period II|Adverse Event|2|||
156974670|NCT01490125|566662176|FG003|Period II|Adverse Event|2|||
156974671|NCT01490125|566662177|FG004|Period II|Adverse Event|4|||
156974672|NCT01490125|566662178|FG005|Period II|Adverse Event|2|||
156974673|NCT01490125|566662173|FG000|Period II|Protocol Violation|0|||
156974674|NCT01490125|566662174|FG001|Period II|Protocol Violation|0|||
156974675|NCT01490125|566662175|FG002|Period II|Protocol Violation|1|||
156974676|NCT01490125|566662176|FG003|Period II|Protocol Violation|1|||
156974677|NCT01490125|566662177|FG004|Period II|Protocol Violation|0|||
156974678|NCT01490125|566662178|FG005|Period II|Protocol Violation|0|||
156974679|NCT01490125|566662173|FG000|Period II|Lost to Follow-up|0|||
156974680|NCT01490125|566662174|FG001|Period II|Lost to Follow-up|1|||
156974681|NCT01490125|566662175|FG002|Period II|Lost to Follow-up|0|||
156974682|NCT01490125|566662176|FG003|Period II|Lost to Follow-up|0|||
156974683|NCT01490125|566662177|FG004|Period II|Lost to Follow-up|0|||
156974684|NCT01490125|566662178|FG005|Period II|Lost to Follow-up|0|||
156974685|NCT01490125|566662173|FG000|Period II|Withdrawal by Subject|1|||
156974686|NCT01490125|566662174|FG001|Period II|Withdrawal by Subject|0|||
156974687|NCT01490125|566662175|FG002|Period II|Withdrawal by Subject|0|||
156974688|NCT01490125|566662176|FG003|Period II|Withdrawal by Subject|0|||
156974689|NCT01490125|566662177|FG004|Period II|Withdrawal by Subject|0|||
156974690|NCT01490125|566662178|FG005|Period II|Withdrawal by Subject|0|||
156974691|NCT01490125|566662173|FG000|Period III|Adverse Event|3|||
156974692|NCT01490125|566662174|FG001|Period III|Adverse Event|1|||
156974693|NCT01490125|566662175|FG002|Period III|Adverse Event|0|||
156974694|NCT01490125|566662176|FG003|Period III|Adverse Event|1|||
156974695|NCT01490125|566662177|FG004|Period III|Adverse Event|0|||
156974696|NCT01490125|566662178|FG005|Period III|Adverse Event|0|||
156974697|NCT01490125|566662173|FG000|Period III|Death|0|||
156974698|NCT01490125|566662174|FG001|Period III|Death|0|||
156974699|NCT01490125|566662175|FG002|Period III|Death|0|||
156974700|NCT01490125|566662176|FG003|Period III|Death|1|||
156974701|NCT01490125|566662177|FG004|Period III|Death|0|||
156974702|NCT01490125|566662178|FG005|Period III|Death|0|||
156974703|NCT01490125|566662173|FG000|Period III|Lack of Efficacy|0|||
156974704|NCT01490125|566662174|FG001|Period III|Lack of Efficacy|0|||
156974705|NCT01490125|566662175|FG002|Period III|Lack of Efficacy|0|||
156974706|NCT01490125|566662176|FG003|Period III|Lack of Efficacy|0|||
156974707|NCT01490125|566662177|FG004|Period III|Lack of Efficacy|1|||
156974708|NCT01490125|566662178|FG005|Period III|Lack of Efficacy|0|||
156974709|NCT01320943|566662179|FG000|Overall Study|Lost to Follow-up|1|||
156974710|NCT01320943|566662180|FG001|Overall Study|Lost to Follow-up|0|||
156974711|NCT01320943|566662179|FG000|Overall Study|Physician Decision|0|||
156974712|NCT01320943|566662180|FG001|Overall Study|Physician Decision|1|||
156974713|NCT01320943|566662179|FG000|Overall Study|Randomized but not Treated|0|||
156974714|NCT01320943|566662180|FG001|Overall Study|Randomized but not Treated|1|||
156974715|NCT05458024|566662182|FG000|Overall Study|Withdrawal by Subject|1|||
156974716|NCT05458024|566662183|FG001|Overall Study|Withdrawal by Subject|1|||
156974717|NCT04522180|566662185|FG000|Overall Study|Investigator judgement|3|||
156974718|NCT04522180|566662186|FG001|Overall Study|Investigator judgement|4|||
156974719|NCT04522180|566662185|FG000|Overall Study|Voluntary withdrawal|1|||
156974720|NCT04522180|566662186|FG001|Overall Study|Voluntary withdrawal|0|||
156974721|NCT04522180|566662185|FG000|Overall Study|Pregnancy|0|||
156974722|NCT04522180|566662186|FG001|Overall Study|Pregnancy|1|||
156974723|NCT04522180|566662185|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
156974724|NCT04522180|566662186|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
156974725|NCT04522180|566662185|FG000|Overall Study|Reason not specified|8|||
156974726|NCT04522180|566662186|FG001|Overall Study|Reason not specified|5|||
156974727|NCT05807919|566662187|FG000|Overall Study|Received antibiotics - excluded|0|||
156974728|NCT05807919|566662188|FG001|Overall Study|Received antibiotics - excluded|1|||
156974729|NCT05807919|566662187|FG000|Overall Study|Withdrawal by Subject|0|||
156974730|NCT05807919|566662188|FG001|Overall Study|Withdrawal by Subject|3|||
156974731|NCT05807919|566662187|FG000|Overall Study|Adverse Event|1|||
157054974|NCT02660034|566954126|FG006|Overall Study|Adverse Event|0|||
156974732|NCT05807919|566662188|FG001|Overall Study|Adverse Event|1|||
156974733|NCT00747123|566662189|FG000|Overall Study|Investigator's request|0|||
156974734|NCT00747123|566662190|FG001|Overall Study|Investigator's request|0|||
157054975|NCT02660034|566954127|FG007|Overall Study|Adverse Event|0|||
157178787|NCT01041404|567395803|FG000|Overall Study|Other|11|||
156974735|NCT00747123|566662191|FG002|Overall Study|Investigator's request|1|||
157054976|NCT02660034|566954128|FG008|Overall Study|Adverse Event|0|||
156974736|NCT00747123|566662192|FG003|Overall Study|Investigator's request|0|||
156974737|NCT00747123|566662189|FG000|Overall Study|Withdrew consent|0|||
156974738|NCT00747123|566662190|FG001|Overall Study|Withdrew consent|1|||
156974739|NCT00747123|566662191|FG002|Overall Study|Withdrew consent|0|||
156974740|NCT00747123|566662192|FG003|Overall Study|Withdrew consent|0|||
156974741|NCT00747123|566662189|FG000|Overall Study|Adverse Event|0|||
156974742|NCT00747123|566662190|FG001|Overall Study|Adverse Event|1|||
156974743|NCT00747123|566662191|FG002|Overall Study|Adverse Event|0|||
156974744|NCT00747123|566662192|FG003|Overall Study|Adverse Event|1|||
156974745|NCT03489057|566662197|FG000|Overall Study|Lost to Follow-up|16|||
156974746|NCT03489057|566662198|FG001|Overall Study|Lost to Follow-up|16|||
156974747|NCT03489057|566662199|FG002|Overall Study|Lost to Follow-up|14|||
156974748|NCT03489057|566662200|FG003|Overall Study|Lost to Follow-up|14|||
156974749|NCT03489057|566662197|FG000|Overall Study|Withdrawal by Subject|12|||
156974750|NCT03489057|566662198|FG001|Overall Study|Withdrawal by Subject|12|||
156974751|NCT03489057|566662199|FG002|Overall Study|Withdrawal by Subject|8|||
156974752|NCT03489057|566662200|FG003|Overall Study|Withdrawal by Subject|8|||
156974753|NCT03489057|566662197|FG000|Overall Study|Protocol Violation|7|||
156974754|NCT03489057|566662198|FG001|Overall Study|Protocol Violation|7|||
156974755|NCT03489057|566662199|FG002|Overall Study|Protocol Violation|2|||
156974756|NCT03489057|566662200|FG003|Overall Study|Protocol Violation|2|||
156974757|NCT02277743|566662206|FG000|Overall Study|Protocol Violation|1|||
156974758|NCT02277743|566662207|FG001|Overall Study|Protocol Violation|1|||
156974759|NCT02277743|566662208|FG002|Overall Study|Protocol Violation|1|||
156974760|NCT02277743|566662206|FG000|Overall Study|Adverse Event|10|||
156974761|NCT02277743|566662207|FG001|Overall Study|Adverse Event|6|||
156974762|NCT02277743|566662208|FG002|Overall Study|Adverse Event|6|||
156974763|NCT02277743|566662206|FG000|Overall Study|Lack of Efficacy|11|||
156974764|NCT02277743|566662207|FG001|Overall Study|Lack of Efficacy|4|||
156974765|NCT02277743|566662208|FG002|Overall Study|Lack of Efficacy|3|||
156974766|NCT02277743|566662206|FG000|Overall Study|Other than specified above|18|||
156974767|NCT02277743|566662207|FG001|Overall Study|Other than specified above|5|||
156974768|NCT02277743|566662208|FG002|Overall Study|Other than specified above|16|||
156974769|NCT01224158|566662209|FG000|Overall Study|Withdrawal by Subject|1|||
156974770|NCT01224158|566662210|FG001|Overall Study|Withdrawal by Subject|0|||
156974771|NCT03976466|566662213|FG000|Overall Study|Lost to Follow-up|1|||
156974772|NCT03976466|566662214|FG001|Overall Study|Lost to Follow-up|3|||
156974773|NCT02055157|566662215|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156974774|NCT02055157|566662216|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
156974775|NCT02055157|566662217|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156974776|NCT02055157|566662218|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
156974777|NCT02055157|566662215|FG000|Initial 6 Months|Adverse Event|0|||
156974778|NCT02055157|566662216|FG001|Initial 6 Months|Adverse Event|0|||
156974779|NCT02055157|566662217|FG002|Initial 6 Months|Adverse Event|0|||
156974780|NCT02055157|566662218|FG003|Initial 6 Months|Adverse Event|1|||
156974781|NCT02055157|566662215|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
156974782|NCT02055157|566662216|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
156974783|NCT02055157|566662217|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
156974784|NCT02055157|566662218|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
156974785|NCT02055157|566662215|FG000|18-month Extension|Investigator decision|0|||
156974786|NCT02055157|566662216|FG001|18-month Extension|Investigator decision|1|||
156974787|NCT02055157|566662217|FG002|18-month Extension|Investigator decision|0|||
156974788|NCT02055157|566662218|FG003|18-month Extension|Investigator decision|0|||
156974789|NCT02055157|566662215|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
156974790|NCT02055157|566662216|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156974791|NCT02055157|566662217|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156974792|NCT02055157|566662218|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
156974793|NCT02034708|566662219|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
156974794|NCT02034708|566662220|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
156974795|NCT02034708|566662219|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
156974796|NCT02034708|566662220|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
156974797|NCT02034708|566662219|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
156974798|NCT02034708|566662220|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
156974799|NCT02034708|566662219|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
156974800|NCT02034708|566662220|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
156974801|NCT00943306|566662223|FG000|Overall Study|Physician Decision|1|||
156974802|NCT00943306|566662223|FG000|Overall Study|Death|1|||
156974803|NCT00943306|566662223|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
157229609|NCT00728949|567586496|FG001|Overall Study|Abnormal Lab Results|2|||
157229610|NCT00728949|567586495|FG000|Overall Study|On treatment at cutoff date|1|||
156974804|NCT00733499|566662224|FG000|Pre-operative|Protocol Violation|0|||
156974805|NCT00733499|566662225|FG001|Pre-operative|Protocol Violation|1|||
156974806|NCT00733499|566662224|FG000|3 Months Follow-up|Death|1|||
156974807|NCT00733499|566662225|FG001|3 Months Follow-up|Death|2|||
156974808|NCT00733499|566662224|FG000|6 Months Follow-up|Death|0|||
156974809|NCT00733499|566662225|FG001|6 Months Follow-up|Death|2|||
157054977|NCT02660034|566954129|FG009|Overall Study|Adverse Event|0|||
157054978|NCT02660034|566954130|FG010|Overall Study|Adverse Event|0|||
157178788|NCT01041404|567395804|FG001|Overall Study|Other|23|||
157178789|NCT04968353|567395805|FG000|Overall Study|Non-compliance|1|||
157178790|NCT04968353|567395806|FG001|Overall Study|Non-compliance|0|||
157178791|NCT04968353|567395807|FG002|Overall Study|Non-compliance|2|||
157178792|NCT04968353|567395808|FG003|Overall Study|Non-compliance|0|||
157178793|NCT01750840|567395809|FG000|Overall Study|Lost to Follow-up|4|||
157205226|NCT03669640|567496074|FG001|Overall Study|Withdrawal by Subject|2|||
157205227|NCT03669640|567496075|FG002|Overall Study|Withdrawal by Subject|1|||
157205228|NCT03669640|567496076|FG003|Overall Study|Withdrawal by Subject|0|||
157205229|NCT03669640|567496077|FG004|Overall Study|Withdrawal by Subject|1|||
157205230|NCT03669640|567496078|FG005|Overall Study|Withdrawal by Subject|3|||
157205231|NCT03669640|567496073|FG000|Overall Study|Protocol Violation|1|||
157205232|NCT03669640|567496074|FG001|Overall Study|Protocol Violation|0|||
157205233|NCT03669640|567496075|FG002|Overall Study|Protocol Violation|0|||
157205234|NCT03669640|567496076|FG003|Overall Study|Protocol Violation|0|||
157205235|NCT03669640|567496077|FG004|Overall Study|Protocol Violation|0|||
157205236|NCT03669640|567496078|FG005|Overall Study|Protocol Violation|0|||
157205237|NCT03669640|567496073|FG000|Overall Study|Physician Decision|0|||
157205238|NCT03669640|567496074|FG001|Overall Study|Physician Decision|2|||
157205239|NCT03669640|567496075|FG002|Overall Study|Physician Decision|0|||
157205240|NCT03669640|567496076|FG003|Overall Study|Physician Decision|0|||
157205241|NCT03669640|567496077|FG004|Overall Study|Physician Decision|0|||
157205242|NCT03669640|567496078|FG005|Overall Study|Physician Decision|0|||
157205243|NCT03669640|567496073|FG000|Overall Study|Disease Relapse|1|||
157205244|NCT03669640|567496074|FG001|Overall Study|Disease Relapse|0|||
157205245|NCT03669640|567496075|FG002|Overall Study|Disease Relapse|0|||
157205246|NCT03669640|567496076|FG003|Overall Study|Disease Relapse|0|||
157205247|NCT03669640|567496077|FG004|Overall Study|Disease Relapse|0|||
157205248|NCT03669640|567496078|FG005|Overall Study|Disease Relapse|0|||
157205249|NCT03669640|567496073|FG000|Overall Study|Adverse Event|2|||
157205250|NCT03669640|567496074|FG001|Overall Study|Adverse Event|1|||
157205251|NCT03669640|567496075|FG002|Overall Study|Adverse Event|0|||
156974810|NCT00733499|566662224|FG000|6 Months Follow-up|Adverse Event|0|||
156974811|NCT00733499|566662225|FG001|6 Months Follow-up|Adverse Event|1|||
156974812|NCT00733499|566662224|FG000|12 Months Follow-up|Death|2|||
156974813|NCT00733499|566662225|FG001|12 Months Follow-up|Death|1|||
156974814|NCT00733499|566662224|FG000|24 Months Follow-up|Death|0|||
156974815|NCT00733499|566662225|FG001|24 Months Follow-up|Death|1|||
156974816|NCT00733499|566662224|FG000|5 Year Followup|Adverse Event|2|||
156974817|NCT00733499|566662225|FG001|5 Year Followup|Adverse Event|2|||
156974818|NCT00733499|566662224|FG000|5 Year Followup|Non device related AE|0|||
156974819|NCT00733499|566662225|FG001|5 Year Followup|Non device related AE|1|||
156974820|NCT00733499|566662224|FG000|5 Year Followup|Revision of Study Implant|0|||
156974821|NCT00733499|566662225|FG001|5 Year Followup|Revision of Study Implant|1|||
156974822|NCT00733499|566662224|FG000|5 Year Followup|Lost to Follow-up|2|||
156974823|NCT00733499|566662225|FG001|5 Year Followup|Lost to Follow-up|0|||
156974824|NCT00733499|566662224|FG000|5 Year Followup|Death|13|||
156974825|NCT00733499|566662225|FG001|5 Year Followup|Death|19|||
156974826|NCT00733499|566662224|FG000|5 Year Followup|missing, unable to locate|0|||
156974827|NCT00733499|566662225|FG001|5 Year Followup|missing, unable to locate|1|||
156974828|NCT00733499|566662224|FG000|5 Year Followup|Withdrawal by Subject|4|||
156974829|NCT00733499|566662225|FG001|5 Year Followup|Withdrawal by Subject|1|||
156974830|NCT00733499|566662224|FG000|10 Year Followup|Death|9|||
156974831|NCT00733499|566662225|FG001|10 Year Followup|Death|7|||
156974832|NCT00733499|566662224|FG000|10 Year Followup|Adverse Event|3|||
156974833|NCT00733499|566662225|FG001|10 Year Followup|Adverse Event|3|||
156974834|NCT00733499|566662224|FG000|10 Year Followup|Lost to Follow-up|3|||
156974835|NCT00733499|566662225|FG001|10 Year Followup|Lost to Follow-up|2|||
156974836|NCT00733499|566662224|FG000|10 Year Followup|Withdrawal by Subject|5|||
156974837|NCT00733499|566662225|FG001|10 Year Followup|Withdrawal by Subject|5|||
156974838|NCT00733499|566662224|FG000|10 Year Followup|missing, unable to locate|0|||
156974839|NCT00733499|566662225|FG001|10 Year Followup|missing, unable to locate|2|||
156974840|NCT00733980|566662226|FG000|Overall Study|Adverse Event|5|||
157205252|NCT03669640|567496076|FG003|Overall Study|Adverse Event|0|||
157205253|NCT03669640|567496077|FG004|Overall Study|Adverse Event|1|||
157205254|NCT03669640|567496078|FG005|Overall Study|Adverse Event|0|||
156974841|NCT00733980|566662227|FG001|Overall Study|Adverse Event|2|||
156974842|NCT00733980|566662226|FG000|Overall Study|Lack of Efficacy|0|||
156974843|NCT00733980|566662227|FG001|Overall Study|Lack of Efficacy|1|||
156974844|NCT00733980|566662226|FG000|Overall Study|Protocol Violation|2|||
157205255|NCT03722849|567496081|FG000|Overall Study|Withdrawal by Subject|1|||
157205256|NCT03722849|567496082|FG001|Overall Study|Withdrawal by Subject|1|||
156974845|NCT00733980|566662227|FG001|Overall Study|Protocol Violation|1|||
156974846|NCT00733980|566662226|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
156974847|NCT00733980|566662227|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
157205257|NCT03993288|567496083|FG000|Overall Study|Lost to Follow-up|2|||
157205258|NCT03993288|567496084|FG001|Overall Study|Lost to Follow-up|1|||
157205259|NCT03993288|567496083|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
157205260|NCT03993288|567496084|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
156974848|NCT00733980|566662226|FG000|Overall Study|Lost to Follow-up|6|||
156974849|NCT00733980|566662227|FG001|Overall Study|Lost to Follow-up|11|||
156974850|NCT00733980|566662226|FG000|Overall Study|Physician Decision|2|||
156974851|NCT00733980|566662227|FG001|Overall Study|Physician Decision|3|||
156974852|NCT00733980|566662226|FG000|Overall Study|Withdrawal by Subject|6|||
156974853|NCT00733980|566662227|FG001|Overall Study|Withdrawal by Subject|2|||
156974854|NCT02739347|566662228|FG000|Overall Study|Adverse Event|3|||
156974855|NCT02739347|566662229|FG001|Overall Study|Adverse Event|0|||
156974856|NCT02739347|566662228|FG000|Overall Study|Protocol Violation|0|||
156974857|NCT02739347|566662229|FG001|Overall Study|Protocol Violation|1|||
156974858|NCT02739347|566662228|FG000|Overall Study|Lost to Follow-up|0|||
156974859|NCT02739347|566662229|FG001|Overall Study|Lost to Follow-up|2|||
156974860|NCT01931735|566662230|FG000|Randomized Phase|Lost to Follow-up|2|||
156974861|NCT01931735|566662231|FG001|Randomized Phase|Lost to Follow-up|2|||
156974862|NCT01931735|566662232|FG002|Randomized Phase|Lost to Follow-up|5|||
156974863|NCT01931735|566662233|FG003|Randomized Phase|Lost to Follow-up|0|||
156974864|NCT01931735|566662230|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
156974865|NCT01931735|566662231|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
156974866|NCT01931735|566662232|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
156974867|NCT01931735|566662233|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
156974868|NCT01931735|566662230|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156974869|NCT01931735|566662231|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156974870|NCT01931735|566662232|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
156974871|NCT01931735|566662233|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
156974872|NCT02719990|566662234|FG000|Overall Study|Physician Decision|2|||
156974873|NCT02719990|566662234|FG000|Overall Study|Withdrawal by Subject|2|||
156974874|NCT02719990|566662234|FG000|Overall Study|Study Terminated By Sponsor|32|||
157178794|NCT00608894|567397966|FG000|Overall Study|Withdrawal by Subject|0|||
157178795|NCT00608894|567397967|FG001|Overall Study|Withdrawal by Subject|2|||
157178796|NCT02828644|567397969|FG000|Overall Study|Lost to Follow-up|23|||
157178797|NCT02828644|567397970|FG001|Overall Study|Lost to Follow-up|22|||
157178798|NCT02408484|567397971|FG000|Overall Study|Withdrawal by Subject|3|||
157178799|NCT02408484|567397971|FG000|Overall Study|Not treated during study period|1|||
157178800|NCT02436915|567397972|FG000|Overall Study|Withdrawal by Subject|0|||
157178801|NCT02436915|567397973|FG001|Overall Study|Withdrawal by Subject|1|||
157178802|NCT01117181|567397975|FG000|Overall Study|Lost to Follow-up|1|||
157178803|NCT01117181|567397976|FG001|Overall Study|Lost to Follow-up|0|||
157178804|NCT01117181|567397975|FG000|Overall Study|Withdrawal by Subject|0|||
157178805|NCT01117181|567397976|FG001|Overall Study|Withdrawal by Subject|2|||
157178806|NCT01495689|567397983|FG000|Overall Study|Death|0|||
157178807|NCT01495689|567397984|FG001|Overall Study|Death|1|||
157178808|NCT01495689|567397983|FG000|Overall Study|Withdrawal by Subject|3|||
157178809|NCT01495689|567397984|FG001|Overall Study|Withdrawal by Subject|0|||
157178810|NCT01495689|567397983|FG000|Overall Study|Lost to Follow-up|7|||
157178811|NCT01495689|567397984|FG001|Overall Study|Lost to Follow-up|6|||
157178812|NCT03805971|567397985|FG000|Overall Study|Withdrawal by Subject|1|||
157178813|NCT03805971|567397985|FG000|Overall Study|Protocol Violation|2|||
157178814|NCT01119963|567397988|FG000|Overall Study|Lost to Follow-up|1|||
157178815|NCT01119963|567397989|FG001|Overall Study|Lost to Follow-up|1|||
157178816|NCT00254163|567397990|FG000|Overall Study|Adverse Event|29|||
157178817|NCT00254163|567397991|FG001|Overall Study|Adverse Event|26|||
157178818|NCT00254163|567397990|FG000|Overall Study|Patient request/withdrew consent|6|||
157178819|NCT00254163|567397991|FG001|Overall Study|Patient request/withdrew consent|4|||
157178820|NCT00254163|567397990|FG000|Overall Study|Investigator request|1|||
157178821|NCT00254163|567397991|FG001|Overall Study|Investigator request|3|||
157178822|NCT00254163|567397990|FG000|Overall Study|Failed entry|1|||
157178823|NCT00254163|567397991|FG001|Overall Study|Failed entry|3|||
157178824|NCT00254163|567397990|FG000|Overall Study|Progressive disease|0|||
157178825|NCT00254163|567397991|FG001|Overall Study|Progressive disease|1|||
157178826|NCT00254163|567397990|FG000|Overall Study|Death|0|||
157178827|NCT00254163|567397991|FG001|Overall Study|Death|1|||
157178828|NCT00254163|567397990|FG000|Overall Study|Other|8|||
157178829|NCT00254163|567397991|FG001|Overall Study|Other|8|||
157178830|NCT00524043|567397997|FG000|Overall Study|Lack of Efficacy|15|||
157178831|NCT00524043|567397998|FG001|Overall Study|Lack of Efficacy|13|||
157178832|NCT00524043|567397999|FG002|Overall Study|Lack of Efficacy|14|||
157178833|NCT00524043|567397997|FG000|Overall Study|Withdrawal by Subject|5|||
157178834|NCT00524043|567397998|FG001|Overall Study|Withdrawal by Subject|7|||
157178835|NCT00524043|567397999|FG002|Overall Study|Withdrawal by Subject|7|||
156974875|NCT03324880|566662235|FG000|Overall Study|Adverse Event|0|||
156974876|NCT03324880|566662236|FG001|Overall Study|Adverse Event|2|||
156974877|NCT03324880|566662235|FG000|Overall Study|Withdrawal by Subject|2|||
157178836|NCT00524043|567397997|FG000|Overall Study|Adverse Event|5|||
157178837|NCT00524043|567397998|FG001|Overall Study|Adverse Event|2|||
157178838|NCT00524043|567397999|FG002|Overall Study|Adverse Event|7|||
157178839|NCT00524043|567397997|FG000|Overall Study|Lost to Follow-up|3|||
157178840|NCT00524043|567397998|FG001|Overall Study|Lost to Follow-up|5|||
157178841|NCT00524043|567397999|FG002|Overall Study|Lost to Follow-up|3|||
156974878|NCT03324880|566662236|FG001|Overall Study|Withdrawal by Subject|2|||
156974879|NCT03324880|566662235|FG000|Overall Study|Lost to Follow-up|0|||
156974880|NCT03324880|566662236|FG001|Overall Study|Lost to Follow-up|1|||
156974881|NCT03324880|566662235|FG000|Overall Study|Product Recall|0|||
156974882|NCT03324880|566662236|FG001|Overall Study|Product Recall|1|||
156974883|NCT01235403|566662237|FG000|Overall Study|Adverse Event|14|||
156974884|NCT01235403|566662237|FG000|Overall Study|Lost to Follow-up|2|||
156974885|NCT01235403|566662237|FG000|Overall Study|Withdrawal by Subject|4|||
156974886|NCT01235403|566662237|FG000|Overall Study|Lack of Efficacy|2|||
156974887|NCT01235403|566662237|FG000|Overall Study|Other reasons for premature termination|4|||
156974888|NCT00717314|566662238|FG000|Overall Study|Adverse Event|3|||
156974889|NCT00717314|566662239|FG001|Overall Study|Adverse Event|2|||
156974890|NCT00717314|566662238|FG000|Overall Study|Protocol Violation|1|||
156974891|NCT00717314|566662239|FG001|Overall Study|Protocol Violation|0|||
156974892|NCT00717314|566662238|FG000|Overall Study|Lost to Follow-up|1|||
156974893|NCT00717314|566662239|FG001|Overall Study|Lost to Follow-up|5|||
156974894|NCT00717314|566662238|FG000|Overall Study|Withdrawal by Subject|1|||
156974895|NCT00717314|566662239|FG001|Overall Study|Withdrawal by Subject|3|||
156974896|NCT05076149|566662240|FG000|Overall Study|Adverse Event|3|||
156974897|NCT05076149|566662241|FG001|Overall Study|Adverse Event|9|||
156974898|NCT05076149|566662240|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
156974899|NCT05076149|566662241|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
156974900|NCT05076149|566662240|FG000|Overall Study|Lost to Follow-up|0|||
156974901|NCT05076149|566662241|FG001|Overall Study|Lost to Follow-up|1|||
156974902|NCT05076149|566662240|FG000|Overall Study|Commercial drug is available for participant|0|||
156974903|NCT05076149|566662241|FG001|Overall Study|Commercial drug is available for participant|1|||
156974904|NCT05076149|566662240|FG000|Overall Study|Other non compliance|1|||
156974905|NCT05076149|566662241|FG001|Overall Study|Other non compliance|1|||
156974906|NCT05076149|566662240|FG000|Overall Study|Physician Decision|0|||
156974907|NCT05076149|566662241|FG001|Overall Study|Physician Decision|1|||
156974908|NCT05076149|566662240|FG000|Overall Study|Other|5|||
156974909|NCT05076149|566662241|FG001|Overall Study|Other|4|||
156974910|NCT05096208|566662242|FG000|Overall Study|Lost to Follow-up|3|||
156974911|NCT05096208|566662243|FG001|Overall Study|Lost to Follow-up|5|||
156974912|NCT05096208|566662244|FG002|Overall Study|Lost to Follow-up|5|||
156974913|NCT05096208|566662245|FG003|Overall Study|Lost to Follow-up|2|||
156974914|NCT05096208|566662242|FG000|Overall Study|Withdrawal by Subject|0|||
156974915|NCT05096208|566662243|FG001|Overall Study|Withdrawal by Subject|1|||
156974916|NCT05096208|566662244|FG002|Overall Study|Withdrawal by Subject|2|||
156974917|NCT05096208|566662245|FG003|Overall Study|Withdrawal by Subject|3|||
156974918|NCT05096208|566662242|FG000|Overall Study|No longer met eligibility criteria|1|||
156974919|NCT05096208|566662243|FG001|Overall Study|No longer met eligibility criteria|0|||
156974920|NCT05096208|566662244|FG002|Overall Study|No longer met eligibility criteria|0|||
156974921|NCT05096208|566662245|FG003|Overall Study|No longer met eligibility criteria|0|||
156974922|NCT05096208|566662242|FG000|Overall Study|Other|0|||
156974923|NCT05096208|566662243|FG001|Overall Study|Other|0|||
156974924|NCT05096208|566662244|FG002|Overall Study|Other|1|||
156974925|NCT05096208|566662245|FG003|Overall Study|Other|0|||
156974926|NCT02087501|566662246|FG000|Overall Study|Death|7|||
156974927|NCT02087501|566662246|FG000|Overall Study|Open repair of aneurysm|1|||
156974928|NCT02087501|566662246|FG000|Overall Study|Lost to Follow-up|2|||
156974929|NCT00094328|566662247|FG000|Overall Study|Lost to Follow-up|1|||
156974930|NCT03682705|566662248|FG000|Overall Study|Adverse Event|1|||
156974931|NCT03682705|566662249|FG001|Overall Study|Adverse Event|1|||
156974932|NCT03682705|566662250|FG002|Overall Study|Adverse Event|1|||
156974933|NCT03682705|566662251|FG003|Overall Study|Adverse Event|0|||
156974934|NCT03682705|566662252|FG004|Overall Study|Adverse Event|1|||
156974935|NCT03682705|566662253|FG005|Overall Study|Adverse Event|1|||
156974936|NCT03682705|566662248|FG000|Overall Study|Withdrawal by Subject|1|||
156974937|NCT03682705|566662249|FG001|Overall Study|Withdrawal by Subject|3|||
156974938|NCT03682705|566662250|FG002|Overall Study|Withdrawal by Subject|2|||
156974939|NCT03682705|566662251|FG003|Overall Study|Withdrawal by Subject|4|||
156974940|NCT03682705|566662252|FG004|Overall Study|Withdrawal by Subject|0|||
156974941|NCT03682705|566662253|FG005|Overall Study|Withdrawal by Subject|1|||
156974942|NCT03682705|566662248|FG000|Overall Study|Other, not specified|0|||
156974943|NCT03682705|566662249|FG001|Overall Study|Other, not specified|0|||
156974944|NCT03682705|566662250|FG002|Overall Study|Other, not specified|0|||
156974945|NCT03682705|566662251|FG003|Overall Study|Other, not specified|1|||
156974946|NCT03682705|566662252|FG004|Overall Study|Other, not specified|2|||
156974947|NCT03682705|566662253|FG005|Overall Study|Other, not specified|0|||
156974948|NCT03682705|566662248|FG000|Overall Study|Lost to Follow-up|0|||
156974949|NCT03682705|566662249|FG001|Overall Study|Lost to Follow-up|0|||
156974950|NCT03682705|566662250|FG002|Overall Study|Lost to Follow-up|0|||
156974951|NCT03682705|566662251|FG003|Overall Study|Lost to Follow-up|0|||
156974952|NCT03682705|566662252|FG004|Overall Study|Lost to Follow-up|3|||
156974953|NCT03682705|566662253|FG005|Overall Study|Lost to Follow-up|0|||
156974954|NCT02213328|566662254|FG000|Overall Study|Withdrawal by Subject|10|||
157054979|NCT02660034|566954131|FG011|Overall Study|Adverse Event|0|||
156974955|NCT02213328|566662254|FG000|Overall Study|Physician Decision|2|||
156974956|NCT02213328|566662254|FG000|Overall Study|Lost to Follow-up|16|||
156974957|NCT04043962|566662255|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
156974958|NCT04043962|566662255|FG000|Post-Treatment|Withdrawal by Subject|5|||
156974959|NCT04043962|566662255|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
156974960|NCT00990340|566662256|FG000|First 14-day Treatment|Not Compliant|2|||
156974961|NCT00990340|566662257|FG001|First 14-day Treatment|Not Compliant|1|||
156974962|NCT00990340|566662256|FG000|First 14-day Treatment|Lost to Follow-up|2|||
156974963|NCT00990340|566662257|FG001|First 14-day Treatment|Lost to Follow-up|1|||
156974964|NCT00990340|566662256|FG000|First 14-day Treatment|Protocol Violation|2|||
156974965|NCT00990340|566662257|FG001|First 14-day Treatment|Protocol Violation|2|||
156974966|NCT01654601|566662264|FG000|1st Administration|Withdrawal by Subject|2|||
156974967|NCT01654601|566662265|FG001|1st Administration|Withdrawal by Subject|0|||
156974968|NCT01654601|566662264|FG000|1st Administration|Protocol Violation|0|||
156974969|NCT01654601|566662265|FG001|1st Administration|Protocol Violation|2|||
156974970|NCT01654601|566662264|FG000|2nd Administration|Adverse Event|1|||
156974971|NCT01654601|566662265|FG001|2nd Administration|Adverse Event|0|||
156974972|NCT01654601|566662264|FG000|2nd Administration|Protocol Violation|0|||
156974973|NCT01654601|566662265|FG001|2nd Administration|Protocol Violation|1|||
156974974|NCT02636270|566662266|FG000|Overall Study|Adverse Event|1|||
156974975|NCT02636270|566662267|FG001|Overall Study|Adverse Event|0|||
156974976|NCT02636270|566662268|FG002|Overall Study|Adverse Event|0|||
156974977|NCT02636270|566662266|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
156974978|NCT02636270|566662267|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
156974979|NCT02636270|566662268|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
156974980|NCT00957931|566663486|FG000|Overall Study|Death|4|||
156974981|NCT04867785|566663487|FG000|Overall Study|Adverse Event|1|||
156974982|NCT04867785|566663488|FG001|Overall Study|Adverse Event|0|||
156974983|NCT04867785|566663489|FG002|Overall Study|Adverse Event|1|||
156974984|NCT04867785|566663490|FG003|Overall Study|Adverse Event|0|||
156974985|NCT04867785|566663491|FG004|Overall Study|Adverse Event|0|||
156974986|NCT04867785|566663492|FG005|Overall Study|Adverse Event|0|||
156974987|NCT04867785|566663493|FG006|Overall Study|Adverse Event|0|||
156974988|NCT04867785|566663494|FG007|Overall Study|Adverse Event|2|||
156974989|NCT04867785|566663487|FG000|Overall Study|Lost to Follow-up|4|||
156974990|NCT04867785|566663488|FG001|Overall Study|Lost to Follow-up|4|||
156974991|NCT04867785|566663489|FG002|Overall Study|Lost to Follow-up|3|||
156974992|NCT04867785|566663490|FG003|Overall Study|Lost to Follow-up|2|||
156974993|NCT04867785|566663491|FG004|Overall Study|Lost to Follow-up|0|||
156974994|NCT04867785|566663492|FG005|Overall Study|Lost to Follow-up|1|||
156974995|NCT04867785|566663493|FG006|Overall Study|Lost to Follow-up|0|||
156974996|NCT04867785|566663494|FG007|Overall Study|Lost to Follow-up|1|||
156974997|NCT04867785|566663487|FG000|Overall Study|Withdrawal by Subject|6|||
156974998|NCT04867785|566663488|FG001|Overall Study|Withdrawal by Subject|2|||
156974999|NCT04867785|566663489|FG002|Overall Study|Withdrawal by Subject|2|||
156975000|NCT04867785|566663490|FG003|Overall Study|Withdrawal by Subject|1|||
156975001|NCT04867785|566663491|FG004|Overall Study|Withdrawal by Subject|2|||
156975002|NCT04867785|566663492|FG005|Overall Study|Withdrawal by Subject|0|||
156975003|NCT04867785|566663493|FG006|Overall Study|Withdrawal by Subject|2|||
156975004|NCT04867785|566663494|FG007|Overall Study|Withdrawal by Subject|5|||
156975005|NCT04867785|566663487|FG000|Overall Study|Physician Decision|0|||
156975006|NCT04867785|566663488|FG001|Overall Study|Physician Decision|0|||
156975007|NCT04867785|566663489|FG002|Overall Study|Physician Decision|0|||
156975008|NCT04867785|566663490|FG003|Overall Study|Physician Decision|0|||
156975009|NCT04867785|566663491|FG004|Overall Study|Physician Decision|0|||
156975010|NCT04867785|566663492|FG005|Overall Study|Physician Decision|0|||
156975011|NCT04867785|566663493|FG006|Overall Study|Physician Decision|0|||
156975012|NCT04867785|566663494|FG007|Overall Study|Physician Decision|1|||
156975013|NCT04867785|566663487|FG000|Overall Study|Inadvertent Enrollment|0|||
156975014|NCT04867785|566663488|FG001|Overall Study|Inadvertent Enrollment|0|||
156975015|NCT04867785|566663489|FG002|Overall Study|Inadvertent Enrollment|0|||
156975016|NCT04867785|566663490|FG003|Overall Study|Inadvertent Enrollment|1|||
156975017|NCT04867785|566663491|FG004|Overall Study|Inadvertent Enrollment|1|||
156975018|NCT04867785|566663492|FG005|Overall Study|Inadvertent Enrollment|0|||
156975019|NCT04867785|566663493|FG006|Overall Study|Inadvertent Enrollment|0|||
156975020|NCT04867785|566663494|FG007|Overall Study|Inadvertent Enrollment|1|||
156975021|NCT04867785|566663487|FG000|Overall Study|Eligibility Criteria Not Met|0|||
156975022|NCT04867785|566663488|FG001|Overall Study|Eligibility Criteria Not Met|0|||
156975023|NCT04867785|566663489|FG002|Overall Study|Eligibility Criteria Not Met|0|||
156975024|NCT04867785|566663490|FG003|Overall Study|Eligibility Criteria Not Met|0|||
156975025|NCT04867785|566663491|FG004|Overall Study|Eligibility Criteria Not Met|0|||
156975026|NCT04867785|566663492|FG005|Overall Study|Eligibility Criteria Not Met|0|||
156975027|NCT04867785|566663493|FG006|Overall Study|Eligibility Criteria Not Met|0|||
156975028|NCT04867785|566663494|FG007|Overall Study|Eligibility Criteria Not Met|1|||
156975029|NCT00553202|566663507|FG000|Overall Study|Death|16|||
157229611|NCT00728949|567586496|FG001|Overall Study|On treatment at cutoff date|0|||
157229612|NCT01996033|567586498|FG000|Overall Study|Death|1|||
157229613|NCT01996033|567586498|FG000|Overall Study|Physician Decision|1|||
157229614|NCT01996033|567586498|FG000|Overall Study|Withdrawal by Subject|4|||
157229615|NCT01996033|567586498|FG000|Overall Study|Lost to Follow-up|3|||
157229616|NCT02636907|567586526|FG000|Autoinjector Assessment Period|Adverse Event|2|||
157229617|NCT02636907|567586526|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
156975030|NCT00553202|566663507|FG000|Overall Study|Lost to Follow-up|1|||
156975031|NCT00553202|566663507|FG000|Overall Study|Physician Decision|28|||
156975032|NCT00553202|566663507|FG000|Overall Study|Withdrawal by Subject|1|||
156975033|NCT00553202|566663507|FG000|Overall Study|No donor identified|16|||
156975034|NCT00553202|566663507|FG000|Overall Study|Fails to meet organ function|6|||
156975035|NCT00369681|566663508|FG000|Overall Study|Death|1|||
156975036|NCT00605319|566663516|FG000|Overall Study|Adverse Event|6|||
156975037|NCT02045433|566663521|FG000|Overall Study|Withdrawal by Subject|1|||
156975038|NCT02966002|566663522|FG000|Overall Study|Withdrawal by Subject|2|||
156975039|NCT02966002|566663522|FG000|Overall Study|Adverse Event|1|||
156975040|NCT02966002|566663522|FG000|Overall Study|Lost to Follow-up|1|||
156975041|NCT02291432|566663523|FG000|Overall Study|Withdrawal by Subject|2|||
156975042|NCT02145078|566663526|FG000|Overall Study|Death|1|||
156975043|NCT02145078|566663526|FG000|Overall Study|Reason not given|3|||
156975044|NCT01350141|566663527|FG000|Overall Study|Lost to Follow-up|1|||
156975045|NCT01350141|566663528|FG001|Overall Study|Lost to Follow-up|0|||
156975046|NCT01350141|566663529|FG002|Overall Study|Lost to Follow-up|1|||
156975047|NCT01350141|566663527|FG000|Overall Study|Withdrawal by Subject|1|||
156975048|NCT01350141|566663528|FG001|Overall Study|Withdrawal by Subject|0|||
156975049|NCT01350141|566663529|FG002|Overall Study|Withdrawal by Subject|0|||
156975050|NCT01350141|566663527|FG000|Overall Study|Randomized but not treated|1|||
156975051|NCT01350141|566663528|FG001|Overall Study|Randomized but not treated|0|||
156975052|NCT01350141|566663529|FG002|Overall Study|Randomized but not treated|0|||
156975053|NCT02367716|566663530|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
156975054|NCT01473381|566663531|FG000|Overall Study|Adverse Event|8|||
156975055|NCT01473381|566663532|FG001|Overall Study|Adverse Event|20|||
156975056|NCT01473381|566663533|FG002|Overall Study|Adverse Event|25|||
156975057|NCT01473381|566663534|FG003|Overall Study|Adverse Event|17|||
156975058|NCT01473381|566663531|FG000|Overall Study|Insufficient Therapeutic Response|10|||
156975059|NCT01473381|566663532|FG001|Overall Study|Insufficient Therapeutic Response|1|||
156975060|NCT01473381|566663533|FG002|Overall Study|Insufficient Therapeutic Response|2|||
156975061|NCT01473381|566663534|FG003|Overall Study|Insufficient Therapeutic Response|3|||
156975062|NCT01473381|566663531|FG000|Overall Study|Protocol Violation|17|||
156975063|NCT01473381|566663532|FG001|Overall Study|Protocol Violation|23|||
156975064|NCT01473381|566663533|FG002|Overall Study|Protocol Violation|19|||
156975065|NCT01473381|566663534|FG003|Overall Study|Protocol Violation|17|||
156975066|NCT01473381|566663531|FG000|Overall Study|Withdrawal of Consent|20|||
156975067|NCT01473381|566663532|FG001|Overall Study|Withdrawal of Consent|21|||
156975068|NCT01473381|566663533|FG002|Overall Study|Withdrawal of Consent|20|||
156975069|NCT01473381|566663534|FG003|Overall Study|Withdrawal of Consent|26|||
156975070|NCT01473381|566663531|FG000|Overall Study|Lost to Follow-up|25|||
156975071|NCT01473381|566663532|FG001|Overall Study|Lost to Follow-up|28|||
156975072|NCT01473381|566663533|FG002|Overall Study|Lost to Follow-up|35|||
156975073|NCT01473381|566663534|FG003|Overall Study|Lost to Follow-up|23|||
156975074|NCT01473381|566663531|FG000|Overall Study|Other Reasons|0|||
156975075|NCT01473381|566663532|FG001|Overall Study|Other Reasons|0|||
156975076|NCT01473381|566663533|FG002|Overall Study|Other Reasons|1|||
156975077|NCT01473381|566663534|FG003|Overall Study|Other Reasons|3|||
156975078|NCT03673462|566663539|FG000|Overall Study|Adverse Event|11|||
156975079|NCT03673462|566663540|FG001|Overall Study|Adverse Event|1|||
156975080|NCT03673462|566663539|FG000|Overall Study|Protocol Violation|25|||
156975081|NCT03673462|566663540|FG001|Overall Study|Protocol Violation|11|||
156975082|NCT03673462|566663539|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
156975083|NCT03673462|566663540|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
156975084|NCT03673462|566663539|FG000|Overall Study|Lost to Follow-up|102|||
157229618|NCT02636907|567586526|FG000|Extension Phase|Adverse Event|2|||
156975085|NCT03673462|566663540|FG001|Overall Study|Lost to Follow-up|19|||
156975086|NCT02768662|566663541|FG000|Overall Study|Adverse Event|1|||
156975087|NCT02768662|566663541|FG000|Overall Study|Lost to Follow-up|4|||
156975088|NCT02768662|566663541|FG000|Overall Study|Withdrawal by Subject|3|||
156975089|NCT02768662|566663541|FG000|Overall Study|Study terminated by Sponsor|78|||
156975090|NCT04503096|566663542|FG000|Overall Study|Withdrawal by Subject|3|||
156975091|NCT01576367|566663543|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
156975092|NCT01576367|566663543|FG000|Overall Study|Moved to commercial use after 6 months|1|||
156975093|NCT04359771|566663544|FG000|Overall Study|Lack of Efficacy|2|||
156975094|NCT04359771|566663545|FG001|Overall Study|Lack of Efficacy|2|||
156975095|NCT02091739|566663546|FG000|MP: 16 Weeks|Adverse Event|1|||
156975096|NCT02091739|566663547|FG001|MP: 16 Weeks|Adverse Event|1|||
156975097|NCT02091739|566663548|FG002|MP: 16 Weeks|Adverse Event|1|||
157229619|NCT02636907|567586526|FG000|Extension Phase|Withdrawal by Subject|4|||
157229620|NCT02636907|567586526|FG000|Extension Phase|Physician Decision|1|||
156975098|NCT02091739|566663549|FG003|MP: 16 Weeks|Adverse Event|0|||
156975099|NCT02091739|566663550|FG004|MP: 16 Weeks|Adverse Event|0|||
156975100|NCT02091739|566663546|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
156975101|NCT02091739|566663547|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
156975102|NCT02091739|566663548|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
156975103|NCT02091739|566663549|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
156975104|NCT02091739|566663550|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
156975105|NCT02091739|566663546|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
156975106|NCT02091739|566663547|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
156975107|NCT02091739|566663548|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
156975108|NCT02091739|566663549|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
156975109|NCT02091739|566663550|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
156975110|NCT02091739|566663546|FG000|EP: 48 Weeks|Other|0|||
156975111|NCT02091739|566663547|FG001|EP: 48 Weeks|Other|0|||
156975112|NCT02091739|566663548|FG002|EP: 48 Weeks|Other|0|||
156975113|NCT02091739|566663549|FG003|EP: 48 Weeks|Other|1|||
156975114|NCT02091739|566663550|FG004|EP: 48 Weeks|Other|0|||
156975115|NCT02091739|566663546|FG000|EP: 48 Weeks|Death|0|||
156975116|NCT02091739|566663547|FG001|EP: 48 Weeks|Death|0|||
156975117|NCT02091739|566663548|FG002|EP: 48 Weeks|Death|0|||
156975118|NCT02091739|566663549|FG003|EP: 48 Weeks|Death|3|||
156975119|NCT02091739|566663550|FG004|EP: 48 Weeks|Death|2|||
156975120|NCT02091739|566663546|FG000|EP: 48 Weeks|Adverse Event|0|||
156975121|NCT02091739|566663547|FG001|EP: 48 Weeks|Adverse Event|0|||
156975122|NCT02091739|566663548|FG002|EP: 48 Weeks|Adverse Event|0|||
156975123|NCT02091739|566663549|FG003|EP: 48 Weeks|Adverse Event|2|||
156975124|NCT02091739|566663550|FG004|EP: 48 Weeks|Adverse Event|6|||
156975125|NCT02091739|566663546|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
156975126|NCT02091739|566663547|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
156975127|NCT02091739|566663548|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
156975128|NCT02091739|566663549|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
156975129|NCT02091739|566663550|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
156975130|NCT04041440|566663551|FG000|Overall Study|Withdrawal by Subject|0|||
156975131|NCT04041440|566663552|FG001|Overall Study|Withdrawal by Subject|1|||
156975132|NCT04041440|566663551|FG000|Overall Study|Lost to Follow-up|0|||
156975133|NCT04041440|566663552|FG001|Overall Study|Lost to Follow-up|1|||
156975134|NCT01346514|566663553|FG000|Overall Study|Lost to Follow-up|19|||
156975135|NCT01346514|566663554|FG001|Overall Study|Lost to Follow-up|30|||
156975136|NCT01346514|566663553|FG000|Overall Study|Withdrawal by Subject|7|||
156975137|NCT01346514|566663554|FG001|Overall Study|Withdrawal by Subject|3|||
156975138|NCT01346514|566663553|FG000|Overall Study|Death|3|||
156975139|NCT01346514|566663554|FG001|Overall Study|Death|4|||
156975140|NCT03002038|566663555|FG000|Overall Study|Adverse Event|3|||
156975141|NCT03002038|566663556|FG001|Overall Study|Adverse Event|1|||
156975142|NCT03002038|566663555|FG000|Overall Study|Withdrawal by Subject|8|||
156975143|NCT03002038|566663556|FG001|Overall Study|Withdrawal by Subject|4|||
156975144|NCT03002038|566663555|FG000|Overall Study|Immigration to another region|0|||
156975145|NCT03002038|566663556|FG001|Overall Study|Immigration to another region|2|||
156975146|NCT01778556|566663559|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
156975147|NCT01778556|566663560|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
156975148|NCT01778556|566663559|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
156975149|NCT01778556|566663560|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
156975150|NCT01778556|566663559|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
156975151|NCT01778556|566663560|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
156975152|NCT01778556|566663559|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
156975153|NCT01778556|566663560|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
156975154|NCT00116272|566663561|FG000|Overall Study|Lost to Follow-up|11|||
156975155|NCT00116272|566663562|FG001|Overall Study|Lost to Follow-up|6|||
156975156|NCT02296190|566663564|FG000|Overall Study|Lost to Follow-up|0|||
157054980|NCT02660034|566954132|FG012|Overall Study|Adverse Event|0|||
157054981|NCT02660034|566954133|FG013|Overall Study|Adverse Event|0|||
157054982|NCT02660034|566954120|FG000|Overall Study|Sponsor Decision|0|||
157229621|NCT02636907|567586526|FG000|Extension Phase|Lost to Follow-up|2|||
156975157|NCT02296190|566663565|FG001|Overall Study|Lost to Follow-up|0|||
156975158|NCT02296190|566663566|FG002|Overall Study|Lost to Follow-up|0|||
156975159|NCT02296190|566663567|FG003|Overall Study|Lost to Follow-up|0|||
156975160|NCT02296190|566663568|FG004|Overall Study|Lost to Follow-up|1|||
156975161|NCT02296190|566663569|FG005|Overall Study|Lost to Follow-up|0|||
156975162|NCT02296190|566663564|FG000|Overall Study|Failure to induce PSVT|6|||
156975163|NCT02296190|566663565|FG001|Overall Study|Failure to induce PSVT|10|||
156975164|NCT02296190|566663566|FG002|Overall Study|Failure to induce PSVT|5|||
156975165|NCT02296190|566663567|FG003|Overall Study|Failure to induce PSVT|13|||
156975166|NCT02296190|566663568|FG004|Overall Study|Failure to induce PSVT|8|||
156975167|NCT02296190|566663569|FG005|Overall Study|Failure to induce PSVT|0|||
156975168|NCT02296190|566663564|FG000|Overall Study|Physician Decision|1|||
156975169|NCT02296190|566663565|FG001|Overall Study|Physician Decision|1|||
156975170|NCT02296190|566663566|FG002|Overall Study|Physician Decision|0|||
156975171|NCT02296190|566663567|FG003|Overall Study|Physician Decision|1|||
157054983|NCT02660034|566954121|FG001|Overall Study|Sponsor Decision|1|||
156975172|NCT02296190|566663568|FG004|Overall Study|Physician Decision|2|||
156975173|NCT02296190|566663569|FG005|Overall Study|Physician Decision|0|||
156975174|NCT02296190|566663564|FG000|Overall Study|Withdrawal by Subject|0|||
156975175|NCT02296190|566663565|FG001|Overall Study|Withdrawal by Subject|1|||
156975176|NCT02296190|566663566|FG002|Overall Study|Withdrawal by Subject|0|||
156975177|NCT02296190|566663567|FG003|Overall Study|Withdrawal by Subject|0|||
156975178|NCT02296190|566663568|FG004|Overall Study|Withdrawal by Subject|0|||
156975179|NCT02296190|566663569|FG005|Overall Study|Withdrawal by Subject|0|||
156975180|NCT02296190|566663564|FG000|Overall Study|PSVT < 5 minutes|5|||
156975181|NCT02296190|566663565|FG001|Overall Study|PSVT < 5 minutes|6|||
156975182|NCT02296190|566663566|FG002|Overall Study|PSVT < 5 minutes|6|||
156975183|NCT02296190|566663567|FG003|Overall Study|PSVT < 5 minutes|6|||
156975184|NCT02296190|566663568|FG004|Overall Study|PSVT < 5 minutes|5|||
156975185|NCT02296190|566663569|FG005|Overall Study|PSVT < 5 minutes|0|||
156975186|NCT02296190|566663564|FG000|Overall Study|Patient was given Propofol|0|||
156975187|NCT02296190|566663565|FG001|Overall Study|Patient was given Propofol|1|||
156975188|NCT02296190|566663566|FG002|Overall Study|Patient was given Propofol|0|||
156975189|NCT02296190|566663567|FG003|Overall Study|Patient was given Propofol|1|||
156975190|NCT02296190|566663568|FG004|Overall Study|Patient was given Propofol|0|||
157054984|NCT02660034|566954122|FG002|Overall Study|Sponsor Decision|2|||
157054985|NCT02660034|566954123|FG003|Overall Study|Sponsor Decision|2|||
157054986|NCT02660034|566954124|FG004|Overall Study|Sponsor Decision|3|||
157054987|NCT02660034|566954125|FG005|Overall Study|Sponsor Decision|0|||
157054988|NCT02660034|566954126|FG006|Overall Study|Sponsor Decision|0|||
157054989|NCT02660034|566954127|FG007|Overall Study|Sponsor Decision|0|||
157054990|NCT02660034|566954128|FG008|Overall Study|Sponsor Decision|0|||
157054991|NCT02660034|566954129|FG009|Overall Study|Sponsor Decision|0|||
157054992|NCT02660034|566954130|FG010|Overall Study|Sponsor Decision|0|||
157054993|NCT02660034|566954131|FG011|Overall Study|Sponsor Decision|0|||
157054994|NCT02660034|566954132|FG012|Overall Study|Sponsor Decision|0|||
157054995|NCT02660034|566954133|FG013|Overall Study|Sponsor Decision|1|||
157054996|NCT02660034|566954120|FG000|Overall Study|Withdrawal by Subject|0|||
157054997|NCT02660034|566954121|FG001|Overall Study|Withdrawal by Subject|0|||
157054998|NCT02660034|566954122|FG002|Overall Study|Withdrawal by Subject|0|||
157054999|NCT02660034|566954123|FG003|Overall Study|Withdrawal by Subject|0|||
157055000|NCT02660034|566954124|FG004|Overall Study|Withdrawal by Subject|0|||
157055001|NCT02660034|566954125|FG005|Overall Study|Withdrawal by Subject|0|||
157055002|NCT02660034|566954126|FG006|Overall Study|Withdrawal by Subject|1|||
157055003|NCT02660034|566954127|FG007|Overall Study|Withdrawal by Subject|1|||
157055004|NCT02660034|566954128|FG008|Overall Study|Withdrawal by Subject|1|||
157055005|NCT02660034|566954129|FG009|Overall Study|Withdrawal by Subject|0|||
157055006|NCT02660034|566954130|FG010|Overall Study|Withdrawal by Subject|0|||
157055007|NCT02660034|566954131|FG011|Overall Study|Withdrawal by Subject|1|||
157055008|NCT02660034|566954132|FG012|Overall Study|Withdrawal by Subject|2|||
157055009|NCT02660034|566954133|FG013|Overall Study|Withdrawal by Subject|0|||
157055010|NCT02660034|566954120|FG000|Overall Study|Death|0|||
157055011|NCT02660034|566954121|FG001|Overall Study|Death|0|||
157055012|NCT02660034|566954122|FG002|Overall Study|Death|0|||
157055013|NCT02660034|566954123|FG003|Overall Study|Death|0|||
157055014|NCT02660034|566954124|FG004|Overall Study|Death|0|||
157055015|NCT02660034|566954125|FG005|Overall Study|Death|13|||
157055016|NCT02660034|566954126|FG006|Overall Study|Death|14|||
157055017|NCT02660034|566954127|FG007|Overall Study|Death|10|||
157055018|NCT02660034|566954128|FG008|Overall Study|Death|9|||
157055019|NCT02660034|566954129|FG009|Overall Study|Death|21|||
157055020|NCT02660034|566954130|FG010|Overall Study|Death|17|||
157055021|NCT02660034|566954131|FG011|Overall Study|Death|15|||
157055022|NCT02660034|566954132|FG012|Overall Study|Death|18|||
157055023|NCT02660034|566954133|FG013|Overall Study|Death|7|||
157055024|NCT02660034|566954120|FG000|Overall Study|Physician Decision|0|||
157055025|NCT02660034|566954121|FG001|Overall Study|Physician Decision|0|||
157055026|NCT02660034|566954122|FG002|Overall Study|Physician Decision|0|||
157229622|NCT02636907|567586526|FG000|Extension Phase|Lack of Efficacy|1|||
157229623|NCT01682083|567586527|FG000|Overall Study|Lost to Follow-up|11|||
156975191|NCT02296190|566663569|FG005|Overall Study|Patient was given Propofol|0|||
156975192|NCT02296190|566663564|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
157055027|NCT02660034|566954123|FG003|Overall Study|Physician Decision|0|||
157055028|NCT02660034|566954124|FG004|Overall Study|Physician Decision|0|||
157055029|NCT02660034|566954125|FG005|Overall Study|Physician Decision|0|||
157055030|NCT02660034|566954126|FG006|Overall Study|Physician Decision|0|||
156975193|NCT02296190|566663565|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
156975194|NCT02296190|566663566|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
156975195|NCT02296190|566663567|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
157055031|NCT02660034|566954127|FG007|Overall Study|Physician Decision|0|||
157229624|NCT01682083|567586528|FG001|Overall Study|Lost to Follow-up|18|||
157055032|NCT02660034|566954128|FG008|Overall Study|Physician Decision|0|||
157055033|NCT02660034|566954129|FG009|Overall Study|Physician Decision|0|||
157055034|NCT02660034|566954130|FG010|Overall Study|Physician Decision|0|||
157055035|NCT02660034|566954131|FG011|Overall Study|Physician Decision|0|||
157055036|NCT02660034|566954132|FG012|Overall Study|Physician Decision|0|||
157055037|NCT02660034|566954133|FG013|Overall Study|Physician Decision|1|||
157055038|NCT02660034|566954120|FG000|Overall Study|Participants transferred to LTE|0|||
157055039|NCT02660034|566954121|FG001|Overall Study|Participants transferred to LTE|0|||
157055040|NCT02660034|566954122|FG002|Overall Study|Participants transferred to LTE|0|||
157055041|NCT02660034|566954123|FG003|Overall Study|Participants transferred to LTE|0|||
157055042|NCT02660034|566954124|FG004|Overall Study|Participants transferred to LTE|0|||
157055043|NCT02660034|566954125|FG005|Overall Study|Participants transferred to LTE|10|||
157055044|NCT02660034|566954126|FG006|Overall Study|Participants transferred to LTE|8|||
157055045|NCT02660034|566954127|FG007|Overall Study|Participants transferred to LTE|8|||
157055046|NCT02660034|566954128|FG008|Overall Study|Participants transferred to LTE|10|||
157055047|NCT02660034|566954129|FG009|Overall Study|Participants transferred to LTE|1|||
157055048|NCT02660034|566954130|FG010|Overall Study|Participants transferred to LTE|2|||
157055049|NCT02660034|566954131|FG011|Overall Study|Participants transferred to LTE|4|||
157055050|NCT02660034|566954132|FG012|Overall Study|Participants transferred to LTE|1|||
157055051|NCT02660034|566954133|FG013|Overall Study|Participants transferred to LTE|1|||
157055052|NCT02995733|566954136|FG000|Overall Study|Study site closed|9|||
157055053|NCT02995733|566954137|FG001|Overall Study|Study site closed|10|||
157055054|NCT02995733|566954136|FG000|Overall Study|Death|3|||
157055055|NCT02995733|566954137|FG001|Overall Study|Death|4|||
157055056|NCT02995733|566954136|FG000|Overall Study|Withdrawal by Subject|6|||
157055057|NCT02995733|566954137|FG001|Overall Study|Withdrawal by Subject|2|||
157055058|NCT02995733|566954136|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
157055059|NCT02995733|566954137|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
157055060|NCT02995733|566954136|FG000|Overall Study|Lost to Follow-up|48|||
157055061|NCT02995733|566954137|FG001|Overall Study|Lost to Follow-up|37|||
157055062|NCT02995733|566954136|FG000|Overall Study|Other|0|||
157055063|NCT02995733|566954137|FG001|Overall Study|Other|1|||
157055064|NCT02720198|566954138|FG000|Overall Study|Withdrawal by Subject|0|||
157055065|NCT02720198|566954139|FG001|Overall Study|Withdrawal by Subject|1|||
157055066|NCT04879823|566954140|FG000|Overall Study|Physician Decision|3|||
157055067|NCT04879823|566954141|FG001|Overall Study|Physician Decision|1|||
157055068|NCT04879823|566954140|FG000|Overall Study|Protocol Violation|2|||
157055069|NCT04879823|566954141|FG001|Overall Study|Protocol Violation|3|||
157055070|NCT04879823|566954140|FG000|Overall Study|Lost to Follow-up|43|||
157055071|NCT04879823|566954141|FG001|Overall Study|Lost to Follow-up|35|||
157055072|NCT02592434|566954142|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
157055073|NCT02592434|566954143|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
157055074|NCT02592434|566954144|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
157055075|NCT02592434|566954142|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
157055076|NCT02592434|566954143|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
157055077|NCT02592434|566954144|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
157055078|NCT02592434|566954142|FG000|Open-Label Phase (18 Weeks)|Other|3|||
157055079|NCT02592434|566954143|FG001|Open-Label Phase (18 Weeks)|Other|0|||
157055080|NCT02592434|566954144|FG002|Open-Label Phase (18 Weeks)|Other|0|||
157055081|NCT02592434|566954142|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
157055082|NCT02592434|566954143|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
157055083|NCT02592434|566954144|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
157055084|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
157055085|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
157055086|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
157055087|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
157055088|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
157055089|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
157055090|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Other|0|||
157055091|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Other|1|||
157055092|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Other|0|||
157055093|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
157055094|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
157055095|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
157055096|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
157055097|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
157055098|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
157178842|NCT00524043|567397997|FG000|Overall Study|Various (eg, incarceration)|2|||
157178843|NCT00524043|567397998|FG001|Overall Study|Various (eg, incarceration)|1|||
157055099|NCT02592434|566954142|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
157055100|NCT02592434|566954143|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
157055101|NCT02592434|566954144|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
157055102|NCT00472199|566954145|FG000|Overall Study|Adverse Event|19|||
157055103|NCT00472199|566954146|FG001|Overall Study|Adverse Event|23|||
157055104|NCT00472199|566954145|FG000|Overall Study|Lack of Efficacy|4|||
157055105|NCT00472199|566954146|FG001|Overall Study|Lack of Efficacy|25|||
157055106|NCT00472199|566954145|FG000|Overall Study|Lost to Follow-up|2|||
157055107|NCT00472199|566954146|FG001|Overall Study|Lost to Follow-up|4|||
157055108|NCT00472199|566954145|FG000|Overall Study|Protocol Violation|3|||
157055109|NCT00472199|566954146|FG001|Overall Study|Protocol Violation|2|||
157055110|NCT00472199|566954145|FG000|Overall Study|Withdrawal by Subject|6|||
157055111|NCT00472199|566954146|FG001|Overall Study|Withdrawal by Subject|5|||
157055112|NCT00472199|566954145|FG000|Overall Study|personal reason|0|||
157055113|NCT00472199|566954146|FG001|Overall Study|personal reason|1|||
157055114|NCT00472199|566954145|FG000|Overall Study|patient was asymptomatic|1|||
157055115|NCT00472199|566954146|FG001|Overall Study|patient was asymptomatic|0|||
157055116|NCT01106586|566954148|FG000|Overall Study|Adverse Event|9|||
157055117|NCT01106586|566954149|FG001|Overall Study|Adverse Event|15|||
157055118|NCT01106586|566954148|FG000|Overall Study|Death|1|||
157055119|NCT01106586|566954149|FG001|Overall Study|Death|3|||
157055120|NCT01106586|566954148|FG000|Overall Study|Pregnancy|2|||
157055121|NCT01106586|566954149|FG001|Overall Study|Pregnancy|2|||
157055122|NCT01106586|566954148|FG000|Overall Study|Lack of Efficacy|1|||
157055123|NCT01106586|566954149|FG001|Overall Study|Lack of Efficacy|0|||
157055124|NCT01106586|566954148|FG000|Overall Study|Investigator's Discretion|5|||
157055125|NCT01106586|566954149|FG001|Overall Study|Investigator's Discretion|8|||
157055126|NCT01106586|566954148|FG000|Overall Study|Withdrew Consent|18|||
157055127|NCT01106586|566954149|FG001|Overall Study|Withdrew Consent|30|||
157055128|NCT01106586|566954148|FG000|Overall Study|Lost to Follow-up|24|||
157055129|NCT01106586|566954149|FG001|Overall Study|Lost to Follow-up|20|||
157055130|NCT01106586|566954148|FG000|Overall Study|Participant Noncompliance|12|||
157055131|NCT01106586|566954149|FG001|Overall Study|Participant Noncompliance|10|||
157055132|NCT01106586|566954148|FG000|Overall Study|Protocol Violation|1|||
157055133|NCT01106586|566954149|FG001|Overall Study|Protocol Violation|0|||
157055134|NCT01106586|566954148|FG000|Overall Study|Participant Transferred to Another Study|212|||
157055135|NCT01106586|566954149|FG001|Overall Study|Participant Transferred to Another Study|197|||
157055136|NCT00105521|566954150|FG000|Overall Study|Other|1|||
157055137|NCT00105521|566954151|FG001|Overall Study|Other|1|||
157055138|NCT00105521|566954152|FG002|Overall Study|Other|2|||
157055139|NCT00105521|566954153|FG003|Overall Study|Other|0|||
157055140|NCT00105521|566954150|FG000|Overall Study|Adverse Event|10|||
157055141|NCT00105521|566954151|FG001|Overall Study|Adverse Event|4|||
157055142|NCT00105521|566954152|FG002|Overall Study|Adverse Event|10|||
157055143|NCT00105521|566954153|FG003|Overall Study|Adverse Event|8|||
157055144|NCT00105521|566954150|FG000|Overall Study|Withdrawal by Subject|1|||
157055145|NCT00105521|566954151|FG001|Overall Study|Withdrawal by Subject|0|||
157055146|NCT00105521|566954152|FG002|Overall Study|Withdrawal by Subject|1|||
157055147|NCT00105521|566954153|FG003|Overall Study|Withdrawal by Subject|4|||
157055148|NCT00105521|566954150|FG000|Overall Study|Lack of Efficacy|0|||
157055149|NCT00105521|566954151|FG001|Overall Study|Lack of Efficacy|0|||
157055150|NCT00105521|566954152|FG002|Overall Study|Lack of Efficacy|0|||
157055151|NCT00105521|566954153|FG003|Overall Study|Lack of Efficacy|1|||
157055152|NCT00105521|566954150|FG000|Overall Study|Protocol Violation|3|||
157055153|NCT00105521|566954151|FG001|Overall Study|Protocol Violation|5|||
157055154|NCT00105521|566954152|FG002|Overall Study|Protocol Violation|4|||
157055155|NCT00105521|566954153|FG003|Overall Study|Protocol Violation|4|||
157055156|NCT00105521|566954150|FG000|Overall Study|Lost to Follow-up|0|||
157055157|NCT00105521|566954151|FG001|Overall Study|Lost to Follow-up|1|||
157055158|NCT00105521|566954152|FG002|Overall Study|Lost to Follow-up|0|||
157055159|NCT00105521|566954153|FG003|Overall Study|Lost to Follow-up|0|||
157055160|NCT01721109|566954162|FG000|Overall Study|Lack of Efficacy|1|||
157055161|NCT01721109|566954162|FG000|Overall Study|Non- Compliance with Study Drug|3|||
157055162|NCT01721109|566954162|FG000|Overall Study|Withdrew Consent|1|||
157055163|NCT01721109|566954162|FG000|Overall Study|Lost to Follow-up|2|||
157055164|NCT03045302|566954163|FG000|Overall Study|Pre-treatment adverse event|1|||
157055165|NCT00134056|566954164|FG000|Randomization|Not eligible for assigned treatment|22|||
157055166|NCT00134056|566954165|FG001|Randomization|Not eligible for assigned treatment|20|||
157055167|NCT00134056|566954164|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
157055168|NCT00134056|566954165|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
157178844|NCT00524043|567397999|FG002|Overall Study|Various (eg, incarceration)|0|||
157178845|NCT00517413|567398000|FG000|Overall Study|Adverse Event|7|||
157055169|NCT00134056|566954164|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
157055170|NCT00134056|566954165|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
157055171|NCT00134056|566954164|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
157055172|NCT00134056|566954165|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
157055173|NCT00134056|566954164|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
157055174|NCT00134056|566954165|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
157055175|NCT00742560|566954167|FG000|Overall Study|Adverse Event|0|||
157055176|NCT00742560|566954168|FG001|Overall Study|Adverse Event|0|||
157055177|NCT00742560|566954169|FG002|Overall Study|Adverse Event|1|||
157055178|NCT00742560|566954170|FG003|Overall Study|Adverse Event|1|||
157055179|NCT00742560|566954171|FG004|Overall Study|Adverse Event|1|||
157055180|NCT00742560|566954167|FG000|Overall Study|Death|0|||
157055181|NCT00742560|566954168|FG001|Overall Study|Death|2|||
157178846|NCT00517413|567398000|FG000|Overall Study|Death|13|||
157055182|NCT00742560|566954169|FG002|Overall Study|Death|0|||
157055183|NCT00742560|566954170|FG003|Overall Study|Death|2|||
157055184|NCT00742560|566954171|FG004|Overall Study|Death|3|||
157055185|NCT00742560|566954167|FG000|Overall Study|Subject's Decision|1|||
157055186|NCT00742560|566954168|FG001|Overall Study|Subject's Decision|0|||
157055187|NCT00742560|566954169|FG002|Overall Study|Subject's Decision|2|||
157055188|NCT00742560|566954170|FG003|Overall Study|Subject's Decision|3|||
157055189|NCT00742560|566954171|FG004|Overall Study|Subject's Decision|3|||
157055190|NCT00742560|566954167|FG000|Overall Study|Investigator's Decision|0|||
157055191|NCT00742560|566954168|FG001|Overall Study|Investigator's Decision|0|||
157055192|NCT00742560|566954169|FG002|Overall Study|Investigator's Decision|4|||
157055193|NCT00742560|566954170|FG003|Overall Study|Investigator's Decision|1|||
157055194|NCT00742560|566954171|FG004|Overall Study|Investigator's Decision|0|||
157055195|NCT00742560|566954167|FG000|Overall Study|Disease Progression|1|||
157055196|NCT00742560|566954168|FG001|Overall Study|Disease Progression|0|||
157055197|NCT00742560|566954169|FG002|Overall Study|Disease Progression|5|||
157055198|NCT00742560|566954170|FG003|Overall Study|Disease Progression|17|||
157055199|NCT00742560|566954171|FG004|Overall Study|Disease Progression|16|||
157055200|NCT00742560|566954167|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
157055201|NCT00742560|566954168|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
157055202|NCT00742560|566954169|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
157055203|NCT00742560|566954170|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
157055204|NCT00742560|566954171|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
157055205|NCT00742560|566954167|FG000|Overall Study|Other|0|||
157055206|NCT00742560|566954168|FG001|Overall Study|Other|1|||
157055207|NCT00742560|566954169|FG002|Overall Study|Other|8|||
157055208|NCT00742560|566954170|FG003|Overall Study|Other|9|||
157055209|NCT00742560|566954171|FG004|Overall Study|Other|9|||
157055210|NCT00742560|566954167|FG000|Overall Study|MIssing|0|||
156975196|NCT02296190|566663568|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
156975197|NCT02296190|566663569|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
156975198|NCT02296190|566663564|FG000|Overall Study|Blood pressure <100 after sedation|0|||
156975199|NCT02296190|566663565|FG001|Overall Study|Blood pressure <100 after sedation|0|||
156975200|NCT02296190|566663566|FG002|Overall Study|Blood pressure <100 after sedation|0|||
156975201|NCT02296190|566663567|FG003|Overall Study|Blood pressure <100 after sedation|1|||
156975202|NCT02296190|566663568|FG004|Overall Study|Blood pressure <100 after sedation|0|||
156975203|NCT02296190|566663569|FG005|Overall Study|Blood pressure <100 after sedation|0|||
156975204|NCT02296190|566663564|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156975205|NCT02296190|566663565|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
156975206|NCT02296190|566663566|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
156975207|NCT02296190|566663567|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156975208|NCT02296190|566663568|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156975209|NCT02296190|566663569|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
156975210|NCT02296190|566663564|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
156975211|NCT02296190|566663565|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
156975212|NCT02296190|566663566|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
156975213|NCT02296190|566663567|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
156975214|NCT02296190|566663568|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
156975215|NCT02296190|566663569|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
156975216|NCT02296190|566663564|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156975217|NCT02296190|566663565|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
156975218|NCT02296190|566663566|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156975219|NCT02296190|566663567|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156975220|NCT02296190|566663568|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156975221|NCT02296190|566663569|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
156975222|NCT02296190|566663564|FG000|Overall Study|Lab result not available in time|1|||
156975223|NCT02296190|566663565|FG001|Overall Study|Lab result not available in time|0|||
156975224|NCT02296190|566663566|FG002|Overall Study|Lab result not available in time|0|||
156975225|NCT02296190|566663567|FG003|Overall Study|Lab result not available in time|0|||
156975226|NCT02296190|566663568|FG004|Overall Study|Lab result not available in time|0|||
156975227|NCT02296190|566663569|FG005|Overall Study|Lab result not available in time|0|||
156975228|NCT00265330|566663570|FG000|Overall Study|Adverse Event|41|||
156975229|NCT00265330|566663570|FG000|Overall Study|Lost to Follow-up|8|||
156975230|NCT00265330|566663570|FG000|Overall Study|Withdrawal by Subject|34|||
157055211|NCT00742560|566954168|FG001|Overall Study|MIssing|0|||
157055212|NCT00742560|566954169|FG002|Overall Study|MIssing|0|||
157055213|NCT00742560|566954170|FG003|Overall Study|MIssing|0|||
156975231|NCT00265330|566663570|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
156975232|NCT00265330|566663570|FG000|Overall Study|Lack of Efficacy|4|||
156975233|NCT00265330|566663570|FG000|Overall Study|Family Scheduling Conflicts|1|||
157055214|NCT00742560|566954171|FG004|Overall Study|MIssing|1|||
157055215|NCT01536795|566954172|FG000|Overall Study|Lost to Follow-up|0|||
157055216|NCT01536795|566954173|FG001|Overall Study|Lost to Follow-up|2|||
157055217|NCT01536795|566954172|FG000|Overall Study|Lack of Efficacy|1|||
157055218|NCT01536795|566954173|FG001|Overall Study|Lack of Efficacy|0|||
157055219|NCT01812837|566954174|FG000|Overall Study|Lost to Follow-up|1|||
157055220|NCT01812837|566954175|FG001|Overall Study|Lost to Follow-up|1|||
157055221|NCT01812837|566954176|FG002|Overall Study|Lost to Follow-up|0|||
157055222|NCT01812837|566954174|FG000|Overall Study|Protocol Violation|1|||
157055223|NCT01812837|566954175|FG001|Overall Study|Protocol Violation|0|||
157055224|NCT01812837|566954176|FG002|Overall Study|Protocol Violation|0|||
157055225|NCT05008224|566954177|FG000|Overall Study|Death|3|||
157055226|NCT05008224|566954177|FG000|Overall Study|Lost to Follow-up|2|||
157055227|NCT05008224|566954177|FG000|Overall Study|Did Not Continue on Extension Study|39|||
157055228|NCT05008224|566954177|FG000|Overall Study|Transferred to Extension Study|100|||
157055229|NCT05008224|566954177|FG000|Overall Study|Withdrawal by Subject|2|||
157055230|NCT00348283|566954178|FG000|Induction|Adverse Event|0|||
157055231|NCT00348283|566954179|FG001|Induction|Adverse Event|2|||
157055232|NCT00348283|566954178|FG000|Induction|Protocol Violation|0|||
157055233|NCT00348283|566954179|FG001|Induction|Protocol Violation|4|||
157055234|NCT00348283|566954178|FG000|Double Blind|Adverse Event|2|||
157055235|NCT00348283|566954179|FG001|Double Blind|Adverse Event|5|||
157055236|NCT00348283|566954178|FG000|Double Blind|Withdrawal by Subject|1|||
157055237|NCT00348283|566954179|FG001|Double Blind|Withdrawal by Subject|1|||
157055238|NCT00348283|566954178|FG000|Double Blind|Protocol Violation|0|||
157055239|NCT00348283|566954179|FG001|Double Blind|Protocol Violation|1|||
157055240|NCT00348283|566954178|FG000|Double Blind|Lack of Efficacy|2|||
157055241|NCT00348283|566954179|FG001|Double Blind|Lack of Efficacy|2|||
157055242|NCT00348283|566954178|FG000|Double Blind|Pregnancy|0|||
157055243|NCT00348283|566954179|FG001|Double Blind|Pregnancy|1|||
157055244|NCT00348283|566954178|FG000|Open Label|Adverse Event|0|||
157055245|NCT00348283|566954179|FG001|Open Label|Adverse Event|8|||
157055246|NCT00348283|566954178|FG000|Open Label|Withdrawal by Subject|0|||
157055247|NCT00348283|566954179|FG001|Open Label|Withdrawal by Subject|4|||
157055248|NCT00348283|566954178|FG000|Open Label|Lost to Follow-up|0|||
157055249|NCT00348283|566954179|FG001|Open Label|Lost to Follow-up|1|||
157055250|NCT00348283|566954178|FG000|Open Label|Lack of Efficacy|0|||
157055251|NCT00348283|566954179|FG001|Open Label|Lack of Efficacy|13|||
157055252|NCT00348283|566954178|FG000|Open Label|Administrative reasons|0|||
157055253|NCT00348283|566954179|FG001|Open Label|Administrative reasons|5|||
157055254|NCT00348283|566954178|FG000|Open Label|Subject moved to the United States|0|||
157055255|NCT00348283|566954179|FG001|Open Label|Subject moved to the United States|1|||
157055256|NCT00348283|566954178|FG000|Open Label|Pregnancy|0|||
157055257|NCT00348283|566954179|FG001|Open Label|Pregnancy|1|||
157055258|NCT00348283|566954178|FG000|Open Label|Sponsor decision|0|||
157055259|NCT00348283|566954179|FG001|Open Label|Sponsor decision|1|||
157055260|NCT05878522|566954185|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055261|NCT05878522|566954186|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055262|NCT05878522|566954187|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055263|NCT05878522|566954188|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055264|NCT05878522|566954189|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055265|NCT05878522|566954190|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055266|NCT05878522|566954191|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055267|NCT05878522|566954192|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055268|NCT05878522|566954193|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
157055269|NCT05878522|566954194|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055270|NCT05878522|566954195|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055271|NCT05878522|566954196|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
157055272|NCT05878522|566954185|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
157055273|NCT05878522|566954186|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055274|NCT05878522|566954187|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055275|NCT05878522|566954188|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055276|NCT05878522|566954189|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055277|NCT05878522|566954190|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055278|NCT05878522|566954191|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055279|NCT05878522|566954192|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055280|NCT05878522|566954193|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055281|NCT05878522|566954194|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
157055282|NCT05878522|566954195|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055283|NCT05878522|566954196|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
157055284|NCT05878522|566954185|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055285|NCT05878522|566954186|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
157055286|NCT05878522|566954187|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055287|NCT05878522|566954188|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
157055288|NCT05878522|566954189|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055289|NCT05878522|566954190|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055290|NCT05878522|566954191|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055291|NCT05878522|566954192|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055292|NCT05878522|566954193|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157178847|NCT00517413|567398000|FG000|Overall Study|Protocol Violation|15|||
157178848|NCT00517413|567398000|FG000|Overall Study|Withdrawal by Subject|2|||
156975234|NCT00265330|566663570|FG000|Overall Study|Began Taking Formulary Geodon|1|||
156975235|NCT00265330|566663570|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
156975236|NCT00265330|566663570|FG000|Overall Study|Site Closed by Sponsor|1|||
156975237|NCT00265330|566663570|FG000|Overall Study|Principal Investigators Request|1|||
156975238|NCT00265330|566663570|FG000|Overall Study|Withdrew Consent|1|||
156975239|NCT00265330|566663570|FG000|Overall Study|Protocol Violation|1|||
156975240|NCT02658630|566663577|FG000|Overall Study|Withdrawal by Subject|4|||
156975241|NCT01875185|566663578|FG000|Overall Study|study was terminated|52|||
156975242|NCT01875185|566663579|FG001|Overall Study|study was terminated|48|||
156975243|NCT00110890|566663580|FG000|Overall Study|Adverse Event|30|||
156975244|NCT00110890|566663581|FG001|Overall Study|Adverse Event|7|||
156975245|NCT00110890|566663580|FG000|Overall Study|Death|16|||
156975246|NCT00110890|566663581|FG001|Overall Study|Death|9|||
156975247|NCT00110890|566663580|FG000|Overall Study|Lost to Follow-up|3|||
156975248|NCT00110890|566663581|FG001|Overall Study|Lost to Follow-up|1|||
156975249|NCT00110890|566663580|FG000|Overall Study|Physician Decision|4|||
156975250|NCT00110890|566663581|FG001|Overall Study|Physician Decision|5|||
156975251|NCT00110890|566663580|FG000|Overall Study|Withdrawal by Subject|17|||
156975252|NCT00110890|566663581|FG001|Overall Study|Withdrawal by Subject|5|||
156975253|NCT00110890|566663580|FG000|Overall Study|Protocol Deviation|1|||
156975254|NCT00110890|566663581|FG001|Overall Study|Protocol Deviation|0|||
156975255|NCT00110890|566663580|FG000|Overall Study|Noncompliance|10|||
156975256|NCT00110890|566663581|FG001|Overall Study|Noncompliance|0|||
156975257|NCT00110890|566663580|FG000|Overall Study|Kidney Transplant|16|||
156975258|NCT00110890|566663581|FG001|Overall Study|Kidney Transplant|12|||
156975259|NCT00110890|566663580|FG000|Overall Study|Invest. Product Commercially Available|217|||
156975260|NCT00110890|566663581|FG001|Overall Study|Invest. Product Commercially Available|110|||
156975261|NCT00110890|566663580|FG000|Overall Study|Other|34|||
156975262|NCT00110890|566663581|FG001|Overall Study|Other|23|||
156975263|NCT00110890|566663580|FG000|Overall Study|Ineligibility determined|3|||
156975264|NCT00110890|566663581|FG001|Overall Study|Ineligibility determined|0|||
156975265|NCT00110890|566663580|FG000|Overall Study|Requirement for alternative therapy|0|||
156975266|NCT00110890|566663581|FG001|Overall Study|Requirement for alternative therapy|1|||
156975267|NCT00110890|566663580|FG000|Overall Study|Disease progression|0|||
156975268|NCT00110890|566663581|FG001|Overall Study|Disease progression|1|||
156975269|NCT00110890|566663580|FG000|Overall Study|Parathyroidectomy|0|||
156975270|NCT00110890|566663581|FG001|Overall Study|Parathyroidectomy|1|||
156975271|NCT00110890|566663580|FG000|Overall Study|Did not enter follow-up phase|10|||
156975272|NCT00110890|566663581|FG001|Overall Study|Did not enter follow-up phase|4|||
156975273|NCT01686581|566663582|FG000|Overall Study|Side-effects or Health Problems|15|||
156975274|NCT01686581|566663582|FG000|Overall Study|Lack of Efficacy|90|||
156975275|NCT01686581|566663582|FG000|Overall Study|Participant Concerned about Risks|6|||
156975276|NCT01686581|566663582|FG000|Overall Study|Thinks Injections Too Painful|8|||
156975277|NCT01686581|566663582|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
156975278|NCT01686581|566663582|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
156975279|NCT01686581|566663582|FG000|Overall Study|Thinks it is Inconvenient|17|||
156975280|NCT01686581|566663582|FG000|Overall Study|Other Miscellaneous Reasons|36|||
156975281|NCT01686581|566663582|FG000|Overall Study|Reason Missing|1|||
156975282|NCT01975220|566663583|FG000|Test Period 1|Not treated|0|||
156975283|NCT01975220|566663584|FG001|Test Period 1|Not treated|1|||
156975284|NCT01975220|566663585|FG002|Test Period 1|Not treated|0|||
156975285|NCT01975220|566663586|FG003|Test Period 1|Not treated|0|||
156975286|NCT01975220|566663587|FG004|Test Period 1|Not treated|0|||
156975287|NCT01975220|566663588|FG005|Test Period 1|Not treated|0|||
156975288|NCT00263328|566663589|FG000|Overall Study|Death|0|||
156975289|NCT00263328|566663590|FG001|Overall Study|Death|0|||
156975290|NCT00263328|566663591|FG002|Overall Study|Death|1|||
156975291|NCT00263328|566663589|FG000|Overall Study|Lost to Follow-up|1|||
156975292|NCT00263328|566663590|FG001|Overall Study|Lost to Follow-up|1|||
156975293|NCT00263328|566663591|FG002|Overall Study|Lost to Follow-up|0|||
156975294|NCT00263328|566663589|FG000|Overall Study|Withdrawal by Subject|3|||
156975295|NCT00263328|566663590|FG001|Overall Study|Withdrawal by Subject|0|||
156975296|NCT00263328|566663591|FG002|Overall Study|Withdrawal by Subject|1|||
156975297|NCT00263328|566663589|FG000|Overall Study|Other|3|||
156975298|NCT00263328|566663590|FG001|Overall Study|Other|0|||
156975299|NCT00263328|566663591|FG002|Overall Study|Other|1|||
156975300|NCT00263328|566663589|FG000|Overall Study|Adverse Event|1|||
156975301|NCT00263328|566663590|FG001|Overall Study|Adverse Event|1|||
156975302|NCT00263328|566663591|FG002|Overall Study|Adverse Event|4|||
156975303|NCT03287414|566663592|FG000|Treatment Epoch|Adverse Event|0|||
156975304|NCT03287414|566663593|FG001|Treatment Epoch|Adverse Event|1|||
156975305|NCT03287414|566663592|FG000|Treatment Epoch|Study terminated by sponsor|2|||
156975306|NCT03287414|566663593|FG001|Treatment Epoch|Study terminated by sponsor|2|||
156975307|NCT03287414|566663592|FG000|Treatment Epoch|Subject/Guardian decision|4|||
157178849|NCT00517413|567398000|FG000|Overall Study|Failure to return|1|||
156975308|NCT03287414|566663593|FG001|Treatment Epoch|Subject/Guardian decision|0|||
157055293|NCT05878522|566954194|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055294|NCT05878522|566954195|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055295|NCT05878522|566954196|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
157055296|NCT05878522|566954185|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055297|NCT05878522|566954186|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055298|NCT05878522|566954187|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055299|NCT05878522|566954188|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055300|NCT05878522|566954189|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
157055301|NCT05878522|566954190|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055302|NCT05878522|566954191|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055303|NCT05878522|566954192|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055304|NCT05878522|566954193|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055305|NCT05878522|566954194|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055306|NCT05878522|566954195|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055307|NCT05878522|566954196|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
157055308|NCT05263492|566954197|FG000|Overall Study|Adverse Event|1|||
157055309|NCT05263492|566954197|FG000|Overall Study|Disease progression during active treatment|3|||
157055310|NCT05216835|566954200|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
157055311|NCT05216835|566954201|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
157055312|NCT05216835|566954202|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
157055313|NCT05216835|566954203|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
157055314|NCT05216835|566954204|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
157055315|NCT05216835|566954205|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
157055316|NCT05216835|566954206|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
157055317|NCT05216835|566954207|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
157055318|NCT05216835|566954200|FG000|Overall Study|Death|0|||
157055319|NCT05216835|566954201|FG001|Overall Study|Death|0|||
157055320|NCT05216835|566954202|FG002|Overall Study|Death|0|||
157055321|NCT05216835|566954203|FG003|Overall Study|Death|1|||
157055322|NCT05216835|566954204|FG004|Overall Study|Death|1|||
157055323|NCT05216835|566954205|FG005|Overall Study|Death|1|||
157055324|NCT05216835|566954206|FG006|Overall Study|Death|1|||
157055325|NCT05216835|566954207|FG007|Overall Study|Death|1|||
157055326|NCT05216835|566954200|FG000|Overall Study|Physician Decision|0|||
157055327|NCT05216835|566954201|FG001|Overall Study|Physician Decision|0|||
157055328|NCT05216835|566954202|FG002|Overall Study|Physician Decision|0|||
157055329|NCT05216835|566954203|FG003|Overall Study|Physician Decision|0|||
157055330|NCT05216835|566954204|FG004|Overall Study|Physician Decision|0|||
157055331|NCT05216835|566954205|FG005|Overall Study|Physician Decision|1|||
157055332|NCT05216835|566954206|FG006|Overall Study|Physician Decision|1|||
157055333|NCT05216835|566954207|FG007|Overall Study|Physician Decision|0|||
157055334|NCT05216835|566954200|FG000|Overall Study|Study terminated by Sponsor|0|||
157055335|NCT05216835|566954201|FG001|Overall Study|Study terminated by Sponsor|0|||
157055336|NCT05216835|566954202|FG002|Overall Study|Study terminated by Sponsor|0|||
157055337|NCT05216835|566954203|FG003|Overall Study|Study terminated by Sponsor|0|||
157055338|NCT05216835|566954204|FG004|Overall Study|Study terminated by Sponsor|0|||
157055339|NCT05216835|566954205|FG005|Overall Study|Study terminated by Sponsor|0|||
157055340|NCT05216835|566954206|FG006|Overall Study|Study terminated by Sponsor|0|||
157055341|NCT05216835|566954207|FG007|Overall Study|Study terminated by Sponsor|1|||
157055342|NCT05216835|566954200|FG000|Overall Study|Withdrawal by Subject|1|||
157055343|NCT05216835|566954201|FG001|Overall Study|Withdrawal by Subject|0|||
157055344|NCT05216835|566954202|FG002|Overall Study|Withdrawal by Subject|1|||
157055345|NCT05216835|566954203|FG003|Overall Study|Withdrawal by Subject|0|||
157055346|NCT05216835|566954204|FG004|Overall Study|Withdrawal by Subject|1|||
157055347|NCT05216835|566954205|FG005|Overall Study|Withdrawal by Subject|0|||
157055348|NCT05216835|566954206|FG006|Overall Study|Withdrawal by Subject|0|||
157055349|NCT05216835|566954207|FG007|Overall Study|Withdrawal by Subject|1|||
157055350|NCT05216835|566954200|FG000|Overall Study|Other|0|||
157055351|NCT05216835|566954201|FG001|Overall Study|Other|1|||
157055352|NCT05216835|566954202|FG002|Overall Study|Other|0|||
157055353|NCT05216835|566954203|FG003|Overall Study|Other|0|||
157055354|NCT05216835|566954204|FG004|Overall Study|Other|0|||
157055355|NCT05216835|566954205|FG005|Overall Study|Other|0|||
157055356|NCT05216835|566954206|FG006|Overall Study|Other|0|||
157055357|NCT05216835|566954207|FG007|Overall Study|Other|0|||
157055358|NCT00617708|566954208|FG000|Overall Study|Adverse Event|0|||
157055359|NCT00617708|566954209|FG001|Overall Study|Adverse Event|6|||
157055360|NCT00617708|566954210|FG002|Overall Study|Adverse Event|9|||
157055361|NCT00617708|566954208|FG000|Overall Study|Withdrawal by Subject|1|||
157055362|NCT00617708|566954209|FG001|Overall Study|Withdrawal by Subject|1|||
157055363|NCT00617708|566954210|FG002|Overall Study|Withdrawal by Subject|7|||
157055364|NCT00617708|566954208|FG000|Overall Study|Death|0|||
157055365|NCT00617708|566954209|FG001|Overall Study|Death|6|||
157055366|NCT00617708|566954210|FG002|Overall Study|Death|5|||
157055367|NCT00617708|566954208|FG000|Overall Study|Progression/Relapse|7|||
157178850|NCT00517413|567398000|FG000|Overall Study|Other-Reasons|23|||
157055368|NCT00617708|566954209|FG001|Overall Study|Progression/Relapse|40|||
157055369|NCT00617708|566954210|FG002|Overall Study|Progression/Relapse|36|||
157055370|NCT00617708|566954208|FG000|Overall Study|Not protocol specified|1|||
157055371|NCT00617708|566954209|FG001|Overall Study|Not protocol specified|4|||
157055372|NCT00617708|566954210|FG002|Overall Study|Not protocol specified|2|||
157055373|NCT00617708|566954208|FG000|Overall Study|Not eligible|1|||
157055374|NCT00617708|566954209|FG001|Overall Study|Not eligible|3|||
157055375|NCT00617708|566954210|FG002|Overall Study|Not eligible|5|||
157055376|NCT01075815|566954211|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
157055377|NCT01075815|566954212|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
157055378|NCT01075815|566954211|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
157055379|NCT01075815|566954212|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
157055380|NCT01075815|566954211|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
157055381|NCT01075815|566954212|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
157055382|NCT02058992|566954213|FG000|Overall Study|Lost to Follow-up|4|||
157055383|NCT02058992|566954213|FG000|Overall Study|Protocol Violation|92|||
157055384|NCT02058992|566954213|FG000|Overall Study|CRF Uncollected|20|||
157055385|NCT02991456|566954214|FG000|Overall Study|Adverse Event|2|||
157055386|NCT02991456|566954215|FG001|Overall Study|Adverse Event|0|||
157055387|NCT02991456|566954214|FG000|Overall Study|Lost to Follow-up|0|||
157055388|NCT02991456|566954215|FG001|Overall Study|Lost to Follow-up|2|||
157055389|NCT02991456|566954214|FG000|Overall Study|Withdrawal by Subject|1|||
157055390|NCT02991456|566954215|FG001|Overall Study|Withdrawal by Subject|0|||
157055391|NCT03747575|566954216|FG000|Overall Study|Withdrawal by Subject|6|||
157055392|NCT03747575|566954217|FG001|Overall Study|Withdrawal by Subject|3|||
157055393|NCT03747575|566954216|FG000|Overall Study|Lost to Follow-up|3|||
157055394|NCT03747575|566954217|FG001|Overall Study|Lost to Follow-up|3|||
157055395|NCT03747575|566954216|FG000|Overall Study|Adverse Event|0|||
157055396|NCT03747575|566954217|FG001|Overall Study|Adverse Event|1|||
157055397|NCT00705614|566955506|FG000|Initial Intervention|Adverse Event|40|||
157055398|NCT00705614|566955507|FG001|Initial Intervention|Adverse Event|21|||
157055399|NCT00705614|566955506|FG000|Initial Intervention|Lost to Follow-up|310|||
157055400|NCT00705614|566955507|FG001|Initial Intervention|Lost to Follow-up|191|||
157055401|NCT00705614|566955506|FG000|Initial Intervention|Withdrawal by Subject|114|||
157055402|NCT00705614|566955507|FG001|Initial Intervention|Withdrawal by Subject|71|||
157055403|NCT00705614|566955506|FG000|Initial Intervention|Administrative Reason|51|||
157055404|NCT00705614|566955507|FG001|Initial Intervention|Administrative Reason|38|||
157055405|NCT00705614|566955506|FG000|Initial Intervention|Status completion unknown|3|||
157055406|NCT00705614|566955507|FG001|Initial Intervention|Status completion unknown|0|||
157055407|NCT00705614|566955506|FG000|Switch to Remicade|Adverse Event|0|||
157055408|NCT00705614|566955507|FG001|Switch to Remicade|Adverse Event|5|||
157055409|NCT00705614|566955506|FG000|Switch to Remicade|Lost to Follow-up|0|||
157055410|NCT00705614|566955507|FG001|Switch to Remicade|Lost to Follow-up|23|||
157055411|NCT00705614|566955506|FG000|Switch to Remicade|Withdrawal by Subject|0|||
157055412|NCT00705614|566955507|FG001|Switch to Remicade|Withdrawal by Subject|12|||
157055413|NCT00705614|566955506|FG000|Switch to Remicade|Administrative Reason|0|||
157055414|NCT00705614|566955507|FG001|Switch to Remicade|Administrative Reason|9|||
157055415|NCT00088452|566955511|FG000|Overall Study|Did not receive intervention|1|||
157055416|NCT00088452|566955512|FG001|Overall Study|Did not receive intervention|0|||
157055417|NCT00088452|566955513|FG002|Overall Study|Did not receive intervention|1|||
157055418|NCT01184859|566955514|FG000|Period 1: Single Dose|Insufficient urine production|0|||
157055419|NCT01184859|566955515|FG001|Period 1: Single Dose|Insufficient urine production|1|||
157055420|NCT01184859|566955516|FG002|Period 1: Single Dose|Insufficient urine production|0|||
157055421|NCT01184859|566955517|FG003|Period 1: Single Dose|Insufficient urine production|0|||
157055422|NCT01184859|566955518|FG004|Period 1: Single Dose|Insufficient urine production|0|||
157229625|NCT01682083|567586527|FG000|Overall Study|Withdrawal by Subject|31|||
157229626|NCT01682083|567586528|FG001|Overall Study|Withdrawal by Subject|40|||
157055423|NCT01184859|566955514|FG000|Period 1: Single Dose|Protocol Violation|0|||
157055424|NCT01184859|566955515|FG001|Period 1: Single Dose|Protocol Violation|1|||
157055425|NCT01184859|566955516|FG002|Period 1: Single Dose|Protocol Violation|0|||
157055426|NCT01184859|566955517|FG003|Period 1: Single Dose|Protocol Violation|0|||
157055427|NCT01184859|566955518|FG004|Period 1: Single Dose|Protocol Violation|0|||
157055428|NCT01184859|566955514|FG000|Period 1: Single Dose|Adverse Event|0|||
157055429|NCT01184859|566955515|FG001|Period 1: Single Dose|Adverse Event|0|||
157055430|NCT01184859|566955516|FG002|Period 1: Single Dose|Adverse Event|0|||
157055431|NCT01184859|566955517|FG003|Period 1: Single Dose|Adverse Event|0|||
157055432|NCT01184859|566955518|FG004|Period 1: Single Dose|Adverse Event|1|||
157055433|NCT01184859|566955514|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
157055434|NCT01184859|566955515|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
157055435|NCT01184859|566955516|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
157055436|NCT01184859|566955517|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
157055437|NCT01184859|566955518|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
157229627|NCT01682083|567586527|FG000|Overall Study|Death|60|||
157229628|NCT01682083|567586528|FG001|Overall Study|Death|93|||
157055438|NCT01184859|566955514|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
157055439|NCT01184859|566955515|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
157055440|NCT01184859|566955516|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
157055441|NCT01184859|566955517|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
157055442|NCT01184859|566955518|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
157055443|NCT02081196|566955520|FG000|Overall Study|Lost to Follow-up|1|||
157055444|NCT05335005|566955526|FG000|Overall Study|Lost to Follow-up|1|||
157055445|NCT01636258|566955532|FG000|Overall Study|Lost to Follow-up|1|||
157055446|NCT01636258|566955533|FG001|Overall Study|Lost to Follow-up|0|||
157055447|NCT02798861|566955536|FG000|Overall Study|Lost to Follow-up|22|||
157055448|NCT02798861|566955536|FG000|Overall Study|Withdrawal by Subject|1|||
157055449|NCT00730925|566955546|FG000|Overall Study|Progressive Disease|21|||
157055450|NCT00730925|566955546|FG000|Overall Study|Dose reducing Event|2|||
157055451|NCT00730925|566955546|FG000|Overall Study|Other Averse Event|7|||
157055452|NCT00730925|566955546|FG000|Overall Study|Protocol Violation|1|||
157055453|NCT00730925|566955546|FG000|Overall Study|Withdrawal by Subject|1|||
157055454|NCT00730925|566955546|FG000|Overall Study|Switch to combination therapy|8|||
157055455|NCT00730925|566955546|FG000|Overall Study|Other|1|||
157055456|NCT02137239|566955547|FG000|Overall Study|Discontinued Study Treatment|0|||
157055457|NCT02137239|566955548|FG001|Overall Study|Discontinued Study Treatment|3|||
157055458|NCT02137239|566955547|FG000|Overall Study|Withdrew Consent|1|||
157055459|NCT02137239|566955548|FG001|Overall Study|Withdrew Consent|1|||
157055460|NCT02137239|566955547|FG000|Overall Study|Adverse Event|2|||
157055461|NCT02137239|566955548|FG001|Overall Study|Adverse Event|2|||
157055462|NCT04057937|566955549|FG000|Placebo-controlled Phase|Adverse Event|3|||
157055463|NCT04057937|566955550|FG001|Placebo-controlled Phase|Adverse Event|0|||
157055464|NCT04057937|566955549|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
157055465|NCT04057937|566955550|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
157055466|NCT04057937|566955549|FG000|Active-treatment Phase|Pregnancy|0|||
157055467|NCT04057937|566955550|FG001|Active-treatment Phase|Pregnancy|1|||
157055468|NCT04057937|566955549|FG000|Active-treatment Phase|Physician Decision|0|||
157055469|NCT04057937|566955550|FG001|Active-treatment Phase|Physician Decision|1|||
157055470|NCT02446912|566955551|FG000|Overall Study|Adverse Event|3|||
157055471|NCT02446912|566955552|FG001|Overall Study|Adverse Event|13|||
157055472|NCT02446912|566955553|FG002|Overall Study|Adverse Event|5|||
157055473|NCT02446912|566955551|FG000|Overall Study|Condition under investigation worsened|0|||
157055474|NCT02446912|566955552|FG001|Overall Study|Condition under investigation worsened|1|||
157055475|NCT02446912|566955553|FG002|Overall Study|Condition under investigation worsened|1|||
157055476|NCT02446912|566955551|FG000|Overall Study|Study-specific withdrawal criteria|1|||
157055477|NCT02446912|566955552|FG001|Overall Study|Study-specific withdrawal criteria|0|||
157055478|NCT02446912|566955553|FG002|Overall Study|Study-specific withdrawal criteria|0|||
157055479|NCT02446912|566955551|FG000|Overall Study|Lack of Efficacy|1|||
157055480|NCT02446912|566955552|FG001|Overall Study|Lack of Efficacy|4|||
157055481|NCT02446912|566955553|FG002|Overall Study|Lack of Efficacy|7|||
157055482|NCT02446912|566955551|FG000|Overall Study|Lost to Follow-up|0|||
157055483|NCT02446912|566955552|FG001|Overall Study|Lost to Follow-up|0|||
157055484|NCT02446912|566955553|FG002|Overall Study|Lost to Follow-up|2|||
157055485|NCT02446912|566955551|FG000|Overall Study|Severe non-compliance to protocol|1|||
157055486|NCT02446912|566955552|FG001|Overall Study|Severe non-compliance to protocol|0|||
157055487|NCT02446912|566955553|FG002|Overall Study|Severe non-compliance to protocol|1|||
157055488|NCT02446912|566955551|FG000|Overall Study|Withdrawal by Subject|10|||
157055489|NCT02446912|566955552|FG001|Overall Study|Withdrawal by Subject|15|||
157055490|NCT02446912|566955553|FG002|Overall Study|Withdrawal by Subject|15|||
157055491|NCT02446912|566955551|FG000|Overall Study|Miscellaneous|2|||
157055492|NCT02446912|566955552|FG001|Overall Study|Miscellaneous|2|||
157055493|NCT02446912|566955553|FG002|Overall Study|Miscellaneous|4|||
157055494|NCT01757171|566955556|FG000|Overall Study|Adverse Event|5|||
157055495|NCT01757171|566955557|FG001|Overall Study|Adverse Event|1|||
157055496|NCT01757171|566955556|FG000|Overall Study|Disease Progression|1|||
157055497|NCT01757171|566955557|FG001|Overall Study|Disease Progression|0|||
157055498|NCT01757171|566955556|FG000|Overall Study|Hospitalization|1|||
157055499|NCT01757171|566955557|FG001|Overall Study|Hospitalization|0|||
157055500|NCT01757171|566955556|FG000|Overall Study|ECOG decline|1|||
157055501|NCT01757171|566955557|FG001|Overall Study|ECOG decline|0|||
157055502|NCT00385697|566955562|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
157055503|NCT00385697|566955563|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
157055504|NCT00385697|566955564|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
157055505|NCT00385697|566955565|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
157055506|NCT00385697|566955566|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
157055507|NCT00385697|566955562|FG000|Open-label Segment 1|Lost to Follow-up|1|||
157055508|NCT00385697|566955563|FG001|Open-label Segment 1|Lost to Follow-up|0|||
157055509|NCT00385697|566955564|FG002|Open-label Segment 1|Lost to Follow-up|0|||
157178851|NCT03938636|567398001|FG000|Overall Study|Protocol Violation|0|||
157055510|NCT00385697|566955565|FG003|Open-label Segment 1|Lost to Follow-up|0|||
157055511|NCT00385697|566955566|FG004|Open-label Segment 1|Lost to Follow-up|0|||
157055512|NCT00385697|566955562|FG000|Double-blind Segment 2|Adverse Event|0|||
157055513|NCT00385697|566955563|FG001|Double-blind Segment 2|Adverse Event|3|||
157055514|NCT00385697|566955564|FG002|Double-blind Segment 2|Adverse Event|1|||
157055515|NCT00385697|566955565|FG003|Double-blind Segment 2|Adverse Event|0|||
157055516|NCT00385697|566955566|FG004|Double-blind Segment 2|Adverse Event|0|||
157055517|NCT00385697|566955562|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
157055518|NCT00385697|566955563|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
157055519|NCT00385697|566955564|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
157055520|NCT00385697|566955565|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
157055521|NCT00385697|566955566|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
157055522|NCT00385697|566955562|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
157055523|NCT00385697|566955563|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
157055524|NCT00385697|566955564|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
157055525|NCT00385697|566955565|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
157055526|NCT00385697|566955566|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
157055527|NCT00385697|566955562|FG000|Double-blind Segment 2|Other|0|||
157055528|NCT00385697|566955563|FG001|Double-blind Segment 2|Other|2|||
157055529|NCT00385697|566955564|FG002|Double-blind Segment 2|Other|0|||
157055530|NCT00385697|566955565|FG003|Double-blind Segment 2|Other|0|||
157055531|NCT00385697|566955566|FG004|Double-blind Segment 2|Other|0|||
157055532|NCT03906240|566955569|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
157055533|NCT03906240|566955570|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
157055534|NCT03906240|566955569|FG000|Overall Study|Lost to Follow-up|1|||
157055535|NCT03906240|566955570|FG001|Overall Study|Lost to Follow-up|0|||
157055536|NCT03906240|566955569|FG000|Overall Study|Withdrawal by Subject|0|||
157055537|NCT03906240|566955570|FG001|Overall Study|Withdrawal by Subject|1|||
157055538|NCT01426217|566955571|FG000|Overall Study|lost sample|8|||
157055539|NCT01426217|566955572|FG001|Overall Study|lost sample|14|||
157055540|NCT02267746|566955573|FG000|Overall Study|Adverse Event|0|||
157055541|NCT02267746|566955574|FG001|Overall Study|Adverse Event|2|||
157055542|NCT02267746|566955575|FG002|Overall Study|Adverse Event|1|||
157055543|NCT02267746|566955573|FG000|Overall Study|Protocol Violation|8|||
157055544|NCT02267746|566955574|FG001|Overall Study|Protocol Violation|7|||
157055545|NCT02267746|566955575|FG002|Overall Study|Protocol Violation|3|||
157055546|NCT02267746|566955573|FG000|Overall Study|Lack of Efficacy|11|||
157055547|NCT02267746|566955574|FG001|Overall Study|Lack of Efficacy|11|||
157055548|NCT02267746|566955575|FG002|Overall Study|Lack of Efficacy|15|||
157055549|NCT02267746|566955573|FG000|Overall Study|Protocol Violation|1|||
157055550|NCT02267746|566955574|FG001|Overall Study|Protocol Violation|2|||
157055551|NCT02267746|566955575|FG002|Overall Study|Protocol Violation|1|||
157055552|NCT02267746|566955573|FG000|Overall Study|Miscellaneous|1|||
157055553|NCT02267746|566955574|FG001|Overall Study|Miscellaneous|0|||
157055554|NCT02267746|566955575|FG002|Overall Study|Miscellaneous|1|||
157055555|NCT02924051|566955581|FG000|Overall Study|Withdrawal by Subject|1|||
157055556|NCT02924051|566955582|FG001|Overall Study|Withdrawal by Subject|9|||
157055557|NCT02130401|566955587|FG000|Overall Study|Poor enrollment|6|||
157055558|NCT00936065|566955588|FG000|Overall Study|Adverse Event|1|||
157055559|NCT00936065|566955589|FG001|Overall Study|Adverse Event|0|||
157055560|NCT00936065|566955590|FG002|Overall Study|Adverse Event|1|||
157055561|NCT00936065|566955588|FG000|Overall Study|Lack of Efficacy|1|||
157055562|NCT00936065|566955589|FG001|Overall Study|Lack of Efficacy|0|||
157055563|NCT00936065|566955590|FG002|Overall Study|Lack of Efficacy|1|||
157055564|NCT00936065|566955588|FG000|Overall Study|Lost to Follow-up|1|||
157055565|NCT00936065|566955589|FG001|Overall Study|Lost to Follow-up|0|||
157055566|NCT00936065|566955590|FG002|Overall Study|Lost to Follow-up|0|||
157055567|NCT00936065|566955588|FG000|Overall Study|Protocol Violation|1|||
157055568|NCT00936065|566955589|FG001|Overall Study|Protocol Violation|2|||
157055569|NCT00936065|566955590|FG002|Overall Study|Protocol Violation|1|||
157055570|NCT00936065|566955588|FG000|Overall Study|Withdrawal by Subject|0|||
157055571|NCT00936065|566955589|FG001|Overall Study|Withdrawal by Subject|2|||
157055572|NCT00936065|566955590|FG002|Overall Study|Withdrawal by Subject|4|||
157055573|NCT01549951|566955593|FG000|Overall Study|Adverse Event|15|||
157055574|NCT01549951|566955593|FG000|Overall Study|Withdrawal by Subject|2|||
157055575|NCT01549951|566955593|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
157229629|NCT01682083|567586527|FG000|Overall Study|Physician Decision|5|||
157229630|NCT01682083|567586528|FG001|Overall Study|Physician Decision|4|||
157229631|NCT02731157|567586533|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
157229632|NCT00497796|567586536|FG000|Overall Study|Adverse event (not related)|9|||
157055576|NCT01549951|566955593|FG000|Overall Study|Progressive disease|29|||
157055577|NCT01549951|566955593|FG000|Overall Study|Symptomatic deterioration|1|||
157055578|NCT01549951|566955593|FG000|Overall Study|Other|2|||
157055579|NCT00990314|566955596|FG000|Overall Study|Death|2|||
157055580|NCT00990314|566955596|FG000|Overall Study|Adverse Event|2|||
157055581|NCT00990314|566955596|FG000|Overall Study|Withdrawal by Subject|3|||
157055582|NCT00990314|566955596|FG000|Overall Study|Non-Compliance|1|||
157055583|NCT00990314|566955596|FG000|Overall Study|Physician Decision|3|||
157055584|NCT00990314|566955596|FG000|Overall Study|Lack of Efficacy|1|||
157055585|NCT03689452|566955597|FG000|Overall Study|Lost to Follow-up|1|||
157055586|NCT03689452|566955598|FG001|Overall Study|Lost to Follow-up|1|||
157055587|NCT02676778|566955599|FG000|Overall Study|Disease Progression|7|||
157055588|NCT02676778|566955600|FG001|Overall Study|Disease Progression|3|||
157055589|NCT02676778|566955601|FG002|Overall Study|Disease Progression|1|||
157055590|NCT02676778|566955599|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
157055591|NCT02676778|566955600|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
157055592|NCT02676778|566955601|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
157055593|NCT02676778|566955599|FG000|Overall Study|Withdrawal by Subject|3|||
157055594|NCT02676778|566955600|FG001|Overall Study|Withdrawal by Subject|2|||
157055595|NCT02676778|566955601|FG002|Overall Study|Withdrawal by Subject|0|||
157055596|NCT02676778|566955599|FG000|Overall Study|Other|4|||
157055597|NCT02676778|566955600|FG001|Overall Study|Other|3|||
157055598|NCT02676778|566955601|FG002|Overall Study|Other|0|||
157055599|NCT02676778|566955599|FG000|Overall Study|Adverse Event|2|||
157055600|NCT02676778|566955600|FG001|Overall Study|Adverse Event|3|||
157055601|NCT02676778|566955601|FG002|Overall Study|Adverse Event|0|||
157055602|NCT03686176|566955608|FG000|Overall Study|Procedure cancelled|1|||
157055603|NCT03686176|566955609|FG001|Overall Study|Procedure cancelled|0|||
157055604|NCT03686176|566955610|FG002|Overall Study|Procedure cancelled|0|||
157055605|NCT03686176|566955608|FG000|Overall Study|VR Malfunction|1|||
157055606|NCT03686176|566955609|FG001|Overall Study|VR Malfunction|0|||
157055607|NCT03686176|566955610|FG002|Overall Study|VR Malfunction|0|||
157055608|NCT02819141|566955615|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
157055609|NCT02819141|566955616|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
157055610|NCT01232569|566957365|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
157055611|NCT01232569|566957366|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
157055612|NCT01232569|566957367|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157055613|NCT01232569|566957368|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
157055614|NCT01232569|566957365|FG000|Double-blind Treatment Period|Escape|2|||
157055615|NCT01232569|566957366|FG001|Double-blind Treatment Period|Escape|2|||
157055616|NCT01232569|566957367|FG002|Double-blind Treatment Period|Escape|0|||
157055617|NCT01232569|566957368|FG003|Double-blind Treatment Period|Escape|0|||
157055618|NCT01232569|566957365|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
157055619|NCT01232569|566957366|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
157055620|NCT01232569|566957367|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
157055621|NCT01232569|566957368|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
157055622|NCT01232569|566957365|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
157055623|NCT01232569|566957366|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
157055624|NCT01232569|566957367|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
157055625|NCT01232569|566957368|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
156975309|NCT03287414|566663592|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
156975310|NCT03287414|566663593|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
156975311|NCT03287414|566663592|FG000|Treatment Epoch|Withdrawal by Subject|1|||
156975312|NCT03287414|566663593|FG001|Treatment Epoch|Withdrawal by Subject|0|||
156975313|NCT03287414|566663592|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
156975314|NCT03287414|566663593|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
156975315|NCT03287414|566663592|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
156975316|NCT03287414|566663593|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
156975317|NCT02613221|566663596|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
156975318|NCT02613221|566663596|FG000|Overall Study|Adverse Event|2|||
156975319|NCT02613221|566663596|FG000|Overall Study|Voluntary Discontinuation|1|||
156975320|NCT02613221|566663596|FG000|Overall Study|Delayed Treatment|1|||
156975321|NCT02613221|566663596|FG000|Overall Study|Enrolled but Not Treated|1|||
156975322|NCT01301274|566663597|FG000|Overall Study|Physician Decision|2|||
156975323|NCT01301274|566663598|FG001|Overall Study|Physician Decision|1|||
156975324|NCT01893827|566663599|FG000|Overall Study|Lost to Follow-up|19|||
156975325|NCT01893827|566663600|FG001|Overall Study|Lost to Follow-up|26|||
156975326|NCT02917941|566663601|FG000|Treatment Period|Adverse Event|11|||
156975327|NCT02917941|566663601|FG000|Treatment Period|Progressive Disease|11|||
156975328|NCT02917941|566663601|FG000|Treatment Period|Reason not Specified|2|||
156975329|NCT02917941|566663601|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
156975330|NCT02917941|566663601|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
156975331|NCT01833143|566663603|FG000|Overall Study|Not Treated|1|||
156975332|NCT03021668|566663604|FG000|Overall Study|Physician Decision|0|||
156975333|NCT03021668|566663605|FG001|Overall Study|Physician Decision|1|||
156975334|NCT01786330|566663606|FG000|Overall Study|Withdrawal by Subject|0|||
157055626|NCT01232569|566957365|FG000|Double-blind Treatment Period|Physician Decision|1|||
157055627|NCT01232569|566957366|FG001|Double-blind Treatment Period|Physician Decision|0|||
157055628|NCT01232569|566957367|FG002|Double-blind Treatment Period|Physician Decision|0|||
157055629|NCT01232569|566957368|FG003|Double-blind Treatment Period|Physician Decision|0|||
156975335|NCT01786330|566663607|FG001|Overall Study|Withdrawal by Subject|1|||
157055630|NCT01232569|566957365|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
157055631|NCT01232569|566957366|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
157055632|NCT01232569|566957367|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
157055633|NCT01232569|566957368|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
157055634|NCT01232569|566957365|FG000|Double-blind Treatment Period|Death|2|||
157055635|NCT01232569|566957366|FG001|Double-blind Treatment Period|Death|0|||
157055636|NCT01232569|566957367|FG002|Double-blind Treatment Period|Death|0|||
157055637|NCT01232569|566957368|FG003|Double-blind Treatment Period|Death|0|||
157055638|NCT04044352|566957369|FG000|Overall Study|Lost to Follow-up|9|||
157055639|NCT04044352|566957369|FG000|Overall Study|Withdrawal by Subject|2|||
157055640|NCT02176356|566957375|FG000|Overall Study|Screen Failure|14|||
157055641|NCT02176356|566957375|FG000|Overall Study|Lost to Follow-up|4|||
157055642|NCT02176356|566957375|FG000|Overall Study|Personal Reasons|3|||
157055643|NCT02176356|566957375|FG000|Overall Study|Other Miscellaneous Reasons|2|||
157055644|NCT00958711|566957377|FG000|Overall Study|Withdrawal by Subject|0|||
157055645|NCT00958711|566957378|FG001|Overall Study|Withdrawal by Subject|4|||
157055646|NCT00958711|566957377|FG000|Overall Study|Physician Decision|5|||
157055647|NCT00958711|566957378|FG001|Overall Study|Physician Decision|7|||
157055648|NCT00958711|566957377|FG000|Overall Study|Lost to Follow-up|4|||
157055649|NCT00958711|566957378|FG001|Overall Study|Lost to Follow-up|1|||
157055650|NCT00958711|566957377|FG000|Overall Study|Other|2|||
157055651|NCT00958711|566957378|FG001|Overall Study|Other|5|||
157055652|NCT00958711|566957377|FG000|Overall Study|Death|1|||
157055653|NCT00958711|566957378|FG001|Overall Study|Death|2|||
157055654|NCT00958711|566957377|FG000|Overall Study|Adverse Event|1|||
157055655|NCT00958711|566957378|FG001|Overall Study|Adverse Event|2|||
157055656|NCT03722485|566957379|FG000|Overall Study|Withdrawal by Subject|1|||
157055657|NCT03722485|566957380|FG001|Overall Study|Withdrawal by Subject|0|||
157055658|NCT03722485|566957379|FG000|Overall Study|Adverse Event|0|||
157055659|NCT03722485|566957380|FG001|Overall Study|Adverse Event|2|||
157055660|NCT03722485|566957379|FG000|Overall Study|subject discharged prior to study completion|1|||
157055661|NCT03722485|566957380|FG001|Overall Study|subject discharged prior to study completion|5|||
157055662|NCT03722485|566957379|FG000|Overall Study|eligibility criteria not met|2|||
157055663|NCT03722485|566957380|FG001|Overall Study|eligibility criteria not met|0|||
157055664|NCT02151643|566957383|FG000|Overall Study|Adverse Event|2|||
157055665|NCT02151643|566957384|FG001|Overall Study|Adverse Event|0|||
157055666|NCT02151643|566957385|FG002|Overall Study|Adverse Event|1|||
157055667|NCT02151643|566957386|FG003|Overall Study|Adverse Event|4|||
157178852|NCT03938636|567398002|FG001|Overall Study|Protocol Violation|1|||
156975336|NCT01786330|566663606|FG000|Overall Study|Lost to Follow-up|0|||
156975337|NCT01786330|566663607|FG001|Overall Study|Lost to Follow-up|1|||
156975338|NCT01786330|566663606|FG000|Overall Study|Excluded intraoperatively|0|||
156975339|NCT01786330|566663607|FG001|Overall Study|Excluded intraoperatively|1|||
156975340|NCT01786330|566663606|FG000|Overall Study|Protocol Violation|1|||
156975341|NCT01786330|566663607|FG001|Overall Study|Protocol Violation|0|||
156975342|NCT03722264|566665455|FG000|Overall Study|Physician Decision|3|||
156975343|NCT01486758|566665456|FG000|Overall Study|Lost to Follow-up|0|||
156975344|NCT01486758|566665457|FG001|Overall Study|Lost to Follow-up|1|||
156975345|NCT01062763|566665458|FG000|Overall Study|Adverse Event|3|||
156975346|NCT01062763|566665459|FG001|Overall Study|Adverse Event|4|||
156975347|NCT02494921|566665460|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
156975348|NCT02494921|566665461|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
156975349|NCT02494921|566665462|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
156975350|NCT02494921|566665463|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
156975351|NCT02494921|566665464|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
156975352|NCT02494921|566665460|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
156975353|NCT02494921|566665461|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
156975354|NCT02494921|566665462|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
156975355|NCT02494921|566665463|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
156975356|NCT02494921|566665464|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
156975357|NCT02494921|566665460|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
156975358|NCT02494921|566665461|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
156975359|NCT02494921|566665462|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
156975360|NCT02494921|566665463|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
156975361|NCT02494921|566665464|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
156975362|NCT02392611|566665465|FG000|Overall Study|Adverse Event|0|||
156975363|NCT02392611|566665466|FG001|Overall Study|Adverse Event|0|||
157055668|NCT02151643|566957387|FG004|Overall Study|Adverse Event|0|||
156975364|NCT02392611|566665467|FG002|Overall Study|Adverse Event|0|||
156975365|NCT02392611|566665468|FG003|Overall Study|Adverse Event|1|||
156975366|NCT02392611|566665469|FG004|Overall Study|Adverse Event|0|||
156975367|NCT02392611|566665470|FG005|Overall Study|Adverse Event|0|||
157055669|NCT02151643|566957383|FG000|Overall Study|Withdrawal by Subject|0|||
157055670|NCT02151643|566957384|FG001|Overall Study|Withdrawal by Subject|1|||
157055671|NCT02151643|566957385|FG002|Overall Study|Withdrawal by Subject|1|||
156975368|NCT02392611|566665471|FG006|Overall Study|Adverse Event|0|||
156975369|NCT02392611|566665472|FG007|Overall Study|Adverse Event|0|||
157055672|NCT02151643|566957386|FG003|Overall Study|Withdrawal by Subject|1|||
157055673|NCT02151643|566957387|FG004|Overall Study|Withdrawal by Subject|1|||
156975370|NCT02392611|566665473|FG008|Overall Study|Adverse Event|0|||
156975371|NCT02392611|566665465|FG000|Overall Study|Progressive disease|0|||
156975372|NCT02392611|566665466|FG001|Overall Study|Progressive disease|0|||
156975373|NCT02392611|566665467|FG002|Overall Study|Progressive disease|0|||
156975374|NCT02392611|566665468|FG003|Overall Study|Progressive disease|2|||
156975375|NCT02392611|566665469|FG004|Overall Study|Progressive disease|1|||
156975376|NCT02392611|566665470|FG005|Overall Study|Progressive disease|0|||
156975377|NCT02392611|566665471|FG006|Overall Study|Progressive disease|0|||
156975378|NCT02392611|566665472|FG007|Overall Study|Progressive disease|0|||
156975379|NCT02392611|566665473|FG008|Overall Study|Progressive disease|0|||
156975380|NCT02392611|566665465|FG000|Overall Study|Death|1|||
156975381|NCT02392611|566665466|FG001|Overall Study|Death|0|||
156975382|NCT02392611|566665467|FG002|Overall Study|Death|0|||
156975383|NCT02392611|566665468|FG003|Overall Study|Death|0|||
156975384|NCT02392611|566665469|FG004|Overall Study|Death|0|||
156975385|NCT02392611|566665470|FG005|Overall Study|Death|1|||
156975386|NCT02392611|566665471|FG006|Overall Study|Death|0|||
156975387|NCT02392611|566665472|FG007|Overall Study|Death|0|||
156975388|NCT02392611|566665473|FG008|Overall Study|Death|0|||
156975389|NCT02392611|566665465|FG000|Overall Study|Withdrawal by Subject|0|||
156975390|NCT02392611|566665466|FG001|Overall Study|Withdrawal by Subject|0|||
156975391|NCT02392611|566665467|FG002|Overall Study|Withdrawal by Subject|0|||
156975392|NCT02392611|566665468|FG003|Overall Study|Withdrawal by Subject|1|||
156975393|NCT02392611|566665469|FG004|Overall Study|Withdrawal by Subject|0|||
156975394|NCT02392611|566665470|FG005|Overall Study|Withdrawal by Subject|0|||
156975395|NCT02392611|566665471|FG006|Overall Study|Withdrawal by Subject|0|||
156975396|NCT02392611|566665472|FG007|Overall Study|Withdrawal by Subject|0|||
156975397|NCT02392611|566665473|FG008|Overall Study|Withdrawal by Subject|0|||
156975398|NCT02392611|566665465|FG000|Overall Study|Lost to Follow-up|0|||
156975399|NCT02392611|566665466|FG001|Overall Study|Lost to Follow-up|0|||
156975400|NCT02392611|566665467|FG002|Overall Study|Lost to Follow-up|0|||
156975401|NCT02392611|566665468|FG003|Overall Study|Lost to Follow-up|0|||
156975402|NCT02392611|566665469|FG004|Overall Study|Lost to Follow-up|0|||
156975403|NCT02392611|566665470|FG005|Overall Study|Lost to Follow-up|0|||
156975404|NCT02392611|566665471|FG006|Overall Study|Lost to Follow-up|1|||
156975405|NCT02392611|566665472|FG007|Overall Study|Lost to Follow-up|0|||
156975406|NCT02392611|566665473|FG008|Overall Study|Lost to Follow-up|0|||
156975407|NCT02392611|566665465|FG000|Overall Study|Enrolled, not treated|0|||
156975408|NCT02392611|566665466|FG001|Overall Study|Enrolled, not treated|0|||
156975409|NCT02392611|566665467|FG002|Overall Study|Enrolled, not treated|0|||
156975410|NCT02392611|566665468|FG003|Overall Study|Enrolled, not treated|2|||
156975411|NCT02392611|566665469|FG004|Overall Study|Enrolled, not treated|0|||
156975412|NCT02392611|566665470|FG005|Overall Study|Enrolled, not treated|0|||
156975413|NCT02392611|566665471|FG006|Overall Study|Enrolled, not treated|0|||
156975414|NCT02392611|566665472|FG007|Overall Study|Enrolled, not treated|0|||
156975415|NCT02392611|566665473|FG008|Overall Study|Enrolled, not treated|0|||
156975416|NCT03239873|566665477|FG000|Overall Study|Lost to Follow-up|15|||
156975417|NCT03239873|566665478|FG001|Overall Study|Lost to Follow-up|16|||
156975418|NCT03239873|566665477|FG000|Overall Study|Physician Decision|1|||
156975419|NCT03239873|566665478|FG001|Overall Study|Physician Decision|0|||
156975420|NCT03239873|566665477|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
156975421|NCT03239873|566665478|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
156975422|NCT03239873|566665477|FG000|Overall Study|Withdrawal by Subject|2|||
156975423|NCT03239873|566665478|FG001|Overall Study|Withdrawal by Subject|0|||
156975424|NCT03239873|566665477|FG000|Overall Study|Contraindication to study medication|1|||
156975425|NCT03239873|566665478|FG001|Overall Study|Contraindication to study medication|0|||
156975426|NCT03239873|566665477|FG000|Overall Study|Protocol Violation|1|||
156975427|NCT03239873|566665478|FG001|Overall Study|Protocol Violation|0|||
156975428|NCT00768430|566665481|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
156975429|NCT00768430|566665482|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
156975430|NCT03585296|566665487|FG000|Overall Study|Adverse Event|1|||
156975431|NCT03585296|566665487|FG000|Overall Study|Lost to Follow-up|2|||
156975432|NCT03585296|566665487|FG000|Overall Study|Withdrawal by Subject|2|||
156975433|NCT00041756|566665488|FG000|Overall Study|Adverse Event|4|||
156975434|NCT00041756|566665489|FG001|Overall Study|Adverse Event|10|||
156975435|NCT00041756|566665490|FG002|Overall Study|Adverse Event|6|||
156975436|NCT00041756|566665491|FG003|Overall Study|Adverse Event|11|||
156975437|NCT00041756|566665492|FG004|Overall Study|Adverse Event|34|||
156975438|NCT00041756|566665488|FG000|Overall Study|Protocol Violation|1|||
156975439|NCT00041756|566665489|FG001|Overall Study|Protocol Violation|1|||
156975440|NCT00041756|566665490|FG002|Overall Study|Protocol Violation|2|||
156975441|NCT00041756|566665491|FG003|Overall Study|Protocol Violation|2|||
156975442|NCT00041756|566665492|FG004|Overall Study|Protocol Violation|1|||
156975443|NCT00041756|566665488|FG000|Overall Study|Withdrawal by Subject|3|||
156975444|NCT00041756|566665489|FG001|Overall Study|Withdrawal by Subject|3|||
156975445|NCT00041756|566665490|FG002|Overall Study|Withdrawal by Subject|4|||
156975446|NCT00041756|566665491|FG003|Overall Study|Withdrawal by Subject|2|||
156975447|NCT00041756|566665492|FG004|Overall Study|Withdrawal by Subject|3|||
156975448|NCT00041756|566665488|FG000|Overall Study|Lost to Follow-up|0|||
157055674|NCT02151643|566957383|FG000|Overall Study|Hyperphosphataemia|1|||
157055675|NCT02151643|566957384|FG001|Overall Study|Hyperphosphataemia|0|||
157055676|NCT02151643|566957385|FG002|Overall Study|Hyperphosphataemia|0|||
157055677|NCT02151643|566957386|FG003|Overall Study|Hyperphosphataemia|0|||
157055678|NCT02151643|566957387|FG004|Overall Study|Hyperphosphataemia|1|||
157055679|NCT02151643|566957383|FG000|Overall Study|High Ferritin levels|3|||
157055680|NCT02151643|566957384|FG001|Overall Study|High Ferritin levels|3|||
157055681|NCT02151643|566957385|FG002|Overall Study|High Ferritin levels|2|||
157055682|NCT02151643|566957386|FG003|Overall Study|High Ferritin levels|2|||
157055683|NCT02151643|566957387|FG004|Overall Study|High Ferritin levels|1|||
157055684|NCT03087851|566957389|FG000|Overall Study|Withdraw on medical grounds|0|||
157055685|NCT03087851|566957390|FG001|Overall Study|Withdraw on medical grounds|1|||
157055686|NCT03087851|566957391|FG002|Overall Study|Withdraw on medical grounds|2|||
157055687|NCT00644332|566957392|FG000|Overall Study|Adverse Event|11|||
157055688|NCT00644332|566957392|FG000|Overall Study|Withdrawal by Subject|6|||
157055689|NCT00644332|566957392|FG000|Overall Study|Completion Status Unknown|2|||
157055690|NCT00644332|566957392|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
157055691|NCT00644332|566957392|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
157055692|NCT03694210|566957393|FG000|Overall Study|Death|1|||
157055693|NCT03694210|566957393|FG000|Overall Study|Screen Failure|7|||
157055694|NCT03050372|566957394|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
157055695|NCT03050372|566957395|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
157055696|NCT03050372|566957394|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
157055697|NCT03050372|566957395|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
157055698|NCT00443755|566957400|FG000|Overall Study|Withdrawal by Subject|2|||
157055699|NCT00443755|566957401|FG001|Overall Study|Withdrawal by Subject|1|||
157055700|NCT02775214|566957402|FG000|Overall Study|Withdrawal by Subject|2|||
157055701|NCT02775214|566957403|FG001|Overall Study|Withdrawal by Subject|0|||
157055702|NCT02706834|566957405|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
157055703|NCT02706834|566957406|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
157055704|NCT02706834|566957407|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
157055705|NCT02706834|566957408|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
157055706|NCT02706834|566957409|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
157055707|NCT02706834|566957410|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
157055708|NCT02706834|566957411|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
157055709|NCT02706834|566957412|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
157055710|NCT02706834|566957413|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
157055711|NCT02706834|566957414|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
157055712|NCT02706834|566957415|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
157055713|NCT02706834|566957405|FG000|Overall Study|Lost to Follow-up|0|||
157055714|NCT02706834|566957406|FG001|Overall Study|Lost to Follow-up|0|||
157055715|NCT02706834|566957407|FG002|Overall Study|Lost to Follow-up|1|||
157055716|NCT02706834|566957408|FG003|Overall Study|Lost to Follow-up|0|||
157178853|NCT03938636|567398003|FG002|Overall Study|Protocol Violation|1|||
157178854|NCT03938636|567398001|FG000|Overall Study|Subject withdrew due to death in family|0|||
157178855|NCT03938636|567398002|FG001|Overall Study|Subject withdrew due to death in family|1|||
157178856|NCT03938636|567398003|FG002|Overall Study|Subject withdrew due to death in family|0|||
157178857|NCT03938636|567398001|FG000|Overall Study|Missed visit|0|||
157178858|NCT03938636|567398002|FG001|Overall Study|Missed visit|1|||
157178859|NCT03938636|567398003|FG002|Overall Study|Missed visit|0|||
157178860|NCT03938636|567398001|FG000|Overall Study|Adverse Event|0|||
157178861|NCT03938636|567398002|FG001|Overall Study|Adverse Event|0|||
157178862|NCT03938636|567398003|FG002|Overall Study|Adverse Event|1|||
157178863|NCT03938636|567398001|FG000|Overall Study|Lost to Follow-up|0|||
157178864|NCT03938636|567398002|FG001|Overall Study|Lost to Follow-up|0|||
157178865|NCT03938636|567398003|FG002|Overall Study|Lost to Follow-up|1|||
157178866|NCT02579863|567398004|FG000|Overall Study|Final Disposition Unknown|2|||
157178867|NCT02579863|567398005|FG001|Overall Study|Final Disposition Unknown|1|||
157178868|NCT02579863|567398004|FG000|Overall Study|Adverse Event|18|||
157178869|NCT02579863|567398005|FG001|Overall Study|Adverse Event|11|||
157178870|NCT02579863|567398004|FG000|Overall Study|Death|31|||
157178871|NCT02579863|567398005|FG001|Overall Study|Death|29|||
157178872|NCT02579863|567398004|FG000|Overall Study|Lost to Follow-up|2|||
157178873|NCT02579863|567398005|FG001|Overall Study|Lost to Follow-up|1|||
157178874|NCT02579863|567398004|FG000|Overall Study|Physician Decision|1|||
157055717|NCT02706834|566957409|FG004|Overall Study|Lost to Follow-up|0|||
157178875|NCT02579863|567398005|FG001|Overall Study|Physician Decision|2|||
157055718|NCT02706834|566957410|FG005|Overall Study|Lost to Follow-up|0|||
157055719|NCT02706834|566957411|FG006|Overall Study|Lost to Follow-up|0|||
157055720|NCT02706834|566957412|FG007|Overall Study|Lost to Follow-up|0|||
157055721|NCT02706834|566957413|FG008|Overall Study|Lost to Follow-up|0|||
157055722|NCT02706834|566957414|FG009|Overall Study|Lost to Follow-up|0|||
157055723|NCT02706834|566957415|FG010|Overall Study|Lost to Follow-up|0|||
157055724|NCT02706834|566957405|FG000|Overall Study|Voluntary Withdrawal|1|||
157055725|NCT02706834|566957406|FG001|Overall Study|Voluntary Withdrawal|0|||
157178876|NCT02579863|567398004|FG000|Overall Study|Screen Failure|0|||
157055726|NCT02706834|566957407|FG002|Overall Study|Voluntary Withdrawal|0|||
157055727|NCT02706834|566957408|FG003|Overall Study|Voluntary Withdrawal|0|||
157055728|NCT02706834|566957409|FG004|Overall Study|Voluntary Withdrawal|0|||
157055729|NCT02706834|566957410|FG005|Overall Study|Voluntary Withdrawal|0|||
157055730|NCT02706834|566957411|FG006|Overall Study|Voluntary Withdrawal|0|||
157055731|NCT02706834|566957412|FG007|Overall Study|Voluntary Withdrawal|0|||
157055732|NCT02706834|566957413|FG008|Overall Study|Voluntary Withdrawal|0|||
157055733|NCT02706834|566957414|FG009|Overall Study|Voluntary Withdrawal|1|||
157055734|NCT02706834|566957415|FG010|Overall Study|Voluntary Withdrawal|0|||
157055735|NCT02706834|566957405|FG000|Overall Study|Other Reason Not Specified|1|||
157055736|NCT02706834|566957406|FG001|Overall Study|Other Reason Not Specified|0|||
157055737|NCT02706834|566957407|FG002|Overall Study|Other Reason Not Specified|0|||
157055738|NCT02706834|566957408|FG003|Overall Study|Other Reason Not Specified|0|||
157055739|NCT02706834|566957409|FG004|Overall Study|Other Reason Not Specified|1|||
157055740|NCT02706834|566957410|FG005|Overall Study|Other Reason Not Specified|0|||
157055741|NCT02706834|566957411|FG006|Overall Study|Other Reason Not Specified|0|||
157055742|NCT02706834|566957412|FG007|Overall Study|Other Reason Not Specified|0|||
157055743|NCT02706834|566957413|FG008|Overall Study|Other Reason Not Specified|0|||
157055744|NCT02706834|566957414|FG009|Overall Study|Other Reason Not Specified|0|||
157055745|NCT02706834|566957415|FG010|Overall Study|Other Reason Not Specified|0|||
157055746|NCT00678899|566957416|FG000|Overall Study|Adverse Event|1|||
157055747|NCT02543294|566957417|FG000|Overall Study|Lost to Follow-up|3|||
157055748|NCT02543294|566957417|FG000|Overall Study|Physician Decision|2|||
157055749|NCT02543294|566957417|FG000|Overall Study|Withdrawal by Subject|7|||
157055750|NCT01107353|566957420|FG000|Overall Study|Positive Drug Screen|1|||
157055751|NCT01107353|566957421|FG001|Overall Study|Positive Drug Screen|0|||
157055752|NCT00907517|566957422|FG000|Overall Study|Progressive Disease|3|||
157055753|NCT00907517|566957423|FG001|Overall Study|Progressive Disease|3|||
157055754|NCT00907517|566957424|FG002|Overall Study|Progressive Disease|4|||
157055755|NCT00907517|566957425|FG003|Overall Study|Progressive Disease|4|||
157055756|NCT00907517|566957426|FG004|Overall Study|Progressive Disease|4|||
157055757|NCT00907517|566957422|FG000|Overall Study|Symptomatic Deterioration|0|||
157055758|NCT00907517|566957423|FG001|Overall Study|Symptomatic Deterioration|0|||
157055759|NCT00907517|566957424|FG002|Overall Study|Symptomatic Deterioration|0|||
157055760|NCT00907517|566957425|FG003|Overall Study|Symptomatic Deterioration|0|||
157055761|NCT00907517|566957426|FG004|Overall Study|Symptomatic Deterioration|1|||
157055762|NCT02029521|566957449|FG000|Overall Study|Protocol Violation|1|||
157055763|NCT02029521|566957450|FG001|Overall Study|Protocol Violation|0|||
157055764|NCT02029521|566957449|FG000|Overall Study|Withdrawal by Subject|1|||
157055765|NCT02029521|566957450|FG001|Overall Study|Withdrawal by Subject|1|||
157055766|NCT01072396|566957451|FG000|Period One|Adverse Event|1|||
157055767|NCT01072396|566957452|FG001|Period One|Adverse Event|1|||
157055768|NCT01072396|566957451|FG000|Period One|Protocol Violation|2|||
157055769|NCT01072396|566957452|FG001|Period One|Protocol Violation|1|||
157055770|NCT01072396|566957451|FG000|Period One|Withdrawal by Subject|2|||
157055771|NCT01072396|566957452|FG001|Period One|Withdrawal by Subject|0|||
157055772|NCT01072396|566957451|FG000|Washout Period|Missing termination information|0|||
157055773|NCT01072396|566957452|FG001|Washout Period|Missing termination information|1|||
157055774|NCT01072396|566957451|FG000|Period Two|Adverse Event|0|||
157055775|NCT01072396|566957452|FG001|Period Two|Adverse Event|3|||
157055776|NCT01072396|566957451|FG000|Period Two|Lost to Follow-up|1|||
157055777|NCT01072396|566957452|FG001|Period Two|Lost to Follow-up|0|||
157055778|NCT01268488|566957453|FG000|Overall Study|Adverse Event|3|||
157055779|NCT01268488|566957453|FG000|Overall Study|Physician Decision|2|||
157055780|NCT02131155|566957455|FG000|Overall Study|Adverse Event|1|||
157055781|NCT02131155|566957456|FG001|Overall Study|Adverse Event|0|||
157055782|NCT02131155|566957455|FG000|Overall Study|Treatment completed|1|||
157055783|NCT02131155|566957456|FG001|Overall Study|Treatment completed|0|||
157055784|NCT02131155|566957455|FG000|Overall Study|Primary tumour recurrence|2|||
157055785|NCT02131155|566957456|FG001|Overall Study|Primary tumour recurrence|1|||
157178877|NCT02579863|567398005|FG001|Overall Study|Screen Failure|2|||
157178878|NCT02579863|567398004|FG000|Overall Study|Study Terminated at Selected Sites|82|||
157055786|NCT02131155|566957455|FG000|Overall Study|Refused to continue study medication|1|||
157055787|NCT02131155|566957456|FG001|Overall Study|Refused to continue study medication|0|||
157055788|NCT02131155|566957455|FG000|Overall Study|Study early termination|20|||
157055789|NCT02131155|566957456|FG001|Overall Study|Study early termination|10|||
157055790|NCT01014013|566957459|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
157055791|NCT01014013|566957460|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
157055792|NCT01014013|566957459|FG000|Overall Study|Clinical adverse experience|4|||
157055793|NCT01014013|566957460|FG001|Overall Study|Clinical adverse experience|2|||
157055794|NCT01014013|566957459|FG000|Overall Study|Laboratory adverse experience|1|||
157055795|NCT01014013|566957460|FG001|Overall Study|Laboratory adverse experience|1|||
157055796|NCT01014013|566957459|FG000|Overall Study|Protocol Violation|1|||
157055797|NCT01014013|566957460|FG001|Overall Study|Protocol Violation|3|||
157055798|NCT01014013|566957459|FG000|Overall Study|Withdrawal by Subject|7|||
157055799|NCT01014013|566957460|FG001|Overall Study|Withdrawal by Subject|4|||
157178879|NCT02579863|567398005|FG001|Overall Study|Study Terminated at Selected Sites|88|||
157055800|NCT01014013|566957459|FG000|Overall Study|Clinical/microbiologic failure|1|||
157055801|NCT01014013|566957460|FG001|Overall Study|Clinical/microbiologic failure|2|||
157055802|NCT01014013|566957459|FG000|Overall Study|Pathogen culture = no growth|26|||
157055803|NCT01014013|566957460|FG001|Overall Study|Pathogen culture = no growth|34|||
157055804|NCT01014013|566957459|FG000|Overall Study|Negative urine culture|2|||
157055805|NCT01014013|566957460|FG001|Overall Study|Negative urine culture|0|||
157055806|NCT01014013|566957459|FG000|Overall Study|Pathogen resistant|7|||
157055807|NCT01014013|566957460|FG001|Overall Study|Pathogen resistant|4|||
157055808|NCT01014013|566957459|FG000|Overall Study|Physician Decision|0|||
157055809|NCT01014013|566957460|FG001|Overall Study|Physician Decision|1|||
157055810|NCT01014013|566957459|FG000|Overall Study|Another antibiotic therapy required|0|||
157055811|NCT01014013|566957460|FG001|Overall Study|Another antibiotic therapy required|1|||
157055812|NCT01014013|566957459|FG000|Overall Study|Appendectomy|1|||
157055813|NCT01014013|566957460|FG001|Overall Study|Appendectomy|0|||
157055814|NCT01014013|566957459|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
157055815|NCT01014013|566957460|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
157055816|NCT00442559|566957461|FG000|Overall Study|Lost to Follow-up|32|||
157055817|NCT00442559|566957462|FG001|Overall Study|Lost to Follow-up|34|||
157055818|NCT00442559|566957461|FG000|Overall Study|Protocol Violation|1|||
157055819|NCT00442559|566957462|FG001|Overall Study|Protocol Violation|1|||
157055820|NCT00442559|566957461|FG000|Overall Study|Withdrawal by Subject|1|||
157055821|NCT00442559|566957462|FG001|Overall Study|Withdrawal by Subject|0|||
157055822|NCT02305797|566957463|FG000|Overall Study|Adverse Event|11|||
157055823|NCT02305797|566957464|FG001|Overall Study|Adverse Event|2|||
157055824|NCT02305797|566957463|FG000|Overall Study|Withdrawal by Subject|9|||
157055825|NCT02305797|566957464|FG001|Overall Study|Withdrawal by Subject|10|||
157055826|NCT02305797|566957463|FG000|Overall Study|Lack of Efficacy|6|||
157055827|NCT02305797|566957464|FG001|Overall Study|Lack of Efficacy|0|||
157055828|NCT02305797|566957463|FG000|Overall Study|Lost to Follow-up|5|||
157055829|NCT02305797|566957464|FG001|Overall Study|Lost to Follow-up|11|||
157055830|NCT02305797|566957463|FG000|Overall Study|Pregnancy|0|||
157055831|NCT02305797|566957464|FG001|Overall Study|Pregnancy|2|||
157055832|NCT02305797|566957463|FG000|Overall Study|Noncompliance|14|||
157055833|NCT02305797|566957464|FG001|Overall Study|Noncompliance|12|||
157055834|NCT02305797|566957463|FG000|Overall Study|Reason not collected|0|||
157055835|NCT02305797|566957464|FG001|Overall Study|Reason not collected|1|||
157055836|NCT03575572|566957465|FG000|Overall Study|Withdrawal by Subject|2|||
157055837|NCT03575572|566957465|FG000|Overall Study|Physician Decision|2|||
157055838|NCT04908800|566957466|FG000|Overall Study|Adverse Event|0|||
157055839|NCT04908800|566957467|FG001|Overall Study|Adverse Event|0|||
157055840|NCT04908800|566957468|FG002|Overall Study|Adverse Event|0|||
157055841|NCT04908800|566957469|FG003|Overall Study|Adverse Event|0|||
157055842|NCT04908800|566957470|FG004|Overall Study|Adverse Event|0|||
157055843|NCT04908800|566957471|FG005|Overall Study|Adverse Event|0|||
157055844|NCT04908800|566957472|FG006|Overall Study|Adverse Event|0|||
157055845|NCT04908800|566957473|FG007|Overall Study|Adverse Event|0|||
157055846|NCT04908800|566957474|FG008|Overall Study|Adverse Event|0|||
157055847|NCT04908800|566957475|FG009|Overall Study|Adverse Event|0|||
157055848|NCT04908800|566957476|FG010|Overall Study|Adverse Event|1|||
157055849|NCT04908800|566957477|FG011|Overall Study|Adverse Event|0|||
157055850|NCT04908800|566957478|FG012|Overall Study|Adverse Event|0|||
157055851|NCT03751280|566957479|FG000|Overall Study|Adverse Event|0|||
157055852|NCT03751280|566957480|FG001|Overall Study|Adverse Event|1|||
157055853|NCT03751280|566957479|FG000|Overall Study|Lost to Follow-up|3|||
157055854|NCT03751280|566957480|FG001|Overall Study|Lost to Follow-up|5|||
157055855|NCT03751280|566957479|FG000|Overall Study|Physician Decision|0|||
157055856|NCT03751280|566957480|FG001|Overall Study|Physician Decision|2|||
157055857|NCT03751280|566957479|FG000|Overall Study|Protocol Violation|0|||
157055858|NCT03751280|566957480|FG001|Overall Study|Protocol Violation|2|||
157055859|NCT03751280|566957479|FG000|Overall Study|Withdrawal by Subject|5|||
157055860|NCT03751280|566957480|FG001|Overall Study|Withdrawal by Subject|2|||
157055861|NCT03647709|566957483|FG000|Overall Study|Lost to Follow-up|5|||
157055862|NCT03647709|566957483|FG000|Overall Study|Physician Decision|6|||
157055863|NCT03647709|566957483|FG000|Overall Study|Withdrawal by Subject|3|||
157055864|NCT05287178|566957484|FG000|Overall Study|Lost to Follow-up|2|||
157055865|NCT01648699|566957485|FG000|Overall Study|Death|1|||
157178880|NCT02579863|567398004|FG000|Overall Study|Withdrawal by Subject|20|||
157055866|NCT01648699|566957485|FG000|Overall Study|Lost to Follow-up|2|||
157055867|NCT01648699|566957485|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
157178881|NCT02579863|567398005|FG001|Overall Study|Withdrawal by Subject|20|||
157178882|NCT00809614|567398010|FG000|Overall Study|Lack of Efficacy|2|||
157055868|NCT01920178|566957486|FG000|Overall Study|Lost to Follow-up|2|||
157055869|NCT01920178|566957487|FG001|Overall Study|Lost to Follow-up|1|||
157055870|NCT03023878|566957488|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
157055871|NCT03023878|566957488|FG000|Pre-Study Run-In Period|Death|1|||
157055872|NCT03023878|566957488|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
157055873|NCT03023878|566957488|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
157055874|NCT03023878|566957488|FG000|Treatment Period|Disease Progression|1|||
157055875|NCT03023878|566957488|FG000|Treatment Period|Withdrawal by Subject|1|||
157055876|NCT03023878|566957488|FG000|Treatment Period|Adverse Event|1|||
157055877|NCT03023878|566957488|FG000|Long Term Follow-Up Period|Death|2|||
157055878|NCT00288353|566957493|FG000|Overall Study|Lack of Efficacy|2|||
157055879|NCT00288353|566957494|FG001|Overall Study|Lack of Efficacy|2|||
157055880|NCT00288353|566957493|FG000|Overall Study|Withdrawal by Subject|5|||
157055881|NCT00288353|566957494|FG001|Overall Study|Withdrawal by Subject|5|||
157055882|NCT05234632|566957495|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
157055883|NCT05234632|566957496|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
157055884|NCT05234632|566957495|FG000|Overall Study|Withdrawal by Subject|2|||
157055885|NCT05234632|566957496|FG001|Overall Study|Withdrawal by Subject|0|||
157055886|NCT05234632|566957495|FG000|Overall Study|Adverse Event|0|||
157055887|NCT05234632|566957496|FG001|Overall Study|Adverse Event|4|||
157055888|NCT05234632|566957495|FG000|Overall Study|Physician Decision|1|||
157055889|NCT05234632|566957496|FG001|Overall Study|Physician Decision|1|||
157055890|NCT05234632|566957495|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
157055891|NCT05234632|566957496|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
157055892|NCT05234632|566957495|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
157055893|NCT05234632|566957496|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
157055894|NCT04799587|566957497|FG000|Overall Study|Withdrawal by Subject|0|||
157055895|NCT04799587|566957498|FG001|Overall Study|Withdrawal by Subject|1|||
157055896|NCT00728884|566957499|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
157055897|NCT00728884|566957499|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
157055898|NCT02849509|566957500|FG000|Overall Study|Worsening of disease under study|1|||
157055899|NCT02849509|566957501|FG001|Overall Study|Worsening of disease under study|1|||
157055900|NCT02849509|566957502|FG002|Overall Study|Worsening of disease under study|1|||
157055901|NCT02849509|566957500|FG000|Overall Study|Worsening of other pre-existing disease|0|||
157055902|NCT02849509|566957501|FG001|Overall Study|Worsening of other pre-existing disease|1|||
157055903|NCT02849509|566957502|FG002|Overall Study|Worsening of other pre-existing disease|2|||
157055904|NCT02849509|566957500|FG000|Overall Study|Other adverse event|36|||
157055905|NCT02849509|566957501|FG001|Overall Study|Other adverse event|41|||
157055906|NCT02849509|566957502|FG002|Overall Study|Other adverse event|8|||
157055907|NCT02849509|566957500|FG000|Overall Study|Withdrawal by Subject|6|||
157055908|NCT02849509|566957501|FG001|Overall Study|Withdrawal by Subject|17|||
157055909|NCT02849509|566957502|FG002|Overall Study|Withdrawal by Subject|12|||
157055910|NCT02849509|566957500|FG000|Overall Study|Lost to Follow-up|27|||
157055911|NCT02849509|566957501|FG001|Overall Study|Lost to Follow-up|67|||
157055912|NCT02849509|566957502|FG002|Overall Study|Lost to Follow-up|36|||
157055913|NCT02849509|566957500|FG000|Overall Study|Other, reason not specified|14|||
157055914|NCT02849509|566957501|FG001|Overall Study|Other, reason not specified|29|||
157055915|NCT02849509|566957502|FG002|Overall Study|Other, reason not specified|25|||
157055916|NCT02849509|566957500|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
157055917|NCT02849509|566957501|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
157055918|NCT02849509|566957502|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
157055919|NCT02374476|566957511|FG000|VT Induced Ablation|Screening Failures|36|||
157055920|NCT02374476|566957512|FG001|VT Induced Ablation|Screening Failures|0|||
157055921|NCT02374476|566957513|FG002|VT Induced Ablation|Screening Failures|0|||
157055922|NCT02374476|566957511|FG000|Arm Assignment|Withdrawal by Subject|0|||
157055923|NCT02374476|566957512|FG001|Arm Assignment|Withdrawal by Subject|0|||
157055924|NCT02374476|566957513|FG002|Arm Assignment|Withdrawal by Subject|1|||
157055925|NCT05431543|566957516|FG000|Overall Study|Medical History|1|||
157055926|NCT05431543|566957517|FG001|Overall Study|Medical History|0|||
157055927|NCT05431543|566957518|FG002|Overall Study|Medical History|0|||
157055928|NCT02784535|566957519|FG000|Overall Study|Adverse Event|1|||
157055929|NCT02784535|566957520|FG001|Overall Study|Adverse Event|0|||
157055930|NCT02784535|566957519|FG000|Overall Study|Withdrawal by Subject|0|||
157055931|NCT02784535|566957520|FG001|Overall Study|Withdrawal by Subject|1|||
157055932|NCT02784535|566957519|FG000|Overall Study|Physician Decision|0|||
157055933|NCT02784535|566957520|FG001|Overall Study|Physician Decision|1|||
157229633|NCT00497796|567586537|FG001|Overall Study|Adverse event (not related)|9|||
157229634|NCT00497796|567586536|FG000|Overall Study|Adverse event (related)|5|||
157229635|NCT00497796|567586537|FG001|Overall Study|Adverse event (related)|4|||
157229636|NCT00497796|567586536|FG000|Overall Study|CMV infection or disease treatment|30|||
157229637|NCT00497796|567586537|FG001|Overall Study|CMV infection or disease treatment|4|||
157055934|NCT00914732|566957521|FG000|Overall Study|Lost to Follow-up|6|||
157055935|NCT00914732|566957522|FG001|Overall Study|Lost to Follow-up|7|||
157055936|NCT00914732|566957523|FG002|Overall Study|Lost to Follow-up|9|||
157055937|NCT00914732|566957521|FG000|Overall Study|Withdrawal by Subject|3|||
157055938|NCT00914732|566957522|FG001|Overall Study|Withdrawal by Subject|0|||
157055939|NCT00914732|566957523|FG002|Overall Study|Withdrawal by Subject|2|||
157055940|NCT00914732|566957521|FG000|Overall Study|Adverse Event|1|||
157055941|NCT00914732|566957522|FG001|Overall Study|Adverse Event|0|||
157055942|NCT00914732|566957523|FG002|Overall Study|Adverse Event|0|||
157229638|NCT00497796|567586536|FG000|Overall Study|Consent withdrawn|10|||
157055943|NCT05615870|566957524|FG000|Overall Study|Lost to Follow-up|10|||
157055944|NCT05615870|566957525|FG001|Overall Study|Lost to Follow-up|13|||
157055945|NCT05615870|566957524|FG000|Overall Study|Physician Decision|2|||
157055946|NCT05615870|566957525|FG001|Overall Study|Physician Decision|0|||
157055947|NCT05615870|566957524|FG000|Overall Study|Withdrawal by Subject|0|||
157055948|NCT05615870|566957525|FG001|Overall Study|Withdrawal by Subject|2|||
157055949|NCT05615870|566957524|FG000|Overall Study|Protocol Violation|0|||
157055950|NCT05615870|566957525|FG001|Overall Study|Protocol Violation|3|||
157055951|NCT05615870|566957524|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
157055952|NCT05615870|566957525|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
157055953|NCT05615870|566957524|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
157055954|NCT05615870|566957525|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
157055955|NCT05615870|566957524|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
157055956|NCT05615870|566957525|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
157055957|NCT03005106|566957528|FG000|Overall Study|Lost to Follow-up|16|||
157055958|NCT03005106|566957528|FG000|Overall Study|Adverse Event|1|||
157055959|NCT03005106|566957528|FG000|Overall Study|Physician Decision|1|||
157055960|NCT03005106|566957528|FG000|Overall Study|Death|2|||
157055961|NCT00321672|566957531|FG000|Overall Study|Withdrawal by Subject|5|||
157055962|NCT00321672|566957532|FG001|Overall Study|Withdrawal by Subject|1|||
157055963|NCT00321672|566957533|FG002|Overall Study|Withdrawal by Subject|2|||
157055964|NCT00321672|566957534|FG003|Overall Study|Withdrawal by Subject|0|||
157055965|NCT00321672|566957531|FG000|Overall Study|Noncompliance|1|||
157055966|NCT00321672|566957532|FG001|Overall Study|Noncompliance|2|||
157055967|NCT00321672|566957533|FG002|Overall Study|Noncompliance|1|||
157055968|NCT00321672|566957534|FG003|Overall Study|Noncompliance|0|||
157055969|NCT00321672|566957531|FG000|Overall Study|Adverse Event|1|||
157055970|NCT00321672|566957532|FG001|Overall Study|Adverse Event|1|||
157055971|NCT00321672|566957533|FG002|Overall Study|Adverse Event|0|||
157055972|NCT00321672|566957534|FG003|Overall Study|Adverse Event|0|||
157055973|NCT00321672|566957531|FG000|Overall Study|Lack of Efficacy|1|||
157055974|NCT00321672|566957532|FG001|Overall Study|Lack of Efficacy|1|||
157055975|NCT00321672|566957533|FG002|Overall Study|Lack of Efficacy|0|||
157055976|NCT00321672|566957534|FG003|Overall Study|Lack of Efficacy|0|||
157055977|NCT00321672|566957531|FG000|Overall Study|Lost to Follow-up|2|||
157055978|NCT00321672|566957532|FG001|Overall Study|Lost to Follow-up|0|||
157055979|NCT00321672|566957533|FG002|Overall Study|Lost to Follow-up|4|||
157055980|NCT00321672|566957534|FG003|Overall Study|Lost to Follow-up|2|||
157055981|NCT00321672|566957531|FG000|Overall Study|Death|1|||
157055982|NCT00321672|566957532|FG001|Overall Study|Death|0|||
157055983|NCT00321672|566957533|FG002|Overall Study|Death|0|||
157055984|NCT00321672|566957534|FG003|Overall Study|Death|0|||
157055985|NCT00321672|566957531|FG000|Overall Study|Too far to travel for visits|1|||
157055986|NCT00321672|566957532|FG001|Overall Study|Too far to travel for visits|0|||
157055987|NCT00321672|566957533|FG002|Overall Study|Too far to travel for visits|0|||
157055988|NCT00321672|566957534|FG003|Overall Study|Too far to travel for visits|0|||
157055989|NCT00321672|566957531|FG000|Overall Study|Incarcerated|0|||
157055990|NCT00321672|566957532|FG001|Overall Study|Incarcerated|0|||
157055991|NCT00321672|566957533|FG002|Overall Study|Incarcerated|2|||
157055992|NCT00321672|566957534|FG003|Overall Study|Incarcerated|0|||
157055993|NCT00321672|566957531|FG000|Overall Study|Moved out of state|0|||
157055994|NCT00321672|566957532|FG001|Overall Study|Moved out of state|1|||
157055995|NCT00321672|566957533|FG002|Overall Study|Moved out of state|1|||
157055996|NCT00321672|566957534|FG003|Overall Study|Moved out of state|0|||
157055997|NCT00321672|566957531|FG000|Overall Study|Protocol Violation|0|||
157055998|NCT00321672|566957532|FG001|Overall Study|Protocol Violation|0|||
157055999|NCT00321672|566957533|FG002|Overall Study|Protocol Violation|1|||
157056000|NCT00321672|566957534|FG003|Overall Study|Protocol Violation|0|||
157056001|NCT00321672|566957531|FG000|Overall Study|Diagnosis of testicular cancer|0|||
157056002|NCT00321672|566957532|FG001|Overall Study|Diagnosis of testicular cancer|1|||
157056003|NCT00321672|566957533|FG002|Overall Study|Diagnosis of testicular cancer|0|||
157056004|NCT00321672|566957534|FG003|Overall Study|Diagnosis of testicular cancer|0|||
157056005|NCT00321672|566957531|FG000|Overall Study|Extensive travel required for new job|0|||
157056006|NCT00321672|566957532|FG001|Overall Study|Extensive travel required for new job|1|||
157056007|NCT00321672|566957533|FG002|Overall Study|Extensive travel required for new job|0|||
157056008|NCT00321672|566957534|FG003|Overall Study|Extensive travel required for new job|0|||
157056009|NCT03953079|566957535|FG000|Core Study|Withdrawal by Subject|1|||
157056010|NCT03953079|566957536|FG001|Core Study|Withdrawal by Subject|2|||
157056011|NCT03953079|566957537|FG002|Core Study|Withdrawal by Subject|1|||
157056012|NCT03953079|566957535|FG000|Core Study|COVID-19|0|||
157056013|NCT03953079|566957536|FG001|Core Study|COVID-19|1|||
157056014|NCT03953079|566957537|FG002|Core Study|COVID-19|0|||
157056015|NCT03953079|566957535|FG000|Core Study|Difficulties leaving the house|0|||
157056016|NCT03953079|566957536|FG001|Core Study|Difficulties leaving the house|1|||
157056017|NCT03953079|566957537|FG002|Core Study|Difficulties leaving the house|0|||
157178883|NCT00809614|567398011|FG001|Overall Study|Lack of Efficacy|3|||
157056018|NCT03953079|566957535|FG000|Extension Study|Withdrawal by Subject|1|||
157056019|NCT03953079|566957536|FG001|Extension Study|Withdrawal by Subject|0|||
157056020|NCT03953079|566957537|FG002|Extension Study|Withdrawal by Subject|0|||
157056021|NCT03953079|566957535|FG000|Extension Study|Received Rescue Treatment|5|||
157056022|NCT03953079|566957536|FG001|Extension Study|Received Rescue Treatment|6|||
157056023|NCT03953079|566957537|FG002|Extension Study|Received Rescue Treatment|5|||
157056024|NCT03019289|566957538|FG000|Overall Study|Adverse Event|1|||
157056025|NCT03019289|566957539|FG001|Overall Study|Adverse Event|0|||
157056026|NCT03019289|566957540|FG002|Overall Study|Adverse Event|0|||
157056027|NCT03019289|566957541|FG003|Overall Study|Adverse Event|0|||
157056028|NCT03019289|566957542|FG004|Overall Study|Adverse Event|0|||
157056029|NCT03019289|566957543|FG005|Overall Study|Adverse Event|0|||
157056030|NCT03019289|566957544|FG006|Overall Study|Adverse Event|0|||
157056031|NCT03019289|566957545|FG007|Overall Study|Adverse Event|0|||
157056032|NCT03019289|566957546|FG008|Overall Study|Adverse Event|1|||
157056033|NCT03019289|566957538|FG000|Overall Study|Other|1|||
157056034|NCT03019289|566957539|FG001|Overall Study|Other|0|||
157056035|NCT03019289|566957540|FG002|Overall Study|Other|0|||
157056036|NCT03019289|566957541|FG003|Overall Study|Other|0|||
157056037|NCT03019289|566957542|FG004|Overall Study|Other|0|||
157056038|NCT03019289|566957543|FG005|Overall Study|Other|0|||
157056039|NCT03019289|566957544|FG006|Overall Study|Other|0|||
157056040|NCT03019289|566957545|FG007|Overall Study|Other|0|||
157056041|NCT03019289|566957546|FG008|Overall Study|Other|0|||
157056042|NCT00145496|566957550|FG000|Overall Study|Adverse Event|42|||
157056043|NCT00145496|566957551|FG001|Overall Study|Adverse Event|30|||
157056044|NCT00145496|566957550|FG000|Overall Study|Lack of Efficacy|12|||
157056045|NCT00145496|566957551|FG001|Overall Study|Lack of Efficacy|7|||
157056046|NCT00145496|566957550|FG000|Overall Study|Withdrawal by Subject|32|||
157056047|NCT00145496|566957551|FG001|Overall Study|Withdrawal by Subject|26|||
157056048|NCT00145496|566957550|FG000|Overall Study|Lost to Follow-up|12|||
157056049|NCT00145496|566957551|FG001|Overall Study|Lost to Follow-up|5|||
157056050|NCT00145496|566957550|FG000|Overall Study|Other|25|||
157056051|NCT00145496|566957551|FG001|Overall Study|Other|13|||
157056052|NCT01334606|566957552|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
157056053|NCT02312245|566957553|FG000|Overall Study|Death|0|||
157056054|NCT02312245|566957554|FG001|Overall Study|Death|0|||
157056055|NCT02312245|566957555|FG002|Overall Study|Death|0|||
157056056|NCT02312245|566957556|FG003|Overall Study|Death|1|||
157056057|NCT02312245|566957553|FG000|Overall Study|Withdrawal by Subject|1|||
157056058|NCT02312245|566957554|FG001|Overall Study|Withdrawal by Subject|1|||
157056059|NCT02312245|566957555|FG002|Overall Study|Withdrawal by Subject|0|||
157056060|NCT02312245|566957556|FG003|Overall Study|Withdrawal by Subject|2|||
157056061|NCT02312245|566957553|FG000|Overall Study|Alternative Therapy|1|||
157056062|NCT02312245|566957554|FG001|Overall Study|Alternative Therapy|0|||
157056063|NCT02312245|566957555|FG002|Overall Study|Alternative Therapy|0|||
157056064|NCT02312245|566957556|FG003|Overall Study|Alternative Therapy|0|||
157056065|NCT02312245|566957553|FG000|Overall Study|Progression|0|||
157056066|NCT02312245|566957554|FG001|Overall Study|Progression|0|||
157056067|NCT02312245|566957555|FG002|Overall Study|Progression|0|||
157056068|NCT02312245|566957556|FG003|Overall Study|Progression|5|||
157056069|NCT02312245|566957553|FG000|Overall Study|Patient went to hospice|0|||
157056070|NCT02312245|566957554|FG001|Overall Study|Patient went to hospice|0|||
157056071|NCT02312245|566957555|FG002|Overall Study|Patient went to hospice|0|||
157056072|NCT02312245|566957556|FG003|Overall Study|Patient went to hospice|1|||
157056073|NCT02312245|566957553|FG000|Overall Study|Ineligible|1|||
157056074|NCT02312245|566957554|FG001|Overall Study|Ineligible|0|||
157056075|NCT02312245|566957555|FG002|Overall Study|Ineligible|0|||
157056076|NCT02312245|566957556|FG003|Overall Study|Ineligible|0|||
157056077|NCT01002547|566959488|FG000|Overall Study|Withdrawal by Subject|4|||
157056078|NCT01002547|566959489|FG001|Overall Study|Withdrawal by Subject|0|||
157056079|NCT01002547|566959490|FG002|Overall Study|Withdrawal by Subject|5|||
157056080|NCT01002547|566959488|FG000|Overall Study|Lost to Follow-up|2|||
157056081|NCT01002547|566959489|FG001|Overall Study|Lost to Follow-up|1|||
157056082|NCT01002547|566959490|FG002|Overall Study|Lost to Follow-up|1|||
157056083|NCT01002547|566959488|FG000|Overall Study|Physician Decision|1|||
157056084|NCT01002547|566959489|FG001|Overall Study|Physician Decision|0|||
157056085|NCT01002547|566959490|FG002|Overall Study|Physician Decision|0|||
157056086|NCT01002547|566959488|FG000|Overall Study|Death|0|||
157056087|NCT01002547|566959489|FG001|Overall Study|Death|2|||
157056088|NCT01002547|566959490|FG002|Overall Study|Death|2|||
157056089|NCT01002547|566959488|FG000|Overall Study|Adverse Event|1|||
157056090|NCT01002547|566959489|FG001|Overall Study|Adverse Event|0|||
157056091|NCT01002547|566959490|FG002|Overall Study|Adverse Event|0|||
157056092|NCT00925288|566959493|FG000|Overall Study|Lost to Follow-up|9|||
157056093|NCT00925288|566959494|FG001|Overall Study|Lost to Follow-up|7|||
157056094|NCT00434577|566959495|FG000|Months 0-3|Serious Adverse Event|0|||
157056095|NCT00434577|566959496|FG001|Months 0-3|Serious Adverse Event|0|||
157056096|NCT00434577|566959497|FG002|Months 0-3|Serious Adverse Event|1|||
157056097|NCT00434577|566959498|FG003|Months 0-3|Serious Adverse Event|0|||
157056098|NCT00434577|566959499|FG004|Months 0-3|Serious Adverse Event|0|||
157056099|NCT00434577|566959495|FG000|Months 0-3|Adverse Event|0|||
157056100|NCT00434577|566959496|FG001|Months 0-3|Adverse Event|1|||
157056101|NCT00434577|566959497|FG002|Months 0-3|Adverse Event|1|||
157056102|NCT00434577|566959498|FG003|Months 0-3|Adverse Event|0|||
157056103|NCT00434577|566959499|FG004|Months 0-3|Adverse Event|0|||
157056104|NCT00434577|566959495|FG000|Months 0-3|Lost to Follow-up|0|||
157056105|NCT00434577|566959496|FG001|Months 0-3|Lost to Follow-up|0|||
157056106|NCT00434577|566959497|FG002|Months 0-3|Lost to Follow-up|0|||
157056107|NCT00434577|566959498|FG003|Months 0-3|Lost to Follow-up|0|||
157056108|NCT00434577|566959499|FG004|Months 0-3|Lost to Follow-up|2|||
157056109|NCT00434577|566959495|FG000|Months 0-3|Protocol Violation|1|||
157056110|NCT00434577|566959496|FG001|Months 0-3|Protocol Violation|0|||
157056111|NCT00434577|566959497|FG002|Months 0-3|Protocol Violation|1|||
157056112|NCT00434577|566959498|FG003|Months 0-3|Protocol Violation|0|||
157056113|NCT00434577|566959499|FG004|Months 0-3|Protocol Violation|0|||
157056114|NCT00434577|566959495|FG000|Months 0-3|Withdrawal by Subject|2|||
157056115|NCT00434577|566959496|FG001|Months 0-3|Withdrawal by Subject|1|||
157056116|NCT00434577|566959497|FG002|Months 0-3|Withdrawal by Subject|1|||
157056117|NCT00434577|566959498|FG003|Months 0-3|Withdrawal by Subject|1|||
157056118|NCT00434577|566959499|FG004|Months 0-3|Withdrawal by Subject|1|||
157056119|NCT00381888|566959502|FG000|Overall Study|Death|1|||
157056120|NCT00381888|566959502|FG000|Overall Study|Withdrawal by Subject|1|||
157056121|NCT00381888|566959502|FG000|Overall Study|Physician Decision|1|||
157056122|NCT00381888|566959502|FG000|Overall Study|Protocol Violation|9|||
157056123|NCT00381888|566959502|FG000|Overall Study|Had laparoscopic surgery|2|||
157056124|NCT00381888|566959502|FG000|Overall Study|Surgery was cancelled|2|||
157056125|NCT00381888|566959502|FG000|Overall Study|Adverse Event|1|||
157056126|NCT01537120|566959506|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
157056127|NCT01537120|566959506|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
157056128|NCT01732627|566959509|FG000|Overall Study|Withdrawal by Subject|1|||
157056129|NCT01732627|566959510|FG001|Overall Study|Withdrawal by Subject|0|||
157056130|NCT02475733|566959511|FG000|Overall Study|Withdrawal by Subject|1|||
157056131|NCT02475733|566959512|FG001|Overall Study|Withdrawal by Subject|0|||
157056132|NCT02475733|566959511|FG000|Overall Study|Physician Decision|1|||
157056133|NCT02475733|566959512|FG001|Overall Study|Physician Decision|0|||
157056134|NCT01887418|566959513|FG000|Overall Study|Travelling difficulties|0|||
157056135|NCT01887418|566959514|FG001|Overall Study|Travelling difficulties|0|||
157056136|NCT01887418|566959515|FG002|Overall Study|Travelling difficulties|1|||
157056137|NCT03508830|566959522|FG000|Overall Study|Withdrawal by Subject|3|||
157056138|NCT03508830|566959523|FG001|Overall Study|Withdrawal by Subject|4|||
157056139|NCT03508830|566959522|FG000|Overall Study|Physician Decision|2|||
157056140|NCT03508830|566959523|FG001|Overall Study|Physician Decision|2|||
157056141|NCT02522299|566959524|FG000|Overall Study|Adverse Event|2|||
157056142|NCT02522299|566959525|FG001|Overall Study|Adverse Event|0|||
157056143|NCT02522299|566959524|FG000|Overall Study|Physician Decision|0|||
157056144|NCT02522299|566959525|FG001|Overall Study|Physician Decision|1|||
157056145|NCT02522299|566959524|FG000|Overall Study|Withdrawal by Subject|2|||
157056146|NCT02522299|566959525|FG001|Overall Study|Withdrawal by Subject|0|||
157056147|NCT02097056|566959528|FG000|Overall Study|Protocol Violation|2|||
157056148|NCT02097056|566959528|FG000|Overall Study|Withdrawal by Subject|15|||
157056149|NCT02097056|566959528|FG000|Overall Study|Lost to Follow-up|2|||
157056150|NCT02097056|566959528|FG000|Overall Study|Adverse Event|37|||
157056151|NCT02097056|566959528|FG000|Overall Study|Other|2|||
157056152|NCT01446042|566959529|FG000|Overall Study|Withdrawal by Subject|12|||
157056153|NCT01446042|566959530|FG001|Overall Study|Withdrawal by Subject|2|||
157056154|NCT01446042|566959531|FG002|Overall Study|Withdrawal by Subject|4|||
157056155|NCT01446042|566959529|FG000|Overall Study|Adverse Event|1|||
157056156|NCT01446042|566959530|FG001|Overall Study|Adverse Event|0|||
157056157|NCT01446042|566959531|FG002|Overall Study|Adverse Event|4|||
157056158|NCT01446042|566959529|FG000|Overall Study|Lost to Follow-up|5|||
157056159|NCT01446042|566959530|FG001|Overall Study|Lost to Follow-up|0|||
157056160|NCT01446042|566959531|FG002|Overall Study|Lost to Follow-up|0|||
157205261|NCT03993288|567496083|FG000|Overall Study|wrong randomization|0|||
157056161|NCT01446042|566959529|FG000|Overall Study|Other reasons|2|||
157056162|NCT01446042|566959530|FG001|Overall Study|Other reasons|1|||
157056163|NCT01446042|566959531|FG002|Overall Study|Other reasons|1|||
157056164|NCT00296504|566959539|FG000|Interim Analysis|Withdrawal by Subject|8|||
157056165|NCT00296504|566959540|FG001|Interim Analysis|Withdrawal by Subject|0|||
157056166|NCT00296504|566959541|FG002|Interim Analysis|Withdrawal by Subject|12|||
157056167|NCT00296504|566959542|FG003|Interim Analysis|Withdrawal by Subject|0|||
157056168|NCT00296504|566959543|FG004|Interim Analysis|Withdrawal by Subject|5|||
157056169|NCT00296504|566959544|FG005|Interim Analysis|Withdrawal by Subject|5|||
157056170|NCT00296504|566959545|FG006|Interim Analysis|Withdrawal by Subject|9|||
157056171|NCT00296504|566959546|FG007|Interim Analysis|Withdrawal by Subject|3|||
157056172|NCT00296504|566959547|FG008|Interim Analysis|Withdrawal by Subject|0|||
157056173|NCT00296504|566959539|FG000|Interim Analysis|Lost to Follow-up|13|||
157056174|NCT00296504|566959540|FG001|Interim Analysis|Lost to Follow-up|3|||
157056175|NCT00296504|566959541|FG002|Interim Analysis|Lost to Follow-up|26|||
157056176|NCT00296504|566959542|FG003|Interim Analysis|Lost to Follow-up|8|||
157056177|NCT00296504|566959543|FG004|Interim Analysis|Lost to Follow-up|14|||
157229639|NCT00497796|567586537|FG001|Overall Study|Consent withdrawn|3|||
157229640|NCT00497796|567586536|FG000|Overall Study|Investigator/sponsor discretion|31|||
156975449|NCT00041756|566665489|FG001|Overall Study|Lost to Follow-up|1|||
156975450|NCT00041756|566665490|FG002|Overall Study|Lost to Follow-up|0|||
156975451|NCT00041756|566665491|FG003|Overall Study|Lost to Follow-up|1|||
156975452|NCT00041756|566665492|FG004|Overall Study|Lost to Follow-up|0|||
156975453|NCT00041756|566665488|FG000|Overall Study|Unable to meet protocol criteria|0|||
156975454|NCT00041756|566665489|FG001|Overall Study|Unable to meet protocol criteria|0|||
156975455|NCT00041756|566665490|FG002|Overall Study|Unable to meet protocol criteria|1|||
156975456|NCT00041756|566665491|FG003|Overall Study|Unable to meet protocol criteria|0|||
156975457|NCT00041756|566665492|FG004|Overall Study|Unable to meet protocol criteria|1|||
156975458|NCT00041756|566665488|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
156975459|NCT00041756|566665489|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
156975460|NCT00041756|566665490|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
156975461|NCT00041756|566665491|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
156975462|NCT00041756|566665492|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
156975463|NCT00519896|566665493|FG000|Overall Study|Protocol Violation|1|||
156975464|NCT00519896|566665493|FG000|Overall Study|Adverse Event|1|||
156975465|NCT00810082|566665494|FG000|Overall Study|Lost to Follow-up|0|||
156975466|NCT00810082|566665495|FG001|Overall Study|Lost to Follow-up|4|||
156975467|NCT03327402|566665496|FG000|Overall Study|Withdrawal by Subject|1|||
156975468|NCT03327402|566665496|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
156975469|NCT01454830|566665499|FG000|Overall Study|Withdrawal by Subject|4|||
156975470|NCT01454830|566665500|FG001|Overall Study|Withdrawal by Subject|4|||
156975471|NCT01454830|566665499|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
156975472|NCT01454830|566665500|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
156975473|NCT01454830|566665499|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
156975474|NCT01454830|566665500|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
156975475|NCT01454830|566665499|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
156975476|NCT01454830|566665500|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
156975477|NCT01454830|566665499|FG000|Overall Study|Withdrawal - no polysomnography|3|||
156975478|NCT01454830|566665500|FG001|Overall Study|Withdrawal - no polysomnography|2|||
156975479|NCT00584805|566665501|FG000|Overall Study|No longer at risk of exposure|39|||
156975480|NCT00584805|566665501|FG000|Overall Study|Relocation|36|||
156975481|NCT00584805|566665501|FG000|Overall Study|Withdrawal by Subject|18|||
156975482|NCT00584805|566665501|FG000|Overall Study|Non-compliance|1|||
156975483|NCT00584805|566665501|FG000|Overall Study|Lost to follow up|3|||
156975484|NCT00584805|566665501|FG000|Overall Study|Screen failures|2|||
156975485|NCT01077362|566665502|FG000|Overall Study|Lack of Efficacy|13|||
156975486|NCT01077362|566665503|FG001|Overall Study|Lack of Efficacy|8|||
156975487|NCT01077362|566665504|FG002|Overall Study|Lack of Efficacy|10|||
156975488|NCT01077362|566665502|FG000|Overall Study|Lost to Follow-up|1|||
156975489|NCT01077362|566665503|FG001|Overall Study|Lost to Follow-up|0|||
156975490|NCT01077362|566665504|FG002|Overall Study|Lost to Follow-up|3|||
156975491|NCT01077362|566665502|FG000|Overall Study|Adverse Event|12|||
156975492|NCT01077362|566665503|FG001|Overall Study|Adverse Event|7|||
156975493|NCT01077362|566665504|FG002|Overall Study|Adverse Event|4|||
156975494|NCT01077362|566665502|FG000|Overall Study|Withdrawal by Subject|5|||
156975495|NCT01077362|566665503|FG001|Overall Study|Withdrawal by Subject|3|||
156975496|NCT01077362|566665504|FG002|Overall Study|Withdrawal by Subject|5|||
156975497|NCT01077362|566665502|FG000|Overall Study|Other|0|||
156975498|NCT01077362|566665503|FG001|Overall Study|Other|1|||
156975499|NCT01077362|566665504|FG002|Overall Study|Other|2|||
156975500|NCT02508532|566665506|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975501|NCT02508532|566665507|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975502|NCT02508532|566665508|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975503|NCT02508532|566665509|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975504|NCT02508532|566665510|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975505|NCT02508532|566665511|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975506|NCT02508532|566665512|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
156975507|NCT02508532|566665513|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975508|NCT02508532|566665514|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
156975509|NCT02508532|566665506|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975510|NCT02508532|566665507|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975511|NCT02508532|566665508|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975512|NCT02508532|566665509|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975513|NCT02508532|566665510|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975514|NCT02508532|566665511|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975515|NCT02508532|566665512|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975516|NCT02508532|566665513|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
156975517|NCT02508532|566665514|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
156975518|NCT02508532|566665506|FG000|Part 2 - Treatment|Disease Progression|0|||
157056178|NCT00296504|566959544|FG005|Interim Analysis|Lost to Follow-up|4|||
157056179|NCT00296504|566959545|FG006|Interim Analysis|Lost to Follow-up|11|||
157056180|NCT00296504|566959546|FG007|Interim Analysis|Lost to Follow-up|4|||
157056181|NCT00296504|566959547|FG008|Interim Analysis|Lost to Follow-up|0|||
156975519|NCT02508532|566665507|FG001|Part 2 - Treatment|Disease Progression|0|||
156975520|NCT02508532|566665508|FG002|Part 2 - Treatment|Disease Progression|0|||
156975521|NCT02508532|566665509|FG003|Part 2 - Treatment|Disease Progression|0|||
156975522|NCT02508532|566665510|FG004|Part 2 - Treatment|Disease Progression|0|||
156975523|NCT02508532|566665511|FG005|Part 2 - Treatment|Disease Progression|0|||
156975524|NCT02508532|566665512|FG006|Part 2 - Treatment|Disease Progression|0|||
156975525|NCT02508532|566665513|FG007|Part 2 - Treatment|Disease Progression|0|||
156975526|NCT02508532|566665514|FG008|Part 2 - Treatment|Disease Progression|118|||
156975527|NCT02508532|566665506|FG000|Part 2 - Treatment|Adverse Event|0|||
156975528|NCT02508532|566665507|FG001|Part 2 - Treatment|Adverse Event|0|||
156975529|NCT02508532|566665508|FG002|Part 2 - Treatment|Adverse Event|0|||
156975530|NCT02508532|566665509|FG003|Part 2 - Treatment|Adverse Event|0|||
156975531|NCT02508532|566665510|FG004|Part 2 - Treatment|Adverse Event|0|||
156975532|NCT02508532|566665511|FG005|Part 2 - Treatment|Adverse Event|0|||
156975533|NCT02508532|566665512|FG006|Part 2 - Treatment|Adverse Event|0|||
156975534|NCT02508532|566665513|FG007|Part 2 - Treatment|Adverse Event|0|||
156975535|NCT02508532|566665514|FG008|Part 2 - Treatment|Adverse Event|49|||
156975536|NCT02508532|566665506|FG000|Part 2 - Treatment|Physician Decision|0|||
156975537|NCT02508532|566665507|FG001|Part 2 - Treatment|Physician Decision|0|||
156975538|NCT02508532|566665508|FG002|Part 2 - Treatment|Physician Decision|0|||
156975539|NCT02508532|566665509|FG003|Part 2 - Treatment|Physician Decision|0|||
156975540|NCT02508532|566665510|FG004|Part 2 - Treatment|Physician Decision|0|||
156975541|NCT02508532|566665511|FG005|Part 2 - Treatment|Physician Decision|0|||
156975542|NCT02508532|566665512|FG006|Part 2 - Treatment|Physician Decision|0|||
156975543|NCT02508532|566665513|FG007|Part 2 - Treatment|Physician Decision|0|||
156975544|NCT02508532|566665514|FG008|Part 2 - Treatment|Physician Decision|12|||
156975545|NCT02508532|566665506|FG000|Part 2 - Treatment|Administrative|0|||
156975546|NCT02508532|566665507|FG001|Part 2 - Treatment|Administrative|0|||
156975547|NCT02508532|566665508|FG002|Part 2 - Treatment|Administrative|0|||
156975548|NCT02508532|566665509|FG003|Part 2 - Treatment|Administrative|0|||
156975549|NCT02508532|566665510|FG004|Part 2 - Treatment|Administrative|0|||
156975550|NCT02508532|566665511|FG005|Part 2 - Treatment|Administrative|0|||
156975551|NCT02508532|566665512|FG006|Part 2 - Treatment|Administrative|0|||
156975552|NCT02508532|566665513|FG007|Part 2 - Treatment|Administrative|0|||
156975553|NCT02508532|566665514|FG008|Part 2 - Treatment|Administrative|3|||
156975554|NCT02508532|566665506|FG000|Part 2 - Treatment|Sponsor Decision|0|||
156975555|NCT02508532|566665507|FG001|Part 2 - Treatment|Sponsor Decision|0|||
156975556|NCT02508532|566665508|FG002|Part 2 - Treatment|Sponsor Decision|0|||
156975557|NCT02508532|566665509|FG003|Part 2 - Treatment|Sponsor Decision|0|||
156975558|NCT02508532|566665510|FG004|Part 2 - Treatment|Sponsor Decision|0|||
156975559|NCT02508532|566665511|FG005|Part 2 - Treatment|Sponsor Decision|0|||
156975560|NCT02508532|566665512|FG006|Part 2 - Treatment|Sponsor Decision|0|||
156975561|NCT02508532|566665513|FG007|Part 2 - Treatment|Sponsor Decision|0|||
156975562|NCT02508532|566665514|FG008|Part 2 - Treatment|Sponsor Decision|28|||
156975563|NCT02508532|566665506|FG000|Part 2 - Treatment|Death|0|||
156975564|NCT02508532|566665507|FG001|Part 2 - Treatment|Death|0|||
156975565|NCT02508532|566665508|FG002|Part 2 - Treatment|Death|0|||
156975566|NCT02508532|566665509|FG003|Part 2 - Treatment|Death|0|||
156975567|NCT02508532|566665510|FG004|Part 2 - Treatment|Death|0|||
156975568|NCT02508532|566665511|FG005|Part 2 - Treatment|Death|0|||
156975569|NCT02508532|566665512|FG006|Part 2 - Treatment|Death|0|||
156975570|NCT02508532|566665513|FG007|Part 2 - Treatment|Death|0|||
156975571|NCT02508532|566665514|FG008|Part 2 - Treatment|Death|1|||
156975572|NCT02508532|566665506|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
156975573|NCT02508532|566665507|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
156975574|NCT02508532|566665508|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
156975575|NCT02508532|566665509|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
156975576|NCT02508532|566665510|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
156975577|NCT02508532|566665511|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
156975578|NCT02508532|566665512|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
156975579|NCT02508532|566665513|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
156975580|NCT02508532|566665514|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
156975581|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
156975582|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975583|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975584|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975585|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975586|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975587|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
156975588|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
156975589|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
156975590|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
157056182|NCT00296504|566959539|FG000|Interim Analysis|Clinical Progression|1|||
157056183|NCT00296504|566959540|FG001|Interim Analysis|Clinical Progression|0|||
157056184|NCT00296504|566959541|FG002|Interim Analysis|Clinical Progression|1|||
157056185|NCT00296504|566959542|FG003|Interim Analysis|Clinical Progression|1|||
157056186|NCT00296504|566959543|FG004|Interim Analysis|Clinical Progression|0|||
157056187|NCT00296504|566959544|FG005|Interim Analysis|Clinical Progression|2|||
157056188|NCT00296504|566959545|FG006|Interim Analysis|Clinical Progression|1|||
157056189|NCT00296504|566959546|FG007|Interim Analysis|Clinical Progression|2|||
157056190|NCT00296504|566959547|FG008|Interim Analysis|Clinical Progression|0|||
157056191|NCT00296504|566959539|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
157056192|NCT00296504|566959540|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
157056193|NCT00296504|566959541|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
157056194|NCT00296504|566959542|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
157056195|NCT00296504|566959543|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
157056196|NCT00296504|566959544|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
157056197|NCT00296504|566959545|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
157056198|NCT00296504|566959546|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
157056199|NCT00296504|566959547|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
157056200|NCT00296504|566959539|FG000|Interim Analysis|Adverse Event|0|||
157056201|NCT00296504|566959540|FG001|Interim Analysis|Adverse Event|0|||
157056202|NCT00296504|566959541|FG002|Interim Analysis|Adverse Event|13|||
157056203|NCT00296504|566959542|FG003|Interim Analysis|Adverse Event|4|||
157056204|NCT00296504|566959543|FG004|Interim Analysis|Adverse Event|6|||
157056205|NCT00296504|566959544|FG005|Interim Analysis|Adverse Event|3|||
157056206|NCT00296504|566959545|FG006|Interim Analysis|Adverse Event|4|||
157056207|NCT00296504|566959546|FG007|Interim Analysis|Adverse Event|5|||
157056208|NCT00296504|566959547|FG008|Interim Analysis|Adverse Event|0|||
157056209|NCT00296504|566959539|FG000|Interim Analysis|Protocol Violation|0|||
157056210|NCT00296504|566959540|FG001|Interim Analysis|Protocol Violation|0|||
157056211|NCT00296504|566959541|FG002|Interim Analysis|Protocol Violation|2|||
157056212|NCT00296504|566959542|FG003|Interim Analysis|Protocol Violation|0|||
157056213|NCT00296504|566959543|FG004|Interim Analysis|Protocol Violation|1|||
157056214|NCT00296504|566959544|FG005|Interim Analysis|Protocol Violation|0|||
157056215|NCT00296504|566959545|FG006|Interim Analysis|Protocol Violation|0|||
157056216|NCT00296504|566959546|FG007|Interim Analysis|Protocol Violation|1|||
157056217|NCT00296504|566959547|FG008|Interim Analysis|Protocol Violation|0|||
157056218|NCT00296504|566959539|FG000|Interim Analysis|Insufficient CD4 Response|0|||
157056219|NCT00296504|566959540|FG001|Interim Analysis|Insufficient CD4 Response|0|||
157056220|NCT00296504|566959541|FG002|Interim Analysis|Insufficient CD4 Response|0|||
157056221|NCT00296504|566959542|FG003|Interim Analysis|Insufficient CD4 Response|0|||
157056222|NCT00296504|566959543|FG004|Interim Analysis|Insufficient CD4 Response|1|||
157056223|NCT00296504|566959544|FG005|Interim Analysis|Insufficient CD4 Response|1|||
157056224|NCT00296504|566959545|FG006|Interim Analysis|Insufficient CD4 Response|0|||
157056225|NCT00296504|566959546|FG007|Interim Analysis|Insufficient CD4 Response|0|||
157056226|NCT00296504|566959547|FG008|Interim Analysis|Insufficient CD4 Response|0|||
157056227|NCT00296504|566959539|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
157056228|NCT00296504|566959540|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
157056229|NCT00296504|566959541|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
157056230|NCT00296504|566959542|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
157056231|NCT00296504|566959543|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
157056232|NCT00296504|566959544|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
157056233|NCT00296504|566959545|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
157056234|NCT00296504|566959546|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
157056235|NCT00296504|566959547|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
157056236|NCT00296504|566959539|FG000|Interim Analysis|Pregnancy|4|||
157056237|NCT00296504|566959540|FG001|Interim Analysis|Pregnancy|1|||
157056238|NCT00296504|566959541|FG002|Interim Analysis|Pregnancy|4|||
157056239|NCT00296504|566959542|FG003|Interim Analysis|Pregnancy|2|||
157178884|NCT00809614|567398010|FG000|Overall Study|Withdrawal by Subject|1|||
157178885|NCT00809614|567398011|FG001|Overall Study|Withdrawal by Subject|1|||
157178886|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Death|3|||
157178887|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Death|0|||
157178888|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Death|0|||
157056240|NCT00296504|566959543|FG004|Interim Analysis|Pregnancy|0|||
157056241|NCT00296504|566959544|FG005|Interim Analysis|Pregnancy|1|||
157178889|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Death|0|||
157056242|NCT00296504|566959545|FG006|Interim Analysis|Pregnancy|1|||
157056243|NCT00296504|566959546|FG007|Interim Analysis|Pregnancy|1|||
157056244|NCT00296504|566959547|FG008|Interim Analysis|Pregnancy|0|||
157056245|NCT00296504|566959539|FG000|Interim Analysis|Death|1|||
157056246|NCT00296504|566959540|FG001|Interim Analysis|Death|0|||
157056247|NCT00296504|566959541|FG002|Interim Analysis|Death|3|||
157056248|NCT00296504|566959542|FG003|Interim Analysis|Death|0|||
157056249|NCT00296504|566959543|FG004|Interim Analysis|Death|0|||
157178890|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Death|0|||
157056250|NCT00296504|566959544|FG005|Interim Analysis|Death|0|||
157056251|NCT00296504|566959545|FG006|Interim Analysis|Death|0|||
157056252|NCT00296504|566959546|FG007|Interim Analysis|Death|0|||
157056253|NCT00296504|566959547|FG008|Interim Analysis|Death|0|||
157056254|NCT00296504|566959539|FG000|Interim Analysis|Participant Non-compliant|0|||
157056255|NCT00296504|566959540|FG001|Interim Analysis|Participant Non-compliant|1|||
157056256|NCT00296504|566959541|FG002|Interim Analysis|Participant Non-compliant|2|||
157056257|NCT00296504|566959542|FG003|Interim Analysis|Participant Non-compliant|1|||
157056258|NCT00296504|566959543|FG004|Interim Analysis|Participant Non-compliant|1|||
156975591|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975592|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
156975593|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975594|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975595|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975596|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975597|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
156975598|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
156975599|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Death|0|||
156975600|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Death|4|||
156975601|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Death|2|||
156975602|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Death|4|||
156975603|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Death|3|||
156975604|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Death|0|||
156975605|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Death|0|||
156975606|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Death|1|||
156975607|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Death|111|||
156975608|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
157056259|NCT00296504|566959544|FG005|Interim Analysis|Participant Non-compliant|3|||
157056260|NCT00296504|566959545|FG006|Interim Analysis|Participant Non-compliant|6|||
157056261|NCT00296504|566959546|FG007|Interim Analysis|Participant Non-compliant|2|||
157056262|NCT00296504|566959547|FG008|Interim Analysis|Participant Non-compliant|0|||
157056263|NCT00296504|566959539|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056264|NCT00296504|566959540|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056265|NCT00296504|566959541|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
157056266|NCT00296504|566959542|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056267|NCT00296504|566959543|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056268|NCT00296504|566959544|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
157056269|NCT00296504|566959545|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056270|NCT00296504|566959546|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056271|NCT00296504|566959547|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
157056272|NCT00296504|566959539|FG000|Interim Analysis|To Simplify Treatment|0|||
157056273|NCT00296504|566959540|FG001|Interim Analysis|To Simplify Treatment|0|||
157056274|NCT00296504|566959541|FG002|Interim Analysis|To Simplify Treatment|1|||
157056275|NCT00296504|566959542|FG003|Interim Analysis|To Simplify Treatment|0|||
157056276|NCT00296504|566959543|FG004|Interim Analysis|To Simplify Treatment|0|||
157056277|NCT00296504|566959544|FG005|Interim Analysis|To Simplify Treatment|0|||
157056278|NCT00296504|566959545|FG006|Interim Analysis|To Simplify Treatment|2|||
157056279|NCT00296504|566959546|FG007|Interim Analysis|To Simplify Treatment|0|||
157056280|NCT00296504|566959547|FG008|Interim Analysis|To Simplify Treatment|0|||
157056281|NCT00296504|566959539|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056282|NCT00296504|566959540|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056283|NCT00296504|566959541|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
157056284|NCT00296504|566959542|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056285|NCT00296504|566959543|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056286|NCT00296504|566959544|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056287|NCT00296504|566959545|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056288|NCT00296504|566959546|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
157056289|NCT00296504|566959547|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
157229641|NCT00497796|567586537|FG001|Overall Study|Investigator/sponsor discretion|34|||
157229642|NCT00497796|567586536|FG000|Overall Study|Lost to Follow-up|0|||
157229643|NCT00497796|567586537|FG001|Overall Study|Lost to Follow-up|1|||
157229644|NCT00497796|567586536|FG000|Overall Study|Not applicable (randomized not treated)|0|||
157056290|NCT00296504|566959539|FG000|Interim Analysis|Participant Moved|1|||
157056291|NCT00296504|566959540|FG001|Interim Analysis|Participant Moved|0|||
157056292|NCT00296504|566959541|FG002|Interim Analysis|Participant Moved|1|||
157056293|NCT00296504|566959542|FG003|Interim Analysis|Participant Moved|0|||
156975609|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
156975610|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
157056294|NCT00296504|566959543|FG004|Interim Analysis|Participant Moved|0|||
157056295|NCT00296504|566959544|FG005|Interim Analysis|Participant Moved|1|||
157056296|NCT00296504|566959545|FG006|Interim Analysis|Participant Moved|1|||
157056297|NCT00296504|566959546|FG007|Interim Analysis|Participant Moved|0|||
157056298|NCT00296504|566959547|FG008|Interim Analysis|Participant Moved|0|||
157056299|NCT00296504|566959539|FG000|Interim Analysis|Participant Was Incarcerated|2|||
157056300|NCT00296504|566959540|FG001|Interim Analysis|Participant Was Incarcerated|0|||
157056301|NCT00296504|566959541|FG002|Interim Analysis|Participant Was Incarcerated|1|||
157056302|NCT00296504|566959542|FG003|Interim Analysis|Participant Was Incarcerated|0|||
157056303|NCT00296504|566959543|FG004|Interim Analysis|Participant Was Incarcerated|0|||
157056304|NCT00296504|566959544|FG005|Interim Analysis|Participant Was Incarcerated|0|||
157056305|NCT00296504|566959545|FG006|Interim Analysis|Participant Was Incarcerated|0|||
157056306|NCT00296504|566959546|FG007|Interim Analysis|Participant Was Incarcerated|0|||
157056307|NCT00296504|566959547|FG008|Interim Analysis|Participant Was Incarcerated|0|||
157056308|NCT00296504|566959539|FG000|Interim Analysis|Resistance to FPV|0|||
157056309|NCT00296504|566959540|FG001|Interim Analysis|Resistance to FPV|0|||
157056310|NCT00296504|566959541|FG002|Interim Analysis|Resistance to FPV|1|||
157056311|NCT00296504|566959542|FG003|Interim Analysis|Resistance to FPV|0|||
157056312|NCT00296504|566959543|FG004|Interim Analysis|Resistance to FPV|0|||
157056313|NCT00296504|566959544|FG005|Interim Analysis|Resistance to FPV|0|||
157056314|NCT00296504|566959545|FG006|Interim Analysis|Resistance to FPV|0|||
157056315|NCT00296504|566959546|FG007|Interim Analysis|Resistance to FPV|0|||
157056316|NCT00296504|566959547|FG008|Interim Analysis|Resistance to FPV|0|||
157056317|NCT00296504|566959539|FG000|Interim Analysis|Physician Decision|0|||
157056318|NCT00296504|566959540|FG001|Interim Analysis|Physician Decision|0|||
157056319|NCT00296504|566959541|FG002|Interim Analysis|Physician Decision|1|||
157056320|NCT00296504|566959542|FG003|Interim Analysis|Physician Decision|0|||
157056321|NCT00296504|566959543|FG004|Interim Analysis|Physician Decision|0|||
157056322|NCT00296504|566959544|FG005|Interim Analysis|Physician Decision|0|||
157056323|NCT00296504|566959545|FG006|Interim Analysis|Physician Decision|0|||
157056324|NCT00296504|566959546|FG007|Interim Analysis|Physician Decision|0|||
157056325|NCT00296504|566959547|FG008|Interim Analysis|Physician Decision|0|||
157056326|NCT00296504|566959539|FG000|Interim Analysis|Principle Investigator Discretion|2|||
157056327|NCT00296504|566959540|FG001|Interim Analysis|Principle Investigator Discretion|0|||
157056328|NCT00296504|566959541|FG002|Interim Analysis|Principle Investigator Discretion|1|||
157056329|NCT00296504|566959542|FG003|Interim Analysis|Principle Investigator Discretion|1|||
157056330|NCT00296504|566959543|FG004|Interim Analysis|Principle Investigator Discretion|0|||
157056331|NCT00296504|566959544|FG005|Interim Analysis|Principle Investigator Discretion|0|||
157056332|NCT00296504|566959545|FG006|Interim Analysis|Principle Investigator Discretion|0|||
157056333|NCT00296504|566959546|FG007|Interim Analysis|Principle Investigator Discretion|0|||
157056334|NCT00296504|566959547|FG008|Interim Analysis|Principle Investigator Discretion|0|||
157056335|NCT00296504|566959539|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
157056336|NCT00296504|566959540|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
157056337|NCT00296504|566959541|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
157056338|NCT00296504|566959542|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
157056339|NCT00296504|566959543|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
157056340|NCT00296504|566959544|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
157056341|NCT00296504|566959545|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
157056342|NCT00296504|566959546|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
157056343|NCT00296504|566959547|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
157056344|NCT00296504|566959539|FG000|Interim Analysis|Non-adherence|2|||
157056345|NCT00296504|566959540|FG001|Interim Analysis|Non-adherence|0|||
157056346|NCT00296504|566959541|FG002|Interim Analysis|Non-adherence|0|||
157056347|NCT00296504|566959542|FG003|Interim Analysis|Non-adherence|0|||
157056348|NCT00296504|566959543|FG004|Interim Analysis|Non-adherence|1|||
157056349|NCT00296504|566959544|FG005|Interim Analysis|Non-adherence|0|||
157056350|NCT00296504|566959545|FG006|Interim Analysis|Non-adherence|0|||
157056351|NCT00296504|566959546|FG007|Interim Analysis|Non-adherence|1|||
157056352|NCT00296504|566959547|FG008|Interim Analysis|Non-adherence|0|||
157056353|NCT00296504|566959539|FG000|Interim Analysis|Site Closing|1|||
157056354|NCT00296504|566959540|FG001|Interim Analysis|Site Closing|0|||
157056355|NCT00296504|566959541|FG002|Interim Analysis|Site Closing|0|||
157056356|NCT00296504|566959542|FG003|Interim Analysis|Site Closing|0|||
157056357|NCT00296504|566959543|FG004|Interim Analysis|Site Closing|0|||
157056358|NCT00296504|566959544|FG005|Interim Analysis|Site Closing|1|||
157056359|NCT00296504|566959545|FG006|Interim Analysis|Site Closing|2|||
157056360|NCT00296504|566959546|FG007|Interim Analysis|Site Closing|0|||
157056361|NCT00296504|566959547|FG008|Interim Analysis|Site Closing|0|||
157056362|NCT00296504|566959539|FG000|Interim Analysis|Lack of Personnel at Site|1|||
157056363|NCT00296504|566959540|FG001|Interim Analysis|Lack of Personnel at Site|0|||
157056364|NCT00296504|566959541|FG002|Interim Analysis|Lack of Personnel at Site|0|||
157056365|NCT00296504|566959542|FG003|Interim Analysis|Lack of Personnel at Site|0|||
157056366|NCT00296504|566959543|FG004|Interim Analysis|Lack of Personnel at Site|0|||
157056367|NCT00296504|566959544|FG005|Interim Analysis|Lack of Personnel at Site|0|||
157056368|NCT00296504|566959545|FG006|Interim Analysis|Lack of Personnel at Site|0|||
157056369|NCT00296504|566959546|FG007|Interim Analysis|Lack of Personnel at Site|0|||
157056370|NCT00296504|566959547|FG008|Interim Analysis|Lack of Personnel at Site|0|||
157056371|NCT00296504|566959539|FG000|Interim Analysis|Missed Schedule Date|1|||
157056372|NCT00296504|566959540|FG001|Interim Analysis|Missed Schedule Date|0|||
157056373|NCT00296504|566959541|FG002|Interim Analysis|Missed Schedule Date|0|||
157056374|NCT00296504|566959542|FG003|Interim Analysis|Missed Schedule Date|0|||
157056375|NCT00296504|566959543|FG004|Interim Analysis|Missed Schedule Date|0|||
157056376|NCT00296504|566959544|FG005|Interim Analysis|Missed Schedule Date|0|||
157056377|NCT00296504|566959545|FG006|Interim Analysis|Missed Schedule Date|0|||
157056378|NCT00296504|566959546|FG007|Interim Analysis|Missed Schedule Date|0|||
157056379|NCT00296504|566959547|FG008|Interim Analysis|Missed Schedule Date|0|||
157056380|NCT00296504|566959539|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
157056381|NCT00296504|566959540|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
157056382|NCT00296504|566959541|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
157056383|NCT00296504|566959542|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
157056384|NCT00296504|566959543|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
157056385|NCT00296504|566959544|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
157056386|NCT00296504|566959545|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
157056387|NCT00296504|566959546|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
157056388|NCT00296504|566959547|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
157056389|NCT00296504|566959539|FG000|Interim Analysis|Participant Stopped|0|||
157056390|NCT00296504|566959540|FG001|Interim Analysis|Participant Stopped|0|||
157056391|NCT00296504|566959541|FG002|Interim Analysis|Participant Stopped|0|||
157056392|NCT00296504|566959542|FG003|Interim Analysis|Participant Stopped|0|||
157056393|NCT00296504|566959543|FG004|Interim Analysis|Participant Stopped|1|||
157056394|NCT00296504|566959544|FG005|Interim Analysis|Participant Stopped|0|||
157056395|NCT00296504|566959545|FG006|Interim Analysis|Participant Stopped|0|||
157056396|NCT00296504|566959546|FG007|Interim Analysis|Participant Stopped|0|||
157056397|NCT00296504|566959547|FG008|Interim Analysis|Participant Stopped|0|||
157056398|NCT00296504|566959539|FG000|Interim Analysis|Physician and Participant Decision|0|||
157056399|NCT00296504|566959540|FG001|Interim Analysis|Physician and Participant Decision|0|||
157056400|NCT00296504|566959541|FG002|Interim Analysis|Physician and Participant Decision|0|||
157056401|NCT00296504|566959542|FG003|Interim Analysis|Physician and Participant Decision|0|||
157056402|NCT00296504|566959543|FG004|Interim Analysis|Physician and Participant Decision|0|||
157056403|NCT00296504|566959544|FG005|Interim Analysis|Physician and Participant Decision|1|||
157056404|NCT00296504|566959545|FG006|Interim Analysis|Physician and Participant Decision|0|||
157056405|NCT00296504|566959546|FG007|Interim Analysis|Physician and Participant Decision|0|||
157056406|NCT00296504|566959547|FG008|Interim Analysis|Physician and Participant Decision|0|||
157056407|NCT00296504|566959539|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
157056408|NCT00296504|566959540|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
157056409|NCT00296504|566959541|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
157056410|NCT00296504|566959542|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
157056411|NCT00296504|566959543|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
157056412|NCT00296504|566959544|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
157056413|NCT00296504|566959545|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
157056414|NCT00296504|566959546|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
157056415|NCT00296504|566959547|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
157056416|NCT00296504|566959539|FG000|Interim Analysis|Study Ended|0|||
157056417|NCT00296504|566959540|FG001|Interim Analysis|Study Ended|0|||
157056418|NCT00296504|566959541|FG002|Interim Analysis|Study Ended|0|||
157056419|NCT00296504|566959542|FG003|Interim Analysis|Study Ended|0|||
157056420|NCT00296504|566959543|FG004|Interim Analysis|Study Ended|0|||
157056421|NCT00296504|566959544|FG005|Interim Analysis|Study Ended|0|||
157056422|NCT00296504|566959545|FG006|Interim Analysis|Study Ended|1|||
157056423|NCT00296504|566959546|FG007|Interim Analysis|Study Ended|0|||
157056424|NCT00296504|566959547|FG008|Interim Analysis|Study Ended|0|||
157056425|NCT00296504|566959539|FG000|Interim Analysis|Participant Needed Interferon|0|||
157056426|NCT00296504|566959540|FG001|Interim Analysis|Participant Needed Interferon|0|||
157056427|NCT00296504|566959541|FG002|Interim Analysis|Participant Needed Interferon|0|||
157056428|NCT00296504|566959542|FG003|Interim Analysis|Participant Needed Interferon|0|||
157056429|NCT00296504|566959543|FG004|Interim Analysis|Participant Needed Interferon|0|||
157056430|NCT00296504|566959544|FG005|Interim Analysis|Participant Needed Interferon|0|||
157056431|NCT00296504|566959545|FG006|Interim Analysis|Participant Needed Interferon|0|||
157056432|NCT00296504|566959546|FG007|Interim Analysis|Participant Needed Interferon|1|||
157056433|NCT00296504|566959547|FG008|Interim Analysis|Participant Needed Interferon|0|||
157056434|NCT00296504|566959539|FG000|Interim Analysis|Ongoing|32|||
157056435|NCT00296504|566959540|FG001|Interim Analysis|Ongoing|12|||
157056436|NCT00296504|566959541|FG002|Interim Analysis|Ongoing|16|||
157056437|NCT00296504|566959542|FG003|Interim Analysis|Ongoing|22|||
157056438|NCT00296504|566959543|FG004|Interim Analysis|Ongoing|0|||
157056439|NCT00296504|566959544|FG005|Interim Analysis|Ongoing|0|||
157056440|NCT00296504|566959545|FG006|Interim Analysis|Ongoing|30|||
157056441|NCT00296504|566959546|FG007|Interim Analysis|Ongoing|1|||
157056442|NCT00296504|566959547|FG008|Interim Analysis|Ongoing|0|||
157056443|NCT00296504|566959539|FG000|Final Analysis|Withdrawal by Subject|0|||
157056444|NCT00296504|566959540|FG001|Final Analysis|Withdrawal by Subject|0|||
157056445|NCT00296504|566959541|FG002|Final Analysis|Withdrawal by Subject|0|||
157056446|NCT00296504|566959542|FG003|Final Analysis|Withdrawal by Subject|0|||
157056447|NCT00296504|566959543|FG004|Final Analysis|Withdrawal by Subject|0|||
157056448|NCT00296504|566959544|FG005|Final Analysis|Withdrawal by Subject|0|||
157056449|NCT00296504|566959545|FG006|Final Analysis|Withdrawal by Subject|0|||
157056450|NCT00296504|566959546|FG007|Final Analysis|Withdrawal by Subject|0|||
157056451|NCT00296504|566959547|FG008|Final Analysis|Withdrawal by Subject|1|||
157056452|NCT00296504|566959539|FG000|Final Analysis|Lost to Follow-up|0|||
157056453|NCT00296504|566959540|FG001|Final Analysis|Lost to Follow-up|0|||
157056454|NCT00296504|566959541|FG002|Final Analysis|Lost to Follow-up|0|||
157056455|NCT00296504|566959542|FG003|Final Analysis|Lost to Follow-up|0|||
157056456|NCT00296504|566959543|FG004|Final Analysis|Lost to Follow-up|0|||
157056457|NCT00296504|566959544|FG005|Final Analysis|Lost to Follow-up|0|||
157056458|NCT00296504|566959545|FG006|Final Analysis|Lost to Follow-up|0|||
157056459|NCT00296504|566959546|FG007|Final Analysis|Lost to Follow-up|0|||
157056460|NCT00296504|566959547|FG008|Final Analysis|Lost to Follow-up|5|||
157056461|NCT00296504|566959539|FG000|Final Analysis|Insufficient Viral Load Response|0|||
157056462|NCT00296504|566959540|FG001|Final Analysis|Insufficient Viral Load Response|0|||
157056463|NCT00296504|566959541|FG002|Final Analysis|Insufficient Viral Load Response|0|||
157056464|NCT00296504|566959542|FG003|Final Analysis|Insufficient Viral Load Response|0|||
157056465|NCT00296504|566959543|FG004|Final Analysis|Insufficient Viral Load Response|0|||
157056466|NCT00296504|566959544|FG005|Final Analysis|Insufficient Viral Load Response|0|||
157056467|NCT00296504|566959545|FG006|Final Analysis|Insufficient Viral Load Response|0|||
157056468|NCT00296504|566959546|FG007|Final Analysis|Insufficient Viral Load Response|0|||
157056469|NCT00296504|566959547|FG008|Final Analysis|Insufficient Viral Load Response|6|||
157056470|NCT00296504|566959539|FG000|Final Analysis|Adverse Event|0|||
157056471|NCT00296504|566959540|FG001|Final Analysis|Adverse Event|0|||
157056472|NCT00296504|566959541|FG002|Final Analysis|Adverse Event|0|||
157056473|NCT00296504|566959542|FG003|Final Analysis|Adverse Event|0|||
157056474|NCT00296504|566959543|FG004|Final Analysis|Adverse Event|0|||
157056475|NCT00296504|566959544|FG005|Final Analysis|Adverse Event|0|||
157056476|NCT00296504|566959545|FG006|Final Analysis|Adverse Event|0|||
157056477|NCT00296504|566959546|FG007|Final Analysis|Adverse Event|0|||
157056478|NCT00296504|566959547|FG008|Final Analysis|Adverse Event|2|||
157056479|NCT00296504|566959539|FG000|Final Analysis|Pregnancy|0|||
157056480|NCT00296504|566959540|FG001|Final Analysis|Pregnancy|0|||
157056481|NCT00296504|566959541|FG002|Final Analysis|Pregnancy|0|||
157056482|NCT00296504|566959542|FG003|Final Analysis|Pregnancy|0|||
157056483|NCT00296504|566959543|FG004|Final Analysis|Pregnancy|0|||
157056484|NCT00296504|566959544|FG005|Final Analysis|Pregnancy|0|||
157056485|NCT00296504|566959545|FG006|Final Analysis|Pregnancy|0|||
157056486|NCT00296504|566959546|FG007|Final Analysis|Pregnancy|0|||
157056487|NCT00296504|566959547|FG008|Final Analysis|Pregnancy|4|||
157056488|NCT00296504|566959539|FG000|Final Analysis|Tuberculosis|0|||
157056489|NCT00296504|566959540|FG001|Final Analysis|Tuberculosis|0|||
157056490|NCT00296504|566959541|FG002|Final Analysis|Tuberculosis|0|||
157056491|NCT00296504|566959542|FG003|Final Analysis|Tuberculosis|0|||
157056492|NCT00296504|566959543|FG004|Final Analysis|Tuberculosis|0|||
157056493|NCT00296504|566959544|FG005|Final Analysis|Tuberculosis|0|||
157056494|NCT00296504|566959545|FG006|Final Analysis|Tuberculosis|0|||
157056495|NCT00296504|566959546|FG007|Final Analysis|Tuberculosis|0|||
157178891|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
157178892|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
157178893|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
157178894|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
157178895|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
157178896|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
157178897|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
157178898|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
157178899|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
157178900|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
157056496|NCT00296504|566959547|FG008|Final Analysis|Tuberculosis|1|||
157056497|NCT00296504|566959539|FG000|Final Analysis|Participant Moved to Another Country|0|||
157056498|NCT00296504|566959540|FG001|Final Analysis|Participant Moved to Another Country|0|||
157056499|NCT00296504|566959541|FG002|Final Analysis|Participant Moved to Another Country|0|||
157056500|NCT00296504|566959542|FG003|Final Analysis|Participant Moved to Another Country|0|||
157056501|NCT00296504|566959543|FG004|Final Analysis|Participant Moved to Another Country|0|||
157056502|NCT00296504|566959544|FG005|Final Analysis|Participant Moved to Another Country|0|||
157056503|NCT00296504|566959545|FG006|Final Analysis|Participant Moved to Another Country|0|||
157056504|NCT00296504|566959546|FG007|Final Analysis|Participant Moved to Another Country|0|||
157056505|NCT00296504|566959547|FG008|Final Analysis|Participant Moved to Another Country|1|||
157056506|NCT00296504|566959539|FG000|Final Analysis|Poor Adherence|0|||
157056507|NCT00296504|566959540|FG001|Final Analysis|Poor Adherence|0|||
157056508|NCT00296504|566959541|FG002|Final Analysis|Poor Adherence|0|||
157056509|NCT00296504|566959542|FG003|Final Analysis|Poor Adherence|0|||
157056510|NCT00296504|566959543|FG004|Final Analysis|Poor Adherence|0|||
157056511|NCT00296504|566959544|FG005|Final Analysis|Poor Adherence|0|||
157056512|NCT00296504|566959545|FG006|Final Analysis|Poor Adherence|0|||
157056513|NCT00296504|566959546|FG007|Final Analysis|Poor Adherence|0|||
157056514|NCT00296504|566959547|FG008|Final Analysis|Poor Adherence|1|||
157056515|NCT01323309|566959553|FG000|Overall Study|Death|9|||
157056516|NCT01323309|566959554|FG001|Overall Study|Death|15|||
157056517|NCT01323309|566959555|FG002|Overall Study|Death|5|||
157056518|NCT01323309|566959553|FG000|Overall Study|Lost to Follow-up|11|||
157056519|NCT01323309|566959554|FG001|Overall Study|Lost to Follow-up|14|||
157056520|NCT01323309|566959555|FG002|Overall Study|Lost to Follow-up|24|||
157056521|NCT01323309|566959553|FG000|Overall Study|Withdrawal by Subject|14|||
157056522|NCT01323309|566959554|FG001|Overall Study|Withdrawal by Subject|14|||
157056523|NCT01323309|566959555|FG002|Overall Study|Withdrawal by Subject|18|||
157056524|NCT01323309|566959553|FG000|Overall Study|Disease progression|5|||
157056525|NCT01323309|566959554|FG001|Overall Study|Disease progression|11|||
157056526|NCT01323309|566959555|FG002|Overall Study|Disease progression|4|||
157056527|NCT02162771|566959559|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
157056528|NCT02162771|566959560|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
157056529|NCT02162771|566959559|FG000|Core Study Period (Part 2)|Adverse Event|4|||
157056530|NCT02162771|566959560|FG001|Core Study Period (Part 2)|Adverse Event|1|||
157056531|NCT02162771|566959559|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
157056532|NCT02162771|566959560|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
157056533|NCT02162771|566959559|FG000|Core Study Period (Part 2)|Physician Decision|0|||
157056534|NCT02162771|566959560|FG001|Core Study Period (Part 2)|Physician Decision|2|||
157056535|NCT02162771|566959559|FG000|Core Study Period (Part 2)|Death|1|||
157056536|NCT02162771|566959560|FG001|Core Study Period (Part 2)|Death|0|||
157056537|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
157056538|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
157056539|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
157056540|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
157056541|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Death|2|||
157056542|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Death|1|||
157056543|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
157056544|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
157056545|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
157056546|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
157056547|NCT02162771|566959559|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
157056548|NCT02162771|566959560|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
157056549|NCT01078571|566959561|FG000|Overall Study|Adverse Event|36|||
157056550|NCT01078571|566959561|FG000|Overall Study|Lack of effectiveness|36|||
157056551|NCT01078571|566959561|FG000|Overall Study|Reason not reported|21|||
157056552|NCT01078571|566959561|FG000|Overall Study|Withdrawal by Subject|12|||
157056553|NCT01078571|566959561|FG000|Overall Study|Lost to Follow-up|8|||
157056554|NCT01078571|566959561|FG000|Overall Study|Protocol Violation|2|||
157056555|NCT01047306|566959566|FG000|Overall Study|Withdrawal by Subject|2|||
157056556|NCT01047306|566959567|FG001|Overall Study|Withdrawal by Subject|0|||
157056557|NCT01047306|566959566|FG000|Overall Study|Lost to Follow-up|1|||
157056558|NCT01047306|566959567|FG001|Overall Study|Lost to Follow-up|0|||
157056559|NCT01878253|566959568|FG000|Overall Study|Death|1|||
157056560|NCT01878253|566959568|FG000|Overall Study|SIdus System Removal|3|||
157056561|NCT01878253|566959568|FG000|Overall Study|Withdrawal by Subject|1|||
157056562|NCT01878253|566959568|FG000|Overall Study|Lost to Follow-up|2|||
157056563|NCT01878253|566959568|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
157056564|NCT00449033|566959573|FG000|Treatment Period|Adverse Event|117|||
157056565|NCT00449033|566959574|FG001|Treatment Period|Adverse Event|83|||
157056566|NCT00449033|566959573|FG000|Treatment Period|Death|21|||
157056567|NCT00449033|566959574|FG001|Treatment Period|Death|12|||
157056568|NCT00449033|566959573|FG000|Treatment Period|Lost to Follow-up|0|||
157056569|NCT00449033|566959574|FG001|Treatment Period|Lost to Follow-up|2|||
157056570|NCT00449033|566959573|FG000|Treatment Period|Physician Decision|4|||
157056571|NCT00449033|566959574|FG001|Treatment Period|Physician Decision|5|||
157056572|NCT00449033|566959573|FG000|Treatment Period|Protocol Violation|8|||
157178901|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Other|0|||
157178902|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Other|0|||
157056573|NCT00449033|566959574|FG001|Treatment Period|Protocol Violation|7|||
157056574|NCT00449033|566959573|FG000|Treatment Period|Disease Progression|231|||
157056575|NCT00449033|566959574|FG001|Treatment Period|Disease Progression|288|||
157056576|NCT00449033|566959573|FG000|Treatment Period|Consent Withdrawn|36|||
157056577|NCT00449033|566959574|FG001|Treatment Period|Consent Withdrawn|20|||
157056578|NCT00449033|566959573|FG000|Treatment Period|Amended Protocol Criteria|22|||
157056579|NCT00449033|566959574|FG001|Treatment Period|Amended Protocol Criteria|18|||
157056580|NCT00449033|566959573|FG000|Treatment Period|Non-compliance|7|||
157056581|NCT00449033|566959574|FG001|Treatment Period|Non-compliance|8|||
157056582|NCT00449033|566959573|FG000|Treatment Period|Second Malignancy|0|||
157056583|NCT00449033|566959574|FG001|Treatment Period|Second Malignancy|1|||
157056584|NCT00449033|566959573|FG000|Treatment Period|Reason Missing|0|||
157056585|NCT00449033|566959574|FG001|Treatment Period|Reason Missing|4|||
157056586|NCT00449033|566959573|FG000|Treatment Period|Treatment Ongoing|6|||
157056587|NCT00449033|566959574|FG001|Treatment Period|Treatment Ongoing|4|||
157056588|NCT00449033|566959573|FG000|Follow-up Period|Death|299|||
157056589|NCT00449033|566959574|FG001|Follow-up Period|Death|311|||
157056590|NCT00449033|566959573|FG000|Follow-up Period|Lost to Follow-up|6|||
157056591|NCT00449033|566959574|FG001|Follow-up Period|Lost to Follow-up|10|||
157056592|NCT00449033|566959573|FG000|Follow-up Period|Reason Missing|120|||
157056593|NCT00449033|566959574|FG001|Follow-up Period|Reason Missing|113|||
157056594|NCT04393779|566959577|FG000|Overall Study|Death|1|||
157056595|NCT04393779|566959577|FG000|Overall Study|Device reintervention or explant|4|||
157056596|NCT03802513|566959579|FG000|Overall Study|Lost to Follow-up|1|||
157056597|NCT01261793|566959582|FG000|Overall Study|Lack of Efficacy|44|||
157056598|NCT01261793|566959583|FG001|Overall Study|Lack of Efficacy|37|||
157056599|NCT01261793|566959584|FG002|Overall Study|Lack of Efficacy|32|||
157056600|NCT01261793|566959582|FG000|Overall Study|Protocol Violation|3|||
157056601|NCT01261793|566959583|FG001|Overall Study|Protocol Violation|5|||
157056602|NCT01261793|566959584|FG002|Overall Study|Protocol Violation|6|||
157056603|NCT01261793|566959582|FG000|Overall Study|Lost to Follow-up|10|||
157056604|NCT01261793|566959583|FG001|Overall Study|Lost to Follow-up|3|||
157056605|NCT01261793|566959584|FG002|Overall Study|Lost to Follow-up|7|||
157056606|NCT01261793|566959582|FG000|Overall Study|Withdrawal by Subject|12|||
157056607|NCT01261793|566959583|FG001|Overall Study|Withdrawal by Subject|14|||
157056608|NCT01261793|566959584|FG002|Overall Study|Withdrawal by Subject|14|||
157056609|NCT01261793|566959582|FG000|Overall Study|Death|3|||
157056610|NCT01261793|566959583|FG001|Overall Study|Death|1|||
157056611|NCT01261793|566959584|FG002|Overall Study|Death|0|||
157056612|NCT01261793|566959582|FG000|Overall Study|Adverse Event|9|||
157056613|NCT01261793|566959583|FG001|Overall Study|Adverse Event|24|||
157056614|NCT01261793|566959584|FG002|Overall Study|Adverse Event|19|||
157056615|NCT01261793|566959582|FG000|Overall Study|Patient non-availability|1|||
157056616|NCT01261793|566959583|FG001|Overall Study|Patient non-availability|1|||
157056617|NCT01261793|566959584|FG002|Overall Study|Patient non-availability|1|||
157056618|NCT01261793|566959582|FG000|Overall Study|Suspected pregnancy|1|||
157056619|NCT01261793|566959583|FG001|Overall Study|Suspected pregnancy|1|||
157056620|NCT01261793|566959584|FG002|Overall Study|Suspected pregnancy|0|||
157056621|NCT01261793|566959582|FG000|Overall Study|Patient non-compliance|1|||
157056622|NCT01261793|566959583|FG001|Overall Study|Patient non-compliance|0|||
157056623|NCT01261793|566959584|FG002|Overall Study|Patient non-compliance|1|||
157056624|NCT01261793|566959582|FG000|Overall Study|Patient pregnant|1|||
157056625|NCT01261793|566959583|FG001|Overall Study|Patient pregnant|0|||
157056626|NCT01261793|566959584|FG002|Overall Study|Patient pregnant|0|||
157056627|NCT01261793|566959582|FG000|Overall Study|Outside the study area|0|||
157056628|NCT01261793|566959583|FG001|Overall Study|Outside the study area|2|||
157056629|NCT01261793|566959584|FG002|Overall Study|Outside the study area|1|||
157056630|NCT01261793|566959582|FG000|Overall Study|Lack of efficacy & patient not available|0|||
157056631|NCT01261793|566959583|FG001|Overall Study|Lack of efficacy & patient not available|1|||
157056632|NCT01261793|566959584|FG002|Overall Study|Lack of efficacy & patient not available|0|||
157056633|NCT01261793|566959582|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
157056634|NCT01261793|566959583|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
157056635|NCT01261793|566959584|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
157056636|NCT01261793|566959582|FG000|Overall Study|Randomization error|0|||
157056637|NCT01261793|566959583|FG001|Overall Study|Randomization error|1|||
157056638|NCT01261793|566959584|FG002|Overall Study|Randomization error|0|||
157056639|NCT01261793|566959582|FG000|Overall Study|Patient unable to start IV line|0|||
157056640|NCT01261793|566959583|FG001|Overall Study|Patient unable to start IV line|0|||
157229645|NCT00497796|567586537|FG001|Overall Study|Not applicable (randomized not treated)|4|||
157056641|NCT01261793|566959584|FG002|Overall Study|Patient unable to start IV line|1|||
157056642|NCT03219216|566959585|FG000|Overall Study|Lost to Follow-up|0|||
157056643|NCT03219216|566959586|FG001|Overall Study|Lost to Follow-up|1|||
157056644|NCT01855399|566959587|FG000|6 Month|Lost to Follow-up|12|||
157056645|NCT01855399|566959588|FG001|6 Month|Lost to Follow-up|9|||
157056646|NCT01855399|566959587|FG000|6 Month|Withdrawal by Subject|8|||
157056647|NCT01855399|566959588|FG001|6 Month|Withdrawal by Subject|6|||
157056648|NCT01855399|566959587|FG000|12 Month|Lost to Follow-up|7|||
157056649|NCT01855399|566959588|FG001|12 Month|Lost to Follow-up|11|||
157056650|NCT00512902|566959589|FG000|Overall Study|Adverse Event|7|||
157056651|NCT00512902|566959589|FG000|Overall Study|Lost to Follow-up|1|||
157056652|NCT02389894|566959590|FG000|Overall Study|Death|4|||
157056653|NCT02389894|566959591|FG001|Overall Study|Death|5|||
157056654|NCT02389894|566959592|FG002|Overall Study|Death|3|||
157056655|NCT02389894|566959590|FG000|Overall Study|Withdrawal by Subject|2|||
157056656|NCT02389894|566959591|FG001|Overall Study|Withdrawal by Subject|4|||
157056657|NCT02389894|566959592|FG002|Overall Study|Withdrawal by Subject|5|||
157056658|NCT02389894|566959590|FG000|Overall Study|Lost to Follow-up|2|||
157056659|NCT02389894|566959591|FG001|Overall Study|Lost to Follow-up|1|||
157056660|NCT02389894|566959592|FG002|Overall Study|Lost to Follow-up|1|||
157056661|NCT01429285|566959594|FG000|Overall Study|Protocol Violation|9|||
157056662|NCT01429285|566959595|FG001|Overall Study|Protocol Violation|4|||
157056663|NCT01429285|566959594|FG000|Overall Study|Missing Data|5|||
157056664|NCT01429285|566959595|FG001|Overall Study|Missing Data|3|||
157056665|NCT01429285|566959594|FG000|Overall Study|Erroneously Enrolled Twice|8|||
157056666|NCT01429285|566959595|FG001|Overall Study|Erroneously Enrolled Twice|2|||
157056667|NCT01123200|566959596|FG000|Overall Study|Withdrawal by Subject|1|||
157056668|NCT01288729|566959602|FG000|Overall Study|Withdrawal by Subject|1|||
157056669|NCT01288729|566959603|FG001|Overall Study|Withdrawal by Subject|0|||
157056670|NCT03214198|566959604|FG000|Overall Study|Case Report Forms Uncollected|18|||
157056671|NCT03214198|566959604|FG000|Overall Study|Protocol Deviation|18|||
157056672|NCT02577315|566959605|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157056673|NCT02577315|566959606|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
157056674|NCT01636778|566959611|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
157056675|NCT01636778|566959612|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
157056676|NCT01636778|566959613|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
157056677|NCT01636778|566959611|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
157056678|NCT01636778|566959612|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
157056679|NCT01636778|566959613|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
157056680|NCT01636778|566959611|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
157056681|NCT01636778|566959612|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
157056682|NCT01636778|566959613|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
157056683|NCT01636778|566959611|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
157056684|NCT01636778|566959612|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
157056685|NCT01636778|566959613|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
157056686|NCT01636778|566959611|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
157056687|NCT01636778|566959612|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
157056688|NCT01636778|566959613|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
157056689|NCT01636778|566959611|FG000|Follow-up Period After Part 2|Other|0|||
157056690|NCT01636778|566959612|FG001|Follow-up Period After Part 2|Other|0|||
157056691|NCT01636778|566959613|FG002|Follow-up Period After Part 2|Other|1|||
157056692|NCT01636778|566959611|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
157056693|NCT01636778|566959612|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
157056694|NCT01636778|566959613|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
157056695|NCT01636778|566959611|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
157056696|NCT01636778|566959612|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
157056697|NCT01636778|566959613|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
157056698|NCT03530345|566959617|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
157056699|NCT03530345|566959618|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
157056700|NCT03530345|566959617|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
157056701|NCT03530345|566959618|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
157056702|NCT03530345|566959617|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
157056703|NCT03530345|566959618|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
157056704|NCT03530345|566959617|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
157056705|NCT03530345|566959618|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
157056706|NCT00170950|566959621|FG000|Overall Study|Death|236|||
157056707|NCT00170950|566959622|FG001|Overall Study|Death|274|||
157056708|NCT00170950|566959621|FG000|Overall Study|Withdrawal by Subject|496|||
157056709|NCT00170950|566959622|FG001|Overall Study|Withdrawal by Subject|498|||
157056710|NCT00170950|566959621|FG000|Overall Study|Lost to Follow-up|134|||
157056711|NCT00170950|566959622|FG001|Overall Study|Lost to Follow-up|115|||
157056712|NCT00170950|566959621|FG000|Overall Study|Missing|2|||
157056713|NCT00170950|566959622|FG001|Overall Study|Missing|1|||
157056714|NCT00170950|566959621|FG000|Overall Study|Termination Data Not Recorded|17|||
157056715|NCT00170950|566959622|FG001|Overall Study|Termination Data Not Recorded|22|||
157056716|NCT00748098|566959623|FG000|First Treatment Intervention Period|Adverse Event|1|||
157056717|NCT00748098|566959624|FG001|First Treatment Intervention Period|Adverse Event|1|||
157056718|NCT00748098|566959623|FG000|First Treatment Intervention Period|Protocol Violation|1|||
157056719|NCT00748098|566959624|FG001|First Treatment Intervention Period|Protocol Violation|0|||
157056720|NCT00748098|566959623|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
157056721|NCT00748098|566959624|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
157056722|NCT00748098|566959623|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
157056723|NCT00748098|566959624|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
157178903|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Other|1|||
157178904|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Other|0|||
157056724|NCT00748098|566959623|FG000|First Taper Period|Protocol Violation|1|||
157178905|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Other|0|||
157178906|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
157056725|NCT00748098|566959624|FG001|First Taper Period|Protocol Violation|0|||
156975611|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156975612|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156975613|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156975614|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156975615|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
156975616|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
156975617|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975618|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975619|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975620|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975621|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975622|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975623|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975624|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
156975625|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
156975626|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975627|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975628|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
156975629|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975630|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
156975631|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975632|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975633|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
156975634|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
156975635|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975636|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975637|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975638|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975639|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975640|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975641|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975642|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
156975643|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
156975644|NCT02508532|566665506|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156975645|NCT02508532|566665507|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156975646|NCT02508532|566665508|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156975647|NCT02508532|566665509|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156975648|NCT02508532|566665510|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
156975649|NCT02508532|566665511|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
156975650|NCT02508532|566665512|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
156975651|NCT02508532|566665513|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
156975652|NCT02508532|566665514|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
156975653|NCT00301080|566665515|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
156975654|NCT00301080|566665516|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156975655|NCT00301080|566665517|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156975656|NCT00301080|566665518|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156975657|NCT00301080|566665519|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
156975658|NCT01111838|566665520|FG000|Overall Study|Patient Ineligible|2|||
156975659|NCT01111838|566665520|FG000|Overall Study|Not Treated|3|||
156975660|NCT01111838|566665520|FG000|Overall Study|Clinical deterioration|1|||
156975661|NCT01111838|566665520|FG000|Overall Study|Other Complicating Disease|1|||
156975662|NCT01616771|566665528|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
156975663|NCT00744328|566665529|FG000|Overall Study|Lost to Follow-up|2|||
156975664|NCT00744328|566665530|FG001|Overall Study|Lost to Follow-up|5|||
156975665|NCT00744328|566665531|FG002|Overall Study|Lost to Follow-up|3|||
156975666|NCT00744328|566665529|FG000|Overall Study|Withdrawal by Subject|5|||
156975667|NCT00744328|566665530|FG001|Overall Study|Withdrawal by Subject|3|||
156975668|NCT00744328|566665531|FG002|Overall Study|Withdrawal by Subject|4|||
156975669|NCT00744328|566665529|FG000|Overall Study|Found ineligible after randomization|0|||
156975670|NCT00744328|566665530|FG001|Overall Study|Found ineligible after randomization|0|||
156975671|NCT00744328|566665531|FG002|Overall Study|Found ineligible after randomization|1|||
156975672|NCT04399356|566665536|FG000|Overall Study|Lost to Follow-up|1|||
156975673|NCT04399356|566665537|FG001|Overall Study|Lost to Follow-up|1|||
156975674|NCT04399356|566665536|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
156975675|NCT04399356|566665537|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
156975676|NCT04399356|566665536|FG000|Overall Study|Withdrawal by Subject|1|||
156975677|NCT04399356|566665537|FG001|Overall Study|Withdrawal by Subject|0|||
156975678|NCT02306265|566665539|FG000|Overall Study|Withdrawal by Subject|1|||
157056726|NCT00748098|566959623|FG000|First Taper Period|Withdrawal by Subject|2|||
157056727|NCT00748098|566959624|FG001|First Taper Period|Withdrawal by Subject|0|||
157056728|NCT00748098|566959623|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
157056729|NCT00748098|566959624|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
157056730|NCT00748098|566959623|FG000|1-Week Washout Period|Adverse Event|0|||
157056731|NCT00748098|566959624|FG001|1-Week Washout Period|Adverse Event|1|||
157056732|NCT00748098|566959623|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
157056733|NCT00748098|566959624|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
157056734|NCT00748098|566959623|FG000|Second Treatment Intervention Period|Adverse Event|4|||
157056735|NCT00748098|566959624|FG001|Second Treatment Intervention Period|Adverse Event|1|||
157056736|NCT00748098|566959623|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
157056737|NCT00748098|566959624|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
157056738|NCT00748098|566959623|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
157056739|NCT00748098|566959624|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
157056740|NCT02442622|566959627|FG000|Overall Study|Withdrawal by Subject|3|||
157056741|NCT02442622|566959628|FG001|Overall Study|Withdrawal by Subject|1|||
157056742|NCT04448561|566959632|FG000|Overall Study|Noncompliance|1|||
157056743|NCT04448561|566959633|FG001|Overall Study|Noncompliance|0|||
157056744|NCT00651937|566961150|FG000|Overall Study|Withdrawal by Subject|4|||
157056745|NCT00651937|566961151|FG001|Overall Study|Withdrawal by Subject|1|||
157056746|NCT01904019|566961154|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
157056747|NCT01904019|566961154|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
157056748|NCT01904019|566961154|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
157056749|NCT01904019|566961154|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
157056750|NCT01904019|566961154|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
157056751|NCT01904019|566961154|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
157056752|NCT00635570|566961155|FG000|Overall Study|Lost to Follow-up|8|||
157056753|NCT00635570|566961156|FG001|Overall Study|Lost to Follow-up|8|||
157056754|NCT00635570|566961155|FG000|Overall Study|Withdrawal by Subject|1|||
157056755|NCT00635570|566961156|FG001|Overall Study|Withdrawal by Subject|1|||
157056756|NCT00635570|566961155|FG000|Overall Study|Adverse Event|2|||
157056757|NCT00635570|566961156|FG001|Overall Study|Adverse Event|0|||
157056758|NCT00635570|566961155|FG000|Overall Study|Physician Decision|1|||
157056759|NCT00635570|566961156|FG001|Overall Study|Physician Decision|0|||
157056760|NCT00635570|566961155|FG000|Overall Study|Did not complete survey|2|||
157056761|NCT00635570|566961156|FG001|Overall Study|Did not complete survey|1|||
157056762|NCT00635570|566961155|FG000|Overall Study|Early termination(No sexual activity)|1|||
157056763|NCT00635570|566961156|FG001|Overall Study|Early termination(No sexual activity)|1|||
157056764|NCT01816685|566961159|FG000|Overall Study|Lost to Follow-up|7|||
157056765|NCT01816685|566961160|FG001|Overall Study|Lost to Follow-up|9|||
157056766|NCT01816685|566961159|FG000|Overall Study|Surgery Cancelled|3|||
157056767|NCT01816685|566961160|FG001|Overall Study|Surgery Cancelled|2|||
157056768|NCT03721978|566961162|FG000|Overall Study|Withdrawal by Subject|6|||
157056769|NCT03721978|566961163|FG001|Overall Study|Withdrawal by Subject|1|||
157056770|NCT03721978|566961162|FG000|Overall Study|Adverse Event|1|||
157056771|NCT03721978|566961163|FG001|Overall Study|Adverse Event|1|||
157056772|NCT03721978|566961162|FG000|Overall Study|Progressive Disease|1|||
157056773|NCT03721978|566961163|FG001|Overall Study|Progressive Disease|0|||
157056774|NCT03721978|566961162|FG000|Overall Study|Lost to Follow-up|5|||
157056775|NCT03721978|566961163|FG001|Overall Study|Lost to Follow-up|1|||
157056776|NCT03721978|566961162|FG000|Overall Study|Reason not Specified|0|||
157056777|NCT03721978|566961163|FG001|Overall Study|Reason not Specified|2|||
157056778|NCT04816708|566961166|FG000|Overall Study|Lost to Follow-up|10|||
157056779|NCT04816708|566961167|FG001|Overall Study|Lost to Follow-up|4|||
157056780|NCT00197106|566961168|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
157056781|NCT00197106|566961169|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
157056782|NCT00197106|566961170|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
157056783|NCT00197106|566961168|FG000|Overall Treatment Period|Lack of Efficacy|0|||
157056784|NCT00197106|566961169|FG001|Overall Treatment Period|Lack of Efficacy|1|||
157056785|NCT00197106|566961170|FG002|Overall Treatment Period|Lack of Efficacy|0|||
157056786|NCT00197106|566961168|FG000|Overall Treatment Period|Lost to Follow-up|0|||
157056787|NCT00197106|566961169|FG001|Overall Treatment Period|Lost to Follow-up|0|||
157056788|NCT00197106|566961170|FG002|Overall Treatment Period|Lost to Follow-up|2|||
157056789|NCT00197106|566961168|FG000|Overall Treatment Period|Protocol Violation|0|||
157056790|NCT00197106|566961169|FG001|Overall Treatment Period|Protocol Violation|0|||
157056791|NCT00197106|566961170|FG002|Overall Treatment Period|Protocol Violation|2|||
157056792|NCT00197106|566961168|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
157056793|NCT00197106|566961169|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
157056794|NCT00197106|566961170|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
157056795|NCT00762723|566961171|FG000|Overall Study|Study Terminated slow enrollement|5|||
157056796|NCT00762723|566961172|FG001|Overall Study|Study Terminated slow enrollement|5|||
157056797|NCT00762723|566961173|FG002|Overall Study|Study Terminated slow enrollement|3|||
157178907|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
157205262|NCT03993288|567496084|FG001|Overall Study|wrong randomization|1|||
157056798|NCT00382408|566961174|FG000|Overall Study|Did not meet protocol requirement|3|||
157056799|NCT00382408|566961175|FG001|Overall Study|Did not meet protocol requirement|3|||
157056800|NCT00382408|566961174|FG000|Overall Study|Protocol Violation|2|||
157056801|NCT00382408|566961175|FG001|Overall Study|Protocol Violation|2|||
157056802|NCT00382408|566961174|FG000|Overall Study|Physician Decision|1|||
157056803|NCT00382408|566961175|FG001|Overall Study|Physician Decision|0|||
157056804|NCT00382408|566961174|FG000|Overall Study|Withdrawal by Subject|17|||
157056805|NCT00382408|566961175|FG001|Overall Study|Withdrawal by Subject|6|||
157056806|NCT00382408|566961174|FG000|Overall Study|Pregnancy|2|||
157056807|NCT00382408|566961175|FG001|Overall Study|Pregnancy|0|||
157056808|NCT00382408|566961174|FG000|Overall Study|Lost to Follow-up|19|||
157056809|NCT00382408|566961175|FG001|Overall Study|Lost to Follow-up|8|||
157056810|NCT00382408|566961174|FG000|Overall Study|Other|100|||
157056811|NCT00382408|566961175|FG001|Overall Study|Other|35|||
157056812|NCT01572493|566961176|FG000|Overall Study|Physician Decision|1|||
157056813|NCT01572493|566961177|FG001|Overall Study|Physician Decision|0|||
157056814|NCT01572493|566961178|FG002|Overall Study|Physician Decision|0|||
157056815|NCT01572493|566961179|FG003|Overall Study|Physician Decision|0|||
157056816|NCT01572493|566961180|FG004|Overall Study|Physician Decision|0|||
157056817|NCT01572493|566961181|FG005|Overall Study|Physician Decision|0|||
157056818|NCT01572493|566961182|FG006|Overall Study|Physician Decision|0|||
157056819|NCT01572493|566961183|FG007|Overall Study|Physician Decision|0|||
157056820|NCT01572493|566961184|FG008|Overall Study|Physician Decision|0|||
157056821|NCT01572493|566961176|FG000|Overall Study|Switched to alternative treatment|0|||
157056822|NCT01572493|566961177|FG001|Overall Study|Switched to alternative treatment|1|||
157056823|NCT01572493|566961178|FG002|Overall Study|Switched to alternative treatment|2|||
157056824|NCT01572493|566961179|FG003|Overall Study|Switched to alternative treatment|1|||
157056825|NCT01572493|566961180|FG004|Overall Study|Switched to alternative treatment|2|||
157056826|NCT01572493|566961181|FG005|Overall Study|Switched to alternative treatment|0|||
157056827|NCT01572493|566961182|FG006|Overall Study|Switched to alternative treatment|2|||
157056828|NCT01572493|566961183|FG007|Overall Study|Switched to alternative treatment|0|||
157056829|NCT01572493|566961184|FG008|Overall Study|Switched to alternative treatment|2|||
157056830|NCT01572493|566961176|FG000|Overall Study|Death|0|||
157056831|NCT01572493|566961177|FG001|Overall Study|Death|0|||
157056832|NCT01572493|566961178|FG002|Overall Study|Death|0|||
157056833|NCT01572493|566961179|FG003|Overall Study|Death|1|||
157056834|NCT01572493|566961180|FG004|Overall Study|Death|0|||
157056835|NCT01572493|566961181|FG005|Overall Study|Death|1|||
157056836|NCT01572493|566961182|FG006|Overall Study|Death|0|||
157056837|NCT01572493|566961183|FG007|Overall Study|Death|0|||
157056838|NCT01572493|566961184|FG008|Overall Study|Death|0|||
157056839|NCT01572493|566961176|FG000|Overall Study|Adverse Event|0|||
157056840|NCT01572493|566961177|FG001|Overall Study|Adverse Event|0|||
157056841|NCT01572493|566961178|FG002|Overall Study|Adverse Event|0|||
157056842|NCT01572493|566961179|FG003|Overall Study|Adverse Event|0|||
157056843|NCT01572493|566961180|FG004|Overall Study|Adverse Event|0|||
157056844|NCT01572493|566961181|FG005|Overall Study|Adverse Event|0|||
157056845|NCT01572493|566961182|FG006|Overall Study|Adverse Event|1|||
157056846|NCT01572493|566961183|FG007|Overall Study|Adverse Event|0|||
157056847|NCT01572493|566961184|FG008|Overall Study|Adverse Event|0|||
157056848|NCT01090076|566961185|FG000|Overall Study|Death|1|||
157056849|NCT01090076|566961186|FG001|Overall Study|Death|1|||
157056850|NCT01090076|566961185|FG000|Overall Study|Withdrawal by Subject|0|||
157056851|NCT01090076|566961186|FG001|Overall Study|Withdrawal by Subject|1|||
157056852|NCT02402465|566961191|FG000|Overall Study|Withdrawal by Subject|0|||
157056853|NCT02402465|566961192|FG001|Overall Study|Withdrawal by Subject|0|||
157056854|NCT02402465|566961193|FG002|Overall Study|Withdrawal by Subject|0|||
157056855|NCT02402465|566961194|FG003|Overall Study|Withdrawal by Subject|0|||
157056856|NCT02402465|566961195|FG004|Overall Study|Withdrawal by Subject|0|||
157056857|NCT02402465|566961196|FG005|Overall Study|Withdrawal by Subject|1|||
157056858|NCT02402465|566961191|FG000|Overall Study|Lost to Follow-up|0|||
157056859|NCT02402465|566961192|FG001|Overall Study|Lost to Follow-up|1|||
157056860|NCT02402465|566961193|FG002|Overall Study|Lost to Follow-up|0|||
157056861|NCT02402465|566961194|FG003|Overall Study|Lost to Follow-up|0|||
157056862|NCT02402465|566961195|FG004|Overall Study|Lost to Follow-up|1|||
157056863|NCT02402465|566961196|FG005|Overall Study|Lost to Follow-up|0|||
157056864|NCT01284634|566961197|FG000|Overall Study|Adverse Event|1|||
157056865|NCT01284634|566961198|FG001|Overall Study|Adverse Event|0|||
157056866|NCT01284634|566961199|FG002|Overall Study|Adverse Event|2|||
157056867|NCT01284634|566961200|FG003|Overall Study|Adverse Event|1|||
157056868|NCT02236598|566961201|FG000|Overall Study|Adverse Event|0|||
157056869|NCT02236598|566961202|FG001|Overall Study|Adverse Event|1|||
157056870|NCT02236598|566961201|FG000|Overall Study|Withdrawal by Subject|0|||
157056871|NCT02236598|566961202|FG001|Overall Study|Withdrawal by Subject|1|||
157056872|NCT00428441|566961216|FG000|Overall Study|Lost to Follow-up|1|||
157056873|NCT03132753|566961217|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
157056874|NCT03132753|566961218|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
157056875|NCT03132753|566961217|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
157056876|NCT03132753|566961218|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
157056877|NCT00084747|566961219|FG000|Overall Study|Relapsed|8|||
157056878|NCT00084747|566961219|FG000|Overall Study|Death|3|||
157056879|NCT00084747|566961219|FG000|Overall Study|Withdrawal by Subject|2|||
157056880|NCT00679549|566961221|FG000|Overall Study|dropout|2|||
157056881|NCT00679549|566961222|FG001|Overall Study|dropout|4|||
157056882|NCT00679549|566961221|FG000|Overall Study|missing outcome echocardiograms|4|||
157056883|NCT00679549|566961222|FG001|Overall Study|missing outcome echocardiograms|5|||
157056884|NCT00125853|566961223|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
157056885|NCT00125853|566961224|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
157056886|NCT02744898|566961227|FG000|Overall Study|Progressive Disease|2|||
157056887|NCT02744898|566961227|FG000|Overall Study|Physician Decision|1|||
157056888|NCT02744898|566961227|FG000|Overall Study|Toxicity|1|||
157056889|NCT00157209|566961232|FG000|Overall Study|Ongoing at data cut-off|10|||
157056890|NCT00157209|566961233|FG001|Overall Study|Ongoing at data cut-off|0|||
157056891|NCT04474691|566961234|FG000|Overall Study|Withdrawal by Subject|9|||
157056892|NCT01348763|566961236|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
157056893|NCT01348763|566961236|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
157056894|NCT03048058|566961237|FG000|Overall Study|Lost to Follow-up|4|||
157056895|NCT03048058|566961238|FG001|Overall Study|Lost to Follow-up|0|||
157056896|NCT03048058|566961237|FG000|Overall Study|Withdrawal by Subject|0|||
157056897|NCT03048058|566961238|FG001|Overall Study|Withdrawal by Subject|4|||
157056898|NCT01257698|566961247|FG000|Overall Study|Protocol Violation|4|||
157056899|NCT01257698|566961248|FG001|Overall Study|Protocol Violation|0|||
157056900|NCT00274846|566961251|FG000|Overall Study|Did not receive adequate NK cells|1|||
157056901|NCT01190228|566961255|FG000|Overall Study|Protocol Violation|4|||
157056902|NCT01190228|566961256|FG001|Overall Study|Protocol Violation|0|||
157056903|NCT01190228|566961257|FG002|Overall Study|Protocol Violation|0|||
157056904|NCT01190228|566961255|FG000|Overall Study|Withdrawal by Subject|1|||
157056905|NCT01190228|566961256|FG001|Overall Study|Withdrawal by Subject|0|||
157056906|NCT01190228|566961257|FG002|Overall Study|Withdrawal by Subject|0|||
157056907|NCT01395914|566961263|FG000|Overall Study|Unrelated to study drug AE|6|||
157056908|NCT01395914|566961264|FG001|Overall Study|Unrelated to study drug AE|1|||
157056909|NCT01395914|566961263|FG000|Overall Study|Death|23|||
157056910|NCT01395914|566961264|FG001|Overall Study|Death|17|||
157056911|NCT01395914|566961263|FG000|Overall Study|Other|9|||
157056912|NCT01395914|566961264|FG001|Overall Study|Other|3|||
157056913|NCT01395914|566961263|FG000|Overall Study|Withdrawal by patient|27|||
157056914|NCT01395914|566961264|FG001|Overall Study|Withdrawal by patient|14|||
157056915|NCT01395914|566961263|FG000|Overall Study|Study drug-related AE|1|||
157056916|NCT01395914|566961264|FG001|Overall Study|Study drug-related AE|0|||
157056917|NCT01395914|566961263|FG000|Overall Study|Lost to Follow-up|6|||
157056918|NCT01395914|566961264|FG001|Overall Study|Lost to Follow-up|2|||
157056919|NCT02256488|566961267|FG000|Overall Study|Lost to Follow-up|6|||
157056920|NCT02256488|566961268|FG001|Overall Study|Lost to Follow-up|6|||
157056921|NCT02256488|566961269|FG002|Overall Study|Lost to Follow-up|9|||
157056922|NCT02256488|566961270|FG003|Overall Study|Lost to Follow-up|3|||
157056923|NCT02256488|566961267|FG000|Overall Study|OTHER|1|||
157056924|NCT02256488|566961268|FG001|Overall Study|OTHER|0|||
157056925|NCT02256488|566961269|FG002|Overall Study|OTHER|1|||
157056926|NCT02256488|566961270|FG003|Overall Study|OTHER|1|||
157056927|NCT02256488|566961267|FG000|Overall Study|Withdrawal by Subject|1|||
157056928|NCT02256488|566961268|FG001|Overall Study|Withdrawal by Subject|0|||
157056929|NCT02256488|566961269|FG002|Overall Study|Withdrawal by Subject|0|||
157056930|NCT02256488|566961270|FG003|Overall Study|Withdrawal by Subject|2|||
157056931|NCT00975130|566961271|FG000|Study Part 1|Adverse Event|150|||
157056932|NCT00975130|566961272|FG001|Study Part 1|Adverse Event|0|||
157056933|NCT00975130|566961273|FG002|Study Part 1|Adverse Event|0|||
157056934|NCT00975130|566961271|FG000|Study Part 1|Lost to Follow-up|19|||
157056935|NCT00975130|566961272|FG001|Study Part 1|Lost to Follow-up|0|||
157056936|NCT00975130|566961273|FG002|Study Part 1|Lost to Follow-up|0|||
157056937|NCT00975130|566961271|FG000|Study Part 1|Withdrawal by Subject|61|||
157056938|NCT00975130|566961272|FG001|Study Part 1|Withdrawal by Subject|0|||
157056939|NCT00975130|566961273|FG002|Study Part 1|Withdrawal by Subject|0|||
157056940|NCT00975130|566961271|FG000|Study Part 1|Protocol Violation|13|||
157056941|NCT00975130|566961272|FG001|Study Part 1|Protocol Violation|0|||
157056942|NCT00975130|566961273|FG002|Study Part 1|Protocol Violation|0|||
157178908|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
157178909|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
157178910|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
157178911|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
157178912|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
157056943|NCT00975130|566961271|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
157056944|NCT00975130|566961272|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
157056945|NCT00975130|566961273|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
157056946|NCT00975130|566961271|FG000|Study Part 1|Administrative|4|||
157056947|NCT00975130|566961272|FG001|Study Part 1|Administrative|0|||
157056948|NCT00975130|566961273|FG002|Study Part 1|Administrative|0|||
157056949|NCT00975130|566961271|FG000|Study Part 1|Withdrew Consent|24|||
157056950|NCT00975130|566961272|FG001|Study Part 1|Withdrew Consent|0|||
157056951|NCT00975130|566961273|FG002|Study Part 1|Withdrew Consent|0|||
157056952|NCT00975130|566961271|FG000|Study Part 2|Adverse Event|0|||
157056953|NCT00975130|566961272|FG001|Study Part 2|Adverse Event|14|||
157056954|NCT00975130|566961273|FG002|Study Part 2|Adverse Event|7|||
157056955|NCT00975130|566961271|FG000|Study Part 2|Lost to Follow-up|0|||
157056956|NCT00975130|566961272|FG001|Study Part 2|Lost to Follow-up|0|||
157056957|NCT00975130|566961273|FG002|Study Part 2|Lost to Follow-up|1|||
157056958|NCT00975130|566961271|FG000|Study Part 2|Withdrawal by Subject|0|||
157056959|NCT00975130|566961272|FG001|Study Part 2|Withdrawal by Subject|13|||
157056960|NCT00975130|566961273|FG002|Study Part 2|Withdrawal by Subject|5|||
157056961|NCT00975130|566961271|FG000|Study Part 2|Withdrew Consent|0|||
157056962|NCT00975130|566961272|FG001|Study Part 2|Withdrew Consent|6|||
157056963|NCT00975130|566961273|FG002|Study Part 2|Withdrew Consent|2|||
157056964|NCT00975130|566961271|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
157056965|NCT00975130|566961272|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
157056966|NCT00975130|566961273|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
157056967|NCT00975130|566961271|FG000|Study Part 2|Administrative|0|||
157056968|NCT00975130|566961272|FG001|Study Part 2|Administrative|1|||
157056969|NCT00975130|566961273|FG002|Study Part 2|Administrative|0|||
157056970|NCT00975130|566961271|FG000|Study Part 2|Protocol Violation|0|||
157056971|NCT00975130|566961272|FG001|Study Part 2|Protocol Violation|0|||
157056972|NCT00975130|566961273|FG002|Study Part 2|Protocol Violation|1|||
157056973|NCT02268526|566961274|FG000|Overall Study|Adverse Event|0|||
157056974|NCT02268526|566961275|FG001|Overall Study|Adverse Event|2|||
157056975|NCT02268526|566961276|FG002|Overall Study|Adverse Event|1|||
157056976|NCT02268526|566961274|FG000|Overall Study|Death|1|||
157056977|NCT02268526|566961275|FG001|Overall Study|Death|11|||
157056978|NCT02268526|566961276|FG002|Overall Study|Death|0|||
157056979|NCT02268526|566961274|FG000|Overall Study|protocol deviation|0|||
157056980|NCT02268526|566961275|FG001|Overall Study|protocol deviation|1|||
157056981|NCT02268526|566961276|FG002|Overall Study|protocol deviation|0|||
157056982|NCT02268526|566961274|FG000|Overall Study|Physician Decision|0|||
157056983|NCT02268526|566961275|FG001|Overall Study|Physician Decision|0|||
157056984|NCT02268526|566961276|FG002|Overall Study|Physician Decision|1|||
157056985|NCT02268526|566961274|FG000|Overall Study|Subject/guardian decision|0|||
157056986|NCT02268526|566961275|FG001|Overall Study|Subject/guardian decision|7|||
157056987|NCT02268526|566961276|FG002|Overall Study|Subject/guardian decision|3|||
157056988|NCT03305458|566961277|FG000|Overall Study|Withdrawal by Subject|50|||
157056989|NCT03305458|566961278|FG001|Overall Study|Withdrawal by Subject|46|||
157056990|NCT03305458|566961279|FG002|Overall Study|Withdrawal by Subject|93|||
157056991|NCT03305458|566961277|FG000|Overall Study|Lost to Follow-up|85|||
157056992|NCT03305458|566961278|FG001|Overall Study|Lost to Follow-up|85|||
157056993|NCT03305458|566961279|FG002|Overall Study|Lost to Follow-up|35|||
157056994|NCT02332824|566961280|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
157178913|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
157178914|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
157178915|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
157178916|NCT01224106|567398012|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
157178917|NCT01224106|567398013|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157178918|NCT01224106|567398014|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
156975679|NCT02247804|566665544|FG000|Treatment Period 1|Adverse Event|9|||
156975680|NCT02247804|566665545|FG001|Treatment Period 1|Adverse Event|2|||
156975681|NCT02247804|566665546|FG002|Treatment Period 1|Adverse Event|0|||
156975682|NCT02247804|566665544|FG000|Treatment Period 1|Lack of Efficacy|0|||
156975683|NCT02247804|566665545|FG001|Treatment Period 1|Lack of Efficacy|0|||
156975684|NCT02247804|566665546|FG002|Treatment Period 1|Lack of Efficacy|2|||
156975685|NCT02247804|566665544|FG000|Treatment Period 1|Lost to Follow-up|1|||
156975686|NCT02247804|566665545|FG001|Treatment Period 1|Lost to Follow-up|0|||
156975687|NCT02247804|566665546|FG002|Treatment Period 1|Lost to Follow-up|2|||
156975688|NCT02247804|566665544|FG000|Treatment Period 1|Personal Reasons|7|||
156975689|NCT02247804|566665545|FG001|Treatment Period 1|Personal Reasons|1|||
156975690|NCT02247804|566665546|FG002|Treatment Period 1|Personal Reasons|2|||
156975691|NCT02247804|566665544|FG000|Treatment Period 1|Protocol Deviation|0|||
156975692|NCT02247804|566665545|FG001|Treatment Period 1|Protocol Deviation|0|||
156975693|NCT02247804|566665546|FG002|Treatment Period 1|Protocol Deviation|1|||
156975694|NCT02247804|566665544|FG000|Treatment Period 1|Randomized but not Treated|5|||
157056995|NCT02332824|566961281|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
157056996|NCT02332824|566961282|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
157056997|NCT02332824|566961283|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
157056998|NCT02332824|566961284|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
157056999|NCT02332824|566961285|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
157057000|NCT02332824|566961280|FG000|Overall Study|Voluntary Withdrawal|1|||
157057001|NCT02332824|566961281|FG001|Overall Study|Voluntary Withdrawal|0|||
157057002|NCT02332824|566961282|FG002|Overall Study|Voluntary Withdrawal|0|||
157057003|NCT02332824|566961283|FG003|Overall Study|Voluntary Withdrawal|0|||
157057004|NCT02332824|566961284|FG004|Overall Study|Voluntary Withdrawal|0|||
157057005|NCT02332824|566961285|FG005|Overall Study|Voluntary Withdrawal|0|||
157057006|NCT02332824|566961280|FG000|Overall Study|Inconvenient schedule|1|||
157057007|NCT02332824|566961281|FG001|Overall Study|Inconvenient schedule|1|||
157057008|NCT02332824|566961282|FG002|Overall Study|Inconvenient schedule|0|||
157057009|NCT02332824|566961283|FG003|Overall Study|Inconvenient schedule|0|||
157057010|NCT02332824|566961284|FG004|Overall Study|Inconvenient schedule|0|||
157057011|NCT02332824|566961285|FG005|Overall Study|Inconvenient schedule|0|||
157057012|NCT02332824|566961280|FG000|Overall Study|Transfer|0|||
157057013|NCT02332824|566961281|FG001|Overall Study|Transfer|0|||
157057014|NCT02332824|566961282|FG002|Overall Study|Transfer|1|||
157057015|NCT02332824|566961283|FG003|Overall Study|Transfer|1|||
157057016|NCT02332824|566961284|FG004|Overall Study|Transfer|0|||
157057017|NCT02332824|566961285|FG005|Overall Study|Transfer|0|||
157057018|NCT00498797|566961286|FG000|Overall Study|Withdrawal by Subject|4|||
157057019|NCT00498797|566961287|FG001|Overall Study|Withdrawal by Subject|2|||
157057020|NCT00498797|566961286|FG000|Overall Study|Adverse Event|12|||
157057021|NCT00498797|566961287|FG001|Overall Study|Adverse Event|5|||
157057022|NCT00498797|566961286|FG000|Overall Study|Condition under investigation worsened|19|||
157057023|NCT00498797|566961287|FG001|Overall Study|Condition under investigation worsened|21|||
157057024|NCT00498797|566961286|FG000|Overall Study|Other|3|||
157057025|NCT00498797|566961287|FG001|Overall Study|Other|1|||
157057026|NCT03562117|566961288|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
157057027|NCT03562117|566961289|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
157057028|NCT03562117|566961290|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
157057029|NCT03928821|566961291|FG000|Overall Study|Death|0|||
157057030|NCT03928821|566961292|FG001|Overall Study|Death|1|||
157057031|NCT03928821|566961293|FG002|Overall Study|Death|0|||
157057032|NCT03928821|566961294|FG003|Overall Study|Death|0|||
157057033|NCT03928821|566961291|FG000|Overall Study|Lost to Follow-up|0|||
157057034|NCT03928821|566961292|FG001|Overall Study|Lost to Follow-up|2|||
157057035|NCT03928821|566961293|FG002|Overall Study|Lost to Follow-up|3|||
157057036|NCT03928821|566961294|FG003|Overall Study|Lost to Follow-up|0|||
157057037|NCT03928821|566961291|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
157057038|NCT03928821|566961292|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
157057039|NCT03928821|566961293|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
157057040|NCT03928821|566961294|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
157057041|NCT04743999|566961301|FG000|3-month Questionnaire|Death|1|||
157057042|NCT04743999|566961301|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
157057043|NCT04743999|566961301|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
157057044|NCT04743999|566961301|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
157057045|NCT01721759|566961302|FG000|Treatment Period|Disease Progression|85|||
157057046|NCT01721759|566961302|FG000|Treatment Period|Study drug toxicity|14|||
157057047|NCT01721759|566961302|FG000|Treatment Period|Death|1|||
157057048|NCT01721759|566961302|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
157057049|NCT01721759|566961302|FG000|Treatment Period|Participant request to withdraw|3|||
157057050|NCT01721759|566961302|FG000|Treatment Period|Other Reasons|3|||
157057051|NCT01721759|566961302|FG000|End of Study Period|Participant Withdrew Consent|5|||
157057052|NCT01721759|566961302|FG000|End of Study Period|Death|101|||
157057053|NCT01721759|566961302|FG000|End of Study Period|Lost to Follow-up|1|||
157057054|NCT01721759|566961302|FG000|End of Study Period|Other Reasons|10|||
157057055|NCT00509821|566962392|FG000|Study Period 1 (Induction)|Death|0|||
157057056|NCT00509821|566962393|FG001|Study Period 1 (Induction)|Death|1|||
157057057|NCT00509821|566962392|FG000|Study Period 1 (Induction)|Adverse Event|0|||
157057058|NCT00509821|566962393|FG001|Study Period 1 (Induction)|Adverse Event|2|||
157057059|NCT00509821|566962392|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
157057060|NCT00509821|566962393|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
157057061|NCT02720185|566962396|FG000|Overall Study|Lost to Follow-up|1|||
157178919|NCT01224106|567398015|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157178920|NCT01224106|567398016|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157178921|NCT01224106|567398012|FG000|Open-Label Extension (OLE) Phase|Death|0|||
157178922|NCT01224106|567398013|FG001|Open-Label Extension (OLE) Phase|Death|0|||
157178923|NCT01224106|567398014|FG002|Open-Label Extension (OLE) Phase|Death|0|||
157178924|NCT01224106|567398015|FG003|Open-Label Extension (OLE) Phase|Death|1|||
157178925|NCT01224106|567398016|FG004|Open-Label Extension (OLE) Phase|Death|3|||
157178926|NCT01224106|567398012|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
157178927|NCT01224106|567398013|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
157178928|NCT01224106|567398014|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
157057062|NCT01157351|566962397|FG000|Overall Study|Adverse Event|5|||
157057063|NCT01157351|566962398|FG001|Overall Study|Adverse Event|4|||
157057064|NCT01157351|566962397|FG000|Overall Study|Death|1|||
157057065|NCT01157351|566962398|FG001|Overall Study|Death|0|||
157057066|NCT01157351|566962397|FG000|Overall Study|Lost to Follow-up|53|||
157178929|NCT01224106|567398015|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
157178930|NCT01224106|567398016|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
157057067|NCT01157351|566962398|FG001|Overall Study|Lost to Follow-up|55|||
157057068|NCT01157351|566962397|FG000|Overall Study|Withdrawal by Subject|37|||
157057069|NCT01157351|566962398|FG001|Overall Study|Withdrawal by Subject|27|||
157057070|NCT01157351|566962397|FG000|Overall Study|Physician Decision|5|||
157057071|NCT01157351|566962398|FG001|Overall Study|Physician Decision|4|||
157057072|NCT01157351|566962397|FG000|Overall Study|Protocol Violation|0|||
157057073|NCT01157351|566962398|FG001|Overall Study|Protocol Violation|1|||
157057074|NCT01157351|566962397|FG000|Overall Study|Other|32|||
157057075|NCT01157351|566962398|FG001|Overall Study|Other|36|||
157057076|NCT01157351|566962397|FG000|Overall Study|Noncompliance with Study Drug|0|||
157057077|NCT01157351|566962398|FG001|Overall Study|Noncompliance with Study Drug|3|||
157057078|NCT01157351|566962397|FG000|Overall Study|Randomized but not Treated|4|||
157057079|NCT01157351|566962398|FG001|Overall Study|Randomized but not Treated|2|||
157057080|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
157057081|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
157057082|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
157057083|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
157057084|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
157057085|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
157057086|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
157057087|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
157057088|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
157057089|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
157057090|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
157057091|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
157057092|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
157057093|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
157057094|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
157057095|NCT00332488|566962399|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
157057096|NCT00332488|566962400|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
157057097|NCT00332488|566962401|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
157057098|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
157057099|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
157057100|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
157057101|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
157057102|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
157057103|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
157057104|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
157057105|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
157057106|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
157057107|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
157057108|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
157057109|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
157057110|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
157057111|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
157057112|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
157057113|NCT00332488|566962399|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
157057114|NCT00332488|566962400|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
157057115|NCT00332488|566962401|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
157057116|NCT00792259|566962402|FG000|Overall Study|Poor Quality Scans|1|||
157057117|NCT00792259|566962403|FG001|Overall Study|Poor Quality Scans|0|||
157057118|NCT00792259|566962404|FG002|Overall Study|Poor Quality Scans|0|||
157057119|NCT05244226|566962405|FG000|Overall Study|Adverse Event|1|||
157057120|NCT05244226|566962406|FG001|Overall Study|Adverse Event|0|||
157057121|NCT05244226|566962407|FG002|Overall Study|Adverse Event|0|||
157057122|NCT05244226|566962405|FG000|Overall Study|Lost to Follow-up|0|||
157057123|NCT05244226|566962406|FG001|Overall Study|Lost to Follow-up|0|||
157057124|NCT05244226|566962407|FG002|Overall Study|Lost to Follow-up|1|||
157057125|NCT05244226|566962405|FG000|Overall Study|Protocol Violation|0|||
157057126|NCT05244226|566962406|FG001|Overall Study|Protocol Violation|2|||
157057127|NCT05244226|566962407|FG002|Overall Study|Protocol Violation|2|||
157057128|NCT04050722|566962416|FG000|Overall Study|Withdrawal by Subject|1|||
157178931|NCT01224106|567398012|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
157178932|NCT01224106|567398013|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
157178933|NCT01224106|567398014|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
157178934|NCT01224106|567398015|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
157178935|NCT01224106|567398016|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
157178936|NCT01224106|567398012|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
157057129|NCT04050722|566962417|FG001|Overall Study|Withdrawal by Subject|0|||
157205263|NCT03993288|567496083|FG000|Overall Study|improper enrollment|0|||
157057130|NCT03303521|566962422|FG000|Overall Study|Withdrawal by Subject|2|||
157057131|NCT03303521|566962423|FG001|Overall Study|Withdrawal by Subject|0|||
157057132|NCT03303521|566962422|FG000|Overall Study|Death|1|||
157057133|NCT03303521|566962423|FG001|Overall Study|Death|0|||
157057134|NCT03303521|566962422|FG000|Overall Study|Kidney transplantation|0|||
157057135|NCT03303521|566962423|FG001|Overall Study|Kidney transplantation|1|||
157057136|NCT03303521|566962422|FG000|Overall Study|Investigational product discontinuation|0|||
157057137|NCT03303521|566962423|FG001|Overall Study|Investigational product discontinuation|1|||
157057138|NCT03303521|566962422|FG000|Overall Study|Transferred to non-study dialysis center|1|||
157057139|NCT03303521|566962423|FG001|Overall Study|Transferred to non-study dialysis center|0|||
157057140|NCT03303521|566962422|FG000|Overall Study|Non-comliance to study protocol|0|||
157057141|NCT03303521|566962423|FG001|Overall Study|Non-comliance to study protocol|1|||
157057142|NCT03303521|566962422|FG000|Overall Study|Adverse Event|1|||
157057143|NCT03303521|566962423|FG001|Overall Study|Adverse Event|0|||
157057144|NCT00191984|566962424|FG000|Overall Study|Disease Progression|21|||
157057145|NCT00191984|566962424|FG000|Overall Study|Adverse Event|4|||
157057146|NCT00191984|566962424|FG000|Overall Study|Death|2|||
157057147|NCT00191984|566962424|FG000|Overall Study|Entry Criteria Exclusion|1|||
157057148|NCT00191984|566962424|FG000|Overall Study|Withdrawal by Subject|7|||
157057149|NCT00191984|566962424|FG000|Overall Study|Physician Decision|4|||
157057150|NCT01654289|566962425|FG000|Overall Study|Withdrawal by Subject|10|||
157057151|NCT01654289|566962426|FG001|Overall Study|Withdrawal by Subject|8|||
157057152|NCT01654289|566962427|FG002|Overall Study|Withdrawal by Subject|5|||
157057153|NCT01654289|566962425|FG000|Overall Study|Withdrew from intervention only|17|||
157057154|NCT01654289|566962426|FG001|Overall Study|Withdrew from intervention only|20|||
157057155|NCT01654289|566962427|FG002|Overall Study|Withdrew from intervention only|0|||
157057156|NCT04748445|566962431|FG000|Overall Study|No longer met eligibility criteria|12|||
157057157|NCT04748445|566962431|FG000|Overall Study|Other|36|||
157057158|NCT04748445|566962431|FG000|Overall Study|Withdrawal by Subject|553|||
157057159|NCT04748445|566962431|FG000|Overall Study|Lost to Follow-up|30|||
157057160|NCT04736602|566962432|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
157057161|NCT04736602|566962432|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
157057162|NCT00938041|566962439|FG000|Overall Study|Lost to Follow-up|6|||
157057163|NCT00938041|566962439|FG000|Overall Study|Received Alternative Therapy|1|||
157057164|NCT00938041|566962439|FG000|Overall Study|Progressive Disease|5|||
157057165|NCT00938041|566962439|FG000|Overall Study|Death|12|||
157057166|NCT00938041|566962439|FG000|Overall Study|Adrenal Insufficiency|3|||
157057167|NCT03042559|566962440|FG000|Overall Study|drop out|1|||
157057168|NCT03042559|566962441|FG001|Overall Study|drop out|1|||
157057169|NCT01536535|566962445|FG000|Overall Study|Withdrawal by Subject|10|||
157057170|NCT01536535|566962446|FG001|Overall Study|Withdrawal by Subject|5|||
157057171|NCT01536535|566962445|FG000|Overall Study|Lost to Follow-up|4|||
157057172|NCT01536535|566962446|FG001|Overall Study|Lost to Follow-up|6|||
157057173|NCT01536535|566962445|FG000|Overall Study|Physician Decision|1|||
157057174|NCT01536535|566962446|FG001|Overall Study|Physician Decision|1|||
157057175|NCT01536535|566962445|FG000|Overall Study|Participant moved|0|||
157057176|NCT01536535|566962446|FG001|Overall Study|Participant moved|1|||
157057177|NCT00404547|566962447|FG000|Overall Study|Adverse Event|39|||
157057178|NCT00404547|566962448|FG001|Overall Study|Adverse Event|6|||
157057179|NCT00404547|566962447|FG000|Overall Study|Withdrawal by Subject|19|||
157057180|NCT00404547|566962448|FG001|Overall Study|Withdrawal by Subject|2|||
157057181|NCT00404547|566962447|FG000|Overall Study|Protocol Violation|0|||
157057182|NCT00404547|566962448|FG001|Overall Study|Protocol Violation|1|||
157057183|NCT00404547|566962447|FG000|Overall Study|Lost to Follow-up|20|||
157057184|NCT00404547|566962448|FG001|Overall Study|Lost to Follow-up|9|||
157057185|NCT00404547|566962447|FG000|Overall Study|Lack of compliance|5|||
157057186|NCT00404547|566962448|FG001|Overall Study|Lack of compliance|1|||
157057187|NCT00404547|566962447|FG000|Overall Study|Other|4|||
157057188|NCT00404547|566962448|FG001|Overall Study|Other|0|||
157057189|NCT00404547|566962447|FG000|Overall Study|Reason not stated|3|||
157057190|NCT00404547|566962448|FG001|Overall Study|Reason not stated|6|||
157057191|NCT01485991|566962449|FG000|Overall Study|Adverse Event|0|||
157057192|NCT01485991|566962450|FG001|Overall Study|Adverse Event|4|||
157057193|NCT01485991|566962449|FG000|Overall Study|Lost to Follow-up|13|||
157057194|NCT01485991|566962450|FG001|Overall Study|Lost to Follow-up|10|||
157057195|NCT01485991|566962449|FG000|Overall Study|Withdrawal by Subject|13|||
157057196|NCT01485991|566962450|FG001|Overall Study|Withdrawal by Subject|20|||
157057197|NCT01485991|566962449|FG000|Overall Study|randomized but not treated|6|||
157057198|NCT01485991|566962450|FG001|Overall Study|randomized but not treated|2|||
157057199|NCT01475370|566962451|FG000|Overall Study|Exacerbation of primary disease|2|||
157057200|NCT01475370|566962452|FG001|Overall Study|Exacerbation of primary disease|2|||
157057201|NCT01475370|566962453|FG002|Overall Study|Exacerbation of primary disease|2|||
157057202|NCT01475370|566962451|FG000|Overall Study|Study drug administration difficult|0|||
157178937|NCT01224106|567398013|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
157057203|NCT01475370|566962452|FG001|Overall Study|Study drug administration difficult|1|||
157057204|NCT01475370|566962453|FG002|Overall Study|Study drug administration difficult|1|||
157057205|NCT01475370|566962451|FG000|Overall Study|Other than specified|1|||
157057206|NCT01475370|566962452|FG001|Overall Study|Other than specified|0|||
157057207|NCT01475370|566962453|FG002|Overall Study|Other than specified|0|||
157057208|NCT02038803|566962457|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
157057209|NCT02038803|566962457|FG000|Overall Study|Lost to Follow-up|1|||
157057210|NCT01247922|566962458|FG000|Overall Study|Disease progression|4|||
157057211|NCT01911819|566962459|FG000|Overall Study|Adverse Event|0|||
157057212|NCT01911819|566962460|FG001|Overall Study|Adverse Event|1|||
157057213|NCT01911819|566962461|FG002|Overall Study|Adverse Event|0|||
157057214|NCT01911819|566962459|FG000|Overall Study|Withdrawal by Subject|1|||
157057215|NCT01911819|566962460|FG001|Overall Study|Withdrawal by Subject|1|||
157057216|NCT01911819|566962461|FG002|Overall Study|Withdrawal by Subject|0|||
157057217|NCT04374253|566962466|FG000|Overall Study|Adverse Event|0|||
157057218|NCT04374253|566962467|FG001|Overall Study|Adverse Event|26|||
157057219|NCT04374253|566962468|FG002|Overall Study|Adverse Event|2|||
157057220|NCT04374253|566962469|FG003|Overall Study|Adverse Event|12|||
157057221|NCT04374253|566962466|FG000|Overall Study|Study terminated by sponsor|13|||
157057222|NCT04374253|566962467|FG001|Overall Study|Study terminated by sponsor|593|||
157057223|NCT04374253|566962468|FG002|Overall Study|Study terminated by sponsor|21|||
157057224|NCT04374253|566962469|FG003|Overall Study|Study terminated by sponsor|567|||
157057225|NCT04374253|566962466|FG000|Overall Study|Withdrawal by Subject|0|||
157057226|NCT04374253|566962467|FG001|Overall Study|Withdrawal by Subject|55|||
157057227|NCT04374253|566962468|FG002|Overall Study|Withdrawal by Subject|3|||
157057228|NCT04374253|566962469|FG003|Overall Study|Withdrawal by Subject|40|||
157057229|NCT04374253|566962466|FG000|Overall Study|Physician Decision|1|||
157057230|NCT04374253|566962467|FG001|Overall Study|Physician Decision|10|||
157057231|NCT04374253|566962468|FG002|Overall Study|Physician Decision|1|||
157057232|NCT04374253|566962469|FG003|Overall Study|Physician Decision|10|||
157057233|NCT04374253|566962466|FG000|Overall Study|Protocol Violation|0|||
157057234|NCT04374253|566962467|FG001|Overall Study|Protocol Violation|0|||
157229646|NCT01074554|567586538|FG000|Overall Study|Adverse Event|3|||
157229647|NCT01074554|567586539|FG001|Overall Study|Adverse Event|3|||
157229648|NCT01074554|567586538|FG000|Overall Study|Lost to Follow-up|0|||
157229649|NCT01074554|567586539|FG001|Overall Study|Lost to Follow-up|1|||
157229650|NCT01856309|567586543|FG000|Overall Study|Death|4|||
157229651|NCT01856309|567586544|FG001|Overall Study|Death|6|||
157229652|NCT01856309|567586545|FG002|Overall Study|Death|11|||
157229653|NCT01856309|567586546|FG003|Overall Study|Death|6|||
157229654|NCT01856309|567586543|FG000|Overall Study|Lost to Follow-up|6|||
156975695|NCT02247804|566665545|FG001|Treatment Period 1|Randomized but not Treated|1|||
156975696|NCT02247804|566665546|FG002|Treatment Period 1|Randomized but not Treated|1|||
156975697|NCT02247804|566665544|FG000|Treatment Period 2|Adverse Event|6|||
156975698|NCT02247804|566665545|FG001|Treatment Period 2|Adverse Event|3|||
156975699|NCT02247804|566665546|FG002|Treatment Period 2|Adverse Event|3|||
156975700|NCT02247804|566665544|FG000|Treatment Period 2|Lack of Efficacy|0|||
156975701|NCT02247804|566665545|FG001|Treatment Period 2|Lack of Efficacy|0|||
156975702|NCT02247804|566665546|FG002|Treatment Period 2|Lack of Efficacy|1|||
156975703|NCT02247804|566665544|FG000|Treatment Period 2|Lost to Follow-up|0|||
156975704|NCT02247804|566665545|FG001|Treatment Period 2|Lost to Follow-up|1|||
156975705|NCT02247804|566665546|FG002|Treatment Period 2|Lost to Follow-up|1|||
156975706|NCT02247804|566665544|FG000|Treatment Period 2|Personal Reasons|2|||
156975707|NCT02247804|566665545|FG001|Treatment Period 2|Personal Reasons|1|||
156975708|NCT02247804|566665546|FG002|Treatment Period 2|Personal Reasons|1|||
156975709|NCT02247804|566665544|FG000|Treatment Period 2|Reason not Specified|0|||
156975710|NCT02247804|566665545|FG001|Treatment Period 2|Reason not Specified|0|||
156975711|NCT02247804|566665546|FG002|Treatment Period 2|Reason not Specified|2|||
156975712|NCT02247804|566665544|FG000|Treatment Period 3|Adverse Event|4|||
156975713|NCT02247804|566665545|FG001|Treatment Period 3|Adverse Event|3|||
156975714|NCT02247804|566665546|FG002|Treatment Period 3|Adverse Event|3|||
156975715|NCT02247804|566665544|FG000|Treatment Period 3|Lack of Efficacy|0|||
156975716|NCT02247804|566665545|FG001|Treatment Period 3|Lack of Efficacy|1|||
156975717|NCT02247804|566665546|FG002|Treatment Period 3|Lack of Efficacy|0|||
156975718|NCT02247804|566665544|FG000|Treatment Period 3|Lost to Follow-up|1|||
156975719|NCT02247804|566665545|FG001|Treatment Period 3|Lost to Follow-up|2|||
156975720|NCT02247804|566665546|FG002|Treatment Period 3|Lost to Follow-up|2|||
156975721|NCT02247804|566665544|FG000|Treatment Period 3|Personal Reasons|4|||
156975722|NCT02247804|566665545|FG001|Treatment Period 3|Personal Reasons|3|||
156975723|NCT02247804|566665546|FG002|Treatment Period 3|Personal Reasons|2|||
156975724|NCT02247804|566665544|FG000|Treatment Period 3|Reason not Specified|2|||
156975725|NCT02247804|566665545|FG001|Treatment Period 3|Reason not Specified|1|||
156975726|NCT02247804|566665546|FG002|Treatment Period 3|Reason not Specified|3|||
156975727|NCT04251065|566665550|FG000|Overall Study|Death|2|||
156975728|NCT04251065|566665550|FG000|Overall Study|Lack of Efficacy|3|||
156975729|NCT04251065|566665550|FG000|Overall Study|Death|1|||
156975730|NCT01054573|566665551|FG000|Overall Study|Adverse Event|1|||
157229655|NCT01856309|567586544|FG001|Overall Study|Lost to Follow-up|2|||
157229656|NCT01856309|567586545|FG002|Overall Study|Lost to Follow-up|4|||
157057235|NCT04374253|566962468|FG002|Overall Study|Protocol Violation|0|||
157057236|NCT04374253|566962469|FG003|Overall Study|Protocol Violation|2|||
157057237|NCT04374253|566962466|FG000|Overall Study|Death|0|||
157057238|NCT04374253|566962467|FG001|Overall Study|Death|3|||
157057239|NCT04374253|566962468|FG002|Overall Study|Death|1|||
157057240|NCT04374253|566962469|FG003|Overall Study|Death|1|||
157057241|NCT04374253|566962466|FG000|Overall Study|Lack of Efficacy|0|||
157057242|NCT04374253|566962467|FG001|Overall Study|Lack of Efficacy|0|||
157057243|NCT04374253|566962468|FG002|Overall Study|Lack of Efficacy|0|||
157057244|NCT04374253|566962469|FG003|Overall Study|Lack of Efficacy|1|||
157057245|NCT04374253|566962466|FG000|Overall Study|Lost to Follow-up|1|||
157057246|NCT04374253|566962467|FG001|Overall Study|Lost to Follow-up|1|||
157057247|NCT04374253|566962468|FG002|Overall Study|Lost to Follow-up|0|||
157057248|NCT04374253|566962469|FG003|Overall Study|Lost to Follow-up|2|||
157057249|NCT04374253|566962466|FG000|Overall Study|Reason Not Specified|0|||
157057250|NCT04374253|566962467|FG001|Overall Study|Reason Not Specified|8|||
157057251|NCT04374253|566962468|FG002|Overall Study|Reason Not Specified|0|||
157057252|NCT04374253|566962469|FG003|Overall Study|Reason Not Specified|8|||
157057253|NCT03138499|566962473|FG000|Overall Study|Lost to Follow-up|1|||
157057254|NCT03138499|566962474|FG001|Overall Study|Lost to Follow-up|0|||
157057255|NCT03138499|566962473|FG000|Overall Study|Participants withdrew consent|1|||
157057256|NCT03138499|566962474|FG001|Overall Study|Participants withdrew consent|0|||
157057257|NCT03138499|566962473|FG000|Overall Study|Participant discontinued study before treatment|0|||
157057258|NCT03138499|566962474|FG001|Overall Study|Participant discontinued study before treatment|1|||
157057259|NCT03138499|566962473|FG000|Overall Study|Disease Progression|2|||
157057260|NCT03138499|566962474|FG001|Overall Study|Disease Progression|6|||
157057261|NCT03138499|566962473|FG000|Overall Study|Study drug toxicity|2|||
157057262|NCT03138499|566962474|FG001|Overall Study|Study drug toxicity|2|||
157057263|NCT03138499|566962473|FG000|Overall Study|Participant request to discontinue study treatment|1|||
157057264|NCT03138499|566962474|FG001|Overall Study|Participant request to discontinue study treatment|1|||
157057265|NCT03138499|566962473|FG000|Overall Study|Other reasons|2|||
157057266|NCT03138499|566962474|FG001|Overall Study|Other reasons|0|||
157057267|NCT00448344|566962475|FG000|Overall Study|Lost to Follow-up|20|||
157057268|NCT00448344|566962476|FG001|Overall Study|Lost to Follow-up|22|||
157057269|NCT00448344|566962475|FG000|Overall Study|Withdrawal by Subject|6|||
157057270|NCT00448344|566962476|FG001|Overall Study|Withdrawal by Subject|8|||
157057271|NCT00448344|566962475|FG000|Overall Study|Death|3|||
157057272|NCT00448344|566962476|FG001|Overall Study|Death|4|||
157057273|NCT00448344|566962475|FG000|Overall Study|Physician Decision|1|||
157057274|NCT00448344|566962476|FG001|Overall Study|Physician Decision|2|||
157057275|NCT01052714|566962482|FG000|Overall Study|Adverse Event|6|||
157057276|NCT01052714|566962483|FG001|Overall Study|Adverse Event|3|||
157057277|NCT01052714|566962484|FG002|Overall Study|Adverse Event|0|||
157057278|NCT01052714|566962482|FG000|Overall Study|Death|1|||
157057279|NCT01052714|566962483|FG001|Overall Study|Death|2|||
157057280|NCT01052714|566962484|FG002|Overall Study|Death|0|||
157057281|NCT01052714|566962482|FG000|Overall Study|Lost to Follow-up|2|||
157057282|NCT01052714|566962483|FG001|Overall Study|Lost to Follow-up|3|||
157057283|NCT01052714|566962484|FG002|Overall Study|Lost to Follow-up|0|||
157057284|NCT01052714|566962482|FG000|Overall Study|Physician Decision|9|||
157057285|NCT01052714|566962483|FG001|Overall Study|Physician Decision|9|||
157057286|NCT01052714|566962484|FG002|Overall Study|Physician Decision|1|||
157057287|NCT01052714|566962482|FG000|Overall Study|Withdrawal by Subject|7|||
157057288|NCT01052714|566962483|FG001|Overall Study|Withdrawal by Subject|12|||
157057289|NCT01052714|566962484|FG002|Overall Study|Withdrawal by Subject|1|||
157057290|NCT04382053|566962490|FG000|Overall Study|Death|6|||
157057291|NCT04382053|566962491|FG001|Overall Study|Death|8|||
157057292|NCT04382053|566962490|FG000|Overall Study|Lost to Follow-up|0|||
157057293|NCT04382053|566962491|FG001|Overall Study|Lost to Follow-up|2|||
157057294|NCT04382053|566962490|FG000|Overall Study|Protocol Deviation|1|||
157057295|NCT04382053|566962491|FG001|Overall Study|Protocol Deviation|2|||
157057296|NCT04382053|566962490|FG000|Overall Study|Withdrawal by Subject|2|||
157057297|NCT04382053|566962491|FG001|Overall Study|Withdrawal by Subject|1|||
157057298|NCT00417989|566962494|FG000|Overall Study|Withdrawal by Subject|13|||
157057299|NCT00417989|566962495|FG001|Overall Study|Withdrawal by Subject|13|||
157057300|NCT00417989|566962494|FG000|Overall Study|Lost to Follow-up|1|||
157057301|NCT00417989|566962495|FG001|Overall Study|Lost to Follow-up|6|||
157057302|NCT00417989|566962494|FG000|Overall Study|Protocol Violation|1|||
157057303|NCT00417989|566962495|FG001|Overall Study|Protocol Violation|0|||
157057304|NCT00417989|566962494|FG000|Overall Study|Death|0|||
157057305|NCT00417989|566962495|FG001|Overall Study|Death|1|||
157229657|NCT01856309|567586546|FG003|Overall Study|Lost to Follow-up|8|||
157057306|NCT00417989|566962494|FG000|Overall Study|Physician Decision|5|||
157057307|NCT00417989|566962495|FG001|Overall Study|Physician Decision|2|||
157057308|NCT00990821|566962496|FG000|Overall Study|Withdrawal by Subject|0|||
157057309|NCT00990821|566962497|FG001|Overall Study|Withdrawal by Subject|2|||
157057310|NCT00990821|566962498|FG002|Overall Study|Withdrawal by Subject|0|||
157057311|NCT00990821|566962499|FG003|Overall Study|Withdrawal by Subject|0|||
157057312|NCT00990821|566962500|FG004|Overall Study|Withdrawal by Subject|3|||
157057313|NCT00990821|566962501|FG005|Overall Study|Withdrawal by Subject|3|||
157057314|NCT00990821|566962502|FG006|Overall Study|Withdrawal by Subject|1|||
157057315|NCT00990821|566962503|FG007|Overall Study|Withdrawal by Subject|0|||
157057316|NCT00990821|566962504|FG008|Overall Study|Withdrawal by Subject|0|||
157057317|NCT00990821|566962505|FG009|Overall Study|Withdrawal by Subject|1|||
157057318|NCT00990821|566962506|FG010|Overall Study|Withdrawal by Subject|3|||
157057319|NCT00990821|566962507|FG011|Overall Study|Withdrawal by Subject|5|||
157057320|NCT00990821|566962508|FG012|Overall Study|Withdrawal by Subject|2|||
157057321|NCT00990821|566962509|FG013|Overall Study|Withdrawal by Subject|1|||
157057322|NCT04150250|566962510|FG000|Overall Study|Lost to Follow-up|0|||
157057323|NCT04150250|566962511|FG001|Overall Study|Lost to Follow-up|2|||
157057324|NCT01945086|566962514|FG000|Overall Study|Withdrawal by Subject|1|||
157057325|NCT01945086|566962515|FG001|Overall Study|Withdrawal by Subject|0|||
157057326|NCT01945086|566962516|FG002|Overall Study|Withdrawal by Subject|1|||
157057327|NCT01945086|566962514|FG000|Overall Study|Adverse Event|0|||
157057328|NCT01945086|566962515|FG001|Overall Study|Adverse Event|0|||
157057329|NCT01945086|566962516|FG002|Overall Study|Adverse Event|1|||
157057330|NCT04212299|566962521|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
157057331|NCT02956278|566964373|FG000|Overall Study|Withdrawal by Subject|6|||
157057332|NCT02956278|566964374|FG001|Overall Study|Withdrawal by Subject|2|||
157057333|NCT02956278|566964375|FG002|Overall Study|Withdrawal by Subject|0|||
157057334|NCT02329223|566964376|FG000|Overall Study|Withdrawal by Subject|1|||
157057335|NCT02329223|566964377|FG001|Overall Study|Withdrawal by Subject|2|||
157057336|NCT02329223|566964378|FG002|Overall Study|Withdrawal by Subject|5|||
157057337|NCT02329223|566964376|FG000|Overall Study|Physician Decision|0|||
157057338|NCT02329223|566964377|FG001|Overall Study|Physician Decision|0|||
157057339|NCT02329223|566964378|FG002|Overall Study|Physician Decision|1|||
157057340|NCT02329223|566964376|FG000|Overall Study|Adverse Event|0|||
157057341|NCT02329223|566964377|FG001|Overall Study|Adverse Event|1|||
157057342|NCT02329223|566964378|FG002|Overall Study|Adverse Event|0|||
157057343|NCT01589523|566964379|FG000|Overall Study|Withdrawal by Subject|1|||
157057344|NCT00506922|566964380|FG000|Overall Study|Physician Decision|0|||
157057345|NCT00506922|566964381|FG001|Overall Study|Physician Decision|0|||
157057346|NCT00506922|566964382|FG002|Overall Study|Physician Decision|0|||
157057347|NCT00506922|566964383|FG003|Overall Study|Physician Decision|2|||
157057348|NCT00506922|566964384|FG004|Overall Study|Physician Decision|0|||
157057349|NCT00506922|566964380|FG000|Overall Study|Withdrawal by Subject|0|||
157057350|NCT00506922|566964381|FG001|Overall Study|Withdrawal by Subject|0|||
157057351|NCT00506922|566964382|FG002|Overall Study|Withdrawal by Subject|0|||
157057352|NCT00506922|566964383|FG003|Overall Study|Withdrawal by Subject|0|||
157057353|NCT00506922|566964384|FG004|Overall Study|Withdrawal by Subject|1|||
157057354|NCT02675998|566964387|FG000|8-Week Treatment Period|Adverse Event|6|||
157057355|NCT02675998|566964388|FG001|8-Week Treatment Period|Adverse Event|5|||
157057356|NCT02675998|566964389|FG002|8-Week Treatment Period|Adverse Event|6|||
157057357|NCT02675998|566964390|FG003|8-Week Treatment Period|Adverse Event|0|||
157057358|NCT02675998|566964387|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
157057359|NCT02675998|566964388|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
157057360|NCT02675998|566964389|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
157057361|NCT02675998|566964390|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
157057362|NCT02675998|566964387|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
157057363|NCT02675998|566964388|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
157057364|NCT02675998|566964389|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
157057365|NCT02675998|566964390|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
157057366|NCT02675998|566964387|FG000|8-Week Treatment Period|Physician Decision|1|||
157057367|NCT02675998|566964388|FG001|8-Week Treatment Period|Physician Decision|0|||
157057368|NCT02675998|566964389|FG002|8-Week Treatment Period|Physician Decision|2|||
157057369|NCT02675998|566964390|FG003|8-Week Treatment Period|Physician Decision|0|||
157057370|NCT02675998|566964387|FG000|8-Week Treatment Period|GI side Effects|1|||
157057371|NCT02675998|566964388|FG001|8-Week Treatment Period|GI side Effects|4|||
157057372|NCT02675998|566964389|FG002|8-Week Treatment Period|GI side Effects|2|||
157057373|NCT02675998|566964390|FG003|8-Week Treatment Period|GI side Effects|0|||
157057374|NCT02675998|566964387|FG000|8-Week Treatment Period|Protocol Violation|1|||
157057375|NCT02675998|566964388|FG001|8-Week Treatment Period|Protocol Violation|1|||
157057376|NCT02675998|566964389|FG002|8-Week Treatment Period|Protocol Violation|1|||
157057377|NCT02675998|566964390|FG003|8-Week Treatment Period|Protocol Violation|0|||
157057378|NCT02675998|566964387|FG000|8-Week Treatment Period|Other|3|||
157057379|NCT02675998|566964388|FG001|8-Week Treatment Period|Other|1|||
157057380|NCT02675998|566964389|FG002|8-Week Treatment Period|Other|2|||
157057381|NCT02675998|566964390|FG003|8-Week Treatment Period|Other|0|||
157205264|NCT03993288|567496084|FG001|Overall Study|improper enrollment|1|||
157205265|NCT03993288|567496083|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
157205266|NCT03993288|567496084|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
157205267|NCT03993288|567496083|FG000|Overall Study|developed SAE|2|||
157205268|NCT03993288|567496084|FG001|Overall Study|developed SAE|0|||
157205269|NCT03993288|567496083|FG000|Overall Study|consent withdrawal|1|||
157205270|NCT03993288|567496084|FG001|Overall Study|consent withdrawal|0|||
157205271|NCT03993288|567496083|FG000|Overall Study|did not follow the treatment schedule|1|||
156975731|NCT01054573|566665552|FG001|Overall Study|Adverse Event|0|||
156975732|NCT01054573|566665553|FG002|Overall Study|Adverse Event|1|||
156975733|NCT01054573|566665554|FG003|Overall Study|Adverse Event|1|||
156975734|NCT01054573|566665551|FG000|Overall Study|Lost to Follow-up|0|||
156975735|NCT01054573|566665552|FG001|Overall Study|Lost to Follow-up|2|||
156975736|NCT01054573|566665553|FG002|Overall Study|Lost to Follow-up|0|||
156975737|NCT01054573|566665554|FG003|Overall Study|Lost to Follow-up|0|||
156975738|NCT01054573|566665551|FG000|Overall Study|Withdrawal by Subject|0|||
156975739|NCT01054573|566665552|FG001|Overall Study|Withdrawal by Subject|2|||
156975740|NCT01054573|566665553|FG002|Overall Study|Withdrawal by Subject|2|||
156975741|NCT01054573|566665554|FG003|Overall Study|Withdrawal by Subject|1|||
156975742|NCT00152009|566665555|FG000|Overall Study|Adverse Event|9|||
156975743|NCT00152009|566665556|FG001|Overall Study|Adverse Event|13|||
156975744|NCT00152009|566665557|FG002|Overall Study|Adverse Event|20|||
156975745|NCT00152009|566665558|FG003|Overall Study|Adverse Event|1|||
156975746|NCT00152009|566665555|FG000|Overall Study|Protocol Violation|3|||
156975747|NCT00152009|566665556|FG001|Overall Study|Protocol Violation|0|||
156975748|NCT00152009|566665557|FG002|Overall Study|Protocol Violation|0|||
156975749|NCT00152009|566665558|FG003|Overall Study|Protocol Violation|1|||
156975750|NCT00152009|566665555|FG000|Overall Study|Withdrawal by Subject|2|||
156975751|NCT00152009|566665556|FG001|Overall Study|Withdrawal by Subject|3|||
156975752|NCT00152009|566665557|FG002|Overall Study|Withdrawal by Subject|4|||
156975753|NCT00152009|566665558|FG003|Overall Study|Withdrawal by Subject|9|||
156975754|NCT00152009|566665555|FG000|Overall Study|Lost to Follow-up|2|||
156975755|NCT00152009|566665556|FG001|Overall Study|Lost to Follow-up|4|||
156975756|NCT00152009|566665557|FG002|Overall Study|Lost to Follow-up|3|||
156975757|NCT00152009|566665558|FG003|Overall Study|Lost to Follow-up|3|||
156975758|NCT00152009|566665555|FG000|Overall Study|Lack of Efficacy|8|||
156975759|NCT00152009|566665556|FG001|Overall Study|Lack of Efficacy|6|||
156975760|NCT00152009|566665557|FG002|Overall Study|Lack of Efficacy|7|||
156975761|NCT00152009|566665558|FG003|Overall Study|Lack of Efficacy|15|||
156975762|NCT00152009|566665555|FG000|Overall Study|ECG abnormalities|2|||
156975763|NCT00152009|566665556|FG001|Overall Study|ECG abnormalities|2|||
156975764|NCT00152009|566665557|FG002|Overall Study|ECG abnormalities|2|||
156975765|NCT00152009|566665558|FG003|Overall Study|ECG abnormalities|1|||
156975766|NCT00152009|566665555|FG000|Overall Study|Sponsor's decision|3|||
156975767|NCT00152009|566665556|FG001|Overall Study|Sponsor's decision|3|||
156975768|NCT00152009|566665557|FG002|Overall Study|Sponsor's decision|1|||
156975769|NCT00152009|566665558|FG003|Overall Study|Sponsor's decision|3|||
156975770|NCT00393523|566665559|FG000|Overall Study|Lost to Follow-up|0|||
156975771|NCT00393523|566665560|FG001|Overall Study|Lost to Follow-up|0|||
156975772|NCT00393523|566665561|FG002|Overall Study|Lost to Follow-up|0|||
156975773|NCT00393523|566665562|FG003|Overall Study|Lost to Follow-up|2|||
156975774|NCT00393523|566665563|FG004|Overall Study|Lost to Follow-up|1|||
156975775|NCT00393523|566665559|FG000|Overall Study|Protocol Violation|6|||
156975776|NCT00393523|566665560|FG001|Overall Study|Protocol Violation|2|||
156975777|NCT00393523|566665561|FG002|Overall Study|Protocol Violation|0|||
156975778|NCT00393523|566665562|FG003|Overall Study|Protocol Violation|1|||
156975779|NCT00393523|566665563|FG004|Overall Study|Protocol Violation|0|||
156975780|NCT00393523|566665559|FG000|Overall Study|Withdrawal by Subject|6|||
156975781|NCT00393523|566665560|FG001|Overall Study|Withdrawal by Subject|7|||
156975782|NCT00393523|566665561|FG002|Overall Study|Withdrawal by Subject|2|||
156975783|NCT00393523|566665562|FG003|Overall Study|Withdrawal by Subject|3|||
156975784|NCT00393523|566665563|FG004|Overall Study|Withdrawal by Subject|0|||
156975785|NCT00393523|566665559|FG000|Overall Study|Difficulties in specimen collection|0|||
156975786|NCT00393523|566665560|FG001|Overall Study|Difficulties in specimen collection|0|||
156975787|NCT00393523|566665561|FG002|Overall Study|Difficulties in specimen collection|1|||
156975788|NCT00393523|566665562|FG003|Overall Study|Difficulties in specimen collection|0|||
156975789|NCT00393523|566665563|FG004|Overall Study|Difficulties in specimen collection|0|||
156975790|NCT00393523|566665559|FG000|Overall Study|Vaccine supply issue|0|||
156975791|NCT00393523|566665560|FG001|Overall Study|Vaccine supply issue|0|||
156975792|NCT00393523|566665561|FG002|Overall Study|Vaccine supply issue|1|||
156975793|NCT00393523|566665562|FG003|Overall Study|Vaccine supply issue|0|||
156975794|NCT00393523|566665563|FG004|Overall Study|Vaccine supply issue|0|||
156975795|NCT00130793|566665580|FG000|Overall Study|Lost to Follow-up|1|||
156975796|NCT00130793|566665581|FG001|Overall Study|Lost to Follow-up|4|||
156975797|NCT00130793|566665580|FG000|Overall Study|Withdrew consent|2|||
156975798|NCT00130793|566665581|FG001|Overall Study|Withdrew consent|0|||
156975799|NCT00211237|566665582|FG000|Baseline|Withdrew|1|||
156975800|NCT00211237|566665583|FG001|Baseline|Withdrew|3|||
156975801|NCT00211237|566665584|FG002|Baseline|Withdrew|0|||
156975802|NCT00211237|566665582|FG000|Baseline|Refused random assignment|1|||
156975803|NCT00211237|566665583|FG001|Baseline|Refused random assignment|0|||
156975804|NCT00211237|566665584|FG002|Baseline|Refused random assignment|0|||
156975805|NCT00211237|566665582|FG000|1 Month|Death|2|||
156975806|NCT00211237|566665583|FG001|1 Month|Death|1|||
156975807|NCT00211237|566665584|FG002|1 Month|Death|0|||
156975808|NCT00211237|566665582|FG000|1 Month|Lost to Follow-up|0|||
156975809|NCT00211237|566665583|FG001|1 Month|Lost to Follow-up|2|||
157057382|NCT02675998|566964387|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
157057383|NCT02675998|566964388|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
157057384|NCT02675998|566964389|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
157057385|NCT02675998|566964390|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
157057386|NCT02675998|566964387|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
157057387|NCT02675998|566964388|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
157057388|NCT02675998|566964389|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
157057389|NCT02675998|566964390|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
157057390|NCT02675998|566964387|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
157057391|NCT02675998|566964388|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
157057392|NCT02675998|566964389|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
157057393|NCT02675998|566964390|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
157057394|NCT02675998|566964387|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
157057395|NCT02675998|566964388|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
157057396|NCT02675998|566964389|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
157057397|NCT02675998|566964390|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
157057398|NCT02675998|566964387|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
157057399|NCT02675998|566964388|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
157057400|NCT02675998|566964389|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
157057401|NCT02675998|566964390|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
157057402|NCT02561078|566964395|FG000|Overall Study|Adverse Event|5|||
157057403|NCT02561078|566964396|FG001|Overall Study|Adverse Event|2|||
157057404|NCT02561078|566964395|FG000|Overall Study|Death|2|||
157057405|NCT02561078|566964396|FG001|Overall Study|Death|1|||
157057406|NCT02561078|566964395|FG000|Overall Study|Lost to Follow-up|2|||
157057407|NCT02561078|566964396|FG001|Overall Study|Lost to Follow-up|6|||
157057408|NCT02561078|566964395|FG000|Overall Study|Non-Compliance with Study Drug|6|||
157057409|NCT02561078|566964396|FG001|Overall Study|Non-Compliance with Study Drug|3|||
157057410|NCT02561078|566964395|FG000|Overall Study|Physician Decision|2|||
157057411|NCT02561078|566964396|FG001|Overall Study|Physician Decision|3|||
157057412|NCT02561078|566964395|FG000|Overall Study|Withdrawal by Subject|13|||
157057413|NCT02561078|566964396|FG001|Overall Study|Withdrawal by Subject|10|||
157057414|NCT00598871|566964399|FG000|Overall Study|Adverse Event|0|||
157057415|NCT00598871|566964400|FG001|Overall Study|Adverse Event|1|||
157057416|NCT01194271|566964401|FG000|Overall Study|Withdrawal by Subject|1|||
157057417|NCT01194271|566964401|FG000|Overall Study|Ineligible, Screen Failure|1|||
157057418|NCT01194271|566964401|FG000|Overall Study|Death|1|||
157057419|NCT00349622|566964402|FG000|Overall Study|Death|168|||
157057420|NCT00349622|566964403|FG001|Overall Study|Death|86|||
157057421|NCT00349622|566964402|FG000|Overall Study|Lost to Follow-up|5|||
157057422|NCT00349622|566964403|FG001|Overall Study|Lost to Follow-up|1|||
157057423|NCT00349622|566964402|FG000|Overall Study|Withdrawal by Subject|5|||
157057424|NCT00349622|566964403|FG001|Overall Study|Withdrawal by Subject|9|||
157057425|NCT00508274|566964406|FG000|Overall Study|Adverse Event|5|||
157057426|NCT00508274|566964406|FG000|Overall Study|Death|7|||
157057427|NCT00508274|566964406|FG000|Overall Study|Disease progression|32|||
157057428|NCT00508274|566964406|FG000|Overall Study|Withdrawal by Subject|1|||
157057429|NCT00508274|566964406|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
157057430|NCT00508274|566964406|FG000|Overall Study|Missing|3|||
157057431|NCT03296566|566964407|FG000|Overall Study|Lost to Follow-up|19|||
157057432|NCT03296566|566964408|FG001|Overall Study|Lost to Follow-up|46|||
157057433|NCT03296566|566964407|FG000|Overall Study|Withdrawal by Subject|0|||
157057434|NCT03296566|566964408|FG001|Overall Study|Withdrawal by Subject|3|||
157057435|NCT00726388|566964412|FG000|Overall Study|Withdrawal by Subject|5|||
157057436|NCT00726388|566964412|FG000|Overall Study|Adverse Event|3|||
157057437|NCT00726388|566964412|FG000|Overall Study|Lost to Follow-up|10|||
157057438|NCT00726388|566964412|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
157057439|NCT00726388|566964412|FG000|Overall Study|Other|5|||
157057440|NCT00726388|566964412|FG000|Overall Study|Enrolled, Not Treated|79|||
157057441|NCT00377312|566964413|FG000|Overall Study|Adverse Event|1|||
157057442|NCT00377312|566964414|FG001|Overall Study|Adverse Event|1|||
157057443|NCT03451292|566964417|FG000|Overall Study|Death|44|||
157057444|NCT03451292|566964418|FG001|Overall Study|Death|59|||
157057445|NCT03451292|566964417|FG000|Overall Study|Withdrawal by Subject|18|||
157057446|NCT03451292|566964418|FG001|Overall Study|Withdrawal by Subject|13|||
157057447|NCT03451292|566964417|FG000|Overall Study|Transplantation|18|||
157057448|NCT03451292|566964418|FG001|Overall Study|Transplantation|12|||
157057449|NCT03451292|566964417|FG000|Overall Study|Lost to Follow-up|4|||
157057450|NCT03451292|566964418|FG001|Overall Study|Lost to Follow-up|12|||
157057451|NCT03451292|566964417|FG000|Overall Study|Physician Decision|4|||
157057452|NCT03451292|566964418|FG001|Overall Study|Physician Decision|3|||
157057453|NCT03451292|566964417|FG000|Overall Study|Adverse Event|3|||
157057454|NCT03451292|566964418|FG001|Overall Study|Adverse Event|3|||
157057455|NCT03451292|566964417|FG000|Overall Study|Non-compliance with Study Drug|2|||
157057456|NCT03451292|566964418|FG001|Overall Study|Non-compliance with Study Drug|0|||
157229658|NCT01856309|567586543|FG000|Overall Study|Withdrawal by Subject|11|||
157229659|NCT01856309|567586544|FG001|Overall Study|Withdrawal by Subject|13|||
156975810|NCT00211237|566665584|FG002|1 Month|Lost to Follow-up|0|||
156975811|NCT00211237|566665582|FG000|1 Month|Withdrew|0|||
156975812|NCT00211237|566665583|FG001|1 Month|Withdrew|4|||
156975813|NCT00211237|566665584|FG002|1 Month|Withdrew|0|||
156975814|NCT00211237|566665582|FG000|1 Month|Additional surgery needed|1|||
156975815|NCT00211237|566665583|FG001|1 Month|Additional surgery needed|0|||
156975816|NCT00211237|566665584|FG002|1 Month|Additional surgery needed|0|||
156975817|NCT00211237|566665582|FG000|1 Month|Non-medical problem|0|||
156975818|NCT00211237|566665583|FG001|1 Month|Non-medical problem|2|||
156975819|NCT00211237|566665584|FG002|1 Month|Non-medical problem|0|||
156975820|NCT00211237|566665582|FG000|3 Months|Death|7|||
156975821|NCT00211237|566665583|FG001|3 Months|Death|3|||
156975822|NCT00211237|566665584|FG002|3 Months|Death|0|||
156975823|NCT00211237|566665582|FG000|3 Months|Could not comply with protocol|1|||
156975824|NCT00211237|566665583|FG001|3 Months|Could not comply with protocol|0|||
156975825|NCT00211237|566665584|FG002|3 Months|Could not comply with protocol|0|||
156975826|NCT00211237|566665582|FG000|3 Months|Withdrew|0|||
156975827|NCT00211237|566665583|FG001|3 Months|Withdrew|1|||
156975828|NCT00211237|566665584|FG002|3 Months|Withdrew|0|||
156975829|NCT00211237|566665582|FG000|3 Months|Non-medical problem|0|||
156975830|NCT00211237|566665583|FG001|3 Months|Non-medical problem|0|||
156975831|NCT00211237|566665584|FG002|3 Months|Non-medical problem|1|||
156975832|NCT00211237|566665582|FG000|6 Months|Death|6|||
156975833|NCT00211237|566665583|FG001|6 Months|Death|0|||
156975834|NCT00211237|566665584|FG002|6 Months|Death|3|||
156975835|NCT00211237|566665582|FG000|6 Months|Lost to Follow-up|2|||
156975836|NCT00211237|566665583|FG001|6 Months|Lost to Follow-up|0|||
156975837|NCT00211237|566665584|FG002|6 Months|Lost to Follow-up|0|||
156975838|NCT00211237|566665582|FG000|6 Months|Could not comply with protocol|0|||
156975839|NCT00211237|566665583|FG001|6 Months|Could not comply with protocol|2|||
156975840|NCT00211237|566665584|FG002|6 Months|Could not comply with protocol|0|||
156975841|NCT00211237|566665582|FG000|12 Months|Death|8|||
156975842|NCT00211237|566665583|FG001|12 Months|Death|2|||
156975843|NCT00211237|566665584|FG002|12 Months|Death|3|||
156975844|NCT00211237|566665582|FG000|12 Months|Lost to Follow-up|1|||
156975845|NCT00211237|566665583|FG001|12 Months|Lost to Follow-up|0|||
156975846|NCT00211237|566665584|FG002|12 Months|Lost to Follow-up|1|||
156975847|NCT00211237|566665582|FG000|12 Months|Withdrew|0|||
156975848|NCT00211237|566665583|FG001|12 Months|Withdrew|0|||
156975849|NCT00211237|566665584|FG002|12 Months|Withdrew|1|||
156975850|NCT00211237|566665582|FG000|12 Months|unrelated medical problem|0|||
156975851|NCT00211237|566665583|FG001|12 Months|unrelated medical problem|0|||
156975852|NCT00211237|566665584|FG002|12 Months|unrelated medical problem|1|||
156975853|NCT01003639|566665587|FG000|Overall Study|Lost to Follow-up|6|||
156975854|NCT01003639|566665588|FG001|Overall Study|Lost to Follow-up|9|||
156975855|NCT01003639|566665587|FG000|Overall Study|Withdrawal by Subject|9|||
156975856|NCT01003639|566665588|FG001|Overall Study|Withdrawal by Subject|5|||
156975857|NCT01003639|566665587|FG000|Overall Study|Lack of Efficacy|1|||
156975858|NCT01003639|566665588|FG001|Overall Study|Lack of Efficacy|6|||
156975859|NCT01003639|566665587|FG000|Overall Study|Adverse Event|0|||
156975860|NCT01003639|566665588|FG001|Overall Study|Adverse Event|1|||
156975861|NCT01003639|566665587|FG000|Overall Study|Protocol Violation|0|||
156975862|NCT01003639|566665588|FG001|Overall Study|Protocol Violation|1|||
156975863|NCT01003639|566665587|FG000|Overall Study|Physician Decision|1|||
156975864|NCT01003639|566665588|FG001|Overall Study|Physician Decision|0|||
156975865|NCT04296890|566665589|FG000|Overall Study|Withdrawal by Subject|1|||
156975866|NCT04296890|566665589|FG000|Overall Study|Death|62|||
156975867|NCT04296890|566665589|FG000|Overall Study|Lost to Follow-up|3|||
156975868|NCT04296890|566665589|FG000|Overall Study|Other than specified|2|||
156975869|NCT02237508|566665591|FG000|Overall Study|Withdrawal by Subject|0|||
156975870|NCT02237508|566665592|FG001|Overall Study|Withdrawal by Subject|2|||
156975871|NCT02237508|566665593|FG002|Overall Study|Withdrawal by Subject|0|||
156975872|NCT02237508|566665594|FG003|Overall Study|Withdrawal by Subject|1|||
156975873|NCT02237508|566665595|FG004|Overall Study|Withdrawal by Subject|0|||
156975874|NCT02237508|566665596|FG005|Overall Study|Withdrawal by Subject|1|||
156975875|NCT02237508|566665597|FG006|Overall Study|Withdrawal by Subject|1|||
156975876|NCT02237508|566665598|FG007|Overall Study|Withdrawal by Subject|0|||
156975877|NCT02237508|566665599|FG008|Overall Study|Withdrawal by Subject|1|||
156975878|NCT02237508|566665600|FG009|Overall Study|Withdrawal by Subject|0|||
156975879|NCT02237508|566665591|FG000|Overall Study|Physician Decision|0|||
156975880|NCT02237508|566665592|FG001|Overall Study|Physician Decision|1|||
156975881|NCT02237508|566665593|FG002|Overall Study|Physician Decision|0|||
156975882|NCT02237508|566665594|FG003|Overall Study|Physician Decision|0|||
156975883|NCT02237508|566665595|FG004|Overall Study|Physician Decision|0|||
156975884|NCT02237508|566665596|FG005|Overall Study|Physician Decision|0|||
156975885|NCT02237508|566665597|FG006|Overall Study|Physician Decision|0|||
156975886|NCT02237508|566665598|FG007|Overall Study|Physician Decision|0|||
156975887|NCT02237508|566665599|FG008|Overall Study|Physician Decision|0|||
156975888|NCT02237508|566665600|FG009|Overall Study|Physician Decision|0|||
156975889|NCT02237508|566665591|FG000|Overall Study|Protocol Violation|0|||
157057457|NCT00609245|566964426|FG000|Overall Study|Adverse Event|1|||
157057458|NCT03022045|566964427|FG000|Overall Study|Adverse Event|0|||
157057459|NCT03022045|566964428|FG001|Overall Study|Adverse Event|1|||
157057460|NCT03022045|566964427|FG000|Overall Study|Withdrawal by Subject|1|||
157057461|NCT03022045|566964428|FG001|Overall Study|Withdrawal by Subject|1|||
157057462|NCT02469077|566964429|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
157057463|NCT02469077|566964430|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
157057464|NCT02469077|566964429|FG000|Post Randomization/Intervention Period|Relocated|1|||
157057465|NCT02469077|566964430|FG001|Post Randomization/Intervention Period|Relocated|1|||
157057466|NCT02469077|566964429|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
157057467|NCT02469077|566964430|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
157057468|NCT02469077|566964429|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
157057469|NCT02469077|566964430|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
157057470|NCT02973477|566964431|FG000|First Intervention|Lost to Follow-up|0|||
157057471|NCT02973477|566964432|FG001|First Intervention|Lost to Follow-up|2|||
157057472|NCT02973477|566964431|FG000|Washout|Withdrawal by Subject|1|||
157057473|NCT02973477|566964432|FG001|Washout|Withdrawal by Subject|0|||
157057474|NCT02973477|566964431|FG000|Second Intervention|Lost to Follow-up|1|||
157057475|NCT02973477|566964432|FG001|Second Intervention|Lost to Follow-up|0|||
157057476|NCT03807700|566964433|FG000|Overall Study|Withdrawal by Subject|2|||
157057477|NCT03807700|566964434|FG001|Overall Study|Withdrawal by Subject|1|||
157057478|NCT01059526|566964435|FG000|Overall Study|Patient enrolled but not treated|20|||
157057479|NCT01059526|566964436|FG001|Overall Study|Patient enrolled but not treated|17|||
157057480|NCT01059526|566964435|FG000|Overall Study|Adverse Event|2|||
157057481|NCT01059526|566964436|FG001|Overall Study|Adverse Event|2|||
157057482|NCT01059526|566964435|FG000|Overall Study|Protocol Violation|0|||
157057483|NCT01059526|566964436|FG001|Overall Study|Protocol Violation|1|||
157057484|NCT01059526|566964435|FG000|Overall Study|Withdrawal by Subject|3|||
157057485|NCT01059526|566964436|FG001|Overall Study|Withdrawal by Subject|1|||
157057486|NCT01059526|566964435|FG000|Overall Study|Lost to Follow-up|4|||
157057487|NCT01059526|566964436|FG001|Overall Study|Lost to Follow-up|1|||
157057488|NCT01059526|566964435|FG000|Overall Study|Patient found to be dermatographic|1|||
157057489|NCT01059526|566964436|FG001|Overall Study|Patient found to be dermatographic|0|||
157057490|NCT01732588|566964437|FG000|First Intervention (7 Days)|Adverse Event|0|||
157057491|NCT01732588|566964438|FG001|First Intervention (7 Days)|Adverse Event|1|||
157057492|NCT01732588|566964439|FG002|First Intervention (7 Days)|Adverse Event|0|||
157057493|NCT02720081|566964440|FG000|Overall Study|Adverse Event|0|||
157057494|NCT02720081|566964441|FG001|Overall Study|Adverse Event|3|||
157057495|NCT02720081|566964440|FG000|Overall Study|Protocol Violation|4|||
157057496|NCT02720081|566964441|FG001|Overall Study|Protocol Violation|1|||
157057497|NCT05012397|566964442|FG000|Overall Study|Death|10|||
157057498|NCT05012397|566964442|FG000|Overall Study|Physician Decision|9|||
157057499|NCT05012397|566964442|FG000|Overall Study|Withdrawal by Subject|5|||
157057500|NCT05012397|566964442|FG000|Overall Study|Lost to Follow-up|2|||
157057501|NCT03334747|566964443|FG000|Treatment Phase|Technical problems|0|||
157057502|NCT03334747|566964444|FG001|Treatment Phase|Technical problems|0|||
157057503|NCT03334747|566964445|FG002|Treatment Phase|Technical problems|0|||
157057504|NCT03334747|566964446|FG003|Treatment Phase|Technical problems|0|||
157057505|NCT03334747|566964447|FG004|Treatment Phase|Technical problems|1|||
157057506|NCT03334747|566964448|FG005|Treatment Phase|Technical problems|0|||
157057507|NCT03334747|566964449|FG006|Treatment Phase|Technical problems|0|||
157057508|NCT03334747|566964450|FG007|Treatment Phase|Technical problems|0|||
157057509|NCT03334747|566964451|FG008|Treatment Phase|Technical problems|0|||
157057510|NCT03334747|566964443|FG000|Treatment Phase|Subject/guardian decision|1|||
157057511|NCT03334747|566964444|FG001|Treatment Phase|Subject/guardian decision|0|||
157057512|NCT03334747|566964445|FG002|Treatment Phase|Subject/guardian decision|0|||
157057513|NCT03334747|566964446|FG003|Treatment Phase|Subject/guardian decision|0|||
157057514|NCT03334747|566964447|FG004|Treatment Phase|Subject/guardian decision|0|||
157057515|NCT03334747|566964448|FG005|Treatment Phase|Subject/guardian decision|1|||
157057516|NCT03334747|566964449|FG006|Treatment Phase|Subject/guardian decision|0|||
157057517|NCT03334747|566964450|FG007|Treatment Phase|Subject/guardian decision|0|||
157057518|NCT03334747|566964451|FG008|Treatment Phase|Subject/guardian decision|0|||
157057519|NCT03334747|566964443|FG000|Follow-Up Phase|Subject/guardian decision|0|||
157057520|NCT03334747|566964444|FG001|Follow-Up Phase|Subject/guardian decision|0|||
157057521|NCT03334747|566964445|FG002|Follow-Up Phase|Subject/guardian decision|0|||
157057522|NCT03334747|566964446|FG003|Follow-Up Phase|Subject/guardian decision|0|||
157057523|NCT03334747|566964447|FG004|Follow-Up Phase|Subject/guardian decision|0|||
157057524|NCT03334747|566964448|FG005|Follow-Up Phase|Subject/guardian decision|0|||
157057525|NCT03334747|566964449|FG006|Follow-Up Phase|Subject/guardian decision|1|||
157057526|NCT03334747|566964450|FG007|Follow-Up Phase|Subject/guardian decision|0|||
157057527|NCT03334747|566964451|FG008|Follow-Up Phase|Subject/guardian decision|1|||
157057528|NCT00005908|566964452|FG000|Overall Study|Withdrawal by Subject|1|||
157057529|NCT00005908|566964453|FG001|Overall Study|Withdrawal by Subject|0|||
157057530|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Adverse Event|3|||
157057531|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Adverse Event|0|||
157057532|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
157057533|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
157057534|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Disease Progression|23|||
157057535|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Disease Progression|22|||
157057536|NCT01379521|566964454|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
157057537|NCT01379521|566964455|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
157057538|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
157057539|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
157057540|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
157057541|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
157057542|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
157057543|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
157057544|NCT01379521|566964454|FG000|Overall Study -Treatment Period|Death|2|||
157057545|NCT01379521|566964455|FG001|Overall Study -Treatment Period|Death|1|||
157057546|NCT01379521|566964454|FG000|Post-Treatment Evaluations|Disease Progression|22|||
157057547|NCT01379521|566964455|FG001|Post-Treatment Evaluations|Disease Progression|20|||
157057548|NCT01379521|566964454|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
157057549|NCT01379521|566964455|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
157057550|NCT01379521|566964454|FG000|Post-Treatment Evaluations|Death|1|||
157057551|NCT01379521|566964455|FG001|Post-Treatment Evaluations|Death|0|||
157057552|NCT02504502|566964456|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
157057553|NCT02504502|566964457|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
157057554|NCT02504502|566964456|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
157057555|NCT02504502|566964457|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
157057556|NCT02538471|566964461|FG000|Overall Study|Progression of disease|2|||
157057557|NCT00475735|566964462|FG000|Treatment Period 1|Adverse Event|2|||
157057558|NCT00475735|566964463|FG001|Treatment Period 1|Adverse Event|0|||
157057559|NCT00475735|566964464|FG002|Treatment Period 1|Adverse Event|0|||
157057560|NCT00475735|566964465|FG003|Treatment Period 1|Adverse Event|0|||
157057561|NCT00475735|566964466|FG004|Treatment Period 1|Adverse Event|0|||
157057562|NCT00475735|566964467|FG005|Treatment Period 1|Adverse Event|0|||
157057563|NCT00475735|566964462|FG000|Treatment Period 1|Lack of Efficacy|1|||
157057564|NCT00475735|566964463|FG001|Treatment Period 1|Lack of Efficacy|0|||
157057565|NCT00475735|566964464|FG002|Treatment Period 1|Lack of Efficacy|0|||
157057566|NCT00475735|566964465|FG003|Treatment Period 1|Lack of Efficacy|0|||
157057567|NCT00475735|566964466|FG004|Treatment Period 1|Lack of Efficacy|0|||
157057568|NCT00475735|566964467|FG005|Treatment Period 1|Lack of Efficacy|0|||
157057569|NCT00475735|566964462|FG000|Treatment Period 1|Lost to Follow-up|0|||
157057570|NCT00475735|566964463|FG001|Treatment Period 1|Lost to Follow-up|0|||
157057571|NCT00475735|566964464|FG002|Treatment Period 1|Lost to Follow-up|0|||
157057572|NCT00475735|566964465|FG003|Treatment Period 1|Lost to Follow-up|0|||
157057573|NCT00475735|566964466|FG004|Treatment Period 1|Lost to Follow-up|0|||
157057574|NCT00475735|566964467|FG005|Treatment Period 1|Lost to Follow-up|1|||
157057575|NCT00475735|566964462|FG000|Treatment Period 1|Protocol Violation|0|||
157057576|NCT00475735|566964463|FG001|Treatment Period 1|Protocol Violation|0|||
157057577|NCT00475735|566964464|FG002|Treatment Period 1|Protocol Violation|0|||
157057578|NCT00475735|566964465|FG003|Treatment Period 1|Protocol Violation|1|||
157057579|NCT00475735|566964466|FG004|Treatment Period 1|Protocol Violation|0|||
157057580|NCT00475735|566964467|FG005|Treatment Period 1|Protocol Violation|0|||
157057581|NCT00475735|566964462|FG000|Treatment Period 1|Withdrawal by Subject|1|||
157057582|NCT00475735|566964463|FG001|Treatment Period 1|Withdrawal by Subject|1|||
157057583|NCT00475735|566964464|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157057584|NCT00475735|566964465|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157057585|NCT00475735|566964466|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157057586|NCT00475735|566964467|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157057587|NCT00475735|566964462|FG000|Treatment Period 1|DC due to AE but continuing|0|||
157057588|NCT00475735|566964463|FG001|Treatment Period 1|DC due to AE but continuing|0|||
157057589|NCT00475735|566964464|FG002|Treatment Period 1|DC due to AE but continuing|0|||
157057590|NCT00475735|566964465|FG003|Treatment Period 1|DC due to AE but continuing|1|||
157057591|NCT00475735|566964466|FG004|Treatment Period 1|DC due to AE but continuing|2|||
157057592|NCT00475735|566964467|FG005|Treatment Period 1|DC due to AE but continuing|2|||
157057593|NCT00475735|566964462|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
157057594|NCT00475735|566964463|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
157057595|NCT00475735|566964464|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
157178938|NCT01224106|567398014|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
157178939|NCT01224106|567398015|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
157057596|NCT00475735|566964465|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
157057597|NCT00475735|566964466|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
157178940|NCT01224106|567398016|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
157057598|NCT00475735|566964467|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
157057599|NCT00475735|566964462|FG000|Treatment Washout|Lost to Follow-up|0|||
157057600|NCT00475735|566964463|FG001|Treatment Washout|Lost to Follow-up|1|||
157057601|NCT00475735|566964464|FG002|Treatment Washout|Lost to Follow-up|0|||
157057602|NCT00475735|566964465|FG003|Treatment Washout|Lost to Follow-up|0|||
157057603|NCT00475735|566964466|FG004|Treatment Washout|Lost to Follow-up|0|||
157057604|NCT00475735|566964467|FG005|Treatment Washout|Lost to Follow-up|0|||
157057605|NCT00475735|566964462|FG000|Treatment Washout|Protocol Violation|0|||
157057606|NCT00475735|566964463|FG001|Treatment Washout|Protocol Violation|1|||
157057607|NCT00475735|566964464|FG002|Treatment Washout|Protocol Violation|0|||
157057608|NCT00475735|566964465|FG003|Treatment Washout|Protocol Violation|0|||
157057609|NCT00475735|566964466|FG004|Treatment Washout|Protocol Violation|0|||
157057610|NCT00475735|566964467|FG005|Treatment Washout|Protocol Violation|0|||
157057611|NCT00475735|566964462|FG000|Treatment Period 2|Adverse Event|0|||
157057612|NCT00475735|566964463|FG001|Treatment Period 2|Adverse Event|1|||
157057613|NCT00475735|566964464|FG002|Treatment Period 2|Adverse Event|0|||
157057614|NCT00475735|566964465|FG003|Treatment Period 2|Adverse Event|2|||
157057615|NCT00475735|566964466|FG004|Treatment Period 2|Adverse Event|0|||
157057616|NCT00475735|566964467|FG005|Treatment Period 2|Adverse Event|0|||
157057617|NCT00475735|566964462|FG000|Treatment Period 2|Lack of Efficacy|0|||
157057618|NCT00475735|566964463|FG001|Treatment Period 2|Lack of Efficacy|0|||
157057619|NCT00475735|566964464|FG002|Treatment Period 2|Lack of Efficacy|0|||
157057620|NCT00475735|566964465|FG003|Treatment Period 2|Lack of Efficacy|0|||
157057621|NCT00475735|566964466|FG004|Treatment Period 2|Lack of Efficacy|0|||
157057622|NCT00475735|566964467|FG005|Treatment Period 2|Lack of Efficacy|1|||
157057623|NCT00475735|566964462|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157057624|NCT00475735|566964463|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157057625|NCT00475735|566964464|FG002|Treatment Period 2|Withdrawal by Subject|0|||
157057626|NCT00475735|566964465|FG003|Treatment Period 2|Withdrawal by Subject|0|||
157057627|NCT00475735|566964466|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157057628|NCT00475735|566964467|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157057629|NCT02350127|566964468|FG000|4-Month Assessment|Withdrawal by Subject|10|||
157057630|NCT02350127|566964469|FG001|4-Month Assessment|Withdrawal by Subject|9|||
157057631|NCT02350127|566964468|FG000|4-Month Assessment|Death|1|||
157057632|NCT02350127|566964469|FG001|4-Month Assessment|Death|0|||
157057633|NCT02350127|566964468|FG000|8-Month Assessment|Death|1|||
157057634|NCT02350127|566964469|FG001|8-Month Assessment|Death|1|||
157057635|NCT02350127|566964468|FG000|8-Month Assessment|Withdrawal by Subject|5|||
157057636|NCT02350127|566964469|FG001|8-Month Assessment|Withdrawal by Subject|8|||
157057637|NCT00050167|566964471|FG000|Overall Study|not eligible not invasive|1|||
157057638|NCT00050167|566964472|FG001|Overall Study|not eligible not invasive|1|||
157057639|NCT04754594|566964473|FG000|Blinded Period|Withdrawal by Subject|4|||
157057640|NCT04754594|566964474|FG001|Blinded Period|Withdrawal by Subject|9|||
157057641|NCT04754594|566964475|FG002|Blinded Period|Withdrawal by Subject|0|||
157057642|NCT04754594|566964476|FG003|Blinded Period|Withdrawal by Subject|0|||
157057643|NCT04754594|566964473|FG000|Blinded Period|Protocol Violation|2|||
157057644|NCT04754594|566964474|FG001|Blinded Period|Protocol Violation|2|||
157057645|NCT04754594|566964475|FG002|Blinded Period|Protocol Violation|0|||
157057646|NCT04754594|566964476|FG003|Blinded Period|Protocol Violation|0|||
157057647|NCT04754594|566964473|FG000|Blinded Period|Lost to Follow-up|1|||
157057648|NCT04754594|566964474|FG001|Blinded Period|Lost to Follow-up|1|||
157057649|NCT04754594|566964475|FG002|Blinded Period|Lost to Follow-up|0|||
157057650|NCT04754594|566964476|FG003|Blinded Period|Lost to Follow-up|0|||
157057651|NCT04754594|566964473|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
157057652|NCT04754594|566964474|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
157057653|NCT04754594|566964475|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
157057654|NCT04754594|566964476|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
157057655|NCT04754594|566964473|FG000|Unblinded Period|Withdrawal by Subject|6|||
157057656|NCT04754594|566964474|FG001|Unblinded Period|Withdrawal by Subject|8|||
157057657|NCT04754594|566964475|FG002|Unblinded Period|Withdrawal by Subject|0|||
157057658|NCT04754594|566964476|FG003|Unblinded Period|Withdrawal by Subject|0|||
157057659|NCT04754594|566964473|FG000|Unblinded Period|Lost to Follow-up|5|||
157057660|NCT04754594|566964474|FG001|Unblinded Period|Lost to Follow-up|3|||
157057661|NCT04754594|566964475|FG002|Unblinded Period|Lost to Follow-up|0|||
157057662|NCT04754594|566964476|FG003|Unblinded Period|Lost to Follow-up|0|||
157057663|NCT04754594|566964473|FG000|Unblinded Period|Protocol Violation|2|||
157057664|NCT04754594|566964474|FG001|Unblinded Period|Protocol Violation|4|||
157057665|NCT04754594|566964475|FG002|Unblinded Period|Protocol Violation|0|||
157057666|NCT04754594|566964476|FG003|Unblinded Period|Protocol Violation|0|||
157057667|NCT04754594|566964473|FG000|Unblinded Period|Other|3|||
157057668|NCT04754594|566964474|FG001|Unblinded Period|Other|0|||
157057669|NCT04754594|566964475|FG002|Unblinded Period|Other|0|||
157057670|NCT04754594|566964476|FG003|Unblinded Period|Other|0|||
157057671|NCT04754594|566964473|FG000|Infant Participants|Withdrawal by Subject|0|||
157057672|NCT04754594|566964474|FG001|Infant Participants|Withdrawal by Subject|0|||
157057673|NCT04754594|566964475|FG002|Infant Participants|Withdrawal by Subject|9|||
157057674|NCT04754594|566964476|FG003|Infant Participants|Withdrawal by Subject|17|||
157057675|NCT04754594|566964473|FG000|Infant Participants|Lost to Follow-up|0|||
157057676|NCT04754594|566964474|FG001|Infant Participants|Lost to Follow-up|0|||
157057677|NCT04754594|566964475|FG002|Infant Participants|Lost to Follow-up|4|||
157057678|NCT04754594|566964476|FG003|Infant Participants|Lost to Follow-up|10|||
157057679|NCT04754594|566964473|FG000|Infant Participants|Death|0|||
157057680|NCT04754594|566964474|FG001|Infant Participants|Death|0|||
157057681|NCT04754594|566964475|FG002|Infant Participants|Death|1|||
157057682|NCT04754594|566964476|FG003|Infant Participants|Death|1|||
157057683|NCT04754594|566964473|FG000|Infant Participants|Other|0|||
157057684|NCT04754594|566964474|FG001|Infant Participants|Other|0|||
157057685|NCT04754594|566964475|FG002|Infant Participants|Other|1|||
157057686|NCT04754594|566964476|FG003|Infant Participants|Other|1|||
157057687|NCT04372186|566964477|FG000|Overall Study|Death|24|||
157057688|NCT04372186|566964478|FG001|Overall Study|Death|11|||
157057689|NCT04372186|566964477|FG000|Overall Study|Transferred to a different facility for care|0|||
157057690|NCT04372186|566964478|FG001|Overall Study|Transferred to a different facility for care|2|||
157057691|NCT04736472|566964479|FG000|Overall Study|Lost to Follow-up|1|||
157057692|NCT04736472|566964480|FG001|Overall Study|Lost to Follow-up|0|||
157057693|NCT04736472|566964481|FG002|Overall Study|Lost to Follow-up|0|||
157057694|NCT04736472|566964479|FG000|Overall Study|Withdrawal by Subject|2|||
157057695|NCT04736472|566964480|FG001|Overall Study|Withdrawal by Subject|0|||
157178941|NCT01224106|567398012|FG000|Open-Label Extension (OLE) Phase|Other|0|||
157178942|NCT01224106|567398013|FG001|Open-Label Extension (OLE) Phase|Other|0|||
157178943|NCT01224106|567398014|FG002|Open-Label Extension (OLE) Phase|Other|0|||
157178944|NCT01224106|567398015|FG003|Open-Label Extension (OLE) Phase|Other|5|||
157178945|NCT01224106|567398016|FG004|Open-Label Extension (OLE) Phase|Other|3|||
157178946|NCT00364832|567398017|FG000|Core Period|Early Withdrawals|2|||
157178947|NCT00364832|567398018|FG001|Core Period|Early Withdrawals|2|||
157178948|NCT00364832|567398019|FG002|Core Period|Early Withdrawals|1|||
157178949|NCT00364832|567398020|FG003|Core Period|Early Withdrawals|1|||
157178950|NCT00364832|567398021|FG004|Core Period|Early Withdrawals|0|||
157178951|NCT00364832|567398022|FG005|Core Period|Early Withdrawals|0|||
157178952|NCT00364832|567398023|FG006|Core Period|Early Withdrawals|4|||
156975890|NCT02237508|566665592|FG001|Overall Study|Protocol Violation|0|||
156975891|NCT02237508|566665593|FG002|Overall Study|Protocol Violation|1|||
156975892|NCT02237508|566665594|FG003|Overall Study|Protocol Violation|0|||
156975893|NCT02237508|566665595|FG004|Overall Study|Protocol Violation|0|||
156975894|NCT02237508|566665596|FG005|Overall Study|Protocol Violation|0|||
156975895|NCT02237508|566665597|FG006|Overall Study|Protocol Violation|0|||
156975896|NCT02237508|566665598|FG007|Overall Study|Protocol Violation|0|||
156975897|NCT02237508|566665599|FG008|Overall Study|Protocol Violation|0|||
156975898|NCT02237508|566665600|FG009|Overall Study|Protocol Violation|0|||
156975899|NCT01650519|566665601|FG000|Overall Study|Withdrawal by Subject|1|||
156975900|NCT01650519|566665602|FG001|Overall Study|Withdrawal by Subject|0|||
156975901|NCT02954458|566665603|FG000|Overall Study|Adverse Event|0|||
156975902|NCT02954458|566665604|FG001|Overall Study|Adverse Event|0|||
156975903|NCT02954458|566665605|FG002|Overall Study|Adverse Event|0|||
156975904|NCT02954458|566665606|FG003|Overall Study|Adverse Event|1|||
156975905|NCT02954458|566665603|FG000|Overall Study|Withdrawal by Subject|0|||
156975906|NCT02954458|566665604|FG001|Overall Study|Withdrawal by Subject|0|||
156975907|NCT02954458|566665605|FG002|Overall Study|Withdrawal by Subject|0|||
156975908|NCT02954458|566665606|FG003|Overall Study|Withdrawal by Subject|1|||
156975909|NCT02954458|566665603|FG000|Overall Study|Physician Decision|0|||
156975910|NCT02954458|566665604|FG001|Overall Study|Physician Decision|0|||
156975911|NCT02954458|566665605|FG002|Overall Study|Physician Decision|1|||
156975912|NCT02954458|566665606|FG003|Overall Study|Physician Decision|1|||
156975913|NCT02954458|566665603|FG000|Overall Study|Lost to Follow-up|1|||
156975914|NCT02954458|566665604|FG001|Overall Study|Lost to Follow-up|0|||
156975915|NCT02954458|566665605|FG002|Overall Study|Lost to Follow-up|0|||
156975916|NCT02954458|566665606|FG003|Overall Study|Lost to Follow-up|1|||
156975917|NCT02954458|566665603|FG000|Overall Study|Death|0|||
156975918|NCT02954458|566665604|FG001|Overall Study|Death|0|||
156975919|NCT02954458|566665605|FG002|Overall Study|Death|0|||
156975920|NCT02954458|566665606|FG003|Overall Study|Death|1|||
156975921|NCT02954458|566665603|FG000|Overall Study|Other|0|||
156975922|NCT02954458|566665604|FG001|Overall Study|Other|0|||
156975923|NCT02954458|566665605|FG002|Overall Study|Other|0|||
156975924|NCT02954458|566665606|FG003|Overall Study|Other|7|||
156975925|NCT04000594|566665607|FG000|Overall Study|Withdrawal by Subject|1|||
156975926|NCT04000594|566665608|FG001|Overall Study|Withdrawal by Subject|0|||
156975927|NCT04000594|566665609|FG002|Overall Study|Withdrawal by Subject|0|||
156975928|NCT01552954|566665612|FG000|Overall Study|Adverse Event|1|||
157057696|NCT04736472|566964481|FG002|Overall Study|Withdrawal by Subject|0|||
157057697|NCT04736472|566964479|FG000|Overall Study|Protocol Violation|48|||
157057698|NCT04736472|566964480|FG001|Overall Study|Protocol Violation|0|||
157057699|NCT04736472|566964481|FG002|Overall Study|Protocol Violation|6|||
157057700|NCT00577096|566964484|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
157178953|NCT00364832|567398024|FG007|Core Period|Early Withdrawals|1|||
156975929|NCT01552954|566665613|FG001|Overall Study|Adverse Event|2|||
156975930|NCT01552954|566665612|FG000|Overall Study|Lost to Follow-up|1|||
156975931|NCT01552954|566665613|FG001|Overall Study|Lost to Follow-up|1|||
157229660|NCT01856309|567586545|FG002|Overall Study|Withdrawal by Subject|28|||
157229661|NCT01856309|567586546|FG003|Overall Study|Withdrawal by Subject|26|||
157229662|NCT01856309|567586543|FG000|Overall Study|Other|227|||
157229663|NCT01856309|567586544|FG001|Overall Study|Other|225|||
157229664|NCT01856309|567586545|FG002|Overall Study|Other|447|||
157229665|NCT01856309|567586546|FG003|Overall Study|Other|469|||
157229666|NCT01856309|567586543|FG000|Overall Study|Lack of Efficacy|14|||
157229667|NCT01856309|567586544|FG001|Overall Study|Lack of Efficacy|9|||
157229668|NCT01856309|567586545|FG002|Overall Study|Lack of Efficacy|40|||
157229669|NCT01856309|567586546|FG003|Overall Study|Lack of Efficacy|25|||
157229670|NCT01856309|567586543|FG000|Overall Study|Adverse Event|31|||
157229671|NCT01856309|567586544|FG001|Overall Study|Adverse Event|31|||
157229672|NCT01856309|567586545|FG002|Overall Study|Adverse Event|55|||
157229673|NCT01856309|567586546|FG003|Overall Study|Adverse Event|65|||
157229674|NCT01856309|567586543|FG000|Overall Study|Pregnancy|0|||
157229675|NCT01856309|567586544|FG001|Overall Study|Pregnancy|0|||
157178954|NCT00364832|567398025|FG008|Core Period|Early Withdrawals|0|||
157178955|NCT00364832|567398026|FG009|Core Period|Early Withdrawals|0|||
157178956|NCT00364832|567398027|FG010|Core Period|Early Withdrawals|0|||
157178957|NCT00364832|567398028|FG011|Core Period|Early Withdrawals|0|||
157178958|NCT00364832|567398017|FG000|Extension Year 1|Early Withdrawals|0|||
157178959|NCT00364832|567398018|FG001|Extension Year 1|Early Withdrawals|0|||
157178960|NCT00364832|567398019|FG002|Extension Year 1|Early Withdrawals|0|||
157178961|NCT00364832|567398020|FG003|Extension Year 1|Early Withdrawals|0|||
157178962|NCT00364832|567398021|FG004|Extension Year 1|Early Withdrawals|0|||
157178963|NCT00364832|567398022|FG005|Extension Year 1|Early Withdrawals|0|||
157178964|NCT00364832|567398023|FG006|Extension Year 1|Early Withdrawals|0|||
157178965|NCT00364832|567398024|FG007|Extension Year 1|Early Withdrawals|0|||
157178966|NCT00364832|567398025|FG008|Extension Year 1|Early Withdrawals|0|||
157178967|NCT00364832|567398026|FG009|Extension Year 1|Early Withdrawals|4|||
157178968|NCT00364832|567398027|FG010|Extension Year 1|Early Withdrawals|2|||
157178969|NCT00364832|567398028|FG011|Extension Year 1|Early Withdrawals|10|||
157178970|NCT00364832|567398017|FG000|Extension Year 2|Early Withdrawals|0|||
157178971|NCT00364832|567398018|FG001|Extension Year 2|Early Withdrawals|0|||
157178972|NCT00364832|567398019|FG002|Extension Year 2|Early Withdrawals|0|||
157178973|NCT00364832|567398020|FG003|Extension Year 2|Early Withdrawals|0|||
157178974|NCT00364832|567398021|FG004|Extension Year 2|Early Withdrawals|0|||
157178975|NCT00364832|567398022|FG005|Extension Year 2|Early Withdrawals|0|||
157178976|NCT00364832|567398023|FG006|Extension Year 2|Early Withdrawals|0|||
157178977|NCT00364832|567398024|FG007|Extension Year 2|Early Withdrawals|0|||
157178978|NCT00364832|567398025|FG008|Extension Year 2|Early Withdrawals|0|||
157178979|NCT00364832|567398026|FG009|Extension Year 2|Early Withdrawals|5|||
157178980|NCT00364832|567398027|FG010|Extension Year 2|Early Withdrawals|5|||
157178981|NCT00364832|567398028|FG011|Extension Year 2|Early Withdrawals|3|||
157178982|NCT03210220|567398029|FG000|Overall Study|Physician Decision|1|||
157178983|NCT03210220|567398030|FG001|Overall Study|Physician Decision|0|||
157178984|NCT00865046|567398036|FG000|Overall Study|Lost to Follow-up|1|||
157178985|NCT00865046|567398037|FG001|Overall Study|Lost to Follow-up|4|||
157178986|NCT00865046|567398038|FG002|Overall Study|Lost to Follow-up|0|||
157178987|NCT00865046|567398036|FG000|Overall Study|Death|0|||
157178988|NCT00865046|567398037|FG001|Overall Study|Death|1|||
157178989|NCT00865046|567398038|FG002|Overall Study|Death|1|||
157178990|NCT00865046|567398036|FG000|Overall Study|Withdrawal by Subject|5|||
157178991|NCT00865046|567398037|FG001|Overall Study|Withdrawal by Subject|0|||
157178992|NCT00865046|567398038|FG002|Overall Study|Withdrawal by Subject|0|||
157178993|NCT01098032|567398044|FG000|Overall Study|Withdrawal by Subject|1|||
157178994|NCT01098032|567398045|FG001|Overall Study|Withdrawal by Subject|1|||
157229676|NCT01856309|567586545|FG002|Overall Study|Pregnancy|0|||
157178995|NCT02959190|567398046|FG000|Open Label|Adverse Event|5|||
157178996|NCT02959190|567398047|FG001|Open Label|Adverse Event|7|||
157178997|NCT02959190|567398048|FG002|Open Label|Adverse Event|3|||
157178998|NCT02959190|567398049|FG003|Open Label|Adverse Event|4|||
157178999|NCT02959190|567398046|FG000|Open Label|Pregnancy|0|||
157179000|NCT02959190|567398047|FG001|Open Label|Pregnancy|1|||
157179001|NCT02959190|567398048|FG002|Open Label|Pregnancy|0|||
157229677|NCT01856309|567586546|FG003|Overall Study|Pregnancy|1|||
157179002|NCT02959190|567398049|FG003|Open Label|Pregnancy|0|||
157179003|NCT02959190|567398046|FG000|Open Label|Withdrawal by Subject|2|||
157179004|NCT02959190|567398047|FG001|Open Label|Withdrawal by Subject|8|||
157179005|NCT02959190|567398048|FG002|Open Label|Withdrawal by Subject|0|||
157179006|NCT02959190|567398049|FG003|Open Label|Withdrawal by Subject|0|||
157179007|NCT02959190|567398046|FG000|Open Label|Physician Decision|0|||
157179008|NCT02959190|567398047|FG001|Open Label|Physician Decision|0|||
157179009|NCT02959190|567398048|FG002|Open Label|Physician Decision|1|||
157179010|NCT02959190|567398049|FG003|Open Label|Physician Decision|0|||
157179011|NCT02959190|567398046|FG000|Open Label|Protocol Violation|0|||
157179012|NCT02959190|567398047|FG001|Open Label|Protocol Violation|0|||
157179013|NCT02959190|567398048|FG002|Open Label|Protocol Violation|0|||
157229678|NCT01856309|567586543|FG000|Overall Study|Physician Decision|6|||
157229679|NCT01856309|567586544|FG001|Overall Study|Physician Decision|1|||
157179014|NCT02959190|567398049|FG003|Open Label|Protocol Violation|2|||
157179015|NCT02959190|567398046|FG000|Post Treatment Follow Up|Adverse Event|1|||
157179016|NCT02959190|567398047|FG001|Post Treatment Follow Up|Adverse Event|1|||
157179017|NCT02959190|567398048|FG002|Post Treatment Follow Up|Adverse Event|0|||
157179018|NCT02959190|567398049|FG003|Post Treatment Follow Up|Adverse Event|0|||
157179019|NCT02959190|567398046|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
157179020|NCT02959190|567398047|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
157179021|NCT02959190|567398048|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
157179022|NCT02959190|567398049|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
157179023|NCT02709109|567398060|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
157179024|NCT02709109|567398061|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
157179025|NCT02709109|567398062|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
157179026|NCT02709109|567398063|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
157179027|NCT02709109|567398060|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
157179028|NCT02709109|567398061|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
157179029|NCT02709109|567398062|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
157179030|NCT02709109|567398063|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
157179031|NCT02709109|567398060|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
157179032|NCT02709109|567398061|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
157179033|NCT02709109|567398062|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
157179034|NCT02709109|567398063|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
157179035|NCT02709109|567398060|FG000|Washout Period (28 Days)|Other|2|||
157179036|NCT02709109|567398061|FG001|Washout Period (28 Days)|Other|2|||
157179037|NCT02709109|567398062|FG002|Washout Period (28 Days)|Other|3|||
157179038|NCT02709109|567398063|FG003|Washout Period (28 Days)|Other|0|||
157179039|NCT02709109|567398060|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
157179040|NCT02709109|567398061|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
157179041|NCT02709109|567398062|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
157179042|NCT02709109|567398063|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
157179043|NCT02709109|567398060|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
157179044|NCT02709109|567398061|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
157179045|NCT02709109|567398062|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
157179046|NCT02709109|567398063|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
157179047|NCT02709109|567398060|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
157179048|NCT02709109|567398061|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
157179049|NCT02709109|567398062|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
157179050|NCT02709109|567398063|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
157179051|NCT02709109|567398060|FG000|Treatment Period 2 (28 Days)|Other|0|||
157179052|NCT02709109|567398061|FG001|Treatment Period 2 (28 Days)|Other|0|||
157179053|NCT02709109|567398062|FG002|Treatment Period 2 (28 Days)|Other|1|||
157179054|NCT02709109|567398063|FG003|Treatment Period 2 (28 Days)|Other|0|||
157179055|NCT00741260|567398064|FG000|Overall Study|Disease Progression|3|||
157179056|NCT00741260|567398065|FG001|Overall Study|Disease Progression|5|||
157179057|NCT00741260|567398066|FG002|Overall Study|Disease Progression|3|||
157179058|NCT00741260|567398067|FG003|Overall Study|Disease Progression|3|||
157179059|NCT00741260|567398068|FG004|Overall Study|Disease Progression|5|||
157179060|NCT00741260|567398069|FG005|Overall Study|Disease Progression|37|||
157179061|NCT00741260|567398070|FG006|Overall Study|Disease Progression|4|||
157179062|NCT00741260|567398064|FG000|Overall Study|Death|0|||
157179063|NCT00741260|567398065|FG001|Overall Study|Death|1|||
157179064|NCT00741260|567398066|FG002|Overall Study|Death|0|||
157179065|NCT00741260|567398067|FG003|Overall Study|Death|1|||
157179066|NCT00741260|567398068|FG004|Overall Study|Death|2|||
157179067|NCT00741260|567398069|FG005|Overall Study|Death|2|||
157179068|NCT00741260|567398070|FG006|Overall Study|Death|1|||
157179069|NCT00741260|567398064|FG000|Overall Study|Withdrawal by Subject|0|||
157179070|NCT00741260|567398065|FG001|Overall Study|Withdrawal by Subject|0|||
157179071|NCT00741260|567398066|FG002|Overall Study|Withdrawal by Subject|0|||
157179072|NCT00741260|567398067|FG003|Overall Study|Withdrawal by Subject|0|||
157179073|NCT00741260|567398068|FG004|Overall Study|Withdrawal by Subject|1|||
157179074|NCT00741260|567398069|FG005|Overall Study|Withdrawal by Subject|3|||
157179075|NCT00741260|567398070|FG006|Overall Study|Withdrawal by Subject|1|||
156975932|NCT01552954|566665612|FG000|Overall Study|Withdrawal by Subject|1|||
156975933|NCT01552954|566665613|FG001|Overall Study|Withdrawal by Subject|1|||
157179076|NCT00741260|567398064|FG000|Overall Study|Physician Decision|1|||
157179077|NCT00741260|567398065|FG001|Overall Study|Physician Decision|1|||
157179078|NCT00741260|567398066|FG002|Overall Study|Physician Decision|0|||
157179079|NCT00741260|567398067|FG003|Overall Study|Physician Decision|0|||
157179080|NCT00741260|567398068|FG004|Overall Study|Physician Decision|0|||
157179081|NCT00741260|567398069|FG005|Overall Study|Physician Decision|0|||
157179082|NCT00741260|567398070|FG006|Overall Study|Physician Decision|0|||
157179083|NCT00741260|567398064|FG000|Overall Study|Other|2|||
157179084|NCT00741260|567398065|FG001|Overall Study|Other|1|||
156975934|NCT01552954|566665612|FG000|Overall Study|Protocol Violation|1|||
157057701|NCT00577096|566964485|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
157057702|NCT00577096|566964484|FG000|Short Term Participation|Withdrawal by Subject|3|||
157057703|NCT00577096|566964485|FG001|Short Term Participation|Withdrawal by Subject|5|||
157057704|NCT00577096|566964484|FG000|Short Term Participation|Death|1|||
157057705|NCT00577096|566964485|FG001|Short Term Participation|Death|1|||
157057706|NCT00832650|566964486|FG000|Overall Study|Randomized but not treated|0|||
157057707|NCT00832650|566964487|FG001|Overall Study|Randomized but not treated|0|||
157057708|NCT00832650|566964488|FG002|Overall Study|Randomized but not treated|1|||
157057709|NCT00440037|566964490|FG000|Overall Study|Withdrawal by Subject|6|||
157057710|NCT00440037|566964490|FG000|Overall Study|Administrative decision|3|||
157057711|NCT03356145|566964491|FG000|Overall Study|Withdrawal by Subject|2|||
157057712|NCT03356145|566964492|FG001|Overall Study|Withdrawal by Subject|1|||
157057713|NCT03356145|566964491|FG000|Overall Study|Did not meet inclusion criteria|1|||
157057714|NCT03356145|566964492|FG001|Overall Study|Did not meet inclusion criteria|0|||
157057715|NCT03740919|566964495|FG000|Lead-in Period|Lost to Follow-up|1|||
157057716|NCT03740919|566964496|FG001|Lead-in Period|Lost to Follow-up|0|||
157057717|NCT03740919|566964497|FG002|Lead-in Period|Lost to Follow-up|0|||
157057718|NCT03740919|566964498|FG003|Lead-in Period|Lost to Follow-up|0|||
157057719|NCT03740919|566964495|FG000|Lead-in Period|Physician Decision|2|||
157057720|NCT03740919|566964496|FG001|Lead-in Period|Physician Decision|0|||
157057721|NCT03740919|566964497|FG002|Lead-in Period|Physician Decision|0|||
157057722|NCT03740919|566964498|FG003|Lead-in Period|Physician Decision|0|||
157057723|NCT03740919|566964495|FG000|Lead-in Period|Protocol Violation|1|||
157057724|NCT03740919|566964496|FG001|Lead-in Period|Protocol Violation|0|||
157057725|NCT03740919|566964497|FG002|Lead-in Period|Protocol Violation|0|||
157057726|NCT03740919|566964498|FG003|Lead-in Period|Protocol Violation|0|||
157057727|NCT03740919|566964495|FG000|Lead-in Period|Withdrawal by Subject|10|||
157057728|NCT03740919|566964496|FG001|Lead-in Period|Withdrawal by Subject|0|||
157057729|NCT03740919|566964497|FG002|Lead-in Period|Withdrawal by Subject|0|||
157179085|NCT00741260|567398066|FG002|Overall Study|Other|1|||
157179086|NCT00741260|567398067|FG003|Overall Study|Other|2|||
157179087|NCT00741260|567398068|FG004|Overall Study|Other|1|||
157179088|NCT00741260|567398069|FG005|Overall Study|Other|3|||
157179089|NCT00741260|567398070|FG006|Overall Study|Other|1|||
157179090|NCT02565615|567398071|FG000|Overall Study|Death|0|||
157179091|NCT02565615|567398072|FG001|Overall Study|Death|1|||
157179092|NCT02565615|567398073|FG002|Overall Study|Death|0|||
157179093|NCT02565615|567398074|FG003|Overall Study|Death|0|||
157179094|NCT02565615|567398075|FG004|Overall Study|Death|4|||
157179095|NCT02565615|567398071|FG000|Overall Study|Not willing to participate in study|2|||
157179096|NCT02565615|567398072|FG001|Overall Study|Not willing to participate in study|21|||
157179097|NCT02565615|567398073|FG002|Overall Study|Not willing to participate in study|0|||
157179098|NCT02565615|567398074|FG003|Overall Study|Not willing to participate in study|1|||
157179099|NCT02565615|567398075|FG004|Overall Study|Not willing to participate in study|169|||
157179100|NCT02565615|567398071|FG000|Overall Study|Lost to Follow-up|0|||
157179101|NCT02565615|567398072|FG001|Overall Study|Lost to Follow-up|4|||
157179102|NCT02565615|567398073|FG002|Overall Study|Lost to Follow-up|0|||
157179103|NCT02565615|567398074|FG003|Overall Study|Lost to Follow-up|1|||
157179104|NCT02565615|567398075|FG004|Overall Study|Lost to Follow-up|765|||
157179105|NCT02565615|567398071|FG000|Overall Study|Not meeting eligibility criteria|0|||
157179106|NCT02565615|567398072|FG001|Overall Study|Not meeting eligibility criteria|7|||
157179107|NCT02565615|567398073|FG002|Overall Study|Not meeting eligibility criteria|0|||
157179108|NCT02565615|567398074|FG003|Overall Study|Not meeting eligibility criteria|0|||
157179109|NCT02565615|567398075|FG004|Overall Study|Not meeting eligibility criteria|25|||
157179110|NCT02565615|567398071|FG000|Overall Study|Reason not defined|0|||
157179111|NCT02565615|567398072|FG001|Overall Study|Reason not defined|2|||
157179112|NCT02565615|567398073|FG002|Overall Study|Reason not defined|0|||
157179113|NCT02565615|567398074|FG003|Overall Study|Reason not defined|1|||
157179114|NCT02565615|567398075|FG004|Overall Study|Reason not defined|62|||
157179115|NCT02565615|567398071|FG000|Overall Study|Adverse Event|1|||
157179116|NCT02565615|567398072|FG001|Overall Study|Adverse Event|1|||
157179117|NCT02565615|567398073|FG002|Overall Study|Adverse Event|0|||
157179118|NCT02565615|567398074|FG003|Overall Study|Adverse Event|0|||
157179119|NCT02565615|567398075|FG004|Overall Study|Adverse Event|9|||
157179120|NCT02565615|567398071|FG000|Overall Study|Untreated|0|||
157179121|NCT02565615|567398072|FG001|Overall Study|Untreated|0|||
157179122|NCT02565615|567398073|FG002|Overall Study|Untreated|0|||
157179123|NCT02565615|567398074|FG003|Overall Study|Untreated|0|||
157179124|NCT02565615|567398075|FG004|Overall Study|Untreated|567|||
157179125|NCT01928082|567398080|FG000|Overall Study|Study terminated.|1|||
157179126|NCT05563714|567398082|FG000|Overall Study|Death|2|||
157179127|NCT05563714|567398083|FG001|Overall Study|Death|2|||
157179128|NCT05563714|567398084|FG002|Overall Study|Death|0|||
157179129|NCT05563714|567398085|FG003|Overall Study|Death|0|||
157179130|NCT05563714|567398082|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
157179131|NCT05563714|567398083|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
157179132|NCT05563714|567398084|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
157179133|NCT05563714|567398085|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
157179134|NCT05563714|567398082|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
157179135|NCT05563714|567398083|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
157179136|NCT05563714|567398084|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
157179137|NCT05563714|567398085|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
157179138|NCT05563714|567398082|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
157179139|NCT05563714|567398083|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
157179140|NCT05563714|567398084|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
157179141|NCT05563714|567398085|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
157179142|NCT05563714|567398082|FG000|Overall Study|Lost to Follow-up|22|||
157179143|NCT05563714|567398083|FG001|Overall Study|Lost to Follow-up|19|||
157179144|NCT05563714|567398084|FG002|Overall Study|Lost to Follow-up|0|||
157179145|NCT05563714|567398085|FG003|Overall Study|Lost to Follow-up|0|||
157179146|NCT01815580|567398088|FG000|Overall Study|Lost to Follow-up|4|||
157179147|NCT01815580|567398089|FG001|Overall Study|Lost to Follow-up|7|||
157179148|NCT01815580|567398088|FG000|Overall Study|Withdrawal by Subject|3|||
157179149|NCT01815580|567398089|FG001|Overall Study|Withdrawal by Subject|4|||
157179150|NCT01815580|567398088|FG000|Overall Study|Excluded from analysis|5|||
157179151|NCT01815580|567398089|FG001|Overall Study|Excluded from analysis|4|||
157179152|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
157179153|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
157179154|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
157179155|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
157179156|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
157229680|NCT01856309|567586545|FG002|Overall Study|Physician Decision|6|||
157229681|NCT01856309|567586546|FG003|Overall Study|Physician Decision|8|||
157229682|NCT01856309|567586543|FG000|Overall Study|Noncompliance With Study Drug|0|||
157229683|NCT01856309|567586544|FG001|Overall Study|Noncompliance With Study Drug|1|||
157229684|NCT01856309|567586545|FG002|Overall Study|Noncompliance With Study Drug|4|||
157229685|NCT01856309|567586546|FG003|Overall Study|Noncompliance With Study Drug|1|||
157229686|NCT00832377|567586549|FG000|Overall Study|Protocol Violation|1|||
157229687|NCT00220337|567586550|FG000|Overall Study|Adverse Event|70|||
157229688|NCT00220337|567586550|FG000|Overall Study|Lack of Efficacy|17|||
157229689|NCT00220337|567586550|FG000|Overall Study|Withdrawal by Subject|68|||
156975935|NCT01552954|566665613|FG001|Overall Study|Protocol Violation|2|||
156975936|NCT01552954|566665612|FG000|Overall Study|diagnosed DM|1|||
156975937|NCT01552954|566665613|FG001|Overall Study|diagnosed DM|0|||
156975938|NCT00779779|566665614|FG000|Overall Study|Adverse Event|1|||
156975939|NCT00779779|566665614|FG000|Overall Study|Protocol Violation|14|||
156975940|NCT00779779|566665614|FG000|Overall Study|Withdrawal by Subject|4|||
156975941|NCT00779779|566665614|FG000|Overall Study|Lost to Follow-up|5|||
156975942|NCT01395823|566665615|FG000|Overall Study|Death|4|||
156975943|NCT01395823|566665616|FG001|Overall Study|Death|4|||
156975944|NCT01395823|566665615|FG000|Overall Study|Physician Decision|3|||
156975945|NCT01395823|566665616|FG001|Overall Study|Physician Decision|1|||
156975946|NCT01395823|566665615|FG000|Overall Study|Lost to Follow-up|1|||
156975947|NCT01395823|566665616|FG001|Overall Study|Lost to Follow-up|0|||
156975948|NCT01395823|566665615|FG000|Overall Study|Transplant|1|||
156975949|NCT01395823|566665616|FG001|Overall Study|Transplant|0|||
156975950|NCT01395823|566665615|FG000|Overall Study|GI symptoms|1|||
156975951|NCT01395823|566665616|FG001|Overall Study|GI symptoms|0|||
156975952|NCT01395823|566665615|FG000|Overall Study|Withdrawal by Subject|5|||
156975953|NCT01395823|566665616|FG001|Overall Study|Withdrawal by Subject|4|||
156975954|NCT03300570|566665618|FG000|Overall Study|Adverse Event|0|||
156975955|NCT03300570|566665619|FG001|Overall Study|Adverse Event|1|||
156975956|NCT03300570|566665618|FG000|Overall Study|Withdrawal by Subject|1|||
156975957|NCT03300570|566665619|FG001|Overall Study|Withdrawal by Subject|0|||
156975958|NCT03300570|566665618|FG000|Overall Study|Inadequate bowel prep|1|||
156975959|NCT03300570|566665619|FG001|Overall Study|Inadequate bowel prep|0|||
156975960|NCT03188120|566665620|FG000|Overall Study|Adverse Event|4|||
156975961|NCT03188120|566665620|FG000|Overall Study|Insufficient Effectiveness|8|||
156975962|NCT03188120|566665620|FG000|Overall Study|Improved|12|||
156975963|NCT03188120|566665620|FG000|Overall Study|Lost to Follow-up|7|||
156975964|NCT03188120|566665620|FG000|Overall Study|Other than specified|3|||
156975965|NCT03188120|566665620|FG000|Overall Study|No visit after the first visit|13|||
156975966|NCT00576732|566665621|FG000|DOUBLE BLIND|Adverse Event|0|||
156975967|NCT00576732|566665622|FG001|DOUBLE BLIND|Adverse Event|0|||
156975968|NCT00576732|566665623|FG002|DOUBLE BLIND|Adverse Event|1|||
156975969|NCT00576732|566665624|FG003|DOUBLE BLIND|Adverse Event|0|||
156975970|NCT00576732|566665625|FG004|DOUBLE BLIND|Adverse Event|0|||
156975971|NCT00576732|566665626|FG005|DOUBLE BLIND|Adverse Event|0|||
156975972|NCT00576732|566665621|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
157057730|NCT03740919|566964498|FG003|Lead-in Period|Withdrawal by Subject|0|||
157057731|NCT03740919|566964495|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
157057732|NCT03740919|566964496|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
157057733|NCT03740919|566964497|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
157057734|NCT03740919|566964498|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
157057735|NCT03740919|566964495|FG000|Lead-in Period|Study Task Too Burdensome|1|||
157057736|NCT03740919|566964496|FG001|Lead-in Period|Study Task Too Burdensome|0|||
157057737|NCT03740919|566964497|FG002|Lead-in Period|Study Task Too Burdensome|0|||
157057738|NCT03740919|566964498|FG003|Lead-in Period|Study Task Too Burdensome|0|||
157057739|NCT03740919|566964495|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
157057740|NCT03740919|566964496|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
157057741|NCT03740919|566964497|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
157057742|NCT03740919|566964498|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
157057743|NCT03740919|566964495|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
157057744|NCT03740919|566964496|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
157057745|NCT03740919|566964497|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
157057746|NCT03740919|566964498|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
157057747|NCT03740919|566964495|FG000|Treatment Period|Adverse Event|0|||
157057748|NCT03740919|566964496|FG001|Treatment Period|Adverse Event|0|||
157057749|NCT03740919|566964497|FG002|Treatment Period|Adverse Event|2|||
157057750|NCT03740919|566964498|FG003|Treatment Period|Adverse Event|0|||
157057751|NCT03740919|566964495|FG000|Treatment Period|Protocol Violation|0|||
157057752|NCT03740919|566964496|FG001|Treatment Period|Protocol Violation|1|||
157057753|NCT03740919|566964497|FG002|Treatment Period|Protocol Violation|0|||
157057754|NCT03740919|566964498|FG003|Treatment Period|Protocol Violation|0|||
157057755|NCT03740919|566964495|FG000|Treatment Period|Withdrawal by Subject|0|||
157057756|NCT03740919|566964496|FG001|Treatment Period|Withdrawal by Subject|7|||
157057757|NCT03740919|566964497|FG002|Treatment Period|Withdrawal by Subject|6|||
157057758|NCT03740919|566964498|FG003|Treatment Period|Withdrawal by Subject|2|||
157057759|NCT03740919|566964495|FG000|Treatment Period|Terminated by Sponsor|0|||
157057760|NCT03740919|566964496|FG001|Treatment Period|Terminated by Sponsor|1|||
157057761|NCT03740919|566964497|FG002|Treatment Period|Terminated by Sponsor|0|||
157057762|NCT03740919|566964498|FG003|Treatment Period|Terminated by Sponsor|0|||
157057763|NCT03740919|566964495|FG000|Treatment Period|Issue with Insulin Pump|0|||
157057764|NCT03740919|566964496|FG001|Treatment Period|Issue with Insulin Pump|1|||
157057765|NCT03740919|566964497|FG002|Treatment Period|Issue with Insulin Pump|0|||
157057766|NCT03740919|566964498|FG003|Treatment Period|Issue with Insulin Pump|0|||
157057767|NCT03740919|566964495|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
157057768|NCT03740919|566964496|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
157057769|NCT03740919|566964497|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
157057770|NCT03740919|566964498|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
157057771|NCT03740919|566964495|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
157057772|NCT03740919|566964496|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
157057773|NCT03740919|566964497|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
157057774|NCT03740919|566964498|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
157057775|NCT03740919|566964495|FG000|Treatment Period|Not Completing Diary|0|||
157057776|NCT03740919|566964496|FG001|Treatment Period|Not Completing Diary|0|||
157057777|NCT03740919|566964497|FG002|Treatment Period|Not Completing Diary|1|||
157057778|NCT03740919|566964498|FG003|Treatment Period|Not Completing Diary|0|||
157057779|NCT03740919|566964495|FG000|Treatment Period|Insulin Painful to Participant|0|||
157057780|NCT03740919|566964496|FG001|Treatment Period|Insulin Painful to Participant|0|||
157057781|NCT03740919|566964497|FG002|Treatment Period|Insulin Painful to Participant|1|||
157057782|NCT03740919|566964498|FG003|Treatment Period|Insulin Painful to Participant|0|||
157057783|NCT00985621|566964501|FG000|Overall Study|Adverse Event|2|||
157057784|NCT00985621|566964502|FG001|Overall Study|Adverse Event|3|||
157057785|NCT00985621|566964503|FG002|Overall Study|Adverse Event|4|||
157057786|NCT00985621|566964504|FG003|Overall Study|Adverse Event|16|||
157057787|NCT00985621|566964501|FG000|Overall Study|Lack of Efficacy|10|||
157057788|NCT00985621|566964502|FG001|Overall Study|Lack of Efficacy|6|||
157057789|NCT00985621|566964503|FG002|Overall Study|Lack of Efficacy|5|||
157057790|NCT00985621|566964504|FG003|Overall Study|Lack of Efficacy|12|||
157057791|NCT00985621|566964501|FG000|Overall Study|Lost to Follow-up|2|||
157057792|NCT00985621|566964502|FG001|Overall Study|Lost to Follow-up|3|||
157057793|NCT00985621|566964503|FG002|Overall Study|Lost to Follow-up|4|||
157057794|NCT00985621|566964504|FG003|Overall Study|Lost to Follow-up|4|||
157057795|NCT00985621|566964501|FG000|Overall Study|Study Terminated by Sponsor|89|||
157057796|NCT00985621|566964502|FG001|Overall Study|Study Terminated by Sponsor|108|||
157229690|NCT00220337|567586550|FG000|Overall Study|Protocol Violation|2|||
157057797|NCT00985621|566964503|FG002|Overall Study|Study Terminated by Sponsor|99|||
157057798|NCT00985621|566964504|FG003|Overall Study|Study Terminated by Sponsor|92|||
157057799|NCT00985621|566964501|FG000|Overall Study|Protocol Violation|1|||
157057800|NCT00985621|566964502|FG001|Overall Study|Protocol Violation|1|||
157057801|NCT00985621|566964503|FG002|Overall Study|Protocol Violation|1|||
157057802|NCT00985621|566964504|FG003|Overall Study|Protocol Violation|0|||
157057803|NCT00985621|566964501|FG000|Overall Study|Withdrawal by Subject|8|||
157057804|NCT00985621|566964502|FG001|Overall Study|Withdrawal by Subject|10|||
157057805|NCT00985621|566964503|FG002|Overall Study|Withdrawal by Subject|8|||
157057806|NCT00985621|566964504|FG003|Overall Study|Withdrawal by Subject|12|||
157057807|NCT00985621|566964501|FG000|Overall Study|Other|1|||
157057808|NCT00985621|566964502|FG001|Overall Study|Other|0|||
157057809|NCT00985621|566964503|FG002|Overall Study|Other|0|||
157057810|NCT00985621|566964504|FG003|Overall Study|Other|0|||
157057811|NCT00985621|566964501|FG000|Overall Study|Randomized but not Treated|1|||
157057812|NCT00985621|566964502|FG001|Overall Study|Randomized but not Treated|0|||
157057813|NCT00985621|566964503|FG002|Overall Study|Randomized but not Treated|2|||
157057814|NCT00985621|566964504|FG003|Overall Study|Randomized but not Treated|1|||
157057815|NCT04394624|566964508|FG000|Overall Study|Adverse Event|6|||
157057816|NCT04394624|566964509|FG001|Overall Study|Adverse Event|0|||
157057817|NCT04394624|566964508|FG000|Overall Study|Progressive disease|24|||
157057818|NCT04394624|566964509|FG001|Overall Study|Progressive disease|0|||
157057819|NCT04394624|566964508|FG000|Overall Study|Not related to COVID-19|1|||
157057820|NCT04394624|566964509|FG001|Overall Study|Not related to COVID-19|0|||
157057821|NCT00905255|566964510|FG000|Overall Study|Adverse Event|7|||
157057822|NCT00905255|566964511|FG001|Overall Study|Adverse Event|5|||
157057823|NCT00905255|566964510|FG000|Overall Study|Withdrawal by Subject|5|||
157057824|NCT00905255|566964511|FG001|Overall Study|Withdrawal by Subject|4|||
157057825|NCT00905255|566964510|FG000|Overall Study|Familial and Personal Reasons|1|||
157057826|NCT00905255|566964511|FG001|Overall Study|Familial and Personal Reasons|0|||
157057827|NCT00603278|566964514|FG000|Overall Study|Lack of Efficacy|35|||
157057828|NCT00603278|566964515|FG001|Overall Study|Lack of Efficacy|10|||
157057829|NCT00603278|566964516|FG002|Overall Study|Lack of Efficacy|11|||
157057830|NCT00603278|566964517|FG003|Overall Study|Lack of Efficacy|8|||
157057831|NCT00603278|566964518|FG004|Overall Study|Lack of Efficacy|7|||
157057832|NCT00603278|566964519|FG005|Overall Study|Lack of Efficacy|14|||
157057833|NCT00603278|566964514|FG000|Overall Study|Adverse Event|0|||
157057834|NCT00603278|566964515|FG001|Overall Study|Adverse Event|3|||
157057835|NCT00603278|566964516|FG002|Overall Study|Adverse Event|1|||
157057836|NCT00603278|566964517|FG003|Overall Study|Adverse Event|0|||
157057837|NCT00603278|566964518|FG004|Overall Study|Adverse Event|2|||
157057838|NCT00603278|566964519|FG005|Overall Study|Adverse Event|1|||
157057839|NCT00603278|566964514|FG000|Overall Study|Withdrawal by Subject|2|||
157057840|NCT00603278|566964515|FG001|Overall Study|Withdrawal by Subject|3|||
157057841|NCT00603278|566964516|FG002|Overall Study|Withdrawal by Subject|1|||
157057842|NCT00603278|566964517|FG003|Overall Study|Withdrawal by Subject|2|||
157057843|NCT00603278|566964518|FG004|Overall Study|Withdrawal by Subject|1|||
157057844|NCT00603278|566964519|FG005|Overall Study|Withdrawal by Subject|2|||
157057845|NCT00603278|566964514|FG000|Overall Study|Protocol Violation|3|||
157057846|NCT00603278|566964515|FG001|Overall Study|Protocol Violation|0|||
157057847|NCT00603278|566964516|FG002|Overall Study|Protocol Violation|1|||
157057848|NCT00603278|566964517|FG003|Overall Study|Protocol Violation|1|||
157057849|NCT00603278|566964518|FG004|Overall Study|Protocol Violation|0|||
157057850|NCT00603278|566964519|FG005|Overall Study|Protocol Violation|1|||
157057851|NCT00603278|566964514|FG000|Overall Study|Physician Decision|0|||
157057852|NCT00603278|566964515|FG001|Overall Study|Physician Decision|1|||
157057853|NCT00603278|566964516|FG002|Overall Study|Physician Decision|0|||
157057854|NCT00603278|566964517|FG003|Overall Study|Physician Decision|0|||
157057855|NCT00603278|566964518|FG004|Overall Study|Physician Decision|2|||
157057856|NCT00603278|566964519|FG005|Overall Study|Physician Decision|1|||
157057857|NCT00603278|566964514|FG000|Overall Study|Lost to Follow-up|1|||
157057858|NCT00603278|566964515|FG001|Overall Study|Lost to Follow-up|0|||
157057859|NCT00603278|566964516|FG002|Overall Study|Lost to Follow-up|0|||
157057860|NCT00603278|566964517|FG003|Overall Study|Lost to Follow-up|0|||
157057861|NCT00603278|566964518|FG004|Overall Study|Lost to Follow-up|1|||
157057862|NCT00603278|566964519|FG005|Overall Study|Lost to Follow-up|0|||
157057863|NCT02418819|566964521|FG000|Overall Study|Adverse Event|0|||
157057864|NCT02418819|566964522|FG001|Overall Study|Adverse Event|0|||
157057865|NCT02418819|566964523|FG002|Overall Study|Adverse Event|1|||
157057866|NCT02418819|566964524|FG003|Overall Study|Adverse Event|0|||
157057867|NCT02418819|566964521|FG000|Overall Study|Lost to Follow-up|1|||
157057868|NCT02418819|566964522|FG001|Overall Study|Lost to Follow-up|0|||
157057869|NCT02418819|566964523|FG002|Overall Study|Lost to Follow-up|0|||
157057870|NCT02418819|566964524|FG003|Overall Study|Lost to Follow-up|0|||
157057871|NCT02418819|566964521|FG000|Overall Study|No longer meets eligibility criteria|0|||
157057872|NCT02418819|566964522|FG001|Overall Study|No longer meets eligibility criteria|0|||
157057873|NCT02418819|566964523|FG002|Overall Study|No longer meets eligibility criteria|1|||
157057874|NCT02418819|566964524|FG003|Overall Study|No longer meets eligibility criteria|0|||
157057875|NCT02418819|566964521|FG000|Overall Study|No longer willing to participate|0|||
157057876|NCT02418819|566964522|FG001|Overall Study|No longer willing to participate|0|||
157057877|NCT02418819|566964523|FG002|Overall Study|No longer willing to participate|2|||
157057878|NCT02418819|566964524|FG003|Overall Study|No longer willing to participate|1|||
157057879|NCT01332318|566964528|FG000|Overall Study|Adverse Event|0|||
157057880|NCT01332318|566964529|FG001|Overall Study|Adverse Event|3|||
157057881|NCT01332318|566964530|FG002|Overall Study|Adverse Event|0|||
157057882|NCT01332318|566964531|FG003|Overall Study|Adverse Event|0|||
157057883|NCT01332318|566964528|FG000|Overall Study|Withdrawal by Subject|1|||
157057884|NCT01332318|566964529|FG001|Overall Study|Withdrawal by Subject|1|||
157057885|NCT01332318|566964530|FG002|Overall Study|Withdrawal by Subject|0|||
157057886|NCT01332318|566964531|FG003|Overall Study|Withdrawal by Subject|1|||
157057887|NCT01332318|566964528|FG000|Overall Study|Protocol Violation|1|||
157057888|NCT01332318|566964529|FG001|Overall Study|Protocol Violation|0|||
157057889|NCT01332318|566964530|FG002|Overall Study|Protocol Violation|1|||
157057890|NCT01332318|566964531|FG003|Overall Study|Protocol Violation|1|||
157057891|NCT02040532|566964532|FG000|Overall Study|Lost to Follow-up|1|||
157057892|NCT02040532|566964532|FG000|Overall Study|Physician Decision|4|||
157057893|NCT02040532|566964532|FG000|Overall Study|Adverse Event|4|||
157057894|NCT02040532|566964532|FG000|Overall Study|Withdrawal by Subject|3|||
157057895|NCT01207453|566964533|FG000|First Intervention|Adverse Event|2|||
157057896|NCT01207453|566964534|FG001|First Intervention|Adverse Event|1|||
157057897|NCT01207453|566964533|FG000|Washout|Adverse Event|1|||
157057898|NCT01207453|566964534|FG001|Washout|Adverse Event|0|||
157057899|NCT01207453|566964533|FG000|Washout|Lost to Follow-up|1|||
157057900|NCT01207453|566964534|FG001|Washout|Lost to Follow-up|0|||
157057901|NCT01207453|566964533|FG000|2nd Intervention|Adverse Event|1|||
157057902|NCT01207453|566964534|FG001|2nd Intervention|Adverse Event|2|||
157057903|NCT01207453|566964533|FG000|2nd Intervention|Lost to Follow-up|1|||
157057904|NCT01207453|566964534|FG001|2nd Intervention|Lost to Follow-up|0|||
157057905|NCT00676663|566964535|FG000|Overall Study|Death|43|||
157057906|NCT00676663|566964536|FG001|Overall Study|Death|27|||
157057907|NCT00676663|566964535|FG000|Overall Study|Withdrew Consent|1|||
157057908|NCT00676663|566964536|FG001|Overall Study|Withdrew Consent|8|||
157057909|NCT00676663|566964535|FG000|Overall Study|Lost to Follow-up|1|||
157057910|NCT00676663|566964536|FG001|Overall Study|Lost to Follow-up|3|||
157057911|NCT01399905|566964537|FG000|Overall Study|Withdrawal by Subject|1|||
157057912|NCT01399905|566964538|FG001|Overall Study|Withdrawal by Subject|1|||
157057913|NCT00714688|566964546|FG000|Overall Study|Lack of Efficacy|14|||
157057914|NCT00714688|566964547|FG001|Overall Study|Lack of Efficacy|1|||
157057915|NCT00714688|566964548|FG002|Overall Study|Lack of Efficacy|4|||
157057916|NCT00714688|566964546|FG000|Overall Study|Withdrawal by Subject|4|||
157057917|NCT00714688|566964547|FG001|Overall Study|Withdrawal by Subject|3|||
157057918|NCT00714688|566964548|FG002|Overall Study|Withdrawal by Subject|3|||
157057919|NCT00714688|566964546|FG000|Overall Study|Lost to Follow-up|5|||
157057920|NCT00714688|566964547|FG001|Overall Study|Lost to Follow-up|2|||
157057921|NCT00714688|566964548|FG002|Overall Study|Lost to Follow-up|0|||
157057922|NCT00714688|566964546|FG000|Overall Study|Adverse Event|2|||
157057923|NCT00714688|566964547|FG001|Overall Study|Adverse Event|15|||
157057924|NCT00714688|566964548|FG002|Overall Study|Adverse Event|19|||
157057925|NCT00714688|566964546|FG000|Overall Study|Subject Non-compliant|3|||
157057926|NCT00714688|566964547|FG001|Overall Study|Subject Non-compliant|5|||
157057927|NCT00714688|566964548|FG002|Overall Study|Subject Non-compliant|5|||
157057928|NCT00714688|566964546|FG000|Overall Study|Ineligible to Continue the Study|0|||
157057929|NCT00714688|566964547|FG001|Overall Study|Ineligible to Continue the Study|1|||
157229691|NCT00220337|567586550|FG000|Overall Study|Lost to Follow-up|5|||
157229692|NCT00220337|567586550|FG000|Overall Study|Other|12|||
157229693|NCT00220337|567586550|FG000|Overall Study|Unsatisfactory compliance|5|||
157229694|NCT01273181|567586551|FG000|Phase I, Dose 1|Study termination|1|||
157229695|NCT01273181|567586552|FG001|Phase I, Dose 1|Study termination|0|||
156975973|NCT00576732|566665622|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
156975974|NCT00576732|566665623|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
156975975|NCT00576732|566665624|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
156975976|NCT00576732|566665625|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
156975977|NCT00576732|566665626|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
156975978|NCT00576732|566665621|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
156975979|NCT00576732|566665622|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
156975980|NCT00576732|566665623|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
156975981|NCT00576732|566665624|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
156975982|NCT00576732|566665625|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
156975983|NCT00576732|566665626|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
156975984|NCT00576732|566665621|FG000|DOUBLE BLIND|OTHER|0|||
156975985|NCT00576732|566665622|FG001|DOUBLE BLIND|OTHER|2|||
156975986|NCT00576732|566665623|FG002|DOUBLE BLIND|OTHER|1|||
156975987|NCT00576732|566665624|FG003|DOUBLE BLIND|OTHER|0|||
156975988|NCT00576732|566665625|FG004|DOUBLE BLIND|OTHER|0|||
156975989|NCT00576732|566665626|FG005|DOUBLE BLIND|OTHER|0|||
156975990|NCT00576732|566665621|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
156975991|NCT00576732|566665622|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
156975992|NCT00576732|566665623|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
156975993|NCT00576732|566665624|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
156975994|NCT00576732|566665625|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
156975995|NCT00576732|566665626|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
156975996|NCT00576732|566665621|FG000|DOUBLE BLIND|Protocol Violation|1|||
157057930|NCT00714688|566964548|FG002|Overall Study|Ineligible to Continue the Study|1|||
157057931|NCT00714688|566964546|FG000|Overall Study|Sponsor's Decision|0|||
157057932|NCT00714688|566964547|FG001|Overall Study|Sponsor's Decision|2|||
157057933|NCT00714688|566964548|FG002|Overall Study|Sponsor's Decision|0|||
157057934|NCT00714688|566964546|FG000|Overall Study|Other|1|||
157057935|NCT00714688|566964547|FG001|Overall Study|Other|6|||
157057936|NCT00714688|566964548|FG002|Overall Study|Other|5|||
157057937|NCT01786551|566964549|FG000|Overall Study|Participant withdrew consent|2|||
157057938|NCT04853394|566964552|FG000|Follow-up Interviews|Lost to Follow-up|22|||
157057939|NCT04853394|566964553|FG001|Follow-up Interviews|Lost to Follow-up|15|||
157057940|NCT01524887|566964554|FG000|Overall Study|Withdrawal by Subject|6|||
157057941|NCT01524887|566964555|FG001|Overall Study|Withdrawal by Subject|2|||
157057942|NCT01524887|566964556|FG002|Overall Study|Withdrawal by Subject|3|||
157057943|NCT01524887|566964554|FG000|Overall Study|Adverse Event|5|||
157057944|NCT01524887|566964555|FG001|Overall Study|Adverse Event|1|||
157057945|NCT01524887|566964556|FG002|Overall Study|Adverse Event|1|||
157057946|NCT01524887|566964554|FG000|Overall Study|Protocol Violation|0|||
157057947|NCT01524887|566964555|FG001|Overall Study|Protocol Violation|0|||
157057948|NCT01524887|566964556|FG002|Overall Study|Protocol Violation|1|||
157057949|NCT01524887|566964554|FG000|Overall Study|Study termination|73|||
157057950|NCT01524887|566964555|FG001|Overall Study|Study termination|87|||
157057951|NCT01524887|566964556|FG002|Overall Study|Study termination|79|||
157057952|NCT01524887|566964554|FG000|Overall Study|Withdrawal by Caregiver|0|||
157057953|NCT01524887|566964555|FG001|Overall Study|Withdrawal by Caregiver|0|||
157229696|NCT01273181|567586553|FG002|Phase I, Dose 1|Study termination|0|||
157229697|NCT01273181|567586554|FG003|Phase I, Dose 1|Study termination|0|||
157229698|NCT01273181|567586551|FG000|Phase I, Dose 2|Death during treatment|0|||
157229699|NCT01273181|567586552|FG001|Phase I, Dose 2|Death during treatment|1|||
157229700|NCT01273181|567586553|FG002|Phase I, Dose 2|Death during treatment|0|||
157229701|NCT01273181|567586554|FG003|Phase I, Dose 2|Death during treatment|0|||
157229702|NCT01273181|567586551|FG000|Phase 2, Dose 1|Study termination|0|||
157229703|NCT01273181|567586552|FG001|Phase 2, Dose 1|Study termination|0|||
157229704|NCT01273181|567586553|FG002|Phase 2, Dose 1|Study termination|1|||
157229705|NCT01273181|567586554|FG003|Phase 2, Dose 1|Study termination|0|||
157229706|NCT01273181|567586551|FG000|Phase 2, Dose 2|Death during treatment|0|||
157229707|NCT01273181|567586552|FG001|Phase 2, Dose 2|Death during treatment|0|||
157229708|NCT01273181|567586553|FG002|Phase 2, Dose 2|Death during treatment|0|||
157229709|NCT01273181|567586554|FG003|Phase 2, Dose 2|Death during treatment|1|||
157229710|NCT00944697|567586555|FG000|Overall Study|Withdrawal by Subject|1|||
157229711|NCT00944697|567586556|FG001|Overall Study|Withdrawal by Subject|1|||
157057954|NCT01524887|566964556|FG002|Overall Study|Withdrawal by Caregiver|2|||
157179157|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
157179158|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
157179159|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
157179160|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179161|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179162|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179163|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179164|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179165|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
157179166|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
157179167|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
157179168|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
157179169|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
157179170|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
157179171|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
157179172|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
157179173|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
157229712|NCT00944697|567586555|FG000|Overall Study|Adverse Event|0|||
157229713|NCT00944697|567586556|FG001|Overall Study|Adverse Event|3|||
157229714|NCT00944697|567586555|FG000|Overall Study|Administrative|1|||
157229715|NCT00944697|567586556|FG001|Overall Study|Administrative|1|||
157229716|NCT04276883|567586557|FG000|Overall Study|Withdrawal by Subject|2|||
157229717|NCT04276883|567586558|FG001|Overall Study|Withdrawal by Subject|3|||
157229718|NCT04276883|567586559|FG002|Overall Study|Withdrawal by Subject|6|||
157229719|NCT04276883|567586557|FG000|Overall Study|Lost to Follow-up|1|||
157057955|NCT01524887|566964554|FG000|Overall Study|Use of prohibited medication|1|||
157179174|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157229720|NCT04276883|567586558|FG001|Overall Study|Lost to Follow-up|3|||
157229721|NCT04276883|567586559|FG002|Overall Study|Lost to Follow-up|0|||
157229722|NCT04276883|567586557|FG000|Overall Study|Adverse Event|0|||
157229723|NCT04276883|567586558|FG001|Overall Study|Adverse Event|1|||
157229724|NCT04276883|567586559|FG002|Overall Study|Adverse Event|0|||
157229725|NCT04276883|567586557|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
157057956|NCT01524887|566964555|FG001|Overall Study|Use of prohibited medication|0|||
157057957|NCT01524887|566964556|FG002|Overall Study|Use of prohibited medication|0|||
157057958|NCT01808144|566964557|FG000|Overall Study|Death|1|||
157057959|NCT01808144|566964558|FG001|Overall Study|Death|0|||
157179175|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157179176|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157179177|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157179178|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157179179|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
157179180|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
157179181|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179182|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179183|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179184|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179185|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179186|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
157179187|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
157179188|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179189|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179190|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179191|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179192|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179193|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
157179194|NCT02120352|567398095|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
157179195|NCT02120352|567398096|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
157179196|NCT02120352|567398097|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
157179197|NCT02120352|567398098|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
157179198|NCT02120352|567398099|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
157229726|NCT04276883|567586558|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
157229727|NCT04276883|567586559|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
157229728|NCT02732210|567586560|FG000|Overall Study|Site Closed|0|||
157229729|NCT02732210|567586561|FG001|Overall Study|Site Closed|11|||
157229730|NCT02732210|567586560|FG000|Overall Study|Study Ended|13|||
157229731|NCT02732210|567586561|FG001|Overall Study|Study Ended|13|||
157229732|NCT02732210|567586560|FG000|Overall Study|Withdrawal by Subject|28|||
157229733|NCT02732210|567586561|FG001|Overall Study|Withdrawal by Subject|87|||
157229734|NCT02732210|567586560|FG000|Overall Study|Lost to Follow-up|5|||
157229735|NCT02732210|567586561|FG001|Overall Study|Lost to Follow-up|57|||
157229736|NCT02732210|567586560|FG000|Overall Study|Death|4|||
157229737|NCT02732210|567586561|FG001|Overall Study|Death|15|||
157229738|NCT02732210|567586560|FG000|Overall Study|Other|35|||
157229739|NCT02732210|567586561|FG001|Overall Study|Other|103|||
157229740|NCT02732210|567586560|FG000|Overall Study|Missing|0|||
157229741|NCT02732210|567586561|FG001|Overall Study|Missing|8|||
157229742|NCT01876706|567586562|FG000|Overall Study|BPH Intervention|9|||
157229743|NCT01876706|567586562|FG000|Overall Study|Lost to Follow-up|7|||
157229744|NCT01876706|567586562|FG000|Overall Study|Withdrawals|6|||
157229745|NCT01876706|567586562|FG000|Overall Study|Death|3|||
157229746|NCT00604500|567586563|FG000|Overall Study|Adverse Event|2|||
157229747|NCT00604500|567586563|FG000|Overall Study|Protocol Violation|2|||
157229748|NCT00604500|567586563|FG000|Overall Study|Treatment Failure|1|||
157229749|NCT00604500|567586563|FG000|Overall Study|Withdrawal by Subject|4|||
157229750|NCT00604500|567586563|FG000|Overall Study|Administrative|1|||
157229751|NCT00604500|567586563|FG000|Overall Study|Did not meet protocol eligibility|1|||
157229752|NCT06354270|567586567|FG000|Overall Study|Withdrawal by Subject|1|||
157229753|NCT06354270|567586568|FG001|Overall Study|Withdrawal by Subject|0|||
157229754|NCT01936948|567586585|FG000|Overall Study|no 30-day follow-up data|0|||
157229755|NCT01936948|567586586|FG001|Overall Study|no 30-day follow-up data|3|||
157229756|NCT01936948|567586587|FG002|Overall Study|no 30-day follow-up data|3|||
157229757|NCT01936948|567586588|FG003|Overall Study|no 30-day follow-up data|3|||
157229758|NCT01974141|567586592|FG000|Overall Study|Other Reasons|28|||
157229759|NCT01974141|567586593|FG001|Overall Study|Other Reasons|18|||
157229760|NCT01974141|567586592|FG000|Overall Study|Protocol Violation|2|||
157229761|NCT01974141|567586593|FG001|Overall Study|Protocol Violation|6|||
157229762|NCT01974141|567586592|FG000|Overall Study|Personal Reasons|21|||
157229763|NCT01974141|567586593|FG001|Overall Study|Personal Reasons|20|||
157229764|NCT01974141|567586592|FG000|Overall Study|Lost to Follow-up|38|||
157229765|NCT01974141|567586593|FG001|Overall Study|Lost to Follow-up|29|||
157229766|NCT01974141|567586592|FG000|Overall Study|Pregnancy|3|||
157179199|NCT02120352|567398100|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
157179200|NCT02120352|567398101|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
157179201|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
156975997|NCT00576732|566665622|FG001|DOUBLE BLIND|Protocol Violation|0|||
157179202|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
157229767|NCT01974141|567586593|FG001|Overall Study|Pregnancy|3|||
157229768|NCT01974141|567586592|FG000|Overall Study|Lack of Efficacy|0|||
157229769|NCT01974141|567586593|FG001|Overall Study|Lack of Efficacy|1|||
157229770|NCT01974141|567586592|FG000|Overall Study|Adverse Event|4|||
157229771|NCT01974141|567586593|FG001|Overall Study|Adverse Event|5|||
157179203|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
157179204|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
157179205|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
157179206|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
157179207|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
157179208|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
157179209|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
157179210|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
157179211|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
157179212|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
157179213|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
157179214|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
157179215|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
157179216|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
157179217|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
157179218|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
157179219|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
157179220|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
157179221|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
157179222|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
157179223|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
157179224|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
157179225|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
157179226|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
157179227|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
157179228|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
157179229|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179230|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179231|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179232|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
157179233|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179234|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179235|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
157179236|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
157179237|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
157179238|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
157179239|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
157179240|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
157179241|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
157179242|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
157179243|NCT02120352|567398095|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179244|NCT02120352|567398096|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
157179245|NCT02120352|567398097|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179246|NCT02120352|567398098|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179247|NCT02120352|567398099|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179248|NCT02120352|567398100|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179249|NCT02120352|567398101|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
157179250|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
157179251|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
157179252|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
157179253|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
157179254|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
157179255|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
157179256|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
157179257|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179258|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179259|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179260|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179261|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
157179262|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179263|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
157179264|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
157179265|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
157179266|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
157179267|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
157179268|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
157179269|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
157179270|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
157179271|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
157179272|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
157179273|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
157179274|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
157179275|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
157179276|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
157179277|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
157179278|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
157179279|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
157179280|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
157179281|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
157179282|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
157179283|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
157179284|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
157179285|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
157179286|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
157179287|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
157179288|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
157179289|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
157179290|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
157179291|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
157179292|NCT02120352|567398095|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
157179293|NCT02120352|567398096|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
157179294|NCT02120352|567398097|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
157179295|NCT02120352|567398098|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
157179296|NCT02120352|567398099|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
157179297|NCT02120352|567398100|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
157179298|NCT02120352|567398101|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
157179299|NCT02120352|567398095|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179300|NCT02120352|567398096|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179301|NCT02120352|567398097|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179302|NCT02120352|567398098|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179303|NCT02120352|567398099|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179304|NCT02120352|567398100|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
157179305|NCT02120352|567398101|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
157179306|NCT03997760|567398105|FG000|Overall Study|Protocol Deviation|0|||
157179307|NCT03997760|567398106|FG001|Overall Study|Protocol Deviation|1|||
157179308|NCT03997760|567398107|FG002|Overall Study|Protocol Deviation|0|||
157179309|NCT03997760|567398108|FG003|Overall Study|Protocol Deviation|0|||
157179310|NCT00431496|567398109|FG000|Overall Study|Adverse Event|3|||
157179311|NCT00431496|567398109|FG000|Overall Study|Lost to Follow-up|1|||
157179312|NCT00431496|567398109|FG000|Overall Study|Withdrawal by Subject|2|||
157179313|NCT00431496|567398109|FG000|Overall Study|Protocol-specified criteria|5|||
157179314|NCT02343952|567398110|FG000|Study Treatment|Disease Progression|23|||
157179315|NCT02343952|567398110|FG000|Study Treatment|Death|3|||
157179316|NCT02343952|567398110|FG000|Study Treatment|Adverse Event|19|||
157179317|NCT02343952|567398110|FG000|Study Treatment|Withdrawal by Subject|7|||
157179318|NCT02343952|567398110|FG000|Study Treatment|other complicating Diseases|1|||
157179319|NCT02343952|567398110|FG000|Follow up|Withdrawal by Subject|3|||
157179320|NCT02343952|567398110|FG000|Follow up|Death|33|||
157179321|NCT02343952|567398110|FG000|Follow up|Patient does not meet eligibility for study.|1|||
157179322|NCT02343952|567398110|FG000|Follow up|Research department closed by the practice.|5|||
157179323|NCT02343952|567398110|FG000|Follow up|Patient went home to Russia|1|||
157179324|NCT02343952|567398110|FG000|Follow up|Disease Progression|1|||
157179325|NCT02343952|567398110|FG000|Follow up|study terminated|1|||
157179326|NCT02671760|567398112|FG000|Overall Study|Lost to Follow-up|0|||
157179327|NCT02671760|567398113|FG001|Overall Study|Lost to Follow-up|1|||
157179328|NCT02671760|567398114|FG002|Overall Study|Lost to Follow-up|0|||
157179329|NCT02999191|567398115|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
157179330|NCT02999191|567398116|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
157179331|NCT02999191|567398117|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
157179332|NCT02079519|567398123|FG000|Overall Study|Disease Progression|9|||
157179333|NCT02079519|567398123|FG000|Overall Study|Adverse Event|1|||
157179334|NCT01802515|567398124|FG000|Overall Study|Withdrawal by Subject|3|||
157179335|NCT01802515|567398125|FG001|Overall Study|Withdrawal by Subject|0|||
157179336|NCT01802515|567398126|FG002|Overall Study|Withdrawal by Subject|0|||
157179337|NCT01906476|567398127|FG000|Overall Study|Lost to Follow-up|17|||
157057960|NCT01808144|566964557|FG000|Overall Study|Withdrawal by Subject|16|||
157057961|NCT01808144|566964558|FG001|Overall Study|Withdrawal by Subject|23|||
157057962|NCT01808144|566964557|FG000|Overall Study|Lost to Follow-up|6|||
157057963|NCT01808144|566964558|FG001|Overall Study|Lost to Follow-up|3|||
157057964|NCT01808144|566964557|FG000|Overall Study|Protocol Violation|6|||
157057965|NCT01808144|566964558|FG001|Overall Study|Protocol Violation|6|||
157057966|NCT01808144|566964557|FG000|Overall Study|Gout flare|0|||
157057967|NCT01808144|566964558|FG001|Overall Study|Gout flare|1|||
157057968|NCT01808144|566964557|FG000|Overall Study|Adverse Event|11|||
157057969|NCT01808144|566964558|FG001|Overall Study|Adverse Event|15|||
157057970|NCT03098797|566966626|FG000|Part 2 Open Label Extension|Adverse Event|2|||
157057971|NCT03098797|566966627|FG001|Part 2 Open Label Extension|Adverse Event|0|||
157057972|NCT00552513|566966630|FG000|Overall Study|Lost to Follow-up|5|||
157057973|NCT00552513|566966631|FG001|Overall Study|Lost to Follow-up|1|||
157057974|NCT02507687|566966632|FG000|Overall Study|Adverse Event|3|||
157057975|NCT02507687|566966633|FG001|Overall Study|Adverse Event|2|||
157057976|NCT02507687|566966634|FG002|Overall Study|Adverse Event|2|||
157057977|NCT02507687|566966635|FG003|Overall Study|Adverse Event|2|||
157057978|NCT02507687|566966632|FG000|Overall Study|Withdrawal by Subject|1|||
157057979|NCT02507687|566966633|FG001|Overall Study|Withdrawal by Subject|4|||
157057980|NCT02507687|566966634|FG002|Overall Study|Withdrawal by Subject|6|||
157057981|NCT02507687|566966635|FG003|Overall Study|Withdrawal by Subject|6|||
157057982|NCT02507687|566966632|FG000|Overall Study|Protocol Violation|1|||
157057983|NCT02507687|566966633|FG001|Overall Study|Protocol Violation|0|||
157057984|NCT02507687|566966634|FG002|Overall Study|Protocol Violation|2|||
157057985|NCT02507687|566966635|FG003|Overall Study|Protocol Violation|0|||
157057986|NCT02507687|566966632|FG000|Overall Study|Lost to Follow-up|0|||
157057987|NCT02507687|566966633|FG001|Overall Study|Lost to Follow-up|0|||
157057988|NCT02507687|566966634|FG002|Overall Study|Lost to Follow-up|2|||
157057989|NCT02507687|566966635|FG003|Overall Study|Lost to Follow-up|1|||
157057990|NCT02507687|566966632|FG000|Overall Study|Screen Failure|0|||
157057991|NCT02507687|566966633|FG001|Overall Study|Screen Failure|0|||
157057992|NCT02507687|566966634|FG002|Overall Study|Screen Failure|1|||
157057993|NCT02507687|566966635|FG003|Overall Study|Screen Failure|0|||
157057994|NCT02507687|566966632|FG000|Overall Study|Other, Not Specified|0|||
157057995|NCT02507687|566966633|FG001|Overall Study|Other, Not Specified|0|||
157057996|NCT02507687|566966634|FG002|Overall Study|Other, Not Specified|2|||
157057997|NCT02507687|566966635|FG003|Overall Study|Other, Not Specified|4|||
157057998|NCT00275301|566966636|FG000|Overall Study|Adverse Event|5|||
157057999|NCT04357964|566966637|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
157058000|NCT04357964|566966638|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
157058001|NCT04357964|566966637|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
157058002|NCT04357964|566966638|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
157058003|NCT04357964|566966637|FG000|Overall Study|Adipose sample was insufficient quality|0|||
157058004|NCT04357964|566966638|FG001|Overall Study|Adipose sample was insufficient quality|1|||
157058005|NCT00733226|566966639|FG000|Overall Study|Withdrawal by Subject|1|||
157058006|NCT00733226|566966640|FG001|Overall Study|Withdrawal by Subject|0|||
157058007|NCT00733226|566966639|FG000|Overall Study|Lost to Follow-up|2|||
157058008|NCT00733226|566966640|FG001|Overall Study|Lost to Follow-up|0|||
157058009|NCT00733226|566966639|FG000|Overall Study|moved to another place|2|||
157058010|NCT00733226|566966640|FG001|Overall Study|moved to another place|0|||
157058011|NCT00848393|566966643|FG000|Overall Study|Protocol Violation|0|||
157058012|NCT00848393|566966644|FG001|Overall Study|Protocol Violation|0|||
157058013|NCT00848393|566966645|FG002|Overall Study|Protocol Violation|1|||
157058014|NCT00848393|566966643|FG000|Overall Study|surgical complications unrelated to stud|0|||
157058015|NCT00848393|566966644|FG001|Overall Study|surgical complications unrelated to stud|0|||
157058016|NCT00848393|566966645|FG002|Overall Study|surgical complications unrelated to stud|2|||
157058017|NCT00443898|566966650|FG000|Overall Study|Adverse Event|0|||
157058018|NCT00443898|566966651|FG001|Overall Study|Adverse Event|0|||
157058019|NCT00443898|566966652|FG002|Overall Study|Adverse Event|1|||
157179338|NCT01906476|567398128|FG001|Overall Study|Lost to Follow-up|16|||
157179339|NCT01993667|567398132|FG000|Overall Study|Insufficient data to analyze|16|||
157179340|NCT01993667|567398133|FG001|Overall Study|Insufficient data to analyze|16|||
157179341|NCT01993667|567398132|FG000|Overall Study|Insufficient altitude reached|3|||
157058020|NCT00443898|566966653|FG003|Overall Study|Adverse Event|1|||
157058021|NCT00443898|566966650|FG000|Overall Study|Lack of Efficacy|2|||
157058022|NCT00443898|566966651|FG001|Overall Study|Lack of Efficacy|3|||
157058023|NCT00443898|566966652|FG002|Overall Study|Lack of Efficacy|3|||
157058024|NCT00443898|566966653|FG003|Overall Study|Lack of Efficacy|1|||
157058025|NCT00443898|566966650|FG000|Overall Study|Protocol Violation|1|||
157058026|NCT00443898|566966651|FG001|Overall Study|Protocol Violation|1|||
157058027|NCT00443898|566966652|FG002|Overall Study|Protocol Violation|1|||
157058028|NCT00443898|566966653|FG003|Overall Study|Protocol Violation|0|||
157058029|NCT00443898|566966650|FG000|Overall Study|Withdrawal by Subject|11|||
157179342|NCT01993667|567398133|FG001|Overall Study|Insufficient altitude reached|1|||
157179343|NCT01993667|567398132|FG000|Overall Study|Lost to Follow-up|2|||
157179344|NCT01993667|567398133|FG001|Overall Study|Lost to Follow-up|2|||
157179345|NCT01931150|567398134|FG000|Overall Study|Withdrawal by Subject|1|||
157179346|NCT01931150|567398135|FG001|Overall Study|Withdrawal by Subject|2|||
157179347|NCT01570309|567398138|FG000|Overall Study|Withdrawal by Subject|3|||
157179348|NCT01570309|567398139|FG001|Overall Study|Withdrawal by Subject|3|||
157179349|NCT01602549|567398140|FG000|Overall Study|Protocol Violation|0|||
157179350|NCT01602549|567398141|FG001|Overall Study|Protocol Violation|1|||
157179351|NCT01602549|567398140|FG000|Overall Study|Withdrawal by Subject|1|||
157179352|NCT01602549|567398141|FG001|Overall Study|Withdrawal by Subject|0|||
157179353|NCT01576406|567398142|FG000|Overall Study|Lost to Follow-up|1|||
157179354|NCT01576406|567398143|FG001|Overall Study|Lost to Follow-up|2|||
157179355|NCT01576406|567398144|FG002|Overall Study|Lost to Follow-up|0|||
157179356|NCT01576406|567398145|FG003|Overall Study|Lost to Follow-up|0|||
157179357|NCT01576406|567398146|FG004|Overall Study|Lost to Follow-up|0|||
157179358|NCT01576406|567398147|FG005|Overall Study|Lost to Follow-up|0|||
157179359|NCT01576406|567398142|FG000|Overall Study|Death|3|||
157179360|NCT01576406|567398143|FG001|Overall Study|Death|4|||
157179361|NCT01576406|567398144|FG002|Overall Study|Death|8|||
157179362|NCT01576406|567398145|FG003|Overall Study|Death|5|||
157179363|NCT01576406|567398146|FG004|Overall Study|Death|7|||
157179364|NCT01576406|567398147|FG005|Overall Study|Death|9|||
157179365|NCT01576406|567398142|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
157179366|NCT01576406|567398143|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
157179367|NCT01576406|567398144|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
157179368|NCT01576406|567398145|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
157179369|NCT01576406|567398146|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
157179370|NCT01576406|567398147|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
157179371|NCT01576406|567398142|FG000|Overall Study|Withdrawal the consent|2|||
157179372|NCT01576406|567398143|FG001|Overall Study|Withdrawal the consent|2|||
157179373|NCT01576406|567398144|FG002|Overall Study|Withdrawal the consent|5|||
157179374|NCT01576406|567398145|FG003|Overall Study|Withdrawal the consent|1|||
157179375|NCT01576406|567398146|FG004|Overall Study|Withdrawal the consent|1|||
157179376|NCT01576406|567398147|FG005|Overall Study|Withdrawal the consent|3|||
157179377|NCT01576406|567398142|FG000|Overall Study|Other|0|||
157179378|NCT01576406|567398143|FG001|Overall Study|Other|0|||
157179379|NCT01576406|567398144|FG002|Overall Study|Other|2|||
157179380|NCT01576406|567398145|FG003|Overall Study|Other|2|||
157179381|NCT01576406|567398146|FG004|Overall Study|Other|0|||
157179382|NCT01576406|567398147|FG005|Overall Study|Other|0|||
157179383|NCT02091921|567398148|FG000|Overall Study|Adverse Event|3|||
157179384|NCT02483078|567398149|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
157179385|NCT02483078|567398150|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
157179386|NCT02483078|567398149|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
157179387|NCT02483078|567398150|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
157179388|NCT02483078|567398149|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
157179389|NCT02483078|567398150|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
157179390|NCT02483078|567398149|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
157179391|NCT02483078|567398150|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
157179392|NCT02483078|567398149|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
157179393|NCT02483078|567398150|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
157179394|NCT02483078|567398149|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
157179395|NCT02483078|567398150|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
157179396|NCT03627494|567398153|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
157179397|NCT03627494|567398154|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179398|NCT03627494|567398155|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
157179399|NCT03627494|567398156|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179400|NCT03627494|567398157|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179401|NCT03627494|567398158|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179402|NCT03627494|567398159|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179403|NCT03627494|567398160|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179404|NCT03627494|567398161|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179405|NCT03627494|567398162|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
157058030|NCT00443898|566966651|FG001|Overall Study|Withdrawal by Subject|10|||
157058031|NCT00443898|566966652|FG002|Overall Study|Withdrawal by Subject|10|||
157179406|NCT03627494|567398163|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179407|NCT03627494|567398164|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
157179408|NCT03627494|567398153|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179409|NCT03627494|567398154|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179410|NCT03627494|567398155|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179411|NCT03627494|567398156|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179412|NCT03627494|567398157|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179413|NCT03627494|567398158|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179414|NCT03627494|567398159|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179415|NCT03627494|567398160|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179416|NCT03627494|567398161|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
157058032|NCT00443898|566966653|FG003|Overall Study|Withdrawal by Subject|6|||
157058033|NCT00443898|566966650|FG000|Overall Study|Lost to Follow-up|10|||
157058034|NCT00443898|566966651|FG001|Overall Study|Lost to Follow-up|10|||
157058035|NCT00443898|566966652|FG002|Overall Study|Lost to Follow-up|14|||
157058036|NCT00443898|566966653|FG003|Overall Study|Lost to Follow-up|10|||
157058037|NCT00443898|566966650|FG000|Overall Study|Death|0|||
157058038|NCT00443898|566966651|FG001|Overall Study|Death|1|||
157058039|NCT00443898|566966652|FG002|Overall Study|Death|0|||
157058040|NCT00443898|566966653|FG003|Overall Study|Death|0|||
157058041|NCT00043186|566966654|FG000|Overall Study|Physician Decision|0|||
157058042|NCT00043186|566966655|FG001|Overall Study|Physician Decision|0|||
157058043|NCT00043186|566966656|FG002|Overall Study|Physician Decision|3|||
157058044|NCT00043186|566966657|FG003|Overall Study|Physician Decision|0|||
157058045|NCT00043186|566966658|FG004|Overall Study|Physician Decision|1|||
157058046|NCT00043186|566966659|FG005|Overall Study|Physician Decision|0|||
157058047|NCT00043186|566966660|FG006|Overall Study|Physician Decision|0|||
157058048|NCT00043186|566966661|FG007|Overall Study|Physician Decision|1|||
157058049|NCT00043186|566966662|FG008|Overall Study|Physician Decision|1|||
157058050|NCT00043186|566966654|FG000|Overall Study|Adverse Event|2|||
157058051|NCT00043186|566966655|FG001|Overall Study|Adverse Event|2|||
157058052|NCT00043186|566966656|FG002|Overall Study|Adverse Event|2|||
157058053|NCT00043186|566966657|FG003|Overall Study|Adverse Event|3|||
157058054|NCT00043186|566966658|FG004|Overall Study|Adverse Event|2|||
157058055|NCT00043186|566966659|FG005|Overall Study|Adverse Event|1|||
157058056|NCT00043186|566966660|FG006|Overall Study|Adverse Event|2|||
157058057|NCT00043186|566966661|FG007|Overall Study|Adverse Event|1|||
157058058|NCT00043186|566966662|FG008|Overall Study|Adverse Event|3|||
157058059|NCT00043186|566966654|FG000|Overall Study|Withdrawal by Subject|11|||
157058060|NCT00043186|566966655|FG001|Overall Study|Withdrawal by Subject|8|||
157058061|NCT00043186|566966656|FG002|Overall Study|Withdrawal by Subject|11|||
157058062|NCT00043186|566966657|FG003|Overall Study|Withdrawal by Subject|13|||
157058063|NCT00043186|566966658|FG004|Overall Study|Withdrawal by Subject|14|||
157058064|NCT00043186|566966659|FG005|Overall Study|Withdrawal by Subject|6|||
157058065|NCT00043186|566966660|FG006|Overall Study|Withdrawal by Subject|12|||
157058066|NCT00043186|566966661|FG007|Overall Study|Withdrawal by Subject|9|||
157058067|NCT00043186|566966662|FG008|Overall Study|Withdrawal by Subject|10|||
157058068|NCT00043186|566966654|FG000|Overall Study|Death|0|||
157058069|NCT00043186|566966655|FG001|Overall Study|Death|0|||
157058070|NCT00043186|566966656|FG002|Overall Study|Death|1|||
157058071|NCT00043186|566966657|FG003|Overall Study|Death|0|||
157058072|NCT00043186|566966658|FG004|Overall Study|Death|0|||
157058073|NCT00043186|566966659|FG005|Overall Study|Death|0|||
157058074|NCT00043186|566966660|FG006|Overall Study|Death|2|||
157058075|NCT00043186|566966661|FG007|Overall Study|Death|0|||
157058076|NCT00043186|566966662|FG008|Overall Study|Death|0|||
157058077|NCT00043186|566966654|FG000|Overall Study|Disease progression|1|||
157058078|NCT00043186|566966655|FG001|Overall Study|Disease progression|0|||
157058079|NCT00043186|566966656|FG002|Overall Study|Disease progression|0|||
157058080|NCT00043186|566966657|FG003|Overall Study|Disease progression|3|||
157058081|NCT00043186|566966658|FG004|Overall Study|Disease progression|0|||
157058082|NCT00043186|566966659|FG005|Overall Study|Disease progression|0|||
157058083|NCT00043186|566966660|FG006|Overall Study|Disease progression|0|||
157058084|NCT00043186|566966661|FG007|Overall Study|Disease progression|4|||
157058085|NCT00043186|566966662|FG008|Overall Study|Disease progression|0|||
157058086|NCT00043186|566966654|FG000|Overall Study|Ineligibility determined|0|||
157058087|NCT00043186|566966655|FG001|Overall Study|Ineligibility determined|0|||
157058088|NCT00043186|566966656|FG002|Overall Study|Ineligibility determined|0|||
157058089|NCT00043186|566966657|FG003|Overall Study|Ineligibility determined|0|||
157058090|NCT00043186|566966658|FG004|Overall Study|Ineligibility determined|0|||
157058091|NCT00043186|566966659|FG005|Overall Study|Ineligibility determined|0|||
157058092|NCT00043186|566966660|FG006|Overall Study|Ineligibility determined|0|||
157058093|NCT00043186|566966661|FG007|Overall Study|Ineligibility determined|0|||
157179417|NCT03627494|567398162|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179418|NCT03627494|567398163|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179419|NCT03627494|567398164|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
157179420|NCT03627494|567398153|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179421|NCT03627494|567398154|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179422|NCT03627494|567398155|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
157058094|NCT00043186|566966662|FG008|Overall Study|Ineligibility determined|1|||
157058095|NCT00043186|566966654|FG000|Overall Study|Lost to Follow-up|3|||
157058096|NCT00043186|566966655|FG001|Overall Study|Lost to Follow-up|5|||
157058097|NCT00043186|566966656|FG002|Overall Study|Lost to Follow-up|1|||
157058098|NCT00043186|566966657|FG003|Overall Study|Lost to Follow-up|1|||
157058099|NCT00043186|566966658|FG004|Overall Study|Lost to Follow-up|1|||
157058100|NCT00043186|566966659|FG005|Overall Study|Lost to Follow-up|1|||
157179423|NCT03627494|567398156|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
157058101|NCT00043186|566966660|FG006|Overall Study|Lost to Follow-up|1|||
157058102|NCT00043186|566966661|FG007|Overall Study|Lost to Follow-up|1|||
157058103|NCT00043186|566966662|FG008|Overall Study|Lost to Follow-up|2|||
157058104|NCT00043186|566966654|FG000|Overall Study|Noncompliance|0|||
157229772|NCT02327130|567586594|FG000|Overall Study|Discharged in less than 5 days|5|||
157229773|NCT02327130|567586594|FG000|Overall Study|Physician Decision|2|||
157229774|NCT02327130|567586594|FG000|Overall Study|Unable to provide breath sample|1|||
157229775|NCT02327130|567586594|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
157229776|NCT02327130|567586594|FG000|Overall Study|Met exclusion criteria|3|||
157229777|NCT04028843|567586595|FG000|Overall Study|Lost to Follow-up|32|||
157229778|NCT04028843|567586596|FG001|Overall Study|Lost to Follow-up|39|||
157229779|NCT04028843|567586595|FG000|Overall Study|Adverse Event|1|||
157229780|NCT04028843|567586596|FG001|Overall Study|Adverse Event|0|||
157229781|NCT04028843|567586595|FG000|Overall Study|Non-viable Pregnancy|0|||
157229782|NCT04028843|567586596|FG001|Overall Study|Non-viable Pregnancy|1|||
157229783|NCT04028843|567586595|FG000|Overall Study|Withdrawal by Subject|4|||
157229784|NCT04028843|567586596|FG001|Overall Study|Withdrawal by Subject|2|||
157229785|NCT00950872|567586597|FG000|Overall Study|Withdrawal by Subject|1|||
157229786|NCT00950872|567586597|FG000|Overall Study|Did not have surgery|2|||
157229787|NCT00860028|567586598|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
157229788|NCT00860028|567586599|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
157229789|NCT00441467|567588148|FG000|Overall Study|Adverse Event|6|||
157229790|NCT00441467|567588148|FG000|Overall Study|Withdrawal by Subject|3|||
157229791|NCT00441467|567588148|FG000|Overall Study|Progressive disease|9|||
157229792|NCT02289963|567588149|FG000|Overall Study|Adverse Event|1|||
156975998|NCT00576732|566665623|FG002|DOUBLE BLIND|Protocol Violation|0|||
157179424|NCT03627494|567398157|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179425|NCT03627494|567398158|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179426|NCT03627494|567398159|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179427|NCT03627494|567398160|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179428|NCT03627494|567398161|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179429|NCT03627494|567398162|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
157179430|NCT03627494|567398163|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
157179431|NCT03627494|567398164|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
157179432|NCT01432756|567400058|FG000|Overall Study|Lost to Follow-up|1|||
157179433|NCT01432756|567400059|FG001|Overall Study|Lost to Follow-up|0|||
157179434|NCT01432756|567400060|FG002|Overall Study|Lost to Follow-up|2|||
157179435|NCT01432756|567400061|FG003|Overall Study|Lost to Follow-up|1|||
157179436|NCT02712008|567400062|FG000|Baseline (Day 1) up to Week 12|Death|3|||
157179437|NCT02712008|567400063|FG001|Baseline (Day 1) up to Week 12|Death|0|||
157179438|NCT02712008|567400064|FG002|Baseline (Day 1) up to Week 12|Death|0|||
156975999|NCT00576732|566665624|FG003|DOUBLE BLIND|Protocol Violation|0|||
156976000|NCT00576732|566665625|FG004|DOUBLE BLIND|Protocol Violation|0|||
156976001|NCT00576732|566665626|FG005|DOUBLE BLIND|Protocol Violation|0|||
156976002|NCT00576732|566665621|FG000|OPEN LABEL|Adverse Event|0|||
156976003|NCT00576732|566665622|FG001|OPEN LABEL|Adverse Event|0|||
156976004|NCT00576732|566665623|FG002|OPEN LABEL|Adverse Event|0|||
156976005|NCT00576732|566665624|FG003|OPEN LABEL|Adverse Event|4|||
156976006|NCT00576732|566665625|FG004|OPEN LABEL|Adverse Event|0|||
156976007|NCT00576732|566665626|FG005|OPEN LABEL|Adverse Event|1|||
156976008|NCT00576732|566665621|FG000|OPEN LABEL|Lost to Follow-up|0|||
156976009|NCT00576732|566665622|FG001|OPEN LABEL|Lost to Follow-up|0|||
156976010|NCT00576732|566665623|FG002|OPEN LABEL|Lost to Follow-up|0|||
156976011|NCT00576732|566665624|FG003|OPEN LABEL|Lost to Follow-up|2|||
156976012|NCT00576732|566665625|FG004|OPEN LABEL|Lost to Follow-up|1|||
156976013|NCT00576732|566665626|FG005|OPEN LABEL|Lost to Follow-up|1|||
156976014|NCT00576732|566665621|FG000|OPEN LABEL|Withdrawal by Subject|0|||
156976015|NCT00576732|566665622|FG001|OPEN LABEL|Withdrawal by Subject|0|||
156976016|NCT00576732|566665623|FG002|OPEN LABEL|Withdrawal by Subject|0|||
156976017|NCT00576732|566665624|FG003|OPEN LABEL|Withdrawal by Subject|1|||
156976018|NCT00576732|566665625|FG004|OPEN LABEL|Withdrawal by Subject|0|||
156976019|NCT00576732|566665626|FG005|OPEN LABEL|Withdrawal by Subject|1|||
156976020|NCT00576732|566665621|FG000|OPEN LABEL|OTHER|0|||
156976021|NCT00576732|566665622|FG001|OPEN LABEL|OTHER|0|||
156976022|NCT00576732|566665623|FG002|OPEN LABEL|OTHER|0|||
156976023|NCT00576732|566665624|FG003|OPEN LABEL|OTHER|0|||
156976024|NCT00576732|566665625|FG004|OPEN LABEL|OTHER|0|||
156976025|NCT00576732|566665626|FG005|OPEN LABEL|OTHER|2|||
156976026|NCT00576732|566665621|FG000|OPEN LABEL|Lack of Efficacy|0|||
156976027|NCT00576732|566665622|FG001|OPEN LABEL|Lack of Efficacy|0|||
156976028|NCT00576732|566665623|FG002|OPEN LABEL|Lack of Efficacy|0|||
156976029|NCT00576732|566665624|FG003|OPEN LABEL|Lack of Efficacy|2|||
156976030|NCT00576732|566665625|FG004|OPEN LABEL|Lack of Efficacy|2|||
156976031|NCT00576732|566665626|FG005|OPEN LABEL|Lack of Efficacy|3|||
156976032|NCT00576732|566665621|FG000|OPEN LABEL|Protocol Violation|0|||
156976033|NCT00576732|566665622|FG001|OPEN LABEL|Protocol Violation|0|||
157179439|NCT02712008|567400065|FG003|Baseline (Day 1) up to Week 12|Death|0|||
157229793|NCT02289963|567588150|FG001|Overall Study|Adverse Event|2|||
156976034|NCT00576732|566665623|FG002|OPEN LABEL|Protocol Violation|0|||
157229794|NCT02289963|567588149|FG000|Overall Study|Poor compliance to protocol|1|||
157229795|NCT02289963|567588150|FG001|Overall Study|Poor compliance to protocol|0|||
157229796|NCT02289963|567588149|FG000|Overall Study|Withdrawal by Subject|1|||
157229797|NCT02289963|567588150|FG001|Overall Study|Withdrawal by Subject|0|||
157179440|NCT02712008|567400066|FG004|Baseline (Day 1) up to Week 12|Death|0|||
157179441|NCT02712008|567400067|FG005|Baseline (Day 1) up to Week 12|Death|0|||
157179442|NCT02712008|567400068|FG006|Baseline (Day 1) up to Week 12|Death|0|||
157179443|NCT02712008|567400069|FG007|Baseline (Day 1) up to Week 12|Death|0|||
157179444|NCT02712008|567400062|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179445|NCT02712008|567400063|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
157179446|NCT02712008|567400064|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
157179447|NCT02712008|567400065|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179448|NCT02712008|567400066|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179449|NCT02712008|567400067|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179450|NCT02712008|567400068|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179451|NCT02712008|567400069|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
157179452|NCT02712008|567400062|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
157179453|NCT02712008|567400063|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179454|NCT02712008|567400064|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
157179455|NCT02712008|567400065|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179456|NCT02712008|567400066|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179457|NCT02712008|567400067|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179458|NCT02712008|567400068|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179459|NCT02712008|567400069|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
157179460|NCT02712008|567400062|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179461|NCT02712008|567400063|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179462|NCT02712008|567400064|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
157179463|NCT02712008|567400065|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179464|NCT02712008|567400066|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179465|NCT02712008|567400067|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179466|NCT02712008|567400068|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179467|NCT02712008|567400069|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
157179468|NCT02712008|567400062|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179469|NCT02712008|567400063|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
157179470|NCT02712008|567400064|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179471|NCT02712008|567400065|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179472|NCT02712008|567400066|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179473|NCT02712008|567400067|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179474|NCT02712008|567400068|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179475|NCT02712008|567400069|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
157179476|NCT02712008|567400062|FG000|From Week 12 up to Week 36|Adverse Event|0|||
157179477|NCT02712008|567400063|FG001|From Week 12 up to Week 36|Adverse Event|0|||
157179478|NCT02712008|567400064|FG002|From Week 12 up to Week 36|Adverse Event|0|||
157179479|NCT02712008|567400065|FG003|From Week 12 up to Week 36|Adverse Event|0|||
157179480|NCT02712008|567400066|FG004|From Week 12 up to Week 36|Adverse Event|1|||
157179481|NCT02712008|567400067|FG005|From Week 12 up to Week 36|Adverse Event|0|||
157179482|NCT02712008|567400068|FG006|From Week 12 up to Week 36|Adverse Event|0|||
157179483|NCT02712008|567400069|FG007|From Week 12 up to Week 36|Adverse Event|2|||
157179484|NCT02712008|567400062|FG000|From Week 12 up to Week 36|Death|1|||
157179485|NCT02712008|567400063|FG001|From Week 12 up to Week 36|Death|0|||
157179486|NCT02712008|567400064|FG002|From Week 12 up to Week 36|Death|0|||
157179487|NCT02712008|567400065|FG003|From Week 12 up to Week 36|Death|0|||
157179488|NCT02712008|567400066|FG004|From Week 12 up to Week 36|Death|0|||
157179489|NCT02712008|567400067|FG005|From Week 12 up to Week 36|Death|0|||
157179490|NCT02712008|567400068|FG006|From Week 12 up to Week 36|Death|1|||
157179491|NCT02712008|567400069|FG007|From Week 12 up to Week 36|Death|0|||
157179492|NCT02712008|567400062|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
157179493|NCT02712008|567400063|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
157179494|NCT02712008|567400064|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
157179495|NCT02712008|567400065|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
157179496|NCT02712008|567400066|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
157058105|NCT00043186|566966655|FG001|Overall Study|Noncompliance|0|||
157058106|NCT00043186|566966656|FG002|Overall Study|Noncompliance|1|||
157179497|NCT02712008|567400067|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
157179498|NCT02712008|567400068|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
157179499|NCT02712008|567400069|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
157179500|NCT02712008|567400062|FG000|From Week 12 up to Week 36|Physician Decision|0|||
157179501|NCT02712008|567400063|FG001|From Week 12 up to Week 36|Physician Decision|0|||
157179502|NCT02712008|567400064|FG002|From Week 12 up to Week 36|Physician Decision|0|||
157179503|NCT02712008|567400065|FG003|From Week 12 up to Week 36|Physician Decision|1|||
157179504|NCT02712008|567400066|FG004|From Week 12 up to Week 36|Physician Decision|1|||
157179505|NCT02712008|567400067|FG005|From Week 12 up to Week 36|Physician Decision|0|||
157179506|NCT02712008|567400068|FG006|From Week 12 up to Week 36|Physician Decision|0|||
157179507|NCT02712008|567400069|FG007|From Week 12 up to Week 36|Physician Decision|0|||
157179508|NCT02712008|567400062|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179509|NCT02712008|567400063|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179510|NCT02712008|567400064|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179511|NCT02712008|567400065|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179512|NCT02712008|567400066|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179513|NCT02712008|567400067|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
157179514|NCT02712008|567400068|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
157179515|NCT02712008|567400069|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
157179516|NCT01131078|567400070|FG000|Overall Study|Adverse Event|22|||
157179517|NCT01131078|567400071|FG001|Overall Study|Adverse Event|12|||
157179518|NCT01131078|567400072|FG002|Overall Study|Adverse Event|17|||
157179519|NCT01131078|567400070|FG000|Overall Study|Progressive Disease|58|||
157179520|NCT01131078|567400071|FG001|Overall Study|Progressive Disease|77|||
157179521|NCT01131078|567400072|FG002|Overall Study|Progressive Disease|71|||
157179522|NCT01131078|567400070|FG000|Overall Study|Protocol Violation|1|||
157179523|NCT01131078|567400071|FG001|Overall Study|Protocol Violation|0|||
157179524|NCT01131078|567400072|FG002|Overall Study|Protocol Violation|0|||
157179525|NCT01131078|567400070|FG000|Overall Study|Lost to Follow-up|1|||
157179526|NCT01131078|567400071|FG001|Overall Study|Lost to Follow-up|1|||
157179527|NCT01131078|567400072|FG002|Overall Study|Lost to Follow-up|1|||
157179528|NCT01131078|567400070|FG000|Overall Study|Withdrawal by Subject|2|||
157179529|NCT01131078|567400071|FG001|Overall Study|Withdrawal by Subject|4|||
157179530|NCT01131078|567400072|FG002|Overall Study|Withdrawal by Subject|3|||
157179531|NCT01131078|567400070|FG000|Overall Study|Non-compliance|3|||
157179532|NCT01131078|567400071|FG001|Overall Study|Non-compliance|0|||
157179533|NCT01131078|567400072|FG002|Overall Study|Non-compliance|0|||
157179534|NCT01131078|567400070|FG000|Overall Study|Physician Decision|10|||
157179535|NCT01131078|567400071|FG001|Overall Study|Physician Decision|6|||
157179536|NCT01131078|567400072|FG002|Overall Study|Physician Decision|8|||
157179537|NCT01131078|567400070|FG000|Overall Study|Death|4|||
157179538|NCT01131078|567400071|FG001|Overall Study|Death|0|||
157179539|NCT01131078|567400072|FG002|Overall Study|Death|2|||
157179540|NCT01131078|567400070|FG000|Overall Study|Other|0|||
157179541|NCT01131078|567400071|FG001|Overall Study|Other|1|||
157179542|NCT01131078|567400072|FG002|Overall Study|Other|0|||
157179543|NCT01199198|567400073|FG000|Overall Study|Adverse Event|3|||
157179544|NCT01199198|567400074|FG001|Overall Study|Adverse Event|0|||
157179545|NCT01199198|567400073|FG000|Overall Study|Lost to Follow-up|1|||
157179546|NCT01199198|567400074|FG001|Overall Study|Lost to Follow-up|5|||
157179547|NCT01199198|567400073|FG000|Overall Study|Withdrawal by Subject|1|||
157179548|NCT01199198|567400074|FG001|Overall Study|Withdrawal by Subject|2|||
157179549|NCT01199198|567400073|FG000|Overall Study|ICU Transfer|1|||
157179550|NCT01199198|567400074|FG001|Overall Study|ICU Transfer|2|||
157179551|NCT01199198|567400073|FG000|Overall Study|Hospice-care transfer|1|||
157179552|NCT01199198|567400074|FG001|Overall Study|Hospice-care transfer|2|||
157179553|NCT02177786|567400076|FG000|Overall Study|Withdrew Consent|2|||
157179554|NCT02177786|567400077|FG001|Overall Study|Withdrew Consent|6|||
157179555|NCT02177786|567400078|FG002|Overall Study|Withdrew Consent|9|||
157179556|NCT02177786|567400079|FG003|Overall Study|Withdrew Consent|5|||
157179557|NCT02177786|567400076|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
157179558|NCT02177786|567400077|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
157179559|NCT02177786|567400078|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
157179560|NCT02177786|567400079|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
157179561|NCT02177786|567400076|FG000|Overall Study|Adverse Event|1|||
157179562|NCT02177786|567400077|FG001|Overall Study|Adverse Event|1|||
157179563|NCT02177786|567400078|FG002|Overall Study|Adverse Event|2|||
157179564|NCT02177786|567400079|FG003|Overall Study|Adverse Event|3|||
157179565|NCT02177786|567400076|FG000|Overall Study|Death|1|||
157179566|NCT02177786|567400077|FG001|Overall Study|Death|1|||
157179567|NCT02177786|567400078|FG002|Overall Study|Death|1|||
157179568|NCT02177786|567400079|FG003|Overall Study|Death|1|||
157179569|NCT02177786|567400076|FG000|Overall Study|Lost to Follow-up|0|||
157179570|NCT02177786|567400077|FG001|Overall Study|Lost to Follow-up|0|||
157179571|NCT02177786|567400078|FG002|Overall Study|Lost to Follow-up|2|||
157229798|NCT02289963|567588149|FG000|Overall Study|Last injection missed|2|||
157229799|NCT02289963|567588150|FG001|Overall Study|Last injection missed|2|||
156976035|NCT00576732|566665624|FG003|OPEN LABEL|Protocol Violation|2|||
157179572|NCT02177786|567400079|FG003|Overall Study|Lost to Follow-up|2|||
157179573|NCT02177786|567400076|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157179574|NCT02177786|567400077|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157179575|NCT02177786|567400078|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157179576|NCT02177786|567400079|FG003|Overall Study|Non-Compliance with Study Drug|1|||
157179577|NCT02177786|567400076|FG000|Overall Study|Protocol Violation|0|||
157179578|NCT02177786|567400077|FG001|Overall Study|Protocol Violation|0|||
157179579|NCT02177786|567400078|FG002|Overall Study|Protocol Violation|2|||
157179580|NCT02177786|567400079|FG003|Overall Study|Protocol Violation|0|||
157179581|NCT02177786|567400076|FG000|Overall Study|Progressive Disease|0|||
157179582|NCT02177786|567400077|FG001|Overall Study|Progressive Disease|1|||
157179583|NCT02177786|567400078|FG002|Overall Study|Progressive Disease|0|||
157179584|NCT02177786|567400079|FG003|Overall Study|Progressive Disease|0|||
157179585|NCT02177786|567400076|FG000|Overall Study|Missing study completion status|0|||
157179586|NCT02177786|567400077|FG001|Overall Study|Missing study completion status|1|||
157179587|NCT02177786|567400078|FG002|Overall Study|Missing study completion status|0|||
157179588|NCT02177786|567400079|FG003|Overall Study|Missing study completion status|0|||
157179589|NCT01305941|567400080|FG000|Overall Study|Adverse Event|6|||
157179590|NCT01305941|567400080|FG000|Overall Study|Clinical decline|2|||
157179591|NCT01305941|567400080|FG000|Overall Study|Withdrawal by Subject|1|||
157179592|NCT01305941|567400080|FG000|Overall Study|Death|1|||
157179593|NCT02043509|567400081|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
157179594|NCT02043509|567400082|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
157179595|NCT02043509|567400081|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
157179596|NCT02043509|567400082|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
157179597|NCT02043509|567400081|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
157179598|NCT02043509|567400082|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
157179599|NCT02043509|567400081|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
157179600|NCT02043509|567400082|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
157179601|NCT00608244|567400088|FG000|Overall Study|Adverse Event|1|||
157179602|NCT00608244|567400088|FG000|Overall Study|Low trough levels|1|||
157179603|NCT00430027|567400089|FG000|Overall Study|Study terminated|8|||
157179604|NCT01977040|567400094|FG000|Overall Study|Vasa previa not confirmed|2|||
157179605|NCT00688623|567400097|FG000|Overall Study|Adverse Event|22|||
157179606|NCT00688623|567400097|FG000|Overall Study|abnormal lab value|1|||
157179607|NCT00688623|567400097|FG000|Overall Study|Withdrawal by Subject|4|||
157179608|NCT00688623|567400097|FG000|Overall Study|Death|3|||
157179609|NCT00688623|567400097|FG000|Overall Study|disease progression|23|||
157179610|NCT00688623|567400097|FG000|Overall Study|Protocol Violation|2|||
157179611|NCT02443155|567400098|FG000|Overall Study|Adverse Event|3|||
157179612|NCT02443155|567400099|FG001|Overall Study|Adverse Event|4|||
157179613|NCT02443155|567400100|FG002|Overall Study|Adverse Event|1|||
157179614|NCT02443155|567400101|FG003|Overall Study|Adverse Event|2|||
157179615|NCT02443155|567400098|FG000|Overall Study|Unclassified|0|||
157179616|NCT02443155|567400099|FG001|Overall Study|Unclassified|0|||
157179617|NCT02443155|567400100|FG002|Overall Study|Unclassified|2|||
157058107|NCT00043186|566966657|FG003|Overall Study|Noncompliance|1|||
157058108|NCT00043186|566966658|FG004|Overall Study|Noncompliance|0|||
157058109|NCT00043186|566966659|FG005|Overall Study|Noncompliance|0|||
157058110|NCT00043186|566966660|FG006|Overall Study|Noncompliance|0|||
157058111|NCT00043186|566966661|FG007|Overall Study|Noncompliance|0|||
157058112|NCT00043186|566966662|FG008|Overall Study|Noncompliance|0|||
157058113|NCT00043186|566966654|FG000|Overall Study|Other|0|||
157058114|NCT00043186|566966655|FG001|Overall Study|Other|0|||
157058115|NCT00043186|566966656|FG002|Overall Study|Other|1|||
157058116|NCT00043186|566966657|FG003|Overall Study|Other|1|||
157058117|NCT00043186|566966658|FG004|Overall Study|Other|0|||
157058118|NCT00043186|566966659|FG005|Overall Study|Other|0|||
157058119|NCT00043186|566966660|FG006|Overall Study|Other|0|||
157058120|NCT00043186|566966661|FG007|Overall Study|Other|0|||
157058121|NCT00043186|566966662|FG008|Overall Study|Other|0|||
157058122|NCT01503515|566966667|FG000|Overall Study|Adverse Event|4|||
157058123|NCT01503515|566966668|FG001|Overall Study|Adverse Event|5|||
157058124|NCT01503515|566966667|FG000|Overall Study|Death|0|||
157058125|NCT01503515|566966668|FG001|Overall Study|Death|1|||
157058126|NCT01503515|566966667|FG000|Overall Study|Physician Decision|14|||
157058127|NCT01503515|566966668|FG001|Overall Study|Physician Decision|23|||
157058128|NCT01503515|566966667|FG000|Overall Study|Withdrawal by Subject|0|||
157058129|NCT01503515|566966668|FG001|Overall Study|Withdrawal by Subject|1|||
157179618|NCT02443155|567400101|FG003|Overall Study|Unclassified|1|||
157179619|NCT02443155|567400098|FG000|Overall Study|Withdrawal by Subject|4|||
157179620|NCT02443155|567400099|FG001|Overall Study|Withdrawal by Subject|7|||
157179621|NCT02443155|567400100|FG002|Overall Study|Withdrawal by Subject|3|||
157179622|NCT02443155|567400101|FG003|Overall Study|Withdrawal by Subject|9|||
157179623|NCT02443155|567400098|FG000|Overall Study|Pregnancy|3|||
157058130|NCT01503515|566966667|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
157058131|NCT01503515|566966668|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
157058132|NCT01503515|566966667|FG000|Overall Study|Ineligible|1|||
157179624|NCT02443155|567400099|FG001|Overall Study|Pregnancy|1|||
157179625|NCT02443155|567400100|FG002|Overall Study|Pregnancy|1|||
157179626|NCT02443155|567400101|FG003|Overall Study|Pregnancy|2|||
157179627|NCT02443155|567400098|FG000|Overall Study|Lost to Follow-up|1|||
157179628|NCT02443155|567400099|FG001|Overall Study|Lost to Follow-up|2|||
157179629|NCT02443155|567400100|FG002|Overall Study|Lost to Follow-up|0|||
157179630|NCT02443155|567400101|FG003|Overall Study|Lost to Follow-up|1|||
157179631|NCT02443155|567400098|FG000|Overall Study|Protocol Violation|1|||
157179632|NCT02443155|567400099|FG001|Overall Study|Protocol Violation|0|||
157179633|NCT02443155|567400100|FG002|Overall Study|Protocol Violation|1|||
157058133|NCT01503515|566966668|FG001|Overall Study|Ineligible|1|||
157058134|NCT01350102|566966669|FG000|Overall Study|Adverse Event|0|||
157058135|NCT01350102|566966670|FG001|Overall Study|Adverse Event|0|||
157058136|NCT01350102|566966671|FG002|Overall Study|Adverse Event|1|||
157058137|NCT01350102|566966672|FG003|Overall Study|Adverse Event|0|||
157058138|NCT00550771|566966673|FG000|Overall Study|Adverse Event|11|||
157058139|NCT00550771|566966674|FG001|Overall Study|Adverse Event|3|||
157058140|NCT00550771|566966673|FG000|Overall Study|Discontinued for study-related reasons|0|||
157058141|NCT00550771|566966674|FG001|Overall Study|Discontinued for study-related reasons|1|||
157058142|NCT00550771|566966673|FG000|Overall Study|Physician Decision|2|||
157058143|NCT00550771|566966674|FG001|Overall Study|Physician Decision|0|||
157058144|NCT00550771|566966673|FG000|Overall Study|Withdrawal by Subject|0|||
157058145|NCT00550771|566966674|FG001|Overall Study|Withdrawal by Subject|1|||
157058146|NCT00550771|566966673|FG000|Overall Study|Protocol Violation|4|||
157058147|NCT00550771|566966674|FG001|Overall Study|Protocol Violation|5|||
157058148|NCT03022578|566966678|FG000|Overall Study|Adverse Event|1|||
157058149|NCT03022578|566966678|FG000|Overall Study|Lack of Efficacy|2|||
157058150|NCT03022578|566966678|FG000|Overall Study|Withdrawal by Subject|1|||
157058151|NCT03681353|566966679|FG000|Overall Study|Lost to Follow-up|2|||
157058152|NCT03681353|566966679|FG000|Overall Study|Withdrawal by Subject|3|||
157058153|NCT03681353|566966679|FG000|Overall Study|withdrawn by PI|2|||
157058154|NCT00111839|566966685|FG000|Overall Study|Disease Progression|30|||
157058155|NCT00111839|566966686|FG001|Overall Study|Disease Progression|33|||
157058156|NCT00111839|566966687|FG002|Overall Study|Disease Progression|33|||
157058157|NCT00111839|566966685|FG000|Overall Study|Adverse Event|5|||
157058158|NCT00111839|566966686|FG001|Overall Study|Adverse Event|3|||
157058159|NCT00111839|566966687|FG002|Overall Study|Adverse Event|1|||
157058160|NCT00111839|566966685|FG000|Overall Study|Protocol Violation|2|||
157058161|NCT00111839|566966686|FG001|Overall Study|Protocol Violation|4|||
157058162|NCT00111839|566966687|FG002|Overall Study|Protocol Violation|2|||
157058163|NCT00111839|566966685|FG000|Overall Study|Death|1|||
157058164|NCT00111839|566966686|FG001|Overall Study|Death|1|||
157058165|NCT00111839|566966687|FG002|Overall Study|Death|6|||
157058166|NCT00111839|566966685|FG000|Overall Study|Withdrawal by Subject|2|||
157058167|NCT00111839|566966686|FG001|Overall Study|Withdrawal by Subject|2|||
157058168|NCT00111839|566966687|FG002|Overall Study|Withdrawal by Subject|2|||
157058169|NCT00111839|566966685|FG000|Overall Study|Lost to Follow-up|1|||
157058170|NCT00111839|566966686|FG001|Overall Study|Lost to Follow-up|0|||
157058171|NCT00111839|566966687|FG002|Overall Study|Lost to Follow-up|0|||
157058172|NCT00111839|566966685|FG000|Overall Study|Logistical Constraint|1|||
157058173|NCT00111839|566966686|FG001|Overall Study|Logistical Constraint|0|||
157058174|NCT00111839|566966687|FG002|Overall Study|Logistical Constraint|0|||
157058175|NCT00111839|566966685|FG000|Overall Study|Other|6|||
157058176|NCT00111839|566966686|FG001|Overall Study|Other|3|||
157058177|NCT00111839|566966687|FG002|Overall Study|Other|3|||
157058178|NCT00111839|566966685|FG000|Overall Study|Randomized but Not Treated|0|||
157058179|NCT00111839|566966686|FG001|Overall Study|Randomized but Not Treated|0|||
157058180|NCT00111839|566966687|FG002|Overall Study|Randomized but Not Treated|2|||
157058181|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
157058182|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
157058183|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
157058184|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
157058185|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
157058186|NCT00520403|566966688|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
157058187|NCT00520403|566966688|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
157058188|NCT00520403|566966688|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
157058189|NCT03924947|566966689|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
157058190|NCT03924947|566966690|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
157058191|NCT03924947|566966691|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
157058192|NCT03924947|566966692|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
157058193|NCT03924947|566966693|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
157058194|NCT03924947|566966694|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
157058195|NCT01145417|566966695|FG000|Overall Study|Death|1|||
157058196|NCT01145417|566966696|FG001|Overall Study|Death|0|||
157058197|NCT01145417|566966695|FG000|Overall Study|Lost to Follow-up|2|||
157058198|NCT01145417|566966696|FG001|Overall Study|Lost to Follow-up|1|||
157058199|NCT01145417|566966695|FG000|Overall Study|Withdrawal by Subject|1|||
157058200|NCT01145417|566966696|FG001|Overall Study|Withdrawal by Subject|2|||
157058201|NCT01145417|566966695|FG000|Overall Study|Pregnancy|1|||
157058202|NCT01145417|566966696|FG001|Overall Study|Pregnancy|0|||
157058203|NCT01145417|566966695|FG000|Overall Study|Adverse Event|0|||
157058204|NCT01145417|566966696|FG001|Overall Study|Adverse Event|1|||
157058205|NCT01145417|566966695|FG000|Overall Study|Study terminated by sponsor|35|||
157058206|NCT01145417|566966696|FG001|Overall Study|Study terminated by sponsor|43|||
157179634|NCT02443155|567400101|FG003|Overall Study|Protocol Violation|1|||
157058207|NCT01145417|566966695|FG000|Overall Study|Other|1|||
157058208|NCT01145417|566966696|FG001|Overall Study|Other|0|||
157058209|NCT01797562|566966697|FG000|Overall Study|Protocol Violation|5|||
157179635|NCT02443155|567400098|FG000|Overall Study|Death|0|||
157058210|NCT00805285|566966702|FG000|Overall Study|Lack of Efficacy|1|||
157058211|NCT00917462|566966703|FG000|Overall Study|Clinical Deterioration|1|||
157058212|NCT01441583|566966704|FG000|Overall Study|Withdrawal by Subject|1|||
157058213|NCT01441583|566966705|FG001|Overall Study|Withdrawal by Subject|1|||
157058214|NCT01441583|566966706|FG002|Overall Study|Withdrawal by Subject|1|||
157058215|NCT01441583|566966704|FG000|Overall Study|Death|1|||
157058216|NCT01441583|566966705|FG001|Overall Study|Death|0|||
157058217|NCT01441583|566966706|FG002|Overall Study|Death|4|||
157058218|NCT01441583|566966704|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
157058219|NCT01441583|566966705|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
157058220|NCT01441583|566966706|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
157058221|NCT03341312|566966710|FG000|Period 1|Withdrawal by Subject|0|||
157058222|NCT03341312|566966711|FG001|Period 1|Withdrawal by Subject|1|||
157058223|NCT03341312|566966712|FG002|Period 1|Withdrawal by Subject|0|||
157058224|NCT03341312|566966713|FG003|Period 1|Withdrawal by Subject|0|||
157058225|NCT00839306|566966714|FG000|Overall Study|Adverse Event|3|||
157058226|NCT00839306|566966715|FG001|Overall Study|Adverse Event|5|||
157058227|NCT00839306|566966714|FG000|Overall Study|Lost to Follow-up|6|||
157058228|NCT00839306|566966715|FG001|Overall Study|Lost to Follow-up|9|||
157058229|NCT00839306|566966714|FG000|Overall Study|Withdrawal by Subject|5|||
157058230|NCT00839306|566966715|FG001|Overall Study|Withdrawal by Subject|7|||
157058231|NCT00839306|566966714|FG000|Overall Study|Lack of Efficacy|5|||
157058232|NCT00839306|566966715|FG001|Overall Study|Lack of Efficacy|4|||
157058233|NCT00839306|566966714|FG000|Overall Study|Other|6|||
157058234|NCT00839306|566966715|FG001|Overall Study|Other|18|||
157058235|NCT01812707|566966716|FG000|Overall Study|Adverse Event|0|||
157058236|NCT01812707|566966717|FG001|Overall Study|Adverse Event|0|||
157058237|NCT01812707|566966718|FG002|Overall Study|Adverse Event|0|||
157179636|NCT02443155|567400099|FG001|Overall Study|Death|0|||
157179637|NCT02443155|567400100|FG002|Overall Study|Death|1|||
157179638|NCT02443155|567400101|FG003|Overall Study|Death|0|||
157179639|NCT02000219|567400102|FG000|14-Week Study Period|Physician Decision|1|||
157179640|NCT02000219|567400102|FG000|14-Week Study Period|Adverse Event|1|||
157179641|NCT02000219|567400102|FG000|14-Week Study Period|Underwent transplantation|1|||
157179642|NCT02000219|567400102|FG000|Continuation Period|Withdrawal by Subject|1|||
157179643|NCT02000219|567400102|FG000|Continuation Period|Had liver transplant|2|||
157179644|NCT02000219|567400102|FG000|Continuation Period|Non-compliance with study drug|2|||
157179645|NCT02667236|567400104|FG000|Overall Study|Adverse Event|1|||
156976036|NCT00576732|566665625|FG004|OPEN LABEL|Protocol Violation|1|||
156976037|NCT00576732|566665626|FG005|OPEN LABEL|Protocol Violation|0|||
156976038|NCT02978443|566665627|FG000|Overall Study|Withdrawal by Subject|1|||
156976039|NCT02978443|566665627|FG000|Overall Study|Adverse Event|3|||
156976040|NCT02978443|566665627|FG000|Overall Study|Disease Progression on study|6|||
156976041|NCT02978443|566665627|FG000|Overall Study|Death|1|||
156976042|NCT02978443|566665627|FG000|Overall Study|Physician Decision|1|||
156976043|NCT02978443|566665627|FG000|Overall Study|Switch to alternative therapy|1|||
156976044|NCT02978443|566665627|FG000|Overall Study|Refused further treatment|1|||
156976045|NCT02178566|566665630|FG000|Overall Study|patient did not complete due to noncompliance|0|||
156976046|NCT02178566|566665631|FG001|Overall Study|patient did not complete due to noncompliance|1|||
156976047|NCT00682643|566665632|FG000|Overall Study|Adverse Event|12|||
156976048|NCT00682643|566665633|FG001|Overall Study|Adverse Event|23|||
156976049|NCT00682643|566665632|FG000|Overall Study|Lack of Efficacy|2|||
156976050|NCT00682643|566665633|FG001|Overall Study|Lack of Efficacy|0|||
156976051|NCT00682643|566665632|FG000|Overall Study|Protocol Violation|38|||
156976052|NCT00682643|566665633|FG001|Overall Study|Protocol Violation|76|||
156976053|NCT00682643|566665632|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
156976054|NCT00682643|566665633|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
156976055|NCT00682643|566665632|FG000|Overall Study|Lost to Follow-up|1|||
156976056|NCT00682643|566665633|FG001|Overall Study|Lost to Follow-up|6|||
156976057|NCT00682643|566665632|FG000|Overall Study|Physician Decision|2|||
156976058|NCT00682643|566665633|FG001|Overall Study|Physician Decision|6|||
156976059|NCT00682643|566665632|FG000|Overall Study|Withdrawal by Subject|19|||
156976060|NCT00682643|566665633|FG001|Overall Study|Withdrawal by Subject|53|||
156976061|NCT00682643|566665632|FG000|Overall Study|Did Not Receive Study Drug|1|||
156976062|NCT00682643|566665633|FG001|Overall Study|Did Not Receive Study Drug|1|||
156976063|NCT00085202|566665634|FG000|Overall Study|Still on therapy|2|||
156976064|NCT00085202|566665635|FG001|Overall Study|Still on therapy|0|||
156976065|NCT00085202|566665634|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
156976066|NCT00085202|566665635|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
156976067|NCT00085202|566665634|FG000|Overall Study|Excessive toxicity|6|||
156976068|NCT00085202|566665635|FG001|Overall Study|Excessive toxicity|5|||
157058238|NCT01812707|566966719|FG003|Overall Study|Adverse Event|2|||
157058239|NCT01812707|566966716|FG000|Overall Study|Poor compliance to protocol|1|||
157058240|NCT01812707|566966717|FG001|Overall Study|Poor compliance to protocol|0|||
157179646|NCT02667236|567400105|FG001|Overall Study|Adverse Event|1|||
156976069|NCT00085202|566665634|FG000|Overall Study|Non-specified|3|||
156976070|NCT00085202|566665635|FG001|Overall Study|Non-specified|5|||
156976071|NCT00085202|566665634|FG000|Overall Study|Withdrawal by Subject|2|||
156976072|NCT00085202|566665635|FG001|Overall Study|Withdrawal by Subject|1|||
156976073|NCT00085202|566665634|FG000|Overall Study|Physician Decision|4|||
156976074|NCT00085202|566665635|FG001|Overall Study|Physician Decision|1|||
156976075|NCT00085202|566665634|FG000|Overall Study|Progressive disease|1|||
156976076|NCT00085202|566665635|FG001|Overall Study|Progressive disease|11|||
156976077|NCT03238300|566665636|FG000|Baseline (Before Intervention)|Physician Decision|0|||
156976078|NCT03238300|566665637|FG001|Baseline (Before Intervention)|Physician Decision|1|||
156976079|NCT03238300|566665636|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
156976080|NCT03238300|566665637|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
156976081|NCT03238300|566665636|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
156976082|NCT03238300|566665637|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
156976083|NCT03238300|566665636|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
156976084|NCT03238300|566665637|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
156976085|NCT02839343|566665645|FG000|Overall Study|Withdrawal by Subject|3|||
156976086|NCT02839343|566665646|FG001|Overall Study|Withdrawal by Subject|1|||
156976087|NCT02839343|566665645|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
156976088|NCT02839343|566665646|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
156976089|NCT02839343|566665645|FG000|Overall Study|Adverse Event|1|||
156976090|NCT02839343|566665646|FG001|Overall Study|Adverse Event|0|||
156976091|NCT01852058|566665649|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
156976092|NCT01852058|566665650|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976093|NCT01852058|566665651|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976094|NCT01852058|566665652|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976095|NCT01852058|566665653|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976096|NCT01852058|566665654|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976097|NCT01852058|566665655|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976098|NCT01852058|566665656|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976099|NCT01852058|566665657|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976100|NCT01852058|566665658|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976101|NCT01852058|566665659|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976102|NCT01852058|566665660|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
156976103|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976104|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976105|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976106|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976107|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
156976108|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976109|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976110|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976111|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976112|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976113|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976114|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
156976115|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976116|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976117|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976118|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976119|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
156976120|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
156976121|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976122|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976123|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976124|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976125|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976126|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
156976127|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976128|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976129|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976130|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976131|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
156976132|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976133|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976134|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976135|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976136|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976137|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
156976138|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
157058241|NCT01812707|566966718|FG002|Overall Study|Poor compliance to protocol|0|||
157058242|NCT01812707|566966719|FG003|Overall Study|Poor compliance to protocol|0|||
157058243|NCT01812707|566966716|FG000|Overall Study|Consent withdrawn by participant|1|||
157058244|NCT01812707|566966717|FG001|Overall Study|Consent withdrawn by participant|0|||
157058245|NCT01812707|566966718|FG002|Overall Study|Consent withdrawn by participant|0|||
157058246|NCT01812707|566966719|FG003|Overall Study|Consent withdrawn by participant|0|||
157058247|NCT05060237|566966721|FG000|Overall Study|Withdrawal by Subject|4|||
157179647|NCT02667236|567400104|FG000|Overall Study|Withdrawal by Subject|2|||
157179648|NCT02667236|567400105|FG001|Overall Study|Withdrawal by Subject|0|||
157179649|NCT00634751|567400109|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
157179650|NCT00634751|567400110|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
157179651|NCT00634751|567400111|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
157179652|NCT00634751|567400112|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
157179653|NCT00634751|567400109|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
157179654|NCT00634751|567400110|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
157179655|NCT00634751|567400111|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
157179656|NCT00634751|567400112|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
157179657|NCT00634751|567400109|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
157179658|NCT00634751|567400110|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
157179659|NCT00634751|567400111|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
157179660|NCT00634751|567400112|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
157179661|NCT01235338|567400115|FG000|Overall Study|Adverse Event|3|||
157179662|NCT01235338|567400116|FG001|Overall Study|Adverse Event|2|||
157179663|NCT01235338|567400115|FG000|Overall Study|Protocol Violation|1|||
157179664|NCT01235338|567400116|FG001|Overall Study|Protocol Violation|1|||
157179665|NCT01235338|567400115|FG000|Overall Study|Withdrawal by Subject|5|||
157179666|NCT01235338|567400116|FG001|Overall Study|Withdrawal by Subject|0|||
157179667|NCT01235338|567400115|FG000|Overall Study|Exclusion criteria violations|1|||
157179668|NCT01235338|567400116|FG001|Overall Study|Exclusion criteria violations|1|||
157179669|NCT01235338|567400115|FG000|Overall Study|Positive drug screen|0|||
157179670|NCT01235338|567400116|FG001|Overall Study|Positive drug screen|1|||
157179671|NCT01235338|567400115|FG000|Overall Study|Prohibited meds|1|||
157179672|NCT01235338|567400116|FG001|Overall Study|Prohibited meds|0|||
157179673|NCT02809118|567400117|FG000|Overall Study|Withdrawal by Subject|0|||
157179674|NCT02809118|567400118|FG001|Overall Study|Withdrawal by Subject|1|||
157179675|NCT02809118|567400119|FG002|Overall Study|Withdrawal by Subject|1|||
157179676|NCT02996110|567400121|FG000|Pre-Treatment|Other Reasons|0|||
157179677|NCT02996110|567400122|FG001|Pre-Treatment|Other Reasons|1|||
157179678|NCT02996110|567400123|FG002|Pre-Treatment|Other Reasons|0|||
157179679|NCT02996110|567400124|FG003|Pre-Treatment|Other Reasons|0|||
157179680|NCT02996110|567400125|FG004|Pre-Treatment|Other Reasons|1|||
157179681|NCT02996110|567400121|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
157179682|NCT02996110|567400122|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
157179683|NCT02996110|567400123|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
157179684|NCT02996110|567400124|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
157179685|NCT02996110|567400125|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
157179686|NCT02996110|567400121|FG000|Track 1|Disease Progression|15|||
157179687|NCT02996110|567400122|FG001|Track 1|Disease Progression|17|||
157179688|NCT02996110|567400123|FG002|Track 1|Disease Progression|0|||
157179689|NCT02996110|567400124|FG003|Track 1|Disease Progression|0|||
157179690|NCT02996110|567400125|FG004|Track 1|Disease Progression|0|||
157179691|NCT02996110|567400121|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
157179692|NCT02996110|567400122|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
157179693|NCT02996110|567400123|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
157179694|NCT02996110|567400124|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
157179695|NCT02996110|567400125|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
157058248|NCT05060237|566966721|FG000|Overall Study|Screening failure|8|||
157058249|NCT01066897|566966722|FG000|Overall Study|Withdrawal by Subject|1|||
157058250|NCT01066897|566966723|FG001|Overall Study|Withdrawal by Subject|0|||
157058251|NCT01066897|566966722|FG000|Overall Study|stopped study after developing the flu.|1|||
157058252|NCT01066897|566966723|FG001|Overall Study|stopped study after developing the flu.|0|||
157058253|NCT01697592|566966724|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
157058254|NCT01697592|566966725|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058255|NCT01697592|566966726|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157179696|NCT02996110|567400121|FG000|Track 1|Study Drug Toxicity|5|||
157179697|NCT02996110|567400122|FG001|Track 1|Study Drug Toxicity|3|||
157179698|NCT02996110|567400123|FG002|Track 1|Study Drug Toxicity|0|||
157179699|NCT02996110|567400124|FG003|Track 1|Study Drug Toxicity|0|||
157179700|NCT02996110|567400125|FG004|Track 1|Study Drug Toxicity|0|||
157179701|NCT02996110|567400121|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
157179702|NCT02996110|567400122|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
157179703|NCT02996110|567400123|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
157179704|NCT02996110|567400124|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
157179705|NCT02996110|567400125|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
157058256|NCT01697592|566966727|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058257|NCT01697592|566966728|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058258|NCT01697592|566966729|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058259|NCT01697592|566966730|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058260|NCT01697592|566966731|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058261|NCT01697592|566966732|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058262|NCT01697592|566966733|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
157058263|NCT01697592|566966724|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058264|NCT01697592|566966725|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058265|NCT01697592|566966726|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058266|NCT01697592|566966727|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058267|NCT01697592|566966728|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058268|NCT01697592|566966729|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
157058269|NCT01697592|566966730|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058270|NCT01697592|566966731|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058271|NCT01697592|566966732|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058272|NCT01697592|566966733|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
157058273|NCT01697592|566966724|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
157058274|NCT01697592|566966725|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058275|NCT01697592|566966726|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058276|NCT01697592|566966727|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058277|NCT01697592|566966728|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058278|NCT01697592|566966729|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058279|NCT01697592|566966730|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058280|NCT01697592|566966731|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058281|NCT01697592|566966732|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058282|NCT01697592|566966733|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
157058283|NCT01697592|566966724|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
157058284|NCT01697592|566966725|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
157058285|NCT01697592|566966726|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058286|NCT01697592|566966727|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058287|NCT01697592|566966728|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058288|NCT01697592|566966729|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058289|NCT01697592|566966730|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
157058290|NCT01697592|566966731|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058291|NCT01697592|566966732|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
157058292|NCT01697592|566966733|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
157058293|NCT01697592|566966724|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
157058294|NCT01697592|566966725|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
157058295|NCT01697592|566966726|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
157058296|NCT01697592|566966727|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
157058297|NCT01697592|566966728|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
157058298|NCT01697592|566966729|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
157058299|NCT01697592|566966730|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
157058300|NCT01697592|566966731|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
157058301|NCT01697592|566966732|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
157058302|NCT01697592|566966733|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
157058303|NCT01697592|566966724|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
157058304|NCT01697592|566966725|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058305|NCT01697592|566966726|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058306|NCT01697592|566966727|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
157058307|NCT01697592|566966728|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058308|NCT01697592|566966729|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058309|NCT01697592|566966730|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058310|NCT01697592|566966731|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058311|NCT01697592|566966732|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058312|NCT01697592|566966733|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
157058313|NCT01697592|566966724|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
157058314|NCT01697592|566966725|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058315|NCT01697592|566966726|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058316|NCT01697592|566966727|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058317|NCT01697592|566966728|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058318|NCT01697592|566966729|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
157058319|NCT01697592|566966730|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058320|NCT01697592|566966731|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
157058321|NCT01697592|566966732|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058322|NCT01697592|566966733|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
157058323|NCT01697592|566966724|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
157058324|NCT01697592|566966725|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
157058325|NCT01697592|566966726|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
157179706|NCT02996110|567400121|FG000|Track 1|Administrative Reason by Sponsor|0|||
157179707|NCT02996110|567400122|FG001|Track 1|Administrative Reason by Sponsor|1|||
157179708|NCT02996110|567400123|FG002|Track 1|Administrative Reason by Sponsor|0|||
157179709|NCT02996110|567400124|FG003|Track 1|Administrative Reason by Sponsor|0|||
157179710|NCT02996110|567400125|FG004|Track 1|Administrative Reason by Sponsor|0|||
157179711|NCT02996110|567400121|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
157179712|NCT02996110|567400122|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
157179713|NCT02996110|567400123|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
157179714|NCT02996110|567400124|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
157179715|NCT02996110|567400125|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
157179716|NCT02996110|567400121|FG000|Track 2|Disease Progression|33|||
157179717|NCT02996110|567400122|FG001|Track 2|Disease Progression|26|||
157179718|NCT02996110|567400123|FG002|Track 2|Disease Progression|19|||
157179719|NCT02996110|567400124|FG003|Track 2|Disease Progression|16|||
157179720|NCT02996110|567400125|FG004|Track 2|Disease Progression|15|||
157179721|NCT02996110|567400121|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
157179722|NCT02996110|567400122|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
157179723|NCT02996110|567400123|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
157179724|NCT02996110|567400124|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
157179725|NCT02996110|567400125|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
157179726|NCT02996110|567400121|FG000|Track 2|Death|0|||
157179727|NCT02996110|567400122|FG001|Track 2|Death|0|||
157179728|NCT02996110|567400123|FG002|Track 2|Death|1|||
157179729|NCT02996110|567400124|FG003|Track 2|Death|0|||
157179730|NCT02996110|567400125|FG004|Track 2|Death|1|||
157179731|NCT02996110|567400121|FG000|Track 2|Study Drug Toxicity|4|||
157179732|NCT02996110|567400122|FG001|Track 2|Study Drug Toxicity|1|||
157179733|NCT02996110|567400123|FG002|Track 2|Study Drug Toxicity|4|||
157229800|NCT02289963|567588149|FG000|Overall Study|End treatment visit outside visit window|0|||
157229801|NCT02289963|567588150|FG001|Overall Study|End treatment visit outside visit window|4|||
157229802|NCT02289963|567588149|FG000|Overall Study|Other than specified above|0|||
157229803|NCT02289963|567588150|FG001|Overall Study|Other than specified above|2|||
157229804|NCT01042522|567588152|FG000|Overall Study|Adverse Event|1|||
157229805|NCT01042522|567588153|FG001|Overall Study|Adverse Event|2|||
157229806|NCT01042522|567588152|FG000|Overall Study|Disease Progression|5|||
157229807|NCT01042522|567588153|FG001|Overall Study|Disease Progression|0|||
157229808|NCT01042522|567588152|FG000|Overall Study|Death|1|||
157229809|NCT01042522|567588153|FG001|Overall Study|Death|0|||
157229810|NCT01042522|567588152|FG000|Overall Study|Patient Refused|0|||
157229811|NCT01042522|567588153|FG001|Overall Study|Patient Refused|3|||
157229812|NCT01042522|567588152|FG000|Overall Study|Withdrawal by Subject|1|||
157229813|NCT01042522|567588153|FG001|Overall Study|Withdrawal by Subject|1|||
157229814|NCT01941095|567588155|FG000|Overall Study|Insufficient therapeutic response|13|||
157229815|NCT01941095|567588155|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
157229816|NCT01941095|567588155|FG000|Overall Study|Adverse Event|11|||
157229817|NCT01941095|567588155|FG000|Overall Study|Physician Decision|3|||
157229818|NCT01941095|567588155|FG000|Overall Study|Withdrawal by Subject|17|||
157229819|NCT01941095|567588155|FG000|Overall Study|Lost to Follow-up|10|||
157229820|NCT02143102|567588159|FG000|Overall Study|Lost to Follow-up|11|||
157229821|NCT02143102|567588160|FG001|Overall Study|Lost to Follow-up|0|||
157229822|NCT01345019|567588161|FG000|Blinded Treatment Phase|Death|147|||
157229823|NCT01345019|567588162|FG001|Blinded Treatment Phase|Death|137|||
157229824|NCT01345019|567588161|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
157229825|NCT01345019|567588162|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
157229826|NCT01345019|567588161|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
157229827|NCT01345019|567588162|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
157229828|NCT01345019|567588161|FG000|Blinded Treatment Phase|Disease Progression|12|||
157229829|NCT01345019|567588162|FG001|Blinded Treatment Phase|Disease Progression|10|||
157229830|NCT01345019|567588161|FG000|Blinded Treatment Phase|Adverse Event|6|||
157229831|NCT01345019|567588162|FG001|Blinded Treatment Phase|Adverse Event|13|||
156976139|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976140|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976141|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
157179734|NCT02996110|567400124|FG003|Track 2|Study Drug Toxicity|1|||
157179735|NCT02996110|567400125|FG004|Track 2|Study Drug Toxicity|0|||
157179736|NCT02996110|567400121|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
157179737|NCT02996110|567400122|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
157179738|NCT02996110|567400123|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
157229832|NCT01345019|567588161|FG000|Blinded Treatment Phase|Administrative Decision|10|||
157229833|NCT01345019|567588162|FG001|Blinded Treatment Phase|Administrative Decision|8|||
157229834|NCT01345019|567588161|FG000|Blinded Treatment Phase|Noncompliance|5|||
157229835|NCT01345019|567588162|FG001|Blinded Treatment Phase|Noncompliance|3|||
157229836|NCT01345019|567588161|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
157229837|NCT01345019|567588162|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
157229838|NCT01345019|567588161|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
157179739|NCT02996110|567400124|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
157179740|NCT02996110|567400125|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
157179741|NCT02996110|567400121|FG000|Track 2|Participant Withdrew Consent|1|||
157179742|NCT02996110|567400122|FG001|Track 2|Participant Withdrew Consent|2|||
157179743|NCT02996110|567400123|FG002|Track 2|Participant Withdrew Consent|3|||
157179744|NCT02996110|567400124|FG003|Track 2|Participant Withdrew Consent|1|||
157179745|NCT02996110|567400125|FG004|Track 2|Participant Withdrew Consent|1|||
157179746|NCT02996110|567400121|FG000|Track 2|Other Reasons|0|||
157179747|NCT02996110|567400122|FG001|Track 2|Other Reasons|0|||
157179748|NCT02996110|567400123|FG002|Track 2|Other Reasons|1|||
157179749|NCT02996110|567400124|FG003|Track 2|Other Reasons|0|||
157179750|NCT02996110|567400125|FG004|Track 2|Other Reasons|1|||
157179751|NCT00216086|567400126|FG000|Overall Study|Protocol Violation|1|||
157179752|NCT00216086|567400126|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
157179753|NCT00216086|567400126|FG000|Overall Study|Social Reasons|2|||
157179754|NCT01080625|567400127|FG000|Overall Study|Physician Decision|0|||
157179755|NCT01080625|567400128|FG001|Overall Study|Physician Decision|2|||
157179756|NCT01080625|567400129|FG002|Overall Study|Physician Decision|1|||
157179757|NCT00446797|567400132|FG000|Overall Study|Lack of Efficacy|0|||
157179758|NCT00446797|567400133|FG001|Overall Study|Lack of Efficacy|2|||
157179759|NCT00446797|567400132|FG000|Overall Study|Lost to Follow-up|5|||
157179760|NCT00446797|567400133|FG001|Overall Study|Lost to Follow-up|3|||
157179761|NCT00446797|567400132|FG000|Overall Study|Withdrawal by Subject|2|||
157179762|NCT00446797|567400133|FG001|Overall Study|Withdrawal by Subject|2|||
157179763|NCT00446797|567400132|FG000|Overall Study|Protocol Violation|1|||
157179764|NCT00446797|567400133|FG001|Overall Study|Protocol Violation|3|||
157179765|NCT00446797|567400132|FG000|Overall Study|subject entered at another site|0|||
157179766|NCT00446797|567400133|FG001|Overall Study|subject entered at another site|1|||
157179767|NCT00446797|567400132|FG000|Overall Study|did not meet entrance criteria|0|||
157179768|NCT00446797|567400133|FG001|Overall Study|did not meet entrance criteria|1|||
157179769|NCT02728206|567400137|FG000|Overall Study|Death|1|||
157179770|NCT01929018|567400150|FG000|Overall Study|Lost to Follow-up|1|||
157179771|NCT01929018|567400151|FG001|Overall Study|Lost to Follow-up|0|||
157179772|NCT01929018|567400150|FG000|Overall Study|Hospitalization|0|||
157179773|NCT01929018|567400151|FG001|Overall Study|Hospitalization|1|||
157179774|NCT01366534|567400152|FG000|Overall Study|Lost to Follow-up|1|||
157179775|NCT01366534|567400153|FG001|Overall Study|Lost to Follow-up|0|||
157179776|NCT01366534|567400154|FG002|Overall Study|Lost to Follow-up|0|||
157179777|NCT01366534|567400152|FG000|Overall Study|Migrated|1|||
157179778|NCT01366534|567400153|FG001|Overall Study|Migrated|1|||
157179779|NCT01366534|567400154|FG002|Overall Study|Migrated|0|||
157179780|NCT01366534|567400152|FG000|Overall Study|Declined challenged|0|||
157179781|NCT01366534|567400153|FG001|Overall Study|Declined challenged|1|||
157058326|NCT01697592|566966727|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
157058327|NCT01697592|566966728|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
157058328|NCT01697592|566966729|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
157058329|NCT01697592|566966730|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
157058330|NCT01697592|566966731|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
157058331|NCT01697592|566966732|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
157058332|NCT01697592|566966733|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
157058333|NCT02396758|566966734|FG000|Overall Study|Withdrawal by Subject|2|||
157058334|NCT02396758|566966735|FG001|Overall Study|Withdrawal by Subject|0|||
157058335|NCT02396758|566966736|FG002|Overall Study|Withdrawal by Subject|0|||
157058336|NCT02396758|566966737|FG003|Overall Study|Withdrawal by Subject|1|||
157058337|NCT02396758|566966734|FG000|Overall Study|Lost to Follow-up|8|||
157058338|NCT02396758|566966735|FG001|Overall Study|Lost to Follow-up|5|||
157058339|NCT02396758|566966736|FG002|Overall Study|Lost to Follow-up|3|||
157058340|NCT02396758|566966737|FG003|Overall Study|Lost to Follow-up|3|||
157058341|NCT02396758|566966734|FG000|Overall Study|Death|1|||
157058342|NCT02396758|566966735|FG001|Overall Study|Death|1|||
157058343|NCT02396758|566966736|FG002|Overall Study|Death|0|||
157058344|NCT02396758|566966737|FG003|Overall Study|Death|1|||
157058345|NCT02396758|566966734|FG000|Overall Study|Randomized but not treated|1|||
157058346|NCT02396758|566966735|FG001|Overall Study|Randomized but not treated|0|||
157058347|NCT02396758|566966736|FG002|Overall Study|Randomized but not treated|1|||
157179782|NCT01366534|567400154|FG002|Overall Study|Declined challenged|0|||
157179783|NCT00282568|567400157|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
157179784|NCT00282568|567400157|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
157179785|NCT00282568|567400157|FG000|Extended Treatment Period|Adverse Event|17|||
157179786|NCT00282568|567400157|FG000|Extended Treatment Period|Non-compliance|4|||
157179787|NCT00282568|567400157|FG000|Extended Treatment Period|Physician Decision|1|||
157179788|NCT00282568|567400157|FG000|Extended Treatment Period|Lost to Follow-up|2|||
157179789|NCT01266070|567400158|FG000|Overall Study|Adverse Event|3|||
157179790|NCT01266070|567400158|FG000|Overall Study|Protocol Violation|1|||
157179791|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
157179792|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
157179793|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
157179794|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
157179795|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
157179796|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
157179797|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
157179798|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
157179799|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
157179800|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
157179801|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
157179802|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
157179803|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
157179804|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
157179805|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
157179806|NCT02417064|567400159|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
157179807|NCT02417064|567400160|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
157179808|NCT02417064|567400161|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
157179809|NCT02417064|567400159|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
157179810|NCT02417064|567400160|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
157179811|NCT02417064|567400161|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
157179812|NCT02417064|567400159|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
157179813|NCT02417064|567400160|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
157179814|NCT02417064|567400161|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
157179815|NCT02417064|567400159|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
157179816|NCT02417064|567400160|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
157179817|NCT02417064|567400161|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
157179818|NCT02417064|567400159|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
157179819|NCT02417064|567400160|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
157179820|NCT02417064|567400161|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
157179821|NCT02417064|567400159|FG000|Follow-up Phase (24 Weeks)|Other|2|||
157179822|NCT02417064|567400160|FG001|Follow-up Phase (24 Weeks)|Other|2|||
157179823|NCT02417064|567400161|FG002|Follow-up Phase (24 Weeks)|Other|3|||
157179824|NCT03185819|567400162|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
157179825|NCT03185819|567400163|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
157179826|NCT03185819|567400164|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
157179827|NCT03185819|567400165|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
157179828|NCT03185819|567400162|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
157179829|NCT03185819|567400163|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
157179830|NCT03185819|567400164|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
157179831|NCT03185819|567400165|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
157179832|NCT03185819|567400162|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
157179833|NCT03185819|567400163|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
157179834|NCT03185819|567400164|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
157179835|NCT03185819|567400165|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
157179836|NCT03185819|567400162|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
157179837|NCT03185819|567400163|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
157179838|NCT03185819|567400164|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
157179839|NCT03185819|567400165|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
157179840|NCT03185819|567400162|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
157179841|NCT03185819|567400163|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
157179842|NCT03185819|567400164|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
157179843|NCT03185819|567400165|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
157179844|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
157179845|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
157179846|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
157179847|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
157179848|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
157179849|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
157179850|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
157179851|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
157179852|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
157179853|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
156976142|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976143|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
157179854|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
157179855|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
157179856|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
157205272|NCT03993288|567496084|FG001|Overall Study|did not follow the treatment schedule|0|||
157179857|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
157179858|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
157179859|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
157179860|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
157179861|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
157179862|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
157179863|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
157179864|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
157179865|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
157179866|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
157179867|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
157179868|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
157179869|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
157179870|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
157179871|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
157179872|NCT03185819|567400162|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
157179873|NCT03185819|567400163|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
157179874|NCT03185819|567400164|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
157179875|NCT03185819|567400165|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
157179876|NCT02939976|567400166|FG000|Overall Study|Lost to Follow-up|7|||
157179877|NCT02939976|567400167|FG001|Overall Study|Lost to Follow-up|1|||
157179878|NCT02939976|567400168|FG002|Overall Study|Lost to Follow-up|1|||
157179879|NCT02939976|567400169|FG003|Overall Study|Lost to Follow-up|2|||
157179880|NCT02939976|567400166|FG000|Overall Study|Withdrawal by Subject|4|||
157179881|NCT02939976|567400167|FG001|Overall Study|Withdrawal by Subject|0|||
157179882|NCT02939976|567400168|FG002|Overall Study|Withdrawal by Subject|2|||
157179883|NCT02939976|567400169|FG003|Overall Study|Withdrawal by Subject|4|||
157179884|NCT02939976|567400166|FG000|Overall Study|Due to early study closure|4|||
157179885|NCT02939976|567400167|FG001|Overall Study|Due to early study closure|3|||
157179886|NCT02939976|567400168|FG002|Overall Study|Due to early study closure|2|||
157179887|NCT02939976|567400169|FG003|Overall Study|Due to early study closure|3|||
157179888|NCT04080752|567400170|FG000|Overall Study|Adverse Event|2|||
157179889|NCT04080752|567400171|FG001|Overall Study|Adverse Event|3|||
157179890|NCT04080752|567400170|FG000|Overall Study|Lack of Efficacy|1|||
157179891|NCT04080752|567400171|FG001|Overall Study|Lack of Efficacy|0|||
157179892|NCT04080752|567400170|FG000|Overall Study|Lost to Follow-up|1|||
157179893|NCT04080752|567400171|FG001|Overall Study|Lost to Follow-up|0|||
157179894|NCT04080752|567400170|FG000|Overall Study|Pregnancy|0|||
157179895|NCT04080752|567400171|FG001|Overall Study|Pregnancy|1|||
157179896|NCT04080752|567400170|FG000|Overall Study|Withdrawal by Subject|7|||
157179897|NCT04080752|567400171|FG001|Overall Study|Withdrawal by Subject|0|||
157179898|NCT04080752|567400170|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157179899|NCT04080752|567400171|FG001|Overall Study|Non-Compliance with Study Drug|1|||
157179900|NCT04080752|567400170|FG000|Overall Study|Other|2|||
157179901|NCT04080752|567400171|FG001|Overall Study|Other|1|||
157179902|NCT01585168|567400172|FG000|Overall Study|Lost to Follow-up|3|||
157179903|NCT01585168|567400173|FG001|Overall Study|Lost to Follow-up|1|||
157179904|NCT01585168|567400174|FG002|Overall Study|Lost to Follow-up|1|||
157179905|NCT01585168|567400175|FG003|Overall Study|Lost to Follow-up|1|||
157179906|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
157179907|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
157229839|NCT01345019|567588162|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
157229840|NCT01345019|567588161|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
157229841|NCT01345019|567588162|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
157179908|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
157179909|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
157179910|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
157179911|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
157179912|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
157179913|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
157179914|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
157179915|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
157058348|NCT02396758|566966737|FG003|Overall Study|Randomized but not treated|0|||
157058349|NCT01631825|566966738|FG000|Overall Study|Adverse Event|42|||
157058350|NCT01631825|566966738|FG000|Overall Study|Lack of Efficacy|7|||
157179916|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
157179917|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
157229842|NCT01345019|567588161|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
157229843|NCT01345019|567588162|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
157179918|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
157179919|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
157179920|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
157179921|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
157179922|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
157179923|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
157179924|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
157179925|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
157179926|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
157179927|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
157179928|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
157179929|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
157179930|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Other|0|||
157179931|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Other|1|||
157179932|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Other|0|||
157179933|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Other|0|||
157179934|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
157179935|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
157179936|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
157179937|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
157179938|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
157179939|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
157179940|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
157179941|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
157179942|NCT01194414|567400176|FG000|24 Weeks Double Blind Period|Death|0|||
157179943|NCT01194414|567400177|FG001|24 Weeks Double Blind Period|Death|1|||
157179944|NCT01194414|567400178|FG002|24 Weeks Double Blind Period|Death|0|||
157179945|NCT01194414|567400179|FG003|24 Weeks Double Blind Period|Death|0|||
157179946|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
157179947|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
157179948|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
157179949|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
157179950|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
157179951|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
157179952|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
157179953|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
157179954|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
157179955|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
157179956|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
157179957|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
157179958|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
157179959|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
157179960|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
157179961|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
157179962|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
157179963|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
157179964|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
157179965|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
157179966|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
157179967|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
157179968|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
157179969|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
157179970|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Other|2|||
157179971|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Other|1|||
157179972|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Other|0|||
157179973|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Other|0|||
157179974|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
157179975|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
157179976|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
157179977|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
157179978|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
157179979|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
157179980|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
157179981|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
157179982|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
157179983|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
157229844|NCT01345019|567588161|FG000|Open Label Treatment Phase|Death|49|||
157179984|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
157179985|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
157179986|NCT01194414|567400176|FG000|72 Weeks Open Label Extension|Death|1|||
157179987|NCT01194414|567400177|FG001|72 Weeks Open Label Extension|Death|2|||
157179988|NCT01194414|567400178|FG002|72 Weeks Open Label Extension|Death|0|||
157179989|NCT01194414|567400179|FG003|72 Weeks Open Label Extension|Death|2|||
157179990|NCT01782885|567400181|FG000|Overall Study|Lost to Follow-up|4|||
157179991|NCT01782885|567400182|FG001|Overall Study|Lost to Follow-up|6|||
157179992|NCT03447821|567400183|FG000|Overall Study|Withdrawal by Subject|1|||
157179993|NCT03447821|567400184|FG001|Overall Study|Withdrawal by Subject|1|||
157179994|NCT03447821|567400185|FG002|Overall Study|Withdrawal by Subject|0|||
157179995|NCT03447821|567400183|FG000|Overall Study|Lost to Follow-up|0|||
157179996|NCT03447821|567400184|FG001|Overall Study|Lost to Follow-up|0|||
157179997|NCT03447821|567400185|FG002|Overall Study|Lost to Follow-up|1|||
157179998|NCT02977507|567400186|FG000|Overall Study|Protocol Deviation|1|||
157179999|NCT02977507|567400187|FG001|Overall Study|Protocol Deviation|0|||
157180000|NCT02977507|567400186|FG000|Overall Study|Lost to Follow-up|1|||
157180001|NCT02977507|567400187|FG001|Overall Study|Lost to Follow-up|0|||
157180002|NCT00654420|567400188|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
157180003|NCT00654420|567400189|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
157180004|NCT00654420|567400190|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
157180005|NCT00654420|567400191|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
157180006|NCT00654420|567400188|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
157180007|NCT00654420|567400189|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
157180008|NCT00654420|567400190|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
157180009|NCT00654420|567400191|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
157180010|NCT00654420|567400188|FG000|Phase II|Adverse Event|0|||
157180011|NCT00654420|567400189|FG001|Phase II|Adverse Event|0|||
157180012|NCT00654420|567400190|FG002|Phase II|Adverse Event|3|||
157180013|NCT00654420|567400191|FG003|Phase II|Adverse Event|3|||
157180014|NCT00654420|567400188|FG000|Phase II|Lost to Follow-up|0|||
157180015|NCT00654420|567400189|FG001|Phase II|Lost to Follow-up|0|||
157180016|NCT00654420|567400190|FG002|Phase II|Lost to Follow-up|0|||
157180017|NCT00654420|567400191|FG003|Phase II|Lost to Follow-up|1|||
157180018|NCT00654420|567400188|FG000|Phase II|Physician Decision|0|||
157180019|NCT00654420|567400189|FG001|Phase II|Physician Decision|0|||
157180020|NCT00654420|567400190|FG002|Phase II|Physician Decision|0|||
157180021|NCT00654420|567400191|FG003|Phase II|Physician Decision|4|||
157180022|NCT00654420|567400188|FG000|Phase II|Progressive Disease|0|||
157180023|NCT00654420|567400189|FG001|Phase II|Progressive Disease|0|||
157180024|NCT00654420|567400190|FG002|Phase II|Progressive Disease|29|||
157180025|NCT00654420|567400191|FG003|Phase II|Progressive Disease|29|||
157180026|NCT00654420|567400188|FG000|Phase II|Withdrawal by Subject|0|||
157180027|NCT00654420|567400189|FG001|Phase II|Withdrawal by Subject|0|||
157180028|NCT00654420|567400190|FG002|Phase II|Withdrawal by Subject|4|||
157180029|NCT00654420|567400191|FG003|Phase II|Withdrawal by Subject|1|||
157180030|NCT00654420|567400188|FG000|Phase II|Missing Disposition Record|0|||
157180031|NCT00654420|567400189|FG001|Phase II|Missing Disposition Record|0|||
157180032|NCT00654420|567400190|FG002|Phase II|Missing Disposition Record|1|||
157180033|NCT00654420|567400191|FG003|Phase II|Missing Disposition Record|0|||
157180034|NCT00610207|567400196|FG000|Overall Study|Lost to Follow-up|3|||
157180035|NCT00845845|567400204|FG000|Overall Study|Lost to Follow-up|0|||
157180036|NCT00845845|567400205|FG001|Overall Study|Lost to Follow-up|4|||
157180037|NCT01685203|567400206|FG000|Overall Study|Lost to Follow-up|3|||
157180038|NCT01685203|567400207|FG001|Overall Study|Lost to Follow-up|3|||
157180039|NCT01685203|567400208|FG002|Overall Study|Lost to Follow-up|0|||
157180040|NCT01685203|567400209|FG003|Overall Study|Lost to Follow-up|1|||
157180041|NCT01685203|567400210|FG004|Overall Study|Lost to Follow-up|0|||
157180042|NCT01685203|567400211|FG005|Overall Study|Lost to Follow-up|0|||
157180043|NCT01685203|567400212|FG006|Overall Study|Lost to Follow-up|0|||
157180044|NCT01685203|567400206|FG000|Overall Study|Adverse Event|0|||
157180045|NCT01685203|567400207|FG001|Overall Study|Adverse Event|0|||
157180046|NCT01685203|567400208|FG002|Overall Study|Adverse Event|0|||
157229845|NCT01345019|567588162|FG001|Open Label Treatment Phase|Death|48|||
157229846|NCT01345019|567588161|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
157180047|NCT01685203|567400209|FG003|Overall Study|Adverse Event|0|||
157180048|NCT01685203|567400210|FG004|Overall Study|Adverse Event|0|||
157180049|NCT01685203|567400211|FG005|Overall Study|Adverse Event|2|||
157180050|NCT01685203|567400212|FG006|Overall Study|Adverse Event|0|||
157180051|NCT01685203|567400206|FG000|Overall Study|Adverse event and withdrew consent|1|||
157180052|NCT01685203|567400207|FG001|Overall Study|Adverse event and withdrew consent|0|||
157180053|NCT01685203|567400208|FG002|Overall Study|Adverse event and withdrew consent|0|||
157180054|NCT01685203|567400209|FG003|Overall Study|Adverse event and withdrew consent|0|||
157180055|NCT01685203|567400210|FG004|Overall Study|Adverse event and withdrew consent|0|||
157180056|NCT01685203|567400211|FG005|Overall Study|Adverse event and withdrew consent|0|||
157180057|NCT01685203|567400212|FG006|Overall Study|Adverse event and withdrew consent|0|||
157180058|NCT01685203|567400206|FG000|Overall Study|Patient's decision|0|||
157180059|NCT01685203|567400207|FG001|Overall Study|Patient's decision|0|||
157180060|NCT01685203|567400208|FG002|Overall Study|Patient's decision|0|||
157180061|NCT01685203|567400209|FG003|Overall Study|Patient's decision|0|||
157180062|NCT01685203|567400210|FG004|Overall Study|Patient's decision|0|||
157180063|NCT01685203|567400211|FG005|Overall Study|Patient's decision|1|||
157180064|NCT01685203|567400212|FG006|Overall Study|Patient's decision|0|||
157180065|NCT02896192|567400213|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
157180066|NCT02896192|567400213|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
157180067|NCT02896192|567400213|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
157180068|NCT00479167|567400217|FG000|Overall Study|Withdrawal by Subject|1|||
157180069|NCT04095793|567400218|FG000|Overall Study|Adverse Event|3|||
157180070|NCT04095793|567400218|FG000|Overall Study|Study Terminated by Sponsor|103|||
157180071|NCT04095793|567400218|FG000|Overall Study|Withdrawal by Subject|4|||
157180072|NCT03619837|567400219|FG000|Screening|received organs from HCV-negative donors|47|||
157180073|NCT03619837|567400219|FG000|Screening|died on the wait-list|2|||
157180074|NCT03619837|567400219|FG000|Screening|remained on the wait list|40|||
157180075|NCT03619837|567400219|FG000|Screening|didn't meet eligibility criteria|3|||
157180076|NCT03619837|567400219|FG000|Screening|withdrew consent|2|||
157180077|NCT03619837|567400219|FG000|Screening|never listed for HCV-viremic donor|1|||
157180078|NCT03619837|567400219|FG000|Screening|developed exclusion criteria|2|||
157180079|NCT03619837|567400219|FG000|Screening|excluded by the investigator due to non-compliance|1|||
157180080|NCT00400946|567402496|FG000|Overall Study|Ineligible|0|||
157180081|NCT00400946|567402497|FG001|Overall Study|Ineligible|0|||
157180082|NCT00400946|567402498|FG002|Overall Study|Ineligible|0|||
157180083|NCT00400946|567402499|FG003|Overall Study|Ineligible|5|||
157180084|NCT00400946|567402500|FG004|Overall Study|Ineligible|1|||
157180085|NCT00400946|567402496|FG000|Overall Study|Induction Failure|0|||
157180086|NCT00400946|567402497|FG001|Overall Study|Induction Failure|0|||
157180087|NCT00400946|567402498|FG002|Overall Study|Induction Failure|0|||
157180088|NCT00400946|567402499|FG003|Overall Study|Induction Failure|11|||
157180089|NCT00400946|567402500|FG004|Overall Study|Induction Failure|8|||
157180090|NCT00400946|567402496|FG000|Overall Study|Induction Death|0|||
157180091|NCT00400946|567402497|FG001|Overall Study|Induction Death|0|||
157180092|NCT00400946|567402498|FG002|Overall Study|Induction Death|0|||
157180093|NCT00400946|567402499|FG003|Overall Study|Induction Death|13|||
157180094|NCT00400946|567402500|FG004|Overall Study|Induction Death|3|||
157180095|NCT00400946|567402496|FG000|Overall Study|Lost to Follow-up|1|||
157180096|NCT00400946|567402497|FG001|Overall Study|Lost to Follow-up|1|||
157180097|NCT00400946|567402498|FG002|Overall Study|Lost to Follow-up|0|||
157180098|NCT00400946|567402499|FG003|Overall Study|Lost to Follow-up|0|||
157180099|NCT00400946|567402500|FG004|Overall Study|Lost to Follow-up|1|||
157180100|NCT00400946|567402496|FG000|Overall Study|Remission Death|1|||
157180101|NCT00400946|567402497|FG001|Overall Study|Remission Death|1|||
157180102|NCT00400946|567402498|FG002|Overall Study|Remission Death|0|||
157180103|NCT00400946|567402499|FG003|Overall Study|Remission Death|0|||
157180104|NCT00400946|567402500|FG004|Overall Study|Remission Death|1|||
157180105|NCT00400946|567402496|FG000|Overall Study|Relapse|9|||
157180106|NCT00400946|567402497|FG001|Overall Study|Relapse|2|||
157180107|NCT00400946|567402498|FG002|Overall Study|Relapse|1|||
157180108|NCT00400946|567402499|FG003|Overall Study|Relapse|1|||
157180109|NCT00400946|567402500|FG004|Overall Study|Relapse|5|||
157180110|NCT00400946|567402496|FG000|Overall Study|Transplant in CR1|0|||
157180111|NCT00400946|567402497|FG001|Overall Study|Transplant in CR1|0|||
157180112|NCT00400946|567402498|FG002|Overall Study|Transplant in CR1|0|||
157180113|NCT00400946|567402499|FG003|Overall Study|Transplant in CR1|10|||
157180114|NCT00400946|567402500|FG004|Overall Study|Transplant in CR1|1|||
157180115|NCT00400946|567402496|FG000|Overall Study|Withdrawal by Subject|2|||
157180116|NCT00400946|567402497|FG001|Overall Study|Withdrawal by Subject|5|||
157180117|NCT00400946|567402498|FG002|Overall Study|Withdrawal by Subject|1|||
157180118|NCT00400946|567402499|FG003|Overall Study|Withdrawal by Subject|5|||
157180119|NCT00400946|567402500|FG004|Overall Study|Withdrawal by Subject|8|||
157058351|NCT01631825|566966738|FG000|Overall Study|Withdrawal by Subject|9|||
157058352|NCT01631825|566966738|FG000|Overall Study|Protocol Violation|4|||
157058353|NCT01631825|566966738|FG000|Overall Study|Discontinuation criteria|1|||
157058354|NCT01631825|566966738|FG000|Overall Study|Physician Decision|2|||
157180120|NCT00400946|567402496|FG000|Overall Study|Clinical|1|||
157180121|NCT00400946|567402497|FG001|Overall Study|Clinical|2|||
157180122|NCT00400946|567402498|FG002|Overall Study|Clinical|0|||
157180123|NCT00400946|567402499|FG003|Overall Study|Clinical|2|||
157180124|NCT00400946|567402500|FG004|Overall Study|Clinical|9|||
157180125|NCT00400946|567402496|FG000|Overall Study|Other|0|||
157058355|NCT02110225|566966739|FG000|Overall Study|Lost to Follow-up|0|||
157180126|NCT00400946|567402497|FG001|Overall Study|Other|0|||
157058356|NCT02110225|566966740|FG001|Overall Study|Lost to Follow-up|1|||
157180127|NCT00400946|567402498|FG002|Overall Study|Other|0|||
157180128|NCT00400946|567402499|FG003|Overall Study|Other|0|||
157180129|NCT00400946|567402500|FG004|Overall Study|Other|1|||
157180130|NCT01004159|567402501|FG000|Overall Study|Adverse Event|2|||
157180131|NCT01004159|567402501|FG000|Overall Study|Disease Progression|18|||
157180132|NCT04483544|567402503|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
157180133|NCT04483544|567402503|FG000|Post-Treatment|Admitted to hospice|2|||
157180134|NCT04483544|567402503|FG000|Post-Treatment|Study terminated|3|||
157180135|NCT04315298|567402508|FG000|Overall Study|Withdrawal by Subject|0|||
157180136|NCT04315298|567402509|FG001|Overall Study|Withdrawal by Subject|0|||
157180137|NCT04315298|567402510|FG002|Overall Study|Withdrawal by Subject|0|||
157180138|NCT04315298|567402511|FG003|Overall Study|Withdrawal by Subject|2|||
157180139|NCT04315298|567402512|FG004|Overall Study|Withdrawal by Subject|2|||
157180140|NCT04315298|567402513|FG005|Overall Study|Withdrawal by Subject|2|||
157180141|NCT04315298|567402514|FG006|Overall Study|Withdrawal by Subject|0|||
157180142|NCT04315298|567402515|FG007|Overall Study|Withdrawal by Subject|1|||
157180143|NCT04315298|567402516|FG008|Overall Study|Withdrawal by Subject|1|||
157180144|NCT04315298|567402517|FG009|Overall Study|Withdrawal by Subject|1|||
157180145|NCT04315298|567402518|FG010|Overall Study|Withdrawal by Subject|0|||
157180146|NCT04315298|567402519|FG011|Overall Study|Withdrawal by Subject|0|||
157180147|NCT04315298|567402520|FG012|Overall Study|Withdrawal by Subject|0|||
157180148|NCT04315298|567402521|FG013|Overall Study|Withdrawal by Subject|0|||
157180149|NCT04315298|567402522|FG014|Overall Study|Withdrawal by Subject|0|||
157180150|NCT04315298|567402523|FG015|Overall Study|Withdrawal by Subject|0|||
157180151|NCT04315298|567402524|FG016|Overall Study|Withdrawal by Subject|0|||
157180152|NCT04315298|567402525|FG017|Overall Study|Withdrawal by Subject|0|||
157180153|NCT04315298|567402526|FG018|Overall Study|Withdrawal by Subject|0|||
157180154|NCT04315298|567402508|FG000|Overall Study|Physician Decision|0|||
157180155|NCT04315298|567402509|FG001|Overall Study|Physician Decision|0|||
157180156|NCT04315298|567402510|FG002|Overall Study|Physician Decision|0|||
157180157|NCT04315298|567402511|FG003|Overall Study|Physician Decision|0|||
157180158|NCT04315298|567402512|FG004|Overall Study|Physician Decision|1|||
157180159|NCT04315298|567402513|FG005|Overall Study|Physician Decision|0|||
157180160|NCT04315298|567402514|FG006|Overall Study|Physician Decision|0|||
157180161|NCT04315298|567402515|FG007|Overall Study|Physician Decision|0|||
157180162|NCT04315298|567402516|FG008|Overall Study|Physician Decision|0|||
157180163|NCT04315298|567402517|FG009|Overall Study|Physician Decision|0|||
157180164|NCT04315298|567402518|FG010|Overall Study|Physician Decision|0|||
157180165|NCT04315298|567402519|FG011|Overall Study|Physician Decision|0|||
157180166|NCT04315298|567402520|FG012|Overall Study|Physician Decision|0|||
157180167|NCT04315298|567402521|FG013|Overall Study|Physician Decision|0|||
157180168|NCT04315298|567402522|FG014|Overall Study|Physician Decision|0|||
157180169|NCT04315298|567402523|FG015|Overall Study|Physician Decision|0|||
157180170|NCT04315298|567402524|FG016|Overall Study|Physician Decision|0|||
157180171|NCT04315298|567402525|FG017|Overall Study|Physician Decision|0|||
157180172|NCT04315298|567402526|FG018|Overall Study|Physician Decision|0|||
157180173|NCT04315298|567402508|FG000|Overall Study|Lost to Follow-up|5|||
157180174|NCT04315298|567402509|FG001|Overall Study|Lost to Follow-up|10|||
157180175|NCT04315298|567402510|FG002|Overall Study|Lost to Follow-up|6|||
157180176|NCT04315298|567402511|FG003|Overall Study|Lost to Follow-up|8|||
157180177|NCT04315298|567402512|FG004|Overall Study|Lost to Follow-up|12|||
157180178|NCT04315298|567402513|FG005|Overall Study|Lost to Follow-up|13|||
157058357|NCT02110225|566966741|FG002|Overall Study|Lost to Follow-up|0|||
157058358|NCT02176018|566966742|FG000|Overall Study|Adverse Event|0|||
157058359|NCT02176018|566966743|FG001|Overall Study|Adverse Event|2|||
157180179|NCT04315298|567402514|FG006|Overall Study|Lost to Follow-up|9|||
157180180|NCT04315298|567402515|FG007|Overall Study|Lost to Follow-up|16|||
157180181|NCT04315298|567402516|FG008|Overall Study|Lost to Follow-up|14|||
157180182|NCT04315298|567402517|FG009|Overall Study|Lost to Follow-up|0|||
157180183|NCT04315298|567402518|FG010|Overall Study|Lost to Follow-up|2|||
157180184|NCT04315298|567402519|FG011|Overall Study|Lost to Follow-up|1|||
157180185|NCT04315298|567402520|FG012|Overall Study|Lost to Follow-up|0|||
157180186|NCT04315298|567402521|FG013|Overall Study|Lost to Follow-up|0|||
157180187|NCT04315298|567402522|FG014|Overall Study|Lost to Follow-up|0|||
157180188|NCT04315298|567402523|FG015|Overall Study|Lost to Follow-up|2|||
157180189|NCT04315298|567402524|FG016|Overall Study|Lost to Follow-up|0|||
157180190|NCT04315298|567402525|FG017|Overall Study|Lost to Follow-up|0|||
157180191|NCT04315298|567402526|FG018|Overall Study|Lost to Follow-up|0|||
157180192|NCT04315298|567402508|FG000|Overall Study|Death|24|||
157058360|NCT02176018|566966742|FG000|Overall Study|Lost to Follow-up|3|||
157180193|NCT04315298|567402509|FG001|Overall Study|Death|60|||
157180194|NCT04315298|567402510|FG002|Overall Study|Death|49|||
157180195|NCT04315298|567402511|FG003|Overall Study|Death|59|||
157180196|NCT04315298|567402512|FG004|Overall Study|Death|70|||
157180197|NCT04315298|567402513|FG005|Overall Study|Death|114|||
157180198|NCT04315298|567402514|FG006|Overall Study|Death|9|||
157180199|NCT04315298|567402515|FG007|Overall Study|Death|12|||
157180200|NCT04315298|567402516|FG008|Overall Study|Death|21|||
157180201|NCT04315298|567402517|FG009|Overall Study|Death|16|||
157180202|NCT04315298|567402518|FG010|Overall Study|Death|40|||
157180203|NCT04315298|567402519|FG011|Overall Study|Death|40|||
157180204|NCT04315298|567402520|FG012|Overall Study|Death|3|||
157180205|NCT04315298|567402521|FG013|Overall Study|Death|4|||
157180206|NCT04315298|567402522|FG014|Overall Study|Death|6|||
157058361|NCT02176018|566966743|FG001|Overall Study|Lost to Follow-up|1|||
157180207|NCT04315298|567402523|FG015|Overall Study|Death|4|||
157180208|NCT04315298|567402524|FG016|Overall Study|Death|3|||
157058362|NCT02176018|566966742|FG000|Overall Study|Protocol Violation|1|||
157058363|NCT02176018|566966743|FG001|Overall Study|Protocol Violation|1|||
157058364|NCT02176018|566966742|FG000|Overall Study|Withdrawal by Subject|1|||
157058365|NCT02176018|566966743|FG001|Overall Study|Withdrawal by Subject|2|||
157058366|NCT00265096|566966745|FG000|Overall Study|Adverse Event|14|||
157058367|NCT00265096|566966746|FG001|Overall Study|Adverse Event|18|||
157058368|NCT00265096|566966747|FG002|Overall Study|Adverse Event|18|||
157058369|NCT00265096|566966745|FG000|Overall Study|Lost to Follow-up|2|||
157058370|NCT00265096|566966746|FG001|Overall Study|Lost to Follow-up|5|||
157058371|NCT00265096|566966747|FG002|Overall Study|Lost to Follow-up|3|||
157058372|NCT00265096|566966745|FG000|Overall Study|Death|0|||
157058373|NCT00265096|566966746|FG001|Overall Study|Death|1|||
157058374|NCT00265096|566966747|FG002|Overall Study|Death|2|||
157058375|NCT00265096|566966745|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
157058376|NCT00265096|566966746|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
157058377|NCT00265096|566966747|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
157058378|NCT00265096|566966745|FG000|Overall Study|Other|11|||
157058379|NCT00265096|566966746|FG001|Overall Study|Other|19|||
157058380|NCT00265096|566966747|FG002|Overall Study|Other|10|||
157058381|NCT01116440|566966748|FG000|Treatment|Withdrawal by Subject|2|||
157058382|NCT01116440|566966749|FG001|Treatment|Withdrawal by Subject|2|||
157058383|NCT01116440|566966748|FG000|Treatment|Lost to Follow-up|1|||
157058384|NCT01116440|566966749|FG001|Treatment|Lost to Follow-up|1|||
157058385|NCT01116440|566966748|FG000|Treatment|Protocol Violation|0|||
157058386|NCT01116440|566966749|FG001|Treatment|Protocol Violation|2|||
157058387|NCT01116440|566966748|FG000|Treatment|Lack of Efficacy|0|||
157058388|NCT01116440|566966749|FG001|Treatment|Lack of Efficacy|1|||
157058389|NCT01116440|566966748|FG000|Treatment|Adverse Event|0|||
157058390|NCT01116440|566966749|FG001|Treatment|Adverse Event|1|||
157058391|NCT01116440|566966748|FG000|Withdrawal|Withdrawal by Subject|0|||
157058392|NCT01116440|566966749|FG001|Withdrawal|Withdrawal by Subject|1|||
157058393|NCT01116440|566966748|FG000|Withdrawal|Lost to Follow-up|0|||
157058394|NCT01116440|566966749|FG001|Withdrawal|Lost to Follow-up|1|||
157058395|NCT01116440|566966748|FG000|Follow-up|Lost to Follow-up|0|||
157058396|NCT01116440|566966749|FG001|Follow-up|Lost to Follow-up|1|||
157058397|NCT01116440|566966748|FG000|Follow-up|Withdrawal by Subject|0|||
157058398|NCT01116440|566966749|FG001|Follow-up|Withdrawal by Subject|1|||
157058399|NCT00774306|566966750|FG000|Overall Study|Adverse Event|3|||
157058400|NCT00774306|566966751|FG001|Overall Study|Adverse Event|0|||
157058401|NCT00774306|566966752|FG002|Overall Study|Adverse Event|0|||
157058402|NCT00774306|566966753|FG003|Overall Study|Adverse Event|0|||
157058403|NCT00774306|566966750|FG000|Overall Study|Protocol Violation|2|||
157058404|NCT00774306|566966751|FG001|Overall Study|Protocol Violation|0|||
157058405|NCT00774306|566966752|FG002|Overall Study|Protocol Violation|3|||
157058406|NCT00774306|566966753|FG003|Overall Study|Protocol Violation|0|||
157058407|NCT00774306|566966750|FG000|Overall Study|Withdrawal by Subject|6|||
157058408|NCT00774306|566966751|FG001|Overall Study|Withdrawal by Subject|1|||
157058409|NCT00774306|566966752|FG002|Overall Study|Withdrawal by Subject|1|||
157058410|NCT00774306|566966753|FG003|Overall Study|Withdrawal by Subject|0|||
157058411|NCT00774306|566966750|FG000|Overall Study|Lost to Follow-up|6|||
157058412|NCT00774306|566966751|FG001|Overall Study|Lost to Follow-up|0|||
157058413|NCT00774306|566966752|FG002|Overall Study|Lost to Follow-up|4|||
157058414|NCT00774306|566966753|FG003|Overall Study|Lost to Follow-up|5|||
157058415|NCT00774306|566966750|FG000|Overall Study|Death|1|||
157058416|NCT00774306|566966751|FG001|Overall Study|Death|1|||
157180209|NCT04315298|567402525|FG017|Overall Study|Death|1|||
157180210|NCT04315298|567402526|FG018|Overall Study|Death|0|||
157058417|NCT00774306|566966752|FG002|Overall Study|Death|0|||
157058418|NCT00774306|566966753|FG003|Overall Study|Death|0|||
157058419|NCT03568708|566966759|FG000|Overall Study|Withdrawal by Subject|1|||
157058420|NCT03568708|566966760|FG001|Overall Study|Withdrawal by Subject|1|||
157058421|NCT03568708|566966759|FG000|Overall Study|Lost to Follow-up|0|||
157058422|NCT03568708|566966760|FG001|Overall Study|Lost to Follow-up|1|||
157058423|NCT01126879|566966761|FG000|Overall Study|Progressive Disease|3|||
157058424|NCT01126879|566966762|FG001|Overall Study|Progressive Disease|1|||
157058425|NCT01126879|566966761|FG000|Overall Study|Withdrawal by Subject|1|||
157058426|NCT01126879|566966762|FG001|Overall Study|Withdrawal by Subject|0|||
157058427|NCT01126879|566966761|FG000|Overall Study|Adverse Event|0|||
157058428|NCT01126879|566966762|FG001|Overall Study|Adverse Event|1|||
157058429|NCT01126879|566966761|FG000|Overall Study|Physician Decision|1|||
157058430|NCT01126879|566966762|FG001|Overall Study|Physician Decision|0|||
157058431|NCT00666835|566966763|FG000|Overall Study|Withdrawal by Subject|5|||
157058432|NCT00666835|566966764|FG001|Overall Study|Withdrawal by Subject|2|||
157058433|NCT00666835|566966763|FG000|Overall Study|Lack of Efficacy|0|||
157058434|NCT00666835|566966764|FG001|Overall Study|Lack of Efficacy|1|||
157058435|NCT00666835|566966763|FG000|Overall Study|Incl./excl. not fulfilled|7|||
157058436|NCT00666835|566966764|FG001|Overall Study|Incl./excl. not fulfilled|2|||
157058437|NCT00666835|566966763|FG000|Overall Study|Adverse Event|7|||
157058438|NCT00666835|566966764|FG001|Overall Study|Adverse Event|6|||
157058439|NCT00666835|566966763|FG000|Overall Study|Protocol Violation|2|||
157180211|NCT00736385|567402527|FG000|Overall Study|Withdrawal by Subject|2|||
157180212|NCT00736385|567402528|FG001|Overall Study|Withdrawal by Subject|2|||
156976144|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
156976145|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976146|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976147|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976148|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976149|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976150|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
156976151|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976152|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976153|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976154|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
156976155|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976156|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976157|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976158|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976159|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976160|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976161|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976162|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
156976163|NCT01852058|566665649|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976164|NCT01852058|566665650|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976165|NCT01852058|566665651|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976166|NCT01852058|566665652|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976167|NCT01852058|566665653|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
156976168|NCT01852058|566665654|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
156976169|NCT01852058|566665655|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976170|NCT01852058|566665656|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976171|NCT01852058|566665657|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976172|NCT01852058|566665658|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976173|NCT01852058|566665659|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976174|NCT01852058|566665660|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
156976175|NCT01852058|566665649|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976176|NCT01852058|566665650|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976177|NCT01852058|566665651|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976178|NCT01852058|566665652|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976179|NCT01852058|566665653|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976180|NCT01852058|566665654|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976181|NCT01852058|566665655|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976182|NCT01852058|566665656|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
156976183|NCT01852058|566665657|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976184|NCT01852058|566665658|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976185|NCT01852058|566665659|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976186|NCT01852058|566665660|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
156976187|NCT01852058|566665649|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976188|NCT01852058|566665650|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976189|NCT01852058|566665651|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976190|NCT01852058|566665652|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976191|NCT01852058|566665653|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976192|NCT01852058|566665654|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976193|NCT01852058|566665655|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976194|NCT01852058|566665656|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976195|NCT01852058|566665657|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
156976196|NCT01852058|566665658|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976197|NCT01852058|566665659|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976198|NCT01852058|566665660|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
156976199|NCT00399763|566665664|FG000|Overall Study|Lost to Follow-up|2|||
156976200|NCT00399763|566665665|FG001|Overall Study|Lost to Follow-up|3|||
156976201|NCT00909428|566665666|FG000|Overall Study|Lost to Follow-up|13|||
156976202|NCT00909428|566665667|FG001|Overall Study|Lost to Follow-up|10|||
156976203|NCT00909428|566665668|FG002|Overall Study|Lost to Follow-up|9|||
156976204|NCT00386308|566667394|FG000|Overall Study|Adverse Event|3|||
157180213|NCT00736385|567402527|FG000|Overall Study|Adverse Event|0|||
157180214|NCT00736385|567402528|FG001|Overall Study|Adverse Event|1|||
157180215|NCT00098865|567402529|FG000|Overall Study|Progressive Disease|6|||
157180216|NCT00098865|567402529|FG000|Overall Study|Adverse Event|2|||
157180217|NCT00098865|567402529|FG000|Overall Study|Alternative Therapy|1|||
157180218|NCT03267511|567402530|FG000|Overall Study|Lost to Follow-up|0|||
157180219|NCT03267511|567402531|FG001|Overall Study|Lost to Follow-up|0|||
157180220|NCT03267511|567402532|FG002|Overall Study|Lost to Follow-up|0|||
157180221|NCT03267511|567402533|FG003|Overall Study|Lost to Follow-up|1|||
157180222|NCT00364351|567402534|FG000|Overall Study|Adverse Event|90|||
157180223|NCT00364351|567402535|FG001|Overall Study|Adverse Event|44|||
157180224|NCT00364351|567402534|FG000|Overall Study|Condition under investigation worsened|469|||
157180225|NCT00364351|567402535|FG001|Overall Study|Condition under investigation worsened|497|||
157180226|NCT00364351|567402534|FG000|Overall Study|Prohibited concomitant medication|0|||
157180227|NCT00364351|567402535|FG001|Overall Study|Prohibited concomitant medication|2|||
157180228|NCT00364351|567402534|FG000|Overall Study|Lost to Follow-up|1|||
157180229|NCT00364351|567402535|FG001|Overall Study|Lost to Follow-up|1|||
157180230|NCT00364351|567402534|FG000|Overall Study|Withdrawal by Subject|30|||
157180231|NCT00364351|567402535|FG001|Overall Study|Withdrawal by Subject|29|||
157180232|NCT00364351|567402534|FG000|Overall Study|Incorrect enrollment|1|||
157180233|NCT00364351|567402535|FG001|Overall Study|Incorrect enrollment|1|||
157180234|NCT00364351|567402534|FG000|Overall Study|Sponsor decision|1|||
157180235|NCT00364351|567402535|FG001|Overall Study|Sponsor decision|0|||
157180236|NCT00364351|567402534|FG000|Overall Study|Poor treatment compliance|0|||
157180237|NCT00364351|567402535|FG001|Overall Study|Poor treatment compliance|3|||
157180238|NCT00364351|567402534|FG000|Overall Study|Investigator error|0|||
157180239|NCT00364351|567402535|FG001|Overall Study|Investigator error|2|||
157180240|NCT00364351|567402534|FG000|Overall Study|Patient could not travel to site|0|||
157180241|NCT00364351|567402535|FG001|Overall Study|Patient could not travel to site|1|||
157180242|NCT00364351|567402534|FG000|Overall Study|Randomised treatment not started|0|||
157180243|NCT00364351|567402535|FG001|Overall Study|Randomised treatment not started|3|||
157180244|NCT01685060|567402536|FG000|Overall Study|Rollover patients|16|||
157180245|NCT01685060|567402536|FG000|Overall Study|Adverse Event|12|||
157180246|NCT01685060|567402536|FG000|Overall Study|Progressive disease|69|||
157180247|NCT01685060|567402536|FG000|Overall Study|Physician Decision|14|||
157180248|NCT01685060|567402536|FG000|Overall Study|Subject/guardian decision|20|||
157180249|NCT01685060|567402536|FG000|Overall Study|Lost to Follow-up|1|||
157180250|NCT01685060|567402536|FG000|Overall Study|Death|8|||
157180251|NCT01572844|567402537|FG000|Overall Study|Physician Decision|1|||
157180252|NCT01572844|567402538|FG001|Overall Study|Physician Decision|1|||
157180253|NCT03654560|567402545|FG000|Overall Study|Death|3|||
157180254|NCT03654560|567402546|FG001|Overall Study|Death|1|||
157180255|NCT03654560|567402545|FG000|Overall Study|Lost to Follow-up|1|||
157180256|NCT03654560|567402546|FG001|Overall Study|Lost to Follow-up|0|||
157180257|NCT00209092|567402547|FG000|Overall Study|Progression of disease|7|||
157180258|NCT00209092|567402548|FG001|Overall Study|Progression of disease|1|||
157180259|NCT00209092|567402547|FG000|Overall Study|Adverse Event|0|||
157180260|NCT00209092|567402548|FG001|Overall Study|Adverse Event|1|||
157180261|NCT00209092|567402547|FG000|Overall Study|Withdrawal by Subject|1|||
157180262|NCT00209092|567402548|FG001|Overall Study|Withdrawal by Subject|0|||
157180263|NCT05283499|567402549|FG000|Overall Study|Did not receive intervention|1|||
157180264|NCT05283499|567402550|FG001|Overall Study|Did not receive intervention|2|||
157180265|NCT06048809|567402557|FG000|Overall Study|Adverse Event|2|||
156976205|NCT00386308|566667395|FG001|Overall Study|Adverse Event|3|||
156976206|NCT00386308|566667394|FG000|Overall Study|Protocol Violation|2|||
156976207|NCT00386308|566667395|FG001|Overall Study|Protocol Violation|5|||
156976208|NCT00386308|566667394|FG000|Overall Study|Lack of Efficacy|0|||
156976209|NCT00386308|566667395|FG001|Overall Study|Lack of Efficacy|2|||
156976210|NCT00386308|566667394|FG000|Overall Study|Lost to Follow-up|10|||
156976211|NCT00386308|566667395|FG001|Overall Study|Lost to Follow-up|6|||
156976212|NCT00386308|566667394|FG000|Overall Study|Withdrawal by Subject|6|||
156976213|NCT00386308|566667395|FG001|Overall Study|Withdrawal by Subject|2|||
156976214|NCT00386308|566667394|FG000|Overall Study|Other Event|8|||
156976215|NCT00386308|566667395|FG001|Overall Study|Other Event|1|||
156976216|NCT01478113|566667398|FG000|Overall Study|Withdrawal by Subject|0|||
156976217|NCT01478113|566667399|FG001|Overall Study|Withdrawal by Subject|1|||
156976218|NCT01478113|566667398|FG000|Overall Study|Physician Decision|1|||
156976219|NCT01478113|566667399|FG001|Overall Study|Physician Decision|0|||
156976220|NCT03980184|566667406|FG000|Overall Study|Dropped out before treatment|2|||
157180266|NCT06048809|567402558|FG001|Overall Study|Adverse Event|0|||
157180267|NCT06048809|567402557|FG000|Overall Study|Withdrawal by Subject|1|||
157180268|NCT06048809|567402558|FG001|Overall Study|Withdrawal by Subject|1|||
157180269|NCT03135262|567402565|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
157180270|NCT03135262|567402566|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
157180271|NCT03135262|567402567|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
157180272|NCT03135262|567402568|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
156976221|NCT03980184|566667407|FG001|Overall Study|Dropped out before treatment|2|||
156976222|NCT03980184|566667406|FG000|Overall Study|Lost to Follow-up|11|||
157058440|NCT00666835|566966764|FG001|Overall Study|Protocol Violation|0|||
157058441|NCT00666835|566966763|FG000|Overall Study|Death|15|||
157058442|NCT00666835|566966764|FG001|Overall Study|Death|4|||
157058443|NCT00666835|566966763|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
157058444|NCT00666835|566966764|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
157058445|NCT00666835|566966763|FG000|Overall Study|Hemoglobulin concentration|4|||
157058446|NCT00666835|566966764|FG001|Overall Study|Hemoglobulin concentration|3|||
157058447|NCT00666835|566966763|FG000|Overall Study|Planned operation|2|||
157058448|NCT00666835|566966764|FG001|Overall Study|Planned operation|0|||
157058449|NCT00666835|566966763|FG000|Overall Study|Physician Decision|1|||
157058450|NCT00666835|566966764|FG001|Overall Study|Physician Decision|2|||
157058451|NCT00511147|566966767|FG000|Overall Study|Withdrawal by Subject|1|||
157058452|NCT00511147|566966767|FG000|Overall Study|Disease progression|5|||
157058453|NCT00511147|566966767|FG000|Overall Study|Required platelet transfusion|1|||
157058454|NCT00899379|566966768|FG000|Overall Study|Adverse Event|2|||
157058455|NCT00899379|566966769|FG001|Overall Study|Adverse Event|2|||
157058456|NCT00899379|566966770|FG002|Overall Study|Adverse Event|1|||
157058457|NCT00899379|566966771|FG003|Overall Study|Adverse Event|1|||
157058458|NCT00899379|566966772|FG004|Overall Study|Adverse Event|2|||
157058459|NCT00899379|566966768|FG000|Overall Study|Lack of Efficacy|0|||
157180273|NCT03135262|567402569|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
157180274|NCT03135262|567402565|FG000|Overall Study|Progression of disease|0|||
157180275|NCT03135262|567402566|FG001|Overall Study|Progression of disease|0|||
157180276|NCT03135262|567402567|FG002|Overall Study|Progression of disease|0|||
157180277|NCT03135262|567402568|FG003|Overall Study|Progression of disease|1|||
157180278|NCT03135262|567402569|FG004|Overall Study|Progression of disease|0|||
157180279|NCT03135262|567402565|FG000|Overall Study|Death|6|||
157180280|NCT03135262|567402566|FG001|Overall Study|Death|2|||
157180281|NCT03135262|567402567|FG002|Overall Study|Death|2|||
157180282|NCT03135262|567402568|FG003|Overall Study|Death|2|||
157180283|NCT03135262|567402569|FG004|Overall Study|Death|0|||
157180284|NCT03135262|567402565|FG000|Overall Study|Withdrawal by Subject|0|||
157180285|NCT03135262|567402566|FG001|Overall Study|Withdrawal by Subject|0|||
157180286|NCT03135262|567402567|FG002|Overall Study|Withdrawal by Subject|1|||
157180287|NCT03135262|567402568|FG003|Overall Study|Withdrawal by Subject|0|||
157180288|NCT03135262|567402569|FG004|Overall Study|Withdrawal by Subject|1|||
157180289|NCT03135262|567402565|FG000|Overall Study|Study terminated by sponsor|2|||
157180290|NCT03135262|567402566|FG001|Overall Study|Study terminated by sponsor|4|||
157180291|NCT03135262|567402567|FG002|Overall Study|Study terminated by sponsor|4|||
157180292|NCT03135262|567402568|FG003|Overall Study|Study terminated by sponsor|3|||
157180293|NCT03135262|567402569|FG004|Overall Study|Study terminated by sponsor|0|||
157180294|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
157180295|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
157180296|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
157180297|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
157180298|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
157180299|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
157180300|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
157180301|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
157180302|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
157180303|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
157180304|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
157180305|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
157180306|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
157180307|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
157180308|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
157180309|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
157180310|NCT01291511|567402570|FG000|Cross-Titration and Stabilization Phase|Death|1|||
157180311|NCT01291511|567402571|FG001|Cross-Titration and Stabilization Phase|Death|0|||
157180312|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
157180313|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
157180314|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
157180315|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
157229847|NCT01345019|567588162|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
157058460|NCT00899379|566966769|FG001|Overall Study|Lack of Efficacy|4|||
157058461|NCT00899379|566966770|FG002|Overall Study|Lack of Efficacy|3|||
157058462|NCT00899379|566966771|FG003|Overall Study|Lack of Efficacy|0|||
157058463|NCT00899379|566966772|FG004|Overall Study|Lack of Efficacy|1|||
157058464|NCT00899379|566966768|FG000|Overall Study|Lost to Follow-up|9|||
157058465|NCT00899379|566966769|FG001|Overall Study|Lost to Follow-up|3|||
157058466|NCT00899379|566966770|FG002|Overall Study|Lost to Follow-up|0|||
157058467|NCT00899379|566966771|FG003|Overall Study|Lost to Follow-up|6|||
157058468|NCT00899379|566966772|FG004|Overall Study|Lost to Follow-up|2|||
157180316|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
157180317|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
157180318|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
157180319|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
157180320|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
157180321|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
157180322|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
157180323|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
157180324|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
157180325|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
157180326|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
157180327|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
157180328|NCT01291511|567402570|FG000|Double-blind Relapse Prevention Phase|Death|1|||
157180329|NCT01291511|567402571|FG001|Double-blind Relapse Prevention Phase|Death|0|||
157180330|NCT01047436|567402573|FG000|Overall Study|Protocol Violation|1|||
157180331|NCT01047436|567402574|FG001|Overall Study|Protocol Violation|0|||
157180332|NCT00424099|567402577|FG000|Overall Study|Adverse Event|0|||
157180333|NCT00424099|567402578|FG001|Overall Study|Adverse Event|1|||
157058469|NCT00899379|566966768|FG000|Overall Study|Protocol Violation|0|||
157058470|NCT00899379|566966769|FG001|Overall Study|Protocol Violation|0|||
157058471|NCT00899379|566966770|FG002|Overall Study|Protocol Violation|1|||
157058472|NCT00899379|566966771|FG003|Overall Study|Protocol Violation|1|||
157058473|NCT00899379|566966772|FG004|Overall Study|Protocol Violation|0|||
157058474|NCT00899379|566966768|FG000|Overall Study|Withdrawal by Subject|2|||
157058475|NCT00899379|566966769|FG001|Overall Study|Withdrawal by Subject|4|||
157058476|NCT00899379|566966770|FG002|Overall Study|Withdrawal by Subject|2|||
157058477|NCT00899379|566966771|FG003|Overall Study|Withdrawal by Subject|3|||
157058478|NCT00899379|566966772|FG004|Overall Study|Withdrawal by Subject|6|||
157058479|NCT00899379|566966768|FG000|Overall Study|Pregnancy|0|||
157058480|NCT00899379|566966769|FG001|Overall Study|Pregnancy|0|||
157058481|NCT00899379|566966770|FG002|Overall Study|Pregnancy|1|||
157058482|NCT00899379|566966771|FG003|Overall Study|Pregnancy|0|||
157058483|NCT00899379|566966772|FG004|Overall Study|Pregnancy|1|||
157058484|NCT00899379|566966768|FG000|Overall Study|Patient Uncooperative|0|||
157058485|NCT00899379|566966769|FG001|Overall Study|Patient Uncooperative|1|||
157058486|NCT00899379|566966770|FG002|Overall Study|Patient Uncooperative|0|||
157058487|NCT00899379|566966771|FG003|Overall Study|Patient Uncooperative|1|||
157058488|NCT00899379|566966772|FG004|Overall Study|Patient Uncooperative|2|||
157058489|NCT00899379|566966768|FG000|Overall Study|Abnormal Baseline ECG|0|||
157058490|NCT00899379|566966769|FG001|Overall Study|Abnormal Baseline ECG|0|||
157058491|NCT00899379|566966770|FG002|Overall Study|Abnormal Baseline ECG|0|||
157058492|NCT00899379|566966771|FG003|Overall Study|Abnormal Baseline ECG|1|||
157058493|NCT00899379|566966772|FG004|Overall Study|Abnormal Baseline ECG|0|||
157058494|NCT00899379|566966768|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
157058495|NCT00899379|566966769|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
157058496|NCT00899379|566966770|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
157058497|NCT00899379|566966771|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058498|NCT00899379|566966772|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058499|NCT00899379|566966768|FG000|Overall Study|Not Completed/Entered Extn|5|||
157058500|NCT00899379|566966769|FG001|Overall Study|Not Completed/Entered Extn|1|||
157058501|NCT00899379|566966770|FG002|Overall Study|Not Completed/Entered Extn|6|||
157058502|NCT00899379|566966771|FG003|Overall Study|Not Completed/Entered Extn|4|||
157058503|NCT00899379|566966772|FG004|Overall Study|Not Completed/Entered Extn|3|||
157058504|NCT00899379|566966768|FG000|Overall Study|Study Terminated|3|||
157058505|NCT00899379|566966769|FG001|Overall Study|Study Terminated|0|||
157058506|NCT00899379|566966770|FG002|Overall Study|Study Terminated|3|||
157058507|NCT00899379|566966771|FG003|Overall Study|Study Terminated|3|||
157058508|NCT00899379|566966772|FG004|Overall Study|Study Terminated|1|||
157229848|NCT01345019|567588161|FG000|Open Label Treatment Phase|Adverse Event|30|||
156976223|NCT03980184|566667407|FG001|Overall Study|Lost to Follow-up|13|||
157058509|NCT00899379|566966768|FG000|Overall Study|Lost to Follow-up|3|||
157058510|NCT00899379|566966769|FG001|Overall Study|Lost to Follow-up|1|||
156976224|NCT02002884|566667408|FG000|Main Period (MP)|Other|0|||
156976225|NCT02002884|566667409|FG001|Main Period (MP)|Other|3|||
156976226|NCT02002884|566667410|FG002|Main Period (MP)|Other|3|||
156976227|NCT02002884|566667411|FG003|Main Period (MP)|Other|0|||
156976228|NCT02002884|566667408|FG000|Main Period (MP)|Adverse Event|0|||
156976229|NCT02002884|566667409|FG001|Main Period (MP)|Adverse Event|1|||
156976230|NCT02002884|566667410|FG002|Main Period (MP)|Adverse Event|1|||
156976231|NCT02002884|566667411|FG003|Main Period (MP)|Adverse Event|0|||
156976232|NCT02002884|566667408|FG000|Main Period (MP)|Withdrawal by Subject|6|||
156976233|NCT02002884|566667409|FG001|Main Period (MP)|Withdrawal by Subject|2|||
156976234|NCT02002884|566667410|FG002|Main Period (MP)|Withdrawal by Subject|2|||
156976235|NCT02002884|566667411|FG003|Main Period (MP)|Withdrawal by Subject|0|||
156976236|NCT02002884|566667408|FG000|Main Period (MP)|Lost to Follow-up|0|||
157180334|NCT00424099|567402579|FG002|Overall Study|Adverse Event|1|||
157180335|NCT00424099|567402580|FG003|Overall Study|Adverse Event|0|||
157180336|NCT00424099|567402577|FG000|Overall Study|Death|0|||
157180337|NCT00424099|567402578|FG001|Overall Study|Death|1|||
157180338|NCT00424099|567402579|FG002|Overall Study|Death|0|||
157180339|NCT00424099|567402580|FG003|Overall Study|Death|0|||
157180340|NCT00424099|567402577|FG000|Overall Study|Illness|2|||
157180341|NCT00424099|567402578|FG001|Overall Study|Illness|0|||
157180342|NCT00424099|567402579|FG002|Overall Study|Illness|1|||
157180343|NCT00424099|567402580|FG003|Overall Study|Illness|4|||
157180344|NCT00424099|567402577|FG000|Overall Study|Lost to Follow-up|0|||
157180345|NCT00424099|567402578|FG001|Overall Study|Lost to Follow-up|0|||
157180346|NCT00424099|567402579|FG002|Overall Study|Lost to Follow-up|3|||
157180347|NCT00424099|567402580|FG003|Overall Study|Lost to Follow-up|0|||
157180348|NCT00424099|567402577|FG000|Overall Study|Hospitalized|1|||
157180349|NCT00424099|567402578|FG001|Overall Study|Hospitalized|2|||
157180350|NCT00424099|567402579|FG002|Overall Study|Hospitalized|1|||
157180351|NCT00424099|567402580|FG003|Overall Study|Hospitalized|3|||
157180352|NCT00424099|567402577|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
157180353|NCT00424099|567402578|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
157180354|NCT00424099|567402579|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
157180355|NCT00424099|567402580|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
157180356|NCT00424099|567402577|FG000|Overall Study|Withdrawal by Subject|1|||
157180357|NCT00424099|567402578|FG001|Overall Study|Withdrawal by Subject|9|||
157180358|NCT00424099|567402579|FG002|Overall Study|Withdrawal by Subject|4|||
157180359|NCT00424099|567402580|FG003|Overall Study|Withdrawal by Subject|6|||
157180360|NCT00424099|567402577|FG000|Overall Study|Physician Decision|0|||
157180361|NCT00424099|567402578|FG001|Overall Study|Physician Decision|0|||
157180362|NCT00424099|567402579|FG002|Overall Study|Physician Decision|1|||
157180363|NCT00424099|567402580|FG003|Overall Study|Physician Decision|0|||
157180364|NCT00424099|567402577|FG000|Overall Study|Missing|0|||
157180365|NCT00424099|567402578|FG001|Overall Study|Missing|0|||
157180366|NCT00424099|567402579|FG002|Overall Study|Missing|1|||
157180367|NCT00424099|567402580|FG003|Overall Study|Missing|0|||
157180368|NCT01408732|567402581|FG000|Overall Study|Withdrawal by Subject|2|||
157180369|NCT01408732|567402582|FG001|Overall Study|Withdrawal by Subject|2|||
157180370|NCT00764322|567402583|FG000|Overall Study|Withdrawal by Subject|11|||
157180371|NCT00764322|567402583|FG000|Overall Study|No CYP2D6 genotyping|9|||
157180372|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
157180373|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
157180374|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
157180375|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
157180376|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
157180377|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
157180378|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
157180379|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
157180380|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
157180381|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
157180382|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
157180383|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
157180384|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
157180385|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
157180386|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
157180387|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
157180388|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
157180389|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
157180390|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
157180391|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
157180392|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
157180393|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
157180394|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
157180395|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
157180396|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
157180397|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
157180398|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
157180399|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
157180400|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
157180401|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
157180402|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
157180403|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
157180404|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
157180405|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
157180406|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
157180407|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
157180408|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
157180409|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
157180410|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
157180411|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
157180412|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
157180413|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
157180414|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
157180415|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
157180416|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
157180417|NCT03689972|567402584|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
157180418|NCT03689972|567402585|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
157180419|NCT03689972|567402586|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
157180420|NCT03689972|567402587|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
157180421|NCT03689972|567402588|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
157180422|NCT03689972|567402584|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
157180423|NCT03689972|567402585|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
157180424|NCT03689972|567402586|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
157180425|NCT03689972|567402587|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
157180426|NCT03689972|567402588|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
157180427|NCT03689972|567402584|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
157180428|NCT03689972|567402585|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
157180429|NCT03689972|567402586|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
157180430|NCT03689972|567402587|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
157180431|NCT03689972|567402588|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
157180432|NCT03689972|567402584|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
157180433|NCT03689972|567402585|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
157180434|NCT03689972|567402586|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
157180435|NCT03689972|567402587|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
157180436|NCT03689972|567402588|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
157180437|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
157180438|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
157180439|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
157180440|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
157180441|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
157180442|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
157180443|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
157180444|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
157180445|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
157180446|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
157180447|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
157180448|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
157180449|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
157180450|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
157180451|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
157180452|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
157180453|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
157180454|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
157180455|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
157180456|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
157180457|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
157180458|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
157180459|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
157180460|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
157180461|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
157180462|NCT03689972|567402584|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
157180463|NCT03689972|567402585|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
157180464|NCT03689972|567402586|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
157180465|NCT03689972|567402587|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
157180466|NCT03689972|567402588|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
157180467|NCT01131130|567402590|FG000|Period 1 - Baseline|Pregnancy|1|||
156976237|NCT02002884|566667409|FG001|Main Period (MP)|Lost to Follow-up|0|||
156976238|NCT02002884|566667410|FG002|Main Period (MP)|Lost to Follow-up|2|||
157180468|NCT01131130|567402590|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
157180469|NCT02437162|567402591|FG000|Overall Study|Protocol Violation|0|||
157180470|NCT02437162|567402592|FG001|Overall Study|Protocol Violation|1|||
157180471|NCT02437162|567402593|FG002|Overall Study|Protocol Violation|0|||
157180472|NCT02437162|567402591|FG000|Overall Study|Randomized but not treated|0|||
157180473|NCT02437162|567402592|FG001|Overall Study|Randomized but not treated|0|||
157180474|NCT02437162|567402593|FG002|Overall Study|Randomized but not treated|1|||
157180475|NCT02437162|567402591|FG000|Overall Study|Study discontinued by Sponsor|93|||
157180476|NCT02437162|567402592|FG001|Overall Study|Study discontinued by Sponsor|98|||
157180477|NCT02437162|567402593|FG002|Overall Study|Study discontinued by Sponsor|97|||
157180478|NCT02437162|567402591|FG000|Overall Study|Withdrawal by Subject|13|||
157180479|NCT02437162|567402592|FG001|Overall Study|Withdrawal by Subject|7|||
156976239|NCT02002884|566667411|FG003|Main Period (MP)|Lost to Follow-up|0|||
156976240|NCT02002884|566667408|FG000|Open-Label Extension Period (OLEX)|Other|0|||
156976241|NCT02002884|566667409|FG001|Open-Label Extension Period (OLEX)|Other|0|||
156976242|NCT02002884|566667410|FG002|Open-Label Extension Period (OLEX)|Other|0|||
156976243|NCT02002884|566667411|FG003|Open-Label Extension Period (OLEX)|Other|24|||
156976244|NCT02002884|566667408|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156976245|NCT02002884|566667409|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156976246|NCT02002884|566667410|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
156976247|NCT02002884|566667411|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
156976248|NCT02002884|566667408|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156976249|NCT02002884|566667409|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156976250|NCT02002884|566667410|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
156976251|NCT02002884|566667411|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
156976252|NCT02002884|566667408|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156976253|NCT02002884|566667409|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156976254|NCT02002884|566667410|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
156976255|NCT02002884|566667411|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
156976256|NCT02002884|566667408|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156976257|NCT02002884|566667409|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156976258|NCT02002884|566667410|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
156976259|NCT02002884|566667411|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
156976260|NCT00067990|566667413|FG000|Overall Study|Death|5|||
156976261|NCT00067990|566667414|FG001|Overall Study|Death|7|||
156976262|NCT00067990|566667413|FG000|Overall Study|ESRD, Non IF/TA|1|||
156976263|NCT00067990|566667414|FG001|Overall Study|ESRD, Non IF/TA|3|||
156976264|NCT00067990|566667413|FG000|Overall Study|Withdrawal by Subject|4|||
156976265|NCT00067990|566667414|FG001|Overall Study|Withdrawal by Subject|12|||
156976266|NCT02341456|566667421|FG000|Overall Study|Disease progression|2|||
156976267|NCT02341456|566667422|FG001|Overall Study|Disease progression|3|||
156976268|NCT02341456|566667423|FG002|Overall Study|Disease progression|1|||
156976269|NCT02341456|566667421|FG000|Overall Study|Death|1|||
156976270|NCT02341456|566667422|FG001|Overall Study|Death|1|||
156976271|NCT02341456|566667423|FG002|Overall Study|Death|1|||
156976272|NCT02341456|566667421|FG000|Overall Study|Withdrawal by Subject|0|||
156976273|NCT02341456|566667422|FG001|Overall Study|Withdrawal by Subject|1|||
156976274|NCT02341456|566667423|FG002|Overall Study|Withdrawal by Subject|1|||
156976275|NCT02341456|566667421|FG000|Overall Study|Moved to local access programme.|0|||
156976276|NCT02341456|566667422|FG001|Overall Study|Moved to local access programme.|1|||
156976277|NCT02341456|566667423|FG002|Overall Study|Moved to local access programme.|1|||
156976278|NCT02341456|566667421|FG000|Overall Study|Physician Decision|1|||
156976279|NCT02341456|566667422|FG001|Overall Study|Physician Decision|0|||
156976280|NCT02341456|566667423|FG002|Overall Study|Physician Decision|0|||
156976281|NCT02567825|566667427|FG000|Overall Study|No follow-up post-randomization|5|||
156976282|NCT02567825|566667428|FG001|Overall Study|No follow-up post-randomization|1|||
156976283|NCT02567825|566667427|FG000|Overall Study|Follow-up less than 23 months|16|||
156976284|NCT02567825|566667428|FG001|Overall Study|Follow-up less than 23 months|20|||
156976285|NCT05061537|566667431|FG000|Treatment Phase|Progressive disease|0|||
156976286|NCT05061537|566667432|FG001|Treatment Phase|Progressive disease|1|||
156976287|NCT05061537|566667433|FG002|Treatment Phase|Progressive disease|2|||
156976288|NCT05061537|566667434|FG003|Treatment Phase|Progressive disease|0|||
156976289|NCT05061537|566667435|FG004|Treatment Phase|Progressive disease|0|||
156976290|NCT05061537|566667431|FG000|Treatment Phase|Adverse Event|0|||
156976291|NCT05061537|566667432|FG001|Treatment Phase|Adverse Event|0|||
156976292|NCT05061537|566667433|FG002|Treatment Phase|Adverse Event|2|||
156976293|NCT05061537|566667434|FG003|Treatment Phase|Adverse Event|0|||
156976294|NCT05061537|566667435|FG004|Treatment Phase|Adverse Event|0|||
156976295|NCT05061537|566667431|FG000|Treatment Phase|Global deterioration of health status|0|||
156976296|NCT05061537|566667432|FG001|Treatment Phase|Global deterioration of health status|1|||
156976297|NCT05061537|566667433|FG002|Treatment Phase|Global deterioration of health status|0|||
156976298|NCT05061537|566667434|FG003|Treatment Phase|Global deterioration of health status|0|||
156976299|NCT05061537|566667435|FG004|Treatment Phase|Global deterioration of health status|0|||
157180480|NCT02437162|567402593|FG002|Overall Study|Withdrawal by Subject|9|||
157180481|NCT02437162|567402591|FG000|Overall Study|Adverse Event|0|||
157180482|NCT02437162|567402592|FG001|Overall Study|Adverse Event|1|||
157180483|NCT02437162|567402593|FG002|Overall Study|Adverse Event|0|||
157180484|NCT02437162|567402591|FG000|Overall Study|Lost to Follow-up|1|||
157180485|NCT02437162|567402592|FG001|Overall Study|Lost to Follow-up|0|||
157180486|NCT02437162|567402593|FG002|Overall Study|Lost to Follow-up|1|||
157180487|NCT02437162|567402591|FG000|Overall Study|Death|0|||
157180488|NCT02437162|567402592|FG001|Overall Study|Death|1|||
157180489|NCT02437162|567402593|FG002|Overall Study|Death|0|||
157180490|NCT02437162|567402591|FG000|Overall Study|Other|0|||
157180491|NCT02437162|567402592|FG001|Overall Study|Other|0|||
157180492|NCT02437162|567402593|FG002|Overall Study|Other|1|||
157180493|NCT03981744|567402594|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
157180494|NCT03981744|567402595|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
157180495|NCT03981744|567402596|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
157180496|NCT03981744|567402597|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
157180497|NCT03981744|567402594|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
157180498|NCT03981744|567402595|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
157180499|NCT03981744|567402596|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
157180500|NCT03981744|567402597|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
157180501|NCT03981744|567402594|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
157180502|NCT03981744|567402595|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
157180503|NCT03981744|567402596|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
157180504|NCT03981744|567402597|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
157180505|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
157180506|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
157180507|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
157180508|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
157180509|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
157180510|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
157180511|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
157180512|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
157180513|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
157180514|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
157180515|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
157180516|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
157180517|NCT03321526|567402598|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
157180518|NCT03321526|567402599|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
157180519|NCT03321526|567402598|FG000|Follow-up Phase (2 Weeks)|Other|24|||
157180520|NCT03321526|567402599|FG001|Follow-up Phase (2 Weeks)|Other|24|||
157180521|NCT03097133|567402600|FG000|Overall Study|Lost to Follow-up|3|||
157180522|NCT03097133|567402601|FG001|Overall Study|Lost to Follow-up|2|||
157180523|NCT03097133|567402600|FG000|Overall Study|Withdrawal by Subject|2|||
157180524|NCT03097133|567402601|FG001|Overall Study|Withdrawal by Subject|5|||
157180525|NCT03097133|567402600|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
157180526|NCT03097133|567402601|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
157180527|NCT03097133|567402600|FG000|Overall Study|Other|3|||
157180528|NCT03097133|567402601|FG001|Overall Study|Other|2|||
157180529|NCT03097133|567402600|FG000|Overall Study|Adverse Event|1|||
157180530|NCT03097133|567402601|FG001|Overall Study|Adverse Event|0|||
157180531|NCT01989572|567402604|FG000|Overall Study|Lack of Efficacy|35|||
157180532|NCT01989572|567402605|FG001|Overall Study|Lack of Efficacy|48|||
157180533|NCT01989572|567402606|FG002|Overall Study|Lack of Efficacy|48|||
157180534|NCT01989572|567402607|FG003|Overall Study|Lack of Efficacy|43|||
157180535|NCT01989572|567402608|FG004|Overall Study|Lack of Efficacy|71|||
157180536|NCT01989572|567402609|FG005|Overall Study|Lack of Efficacy|79|||
157180537|NCT01989572|567402604|FG000|Overall Study|Adverse Event|2|||
157180538|NCT01989572|567402605|FG001|Overall Study|Adverse Event|1|||
157180539|NCT01989572|567402606|FG002|Overall Study|Adverse Event|3|||
157229849|NCT01345019|567588162|FG001|Open Label Treatment Phase|Adverse Event|51|||
157229850|NCT01345019|567588161|FG000|Open Label Treatment Phase|Administrative Decision|30|||
157180540|NCT01989572|567402607|FG003|Overall Study|Adverse Event|0|||
157180541|NCT01989572|567402608|FG004|Overall Study|Adverse Event|3|||
157180542|NCT01989572|567402609|FG005|Overall Study|Adverse Event|0|||
157229851|NCT01345019|567588162|FG001|Open Label Treatment Phase|Administrative Decision|15|||
157229852|NCT01345019|567588161|FG000|Open Label Treatment Phase|Disease Progression|17|||
157180543|NCT01989572|567402604|FG000|Overall Study|Death|0|||
157180544|NCT01989572|567402605|FG001|Overall Study|Death|0|||
157180545|NCT01989572|567402606|FG002|Overall Study|Death|0|||
157180546|NCT01989572|567402607|FG003|Overall Study|Death|0|||
157180547|NCT01989572|567402608|FG004|Overall Study|Death|1|||
157180548|NCT01989572|567402609|FG005|Overall Study|Death|0|||
157180549|NCT01989572|567402604|FG000|Overall Study|Withdrawal by Subject|4|||
157180550|NCT01989572|567402605|FG001|Overall Study|Withdrawal by Subject|1|||
157180551|NCT01989572|567402606|FG002|Overall Study|Withdrawal by Subject|5|||
157180552|NCT01989572|567402607|FG003|Overall Study|Withdrawal by Subject|1|||
157180553|NCT01989572|567402608|FG004|Overall Study|Withdrawal by Subject|12|||
157180554|NCT01989572|567402609|FG005|Overall Study|Withdrawal by Subject|4|||
157180555|NCT01989572|567402604|FG000|Overall Study|complicating disease|1|||
157180556|NCT01989572|567402605|FG001|Overall Study|complicating disease|1|||
157180557|NCT01989572|567402606|FG002|Overall Study|complicating disease|2|||
157180558|NCT01989572|567402607|FG003|Overall Study|complicating disease|0|||
157180559|NCT01989572|567402608|FG004|Overall Study|complicating disease|1|||
157180560|NCT01989572|567402609|FG005|Overall Study|complicating disease|0|||
157180561|NCT01989572|567402604|FG000|Overall Study|error|2|||
157180562|NCT01989572|567402605|FG001|Overall Study|error|1|||
157180563|NCT01989572|567402606|FG002|Overall Study|error|1|||
157180564|NCT01989572|567402607|FG003|Overall Study|error|1|||
157180565|NCT01989572|567402608|FG004|Overall Study|error|1|||
157180566|NCT01989572|567402609|FG005|Overall Study|error|1|||
157180567|NCT01989572|567402604|FG000|Overall Study|maximum dose reached|0|||
157180568|NCT01989572|567402605|FG001|Overall Study|maximum dose reached|1|||
157180569|NCT01989572|567402606|FG002|Overall Study|maximum dose reached|0|||
157180570|NCT01989572|567402607|FG003|Overall Study|maximum dose reached|0|||
157180571|NCT01989572|567402608|FG004|Overall Study|maximum dose reached|1|||
157180572|NCT01989572|567402609|FG005|Overall Study|maximum dose reached|0|||
157180573|NCT01989572|567402604|FG000|Overall Study|unknown/not specify|3|||
157180574|NCT01989572|567402605|FG001|Overall Study|unknown/not specify|4|||
157180575|NCT01989572|567402606|FG002|Overall Study|unknown/not specify|1|||
157180576|NCT01989572|567402607|FG003|Overall Study|unknown/not specify|3|||
157180577|NCT01989572|567402608|FG004|Overall Study|unknown/not specify|3|||
157180578|NCT01989572|567402609|FG005|Overall Study|unknown/not specify|5|||
157180579|NCT01989572|567402604|FG000|Overall Study|not start protocol therapy|5|||
157180580|NCT01989572|567402605|FG001|Overall Study|not start protocol therapy|1|||
157180581|NCT01989572|567402606|FG002|Overall Study|not start protocol therapy|2|||
157180582|NCT01989572|567402607|FG003|Overall Study|not start protocol therapy|3|||
157180583|NCT01989572|567402608|FG004|Overall Study|not start protocol therapy|4|||
157180584|NCT01989572|567402609|FG005|Overall Study|not start protocol therapy|18|||
157180585|NCT01989572|567402604|FG000|Overall Study|alternative therapy|3|||
157180586|NCT01989572|567402605|FG001|Overall Study|alternative therapy|0|||
157180587|NCT01989572|567402606|FG002|Overall Study|alternative therapy|0|||
157180588|NCT01989572|567402607|FG003|Overall Study|alternative therapy|0|||
157180589|NCT01989572|567402608|FG004|Overall Study|alternative therapy|1|||
157180590|NCT01989572|567402609|FG005|Overall Study|alternative therapy|3|||
157180591|NCT00732641|567402614|FG000|Overall Study|Relapse or Progressive Disease|65|||
157180592|NCT00732641|567402615|FG001|Overall Study|Relapse or Progressive Disease|101|||
157180593|NCT00732641|567402614|FG000|Overall Study|Serious Adverse Events|12|||
157180594|NCT00732641|567402615|FG001|Overall Study|Serious Adverse Events|3|||
157180595|NCT00732641|567402614|FG000|Overall Study|Physician Decision|6|||
157180596|NCT00732641|567402615|FG001|Overall Study|Physician Decision|0|||
157180597|NCT00732641|567402614|FG000|Overall Study|Withdrawal by Subject|4|||
157180598|NCT00732641|567402615|FG001|Overall Study|Withdrawal by Subject|2|||
157180599|NCT00732641|567402614|FG000|Overall Study|Unable to Complete|1|||
157180600|NCT00732641|567402615|FG001|Overall Study|Unable to Complete|1|||
157180601|NCT00732641|567402614|FG000|Overall Study|Other|18|||
157180602|NCT00732641|567402615|FG001|Overall Study|Other|5|||
157180603|NCT00732238|567402616|FG000|Overall Study|Bacteremia|4|||
157180604|NCT00732238|567402617|FG001|Overall Study|Bacteremia|1|||
157180605|NCT00732238|567402616|FG000|Overall Study|Asymptomatic bacteriuria|1|||
157180606|NCT00732238|567402617|FG001|Overall Study|Asymptomatic bacteriuria|0|||
157180607|NCT02280096|567402618|FG000|Overall Study|Pregnancy|1|||
157180608|NCT02280096|567402619|FG001|Overall Study|Pregnancy|0|||
157180609|NCT02280096|567402618|FG000|Overall Study|Functional neurological disorder|1|||
157180610|NCT02280096|567402619|FG001|Overall Study|Functional neurological disorder|0|||
157180611|NCT02280096|567402618|FG000|Overall Study|Lack of attachment|0|||
157180612|NCT02280096|567402619|FG001|Overall Study|Lack of attachment|1|||
157180613|NCT00246376|567402622|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
157180614|NCT00246376|567402623|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
157180615|NCT00246376|567402624|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
157180616|NCT00246376|567402625|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
157180617|NCT00246376|567402626|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
157180618|NCT00246376|567402622|FG000|Overall Study|Adverse Event|2|||
157180619|NCT00246376|567402623|FG001|Overall Study|Adverse Event|3|||
157180620|NCT00246376|567402624|FG002|Overall Study|Adverse Event|1|||
157180621|NCT00246376|567402625|FG003|Overall Study|Adverse Event|3|||
157180622|NCT00246376|567402626|FG004|Overall Study|Adverse Event|1|||
157229853|NCT01345019|567588162|FG001|Open Label Treatment Phase|Disease Progression|18|||
157180623|NCT00246376|567402622|FG000|Overall Study|Lost to Follow-up|2|||
157180624|NCT00246376|567402623|FG001|Overall Study|Lost to Follow-up|11|||
157180625|NCT00246376|567402624|FG002|Overall Study|Lost to Follow-up|11|||
157180626|NCT00246376|567402625|FG003|Overall Study|Lost to Follow-up|16|||
157058511|NCT00899379|566966770|FG002|Overall Study|Lost to Follow-up|0|||
157058512|NCT00899379|566966771|FG003|Overall Study|Lost to Follow-up|2|||
157058513|NCT00899379|566966772|FG004|Overall Study|Lost to Follow-up|5|||
157058514|NCT00899379|566966768|FG000|Overall Study|Withdrawal by Subject|4|||
157058515|NCT00899379|566966769|FG001|Overall Study|Withdrawal by Subject|7|||
157058516|NCT00899379|566966770|FG002|Overall Study|Withdrawal by Subject|4|||
157058517|NCT00899379|566966771|FG003|Overall Study|Withdrawal by Subject|7|||
157058518|NCT00899379|566966772|FG004|Overall Study|Withdrawal by Subject|2|||
157058519|NCT00899379|566966768|FG000|Overall Study|Pregnancy|1|||
157058520|NCT00899379|566966769|FG001|Overall Study|Pregnancy|0|||
157058521|NCT00899379|566966770|FG002|Overall Study|Pregnancy|0|||
157058522|NCT00899379|566966771|FG003|Overall Study|Pregnancy|0|||
157058523|NCT00899379|566966772|FG004|Overall Study|Pregnancy|0|||
157058524|NCT00899379|566966768|FG000|Overall Study|Patient Uncooperative|0|||
157058525|NCT00899379|566966769|FG001|Overall Study|Patient Uncooperative|0|||
157058526|NCT00899379|566966770|FG002|Overall Study|Patient Uncooperative|0|||
157058527|NCT00899379|566966771|FG003|Overall Study|Patient Uncooperative|1|||
157058528|NCT00899379|566966772|FG004|Overall Study|Patient Uncooperative|0|||
157058529|NCT00899379|566966768|FG000|Overall Study|Abnormal Prestudy Labs|0|||
157058530|NCT00899379|566966769|FG001|Overall Study|Abnormal Prestudy Labs|0|||
157058531|NCT00899379|566966770|FG002|Overall Study|Abnormal Prestudy Labs|0|||
157058532|NCT00899379|566966771|FG003|Overall Study|Abnormal Prestudy Labs|0|||
157058533|NCT00899379|566966772|FG004|Overall Study|Abnormal Prestudy Labs|2|||
157058534|NCT00899379|566966768|FG000|Overall Study|Abnormal Baseline ECG|0|||
157058535|NCT00899379|566966769|FG001|Overall Study|Abnormal Baseline ECG|0|||
157058536|NCT00899379|566966770|FG002|Overall Study|Abnormal Baseline ECG|1|||
157058537|NCT00899379|566966771|FG003|Overall Study|Abnormal Baseline ECG|1|||
157058538|NCT00899379|566966772|FG004|Overall Study|Abnormal Baseline ECG|0|||
157058539|NCT00899379|566966768|FG000|Overall Study|No Attack Pretreatment|3|||
157058540|NCT00899379|566966769|FG001|Overall Study|No Attack Pretreatment|5|||
157058541|NCT00899379|566966770|FG002|Overall Study|No Attack Pretreatment|5|||
157058542|NCT00899379|566966771|FG003|Overall Study|No Attack Pretreatment|6|||
157058543|NCT00899379|566966772|FG004|Overall Study|No Attack Pretreatment|4|||
157058544|NCT00899379|566966768|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
157058545|NCT00899379|566966769|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058546|NCT00899379|566966770|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058547|NCT00899379|566966771|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058548|NCT00899379|566966772|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
157058549|NCT00899379|566966768|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
157058550|NCT00899379|566966769|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
157058551|NCT00899379|566966770|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
157058552|NCT00899379|566966771|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
157058553|NCT00899379|566966772|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
157058554|NCT00809783|566966775|FG000|Overall Study|Death|1|||
157058555|NCT00809783|566966776|FG001|Overall Study|Death|0|||
157058556|NCT00809783|566966777|FG002|Overall Study|Death|0|||
157058557|NCT00809783|566966775|FG000|Overall Study|Adverse Event|34|||
157058558|NCT00809783|566966776|FG001|Overall Study|Adverse Event|52|||
157058559|NCT00809783|566966777|FG002|Overall Study|Adverse Event|71|||
157058560|NCT00809783|566966775|FG000|Overall Study|Lack of Efficacy|39|||
157058561|NCT00809783|566966776|FG001|Overall Study|Lack of Efficacy|52|||
157058562|NCT00809783|566966777|FG002|Overall Study|Lack of Efficacy|63|||
157058563|NCT00809783|566966775|FG000|Overall Study|Lost to Follow-up|0|||
157058564|NCT00809783|566966776|FG001|Overall Study|Lost to Follow-up|3|||
157058565|NCT00809783|566966777|FG002|Overall Study|Lost to Follow-up|4|||
157058566|NCT00809783|566966775|FG000|Overall Study|Withdrawal by Subject|47|||
157058567|NCT00809783|566966776|FG001|Overall Study|Withdrawal by Subject|72|||
157058568|NCT00809783|566966777|FG002|Overall Study|Withdrawal by Subject|64|||
157058569|NCT00809783|566966775|FG000|Overall Study|Protocol Violation|2|||
157058570|NCT00809783|566966776|FG001|Overall Study|Protocol Violation|6|||
157058571|NCT00809783|566966777|FG002|Overall Study|Protocol Violation|5|||
157058572|NCT00809783|566966775|FG000|Overall Study|Randomized, but not treated|3|||
157058573|NCT00809783|566966776|FG001|Overall Study|Randomized, but not treated|0|||
157058574|NCT00809783|566966777|FG002|Overall Study|Randomized, but not treated|2|||
157058575|NCT00809783|566966775|FG000|Overall Study|Study Terminated by Sponsor|378|||
157058576|NCT00809783|566966776|FG001|Overall Study|Study Terminated by Sponsor|626|||
157058577|NCT00809783|566966777|FG002|Overall Study|Study Terminated by Sponsor|565|||
157058578|NCT00809783|566966775|FG000|Overall Study|Other|21|||
157058579|NCT00809783|566966776|FG001|Overall Study|Other|21|||
157058580|NCT00809783|566966777|FG002|Overall Study|Other|16|||
157058581|NCT00126555|566966778|FG000|Overall Study|Withdrawal by Subject|1|||
157058582|NCT00126555|566966778|FG000|Overall Study|Adverse Event|2|||
157058583|NCT00126555|566966778|FG000|Overall Study|Progressive Disease|3|||
157058584|NCT01780545|566966785|FG000|Overall Study|Withdrawal by Subject|3|||
157058585|NCT01780545|566966786|FG001|Overall Study|Withdrawal by Subject|1|||
157058586|NCT01780545|566966785|FG000|Overall Study|Lost to Follow-up|1|||
157058587|NCT01780545|566966786|FG001|Overall Study|Lost to Follow-up|1|||
157058588|NCT03441789|566966787|FG000|Overall Study|Withdrawal by Subject|1|||
157058589|NCT03441789|566966788|FG001|Overall Study|Withdrawal by Subject|1|||
157058590|NCT03441789|566966787|FG000|Overall Study|Adverse Event|0|||
157180627|NCT00246376|567402626|FG004|Overall Study|Lost to Follow-up|13|||
157180628|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
157180629|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
157180630|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
157180631|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
157180632|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
157180633|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
157180634|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
157180635|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
157180636|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
157180637|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
157180638|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
157180639|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
157180640|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
157180641|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
157180642|NCT03434041|567402631|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
157180643|NCT03434041|567402632|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
157180644|NCT03434041|567402631|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
157180645|NCT03434041|567402632|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
157180646|NCT03434041|567402631|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
157180647|NCT03434041|567402632|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
157180648|NCT03434041|567402631|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
157180649|NCT03434041|567402632|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
157180650|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
157180651|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
157180652|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
157180653|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
157180654|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
157180655|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
157180656|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
157180657|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
157180658|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
157058591|NCT03441789|566966788|FG001|Overall Study|Adverse Event|1|||
157058592|NCT03441789|566966787|FG000|Overall Study|Protocol Violation|0|||
157180659|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
157180660|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
157180661|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
157180662|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
157180663|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
157180664|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
157180665|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
157180666|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
157180667|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
157180668|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
157180669|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
157180670|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
157180671|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
157180672|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
157180673|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
157180674|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
157180675|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
157180676|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
157180677|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
157180678|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
157180679|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
157058593|NCT03441789|566966788|FG001|Overall Study|Protocol Violation|1|||
157058594|NCT03441789|566966787|FG000|Overall Study|Lost to Follow-up|0|||
157180680|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
157180681|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
157180682|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
157229854|NCT01345019|567588161|FG000|Open Label Treatment Phase|Noncompliance|5|||
157229855|NCT01345019|567588162|FG001|Open Label Treatment Phase|Noncompliance|4|||
157058595|NCT03441789|566966788|FG001|Overall Study|Lost to Follow-up|1|||
157058596|NCT00744796|566966793|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
157180683|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
157180684|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
157180685|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
157180686|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
157180687|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
157180688|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
157180689|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
157180690|NCT03605836|567402633|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
157180691|NCT03605836|567402634|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
157180692|NCT03605836|567402635|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
157180693|NCT03605836|567402636|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
157180694|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
157180695|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
157180696|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
157180697|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
157180698|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
157180699|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
157180700|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
157180701|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
157180702|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
157180703|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
157180704|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
157180705|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
157180706|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
157180707|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
157180708|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
157180709|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
157180710|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
157180711|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
157180712|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
157180713|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
157180714|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
157180715|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
157180716|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
157180717|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
157180718|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
157180719|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
157180720|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
157180721|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
157180722|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
157180723|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
157180724|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
157180725|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
157180726|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
157180727|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
157180728|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
157180729|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
157180730|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
157180731|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
157180732|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
157180733|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
157180734|NCT03605836|567402633|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
157180735|NCT03605836|567402634|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
157180736|NCT03605836|567402635|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
157180737|NCT03605836|567402636|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
157180738|NCT00329784|567402638|FG000|Overall Study|Lost to Follow-up|0|||
157180739|NCT00329784|567402639|FG001|Overall Study|Lost to Follow-up|1|||
157180740|NCT00329784|567402640|FG002|Overall Study|Lost to Follow-up|0|||
157180741|NCT00329784|567402641|FG003|Overall Study|Lost to Follow-up|0|||
157180742|NCT00329784|567402638|FG000|Overall Study|Withdrawal by Subject|4|||
157180743|NCT00329784|567402639|FG001|Overall Study|Withdrawal by Subject|2|||
157180744|NCT00329784|567402640|FG002|Overall Study|Withdrawal by Subject|0|||
157229856|NCT01345019|567588161|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
157180745|NCT00329784|567402641|FG003|Overall Study|Withdrawal by Subject|0|||
157180746|NCT00329784|567402638|FG000|Overall Study|Other|1|||
157180747|NCT00329784|567402639|FG001|Overall Study|Other|2|||
157180748|NCT00329784|567402640|FG002|Overall Study|Other|0|||
157180749|NCT00329784|567402641|FG003|Overall Study|Other|0|||
157180750|NCT03236506|567402644|FG000|Overall Study|Death|1|||
157180751|NCT03236506|567402645|FG001|Overall Study|Death|1|||
157180752|NCT03236506|567402646|FG002|Overall Study|Death|1|||
157180753|NCT03236506|567402644|FG000|Overall Study|Withdrawal by Subject|3|||
157180754|NCT03236506|567402645|FG001|Overall Study|Withdrawal by Subject|3|||
157180755|NCT03236506|567402646|FG002|Overall Study|Withdrawal by Subject|4|||
157180756|NCT03236506|567402644|FG000|Overall Study|Did not initiate treatment|2|||
157180757|NCT03236506|567402645|FG001|Overall Study|Did not initiate treatment|1|||
157180758|NCT03236506|567402646|FG002|Overall Study|Did not initiate treatment|2|||
157180759|NCT01594411|567402655|FG000|Overall Study|Lost to Follow-up|2|||
157180760|NCT01451398|567402656|FG000|Overall Study|Adverse Event|7|||
157180761|NCT01451398|567402657|FG001|Overall Study|Adverse Event|9|||
157180762|NCT01451398|567402656|FG000|Overall Study|Protocol Violation|1|||
157180763|NCT01451398|567402657|FG001|Overall Study|Protocol Violation|2|||
157180764|NCT01451398|567402656|FG000|Overall Study|Physician Decision|1|||
157180765|NCT01451398|567402657|FG001|Overall Study|Physician Decision|1|||
157180766|NCT01451398|567402656|FG000|Overall Study|Withdrawal by Subject|10|||
157180767|NCT01451398|567402657|FG001|Overall Study|Withdrawal by Subject|14|||
157180768|NCT01451398|567402656|FG000|Overall Study|Lost to Follow-up|6|||
157180769|NCT01451398|567402657|FG001|Overall Study|Lost to Follow-up|4|||
157180770|NCT01451398|567402656|FG000|Overall Study|Non-compliance with study drug|1|||
157180771|NCT01451398|567402657|FG001|Overall Study|Non-compliance with study drug|3|||
157180772|NCT01451398|567402656|FG000|Overall Study|Non-compliance with protocol|1|||
157180773|NCT01451398|567402657|FG001|Overall Study|Non-compliance with protocol|1|||
157180774|NCT01451398|567402656|FG000|Overall Study|Moved out of country|0|||
157180775|NCT01451398|567402657|FG001|Overall Study|Moved out of country|1|||
157180776|NCT01451398|567402656|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
157180777|NCT01451398|567402657|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
157180778|NCT01451398|567402656|FG000|Overall Study|Lack of Efficacy|0|||
157180779|NCT01451398|567402657|FG001|Overall Study|Lack of Efficacy|1|||
157180780|NCT00422669|567402658|FG000|Overall Study|The study was terminated early.|98|||
157180781|NCT00422669|567402659|FG001|Overall Study|The study was terminated early.|100|||
157180782|NCT00422669|567402660|FG002|Overall Study|The study was terminated early.|7|||
157180783|NCT02427100|567402662|FG000|Overall Study|Lost to Follow-up|0|||
157180784|NCT02427100|567402663|FG001|Overall Study|Lost to Follow-up|2|||
157180785|NCT01610206|567402666|FG000|Overall Study|Adverse Event|10|||
157180786|NCT01610206|567402667|FG001|Overall Study|Adverse Event|30|||
157180787|NCT00924729|567402668|FG000|Overall Study|insufficient volume for analysis|1|||
157180788|NCT00924729|567402669|FG001|Overall Study|insufficient volume for analysis|0|||
157180789|NCT00924729|567402668|FG000|Overall Study|Protocol Violation|1|||
157180790|NCT00924729|567402669|FG001|Overall Study|Protocol Violation|0|||
157180791|NCT01929707|567402670|FG000|Intervention Period 1|Lost to Follow-up|0|||
157180792|NCT01929707|567402671|FG001|Intervention Period 1|Lost to Follow-up|0|||
157180793|NCT01929707|567402672|FG002|Intervention Period 1|Lost to Follow-up|0|||
157180794|NCT01929707|567402673|FG003|Intervention Period 1|Lost to Follow-up|1|||
157180795|NCT01929707|567402674|FG004|Intervention Period 1|Lost to Follow-up|0|||
157180796|NCT01929707|567402675|FG005|Intervention Period 1|Lost to Follow-up|0|||
157180797|NCT01929707|567402676|FG006|Intervention Period 1|Lost to Follow-up|0|||
157180798|NCT01929707|567402677|FG007|Intervention Period 1|Lost to Follow-up|0|||
157180799|NCT01929707|567402670|FG000|Intervention Period 1|Withdrawal by Subject|0|||
157180800|NCT01929707|567402671|FG001|Intervention Period 1|Withdrawal by Subject|0|||
157180801|NCT01929707|567402672|FG002|Intervention Period 1|Withdrawal by Subject|0|||
157180802|NCT01929707|567402673|FG003|Intervention Period 1|Withdrawal by Subject|2|||
157180803|NCT01929707|567402674|FG004|Intervention Period 1|Withdrawal by Subject|0|||
157180804|NCT01929707|567402675|FG005|Intervention Period 1|Withdrawal by Subject|0|||
157180805|NCT01929707|567402676|FG006|Intervention Period 1|Withdrawal by Subject|0|||
157180806|NCT01929707|567402677|FG007|Intervention Period 1|Withdrawal by Subject|0|||
157180807|NCT01929707|567402670|FG000|Intervention Period 2|Withdrawal by Subject|0|||
157180808|NCT01929707|567402671|FG001|Intervention Period 2|Withdrawal by Subject|0|||
157180809|NCT01929707|567402672|FG002|Intervention Period 2|Withdrawal by Subject|0|||
157180810|NCT01929707|567402673|FG003|Intervention Period 2|Withdrawal by Subject|0|||
157180811|NCT01929707|567402674|FG004|Intervention Period 2|Withdrawal by Subject|0|||
157180812|NCT01929707|567402675|FG005|Intervention Period 2|Withdrawal by Subject|2|||
157180813|NCT01929707|567402676|FG006|Intervention Period 2|Withdrawal by Subject|0|||
157180814|NCT01929707|567402677|FG007|Intervention Period 2|Withdrawal by Subject|0|||
157180815|NCT00023712|567402678|FG000|Overall Study|Not platinum sensitive|1|||
157180816|NCT00023712|567402679|FG001|Overall Study|Not platinum sensitive|0|||
157180817|NCT00023712|567402678|FG000|Overall Study|Never treated|1|||
157180818|NCT00023712|567402679|FG001|Overall Study|Never treated|1|||
157180819|NCT00437203|567402680|FG000|Overall Study|Death|0|||
157180820|NCT00437203|567402681|FG001|Overall Study|Death|0|||
157180821|NCT00437203|567402682|FG002|Overall Study|Death|1|||
157180822|NCT00437203|567402683|FG003|Overall Study|Death|0|||
157180823|NCT00437203|567402684|FG004|Overall Study|Death|0|||
157180824|NCT00437203|567402685|FG005|Overall Study|Death|0|||
157180825|NCT00437203|567402686|FG006|Overall Study|Death|0|||
157180826|NCT00437203|567402687|FG007|Overall Study|Death|1|||
157180827|NCT00437203|567402688|FG008|Overall Study|Death|0|||
157180828|NCT00437203|567402689|FG009|Overall Study|Death|1|||
157180829|NCT00437203|567402680|FG000|Overall Study|Adverse Event|1|||
157180830|NCT00437203|567402681|FG001|Overall Study|Adverse Event|1|||
157180831|NCT00437203|567402682|FG002|Overall Study|Adverse Event|0|||
157180832|NCT00437203|567402683|FG003|Overall Study|Adverse Event|0|||
157180833|NCT00437203|567402684|FG004|Overall Study|Adverse Event|0|||
157180834|NCT00437203|567402685|FG005|Overall Study|Adverse Event|0|||
157180835|NCT00437203|567402686|FG006|Overall Study|Adverse Event|0|||
157180836|NCT00437203|567402687|FG007|Overall Study|Adverse Event|1|||
157180837|NCT00437203|567402688|FG008|Overall Study|Adverse Event|0|||
157180838|NCT00437203|567402689|FG009|Overall Study|Adverse Event|1|||
157180839|NCT00437203|567402680|FG000|Overall Study|Study terminated by sponsor|0|||
157180840|NCT00437203|567402681|FG001|Overall Study|Study terminated by sponsor|0|||
157180841|NCT00437203|567402682|FG002|Overall Study|Study terminated by sponsor|0|||
157180842|NCT00437203|567402683|FG003|Overall Study|Study terminated by sponsor|0|||
157180843|NCT00437203|567402684|FG004|Overall Study|Study terminated by sponsor|0|||
157180844|NCT00437203|567402685|FG005|Overall Study|Study terminated by sponsor|0|||
157180845|NCT00437203|567402686|FG006|Overall Study|Study terminated by sponsor|0|||
157180846|NCT00437203|567402687|FG007|Overall Study|Study terminated by sponsor|0|||
157180847|NCT00437203|567402688|FG008|Overall Study|Study terminated by sponsor|1|||
157180848|NCT00437203|567402689|FG009|Overall Study|Study terminated by sponsor|0|||
157180849|NCT00437203|567402680|FG000|Overall Study|Objective progression or relapse|5|||
157180850|NCT00437203|567402681|FG001|Overall Study|Objective progression or relapse|6|||
157180851|NCT00437203|567402682|FG002|Overall Study|Objective progression or relapse|2|||
157180852|NCT00437203|567402683|FG003|Overall Study|Objective progression or relapse|3|||
157180853|NCT00437203|567402684|FG004|Overall Study|Objective progression or relapse|3|||
157180854|NCT00437203|567402685|FG005|Overall Study|Objective progression or relapse|3|||
157180855|NCT00437203|567402686|FG006|Overall Study|Objective progression or relapse|6|||
157180856|NCT00437203|567402687|FG007|Overall Study|Objective progression or relapse|1|||
157180857|NCT00437203|567402688|FG008|Overall Study|Objective progression or relapse|2|||
157180858|NCT00437203|567402689|FG009|Overall Study|Objective progression or relapse|2|||
157180859|NCT00437203|567402680|FG000|Overall Study|Other|0|||
157180860|NCT00437203|567402681|FG001|Overall Study|Other|1|||
157180861|NCT00437203|567402682|FG002|Overall Study|Other|0|||
157180862|NCT00437203|567402683|FG003|Overall Study|Other|0|||
157180863|NCT00437203|567402684|FG004|Overall Study|Other|0|||
157180864|NCT00437203|567402685|FG005|Overall Study|Other|0|||
157180865|NCT00437203|567402686|FG006|Overall Study|Other|1|||
157180866|NCT00437203|567402687|FG007|Overall Study|Other|0|||
157180867|NCT00437203|567402688|FG008|Overall Study|Other|0|||
157180868|NCT00437203|567402689|FG009|Overall Study|Other|0|||
157180869|NCT01915095|567402696|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
157180870|NCT01915095|567402697|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
157180871|NCT01915095|567402698|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
157180872|NCT01915095|567402699|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
157180873|NCT01915095|567402700|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
157180874|NCT02067533|567402701|FG000|Overall Study|Lost to Follow-up|4|||
157180875|NCT02067533|567402702|FG001|Overall Study|Lost to Follow-up|2|||
157180876|NCT00565812|567402703|FG000|Overall Study|Death|2|||
157180877|NCT00565812|567402704|FG001|Overall Study|Death|1|||
157180878|NCT00565812|567402705|FG002|Overall Study|Death|3|||
157180879|NCT00565812|567402703|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
157180880|NCT00565812|567402704|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
157180881|NCT00565812|567402705|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
157180882|NCT00565812|567402703|FG000|Overall Study|Lost to Follow-up|10|||
157180883|NCT00565812|567402704|FG001|Overall Study|Lost to Follow-up|8|||
157180884|NCT00565812|567402705|FG002|Overall Study|Lost to Follow-up|8|||
157180885|NCT00565812|567402703|FG000|Overall Study|Withdrawal by Subject|58|||
157180886|NCT00565812|567402704|FG001|Overall Study|Withdrawal by Subject|47|||
157180887|NCT00565812|567402705|FG002|Overall Study|Withdrawal by Subject|48|||
157180888|NCT00565812|567402703|FG000|Overall Study|Work Schedule|5|||
157180889|NCT00565812|567402704|FG001|Overall Study|Work Schedule|3|||
157180890|NCT00565812|567402705|FG002|Overall Study|Work Schedule|1|||
157180891|NCT00565812|567402703|FG000|Overall Study|Protocol Violation|2|||
157180892|NCT00565812|567402704|FG001|Overall Study|Protocol Violation|6|||
157180893|NCT00565812|567402705|FG002|Overall Study|Protocol Violation|4|||
157180894|NCT00565812|567402703|FG000|Overall Study|Adverse Event|41|||
157180895|NCT00565812|567402704|FG001|Overall Study|Adverse Event|54|||
157180896|NCT00565812|567402705|FG002|Overall Study|Adverse Event|40|||
157180897|NCT00565812|567402703|FG000|Overall Study|Jury Duty|1|||
157180898|NCT00565812|567402704|FG001|Overall Study|Jury Duty|0|||
157180899|NCT00565812|567402705|FG002|Overall Study|Jury Duty|0|||
157180900|NCT00565812|567402703|FG000|Overall Study|Relocated Out of Area|5|||
157180901|NCT00565812|567402704|FG001|Overall Study|Relocated Out of Area|8|||
157180902|NCT00565812|567402705|FG002|Overall Study|Relocated Out of Area|9|||
157180903|NCT00565812|567402703|FG000|Overall Study|Sponsor Decision|1|||
157180904|NCT00565812|567402704|FG001|Overall Study|Sponsor Decision|5|||
157180905|NCT00565812|567402705|FG002|Overall Study|Sponsor Decision|1|||
157180906|NCT00565812|567402703|FG000|Overall Study|Domestic Reasons|7|||
157180907|NCT00565812|567402704|FG001|Overall Study|Domestic Reasons|1|||
157180908|NCT00565812|567402705|FG002|Overall Study|Domestic Reasons|3|||
157180909|NCT00565812|567402703|FG000|Overall Study|Research Site Closure|6|||
157180910|NCT00565812|567402704|FG001|Overall Study|Research Site Closure|1|||
157180911|NCT00565812|567402705|FG002|Overall Study|Research Site Closure|8|||
157180912|NCT00565812|567402703|FG000|Overall Study|Surgical Intervention|0|||
157180913|NCT00565812|567402704|FG001|Overall Study|Surgical Intervention|1|||
157180914|NCT00565812|567402705|FG002|Overall Study|Surgical Intervention|2|||
157180915|NCT00565812|567402703|FG000|Overall Study|Low Compliance|1|||
157180916|NCT00565812|567402704|FG001|Overall Study|Low Compliance|0|||
157180917|NCT00565812|567402705|FG002|Overall Study|Low Compliance|1|||
157180918|NCT00565812|567402703|FG000|Overall Study|Follow-up Visit Not Completed|2|||
157180919|NCT00565812|567402704|FG001|Overall Study|Follow-up Visit Not Completed|0|||
157180920|NCT00565812|567402705|FG002|Overall Study|Follow-up Visit Not Completed|1|||
157180921|NCT00565812|567402703|FG000|Overall Study|Physician Decision|2|||
157180922|NCT00565812|567402704|FG001|Overall Study|Physician Decision|0|||
157180923|NCT00565812|567402705|FG002|Overall Study|Physician Decision|0|||
157180924|NCT00383708|567402706|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
157180925|NCT00383708|567402706|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
157180926|NCT00383708|567402706|FG000|Run-in Period|Protocol Violation|4|||
157180927|NCT00383708|567402706|FG000|Run-in Period|Adverse Event|2|||
157180928|NCT00383708|567402706|FG000|Run-in Period|Claustrophobia|1|||
157180929|NCT00383708|567402706|FG000|Co-administration Period|Adverse Event|5|||
157180930|NCT01997281|567402710|FG000|Overall Study|Withdrawal by Subject|1|||
157180931|NCT01997281|567402711|FG001|Overall Study|Withdrawal by Subject|0|||
157180932|NCT02650895|567402712|FG000|Overall Study|Withdrawal by Subject|0|||
157180933|NCT02650895|567402713|FG001|Overall Study|Withdrawal by Subject|1|||
157180934|NCT02650895|567402714|FG002|Overall Study|Withdrawal by Subject|0|||
157180935|NCT02650895|567402715|FG003|Overall Study|Withdrawal by Subject|0|||
157180936|NCT02650895|567402716|FG004|Overall Study|Withdrawal by Subject|0|||
157180937|NCT02650895|567402717|FG005|Overall Study|Withdrawal by Subject|0|||
157180938|NCT03695471|567404481|FG000|Overall Study|Cancellation|1|||
157180939|NCT02859558|567404482|FG000|Step 1|Not Eligible|0|||
157180940|NCT02859558|567404483|FG001|Step 1|Not Eligible|0|||
157180941|NCT02859558|567404484|FG002|Step 1|Not Eligible|0|||
157180942|NCT02859558|567404485|FG003|Step 1|Not Eligible|0|||
157180943|NCT02859558|567404486|FG004|Step 1|Not Eligible|3|||
157180944|NCT02859558|567404482|FG000|Step 1|Lost to Follow-up|1|||
157180945|NCT02859558|567404483|FG001|Step 1|Lost to Follow-up|3|||
157180946|NCT02859558|567404484|FG002|Step 1|Lost to Follow-up|3|||
157180947|NCT02859558|567404485|FG003|Step 1|Lost to Follow-up|0|||
157180948|NCT02859558|567404486|FG004|Step 1|Lost to Follow-up|0|||
157180949|NCT02859558|567404482|FG000|Step 1|Did Not Return to Clinic|2|||
157180950|NCT02859558|567404483|FG001|Step 1|Did Not Return to Clinic|3|||
157180951|NCT02859558|567404484|FG002|Step 1|Did Not Return to Clinic|4|||
157180952|NCT02859558|567404485|FG003|Step 1|Did Not Return to Clinic|0|||
157180953|NCT02859558|567404486|FG004|Step 1|Did Not Return to Clinic|0|||
157180954|NCT02859558|567404482|FG000|Step 1|Moved|0|||
157180955|NCT02859558|567404483|FG001|Step 1|Moved|1|||
157180956|NCT02859558|567404484|FG002|Step 1|Moved|1|||
157180957|NCT02859558|567404485|FG003|Step 1|Moved|0|||
157180958|NCT02859558|567404486|FG004|Step 1|Moved|0|||
157180959|NCT02859558|567404482|FG000|Step 1|Withdrawal By Participant|1|||
157180960|NCT02859558|567404483|FG001|Step 1|Withdrawal By Participant|2|||
157180961|NCT02859558|567404484|FG002|Step 1|Withdrawal By Participant|1|||
157180962|NCT02859558|567404485|FG003|Step 1|Withdrawal By Participant|0|||
157180963|NCT02859558|567404486|FG004|Step 1|Withdrawal By Participant|0|||
157180964|NCT02859558|567404482|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
157180965|NCT02859558|567404483|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
157180966|NCT02859558|567404484|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
157180967|NCT02859558|567404485|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
157180968|NCT02859558|567404486|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
157180969|NCT02859558|567404482|FG000|Step 1|Incarceration|0|||
157180970|NCT02859558|567404483|FG001|Step 1|Incarceration|1|||
157180971|NCT02859558|567404484|FG002|Step 1|Incarceration|0|||
157180972|NCT02859558|567404485|FG003|Step 1|Incarceration|0|||
157180973|NCT02859558|567404486|FG004|Step 1|Incarceration|0|||
157180974|NCT02859558|567404482|FG000|Step 1|Non-Adherence to Study Drug|2|||
157180975|NCT02859558|567404483|FG001|Step 1|Non-Adherence to Study Drug|0|||
157180976|NCT02859558|567404484|FG002|Step 1|Non-Adherence to Study Drug|1|||
157058597|NCT05372913|566966794|FG000|Overall Study|Withdrawal by Subject|0|||
157058598|NCT05372913|566966795|FG001|Overall Study|Withdrawal by Subject|2|||
157058599|NCT05372913|566966794|FG000|Overall Study|Protocol Violation|2|||
157058600|NCT05372913|566966795|FG001|Overall Study|Protocol Violation|2|||
157058601|NCT05372913|566966794|FG000|Overall Study|Adverse Event|0|||
157058602|NCT05372913|566966795|FG001|Overall Study|Adverse Event|1|||
157058603|NCT05135156|566966799|FG000|Overall Study|Lost to Follow-up|0|||
157058604|NCT05135156|566966800|FG001|Overall Study|Lost to Follow-up|0|||
157058605|NCT05135156|566966801|FG002|Overall Study|Lost to Follow-up|2|||
157058606|NCT02253147|566966802|FG000|Overall Study|Protocol Violation|30|||
157058607|NCT02253147|566966802|FG000|Overall Study|Did not consent to study extension|9|||
157058608|NCT02253147|566966802|FG000|Overall Study|Conditional re-treatment at W52|5|||
157058609|NCT02253147|566966802|FG000|Overall Study|Lost to Follow-up|2|||
157058610|NCT02253147|566966802|FG000|Overall Study|Withdrawal by Subject|1|||
157058611|NCT02986659|566966803|FG000|First Intervention Period|Adverse Event|3|||
157058612|NCT02986659|566966804|FG001|First Intervention Period|Adverse Event|1|||
157058613|NCT02986659|566966803|FG000|First Intervention Period|Lost to Follow-up|1|||
157058614|NCT02986659|566966804|FG001|First Intervention Period|Lost to Follow-up|0|||
157058615|NCT02986659|566966803|FG000|First Intervention Period|Withdrawal by Subject|0|||
157058616|NCT02986659|566966804|FG001|First Intervention Period|Withdrawal by Subject|1|||
157058617|NCT02986659|566966803|FG000|Second Intervention Period|Adverse Event|0|||
157058618|NCT02986659|566966804|FG001|Second Intervention Period|Adverse Event|6|||
157058619|NCT02254681|566966813|FG000|Overall Study|Lack of Efficacy|6|||
157058620|NCT00396097|566966814|FG000|Overall Study|Withdrawal by Subject|17|||
157058621|NCT00396097|566966815|FG001|Overall Study|Withdrawal by Subject|17|||
157058622|NCT00396097|566966814|FG000|Overall Study|Lost to Follow-up|4|||
157058623|NCT00396097|566966815|FG001|Overall Study|Lost to Follow-up|9|||
157058624|NCT00396097|566966814|FG000|Overall Study|Other|3|||
157058625|NCT00396097|566966815|FG001|Overall Study|Other|5|||
157058626|NCT00396097|566966814|FG000|Overall Study|Protocol Violation|0|||
157058627|NCT00396097|566966815|FG001|Overall Study|Protocol Violation|6|||
157058628|NCT00396097|566966814|FG000|Overall Study|Adverse Event|1|||
157058629|NCT00396097|566966815|FG001|Overall Study|Adverse Event|5|||
157058630|NCT00396097|566966814|FG000|Overall Study|Insufficient Clinical Response|1|||
157058631|NCT00396097|566966815|FG001|Overall Study|Insufficient Clinical Response|4|||
157058632|NCT03461211|566966816|FG000|Overall Study|Adverse Event|1|||
157058633|NCT03461211|566966817|FG001|Overall Study|Adverse Event|1|||
157058634|NCT03461211|566966816|FG000|Overall Study|Lack of Efficacy|0|||
157058635|NCT03461211|566966817|FG001|Overall Study|Lack of Efficacy|1|||
157058636|NCT02005029|566966819|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
157058637|NCT02005029|566966820|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
157058638|NCT02316847|566966821|FG000|Overall Study|Adverse Event|0|||
157058639|NCT02316847|566966822|FG001|Overall Study|Adverse Event|3|||
157058640|NCT02316847|566966821|FG000|Overall Study|Lost to Follow-up|0|||
157058641|NCT02316847|566966822|FG001|Overall Study|Lost to Follow-up|2|||
157058642|NCT02316847|566966821|FG000|Overall Study|Physician Decision|0|||
157058643|NCT02316847|566966822|FG001|Overall Study|Physician Decision|1|||
157058644|NCT02316847|566966821|FG000|Overall Study|Pregnancy|0|||
157058645|NCT02316847|566966822|FG001|Overall Study|Pregnancy|1|||
157058646|NCT02316847|566966821|FG000|Overall Study|Withdrawal by Subject|2|||
157058647|NCT02316847|566966822|FG001|Overall Study|Withdrawal by Subject|9|||
157058648|NCT02316847|566966821|FG000|Overall Study|Noncompliance with study drug|0|||
157180977|NCT02859558|567404485|FG003|Step 1|Non-Adherence to Study Drug|0|||
157180978|NCT02859558|567404486|FG004|Step 1|Non-Adherence to Study Drug|0|||
157180979|NCT02859558|567404482|FG000|Step 1|Non-Adherence to Study Requirements|3|||
157180980|NCT02859558|567404483|FG001|Step 1|Non-Adherence to Study Requirements|1|||
157180981|NCT02859558|567404484|FG002|Step 1|Non-Adherence to Study Requirements|0|||
157180982|NCT02859558|567404485|FG003|Step 1|Non-Adherence to Study Requirements|0|||
157180983|NCT02859558|567404486|FG004|Step 1|Non-Adherence to Study Requirements|0|||
157180984|NCT02859558|567404482|FG000|Step 1|Virologic Failure|2|||
157180985|NCT02859558|567404483|FG001|Step 1|Virologic Failure|1|||
157180986|NCT02859558|567404484|FG002|Step 1|Virologic Failure|1|||
157180987|NCT02859558|567404485|FG003|Step 1|Virologic Failure|0|||
157180988|NCT02859558|567404486|FG004|Step 1|Virologic Failure|0|||
157180989|NCT02859558|567404482|FG000|Step 2|Lost to Follow-up|3|||
157180990|NCT02859558|567404483|FG001|Step 2|Lost to Follow-up|3|||
157180991|NCT02859558|567404484|FG002|Step 2|Lost to Follow-up|1|||
157058649|NCT02316847|566966822|FG001|Overall Study|Noncompliance with study drug|3|||
157180992|NCT02859558|567404485|FG003|Step 2|Lost to Follow-up|0|||
157180993|NCT02859558|567404486|FG004|Step 2|Lost to Follow-up|0|||
157058650|NCT02316847|566966821|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
157058651|NCT02316847|566966822|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
157058652|NCT02621047|566966823|FG000|Overall Study|Adverse Event|0|||
157180994|NCT02859558|567404482|FG000|Step 2|Withdrawal by Subject|0|||
157180995|NCT02859558|567404483|FG001|Step 2|Withdrawal by Subject|1|||
157180996|NCT02859558|567404484|FG002|Step 2|Withdrawal by Subject|1|||
157180997|NCT02859558|567404485|FG003|Step 2|Withdrawal by Subject|0|||
157180998|NCT02859558|567404486|FG004|Step 2|Withdrawal by Subject|0|||
157180999|NCT02859558|567404482|FG000|Step 2|Unexpected Closure of Site|0|||
157181000|NCT02859558|567404483|FG001|Step 2|Unexpected Closure of Site|1|||
157181001|NCT02859558|567404484|FG002|Step 2|Unexpected Closure of Site|1|||
157181002|NCT02859558|567404485|FG003|Step 2|Unexpected Closure of Site|0|||
157181003|NCT02859558|567404486|FG004|Step 2|Unexpected Closure of Site|0|||
157181004|NCT02859558|567404482|FG000|Step 2|Death|1|||
157181005|NCT02859558|567404483|FG001|Step 2|Death|0|||
157181006|NCT02859558|567404484|FG002|Step 2|Death|0|||
157181007|NCT02859558|567404485|FG003|Step 2|Death|0|||
157181008|NCT02859558|567404486|FG004|Step 2|Death|0|||
157181009|NCT02859558|567404482|FG000|Step 2|Incarceration|0|||
157181010|NCT02859558|567404483|FG001|Step 2|Incarceration|0|||
157181011|NCT02859558|567404484|FG002|Step 2|Incarceration|1|||
157181012|NCT02859558|567404485|FG003|Step 2|Incarceration|0|||
157181013|NCT02859558|567404486|FG004|Step 2|Incarceration|0|||
157181014|NCT04507360|567404487|FG000|Week 1|Lost to Follow-up|0|||
157181015|NCT04507360|567404488|FG001|Week 1|Lost to Follow-up|0|||
157181016|NCT04507360|567404489|FG002|Week 1|Lost to Follow-up|0|||
157181017|NCT04507360|567404490|FG003|Week 1|Lost to Follow-up|0|||
157181018|NCT04507360|567404491|FG004|Week 1|Lost to Follow-up|0|||
157181019|NCT04507360|567404492|FG005|Week 1|Lost to Follow-up|0|||
157181020|NCT04507360|567404493|FG006|Week 1|Lost to Follow-up|0|||
157181021|NCT04507360|567404494|FG007|Week 1|Lost to Follow-up|0|||
157181022|NCT04507360|567404495|FG008|Week 1|Lost to Follow-up|72|||
157181023|NCT04507360|567404496|FG009|Week 1|Lost to Follow-up|22|||
157181024|NCT04507360|567404497|FG010|Week 1|Lost to Follow-up|10|||
157181025|NCT04507360|567404487|FG000|Week 2|Lost to Follow-up|0|||
157181026|NCT04507360|567404488|FG001|Week 2|Lost to Follow-up|0|||
157181027|NCT04507360|567404489|FG002|Week 2|Lost to Follow-up|0|||
157181028|NCT04507360|567404490|FG003|Week 2|Lost to Follow-up|0|||
157181029|NCT04507360|567404491|FG004|Week 2|Lost to Follow-up|0|||
157181030|NCT04507360|567404492|FG005|Week 2|Lost to Follow-up|0|||
157181031|NCT04507360|567404493|FG006|Week 2|Lost to Follow-up|0|||
157181032|NCT04507360|567404494|FG007|Week 2|Lost to Follow-up|0|||
157181033|NCT04507360|567404495|FG008|Week 2|Lost to Follow-up|121|||
157181034|NCT04507360|567404496|FG009|Week 2|Lost to Follow-up|85|||
157181035|NCT04507360|567404497|FG010|Week 2|Lost to Follow-up|82|||
157181036|NCT04507360|567404487|FG000|Week 3|Lost to Follow-up|0|||
157181037|NCT04507360|567404488|FG001|Week 3|Lost to Follow-up|0|||
157181038|NCT04507360|567404489|FG002|Week 3|Lost to Follow-up|0|||
157181039|NCT04507360|567404490|FG003|Week 3|Lost to Follow-up|0|||
157181040|NCT04507360|567404491|FG004|Week 3|Lost to Follow-up|0|||
157181041|NCT04507360|567404492|FG005|Week 3|Lost to Follow-up|0|||
157181042|NCT04507360|567404493|FG006|Week 3|Lost to Follow-up|0|||
157181043|NCT04507360|567404494|FG007|Week 3|Lost to Follow-up|0|||
157181044|NCT04507360|567404495|FG008|Week 3|Lost to Follow-up|123|||
157181045|NCT04507360|567404496|FG009|Week 3|Lost to Follow-up|92|||
157181046|NCT04507360|567404497|FG010|Week 3|Lost to Follow-up|84|||
157181047|NCT04507360|567404487|FG000|Week 4|Lost to Follow-up|0|||
157181048|NCT04507360|567404488|FG001|Week 4|Lost to Follow-up|0|||
157181049|NCT04507360|567404489|FG002|Week 4|Lost to Follow-up|0|||
157181050|NCT04507360|567404490|FG003|Week 4|Lost to Follow-up|0|||
157181051|NCT04507360|567404491|FG004|Week 4|Lost to Follow-up|0|||
156976300|NCT05061537|566667431|FG000|Follow up|Other|2|||
156976301|NCT05061537|566667432|FG001|Follow up|Other|0|||
156976302|NCT05061537|566667433|FG002|Follow up|Other|2|||
156976303|NCT05061537|566667434|FG003|Follow up|Other|0|||
156976304|NCT05061537|566667435|FG004|Follow up|Other|0|||
156976305|NCT05061537|566667431|FG000|Follow up|Study terminated by sponsor|0|||
156976306|NCT05061537|566667432|FG001|Follow up|Study terminated by sponsor|0|||
156976307|NCT05061537|566667433|FG002|Follow up|Study terminated by sponsor|2|||
157181052|NCT04507360|567404492|FG005|Week 4|Lost to Follow-up|0|||
157181053|NCT04507360|567404493|FG006|Week 4|Lost to Follow-up|0|||
157181054|NCT04507360|567404494|FG007|Week 4|Lost to Follow-up|0|||
157181055|NCT04507360|567404495|FG008|Week 4|Lost to Follow-up|131|||
157181056|NCT04507360|567404496|FG009|Week 4|Lost to Follow-up|115|||
157181057|NCT04507360|567404497|FG010|Week 4|Lost to Follow-up|102|||
157181058|NCT04507360|567404487|FG000|Week 5|Lost to Follow-up|0|||
157181059|NCT04507360|567404488|FG001|Week 5|Lost to Follow-up|0|||
157181060|NCT04507360|567404489|FG002|Week 5|Lost to Follow-up|0|||
157181061|NCT04507360|567404490|FG003|Week 5|Lost to Follow-up|0|||
157181062|NCT04507360|567404491|FG004|Week 5|Lost to Follow-up|0|||
157181063|NCT04507360|567404492|FG005|Week 5|Lost to Follow-up|0|||
157181064|NCT04507360|567404493|FG006|Week 5|Lost to Follow-up|0|||
157181065|NCT04507360|567404494|FG007|Week 5|Lost to Follow-up|0|||
157181066|NCT04507360|567404495|FG008|Week 5|Lost to Follow-up|103|||
157229857|NCT01345019|567588162|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
156976308|NCT05061537|566667434|FG003|Follow up|Study terminated by sponsor|0|||
157181067|NCT04507360|567404496|FG009|Week 5|Lost to Follow-up|135|||
157181068|NCT04507360|567404497|FG010|Week 5|Lost to Follow-up|143|||
157181069|NCT04507360|567404487|FG000|Week 8|Lost to Follow-up|0|||
157181070|NCT04507360|567404488|FG001|Week 8|Lost to Follow-up|0|||
157181071|NCT04507360|567404489|FG002|Week 8|Lost to Follow-up|0|||
157181072|NCT04507360|567404490|FG003|Week 8|Lost to Follow-up|0|||
157181073|NCT04507360|567404491|FG004|Week 8|Lost to Follow-up|0|||
157181074|NCT04507360|567404492|FG005|Week 8|Lost to Follow-up|0|||
157181075|NCT04507360|567404493|FG006|Week 8|Lost to Follow-up|0|||
157181076|NCT04507360|567404494|FG007|Week 8|Lost to Follow-up|0|||
157058653|NCT02621047|566966824|FG001|Overall Study|Adverse Event|0|||
157058654|NCT02621047|566966825|FG002|Overall Study|Adverse Event|1|||
157058655|NCT01370018|566966826|FG000|Overall Study|Did not meet criteria for analysis|1|||
157058656|NCT02972242|566968358|FG000|Overall Study|Withdrawal by Subject|1|||
157058657|NCT02972242|566968359|FG001|Overall Study|Withdrawal by Subject|0|||
157058658|NCT04572997|566968363|FG000|Overall Study|Adverse Event|1|||
157058659|NCT01967719|566968364|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
157058660|NCT01967719|566968365|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
157058661|NCT01967719|566968366|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
157058662|NCT01967719|566968367|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
157058663|NCT01967719|566968364|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
157058664|NCT01967719|566968365|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
157058665|NCT01967719|566968366|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
157058666|NCT01967719|566968367|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
157058667|NCT00961896|566968370|FG000|Overall Study|Abnormal laboratory value|0|||
157058668|NCT00961896|566968371|FG001|Overall Study|Abnormal laboratory value|0|||
157058669|NCT00961896|566968372|FG002|Overall Study|Abnormal laboratory value|1|||
157058670|NCT00371462|566968373|FG000|Overall Study|Withdrawal by Subject|1|||
157058671|NCT00371462|566968374|FG001|Overall Study|Withdrawal by Subject|0|||
157058672|NCT00371462|566968373|FG000|Overall Study|Other|7|||
157058673|NCT00371462|566968374|FG001|Overall Study|Other|8|||
157058674|NCT03511378|566968375|FG000|Overall Study|Withdrawal by Subject|2|||
157058675|NCT03511378|566968376|FG001|Overall Study|Withdrawal by Subject|2|||
157058676|NCT03511378|566968375|FG000|Overall Study|Patient not coming or schedule visit|1|||
157058677|NCT03511378|566968376|FG001|Overall Study|Patient not coming or schedule visit|0|||
157058678|NCT00755716|566968377|FG000|Overall Study|Adverse Event|1|||
157058679|NCT00755716|566968378|FG001|Overall Study|Adverse Event|4|||
157058680|NCT00755716|566968379|FG002|Overall Study|Adverse Event|1|||
157058681|NCT00755716|566968377|FG000|Overall Study|Lack of Efficacy|2|||
157058682|NCT00755716|566968378|FG001|Overall Study|Lack of Efficacy|0|||
157058683|NCT00755716|566968379|FG002|Overall Study|Lack of Efficacy|0|||
157058684|NCT00755716|566968377|FG000|Overall Study|Lost to Follow-up|5|||
157058685|NCT00755716|566968378|FG001|Overall Study|Lost to Follow-up|3|||
157058686|NCT00755716|566968379|FG002|Overall Study|Lost to Follow-up|1|||
157058687|NCT00755716|566968377|FG000|Overall Study|work schedule issues|0|||
157058688|NCT00755716|566968378|FG001|Overall Study|work schedule issues|1|||
157058689|NCT00755716|566968379|FG002|Overall Study|work schedule issues|1|||
157058690|NCT02581189|566968390|FG000|Overall Study|Failure to return|36|||
157058691|NCT02581189|566968390|FG000|Overall Study|Withdrew consent|5|||
157058692|NCT02581189|566968390|FG000|Overall Study|Death|3|||
157058693|NCT02581189|566968390|FG000|Overall Study|Insufficient virological response|2|||
157058694|NCT02581189|566968390|FG000|Overall Study|Other, not specified|7|||
157058695|NCT03275402|566968395|FG000|Overall Study|Death|17|||
157058696|NCT03275402|566968395|FG000|Overall Study|Study terminated by sponsor|21|||
157058697|NCT03275402|566968395|FG000|Overall Study|Withdrawal by Subject|1|||
157229858|NCT01345019|567588161|FG000|Open Label Treatment Phase|Pregnancy|1|||
157229859|NCT01345019|567588162|FG001|Open Label Treatment Phase|Pregnancy|0|||
157229860|NCT01345019|567588161|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
157229861|NCT01345019|567588162|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
157229862|NCT01345019|567588161|FG000|Open Label Treatment Phase|Protocol Violation|0|||
157229863|NCT01345019|567588162|FG001|Open Label Treatment Phase|Protocol Violation|1|||
157229864|NCT03830164|567588167|FG000|Overall Study|Adverse Event|0|||
157229865|NCT03830164|567588168|FG001|Overall Study|Adverse Event|2|||
157058698|NCT01514864|566968396|FG000|Overall Study|Disease progression|7|||
157058699|NCT01514864|566968397|FG001|Overall Study|Disease progression|5|||
157058700|NCT01514864|566968396|FG000|Overall Study|Study drug toxicity|2|||
157058701|NCT01514864|566968397|FG001|Overall Study|Study drug toxicity|0|||
157058702|NCT01525641|566968399|FG000|Overall Study|Case report form not collected|25|||
157058703|NCT01525641|566968399|FG000|Overall Study|No visit since the first visit|16|||
157058704|NCT01525641|566968399|FG000|Overall Study|Adverse Event|73|||
157058705|NCT01525641|566968399|FG000|Overall Study|Lack of Efficacy|24|||
157058706|NCT01525641|566968399|FG000|Overall Study|Improvement|5|||
157058707|NCT01525641|566968399|FG000|Overall Study|Lost to follow-up (relocation)|1|||
157229866|NCT03830164|567588169|FG002|Overall Study|Adverse Event|0|||
157229867|NCT03830164|567588167|FG000|Overall Study|Lack of Efficacy|1|||
157229868|NCT03830164|567588168|FG001|Overall Study|Lack of Efficacy|5|||
157058708|NCT01525641|566968399|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
157058709|NCT01525641|566968399|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
157058710|NCT01525641|566968399|FG000|Overall Study|Other than stated above|7|||
157058711|NCT03772041|566968400|FG000|Overall Study|Adverse Event|8|||
157058712|NCT03772041|566968401|FG001|Overall Study|Adverse Event|3|||
157058713|NCT03772041|566968400|FG000|Overall Study|Withdrawal by Subject|0|||
157058714|NCT03772041|566968401|FG001|Overall Study|Withdrawal by Subject|2|||
157058715|NCT03772041|566968400|FG000|Overall Study|Protocol Violation|4|||
157058716|NCT03772041|566968401|FG001|Overall Study|Protocol Violation|2|||
157058717|NCT03772041|566968400|FG000|Overall Study|Physician Decision|2|||
156976309|NCT05061537|566667435|FG004|Follow up|Study terminated by sponsor|0|||
156976310|NCT05061537|566667431|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
157181077|NCT04507360|567404495|FG008|Week 8|Lost to Follow-up|139|||
157181078|NCT04507360|567404496|FG009|Week 8|Lost to Follow-up|145|||
157181079|NCT04507360|567404497|FG010|Week 8|Lost to Follow-up|152|||
157181080|NCT03050307|567404501|FG000|Overall Study|Adverse Event|4|||
157181081|NCT03050307|567404502|FG001|Overall Study|Adverse Event|2|||
157181082|NCT03050307|567404501|FG000|Overall Study|Significant Protocol Deviation|0|||
157181083|NCT03050307|567404502|FG001|Overall Study|Significant Protocol Deviation|1|||
157181084|NCT03050307|567404501|FG000|Overall Study|Lost to Follow-up|0|||
157181085|NCT03050307|567404502|FG001|Overall Study|Lost to Follow-up|1|||
157181086|NCT03050307|567404501|FG000|Overall Study|Voluntary Withdrawal|3|||
157181087|NCT03050307|567404502|FG001|Overall Study|Voluntary Withdrawal|4|||
157181088|NCT03050307|567404501|FG000|Overall Study|Reason not Specified|1|||
157181089|NCT03050307|567404502|FG001|Overall Study|Reason not Specified|1|||
157181090|NCT00653068|567404503|FG000|Overall Study|Death|9|||
157181091|NCT00653068|567404503|FG000|Overall Study|Lack of Efficacy|34|||
157181092|NCT00653068|567404503|FG000|Overall Study|Physician Decision|4|||
157181093|NCT00653068|567404503|FG000|Overall Study|Withdrawal by Subject|1|||
157181094|NCT00653068|567404503|FG000|Overall Study|Ineligible|2|||
157181095|NCT03950440|567404504|FG000|Overall Study|Death|8|||
157181096|NCT03950440|567404505|FG001|Overall Study|Death|2|||
157181097|NCT03950440|567404506|FG002|Overall Study|Death|1|||
157181098|NCT02892734|567404507|FG000|Treatment on Study|Progressive Disease|2|||
157181099|NCT02892734|567404507|FG000|Follow up for 2 Years|Death|2|||
157181100|NCT02892734|567404507|FG000|Follow up for 2 Years|Study closed early|1|||
157181101|NCT00439309|567404508|FG000|Follow-Up|Death|1|||
157181102|NCT00439309|567404509|FG001|Follow-Up|Death|0|||
157181103|NCT00439309|567404508|FG000|Follow-Up|Lost to Follow-up|2|||
157181104|NCT00439309|567404509|FG001|Follow-Up|Lost to Follow-up|0|||
157181105|NCT00439309|567404508|FG000|Follow-Up|Withdrawal by Subject|0|||
157181106|NCT00439309|567404509|FG001|Follow-Up|Withdrawal by Subject|1|||
157181107|NCT00439309|567404508|FG000|Follow-Up|Late response by subject|0|||
157181108|NCT00439309|567404509|FG001|Follow-Up|Late response by subject|1|||
157181109|NCT00464620|567404510|FG000|Overall Study|Physician Decision|1|||
157181110|NCT00464620|567404511|FG001|Overall Study|Physician Decision|0|||
157181111|NCT00464620|567404512|FG002|Overall Study|Physician Decision|0|||
157181112|NCT00464620|567404510|FG000|Overall Study|Withdrawal by Subject|1|||
156976311|NCT05061537|566667432|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
156976312|NCT05061537|566667433|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
156976313|NCT05061537|566667434|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
156976314|NCT05061537|566667435|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
156976315|NCT05061537|566667431|FG000|Long-term Follow-up|Death|0|||
156976316|NCT05061537|566667432|FG001|Long-term Follow-up|Death|1|||
156976317|NCT05061537|566667433|FG002|Long-term Follow-up|Death|0|||
156976318|NCT05061537|566667434|FG003|Long-term Follow-up|Death|0|||
156976319|NCT05061537|566667435|FG004|Long-term Follow-up|Death|0|||
156976320|NCT03502616|566667436|FG000|Up to Week 16|Withdrawal by Subject|1|||
156976321|NCT03502616|566667437|FG001|Up to Week 16|Withdrawal by Subject|2|||
156976322|NCT03502616|566667436|FG000|Up to Week 16|Lost to Follow-up|0|||
156976323|NCT03502616|566667437|FG001|Up to Week 16|Lost to Follow-up|1|||
156976324|NCT03502616|566667436|FG000|Up to Week 16|Randomized, but not treated|1|||
156976325|NCT03502616|566667437|FG001|Up to Week 16|Randomized, but not treated|0|||
156976326|NCT03502616|566667436|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
156976327|NCT03502616|566667437|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
156976328|NCT03502616|566667436|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
156976329|NCT03502616|566667437|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
156976330|NCT01872910|566667439|FG000|Overall Study|Lost to Follow-up|2|||
156976331|NCT01872910|566667440|FG001|Overall Study|Lost to Follow-up|0|||
156976332|NCT01872910|566667441|FG002|Overall Study|Lost to Follow-up|2|||
156976333|NCT01872910|566667442|FG003|Overall Study|Lost to Follow-up|0|||
156976334|NCT01872910|566667443|FG004|Overall Study|Lost to Follow-up|0|||
157181113|NCT00464620|567404511|FG001|Overall Study|Withdrawal by Subject|0|||
157181114|NCT00464620|567404512|FG002|Overall Study|Withdrawal by Subject|3|||
157181115|NCT00464620|567404510|FG000|Overall Study|Ineligible sarcoma subtype|0|||
157181116|NCT00464620|567404511|FG001|Overall Study|Ineligible sarcoma subtype|2|||
157181117|NCT00464620|567404512|FG002|Overall Study|Ineligible sarcoma subtype|2|||
157181118|NCT00464620|567404510|FG000|Overall Study|Use of prohibited concomitant medication|0|||
157181119|NCT00464620|567404511|FG001|Overall Study|Use of prohibited concomitant medication|0|||
157181120|NCT00464620|567404512|FG002|Overall Study|Use of prohibited concomitant medication|2|||
157181121|NCT02158728|567404526|FG000|Overall Study|no procedure according to CIP done|3|||
157181122|NCT02158728|567404526|FG000|Overall Study|no qualified dataset|24|||
157181123|NCT01536418|567404530|FG000|Overall Study|Protocol Violation|2|||
157181124|NCT01536418|567404531|FG001|Overall Study|Protocol Violation|3|||
157181125|NCT01536418|567404530|FG000|Overall Study|Physician Decision|1|||
157181126|NCT01536418|567404531|FG001|Overall Study|Physician Decision|3|||
157181127|NCT01536418|567404530|FG000|Overall Study|Study closed/terminated|41|||
157181128|NCT01536418|567404531|FG001|Overall Study|Study closed/terminated|37|||
157229869|NCT03830164|567588169|FG002|Overall Study|Lack of Efficacy|0|||
157229870|NCT03830164|567588167|FG000|Overall Study|Lost to Follow-up|0|||
157229871|NCT03830164|567588168|FG001|Overall Study|Lost to Follow-up|1|||
157229872|NCT03830164|567588169|FG002|Overall Study|Lost to Follow-up|0|||
157229873|NCT03830164|567588167|FG000|Overall Study|Withdrawal by Subject|1|||
157229874|NCT03830164|567588168|FG001|Overall Study|Withdrawal by Subject|0|||
157229875|NCT03830164|567588169|FG002|Overall Study|Withdrawal by Subject|0|||
157229876|NCT04099888|567588170|FG000|Overall Study|Study terminated by sponsor|9|||
157229877|NCT04099888|567588171|FG001|Overall Study|Study terminated by sponsor|11|||
157229878|NCT04099888|567588170|FG000|Overall Study|Lost to Follow-up|1|||
156976335|NCT01872910|566667444|FG005|Overall Study|Lost to Follow-up|0|||
156976336|NCT01834222|566667445|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
156976337|NCT03812536|566667446|FG000|Overall Study|Protocol Violation|2|||
156976338|NCT03812536|566667447|FG001|Overall Study|Protocol Violation|0|||
156976339|NCT03812536|566667446|FG000|Overall Study|Withdrawal by Subject|1|||
156976340|NCT03812536|566667447|FG001|Overall Study|Withdrawal by Subject|1|||
156976341|NCT01306201|566667448|FG000|Overall Study|Arrhythmia|4|||
156976342|NCT01306201|566667448|FG000|Overall Study|Files could not be processed|3|||
156976343|NCT01306201|566667448|FG000|Overall Study|Files unreadable|3|||
156976344|NCT01735396|566667449|FG000|Overall Study|not evaluable|1|||
156976345|NCT00423852|566667454|FG000|Overall Study|Removed pior to the high-dose portion|3|||
156976346|NCT00980005|566667455|FG000|Overall Study|Withdrawal by Subject|6|||
156976347|NCT00980005|566667456|FG001|Overall Study|Withdrawal by Subject|17|||
156976348|NCT00980005|566667455|FG000|Overall Study|Lost to Follow-up|37|||
156976349|NCT00980005|566667456|FG001|Overall Study|Lost to Follow-up|43|||
156976350|NCT00980005|566667455|FG000|Overall Study|Other|4|||
156976351|NCT00980005|566667456|FG001|Overall Study|Other|3|||
156976352|NCT00572624|566667457|FG000|Overall Study|Lost to Follow-up|10|||
156976353|NCT00572624|566667458|FG001|Overall Study|Lost to Follow-up|4|||
156976354|NCT00572624|566667457|FG000|Overall Study|Wanted to do a different diet program|1|||
156976355|NCT00572624|566667458|FG001|Overall Study|Wanted to do a different diet program|0|||
156976356|NCT00572624|566667457|FG000|Overall Study|Medication change|1|||
156976357|NCT00572624|566667458|FG001|Overall Study|Medication change|0|||
156976358|NCT00572624|566667457|FG000|Overall Study|Started a new job-- no time for study|1|||
156976359|NCT00572624|566667458|FG001|Overall Study|Started a new job-- no time for study|0|||
156976360|NCT00572624|566667457|FG000|Overall Study|Admitted to being a smoker|1|||
156976361|NCT00572624|566667458|FG001|Overall Study|Admitted to being a smoker|0|||
156976362|NCT00572624|566667457|FG000|Overall Study|Refused to do the stress test|1|||
156976363|NCT00572624|566667458|FG001|Overall Study|Refused to do the stress test|0|||
156976364|NCT00572624|566667457|FG000|Overall Study|Problem with vascular access|1|||
156976365|NCT00572624|566667458|FG001|Overall Study|Problem with vascular access|0|||
156976366|NCT00572624|566667457|FG000|Overall Study|Health issues unrelated to the study|1|||
156976367|NCT00572624|566667458|FG001|Overall Study|Health issues unrelated to the study|0|||
156976368|NCT01436201|566667461|FG000|Overall Study|Adverse Event|2|||
156976369|NCT01436201|566667461|FG000|Overall Study|Withdrawal by Subject|1|||
156976370|NCT01436201|566667461|FG000|Overall Study|Protocol Violation|1|||
156976371|NCT01279343|566667462|FG000|Overall Study|Did not receive treatment|2|||
156976372|NCT01279343|566667463|FG001|Overall Study|Did not receive treatment|6|||
156976373|NCT00661661|566667467|FG000|Overall Study|Adverse Event|99|||
156976374|NCT00661661|566667468|FG001|Overall Study|Adverse Event|24|||
156976375|NCT00661661|566667467|FG000|Overall Study|Lack of Efficacy|3|||
156976376|NCT00661661|566667468|FG001|Overall Study|Lack of Efficacy|2|||
156976377|NCT00661661|566667467|FG000|Overall Study|Lost to Follow-up|0|||
156976378|NCT00661661|566667468|FG001|Overall Study|Lost to Follow-up|1|||
156976379|NCT00661661|566667467|FG000|Overall Study|Withdrawal by Subject|15|||
156976380|NCT00661661|566667468|FG001|Overall Study|Withdrawal by Subject|5|||
156976381|NCT00661661|566667467|FG000|Overall Study|Other|22|||
156976382|NCT00661661|566667468|FG001|Overall Study|Other|7|||
156976383|NCT00661661|566667467|FG000|Overall Study|Not assigned treatment|1|||
156976384|NCT00661661|566667468|FG001|Overall Study|Not assigned treatment|0|||
156976385|NCT03389477|566667471|FG000|Step 1|Withdrawal by Subject|1|||
156976386|NCT03389477|566667472|FG001|Step 1|Withdrawal by Subject|0|||
156976387|NCT03389477|566667471|FG000|Step 2|Withdrawal by Subject|1|||
156976388|NCT03389477|566667472|FG001|Step 2|Withdrawal by Subject|2|||
156976389|NCT03389477|566667471|FG000|Step 2|Disease progression|1|||
156976390|NCT03389477|566667472|FG001|Step 2|Disease progression|0|||
156976391|NCT03389477|566667471|FG000|Step 2|Death|0|||
156976392|NCT03389477|566667472|FG001|Step 2|Death|1|||
156976393|NCT03389477|566667471|FG000|Step 2|Poor performance status and nutrition|0|||
156976394|NCT03389477|566667472|FG001|Step 2|Poor performance status and nutrition|1|||
156976395|NCT03389477|566667471|FG000|Step 3|Withdrawal after 3 cycles|0|||
156976396|NCT03389477|566667472|FG001|Step 3|Withdrawal after 3 cycles|1|||
156976397|NCT03389477|566667471|FG000|Step 3|Still receiving active treatment|4|||
156976398|NCT03389477|566667472|FG001|Step 3|Still receiving active treatment|0|||
156976399|NCT03389477|566667471|FG000|Step 3|Progressive disease after 2 cycles|1|||
156976400|NCT03389477|566667472|FG001|Step 3|Progressive disease after 2 cycles|0|||
156976401|NCT04512066|566667475|FG000|Double-blind Treatment Period|Adverse Event|6|||
157181129|NCT01536418|567404530|FG000|Overall Study|Lack of Efficacy|10|||
157181130|NCT01536418|567404531|FG001|Overall Study|Lack of Efficacy|16|||
157181131|NCT01536418|567404530|FG000|Overall Study|Adverse Event|9|||
157181132|NCT01536418|567404531|FG001|Overall Study|Adverse Event|4|||
157181133|NCT01536418|567404530|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
157181134|NCT01536418|567404531|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
157181135|NCT01536418|567404530|FG000|Overall Study|Withdrawal by Subject|5|||
157181136|NCT01536418|567404531|FG001|Overall Study|Withdrawal by Subject|3|||
157181137|NCT02658149|567404536|FG000|Overall Study|Physician Decision|1|||
157181138|NCT02658149|567404537|FG001|Overall Study|Physician Decision|0|||
157181139|NCT00711412|567404538|FG000|Induction Treatment|Death|2|||
157181140|NCT00711412|567404538|FG000|Induction Treatment|Adverse Event|1|||
157181141|NCT00711412|567404538|FG000|Induction Treatment|Other|1|||
157181142|NCT00711412|567404538|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
157181143|NCT00711412|567404538|FG000|Evaluated for Combination Treatment|Death|1|||
157181144|NCT00711412|567404538|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
157181145|NCT00711412|567404538|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
157181146|NCT00711412|567404538|FG000|Combination Treatment|Progressive Disease|1|||
157181147|NCT00711412|567404538|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
157181148|NCT00711412|567404538|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
157181149|NCT00711412|567404538|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
157181150|NCT00711412|567404538|FG000|Evaluation for Response and Surgery|Death|1|||
157181151|NCT00711412|567404538|FG000|Survival Follow up Until Death|Other|12|||
157181152|NCT02234050|567404540|FG000|Overall Study|Lack of Efficacy|38|||
157181153|NCT02234050|567404541|FG001|Overall Study|Lack of Efficacy|22|||
157181154|NCT02234050|567404540|FG000|Overall Study|Adverse Event|13|||
157181155|NCT02234050|567404541|FG001|Overall Study|Adverse Event|1|||
157181156|NCT02234050|567404540|FG000|Overall Study|Withdrawal by Subject|4|||
157181157|NCT02234050|567404541|FG001|Overall Study|Withdrawal by Subject|2|||
157181158|NCT02234050|567404540|FG000|Overall Study|Sponsor's decision|6|||
157181159|NCT02234050|567404541|FG001|Overall Study|Sponsor's decision|0|||
157181160|NCT01680991|567404543|FG000|Overall Study|Adverse Event|1|||
157181161|NCT01680991|567404544|FG001|Overall Study|Adverse Event|0|||
157181162|NCT01680991|567404545|FG002|Overall Study|Adverse Event|0|||
157181163|NCT01680991|567404543|FG000|Overall Study|Death|1|||
157181164|NCT01680991|567404544|FG001|Overall Study|Death|0|||
157181165|NCT01680991|567404545|FG002|Overall Study|Death|1|||
157181166|NCT01680991|567404543|FG000|Overall Study|Protocol Violation|0|||
157181167|NCT01680991|567404544|FG001|Overall Study|Protocol Violation|1|||
157181168|NCT01680991|567404545|FG002|Overall Study|Protocol Violation|0|||
157181169|NCT01680991|567404543|FG000|Overall Study|Withdrawal by Subject|5|||
157181170|NCT01680991|567404544|FG001|Overall Study|Withdrawal by Subject|1|||
157181171|NCT01680991|567404545|FG002|Overall Study|Withdrawal by Subject|0|||
157181172|NCT01680991|567404543|FG000|Overall Study|Progressive disease (PD)|0|||
157181173|NCT01680991|567404544|FG001|Overall Study|Progressive disease (PD)|10|||
157181174|NCT01680991|567404545|FG002|Overall Study|Progressive disease (PD)|0|||
157181175|NCT01680991|567404543|FG000|Overall Study|Physician Decision|0|||
157181176|NCT01680991|567404544|FG001|Overall Study|Physician Decision|7|||
157181177|NCT01680991|567404545|FG002|Overall Study|Physician Decision|2|||
157181178|NCT01680991|567404543|FG000|Overall Study|Bad physical condition|0|||
157181179|NCT01680991|567404544|FG001|Overall Study|Bad physical condition|0|||
157181180|NCT01680991|567404545|FG002|Overall Study|Bad physical condition|1|||
157181181|NCT01680991|567404543|FG000|Overall Study|PD confirmed in other hospital|1|||
157181182|NCT01680991|567404544|FG001|Overall Study|PD confirmed in other hospital|0|||
157181183|NCT01680991|567404545|FG002|Overall Study|PD confirmed in other hospital|0|||
157181184|NCT04097028|567404546|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
157181185|NCT04097028|567404546|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
157181186|NCT04097028|567404546|FG000|Overall Study|Disease Progression prior to Surgery|2|||
157181187|NCT04097028|567404546|FG000|Overall Study|Adverse Event prior to Surgery|1|||
157181188|NCT02244619|567404547|FG000|Overall Study|Did not receive study intervention|8|||
157181189|NCT02244619|567404548|FG001|Overall Study|Did not receive study intervention|21|||
157181190|NCT01156363|567404549|FG000|Overall Study|Adverse Event|6|||
157181191|NCT01156363|567404549|FG000|Overall Study|Insufficient Therapeutic Response|5|||
157181192|NCT01156363|567404549|FG000|Overall Study|Failure to Return|1|||
157181193|NCT01156363|567404549|FG000|Overall Study|Refused Treatment|4|||
157181194|NCT01156363|567404549|FG000|Overall Study|Other|6|||
157181195|NCT03285490|567404551|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
157181196|NCT03285490|567404552|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
157181197|NCT03285490|567404551|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
157181198|NCT03285490|567404552|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
157181199|NCT03745989|567404553|FG000|Overall Study|Death|3|||
157181200|NCT03745989|567404554|FG001|Overall Study|Death|7|||
157181201|NCT03745989|567404555|FG002|Overall Study|Death|4|||
157181202|NCT03745989|567404553|FG000|Overall Study|Lost to Follow-up|0|||
157181203|NCT03745989|567404554|FG001|Overall Study|Lost to Follow-up|2|||
157058718|NCT03772041|566968401|FG001|Overall Study|Physician Decision|3|||
157058719|NCT02204319|566968406|FG000|Overall Study|Pregnancy|1|||
157058720|NCT02204319|566968406|FG000|Overall Study|Withdrawal by Subject|2|||
157058721|NCT03371485|566968407|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
157058722|NCT03371485|566968407|FG000|2-year Follow-up|Death|5|||
157058723|NCT03544229|566968410|FG000|Overall Study|Adverse Event|1|||
157058724|NCT03544229|566968411|FG001|Overall Study|Adverse Event|0|||
157058725|NCT03544229|566968412|FG002|Overall Study|Adverse Event|1|||
157058726|NCT03544229|566968413|FG003|Overall Study|Adverse Event|0|||
157058727|NCT03544229|566968410|FG000|Overall Study|Protocol Deviation|0|||
157058728|NCT03544229|566968411|FG001|Overall Study|Protocol Deviation|0|||
157058729|NCT03544229|566968412|FG002|Overall Study|Protocol Deviation|1|||
157058730|NCT03544229|566968413|FG003|Overall Study|Protocol Deviation|0|||
157058731|NCT03544229|566968410|FG000|Overall Study|Lost to Follow-up|3|||
157058732|NCT03544229|566968411|FG001|Overall Study|Lost to Follow-up|0|||
157058733|NCT03544229|566968412|FG002|Overall Study|Lost to Follow-up|0|||
157058734|NCT03544229|566968413|FG003|Overall Study|Lost to Follow-up|2|||
157058735|NCT03544229|566968410|FG000|Overall Study|Voluntary Withdrawal|2|||
157058736|NCT03544229|566968411|FG001|Overall Study|Voluntary Withdrawal|1|||
157058737|NCT03544229|566968412|FG002|Overall Study|Voluntary Withdrawal|3|||
157058738|NCT03544229|566968413|FG003|Overall Study|Voluntary Withdrawal|0|||
157058739|NCT03544229|566968410|FG000|Overall Study|Lack of Efficacy|0|||
157058740|NCT03544229|566968411|FG001|Overall Study|Lack of Efficacy|1|||
157058741|NCT03544229|566968412|FG002|Overall Study|Lack of Efficacy|0|||
157058742|NCT03544229|566968413|FG003|Overall Study|Lack of Efficacy|0|||
157058743|NCT03187353|566968414|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
157058744|NCT03187353|566968415|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
157058745|NCT03187353|566968414|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
157058746|NCT03187353|566968415|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
157058747|NCT03187353|566968414|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
157058748|NCT03187353|566968415|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
157058749|NCT03187353|566968414|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
157058750|NCT03187353|566968415|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
157058751|NCT03187353|566968414|FG000|Washout (2 Weeks)|Adverse Event|2|||
157058752|NCT03187353|566968415|FG001|Washout (2 Weeks)|Adverse Event|0|||
157058753|NCT03187353|566968414|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
157058754|NCT03187353|566968415|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
157058755|NCT00588341|566968416|FG000|Overall Study|Withdrawal by Subject|3|||
157058756|NCT00588341|566968416|FG000|Overall Study|Not treated due to metastatic disease|1|||
157058757|NCT00588341|566968416|FG000|Overall Study|Patient ineligible|1|||
157058758|NCT02567227|566968417|FG000|9 Weeks|Adverse Event|5|||
157058759|NCT02567227|566968418|FG001|9 Weeks|Adverse Event|5|||
157058760|NCT02567227|566968417|FG000|9 Weeks|Withdrawal by Subject|18|||
157058761|NCT02567227|566968418|FG001|9 Weeks|Withdrawal by Subject|8|||
157058762|NCT02567227|566968417|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
157058763|NCT02567227|566968418|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
157058764|NCT02567227|566968417|FG000|6 Month|Death|2|||
157058765|NCT02567227|566968418|FG001|6 Month|Death|0|||
157058766|NCT02567227|566968417|FG000|6 Month|Lost to Follow-up|43|||
157058767|NCT02567227|566968418|FG001|6 Month|Lost to Follow-up|40|||
157058768|NCT02567227|566968417|FG000|12 Months|Lost to Follow-up|31|||
157058769|NCT02567227|566968418|FG001|12 Months|Lost to Follow-up|32|||
157058770|NCT02567227|566968417|FG000|12 Months|Death|0|||
157181204|NCT03745989|567404555|FG002|Overall Study|Lost to Follow-up|0|||
157181205|NCT03745989|567404553|FG000|Overall Study|Sponsor Decision|0|||
157181206|NCT03745989|567404554|FG001|Overall Study|Sponsor Decision|2|||
157181207|NCT03745989|567404555|FG002|Overall Study|Sponsor Decision|8|||
157181208|NCT03745989|567404553|FG000|Overall Study|Withdrawal by Subject|0|||
157181209|NCT03745989|567404554|FG001|Overall Study|Withdrawal by Subject|1|||
157181210|NCT03745989|567404555|FG002|Overall Study|Withdrawal by Subject|3|||
157181211|NCT00068822|567404556|FG000|First Randomized Intervention|Lost to Follow-up|1|||
157181212|NCT00068822|567404557|FG001|First Randomized Intervention|Lost to Follow-up|2|||
157181213|NCT00735072|567404563|FG000|Overall Study|interrupted study med during ARV change|1|||
157181214|NCT00735072|567404564|FG001|Overall Study|interrupted study med during ARV change|0|||
157181215|NCT00735072|567404563|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
157181216|NCT00735072|567404564|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
157181217|NCT00911144|567404565|FG000|Overall Study|Withdrawal by Subject|16|||
157181218|NCT00911144|567404566|FG001|Overall Study|Withdrawal by Subject|5|||
157058771|NCT02567227|566968418|FG001|12 Months|Death|2|||
157058772|NCT03746483|566968419|FG000|Overall Study|Adverse Event|0|||
157058773|NCT03746483|566968420|FG001|Overall Study|Adverse Event|1|||
157058774|NCT03746483|566968419|FG000|Overall Study|Lack of Efficacy|3|||
157058775|NCT03746483|566968420|FG001|Overall Study|Lack of Efficacy|2|||
157058776|NCT03746483|566968419|FG000|Overall Study|Lost to Follow-up|1|||
157181219|NCT00047008|567404568|FG000|Overall Study|Withdrawn consent|2|||
157058777|NCT03746483|566968420|FG001|Overall Study|Lost to Follow-up|0|||
157058778|NCT03746483|566968419|FG000|Overall Study|Protocol Violation|2|||
157058779|NCT03746483|566968420|FG001|Overall Study|Protocol Violation|0|||
157181220|NCT00047008|567404569|FG001|Overall Study|Withdrawn consent|3|||
157181221|NCT00047008|567404568|FG000|Overall Study|Ineligible|9|||
157181222|NCT00047008|567404569|FG001|Overall Study|Ineligible|8|||
157181223|NCT00429572|567404570|FG000|Overall Study|Disease progression|1|||
157181224|NCT02773368|567404571|FG000|Overall Study|Lost to Follow-up|4|||
157181225|NCT02773368|567404572|FG001|Overall Study|Lost to Follow-up|1|||
157181226|NCT02773368|567404571|FG000|Overall Study|Withdrawal by Subject|5|||
157181227|NCT02773368|567404572|FG001|Overall Study|Withdrawal by Subject|1|||
157181228|NCT02773368|567404571|FG000|Overall Study|Unclassified|1|||
157181229|NCT02773368|567404572|FG001|Overall Study|Unclassified|1|||
157181230|NCT02773368|567404571|FG000|Overall Study|Missing|0|||
157181231|NCT02773368|567404572|FG001|Overall Study|Missing|1|||
157181232|NCT02635867|567404575|FG000|Overall Study|Lost to Follow-up|4|||
157181233|NCT02635867|567404576|FG001|Overall Study|Lost to Follow-up|3|||
157181234|NCT02635867|567404577|FG002|Overall Study|Lost to Follow-up|3|||
157181235|NCT02635867|567404578|FG003|Overall Study|Lost to Follow-up|4|||
157181236|NCT02635867|567404579|FG004|Overall Study|Lost to Follow-up|1|||
157181237|NCT02565576|567404582|FG000|Overall Study|abnormal lab value|2|||
157181238|NCT02565576|567404583|FG001|Overall Study|abnormal lab value|0|||
157181239|NCT02565576|567404582|FG000|Overall Study|subject / guardian decision|1|||
157181240|NCT02565576|567404583|FG001|Overall Study|subject / guardian decision|3|||
157181241|NCT02565576|567404582|FG000|Overall Study|Lost to Follow-up|1|||
157181242|NCT02565576|567404583|FG001|Overall Study|Lost to Follow-up|0|||
157181243|NCT02565576|567404582|FG000|Overall Study|Death|0|||
157181244|NCT02565576|567404583|FG001|Overall Study|Death|2|||
157181245|NCT02565576|567404582|FG000|Overall Study|Adverse Event|1|||
157181246|NCT02565576|567404583|FG001|Overall Study|Adverse Event|0|||
157181247|NCT00939341|567404584|FG000|Overall Study|Adverse Event|15|||
157181248|NCT00939341|567404584|FG000|Overall Study|Pregnancy|1|||
157181249|NCT00939341|567404584|FG000|Overall Study|Lost to Follow-up|23|||
157181250|NCT00939341|567404584|FG000|Overall Study|Withdrawal by Subject|13|||
157181251|NCT00939341|567404584|FG000|Overall Study|Protocol Violation|6|||
157181252|NCT00939341|567404584|FG000|Overall Study|Incorrect enrolment|8|||
157181253|NCT00796003|567404586|FG000|Overall Study|Disease Progression|2|||
157181254|NCT00796003|567404587|FG001|Overall Study|Disease Progression|13|||
157181255|NCT00796003|567404586|FG000|Overall Study|Adverse Event|1|||
157181256|NCT00796003|567404587|FG001|Overall Study|Adverse Event|7|||
157181257|NCT00796003|567404586|FG000|Overall Study|Specified organ function not met|0|||
157181258|NCT00796003|567404587|FG001|Overall Study|Specified organ function not met|1|||
157181259|NCT00796003|567404586|FG000|Overall Study|Physician Decision|0|||
157181260|NCT00796003|567404587|FG001|Overall Study|Physician Decision|4|||
157181261|NCT00796003|567404586|FG000|Overall Study|Withdrawal by Subject|0|||
157181262|NCT00796003|567404587|FG001|Overall Study|Withdrawal by Subject|1|||
157181263|NCT00796003|567404586|FG000|Overall Study|Other|0|||
157181264|NCT00796003|567404587|FG001|Overall Study|Other|1|||
157181265|NCT00796003|567404586|FG000|Overall Study|Participants Not treated|0|||
157181266|NCT00796003|567404587|FG001|Overall Study|Participants Not treated|2|||
157181267|NCT04338321|567404592|FG000|Overall Study|Adverse Event|4|||
157181268|NCT04338321|567404593|FG001|Overall Study|Adverse Event|10|||
157181269|NCT04338321|567404592|FG000|Overall Study|Death|1|||
157181270|NCT04338321|567404593|FG001|Overall Study|Death|1|||
157181271|NCT04338321|567404592|FG000|Overall Study|Lost to Follow-up|4|||
157181272|NCT04338321|567404593|FG001|Overall Study|Lost to Follow-up|9|||
157181273|NCT04338321|567404592|FG000|Overall Study|Withdrawal by Subject|45|||
157181274|NCT04338321|567404593|FG001|Overall Study|Withdrawal by Subject|69|||
157181275|NCT04338321|567404592|FG000|Overall Study|Physician Decision|5|||
157181276|NCT04338321|567404593|FG001|Overall Study|Physician Decision|9|||
157181277|NCT04338321|567404592|FG000|Overall Study|Other|3|||
157181278|NCT04338321|567404593|FG001|Overall Study|Other|10|||
157181279|NCT02910089|567404594|FG000|Overall Study|Lost insurance eligibility|22|||
157181280|NCT02910089|567404595|FG001|Overall Study|Lost insurance eligibility|16|||
157181281|NCT00633360|567404596|FG000|Overall Study|Lost to Follow-up|1|||
157181282|NCT00633360|567404597|FG001|Overall Study|Lost to Follow-up|1|||
157181283|NCT00633360|567404596|FG000|Overall Study|Adverse Event|3|||
157181284|NCT00633360|567404597|FG001|Overall Study|Adverse Event|1|||
157181285|NCT00633360|567404596|FG000|Overall Study|Protocol Violation|0|||
157181286|NCT00633360|567404597|FG001|Overall Study|Protocol Violation|1|||
157181287|NCT00621244|567404600|FG000|Overall Study|Withdrawal by Subject|7|||
157058780|NCT01924806|566968425|FG000|Overall Study|Physician Decision|2|||
157181288|NCT00621244|567404601|FG001|Overall Study|Withdrawal by Subject|3|||
157058781|NCT01924806|566968426|FG001|Overall Study|Physician Decision|1|||
157181289|NCT00621244|567404602|FG002|Overall Study|Withdrawal by Subject|3|||
157181290|NCT00621244|567404603|FG003|Overall Study|Withdrawal by Subject|3|||
157058782|NCT01954771|566968427|FG000|Overall Study|Missing HbA1c of end-point|1|||
157181291|NCT00621244|567404600|FG000|Overall Study|Disease progression|44|||
157181292|NCT00621244|567404601|FG001|Overall Study|Disease progression|20|||
157181293|NCT00621244|567404602|FG002|Overall Study|Disease progression|20|||
157181294|NCT00621244|567404603|FG003|Overall Study|Disease progression|15|||
157181295|NCT00621244|567404600|FG000|Overall Study|Death|3|||
157181296|NCT00621244|567404601|FG001|Overall Study|Death|3|||
157181297|NCT00621244|567404602|FG002|Overall Study|Death|1|||
157058783|NCT01954771|566968428|FG001|Overall Study|Missing HbA1c of end-point|1|||
157058784|NCT01954771|566968429|FG002|Overall Study|Missing HbA1c of end-point|0|||
157058785|NCT01954771|566968427|FG000|Overall Study|Missing CGMS of end-point|1|||
157058786|NCT01954771|566968428|FG001|Overall Study|Missing CGMS of end-point|1|||
157058787|NCT01954771|566968429|FG002|Overall Study|Missing CGMS of end-point|0|||
157058788|NCT01954771|566968427|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
157058789|NCT01954771|566968428|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
157058790|NCT01954771|566968429|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
157058791|NCT01026103|566968433|FG000|Overall Study|Physician Decision|1|||
157058792|NCT01026103|566968433|FG000|Overall Study|did not receive study device bc of error|1|||
157058793|NCT02498418|566968435|FG000|Overall Study|Lack of Efficacy|0|||
157058794|NCT02498418|566968436|FG001|Overall Study|Lack of Efficacy|0|||
157058795|NCT02498418|566968437|FG002|Overall Study|Lack of Efficacy|1|||
157058796|NCT02498418|566968435|FG000|Overall Study|Withdrawal by Subject|2|||
157058797|NCT02498418|566968436|FG001|Overall Study|Withdrawal by Subject|0|||
157058798|NCT02498418|566968437|FG002|Overall Study|Withdrawal by Subject|3|||
157058799|NCT02498418|566968435|FG000|Overall Study|Lost to Follow-up|0|||
157058800|NCT02498418|566968436|FG001|Overall Study|Lost to Follow-up|1|||
157058801|NCT02498418|566968437|FG002|Overall Study|Lost to Follow-up|1|||
157058802|NCT02498418|566968435|FG000|Overall Study|Participant taken prohibited medication|0|||
157058803|NCT02498418|566968436|FG001|Overall Study|Participant taken prohibited medication|1|||
157058804|NCT02498418|566968437|FG002|Overall Study|Participant taken prohibited medication|1|||
157058805|NCT03635775|566968438|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
157058806|NCT03635775|566968439|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
157058807|NCT03635775|566968440|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
157058808|NCT03635775|566968441|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
157058809|NCT00762502|566968442|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
157058810|NCT00762502|566968443|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
157058811|NCT00762502|566968444|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
157058812|NCT00762502|566968442|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
157058813|NCT00762502|566968443|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
157058814|NCT00762502|566968444|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
157058815|NCT00762502|566968442|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
157058816|NCT00762502|566968443|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
157058817|NCT00762502|566968444|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
157058818|NCT01363297|566968467|FG000|Overall Study|Other|0|||
157058819|NCT01363297|566968468|FG001|Overall Study|Other|0|||
157058820|NCT01363297|566968469|FG002|Overall Study|Other|0|||
157058821|NCT01363297|566968470|FG003|Overall Study|Other|0|||
157058822|NCT01363297|566968471|FG004|Overall Study|Other|1|||
157058823|NCT01363297|566968467|FG000|Overall Study|Death|3|||
157058824|NCT01363297|566968468|FG001|Overall Study|Death|6|||
157058825|NCT01363297|566968469|FG002|Overall Study|Death|6|||
157058826|NCT01363297|566968470|FG003|Overall Study|Death|10|||
157058827|NCT01363297|566968471|FG004|Overall Study|Death|30|||
157058828|NCT02588027|566968475|FG000|Overall Study|Withdrawal by Subject|1|||
157058829|NCT02588027|566968476|FG001|Overall Study|Withdrawal by Subject|3|||
157058830|NCT02588027|566968475|FG000|Overall Study|Protocol Violation|4|||
157058831|NCT02588027|566968476|FG001|Overall Study|Protocol Violation|1|||
157058832|NCT02116582|566968477|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
157058833|NCT02116582|566968477|FG000|Overall Study|Adverse Event|22|||
157058834|NCT02116582|566968477|FG000|Overall Study|Death|9|||
157058835|NCT02116582|566968477|FG000|Overall Study|Progressive Disease|148|||
157058836|NCT02116582|566968477|FG000|Overall Study|Protocol Violation|3|||
157058837|NCT02116582|566968477|FG000|Overall Study|Withdrawal by Subject|8|||
157058838|NCT02116582|566968477|FG000|Overall Study|Other: Miscellaneous|11|||
157058839|NCT02116582|566968477|FG000|Overall Study|Lost to Follow-up|1|||
157058840|NCT02116582|566968477|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
157058841|NCT01876823|566968478|FG000|Overall Study|Withdrawal by Subject|5|||
157058842|NCT01876823|566968478|FG000|Overall Study|Physician Decision|2|||
157058843|NCT01876823|566968478|FG000|Overall Study|Patients moved|2|||
157058844|NCT01770509|566968482|FG000|Overall Study|Injury|0|||
157058845|NCT01770509|566968483|FG001|Overall Study|Injury|1|||
157058846|NCT01770509|566968482|FG000|Overall Study|Lost to Follow-up|1|||
157058847|NCT01770509|566968483|FG001|Overall Study|Lost to Follow-up|2|||
157181298|NCT00621244|567404603|FG003|Overall Study|Death|1|||
157181299|NCT00621244|567404600|FG000|Overall Study|Adverse Event|27|||
157181300|NCT00621244|567404601|FG001|Overall Study|Adverse Event|7|||
157181301|NCT00621244|567404602|FG002|Overall Study|Adverse Event|9|||
157181302|NCT00621244|567404603|FG003|Overall Study|Adverse Event|2|||
157058848|NCT00794573|566968488|FG000|Overall Study|Death|3|||
157058849|NCT00794573|566968489|FG001|Overall Study|Death|0|||
157058850|NCT00794573|566968488|FG000|Overall Study|Withdrawal by Subject|9|||
157058851|NCT00794573|566968489|FG001|Overall Study|Withdrawal by Subject|12|||
157058852|NCT00794573|566968488|FG000|Overall Study|Lost to Follow-up|26|||
157181303|NCT00621244|567404600|FG000|Overall Study|Administrative problems|5|||
157181304|NCT00621244|567404601|FG001|Overall Study|Administrative problems|1|||
157181305|NCT00621244|567404602|FG002|Overall Study|Administrative problems|0|||
157181306|NCT00621244|567404603|FG003|Overall Study|Administrative problems|2|||
157181307|NCT01690988|567404604|FG000|Overall Study|Withdrawal by Subject|2|||
157181308|NCT01690988|567404605|FG001|Overall Study|Withdrawal by Subject|2|||
157181309|NCT01690988|567404606|FG002|Overall Study|Withdrawal by Subject|3|||
157181310|NCT01690988|567404604|FG000|Overall Study|Physician Decision|0|||
157181311|NCT01690988|567404605|FG001|Overall Study|Physician Decision|0|||
157181312|NCT01690988|567404606|FG002|Overall Study|Physician Decision|1|||
157181313|NCT01690988|567404604|FG000|Overall Study|Operation Cancelled|1|||
157181314|NCT01690988|567404605|FG001|Overall Study|Operation Cancelled|1|||
157181315|NCT01690988|567404606|FG002|Overall Study|Operation Cancelled|0|||
157181316|NCT01690988|567404604|FG000|Overall Study|Determined ineligible|1|||
157181317|NCT01690988|567404605|FG001|Overall Study|Determined ineligible|0|||
157181318|NCT01690988|567404606|FG002|Overall Study|Determined ineligible|0|||
157181319|NCT01690988|567404604|FG000|Overall Study|Death|1|||
157181320|NCT01690988|567404605|FG001|Overall Study|Death|1|||
157181321|NCT01690988|567404606|FG002|Overall Study|Death|1|||
157181322|NCT01690988|567404604|FG000|Overall Study|Sedated|1|||
157181323|NCT01690988|567404605|FG001|Overall Study|Sedated|1|||
157181324|NCT01690988|567404606|FG002|Overall Study|Sedated|2|||
157181325|NCT03696576|567404607|FG000|Overall Study|Soreness of throat after therapy|1|||
157181326|NCT03696576|567404608|FG001|Overall Study|Soreness of throat after therapy|1|||
157181327|NCT03696576|567404607|FG000|Overall Study|Lost to Follow-up|2|||
157181328|NCT03696576|567404608|FG001|Overall Study|Lost to Follow-up|4|||
157181329|NCT00312728|567404609|FG000|Overall Study|Progressive disease|53|||
157181330|NCT00312728|567404609|FG000|Overall Study|Adverse Event|32|||
157181331|NCT00312728|567404609|FG000|Overall Study|Withdrawal by Subject|10|||
157181332|NCT00312728|567404609|FG000|Overall Study|Required non-protocol cancer treatment|2|||
157181333|NCT00312728|567404609|FG000|Overall Study|Protocol Violation|2|||
157181334|NCT00312728|567404609|FG000|Overall Study|Other|10|||
157181335|NCT00312728|567404609|FG000|Overall Study|Other|1|||
157181336|NCT00560794|567404611|FG000|Overall Study|Adverse Event|2|||
157181337|NCT00560794|567404611|FG000|Overall Study|Patient was not Compliant|1|||
157181338|NCT00560794|567404611|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
157181339|NCT00560794|567404611|FG000|Overall Study|Hematological Relapse|1|||
157181340|NCT00560794|567404611|FG000|Overall Study|Received Bone Marrow Transplant|6|||
157181341|NCT04857892|567404612|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
157181342|NCT04857892|567404613|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
157181343|NCT04857892|567404614|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
157181344|NCT04857892|567404615|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
157181345|NCT04857892|567404616|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
157181346|NCT04857892|567404612|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
157181347|NCT04857892|567404613|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
157181348|NCT04857892|567404614|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
157181349|NCT04857892|567404615|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
157181350|NCT04857892|567404616|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
157181351|NCT04857892|567404612|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
157181352|NCT04857892|567404613|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
157181353|NCT04857892|567404614|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
157181354|NCT04857892|567404615|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
157181355|NCT04857892|567404616|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
157181356|NCT00368472|567404621|FG000|Overall Study|Adverse Event|22|||
157181357|NCT00368472|567404621|FG000|Overall Study|Medication non-compliance|4|||
157181358|NCT00368472|567404621|FG000|Overall Study|Protocol Violation|2|||
157181359|NCT00368472|567404621|FG000|Overall Study|Request of Investigator or Sponsor|3|||
157181360|NCT00368472|567404621|FG000|Overall Study|Withdrawal by Subject|40|||
157181361|NCT00368472|567404621|FG000|Overall Study|Diary non-compliance|1|||
157181362|NCT00368472|567404621|FG000|Overall Study|Other|32|||
157181363|NCT00368472|567404621|FG000|Overall Study|Missing Final Disposition Date|1|||
157181364|NCT02384993|567404622|FG000|Overall Study|Adverse Event|0|||
157181365|NCT02384993|567404623|FG001|Overall Study|Adverse Event|1|||
157229879|NCT04099888|567588171|FG001|Overall Study|Lost to Follow-up|1|||
157181366|NCT01627782|567404629|FG000|Overall Study|Adverse Event|1|||
157181367|NCT01627782|567404630|FG001|Overall Study|Adverse Event|2|||
157181368|NCT01627782|567404631|FG002|Overall Study|Adverse Event|0|||
157181369|NCT01627782|567404632|FG003|Overall Study|Adverse Event|1|||
157181370|NCT01627782|567404629|FG000|Overall Study|Lack of Efficacy|11|||
157181371|NCT01627782|567404630|FG001|Overall Study|Lack of Efficacy|1|||
157181372|NCT01627782|567404631|FG002|Overall Study|Lack of Efficacy|15|||
157181373|NCT01627782|567404632|FG003|Overall Study|Lack of Efficacy|2|||
157181374|NCT01627782|567404629|FG000|Overall Study|Protocol Violation|1|||
157181375|NCT01627782|567404630|FG001|Overall Study|Protocol Violation|0|||
157181376|NCT01627782|567404631|FG002|Overall Study|Protocol Violation|0|||
157181377|NCT01627782|567404632|FG003|Overall Study|Protocol Violation|0|||
157181378|NCT01627782|567404629|FG000|Overall Study|Withdrawal by Subject|2|||
157058853|NCT00794573|566968489|FG001|Overall Study|Lost to Follow-up|33|||
157058854|NCT01774929|566968492|FG000|Overall Study|Adverse Event|3|||
157058855|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
157058856|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
157058857|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
157058858|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
157058859|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
157058860|NCT00500539|566968493|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
157058861|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
157058862|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
157058863|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
157058864|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
157058865|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Death|1|||
157058866|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
157058867|NCT00500539|566968493|FG000|Follow-up Period (16 Weeks)|Missing|3|||
157058868|NCT01123642|566968494|FG000|Overall Study|Lost to Follow-up|23|||
157058869|NCT01123642|566968494|FG000|Overall Study|Withdrawal by Subject|9|||
157058870|NCT01123642|566968494|FG000|Overall Study|ineligible at baseline assessment|36|||
157058871|NCT04853238|566968495|FG000|Overall Study|Death|4|||
157058872|NCT04853238|566968496|FG001|Overall Study|Death|0|||
157058873|NCT04853238|566968497|FG002|Overall Study|Death|2|||
157058874|NCT04853238|566968495|FG000|Overall Study|Lost to Follow-up|16|||
157058875|NCT04853238|566968496|FG001|Overall Study|Lost to Follow-up|2|||
157058876|NCT04853238|566968497|FG002|Overall Study|Lost to Follow-up|37|||
157058877|NCT04853238|566968495|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
157058878|NCT04853238|566968496|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
157058879|NCT04853238|566968497|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
157058880|NCT04853238|566968495|FG000|Overall Study|Withdrawal by Subject|6|||
157058881|NCT04853238|566968496|FG001|Overall Study|Withdrawal by Subject|0|||
157058882|NCT04853238|566968497|FG002|Overall Study|Withdrawal by Subject|21|||
157058883|NCT04853238|566968495|FG000|Overall Study|Physician Decision|0|||
157058884|NCT04853238|566968496|FG001|Overall Study|Physician Decision|0|||
157058885|NCT04853238|566968497|FG002|Overall Study|Physician Decision|2|||
157058886|NCT04853238|566968495|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
157058887|NCT04853238|566968496|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
157058888|NCT04853238|566968497|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
157058889|NCT02093897|566970033|FG000|Overall Study|Physician Decision|1|||
157058890|NCT02093897|566970033|FG000|Overall Study|Planned age group closure - no's reached|17|||
157058891|NCT02093897|566970033|FG000|Overall Study|Adverse event, non-fatal|1|||
157058892|NCT01983462|566970034|FG000|Overall Study|Adverse Event|1|||
157058893|NCT01983462|566970035|FG001|Overall Study|Adverse Event|0|||
157058894|NCT01983462|566970036|FG002|Overall Study|Adverse Event|0|||
157058895|NCT02229396|566970037|FG000|Overall Study|Adverse Event|6|||
157058896|NCT02229396|566970038|FG001|Overall Study|Adverse Event|12|||
157058897|NCT02229396|566970039|FG002|Overall Study|Adverse Event|12|||
157058898|NCT02229396|566970037|FG000|Overall Study|Death|2|||
157058899|NCT02229396|566970038|FG001|Overall Study|Death|3|||
157058900|NCT02229396|566970039|FG002|Overall Study|Death|1|||
157058901|NCT02229396|566970037|FG000|Overall Study|Lost to Follow-up|14|||
157058902|NCT02229396|566970038|FG001|Overall Study|Lost to Follow-up|14|||
157058903|NCT02229396|566970039|FG002|Overall Study|Lost to Follow-up|21|||
157058904|NCT02229396|566970037|FG000|Overall Study|Protocol Violation|2|||
157058905|NCT02229396|566970038|FG001|Overall Study|Protocol Violation|1|||
157058906|NCT02229396|566970039|FG002|Overall Study|Protocol Violation|0|||
157058907|NCT02229396|566970037|FG000|Overall Study|Patient Incorrectly Randomized|0|||
157058908|NCT02229396|566970038|FG001|Overall Study|Patient Incorrectly Randomized|0|||
157058909|NCT02229396|566970039|FG002|Overall Study|Patient Incorrectly Randomized|1|||
157058910|NCT02229396|566970037|FG000|Overall Study|Other|10|||
157058911|NCT02229396|566970038|FG001|Overall Study|Other|18|||
157058912|NCT02229396|566970039|FG002|Overall Study|Other|15|||
157058913|NCT02229396|566970037|FG000|Overall Study|Withdrawal by Subject|42|||
157181379|NCT01627782|567404630|FG001|Overall Study|Withdrawal by Subject|1|||
157181380|NCT01627782|567404631|FG002|Overall Study|Withdrawal by Subject|0|||
157181381|NCT01627782|567404632|FG003|Overall Study|Withdrawal by Subject|0|||
157181382|NCT01627782|567404629|FG000|Overall Study|Other|0|||
157181383|NCT01627782|567404630|FG001|Overall Study|Other|2|||
157058914|NCT02229396|566970038|FG001|Overall Study|Withdrawal by Subject|28|||
157058915|NCT02229396|566970039|FG002|Overall Study|Withdrawal by Subject|41|||
157181384|NCT01627782|567404631|FG002|Overall Study|Other|0|||
157181385|NCT01627782|567404632|FG003|Overall Study|Other|3|||
157181386|NCT01627782|567404629|FG000|Overall Study|Randomized But Not Treated|1|||
157058916|NCT02229396|566970037|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
157058917|NCT02229396|566970038|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
157058918|NCT02229396|566970039|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
157181387|NCT01627782|567404630|FG001|Overall Study|Randomized But Not Treated|0|||
157181388|NCT01627782|567404631|FG002|Overall Study|Randomized But Not Treated|0|||
157181389|NCT01627782|567404632|FG003|Overall Study|Randomized But Not Treated|0|||
157181390|NCT00643448|567404633|FG000|Overall Study|Lack of Efficacy|2|||
157181391|NCT00643448|567404634|FG001|Overall Study|Lack of Efficacy|0|||
157181392|NCT00643448|567404635|FG002|Overall Study|Lack of Efficacy|4|||
157181393|NCT00643448|567404633|FG000|Overall Study|Adverse Event|2|||
157181394|NCT00643448|567404634|FG001|Overall Study|Adverse Event|2|||
157181395|NCT00643448|567404635|FG002|Overall Study|Adverse Event|2|||
157181396|NCT00643448|567404633|FG000|Overall Study|QTcF>550 ms|0|||
157181397|NCT00643448|567404634|FG001|Overall Study|QTcF>550 ms|3|||
157181398|NCT00643448|567404635|FG002|Overall Study|QTcF>550 ms|0|||
157181399|NCT00981682|567404636|FG000|Overall Study|Adverse Event|48|||
157181400|NCT00981682|567404636|FG000|Overall Study|Withdrawal by Subject|52|||
157181401|NCT00981682|567404636|FG000|Overall Study|Lost to Follow-up|14|||
157181402|NCT00981682|567404636|FG000|Overall Study|Lack of Efficacy|13|||
157181403|NCT00981682|567404636|FG000|Overall Study|Protocol Violation|6|||
157181404|NCT00981682|567404636|FG000|Overall Study|administrative|9|||
157181405|NCT01998906|567406482|FG000|Overall Study|Participants ongoing in follow-up|77|||
157181406|NCT01998906|567406483|FG001|Overall Study|Participants ongoing in follow-up|60|||
157181407|NCT01998906|567406484|FG002|Overall Study|Participants ongoing in follow-up|58|||
157181408|NCT01998906|567406482|FG000|Overall Study|Death|21|||
157181409|NCT01998906|567406483|FG001|Overall Study|Death|30|||
157181410|NCT01998906|567406484|FG002|Overall Study|Death|17|||
157181411|NCT01998906|567406482|FG000|Overall Study|Lack of Efficacy|10|||
157181412|NCT01998906|567406483|FG001|Overall Study|Lack of Efficacy|9|||
157181413|NCT01998906|567406484|FG002|Overall Study|Lack of Efficacy|8|||
157181414|NCT01998906|567406482|FG000|Overall Study|Failure to return|0|||
157181415|NCT01998906|567406483|FG001|Overall Study|Failure to return|2|||
157181416|NCT01998906|567406484|FG002|Overall Study|Failure to return|4|||
157181417|NCT01998906|567406482|FG000|Overall Study|Violation of Selection Criteria|0|||
157181418|NCT01998906|567406483|FG001|Overall Study|Violation of Selection Criteria|0|||
157181419|NCT01998906|567406484|FG002|Overall Study|Violation of Selection Criteria|1|||
157181420|NCT01998906|567406482|FG000|Overall Study|Withdrawal by Subject|1|||
157181421|NCT01998906|567406483|FG001|Overall Study|Withdrawal by Subject|4|||
157181422|NCT01998906|567406484|FG002|Overall Study|Withdrawal by Subject|3|||
157181423|NCT01998906|567406482|FG000|Overall Study|Administrative/Other|2|||
157181424|NCT01998906|567406483|FG001|Overall Study|Administrative/Other|1|||
157181425|NCT01998906|567406484|FG002|Overall Study|Administrative/Other|3|||
157181426|NCT01998906|567406482|FG000|Overall Study|Other|3|||
157181427|NCT01998906|567406483|FG001|Overall Study|Other|8|||
157181428|NCT01998906|567406484|FG002|Overall Study|Other|4|||
157181429|NCT02204410|567406485|FG000|Overall Study|Lost to Follow-up|5|||
157181430|NCT02204410|567406485|FG000|Overall Study|Physician Decision|2|||
157181431|NCT02204410|567406485|FG000|Overall Study|Protocol Violation|1|||
157181432|NCT02204410|567406485|FG000|Overall Study|Withdrawal by Subject|3|||
157181433|NCT02473289|567406501|FG000|Overall Study|Adverse Event|2|||
157181434|NCT02473289|567406502|FG001|Overall Study|Adverse Event|3|||
157181435|NCT02473289|567406501|FG000|Overall Study|Lost to Follow-up|1|||
157181436|NCT02473289|567406502|FG001|Overall Study|Lost to Follow-up|1|||
157181437|NCT02473289|567406501|FG000|Overall Study|Protocol Violation|0|||
157181438|NCT02473289|567406502|FG001|Overall Study|Protocol Violation|1|||
157181439|NCT02473289|567406501|FG000|Overall Study|Withdrawal of consent|6|||
157181440|NCT02473289|567406502|FG001|Overall Study|Withdrawal of consent|7|||
157181441|NCT02473289|567406501|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
157181442|NCT02473289|567406502|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
157181443|NCT02473289|567406501|FG000|Overall Study|Other|2|||
157181444|NCT02473289|567406502|FG001|Overall Study|Other|0|||
157181445|NCT04159701|567406505|FG000|Period 1: Treatment Period|Pregnancy|1|||
157181446|NCT04159701|567406506|FG001|Period 1: Treatment Period|Pregnancy|0|||
157181447|NCT04159701|567406505|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
157181448|NCT04159701|567406506|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
157181449|NCT04159701|567406505|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
157181450|NCT04159701|567406506|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
157181451|NCT04159701|567406505|FG000|Washout Period|site terminated by sponsor|0|||
157181452|NCT04159701|567406506|FG001|Washout Period|site terminated by sponsor|1|||
157181453|NCT04159701|567406505|FG000|Washout Period|study terminated by sponsor|10|||
157181454|NCT04159701|567406506|FG001|Washout Period|study terminated by sponsor|3|||
157181455|NCT04159701|567406505|FG000|Washout Period|Withdrawal by Subject|1|||
157181456|NCT04159701|567406506|FG001|Washout Period|Withdrawal by Subject|0|||
157181457|NCT04159701|567406505|FG000|Washout Period|Inadvertent Enrollment|1|||
157181458|NCT04159701|567406506|FG001|Washout Period|Inadvertent Enrollment|0|||
157181459|NCT04159701|567406505|FG000|Washout Period|Miscellaneous|1|||
157181460|NCT04159701|567406506|FG001|Washout Period|Miscellaneous|0|||
157181461|NCT04159701|567406505|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
157181462|NCT04159701|567406506|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
157181463|NCT04159701|567406505|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
157181464|NCT04159701|567406506|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
157058919|NCT02229396|566970037|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
157058920|NCT02229396|566970038|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
157058921|NCT02229396|566970039|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
157181465|NCT04159701|567406505|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
157181466|NCT04159701|567406506|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
157181467|NCT04159701|567406505|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
157181468|NCT04159701|567406506|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
157181469|NCT04159701|567406505|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
157181470|NCT04159701|567406506|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
157181471|NCT01849562|567406510|FG000|Overall Study|Lost to Follow-up|1|||
157181472|NCT01849562|567406511|FG001|Overall Study|Lost to Follow-up|0|||
157181473|NCT01849562|567406512|FG002|Overall Study|Lost to Follow-up|0|||
157181474|NCT01849562|567406510|FG000|Overall Study|Non-compliance with Study Drug|1|||
157181475|NCT01849562|567406511|FG001|Overall Study|Non-compliance with Study Drug|0|||
157181476|NCT01849562|567406512|FG002|Overall Study|Non-compliance with Study Drug|0|||
157181477|NCT00481988|567406515|FG000|Overall Study|Withdrawal by Subject|1|||
157181478|NCT00481988|567406516|FG001|Overall Study|Withdrawal by Subject|1|||
157181479|NCT04599972|567406523|FG000|Overall Study|Withdrawal by Subject|6|||
157181480|NCT04599972|567406524|FG001|Overall Study|Withdrawal by Subject|1|||
157181481|NCT04599972|567406523|FG000|Overall Study|Adverse Event|1|||
157181482|NCT04599972|567406524|FG001|Overall Study|Adverse Event|1|||
157181483|NCT04599972|567406523|FG000|Overall Study|Lost to Follow-up|1|||
157181484|NCT04599972|567406524|FG001|Overall Study|Lost to Follow-up|6|||
157181485|NCT04599972|567406523|FG000|Overall Study|Protocol Violation|1|||
157181486|NCT04599972|567406524|FG001|Overall Study|Protocol Violation|0|||
157181487|NCT04599972|567406523|FG000|Overall Study|Other reason|1|||
157181488|NCT04599972|567406524|FG001|Overall Study|Other reason|0|||
157181489|NCT00638690|567406527|FG000|Overall Study|Death|655|||
157181490|NCT00638690|567406528|FG001|Overall Study|Death|335|||
157181491|NCT00638690|567406527|FG000|Overall Study|Withdrawal by Subject|22|||
157181492|NCT00638690|567406528|FG001|Overall Study|Withdrawal by Subject|5|||
157181493|NCT00638690|567406527|FG000|Overall Study|Lost to Follow-up|4|||
157181494|NCT00638690|567406528|FG001|Overall Study|Lost to Follow-up|2|||
157181495|NCT01347073|567406531|FG000|Overall Study|Adverse Event|1|||
157181496|NCT01347073|567406531|FG000|Overall Study|Liver Transplant|1|||
157181497|NCT01975376|567406543|FG000|Overall Study|Adverse Event|5|||
157181498|NCT01975376|567406544|FG001|Overall Study|Adverse Event|5|||
157181499|NCT01975376|567406543|FG000|Overall Study|Death|65|||
157181500|NCT01975376|567406544|FG001|Overall Study|Death|72|||
157181501|NCT01975376|567406543|FG000|Overall Study|Lost to Follow-up|70|||
157181502|NCT01975376|567406544|FG001|Overall Study|Lost to Follow-up|66|||
157181503|NCT01975376|567406543|FG000|Overall Study|Withdrew consent|68|||
157181504|NCT01975376|567406544|FG001|Overall Study|Withdrew consent|62|||
157181505|NCT01975376|567406543|FG000|Overall Study|Other|2|||
157181506|NCT01975376|567406544|FG001|Overall Study|Other|4|||
157181507|NCT01975376|567406543|FG000|Overall Study|Randomized, Not Treated|16|||
157181508|NCT01975376|567406544|FG001|Overall Study|Randomized, Not Treated|8|||
157181509|NCT01819194|567406550|FG000|Overall Study|Loss of study articles|2|||
157058922|NCT02679079|566970041|FG000|Overall Study|Adverse Event|2|||
157058923|NCT02679079|566970042|FG001|Overall Study|Adverse Event|0|||
157058924|NCT02679079|566970043|FG002|Overall Study|Adverse Event|2|||
157058925|NCT02679079|566970041|FG000|Overall Study|Protocol Violation|0|||
157058926|NCT02679079|566970042|FG001|Overall Study|Protocol Violation|1|||
157058927|NCT02679079|566970043|FG002|Overall Study|Protocol Violation|0|||
157058928|NCT02679079|566970041|FG000|Overall Study|Withdrawal by Subject|2|||
157058929|NCT02679079|566970042|FG001|Overall Study|Withdrawal by Subject|1|||
157058930|NCT02679079|566970043|FG002|Overall Study|Withdrawal by Subject|0|||
157058931|NCT01264887|566970049|FG000|Overall Study|Adverse Event|5|||
157058932|NCT01264887|566970049|FG000|Overall Study|Death|7|||
157058933|NCT01264887|566970049|FG000|Overall Study|Lack of Efficacy|5|||
157058934|NCT01264887|566970049|FG000|Overall Study|Physician Decision|4|||
157058935|NCT01264887|566970049|FG000|Overall Study|Withdrawal by Subject|6|||
157058936|NCT01264887|566970049|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
157058937|NCT01264887|566970049|FG000|Overall Study|Other|2|||
157058938|NCT04772313|566970050|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
157058939|NCT04772313|566970050|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
157058940|NCT02215954|566970051|FG000|Overall Study|Adverse Event|0|||
157058941|NCT02215954|566970052|FG001|Overall Study|Adverse Event|0|||
157058942|NCT02215954|566970053|FG002|Overall Study|Adverse Event|1|||
157181510|NCT00045630|567406551|FG000|Overall Study|Adverse Event|1|||
157181511|NCT00045630|567406551|FG000|Overall Study|Refusal unrelated to adverse event|1|||
157181512|NCT00045630|567406551|FG000|Overall Study|Progression/relapse|1|||
157181513|NCT00045630|567406551|FG000|Overall Study|Death|1|||
157181514|NCT00045630|567406551|FG000|Overall Study|Ineligible|2|||
157181515|NCT04449276|567406552|FG000|Overall Study|Adverse Event|1|||
157181516|NCT04449276|567406553|FG001|Overall Study|Adverse Event|2|||
157058943|NCT02215954|566970051|FG000|Overall Study|Withdrawal by Subject|0|||
157181517|NCT04449276|567406554|FG002|Overall Study|Adverse Event|0|||
157058944|NCT02215954|566970052|FG001|Overall Study|Withdrawal by Subject|0|||
157058945|NCT02215954|566970053|FG002|Overall Study|Withdrawal by Subject|2|||
157058946|NCT02215954|566970051|FG000|Overall Study|Not exposed|1|||
157058947|NCT02215954|566970052|FG001|Overall Study|Not exposed|1|||
157058948|NCT02215954|566970053|FG002|Overall Study|Not exposed|3|||
157058949|NCT01061775|566970058|FG000|Overall Study|Physician Decision|2|||
157058950|NCT01061775|566970058|FG000|Overall Study|Lost to Follow-up|1|||
157058951|NCT00784277|566970059|FG000|IR Treatment|Adverse Event|4|||
157058952|NCT00784277|566970060|FG001|IR Treatment|Adverse Event|8|||
157058953|NCT00784277|566970061|FG002|IR Treatment|Adverse Event|19|||
157058954|NCT00784277|566970062|FG003|IR Treatment|Adverse Event|35|||
157058955|NCT00784277|566970063|FG004|IR Treatment|Adverse Event|0|||
157058956|NCT00784277|566970064|FG005|IR Treatment|Adverse Event|0|||
157058957|NCT00784277|566970065|FG006|IR Treatment|Adverse Event|0|||
157058958|NCT00784277|566970059|FG000|IR Treatment|Lack of Efficacy|4|||
157058959|NCT00784277|566970060|FG001|IR Treatment|Lack of Efficacy|4|||
157058960|NCT00784277|566970061|FG002|IR Treatment|Lack of Efficacy|1|||
157058961|NCT00784277|566970062|FG003|IR Treatment|Lack of Efficacy|0|||
157058962|NCT00784277|566970063|FG004|IR Treatment|Lack of Efficacy|0|||
157058963|NCT00784277|566970064|FG005|IR Treatment|Lack of Efficacy|0|||
157058964|NCT00784277|566970065|FG006|IR Treatment|Lack of Efficacy|0|||
157058965|NCT00784277|566970059|FG000|IR Treatment|Lost to Follow-up|1|||
157058966|NCT00784277|566970060|FG001|IR Treatment|Lost to Follow-up|0|||
157058967|NCT00784277|566970061|FG002|IR Treatment|Lost to Follow-up|1|||
157058968|NCT00784277|566970062|FG003|IR Treatment|Lost to Follow-up|0|||
157058969|NCT00784277|566970063|FG004|IR Treatment|Lost to Follow-up|0|||
157058970|NCT00784277|566970064|FG005|IR Treatment|Lost to Follow-up|0|||
157058971|NCT00784277|566970065|FG006|IR Treatment|Lost to Follow-up|0|||
157058972|NCT00784277|566970059|FG000|IR Treatment|Withdrawal by Subject|5|||
157058973|NCT00784277|566970060|FG001|IR Treatment|Withdrawal by Subject|1|||
157058974|NCT00784277|566970061|FG002|IR Treatment|Withdrawal by Subject|4|||
157058975|NCT00784277|566970062|FG003|IR Treatment|Withdrawal by Subject|6|||
157058976|NCT00784277|566970063|FG004|IR Treatment|Withdrawal by Subject|0|||
157058977|NCT00784277|566970064|FG005|IR Treatment|Withdrawal by Subject|0|||
157058978|NCT00784277|566970065|FG006|IR Treatment|Withdrawal by Subject|0|||
157058979|NCT00784277|566970059|FG000|IR Treatment|Resolution Of Pain|0|||
157058980|NCT00784277|566970060|FG001|IR Treatment|Resolution Of Pain|1|||
157058981|NCT00784277|566970061|FG002|IR Treatment|Resolution Of Pain|0|||
157058982|NCT00784277|566970062|FG003|IR Treatment|Resolution Of Pain|0|||
157058983|NCT00784277|566970063|FG004|IR Treatment|Resolution Of Pain|0|||
157058984|NCT00784277|566970064|FG005|IR Treatment|Resolution Of Pain|0|||
157058985|NCT00784277|566970065|FG006|IR Treatment|Resolution Of Pain|0|||
157058986|NCT00784277|566970059|FG000|IR Treatment|Other|2|||
157058987|NCT00784277|566970060|FG001|IR Treatment|Other|3|||
157058988|NCT00784277|566970061|FG002|IR Treatment|Other|3|||
157058989|NCT00784277|566970062|FG003|IR Treatment|Other|2|||
157058990|NCT00784277|566970063|FG004|IR Treatment|Other|0|||
157058991|NCT00784277|566970064|FG005|IR Treatment|Other|0|||
157058992|NCT00784277|566970065|FG006|IR Treatment|Other|0|||
157058993|NCT00784277|566970059|FG000|ER Treatment|Adverse Event|0|||
157058994|NCT00784277|566970060|FG001|ER Treatment|Adverse Event|0|||
157058995|NCT00784277|566970061|FG002|ER Treatment|Adverse Event|0|||
157058996|NCT00784277|566970062|FG003|ER Treatment|Adverse Event|0|||
157058997|NCT00784277|566970063|FG004|ER Treatment|Adverse Event|1|||
157058998|NCT00784277|566970064|FG005|ER Treatment|Adverse Event|7|||
157058999|NCT00784277|566970065|FG006|ER Treatment|Adverse Event|7|||
157059000|NCT00784277|566970059|FG000|ER Treatment|Lack of Efficacy|0|||
157059001|NCT00784277|566970060|FG001|ER Treatment|Lack of Efficacy|0|||
157059002|NCT00784277|566970061|FG002|ER Treatment|Lack of Efficacy|0|||
157059003|NCT00784277|566970062|FG003|ER Treatment|Lack of Efficacy|0|||
157059004|NCT00784277|566970063|FG004|ER Treatment|Lack of Efficacy|3|||
157181518|NCT04449276|567406555|FG003|Overall Study|Adverse Event|0|||
157181519|NCT04449276|567406556|FG004|Overall Study|Adverse Event|2|||
157181520|NCT04449276|567406557|FG005|Overall Study|Adverse Event|0|||
157181521|NCT04449276|567406558|FG006|Overall Study|Adverse Event|0|||
157181522|NCT04449276|567406559|FG007|Overall Study|Adverse Event|1|||
157181523|NCT04449276|567406552|FG000|Overall Study|Withdrawal by Subject|2|||
157181524|NCT04449276|567406553|FG001|Overall Study|Withdrawal by Subject|0|||
157181525|NCT04449276|567406554|FG002|Overall Study|Withdrawal by Subject|0|||
157181526|NCT04449276|567406555|FG003|Overall Study|Withdrawal by Subject|1|||
157181527|NCT04449276|567406556|FG004|Overall Study|Withdrawal by Subject|0|||
157181528|NCT04449276|567406557|FG005|Overall Study|Withdrawal by Subject|0|||
157181529|NCT04449276|567406558|FG006|Overall Study|Withdrawal by Subject|0|||
157059005|NCT00784277|566970064|FG005|ER Treatment|Lack of Efficacy|4|||
157059006|NCT00784277|566970065|FG006|ER Treatment|Lack of Efficacy|0|||
157059007|NCT00784277|566970059|FG000|ER Treatment|Lost to Follow-up|0|||
157059008|NCT00784277|566970060|FG001|ER Treatment|Lost to Follow-up|0|||
157059009|NCT00784277|566970061|FG002|ER Treatment|Lost to Follow-up|0|||
157059010|NCT00784277|566970062|FG003|ER Treatment|Lost to Follow-up|0|||
157059011|NCT00784277|566970063|FG004|ER Treatment|Lost to Follow-up|0|||
157181530|NCT04449276|567406559|FG007|Overall Study|Withdrawal by Subject|0|||
157059012|NCT00784277|566970064|FG005|ER Treatment|Lost to Follow-up|2|||
157181531|NCT04449276|567406552|FG000|Overall Study|Other|0|||
157181532|NCT04449276|567406553|FG001|Overall Study|Other|2|||
157181533|NCT04449276|567406554|FG002|Overall Study|Other|3|||
157181534|NCT04449276|567406555|FG003|Overall Study|Other|2|||
157181535|NCT04449276|567406556|FG004|Overall Study|Other|0|||
157181536|NCT04449276|567406557|FG005|Overall Study|Other|0|||
157181537|NCT04449276|567406558|FG006|Overall Study|Other|0|||
156976402|NCT04512066|566667476|FG001|Double-blind Treatment Period|Adverse Event|4|||
156976403|NCT04512066|566667477|FG002|Double-blind Treatment Period|Adverse Event|5|||
156976404|NCT04512066|566667478|FG003|Double-blind Treatment Period|Adverse Event|1|||
156976405|NCT04512066|566667479|FG004|Double-blind Treatment Period|Adverse Event|0|||
156976406|NCT04512066|566667480|FG005|Double-blind Treatment Period|Adverse Event|0|||
156976407|NCT04512066|566667475|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
156976408|NCT04512066|566667476|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
156976409|NCT04512066|566667477|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
156976410|NCT04512066|566667478|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
156976411|NCT04512066|566667479|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
156976412|NCT04512066|566667480|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
156976413|NCT04512066|566667475|FG000|Double-blind Treatment Period|Physician Decision|1|||
156976414|NCT04512066|566667476|FG001|Double-blind Treatment Period|Physician Decision|0|||
156976415|NCT04512066|566667477|FG002|Double-blind Treatment Period|Physician Decision|1|||
156976416|NCT04512066|566667478|FG003|Double-blind Treatment Period|Physician Decision|0|||
156976417|NCT04512066|566667479|FG004|Double-blind Treatment Period|Physician Decision|0|||
156976418|NCT04512066|566667480|FG005|Double-blind Treatment Period|Physician Decision|0|||
156976419|NCT04512066|566667475|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
156976420|NCT04512066|566667476|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
156976421|NCT04512066|566667477|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
156976422|NCT04512066|566667478|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
156976423|NCT04512066|566667479|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
156976424|NCT04512066|566667480|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
156976425|NCT04512066|566667475|FG000|Extension Period|Adverse Event|0|||
156976426|NCT04512066|566667476|FG001|Extension Period|Adverse Event|1|||
156976427|NCT04512066|566667477|FG002|Extension Period|Adverse Event|4|||
156976428|NCT04512066|566667478|FG003|Extension Period|Adverse Event|3|||
156976429|NCT04512066|566667479|FG004|Extension Period|Adverse Event|1|||
156976430|NCT04512066|566667480|FG005|Extension Period|Adverse Event|3|||
156976431|NCT04512066|566667475|FG000|Extension Period|Death|0|||
156976432|NCT04512066|566667476|FG001|Extension Period|Death|0|||
156976433|NCT04512066|566667477|FG002|Extension Period|Death|0|||
156976434|NCT04512066|566667478|FG003|Extension Period|Death|0|||
156976435|NCT04512066|566667479|FG004|Extension Period|Death|0|||
156976436|NCT04512066|566667480|FG005|Extension Period|Death|1|||
156976437|NCT04512066|566667475|FG000|Extension Period|Lack of Efficacy|0|||
156976438|NCT04512066|566667476|FG001|Extension Period|Lack of Efficacy|4|||
156976439|NCT04512066|566667477|FG002|Extension Period|Lack of Efficacy|4|||
156976440|NCT04512066|566667478|FG003|Extension Period|Lack of Efficacy|1|||
156976441|NCT04512066|566667479|FG004|Extension Period|Lack of Efficacy|3|||
156976442|NCT04512066|566667480|FG005|Extension Period|Lack of Efficacy|3|||
156976443|NCT04512066|566667475|FG000|Extension Period|Lost to Follow-up|0|||
156976444|NCT04512066|566667476|FG001|Extension Period|Lost to Follow-up|1|||
156976445|NCT04512066|566667477|FG002|Extension Period|Lost to Follow-up|5|||
156976446|NCT04512066|566667478|FG003|Extension Period|Lost to Follow-up|2|||
156976447|NCT04512066|566667479|FG004|Extension Period|Lost to Follow-up|3|||
156976448|NCT04512066|566667480|FG005|Extension Period|Lost to Follow-up|2|||
156976449|NCT04512066|566667475|FG000|Extension Period|Non-compliance with study drug|0|||
156976450|NCT04512066|566667476|FG001|Extension Period|Non-compliance with study drug|1|||
156976451|NCT04512066|566667477|FG002|Extension Period|Non-compliance with study drug|0|||
156976452|NCT04512066|566667478|FG003|Extension Period|Non-compliance with study drug|0|||
156976453|NCT04512066|566667479|FG004|Extension Period|Non-compliance with study drug|0|||
156976454|NCT04512066|566667480|FG005|Extension Period|Non-compliance with study drug|1|||
156976455|NCT04512066|566667475|FG000|Extension Period|Other|0|||
156976456|NCT04512066|566667476|FG001|Extension Period|Other|2|||
156976457|NCT04512066|566667477|FG002|Extension Period|Other|0|||
156976458|NCT04512066|566667478|FG003|Extension Period|Other|0|||
156976459|NCT04512066|566667479|FG004|Extension Period|Other|0|||
156976460|NCT04512066|566667480|FG005|Extension Period|Other|0|||
156976461|NCT04512066|566667475|FG000|Extension Period|Physician Decision|0|||
156976462|NCT04512066|566667476|FG001|Extension Period|Physician Decision|2|||
156976463|NCT04512066|566667477|FG002|Extension Period|Physician Decision|0|||
156976464|NCT04512066|566667478|FG003|Extension Period|Physician Decision|1|||
157059013|NCT00784277|566970065|FG006|ER Treatment|Lost to Follow-up|0|||
157181538|NCT04449276|567406559|FG007|Overall Study|Other|1|||
157181539|NCT01614795|567406560|FG000|Overall Study|Adverse Event|0|||
156976465|NCT04512066|566667479|FG004|Extension Period|Physician Decision|1|||
157181540|NCT01614795|567406561|FG001|Overall Study|Adverse Event|0|||
157181541|NCT01614795|567406562|FG002|Overall Study|Adverse Event|1|||
157181542|NCT01614795|567406563|FG003|Overall Study|Adverse Event|1|||
157181543|NCT01614795|567406560|FG000|Overall Study|Lack of Efficacy|10|||
157181544|NCT01614795|567406561|FG001|Overall Study|Lack of Efficacy|10|||
157181545|NCT01614795|567406562|FG002|Overall Study|Lack of Efficacy|9|||
157181546|NCT01614795|567406563|FG003|Overall Study|Lack of Efficacy|8|||
157181547|NCT01614795|567406560|FG000|Overall Study|Physician Decision|1|||
157181548|NCT01614795|567406561|FG001|Overall Study|Physician Decision|0|||
157181549|NCT01614795|567406562|FG002|Overall Study|Physician Decision|1|||
157181550|NCT01614795|567406563|FG003|Overall Study|Physician Decision|1|||
157181551|NCT01614795|567406560|FG000|Overall Study|Withdrawal by Subject|0|||
157181552|NCT01614795|567406561|FG001|Overall Study|Withdrawal by Subject|1|||
157181553|NCT01614795|567406562|FG002|Overall Study|Withdrawal by Subject|0|||
157181554|NCT01614795|567406563|FG003|Overall Study|Withdrawal by Subject|2|||
157181555|NCT01614795|567406560|FG000|Overall Study|Ineligible|0|||
157181556|NCT01614795|567406561|FG001|Overall Study|Ineligible|1|||
157181557|NCT01614795|567406562|FG002|Overall Study|Ineligible|0|||
157181558|NCT01614795|567406563|FG003|Overall Study|Ineligible|0|||
157181559|NCT00701103|567406565|FG000|Overall Study|Adverse Event|0|||
157181560|NCT00701103|567406566|FG001|Overall Study|Adverse Event|0|||
157181561|NCT00701103|567406567|FG002|Overall Study|Adverse Event|1|||
157181562|NCT00701103|567406568|FG003|Overall Study|Adverse Event|1|||
157181563|NCT00701103|567406569|FG004|Overall Study|Adverse Event|0|||
157181564|NCT00701103|567406570|FG005|Overall Study|Adverse Event|1|||
157181565|NCT00701103|567406571|FG006|Overall Study|Adverse Event|1|||
157181566|NCT00701103|567406572|FG007|Overall Study|Adverse Event|0|||
157181567|NCT00701103|567406573|FG008|Overall Study|Adverse Event|0|||
157181568|NCT00701103|567406574|FG009|Overall Study|Adverse Event|2|||
157181569|NCT00701103|567406575|FG010|Overall Study|Adverse Event|0|||
157181570|NCT00701103|567406565|FG000|Overall Study|Progressive Disease|5|||
157181571|NCT00701103|567406566|FG001|Overall Study|Progressive Disease|2|||
157181572|NCT00701103|567406567|FG002|Overall Study|Progressive Disease|6|||
157181573|NCT00701103|567406568|FG003|Overall Study|Progressive Disease|5|||
157181574|NCT00701103|567406569|FG004|Overall Study|Progressive Disease|6|||
157181575|NCT00701103|567406570|FG005|Overall Study|Progressive Disease|5|||
157181576|NCT00701103|567406571|FG006|Overall Study|Progressive Disease|7|||
157181577|NCT00701103|567406572|FG007|Overall Study|Progressive Disease|7|||
157181578|NCT00701103|567406573|FG008|Overall Study|Progressive Disease|8|||
157181579|NCT00701103|567406574|FG009|Overall Study|Progressive Disease|8|||
157181580|NCT00701103|567406575|FG010|Overall Study|Progressive Disease|11|||
157181581|NCT00701103|567406565|FG000|Overall Study|Withdrawal by Subject|0|||
157181582|NCT00701103|567406566|FG001|Overall Study|Withdrawal by Subject|1|||
157181583|NCT00701103|567406567|FG002|Overall Study|Withdrawal by Subject|1|||
157181584|NCT00701103|567406568|FG003|Overall Study|Withdrawal by Subject|0|||
157181585|NCT00701103|567406569|FG004|Overall Study|Withdrawal by Subject|0|||
157181586|NCT00701103|567406570|FG005|Overall Study|Withdrawal by Subject|0|||
157181587|NCT00701103|567406571|FG006|Overall Study|Withdrawal by Subject|0|||
157181588|NCT00701103|567406572|FG007|Overall Study|Withdrawal by Subject|0|||
157181589|NCT00701103|567406573|FG008|Overall Study|Withdrawal by Subject|0|||
157181590|NCT00701103|567406574|FG009|Overall Study|Withdrawal by Subject|0|||
157181591|NCT00701103|567406575|FG010|Overall Study|Withdrawal by Subject|0|||
157181592|NCT00701103|567406565|FG000|Overall Study|Other|0|||
157181593|NCT00701103|567406566|FG001|Overall Study|Other|0|||
157181594|NCT00701103|567406567|FG002|Overall Study|Other|0|||
157181595|NCT00701103|567406568|FG003|Overall Study|Other|0|||
157181596|NCT00701103|567406569|FG004|Overall Study|Other|0|||
157181597|NCT00701103|567406570|FG005|Overall Study|Other|0|||
157181598|NCT00701103|567406571|FG006|Overall Study|Other|0|||
157181599|NCT00701103|567406572|FG007|Overall Study|Other|0|||
157181600|NCT00701103|567406573|FG008|Overall Study|Other|1|||
157181601|NCT00701103|567406574|FG009|Overall Study|Other|1|||
157181602|NCT00701103|567406575|FG010|Overall Study|Other|0|||
157181603|NCT00179517|567406576|FG000|Overall Study|Withdrawal by Subject|2|||
157181604|NCT00179517|567406577|FG001|Overall Study|Withdrawal by Subject|1|||
157181605|NCT01448707|567406583|FG000|Overall Study|Adverse Event|3|||
157181606|NCT01448707|567406584|FG001|Overall Study|Adverse Event|1|||
157181607|NCT01448707|567406583|FG000|Overall Study|Lost to Follow-up|2|||
157181608|NCT01448707|567406584|FG001|Overall Study|Lost to Follow-up|6|||
157181609|NCT01448707|567406583|FG000|Overall Study|Withdrawal by Subject|6|||
157181610|NCT01448707|567406584|FG001|Overall Study|Withdrawal by Subject|7|||
157181611|NCT01448707|567406583|FG000|Overall Study|Other|7|||
157181612|NCT01448707|567406584|FG001|Overall Study|Other|4|||
157181613|NCT02033850|567406590|FG000|Overall Study|Death|1|||
157181614|NCT02033850|567406591|FG001|Overall Study|Death|0|||
157181615|NCT02033850|567406590|FG000|Overall Study|unrelated medical reason|1|||
157181616|NCT02033850|567406591|FG001|Overall Study|unrelated medical reason|1|||
157181617|NCT02820038|567406595|FG000|Overall Study|Lost to Follow-up|7|||
157181618|NCT02820038|567406596|FG001|Overall Study|Lost to Follow-up|11|||
157181619|NCT02820038|567406597|FG002|Overall Study|Lost to Follow-up|2|||
157181620|NCT02820038|567406598|FG003|Overall Study|Lost to Follow-up|9|||
157181621|NCT02820038|567406595|FG000|Overall Study|Withdrawal by Subject|3|||
157181622|NCT02820038|567406596|FG001|Overall Study|Withdrawal by Subject|14|||
157181623|NCT02820038|567406597|FG002|Overall Study|Withdrawal by Subject|3|||
157181624|NCT02820038|567406598|FG003|Overall Study|Withdrawal by Subject|13|||
157181625|NCT03215667|567406599|FG000|Overall Study|Physician Decision|4|||
157181626|NCT00614991|567406600|FG000|Overall Study|Adverse Event|3|||
157181627|NCT00614991|567406601|FG001|Overall Study|Adverse Event|3|||
157181628|NCT00614991|567406602|FG002|Overall Study|Adverse Event|0|||
157181629|NCT00614991|567406603|FG003|Overall Study|Adverse Event|0|||
157181630|NCT00614991|567406604|FG004|Overall Study|Adverse Event|1|||
157181631|NCT00614991|567406605|FG005|Overall Study|Adverse Event|0|||
157181632|NCT01922739|567406611|FG000|Titration/Adjustment Period|Adverse Event|3|||
157181633|NCT01922739|567406611|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
157181634|NCT01922739|567406611|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
157181635|NCT01922739|567406611|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
157181636|NCT01922739|567406611|FG000|Open-label Treatment Period|Adverse Event|6|||
157181637|NCT01922739|567406611|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
157181638|NCT01922739|567406611|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
156976466|NCT04512066|566667480|FG005|Extension Period|Physician Decision|0|||
156976467|NCT04512066|566667475|FG000|Extension Period|Withdrawal by Subject|0|||
156976468|NCT04512066|566667476|FG001|Extension Period|Withdrawal by Subject|3|||
156976469|NCT04512066|566667477|FG002|Extension Period|Withdrawal by Subject|7|||
156976470|NCT04512066|566667478|FG003|Extension Period|Withdrawal by Subject|11|||
156976471|NCT04512066|566667479|FG004|Extension Period|Withdrawal by Subject|8|||
156976472|NCT04512066|566667480|FG005|Extension Period|Withdrawal by Subject|4|||
156976473|NCT03403426|566667481|FG000|Overall Study|Death|1|||
156976474|NCT03403426|566667481|FG000|Overall Study|Lost to Follow-up|2|||
156976475|NCT01657266|566667485|FG000|Overall Study|Lost to Follow-up|2|||
156976476|NCT01657266|566667486|FG001|Overall Study|Lost to Follow-up|2|||
156976477|NCT01657266|566667485|FG000|Overall Study|Adverse Event|2|||
156976478|NCT01657266|566667486|FG001|Overall Study|Adverse Event|3|||
156976479|NCT03520400|566667487|FG000|Overall Study|Physician Decision|15|||
156976480|NCT03520400|566667488|FG001|Overall Study|Physician Decision|7|||
156976481|NCT00445679|566667491|FG000|Overall Study|Adverse Event|22|||
156976482|NCT00445679|566667492|FG001|Overall Study|Adverse Event|12|||
156976483|NCT00445679|566667493|FG002|Overall Study|Adverse Event|30|||
156976484|NCT00445679|566667494|FG003|Overall Study|Adverse Event|19|||
156976485|NCT00445679|566667491|FG000|Overall Study|Failed to return|1|||
156976486|NCT00445679|566667492|FG001|Overall Study|Failed to return|3|||
156976487|NCT00445679|566667493|FG002|Overall Study|Failed to return|2|||
156976488|NCT00445679|566667494|FG003|Overall Study|Failed to return|2|||
156976489|NCT00445679|566667491|FG000|Overall Study|Physician Decision|0|||
156976490|NCT00445679|566667492|FG001|Overall Study|Physician Decision|0|||
156976491|NCT00445679|566667493|FG002|Overall Study|Physician Decision|1|||
156976492|NCT00445679|566667494|FG003|Overall Study|Physician Decision|0|||
156976493|NCT00445679|566667491|FG000|Overall Study|Lost to Follow-up|10|||
156976494|NCT00445679|566667492|FG001|Overall Study|Lost to Follow-up|6|||
156976495|NCT00445679|566667493|FG002|Overall Study|Lost to Follow-up|6|||
156976496|NCT00445679|566667494|FG003|Overall Study|Lost to Follow-up|5|||
156976497|NCT00445679|566667491|FG000|Overall Study|Compliance|3|||
156976498|NCT00445679|566667492|FG001|Overall Study|Compliance|2|||
156976499|NCT00445679|566667493|FG002|Overall Study|Compliance|1|||
156976500|NCT00445679|566667494|FG003|Overall Study|Compliance|2|||
156976501|NCT00445679|566667491|FG000|Overall Study|Withdrawal of Informed Consent|0|||
156976502|NCT00445679|566667492|FG001|Overall Study|Withdrawal of Informed Consent|0|||
156976503|NCT00445679|566667493|FG002|Overall Study|Withdrawal of Informed Consent|1|||
156976504|NCT00445679|566667494|FG003|Overall Study|Withdrawal of Informed Consent|0|||
156976505|NCT00445679|566667491|FG000|Overall Study|Protocol Violation|2|||
156976506|NCT00445679|566667492|FG001|Overall Study|Protocol Violation|3|||
156976507|NCT00445679|566667493|FG002|Overall Study|Protocol Violation|3|||
156976508|NCT00445679|566667494|FG003|Overall Study|Protocol Violation|1|||
156976509|NCT00445679|566667491|FG000|Overall Study|Withdrawal by Subject|8|||
156976510|NCT00445679|566667492|FG001|Overall Study|Withdrawal by Subject|14|||
156976511|NCT00445679|566667493|FG002|Overall Study|Withdrawal by Subject|20|||
156976512|NCT00445679|566667494|FG003|Overall Study|Withdrawal by Subject|18|||
156976513|NCT00445679|566667491|FG000|Overall Study|Lack of Efficacy|2|||
156976514|NCT00445679|566667492|FG001|Overall Study|Lack of Efficacy|6|||
156976515|NCT00445679|566667493|FG002|Overall Study|Lack of Efficacy|2|||
156976516|NCT00445679|566667494|FG003|Overall Study|Lack of Efficacy|0|||
157181639|NCT01922739|567406611|FG000|Open-label Treatment Period|Protocol Violation|5|||
156976517|NCT01353222|566667497|FG000|Overall Study|Death|30|||
156976518|NCT01353222|566667498|FG001|Overall Study|Death|30|||
156976519|NCT01353222|566667497|FG000|Overall Study|Withdrawal by Subject|8|||
156976520|NCT01353222|566667498|FG001|Overall Study|Withdrawal by Subject|5|||
156976521|NCT01353222|566667497|FG000|Overall Study|Study Terminated|31|||
156976522|NCT01353222|566667498|FG001|Overall Study|Study Terminated|37|||
156976523|NCT01353222|566667497|FG000|Overall Study|Site closed research department|1|||
156976524|NCT01353222|566667498|FG001|Overall Study|Site closed research department|0|||
156976525|NCT01119898|566667499|FG000|Overall Study|Adverse Event|4|||
156976526|NCT01119898|566667500|FG001|Overall Study|Adverse Event|5|||
156976527|NCT01119898|566667499|FG000|Overall Study|Withdrawal by Subject|1|||
156976528|NCT01119898|566667500|FG001|Overall Study|Withdrawal by Subject|4|||
156976529|NCT01119898|566667499|FG000|Overall Study|Lack of Efficacy|0|||
156976530|NCT01119898|566667500|FG001|Overall Study|Lack of Efficacy|2|||
156976531|NCT01119898|566667499|FG000|Overall Study|Protocol Violation|1|||
156976532|NCT01119898|566667500|FG001|Overall Study|Protocol Violation|1|||
156976533|NCT01119898|566667499|FG000|Overall Study|Medical procedure|1|||
156976534|NCT01119898|566667500|FG001|Overall Study|Medical procedure|0|||
156976535|NCT01119898|566667499|FG000|Overall Study|Randomized in error did not participate|1|||
156976536|NCT01119898|566667500|FG001|Overall Study|Randomized in error did not participate|0|||
156976537|NCT02217280|566667503|FG000|Overall Study|Withdrawal by Subject|2|||
156976538|NCT02217280|566667503|FG000|Overall Study|Post-consent sceen fail|2|||
156976539|NCT00116844|566667506|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
156976540|NCT00116844|566667507|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
156976541|NCT00116844|566667506|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
156976542|NCT00116844|566667507|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
156976543|NCT00116844|566667506|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
156976544|NCT00116844|566667507|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
156976545|NCT00116844|566667506|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
156976546|NCT00116844|566667507|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
156976547|NCT00116844|566667506|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
156976548|NCT00116844|566667507|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
156976549|NCT00116844|566667506|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
156976550|NCT00116844|566667507|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
156976551|NCT00116844|566667506|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
156976552|NCT00116844|566667507|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
156976553|NCT00116844|566667506|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
156976554|NCT00116844|566667507|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
156976555|NCT00116844|566667506|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
156976556|NCT00116844|566667507|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
156976557|NCT01933880|566667508|FG000|Overall Study|Withdrawal by Subject|5|||
156976558|NCT01933880|566667509|FG001|Overall Study|Withdrawal by Subject|0|||
156976559|NCT01933880|566667508|FG000|Overall Study|Lack of Efficacy|1|||
156976560|NCT01933880|566667509|FG001|Overall Study|Lack of Efficacy|0|||
156976561|NCT01933880|566667508|FG000|Overall Study|Concomitant medication Interference|0|||
156976562|NCT01933880|566667509|FG001|Overall Study|Concomitant medication Interference|1|||
156976563|NCT01933880|566667508|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
156976564|NCT01933880|566667509|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
156976565|NCT01933880|566667508|FG000|Overall Study|Other|4|||
156976566|NCT01933880|566667509|FG001|Overall Study|Other|0|||
156976567|NCT01933880|566667508|FG000|Overall Study|Protocol Violation|1|||
156976568|NCT01933880|566667509|FG001|Overall Study|Protocol Violation|0|||
156976569|NCT01125722|566667510|FG000|Overall Study|Withdrawal by Subject|2|||
156976570|NCT01125722|566667511|FG001|Overall Study|Withdrawal by Subject|1|||
156976571|NCT01125722|566667510|FG000|Overall Study|Lost to Follow-up|1|||
156976572|NCT01125722|566667511|FG001|Overall Study|Lost to Follow-up|0|||
156976573|NCT03474549|566667514|FG000|Overall Study|Death|31|||
156976574|NCT03474549|566667514|FG000|Overall Study|Lost to Follow-up|4|||
156976575|NCT03474549|566667514|FG000|Overall Study|Withdrawal by Subject|2|||
156976576|NCT01861522|566667515|FG000|Overall Study|Adverse Event|1|||
156976577|NCT01861522|566667516|FG001|Overall Study|Adverse Event|0|||
156976578|NCT01861522|566667515|FG000|Overall Study|Withdrawal by Subject|2|||
156976579|NCT01861522|566667516|FG001|Overall Study|Withdrawal by Subject|0|||
156976580|NCT03573908|566667520|FG000|Treatment Period|Adverse Event|4|||
156976581|NCT03573908|566667521|FG001|Treatment Period|Adverse Event|9|||
156976582|NCT03573908|566667522|FG002|Treatment Period|Adverse Event|0|||
156976583|NCT03573908|566667523|FG003|Treatment Period|Adverse Event|0|||
156976584|NCT03573908|566667524|FG004|Treatment Period|Adverse Event|0|||
156976585|NCT03573908|566667520|FG000|Treatment Period|Protocol Violation|1|||
156976586|NCT03573908|566667521|FG001|Treatment Period|Protocol Violation|0|||
156976587|NCT03573908|566667522|FG002|Treatment Period|Protocol Violation|0|||
156976588|NCT03573908|566667523|FG003|Treatment Period|Protocol Violation|0|||
156976589|NCT03573908|566667524|FG004|Treatment Period|Protocol Violation|0|||
156976590|NCT03573908|566667520|FG000|Treatment Period|Withdrawal by Subject|7|||
156976591|NCT03573908|566667521|FG001|Treatment Period|Withdrawal by Subject|5|||
156976592|NCT03573908|566667522|FG002|Treatment Period|Withdrawal by Subject|0|||
156976593|NCT03573908|566667523|FG003|Treatment Period|Withdrawal by Subject|0|||
156976594|NCT03573908|566667524|FG004|Treatment Period|Withdrawal by Subject|0|||
156976595|NCT03573908|566667520|FG000|Treatment Period|Lost to Follow-up|7|||
156976596|NCT03573908|566667521|FG001|Treatment Period|Lost to Follow-up|6|||
156976597|NCT03573908|566667522|FG002|Treatment Period|Lost to Follow-up|0|||
156976598|NCT03573908|566667523|FG003|Treatment Period|Lost to Follow-up|0|||
156976599|NCT03573908|566667524|FG004|Treatment Period|Lost to Follow-up|0|||
157059014|NCT00784277|566970059|FG000|ER Treatment|Withdrawal by Subject|0|||
157059015|NCT00784277|566970060|FG001|ER Treatment|Withdrawal by Subject|0|||
157059016|NCT00784277|566970061|FG002|ER Treatment|Withdrawal by Subject|0|||
157059017|NCT00784277|566970062|FG003|ER Treatment|Withdrawal by Subject|0|||
157059018|NCT00784277|566970063|FG004|ER Treatment|Withdrawal by Subject|2|||
157059019|NCT00784277|566970064|FG005|ER Treatment|Withdrawal by Subject|5|||
157059020|NCT00784277|566970065|FG006|ER Treatment|Withdrawal by Subject|3|||
157059021|NCT00784277|566970059|FG000|ER Treatment|Study Medication Non-Compliant|0|||
157059022|NCT00784277|566970060|FG001|ER Treatment|Study Medication Non-Compliant|0|||
157059023|NCT00784277|566970061|FG002|ER Treatment|Study Medication Non-Compliant|0|||
157059024|NCT00784277|566970062|FG003|ER Treatment|Study Medication Non-Compliant|0|||
157059025|NCT00784277|566970063|FG004|ER Treatment|Study Medication Non-Compliant|2|||
157059026|NCT00784277|566970064|FG005|ER Treatment|Study Medication Non-Compliant|3|||
157059027|NCT00784277|566970065|FG006|ER Treatment|Study Medication Non-Compliant|3|||
157059028|NCT00784277|566970059|FG000|ER Treatment|Other|0|||
157059029|NCT00784277|566970060|FG001|ER Treatment|Other|0|||
157181640|NCT01922739|567406611|FG000|Open-label Treatment Period|Pregnancy|1|||
157181641|NCT01922739|567406611|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
157181642|NCT01922739|567406611|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
157181643|NCT01922739|567406611|FG000|Open-label Treatment Period|Physician Decision|1|||
157181644|NCT01922739|567406611|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
157181645|NCT00044213|567406612|FG000|Overall Study|Withdrawal by Subject|50|||
157181646|NCT00044213|567406613|FG001|Overall Study|Withdrawal by Subject|65|||
157181647|NCT00044213|567406614|FG002|Overall Study|Withdrawal by Subject|91|||
157181648|NCT00044213|567406615|FG003|Overall Study|Withdrawal by Subject|83|||
157181649|NCT00044213|567406612|FG000|Overall Study|Death|42|||
157181650|NCT00044213|567406613|FG001|Overall Study|Death|42|||
157181651|NCT00044213|567406614|FG002|Overall Study|Death|42|||
157181652|NCT00044213|567406615|FG003|Overall Study|Death|49|||
157181653|NCT00044213|567406612|FG000|Overall Study|Lost to Follow-up|8|||
157181654|NCT00044213|567406613|FG001|Overall Study|Lost to Follow-up|5|||
157181655|NCT00044213|567406614|FG002|Overall Study|Lost to Follow-up|5|||
157181656|NCT00044213|567406615|FG003|Overall Study|Lost to Follow-up|4|||
157181657|NCT00422240|567406616|FG000|Overall Study|Lack of Efficacy|1|||
157181658|NCT00422240|567406617|FG001|Overall Study|Lack of Efficacy|2|||
157181659|NCT00422240|567406618|FG002|Overall Study|Lack of Efficacy|0|||
157181660|NCT00422240|567406619|FG003|Overall Study|Lack of Efficacy|1|||
157181661|NCT00422240|567406616|FG000|Overall Study|Adverse Event|11|||
157181662|NCT00422240|567406617|FG001|Overall Study|Adverse Event|4|||
157181663|NCT00422240|567406618|FG002|Overall Study|Adverse Event|5|||
157181664|NCT00422240|567406619|FG003|Overall Study|Adverse Event|2|||
157181665|NCT00422240|567406616|FG000|Overall Study|Subject request|21|||
157059030|NCT00784277|566970061|FG002|ER Treatment|Other|0|||
157059031|NCT00784277|566970062|FG003|ER Treatment|Other|0|||
157059032|NCT00784277|566970063|FG004|ER Treatment|Other|1|||
157059033|NCT00784277|566970064|FG005|ER Treatment|Other|3|||
157059034|NCT00784277|566970065|FG006|ER Treatment|Other|2|||
157059035|NCT01093222|566970066|FG000|Overall Study|Ineligible|6|||
157059036|NCT01093222|566970066|FG000|Overall Study|Adverse Event|7|||
157059037|NCT01093222|566970066|FG000|Overall Study|Progression/relapse|24|||
157059038|NCT01093222|566970066|FG000|Overall Study|Death|2|||
157059039|NCT01093222|566970066|FG000|Overall Study|Not protocol specified|1|||
157059040|NCT02642159|566970067|FG000|Overall Study|Randomized but not treated|1|||
157059041|NCT02642159|566970068|FG001|Overall Study|Randomized but not treated|0|||
157059042|NCT02642159|566970067|FG000|Overall Study|Adverse Event|10|||
157059043|NCT02642159|566970068|FG001|Overall Study|Adverse Event|4|||
157059044|NCT02642159|566970067|FG000|Overall Study|Withdrawal by Subject|9|||
157059045|NCT02642159|566970068|FG001|Overall Study|Withdrawal by Subject|1|||
157059046|NCT02642159|566970067|FG000|Overall Study|Poor compliance to study protocol|1|||
157059047|NCT02642159|566970068|FG001|Overall Study|Poor compliance to study protocol|0|||
157229880|NCT04099888|567588170|FG000|Overall Study|Withdrawal by Subject|5|||
157229881|NCT04099888|567588171|FG001|Overall Study|Withdrawal by Subject|6|||
157181666|NCT00422240|567406617|FG001|Overall Study|Subject request|17|||
157229882|NCT04099888|567588170|FG000|Overall Study|Death|5|||
157059048|NCT02642159|566970067|FG000|Overall Study|Other than specified above|10|||
157059049|NCT02642159|566970068|FG001|Overall Study|Other than specified above|3|||
157181667|NCT00422240|567406618|FG002|Overall Study|Subject request|18|||
157181668|NCT00422240|567406619|FG003|Overall Study|Subject request|30|||
157181669|NCT00422240|567406616|FG000|Overall Study|Protocol Violation|0|||
157229883|NCT04099888|567588171|FG001|Overall Study|Death|2|||
157181670|NCT00422240|567406617|FG001|Overall Study|Protocol Violation|1|||
157229884|NCT04099888|567588170|FG000|Overall Study|Other|1|||
157229885|NCT04099888|567588171|FG001|Overall Study|Other|0|||
157059050|NCT03280108|566970072|FG000|Overall Study|Lost to Follow-up|2|||
157059051|NCT03280108|566970073|FG001|Overall Study|Lost to Follow-up|0|||
157059052|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
157181671|NCT00422240|567406618|FG002|Overall Study|Protocol Violation|0|||
157181672|NCT00422240|567406619|FG003|Overall Study|Protocol Violation|1|||
157181673|NCT00422240|567406616|FG000|Overall Study|Lost to Follow-up|31|||
157181674|NCT00422240|567406617|FG001|Overall Study|Lost to Follow-up|32|||
157181675|NCT00422240|567406618|FG002|Overall Study|Lost to Follow-up|19|||
157181676|NCT00422240|567406619|FG003|Overall Study|Lost to Follow-up|34|||
157181677|NCT00422240|567406616|FG000|Overall Study|Other|1|||
157181678|NCT00422240|567406617|FG001|Overall Study|Other|0|||
157181679|NCT00422240|567406618|FG002|Overall Study|Other|0|||
157181680|NCT00422240|567406619|FG003|Overall Study|Other|1|||
157181681|NCT00422240|567406616|FG000|Overall Study|Pregnancy|3|||
157181682|NCT00422240|567406617|FG001|Overall Study|Pregnancy|1|||
157181683|NCT00422240|567406618|FG002|Overall Study|Pregnancy|1|||
157181684|NCT00422240|567406619|FG003|Overall Study|Pregnancy|2|||
157181685|NCT01927068|567406623|FG000|Overall Study|Death|37|||
157181686|NCT01927068|567406624|FG001|Overall Study|Death|3|||
157181687|NCT01927068|567406623|FG000|Overall Study|Withdrawal by Subject|50|||
157181688|NCT01927068|567406624|FG001|Overall Study|Withdrawal by Subject|3|||
157181689|NCT01927068|567406623|FG000|Overall Study|Lost to Follow-up|10|||
157181690|NCT01927068|567406624|FG001|Overall Study|Lost to Follow-up|2|||
157181691|NCT01927068|567406623|FG000|Overall Study|Physician Decision|9|||
157181692|NCT01927068|567406624|FG001|Overall Study|Physician Decision|0|||
157181693|NCT01927068|567406623|FG000|Overall Study|Missed last follow-up visit|2|||
157181694|NCT01927068|567406624|FG001|Overall Study|Missed last follow-up visit|0|||
157181695|NCT00880607|567406625|FG000|Overall Study|Physician Decision|2|||
157181696|NCT00880607|567406626|FG001|Overall Study|Physician Decision|2|||
157181697|NCT00880607|567406625|FG000|Overall Study|Protocol Violation|2|||
157181698|NCT00880607|567406626|FG001|Overall Study|Protocol Violation|1|||
157181699|NCT00880607|567406625|FG000|Overall Study|surgery did not extend past L1 level|3|||
157181700|NCT00880607|567406626|FG001|Overall Study|surgery did not extend past L1 level|0|||
157181701|NCT05104749|567406627|FG000|Overall Study|Lost to Follow-up|2|||
157181702|NCT05104749|567406628|FG001|Overall Study|Lost to Follow-up|3|||
157181703|NCT02963766|567406629|FG000|Double-Blind Period|Adverse Event|1|||
157181704|NCT02963766|567406630|FG001|Double-Blind Period|Adverse Event|0|||
157181705|NCT02963766|567406631|FG002|Double-Blind Period|Adverse Event|1|||
157181706|NCT02963766|567406629|FG000|Double-Blind Period|Physician Decision|1|||
157181707|NCT02963766|567406630|FG001|Double-Blind Period|Physician Decision|0|||
157181708|NCT02963766|567406631|FG002|Double-Blind Period|Physician Decision|0|||
157181709|NCT02963766|567406629|FG000|Double-Blind Period|Withdrawal by Subject|1|||
157181710|NCT02963766|567406630|FG001|Double-Blind Period|Withdrawal by Subject|1|||
157181711|NCT02963766|567406631|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157181712|NCT02963766|567406629|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
157181713|NCT02963766|567406630|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
157181714|NCT02963766|567406631|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
157181715|NCT02963766|567406629|FG000|Double-Blind Period|Protocol Violation|1|||
157181716|NCT02963766|567406630|FG001|Double-Blind Period|Protocol Violation|0|||
157181717|NCT02963766|567406631|FG002|Double-Blind Period|Protocol Violation|0|||
157181718|NCT02963766|567406629|FG000|Double-Blind Period|Lost to Follow-up|0|||
157181719|NCT02963766|567406630|FG001|Double-Blind Period|Lost to Follow-up|1|||
157181720|NCT02963766|567406631|FG002|Double-Blind Period|Lost to Follow-up|0|||
157181721|NCT02963766|567406629|FG000|Open Label Extension (OLE)|Physician Decision|1|||
157181722|NCT02963766|567406630|FG001|Open Label Extension (OLE)|Physician Decision|2|||
157181723|NCT02963766|567406631|FG002|Open Label Extension (OLE)|Physician Decision|2|||
157181724|NCT02963766|567406629|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
157181725|NCT02963766|567406630|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
157181726|NCT02963766|567406631|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
157181727|NCT02224274|567406634|FG000|Overall Study|Death|1|||
157181728|NCT02224274|567406635|FG001|Overall Study|Death|0|||
157181729|NCT00499460|567406636|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
157181730|NCT00499460|567406637|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
157181731|NCT00499460|567406636|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
157229886|NCT04538170|567588174|FG000|Overall Study|Withdrawal by Subject|104|||
157229887|NCT04538170|567588175|FG001|Overall Study|Withdrawal by Subject|210|||
157229888|NCT02932878|567588179|FG000|Overall Study|Due to Lab Results|2|||
157229889|NCT02932878|567588180|FG001|Overall Study|Due to Lab Results|1|||
157229890|NCT01866319|567588181|FG000|Overall Study|Adverse Event|12|||
157229891|NCT01866319|567588182|FG001|Overall Study|Adverse Event|5|||
156976600|NCT03573908|566667520|FG000|Treatment Period|Pregnancy|1|||
157181732|NCT00499460|567406637|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
157181733|NCT00499460|567406636|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
157181734|NCT00499460|567406637|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
157181735|NCT00887068|567406638|FG000|Overall Study|Withdrawal by Subject|2|||
157181736|NCT00887068|567406639|FG001|Overall Study|Withdrawal by Subject|0|||
157181737|NCT00887068|567406638|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
157181738|NCT00887068|567406639|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
157181739|NCT03073200|567406641|FG000|Double Blind Treatment Period|Protocol Violation|1|||
157181740|NCT03073200|567406642|FG001|Double Blind Treatment Period|Protocol Violation|0|||
157181741|NCT03073200|567406643|FG002|Double Blind Treatment Period|Protocol Violation|0|||
157181742|NCT03073200|567406644|FG003|Double Blind Treatment Period|Protocol Violation|0|||
157181743|NCT03073200|567406645|FG004|Double Blind Treatment Period|Protocol Violation|0|||
157181744|NCT03073200|567406646|FG005|Double Blind Treatment Period|Protocol Violation|0|||
157181745|NCT03073200|567406647|FG006|Double Blind Treatment Period|Protocol Violation|0|||
157181746|NCT03073200|567406648|FG007|Double Blind Treatment Period|Protocol Violation|0|||
157181747|NCT03073200|567406649|FG008|Double Blind Treatment Period|Protocol Violation|0|||
157181748|NCT03073200|567406650|FG009|Double Blind Treatment Period|Protocol Violation|0|||
157181749|NCT03073200|567406651|FG010|Double Blind Treatment Period|Protocol Violation|0|||
157181750|NCT03073200|567406652|FG011|Double Blind Treatment Period|Protocol Violation|0|||
157181751|NCT03073200|567406653|FG012|Double Blind Treatment Period|Protocol Violation|0|||
157181752|NCT03073200|567406654|FG013|Double Blind Treatment Period|Protocol Violation|0|||
157181753|NCT03073200|567406655|FG014|Double Blind Treatment Period|Protocol Violation|0|||
157181754|NCT03073200|567406641|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181755|NCT03073200|567406642|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
157181756|NCT03073200|567406643|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181757|NCT03073200|567406644|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181758|NCT03073200|567406645|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181759|NCT03073200|567406646|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181760|NCT03073200|567406647|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181761|NCT03073200|567406648|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181762|NCT03073200|567406649|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181763|NCT03073200|567406650|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181764|NCT03073200|567406651|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181765|NCT03073200|567406652|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181766|NCT03073200|567406653|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181767|NCT03073200|567406654|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181768|NCT03073200|567406655|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
157181769|NCT03073200|567406641|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
157181770|NCT03073200|567406642|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181771|NCT03073200|567406643|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181772|NCT03073200|567406644|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181773|NCT03073200|567406645|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181774|NCT03073200|567406646|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181775|NCT03073200|567406647|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181776|NCT03073200|567406648|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181777|NCT03073200|567406649|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181778|NCT03073200|567406650|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181779|NCT03073200|567406651|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181780|NCT03073200|567406652|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181781|NCT03073200|567406653|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181782|NCT03073200|567406654|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181783|NCT03073200|567406655|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
157181784|NCT03073200|567406641|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181785|NCT03073200|567406642|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181786|NCT03073200|567406643|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181787|NCT03073200|567406644|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
157181788|NCT03073200|567406645|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
157181789|NCT03073200|567406646|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181790|NCT03073200|567406647|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181791|NCT03073200|567406648|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181792|NCT03073200|567406649|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181793|NCT03073200|567406650|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181794|NCT03073200|567406651|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181795|NCT03073200|567406652|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181796|NCT03073200|567406653|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181797|NCT03073200|567406654|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181798|NCT03073200|567406655|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
157181799|NCT03073200|567406641|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
157181800|NCT03073200|567406642|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
157181801|NCT03073200|567406643|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
157181802|NCT03073200|567406644|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
157181803|NCT03073200|567406645|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
157229892|NCT01866319|567588183|FG002|Overall Study|Adverse Event|9|||
157229893|NCT01866319|567588181|FG000|Overall Study|Clinical progression|3|||
157229894|NCT01866319|567588182|FG001|Overall Study|Clinical progression|2|||
157181804|NCT03073200|567406646|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
157181805|NCT03073200|567406647|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
157181806|NCT03073200|567406648|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
157181807|NCT03073200|567406649|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
157181808|NCT03073200|567406650|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
157181809|NCT03073200|567406651|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
157181810|NCT03073200|567406652|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
157181811|NCT03073200|567406653|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
157181812|NCT03073200|567406654|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
157181813|NCT03073200|567406655|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
157181814|NCT03073200|567406641|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181815|NCT03073200|567406642|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181816|NCT03073200|567406643|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181817|NCT03073200|567406644|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181818|NCT03073200|567406645|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
157181819|NCT03073200|567406646|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181820|NCT03073200|567406647|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181821|NCT03073200|567406648|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181822|NCT03073200|567406649|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181823|NCT03073200|567406650|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181824|NCT03073200|567406651|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181825|NCT03073200|567406652|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181826|NCT03073200|567406653|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181827|NCT03073200|567406654|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181828|NCT03073200|567406655|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
157181829|NCT03073200|567406641|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181830|NCT03073200|567406642|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181831|NCT03073200|567406643|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181832|NCT03073200|567406644|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
157181833|NCT03073200|567406645|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
157181834|NCT03073200|567406646|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181835|NCT03073200|567406647|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181836|NCT03073200|567406648|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181837|NCT03073200|567406649|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181838|NCT03073200|567406650|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181839|NCT03073200|567406651|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181840|NCT03073200|567406652|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157059053|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157059054|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157059055|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157059056|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
157059057|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
157059058|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157059059|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157059060|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157059061|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
157059062|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
157059063|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157059064|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157059065|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157059066|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
157059067|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
157059068|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157059069|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157059070|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157059071|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
157059072|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
157059073|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157059074|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157059075|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157059076|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
157059077|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
157181841|NCT03073200|567406653|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181842|NCT03073200|567406654|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157059078|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157059079|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157059080|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157059081|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
157181843|NCT03073200|567406655|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
157181844|NCT03073200|567406641|FG000|Extension Period|Lost to Follow-up|0|||
157181845|NCT03073200|567406642|FG001|Extension Period|Lost to Follow-up|0|||
157181846|NCT03073200|567406643|FG002|Extension Period|Lost to Follow-up|0|||
157181847|NCT03073200|567406644|FG003|Extension Period|Lost to Follow-up|0|||
157181848|NCT03073200|567406645|FG004|Extension Period|Lost to Follow-up|0|||
157181849|NCT03073200|567406646|FG005|Extension Period|Lost to Follow-up|0|||
157181850|NCT03073200|567406647|FG006|Extension Period|Lost to Follow-up|1|||
157181851|NCT03073200|567406648|FG007|Extension Period|Lost to Follow-up|1|||
157181852|NCT03073200|567406649|FG008|Extension Period|Lost to Follow-up|0|||
157181853|NCT03073200|567406650|FG009|Extension Period|Lost to Follow-up|0|||
157181854|NCT03073200|567406651|FG010|Extension Period|Lost to Follow-up|0|||
157181855|NCT03073200|567406652|FG011|Extension Period|Lost to Follow-up|0|||
157181856|NCT03073200|567406653|FG012|Extension Period|Lost to Follow-up|0|||
157181857|NCT03073200|567406654|FG013|Extension Period|Lost to Follow-up|0|||
157181858|NCT03073200|567406655|FG014|Extension Period|Lost to Follow-up|0|||
157181859|NCT03073200|567406641|FG000|Extension Period|Sponsor Decision|0|||
157181860|NCT03073200|567406642|FG001|Extension Period|Sponsor Decision|0|||
157181861|NCT03073200|567406643|FG002|Extension Period|Sponsor Decision|0|||
157181862|NCT03073200|567406644|FG003|Extension Period|Sponsor Decision|0|||
157181863|NCT03073200|567406645|FG004|Extension Period|Sponsor Decision|0|||
157181864|NCT03073200|567406646|FG005|Extension Period|Sponsor Decision|0|||
157181865|NCT03073200|567406647|FG006|Extension Period|Sponsor Decision|0|||
157181866|NCT03073200|567406648|FG007|Extension Period|Sponsor Decision|0|||
157181867|NCT03073200|567406649|FG008|Extension Period|Sponsor Decision|1|||
157181868|NCT03073200|567406650|FG009|Extension Period|Sponsor Decision|0|||
157181869|NCT03073200|567406651|FG010|Extension Period|Sponsor Decision|0|||
157181870|NCT03073200|567406652|FG011|Extension Period|Sponsor Decision|0|||
157181871|NCT03073200|567406653|FG012|Extension Period|Sponsor Decision|0|||
157181872|NCT03073200|567406654|FG013|Extension Period|Sponsor Decision|0|||
157181873|NCT03073200|567406655|FG014|Extension Period|Sponsor Decision|0|||
157181874|NCT03073200|567406641|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
157181875|NCT03073200|567406642|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
157181876|NCT03073200|567406643|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
157181877|NCT03073200|567406644|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
157181878|NCT03073200|567406645|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
157181879|NCT03073200|567406646|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
157181880|NCT03073200|567406647|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
157181881|NCT03073200|567406648|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
157181882|NCT03073200|567406649|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
157181883|NCT03073200|567406650|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
157181884|NCT03073200|567406651|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
157181885|NCT03073200|567406652|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
157181886|NCT03073200|567406653|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
157181887|NCT03073200|567406654|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
157181888|NCT03073200|567406655|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
157181889|NCT03073200|567406641|FG000|Extension Period|Withdrawal by Subject|0|||
157181890|NCT03073200|567406642|FG001|Extension Period|Withdrawal by Subject|0|||
157181891|NCT03073200|567406643|FG002|Extension Period|Withdrawal by Subject|0|||
157181892|NCT03073200|567406644|FG003|Extension Period|Withdrawal by Subject|0|||
157181893|NCT03073200|567406645|FG004|Extension Period|Withdrawal by Subject|0|||
157181894|NCT03073200|567406646|FG005|Extension Period|Withdrawal by Subject|0|||
157181895|NCT03073200|567406647|FG006|Extension Period|Withdrawal by Subject|1|||
157181896|NCT03073200|567406648|FG007|Extension Period|Withdrawal by Subject|2|||
157181897|NCT03073200|567406649|FG008|Extension Period|Withdrawal by Subject|0|||
157181898|NCT03073200|567406650|FG009|Extension Period|Withdrawal by Subject|0|||
157181899|NCT03073200|567406651|FG010|Extension Period|Withdrawal by Subject|0|||
157181900|NCT03073200|567406652|FG011|Extension Period|Withdrawal by Subject|0|||
157181901|NCT03073200|567406653|FG012|Extension Period|Withdrawal by Subject|0|||
157181902|NCT03073200|567406654|FG013|Extension Period|Withdrawal by Subject|0|||
157181903|NCT03073200|567406655|FG014|Extension Period|Withdrawal by Subject|0|||
157181904|NCT03073200|567406641|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
157059082|NCT01187407|566970074|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
157059083|NCT01187407|566970075|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157059084|NCT01187407|566970076|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157059085|NCT01187407|566970077|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157181905|NCT03073200|567406642|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181906|NCT03073200|567406643|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181907|NCT03073200|567406644|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181908|NCT03073200|567406645|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181909|NCT03073200|567406646|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181910|NCT03073200|567406647|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181911|NCT03073200|567406648|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
157229895|NCT01866319|567588183|FG002|Overall Study|Clinical progression|2|||
157229896|NCT01866319|567588181|FG000|Overall Study|Death|153|||
157229897|NCT01866319|567588182|FG001|Overall Study|Death|154|||
157229898|NCT01866319|567588183|FG002|Overall Study|Death|147|||
157229899|NCT01866319|567588181|FG000|Overall Study|Lost to Follow-up|6|||
157229900|NCT01866319|567588182|FG001|Overall Study|Lost to Follow-up|3|||
157229901|NCT01866319|567588183|FG002|Overall Study|Lost to Follow-up|8|||
157229902|NCT01866319|567588181|FG000|Overall Study|Physician Decision|1|||
157229903|NCT01866319|567588182|FG001|Overall Study|Physician Decision|0|||
157229904|NCT01866319|567588183|FG002|Overall Study|Physician Decision|1|||
157229905|NCT01866319|567588181|FG000|Overall Study|Protocol Violation|0|||
157229906|NCT01866319|567588182|FG001|Overall Study|Protocol Violation|0|||
157229907|NCT01866319|567588183|FG002|Overall Study|Protocol Violation|1|||
157229908|NCT01866319|567588181|FG000|Overall Study|Withdrawal by Subject|32|||
157229909|NCT01866319|567588182|FG001|Overall Study|Withdrawal by Subject|14|||
157229910|NCT01866319|567588183|FG002|Overall Study|Withdrawal by Subject|12|||
157229911|NCT02191891|567588188|FG000|Overall Study|Withdrawal by Subject|0|||
157229912|NCT02191891|567588189|FG001|Overall Study|Withdrawal by Subject|1|||
157229913|NCT02191891|567588190|FG002|Overall Study|Withdrawal by Subject|0|||
157229914|NCT02191891|567588191|FG003|Overall Study|Withdrawal by Subject|0|||
157229915|NCT02191891|567588192|FG004|Overall Study|Withdrawal by Subject|1|||
157059086|NCT01187407|566970078|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
157059087|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
157059088|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
157059089|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
157059090|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
157059091|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
157059092|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
157181912|NCT03073200|567406649|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181913|NCT03073200|567406650|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181914|NCT03073200|567406651|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181915|NCT03073200|567406652|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
157181916|NCT03073200|567406653|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181917|NCT03073200|567406654|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181918|NCT03073200|567406655|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
157181919|NCT03073200|567406641|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181920|NCT03073200|567406642|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181921|NCT03073200|567406643|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181922|NCT03073200|567406644|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181923|NCT03073200|567406645|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181924|NCT03073200|567406646|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181925|NCT03073200|567406647|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181926|NCT03073200|567406648|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181927|NCT03073200|567406649|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181928|NCT03073200|567406650|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181929|NCT03073200|567406651|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181930|NCT03073200|567406652|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
157181931|NCT03073200|567406653|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181932|NCT03073200|567406654|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181933|NCT03073200|567406655|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
157181934|NCT03073200|567406641|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181935|NCT03073200|567406642|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181936|NCT03073200|567406643|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181937|NCT03073200|567406644|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181938|NCT03073200|567406645|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181939|NCT03073200|567406646|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181940|NCT03073200|567406647|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181941|NCT03073200|567406648|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181942|NCT03073200|567406649|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157229916|NCT02191891|567588188|FG000|Overall Study|Adverse Event|0|||
157229917|NCT02191891|567588189|FG001|Overall Study|Adverse Event|1|||
157229918|NCT02191891|567588190|FG002|Overall Study|Adverse Event|0|||
157229919|NCT02191891|567588191|FG003|Overall Study|Adverse Event|0|||
157229920|NCT02191891|567588192|FG004|Overall Study|Adverse Event|2|||
157229921|NCT02191891|567588188|FG000|Overall Study|Disease Progression|4|||
157229922|NCT02191891|567588189|FG001|Overall Study|Disease Progression|10|||
157229923|NCT02191891|567588190|FG002|Overall Study|Disease Progression|4|||
157229924|NCT02191891|567588191|FG003|Overall Study|Disease Progression|2|||
157229925|NCT02191891|567588192|FG004|Overall Study|Disease Progression|7|||
157229926|NCT01448057|567588196|FG000|Overall Study|Protocol Violation|3|||
157229927|NCT01448057|567588197|FG001|Overall Study|Protocol Violation|2|||
157181943|NCT03073200|567406650|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181944|NCT03073200|567406651|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
157181945|NCT03073200|567406652|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
157181946|NCT03073200|567406653|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181947|NCT03073200|567406654|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181948|NCT03073200|567406655|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157181949|NCT03073200|567406641|FG000|Randomized Withdrawal Period|Adverse Event|0|||
157181950|NCT03073200|567406642|FG001|Randomized Withdrawal Period|Adverse Event|0|||
157181951|NCT03073200|567406643|FG002|Randomized Withdrawal Period|Adverse Event|0|||
157181952|NCT03073200|567406644|FG003|Randomized Withdrawal Period|Adverse Event|0|||
157181953|NCT03073200|567406645|FG004|Randomized Withdrawal Period|Adverse Event|0|||
157181954|NCT03073200|567406646|FG005|Randomized Withdrawal Period|Adverse Event|0|||
157181955|NCT03073200|567406647|FG006|Randomized Withdrawal Period|Adverse Event|0|||
157181956|NCT03073200|567406648|FG007|Randomized Withdrawal Period|Adverse Event|0|||
157181957|NCT03073200|567406649|FG008|Randomized Withdrawal Period|Adverse Event|0|||
157181958|NCT03073200|567406650|FG009|Randomized Withdrawal Period|Adverse Event|0|||
157181959|NCT03073200|567406651|FG010|Randomized Withdrawal Period|Adverse Event|1|||
157181960|NCT03073200|567406652|FG011|Randomized Withdrawal Period|Adverse Event|0|||
157181961|NCT03073200|567406653|FG012|Randomized Withdrawal Period|Adverse Event|0|||
157181962|NCT03073200|567406654|FG013|Randomized Withdrawal Period|Adverse Event|0|||
157181963|NCT03073200|567406655|FG014|Randomized Withdrawal Period|Adverse Event|0|||
157181964|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181965|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181966|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181967|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181968|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181969|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181970|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181971|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181972|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181973|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181974|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181975|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181976|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181977|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
157181978|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
157181979|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181980|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181981|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181982|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181983|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181984|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181985|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181986|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181987|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181988|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181989|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181990|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181991|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181992|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
157181993|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157181994|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157181995|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157181996|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157181997|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157181998|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157181999|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182000|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182001|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182002|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182003|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182004|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182005|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182006|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182007|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
157182008|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
157182009|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157229928|NCT01448057|567588196|FG000|Overall Study|Lost to Follow-up|3|||
157182010|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182011|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182012|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182013|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182014|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182015|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157059093|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
157059094|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
157182016|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182017|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182018|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182019|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182020|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182021|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182022|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
157182023|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157182024|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182025|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182026|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182027|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182028|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182029|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182030|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182031|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182032|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182033|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182034|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182035|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182036|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182037|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
157182038|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
157182039|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182040|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182041|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182042|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182043|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182044|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182045|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182046|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182047|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182048|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182049|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182050|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182051|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182052|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
157182053|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
157182054|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182055|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182056|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182057|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157229929|NCT01448057|567588197|FG001|Overall Study|Lost to Follow-up|0|||
157059095|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
157059096|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
157059097|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
157059098|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
157059099|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
157059100|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
157059101|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
157059102|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
157059103|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
157059104|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
157229930|NCT01448057|567588196|FG000|Overall Study|Adverse Event|0|||
157059105|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
157182058|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182059|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182060|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182061|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182062|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182063|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182064|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182065|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182066|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182067|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
157182068|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157182069|NCT03073200|567406641|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182070|NCT03073200|567406642|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182071|NCT03073200|567406643|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182072|NCT03073200|567406644|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182073|NCT03073200|567406645|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182074|NCT03073200|567406646|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182075|NCT03073200|567406647|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182076|NCT03073200|567406648|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182077|NCT03073200|567406649|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182078|NCT03073200|567406650|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182079|NCT03073200|567406651|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182080|NCT03073200|567406652|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182081|NCT03073200|567406653|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182082|NCT03073200|567406654|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
157182083|NCT03073200|567406655|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
157182084|NCT01474889|567406656|FG000|Overall Study|Physician Decision|1|||
157182085|NCT01474889|567406657|FG001|Overall Study|Physician Decision|0|||
157182086|NCT01474889|567406658|FG002|Overall Study|Physician Decision|0|||
157182087|NCT01474889|567406656|FG000|Overall Study|Did not meet inclusion|1|||
157182088|NCT01474889|567406657|FG001|Overall Study|Did not meet inclusion|0|||
157182089|NCT01474889|567406658|FG002|Overall Study|Did not meet inclusion|0|||
157182090|NCT01474889|567406656|FG000|Overall Study|Withdrawal by Subject|0|||
157182091|NCT01474889|567406657|FG001|Overall Study|Withdrawal by Subject|1|||
157182092|NCT01474889|567406658|FG002|Overall Study|Withdrawal by Subject|0|||
157182093|NCT00901394|567406659|FG000|Overall Study|Physician Decision|1|||
157182094|NCT00901394|567406660|FG001|Overall Study|Physician Decision|1|||
157182095|NCT00901394|567406661|FG002|Overall Study|Physician Decision|2|||
157182096|NCT02290340|567406663|FG000|Overall Study|Lost to Follow-up|0|||
157182097|NCT02290340|567406664|FG001|Overall Study|Lost to Follow-up|0|||
157182098|NCT02290340|567406665|FG002|Overall Study|Lost to Follow-up|0|||
157182099|NCT02290340|567406666|FG003|Overall Study|Lost to Follow-up|1|||
157182100|NCT02290340|567406663|FG000|Overall Study|Withdrawal by Subject|1|||
157182101|NCT02290340|567406664|FG001|Overall Study|Withdrawal by Subject|0|||
157182102|NCT02290340|567406665|FG002|Overall Study|Withdrawal by Subject|0|||
157182103|NCT02290340|567406666|FG003|Overall Study|Withdrawal by Subject|0|||
157182104|NCT02290340|567406663|FG000|Overall Study|Other|1|||
157182105|NCT02290340|567406664|FG001|Overall Study|Other|0|||
157182106|NCT02290340|567406665|FG002|Overall Study|Other|0|||
157182107|NCT02290340|567406666|FG003|Overall Study|Other|1|||
157182108|NCT04964557|567406670|FG000|Overall Study|Withdrawal by Subject|3|||
157182109|NCT04964557|567406671|FG001|Overall Study|Withdrawal by Subject|2|||
157182110|NCT04964557|567406670|FG000|Overall Study|Lost to Follow-up|1|||
157182111|NCT04964557|567406671|FG001|Overall Study|Lost to Follow-up|2|||
157182112|NCT04964557|567406670|FG000|Overall Study|Physician Decision|2|||
157182113|NCT04964557|567406671|FG001|Overall Study|Physician Decision|0|||
157182114|NCT04964557|567406670|FG000|Overall Study|Death|3|||
157182115|NCT04964557|567406671|FG001|Overall Study|Death|0|||
157182116|NCT04964557|567406670|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
157182117|NCT04964557|567406671|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
157182118|NCT03209362|567406673|FG000|Overall Study|Adverse Event|0|||
157182119|NCT03209362|567406674|FG001|Overall Study|Adverse Event|1|||
157182120|NCT03209362|567406673|FG000|Overall Study|Lost to Follow-up|0|||
157182121|NCT03209362|567406674|FG001|Overall Study|Lost to Follow-up|1|||
157182122|NCT03209362|567406673|FG000|Overall Study|Withdrawal by Subject|2|||
157182123|NCT03209362|567406674|FG001|Overall Study|Withdrawal by Subject|0|||
157182124|NCT03209362|567406673|FG000|Overall Study|Other|0|||
157182125|NCT03209362|567406674|FG001|Overall Study|Other|1|||
156976601|NCT03573908|566667521|FG001|Treatment Period|Pregnancy|0|||
156976602|NCT03573908|566667522|FG002|Treatment Period|Pregnancy|0|||
156976603|NCT03573908|566667523|FG003|Treatment Period|Pregnancy|0|||
156976604|NCT03573908|566667524|FG004|Treatment Period|Pregnancy|0|||
157182126|NCT00251589|567406675|FG000|Overall Study|Adverse Event|5|||
157182127|NCT00251589|567406676|FG001|Overall Study|Adverse Event|1|||
157182128|NCT00251589|567406677|FG002|Overall Study|Adverse Event|2|||
157182129|NCT00251589|567406678|FG003|Overall Study|Adverse Event|1|||
157182130|NCT00251589|567406675|FG000|Overall Study|Withdrawal by Subject|1|||
157182131|NCT00251589|567406676|FG001|Overall Study|Withdrawal by Subject|1|||
157182132|NCT00251589|567406677|FG002|Overall Study|Withdrawal by Subject|0|||
157182133|NCT00251589|567406678|FG003|Overall Study|Withdrawal by Subject|0|||
157182134|NCT00251589|567406675|FG000|Overall Study|Discontinued due to progressive disease|9|||
157182135|NCT00251589|567406676|FG001|Overall Study|Discontinued due to progressive disease|1|||
157182136|NCT00251589|567406677|FG002|Overall Study|Discontinued due to progressive disease|0|||
157182137|NCT00251589|567406678|FG003|Overall Study|Discontinued due to progressive disease|1|||
157182138|NCT04888507|567409194|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
157182139|NCT00636155|567409195|FG000|Overall Study|Adverse Event|8|||
157182140|NCT00636155|567409195|FG000|Overall Study|Lack of Efficacy|1|||
157182141|NCT00636155|567409195|FG000|Overall Study|Withdrawal by Subject|3|||
157182142|NCT00636155|567409195|FG000|Overall Study|Stem cell transplant|1|||
157182143|NCT00636155|567409195|FG000|Overall Study|Physician Decision|5|||
157182144|NCT00766142|567409196|FG000|Overall Study|Protocol Violation|4|||
157182145|NCT00777257|567409197|FG000|Overall Study|Adverse Event|3|||
157182146|NCT00777257|567409198|FG001|Overall Study|Adverse Event|1|||
157182147|NCT00777257|567409199|FG002|Overall Study|Adverse Event|0|||
157182148|NCT00777257|567409197|FG000|Overall Study|Lost to Follow-up|3|||
157182149|NCT00777257|567409198|FG001|Overall Study|Lost to Follow-up|3|||
157182150|NCT00777257|567409199|FG002|Overall Study|Lost to Follow-up|2|||
157182151|NCT00777257|567409197|FG000|Overall Study|Protocol Violation|2|||
157182152|NCT00777257|567409198|FG001|Overall Study|Protocol Violation|2|||
157182153|NCT00777257|567409199|FG002|Overall Study|Protocol Violation|2|||
157182154|NCT00777257|567409197|FG000|Overall Study|Withdrawal by Subject|3|||
157182155|NCT00777257|567409198|FG001|Overall Study|Withdrawal by Subject|6|||
157182156|NCT00777257|567409199|FG002|Overall Study|Withdrawal by Subject|5|||
157182157|NCT01431521|567409200|FG000|Overall Study|Withdrawal by Subject|0|||
157182158|NCT01431521|567409201|FG001|Overall Study|Withdrawal by Subject|0|||
157182159|NCT01431521|567409202|FG002|Overall Study|Withdrawal by Subject|1|||
157182160|NCT01431521|567409203|FG003|Overall Study|Withdrawal by Subject|0|||
157182161|NCT02000622|567409204|FG000|Overall Study|Withdrawal by Subject|5|||
157182162|NCT02000622|567409205|FG001|Overall Study|Withdrawal by Subject|7|||
157182163|NCT02000622|567409204|FG000|Overall Study|Lost to Follow-up|4|||
157182164|NCT02000622|567409205|FG001|Overall Study|Lost to Follow-up|0|||
157182165|NCT02000622|567409204|FG000|Overall Study|Death|159|||
157182166|NCT02000622|567409205|FG001|Overall Study|Death|73|||
157182167|NCT02000622|567409204|FG000|Overall Study|Withdrawn due to site closure|1|||
157182168|NCT02000622|567409205|FG001|Overall Study|Withdrawn due to site closure|0|||
157182169|NCT01405027|567409206|FG000|Overall Study|Withdrawn consent|3|||
157182170|NCT01405027|567409207|FG001|Overall Study|Withdrawn consent|0|||
157182171|NCT01405027|567409206|FG000|Overall Study|Lost to Follow-up|16|||
157182172|NCT01405027|567409207|FG001|Overall Study|Lost to Follow-up|24|||
157182173|NCT01405027|567409206|FG000|Overall Study|Investigator judgement|0|||
157182174|NCT01405027|567409207|FG001|Overall Study|Investigator judgement|2|||
157182175|NCT01405027|567409206|FG000|Overall Study|Death|1|||
157182176|NCT01405027|567409207|FG001|Overall Study|Death|0|||
157182177|NCT01405027|567409206|FG000|Overall Study|Other or Unknown|12|||
157182178|NCT01405027|567409207|FG001|Overall Study|Other or Unknown|25|||
157182179|NCT01938391|567409211|FG000|6 Month Follow up|Withdrawal by Subject|1|||
157182180|NCT01938391|567409211|FG000|12 Month Follow up|Physician Decision|1|||
157182181|NCT01938391|567409211|FG000|12 Month Follow up|Withdrawal by Subject|1|||
157182182|NCT01077193|567409212|FG000|Overall Study|Lost to Follow-up|1|||
157182183|NCT01077193|567409212|FG000|Overall Study|Withdrawal by Subject|2|||
157182184|NCT01077193|567409212|FG000|Overall Study|Lack of Efficacy|1|||
157182185|NCT01077193|567409212|FG000|Overall Study|Study Terminated by Sponsor|40|||
157182186|NCT04924114|567409216|FG000|Overall Study|Withdrawal by Subject|0|||
157182187|NCT04924114|567409217|FG001|Overall Study|Withdrawal by Subject|2|||
157182188|NCT04924114|567409218|FG002|Overall Study|Withdrawal by Subject|2|||
157182189|NCT04924114|567409219|FG003|Overall Study|Withdrawal by Subject|0|||
157182190|NCT04924114|567409220|FG004|Overall Study|Withdrawal by Subject|2|||
157182191|NCT04960202|567409221|FG000|Overall Study|Other|5|||
157182192|NCT04960202|567409222|FG001|Overall Study|Other|0|||
157182193|NCT04960202|567409221|FG000|Overall Study|Withdrawal by Subject|37|||
157182194|NCT04960202|567409222|FG001|Overall Study|Withdrawal by Subject|43|||
156976605|NCT03573908|566667520|FG000|Treatment Period|Other, Not Specified|4|||
156976606|NCT03573908|566667521|FG001|Treatment Period|Other, Not Specified|6|||
156976607|NCT03573908|566667522|FG002|Treatment Period|Other, Not Specified|0|||
156976608|NCT03573908|566667523|FG003|Treatment Period|Other, Not Specified|0|||
156976609|NCT03573908|566667524|FG004|Treatment Period|Other, Not Specified|0|||
156976610|NCT03573908|566667520|FG000|Randomized Withdrawal Period|Adverse Event|0|||
156976611|NCT03573908|566667521|FG001|Randomized Withdrawal Period|Adverse Event|0|||
156976612|NCT03573908|566667522|FG002|Randomized Withdrawal Period|Adverse Event|3|||
157182195|NCT04960202|567409221|FG000|Overall Study|Lost to Follow-up|20|||
157182196|NCT04960202|567409222|FG001|Overall Study|Lost to Follow-up|16|||
157182197|NCT04960202|567409221|FG000|Overall Study|Death|0|||
157182198|NCT04960202|567409222|FG001|Overall Study|Death|15|||
157182199|NCT03671148|567409223|FG000|Overall Study|Adverse Event|3|||
157182200|NCT03671148|567409224|FG001|Overall Study|Adverse Event|2|||
157182201|NCT03671148|567409223|FG000|Overall Study|Withdrawal by Subject|8|||
157182202|NCT03671148|567409224|FG001|Overall Study|Withdrawal by Subject|2|||
157182203|NCT03671148|567409223|FG000|Overall Study|Lost to Follow-up|1|||
157182204|NCT03671148|567409224|FG001|Overall Study|Lost to Follow-up|2|||
157182205|NCT03671148|567409223|FG000|Overall Study|Lack of Efficacy|7|||
157182206|NCT03671148|567409224|FG001|Overall Study|Lack of Efficacy|2|||
157182207|NCT03671148|567409223|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
157182208|NCT03671148|567409224|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
157182209|NCT03671148|567409223|FG000|Overall Study|Other|1|||
157182210|NCT03671148|567409224|FG001|Overall Study|Other|0|||
157182211|NCT03671148|567409223|FG000|Overall Study|Incomplete Randomization Visit|1|||
157182212|NCT03671148|567409224|FG001|Overall Study|Incomplete Randomization Visit|0|||
157182213|NCT00673816|567409227|FG000|Overall Study|Adverse Event|1|||
157182214|NCT00673816|567409227|FG000|Overall Study|Withdrawal by Subject|1|||
157182215|NCT01804842|567409232|FG000|Overall Study|Adverse Event|1|||
157182216|NCT01804842|567409233|FG001|Overall Study|Adverse Event|1|||
157182217|NCT01804842|567409234|FG002|Overall Study|Adverse Event|0|||
157182218|NCT01804842|567409232|FG000|Overall Study|Lost to Follow-up|1|||
157182219|NCT01804842|567409233|FG001|Overall Study|Lost to Follow-up|0|||
157182220|NCT01804842|567409234|FG002|Overall Study|Lost to Follow-up|0|||
157182221|NCT01804842|567409232|FG000|Overall Study|Non-Compliance|1|||
157182222|NCT01804842|567409233|FG001|Overall Study|Non-Compliance|1|||
157182223|NCT01804842|567409234|FG002|Overall Study|Non-Compliance|0|||
157182224|NCT01804842|567409232|FG000|Overall Study|Personal Reason|0|||
157182225|NCT01804842|567409233|FG001|Overall Study|Personal Reason|0|||
157182226|NCT01804842|567409234|FG002|Overall Study|Personal Reason|1|||
157182227|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
157182228|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
157182229|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
157182230|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
157182231|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
157182232|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
157182233|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
157182234|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
157182235|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
157182236|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
157182237|NCT03774875|567409238|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
157182238|NCT03774875|567409239|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
157182239|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
157182240|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
157182241|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
157182242|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
157182243|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
157182244|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
157182245|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
157182246|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
157182247|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
157182248|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
157182249|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
157182250|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
157182251|NCT03774875|567409238|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
157182252|NCT03774875|567409239|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
157182253|NCT02498392|567409240|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
157182254|NCT02498392|567409241|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
157182255|NCT02498392|567409240|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
156976613|NCT03573908|566667523|FG003|Randomized Withdrawal Period|Adverse Event|0|||
157182256|NCT02498392|567409241|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
157182257|NCT02498392|567409240|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
157182258|NCT02498392|567409241|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
157182259|NCT02498392|567409240|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
157182260|NCT02498392|567409241|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
157182261|NCT02498392|567409240|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
157182262|NCT02498392|567409241|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
157182263|NCT02498392|567409240|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
157182264|NCT02498392|567409241|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
157182265|NCT02352090|567409242|FG000|Overall Study|general malaise|1|||
157182266|NCT02352090|567409243|FG001|Overall Study|general malaise|0|||
157182267|NCT02352090|567409244|FG002|Overall Study|general malaise|0|||
157182268|NCT02352090|567409242|FG000|Overall Study|non-specified mild side-effects|0|||
157182269|NCT02352090|567409243|FG001|Overall Study|non-specified mild side-effects|0|||
157182270|NCT02352090|567409244|FG002|Overall Study|non-specified mild side-effects|2|||
157182271|NCT06073054|567409245|FG000|Overall Study|Withdrawal by Subject|2|||
157182272|NCT03687827|567409246|FG000|Treatment Period 1|Death|0|||
157182273|NCT03687827|567409247|FG001|Treatment Period 1|Death|1|||
157182274|NCT03687827|567409246|FG000|Treatment Period 1|Lost to Follow-up|2|||
157182275|NCT03687827|567409247|FG001|Treatment Period 1|Lost to Follow-up|2|||
157182276|NCT03687827|567409246|FG000|Treatment Period 1|Physician Decision|5|||
157182277|NCT03687827|567409247|FG001|Treatment Period 1|Physician Decision|2|||
157182278|NCT03687827|567409246|FG000|Treatment Period 1|Withdrawal by Subject|7|||
157182279|NCT03687827|567409247|FG001|Treatment Period 1|Withdrawal by Subject|3|||
157182280|NCT03687827|567409246|FG000|Treatment Period 2|Physician Decision|4|||
157182281|NCT03687827|567409247|FG001|Treatment Period 2|Physician Decision|1|||
157182282|NCT03687827|567409246|FG000|Treatment Period 2|Withdrawal by Subject|1|||
157182283|NCT03687827|567409247|FG001|Treatment Period 2|Withdrawal by Subject|2|||
157182284|NCT00413777|567409251|FG000|Fixed-dose Period|Lost to Follow-up|1|||
157182285|NCT00413777|567409252|FG001|Fixed-dose Period|Lost to Follow-up|1|||
157182286|NCT00413777|567409251|FG000|Fixed-dose Period|Adverse Event|2|||
157229931|NCT01448057|567588197|FG001|Overall Study|Adverse Event|2|||
157229932|NCT01448057|567588196|FG000|Overall Study|Withdrawal by Subject|2|||
157059106|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
157059107|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
157059108|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
157059109|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
157059110|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
157059111|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
157059112|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
157059113|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
157059114|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
157059115|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
157059116|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
157059117|NCT01187407|566970074|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
157059118|NCT01187407|566970075|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
157059119|NCT01187407|566970076|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
157059120|NCT01187407|566970077|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
157059121|NCT01187407|566970078|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
157059122|NCT02996097|566970079|FG000|Overall Study|Lost to Follow-up|11|||
157059123|NCT02996097|566970080|FG001|Overall Study|Lost to Follow-up|11|||
157059124|NCT00264498|566970081|FG000|Randomized Treatment|Death|0|||
157059125|NCT00264498|566970082|FG001|Randomized Treatment|Death|3|||
157059126|NCT00264498|566970081|FG000|Randomized Treatment|Withdrawal by Subject|0|||
157059127|NCT00264498|566970082|FG001|Randomized Treatment|Withdrawal by Subject|1|||
157059128|NCT00264498|566970081|FG000|Randomized Treatment|Objective disease Progression|13|||
157059129|NCT00264498|566970082|FG001|Randomized Treatment|Objective disease Progression|14|||
157059130|NCT00264498|566970081|FG000|Randomized Treatment|Physician Decision|1|||
157059131|NCT00264498|566970082|FG001|Randomized Treatment|Physician Decision|0|||
157059132|NCT00264498|566970081|FG000|Randomized Treatment|Incorrectly randomized|1|||
157059133|NCT00264498|566970082|FG001|Randomized Treatment|Incorrectly randomized|0|||
157059134|NCT00264498|566970081|FG000|Randomized Treatment|Study Closure|1|||
157059135|NCT00264498|566970082|FG001|Randomized Treatment|Study Closure|0|||
157059136|NCT00264498|566970081|FG000|Randomized Treatment|Protocol Violation|1|||
157059137|NCT00264498|566970082|FG001|Randomized Treatment|Protocol Violation|0|||
157059138|NCT00264498|566970081|FG000|Crossover Treatment|Death|1|||
157059139|NCT00264498|566970082|FG001|Crossover Treatment|Death|3|||
157059140|NCT00264498|566970081|FG000|Crossover Treatment|Objective disease progression|4|||
157059141|NCT00264498|566970082|FG001|Crossover Treatment|Objective disease progression|5|||
157059142|NCT00264498|566970081|FG000|Crossover Treatment|Study closure|0|||
157182287|NCT00413777|567409252|FG001|Fixed-dose Period|Adverse Event|1|||
157059143|NCT00264498|566970082|FG001|Crossover Treatment|Study closure|1|||
157059144|NCT00264498|566970081|FG000|Crossover Treatment|Withdrawal by Subject|1|||
157059145|NCT00264498|566970082|FG001|Crossover Treatment|Withdrawal by Subject|0|||
157059146|NCT02382406|566970083|FG000|Study Treatment|Disease Progression|8|||
157182288|NCT00413777|567409251|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
157182289|NCT00413777|567409252|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
157182290|NCT00413777|567409251|FG000|Fixed-dose Period|Withdrew Consent|0|||
157182291|NCT00413777|567409252|FG001|Fixed-dose Period|Withdrew Consent|1|||
157182292|NCT01678313|567409255|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
157182293|NCT01678313|567409256|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
157182294|NCT01678313|567409255|FG000|Completed the 3-month Therapy|Physician Decision|3|||
157182295|NCT01678313|567409256|FG001|Completed the 3-month Therapy|Physician Decision|4|||
157182296|NCT01678313|567409255|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
157182297|NCT01678313|567409256|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
157182298|NCT01678313|567409255|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
157182299|NCT01678313|567409256|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
157182300|NCT00981292|567409257|FG000|Day 1|Protocol Violation|1|||
157182301|NCT00981292|567409258|FG001|Day 1|Protocol Violation|0|||
157182302|NCT00981292|567409259|FG002|Day 1|Protocol Violation|0|||
157182303|NCT00981292|567409260|FG003|Day 1|Protocol Violation|0|||
157182304|NCT00981292|567409261|FG004|Day 1|Protocol Violation|0|||
157182305|NCT00981292|567409262|FG005|Day 1|Protocol Violation|2|||
157182306|NCT00981292|567409257|FG000|Day 2|Protocol Violation|2|||
157182307|NCT00981292|567409258|FG001|Day 2|Protocol Violation|0|||
157182308|NCT00981292|567409259|FG002|Day 2|Protocol Violation|0|||
157182309|NCT00981292|567409260|FG003|Day 2|Protocol Violation|0|||
157182310|NCT00981292|567409261|FG004|Day 2|Protocol Violation|0|||
157182311|NCT00981292|567409262|FG005|Day 2|Protocol Violation|0|||
157182312|NCT00981292|567409257|FG000|Day 3|Protocol Violation|0|||
157182313|NCT00981292|567409258|FG001|Day 3|Protocol Violation|0|||
157182314|NCT00981292|567409259|FG002|Day 3|Protocol Violation|0|||
157182315|NCT00981292|567409260|FG003|Day 3|Protocol Violation|0|||
157182316|NCT00981292|567409261|FG004|Day 3|Protocol Violation|0|||
157182317|NCT00981292|567409262|FG005|Day 3|Protocol Violation|1|||
157182318|NCT03377452|567409263|FG000|Overall Study|Refused assessment|0|||
157182319|NCT03377452|567409264|FG001|Overall Study|Refused assessment|2|||
157182320|NCT03377452|567409263|FG000|Overall Study|Lost to Follow-up|5|||
157182321|NCT03377452|567409264|FG001|Overall Study|Lost to Follow-up|4|||
157182322|NCT05179057|567409265|FG000|Overall Study|Adverse Event|3|||
157182323|NCT05179057|567409266|FG001|Overall Study|Adverse Event|2|||
157182324|NCT05179057|567409265|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
157182325|NCT05179057|567409266|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
157182326|NCT05179057|567409265|FG000|Overall Study|Study terminated|13|||
157182327|NCT05179057|567409266|FG001|Overall Study|Study terminated|7|||
157182328|NCT05179057|567409265|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
157182329|NCT05179057|567409266|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
157182330|NCT05179057|567409265|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
157182331|NCT05179057|567409266|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
157182332|NCT03345342|567409269|FG000|Open-Label Phase|Adverse Event|30|||
157182333|NCT03345342|567409270|FG001|Open-Label Phase|Adverse Event|0|||
157182334|NCT03345342|567409271|FG002|Open-Label Phase|Adverse Event|0|||
157182335|NCT03345342|567409272|FG003|Open-Label Phase|Adverse Event|0|||
157182336|NCT03345342|567409273|FG004|Open-Label Phase|Adverse Event|0|||
157182337|NCT03345342|567409269|FG000|Open-Label Phase|Death|1|||
157182338|NCT03345342|567409270|FG001|Open-Label Phase|Death|0|||
157182339|NCT03345342|567409271|FG002|Open-Label Phase|Death|0|||
157182340|NCT03345342|567409272|FG003|Open-Label Phase|Death|0|||
157182341|NCT03345342|567409273|FG004|Open-Label Phase|Death|0|||
157182342|NCT03345342|567409269|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
157182343|NCT03345342|567409270|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
157182344|NCT03345342|567409271|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
157182345|NCT03345342|567409272|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
157182346|NCT03345342|567409273|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
157182347|NCT03345342|567409269|FG000|Open-Label Phase|Lack of Efficacy|6|||
157182348|NCT03345342|567409270|FG001|Open-Label Phase|Lack of Efficacy|0|||
157182349|NCT03345342|567409271|FG002|Open-Label Phase|Lack of Efficacy|0|||
157182350|NCT03345342|567409272|FG003|Open-Label Phase|Lack of Efficacy|0|||
157182351|NCT03345342|567409273|FG004|Open-Label Phase|Lack of Efficacy|0|||
157182352|NCT03345342|567409269|FG000|Open-Label Phase|Lost to Follow-up|9|||
157182353|NCT03345342|567409270|FG001|Open-Label Phase|Lost to Follow-up|0|||
157182354|NCT03345342|567409271|FG002|Open-Label Phase|Lost to Follow-up|0|||
157182355|NCT03345342|567409272|FG003|Open-Label Phase|Lost to Follow-up|0|||
157229933|NCT01448057|567588197|FG001|Overall Study|Withdrawal by Subject|0|||
157182356|NCT03345342|567409273|FG004|Open-Label Phase|Lost to Follow-up|0|||
157182357|NCT03345342|567409269|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
157182358|NCT03345342|567409270|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
157182359|NCT03345342|567409271|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
157182360|NCT03345342|567409272|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
157182361|NCT03345342|567409273|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
157182362|NCT03345342|567409269|FG000|Open-Label Phase|Physician Decision|4|||
157182363|NCT03345342|567409270|FG001|Open-Label Phase|Physician Decision|0|||
157182364|NCT03345342|567409271|FG002|Open-Label Phase|Physician Decision|0|||
157182365|NCT03345342|567409272|FG003|Open-Label Phase|Physician Decision|0|||
157182366|NCT03345342|567409273|FG004|Open-Label Phase|Physician Decision|0|||
157182367|NCT03345342|567409269|FG000|Open-Label Phase|Protocol Violation|8|||
157229934|NCT02603952|567588198|FG000|Overall Study|Withdrawal by Subject|1|||
157182368|NCT03345342|567409270|FG001|Open-Label Phase|Protocol Violation|0|||
157182369|NCT03345342|567409271|FG002|Open-Label Phase|Protocol Violation|0|||
157182370|NCT03345342|567409272|FG003|Open-Label Phase|Protocol Violation|0|||
157182371|NCT03345342|567409273|FG004|Open-Label Phase|Protocol Violation|0|||
157182372|NCT03345342|567409269|FG000|Open-Label Phase|Withdrawal by Subject|57|||
157182373|NCT03345342|567409270|FG001|Open-Label Phase|Withdrawal by Subject|0|||
157182374|NCT03345342|567409271|FG002|Open-Label Phase|Withdrawal by Subject|0|||
157182375|NCT03345342|567409272|FG003|Open-Label Phase|Withdrawal by Subject|0|||
157182376|NCT03345342|567409273|FG004|Open-Label Phase|Withdrawal by Subject|0|||
157182377|NCT03345342|567409269|FG000|Open-Label Phase|Other|15|||
157182378|NCT03345342|567409270|FG001|Open-Label Phase|Other|0|||
157182379|NCT03345342|567409271|FG002|Open-Label Phase|Other|0|||
157182380|NCT03345342|567409272|FG003|Open-Label Phase|Other|0|||
157182381|NCT03345342|567409273|FG004|Open-Label Phase|Other|0|||
157182382|NCT03345342|567409269|FG000|Double-Blind Phase|Adverse Event|0|||
157182383|NCT03345342|567409270|FG001|Double-Blind Phase|Adverse Event|1|||
157182384|NCT03345342|567409271|FG002|Double-Blind Phase|Adverse Event|6|||
157182385|NCT03345342|567409272|FG003|Double-Blind Phase|Adverse Event|0|||
157182386|NCT03345342|567409273|FG004|Double-Blind Phase|Adverse Event|0|||
157182387|NCT03345342|567409269|FG000|Double-Blind Phase|Death|0|||
157182388|NCT03345342|567409270|FG001|Double-Blind Phase|Death|2|||
157182389|NCT03345342|567409271|FG002|Double-Blind Phase|Death|1|||
157182390|NCT03345342|567409272|FG003|Double-Blind Phase|Death|0|||
157182391|NCT03345342|567409273|FG004|Double-Blind Phase|Death|0|||
157182392|NCT03345342|567409269|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
157182393|NCT03345342|567409270|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
157182394|NCT03345342|567409271|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
157182395|NCT03345342|567409272|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
157182396|NCT03345342|567409273|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
157182397|NCT03345342|567409269|FG000|Double-Blind Phase|Lost to Follow-up|0|||
157182398|NCT03345342|567409270|FG001|Double-Blind Phase|Lost to Follow-up|1|||
157182399|NCT03345342|567409271|FG002|Double-Blind Phase|Lost to Follow-up|7|||
157182400|NCT03345342|567409272|FG003|Double-Blind Phase|Lost to Follow-up|0|||
157182401|NCT03345342|567409273|FG004|Double-Blind Phase|Lost to Follow-up|0|||
157182402|NCT03345342|567409269|FG000|Double-Blind Phase|Physician Decision|0|||
157182403|NCT03345342|567409270|FG001|Double-Blind Phase|Physician Decision|1|||
157182404|NCT03345342|567409271|FG002|Double-Blind Phase|Physician Decision|4|||
157182405|NCT03345342|567409272|FG003|Double-Blind Phase|Physician Decision|0|||
157182406|NCT03345342|567409273|FG004|Double-Blind Phase|Physician Decision|0|||
157182407|NCT03345342|567409269|FG000|Double-Blind Phase|Protocol Violation|0|||
157182408|NCT03345342|567409270|FG001|Double-Blind Phase|Protocol Violation|0|||
157182409|NCT03345342|567409271|FG002|Double-Blind Phase|Protocol Violation|1|||
157182410|NCT03345342|567409272|FG003|Double-Blind Phase|Protocol Violation|0|||
157182411|NCT03345342|567409273|FG004|Double-Blind Phase|Protocol Violation|0|||
157182412|NCT03345342|567409269|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
157182413|NCT03345342|567409270|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
157182414|NCT03345342|567409271|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
157182415|NCT03345342|567409272|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
157182416|NCT03345342|567409273|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
157182417|NCT03345342|567409269|FG000|Double-Blind Phase|Other|0|||
157182418|NCT03345342|567409270|FG001|Double-Blind Phase|Other|1|||
157182419|NCT03345342|567409271|FG002|Double-Blind Phase|Other|3|||
157182420|NCT03345342|567409272|FG003|Double-Blind Phase|Other|0|||
157182421|NCT03345342|567409273|FG004|Double-Blind Phase|Other|0|||
157182422|NCT03345342|567409269|FG000|Follow-Up Phase|Adverse Event|0|||
157182423|NCT03345342|567409270|FG001|Follow-Up Phase|Adverse Event|0|||
157182424|NCT03345342|567409271|FG002|Follow-Up Phase|Adverse Event|0|||
157182425|NCT03345342|567409272|FG003|Follow-Up Phase|Adverse Event|0|||
157182426|NCT03345342|567409273|FG004|Follow-Up Phase|Adverse Event|4|||
157182427|NCT03345342|567409269|FG000|Follow-Up Phase|Lost to Follow-up|0|||
157182428|NCT03345342|567409270|FG001|Follow-Up Phase|Lost to Follow-up|0|||
157182429|NCT03345342|567409271|FG002|Follow-Up Phase|Lost to Follow-up|0|||
157182430|NCT03345342|567409272|FG003|Follow-Up Phase|Lost to Follow-up|0|||
157182431|NCT03345342|567409273|FG004|Follow-Up Phase|Lost to Follow-up|6|||
157182432|NCT03345342|567409269|FG000|Follow-Up Phase|Physician Decision|0|||
157182433|NCT03345342|567409270|FG001|Follow-Up Phase|Physician Decision|0|||
157182434|NCT03345342|567409271|FG002|Follow-Up Phase|Physician Decision|0|||
157182435|NCT03345342|567409272|FG003|Follow-Up Phase|Physician Decision|0|||
157182436|NCT03345342|567409273|FG004|Follow-Up Phase|Physician Decision|5|||
157182437|NCT03345342|567409269|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
157182438|NCT03345342|567409270|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
157182439|NCT03345342|567409271|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
157182440|NCT03345342|567409272|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
157182441|NCT03345342|567409273|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
157182442|NCT03345342|567409269|FG000|Follow-Up Phase|Other|0|||
157182443|NCT03345342|567409270|FG001|Follow-Up Phase|Other|0|||
157182444|NCT03345342|567409271|FG002|Follow-Up Phase|Other|0|||
157182445|NCT03345342|567409272|FG003|Follow-Up Phase|Other|3|||
157059147|NCT02382406|566970084|FG001|Study Treatment|Disease Progression|0|||
157059148|NCT02382406|566970085|FG002|Study Treatment|Disease Progression|20|||
157059149|NCT02382406|566970083|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
157059150|NCT02382406|566970084|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
157059151|NCT02382406|566970085|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
157059152|NCT02382406|566970083|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
157059153|NCT02382406|566970084|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
157059154|NCT02382406|566970085|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
157059155|NCT02382406|566970083|FG000|Study Treatment|symptomatic deterioration|1|||
157059156|NCT02382406|566970084|FG001|Study Treatment|symptomatic deterioration|0|||
157059157|NCT02382406|566970085|FG002|Study Treatment|symptomatic deterioration|1|||
157059158|NCT02382406|566970083|FG000|Study Treatment|Death|0|||
157059159|NCT02382406|566970084|FG001|Study Treatment|Death|0|||
157059160|NCT02382406|566970085|FG002|Study Treatment|Death|2|||
157059161|NCT02382406|566970083|FG000|Follow up|Death|11|||
157059162|NCT02382406|566970084|FG001|Follow up|Death|0|||
157059163|NCT02382406|566970085|FG002|Follow up|Death|19|||
157059164|NCT02382406|566970083|FG000|Follow up|Symptomatic deterioration|1|||
157059165|NCT02382406|566970084|FG001|Follow up|Symptomatic deterioration|0|||
157059166|NCT02382406|566970085|FG002|Follow up|Symptomatic deterioration|1|||
157059167|NCT02382406|566970083|FG000|Follow up|Patient Refused Follow-up|1|||
157059168|NCT02382406|566970084|FG001|Follow up|Patient Refused Follow-up|0|||
157059169|NCT02382406|566970085|FG002|Follow up|Patient Refused Follow-up|0|||
157059170|NCT02382406|566970083|FG000|Follow up|Study Terminated|1|||
157059171|NCT02382406|566970084|FG001|Follow up|Study Terminated|0|||
157059172|NCT02382406|566970085|FG002|Follow up|Study Terminated|8|||
157059173|NCT02382406|566970083|FG000|Follow up|Withdrawal by Subject|0|||
157059174|NCT02382406|566970084|FG001|Follow up|Withdrawal by Subject|0|||
157059175|NCT02382406|566970085|FG002|Follow up|Withdrawal by Subject|2|||
157059176|NCT01713998|566970086|FG000|Overall Study|Lost to Follow-up|2|||
157059177|NCT01713998|566970087|FG001|Overall Study|Lost to Follow-up|0|||
157059178|NCT01713998|566970088|FG002|Overall Study|Lost to Follow-up|2|||
157059179|NCT01713998|566970086|FG000|Overall Study|Withdrawal by Subject|1|||
157059180|NCT01713998|566970087|FG001|Overall Study|Withdrawal by Subject|0|||
157059181|NCT01713998|566970088|FG002|Overall Study|Withdrawal by Subject|0|||
157059182|NCT03794609|566970089|FG000|Overall Study|Other|10|||
157059183|NCT03794609|566970089|FG000|Overall Study|Withdrawal by Subject|66|||
157059184|NCT03794609|566970089|FG000|Overall Study|The child is enrolled in an interventional study|70|||
157059185|NCT03794609|566970089|FG000|Overall Study|Inclusion/exclusion criteria|8|||
157059186|NCT03794609|566970089|FG000|Overall Study|At sponsor's request|151|||
157059187|NCT03794609|566970089|FG000|Overall Study|Physician Decision|1|||
157059188|NCT03794609|566970089|FG000|Overall Study|Lost to Follow-up|5|||
157059189|NCT03638258|566970090|FG000|Overall Study|Adverse Event|1|||
157059190|NCT03638258|566970091|FG001|Overall Study|Adverse Event|0|||
157059191|NCT03638258|566970092|FG002|Overall Study|Adverse Event|2|||
157059192|NCT03638258|566970090|FG000|Overall Study|Lost to Follow-up|2|||
157059193|NCT03638258|566970091|FG001|Overall Study|Lost to Follow-up|4|||
157059194|NCT03638258|566970092|FG002|Overall Study|Lost to Follow-up|5|||
157059195|NCT03638258|566970090|FG000|Overall Study|Pregnancy|0|||
157059196|NCT03638258|566970091|FG001|Overall Study|Pregnancy|0|||
157059197|NCT03638258|566970092|FG002|Overall Study|Pregnancy|1|||
157059198|NCT03638258|566970090|FG000|Overall Study|Protocol Violation|0|||
157059199|NCT03638258|566970091|FG001|Overall Study|Protocol Violation|0|||
157059200|NCT03638258|566970092|FG002|Overall Study|Protocol Violation|1|||
157059201|NCT03638258|566970090|FG000|Overall Study|Withdrawal by Subject|4|||
157059202|NCT03638258|566970091|FG001|Overall Study|Withdrawal by Subject|5|||
157059203|NCT03638258|566970092|FG002|Overall Study|Withdrawal by Subject|12|||
157059204|NCT03638258|566970090|FG000|Overall Study|Lack of Efficacy|0|||
157182446|NCT03345342|567409273|FG004|Follow-Up Phase|Other|1|||
157182447|NCT02782104|567409274|FG000|Overall Study|Other|215|||
157182448|NCT02782104|567409274|FG000|Overall Study|Induction Day 28 Non Responder|9|||
157182449|NCT02782104|567409274|FG000|Overall Study|Non-Compliance with Study Drug|2|||
157059205|NCT03638258|566970091|FG001|Overall Study|Lack of Efficacy|0|||
157059206|NCT03638258|566970092|FG002|Overall Study|Lack of Efficacy|2|||
157059207|NCT04543942|566970093|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
157059208|NCT04543942|566970094|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
157059209|NCT04543942|566970093|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
157059210|NCT04543942|566970094|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
157059211|NCT02205476|566970095|FG000|Overall Study|Study termination by Sponsor|7|||
157059212|NCT02205476|566970096|FG001|Overall Study|Study termination by Sponsor|3|||
157059213|NCT00139659|566970097|FG000|Overall Study|Adverse Event|12|||
157182450|NCT02782104|567409274|FG000|Overall Study|Death|8|||
157182451|NCT02782104|567409274|FG000|Overall Study|Pregnancy|6|||
157059214|NCT00139659|566970098|FG001|Overall Study|Adverse Event|1|||
157059215|NCT00139659|566970097|FG000|Overall Study|Lack of Efficacy|1|||
157059216|NCT00139659|566970098|FG001|Overall Study|Lack of Efficacy|1|||
157182452|NCT02782104|567409274|FG000|Overall Study|Withdrawal by Subject|63|||
157059217|NCT00139659|566970097|FG000|Overall Study|Lost to Follow-up|7|||
157182453|NCT02782104|567409274|FG000|Overall Study|Protocol Violation|7|||
157182454|NCT02782104|567409274|FG000|Overall Study|Lack of Efficacy|61|||
157182455|NCT02782104|567409274|FG000|Overall Study|Lost to Follow-up|23|||
157182456|NCT02782104|567409274|FG000|Overall Study|Adverse Event|74|||
157182457|NCT03464136|567409275|FG000|Overall Study|Lost to Follow-up|5|||
157182458|NCT03464136|567409276|FG001|Overall Study|Lost to Follow-up|8|||
157182459|NCT03464136|567409275|FG000|Overall Study|Withdrawal by Subject|16|||
157182460|NCT03464136|567409276|FG001|Overall Study|Withdrawal by Subject|13|||
157182461|NCT03464136|567409275|FG000|Overall Study|Death|1|||
157182462|NCT03464136|567409276|FG001|Overall Study|Death|0|||
157182463|NCT03464136|567409275|FG000|Overall Study|Other|8|||
157182464|NCT03464136|567409276|FG001|Overall Study|Other|4|||
157182465|NCT02438787|567409277|FG000|Overall Study|Adverse Event|1|||
157182466|NCT02438787|567409278|FG001|Overall Study|Adverse Event|0|||
157182467|NCT02438787|567409279|FG002|Overall Study|Adverse Event|2|||
157182468|NCT02438787|567409277|FG000|Overall Study|Lack of Efficacy|1|||
157182469|NCT02438787|567409278|FG001|Overall Study|Lack of Efficacy|2|||
157182470|NCT02438787|567409279|FG002|Overall Study|Lack of Efficacy|0|||
157182471|NCT02438787|567409277|FG000|Overall Study|Lost to Follow-up|0|||
157182472|NCT02438787|567409278|FG001|Overall Study|Lost to Follow-up|1|||
157182473|NCT02438787|567409279|FG002|Overall Study|Lost to Follow-up|0|||
157182474|NCT02438787|567409277|FG000|Overall Study|Protocol Violation|0|||
157182475|NCT02438787|567409278|FG001|Overall Study|Protocol Violation|0|||
157182476|NCT02438787|567409279|FG002|Overall Study|Protocol Violation|1|||
157182477|NCT02438787|567409277|FG000|Overall Study|Withdrawal by Subject|15|||
157182478|NCT02438787|567409278|FG001|Overall Study|Withdrawal by Subject|7|||
157182479|NCT02438787|567409279|FG002|Overall Study|Withdrawal by Subject|10|||
157182480|NCT02438787|567409277|FG000|Overall Study|Study discontinued by sponsor|64|||
157182481|NCT02438787|567409278|FG001|Overall Study|Study discontinued by sponsor|72|||
157182482|NCT02438787|567409279|FG002|Overall Study|Study discontinued by sponsor|69|||
157182483|NCT02438787|567409277|FG000|Overall Study|Other|0|||
157182484|NCT02438787|567409278|FG001|Overall Study|Other|1|||
157182485|NCT02438787|567409279|FG002|Overall Study|Other|0|||
157182486|NCT02438787|567409277|FG000|Overall Study|Site terminated by sponsor|0|||
157182487|NCT02438787|567409278|FG001|Overall Study|Site terminated by sponsor|0|||
157182488|NCT02438787|567409279|FG002|Overall Study|Site terminated by sponsor|1|||
157182489|NCT03412565|567409280|FG000|Overall Study|Lost to Follow-up|0|||
157182490|NCT03412565|567409281|FG001|Overall Study|Lost to Follow-up|0|||
157182491|NCT03412565|567409282|FG002|Overall Study|Lost to Follow-up|1|||
157182492|NCT03412565|567409283|FG003|Overall Study|Lost to Follow-up|0|||
157182493|NCT03412565|567409280|FG000|Overall Study|Physician Decision|0|||
157182494|NCT03412565|567409281|FG001|Overall Study|Physician Decision|0|||
157182495|NCT03412565|567409282|FG002|Overall Study|Physician Decision|0|||
157182496|NCT03412565|567409283|FG003|Overall Study|Physician Decision|1|||
157182497|NCT03412565|567409280|FG000|Overall Study|Withdrawal by Subject|0|||
157182498|NCT03412565|567409281|FG001|Overall Study|Withdrawal by Subject|4|||
157182499|NCT03412565|567409282|FG002|Overall Study|Withdrawal by Subject|5|||
157182500|NCT03412565|567409283|FG003|Overall Study|Withdrawal by Subject|5|||
157182501|NCT03412565|567409280|FG000|Overall Study|Death|1|||
157182502|NCT03412565|567409281|FG001|Overall Study|Death|3|||
157182503|NCT03412565|567409282|FG002|Overall Study|Death|4|||
157182504|NCT03412565|567409283|FG003|Overall Study|Death|5|||
157182505|NCT03412565|567409280|FG000|Overall Study|Data collection ended|0|||
157182506|NCT03412565|567409281|FG001|Overall Study|Data collection ended|41|||
157182507|NCT03412565|567409282|FG002|Overall Study|Data collection ended|41|||
157182508|NCT03412565|567409283|FG003|Overall Study|Data collection ended|40|||
157182509|NCT03375203|567409284|FG000|Overall Study|Protocol Violation|0|||
157182510|NCT03375203|567409285|FG001|Overall Study|Protocol Violation|0|||
157182511|NCT03375203|567409286|FG002|Overall Study|Protocol Violation|1|||
157182512|NCT03375203|567409287|FG003|Overall Study|Protocol Violation|0|||
157229935|NCT02603952|567588199|FG001|Overall Study|Withdrawal by Subject|0|||
157229936|NCT02603952|567588200|FG002|Overall Study|Withdrawal by Subject|0|||
157182513|NCT03375203|567409288|FG004|Overall Study|Protocol Violation|0|||
157182514|NCT03375203|567409284|FG000|Overall Study|Adverse Event|2|||
157182515|NCT03375203|567409285|FG001|Overall Study|Adverse Event|3|||
157182516|NCT03375203|567409286|FG002|Overall Study|Adverse Event|0|||
157182517|NCT03375203|567409287|FG003|Overall Study|Adverse Event|2|||
157182518|NCT03375203|567409288|FG004|Overall Study|Adverse Event|2|||
157182519|NCT03375203|567409284|FG000|Overall Study|Withdrawal by Subject|3|||
157182520|NCT03375203|567409285|FG001|Overall Study|Withdrawal by Subject|0|||
157182521|NCT03375203|567409286|FG002|Overall Study|Withdrawal by Subject|1|||
157182522|NCT03375203|567409287|FG003|Overall Study|Withdrawal by Subject|0|||
156976614|NCT03573908|566667524|FG004|Randomized Withdrawal Period|Adverse Event|0|||
157182523|NCT03375203|567409288|FG004|Overall Study|Withdrawal by Subject|2|||
157182524|NCT03375203|567409284|FG000|Overall Study|Non-compliance with study drug|1|||
157182525|NCT03375203|567409285|FG001|Overall Study|Non-compliance with study drug|0|||
157182526|NCT03375203|567409286|FG002|Overall Study|Non-compliance with study drug|0|||
157182527|NCT03375203|567409287|FG003|Overall Study|Non-compliance with study drug|0|||
157229937|NCT02603952|567588201|FG003|Overall Study|Withdrawal by Subject|0|||
157059218|NCT00139659|566970098|FG001|Overall Study|Lost to Follow-up|3|||
157059219|NCT00139659|566970097|FG000|Overall Study|Reason not Specified|6|||
157059220|NCT00139659|566970098|FG001|Overall Study|Reason not Specified|3|||
157059221|NCT00139659|566970097|FG000|Overall Study|Withdrawal by Subject|14|||
157059222|NCT00139659|566970098|FG001|Overall Study|Withdrawal by Subject|10|||
157059223|NCT02625922|566970104|FG000|Overall Study|Non-availability of IMP|1|||
157059224|NCT02625922|566970105|FG001|Overall Study|Non-availability of IMP|1|||
157059225|NCT02625922|566970104|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
157059226|NCT02625922|566970105|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
157059227|NCT00640042|566970106|FG000|Enrollment|Did not receive study drug|83|||
157059228|NCT02359552|566970107|FG000|Overall Study|Lost to Follow-up|3|||
157059229|NCT02359552|566970108|FG001|Overall Study|Lost to Follow-up|4|||
157059230|NCT02391116|566970119|FG000|Treatment|Withdrawal by Subject|1|||
157059231|NCT02391116|566970119|FG000|Treatment|Protocol Violation|1|||
157059232|NCT02391116|566970119|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
157059233|NCT02391116|566970119|FG000|Treatment|AE with Clinical PD|3|||
157059234|NCT02391116|566970119|FG000|Safety Follow-up|Adverse Event|1|||
157059235|NCT02391116|566970119|FG000|Safety Follow-up|Withdrawal by Subject|4|||
157059236|NCT02391116|566970119|FG000|Safety Follow-up|Switching to Other Therapy|4|||
157059237|NCT02391116|566970119|FG000|Safety Follow-up|No Follow Up|1|||
157059238|NCT02391116|566970119|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
157059239|NCT02391116|566970119|FG000|Active Follow-up|Withdrawal by Subject|1|||
157059240|NCT02391116|566970119|FG000|Active Follow-up|Switching to Other Therapy|2|||
157059241|NCT02391116|566970119|FG000|Survival Follow-up|Withdrawal by Subject|3|||
157059242|NCT02391116|566970119|FG000|Survival Follow-up|Switching to Other Therapy|1|||
157059243|NCT01747629|566970121|FG000|Overall Study|Adverse Event|1|||
157059244|NCT01747629|566970122|FG001|Overall Study|Adverse Event|2|||
157059245|NCT01747629|566970121|FG000|Overall Study|Withdrawal by Subject|2|||
157059246|NCT01747629|566970122|FG001|Overall Study|Withdrawal by Subject|2|||
157059247|NCT01747629|566970121|FG000|Overall Study|Noncompliance|1|||
157059248|NCT01747629|566970122|FG001|Overall Study|Noncompliance|1|||
157059249|NCT01747629|566970121|FG000|Overall Study|Inclusion criteria not met|1|||
157059250|NCT01747629|566970122|FG001|Overall Study|Inclusion criteria not met|0|||
157059251|NCT01747629|566970121|FG000|Overall Study|Not treated|1|||
157059252|NCT01747629|566970122|FG001|Overall Study|Not treated|0|||
157059253|NCT01747629|566970121|FG000|Overall Study|Other|2|||
157059254|NCT01747629|566970122|FG001|Overall Study|Other|1|||
157059255|NCT01313299|566970123|FG000|Overall Study|Adverse Event|3|||
157059256|NCT01313299|566970124|FG001|Overall Study|Adverse Event|1|||
157059257|NCT01313299|566970125|FG002|Overall Study|Adverse Event|1|||
157059258|NCT01313299|566970123|FG000|Overall Study|Lost to Follow-up|1|||
157059259|NCT01313299|566970124|FG001|Overall Study|Lost to Follow-up|0|||
157059260|NCT01313299|566970125|FG002|Overall Study|Lost to Follow-up|0|||
157059261|NCT01313299|566970123|FG000|Overall Study|Protocol Violation|2|||
157059262|NCT01313299|566970124|FG001|Overall Study|Protocol Violation|0|||
157059263|NCT01313299|566970125|FG002|Overall Study|Protocol Violation|0|||
157059264|NCT01313299|566970123|FG000|Overall Study|Withdrawal by Subject|1|||
157059265|NCT01313299|566970124|FG001|Overall Study|Withdrawal by Subject|0|||
157059266|NCT01313299|566970125|FG002|Overall Study|Withdrawal by Subject|2|||
157059267|NCT01313299|566970123|FG000|Overall Study|Family reason and moved out of state|0|||
157059268|NCT01313299|566970124|FG001|Overall Study|Family reason and moved out of state|2|||
157059269|NCT01313299|566970125|FG002|Overall Study|Family reason and moved out of state|0|||
157059270|NCT01313299|566970123|FG000|Overall Study|Lack of subject compliance|0|||
157059271|NCT01313299|566970124|FG001|Overall Study|Lack of subject compliance|0|||
157059272|NCT01313299|566970125|FG002|Overall Study|Lack of subject compliance|1|||
157059273|NCT02506881|566970126|FG000|First Intervention (Day 1)|Protocol Violation|0|||
157182528|NCT03375203|567409288|FG004|Overall Study|Non-compliance with study drug|0|||
157182529|NCT03375203|567409284|FG000|Overall Study|Randomized, not treated.|0|||
157059274|NCT02506881|566970127|FG001|First Intervention (Day 1)|Protocol Violation|0|||
157059275|NCT02506881|566970128|FG002|First Intervention (Day 1)|Protocol Violation|1|||
157059276|NCT02506881|566970129|FG003|First Intervention (Day 1)|Protocol Violation|0|||
157059277|NCT02506881|566970126|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
157059278|NCT02506881|566970127|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
157059279|NCT02506881|566970128|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
157059280|NCT02506881|566970129|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
157059281|NCT02506881|566970126|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
157059282|NCT02506881|566970127|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
157059283|NCT02506881|566970128|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
157059284|NCT02506881|566970129|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
157059285|NCT01919398|566970130|FG000|Overall Study|Progressive Disease|0|||
157059286|NCT01919398|566970131|FG001|Overall Study|Progressive Disease|0|||
157182530|NCT03375203|567409285|FG001|Overall Study|Randomized, not treated.|1|||
157182531|NCT03375203|567409286|FG002|Overall Study|Randomized, not treated.|0|||
157182532|NCT03375203|567409287|FG003|Overall Study|Randomized, not treated.|0|||
157182533|NCT03375203|567409288|FG004|Overall Study|Randomized, not treated.|0|||
157182534|NCT03107793|567409289|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
157182535|NCT03107793|567409290|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
157182536|NCT03107793|567409291|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
157182537|NCT03107793|567409292|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
157182538|NCT03107793|567409293|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
157182539|NCT03107793|567409289|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
157182540|NCT03107793|567409290|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
157182541|NCT03107793|567409291|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
157182542|NCT03107793|567409292|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
157182543|NCT03107793|567409293|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
157182544|NCT03107793|567409289|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
157182545|NCT03107793|567409290|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
157182546|NCT03107793|567409291|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
157182547|NCT03107793|567409292|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
157182548|NCT03107793|567409293|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
157182549|NCT03107793|567409289|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
157182550|NCT03107793|567409290|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157182551|NCT03107793|567409291|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157182552|NCT03107793|567409292|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157182553|NCT03107793|567409293|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
157182554|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
157182555|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
157182556|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
157182557|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
157182558|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
157182559|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
157182560|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
157182561|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
157182562|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
157182563|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
157182564|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
157182565|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
157182566|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
157182567|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
157182568|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
157182569|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
157182570|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
157182571|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
157182572|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
157182573|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
157182574|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
157182575|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
157182576|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
157182577|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
157182578|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
157182579|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
157182580|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
157182581|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
157182582|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
157182583|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
157182584|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
157182585|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
157182586|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
157182587|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
157182588|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
157182589|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
157182590|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
157182591|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
157182592|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
157182593|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
157182594|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
157182595|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
157182596|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
156976615|NCT03573908|566667520|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
157182597|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
157182598|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
157182599|NCT03107793|567409289|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
157182600|NCT03107793|567409290|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
157182601|NCT03107793|567409291|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
157182602|NCT03107793|567409292|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
157182603|NCT03107793|567409293|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
157182604|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
157182605|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
157182606|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
157182607|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
157182608|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
157182609|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
157182610|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
157182611|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
157182612|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
157182613|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
157182614|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
157059287|NCT01919398|566970132|FG002|Overall Study|Progressive Disease|4|||
157059288|NCT02391545|566970134|FG000|Overall Study|Death|0|||
157059289|NCT02391545|566970135|FG001|Overall Study|Death|2|||
157059290|NCT02391545|566970134|FG000|Overall Study|Lost to Follow-up|0|||
157059291|NCT02391545|566970135|FG001|Overall Study|Lost to Follow-up|1|||
157059292|NCT02391545|566970134|FG000|Overall Study|Termination of study by sponsor|20|||
157059293|NCT02391545|566970135|FG001|Overall Study|Termination of study by sponsor|20|||
157059294|NCT02391545|566970134|FG000|Overall Study|Withdrawal by Subject|0|||
157059295|NCT02391545|566970135|FG001|Overall Study|Withdrawal by Subject|1|||
157059296|NCT02391545|566970134|FG000|Overall Study|Other Reasons|6|||
157059297|NCT02391545|566970135|FG001|Overall Study|Other Reasons|4|||
157059298|NCT02016690|566970136|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
157059299|NCT02016690|566970136|FG000|Overall Study|Excluded from SAS: Duplication|2|||
157059300|NCT02016690|566970136|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
157059301|NCT02016690|566970136|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
157059302|NCT02016690|566970136|FG000|Overall Study|Did not meet inclusion criteria|13|||
157059303|NCT02016690|566970136|FG000|Overall Study|Hospitalized for RSV at study start|3|||
157059304|NCT01222078|566970137|FG000|Overall Study|Early termination of the study|1|||
157059305|NCT04089332|566970138|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
157059306|NCT04089332|566970138|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
157059307|NCT04089332|566970138|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
157059308|NCT00495612|566970142|FG000|Overall Study|Lost to Follow-up|1|||
157059309|NCT00495612|566970143|FG001|Overall Study|Lost to Follow-up|0|||
157059310|NCT00495612|566970142|FG000|Overall Study|Subject's Decision to Withdraw|3|||
157059311|NCT00495612|566970143|FG001|Overall Study|Subject's Decision to Withdraw|0|||
157059312|NCT00853021|566970146|FG000|Overall Study|Adverse Event|2|||
157059313|NCT00853021|566970146|FG000|Overall Study|Withdrawal by Subject|2|||
157059314|NCT00853021|566970146|FG000|Overall Study|Death|1|||
157059315|NCT02864147|566970147|FG000|Overall Study|Withdrawal by Subject|3|||
157059316|NCT02864147|566970148|FG001|Overall Study|Withdrawal by Subject|2|||
157059317|NCT02864147|566970149|FG002|Overall Study|Withdrawal by Subject|1|||
157059318|NCT02864147|566970147|FG000|Overall Study|Lost to Follow-up|0|||
157059319|NCT02864147|566970148|FG001|Overall Study|Lost to Follow-up|4|||
157059320|NCT02864147|566970149|FG002|Overall Study|Lost to Follow-up|0|||
157059321|NCT02864147|566970147|FG000|Overall Study|Adverse Event|0|||
157059322|NCT02864147|566970148|FG001|Overall Study|Adverse Event|1|||
157059323|NCT02864147|566970149|FG002|Overall Study|Adverse Event|0|||
157059324|NCT02864147|566970147|FG000|Overall Study|Pregnancy|4|||
157059325|NCT02864147|566970148|FG001|Overall Study|Pregnancy|0|||
157059326|NCT02864147|566970149|FG002|Overall Study|Pregnancy|0|||
157059327|NCT02864147|566970147|FG000|Overall Study|Physician Decision|0|||
157182615|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
157182616|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
157182617|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
157182618|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
157059328|NCT02864147|566970148|FG001|Overall Study|Physician Decision|0|||
157059329|NCT02864147|566970149|FG002|Overall Study|Physician Decision|1|||
157059330|NCT02864147|566970147|FG000|Overall Study|Opted for excisional procedures|0|||
157059331|NCT02864147|566970148|FG001|Overall Study|Opted for excisional procedures|0|||
157059332|NCT02864147|566970149|FG002|Overall Study|Opted for excisional procedures|3|||
157059333|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
157059334|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
157059335|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
157059336|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
157059337|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
157059338|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
157059339|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
157182619|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Death|0|||
157182620|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Death|0|||
157182621|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Death|0|||
157182622|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Death|0|||
157182623|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Death|1|||
157182624|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
157182625|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
157182626|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
157182627|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
157182628|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
157182629|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
157182630|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
157182631|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
157182632|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
157182633|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
157182634|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
157182635|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
157182636|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
157182637|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
157182638|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
157182639|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
157182640|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
157182641|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
157182642|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
157182643|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
157182644|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
157182645|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
157182646|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
157182647|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
157182648|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
157182649|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Other|0|||
157182650|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Other|0|||
157182651|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Other|0|||
157182652|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Other|1|||
157182653|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Other|3|||
157182654|NCT03107793|567409289|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
157182655|NCT03107793|567409290|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
157182656|NCT03107793|567409291|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
157182657|NCT03107793|567409292|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
157182658|NCT03107793|567409293|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
157182659|NCT03277105|567409294|FG000|Overall Study|Death|129|||
157182660|NCT03277105|567409295|FG001|Overall Study|Death|124|||
157182661|NCT03277105|567409294|FG000|Overall Study|Lost to Follow-up|2|||
157182662|NCT03277105|567409295|FG001|Overall Study|Lost to Follow-up|4|||
157182663|NCT03277105|567409294|FG000|Overall Study|Withdrawal by Subject|10|||
157182664|NCT03277105|567409295|FG001|Overall Study|Withdrawal by Subject|10|||
157182665|NCT03277105|567409294|FG000|Overall Study|Other|118|||
157182666|NCT03277105|567409295|FG001|Overall Study|Other|125|||
157182667|NCT05180721|567409299|FG000|Overall Study|Lost to Follow-up|4|||
157182668|NCT01872897|567409307|FG000|Overall Study|Withdrawal by Subject|1|||
157182669|NCT01872897|567409308|FG001|Overall Study|Withdrawal by Subject|0|||
157182670|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
157182671|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
157182672|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
157182673|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
157182674|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
157182675|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
157182676|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
157182677|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
157182678|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
157182679|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
157182680|NCT02418585|567409309|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
157182681|NCT02418585|567409310|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
157182682|NCT02418585|567409309|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
157182683|NCT02418585|567409310|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
157182684|NCT02418585|567409309|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
157182685|NCT02418585|567409310|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
157182686|NCT02418585|567409309|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
157182687|NCT02418585|567409310|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
157182688|NCT02418585|567409309|FG000|Follow-up Phase (24 Weeks)|Other|3|||
157182689|NCT02418585|567409310|FG001|Follow-up Phase (24 Weeks)|Other|2|||
157182690|NCT02040857|567409311|FG000|Overall Study|Adverse Event|14|||
157182691|NCT02040857|567409311|FG000|Overall Study|Physician Decision|5|||
157182692|NCT02040857|567409311|FG000|Overall Study|Withdrawal by Subject|31|||
157182693|NCT02040857|567409311|FG000|Overall Study|patient non-compliance|3|||
157182694|NCT02040857|567409311|FG000|Overall Study|Lost to Follow-up|2|||
157182695|NCT02040857|567409311|FG000|Overall Study|recurrence|4|||
157182696|NCT02040857|567409311|FG000|Overall Study|ineligible|1|||
157182697|NCT03146403|567409317|FG000|Overall Study|Withdrawal by Subject|0|||
157182698|NCT03146403|567409318|FG001|Overall Study|Withdrawal by Subject|3|||
157182699|NCT03146403|567409317|FG000|Overall Study|Lost to Follow-up|2|||
157182700|NCT03146403|567409318|FG001|Overall Study|Lost to Follow-up|0|||
157182701|NCT01024920|567409319|FG000|Overall Study|Progressive disease|47|||
157182702|NCT01024920|567409320|FG001|Overall Study|Progressive disease|25|||
157182703|NCT01024920|567409319|FG000|Overall Study|Adverse Event|8|||
157182704|NCT01024920|567409320|FG001|Overall Study|Adverse Event|4|||
157182705|NCT01024920|567409319|FG000|Overall Study|Lost to Follow-up|0|||
157182706|NCT01024920|567409320|FG001|Overall Study|Lost to Follow-up|1|||
157182707|NCT01024920|567409319|FG000|Overall Study|Patient refusal to continue|4|||
157182708|NCT01024920|567409320|FG001|Overall Study|Patient refusal to continue|0|||
157182709|NCT01024920|567409319|FG000|Overall Study|Other than listed|5|||
157182710|NCT01024920|567409320|FG001|Overall Study|Other than listed|1|||
157182711|NCT01024920|567409319|FG000|Overall Study|Not treated|3|||
157182712|NCT01024920|567409320|FG001|Overall Study|Not treated|0|||
157182713|NCT01024920|567409319|FG000|Overall Study|Protocol Violation|0|||
157182714|NCT01024920|567409320|FG001|Overall Study|Protocol Violation|1|||
157182715|NCT02182999|567409322|FG000|Overall Study|Adverse Event|4|||
157182716|NCT02182999|567409323|FG001|Overall Study|Adverse Event|3|||
157182717|NCT02182999|567409322|FG000|Overall Study|Physician Decision|1|||
157182718|NCT02182999|567409323|FG001|Overall Study|Physician Decision|0|||
157182719|NCT02348840|567409329|FG000|Overall Study|Withdrawal by Subject|2|||
157182720|NCT02348840|567409330|FG001|Overall Study|Withdrawal by Subject|1|||
157182721|NCT02348840|567409331|FG002|Overall Study|Withdrawal by Subject|0|||
157182722|NCT02348840|567409332|FG003|Overall Study|Withdrawal by Subject|0|||
157182723|NCT00373880|567409333|FG000|Overall Study|Physician Decision|3|||
157182724|NCT00373880|567409333|FG000|Overall Study|Arrested|1|||
157182725|NCT00373880|567409333|FG000|Overall Study|Protocol Violation|14|||
157182726|NCT02865928|567409341|FG000|Overall Study|Withdrawal by Subject|1|||
157182727|NCT02865928|567409342|FG001|Overall Study|Withdrawal by Subject|0|||
157182728|NCT02865928|567409341|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
157182729|NCT02865928|567409342|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
157182730|NCT02865928|567409341|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
157182731|NCT02865928|567409342|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
157182732|NCT03152110|567409343|FG000|Overall Study|Withdrawal by Subject|3|||
157182733|NCT01634100|567409348|FG000|Overall Study|Withdrawal by Subject|1|||
157182734|NCT01634100|567409349|FG001|Overall Study|Withdrawal by Subject|0|||
157182735|NCT01634100|567409350|FG002|Overall Study|Withdrawal by Subject|1|||
157182736|NCT01634100|567409351|FG003|Overall Study|Withdrawal by Subject|0|||
157182737|NCT01634100|567409352|FG004|Overall Study|Withdrawal by Subject|0|||
157182738|NCT01634100|567409353|FG005|Overall Study|Withdrawal by Subject|0|||
157182739|NCT00552344|567409354|FG000|Overall Study|Lack of Efficacy|55|||
157182740|NCT00552344|567409354|FG000|Overall Study|Loss of efficacy|75|||
157182741|NCT00552344|567409354|FG000|Overall Study|Lost to Follow-up|8|||
157182742|NCT00552344|567409354|FG000|Overall Study|Withdrawal by Subject|48|||
157182743|NCT00552344|567409354|FG000|Overall Study|SAE, non-fatal|6|||
157182744|NCT00552344|567409354|FG000|Overall Study|AE, non-serious non-fatal|38|||
157182745|NCT00552344|567409354|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
157182746|NCT00552344|567409354|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
157182747|NCT00552344|567409354|FG000|Overall Study|Other Reason|22|||
157182748|NCT00338806|567409355|FG000|Acute Phase|Withdrawal by Subject|0|||
157182749|NCT00338806|567409356|FG001|Acute Phase|Withdrawal by Subject|1|||
157182750|NCT00338806|567409355|FG000|Follow-up|Lost to Follow-up|1|||
157182751|NCT00338806|567409356|FG001|Follow-up|Lost to Follow-up|3|||
157182752|NCT00744991|567409357|FG000|Overall Study|Progressive Disease|11|||
157182753|NCT00744991|567409357|FG000|Overall Study|Withdrawal by Subject|8|||
157182754|NCT00744991|567409357|FG000|Overall Study|Physician Decision|3|||
157182755|NCT00744991|567409357|FG000|Overall Study|Adverse Event|2|||
157182756|NCT00744991|567409357|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
157182757|NCT01662986|567409360|FG000|Overall Study|Adverse Event|5|||
157182758|NCT01662986|567409361|FG001|Overall Study|Adverse Event|4|||
157182759|NCT01662986|567409360|FG000|Overall Study|Protocol Violation|2|||
157182760|NCT01662986|567409361|FG001|Overall Study|Protocol Violation|3|||
157182761|NCT01662986|567409360|FG000|Overall Study|Lost to Follow-up|5|||
157182762|NCT01662986|567409361|FG001|Overall Study|Lost to Follow-up|4|||
157182763|NCT01662986|567409360|FG000|Overall Study|Withdrawal by Subject|2|||
157182764|NCT01662986|567409361|FG001|Overall Study|Withdrawal by Subject|2|||
157182765|NCT01662986|567409360|FG000|Overall Study|Not Treated|1|||
157182766|NCT01662986|567409361|FG001|Overall Study|Not Treated|0|||
157182767|NCT01662986|567409360|FG000|Overall Study|Other than stated above|3|||
157182768|NCT01662986|567409361|FG001|Overall Study|Other than stated above|0|||
157182769|NCT01624467|567409362|FG000|Overall Study|Withdrawal by Subject|2|||
157182770|NCT01624467|567409362|FG000|Overall Study|Lost to Follow-up|1|||
157182771|NCT01624467|567409362|FG000|Overall Study|Adverse Event|7|||
157182772|NCT01624467|567409362|FG000|Overall Study|Progressive Disease|19|||
157182773|NCT01624467|567409362|FG000|Overall Study|Per Sponsor Requirement|1|||
157182774|NCT01624467|567409362|FG000|Overall Study|Subject Withdrew from Treatment|1|||
157182775|NCT03964493|567409363|FG000|Overall Study|Withdrawal by Subject|4|||
157182776|NCT03964493|567409364|FG001|Overall Study|Withdrawal by Subject|1|||
157182777|NCT03964493|567409363|FG000|Overall Study|Lost to Follow-up|13|||
157182778|NCT03964493|567409364|FG001|Overall Study|Lost to Follow-up|4|||
157182779|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Adverse Event|22|||
157182780|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Adverse Event|0|||
157182781|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
157182782|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
157182783|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
157182784|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
157182785|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
157182786|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
157182787|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
157182788|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
157182789|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
157182790|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
157182791|NCT02493868|567409373|FG000|Induction Phase: DE Participants|Other|8|||
157182792|NCT02493868|567409374|FG001|Induction Phase: DE Participants|Other|0|||
157182793|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
157182794|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
157182795|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
157182796|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
157182797|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
157182798|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
157182799|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
157182800|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
157182801|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
157182802|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
157182803|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
157182804|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
157182805|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
157182806|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
157182807|NCT02493868|567409373|FG000|Optimization Phase: DE+TE Participants|Other|10|||
157182808|NCT02493868|567409374|FG001|Optimization Phase: DE+TE Participants|Other|2|||
157182809|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
157182810|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
157182811|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
157182812|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
157182813|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
157182814|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
157182815|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
157182816|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
157182817|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
157182818|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
157182819|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
157182820|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
157182821|NCT02493868|567409373|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
157182822|NCT02493868|567409374|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
157182823|NCT02493868|567409373|FG000|Follow-up Phase|Lost to Follow-up|1|||
157182824|NCT02493868|567409374|FG001|Follow-up Phase|Lost to Follow-up|0|||
157182825|NCT02493868|567409373|FG000|Follow-up Phase|Withdrawal by Subject|3|||
157059340|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
157182826|NCT02493868|567409374|FG001|Follow-up Phase|Withdrawal by Subject|0|||
157182827|NCT02493868|567409373|FG000|Follow-up Phase|Investigator Decision|5|||
157182828|NCT02493868|567409374|FG001|Follow-up Phase|Investigator Decision|1|||
157182829|NCT02493868|567409373|FG000|Follow-up Phase|Other|2|||
157059341|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
157059342|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
157059343|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
157059344|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
157059345|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
157059346|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
157059347|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
157059348|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
157059349|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
157059350|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
157059351|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
157059352|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
157059353|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
157059354|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
157059355|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
157059356|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
157059357|NCT02269917|566970150|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
157059358|NCT02269917|566970151|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
157059359|NCT02269917|566970152|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
157059360|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
157059361|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
157059362|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
157059363|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
157059364|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
157059365|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
157059366|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
157059367|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
157059368|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
157059369|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
157059370|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
157059371|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
157059372|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
157059373|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
157059374|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
157059375|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
157059376|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
157059377|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
157059378|NCT02269917|566970150|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
157059379|NCT02269917|566970151|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
157059380|NCT02269917|566970152|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
157059381|NCT02865135|566970156|FG000|Overall Study|Death|0|||
157059382|NCT02865135|566970157|FG001|Overall Study|Death|1|||
157059383|NCT02865135|566970158|FG002|Overall Study|Death|0|||
157059384|NCT02865135|566970156|FG000|Overall Study|Progression|6|||
157059385|NCT02865135|566970157|FG001|Overall Study|Progression|2|||
157059386|NCT02865135|566970158|FG002|Overall Study|Progression|2|||
157059387|NCT03993054|566970162|FG000|Overall Study|PI Decision|1|||
157059388|NCT00383500|566970163|FG000|Overall Study|Withdrawal by Subject|8|||
157059389|NCT00383500|566970164|FG001|Overall Study|Withdrawal by Subject|3|||
157059390|NCT00383500|566970165|FG002|Overall Study|Withdrawal by Subject|0|||
157059391|NCT00383500|566970163|FG000|Overall Study|Lost to Follow-up|0|||
157059392|NCT00383500|566970164|FG001|Overall Study|Lost to Follow-up|0|||
157059393|NCT00383500|566970165|FG002|Overall Study|Lost to Follow-up|2|||
157059394|NCT00746785|566971746|FG000|Overall Study|Lost to Follow-up|29|||
157059395|NCT00746785|566971747|FG001|Overall Study|Lost to Follow-up|25|||
157059396|NCT00746785|566971748|FG002|Overall Study|Lost to Follow-up|27|||
157059397|NCT00381797|566971756|FG000|Overall Study|Withdrawal by Subject|1|||
157059398|NCT00381797|566971757|FG001|Overall Study|Withdrawal by Subject|1|||
157059399|NCT00381797|566971758|FG002|Overall Study|Withdrawal by Subject|0|||
157059400|NCT00381797|566971759|FG003|Overall Study|Withdrawal by Subject|0|||
157059401|NCT00381797|566971760|FG004|Overall Study|Withdrawal by Subject|2|||
157059402|NCT00381797|566971756|FG000|Overall Study|Ineligible|0|||
157059403|NCT00381797|566971757|FG001|Overall Study|Ineligible|0|||
157059404|NCT00381797|566971758|FG002|Overall Study|Ineligible|0|||
157059405|NCT00381797|566971759|FG003|Overall Study|Ineligible|1|||
157059406|NCT00381797|566971760|FG004|Overall Study|Ineligible|0|||
157059407|NCT00684203|566971761|FG000|Overall Study|Adverse Event|6|||
157059408|NCT00684203|566971762|FG001|Overall Study|Adverse Event|4|||
157059409|NCT00684203|566971763|FG002|Overall Study|Adverse Event|8|||
157059410|NCT00684203|566971764|FG003|Overall Study|Adverse Event|0|||
157059411|NCT00684203|566971765|FG004|Overall Study|Adverse Event|0|||
157059412|NCT00684203|566971766|FG005|Overall Study|Adverse Event|0|||
157182830|NCT02493868|567409374|FG001|Follow-up Phase|Other|1|||
156976616|NCT03573908|566667521|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156976617|NCT03573908|566667522|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156976618|NCT03573908|566667523|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
156976619|NCT03573908|566667524|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
156976620|NCT03573908|566667520|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
156976621|NCT03573908|566667521|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
156976622|NCT03573908|566667522|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
156976623|NCT03573908|566667523|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
156976624|NCT03573908|566667524|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
156976625|NCT03573908|566667520|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
156976626|NCT03573908|566667521|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
156976627|NCT03573908|566667522|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
156976628|NCT03573908|566667523|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
156976629|NCT03573908|566667524|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
156976630|NCT04006925|566667525|FG000|Overall Study|Side effects|2|||
156976631|NCT04006925|566667526|FG001|Overall Study|Side effects|0|||
156976632|NCT00738101|566667533|FG000|Overall Study|Physician Decision|5|||
156976633|NCT00738101|566667533|FG000|Overall Study|Death|1|||
156976634|NCT00738101|566667533|FG000|Overall Study|Repeat enrollment|1|||
156976635|NCT00926003|566667534|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
156976636|NCT00926003|566667535|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
156976637|NCT00926003|566667536|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
156976638|NCT00926003|566667534|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
156976639|NCT00926003|566667535|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
156976640|NCT00926003|566667536|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
156976641|NCT00709059|566667538|FG000|Overall Study|Lost to Follow-up|34|||
156976642|NCT00709059|566667538|FG000|Overall Study|Withdrawal by Subject|19|||
156976643|NCT00709059|566667538|FG000|Overall Study|Physician Decision|7|||
156976644|NCT00709059|566667538|FG000|Overall Study|Disease complication|3|||
156976645|NCT00709059|566667538|FG000|Overall Study|Side effects|20|||
156976646|NCT00709059|566667538|FG000|Overall Study|Serious side effects|11|||
156976647|NCT01396317|566667539|FG000|Overall Study|Adverse Event|1|||
156976648|NCT01396317|566667540|FG001|Overall Study|Adverse Event|0|||
156976649|NCT02172625|566667543|FG000|Overall Study|Adverse Event|0|||
156976650|NCT02172625|566667544|FG001|Overall Study|Adverse Event|1|||
156976651|NCT02172625|566667543|FG000|Overall Study|Pregnancy|0|||
156976652|NCT02172625|566667544|FG001|Overall Study|Pregnancy|1|||
156976653|NCT02172625|566667543|FG000|Overall Study|car accident|0|||
156976654|NCT02172625|566667544|FG001|Overall Study|car accident|1|||
156976655|NCT03315130|566667545|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156976656|NCT03315130|566667546|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
156976657|NCT03315130|566667547|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156976658|NCT03315130|566667548|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
156976659|NCT03315130|566667545|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156976660|NCT03315130|566667546|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
156976661|NCT03315130|566667547|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156976662|NCT03315130|566667548|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
156976663|NCT03315130|566667545|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
156976664|NCT03315130|566667546|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156976665|NCT03315130|566667547|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156976666|NCT03315130|566667548|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
156976667|NCT03315130|566667545|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156976668|NCT03315130|566667546|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
156976669|NCT03315130|566667547|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156976670|NCT03315130|566667548|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
156976671|NCT03315130|566667545|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156976672|NCT03315130|566667546|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
156976673|NCT03315130|566667547|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156976674|NCT03315130|566667548|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
156976675|NCT03315130|566667545|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
156976676|NCT03315130|566667546|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
156976677|NCT03315130|566667547|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
156976678|NCT03315130|566667548|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
156976679|NCT00524030|566667549|FG000|Overall Study|Lack of Efficacy|10|||
156976680|NCT00524030|566667550|FG001|Overall Study|Lack of Efficacy|24|||
156976681|NCT00524030|566667549|FG000|Overall Study|Lost to Follow-up|0|||
156976682|NCT00524030|566667550|FG001|Overall Study|Lost to Follow-up|2|||
156976683|NCT00524030|566667549|FG000|Overall Study|Withdrawal by Subject|3|||
156976684|NCT00524030|566667550|FG001|Overall Study|Withdrawal by Subject|8|||
156976685|NCT00524030|566667549|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
156976686|NCT00524030|566667550|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
156976687|NCT00524030|566667549|FG000|Overall Study|Protocol Violation|0|||
157182831|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
157182832|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
157182833|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
157182834|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
157182835|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
157182836|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
157182837|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
157182838|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
157182839|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
157182840|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
157182841|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
157182842|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
157182843|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
157182844|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Death|0|||
157182845|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Death|0|||
157182846|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Death|1|||
157182847|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Death|0|||
157182848|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Death|0|||
157182849|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Death|0|||
157182850|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Death|0|||
157182851|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Death|0|||
157182852|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Death|0|||
157182853|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Death|0|||
157182854|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Death|0|||
157182855|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Death|0|||
157182856|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Death|0|||
157182857|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
157182858|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
157182859|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
157182860|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182861|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182862|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182863|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182864|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182865|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182866|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182867|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182868|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182869|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
157182870|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182871|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182872|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
157182873|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182874|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182875|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182876|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182877|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182878|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182879|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182880|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182881|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182882|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
157182883|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
157182884|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
157182885|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
157182886|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
157182887|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
157182888|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
157182889|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
157182890|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
157182891|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
157182892|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
157182893|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
157182894|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
157182895|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
157182896|NCT02407236|567409375|FG000|Induction Study (8 Weeks)|Other|2|||
157182897|NCT02407236|567409376|FG001|Induction Study (8 Weeks)|Other|1|||
157182898|NCT02407236|567409377|FG002|Induction Study (8 Weeks)|Other|5|||
157182899|NCT02407236|567409378|FG003|Induction Study (8 Weeks)|Other|0|||
157182900|NCT02407236|567409379|FG004|Induction Study (8 Weeks)|Other|0|||
157182901|NCT02407236|567409380|FG005|Induction Study (8 Weeks)|Other|0|||
157182902|NCT02407236|567409381|FG006|Induction Study (8 Weeks)|Other|0|||
157182903|NCT02407236|567409382|FG007|Induction Study (8 Weeks)|Other|0|||
157182904|NCT02407236|567409383|FG008|Induction Study (8 Weeks)|Other|0|||
157182905|NCT02407236|567409384|FG009|Induction Study (8 Weeks)|Other|0|||
157182906|NCT02407236|567409385|FG010|Induction Study (8 Weeks)|Other|0|||
157182907|NCT02407236|567409386|FG011|Induction Study (8 Weeks)|Other|0|||
157182908|NCT02407236|567409387|FG012|Induction Study (8 Weeks)|Other|0|||
157182909|NCT02407236|567409375|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182910|NCT02407236|567409376|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182911|NCT02407236|567409377|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182912|NCT02407236|567409378|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
157182913|NCT02407236|567409379|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
157182914|NCT02407236|567409380|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
157182915|NCT02407236|567409381|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
157182916|NCT02407236|567409382|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
157182917|NCT02407236|567409383|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182918|NCT02407236|567409384|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182919|NCT02407236|567409385|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182920|NCT02407236|567409386|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182921|NCT02407236|567409387|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
157182922|NCT02407236|567409375|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182923|NCT02407236|567409376|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182924|NCT02407236|567409377|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182925|NCT02407236|567409378|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
157182926|NCT02407236|567409379|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
157182927|NCT02407236|567409380|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
157229938|NCT02603952|567588198|FG000|Overall Study|Received oseltamivir by error|0|||
157229939|NCT02603952|567588199|FG001|Overall Study|Received oseltamivir by error|0|||
157229940|NCT02603952|567588200|FG002|Overall Study|Received oseltamivir by error|0|||
157229941|NCT02603952|567588201|FG003|Overall Study|Received oseltamivir by error|1|||
157229942|NCT00958243|567588205|FG000|Overall Study|Withdrawal by Subject|0|||
157182928|NCT02407236|567409381|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
157182929|NCT02407236|567409382|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
157182930|NCT02407236|567409383|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182931|NCT02407236|567409384|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182932|NCT02407236|567409385|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182933|NCT02407236|567409386|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182934|NCT02407236|567409387|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
157182935|NCT02407236|567409375|FG000|Maintenance Study (44 Weeks)|Other|0|||
157182936|NCT02407236|567409376|FG001|Maintenance Study (44 Weeks)|Other|0|||
157182937|NCT02407236|567409377|FG002|Maintenance Study (44 Weeks)|Other|0|||
157182938|NCT02407236|567409378|FG003|Maintenance Study (44 Weeks)|Other|5|||
157182939|NCT02407236|567409379|FG004|Maintenance Study (44 Weeks)|Other|7|||
157182940|NCT02407236|567409380|FG005|Maintenance Study (44 Weeks)|Other|8|||
157182941|NCT02407236|567409381|FG006|Maintenance Study (44 Weeks)|Other|4|||
157182942|NCT02407236|567409382|FG007|Maintenance Study (44 Weeks)|Other|6|||
157229943|NCT00958243|567588206|FG001|Overall Study|Withdrawal by Subject|1|||
157229944|NCT00958243|567588207|FG002|Overall Study|Withdrawal by Subject|3|||
156976688|NCT00524030|566667550|FG001|Overall Study|Protocol Violation|1|||
156976689|NCT00524030|566667549|FG000|Overall Study|Pregnancy|1|||
156976690|NCT00524030|566667550|FG001|Overall Study|Pregnancy|0|||
156976691|NCT00524030|566667549|FG000|Overall Study|Adverse Event|3|||
156976692|NCT00524030|566667550|FG001|Overall Study|Adverse Event|21|||
156976693|NCT00524030|566667549|FG000|Overall Study|Death|0|||
156976694|NCT00524030|566667550|FG001|Overall Study|Death|1|||
156976695|NCT02944656|566667551|FG000|Overall Study|No longer eligible|3|||
156976696|NCT02944656|566667552|FG001|Overall Study|No longer eligible|0|||
156976697|NCT02944656|566667551|FG000|Overall Study|Lost to Follow-up|7|||
156976698|NCT02944656|566667552|FG001|Overall Study|Lost to Follow-up|10|||
156976699|NCT03535337|566667553|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
156976700|NCT03535337|566667554|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
156976701|NCT03535337|566667555|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
156976702|NCT03535337|566667556|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
156976703|NCT03535337|566667557|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
156976704|NCT03535337|566667558|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
156976705|NCT03535337|566667559|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
156976706|NCT03535337|566667560|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
156976707|NCT03535337|566667561|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
156976708|NCT03535337|566667562|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
156976709|NCT03518658|566669178|FG000|Overall Study|Other|51|||
156976710|NCT03518658|566669179|FG001|Overall Study|Other|0|||
156976711|NCT00649389|566669180|FG000|Overall Study|Adverse Event|22|||
156976712|NCT00649389|566669181|FG001|Overall Study|Adverse Event|46|||
156976713|NCT00649389|566669182|FG002|Overall Study|Adverse Event|38|||
156976714|NCT00649389|566669183|FG003|Overall Study|Adverse Event|48|||
156976715|NCT00649389|566669180|FG000|Overall Study|Lost to Follow-up|15|||
156976716|NCT00649389|566669181|FG001|Overall Study|Lost to Follow-up|17|||
157182943|NCT02407236|567409383|FG008|Maintenance Study (44 Weeks)|Other|0|||
157182944|NCT02407236|567409384|FG009|Maintenance Study (44 Weeks)|Other|0|||
157182945|NCT02407236|567409385|FG010|Maintenance Study (44 Weeks)|Other|0|||
157182946|NCT02407236|567409386|FG011|Maintenance Study (44 Weeks)|Other|0|||
157182947|NCT02407236|567409387|FG012|Maintenance Study (44 Weeks)|Other|0|||
157182948|NCT02407236|567409375|FG000|Maintenance Study (44 Weeks)|Death|0|||
157182949|NCT02407236|567409376|FG001|Maintenance Study (44 Weeks)|Death|0|||
157182950|NCT02407236|567409377|FG002|Maintenance Study (44 Weeks)|Death|0|||
157182951|NCT02407236|567409378|FG003|Maintenance Study (44 Weeks)|Death|0|||
157059413|NCT00684203|566971761|FG000|Overall Study|Protocol-defined clinical event|3|||
157059414|NCT00684203|566971762|FG001|Overall Study|Protocol-defined clinical event|1|||
157182952|NCT02407236|567409379|FG004|Maintenance Study (44 Weeks)|Death|0|||
157182953|NCT02407236|567409380|FG005|Maintenance Study (44 Weeks)|Death|0|||
157182954|NCT02407236|567409381|FG006|Maintenance Study (44 Weeks)|Death|0|||
157182955|NCT02407236|567409382|FG007|Maintenance Study (44 Weeks)|Death|1|||
157182956|NCT02407236|567409383|FG008|Maintenance Study (44 Weeks)|Death|0|||
157182957|NCT02407236|567409384|FG009|Maintenance Study (44 Weeks)|Death|0|||
157182958|NCT02407236|567409385|FG010|Maintenance Study (44 Weeks)|Death|0|||
157182959|NCT02407236|567409386|FG011|Maintenance Study (44 Weeks)|Death|0|||
157182960|NCT02407236|567409387|FG012|Maintenance Study (44 Weeks)|Death|0|||
157182961|NCT02407236|567409375|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157059415|NCT00684203|566971763|FG002|Overall Study|Protocol-defined clinical event|0|||
157059416|NCT00684203|566971764|FG003|Overall Study|Protocol-defined clinical event|0|||
157059417|NCT00684203|566971765|FG004|Overall Study|Protocol-defined clinical event|0|||
157059418|NCT00684203|566971766|FG005|Overall Study|Protocol-defined clinical event|0|||
157059419|NCT00684203|566971761|FG000|Overall Study|Withdrawal by Subject|0|||
157059420|NCT00684203|566971762|FG001|Overall Study|Withdrawal by Subject|2|||
157059421|NCT00684203|566971763|FG002|Overall Study|Withdrawal by Subject|1|||
157059422|NCT00684203|566971764|FG003|Overall Study|Withdrawal by Subject|0|||
157059423|NCT00684203|566971765|FG004|Overall Study|Withdrawal by Subject|0|||
157059424|NCT00684203|566971766|FG005|Overall Study|Withdrawal by Subject|0|||
157059425|NCT00684203|566971761|FG000|Overall Study|Did not meet protocol eligibility|0|||
157059426|NCT00684203|566971762|FG001|Overall Study|Did not meet protocol eligibility|1|||
157059427|NCT00684203|566971763|FG002|Overall Study|Did not meet protocol eligibility|0|||
157059428|NCT00684203|566971764|FG003|Overall Study|Did not meet protocol eligibility|0|||
157059429|NCT00684203|566971765|FG004|Overall Study|Did not meet protocol eligibility|0|||
157059430|NCT00684203|566971766|FG005|Overall Study|Did not meet protocol eligibility|0|||
157059431|NCT02762500|566971771|FG000|Overall Study|Lack of Efficacy|1|||
157059432|NCT02762500|566971772|FG001|Overall Study|Lack of Efficacy|0|||
157059433|NCT02762500|566971771|FG000|Overall Study|Withdrawal by Subject|1|||
157059434|NCT02762500|566971772|FG001|Overall Study|Withdrawal by Subject|1|||
157059435|NCT02762500|566971771|FG000|Overall Study|Adverse Event|0|||
157059436|NCT02762500|566971772|FG001|Overall Study|Adverse Event|2|||
157059437|NCT00730847|566971773|FG000|Overall Study|Adverse Event|1|||
157059438|NCT00730847|566971773|FG000|Overall Study|Protocol Violation|2|||
157059439|NCT00730847|566971773|FG000|Overall Study|Withdrawal by Subject|16|||
157059440|NCT00730847|566971773|FG000|Overall Study|Lost to Follow-up|67|||
157059441|NCT00730847|566971773|FG000|Overall Study|Unknown completion status|21|||
157059442|NCT00730847|566971773|FG000|Overall Study|Other|24|||
157059443|NCT00280683|566971774|FG000|Overall Study|Withdrawal by Subject|1|||
157059444|NCT00280683|566971775|FG001|Overall Study|Withdrawal by Subject|2|||
157059445|NCT00280683|566971774|FG000|Overall Study|Adverse Event|1|||
157059446|NCT00280683|566971775|FG001|Overall Study|Adverse Event|1|||
157182962|NCT02407236|567409376|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182963|NCT02407236|567409377|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182964|NCT02407236|567409378|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182965|NCT02407236|567409379|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182966|NCT02407236|567409380|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182967|NCT02407236|567409381|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157059447|NCT01243411|566971776|FG000|Overall Study|Withdrawal by Subject|18|||
157059448|NCT01243411|566971776|FG000|Overall Study|Lost to Follow-up|10|||
157059449|NCT01243411|566971776|FG000|Overall Study|Adverse Event|5|||
157059450|NCT01243411|566971776|FG000|Overall Study|Other|8|||
157059451|NCT00488319|566971785|FG000|Overall Study|Adverse Event|1|||
157059452|NCT00488319|566971786|FG001|Overall Study|Adverse Event|2|||
157059453|NCT00488319|566971787|FG002|Overall Study|Adverse Event|23|||
157059454|NCT00488319|566971785|FG000|Overall Study|Lack of Efficacy|6|||
157059455|NCT00488319|566971786|FG001|Overall Study|Lack of Efficacy|12|||
157182968|NCT02407236|567409382|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
157182969|NCT02407236|567409383|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
157059456|NCT00488319|566971787|FG002|Overall Study|Lack of Efficacy|27|||
157059457|NCT00488319|566971785|FG000|Overall Study|Lost to Follow-up|3|||
157059458|NCT00488319|566971786|FG001|Overall Study|Lost to Follow-up|5|||
157059459|NCT00488319|566971787|FG002|Overall Study|Lost to Follow-up|16|||
157182970|NCT02407236|567409384|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
157182971|NCT02407236|567409385|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
157182972|NCT02407236|567409386|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
157182973|NCT02407236|567409387|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
157182974|NCT02407236|567409375|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182975|NCT02407236|567409376|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182976|NCT02407236|567409377|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182977|NCT02407236|567409378|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182978|NCT02407236|567409379|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182979|NCT02407236|567409380|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182980|NCT02407236|567409381|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182981|NCT02407236|567409382|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182982|NCT02407236|567409383|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182983|NCT02407236|567409384|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182984|NCT02407236|567409385|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
157182985|NCT02407236|567409386|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182986|NCT02407236|567409387|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
157182987|NCT02407236|567409375|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182988|NCT02407236|567409376|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182989|NCT02407236|567409377|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182990|NCT02407236|567409378|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182991|NCT02407236|567409379|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182992|NCT02407236|567409380|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182993|NCT02407236|567409381|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182994|NCT02407236|567409382|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
157182995|NCT02407236|567409383|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
157182996|NCT02407236|567409384|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
157182997|NCT02407236|567409385|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
157182998|NCT02407236|567409386|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
157182999|NCT02407236|567409387|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
157183000|NCT02407236|567409375|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
157183001|NCT02407236|567409376|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
157183002|NCT02407236|567409377|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
157183003|NCT02407236|567409378|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
157183004|NCT02407236|567409379|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
157183005|NCT02407236|567409380|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
157183006|NCT02407236|567409381|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
157183007|NCT02407236|567409382|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
157183008|NCT02407236|567409383|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
157183009|NCT02407236|567409384|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
157183010|NCT02407236|567409385|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
157183011|NCT02407236|567409386|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
157183012|NCT02407236|567409387|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
157183013|NCT03039569|567409390|FG000|Overall Study|Lost to Follow-up|5|||
157183014|NCT03039569|567409391|FG001|Overall Study|Lost to Follow-up|4|||
157183015|NCT05643170|567410772|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
157183016|NCT05643170|567410772|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
157183017|NCT02358863|567410777|FG000|Overall Study|Physician Decision|3|||
157183018|NCT02632344|567410790|FG000|Overall Study|Adverse Event|3|||
157183019|NCT02632344|567410790|FG000|Overall Study|Lack of Efficacy|3|||
157183020|NCT02632344|567410790|FG000|Overall Study|Withdrawal by Subject|2|||
157183021|NCT05426460|567410795|FG000|Overall Study|Protocol Violation|1|||
157183022|NCT05426460|567410796|FG001|Overall Study|Protocol Violation|1|||
157183023|NCT05426460|567410797|FG002|Overall Study|Protocol Violation|1|||
157183024|NCT05426460|567410798|FG003|Overall Study|Protocol Violation|0|||
157183025|NCT04984876|567410799|FG000|Overall Study|Subject decision|2|||
157183026|NCT04984876|567410800|FG001|Overall Study|Subject decision|10|||
157183027|NCT04984876|567410801|FG002|Overall Study|Subject decision|3|||
157183028|NCT04984876|567410802|FG003|Overall Study|Subject decision|3|||
157183029|NCT04984876|567410803|FG004|Overall Study|Subject decision|3|||
157183030|NCT04984876|567410804|FG005|Overall Study|Subject decision|0|||
157183031|NCT04984876|567410799|FG000|Overall Study|Guardian decision|0|||
157229945|NCT00958243|567588208|FG003|Overall Study|Withdrawal by Subject|1|||
157229946|NCT00958243|567588209|FG004|Overall Study|Withdrawal by Subject|1|||
157183032|NCT04984876|567410800|FG001|Overall Study|Guardian decision|1|||
157183033|NCT04984876|567410801|FG002|Overall Study|Guardian decision|0|||
157183034|NCT04984876|567410802|FG003|Overall Study|Guardian decision|2|||
157183035|NCT04984876|567410803|FG004|Overall Study|Guardian decision|0|||
157183036|NCT04984876|567410804|FG005|Overall Study|Guardian decision|1|||
157183037|NCT04984876|567410799|FG000|Overall Study|Lost to Follow-up|0|||
157183038|NCT04984876|567410800|FG001|Overall Study|Lost to Follow-up|0|||
157183039|NCT04984876|567410801|FG002|Overall Study|Lost to Follow-up|1|||
157183040|NCT04984876|567410802|FG003|Overall Study|Lost to Follow-up|1|||
157183041|NCT04984876|567410803|FG004|Overall Study|Lost to Follow-up|0|||
157183042|NCT04984876|567410804|FG005|Overall Study|Lost to Follow-up|0|||
157183043|NCT04984876|567410799|FG000|Overall Study|Physician Decision|1|||
157183044|NCT04984876|567410800|FG001|Overall Study|Physician Decision|0|||
157183045|NCT04984876|567410801|FG002|Overall Study|Physician Decision|0|||
157183046|NCT04984876|567410802|FG003|Overall Study|Physician Decision|1|||
157183047|NCT04984876|567410803|FG004|Overall Study|Physician Decision|0|||
157183048|NCT04984876|567410804|FG005|Overall Study|Physician Decision|0|||
157183049|NCT04984876|567410799|FG000|Overall Study|Adverse Event|0|||
157183050|NCT04984876|567410800|FG001|Overall Study|Adverse Event|0|||
157183051|NCT04984876|567410801|FG002|Overall Study|Adverse Event|1|||
157183052|NCT04984876|567410802|FG003|Overall Study|Adverse Event|0|||
157183053|NCT04984876|567410803|FG004|Overall Study|Adverse Event|0|||
157183054|NCT04984876|567410804|FG005|Overall Study|Adverse Event|0|||
157183055|NCT01462045|567410807|FG000|Overall Study|Family matter|0|||
157183056|NCT01462045|567410808|FG001|Overall Study|Family matter|1|||
157183057|NCT01462045|567410809|FG002|Overall Study|Family matter|0|||
157183058|NCT03558828|567410810|FG000|Overall Study|Lost to Follow-up|4|||
157183059|NCT03558828|567410811|FG001|Overall Study|Lost to Follow-up|3|||
157183060|NCT03558828|567410812|FG002|Overall Study|Lost to Follow-up|3|||
157059460|NCT00488319|566971785|FG000|Overall Study|Withdrawal by Subject|5|||
157059461|NCT00488319|566971786|FG001|Overall Study|Withdrawal by Subject|20|||
157059462|NCT00488319|566971787|FG002|Overall Study|Withdrawal by Subject|44|||
157059463|NCT00488319|566971785|FG000|Overall Study|Other reasons for withdrawal|0|||
157059464|NCT00488319|566971786|FG001|Overall Study|Other reasons for withdrawal|4|||
157059465|NCT00488319|566971787|FG002|Overall Study|Other reasons for withdrawal|12|||
157059466|NCT00352053|566971788|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
157059467|NCT00352053|566971789|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
157059468|NCT00352053|566971788|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
157059469|NCT00352053|566971789|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
157059470|NCT00352053|566971788|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
157059471|NCT00352053|566971789|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
157059472|NCT00352053|566971788|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
157059473|NCT00352053|566971789|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
157059474|NCT00352053|566971788|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
157059475|NCT00352053|566971789|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
157059476|NCT00352053|566971788|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
157059477|NCT00352053|566971789|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
157059478|NCT00352053|566971788|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
157059479|NCT00352053|566971789|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
157059480|NCT00352053|566971788|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
157059481|NCT00352053|566971789|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
157059482|NCT00352053|566971788|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
157059483|NCT00352053|566971789|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
157059484|NCT00352053|566971788|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
157059485|NCT00352053|566971789|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
157059486|NCT00352053|566971788|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
157059487|NCT00352053|566971789|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
157059488|NCT00352053|566971788|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
157059489|NCT00352053|566971789|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
157059490|NCT00352053|566971788|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
157059491|NCT00352053|566971789|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
157059492|NCT02499835|566971795|FG000|Overall Study|Withdrawal by Subject|1|||
157059493|NCT02499835|566971796|FG001|Overall Study|Withdrawal by Subject|0|||
157059494|NCT02499835|566971797|FG002|Overall Study|Withdrawal by Subject|0|||
157059495|NCT02499835|566971798|FG003|Overall Study|Withdrawal by Subject|1|||
157059496|NCT02499835|566971795|FG000|Overall Study|Physician Decision|0|||
157059497|NCT02499835|566971796|FG001|Overall Study|Physician Decision|3|||
157183061|NCT03558828|567410813|FG003|Overall Study|Lost to Follow-up|5|||
157059498|NCT02499835|566971797|FG002|Overall Study|Physician Decision|18|||
157059499|NCT02499835|566971798|FG003|Overall Study|Physician Decision|7|||
157183062|NCT03558828|567410814|FG004|Overall Study|Lost to Follow-up|2|||
157059500|NCT02499835|566971795|FG000|Overall Study|Adverse Event|0|||
157183063|NCT03558828|567410815|FG005|Overall Study|Lost to Follow-up|3|||
157183064|NCT03558828|567410810|FG000|Overall Study|dropped before the intervention|1|||
157183065|NCT03558828|567410811|FG001|Overall Study|dropped before the intervention|1|||
157183066|NCT03558828|567410812|FG002|Overall Study|dropped before the intervention|0|||
157183067|NCT03558828|567410813|FG003|Overall Study|dropped before the intervention|0|||
157183068|NCT03558828|567410814|FG004|Overall Study|dropped before the intervention|0|||
157229947|NCT00958243|567588210|FG005|Overall Study|Withdrawal by Subject|5|||
157183069|NCT03558828|567410815|FG005|Overall Study|dropped before the intervention|0|||
157183070|NCT02252588|567410817|FG000|Overall Study|Withdrawal by Subject|4|||
157183071|NCT02252588|567410818|FG001|Overall Study|Withdrawal by Subject|0|||
157183072|NCT00693693|567410831|FG000|Overall Study|Lost to Follow-up|1|||
157183073|NCT00693693|567410832|FG001|Overall Study|Lost to Follow-up|1|||
157183074|NCT00693693|567410833|FG002|Overall Study|Lost to Follow-up|2|||
157183075|NCT02972593|567410834|FG000|Overall Study|Lost to Follow-up|19|||
157183076|NCT02972593|567410835|FG001|Overall Study|Lost to Follow-up|15|||
157183077|NCT02972593|567410834|FG000|Overall Study|Protocol Violation|1|||
157183078|NCT02972593|567410835|FG001|Overall Study|Protocol Violation|0|||
157183079|NCT00285649|567410836|FG000|Overall Study|Lost to Follow-up|6|||
157183080|NCT00285649|567410837|FG001|Overall Study|Lost to Follow-up|4|||
157183081|NCT00285649|567410838|FG002|Overall Study|Lost to Follow-up|4|||
157183082|NCT00285649|567410836|FG000|Overall Study|Withdrawal by Subject|3|||
157183083|NCT00285649|567410837|FG001|Overall Study|Withdrawal by Subject|2|||
157183084|NCT00285649|567410838|FG002|Overall Study|Withdrawal by Subject|2|||
157183085|NCT01855425|567410843|FG000|Overall Study|Physician Decision|20|||
157183086|NCT01025232|567410853|FG000|Overall Study|Study drug no longer available|3|||
157183087|NCT01025232|567410854|FG001|Overall Study|Study drug no longer available|6|||
157183088|NCT03748420|567410855|FG000|Overall Study|No 12 month medication adherence data available|0|||
157183089|NCT03748420|567410856|FG001|Overall Study|No 12 month medication adherence data available|1|||
157183090|NCT03748420|567410855|FG000|Overall Study|Death|24|||
157183091|NCT03748420|567410856|FG001|Overall Study|Death|28|||
157183092|NCT03748420|567410855|FG000|Overall Study|Lost to Follow-up|231|||
157183093|NCT03748420|567410856|FG001|Overall Study|Lost to Follow-up|230|||
157183094|NCT02203916|567410858|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
157183095|NCT02203916|567410859|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
157183096|NCT02203916|567410860|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
157183097|NCT02203916|567410858|FG000|Overall Study|Major Protocol Deviation|1|||
157183098|NCT02203916|567410859|FG001|Overall Study|Major Protocol Deviation|1|||
157183099|NCT02203916|567410860|FG002|Overall Study|Major Protocol Deviation|0|||
157183100|NCT02203916|567410858|FG000|Overall Study|Lost to Follow-up|0|||
157183101|NCT02203916|567410859|FG001|Overall Study|Lost to Follow-up|1|||
157183102|NCT02203916|567410860|FG002|Overall Study|Lost to Follow-up|0|||
157183103|NCT02203916|567410858|FG000|Overall Study|Voluntary Withdrawal|3|||
157183104|NCT02203916|567410859|FG001|Overall Study|Voluntary Withdrawal|3|||
157183105|NCT02203916|567410860|FG002|Overall Study|Voluntary Withdrawal|8|||
157183106|NCT02203916|567410858|FG000|Overall Study|Lack of Efficacy|3|||
157183107|NCT02203916|567410859|FG001|Overall Study|Lack of Efficacy|0|||
157183108|NCT02203916|567410860|FG002|Overall Study|Lack of Efficacy|0|||
157183109|NCT02203916|567410858|FG000|Overall Study|Reason Not Specified|0|||
157183110|NCT02203916|567410859|FG001|Overall Study|Reason Not Specified|2|||
157183111|NCT02203916|567410860|FG002|Overall Study|Reason Not Specified|1|||
157183112|NCT00414973|567410861|FG000|Overall Study|Withdrawal by Subject|14|||
157183113|NCT00414973|567410862|FG001|Overall Study|Withdrawal by Subject|4|||
157183114|NCT00414973|567410863|FG002|Overall Study|Withdrawal by Subject|1|||
157183115|NCT00414973|567410864|FG003|Overall Study|Withdrawal by Subject|0|||
157183116|NCT00414973|567410861|FG000|Overall Study|Adverse Event|10|||
157183117|NCT00414973|567410862|FG001|Overall Study|Adverse Event|0|||
157183118|NCT00414973|567410863|FG002|Overall Study|Adverse Event|1|||
157183119|NCT00414973|567410864|FG003|Overall Study|Adverse Event|0|||
157183120|NCT00414973|567410861|FG000|Overall Study|Protocol Violation|3|||
157183121|NCT00414973|567410862|FG001|Overall Study|Protocol Violation|4|||
157183122|NCT00414973|567410863|FG002|Overall Study|Protocol Violation|0|||
157183123|NCT00414973|567410864|FG003|Overall Study|Protocol Violation|0|||
157183124|NCT00414973|567410861|FG000|Overall Study|Lost to Follow-up|0|||
157183125|NCT00414973|567410862|FG001|Overall Study|Lost to Follow-up|2|||
157183126|NCT00414973|567410863|FG002|Overall Study|Lost to Follow-up|0|||
157183127|NCT00414973|567410864|FG003|Overall Study|Lost to Follow-up|0|||
157183128|NCT00414973|567410861|FG000|Overall Study|Sponsor Decision|1|||
157183129|NCT00414973|567410862|FG001|Overall Study|Sponsor Decision|0|||
157183130|NCT00414973|567410863|FG002|Overall Study|Sponsor Decision|0|||
157183131|NCT00414973|567410864|FG003|Overall Study|Sponsor Decision|0|||
157183132|NCT00414973|567410861|FG000|Overall Study|Death|0|||
157183133|NCT00414973|567410862|FG001|Overall Study|Death|0|||
157183134|NCT00414973|567410863|FG002|Overall Study|Death|1|||
157183135|NCT00414973|567410864|FG003|Overall Study|Death|0|||
157183136|NCT01466062|567410865|FG000|Overall Study|Adverse Event|1|||
157183137|NCT01466062|567410865|FG000|Overall Study|Withdrawal by Subject|1|||
157183138|NCT01925014|567410866|FG000|Overall Study|Inappropriate enrollment|4|||
157183139|NCT01925014|567410867|FG001|Overall Study|Inappropriate enrollment|6|||
157183140|NCT01925014|567410866|FG000|Overall Study|Withdrawal by Subject|5|||
157183141|NCT01925014|567410867|FG001|Overall Study|Withdrawal by Subject|13|||
157183142|NCT00471276|567410871|FG000|Overall Study|Death|2|||
157229948|NCT00958243|567588205|FG000|Overall Study|Lost to Follow-up|2|||
157183143|NCT00471276|567410871|FG000|Overall Study|Adverse Event|16|||
157183144|NCT00471276|567410871|FG000|Overall Study|Protocol Violation|1|||
157183145|NCT00471276|567410871|FG000|Overall Study|Objective progression or relapse|54|||
157183146|NCT00471276|567410871|FG000|Overall Study|Global deterioration of health status|1|||
157183147|NCT00471276|567410871|FG000|Overall Study|Other|3|||
157183148|NCT00471276|567410871|FG000|Overall Study|Refused treatment|6|||
157183149|NCT03077711|567410874|FG000|Overall Study|Lost to Follow-up|2|||
157183150|NCT03077711|567410875|FG001|Overall Study|Lost to Follow-up|2|||
157183151|NCT03077711|567410874|FG000|Overall Study|noncompliant taking medication|2|||
157183152|NCT03077711|567410875|FG001|Overall Study|noncompliant taking medication|0|||
157183153|NCT01437267|567410876|FG000|Overall Study|Withdrawal by Subject|0|||
157183154|NCT01437267|567410877|FG001|Overall Study|Withdrawal by Subject|0|||
157183155|NCT01437267|567410878|FG002|Overall Study|Withdrawal by Subject|0|||
157183156|NCT01437267|567410879|FG003|Overall Study|Withdrawal by Subject|1|||
157183157|NCT01437267|567410880|FG004|Overall Study|Withdrawal by Subject|0|||
157183158|NCT01437267|567410881|FG005|Overall Study|Withdrawal by Subject|0|||
157183159|NCT01437267|567410876|FG000|Overall Study|Protocol Violation|0|||
157183160|NCT01437267|567410877|FG001|Overall Study|Protocol Violation|1|||
157183161|NCT01437267|567410878|FG002|Overall Study|Protocol Violation|0|||
157183162|NCT01437267|567410879|FG003|Overall Study|Protocol Violation|0|||
157183163|NCT01437267|567410880|FG004|Overall Study|Protocol Violation|0|||
157183164|NCT01437267|567410881|FG005|Overall Study|Protocol Violation|0|||
157183165|NCT03934203|567410882|FG000|Overall Study|Adverse Event|0|||
157183166|NCT03934203|567410883|FG001|Overall Study|Adverse Event|0|||
157183167|NCT03934203|567410884|FG002|Overall Study|Adverse Event|1|||
157183168|NCT03934203|567410885|FG003|Overall Study|Adverse Event|0|||
157183169|NCT03934203|567410886|FG004|Overall Study|Adverse Event|1|||
157183170|NCT03934203|567410887|FG005|Overall Study|Adverse Event|0|||
157183171|NCT03934203|567410888|FG006|Overall Study|Adverse Event|2|||
157183172|NCT03934203|567410889|FG007|Overall Study|Adverse Event|0|||
157183173|NCT03934203|567410890|FG008|Overall Study|Adverse Event|0|||
157183174|NCT03934203|567410891|FG009|Overall Study|Adverse Event|0|||
157183175|NCT03934203|567410892|FG010|Overall Study|Adverse Event|0|||
157183176|NCT03934203|567410893|FG011|Overall Study|Adverse Event|0|||
157183177|NCT03934203|567410894|FG012|Overall Study|Adverse Event|0|||
157183178|NCT03934203|567410895|FG013|Overall Study|Adverse Event|1|||
157183179|NCT03934203|567410896|FG014|Overall Study|Adverse Event|0|||
157183180|NCT00333970|567410897|FG000|Overall Study|Withdrawal by Subject|13|||
157183181|NCT00333970|567410898|FG001|Overall Study|Withdrawal by Subject|7|||
157183182|NCT00441480|567410899|FG000|Overall Study|Protocol Violation|1|||
157183183|NCT00441480|567410900|FG001|Overall Study|Protocol Violation|1|||
157183184|NCT00441480|567410899|FG000|Overall Study|Withdrawal by Subject|2|||
157183185|NCT00441480|567410900|FG001|Overall Study|Withdrawal by Subject|3|||
157183186|NCT00899678|567410901|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
157183187|NCT00899678|567410902|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
157183188|NCT00899678|567410903|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
157183189|NCT00899678|567410901|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
157183190|NCT00899678|567410902|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
157183191|NCT00899678|567410903|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
157183192|NCT00899678|567410901|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
157183193|NCT00899678|567410902|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
157183194|NCT00899678|567410903|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
157183195|NCT00899678|567410901|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
157183196|NCT00899678|567410902|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
157183197|NCT00899678|567410903|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
157183198|NCT00899678|567410901|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
157183199|NCT00899678|567410902|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
157183200|NCT00899678|567410903|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
157183201|NCT00899678|567410901|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
157183202|NCT00899678|567410902|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
157183203|NCT00899678|567410903|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
157059501|NCT02499835|566971796|FG001|Overall Study|Adverse Event|0|||
157059502|NCT02499835|566971797|FG002|Overall Study|Adverse Event|0|||
157059503|NCT02499835|566971798|FG003|Overall Study|Adverse Event|1|||
157059504|NCT02499835|566971795|FG000|Overall Study|Disease progression|2|||
157059505|NCT02499835|566971796|FG001|Overall Study|Disease progression|1|||
157183204|NCT00899678|567410901|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
157183205|NCT00899678|567410902|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
157183206|NCT00899678|567410903|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
157183207|NCT00899678|567410901|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
157183208|NCT00899678|567410902|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
157183209|NCT00899678|567410903|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
157183210|NCT00899678|567410901|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
157183211|NCT00899678|567410902|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
157183212|NCT00899678|567410903|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
157183213|NCT02092324|567410904|FG000|Overall Study|Adverse Event|1|||
157183214|NCT02092324|567410904|FG000|Overall Study|Lack of Efficacy|6|||
157183215|NCT02092324|567410904|FG000|Overall Study|Proceed to Transplant|3|||
157059506|NCT02499835|566971797|FG002|Overall Study|Disease progression|0|||
157059507|NCT02499835|566971798|FG003|Overall Study|Disease progression|7|||
157059508|NCT03226353|566971807|FG000|Overall Study|Withdrawal by Subject|1|||
157059509|NCT03226353|566971807|FG000|Overall Study|Screen Failure|5|||
157059510|NCT03319719|566971808|FG000|Overall Study|Lost to Follow-up|1|||
157059511|NCT03193216|566971809|FG000|Overall Study|Lost to Follow-up|1|||
157059512|NCT03193216|566971810|FG001|Overall Study|Lost to Follow-up|0|||
157059513|NCT03193216|566971809|FG000|Overall Study|Withdrawal by Subject|5|||
157059514|NCT03193216|566971810|FG001|Overall Study|Withdrawal by Subject|0|||
157059515|NCT03193216|566971809|FG000|Overall Study|Physician Decision|4|||
157059516|NCT03193216|566971810|FG001|Overall Study|Physician Decision|0|||
157059517|NCT02490878|566971811|FG000|Overall Study|deemed ineligible|0|||
157059518|NCT02490878|566971812|FG001|Overall Study|deemed ineligible|1|||
157059519|NCT02490878|566971811|FG000|Overall Study|progression prior to treatment|0|||
157059520|NCT02490878|566971812|FG001|Overall Study|progression prior to treatment|1|||
157059521|NCT02490878|566971811|FG000|Overall Study|only submitted baseline QOL|0|||
157059522|NCT02490878|566971812|FG001|Overall Study|only submitted baseline QOL|1|||
157059523|NCT00843115|566971815|FG000|Overall Study|Death|4|||
157059524|NCT00843115|566971815|FG000|Overall Study|Adverse Event|30|||
157059525|NCT00843115|566971815|FG000|Overall Study|Lost to Follow-up|4|||
157059526|NCT00843115|566971815|FG000|Overall Study|Withdrawal by Subject|17|||
157059527|NCT00843115|566971815|FG000|Overall Study|Family wanted meds stopped|1|||
157059528|NCT00843115|566971815|FG000|Overall Study|Family does not want continuation|1|||
157059529|NCT00843115|566971815|FG000|Overall Study|Patient forgot to take meds|1|||
157059530|NCT00843115|566971815|FG000|Overall Study|Does not meet entrance criteria|1|||
157059531|NCT00843115|566971815|FG000|Overall Study|Physician Decision|1|||
157059532|NCT00843115|566971815|FG000|Overall Study|Family discontinued meds|1|||
157059533|NCT00843115|566971815|FG000|Overall Study|patient took for 2 days then stopped|1|||
157059534|NCT00843115|566971815|FG000|Overall Study|patient never took the medication|1|||
157059535|NCT00843115|566971815|FG000|Overall Study|hospitalized due to deterioration|1|||
157059536|NCT00843115|566971815|FG000|Overall Study|week 12 not done|1|||
157059537|NCT00843115|566971815|FG000|Overall Study|Syndrome De Glissement|1|||
157059538|NCT02959177|566971822|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
157059539|NCT02959177|566971823|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
157059540|NCT02959177|566971824|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
157059541|NCT02959177|566971822|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
157059542|NCT02959177|566971823|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
157059543|NCT02959177|566971824|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
157059544|NCT02959177|566971822|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
157059545|NCT02959177|566971823|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
157059546|NCT02959177|566971824|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
157059547|NCT02959177|566971822|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
157059548|NCT02959177|566971823|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
157059549|NCT02959177|566971824|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
157059550|NCT02959177|566971822|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
157059551|NCT02959177|566971823|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
157059552|NCT02959177|566971824|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
157059553|NCT02959177|566971822|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
157059554|NCT02959177|566971823|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
157059555|NCT02959177|566971824|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
157059556|NCT02959177|566971822|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
157059557|NCT02959177|566971823|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
157059558|NCT02959177|566971824|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
157059559|NCT00591409|566971828|FG000|Overall Study|Not Treated|0|||
157059560|NCT00591409|566971829|FG001|Overall Study|Not Treated|0|||
157059561|NCT00591409|566971830|FG002|Overall Study|Not Treated|0|||
157059562|NCT00591409|566971831|FG003|Overall Study|Not Treated|0|||
157059563|NCT00591409|566971832|FG004|Overall Study|Not Treated|1|||
157059564|NCT00591409|566971833|FG005|Overall Study|Not Treated|0|||
157059565|NCT00591409|566971834|FG006|Overall Study|Not Treated|0|||
157059566|NCT00591409|566971835|FG007|Overall Study|Not Treated|0|||
157059567|NCT00591409|566971836|FG008|Overall Study|Not Treated|0|||
157059568|NCT00591409|566971837|FG009|Overall Study|Not Treated|1|||
157059569|NCT02171130|566971838|FG000|Overall Study|Death|1|||
157059570|NCT02171130|566971838|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
157059571|NCT02171130|566971838|FG000|Overall Study|Discontinued; Site Termination|5|||
157059572|NCT02171130|566971838|FG000|Overall Study|Withdrawal by Subject|3|||
157059573|NCT02171130|566971838|FG000|Overall Study|Physician Decision|1|||
157059574|NCT02171130|566971838|FG000|Overall Study|Lost to Follow-up|1|||
157059575|NCT02171130|566971838|FG000|Overall Study|Met Exclusion Criteria|1|||
157059576|NCT02853305|566971839|FG000|Overall Study|Death|287|||
157059577|NCT02853305|566971840|FG001|Overall Study|Death|249|||
157059578|NCT02853305|566971841|FG002|Overall Study|Death|300|||
157059579|NCT02853305|566971839|FG000|Overall Study|Withdrawal by Subject|2|||
157059580|NCT02853305|566971840|FG001|Overall Study|Withdrawal by Subject|8|||
157059581|NCT02853305|566971841|FG002|Overall Study|Withdrawal by Subject|3|||
157183216|NCT02092324|567410904|FG000|Overall Study|Physician Decision|7|||
157183217|NCT02092324|567410904|FG000|Overall Study|Misdiagnosis|2|||
157183218|NCT00398138|567410907|FG000|Overall Study|Adverse Event|2|||
157183219|NCT02569398|567410908|FG000|Overall Study|Adverse Event|0|||
157183220|NCT02569398|567410909|FG001|Overall Study|Adverse Event|1|||
157183221|NCT02569398|567410910|FG002|Overall Study|Adverse Event|6|||
157183222|NCT02569398|567410908|FG000|Overall Study|Withdrawal by Subject|43|||
157183223|NCT02569398|567410909|FG001|Overall Study|Withdrawal by Subject|43|||
157183224|NCT02569398|567410910|FG002|Overall Study|Withdrawal by Subject|30|||
157183225|NCT02569398|567410908|FG000|Overall Study|Study terminated by sponsor|130|||
157183226|NCT02569398|567410909|FG001|Overall Study|Study terminated by sponsor|131|||
157183227|NCT02569398|567410910|FG002|Overall Study|Study terminated by sponsor|134|||
157183228|NCT02569398|567410908|FG000|Overall Study|Other|12|||
157183229|NCT02569398|567410909|FG001|Overall Study|Other|14|||
157183230|NCT02569398|567410910|FG002|Overall Study|Other|13|||
157183231|NCT03039192|567410911|FG000|Overall Study|Lost to Follow-up|4|||
157183232|NCT03039192|567410912|FG001|Overall Study|Lost to Follow-up|4|||
157183233|NCT03039192|567410911|FG000|Overall Study|Adverse event, serious fatal|0|||
157183234|NCT03039192|567410912|FG001|Overall Study|Adverse event, serious fatal|1|||
157183235|NCT03039192|567410911|FG000|Overall Study|Adverse event, non-fatal|0|||
157183236|NCT03039192|567410912|FG001|Overall Study|Adverse event, non-fatal|2|||
157183237|NCT03039192|567410911|FG000|Overall Study|Withdrawal by Subject|6|||
157183238|NCT03039192|567410912|FG001|Overall Study|Withdrawal by Subject|9|||
157183239|NCT03039192|567410911|FG000|Overall Study|Discontinued from treatment phase|19|||
157183240|NCT03039192|567410912|FG001|Overall Study|Discontinued from treatment phase|12|||
157183241|NCT03039192|567410911|FG000|Overall Study|Other|3|||
157183242|NCT03039192|567410912|FG001|Overall Study|Other|2|||
157183243|NCT02177812|567410916|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183244|NCT02177812|567410917|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183245|NCT02177812|567410918|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183246|NCT02177812|567410919|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183247|NCT02177812|567410920|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183248|NCT02177812|567410921|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
157183249|NCT02177812|567410922|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
157183250|NCT02177812|567410923|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
157183251|NCT02177812|567410924|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
157183252|NCT02177812|567410916|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183253|NCT02177812|567410917|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183254|NCT02177812|567410918|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183255|NCT02177812|567410919|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183256|NCT02177812|567410920|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183257|NCT02177812|567410921|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
157183258|NCT02177812|567410922|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
157183259|NCT02177812|567410923|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183260|NCT02177812|567410924|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
157183261|NCT02177812|567410916|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
157183262|NCT02177812|567410917|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
157183263|NCT02177812|567410918|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
157183264|NCT02177812|567410919|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
157183265|NCT02177812|567410920|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
157183266|NCT02177812|567410921|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
157183267|NCT02177812|567410922|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
157183268|NCT02177812|567410923|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
157183269|NCT02177812|567410924|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
157183270|NCT00089999|567410925|FG000|Overall Study|Adverse Event|4|||
157183271|NCT00089999|567410926|FG001|Overall Study|Adverse Event|7|||
157183272|NCT00089999|567410925|FG000|Overall Study|Withdrawal by Subject|0|||
157183273|NCT00089999|567410926|FG001|Overall Study|Withdrawal by Subject|4|||
157183274|NCT00089999|567410925|FG000|Overall Study|Lost to Follow-up|2|||
157183275|NCT00089999|567410926|FG001|Overall Study|Lost to Follow-up|1|||
157183276|NCT00089999|567410925|FG000|Overall Study|Radiological Progression of Cancer|52|||
157183277|NCT00089999|567410926|FG001|Overall Study|Radiological Progression of Cancer|44|||
157183278|NCT00089999|567410925|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
157183279|NCT00089999|567410926|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
157183280|NCT00089999|567410925|FG000|Overall Study|Death|3|||
157183281|NCT00089999|567410926|FG001|Overall Study|Death|3|||
157183282|NCT00089999|567410925|FG000|Overall Study|Poor General Condition|1|||
157183283|NCT00089999|567410926|FG001|Overall Study|Poor General Condition|0|||
157183284|NCT00089999|567410925|FG000|Overall Study|Clinical Progression|1|||
157183285|NCT00089999|567410926|FG001|Overall Study|Clinical Progression|2|||
157183286|NCT00089999|567410925|FG000|Overall Study|Physician Decision|2|||
157183287|NCT00089999|567410926|FG001|Overall Study|Physician Decision|2|||
157183288|NCT00089999|567410925|FG000|Overall Study|Patient Underwent Surgery|2|||
157183289|NCT00089999|567410926|FG001|Overall Study|Patient Underwent Surgery|0|||
156976717|NCT00649389|566669182|FG002|Overall Study|Lost to Follow-up|21|||
157059582|NCT02853305|566971839|FG000|Overall Study|Transferred to Extension Study|46|||
157059583|NCT02853305|566971840|FG001|Overall Study|Transferred to Extension Study|30|||
157059584|NCT02853305|566971841|FG002|Overall Study|Transferred to Extension Study|25|||
157059585|NCT02853305|566971839|FG000|Overall Study|Did Not Continue on Extension Study|16|||
157059586|NCT02853305|566971840|FG001|Overall Study|Did Not Continue on Extension Study|20|||
157059587|NCT02853305|566971841|FG002|Overall Study|Did Not Continue on Extension Study|24|||
157059588|NCT00677092|566971844|FG000|Overall Study|Adverse Event|1|||
157059589|NCT00677092|566971844|FG000|Overall Study|Lost to Follow-up|1|||
157059590|NCT00677092|566971844|FG000|Overall Study|Withdrawal by Subject|3|||
157059591|NCT00677092|566971844|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
157059592|NCT02381652|566971847|FG000|Overall Study|Withdrawal by Subject|0|||
157059593|NCT02381652|566971848|FG001|Overall Study|Withdrawal by Subject|0|||
157059594|NCT02381652|566971849|FG002|Overall Study|Withdrawal by Subject|1|||
157059595|NCT01340300|566971850|FG000|Overall Study|Lost to Follow-up|3|||
157059596|NCT01340300|566971851|FG001|Overall Study|Lost to Follow-up|0|||
157059597|NCT01340300|566971852|FG002|Overall Study|Lost to Follow-up|5|||
157059598|NCT01340300|566971853|FG003|Overall Study|Lost to Follow-up|10|||
157059599|NCT01340300|566971850|FG000|Overall Study|Withdrawal by Subject|5|||
157059600|NCT01340300|566971851|FG001|Overall Study|Withdrawal by Subject|6|||
157059601|NCT01340300|566971852|FG002|Overall Study|Withdrawal by Subject|6|||
157059602|NCT01340300|566971853|FG003|Overall Study|Withdrawal by Subject|3|||
157059603|NCT01340300|566971850|FG000|Overall Study|Adverse Event|1|||
157059604|NCT01340300|566971851|FG001|Overall Study|Adverse Event|0|||
157059605|NCT01340300|566971852|FG002|Overall Study|Adverse Event|4|||
157059606|NCT01340300|566971853|FG003|Overall Study|Adverse Event|0|||
157059607|NCT01340300|566971850|FG000|Overall Study|Physician Decision|0|||
157059608|NCT01340300|566971851|FG001|Overall Study|Physician Decision|1|||
157059609|NCT01340300|566971852|FG002|Overall Study|Physician Decision|0|||
157059610|NCT01340300|566971853|FG003|Overall Study|Physician Decision|0|||
157059611|NCT01340300|566971850|FG000|Overall Study|Unrelated sickness|0|||
157059612|NCT01340300|566971851|FG001|Overall Study|Unrelated sickness|2|||
157059613|NCT01340300|566971852|FG002|Overall Study|Unrelated sickness|0|||
157059614|NCT01340300|566971853|FG003|Overall Study|Unrelated sickness|1|||
157059615|NCT01836198|566971854|FG000|Part A, Period 2|Protocol Violation|0|||
157059616|NCT01836198|566971855|FG001|Part A, Period 2|Protocol Violation|1|||
157059617|NCT01836198|566971856|FG002|Part A, Period 2|Protocol Violation|0|||
157059618|NCT02460562|566971858|FG000|Overall Study|Lost to Follow-up|15|||
157059619|NCT02460562|566971859|FG001|Overall Study|Lost to Follow-up|16|||
157059620|NCT04194541|566971860|FG000|Day 1 Through 13|Lost to Follow-up|3|||
157059621|NCT04194541|566971860|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
157059622|NCT04194541|566971860|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
157059623|NCT00187135|566971863|FG000|Visit One|Withdrawal by Subject|1|||
157059624|NCT00187135|566971864|FG001|Visit One|Withdrawal by Subject|0|||
157059625|NCT00187135|566971865|FG002|Visit One|Withdrawal by Subject|0|||
157059626|NCT00187135|566971866|FG003|Visit One|Withdrawal by Subject|0|||
157059627|NCT00187135|566971867|FG004|Visit One|Withdrawal by Subject|0|||
157059628|NCT00187135|566971868|FG005|Visit One|Withdrawal by Subject|1|||
157059629|NCT00187135|566971863|FG000|Visit One|Physician Decision|3|||
157059630|NCT00187135|566971864|FG001|Visit One|Physician Decision|1|||
157059631|NCT00187135|566971865|FG002|Visit One|Physician Decision|0|||
157059632|NCT00187135|566971866|FG003|Visit One|Physician Decision|0|||
157059633|NCT00187135|566971867|FG004|Visit One|Physician Decision|0|||
157059634|NCT00187135|566971868|FG005|Visit One|Physician Decision|1|||
157059635|NCT00187135|566971863|FG000|Visit Two|Death|0|||
157059636|NCT00187135|566971864|FG001|Visit Two|Death|0|||
157059637|NCT00187135|566971865|FG002|Visit Two|Death|0|||
157059638|NCT00187135|566971866|FG003|Visit Two|Death|1|||
157183290|NCT00089999|567410925|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
157183291|NCT00089999|567410926|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
157183292|NCT01167153|567410927|FG000|Overall Study|Non-effective therapy|1|||
157183293|NCT01167153|567410928|FG001|Overall Study|Non-effective therapy|4|||
157183294|NCT01167153|567410927|FG000|Overall Study|AE including clinical laboratory AE|2|||
157059639|NCT00187135|566971867|FG004|Visit Two|Death|0|||
157059640|NCT00187135|566971868|FG005|Visit Two|Death|1|||
157059641|NCT00187135|566971863|FG000|Visit Two|Physician Decision|1|||
157059642|NCT00187135|566971864|FG001|Visit Two|Physician Decision|0|||
157059643|NCT00187135|566971865|FG002|Visit Two|Physician Decision|0|||
157059644|NCT00187135|566971866|FG003|Visit Two|Physician Decision|0|||
157183295|NCT01167153|567410928|FG001|Overall Study|AE including clinical laboratory AE|8|||
157183296|NCT01167153|567410927|FG000|Overall Study|Hypotension|1|||
157183297|NCT01167153|567410928|FG001|Overall Study|Hypotension|0|||
157059645|NCT00187135|566971867|FG004|Visit Two|Physician Decision|0|||
157059646|NCT00187135|566971868|FG005|Visit Two|Physician Decision|0|||
157059647|NCT00187135|566971863|FG000|Visit Two|Withdrawal by Subject|1|||
157059648|NCT00187135|566971864|FG001|Visit Two|Withdrawal by Subject|1|||
157059649|NCT00187135|566971865|FG002|Visit Two|Withdrawal by Subject|1|||
157059650|NCT00187135|566971866|FG003|Visit Two|Withdrawal by Subject|0|||
157059651|NCT00187135|566971867|FG004|Visit Two|Withdrawal by Subject|1|||
157183298|NCT01167153|567410927|FG000|Overall Study|Lost to Follow-up|7|||
157059652|NCT00187135|566971868|FG005|Visit Two|Withdrawal by Subject|1|||
157059653|NCT00187135|566971863|FG000|Visit Two|Study Discontinued|3|||
157059654|NCT00187135|566971864|FG001|Visit Two|Study Discontinued|2|||
157059655|NCT00187135|566971865|FG002|Visit Two|Study Discontinued|1|||
157059656|NCT00187135|566971866|FG003|Visit Two|Study Discontinued|7|||
157059657|NCT00187135|566971867|FG004|Visit Two|Study Discontinued|5|||
157059658|NCT00187135|566971868|FG005|Visit Two|Study Discontinued|6|||
157059659|NCT00187135|566971863|FG000|Visit Three|Death|0|||
157059660|NCT00187135|566971864|FG001|Visit Three|Death|0|||
157059661|NCT00187135|566971865|FG002|Visit Three|Death|1|||
157059662|NCT00187135|566971866|FG003|Visit Three|Death|0|||
157059663|NCT00187135|566971867|FG004|Visit Three|Death|1|||
157059664|NCT00187135|566971868|FG005|Visit Three|Death|0|||
157059665|NCT00187135|566971863|FG000|Visit Three|Withdrawal by Subject|0|||
157059666|NCT00187135|566971864|FG001|Visit Three|Withdrawal by Subject|1|||
157059667|NCT00187135|566971865|FG002|Visit Three|Withdrawal by Subject|1|||
157059668|NCT00187135|566971866|FG003|Visit Three|Withdrawal by Subject|2|||
157059669|NCT00187135|566971867|FG004|Visit Three|Withdrawal by Subject|0|||
157059670|NCT00187135|566971868|FG005|Visit Three|Withdrawal by Subject|0|||
157059671|NCT00187135|566971863|FG000|Visit Three|Study Discontinued|7|||
157059672|NCT00187135|566971864|FG001|Visit Three|Study Discontinued|6|||
157059673|NCT00187135|566971865|FG002|Visit Three|Study Discontinued|7|||
157059674|NCT00187135|566971866|FG003|Visit Three|Study Discontinued|7|||
157059675|NCT00187135|566971867|FG004|Visit Three|Study Discontinued|7|||
157059676|NCT00187135|566971868|FG005|Visit Three|Study Discontinued|6|||
157059677|NCT01675050|566971872|FG000|Period One Treatment|Withdrawal by Subject|1|||
157059678|NCT01675050|566971873|FG001|Period One Treatment|Withdrawal by Subject|0|||
157059679|NCT00745121|566971874|FG000|Overall Study|Death|3|||
157059680|NCT00745121|566971875|FG001|Overall Study|Death|0|||
157059681|NCT00745121|566971874|FG000|Overall Study|Adverse Event|1|||
157059682|NCT00745121|566971875|FG001|Overall Study|Adverse Event|0|||
157059683|NCT00745121|566971874|FG000|Overall Study|Lost to Follow-up|1|||
157059684|NCT00745121|566971875|FG001|Overall Study|Lost to Follow-up|0|||
157059685|NCT00745121|566971874|FG000|Overall Study|Withdrawal by Subject|4|||
157059686|NCT00745121|566971875|FG001|Overall Study|Withdrawal by Subject|2|||
157059687|NCT01820637|566971876|FG000|Overall Study|Death|2|||
157059688|NCT01820637|566971876|FG000|Overall Study|Withdrawal by Subject|1|||
157059689|NCT00607789|566971882|FG000|Overall Study|Adverse Event|3|||
157059690|NCT00607789|566971883|FG001|Overall Study|Adverse Event|0|||
157059691|NCT00607789|566971882|FG000|Overall Study|Lack of Efficacy|0|||
157059692|NCT00607789|566971883|FG001|Overall Study|Lack of Efficacy|1|||
157059693|NCT00607789|566971882|FG000|Overall Study|Inadequate adherence|3|||
157059694|NCT00607789|566971883|FG001|Overall Study|Inadequate adherence|0|||
157059695|NCT00607789|566971882|FG000|Overall Study|Lost to Follow-up|0|||
157059696|NCT00607789|566971883|FG001|Overall Study|Lost to Follow-up|5|||
157059697|NCT00607789|566971882|FG000|Overall Study|Withdrawal by Subject|1|||
157059698|NCT00607789|566971883|FG001|Overall Study|Withdrawal by Subject|0|||
157059699|NCT06016127|566971886|FG000|Overall Study|Withdrawal by Subject|4|||
157059700|NCT06016127|566971887|FG001|Overall Study|Withdrawal by Subject|3|||
157059701|NCT03340766|566971892|FG000|Overall Study|Withdrawal by Subject|2|||
157059702|NCT03340766|566971893|FG001|Overall Study|Withdrawal by Subject|1|||
157059703|NCT03340766|566971894|FG002|Overall Study|Withdrawal by Subject|3|||
157059704|NCT03340766|566971892|FG000|Overall Study|Lost to Follow-up|0|||
157059705|NCT03340766|566971893|FG001|Overall Study|Lost to Follow-up|0|||
157059706|NCT03340766|566971894|FG002|Overall Study|Lost to Follow-up|1|||
157059707|NCT03340766|566971892|FG000|Overall Study|Death|6|||
157059708|NCT03340766|566971893|FG001|Overall Study|Death|7|||
157059709|NCT03340766|566971894|FG002|Overall Study|Death|4|||
157059710|NCT00240097|566971895|FG000|Part I|Adverse Event|1|||
157059711|NCT00240097|566971895|FG000|Part I|Death|1|||
157059712|NCT00240097|566971895|FG000|Part I|histology|1|||
157059713|NCT00240097|566971895|FG000|Part I|unevaluable|1|||
157059714|NCT00240097|566971895|FG000|Part II|did not continue from Part I|23|||
157059715|NCT00981578|566971899|FG000|Overall Study|Death|1|||
157059716|NCT00981578|566971899|FG000|Overall Study|Withdrawal by Subject|2|||
157059717|NCT04531813|566971902|FG000|Overall Study|Protocol Violation|1|||
157059718|NCT04531813|566971902|FG000|Overall Study|Withdrawal by Subject|1|||
157059719|NCT01772147|566974053|FG000|Overall Study|Adverse Event|13|||
157059720|NCT01772147|566974054|FG001|Overall Study|Adverse Event|10|||
157059721|NCT01772147|566974055|FG002|Overall Study|Adverse Event|6|||
157059722|NCT01772147|566974053|FG000|Overall Study|Withdrew Consent|7|||
157059723|NCT01772147|566974054|FG001|Overall Study|Withdrew Consent|8|||
157059724|NCT01772147|566974055|FG002|Overall Study|Withdrew Consent|4|||
157059725|NCT01772147|566974053|FG000|Overall Study|Lost to Follow-up|1|||
157059726|NCT01772147|566974054|FG001|Overall Study|Lost to Follow-up|0|||
157059727|NCT01772147|566974055|FG002|Overall Study|Lost to Follow-up|1|||
157059728|NCT01772147|566974053|FG000|Overall Study|Protocol Deviation|2|||
157059729|NCT01772147|566974054|FG001|Overall Study|Protocol Deviation|1|||
157059730|NCT01772147|566974055|FG002|Overall Study|Protocol Deviation|1|||
157059731|NCT01772147|566974053|FG000|Overall Study|Lack of Efficacy|8|||
157059732|NCT01772147|566974054|FG001|Overall Study|Lack of Efficacy|6|||
157059733|NCT01772147|566974055|FG002|Overall Study|Lack of Efficacy|6|||
157183299|NCT01167153|567410928|FG001|Overall Study|Lost to Follow-up|9|||
157183300|NCT01167153|567410927|FG000|Overall Study|Non-compliance to concomitant medication|0|||
157183301|NCT01167153|567410928|FG001|Overall Study|Non-compliance to concomitant medication|2|||
157183302|NCT01167153|567410927|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
157183303|NCT01167153|567410928|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
157183304|NCT01167153|567410927|FG000|Overall Study|Withdrawal consent|1|||
157183305|NCT01167153|567410928|FG001|Overall Study|Withdrawal consent|1|||
157183306|NCT01167153|567410927|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
157183307|NCT01167153|567410928|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
157183308|NCT02973997|567412994|FG000|Overall Study|Withdrawal by Subject|4|||
157183309|NCT02973997|567412995|FG001|Overall Study|Withdrawal by Subject|0|||
157183310|NCT02973997|567412994|FG000|Overall Study|Adverse Event|4|||
157183311|NCT02973997|567412995|FG001|Overall Study|Adverse Event|1|||
157183312|NCT02973997|567412994|FG000|Overall Study|Disease Progression|11|||
157183313|NCT02973997|567412995|FG001|Overall Study|Disease Progression|20|||
157183314|NCT02973997|567412994|FG000|Overall Study|Alternative Therapy|3|||
157183315|NCT02973997|567412995|FG001|Overall Study|Alternative Therapy|0|||
157183316|NCT02973997|567412994|FG000|Overall Study|Other complicating disease|0|||
157183317|NCT02973997|567412995|FG001|Overall Study|Other complicating disease|1|||
157183318|NCT02973997|567412994|FG000|Overall Study|Death|0|||
157183319|NCT02973997|567412995|FG001|Overall Study|Death|1|||
157183320|NCT00444951|567412996|FG000|Overall Study|Lost to Follow-up|1|||
157183321|NCT00444951|567412997|FG001|Overall Study|Lost to Follow-up|1|||
157183322|NCT00444951|567412998|FG002|Overall Study|Lost to Follow-up|0|||
157183323|NCT00444951|567412996|FG000|Overall Study|Withdrawal by Subject|4|||
157183324|NCT00444951|567412997|FG001|Overall Study|Withdrawal by Subject|5|||
157183325|NCT00444951|567412998|FG002|Overall Study|Withdrawal by Subject|3|||
157183326|NCT00366444|567413000|FG000|Overall Study|Withdrawal by Subject|1|||
157183327|NCT00366444|567413001|FG001|Overall Study|Withdrawal by Subject|1|||
157183328|NCT00366444|567413000|FG000|Overall Study|Lack of Efficacy|0|||
157183329|NCT00366444|567413001|FG001|Overall Study|Lack of Efficacy|1|||
157183330|NCT03287830|567413006|FG000|Overall Study|Withdrawal by Subject|1|||
157183331|NCT03287830|567413007|FG001|Overall Study|Withdrawal by Subject|1|||
157183332|NCT03287830|567413006|FG000|Overall Study|not meeting inclusion criteria|5|||
157183333|NCT03287830|567413007|FG001|Overall Study|not meeting inclusion criteria|12|||
157183334|NCT02155712|567413010|FG000|Overall Study|Death|12|||
157183335|NCT02155712|567413011|FG001|Overall Study|Death|0|||
157183336|NCT02155712|567413010|FG000|Overall Study|Lost to Follow-up|37|||
157183337|NCT02155712|567413011|FG001|Overall Study|Lost to Follow-up|22|||
157183338|NCT02155712|567413010|FG000|Overall Study|Revision of device|4|||
157183339|NCT02155712|567413011|FG001|Overall Study|Revision of device|3|||
157183340|NCT02155712|567413010|FG000|Overall Study|Withdrawal by Subject|39|||
157183341|NCT02155712|567413011|FG001|Overall Study|Withdrawal by Subject|21|||
157183342|NCT02155712|567413010|FG000|Overall Study|Site termination|77|||
157183343|NCT02155712|567413011|FG001|Overall Study|Site termination|19|||
157183344|NCT02155712|567413010|FG000|Overall Study|Sponsor terminated study early|150|||
157183345|NCT02155712|567413011|FG001|Overall Study|Sponsor terminated study early|0|||
157183346|NCT02155712|567413010|FG000|Overall Study|Missed final 5-year protocol visit|0|||
157183347|NCT02155712|567413011|FG001|Overall Study|Missed final 5-year protocol visit|32|||
157183348|NCT02155712|567413010|FG000|Overall Study|Censored because surgery cancelled|6|||
157183349|NCT02155712|567413011|FG001|Overall Study|Censored because surgery cancelled|10|||
157183350|NCT02155712|567413010|FG000|Overall Study|Censored because study device was not implanted|61|||
157183351|NCT02155712|567413011|FG001|Overall Study|Censored because study device was not implanted|66|||
157183352|NCT02155712|567413010|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
157183353|NCT02155712|567413011|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
157183354|NCT00976963|567413012|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
157183355|NCT00976963|567413013|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
157183356|NCT00976963|567413012|FG000|Overall Study|administrative error|1|||
157183357|NCT00976963|567413013|FG001|Overall Study|administrative error|0|||
157183358|NCT00976963|567413012|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
157183359|NCT00976963|567413013|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
157059734|NCT00796614|566974063|FG000|Overall Study|Adverse Event|1|||
157059735|NCT00796614|566974064|FG001|Overall Study|Adverse Event|2|||
157059736|NCT00796614|566974065|FG002|Overall Study|Adverse Event|0|||
157183360|NCT00608842|567413014|FG000|Overall Study|Participant's Request|0|||
157183361|NCT00608842|567413015|FG001|Overall Study|Participant's Request|1|||
157183362|NCT00608842|567413016|FG002|Overall Study|Participant's Request|2|||
157183363|NCT00608842|567413017|FG003|Overall Study|Participant's Request|1|||
157183364|NCT00608842|567413014|FG000|Overall Study|Lost to Follow-up|1|||
157183365|NCT00608842|567413015|FG001|Overall Study|Lost to Follow-up|0|||
157183366|NCT00608842|567413016|FG002|Overall Study|Lost to Follow-up|0|||
157183367|NCT00608842|567413017|FG003|Overall Study|Lost to Follow-up|0|||
157183368|NCT01688999|567413020|FG000|Overall Study|Withdrawal by Subject|5|||
157059737|NCT00796614|566974066|FG003|Overall Study|Adverse Event|0|||
157059738|NCT00796614|566974063|FG000|Overall Study|Protocol Violation|0|||
157059739|NCT00796614|566974064|FG001|Overall Study|Protocol Violation|0|||
157059740|NCT00796614|566974065|FG002|Overall Study|Protocol Violation|2|||
157059741|NCT00796614|566974066|FG003|Overall Study|Protocol Violation|0|||
157059742|NCT00796614|566974063|FG000|Overall Study|Lost to Follow-up|2|||
157059743|NCT00796614|566974064|FG001|Overall Study|Lost to Follow-up|2|||
157059744|NCT00796614|566974065|FG002|Overall Study|Lost to Follow-up|1|||
157059745|NCT00796614|566974066|FG003|Overall Study|Lost to Follow-up|0|||
157059746|NCT00796614|566974063|FG000|Overall Study|Withdrawal by Subject|1|||
157059747|NCT00796614|566974064|FG001|Overall Study|Withdrawal by Subject|0|||
157059748|NCT00796614|566974065|FG002|Overall Study|Withdrawal by Subject|0|||
157059749|NCT00796614|566974066|FG003|Overall Study|Withdrawal by Subject|1|||
157059750|NCT00796614|566974063|FG000|Overall Study|Other than stated|1|||
157059751|NCT00796614|566974064|FG001|Overall Study|Other than stated|0|||
157059752|NCT00796614|566974065|FG002|Overall Study|Other than stated|0|||
157059753|NCT00796614|566974066|FG003|Overall Study|Other than stated|0|||
157059754|NCT00740597|566974067|FG000|Overall Study|insurance would not cover treatment|1|||
157059755|NCT00957996|566974074|FG000|Overall Study|Death|4|||
157059756|NCT00957996|566974075|FG001|Overall Study|Death|10|||
157059757|NCT00957996|566974074|FG000|Overall Study|Lost to Follow-up|4|||
157059758|NCT00957996|566974075|FG001|Overall Study|Lost to Follow-up|7|||
157059759|NCT00957996|566974074|FG000|Overall Study|Withdrawal by Subject|9|||
157059760|NCT00957996|566974075|FG001|Overall Study|Withdrawal by Subject|2|||
157059761|NCT00957996|566974074|FG000|Overall Study|Adverse Event|2|||
157059762|NCT00957996|566974075|FG001|Overall Study|Adverse Event|1|||
157059763|NCT00957996|566974074|FG000|Overall Study|Physician Decision|1|||
157059764|NCT00957996|566974075|FG001|Overall Study|Physician Decision|1|||
157059765|NCT00957996|566974074|FG000|Overall Study|Influenza-related complication|0|||
157059766|NCT00957996|566974075|FG001|Overall Study|Influenza-related complication|1|||
157059767|NCT00957996|566974074|FG000|Overall Study|Missing|1|||
157059768|NCT00957996|566974075|FG001|Overall Study|Missing|0|||
157059769|NCT00957996|566974074|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
157059770|NCT00957996|566974075|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
157059771|NCT01902381|566974076|FG000|Overall Study|Withdrawal by Subject|1|||
157059772|NCT03972137|566974080|FG000|Overall Study|Lost to Follow-up|2|||
157059773|NCT03972137|566974080|FG000|Overall Study|Withdrawal by Subject|4|||
157059774|NCT00498433|566974081|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
157059775|NCT00498433|566974082|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
157059776|NCT00498433|566974083|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
157059777|NCT00498433|566974081|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
157059778|NCT00498433|566974082|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
157059779|NCT00498433|566974083|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
157059780|NCT00498433|566974081|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
157059781|NCT00498433|566974082|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
157059782|NCT00498433|566974083|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
157059783|NCT00498433|566974081|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
157059784|NCT00498433|566974082|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
157059785|NCT00498433|566974083|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
157059786|NCT00922441|566974084|FG000|Overall Study|Protocol Violation|0|||
157059787|NCT00922441|566974085|FG001|Overall Study|Protocol Violation|0|||
157059788|NCT00922441|566974086|FG002|Overall Study|Protocol Violation|2|||
157059789|NCT00922441|566974084|FG000|Overall Study|Withdrawal by Subject|0|||
157059790|NCT00922441|566974085|FG001|Overall Study|Withdrawal by Subject|0|||
157059791|NCT00922441|566974086|FG002|Overall Study|Withdrawal by Subject|1|||
157059792|NCT01885936|566974087|FG000|Overall Study|Withdrawal by Subject|1|||
157059793|NCT01885936|566974088|FG001|Overall Study|Withdrawal by Subject|0|||
157059794|NCT03214250|566974089|FG000|Overall Study|Death|5|||
157059795|NCT03214250|566974090|FG001|Overall Study|Death|5|||
157059796|NCT03214250|566974091|FG002|Overall Study|Death|7|||
157059797|NCT03214250|566974092|FG003|Overall Study|Death|4|||
157059798|NCT03214250|566974093|FG004|Overall Study|Death|23|||
157059799|NCT03214250|566974094|FG005|Overall Study|Death|23|||
157059800|NCT03214250|566974095|FG006|Overall Study|Death|24|||
157059801|NCT03214250|566974089|FG000|Overall Study|Lost to Follow-up|0|||
157059802|NCT03214250|566974090|FG001|Overall Study|Lost to Follow-up|0|||
157059803|NCT03214250|566974091|FG002|Overall Study|Lost to Follow-up|0|||
157059804|NCT03214250|566974092|FG003|Overall Study|Lost to Follow-up|1|||
157059805|NCT03214250|566974093|FG004|Overall Study|Lost to Follow-up|1|||
157059806|NCT03214250|566974094|FG005|Overall Study|Lost to Follow-up|2|||
157059807|NCT03214250|566974095|FG006|Overall Study|Lost to Follow-up|0|||
157059808|NCT03214250|566974089|FG000|Overall Study|Other|0|||
157059809|NCT03214250|566974090|FG001|Overall Study|Other|0|||
157059810|NCT03214250|566974091|FG002|Overall Study|Other|0|||
157059811|NCT03214250|566974092|FG003|Overall Study|Other|0|||
157059812|NCT03214250|566974093|FG004|Overall Study|Other|1|||
157059813|NCT03214250|566974094|FG005|Overall Study|Other|1|||
157059814|NCT03214250|566974095|FG006|Overall Study|Other|2|||
157059815|NCT03214250|566974089|FG000|Overall Study|Remains on Study|2|||
157059816|NCT03214250|566974090|FG001|Overall Study|Remains on Study|2|||
157059817|NCT03214250|566974091|FG002|Overall Study|Remains on Study|0|||
157059818|NCT03214250|566974092|FG003|Overall Study|Remains on Study|1|||
157059819|NCT03214250|566974093|FG004|Overall Study|Remains on Study|7|||
157059820|NCT03214250|566974094|FG005|Overall Study|Remains on Study|5|||
157059821|NCT03214250|566974095|FG006|Overall Study|Remains on Study|3|||
157059822|NCT03214250|566974089|FG000|Overall Study|Withdrawal by Subject|0|||
157059823|NCT03214250|566974090|FG001|Overall Study|Withdrawal by Subject|0|||
157059824|NCT03214250|566974091|FG002|Overall Study|Withdrawal by Subject|1|||
157059825|NCT03214250|566974092|FG003|Overall Study|Withdrawal by Subject|2|||
157059826|NCT03214250|566974093|FG004|Overall Study|Withdrawal by Subject|5|||
157059827|NCT03214250|566974094|FG005|Overall Study|Withdrawal by Subject|0|||
157059828|NCT03214250|566974095|FG006|Overall Study|Withdrawal by Subject|2|||
157059829|NCT00317603|566974096|FG000|Overall Study|Progressive Disease|3|||
157059830|NCT00523549|566974097|FG000|Overall Study|Adverse Event|6|||
157059831|NCT00523549|566974098|FG001|Overall Study|Adverse Event|3|||
157059832|NCT00523549|566974097|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157059833|NCT00523549|566974098|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
157059834|NCT00523549|566974097|FG000|Overall Study|Protocol Deviation|3|||
157059835|NCT00523549|566974098|FG001|Overall Study|Protocol Deviation|1|||
157059836|NCT00523549|566974097|FG000|Overall Study|Patient withdrew consent|7|||
157059837|NCT00523549|566974098|FG001|Overall Study|Patient withdrew consent|6|||
157059838|NCT00523549|566974097|FG000|Overall Study|Lost to Follow-up|3|||
157059839|NCT00523549|566974098|FG001|Overall Study|Lost to Follow-up|5|||
157059840|NCT00439647|566974099|FG000|Overall Study|Withdrawal by Subject|25|||
157059841|NCT00439647|566974100|FG001|Overall Study|Withdrawal by Subject|22|||
157059842|NCT00439647|566974099|FG000|Overall Study|Death|15|||
157059843|NCT00439647|566974100|FG001|Overall Study|Death|18|||
157059844|NCT00439647|566974099|FG000|Overall Study|Adverse Event|11|||
157059845|NCT00439647|566974100|FG001|Overall Study|Adverse Event|11|||
157059846|NCT00439647|566974099|FG000|Overall Study|Lost to Follow-up|4|||
157059847|NCT00439647|566974100|FG001|Overall Study|Lost to Follow-up|12|||
157059848|NCT00439647|566974099|FG000|Overall Study|Protocol Violation|3|||
157059849|NCT00439647|566974100|FG001|Overall Study|Protocol Violation|4|||
157059850|NCT00439647|566974099|FG000|Overall Study|Lack of Efficacy|0|||
157059851|NCT00439647|566974100|FG001|Overall Study|Lack of Efficacy|4|||
157059852|NCT02845375|566974101|FG000|Overall Study|upper airway obstruction|1|||
157059853|NCT02845375|566974102|FG001|Overall Study|upper airway obstruction|2|||
157059854|NCT02845375|566974103|FG002|Overall Study|upper airway obstruction|1|||
157059855|NCT01951261|566974104|FG000|Overall Study|Death|1|||
157059856|NCT01951261|566974105|FG001|Overall Study|Death|0|||
157059857|NCT01951261|566974104|FG000|Overall Study|Lost to Follow-up|4|||
157059858|NCT01951261|566974105|FG001|Overall Study|Lost to Follow-up|3|||
157059859|NCT01951261|566974104|FG000|Overall Study|Protocol Violation|4|||
157059860|NCT01951261|566974105|FG001|Overall Study|Protocol Violation|3|||
157059861|NCT03927222|566974109|FG000|Overall Study|Progression|3|||
157059862|NCT03927222|566974109|FG000|Overall Study|CMV testing results inconclusive|1|||
157059863|NCT03927222|566974109|FG000|Overall Study|Unable to generate enough vaccines|1|||
157059864|NCT03927222|566974109|FG000|Overall Study|Early study termination|1|||
157059865|NCT00297778|566974112|FG000|Overall Study|Adverse Event|16|||
157059866|NCT00297778|566974113|FG001|Overall Study|Adverse Event|10|||
157059867|NCT00297778|566974112|FG000|Overall Study|Withdrawal by Subject|1|||
157059868|NCT00297778|566974113|FG001|Overall Study|Withdrawal by Subject|5|||
157059869|NCT00297778|566974112|FG000|Overall Study|Lack of Efficacy|2|||
157059870|NCT00297778|566974113|FG001|Overall Study|Lack of Efficacy|1|||
157059871|NCT00297778|566974112|FG000|Overall Study|Non-compliant with trial protocol|0|||
157059872|NCT00297778|566974113|FG001|Overall Study|Non-compliant with trial protocol|3|||
157059873|NCT00297778|566974112|FG000|Overall Study|Other|0|||
157059874|NCT00297778|566974113|FG001|Overall Study|Other|1|||
157059875|NCT01287416|566974116|FG000|Pre-post Training|Withdrawal by Subject|17|||
157059876|NCT01287416|566974117|FG001|Pre-post Training|Withdrawal by Subject|24|||
157059877|NCT01287416|566974116|FG000|Pre-post Training|Lost to Follow-up|5|||
157059878|NCT01287416|566974117|FG001|Pre-post Training|Lost to Follow-up|1|||
157059879|NCT01287416|566974116|FG000|6 Month Follow-up|Lost to Follow-up|3|||
157059880|NCT01287416|566974117|FG001|6 Month Follow-up|Lost to Follow-up|2|||
157059881|NCT02109107|566974122|FG000|Overall Study|Lost to Follow-up|2|||
157059882|NCT02383927|566974126|FG000|Overall Study|Disease Progression|8|||
157059883|NCT02383927|566974127|FG001|Overall Study|Disease Progression|8|||
157059884|NCT02383927|566974128|FG002|Overall Study|Disease Progression|15|||
157059885|NCT02383927|566974129|FG003|Overall Study|Disease Progression|4|||
157059886|NCT02383927|566974126|FG000|Overall Study|Physician Decision|0|||
157059887|NCT02383927|566974127|FG001|Overall Study|Physician Decision|0|||
157059888|NCT02383927|566974128|FG002|Overall Study|Physician Decision|2|||
157059889|NCT02383927|566974129|FG003|Overall Study|Physician Decision|0|||
157059890|NCT02383927|566974126|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
157059891|NCT02383927|566974127|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
157059892|NCT02383927|566974128|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
157059893|NCT02383927|566974129|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
157183369|NCT01688999|567413021|FG001|Overall Study|Withdrawal by Subject|1|||
157183370|NCT01688999|567413022|FG002|Overall Study|Withdrawal by Subject|1|||
157183371|NCT01688999|567413020|FG000|Overall Study|Adverse Event|2|||
157183372|NCT01688999|567413021|FG001|Overall Study|Adverse Event|0|||
157183373|NCT01688999|567413022|FG002|Overall Study|Adverse Event|2|||
157183374|NCT01688999|567413020|FG000|Overall Study|Ineligible/Not treated|1|||
157183375|NCT01688999|567413021|FG001|Overall Study|Ineligible/Not treated|0|||
157183376|NCT01688999|567413022|FG002|Overall Study|Ineligible/Not treated|0|||
157183377|NCT02768103|567413023|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
157183378|NCT03039790|567413040|FG000|Overall Study|Lost to Follow-up|2|||
157183379|NCT03039790|567413041|FG001|Overall Study|Lost to Follow-up|0|||
157183380|NCT03039790|567413042|FG002|Overall Study|Lost to Follow-up|1|||
157183381|NCT03039790|567413043|FG003|Overall Study|Lost to Follow-up|1|||
157183382|NCT03039790|567413044|FG004|Overall Study|Lost to Follow-up|0|||
157183383|NCT03039790|567413045|FG005|Overall Study|Lost to Follow-up|1|||
157183384|NCT03039790|567413046|FG006|Overall Study|Lost to Follow-up|1|||
157183385|NCT03039790|567413047|FG007|Overall Study|Lost to Follow-up|1|||
157183386|NCT03039790|567413048|FG008|Overall Study|Lost to Follow-up|0|||
157183387|NCT03039790|567413049|FG009|Overall Study|Lost to Follow-up|1|||
157183388|NCT03039790|567413050|FG010|Overall Study|Lost to Follow-up|1|||
157183389|NCT03039790|567413051|FG011|Overall Study|Lost to Follow-up|0|||
157183390|NCT03039790|567413052|FG012|Overall Study|Lost to Follow-up|1|||
157183391|NCT03039790|567413053|FG013|Overall Study|Lost to Follow-up|0|||
157183392|NCT03039790|567413054|FG014|Overall Study|Lost to Follow-up|3|||
157183393|NCT03039790|567413055|FG015|Overall Study|Lost to Follow-up|1|||
157183394|NCT03039790|567413056|FG016|Overall Study|Lost to Follow-up|2|||
157183395|NCT03039790|567413057|FG017|Overall Study|Lost to Follow-up|2|||
157183396|NCT03039790|567413058|FG018|Overall Study|Lost to Follow-up|1|||
157183397|NCT03039790|567413059|FG019|Overall Study|Lost to Follow-up|3|||
157183398|NCT03039790|567413040|FG000|Overall Study|Withdrawal of Consent|1|||
157183399|NCT03039790|567413041|FG001|Overall Study|Withdrawal of Consent|0|||
157183400|NCT03039790|567413042|FG002|Overall Study|Withdrawal of Consent|0|||
157183401|NCT03039790|567413043|FG003|Overall Study|Withdrawal of Consent|1|||
157183402|NCT03039790|567413044|FG004|Overall Study|Withdrawal of Consent|0|||
157183403|NCT03039790|567413045|FG005|Overall Study|Withdrawal of Consent|0|||
157183404|NCT03039790|567413046|FG006|Overall Study|Withdrawal of Consent|0|||
157183405|NCT03039790|567413047|FG007|Overall Study|Withdrawal of Consent|0|||
157183406|NCT03039790|567413048|FG008|Overall Study|Withdrawal of Consent|0|||
157183407|NCT03039790|567413049|FG009|Overall Study|Withdrawal of Consent|1|||
157183408|NCT03039790|567413050|FG010|Overall Study|Withdrawal of Consent|0|||
157059894|NCT02383927|566974126|FG000|Overall Study|Adverse Event|4|||
157059895|NCT02383927|566974127|FG001|Overall Study|Adverse Event|1|||
157059896|NCT02383927|566974128|FG002|Overall Study|Adverse Event|3|||
157059897|NCT02383927|566974129|FG003|Overall Study|Adverse Event|5|||
157059898|NCT02383927|566974126|FG000|Overall Study|Miscellaneous|1|||
157059899|NCT02383927|566974127|FG001|Overall Study|Miscellaneous|0|||
157059900|NCT02383927|566974128|FG002|Overall Study|Miscellaneous|0|||
157059901|NCT02383927|566974129|FG003|Overall Study|Miscellaneous|1|||
157059902|NCT02383927|566974126|FG000|Overall Study|Withdrawal by Subject|0|||
157059903|NCT02383927|566974127|FG001|Overall Study|Withdrawal by Subject|1|||
157059904|NCT02383927|566974128|FG002|Overall Study|Withdrawal by Subject|4|||
157059905|NCT02383927|566974129|FG003|Overall Study|Withdrawal by Subject|0|||
157059906|NCT00734851|566974130|FG000|Overall Study|Withdrawal by Subject|2|||
157059907|NCT00734851|566974130|FG000|Overall Study|Lost to Follow-up|1|||
157059908|NCT00734851|566974130|FG000|Overall Study|Physician Decision|18|||
157059909|NCT01294358|566974133|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
157059910|NCT01294358|566974134|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
157059911|NCT01294358|566974135|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
157059912|NCT01294358|566974136|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
157059913|NCT01294358|566974137|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
157059914|NCT01294358|566974133|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
157059915|NCT01294358|566974134|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
157059916|NCT01294358|566974135|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
157059917|NCT01294358|566974136|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
157183409|NCT03039790|567413051|FG011|Overall Study|Withdrawal of Consent|0|||
157183410|NCT03039790|567413052|FG012|Overall Study|Withdrawal of Consent|2|||
157183411|NCT03039790|567413053|FG013|Overall Study|Withdrawal of Consent|0|||
157183412|NCT03039790|567413054|FG014|Overall Study|Withdrawal of Consent|1|||
157183413|NCT03039790|567413055|FG015|Overall Study|Withdrawal of Consent|5|||
157183414|NCT03039790|567413056|FG016|Overall Study|Withdrawal of Consent|3|||
157059918|NCT01294358|566974137|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
157059919|NCT01294358|566974133|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
157059920|NCT01294358|566974134|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
157059921|NCT01294358|566974135|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
157183415|NCT03039790|567413057|FG017|Overall Study|Withdrawal of Consent|0|||
157183416|NCT03039790|567413058|FG018|Overall Study|Withdrawal of Consent|2|||
157059922|NCT01294358|566974136|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
157059923|NCT01294358|566974137|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
157059924|NCT01294358|566974133|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
157059925|NCT01294358|566974134|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
157059926|NCT01294358|566974135|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
157059927|NCT01294358|566974136|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
157059928|NCT01294358|566974137|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
157059929|NCT03613454|566974138|FG000|Overall Study|Protocol Violation|1|||
157059930|NCT03613454|566974139|FG001|Overall Study|Protocol Violation|0|||
157059931|NCT03613454|566974138|FG000|Overall Study|Protocol Violation|0|||
157059932|NCT03613454|566974139|FG001|Overall Study|Protocol Violation|1|||
157059933|NCT02963922|566974140|FG000|Overall Study|Adverse Event|15|||
157059934|NCT02963922|566974141|FG001|Overall Study|Adverse Event|6|||
157059935|NCT02963922|566974140|FG000|Overall Study|Protocol deviation|6|||
157059936|NCT02963922|566974141|FG001|Overall Study|Protocol deviation|6|||
157059937|NCT02963922|566974140|FG000|Overall Study|Lack of Efficacy|1|||
157059938|NCT02963922|566974141|FG001|Overall Study|Lack of Efficacy|1|||
157059939|NCT02963922|566974140|FG000|Overall Study|Lost to Follow-up|2|||
157059940|NCT02963922|566974141|FG001|Overall Study|Lost to Follow-up|3|||
157059941|NCT02963922|566974140|FG000|Overall Study|Other|8|||
157059942|NCT02963922|566974141|FG001|Overall Study|Other|14|||
157059943|NCT01180790|566974151|FG000|Overall Study|Adverse Event|1|||
157059944|NCT01180790|566974152|FG001|Overall Study|Adverse Event|1|||
157059945|NCT01180790|566974153|FG002|Overall Study|Adverse Event|2|||
157059946|NCT01180790|566974154|FG003|Overall Study|Adverse Event|0|||
157059947|NCT01180790|566974155|FG004|Overall Study|Adverse Event|1|||
157059948|NCT01180790|566974156|FG005|Overall Study|Adverse Event|3|||
157059949|NCT01180790|566974157|FG006|Overall Study|Adverse Event|0|||
157059950|NCT01180790|566974151|FG000|Overall Study|Withdrawal by Subject|3|||
157059951|NCT01180790|566974152|FG001|Overall Study|Withdrawal by Subject|0|||
157059952|NCT01180790|566974153|FG002|Overall Study|Withdrawal by Subject|5|||
157059953|NCT01180790|566974154|FG003|Overall Study|Withdrawal by Subject|0|||
157059954|NCT01180790|566974155|FG004|Overall Study|Withdrawal by Subject|2|||
157059955|NCT01180790|566974156|FG005|Overall Study|Withdrawal by Subject|1|||
157059956|NCT01180790|566974157|FG006|Overall Study|Withdrawal by Subject|0|||
157059957|NCT01180790|566974151|FG000|Overall Study|Lost to Follow-up|3|||
157059958|NCT01180790|566974152|FG001|Overall Study|Lost to Follow-up|1|||
157059959|NCT01180790|566974153|FG002|Overall Study|Lost to Follow-up|0|||
157059960|NCT01180790|566974154|FG003|Overall Study|Lost to Follow-up|2|||
157059961|NCT01180790|566974155|FG004|Overall Study|Lost to Follow-up|1|||
157059962|NCT01180790|566974156|FG005|Overall Study|Lost to Follow-up|0|||
157059963|NCT01180790|566974157|FG006|Overall Study|Lost to Follow-up|1|||
157059964|NCT01180790|566974151|FG000|Overall Study|Physician Decision|1|||
157059965|NCT01180790|566974152|FG001|Overall Study|Physician Decision|0|||
157059966|NCT01180790|566974153|FG002|Overall Study|Physician Decision|0|||
157059967|NCT01180790|566974154|FG003|Overall Study|Physician Decision|1|||
157059968|NCT01180790|566974155|FG004|Overall Study|Physician Decision|0|||
157059969|NCT01180790|566974156|FG005|Overall Study|Physician Decision|0|||
157059970|NCT01180790|566974157|FG006|Overall Study|Physician Decision|0|||
157059971|NCT01180790|566974151|FG000|Overall Study|Lack of Efficacy|1|||
157059972|NCT01180790|566974152|FG001|Overall Study|Lack of Efficacy|2|||
157059973|NCT01180790|566974153|FG002|Overall Study|Lack of Efficacy|5|||
157059974|NCT01180790|566974154|FG003|Overall Study|Lack of Efficacy|6|||
157059975|NCT01180790|566974155|FG004|Overall Study|Lack of Efficacy|1|||
157059976|NCT01180790|566974156|FG005|Overall Study|Lack of Efficacy|3|||
157059977|NCT01180790|566974157|FG006|Overall Study|Lack of Efficacy|0|||
157059978|NCT01180790|566974151|FG000|Overall Study|compliance|0|||
157059979|NCT01180790|566974152|FG001|Overall Study|compliance|1|||
157059980|NCT01180790|566974153|FG002|Overall Study|compliance|0|||
157059981|NCT01180790|566974154|FG003|Overall Study|compliance|0|||
157059982|NCT01180790|566974155|FG004|Overall Study|compliance|0|||
157059983|NCT01180790|566974156|FG005|Overall Study|compliance|0|||
157059984|NCT01180790|566974157|FG006|Overall Study|compliance|0|||
157059985|NCT01180790|566974151|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059986|NCT01180790|566974152|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059987|NCT01180790|566974153|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
157059988|NCT01180790|566974154|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059989|NCT01180790|566974155|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059990|NCT01180790|566974156|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059991|NCT01180790|566974157|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
157059992|NCT00655668|566974158|FG000|Overall Study|Adverse Event|6|||
157059993|NCT00655668|566974158|FG000|Overall Study|Death|5|||
157059994|NCT00655668|566974158|FG000|Overall Study|Disease Progression|27|||
157059995|NCT00655668|566974158|FG000|Overall Study|Study Terminated|9|||
157059996|NCT00655668|566974158|FG000|Overall Study|Other|1|||
157059997|NCT00655668|566974158|FG000|Overall Study|New Lymphoma Treatment Started|4|||
157059998|NCT00655668|566974158|FG000|Overall Study|Withdrawal by Subject|2|||
157229949|NCT00958243|567588206|FG001|Overall Study|Lost to Follow-up|5|||
157183417|NCT03039790|567413059|FG019|Overall Study|Withdrawal of Consent|5|||
157183418|NCT03039790|567413040|FG000|Overall Study|Death|0|||
157183419|NCT03039790|567413041|FG001|Overall Study|Death|0|||
157183420|NCT03039790|567413042|FG002|Overall Study|Death|0|||
157183421|NCT03039790|567413043|FG003|Overall Study|Death|0|||
157183422|NCT03039790|567413044|FG004|Overall Study|Death|0|||
157183423|NCT03039790|567413045|FG005|Overall Study|Death|0|||
157183424|NCT03039790|567413046|FG006|Overall Study|Death|0|||
157183425|NCT03039790|567413047|FG007|Overall Study|Death|0|||
157183426|NCT03039790|567413048|FG008|Overall Study|Death|0|||
157183427|NCT03039790|567413049|FG009|Overall Study|Death|0|||
157183428|NCT03039790|567413050|FG010|Overall Study|Death|0|||
157183429|NCT03039790|567413051|FG011|Overall Study|Death|0|||
157183430|NCT03039790|567413052|FG012|Overall Study|Death|0|||
157183431|NCT03039790|567413053|FG013|Overall Study|Death|0|||
157183432|NCT03039790|567413054|FG014|Overall Study|Death|0|||
157183433|NCT03039790|567413055|FG015|Overall Study|Death|1|||
157183434|NCT03039790|567413056|FG016|Overall Study|Death|3|||
157183435|NCT03039790|567413057|FG017|Overall Study|Death|0|||
157183436|NCT03039790|567413058|FG018|Overall Study|Death|2|||
157183437|NCT03039790|567413059|FG019|Overall Study|Death|0|||
157183438|NCT03039790|567413040|FG000|Overall Study|Reason, not Specified|1|||
157183439|NCT03039790|567413041|FG001|Overall Study|Reason, not Specified|0|||
157183440|NCT03039790|567413042|FG002|Overall Study|Reason, not Specified|0|||
157183441|NCT03039790|567413043|FG003|Overall Study|Reason, not Specified|0|||
157183442|NCT03039790|567413044|FG004|Overall Study|Reason, not Specified|0|||
157183443|NCT03039790|567413045|FG005|Overall Study|Reason, not Specified|0|||
157183444|NCT03039790|567413046|FG006|Overall Study|Reason, not Specified|0|||
157183445|NCT03039790|567413047|FG007|Overall Study|Reason, not Specified|0|||
157183446|NCT03039790|567413048|FG008|Overall Study|Reason, not Specified|0|||
157183447|NCT03039790|567413049|FG009|Overall Study|Reason, not Specified|0|||
157183448|NCT03039790|567413050|FG010|Overall Study|Reason, not Specified|0|||
157183449|NCT03039790|567413051|FG011|Overall Study|Reason, not Specified|0|||
157183450|NCT03039790|567413052|FG012|Overall Study|Reason, not Specified|0|||
157183451|NCT03039790|567413053|FG013|Overall Study|Reason, not Specified|0|||
157183452|NCT03039790|567413054|FG014|Overall Study|Reason, not Specified|0|||
157183453|NCT03039790|567413055|FG015|Overall Study|Reason, not Specified|0|||
157183454|NCT03039790|567413056|FG016|Overall Study|Reason, not Specified|2|||
157183455|NCT03039790|567413057|FG017|Overall Study|Reason, not Specified|0|||
157183456|NCT03039790|567413058|FG018|Overall Study|Reason, not Specified|1|||
157183457|NCT03039790|567413059|FG019|Overall Study|Reason, not Specified|0|||
157183458|NCT00498368|567413062|FG000|Overall Study|Withdrawal by Subject|3|||
157183459|NCT00498368|567413063|FG001|Overall Study|Withdrawal by Subject|2|||
157183460|NCT02266004|567413064|FG000|Overall Study|unrelated adverse event|1|||
157183461|NCT02266004|567413064|FG000|Overall Study|Physician Decision|1|||
157183462|NCT00537771|567413068|FG000|Overall Study|Withdrawal by Subject|6|||
157183463|NCT00537771|567413069|FG001|Overall Study|Withdrawal by Subject|23|||
157183464|NCT00537771|567413068|FG000|Overall Study|Adverse Event|8|||
157183465|NCT00537771|567413069|FG001|Overall Study|Adverse Event|15|||
157183466|NCT00537771|567413068|FG000|Overall Study|Lost to Follow-up|9|||
157183467|NCT00537771|567413069|FG001|Overall Study|Lost to Follow-up|15|||
157183468|NCT00537771|567413068|FG000|Overall Study|Protocol Violation|2|||
157183469|NCT00537771|567413069|FG001|Overall Study|Protocol Violation|6|||
157183470|NCT00537771|567413068|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
157183471|NCT00537771|567413069|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
157183472|NCT02736929|567413070|FG000|Main Study|Lost to Follow-up|7|||
157183473|NCT02736929|567413071|FG001|Main Study|Lost to Follow-up|1|||
157183474|NCT02736929|567413072|FG002|Main Study|Lost to Follow-up|0|||
157183475|NCT02736929|567413070|FG000|Main Study|Withdrawal by Subject|1|||
157183476|NCT02736929|567413071|FG001|Main Study|Withdrawal by Subject|1|||
157183477|NCT02736929|567413072|FG002|Main Study|Withdrawal by Subject|0|||
157183478|NCT02736929|567413070|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
157183479|NCT02736929|567413071|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
157183480|NCT02736929|567413072|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
157183481|NCT02465489|567413075|FG000|Overall Study|Adverse Event|5|||
157183482|NCT02148952|567413078|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
157183483|NCT02148952|567413079|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
157183484|NCT02148952|567413078|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
157183485|NCT02148952|567413079|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
157183486|NCT02148952|567413078|FG000|Follow-Up|Lost to Follow-up|219|||
157183487|NCT02148952|567413079|FG001|Follow-Up|Lost to Follow-up|231|||
157183488|NCT02148952|567413078|FG000|Follow-Up|Withdrawal by Subject|46|||
157183489|NCT02148952|567413079|FG001|Follow-Up|Withdrawal by Subject|48|||
157183490|NCT01600105|567413080|FG000|Total Participants|Withdrawal by Subject|1|||
157183491|NCT01600105|567413081|FG001|Total Participants|Withdrawal by Subject|0|||
157183492|NCT01600105|567413080|FG000|Total Participants|No images in PACS|10|||
157183493|NCT01600105|567413081|FG001|Total Participants|No images in PACS|0|||
157183494|NCT01600105|567413080|FG000|Total Participants|Insufficient image quality|30|||
157183495|NCT01600105|567413081|FG001|Total Participants|Insufficient image quality|10|||
157183496|NCT01600105|567413080|FG000|Sub Study I|Insufficient image quality|0|||
157183497|NCT01600105|567413081|FG001|Sub Study I|Insufficient image quality|10|||
157183498|NCT01600105|567413080|FG000|Sub Study II|Withdrawal by Subject|1|||
157183499|NCT01600105|567413081|FG001|Sub Study II|Withdrawal by Subject|0|||
157183500|NCT01600105|567413080|FG000|Sub Study II|No images in PACS|1|||
157183501|NCT01600105|567413081|FG001|Sub Study II|No images in PACS|0|||
157183502|NCT01600105|567413080|FG000|Sub Study II|Insufficient image quality|3|||
157183503|NCT01600105|567413081|FG001|Sub Study II|Insufficient image quality|0|||
157183504|NCT01600105|567413080|FG000|Sub Study III|Insufficient image quality|5|||
157183505|NCT01600105|567413081|FG001|Sub Study III|Insufficient image quality|0|||
157229950|NCT00958243|567588207|FG002|Overall Study|Lost to Follow-up|11|||
157229951|NCT00958243|567588208|FG003|Overall Study|Lost to Follow-up|2|||
157229952|NCT00958243|567588209|FG004|Overall Study|Lost to Follow-up|8|||
157229953|NCT00958243|567588210|FG005|Overall Study|Lost to Follow-up|5|||
157229954|NCT04646109|567588211|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
157059999|NCT02335242|566974159|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
157060000|NCT02335242|566974160|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
157060001|NCT02335242|566974159|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
157060002|NCT02335242|566974160|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
157060003|NCT02335242|566974159|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
157060004|NCT02335242|566974160|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
157060005|NCT04167085|566974161|FG000|Baseline|Withdrawal by Subject|2|||
157060006|NCT04167085|566974162|FG001|Baseline|Withdrawal by Subject|1|||
157060007|NCT04167085|566974161|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
157060008|NCT04167085|566974162|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
157060009|NCT03840148|566974163|FG000|Study Drug Disposition|Adverse Event|13|||
157060010|NCT03840148|566974164|FG001|Study Drug Disposition|Adverse Event|2|||
157060011|NCT03840148|566974163|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
157060012|NCT03840148|566974164|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
157060013|NCT03840148|566974163|FG000|Study Drug Disposition|Lack of Efficacy|3|||
157060014|NCT03840148|566974164|FG001|Study Drug Disposition|Lack of Efficacy|0|||
157060015|NCT03840148|566974163|FG000|Study Drug Disposition|Physician Decision|2|||
157060016|NCT03840148|566974164|FG001|Study Drug Disposition|Physician Decision|0|||
157060017|NCT03840148|566974163|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
157060018|NCT03840148|566974164|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
157060019|NCT03840148|566974163|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
157060020|NCT03840148|566974164|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
157060021|NCT03840148|566974163|FG000|Study Completion Disposition|Physician Decision|2|||
157060022|NCT03840148|566974164|FG001|Study Completion Disposition|Physician Decision|0|||
157060023|NCT03840148|566974163|FG000|Study Completion Disposition|Covid-19 related|2|||
157060024|NCT03840148|566974164|FG001|Study Completion Disposition|Covid-19 related|0|||
157060025|NCT03840148|566974163|FG000|Study Completion Disposition|Lost to Follow-up|1|||
157060026|NCT03840148|566974164|FG001|Study Completion Disposition|Lost to Follow-up|1|||
157060027|NCT03840148|566974163|FG000|Study Completion Disposition|Death|1|||
157060028|NCT03840148|566974164|FG001|Study Completion Disposition|Death|0|||
157060029|NCT03840148|566974163|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
157060030|NCT03840148|566974164|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
157060031|NCT03615404|566974165|FG000|Overall Study|Death|1|||
157060032|NCT03615404|566974165|FG000|Overall Study|vaccine did not pass quality assurance|1|||
157060033|NCT00257556|566974166|FG000|Overall Study|Adverse Event|1|||
157060034|NCT00257556|566974167|FG001|Overall Study|Adverse Event|4|||
157060035|NCT00257556|566974166|FG000|Overall Study|Physician Decision|6|||
157060036|NCT00257556|566974167|FG001|Overall Study|Physician Decision|0|||
157060037|NCT00257556|566974166|FG000|Overall Study|Did not meet hCG criterion|3|||
157183506|NCT01600105|567413080|FG000|Sub Study V|Poor Image Quality|2|||
157060038|NCT00257556|566974167|FG001|Overall Study|Did not meet hCG criterion|0|||
157060039|NCT00257556|566974166|FG000|Overall Study|other reason|4|||
157060040|NCT00257556|566974167|FG001|Overall Study|other reason|6|||
157060041|NCT03873038|566974168|FG000|Part 2|Withdrawal by Subject|0|||
157060042|NCT03873038|566974169|FG001|Part 2|Withdrawal by Subject|0|||
157060043|NCT03873038|566974170|FG002|Part 2|Withdrawal by Subject|0|||
157060044|NCT03873038|566974171|FG003|Part 2|Withdrawal by Subject|0|||
157060045|NCT03873038|566974172|FG004|Part 2|Withdrawal by Subject|0|||
157060046|NCT03873038|566974173|FG005|Part 2|Withdrawal by Subject|1|||
157183507|NCT01600105|567413081|FG001|Sub Study V|Poor Image Quality|0|||
157183508|NCT01263444|567413082|FG000|Overall Study|Adverse Event|8|||
157183509|NCT01263444|567413082|FG000|Overall Study|Withdrawal by Subject|1|||
157183510|NCT01263444|567413082|FG000|Overall Study|Protocol Violation|1|||
157229955|NCT04646109|567588212|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
157060047|NCT03873038|566974168|FG000|Part 2|Unknon|0|||
157060048|NCT03873038|566974169|FG001|Part 2|Unknon|0|||
157060049|NCT03873038|566974170|FG002|Part 2|Unknon|0|||
157060050|NCT03873038|566974171|FG003|Part 2|Unknon|0|||
157060051|NCT03873038|566974172|FG004|Part 2|Unknon|1|||
157060052|NCT03873038|566974173|FG005|Part 2|Unknon|0|||
157060053|NCT00595764|566974175|FG000|Overall Study|Protocol Violation|24|||
157060054|NCT00595764|566974176|FG001|Overall Study|Protocol Violation|19|||
157060055|NCT00595764|566974175|FG000|Overall Study|Missed Medication >1 week|10|||
157060056|NCT00595764|566974176|FG001|Overall Study|Missed Medication >1 week|17|||
157060057|NCT00595764|566974175|FG000|Overall Study|Missed 3 PM visits|1|||
157060058|NCT00595764|566974176|FG001|Overall Study|Missed 3 PM visits|7|||
157060059|NCT00595764|566974175|FG000|Overall Study|Withdrawal by Subject|4|||
157060060|NCT00595764|566974176|FG001|Overall Study|Withdrawal by Subject|0|||
157060061|NCT04222088|566974177|FG000|Overall Study|Lost to Follow-up|5|||
157060062|NCT04222088|566974178|FG001|Overall Study|Lost to Follow-up|1|||
157060063|NCT04222088|566974177|FG000|Overall Study|Withdrawal by Subject|4|||
157060064|NCT04222088|566974178|FG001|Overall Study|Withdrawal by Subject|0|||
157060065|NCT03849300|566974179|FG000|Overall Study|move out to different area|1|||
157060066|NCT03849300|566974180|FG001|Overall Study|move out to different area|3|||
157060067|NCT03849300|566974181|FG002|Overall Study|move out to different area|1|||
157060068|NCT03849300|566974182|FG003|Overall Study|move out to different area|4|||
157060069|NCT03849300|566974179|FG000|Overall Study|scheduling/transportation conflict|4|||
157060070|NCT03849300|566974180|FG001|Overall Study|scheduling/transportation conflict|4|||
157060071|NCT03849300|566974181|FG002|Overall Study|scheduling/transportation conflict|3|||
157060072|NCT03849300|566974182|FG003|Overall Study|scheduling/transportation conflict|2|||
157060073|NCT04839289|566974183|FG000|Overall Study|Withdrawal by Subject|1|||
157060074|NCT04839289|566974184|FG001|Overall Study|Withdrawal by Subject|0|||
157060075|NCT00464737|566974186|FG000|Overall Study|Adverse Event|12|||
157060076|NCT00464737|566974187|FG001|Overall Study|Adverse Event|17|||
157060077|NCT00464737|566974188|FG002|Overall Study|Adverse Event|33|||
157060078|NCT00464737|566974186|FG000|Overall Study|Lack of Efficacy|7|||
157060079|NCT00464737|566974187|FG001|Overall Study|Lack of Efficacy|7|||
157060080|NCT00464737|566974188|FG002|Overall Study|Lack of Efficacy|4|||
157060081|NCT00464737|566974186|FG000|Overall Study|Withdrawal by Subject|5|||
157060082|NCT00464737|566974187|FG001|Overall Study|Withdrawal by Subject|3|||
157060083|NCT00464737|566974188|FG002|Overall Study|Withdrawal by Subject|5|||
157060084|NCT00464737|566974186|FG000|Overall Study|Protocol Violation|1|||
157060085|NCT00464737|566974187|FG001|Overall Study|Protocol Violation|1|||
157060086|NCT00464737|566974188|FG002|Overall Study|Protocol Violation|5|||
157060087|NCT00464737|566974186|FG000|Overall Study|Non-compliance|0|||
157060088|NCT00464737|566974187|FG001|Overall Study|Non-compliance|1|||
157060089|NCT00464737|566974188|FG002|Overall Study|Non-compliance|1|||
157060090|NCT00464737|566974186|FG000|Overall Study|Lost to Follow-up|5|||
157060091|NCT00464737|566974187|FG001|Overall Study|Lost to Follow-up|2|||
157060092|NCT00464737|566974188|FG002|Overall Study|Lost to Follow-up|5|||
157060093|NCT00464737|566974186|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
157060094|NCT00464737|566974187|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
157060095|NCT00464737|566974188|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
157060096|NCT00464737|566974186|FG000|Overall Study|Other: Subject left town; family illness|1|||
157060097|NCT00464737|566974187|FG001|Overall Study|Other: Subject left town; family illness|0|||
157060098|NCT00464737|566974188|FG002|Overall Study|Other: Subject left town; family illness|0|||
157060099|NCT00464737|566974186|FG000|Overall Study|Other: Study demands too great|0|||
157060100|NCT00464737|566974187|FG001|Overall Study|Other: Study demands too great|1|||
157060101|NCT00464737|566974188|FG002|Overall Study|Other: Study demands too great|0|||
157060102|NCT00464737|566974186|FG000|Overall Study|Other: Personal family reasons|0|||
157060103|NCT00464737|566974187|FG001|Overall Study|Other: Personal family reasons|0|||
157060104|NCT00464737|566974188|FG002|Overall Study|Other: Personal family reasons|1|||
157060105|NCT00464737|566974186|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
157060106|NCT00464737|566974187|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
157060107|NCT00464737|566974188|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
157060108|NCT00580047|566974191|FG000|Overall Study|Lost to Follow-up|1|||
157060109|NCT00580047|566974192|FG001|Overall Study|Lost to Follow-up|1|||
157060110|NCT00580047|566974193|FG002|Overall Study|Lost to Follow-up|0|||
157060111|NCT00580047|566974191|FG000|Overall Study|Withdrawal by Subject|1|||
157060112|NCT00580047|566974192|FG001|Overall Study|Withdrawal by Subject|1|||
157060113|NCT00580047|566974193|FG002|Overall Study|Withdrawal by Subject|2|||
157060114|NCT00580047|566974191|FG000|Overall Study|Withdrawal by Subject|1|||
157060115|NCT00580047|566974192|FG001|Overall Study|Withdrawal by Subject|0|||
157060116|NCT00580047|566974193|FG002|Overall Study|Withdrawal by Subject|0|||
157060117|NCT01780584|566974196|FG000|Overall Study|Death|1|||
157060118|NCT01780584|566974197|FG001|Overall Study|Death|0|||
157060119|NCT01780584|566974198|FG002|Overall Study|Death|1|||
157060120|NCT01780584|566974196|FG000|Overall Study|Adverse Event|0|||
157060121|NCT01780584|566974197|FG001|Overall Study|Adverse Event|1|||
157060122|NCT01780584|566974198|FG002|Overall Study|Adverse Event|0|||
157060123|NCT01780584|566974196|FG000|Overall Study|Protocol Violation|0|||
157060124|NCT01780584|566974197|FG001|Overall Study|Protocol Violation|0|||
157060125|NCT01780584|566974198|FG002|Overall Study|Protocol Violation|1|||
157183511|NCT01764022|567413083|FG000|Overall Study|Death|3|||
157183512|NCT01764022|567413084|FG001|Overall Study|Death|5|||
157183513|NCT01764022|567413083|FG000|Overall Study|Withdrawal by Subject|2|||
157183514|NCT01764022|567413084|FG001|Overall Study|Withdrawal by Subject|6|||
157183515|NCT01764022|567413083|FG000|Overall Study|Lack of Efficacy|0|||
157183516|NCT01764022|567413084|FG001|Overall Study|Lack of Efficacy|1|||
157183517|NCT01764022|567413083|FG000|Overall Study|Physician Decision|0|||
157183518|NCT01764022|567413084|FG001|Overall Study|Physician Decision|2|||
157183519|NCT01764022|567413083|FG000|Overall Study|Lost to Follow-up|2|||
157183520|NCT01764022|567413084|FG001|Overall Study|Lost to Follow-up|0|||
157183521|NCT01764022|567413083|FG000|Overall Study|Protocol Violation|1|||
157183522|NCT01764022|567413084|FG001|Overall Study|Protocol Violation|0|||
157183523|NCT01899768|567413085|FG000|Part A|Adverse Event|2|||
157183524|NCT01899768|567413085|FG000|Part A|Withdrawal by Subject|1|||
157183525|NCT01899768|567413085|FG000|Part B|Adverse Event|1|||
157183526|NCT01899768|567413085|FG000|Part B|Withdrawal by Subject|1|||
157183527|NCT04043416|567413086|FG000|Washout|Change in health condition|0|||
157183528|NCT04043416|567413087|FG001|Washout|Change in health condition|1|||
157183529|NCT01196091|567413088|FG000|Overall Study|Adverse Event|22|||
157183530|NCT01196091|567413089|FG001|Overall Study|Adverse Event|27|||
157183531|NCT01196091|567413090|FG002|Overall Study|Adverse Event|26|||
157183532|NCT01196091|567413088|FG000|Overall Study|Death|3|||
157183533|NCT01196091|567413089|FG001|Overall Study|Death|2|||
157183534|NCT01196091|567413090|FG002|Overall Study|Death|2|||
157183535|NCT01196091|567413088|FG000|Overall Study|Entry Criteria Not Met|11|||
157183536|NCT01196091|567413089|FG001|Overall Study|Entry Criteria Not Met|11|||
157183537|NCT01196091|567413090|FG002|Overall Study|Entry Criteria Not Met|10|||
157183538|NCT01196091|567413088|FG000|Overall Study|Lack of Efficacy|15|||
157183539|NCT01196091|567413089|FG001|Overall Study|Lack of Efficacy|12|||
157183540|NCT01196091|567413090|FG002|Overall Study|Lack of Efficacy|17|||
157183541|NCT01196091|567413088|FG000|Overall Study|Lost to Follow-up|5|||
157183542|NCT01196091|567413089|FG001|Overall Study|Lost to Follow-up|5|||
157183543|NCT01196091|567413090|FG002|Overall Study|Lost to Follow-up|6|||
157183544|NCT01196091|567413088|FG000|Overall Study|Parent/Caregiver Decision|0|||
157060126|NCT00141271|566974203|FG000|Overall Study|Adverse Event|31|||
157060127|NCT00141271|566974204|FG001|Overall Study|Adverse Event|19|||
157060128|NCT00141271|566974205|FG002|Overall Study|Adverse Event|17|||
157060129|NCT00141271|566974203|FG000|Overall Study|Laboratory Abnormality|2|||
157060130|NCT00141271|566974204|FG001|Overall Study|Laboratory Abnormality|1|||
157060131|NCT00141271|566974205|FG002|Overall Study|Laboratory Abnormality|1|||
157060132|NCT00141271|566974203|FG000|Overall Study|Lack of Efficacy|7|||
157060133|NCT00141271|566974204|FG001|Overall Study|Lack of Efficacy|7|||
157060134|NCT00141271|566974205|FG002|Overall Study|Lack of Efficacy|3|||
157060135|NCT00141271|566974203|FG000|Overall Study|Lost to Follow-up|15|||
157060136|NCT00141271|566974204|FG001|Overall Study|Lost to Follow-up|15|||
157060137|NCT00141271|566974205|FG002|Overall Study|Lost to Follow-up|21|||
157060138|NCT00141271|566974203|FG000|Overall Study|Withdrawal by Subject|14|||
157060139|NCT00141271|566974204|FG001|Overall Study|Withdrawal by Subject|9|||
157060140|NCT00141271|566974205|FG002|Overall Study|Withdrawal by Subject|10|||
157060141|NCT00141271|566974203|FG000|Overall Study|Other|11|||
157060142|NCT00141271|566974204|FG001|Overall Study|Other|12|||
157060143|NCT00141271|566974205|FG002|Overall Study|Other|5|||
157060144|NCT01544153|566974211|FG000|Overall Study|Under 18|0|||
157060145|NCT01544153|566974212|FG001|Overall Study|Under 18|1|||
157060146|NCT01544153|566974213|FG002|Overall Study|Under 18|0|||
157060147|NCT01544153|566974214|FG003|Overall Study|Under 18|0|||
157060148|NCT01544153|566974211|FG000|Overall Study|Non-smoker|0|||
157060149|NCT01544153|566974212|FG001|Overall Study|Non-smoker|0|||
157060150|NCT01544153|566974213|FG002|Overall Study|Non-smoker|1|||
157060151|NCT01544153|566974214|FG003|Overall Study|Non-smoker|0|||
157060152|NCT00390806|566974219|FG000|Overall Study|Lost to Follow-up|7|||
157060153|NCT00390806|566974220|FG001|Overall Study|Lost to Follow-up|6|||
157060154|NCT00390806|566974219|FG000|Overall Study|Protocol Violation|2|||
157060155|NCT00390806|566974220|FG001|Overall Study|Protocol Violation|2|||
157060156|NCT00390806|566974219|FG000|Overall Study|Withdrawal by Subject|12|||
157060157|NCT00390806|566974220|FG001|Overall Study|Withdrawal by Subject|15|||
157060158|NCT00390806|566974219|FG000|Overall Study|Investigator Decision|4|||
157060159|NCT00390806|566974220|FG001|Overall Study|Investigator Decision|6|||
157060160|NCT00390806|566974219|FG000|Overall Study|Death|1|||
157060161|NCT00390806|566974220|FG001|Overall Study|Death|0|||
157060162|NCT00390806|566974219|FG000|Overall Study|Physician Decision|0|||
157060163|NCT00390806|566974220|FG001|Overall Study|Physician Decision|1|||
157060164|NCT00390806|566974219|FG000|Overall Study|Ongoing|4|||
157060165|NCT00390806|566974220|FG001|Overall Study|Ongoing|2|||
157060166|NCT03169530|566974223|FG000|Overall Study|Study ended by NIH|15|||
157060167|NCT03169530|566974224|FG001|Overall Study|Study ended by NIH|17|||
157060168|NCT00884793|566974225|FG000|Overall Study|Withdrawal by Subject|1|||
157060169|NCT04783519|566974226|FG000|Overall Study|Withdrawal by Subject|2|||
157060170|NCT04783519|566974227|FG001|Overall Study|Withdrawal by Subject|7|||
157060171|NCT04783519|566974228|FG002|Overall Study|Withdrawal by Subject|3|||
157060172|NCT04783519|566974226|FG000|Overall Study|Lost to Follow-up|9|||
157060173|NCT04783519|566974227|FG001|Overall Study|Lost to Follow-up|7|||
157060174|NCT04783519|566974228|FG002|Overall Study|Lost to Follow-up|6|||
157060175|NCT01032200|566974229|FG000|Overall Study|Death|1|||
157060176|NCT01032200|566974230|FG001|Overall Study|Death|1|||
157060177|NCT01032200|566974229|FG000|Overall Study|Withdrawal by Subject|1|||
157060178|NCT01032200|566974230|FG001|Overall Study|Withdrawal by Subject|3|||
157060179|NCT01032200|566974229|FG000|Overall Study|Toxicity|0|||
157060180|NCT01032200|566974230|FG001|Overall Study|Toxicity|2|||
157060181|NCT01032200|566974229|FG000|Overall Study|Progression|1|||
157060182|NCT01032200|566974230|FG001|Overall Study|Progression|0|||
157060183|NCT01032200|566974229|FG000|Overall Study|Multiple|1|||
157060184|NCT01032200|566974230|FG001|Overall Study|Multiple|1|||
157060185|NCT00727259|566974234|FG000|Overall Study|Not all questionnaires completed|1055|||
157060186|NCT01021683|566974235|FG000|Overall Study|Lack of Efficacy|12|||
157060187|NCT01021683|566974235|FG000|Overall Study|Recovery of neutrophil count|51|||
157060188|NCT01021683|566974235|FG000|Overall Study|Other|8|||
157060189|NCT01374971|566974236|FG000|Overall Study|Withdrawal by Subject|1|||
157060190|NCT02273180|566974237|FG000|Overall Study|Adverse Event|2|||
157060191|NCT02273180|566974238|FG001|Overall Study|Adverse Event|2|||
157060192|NCT02273180|566974237|FG000|Overall Study|Lack of Efficacy|1|||
157060193|NCT02273180|566974238|FG001|Overall Study|Lack of Efficacy|0|||
157060194|NCT02273180|566974237|FG000|Overall Study|Protocol Violation|1|||
157060195|NCT02273180|566974238|FG001|Overall Study|Protocol Violation|7|||
157060196|NCT02273180|566974237|FG000|Overall Study|Randomized but not treated|1|||
157060197|NCT02273180|566974238|FG001|Overall Study|Randomized but not treated|0|||
157060198|NCT02273180|566974237|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
157060199|NCT02273180|566974238|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
157060200|NCT02273180|566974237|FG000|Overall Study|Other than specified above|21|||
157060201|NCT02273180|566974238|FG001|Overall Study|Other than specified above|10|||
157060202|NCT00645099|566974239|FG000|Overall Study|Lack of Efficacy|15|||
157060203|NCT00645099|566974240|FG001|Overall Study|Lack of Efficacy|6|||
157060204|NCT00645099|566974239|FG000|Overall Study|Withdrawal by Subject|30|||
157060205|NCT00645099|566974240|FG001|Overall Study|Withdrawal by Subject|22|||
157060206|NCT00645099|566974239|FG000|Overall Study|Lost to Follow-up|6|||
157060207|NCT00645099|566974240|FG001|Overall Study|Lost to Follow-up|4|||
157060208|NCT00645099|566974239|FG000|Overall Study|Adverse Event|11|||
157060209|NCT00645099|566974240|FG001|Overall Study|Adverse Event|5|||
157060210|NCT00645099|566974239|FG000|Overall Study|Other|9|||
157060211|NCT00645099|566974240|FG001|Overall Study|Other|5|||
157060212|NCT01201915|566974241|FG000|Overall Study|Adverse Event|2|||
157060213|NCT01201915|566974242|FG001|Overall Study|Adverse Event|1|||
157060214|NCT01201915|566974243|FG002|Overall Study|Adverse Event|1|||
157060215|NCT01201915|566974241|FG000|Overall Study|Lost to Follow-up|0|||
157060216|NCT01201915|566974242|FG001|Overall Study|Lost to Follow-up|4|||
157060217|NCT01201915|566974243|FG002|Overall Study|Lost to Follow-up|0|||
157060218|NCT01201915|566974241|FG000|Overall Study|Physician Decision|3|||
157060219|NCT01201915|566974242|FG001|Overall Study|Physician Decision|0|||
157060220|NCT01201915|566974243|FG002|Overall Study|Physician Decision|0|||
157060221|NCT01201915|566974241|FG000|Overall Study|Subject Decision|3|||
157060222|NCT01201915|566974242|FG001|Overall Study|Subject Decision|3|||
157060223|NCT01201915|566974243|FG002|Overall Study|Subject Decision|5|||
157060224|NCT01201915|566974241|FG000|Overall Study|Target Lesion Progression|0|||
157060225|NCT01201915|566974242|FG001|Overall Study|Target Lesion Progression|3|||
157060226|NCT01201915|566974243|FG002|Overall Study|Target Lesion Progression|0|||
157060227|NCT02154516|566974244|FG000|Overall Study|Withdrawal by Subject|0|||
157060228|NCT02154516|566974245|FG001|Overall Study|Withdrawal by Subject|1|||
157060229|NCT02154516|566974244|FG000|Overall Study|Lost to Follow-up|1|||
157060230|NCT02154516|566974245|FG001|Overall Study|Lost to Follow-up|0|||
157060231|NCT02154516|566974244|FG000|Overall Study|Removal/revision of device|1|||
157060232|NCT02154516|566974245|FG001|Overall Study|Removal/revision of device|0|||
157060233|NCT02154516|566974244|FG000|Overall Study|Death|2|||
157060234|NCT02154516|566974245|FG001|Overall Study|Death|1|||
157060235|NCT00663923|566974246|FG000|Overall Study|Lost to Follow-up|2|||
157060236|NCT02316171|566974249|FG000|Overall Study|difficulties with urinary catheter|1|||
157060237|NCT02316171|566974250|FG001|Overall Study|difficulties with urinary catheter|0|||
157060238|NCT02316171|566974251|FG002|Overall Study|difficulties with urinary catheter|0|||
157060239|NCT02316171|566974252|FG003|Overall Study|difficulties with urinary catheter|0|||
157060240|NCT02785900|566974253|FG000|Overall Study|Study Termination by Sponsor|64|||
157060241|NCT02785900|566974254|FG001|Overall Study|Study Termination by Sponsor|81|||
157060242|NCT02785900|566974253|FG000|Overall Study|Death|46|||
157060243|NCT02785900|566974254|FG001|Overall Study|Death|32|||
157060244|NCT02785900|566974253|FG000|Overall Study|Withdrawal by Subject|4|||
157060245|NCT02785900|566974254|FG001|Overall Study|Withdrawal by Subject|8|||
157060246|NCT02785900|566974253|FG000|Overall Study|Physician Decision|3|||
157060247|NCT02785900|566974254|FG001|Overall Study|Physician Decision|2|||
157060248|NCT04341584|566974255|FG000|Overall Study|Withdrew consent|0|||
157060249|NCT04341584|566974256|FG001|Overall Study|Withdrew consent|2|||
157060250|NCT04341584|566974257|FG002|Overall Study|Withdrew consent|2|||
157060251|NCT04341584|566974258|FG003|Overall Study|Withdrew consent|1|||
157060252|NCT00497198|566974259|FG000|Overall Study|Adverse Event|4|||
157060253|NCT00497198|566974260|FG001|Overall Study|Adverse Event|2|||
157060254|NCT00497198|566974259|FG000|Overall Study|Physician Decision|1|||
157060255|NCT00497198|566974260|FG001|Overall Study|Physician Decision|2|||
157060256|NCT00497198|566974259|FG000|Overall Study|Withdrawal by Subject|0|||
157060257|NCT00497198|566974260|FG001|Overall Study|Withdrawal by Subject|1|||
157060258|NCT04130061|566974261|FG000|Overall Study|OR team forgot to request membrane|1|||
157060259|NCT04130061|566974262|FG001|Overall Study|OR team forgot to request membrane|0|||
157060260|NCT01231464|566975693|FG000|Overall Study|Adverse Event|0|||
157060261|NCT01231464|566975694|FG001|Overall Study|Adverse Event|1|||
157060262|NCT01231464|566975693|FG000|Overall Study|Protocol Violation|1|||
157060263|NCT01231464|566975694|FG001|Overall Study|Protocol Violation|2|||
157060264|NCT01231464|566975693|FG000|Overall Study|Lost to Follow-up|1|||
157060265|NCT01231464|566975694|FG001|Overall Study|Lost to Follow-up|2|||
157060266|NCT01231464|566975693|FG000|Overall Study|Withdrawal by Subject|3|||
157060267|NCT01231464|566975694|FG001|Overall Study|Withdrawal by Subject|2|||
157060268|NCT00966979|566975695|FG000|Overall Study|Death|1|||
157060269|NCT00966979|566975695|FG000|Overall Study|Lost to Follow-up|6|||
157060270|NCT00966979|566975695|FG000|Overall Study|Withdrawal by Subject|14|||
157060271|NCT00966979|566975695|FG000|Overall Study|Adverse Event|5|||
157060272|NCT00966979|566975695|FG000|Overall Study|Sponsor terminated early|49|||
157060273|NCT00966979|566975695|FG000|Overall Study|Censored because surgery not done|2|||
157060274|NCT00966979|566975695|FG000|Overall Study|Censored because study device was not implanted|14|||
157060275|NCT00966979|566975695|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
157060276|NCT03713281|566975699|FG000|Overall Study|Lens handling difficuluties|2|||
157060277|NCT03713281|566975699|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
157060278|NCT00837096|566975700|FG000|Overall Study|Physician Decision|1|||
157060279|NCT00837096|566975701|FG001|Overall Study|Physician Decision|1|||
157060280|NCT00837096|566975700|FG000|Overall Study|Not reported|9|||
157060281|NCT00837096|566975701|FG001|Overall Study|Not reported|8|||
157060282|NCT00983905|566975702|FG000|Theophylline Alone|Adverse Event|1|||
157060283|NCT00983905|566975702|FG000|Colchicine Alone|Adverse Event|2|||
157060284|NCT00329550|566975704|FG000|Overall Study|Adverse Event|3|||
157060285|NCT00329550|566975705|FG001|Overall Study|Adverse Event|4|||
157060286|NCT00329550|566975706|FG002|Overall Study|Adverse Event|2|||
157060287|NCT00329550|566975704|FG000|Overall Study|Withdrawal of Consent|1|||
157060288|NCT00329550|566975705|FG001|Overall Study|Withdrawal of Consent|0|||
157060289|NCT00329550|566975706|FG002|Overall Study|Withdrawal of Consent|1|||
157060290|NCT00329550|566975704|FG000|Overall Study|Due to Relocation|0|||
157060291|NCT00329550|566975705|FG001|Overall Study|Due to Relocation|0|||
157060292|NCT00329550|566975706|FG002|Overall Study|Due to Relocation|1|||
157060293|NCT00494026|566975707|FG000|Overall Study|Sponsor Decision|4|||
157060294|NCT01649557|566975709|FG000|Overall Study|Lost to Follow-up|5|||
157060295|NCT01649557|566975710|FG001|Overall Study|Lost to Follow-up|0|||
157060296|NCT01649557|566975711|FG002|Overall Study|Lost to Follow-up|3|||
157060297|NCT01649557|566975709|FG000|Overall Study|Adverse Event|7|||
157060298|NCT01649557|566975710|FG001|Overall Study|Adverse Event|5|||
157060299|NCT01649557|566975711|FG002|Overall Study|Adverse Event|1|||
157060300|NCT01649557|566975709|FG000|Overall Study|Met withdrawal criteria|4|||
157060301|NCT01649557|566975710|FG001|Overall Study|Met withdrawal criteria|0|||
157060302|NCT01649557|566975711|FG002|Overall Study|Met withdrawal criteria|0|||
157060303|NCT01649557|566975709|FG000|Overall Study|Physician Decision|8|||
157060304|NCT01649557|566975710|FG001|Overall Study|Physician Decision|2|||
157060305|NCT01649557|566975711|FG002|Overall Study|Physician Decision|1|||
157060306|NCT01649557|566975709|FG000|Overall Study|Withdrawal by Subject|15|||
157060307|NCT01649557|566975710|FG001|Overall Study|Withdrawal by Subject|5|||
157060308|NCT01649557|566975711|FG002|Overall Study|Withdrawal by Subject|4|||
157060309|NCT01649557|566975709|FG000|Overall Study|Protocol deviation|0|||
157060310|NCT01649557|566975710|FG001|Overall Study|Protocol deviation|2|||
157060311|NCT01649557|566975711|FG002|Overall Study|Protocol deviation|0|||
157060312|NCT01649557|566975709|FG000|Overall Study|Lack of Efficacy|5|||
157060313|NCT01649557|566975710|FG001|Overall Study|Lack of Efficacy|0|||
157060314|NCT01649557|566975711|FG002|Overall Study|Lack of Efficacy|0|||
157060315|NCT00632931|566975719|FG000|Part 1, Period 1|Protocol Violation|1|||
157060316|NCT00632931|566975720|FG001|Part 1, Period 1|Protocol Violation|0|||
157060317|NCT00632931|566975721|FG002|Part 1, Period 1|Protocol Violation|0|||
157060318|NCT00632931|566975719|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
157060319|NCT00632931|566975720|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
157060320|NCT00632931|566975721|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
157060321|NCT00632931|566975719|FG000|Part 2|Adverse Event|0|||
157060322|NCT00632931|566975720|FG001|Part 2|Adverse Event|0|||
157060323|NCT00632931|566975721|FG002|Part 2|Adverse Event|3|||
157060324|NCT00632931|566975719|FG000|Part 2|Death|0|||
157060325|NCT00632931|566975720|FG001|Part 2|Death|0|||
157229956|NCT06176768|567588213|FG000|Overall Study|Adverse Event|1|||
157060326|NCT00632931|566975721|FG002|Part 2|Death|1|||
157060327|NCT00632931|566975719|FG000|Part 2|Lack of Efficacy|0|||
157060328|NCT00632931|566975720|FG001|Part 2|Lack of Efficacy|0|||
157060329|NCT00632931|566975721|FG002|Part 2|Lack of Efficacy|17|||
157060330|NCT00632931|566975719|FG000|Part 2|Withdrawal by Subject|0|||
157060331|NCT00632931|566975720|FG001|Part 2|Withdrawal by Subject|0|||
157060332|NCT00632931|566975721|FG002|Part 2|Withdrawal by Subject|3|||
157060333|NCT00833898|566975722|FG000|Overall Study|Withdrawal by Subject|33|||
157060334|NCT00833898|566975723|FG001|Overall Study|Withdrawal by Subject|27|||
157060335|NCT00833898|566975722|FG000|Overall Study|Lost to Follow-up|7|||
157060336|NCT00833898|566975723|FG001|Overall Study|Lost to Follow-up|7|||
157060337|NCT00833898|566975722|FG000|Overall Study|Patient did not receive transplant|0|||
157060338|NCT00833898|566975723|FG001|Overall Study|Patient did not receive transplant|2|||
157060339|NCT03168425|566975726|FG000|Overall Study|Lost to Follow-up|5|||
157060340|NCT03168425|566975727|FG001|Overall Study|Lost to Follow-up|8|||
157060341|NCT03168425|566975726|FG000|Overall Study|unable to confirm post op opioids|2|||
157060342|NCT03168425|566975727|FG001|Overall Study|unable to confirm post op opioids|3|||
157060343|NCT01960114|566975728|FG000|Overall Study|Adverse Event|1|||
157060344|NCT01960114|566975729|FG001|Overall Study|Adverse Event|0|||
157060345|NCT01960114|566975728|FG000|Overall Study|Could not swallow study medication|0|||
157060346|NCT01960114|566975729|FG001|Overall Study|Could not swallow study medication|1|||
157060347|NCT00468858|566975735|FG000|Overall Study|Adverse Event|0|||
157060348|NCT00468858|566975736|FG001|Overall Study|Adverse Event|1|||
157060349|NCT00468858|566975737|FG002|Overall Study|Adverse Event|0|||
157060350|NCT00468858|566975735|FG000|Overall Study|Withdrawal by Subject|7|||
157060351|NCT00468858|566975736|FG001|Overall Study|Withdrawal by Subject|4|||
157060352|NCT00468858|566975737|FG002|Overall Study|Withdrawal by Subject|5|||
157060353|NCT00468858|566975735|FG000|Overall Study|Relocation|1|||
157060354|NCT00468858|566975736|FG001|Overall Study|Relocation|3|||
157060355|NCT00468858|566975737|FG002|Overall Study|Relocation|3|||
157060356|NCT00468858|566975735|FG000|Overall Study|Lost to Follow-up|1|||
157060357|NCT00468858|566975736|FG001|Overall Study|Lost to Follow-up|2|||
157060358|NCT00468858|566975737|FG002|Overall Study|Lost to Follow-up|5|||
157060359|NCT00468858|566975735|FG000|Overall Study|Other|0|||
157060360|NCT00468858|566975736|FG001|Overall Study|Other|0|||
157060361|NCT00468858|566975737|FG002|Overall Study|Other|1|||
157060362|NCT00427778|566975744|FG000|First Intervention (4 Weeks)|no longer interested|1|||
157060363|NCT00427778|566975745|FG001|First Intervention (4 Weeks)|no longer interested|0|||
157060364|NCT00427778|566975744|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
157060365|NCT00427778|566975745|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
157060366|NCT00427778|566975744|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
157060367|NCT00427778|566975745|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
157060368|NCT00427778|566975744|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
157060369|NCT00427778|566975745|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
157060370|NCT00225277|566975749|FG000|Overall Study|Adverse Event|30|||
157060371|NCT00225277|566975750|FG001|Overall Study|Adverse Event|34|||
157060372|NCT00225277|566975749|FG000|Overall Study|Lack of Efficacy|4|||
157060373|NCT00225277|566975750|FG001|Overall Study|Lack of Efficacy|1|||
157060374|NCT00225277|566975749|FG000|Overall Study|Lost to Follow-up|4|||
157060375|NCT00225277|566975750|FG001|Overall Study|Lost to Follow-up|6|||
157060376|NCT00225277|566975749|FG000|Overall Study|Physician Decision|6|||
157060377|NCT00225277|566975750|FG001|Overall Study|Physician Decision|8|||
157060378|NCT00225277|566975749|FG000|Overall Study|Protocol Violation|6|||
157060379|NCT00225277|566975750|FG001|Overall Study|Protocol Violation|3|||
157060380|NCT00225277|566975749|FG000|Overall Study|Withdrawal by Subject|40|||
157060381|NCT00225277|566975750|FG001|Overall Study|Withdrawal by Subject|34|||
157060382|NCT00225277|566975749|FG000|Overall Study|Other|7|||
157060383|NCT00225277|566975750|FG001|Overall Study|Other|9|||
157229957|NCT06176768|567588214|FG001|Overall Study|Adverse Event|0|||
157060384|NCT01177137|566975753|FG000|Overall Study|Withdrawal by Subject|10|||
157060385|NCT01177137|566975754|FG001|Overall Study|Withdrawal by Subject|10|||
157060386|NCT01177137|566975755|FG002|Overall Study|Withdrawal by Subject|2|||
157060387|NCT03723915|566975759|FG000|Screening|Failed to meet screening requirements.|2|||
157060388|NCT03723915|566975759|FG000|On Treatment|Failed to meet treatment requirements|2|||
157060389|NCT02201771|566975760|FG000|Overall Study|Death|3|||
157060390|NCT02201771|566975761|FG001|Overall Study|Death|2|||
157060391|NCT02201771|566975762|FG002|Overall Study|Death|0|||
157060392|NCT02201771|566975760|FG000|Overall Study|Protocol Violation|10|||
157060393|NCT02201771|566975761|FG001|Overall Study|Protocol Violation|8|||
157060394|NCT02201771|566975762|FG002|Overall Study|Protocol Violation|10|||
157060395|NCT00583115|566975763|FG000|Overall Study|Death|1|||
157060396|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
157229958|NCT06176768|567588213|FG000|Overall Study|Assigned treatment by mistake|1|||
157060397|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
157060398|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
157060399|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
157060400|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
157060401|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
157229959|NCT06176768|567588214|FG001|Overall Study|Assigned treatment by mistake|0|||
157229960|NCT06176768|567588213|FG000|Overall Study|Lost to Follow-up|0|||
157060402|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
157060403|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
157060404|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
157060405|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
157060406|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
157060407|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
157060408|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
157060409|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
157060410|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
157060411|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
157060412|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
157060413|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
157060414|NCT03569475|566975764|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
157060415|NCT03569475|566975765|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
157060416|NCT03569475|566975766|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
157060417|NCT03569475|566975764|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
157060418|NCT03569475|566975765|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
157060419|NCT03569475|566975766|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
157060420|NCT03569475|566975764|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
157060421|NCT03569475|566975765|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
157060422|NCT03569475|566975766|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
157060423|NCT00818519|566975768|FG000|Overall Study|Adverse Event|2|||
157060424|NCT00818519|566975769|FG001|Overall Study|Adverse Event|2|||
157060425|NCT00818519|566975768|FG000|Overall Study|Lost to Follow-up|4|||
157060426|NCT00818519|566975769|FG001|Overall Study|Lost to Follow-up|6|||
157060427|NCT00818519|566975768|FG000|Overall Study|Protocol Violation|2|||
157060428|NCT00818519|566975769|FG001|Overall Study|Protocol Violation|1|||
157060429|NCT00818519|566975768|FG000|Overall Study|Pregnancy|0|||
157060430|NCT00818519|566975769|FG001|Overall Study|Pregnancy|1|||
157060431|NCT00818519|566975768|FG000|Overall Study|Withdrawal by Subject|4|||
157060432|NCT00818519|566975769|FG001|Overall Study|Withdrawal by Subject|9|||
157060433|NCT00818519|566975768|FG000|Overall Study|participant recovered completely|1|||
157060434|NCT00818519|566975769|FG001|Overall Study|participant recovered completely|0|||
157060435|NCT00818519|566975768|FG000|Overall Study|participant will leave for long tme|1|||
157060436|NCT00818519|566975769|FG001|Overall Study|participant will leave for long tme|0|||
157060437|NCT02820298|566975772|FG000|Overall Study|Withdrawal by Subject|0|||
157060438|NCT02820298|566975773|FG001|Overall Study|Withdrawal by Subject|1|||
157060439|NCT02820298|566975772|FG000|Overall Study|Physician Decision|1|||
157060440|NCT02820298|566975773|FG001|Overall Study|Physician Decision|0|||
157060441|NCT02820298|566975772|FG000|Overall Study|Protocol Violation|0|||
157060442|NCT02820298|566975773|FG001|Overall Study|Protocol Violation|1|||
157060443|NCT01894256|566975774|FG000|Part A|Adverse Event|0|||
157060444|NCT01894256|566975775|FG001|Part A|Adverse Event|1|||
157060445|NCT01894256|566975776|FG002|Part A|Adverse Event|0|||
157060446|NCT01894256|566975774|FG000|Part B|Death|0|||
157060447|NCT01894256|566975775|FG001|Part B|Death|1|||
157060448|NCT01894256|566975776|FG002|Part B|Death|1|||
157060449|NCT01894256|566975774|FG000|Part B|Withdrawal by Subject|0|||
157060450|NCT01894256|566975775|FG001|Part B|Withdrawal by Subject|1|||
157060451|NCT01894256|566975776|FG002|Part B|Withdrawal by Subject|0|||
157060452|NCT01894256|566975774|FG000|Part B|Lack of Efficacy|15|||
157060453|NCT01894256|566975775|FG001|Part B|Lack of Efficacy|12|||
157060454|NCT01894256|566975776|FG002|Part B|Lack of Efficacy|13|||
157060455|NCT03406507|566975777|FG000|Extension Period|Lack of Efficacy|0|||
157060456|NCT03406507|566975778|FG001|Extension Period|Lack of Efficacy|1|||
157060457|NCT01804140|566975781|FG000|Overall Study|No sampling or biopsy procedures done|114|||
157060458|NCT00547300|566975784|FG000|Overall Study|Study was Administratively Terminated|25|||
157060459|NCT00547300|566975785|FG001|Overall Study|Study was Administratively Terminated|24|||
157060460|NCT00547300|566975784|FG000|Overall Study|Did not Meet Entry Criteria|0|||
157060461|NCT00547300|566975785|FG001|Overall Study|Did not Meet Entry Criteria|2|||
157060462|NCT02965599|566975786|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
157060463|NCT02965599|566975787|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
157060464|NCT04435522|566975791|FG000|Overall Study|Withdrawal by Subject|2|||
157229961|NCT06176768|567588214|FG001|Overall Study|Lost to Follow-up|3|||
157060465|NCT02799745|566975792|FG000|Overall Study|Participant moved out of state|1|||
157060466|NCT02799745|566975793|FG001|Overall Study|Participant moved out of state|0|||
157060467|NCT02799745|566975792|FG000|Overall Study|Discontinued due to planned surgery|1|||
157060468|NCT02799745|566975793|FG001|Overall Study|Discontinued due to planned surgery|0|||
157060469|NCT02799745|566975792|FG000|Overall Study|Withdrawal by Subject|16|||
157060470|NCT02799745|566975793|FG001|Overall Study|Withdrawal by Subject|25|||
157060471|NCT02799745|566975792|FG000|Overall Study|Protocol Deviation|4|||
157060472|NCT02799745|566975793|FG001|Overall Study|Protocol Deviation|5|||
157229962|NCT06176768|567588213|FG000|Overall Study|Physician Decision|1|||
157060473|NCT02799745|566975792|FG000|Overall Study|Progressive Disease|28|||
157060474|NCT02799745|566975793|FG001|Overall Study|Progressive Disease|38|||
157060475|NCT02799745|566975792|FG000|Overall Study|Lost to Follow-up|3|||
157060476|NCT02799745|566975793|FG001|Overall Study|Lost to Follow-up|2|||
157060477|NCT02799745|566975792|FG000|Overall Study|Death|3|||
157060478|NCT02799745|566975793|FG001|Overall Study|Death|0|||
157060479|NCT02799745|566975792|FG000|Overall Study|Adverse Event|0|||
157060480|NCT02799745|566975793|FG001|Overall Study|Adverse Event|1|||
157060481|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
157060482|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
157060483|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
157060484|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
157060485|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
157060486|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
157060487|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
157060488|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
157060489|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
157060490|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
157060491|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
157060492|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
157060493|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
157060494|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
157060495|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
157060496|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
157060497|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
157060498|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
157060499|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
157060500|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
157060501|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
157060502|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
157060503|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
157060504|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
157060505|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
157060506|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
157060507|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
157060508|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
157060509|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
157060510|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
157060511|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
157060512|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
157060513|NCT00092521|566977513|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
157060514|NCT00092521|566977514|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
157060515|NCT00092521|566977515|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
157060516|NCT00092521|566977516|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
157060517|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
157060518|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
157060519|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
157060520|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
157060521|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
157060522|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
157060523|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
157060524|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
157060525|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
157060526|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
157060527|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
157060528|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
157060529|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Death|2|||
157060530|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Death|0|||
157060531|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Death|1|||
157060532|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Death|0|||
157060533|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
157229963|NCT06176768|567588214|FG001|Overall Study|Physician Decision|0|||
157229964|NCT06176768|567588213|FG000|Overall Study|Protocol deviation|3|||
157060534|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
157060535|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
157060536|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
157060537|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
157060538|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
157060539|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
157060540|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
157229965|NCT06176768|567588214|FG001|Overall Study|Protocol deviation|1|||
157229966|NCT06176768|567588213|FG000|Overall Study|Other|1|||
157060541|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
157060542|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
157060543|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
157060544|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
157060545|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Moved|32|||
157060546|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Moved|2|||
157060547|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Moved|28|||
157060548|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Moved|0|||
157060549|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
157060550|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
157060551|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
157060552|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
157060553|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Travel|2|||
157060554|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Travel|0|||
157060555|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Travel|0|||
157060556|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Travel|0|||
157060557|NCT00092521|566977513|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
157060558|NCT00092521|566977514|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
157060559|NCT00092521|566977515|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
157060560|NCT00092521|566977516|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
157060561|NCT00092521|566977513|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
157060562|NCT00092521|566977514|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
157060563|NCT00092521|566977515|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
157060564|NCT00092521|566977516|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
157060565|NCT00092521|566977513|FG000|Extension Study (Group 4)|Adverse Event|0|||
157060566|NCT00092521|566977514|FG001|Extension Study (Group 4)|Adverse Event|0|||
157060567|NCT00092521|566977515|FG002|Extension Study (Group 4)|Adverse Event|0|||
157060568|NCT00092521|566977516|FG003|Extension Study (Group 4)|Adverse Event|2|||
157060569|NCT00092521|566977513|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
157060570|NCT00092521|566977514|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
157060571|NCT00092521|566977515|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
157060572|NCT00092521|566977516|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
157060573|NCT00092521|566977513|FG000|Extension Study (Group 4)|Pregnancy|0|||
157060574|NCT00092521|566977514|FG001|Extension Study (Group 4)|Pregnancy|0|||
157060575|NCT00092521|566977515|FG002|Extension Study (Group 4)|Pregnancy|0|||
157060576|NCT00092521|566977516|FG003|Extension Study (Group 4)|Pregnancy|4|||
157060577|NCT00092521|566977513|FG000|Extension Study (Group 4)|Protocol Violation|0|||
157060578|NCT00092521|566977514|FG001|Extension Study (Group 4)|Protocol Violation|0|||
157060579|NCT00092521|566977515|FG002|Extension Study (Group 4)|Protocol Violation|0|||
157060580|NCT00092521|566977516|FG003|Extension Study (Group 4)|Protocol Violation|2|||
157060581|NCT00092521|566977513|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
157060582|NCT00092521|566977514|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
157060583|NCT00092521|566977515|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
157060584|NCT00092521|566977516|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
157060585|NCT00092521|566977513|FG000|Extension Study (Group 4)|Moved|0|||
157060586|NCT00092521|566977514|FG001|Extension Study (Group 4)|Moved|0|||
157060587|NCT00092521|566977515|FG002|Extension Study (Group 4)|Moved|0|||
157060588|NCT00092521|566977516|FG003|Extension Study (Group 4)|Moved|16|||
157060589|NCT00092521|566977513|FG000|Extension Study (Group 4)|Site Terminated|0|||
157060590|NCT00092521|566977514|FG001|Extension Study (Group 4)|Site Terminated|0|||
157060591|NCT00092521|566977515|FG002|Extension Study (Group 4)|Site Terminated|0|||
157060592|NCT00092521|566977516|FG003|Extension Study (Group 4)|Site Terminated|4|||
157060593|NCT00092521|566977513|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
157060594|NCT00092521|566977514|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
157060595|NCT00092521|566977515|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
157060596|NCT00092521|566977516|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
157060597|NCT01878383|566977517|FG000|Overall Study|Lost to Follow-up|0|||
157060598|NCT01878383|566977518|FG001|Overall Study|Lost to Follow-up|1499|||
157060599|NCT03449134|566977519|FG000|52-Week Treatment Period|Death|2|||
157060600|NCT03449134|566977520|FG001|52-Week Treatment Period|Death|1|||
157060601|NCT03449134|566977521|FG002|52-Week Treatment Period|Death|0|||
157060602|NCT03449134|566977519|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
157060603|NCT03449134|566977520|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
157060604|NCT03449134|566977521|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
157060605|NCT03449134|566977519|FG000|52-Week Treatment Period|Physician Decision|2|||
157060606|NCT03449134|566977520|FG001|52-Week Treatment Period|Physician Decision|3|||
157060607|NCT03449134|566977521|FG002|52-Week Treatment Period|Physician Decision|3|||
157060608|NCT03449134|566977519|FG000|52-Week Treatment Period|Screen Failure|1|||
157060609|NCT03449134|566977520|FG001|52-Week Treatment Period|Screen Failure|0|||
157060610|NCT03449134|566977521|FG002|52-Week Treatment Period|Screen Failure|1|||
157060611|NCT03449134|566977519|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
157060612|NCT03449134|566977520|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
157060613|NCT03449134|566977521|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
156976718|NCT00649389|566669183|FG003|Overall Study|Lost to Follow-up|26|||
156976719|NCT00649389|566669180|FG000|Overall Study|Protocol Violation|11|||
156976720|NCT00649389|566669181|FG001|Overall Study|Protocol Violation|13|||
156976721|NCT00649389|566669182|FG002|Overall Study|Protocol Violation|9|||
156976722|NCT00649389|566669183|FG003|Overall Study|Protocol Violation|8|||
156976723|NCT00649389|566669180|FG000|Overall Study|Withdrawal by Subject|20|||
156976724|NCT00649389|566669181|FG001|Overall Study|Withdrawal by Subject|21|||
156976725|NCT00649389|566669182|FG002|Overall Study|Withdrawal by Subject|19|||
156976726|NCT00649389|566669183|FG003|Overall Study|Withdrawal by Subject|23|||
156976727|NCT00649389|566669180|FG000|Overall Study|Other|3|||
156976728|NCT00649389|566669181|FG001|Overall Study|Other|9|||
156976729|NCT00649389|566669182|FG002|Overall Study|Other|1|||
156976730|NCT00649389|566669183|FG003|Overall Study|Other|6|||
156976731|NCT02746575|566669186|FG000|Overall Study|Surgery cancelled or time chaned|13|||
156976732|NCT02746575|566669186|FG000|Overall Study|Received epidural|10|||
156976733|NCT02746575|566669186|FG000|Overall Study|Withdrawal by Subject|3|||
156976734|NCT02746575|566669186|FG000|Overall Study|Bradycardia/hypotension|9|||
156976735|NCT02746575|566669186|FG000|Overall Study|Study paused|8|||
156976736|NCT02746575|566669186|FG000|Overall Study|put on beta-blocker|3|||
156976737|NCT02746575|566669186|FG000|Overall Study|type of surgery|1|||
156976738|NCT02746575|566669186|FG000|Overall Study|typ of surgery|1|||
156976739|NCT02746575|566669186|FG000|Overall Study|PI unavailable|1|||
156976740|NCT02746575|566669186|FG000|Overall Study|Unknown history of CVA|1|||
156976741|NCT00976482|566669187|FG000|Overall Study|Death|208|||
156976742|NCT00976482|566669187|FG000|Overall Study|Withdrawal by Subject|45|||
156976743|NCT00976482|566669187|FG000|Overall Study|Center terminated|1|||
156976744|NCT00976482|566669187|FG000|Overall Study|Protocol Violation|5|||
156976745|NCT02959671|566669188|FG000|Overall Study|Adverse Event|2|||
156976746|NCT02959671|566669188|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
156976747|NCT04105972|566669197|FG000|Overall Study|Adverse Event|2|||
156976748|NCT04105972|566669198|FG001|Overall Study|Adverse Event|1|||
156976749|NCT02254408|566669201|FG000|Overall Study|Randomized But Not Treated|1|||
156976750|NCT02254408|566669202|FG001|Overall Study|Randomized But Not Treated|3|||
156976751|NCT02254408|566669201|FG000|Overall Study|Adverse Event|1|||
156976752|NCT02254408|566669202|FG001|Overall Study|Adverse Event|0|||
156976753|NCT02254408|566669201|FG000|Overall Study|Death|2|||
156976754|NCT02254408|566669202|FG001|Overall Study|Death|3|||
156976755|NCT02254408|566669201|FG000|Overall Study|Investigator's Discretion|0|||
156976756|NCT02254408|566669202|FG001|Overall Study|Investigator's Discretion|1|||
156976757|NCT02254408|566669201|FG000|Overall Study|Withdrawal by Subject|3|||
156976758|NCT02254408|566669202|FG001|Overall Study|Withdrawal by Subject|3|||
156976759|NCT02254408|566669201|FG000|Overall Study|Lost to Follow-up|1|||
156976760|NCT02254408|566669202|FG001|Overall Study|Lost to Follow-up|0|||
156976761|NCT00917267|566669204|FG000|Overall Study|Adverse Event|15|||
156976762|NCT00917267|566669205|FG001|Overall Study|Adverse Event|36|||
156976763|NCT00917267|566669204|FG000|Overall Study|Physician Decision|2|||
156976764|NCT00917267|566669205|FG001|Overall Study|Physician Decision|4|||
156976765|NCT00917267|566669204|FG000|Overall Study|Protocol Violation|9|||
156976766|NCT00917267|566669205|FG001|Overall Study|Protocol Violation|18|||
156976767|NCT00917267|566669204|FG000|Overall Study|Withdrawal by Subject|5|||
156976768|NCT00917267|566669205|FG001|Overall Study|Withdrawal by Subject|12|||
156976769|NCT00917267|566669204|FG000|Overall Study|Lost to follow up|0|||
156976770|NCT00917267|566669205|FG001|Overall Study|Lost to follow up|2|||
156976771|NCT00917267|566669204|FG000|Overall Study|Entry Criteria Not Met|1|||
156976772|NCT00917267|566669205|FG001|Overall Study|Entry Criteria Not Met|0|||
156976773|NCT00917267|566669204|FG000|Overall Study|Sponsor Decision|5|||
156976774|NCT00917267|566669205|FG001|Overall Study|Sponsor Decision|5|||
156976775|NCT00917267|566669204|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
156976776|NCT00917267|566669205|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
156976777|NCT03097861|566669209|FG000|Overall Study|Adverse Event|3|||
156976778|NCT03097861|566669210|FG001|Overall Study|Adverse Event|8|||
156976779|NCT03097861|566669211|FG002|Overall Study|Adverse Event|4|||
156976780|NCT03097861|566669209|FG000|Overall Study|Investigator Decision|0|||
156976781|NCT03097861|566669210|FG001|Overall Study|Investigator Decision|1|||
156976782|NCT03097861|566669211|FG002|Overall Study|Investigator Decision|0|||
156976783|NCT03097861|566669209|FG000|Overall Study|Lost to Follow-up|0|||
156976784|NCT03097861|566669210|FG001|Overall Study|Lost to Follow-up|7|||
156976785|NCT03097861|566669211|FG002|Overall Study|Lost to Follow-up|1|||
156976786|NCT03097861|566669209|FG000|Overall Study|Withdrawal by Subject|1|||
156976787|NCT03097861|566669210|FG001|Overall Study|Withdrawal by Subject|5|||
156976788|NCT03097861|566669211|FG002|Overall Study|Withdrawal by Subject|3|||
156976789|NCT03097861|566669209|FG000|Overall Study|Reason not provided|3|||
156976790|NCT03097861|566669210|FG001|Overall Study|Reason not provided|1|||
156976791|NCT03097861|566669211|FG002|Overall Study|Reason not provided|1|||
156976792|NCT01785563|566669215|FG000|Overall Study|Physician Decision|10|||
156976793|NCT01785563|566669215|FG000|Overall Study|Withdrawal by Subject|1|||
157060614|NCT03449134|566977519|FG000|52-Week Treatment Period|Site Closure|1|||
157060615|NCT03449134|566977520|FG001|52-Week Treatment Period|Site Closure|0|||
157060616|NCT03449134|566977521|FG002|52-Week Treatment Period|Site Closure|0|||
157060617|NCT03475056|566977522|FG000|Overall Study|Lost to Follow-up|0|||
157060618|NCT03475056|566977523|FG001|Overall Study|Lost to Follow-up|1|||
157060619|NCT03475056|566977522|FG000|Overall Study|Moved from Area|0|||
157060620|NCT03475056|566977523|FG001|Overall Study|Moved from Area|2|||
157060621|NCT00113269|566977524|FG000|Overall Study|Not transplanted, donor issues|4|||
157060622|NCT00113269|566977525|FG001|Overall Study|Not transplanted, donor issues|0|||
157060623|NCT00113269|566977526|FG002|Overall Study|Not transplanted, donor issues|2|||
157060624|NCT00113269|566977527|FG003|Overall Study|Not transplanted, donor issues|2|||
157060625|NCT00113269|566977524|FG000|Overall Study|Not transplanted, recipient issues|2|||
157060626|NCT00113269|566977525|FG001|Overall Study|Not transplanted, recipient issues|1|||
157060627|NCT00113269|566977526|FG002|Overall Study|Not transplanted, recipient issues|7|||
157060628|NCT00113269|566977527|FG003|Overall Study|Not transplanted, recipient issues|4|||
157060629|NCT00113269|566977524|FG000|Overall Study|Early graft loss, technical|0|||
157060630|NCT00113269|566977525|FG001|Overall Study|Early graft loss, technical|0|||
157060631|NCT00113269|566977526|FG002|Overall Study|Early graft loss, technical|2|||
157060632|NCT00113269|566977527|FG003|Overall Study|Early graft loss, technical|0|||
157060633|NCT00113269|566977524|FG000|Overall Study|Death in operating room|0|||
157060634|NCT00113269|566977525|FG001|Overall Study|Death in operating room|0|||
157060635|NCT00113269|566977526|FG002|Overall Study|Death in operating room|0|||
157060636|NCT00113269|566977527|FG003|Overall Study|Death in operating room|1|||
157060637|NCT00113269|566977524|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
157060638|NCT00113269|566977525|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
157060639|NCT00113269|566977526|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
157060640|NCT00113269|566977527|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
157060641|NCT00113269|566977524|FG000|Overall Study|Adverse Event|2|||
157060642|NCT00113269|566977525|FG001|Overall Study|Adverse Event|7|||
157060643|NCT00113269|566977526|FG002|Overall Study|Adverse Event|11|||
157060644|NCT00113269|566977527|FG003|Overall Study|Adverse Event|7|||
157060645|NCT00113269|566977524|FG000|Overall Study|Withdrawal by Subject|4|||
157060646|NCT00113269|566977525|FG001|Overall Study|Withdrawal by Subject|3|||
157060647|NCT00113269|566977526|FG002|Overall Study|Withdrawal by Subject|4|||
157060648|NCT00113269|566977527|FG003|Overall Study|Withdrawal by Subject|2|||
157060649|NCT00113269|566977524|FG000|Overall Study|Graft loss|6|||
157060650|NCT00113269|566977525|FG001|Overall Study|Graft loss|6|||
157060651|NCT00113269|566977526|FG002|Overall Study|Graft loss|4|||
157060652|NCT00113269|566977527|FG003|Overall Study|Graft loss|9|||
157060653|NCT00113269|566977524|FG000|Overall Study|Protocol Violation|1|||
157060654|NCT00113269|566977525|FG001|Overall Study|Protocol Violation|0|||
157060655|NCT00113269|566977526|FG002|Overall Study|Protocol Violation|4|||
157060656|NCT00113269|566977527|FG003|Overall Study|Protocol Violation|2|||
157060657|NCT00113269|566977524|FG000|Overall Study|Lost to Follow-up|2|||
157060658|NCT00113269|566977525|FG001|Overall Study|Lost to Follow-up|3|||
157060659|NCT00113269|566977526|FG002|Overall Study|Lost to Follow-up|6|||
157060660|NCT00113269|566977527|FG003|Overall Study|Lost to Follow-up|3|||
157060661|NCT00113269|566977524|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
157060662|NCT00113269|566977525|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
157060663|NCT00113269|566977526|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
157060664|NCT00113269|566977527|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
157060665|NCT00113269|566977524|FG000|Overall Study|Discontinued due to rejection|0|||
157060666|NCT00113269|566977525|FG001|Overall Study|Discontinued due to rejection|0|||
157060667|NCT00113269|566977526|FG002|Overall Study|Discontinued due to rejection|1|||
157060668|NCT00113269|566977527|FG003|Overall Study|Discontinued due to rejection|0|||
157060669|NCT00113269|566977524|FG000|Overall Study|Moved|0|||
157060670|NCT00113269|566977525|FG001|Overall Study|Moved|1|||
157060671|NCT00113269|566977526|FG002|Overall Study|Moved|0|||
157060672|NCT00113269|566977527|FG003|Overall Study|Moved|3|||
157229967|NCT06176768|567588214|FG001|Overall Study|Other|0|||
157229968|NCT06176768|567588213|FG000|Overall Study|Withdrawal by Subject|6|||
157060673|NCT00113269|566977524|FG000|Overall Study|Received pancreas transplant|0|||
157060674|NCT00113269|566977525|FG001|Overall Study|Received pancreas transplant|0|||
157060675|NCT00113269|566977526|FG002|Overall Study|Received pancreas transplant|0|||
157060676|NCT00113269|566977527|FG003|Overall Study|Received pancreas transplant|2|||
157060677|NCT00113269|566977524|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
157060678|NCT00113269|566977525|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
157060679|NCT00113269|566977526|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
157060680|NCT00113269|566977527|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
157060681|NCT00113269|566977524|FG000|Overall Study|Did not meet eligibility criteria|1|||
157060682|NCT00113269|566977525|FG001|Overall Study|Did not meet eligibility criteria|0|||
157060683|NCT00113269|566977526|FG002|Overall Study|Did not meet eligibility criteria|0|||
157060684|NCT00113269|566977527|FG003|Overall Study|Did not meet eligibility criteria|1|||
157060685|NCT00113269|566977524|FG000|Overall Study|Unable to return for follow up|2|||
157060686|NCT00113269|566977525|FG001|Overall Study|Unable to return for follow up|1|||
157060687|NCT00113269|566977526|FG002|Overall Study|Unable to return for follow up|0|||
157060688|NCT00113269|566977527|FG003|Overall Study|Unable to return for follow up|0|||
157060689|NCT01960348|566977534|FG000|Overall Study|Adverse event, not serious|2|||
157060690|NCT01960348|566977535|FG001|Overall Study|Adverse event, not serious|2|||
157060691|NCT01960348|566977534|FG000|Overall Study|Adverse event, serious fatal|6|||
157060692|NCT01960348|566977535|FG001|Overall Study|Adverse event, serious fatal|5|||
157060693|NCT01960348|566977534|FG000|Overall Study|Adverse event, serious non-fatal|0|||
157060694|NCT01960348|566977535|FG001|Overall Study|Adverse event, serious non-fatal|3|||
157060695|NCT01960348|566977534|FG000|Overall Study|Withdrawal by Subject|1|||
157060696|NCT01960348|566977535|FG001|Overall Study|Withdrawal by Subject|11|||
157060697|NCT01960348|566977534|FG000|Overall Study|Physician Decision|0|||
157060698|NCT01960348|566977535|FG001|Overall Study|Physician Decision|1|||
157060699|NCT01960348|566977534|FG000|Overall Study|Protocol Violation|1|||
157060700|NCT01960348|566977535|FG001|Overall Study|Protocol Violation|0|||
157060701|NCT01580995|566977536|FG000|Overall Study|Lost to Follow-up|2|||
157060702|NCT01580995|566977537|FG001|Overall Study|Lost to Follow-up|2|||
157060703|NCT01821729|566977538|FG000|Overall Study|Withdrawal by Subject|1|||
157060704|NCT02517528|566977539|FG000|Overall Study|Withdrawal by Subject|1|||
157060705|NCT02916706|566977542|FG000|Overall Study|Adverse Event|0|||
157060706|NCT02916706|566977543|FG001|Overall Study|Adverse Event|1|||
157060707|NCT02916706|566977542|FG000|Overall Study|Lost to Follow-up|0|||
157060708|NCT02916706|566977543|FG001|Overall Study|Lost to Follow-up|1|||
157060709|NCT02916706|566977542|FG000|Overall Study|Physician Decision|1|||
157060710|NCT02916706|566977543|FG001|Overall Study|Physician Decision|0|||
157060711|NCT02916706|566977542|FG000|Overall Study|Protocol Violation|3|||
157060712|NCT02916706|566977543|FG001|Overall Study|Protocol Violation|1|||
157060713|NCT02916706|566977542|FG000|Overall Study|Withdrawal by Subject|6|||
157060714|NCT02916706|566977543|FG001|Overall Study|Withdrawal by Subject|9|||
157060715|NCT02916706|566977542|FG000|Overall Study|Other|5|||
157060716|NCT02916706|566977543|FG001|Overall Study|Other|19|||
157060717|NCT01093599|566977545|FG000|Overall Study|Lost to Follow-up|32|||
157060718|NCT01093599|566977546|FG001|Overall Study|Lost to Follow-up|46|||
157060719|NCT01703845|566977547|FG000|Overall Study|Adverse Event|1|||
157060720|NCT01703845|566977548|FG001|Overall Study|Adverse Event|0|||
157060721|NCT01703845|566977547|FG000|Overall Study|Protocol Violation|1|||
157060722|NCT01703845|566977548|FG001|Overall Study|Protocol Violation|0|||
157060723|NCT01703845|566977547|FG000|Overall Study|other than stated above|1|||
157060724|NCT01703845|566977548|FG001|Overall Study|other than stated above|0|||
157060725|NCT01644188|566977549|FG000|Overall Study|Adverse Event|44|||
157060726|NCT01644188|566977550|FG001|Overall Study|Adverse Event|20|||
157060727|NCT01644188|566977549|FG000|Overall Study|Poor compliance to protocol|26|||
157060728|NCT01644188|566977550|FG001|Overall Study|Poor compliance to protocol|14|||
157060729|NCT01644188|566977549|FG000|Overall Study|Physician Decision|1|||
157060730|NCT01644188|566977550|FG001|Overall Study|Physician Decision|3|||
157060731|NCT01644188|566977549|FG000|Overall Study|Participant moved|7|||
157060732|NCT01644188|566977550|FG001|Overall Study|Participant moved|2|||
157060733|NCT01644188|566977549|FG000|Overall Study|Related to auto-injector administration|2|||
157060734|NCT01644188|566977550|FG001|Overall Study|Related to auto-injector administration|2|||
157060735|NCT01644188|566977549|FG000|Overall Study|Consent withdrawn by participant|14|||
157060736|NCT01644188|566977550|FG001|Overall Study|Consent withdrawn by participant|7|||
157060737|NCT01644188|566977549|FG000|Overall Study|Selection criteria finally not met|2|||
157060738|NCT01644188|566977550|FG001|Overall Study|Selection criteria finally not met|0|||
157060739|NCT01644188|566977549|FG000|Overall Study|Lost to Follow-up|1|||
157060740|NCT01644188|566977550|FG001|Overall Study|Lost to Follow-up|0|||
157060741|NCT01644188|566977549|FG000|Overall Study|Death|4|||
157060742|NCT01644188|566977550|FG001|Overall Study|Death|3|||
157060743|NCT01644188|566977549|FG000|Overall Study|Last visit outside protocol visit window|14|||
157060744|NCT01644188|566977550|FG001|Overall Study|Last visit outside protocol visit window|16|||
157060745|NCT01644188|566977549|FG000|Overall Study|Site closure|1|||
157060746|NCT01644188|566977550|FG001|Overall Study|Site closure|1|||
157060747|NCT01644188|566977549|FG000|Overall Study|Other than specified above|6|||
157060748|NCT01644188|566977550|FG001|Overall Study|Other than specified above|7|||
157060749|NCT01845649|566977556|FG000|Overall Study|Adverse Event|7|||
157060750|NCT01845649|566977557|FG001|Overall Study|Adverse Event|10|||
157060751|NCT01845649|566977556|FG000|Overall Study|Lack of Efficacy|1|||
157060752|NCT01845649|566977557|FG001|Overall Study|Lack of Efficacy|1|||
157060753|NCT01845649|566977556|FG000|Overall Study|Lost to Follow-up|2|||
157060754|NCT01845649|566977557|FG001|Overall Study|Lost to Follow-up|2|||
157060755|NCT01845649|566977556|FG000|Overall Study|Withdrew Consent|12|||
157060756|NCT01845649|566977557|FG001|Overall Study|Withdrew Consent|4|||
157229969|NCT06176768|567588214|FG001|Overall Study|Withdrawal by Subject|9|||
157060757|NCT01845649|566977556|FG000|Overall Study|Protocol Deviation|7|||
157060758|NCT01845649|566977557|FG001|Overall Study|Protocol Deviation|4|||
157060759|NCT01845649|566977556|FG000|Overall Study|Reason not Specified|2|||
157060760|NCT01845649|566977557|FG001|Overall Study|Reason not Specified|1|||
157060761|NCT00719212|566977560|FG000|Overall Study|Death|41|||
157229970|NCT01226797|567588215|FG000|Overall Study|Adverse Event|1|||
157060762|NCT00719212|566977560|FG000|Overall Study|Lost to Follow-up|2|||
157060763|NCT00719212|566977560|FG000|Overall Study|Withdrawal by Subject|1|||
157060764|NCT00526097|566977564|FG000|Overall Study|Adverse Event|6|||
157060765|NCT00526097|566977565|FG001|Overall Study|Adverse Event|44|||
157060766|NCT00526097|566977564|FG000|Overall Study|Protocol Violation|4|||
157060767|NCT00526097|566977565|FG001|Overall Study|Protocol Violation|10|||
157060768|NCT00526097|566977564|FG000|Overall Study|Withdrawal by Subject|3|||
157060769|NCT00526097|566977565|FG001|Overall Study|Withdrawal by Subject|1|||
157060770|NCT00526097|566977564|FG000|Overall Study|Other|2|||
157060771|NCT00526097|566977565|FG001|Overall Study|Other|1|||
157060772|NCT04140266|566977566|FG000|Overall Study|Physician Decision|2|||
157060773|NCT04140266|566977567|FG001|Overall Study|Physician Decision|0|||
157060774|NCT04140266|566977566|FG000|Overall Study|Withdrawal by Subject|4|||
157060775|NCT04140266|566977567|FG001|Overall Study|Withdrawal by Subject|2|||
157060776|NCT00943618|566977568|FG000|Overall Study|Lost to Follow-up|38|||
157060777|NCT00943618|566977569|FG001|Overall Study|Lost to Follow-up|48|||
157060778|NCT00943618|566977570|FG002|Overall Study|Lost to Follow-up|20|||
157060779|NCT00943618|566977568|FG000|Overall Study|Discontinued Medication|17|||
157060780|NCT00943618|566977569|FG001|Overall Study|Discontinued Medication|29|||
157060781|NCT00943618|566977570|FG002|Overall Study|Discontinued Medication|11|||
157060782|NCT01990313|566977576|FG000|Overall Study|Lost to Follow-up|1|||
157060783|NCT02412111|566977577|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
157060784|NCT02412111|566977578|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
157060785|NCT02412111|566977579|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
157060786|NCT02412111|566977577|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
157060787|NCT02412111|566977578|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
157060788|NCT02412111|566977579|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
157060789|NCT02412111|566977577|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
157060790|NCT02412111|566977578|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
157060791|NCT02412111|566977579|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
157060792|NCT02412111|566977577|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
157060793|NCT02412111|566977578|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
157060794|NCT02412111|566977579|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
157060795|NCT02412111|566977577|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
157060796|NCT02412111|566977578|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
157060797|NCT02412111|566977579|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
157060798|NCT02412111|566977577|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
157060799|NCT02412111|566977578|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
157060800|NCT02412111|566977579|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
157060801|NCT02412111|566977577|FG000|Active Comparator Period (8 Weeks)|Other|0|||
157060802|NCT02412111|566977578|FG001|Active Comparator Period (8 Weeks)|Other|0|||
157060803|NCT02412111|566977579|FG002|Active Comparator Period (8 Weeks)|Other|2|||
157060804|NCT00721214|566977580|FG000|Overall Study|Chose another center for transplant|1|||
157060805|NCT00721214|566977580|FG000|Overall Study|Death|3|||
157060806|NCT01169636|566977581|FG000|Overall Study|Adverse Event|0|||
157060807|NCT01169636|566977582|FG001|Overall Study|Adverse Event|0|||
157060808|NCT01169636|566977583|FG002|Overall Study|Adverse Event|1|||
157060809|NCT01169636|566977584|FG003|Overall Study|Adverse Event|1|||
157060810|NCT01169636|566977585|FG004|Overall Study|Adverse Event|0|||
157060811|NCT01169636|566977581|FG000|Overall Study|Screen failure|0|||
157060812|NCT01169636|566977582|FG001|Overall Study|Screen failure|0|||
157060813|NCT01169636|566977583|FG002|Overall Study|Screen failure|2|||
157060814|NCT01169636|566977584|FG003|Overall Study|Screen failure|0|||
157060815|NCT01169636|566977585|FG004|Overall Study|Screen failure|0|||
157060816|NCT01169636|566977581|FG000|Overall Study|Withdrawal by Subject|0|||
157060817|NCT01169636|566977582|FG001|Overall Study|Withdrawal by Subject|0|||
157060818|NCT01169636|566977583|FG002|Overall Study|Withdrawal by Subject|0|||
157060819|NCT01169636|566977584|FG003|Overall Study|Withdrawal by Subject|0|||
157060820|NCT01169636|566977585|FG004|Overall Study|Withdrawal by Subject|3|||
157060821|NCT02396953|566977586|FG000|Overall Study|Withdrawal by Subject|0|||
157060822|NCT02396953|566977587|FG001|Overall Study|Withdrawal by Subject|0|||
157060823|NCT02396953|566977588|FG002|Overall Study|Withdrawal by Subject|1|||
157060824|NCT02396953|566977586|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
157060825|NCT02396953|566977587|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
157060826|NCT02396953|566977588|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
157060827|NCT02396953|566977586|FG000|Overall Study|Personal Reasons|1|||
157060828|NCT02396953|566977587|FG001|Overall Study|Personal Reasons|1|||
157060829|NCT02396953|566977588|FG002|Overall Study|Personal Reasons|0|||
157060830|NCT02994784|566977589|FG000|6 Months Follow-up|Lost to Follow-up|3|||
157060831|NCT02466243|566977590|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
157060832|NCT02466243|566977591|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
157060833|NCT02466243|566977590|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
157060834|NCT02466243|566977591|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
157060835|NCT02466243|566977590|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
157060836|NCT02466243|566977591|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
157060837|NCT02466243|566977590|FG000|Part B Open-label Treatment Period|Missing|2|||
157060838|NCT02466243|566977591|FG001|Part B Open-label Treatment Period|Missing|2|||
157060839|NCT01011049|566977592|FG000|Overall Study|Protocol Violation|0|||
157060840|NCT01011049|566977593|FG001|Overall Study|Protocol Violation|0|||
157060841|NCT01011049|566977594|FG002|Overall Study|Protocol Violation|2|||
157060842|NCT01011049|566977595|FG003|Overall Study|Protocol Violation|0|||
157060843|NCT01011049|566977592|FG000|Overall Study|Lost to Follow-up|1|||
157060844|NCT01011049|566977593|FG001|Overall Study|Lost to Follow-up|2|||
157060845|NCT01011049|566977594|FG002|Overall Study|Lost to Follow-up|1|||
157060846|NCT01011049|566977595|FG003|Overall Study|Lost to Follow-up|0|||
157060847|NCT01011049|566977592|FG000|Overall Study|Withdrawal by Subject|0|||
157060848|NCT01011049|566977593|FG001|Overall Study|Withdrawal by Subject|0|||
157060849|NCT01011049|566977594|FG002|Overall Study|Withdrawal by Subject|1|||
157060850|NCT01011049|566977595|FG003|Overall Study|Withdrawal by Subject|0|||
157060851|NCT02435381|566977596|FG000|Overall Study|Lost to Follow-up|2|||
157060852|NCT02435381|566977597|FG001|Overall Study|Lost to Follow-up|1|||
157060853|NCT04150341|566977598|FG000|Overall Study|Physician Decision|0|||
157060854|NCT04150341|566977599|FG001|Overall Study|Physician Decision|0|||
157060855|NCT04150341|566977600|FG002|Overall Study|Physician Decision|1|||
157060856|NCT04150341|566977601|FG003|Overall Study|Physician Decision|0|||
157060857|NCT04150341|566977602|FG004|Overall Study|Physician Decision|0|||
157060858|NCT04150341|566977603|FG005|Overall Study|Physician Decision|0|||
157060859|NCT04150341|566977598|FG000|Overall Study|Adverse Event|0|||
157060860|NCT04150341|566977599|FG001|Overall Study|Adverse Event|0|||
157060861|NCT04150341|566977600|FG002|Overall Study|Adverse Event|0|||
157060862|NCT04150341|566977601|FG003|Overall Study|Adverse Event|0|||
157060863|NCT04150341|566977602|FG004|Overall Study|Adverse Event|1|||
157060864|NCT04150341|566977603|FG005|Overall Study|Adverse Event|0|||
157060865|NCT00875615|566977604|FG000|Overall Study|Withdrawal by Subject|1|||
157060866|NCT00405912|566977606|FG000|Overall Study|Withdrawal by Subject|12|||
157060867|NCT00405912|566977607|FG001|Overall Study|Withdrawal by Subject|11|||
157060868|NCT00405912|566977608|FG002|Overall Study|Withdrawal by Subject|12|||
157060869|NCT00405912|566977606|FG000|Overall Study|Lost to Follow-up|4|||
157060870|NCT00405912|566977607|FG001|Overall Study|Lost to Follow-up|8|||
157060871|NCT00405912|566977608|FG002|Overall Study|Lost to Follow-up|4|||
157060872|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
157060873|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
157060874|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
157060875|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
157060876|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
157060877|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
157060878|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
157060879|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
157060880|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Death|6|||
157060881|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Death|2|||
157060882|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Death|2|||
157060883|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Death|9|||
157060884|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
157060885|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
157060886|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
157060887|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
157060888|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
157060889|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
157060890|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
157060891|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
157060892|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
157060893|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
157060894|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
157060895|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
157060896|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
157060897|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
157060898|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
157060899|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
157060900|NCT03730662|566977609|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
157060901|NCT03730662|566977610|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
157060902|NCT03730662|566977611|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
157060903|NCT03730662|566977612|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
157060904|NCT03730662|566977609|FG000|Variable Treatment Period|Adverse Event|1|||
157060905|NCT03730662|566977610|FG001|Variable Treatment Period|Adverse Event|2|||
157060906|NCT03730662|566977611|FG002|Variable Treatment Period|Adverse Event|0|||
157060907|NCT03730662|566977612|FG003|Variable Treatment Period|Adverse Event|7|||
157060908|NCT03730662|566977609|FG000|Variable Treatment Period|Death|9|||
157060909|NCT03730662|566977610|FG001|Variable Treatment Period|Death|0|||
157060910|NCT03730662|566977611|FG002|Variable Treatment Period|Death|6|||
157060911|NCT03730662|566977612|FG003|Variable Treatment Period|Death|26|||
157060912|NCT03730662|566977609|FG000|Variable Treatment Period|Lost to Follow-up|2|||
157060913|NCT03730662|566977610|FG001|Variable Treatment Period|Lost to Follow-up|1|||
157060914|NCT03730662|566977611|FG002|Variable Treatment Period|Lost to Follow-up|4|||
157060915|NCT03730662|566977612|FG003|Variable Treatment Period|Lost to Follow-up|11|||
157060916|NCT03730662|566977609|FG000|Variable Treatment Period|Personal Reason|0|||
157060917|NCT03730662|566977610|FG001|Variable Treatment Period|Personal Reason|2|||
157060918|NCT03730662|566977611|FG002|Variable Treatment Period|Personal Reason|1|||
157060919|NCT03730662|566977612|FG003|Variable Treatment Period|Personal Reason|6|||
157060920|NCT03730662|566977609|FG000|Variable Treatment Period|Physician Decision|0|||
157060921|NCT03730662|566977610|FG001|Variable Treatment Period|Physician Decision|0|||
157060922|NCT03730662|566977611|FG002|Variable Treatment Period|Physician Decision|0|||
157060923|NCT03730662|566977612|FG003|Variable Treatment Period|Physician Decision|3|||
157060924|NCT03730662|566977609|FG000|Variable Treatment Period|Protocol Violation|0|||
157060925|NCT03730662|566977610|FG001|Variable Treatment Period|Protocol Violation|1|||
157060926|NCT03730662|566977611|FG002|Variable Treatment Period|Protocol Violation|1|||
157060927|NCT03730662|566977612|FG003|Variable Treatment Period|Protocol Violation|1|||
157060928|NCT03730662|566977609|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
157060929|NCT03730662|566977610|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
157060930|NCT03730662|566977611|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
157060931|NCT03730662|566977612|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
157060932|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
157060933|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
157060934|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
157060935|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
157060936|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Death|0|||
157060937|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Death|1|||
157060938|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
157060939|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
157060940|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
157060941|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
157060942|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
157060943|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
157060944|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
157060945|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
157060946|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
157060947|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
157060948|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
157060949|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
157060950|NCT01309243|566977613|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
157060951|NCT01309243|566977614|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
157060952|NCT01309243|566977613|FG000|Extension Phase|Lost to Follow-up|6|||
157060953|NCT01309243|566977614|FG001|Extension Phase|Lost to Follow-up|0|||
157060954|NCT01402063|566977617|FG000|Overall Study|Withdrawal by Subject|3|||
157060955|NCT01402063|566977618|FG001|Overall Study|Withdrawal by Subject|3|||
157060956|NCT03712449|566977623|FG000|Overall Study|Withdraw Consent|0|||
157060957|NCT03712449|566977624|FG001|Overall Study|Withdraw Consent|1|||
157060958|NCT00666198|566977625|FG000|Overall Study|Protocol Violation|10|||
157060959|NCT00666198|566977625|FG000|Overall Study|No Visit After First Day of Treatment|13|||
157060960|NCT00666198|566977625|FG000|Overall Study|Safety Not Assessable|6|||
157060961|NCT00666198|566977625|FG000|Overall Study|No Drug Administration|4|||
157060962|NCT05153499|566977626|FG000|Overall Study|Withdrawal by Subject|1|||
157060963|NCT05153499|566977627|FG001|Overall Study|Withdrawal by Subject|0|||
157060964|NCT05153499|566977626|FG000|Overall Study|Clinical Hold|1|||
157060965|NCT05153499|566977627|FG001|Overall Study|Clinical Hold|0|||
157060966|NCT05153499|566977626|FG000|Overall Study|Study Termination|6|||
157060967|NCT05153499|566977627|FG001|Overall Study|Study Termination|5|||
157060968|NCT05109117|566977628|FG000|Overall Study|Lost to Follow-up|1|||
157060969|NCT05109117|566977628|FG000|Overall Study|Discontinued for non-compliance|1|||
157060970|NCT03220776|566977629|FG000|Overall Study|Claustrophobia|0|||
157060971|NCT03220776|566977630|FG001|Overall Study|Claustrophobia|1|||
157060972|NCT03220776|566977631|FG002|Overall Study|Claustrophobia|1|||
157060973|NCT03220776|566977632|FG003|Overall Study|Claustrophobia|0|||
157229971|NCT01226797|567588216|FG001|Overall Study|Adverse Event|0|||
157060974|NCT03220776|566977633|FG004|Overall Study|Claustrophobia|1|||
157229972|NCT01226797|567588215|FG000|Overall Study|No longer willing to participate|1|||
157060975|NCT03220776|566977634|FG005|Overall Study|Claustrophobia|0|||
157060976|NCT03220776|566977629|FG000|Overall Study|MRI Equipment Failure|1|||
157060977|NCT03220776|566977630|FG001|Overall Study|MRI Equipment Failure|0|||
157060978|NCT03220776|566977631|FG002|Overall Study|MRI Equipment Failure|0|||
157060979|NCT03220776|566977632|FG003|Overall Study|MRI Equipment Failure|0|||
157229973|NCT01226797|567588216|FG001|Overall Study|No longer willing to participate|0|||
157060980|NCT03220776|566977633|FG004|Overall Study|MRI Equipment Failure|0|||
157060981|NCT03220776|566977634|FG005|Overall Study|MRI Equipment Failure|0|||
157060982|NCT03220776|566977629|FG000|Overall Study|Inclimate Weather|0|||
157060983|NCT03220776|566977630|FG001|Overall Study|Inclimate Weather|0|||
157060984|NCT03220776|566977631|FG002|Overall Study|Inclimate Weather|0|||
157060985|NCT03220776|566977632|FG003|Overall Study|Inclimate Weather|0|||
157060986|NCT03220776|566977633|FG004|Overall Study|Inclimate Weather|0|||
157060987|NCT03220776|566977634|FG005|Overall Study|Inclimate Weather|1|||
157060988|NCT03220776|566977629|FG000|Overall Study|Physician Decision|0|||
157060989|NCT03220776|566977630|FG001|Overall Study|Physician Decision|0|||
157060990|NCT03220776|566977631|FG002|Overall Study|Physician Decision|0|||
157060991|NCT03220776|566977632|FG003|Overall Study|Physician Decision|1|||
157060992|NCT03220776|566977633|FG004|Overall Study|Physician Decision|0|||
157060993|NCT03220776|566977634|FG005|Overall Study|Physician Decision|0|||
157060994|NCT03220776|566977629|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
157060995|NCT03220776|566977630|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
157060996|NCT03220776|566977631|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
157060997|NCT03220776|566977632|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
157060998|NCT03220776|566977633|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
157060999|NCT03220776|566977634|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
157061000|NCT03220776|566977629|FG000|Overall Study|Protocol Violation|0|||
157061001|NCT03220776|566977630|FG001|Overall Study|Protocol Violation|0|||
157061002|NCT03220776|566977631|FG002|Overall Study|Protocol Violation|0|||
157061003|NCT03220776|566977632|FG003|Overall Study|Protocol Violation|2|||
157061004|NCT03220776|566977633|FG004|Overall Study|Protocol Violation|0|||
157061005|NCT03220776|566977634|FG005|Overall Study|Protocol Violation|1|||
157061006|NCT03220776|566977629|FG000|Overall Study|Withdrawal by Subject|1|||
157061007|NCT03220776|566977630|FG001|Overall Study|Withdrawal by Subject|0|||
157061008|NCT03220776|566977631|FG002|Overall Study|Withdrawal by Subject|0|||
157061009|NCT03220776|566977632|FG003|Overall Study|Withdrawal by Subject|0|||
157061010|NCT03220776|566977633|FG004|Overall Study|Withdrawal by Subject|0|||
157061011|NCT03220776|566977634|FG005|Overall Study|Withdrawal by Subject|0|||
157061012|NCT03029234|566977638|FG000|Overall Study|Sponsor Decision|1|||
157061013|NCT03029234|566977638|FG000|Overall Study|Withdrawal by Subject|5|||
157061014|NCT03029234|566977638|FG000|Overall Study|Death|91|||
157061015|NCT03029234|566977638|FG000|Overall Study|Lost to Follow-up|2|||
157061016|NCT04491006|566977639|FG000|Overall Study|Adverse Event|0|||
157061017|NCT04491006|566977640|FG001|Overall Study|Adverse Event|3|||
157061018|NCT04491006|566977641|FG002|Overall Study|Adverse Event|5|||
157061019|NCT04491006|566977639|FG000|Overall Study|Withdrawal by Subject|1|||
157061020|NCT04491006|566977640|FG001|Overall Study|Withdrawal by Subject|0|||
157061021|NCT04491006|566977641|FG002|Overall Study|Withdrawal by Subject|2|||
157061022|NCT02166047|566977642|FG000|Overall Study|Withdrawal by Participant|0|||
157061023|NCT02166047|566977643|FG001|Overall Study|Withdrawal by Participant|1|||
157061024|NCT02166047|566977644|FG002|Overall Study|Withdrawal by Participant|2|||
157061025|NCT02166047|566977645|FG003|Overall Study|Withdrawal by Participant|0|||
157061026|NCT02166047|566977646|FG004|Overall Study|Withdrawal by Participant|0|||
157061027|NCT02166047|566977647|FG005|Overall Study|Withdrawal by Participant|0|||
157061028|NCT02166047|566977648|FG006|Overall Study|Withdrawal by Participant|1|||
157061029|NCT02166047|566977649|FG007|Overall Study|Withdrawal by Participant|0|||
157061030|NCT02166047|566977650|FG008|Overall Study|Withdrawal by Participant|0|||
157061031|NCT02166047|566977651|FG009|Overall Study|Withdrawal by Participant|0|||
157061032|NCT02166047|566977652|FG010|Overall Study|Withdrawal by Participant|0|||
157061033|NCT02166047|566977653|FG011|Overall Study|Withdrawal by Participant|0|||
157061034|NCT02166047|566977642|FG000|Overall Study|Adverse Event|0|||
157061035|NCT02166047|566977643|FG001|Overall Study|Adverse Event|0|||
157061036|NCT02166047|566977644|FG002|Overall Study|Adverse Event|0|||
157061037|NCT02166047|566977645|FG003|Overall Study|Adverse Event|0|||
157061038|NCT02166047|566977646|FG004|Overall Study|Adverse Event|1|||
157061039|NCT02166047|566977647|FG005|Overall Study|Adverse Event|0|||
157061040|NCT02166047|566977648|FG006|Overall Study|Adverse Event|1|||
157061041|NCT02166047|566977649|FG007|Overall Study|Adverse Event|0|||
157061042|NCT02166047|566977650|FG008|Overall Study|Adverse Event|0|||
157061043|NCT02166047|566977651|FG009|Overall Study|Adverse Event|0|||
157061044|NCT02166047|566977652|FG010|Overall Study|Adverse Event|2|||
157061045|NCT02166047|566977653|FG011|Overall Study|Adverse Event|0|||
157061046|NCT00451555|566977659|FG000|Overall Study|Protocol Violation|2|||
157061047|NCT00451555|566977660|FG001|Overall Study|Protocol Violation|2|||
157061048|NCT00451555|566977659|FG000|Overall Study|Adverse Event|3|||
157061049|NCT00451555|566977660|FG001|Overall Study|Adverse Event|1|||
157061050|NCT00451555|566977659|FG000|Overall Study|Withdrawal by Subject|6|||
157061051|NCT00451555|566977660|FG001|Overall Study|Withdrawal by Subject|0|||
157061052|NCT00451555|566977659|FG000|Overall Study|Physician Decision|2|||
157061053|NCT00451555|566977660|FG001|Overall Study|Physician Decision|1|||
157061054|NCT00797511|566977669|FG000|Overall Study|Withdrawal by Subject|1|||
157061055|NCT02630706|566977673|FG000|Overall Study|Adverse Event|2|||
157061056|NCT02630706|566977674|FG001|Overall Study|Adverse Event|1|||
157061057|NCT02630706|566977675|FG002|Overall Study|Adverse Event|1|||
157061058|NCT02630706|566977673|FG000|Overall Study|Lost to Follow-up|0|||
157061059|NCT02630706|566977674|FG001|Overall Study|Lost to Follow-up|1|||
157061060|NCT02630706|566977675|FG002|Overall Study|Lost to Follow-up|2|||
157061061|NCT02630706|566977673|FG000|Overall Study|Physician Decision|1|||
157061062|NCT02630706|566977674|FG001|Overall Study|Physician Decision|1|||
157061063|NCT02630706|566977675|FG002|Overall Study|Physician Decision|0|||
157061064|NCT02630706|566977673|FG000|Overall Study|Pregnancy|0|||
157061065|NCT02630706|566977674|FG001|Overall Study|Pregnancy|1|||
157061066|NCT02630706|566977675|FG002|Overall Study|Pregnancy|0|||
157061067|NCT02630706|566977673|FG000|Overall Study|Withdrawal by Subject|4|||
157061068|NCT02630706|566977674|FG001|Overall Study|Withdrawal by Subject|5|||
157061069|NCT02630706|566977675|FG002|Overall Study|Withdrawal by Subject|7|||
157061070|NCT01678898|566977676|FG000|PB-102-F01|Adverse Event|0|||
157061071|NCT01678898|566977677|FG001|PB-102-F01|Adverse Event|1|||
157061072|NCT01678898|566977678|FG002|PB-102-F01|Adverse Event|0|||
157061073|NCT01678898|566977676|FG000|PB-102-F01|Physician Decision|0|||
157061074|NCT01678898|566977677|FG001|PB-102-F01|Physician Decision|1|||
157061075|NCT01678898|566977678|FG002|PB-102-F01|Physician Decision|0|||
157061076|NCT00230971|566977679|FG000|Randomization|No study drug administered|3|||
157061077|NCT00230971|566977680|FG001|Randomization|No study drug administered|3|||
157061078|NCT00230971|566977679|FG000|Baseline Participants|Lost to Follow-up|5|||
157061079|NCT00230971|566977680|FG001|Baseline Participants|Lost to Follow-up|12|||
157061080|NCT00230971|566977679|FG000|Baseline Participants|Death|6|||
157061081|NCT00230971|566977680|FG001|Baseline Participants|Death|5|||
157061082|NCT00230971|566977679|FG000|Baseline Participants|Withdrawal by Subject|7|||
157061083|NCT00230971|566977680|FG001|Baseline Participants|Withdrawal by Subject|1|||
157061084|NCT00230971|566977679|FG000|Baseline Participants|Adverse Event|1|||
157061085|NCT00230971|566977680|FG001|Baseline Participants|Adverse Event|0|||
157061086|NCT00230971|566977679|FG000|Baseline Participants|No bacteria observed|1|||
157061087|NCT00230971|566977680|FG001|Baseline Participants|No bacteria observed|0|||
157061088|NCT00230971|566977679|FG000|Baseline Participants|Failure to return|1|||
157061089|NCT00230971|566977680|FG001|Baseline Participants|Failure to return|1|||
157061090|NCT00230971|566977679|FG000|Baseline Participants|Reintervention|1|||
157061091|NCT00230971|566977680|FG001|Baseline Participants|Reintervention|0|||
157061092|NCT03464383|566978985|FG000|Overall Study|Lost to Follow-up|1|||
157061093|NCT03464383|566978986|FG001|Overall Study|Lost to Follow-up|0|||
157061094|NCT03464383|566978987|FG002|Overall Study|Lost to Follow-up|0|||
157061095|NCT03464383|566978985|FG000|Overall Study|Withdrawal by Subject|0|||
157061096|NCT03464383|566978986|FG001|Overall Study|Withdrawal by Subject|1|||
157061097|NCT03464383|566978987|FG002|Overall Study|Withdrawal by Subject|0|||
157061098|NCT00560313|566978988|FG000|Overall Study|Adverse Events or Death|2|||
157061099|NCT00560313|566978988|FG000|Overall Study|Withdrawal by Subject|2|||
157061100|NCT00560313|566978988|FG000|Overall Study|Lost to Follow-up|1|||
157061101|NCT00560313|566978988|FG000|Overall Study|Protocol Violation|1|||
157061102|NCT00853372|566978995|FG000|Overall Study|Death|30|||
157061103|NCT00853372|566978996|FG001|Overall Study|Death|26|||
157061104|NCT00853372|566978995|FG000|Overall Study|Lost to Follow-up|1|||
157061105|NCT00853372|566978996|FG001|Overall Study|Lost to Follow-up|2|||
157061106|NCT00853372|566978995|FG000|Overall Study|Full Consent Withdrawn|1|||
157061107|NCT00853372|566978996|FG001|Overall Study|Full Consent Withdrawn|1|||
157061108|NCT01268098|566978999|FG000|Overall Study|Adverse Event|1|||
157061109|NCT01268098|566979000|FG001|Overall Study|Adverse Event|0|||
157061110|NCT02624869|566979004|FG000|Overall Study|Lost to Follow-up|0|||
157061111|NCT02624869|566979005|FG001|Overall Study|Lost to Follow-up|0|||
157061112|NCT02624869|566979006|FG002|Overall Study|Lost to Follow-up|1|||
157061113|NCT02624869|566979004|FG000|Overall Study|Withdrawal by Subject|1|||
157061114|NCT02624869|566979005|FG001|Overall Study|Withdrawal by Subject|3|||
157061115|NCT02624869|566979006|FG002|Overall Study|Withdrawal by Subject|1|||
157061116|NCT00510198|566979007|FG000|Overall Study|Withdrawal by Subject|5|||
157061117|NCT00510198|566979008|FG001|Overall Study|Withdrawal by Subject|4|||
157061118|NCT02895360|566979011|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
157061119|NCT02895360|566979012|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
157061120|NCT02895360|566979013|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
157061121|NCT02895360|566979014|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
157061122|NCT02895360|566979015|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
157061123|NCT02895360|566979016|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
157061124|NCT02895360|566979011|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
157061125|NCT02895360|566979012|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
157061126|NCT02895360|566979013|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
157061127|NCT02895360|566979014|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
157061128|NCT02895360|566979015|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
157061129|NCT02895360|566979016|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
157061130|NCT02895360|566979011|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
157061131|NCT02895360|566979012|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
157061132|NCT02895360|566979013|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
157061133|NCT02895360|566979014|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
157061134|NCT02895360|566979015|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
157061135|NCT02895360|566979016|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
157061136|NCT02895360|566979011|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
157061137|NCT02895360|566979012|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
157061138|NCT02895360|566979013|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
157061139|NCT02895360|566979014|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
157061140|NCT02895360|566979015|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
157061141|NCT02895360|566979016|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
157061142|NCT02895360|566979011|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
157061143|NCT02895360|566979012|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
157061144|NCT02895360|566979013|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
157061145|NCT02895360|566979014|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
157061146|NCT02895360|566979015|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
157061147|NCT02895360|566979016|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
157061148|NCT02895360|566979011|FG000|Phase 2a|Adverse Event|0|||
157061149|NCT02895360|566979012|FG001|Phase 2a|Adverse Event|0|||
157061150|NCT02895360|566979013|FG002|Phase 2a|Adverse Event|0|||
157061151|NCT02895360|566979014|FG003|Phase 2a|Adverse Event|0|||
157061152|NCT02895360|566979015|FG004|Phase 2a|Adverse Event|0|||
157061153|NCT02895360|566979016|FG005|Phase 2a|Adverse Event|1|||
157061154|NCT02895360|566979011|FG000|Phase 2a|Progressive disease|0|||
157061155|NCT02895360|566979012|FG001|Phase 2a|Progressive disease|0|||
157061156|NCT02895360|566979013|FG002|Phase 2a|Progressive disease|0|||
157061157|NCT02895360|566979014|FG003|Phase 2a|Progressive disease|0|||
157061158|NCT02895360|566979015|FG004|Phase 2a|Progressive disease|11|||
157061159|NCT02895360|566979016|FG005|Phase 2a|Progressive disease|11|||
157061160|NCT00307164|566979017|FG000|Overall Study|Death|1|||
157061161|NCT00307164|566979018|FG001|Overall Study|Death|0|||
157061162|NCT00307164|566979017|FG000|Overall Study|Severe debilitation, unable to continue|1|||
157061163|NCT00307164|566979018|FG001|Overall Study|Severe debilitation, unable to continue|0|||
157061164|NCT00307164|566979017|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
157061165|NCT00307164|566979018|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
157061166|NCT00307164|566979017|FG000|Overall Study|Withdrawal by Subject|1|||
157061167|NCT00307164|566979018|FG001|Overall Study|Withdrawal by Subject|8|||
157061168|NCT00307164|566979017|FG000|Overall Study|Not compliant with requirements|4|||
157061169|NCT00307164|566979018|FG001|Overall Study|Not compliant with requirements|4|||
157061170|NCT00307164|566979017|FG000|Overall Study|Lost to Follow-up|6|||
157061171|NCT00307164|566979018|FG001|Overall Study|Lost to Follow-up|1|||
157061172|NCT01004185|566979019|FG000|Overall Study|Adverse Event|1|||
157061173|NCT01004185|566979020|FG001|Overall Study|Adverse Event|1|||
157061174|NCT01004185|566979019|FG000|Overall Study|Lost to Follow-up|0|||
157061175|NCT01004185|566979020|FG001|Overall Study|Lost to Follow-up|1|||
157061176|NCT01004185|566979019|FG000|Overall Study|Lack of Efficacy|2|||
157061177|NCT01004185|566979020|FG001|Overall Study|Lack of Efficacy|1|||
157061178|NCT01004185|566979019|FG000|Overall Study|Sponsor Terminated Study|4|||
157061179|NCT01004185|566979020|FG001|Overall Study|Sponsor Terminated Study|5|||
157061180|NCT01004185|566979019|FG000|Overall Study|Withdrawal by Subject|2|||
157061181|NCT01004185|566979020|FG001|Overall Study|Withdrawal by Subject|1|||
157061182|NCT00053352|566979026|FG000|Overall Study|Lost to Follow-up|0|||
157061183|NCT00053352|566979027|FG001|Overall Study|Lost to Follow-up|1|||
157061184|NCT00053352|566979026|FG000|Overall Study|Physician Decision|11|||
157061185|NCT00053352|566979027|FG001|Overall Study|Physician Decision|1|||
157061186|NCT00053352|566979026|FG000|Overall Study|Withdrawal by Subject|1|||
157061187|NCT00053352|566979027|FG001|Overall Study|Withdrawal by Subject|0|||
157061188|NCT00053352|566979026|FG000|Overall Study|Ineligible|8|||
157061189|NCT00053352|566979027|FG001|Overall Study|Ineligible|8|||
157061190|NCT00053352|566979026|FG000|Overall Study|Disease at new site|1|||
157061191|NCT00053352|566979027|FG001|Overall Study|Disease at new site|0|||
157061192|NCT01037413|566979030|FG000|Part A: Skin Testing|Adverse Event|1|||
157061193|NCT01037413|566979031|FG001|Part A: Skin Testing|Adverse Event|0|||
157061194|NCT01037413|566979030|FG000|Part A: Skin Testing|Protocol Violation|1|||
157061195|NCT01037413|566979031|FG001|Part A: Skin Testing|Protocol Violation|0|||
157061196|NCT01037413|566979030|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
157061197|NCT01037413|566979031|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
157061198|NCT01037413|566979030|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
157061199|NCT01037413|566979031|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
157061200|NCT01990664|566979032|FG000|Overall Study|Lost to Follow-up|2|||
157061201|NCT01990664|566979033|FG001|Overall Study|Lost to Follow-up|6|||
157061202|NCT01990664|566979032|FG000|Overall Study|Withdrawal by Subject|2|||
157061203|NCT01990664|566979033|FG001|Overall Study|Withdrawal by Subject|3|||
157061204|NCT01990664|566979032|FG000|Overall Study|Protocol Violation|1|||
157061205|NCT01990664|566979033|FG001|Overall Study|Protocol Violation|0|||
157061206|NCT01990664|566979032|FG000|Overall Study|Lens Discomfort|1|||
157061207|NCT01990664|566979033|FG001|Overall Study|Lens Discomfort|1|||
157061208|NCT01990664|566979032|FG000|Overall Study|Lens Handling Difficulties|1|||
157061209|NCT01990664|566979033|FG001|Overall Study|Lens Handling Difficulties|0|||
157061210|NCT01990664|566979032|FG000|Overall Study|Unsatisfactory Visual Response|0|||
157061211|NCT01990664|566979033|FG001|Overall Study|Unsatisfactory Visual Response|1|||
157061212|NCT00619983|566979034|FG000|Test Drug Alone|Withdrawal by Subject|1|||
157061213|NCT00619983|566979035|FG001|Test Drug Alone|Withdrawal by Subject|0|||
157061214|NCT00619983|566979036|FG002|Test Drug Alone|Withdrawal by Subject|0|||
157061215|NCT00619983|566979037|FG003|Test Drug Alone|Withdrawal by Subject|1|||
157061216|NCT00619983|566979034|FG000|Test Drug Alone|Failure of daily diary device|1|||
157061217|NCT00619983|566979035|FG001|Test Drug Alone|Failure of daily diary device|1|||
157061218|NCT00619983|566979036|FG002|Test Drug Alone|Failure of daily diary device|2|||
157061219|NCT00619983|566979037|FG003|Test Drug Alone|Failure of daily diary device|2|||
157061220|NCT02560389|566979042|FG000|Overall Study|Lost to Follow-up|1|||
157061221|NCT02560389|566979043|FG001|Overall Study|Lost to Follow-up|2|||
157061222|NCT02560389|566979044|FG002|Overall Study|Lost to Follow-up|2|||
157061223|NCT02560389|566979042|FG000|Overall Study|Tested positive for illicit substance|0|||
157061224|NCT02560389|566979043|FG001|Overall Study|Tested positive for illicit substance|1|||
157061225|NCT02560389|566979044|FG002|Overall Study|Tested positive for illicit substance|0|||
157061226|NCT02716298|566979045|FG000|First Intervention (1 Month)|Lens discomfort|1|||
157061227|NCT02716298|566979046|FG001|First Intervention (1 Month)|Lens discomfort|1|||
157061228|NCT02212301|566979051|FG000|Period 1|Lost to Follow-up|0|||
157061229|NCT02212301|566979052|FG001|Period 1|Lost to Follow-up|1|||
157061230|NCT00866918|566979055|FG000|Overall Study|Death|1|||
157061231|NCT00866918|566979056|FG001|Overall Study|Death|5|||
157061232|NCT00866918|566979055|FG000|Overall Study|Lack of Efficacy|1|||
157061233|NCT00866918|566979056|FG001|Overall Study|Lack of Efficacy|1|||
157061234|NCT00866918|566979055|FG000|Overall Study|Physician Decision|10|||
157061235|NCT00866918|566979056|FG001|Overall Study|Physician Decision|2|||
157061236|NCT00866918|566979055|FG000|Overall Study|Ineligible|2|||
157061237|NCT00866918|566979056|FG001|Overall Study|Ineligible|4|||
157061238|NCT00866918|566979055|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
157061239|NCT00866918|566979056|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
157061240|NCT00866918|566979055|FG000|Overall Study|Secondary malignancy|1|||
157061241|NCT00866918|566979056|FG001|Overall Study|Secondary malignancy|0|||
157061242|NCT03041701|566979057|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
157061243|NCT03041701|566979058|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
157061244|NCT03041701|566979059|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
157061245|NCT03041701|566979057|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
157061246|NCT03041701|566979058|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
157061247|NCT03041701|566979059|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
157061248|NCT00527514|566979060|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
157061249|NCT00527514|566979060|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
157061250|NCT00527514|566979060|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
157061251|NCT00527514|566979060|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
157061252|NCT00527514|566979060|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
157061253|NCT00527514|566979060|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
157061254|NCT00527514|566979060|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
157061255|NCT00802438|566979072|FG000|Overall Study|Screen Failure|20|||
157061256|NCT00802438|566979072|FG000|Overall Study|Withdrawal by Subject|7|||
157061257|NCT00802438|566979072|FG000|Overall Study|Physician Decision|1|||
157061258|NCT04016805|566979074|FG000|Overall Study|Sponsor's Discretion|30|||
157061259|NCT04016805|566979075|FG001|Overall Study|Sponsor's Discretion|6|||
157061260|NCT04016805|566979076|FG002|Overall Study|Sponsor's Discretion|5|||
157061261|NCT00839332|566979078|FG000|Phase 1|Disease Progression|38|||
157061262|NCT00839332|566979079|FG001|Phase 1|Disease Progression|0|||
157061263|NCT00839332|566979080|FG002|Phase 1|Disease Progression|0|||
157061264|NCT00839332|566979078|FG000|Phase 1|Adverse Event|6|||
157061265|NCT00839332|566979079|FG001|Phase 1|Adverse Event|0|||
157061266|NCT00839332|566979080|FG002|Phase 1|Adverse Event|0|||
157061267|NCT00839332|566979078|FG000|Phase 1|Withdrawal by Subject|4|||
157061268|NCT00839332|566979079|FG001|Phase 1|Withdrawal by Subject|0|||
157061269|NCT00839332|566979080|FG002|Phase 1|Withdrawal by Subject|0|||
157061270|NCT00839332|566979078|FG000|Phase 1|Physician Decision|2|||
157061271|NCT00839332|566979079|FG001|Phase 1|Physician Decision|0|||
157061272|NCT00839332|566979080|FG002|Phase 1|Physician Decision|0|||
157061273|NCT00839332|566979078|FG000|Phase 2|Protocol Violation|0|||
157061274|NCT00839332|566979079|FG001|Phase 2|Protocol Violation|1|||
157061275|NCT00839332|566979080|FG002|Phase 2|Protocol Violation|0|||
157061276|NCT00839332|566979078|FG000|Phase 2|Disease Progression|0|||
157061277|NCT00839332|566979079|FG001|Phase 2|Disease Progression|46|||
157061278|NCT00839332|566979080|FG002|Phase 2|Disease Progression|21|||
157061279|NCT00839332|566979078|FG000|Phase 2|Adverse Event|0|||
157061280|NCT00839332|566979079|FG001|Phase 2|Adverse Event|8|||
157061281|NCT00839332|566979080|FG002|Phase 2|Adverse Event|6|||
157061282|NCT00839332|566979078|FG000|Phase 2|Death|0|||
157061283|NCT00839332|566979079|FG001|Phase 2|Death|4|||
157061284|NCT00839332|566979080|FG002|Phase 2|Death|2|||
157061285|NCT00839332|566979078|FG000|Phase 2|Withdrawal by Subject|0|||
157061286|NCT00839332|566979079|FG001|Phase 2|Withdrawal by Subject|5|||
157061287|NCT00839332|566979080|FG002|Phase 2|Withdrawal by Subject|8|||
157061288|NCT00839332|566979078|FG000|Phase 2|Physician Decision|0|||
157061289|NCT00839332|566979079|FG001|Phase 2|Physician Decision|4|||
157061290|NCT00839332|566979080|FG002|Phase 2|Physician Decision|1|||
157061291|NCT00839332|566979078|FG000|Phase 2|Lost to Follow-up|0|||
157061292|NCT00839332|566979079|FG001|Phase 2|Lost to Follow-up|0|||
157061293|NCT00839332|566979080|FG002|Phase 2|Lost to Follow-up|1|||
157061294|NCT01200485|566979081|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
157061295|NCT01200485|566979082|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
157061296|NCT01200485|566979083|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
157061297|NCT01200485|566979081|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
157061298|NCT01200485|566979082|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
157061299|NCT01200485|566979083|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
157061300|NCT04414397|566979090|FG000|Control Period|Withdrawal by Subject|2|||
157061301|NCT04414397|566979091|FG001|Control Period|Withdrawal by Subject|2|||
157061302|NCT04414397|566979090|FG000|Control Period|Lost to Follow-up|0|||
157061303|NCT04414397|566979091|FG001|Control Period|Lost to Follow-up|4|||
157061304|NCT04414397|566979090|FG000|Control Period|Protocol deviation|0|||
157061305|NCT04414397|566979091|FG001|Control Period|Protocol deviation|1|||
157061306|NCT04414397|566979090|FG000|Post-Control Period|Withdrawal by Subject|3|||
157061307|NCT04414397|566979091|FG001|Post-Control Period|Withdrawal by Subject|6|||
157061308|NCT04414397|566979090|FG000|Post-Control Period|Lost to Follow-up|4|||
157061309|NCT04414397|566979091|FG001|Post-Control Period|Lost to Follow-up|9|||
157061310|NCT04414397|566979090|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
157061311|NCT04414397|566979091|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
157061312|NCT04414397|566979090|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
157061313|NCT04414397|566979091|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
157061314|NCT02515097|566979097|FG000|Overall Study|Lost to Follow-up|4|||
157061315|NCT02515097|566979098|FG001|Overall Study|Lost to Follow-up|2|||
157061316|NCT02515097|566979097|FG000|Overall Study|Withdrawal by Subject|1|||
157061317|NCT02515097|566979098|FG001|Overall Study|Withdrawal by Subject|3|||
157061318|NCT02515097|566979097|FG000|Overall Study|Adverse Event|2|||
157061319|NCT02515097|566979098|FG001|Overall Study|Adverse Event|1|||
157061320|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
157061321|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
157061322|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
157061323|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Other|1|||
157061324|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Other|0|||
157061325|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Other|0|||
157061326|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Physician Decision|3|||
157061327|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Physician Decision|0|||
157061328|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Physician Decision|0|||
157061329|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
157061330|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
157061331|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
157061332|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
157061333|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
157061334|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
157061335|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Adverse Event|18|||
157061336|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Adverse Event|0|||
157061337|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Adverse Event|0|||
157061338|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
157061339|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
157061340|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
157061341|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
157061342|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
157061343|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
157061344|NCT03030599|566979101|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
157061345|NCT03030599|566979102|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
157061346|NCT03030599|566979103|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
157061347|NCT03030599|566979101|FG000|Stable Dose|Protocol deviation|3|||
157061348|NCT03030599|566979102|FG001|Stable Dose|Protocol deviation|0|||
157061349|NCT03030599|566979103|FG002|Stable Dose|Protocol deviation|0|||
157061350|NCT03030599|566979101|FG000|Stable Dose|Adverse Event|1|||
157061351|NCT03030599|566979102|FG001|Stable Dose|Adverse Event|0|||
157061352|NCT03030599|566979103|FG002|Stable Dose|Adverse Event|0|||
157061353|NCT03030599|566979101|FG000|Stable Dose|Lost to Follow-up|1|||
157061354|NCT03030599|566979102|FG001|Stable Dose|Lost to Follow-up|0|||
157061355|NCT03030599|566979103|FG002|Stable Dose|Lost to Follow-up|0|||
157061356|NCT03030599|566979101|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
157061357|NCT03030599|566979102|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
157061358|NCT03030599|566979103|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
157061359|NCT03030599|566979101|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
157061360|NCT03030599|566979102|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
157061361|NCT03030599|566979103|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
157061362|NCT03030599|566979101|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
157061363|NCT03030599|566979102|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
157061364|NCT03030599|566979103|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
157061365|NCT03030599|566979101|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
157061366|NCT03030599|566979102|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
157061367|NCT03030599|566979103|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
157061368|NCT03030599|566979101|FG000|Open-label Extension|Adverse Event|3|||
157061369|NCT03030599|566979102|FG001|Open-label Extension|Adverse Event|0|||
157061370|NCT03030599|566979103|FG002|Open-label Extension|Adverse Event|0|||
157061371|NCT03030599|566979101|FG000|Open-label Extension|Lost to Follow-up|2|||
157061372|NCT03030599|566979102|FG001|Open-label Extension|Lost to Follow-up|0|||
157229974|NCT01226797|567588215|FG000|Overall Study|Protocol Violation|0|||
157229975|NCT01226797|567588216|FG001|Overall Study|Protocol Violation|1|||
157061373|NCT03030599|566979103|FG002|Open-label Extension|Lost to Follow-up|0|||
157061374|NCT03030599|566979101|FG000|Open-label Extension|Lack of Efficacy|1|||
157061375|NCT03030599|566979102|FG001|Open-label Extension|Lack of Efficacy|0|||
157061376|NCT03030599|566979103|FG002|Open-label Extension|Lack of Efficacy|0|||
157061377|NCT03030599|566979101|FG000|Open-label Extension|Other Reason|1|||
157061378|NCT03030599|566979102|FG001|Open-label Extension|Other Reason|0|||
157061379|NCT03030599|566979103|FG002|Open-label Extension|Other Reason|0|||
157061380|NCT01592383|566979104|FG000|Overall Study|Adverse Event|1|||
157061381|NCT01064856|566979105|FG000|Double-blind (DB) Period|Adverse Event|1|||
157061382|NCT01064856|566979106|FG001|Double-blind (DB) Period|Adverse Event|0|||
157061383|NCT01064856|566979107|FG002|Double-blind (DB) Period|Adverse Event|0|||
157061384|NCT01064856|566979108|FG003|Double-blind (DB) Period|Adverse Event|0|||
157061385|NCT01064856|566979105|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
157061386|NCT01064856|566979106|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
157061387|NCT01064856|566979107|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
157061388|NCT01064856|566979108|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
157061389|NCT01064856|566979105|FG000|Open-label (OL) Period|Adverse Event|0|||
157061390|NCT01064856|566979106|FG001|Open-label (OL) Period|Adverse Event|0|||
157061391|NCT01064856|566979107|FG002|Open-label (OL) Period|Adverse Event|12|||
157061392|NCT01064856|566979108|FG003|Open-label (OL) Period|Adverse Event|6|||
157061393|NCT01064856|566979105|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
157061394|NCT01064856|566979106|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
157061395|NCT01064856|566979107|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
157061396|NCT01064856|566979108|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
157061397|NCT01064856|566979105|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
157061398|NCT01064856|566979106|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
157061399|NCT01064856|566979107|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
157061400|NCT01064856|566979108|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
157061401|NCT01064856|566979105|FG000|Open-label (OL) Period|Other|0|||
157061402|NCT01064856|566979106|FG001|Open-label (OL) Period|Other|0|||
157061403|NCT01064856|566979107|FG002|Open-label (OL) Period|Other|7|||
157061404|NCT01064856|566979108|FG003|Open-label (OL) Period|Other|7|||
157061405|NCT02133131|566979109|FG000|Overall Study|Adverse Event|0|||
157061406|NCT02133131|566979110|FG001|Overall Study|Adverse Event|0|||
157061407|NCT02133131|566979111|FG002|Overall Study|Adverse Event|0|||
157061408|NCT02133131|566979112|FG003|Overall Study|Adverse Event|1|||
157061409|NCT02133131|566979113|FG004|Overall Study|Adverse Event|0|||
157061410|NCT02133131|566979114|FG005|Overall Study|Adverse Event|0|||
157061411|NCT02133131|566979115|FG006|Overall Study|Adverse Event|0|||
157061412|NCT02133131|566979109|FG000|Overall Study|Lost to Follow-up|1|||
157061413|NCT02133131|566979110|FG001|Overall Study|Lost to Follow-up|0|||
157061414|NCT02133131|566979111|FG002|Overall Study|Lost to Follow-up|0|||
157061415|NCT02133131|566979112|FG003|Overall Study|Lost to Follow-up|1|||
157061416|NCT02133131|566979113|FG004|Overall Study|Lost to Follow-up|0|||
157061417|NCT02133131|566979114|FG005|Overall Study|Lost to Follow-up|0|||
157061418|NCT02133131|566979115|FG006|Overall Study|Lost to Follow-up|0|||
157061419|NCT02133131|566979109|FG000|Overall Study|Status not recorded|4|||
157061420|NCT02133131|566979110|FG001|Overall Study|Status not recorded|5|||
157061421|NCT02133131|566979111|FG002|Overall Study|Status not recorded|1|||
157061422|NCT02133131|566979112|FG003|Overall Study|Status not recorded|4|||
157061423|NCT02133131|566979113|FG004|Overall Study|Status not recorded|0|||
157061424|NCT02133131|566979114|FG005|Overall Study|Status not recorded|0|||
157061425|NCT02133131|566979115|FG006|Overall Study|Status not recorded|0|||
157061426|NCT02133131|566979109|FG000|Overall Study|Ongoing in study|0|||
157061427|NCT02133131|566979110|FG001|Overall Study|Ongoing in study|0|||
157061428|NCT02133131|566979111|FG002|Overall Study|Ongoing in study|0|||
157061429|NCT02133131|566979112|FG003|Overall Study|Ongoing in study|0|||
157061430|NCT02133131|566979113|FG004|Overall Study|Ongoing in study|15|||
157061431|NCT02133131|566979114|FG005|Overall Study|Ongoing in study|14|||
157061432|NCT02133131|566979115|FG006|Overall Study|Ongoing in study|11|||
157061433|NCT02133131|566979109|FG000|Overall Study|Protocol Violation|0|||
157061434|NCT02133131|566979110|FG001|Overall Study|Protocol Violation|0|||
157061435|NCT02133131|566979111|FG002|Overall Study|Protocol Violation|0|||
157061436|NCT02133131|566979112|FG003|Overall Study|Protocol Violation|0|||
157061437|NCT02133131|566979113|FG004|Overall Study|Protocol Violation|0|||
157061438|NCT02133131|566979114|FG005|Overall Study|Protocol Violation|0|||
157061439|NCT02133131|566979115|FG006|Overall Study|Protocol Violation|1|||
157061440|NCT00509925|566979116|FG000|Overall Study|Personal reasons|0|||
157061441|NCT00509925|566979117|FG001|Overall Study|Personal reasons|1|||
157061442|NCT00951171|566979119|FG000|Overall Study|Adverse Event|2|||
157061443|NCT00951171|566979120|FG001|Overall Study|Adverse Event|0|||
157061444|NCT05294328|566979123|FG000|Overall Study|Adverse Event|1|||
157061445|NCT05294328|566979124|FG001|Overall Study|Adverse Event|0|||
157061446|NCT05294328|566979125|FG002|Overall Study|Adverse Event|0|||
157061447|NCT05294328|566979123|FG000|Overall Study|Physician Decision|1|||
157061448|NCT05294328|566979124|FG001|Overall Study|Physician Decision|1|||
157061449|NCT05294328|566979125|FG002|Overall Study|Physician Decision|0|||
157061450|NCT05294328|566979123|FG000|Overall Study|Withdrawal by Subject|0|||
157061451|NCT05294328|566979124|FG001|Overall Study|Withdrawal by Subject|2|||
157061452|NCT05294328|566979125|FG002|Overall Study|Withdrawal by Subject|1|||
157061453|NCT05294328|566979123|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
157061454|NCT05294328|566979124|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
157061455|NCT05294328|566979125|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
157061456|NCT04267393|566979126|FG000|Randomization|Adverse Event|1|||
157061457|NCT04267393|566979127|FG001|Randomization|Adverse Event|0|||
157061458|NCT04267393|566979128|FG002|Randomization|Adverse Event|0|||
157061459|NCT04267393|566979126|FG000|Randomization|Administrative Reasons by Sponsor|0|||
157061460|NCT04267393|566979127|FG001|Randomization|Administrative Reasons by Sponsor|1|||
157061461|NCT04267393|566979128|FG002|Randomization|Administrative Reasons by Sponsor|0|||
157061462|NCT04267393|566979126|FG000|Treatment Period|Adverse Event|0|||
157061463|NCT04267393|566979127|FG001|Treatment Period|Adverse Event|2|||
157061464|NCT04267393|566979128|FG002|Treatment Period|Adverse Event|3|||
157061465|NCT04267393|566979126|FG000|Treatment Period|Participant Withdrew Consent|0|||
157061466|NCT04267393|566979127|FG001|Treatment Period|Participant Withdrew Consent|0|||
157061467|NCT04267393|566979128|FG002|Treatment Period|Participant Withdrew Consent|1|||
157061468|NCT04267393|566979126|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
157061469|NCT04267393|566979127|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
157061470|NCT04267393|566979128|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
157061471|NCT00605566|566981462|FG000|Overall Study|Adverse Event|1|||
157061472|NCT00605566|566981462|FG000|Overall Study|Clinical deterioration|1|||
157061473|NCT00605566|566981462|FG000|Overall Study|Poor compliance in run-in period|1|||
157061474|NCT03864341|566981463|FG000|Overall Study|Withdrawal by Subject|1|||
157061475|NCT01066936|566981464|FG000|Overall Study|Death|2|||
157061476|NCT01066936|566981464|FG000|Overall Study|Device revised/removed|1|||
157061477|NCT01066936|566981464|FG000|Overall Study|Lost to Follow-up|3|||
157061478|NCT01066936|566981464|FG000|Overall Study|Withdrawal by Subject|4|||
157061479|NCT01904136|566981465|FG000|Overall Study|Physician Decision|0|||
157061480|NCT01904136|566981466|FG001|Overall Study|Physician Decision|0|||
157061481|NCT01904136|566981467|FG002|Overall Study|Physician Decision|0|||
157061482|NCT01904136|566981468|FG003|Overall Study|Physician Decision|0|||
157061483|NCT01904136|566981469|FG004|Overall Study|Physician Decision|0|||
157061484|NCT01904136|566981470|FG005|Overall Study|Physician Decision|1|||
157061485|NCT01904136|566981471|FG006|Overall Study|Physician Decision|0|||
157061486|NCT01904136|566981472|FG007|Overall Study|Physician Decision|0|||
157061487|NCT01904136|566981473|FG008|Overall Study|Physician Decision|0|||
157061488|NCT02202109|566981476|FG000|Overall Study|Lost to Follow-up|88|||
157061489|NCT02202109|566981477|FG001|Overall Study|Lost to Follow-up|87|||
157061490|NCT02202109|566981476|FG000|Overall Study|Withdrawal by Subject|2|||
157061491|NCT02202109|566981477|FG001|Overall Study|Withdrawal by Subject|0|||
157061492|NCT04156399|566981484|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
157061493|NCT04156399|566981484|FG000|Overall Study|study suspension due to COVID pandemic|3|||
157061494|NCT03834623|566981487|FG000|Overall Study|Progression|0|||
157061495|NCT03834623|566981488|FG001|Overall Study|Progression|1|||
157061496|NCT01947517|566981489|FG000|Overall Study|Withdrawal by Subject|1|||
157061497|NCT01947517|566981490|FG001|Overall Study|Withdrawal by Subject|1|||
157061498|NCT03418493|566981491|FG000|Overall Study|Adverse Event|1|||
157061499|NCT03418493|566981492|FG001|Overall Study|Adverse Event|0|||
157061500|NCT03418493|566981493|FG002|Overall Study|Adverse Event|0|||
157061501|NCT03418493|566981494|FG003|Overall Study|Adverse Event|0|||
157061502|NCT03418493|566981495|FG004|Overall Study|Adverse Event|0|||
157061503|NCT03418493|566981496|FG005|Overall Study|Adverse Event|0|||
157061504|NCT03418493|566981497|FG006|Overall Study|Adverse Event|0|||
157061505|NCT03418493|566981498|FG007|Overall Study|Adverse Event|0|||
157061506|NCT03418493|566981499|FG008|Overall Study|Adverse Event|0|||
157061507|NCT03418493|566981500|FG009|Overall Study|Adverse Event|0|||
157061508|NCT03418493|566981501|FG010|Overall Study|Adverse Event|0|||
157061509|NCT03418493|566981491|FG000|Overall Study|Protocol Violation|0|||
157061510|NCT03418493|566981492|FG001|Overall Study|Protocol Violation|0|||
157061511|NCT03418493|566981493|FG002|Overall Study|Protocol Violation|0|||
157061512|NCT03418493|566981494|FG003|Overall Study|Protocol Violation|0|||
157061513|NCT03418493|566981495|FG004|Overall Study|Protocol Violation|0|||
157061514|NCT03418493|566981496|FG005|Overall Study|Protocol Violation|0|||
157061515|NCT03418493|566981497|FG006|Overall Study|Protocol Violation|0|||
157061516|NCT03418493|566981498|FG007|Overall Study|Protocol Violation|0|||
157061517|NCT03418493|566981499|FG008|Overall Study|Protocol Violation|0|||
157061518|NCT03418493|566981500|FG009|Overall Study|Protocol Violation|1|||
157061519|NCT03418493|566981501|FG010|Overall Study|Protocol Violation|0|||
157061520|NCT00460564|566981503|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
157061521|NCT00460564|566981504|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
157061522|NCT00460564|566981505|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061523|NCT00460564|566981506|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061524|NCT00460564|566981507|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061525|NCT00460564|566981508|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061526|NCT00460564|566981509|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061527|NCT00460564|566981510|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
157061528|NCT00460564|566981503|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
157061529|NCT00460564|566981504|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061530|NCT00460564|566981505|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061531|NCT00460564|566981506|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061532|NCT00460564|566981507|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061533|NCT00460564|566981508|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061534|NCT00460564|566981509|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061535|NCT00460564|566981510|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
157061536|NCT00460564|566981503|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157061537|NCT00460564|566981504|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157061538|NCT00460564|566981505|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157061539|NCT00460564|566981506|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157061540|NCT00460564|566981507|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
157061541|NCT00460564|566981508|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
157061542|NCT00460564|566981509|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
157061543|NCT00460564|566981510|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
157061544|NCT00460564|566981503|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061545|NCT00460564|566981504|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061546|NCT00460564|566981505|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061547|NCT00460564|566981506|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061548|NCT00460564|566981507|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
157061549|NCT00460564|566981508|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
157061550|NCT00460564|566981509|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061551|NCT00460564|566981510|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
157061552|NCT00460564|566981503|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061553|NCT00460564|566981504|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061554|NCT00460564|566981505|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061555|NCT00460564|566981506|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061556|NCT00460564|566981507|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
157061557|NCT00460564|566981508|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061558|NCT00460564|566981509|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061559|NCT00460564|566981510|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
157061560|NCT03226106|566981514|FG000|Overall Study|Withdrawal by Subject|2|||
157061561|NCT03226106|566981515|FG001|Overall Study|Withdrawal by Subject|0|||
157061562|NCT03226106|566981514|FG000|Overall Study|Adverse Event|1|||
157061563|NCT03226106|566981515|FG001|Overall Study|Adverse Event|0|||
157061564|NCT03226106|566981514|FG000|Overall Study|Lost to Follow-up|2|||
157061565|NCT03226106|566981515|FG001|Overall Study|Lost to Follow-up|0|||
157061566|NCT04349644|566981516|FG000|Allocation/Pretest|Lost to pretest|0|||
157061567|NCT04349644|566981517|FG001|Allocation/Pretest|Lost to pretest|3|||
157061568|NCT04349644|566981516|FG000|Posttest|Lost to posttest|0|||
157061569|NCT04349644|566981517|FG001|Posttest|Lost to posttest|8|||
157061570|NCT04349644|566981516|FG000|Posttest|Discontinued intervention|6|||
157061571|NCT04349644|566981517|FG001|Posttest|Discontinued intervention|0|||
157061572|NCT04349644|566981516|FG000|Follow-up|Lost to Follow-up|0|||
157061573|NCT04349644|566981517|FG001|Follow-up|Lost to Follow-up|2|||
157061574|NCT01084239|566981518|FG000|28-Day Follow-up|Lost to Follow-up|4|||
157061575|NCT01084239|566981519|FG001|28-Day Follow-up|Lost to Follow-up|9|||
157061576|NCT05006417|566981520|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
157061577|NCT00863798|566981521|FG000|Overall Study|Adverse Event|5|||
157061578|NCT00863798|566981522|FG001|Overall Study|Adverse Event|2|||
157061579|NCT00863798|566981523|FG002|Overall Study|Adverse Event|4|||
157229976|NCT00577460|567588217|FG000|Overall Study|Adverse Event|11|||
157061580|NCT00863798|566981521|FG000|Overall Study|Participant failed to return|2|||
157061581|NCT00863798|566981522|FG001|Overall Study|Participant failed to return|1|||
157061582|NCT00863798|566981523|FG002|Overall Study|Participant failed to return|0|||
157061583|NCT00863798|566981521|FG000|Overall Study|Investigator request|1|||
157061584|NCT00863798|566981522|FG001|Overall Study|Investigator request|2|||
157061585|NCT00863798|566981523|FG002|Overall Study|Investigator request|1|||
157061586|NCT00863798|566981521|FG000|Overall Study|Lack of Efficacy|4|||
157061587|NCT00863798|566981522|FG001|Overall Study|Lack of Efficacy|3|||
157061588|NCT00863798|566981523|FG002|Overall Study|Lack of Efficacy|6|||
157061589|NCT00863798|566981521|FG000|Overall Study|Lost to Follow-up|6|||
157061590|NCT00863798|566981522|FG001|Overall Study|Lost to Follow-up|9|||
157061591|NCT00863798|566981523|FG002|Overall Study|Lost to Follow-up|5|||
157061592|NCT00863798|566981521|FG000|Overall Study|Other|2|||
157061593|NCT00863798|566981522|FG001|Overall Study|Other|3|||
157061594|NCT00863798|566981523|FG002|Overall Study|Other|1|||
157061595|NCT00863798|566981521|FG000|Overall Study|Protocol Violation|0|||
157061596|NCT00863798|566981522|FG001|Overall Study|Protocol Violation|1|||
157061597|NCT00863798|566981523|FG002|Overall Study|Protocol Violation|1|||
157061598|NCT00863798|566981521|FG000|Overall Study|Withdrawal by Subject|8|||
157061599|NCT00863798|566981522|FG001|Overall Study|Withdrawal by Subject|7|||
157061600|NCT00863798|566981523|FG002|Overall Study|Withdrawal by Subject|4|||
157061601|NCT00863798|566981521|FG000|Overall Study|Randomized not treated|4|||
157061602|NCT00863798|566981522|FG001|Overall Study|Randomized not treated|2|||
157061603|NCT00863798|566981523|FG002|Overall Study|Randomized not treated|3|||
157061604|NCT04238520|566981524|FG000|Overall Study|Withdrawal by Subject|1|||
157061605|NCT04238520|566981525|FG001|Overall Study|Withdrawal by Subject|1|||
157061606|NCT04238520|566981524|FG000|Overall Study|Lost to Follow-up|1|||
157061607|NCT04238520|566981525|FG001|Overall Study|Lost to Follow-up|2|||
157061608|NCT04238520|566981524|FG000|Overall Study|Death|0|||
157061609|NCT04238520|566981525|FG001|Overall Study|Death|2|||
157061610|NCT04238520|566981524|FG000|Overall Study|Unsafe home environment for research staff|0|||
157061611|NCT04238520|566981525|FG001|Overall Study|Unsafe home environment for research staff|1|||
157061612|NCT01470599|566981526|FG000|Overall Study|Did not meet entrance criteria|1|||
157061613|NCT01470599|566981527|FG001|Overall Study|Did not meet entrance criteria|0|||
157061614|NCT01470599|566981526|FG000|Overall Study|Lost to Follow-up|2|||
157061615|NCT01470599|566981527|FG001|Overall Study|Lost to Follow-up|1|||
157061616|NCT01470599|566981526|FG000|Overall Study|Withdrawal by Subject|3|||
157061617|NCT01470599|566981527|FG001|Overall Study|Withdrawal by Subject|4|||
157061618|NCT01470599|566981526|FG000|Overall Study|Other|1|||
157061619|NCT01470599|566981527|FG001|Overall Study|Other|0|||
157061620|NCT01470599|566981526|FG000|Overall Study|Protocol Violation|3|||
157061621|NCT01470599|566981527|FG001|Overall Study|Protocol Violation|1|||
157061622|NCT01470599|566981526|FG000|Overall Study|Adverse event related to study drug|2|||
157061623|NCT01470599|566981527|FG001|Overall Study|Adverse event related to study drug|5|||
157061624|NCT01470599|566981526|FG000|Overall Study|Insufficient clinical response|6|||
157061625|NCT01470599|566981527|FG001|Overall Study|Insufficient clinical response|27|||
157061626|NCT01470599|566981526|FG000|Overall Study|Adverse event not related to study drug|1|||
157061627|NCT01470599|566981527|FG001|Overall Study|Adverse event not related to study drug|5|||
157061628|NCT00195442|566981528|FG000|Overall Study|Less than expected therapeutic effect|38|||
157061629|NCT00195442|566981528|FG000|Overall Study|Lost to Follow-up|27|||
157061630|NCT00195442|566981528|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
157061631|NCT00195442|566981528|FG000|Overall Study|Intermittent product shortage|21|||
157061632|NCT00195442|566981528|FG000|Overall Study|Death|7|||
157061633|NCT00195442|566981528|FG000|Overall Study|No reason specified|4|||
157061634|NCT00195442|566981528|FG000|Overall Study|Poor cooperation|2|||
157061635|NCT00195442|566981528|FG000|Overall Study|Other|14|||
157061636|NCT01917006|566981529|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
157061637|NCT01917006|566981530|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
157061638|NCT01917006|566981531|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
157061639|NCT01917006|566981532|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
157061640|NCT01917006|566981533|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
157061641|NCT01917006|566981534|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
157061642|NCT01917006|566981535|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
157061643|NCT01917006|566981536|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
157061644|NCT01917006|566981529|FG000|Randomized-treatment Period|Personal Reasons|0|||
157061645|NCT01917006|566981530|FG001|Randomized-treatment Period|Personal Reasons|0|||
157061646|NCT01917006|566981531|FG002|Randomized-treatment Period|Personal Reasons|0|||
157061647|NCT01917006|566981532|FG003|Randomized-treatment Period|Personal Reasons|0|||
157061648|NCT01917006|566981533|FG004|Randomized-treatment Period|Personal Reasons|0|||
157061649|NCT01917006|566981534|FG005|Randomized-treatment Period|Personal Reasons|1|||
157061650|NCT01917006|566981535|FG006|Randomized-treatment Period|Personal Reasons|0|||
157061651|NCT01917006|566981536|FG007|Randomized-treatment Period|Personal Reasons|0|||
157061652|NCT01917006|566981529|FG000|Randomized-treatment Period|Protocol Violation|1|||
157061653|NCT01917006|566981530|FG001|Randomized-treatment Period|Protocol Violation|0|||
157061654|NCT01917006|566981531|FG002|Randomized-treatment Period|Protocol Violation|0|||
157061655|NCT01917006|566981532|FG003|Randomized-treatment Period|Protocol Violation|0|||
157061656|NCT01917006|566981533|FG004|Randomized-treatment Period|Protocol Violation|0|||
157061657|NCT01917006|566981534|FG005|Randomized-treatment Period|Protocol Violation|0|||
157061658|NCT01917006|566981535|FG006|Randomized-treatment Period|Protocol Violation|0|||
157061659|NCT01917006|566981536|FG007|Randomized-treatment Period|Protocol Violation|0|||
157061660|NCT01917006|566981529|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061661|NCT01917006|566981530|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061662|NCT01917006|566981531|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061663|NCT01917006|566981532|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061664|NCT01917006|566981533|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061665|NCT01917006|566981534|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061666|NCT01917006|566981535|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
157061667|NCT01917006|566981536|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
157061668|NCT01917006|566981529|FG000|Open-label Period|Adverse Event|0|||
157061669|NCT01917006|566981530|FG001|Open-label Period|Adverse Event|0|||
157061670|NCT01917006|566981531|FG002|Open-label Period|Adverse Event|0|||
157061671|NCT01917006|566981532|FG003|Open-label Period|Adverse Event|0|||
157061672|NCT01917006|566981533|FG004|Open-label Period|Adverse Event|0|||
157061673|NCT01917006|566981534|FG005|Open-label Period|Adverse Event|0|||
157061674|NCT01917006|566981535|FG006|Open-label Period|Adverse Event|0|||
157061675|NCT01917006|566981536|FG007|Open-label Period|Adverse Event|1|||
157061676|NCT01917006|566981529|FG000|Open-label Period|Lost to Follow-up|0|||
157061677|NCT01917006|566981530|FG001|Open-label Period|Lost to Follow-up|0|||
157061678|NCT01917006|566981531|FG002|Open-label Period|Lost to Follow-up|0|||
157061679|NCT01917006|566981532|FG003|Open-label Period|Lost to Follow-up|0|||
157061680|NCT01917006|566981533|FG004|Open-label Period|Lost to Follow-up|0|||
157061681|NCT01917006|566981534|FG005|Open-label Period|Lost to Follow-up|0|||
157061682|NCT01917006|566981535|FG006|Open-label Period|Lost to Follow-up|0|||
157061683|NCT01917006|566981536|FG007|Open-label Period|Lost to Follow-up|1|||
157061684|NCT02158247|566981542|FG000|Overall Study|Invisible vocal cords|5|||
157061685|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
157061686|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
157061687|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
157061688|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
157061689|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
157061690|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
157061691|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
157061692|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
157061693|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
157061694|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
157061695|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
157061696|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
157061697|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
157061698|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
157061699|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
157061700|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
157061701|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
157061702|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
157061703|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
157061704|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
157061705|NCT02637856|566981549|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
157061706|NCT02637856|566981550|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
157061707|NCT02637856|566981549|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
157061708|NCT02637856|566981550|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
157061709|NCT02637856|566981549|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
157061710|NCT02637856|566981550|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
157061711|NCT02509312|566981551|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
157061712|NCT02509312|566981552|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
157061713|NCT02509312|566981551|FG000|Overall Study|Obstetrician refusal|0|||
157061714|NCT02509312|566981552|FG001|Overall Study|Obstetrician refusal|1|||
157061715|NCT02509312|566981551|FG000|Overall Study|Patient elected for TOLAC|1|||
157061716|NCT02509312|566981552|FG001|Overall Study|Patient elected for TOLAC|0|||
157061717|NCT02509312|566981551|FG000|Overall Study|Cesarean deemed stat|1|||
157061718|NCT02509312|566981552|FG001|Overall Study|Cesarean deemed stat|0|||
157061719|NCT02509312|566981551|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
157061720|NCT02509312|566981552|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
157061721|NCT02815735|566981553|FG000|First Intervention (4 Weeks)|Discomfort|1|||
157061722|NCT02815735|566981554|FG001|First Intervention (4 Weeks)|Discomfort|0|||
157061723|NCT02815735|566981553|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
157061724|NCT02815735|566981554|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
157061725|NCT02815735|566981553|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
157061726|NCT02815735|566981554|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
157061727|NCT02815735|566981553|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
157061728|NCT02815735|566981554|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
157061729|NCT00702650|566981555|FG000|Overall Study|Withdrawal by Subject|9|||
157061730|NCT00702650|566981555|FG000|Overall Study|Non-Compliance of Study Drug|3|||
157061731|NCT00702650|566981555|FG000|Overall Study|Lost to Follow-up|2|||
157061732|NCT00702650|566981555|FG000|Overall Study|Non-Compliance with Site Directives|1|||
157061733|NCT00702650|566981555|FG000|Overall Study|Sponsor Request|1|||
157061734|NCT00702650|566981555|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
157061735|NCT00702650|566981555|FG000|Overall Study|Adverse Event|3|||
157061736|NCT00943722|566981557|FG000|Base Study|Adverse Event|0|||
157061737|NCT00943722|566981558|FG001|Base Study|Adverse Event|0|||
157061738|NCT00943722|566981559|FG002|Base Study|Adverse Event|0|||
157061739|NCT00943722|566981560|FG003|Base Study|Adverse Event|1|||
157061740|NCT00943722|566981561|FG004|Base Study|Adverse Event|0|||
157061741|NCT00943722|566981562|FG005|Base Study|Adverse Event|0|||
157061742|NCT00943722|566981563|FG006|Base Study|Adverse Event|0|||
157061743|NCT00943722|566981557|FG000|Base Study|Lost to Follow-up|12|||
157061744|NCT00943722|566981558|FG001|Base Study|Lost to Follow-up|8|||
157061745|NCT00943722|566981559|FG002|Base Study|Lost to Follow-up|10|||
157061746|NCT00943722|566981560|FG003|Base Study|Lost to Follow-up|8|||
157061747|NCT00943722|566981561|FG004|Base Study|Lost to Follow-up|11|||
157061748|NCT00943722|566981562|FG005|Base Study|Lost to Follow-up|0|||
157061749|NCT00943722|566981563|FG006|Base Study|Lost to Follow-up|0|||
157061750|NCT00943722|566981557|FG000|Base Study|Physician Decision|1|||
157061751|NCT00943722|566981558|FG001|Base Study|Physician Decision|0|||
157061752|NCT00943722|566981559|FG002|Base Study|Physician Decision|0|||
157061753|NCT00943722|566981560|FG003|Base Study|Physician Decision|0|||
157061754|NCT00943722|566981561|FG004|Base Study|Physician Decision|1|||
157061755|NCT00943722|566981562|FG005|Base Study|Physician Decision|0|||
157061756|NCT00943722|566981563|FG006|Base Study|Physician Decision|0|||
157061757|NCT00943722|566981557|FG000|Base Study|Pregnancy|0|||
157061758|NCT00943722|566981558|FG001|Base Study|Pregnancy|0|||
157061759|NCT00943722|566981559|FG002|Base Study|Pregnancy|1|||
157061760|NCT00943722|566981560|FG003|Base Study|Pregnancy|0|||
157061761|NCT00943722|566981561|FG004|Base Study|Pregnancy|2|||
157061762|NCT00943722|566981562|FG005|Base Study|Pregnancy|0|||
157061763|NCT00943722|566981563|FG006|Base Study|Pregnancy|0|||
157061764|NCT00943722|566981557|FG000|Base Study|Protocol Violation|0|||
157061765|NCT00943722|566981558|FG001|Base Study|Protocol Violation|1|||
157061766|NCT00943722|566981559|FG002|Base Study|Protocol Violation|0|||
157061767|NCT00943722|566981560|FG003|Base Study|Protocol Violation|0|||
157061768|NCT00943722|566981561|FG004|Base Study|Protocol Violation|2|||
157061769|NCT00943722|566981562|FG005|Base Study|Protocol Violation|0|||
157061770|NCT00943722|566981563|FG006|Base Study|Protocol Violation|0|||
157061771|NCT00943722|566981557|FG000|Base Study|Withdrawal by Subject|12|||
157061772|NCT00943722|566981558|FG001|Base Study|Withdrawal by Subject|13|||
157061773|NCT00943722|566981559|FG002|Base Study|Withdrawal by Subject|2|||
157061774|NCT00943722|566981560|FG003|Base Study|Withdrawal by Subject|13|||
157061775|NCT00943722|566981561|FG004|Base Study|Withdrawal by Subject|8|||
157061776|NCT00943722|566981562|FG005|Base Study|Withdrawal by Subject|0|||
157061777|NCT00943722|566981563|FG006|Base Study|Withdrawal by Subject|0|||
157061778|NCT00943722|566981557|FG000|Base Study|Month 12 visit not completed|0|||
157061779|NCT00943722|566981558|FG001|Base Study|Month 12 visit not completed|0|||
157061780|NCT00943722|566981559|FG002|Base Study|Month 12 visit not completed|0|||
157061781|NCT00943722|566981560|FG003|Base Study|Month 12 visit not completed|0|||
157061782|NCT00943722|566981561|FG004|Base Study|Month 12 visit not completed|2|||
157061783|NCT00943722|566981562|FG005|Base Study|Month 12 visit not completed|0|||
157061784|NCT00943722|566981563|FG006|Base Study|Month 12 visit not completed|0|||
157061785|NCT00943722|566981557|FG000|First Extension Study: EXT 1|Adverse Event|0|||
157061786|NCT00943722|566981558|FG001|First Extension Study: EXT 1|Adverse Event|0|||
157061787|NCT00943722|566981559|FG002|First Extension Study: EXT 1|Adverse Event|0|||
157061788|NCT00943722|566981560|FG003|First Extension Study: EXT 1|Adverse Event|0|||
157061789|NCT00943722|566981561|FG004|First Extension Study: EXT 1|Adverse Event|0|||
157061790|NCT00943722|566981562|FG005|First Extension Study: EXT 1|Adverse Event|1|||
157061791|NCT00943722|566981563|FG006|First Extension Study: EXT 1|Adverse Event|0|||
157061792|NCT00943722|566981557|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
157061793|NCT00943722|566981558|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
157061794|NCT00943722|566981559|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
157061795|NCT00943722|566981560|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
157061796|NCT00943722|566981561|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
157061797|NCT00943722|566981562|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
157061798|NCT00943722|566981563|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
157061799|NCT00943722|566981557|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
157061800|NCT00943722|566981558|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
157061801|NCT00943722|566981559|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
157061802|NCT00943722|566981560|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
157061803|NCT00943722|566981561|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
157061804|NCT00943722|566981562|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
157061805|NCT00943722|566981563|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
157061806|NCT00943722|566981557|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
157061807|NCT00943722|566981558|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
157061808|NCT00943722|566981559|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
157061809|NCT00943722|566981560|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
157061810|NCT00943722|566981561|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
157061811|NCT00943722|566981562|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
157061812|NCT00943722|566981563|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
157061813|NCT00943722|566981557|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
157061814|NCT00943722|566981558|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
157061815|NCT00943722|566981559|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
157061816|NCT00943722|566981560|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
157061817|NCT00943722|566981561|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
157061818|NCT00943722|566981562|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
157061819|NCT00943722|566981563|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
157061820|NCT00943722|566981557|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
157061821|NCT00943722|566981558|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
157061822|NCT00943722|566981559|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
157061823|NCT00943722|566981560|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
157061824|NCT00943722|566981561|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
157061825|NCT00943722|566981562|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
157061826|NCT00943722|566981563|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
157061827|NCT00943722|566981557|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
157061828|NCT00943722|566981558|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
157061829|NCT00943722|566981559|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
157061830|NCT00943722|566981560|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
157061831|NCT00943722|566981561|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
157061832|NCT00943722|566981562|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
157061833|NCT00943722|566981563|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
157061834|NCT00943722|566981557|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
157061835|NCT00943722|566981558|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
157229977|NCT00577460|567588218|FG001|Overall Study|Adverse Event|7|||
157229978|NCT00577460|567588219|FG002|Overall Study|Adverse Event|14|||
157229979|NCT00577460|567588217|FG000|Overall Study|Protocol Violation|0|||
157229980|NCT00577460|567588218|FG001|Overall Study|Protocol Violation|1|||
157229981|NCT00577460|567588219|FG002|Overall Study|Protocol Violation|1|||
157229982|NCT00577460|567588217|FG000|Overall Study|Lost to Follow-up|0|||
157229983|NCT00577460|567588218|FG001|Overall Study|Lost to Follow-up|3|||
157229984|NCT00577460|567588219|FG002|Overall Study|Lost to Follow-up|4|||
157229985|NCT00577460|567588217|FG000|Overall Study|Withdrawal by Subject|5|||
157229986|NCT00577460|567588218|FG001|Overall Study|Withdrawal by Subject|5|||
157229987|NCT00577460|567588219|FG002|Overall Study|Withdrawal by Subject|6|||
157229988|NCT00577460|567588217|FG000|Overall Study|Other|0|||
157229989|NCT00577460|567588218|FG001|Overall Study|Other|3|||
157229990|NCT00577460|567588219|FG002|Overall Study|Other|2|||
157229991|NCT00162123|567588220|FG000|Overall Study|Disease progression|27|||
157229992|NCT00162123|567588221|FG001|Overall Study|Disease progression|19|||
157229993|NCT00162123|567588222|FG002|Overall Study|Disease progression|10|||
157229994|NCT00162123|567588223|FG003|Overall Study|Disease progression|4|||
157229995|NCT00162123|567588224|FG004|Overall Study|Disease progression|8|||
157229996|NCT00162123|567588225|FG005|Overall Study|Disease progression|3|||
157229997|NCT00162123|567588226|FG006|Overall Study|Disease progression|1|||
157229998|NCT00162123|567588227|FG007|Overall Study|Disease progression|0|||
157229999|NCT00162123|567588220|FG000|Overall Study|Study drug toxicity|6|||
157230000|NCT00162123|567588221|FG001|Overall Study|Study drug toxicity|1|||
157230001|NCT00162123|567588222|FG002|Overall Study|Study drug toxicity|5|||
157230002|NCT00162123|567588223|FG003|Overall Study|Study drug toxicity|0|||
157230003|NCT00162123|567588224|FG004|Overall Study|Study drug toxicity|4|||
157230004|NCT00162123|567588225|FG005|Overall Study|Study drug toxicity|1|||
157230005|NCT00162123|567588226|FG006|Overall Study|Study drug toxicity|1|||
157230006|NCT00162123|567588227|FG007|Overall Study|Study drug toxicity|0|||
157230007|NCT00162123|567588220|FG000|Overall Study|Death|3|||
157061836|NCT00943722|566981559|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
157061837|NCT00943722|566981560|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
157061838|NCT00943722|566981561|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
157230008|NCT00162123|567588221|FG001|Overall Study|Death|3|||
157230009|NCT00162123|567588222|FG002|Overall Study|Death|1|||
157230010|NCT00162123|567588223|FG003|Overall Study|Death|1|||
157230011|NCT00162123|567588224|FG004|Overall Study|Death|1|||
157230012|NCT00162123|567588225|FG005|Overall Study|Death|1|||
157230013|NCT00162123|567588226|FG006|Overall Study|Death|0|||
157230014|NCT00162123|567588227|FG007|Overall Study|Death|0|||
157183545|NCT01196091|567413089|FG001|Overall Study|Parent/Caregiver Decision|0|||
157183546|NCT01196091|567413090|FG002|Overall Study|Parent/Caregiver Decision|1|||
157183547|NCT01196091|567413088|FG000|Overall Study|Withdrawal by Subject|16|||
157183548|NCT01196091|567413089|FG001|Overall Study|Withdrawal by Subject|19|||
157183549|NCT01196091|567413090|FG002|Overall Study|Withdrawal by Subject|22|||
157183550|NCT01196091|567413088|FG000|Overall Study|Physician Decision|3|||
157183551|NCT01196091|567413089|FG001|Overall Study|Physician Decision|3|||
157183552|NCT01196091|567413090|FG002|Overall Study|Physician Decision|4|||
157183553|NCT01196091|567413088|FG000|Overall Study|Protocol Violation|1|||
157183554|NCT01196091|567413089|FG001|Overall Study|Protocol Violation|3|||
157183555|NCT01196091|567413090|FG002|Overall Study|Protocol Violation|3|||
157183556|NCT01196091|567413088|FG000|Overall Study|Sponsor Decision|6|||
157183557|NCT01196091|567413089|FG001|Overall Study|Sponsor Decision|5|||
157183558|NCT01196091|567413090|FG002|Overall Study|Sponsor Decision|4|||
157183559|NCT01196091|567413088|FG000|Overall Study|Excluded Site|5|||
157183560|NCT01196091|567413089|FG001|Overall Study|Excluded Site|11|||
157183561|NCT01196091|567413090|FG002|Overall Study|Excluded Site|8|||
157183562|NCT01196091|567413088|FG000|Overall Study|Randomized, No Study Drug Received|1|||
157183563|NCT01196091|567413089|FG001|Overall Study|Randomized, No Study Drug Received|0|||
157183564|NCT01196091|567413090|FG002|Overall Study|Randomized, No Study Drug Received|1|||
157183565|NCT01487863|567413094|FG000|Overall Study|Death|19|||
157183566|NCT01487863|567413095|FG001|Overall Study|Death|19|||
157183567|NCT04247828|567413099|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
157183568|NCT02324049|567413100|FG000|Part C|Study terminated|11|||
157183569|NCT02159365|567413101|FG000|Overall Study|Disease Progression|23|||
157183570|NCT02159365|567413101|FG000|Overall Study|Other reasons|11|||
157183571|NCT02159365|567413101|FG000|Overall Study|Administrative reason by Sponsor|9|||
157183572|NCT02159365|567413101|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
157183573|NCT02159365|567413101|FG000|Overall Study|Study drug toxicity|7|||
157183574|NCT02159365|567413101|FG000|Overall Study|Maximum clinical benefit|3|||
157183575|NCT02159365|567413101|FG000|Overall Study|Subject request to discontinue treatment|3|||
157061839|NCT00943722|566981562|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
157061840|NCT00943722|566981563|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
157061841|NCT00943722|566981557|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
157061842|NCT00943722|566981558|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
157061843|NCT00943722|566981559|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
157061844|NCT00943722|566981560|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
157061845|NCT00943722|566981561|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
157061846|NCT00943722|566981562|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
157061847|NCT00943722|566981563|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
157061848|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
157061849|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
157061850|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
157061851|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
157061852|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
157061853|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
157061854|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
157061855|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
157061856|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
157061857|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
157061858|NCT01772823|566981568|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
157061859|NCT01772823|566981569|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
157061860|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
157061861|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
157061862|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
157061863|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
157061864|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
157061865|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
157061866|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
157061867|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
157061868|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
157061869|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
157061870|NCT01772823|566981568|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
157183576|NCT02159365|567413101|FG000|Overall Study|Subject withdrew consent|3|||
157183577|NCT02159365|567413101|FG000|Overall Study|Death|1|||
157183578|NCT02159365|567413101|FG000|Overall Study|Lost to Follow-up|1|||
157183579|NCT03198728|567413102|FG000|Overall Study|Adverse Event|10|||
157183580|NCT03198728|567413103|FG001|Overall Study|Adverse Event|5|||
157183581|NCT03198728|567413102|FG000|Overall Study|Lost to Follow-up|21|||
157183582|NCT03198728|567413103|FG001|Overall Study|Lost to Follow-up|7|||
157183583|NCT03198728|567413102|FG000|Overall Study|Physician Decision|7|||
157061871|NCT01772823|566981569|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
157061872|NCT01772823|566981568|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
157061873|NCT01772823|566981569|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
157061874|NCT01772823|566981568|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
157061875|NCT01772823|566981569|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
157061876|NCT01772823|566981568|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
157061877|NCT01772823|566981569|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
157061878|NCT01772823|566981568|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
157061879|NCT01772823|566981569|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
157061880|NCT01036165|566981570|FG000|Overall Study|Adverse Event|6|||
157061881|NCT01036165|566981570|FG000|Overall Study|Lost to Follow-up|2|||
157061882|NCT01036165|566981570|FG000|Overall Study|Withdrawal by Subject|3|||
157061883|NCT01036165|566981570|FG000|Overall Study|Device Related Issues|3|||
157061884|NCT01036165|566981570|FG000|Overall Study|Problems finding proper area to inject|1|||
157061885|NCT02544113|566981575|FG000|Overall Study|Death|3|||
157061886|NCT02544113|566981576|FG001|Overall Study|Death|4|||
157061887|NCT02847637|566981578|FG000|Overall Study|Withdrawal by Subject|0|||
157061888|NCT02847637|566981579|FG001|Overall Study|Withdrawal by Subject|1|||
157061889|NCT02847637|566981580|FG002|Overall Study|Withdrawal by Subject|1|||
157061890|NCT02847637|566981581|FG003|Overall Study|Withdrawal by Subject|0|||
157061891|NCT02847637|566981578|FG000|Overall Study|Lost to Follow-up|1|||
157061892|NCT02847637|566981579|FG001|Overall Study|Lost to Follow-up|1|||
157061893|NCT02847637|566981580|FG002|Overall Study|Lost to Follow-up|0|||
157061894|NCT02847637|566981581|FG003|Overall Study|Lost to Follow-up|0|||
157061895|NCT01746108|566981584|FG000|Overall Study|Migrated /moved from study area|0|||
157061896|NCT01746108|566981585|FG001|Overall Study|Migrated /moved from study area|1|||
157061897|NCT01746108|566981586|FG002|Overall Study|Migrated /moved from study area|0|||
157061898|NCT01746108|566981584|FG000|Overall Study|Adverse event, non-fatal|0|||
157061899|NCT01746108|566981585|FG001|Overall Study|Adverse event, non-fatal|1|||
157061900|NCT01746108|566981586|FG002|Overall Study|Adverse event, non-fatal|0|||
157061901|NCT01746108|566981584|FG000|Overall Study|Withdrawal by Subject|0|||
157061902|NCT01746108|566981585|FG001|Overall Study|Withdrawal by Subject|1|||
157061903|NCT01746108|566981586|FG002|Overall Study|Withdrawal by Subject|0|||
157061904|NCT01746108|566981584|FG000|Overall Study|Lost to Follow-up|0|||
157061905|NCT01746108|566981585|FG001|Overall Study|Lost to Follow-up|1|||
157061906|NCT01746108|566981586|FG002|Overall Study|Lost to Follow-up|0|||
157061907|NCT03036150|566981587|FG000|Overall Study|Withdrawal by Subject|8|||
157061908|NCT03036150|566981588|FG001|Overall Study|Withdrawal by Subject|3|||
157061909|NCT03036150|566981587|FG000|Overall Study|Lost to Follow-up|2|||
157061910|NCT03036150|566981588|FG001|Overall Study|Lost to Follow-up|2|||
157061911|NCT02741713|566981594|FG000|Overall Study|Surgery type changed intra-operatively|2|||
157061912|NCT02741713|566981595|FG001|Overall Study|Surgery type changed intra-operatively|1|||
157061913|NCT01388478|566981596|FG000|Overall Study|Adverse Event|4|||
157061914|NCT01388478|566981596|FG000|Overall Study|Withdrawal by Subject|1|||
157061915|NCT00809341|566981599|FG000|Overall Study|Physician Decision|0|||
157061916|NCT00809341|566981600|FG001|Overall Study|Physician Decision|1|||
157061917|NCT00496626|566981601|FG000|Overall Study|Lost to Follow-up|0|||
157061918|NCT00496626|566981602|FG001|Overall Study|Lost to Follow-up|1|||
157061919|NCT00496626|566981601|FG000|Overall Study|Protocol Violation|1|||
157061920|NCT00496626|566981602|FG001|Overall Study|Protocol Violation|0|||
157061921|NCT00496626|566981601|FG000|Overall Study|Withdrawal by Subject|5|||
157061922|NCT00496626|566981602|FG001|Overall Study|Withdrawal by Subject|4|||
157061923|NCT00496626|566981601|FG000|Overall Study|Relocated|0|||
157061924|NCT00496626|566981602|FG001|Overall Study|Relocated|1|||
157061925|NCT00570921|566981606|FG000|Overall Study|Protocol Violation|1|||
157061926|NCT00570921|566981606|FG000|Overall Study|Physician Decision|1|||
157061927|NCT00550446|566981609|FG000|Up To Week 12|Adverse Event|2|||
157061928|NCT00550446|566981610|FG001|Up To Week 12|Adverse Event|2|||
157061929|NCT00550446|566981611|FG002|Up To Week 12|Adverse Event|0|||
157061930|NCT00550446|566981612|FG003|Up To Week 12|Adverse Event|0|||
157061931|NCT00550446|566981613|FG004|Up To Week 12|Adverse Event|2|||
157061932|NCT00550446|566981614|FG005|Up To Week 12|Adverse Event|2|||
157061933|NCT00550446|566981615|FG006|Up To Week 12|Adverse Event|1|||
157061934|NCT00550446|566981616|FG007|Up To Week 12|Adverse Event|0|||
157061935|NCT00550446|566981617|FG008|Up To Week 12|Adverse Event|0|||
157061936|NCT00550446|566981618|FG009|Up To Week 12|Adverse Event|0|||
157061937|NCT00550446|566981619|FG010|Up To Week 12|Adverse Event|0|||
157061938|NCT00550446|566981609|FG000|Up To Week 12|Lack of Efficacy|3|||
157061939|NCT00550446|566981610|FG001|Up To Week 12|Lack of Efficacy|1|||
157061940|NCT00550446|566981611|FG002|Up To Week 12|Lack of Efficacy|0|||
157061941|NCT00550446|566981612|FG003|Up To Week 12|Lack of Efficacy|1|||
157061942|NCT00550446|566981613|FG004|Up To Week 12|Lack of Efficacy|0|||
157061943|NCT00550446|566981614|FG005|Up To Week 12|Lack of Efficacy|3|||
157061944|NCT00550446|566981615|FG006|Up To Week 12|Lack of Efficacy|3|||
157061945|NCT00550446|566981616|FG007|Up To Week 12|Lack of Efficacy|0|||
157061946|NCT00550446|566981617|FG008|Up To Week 12|Lack of Efficacy|0|||
157183584|NCT03198728|567413103|FG001|Overall Study|Physician Decision|2|||
157183585|NCT03198728|567413102|FG000|Overall Study|Withdrawal by Subject|14|||
157183586|NCT03198728|567413103|FG001|Overall Study|Withdrawal by Subject|10|||
157183587|NCT04051944|567413104|FG000|Overall Study|Study ending|1|||
157183588|NCT04051944|567413105|FG001|Overall Study|Study ending|1|||
157183589|NCT04051944|567413104|FG000|Overall Study|Early study termination by participant|1|||
157183590|NCT04051944|567413105|FG001|Overall Study|Early study termination by participant|0|||
157183591|NCT04051944|567413104|FG000|Overall Study|Withdrawal by Subject|2|||
157183592|NCT04051944|567413105|FG001|Overall Study|Withdrawal by Subject|2|||
157183593|NCT04051944|567413104|FG000|Overall Study|Lack of Efficacy|3|||
157183594|NCT04051944|567413105|FG001|Overall Study|Lack of Efficacy|0|||
157183595|NCT04051944|567413104|FG000|Overall Study|Adverse event, non- fatal|1|||
157183596|NCT04051944|567413105|FG001|Overall Study|Adverse event, non- fatal|1|||
157183597|NCT03083470|567413106|FG000|Overall Study|Lost to Follow-up|0|||
157183598|NCT03083470|567413107|FG001|Overall Study|Lost to Follow-up|0|||
157183599|NCT03083470|567413108|FG002|Overall Study|Lost to Follow-up|0|||
157183600|NCT03083470|567413109|FG003|Overall Study|Lost to Follow-up|0|||
157183601|NCT03083470|567413110|FG004|Overall Study|Lost to Follow-up|1|||
157183602|NCT03083470|567413106|FG000|Overall Study|Withdrawal by Subject|0|||
157183603|NCT03083470|567413107|FG001|Overall Study|Withdrawal by Subject|0|||
157183604|NCT03083470|567413108|FG002|Overall Study|Withdrawal by Subject|0|||
157183605|NCT03083470|567413109|FG003|Overall Study|Withdrawal by Subject|0|||
157183606|NCT03083470|567413110|FG004|Overall Study|Withdrawal by Subject|1|||
157183607|NCT01512693|567413111|FG000|Overall Study|Withdrawal by Subject|0|||
157183608|NCT01512693|567413112|FG001|Overall Study|Withdrawal by Subject|1|||
157183609|NCT01526928|567413113|FG000|Overall Study|Progressive Disease|35|||
157183610|NCT01526928|567413114|FG001|Overall Study|Progressive Disease|17|||
157183611|NCT01526928|567413115|FG002|Overall Study|Progressive Disease|150|||
157183612|NCT01526928|567413116|FG003|Overall Study|Progressive Disease|182|||
157183613|NCT01526928|567413117|FG004|Overall Study|Progressive Disease|76|||
157183614|NCT01526928|567413118|FG005|Overall Study|Progressive Disease|4|||
157183615|NCT01526928|567413113|FG000|Overall Study|Adverse Event|2|||
157183616|NCT01526928|567413114|FG001|Overall Study|Adverse Event|1|||
157183617|NCT01526928|567413115|FG002|Overall Study|Adverse Event|29|||
157183618|NCT01526928|567413116|FG003|Overall Study|Adverse Event|40|||
157183619|NCT01526928|567413117|FG004|Overall Study|Adverse Event|13|||
157183620|NCT01526928|567413118|FG005|Overall Study|Adverse Event|2|||
157183621|NCT01526928|567413113|FG000|Overall Study|Death|0|||
157183622|NCT01526928|567413114|FG001|Overall Study|Death|0|||
157183623|NCT01526928|567413115|FG002|Overall Study|Death|3|||
157183624|NCT01526928|567413116|FG003|Overall Study|Death|0|||
157183625|NCT01526928|567413117|FG004|Overall Study|Death|0|||
157183626|NCT01526928|567413118|FG005|Overall Study|Death|0|||
157183627|NCT01526928|567413113|FG000|Overall Study|Withdrawal by Subject|1|||
157183628|NCT01526928|567413114|FG001|Overall Study|Withdrawal by Subject|0|||
157183629|NCT01526928|567413115|FG002|Overall Study|Withdrawal by Subject|13|||
157183630|NCT01526928|567413116|FG003|Overall Study|Withdrawal by Subject|11|||
157183631|NCT01526928|567413117|FG004|Overall Study|Withdrawal by Subject|3|||
157183632|NCT01526928|567413118|FG005|Overall Study|Withdrawal by Subject|0|||
157183633|NCT01526928|567413113|FG000|Overall Study|Physician Decision|0|||
157183634|NCT01526928|567413114|FG001|Overall Study|Physician Decision|0|||
157183635|NCT01526928|567413115|FG002|Overall Study|Physician Decision|2|||
157183636|NCT01526928|567413116|FG003|Overall Study|Physician Decision|5|||
157183637|NCT01526928|567413117|FG004|Overall Study|Physician Decision|0|||
157183638|NCT01526928|567413118|FG005|Overall Study|Physician Decision|0|||
157183639|NCT01526928|567413113|FG000|Overall Study|Other Reason|0|||
157183640|NCT01526928|567413114|FG001|Overall Study|Other Reason|1|||
157183641|NCT01526928|567413115|FG002|Overall Study|Other Reason|11|||
157061947|NCT00550446|566981618|FG009|Up To Week 12|Lack of Efficacy|0|||
157061948|NCT00550446|566981619|FG010|Up To Week 12|Lack of Efficacy|0|||
157061949|NCT00550446|566981609|FG000|Up To Week 12|Lost to Follow-up|0|||
157061950|NCT00550446|566981610|FG001|Up To Week 12|Lost to Follow-up|1|||
157061951|NCT00550446|566981611|FG002|Up To Week 12|Lost to Follow-up|0|||
157183642|NCT01526928|567413116|FG003|Overall Study|Other Reason|4|||
157183643|NCT01526928|567413117|FG004|Overall Study|Other Reason|1|||
157183644|NCT01526928|567413118|FG005|Overall Study|Other Reason|0|||
157183645|NCT01526928|567413113|FG000|Overall Study|Lost to Follow-up|0|||
157183646|NCT01526928|567413114|FG001|Overall Study|Lost to Follow-up|0|||
157183647|NCT01526928|567413115|FG002|Overall Study|Lost to Follow-up|0|||
157183648|NCT01526928|567413116|FG003|Overall Study|Lost to Follow-up|1|||
157183649|NCT01526928|567413117|FG004|Overall Study|Lost to Follow-up|0|||
157183650|NCT01526928|567413118|FG005|Overall Study|Lost to Follow-up|0|||
157183651|NCT01526928|567413113|FG000|Overall Study|Protocol Deviation|0|||
157061952|NCT00550446|566981612|FG003|Up To Week 12|Lost to Follow-up|0|||
157183652|NCT01526928|567413114|FG001|Overall Study|Protocol Deviation|0|||
157183653|NCT01526928|567413115|FG002|Overall Study|Protocol Deviation|0|||
157183654|NCT01526928|567413116|FG003|Overall Study|Protocol Deviation|2|||
157061953|NCT00550446|566981613|FG004|Up To Week 12|Lost to Follow-up|1|||
157061954|NCT00550446|566981614|FG005|Up To Week 12|Lost to Follow-up|1|||
157183655|NCT01526928|567413117|FG004|Overall Study|Protocol Deviation|0|||
157061955|NCT00550446|566981615|FG006|Up To Week 12|Lost to Follow-up|2|||
157061956|NCT00550446|566981616|FG007|Up To Week 12|Lost to Follow-up|0|||
157061957|NCT00550446|566981617|FG008|Up To Week 12|Lost to Follow-up|0|||
157061958|NCT00550446|566981618|FG009|Up To Week 12|Lost to Follow-up|0|||
157061959|NCT00550446|566981619|FG010|Up To Week 12|Lost to Follow-up|0|||
157061960|NCT00550446|566981609|FG000|Up To Week 12|Withdrawal by Subject|2|||
157061961|NCT00550446|566981610|FG001|Up To Week 12|Withdrawal by Subject|0|||
157061962|NCT00550446|566981611|FG002|Up To Week 12|Withdrawal by Subject|3|||
157061963|NCT00550446|566981612|FG003|Up To Week 12|Withdrawal by Subject|2|||
157061964|NCT00550446|566981613|FG004|Up To Week 12|Withdrawal by Subject|0|||
157061965|NCT00550446|566981614|FG005|Up To Week 12|Withdrawal by Subject|1|||
157061966|NCT00550446|566981615|FG006|Up To Week 12|Withdrawal by Subject|3|||
157061967|NCT00550446|566981616|FG007|Up To Week 12|Withdrawal by Subject|0|||
157061968|NCT00550446|566981617|FG008|Up To Week 12|Withdrawal by Subject|0|||
157061969|NCT00550446|566981618|FG009|Up To Week 12|Withdrawal by Subject|0|||
157061970|NCT00550446|566981619|FG010|Up To Week 12|Withdrawal by Subject|0|||
157061971|NCT00550446|566981609|FG000|Up To Week 12|Other|3|||
157061972|NCT00550446|566981610|FG001|Up To Week 12|Other|0|||
157061973|NCT00550446|566981611|FG002|Up To Week 12|Other|0|||
157061974|NCT00550446|566981612|FG003|Up To Week 12|Other|0|||
157061975|NCT00550446|566981613|FG004|Up To Week 12|Other|0|||
157061976|NCT00550446|566981614|FG005|Up To Week 12|Other|1|||
157061977|NCT00550446|566981615|FG006|Up To Week 12|Other|4|||
157061978|NCT00550446|566981616|FG007|Up To Week 12|Other|0|||
157061979|NCT00550446|566981617|FG008|Up To Week 12|Other|0|||
157061980|NCT00550446|566981618|FG009|Up To Week 12|Other|0|||
157061981|NCT00550446|566981619|FG010|Up To Week 12|Other|0|||
157061982|NCT00550446|566981609|FG000|Up To Week 12|Randomized not treated|0|||
157061983|NCT00550446|566981610|FG001|Up To Week 12|Randomized not treated|1|||
157061984|NCT00550446|566981611|FG002|Up To Week 12|Randomized not treated|1|||
157061985|NCT00550446|566981612|FG003|Up To Week 12|Randomized not treated|0|||
157061986|NCT00550446|566981613|FG004|Up To Week 12|Randomized not treated|0|||
157061987|NCT00550446|566981614|FG005|Up To Week 12|Randomized not treated|0|||
157061988|NCT00550446|566981615|FG006|Up To Week 12|Randomized not treated|0|||
157061989|NCT00550446|566981616|FG007|Up To Week 12|Randomized not treated|0|||
157061990|NCT00550446|566981617|FG008|Up To Week 12|Randomized not treated|0|||
157061991|NCT00550446|566981618|FG009|Up To Week 12|Randomized not treated|0|||
157061992|NCT00550446|566981619|FG010|Up To Week 12|Randomized not treated|0|||
157061993|NCT00550446|566981609|FG000|Post Week 12|Adverse Event|2|||
157061994|NCT00550446|566981610|FG001|Post Week 12|Adverse Event|1|||
157061995|NCT00550446|566981611|FG002|Post Week 12|Adverse Event|1|||
157061996|NCT00550446|566981612|FG003|Post Week 12|Adverse Event|1|||
157061997|NCT00550446|566981613|FG004|Post Week 12|Adverse Event|1|||
157061998|NCT00550446|566981614|FG005|Post Week 12|Adverse Event|1|||
157061999|NCT00550446|566981615|FG006|Post Week 12|Adverse Event|0|||
157062000|NCT00550446|566981616|FG007|Post Week 12|Adverse Event|0|||
157062001|NCT00550446|566981617|FG008|Post Week 12|Adverse Event|0|||
157062002|NCT00550446|566981618|FG009|Post Week 12|Adverse Event|4|||
157062003|NCT00550446|566981619|FG010|Post Week 12|Adverse Event|0|||
157062004|NCT00550446|566981609|FG000|Post Week 12|Lack of Efficacy|0|||
157062005|NCT00550446|566981610|FG001|Post Week 12|Lack of Efficacy|0|||
157062006|NCT00550446|566981611|FG002|Post Week 12|Lack of Efficacy|1|||
157062007|NCT00550446|566981612|FG003|Post Week 12|Lack of Efficacy|0|||
157062008|NCT00550446|566981613|FG004|Post Week 12|Lack of Efficacy|0|||
157062009|NCT00550446|566981614|FG005|Post Week 12|Lack of Efficacy|0|||
157062010|NCT00550446|566981615|FG006|Post Week 12|Lack of Efficacy|0|||
157062011|NCT00550446|566981616|FG007|Post Week 12|Lack of Efficacy|1|||
157062012|NCT00550446|566981617|FG008|Post Week 12|Lack of Efficacy|1|||
157062013|NCT00550446|566981618|FG009|Post Week 12|Lack of Efficacy|2|||
157062014|NCT00550446|566981619|FG010|Post Week 12|Lack of Efficacy|1|||
157062015|NCT00550446|566981609|FG000|Post Week 12|Lost to Follow-up|0|||
157062016|NCT00550446|566981610|FG001|Post Week 12|Lost to Follow-up|0|||
157062017|NCT00550446|566981611|FG002|Post Week 12|Lost to Follow-up|1|||
157062018|NCT00550446|566981612|FG003|Post Week 12|Lost to Follow-up|1|||
157062019|NCT00550446|566981613|FG004|Post Week 12|Lost to Follow-up|0|||
157062020|NCT00550446|566981614|FG005|Post Week 12|Lost to Follow-up|0|||
157062021|NCT00550446|566981615|FG006|Post Week 12|Lost to Follow-up|1|||
157062022|NCT00550446|566981616|FG007|Post Week 12|Lost to Follow-up|0|||
157062023|NCT00550446|566981617|FG008|Post Week 12|Lost to Follow-up|0|||
157062024|NCT00550446|566981618|FG009|Post Week 12|Lost to Follow-up|0|||
157062025|NCT00550446|566981619|FG010|Post Week 12|Lost to Follow-up|0|||
157062026|NCT00550446|566981609|FG000|Post Week 12|Withdrawal by Subject|0|||
157062027|NCT00550446|566981610|FG001|Post Week 12|Withdrawal by Subject|0|||
157062028|NCT00550446|566981611|FG002|Post Week 12|Withdrawal by Subject|0|||
157062029|NCT00550446|566981612|FG003|Post Week 12|Withdrawal by Subject|0|||
157062030|NCT00550446|566981613|FG004|Post Week 12|Withdrawal by Subject|1|||
157062031|NCT00550446|566981614|FG005|Post Week 12|Withdrawal by Subject|0|||
157062032|NCT00550446|566981615|FG006|Post Week 12|Withdrawal by Subject|0|||
157062033|NCT00550446|566981616|FG007|Post Week 12|Withdrawal by Subject|0|||
157062034|NCT00550446|566981617|FG008|Post Week 12|Withdrawal by Subject|0|||
157062035|NCT00550446|566981618|FG009|Post Week 12|Withdrawal by Subject|0|||
157062036|NCT00550446|566981619|FG010|Post Week 12|Withdrawal by Subject|0|||
157062037|NCT00550446|566981609|FG000|Post Week 12|Other|1|||
157062038|NCT00550446|566981610|FG001|Post Week 12|Other|1|||
157062039|NCT00550446|566981611|FG002|Post Week 12|Other|0|||
157062040|NCT00550446|566981612|FG003|Post Week 12|Other|1|||
157062041|NCT00550446|566981613|FG004|Post Week 12|Other|0|||
157183656|NCT01526928|567413118|FG005|Overall Study|Protocol Deviation|0|||
157183657|NCT01526928|567413113|FG000|Overall Study|Missing|0|||
157183658|NCT01526928|567413114|FG001|Overall Study|Missing|0|||
157183659|NCT01526928|567413115|FG002|Overall Study|Missing|1|||
157183660|NCT01526928|567413116|FG003|Overall Study|Missing|0|||
157183661|NCT01526928|567413117|FG004|Overall Study|Missing|2|||
157183662|NCT01526928|567413118|FG005|Overall Study|Missing|0|||
157183663|NCT00736450|567413125|FG000|Overall Study|Not ABC gene eligible|19|||
157183664|NCT00736450|567413125|FG000|Overall Study|Withdrawal by Subject|5|||
157183665|NCT00736450|567413125|FG000|Overall Study|Physician Decision|1|||
157183666|NCT00981747|567413142|FG000|Losartan|Withdrawal by Subject|1|||
157183667|NCT00981747|567413142|FG000|Losartan|Death|1|||
157183668|NCT00981747|567413142|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
157183669|NCT00033371|567413150|FG000|Overall Study|Adverse Event|1|||
157183670|NCT00033371|567413151|FG001|Overall Study|Adverse Event|5|||
157183671|NCT00033371|567413150|FG000|Overall Study|Lost to Follow-up|2|||
157183672|NCT00033371|567413151|FG001|Overall Study|Lost to Follow-up|1|||
157183673|NCT00033371|567413150|FG000|Overall Study|Withdrawal by Subject|3|||
157183674|NCT00033371|567413151|FG001|Overall Study|Withdrawal by Subject|3|||
157183675|NCT00033371|567413150|FG000|Overall Study|Disease Progression|0|||
157183676|NCT00033371|567413151|FG001|Overall Study|Disease Progression|1|||
157183677|NCT02699125|567413154|FG000|Placebo|Lost to Follow-up|2|||
157183678|NCT02699125|567413155|FG001|Placebo|Lost to Follow-up|0|||
157183679|NCT02699125|567413154|FG000|Placebo|Protocol Violation|1|||
157183680|NCT02699125|567413155|FG001|Placebo|Protocol Violation|0|||
157183681|NCT02699125|567413154|FG000|Placebo|Withdrawal by Subject|0|||
157183682|NCT02699125|567413155|FG001|Placebo|Withdrawal by Subject|4|||
157183683|NCT02699125|567413154|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
157183684|NCT02699125|567413155|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
157183685|NCT01390038|567413158|FG000|Overall Study|Death|1|||
157183686|NCT01390038|567413158|FG000|Overall Study|Lost to Follow-up|1|||
157062042|NCT00550446|566981614|FG005|Post Week 12|Other|0|||
157062043|NCT00550446|566981615|FG006|Post Week 12|Other|1|||
157062044|NCT00550446|566981616|FG007|Post Week 12|Other|0|||
157062045|NCT00550446|566981617|FG008|Post Week 12|Other|1|||
157062046|NCT00550446|566981618|FG009|Post Week 12|Other|1|||
157062047|NCT00550446|566981619|FG010|Post Week 12|Other|0|||
157062048|NCT04081389|566981624|FG000|Overall Study|Withdrawal by Subject|0|||
157062049|NCT04081389|566981625|FG001|Overall Study|Withdrawal by Subject|0|||
157062050|NCT04081389|566981626|FG002|Overall Study|Withdrawal by Subject|1|||
157062051|NCT04081389|566981627|FG003|Overall Study|Withdrawal by Subject|0|||
157062052|NCT01114672|566981632|FG000|Overall Study|Death|0|||
157062053|NCT01114672|566981633|FG001|Overall Study|Death|1|||
157062054|NCT01114672|566981632|FG000|Overall Study|Withdrawal by Subject|2|||
157062055|NCT01114672|566981633|FG001|Overall Study|Withdrawal by Subject|1|||
157062056|NCT01114672|566981632|FG000|Overall Study|Lost to Follow-up|1|||
157062057|NCT01114672|566981633|FG001|Overall Study|Lost to Follow-up|0|||
157062058|NCT01114672|566981632|FG000|Overall Study|transplanted|1|||
157062059|NCT01114672|566981633|FG001|Overall Study|transplanted|0|||
157062060|NCT01710800|566981635|FG000|Overall Study|Withdrawal by Subject|21|||
157062061|NCT01710800|566981635|FG000|Overall Study|Protocol Violation|1|||
157062062|NCT00827775|566981636|FG000|Overall Study|Withdrawal by Subject|0|||
157062063|NCT00827775|566981637|FG001|Overall Study|Withdrawal by Subject|5|||
157062064|NCT03891641|566981638|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
157062065|NCT03891641|566981639|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
157062066|NCT00001941|566981640|FG000|Overall Study|not treated- rapidly progressing disease|0|||
157062067|NCT00001941|566981641|FG001|Overall Study|not treated- rapidly progressing disease|0|||
157062068|NCT00001941|566981642|FG002|Overall Study|not treated- rapidly progressing disease|0|||
157062069|NCT00001941|566981643|FG003|Overall Study|not treated- rapidly progressing disease|0|||
157062070|NCT00001941|566981644|FG004|Overall Study|not treated- rapidly progressing disease|1|||
157062071|NCT01281917|566981645|FG000|Overall Study|Withdrawal by Subject|1|||
157062072|NCT00740870|566981646|FG000|Overall Study|Not Catheterized|4|||
157183687|NCT01390038|567413158|FG000|Overall Study|Withdrawal by Subject|4|||
157183688|NCT01390038|567413158|FG000|Overall Study|Simpliciti System Removal|2|||
157183689|NCT03799627|567413163|FG000|Overall Study|Adverse Event|1|||
157183690|NCT03799627|567413164|FG001|Overall Study|Adverse Event|2|||
157183691|NCT03799627|567413165|FG002|Overall Study|Adverse Event|0|||
157183692|NCT03799627|567413166|FG003|Overall Study|Adverse Event|0|||
157183693|NCT03799627|567413167|FG004|Overall Study|Adverse Event|2|||
157183694|NCT03799627|567413168|FG005|Overall Study|Adverse Event|5|||
157062073|NCT00740870|566981646|FG000|Overall Study|Further testing contraindicated implant|17|||
157183695|NCT03799627|567413169|FG006|Overall Study|Adverse Event|0|||
157183696|NCT03799627|567413170|FG007|Overall Study|Adverse Event|2|||
157183697|NCT03799627|567413171|FG008|Overall Study|Adverse Event|0|||
157183698|NCT03799627|567413163|FG000|Overall Study|Physician Decision|2|||
157183699|NCT03799627|567413164|FG001|Overall Study|Physician Decision|2|||
157183700|NCT03799627|567413165|FG002|Overall Study|Physician Decision|0|||
157183701|NCT03799627|567413166|FG003|Overall Study|Physician Decision|0|||
157183702|NCT03799627|567413167|FG004|Overall Study|Physician Decision|2|||
157183703|NCT03799627|567413168|FG005|Overall Study|Physician Decision|2|||
157183704|NCT03799627|567413169|FG006|Overall Study|Physician Decision|0|||
157183705|NCT03799627|567413170|FG007|Overall Study|Physician Decision|0|||
157183706|NCT03799627|567413171|FG008|Overall Study|Physician Decision|0|||
157183707|NCT03799627|567413163|FG000|Overall Study|Withdrawal by Subject|1|||
157183708|NCT03799627|567413164|FG001|Overall Study|Withdrawal by Subject|1|||
157183709|NCT03799627|567413165|FG002|Overall Study|Withdrawal by Subject|0|||
157183710|NCT03799627|567413166|FG003|Overall Study|Withdrawal by Subject|2|||
157183711|NCT03799627|567413167|FG004|Overall Study|Withdrawal by Subject|0|||
157183712|NCT03799627|567413168|FG005|Overall Study|Withdrawal by Subject|3|||
157183713|NCT03799627|567413169|FG006|Overall Study|Withdrawal by Subject|0|||
157183714|NCT03799627|567413170|FG007|Overall Study|Withdrawal by Subject|0|||
157183715|NCT03799627|567413171|FG008|Overall Study|Withdrawal by Subject|0|||
157183716|NCT03799627|567413163|FG000|Overall Study|Lack of Efficacy|0|||
157183717|NCT03799627|567413164|FG001|Overall Study|Lack of Efficacy|0|||
157183718|NCT03799627|567413165|FG002|Overall Study|Lack of Efficacy|0|||
157183719|NCT03799627|567413166|FG003|Overall Study|Lack of Efficacy|1|||
157183720|NCT03799627|567413167|FG004|Overall Study|Lack of Efficacy|0|||
157183721|NCT03799627|567413168|FG005|Overall Study|Lack of Efficacy|0|||
157183722|NCT03799627|567413169|FG006|Overall Study|Lack of Efficacy|0|||
157183723|NCT03799627|567413170|FG007|Overall Study|Lack of Efficacy|0|||
157183724|NCT03799627|567413171|FG008|Overall Study|Lack of Efficacy|0|||
157183725|NCT03799627|567413163|FG000|Overall Study|Lost to Follow-up|0|||
157183726|NCT03799627|567413164|FG001|Overall Study|Lost to Follow-up|0|||
157183727|NCT03799627|567413165|FG002|Overall Study|Lost to Follow-up|0|||
157183728|NCT03799627|567413166|FG003|Overall Study|Lost to Follow-up|0|||
157183729|NCT03799627|567413167|FG004|Overall Study|Lost to Follow-up|0|||
157183730|NCT03799627|567413168|FG005|Overall Study|Lost to Follow-up|0|||
157183731|NCT03799627|567413169|FG006|Overall Study|Lost to Follow-up|1|||
157183732|NCT03799627|567413170|FG007|Overall Study|Lost to Follow-up|0|||
157183733|NCT03799627|567413171|FG008|Overall Study|Lost to Follow-up|1|||
157183734|NCT03799627|567413163|FG000|Overall Study|Death|0|||
157183735|NCT03799627|567413164|FG001|Overall Study|Death|0|||
157183736|NCT03799627|567413165|FG002|Overall Study|Death|0|||
157183737|NCT03799627|567413166|FG003|Overall Study|Death|1|||
157183738|NCT03799627|567413167|FG004|Overall Study|Death|0|||
157183739|NCT03799627|567413168|FG005|Overall Study|Death|0|||
157183740|NCT03799627|567413169|FG006|Overall Study|Death|0|||
157183741|NCT03799627|567413170|FG007|Overall Study|Death|0|||
157183742|NCT03799627|567413171|FG008|Overall Study|Death|0|||
157183743|NCT03799627|567413163|FG000|Overall Study|Study Drug Put on Hold|1|||
157183744|NCT03799627|567413164|FG001|Overall Study|Study Drug Put on Hold|0|||
157183745|NCT03799627|567413165|FG002|Overall Study|Study Drug Put on Hold|0|||
157183746|NCT03799627|567413166|FG003|Overall Study|Study Drug Put on Hold|0|||
157183747|NCT03799627|567413167|FG004|Overall Study|Study Drug Put on Hold|0|||
157183748|NCT03799627|567413168|FG005|Overall Study|Study Drug Put on Hold|0|||
157183749|NCT03799627|567413169|FG006|Overall Study|Study Drug Put on Hold|0|||
157183750|NCT03799627|567413170|FG007|Overall Study|Study Drug Put on Hold|0|||
157183751|NCT03799627|567413171|FG008|Overall Study|Study Drug Put on Hold|0|||
157183752|NCT03799627|567413163|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
157183753|NCT03799627|567413164|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
157183754|NCT03799627|567413165|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
157183755|NCT03799627|567413166|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
157230015|NCT00162123|567588220|FG000|Overall Study|Withdrawal by Subject|2|||
157230016|NCT00162123|567588221|FG001|Overall Study|Withdrawal by Subject|0|||
157230017|NCT00162123|567588222|FG002|Overall Study|Withdrawal by Subject|2|||
157183756|NCT03799627|567413167|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
157183757|NCT03799627|567413168|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
157183758|NCT03799627|567413169|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
157183759|NCT03799627|567413170|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
157230018|NCT00162123|567588223|FG003|Overall Study|Withdrawal by Subject|1|||
157183760|NCT03799627|567413171|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
157183761|NCT03799627|567413163|FG000|Overall Study|Kidney Transplantation|1|||
157183762|NCT03799627|567413164|FG001|Overall Study|Kidney Transplantation|0|||
157183763|NCT03799627|567413165|FG002|Overall Study|Kidney Transplantation|0|||
157183764|NCT03799627|567413166|FG003|Overall Study|Kidney Transplantation|1|||
157183765|NCT03799627|567413167|FG004|Overall Study|Kidney Transplantation|1|||
157183766|NCT03799627|567413168|FG005|Overall Study|Kidney Transplantation|0|||
157183767|NCT03799627|567413169|FG006|Overall Study|Kidney Transplantation|0|||
157183768|NCT03799627|567413170|FG007|Overall Study|Kidney Transplantation|0|||
157183769|NCT03799627|567413171|FG008|Overall Study|Kidney Transplantation|0|||
157183770|NCT03799627|567413163|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
157183771|NCT03799627|567413164|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
157183772|NCT03799627|567413165|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
157183773|NCT03799627|567413166|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
157183774|NCT03799627|567413167|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
157183775|NCT03799627|567413168|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
157183776|NCT03799627|567413169|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
157183777|NCT03799627|567413170|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
157183778|NCT03799627|567413171|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
157183779|NCT03799627|567413163|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183780|NCT03799627|567413164|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
157183781|NCT03799627|567413165|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183782|NCT03799627|567413166|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183783|NCT03799627|567413167|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183784|NCT03799627|567413168|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183785|NCT03799627|567413169|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183786|NCT03799627|567413170|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183787|NCT03799627|567413171|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
157183788|NCT03799627|567413163|FG000|Overall Study|Met Exclusion Criteria|0|||
157183789|NCT03799627|567413164|FG001|Overall Study|Met Exclusion Criteria|0|||
157183790|NCT03799627|567413165|FG002|Overall Study|Met Exclusion Criteria|0|||
157183791|NCT03799627|567413166|FG003|Overall Study|Met Exclusion Criteria|1|||
157183792|NCT03799627|567413167|FG004|Overall Study|Met Exclusion Criteria|0|||
157183793|NCT03799627|567413168|FG005|Overall Study|Met Exclusion Criteria|0|||
157183794|NCT03799627|567413169|FG006|Overall Study|Met Exclusion Criteria|0|||
157183795|NCT03799627|567413170|FG007|Overall Study|Met Exclusion Criteria|0|||
157183796|NCT03799627|567413171|FG008|Overall Study|Met Exclusion Criteria|0|||
157183797|NCT03799627|567413163|FG000|Overall Study|Investigational Product Noncompliance|0|||
157183798|NCT03799627|567413164|FG001|Overall Study|Investigational Product Noncompliance|0|||
157183799|NCT03799627|567413165|FG002|Overall Study|Investigational Product Noncompliance|0|||
157183800|NCT03799627|567413166|FG003|Overall Study|Investigational Product Noncompliance|1|||
157183801|NCT03799627|567413167|FG004|Overall Study|Investigational Product Noncompliance|0|||
157183802|NCT03799627|567413168|FG005|Overall Study|Investigational Product Noncompliance|0|||
157183803|NCT03799627|567413169|FG006|Overall Study|Investigational Product Noncompliance|0|||
157183804|NCT03799627|567413170|FG007|Overall Study|Investigational Product Noncompliance|0|||
157183805|NCT03799627|567413171|FG008|Overall Study|Investigational Product Noncompliance|0|||
157183806|NCT03799627|567413163|FG000|Overall Study|Participant Relocation|0|||
157183807|NCT03799627|567413164|FG001|Overall Study|Participant Relocation|0|||
157183808|NCT03799627|567413165|FG002|Overall Study|Participant Relocation|0|||
157183809|NCT03799627|567413166|FG003|Overall Study|Participant Relocation|1|||
157183810|NCT03799627|567413167|FG004|Overall Study|Participant Relocation|0|||
157183811|NCT03799627|567413168|FG005|Overall Study|Participant Relocation|1|||
157183812|NCT03799627|567413169|FG006|Overall Study|Participant Relocation|0|||
157183813|NCT03799627|567413170|FG007|Overall Study|Participant Relocation|0|||
157183814|NCT03799627|567413171|FG008|Overall Study|Participant Relocation|0|||
157183815|NCT03799627|567413163|FG000|Overall Study|Eurofin Issue|0|||
157183816|NCT03799627|567413164|FG001|Overall Study|Eurofin Issue|0|||
157183817|NCT03799627|567413165|FG002|Overall Study|Eurofin Issue|0|||
157183818|NCT03799627|567413166|FG003|Overall Study|Eurofin Issue|0|||
157183819|NCT03799627|567413167|FG004|Overall Study|Eurofin Issue|1|||
157183820|NCT03799627|567413168|FG005|Overall Study|Eurofin Issue|0|||
157183821|NCT03799627|567413169|FG006|Overall Study|Eurofin Issue|0|||
157183822|NCT03799627|567413170|FG007|Overall Study|Eurofin Issue|0|||
157183823|NCT03799627|567413171|FG008|Overall Study|Eurofin Issue|0|||
157183824|NCT03799627|567413163|FG000|Overall Study|Noncompliance with Site Instructions|0|||
157183825|NCT03799627|567413164|FG001|Overall Study|Noncompliance with Site Instructions|0|||
157183826|NCT03799627|567413165|FG002|Overall Study|Noncompliance with Site Instructions|0|||
157183827|NCT03799627|567413166|FG003|Overall Study|Noncompliance with Site Instructions|0|||
157183828|NCT03799627|567413167|FG004|Overall Study|Noncompliance with Site Instructions|1|||
157183829|NCT03799627|567413168|FG005|Overall Study|Noncompliance with Site Instructions|0|||
157183830|NCT03799627|567413169|FG006|Overall Study|Noncompliance with Site Instructions|0|||
157230019|NCT00162123|567588224|FG004|Overall Study|Withdrawal by Subject|1|||
157230020|NCT00162123|567588225|FG005|Overall Study|Withdrawal by Subject|2|||
157230021|NCT00162123|567588226|FG006|Overall Study|Withdrawal by Subject|1|||
157230022|NCT00162123|567588227|FG007|Overall Study|Withdrawal by Subject|0|||
157183831|NCT03799627|567413170|FG007|Overall Study|Noncompliance with Site Instructions|0|||
157183832|NCT03799627|567413171|FG008|Overall Study|Noncompliance with Site Instructions|0|||
157183833|NCT03799627|567413163|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183834|NCT03799627|567413164|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157230023|NCT00162123|567588220|FG000|Overall Study|Deterioration without progression|2|||
157183835|NCT03799627|567413165|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183836|NCT03799627|567413166|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183837|NCT03799627|567413167|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
157183838|NCT03799627|567413168|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183839|NCT03799627|567413169|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183840|NCT03799627|567413170|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183841|NCT03799627|567413171|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
157183842|NCT03799627|567413163|FG000|Overall Study|Changes In Hemoglobin Values|1|||
157183843|NCT03799627|567413164|FG001|Overall Study|Changes In Hemoglobin Values|2|||
157183844|NCT03799627|567413165|FG002|Overall Study|Changes In Hemoglobin Values|1|||
157183845|NCT03799627|567413166|FG003|Overall Study|Changes In Hemoglobin Values|0|||
157183846|NCT03799627|567413167|FG004|Overall Study|Changes In Hemoglobin Values|0|||
157183847|NCT03799627|567413168|FG005|Overall Study|Changes In Hemoglobin Values|2|||
157183848|NCT03799627|567413169|FG006|Overall Study|Changes In Hemoglobin Values|1|||
157183849|NCT03799627|567413170|FG007|Overall Study|Changes In Hemoglobin Values|0|||
157183850|NCT03799627|567413171|FG008|Overall Study|Changes In Hemoglobin Values|1|||
157183851|NCT03418376|567413181|FG000|Overall Study|Musculoskeletal injury|1|||
157183852|NCT03418376|567413182|FG001|Overall Study|Musculoskeletal injury|2|||
157183853|NCT03418376|567413183|FG002|Overall Study|Musculoskeletal injury|1|||
157183854|NCT03418376|567413184|FG003|Overall Study|Musculoskeletal injury|0|||
157183855|NCT03418376|567413181|FG000|Overall Study|Personal reasons|0|||
157183856|NCT03418376|567413182|FG001|Overall Study|Personal reasons|2|||
157183857|NCT03418376|567413183|FG002|Overall Study|Personal reasons|2|||
157183858|NCT03418376|567413184|FG003|Overall Study|Personal reasons|1|||
157183859|NCT03418376|567413181|FG000|Overall Study|Exacerbation|0|||
157183860|NCT03418376|567413182|FG001|Overall Study|Exacerbation|1|||
157183861|NCT03418376|567413183|FG002|Overall Study|Exacerbation|0|||
157183862|NCT03418376|567413184|FG003|Overall Study|Exacerbation|0|||
157183863|NCT00814307|567413185|FG000|Overall Study|Randomized but not treated|1|||
157183864|NCT00814307|567413186|FG001|Overall Study|Randomized but not treated|0|||
157183865|NCT00814307|567413187|FG002|Overall Study|Randomized but not treated|0|||
157183866|NCT00814307|567413188|FG003|Overall Study|Randomized but not treated|0|||
157183867|NCT00814307|567413185|FG000|Overall Study|Adverse Event|3|||
157183868|NCT00814307|567413186|FG001|Overall Study|Adverse Event|9|||
157183869|NCT00814307|567413187|FG002|Overall Study|Adverse Event|3|||
157183870|NCT00814307|567413188|FG003|Overall Study|Adverse Event|2|||
157183871|NCT00814307|567413185|FG000|Overall Study|Lack of Efficacy|1|||
157183872|NCT00814307|567413186|FG001|Overall Study|Lack of Efficacy|1|||
157183873|NCT00814307|567413187|FG002|Overall Study|Lack of Efficacy|3|||
157183874|NCT00814307|567413188|FG003|Overall Study|Lack of Efficacy|4|||
157183875|NCT00814307|567413185|FG000|Overall Study|Other|1|||
157183876|NCT00814307|567413186|FG001|Overall Study|Other|2|||
157183877|NCT00814307|567413187|FG002|Overall Study|Other|0|||
157183878|NCT00814307|567413188|FG003|Overall Study|Other|1|||
157183879|NCT00814307|567413185|FG000|Overall Study|Protocol Violation|2|||
157183880|NCT00814307|567413186|FG001|Overall Study|Protocol Violation|8|||
157183881|NCT00814307|567413187|FG002|Overall Study|Protocol Violation|1|||
157183882|NCT00814307|567413188|FG003|Overall Study|Protocol Violation|1|||
157183883|NCT00814307|567413185|FG000|Overall Study|Withdrawal by Subject|4|||
157183884|NCT00814307|567413186|FG001|Overall Study|Withdrawal by Subject|6|||
157183885|NCT00814307|567413187|FG002|Overall Study|Withdrawal by Subject|0|||
157183886|NCT00814307|567413188|FG003|Overall Study|Withdrawal by Subject|2|||
157183887|NCT00814307|567413185|FG000|Overall Study|Death|0|||
157183888|NCT00814307|567413186|FG001|Overall Study|Death|1|||
157183889|NCT00814307|567413187|FG002|Overall Study|Death|0|||
157062074|NCT00819013|566981647|FG000|Overall Study|Not meeting continuing study eligibility|2|||
157062075|NCT00819013|566981648|FG001|Overall Study|Not meeting continuing study eligibility|1|||
157230024|NCT00162123|567588221|FG001|Overall Study|Deterioration without progression|2|||
157062076|NCT00819013|566981649|FG002|Overall Study|Not meeting continuing study eligibility|2|||
157183890|NCT00814307|567413188|FG003|Overall Study|Death|0|||
157183891|NCT00149890|567413192|FG000|Overall Study|Adverse Event|1|||
157183892|NCT00149890|567413193|FG001|Overall Study|Adverse Event|8|||
157183893|NCT00149890|567413192|FG000|Overall Study|Lack of Efficacy|8|||
157183894|NCT00149890|567413193|FG001|Overall Study|Lack of Efficacy|9|||
157183895|NCT00149890|567413192|FG000|Overall Study|Protocol Violation|1|||
157183896|NCT00149890|567413193|FG001|Overall Study|Protocol Violation|0|||
157183897|NCT00149890|567413192|FG000|Overall Study|Lost to Follow-up|1|||
157183898|NCT00149890|567413193|FG001|Overall Study|Lost to Follow-up|0|||
157183899|NCT00149890|567413192|FG000|Overall Study|Graft Loss|2|||
157183900|NCT00149890|567413193|FG001|Overall Study|Graft Loss|1|||
157183901|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
157183902|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
157183903|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
157183904|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
157183905|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
157183906|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
157183907|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
157183908|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
157183909|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
157183910|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
157183911|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
157183912|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
157183913|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
157183914|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
157183915|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
157183916|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
157183917|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
157183918|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
157183919|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
157183920|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
157183921|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
157183922|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
157183923|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
157183924|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
157183925|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
157183926|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
157183927|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
157183928|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
157183929|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
157183930|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
157183931|NCT04757376|567413194|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
157183932|NCT04757376|567413195|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
157183933|NCT04757376|567413196|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
157183934|NCT04757376|567413197|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
157183935|NCT04757376|567413198|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
157183936|NCT04757376|567413194|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
157183937|NCT04757376|567413195|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
157183938|NCT04757376|567413196|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
157183939|NCT04757376|567413197|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
157183940|NCT04757376|567413198|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
157183941|NCT01307046|567413199|FG000|Overall Study|Adverse Event|3|||
157183942|NCT01307046|567413200|FG001|Overall Study|Adverse Event|3|||
157183943|NCT01307046|567413199|FG000|Overall Study|Lack of Efficacy|0|||
157183944|NCT01307046|567413200|FG001|Overall Study|Lack of Efficacy|2|||
157183945|NCT01307046|567413199|FG000|Overall Study|Physician Decision|2|||
157183946|NCT01307046|567413200|FG001|Overall Study|Physician Decision|0|||
157183947|NCT01307046|567413199|FG000|Overall Study|Withdrawal by Subject|1|||
157183948|NCT01307046|567413200|FG001|Overall Study|Withdrawal by Subject|1|||
157183949|NCT01307046|567413199|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
157183950|NCT01307046|567413200|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
157183951|NCT01307046|567413199|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
157183952|NCT01307046|567413200|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
157183953|NCT03898323|567413201|FG000|Overall Study|Physician Decision|1|||
157183954|NCT02571972|567413208|FG000|Overall Study|Protocol Violation|2|||
157183955|NCT02571972|567413208|FG000|Overall Study|Withdrawal by Subject|2|||
157183956|NCT03277794|567413213|FG000|Overall Study|Lost to Follow-up|2|||
157183957|NCT03277794|567413214|FG001|Overall Study|Lost to Follow-up|4|||
157183958|NCT03277794|567413213|FG000|Overall Study|Withdrew due to high acuity|1|||
157183959|NCT03277794|567413214|FG001|Overall Study|Withdrew due to high acuity|0|||
157183960|NCT05166603|567413218|FG000|Overall Study|Withdrawal by Subject|68|||
157183961|NCT05166603|567413219|FG001|Overall Study|Withdrawal by Subject|0|||
157183962|NCT02710422|567415154|FG000|Overall Study|Termination of study|9|||
157183963|NCT02710422|567415155|FG001|Overall Study|Termination of study|9|||
157183964|NCT01370499|567415156|FG000|Overall Study|Adverse Event|38|||
157183965|NCT01370499|567415157|FG001|Overall Study|Adverse Event|12|||
157183966|NCT01370499|567415156|FG000|Overall Study|Lack of Efficacy|4|||
157183967|NCT01370499|567415157|FG001|Overall Study|Lack of Efficacy|2|||
157183968|NCT01370499|567415156|FG000|Overall Study|Lost to Follow-up|2|||
157183969|NCT01370499|567415157|FG001|Overall Study|Lost to Follow-up|1|||
157062077|NCT00819013|566981650|FG003|Overall Study|Not meeting continuing study eligibility|1|||
157062078|NCT00819013|566981647|FG000|Overall Study|Adverse Event|0|||
157062079|NCT00819013|566981648|FG001|Overall Study|Adverse Event|0|||
157062080|NCT00819013|566981649|FG002|Overall Study|Adverse Event|1|||
157062081|NCT00819013|566981650|FG003|Overall Study|Adverse Event|0|||
157062082|NCT00819013|566981647|FG000|Overall Study|Withdrawal by Subject|1|||
157062083|NCT00819013|566981648|FG001|Overall Study|Withdrawal by Subject|0|||
157062084|NCT00819013|566981649|FG002|Overall Study|Withdrawal by Subject|1|||
157062085|NCT00819013|566981650|FG003|Overall Study|Withdrawal by Subject|0|||
157062086|NCT00819013|566981647|FG000|Overall Study|Lost to Follow-up|0|||
157062087|NCT00819013|566981648|FG001|Overall Study|Lost to Follow-up|0|||
157062088|NCT00819013|566981649|FG002|Overall Study|Lost to Follow-up|1|||
157062089|NCT00819013|566981650|FG003|Overall Study|Lost to Follow-up|2|||
157062090|NCT00819013|566981647|FG000|Overall Study|Death|0|||
157062091|NCT00819013|566981648|FG001|Overall Study|Death|0|||
157062092|NCT00819013|566981649|FG002|Overall Study|Death|0|||
157062093|NCT00819013|566981650|FG003|Overall Study|Death|1|||
157062094|NCT00607997|566981651|FG000|Overall Study|Lack of Efficacy|6|||
157062095|NCT00607997|566981652|FG001|Overall Study|Lack of Efficacy|20|||
157062096|NCT00607997|566981653|FG002|Overall Study|Lack of Efficacy|14|||
157062097|NCT00607997|566981654|FG003|Overall Study|Lack of Efficacy|10|||
157062098|NCT00607997|566981651|FG000|Overall Study|Death|8|||
157062099|NCT00607997|566981652|FG001|Overall Study|Death|5|||
157062100|NCT00607997|566981653|FG002|Overall Study|Death|2|||
157062101|NCT00607997|566981654|FG003|Overall Study|Death|5|||
157062102|NCT00607997|566981651|FG000|Overall Study|Adverse Event|3|||
157062103|NCT00607997|566981652|FG001|Overall Study|Adverse Event|1|||
157062104|NCT00607997|566981653|FG002|Overall Study|Adverse Event|2|||
157062105|NCT00607997|566981654|FG003|Overall Study|Adverse Event|0|||
157062106|NCT00607997|566981651|FG000|Overall Study|Physician Decision|4|||
157062107|NCT00607997|566981652|FG001|Overall Study|Physician Decision|1|||
157062108|NCT00607997|566981653|FG002|Overall Study|Physician Decision|0|||
157062109|NCT00607997|566981654|FG003|Overall Study|Physician Decision|0|||
157062110|NCT00607997|566981651|FG000|Overall Study|Relapse, recurrent illness|4|||
157062111|NCT00607997|566981652|FG001|Overall Study|Relapse, recurrent illness|0|||
157062112|NCT00607997|566981653|FG002|Overall Study|Relapse, recurrent illness|2|||
157062113|NCT00607997|566981654|FG003|Overall Study|Relapse, recurrent illness|0|||
157062114|NCT00607997|566981651|FG000|Overall Study|Other without explanation|2|||
157062115|NCT00607997|566981652|FG001|Overall Study|Other without explanation|0|||
157062116|NCT00607997|566981653|FG002|Overall Study|Other without explanation|4|||
157062117|NCT00607997|566981654|FG003|Overall Study|Other without explanation|1|||
157062118|NCT06080438|566981655|FG000|Overall Study|Lost to Follow-up|2|||
157062119|NCT03078751|566981656|FG000|Overall Study|Adverse Event|4|||
157062120|NCT03078751|566981657|FG001|Overall Study|Adverse Event|0|||
157062121|NCT03078751|566981656|FG000|Overall Study|Physician Decision|1|||
157062122|NCT03078751|566981657|FG001|Overall Study|Physician Decision|0|||
157062123|NCT03078751|566981656|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
157062124|NCT03078751|566981657|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
157062125|NCT03078751|566981656|FG000|Overall Study|Subject/guardian decision|8|||
157062126|NCT03078751|566981657|FG001|Overall Study|Subject/guardian decision|1|||
157062127|NCT03078751|566981656|FG000|Overall Study|Untreated|0|||
157062128|NCT03078751|566981657|FG001|Overall Study|Untreated|4|||
157062129|NCT02551692|566981661|FG000|Overall Study|Lost to Follow-up|0|||
157062130|NCT02551692|566981662|FG001|Overall Study|Lost to Follow-up|1|||
157062131|NCT02551692|566981663|FG002|Overall Study|Lost to Follow-up|4|||
157062132|NCT02551692|566981661|FG000|Overall Study|Withdrawal by Subject|1|||
157062133|NCT02551692|566981662|FG001|Overall Study|Withdrawal by Subject|0|||
157062134|NCT02551692|566981663|FG002|Overall Study|Withdrawal by Subject|1|||
157062135|NCT01196741|566981664|FG000|Overall Study|Disease progression|34|||
157062136|NCT01196741|566981665|FG001|Overall Study|Disease progression|14|||
157062137|NCT01196741|566981664|FG000|Overall Study|Adverse Event|10|||
157062138|NCT01196741|566981665|FG001|Overall Study|Adverse Event|6|||
157062139|NCT01196741|566981664|FG000|Overall Study|Serious Adverse Event|3|||
157062140|NCT01196741|566981665|FG001|Overall Study|Serious Adverse Event|1|||
157062141|NCT01196741|566981664|FG000|Overall Study|Dose limiting Adverse Event|2|||
157062142|NCT01196741|566981665|FG001|Overall Study|Dose limiting Adverse Event|1|||
157062143|NCT01196741|566981664|FG000|Overall Study|Withdrawal by Subject|3|||
157062144|NCT01196741|566981665|FG001|Overall Study|Withdrawal by Subject|0|||
157062145|NCT01196741|566981664|FG000|Overall Study|Other reason|3|||
157062146|NCT01196741|566981665|FG001|Overall Study|Other reason|3|||
157183970|NCT01370499|567415156|FG000|Overall Study|Physician Decision|3|||
157062147|NCT01196741|566981664|FG000|Overall Study|Other|3|||
157062148|NCT01196741|566981665|FG001|Overall Study|Other|2|||
157062149|NCT01196741|566981664|FG000|Overall Study|Protocol Violation|2|||
157062150|NCT01196741|566981665|FG001|Overall Study|Protocol Violation|1|||
157062151|NCT04380688|566981666|FG000|Overall Study|Death|2|||
157062152|NCT04380688|566981667|FG001|Overall Study|Death|2|||
157062153|NCT04380688|566981666|FG000|Overall Study|Lost to Follow-up|2|||
157062154|NCT04380688|566981667|FG001|Overall Study|Lost to Follow-up|4|||
157183971|NCT01370499|567415157|FG001|Overall Study|Physician Decision|3|||
157183972|NCT01370499|567415156|FG000|Overall Study|Protocol Violation|5|||
157183973|NCT01370499|567415157|FG001|Overall Study|Protocol Violation|4|||
157183974|NCT01370499|567415156|FG000|Overall Study|Withdrawal by Subject|18|||
157183975|NCT01370499|567415157|FG001|Overall Study|Withdrawal by Subject|7|||
157183976|NCT01370499|567415156|FG000|Overall Study|Sponsor Decision|41|||
157183977|NCT01370499|567415157|FG001|Overall Study|Sponsor Decision|15|||
157183978|NCT00887822|567415158|FG000|Overall Study|Insufficient therapeutic response|53|||
157183979|NCT00887822|567415159|FG001|Overall Study|Insufficient therapeutic response|55|||
157183980|NCT00887822|567415158|FG000|Overall Study|Adverse Event|14|||
157183981|NCT00887822|567415159|FG001|Overall Study|Adverse Event|17|||
157183982|NCT00887822|567415158|FG000|Overall Study|Failure to return|11|||
157183983|NCT00887822|567415159|FG001|Overall Study|Failure to return|11|||
157183984|NCT00887822|567415158|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
157183985|NCT00887822|567415159|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
157183986|NCT00887822|567415158|FG000|Overall Study|Administrative/Other than specified|5|||
157062155|NCT04380688|566981666|FG000|Overall Study|Withdrawal by Subject|3|||
157062156|NCT04380688|566981667|FG001|Overall Study|Withdrawal by Subject|3|||
157062157|NCT00919061|566981668|FG000|Overall Study|Adverse Event|1|||
157062158|NCT00919061|566981668|FG000|Overall Study|Withdrawal by Subject|1|||
157062159|NCT02056873|566981669|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
157062160|NCT01932762|566983203|FG000|Overall Study|Withdrawal by Subject|1|||
157062161|NCT01932762|566983204|FG001|Overall Study|Withdrawal by Subject|2|||
157062162|NCT01932762|566983205|FG002|Overall Study|Withdrawal by Subject|0|||
157062163|NCT01932762|566983206|FG003|Overall Study|Withdrawal by Subject|0|||
157062164|NCT01932762|566983203|FG000|Overall Study|Lost to Follow-up|4|||
157062165|NCT01932762|566983204|FG001|Overall Study|Lost to Follow-up|0|||
157062166|NCT01932762|566983205|FG002|Overall Study|Lost to Follow-up|0|||
157062167|NCT01932762|566983206|FG003|Overall Study|Lost to Follow-up|1|||
157062168|NCT01932762|566983203|FG000|Overall Study|Physician Decision|1|||
157062169|NCT01932762|566983204|FG001|Overall Study|Physician Decision|0|||
157062170|NCT01932762|566983205|FG002|Overall Study|Physician Decision|0|||
157062171|NCT01932762|566983206|FG003|Overall Study|Physician Decision|0|||
157062172|NCT02210208|566983207|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
157062173|NCT02210208|566983207|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
157062174|NCT02210208|566983207|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
157062175|NCT00695136|566983208|FG000|Overall Study|Withdrawal by Subject|1|||
157062176|NCT00695136|566983208|FG000|Overall Study|unrelated adverse event|1|||
157062177|NCT01726049|566983209|FG000|Overall Study|Death|1|||
157062178|NCT01726049|566983210|FG001|Overall Study|Death|1|||
157062179|NCT01726049|566983209|FG000|Overall Study|Adverse Event|4|||
157062180|NCT01726049|566983210|FG001|Overall Study|Adverse Event|1|||
157062181|NCT01726049|566983209|FG000|Overall Study|refused second HC|0|||
157062182|NCT01726049|566983210|FG001|Overall Study|refused second HC|2|||
157062183|NCT01929876|566983211|FG000|Period 2|Non-Compliance|1|||
157062184|NCT03991988|566983212|FG000|Overall Study|Withdrawal by Subject|2|||
157062185|NCT03991988|566983213|FG001|Overall Study|Withdrawal by Subject|2|||
157062186|NCT01222533|566983215|FG000|Overall Study|Adverse Event|5|||
157062187|NCT01222533|566983215|FG000|Overall Study|Withdrawal by Subject|5|||
157062188|NCT01222533|566983215|FG000|Overall Study|Other|4|||
157062189|NCT05446714|566983216|FG000|Overall Study|Lost to Follow-up|1|||
157062190|NCT05446714|566983217|FG001|Overall Study|Lost to Follow-up|3|||
157062191|NCT05446714|566983218|FG002|Overall Study|Lost to Follow-up|2|||
157062192|NCT05446714|566983216|FG000|Overall Study|Protocol Violation|2|||
157062193|NCT05446714|566983217|FG001|Overall Study|Protocol Violation|0|||
157062194|NCT05446714|566983218|FG002|Overall Study|Protocol Violation|0|||
157062195|NCT03024996|566983222|FG000|Overall Study|Death|57|||
157062196|NCT03024996|566983223|FG001|Overall Study|Death|55|||
157183987|NCT00887822|567415159|FG001|Overall Study|Administrative/Other than specified|4|||
157183988|NCT00887822|567415158|FG000|Overall Study|Death|2|||
157183989|NCT00887822|567415159|FG001|Overall Study|Death|3|||
157183990|NCT00887822|567415158|FG000|Overall Study|Protocol Violation|0|||
157183991|NCT00887822|567415159|FG001|Overall Study|Protocol Violation|1|||
157062197|NCT03024996|566983222|FG000|Overall Study|Disease relapse|1|||
157062198|NCT03024996|566983223|FG001|Overall Study|Disease relapse|0|||
157062199|NCT03024996|566983222|FG000|Overall Study|Lost to Follow-up|5|||
157062200|NCT03024996|566983223|FG001|Overall Study|Lost to Follow-up|10|||
157183992|NCT00887822|567415158|FG000|Overall Study|Randomized but not treated|0|||
157183993|NCT00887822|567415159|FG001|Overall Study|Randomized but not treated|1|||
157062201|NCT03024996|566983222|FG000|Overall Study|Other|3|||
157062202|NCT03024996|566983223|FG001|Overall Study|Other|3|||
157062203|NCT03024996|566983222|FG000|Overall Study|Physician Decision|0|||
157062204|NCT03024996|566983223|FG001|Overall Study|Physician Decision|1|||
157062205|NCT03024996|566983222|FG000|Overall Study|Study terminated by sponsor|303|||
157183994|NCT02045979|567415163|FG000|Overall Study|Informed Consent Withdrawn|2|||
157183995|NCT02045979|567415164|FG001|Overall Study|Informed Consent Withdrawn|0|||
157062206|NCT03024996|566983223|FG001|Overall Study|Study terminated by sponsor|283|||
157062207|NCT03024996|566983222|FG000|Overall Study|Withdrawal by Subject|21|||
157183996|NCT02045979|567415165|FG002|Overall Study|Informed Consent Withdrawn|1|||
157183997|NCT02045979|567415163|FG000|Overall Study|not specified above|0|||
157183998|NCT02045979|567415164|FG001|Overall Study|not specified above|1|||
157183999|NCT02045979|567415165|FG002|Overall Study|not specified above|0|||
157184000|NCT00378534|567415171|FG000|Overall Study|Participants did not receive transplant|3|||
157184001|NCT00378534|567415172|FG001|Overall Study|Participants did not receive transplant|0|||
157184002|NCT00425945|567415176|FG000|Overall Study|Concern about Supplement|2|||
157184003|NCT00425945|567415177|FG001|Overall Study|Concern about Supplement|0|||
157184004|NCT00425945|567415176|FG000|Overall Study|Inconvenience|0|||
157184005|NCT00425945|567415177|FG001|Overall Study|Inconvenience|2|||
157184006|NCT00425945|567415176|FG000|Overall Study|Lost to Follow-up|0|||
157184007|NCT00425945|567415177|FG001|Overall Study|Lost to Follow-up|2|||
157184008|NCT00425945|567415176|FG000|Overall Study|Began hypertension medication|1|||
157184009|NCT00425945|567415177|FG001|Overall Study|Began hypertension medication|0|||
157184010|NCT00425945|567415176|FG000|Overall Study|Began cancer treatments|1|||
157184011|NCT00425945|567415177|FG001|Overall Study|Began cancer treatments|0|||
157184012|NCT00425945|567415176|FG000|Overall Study|Moved from area|0|||
157184013|NCT00425945|567415177|FG001|Overall Study|Moved from area|1|||
157184014|NCT03878160|567415181|FG000|Overall Study|Lost to Follow-up|1|||
157184015|NCT03878160|567415182|FG001|Overall Study|Lost to Follow-up|1|||
157184016|NCT03878160|567415183|FG002|Overall Study|Lost to Follow-up|1|||
157184017|NCT03878160|567415181|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
157184018|NCT03878160|567415182|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
157184019|NCT03878160|567415183|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
157184020|NCT05618808|567415185|FG000|Overall Study|Withdrawal by Subject|3|||
157184021|NCT05618808|567415186|FG001|Overall Study|Withdrawal by Subject|1|||
157184022|NCT05618808|567415187|FG002|Overall Study|Withdrawal by Subject|3|||
157184023|NCT02365506|567415188|FG000|Overall Study|Investigator's Discretion|0|||
157184024|NCT02365506|567415189|FG001|Overall Study|Investigator's Discretion|0|||
157184025|NCT02365506|567415190|FG002|Overall Study|Investigator's Discretion|1|||
157184026|NCT04007367|567415194|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
157184027|NCT04007367|567415195|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
157184028|NCT04007367|567415196|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
157184029|NCT04007367|567415194|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
157184030|NCT04007367|567415195|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
157184031|NCT04007367|567415196|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
157184032|NCT04007367|567415194|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
157184033|NCT04007367|567415195|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
157184034|NCT04007367|567415196|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
157184035|NCT04007367|567415194|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
157184036|NCT04007367|567415195|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
157184037|NCT04007367|567415196|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
157184038|NCT04007367|567415194|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
157184039|NCT04007367|567415195|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
157184040|NCT04007367|567415196|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
157184041|NCT02010567|567415197|FG000|Overall Study|Adverse Event|0|||
157184042|NCT02010567|567415198|FG001|Overall Study|Adverse Event|0|||
157184043|NCT02010567|567415199|FG002|Overall Study|Adverse Event|1|||
157184044|NCT02010567|567415200|FG003|Overall Study|Adverse Event|0|||
157184045|NCT02010567|567415201|FG004|Overall Study|Adverse Event|1|||
157184046|NCT00118040|567415203|FG000|Overall Study|Adverse Event|0|||
157184047|NCT00118040|567415204|FG001|Overall Study|Adverse Event|1|||
157184048|NCT00118040|567415205|FG002|Overall Study|Adverse Event|0|||
157184049|NCT00118040|567415203|FG000|Overall Study|Withdrawal by Subject|0|||
157184050|NCT00118040|567415204|FG001|Overall Study|Withdrawal by Subject|0|||
157184051|NCT00118040|567415205|FG002|Overall Study|Withdrawal by Subject|2|||
157184052|NCT00118040|567415203|FG000|Overall Study|Medical Contraindication|0|||
157184053|NCT00118040|567415204|FG001|Overall Study|Medical Contraindication|0|||
157184054|NCT00118040|567415205|FG002|Overall Study|Medical Contraindication|1|||
157184055|NCT00118040|567415203|FG000|Overall Study|Non-Compliant Participant|1|||
157184056|NCT00118040|567415204|FG001|Overall Study|Non-Compliant Participant|1|||
157184057|NCT00118040|567415205|FG002|Overall Study|Non-Compliant Participant|2|||
157184058|NCT00118040|567415203|FG000|Overall Study|Other|0|||
157184059|NCT00118040|567415204|FG001|Overall Study|Other|0|||
157184060|NCT00118040|567415205|FG002|Overall Study|Other|1|||
157184061|NCT04476108|567415206|FG000|Overall Study|Adverse Event|4|||
157184062|NCT04476108|567415207|FG001|Overall Study|Adverse Event|1|||
157184063|NCT04476108|567415206|FG000|Overall Study|Lost to Follow-up|1|||
157184064|NCT04476108|567415207|FG001|Overall Study|Lost to Follow-up|0|||
157184065|NCT04476108|567415206|FG000|Overall Study|Inadvertent Enrollment|1|||
157230025|NCT00162123|567588222|FG002|Overall Study|Deterioration without progression|3|||
157184066|NCT04476108|567415207|FG001|Overall Study|Inadvertent Enrollment|0|||
157184067|NCT04476108|567415206|FG000|Overall Study|Protocol Violation|1|||
157230026|NCT00162123|567588223|FG003|Overall Study|Deterioration without progression|0|||
157184068|NCT04476108|567415207|FG001|Overall Study|Protocol Violation|1|||
157184069|NCT04476108|567415206|FG000|Overall Study|Withdrawal by Subject|1|||
157184070|NCT04476108|567415207|FG001|Overall Study|Withdrawal by Subject|1|||
157184071|NCT00850135|567415208|FG000|Overall Study|Physician Decision|1|||
157184072|NCT02253992|567415209|FG000|Overall Study|Study drug toxicity|1|||
157062208|NCT03024996|566983223|FG001|Overall Study|Withdrawal by Subject|36|||
157062209|NCT02418845|566983226|FG000|Overall Study|Lost to Follow-up|7|||
157062210|NCT02418845|566983227|FG001|Overall Study|Lost to Follow-up|2|||
157062211|NCT02418845|566983226|FG000|Overall Study|Lack of Efficacy|0|||
157062212|NCT02418845|566983227|FG001|Overall Study|Lack of Efficacy|3|||
157062213|NCT02418845|566983226|FG000|Overall Study|Physician Decision|5|||
157062214|NCT02418845|566983227|FG001|Overall Study|Physician Decision|5|||
157062215|NCT02418845|566983226|FG000|Overall Study|Protocol Violation|1|||
157062216|NCT02418845|566983227|FG001|Overall Study|Protocol Violation|0|||
157062217|NCT02418845|566983226|FG000|Overall Study|Withdrawal by Subject|3|||
157062218|NCT02418845|566983227|FG001|Overall Study|Withdrawal by Subject|2|||
157062219|NCT00478647|566983228|FG000|Overall Study|Adverse Event|1|||
157062220|NCT00478647|566983228|FG000|Overall Study|Withdrawal by Subject|1|||
157062221|NCT00487552|566983238|FG000|Overall Study|Unsuccessful magnet placements|3|||
157062222|NCT00487552|566983238|FG000|Overall Study|Death due to progressive malignancy|2|||
157062223|NCT00487552|566983238|FG000|Overall Study|Stent not placed|1|||
157062224|NCT03119688|566983239|FG000|Overall Study|Adverse Event|4|||
157062225|NCT00320398|566983240|FG000|Overall Study|Adverse Event|1|||
157062226|NCT00320398|566983241|FG001|Overall Study|Adverse Event|4|||
157062227|NCT00320398|566983240|FG000|Overall Study|Other|1|||
157062228|NCT00320398|566983241|FG001|Overall Study|Other|0|||
157062229|NCT00630552|566983242|FG000|Overall Study|Adverse Event|0|||
157062230|NCT00630552|566983243|FG001|Overall Study|Adverse Event|1|||
157062231|NCT00630552|566983244|FG002|Overall Study|Adverse Event|5|||
157062232|NCT00630552|566983245|FG003|Overall Study|Adverse Event|4|||
157062233|NCT00630552|566983246|FG004|Overall Study|Adverse Event|2|||
157062234|NCT00630552|566983242|FG000|Overall Study|Disease progression|5|||
157062235|NCT00630552|566983243|FG001|Overall Study|Disease progression|6|||
157062236|NCT00630552|566983244|FG002|Overall Study|Disease progression|27|||
157062237|NCT00630552|566983245|FG003|Overall Study|Disease progression|22|||
157062238|NCT00630552|566983246|FG004|Overall Study|Disease progression|31|||
157062239|NCT00630552|566983242|FG000|Overall Study|Never received IP|0|||
157062240|NCT00630552|566983243|FG001|Overall Study|Never received IP|0|||
157062241|NCT00630552|566983244|FG002|Overall Study|Never received IP|0|||
157062242|NCT00630552|566983245|FG003|Overall Study|Never received IP|2|||
157062243|NCT00630552|566983246|FG004|Overall Study|Never received IP|2|||
157062244|NCT00630552|566983242|FG000|Overall Study|Ineligibility determined|0|||
157062245|NCT00630552|566983243|FG001|Overall Study|Ineligibility determined|0|||
157062246|NCT00630552|566983244|FG002|Overall Study|Ineligibility determined|0|||
157062247|NCT00630552|566983245|FG003|Overall Study|Ineligibility determined|0|||
157062248|NCT00630552|566983246|FG004|Overall Study|Ineligibility determined|1|||
157062249|NCT00630552|566983242|FG000|Overall Study|Protocol Violation|0|||
157062250|NCT00630552|566983243|FG001|Overall Study|Protocol Violation|0|||
157062251|NCT00630552|566983244|FG002|Overall Study|Protocol Violation|0|||
157062252|NCT00630552|566983245|FG003|Overall Study|Protocol Violation|1|||
157062253|NCT00630552|566983246|FG004|Overall Study|Protocol Violation|0|||
157062254|NCT00630552|566983242|FG000|Overall Study|Physician Decision|0|||
157062255|NCT00630552|566983243|FG001|Overall Study|Physician Decision|0|||
157062256|NCT00630552|566983244|FG002|Overall Study|Physician Decision|0|||
157062257|NCT00630552|566983245|FG003|Overall Study|Physician Decision|0|||
157062258|NCT00630552|566983246|FG004|Overall Study|Physician Decision|1|||
157062259|NCT00630552|566983242|FG000|Overall Study|Death|0|||
157062260|NCT00630552|566983243|FG001|Overall Study|Death|0|||
157184073|NCT02253992|567415210|FG001|Overall Study|Study drug toxicity|0|||
157184074|NCT02253992|567415211|FG002|Overall Study|Study drug toxicity|10|||
157184075|NCT02253992|567415209|FG000|Overall Study|Disease progression|4|||
157062261|NCT00630552|566983244|FG002|Overall Study|Death|1|||
157062262|NCT00630552|566983245|FG003|Overall Study|Death|2|||
157062263|NCT00630552|566983246|FG004|Overall Study|Death|2|||
157062264|NCT00630552|566983242|FG000|Overall Study|Withdrawal by Subject|0|||
157062265|NCT00630552|566983243|FG001|Overall Study|Withdrawal by Subject|0|||
157062266|NCT00630552|566983244|FG002|Overall Study|Withdrawal by Subject|0|||
157062267|NCT00630552|566983245|FG003|Overall Study|Withdrawal by Subject|1|||
157062268|NCT00630552|566983246|FG004|Overall Study|Withdrawal by Subject|0|||
157062269|NCT00630552|566983242|FG000|Overall Study|Other|0|||
157062270|NCT00630552|566983243|FG001|Overall Study|Other|0|||
157062271|NCT00630552|566983244|FG002|Overall Study|Other|4|||
157062272|NCT00630552|566983245|FG003|Overall Study|Other|2|||
157184076|NCT02253992|567415210|FG001|Overall Study|Disease progression|3|||
157184077|NCT02253992|567415211|FG002|Overall Study|Disease progression|98|||
157062273|NCT00630552|566983246|FG004|Overall Study|Other|0|||
157062274|NCT02705625|566983247|FG000|Overall Study|Protocol Violation|1|||
157062275|NCT02705625|566983248|FG001|Overall Study|Protocol Violation|0|||
157062276|NCT02705625|566983249|FG002|Overall Study|Protocol Violation|0|||
157062277|NCT02705625|566983247|FG000|Overall Study|Adverse Event|6|||
157062278|NCT02705625|566983248|FG001|Overall Study|Adverse Event|5|||
157062279|NCT02705625|566983249|FG002|Overall Study|Adverse Event|2|||
157062280|NCT02705625|566983247|FG000|Overall Study|Death|0|||
157062281|NCT02705625|566983248|FG001|Overall Study|Death|0|||
157062282|NCT02705625|566983249|FG002|Overall Study|Death|1|||
157062283|NCT02705625|566983247|FG000|Overall Study|Withdrawal by Subject|1|||
157062284|NCT02705625|566983248|FG001|Overall Study|Withdrawal by Subject|4|||
157062285|NCT02705625|566983249|FG002|Overall Study|Withdrawal by Subject|5|||
157062286|NCT02705625|566983247|FG000|Overall Study|Lost to Follow-up|0|||
157062287|NCT02705625|566983248|FG001|Overall Study|Lost to Follow-up|0|||
157062288|NCT02705625|566983249|FG002|Overall Study|Lost to Follow-up|1|||
157062289|NCT02705625|566983247|FG000|Overall Study|Non-compliance|0|||
157062290|NCT02705625|566983248|FG001|Overall Study|Non-compliance|1|||
157062291|NCT02705625|566983249|FG002|Overall Study|Non-compliance|1|||
157062292|NCT02705625|566983247|FG000|Overall Study|Overdosing|0|||
157062293|NCT02705625|566983248|FG001|Overall Study|Overdosing|0|||
157062294|NCT02705625|566983249|FG002|Overall Study|Overdosing|1|||
157062295|NCT03596242|566983250|FG000|Overall Study|Lost to Follow-up|2|||
157062296|NCT03596242|566983251|FG001|Overall Study|Lost to Follow-up|2|||
157062297|NCT01649297|566983253|FG000|Overall Study|Adverse Event|5|||
157062298|NCT01649297|566983254|FG001|Overall Study|Adverse Event|5|||
157062299|NCT01649297|566983255|FG002|Overall Study|Adverse Event|4|||
157062300|NCT01649297|566983256|FG003|Overall Study|Adverse Event|13|||
157062301|NCT01649297|566983257|FG004|Overall Study|Adverse Event|1|||
157062302|NCT01649297|566983253|FG000|Overall Study|Lack of Efficacy|0|||
157062303|NCT01649297|566983254|FG001|Overall Study|Lack of Efficacy|0|||
157062304|NCT01649297|566983255|FG002|Overall Study|Lack of Efficacy|0|||
157062305|NCT01649297|566983256|FG003|Overall Study|Lack of Efficacy|0|||
157062306|NCT01649297|566983257|FG004|Overall Study|Lack of Efficacy|1|||
157062307|NCT01649297|566983253|FG000|Overall Study|Non compliant with Protocol|1|||
157062308|NCT01649297|566983254|FG001|Overall Study|Non compliant with Protocol|0|||
157062309|NCT01649297|566983255|FG002|Overall Study|Non compliant with Protocol|3|||
157062310|NCT01649297|566983256|FG003|Overall Study|Non compliant with Protocol|2|||
157062311|NCT01649297|566983257|FG004|Overall Study|Non compliant with Protocol|1|||
157062312|NCT01649297|566983253|FG000|Overall Study|Lost to Follow-up|1|||
157062313|NCT01649297|566983254|FG001|Overall Study|Lost to Follow-up|1|||
157062314|NCT01649297|566983255|FG002|Overall Study|Lost to Follow-up|4|||
157062315|NCT01649297|566983256|FG003|Overall Study|Lost to Follow-up|3|||
157062316|NCT01649297|566983257|FG004|Overall Study|Lost to Follow-up|0|||
157062317|NCT01649297|566983253|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
157062318|NCT01649297|566983254|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
157062319|NCT01649297|566983255|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
157062320|NCT01649297|566983256|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
157062321|NCT01649297|566983257|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
157062322|NCT01649297|566983253|FG000|Overall Study|For other reason|4|||
157062323|NCT01649297|566983254|FG001|Overall Study|For other reason|1|||
157062324|NCT01649297|566983255|FG002|Overall Study|For other reason|2|||
157062325|NCT01649297|566983256|FG003|Overall Study|For other reason|0|||
157062326|NCT01649297|566983257|FG004|Overall Study|For other reason|0|||
157062327|NCT02262364|566983261|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
157062328|NCT01049984|566983262|FG000|Overall Study|Withdrawal by Subject|1|||
157062329|NCT01049984|566983263|FG001|Overall Study|Withdrawal by Subject|5|||
157062330|NCT01049984|566983262|FG000|Overall Study|Protocol Violation|3|||
157062331|NCT01049984|566983263|FG001|Overall Study|Protocol Violation|4|||
157062332|NCT01049984|566983262|FG000|Overall Study|Lost to Follow-up|2|||
157062333|NCT01049984|566983263|FG001|Overall Study|Lost to Follow-up|1|||
157062334|NCT01049984|566983262|FG000|Overall Study|Adverse Event|13|||
157062335|NCT01049984|566983263|FG001|Overall Study|Adverse Event|7|||
157062336|NCT01049984|566983262|FG000|Overall Study|Treatment failure|0|||
157062337|NCT01049984|566983263|FG001|Overall Study|Treatment failure|2|||
157062338|NCT00931918|566983264|FG000|Overall Study|Adverse Event|4|||
157062339|NCT00931918|566983265|FG001|Overall Study|Adverse Event|6|||
157184078|NCT02253992|567415209|FG000|Overall Study|Withdrawal by Subject|0|||
157184079|NCT02253992|567415210|FG001|Overall Study|Withdrawal by Subject|0|||
157184080|NCT02253992|567415211|FG002|Overall Study|Withdrawal by Subject|3|||
157184081|NCT02253992|567415209|FG000|Overall Study|Adverse Event|0|||
157062340|NCT00931918|566983264|FG000|Overall Study|Progressive Disease|2|||
157062341|NCT00931918|566983265|FG001|Overall Study|Progressive Disease|1|||
157062342|NCT00931918|566983264|FG000|Overall Study|Symptomatic Deterioration|1|||
157062343|NCT00931918|566983265|FG001|Overall Study|Symptomatic Deterioration|0|||
157062344|NCT00931918|566983264|FG000|Overall Study|Withdrawal by Patient|3|||
157062345|NCT00931918|566983265|FG001|Overall Study|Withdrawal by Patient|4|||
157062346|NCT00931918|566983264|FG000|Overall Study|Other Reason not Specified|4|||
157062347|NCT00931918|566983265|FG001|Overall Study|Other Reason not Specified|4|||
157062348|NCT00931918|566983264|FG000|Overall Study|Did not receive study drug|3|||
157062349|NCT00931918|566983265|FG001|Overall Study|Did not receive study drug|2|||
157062350|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
157062351|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
157062352|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
157184082|NCT02253992|567415210|FG001|Overall Study|Adverse Event|0|||
156976794|NCT01785563|566669215|FG000|Overall Study|Protocol Violation|2|||
156976795|NCT01540565|566669221|FG000|Overall Study|Ineligible|2|||
156976796|NCT01350505|566669222|FG000|Overall Study|Lost to Follow-up|4|||
156976797|NCT04702568|566669226|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
156976798|NCT04702568|566669227|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
156976799|NCT04702568|566669226|FG000|Overall Study|Pregnancy|1|||
156976800|NCT04702568|566669227|FG001|Overall Study|Pregnancy|0|||
156976801|NCT04702568|566669226|FG000|Overall Study|Bone marrow transplant|1|||
156976802|NCT04702568|566669227|FG001|Overall Study|Bone marrow transplant|0|||
156976803|NCT04702568|566669226|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
156976804|NCT04702568|566669227|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
156976805|NCT04702568|566669226|FG000|Overall Study|Withdrawal by Subject|0|||
156976806|NCT04702568|566669227|FG001|Overall Study|Withdrawal by Subject|2|||
156976807|NCT04145037|566669228|FG000|Overall Study|Study terminated|2|||
156976808|NCT04145037|566669229|FG001|Overall Study|Study terminated|0|||
156976809|NCT04145037|566669228|FG000|Overall Study|Withdrawal by Subject|1|||
156976810|NCT04145037|566669229|FG001|Overall Study|Withdrawal by Subject|0|||
156976811|NCT04145037|566669228|FG000|Overall Study|Lost to Follow-up|1|||
156976812|NCT04145037|566669229|FG001|Overall Study|Lost to Follow-up|0|||
156976813|NCT00525265|566669236|FG000|Overall Study|Protocol Violation|1|||
156976814|NCT00525265|566669237|FG001|Overall Study|Protocol Violation|0|||
156976815|NCT00098254|566669240|FG000|Overall Study|Adverse Event|2|||
156976816|NCT00098254|566669240|FG000|Overall Study|Death|1|||
156976817|NCT00744263|566669241|FG000|Overall Study|Death|3006|||
156976818|NCT00744263|566669242|FG001|Overall Study|Death|3005|||
156976819|NCT00744263|566669241|FG000|Overall Study|Lost to Follow-up|2038|||
156976820|NCT00744263|566669242|FG001|Overall Study|Lost to Follow-up|2135|||
156976821|NCT00744263|566669241|FG000|Overall Study|Withdrawal by Subject|166|||
156976822|NCT00744263|566669242|FG001|Overall Study|Withdrawal by Subject|150|||
156976823|NCT00744263|566669241|FG000|Overall Study|Physician Decision|20|||
156976824|NCT00744263|566669242|FG001|Overall Study|Physician Decision|23|||
156976825|NCT00744263|566669241|FG000|Overall Study|Protocol Violation|3|||
156976826|NCT00744263|566669242|FG001|Overall Study|Protocol Violation|5|||
156976827|NCT00744263|566669241|FG000|Overall Study|Adverse Event|1|||
156976828|NCT00744263|566669242|FG001|Overall Study|Adverse Event|0|||
156976829|NCT00744263|566669241|FG000|Overall Study|Other|2|||
156976830|NCT00744263|566669242|FG001|Overall Study|Other|2|||
156976831|NCT01225822|566669243|FG000|Overall Study|Adverse Event|13|||
156976832|NCT01225822|566669244|FG001|Overall Study|Adverse Event|31|||
156976833|NCT01225822|566669245|FG002|Overall Study|Adverse Event|18|||
156976834|NCT01225822|566669246|FG003|Overall Study|Adverse Event|23|||
156976835|NCT01225822|566669247|FG004|Overall Study|Adverse Event|14|||
156976836|NCT01225822|566669243|FG000|Overall Study|Protocol Violation|6|||
156976837|NCT01225822|566669244|FG001|Overall Study|Protocol Violation|8|||
156976838|NCT01225822|566669245|FG002|Overall Study|Protocol Violation|6|||
156976839|NCT01225822|566669246|FG003|Overall Study|Protocol Violation|7|||
156976840|NCT01225822|566669247|FG004|Overall Study|Protocol Violation|4|||
156976841|NCT01225822|566669243|FG000|Overall Study|Lost to Follow-up|0|||
156976842|NCT01225822|566669244|FG001|Overall Study|Lost to Follow-up|0|||
156976843|NCT01225822|566669245|FG002|Overall Study|Lost to Follow-up|0|||
156976844|NCT01225822|566669246|FG003|Overall Study|Lost to Follow-up|1|||
156976845|NCT01225822|566669247|FG004|Overall Study|Lost to Follow-up|0|||
156976846|NCT01225822|566669243|FG000|Overall Study|Withdrawal by Subject|6|||
156976847|NCT01225822|566669244|FG001|Overall Study|Withdrawal by Subject|7|||
156976848|NCT01225822|566669245|FG002|Overall Study|Withdrawal by Subject|7|||
156976849|NCT01225822|566669246|FG003|Overall Study|Withdrawal by Subject|11|||
156976850|NCT01225822|566669247|FG004|Overall Study|Withdrawal by Subject|6|||
156976851|NCT01225822|566669243|FG000|Overall Study|Other|13|||
156976852|NCT01225822|566669244|FG001|Overall Study|Other|10|||
156976853|NCT01225822|566669245|FG002|Overall Study|Other|7|||
156976854|NCT01225822|566669246|FG003|Overall Study|Other|10|||
156976855|NCT01225822|566669247|FG004|Overall Study|Other|7|||
156976856|NCT04078035|566669248|FG000|Session 2|Lost to Follow-up|3|||
156976857|NCT04078035|566669249|FG001|Session 2|Lost to Follow-up|1|||
156976858|NCT04078035|566669248|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
156976859|NCT04078035|566669249|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
156976860|NCT03500640|566669252|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
156976861|NCT03500640|566669253|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
156976862|NCT03500640|566669254|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
156976863|NCT03500640|566669252|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
156976864|NCT03500640|566669253|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
156976865|NCT03500640|566669254|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
156976866|NCT03500640|566669252|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
156976867|NCT03500640|566669253|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
156976868|NCT03500640|566669254|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
157062353|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
157062354|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
157062355|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
157062356|NCT03201900|566983268|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
157062357|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
157062358|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
157062359|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
157062360|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
157062361|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
157062362|NCT03201900|566983268|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
157062363|NCT02971228|566983269|FG000|Overall Study|Withdrawal by Subject|1|||
157062364|NCT02971228|566983270|FG001|Overall Study|Withdrawal by Subject|1|||
157062365|NCT02971228|566983271|FG002|Overall Study|Withdrawal by Subject|0|||
157062366|NCT02971228|566983272|FG003|Overall Study|Withdrawal by Subject|0|||
157062367|NCT02971228|566983273|FG004|Overall Study|Withdrawal by Subject|0|||
157062368|NCT02971228|566983269|FG000|Overall Study|Logistical challenges|0|||
157062369|NCT02971228|566983270|FG001|Overall Study|Logistical challenges|1|||
157062370|NCT02971228|566983271|FG002|Overall Study|Logistical challenges|0|||
157062371|NCT02971228|566983272|FG003|Overall Study|Logistical challenges|0|||
157062372|NCT02971228|566983273|FG004|Overall Study|Logistical challenges|0|||
157062373|NCT01233999|566983274|FG000|Overall Study|Withdrawal by Subject|1|||
157062374|NCT01233999|566983274|FG000|Overall Study|Lost to Follow-up|1|||
157062375|NCT00129649|566983275|FG000|Overall Study|Withdrawal by Subject|76|||
157062376|NCT00129649|566983276|FG001|Overall Study|Withdrawal by Subject|65|||
157062377|NCT00025506|566983277|FG000|Overall Study|Ineligible: clerical error|1|||
157062378|NCT00025506|566983277|FG000|Overall Study|Ineligible: wrong cell type|5|||
157062379|NCT00025506|566983277|FG000|Overall Study|Ineligible: inadequate pathology|2|||
157062380|NCT00025506|566983277|FG000|Overall Study|Never Treated|2|||
157062381|NCT00713206|566983278|FG000|Overall Study|Lost to Follow-up|4|||
157062382|NCT00713206|566983279|FG001|Overall Study|Lost to Follow-up|4|||
157062383|NCT00713206|566983278|FG000|Overall Study|Death|1|||
157062384|NCT00713206|566983279|FG001|Overall Study|Death|0|||
157062385|NCT01657877|566983280|FG000|Overall Study|Withdrawal by Subject|4|||
157062386|NCT01657877|566983280|FG000|Overall Study|Protocol Violation|6|||
157062387|NCT01657877|566983280|FG000|Overall Study|Adverse Event|2|||
157062388|NCT01657877|566983280|FG000|Overall Study|Other Reason|2|||
157062389|NCT01670188|566983286|FG000|Overall Study|Death|0|||
157062390|NCT01670188|566983287|FG001|Overall Study|Death|1|||
157062391|NCT02427958|566983290|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
157062392|NCT02427958|566983290|FG000|Overall Study|Lost to Follow-up|6|||
157062393|NCT02427958|566983290|FG000|Overall Study|Withdrawal by Subject|14|||
157062394|NCT02427958|566983290|FG000|Overall Study|Lack of Efficacy|1|||
157062395|NCT00578318|566983291|FG000|Overall Study|Lost to Follow-up|2|||
157062396|NCT00578318|566983292|FG001|Overall Study|Lost to Follow-up|0|||
157062397|NCT00578318|566983291|FG000|Overall Study|Physician Decision|1|||
157062398|NCT00578318|566983292|FG001|Overall Study|Physician Decision|0|||
157062399|NCT02025985|566983293|FG000|Overall Study|Consent withdrawn|0|||
157062400|NCT02025985|566983294|FG001|Overall Study|Consent withdrawn|0|||
157062401|NCT02025985|566983295|FG002|Overall Study|Consent withdrawn|1|||
157062402|NCT02025985|566983296|FG003|Overall Study|Consent withdrawn|0|||
157062403|NCT02025985|566983297|FG004|Overall Study|Consent withdrawn|0|||
157062404|NCT02025985|566983293|FG000|Overall Study|Termination of study by Sponsor|4|||
157062405|NCT02025985|566983294|FG001|Overall Study|Termination of study by Sponsor|3|||
157062406|NCT02025985|566983295|FG002|Overall Study|Termination of study by Sponsor|1|||
157062407|NCT02025985|566983296|FG003|Overall Study|Termination of study by Sponsor|1|||
157062408|NCT02025985|566983297|FG004|Overall Study|Termination of study by Sponsor|3|||
157184083|NCT02253992|567415211|FG002|Overall Study|Adverse Event|8|||
157184084|NCT02253992|567415209|FG000|Overall Study|Death|0|||
157184085|NCT02253992|567415210|FG001|Overall Study|Death|0|||
157184086|NCT02253992|567415211|FG002|Overall Study|Death|1|||
157184087|NCT02253992|567415209|FG000|Overall Study|Subject discontinued study drug|1|||
157184088|NCT02253992|567415210|FG001|Overall Study|Subject discontinued study drug|0|||
157184089|NCT02253992|567415211|FG002|Overall Study|Subject discontinued study drug|1|||
157184090|NCT02253992|567415209|FG000|Overall Study|Completed treatment as per protocol|0|||
157062409|NCT02025985|566983293|FG000|Overall Study|Death|21|||
157062410|NCT02025985|566983294|FG001|Overall Study|Death|20|||
157062411|NCT02025985|566983295|FG002|Overall Study|Death|23|||
157062412|NCT02025985|566983296|FG003|Overall Study|Death|20|||
157062413|NCT02025985|566983297|FG004|Overall Study|Death|17|||
157062414|NCT00920699|566983305|FG000|Overall Study|Withdrawal by Subject|2|||
157062415|NCT00920699|566983306|FG001|Overall Study|Withdrawal by Subject|0|||
157062416|NCT00920699|566983307|FG002|Overall Study|Withdrawal by Subject|2|||
157062417|NCT00920699|566983305|FG000|Overall Study|no longer met eligibility|0|||
157062418|NCT00920699|566983306|FG001|Overall Study|no longer met eligibility|1|||
157184091|NCT02253992|567415210|FG001|Overall Study|Completed treatment as per protocol|1|||
157184092|NCT02253992|567415211|FG002|Overall Study|Completed treatment as per protocol|22|||
157062419|NCT00920699|566983307|FG002|Overall Study|no longer met eligibility|0|||
157062420|NCT00920699|566983305|FG000|Overall Study|Lost to Follow-up|0|||
157062421|NCT00920699|566983306|FG001|Overall Study|Lost to Follow-up|0|||
157062422|NCT00920699|566983307|FG002|Overall Study|Lost to Follow-up|2|||
157062423|NCT02287883|566983309|FG000|Overall Study|Death|8|||
157062424|NCT02287883|566983310|FG001|Overall Study|Death|7|||
157062425|NCT02287883|566983309|FG000|Overall Study|No longer eligible|222|||
157062426|NCT02287883|566983310|FG001|Overall Study|No longer eligible|182|||
157062427|NCT02287883|566983309|FG000|Overall Study|Non-response to survey|229|||
157062428|NCT02287883|566983310|FG001|Overall Study|Non-response to survey|237|||
157062429|NCT02101268|566983316|FG000|Randomized Treatment Phase|Subject Decision|8|||
157062430|NCT02101268|566983317|FG001|Randomized Treatment Phase|Subject Decision|4|||
157062431|NCT02101268|566983318|FG002|Randomized Treatment Phase|Subject Decision|0|||
157062432|NCT02101268|566983319|FG003|Randomized Treatment Phase|Subject Decision|0|||
157062433|NCT02101268|566983316|FG000|Randomized Treatment Phase|Physician Decision|4|||
157062434|NCT02101268|566983317|FG001|Randomized Treatment Phase|Physician Decision|1|||
157062435|NCT02101268|566983318|FG002|Randomized Treatment Phase|Physician Decision|0|||
157062436|NCT02101268|566983319|FG003|Randomized Treatment Phase|Physician Decision|0|||
157062437|NCT02101268|566983316|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
157062438|NCT02101268|566983317|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
157062439|NCT02101268|566983318|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
157062440|NCT02101268|566983319|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
157062441|NCT02101268|566983316|FG000|Randomized Treatment Phase|Adverse Event|6|||
157062442|NCT02101268|566983317|FG001|Randomized Treatment Phase|Adverse Event|0|||
157062443|NCT02101268|566983318|FG002|Randomized Treatment Phase|Adverse Event|0|||
157062444|NCT02101268|566983319|FG003|Randomized Treatment Phase|Adverse Event|0|||
157062445|NCT02101268|566983316|FG000|Randomized Treatment Phase|Death|5|||
157062446|NCT02101268|566983317|FG001|Randomized Treatment Phase|Death|4|||
157062447|NCT02101268|566983318|FG002|Randomized Treatment Phase|Death|0|||
157062448|NCT02101268|566983319|FG003|Randomized Treatment Phase|Death|0|||
157062449|NCT02101268|566983316|FG000|Randomized Treatment Phase|Disease Progression|4|||
157062450|NCT02101268|566983317|FG001|Randomized Treatment Phase|Disease Progression|1|||
157062451|NCT02101268|566983318|FG002|Randomized Treatment Phase|Disease Progression|0|||
157062452|NCT02101268|566983319|FG003|Randomized Treatment Phase|Disease Progression|0|||
157062453|NCT02101268|566983316|FG000|Extended Treatment Phase|Subject Decision|0|||
157062454|NCT02101268|566983317|FG001|Extended Treatment Phase|Subject Decision|0|||
157062455|NCT02101268|566983318|FG002|Extended Treatment Phase|Subject Decision|3|||
157062456|NCT02101268|566983319|FG003|Extended Treatment Phase|Subject Decision|2|||
157062457|NCT02101268|566983316|FG000|Extended Treatment Phase|Physician Decision|0|||
157062458|NCT02101268|566983317|FG001|Extended Treatment Phase|Physician Decision|0|||
157062459|NCT02101268|566983318|FG002|Extended Treatment Phase|Physician Decision|5|||
157062460|NCT02101268|566983319|FG003|Extended Treatment Phase|Physician Decision|2|||
157062461|NCT02101268|566983316|FG000|Extended Treatment Phase|Adverse Event|0|||
157062462|NCT02101268|566983317|FG001|Extended Treatment Phase|Adverse Event|0|||
157062463|NCT02101268|566983318|FG002|Extended Treatment Phase|Adverse Event|14|||
157062464|NCT02101268|566983319|FG003|Extended Treatment Phase|Adverse Event|18|||
157062465|NCT02101268|566983316|FG000|Extended Treatment Phase|Death|0|||
157062466|NCT02101268|566983317|FG001|Extended Treatment Phase|Death|0|||
157062467|NCT02101268|566983318|FG002|Extended Treatment Phase|Death|5|||
157062468|NCT02101268|566983319|FG003|Extended Treatment Phase|Death|1|||
157062469|NCT02101268|566983316|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
157062470|NCT02101268|566983317|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
157062471|NCT02101268|566983318|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
157062472|NCT02101268|566983319|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
157062473|NCT02101268|566983316|FG000|Extended Treatment Phase|Disease Progression|0|||
157062474|NCT02101268|566983317|FG001|Extended Treatment Phase|Disease Progression|0|||
157062475|NCT02101268|566983318|FG002|Extended Treatment Phase|Disease Progression|13|||
157062476|NCT02101268|566983319|FG003|Extended Treatment Phase|Disease Progression|6|||
157062477|NCT02101268|566983316|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
157062478|NCT02101268|566983317|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
157062479|NCT02101268|566983318|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
157062480|NCT02101268|566983319|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
157184093|NCT02253992|567415209|FG000|Overall Study|Other|0|||
157184094|NCT02253992|567415210|FG001|Overall Study|Other|0|||
157184095|NCT02253992|567415211|FG002|Overall Study|Other|1|||
157062481|NCT00576823|566983323|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
157062482|NCT00576823|566983324|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
157062483|NCT00576823|566983325|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
157062484|NCT00576823|566983323|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
157062485|NCT00576823|566983324|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
157062486|NCT00576823|566983325|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
157062487|NCT01242371|566983326|FG000|Overall Study|Withdrawal by Subject|2|||
157184096|NCT00623766|567415217|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
157062488|NCT01242371|566983327|FG001|Overall Study|Withdrawal by Subject|2|||
157062489|NCT01242371|566983326|FG000|Overall Study|Protocol Violation|0|||
157062490|NCT01242371|566983327|FG001|Overall Study|Protocol Violation|3|||
157062491|NCT00510146|566983328|FG000|Double-Blind Treatment|Adverse Event|30|||
157062492|NCT00510146|566983329|FG001|Double-Blind Treatment|Adverse Event|13|||
157062493|NCT00510146|566983328|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
157062494|NCT00510146|566983329|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
157062495|NCT00510146|566983328|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
157062496|NCT00510146|566983329|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
157062497|NCT00510146|566983328|FG000|Double-Blind Treatment|Physician Decision|6|||
157062498|NCT00510146|566983329|FG001|Double-Blind Treatment|Physician Decision|0|||
157062499|NCT00510146|566983328|FG000|Double-Blind Treatment|Protocol Violation|1|||
157062500|NCT00510146|566983329|FG001|Double-Blind Treatment|Protocol Violation|2|||
157062501|NCT00510146|566983328|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
157062502|NCT00510146|566983329|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
157062503|NCT00510146|566983328|FG000|Double-Blind Treatment|Clinical Relapse|0|||
157062504|NCT00510146|566983329|FG001|Double-Blind Treatment|Clinical Relapse|1|||
157062505|NCT00510146|566983328|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
157062506|NCT00510146|566983329|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
157062507|NCT00510146|566983328|FG000|Open-Label Treatment|Adverse Event|22|||
157062508|NCT00510146|566983329|FG001|Open-Label Treatment|Adverse Event|8|||
157062509|NCT00510146|566983328|FG000|Open-Label Treatment|Death|1|||
157062510|NCT00510146|566983329|FG001|Open-Label Treatment|Death|1|||
157062511|NCT00510146|566983328|FG000|Open-Label Treatment|Lack of Efficacy|4|||
157062512|NCT00510146|566983329|FG001|Open-Label Treatment|Lack of Efficacy|0|||
157062513|NCT00510146|566983328|FG000|Open-Label Treatment|Lost to Follow-up|10|||
157062514|NCT00510146|566983329|FG001|Open-Label Treatment|Lost to Follow-up|1|||
157062515|NCT00510146|566983328|FG000|Open-Label Treatment|Physician Decision|3|||
157062516|NCT00510146|566983329|FG001|Open-Label Treatment|Physician Decision|1|||
157062517|NCT00510146|566983328|FG000|Open-Label Treatment|Protocol Violation|4|||
157062518|NCT00510146|566983329|FG001|Open-Label Treatment|Protocol Violation|2|||
157062519|NCT00510146|566983328|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
157062520|NCT00510146|566983329|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
157062521|NCT00510146|566983328|FG000|Open-Label Treatment|Clinical Relapse|1|||
157062522|NCT00510146|566983329|FG001|Open-Label Treatment|Clinical Relapse|1|||
157062523|NCT00510146|566983328|FG000|Open-Label Treatment|Sponsor Decision|2|||
157062524|NCT00510146|566983329|FG001|Open-Label Treatment|Sponsor Decision|0|||
157062525|NCT02132117|566983332|FG000|Overall Study|Adverse Event|6|||
157062526|NCT02132117|566983333|FG001|Overall Study|Adverse Event|1|||
157062527|NCT02132117|566983332|FG000|Overall Study|Lost to Follow-up|2|||
157062528|NCT02132117|566983333|FG001|Overall Study|Lost to Follow-up|2|||
157062529|NCT02132117|566983332|FG000|Overall Study|Personal Reasons|1|||
157062530|NCT02132117|566983333|FG001|Overall Study|Personal Reasons|2|||
157062531|NCT02132117|566983332|FG000|Overall Study|Other Miscellaneous Reasons|2|||
157062532|NCT02132117|566983333|FG001|Overall Study|Other Miscellaneous Reasons|0|||
157062533|NCT03589300|566983335|FG000|Overall Study|Adverse Event|2|||
157062534|NCT03589300|566983335|FG000|Overall Study|Death|4|||
157062535|NCT03589300|566983335|FG000|Overall Study|Lost to Follow-up|12|||
157062536|NCT03589300|566983335|FG000|Overall Study|Withdrawal by Subject|5|||
157062537|NCT04947436|566983336|FG000|Overall Study|Lost to Follow-up|3|||
157062538|NCT04947436|566983337|FG001|Overall Study|Lost to Follow-up|7|||
157062539|NCT04947436|566983338|FG002|Overall Study|Lost to Follow-up|5|||
157062540|NCT04947436|566983336|FG000|Overall Study|Death|1|||
157062541|NCT04947436|566983337|FG001|Overall Study|Death|1|||
157062542|NCT04947436|566983338|FG002|Overall Study|Death|1|||
157062543|NCT01544309|566983341|FG000|Overall Study|Withdrawal by Subject|12|||
157062544|NCT01544309|566983342|FG001|Overall Study|Withdrawal by Subject|7|||
157062545|NCT01544309|566983341|FG000|Overall Study|Protocol Violation|2|||
157062546|NCT01544309|566983342|FG001|Overall Study|Protocol Violation|1|||
157062547|NCT01544309|566983341|FG000|Overall Study|Physician Decision|4|||
157062548|NCT01544309|566983342|FG001|Overall Study|Physician Decision|1|||
157062549|NCT01544309|566983341|FG000|Overall Study|Not performed pre-dose examination|1|||
157062550|NCT01544309|566983342|FG001|Overall Study|Not performed pre-dose examination|2|||
157062551|NCT01544309|566983341|FG000|Overall Study|Administered prohibit prior medication|1|||
157184097|NCT00623766|567415218|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
157184098|NCT00623766|567415217|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
157062552|NCT01544309|566983342|FG001|Overall Study|Administered prohibit prior medication|0|||
157062553|NCT04582864|566983343|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
157062554|NCT04582864|566983343|FG000|Overall Study|Death|1|||
157062555|NCT03640754|566983344|FG000|Overall Study|Withdrawal by Subject|1|||
157062556|NCT03640754|566983345|FG001|Overall Study|Withdrawal by Subject|0|||
157062557|NCT03640754|566983344|FG000|Overall Study|Lost to Follow-up|0|||
157062558|NCT03640754|566983345|FG001|Overall Study|Lost to Follow-up|1|||
157062559|NCT01679613|566983348|FG000|Overall Study|other than stated above|0|||
157062560|NCT01679613|566983349|FG001|Overall Study|other than stated above|1|||
157062561|NCT01679613|566983350|FG002|Overall Study|other than stated above|2|||
157062562|NCT01679613|566983351|FG003|Overall Study|other than stated above|2|||
157062563|NCT01333111|566985613|FG000|Overall Study|patient undergoing major surgery|0|||
157062564|NCT01333111|566985614|FG001|Overall Study|patient undergoing major surgery|2|||
157062565|NCT01333111|566985615|FG002|Overall Study|patient undergoing major surgery|0|||
157062566|NCT01333111|566985613|FG000|Overall Study|personal reasons|0|||
157062567|NCT01333111|566985614|FG001|Overall Study|personal reasons|0|||
157062568|NCT01333111|566985615|FG002|Overall Study|personal reasons|1|||
157062569|NCT01333111|566985613|FG000|Overall Study|unclassified|1|||
157062570|NCT01333111|566985614|FG001|Overall Study|unclassified|0|||
157062571|NCT01333111|566985615|FG002|Overall Study|unclassified|0|||
157062572|NCT01333111|566985613|FG000|Overall Study|withdrawal criteria|0|||
157062573|NCT01333111|566985614|FG001|Overall Study|withdrawal criteria|1|||
157062574|NCT01333111|566985615|FG002|Overall Study|withdrawal criteria|0|||
157062575|NCT01333111|566985613|FG000|Overall Study|Non-compliance|1|||
157062576|NCT01333111|566985614|FG001|Overall Study|Non-compliance|0|||
157062577|NCT01333111|566985615|FG002|Overall Study|Non-compliance|0|||
157062578|NCT01333111|566985613|FG000|Overall Study|Ineffective therapy|0|||
157062579|NCT01333111|566985614|FG001|Overall Study|Ineffective therapy|0|||
157062580|NCT01333111|566985615|FG002|Overall Study|Ineffective therapy|1|||
157062581|NCT02161406|566985616|FG000|Overall Study|Death|2|||
157062582|NCT02161406|566985617|FG001|Overall Study|Death|1|||
157062583|NCT02161406|566985616|FG000|Overall Study|Lost to Follow-up|2|||
157062584|NCT02161406|566985617|FG001|Overall Study|Lost to Follow-up|1|||
157062585|NCT02161406|566985616|FG000|Overall Study|Withdrawal by Subject|2|||
157062586|NCT02161406|566985617|FG001|Overall Study|Withdrawal by Subject|4|||
157062587|NCT02161406|566985616|FG000|Overall Study|investigator withdrew subject|3|||
157062588|NCT02161406|566985617|FG001|Overall Study|investigator withdrew subject|1|||
157062589|NCT02161406|566985616|FG000|Overall Study|Lack of Efficacy|1|||
157062590|NCT02161406|566985617|FG001|Overall Study|Lack of Efficacy|1|||
157062591|NCT02161406|566985616|FG000|Overall Study|relocation|0|||
157062592|NCT02161406|566985617|FG001|Overall Study|relocation|1|||
157062593|NCT00664105|566985618|FG000|Overall Study|Death|3|||
157184099|NCT00623766|567415218|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
157184100|NCT00623766|567415217|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
157184101|NCT00623766|567415218|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
157184102|NCT00623766|567415217|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
157184103|NCT00623766|567415218|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
157184104|NCT00623766|567415217|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
157184105|NCT00623766|567415218|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
157184106|NCT00796549|567415219|FG000|Overall Study|Adverse Event|11|||
157184107|NCT00796549|567415219|FG000|Overall Study|not entered|149|||
157184108|NCT00796549|567415219|FG000|Overall Study|Other|2|||
157184109|NCT00796549|567415219|FG000|Overall Study|Progressive disease|56|||
157184110|NCT00606229|567415221|FG000|Overall Study|Adverse Event|11|||
157184111|NCT00606229|567415221|FG000|Overall Study|Lack of Efficacy|1|||
157184112|NCT00606229|567415221|FG000|Overall Study|Withdrawal by Subject|4|||
157184113|NCT00606229|567415221|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
157184114|NCT00606229|567415221|FG000|Overall Study|change of residence or other commitments|2|||
157184115|NCT03523715|567415222|FG000|Overall Study|Lost to Follow-up|11|||
157184116|NCT03523715|567415223|FG001|Overall Study|Lost to Follow-up|14|||
157184117|NCT03523715|567415222|FG000|Overall Study|Did not meet inclusion criteria|1|||
157184118|NCT03523715|567415223|FG001|Overall Study|Did not meet inclusion criteria|0|||
157184119|NCT03523715|567415222|FG000|Overall Study|Internally inconsistent reporting|0|||
157184120|NCT03523715|567415223|FG001|Overall Study|Internally inconsistent reporting|2|||
157184121|NCT02139280|567415224|FG000|Overall Study|No longer eligible|2|||
157230027|NCT00162123|567588224|FG004|Overall Study|Deterioration without progression|1|||
157230028|NCT00162123|567588225|FG005|Overall Study|Deterioration without progression|0|||
157062594|NCT00664105|566985618|FG000|Overall Study|Withdrawal by Subject|5|||
157062595|NCT00664105|566985618|FG000|Overall Study|Adverse Event|9|||
157062596|NCT00664105|566985618|FG000|Overall Study|Disease progression|7|||
157062597|NCT01468077|566985622|FG000|Overall Study|Adverse Event|2|||
157062598|NCT01468077|566985623|FG001|Overall Study|Adverse Event|2|||
157184122|NCT02139280|567415225|FG001|Overall Study|No longer eligible|0|||
157230029|NCT00162123|567588226|FG006|Overall Study|Deterioration without progression|0|||
157230030|NCT00162123|567588227|FG007|Overall Study|Deterioration without progression|0|||
157184123|NCT04157751|567415226|FG000|Overall Study|Withdrawal by Subject|12|||
157062599|NCT01468077|566985622|FG000|Overall Study|Lack of Efficacy|1|||
157062600|NCT01468077|566985623|FG001|Overall Study|Lack of Efficacy|1|||
157062601|NCT01468077|566985622|FG000|Overall Study|Physician Decision|1|||
157062602|NCT01468077|566985623|FG001|Overall Study|Physician Decision|0|||
157062603|NCT04333147|566985624|FG000|Overall Study|Adverse Event|43|||
157062604|NCT04333147|566985625|FG001|Overall Study|Adverse Event|40|||
157062605|NCT04333147|566985624|FG000|Overall Study|Lack of Efficacy|49|||
157062606|NCT04333147|566985625|FG001|Overall Study|Lack of Efficacy|48|||
157184124|NCT04157751|567415227|FG001|Overall Study|Withdrawal by Subject|17|||
157184125|NCT04157751|567415226|FG000|Overall Study|Lost to Follow-up|6|||
157062607|NCT04333147|566985624|FG000|Overall Study|Lost to Follow-up|19|||
157062608|NCT04333147|566985625|FG001|Overall Study|Lost to Follow-up|16|||
157062609|NCT04333147|566985624|FG000|Overall Study|Physician Decision|17|||
157062610|NCT04333147|566985625|FG001|Overall Study|Physician Decision|20|||
157062611|NCT04333147|566985624|FG000|Overall Study|Withdrawal by Subject|65|||
157062612|NCT04333147|566985625|FG001|Overall Study|Withdrawal by Subject|68|||
157062613|NCT04333147|566985624|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
157230031|NCT00162123|567588220|FG000|Overall Study|Adverse Event|1|||
157062614|NCT04333147|566985625|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
157062615|NCT04333147|566985624|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
157062616|NCT04333147|566985625|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
157062617|NCT04333147|566985624|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
157062618|NCT04333147|566985625|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
157062619|NCT00847132|566985629|FG000|Overall Study|Death|1|||
157062620|NCT00847132|566985630|FG001|Overall Study|Death|1|||
157062621|NCT01057251|566985632|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
157062622|NCT01057251|566985633|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
157062623|NCT01057251|566985632|FG000|Overall Study|Adverse Event|4|||
157062624|NCT01057251|566985633|FG001|Overall Study|Adverse Event|2|||
157062625|NCT01057251|566985632|FG000|Overall Study|Lack of Efficacy|2|||
157062626|NCT01057251|566985633|FG001|Overall Study|Lack of Efficacy|11|||
157062627|NCT01057251|566985632|FG000|Overall Study|Protocol Violation|6|||
157062628|NCT01057251|566985633|FG001|Overall Study|Protocol Violation|2|||
157062629|NCT01057251|566985632|FG000|Overall Study|Withdrawal by Subject|4|||
157062630|NCT01057251|566985633|FG001|Overall Study|Withdrawal by Subject|5|||
157062631|NCT01057251|566985632|FG000|Overall Study|Lost to Follow-up|7|||
157062632|NCT01057251|566985633|FG001|Overall Study|Lost to Follow-up|6|||
157062633|NCT01057251|566985632|FG000|Overall Study|Other Reason|1|||
157062634|NCT01057251|566985633|FG001|Overall Study|Other Reason|1|||
157062635|NCT00784147|566985634|FG000|Overall Study|Lost to Follow-up|2|||
157062636|NCT00784147|566985635|FG001|Overall Study|Lost to Follow-up|4|||
157062637|NCT00784147|566985634|FG000|Overall Study|Withdrawal by Subject|1|||
157062638|NCT00784147|566985635|FG001|Overall Study|Withdrawal by Subject|3|||
157062639|NCT00784147|566985634|FG000|Overall Study|Physician Decision|2|||
157062640|NCT00784147|566985635|FG001|Overall Study|Physician Decision|1|||
157230032|NCT00162123|567588221|FG001|Overall Study|Adverse Event|2|||
157230033|NCT00162123|567588222|FG002|Overall Study|Adverse Event|0|||
157230034|NCT00162123|567588223|FG003|Overall Study|Adverse Event|2|||
157230035|NCT00162123|567588224|FG004|Overall Study|Adverse Event|1|||
157230036|NCT00162123|567588225|FG005|Overall Study|Adverse Event|0|||
157062641|NCT00784147|566985634|FG000|Overall Study|Protocol Violation|1|||
157062642|NCT00784147|566985635|FG001|Overall Study|Protocol Violation|1|||
157062643|NCT00784147|566985634|FG000|Overall Study|Death|2|||
157062644|NCT00784147|566985635|FG001|Overall Study|Death|0|||
157062645|NCT04544865|566985637|FG000|Overall Study|Death|0|||
157062646|NCT04544865|566985638|FG001|Overall Study|Death|2|||
157062647|NCT04544865|566985637|FG000|Overall Study|Lost to Follow-up|11|||
157062648|NCT04544865|566985638|FG001|Overall Study|Lost to Follow-up|7|||
157062649|NCT04544865|566985637|FG000|Overall Study|Withdrawal by Subject|0|||
157062650|NCT04544865|566985638|FG001|Overall Study|Withdrawal by Subject|1|||
157184126|NCT04157751|567415227|FG001|Overall Study|Lost to Follow-up|2|||
157184127|NCT04157751|567415226|FG000|Overall Study|Adverse Event|34|||
157184128|NCT04157751|567415227|FG001|Overall Study|Adverse Event|23|||
157184129|NCT04157751|567415226|FG000|Overall Study|Not treated|1|||
157184130|NCT04157751|567415227|FG001|Overall Study|Not treated|5|||
157184131|NCT04157751|567415226|FG000|Overall Study|Other reason not stated above|10|||
157184132|NCT04157751|567415227|FG001|Overall Study|Other reason not stated above|10|||
157062651|NCT04544865|566985637|FG000|Overall Study|Other|0|||
157062652|NCT04544865|566985638|FG001|Overall Study|Other|1|||
157062653|NCT03357471|566985644|FG000|Overall Study|Adverse Event|1|||
157062654|NCT03357471|566985645|FG001|Overall Study|Adverse Event|0|||
157184133|NCT04731922|567415228|FG000|Overall Study|Adverse Event|0|||
157184134|NCT04731922|567415229|FG001|Overall Study|Adverse Event|0|||
157184135|NCT04731922|567415230|FG002|Overall Study|Adverse Event|0|||
157184136|NCT04731922|567415231|FG003|Overall Study|Adverse Event|0|||
157230037|NCT00162123|567588226|FG006|Overall Study|Adverse Event|0|||
157062655|NCT03357471|566985644|FG000|Overall Study|Lost to Follow-up|1|||
157062656|NCT03357471|566985645|FG001|Overall Study|Lost to Follow-up|0|||
157062657|NCT02973802|566985646|FG000|Overall Study|Lost to Follow-up|1|||
157062658|NCT02973802|566985646|FG000|Overall Study|Withdrawal by Subject|1|||
157062659|NCT00706914|566985647|FG000|Overall Study|Lack of Efficacy|0|||
157062660|NCT00706914|566985648|FG001|Overall Study|Lack of Efficacy|1|||
157062661|NCT00706914|566985649|FG002|Overall Study|Lack of Efficacy|0|||
157062662|NCT00706914|566985647|FG000|Overall Study|Lost to Follow-up|1|||
157062663|NCT00706914|566985648|FG001|Overall Study|Lost to Follow-up|0|||
157062664|NCT00706914|566985649|FG002|Overall Study|Lost to Follow-up|0|||
157062665|NCT00706914|566985647|FG000|Overall Study|Adverse Event|2|||
157062666|NCT00706914|566985648|FG001|Overall Study|Adverse Event|2|||
157184137|NCT04731922|567415232|FG004|Overall Study|Adverse Event|0|||
157230038|NCT00162123|567588227|FG007|Overall Study|Adverse Event|0|||
157062667|NCT00706914|566985649|FG002|Overall Study|Adverse Event|0|||
157062668|NCT00706914|566985647|FG000|Overall Study|Protocol Violation|3|||
157062669|NCT00706914|566985648|FG001|Overall Study|Protocol Violation|1|||
157062670|NCT00706914|566985649|FG002|Overall Study|Protocol Violation|1|||
157062671|NCT01850823|566985651|FG000|Overall Study|Early Visit Window|0|||
157062672|NCT01850823|566985652|FG001|Overall Study|Early Visit Window|1|||
157062673|NCT01850823|566985653|FG002|Overall Study|Early Visit Window|4|||
157062674|NCT01850823|566985651|FG000|Overall Study|Enrolled in Error|0|||
157062675|NCT01850823|566985652|FG001|Overall Study|Enrolled in Error|1|||
157062676|NCT01850823|566985653|FG002|Overall Study|Enrolled in Error|2|||
157062677|NCT01850823|566985651|FG000|Overall Study|Lack of Efficacy|1|||
157062678|NCT01850823|566985652|FG001|Overall Study|Lack of Efficacy|0|||
157062679|NCT01850823|566985653|FG002|Overall Study|Lack of Efficacy|0|||
157062680|NCT01850823|566985651|FG000|Overall Study|Lost to Follow-up|0|||
157062681|NCT01850823|566985652|FG001|Overall Study|Lost to Follow-up|0|||
157062682|NCT01850823|566985653|FG002|Overall Study|Lost to Follow-up|1|||
157062683|NCT01850823|566985651|FG000|Overall Study|Restricted Medication|0|||
157062684|NCT01850823|566985652|FG001|Overall Study|Restricted Medication|0|||
157062685|NCT01850823|566985653|FG002|Overall Study|Restricted Medication|2|||
157062686|NCT01850823|566985651|FG000|Overall Study|Significant worstening of SAR|0|||
157062687|NCT01850823|566985652|FG001|Overall Study|Significant worstening of SAR|1|||
157062688|NCT01850823|566985653|FG002|Overall Study|Significant worstening of SAR|0|||
157062689|NCT01850823|566985651|FG000|Overall Study|Withdrawal by Subject|2|||
157062690|NCT01850823|566985652|FG001|Overall Study|Withdrawal by Subject|0|||
157062691|NCT01850823|566985653|FG002|Overall Study|Withdrawal by Subject|1|||
157062692|NCT01751165|566985654|FG000|Overall Study|Adverse event, serious fatal|1|||
157062693|NCT01751165|566985655|FG001|Overall Study|Adverse event, serious fatal|0|||
157062694|NCT01751165|566985656|FG002|Overall Study|Adverse event, serious fatal|1|||
157062695|NCT01751165|566985654|FG000|Overall Study|Withdrawal by Subject|0|||
157062696|NCT01751165|566985655|FG001|Overall Study|Withdrawal by Subject|0|||
157062697|NCT01751165|566985656|FG002|Overall Study|Withdrawal by Subject|1|||
157062698|NCT01751165|566985654|FG000|Overall Study|Serious adverse event|0|||
157062699|NCT01751165|566985655|FG001|Overall Study|Serious adverse event|2|||
157062700|NCT01751165|566985656|FG002|Overall Study|Serious adverse event|0|||
157062701|NCT01751165|566985654|FG000|Overall Study|Lost to Follow-up|1|||
157062702|NCT01751165|566985655|FG001|Overall Study|Lost to Follow-up|1|||
157062703|NCT01751165|566985656|FG002|Overall Study|Lost to Follow-up|1|||
157062704|NCT00988533|566985657|FG000|Overall Study|Lost to Follow-up|3|||
157062705|NCT01685047|566985658|FG000|Overall Study|Withdrawal by Subject|20|||
157062706|NCT01685047|566985658|FG000|Overall Study|Death|26|||
157062707|NCT01685047|566985658|FG000|Overall Study|Lost to Follow-up|8|||
157062708|NCT01685047|566985658|FG000|Overall Study|Physician Decision|25|||
157062709|NCT01685047|566985658|FG000|Overall Study|Adverse Event|5|||
157062710|NCT01685047|566985658|FG000|Overall Study|patient withdrawn by sponsor|1|||
157062711|NCT01202409|566985659|FG000|Overall Study|Adverse Event|1|||
157062712|NCT01202409|566985659|FG000|Overall Study|Ineligible - KRAS mutants|7|||
157062713|NCT01732926|566985660|FG000|Overall Study|Study Terminated by Sponsor|168|||
157062714|NCT01732926|566985661|FG001|Overall Study|Study Terminated by Sponsor|80|||
157062715|NCT01732926|566985660|FG000|Overall Study|Withdrawal by Subject|46|||
157062716|NCT01732926|566985661|FG001|Overall Study|Withdrawal by Subject|8|||
157062717|NCT01732926|566985660|FG000|Overall Study|Physician Decision|24|||
157062718|NCT01732926|566985661|FG001|Overall Study|Physician Decision|11|||
157062719|NCT01732926|566985660|FG000|Overall Study|Other Reason|21|||
157062720|NCT01732926|566985661|FG001|Overall Study|Other Reason|4|||
157062721|NCT01732926|566985660|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
157062722|NCT01732926|566985661|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
157062723|NCT01732926|566985660|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
157062724|NCT01732926|566985661|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
157062725|NCT00337285|566985662|FG000|Overall Study|Withdrawal by Subject|42|||
157062726|NCT00337285|566985662|FG000|Overall Study|Lost to Follow-up|41|||
157062727|NCT00337285|566985662|FG000|Overall Study|Adverse Event|28|||
157062728|NCT00337285|566985662|FG000|Overall Study|Protocol Violation|27|||
157062729|NCT00337285|566985662|FG000|Overall Study|Lack of Efficacy|11|||
157062730|NCT00337285|566985662|FG000|Overall Study|Death|1|||
157062731|NCT00337285|566985662|FG000|Overall Study|Physician Decision|1|||
157062732|NCT00337285|566985662|FG000|Overall Study|Lack of protocol compliance|7|||
157062733|NCT01040403|566985666|FG000|Overall Study|Adverse Event|10|||
157062734|NCT01040403|566985666|FG000|Overall Study|Protocol Violation|2|||
157062735|NCT01040403|566985666|FG000|Overall Study|Lost to Follow-up|1|||
157062736|NCT01040403|566985666|FG000|Overall Study|Not treated|1|||
157062737|NCT01040403|566985666|FG000|Overall Study|Other reason not defined above|6|||
157062738|NCT00292981|566985668|FG000|Overall Study|Adverse Event|1|||
157062739|NCT00292981|566985668|FG000|Overall Study|Lost to Follow-up|13|||
157062740|NCT00292981|566985668|FG000|Overall Study|Withdrawal by Subject|22|||
157062741|NCT00292981|566985668|FG000|Overall Study|Other|3|||
157062742|NCT01085812|566985669|FG000|Open-Label Period|Adverse Event|0|||
157062743|NCT01085812|566985670|FG001|Open-Label Period|Adverse Event|80|||
157062744|NCT01085812|566985669|FG000|Open-Label Period|Lack of Efficacy|0|||
157062745|NCT01085812|566985670|FG001|Open-Label Period|Lack of Efficacy|26|||
157062746|NCT01085812|566985669|FG000|Open-Label Period|Protocol Violation|0|||
157062747|NCT01085812|566985670|FG001|Open-Label Period|Protocol Violation|39|||
157062748|NCT01085812|566985669|FG000|Open-Label Period|Withdrawal by Subject|0|||
157062749|NCT01085812|566985670|FG001|Open-Label Period|Withdrawal by Subject|53|||
157062750|NCT01085812|566985669|FG000|Open-Label Period|Lost to Follow-up|0|||
157062751|NCT01085812|566985670|FG001|Open-Label Period|Lost to Follow-up|42|||
157062752|NCT01085812|566985669|FG000|Double-Blind Period|Adverse Event|3|||
157062753|NCT01085812|566985670|FG001|Double-Blind Period|Adverse Event|8|||
157062754|NCT01085812|566985669|FG000|Double-Blind Period|Protocol Violation|2|||
157062755|NCT01085812|566985670|FG001|Double-Blind Period|Protocol Violation|7|||
157062756|NCT01085812|566985669|FG000|Double-Blind Period|Withdrawal by Subject|11|||
157062757|NCT01085812|566985670|FG001|Double-Blind Period|Withdrawal by Subject|24|||
157062758|NCT01085812|566985669|FG000|Double-Blind Period|Lost to Follow-up|5|||
157062759|NCT01085812|566985670|FG001|Double-Blind Period|Lost to Follow-up|17|||
157062760|NCT01085812|566985669|FG000|Double-Blind Period|Other Reasons|0|||
157062761|NCT01085812|566985670|FG001|Double-Blind Period|Other Reasons|2|||
157062762|NCT01085812|566985669|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
157062763|NCT01085812|566985670|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
157062764|NCT01085812|566985669|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
157062765|NCT01085812|566985670|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
157062766|NCT01085812|566985669|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
157062767|NCT01085812|566985670|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
157062768|NCT01085812|566985669|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
157062769|NCT01085812|566985670|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
157062770|NCT01085812|566985669|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
157062771|NCT01085812|566985670|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
157062772|NCT00594178|566985673|FG000|Overall Study|Physician Decision|5|||
157062773|NCT04191148|566985679|FG000|Overall Study|Withdrawal by Subject|1|||
157062774|NCT04191148|566985680|FG001|Overall Study|Withdrawal by Subject|0|||
157062775|NCT04191148|566985679|FG000|Overall Study|Adverse Event|1|||
157062776|NCT04191148|566985680|FG001|Overall Study|Adverse Event|0|||
157062777|NCT04582669|566985681|FG000|Overall Study|Subject missed appointment(s).|1|||
157062778|NCT04582669|566985682|FG001|Overall Study|Subject missed appointment(s).|0|||
157062779|NCT04582669|566985683|FG002|Overall Study|Subject missed appointment(s).|1|||
157062780|NCT04582669|566985684|FG003|Overall Study|Subject missed appointment(s).|2|||
157062781|NCT04582669|566985681|FG000|Overall Study|Protocol Violation|0|||
157062782|NCT04582669|566985682|FG001|Overall Study|Protocol Violation|1|||
157062783|NCT04582669|566985683|FG002|Overall Study|Protocol Violation|1|||
157062784|NCT04582669|566985684|FG003|Overall Study|Protocol Violation|0|||
157062785|NCT02647788|566985685|FG000|Overall Study|Lost to Follow-up|13|||
157062786|NCT02647788|566985686|FG001|Overall Study|Lost to Follow-up|11|||
157062787|NCT02647788|566985685|FG000|Overall Study|Did not want opiate|0|||
157062788|NCT02647788|566985686|FG001|Overall Study|Did not want opiate|1|||
157062789|NCT02647788|566985685|FG000|Overall Study|Withdrawal by Subject|1|||
157062790|NCT02647788|566985686|FG001|Overall Study|Withdrawal by Subject|0|||
157062791|NCT02647788|566985685|FG000|Overall Study|Felt itchy with assigned medication|1|||
157062792|NCT02647788|566985686|FG001|Overall Study|Felt itchy with assigned medication|0|||
157062793|NCT02647788|566985685|FG000|Overall Study|Felt nauseous with assigned medication|1|||
157062794|NCT02647788|566985686|FG001|Overall Study|Felt nauseous with assigned medication|1|||
157062795|NCT01274559|566985687|FG000|Overall Study|Adverse Event|57|||
157062796|NCT01274559|566985688|FG001|Overall Study|Adverse Event|13|||
157062797|NCT01274559|566985687|FG000|Overall Study|Death|1|||
157062798|NCT01274559|566985688|FG001|Overall Study|Death|1|||
157062799|NCT01274559|566985687|FG000|Overall Study|Lost to Follow-up|3|||
157062800|NCT01274559|566985688|FG001|Overall Study|Lost to Follow-up|3|||
157062801|NCT01274559|566985687|FG000|Overall Study|Non-compliance with Study Drug|2|||
157062802|NCT01274559|566985688|FG001|Overall Study|Non-compliance with Study Drug|4|||
157062803|NCT01274559|566985687|FG000|Overall Study|Physician Decision|2|||
157062804|NCT01274559|566985688|FG001|Overall Study|Physician Decision|1|||
157062805|NCT01274559|566985687|FG000|Overall Study|Protocol Violation|28|||
157062806|NCT01274559|566985688|FG001|Overall Study|Protocol Violation|23|||
157062807|NCT01274559|566985687|FG000|Overall Study|Study Terminated by Sponsor|79|||
157062808|NCT01274559|566985688|FG001|Overall Study|Study Terminated by Sponsor|87|||
157062809|NCT01274559|566985687|FG000|Overall Study|Withdrawal by Subject|25|||
157062810|NCT01274559|566985688|FG001|Overall Study|Withdrawal by Subject|13|||
157062811|NCT03245619|566985689|FG000|Part A (Up to Day 22)|Physician Decision|4|||
157062812|NCT03245619|566985690|FG001|Part A (Up to Day 22)|Physician Decision|6|||
157062813|NCT03245619|566985691|FG002|Part A (Up to Day 22)|Physician Decision|6|||
157062814|NCT03245619|566985692|FG003|Part A (Up to Day 22)|Physician Decision|0|||
157062815|NCT03245619|566985693|FG004|Part A (Up to Day 22)|Physician Decision|0|||
157062816|NCT03245619|566985694|FG005|Part A (Up to Day 22)|Physician Decision|0|||
157062817|NCT03245619|566985695|FG006|Part A (Up to Day 22)|Physician Decision|0|||
157062818|NCT03245619|566985696|FG007|Part A (Up to Day 22)|Physician Decision|0|||
157062819|NCT03245619|566985697|FG008|Part A (Up to Day 22)|Physician Decision|0|||
157062820|NCT03245619|566985698|FG009|Part A (Up to Day 22)|Physician Decision|0|||
157062821|NCT03245619|566985699|FG010|Part A (Up to Day 22)|Physician Decision|0|||
157062822|NCT03245619|566985700|FG011|Part A (Up to Day 22)|Physician Decision|0|||
157062823|NCT03245619|566985701|FG012|Part A (Up to Day 22)|Physician Decision|0|||
157062824|NCT03245619|566985702|FG013|Part A (Up to Day 22)|Physician Decision|0|||
157062825|NCT03245619|566985703|FG014|Part A (Up to Day 22)|Physician Decision|0|||
157062826|NCT03245619|566985704|FG015|Part A (Up to Day 22)|Physician Decision|0|||
157062827|NCT03245619|566985705|FG016|Part A (Up to Day 22)|Physician Decision|0|||
157062828|NCT01167192|566985724|FG000|Overall Study|Adverse Event|1|||
157062829|NCT01167192|566985724|FG000|Overall Study|Death|1|||
157062830|NCT01167192|566985724|FG000|Overall Study|Withdrawal by Subject|1|||
157062831|NCT01167192|566985724|FG000|Overall Study|Insurance denial|1|||
157062832|NCT02482935|566985738|FG000|Period 1|Withdrawal by Subject|1|||
157062833|NCT02482935|566985739|FG001|Period 1|Withdrawal by Subject|0|||
157062834|NCT03503162|566985740|FG000|Overall Study|did not meet eligibility|1|||
157062835|NCT02835092|566985741|FG000|Overall Study|Withdrawal by Subject|3|||
157062836|NCT02835092|566985742|FG001|Overall Study|Withdrawal by Subject|6|||
157062837|NCT02835092|566985743|FG002|Overall Study|Withdrawal by Subject|3|||
157062838|NCT02835092|566985741|FG000|Overall Study|Lost to Follow-up|0|||
157062839|NCT02835092|566985742|FG001|Overall Study|Lost to Follow-up|2|||
157062840|NCT02835092|566985743|FG002|Overall Study|Lost to Follow-up|0|||
157062841|NCT02246218|566985744|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157062842|NCT02246218|566985745|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
157062843|NCT02246218|566985744|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
157062844|NCT02246218|566985745|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
157062845|NCT02246218|566985744|FG000|Overall Study|Adverse Event|1|||
157062846|NCT02246218|566985745|FG001|Overall Study|Adverse Event|1|||
157062847|NCT02246218|566985744|FG000|Overall Study|Lost to Follow-up|1|||
157062848|NCT02246218|566985745|FG001|Overall Study|Lost to Follow-up|0|||
157062849|NCT01321723|566985746|FG000|Overall Study|Adverse Event|3|||
157062850|NCT01321723|566985747|FG001|Overall Study|Adverse Event|5|||
157062851|NCT01321723|566985748|FG002|Overall Study|Adverse Event|2|||
157062852|NCT01321723|566985746|FG000|Overall Study|Withdrawal by Subject|2|||
156976869|NCT03500640|566669252|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
156976870|NCT03500640|566669253|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
156976871|NCT03500640|566669254|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
156976872|NCT03500640|566669252|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
156976873|NCT03500640|566669253|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
156976874|NCT03500640|566669254|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
156976875|NCT03500640|566669252|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
156976876|NCT03500640|566669253|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
156976877|NCT03500640|566669254|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
156976878|NCT03500640|566669252|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
156976879|NCT03500640|566669253|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
156976880|NCT03500640|566669254|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
156976881|NCT03500640|566669252|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
156976882|NCT03500640|566669253|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
156976883|NCT03500640|566669254|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
156976884|NCT03500640|566669252|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
156976885|NCT03500640|566669253|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
156976886|NCT03500640|566669254|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
156976887|NCT03500640|566669252|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
156976888|NCT03500640|566669253|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
156976889|NCT03500640|566669254|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
156976890|NCT02667886|566669259|FG000|Dose Escalation (Part A)|Adverse Event|1|||
157062853|NCT01321723|566985747|FG001|Overall Study|Withdrawal by Subject|0|||
157062854|NCT01321723|566985748|FG002|Overall Study|Withdrawal by Subject|2|||
157062855|NCT04952701|566985749|FG000|Control Lens|Physician Decision|4|||
157062856|NCT04952701|566985749|FG000|Test Lens|Physician Decision|1|||
157062857|NCT02561806|566985750|FG000|Induction Period|Adverse Event|0|||
157062858|NCT02561806|566985751|FG001|Induction Period|Adverse Event|2|||
157062859|NCT02561806|566985750|FG000|Induction Period|Lack of Efficacy|1|||
157062860|NCT02561806|566985751|FG001|Induction Period|Lack of Efficacy|0|||
157184138|NCT04731922|567415233|FG005|Overall Study|Adverse Event|0|||
156976891|NCT02667886|566669260|FG001|Dose Escalation (Part A)|Adverse Event|3|||
156976892|NCT02667886|566669261|FG002|Dose Escalation (Part A)|Adverse Event|1|||
156976893|NCT02667886|566669262|FG003|Dose Escalation (Part A)|Adverse Event|0|||
157062861|NCT02561806|566985750|FG000|Induction Period|Withdrawal by Subject|0|||
157062862|NCT02561806|566985751|FG001|Induction Period|Withdrawal by Subject|2|||
157062863|NCT02561806|566985750|FG000|Induction Period|Site staff became unblinded|1|||
157062864|NCT02561806|566985751|FG001|Induction Period|Site staff became unblinded|0|||
157184139|NCT04731922|567415234|FG006|Overall Study|Adverse Event|0|||
157184140|NCT04731922|567415235|FG007|Overall Study|Adverse Event|0|||
157062865|NCT02561806|566985750|FG000|Induction Period|Randomized but not treated|0|||
157062866|NCT02561806|566985751|FG001|Induction Period|Randomized but not treated|1|||
157062867|NCT02561806|566985750|FG000|Maintenance Period|Adverse Event|2|||
157062868|NCT02561806|566985751|FG001|Maintenance Period|Adverse Event|1|||
157062869|NCT02561806|566985750|FG000|Maintenance Period|Lack of Efficacy|3|||
157062870|NCT02561806|566985751|FG001|Maintenance Period|Lack of Efficacy|1|||
157062871|NCT02561806|566985750|FG000|Maintenance Period|Lost to Follow-up|2|||
157062872|NCT02561806|566985751|FG001|Maintenance Period|Lost to Follow-up|2|||
157184141|NCT04731922|567415236|FG008|Overall Study|Adverse Event|0|||
157184142|NCT04731922|567415237|FG009|Overall Study|Adverse Event|0|||
157184143|NCT04731922|567415238|FG010|Overall Study|Adverse Event|1|||
157184144|NCT04731922|567415239|FG011|Overall Study|Adverse Event|0|||
157184145|NCT04731922|567415240|FG012|Overall Study|Adverse Event|0|||
157184146|NCT04731922|567415241|FG013|Overall Study|Adverse Event|0|||
157184147|NCT04731922|567415242|FG014|Overall Study|Adverse Event|0|||
157184148|NCT04731922|567415243|FG015|Overall Study|Adverse Event|0|||
157184149|NCT04731922|567415244|FG016|Overall Study|Adverse Event|0|||
157184150|NCT04731922|567415228|FG000|Overall Study|Lost to Follow-up|0|||
157184151|NCT04731922|567415229|FG001|Overall Study|Lost to Follow-up|0|||
157184152|NCT04731922|567415230|FG002|Overall Study|Lost to Follow-up|0|||
157184153|NCT04731922|567415231|FG003|Overall Study|Lost to Follow-up|1|||
157184154|NCT04731922|567415232|FG004|Overall Study|Lost to Follow-up|0|||
157184155|NCT04731922|567415233|FG005|Overall Study|Lost to Follow-up|1|||
157184156|NCT04731922|567415234|FG006|Overall Study|Lost to Follow-up|0|||
157184157|NCT04731922|567415235|FG007|Overall Study|Lost to Follow-up|0|||
157184158|NCT04731922|567415236|FG008|Overall Study|Lost to Follow-up|0|||
157184159|NCT04731922|567415237|FG009|Overall Study|Lost to Follow-up|0|||
157062873|NCT02561806|566985750|FG000|Maintenance Period|Protocol Violation|1|||
157062874|NCT02561806|566985751|FG001|Maintenance Period|Protocol Violation|0|||
157062875|NCT02561806|566985750|FG000|Maintenance Period|Withdrawal by Subject|5|||
157062876|NCT02561806|566985751|FG001|Maintenance Period|Withdrawal by Subject|3|||
157062877|NCT02561806|566985750|FG000|Maintenance Period|Site staff became unblinded|0|||
157062878|NCT02561806|566985751|FG001|Maintenance Period|Site staff became unblinded|1|||
157062879|NCT02561806|566985750|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
157062880|NCT02561806|566985751|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
157062881|NCT02561806|566985750|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
157062882|NCT02561806|566985751|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
157062883|NCT02547441|566985752|FG000|Double-Blind Study Period|Adverse Event|4|||
157062884|NCT02547441|566985753|FG001|Double-Blind Study Period|Adverse Event|9|||
157062885|NCT02547441|566985752|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
157062886|NCT02547441|566985753|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
157062887|NCT02547441|566985752|FG000|Double-Blind Study Period|Physician Decision|1|||
157062888|NCT02547441|566985753|FG001|Double-Blind Study Period|Physician Decision|0|||
157062889|NCT02547441|566985752|FG000|Double-Blind Study Period|Protocol Violation|1|||
157062890|NCT02547441|566985753|FG001|Double-Blind Study Period|Protocol Violation|2|||
157062891|NCT02547441|566985752|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
157062892|NCT02547441|566985753|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
157062893|NCT02547441|566985752|FG000|Double-Blind Study Period|Sponsor Decision|1|||
157062894|NCT02547441|566985753|FG001|Double-Blind Study Period|Sponsor Decision|0|||
157062895|NCT02547441|566985752|FG000|Open-Label Study Period|Adverse Event|10|||
157062896|NCT02547441|566985753|FG001|Open-Label Study Period|Adverse Event|11|||
157062897|NCT02547441|566985752|FG000|Open-Label Study Period|Lack of Efficacy|3|||
157062898|NCT02547441|566985753|FG001|Open-Label Study Period|Lack of Efficacy|2|||
157062899|NCT02547441|566985752|FG000|Open-Label Study Period|Lost to Follow-up|7|||
157062900|NCT02547441|566985753|FG001|Open-Label Study Period|Lost to Follow-up|8|||
157062901|NCT02547441|566985752|FG000|Open-Label Study Period|Physician Decision|1|||
157062902|NCT02547441|566985753|FG001|Open-Label Study Period|Physician Decision|0|||
157062903|NCT02547441|566985752|FG000|Open-Label Study Period|Protocol Violation|2|||
157062904|NCT02547441|566985753|FG001|Open-Label Study Period|Protocol Violation|0|||
157184160|NCT04731922|567415238|FG010|Overall Study|Lost to Follow-up|0|||
157184161|NCT04731922|567415239|FG011|Overall Study|Lost to Follow-up|0|||
157184162|NCT04731922|567415240|FG012|Overall Study|Lost to Follow-up|0|||
157184163|NCT04731922|567415241|FG013|Overall Study|Lost to Follow-up|0|||
157184164|NCT04731922|567415242|FG014|Overall Study|Lost to Follow-up|0|||
157062905|NCT02547441|566985752|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
157184165|NCT04731922|567415243|FG015|Overall Study|Lost to Follow-up|0|||
157184166|NCT04731922|567415244|FG016|Overall Study|Lost to Follow-up|0|||
157062906|NCT02547441|566985753|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
157184167|NCT04731922|567415228|FG000|Overall Study|Withdrawal by Subject|1|||
157184168|NCT04731922|567415229|FG001|Overall Study|Withdrawal by Subject|0|||
157184169|NCT04731922|567415230|FG002|Overall Study|Withdrawal by Subject|0|||
157062907|NCT02547441|566985752|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
157184170|NCT04731922|567415231|FG003|Overall Study|Withdrawal by Subject|0|||
157184171|NCT04731922|567415232|FG004|Overall Study|Withdrawal by Subject|1|||
157184172|NCT04731922|567415233|FG005|Overall Study|Withdrawal by Subject|0|||
156976894|NCT02667886|566669263|FG004|Dose Escalation (Part A)|Adverse Event|0|||
156976895|NCT02667886|566669259|FG000|Dose Escalation (Part A)|Disease Progression|1|||
156976896|NCT02667886|566669260|FG001|Dose Escalation (Part A)|Disease Progression|4|||
156976897|NCT02667886|566669261|FG002|Dose Escalation (Part A)|Disease Progression|3|||
156976898|NCT02667886|566669262|FG003|Dose Escalation (Part A)|Disease Progression|0|||
156976899|NCT02667886|566669263|FG004|Dose Escalation (Part A)|Disease Progression|0|||
156976900|NCT02667886|566669259|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156976901|NCT02667886|566669260|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156976902|NCT02667886|566669261|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
156976903|NCT02667886|566669262|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156976904|NCT02667886|566669263|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
156976905|NCT02667886|566669259|FG000|Dose Expansion (Part B)|Adverse Event|0|||
156976906|NCT02667886|566669260|FG001|Dose Expansion (Part B)|Adverse Event|0|||
156976907|NCT02667886|566669261|FG002|Dose Expansion (Part B)|Adverse Event|0|||
156976908|NCT02667886|566669262|FG003|Dose Expansion (Part B)|Adverse Event|9|||
156976909|NCT02667886|566669263|FG004|Dose Expansion (Part B)|Adverse Event|0|||
156976910|NCT02667886|566669259|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
156976911|NCT02667886|566669260|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
156976912|NCT02667886|566669261|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
156976913|NCT02667886|566669262|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
156976914|NCT02667886|566669263|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
156976915|NCT02667886|566669259|FG000|Dose Expansion (Part B)|Disease Progression|0|||
156976916|NCT02667886|566669260|FG001|Dose Expansion (Part B)|Disease Progression|0|||
156976917|NCT02667886|566669261|FG002|Dose Expansion (Part B)|Disease Progression|0|||
156976918|NCT02667886|566669262|FG003|Dose Expansion (Part B)|Disease Progression|38|||
156976919|NCT02667886|566669263|FG004|Dose Expansion (Part B)|Disease Progression|0|||
156976920|NCT02667886|566669259|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156976921|NCT02667886|566669260|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156976922|NCT02667886|566669261|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156976923|NCT02667886|566669262|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
156976924|NCT02667886|566669263|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
156976925|NCT02667886|566669259|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156976926|NCT02667886|566669260|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156976927|NCT02667886|566669261|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156976928|NCT02667886|566669262|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
156976929|NCT02667886|566669263|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
156976930|NCT02667886|566669259|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
156976931|NCT02667886|566669260|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
156976932|NCT02667886|566669261|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
156976933|NCT02667886|566669262|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
156976934|NCT02667886|566669263|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
156976935|NCT01905046|566669264|FG000|Months 13-24|Withdrawal by Subject|10|||
156976936|NCT01905046|566669265|FG001|Months 13-24|Withdrawal by Subject|10|||
156976937|NCT01905046|566669264|FG000|Months 13-24|Adverse Event|3|||
156976938|NCT01905046|566669265|FG001|Months 13-24|Adverse Event|2|||
156976939|NCT01905046|566669264|FG000|Months 13-24|Protocol Violation|3|||
156976940|NCT01905046|566669265|FG001|Months 13-24|Protocol Violation|3|||
156976941|NCT01905046|566669264|FG000|Months 13-24|Physician Decision|1|||
156976942|NCT01905046|566669265|FG001|Months 13-24|Physician Decision|0|||
156976943|NCT00612534|566669269|FG000|Overall Study|Adverse Event|0|||
156976944|NCT00612534|566669270|FG001|Overall Study|Adverse Event|4|||
156976945|NCT00612534|566669271|FG002|Overall Study|Adverse Event|2|||
156976946|NCT00612534|566669272|FG003|Overall Study|Adverse Event|1|||
156976947|NCT00612534|566669269|FG000|Overall Study|Lack of Efficacy|13|||
156976948|NCT00612534|566669270|FG001|Overall Study|Lack of Efficacy|12|||
156976949|NCT00612534|566669271|FG002|Overall Study|Lack of Efficacy|5|||
156976950|NCT00612534|566669272|FG003|Overall Study|Lack of Efficacy|16|||
156976951|NCT00612534|566669269|FG000|Overall Study|Other Reason|0|||
156976952|NCT00612534|566669270|FG001|Overall Study|Other Reason|1|||
156976953|NCT00612534|566669271|FG002|Overall Study|Other Reason|0|||
156976954|NCT00612534|566669272|FG003|Overall Study|Other Reason|0|||
156976955|NCT05778526|566669274|FG000|Overall Study|Lost to Follow-up|0|||
156976956|NCT05778526|566669275|FG001|Overall Study|Lost to Follow-up|1|||
156976957|NCT05778526|566669276|FG002|Overall Study|Lost to Follow-up|3|||
156976958|NCT05778526|566669274|FG000|Overall Study|Protocol Violation|0|||
156976959|NCT05778526|566669275|FG001|Overall Study|Protocol Violation|0|||
156976960|NCT05778526|566669276|FG002|Overall Study|Protocol Violation|8|||
156976961|NCT01435655|566669279|FG000|Overall Study|Death|2|||
156976962|NCT01435655|566669279|FG000|Overall Study|Other|1|||
157062908|NCT02547441|566985753|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
156976963|NCT01008475|566669280|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
156976964|NCT01008475|566669281|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
156976965|NCT01008475|566669282|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
157062909|NCT01322009|566985754|FG000|Overall Study|Death|0|||
157062910|NCT01322009|566985755|FG001|Overall Study|Death|1|||
157062911|NCT01322009|566985754|FG000|Overall Study|Adverse Event|0|||
157062912|NCT01322009|566985755|FG001|Overall Study|Adverse Event|1|||
157062913|NCT01322009|566985754|FG000|Overall Study|ng tube discontinued|0|||
157062914|NCT01322009|566985755|FG001|Overall Study|ng tube discontinued|1|||
157062915|NCT00905034|566985756|FG000|Overall Study|Withdrawal by Subject|1|||
157062916|NCT00394589|566985757|FG000|Overall Study|Adverse Event|2|||
157062917|NCT00394589|566985758|FG001|Overall Study|Adverse Event|1|||
157062918|NCT00394589|566985759|FG002|Overall Study|Adverse Event|2|||
157062919|NCT00394589|566985757|FG000|Overall Study|Lack of Efficacy|2|||
157062920|NCT00394589|566985758|FG001|Overall Study|Lack of Efficacy|2|||
157062921|NCT00394589|566985759|FG002|Overall Study|Lack of Efficacy|3|||
157062922|NCT00394589|566985757|FG000|Overall Study|Protocol Violation|4|||
157062923|NCT00394589|566985758|FG001|Overall Study|Protocol Violation|0|||
157062924|NCT00394589|566985759|FG002|Overall Study|Protocol Violation|2|||
157062925|NCT03409731|566985760|FG000|Overall Study|Withdrawal by Subject|17|||
157062926|NCT03409731|566985760|FG000|Overall Study|Death|4|||
157062927|NCT04545476|566985763|FG000|Overall Study|Lost to Follow-up|1|||
157062928|NCT04545476|566985764|FG001|Overall Study|Lost to Follow-up|1|||
157062929|NCT04545476|566985765|FG002|Overall Study|Lost to Follow-up|0|||
157062930|NCT04545476|566985766|FG003|Overall Study|Lost to Follow-up|0|||
157062931|NCT03175198|566985769|FG000|Overall Study|Adverse Event|480|||
157062932|NCT03175198|566985769|FG000|Overall Study|No actual visit|120|||
157062933|NCT03175198|566985769|FG000|Overall Study|Registration rule not followed|4|||
157062934|NCT03175198|566985769|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
157062935|NCT03175198|566985769|FG000|Overall Study|Other personal reason|509|||
157062936|NCT03175198|566985769|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
157062937|NCT03175198|566985769|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
157062938|NCT03175198|566985769|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
157062939|NCT03175198|566985769|FG000|Overall Study|To conduct invasive treatment of operation|53|||
157062940|NCT03175198|566985769|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
157062941|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
157062942|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
157062943|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
157062944|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
157062945|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
157062946|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
157062947|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Rejections|0|||
157062948|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Rejections|0|||
157062949|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Rejections|55|||
157062950|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
157062951|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
157062952|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
157062953|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
157062954|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
157062955|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
157062956|NCT00634920|566985771|FG000|Period 1 - Pre-Randomization|Other issues|0|||
157062957|NCT00634920|566985772|FG001|Period 1 - Pre-Randomization|Other issues|0|||
157062958|NCT00634920|566985773|FG002|Period 1 - Pre-Randomization|Other issues|6|||
157062959|NCT00634920|566985771|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
157062960|NCT00634920|566985772|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
157062961|NCT00634920|566985773|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
157062962|NCT00634920|566985771|FG000|Period 2 - Post-Randomization|Rejection|11|||
157062963|NCT00634920|566985772|FG001|Period 2 - Post-Randomization|Rejection|5|||
157062964|NCT00634920|566985773|FG002|Period 2 - Post-Randomization|Rejection|0|||
157062965|NCT00634920|566985771|FG000|Period 2 - Post-Randomization|Death|2|||
157062966|NCT00634920|566985772|FG001|Period 2 - Post-Randomization|Death|5|||
157062967|NCT00634920|566985773|FG002|Period 2 - Post-Randomization|Death|0|||
157062968|NCT00634920|566985771|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
157062969|NCT00634920|566985772|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
157062970|NCT00634920|566985773|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
157062971|NCT00634920|566985771|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
157062972|NCT00634920|566985772|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
157062973|NCT00634920|566985773|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
157062974|NCT01193218|566985774|FG000|0-12 Weeks|Adverse Event|6|||
157062975|NCT01193218|566985775|FG001|0-12 Weeks|Adverse Event|0|||
157062976|NCT01193218|566985776|FG002|0-12 Weeks|Adverse Event|1|||
157062977|NCT01193218|566985777|FG003|0-12 Weeks|Adverse Event|0|||
157062978|NCT01193218|566985778|FG004|0-12 Weeks|Adverse Event|0|||
157062979|NCT01193218|566985779|FG005|0-12 Weeks|Adverse Event|2|||
157062980|NCT01193218|566985780|FG006|0-12 Weeks|Adverse Event|2|||
157062981|NCT01193218|566985781|FG007|0-12 Weeks|Adverse Event|0|||
157062982|NCT01193218|566985774|FG000|0-12 Weeks|Protocol Violation|0|||
157062983|NCT01193218|566985775|FG001|0-12 Weeks|Protocol Violation|0|||
157062984|NCT01193218|566985776|FG002|0-12 Weeks|Protocol Violation|0|||
157062985|NCT01193218|566985777|FG003|0-12 Weeks|Protocol Violation|0|||
157062986|NCT01193218|566985778|FG004|0-12 Weeks|Protocol Violation|1|||
157062987|NCT01193218|566985779|FG005|0-12 Weeks|Protocol Violation|1|||
157062988|NCT01193218|566985780|FG006|0-12 Weeks|Protocol Violation|0|||
157062989|NCT01193218|566985781|FG007|0-12 Weeks|Protocol Violation|0|||
157062990|NCT01193218|566985774|FG000|0-12 Weeks|Withdrawal by Subject|3|||
157062991|NCT01193218|566985775|FG001|0-12 Weeks|Withdrawal by Subject|0|||
157062992|NCT01193218|566985776|FG002|0-12 Weeks|Withdrawal by Subject|2|||
157062993|NCT01193218|566985777|FG003|0-12 Weeks|Withdrawal by Subject|0|||
157062994|NCT01193218|566985778|FG004|0-12 Weeks|Withdrawal by Subject|0|||
157062995|NCT01193218|566985779|FG005|0-12 Weeks|Withdrawal by Subject|0|||
157062996|NCT01193218|566985780|FG006|0-12 Weeks|Withdrawal by Subject|1|||
157062997|NCT01193218|566985781|FG007|0-12 Weeks|Withdrawal by Subject|0|||
157062998|NCT01193218|566985774|FG000|12-52 Weeks|Adverse Event|1|||
157062999|NCT01193218|566985775|FG001|12-52 Weeks|Adverse Event|0|||
157063000|NCT01193218|566985776|FG002|12-52 Weeks|Adverse Event|1|||
157063001|NCT01193218|566985777|FG003|12-52 Weeks|Adverse Event|2|||
157063002|NCT01193218|566985778|FG004|12-52 Weeks|Adverse Event|3|||
157063003|NCT01193218|566985779|FG005|12-52 Weeks|Adverse Event|3|||
157063004|NCT01193218|566985780|FG006|12-52 Weeks|Adverse Event|1|||
157063005|NCT01193218|566985781|FG007|12-52 Weeks|Adverse Event|2|||
157063006|NCT01193218|566985774|FG000|12-52 Weeks|Lack of Efficacy|0|||
157063007|NCT01193218|566985775|FG001|12-52 Weeks|Lack of Efficacy|0|||
157063008|NCT01193218|566985776|FG002|12-52 Weeks|Lack of Efficacy|0|||
157063009|NCT01193218|566985777|FG003|12-52 Weeks|Lack of Efficacy|0|||
157063010|NCT01193218|566985778|FG004|12-52 Weeks|Lack of Efficacy|0|||
157063011|NCT01193218|566985779|FG005|12-52 Weeks|Lack of Efficacy|0|||
157063012|NCT01193218|566985780|FG006|12-52 Weeks|Lack of Efficacy|1|||
157063013|NCT01193218|566985781|FG007|12-52 Weeks|Lack of Efficacy|0|||
157063014|NCT01193218|566985774|FG000|12-52 Weeks|Withdrawal by Subject|3|||
157063015|NCT01193218|566985775|FG001|12-52 Weeks|Withdrawal by Subject|0|||
157063016|NCT01193218|566985776|FG002|12-52 Weeks|Withdrawal by Subject|3|||
157063017|NCT01193218|566985777|FG003|12-52 Weeks|Withdrawal by Subject|0|||
157063018|NCT01193218|566985778|FG004|12-52 Weeks|Withdrawal by Subject|0|||
157063019|NCT01193218|566985779|FG005|12-52 Weeks|Withdrawal by Subject|2|||
157063020|NCT01193218|566985780|FG006|12-52 Weeks|Withdrawal by Subject|1|||
157063021|NCT01193218|566985781|FG007|12-52 Weeks|Withdrawal by Subject|2|||
157063022|NCT01193218|566985774|FG000|12-52 Weeks|Other reason than above|1|||
157063023|NCT01193218|566985775|FG001|12-52 Weeks|Other reason than above|0|||
157063024|NCT01193218|566985776|FG002|12-52 Weeks|Other reason than above|0|||
157063025|NCT01193218|566985777|FG003|12-52 Weeks|Other reason than above|1|||
157063026|NCT01193218|566985778|FG004|12-52 Weeks|Other reason than above|1|||
157063027|NCT01193218|566985779|FG005|12-52 Weeks|Other reason than above|0|||
157063028|NCT01193218|566985780|FG006|12-52 Weeks|Other reason than above|0|||
157063029|NCT01193218|566985781|FG007|12-52 Weeks|Other reason than above|0|||
157063030|NCT00363649|566985782|FG000|Overall Study|Withdrawal by Subject|1|||
157063031|NCT00363649|566985783|FG001|Overall Study|Withdrawal by Subject|1|||
157063032|NCT00363649|566985782|FG000|Overall Study|Adverse Event|6|||
157063033|NCT00363649|566985783|FG001|Overall Study|Adverse Event|0|||
157063034|NCT01013740|566985784|FG000|Overall Study|Lost to Follow-up|3|||
157063035|NCT01013740|566985785|FG001|Overall Study|Lost to Follow-up|5|||
157063036|NCT01013740|566985784|FG000|Overall Study|Physician Decision|2|||
157063037|NCT01013740|566985785|FG001|Overall Study|Physician Decision|0|||
157063038|NCT01013740|566985784|FG000|Overall Study|Withdrawal by Subject|2|||
157063039|NCT01013740|566985785|FG001|Overall Study|Withdrawal by Subject|10|||
157063040|NCT01013740|566985784|FG000|Overall Study|study close / terminated : done in error|2|||
157063041|NCT01013740|566985785|FG001|Overall Study|study close / terminated : done in error|1|||
157063042|NCT01013740|566985784|FG000|Overall Study|Missing|2|||
157063043|NCT01013740|566985785|FG001|Overall Study|Missing|1|||
157063044|NCT01013740|566985784|FG000|Overall Study|Ongoing: Study records not completed|0|||
157063045|NCT01013740|566985785|FG001|Overall Study|Ongoing: Study records not completed|2|||
157063046|NCT02161185|566985786|FG000|Treatment Phase|Administrative/Other|7|||
157063047|NCT00776984|566985788|FG000|Overall Study|Adverse Event|8|||
157063048|NCT00776984|566985789|FG001|Overall Study|Adverse Event|2|||
157063049|NCT00776984|566985788|FG000|Overall Study|Protocol Violation|4|||
157063050|NCT00776984|566985789|FG001|Overall Study|Protocol Violation|2|||
157063051|NCT00776984|566985788|FG000|Overall Study|Lost to Follow-up|2|||
157063052|NCT00776984|566985789|FG001|Overall Study|Lost to Follow-up|0|||
157063053|NCT00776984|566985788|FG000|Overall Study|Withdrawal by Subject|12|||
157063054|NCT00776984|566985789|FG001|Overall Study|Withdrawal by Subject|7|||
157063055|NCT00776984|566985788|FG000|Overall Study|Lack of Efficacy|0|||
157063056|NCT00776984|566985789|FG001|Overall Study|Lack of Efficacy|1|||
157063057|NCT00776984|566985788|FG000|Overall Study|Other|5|||
157063058|NCT00776984|566985789|FG001|Overall Study|Other|9|||
157063059|NCT00913523|566987516|FG000|Overall Study|Withdrawal by Subject|3|||
157063060|NCT00913523|566987517|FG001|Overall Study|Withdrawal by Subject|2|||
157063061|NCT00913523|566987518|FG002|Overall Study|Withdrawal by Subject|2|||
157063062|NCT00913523|566987516|FG000|Overall Study|Lost to Follow-up|1|||
157063063|NCT00913523|566987517|FG001|Overall Study|Lost to Follow-up|1|||
157063064|NCT00913523|566987518|FG002|Overall Study|Lost to Follow-up|1|||
157063065|NCT00913523|566987516|FG000|Overall Study|Adverse Event|1|||
157063066|NCT00913523|566987517|FG001|Overall Study|Adverse Event|0|||
157063067|NCT00913523|566987518|FG002|Overall Study|Adverse Event|0|||
157063068|NCT00913523|566987516|FG000|Overall Study|Protocol Violation|5|||
157063069|NCT00913523|566987517|FG001|Overall Study|Protocol Violation|8|||
157063070|NCT00913523|566987518|FG002|Overall Study|Protocol Violation|8|||
157063071|NCT00913523|566987516|FG000|Overall Study|Pregnancy|1|||
157063072|NCT00913523|566987517|FG001|Overall Study|Pregnancy|3|||
157063073|NCT00913523|566987518|FG002|Overall Study|Pregnancy|0|||
157063074|NCT00913523|566987516|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
157063075|NCT00913523|566987517|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
157063076|NCT00913523|566987518|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
157063077|NCT01475461|566987519|FG000|Run-in Period|Not meet eligibility criteria|16|||
157063078|NCT01475461|566987520|FG001|Run-in Period|Not meet eligibility criteria|0|||
157063079|NCT01475461|566987521|FG002|Run-in Period|Not meet eligibility criteria|0|||
157063080|NCT01475461|566987522|FG003|Run-in Period|Not meet eligibility criteria|0|||
157063081|NCT01475461|566987523|FG004|Run-in Period|Not meet eligibility criteria|0|||
157063082|NCT01475461|566987524|FG005|Run-in Period|Not meet eligibility criteria|0|||
157063083|NCT01475461|566987525|FG006|Run-in Period|Not meet eligibility criteria|0|||
157063084|NCT01475461|566987519|FG000|Run-in Period|Lost to Follow-up|7|||
157063085|NCT01475461|566987520|FG001|Run-in Period|Lost to Follow-up|0|||
157063086|NCT01475461|566987521|FG002|Run-in Period|Lost to Follow-up|0|||
157063087|NCT01475461|566987522|FG003|Run-in Period|Lost to Follow-up|0|||
157063088|NCT01475461|566987523|FG004|Run-in Period|Lost to Follow-up|0|||
157063089|NCT01475461|566987524|FG005|Run-in Period|Lost to Follow-up|0|||
157063090|NCT01475461|566987525|FG006|Run-in Period|Lost to Follow-up|0|||
157063091|NCT01475461|566987519|FG000|Run-in Period|Withdrawal by Subject|11|||
157063092|NCT01475461|566987520|FG001|Run-in Period|Withdrawal by Subject|0|||
157063093|NCT01475461|566987521|FG002|Run-in Period|Withdrawal by Subject|0|||
157063094|NCT01475461|566987522|FG003|Run-in Period|Withdrawal by Subject|0|||
157063095|NCT01475461|566987523|FG004|Run-in Period|Withdrawal by Subject|0|||
157063096|NCT01475461|566987524|FG005|Run-in Period|Withdrawal by Subject|0|||
157063097|NCT01475461|566987525|FG006|Run-in Period|Withdrawal by Subject|0|||
157063098|NCT01475461|566987519|FG000|Run-in Period|Other|3|||
157063099|NCT01475461|566987520|FG001|Run-in Period|Other|0|||
157063100|NCT01475461|566987521|FG002|Run-in Period|Other|0|||
157063101|NCT01475461|566987522|FG003|Run-in Period|Other|0|||
157063102|NCT01475461|566987523|FG004|Run-in Period|Other|0|||
157063103|NCT01475461|566987524|FG005|Run-in Period|Other|0|||
157063104|NCT01475461|566987525|FG006|Run-in Period|Other|0|||
157063105|NCT01475461|566987519|FG000|Run-in Period|Protocol Violation|4|||
157063106|NCT01475461|566987520|FG001|Run-in Period|Protocol Violation|0|||
157063107|NCT01475461|566987521|FG002|Run-in Period|Protocol Violation|0|||
157063108|NCT01475461|566987522|FG003|Run-in Period|Protocol Violation|0|||
157063109|NCT01475461|566987523|FG004|Run-in Period|Protocol Violation|0|||
157063110|NCT01475461|566987524|FG005|Run-in Period|Protocol Violation|0|||
157063111|NCT01475461|566987525|FG006|Run-in Period|Protocol Violation|0|||
157063112|NCT01475461|566987519|FG000|Treatment Period|Death|0|||
157063113|NCT01475461|566987520|FG001|Treatment Period|Death|0|||
157063114|NCT01475461|566987521|FG002|Treatment Period|Death|0|||
157063115|NCT01475461|566987522|FG003|Treatment Period|Death|1|||
157063116|NCT01475461|566987523|FG004|Treatment Period|Death|0|||
157063117|NCT01475461|566987524|FG005|Treatment Period|Death|0|||
157063118|NCT01475461|566987525|FG006|Treatment Period|Death|0|||
157063119|NCT01475461|566987519|FG000|Treatment Period|Lost to Follow-up|0|||
157063120|NCT01475461|566987520|FG001|Treatment Period|Lost to Follow-up|3|||
157063121|NCT01475461|566987521|FG002|Treatment Period|Lost to Follow-up|2|||
157063122|NCT01475461|566987522|FG003|Treatment Period|Lost to Follow-up|3|||
157063123|NCT01475461|566987523|FG004|Treatment Period|Lost to Follow-up|1|||
157063124|NCT01475461|566987524|FG005|Treatment Period|Lost to Follow-up|2|||
157063125|NCT01475461|566987525|FG006|Treatment Period|Lost to Follow-up|1|||
157063126|NCT01475461|566987519|FG000|Treatment Period|Withdrawal by Subject|0|||
157063127|NCT01475461|566987520|FG001|Treatment Period|Withdrawal by Subject|2|||
157063128|NCT01475461|566987521|FG002|Treatment Period|Withdrawal by Subject|2|||
157063129|NCT01475461|566987522|FG003|Treatment Period|Withdrawal by Subject|0|||
157063130|NCT01475461|566987523|FG004|Treatment Period|Withdrawal by Subject|2|||
157063131|NCT01475461|566987524|FG005|Treatment Period|Withdrawal by Subject|2|||
157063132|NCT01475461|566987525|FG006|Treatment Period|Withdrawal by Subject|0|||
157063133|NCT01475461|566987519|FG000|Treatment Period|Other|0|||
157063134|NCT01475461|566987520|FG001|Treatment Period|Other|1|||
157063135|NCT01475461|566987521|FG002|Treatment Period|Other|0|||
157063136|NCT01475461|566987522|FG003|Treatment Period|Other|0|||
157063137|NCT01475461|566987523|FG004|Treatment Period|Other|0|||
157063138|NCT01475461|566987524|FG005|Treatment Period|Other|0|||
157063139|NCT01475461|566987525|FG006|Treatment Period|Other|0|||
157063140|NCT01475461|566987519|FG000|Treatment Period|Protocol Violation|0|||
157063141|NCT01475461|566987520|FG001|Treatment Period|Protocol Violation|1|||
157063142|NCT01475461|566987521|FG002|Treatment Period|Protocol Violation|0|||
157063143|NCT01475461|566987522|FG003|Treatment Period|Protocol Violation|0|||
157063144|NCT01475461|566987523|FG004|Treatment Period|Protocol Violation|0|||
157063145|NCT01475461|566987524|FG005|Treatment Period|Protocol Violation|0|||
157063146|NCT01475461|566987525|FG006|Treatment Period|Protocol Violation|1|||
157063147|NCT01475461|566987519|FG000|Treatment Period|Lack of Efficacy|0|||
157063148|NCT01475461|566987520|FG001|Treatment Period|Lack of Efficacy|2|||
157063149|NCT01475461|566987521|FG002|Treatment Period|Lack of Efficacy|0|||
157063150|NCT01475461|566987522|FG003|Treatment Period|Lack of Efficacy|2|||
157063151|NCT01475461|566987523|FG004|Treatment Period|Lack of Efficacy|1|||
157063152|NCT01475461|566987524|FG005|Treatment Period|Lack of Efficacy|1|||
157063153|NCT01475461|566987525|FG006|Treatment Period|Lack of Efficacy|0|||
157063154|NCT01475461|566987519|FG000|Treatment Period|Medication Error|0|||
157063155|NCT01475461|566987520|FG001|Treatment Period|Medication Error|0|||
157063156|NCT01475461|566987521|FG002|Treatment Period|Medication Error|0|||
157063157|NCT01475461|566987522|FG003|Treatment Period|Medication Error|1|||
157063158|NCT01475461|566987523|FG004|Treatment Period|Medication Error|0|||
157063159|NCT01475461|566987524|FG005|Treatment Period|Medication Error|0|||
157063160|NCT01475461|566987525|FG006|Treatment Period|Medication Error|0|||
157063161|NCT01475461|566987519|FG000|Treatment Period|Adverse Event|0|||
157063162|NCT01475461|566987520|FG001|Treatment Period|Adverse Event|0|||
157063163|NCT01475461|566987521|FG002|Treatment Period|Adverse Event|0|||
157063164|NCT01475461|566987522|FG003|Treatment Period|Adverse Event|1|||
157063165|NCT01475461|566987523|FG004|Treatment Period|Adverse Event|0|||
157063166|NCT01475461|566987524|FG005|Treatment Period|Adverse Event|0|||
157063167|NCT01475461|566987525|FG006|Treatment Period|Adverse Event|0|||
157063168|NCT04051242|566987526|FG000|Overall Study|Withdrawal by Subject|1|||
157063169|NCT04051242|566987526|FG000|Overall Study|Physician Decision|1|||
157063170|NCT02512861|566987529|FG000|Overall Study|Protocol Violation|3|||
157063171|NCT02512861|566987530|FG001|Overall Study|Protocol Violation|7|||
157063172|NCT02512861|566987529|FG000|Overall Study|Physician Decision|3|||
157063173|NCT02512861|566987530|FG001|Overall Study|Physician Decision|1|||
157063174|NCT02512861|566987529|FG000|Overall Study|Withdrawal by Subject|0|||
157063175|NCT02512861|566987530|FG001|Overall Study|Withdrawal by Subject|1|||
157184173|NCT04731922|567415234|FG006|Overall Study|Withdrawal by Subject|1|||
157184174|NCT04731922|567415235|FG007|Overall Study|Withdrawal by Subject|0|||
157184175|NCT04731922|567415236|FG008|Overall Study|Withdrawal by Subject|0|||
157184176|NCT04731922|567415237|FG009|Overall Study|Withdrawal by Subject|0|||
157184177|NCT04731922|567415238|FG010|Overall Study|Withdrawal by Subject|0|||
157184178|NCT04731922|567415239|FG011|Overall Study|Withdrawal by Subject|0|||
157184179|NCT04731922|567415240|FG012|Overall Study|Withdrawal by Subject|0|||
157184180|NCT04731922|567415241|FG013|Overall Study|Withdrawal by Subject|1|||
157184181|NCT04731922|567415242|FG014|Overall Study|Withdrawal by Subject|0|||
157184182|NCT04731922|567415243|FG015|Overall Study|Withdrawal by Subject|0|||
157184183|NCT04731922|567415244|FG016|Overall Study|Withdrawal by Subject|0|||
157063176|NCT00553605|566987531|FG000|Overall Study|Did not meet entrance criteria|1|||
157063177|NCT00553605|566987532|FG001|Overall Study|Did not meet entrance criteria|3|||
157063178|NCT00553605|566987531|FG000|Overall Study|Did not receive full dose|1|||
157063179|NCT00553605|566987532|FG001|Overall Study|Did not receive full dose|0|||
157063180|NCT00553605|566987531|FG000|Overall Study|Randomized but not treated|2|||
157063181|NCT00553605|566987532|FG001|Overall Study|Randomized but not treated|0|||
157063182|NCT01874665|566987534|FG000|Overall Study|Adverse Event|6|||
157063183|NCT01874665|566987535|FG001|Overall Study|Adverse Event|2|||
157184184|NCT04731922|567415228|FG000|Overall Study|Other|0|||
157184185|NCT04731922|567415229|FG001|Overall Study|Other|0|||
157184186|NCT04731922|567415230|FG002|Overall Study|Other|0|||
157184187|NCT04731922|567415231|FG003|Overall Study|Other|0|||
157184188|NCT04731922|567415232|FG004|Overall Study|Other|0|||
157184189|NCT04731922|567415233|FG005|Overall Study|Other|0|||
157184190|NCT04731922|567415234|FG006|Overall Study|Other|1|||
157184191|NCT04731922|567415235|FG007|Overall Study|Other|0|||
157184192|NCT04731922|567415236|FG008|Overall Study|Other|0|||
157184193|NCT04731922|567415237|FG009|Overall Study|Other|0|||
157184194|NCT04731922|567415238|FG010|Overall Study|Other|0|||
157184195|NCT04731922|567415239|FG011|Overall Study|Other|0|||
157184196|NCT04731922|567415240|FG012|Overall Study|Other|0|||
157184197|NCT04731922|567415241|FG013|Overall Study|Other|0|||
157184198|NCT04731922|567415242|FG014|Overall Study|Other|0|||
157184199|NCT04731922|567415243|FG015|Overall Study|Other|0|||
157184200|NCT04731922|567415244|FG016|Overall Study|Other|0|||
157184201|NCT00422903|567415247|FG000|Overall Study|Disease Progression|3|||
157184202|NCT00422903|567415248|FG001|Overall Study|Disease Progression|1|||
157184203|NCT00422903|567415247|FG000|Overall Study|Adverse Event|0|||
157184204|NCT00422903|567415248|FG001|Overall Study|Adverse Event|2|||
157063184|NCT01874665|566987534|FG000|Overall Study|Withdrawal by Subject|4|||
157063185|NCT01874665|566987535|FG001|Overall Study|Withdrawal by Subject|1|||
157063186|NCT01874665|566987534|FG000|Overall Study|Physician Decision|3|||
157063187|NCT01874665|566987535|FG001|Overall Study|Physician Decision|0|||
157063188|NCT01874665|566987534|FG000|Overall Study|Clinical Progressive Disease|4|||
157184205|NCT00422903|567415247|FG000|Overall Study|Informed Consent Withdrawn|1|||
157184206|NCT00422903|567415248|FG001|Overall Study|Informed Consent Withdrawn|2|||
157184207|NCT01302691|567415253|FG000|Overall Study|Adverse Event|2|||
157063189|NCT01874665|566987535|FG001|Overall Study|Clinical Progressive Disease|3|||
157063190|NCT01874665|566987534|FG000|Overall Study|Study Terminated by Sponsor|0|||
157063191|NCT01874665|566987535|FG001|Overall Study|Study Terminated by Sponsor|2|||
157063192|NCT01874665|566987534|FG000|Overall Study|Documented Progressive Disease|11|||
157063193|NCT01874665|566987535|FG001|Overall Study|Documented Progressive Disease|7|||
157063194|NCT01874665|566987534|FG000|Overall Study|Other|2|||
157063195|NCT01874665|566987535|FG001|Overall Study|Other|0|||
157063196|NCT02447432|566987538|FG000|Epoch 001|Adverse Event|1|||
157063197|NCT02447432|566987539|FG001|Epoch 001|Adverse Event|1|||
157063198|NCT02447432|566987538|FG000|Epoch 001|Withdrawal by Subject|0|||
157063199|NCT02447432|566987539|FG001|Epoch 001|Withdrawal by Subject|4|||
157063200|NCT02447432|566987538|FG000|Epoch 001|Migrated/moved from study area|3|||
157063201|NCT02447432|566987539|FG001|Epoch 001|Migrated/moved from study area|5|||
157063202|NCT02447432|566987538|FG000|Epoch 001|Lost to Follow-up|1|||
157063203|NCT02447432|566987539|FG001|Epoch 001|Lost to Follow-up|3|||
157063204|NCT00776659|566987542|FG000|Overall Study|Lost to Follow-up|15|||
157063205|NCT00776659|566987542|FG000|Overall Study|Withdrawal by Subject|10|||
157063206|NCT00776659|566987542|FG000|Overall Study|Study Terminated by Sponsor|1|||
157063207|NCT01585298|566987543|FG000|Overall Study|Study completion was not documented.|1|||
157063208|NCT01585298|566987543|FG000|Overall Study|Protocol deviation|1|||
157063209|NCT01585298|566987543|FG000|Overall Study|Administrative problems|4|||
157063210|NCT01585298|566987543|FG000|Overall Study|Lost to Follow-up|2|||
157063211|NCT01585298|566987543|FG000|Overall Study|Withdrawal by Subject|4|||
157063212|NCT01585298|566987543|FG000|Overall Study|Abnormal test procedure results|1|||
157063213|NCT01585298|566987543|FG000|Overall Study|Adverse Event|24|||
157063214|NCT00545571|566987548|FG000|Overall Study|Administrative Reasons|1|||
157063215|NCT00545571|566987548|FG000|Overall Study|Adverse Event|2|||
157063216|NCT00545571|566987548|FG000|Overall Study|Death|5|||
157063217|NCT00545571|566987548|FG000|Overall Study|Lack of Efficacy|1|||
157063218|NCT00545571|566987548|FG000|Overall Study|Protocol Violation|2|||
157063219|NCT00545571|566987548|FG000|Overall Study|Refused Treatment|1|||
157063220|NCT00545571|566987548|FG000|Overall Study|Screen Failure|16|||
157063221|NCT00545571|566987548|FG000|Overall Study|Transfusion|12|||
157063222|NCT00545571|566987548|FG000|Overall Study|Early Termination of Study|24|||
157063223|NCT00545571|566987548|FG000|Overall Study|Kidney Transplantation|3|||
157063224|NCT01978236|566987549|FG000|Overall Study|Discontinued due to study close|2|||
157063225|NCT00874497|566987550|FG000|Overall Study|Lost to Follow-up|2|||
157063226|NCT00874497|566987551|FG001|Overall Study|Lost to Follow-up|4|||
157063227|NCT00874497|566987550|FG000|Overall Study|Adverse Event|9|||
157063228|NCT00874497|566987551|FG001|Overall Study|Adverse Event|4|||
157063229|NCT00874497|566987550|FG000|Overall Study|Sponsor Discontinued Trial|7|||
157063230|NCT00874497|566987551|FG001|Overall Study|Sponsor Discontinued Trial|3|||
157063231|NCT00874497|566987550|FG000|Overall Study|Met Withdrawal Criteria|4|||
157063232|NCT00874497|566987551|FG001|Overall Study|Met Withdrawal Criteria|2|||
157063233|NCT00874497|566987550|FG000|Overall Study|Physician Decision|1|||
157063234|NCT00874497|566987551|FG001|Overall Study|Physician Decision|1|||
157063235|NCT00874497|566987550|FG000|Overall Study|Withdrawal by Subject|5|||
157063236|NCT00874497|566987551|FG001|Overall Study|Withdrawal by Subject|4|||
157063237|NCT04353817|566987554|FG000|Overall Study|Adverse Event|0|||
157063238|NCT04353817|566987555|FG001|Overall Study|Adverse Event|1|||
157063239|NCT00665223|566987558|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
157063240|NCT00665223|566987559|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
157063241|NCT00665223|566987560|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
157063242|NCT00665223|566987558|FG000|Randomized Phase (26 Weeks)|Death|0|||
157063243|NCT00665223|566987559|FG001|Randomized Phase (26 Weeks)|Death|0|||
157063244|NCT00665223|566987560|FG002|Randomized Phase (26 Weeks)|Death|1|||
157063245|NCT00665223|566987558|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
157063246|NCT00665223|566987559|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
157063247|NCT00665223|566987560|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
157063248|NCT00665223|566987558|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
157063249|NCT00665223|566987559|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
157063250|NCT00665223|566987560|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
157063251|NCT00665223|566987558|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
157063252|NCT00665223|566987559|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
157063253|NCT00665223|566987560|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
157063254|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
157063255|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
157063256|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
157063257|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Death|0|||
157063258|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Death|1|||
157063259|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Death|0|||
157063260|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
157063261|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
157063262|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
157063263|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
157063264|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
157063265|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
157063266|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
157063267|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
157063268|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
157063269|NCT00665223|566987558|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
157063270|NCT00665223|566987559|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
157063271|NCT00665223|566987560|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
157063272|NCT00591591|566987561|FG000|Overall Study|Withdrawal by Subject|1|||
157063273|NCT00591591|566987562|FG001|Overall Study|Withdrawal by Subject|37|||
157063274|NCT00591591|566987561|FG000|Overall Study|Lack of Efficacy|10|||
157063275|NCT00591591|566987562|FG001|Overall Study|Lack of Efficacy|2|||
157063276|NCT00002597|566987563|FG000|Overall Study|Protocol Violation|19|||
157063277|NCT00002597|566987564|FG001|Overall Study|Protocol Violation|17|||
157063278|NCT00002597|566987563|FG000|Overall Study|Withdrawal by Subject|7|||
157063279|NCT00002597|566987564|FG001|Overall Study|Withdrawal by Subject|6|||
157063280|NCT03811834|566987565|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
157063281|NCT01527500|566987566|FG000|Part A|Administrative|11|||
157063282|NCT01527500|566987567|FG001|Part A|Administrative|7|||
157063283|NCT01527500|566987566|FG000|Part A|Adverse Event|4|||
157063284|NCT01527500|566987567|FG001|Part A|Adverse Event|2|||
157063285|NCT01527500|566987566|FG000|Part A|Death|4|||
157063286|NCT01527500|566987567|FG001|Part A|Death|1|||
157063287|NCT01527500|566987566|FG000|Part A|Lost to Follow-up|0|||
157063288|NCT01527500|566987567|FG001|Part A|Lost to Follow-up|1|||
157063289|NCT01527500|566987566|FG000|Part A|Protocol Deviation|9|||
157063290|NCT01527500|566987567|FG001|Part A|Protocol Deviation|2|||
157063291|NCT01527500|566987566|FG000|Part A|Withdrawal by Subject|2|||
157063292|NCT01527500|566987567|FG001|Part A|Withdrawal by Subject|0|||
157063293|NCT01527500|566987566|FG000|Part B|Adverse Event|1|||
157063294|NCT01527500|566987567|FG001|Part B|Adverse Event|0|||
157063295|NCT00372255|566987568|FG000|Overall Study|Withdrawn for other reasons|2|||
157063296|NCT00372255|566987569|FG001|Overall Study|Withdrawn for other reasons|1|||
157063297|NCT02573883|566987573|FG000|Six Month Follow Up|Lost to Follow-up|1|||
157063298|NCT02573883|566987574|FG001|Six Month Follow Up|Lost to Follow-up|0|||
157063299|NCT02573883|566987575|FG002|Six Month Follow Up|Lost to Follow-up|0|||
157063300|NCT02573883|566987576|FG003|Six Month Follow Up|Lost to Follow-up|0|||
157063301|NCT02573883|566987573|FG000|One Year Follow Up|Lost to Follow-up|2|||
157063302|NCT02573883|566987574|FG001|One Year Follow Up|Lost to Follow-up|1|||
157063303|NCT02573883|566987575|FG002|One Year Follow Up|Lost to Follow-up|0|||
157063304|NCT02573883|566987576|FG003|One Year Follow Up|Lost to Follow-up|0|||
157063305|NCT00582114|566987577|FG000|Overall Study|Death|4|||
157063306|NCT00582114|566987578|FG001|Overall Study|Death|4|||
157063307|NCT00582114|566987577|FG000|Overall Study|Kidney Transplant|3|||
157063308|NCT00582114|566987578|FG001|Overall Study|Kidney Transplant|1|||
157063309|NCT00582114|566987577|FG000|Overall Study|Lost to Follow-up|7|||
157063310|NCT00582114|566987578|FG001|Overall Study|Lost to Follow-up|6|||
157063311|NCT00582114|566987577|FG000|Overall Study|Withdrawal by Subject|8|||
157063312|NCT00582114|566987578|FG001|Overall Study|Withdrawal by Subject|16|||
157063313|NCT00582114|566987577|FG000|Overall Study|Adverse Event|1|||
157063314|NCT00582114|566987578|FG001|Overall Study|Adverse Event|1|||
157063315|NCT00582114|566987577|FG000|Overall Study|Physician Decision|0|||
157063316|NCT00582114|566987578|FG001|Overall Study|Physician Decision|6|||
157063317|NCT00582114|566987577|FG000|Overall Study|Stopped by data safety monitoring board|19|||
157063318|NCT00582114|566987578|FG001|Overall Study|Stopped by data safety monitoring board|20|||
157063319|NCT00130728|566987579|FG000|Overall Study|Death|258|||
157063320|NCT00130728|566987580|FG001|Overall Study|Death|258|||
157063321|NCT00130728|566987579|FG000|Overall Study|Lost to Follow-up|4|||
157063322|NCT00130728|566987580|FG001|Overall Study|Lost to Follow-up|0|||
157063323|NCT00130728|566987579|FG000|Overall Study|Withdrawal by Subject|0|||
157063324|NCT00130728|566987580|FG001|Overall Study|Withdrawal by Subject|2|||
157063325|NCT03796208|566987582|FG000|Overall Study|Withdrawal by Subject|3|||
157063326|NCT03796208|566987583|FG001|Overall Study|Withdrawal by Subject|0|||
157063327|NCT03796208|566987582|FG000|Overall Study|Loss of pregnancy|1|||
157063328|NCT03796208|566987583|FG001|Overall Study|Loss of pregnancy|1|||
157063329|NCT03796208|566987582|FG000|Overall Study|Changed prenatal clinics|0|||
157063330|NCT03796208|566987583|FG001|Overall Study|Changed prenatal clinics|5|||
157063331|NCT03796208|566987582|FG000|Overall Study|Lost to Follow-up|20|||
157063332|NCT03796208|566987583|FG001|Overall Study|Lost to Follow-up|16|||
157063333|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
157063334|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
157063335|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
157063336|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
157063337|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
157063338|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
157063339|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
157063340|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
157063341|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
157063342|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
157063343|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
157063344|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
157063345|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
157063346|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
157063347|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
157063348|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
157063349|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
157063350|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
157063351|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
157063352|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
157063353|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
157063354|NCT01125566|566987590|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
157063355|NCT01125566|566987591|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
157063356|NCT01125566|566987592|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
157063357|NCT01125566|566987590|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
157063358|NCT01125566|566987591|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
157063359|NCT01125566|566987592|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
157063360|NCT01125566|566987590|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
157063361|NCT01125566|566987591|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
157063362|NCT01125566|566987592|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
157063363|NCT01125566|566987590|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
157063364|NCT01125566|566987591|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
157063365|NCT01125566|566987592|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
157063366|NCT01125566|566987590|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
157063367|NCT01125566|566987591|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
157063368|NCT01125566|566987592|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
157063369|NCT01560585|566987593|FG000|Overall Study|Physician Decision|3|||
157063370|NCT00519285|566987594|FG000|Overall Study|Adverse Event|127|||
157063371|NCT00519285|566987595|FG001|Overall Study|Adverse Event|266|||
157063372|NCT00519285|566987594|FG000|Overall Study|Disease progression|334|||
157063373|NCT00519285|566987595|FG001|Overall Study|Disease progression|186|||
157063374|NCT00519285|566987594|FG000|Overall Study|Physician Decision|75|||
157063375|NCT00519285|566987595|FG001|Overall Study|Physician Decision|47|||
157063376|NCT00519285|566987594|FG000|Overall Study|Participant's request|53|||
157063377|NCT00519285|566987595|FG001|Overall Study|Participant's request|84|||
157063378|NCT00519285|566987594|FG000|Overall Study|Consent withdrawn|4|||
157063379|NCT00519285|566987595|FG001|Overall Study|Consent withdrawn|5|||
157063380|NCT00519285|566987594|FG000|Overall Study|Poor compliance to protocol|5|||
157063381|NCT00519285|566987595|FG001|Overall Study|Poor compliance to protocol|7|||
157063382|NCT00519285|566987594|FG000|Overall Study|Reason unspecified|5|||
157063383|NCT00519285|566987595|FG001|Overall Study|Reason unspecified|8|||
157063384|NCT00519285|566987594|FG000|Overall Study|Not treated|8|||
157063385|NCT00519285|566987595|FG001|Overall Study|Not treated|7|||
157063386|NCT00519285|566987594|FG000|Overall Study|Treatment ongoing|1|||
157063387|NCT00519285|566987595|FG001|Overall Study|Treatment ongoing|2|||
157063388|NCT00983892|566987596|FG000|Overall Study|Withdrawal by Subject|10|||
157063389|NCT00983892|566987597|FG001|Overall Study|Withdrawal by Subject|12|||
157063390|NCT02175745|566987598|FG000|Overall Study|Not Eligible|1|||
157063391|NCT01726517|566987600|FG000|Overall Study|Withdrawal by Subject|0|||
157063392|NCT01726517|566987601|FG001|Overall Study|Withdrawal by Subject|0|||
157063393|NCT01726517|566987602|FG002|Overall Study|Withdrawal by Subject|1|||
157063394|NCT01726517|566987603|FG003|Overall Study|Withdrawal by Subject|0|||
157063395|NCT01726517|566987604|FG004|Overall Study|Withdrawal by Subject|0|||
157063396|NCT03765164|566987605|FG000|Pre-intervention|Withdrawal by Subject|5|||
157063397|NCT03765164|566987606|FG001|Pre-intervention|Withdrawal by Subject|6|||
157063398|NCT00770588|566987607|FG000|Overall Study|Adverse Event|9|||
157063399|NCT00770588|566987608|FG001|Overall Study|Adverse Event|2|||
157063400|NCT00770588|566987607|FG000|Overall Study|Death caused by progression of disease|70|||
157063401|NCT00770588|566987608|FG001|Overall Study|Death caused by progression of disease|91|||
157063402|NCT00770588|566987607|FG000|Overall Study|Lost to Follow-up|1|||
157063403|NCT00770588|566987608|FG001|Overall Study|Lost to Follow-up|1|||
157063404|NCT00770588|566987607|FG000|Overall Study|Withdrawal by Subject|1|||
157063405|NCT00770588|566987608|FG001|Overall Study|Withdrawal by Subject|1|||
157063406|NCT01424189|566987609|FG000|Overall Study|Adverse Event|1|||
157063407|NCT01424189|566987610|FG001|Overall Study|Adverse Event|0|||
157063408|NCT01424189|566987609|FG000|Overall Study|Lost to Follow-up|4|||
157063409|NCT01424189|566987610|FG001|Overall Study|Lost to Follow-up|1|||
157063410|NCT01424189|566987609|FG000|Overall Study|Withdrawal by Subject|4|||
157063411|NCT01424189|566987610|FG001|Overall Study|Withdrawal by Subject|4|||
157063412|NCT01424189|566987609|FG000|Overall Study|Subject moved|1|||
157063413|NCT01424189|566987610|FG001|Overall Study|Subject moved|0|||
157063414|NCT01424189|566987609|FG000|Overall Study|Death|3|||
157063415|NCT01424189|566987610|FG001|Overall Study|Death|1|||
157063416|NCT03120949|566987611|FG000|Overall Study|randomized in error|1|||
157063417|NCT03120949|566987612|FG001|Overall Study|randomized in error|0|||
157063418|NCT03120949|566987611|FG000|Overall Study|Death|13|||
157063419|NCT03120949|566987612|FG001|Overall Study|Death|13|||
157063420|NCT03120949|566987611|FG000|Overall Study|Lost to Follow-up|23|||
157063421|NCT03120949|566987612|FG001|Overall Study|Lost to Follow-up|13|||
157063422|NCT03120949|566987611|FG000|Overall Study|Withdrawal by Subject|139|||
157063423|NCT03120949|566987612|FG001|Overall Study|Withdrawal by Subject|124|||
157063424|NCT03120949|566987611|FG000|Overall Study|Covid-19|43|||
157063425|NCT03120949|566987612|FG001|Overall Study|Covid-19|34|||
157063426|NCT03120949|566987611|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
157063427|NCT03120949|566987612|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
157063428|NCT03120949|566987611|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
157063429|NCT03120949|566987612|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
157063430|NCT03120949|566987611|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
157063431|NCT03120949|566987612|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
157063432|NCT03120949|566987611|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
157063433|NCT03120949|566987612|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
157063434|NCT03120949|566987611|FG000|Overall Study|Site was closed|2|||
157063435|NCT03120949|566987612|FG001|Overall Study|Site was closed|3|||
157063436|NCT03120949|566987611|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
157063437|NCT03120949|566987612|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
157063438|NCT03120949|566987611|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
157063439|NCT03120949|566987612|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
157063440|NCT03120949|566987611|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
157063441|NCT03120949|566987612|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
157063442|NCT03120949|566987611|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
157063443|NCT03120949|566987612|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
157063444|NCT03120949|566987611|FG000|Overall Study|Other: Adverse Event|0|||
157063445|NCT03120949|566987612|FG001|Overall Study|Other: Adverse Event|1|||
157063446|NCT03120949|566987611|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
157063447|NCT03120949|566987612|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
157063448|NCT03120949|566987611|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
157063449|NCT03120949|566987612|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
157063450|NCT03120949|566987611|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
157063451|NCT03120949|566987612|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
157063452|NCT03120949|566987611|FG000|Overall Study|Personal Reasons|0|||
157063453|NCT03120949|566987612|FG001|Overall Study|Personal Reasons|1|||
157063454|NCT03120949|566987611|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
157063455|NCT03120949|566987612|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
157063456|NCT03120949|566987611|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
157063457|NCT03120949|566987612|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
157063458|NCT03120949|566987611|FG000|Overall Study|Compliance With Medication|0|||
157063459|NCT03120949|566987612|FG001|Overall Study|Compliance With Medication|1|||
157063460|NCT03120949|566987611|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
157063461|NCT03120949|566987612|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
157063462|NCT03120949|566987611|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
157063463|NCT03120949|566987612|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
157063464|NCT03120949|566987611|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
157063465|NCT03120949|566987612|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
157184208|NCT01302691|567415254|FG001|Overall Study|Adverse Event|0|||
157063466|NCT00988117|566987613|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
157063467|NCT00988117|566987613|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
157063468|NCT04088500|566987614|FG000|Overall Study|Reason unknown|1|||
157184209|NCT01302691|567415253|FG000|Overall Study|Death|0|||
157184210|NCT01302691|567415254|FG001|Overall Study|Death|1|||
157184211|NCT01302691|567415253|FG000|Overall Study|Lost to Follow-up|1|||
157063469|NCT04088500|566987614|FG000|Overall Study|Participant withdrew consent|1|||
157063470|NCT04088500|566987614|FG000|Overall Study|Disease progression|3|||
157063471|NCT04206384|566987615|FG000|Overall Study|Withdrawal by Subject|8|||
157063472|NCT04206384|566987615|FG000|Overall Study|Adverse Event|2|||
157063473|NCT01078584|566987619|FG000|Overall Study|Final Status Unknown|1073|||
157063474|NCT01078584|566987619|FG000|Overall Study|Lost to Follow-up|670|||
157063475|NCT01078584|566987619|FG000|Overall Study|Non-serious Adverse Event|577|||
157063476|NCT01078584|566987619|FG000|Overall Study|Withdrawal of Consent|244|||
157063477|NCT01078584|566987619|FG000|Overall Study|Physician Withdrew from Study|90|||
157063478|NCT01078584|566987619|FG000|Overall Study|Non-compliance|67|||
157063479|NCT01078584|566987619|FG000|Overall Study|Blood Pressure Controlled|49|||
157063480|NCT01078584|566987619|FG000|Overall Study|Physician Switched Medication|26|||
157063481|NCT01078584|566987619|FG000|Overall Study|Physician Discontinued Patient|12|||
157063482|NCT01078584|566987619|FG000|Overall Study|Lack of Efficacy|98|||
157063483|NCT01078584|566987619|FG000|Overall Study|Protocol Violation|75|||
157063484|NCT01078584|566987619|FG000|Overall Study|Serious Adverse Event|27|||
157063485|NCT01078584|566987619|FG000|Overall Study|Multiple Reasons|2|||
157063486|NCT01208870|566987620|FG000|Overall Study|Lost to Follow-up|2|||
157063487|NCT01208870|566987621|FG001|Overall Study|Lost to Follow-up|8|||
157063488|NCT01121185|566987622|FG000|Overall Study|Not infused|0|||
157063489|NCT01121185|566987623|FG001|Overall Study|Not infused|1|||
157063490|NCT01121185|566987622|FG000|Overall Study|Not transplanted|1|||
157063491|NCT01121185|566987623|FG001|Overall Study|Not transplanted|0|||
157063492|NCT01260142|566987624|FG000|Treatment Period 1|Study on hold|1|||
157063493|NCT01260142|566987625|FG001|Treatment Period 1|Study on hold|1|||
157063494|NCT01260142|566987626|FG002|Treatment Period 1|Study on hold|0|||
157063495|NCT01260142|566987627|FG003|Treatment Period 1|Study on hold|0|||
157063496|NCT01260142|566987628|FG004|Treatment Period 1|Study on hold|1|||
157063497|NCT01260142|566987629|FG005|Treatment Period 1|Study on hold|2|||
157063498|NCT01260142|566987624|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
157063499|NCT01260142|566987625|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
157063500|NCT01260142|566987626|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
157063501|NCT01260142|566987627|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
157063502|NCT01260142|566987628|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
157063503|NCT01260142|566987629|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
157063504|NCT01260142|566987624|FG000|Treatment Period 1|Withdrawal by Subject|0|||
157063505|NCT01260142|566987625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157063506|NCT01260142|566987626|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157063507|NCT01260142|566987627|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157063508|NCT01260142|566987628|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157063509|NCT01260142|566987629|FG005|Treatment Period 1|Withdrawal by Subject|1|||
157063510|NCT01091519|566987637|FG000|Overall Study|Adverse Event|12|||
157063511|NCT01091519|566987638|FG001|Overall Study|Adverse Event|16|||
157063512|NCT01091519|566987637|FG000|Overall Study|Death|1|||
157063513|NCT01091519|566987638|FG001|Overall Study|Death|0|||
157063514|NCT01091519|566987637|FG000|Overall Study|Lack of Efficacy|16|||
157063515|NCT01091519|566987638|FG001|Overall Study|Lack of Efficacy|19|||
157063516|NCT01091519|566987637|FG000|Overall Study|Lost to Follow-up|14|||
157063517|NCT01091519|566987638|FG001|Overall Study|Lost to Follow-up|24|||
157063518|NCT01091519|566987637|FG000|Overall Study|Withdrawal by Subject|2|||
157063519|NCT01091519|566987638|FG001|Overall Study|Withdrawal by Subject|2|||
157063520|NCT01091519|566987637|FG000|Overall Study|Other|6|||
157063521|NCT01091519|566987638|FG001|Overall Study|Other|8|||
157063522|NCT01091519|566987637|FG000|Overall Study|Randomized not treated|4|||
157063523|NCT01091519|566987638|FG001|Overall Study|Randomized not treated|4|||
157063524|NCT00496834|566987641|FG000|Overall Study|Withdrawal by Subject|4|||
157063525|NCT00496834|566987642|FG001|Overall Study|Withdrawal by Subject|6|||
157063526|NCT00496834|566987641|FG000|Overall Study|Contraindicated medication administered|0|||
157063527|NCT00496834|566987642|FG001|Overall Study|Contraindicated medication administered|1|||
157063528|NCT00496834|566987641|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
157063529|NCT00496834|566987642|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
157063530|NCT00496834|566987641|FG000|Overall Study|Adverse Event|5|||
157063531|NCT00496834|566987642|FG001|Overall Study|Adverse Event|3|||
157063532|NCT00496834|566987641|FG000|Overall Study|IP administration violation|2|||
157063533|NCT00496834|566987642|FG001|Overall Study|IP administration violation|0|||
157063534|NCT00496834|566987641|FG000|Overall Study|Lost to Follow-up|2|||
157063535|NCT00496834|566987642|FG001|Overall Study|Lost to Follow-up|0|||
157063536|NCT00496834|566987641|FG000|Overall Study|Blood Pressure control failure|2|||
157184212|NCT01302691|567415254|FG001|Overall Study|Lost to Follow-up|0|||
157184213|NCT01302691|567415253|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
157063537|NCT00496834|566987642|FG001|Overall Study|Blood Pressure control failure|1|||
157063538|NCT01227928|566987643|FG000|Overall Study|Lost to Follow-up|4|||
157063539|NCT01227928|566987644|FG001|Overall Study|Lost to Follow-up|2|||
157063540|NCT01227928|566987643|FG000|Overall Study|Withdrawal by Subject|4|||
157063541|NCT01227928|566987644|FG001|Overall Study|Withdrawal by Subject|3|||
157063542|NCT01227928|566987643|FG000|Overall Study|Death|14|||
157063543|NCT01227928|566987644|FG001|Overall Study|Death|12|||
157063544|NCT00356759|566987647|FG000|Overall Study|Death|5|||
157063545|NCT00356759|566987648|FG001|Overall Study|Death|2|||
157063546|NCT00356759|566987647|FG000|Overall Study|Withdrawal by Subject|2|||
157063547|NCT00356759|566987648|FG001|Overall Study|Withdrawal by Subject|2|||
157063548|NCT00356759|566987647|FG000|Overall Study|Adverse Event|1|||
157063549|NCT00356759|566987648|FG001|Overall Study|Adverse Event|3|||
157063550|NCT00356759|566987647|FG000|Overall Study|Lost to Follow-up|1|||
157063551|NCT00356759|566987648|FG001|Overall Study|Lost to Follow-up|1|||
157063552|NCT00356759|566987647|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
157063553|NCT00356759|566987648|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
157063554|NCT01494298|566987649|FG000|Overall Study|Protocol Violation|2|||
157063555|NCT01494298|566987650|FG001|Overall Study|Protocol Violation|8|||
157063556|NCT04159805|566987651|FG000|Overall Study|Withdrawal by Subject|0|||
157063557|NCT04159805|566987652|FG001|Overall Study|Withdrawal by Subject|2|||
157063558|NCT04159805|566987653|FG002|Overall Study|Withdrawal by Subject|2|||
157063559|NCT02930837|566987654|FG000|Overall Study|Adverse Event|6|||
157063560|NCT02930837|566987654|FG000|Overall Study|Lost to Follow-up|5|||
157063561|NCT02930837|566987654|FG000|Overall Study|Withdrawal by Subject|1|||
157063562|NCT01393613|566987655|FG000|Overall Study|Adverse Event|11|||
157063563|NCT01393613|566987656|FG001|Overall Study|Adverse Event|11|||
157063564|NCT01393613|566987657|FG002|Overall Study|Adverse Event|13|||
157063565|NCT01393613|566987658|FG003|Overall Study|Adverse Event|22|||
157063566|NCT01393613|566987655|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
157063567|NCT01393613|566987656|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
157063568|NCT01393613|566987657|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
157063569|NCT01393613|566987658|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
157063570|NCT01393613|566987655|FG000|Overall Study|Physician Decision|2|||
157063571|NCT01393613|566987656|FG001|Overall Study|Physician Decision|0|||
157063572|NCT01393613|566987657|FG002|Overall Study|Physician Decision|0|||
157063573|NCT01393613|566987658|FG003|Overall Study|Physician Decision|1|||
157063574|NCT01393613|566987655|FG000|Overall Study|Withdrawal by Subject|15|||
157063575|NCT01393613|566987656|FG001|Overall Study|Withdrawal by Subject|25|||
157063576|NCT01393613|566987657|FG002|Overall Study|Withdrawal by Subject|23|||
157063577|NCT01393613|566987658|FG003|Overall Study|Withdrawal by Subject|21|||
157063578|NCT01393613|566987655|FG000|Overall Study|Protocol Deviation|2|||
157063579|NCT01393613|566987656|FG001|Overall Study|Protocol Deviation|1|||
157063580|NCT01393613|566987657|FG002|Overall Study|Protocol Deviation|0|||
157063581|NCT01393613|566987658|FG003|Overall Study|Protocol Deviation|0|||
157063582|NCT01393613|566987655|FG000|Overall Study|Lack of Efficacy|9|||
157063583|NCT01393613|566987656|FG001|Overall Study|Lack of Efficacy|20|||
157063584|NCT01393613|566987657|FG002|Overall Study|Lack of Efficacy|16|||
157063585|NCT01393613|566987658|FG003|Overall Study|Lack of Efficacy|21|||
157063586|NCT02998918|566987664|FG000|Overall Study|Withdrawal by Subject|1|||
157063587|NCT02998918|566987665|FG001|Overall Study|Withdrawal by Subject|0|||
157063588|NCT01071317|566987666|FG000|Overall Study|Lost to Follow-up|2|||
157063589|NCT01071317|566987667|FG001|Overall Study|Lost to Follow-up|2|||
157063590|NCT00316589|566987668|FG000|Overall Study|Withdrawal by Subject|0|||
157063591|NCT00316589|566987669|FG001|Overall Study|Withdrawal by Subject|5|||
157063592|NCT00316589|566987670|FG002|Overall Study|Withdrawal by Subject|0|||
157063593|NCT00316589|566987671|FG003|Overall Study|Withdrawal by Subject|1|||
157063594|NCT00316589|566987668|FG000|Overall Study|Subject unwilling/unable to comply|0|||
157063595|NCT00316589|566987669|FG001|Overall Study|Subject unwilling/unable to comply|6|||
157063596|NCT00316589|566987670|FG002|Overall Study|Subject unwilling/unable to comply|0|||
157063597|NCT00316589|566987671|FG003|Overall Study|Subject unwilling/unable to comply|2|||
157063598|NCT00316589|566987668|FG000|Overall Study|Adverse Event|1|||
157063599|NCT00316589|566987669|FG001|Overall Study|Adverse Event|0|||
157063600|NCT00316589|566987670|FG002|Overall Study|Adverse Event|0|||
157063601|NCT00316589|566987671|FG003|Overall Study|Adverse Event|1|||
157063602|NCT00316589|566987668|FG000|Overall Study|Physician Decision|0|||
157063603|NCT00316589|566987669|FG001|Overall Study|Physician Decision|1|||
157063604|NCT00316589|566987670|FG002|Overall Study|Physician Decision|0|||
157063605|NCT00316589|566987671|FG003|Overall Study|Physician Decision|0|||
157063606|NCT00316589|566987668|FG000|Overall Study|Other reason|0|||
157230039|NCT00162123|567588220|FG000|Overall Study|Not specified (before treatment)|2|||
157230040|NCT00162123|567588221|FG001|Overall Study|Not specified (before treatment)|0|||
157063607|NCT00316589|566987669|FG001|Overall Study|Other reason|12|||
157063608|NCT00316589|566987670|FG002|Overall Study|Other reason|1|||
157063609|NCT00316589|566987671|FG003|Overall Study|Other reason|1|||
157063610|NCT01283971|566987676|FG000|Overall Study|Adverse Event|3|||
157063611|NCT01283971|566987677|FG001|Overall Study|Adverse Event|5|||
157063612|NCT01283971|566987676|FG000|Overall Study|Insufficient therapeutic responses|3|||
157230041|NCT00162123|567588222|FG002|Overall Study|Not specified (before treatment)|0|||
157063613|NCT01283971|566987677|FG001|Overall Study|Insufficient therapeutic responses|3|||
157063614|NCT01283971|566987676|FG000|Overall Study|Protocol Violation|5|||
157063615|NCT01283971|566987677|FG001|Overall Study|Protocol Violation|1|||
157063616|NCT01283971|566987676|FG000|Overall Study|Refused treatment|3|||
157063617|NCT01283971|566987677|FG001|Overall Study|Refused treatment|1|||
157063618|NCT01283971|566987676|FG000|Overall Study|Failure to return|0|||
157063619|NCT01283971|566987677|FG001|Overall Study|Failure to return|1|||
157063620|NCT01283971|566987676|FG000|Overall Study|Administrative reasons|1|||
157063621|NCT01283971|566987677|FG001|Overall Study|Administrative reasons|1|||
157063622|NCT01204775|566987683|FG000|Overall Study|Poor/non-compliance|0|||
157063623|NCT01204775|566987684|FG001|Overall Study|Poor/non-compliance|1|||
157063624|NCT01204775|566987683|FG000|Overall Study|Withdrawal by Subject|1|||
157063625|NCT01204775|566987684|FG001|Overall Study|Withdrawal by Subject|0|||
157063626|NCT00276016|566987685|FG000|Intervention 1|Withdrawal by Subject|0|||
157063627|NCT00276016|566987686|FG001|Intervention 1|Withdrawal by Subject|1|||
157063628|NCT00276016|566987687|FG002|Intervention 1|Withdrawal by Subject|0|||
157063629|NCT00276016|566987688|FG003|Intervention 1|Withdrawal by Subject|0|||
157063630|NCT00276016|566987689|FG004|Intervention 1|Withdrawal by Subject|0|||
157063631|NCT00276016|566987690|FG005|Intervention 1|Withdrawal by Subject|0|||
157063632|NCT01181609|566989115|FG000|Overall Study|Adverse Event|1|||
157063633|NCT01181609|566989115|FG000|Overall Study|Withdrawal by Subject|1|||
157063634|NCT01181609|566989115|FG000|Overall Study|Lost to Follow-up|1|||
157063635|NCT01181609|566989115|FG000|Overall Study|Death|50|||
157063636|NCT00612352|566989116|FG000|Overall Study|Adverse Event|1|||
157063637|NCT00612352|566989117|FG001|Overall Study|Adverse Event|0|||
157063638|NCT00612352|566989116|FG000|Overall Study|Withdrawal by Subject|3|||
157063639|NCT00612352|566989117|FG001|Overall Study|Withdrawal by Subject|5|||
157063640|NCT00612352|566989116|FG000|Overall Study|moved out of state|1|||
157063641|NCT00612352|566989117|FG001|Overall Study|moved out of state|0|||
157063642|NCT00612352|566989116|FG000|Overall Study|didn't return calls/show up on test date|4|||
157063643|NCT00612352|566989117|FG001|Overall Study|didn't return calls/show up on test date|1|||
157063644|NCT00263211|566989120|FG000|Overall Study|Death|1|||
157063645|NCT00263211|566989121|FG001|Overall Study|Death|0|||
157063646|NCT00263211|566989120|FG000|Overall Study|Withdrawal by Subject|3|||
157063647|NCT00263211|566989121|FG001|Overall Study|Withdrawal by Subject|0|||
157063648|NCT00263211|566989120|FG000|Overall Study|Protocol Violation|1|||
157063649|NCT00263211|566989121|FG001|Overall Study|Protocol Violation|0|||
157063650|NCT00263211|566989120|FG000|Overall Study|Disease Progression|0|||
157063651|NCT00263211|566989121|FG001|Overall Study|Disease Progression|1|||
157063652|NCT02820597|566989122|FG000|Overall Study|Lost to Follow-up|12|||
157063653|NCT04606199|566989123|FG000|Overall Study|Withdrawal by Subject|2|||
157063654|NCT00408928|566989124|FG000|Overall Study|Withdrawal by Subject|1|||
157063655|NCT00408928|566989124|FG000|Overall Study|Death|1|||
157063656|NCT00408928|566989124|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
157063657|NCT01774019|566989129|FG000|Overall Study|No longer meets protocol criteria|2|||
157063658|NCT01774019|566989130|FG001|Overall Study|No longer meets protocol criteria|0|||
157063659|NCT01774019|566989129|FG000|Overall Study|Withdrawal by Subject|1|||
157063660|NCT01774019|566989130|FG001|Overall Study|Withdrawal by Subject|0|||
157063661|NCT01774019|566989129|FG000|Overall Study|Surgery delayed > 120 days|1|||
157063662|NCT01774019|566989130|FG001|Overall Study|Surgery delayed > 120 days|0|||
157063663|NCT01774019|566989129|FG000|Overall Study|Patient refused surgery|1|||
157063664|NCT01774019|566989130|FG001|Overall Study|Patient refused surgery|1|||
157063665|NCT01774019|566989129|FG000|Overall Study|Unable to implant study device|1|||
157063666|NCT01774019|566989130|FG001|Overall Study|Unable to implant study device|0|||
157063667|NCT01774019|566989129|FG000|Overall Study|Lost to Follow-up|0|||
157063668|NCT01774019|566989130|FG001|Overall Study|Lost to Follow-up|3|||
157063669|NCT00644878|566989131|FG000|Overall Study|Adverse Event|2|||
157063670|NCT00644878|566989131|FG000|Overall Study|Abnormal laboratory value|3|||
157063671|NCT00644878|566989131|FG000|Overall Study|Protocol deviation|2|||
157063672|NCT00644878|566989131|FG000|Overall Study|Treatment duration completed as per protocol|11|||
157063673|NCT00878553|566989138|FG000|Sleep Study|Withdrawal by Subject|2|||
157063674|NCT00878553|566989139|FG001|Sleep Study|Withdrawal by Subject|0|||
157063675|NCT00878553|566989140|FG002|Sleep Study|Withdrawal by Subject|0|||
157063676|NCT00878553|566989141|FG003|Sleep Study|Withdrawal by Subject|0|||
157063677|NCT00878553|566989142|FG004|Sleep Study|Withdrawal by Subject|0|||
157063678|NCT00878553|566989138|FG000|Sleep Study|Lost to Follow-up|1|||
157063679|NCT00878553|566989139|FG001|Sleep Study|Lost to Follow-up|0|||
157063680|NCT00878553|566989140|FG002|Sleep Study|Lost to Follow-up|0|||
157063681|NCT00878553|566989141|FG003|Sleep Study|Lost to Follow-up|0|||
157063682|NCT00878553|566989142|FG004|Sleep Study|Lost to Follow-up|0|||
157063683|NCT00878553|566989138|FG000|Sleep Study|car accident|1|||
157184214|NCT01302691|567415254|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
157063684|NCT00878553|566989139|FG001|Sleep Study|car accident|0|||
157063685|NCT00878553|566989140|FG002|Sleep Study|car accident|0|||
157063686|NCT00878553|566989141|FG003|Sleep Study|car accident|0|||
157063687|NCT00878553|566989142|FG004|Sleep Study|car accident|0|||
157063688|NCT00878553|566989138|FG000|Sleep Study|family emergency|1|||
157063689|NCT00878553|566989139|FG001|Sleep Study|family emergency|0|||
157063690|NCT00878553|566989140|FG002|Sleep Study|family emergency|0|||
157063691|NCT00878553|566989141|FG003|Sleep Study|family emergency|0|||
157063692|NCT00878553|566989142|FG004|Sleep Study|family emergency|0|||
157063693|NCT00878553|566989138|FG000|PK Study|Withdrawal by Subject|0|||
157063694|NCT00878553|566989139|FG001|PK Study|Withdrawal by Subject|0|||
157063695|NCT00878553|566989140|FG002|PK Study|Withdrawal by Subject|0|||
157063696|NCT00878553|566989141|FG003|PK Study|Withdrawal by Subject|1|||
157063697|NCT00878553|566989142|FG004|PK Study|Withdrawal by Subject|0|||
157063698|NCT02143063|566989143|FG000|Overall Study|Lost to Follow-up|16|||
157063699|NCT02143063|566989144|FG001|Overall Study|Lost to Follow-up|28|||
157063700|NCT02143063|566989145|FG002|Overall Study|Lost to Follow-up|29|||
157063701|NCT02143063|566989143|FG000|Overall Study|Withdrawal by Subject|0|||
157063702|NCT02143063|566989144|FG001|Overall Study|Withdrawal by Subject|1|||
157063703|NCT02143063|566989145|FG002|Overall Study|Withdrawal by Subject|0|||
157063704|NCT02143063|566989143|FG000|Overall Study|Death|0|||
157063705|NCT02143063|566989144|FG001|Overall Study|Death|1|||
157063706|NCT02143063|566989145|FG002|Overall Study|Death|1|||
157063707|NCT00025662|566989146|FG000|Overall Study|Withdrawal by Subject|2|||
157063708|NCT00025662|566989146|FG000|Overall Study|Technical failure of manipulation|1|||
157063709|NCT02062645|566989149|FG000|Overall Study|Adverse Event|2|||
157063710|NCT02062645|566989149|FG000|Overall Study|Protocol Violation|8|||
157063711|NCT02062645|566989149|FG000|Overall Study|Lost to Follow-up|5|||
157063712|NCT02864342|566989151|FG000|Overall Study|Eligibility Criteria Deviation|2|||
157063713|NCT02864342|566989152|FG001|Overall Study|Eligibility Criteria Deviation|3|||
157063714|NCT02864342|566989151|FG000|Overall Study|Withdrawal by Subject|4|||
157063715|NCT02864342|566989152|FG001|Overall Study|Withdrawal by Subject|2|||
157063716|NCT02864342|566989151|FG000|Overall Study|Device Technology Issue|6|||
157063717|NCT02864342|566989152|FG001|Overall Study|Device Technology Issue|7|||
157063718|NCT02864342|566989151|FG000|Overall Study|Death|0|||
157063719|NCT02864342|566989152|FG001|Overall Study|Death|1|||
157063720|NCT02864342|566989151|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
157063721|NCT02864342|566989152|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
157063722|NCT02864342|566989151|FG000|Overall Study|Lost to Follow-up|1|||
157063723|NCT02864342|566989152|FG001|Overall Study|Lost to Follow-up|5|||
157063724|NCT02864342|566989151|FG000|Overall Study|Lost Device|1|||
157063725|NCT02864342|566989152|FG001|Overall Study|Lost Device|0|||
157063726|NCT02864342|566989151|FG000|Overall Study|Adverse Event|1|||
157063727|NCT02864342|566989152|FG001|Overall Study|Adverse Event|0|||
157063728|NCT00118703|566989153|FG000|Overall Study|Protocol Violation|1|||
157063729|NCT00118703|566989154|FG001|Overall Study|Protocol Violation|0|||
157063730|NCT00118703|566989153|FG000|Overall Study|Adverse Event|1|||
157063731|NCT00118703|566989154|FG001|Overall Study|Adverse Event|1|||
157063732|NCT00118703|566989153|FG000|Overall Study|Participant took two different treatment|0|||
157063733|NCT00118703|566989154|FG001|Overall Study|Participant took two different treatment|1|||
157063734|NCT00118703|566989153|FG000|Overall Study|Withdrawal by Subject|2|||
157063735|NCT00118703|566989154|FG001|Overall Study|Withdrawal by Subject|5|||
157063736|NCT00118703|566989153|FG000|Overall Study|Lost to Follow-up|1|||
157063737|NCT00118703|566989154|FG001|Overall Study|Lost to Follow-up|2|||
157063738|NCT01209286|566989155|FG000|Overall Study|Adverse Event|4|||
157063739|NCT01209286|566989156|FG001|Overall Study|Adverse Event|3|||
157063740|NCT01209286|566989157|FG002|Overall Study|Adverse Event|1|||
157063741|NCT01209286|566989155|FG000|Overall Study|Hematological Relapse After Remission|0|||
157063742|NCT01209286|566989156|FG001|Overall Study|Hematological Relapse After Remission|1|||
157063743|NCT01209286|566989157|FG002|Overall Study|Hematological Relapse After Remission|1|||
157063744|NCT01209286|566989155|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
157063745|NCT01209286|566989156|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
157063746|NCT01209286|566989157|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
157063747|NCT01209286|566989155|FG000|Overall Study|Physician Decision|0|||
157063748|NCT01209286|566989156|FG001|Overall Study|Physician Decision|2|||
157063749|NCT01209286|566989157|FG002|Overall Study|Physician Decision|0|||
157063750|NCT01209286|566989155|FG000|Overall Study|Other|0|||
157063751|NCT01209286|566989156|FG001|Overall Study|Other|1|||
157184215|NCT01302691|567415253|FG000|Overall Study|Physician Decision|0|||
157184216|NCT01302691|567415254|FG001|Overall Study|Physician Decision|1|||
157184217|NCT01302691|567415253|FG000|Overall Study|Protocol Violation|1|||
157184218|NCT01302691|567415254|FG001|Overall Study|Protocol Violation|0|||
157184219|NCT03446612|567415255|FG000|Overall Study|Protocol defined stopping criteria|0|||
157184220|NCT03446612|567415256|FG001|Overall Study|Protocol defined stopping criteria|1|||
157063752|NCT01209286|566989157|FG002|Overall Study|Other|0|||
157063753|NCT03029819|566989158|FG000|Overall Study|Lost to Follow-up|3|||
157063754|NCT03029819|566989159|FG001|Overall Study|Lost to Follow-up|5|||
157063755|NCT03029819|566989158|FG000|Overall Study|Removed due to disruptive behavior|0|||
157063756|NCT03029819|566989159|FG001|Overall Study|Removed due to disruptive behavior|1|||
157063757|NCT01215032|566989165|FG000|Overall Study|Adverse Event|3|||
157063758|NCT01215032|566989165|FG000|Overall Study|Lack of Efficacy|17|||
157063759|NCT01020747|566989166|FG000|Overall Study|Withdrawal by Subject|1|||
157063760|NCT00808899|566989167|FG000|Overall Study|Death|1|||
157063761|NCT00808899|566989167|FG000|Overall Study|Physician Decision|3|||
157063762|NCT03028012|566989168|FG000|Overall Study|Lost to Follow-up|2|||
157063763|NCT03028012|566989169|FG001|Overall Study|Lost to Follow-up|3|||
157063764|NCT03028012|566989170|FG002|Overall Study|Lost to Follow-up|3|||
157063765|NCT03448536|566989173|FG000|Overall Study|Protocol Violation|2|||
157063766|NCT03448536|566989174|FG001|Overall Study|Protocol Violation|0|||
157063767|NCT03448536|566989173|FG000|Overall Study|Pregnancy|1|||
157063768|NCT03448536|566989174|FG001|Overall Study|Pregnancy|0|||
157063769|NCT03448536|566989173|FG000|Overall Study|Withdrawal by Subject|1|||
157063770|NCT03448536|566989174|FG001|Overall Study|Withdrawal by Subject|2|||
157063771|NCT03448536|566989173|FG000|Overall Study|Lost to Follow-up|3|||
157063772|NCT03448536|566989174|FG001|Overall Study|Lost to Follow-up|2|||
157063773|NCT03448536|566989173|FG000|Overall Study|Inadequate pain reporter|1|||
157063774|NCT03448536|566989174|FG001|Overall Study|Inadequate pain reporter|0|||
157063775|NCT03448536|566989173|FG000|Overall Study|Other|3|||
157063776|NCT03448536|566989174|FG001|Overall Study|Other|0|||
157063777|NCT03448536|566989173|FG000|Overall Study|Physician Decision|1|||
157063778|NCT03448536|566989174|FG001|Overall Study|Physician Decision|0|||
157063779|NCT01813305|566989175|FG000|Overall Study|Withdrawal by Subject|12|||
157063780|NCT01813305|566989176|FG001|Overall Study|Withdrawal by Subject|5|||
157063781|NCT01813305|566989175|FG000|Overall Study|Safety Concern|4|||
157063782|NCT01813305|566989176|FG001|Overall Study|Safety Concern|0|||
157063783|NCT01813305|566989175|FG000|Overall Study|Ulcer became worse|4|||
157063784|NCT01813305|566989176|FG001|Overall Study|Ulcer became worse|0|||
157063785|NCT01813305|566989175|FG000|Overall Study|Physician Decision|4|||
157063786|NCT01813305|566989176|FG001|Overall Study|Physician Decision|0|||
157063787|NCT01813305|566989175|FG000|Overall Study|Lost to Follow-up|3|||
157063788|NCT01813305|566989176|FG001|Overall Study|Lost to Follow-up|1|||
157063789|NCT01813305|566989175|FG000|Overall Study|Protocol Violation|1|||
157063790|NCT01813305|566989176|FG001|Overall Study|Protocol Violation|0|||
157063791|NCT01813305|566989175|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
157063792|NCT01813305|566989176|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
157063793|NCT01705145|566989177|FG000|Part B|Adverse Event|1|||
157184221|NCT01810380|567415262|FG000|Overall Study|Randomised not treated|2|||
157184222|NCT01810380|567415263|FG001|Overall Study|Randomised not treated|1|||
157184223|NCT01810380|567415264|FG002|Overall Study|Randomised not treated|1|||
157184224|NCT01810380|567415262|FG000|Overall Study|Adverse Event|11|||
157184225|NCT01810380|567415263|FG001|Overall Study|Adverse Event|14|||
157184226|NCT01810380|567415264|FG002|Overall Study|Adverse Event|4|||
157184227|NCT01810380|567415262|FG000|Overall Study|Lack of Efficacy|24|||
157184228|NCT01810380|567415263|FG001|Overall Study|Lack of Efficacy|10|||
157184229|NCT01810380|567415264|FG002|Overall Study|Lack of Efficacy|11|||
157184230|NCT01810380|567415262|FG000|Overall Study|Protocol Violation|1|||
157184231|NCT01810380|567415263|FG001|Overall Study|Protocol Violation|0|||
157184232|NCT01810380|567415264|FG002|Overall Study|Protocol Violation|1|||
157184233|NCT01810380|567415262|FG000|Overall Study|Withdrawal by Subject|6|||
157184234|NCT01810380|567415263|FG001|Overall Study|Withdrawal by Subject|0|||
157184235|NCT01810380|567415264|FG002|Overall Study|Withdrawal by Subject|6|||
157184236|NCT01810380|567415262|FG000|Overall Study|Administrative or other reasons|11|||
157184237|NCT01810380|567415263|FG001|Overall Study|Administrative or other reasons|13|||
157184238|NCT01810380|567415264|FG002|Overall Study|Administrative or other reasons|9|||
157184239|NCT02829775|567415265|FG000|Overall Study|Death|1|||
157184240|NCT02829775|567415265|FG000|Overall Study|Withdrawal by Subject|3|||
157184241|NCT02829775|567415265|FG000|Overall Study|Disease remission|1|||
157184242|NCT03148795|567415275|FG000|Overall Study|Progressive Disease|1|||
157184243|NCT00441012|567415276|FG000|Overall Study|Adverse Event|0|||
157184244|NCT00441012|567415277|FG001|Overall Study|Adverse Event|1|||
157184245|NCT00441012|567415276|FG000|Overall Study|Lost to Follow-up|3|||
157184246|NCT00441012|567415277|FG001|Overall Study|Lost to Follow-up|3|||
157184247|NCT00441012|567415276|FG000|Overall Study|Protocol Violation|10|||
157184248|NCT00441012|567415277|FG001|Overall Study|Protocol Violation|9|||
157184249|NCT00441012|567415276|FG000|Overall Study|Withdrawal by Subject|4|||
157184250|NCT00441012|567415277|FG001|Overall Study|Withdrawal by Subject|0|||
157184251|NCT00441012|567415276|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
157184252|NCT00441012|567415277|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
157184253|NCT04489940|567415278|FG000|Overall Study|Other|2|||
157184254|NCT04489940|567415278|FG000|Overall Study|Withdrawal by Subject|2|||
157184255|NCT04489940|567415278|FG000|Overall Study|Death|5|||
157184256|NCT04489940|567415278|FG000|Overall Study|Lost to Follow-up|1|||
157184257|NCT04498468|567415279|FG000|Overall Study|Lost to Follow-up|3|||
157184258|NCT02725268|567415280|FG000|Overall Study|Death|58|||
157184259|NCT02725268|567415281|FG001|Overall Study|Death|59|||
157184260|NCT02725268|567415282|FG002|Overall Study|Death|30|||
157184261|NCT02725268|567415283|FG003|Overall Study|Death|16|||
157184262|NCT02725268|567415280|FG000|Overall Study|Lost to Follow-up|4|||
157184263|NCT02725268|567415281|FG001|Overall Study|Lost to Follow-up|3|||
157230042|NCT00162123|567588223|FG003|Overall Study|Not specified (before treatment)|0|||
157063794|NCT01203956|566989178|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
157184264|NCT02725268|567415282|FG002|Overall Study|Lost to Follow-up|0|||
157184265|NCT02725268|567415283|FG003|Overall Study|Lost to Follow-up|1|||
157184266|NCT02725268|567415280|FG000|Overall Study|Site Terminated by Sponsor|0|||
157184267|NCT02725268|567415281|FG001|Overall Study|Site Terminated by Sponsor|1|||
157063795|NCT01203956|566989179|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
157063796|NCT02230306|566989182|FG000|Overall Study|Did not receive study treatment|1|||
157063797|NCT00312845|566989184|FG000|Overall Study|Adverse Event|19|||
157063798|NCT00312845|566989185|FG001|Overall Study|Adverse Event|5|||
157063799|NCT00312845|566989184|FG000|Overall Study|Death|2|||
157063800|NCT00312845|566989185|FG001|Overall Study|Death|2|||
157063801|NCT00312845|566989184|FG000|Overall Study|Withdrawal by Subject|14|||
157063802|NCT00312845|566989185|FG001|Overall Study|Withdrawal by Subject|6|||
157063803|NCT00312845|566989184|FG000|Overall Study|Disease Progression|56|||
157063804|NCT00312845|566989185|FG001|Overall Study|Disease Progression|77|||
157063805|NCT00312845|566989184|FG000|Overall Study|Lost to Follow-up|2|||
157063806|NCT00312845|566989185|FG001|Overall Study|Lost to Follow-up|0|||
157063807|NCT00312845|566989184|FG000|Overall Study|Other|6|||
157063808|NCT00312845|566989185|FG001|Overall Study|Other|5|||
157063809|NCT02212197|566989186|FG000|Overall Study|Need for radiotherapy|1|||
157063810|NCT02212197|566989187|FG001|Overall Study|Need for radiotherapy|0|||
157063811|NCT02212197|566989188|FG002|Overall Study|Need for radiotherapy|0|||
157063812|NCT01077622|566989190|FG000|Overall Study|Physician Decision|2|||
157063813|NCT01077622|566989190|FG000|Overall Study|Withdrawal by Subject|1|||
157063814|NCT00424177|566989191|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
157063815|NCT00424177|566989191|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
157063816|NCT00424177|566989191|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
157063817|NCT00424177|566989191|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
157063818|NCT00424177|566989191|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
157063819|NCT00424177|566989191|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
157063820|NCT00424177|566989191|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
157063821|NCT00424177|566989191|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
157063822|NCT00424177|566989191|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
157063823|NCT00424177|566989191|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
157063824|NCT01503164|566989192|FG000|Overall Study|Withdrawal by Subject|2|||
157063825|NCT01503164|566989193|FG001|Overall Study|Withdrawal by Subject|1|||
157063826|NCT04088136|566989194|FG000|Overall Study|Withdrawal by Subject|5|||
157063827|NCT04088136|566989195|FG001|Overall Study|Withdrawal by Subject|0|||
157063828|NCT04088136|566989194|FG000|Overall Study|Lack of Efficacy|0|||
157063829|NCT04088136|566989195|FG001|Overall Study|Lack of Efficacy|1|||
157063830|NCT00562484|566989196|FG000|Overall Study|Adverse Event|6|||
157063831|NCT00562484|566989197|FG001|Overall Study|Adverse Event|1|||
157063832|NCT00562484|566989196|FG000|Overall Study|Protocol Violation|11|||
157063833|NCT00562484|566989197|FG001|Overall Study|Protocol Violation|2|||
157063834|NCT00562484|566989196|FG000|Overall Study|Withdrawal by Subject|12|||
157063835|NCT00562484|566989197|FG001|Overall Study|Withdrawal by Subject|9|||
157063836|NCT00562484|566989196|FG000|Overall Study|Moved away from the study area|20|||
157063837|NCT00562484|566989197|FG001|Overall Study|Moved away from the study area|9|||
157063838|NCT00562484|566989196|FG000|Overall Study|Lost to Follow-up|132|||
157063839|NCT00562484|566989197|FG001|Overall Study|Lost to Follow-up|71|||
157063840|NCT00562484|566989196|FG000|Overall Study|Reason not provided or not specified|25|||
157063841|NCT00562484|566989197|FG001|Overall Study|Reason not provided or not specified|12|||
157063842|NCT02598934|566989201|FG000|Overall Study|Adverse Event|11|||
157063843|NCT02598934|566989202|FG001|Overall Study|Adverse Event|13|||
157063844|NCT02598934|566989201|FG000|Overall Study|Failure to Return|3|||
157063845|NCT02598934|566989202|FG001|Overall Study|Failure to Return|3|||
157063846|NCT02598934|566989201|FG000|Overall Study|Withdrawal by Subject|2|||
157063847|NCT02598934|566989202|FG001|Overall Study|Withdrawal by Subject|3|||
157063848|NCT02598934|566989201|FG000|Overall Study|Administrative|2|||
157063849|NCT02598934|566989202|FG001|Overall Study|Administrative|1|||
157063850|NCT02598934|566989201|FG000|Overall Study|Protocol Violation|1|||
157063851|NCT02598934|566989202|FG001|Overall Study|Protocol Violation|2|||
157063852|NCT00702520|566989204|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
157063853|NCT00702520|566989205|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
157063854|NCT00702520|566989206|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
157063855|NCT00702520|566989207|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
157063856|NCT00702520|566989204|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
157063857|NCT00702520|566989205|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
157063858|NCT00702520|566989206|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
157184268|NCT02725268|567415282|FG002|Overall Study|Site Terminated by Sponsor|0|||
157184269|NCT02725268|567415283|FG003|Overall Study|Site Terminated by Sponsor|0|||
157063859|NCT00702520|566989207|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
157063860|NCT00702520|566989204|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
157063861|NCT00702520|566989205|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
157063862|NCT00702520|566989206|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
157063863|NCT00702520|566989207|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
157063864|NCT02154347|566989208|FG000|Double-blind Period|Adverse Event|1|||
157063865|NCT02154347|566989209|FG001|Double-blind Period|Adverse Event|2|||
157063866|NCT02154347|566989208|FG000|Double-blind Period|Lack of Efficacy|1|||
157063867|NCT02154347|566989209|FG001|Double-blind Period|Lack of Efficacy|0|||
157063868|NCT02154347|566989208|FG000|Double-blind Period|Physician Decision|0|||
157063869|NCT02154347|566989209|FG001|Double-blind Period|Physician Decision|1|||
157063870|NCT02154347|566989208|FG000|Double-blind Period|Withdrawal by Subject|1|||
157063871|NCT02154347|566989209|FG001|Double-blind Period|Withdrawal by Subject|1|||
157063872|NCT02154347|566989208|FG000|Open-label Period|Adverse Event|3|||
157063873|NCT02154347|566989209|FG001|Open-label Period|Adverse Event|4|||
157063874|NCT02154347|566989208|FG000|Open-label Period|Lack of Efficacy|4|||
157063875|NCT02154347|566989209|FG001|Open-label Period|Lack of Efficacy|19|||
157063876|NCT02154347|566989208|FG000|Open-label Period|Protocol Violation|0|||
157063877|NCT02154347|566989209|FG001|Open-label Period|Protocol Violation|1|||
157063878|NCT02154347|566989208|FG000|Open-label Period|Withdrawal by Subject|0|||
157063879|NCT02154347|566989209|FG001|Open-label Period|Withdrawal by Subject|1|||
157063880|NCT02481934|566989210|FG000|Overall Study|Death|2|||
157063881|NCT02473913|566989211|FG000|Overall Study|Lost to Follow-up|3|||
157063882|NCT02473913|566989212|FG001|Overall Study|Lost to Follow-up|3|||
157063883|NCT05041439|566989213|FG000|Overall Study|Withdrawal by Subject|1|||
157063884|NCT05041439|566989214|FG001|Overall Study|Withdrawal by Subject|1|||
157063885|NCT05041439|566989213|FG000|Overall Study|Death|1|||
157063886|NCT05041439|566989214|FG001|Overall Study|Death|0|||
157063887|NCT02979613|566989217|FG000|Double-Blind Phase|Withdrew Consent|2|||
157063888|NCT02979613|566989218|FG001|Double-Blind Phase|Withdrew Consent|4|||
157063889|NCT02979613|566989217|FG000|Double-Blind Phase|Pregnancy|2|||
157063890|NCT02979613|566989218|FG001|Double-Blind Phase|Pregnancy|2|||
157063891|NCT02979613|566989217|FG000|Double-Blind Phase|Adverse Event|2|||
157063892|NCT02979613|566989218|FG001|Double-Blind Phase|Adverse Event|0|||
157063893|NCT02979613|566989217|FG000|Double-Blind Phase|Lost to Follow-up|1|||
157063894|NCT02979613|566989218|FG001|Double-Blind Phase|Lost to Follow-up|1|||
157063895|NCT02979613|566989217|FG000|Double-Blind Phase|Protocol Violation|1|||
157063896|NCT02979613|566989218|FG001|Double-Blind Phase|Protocol Violation|1|||
157063897|NCT02979613|566989217|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
157063898|NCT02979613|566989218|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
157063899|NCT02979613|566989217|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
157063900|NCT02979613|566989218|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
157063901|NCT02979613|566989217|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
157063902|NCT02979613|566989218|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
157063903|NCT02979613|566989217|FG000|Open-Label Extension (OLE) Phase|Death|0|||
157063904|NCT02979613|566989218|FG001|Open-Label Extension (OLE) Phase|Death|1|||
157063905|NCT02979613|566989217|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
157063906|NCT02979613|566989218|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
157063907|NCT02250183|566989224|FG000|Overall Study|Withdrawal by Subject|2|||
157063908|NCT02250183|566989224|FG000|Overall Study|Adverse Event|5|||
157063909|NCT02250183|566989224|FG000|Overall Study|Lost to Follow-up|1|||
157063910|NCT03282799|566989225|FG000|Overall Study|Pregnancy|1|||
157063911|NCT03282799|566989226|FG001|Overall Study|Pregnancy|0|||
157063912|NCT03282799|566989225|FG000|Overall Study|Physician Decision|1|||
157063913|NCT03282799|566989226|FG001|Overall Study|Physician Decision|0|||
157063914|NCT03749616|566989230|FG000|Overall Study|Lost to Follow-up|4|||
157063915|NCT03749616|566989231|FG001|Overall Study|Lost to Follow-up|7|||
157063916|NCT03749616|566989230|FG000|Overall Study|Screen Failure|1|||
157063917|NCT03749616|566989231|FG001|Overall Study|Screen Failure|1|||
157063918|NCT03749616|566989230|FG000|Overall Study|Withdrawal by Subject|2|||
157063919|NCT03749616|566989231|FG001|Overall Study|Withdrawal by Subject|0|||
157063920|NCT03302559|566989232|FG000|Overall Study|Adverse Event|2|||
157063921|NCT03302559|566989232|FG000|Overall Study|Lost to Follow-up|1|||
157063922|NCT03302559|566989232|FG000|Overall Study|Withdrew Consent|3|||
157184270|NCT02725268|567415280|FG000|Overall Study|Withdrawal by Subject|8|||
157184271|NCT02725268|567415281|FG001|Overall Study|Withdrawal by Subject|6|||
157184272|NCT02725268|567415282|FG002|Overall Study|Withdrawal by Subject|8|||
157184273|NCT02725268|567415283|FG003|Overall Study|Withdrawal by Subject|1|||
157184274|NCT02725268|567415280|FG000|Overall Study|Reason not Specified|2|||
157184275|NCT02725268|567415281|FG001|Overall Study|Reason not Specified|1|||
157184276|NCT02725268|567415282|FG002|Overall Study|Reason not Specified|0|||
157184277|NCT02725268|567415283|FG003|Overall Study|Reason not Specified|0|||
157184278|NCT00262314|567415289|FG000|Overall Study|Changing physicians|38|||
157184279|NCT00262314|567415289|FG000|Overall Study|Death|12|||
157184280|NCT00262314|567415289|FG000|Overall Study|Patient's decision|92|||
157184281|NCT00262314|567415289|FG000|Overall Study|Other|95|||
157184282|NCT00262314|567415289|FG000|Overall Study|Lost to Follow-up|70|||
157184283|NCT00262314|567415289|FG000|Overall Study|Administrative withdrawal|30|||
157184284|NCT00117572|567415294|FG000|Overall Study|Site withdrew before starting treatment|2|||
157184285|NCT00117572|567415295|FG001|Overall Study|Site withdrew before starting treatment|3|||
157184286|NCT00117572|567415294|FG000|Overall Study|Withdrawal by Subject|3|||
157184287|NCT00117572|567415295|FG001|Overall Study|Withdrawal by Subject|3|||
157184288|NCT00117572|567415294|FG000|Overall Study|Protocol Violation|1|||
157184289|NCT00117572|567415295|FG001|Overall Study|Protocol Violation|0|||
157184290|NCT04973085|567415296|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
157063923|NCT03614676|566990828|FG000|Overall Study|Delivery before planned visit|2|||
157063924|NCT03614676|566990829|FG001|Overall Study|Delivery before planned visit|0|||
157063925|NCT03614676|566990828|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
157063926|NCT03614676|566990829|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
157063927|NCT03614676|566990828|FG000|Overall Study|Migrated / moved from the study area|30|||
157063928|NCT03614676|566990829|FG001|Overall Study|Migrated / moved from the study area|22|||
157063929|NCT03614676|566990828|FG000|Overall Study|Lost to Follow-up|17|||
157063930|NCT03614676|566990829|FG001|Overall Study|Lost to Follow-up|42|||
157063931|NCT03614676|566990828|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
157063932|NCT03614676|566990829|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
157063933|NCT03614676|566990828|FG000|Overall Study|Other|16|||
157063934|NCT03614676|566990829|FG001|Overall Study|Other|47|||
157063935|NCT03614676|566990828|FG000|Overall Study|Protocol Violation|0|||
157063936|NCT03614676|566990829|FG001|Overall Study|Protocol Violation|2|||
157063937|NCT03614676|566990828|FG000|Overall Study|Neonatal event of interest|0|||
157063938|NCT03614676|566990829|FG001|Overall Study|Neonatal event of interest|6|||
157063939|NCT03614676|566990828|FG000|Overall Study|Death in infant greater than 28 days old|0|||
157063940|NCT03614676|566990829|FG001|Overall Study|Death in infant greater than 28 days old|12|||
157063941|NCT03614676|566990828|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
157063942|NCT03614676|566990829|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
157063943|NCT02388347|566990830|FG000|Overall Study|Withdrawal by Subject|0|||
157063944|NCT02388347|566990831|FG001|Overall Study|Withdrawal by Subject|0|||
157063945|NCT02388347|566990832|FG002|Overall Study|Withdrawal by Subject|1|||
157063946|NCT02388347|566990833|FG003|Overall Study|Withdrawal by Subject|0|||
157184291|NCT04973085|567415297|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
157184292|NCT01387594|567415303|FG000|Overall Study|Withdrawal by Subject|0|||
157184293|NCT01387594|567415304|FG001|Overall Study|Withdrawal by Subject|2|||
157184294|NCT01387594|567415303|FG000|Overall Study|Lost to Follow-up|0|||
157184295|NCT01387594|567415304|FG001|Overall Study|Lost to Follow-up|1|||
157184296|NCT03954704|567415310|FG000|Overall Study|Death|1|||
157184297|NCT03954704|567415311|FG001|Overall Study|Death|1|||
157184298|NCT03954704|567415312|FG002|Overall Study|Death|1|||
157184299|NCT03954704|567415313|FG003|Overall Study|Death|3|||
157184300|NCT03954704|567415314|FG004|Overall Study|Death|2|||
157184301|NCT03954704|567415315|FG005|Overall Study|Death|2|||
157184302|NCT03954704|567415316|FG006|Overall Study|Death|0|||
157184303|NCT03954704|567415310|FG000|Overall Study|Withdrew Consent|0|||
157184304|NCT03954704|567415311|FG001|Overall Study|Withdrew Consent|0|||
157184305|NCT03954704|567415312|FG002|Overall Study|Withdrew Consent|1|||
157184306|NCT03954704|567415313|FG003|Overall Study|Withdrew Consent|0|||
157184307|NCT03954704|567415314|FG004|Overall Study|Withdrew Consent|0|||
157184308|NCT03954704|567415315|FG005|Overall Study|Withdrew Consent|1|||
157184309|NCT03954704|567415316|FG006|Overall Study|Withdrew Consent|0|||
157184310|NCT03954704|567415310|FG000|Overall Study|Lost to Follow-up|0|||
157184311|NCT03954704|567415311|FG001|Overall Study|Lost to Follow-up|0|||
157184312|NCT03954704|567415312|FG002|Overall Study|Lost to Follow-up|0|||
157184313|NCT03954704|567415313|FG003|Overall Study|Lost to Follow-up|0|||
157184314|NCT03954704|567415314|FG004|Overall Study|Lost to Follow-up|0|||
157184315|NCT03954704|567415315|FG005|Overall Study|Lost to Follow-up|0|||
157184316|NCT03954704|567415316|FG006|Overall Study|Lost to Follow-up|1|||
157184317|NCT03954704|567415310|FG000|Overall Study|Study Terminated by Sponsor|0|||
157184318|NCT03954704|567415311|FG001|Overall Study|Study Terminated by Sponsor|0|||
157184319|NCT03954704|567415312|FG002|Overall Study|Study Terminated by Sponsor|1|||
157184320|NCT03954704|567415313|FG003|Overall Study|Study Terminated by Sponsor|0|||
157184321|NCT03954704|567415314|FG004|Overall Study|Study Terminated by Sponsor|1|||
157184322|NCT03954704|567415315|FG005|Overall Study|Study Terminated by Sponsor|4|||
157184323|NCT03954704|567415316|FG006|Overall Study|Study Terminated by Sponsor|2|||
157184324|NCT03954704|567415310|FG000|Overall Study|Enrolled but not Treated|0|||
157184325|NCT03954704|567415311|FG001|Overall Study|Enrolled but not Treated|0|||
157184326|NCT03954704|567415312|FG002|Overall Study|Enrolled but not Treated|0|||
157184327|NCT03954704|567415313|FG003|Overall Study|Enrolled but not Treated|0|||
157184328|NCT03954704|567415314|FG004|Overall Study|Enrolled but not Treated|0|||
157184329|NCT03954704|567415315|FG005|Overall Study|Enrolled but not Treated|1|||
157184330|NCT03954704|567415316|FG006|Overall Study|Enrolled but not Treated|0|||
157184331|NCT03559192|567415317|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
157184332|NCT03559192|567415318|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
157184333|NCT03559192|567415319|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
157184334|NCT03559192|567415317|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
157184335|NCT03559192|567415318|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
157184336|NCT03559192|567415319|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
157184337|NCT03559192|567415317|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
157063947|NCT02388347|566990834|FG004|Overall Study|Withdrawal by Subject|0|||
157063948|NCT00497874|566990835|FG000|Overall Study|Withdrawal by Subject|48|||
157184338|NCT03559192|567415318|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
157230043|NCT00162123|567588224|FG004|Overall Study|Not specified (before treatment)|12|||
157230044|NCT00162123|567588225|FG005|Overall Study|Not specified (before treatment)|1|||
157230045|NCT00162123|567588226|FG006|Overall Study|Not specified (before treatment)|0|||
157230046|NCT00162123|567588227|FG007|Overall Study|Not specified (before treatment)|0|||
157063949|NCT00497874|566990836|FG001|Overall Study|Withdrawal by Subject|17|||
157063950|NCT00497874|566990835|FG000|Overall Study|Illness|8|||
157063951|NCT00497874|566990836|FG001|Overall Study|Illness|4|||
157063952|NCT00497874|566990835|FG000|Overall Study|Death|2|||
157063953|NCT00497874|566990836|FG001|Overall Study|Death|4|||
157063954|NCT00497874|566990835|FG000|Overall Study|Unable to contact|52|||
157063955|NCT00497874|566990836|FG001|Overall Study|Unable to contact|67|||
157063956|NCT00497874|566990835|FG000|Overall Study|Unable to schedule|37|||
157063957|NCT00497874|566990836|FG001|Overall Study|Unable to schedule|24|||
157063958|NCT02080403|566990837|FG000|Overall Study|Adverse Event|5|||
157063959|NCT02080403|566990838|FG001|Overall Study|Adverse Event|1|||
157063960|NCT02080403|566990837|FG000|Overall Study|Death|0|||
157063961|NCT02080403|566990838|FG001|Overall Study|Death|2|||
157063962|NCT02080403|566990837|FG000|Overall Study|Lost to Follow-up|2|||
157063963|NCT02080403|566990838|FG001|Overall Study|Lost to Follow-up|0|||
157063964|NCT02080403|566990837|FG000|Overall Study|Pregnancy|0|||
157063965|NCT02080403|566990838|FG001|Overall Study|Pregnancy|1|||
157063966|NCT02080403|566990837|FG000|Overall Study|Protocol Violation|3|||
157063967|NCT02080403|566990838|FG001|Overall Study|Protocol Violation|7|||
157063968|NCT02080403|566990837|FG000|Overall Study|Withdrawal by Subject|5|||
157184339|NCT03559192|567415319|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
157184340|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
157184341|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
157184342|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
157184343|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
157184344|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
157184345|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
157184346|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
157184347|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
157184348|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
157184349|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
157184350|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
157184351|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
157184352|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
157184353|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
157184354|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
157184355|NCT03559192|567415317|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
157184356|NCT03559192|567415318|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
157184357|NCT03559192|567415319|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
157184358|NCT02254304|567415322|FG000|Overall Study|Adverse Event|2|||
157184359|NCT02254304|567415323|FG001|Overall Study|Adverse Event|1|||
157184360|NCT02254304|567415322|FG000|Overall Study|Lost to Follow-up|2|||
157184361|NCT02254304|567415323|FG001|Overall Study|Lost to Follow-up|2|||
157184362|NCT02254304|567415322|FG000|Overall Study|Protocol Violation|1|||
157184363|NCT02254304|567415323|FG001|Overall Study|Protocol Violation|0|||
157184364|NCT02254304|567415322|FG000|Overall Study|Withdrawal by Subject|3|||
157184365|NCT02254304|567415323|FG001|Overall Study|Withdrawal by Subject|0|||
157184366|NCT02254304|567415322|FG000|Overall Study|Injection site pain and Injection fear|1|||
157184367|NCT02254304|567415323|FG001|Overall Study|Injection site pain and Injection fear|0|||
157184368|NCT02254304|567415322|FG000|Overall Study|Personal causes|4|||
157184369|NCT02254304|567415323|FG001|Overall Study|Personal causes|1|||
157184370|NCT02254304|567415322|FG000|Overall Study|Personal decision|1|||
157184371|NCT02254304|567415323|FG001|Overall Study|Personal decision|0|||
157184372|NCT04418427|567417903|FG000|Overall Study|Death|0|||
157184373|NCT04418427|567417904|FG001|Overall Study|Death|1|||
157184374|NCT04418427|567417905|FG002|Overall Study|Death|0|||
157184375|NCT04418427|567417903|FG000|Overall Study|Lost to Follow-up|0|||
157184376|NCT04418427|567417904|FG001|Overall Study|Lost to Follow-up|2|||
157184377|NCT04418427|567417905|FG002|Overall Study|Lost to Follow-up|2|||
157184378|NCT04418427|567417903|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
157184379|NCT04418427|567417904|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
157184380|NCT04418427|567417905|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
157184381|NCT04418427|567417903|FG000|Overall Study|Pre-existing medical condition|0|||
157184382|NCT04418427|567417904|FG001|Overall Study|Pre-existing medical condition|1|||
157063969|NCT02080403|566990838|FG001|Overall Study|Withdrawal by Subject|1|||
157063970|NCT01999972|566990839|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
157063971|NCT01999972|566990840|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
157184383|NCT04418427|567417905|FG002|Overall Study|Pre-existing medical condition|0|||
157184384|NCT01673373|567417908|FG000|Overall Study|Death|2|||
157184385|NCT02200510|567417914|FG000|Overall Study|Death|1|||
157063972|NCT01999972|566990841|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
157063973|NCT01999972|566990842|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
157063974|NCT01999972|566990843|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
157063975|NCT01999972|566990844|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
157063976|NCT01999972|566990839|FG000|Dose Escalation Part|Death|0|||
157063977|NCT01999972|566990840|FG001|Dose Escalation Part|Death|1|||
157063978|NCT01999972|566990841|FG002|Dose Escalation Part|Death|0|||
157063979|NCT01999972|566990842|FG003|Dose Escalation Part|Death|0|||
157063980|NCT01999972|566990843|FG004|Dose Escalation Part|Death|0|||
157063981|NCT01999972|566990844|FG005|Dose Escalation Part|Death|0|||
157063982|NCT01999972|566990839|FG000|Dose Escalation Part|Enrolled but not treated|0|||
157063983|NCT01999972|566990840|FG001|Dose Escalation Part|Enrolled but not treated|0|||
157063984|NCT01999972|566990841|FG002|Dose Escalation Part|Enrolled but not treated|1|||
157063985|NCT01999972|566990842|FG003|Dose Escalation Part|Enrolled but not treated|1|||
157063986|NCT01999972|566990843|FG004|Dose Escalation Part|Enrolled but not treated|0|||
157063987|NCT01999972|566990844|FG005|Dose Escalation Part|Enrolled but not treated|0|||
157063988|NCT01999972|566990839|FG000|Dose Escalation Part|Disease progression|3|||
157063989|NCT01999972|566990840|FG001|Dose Escalation Part|Disease progression|2|||
157063990|NCT01999972|566990841|FG002|Dose Escalation Part|Disease progression|3|||
157063991|NCT01999972|566990842|FG003|Dose Escalation Part|Disease progression|6|||
157063992|NCT01999972|566990843|FG004|Dose Escalation Part|Disease progression|0|||
157063993|NCT01999972|566990844|FG005|Dose Escalation Part|Disease progression|0|||
157063994|NCT01999972|566990839|FG000|Dose Escalation Part|Adverse Event|0|||
157063995|NCT01999972|566990840|FG001|Dose Escalation Part|Adverse Event|0|||
157063996|NCT01999972|566990841|FG002|Dose Escalation Part|Adverse Event|0|||
157063997|NCT01999972|566990842|FG003|Dose Escalation Part|Adverse Event|2|||
157063998|NCT01999972|566990843|FG004|Dose Escalation Part|Adverse Event|0|||
157063999|NCT01999972|566990844|FG005|Dose Escalation Part|Adverse Event|0|||
157064000|NCT01999972|566990839|FG000|Dose Escalation Part|Global deterioration of health status|1|||
157064001|NCT01999972|566990840|FG001|Dose Escalation Part|Global deterioration of health status|0|||
157064002|NCT01999972|566990841|FG002|Dose Escalation Part|Global deterioration of health status|0|||
157064003|NCT01999972|566990842|FG003|Dose Escalation Part|Global deterioration of health status|1|||
157064004|NCT01999972|566990843|FG004|Dose Escalation Part|Global deterioration of health status|0|||
157064005|NCT01999972|566990844|FG005|Dose Escalation Part|Global deterioration of health status|0|||
157064006|NCT01999972|566990839|FG000|Dose Expansion Part|Death|0|||
157064007|NCT01999972|566990840|FG001|Dose Expansion Part|Death|0|||
157064008|NCT01999972|566990841|FG002|Dose Expansion Part|Death|0|||
157064009|NCT01999972|566990842|FG003|Dose Expansion Part|Death|0|||
157064010|NCT01999972|566990843|FG004|Dose Expansion Part|Death|2|||
157064011|NCT01999972|566990844|FG005|Dose Expansion Part|Death|1|||
157064012|NCT01999972|566990839|FG000|Dose Expansion Part|Disease progression|0|||
157064013|NCT01999972|566990840|FG001|Dose Expansion Part|Disease progression|0|||
157064014|NCT01999972|566990841|FG002|Dose Expansion Part|Disease progression|0|||
157064015|NCT01999972|566990842|FG003|Dose Expansion Part|Disease progression|0|||
157064016|NCT01999972|566990843|FG004|Dose Expansion Part|Disease progression|9|||
157064017|NCT01999972|566990844|FG005|Dose Expansion Part|Disease progression|3|||
157064018|NCT01999972|566990839|FG000|Dose Expansion Part|Sponsor decision|0|||
157064019|NCT01999972|566990840|FG001|Dose Expansion Part|Sponsor decision|0|||
157184386|NCT02200510|567417915|FG001|Overall Study|Death|1|||
157184387|NCT02200510|567417914|FG000|Overall Study|Protocol Violation|0|||
157184388|NCT02200510|567417915|FG001|Overall Study|Protocol Violation|1|||
157184389|NCT02200510|567417914|FG000|Overall Study|Lost to Follow-up|7|||
157184390|NCT02200510|567417915|FG001|Overall Study|Lost to Follow-up|1|||
157064020|NCT01999972|566990841|FG002|Dose Expansion Part|Sponsor decision|0|||
157064021|NCT01999972|566990842|FG003|Dose Expansion Part|Sponsor decision|0|||
157064022|NCT01999972|566990843|FG004|Dose Expansion Part|Sponsor decision|1|||
157064023|NCT01999972|566990844|FG005|Dose Expansion Part|Sponsor decision|0|||
157064024|NCT01999972|566990839|FG000|Dose Expansion Part|Adverse Event|0|||
157064025|NCT01999972|566990840|FG001|Dose Expansion Part|Adverse Event|0|||
157064026|NCT01999972|566990841|FG002|Dose Expansion Part|Adverse Event|0|||
157064027|NCT01999972|566990842|FG003|Dose Expansion Part|Adverse Event|0|||
157064028|NCT01999972|566990843|FG004|Dose Expansion Part|Adverse Event|4|||
157184391|NCT02200510|567417914|FG000|Overall Study|potential COI - joined study team|1|||
157184392|NCT02200510|567417915|FG001|Overall Study|potential COI - joined study team|0|||
157184393|NCT03261037|567417916|FG000|Overall Study|Withdrawal by Subject|2|||
157184394|NCT03261037|567417917|FG001|Overall Study|Withdrawal by Subject|13|||
157184395|NCT03261037|567417918|FG002|Overall Study|Withdrawal by Subject|0|||
157184396|NCT03261037|567417919|FG003|Overall Study|Withdrawal by Subject|18|||
157230047|NCT00162123|567588220|FG000|Overall Study|Not specified (after start of treatment)|0|||
157064029|NCT01999972|566990844|FG005|Dose Expansion Part|Adverse Event|2|||
157064030|NCT01999972|566990839|FG000|Dose Expansion Part|Participant's non-compliance|0|||
157064031|NCT01999972|566990840|FG001|Dose Expansion Part|Participant's non-compliance|0|||
157230048|NCT00162123|567588221|FG001|Overall Study|Not specified (after start of treatment)|0|||
157184397|NCT03261037|567417916|FG000|Overall Study|Non-compliance with study procedures|0|||
157064032|NCT01999972|566990841|FG002|Dose Expansion Part|Participant's non-compliance|0|||
157064033|NCT01999972|566990842|FG003|Dose Expansion Part|Participant's non-compliance|0|||
157064034|NCT01999972|566990843|FG004|Dose Expansion Part|Participant's non-compliance|0|||
157064035|NCT01999972|566990844|FG005|Dose Expansion Part|Participant's non-compliance|1|||
157230049|NCT00162123|567588222|FG002|Overall Study|Not specified (after start of treatment)|0|||
157230050|NCT00162123|567588223|FG003|Overall Study|Not specified (after start of treatment)|0|||
157230051|NCT00162123|567588224|FG004|Overall Study|Not specified (after start of treatment)|3|||
157230052|NCT00162123|567588225|FG005|Overall Study|Not specified (after start of treatment)|0|||
157230053|NCT00162123|567588226|FG006|Overall Study|Not specified (after start of treatment)|0|||
157230054|NCT00162123|567588227|FG007|Overall Study|Not specified (after start of treatment)|0|||
157230055|NCT00162123|567588220|FG000|Overall Study|Physician Decision|1|||
157230056|NCT00162123|567588221|FG001|Overall Study|Physician Decision|2|||
157230057|NCT00162123|567588222|FG002|Overall Study|Physician Decision|0|||
157064036|NCT01999972|566990839|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
157064037|NCT01999972|566990840|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
157064038|NCT01999972|566990841|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
157064039|NCT01999972|566990842|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
157064040|NCT01999972|566990843|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
157064041|NCT01999972|566990844|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
157064042|NCT01999972|566990839|FG000|Dose Expansion Part|Changed to standard of care|0|||
157064043|NCT01999972|566990840|FG001|Dose Expansion Part|Changed to standard of care|0|||
157064044|NCT01999972|566990841|FG002|Dose Expansion Part|Changed to standard of care|0|||
157064045|NCT01999972|566990842|FG003|Dose Expansion Part|Changed to standard of care|0|||
157064046|NCT01999972|566990843|FG004|Dose Expansion Part|Changed to standard of care|1|||
157064047|NCT01999972|566990844|FG005|Dose Expansion Part|Changed to standard of care|0|||
157064048|NCT01171183|566990845|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
157064049|NCT01171183|566990846|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
157064050|NCT01171183|566990845|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
157064051|NCT01171183|566990846|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
157064052|NCT01171183|566990845|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
157064053|NCT01171183|566990846|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
157064054|NCT01171183|566990845|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
157064055|NCT01171183|566990846|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
157064056|NCT01171183|566990845|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
157064057|NCT01171183|566990846|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
157064058|NCT01171183|566990845|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
157064059|NCT01171183|566990846|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
157064060|NCT01101334|566990847|FG000|Overall Study|Adverse Event|9|||
157064061|NCT01101334|566990848|FG001|Overall Study|Adverse Event|4|||
157064062|NCT01101334|566990847|FG000|Overall Study|Death|7|||
157064063|NCT01101334|566990848|FG001|Overall Study|Death|1|||
157064064|NCT01101334|566990847|FG000|Overall Study|Withdrawal by Subject|4|||
157064065|NCT01101334|566990848|FG001|Overall Study|Withdrawal by Subject|3|||
157064066|NCT01101334|566990847|FG000|Overall Study|Withdrawal by Sponsor|1|||
157064067|NCT01101334|566990848|FG001|Overall Study|Withdrawal by Sponsor|1|||
157064068|NCT01101334|566990847|FG000|Overall Study|Progressive Disease|22|||
157064069|NCT01101334|566990848|FG001|Overall Study|Progressive Disease|35|||
157064070|NCT01101334|566990847|FG000|Overall Study|Other|2|||
157184398|NCT03261037|567417917|FG001|Overall Study|Non-compliance with study procedures|2|||
157184399|NCT03261037|567417918|FG002|Overall Study|Non-compliance with study procedures|0|||
157184400|NCT03261037|567417919|FG003|Overall Study|Non-compliance with study procedures|6|||
157184401|NCT03261037|567417916|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
157184402|NCT03261037|567417917|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
157184403|NCT03261037|567417918|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
157184404|NCT03261037|567417919|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
157184405|NCT03261037|567417916|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
157184406|NCT03261037|567417917|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
157184407|NCT03261037|567417918|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
157184408|NCT03261037|567417919|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
157184409|NCT03261037|567417916|FG000|Overall Study|Diagnosed but protocol deviation|1|||
157184410|NCT03261037|567417917|FG001|Overall Study|Diagnosed but protocol deviation|0|||
157184411|NCT03261037|567417918|FG002|Overall Study|Diagnosed but protocol deviation|0|||
157184412|NCT03261037|567417919|FG003|Overall Study|Diagnosed but protocol deviation|0|||
157184413|NCT03261037|567417916|FG000|Overall Study|Participant did not want to continue the study|0|||
157184414|NCT03261037|567417917|FG001|Overall Study|Participant did not want to continue the study|1|||
157230058|NCT00162123|567588223|FG003|Overall Study|Physician Decision|0|||
157230059|NCT00162123|567588224|FG004|Overall Study|Physician Decision|0|||
157230060|NCT00162123|567588225|FG005|Overall Study|Physician Decision|1|||
157064071|NCT01101334|566990848|FG001|Overall Study|Other|1|||
157064072|NCT02826798|566990851|FG000|Overall Study|Withdrawal by Subject|0|||
157064073|NCT02826798|566990852|FG001|Overall Study|Withdrawal by Subject|1|||
157064074|NCT02826798|566990853|FG002|Overall Study|Withdrawal by Subject|0|||
157064075|NCT02826798|566990854|FG003|Overall Study|Withdrawal by Subject|1|||
157064076|NCT02826798|566990855|FG004|Overall Study|Withdrawal by Subject|0|||
157064077|NCT02806505|566990856|FG000|Overall Study|Adverse event/intercurrent illness|1|||
157064078|NCT02806505|566990857|FG001|Overall Study|Adverse event/intercurrent illness|3|||
157064079|NCT02806505|566990856|FG000|Overall Study|Death|4|||
157064080|NCT02806505|566990857|FG001|Overall Study|Death|0|||
157064081|NCT02806505|566990856|FG000|Overall Study|Did not cooperate/refused treatment|3|||
157064082|NCT02806505|566990857|FG001|Overall Study|Did not cooperate/refused treatment|3|||
157064083|NCT02806505|566990856|FG000|Overall Study|Failure to return|0|||
157064084|NCT02806505|566990857|FG001|Overall Study|Failure to return|1|||
157064085|NCT02806505|566990856|FG000|Overall Study|Insufficient therapeutic response|2|||
157064086|NCT02806505|566990857|FG001|Overall Study|Insufficient therapeutic response|4|||
157064087|NCT03440047|566990859|FG000|Overall Study|Withdrawal by Subject|2|||
157064088|NCT04843579|566990868|FG000|Overall Study|Adverse Event|1|||
157064089|NCT04843579|566990868|FG000|Overall Study|Disease Progression|1|||
157064090|NCT04009629|566990869|FG000|Overall Study|Withdrawal by Subject|2|||
157064091|NCT04009629|566990870|FG001|Overall Study|Withdrawal by Subject|0|||
157064092|NCT04398368|566990871|FG000|Overall Study|Withdrawal by Subject|2|||
157184415|NCT03261037|567417918|FG002|Overall Study|Participant did not want to continue the study|0|||
157184416|NCT03261037|567417919|FG003|Overall Study|Participant did not want to continue the study|0|||
157184417|NCT03261037|567417916|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
157184418|NCT03261037|567417917|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
157184419|NCT03261037|567417918|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
157184420|NCT03261037|567417919|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
157184421|NCT03261037|567417916|FG000|Overall Study|Participant presented clinical improvement|0|||
157184422|NCT03261037|567417917|FG001|Overall Study|Participant presented clinical improvement|2|||
157184423|NCT03261037|567417918|FG002|Overall Study|Participant presented clinical improvement|0|||
157184424|NCT03261037|567417919|FG003|Overall Study|Participant presented clinical improvement|0|||
157184425|NCT03261037|567417916|FG000|Overall Study|Technical difficulties|0|||
157184426|NCT03261037|567417917|FG001|Overall Study|Technical difficulties|0|||
157184427|NCT03261037|567417918|FG002|Overall Study|Technical difficulties|0|||
157184428|NCT03261037|567417919|FG003|Overall Study|Technical difficulties|1|||
157184429|NCT03261037|567417916|FG000|Overall Study|Equipment failed to work|0|||
157184430|NCT03261037|567417917|FG001|Overall Study|Equipment failed to work|0|||
157184431|NCT03261037|567417918|FG002|Overall Study|Equipment failed to work|0|||
157184432|NCT03261037|567417919|FG003|Overall Study|Equipment failed to work|1|||
157184433|NCT03261037|567417916|FG000|Overall Study|End of study for participant and no follow up|0|||
157184434|NCT03261037|567417917|FG001|Overall Study|End of study for participant and no follow up|0|||
157184435|NCT03261037|567417918|FG002|Overall Study|End of study for participant and no follow up|0|||
157184436|NCT03261037|567417919|FG003|Overall Study|End of study for participant and no follow up|1|||
157184437|NCT03261037|567417916|FG000|Overall Study|Participant was too weak to continue in study|1|||
157184438|NCT03261037|567417917|FG001|Overall Study|Participant was too weak to continue in study|0|||
157184439|NCT03261037|567417918|FG002|Overall Study|Participant was too weak to continue in study|0|||
157184440|NCT03261037|567417919|FG003|Overall Study|Participant was too weak to continue in study|0|||
157184441|NCT02881151|567417922|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
157184442|NCT00589602|567417927|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
157184443|NCT04284787|567417928|FG000|Overall Study|Disease Progression|9|||
157184444|NCT04284787|567417929|FG001|Overall Study|Disease Progression|12|||
157184445|NCT04284787|567417928|FG000|Overall Study|Physician Decision|12|||
157184446|NCT04284787|567417929|FG001|Overall Study|Physician Decision|7|||
157184447|NCT04284787|567417928|FG000|Overall Study|Transplant|5|||
157184448|NCT04284787|567417929|FG001|Overall Study|Transplant|4|||
157184449|NCT04284787|567417928|FG000|Overall Study|Death|1|||
157184450|NCT04284787|567417929|FG001|Overall Study|Death|2|||
157184451|NCT04284787|567417928|FG000|Overall Study|Adverse Event|0|||
157184452|NCT04284787|567417929|FG001|Overall Study|Adverse Event|4|||
157184453|NCT04284787|567417928|FG000|Overall Study|Non-adherence|2|||
157184454|NCT04284787|567417929|FG001|Overall Study|Non-adherence|0|||
157184455|NCT04284787|567417928|FG000|Overall Study|Lack of Efficacy|2|||
157184456|NCT04284787|567417929|FG001|Overall Study|Lack of Efficacy|0|||
157184457|NCT03887052|567417930|FG000|Overall Study|Adverse Event|2|||
157184458|NCT03887052|567417930|FG000|Overall Study|Physician Decision|2|||
157184459|NCT03887052|567417930|FG000|Overall Study|Withdrawal by Subject|3|||
157184460|NCT03887052|567417930|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
157184461|NCT03887052|567417930|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
157230061|NCT00162123|567588226|FG006|Overall Study|Physician Decision|1|||
157064093|NCT00511836|566990874|FG000|Double-blind Period|Lost to Follow-up|1|||
157064094|NCT00511836|566990875|FG001|Double-blind Period|Lost to Follow-up|0|||
157064095|NCT00030823|566990876|FG000|Overall Study|Withdrawal by Subject|1|||
157064096|NCT04702893|566990882|FG000|Overall Study|Other reasons than listed|11|||
157064097|NCT04702893|566990882|FG000|Overall Study|Withdrawal by Subject|3|||
157064098|NCT04702893|566990882|FG000|Overall Study|Lost to Follow-up|7|||
157064099|NCT04702893|566990882|FG000|Overall Study|Death|10|||
157064100|NCT04702893|566990882|FG000|Overall Study|Not treated|6|||
157064101|NCT01114139|566990884|FG000|Overall Study|Adverse Event|3|||
157064102|NCT01114139|566990885|FG001|Overall Study|Adverse Event|2|||
157064103|NCT01114139|566990884|FG000|Overall Study|Lost to Follow-up|15|||
157064104|NCT01114139|566990885|FG001|Overall Study|Lost to Follow-up|3|||
157064105|NCT01114139|566990884|FG000|Overall Study|Withdrawal by Subject|17|||
157064106|NCT01114139|566990885|FG001|Overall Study|Withdrawal by Subject|6|||
157064107|NCT01114139|566990884|FG000|Overall Study|Other-Missed 1 visit|1|||
157064108|NCT01114139|566990885|FG001|Overall Study|Other-Missed 1 visit|0|||
157064109|NCT01114139|566990884|FG000|Overall Study|Other-Protocol Violation|1|||
157064110|NCT01114139|566990885|FG001|Overall Study|Other-Protocol Violation|0|||
157064111|NCT01114139|566990884|FG000|Overall Study|Other-Out of window for study drug dose|1|||
157064112|NCT01114139|566990885|FG001|Overall Study|Other-Out of window for study drug dose|0|||
157064113|NCT01114139|566990884|FG000|Overall Study|Other-Participant falsified records|0|||
157064114|NCT01114139|566990885|FG001|Overall Study|Other-Participant falsified records|1|||
157064115|NCT01114139|566990884|FG000|Overall Study|Other-Participant went on hospice|0|||
157064116|NCT01114139|566990885|FG001|Overall Study|Other-Participant went on hospice|1|||
157064117|NCT01114139|566990884|FG000|Overall Study|Other-Physician changed treatment|1|||
157064118|NCT01114139|566990885|FG001|Overall Study|Other-Physician changed treatment|0|||
157064119|NCT01114139|566990884|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
157064120|NCT01114139|566990885|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
157064121|NCT01951378|566990886|FG000|Overall Study|Study Terminated-Not completed|23|||
157064122|NCT01951378|566990887|FG001|Overall Study|Study Terminated-Not completed|17|||
157064123|NCT00477464|566990889|FG000|Overall Study|Lost to Follow-up|1|||
157064124|NCT00477464|566990889|FG000|Overall Study|Death|36|||
157064125|NCT00477464|566990889|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
157064126|NCT03568812|566990890|FG000|Overall Study|Physician Decision|0|||
157064127|NCT03568812|566990891|FG001|Overall Study|Physician Decision|1|||
157064128|NCT00639769|566990893|FG000|Overall Study|Death|2|||
157064129|NCT00639769|566990893|FG000|Overall Study|Adverse Event|7|||
157064130|NCT00639769|566990893|FG000|Overall Study|Lack of Efficacy|1|||
157064131|NCT00639769|566990893|FG000|Overall Study|Disease progression|26|||
157064132|NCT00639769|566990893|FG000|Overall Study|Withdrawal by Subject|4|||
157064133|NCT00634842|566990894|FG000|Overall Study|Adverse Event|2|||
157064134|NCT00634842|566990895|FG001|Overall Study|Adverse Event|3|||
157064135|NCT00634842|566990894|FG000|Overall Study|Protocol Violation|8|||
157064136|NCT00634842|566990895|FG001|Overall Study|Protocol Violation|4|||
157064137|NCT00634842|566990894|FG000|Overall Study|Move to another state|1|||
157064138|NCT00634842|566990895|FG001|Overall Study|Move to another state|0|||
157064139|NCT00634842|566990894|FG000|Overall Study|Inclusion criteria were not met|1|||
157064140|NCT00634842|566990895|FG001|Overall Study|Inclusion criteria were not met|0|||
157064141|NCT00634842|566990894|FG000|Overall Study|Lost to Follow-up|1|||
157064142|NCT00634842|566990895|FG001|Overall Study|Lost to Follow-up|2|||
157064143|NCT00634842|566990894|FG000|Overall Study|Physician Decision|1|||
157064144|NCT00634842|566990895|FG001|Overall Study|Physician Decision|0|||
157064145|NCT00634842|566990894|FG000|Overall Study|Withdrawal by Subject|1|||
157064146|NCT00634842|566990895|FG001|Overall Study|Withdrawal by Subject|3|||
157064147|NCT00634842|566990894|FG000|Overall Study|Lack of time and intolerance to drug|0|||
157064148|NCT00634842|566990895|FG001|Overall Study|Lack of time and intolerance to drug|1|||
157064149|NCT00634842|566990894|FG000|Overall Study|Discontinued due to injection|0|||
157064150|NCT00634842|566990895|FG001|Overall Study|Discontinued due to injection|2|||
157064151|NCT00634842|566990894|FG000|Overall Study|No need of study drug to treat diabetes|0|||
157184462|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
157184463|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
157184464|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Death|1|||
157184465|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Death|1|||
157184466|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
157064152|NCT00634842|566990895|FG001|Overall Study|No need of study drug to treat diabetes|1|||
157064153|NCT00634842|566990894|FG000|Overall Study|No wish to keep taking Avandia|0|||
157064154|NCT00634842|566990895|FG001|Overall Study|No wish to keep taking Avandia|1|||
157064155|NCT00634842|566990894|FG000|Overall Study|Subject off study drug for too long|0|||
157064156|NCT00634842|566990895|FG001|Overall Study|Subject off study drug for too long|1|||
157064157|NCT03470545|566990899|FG000|Overall Study|Death|0|||
157064158|NCT03470545|566990900|FG001|Overall Study|Death|1|||
157064159|NCT03470545|566990899|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
157064160|NCT03470545|566990900|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
157064161|NCT03470545|566990899|FG000|Overall Study|Adverse Event|2|||
157064162|NCT03470545|566990900|FG001|Overall Study|Adverse Event|0|||
157230062|NCT00162123|567588227|FG007|Overall Study|Physician Decision|0|||
157064163|NCT03470545|566990899|FG000|Overall Study|Withdrawal by Subject|1|||
157064164|NCT03470545|566990900|FG001|Overall Study|Withdrawal by Subject|1|||
157064165|NCT03470545|566990899|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
157064166|NCT03470545|566990900|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
157064167|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
157064168|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
157064169|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
157064170|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
157064171|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
157064172|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
157064173|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
157064174|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
157064175|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
157064176|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
157064177|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
157064178|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
157064179|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
157064180|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
157064181|NCT01664923|566990901|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
157064182|NCT01664923|566990902|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
157064183|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
157064184|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
157064185|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
157064186|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
157064187|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
157064188|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
157064189|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
157064190|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
157064191|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
157064192|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
157064193|NCT01664923|566990901|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
157064194|NCT01664923|566990902|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
157064195|NCT01336205|566990903|FG000|Overall Study|Other|22|||
157064196|NCT01336205|566990904|FG001|Overall Study|Other|9|||
157064197|NCT01336205|566990903|FG000|Overall Study|Lost to Follow-up|40|||
157064198|NCT01336205|566990904|FG001|Overall Study|Lost to Follow-up|20|||
157064199|NCT01336205|566990903|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
157064200|NCT01336205|566990904|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
157064201|NCT01336205|566990903|FG000|Overall Study|Lack of Efficacy|4|||
157064202|NCT01336205|566990904|FG001|Overall Study|Lack of Efficacy|0|||
157064203|NCT01336205|566990903|FG000|Overall Study|Severe noncompliance with protocol|9|||
157064204|NCT01336205|566990904|FG001|Overall Study|Severe noncompliance with protocol|2|||
157064205|NCT01336205|566990903|FG000|Overall Study|Adverse Event|56|||
157064206|NCT01336205|566990904|FG001|Overall Study|Adverse Event|6|||
157064207|NCT01336205|566990903|FG000|Overall Study|Death|1|||
157064208|NCT01336205|566990904|FG001|Overall Study|Death|1|||
157064209|NCT01336205|566990903|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
157064210|NCT01336205|566990904|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
157064211|NCT01336205|566990903|FG000|Overall Study|Withdrawal by Subject|72|||
157064212|NCT01336205|566990904|FG001|Overall Study|Withdrawal by Subject|38|||
157064213|NCT01336205|566990903|FG000|Overall Study|Did not receive treatment|4|||
157064214|NCT01336205|566990904|FG001|Overall Study|Did not receive treatment|0|||
157064215|NCT00937521|566990909|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064216|NCT00937521|566990910|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064217|NCT00937521|566990911|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
157064218|NCT00937521|566990912|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064219|NCT00937521|566990913|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064220|NCT00937521|566990914|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064221|NCT00937521|566990915|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
157064222|NCT00937521|566990916|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
157064223|NCT00937521|566990909|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
157064224|NCT00937521|566990910|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
157064225|NCT00937521|566990911|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
157064226|NCT00937521|566990912|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
157064227|NCT00937521|566990913|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
157064228|NCT00937521|566990914|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
157064229|NCT00937521|566990915|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
157064230|NCT00937521|566990916|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
157064231|NCT00937521|566990909|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064232|NCT00937521|566990910|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064233|NCT00937521|566990911|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
157064234|NCT00937521|566990912|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
157064235|NCT00937521|566990913|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064236|NCT00937521|566990914|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064237|NCT00937521|566990915|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064238|NCT00937521|566990916|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
157064239|NCT00937521|566990909|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
157064240|NCT00937521|566990910|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
157064241|NCT00937521|566990911|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
157064242|NCT00937521|566990912|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
157064243|NCT00937521|566990913|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
157064244|NCT00937521|566990914|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
157064245|NCT00937521|566990915|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
157064246|NCT00937521|566990916|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
157064247|NCT00937521|566990909|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
157064248|NCT00937521|566990910|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064249|NCT00937521|566990911|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064250|NCT00937521|566990912|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064251|NCT00937521|566990913|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064252|NCT00937521|566990914|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064253|NCT00937521|566990915|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
157064254|NCT00937521|566990916|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
157064255|NCT00937521|566990909|FG000|Booster Phase|Adverse Event|0|||
157064256|NCT00937521|566990910|FG001|Booster Phase|Adverse Event|0|||
157064257|NCT00937521|566990911|FG002|Booster Phase|Adverse Event|0|||
157064258|NCT00937521|566990912|FG003|Booster Phase|Adverse Event|0|||
157064259|NCT00937521|566990913|FG004|Booster Phase|Adverse Event|0|||
157064260|NCT00937521|566990914|FG005|Booster Phase|Adverse Event|0|||
157064261|NCT00937521|566990915|FG006|Booster Phase|Adverse Event|1|||
157064262|NCT00937521|566990916|FG007|Booster Phase|Adverse Event|0|||
157064263|NCT00937521|566990909|FG000|Booster Phase|Withdrawal by Subject|1|||
157064264|NCT00937521|566990910|FG001|Booster Phase|Withdrawal by Subject|0|||
157064265|NCT00937521|566990911|FG002|Booster Phase|Withdrawal by Subject|0|||
157064266|NCT00937521|566990912|FG003|Booster Phase|Withdrawal by Subject|1|||
157064267|NCT00937521|566990913|FG004|Booster Phase|Withdrawal by Subject|0|||
157064268|NCT00937521|566990914|FG005|Booster Phase|Withdrawal by Subject|0|||
157064269|NCT00937521|566990915|FG006|Booster Phase|Withdrawal by Subject|0|||
157064270|NCT00937521|566990916|FG007|Booster Phase|Withdrawal by Subject|2|||
157064271|NCT00937521|566990909|FG000|Booster Phase|Lost to Follow-up|2|||
157064272|NCT00937521|566990910|FG001|Booster Phase|Lost to Follow-up|2|||
157064273|NCT00937521|566990911|FG002|Booster Phase|Lost to Follow-up|4|||
157064274|NCT00937521|566990912|FG003|Booster Phase|Lost to Follow-up|2|||
157064275|NCT00937521|566990913|FG004|Booster Phase|Lost to Follow-up|4|||
157064276|NCT00937521|566990914|FG005|Booster Phase|Lost to Follow-up|4|||
157064277|NCT00937521|566990915|FG006|Booster Phase|Lost to Follow-up|3|||
157064278|NCT00937521|566990916|FG007|Booster Phase|Lost to Follow-up|0|||
157064279|NCT00937521|566990909|FG000|Booster Phase|Administrative Reason|0|||
157064280|NCT00937521|566990910|FG001|Booster Phase|Administrative Reason|0|||
157064281|NCT00937521|566990911|FG002|Booster Phase|Administrative Reason|1|||
157064282|NCT00937521|566990912|FG003|Booster Phase|Administrative Reason|0|||
157064283|NCT00937521|566990913|FG004|Booster Phase|Administrative Reason|1|||
157064284|NCT00937521|566990914|FG005|Booster Phase|Administrative Reason|1|||
157064285|NCT00937521|566990915|FG006|Booster Phase|Administrative Reason|0|||
157064286|NCT00937521|566990916|FG007|Booster Phase|Administrative Reason|0|||
157064287|NCT00937521|566990909|FG000|Booster Phase|Protocol Deviation|0|||
157064288|NCT00937521|566990910|FG001|Booster Phase|Protocol Deviation|0|||
157064289|NCT00937521|566990911|FG002|Booster Phase|Protocol Deviation|0|||
157064290|NCT00937521|566990912|FG003|Booster Phase|Protocol Deviation|0|||
157064291|NCT00937521|566990913|FG004|Booster Phase|Protocol Deviation|0|||
157064292|NCT00937521|566990914|FG005|Booster Phase|Protocol Deviation|0|||
157064293|NCT00937521|566990915|FG006|Booster Phase|Protocol Deviation|1|||
157064294|NCT00937521|566990916|FG007|Booster Phase|Protocol Deviation|0|||
157064295|NCT04035577|566990917|FG000|Overall Study|Lost to Follow-up|1|||
157064296|NCT04035577|566990917|FG000|Overall Study|Withdrawal by Subject|1|||
157064297|NCT00505414|566990918|FG000|Titration Phase|Adverse Event|0|||
157064298|NCT00505414|566990919|FG001|Titration Phase|Adverse Event|0|||
157064299|NCT00505414|566990920|FG002|Titration Phase|Adverse Event|0|||
157064300|NCT00505414|566990921|FG003|Titration Phase|Adverse Event|8|||
157064301|NCT00505414|566990922|FG004|Titration Phase|Adverse Event|3|||
157064302|NCT00505414|566990918|FG000|Titration Phase|Death|0|||
157064303|NCT00505414|566990919|FG001|Titration Phase|Death|0|||
157064304|NCT00505414|566990920|FG002|Titration Phase|Death|0|||
157064305|NCT00505414|566990921|FG003|Titration Phase|Death|2|||
157064306|NCT00505414|566990922|FG004|Titration Phase|Death|0|||
157064307|NCT00505414|566990918|FG000|Titration Phase|Lack of Efficacy|0|||
157064308|NCT00505414|566990919|FG001|Titration Phase|Lack of Efficacy|0|||
157064309|NCT00505414|566990920|FG002|Titration Phase|Lack of Efficacy|0|||
157064310|NCT00505414|566990921|FG003|Titration Phase|Lack of Efficacy|10|||
157064311|NCT00505414|566990922|FG004|Titration Phase|Lack of Efficacy|1|||
157064312|NCT00505414|566990918|FG000|Titration Phase|Protocol Violation|0|||
157064313|NCT00505414|566990919|FG001|Titration Phase|Protocol Violation|0|||
157064314|NCT00505414|566990920|FG002|Titration Phase|Protocol Violation|0|||
157064315|NCT00505414|566990921|FG003|Titration Phase|Protocol Violation|0|||
157064316|NCT00505414|566990922|FG004|Titration Phase|Protocol Violation|1|||
157064317|NCT00505414|566990918|FG000|Titration Phase|Withdrawal by Subject|0|||
157064318|NCT00505414|566990919|FG001|Titration Phase|Withdrawal by Subject|0|||
157064319|NCT00505414|566990920|FG002|Titration Phase|Withdrawal by Subject|0|||
157064320|NCT00505414|566990921|FG003|Titration Phase|Withdrawal by Subject|3|||
157064321|NCT00505414|566990922|FG004|Titration Phase|Withdrawal by Subject|4|||
157064322|NCT00505414|566990918|FG000|Titration Phase|Underlying disease and therapy required|0|||
157064323|NCT00505414|566990919|FG001|Titration Phase|Underlying disease and therapy required|0|||
157064324|NCT00505414|566990920|FG002|Titration Phase|Underlying disease and therapy required|0|||
157064325|NCT00505414|566990921|FG003|Titration Phase|Underlying disease and therapy required|7|||
157064326|NCT00505414|566990922|FG004|Titration Phase|Underlying disease and therapy required|3|||
157064327|NCT00505414|566990918|FG000|Maintenance Phase|Adverse Event|2|||
157064328|NCT00505414|566990919|FG001|Maintenance Phase|Adverse Event|2|||
157064329|NCT00505414|566990920|FG002|Maintenance Phase|Adverse Event|3|||
157064330|NCT00505414|566990921|FG003|Maintenance Phase|Adverse Event|0|||
157064331|NCT00505414|566990922|FG004|Maintenance Phase|Adverse Event|0|||
157064332|NCT00505414|566990918|FG000|Maintenance Phase|Death|2|||
157064333|NCT00505414|566990919|FG001|Maintenance Phase|Death|0|||
157064334|NCT00505414|566990920|FG002|Maintenance Phase|Death|1|||
157064335|NCT00505414|566990921|FG003|Maintenance Phase|Death|0|||
157064336|NCT00505414|566990922|FG004|Maintenance Phase|Death|0|||
157064337|NCT00505414|566990918|FG000|Maintenance Phase|Lack of Efficacy|2|||
157064338|NCT00505414|566990919|FG001|Maintenance Phase|Lack of Efficacy|1|||
157064339|NCT00505414|566990920|FG002|Maintenance Phase|Lack of Efficacy|1|||
157064340|NCT00505414|566990921|FG003|Maintenance Phase|Lack of Efficacy|0|||
157064341|NCT00505414|566990922|FG004|Maintenance Phase|Lack of Efficacy|0|||
157064342|NCT00505414|566990918|FG000|Maintenance Phase|Withdrawal by Subject|0|||
157064343|NCT00505414|566990919|FG001|Maintenance Phase|Withdrawal by Subject|0|||
157064344|NCT00505414|566990920|FG002|Maintenance Phase|Withdrawal by Subject|1|||
157064345|NCT00505414|566990921|FG003|Maintenance Phase|Withdrawal by Subject|0|||
157064346|NCT00505414|566990922|FG004|Maintenance Phase|Withdrawal by Subject|0|||
157064347|NCT00505414|566990918|FG000|Maintenance Phase|underlying disease and therapy required|0|||
157064348|NCT00505414|566990919|FG001|Maintenance Phase|underlying disease and therapy required|2|||
157064349|NCT00505414|566990920|FG002|Maintenance Phase|underlying disease and therapy required|2|||
157064350|NCT00505414|566990921|FG003|Maintenance Phase|underlying disease and therapy required|0|||
157064351|NCT00505414|566990922|FG004|Maintenance Phase|underlying disease and therapy required|0|||
157064352|NCT00846768|566990923|FG000|Overall Study|Adverse Event|0|||
157064353|NCT00846768|566990924|FG001|Overall Study|Adverse Event|1|||
157064354|NCT00846768|566990925|FG002|Overall Study|Adverse Event|0|||
157064355|NCT00846768|566990926|FG003|Overall Study|Adverse Event|0|||
157064356|NCT04358068|566990927|FG000|Overall Study|Did not initiate study treatment|2|||
157064357|NCT04358068|566990928|FG001|Overall Study|Did not initiate study treatment|2|||
157064358|NCT00338949|566990929|FG000|Subject Screening|Screen failures|11|||
157064359|NCT00338949|566990930|FG001|Subject Screening|Screen failures|11|||
157064360|NCT00338949|566990929|FG000|Randomization|Withdrawal by Subject|1|||
157064361|NCT00338949|566990930|FG001|Randomization|Withdrawal by Subject|0|||
157064362|NCT00338949|566990929|FG000|Randomization|Adverse Event|0|||
157064363|NCT00338949|566990930|FG001|Randomization|Adverse Event|5|||
157064364|NCT03517111|566990931|FG000|Enrolled|Withdrawal by Subject|0|||
157064365|NCT03517111|566990932|FG001|Enrolled|Withdrawal by Subject|1|||
157064366|NCT03517111|566990933|FG002|Enrolled|Withdrawal by Subject|0|||
157064367|NCT03517111|566990931|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
157064368|NCT03517111|566990932|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
157064369|NCT03517111|566990933|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
157064370|NCT03517111|566990931|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
157064371|NCT03517111|566990932|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
157064372|NCT03517111|566990933|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
157064373|NCT03517111|566990931|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
157230063|NCT00162123|567588220|FG000|Overall Study|Tumor assessment only (not treated)|0|||
157230064|NCT00162123|567588221|FG001|Overall Study|Tumor assessment only (not treated)|0|||
157230065|NCT00162123|567588222|FG002|Overall Study|Tumor assessment only (not treated)|0|||
157064374|NCT03517111|566990932|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
157230066|NCT00162123|567588223|FG003|Overall Study|Tumor assessment only (not treated)|0|||
157064375|NCT03517111|566990933|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
157064376|NCT03517111|566990931|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
157064377|NCT03517111|566990932|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
157064378|NCT03517111|566990933|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
157064379|NCT00912223|566990934|FG000|Overall Study|Withdrawal by Subject|1|||
157064380|NCT00912223|566990934|FG000|Overall Study|Not transplanted|1|||
157064381|NCT00912223|566990934|FG000|Overall Study|Transformed disease|1|||
157064382|NCT03188536|566990935|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
157064383|NCT03188536|566990935|FG000|Overall Study|Not participated/met inclusion criteria|1|||
157064384|NCT01930214|566990936|FG000|Overall Study|Death|4|||
157064385|NCT01930214|566990937|FG001|Overall Study|Death|4|||
157064386|NCT01930214|566990938|FG002|Overall Study|Death|11|||
157064387|NCT01930214|566990936|FG000|Overall Study|Lost to Follow-up|12|||
157064388|NCT01930214|566990937|FG001|Overall Study|Lost to Follow-up|13|||
157064389|NCT01930214|566990938|FG002|Overall Study|Lost to Follow-up|12|||
157064390|NCT01930214|566990936|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
157064391|NCT01930214|566990937|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
157064392|NCT01930214|566990938|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
157064393|NCT01930214|566990936|FG000|Overall Study|Physician Decision|2|||
157064394|NCT01930214|566990937|FG001|Overall Study|Physician Decision|0|||
157064395|NCT01930214|566990938|FG002|Overall Study|Physician Decision|0|||
157064396|NCT02601209|566990939|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
157064397|NCT02601209|566990940|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
157064398|NCT02601209|566990941|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
157064399|NCT02601209|566990942|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064400|NCT02601209|566990943|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064401|NCT02601209|566990944|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064402|NCT02601209|566990945|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064403|NCT02601209|566990946|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064404|NCT02601209|566990947|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
157064405|NCT02601209|566990939|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064406|NCT02601209|566990940|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064407|NCT02601209|566990941|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064408|NCT02601209|566990942|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064409|NCT02601209|566990943|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
157064410|NCT02601209|566990944|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
157064411|NCT02601209|566990945|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
157064412|NCT02601209|566990946|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064413|NCT02601209|566990947|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
157064414|NCT02261285|566990950|FG000|Overall Study|Disease progression|0|||
157064415|NCT02261285|566990951|FG001|Overall Study|Disease progression|0|||
157064416|NCT02261285|566990952|FG002|Overall Study|Disease progression|1|||
157064417|NCT00927901|566990953|FG000|Treatment Period 1|Subject withdrew consent|0|||
157064418|NCT00927901|566990954|FG001|Treatment Period 1|Subject withdrew consent|0|||
157064419|NCT00927901|566990955|FG002|Treatment Period 1|Subject withdrew consent|1|||
157064420|NCT00927901|566990956|FG003|Treatment Period 1|Subject withdrew consent|0|||
157064421|NCT00927901|566990953|FG000|Treatment Period 4|Adverse Event|0|||
157064422|NCT00927901|566990954|FG001|Treatment Period 4|Adverse Event|0|||
157064423|NCT00927901|566990955|FG002|Treatment Period 4|Adverse Event|0|||
157064424|NCT00927901|566990956|FG003|Treatment Period 4|Adverse Event|1|||
157064425|NCT00927901|566990953|FG000|Treatment Period 4|Subject withdrew consent|0|||
157064426|NCT00927901|566990954|FG001|Treatment Period 4|Subject withdrew consent|0|||
157064427|NCT00927901|566990955|FG002|Treatment Period 4|Subject withdrew consent|1|||
157064428|NCT00927901|566990956|FG003|Treatment Period 4|Subject withdrew consent|0|||
157064429|NCT02344173|566990957|FG000|Procedure|Ablation Procedure Not Performed|7|||
157064430|NCT02344173|566990957|FG000|12-month Visit|Death|8|||
157064431|NCT02344173|566990957|FG000|12-month Visit|Withdrawal by Subject|30|||
157064432|NCT02344173|566990957|FG000|12-month Visit|Lost to Follow-up|58|||
157064433|NCT01349036|566990958|FG000|Overall Study|Disease progression|13|||
157064434|NCT01349036|566990959|FG001|Overall Study|Disease progression|22|||
157064435|NCT01349036|566990958|FG000|Overall Study|Other|1|||
157064436|NCT01349036|566990959|FG001|Overall Study|Other|0|||
157064437|NCT01349036|566990958|FG000|Overall Study|Withdrawal by Subject|0|||
157064438|NCT01349036|566990959|FG001|Overall Study|Withdrawal by Subject|2|||
157064439|NCT01161628|566990960|FG000|Overall Study|Death|6|||
157064440|NCT01161628|566990960|FG000|Overall Study|Lack of Efficacy|2|||
157064441|NCT00746356|566990965|FG000|Overall Study|Withdrawal by Subject|2|||
157064442|NCT00746356|566990966|FG001|Overall Study|Withdrawal by Subject|3|||
157064443|NCT00746356|566990965|FG000|Overall Study|Death|7|||
157064444|NCT00746356|566990966|FG001|Overall Study|Death|3|||
157064445|NCT00746356|566990965|FG000|Overall Study|Lost to Follow-up|1|||
157064446|NCT00746356|566990966|FG001|Overall Study|Lost to Follow-up|0|||
157064447|NCT00746356|566990965|FG000|Overall Study|Removal of Device|0|||
157184467|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
157184468|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
157184469|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
157184470|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
157184471|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
157184472|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
157184473|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
157184474|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
157184475|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
157184476|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
157184477|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
157184478|NCT03728881|567417931|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
157184479|NCT03728881|567417932|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
157184480|NCT03728881|567417931|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
157184481|NCT03728881|567417932|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
157184482|NCT03728881|567417931|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
157184483|NCT03728881|567417932|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
157184484|NCT04517253|567417935|FG000|Primary Treatment Period|Adverse Event|1|||
157184485|NCT04517253|567417936|FG001|Primary Treatment Period|Adverse Event|0|||
157184486|NCT04517253|567417937|FG002|Primary Treatment Period|Adverse Event|0|||
157184487|NCT04517253|567417935|FG000|Primary Treatment Period|Death|0|||
157184488|NCT04517253|567417936|FG001|Primary Treatment Period|Death|1|||
157184489|NCT04517253|567417937|FG002|Primary Treatment Period|Death|0|||
157184490|NCT04517253|567417935|FG000|Maintenance Period|Withdrawal by Subject|1|||
157184491|NCT04517253|567417936|FG001|Maintenance Period|Withdrawal by Subject|0|||
157184492|NCT04517253|567417937|FG002|Maintenance Period|Withdrawal by Subject|0|||
157184493|NCT04517253|567417935|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
157184494|NCT04517253|567417936|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
157184495|NCT04517253|567417937|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
157184496|NCT06048367|567417938|FG000|Overall Study|Withdrawal by Subject|0|||
157184497|NCT06048367|567417939|FG001|Overall Study|Withdrawal by Subject|1|||
157184498|NCT06048367|567417940|FG002|Overall Study|Withdrawal by Subject|0|||
157184499|NCT06048367|567417941|FG003|Overall Study|Withdrawal by Subject|0|||
157184500|NCT06048367|567417942|FG004|Overall Study|Withdrawal by Subject|0|||
157184501|NCT06048367|567417938|FG000|Overall Study|Withdrawal by Subject|0|||
157184502|NCT06048367|567417939|FG001|Overall Study|Withdrawal by Subject|0|||
157184503|NCT06048367|567417940|FG002|Overall Study|Withdrawal by Subject|1|||
157184504|NCT06048367|567417941|FG003|Overall Study|Withdrawal by Subject|0|||
157184505|NCT06048367|567417942|FG004|Overall Study|Withdrawal by Subject|0|||
157184506|NCT06048367|567417938|FG000|Overall Study|Withdrawal by Subject|0|||
157184507|NCT06048367|567417939|FG001|Overall Study|Withdrawal by Subject|0|||
157184508|NCT06048367|567417940|FG002|Overall Study|Withdrawal by Subject|0|||
157184509|NCT06048367|567417941|FG003|Overall Study|Withdrawal by Subject|1|||
157184510|NCT06048367|567417942|FG004|Overall Study|Withdrawal by Subject|0|||
157184511|NCT06048367|567417938|FG000|Overall Study|Withdrawal by Subject|0|||
157184512|NCT06048367|567417939|FG001|Overall Study|Withdrawal by Subject|0|||
157184513|NCT06048367|567417940|FG002|Overall Study|Withdrawal by Subject|0|||
157184514|NCT06048367|567417941|FG003|Overall Study|Withdrawal by Subject|1|||
157184515|NCT06048367|567417942|FG004|Overall Study|Withdrawal by Subject|0|||
157184516|NCT04088331|567417943|FG000|Overall Study|Lost to Follow-up|3|||
157184517|NCT04088331|567417943|FG000|Overall Study|Withdrawal by Subject|7|||
157184518|NCT04088331|567417943|FG000|Overall Study|Adverse Event|4|||
157184519|NCT03598140|567417944|FG000|Overall Study|enrolled but didn't start|1|||
157184520|NCT03598140|567417945|FG001|Overall Study|enrolled but didn't start|0|||
157184521|NCT02060903|567417949|FG000|Overall Study|Lost to Follow-up|4|||
157184522|NCT02060903|567417950|FG001|Overall Study|Lost to Follow-up|0|||
157184523|NCT02060903|567417949|FG000|Overall Study|Withdrawal by Subject|0|||
157184524|NCT02060903|567417950|FG001|Overall Study|Withdrawal by Subject|7|||
157184525|NCT01266876|567417951|FG000|Overall Study|Adverse Event|0|||
157184526|NCT01266876|567417952|FG001|Overall Study|Adverse Event|0|||
157184527|NCT01266876|567417953|FG002|Overall Study|Adverse Event|0|||
157184528|NCT01266876|567417954|FG003|Overall Study|Adverse Event|1|||
157184529|NCT01266876|567417955|FG004|Overall Study|Adverse Event|0|||
157184530|NCT05016037|567417957|FG000|Overall Study|Lost to Follow-up|2|||
157184531|NCT03575351|567417958|FG000|Overall Study|Adverse Event|1|||
157184532|NCT03575351|567417959|FG001|Overall Study|Adverse Event|0|||
157184533|NCT03575351|567417958|FG000|Overall Study|Death|2|||
157184534|NCT03575351|567417959|FG001|Overall Study|Death|2|||
157184535|NCT03575351|567417958|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
157184536|NCT03575351|567417959|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
157230067|NCT00162123|567588224|FG004|Overall Study|Tumor assessment only (not treated)|0|||
157230068|NCT00162123|567588225|FG005|Overall Study|Tumor assessment only (not treated)|0|||
157184537|NCT03575351|567417958|FG000|Overall Study|Lack of Efficacy|28|||
157184538|NCT03575351|567417959|FG001|Overall Study|Lack of Efficacy|0|||
157184539|NCT03575351|567417958|FG000|Overall Study|Withdrawal by Subject|1|||
157230069|NCT00162123|567588226|FG006|Overall Study|Tumor assessment only (not treated)|0|||
157230070|NCT00162123|567588227|FG007|Overall Study|Tumor assessment only (not treated)|1|||
157230071|NCT00162123|567588220|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
157230072|NCT00162123|567588221|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
157230073|NCT00162123|567588222|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
157230074|NCT00162123|567588223|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
157230075|NCT00162123|567588224|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
157184540|NCT03575351|567417959|FG001|Overall Study|Withdrawal by Subject|1|||
157184541|NCT03575351|567417958|FG000|Overall Study|Physician Decision|3|||
157184542|NCT03575351|567417959|FG001|Overall Study|Physician Decision|0|||
157184543|NCT03575351|567417958|FG000|Overall Study|Disease relapse|15|||
157184544|NCT03575351|567417959|FG001|Overall Study|Disease relapse|6|||
157184545|NCT03575351|567417958|FG000|Overall Study|Study drug manufacturing failure|0|||
157184546|NCT03575351|567417959|FG001|Overall Study|Study drug manufacturing failure|1|||
157184547|NCT03575351|567417958|FG000|Overall Study|other reasons|5|||
157230076|NCT00162123|567588225|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
157230077|NCT00162123|567588226|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
157230078|NCT00162123|567588227|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
156976966|NCT01008475|566669283|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
156976967|NCT01008475|566669284|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
156976968|NCT01008475|566669285|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
156976969|NCT01008475|566669286|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
156976970|NCT01807650|566669293|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
156976971|NCT01807650|566669293|FG000|Overall Study|Adverse Event|5|||
156976972|NCT01807650|566669293|FG000|Overall Study|Other|2|||
156976973|NCT01122381|566669294|FG000|Overall Study|study terminated early|0|||
156976974|NCT01122381|566669295|FG001|Overall Study|study terminated early|1|||
156976975|NCT00736489|566669296|FG000|Period 1|Lost to Follow-up|1|||
156976976|NCT00736489|566669297|FG001|Period 1|Lost to Follow-up|0|||
156976977|NCT00736489|566669298|FG002|Period 1|Lost to Follow-up|0|||
156976978|NCT00736489|566669299|FG003|Period 1|Lost to Follow-up|0|||
156976979|NCT00736489|566669300|FG004|Period 1|Lost to Follow-up|0|||
156976980|NCT00736489|566669301|FG005|Period 1|Lost to Follow-up|0|||
156976981|NCT00736489|566669296|FG000|Period 1|Withdrawal by Subject|0|||
156976982|NCT00736489|566669297|FG001|Period 1|Withdrawal by Subject|0|||
156976983|NCT00736489|566669298|FG002|Period 1|Withdrawal by Subject|0|||
156976984|NCT00736489|566669299|FG003|Period 1|Withdrawal by Subject|0|||
156976985|NCT00736489|566669300|FG004|Period 1|Withdrawal by Subject|0|||
156976986|NCT00736489|566669301|FG005|Period 1|Withdrawal by Subject|1|||
156976987|NCT02395133|566669302|FG000|Overall Study|Adverse Event|4|||
156976988|NCT02395133|566669303|FG001|Overall Study|Adverse Event|1|||
156976989|NCT02395133|566669304|FG002|Overall Study|Adverse Event|3|||
156976990|NCT02395133|566669305|FG003|Overall Study|Adverse Event|0|||
156976991|NCT02395133|566669302|FG000|Overall Study|Lack of Efficacy|1|||
156976992|NCT02395133|566669303|FG001|Overall Study|Lack of Efficacy|0|||
156976993|NCT02395133|566669304|FG002|Overall Study|Lack of Efficacy|1|||
156976994|NCT02395133|566669305|FG003|Overall Study|Lack of Efficacy|1|||
156976995|NCT02395133|566669302|FG000|Overall Study|Protocol Violation|1|||
156976996|NCT02395133|566669303|FG001|Overall Study|Protocol Violation|1|||
156976997|NCT02395133|566669304|FG002|Overall Study|Protocol Violation|0|||
156976998|NCT02395133|566669305|FG003|Overall Study|Protocol Violation|3|||
156976999|NCT02395133|566669302|FG000|Overall Study|Lost to Follow-up|0|||
156977000|NCT02395133|566669303|FG001|Overall Study|Lost to Follow-up|1|||
156977001|NCT02395133|566669304|FG002|Overall Study|Lost to Follow-up|1|||
156977002|NCT02395133|566669305|FG003|Overall Study|Lost to Follow-up|0|||
156977003|NCT02395133|566669302|FG000|Overall Study|Pregnancy|0|||
156977004|NCT02395133|566669303|FG001|Overall Study|Pregnancy|0|||
156977005|NCT02395133|566669304|FG002|Overall Study|Pregnancy|3|||
156977006|NCT02395133|566669305|FG003|Overall Study|Pregnancy|0|||
157064448|NCT00746356|566990966|FG001|Overall Study|Removal of Device|1|||
157184548|NCT03575351|567417959|FG001|Overall Study|other reasons|0|||
157230079|NCT02016170|567588228|FG000|Overall Study|Adverse Event|1|||
156977007|NCT02395133|566669302|FG000|Overall Study|Consent withdrawn with no reason given|1|||
156977008|NCT02395133|566669303|FG001|Overall Study|Consent withdrawn with no reason given|3|||
157064449|NCT00746356|566990965|FG000|Overall Study|Patient relocated|1|||
156977009|NCT02395133|566669304|FG002|Overall Study|Consent withdrawn with no reason given|0|||
156977010|NCT02395133|566669305|FG003|Overall Study|Consent withdrawn with no reason given|2|||
156977011|NCT02395133|566669302|FG000|Overall Study|Consent withdrawn with personal reason|0|||
157184549|NCT04288089|567417960|FG000|Overall Study|Ongoing Treatment|2|||
157184550|NCT04288089|567417961|FG001|Overall Study|Ongoing Treatment|1|||
157230080|NCT02016170|567588229|FG001|Overall Study|Adverse Event|1|||
157064450|NCT00746356|566990966|FG001|Overall Study|Patient relocated|0|||
157064451|NCT01263925|566990967|FG000|Overall Study|Protocol Violation|1|||
157064452|NCT01263925|566990968|FG001|Overall Study|Protocol Violation|0|||
157064453|NCT01263925|566990967|FG000|Overall Study|Lack of Efficacy|0|||
157064454|NCT01263925|566990968|FG001|Overall Study|Lack of Efficacy|1|||
157064455|NCT01263925|566990967|FG000|Overall Study|Adverse Event|23|||
157064456|NCT01263925|566990968|FG001|Overall Study|Adverse Event|22|||
157064457|NCT01263925|566990967|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
157064458|NCT01263925|566990968|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
157064459|NCT01263925|566990967|FG000|Overall Study|Withdrawal by Subject|6|||
157064460|NCT01263925|566990968|FG001|Overall Study|Withdrawal by Subject|8|||
157064461|NCT01263925|566990967|FG000|Overall Study|Other|4|||
157064462|NCT01263925|566990968|FG001|Overall Study|Other|4|||
157064463|NCT01263925|566990967|FG000|Overall Study|Lost to Follow-up|3|||
157064464|NCT01263925|566990968|FG001|Overall Study|Lost to Follow-up|1|||
157064465|NCT01263925|566990967|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
157064466|NCT01263925|566990968|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
157064467|NCT01263925|566990967|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
157064468|NCT01263925|566990968|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
157064469|NCT01263925|566990967|FG000|Overall Study|AE/ Withdrawal|1|||
157064470|NCT01263925|566990968|FG001|Overall Study|AE/ Withdrawal|4|||
157064471|NCT01263925|566990967|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
157064472|NCT01263925|566990968|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
157064473|NCT01263925|566990967|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
157064474|NCT01263925|566990968|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
157064475|NCT01263925|566990967|FG000|Overall Study|Withdrawal/ Not specified|0|||
157064476|NCT01263925|566990968|FG001|Overall Study|Withdrawal/ Not specified|1|||
157064477|NCT03605368|566990969|FG000|Overall Study|Lost to Follow-up|2|||
157064478|NCT03605368|566990970|FG001|Overall Study|Lost to Follow-up|1|||
157064479|NCT03605368|566990971|FG002|Overall Study|Lost to Follow-up|3|||
157064480|NCT03605368|566990972|FG003|Overall Study|Lost to Follow-up|2|||
157064481|NCT03605368|566990969|FG000|Overall Study|Withdrawal by Subject|0|||
157064482|NCT03605368|566990970|FG001|Overall Study|Withdrawal by Subject|0|||
157064483|NCT03605368|566990971|FG002|Overall Study|Withdrawal by Subject|4|||
157064484|NCT03605368|566990972|FG003|Overall Study|Withdrawal by Subject|3|||
157064485|NCT02970305|566990979|FG000|Overall Study|Adverse Event|10|||
157064486|NCT02970305|566990980|FG001|Overall Study|Adverse Event|6|||
157064487|NCT02970305|566990979|FG000|Overall Study|Lack of Efficacy|1|||
157064488|NCT02970305|566990980|FG001|Overall Study|Lack of Efficacy|1|||
157064489|NCT02970305|566990979|FG000|Overall Study|Noncompliance with study drug|2|||
157064490|NCT02970305|566990980|FG001|Overall Study|Noncompliance with study drug|4|||
157064491|NCT02970305|566990979|FG000|Overall Study|Protocol Violation|2|||
157064492|NCT02970305|566990980|FG001|Overall Study|Protocol Violation|2|||
157064493|NCT02970305|566990979|FG000|Overall Study|Withdrawal by Subject|12|||
157064494|NCT02970305|566990980|FG001|Overall Study|Withdrawal by Subject|11|||
157064495|NCT02970305|566990979|FG000|Overall Study|Not further specified|1|||
157064496|NCT02970305|566990980|FG001|Overall Study|Not further specified|2|||
157064497|NCT02970305|566990979|FG000|Overall Study|Lost to Follow-up|1|||
157064498|NCT02970305|566990980|FG001|Overall Study|Lost to Follow-up|2|||
157064499|NCT02881047|566990981|FG000|Overall Study|Adverse Event|1|||
157064500|NCT02881047|566990981|FG000|Overall Study|Withdrawal by Subject|1|||
157064501|NCT02484547|566990988|FG000|Placebo-Controlled Period|Adverse Event|10|||
157064502|NCT02484547|566990989|FG001|Placebo-Controlled Period|Adverse Event|13|||
157064503|NCT02484547|566990990|FG002|Placebo-Controlled Period|Adverse Event|20|||
157064504|NCT02484547|566990991|FG003|Placebo-Controlled Period|Adverse Event|0|||
157064505|NCT02484547|566990992|FG004|Placebo-Controlled Period|Adverse Event|0|||
157064506|NCT02484547|566990993|FG005|Placebo-Controlled Period|Adverse Event|0|||
157064507|NCT02484547|566990994|FG006|Placebo-Controlled Period|Adverse Event|0|||
157064508|NCT02484547|566990988|FG000|Placebo-Controlled Period|Change of Treatment|0|||
157064509|NCT02484547|566990989|FG001|Placebo-Controlled Period|Change of Treatment|0|||
157064510|NCT02484547|566990990|FG002|Placebo-Controlled Period|Change of Treatment|1|||
157064511|NCT02484547|566990991|FG003|Placebo-Controlled Period|Change of Treatment|0|||
157064512|NCT02484547|566990992|FG004|Placebo-Controlled Period|Change of Treatment|0|||
157064513|NCT02484547|566990993|FG005|Placebo-Controlled Period|Change of Treatment|0|||
157064514|NCT02484547|566990994|FG006|Placebo-Controlled Period|Change of Treatment|0|||
157064515|NCT02484547|566990988|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
157064516|NCT02484547|566990989|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
157064517|NCT02484547|566990990|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
157064518|NCT02484547|566990991|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
157064519|NCT02484547|566990992|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
157064520|NCT02484547|566990993|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
157064521|NCT02484547|566990994|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
157064522|NCT02484547|566990988|FG000|Placebo-Controlled Period|Death|5|||
157064523|NCT02484547|566990989|FG001|Placebo-Controlled Period|Death|0|||
157064524|NCT02484547|566990990|FG002|Placebo-Controlled Period|Death|6|||
157064525|NCT02484547|566990991|FG003|Placebo-Controlled Period|Death|0|||
157064526|NCT02484547|566990992|FG004|Placebo-Controlled Period|Death|0|||
157064527|NCT02484547|566990993|FG005|Placebo-Controlled Period|Death|0|||
157064528|NCT02484547|566990994|FG006|Placebo-Controlled Period|Death|0|||
157064529|NCT02484547|566990988|FG000|Placebo-Controlled Period|Disease Progression|2|||
157064530|NCT02484547|566990989|FG001|Placebo-Controlled Period|Disease Progression|0|||
157064531|NCT02484547|566990990|FG002|Placebo-Controlled Period|Disease Progression|1|||
157064532|NCT02484547|566990991|FG003|Placebo-Controlled Period|Disease Progression|0|||
157064533|NCT02484547|566990992|FG004|Placebo-Controlled Period|Disease Progression|0|||
157064534|NCT02484547|566990993|FG005|Placebo-Controlled Period|Disease Progression|0|||
157064535|NCT02484547|566990994|FG006|Placebo-Controlled Period|Disease Progression|0|||
157064536|NCT02484547|566990988|FG000|Placebo-Controlled Period|Investigator Decision|2|||
157064537|NCT02484547|566990989|FG001|Placebo-Controlled Period|Investigator Decision|2|||
157064538|NCT02484547|566990990|FG002|Placebo-Controlled Period|Investigator Decision|5|||
157064539|NCT02484547|566990991|FG003|Placebo-Controlled Period|Investigator Decision|0|||
157064540|NCT02484547|566990992|FG004|Placebo-Controlled Period|Investigator Decision|0|||
157064541|NCT02484547|566990993|FG005|Placebo-Controlled Period|Investigator Decision|0|||
157064542|NCT02484547|566990994|FG006|Placebo-Controlled Period|Investigator Decision|0|||
157064543|NCT02484547|566990988|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
157064544|NCT02484547|566990989|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
157064545|NCT02484547|566990990|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
157064546|NCT02484547|566990991|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
157064547|NCT02484547|566990992|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
157064548|NCT02484547|566990993|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
157064549|NCT02484547|566990994|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
157064550|NCT02484547|566990988|FG000|Placebo-Controlled Period|Relocation|1|||
157064551|NCT02484547|566990989|FG001|Placebo-Controlled Period|Relocation|1|||
157064552|NCT02484547|566990990|FG002|Placebo-Controlled Period|Relocation|1|||
157064553|NCT02484547|566990991|FG003|Placebo-Controlled Period|Relocation|0|||
157064554|NCT02484547|566990992|FG004|Placebo-Controlled Period|Relocation|0|||
157064555|NCT02484547|566990993|FG005|Placebo-Controlled Period|Relocation|0|||
157064556|NCT02484547|566990994|FG006|Placebo-Controlled Period|Relocation|0|||
157064557|NCT02484547|566990988|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
157064558|NCT02484547|566990989|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
157064559|NCT02484547|566990990|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
157064560|NCT02484547|566990991|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
157064561|NCT02484547|566990992|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
157064562|NCT02484547|566990993|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
157064563|NCT02484547|566990994|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
157064564|NCT02484547|566990988|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
157064565|NCT02484547|566990989|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
157064566|NCT02484547|566990990|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
157064567|NCT02484547|566990991|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157064568|NCT02484547|566990992|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157064569|NCT02484547|566990993|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157064570|NCT02484547|566990994|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157064571|NCT02484547|566990988|FG000|Placebo-Controlled Period|Reason not Specified|216|||
157064572|NCT02484547|566990989|FG001|Placebo-Controlled Period|Reason not Specified|194|||
157064573|NCT02484547|566990990|FG002|Placebo-Controlled Period|Reason not Specified|183|||
157064574|NCT02484547|566990991|FG003|Placebo-Controlled Period|Reason not Specified|0|||
157064575|NCT02484547|566990992|FG004|Placebo-Controlled Period|Reason not Specified|0|||
157064576|NCT02484547|566990993|FG005|Placebo-Controlled Period|Reason not Specified|0|||
157064577|NCT02484547|566990994|FG006|Placebo-Controlled Period|Reason not Specified|0|||
157064578|NCT02484547|566990988|FG000|Long-Term Extension Period|Adverse Event|0|||
157064579|NCT02484547|566990989|FG001|Long-Term Extension Period|Adverse Event|0|||
157064580|NCT02484547|566990990|FG002|Long-Term Extension Period|Adverse Event|0|||
157064581|NCT02484547|566990991|FG003|Long-Term Extension Period|Adverse Event|0|||
157184551|NCT04288089|567417962|FG002|Overall Study|Ongoing Treatment|1|||
157064582|NCT02484547|566990992|FG004|Long-Term Extension Period|Adverse Event|1|||
157064583|NCT02484547|566990993|FG005|Long-Term Extension Period|Adverse Event|3|||
157064584|NCT02484547|566990994|FG006|Long-Term Extension Period|Adverse Event|2|||
157064585|NCT02484547|566990988|FG000|Long-Term Extension Period|Death|0|||
157064586|NCT02484547|566990989|FG001|Long-Term Extension Period|Death|0|||
157064587|NCT02484547|566990990|FG002|Long-Term Extension Period|Death|0|||
157064588|NCT02484547|566990991|FG003|Long-Term Extension Period|Death|0|||
157064589|NCT02484547|566990992|FG004|Long-Term Extension Period|Death|0|||
157064590|NCT02484547|566990993|FG005|Long-Term Extension Period|Death|3|||
157064591|NCT02484547|566990994|FG006|Long-Term Extension Period|Death|0|||
157064592|NCT02484547|566990988|FG000|Long-Term Extension Period|Disease Progression|0|||
157064593|NCT02484547|566990989|FG001|Long-Term Extension Period|Disease Progression|0|||
157184552|NCT04288089|567417963|FG003|Overall Study|Ongoing Treatment|4|||
157184553|NCT03715205|567417964|FG000|Overall Study|Death|13|||
157184554|NCT03715205|567417964|FG000|Overall Study|Lost to Follow-up|2|||
157064594|NCT02484547|566990990|FG002|Long-Term Extension Period|Disease Progression|0|||
157064595|NCT02484547|566990991|FG003|Long-Term Extension Period|Disease Progression|0|||
157064596|NCT02484547|566990992|FG004|Long-Term Extension Period|Disease Progression|2|||
157064597|NCT02484547|566990993|FG005|Long-Term Extension Period|Disease Progression|4|||
157064598|NCT02484547|566990994|FG006|Long-Term Extension Period|Disease Progression|0|||
157064599|NCT02484547|566990988|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
157064600|NCT02484547|566990989|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
157064601|NCT02484547|566990990|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
157064602|NCT02484547|566990991|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
157064603|NCT02484547|566990992|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
157064604|NCT02484547|566990993|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
157064605|NCT02484547|566990994|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
157064606|NCT02484547|566990988|FG000|Long-Term Extension Period|Loss of Capacity|0|||
157064607|NCT02484547|566990989|FG001|Long-Term Extension Period|Loss of Capacity|0|||
157064608|NCT02484547|566990990|FG002|Long-Term Extension Period|Loss of Capacity|0|||
157064609|NCT02484547|566990991|FG003|Long-Term Extension Period|Loss of Capacity|0|||
157064610|NCT02484547|566990992|FG004|Long-Term Extension Period|Loss of Capacity|1|||
157064611|NCT02484547|566990993|FG005|Long-Term Extension Period|Loss of Capacity|0|||
157064612|NCT02484547|566990994|FG006|Long-Term Extension Period|Loss of Capacity|0|||
157064613|NCT02484547|566990988|FG000|Long-Term Extension Period|Change of Treatment|0|||
157064614|NCT02484547|566990989|FG001|Long-Term Extension Period|Change of Treatment|0|||
157064615|NCT02484547|566990990|FG002|Long-Term Extension Period|Change of Treatment|0|||
157064616|NCT02484547|566990991|FG003|Long-Term Extension Period|Change of Treatment|0|||
157064617|NCT02484547|566990992|FG004|Long-Term Extension Period|Change of Treatment|0|||
157064618|NCT02484547|566990993|FG005|Long-Term Extension Period|Change of Treatment|0|||
157064619|NCT02484547|566990994|FG006|Long-Term Extension Period|Change of Treatment|1|||
157064620|NCT02484547|566990988|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
157064621|NCT02484547|566990989|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
157064622|NCT02484547|566990990|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
157064623|NCT02484547|566990991|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
157064624|NCT02484547|566990992|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
157064625|NCT02484547|566990993|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
157064626|NCT02484547|566990994|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
157064627|NCT02484547|566990988|FG000|Long-Term Extension Period|Investigator Decision|0|||
157064628|NCT02484547|566990989|FG001|Long-Term Extension Period|Investigator Decision|0|||
157064629|NCT02484547|566990990|FG002|Long-Term Extension Period|Investigator Decision|0|||
157064630|NCT02484547|566990991|FG003|Long-Term Extension Period|Investigator Decision|2|||
157064631|NCT02484547|566990992|FG004|Long-Term Extension Period|Investigator Decision|1|||
157064632|NCT02484547|566990993|FG005|Long-Term Extension Period|Investigator Decision|0|||
157064633|NCT02484547|566990994|FG006|Long-Term Extension Period|Investigator Decision|1|||
157064634|NCT02484547|566990988|FG000|Long-Term Extension Period|Relocation|0|||
157064635|NCT02484547|566990989|FG001|Long-Term Extension Period|Relocation|0|||
157064636|NCT02484547|566990990|FG002|Long-Term Extension Period|Relocation|0|||
157064637|NCT02484547|566990991|FG003|Long-Term Extension Period|Relocation|1|||
157064638|NCT02484547|566990992|FG004|Long-Term Extension Period|Relocation|1|||
157064639|NCT02484547|566990993|FG005|Long-Term Extension Period|Relocation|0|||
157064640|NCT02484547|566990994|FG006|Long-Term Extension Period|Relocation|0|||
157064641|NCT02484547|566990988|FG000|Long-Term Extension Period|Study Visit Burden|0|||
157064642|NCT02484547|566990989|FG001|Long-Term Extension Period|Study Visit Burden|0|||
157064643|NCT02484547|566990990|FG002|Long-Term Extension Period|Study Visit Burden|0|||
157064644|NCT02484547|566990991|FG003|Long-Term Extension Period|Study Visit Burden|2|||
157064645|NCT02484547|566990992|FG004|Long-Term Extension Period|Study Visit Burden|0|||
157064646|NCT02484547|566990993|FG005|Long-Term Extension Period|Study Visit Burden|0|||
157064647|NCT02484547|566990994|FG006|Long-Term Extension Period|Study Visit Burden|3|||
157064648|NCT02484547|566990988|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
157064649|NCT02484547|566990989|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
157064650|NCT02484547|566990990|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
157064651|NCT02484547|566990991|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
157064652|NCT02484547|566990992|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
157064653|NCT02484547|566990993|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
157064654|NCT02484547|566990994|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
157064655|NCT02484547|566990988|FG000|Long-Term Extension Period|Reason not Specified|0|||
157064656|NCT02484547|566990989|FG001|Long-Term Extension Period|Reason not Specified|0|||
157064657|NCT02484547|566990990|FG002|Long-Term Extension Period|Reason not Specified|0|||
157064658|NCT02484547|566990991|FG003|Long-Term Extension Period|Reason not Specified|119|||
157064659|NCT02484547|566990992|FG004|Long-Term Extension Period|Reason not Specified|117|||
157064660|NCT02484547|566990993|FG005|Long-Term Extension Period|Reason not Specified|223|||
157064661|NCT02484547|566990994|FG006|Long-Term Extension Period|Reason not Specified|231|||
157064662|NCT01665599|566990998|FG000|Overall Study|Adverse Event|1|||
157064663|NCT01665599|566990998|FG000|Overall Study|Consent Withdrawn|1|||
157184555|NCT03715205|567417964|FG000|Overall Study|Physician Decision|93|||
157184556|NCT03715205|567417964|FG000|Overall Study|Withdrawal by Subject|26|||
157184557|NCT02623699|567417965|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184558|NCT02623699|567417966|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
157184559|NCT02623699|567417967|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184560|NCT02623699|567417968|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184561|NCT02623699|567417969|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184562|NCT02623699|567417970|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184563|NCT02623699|567417971|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184564|NCT02623699|567417972|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184565|NCT02623699|567417973|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184566|NCT02623699|567417974|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184567|NCT02623699|567417975|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184568|NCT02623699|567417976|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
157184569|NCT02623699|567417965|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184570|NCT02623699|567417966|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184571|NCT02623699|567417967|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184572|NCT02623699|567417968|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184573|NCT02623699|567417969|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184574|NCT02623699|567417970|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184575|NCT02623699|567417971|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
157184576|NCT02623699|567417972|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184577|NCT02623699|567417973|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184578|NCT02623699|567417974|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184579|NCT02623699|567417975|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184580|NCT02623699|567417976|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
157184581|NCT02623699|567417965|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184582|NCT02623699|567417966|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184583|NCT02623699|567417967|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184584|NCT02623699|567417968|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184585|NCT02623699|567417969|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184586|NCT02623699|567417970|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
157184587|NCT02623699|567417971|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184588|NCT02623699|567417972|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184589|NCT02623699|567417973|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184590|NCT02623699|567417974|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184591|NCT02623699|567417975|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184592|NCT02623699|567417976|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
157184593|NCT02623699|567417965|FG000|Part B (Up to 289 Days)|Death|0|||
157184594|NCT02623699|567417966|FG001|Part B (Up to 289 Days)|Death|0|||
157184595|NCT02623699|567417967|FG002|Part B (Up to 289 Days)|Death|0|||
157184596|NCT02623699|567417968|FG003|Part B (Up to 289 Days)|Death|0|||
157184597|NCT02623699|567417969|FG004|Part B (Up to 289 Days)|Death|0|||
157184598|NCT02623699|567417970|FG005|Part B (Up to 289 Days)|Death|1|||
157184599|NCT02623699|567417971|FG006|Part B (Up to 289 Days)|Death|1|||
157184600|NCT02623699|567417972|FG007|Part B (Up to 289 Days)|Death|0|||
157184601|NCT02623699|567417973|FG008|Part B (Up to 289 Days)|Death|1|||
157184602|NCT02623699|567417974|FG009|Part B (Up to 289 Days)|Death|0|||
157184603|NCT02623699|567417975|FG010|Part B (Up to 289 Days)|Death|0|||
157184604|NCT02623699|567417976|FG011|Part B (Up to 289 Days)|Death|0|||
157184605|NCT02623699|567417965|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
157184606|NCT02623699|567417966|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
157184607|NCT02623699|567417967|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
157184608|NCT02623699|567417968|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
157184609|NCT02623699|567417969|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
157184610|NCT02623699|567417970|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
157184611|NCT02623699|567417971|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
157184612|NCT02623699|567417972|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
157184613|NCT02623699|567417973|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
157184614|NCT02623699|567417974|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
157184615|NCT02623699|567417975|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
157184616|NCT02623699|567417976|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
157184617|NCT02623699|567417965|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184618|NCT02623699|567417966|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184619|NCT02623699|567417967|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184620|NCT02623699|567417968|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184621|NCT02623699|567417969|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184622|NCT02623699|567417970|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184623|NCT02623699|567417971|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184624|NCT02623699|567417972|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184625|NCT02623699|567417973|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184626|NCT02623699|567417974|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
157184627|NCT02623699|567417975|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
157184628|NCT02623699|567417976|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
157184629|NCT02623699|567417965|FG000|Part C (Up to 236 Days)|Death|0|||
157184630|NCT02623699|567417966|FG001|Part C (Up to 236 Days)|Death|0|||
157064664|NCT01665599|566990998|FG000|Overall Study|Investigator/Sponsor decision|1|||
157064665|NCT01665599|566990998|FG000|Overall Study|Death|1|||
157064666|NCT01665599|566990998|FG000|Overall Study|Lost to Follow-up|2|||
157064667|NCT01665599|566990998|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
157064668|NCT01665599|566990998|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
157064669|NCT01722045|566992677|FG000|Overall Study|Adverse Event|8|||
157064670|NCT01722045|566992677|FG000|Overall Study|Death|3|||
157064671|NCT01722045|566992677|FG000|Overall Study|Withdrawal by Subject|8|||
157064672|NCT01722045|566992677|FG000|Overall Study|Lost to Follow-up|4|||
157064673|NCT01722045|566992677|FG000|Overall Study|Protocol Deviation|1|||
157064674|NCT01722045|566992677|FG000|Overall Study|Physician Decision|3|||
157064675|NCT01722045|566992677|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
157064676|NCT01053247|566992678|FG000|Overall Study|Withdrawal by Subject|9|||
157064677|NCT01053247|566992679|FG001|Overall Study|Withdrawal by Subject|4|||
157064678|NCT01053247|566992680|FG002|Overall Study|Withdrawal by Subject|15|||
157064679|NCT01053247|566992678|FG000|Overall Study|Lack of Efficacy|1|||
157064680|NCT01053247|566992679|FG001|Overall Study|Lack of Efficacy|0|||
157064681|NCT01053247|566992680|FG002|Overall Study|Lack of Efficacy|1|||
157064682|NCT01053247|566992678|FG000|Overall Study|Protocol Violation|2|||
157064683|NCT01053247|566992679|FG001|Overall Study|Protocol Violation|1|||
157064684|NCT01053247|566992680|FG002|Overall Study|Protocol Violation|2|||
157064685|NCT01053247|566992678|FG000|Overall Study|Lost to Follow-up|8|||
157064686|NCT01053247|566992679|FG001|Overall Study|Lost to Follow-up|5|||
157064687|NCT01053247|566992680|FG002|Overall Study|Lost to Follow-up|7|||
157064688|NCT01053247|566992678|FG000|Overall Study|Adverse Event|0|||
157064689|NCT01053247|566992679|FG001|Overall Study|Adverse Event|9|||
157064690|NCT01053247|566992680|FG002|Overall Study|Adverse Event|3|||
157064691|NCT03602586|566992681|FG000|Overall Study|Withdrawal by Subject|3|||
157064692|NCT01755546|566992684|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
157064693|NCT01755546|566992684|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
157064694|NCT01755546|566992684|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
157064695|NCT01755546|566992684|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
157064696|NCT01755546|566992684|FG000|Titration Phase|Adverse Event|11|||
157064697|NCT01755546|566992684|FG000|Titration Phase|Lack of Efficacy|18|||
157064698|NCT01755546|566992684|FG000|Titration Phase|Protocol Violation|9|||
157064699|NCT01755546|566992684|FG000|Titration Phase|Lost to Follow-up|2|||
157064700|NCT01755546|566992684|FG000|Titration Phase|Other and Continuing|22|||
157064701|NCT01755546|566992684|FG000|Titration Phase|Withdrawal by Subject|8|||
157064702|NCT01755546|566992684|FG000|Long Term Treatment|Adverse Event|12|||
157064703|NCT01755546|566992684|FG000|Long Term Treatment|Lack of Efficacy|6|||
157064704|NCT01755546|566992684|FG000|Long Term Treatment|Protocol Violation|10|||
157064705|NCT01755546|566992684|FG000|Long Term Treatment|Withdrawal by Subject|35|||
157064706|NCT01755546|566992684|FG000|Long Term Treatment|Lost to Follow-up|17|||
157064707|NCT01755546|566992684|FG000|Long Term Treatment|other and ongoing|41|||
157064708|NCT00891046|566992685|FG000|Overall Study|Protocol Violation|1|||
157064709|NCT00891046|566992686|FG001|Overall Study|Protocol Violation|1|||
157064710|NCT00891046|566992687|FG002|Overall Study|Protocol Violation|0|||
157064711|NCT00891046|566992688|FG003|Overall Study|Protocol Violation|0|||
157064712|NCT00891046|566992689|FG004|Overall Study|Protocol Violation|1|||
157064713|NCT00891046|566992685|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
157064714|NCT00891046|566992686|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157064715|NCT00891046|566992687|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
157064716|NCT00891046|566992688|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
157064717|NCT00891046|566992689|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
157064718|NCT00891046|566992685|FG000|Overall Study|Administrative problems|0|||
157064719|NCT00891046|566992686|FG001|Overall Study|Administrative problems|0|||
157064720|NCT00891046|566992687|FG002|Overall Study|Administrative problems|0|||
157064721|NCT00891046|566992688|FG003|Overall Study|Administrative problems|0|||
157064722|NCT00891046|566992689|FG004|Overall Study|Administrative problems|1|||
157064723|NCT00891046|566992685|FG000|Overall Study|Participant no longer required drug|0|||
157064724|NCT00891046|566992686|FG001|Overall Study|Participant no longer required drug|2|||
157064725|NCT00891046|566992687|FG002|Overall Study|Participant no longer required drug|0|||
157064726|NCT00891046|566992688|FG003|Overall Study|Participant no longer required drug|0|||
157064727|NCT00891046|566992689|FG004|Overall Study|Participant no longer required drug|1|||
157064728|NCT00891046|566992685|FG000|Overall Study|Adverse Event|4|||
157064729|NCT00891046|566992686|FG001|Overall Study|Adverse Event|3|||
157064730|NCT00891046|566992687|FG002|Overall Study|Adverse Event|2|||
157064731|NCT00891046|566992688|FG003|Overall Study|Adverse Event|0|||
157064732|NCT00891046|566992689|FG004|Overall Study|Adverse Event|14|||
157064733|NCT00891046|566992685|FG000|Overall Study|Withdrawal by Subject|2|||
157064734|NCT00891046|566992686|FG001|Overall Study|Withdrawal by Subject|1|||
157064735|NCT00891046|566992687|FG002|Overall Study|Withdrawal by Subject|2|||
157064736|NCT00891046|566992688|FG003|Overall Study|Withdrawal by Subject|1|||
157064737|NCT00891046|566992689|FG004|Overall Study|Withdrawal by Subject|1|||
157064738|NCT00891046|566992685|FG000|Overall Study|Lost to Follow-up|0|||
157064739|NCT00891046|566992686|FG001|Overall Study|Lost to Follow-up|0|||
157184631|NCT02623699|567417967|FG002|Part C (Up to 236 Days)|Death|0|||
157184632|NCT02623699|567417968|FG003|Part C (Up to 236 Days)|Death|0|||
157184633|NCT02623699|567417969|FG004|Part C (Up to 236 Days)|Death|0|||
157184634|NCT02623699|567417970|FG005|Part C (Up to 236 Days)|Death|0|||
157184635|NCT02623699|567417971|FG006|Part C (Up to 236 Days)|Death|0|||
157184636|NCT02623699|567417972|FG007|Part C (Up to 236 Days)|Death|0|||
157184637|NCT02623699|567417973|FG008|Part C (Up to 236 Days)|Death|0|||
157184638|NCT02623699|567417974|FG009|Part C (Up to 236 Days)|Death|0|||
157184639|NCT02623699|567417975|FG010|Part C (Up to 236 Days)|Death|0|||
157184640|NCT02623699|567417976|FG011|Part C (Up to 236 Days)|Death|1|||
157184641|NCT02623699|567417965|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
157184642|NCT02623699|567417966|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
157184643|NCT02623699|567417967|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
157184644|NCT02623699|567417968|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
157184645|NCT02623699|567417969|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
157184646|NCT02623699|567417970|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
157184647|NCT02623699|567417971|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
157184648|NCT02623699|567417972|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
157184649|NCT02623699|567417973|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
157184650|NCT02623699|567417974|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
157184651|NCT02623699|567417975|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
157184652|NCT02623699|567417976|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
157184653|NCT00557323|567417977|FG000|Overall Study|Death|3|||
157184654|NCT00557323|567417977|FG000|Overall Study|Withdrawal by Subject|2|||
157184655|NCT00557323|567417977|FG000|Overall Study|Administrative change|2|||
157184656|NCT00592072|567417978|FG000|Wash Out Period|Lost to Follow-up|1|||
157184657|NCT00592072|567417979|FG001|Wash Out Period|Lost to Follow-up|1|||
157184658|NCT03369704|567417980|FG000|Treatment Epoch|technical problems|1|||
157184659|NCT03369704|567417981|FG001|Treatment Epoch|technical problems|0|||
157184660|NCT03369704|567417980|FG000|Treatment Epoch|Protocol Violation|1|||
157184661|NCT03369704|567417981|FG001|Treatment Epoch|Protocol Violation|0|||
157184662|NCT03369704|567417980|FG000|Treatment Epoch|Lost to Follow-up|0|||
157184663|NCT03369704|567417981|FG001|Treatment Epoch|Lost to Follow-up|1|||
157184664|NCT03369704|567417980|FG000|Treatment Epoch|Lack of Efficacy|0|||
157184665|NCT03369704|567417981|FG001|Treatment Epoch|Lack of Efficacy|2|||
157184666|NCT03369704|567417980|FG000|Treatment Epoch|Adverse Event|2|||
157184667|NCT03369704|567417981|FG001|Treatment Epoch|Adverse Event|0|||
157184668|NCT03369704|567417980|FG000|Follow-up Epoch|Lost to Follow-up|1|||
157184669|NCT03369704|567417981|FG001|Follow-up Epoch|Lost to Follow-up|0|||
157184670|NCT05333289|567417983|FG000|Overall Study|Other|1|||
157184671|NCT05333289|567417984|FG001|Overall Study|Other|0|||
157184672|NCT05333289|567417985|FG002|Overall Study|Other|0|||
157184673|NCT05333289|567417986|FG003|Overall Study|Other|1|||
157184674|NCT05333289|567417987|FG004|Overall Study|Other|1|||
157184675|NCT05333289|567417988|FG005|Overall Study|Other|2|||
157184676|NCT05333289|567417989|FG006|Overall Study|Other|2|||
157184677|NCT05333289|567417990|FG007|Overall Study|Other|0|||
157184678|NCT05333289|567417983|FG000|Overall Study|Withdrawal by Subject|1|||
157184679|NCT05333289|567417984|FG001|Overall Study|Withdrawal by Subject|2|||
157184680|NCT05333289|567417985|FG002|Overall Study|Withdrawal by Subject|2|||
157184681|NCT05333289|567417986|FG003|Overall Study|Withdrawal by Subject|1|||
157184682|NCT05333289|567417987|FG004|Overall Study|Withdrawal by Subject|1|||
157184683|NCT05333289|567417988|FG005|Overall Study|Withdrawal by Subject|2|||
157184684|NCT05333289|567417989|FG006|Overall Study|Withdrawal by Subject|1|||
157184685|NCT05333289|567417990|FG007|Overall Study|Withdrawal by Subject|3|||
157184686|NCT05333289|567417983|FG000|Overall Study|Protocol Violation|1|||
156977012|NCT02395133|566669303|FG001|Overall Study|Consent withdrawn with personal reason|1|||
156977013|NCT02395133|566669304|FG002|Overall Study|Consent withdrawn with personal reason|0|||
156977014|NCT02395133|566669305|FG003|Overall Study|Consent withdrawn with personal reason|3|||
156977015|NCT02395133|566669302|FG000|Overall Study|Sponsor decision|2|||
156977016|NCT02395133|566669303|FG001|Overall Study|Sponsor decision|0|||
156977017|NCT02395133|566669304|FG002|Overall Study|Sponsor decision|0|||
156977018|NCT02395133|566669305|FG003|Overall Study|Sponsor decision|1|||
157184687|NCT05333289|567417984|FG001|Overall Study|Protocol Violation|0|||
157184688|NCT05333289|567417985|FG002|Overall Study|Protocol Violation|0|||
157184689|NCT05333289|567417986|FG003|Overall Study|Protocol Violation|0|||
157230081|NCT02016170|567588230|FG002|Overall Study|Adverse Event|0|||
156977019|NCT02395133|566669302|FG000|Overall Study|Other than specified above|5|||
156977020|NCT02395133|566669303|FG001|Overall Study|Other than specified above|2|||
157184690|NCT05333289|567417987|FG004|Overall Study|Protocol Violation|0|||
157184691|NCT05333289|567417988|FG005|Overall Study|Protocol Violation|0|||
157184692|NCT05333289|567417989|FG006|Overall Study|Protocol Violation|0|||
157184693|NCT05333289|567417990|FG007|Overall Study|Protocol Violation|0|||
157184694|NCT05333289|567417983|FG000|Overall Study|Physician Decision|0|||
157184695|NCT05333289|567417984|FG001|Overall Study|Physician Decision|0|||
157184696|NCT05333289|567417985|FG002|Overall Study|Physician Decision|1|||
157184697|NCT05333289|567417986|FG003|Overall Study|Physician Decision|0|||
157184698|NCT05333289|567417987|FG004|Overall Study|Physician Decision|0|||
157184699|NCT05333289|567417988|FG005|Overall Study|Physician Decision|2|||
157184700|NCT05333289|567417989|FG006|Overall Study|Physician Decision|0|||
157184701|NCT05333289|567417990|FG007|Overall Study|Physician Decision|0|||
157184702|NCT05333289|567417983|FG000|Overall Study|Lost to Follow-up|6|||
157184703|NCT05333289|567417984|FG001|Overall Study|Lost to Follow-up|0|||
157184704|NCT05333289|567417985|FG002|Overall Study|Lost to Follow-up|1|||
157184705|NCT05333289|567417986|FG003|Overall Study|Lost to Follow-up|6|||
157184706|NCT05333289|567417987|FG004|Overall Study|Lost to Follow-up|3|||
157184707|NCT05333289|567417988|FG005|Overall Study|Lost to Follow-up|3|||
157184708|NCT05333289|567417989|FG006|Overall Study|Lost to Follow-up|2|||
157184709|NCT05333289|567417990|FG007|Overall Study|Lost to Follow-up|1|||
157184710|NCT05333289|567417983|FG000|Overall Study|Death|1|||
157184711|NCT05333289|567417984|FG001|Overall Study|Death|0|||
157184712|NCT05333289|567417985|FG002|Overall Study|Death|0|||
157184713|NCT05333289|567417986|FG003|Overall Study|Death|0|||
157184714|NCT05333289|567417987|FG004|Overall Study|Death|0|||
157184715|NCT05333289|567417988|FG005|Overall Study|Death|0|||
157184716|NCT05333289|567417989|FG006|Overall Study|Death|0|||
157184717|NCT05333289|567417990|FG007|Overall Study|Death|0|||
157184718|NCT00372489|567417992|FG000|Overall Study|Adverse Event|18|||
157184719|NCT00372489|567417992|FG000|Overall Study|Lack of Efficacy|1|||
157184720|NCT00372489|567417992|FG000|Overall Study|Lost to Follow-up|3|||
157184721|NCT00372489|567417992|FG000|Overall Study|Physician Decision|3|||
157184722|NCT00372489|567417992|FG000|Overall Study|Withdrawal by Subject|5|||
157184723|NCT00372489|567417992|FG000|Overall Study|Patient Relocation|2|||
157184724|NCT00372489|567417992|FG000|Overall Study|Renal transplant|6|||
157184725|NCT00372489|567417992|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
157184726|NCT03733249|567417993|FG000|Overall Study|Death|7|||
157184727|NCT03733249|567417993|FG000|Overall Study|Disease relapse|16|||
157184728|NCT03733249|567417993|FG000|Overall Study|Lost to Follow-up|4|||
157184729|NCT03733249|567417993|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
157184730|NCT03733249|567417993|FG000|Overall Study|Withdrawal by Subject|1|||
157184731|NCT00772889|567417995|FG000|Overall Study|Adverse Event|7|||
157184732|NCT00772889|567417996|FG001|Overall Study|Adverse Event|4|||
157184733|NCT00772889|567417997|FG002|Overall Study|Adverse Event|0|||
157184734|NCT00772889|567417995|FG000|Overall Study|Withdrawal by Subject|9|||
157184735|NCT00772889|567417996|FG001|Overall Study|Withdrawal by Subject|8|||
157184736|NCT00772889|567417997|FG002|Overall Study|Withdrawal by Subject|9|||
157184737|NCT00772889|567417995|FG000|Overall Study|Lost to Follow-up|6|||
157184738|NCT00772889|567417996|FG001|Overall Study|Lost to Follow-up|6|||
157184739|NCT00772889|567417997|FG002|Overall Study|Lost to Follow-up|7|||
157184740|NCT03323086|567417998|FG000|Overall Study|Lost to Follow-up|3|||
157184741|NCT03323086|567417999|FG001|Overall Study|Lost to Follow-up|2|||
157184742|NCT00355615|567418000|FG000|Randomized Double Blind Period|Adverse Event|1|||
156977021|NCT02395133|566669304|FG002|Overall Study|Other than specified above|2|||
156977022|NCT02395133|566669305|FG003|Overall Study|Other than specified above|4|||
156977023|NCT00510458|566669306|FG000|Overall Study|5 year not evaluable/missed|21|||
156977024|NCT00510458|566669306|FG000|Overall Study|Death|1|||
156977025|NCT00510458|566669306|FG000|Overall Study|Terminated|14|||
156977026|NCT00510458|566669306|FG000|Overall Study|Lost to Follow-up|6|||
156977027|NCT00510458|566669306|FG000|Overall Study|Withdrawal by Subject|3|||
156977028|NCT00510458|566669306|FG000|Overall Study|Revision|2|||
156977029|NCT02569710|566669307|FG000|Overall Study|Adverse Event|1|||
157064740|NCT00891046|566992687|FG002|Overall Study|Lost to Follow-up|0|||
157064741|NCT00891046|566992688|FG003|Overall Study|Lost to Follow-up|0|||
157064742|NCT00891046|566992689|FG004|Overall Study|Lost to Follow-up|1|||
157064743|NCT00362375|566992690|FG000|Overall Study|Lost to Follow-up|40|||
156977030|NCT02569710|566669308|FG001|Overall Study|Adverse Event|0|||
156977031|NCT02569710|566669309|FG002|Overall Study|Adverse Event|0|||
156977032|NCT02569710|566669310|FG003|Overall Study|Adverse Event|0|||
156977033|NCT02569710|566669311|FG004|Overall Study|Adverse Event|0|||
156977034|NCT02569710|566669312|FG005|Overall Study|Adverse Event|0|||
156977035|NCT02569710|566669313|FG006|Overall Study|Adverse Event|0|||
156977036|NCT02569710|566669314|FG007|Overall Study|Adverse Event|0|||
156977037|NCT02569710|566669315|FG008|Overall Study|Adverse Event|0|||
156977038|NCT02569710|566669316|FG009|Overall Study|Adverse Event|0|||
156977039|NCT02569710|566669307|FG000|Overall Study|Lost to Follow-up|0|||
156977040|NCT02569710|566669308|FG001|Overall Study|Lost to Follow-up|0|||
156977041|NCT02569710|566669309|FG002|Overall Study|Lost to Follow-up|0|||
156977042|NCT02569710|566669310|FG003|Overall Study|Lost to Follow-up|0|||
157184743|NCT00355615|567418001|FG001|Randomized Double Blind Period|Adverse Event|0|||
157184744|NCT00355615|567418002|FG002|Randomized Double Blind Period|Adverse Event|0|||
156977043|NCT02569710|566669311|FG004|Overall Study|Lost to Follow-up|0|||
156977044|NCT02569710|566669312|FG005|Overall Study|Lost to Follow-up|0|||
156977045|NCT02569710|566669313|FG006|Overall Study|Lost to Follow-up|1|||
157184745|NCT00355615|567418003|FG003|Randomized Double Blind Period|Adverse Event|0|||
157184746|NCT00355615|567418004|FG004|Randomized Double Blind Period|Adverse Event|0|||
157184747|NCT00355615|567418000|FG000|Randomized Double Blind Period|Protocol Violation|0|||
157184748|NCT00355615|567418001|FG001|Randomized Double Blind Period|Protocol Violation|0|||
157184749|NCT00355615|567418002|FG002|Randomized Double Blind Period|Protocol Violation|1|||
157064744|NCT00362375|566992691|FG001|Overall Study|Lost to Follow-up|35|||
157064745|NCT02106195|566992692|FG000|Overall Study|Adverse Event|2|||
157064746|NCT02106195|566992692|FG000|Overall Study|Protocol Violation|1|||
157184750|NCT00355615|567418003|FG003|Randomized Double Blind Period|Protocol Violation|1|||
157184751|NCT00355615|567418004|FG004|Randomized Double Blind Period|Protocol Violation|0|||
157184752|NCT00355615|567418000|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
157184753|NCT00355615|567418001|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
157064747|NCT04984239|566992693|FG000|Overall Study|Lost to Follow-up|1|||
157064748|NCT03294941|566992694|FG000|Overall Study|Withdrawal by Subject|0|||
157064749|NCT03294941|566992695|FG001|Overall Study|Withdrawal by Subject|2|||
157064750|NCT04629443|566992696|FG000|Overall Study|Adverse Event|2|||
157064751|NCT04629443|566992697|FG001|Overall Study|Adverse Event|1|||
157064752|NCT04629443|566992698|FG002|Overall Study|Adverse Event|2|||
157064753|NCT04629443|566992696|FG000|Overall Study|Progressive Disease|2|||
157064754|NCT04629443|566992697|FG001|Overall Study|Progressive Disease|3|||
157064755|NCT04629443|566992698|FG002|Overall Study|Progressive Disease|3|||
157064756|NCT04629443|566992696|FG000|Overall Study|Physician Decision|1|||
157064757|NCT04629443|566992697|FG001|Overall Study|Physician Decision|3|||
157064758|NCT04629443|566992698|FG002|Overall Study|Physician Decision|0|||
157064759|NCT01844726|566992704|FG000|Overall Study|Withdrawal by Subject|0|||
157064760|NCT01844726|566992705|FG001|Overall Study|Withdrawal by Subject|1|||
157064761|NCT01844726|566992704|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
157064762|NCT01844726|566992705|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
157064763|NCT00916305|566992706|FG000|Overall Study|Lost to Follow-up|21|||
157064764|NCT00916305|566992707|FG001|Overall Study|Lost to Follow-up|27|||
157064765|NCT00916305|566992706|FG000|Overall Study|Withdrawal by Subject|0|||
157064766|NCT00916305|566992707|FG001|Overall Study|Withdrawal by Subject|1|||
157064767|NCT00858247|566992712|FG000|Baseline Assessment|Withdrawal by Subject|1|||
157064768|NCT00858247|566992713|FG001|Baseline Assessment|Withdrawal by Subject|1|||
157064769|NCT00858247|566992712|FG000|Baseline Assessment|Poor IV access|1|||
157064770|NCT00858247|566992713|FG001|Baseline Assessment|Poor IV access|0|||
157064771|NCT00858247|566992712|FG000|Baseline Assessment|Protocol Violation|0|||
157064772|NCT00858247|566992713|FG001|Baseline Assessment|Protocol Violation|1|||
157064773|NCT00858247|566992712|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
157064774|NCT00858247|566992713|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
157064775|NCT01379703|566992714|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
157064776|NCT01379703|566992715|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
157064777|NCT01379703|566992716|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
157064778|NCT01379703|566992714|FG000|Study Start Through 9 Months|Adverse Event|0|||
157064779|NCT01379703|566992715|FG001|Study Start Through 9 Months|Adverse Event|14|||
157064780|NCT01379703|566992716|FG002|Study Start Through 9 Months|Adverse Event|10|||
157064781|NCT01379703|566992714|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
157064782|NCT01379703|566992715|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
157064783|NCT01379703|566992716|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
157064784|NCT01379703|566992714|FG000|Study Start Through 9 Months|Treatment Failure|0|||
157064785|NCT01379703|566992715|FG001|Study Start Through 9 Months|Treatment Failure|2|||
157064786|NCT01379703|566992716|FG002|Study Start Through 9 Months|Treatment Failure|2|||
157064787|NCT01379703|566992714|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
157064788|NCT01379703|566992715|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
157064789|NCT01379703|566992716|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
157064790|NCT01379703|566992714|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
157064791|NCT01379703|566992715|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
157064792|NCT01379703|566992716|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
157064793|NCT01379703|566992714|FG000|Study Start Through 9 Months|Medication not available|0|||
157064794|NCT01379703|566992715|FG001|Study Start Through 9 Months|Medication not available|2|||
157064795|NCT01379703|566992716|FG002|Study Start Through 9 Months|Medication not available|1|||
157064796|NCT01379703|566992714|FG000|Study Start Through 9 Months|Poor general condition|0|||
157064797|NCT01379703|566992715|FG001|Study Start Through 9 Months|Poor general condition|1|||
157184754|NCT00355615|567418002|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
157184755|NCT00355615|567418003|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
157184756|NCT00355615|567418004|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
157064798|NCT01379703|566992716|FG002|Study Start Through 9 Months|Poor general condition|0|||
157064799|NCT01379703|566992714|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
157064800|NCT01379703|566992715|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
157184757|NCT00355615|567418000|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
157064801|NCT01379703|566992716|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
157064802|NCT01379703|566992714|FG000|Study Start Through 9 Months|Reason unknown|2|||
157184758|NCT00355615|567418001|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
157184759|NCT00355615|567418002|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
157184760|NCT00355615|567418003|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
157064803|NCT01379703|566992715|FG001|Study Start Through 9 Months|Reason unknown|31|||
157064804|NCT01379703|566992716|FG002|Study Start Through 9 Months|Reason unknown|24|||
157064805|NCT01379703|566992714|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
157064806|NCT01379703|566992715|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
157064807|NCT01379703|566992716|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
157064808|NCT01379703|566992714|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
157064809|NCT01379703|566992715|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
157064810|NCT01379703|566992716|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
157064811|NCT01379703|566992714|FG000|9 Months Through 18 Months|Adverse Event|0|||
157064812|NCT01379703|566992715|FG001|9 Months Through 18 Months|Adverse Event|6|||
157064813|NCT01379703|566992716|FG002|9 Months Through 18 Months|Adverse Event|0|||
157064814|NCT01379703|566992714|FG000|9 Months Through 18 Months|Treatment failure|0|||
157064815|NCT01379703|566992715|FG001|9 Months Through 18 Months|Treatment failure|5|||
157064816|NCT01379703|566992716|FG002|9 Months Through 18 Months|Treatment failure|0|||
157064817|NCT01379703|566992714|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
157064818|NCT01379703|566992715|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
157064819|NCT01379703|566992716|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
157064820|NCT01379703|566992714|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
157064821|NCT01379703|566992715|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
157064822|NCT01379703|566992716|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
157064823|NCT01379703|566992714|FG000|9 Months Through 18 Months|Fatigue|0|||
157064824|NCT01379703|566992715|FG001|9 Months Through 18 Months|Fatigue|1|||
157064825|NCT01379703|566992716|FG002|9 Months Through 18 Months|Fatigue|0|||
157064826|NCT01379703|566992714|FG000|9 Months Through 18 Months|Reason Unknown|0|||
157064827|NCT01379703|566992715|FG001|9 Months Through 18 Months|Reason Unknown|23|||
157064828|NCT01379703|566992716|FG002|9 Months Through 18 Months|Reason Unknown|0|||
157064829|NCT03481556|566992717|FG000|Overall Study|Adverse Event|1|||
157064830|NCT03481556|566992718|FG001|Overall Study|Adverse Event|0|||
157064831|NCT03481556|566992719|FG002|Overall Study|Adverse Event|0|||
157064832|NCT03481556|566992720|FG003|Overall Study|Adverse Event|0|||
157064833|NCT03481556|566992717|FG000|Overall Study|Death|4|||
157064834|NCT03481556|566992718|FG001|Overall Study|Death|2|||
157064835|NCT03481556|566992719|FG002|Overall Study|Death|3|||
157064836|NCT03481556|566992720|FG003|Overall Study|Death|16|||
157064837|NCT03481556|566992717|FG000|Overall Study|Study Terminated by Sponsor|10|||
157064838|NCT03481556|566992718|FG001|Overall Study|Study Terminated by Sponsor|5|||
157064839|NCT03481556|566992719|FG002|Overall Study|Study Terminated by Sponsor|2|||
157064840|NCT03481556|566992720|FG003|Overall Study|Study Terminated by Sponsor|9|||
157064841|NCT01101997|566992721|FG000|Overall Study|Withdrawal by Subject|2|||
157064842|NCT01172639|566992722|FG000|Overall Study|Death|1|||
157064843|NCT01172639|566992723|FG001|Overall Study|Death|1|||
157064844|NCT01172639|566992724|FG002|Overall Study|Death|0|||
157064845|NCT01172639|566992725|FG003|Overall Study|Death|0|||
157064846|NCT01172639|566992726|FG004|Overall Study|Death|0|||
157064847|NCT01172639|566992722|FG000|Overall Study|Lost to Follow-up|9|||
157064848|NCT01172639|566992723|FG001|Overall Study|Lost to Follow-up|7|||
157064849|NCT01172639|566992724|FG002|Overall Study|Lost to Follow-up|11|||
157064850|NCT01172639|566992725|FG003|Overall Study|Lost to Follow-up|6|||
157064851|NCT01172639|566992726|FG004|Overall Study|Lost to Follow-up|6|||
157064852|NCT01172639|566992722|FG000|Overall Study|Withdrawal by Subject|3|||
157064853|NCT01172639|566992723|FG001|Overall Study|Withdrawal by Subject|3|||
157064854|NCT01172639|566992724|FG002|Overall Study|Withdrawal by Subject|5|||
157064855|NCT01172639|566992725|FG003|Overall Study|Withdrawal by Subject|5|||
157064856|NCT01172639|566992726|FG004|Overall Study|Withdrawal by Subject|0|||
157064857|NCT02172950|566992727|FG000|Overall Study|Physician Decision|3|||
157064858|NCT02172950|566992728|FG001|Overall Study|Physician Decision|3|||
157064859|NCT02172950|566992727|FG000|Overall Study|Lack of Efficacy|1|||
157064860|NCT02172950|566992728|FG001|Overall Study|Lack of Efficacy|0|||
157064861|NCT02172950|566992727|FG000|Overall Study|Adverse Event|4|||
157064862|NCT02172950|566992728|FG001|Overall Study|Adverse Event|1|||
157064863|NCT02172950|566992727|FG000|Overall Study|Withdrawal by Subject|10|||
157064864|NCT02172950|566992728|FG001|Overall Study|Withdrawal by Subject|0|||
157064865|NCT02172950|566992727|FG000|Overall Study|Protocol Violation|1|||
157064866|NCT02172950|566992728|FG001|Overall Study|Protocol Violation|0|||
157064867|NCT02172950|566992727|FG000|Overall Study|Lost to Follow-up|1|||
157064868|NCT02172950|566992728|FG001|Overall Study|Lost to Follow-up|0|||
157064869|NCT02172950|566992727|FG000|Overall Study|Death|1|||
157064870|NCT02172950|566992728|FG001|Overall Study|Death|0|||
157064871|NCT02172950|566992727|FG000|Overall Study|Patient traveling|1|||
157064872|NCT02172950|566992728|FG001|Overall Study|Patient traveling|0|||
157064873|NCT02172950|566992727|FG000|Overall Study|Patient went to other country|1|||
157064874|NCT02172950|566992728|FG001|Overall Study|Patient went to other country|0|||
157064875|NCT02172950|566992727|FG000|Overall Study|Patient relocated overseas|1|||
157064876|NCT02172950|566992728|FG001|Overall Study|Patient relocated overseas|1|||
157064877|NCT02172950|566992727|FG000|Overall Study|Patient moving|1|||
157064878|NCT02172950|566992728|FG001|Overall Study|Patient moving|0|||
157064879|NCT01086384|566992734|FG000|2-week Run-in Period|Adverse Event|1|||
157064880|NCT01086384|566992735|FG001|2-week Run-in Period|Adverse Event|0|||
157064881|NCT01086384|566992736|FG002|2-week Run-in Period|Adverse Event|0|||
157064882|NCT01086384|566992734|FG000|2-week Run-in Period|Protocol Violation|1|||
157064883|NCT01086384|566992735|FG001|2-week Run-in Period|Protocol Violation|0|||
157064884|NCT01086384|566992736|FG002|2-week Run-in Period|Protocol Violation|0|||
157064885|NCT01086384|566992734|FG000|2-week Run-in Period|Lost to Follow-up|1|||
157064886|NCT01086384|566992735|FG001|2-week Run-in Period|Lost to Follow-up|0|||
157064887|NCT01086384|566992736|FG002|2-week Run-in Period|Lost to Follow-up|0|||
157064888|NCT01086384|566992734|FG000|2-week Run-in Period|Physician Decision|6|||
157064889|NCT01086384|566992735|FG001|2-week Run-in Period|Physician Decision|0|||
157064890|NCT01086384|566992736|FG002|2-week Run-in Period|Physician Decision|0|||
157064891|NCT01086384|566992734|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
157064892|NCT01086384|566992735|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
157064893|NCT01086384|566992736|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
157064894|NCT01086384|566992734|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
157064895|NCT01086384|566992735|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
157064896|NCT01086384|566992736|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
157064897|NCT01086384|566992734|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
157064898|NCT01086384|566992735|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
157064899|NCT01086384|566992736|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
157064900|NCT01086384|566992734|FG000|2-week Run-in Period|Randomized in Error|1|||
157064901|NCT01086384|566992735|FG001|2-week Run-in Period|Randomized in Error|0|||
157064902|NCT01086384|566992736|FG002|2-week Run-in Period|Randomized in Error|0|||
157064903|NCT01086384|566992734|FG000|Treatment Period|Withdrawal by Subject|0|||
157064904|NCT01086384|566992735|FG001|Treatment Period|Withdrawal by Subject|53|||
157064905|NCT01086384|566992736|FG002|Treatment Period|Withdrawal by Subject|55|||
157064906|NCT01086384|566992734|FG000|Treatment Period|Protocol Violation|0|||
157064907|NCT01086384|566992735|FG001|Treatment Period|Protocol Violation|26|||
157064908|NCT01086384|566992736|FG002|Treatment Period|Protocol Violation|17|||
157064909|NCT01086384|566992734|FG000|Treatment Period|Lack of Efficacy|0|||
157064910|NCT01086384|566992735|FG001|Treatment Period|Lack of Efficacy|22|||
157064911|NCT01086384|566992736|FG002|Treatment Period|Lack of Efficacy|13|||
157064912|NCT01086384|566992734|FG000|Treatment Period|Adverse Event|0|||
157064913|NCT01086384|566992735|FG001|Treatment Period|Adverse Event|19|||
157064914|NCT01086384|566992736|FG002|Treatment Period|Adverse Event|15|||
157064915|NCT01086384|566992734|FG000|Treatment Period|Lost to Follow-up|0|||
157064916|NCT01086384|566992735|FG001|Treatment Period|Lost to Follow-up|11|||
157064917|NCT01086384|566992736|FG002|Treatment Period|Lost to Follow-up|9|||
157064918|NCT01086384|566992734|FG000|Treatment Period|Physician Decision|0|||
157064919|NCT01086384|566992735|FG001|Treatment Period|Physician Decision|9|||
157064920|NCT01086384|566992736|FG002|Treatment Period|Physician Decision|6|||
157064921|NCT01086384|566992734|FG000|Treatment Period|Study Closed/Terminated|0|||
157064922|NCT01086384|566992735|FG001|Treatment Period|Study Closed/Terminated|7|||
157064923|NCT01086384|566992736|FG002|Treatment Period|Study Closed/Terminated|8|||
157064924|NCT01086384|566992734|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
157064925|NCT01086384|566992735|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
157064926|NCT01086384|566992736|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
157064927|NCT01086384|566992734|FG000|Treatment Period|Received Treatment in Error|0|||
157064928|NCT01086384|566992735|FG001|Treatment Period|Received Treatment in Error|1|||
157064929|NCT01086384|566992736|FG002|Treatment Period|Received Treatment in Error|0|||
157064930|NCT02586415|566992739|FG000|Overall Study|Death|13|||
157064931|NCT02586415|566992740|FG001|Overall Study|Death|23|||
157064932|NCT02586415|566992739|FG000|Overall Study|Lost to Follow-up|1|||
157064933|NCT02586415|566992740|FG001|Overall Study|Lost to Follow-up|2|||
157064934|NCT00832000|566992741|FG000|Overall Study|Adverse Event|2|||
157064935|NCT00832000|566992742|FG001|Overall Study|Adverse Event|0|||
157064936|NCT00832000|566992741|FG000|Overall Study|Withdrawal by Subject|1|||
157064937|NCT00832000|566992742|FG001|Overall Study|Withdrawal by Subject|0|||
157064938|NCT00832000|566992741|FG000|Overall Study|No calls to IVR in either period|1|||
157064939|NCT00832000|566992742|FG001|Overall Study|No calls to IVR in either period|1|||
157064940|NCT00832000|566992741|FG000|Overall Study|No calls to IVR in period 2|2|||
157064941|NCT00832000|566992742|FG001|Overall Study|No calls to IVR in period 2|0|||
157064942|NCT01898442|566992743|FG000|Overall Study|Hemolysis/technical problems|1|||
157064943|NCT01898442|566992744|FG001|Overall Study|Hemolysis/technical problems|2|||
157064944|NCT01898442|566992745|FG002|Overall Study|Hemolysis/technical problems|2|||
157064945|NCT01898442|566992743|FG000|Overall Study|Patient vomited pills|0|||
157064946|NCT01898442|566992744|FG001|Overall Study|Patient vomited pills|0|||
157064947|NCT01898442|566992745|FG002|Overall Study|Patient vomited pills|1|||
157064948|NCT03974100|566992746|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
157064949|NCT03974100|566992747|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
157064950|NCT03974100|566992748|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
157064951|NCT03974100|566992749|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
157064952|NCT03974100|566992750|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
157064953|NCT03974100|566992746|FG000|TP1 - Day 1 to Week 52|Death|1|||
157184761|NCT00355615|567418004|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
157184762|NCT00355615|567418000|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
157184763|NCT00355615|567418001|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
157184764|NCT00355615|567418002|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
157184765|NCT00355615|567418003|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
157184766|NCT00355615|567418004|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
157184767|NCT00355615|567418000|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
157184768|NCT00355615|567418001|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
157184769|NCT00355615|567418002|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
157184770|NCT00355615|567418003|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
157184771|NCT00355615|567418004|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
157184772|NCT00085644|567418012|FG000|Double-Blind Period|Adverse Event|5|||
156977046|NCT02569710|566669314|FG007|Overall Study|Lost to Follow-up|0|||
156977047|NCT02569710|566669315|FG008|Overall Study|Lost to Follow-up|1|||
156977048|NCT02569710|566669316|FG009|Overall Study|Lost to Follow-up|0|||
156977049|NCT02569710|566669307|FG000|Overall Study|Virologic failure|0|||
156977050|NCT02569710|566669308|FG001|Overall Study|Virologic failure|0|||
156977051|NCT02569710|566669309|FG002|Overall Study|Virologic failure|0|||
156977052|NCT02569710|566669310|FG003|Overall Study|Virologic failure|0|||
156977053|NCT02569710|566669311|FG004|Overall Study|Virologic failure|1|||
156977054|NCT02569710|566669312|FG005|Overall Study|Virologic failure|0|||
156977055|NCT02569710|566669313|FG006|Overall Study|Virologic failure|1|||
156977056|NCT02569710|566669314|FG007|Overall Study|Virologic failure|0|||
156977057|NCT02569710|566669315|FG008|Overall Study|Virologic failure|0|||
156977058|NCT02569710|566669316|FG009|Overall Study|Virologic failure|0|||
156977059|NCT02569710|566669307|FG000|Overall Study|Withdrawal by Subject|0|||
156977060|NCT02569710|566669308|FG001|Overall Study|Withdrawal by Subject|0|||
156977061|NCT02569710|566669309|FG002|Overall Study|Withdrawal by Subject|0|||
156977062|NCT02569710|566669310|FG003|Overall Study|Withdrawal by Subject|0|||
156977063|NCT02569710|566669311|FG004|Overall Study|Withdrawal by Subject|0|||
156977064|NCT02569710|566669312|FG005|Overall Study|Withdrawal by Subject|1|||
156977065|NCT02569710|566669313|FG006|Overall Study|Withdrawal by Subject|0|||
156977066|NCT02569710|566669314|FG007|Overall Study|Withdrawal by Subject|0|||
156977067|NCT02569710|566669315|FG008|Overall Study|Withdrawal by Subject|0|||
156977068|NCT02569710|566669316|FG009|Overall Study|Withdrawal by Subject|0|||
156977069|NCT02946918|566669317|FG000|Overall Study|Patient unblinded himself|1|||
156977070|NCT02946918|566669318|FG001|Overall Study|Patient unblinded himself|0|||
156977071|NCT02946918|566669317|FG000|Overall Study|Physician Decision|0|||
156977072|NCT02946918|566669318|FG001|Overall Study|Physician Decision|2|||
156977073|NCT02946918|566669317|FG000|Overall Study|Ran out of study medication|0|||
156977074|NCT02946918|566669318|FG001|Overall Study|Ran out of study medication|1|||
156977075|NCT00069784|566669319|FG000|Overall Study|Adverse Event|105|||
156977076|NCT00069784|566669320|FG001|Overall Study|Adverse Event|0|||
156977077|NCT00069784|566669319|FG000|Overall Study|Withdrawal by Subject|1090|||
156977078|NCT00069784|566669320|FG001|Overall Study|Withdrawal by Subject|0|||
156977079|NCT00069784|566669319|FG000|Overall Study|Other|17|||
156977080|NCT00069784|566669320|FG001|Overall Study|Other|0|||
156977081|NCT02669095|566669321|FG000|Overall Study|Adverse Event|1|||
156977082|NCT02669095|566669322|FG001|Overall Study|Adverse Event|0|||
156977083|NCT02669095|566669321|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
156977084|NCT02669095|566669322|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
156977085|NCT02669095|566669321|FG000|Overall Study|Torn Lens|0|||
156977086|NCT02669095|566669322|FG001|Overall Study|Torn Lens|1|||
156977087|NCT02669095|566669321|FG000|Overall Study|Visit 5 assessments not completed|0|||
156977088|NCT02669095|566669322|FG001|Overall Study|Visit 5 assessments not completed|1|||
156977089|NCT04398537|566669323|FG000|Overall Study|Physician Decision|10|||
156977090|NCT04398537|566669324|FG001|Overall Study|Physician Decision|15|||
156977091|NCT03017235|566670602|FG000|Overall Study|Withdrawal by Subject|4|||
156977092|NCT03017235|566670603|FG001|Overall Study|Withdrawal by Subject|3|||
156977093|NCT03017235|566670602|FG000|Overall Study|Lost to Follow-up|2|||
156977094|NCT03017235|566670603|FG001|Overall Study|Lost to Follow-up|7|||
156977095|NCT03017235|566670602|FG000|Overall Study|Adverse Event|0|||
156977096|NCT03017235|566670603|FG001|Overall Study|Adverse Event|1|||
156977097|NCT03017235|566670602|FG000|Overall Study|Protocol Violation|2|||
156977098|NCT03017235|566670603|FG001|Overall Study|Protocol Violation|1|||
156977099|NCT03017235|566670602|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
156977100|NCT03017235|566670603|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
156977101|NCT00453310|566670608|FG000|Overall Study|Progression of Disease|10|||
156977102|NCT01806740|566670609|FG000|Overall Study|Withdrawal by Subject|4|||
156977103|NCT01806740|566670609|FG000|Overall Study|Physician Decision|1|||
156977104|NCT01806740|566670609|FG000|Overall Study|Patient's refusal of treatment|1|||
156977105|NCT01382940|566670612|FG000|Overall Study|Adverse Event|19|||
156977106|NCT01382940|566670612|FG000|Overall Study|Lost to Follow-up|4|||
156977107|NCT01382940|566670612|FG000|Overall Study|Physician Decision|7|||
156977108|NCT01382940|566670612|FG000|Overall Study|Withdrawal by Subject|23|||
156977109|NCT01382940|566670612|FG000|Overall Study|Protocol Violation|20|||
157064954|NCT03974100|566992747|FG001|TP1 - Day 1 to Week 52|Death|0|||
157064955|NCT03974100|566992748|FG002|TP1 - Day 1 to Week 52|Death|0|||
157064956|NCT03974100|566992749|FG003|TP1 - Day 1 to Week 52|Death|0|||
157064957|NCT03974100|566992750|FG004|TP1 - Day 1 to Week 52|Death|0|||
157064958|NCT03974100|566992746|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
157064959|NCT03974100|566992747|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
157064960|NCT03974100|566992748|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
157064961|NCT03974100|566992749|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
157064962|NCT03974100|566992750|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
157064963|NCT03974100|566992746|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
157064964|NCT03974100|566992747|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
157064965|NCT03974100|566992748|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
157064966|NCT03974100|566992749|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
157064967|NCT03974100|566992750|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
157064968|NCT03974100|566992746|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
157064969|NCT03974100|566992747|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
157064970|NCT03974100|566992748|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
157064971|NCT03974100|566992749|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
157064972|NCT03974100|566992750|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
157064973|NCT03974100|566992746|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
157064974|NCT03974100|566992747|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
157064975|NCT03974100|566992748|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
157064976|NCT03974100|566992749|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
157064977|NCT03974100|566992750|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
157064978|NCT03974100|566992746|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
157064979|NCT03974100|566992747|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
157064980|NCT03974100|566992748|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
157064981|NCT03974100|566992749|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
157064982|NCT03974100|566992750|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
157064983|NCT03318783|566992751|FG000|Overall Study|Withdrawal by Subject|0|||
157064984|NCT03318783|566992752|FG001|Overall Study|Withdrawal by Subject|1|||
157064985|NCT03318783|566992751|FG000|Overall Study|Death|0|||
157064986|NCT03318783|566992752|FG001|Overall Study|Death|1|||
157064987|NCT01426113|566992757|FG000|Overall Study|Study Discontinued|1|||
157064988|NCT01426113|566992758|FG001|Overall Study|Study Discontinued|1|||
157064989|NCT01426113|566992757|FG000|Overall Study|Adverse Event|0|||
157064990|NCT01426113|566992758|FG001|Overall Study|Adverse Event|1|||
157064991|NCT00436956|566992761|FG000|Overall Study|Not evaluable|1|||
157064992|NCT00436956|566992762|FG001|Overall Study|Not evaluable|0|||
157064993|NCT01841112|566992764|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
157064994|NCT01841112|566992765|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
157064995|NCT01841112|566992766|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
157064996|NCT01841112|566992767|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
157064997|NCT01841112|566992768|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
157064998|NCT02719743|566992769|FG000|Overall Study|Consent withdrawal|0|||
157064999|NCT02719743|566992770|FG001|Overall Study|Consent withdrawal|2|||
157065000|NCT02719743|566992771|FG002|Overall Study|Consent withdrawal|0|||
157065001|NCT02719743|566992772|FG003|Overall Study|Consent withdrawal|1|||
157065002|NCT02719743|566992773|FG004|Overall Study|Consent withdrawal|0|||
157065003|NCT02719743|566992769|FG000|Overall Study|Migrated/moved from study area|0|||
157065004|NCT02719743|566992770|FG001|Overall Study|Migrated/moved from study area|0|||
157065005|NCT02719743|566992771|FG002|Overall Study|Migrated/moved from study area|0|||
157065006|NCT02719743|566992772|FG003|Overall Study|Migrated/moved from study area|0|||
157065007|NCT02719743|566992773|FG004|Overall Study|Migrated/moved from study area|2|||
157065008|NCT02719743|566992769|FG000|Overall Study|Lost to Follow-up|1|||
157065009|NCT02719743|566992770|FG001|Overall Study|Lost to Follow-up|1|||
157065010|NCT02719743|566992771|FG002|Overall Study|Lost to Follow-up|0|||
157065011|NCT02719743|566992772|FG003|Overall Study|Lost to Follow-up|0|||
157065012|NCT02719743|566992773|FG004|Overall Study|Lost to Follow-up|0|||
157065013|NCT01438840|566992774|FG000|Core Study|Adverse Event|0|||
157065014|NCT01438840|566992775|FG001|Core Study|Adverse Event|3|||
157065015|NCT01438840|566992776|FG002|Core Study|Adverse Event|0|||
157065016|NCT01438840|566992774|FG000|Core Study|Lack of Efficacy|15|||
157065017|NCT01438840|566992775|FG001|Core Study|Lack of Efficacy|7|||
157065018|NCT01438840|566992776|FG002|Core Study|Lack of Efficacy|0|||
157065019|NCT01438840|566992774|FG000|Core Study|Withdrawal of consent|1|||
157065020|NCT01438840|566992775|FG001|Core Study|Withdrawal of consent|0|||
157065021|NCT01438840|566992776|FG002|Core Study|Withdrawal of consent|0|||
157065022|NCT01438840|566992774|FG000|Extension Phase|Adverse Event|0|||
157065023|NCT01438840|566992775|FG001|Extension Phase|Adverse Event|0|||
157065024|NCT01438840|566992776|FG002|Extension Phase|Adverse Event|3|||
157065025|NCT01438840|566992774|FG000|Extension Phase|Lost to Follow-up|0|||
157065026|NCT01438840|566992775|FG001|Extension Phase|Lost to Follow-up|0|||
157065027|NCT01438840|566992776|FG002|Extension Phase|Lost to Follow-up|1|||
157065028|NCT01438840|566992774|FG000|Extension Phase|Withdrawal by Subject|0|||
157184773|NCT00085644|567418013|FG001|Double-Blind Period|Adverse Event|2|||
157184774|NCT00085644|567418014|FG002|Double-Blind Period|Adverse Event|0|||
157184775|NCT00085644|567418012|FG000|Double-Blind Period|Withdrawal by Subject|3|||
157065029|NCT01438840|566992775|FG001|Extension Phase|Withdrawal by Subject|0|||
157065030|NCT01438840|566992776|FG002|Extension Phase|Withdrawal by Subject|3|||
157065031|NCT01438840|566992774|FG000|Extension Phase|Lack of Efficacy|0|||
157065032|NCT01438840|566992775|FG001|Extension Phase|Lack of Efficacy|0|||
157065033|NCT01438840|566992776|FG002|Extension Phase|Lack of Efficacy|2|||
157065034|NCT01438840|566992774|FG000|Extension Phase|Other|0|||
157065035|NCT01438840|566992775|FG001|Extension Phase|Other|0|||
157065036|NCT01438840|566992776|FG002|Extension Phase|Other|1|||
157065037|NCT00461123|566992779|FG000|Overall Study|Adverse Event|1|||
157065038|NCT00461123|566992780|FG001|Overall Study|Adverse Event|0|||
157065039|NCT00461123|566992779|FG000|Overall Study|Lost to Follow-up|1|||
157065040|NCT00461123|566992780|FG001|Overall Study|Lost to Follow-up|1|||
157065041|NCT00461123|566992779|FG000|Overall Study|Protocol Violation|3|||
157065042|NCT00461123|566992780|FG001|Overall Study|Protocol Violation|2|||
157065043|NCT00461123|566992779|FG000|Overall Study|Withdrawal by Subject|1|||
157065044|NCT00461123|566992780|FG001|Overall Study|Withdrawal by Subject|3|||
157065045|NCT02024750|566992781|FG000|Overall Study|Withdrawal by Subject|2|||
157065046|NCT02024750|566992782|FG001|Overall Study|Withdrawal by Subject|1|||
157065047|NCT01891890|566992784|FG000|Overall Study|Lost to Follow-up|0|||
157065048|NCT01891890|566992785|FG001|Overall Study|Lost to Follow-up|0|||
157065049|NCT01891890|566992786|FG002|Overall Study|Lost to Follow-up|1|||
157065050|NCT01891890|566992784|FG000|Overall Study|Study ended before endpoint reached|7|||
157065051|NCT01891890|566992785|FG001|Overall Study|Study ended before endpoint reached|3|||
157065052|NCT01891890|566992786|FG002|Overall Study|Study ended before endpoint reached|6|||
157065053|NCT02725008|566992789|FG000|Overall Study|Lost to Follow-up|7|||
157065054|NCT02725008|566992790|FG001|Overall Study|Lost to Follow-up|9|||
157065055|NCT02725008|566992789|FG000|Overall Study|Withdrawal by Subject|2|||
157065056|NCT02725008|566992790|FG001|Overall Study|Withdrawal by Subject|2|||
157065057|NCT02725008|566992789|FG000|Overall Study|Admitted to hospital|0|||
157065058|NCT02725008|566992790|FG001|Overall Study|Admitted to hospital|1|||
157065059|NCT04688086|566992791|FG000|Overall Study|Lost to Follow-up|164|||
157065060|NCT04688086|566992791|FG000|Overall Study|Imaging error;|64|||
157065061|NCT01329419|566992794|FG000|Overall Study|Protocol Violation|235|||
157065062|NCT03015181|566992797|FG000|Overall Study|Enrolled, but product never administered|1|||
157065063|NCT03015181|566992798|FG001|Overall Study|Enrolled, but product never administered|0|||
157065064|NCT03015181|566992799|FG002|Overall Study|Enrolled, but product never administered|0|||
157065065|NCT03015181|566992800|FG003|Overall Study|Enrolled, but product never administered|0|||
157065066|NCT03015181|566992801|FG004|Overall Study|Enrolled, but product never administered|0|||
157065067|NCT03015181|566992802|FG005|Overall Study|Enrolled, but product never administered|0|||
157065068|NCT03015181|566992803|FG006|Overall Study|Enrolled, but product never administered|0|||
157065069|NCT03015181|566992797|FG000|Overall Study|Withdrawal by Subject|0|||
157065070|NCT03015181|566992798|FG001|Overall Study|Withdrawal by Subject|0|||
157065071|NCT03015181|566992799|FG002|Overall Study|Withdrawal by Subject|0|||
157065072|NCT03015181|566992800|FG003|Overall Study|Withdrawal by Subject|0|||
157065073|NCT03015181|566992801|FG004|Overall Study|Withdrawal by Subject|0|||
157065074|NCT03015181|566992802|FG005|Overall Study|Withdrawal by Subject|1|||
157065075|NCT03015181|566992803|FG006|Overall Study|Withdrawal by Subject|0|||
157065076|NCT03015181|566992797|FG000|Overall Study|Physician Decision|0|||
157065077|NCT03015181|566992798|FG001|Overall Study|Physician Decision|0|||
157065078|NCT03015181|566992799|FG002|Overall Study|Physician Decision|0|||
157065079|NCT03015181|566992800|FG003|Overall Study|Physician Decision|0|||
157065080|NCT03015181|566992801|FG004|Overall Study|Physician Decision|0|||
157065081|NCT03015181|566992802|FG005|Overall Study|Physician Decision|0|||
157065082|NCT03015181|566992803|FG006|Overall Study|Physician Decision|1|||
157065083|NCT01831726|566992806|FG000|Overall Study|Adverse Event|16|||
157065084|NCT01831726|566992806|FG000|Overall Study|Death|7|||
157065085|NCT01831726|566992806|FG000|Overall Study|Disease Progression|49|||
157065086|NCT01831726|566992806|FG000|Overall Study|Physician Decision|1|||
157065087|NCT01831726|566992806|FG000|Overall Study|Subject/guardian decision|7|||
157065088|NCT03821064|566992807|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
157065089|NCT00474383|566992809|FG000|Main Study|Adverse Event|11|||
157065090|NCT00474383|566992810|FG001|Main Study|Adverse Event|0|||
157065091|NCT00474383|566992809|FG000|Main Study|Symptomatic Deterioration|1|||
157065092|NCT00474383|566992810|FG001|Main Study|Symptomatic Deterioration|0|||
157065093|NCT00474383|566992809|FG000|Main Study|Progressive Disease|23|||
157065094|NCT00474383|566992810|FG001|Main Study|Progressive Disease|0|||
157065095|NCT00474383|566992809|FG000|Main Study|Other|1|||
157065096|NCT00474383|566992810|FG001|Main Study|Other|0|||
157065097|NCT00474383|566992809|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
157065098|NCT00474383|566992810|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
157065099|NCT00474383|566992809|FG000|Extension|Progressive Disease|0|||
157065100|NCT00474383|566992810|FG001|Extension|Progressive Disease|5|||
157065101|NCT01482819|566992811|FG000|Overall Study|Lost to Follow-up|2|||
157065102|NCT01502371|566992816|FG000|Overall Study|Withdrawal by Subject|1|||
157065103|NCT01502371|566992817|FG001|Overall Study|Withdrawal by Subject|2|||
157065104|NCT01502371|566992818|FG002|Overall Study|Withdrawal by Subject|1|||
157230082|NCT02016170|567588228|FG000|Overall Study|Protocol Violation|1|||
157065105|NCT01502371|566992819|FG003|Overall Study|Withdrawal by Subject|1|||
157065106|NCT01502371|566992820|FG004|Overall Study|Withdrawal by Subject|1|||
157065107|NCT01502371|566992816|FG000|Overall Study|Adverse Event|2|||
157065108|NCT01502371|566992817|FG001|Overall Study|Adverse Event|1|||
157065109|NCT01502371|566992818|FG002|Overall Study|Adverse Event|0|||
157065110|NCT01502371|566992819|FG003|Overall Study|Adverse Event|4|||
157065111|NCT01502371|566992820|FG004|Overall Study|Adverse Event|3|||
157065112|NCT01502371|566992816|FG000|Overall Study|Treatment Failure|22|||
157065113|NCT01502371|566992817|FG001|Overall Study|Treatment Failure|20|||
157065114|NCT01502371|566992818|FG002|Overall Study|Treatment Failure|12|||
157065115|NCT01502371|566992819|FG003|Overall Study|Treatment Failure|19|||
157065116|NCT01502371|566992820|FG004|Overall Study|Treatment Failure|30|||
157065117|NCT01502371|566992816|FG000|Overall Study|Lack of Efficacy|3|||
157065118|NCT01502371|566992817|FG001|Overall Study|Lack of Efficacy|3|||
157065119|NCT01502371|566992818|FG002|Overall Study|Lack of Efficacy|2|||
157065120|NCT01502371|566992819|FG003|Overall Study|Lack of Efficacy|2|||
157065121|NCT01502371|566992820|FG004|Overall Study|Lack of Efficacy|4|||
157065122|NCT01502371|566992816|FG000|Overall Study|Physician Decision|3|||
157065123|NCT01502371|566992817|FG001|Overall Study|Physician Decision|0|||
157065124|NCT01502371|566992818|FG002|Overall Study|Physician Decision|0|||
157065125|NCT01502371|566992819|FG003|Overall Study|Physician Decision|0|||
157065126|NCT01502371|566992820|FG004|Overall Study|Physician Decision|1|||
157065127|NCT01502371|566992816|FG000|Overall Study|Noncompliance with Study Drug|0|||
157065128|NCT01502371|566992817|FG001|Overall Study|Noncompliance with Study Drug|0|||
157065129|NCT01502371|566992818|FG002|Overall Study|Noncompliance with Study Drug|1|||
157065130|NCT01502371|566992819|FG003|Overall Study|Noncompliance with Study Drug|2|||
157065131|NCT01502371|566992820|FG004|Overall Study|Noncompliance with Study Drug|1|||
157065132|NCT01502371|566992816|FG000|Overall Study|Technical Problems|1|||
157065133|NCT01502371|566992817|FG001|Overall Study|Technical Problems|0|||
157065134|NCT01502371|566992818|FG002|Overall Study|Technical Problems|2|||
157065135|NCT01502371|566992819|FG003|Overall Study|Technical Problems|4|||
157065136|NCT01502371|566992820|FG004|Overall Study|Technical Problems|1|||
157065137|NCT01502371|566992816|FG000|Overall Study|Protocol Violation|9|||
157065138|NCT01502371|566992817|FG001|Overall Study|Protocol Violation|5|||
157065139|NCT01502371|566992818|FG002|Overall Study|Protocol Violation|6|||
157065140|NCT01502371|566992819|FG003|Overall Study|Protocol Violation|5|||
157065141|NCT01502371|566992820|FG004|Overall Study|Protocol Violation|10|||
157065142|NCT01502371|566992816|FG000|Overall Study|Excluded Medication|0|||
157065143|NCT01502371|566992817|FG001|Overall Study|Excluded Medication|1|||
157065144|NCT01502371|566992818|FG002|Overall Study|Excluded Medication|1|||
157065145|NCT01502371|566992819|FG003|Overall Study|Excluded Medication|0|||
157065146|NCT01502371|566992820|FG004|Overall Study|Excluded Medication|1|||
157065147|NCT00514813|566992825|FG000|Overall Study|Study terminated|14|||
157065148|NCT00514813|566992826|FG001|Overall Study|Study terminated|74|||
157065149|NCT00514813|566992827|FG002|Overall Study|Study terminated|40|||
157065150|NCT00514813|566992828|FG003|Overall Study|Study terminated|2|||
157065151|NCT00514813|566992825|FG000|Overall Study|Adverse Event|0|||
157065152|NCT00514813|566992826|FG001|Overall Study|Adverse Event|2|||
157065153|NCT00514813|566992827|FG002|Overall Study|Adverse Event|2|||
157065154|NCT00514813|566992828|FG003|Overall Study|Adverse Event|0|||
157065155|NCT00514813|566992825|FG000|Overall Study|Protocol Violation|1|||
157065156|NCT00514813|566992826|FG001|Overall Study|Protocol Violation|0|||
157065157|NCT00514813|566992827|FG002|Overall Study|Protocol Violation|0|||
157065158|NCT00514813|566992828|FG003|Overall Study|Protocol Violation|0|||
157065159|NCT00514813|566992825|FG000|Overall Study|Withdrawal by Subject|0|||
157065160|NCT00514813|566992826|FG001|Overall Study|Withdrawal by Subject|1|||
157065161|NCT00514813|566992827|FG002|Overall Study|Withdrawal by Subject|0|||
157065162|NCT00514813|566992828|FG003|Overall Study|Withdrawal by Subject|0|||
157184776|NCT00085644|567418013|FG001|Double-Blind Period|Withdrawal by Subject|0|||
157184777|NCT00085644|567418014|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157184778|NCT00085644|567418012|FG000|Double-Blind Period|Lost to Follow-up|2|||
157184779|NCT00085644|567418013|FG001|Double-Blind Period|Lost to Follow-up|1|||
157065163|NCT00514813|566992825|FG000|Overall Study|Lack of Efficacy|0|||
157065164|NCT00514813|566992826|FG001|Overall Study|Lack of Efficacy|1|||
157065165|NCT00514813|566992827|FG002|Overall Study|Lack of Efficacy|0|||
157065166|NCT00514813|566992828|FG003|Overall Study|Lack of Efficacy|0|||
157065167|NCT00514813|566992825|FG000|Overall Study|Kidney transplant|0|||
157065168|NCT00514813|566992826|FG001|Overall Study|Kidney transplant|6|||
157065169|NCT00514813|566992827|FG002|Overall Study|Kidney transplant|2|||
157065170|NCT00514813|566992828|FG003|Overall Study|Kidney transplant|0|||
157065171|NCT00514813|566992825|FG000|Overall Study|Death|0|||
157065172|NCT00514813|566992826|FG001|Overall Study|Death|2|||
157065173|NCT00514813|566992827|FG002|Overall Study|Death|3|||
157065174|NCT00514813|566992828|FG003|Overall Study|Death|2|||
157065175|NCT01075100|566992833|FG000|Overall Study|Adverse Event|15|||
157065176|NCT01075100|566992834|FG001|Overall Study|Adverse Event|18|||
157065177|NCT01075100|566992833|FG000|Overall Study|Patient Request|4|||
157065178|NCT01075100|566992834|FG001|Overall Study|Patient Request|4|||
157184780|NCT00085644|567418014|FG002|Double-Blind Period|Lost to Follow-up|0|||
157184781|NCT00085644|567418012|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
157065179|NCT01075100|566992833|FG000|Overall Study|Investigator Request|2|||
157065180|NCT01075100|566992834|FG001|Overall Study|Investigator Request|1|||
157065181|NCT01075100|566992833|FG000|Overall Study|Disease Progression|25|||
157065182|NCT01075100|566992834|FG001|Overall Study|Disease Progression|29|||
157065183|NCT01075100|566992833|FG000|Overall Study|Other|3|||
157065184|NCT01075100|566992834|FG001|Overall Study|Other|1|||
157065185|NCT04944784|566992835|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
157065186|NCT04944784|566992836|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
157065187|NCT04944784|566992837|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
157065188|NCT04944784|566992838|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
157065189|NCT04944784|566992835|FG000|Double-blind Period|Adverse Event|20|||
157065190|NCT04944784|566992836|FG001|Double-blind Period|Adverse Event|4|||
157065191|NCT04944784|566992837|FG002|Double-blind Period|Adverse Event|0|||
157065192|NCT04944784|566992838|FG003|Double-blind Period|Adverse Event|0|||
157065193|NCT04944784|566992835|FG000|Double-blind Period|Withdrawal by Subject|15|||
157065194|NCT04944784|566992836|FG001|Double-blind Period|Withdrawal by Subject|4|||
157065195|NCT04944784|566992837|FG002|Double-blind Period|Withdrawal by Subject|0|||
157065196|NCT04944784|566992838|FG003|Double-blind Period|Withdrawal by Subject|0|||
157065197|NCT04944784|566992835|FG000|Double-blind Period|Death|7|||
157065198|NCT04944784|566992836|FG001|Double-blind Period|Death|2|||
157065199|NCT04944784|566992837|FG002|Double-blind Period|Death|0|||
157065200|NCT04944784|566992838|FG003|Double-blind Period|Death|0|||
157065201|NCT04944784|566992835|FG000|Double-blind Period|Physician Decision|2|||
157065202|NCT04944784|566992836|FG001|Double-blind Period|Physician Decision|1|||
157065203|NCT04944784|566992837|FG002|Double-blind Period|Physician Decision|0|||
157065204|NCT04944784|566992838|FG003|Double-blind Period|Physician Decision|0|||
157065205|NCT04944784|566992835|FG000|Double-blind Period|Lack of Efficacy|0|||
157065206|NCT04944784|566992836|FG001|Double-blind Period|Lack of Efficacy|1|||
157065207|NCT04944784|566992837|FG002|Double-blind Period|Lack of Efficacy|0|||
157065208|NCT04944784|566992838|FG003|Double-blind Period|Lack of Efficacy|0|||
157065209|NCT04944784|566992835|FG000|Double-blind Period|Sponsor Request|2|||
157065210|NCT04944784|566992836|FG001|Double-blind Period|Sponsor Request|1|||
157065211|NCT04944784|566992837|FG002|Double-blind Period|Sponsor Request|0|||
157065212|NCT04944784|566992838|FG003|Double-blind Period|Sponsor Request|0|||
157065213|NCT04944784|566992835|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
157065214|NCT04944784|566992836|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
157065215|NCT04944784|566992837|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
157065216|NCT04944784|566992838|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
157065217|NCT04944784|566992835|FG000|Double-blind Period|Participant Choice|1|||
157065218|NCT04944784|566992836|FG001|Double-blind Period|Participant Choice|1|||
157065219|NCT04944784|566992837|FG002|Double-blind Period|Participant Choice|0|||
157065220|NCT04944784|566992838|FG003|Double-blind Period|Participant Choice|0|||
157065221|NCT04944784|566992835|FG000|Double-blind Period|Progressive Disease|2|||
157065222|NCT04944784|566992836|FG001|Double-blind Period|Progressive Disease|2|||
157065223|NCT04944784|566992837|FG002|Double-blind Period|Progressive Disease|0|||
157065224|NCT04944784|566992838|FG003|Double-blind Period|Progressive Disease|0|||
157065225|NCT04944784|566992835|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
157065226|NCT04944784|566992836|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
157065227|NCT04944784|566992837|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
157065228|NCT04944784|566992838|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
157065229|NCT04944784|566992835|FG000|Active Drug Period|Adverse Event|0|||
157065230|NCT04944784|566992836|FG001|Active Drug Period|Adverse Event|0|||
157065231|NCT04944784|566992837|FG002|Active Drug Period|Adverse Event|3|||
157065232|NCT04944784|566992838|FG003|Active Drug Period|Adverse Event|6|||
157065233|NCT04944784|566992835|FG000|Active Drug Period|Withdrawal by Subject|0|||
157065234|NCT04944784|566992836|FG001|Active Drug Period|Withdrawal by Subject|0|||
157065235|NCT04944784|566992837|FG002|Active Drug Period|Withdrawal by Subject|4|||
157065236|NCT04944784|566992838|FG003|Active Drug Period|Withdrawal by Subject|7|||
157065237|NCT04944784|566992835|FG000|Active Drug Period|Death|0|||
157065238|NCT04944784|566992836|FG001|Active Drug Period|Death|0|||
157065239|NCT04944784|566992837|FG002|Active Drug Period|Death|3|||
157065240|NCT04944784|566992838|FG003|Active Drug Period|Death|4|||
157230083|NCT02016170|567588229|FG001|Overall Study|Protocol Violation|0|||
157230084|NCT02016170|567588230|FG002|Overall Study|Protocol Violation|0|||
157230085|NCT02365207|567588234|FG000|Overall Study|Withdrawal by Subject|1|||
157065241|NCT04944784|566992835|FG000|Active Drug Period|Lack of Efficacy|0|||
157065242|NCT04944784|566992836|FG001|Active Drug Period|Lack of Efficacy|0|||
157065243|NCT04944784|566992837|FG002|Active Drug Period|Lack of Efficacy|2|||
157065244|NCT04944784|566992838|FG003|Active Drug Period|Lack of Efficacy|2|||
157065245|NCT04944784|566992835|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
157065246|NCT04944784|566992836|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
157065247|NCT04944784|566992837|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
157065248|NCT04944784|566992838|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
157065249|NCT04944784|566992835|FG000|Active Drug Period|Participant Choice|0|||
157065250|NCT04944784|566992836|FG001|Active Drug Period|Participant Choice|0|||
157230086|NCT02365207|567588234|FG000|Overall Study|Physician Decision|1|||
157184782|NCT00085644|567418013|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
157184783|NCT00085644|567418014|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
157184784|NCT00085644|567418012|FG000|Double-Blind Period|Contemplating pregnancy|1|||
157184785|NCT00085644|567418013|FG001|Double-Blind Period|Contemplating pregnancy|0|||
157184786|NCT00085644|567418014|FG002|Double-Blind Period|Contemplating pregnancy|0|||
157184787|NCT00085644|567418012|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
157184788|NCT00085644|567418013|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
157184789|NCT00085644|567418014|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
157184790|NCT00085644|567418012|FG000|Open-Label Period|Adverse Event|0|||
157184791|NCT00085644|567418013|FG001|Open-Label Period|Adverse Event|0|||
157184792|NCT00085644|567418014|FG002|Open-Label Period|Adverse Event|38|||
156977110|NCT00244374|566670615|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
156977111|NCT00244374|566670616|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156977112|NCT00244374|566670617|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156977113|NCT00244374|566670618|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156977114|NCT00244374|566670619|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
156977115|NCT00244374|566670615|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
156977116|NCT00244374|566670616|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156977117|NCT00244374|566670617|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156977118|NCT00244374|566670618|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156977119|NCT00244374|566670619|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
156977120|NCT00244374|566670615|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
156977121|NCT00244374|566670616|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156977122|NCT00244374|566670617|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156977123|NCT00244374|566670618|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156977124|NCT00244374|566670619|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
156977125|NCT00244374|566670615|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
156977126|NCT00244374|566670616|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156977127|NCT00244374|566670617|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156977128|NCT00244374|566670618|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156977129|NCT00244374|566670619|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
156977130|NCT00244374|566670615|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
156977131|NCT00244374|566670616|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156977132|NCT00244374|566670617|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156977133|NCT00244374|566670618|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156977134|NCT00244374|566670619|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
156977135|NCT00244374|566670615|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
156977136|NCT00244374|566670616|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156977137|NCT00244374|566670617|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156977138|NCT00244374|566670618|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156977139|NCT00244374|566670619|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
156977140|NCT00244374|566670615|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
156977141|NCT00244374|566670616|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156977142|NCT00244374|566670617|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156977143|NCT00244374|566670618|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156977144|NCT00244374|566670619|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
156977145|NCT00244374|566670615|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
156977146|NCT00244374|566670616|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156977147|NCT00244374|566670617|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156977148|NCT00244374|566670618|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156977149|NCT00244374|566670619|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
156977150|NCT00244374|566670615|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
156977151|NCT00244374|566670616|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156977152|NCT00244374|566670617|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156977153|NCT00244374|566670618|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
157184793|NCT00085644|567418012|FG000|Open-Label Period|Withdrawal by Subject|0|||
157184794|NCT00085644|567418013|FG001|Open-Label Period|Withdrawal by Subject|0|||
157184795|NCT00085644|567418014|FG002|Open-Label Period|Withdrawal by Subject|29|||
157184796|NCT00085644|567418012|FG000|Open-Label Period|Lost to Follow-up|0|||
157065251|NCT04944784|566992837|FG002|Active Drug Period|Participant Choice|0|||
157065252|NCT04944784|566992838|FG003|Active Drug Period|Participant Choice|1|||
157065253|NCT04944784|566992835|FG000|Active Drug Period|Progressive Disease|0|||
157065254|NCT04944784|566992836|FG001|Active Drug Period|Progressive Disease|0|||
157065255|NCT04944784|566992837|FG002|Active Drug Period|Progressive Disease|4|||
157065256|NCT04944784|566992838|FG003|Active Drug Period|Progressive Disease|4|||
157065257|NCT04944784|566992835|FG000|Active Drug Period|Lost to Follow-up|0|||
157065258|NCT04944784|566992836|FG001|Active Drug Period|Lost to Follow-up|0|||
157065259|NCT04944784|566992837|FG002|Active Drug Period|Lost to Follow-up|0|||
157065260|NCT04944784|566992838|FG003|Active Drug Period|Lost to Follow-up|1|||
157065261|NCT02034162|566994264|FG000|Double-blind|Lost to Follow-up|3|||
157065262|NCT02034162|566994265|FG001|Double-blind|Lost to Follow-up|0|||
157065263|NCT02034162|566994266|FG002|Double-blind|Lost to Follow-up|0|||
157065264|NCT02034162|566994264|FG000|Double-blind|Physician Decision|1|||
157065265|NCT02034162|566994265|FG001|Double-blind|Physician Decision|0|||
157065266|NCT02034162|566994266|FG002|Double-blind|Physician Decision|0|||
157065267|NCT02034162|566994264|FG000|Double-blind|Protocol Violation|0|||
157065268|NCT02034162|566994265|FG001|Double-blind|Protocol Violation|1|||
157065269|NCT02034162|566994266|FG002|Double-blind|Protocol Violation|0|||
157065270|NCT02034162|566994264|FG000|Double-blind|Withdrawal by Subject|5|||
157065271|NCT02034162|566994265|FG001|Double-blind|Withdrawal by Subject|7|||
157065272|NCT02034162|566994266|FG002|Double-blind|Withdrawal by Subject|0|||
157065273|NCT00760513|566994267|FG000|Overall Study|Withdrawal by Subject|5|||
157065274|NCT00760513|566994268|FG001|Overall Study|Withdrawal by Subject|7|||
157065275|NCT03458728|566994269|FG000|Overall Study|Adverse Event|1|||
157065276|NCT03458728|566994270|FG001|Overall Study|Adverse Event|0|||
157065277|NCT03458728|566994269|FG000|Overall Study|Physician Decision|1|||
157065278|NCT03458728|566994270|FG001|Overall Study|Physician Decision|0|||
157065279|NCT03458728|566994269|FG000|Overall Study|Progressive disease - clinical assessment|1|||
157065280|NCT03458728|566994270|FG001|Overall Study|Progressive disease - clinical assessment|0|||
157065281|NCT03458728|566994269|FG000|Overall Study|Progressive disease - radiological progression|21|||
157065282|NCT03458728|566994270|FG001|Overall Study|Progressive disease - radiological progression|6|||
157065283|NCT03458728|566994269|FG000|Overall Study|Withdrawal by Subject|0|||
157065284|NCT03458728|566994270|FG001|Overall Study|Withdrawal by Subject|1|||
157065285|NCT03898700|566994273|FG000|Overall Study|Withdrawal by Subject|2|||
157065286|NCT00701909|566994277|FG000|Overall Study|Withdrawal by Subject|0|||
157065287|NCT00701909|566994278|FG001|Overall Study|Withdrawal by Subject|1|||
157065288|NCT00908349|566994281|FG000|Overall Study|Adverse Event|10|||
157065289|NCT00908349|566994281|FG000|Overall Study|Withdrawal by Subject|9|||
157065290|NCT00908349|566994281|FG000|Overall Study|Physician Decision|5|||
157065291|NCT00908349|566994281|FG000|Overall Study|Lost to Follow-up|5|||
157065292|NCT00908349|566994281|FG000|Overall Study|Various|6|||
157065293|NCT00971997|566994282|FG000|Overall Study|Adverse Event|2|||
157065294|NCT00971997|566994282|FG000|Overall Study|Death|1|||
157065295|NCT00971997|566994282|FG000|Overall Study|Protocol Violation|4|||
157065296|NCT00971997|566994282|FG000|Overall Study|Withdrawal by Subject|5|||
157065297|NCT00971997|566994282|FG000|Overall Study|Physician Decision|7|||
157065298|NCT00761956|566994287|FG000|Overall Study|Lost to Follow-up|6|||
157065299|NCT00761956|566994288|FG001|Overall Study|Lost to Follow-up|11|||
157065300|NCT00761956|566994287|FG000|Overall Study|Withdrawal by Subject|3|||
157065301|NCT00761956|566994288|FG001|Overall Study|Withdrawal by Subject|8|||
157065302|NCT00761956|566994287|FG000|Overall Study|Death|0|||
157065303|NCT00761956|566994288|FG001|Overall Study|Death|1|||
157065304|NCT00761956|566994287|FG000|Overall Study|Adverse Event|26|||
157065305|NCT00761956|566994288|FG001|Overall Study|Adverse Event|34|||
157065306|NCT02808975|566994291|FG000|Overall Study|Adverse Event|3|||
157065307|NCT02808975|566994292|FG001|Overall Study|Adverse Event|4|||
157065308|NCT02808975|566994291|FG000|Overall Study|Withdrew consent|9|||
157065309|NCT02808975|566994292|FG001|Overall Study|Withdrew consent|8|||
157065310|NCT02808975|566994291|FG000|Overall Study|Lost to Follow-up|4|||
157065311|NCT02808975|566994292|FG001|Overall Study|Lost to Follow-up|6|||
157065312|NCT02808975|566994291|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
157065313|NCT02808975|566994292|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
157065314|NCT02808975|566994291|FG000|Overall Study|Other, not specified|5|||
157065315|NCT02808975|566994292|FG001|Overall Study|Other, not specified|1|||
157065316|NCT01288209|566994293|FG000|Overall Study|Withdrawal by Subject|1|||
157065317|NCT01288209|566994294|FG001|Overall Study|Withdrawal by Subject|3|||
157065318|NCT01288209|566994293|FG000|Overall Study|Other|1|||
157065319|NCT01288209|566994294|FG001|Overall Study|Other|0|||
157065320|NCT03463577|566994295|FG000|Overall Study|Lost to Follow-up|238|||
157065321|NCT03463577|566994296|FG001|Overall Study|Lost to Follow-up|435|||
157065322|NCT03463577|566994297|FG002|Overall Study|Lost to Follow-up|0|||
157065323|NCT03463577|566994298|FG003|Overall Study|Lost to Follow-up|0|||
157065324|NCT03463577|566994299|FG004|Overall Study|Lost to Follow-up|0|||
157065325|NCT03463577|566994300|FG005|Overall Study|Lost to Follow-up|0|||
157065326|NCT03463577|566994295|FG000|Overall Study|With unknown pregnancy outcome|0|||
157065327|NCT03463577|566994296|FG001|Overall Study|With unknown pregnancy outcome|5|||
157230087|NCT01318499|567588237|FG000|Overall Study|Adverse Event|16|||
157065328|NCT03463577|566994297|FG002|Overall Study|With unknown pregnancy outcome|0|||
157065329|NCT03463577|566994298|FG003|Overall Study|With unknown pregnancy outcome|0|||
157065330|NCT03463577|566994299|FG004|Overall Study|With unknown pregnancy outcome|0|||
157065331|NCT03463577|566994300|FG005|Overall Study|With unknown pregnancy outcome|0|||
157065332|NCT03463577|566994295|FG000|Overall Study|Maternal death|2|||
157065333|NCT03463577|566994296|FG001|Overall Study|Maternal death|0|||
157065334|NCT03463577|566994297|FG002|Overall Study|Maternal death|0|||
157065335|NCT03463577|566994298|FG003|Overall Study|Maternal death|0|||
157065336|NCT03463577|566994299|FG004|Overall Study|Maternal death|0|||
157065337|NCT03463577|566994300|FG005|Overall Study|Maternal death|0|||
157065338|NCT03463577|566994295|FG000|Overall Study|Neonatal death|0|||
157065339|NCT03463577|566994296|FG001|Overall Study|Neonatal death|0|||
157065340|NCT03463577|566994297|FG002|Overall Study|Neonatal death|0|||
157065341|NCT03463577|566994298|FG003|Overall Study|Neonatal death|15|||
157065342|NCT03463577|566994299|FG004|Overall Study|Neonatal death|17|||
157065343|NCT03463577|566994300|FG005|Overall Study|Neonatal death|0|||
157065344|NCT00236184|566994301|FG000|Overall Study|Adverse Event|5|||
157065345|NCT00236184|566994302|FG001|Overall Study|Adverse Event|2|||
157065346|NCT00236184|566994301|FG000|Overall Study|Lack of Efficacy|0|||
157065347|NCT00236184|566994302|FG001|Overall Study|Lack of Efficacy|1|||
157065348|NCT00236184|566994301|FG000|Overall Study|Lost to Follow-up|3|||
157065349|NCT00236184|566994302|FG001|Overall Study|Lost to Follow-up|4|||
157065350|NCT00236184|566994301|FG000|Overall Study|Physician Decision|1|||
157065351|NCT00236184|566994302|FG001|Overall Study|Physician Decision|1|||
157065352|NCT00236184|566994301|FG000|Overall Study|Withdrawal by Subject|3|||
157065353|NCT00236184|566994302|FG001|Overall Study|Withdrawal by Subject|0|||
157065354|NCT00236184|566994301|FG000|Overall Study|Protocol Violation|3|||
157065355|NCT00236184|566994302|FG001|Overall Study|Protocol Violation|0|||
157065356|NCT00236184|566994301|FG000|Overall Study|non-compliance with study drug|2|||
157065357|NCT00236184|566994302|FG001|Overall Study|non-compliance with study drug|1|||
157065358|NCT00236184|566994301|FG000|Overall Study|other|1|||
157065359|NCT00236184|566994302|FG001|Overall Study|other|2|||
157065360|NCT01316887|566994303|FG000|Overall Study|Adverse Event|13|||
157065361|NCT01316887|566994304|FG001|Overall Study|Adverse Event|21|||
157065362|NCT01316887|566994305|FG002|Overall Study|Adverse Event|17|||
157065363|NCT01316887|566994303|FG000|Overall Study|Lack of Efficacy|9|||
157065364|NCT01316887|566994304|FG001|Overall Study|Lack of Efficacy|3|||
157065365|NCT01316887|566994305|FG002|Overall Study|Lack of Efficacy|1|||
157065366|NCT01316887|566994303|FG000|Overall Study|Protocol Violation|2|||
157065367|NCT01316887|566994304|FG001|Overall Study|Protocol Violation|6|||
157065368|NCT01316887|566994305|FG002|Overall Study|Protocol Violation|6|||
157065369|NCT01316887|566994303|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
157065370|NCT01316887|566994304|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
157065371|NCT01316887|566994305|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
157065372|NCT01316887|566994303|FG000|Overall Study|Study Closed/Terminated|2|||
157065373|NCT01316887|566994304|FG001|Overall Study|Study Closed/Terminated|4|||
157065374|NCT01316887|566994305|FG002|Overall Study|Study Closed/Terminated|3|||
157065375|NCT01316887|566994303|FG000|Overall Study|Lost to Follow-up|1|||
157065376|NCT01316887|566994304|FG001|Overall Study|Lost to Follow-up|7|||
157065377|NCT01316887|566994305|FG002|Overall Study|Lost to Follow-up|5|||
157065378|NCT01316887|566994303|FG000|Overall Study|Withdrawal by Subject|8|||
157065379|NCT01316887|566994304|FG001|Overall Study|Withdrawal by Subject|16|||
157065380|NCT01316887|566994305|FG002|Overall Study|Withdrawal by Subject|15|||
157065381|NCT00469456|566994306|FG000|Overall Study|Adverse Event|4|||
157065382|NCT00469456|566994307|FG001|Overall Study|Adverse Event|3|||
157065383|NCT00469456|566994306|FG000|Overall Study|Protocol Violation|1|||
157065384|NCT00469456|566994307|FG001|Overall Study|Protocol Violation|0|||
157065385|NCT00469456|566994306|FG000|Overall Study|Withdrawal by Subject|4|||
157065386|NCT00469456|566994307|FG001|Overall Study|Withdrawal by Subject|1|||
157065387|NCT00704171|566994308|FG000|Overall Study|Withdrawal by Subject|1|||
157065388|NCT00704171|566994309|FG001|Overall Study|Withdrawal by Subject|0|||
157065389|NCT00813098|566994314|FG000|Overall Study|Adverse Event|2|||
157065390|NCT00813098|566994315|FG001|Overall Study|Adverse Event|4|||
157230088|NCT01318499|567588238|FG001|Overall Study|Adverse Event|11|||
157230089|NCT01318499|567588239|FG002|Overall Study|Adverse Event|6|||
157065391|NCT00813098|566994316|FG002|Overall Study|Adverse Event|1|||
157065392|NCT00813098|566994314|FG000|Overall Study|Withdrawal by Subject|0|||
157065393|NCT00813098|566994315|FG001|Overall Study|Withdrawal by Subject|1|||
157065394|NCT00813098|566994316|FG002|Overall Study|Withdrawal by Subject|0|||
157065395|NCT00813098|566994314|FG000|Overall Study|Inability to complete study procedures|1|||
157065396|NCT00813098|566994315|FG001|Overall Study|Inability to complete study procedures|0|||
157065397|NCT00813098|566994316|FG002|Overall Study|Inability to complete study procedures|0|||
157065398|NCT00813098|566994314|FG000|Overall Study|Lost to Follow-up|0|||
157065399|NCT00813098|566994315|FG001|Overall Study|Lost to Follow-up|1|||
157065400|NCT00813098|566994316|FG002|Overall Study|Lost to Follow-up|0|||
157065401|NCT00813098|566994314|FG000|Overall Study|Protocol Violation|0|||
157065402|NCT00813098|566994315|FG001|Overall Study|Protocol Violation|0|||
157230090|NCT01318499|567588237|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
157065403|NCT00813098|566994316|FG002|Overall Study|Protocol Violation|1|||
157065404|NCT00813098|566994314|FG000|Overall Study|Principal Investigator decision|0|||
157065405|NCT00813098|566994315|FG001|Overall Study|Principal Investigator decision|1|||
157065406|NCT00813098|566994316|FG002|Overall Study|Principal Investigator decision|0|||
157065407|NCT00813098|566994314|FG000|Overall Study|Withdrew Consent|0|||
157065408|NCT00813098|566994315|FG001|Overall Study|Withdrew Consent|1|||
157065409|NCT00813098|566994316|FG002|Overall Study|Withdrew Consent|0|||
157065410|NCT01777490|566994319|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
157065411|NCT01777490|566994320|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
157065412|NCT01777490|566994321|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
157065413|NCT01777490|566994322|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
157065414|NCT03672175|566994325|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
157065415|NCT03672175|566994326|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
157065416|NCT03672175|566994327|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
157065417|NCT03672175|566994325|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
157065418|NCT03672175|566994326|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
157065419|NCT03672175|566994327|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
157065420|NCT03672175|566994325|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
157065421|NCT03672175|566994326|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
157065422|NCT03672175|566994327|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
157065423|NCT03672175|566994325|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
157065424|NCT03672175|566994326|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
157065425|NCT03672175|566994327|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
157065426|NCT03672175|566994325|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
157065427|NCT03672175|566994326|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
157065428|NCT03672175|566994327|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
157065429|NCT03672175|566994325|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
157065430|NCT03672175|566994326|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
157065431|NCT03672175|566994327|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
157065432|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
157065433|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
157065434|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
157065435|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
157065436|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
157065437|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
157065438|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
157065439|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
157065440|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
157065441|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
157065442|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
157065443|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
157065444|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
157065445|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
157065446|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
157065447|NCT03672175|566994325|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
157065448|NCT03672175|566994326|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
157065449|NCT03672175|566994327|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
157065450|NCT01772563|566994328|FG000|Cycle 1|Dose limiting toxicity|2|||
157065451|NCT01772563|566994328|FG000|Cycle 1|Progressive disease|2|||
157065452|NCT01772563|566994328|FG000|Cycle 2 and Beyond|Progressive disease|17|||
157065453|NCT01772563|566994328|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
157065454|NCT01772563|566994328|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
157184797|NCT00085644|567418013|FG001|Open-Label Period|Lost to Follow-up|0|||
157184798|NCT00085644|567418014|FG002|Open-Label Period|Lost to Follow-up|13|||
157184799|NCT00085644|567418012|FG000|Open-Label Period|Lack of Efficacy|0|||
157184800|NCT00085644|567418013|FG001|Open-Label Period|Lack of Efficacy|0|||
157184801|NCT00085644|567418014|FG002|Open-Label Period|Lack of Efficacy|15|||
157184802|NCT00085644|567418012|FG000|Open-Label Period|Pregnancy|0|||
157065455|NCT00255944|566994332|FG000|Overall Study|Lost to Follow-up|797|||
157065456|NCT00255944|566994333|FG001|Overall Study|Lost to Follow-up|834|||
157065457|NCT01121913|566994335|FG000|First Intervention Period|Adverse Event|0|||
157065458|NCT01121913|566994336|FG001|First Intervention Period|Adverse Event|0|||
157065459|NCT01121913|566994337|FG002|First Intervention Period|Adverse Event|1|||
157065460|NCT01121913|566994338|FG003|First Intervention Period|Adverse Event|0|||
157184803|NCT00085644|567418013|FG001|Open-Label Period|Pregnancy|0|||
157184804|NCT00085644|567418014|FG002|Open-Label Period|Pregnancy|3|||
157184805|NCT00085644|567418012|FG000|Open-Label Period|Contemplating pregnancy|0|||
157184806|NCT00085644|567418013|FG001|Open-Label Period|Contemplating pregnancy|0|||
157184807|NCT00085644|567418014|FG002|Open-Label Period|Contemplating pregnancy|3|||
157184808|NCT00085644|567418012|FG000|Open-Label Period|Protocol Violation|0|||
157065461|NCT01121913|566994335|FG000|First Washout Period|Withdrawal by Subject|1|||
157065462|NCT01121913|566994336|FG001|First Washout Period|Withdrawal by Subject|0|||
157065463|NCT01121913|566994337|FG002|First Washout Period|Withdrawal by Subject|0|||
157065464|NCT01121913|566994338|FG003|First Washout Period|Withdrawal by Subject|0|||
157065465|NCT01121913|566994335|FG000|Second Intervention Period|Adverse Event|0|||
157065466|NCT01121913|566994336|FG001|Second Intervention Period|Adverse Event|0|||
157065467|NCT01121913|566994337|FG002|Second Intervention Period|Adverse Event|1|||
157065468|NCT01121913|566994338|FG003|Second Intervention Period|Adverse Event|0|||
157065469|NCT01121913|566994335|FG000|Second Washout Period|Withdrawal by Subject|0|||
157065470|NCT01121913|566994336|FG001|Second Washout Period|Withdrawal by Subject|0|||
157065471|NCT01121913|566994337|FG002|Second Washout Period|Withdrawal by Subject|1|||
157065472|NCT01121913|566994338|FG003|Second Washout Period|Withdrawal by Subject|0|||
157065473|NCT01121913|566994335|FG000|Third Washout Period|Adverse Event|1|||
157065474|NCT01121913|566994336|FG001|Third Washout Period|Adverse Event|0|||
157065475|NCT01121913|566994337|FG002|Third Washout Period|Adverse Event|0|||
157065476|NCT01121913|566994338|FG003|Third Washout Period|Adverse Event|0|||
157065477|NCT00690378|566994339|FG000|Overall Study|Adverse Event|1|||
157065478|NCT00690378|566994340|FG001|Overall Study|Adverse Event|0|||
157065479|NCT00690378|566994339|FG000|Overall Study|Withdrawal by Subject|2|||
157065480|NCT00690378|566994340|FG001|Overall Study|Withdrawal by Subject|0|||
157065481|NCT00690378|566994339|FG000|Overall Study|Protocol Violation|1|||
157065482|NCT00690378|566994340|FG001|Overall Study|Protocol Violation|0|||
157065483|NCT00690378|566994339|FG000|Overall Study|Lost to Follow-up|2|||
157065484|NCT00690378|566994340|FG001|Overall Study|Lost to Follow-up|3|||
157065485|NCT00690378|566994339|FG000|Overall Study|Did not meet inc/exc criteria|13|||
157065486|NCT00690378|566994340|FG001|Overall Study|Did not meet inc/exc criteria|11|||
157065487|NCT00690378|566994339|FG000|Overall Study|Social problem|1|||
157065488|NCT00690378|566994340|FG001|Overall Study|Social problem|0|||
157065489|NCT02019641|566994350|FG000|10-Week Follow up|Withdrawal by investigator|2|||
157065490|NCT02019641|566994351|FG001|10-Week Follow up|Withdrawal by investigator|0|||
157065491|NCT02019641|566994352|FG002|10-Week Follow up|Withdrawal by investigator|0|||
157065492|NCT02019641|566994350|FG000|10-Week Follow up|Withdrawal by Subject|1|||
157065493|NCT02019641|566994351|FG001|10-Week Follow up|Withdrawal by Subject|1|||
157065494|NCT02019641|566994352|FG002|10-Week Follow up|Withdrawal by Subject|0|||
157065495|NCT02019641|566994350|FG000|20-Week Follow up|Withdrawal by investigator|0|||
157065496|NCT02019641|566994351|FG001|20-Week Follow up|Withdrawal by investigator|0|||
157065497|NCT02019641|566994352|FG002|20-Week Follow up|Withdrawal by investigator|1|||
157065498|NCT00468130|566994353|FG000|Overall Study|Adverse Event|2|||
157065499|NCT00468130|566994354|FG001|Overall Study|Adverse Event|1|||
157065500|NCT00468130|566994353|FG000|Overall Study|Withdrawal by Subject|0|||
157065501|NCT00468130|566994354|FG001|Overall Study|Withdrawal by Subject|1|||
157065502|NCT02485899|566994355|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
157065503|NCT02485899|566994356|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
157065504|NCT02485899|566994355|FG000|Overall Study|Withdrawal by Subject|1|||
157065505|NCT02485899|566994356|FG001|Overall Study|Withdrawal by Subject|0|||
157065506|NCT02485899|566994355|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
157065507|NCT02485899|566994356|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
157065508|NCT00623363|566994357|FG000|Overall Study|Adverse Event|2|||
157065509|NCT00623363|566994358|FG001|Overall Study|Adverse Event|2|||
157065510|NCT03713320|566994359|FG000|Randomized Period|Adverse Event|1|||
157184809|NCT00085644|567418013|FG001|Open-Label Period|Protocol Violation|0|||
157184810|NCT00085644|567418014|FG002|Open-Label Period|Protocol Violation|4|||
157184811|NCT00085644|567418012|FG000|Open-Label Period|Personal reason|0|||
157184812|NCT00085644|567418013|FG001|Open-Label Period|Personal reason|0|||
157065511|NCT03713320|566994360|FG001|Randomized Period|Adverse Event|5|||
157065512|NCT03713320|566994361|FG002|Randomized Period|Adverse Event|0|||
157065513|NCT03713320|566994359|FG000|Randomized Period|Physician Decision|1|||
157065514|NCT03713320|566994360|FG001|Randomized Period|Physician Decision|1|||
157065515|NCT03713320|566994361|FG002|Randomized Period|Physician Decision|0|||
157065516|NCT03713320|566994359|FG000|Randomized Period|Withdrawal by Subject|4|||
157065517|NCT03713320|566994360|FG001|Randomized Period|Withdrawal by Subject|0|||
157065518|NCT03713320|566994361|FG002|Randomized Period|Withdrawal by Subject|0|||
157065519|NCT03713320|566994359|FG000|Randomized Period|Participant decision|3|||
157184813|NCT00085644|567418014|FG002|Open-Label Period|Personal reason|4|||
157065520|NCT03713320|566994360|FG001|Randomized Period|Participant decision|1|||
157065521|NCT03713320|566994361|FG002|Randomized Period|Participant decision|0|||
157065522|NCT03713320|566994359|FG000|Randomized Period|Study terminated by sponsor|6|||
157065523|NCT03713320|566994360|FG001|Randomized Period|Study terminated by sponsor|3|||
157065524|NCT03713320|566994361|FG002|Randomized Period|Study terminated by sponsor|0|||
157065525|NCT03713320|566994359|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
157065526|NCT03713320|566994360|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
157065527|NCT03713320|566994361|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
157065528|NCT03713320|566994359|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
157184814|NCT04259346|567418015|FG000|Overall Study|Lost to Follow-up|1|||
157230091|NCT01318499|567588238|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
157230092|NCT01318499|567588239|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
157230093|NCT01318499|567588237|FG000|Overall Study|Noncompliance|2|||
157230094|NCT01318499|567588238|FG001|Overall Study|Noncompliance|3|||
157230095|NCT01318499|567588239|FG002|Overall Study|Noncompliance|0|||
157230096|NCT01318499|567588237|FG000|Overall Study|Treatment Failure|19|||
157230097|NCT01318499|567588238|FG001|Overall Study|Treatment Failure|19|||
157230098|NCT01318499|567588239|FG002|Overall Study|Treatment Failure|101|||
157230099|NCT01318499|567588237|FG000|Overall Study|Protocol Violation|2|||
157230100|NCT01318499|567588238|FG001|Overall Study|Protocol Violation|4|||
157230101|NCT01318499|567588239|FG002|Overall Study|Protocol Violation|2|||
157230102|NCT01318499|567588237|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
157230103|NCT01318499|567588238|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
157230104|NCT01318499|567588239|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
157230105|NCT01318499|567588237|FG000|Overall Study|Other|7|||
157230106|NCT01318499|567588238|FG001|Overall Study|Other|10|||
157230107|NCT01318499|567588239|FG002|Overall Study|Other|22|||
157230108|NCT01395030|567588240|FG000|Overall Study|Did not complete FCH PET/CT|7|||
157230109|NCT01347710|567588246|FG000|Overall Study|Withdrawal by Subject|2|||
157230110|NCT01347710|567588246|FG000|Overall Study|Adverse Event|4|||
157230111|NCT01347710|567588246|FG000|Overall Study|Angio or SPECT not completed|18|||
157230112|NCT01347710|567588246|FG000|Overall Study|issue with vitals prior to dosing|1|||
157230113|NCT01347710|567588246|FG000|Overall Study|Lost to Follow-up|1|||
157230114|NCT01347710|567588246|FG000|Overall Study|Physician Decision|2|||
157230115|NCT01347710|567588246|FG000|Overall Study|Other|3|||
157230116|NCT04591626|567588248|FG000|Overall Study|Adverse Event|4|||
157184815|NCT04259346|567418016|FG001|Overall Study|Lost to Follow-up|3|||
157184816|NCT04259346|567418015|FG000|Overall Study|Protocol Violation|1|||
157184817|NCT04259346|567418016|FG001|Overall Study|Protocol Violation|0|||
157184818|NCT04259346|567418015|FG000|Overall Study|Withdrawal by Subject|1|||
157184819|NCT04259346|567418016|FG001|Overall Study|Withdrawal by Subject|0|||
157184820|NCT04259346|567418015|FG000|Overall Study|Adverse Event|1|||
157184821|NCT04259346|567418016|FG001|Overall Study|Adverse Event|1|||
157184822|NCT03330106|567418019|FG000|Part A|Withdrawal by Subject|1|||
157184823|NCT03330106|567418020|FG001|Part A|Withdrawal by Subject|1|||
157184824|NCT03330106|567418021|FG002|Part A|Withdrawal by Subject|0|||
157184825|NCT03330106|567418022|FG003|Part A|Withdrawal by Subject|0|||
157184826|NCT03330106|567418019|FG000|Part A|Death|2|||
157184827|NCT03330106|567418020|FG001|Part A|Death|1|||
157184828|NCT03330106|567418021|FG002|Part A|Death|0|||
157184829|NCT03330106|567418022|FG003|Part A|Death|0|||
157184830|NCT03330106|567418019|FG000|Part A|Adverse Event|0|||
157184831|NCT03330106|567418020|FG001|Part A|Adverse Event|1|||
157184832|NCT03330106|567418021|FG002|Part A|Adverse Event|0|||
157184833|NCT03330106|567418022|FG003|Part A|Adverse Event|0|||
157184834|NCT03330106|567418019|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
157184835|NCT03330106|567418020|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
157184836|NCT03330106|567418021|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
157184837|NCT03330106|567418022|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
157184838|NCT03330106|567418019|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
157184839|NCT03330106|567418020|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
157184840|NCT03330106|567418021|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
157184841|NCT03330106|567418022|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
157184842|NCT03330106|567418019|FG000|Part A|Progressive Disease|0|||
157184843|NCT03330106|567418020|FG001|Part A|Progressive Disease|1|||
157184844|NCT03330106|567418021|FG002|Part A|Progressive Disease|0|||
157184845|NCT03330106|567418022|FG003|Part A|Progressive Disease|0|||
157184846|NCT03330106|567418019|FG000|Part B|Lost to Follow-up|0|||
157184847|NCT03330106|567418020|FG001|Part B|Lost to Follow-up|0|||
157184848|NCT03330106|567418021|FG002|Part B|Lost to Follow-up|0|||
157184849|NCT03330106|567418022|FG003|Part B|Lost to Follow-up|1|||
157184850|NCT03330106|567418019|FG000|Part B|Withdrawal by Subject|0|||
157230117|NCT04591626|567588249|FG001|Overall Study|Adverse Event|0|||
157184851|NCT03330106|567418020|FG001|Part B|Withdrawal by Subject|0|||
157230118|NCT04591626|567588248|FG000|Overall Study|Withdrawal by Subject|5|||
157230119|NCT04591626|567588249|FG001|Overall Study|Withdrawal by Subject|3|||
157230120|NCT04591626|567588248|FG000|Overall Study|Physician Decision|0|||
157230121|NCT04591626|567588249|FG001|Overall Study|Physician Decision|1|||
157184852|NCT03330106|567418021|FG002|Part B|Withdrawal by Subject|4|||
157184853|NCT03330106|567418022|FG003|Part B|Withdrawal by Subject|0|||
157184854|NCT03330106|567418019|FG000|Part B|Death|0|||
157184855|NCT03330106|567418020|FG001|Part B|Death|0|||
157184856|NCT03330106|567418021|FG002|Part B|Death|2|||
157184857|NCT03330106|567418022|FG003|Part B|Death|0|||
157184858|NCT03330106|567418019|FG000|Part B|Clinical Progression|0|||
157230122|NCT04591626|567588248|FG000|Overall Study|Death|0|||
157230123|NCT04591626|567588249|FG001|Overall Study|Death|1|||
157230124|NCT04591626|567588248|FG000|Overall Study|Non-Compliance with Study Drug|1|||
157230125|NCT04591626|567588249|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157230126|NCT02672553|567588253|FG000|Overall Study|Death|3|||
157230127|NCT02672553|567588254|FG001|Overall Study|Death|5|||
157230128|NCT02672553|567588253|FG000|Overall Study|Valve Explant|1|||
157065529|NCT03713320|566994360|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
157065530|NCT03713320|566994361|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
157065531|NCT01880437|566994362|FG000|Overall Study|Death|12|||
157065532|NCT01880437|566994363|FG001|Overall Study|Death|4|||
157065533|NCT01880437|566994364|FG002|Overall Study|Death|17|||
157065534|NCT01880437|566994362|FG000|Overall Study|Study terminated by Sponsor|3|||
157065535|NCT01880437|566994363|FG001|Overall Study|Study terminated by Sponsor|0|||
157065536|NCT01880437|566994364|FG002|Overall Study|Study terminated by Sponsor|2|||
157065537|NCT00909532|566994365|FG000|Overall Study|Adverse Event|4|||
157065538|NCT00909532|566994366|FG001|Overall Study|Adverse Event|1|||
157065539|NCT00909532|566994365|FG000|Overall Study|Pregnancy|0|||
157065540|NCT00909532|566994366|FG001|Overall Study|Pregnancy|1|||
157065541|NCT00909532|566994365|FG000|Overall Study|Prohibited Medication|2|||
157065542|NCT00909532|566994366|FG001|Overall Study|Prohibited Medication|1|||
157065543|NCT00909532|566994365|FG000|Overall Study|Withdrawal of Consent|1|||
157065544|NCT00909532|566994366|FG001|Overall Study|Withdrawal of Consent|1|||
157065545|NCT00909532|566994365|FG000|Overall Study|Noncompliance with Study Requirements|0|||
157065546|NCT00909532|566994366|FG001|Overall Study|Noncompliance with Study Requirements|2|||
157065547|NCT00909532|566994365|FG000|Overall Study|Physician Decision|1|||
157065548|NCT00909532|566994366|FG001|Overall Study|Physician Decision|0|||
157065549|NCT00909532|566994365|FG000|Overall Study|Wrong Genotype|1|||
157065550|NCT00909532|566994366|FG001|Overall Study|Wrong Genotype|0|||
157065551|NCT00909532|566994365|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
157065552|NCT00909532|566994366|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
157065553|NCT01209598|566994367|FG000|Overall Study|Withdrawal by Subject|1|||
157065554|NCT01209598|566994368|FG001|Overall Study|Withdrawal by Subject|0|||
157065555|NCT00085566|566994370|FG000|Overall Study|Adverse Event|0|||
157065556|NCT00085566|566994371|FG001|Overall Study|Adverse Event|0|||
157065557|NCT00085566|566994372|FG002|Overall Study|Adverse Event|10|||
157065558|NCT00085566|566994370|FG000|Overall Study|Patient Not treated|0|||
157065559|NCT00085566|566994371|FG001|Overall Study|Patient Not treated|0|||
157065560|NCT00085566|566994372|FG002|Overall Study|Patient Not treated|3|||
157065561|NCT00085566|566994370|FG000|Overall Study|Clinical progression|0|||
157065562|NCT00085566|566994371|FG001|Overall Study|Clinical progression|0|||
157065563|NCT00085566|566994372|FG002|Overall Study|Clinical progression|1|||
157065564|NCT02604342|566994374|FG000|Overall Study|Death|32|||
157065565|NCT02604342|566994375|FG001|Overall Study|Death|16|||
157065566|NCT02604342|566994374|FG000|Overall Study|Progression of disease|1|||
157065567|NCT02604342|566994375|FG001|Overall Study|Progression of disease|0|||
157065568|NCT02604342|566994374|FG000|Overall Study|Withdrawal by Subject|5|||
157065569|NCT02604342|566994375|FG001|Overall Study|Withdrawal by Subject|6|||
157065570|NCT02604342|566994374|FG000|Overall Study|Other|1|||
157065571|NCT02604342|566994375|FG001|Overall Study|Other|0|||
157065572|NCT02604342|566994374|FG000|Overall Study|Study Termination by Sponsor|1|||
157065573|NCT02604342|566994375|FG001|Overall Study|Study Termination by Sponsor|0|||
157065574|NCT02604342|566994374|FG000|Overall Study|Lost to Follow-up|1|||
157065575|NCT02604342|566994375|FG001|Overall Study|Lost to Follow-up|1|||
157065576|NCT02604342|566994374|FG000|Overall Study|Physician Decision|2|||
157065577|NCT02604342|566994375|FG001|Overall Study|Physician Decision|0|||
157065578|NCT01702519|566994376|FG000|Washout Period|Lost to Follow-up|1|||
157065579|NCT01702519|566994377|FG001|Washout Period|Lost to Follow-up|0|||
157065580|NCT01702519|566994376|FG000|Washout Period|Withdrawal by Subject|0|||
157065581|NCT01702519|566994377|FG001|Washout Period|Withdrawal by Subject|2|||
157065582|NCT00361842|566994378|FG000|Overall Study|Withdrawal by Subject|2|||
157065583|NCT00361842|566994379|FG001|Overall Study|Withdrawal by Subject|3|||
157065584|NCT00361842|566994378|FG000|Overall Study|Death|2|||
157065585|NCT00361842|566994379|FG001|Overall Study|Death|1|||
157065586|NCT00361842|566994378|FG000|Overall Study|Disease progression|19|||
157065587|NCT00361842|566994379|FG001|Overall Study|Disease progression|20|||
157065588|NCT00361842|566994378|FG000|Overall Study|Adverse Event|2|||
157065589|NCT00361842|566994379|FG001|Overall Study|Adverse Event|3|||
157065590|NCT00361842|566994378|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
157230129|NCT02672553|567588254|FG001|Overall Study|Valve Explant|0|||
157230130|NCT02672553|567588253|FG000|Overall Study|Conversion to Commercial Valve|3|||
157065591|NCT00361842|566994379|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
157065592|NCT00361842|566994378|FG000|Overall Study|Other|1|||
157065593|NCT00361842|566994379|FG001|Overall Study|Other|0|||
157065594|NCT00361842|566994378|FG000|Overall Study|Other|0|||
157065595|NCT00361842|566994379|FG001|Overall Study|Other|2|||
157065596|NCT03512288|566994380|FG000|Overall Study|Adverse Event|1|||
157065597|NCT03512288|566994381|FG001|Overall Study|Adverse Event|0|||
157065598|NCT03512288|566994380|FG000|Overall Study|Lost to Follow-up|12|||
157065599|NCT03512288|566994381|FG001|Overall Study|Lost to Follow-up|15|||
157065600|NCT03512288|566994380|FG000|Overall Study|Physician Decision|0|||
157184859|NCT03330106|567418020|FG001|Part B|Clinical Progression|0|||
157184860|NCT03330106|567418021|FG002|Part B|Clinical Progression|1|||
157184861|NCT03330106|567418022|FG003|Part B|Clinical Progression|1|||
157184862|NCT03330106|567418019|FG000|Part B|Symptomatic Deterioration|0|||
157184863|NCT03330106|567418020|FG001|Part B|Symptomatic Deterioration|0|||
157184864|NCT03330106|567418021|FG002|Part B|Symptomatic Deterioration|0|||
157184865|NCT03330106|567418022|FG003|Part B|Symptomatic Deterioration|1|||
157184866|NCT03330106|567418019|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
157184867|NCT03330106|567418020|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
157184868|NCT03330106|567418021|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
157184869|NCT03330106|567418022|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
157184870|NCT03330106|567418019|FG000|Part B|Progressive Disease|0|||
157184871|NCT03330106|567418020|FG001|Part B|Progressive Disease|0|||
157184872|NCT03330106|567418021|FG002|Part B|Progressive Disease|11|||
157184873|NCT03330106|567418022|FG003|Part B|Progressive Disease|4|||
157184874|NCT00486889|567418025|FG000|Overall Study|Death|3|||
157065601|NCT03512288|566994381|FG001|Overall Study|Physician Decision|2|||
157065602|NCT03512288|566994380|FG000|Overall Study|Protocol Violation|6|||
157065603|NCT03512288|566994381|FG001|Overall Study|Protocol Violation|4|||
157065604|NCT03512288|566994380|FG000|Overall Study|Medication error without associated adverse event|1|||
157065605|NCT03512288|566994381|FG001|Overall Study|Medication error without associated adverse event|0|||
157065606|NCT03512288|566994380|FG000|Overall Study|No longer met eligibility criteria|5|||
157065607|NCT03512288|566994381|FG001|Overall Study|No longer met eligibility criteria|2|||
157065608|NCT03512288|566994380|FG000|Overall Study|Withdrawal by parent/guardian|14|||
157065609|NCT03512288|566994381|FG001|Overall Study|Withdrawal by parent/guardian|18|||
157065610|NCT03512288|566994380|FG000|Overall Study|Other|1|||
157065611|NCT03512288|566994381|FG001|Overall Study|Other|1|||
157065612|NCT03512288|566994380|FG000|Overall Study|Randomized but not treated|1|||
157065613|NCT03512288|566994381|FG001|Overall Study|Randomized but not treated|1|||
157065614|NCT01177228|566994391|FG000|Overall Study|Positive tuberculosis test|0|||
157065615|NCT01177228|566994392|FG001|Overall Study|Positive tuberculosis test|1|||
157065616|NCT01177228|566994393|FG002|Overall Study|Positive tuberculosis test|0|||
157065617|NCT01177228|566994394|FG003|Overall Study|Positive tuberculosis test|0|||
157065618|NCT01177228|566994391|FG000|Overall Study|Worsening disease activity|1|||
157065619|NCT01177228|566994392|FG001|Overall Study|Worsening disease activity|0|||
157065620|NCT01177228|566994393|FG002|Overall Study|Worsening disease activity|0|||
157065621|NCT01177228|566994394|FG003|Overall Study|Worsening disease activity|0|||
157065622|NCT01177228|566994391|FG000|Overall Study|Withdrawal by Subject|0|||
157065623|NCT01177228|566994392|FG001|Overall Study|Withdrawal by Subject|1|||
157065624|NCT01177228|566994393|FG002|Overall Study|Withdrawal by Subject|0|||
157065625|NCT01177228|566994394|FG003|Overall Study|Withdrawal by Subject|0|||
157065626|NCT01251887|566994395|FG000|Overall Study|Scheduling conflict|1|||
157065627|NCT01251887|566994396|FG001|Overall Study|Scheduling conflict|2|||
157065628|NCT01251887|566994397|FG002|Overall Study|Scheduling conflict|2|||
157065629|NCT01251887|566994395|FG000|Overall Study|Physician Decision|0|||
157065630|NCT01251887|566994396|FG001|Overall Study|Physician Decision|1|||
157065631|NCT01251887|566994397|FG002|Overall Study|Physician Decision|0|||
157065632|NCT03325608|566994398|FG000|Overall Study|Lost to Follow-up|23|||
157065633|NCT03325608|566994399|FG001|Overall Study|Lost to Follow-up|23|||
157065634|NCT03325608|566994400|FG002|Overall Study|Lost to Follow-up|30|||
157065635|NCT03325608|566994401|FG003|Overall Study|Lost to Follow-up|30|||
157065636|NCT03325608|566994398|FG000|Overall Study|Death of Caregiver|0|||
157065637|NCT03325608|566994399|FG001|Overall Study|Death of Caregiver|0|||
157065638|NCT03325608|566994400|FG002|Overall Study|Death of Caregiver|2|||
157065639|NCT03325608|566994401|FG003|Overall Study|Death of Caregiver|2|||
157065640|NCT03325608|566994398|FG000|Overall Study|Death of Care Recipient|34|||
157065641|NCT03325608|566994399|FG001|Overall Study|Death of Care Recipient|34|||
157065642|NCT03325608|566994400|FG002|Overall Study|Death of Care Recipient|28|||
157065643|NCT03325608|566994401|FG003|Overall Study|Death of Care Recipient|28|||
157065644|NCT03325608|566994398|FG000|Overall Study|Withdrawal by Subject|49|||
157184875|NCT00486889|567418025|FG000|Overall Study|Non-compliant|2|||
157065645|NCT03325608|566994399|FG001|Overall Study|Withdrawal by Subject|49|||
157184876|NCT00486889|567418025|FG000|Overall Study|Withdrawal by Subject|6|||
157065646|NCT03325608|566994400|FG002|Overall Study|Withdrawal by Subject|35|||
157065647|NCT03325608|566994401|FG003|Overall Study|Withdrawal by Subject|35|||
157065648|NCT03325608|566994398|FG000|Overall Study|Ineligible|7|||
157065649|NCT03325608|566994399|FG001|Overall Study|Ineligible|7|||
157065650|NCT03325608|566994400|FG002|Overall Study|Ineligible|5|||
157184877|NCT00893763|567418026|FG000|Overall Study|extubated|110|||
157184878|NCT00893763|567418027|FG001|Overall Study|extubated|110|||
157184879|NCT01738594|567418029|FG000|Registration and Treatment Start|Adverse Event|0|||
157184880|NCT01738594|567418030|FG001|Registration and Treatment Start|Adverse Event|1|||
157065651|NCT03325608|566994401|FG003|Overall Study|Ineligible|5|||
157184881|NCT01738594|567418031|FG002|Registration and Treatment Start|Adverse Event|0|||
157065652|NCT00942188|566994402|FG000|Overall Study|Adverse Event|0|||
157065653|NCT00942188|566994403|FG001|Overall Study|Adverse Event|3|||
157065654|NCT00942188|566994404|FG002|Overall Study|Adverse Event|2|||
157065655|NCT00942188|566994405|FG003|Overall Study|Adverse Event|0|||
157065656|NCT00942188|566994402|FG000|Overall Study|Lack of Efficacy|0|||
157065657|NCT00942188|566994403|FG001|Overall Study|Lack of Efficacy|0|||
157065658|NCT00942188|566994404|FG002|Overall Study|Lack of Efficacy|0|||
157065659|NCT00942188|566994405|FG003|Overall Study|Lack of Efficacy|1|||
157065660|NCT00942188|566994402|FG000|Overall Study|Protocol Violation|1|||
157065661|NCT00942188|566994403|FG001|Overall Study|Protocol Violation|1|||
157065662|NCT00942188|566994404|FG002|Overall Study|Protocol Violation|0|||
157065663|NCT00942188|566994405|FG003|Overall Study|Protocol Violation|0|||
157065664|NCT00942188|566994402|FG000|Overall Study|Lost to Follow-up|2|||
157065665|NCT00942188|566994403|FG001|Overall Study|Lost to Follow-up|1|||
157065666|NCT00942188|566994404|FG002|Overall Study|Lost to Follow-up|2|||
157065667|NCT00942188|566994405|FG003|Overall Study|Lost to Follow-up|0|||
157065668|NCT00942188|566994402|FG000|Overall Study|Withdrawal by Subject|1|||
157065669|NCT00942188|566994403|FG001|Overall Study|Withdrawal by Subject|3|||
157065670|NCT00942188|566994404|FG002|Overall Study|Withdrawal by Subject|4|||
157065671|NCT00942188|566994405|FG003|Overall Study|Withdrawal by Subject|2|||
157065672|NCT00942188|566994402|FG000|Overall Study|Physician Decision|0|||
157065673|NCT00942188|566994403|FG001|Overall Study|Physician Decision|0|||
157065674|NCT00942188|566994404|FG002|Overall Study|Physician Decision|1|||
157065675|NCT00942188|566994405|FG003|Overall Study|Physician Decision|0|||
157065676|NCT00942188|566994402|FG000|Overall Study|Sponsor Decision|0|||
157065677|NCT00942188|566994403|FG001|Overall Study|Sponsor Decision|2|||
157065678|NCT00942188|566994404|FG002|Overall Study|Sponsor Decision|0|||
157065679|NCT00942188|566994405|FG003|Overall Study|Sponsor Decision|1|||
157065680|NCT02188784|566994406|FG000|Overall Study|Death|3|||
157065681|NCT02188784|566994407|FG001|Overall Study|Death|1|||
157065682|NCT02188784|566994406|FG000|Overall Study|Lost to Follow-up|1|||
157065683|NCT02188784|566994407|FG001|Overall Study|Lost to Follow-up|0|||
157065684|NCT02188784|566994406|FG000|Overall Study|Withdrawal by Subject|3|||
157065685|NCT02188784|566994407|FG001|Overall Study|Withdrawal by Subject|9|||
157065686|NCT02188784|566994406|FG000|Overall Study|Physician Decision|2|||
157065687|NCT02188784|566994407|FG001|Overall Study|Physician Decision|3|||
157065688|NCT00143598|566994411|FG000|Overall Study|Lost to Follow-up|23|||
157065689|NCT00143598|566994412|FG001|Overall Study|Lost to Follow-up|21|||
157065690|NCT00143598|566994411|FG000|Overall Study|Withdrawal by Subject|33|||
157065691|NCT00143598|566994412|FG001|Overall Study|Withdrawal by Subject|37|||
157065692|NCT00143598|566994411|FG000|Overall Study|Death|36|||
157065693|NCT00143598|566994412|FG001|Overall Study|Death|36|||
157065694|NCT01568112|566994415|FG000|Overall Study|Randomized But Not Treated|0|||
157065695|NCT01568112|566994416|FG001|Overall Study|Randomized But Not Treated|1|||
157065696|NCT01568112|566994417|FG002|Overall Study|Randomized But Not Treated|0|||
157065697|NCT01568112|566994418|FG003|Overall Study|Randomized But Not Treated|0|||
157065698|NCT01568112|566994415|FG000|Overall Study|Withdrew due to Adverse Event|2|||
157065699|NCT01568112|566994416|FG001|Overall Study|Withdrew due to Adverse Event|4|||
157065700|NCT01568112|566994417|FG002|Overall Study|Withdrew due to Adverse Event|6|||
157065701|NCT01568112|566994418|FG003|Overall Study|Withdrew due to Adverse Event|3|||
157065702|NCT01568112|566994415|FG000|Overall Study|Lost to Follow-up|0|||
157065703|NCT01568112|566994416|FG001|Overall Study|Lost to Follow-up|0|||
157065704|NCT01568112|566994417|FG002|Overall Study|Lost to Follow-up|0|||
157065705|NCT01568112|566994418|FG003|Overall Study|Lost to Follow-up|1|||
157065706|NCT01568112|566994415|FG000|Overall Study|Withdrawal by Subject|2|||
157065707|NCT01568112|566994416|FG001|Overall Study|Withdrawal by Subject|3|||
157065708|NCT01568112|566994417|FG002|Overall Study|Withdrawal by Subject|0|||
157065709|NCT01568112|566994418|FG003|Overall Study|Withdrawal by Subject|7|||
157065710|NCT01568112|566994415|FG000|Overall Study|Withdrawal by Physician|1|||
157065711|NCT01568112|566994416|FG001|Overall Study|Withdrawal by Physician|0|||
157065712|NCT01568112|566994417|FG002|Overall Study|Withdrawal by Physician|1|||
157065713|NCT01568112|566994418|FG003|Overall Study|Withdrawal by Physician|1|||
157065714|NCT01131104|566996274|FG000|Overall Study|Withdrawal by Subject|3|||
157065715|NCT01131104|566996274|FG000|Overall Study|Physician Decision|4|||
157065716|NCT01131104|566996274|FG000|Overall Study|Information Not Available|5|||
157065717|NCT01131104|566996274|FG000|Overall Study|No Information on Index Date of Onset|1|||
157065718|NCT04523207|566996277|FG000|Overall Study|Adverse Event|5|||
157065719|NCT04523207|566996278|FG001|Overall Study|Adverse Event|1|||
157065720|NCT04523207|566996277|FG000|Overall Study|Lost to Follow-up|2|||
157065721|NCT04523207|566996278|FG001|Overall Study|Lost to Follow-up|0|||
157065722|NCT04523207|566996277|FG000|Overall Study|Withdrawal by Subject|2|||
157065723|NCT04523207|566996278|FG001|Overall Study|Withdrawal by Subject|0|||
157065724|NCT04523207|566996277|FG000|Overall Study|Progressive Disease|2|||
157065725|NCT04523207|566996278|FG001|Overall Study|Progressive Disease|1|||
157065726|NCT04523207|566996277|FG000|Overall Study|Other|7|||
157065727|NCT04523207|566996278|FG001|Overall Study|Other|1|||
157065728|NCT03113383|566996279|FG000|Overall Study|Death|4|||
157065729|NCT03113383|566996280|FG001|Overall Study|Death|0|||
157065730|NCT03062449|566996282|FG000|Overall Study|Withdrawal by Subject|7|||
157065731|NCT03062449|566996283|FG001|Overall Study|Withdrawal by Subject|1|||
157065732|NCT03194867|566996288|FG000|Overall Study|Incorrect completion of end of study form|0|||
157184882|NCT01738594|567418032|FG003|Registration and Treatment Start|Adverse Event|0|||
157184883|NCT01738594|567418033|FG004|Registration and Treatment Start|Adverse Event|0|||
157184884|NCT01738594|567418034|FG005|Registration and Treatment Start|Adverse Event|0|||
157184885|NCT01738594|567418035|FG006|Registration and Treatment Start|Adverse Event|0|||
157184886|NCT01738594|567418036|FG007|Registration and Treatment Start|Adverse Event|0|||
157184887|NCT01738594|567418029|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184888|NCT01738594|567418030|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184889|NCT01738594|567418031|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184890|NCT01738594|567418032|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184891|NCT01738594|567418033|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184892|NCT01738594|567418034|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
157184893|NCT01738594|567418035|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184894|NCT01738594|567418036|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
157184895|NCT01738594|567418029|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184896|NCT01738594|567418030|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
157184897|NCT01738594|567418031|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184898|NCT01738594|567418032|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184899|NCT01738594|567418033|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184900|NCT01738594|567418034|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184901|NCT01738594|567418035|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184902|NCT01738594|567418036|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
157184903|NCT01738594|567418029|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184904|NCT01738594|567418030|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184905|NCT01738594|567418031|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184906|NCT01738594|567418032|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184907|NCT01738594|567418033|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184908|NCT01738594|567418034|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
157184909|NCT01738594|567418035|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184910|NCT01738594|567418036|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
157184911|NCT01738594|567418029|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184912|NCT01738594|567418030|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184913|NCT01738594|567418031|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184914|NCT01738594|567418032|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184915|NCT01738594|567418033|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184916|NCT01738594|567418034|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
157184917|NCT01738594|567418035|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184918|NCT01738594|567418036|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
157184919|NCT01738594|567418029|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184920|NCT01738594|567418030|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184921|NCT01738594|567418031|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184922|NCT01738594|567418032|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184923|NCT01738594|567418033|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
157184924|NCT01738594|567418034|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184925|NCT01738594|567418035|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184926|NCT01738594|567418036|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
157184927|NCT01738594|567418029|FG000|Follow up for 1 Year|Death|0|||
157184928|NCT01738594|567418030|FG001|Follow up for 1 Year|Death|0|||
157184929|NCT01738594|567418031|FG002|Follow up for 1 Year|Death|0|||
157184930|NCT01738594|567418032|FG003|Follow up for 1 Year|Death|0|||
157184931|NCT01738594|567418033|FG004|Follow up for 1 Year|Death|0|||
157184932|NCT01738594|567418034|FG005|Follow up for 1 Year|Death|1|||
157184933|NCT01738594|567418035|FG006|Follow up for 1 Year|Death|0|||
157184934|NCT01738594|567418036|FG007|Follow up for 1 Year|Death|0|||
157184935|NCT01738594|567418029|FG000|Follow up for 1 Year|Other|0|||
157184936|NCT01738594|567418030|FG001|Follow up for 1 Year|Other|0|||
157184937|NCT01738594|567418031|FG002|Follow up for 1 Year|Other|0|||
157184938|NCT01738594|567418032|FG003|Follow up for 1 Year|Other|0|||
157184939|NCT01738594|567418033|FG004|Follow up for 1 Year|Other|0|||
157184940|NCT01738594|567418034|FG005|Follow up for 1 Year|Other|2|||
157184941|NCT01738594|567418035|FG006|Follow up for 1 Year|Other|0|||
157184942|NCT01738594|567418036|FG007|Follow up for 1 Year|Other|0|||
157184943|NCT04430036|567418039|FG000|Safety Run in Phase|Progression of disease|2|||
157184944|NCT00942422|567418040|FG000|Overall Study|Withdrawal by Subject|1|||
157184945|NCT00942422|567418040|FG000|Overall Study|Death|1|||
157184946|NCT00942422|567418040|FG000|Overall Study|Progressive diease|1|||
157184947|NCT01039428|567418044|FG000|Overall Study|Protocol Violation|1|||
157184948|NCT01039428|567418045|FG001|Overall Study|Protocol Violation|0|||
157184949|NCT01039428|567418044|FG000|Overall Study|Withdrawal by Subject|1|||
157184950|NCT01039428|567418045|FG001|Overall Study|Withdrawal by Subject|0|||
157065733|NCT03194867|566996289|FG001|Overall Study|Incorrect completion of end of study form|0|||
157065734|NCT03194867|566996290|FG002|Overall Study|Incorrect completion of end of study form|1|||
157065735|NCT03194867|566996291|FG003|Overall Study|Incorrect completion of end of study form|0|||
157065736|NCT00543062|566996292|FG000|Overall Study|Withdrawal by Subject|1|||
157065737|NCT00543062|566996293|FG001|Overall Study|Withdrawal by Subject|0|||
157065738|NCT00543062|566996294|FG002|Overall Study|Withdrawal by Subject|2|||
157065739|NCT00543062|566996295|FG003|Overall Study|Withdrawal by Subject|0|||
157065740|NCT00543062|566996292|FG000|Overall Study|Adverse Event|0|||
157065741|NCT00543062|566996293|FG001|Overall Study|Adverse Event|1|||
157065742|NCT00543062|566996294|FG002|Overall Study|Adverse Event|1|||
157065743|NCT00543062|566996295|FG003|Overall Study|Adverse Event|1|||
157065744|NCT00543062|566996292|FG000|Overall Study|Protocol Violation|1|||
157065745|NCT00543062|566996293|FG001|Overall Study|Protocol Violation|0|||
157065746|NCT00543062|566996294|FG002|Overall Study|Protocol Violation|0|||
157065747|NCT00543062|566996295|FG003|Overall Study|Protocol Violation|0|||
157065748|NCT00464945|566996296|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
157065749|NCT00464945|566996297|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
157065750|NCT00464945|566996296|FG000|Infant Series|Protocol Violation|1|||
157065751|NCT00464945|566996297|FG001|Infant Series|Protocol Violation|0|||
157065752|NCT00464945|566996296|FG000|Infant Series|Lost to Follow-up|1|||
157065753|NCT00464945|566996297|FG001|Infant Series|Lost to Follow-up|0|||
157065754|NCT00464945|566996296|FG000|After Infant Series|Withdrawal by Subject|0|||
157065755|NCT00464945|566996297|FG001|After Infant Series|Withdrawal by Subject|2|||
157065756|NCT00464945|566996296|FG000|Toddler Dose|Lost to Follow-up|0|||
157065757|NCT00464945|566996297|FG001|Toddler Dose|Lost to Follow-up|1|||
157065758|NCT02438371|566996300|FG000|Overall Study|Lost to Follow-up|3|||
157065759|NCT02438371|566996301|FG001|Overall Study|Lost to Follow-up|2|||
157065760|NCT02438371|566996300|FG000|Overall Study|Withdrawal by Subject|1|||
157065761|NCT02438371|566996301|FG001|Overall Study|Withdrawal by Subject|1|||
157065762|NCT01161446|566996302|FG000|Overall Study|Lost to Follow-up|18|||
157065763|NCT01161446|566996303|FG001|Overall Study|Lost to Follow-up|14|||
157065764|NCT01161446|566996302|FG000|Overall Study|Withdrawal by Subject|0|||
157065765|NCT01161446|566996303|FG001|Overall Study|Withdrawal by Subject|1|||
157065766|NCT02536742|566996304|FG000|Overall Study|Did not start protocol therapy|1|||
157065767|NCT02536742|566996304|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
157065768|NCT01496365|566996305|FG000|Overall Study|Adverse Event|2|||
157065769|NCT01496365|566996306|FG001|Overall Study|Adverse Event|3|||
157065770|NCT01496365|566996307|FG002|Overall Study|Adverse Event|3|||
157065771|NCT01496365|566996308|FG003|Overall Study|Adverse Event|2|||
157065772|NCT01496365|566996309|FG004|Overall Study|Adverse Event|5|||
157065773|NCT01496365|566996310|FG005|Overall Study|Adverse Event|6|||
157065774|NCT01496365|566996311|FG006|Overall Study|Adverse Event|4|||
157065775|NCT01496365|566996305|FG000|Overall Study|Withdrawal by Subject|6|||
157065776|NCT01496365|566996306|FG001|Overall Study|Withdrawal by Subject|6|||
157065777|NCT01496365|566996307|FG002|Overall Study|Withdrawal by Subject|0|||
157065778|NCT01496365|566996308|FG003|Overall Study|Withdrawal by Subject|1|||
157065779|NCT01496365|566996309|FG004|Overall Study|Withdrawal by Subject|3|||
157065780|NCT01496365|566996310|FG005|Overall Study|Withdrawal by Subject|2|||
157065781|NCT01496365|566996311|FG006|Overall Study|Withdrawal by Subject|1|||
157065782|NCT01496365|566996305|FG000|Overall Study|Protocol Violation|2|||
157065783|NCT01496365|566996306|FG001|Overall Study|Protocol Violation|1|||
157065784|NCT01496365|566996307|FG002|Overall Study|Protocol Violation|1|||
157065785|NCT01496365|566996308|FG003|Overall Study|Protocol Violation|0|||
157065786|NCT01496365|566996309|FG004|Overall Study|Protocol Violation|0|||
157065787|NCT01496365|566996310|FG005|Overall Study|Protocol Violation|1|||
157065788|NCT01496365|566996311|FG006|Overall Study|Protocol Violation|0|||
157065789|NCT01496365|566996305|FG000|Overall Study|Lack of Efficacy|1|||
157065790|NCT01496365|566996306|FG001|Overall Study|Lack of Efficacy|0|||
157065791|NCT01496365|566996307|FG002|Overall Study|Lack of Efficacy|0|||
157065792|NCT01496365|566996308|FG003|Overall Study|Lack of Efficacy|0|||
157065793|NCT01496365|566996309|FG004|Overall Study|Lack of Efficacy|0|||
157065794|NCT01496365|566996310|FG005|Overall Study|Lack of Efficacy|1|||
157065795|NCT01496365|566996311|FG006|Overall Study|Lack of Efficacy|0|||
157184951|NCT01313039|567418046|FG000|Overall Study|Physician Decision|1|||
157065796|NCT01496365|566996305|FG000|Overall Study|Lost to Follow-up|0|||
157065797|NCT01496365|566996306|FG001|Overall Study|Lost to Follow-up|1|||
157065798|NCT01496365|566996307|FG002|Overall Study|Lost to Follow-up|0|||
157065799|NCT01496365|566996308|FG003|Overall Study|Lost to Follow-up|0|||
157065800|NCT01496365|566996309|FG004|Overall Study|Lost to Follow-up|2|||
157065801|NCT01496365|566996310|FG005|Overall Study|Lost to Follow-up|0|||
157065802|NCT01496365|566996311|FG006|Overall Study|Lost to Follow-up|0|||
157065803|NCT01496365|566996305|FG000|Overall Study|Other|4|||
157065804|NCT01496365|566996306|FG001|Overall Study|Other|4|||
157065805|NCT01496365|566996307|FG002|Overall Study|Other|2|||
157065806|NCT01496365|566996308|FG003|Overall Study|Other|1|||
157065807|NCT01496365|566996309|FG004|Overall Study|Other|3|||
157065808|NCT01496365|566996310|FG005|Overall Study|Other|0|||
157065809|NCT01496365|566996311|FG006|Overall Study|Other|1|||
157065810|NCT01015677|566996312|FG000|Overall Study|Adverse Event|0|||
157065811|NCT01015677|566996313|FG001|Overall Study|Adverse Event|1|||
157065812|NCT01015677|566996314|FG002|Overall Study|Adverse Event|0|||
157065813|NCT01015677|566996312|FG000|Overall Study|Lack of Efficacy|0|||
157065814|NCT01015677|566996313|FG001|Overall Study|Lack of Efficacy|1|||
157065815|NCT01015677|566996314|FG002|Overall Study|Lack of Efficacy|0|||
157065816|NCT01015677|566996312|FG000|Overall Study|Protocol Violation|0|||
157065817|NCT01015677|566996313|FG001|Overall Study|Protocol Violation|1|||
157065818|NCT01015677|566996314|FG002|Overall Study|Protocol Violation|0|||
157065819|NCT01015677|566996312|FG000|Overall Study|Withdrawal by Subject|1|||
157065820|NCT01015677|566996313|FG001|Overall Study|Withdrawal by Subject|1|||
157065821|NCT01015677|566996314|FG002|Overall Study|Withdrawal by Subject|0|||
157065822|NCT01660256|566996315|FG000|Overall Study|Adverse Event|4|||
157065823|NCT01660256|566996316|FG001|Overall Study|Adverse Event|0|||
157065824|NCT01660256|566996317|FG002|Overall Study|Adverse Event|2|||
157065825|NCT01660256|566996315|FG000|Overall Study|Withdrawal by Subject|1|||
157065826|NCT01660256|566996316|FG001|Overall Study|Withdrawal by Subject|0|||
157065827|NCT01660256|566996317|FG002|Overall Study|Withdrawal by Subject|2|||
157065828|NCT01646385|566996319|FG000|Overall Study|Death|202|||
157065829|NCT01646385|566996320|FG001|Overall Study|Death|222|||
157065830|NCT01646385|566996319|FG000|Overall Study|Switched to alternate biologic|636|||
157065831|NCT01646385|566996320|FG001|Overall Study|Switched to alternate biologic|649|||
157065832|NCT03898960|566996321|FG000|Overall Study|Death|10|||
157065833|NCT01129115|566996324|FG000|Overall Study|Adverse Event|1|||
157065834|NCT01129115|566996325|FG001|Overall Study|Adverse Event|2|||
157065835|NCT01129115|566996326|FG002|Overall Study|Adverse Event|3|||
157065836|NCT01129115|566996327|FG003|Overall Study|Adverse Event|3|||
157065837|NCT01129115|566996324|FG000|Overall Study|Withdrawal by Subject|1|||
157065838|NCT01129115|566996325|FG001|Overall Study|Withdrawal by Subject|3|||
157065839|NCT01129115|566996326|FG002|Overall Study|Withdrawal by Subject|1|||
157065840|NCT01129115|566996327|FG003|Overall Study|Withdrawal by Subject|4|||
157065841|NCT01129115|566996324|FG000|Overall Study|Protocol Violation|0|||
157065842|NCT01129115|566996325|FG001|Overall Study|Protocol Violation|2|||
157065843|NCT01129115|566996326|FG002|Overall Study|Protocol Violation|2|||
157065844|NCT01129115|566996327|FG003|Overall Study|Protocol Violation|2|||
157065845|NCT01747837|566996328|FG000|Overall Study|Lost to Follow-up|5|||
157065846|NCT01747837|566996329|FG001|Overall Study|Lost to Follow-up|2|||
157065847|NCT01747837|566996328|FG000|Overall Study|Death|4|||
157065848|NCT01747837|566996329|FG001|Overall Study|Death|4|||
157065849|NCT00935259|566996331|FG000|Period 1|Administrative (scheduling conflict)|1|||
157065850|NCT00935259|566996332|FG001|Period 1|Administrative (scheduling conflict)|1|||
157065851|NCT03856047|566996335|FG000|Overall Study|Withdrawal by Subject|0|||
157065852|NCT03856047|566996336|FG001|Overall Study|Withdrawal by Subject|1|||
157065853|NCT03856047|566996337|FG002|Overall Study|Withdrawal by Subject|1|||
157065854|NCT03856047|566996338|FG003|Overall Study|Withdrawal by Subject|0|||
157065855|NCT03856047|566996339|FG004|Overall Study|Withdrawal by Subject|3|||
157065856|NCT03856047|566996340|FG005|Overall Study|Withdrawal by Subject|0|||
157065857|NCT03856047|566996341|FG006|Overall Study|Withdrawal by Subject|2|||
157065858|NCT03856047|566996335|FG000|Overall Study|Lost to Follow-up|4|||
157065859|NCT03856047|566996336|FG001|Overall Study|Lost to Follow-up|2|||
157065860|NCT03856047|566996337|FG002|Overall Study|Lost to Follow-up|3|||
157065861|NCT03856047|566996338|FG003|Overall Study|Lost to Follow-up|1|||
157065862|NCT03856047|566996339|FG004|Overall Study|Lost to Follow-up|4|||
157065863|NCT03856047|566996340|FG005|Overall Study|Lost to Follow-up|4|||
157065864|NCT03856047|566996341|FG006|Overall Study|Lost to Follow-up|4|||
157065865|NCT03410108|566996342|FG000|Overall Study|Ongoing|41|||
157065866|NCT03410108|566996342|FG000|Overall Study|Adverse Event|4|||
157065867|NCT03410108|566996342|FG000|Overall Study|Progressive Disease|58|||
157065868|NCT03410108|566996342|FG000|Overall Study|Withdrawal by Subject|1|||
157065869|NCT03269695|566996347|FG000|Overall Study|Adverse Event|2|||
157065870|NCT03269695|566996348|FG001|Overall Study|Adverse Event|1|||
157065871|NCT03269695|566996347|FG000|Overall Study|Lack of Efficacy|0|||
157065872|NCT03269695|566996348|FG001|Overall Study|Lack of Efficacy|1|||
157065873|NCT03269695|566996347|FG000|Overall Study|Withdrawal by Subject|0|||
157065874|NCT03269695|566996348|FG001|Overall Study|Withdrawal by Subject|1|||
157184952|NCT01313039|567418046|FG000|Overall Study|Adverse Event|1|||
157065875|NCT01313624|566996349|FG000|Double-Blind Phase|Adverse Event|27|||
157065876|NCT01313624|566996350|FG001|Double-Blind Phase|Adverse Event|4|||
157065877|NCT01313624|566996349|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
157065878|NCT01313624|566996350|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
157065879|NCT01313624|566996349|FG000|Double-Blind Phase|Lost to Follow-up|0|||
157184953|NCT00090766|567418047|FG000|Overall Study|Nephrectomy Planned|0|||
157065880|NCT01313624|566996350|FG001|Double-Blind Phase|Lost to Follow-up|2|||
157065881|NCT01313624|566996349|FG000|Double-Blind Phase|Physician Decision|1|||
157065882|NCT01313624|566996350|FG001|Double-Blind Phase|Physician Decision|0|||
157065883|NCT01313624|566996349|FG000|Double-Blind Phase|Lack of Efficacy|1|||
157065884|NCT01313624|566996350|FG001|Double-Blind Phase|Lack of Efficacy|0|||
157065885|NCT01313624|566996349|FG000|Open-Label Phase|Adverse Event|1|||
157184954|NCT00090766|567418048|FG001|Overall Study|Nephrectomy Planned|0|||
157065886|NCT01313624|566996350|FG001|Open-Label Phase|Adverse Event|10|||
157065887|NCT01313624|566996349|FG000|Open-Label Phase|Withdrawal by Subject|2|||
157065888|NCT01313624|566996350|FG001|Open-Label Phase|Withdrawal by Subject|2|||
157065889|NCT01313624|566996349|FG000|Open-Label Phase|Lost to Follow-up|1|||
157065890|NCT01313624|566996350|FG001|Open-Label Phase|Lost to Follow-up|1|||
157065891|NCT01017263|566996351|FG000|Overall Study|not eligible|12|||
157065892|NCT05043883|566996352|FG000|Overall Study|Minimum required measurements could not be taken|4|||
157065893|NCT02980705|566996353|FG000|Overall Study|Adverse Event|0|||
157065894|NCT02980705|566996354|FG001|Overall Study|Adverse Event|1|||
157065895|NCT02980705|566996353|FG000|Overall Study|Withdrawal by Subject|6|||
157065896|NCT02980705|566996354|FG001|Overall Study|Withdrawal by Subject|9|||
157065897|NCT02980705|566996353|FG000|Overall Study|withdrew participation|0|||
157065898|NCT02980705|566996354|FG001|Overall Study|withdrew participation|1|||
157065899|NCT02980705|566996353|FG000|Overall Study|Lost to Follow-up|2|||
157065900|NCT02980705|566996354|FG001|Overall Study|Lost to Follow-up|0|||
157065901|NCT01721746|566996355|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
157065902|NCT01721746|566996356|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
157065903|NCT01721746|566996355|FG000|Pre-Treatment|Withdrawal by Subject|1|||
157065904|NCT01721746|566996356|FG001|Pre-Treatment|Withdrawal by Subject|16|||
157065905|NCT01721746|566996355|FG000|Pre-Treatment|Poor/Non-compliance|1|||
157065906|NCT01721746|566996356|FG001|Pre-Treatment|Poor/Non-compliance|0|||
157065907|NCT01721746|566996355|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
157065908|NCT01721746|566996356|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
157065909|NCT01721746|566996355|FG000|Treatment|Disease Progression|192|||
157065910|NCT01721746|566996356|FG001|Treatment|Disease Progression|74|||
157065911|NCT01721746|566996355|FG000|Treatment|Study Drug Toxicity|19|||
157065912|NCT01721746|566996356|FG001|Treatment|Study Drug Toxicity|11|||
157065913|NCT01721746|566996355|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
157065914|NCT01721746|566996356|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
157065915|NCT01721746|566996355|FG000|Treatment|Participant request to discontinue Study treatment|26|||
157065916|NCT01721746|566996356|FG001|Treatment|Participant request to discontinue Study treatment|7|||
157065917|NCT01721746|566996355|FG000|Treatment|Participant withdrew consent|4|||
157065918|NCT01721746|566996356|FG001|Treatment|Participant withdrew consent|2|||
157065919|NCT01721746|566996355|FG000|Treatment|Maximum Clinical Benefit|9|||
157065920|NCT01721746|566996356|FG001|Treatment|Maximum Clinical Benefit|3|||
157065921|NCT01721746|566996355|FG000|Treatment|Poor/Non-compliance|2|||
157065922|NCT01721746|566996356|FG001|Treatment|Poor/Non-compliance|0|||
157065923|NCT01721746|566996355|FG000|Treatment|Participant no longer met Study criteria|4|||
157065924|NCT01721746|566996356|FG001|Treatment|Participant no longer met Study criteria|0|||
157065925|NCT01721746|566996355|FG000|Treatment|Other reasons|6|||
157065926|NCT01721746|566996356|FG001|Treatment|Other reasons|2|||
157065927|NCT00263575|566996357|FG000|Titration Period|Adverse Event|14|||
157065928|NCT00263575|566996357|FG000|Titration Period|Withdrawal by Subject|10|||
157065929|NCT00263575|566996357|FG000|Titration Period|Protocol Violation|9|||
157065930|NCT00263575|566996357|FG000|Titration Period|Sponsor Decision|2|||
157065931|NCT00263575|566996357|FG000|Titration Period|Other|2|||
157065932|NCT00263575|566996357|FG000|Titration Period|Lack of Efficacy|6|||
157065933|NCT00263575|566996357|FG000|Maintence Period|Adverse Event|23|||
157065934|NCT00263575|566996357|FG000|Maintence Period|Withdrawal by Subject|8|||
157065935|NCT00263575|566996357|FG000|Maintence Period|Protocol Violation|4|||
157065936|NCT00263575|566996357|FG000|Maintence Period|Lack of Efficacy|4|||
157065937|NCT00263575|566996357|FG000|Maintence Period|Physician Decision|6|||
157065938|NCT00263575|566996357|FG000|Maintence Period|Lost to Follow-up|1|||
157065939|NCT00263575|566996357|FG000|Maintence Period|Sponsor Decision|24|||
157065940|NCT00263575|566996357|FG000|Maintence Period|Other|7|||
157065941|NCT02447718|566996360|FG000|Overall Study|Lost to Follow-up|8|||
157065942|NCT02447718|566996361|FG001|Overall Study|Lost to Follow-up|0|||
157065943|NCT02447718|566996360|FG000|Overall Study|Withdrawal by Subject|3|||
157065944|NCT02447718|566996361|FG001|Overall Study|Withdrawal by Subject|0|||
157065945|NCT02447718|566996360|FG000|Overall Study|Screen Failure|1|||
157065946|NCT02447718|566996361|FG001|Overall Study|Screen Failure|0|||
157065947|NCT00239681|566996362|FG000|Overall Study|Adverse Event|100|||
157184955|NCT00090766|567418049|FG002|Overall Study|Nephrectomy Planned|1|||
157065948|NCT00239681|566996363|FG001|Overall Study|Adverse Event|99|||
157065949|NCT00239681|566996362|FG000|Overall Study|Withdrawal by Subject|458|||
157184956|NCT00090766|567418047|FG000|Overall Study|Death|1|||
157065950|NCT00239681|566996363|FG001|Overall Study|Withdrawal by Subject|489|||
157184957|NCT00090766|567418048|FG001|Overall Study|Death|0|||
157184958|NCT00090766|567418049|FG002|Overall Study|Death|0|||
157065951|NCT00239681|566996362|FG000|Overall Study|Lost to Follow-up|28|||
157065952|NCT00239681|566996363|FG001|Overall Study|Lost to Follow-up|22|||
157065953|NCT00239681|566996362|FG000|Overall Study|Protocol Violation|4|||
157065954|NCT00239681|566996363|FG001|Overall Study|Protocol Violation|4|||
157065955|NCT00239681|566996362|FG000|Overall Study|Physician Decision|13|||
157065956|NCT00239681|566996363|FG001|Overall Study|Physician Decision|17|||
157065957|NCT00239681|566996362|FG000|Overall Study|No information chacked on CaseReportForm|90|||
157184959|NCT00090766|567418047|FG000|Overall Study|Admin|0|||
157184960|NCT00090766|567418048|FG001|Overall Study|Admin|2|||
157184961|NCT00090766|567418049|FG002|Overall Study|Admin|0|||
157184962|NCT00090766|567418047|FG000|Overall Study|Lost to Follow-up|2|||
157184963|NCT00090766|567418048|FG001|Overall Study|Lost to Follow-up|0|||
157184964|NCT00090766|567418049|FG002|Overall Study|Lost to Follow-up|2|||
157184965|NCT00654368|567418050|FG000|Overall Study|Ineligibility determined|6|||
157184966|NCT00654368|567418051|FG001|Overall Study|Ineligibility determined|0|||
157184967|NCT00654368|567418052|FG002|Overall Study|Ineligibility determined|0|||
157184968|NCT00654368|567418050|FG000|Overall Study|Protocol deviation|3|||
157184969|NCT00654368|567418051|FG001|Overall Study|Protocol deviation|2|||
157184970|NCT00654368|567418052|FG002|Overall Study|Protocol deviation|1|||
157184971|NCT00654368|567418050|FG000|Overall Study|Non-compliance|2|||
157184972|NCT00654368|567418051|FG001|Overall Study|Non-compliance|1|||
157184973|NCT00654368|567418052|FG002|Overall Study|Non-compliance|2|||
157184974|NCT00654368|567418050|FG000|Overall Study|Withdrawal by Subject|5|||
157184975|NCT00654368|567418051|FG001|Overall Study|Withdrawal by Subject|2|||
157184976|NCT00654368|567418052|FG002|Overall Study|Withdrawal by Subject|2|||
157184977|NCT00654368|567418050|FG000|Overall Study|Disease progression|21|||
157184978|NCT00654368|567418051|FG001|Overall Study|Disease progression|31|||
157184979|NCT00654368|567418052|FG002|Overall Study|Disease progression|13|||
157184980|NCT00654368|567418050|FG000|Overall Study|Requirement for alternative therapy|1|||
157184981|NCT00654368|567418051|FG001|Overall Study|Requirement for alternative therapy|1|||
157184982|NCT00654368|567418052|FG002|Overall Study|Requirement for alternative therapy|1|||
157184983|NCT00654368|567418050|FG000|Overall Study|Physician Decision|0|||
157184984|NCT00654368|567418051|FG001|Overall Study|Physician Decision|0|||
157184985|NCT00654368|567418052|FG002|Overall Study|Physician Decision|2|||
157184986|NCT00654368|567418050|FG000|Overall Study|Death|1|||
157184987|NCT00654368|567418051|FG001|Overall Study|Death|0|||
157184988|NCT00654368|567418052|FG002|Overall Study|Death|0|||
157184989|NCT00654368|567418050|FG000|Overall Study|Pregnancy|0|||
157184990|NCT00654368|567418051|FG001|Overall Study|Pregnancy|0|||
157184991|NCT00654368|567418052|FG002|Overall Study|Pregnancy|2|||
157184992|NCT00654368|567418050|FG000|Overall Study|Other|0|||
157184993|NCT00654368|567418051|FG001|Overall Study|Other|2|||
157184994|NCT00654368|567418052|FG002|Overall Study|Other|3|||
157184995|NCT00654368|567418050|FG000|Overall Study|Adverse Event|14|||
157184996|NCT00654368|567418051|FG001|Overall Study|Adverse Event|9|||
157184997|NCT00654368|567418052|FG002|Overall Study|Adverse Event|6|||
157184998|NCT00804986|567418053|FG000|Overall Study|Adverse Event|0|||
157184999|NCT00804986|567418054|FG001|Overall Study|Adverse Event|1|||
157185000|NCT00804986|567418055|FG002|Overall Study|Adverse Event|2|||
157185001|NCT00804986|567418056|FG003|Overall Study|Adverse Event|1|||
157185002|NCT00804986|567418057|FG004|Overall Study|Adverse Event|3|||
157185003|NCT00804986|567418058|FG005|Overall Study|Adverse Event|0|||
157185004|NCT00804986|567418053|FG000|Overall Study|Lack of Efficacy|0|||
157185005|NCT00804986|567418054|FG001|Overall Study|Lack of Efficacy|0|||
157185006|NCT00804986|567418055|FG002|Overall Study|Lack of Efficacy|0|||
157185007|NCT00804986|567418056|FG003|Overall Study|Lack of Efficacy|1|||
157185008|NCT00804986|567418057|FG004|Overall Study|Lack of Efficacy|0|||
157185009|NCT00804986|567418058|FG005|Overall Study|Lack of Efficacy|3|||
157185010|NCT00804986|567418053|FG000|Overall Study|Lost to Follow-up|0|||
157185011|NCT00804986|567418054|FG001|Overall Study|Lost to Follow-up|0|||
157185012|NCT00804986|567418055|FG002|Overall Study|Lost to Follow-up|0|||
157185013|NCT00804986|567418056|FG003|Overall Study|Lost to Follow-up|1|||
157185014|NCT00804986|567418057|FG004|Overall Study|Lost to Follow-up|1|||
157185015|NCT00804986|567418058|FG005|Overall Study|Lost to Follow-up|3|||
157185016|NCT00804986|567418053|FG000|Overall Study|Protocol Violation|0|||
157185017|NCT00804986|567418054|FG001|Overall Study|Protocol Violation|1|||
157185018|NCT00804986|567418055|FG002|Overall Study|Protocol Violation|0|||
157185019|NCT00804986|567418056|FG003|Overall Study|Protocol Violation|1|||
157185020|NCT00804986|567418057|FG004|Overall Study|Protocol Violation|0|||
157185021|NCT00804986|567418058|FG005|Overall Study|Protocol Violation|0|||
157185022|NCT00804986|567418053|FG000|Overall Study|Withdrawal by Subject|0|||
157185023|NCT00804986|567418054|FG001|Overall Study|Withdrawal by Subject|3|||
157185024|NCT00804986|567418055|FG002|Overall Study|Withdrawal by Subject|0|||
157185025|NCT00804986|567418056|FG003|Overall Study|Withdrawal by Subject|3|||
157185026|NCT00804986|567418057|FG004|Overall Study|Withdrawal by Subject|5|||
157185027|NCT00804986|567418058|FG005|Overall Study|Withdrawal by Subject|3|||
157185028|NCT00804986|567418053|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
157185029|NCT00804986|567418054|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
157185030|NCT00804986|567418055|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
157185031|NCT00804986|567418056|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
157185032|NCT00804986|567418057|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
157185033|NCT00804986|567418058|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
157185034|NCT00804986|567418053|FG000|Overall Study|Sponsor Decision|0|||
157185035|NCT00804986|567418054|FG001|Overall Study|Sponsor Decision|1|||
157185036|NCT00804986|567418055|FG002|Overall Study|Sponsor Decision|0|||
157185037|NCT00804986|567418056|FG003|Overall Study|Sponsor Decision|0|||
157185038|NCT00804986|567418057|FG004|Overall Study|Sponsor Decision|0|||
157230131|NCT02672553|567588254|FG001|Overall Study|Conversion to Commercial Valve|0|||
157230132|NCT02672553|567588253|FG000|Overall Study|Withdrawal by Subject|3|||
157230133|NCT02672553|567588254|FG001|Overall Study|Withdrawal by Subject|3|||
157230134|NCT02672553|567588253|FG000|Overall Study|Intraoperative screen failure|2|||
157230135|NCT02672553|567588254|FG001|Overall Study|Intraoperative screen failure|0|||
157065958|NCT00239681|566996363|FG001|Overall Study|No information chacked on CaseReportForm|84|||
157065959|NCT02654132|566996366|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
157065960|NCT02654132|566996367|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
157065961|NCT02654132|566996366|FG000|Treatment Period|Disease progression|43|||
157065962|NCT02654132|566996367|FG001|Treatment Period|Disease progression|38|||
157065963|NCT02654132|566996366|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
157065964|NCT02654132|566996367|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
157065965|NCT02654132|566996366|FG000|Treatment Period|Other reasons|4|||
157065966|NCT02654132|566996367|FG001|Treatment Period|Other reasons|2|||
157065967|NCT02654132|566996366|FG000|Treatment Period|Study drug toxicity|2|||
157065968|NCT02654132|566996367|FG001|Treatment Period|Study drug toxicity|2|||
157065969|NCT02654132|566996366|FG000|Treatment Period|Withdrawal by Subject|2|||
157065970|NCT02654132|566996367|FG001|Treatment Period|Withdrawal by Subject|1|||
157065971|NCT02654132|566996366|FG000|Treatment Period|Maximum Clinical Benefit|0|||
157065972|NCT02654132|566996367|FG001|Treatment Period|Maximum Clinical Benefit|2|||
157065973|NCT02654132|566996366|FG000|Treatment Period|Participant request to discontinue|2|||
157065974|NCT02654132|566996367|FG001|Treatment Period|Participant request to discontinue|0|||
157065975|NCT02654132|566996366|FG000|Treatment Period|Administrative reasons by sponsor|0|||
157065976|NCT02654132|566996367|FG001|Treatment Period|Administrative reasons by sponsor|1|||
157065977|NCT02654132|566996366|FG000|Treatment Period|Death|1|||
157065978|NCT02654132|566996367|FG001|Treatment Period|Death|0|||
157065979|NCT01781832|566996376|FG000|Overall Study|Withdrawal by Subject|1|||
157065980|NCT02287233|566996377|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
157065981|NCT02287233|566996378|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
157065982|NCT02287233|566996379|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
157065983|NCT02287233|566996377|FG000|Overall Study|Adverse Event Related to Progression|0|||
157065984|NCT02287233|566996378|FG001|Overall Study|Adverse Event Related to Progression|2|||
157065985|NCT02287233|566996379|FG002|Overall Study|Adverse Event Related to Progression|8|||
157065986|NCT02287233|566996377|FG000|Overall Study|Physician Decision|1|||
157065987|NCT02287233|566996378|FG001|Overall Study|Physician Decision|2|||
157065988|NCT02287233|566996379|FG002|Overall Study|Physician Decision|4|||
157065989|NCT02287233|566996377|FG000|Overall Study|Progressive Disease with Death|0|||
157065990|NCT02287233|566996378|FG001|Overall Study|Progressive Disease with Death|0|||
157065991|NCT02287233|566996379|FG002|Overall Study|Progressive Disease with Death|10|||
157065992|NCT02287233|566996377|FG000|Overall Study|Progressive Disease Without Death|2|||
157065993|NCT02287233|566996378|FG001|Overall Study|Progressive Disease Without Death|3|||
157065994|NCT02287233|566996379|FG002|Overall Study|Progressive Disease Without Death|20|||
157065995|NCT02287233|566996377|FG000|Overall Study|Withdrawal by Subject|1|||
157065996|NCT02287233|566996378|FG001|Overall Study|Withdrawal by Subject|1|||
157065997|NCT02287233|566996379|FG002|Overall Study|Withdrawal by Subject|7|||
157065998|NCT02287233|566996377|FG000|Overall Study|Other|3|||
157065999|NCT02287233|566996378|FG001|Overall Study|Other|0|||
157066000|NCT02287233|566996379|FG002|Overall Study|Other|15|||
157066001|NCT02287233|566996377|FG000|Overall Study|Did Not Receive Treatment|0|||
157066002|NCT02287233|566996378|FG001|Overall Study|Did Not Receive Treatment|0|||
157066003|NCT02287233|566996379|FG002|Overall Study|Did Not Receive Treatment|2|||
157066004|NCT03772613|566996381|FG000|Overall Study|Lost to Follow-up|0|||
157066005|NCT03772613|566996382|FG001|Overall Study|Lost to Follow-up|1|||
157066006|NCT03772613|566996383|FG002|Overall Study|Lost to Follow-up|1|||
157066007|NCT01837797|566996386|FG000|Period 1|Adverse Event|9|||
157066008|NCT01837797|566996387|FG001|Period 1|Adverse Event|0|||
157066009|NCT01837797|566996388|FG002|Period 1|Adverse Event|0|||
157066010|NCT01837797|566996389|FG003|Period 1|Adverse Event|0|||
157066011|NCT01837797|566996390|FG004|Period 1|Adverse Event|0|||
157066012|NCT01837797|566996386|FG000|Period 1|Withdrawal by Subject|6|||
157066013|NCT01837797|566996387|FG001|Period 1|Withdrawal by Subject|0|||
157066014|NCT01837797|566996388|FG002|Period 1|Withdrawal by Subject|0|||
157066015|NCT01837797|566996389|FG003|Period 1|Withdrawal by Subject|0|||
157066016|NCT01837797|566996390|FG004|Period 1|Withdrawal by Subject|0|||
157066017|NCT01837797|566996386|FG000|Period 1|Administrative reasons|76|||
157066018|NCT01837797|566996387|FG001|Period 1|Administrative reasons|0|||
157066019|NCT01837797|566996388|FG002|Period 1|Administrative reasons|0|||
157066020|NCT01837797|566996389|FG003|Period 1|Administrative reasons|0|||
157066021|NCT01837797|566996390|FG004|Period 1|Administrative reasons|0|||
157066022|NCT01837797|566996386|FG000|Period 1|Withdrawal of consent before treatment|1|||
157066023|NCT01837797|566996387|FG001|Period 1|Withdrawal of consent before treatment|0|||
157066024|NCT01837797|566996388|FG002|Period 1|Withdrawal of consent before treatment|0|||
157230136|NCT00970281|567588255|FG000|Overall Study|Lack of Efficacy|1|||
157066025|NCT01837797|566996389|FG003|Period 1|Withdrawal of consent before treatment|0|||
157230137|NCT00970281|567588256|FG001|Overall Study|Lack of Efficacy|14|||
157066026|NCT01837797|566996390|FG004|Period 1|Withdrawal of consent before treatment|0|||
157066027|NCT01837797|566996386|FG000|Period 1|Other|10|||
157066028|NCT01837797|566996387|FG001|Period 1|Other|0|||
157066029|NCT01837797|566996388|FG002|Period 1|Other|0|||
157066030|NCT01837797|566996389|FG003|Period 1|Other|0|||
157066031|NCT01837797|566996390|FG004|Period 1|Other|0|||
157066032|NCT01837797|566996386|FG000|Period 2|Administrative or other reasons|0|||
157066033|NCT01837797|566996387|FG001|Period 2|Administrative or other reasons|5|||
157066034|NCT01837797|566996388|FG002|Period 2|Administrative or other reasons|2|||
157066035|NCT01837797|566996389|FG003|Period 2|Administrative or other reasons|4|||
157066036|NCT01837797|566996390|FG004|Period 2|Administrative or other reasons|0|||
157066037|NCT01837797|566996386|FG000|Period 2|Adverse Event|0|||
157066038|NCT01837797|566996387|FG001|Period 2|Adverse Event|0|||
157066039|NCT01837797|566996388|FG002|Period 2|Adverse Event|0|||
157066040|NCT01837797|566996389|FG003|Period 2|Adverse Event|1|||
157066041|NCT01837797|566996390|FG004|Period 2|Adverse Event|0|||
157066042|NCT01837797|566996386|FG000|Period 3|Adverse Event|0|||
157066043|NCT01837797|566996387|FG001|Period 3|Adverse Event|0|||
157066044|NCT01837797|566996388|FG002|Period 3|Adverse Event|0|||
157066045|NCT01837797|566996389|FG003|Period 3|Adverse Event|0|||
157066046|NCT01837797|566996390|FG004|Period 3|Adverse Event|1|||
157066047|NCT01837797|566996386|FG000|Period 3|Administrative reasons|0|||
157066048|NCT01837797|566996387|FG001|Period 3|Administrative reasons|0|||
157066049|NCT01837797|566996388|FG002|Period 3|Administrative reasons|0|||
157066050|NCT01837797|566996389|FG003|Period 3|Administrative reasons|0|||
157066051|NCT01837797|566996390|FG004|Period 3|Administrative reasons|20|||
157066052|NCT01837797|566996386|FG000|Period 3|Other|0|||
157066053|NCT01837797|566996387|FG001|Period 3|Other|0|||
157066054|NCT01837797|566996388|FG002|Period 3|Other|0|||
157066055|NCT01837797|566996389|FG003|Period 3|Other|0|||
157066056|NCT01837797|566996390|FG004|Period 3|Other|2|||
157066057|NCT04522778|566996412|FG000|Overall Study|Patient did not want to wear the device|1|||
157066058|NCT04522778|566996413|FG001|Overall Study|Patient did not want to wear the device|0|||
157066059|NCT04522778|566996412|FG000|Overall Study|Lost to Follow-up|0|||
157066060|NCT04522778|566996413|FG001|Overall Study|Lost to Follow-up|1|||
157066061|NCT00069277|566996414|FG000|Overall Study|Adverse Event|3|||
157066062|NCT00069277|566996414|FG000|Overall Study|Withdrawal by Subject|1|||
157066063|NCT00069277|566996414|FG000|Overall Study|Progressive Disease|15|||
157066064|NCT00069277|566996414|FG000|Overall Study|Physician Decision|2|||
157066065|NCT01225159|566996417|FG000|Overall Study|Change operation|1|||
157066066|NCT01225159|566996418|FG001|Overall Study|Change operation|0|||
157066067|NCT01024036|566996425|FG000|Blinded Treatment|Adverse Event|1|||
157066068|NCT01024036|566996426|FG001|Blinded Treatment|Adverse Event|1|||
157066069|NCT01024036|566996425|FG000|Blinded Treatment|Lack of Efficacy|16|||
157066070|NCT01024036|566996426|FG001|Blinded Treatment|Lack of Efficacy|14|||
157066071|NCT01024036|566996425|FG000|Blinded Treatment|Physician Decision|1|||
157066072|NCT01024036|566996426|FG001|Blinded Treatment|Physician Decision|0|||
157066073|NCT01024036|566996425|FG000|Blinded Treatment|Death|0|||
157066074|NCT01024036|566996426|FG001|Blinded Treatment|Death|2|||
157066075|NCT01024036|566996425|FG000|Blinded Treatment|Withdrawal by Subject|4|||
157066076|NCT01024036|566996426|FG001|Blinded Treatment|Withdrawal by Subject|3|||
157066077|NCT01024036|566996425|FG000|Unblinded Treatment|Adverse Event|0|||
157066078|NCT01024036|566996426|FG001|Unblinded Treatment|Adverse Event|1|||
157066079|NCT01024036|566996425|FG000|Unblinded Treatment|Lack of Efficacy|0|||
157066080|NCT01024036|566996426|FG001|Unblinded Treatment|Lack of Efficacy|2|||
157066081|NCT01024036|566996425|FG000|Follow-Up Period|Lost to Follow-up|1|||
157066082|NCT01024036|566996426|FG001|Follow-Up Period|Lost to Follow-up|1|||
157066083|NCT01024036|566996425|FG000|Follow-Up Period|Withdrawal by Subject|0|||
157066084|NCT01024036|566996426|FG001|Follow-Up Period|Withdrawal by Subject|1|||
157066085|NCT01024036|566996425|FG000|Follow-Up Period|Adverse Event|4|||
157066086|NCT01024036|566996426|FG001|Follow-Up Period|Adverse Event|1|||
157066087|NCT01220856|566996427|FG000|Overall Study|graft loss|3|||
157066088|NCT01220856|566996428|FG001|Overall Study|graft loss|3|||
157066089|NCT01220856|566996427|FG000|Overall Study|Lost to Follow-up|1|||
157066090|NCT01220856|566996428|FG001|Overall Study|Lost to Follow-up|0|||
157066091|NCT04814992|566996429|FG000|Overall Study|Withdrawal by Subject|6|||
157066092|NCT04814992|566996430|FG001|Overall Study|Withdrawal by Subject|3|||
157066093|NCT04814992|566996429|FG000|Overall Study|Lost to Follow-up|1|||
157066094|NCT04814992|566996430|FG001|Overall Study|Lost to Follow-up|4|||
157066095|NCT00934700|566996431|FG000|Overall Study|missing scan|5|||
157066096|NCT00934700|566996432|FG001|Overall Study|missing scan|9|||
157066097|NCT00934700|566996431|FG000|Overall Study|Death|8|||
157066098|NCT00934700|566996432|FG001|Overall Study|Death|3|||
157066099|NCT03900715|566996433|FG000|Overall Study|Protocol Deviation|1|||
157066100|NCT03900715|566996433|FG000|Overall Study|Lack of Efficacy|1|||
157066101|NCT03900715|566996433|FG000|Overall Study|Progressive Disease|6|||
157066102|NCT03900715|566996433|FG000|Overall Study|Adverse Event|2|||
157066103|NCT03900715|566996433|FG000|Overall Study|Other reasons|11|||
157066104|NCT02166476|566998568|FG000|Overall Study|Withdrawal by Subject|5|||
157066105|NCT02166476|566998569|FG001|Overall Study|Withdrawal by Subject|7|||
157066106|NCT02166476|566998568|FG000|Overall Study|Adverse Event|3|||
157066107|NCT02166476|566998569|FG001|Overall Study|Adverse Event|3|||
157185039|NCT00804986|567418058|FG005|Overall Study|Sponsor Decision|0|||
157185040|NCT00804986|567418053|FG000|Overall Study|Physician Decision|1|||
157185041|NCT00804986|567418054|FG001|Overall Study|Physician Decision|0|||
157185042|NCT00804986|567418055|FG002|Overall Study|Physician Decision|0|||
157185043|NCT00804986|567418056|FG003|Overall Study|Physician Decision|0|||
157185044|NCT00804986|567418057|FG004|Overall Study|Physician Decision|0|||
157185045|NCT00804986|567418058|FG005|Overall Study|Physician Decision|0|||
157185046|NCT02774291|567418060|FG000|Overall Study|Lost to Follow-up|1|||
157185047|NCT00397891|567418067|FG000|Overall Study|Withdrawal by Subject|1|||
157185048|NCT00397891|567418068|FG001|Overall Study|Withdrawal by Subject|0|||
157185049|NCT00397891|567418069|FG002|Overall Study|Withdrawal by Subject|0|||
157185050|NCT00397891|567418070|FG003|Overall Study|Withdrawal by Subject|0|||
157185051|NCT00397891|567418071|FG004|Overall Study|Withdrawal by Subject|1|||
157185052|NCT00412113|567418072|FG000|Overall Study|Adverse Event|11|||
157185053|NCT00412113|567418073|FG001|Overall Study|Adverse Event|15|||
157185054|NCT00412113|567418072|FG000|Overall Study|did not receive treatment|1|||
157185055|NCT00412113|567418073|FG001|Overall Study|did not receive treatment|0|||
157185056|NCT00796224|567418076|FG000|Overall Study|Adverse Event|1|||
157185057|NCT00796224|567418077|FG001|Overall Study|Adverse Event|0|||
157185058|NCT00796224|567418076|FG000|Overall Study|Protocol Violation|0|||
157185059|NCT00796224|567418077|FG001|Overall Study|Protocol Violation|1|||
157185060|NCT02116361|567418080|FG000|Overall Study|Pregnancy|0|||
157185061|NCT02116361|567418081|FG001|Overall Study|Pregnancy|0|||
157185062|NCT02116361|567418082|FG002|Overall Study|Pregnancy|0|||
157185063|NCT02116361|567418083|FG003|Overall Study|Pregnancy|1|||
157185064|NCT02116361|567418080|FG000|Overall Study|Protocol Violation|1|||
157185065|NCT02116361|567418081|FG001|Overall Study|Protocol Violation|0|||
157185066|NCT02116361|567418082|FG002|Overall Study|Protocol Violation|0|||
157185067|NCT02116361|567418083|FG003|Overall Study|Protocol Violation|2|||
157185068|NCT02116361|567418080|FG000|Overall Study|Physician Decision|2|||
157185069|NCT02116361|567418081|FG001|Overall Study|Physician Decision|3|||
157185070|NCT02116361|567418082|FG002|Overall Study|Physician Decision|0|||
157185071|NCT02116361|567418083|FG003|Overall Study|Physician Decision|0|||
157185072|NCT02116361|567418080|FG000|Overall Study|Adverse Event|1|||
157185073|NCT02116361|567418081|FG001|Overall Study|Adverse Event|0|||
157185074|NCT02116361|567418082|FG002|Overall Study|Adverse Event|0|||
157185075|NCT02116361|567418083|FG003|Overall Study|Adverse Event|3|||
157185076|NCT02116361|567418080|FG000|Overall Study|Other Reasons|3|||
157185077|NCT02116361|567418081|FG001|Overall Study|Other Reasons|3|||
157185078|NCT02116361|567418082|FG002|Overall Study|Other Reasons|3|||
157185079|NCT02116361|567418083|FG003|Overall Study|Other Reasons|3|||
157185080|NCT02116361|567418080|FG000|Overall Study|Lack of Efficacy|5|||
157185081|NCT02116361|567418081|FG001|Overall Study|Lack of Efficacy|7|||
157185082|NCT02116361|567418082|FG002|Overall Study|Lack of Efficacy|4|||
157185083|NCT02116361|567418083|FG003|Overall Study|Lack of Efficacy|3|||
157185084|NCT02116361|567418080|FG000|Overall Study|Lost to Follow-up|4|||
157185085|NCT02116361|567418081|FG001|Overall Study|Lost to Follow-up|5|||
157185086|NCT02116361|567418082|FG002|Overall Study|Lost to Follow-up|7|||
157185087|NCT02116361|567418083|FG003|Overall Study|Lost to Follow-up|5|||
157185088|NCT02116361|567418080|FG000|Overall Study|Personal Reasons|6|||
157185089|NCT02116361|567418081|FG001|Overall Study|Personal Reasons|6|||
157185090|NCT02116361|567418082|FG002|Overall Study|Personal Reasons|4|||
157185091|NCT02116361|567418083|FG003|Overall Study|Personal Reasons|9|||
157185092|NCT02116361|567418080|FG000|Overall Study|Investigator Decision - Relapse|9|||
157185093|NCT02116361|567418081|FG001|Overall Study|Investigator Decision - Relapse|7|||
157185094|NCT02116361|567418082|FG002|Overall Study|Investigator Decision - Relapse|8|||
157185095|NCT02116361|567418083|FG003|Overall Study|Investigator Decision - Relapse|5|||
157185096|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
157185097|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
157066108|NCT02166476|566998568|FG000|Overall Study|Lost to Follow-up|5|||
157066109|NCT02166476|566998569|FG001|Overall Study|Lost to Follow-up|10|||
157185098|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
157185099|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
157185100|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
157066110|NCT02166476|566998568|FG000|Overall Study|Physician Decision|1|||
157185101|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
157185102|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
157185103|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
157185104|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
157185105|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
157185106|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
157185107|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
157066111|NCT02166476|566998569|FG001|Overall Study|Physician Decision|0|||
157066112|NCT02166476|566998568|FG000|Overall Study|Unable to Come for Visit|0|||
157185108|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
157185109|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157185110|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157185111|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
157185112|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
157185113|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
157185114|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
157185115|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
157185116|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
157185117|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
157185118|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
157185119|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
157185120|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
157185121|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
157185122|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
157185123|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
157185124|NCT03227224|567418084|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
157185125|NCT03227224|567418085|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
157185126|NCT03227224|567418086|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
157185127|NCT03227224|567418087|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
157185128|NCT03227224|567418084|FG000|Follow-up Phase (2 Weeks)|Other|4|||
157185129|NCT03227224|567418085|FG001|Follow-up Phase (2 Weeks)|Other|4|||
157185130|NCT03227224|567418086|FG002|Follow-up Phase (2 Weeks)|Other|6|||
157185131|NCT03227224|567418087|FG003|Follow-up Phase (2 Weeks)|Other|3|||
157185132|NCT04195750|567418088|FG000|Overall Study|Death|245|||
157185133|NCT04195750|567418089|FG001|Overall Study|Death|253|||
157185134|NCT04195750|567418090|FG002|Overall Study|Death|5|||
157185135|NCT04195750|567418088|FG000|Overall Study|Physician Decision|0|||
157185136|NCT04195750|567418089|FG001|Overall Study|Physician Decision|1|||
157185137|NCT04195750|567418090|FG002|Overall Study|Physician Decision|0|||
157185138|NCT04195750|567418088|FG000|Overall Study|Withdrawal by Subject|9|||
157185139|NCT04195750|567418089|FG001|Overall Study|Withdrawal by Subject|8|||
157185140|NCT04195750|567418090|FG002|Overall Study|Withdrawal by Subject|0|||
157185141|NCT04195750|567418088|FG000|Overall Study|Ongoing|120|||
156977154|NCT00244374|566670619|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
156977155|NCT00432835|566670623|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
156977156|NCT00432835|566670624|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
156977157|NCT00802659|566670625|FG000|Overall Study|Physician Decision|0|||
156977158|NCT00802659|566670626|FG001|Overall Study|Physician Decision|1|||
156977159|NCT00802659|566670627|FG002|Overall Study|Physician Decision|0|||
156977160|NCT00802659|566670628|FG003|Overall Study|Physician Decision|0|||
156977161|NCT00289770|566670629|FG000|Year 15|Withdrawal by Subject|1|||
156977162|NCT00423293|566670630|FG000|Overall Study|Ineligible / No protocol treatment|11|||
156977163|NCT03810313|566670636|FG000|Overall Study|Study terminated by sponsor|164|||
156977164|NCT03810313|566670637|FG001|Overall Study|Study terminated by sponsor|159|||
156977165|NCT03810313|566670636|FG000|Overall Study|Subject decision|10|||
156977166|NCT03810313|566670637|FG001|Overall Study|Subject decision|11|||
156977167|NCT03810313|566670636|FG000|Overall Study|Lost to Follow-up|3|||
156977168|NCT03810313|566670637|FG001|Overall Study|Lost to Follow-up|3|||
156977169|NCT03810313|566670636|FG000|Overall Study|Adverse Event|2|||
156977170|NCT03810313|566670637|FG001|Overall Study|Adverse Event|1|||
156977171|NCT03810313|566670636|FG000|Overall Study|Death|2|||
156977172|NCT03810313|566670637|FG001|Overall Study|Death|1|||
156977173|NCT03810313|566670636|FG000|Overall Study|Physician Decision|0|||
156977174|NCT03810313|566670637|FG001|Overall Study|Physician Decision|1|||
156977175|NCT00154310|566670638|FG000|Overall Study|Adverse Event|19|||
156977176|NCT00154310|566670639|FG001|Overall Study|Adverse Event|9|||
157066113|NCT02166476|566998569|FG001|Overall Study|Unable to Come for Visit|3|||
157066114|NCT04367480|566998576|FG000|Overall Study|Adverse Event|1|||
157066115|NCT04367480|566998577|FG001|Overall Study|Adverse Event|1|||
157066116|NCT04367480|566998576|FG000|Overall Study|Death|1|||
157066117|NCT04367480|566998577|FG001|Overall Study|Death|0|||
157066118|NCT04367480|566998576|FG000|Overall Study|Lost to Follow-up|1|||
157066119|NCT04367480|566998577|FG001|Overall Study|Lost to Follow-up|1|||
157066120|NCT04367480|566998576|FG000|Overall Study|Withdrawal by Subject|0|||
157066121|NCT04367480|566998577|FG001|Overall Study|Withdrawal by Subject|3|||
156977177|NCT00154310|566670638|FG000|Overall Study|Lack of Efficacy|5|||
156977178|NCT00154310|566670639|FG001|Overall Study|Lack of Efficacy|4|||
156977179|NCT00154310|566670638|FG000|Overall Study|Protocol Violation|4|||
157066122|NCT04367480|566998576|FG000|Overall Study|App glitch during the study|1|||
157066123|NCT04367480|566998577|FG001|Overall Study|App glitch during the study|0|||
156977180|NCT00154310|566670639|FG001|Overall Study|Protocol Violation|2|||
156977181|NCT00154310|566670638|FG000|Overall Study|Withdrawal by Subject|9|||
157066124|NCT04367480|566998576|FG000|Overall Study|Device Distribution Error|0|||
157066125|NCT04367480|566998577|FG001|Overall Study|Device Distribution Error|2|||
157066126|NCT04367480|566998576|FG000|Overall Study|Ineligible after Randomization|0|||
156977182|NCT00154310|566670639|FG001|Overall Study|Withdrawal by Subject|3|||
157185142|NCT04195750|567418089|FG001|Overall Study|Ongoing|110|||
157185143|NCT04195750|567418090|FG002|Overall Study|Ongoing|4|||
157185144|NCT02406027|567418091|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
157185145|NCT02406027|567418092|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
157185146|NCT02406027|567418093|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
157185147|NCT02406027|567418094|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
157185148|NCT02406027|567418095|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
157185149|NCT02406027|567418096|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
157185150|NCT02406027|567418097|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
157185151|NCT02406027|567418091|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
157185152|NCT02406027|567418092|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
157185153|NCT02406027|567418093|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
157185154|NCT02406027|567418094|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
157185155|NCT02406027|567418095|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
157185156|NCT02406027|567418096|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
157185157|NCT02406027|567418097|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
157185158|NCT02406027|567418091|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
157185159|NCT02406027|567418092|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
157185160|NCT02406027|567418093|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
157185161|NCT02406027|567418094|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
157185162|NCT02406027|567418095|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
157185163|NCT02406027|567418096|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
157185164|NCT02406027|567418097|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
157185165|NCT02406027|567418091|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
157185166|NCT02406027|567418092|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
157185167|NCT02406027|567418093|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
157185168|NCT02406027|567418094|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
157185169|NCT02406027|567418095|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
157185170|NCT02406027|567418096|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
157185171|NCT02406027|567418097|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
157185172|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
157185173|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
157185174|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
157185175|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
157185176|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
157185177|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
157185178|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
157185179|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
157185180|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
157185181|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
157185182|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
157185183|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
157185184|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
157185185|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
157185186|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
157185187|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
157185188|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
157185189|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
157185190|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
157185191|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
157185192|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
157185193|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
157185194|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
157185195|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
157185196|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
157185197|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
157185198|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
157185199|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
157185200|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
156977183|NCT00154310|566670638|FG000|Overall Study|Lost to Follow-up|0|||
156977184|NCT00154310|566670639|FG001|Overall Study|Lost to Follow-up|8|||
157185201|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
157185202|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
157185203|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
157185204|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
157185205|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
157185206|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
157185207|NCT02406027|567418091|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185208|NCT02406027|567418092|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185209|NCT02406027|567418093|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185210|NCT02406027|567418094|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185211|NCT02406027|567418095|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
157185212|NCT02406027|567418096|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185213|NCT02406027|567418097|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
157185214|NCT03782376|567418098|FG000|Overall Study|Lost to Follow-up|2|||
157185215|NCT03782376|567418099|FG001|Overall Study|Lost to Follow-up|2|||
157185216|NCT03782376|567418098|FG000|Overall Study|Withdrawal by Subject|7|||
157185217|NCT03782376|567418099|FG001|Overall Study|Withdrawal by Subject|11|||
157185218|NCT03782376|567418098|FG000|Overall Study|Death|1|||
157185219|NCT03782376|567418099|FG001|Overall Study|Death|0|||
157185220|NCT03782376|567418098|FG000|Overall Study|Other|16|||
157185221|NCT03782376|567418099|FG001|Overall Study|Other|17|||
157185222|NCT02659098|567418100|FG000|Overall Study|Withdrawal by Subject|7|||
157185223|NCT04363944|567418101|FG000|Overall Study|Withdrawal by Subject|2|||
157185224|NCT04363944|567418102|FG001|Overall Study|Withdrawal by Subject|0|||
157185225|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
157185226|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
157185227|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Death|0|||
157185228|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Death|4|||
157185229|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
157185230|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
157185231|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
157185232|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
157185233|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
157185234|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
157185235|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
157185236|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
157185237|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
157185238|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
157185239|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Other|4|||
157185240|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Other|3|||
157185241|NCT03517722|567418103|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
157185242|NCT03517722|567418104|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
157185243|NCT03517722|567418103|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
157185244|NCT03517722|567418104|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
157185245|NCT03517722|567418103|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
157185246|NCT03517722|567418104|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
157185247|NCT03517722|567418103|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
157185248|NCT03517722|567418104|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
157185249|NCT03517722|567418103|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
157185250|NCT03517722|567418104|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
157185251|NCT03573804|567418105|FG000|Overall Study|claustrophobia or MRI table problems|10|||
157185252|NCT00952419|567418106|FG000|Overall Study|Adverse Event|2|||
157185253|NCT00952419|567418107|FG001|Overall Study|Adverse Event|0|||
157185254|NCT00952419|567418108|FG002|Overall Study|Adverse Event|0|||
157185255|NCT00952419|567418106|FG000|Overall Study|Protocol Violation|3|||
157185256|NCT00952419|567418107|FG001|Overall Study|Protocol Violation|7|||
157185257|NCT00952419|567418108|FG002|Overall Study|Protocol Violation|0|||
157185258|NCT00952419|567418106|FG000|Overall Study|Withdrawal by Subject|1|||
157185259|NCT00952419|567418107|FG001|Overall Study|Withdrawal by Subject|3|||
157185260|NCT00952419|567418108|FG002|Overall Study|Withdrawal by Subject|0|||
157185261|NCT01592773|567419392|FG000|Overall Study|Study Terminated by Sponsor|582|||
157185262|NCT01592773|567419392|FG000|Overall Study|Withdrawal by Subject|35|||
157185263|NCT01592773|567419392|FG000|Overall Study|Lost to Follow-up|19|||
157185264|NCT01592773|567419392|FG000|Overall Study|Adverse Event|17|||
157185265|NCT01592773|567419392|FG000|Overall Study|Lack of Efficacy|9|||
157185266|NCT01592773|567419392|FG000|Overall Study|Protocol Violation|2|||
157185267|NCT01592773|567419392|FG000|Overall Study|Inclusion/exclusion not meet|1|||
157185268|NCT01592773|567419392|FG000|Overall Study|Other Reason|1|||
157185269|NCT00121485|567419393|FG000|Overall Study|Not implanted|1|||
157185270|NCT00121485|567419394|FG001|Overall Study|Not implanted|5|||
157185271|NCT00121485|567419393|FG000|Overall Study|Crossover|0|||
157185272|NCT00121485|567419394|FG001|Overall Study|Crossover|2|||
157185273|NCT01654224|567419395|FG000|Overall Study|Lost to Follow-up|2|||
157185274|NCT01654224|567419396|FG001|Overall Study|Lost to Follow-up|2|||
157185275|NCT01654224|567419395|FG000|Overall Study|Did not receive allocation|1|||
157066127|NCT04367480|566998577|FG001|Overall Study|Ineligible after Randomization|1|||
157066128|NCT04367480|566998576|FG000|Overall Study|Other Medical Reasons|0|||
157066129|NCT04367480|566998577|FG001|Overall Study|Other Medical Reasons|2|||
157066130|NCT03382561|566998578|FG000|Overall Study|Disease progression|47|||
157066131|NCT03382561|566998579|FG001|Overall Study|Disease progression|6|||
157066132|NCT03382561|566998578|FG000|Overall Study|Adverse Event|10|||
157066133|NCT03382561|566998579|FG001|Overall Study|Adverse Event|2|||
157066134|NCT03382561|566998578|FG000|Overall Study|Death|8|||
157066135|NCT03382561|566998579|FG001|Overall Study|Death|3|||
157066136|NCT03382561|566998578|FG000|Overall Study|Withdrawal by Subject|6|||
157066137|NCT03382561|566998579|FG001|Overall Study|Withdrawal by Subject|5|||
157066138|NCT03382561|566998578|FG000|Overall Study|Alternative therapy|2|||
157066139|NCT03382561|566998579|FG001|Overall Study|Alternative therapy|8|||
157066140|NCT03382561|566998578|FG000|Overall Study|Never started treatment|3|||
157066141|NCT03382561|566998579|FG001|Overall Study|Never started treatment|6|||
157066142|NCT03382561|566998578|FG000|Overall Study|Lack of Efficacy|0|||
157066143|NCT03382561|566998579|FG001|Overall Study|Lack of Efficacy|1|||
157066144|NCT03382561|566998578|FG000|Overall Study|Physician Decision|0|||
157066145|NCT03382561|566998579|FG001|Overall Study|Physician Decision|1|||
157066146|NCT03382561|566998578|FG000|Overall Study|Other complicating disease|0|||
157066147|NCT03382561|566998579|FG001|Overall Study|Other complicating disease|1|||
157066148|NCT02641587|566998581|FG000|Confinement Period|Adverse Event|1|||
157066149|NCT02641587|566998582|FG001|Confinement Period|Adverse Event|0|||
157066150|NCT02641587|566998581|FG000|Confinement Period|Withdrawal by Subject|2|||
157066151|NCT02641587|566998582|FG001|Confinement Period|Withdrawal by Subject|1|||
157066152|NCT02641587|566998581|FG000|Ambulatory Period|Withdrawal by Subject|1|||
157066153|NCT02641587|566998582|FG001|Ambulatory Period|Withdrawal by Subject|0|||
157066154|NCT01663506|566998584|FG000|Overall Study|Lack of Efficacy|3|||
157066155|NCT01663506|566998584|FG000|Overall Study|Consent Withdrawal by Subject|1|||
157066156|NCT01663506|566998584|FG000|Overall Study|Lost to Follow-up|1|||
157066157|NCT01663506|566998584|FG000|Overall Study|Adverse Event|1|||
157066158|NCT01663506|566998584|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
157066159|NCT02094898|566998590|FG000|Overall Study|Clinical Worsening|2|||
157066160|NCT02094898|566998590|FG000|Overall Study|Adverse Event|2|||
157066161|NCT02094898|566998590|FG000|Overall Study|Lack of Efficacy|1|||
157066162|NCT03520075|566998591|FG000|Phase 1 (Dose Escalation)|Death|2|||
157066163|NCT03520075|566998592|FG001|Phase 1 (Dose Escalation)|Death|2|||
157066164|NCT03520075|566998593|FG002|Phase 1 (Dose Escalation)|Death|3|||
157066165|NCT03520075|566998594|FG003|Phase 1 (Dose Escalation)|Death|2|||
157066166|NCT03520075|566998595|FG004|Phase 1 (Dose Escalation)|Death|6|||
157066167|NCT03520075|566998596|FG005|Phase 1 (Dose Escalation)|Death|5|||
157066168|NCT03520075|566998597|FG006|Phase 1 (Dose Escalation)|Death|3|||
157066169|NCT03520075|566998598|FG007|Phase 1 (Dose Escalation)|Death|2|||
157066170|NCT03520075|566998599|FG008|Phase 1 (Dose Escalation)|Death|3|||
157066171|NCT03520075|566998600|FG009|Phase 1 (Dose Escalation)|Death|1|||
157066172|NCT03520075|566998601|FG010|Phase 1 (Dose Escalation)|Death|5|||
157066173|NCT03520075|566998602|FG011|Phase 1 (Dose Escalation)|Death|7|||
157066174|NCT03520075|566998603|FG012|Phase 1 (Dose Escalation)|Death|11|||
157066175|NCT03520075|566998604|FG013|Phase 1 (Dose Escalation)|Death|0|||
157066176|NCT03520075|566998605|FG014|Phase 1 (Dose Escalation)|Death|0|||
157066177|NCT03520075|566998606|FG015|Phase 1 (Dose Escalation)|Death|0|||
157066178|NCT03520075|566998607|FG016|Phase 1 (Dose Escalation)|Death|0|||
157066179|NCT03520075|566998608|FG017|Phase 1 (Dose Escalation)|Death|0|||
157066180|NCT03520075|566998609|FG018|Phase 1 (Dose Escalation)|Death|0|||
157066181|NCT03520075|566998591|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
157066182|NCT03520075|566998592|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066183|NCT03520075|566998593|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066184|NCT03520075|566998594|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
157066185|NCT03520075|566998595|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
157066186|NCT03520075|566998596|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
157066187|NCT03520075|566998597|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066188|NCT03520075|566998598|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
157066189|NCT03520075|566998599|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066190|NCT03520075|566998600|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
157066191|NCT03520075|566998601|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066192|NCT03520075|566998602|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066193|NCT03520075|566998603|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
157066194|NCT03520075|566998604|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066195|NCT03520075|566998605|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066196|NCT03520075|566998606|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066197|NCT03520075|566998607|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066198|NCT03520075|566998608|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066199|NCT03520075|566998609|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
157066200|NCT03520075|566998591|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066201|NCT03520075|566998592|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
157185276|NCT01654224|567419396|FG001|Overall Study|Did not receive allocation|8|||
157185277|NCT01654224|567419395|FG000|Overall Study|Insufficient blood sample|3|||
157185278|NCT01654224|567419396|FG001|Overall Study|Insufficient blood sample|2|||
157185279|NCT03763942|567419397|FG000|Overall Study|Lost to Follow-up|114|||
157185280|NCT03763942|567419398|FG001|Overall Study|Lost to Follow-up|54|||
157185281|NCT03763942|567419397|FG000|Overall Study|Protocol Violation|1|||
157185282|NCT03763942|567419398|FG001|Overall Study|Protocol Violation|0|||
157185283|NCT03763942|567419397|FG000|Overall Study|Withdrawal by Subject|2|||
157185284|NCT03763942|567419398|FG001|Overall Study|Withdrawal by Subject|0|||
157185285|NCT03763942|567419397|FG000|Overall Study|Other|2|||
157185286|NCT03763942|567419398|FG001|Overall Study|Other|3|||
157185287|NCT00166504|567419399|FG000|Overall Study|Adverse Event|3|||
157185288|NCT00166504|567419400|FG001|Overall Study|Adverse Event|3|||
157185289|NCT00166504|567419399|FG000|Overall Study|Lost to Follow-up|1|||
157185290|NCT00166504|567419400|FG001|Overall Study|Lost to Follow-up|1|||
157185291|NCT00166504|567419399|FG000|Overall Study|Withdrawal by Subject|1|||
157185292|NCT00166504|567419400|FG001|Overall Study|Withdrawal by Subject|0|||
157185293|NCT04969900|567419401|FG000|Overall Study|Physician Decision|1|||
157185294|NCT04969900|567419402|FG001|Overall Study|Physician Decision|1|||
157185295|NCT04969900|567419401|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
157185296|NCT04969900|567419402|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
157185297|NCT04423718|567419405|FG000|Main Study|Adverse Event|9|||
157185298|NCT04423718|567419406|FG001|Main Study|Adverse Event|5|||
157185299|NCT04423718|567419407|FG002|Main Study|Adverse Event|8|||
157185300|NCT04423718|567419405|FG000|Main Study|Physician Decision|3|||
157185301|NCT04423718|567419406|FG001|Main Study|Physician Decision|3|||
157185302|NCT04423718|567419407|FG002|Main Study|Physician Decision|2|||
157185303|NCT04423718|567419405|FG000|Main Study|Protocol Violation|0|||
157185304|NCT04423718|567419406|FG001|Main Study|Protocol Violation|0|||
157185305|NCT04423718|567419407|FG002|Main Study|Protocol Violation|1|||
157185306|NCT04423718|567419405|FG000|Main Study|Lost to Follow-up|3|||
157185307|NCT04423718|567419406|FG001|Main Study|Lost to Follow-up|3|||
157185308|NCT04423718|567419407|FG002|Main Study|Lost to Follow-up|4|||
157185309|NCT04423718|567419405|FG000|Main Study|Lack of Efficacy|2|||
157185310|NCT04423718|567419406|FG001|Main Study|Lack of Efficacy|1|||
157185311|NCT04423718|567419407|FG002|Main Study|Lack of Efficacy|0|||
157185312|NCT04423718|567419405|FG000|Main Study|Withdrawal by Subject|14|||
157185313|NCT04423718|567419406|FG001|Main Study|Withdrawal by Subject|20|||
157185314|NCT04423718|567419407|FG002|Main Study|Withdrawal by Subject|20|||
157185315|NCT04423718|567419405|FG000|Main Study|Death|10|||
157185316|NCT04423718|567419406|FG001|Main Study|Death|7|||
157185317|NCT04423718|567419407|FG002|Main Study|Death|7|||
157185318|NCT04423718|567419405|FG000|Main Study|COVID-19 pandemic|2|||
157185319|NCT04423718|567419406|FG001|Main Study|COVID-19 pandemic|2|||
157185320|NCT04423718|567419407|FG002|Main Study|COVID-19 pandemic|2|||
157185321|NCT04423718|567419405|FG000|Main Study|Other|7|||
157185322|NCT04423718|567419406|FG001|Main Study|Other|3|||
157185323|NCT04423718|567419407|FG002|Main Study|Other|2|||
157185324|NCT04423718|567419405|FG000|Extension Phase|Other|1|||
157185325|NCT04423718|567419406|FG001|Extension Phase|Other|0|||
157185326|NCT04423718|567419407|FG002|Extension Phase|Other|0|||
157185327|NCT04423718|567419405|FG000|Extension Phase|Logistical problems|0|||
157185328|NCT04423718|567419406|FG001|Extension Phase|Logistical problems|1|||
157185329|NCT04423718|567419407|FG002|Extension Phase|Logistical problems|1|||
157185330|NCT04423718|567419405|FG000|Extension Phase|Physician Decision|1|||
157185331|NCT04423718|567419406|FG001|Extension Phase|Physician Decision|0|||
157185332|NCT04423718|567419407|FG002|Extension Phase|Physician Decision|1|||
157185333|NCT04423718|567419405|FG000|Extension Phase|Lack of Efficacy|2|||
157185334|NCT04423718|567419406|FG001|Extension Phase|Lack of Efficacy|0|||
157185335|NCT04423718|567419407|FG002|Extension Phase|Lack of Efficacy|1|||
157185336|NCT04423718|567419405|FG000|Extension Phase|Lost to Follow-up|0|||
157066202|NCT03520075|566998593|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066203|NCT03520075|566998594|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
157066204|NCT03520075|566998595|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
157185337|NCT04423718|567419406|FG001|Extension Phase|Lost to Follow-up|2|||
157185338|NCT04423718|567419407|FG002|Extension Phase|Lost to Follow-up|3|||
157066205|NCT03520075|566998596|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066206|NCT03520075|566998597|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066207|NCT03520075|566998598|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066208|NCT03520075|566998599|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157185339|NCT04423718|567419405|FG000|Extension Phase|Adverse Event|2|||
157185340|NCT04423718|567419406|FG001|Extension Phase|Adverse Event|3|||
157185341|NCT04423718|567419407|FG002|Extension Phase|Adverse Event|1|||
157185342|NCT04423718|567419405|FG000|Extension Phase|Death|4|||
157185343|NCT04423718|567419406|FG001|Extension Phase|Death|7|||
157185344|NCT04423718|567419407|FG002|Extension Phase|Death|2|||
157185345|NCT04423718|567419405|FG000|Extension Phase|Withdrawal by Subject|11|||
157185346|NCT04423718|567419406|FG001|Extension Phase|Withdrawal by Subject|11|||
157185347|NCT04423718|567419407|FG002|Extension Phase|Withdrawal by Subject|7|||
156977185|NCT00154310|566670638|FG000|Overall Study|Administrative problems|0|||
156977186|NCT00154310|566670639|FG001|Overall Study|Administrative problems|1|||
156977187|NCT00154310|566670638|FG000|Overall Study|Death|0|||
156977188|NCT00154310|566670639|FG001|Overall Study|Death|1|||
156977189|NCT03469349|566670640|FG000|Overall Study|Withdrawal by Subject|1|||
156977190|NCT03469349|566670641|FG001|Overall Study|Withdrawal by Subject|3|||
156977191|NCT03469349|566670640|FG000|Overall Study|Progressive Disease|0|||
156977192|NCT03469349|566670641|FG001|Overall Study|Progressive Disease|1|||
156977193|NCT03469349|566670640|FG000|Overall Study|Lost to Follow-up|2|||
156977194|NCT03469349|566670641|FG001|Overall Study|Lost to Follow-up|2|||
156977195|NCT03469349|566670640|FG000|Overall Study|Adverse Event|2|||
156977196|NCT03469349|566670641|FG001|Overall Study|Adverse Event|4|||
156977197|NCT02086162|566670643|FG000|Overall Study|Withdrawal by Subject|4|||
156977198|NCT02086162|566670644|FG001|Overall Study|Withdrawal by Subject|4|||
156977199|NCT02086162|566670643|FG000|Overall Study|moved|1|||
156977200|NCT02086162|566670644|FG001|Overall Study|moved|1|||
156977201|NCT02086162|566670643|FG000|Overall Study|Lost to Follow-up|4|||
156977202|NCT02086162|566670644|FG001|Overall Study|Lost to Follow-up|2|||
156977203|NCT02086162|566670643|FG000|Overall Study|Death|1|||
156977204|NCT02086162|566670644|FG001|Overall Study|Death|0|||
156977205|NCT03447730|566670645|FG000|Overall Study|Adverse Event|0|||
156977206|NCT03447730|566670646|FG001|Overall Study|Adverse Event|2|||
156977207|NCT03447730|566670647|FG002|Overall Study|Adverse Event|0|||
156977208|NCT01827254|566670651|FG000|Overall Study|Death|10|||
156977209|NCT01827254|566670651|FG000|Overall Study|Case report form not completed|4|||
156977210|NCT01827254|566670651|FG000|Overall Study|Invalidated centre|3|||
156977211|NCT01827254|566670651|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
156977212|NCT01827254|566670651|FG000|Overall Study|Did not complete re-challenge|1|||
156977213|NCT01827254|566670651|FG000|Overall Study|Disease progression|36|||
156977214|NCT01827254|566670651|FG000|Overall Study|Intolerance to treatment|4|||
156977215|NCT01107743|566670655|FG000|Overall Study|Protocol Violation|46|||
156977216|NCT00308737|566670656|FG000|Overall Study|Adverse Event|104|||
156977217|NCT00308737|566670657|FG001|Overall Study|Adverse Event|9|||
156977218|NCT00308737|566670658|FG002|Overall Study|Adverse Event|0|||
156977219|NCT00308737|566670656|FG000|Overall Study|Death|4|||
156977220|NCT00308737|566670657|FG001|Overall Study|Death|3|||
156977221|NCT00308737|566670658|FG002|Overall Study|Death|0|||
156977222|NCT00308737|566670656|FG000|Overall Study|Lost to Follow-up|56|||
156977223|NCT00308737|566670657|FG001|Overall Study|Lost to Follow-up|80|||
156977224|NCT00308737|566670658|FG002|Overall Study|Lost to Follow-up|5|||
156977225|NCT00308737|566670656|FG000|Overall Study|Physician Decision|15|||
156977226|NCT00308737|566670657|FG001|Overall Study|Physician Decision|2|||
156977227|NCT00308737|566670658|FG002|Overall Study|Physician Decision|1|||
156977228|NCT00308737|566670656|FG000|Overall Study|Protocol Violation|34|||
156977229|NCT00308737|566670657|FG001|Overall Study|Protocol Violation|9|||
156977230|NCT00308737|566670658|FG002|Overall Study|Protocol Violation|5|||
156977231|NCT00308737|566670656|FG000|Overall Study|Withdrawal by Subject|218|||
156977232|NCT00308737|566670657|FG001|Overall Study|Withdrawal by Subject|166|||
156977233|NCT00308737|566670658|FG002|Overall Study|Withdrawal by Subject|18|||
156977234|NCT00308737|566670656|FG000|Overall Study|Various|32|||
156977235|NCT00308737|566670657|FG001|Overall Study|Various|20|||
156977236|NCT00308737|566670658|FG002|Overall Study|Various|8|||
156977237|NCT01290822|566670659|FG000|Overall Study|Withdrawal by Subject|1|||
156977238|NCT01290822|566670659|FG000|Overall Study|Physician Decision|10|||
156977239|NCT01515189|566670660|FG000|Induction|Disease Progression|109|||
156977240|NCT01515189|566670661|FG001|Induction|Disease Progression|155|||
156977241|NCT01515189|566670660|FG000|Induction|Study drug toxicity|86|||
156977242|NCT01515189|566670661|FG001|Induction|Study drug toxicity|36|||
156977243|NCT01515189|566670660|FG000|Induction|Death|24|||
156977244|NCT01515189|566670661|FG001|Induction|Death|17|||
156977245|NCT01515189|566670660|FG000|Induction|Adverse Event|14|||
156977246|NCT01515189|566670661|FG001|Induction|Adverse Event|9|||
156977247|NCT01515189|566670660|FG000|Induction|Withdrawal by Subject|3|||
156977248|NCT01515189|566670661|FG001|Induction|Withdrawal by Subject|9|||
156977249|NCT01515189|566670660|FG000|Induction|No longer meets study criteria|0|||
156977250|NCT01515189|566670661|FG001|Induction|No longer meets study criteria|2|||
156977251|NCT01515189|566670660|FG000|Induction|Lost to Follow-up|1|||
156977252|NCT01515189|566670661|FG001|Induction|Lost to Follow-up|0|||
156977253|NCT01515189|566670660|FG000|Induction|Other|0|||
156977254|NCT01515189|566670661|FG001|Induction|Other|4|||
156977255|NCT01515189|566670660|FG000|First Re-Induction Phase|Disease progression|6|||
156977256|NCT01515189|566670661|FG001|First Re-Induction Phase|Disease progression|14|||
156977257|NCT01515189|566670660|FG000|First Re-Induction Phase|Study drug toxicity|5|||
156977258|NCT01515189|566670661|FG001|First Re-Induction Phase|Study drug toxicity|0|||
156977259|NCT01515189|566670660|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
156977260|NCT01515189|566670661|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
156977261|NCT01515189|566670660|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
156977262|NCT01515189|566670661|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
156977263|NCT01515189|566670660|FG000|First Re-Induction Phase|Other|1|||
156977264|NCT01515189|566670661|FG001|First Re-Induction Phase|Other|0|||
157066209|NCT03520075|566998600|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066210|NCT03520075|566998601|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
157066211|NCT03520075|566998602|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066212|NCT03520075|566998603|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
157066213|NCT03520075|566998604|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066214|NCT03520075|566998605|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066215|NCT03520075|566998606|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066216|NCT03520075|566998607|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066217|NCT03520075|566998608|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066218|NCT03520075|566998609|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
157066219|NCT03520075|566998591|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066220|NCT03520075|566998592|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066221|NCT03520075|566998593|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066222|NCT03520075|566998594|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066223|NCT03520075|566998595|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066224|NCT03520075|566998596|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066225|NCT03520075|566998597|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066226|NCT03520075|566998598|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066227|NCT03520075|566998599|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066228|NCT03520075|566998600|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
157066229|NCT03520075|566998601|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066230|NCT03520075|566998602|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066231|NCT03520075|566998603|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
157066232|NCT03520075|566998604|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066233|NCT03520075|566998605|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066234|NCT03520075|566998606|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066235|NCT03520075|566998607|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066236|NCT03520075|566998608|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066237|NCT03520075|566998609|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
157066238|NCT03520075|566998591|FG000|Phase 2 (Dose Expansion)|Death|0|||
157066239|NCT03520075|566998592|FG001|Phase 2 (Dose Expansion)|Death|0|||
157066240|NCT03520075|566998593|FG002|Phase 2 (Dose Expansion)|Death|0|||
157066241|NCT03520075|566998594|FG003|Phase 2 (Dose Expansion)|Death|0|||
157066242|NCT03520075|566998595|FG004|Phase 2 (Dose Expansion)|Death|0|||
157066243|NCT03520075|566998596|FG005|Phase 2 (Dose Expansion)|Death|0|||
157066244|NCT03520075|566998597|FG006|Phase 2 (Dose Expansion)|Death|0|||
157066245|NCT03520075|566998598|FG007|Phase 2 (Dose Expansion)|Death|0|||
157066246|NCT03520075|566998599|FG008|Phase 2 (Dose Expansion)|Death|0|||
157066247|NCT03520075|566998600|FG009|Phase 2 (Dose Expansion)|Death|0|||
157066248|NCT03520075|566998601|FG010|Phase 2 (Dose Expansion)|Death|0|||
157066249|NCT03520075|566998602|FG011|Phase 2 (Dose Expansion)|Death|0|||
157066250|NCT03520075|566998603|FG012|Phase 2 (Dose Expansion)|Death|0|||
157066251|NCT03520075|566998604|FG013|Phase 2 (Dose Expansion)|Death|20|||
157066252|NCT03520075|566998605|FG014|Phase 2 (Dose Expansion)|Death|13|||
157066253|NCT03520075|566998606|FG015|Phase 2 (Dose Expansion)|Death|9|||
157066254|NCT03520075|566998607|FG016|Phase 2 (Dose Expansion)|Death|5|||
157066255|NCT03520075|566998608|FG017|Phase 2 (Dose Expansion)|Death|14|||
157066256|NCT03520075|566998609|FG018|Phase 2 (Dose Expansion)|Death|12|||
157066257|NCT03520075|566998591|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066258|NCT03520075|566998592|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066259|NCT03520075|566998593|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066260|NCT03520075|566998594|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066261|NCT03520075|566998595|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066262|NCT03520075|566998596|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066263|NCT03520075|566998597|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066264|NCT03520075|566998598|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066265|NCT03520075|566998599|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066266|NCT03520075|566998600|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066267|NCT03520075|566998601|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066268|NCT03520075|566998602|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066269|NCT03520075|566998603|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066270|NCT03520075|566998604|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
157066271|NCT03520075|566998605|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
157066272|NCT03520075|566998606|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
157066273|NCT03520075|566998607|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
157066274|NCT03520075|566998608|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
157066275|NCT03520075|566998609|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
157066276|NCT03520075|566998591|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066277|NCT03520075|566998592|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066278|NCT03520075|566998593|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157185348|NCT01874353|567419408|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
157185349|NCT01874353|567419409|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
157185350|NCT01874353|567419410|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
157185351|NCT01874353|567419411|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
157185352|NCT01874353|567419408|FG000|Overall Study|Lost to Follow-up|2|||
157185353|NCT01874353|567419409|FG001|Overall Study|Lost to Follow-up|2|||
157185354|NCT01874353|567419410|FG002|Overall Study|Lost to Follow-up|2|||
157185355|NCT01874353|567419411|FG003|Overall Study|Lost to Follow-up|0|||
157185356|NCT01874353|567419408|FG000|Overall Study|Death|110|||
157185357|NCT01874353|567419409|FG001|Overall Study|Death|60|||
157185358|NCT01874353|567419410|FG002|Overall Study|Death|13|||
157185359|NCT01874353|567419411|FG003|Overall Study|Death|7|||
157185360|NCT01874353|567419408|FG000|Overall Study|Withdrawal by Subject|13|||
157185361|NCT01874353|567419409|FG001|Overall Study|Withdrawal by Subject|11|||
157185362|NCT01874353|567419410|FG002|Overall Study|Withdrawal by Subject|0|||
157185363|NCT01874353|567419411|FG003|Overall Study|Withdrawal by Subject|0|||
157185364|NCT05298774|567419414|FG000|Overall Study|Physician Decision|3|||
157185365|NCT05298774|567419414|FG000|Overall Study|Withdrawal by Subject|2|||
157185366|NCT05298774|567419414|FG000|Overall Study|Lost to Follow-up|3|||
157185367|NCT05298774|567419414|FG000|Overall Study|Screen failure|1|||
157185368|NCT04992507|567419415|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
157185369|NCT04992507|567419416|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
157185370|NCT04992507|567419415|FG000|Overall Study|Death|0|||
157185371|NCT04992507|567419416|FG001|Overall Study|Death|1|||
157185372|NCT04651777|567419417|FG000|Overall Study|Adverse Event|1|||
157185373|NCT04651777|567419417|FG000|Overall Study|Withdrawal by Subject|2|||
157185374|NCT05505734|567419418|FG000|Overall Study|Withdrawal by Subject|51|||
157185375|NCT05505734|567419419|FG001|Overall Study|Withdrawal by Subject|64|||
157185376|NCT05505734|567419418|FG000|Overall Study|Adverse Event|6|||
157185377|NCT05505734|567419419|FG001|Overall Study|Adverse Event|20|||
157185378|NCT05505734|567419418|FG000|Overall Study|Protocol Violation|8|||
157185379|NCT05505734|567419419|FG001|Overall Study|Protocol Violation|15|||
157185380|NCT05505734|567419418|FG000|Overall Study|Lack of therapeutic response|0|||
157185381|NCT05505734|567419419|FG001|Overall Study|Lack of therapeutic response|1|||
157185382|NCT05505734|567419418|FG000|Overall Study|Lost to Follow-up|247|||
157185383|NCT05505734|567419419|FG001|Overall Study|Lost to Follow-up|237|||
157185384|NCT05505734|567419418|FG000|Overall Study|Physician Decision|22|||
157185385|NCT05505734|567419419|FG001|Overall Study|Physician Decision|13|||
157185386|NCT05505734|567419418|FG000|Overall Study|Death|2|||
157185387|NCT05505734|567419419|FG001|Overall Study|Death|1|||
157185388|NCT05505734|567419418|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157185389|NCT05505734|567419419|FG001|Overall Study|Withdrawal by parent/guardian|1|||
157185390|NCT05505734|567419418|FG000|Overall Study|Pregnancy|1|||
157185391|NCT05505734|567419419|FG001|Overall Study|Pregnancy|0|||
157185392|NCT05505734|567419418|FG000|Overall Study|Other|17|||
157185393|NCT05505734|567419419|FG001|Overall Study|Other|13|||
157185394|NCT03070119|567419420|FG000|Overall Study|Adverse Event|0|||
157185395|NCT03070119|567419421|FG001|Overall Study|Adverse Event|0|||
157185396|NCT03070119|567419422|FG002|Overall Study|Adverse Event|1|||
157185397|NCT03070119|567419420|FG000|Overall Study|Lost to Follow-up|0|||
157185398|NCT03070119|567419421|FG001|Overall Study|Lost to Follow-up|1|||
157185399|NCT03070119|567419422|FG002|Overall Study|Lost to Follow-up|0|||
157185400|NCT03070119|567419420|FG000|Overall Study|Consent Withdrawn|6|||
157185401|NCT03070119|567419421|FG001|Overall Study|Consent Withdrawn|5|||
157185402|NCT03070119|567419422|FG002|Overall Study|Consent Withdrawn|3|||
157185403|NCT03070119|567419420|FG000|Overall Study|Investigator Decision|0|||
157185404|NCT03070119|567419421|FG001|Overall Study|Investigator Decision|0|||
157185405|NCT03070119|567419422|FG002|Overall Study|Investigator Decision|1|||
157185406|NCT03070119|567419420|FG000|Overall Study|Death|7|||
157185407|NCT03070119|567419421|FG001|Overall Study|Death|14|||
157185408|NCT03070119|567419422|FG002|Overall Study|Death|5|||
157185409|NCT03070119|567419420|FG000|Overall Study|Disease Progression|5|||
157185410|NCT03070119|567419421|FG001|Overall Study|Disease Progression|7|||
157185411|NCT03070119|567419422|FG002|Overall Study|Disease Progression|7|||
157185412|NCT03070119|567419420|FG000|Overall Study|Reason not Specified|2|||
157185413|NCT03070119|567419421|FG001|Overall Study|Reason not Specified|2|||
157185414|NCT03070119|567419422|FG002|Overall Study|Reason not Specified|1|||
157185415|NCT01023516|567419423|FG000|Overall Study|Voluntary discontinuation|7|||
157185416|NCT01023516|567419424|FG001|Overall Study|Voluntary discontinuation|5|||
157185417|NCT01023516|567419423|FG000|Overall Study|Adverse Event|9|||
157185418|NCT01023516|567419424|FG001|Overall Study|Adverse Event|6|||
157185419|NCT01023516|567419423|FG000|Overall Study|Safety reason|0|||
157185420|NCT01023516|567419424|FG001|Overall Study|Safety reason|3|||
157185421|NCT01023516|567419423|FG000|Overall Study|Study-specific criteria|4|||
157185422|NCT01023516|567419424|FG001|Overall Study|Study-specific criteria|2|||
157185423|NCT01023516|567419423|FG000|Overall Study|Incorrect enrolment|4|||
157185424|NCT01023516|567419424|FG001|Overall Study|Incorrect enrolment|2|||
157185425|NCT01058395|567419425|FG000|Overall Study|Death|2|||
157185426|NCT01058395|567419426|FG001|Overall Study|Death|1|||
157185427|NCT01058395|567419425|FG000|Overall Study|Lost to Follow-up|1|||
157185428|NCT01058395|567419426|FG001|Overall Study|Lost to Follow-up|0|||
157185429|NCT01996865|567419427|FG000|Induction Period|Protocol Violation|1|||
157185430|NCT01996865|567419428|FG001|Induction Period|Protocol Violation|0|||
157185431|NCT01996865|567419429|FG002|Induction Period|Protocol Violation|0|||
157185432|NCT01996865|567419427|FG000|Induction Period|Progressive Disease|4|||
157185433|NCT01996865|567419428|FG001|Induction Period|Progressive Disease|0|||
157185434|NCT01996865|567419429|FG002|Induction Period|Progressive Disease|0|||
157185435|NCT01996865|567419427|FG000|Induction Period|Lost to Follow-up|10|||
157185436|NCT01996865|567419428|FG001|Induction Period|Lost to Follow-up|0|||
157185437|NCT01996865|567419429|FG002|Induction Period|Lost to Follow-up|0|||
157185438|NCT01996865|567419427|FG000|Induction Period|Other Reasons|13|||
157185439|NCT01996865|567419428|FG001|Induction Period|Other Reasons|0|||
157185440|NCT01996865|567419429|FG002|Induction Period|Other Reasons|0|||
157185441|NCT01996865|567419427|FG000|Induction Period|Adverse Event|20|||
157185442|NCT01996865|567419428|FG001|Induction Period|Adverse Event|0|||
157185443|NCT01996865|567419429|FG002|Induction Period|Adverse Event|0|||
157185444|NCT01996865|567419427|FG000|Induction Period|Withdrawal by Subject|60|||
157185445|NCT01996865|567419428|FG001|Induction Period|Withdrawal by Subject|0|||
157185446|NCT01996865|567419429|FG002|Induction Period|Withdrawal by Subject|0|||
157185447|NCT01996865|567419427|FG000|Induction Period|Death|111|||
157185448|NCT01996865|567419428|FG001|Induction Period|Death|0|||
157185449|NCT01996865|567419429|FG002|Induction Period|Death|0|||
157185450|NCT01996865|567419427|FG000|Maintenance Period|Protocol Violation|0|||
157185451|NCT01996865|567419428|FG001|Maintenance Period|Protocol Violation|1|||
157185452|NCT01996865|567419429|FG002|Maintenance Period|Protocol Violation|1|||
157185453|NCT01996865|567419427|FG000|Maintenance Period|Other reasons|0|||
157185454|NCT01996865|567419428|FG001|Maintenance Period|Other reasons|8|||
157185455|NCT01996865|567419429|FG002|Maintenance Period|Other reasons|5|||
157185456|NCT01996865|567419427|FG000|Maintenance Period|Progressive Disease|0|||
157185457|NCT01996865|567419428|FG001|Maintenance Period|Progressive Disease|6|||
157185458|NCT01996865|567419429|FG002|Maintenance Period|Progressive Disease|23|||
157185459|NCT01996865|567419427|FG000|Maintenance Period|Withdrawal by Subject|0|||
157185460|NCT01996865|567419428|FG001|Maintenance Period|Withdrawal by Subject|18|||
157185461|NCT01996865|567419429|FG002|Maintenance Period|Withdrawal by Subject|4|||
157185462|NCT01996865|567419427|FG000|Maintenance Period|Adverse Event|0|||
157185463|NCT01996865|567419428|FG001|Maintenance Period|Adverse Event|7|||
157185464|NCT01996865|567419429|FG002|Maintenance Period|Adverse Event|7|||
157185465|NCT01996865|567419427|FG000|Maintenance Period|Death|0|||
157185466|NCT01996865|567419428|FG001|Maintenance Period|Death|15|||
157185467|NCT01996865|567419429|FG002|Maintenance Period|Death|3|||
157185468|NCT01996865|567419427|FG000|Maintenance Period|Lost to Follow-up|0|||
157185469|NCT01996865|567419428|FG001|Maintenance Period|Lost to Follow-up|2|||
157185470|NCT01996865|567419429|FG002|Maintenance Period|Lost to Follow-up|0|||
157185471|NCT00515099|567419430|FG000|Overall Study|Lost to Follow-up|0|||
157185472|NCT00515099|567419431|FG001|Overall Study|Lost to Follow-up|4|||
157185473|NCT00515099|567419430|FG000|Overall Study|Withdrawal by Subject|2|||
157185474|NCT00515099|567419431|FG001|Overall Study|Withdrawal by Subject|0|||
157185475|NCT00515099|567419430|FG000|Overall Study|IRB Recommendation|1|||
157185476|NCT00515099|567419431|FG001|Overall Study|IRB Recommendation|0|||
157185477|NCT00376675|567419434|FG000|Overall Study|Withdrawal by Subject|9|||
157185478|NCT00376675|567419435|FG001|Overall Study|Withdrawal by Subject|2|||
157185479|NCT00376675|567419434|FG000|Overall Study|Adverse Event|10|||
157185480|NCT00376675|567419435|FG001|Overall Study|Adverse Event|5|||
157185481|NCT00376675|567419434|FG000|Overall Study|Other Reason|1|||
157230138|NCT00970281|567588255|FG000|Overall Study|Withdrawal by Subject|0|||
157230139|NCT00970281|567588256|FG001|Overall Study|Withdrawal by Subject|1|||
157230140|NCT00970281|567588255|FG000|Overall Study|Physician Decision|1|||
157230141|NCT00970281|567588256|FG001|Overall Study|Physician Decision|1|||
157230142|NCT00878995|567588259|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
157185482|NCT00376675|567419435|FG001|Overall Study|Other Reason|7|||
157185483|NCT01332851|567419438|FG000|Overall Study|Withdrawal by Subject|4|||
157185484|NCT01332851|567419439|FG001|Overall Study|Withdrawal by Subject|2|||
157185485|NCT01332851|567419438|FG000|Overall Study|Lost to Follow-up|7|||
157185486|NCT01332851|567419439|FG001|Overall Study|Lost to Follow-up|11|||
157185487|NCT05559203|567419440|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
157185488|NCT01947894|567419441|FG000|Overall Study|Other|3|||
157185489|NCT01947894|567419442|FG001|Overall Study|Other|4|||
157185490|NCT01947894|567419443|FG002|Overall Study|Other|3|||
157185491|NCT01947894|567419441|FG000|Overall Study|Withdrawal by Subject|12|||
157185492|NCT01947894|567419442|FG001|Overall Study|Withdrawal by Subject|4|||
157230143|NCT00878995|567588260|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
157185493|NCT01947894|567419443|FG002|Overall Study|Withdrawal by Subject|1|||
157185494|NCT01947894|567419441|FG000|Overall Study|Death|12|||
157185495|NCT01947894|567419442|FG001|Overall Study|Death|1|||
157230144|NCT02480764|567588261|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
157185496|NCT01947894|567419443|FG002|Overall Study|Death|0|||
157185497|NCT01947894|567419441|FG000|Overall Study|Physician Decision|2|||
157185498|NCT01947894|567419442|FG001|Overall Study|Physician Decision|0|||
157185499|NCT01947894|567419443|FG002|Overall Study|Physician Decision|0|||
157185500|NCT01947894|567419441|FG000|Overall Study|Adverse Event|5|||
157185501|NCT01947894|567419442|FG001|Overall Study|Adverse Event|1|||
157185502|NCT01947894|567419443|FG002|Overall Study|Adverse Event|0|||
157185503|NCT01947894|567419441|FG000|Overall Study|Switched to other growth hormone brand|53|||
157185504|NCT01947894|567419442|FG001|Overall Study|Switched to other growth hormone brand|8|||
157185505|NCT01947894|567419443|FG002|Overall Study|Switched to other growth hormone brand|23|||
157185506|NCT03796195|567419444|FG000|Overall Study|Study closed early|1|||
157185507|NCT04445051|567419445|FG000|Overall Study|Adverse Event|0|||
157185508|NCT04445051|567419446|FG001|Overall Study|Adverse Event|0|||
157185509|NCT04445051|567419447|FG002|Overall Study|Adverse Event|1|||
157185510|NCT04445051|567419448|FG003|Overall Study|Adverse Event|0|||
157185511|NCT04445051|567419449|FG004|Overall Study|Adverse Event|0|||
157185512|NCT04445051|567419450|FG005|Overall Study|Adverse Event|0|||
157185513|NCT02392468|567419451|FG000|Overall Study|Adverse Event|0|||
157185514|NCT02392468|567419452|FG001|Overall Study|Adverse Event|1|||
157185515|NCT02392468|567419453|FG002|Overall Study|Adverse Event|0|||
157185516|NCT02392468|567419454|FG003|Overall Study|Adverse Event|0|||
157185517|NCT02392468|567419455|FG004|Overall Study|Adverse Event|0|||
157185518|NCT02392468|567419456|FG005|Overall Study|Adverse Event|1|||
157185519|NCT03630016|567419457|FG000|Overall Study|Poor Sensor Placement|1|||
157185520|NCT05083949|567419458|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
157185521|NCT05083949|567419459|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
157185522|NCT05083949|567419458|FG000|Period 1|Adverse Event|1|||
157185523|NCT05083949|567419459|FG001|Period 1|Adverse Event|1|||
157185524|NCT05083949|567419458|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
157185525|NCT05083949|567419459|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
157185526|NCT05083949|567419458|FG000|Period 2|Adverse Event|0|||
157185527|NCT05083949|567419459|FG001|Period 2|Adverse Event|2|||
157185528|NCT01678560|567419462|FG000|Overall Study|Physician Decision|4|||
157185529|NCT01678560|567419463|FG001|Overall Study|Physician Decision|4|||
157185530|NCT01678560|567419462|FG000|Overall Study|Death|0|||
157185531|NCT01678560|567419463|FG001|Overall Study|Death|1|||
157185532|NCT01678560|567419462|FG000|Overall Study|Withdrawal by Subject|0|||
157185533|NCT01678560|567419463|FG001|Overall Study|Withdrawal by Subject|1|||
157185534|NCT02201472|567419464|FG000|Overall Study|Lack of Efficacy|2|||
157185535|NCT01300767|567419465|FG000|Overall Study|Discomfort|2|||
157185536|NCT01300767|567419465|FG000|Overall Study|Biomicroscopy|1|||
157185537|NCT01300767|567419465|FG000|Overall Study|Unacceptable fit|1|||
157185538|NCT01188811|567419470|FG000|Overall Study|Withdrawal by Subject|0|||
157185539|NCT01188811|567419471|FG001|Overall Study|Withdrawal by Subject|2|||
157185540|NCT01188811|567419470|FG000|Overall Study|Adverse Event|6|||
157185541|NCT01188811|567419471|FG001|Overall Study|Adverse Event|0|||
157185542|NCT01602744|567419472|FG000|Overall Study|Death|17|||
157185543|NCT01602744|567419473|FG001|Overall Study|Death|15|||
157185544|NCT01602744|567419472|FG000|Overall Study|Lost to Follow-up|13|||
157185545|NCT01602744|567419473|FG001|Overall Study|Lost to Follow-up|8|||
157185546|NCT01316380|567419476|FG000|Overall Study|Adverse Event|0|||
157185547|NCT01316380|567419477|FG001|Overall Study|Adverse Event|2|||
157185548|NCT01316380|567419478|FG002|Overall Study|Adverse Event|1|||
157185549|NCT01316380|567419476|FG000|Overall Study|Protocol Violation|0|||
157185550|NCT01316380|567419477|FG001|Overall Study|Protocol Violation|0|||
157185551|NCT01316380|567419478|FG002|Overall Study|Protocol Violation|1|||
157185552|NCT01316380|567419476|FG000|Overall Study|Withdrawal by Subject|1|||
157185553|NCT01316380|567419477|FG001|Overall Study|Withdrawal by Subject|2|||
157185554|NCT01316380|567419478|FG002|Overall Study|Withdrawal by Subject|0|||
157066279|NCT03520075|566998594|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066280|NCT03520075|566998595|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066281|NCT03520075|566998596|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066282|NCT03520075|566998597|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066283|NCT03520075|566998598|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066284|NCT03520075|566998599|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066285|NCT03520075|566998600|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157185555|NCT01316380|567419476|FG000|Overall Study|Other|0|||
157185556|NCT01316380|567419477|FG001|Overall Study|Other|1|||
157185557|NCT01316380|567419478|FG002|Overall Study|Other|1|||
157185558|NCT01316380|567419476|FG000|Overall Study|Not treated|1|||
157185559|NCT01316380|567419477|FG001|Overall Study|Not treated|0|||
157185560|NCT01316380|567419478|FG002|Overall Study|Not treated|0|||
157185561|NCT00471315|567419480|FG000|Overall Study|Adverse Event|7|||
157185562|NCT00471315|567419480|FG000|Overall Study|Withdrawal by Subject|1|||
157185563|NCT00609167|567419484|FG000|Overall Study|Withdrawal by Subject|1|||
157185564|NCT00609167|567419485|FG001|Overall Study|Withdrawal by Subject|0|||
157185565|NCT00609167|567419484|FG000|Overall Study|Lack of Efficacy|1|||
157185566|NCT00609167|567419485|FG001|Overall Study|Lack of Efficacy|0|||
157185567|NCT00609167|567419484|FG000|Overall Study|Adverse Event|5|||
157185568|NCT00609167|567419485|FG001|Overall Study|Adverse Event|1|||
157185569|NCT00609167|567419484|FG000|Overall Study|Disease Progression|1|||
157185570|NCT00609167|567419485|FG001|Overall Study|Disease Progression|0|||
157185571|NCT00609167|567419484|FG000|Overall Study|Stem Cell Transplant|0|||
157185572|NCT00609167|567419485|FG001|Overall Study|Stem Cell Transplant|6|||
157185573|NCT01365091|567419488|FG000|Period 1|Adverse Event|1|||
157185574|NCT01365091|567419489|FG001|Period 1|Adverse Event|0|||
157185575|NCT01365091|567419490|FG002|Period 1|Adverse Event|2|||
157185576|NCT01365091|567419491|FG003|Period 1|Adverse Event|3|||
157185577|NCT01365091|567419488|FG000|Period 1|Positive test result for drugs of abuse|1|||
157185578|NCT01365091|567419489|FG001|Period 1|Positive test result for drugs of abuse|0|||
157185579|NCT01365091|567419490|FG002|Period 1|Positive test result for drugs of abuse|0|||
157185580|NCT01365091|567419491|FG003|Period 1|Positive test result for drugs of abuse|0|||
157185581|NCT01365091|567419488|FG000|Period 1|No longer met study criteria|0|||
157185582|NCT01365091|567419489|FG001|Period 1|No longer met study criteria|1|||
157185583|NCT01365091|567419490|FG002|Period 1|No longer met study criteria|0|||
157185584|NCT01365091|567419491|FG003|Period 1|No longer met study criteria|0|||
157185585|NCT01365091|567419488|FG000|Period 1|Withdrawal by Subject|0|||
157185586|NCT01365091|567419489|FG001|Period 1|Withdrawal by Subject|1|||
157066286|NCT03520075|566998601|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066287|NCT03520075|566998602|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066288|NCT03520075|566998603|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066289|NCT03520075|566998604|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066290|NCT03520075|566998605|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
157066291|NCT03520075|566998606|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
157066292|NCT03520075|566998607|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066293|NCT03520075|566998608|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
157066294|NCT03520075|566998609|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
157066295|NCT03520075|566998591|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066296|NCT03520075|566998592|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066297|NCT03520075|566998593|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066298|NCT03520075|566998594|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066299|NCT03520075|566998595|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066300|NCT03520075|566998596|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066301|NCT03520075|566998597|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066302|NCT03520075|566998598|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066303|NCT03520075|566998599|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066304|NCT03520075|566998600|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066305|NCT03520075|566998601|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066306|NCT03520075|566998602|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066307|NCT03520075|566998603|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066308|NCT03520075|566998604|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
157066309|NCT03520075|566998605|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066310|NCT03520075|566998606|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066311|NCT03520075|566998607|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
157066312|NCT03520075|566998608|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
157066313|NCT03520075|566998609|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
157066314|NCT01432626|566998612|FG000|Overall Study|LV function recovered|2|||
157066315|NCT01432626|566998612|FG000|Overall Study|Withdrawal by Subject|2|||
157066316|NCT01432626|566998612|FG000|Overall Study|Only 1 image competed|2|||
157066317|NCT01432626|566998612|FG000|Overall Study|Imaging agent not available|1|||
157066318|NCT00328562|566998613|FG000|Overall Study|Disease progression|1|||
157066319|NCT03305809|566998614|FG000|Overall Study|Adverse Event|2|||
157066320|NCT03305809|566998615|FG001|Overall Study|Adverse Event|2|||
157066321|NCT03305809|566998616|FG002|Overall Study|Adverse Event|6|||
157066322|NCT03305809|566998617|FG003|Overall Study|Adverse Event|6|||
157066323|NCT03305809|566998614|FG000|Overall Study|Death|0|||
157066324|NCT03305809|566998615|FG001|Overall Study|Death|0|||
157066325|NCT03305809|566998616|FG002|Overall Study|Death|1|||
157185587|NCT01365091|567419490|FG002|Period 1|Withdrawal by Subject|0|||
157185588|NCT01365091|567419491|FG003|Period 1|Withdrawal by Subject|0|||
157185589|NCT01365091|567419488|FG000|Period 1|Personal reasons|0|||
157066326|NCT03305809|566998617|FG003|Overall Study|Death|1|||
157066327|NCT03305809|566998614|FG000|Overall Study|Lost to Follow-up|1|||
157066328|NCT03305809|566998615|FG001|Overall Study|Lost to Follow-up|2|||
157066329|NCT03305809|566998616|FG002|Overall Study|Lost to Follow-up|0|||
157066330|NCT03305809|566998617|FG003|Overall Study|Lost to Follow-up|0|||
157066331|NCT03305809|566998614|FG000|Overall Study|Sponsor Decision|1|||
157066332|NCT03305809|566998615|FG001|Overall Study|Sponsor Decision|0|||
157185590|NCT01365091|567419489|FG001|Period 1|Personal reasons|0|||
157185591|NCT01365091|567419490|FG002|Period 1|Personal reasons|1|||
157185592|NCT01365091|567419491|FG003|Period 1|Personal reasons|0|||
157185593|NCT01365091|567419488|FG000|Period 2|Withdrawal by Subject|1|||
157066333|NCT03305809|566998616|FG002|Overall Study|Sponsor Decision|1|||
157066334|NCT03305809|566998617|FG003|Overall Study|Sponsor Decision|8|||
157066335|NCT03305809|566998614|FG000|Overall Study|Physician Decision|0|||
157066336|NCT03305809|566998615|FG001|Overall Study|Physician Decision|0|||
157066337|NCT03305809|566998616|FG002|Overall Study|Physician Decision|2|||
157066338|NCT03305809|566998617|FG003|Overall Study|Physician Decision|4|||
157066339|NCT03305809|566998614|FG000|Overall Study|Progressive Disease|0|||
157066340|NCT03305809|566998615|FG001|Overall Study|Progressive Disease|0|||
157066341|NCT03305809|566998616|FG002|Overall Study|Progressive Disease|1|||
157066342|NCT03305809|566998617|FG003|Overall Study|Progressive Disease|0|||
157066343|NCT03305809|566998614|FG000|Overall Study|Protocol Violation|1|||
157066344|NCT03305809|566998615|FG001|Overall Study|Protocol Violation|0|||
157066345|NCT03305809|566998616|FG002|Overall Study|Protocol Violation|2|||
157066346|NCT03305809|566998617|FG003|Overall Study|Protocol Violation|3|||
157066347|NCT03305809|566998614|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
157066348|NCT03305809|566998615|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
157066349|NCT03305809|566998616|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
157066350|NCT03305809|566998617|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
157066351|NCT03305809|566998614|FG000|Overall Study|Withdrawal by Subject|2|||
157066352|NCT03305809|566998615|FG001|Overall Study|Withdrawal by Subject|4|||
157066353|NCT03305809|566998616|FG002|Overall Study|Withdrawal by Subject|5|||
157066354|NCT03305809|566998617|FG003|Overall Study|Withdrawal by Subject|2|||
157066355|NCT03305809|566998614|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
157066356|NCT03305809|566998615|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
157066357|NCT03305809|566998616|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
157066358|NCT03305809|566998617|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
157066359|NCT00816556|566998620|FG000|Overall Study|Adverse Event|1|||
157066360|NCT00816556|566998621|FG001|Overall Study|Adverse Event|1|||
157066361|NCT00816556|566998622|FG002|Overall Study|Adverse Event|1|||
157066362|NCT00816556|566998620|FG000|Overall Study|Withdrawal by Subject|1|||
157066363|NCT00816556|566998621|FG001|Overall Study|Withdrawal by Subject|1|||
157066364|NCT00816556|566998622|FG002|Overall Study|Withdrawal by Subject|1|||
157066365|NCT00816556|566998620|FG000|Overall Study|Lost to Follow-up|0|||
157066366|NCT00816556|566998621|FG001|Overall Study|Lost to Follow-up|0|||
157066367|NCT00816556|566998622|FG002|Overall Study|Lost to Follow-up|1|||
157066368|NCT04014790|566998623|FG000|Overall Study|Death|4|||
157066369|NCT04014790|566998623|FG000|Overall Study|Adverse Event|1|||
157066370|NCT04014790|566998623|FG000|Overall Study|Withdrawal by Subject|1|||
157066371|NCT03546816|566998624|FG000|Overall Study|Adverse Event|5|||
157066372|NCT03546816|566998625|FG001|Overall Study|Adverse Event|3|||
157066373|NCT03546816|566998624|FG000|Overall Study|Lack of Efficacy|2|||
157066374|NCT03546816|566998625|FG001|Overall Study|Lack of Efficacy|4|||
157066375|NCT03546816|566998624|FG000|Overall Study|Pregnancy|1|||
157066376|NCT03546816|566998625|FG001|Overall Study|Pregnancy|0|||
157066377|NCT03546816|566998624|FG000|Overall Study|Physician Decision|2|||
157066378|NCT03546816|566998625|FG001|Overall Study|Physician Decision|0|||
157066379|NCT03546816|566998624|FG000|Overall Study|Withdrawal by Subject|8|||
157066380|NCT03546816|566998625|FG001|Overall Study|Withdrawal by Subject|10|||
157066381|NCT03546816|566998624|FG000|Overall Study|Lost to Follow-up|3|||
157066382|NCT03546816|566998625|FG001|Overall Study|Lost to Follow-up|2|||
157066383|NCT00810342|566998628|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
157066384|NCT00810342|566998629|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
157066385|NCT00810342|566998628|FG000|Month 1 Follow-up|Pregnancy|1|||
157066386|NCT00810342|566998629|FG001|Month 1 Follow-up|Pregnancy|0|||
157066387|NCT00810342|566998628|FG000|6-month Follow-up|Lost to Follow-up|18|||
157066388|NCT00810342|566998629|FG001|6-month Follow-up|Lost to Follow-up|6|||
157066389|NCT00810342|566998628|FG000|6-month Follow-up|Pregnancy|6|||
157066390|NCT00810342|566998629|FG001|6-month Follow-up|Pregnancy|2|||
157066391|NCT00810342|566998628|FG000|12-month Followup|Pregnancy|9|||
157066392|NCT00810342|566998629|FG001|12-month Followup|Pregnancy|10|||
157066393|NCT00810342|566998628|FG000|12-month Followup|Lost to Follow-up|3|||
157066394|NCT00810342|566998629|FG001|12-month Followup|Lost to Follow-up|1|||
157066395|NCT03065933|566998631|FG000|Overall Study|study terminated|5|||
157066396|NCT04504630|566998632|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
157066397|NCT04504630|566998633|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
157066398|NCT04504630|566998632|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
157066399|NCT04504630|566998633|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
157066400|NCT01010204|566998634|FG000|Overall Study|Lost to Follow-up|2|||
157066401|NCT01010204|566998635|FG001|Overall Study|Lost to Follow-up|2|||
157066402|NCT01010204|566998634|FG000|Overall Study|Adverse Event|1|||
157066403|NCT01010204|566998635|FG001|Overall Study|Adverse Event|3|||
157066404|NCT01010204|566998634|FG000|Overall Study|Withdrawal by Subject|2|||
157066405|NCT01010204|566998635|FG001|Overall Study|Withdrawal by Subject|3|||
157066406|NCT01010204|566998634|FG000|Overall Study|psychiatric hospitalization|2|||
157066407|NCT01010204|566998635|FG001|Overall Study|psychiatric hospitalization|1|||
157066408|NCT01513330|566998636|FG000|SenSura Mio First,|Adverse Event|2|||
157066409|NCT01513330|566998637|FG001|SenSura Mio First,|Adverse Event|0|||
157066410|NCT01513330|566998636|FG000|SenSura Mio First,|Lack of Efficacy|0|||
157185594|NCT01365091|567419489|FG001|Period 2|Withdrawal by Subject|0|||
157185595|NCT01365091|567419490|FG002|Period 2|Withdrawal by Subject|0|||
157185596|NCT01365091|567419491|FG003|Period 2|Withdrawal by Subject|0|||
157185597|NCT01365091|567419488|FG000|Period 2|Adverse Event|0|||
157185598|NCT01365091|567419489|FG001|Period 2|Adverse Event|0|||
157185599|NCT01365091|567419490|FG002|Period 2|Adverse Event|1|||
157185600|NCT01365091|567419491|FG003|Period 2|Adverse Event|0|||
157185601|NCT03935594|567419502|FG000|Overall Study|Physician Decision|3|||
157185602|NCT01435122|567419503|FG000|Overall Study|Early withdrawal due to toxicity|8|||
157185603|NCT04412668|567419504|FG000|Overall Study|Death - multiple comorbidities|2|||
157185604|NCT04412668|567419505|FG001|Overall Study|Death - multiple comorbidities|0|||
157185605|NCT04412668|567419506|FG002|Overall Study|Death - multiple comorbidities|0|||
157185606|NCT04412668|567419504|FG000|Overall Study|Withdrawal by Subject|3|||
157185607|NCT04412668|567419505|FG001|Overall Study|Withdrawal by Subject|0|||
157185608|NCT04412668|567419506|FG002|Overall Study|Withdrawal by Subject|0|||
157185609|NCT04412668|567419504|FG000|Overall Study|Other than Specified|2|||
157185610|NCT04412668|567419505|FG001|Overall Study|Other than Specified|0|||
157185611|NCT04412668|567419506|FG002|Overall Study|Other than Specified|0|||
157185612|NCT03864627|567419508|FG000|Overall Study|Adverse Event|0|||
157185613|NCT03864627|567419509|FG001|Overall Study|Adverse Event|1|||
157185614|NCT03864627|567419508|FG000|Overall Study|Lack of Efficacy|0|||
157185615|NCT03864627|567419509|FG001|Overall Study|Lack of Efficacy|1|||
157185616|NCT03864627|567419508|FG000|Overall Study|Lost to Follow-up|0|||
157185617|NCT03864627|567419509|FG001|Overall Study|Lost to Follow-up|1|||
157185618|NCT03864627|567419508|FG000|Overall Study|Withdrawal by Subject|4|||
157185619|NCT03864627|567419509|FG001|Overall Study|Withdrawal by Subject|8|||
157185620|NCT03864627|567419508|FG000|Overall Study|Study terminated by sponsor|0|||
157185621|NCT03864627|567419509|FG001|Overall Study|Study terminated by sponsor|1|||
157185622|NCT01388491|567419511|FG000|Overall Study|Adverse Event|10|||
157185623|NCT01388491|567419512|FG001|Overall Study|Adverse Event|9|||
157185624|NCT01388491|567419511|FG000|Overall Study|Sponsor Request|9|||
157185625|NCT01388491|567419512|FG001|Overall Study|Sponsor Request|7|||
157185626|NCT01388491|567419511|FG000|Overall Study|Withdrawal by Subject|6|||
157185627|NCT01388491|567419512|FG001|Overall Study|Withdrawal by Subject|10|||
157185628|NCT01388491|567419511|FG000|Overall Study|Lost to Follow-up|4|||
157185629|NCT01388491|567419512|FG001|Overall Study|Lost to Follow-up|3|||
157185630|NCT01388491|567419511|FG000|Overall Study|Protocol Violation|2|||
156977265|NCT02100722|566670662|FG000|Overall Study|Withdrawal pre-procedure|4|||
156977266|NCT02100722|566670663|FG001|Overall Study|Withdrawal pre-procedure|9|||
156977267|NCT02100722|566670662|FG000|Overall Study|Withdrawal post-procedure|0|||
156977268|NCT02100722|566670663|FG001|Overall Study|Withdrawal post-procedure|3|||
156977269|NCT02100722|566670662|FG000|Overall Study|Lost to Follow-up|2|||
156977270|NCT02100722|566670663|FG001|Overall Study|Lost to Follow-up|2|||
156977271|NCT02100722|566670662|FG000|Overall Study|Continuing on study|751|||
156977272|NCT02100722|566670663|FG001|Overall Study|Continuing on study|729|||
156977273|NCT05644353|566670664|FG000|Overall Study|Physician Decision|1|||
156977274|NCT05644353|566670665|FG001|Overall Study|Physician Decision|0|||
156977275|NCT05644353|566670666|FG002|Overall Study|Physician Decision|0|||
156977276|NCT05644353|566670667|FG003|Overall Study|Physician Decision|0|||
156977277|NCT05644353|566670668|FG004|Overall Study|Physician Decision|0|||
156977278|NCT05644353|566670669|FG005|Overall Study|Physician Decision|0|||
156977279|NCT05644353|566670664|FG000|Overall Study|Protocol Violation|1|||
156977280|NCT05644353|566670665|FG001|Overall Study|Protocol Violation|0|||
156977281|NCT05644353|566670666|FG002|Overall Study|Protocol Violation|0|||
156977282|NCT05644353|566670667|FG003|Overall Study|Protocol Violation|0|||
156977283|NCT05644353|566670668|FG004|Overall Study|Protocol Violation|0|||
156977284|NCT05644353|566670669|FG005|Overall Study|Protocol Violation|0|||
156977285|NCT05644353|566670664|FG000|Overall Study|Withdrawal by Subject|0|||
156977286|NCT05644353|566670665|FG001|Overall Study|Withdrawal by Subject|2|||
156977287|NCT05644353|566670666|FG002|Overall Study|Withdrawal by Subject|0|||
156977288|NCT05644353|566670667|FG003|Overall Study|Withdrawal by Subject|0|||
156977289|NCT05644353|566670668|FG004|Overall Study|Withdrawal by Subject|1|||
156977290|NCT05644353|566670669|FG005|Overall Study|Withdrawal by Subject|0|||
156977291|NCT05644353|566670664|FG000|Overall Study|Lost to Follow-up|0|||
156977292|NCT05644353|566670665|FG001|Overall Study|Lost to Follow-up|0|||
156977293|NCT05644353|566670666|FG002|Overall Study|Lost to Follow-up|1|||
156977294|NCT05644353|566670667|FG003|Overall Study|Lost to Follow-up|0|||
156977295|NCT05644353|566670668|FG004|Overall Study|Lost to Follow-up|0|||
156977296|NCT05644353|566670669|FG005|Overall Study|Lost to Follow-up|0|||
156977297|NCT04986982|566670670|FG000|Overall Study|Withdrawal by Subject|3|||
156977298|NCT04986982|566670671|FG001|Overall Study|Withdrawal by Subject|1|||
157185631|NCT01388491|567419512|FG001|Overall Study|Protocol Violation|0|||
157185632|NCT01388491|567419511|FG000|Overall Study|Noncompliance|2|||
157185633|NCT01388491|567419512|FG001|Overall Study|Noncompliance|0|||
157185634|NCT01388491|567419511|FG000|Overall Study|Pregnancy|1|||
157185635|NCT01388491|567419512|FG001|Overall Study|Pregnancy|0|||
157185636|NCT04035473|567419513|FG000|Screening/Baseline|Death|0|||
156977299|NCT04986982|566670670|FG000|Overall Study|Lack of Efficacy|0|||
156977300|NCT04986982|566670671|FG001|Overall Study|Lack of Efficacy|2|||
157066411|NCT01513330|566998637|FG001|SenSura Mio First,|Lack of Efficacy|1|||
157066412|NCT01513330|566998636|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
157066413|NCT01513330|566998637|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
157066414|NCT01513330|566998636|FG000|SenSura Mio First,|Other|1|||
157066415|NCT01513330|566998637|FG001|SenSura Mio First,|Other|0|||
157066416|NCT01513330|566998636|FG000|Standard Care First,|Lack of Efficacy|2|||
157066417|NCT01513330|566998637|FG001|Standard Care First,|Lack of Efficacy|2|||
157066418|NCT01513330|566998636|FG000|Standard Care First,|Withdrawal by Subject|1|||
157066419|NCT01513330|566998637|FG001|Standard Care First,|Withdrawal by Subject|2|||
157066420|NCT01513330|566998636|FG000|Standard Care First,|Other|1|||
157066421|NCT01513330|566998637|FG001|Standard Care First,|Other|0|||
157066422|NCT01519778|566998638|FG000|Overall Study|Withdrawal by Subject|3|||
157066423|NCT01519778|566998638|FG000|Overall Study|Lost to Follow-up|10|||
157066424|NCT01519778|566998638|FG000|Overall Study|Physician Decision|1|||
157066425|NCT02270671|566998639|FG000|Overall Study|Withdrawal by Subject|1|||
157066426|NCT02270671|566998640|FG001|Overall Study|Withdrawal by Subject|1|||
157066427|NCT02270671|566998639|FG000|Overall Study|Protocol Violation|0|||
157066428|NCT02270671|566998640|FG001|Overall Study|Protocol Violation|1|||
157066429|NCT02270671|566998639|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
157066430|NCT02270671|566998640|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
157066431|NCT02270671|566998639|FG000|Overall Study|Lost to Follow-up|2|||
157066432|NCT02270671|566998640|FG001|Overall Study|Lost to Follow-up|1|||
157066433|NCT02330562|566998648|FG000|Overall Study|Adverse Event|0|||
157066434|NCT02330562|566998649|FG001|Overall Study|Adverse Event|0|||
157066435|NCT02330562|566998650|FG002|Overall Study|Adverse Event|3|||
157066436|NCT02330562|566998651|FG003|Overall Study|Adverse Event|0|||
157066437|NCT02330562|566998652|FG004|Overall Study|Adverse Event|3|||
157066438|NCT02330562|566998653|FG005|Overall Study|Adverse Event|1|||
157066439|NCT02330562|566998654|FG006|Overall Study|Adverse Event|0|||
157066440|NCT02330562|566998655|FG007|Overall Study|Adverse Event|0|||
157066441|NCT02330562|566998656|FG008|Overall Study|Adverse Event|0|||
157066442|NCT02330562|566998657|FG009|Overall Study|Adverse Event|1|||
157066443|NCT02330562|566998658|FG010|Overall Study|Adverse Event|1|||
157066444|NCT02330562|566998648|FG000|Overall Study|Participant decision|1|||
157066445|NCT02330562|566998649|FG001|Overall Study|Participant decision|0|||
157066446|NCT02330562|566998650|FG002|Overall Study|Participant decision|4|||
157066447|NCT02330562|566998651|FG003|Overall Study|Participant decision|1|||
157066448|NCT02330562|566998652|FG004|Overall Study|Participant decision|5|||
157066449|NCT02330562|566998653|FG005|Overall Study|Participant decision|2|||
157066450|NCT02330562|566998654|FG006|Overall Study|Participant decision|0|||
157066451|NCT02330562|566998655|FG007|Overall Study|Participant decision|0|||
157066452|NCT02330562|566998656|FG008|Overall Study|Participant decision|0|||
157066453|NCT02330562|566998657|FG009|Overall Study|Participant decision|3|||
157066454|NCT02330562|566998658|FG010|Overall Study|Participant decision|0|||
157066455|NCT02330562|566998648|FG000|Overall Study|Disease progression|5|||
157066456|NCT02330562|566998649|FG001|Overall Study|Disease progression|3|||
157066457|NCT02330562|566998650|FG002|Overall Study|Disease progression|20|||
157066458|NCT02330562|566998651|FG003|Overall Study|Disease progression|28|||
157066459|NCT02330562|566998652|FG004|Overall Study|Disease progression|23|||
157066460|NCT02330562|566998653|FG005|Overall Study|Disease progression|7|||
157066461|NCT02330562|566998654|FG006|Overall Study|Disease progression|1|||
157066462|NCT02330562|566998655|FG007|Overall Study|Disease progression|1|||
157066463|NCT02330562|566998656|FG008|Overall Study|Disease progression|1|||
157066464|NCT02330562|566998657|FG009|Overall Study|Disease progression|0|||
157066465|NCT02330562|566998658|FG010|Overall Study|Disease progression|5|||
157066466|NCT02330562|566998648|FG000|Overall Study|Other reasons|0|||
157066467|NCT02330562|566998649|FG001|Overall Study|Other reasons|0|||
157066468|NCT02330562|566998650|FG002|Overall Study|Other reasons|0|||
157066469|NCT02330562|566998651|FG003|Overall Study|Other reasons|1|||
157066470|NCT02330562|566998652|FG004|Overall Study|Other reasons|0|||
157066471|NCT02330562|566998653|FG005|Overall Study|Other reasons|0|||
157066472|NCT02330562|566998654|FG006|Overall Study|Other reasons|0|||
157185637|NCT04035473|567419514|FG001|Screening/Baseline|Death|1|||
157185638|NCT04035473|567419513|FG000|Screening/Baseline|Adverse Event|0|||
157185639|NCT04035473|567419514|FG001|Screening/Baseline|Adverse Event|1|||
157185640|NCT04035473|567419513|FG000|Follow-up Period|Adverse Event|2|||
157066473|NCT02330562|566998655|FG007|Overall Study|Other reasons|0|||
157066474|NCT02330562|566998656|FG008|Overall Study|Other reasons|0|||
157066475|NCT02330562|566998657|FG009|Overall Study|Other reasons|0|||
157066476|NCT02330562|566998658|FG010|Overall Study|Other reasons|0|||
157066477|NCT02330562|566998648|FG000|Overall Study|Withdrawal by Subject|0|||
157066478|NCT02330562|566998649|FG001|Overall Study|Withdrawal by Subject|0|||
157066479|NCT02330562|566998650|FG002|Overall Study|Withdrawal by Subject|0|||
157066480|NCT02330562|566998651|FG003|Overall Study|Withdrawal by Subject|0|||
157066481|NCT02330562|566998652|FG004|Overall Study|Withdrawal by Subject|0|||
157066482|NCT02330562|566998653|FG005|Overall Study|Withdrawal by Subject|0|||
157066483|NCT02330562|566998654|FG006|Overall Study|Withdrawal by Subject|0|||
157066484|NCT02330562|566998655|FG007|Overall Study|Withdrawal by Subject|0|||
157185641|NCT04035473|567419514|FG001|Follow-up Period|Adverse Event|0|||
157185642|NCT01201967|567419515|FG000|Overall Study|Lost to Follow-up|6|||
157185643|NCT01201967|567419516|FG001|Overall Study|Lost to Follow-up|5|||
157185644|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
157185645|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
157185646|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
157185647|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
157185648|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Other|13|||
157185649|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
157185650|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
157185651|NCT02497287|567419517|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
157185652|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
157185653|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
157185654|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
157185655|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
157185656|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
157185657|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
157185658|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
157185659|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
157185660|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
157185661|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
157185662|NCT02497287|567419517|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
157185663|NCT02497287|567419517|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
157185664|NCT02497287|567419517|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
157185665|NCT02497287|567419517|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
157185666|NCT02497287|567419517|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
157185667|NCT02497287|567419517|FG000|Follow-up Phase (4 Week)|Other|1|||
157185668|NCT00740116|567421216|FG000|Overall Study|Withdrawal by Subject|1|||
157185669|NCT00740116|567421217|FG001|Overall Study|Withdrawal by Subject|1|||
157185670|NCT00740116|567421216|FG000|Overall Study|Protocol Violation|1|||
157185671|NCT00740116|567421217|FG001|Overall Study|Protocol Violation|4|||
157185672|NCT04076579|567421220|FG000|Overall Study|Adverse Event|2|||
157185673|NCT04076579|567421221|FG001|Overall Study|Adverse Event|0|||
157185674|NCT04076579|567421220|FG000|Overall Study|discontinued due to toxicity|1|||
157185675|NCT04076579|567421221|FG001|Overall Study|discontinued due to toxicity|0|||
157185676|NCT04076579|567421220|FG000|Overall Study|Physician Decision|1|||
157185677|NCT04076579|567421221|FG001|Overall Study|Physician Decision|0|||
157185678|NCT04076579|567421220|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
157185679|NCT04076579|567421221|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
157185680|NCT04076579|567421220|FG000|Overall Study|Noncompliance|0|||
157185681|NCT04076579|567421221|FG001|Overall Study|Noncompliance|1|||
157185682|NCT04076579|567421220|FG000|Overall Study|Withdrawal by Subject|0|||
157185683|NCT04076579|567421221|FG001|Overall Study|Withdrawal by Subject|2|||
157185684|NCT01997892|567421224|FG000|Overall Study|Physician Decision|2|||
157185685|NCT01997892|567421224|FG000|Overall Study|Lost to Follow-up|6|||
157185686|NCT01997892|567421224|FG000|Overall Study|Death|14|||
157185687|NCT01997892|567421224|FG000|Overall Study|Renal transplant|8|||
157185688|NCT01997892|567421224|FG000|Overall Study|Other|3|||
157185689|NCT01997892|567421224|FG000|Overall Study|Study completion data not recorded|35|||
157185690|NCT02531633|567421225|FG000|Part A (52 Weeks)|Sponsor request|24|||
157185691|NCT02531633|567421226|FG001|Part A (52 Weeks)|Sponsor request|24|||
157185692|NCT02531633|567421227|FG002|Part A (52 Weeks)|Sponsor request|18|||
157185693|NCT02531633|567421228|FG003|Part A (52 Weeks)|Sponsor request|18|||
157185694|NCT02531633|567421229|FG004|Part A (52 Weeks)|Sponsor request|19|||
157185695|NCT02531633|567421230|FG005|Part A (52 Weeks)|Sponsor request|0|||
157185696|NCT02531633|567421231|FG006|Part A (52 Weeks)|Sponsor request|0|||
157185697|NCT02531633|567421232|FG007|Part A (52 Weeks)|Sponsor request|0|||
157185698|NCT02531633|567421233|FG008|Part A (52 Weeks)|Sponsor request|0|||
157185699|NCT02531633|567421234|FG009|Part A (52 Weeks)|Sponsor request|0|||
157185700|NCT02531633|567421225|FG000|Part A (52 Weeks)|Protocol Violation|1|||
157185701|NCT02531633|567421226|FG001|Part A (52 Weeks)|Protocol Violation|0|||
157185702|NCT02531633|567421227|FG002|Part A (52 Weeks)|Protocol Violation|0|||
157185703|NCT02531633|567421228|FG003|Part A (52 Weeks)|Protocol Violation|0|||
157185704|NCT02531633|567421229|FG004|Part A (52 Weeks)|Protocol Violation|0|||
157185705|NCT02531633|567421230|FG005|Part A (52 Weeks)|Protocol Violation|0|||
157185706|NCT02531633|567421231|FG006|Part A (52 Weeks)|Protocol Violation|0|||
157185707|NCT02531633|567421232|FG007|Part A (52 Weeks)|Protocol Violation|0|||
157185708|NCT02531633|567421233|FG008|Part A (52 Weeks)|Protocol Violation|0|||
157185709|NCT02531633|567421234|FG009|Part A (52 Weeks)|Protocol Violation|0|||
157185710|NCT02531633|567421225|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
157185711|NCT02531633|567421226|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
157185712|NCT02531633|567421227|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
157185713|NCT02531633|567421228|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
157185714|NCT02531633|567421229|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
157066485|NCT02330562|566998656|FG008|Overall Study|Withdrawal by Subject|0|||
157066486|NCT02330562|566998657|FG009|Overall Study|Withdrawal by Subject|1|||
157066487|NCT02330562|566998658|FG010|Overall Study|Withdrawal by Subject|0|||
157066488|NCT01547117|566998660|FG000|Overall Study|Physician Decision|0|||
157066489|NCT01547117|566998661|FG001|Overall Study|Physician Decision|1|||
157066490|NCT01547117|566998662|FG002|Overall Study|Physician Decision|1|||
157066491|NCT01547117|566998663|FG003|Overall Study|Physician Decision|3|||
157066492|NCT01547117|566998660|FG000|Overall Study|Withdrawal by Subject|1|||
157066493|NCT01547117|566998661|FG001|Overall Study|Withdrawal by Subject|2|||
157066494|NCT01547117|566998662|FG002|Overall Study|Withdrawal by Subject|1|||
157066495|NCT01547117|566998663|FG003|Overall Study|Withdrawal by Subject|2|||
157066496|NCT03927690|566998664|FG000|Overall Study|Withdrawal by Subject|3|||
157066497|NCT03927690|566998665|FG001|Overall Study|Withdrawal by Subject|1|||
157066498|NCT03927690|566998666|FG002|Overall Study|Withdrawal by Subject|1|||
157066499|NCT03927690|566998664|FG000|Overall Study|Adverse Event|1|||
157066500|NCT03927690|566998665|FG001|Overall Study|Adverse Event|0|||
157066501|NCT03927690|566998666|FG002|Overall Study|Adverse Event|0|||
157066502|NCT03927690|566998664|FG000|Overall Study|Death|1|||
157066503|NCT03927690|566998665|FG001|Overall Study|Death|0|||
157066504|NCT03927690|566998666|FG002|Overall Study|Death|0|||
157066505|NCT03927690|566998664|FG000|Overall Study|Lost to Follow-up|2|||
157066506|NCT03927690|566998665|FG001|Overall Study|Lost to Follow-up|2|||
157066507|NCT03927690|566998666|FG002|Overall Study|Lost to Follow-up|1|||
157066508|NCT00174447|566998671|FG000|Overall Study|Adverse Event|19|||
157066509|NCT00174447|566998671|FG000|Overall Study|Withdrawal by Subject|15|||
157066510|NCT00174447|566998671|FG000|Overall Study|Protocol Violation|1|||
157066511|NCT00174447|566998671|FG000|Overall Study|Lack of Efficacy|1|||
157066512|NCT00174447|566998671|FG000|Overall Study|Administrative reason/Other|2|||
157066513|NCT03491215|566998680|FG000|Overall Study|Death|6|||
157066514|NCT03491215|566998681|FG001|Overall Study|Death|2|||
157066515|NCT03491215|566998682|FG002|Overall Study|Death|1|||
157066516|NCT03491215|566998683|FG003|Overall Study|Death|0|||
157066517|NCT03491215|566998680|FG000|Overall Study|Physician Decision|1|||
157066518|NCT03491215|566998681|FG001|Overall Study|Physician Decision|0|||
157066519|NCT03491215|566998682|FG002|Overall Study|Physician Decision|0|||
157066520|NCT03491215|566998683|FG003|Overall Study|Physician Decision|0|||
157066521|NCT03603639|566998687|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
157066522|NCT03603639|566998688|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
157066523|NCT03603639|566998689|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
157066524|NCT03603639|566998690|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
157066525|NCT03603639|566998691|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
157066526|NCT03603639|566998692|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
157066527|NCT03603639|566998687|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
157066528|NCT03603639|566998688|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
157066529|NCT03603639|566998689|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
157066530|NCT03603639|566998690|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
157066531|NCT03603639|566998691|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
157066532|NCT03603639|566998692|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
157066533|NCT00551135|566998698|FG000|Overall Study|Adverse Event|1|||
157066534|NCT00551135|566998699|FG001|Overall Study|Adverse Event|0|||
157066535|NCT00551135|566998700|FG002|Overall Study|Adverse Event|1|||
157066536|NCT00551135|566998701|FG003|Overall Study|Adverse Event|1|||
157066537|NCT00551135|566998698|FG000|Overall Study|Lost to Follow-up|0|||
157066538|NCT00551135|566998699|FG001|Overall Study|Lost to Follow-up|0|||
157066539|NCT00551135|566998700|FG002|Overall Study|Lost to Follow-up|0|||
157066540|NCT00551135|566998701|FG003|Overall Study|Lost to Follow-up|1|||
157066541|NCT00551135|566998698|FG000|Overall Study|Other|3|||
157066542|NCT00551135|566998699|FG001|Overall Study|Other|2|||
157066543|NCT00551135|566998700|FG002|Overall Study|Other|1|||
157066544|NCT00551135|566998701|FG003|Overall Study|Other|2|||
157066545|NCT00551135|566998698|FG000|Overall Study|Withdrawal by Subject|1|||
157066546|NCT00551135|566998699|FG001|Overall Study|Withdrawal by Subject|0|||
157066547|NCT00551135|566998700|FG002|Overall Study|Withdrawal by Subject|3|||
157066548|NCT00551135|566998701|FG003|Overall Study|Withdrawal by Subject|1|||
157066549|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
157066550|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
157066551|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
157066552|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
157066553|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
157066554|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
157066555|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
157066556|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
157066557|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
157066558|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
157066559|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
157185715|NCT02531633|567421230|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
157185716|NCT02531633|567421231|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
157185717|NCT02531633|567421232|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
157185718|NCT02531633|567421233|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
157185719|NCT02531633|567421234|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
157185720|NCT02531633|567421225|FG000|Part A (52 Weeks)|Physician Decision|1|||
157185721|NCT02531633|567421226|FG001|Part A (52 Weeks)|Physician Decision|4|||
157185722|NCT02531633|567421227|FG002|Part A (52 Weeks)|Physician Decision|3|||
157185723|NCT02531633|567421228|FG003|Part A (52 Weeks)|Physician Decision|1|||
157185724|NCT02531633|567421229|FG004|Part A (52 Weeks)|Physician Decision|0|||
157185725|NCT02531633|567421230|FG005|Part A (52 Weeks)|Physician Decision|0|||
157185726|NCT02531633|567421231|FG006|Part A (52 Weeks)|Physician Decision|0|||
157185727|NCT02531633|567421232|FG007|Part A (52 Weeks)|Physician Decision|0|||
157185728|NCT02531633|567421233|FG008|Part A (52 Weeks)|Physician Decision|0|||
157185729|NCT02531633|567421234|FG009|Part A (52 Weeks)|Physician Decision|0|||
157185730|NCT02531633|567421225|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
157185731|NCT02531633|567421226|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
157185732|NCT02531633|567421227|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
157185733|NCT02531633|567421228|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
157185734|NCT02531633|567421229|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
157185735|NCT02531633|567421230|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
157185736|NCT02531633|567421231|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
157185737|NCT02531633|567421232|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
157185738|NCT02531633|567421233|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
157185739|NCT02531633|567421234|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
157185740|NCT02531633|567421225|FG000|Part A (52 Weeks)|Other|2|||
157185741|NCT02531633|567421226|FG001|Part A (52 Weeks)|Other|0|||
157185742|NCT02531633|567421227|FG002|Part A (52 Weeks)|Other|0|||
157185743|NCT02531633|567421228|FG003|Part A (52 Weeks)|Other|0|||
157185744|NCT02531633|567421229|FG004|Part A (52 Weeks)|Other|0|||
157185745|NCT02531633|567421230|FG005|Part A (52 Weeks)|Other|0|||
157185746|NCT02531633|567421231|FG006|Part A (52 Weeks)|Other|0|||
157185747|NCT02531633|567421232|FG007|Part A (52 Weeks)|Other|0|||
157185748|NCT02531633|567421233|FG008|Part A (52 Weeks)|Other|0|||
157185749|NCT02531633|567421234|FG009|Part A (52 Weeks)|Other|0|||
157185750|NCT02531633|567421225|FG000|Part B (104 Weeks)|Sponsor request|0|||
157185751|NCT02531633|567421226|FG001|Part B (104 Weeks)|Sponsor request|0|||
157185752|NCT02531633|567421227|FG002|Part B (104 Weeks)|Sponsor request|0|||
157185753|NCT02531633|567421228|FG003|Part B (104 Weeks)|Sponsor request|0|||
157185754|NCT02531633|567421229|FG004|Part B (104 Weeks)|Sponsor request|0|||
157185755|NCT02531633|567421230|FG005|Part B (104 Weeks)|Sponsor request|8|||
157185756|NCT02531633|567421231|FG006|Part B (104 Weeks)|Sponsor request|5|||
157230145|NCT02480764|567588262|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
156977301|NCT04986982|566670670|FG000|Overall Study|Ineligibility|3|||
156977302|NCT04986982|566670671|FG001|Overall Study|Ineligibility|0|||
156977303|NCT04986982|566670670|FG000|Overall Study|Adverse Event|4|||
156977304|NCT04986982|566670671|FG001|Overall Study|Adverse Event|4|||
156977305|NCT04986982|566670670|FG000|Overall Study|Lost to Follow-up|0|||
156977306|NCT04986982|566670671|FG001|Overall Study|Lost to Follow-up|1|||
156977307|NCT04986982|566670670|FG000|Overall Study|Sponsor's discretion|1|||
157066560|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
157066561|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
157066562|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
157066563|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
157066564|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
157066565|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
157066566|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
156977308|NCT04986982|566670671|FG001|Overall Study|Sponsor's discretion|0|||
156977309|NCT05796518|566670672|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
156977310|NCT01535274|566670673|FG000|Overall Study|Determined to be ineligible|0|||
156977311|NCT01535274|566670674|FG001|Overall Study|Determined to be ineligible|1|||
156977312|NCT01535274|566670673|FG000|Overall Study|Misallocated to propofol intervention|0|||
156977313|NCT01535274|566670674|FG001|Overall Study|Misallocated to propofol intervention|1|||
156977314|NCT02690077|566670675|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
156977315|NCT02690077|566670676|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
157066567|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
157185757|NCT02531633|567421232|FG007|Part B (104 Weeks)|Sponsor request|3|||
157185758|NCT02531633|567421233|FG008|Part B (104 Weeks)|Sponsor request|5|||
157185759|NCT02531633|567421234|FG009|Part B (104 Weeks)|Sponsor request|4|||
157185760|NCT02531633|567421225|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
157185761|NCT02531633|567421226|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
157185762|NCT02531633|567421227|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
157185763|NCT02531633|567421228|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
157185764|NCT02531633|567421229|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
157185765|NCT02531633|567421230|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
157185766|NCT02531633|567421231|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
157185767|NCT02531633|567421232|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
157185768|NCT02531633|567421233|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
157185769|NCT02531633|567421234|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
157185770|NCT04097925|567421235|FG000|Overall Study|Withdrawal by Subject|1|||
157185771|NCT00186121|567421239|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
157185772|NCT00186121|567421239|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
157185773|NCT00186121|567421239|FG000|Overall Study|Not eligible (no treatment)|1|||
157185774|NCT03650387|567421240|FG000|Overall Study|Withdrawal by Subject|13|||
157185775|NCT03650387|567421240|FG000|Overall Study|Lost to Follow-up|12|||
157185776|NCT03650387|567421240|FG000|Overall Study|Adverse Event (Not related)|1|||
157185777|NCT03650387|567421240|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
157185778|NCT00417248|567421241|FG000|Overall Study|Study Terminated|6|||
157185779|NCT00417248|567421241|FG000|Overall Study|Death|1|||
157185780|NCT00417248|567421241|FG000|Overall Study|Lack of Efficacy|1|||
157185781|NCT01569568|567421242|FG000|Overall Study|Physician Decision|0|||
157185782|NCT01569568|567421243|FG001|Overall Study|Physician Decision|2|||
157185783|NCT05815758|567421244|FG000|Overall Study|Adverse Event|6|||
157185784|NCT05815758|567421245|FG001|Overall Study|Adverse Event|2|||
157185785|NCT05815758|567421244|FG000|Overall Study|Lost to Follow-up|14|||
157185786|NCT05815758|567421245|FG001|Overall Study|Lost to Follow-up|1|||
157185787|NCT05815758|567421244|FG000|Overall Study|Withdrawal by Subject|6|||
157185788|NCT05815758|567421245|FG001|Overall Study|Withdrawal by Subject|6|||
157185789|NCT05815758|567421244|FG000|Overall Study|Protocol Violation|1|||
157185790|NCT05815758|567421245|FG001|Overall Study|Protocol Violation|1|||
157185791|NCT05815758|567421244|FG000|Overall Study|Discontinued|4|||
157185792|NCT05815758|567421245|FG001|Overall Study|Discontinued|4|||
157185793|NCT03661983|567421246|FG000|Open Label Stabilization Phase|Adverse Event|5|||
157185794|NCT03661983|567421247|FG001|Open Label Stabilization Phase|Adverse Event|0|||
157185795|NCT03661983|567421248|FG002|Open Label Stabilization Phase|Adverse Event|0|||
157185796|NCT03661983|567421249|FG003|Open Label Stabilization Phase|Adverse Event|0|||
157185797|NCT03661983|567421246|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
157185798|NCT03661983|567421247|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
157185799|NCT03661983|567421248|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
157185800|NCT03661983|567421249|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
157185801|NCT03661983|567421246|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
157185802|NCT03661983|567421247|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
157185803|NCT03661983|567421248|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
157185804|NCT03661983|567421249|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
157185805|NCT03661983|567421246|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
157185806|NCT03661983|567421247|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
157185807|NCT03661983|567421248|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
157185808|NCT03661983|567421249|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
157185809|NCT03661983|567421246|FG000|Double-blind Randomized Phase|Adverse Event|0|||
157066568|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
157066569|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
157066570|NCT04599855|566998702|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
157066571|NCT04599855|566998703|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
157066572|NCT04599855|566998704|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
157066573|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
157066574|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
157066575|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
157066576|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
157066577|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
157185810|NCT03661983|567421247|FG001|Double-blind Randomized Phase|Adverse Event|1|||
157185811|NCT03661983|567421248|FG002|Double-blind Randomized Phase|Adverse Event|0|||
157185812|NCT03661983|567421249|FG003|Double-blind Randomized Phase|Adverse Event|0|||
157185813|NCT03661983|567421246|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
157185814|NCT03661983|567421247|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
157185815|NCT03661983|567421248|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
157185816|NCT03661983|567421249|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
157185817|NCT03661983|567421246|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
157185818|NCT03661983|567421247|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
157185819|NCT03661983|567421248|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
157185820|NCT03661983|567421249|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
157185821|NCT03661983|567421246|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
157185822|NCT03661983|567421247|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
157185823|NCT03661983|567421248|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
157185824|NCT03661983|567421249|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
157185825|NCT02903966|567421250|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
157066578|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
157066579|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
157066580|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
157066581|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
157066582|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
157066583|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
157066584|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
157066585|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
157066586|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
157066587|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
157066588|NCT04599855|566998702|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
157066589|NCT04599855|566998703|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
157066590|NCT04599855|566998704|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
157066591|NCT04294667|566998705|FG000|Overall Study|Lack of Efficacy|4|||
157066592|NCT04294667|566998706|FG001|Overall Study|Lack of Efficacy|4|||
157066593|NCT04294667|566998705|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
157066594|NCT04294667|566998706|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
157066595|NCT04294667|566998705|FG000|Overall Study|Patient has a Renal Flare|1|||
157066596|NCT04294667|566998706|FG001|Overall Study|Patient has a Renal Flare|0|||
157066597|NCT04294667|566998705|FG000|Overall Study|SLE Worsening|0|||
157066598|NCT04294667|566998706|FG001|Overall Study|SLE Worsening|1|||
157066599|NCT04294667|566998705|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
157066600|NCT04294667|566998706|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
157066601|NCT04294667|566998705|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
157066602|NCT04294667|566998706|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
157066603|NCT04294667|566998705|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
157066604|NCT04294667|566998706|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
157066605|NCT04294667|566998705|FG000|Overall Study|Subject Moved to Another State|0|||
157066606|NCT04294667|566998706|FG001|Overall Study|Subject Moved to Another State|1|||
157066607|NCT04294667|566998705|FG000|Overall Study|Adverse event, serious fatal|0|||
157066608|NCT04294667|566998706|FG001|Overall Study|Adverse event, serious fatal|1|||
157066609|NCT04294667|566998705|FG000|Overall Study|Adverse event, non-fatal|3|||
157066610|NCT04294667|566998706|FG001|Overall Study|Adverse event, non-fatal|4|||
157066611|NCT02165397|566998707|FG000|Overall Study|Death|7|||
157066612|NCT02165397|566998708|FG001|Overall Study|Death|10|||
157066613|NCT02165397|566998709|FG002|Overall Study|Death|8|||
157066614|NCT02165397|566998707|FG000|Overall Study|Lost to Follow-up|1|||
157066615|NCT02165397|566998708|FG001|Overall Study|Lost to Follow-up|3|||
157066616|NCT02165397|566998709|FG002|Overall Study|Lost to Follow-up|0|||
157066617|NCT02165397|566998707|FG000|Overall Study|Withdrawal by Subject|6|||
157066618|NCT02165397|566998708|FG001|Overall Study|Withdrawal by Subject|6|||
157066619|NCT02165397|566998709|FG002|Overall Study|Withdrawal by Subject|1|||
157066620|NCT02165397|566998707|FG000|Overall Study|Other, Not Specified|0|||
157066621|NCT02165397|566998708|FG001|Overall Study|Other, Not Specified|0|||
157066622|NCT02165397|566998709|FG002|Overall Study|Other, Not Specified|1|||
157066623|NCT00548847|566998712|FG000|Overall Study|Disease progression|7|||
157066624|NCT01841697|566998715|FG000|Overall Study|Death|0|||
157066625|NCT01841697|566998716|FG001|Overall Study|Death|1|||
157066626|NCT01841697|566998715|FG000|Overall Study|Lost to Follow-up|4|||
157066627|NCT01841697|566998716|FG001|Overall Study|Lost to Follow-up|1|||
157066628|NCT01841697|566998715|FG000|Overall Study|Withdrawal by Subject|16|||
157066629|NCT01841697|566998716|FG001|Overall Study|Withdrawal by Subject|16|||
157066630|NCT00727415|566998717|FG000|Phase I|Dose Limiting Toxicity|2|||
157066631|NCT00511797|566998720|FG000|Overall Study|Adverse Event|1|||
157066632|NCT00511797|566998721|FG001|Overall Study|Adverse Event|2|||
157066633|NCT00511797|566998722|FG002|Overall Study|Adverse Event|2|||
157066634|NCT00511797|566998723|FG003|Overall Study|Adverse Event|2|||
157066635|NCT00511797|566998720|FG000|Overall Study|Lost to Follow-up|1|||
157066636|NCT00511797|566998721|FG001|Overall Study|Lost to Follow-up|0|||
157066637|NCT00511797|566998722|FG002|Overall Study|Lost to Follow-up|0|||
157066638|NCT00511797|566998723|FG003|Overall Study|Lost to Follow-up|1|||
157066639|NCT00511797|566998720|FG000|Overall Study|Pregnancy|0|||
157066640|NCT00511797|566998721|FG001|Overall Study|Pregnancy|0|||
157066641|NCT00511797|566998722|FG002|Overall Study|Pregnancy|0|||
157066642|NCT00511797|566998723|FG003|Overall Study|Pregnancy|1|||
157066643|NCT00511797|566998720|FG000|Overall Study|Protocol Violation|0|||
157066644|NCT00511797|566998721|FG001|Overall Study|Protocol Violation|2|||
157066645|NCT00511797|566998722|FG002|Overall Study|Protocol Violation|2|||
157066646|NCT00511797|566998723|FG003|Overall Study|Protocol Violation|3|||
157066647|NCT00511797|566998720|FG000|Overall Study|Withdrawal by Subject|3|||
157066648|NCT00511797|566998721|FG001|Overall Study|Withdrawal by Subject|3|||
157066649|NCT00511797|566998722|FG002|Overall Study|Withdrawal by Subject|4|||
157066650|NCT00511797|566998723|FG003|Overall Study|Withdrawal by Subject|2|||
157066651|NCT00511797|566998720|FG000|Overall Study|Never dispensed|1|||
157066652|NCT00511797|566998721|FG001|Overall Study|Never dispensed|0|||
157185826|NCT02903966|567421251|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
157185827|NCT02903966|567421250|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
157185828|NCT02903966|567421251|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
157185829|NCT02903966|567421250|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
157185830|NCT02903966|567421251|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
157185831|NCT00934791|567421252|FG000|Overall Study|Withdrawal by Subject|1|||
157185832|NCT00934791|567421253|FG001|Overall Study|Withdrawal by Subject|0|||
157185833|NCT01320033|567421255|FG000|Overall Study|Lack of Efficacy|0|||
157185834|NCT01320033|567421256|FG001|Overall Study|Lack of Efficacy|0|||
157185835|NCT01320033|567421257|FG002|Overall Study|Lack of Efficacy|1|||
157185836|NCT01320033|567421255|FG000|Overall Study|Adverse Event|9|||
157185837|NCT01320033|567421256|FG001|Overall Study|Adverse Event|7|||
157185838|NCT01320033|567421257|FG002|Overall Study|Adverse Event|8|||
157185839|NCT01320033|567421255|FG000|Overall Study|Withdrawal by Subject|22|||
157185840|NCT01320033|567421256|FG001|Overall Study|Withdrawal by Subject|23|||
157185841|NCT01320033|567421257|FG002|Overall Study|Withdrawal by Subject|23|||
157185842|NCT01320033|567421255|FG000|Overall Study|Protocol Violation|3|||
157185843|NCT01320033|567421256|FG001|Overall Study|Protocol Violation|5|||
157185844|NCT01320033|567421257|FG002|Overall Study|Protocol Violation|3|||
157185845|NCT01320033|567421255|FG000|Overall Study|Lost to Follow-up|22|||
157185846|NCT01320033|567421256|FG001|Overall Study|Lost to Follow-up|26|||
157185847|NCT01320033|567421257|FG002|Overall Study|Lost to Follow-up|17|||
157185848|NCT01320033|567421255|FG000|Overall Study|Other|2|||
157185849|NCT01320033|567421256|FG001|Overall Study|Other|3|||
157185850|NCT01320033|567421257|FG002|Overall Study|Other|1|||
157185851|NCT02425891|567421258|FG000|Overall Study|Death|333|||
157185852|NCT02425891|567421259|FG001|Overall Study|Death|314|||
157185853|NCT02425891|567421258|FG000|Overall Study|Lost to Follow-up|4|||
157185854|NCT02425891|567421259|FG001|Overall Study|Lost to Follow-up|6|||
157185855|NCT02425891|567421258|FG000|Overall Study|Non-Compliance|1|||
157185856|NCT02425891|567421259|FG001|Overall Study|Non-Compliance|1|||
157185857|NCT02425891|567421258|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
157185858|NCT02425891|567421259|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
157185859|NCT02425891|567421258|FG000|Overall Study|Physician Decision|0|||
157185860|NCT02425891|567421259|FG001|Overall Study|Physician Decision|1|||
157185861|NCT02425891|567421258|FG000|Overall Study|Protocol Violation|1|||
157185862|NCT02425891|567421259|FG001|Overall Study|Protocol Violation|1|||
157185863|NCT02425891|567421258|FG000|Overall Study|Study Terminated By Sponsor|85|||
157185864|NCT02425891|567421259|FG001|Overall Study|Study Terminated By Sponsor|95|||
157185865|NCT02425891|567421258|FG000|Overall Study|Withdrawal by Subject|27|||
157185866|NCT02425891|567421259|FG001|Overall Study|Withdrawal by Subject|32|||
157185867|NCT00963469|567421260|FG000|Overall Study|Adverse Event|15|||
157185868|NCT00963469|567421261|FG001|Overall Study|Adverse Event|11|||
157185869|NCT00963469|567421262|FG002|Overall Study|Adverse Event|1|||
157185870|NCT00963469|567421260|FG000|Overall Study|Lack of Efficacy|10|||
157185871|NCT00963469|567421261|FG001|Overall Study|Lack of Efficacy|7|||
157185872|NCT00963469|567421262|FG002|Overall Study|Lack of Efficacy|2|||
157185873|NCT00963469|567421260|FG000|Overall Study|Lost to Follow-up|1|||
157185874|NCT00963469|567421261|FG001|Overall Study|Lost to Follow-up|1|||
157185875|NCT00963469|567421262|FG002|Overall Study|Lost to Follow-up|0|||
157185876|NCT00963469|567421260|FG000|Overall Study|Protocol Violation|5|||
157185877|NCT00963469|567421261|FG001|Overall Study|Protocol Violation|5|||
157185878|NCT00963469|567421262|FG002|Overall Study|Protocol Violation|3|||
157185879|NCT00963469|567421260|FG000|Overall Study|Withdrawal by Subject|4|||
157185880|NCT00963469|567421261|FG001|Overall Study|Withdrawal by Subject|1|||
157185881|NCT00963469|567421262|FG002|Overall Study|Withdrawal by Subject|1|||
157185882|NCT00963469|567421260|FG000|Overall Study|Pre-randomization Adverse Event|1|||
157185883|NCT00963469|567421261|FG001|Overall Study|Pre-randomization Adverse Event|2|||
157185884|NCT00963469|567421262|FG002|Overall Study|Pre-randomization Adverse Event|0|||
157185885|NCT00963469|567421260|FG000|Overall Study|Moved|1|||
157185886|NCT00963469|567421261|FG001|Overall Study|Moved|0|||
157185887|NCT00963469|567421262|FG002|Overall Study|Moved|0|||
157185888|NCT00963469|567421260|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
157185889|NCT00963469|567421261|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
157185890|NCT00963469|567421262|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
157185891|NCT04124952|567421265|FG000|Overall Study|Lost to Follow-up|1|||
157185892|NCT02974621|567421272|FG000|Overall Study|Didn't receive study treatment|1|||
157185893|NCT02974621|567421273|FG001|Overall Study|Didn't receive study treatment|10|||
157185894|NCT05304611|567421275|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185895|NCT05304611|567421276|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
157230146|NCT02480764|567588263|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
157185896|NCT05304611|567421277|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185897|NCT05304611|567421278|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185898|NCT05304611|567421279|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185899|NCT05304611|567421280|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185900|NCT05304611|567421281|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
157185901|NCT05304611|567421282|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185902|NCT05304611|567421283|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
157185903|NCT05304611|567421284|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185904|NCT05304611|567421285|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185905|NCT05304611|567421286|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
157185906|NCT05304611|567421275|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
157185907|NCT05304611|567421276|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
157185908|NCT05304611|567421277|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
157185909|NCT05304611|567421278|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
157185910|NCT05304611|567421279|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
157185911|NCT05304611|567421280|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
157185912|NCT05304611|567421281|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
157185913|NCT05304611|567421282|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
157185914|NCT05304611|567421283|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
157185915|NCT05304611|567421284|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
157185916|NCT05304611|567421285|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
157185917|NCT05304611|567421286|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
157185918|NCT05304611|567421275|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
157185919|NCT05304611|567421276|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
157185920|NCT05304611|567421277|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
157185921|NCT05304611|567421278|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
157185922|NCT05304611|567421279|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
157185923|NCT05304611|567421280|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
157185924|NCT05304611|567421281|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
157185925|NCT05304611|567421282|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
157185926|NCT05304611|567421283|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
157185927|NCT05304611|567421284|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
157185928|NCT05304611|567421285|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
157185929|NCT05304611|567421286|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
157185930|NCT02354690|567421287|FG000|Overall Study|Physician Decision|1|||
157185931|NCT04556175|567421291|FG000|Overall Study|Study terminated due to COVID-19|8|||
157185932|NCT04556175|567421292|FG001|Overall Study|Study terminated due to COVID-19|8|||
157185933|NCT05549505|567421294|FG000|Overall Study|Lost to Follow-up|2|||
157185934|NCT05549505|567421295|FG001|Overall Study|Lost to Follow-up|0|||
157185935|NCT05549505|567421294|FG000|Overall Study|Withdrawal by Subject|3|||
157185936|NCT05549505|567421295|FG001|Overall Study|Withdrawal by Subject|3|||
157185937|NCT05549505|567421294|FG000|Overall Study|Other: Miscellaneous|3|||
157185938|NCT05549505|567421295|FG001|Overall Study|Other: Miscellaneous|6|||
157185939|NCT02756845|567421298|FG000|Overall Study|Death|12|||
157185940|NCT02756845|567421299|FG001|Overall Study|Death|2|||
157185941|NCT02756845|567421298|FG000|Overall Study|Withdrawal by Subject|1|||
157185942|NCT02756845|567421299|FG001|Overall Study|Withdrawal by Subject|0|||
157185943|NCT01878175|567421300|FG000|Overall Study|Developed contraindicated health problem|2|||
157185944|NCT01796106|567421301|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
157185945|NCT01796106|567421302|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
157185946|NCT04107935|567421303|FG000|Overall Study|Death|1|||
157185947|NCT04107935|567421304|FG001|Overall Study|Death|0|||
157185948|NCT01842334|567421305|FG000|Overall Study|Withdrawal by Subject|3|||
157185949|NCT01842334|567421306|FG001|Overall Study|Withdrawal by Subject|3|||
157185950|NCT01842334|567421305|FG000|Overall Study|Moved away mid-study|0|||
157185951|NCT01842334|567421306|FG001|Overall Study|Moved away mid-study|1|||
157185952|NCT01249157|567421307|FG000|Overall Study|Withdrawal by Subject|1|||
157185953|NCT02470429|567421310|FG000|Overall Study|Adverse Event|1|||
157185954|NCT02470429|567421311|FG001|Overall Study|Adverse Event|0|||
157185955|NCT02470429|567421310|FG000|Overall Study|Withdrawal by Subject|1|||
157185956|NCT02470429|567421311|FG001|Overall Study|Withdrawal by Subject|0|||
157185957|NCT00959699|567421312|FG000|Treatment Period|Adverse Event|3|||
157185958|NCT00959699|567421313|FG001|Treatment Period|Adverse Event|13|||
157185959|NCT00959699|567421312|FG000|Treatment Period|Lack of Efficacy|15|||
157185960|NCT00959699|567421313|FG001|Treatment Period|Lack of Efficacy|6|||
157185961|NCT00959699|567421312|FG000|Treatment Period|Lost to Follow-up|0|||
157185962|NCT00959699|567421313|FG001|Treatment Period|Lost to Follow-up|1|||
157185963|NCT00959699|567421312|FG000|Treatment Period|Withdrawal by Subject|1|||
157185964|NCT00959699|567421313|FG001|Treatment Period|Withdrawal by Subject|3|||
157185965|NCT00959699|567421312|FG000|Treatment Period|Non-Compliance with Protocol|0|||
157185966|NCT00959699|567421313|FG001|Treatment Period|Non-Compliance with Protocol|1|||
157185967|NCT00959699|567421312|FG000|Treatment Period|Did not receive treatment|0|||
157185968|NCT00959699|567421313|FG001|Treatment Period|Did not receive treatment|1|||
157185969|NCT00959699|567421312|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
157185970|NCT00959699|567421313|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
157185971|NCT00959699|567421312|FG000|Follow-up Period|Lost to Follow-up|3|||
157185972|NCT00959699|567421313|FG001|Follow-up Period|Lost to Follow-up|2|||
157185973|NCT00959699|567421312|FG000|Follow-up Period|Withdrawal by Subject|3|||
157185974|NCT00959699|567421313|FG001|Follow-up Period|Withdrawal by Subject|4|||
157066653|NCT00511797|566998722|FG002|Overall Study|Never dispensed|1|||
157066654|NCT00511797|566998723|FG003|Overall Study|Never dispensed|3|||
157066655|NCT00511797|566998720|FG000|Overall Study|Study drug not taken|0|||
157066656|NCT00511797|566998721|FG001|Overall Study|Study drug not taken|1|||
157066657|NCT00511797|566998722|FG002|Overall Study|Study drug not taken|0|||
157066658|NCT00511797|566998723|FG003|Overall Study|Study drug not taken|1|||
157066659|NCT00511797|566998720|FG000|Overall Study|Partially missing diary|0|||
157066660|NCT00511797|566998721|FG001|Overall Study|Partially missing diary|0|||
157066661|NCT00511797|566998722|FG002|Overall Study|Partially missing diary|1|||
157066662|NCT00511797|566998723|FG003|Overall Study|Partially missing diary|0|||
157066663|NCT00511797|566998720|FG000|Overall Study|Other (moving etc)|1|||
157066664|NCT00511797|566998721|FG001|Overall Study|Other (moving etc)|0|||
157066665|NCT00511797|566998722|FG002|Overall Study|Other (moving etc)|1|||
157066666|NCT00511797|566998723|FG003|Overall Study|Other (moving etc)|2|||
157066667|NCT01185171|566998726|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
157066668|NCT01185171|566998726|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
157066669|NCT01185171|566998726|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
157066670|NCT01185171|566998726|FG000|Maintenance|Elevated liver transaminases|3|||
157066671|NCT01185171|566998726|FG000|Maintenance|Rush|2|||
157066672|NCT01185171|566998726|FG000|Maintenance|Diarrhea|1|||
157066673|NCT01185171|566998726|FG000|Maintenance|Xerostomia|1|||
157066674|NCT01185171|566998726|FG000|Maintenance|Nausea|1|||
157066675|NCT01185171|566998726|FG000|Maintenance|Comorbid Illness|2|||
157066676|NCT01185171|566998726|FG000|Maintenance|Withdrawal by Subject|1|||
157066677|NCT01185171|566998726|FG000|Maintenance|Disease Recurrence|1|||
157066678|NCT01482429|566998727|FG000|Care Usual|Protocol Violation|0|||
157066679|NCT01482429|566998728|FG001|Care Usual|Protocol Violation|172|||
157066680|NCT01482429|566998727|FG000|Care Usual|Lost to Follow-up|0|||
157066681|NCT01482429|566998728|FG001|Care Usual|Lost to Follow-up|1|||
157066682|NCT01482429|566998727|FG000|Protocol|Protocol Violation|275|||
157066683|NCT01482429|566998728|FG001|Protocol|Protocol Violation|0|||
157066684|NCT03561597|566998732|FG000|Overall Study|Lost to Follow-up|20|||
157066685|NCT00573651|566998733|FG000|Overall Study|Lost to Follow-up|3|||
157066686|NCT00573651|566998733|FG000|Overall Study|Withdrawal by Subject|1|||
157066687|NCT03797989|566998740|FG000|VAC069A|Withdrawal by Subject|0|||
157066688|NCT03797989|566998741|FG001|VAC069A|Withdrawal by Subject|0|||
157066689|NCT03797989|566998742|FG002|VAC069A|Withdrawal by Subject|1|||
157066690|NCT03797989|566998743|FG003|VAC069A|Withdrawal by Subject|0|||
157066691|NCT03797989|566998744|FG004|VAC069A|Withdrawal by Subject|0|||
157066692|NCT03797989|566998745|FG005|VAC069A|Withdrawal by Subject|0|||
157066693|NCT03797989|566998746|FG006|VAC069A|Withdrawal by Subject|0|||
157066694|NCT03797989|566998747|FG007|VAC069A|Withdrawal by Subject|0|||
157066695|NCT03797989|566998748|FG008|VAC069A|Withdrawal by Subject|0|||
157066696|NCT03797989|566998749|FG009|VAC069A|Withdrawal by Subject|0|||
157066697|NCT03797989|566998750|FG010|VAC069A|Withdrawal by Subject|0|||
157066698|NCT03797989|566998751|FG011|VAC069A|Withdrawal by Subject|0|||
157066699|NCT04052997|566998752|FG000|Overall Study|Withdrawal by Subject|17|||
157066700|NCT04052997|566998752|FG000|Overall Study|Physician Decision|50|||
157066701|NCT04052997|566998752|FG000|Overall Study|Death|43|||
157066702|NCT04052997|566998752|FG000|Overall Study|Lost to Follow-up|5|||
157066703|NCT04052997|566998752|FG000|Overall Study|Progression of Disease|1|||
157066704|NCT04594733|566998753|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
157066705|NCT04594733|566998754|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
157066706|NCT04594733|566998753|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
157066707|NCT04594733|566998754|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
157066708|NCT04594733|566998753|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
157066709|NCT04594733|566998754|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
157066710|NCT04811339|566998763|FG000|Overall Study|lack of transportation not wanting to return|4|||
157066711|NCT04811339|566998764|FG001|Overall Study|lack of transportation not wanting to return|8|||
157066712|NCT04811339|566998765|FG002|Overall Study|lack of transportation not wanting to return|0|||
157066713|NCT04811339|566998763|FG000|Overall Study|Adverse Event|3|||
157066714|NCT04811339|566998764|FG001|Overall Study|Adverse Event|0|||
157066715|NCT04811339|566998765|FG002|Overall Study|Adverse Event|0|||
157066716|NCT04811339|566998763|FG000|Overall Study|Lost to Follow-up|1|||
157066717|NCT04811339|566998764|FG001|Overall Study|Lost to Follow-up|0|||
157066718|NCT04811339|566998765|FG002|Overall Study|Lost to Follow-up|0|||
157066719|NCT04811339|566998763|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
157066720|NCT04811339|566998764|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
157066721|NCT04811339|566998765|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
157066722|NCT04811339|566998763|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
157066723|NCT04811339|566998764|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
157066724|NCT04811339|566998765|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
157185975|NCT04228445|567421316|FG000|Overall Study|Lost to Follow-up|1|||
157185976|NCT04228445|567421317|FG001|Overall Study|Lost to Follow-up|1|||
157185977|NCT04228445|567421316|FG000|Overall Study|Physician Decision|1|||
157185978|NCT04228445|567421317|FG001|Overall Study|Physician Decision|2|||
157185979|NCT04228445|567421316|FG000|Overall Study|Withdrawal by Subject|0|||
157185980|NCT04228445|567421317|FG001|Overall Study|Withdrawal by Subject|1|||
157185981|NCT04228445|567421316|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
157185982|NCT04228445|567421317|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
157185983|NCT00606294|567421318|FG000|Overall Study|Withdrawal by Subject|36|||
157185984|NCT00606294|567421319|FG001|Overall Study|Withdrawal by Subject|0|||
157185985|NCT03924427|567421320|FG000|Overall Study|Adverse Event|4|||
157185986|NCT03924427|567421320|FG000|Overall Study|Lack of Efficacy|1|||
157185987|NCT03924427|567421320|FG000|Overall Study|Withdrawal by Subject|1|||
157185988|NCT01976624|567421325|FG000|Overall Study|Participants contraindicated|2|||
157185989|NCT01976624|567421325|FG000|Overall Study|Participants age less than 19 years|12|||
157185990|NCT00712270|567421326|FG000|Overall Study|Withdrawal by Subject|11|||
157185991|NCT00712270|567421326|FG000|Overall Study|Screen Failure|3|||
157185992|NCT02574520|567421327|FG000|Overall Study|Not dosed|2|||
157185993|NCT02574520|567421328|FG001|Overall Study|Not dosed|0|||
157185994|NCT02574520|567421329|FG002|Overall Study|Not dosed|5|||
157185995|NCT02574520|567421330|FG003|Overall Study|Not dosed|4|||
157185996|NCT02574520|567421327|FG000|Overall Study|Adverse Event|0|||
157185997|NCT02574520|567421328|FG001|Overall Study|Adverse Event|0|||
157185998|NCT02574520|567421329|FG002|Overall Study|Adverse Event|0|||
157185999|NCT02574520|567421330|FG003|Overall Study|Adverse Event|1|||
157186000|NCT02574520|567421327|FG000|Overall Study|Withdrawal by Subject|0|||
157186001|NCT02574520|567421328|FG001|Overall Study|Withdrawal by Subject|0|||
157186002|NCT02574520|567421329|FG002|Overall Study|Withdrawal by Subject|0|||
157186003|NCT02574520|567421330|FG003|Overall Study|Withdrawal by Subject|1|||
157186004|NCT02574520|567421327|FG000|Overall Study|Other|0|||
157186005|NCT02574520|567421328|FG001|Overall Study|Other|0|||
157186006|NCT02574520|567421329|FG002|Overall Study|Other|0|||
157186007|NCT02574520|567421330|FG003|Overall Study|Other|2|||
157186008|NCT05307523|567421331|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
157186009|NCT05307523|567421332|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
157186010|NCT05307523|567421331|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
157186011|NCT05307523|567421332|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
157186012|NCT05116683|567421333|FG000|Overall Study|Physician Decision|4|||
157186013|NCT00112840|567421335|FG000|Overall Study|Physician Decision|1|||
157186014|NCT00112840|567421336|FG001|Overall Study|Physician Decision|0|||
157186015|NCT00112840|567421337|FG002|Overall Study|Physician Decision|0|||
157186016|NCT00112840|567421335|FG000|Overall Study|Withdrawal by Subject|1|||
157186017|NCT00112840|567421336|FG001|Overall Study|Withdrawal by Subject|0|||
157186018|NCT00112840|567421337|FG002|Overall Study|Withdrawal by Subject|1|||
157186019|NCT00112840|567421335|FG000|Overall Study|Protocol Violation|0|||
157186020|NCT00112840|567421336|FG001|Overall Study|Protocol Violation|0|||
157186021|NCT00112840|567421337|FG002|Overall Study|Protocol Violation|5|||
157186022|NCT00683774|567421338|FG000|Overall Study|Withdrawal by Subject|0|||
157186023|NCT00683774|567421339|FG001|Overall Study|Withdrawal by Subject|1|||
157186024|NCT00683774|567421338|FG000|Overall Study|Physician Decision|3|||
157186025|NCT00683774|567421339|FG001|Overall Study|Physician Decision|0|||
157186026|NCT02875366|567421340|FG000|Overall Study|Adverse Event|0|||
157186027|NCT02875366|567421341|FG001|Overall Study|Adverse Event|2|||
157186028|NCT02875366|567421340|FG000|Overall Study|Noncompliance|0|||
157186029|NCT02875366|567421341|FG001|Overall Study|Noncompliance|1|||
157186030|NCT03595176|567421342|FG000|Overall Study|Death|0|||
157186031|NCT03595176|567421343|FG001|Overall Study|Death|2|||
157186032|NCT03595176|567421342|FG000|Overall Study|Lost to Follow-up|0|||
157186033|NCT03595176|567421343|FG001|Overall Study|Lost to Follow-up|1|||
157186034|NCT02735044|567421345|FG000|Overall Study|Adverse Event|3|||
157186035|NCT02735044|567421346|FG001|Overall Study|Adverse Event|3|||
157186036|NCT02735044|567421345|FG000|Overall Study|Lack of Efficacy|1|||
157186037|NCT02735044|567421346|FG001|Overall Study|Lack of Efficacy|0|||
157186038|NCT02735044|567421345|FG000|Overall Study|Poor compliance to protocol|7|||
157186039|NCT02735044|567421346|FG001|Overall Study|Poor compliance to protocol|7|||
157186040|NCT02735044|567421345|FG000|Overall Study|Randomized and not treated|0|||
157186041|NCT02735044|567421346|FG001|Overall Study|Randomized and not treated|2|||
157186042|NCT02735044|567421345|FG000|Overall Study|Other, not specified above|5|||
157186043|NCT02735044|567421346|FG001|Overall Study|Other, not specified above|11|||
157186044|NCT01682759|567421347|FG000|Overall Study|Death|2|||
157186045|NCT01682759|567421348|FG001|Overall Study|Death|1|||
157186046|NCT01682759|567421347|FG000|Overall Study|Lost to Follow-up|10|||
157186047|NCT01682759|567421348|FG001|Overall Study|Lost to Follow-up|13|||
157186048|NCT01682759|567421347|FG000|Overall Study|Physician Decision|1|||
157186049|NCT01682759|567421348|FG001|Overall Study|Physician Decision|1|||
157186050|NCT01682759|567421347|FG000|Overall Study|Withdrawal by Subject|56|||
157186051|NCT01682759|567421348|FG001|Overall Study|Withdrawal by Subject|55|||
157186052|NCT01226472|567421352|FG000|Overall Study|Progressive Disease|1|||
157186053|NCT03128307|567421355|FG000|Overall Study|Lost to Follow-up|29|||
157186054|NCT03128307|567421355|FG000|Overall Study|Withdrawal by Subject|5|||
157186055|NCT02608099|567423055|FG000|Overall Study|Ablation procedure not initiated|3|||
157186056|NCT02608099|567423056|FG001|Overall Study|Ablation procedure not initiated|2|||
157230147|NCT02480764|567588261|FG000|Overall Study|Major Protocol Deviation|1|||
157230148|NCT02480764|567588262|FG001|Overall Study|Major Protocol Deviation|4|||
157230149|NCT02480764|567588263|FG002|Overall Study|Major Protocol Deviation|3|||
157230150|NCT02480764|567588261|FG000|Overall Study|Lost to Follow-up|0|||
157230151|NCT02480764|567588262|FG001|Overall Study|Lost to Follow-up|1|||
157230152|NCT02480764|567588263|FG002|Overall Study|Lost to Follow-up|2|||
157230153|NCT02480764|567588261|FG000|Overall Study|Voluntary Withdrawal|6|||
157230154|NCT02480764|567588262|FG001|Overall Study|Voluntary Withdrawal|5|||
157230155|NCT02480764|567588263|FG002|Overall Study|Voluntary Withdrawal|10|||
157230156|NCT02480764|567588261|FG000|Overall Study|Lack of Efficacy|0|||
157230157|NCT02480764|567588262|FG001|Overall Study|Lack of Efficacy|3|||
157230158|NCT02480764|567588263|FG002|Overall Study|Lack of Efficacy|3|||
157230159|NCT02480764|567588261|FG000|Overall Study|Reason not Specified|0|||
157230160|NCT02480764|567588262|FG001|Overall Study|Reason not Specified|1|||
157230161|NCT02480764|567588263|FG002|Overall Study|Reason not Specified|0|||
157230162|NCT03629249|567588264|FG000|Overall Study|Study terminated by sponsor|197|||
157230163|NCT03629249|567588265|FG001|Overall Study|Study terminated by sponsor|197|||
157230164|NCT03629249|567588266|FG002|Overall Study|Study terminated by sponsor|194|||
157066725|NCT04811339|566998763|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
157066726|NCT04811339|566998764|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
157066727|NCT04811339|566998765|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
157066728|NCT04811339|566998763|FG000|Overall Study|Withdrawal by Subject|0|||
157066729|NCT04811339|566998764|FG001|Overall Study|Withdrawal by Subject|3|||
157066730|NCT04811339|566998765|FG002|Overall Study|Withdrawal by Subject|0|||
157066731|NCT04811339|566998763|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
157066732|NCT04811339|566998764|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
157066733|NCT04811339|566998765|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
157066734|NCT04811339|566998763|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
157066735|NCT04811339|566998764|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
157066736|NCT04811339|566998765|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
157066737|NCT05896696|566998768|FG000|Overall Study|Screening Failure|7|||
157066738|NCT05896696|566998768|FG000|Overall Study|Withdrawal by Subject|2|||
157066739|NCT03526679|567000463|FG000|Overall Study|still under treatment|2|||
157066740|NCT00966264|567000464|FG000|Overall Study|Lost to Follow-up|4|||
157066741|NCT00966264|567000465|FG001|Overall Study|Lost to Follow-up|3|||
157066742|NCT00903760|567000466|FG000|Overall Study|Disease Progression/Death|8|||
157066743|NCT00903760|567000467|FG001|Overall Study|Disease Progression/Death|6|||
157066744|NCT00903760|567000466|FG000|Overall Study|Stem Cell Transplant|8|||
157066745|NCT00903760|567000467|FG001|Overall Study|Stem Cell Transplant|4|||
157066746|NCT00903760|567000466|FG000|Overall Study|Physician Decision|1|||
157066747|NCT00903760|567000467|FG001|Overall Study|Physician Decision|2|||
157066748|NCT00903760|567000466|FG000|Overall Study|Death|0|||
157066749|NCT00903760|567000467|FG001|Overall Study|Death|1|||
157066750|NCT00903760|567000466|FG000|Overall Study|Lost to Follow-up|1|||
157066751|NCT00903760|567000467|FG001|Overall Study|Lost to Follow-up|0|||
157066752|NCT00903760|567000466|FG000|Overall Study|Withdrawal by Subject|1|||
157066753|NCT00903760|567000467|FG001|Overall Study|Withdrawal by Subject|2|||
157066754|NCT00903760|567000466|FG000|Overall Study|Off treatment for long period|0|||
157066755|NCT00903760|567000467|FG001|Overall Study|Off treatment for long period|1|||
157066756|NCT01639742|567000471|FG000|Overall Study|Study Ongoing|17|||
157066757|NCT01639742|567000471|FG000|Overall Study|Lost to Follow-up|1|||
157066758|NCT01256671|567000475|FG000|Overall Study|Adverse Event|29|||
157066759|NCT01256671|567000475|FG000|Overall Study|Lost to Follow-up|16|||
157066760|NCT01256671|567000475|FG000|Overall Study|Withdrawal by Subject|31|||
157066761|NCT01256671|567000475|FG000|Overall Study|Physician Decision|3|||
157066762|NCT01256671|567000475|FG000|Overall Study|Lack of Efficacy|4|||
157066763|NCT01256671|567000475|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
157066764|NCT02366143|567000476|FG000|Overall Study|Death|307|||
157066765|NCT02366143|567000477|FG001|Overall Study|Death|278|||
157066766|NCT02366143|567000478|FG002|Overall Study|Death|280|||
157066767|NCT02366143|567000476|FG000|Overall Study|Lost to Follow-up|2|||
157066768|NCT02366143|567000477|FG001|Overall Study|Lost to Follow-up|4|||
157066769|NCT02366143|567000478|FG002|Overall Study|Lost to Follow-up|2|||
157066770|NCT02366143|567000476|FG000|Overall Study|Physician Decision|1|||
157066771|NCT02366143|567000477|FG001|Overall Study|Physician Decision|2|||
157066772|NCT02366143|567000478|FG002|Overall Study|Physician Decision|1|||
157066773|NCT02366143|567000476|FG000|Overall Study|Protocol Violation|0|||
157066774|NCT02366143|567000477|FG001|Overall Study|Protocol Violation|0|||
157066775|NCT02366143|567000478|FG002|Overall Study|Protocol Violation|2|||
157066776|NCT02366143|567000476|FG000|Overall Study|Withdrawal by Subject|16|||
157066777|NCT02366143|567000477|FG001|Overall Study|Withdrawal by Subject|17|||
157230165|NCT03629249|567588264|FG000|Overall Study|Protocol deviation|0|||
157230166|NCT03629249|567588265|FG001|Overall Study|Protocol deviation|2|||
157230167|NCT03629249|567588266|FG002|Overall Study|Protocol deviation|5|||
157230168|NCT03629249|567588264|FG000|Overall Study|Subject decision|1|||
157066778|NCT02366143|567000478|FG002|Overall Study|Withdrawal by Subject|22|||
157066779|NCT02366143|567000476|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
157186057|NCT01952041|567423057|FG000|Overall Study|Lost to Follow-up|9|||
157186058|NCT01952041|567423058|FG001|Overall Study|Lost to Follow-up|16|||
157186059|NCT01952041|567423057|FG000|Overall Study|Withdrawal by Subject|7|||
157186060|NCT01952041|567423058|FG001|Overall Study|Withdrawal by Subject|5|||
157186061|NCT01952041|567423057|FG000|Overall Study|Death|1|||
157186062|NCT01952041|567423058|FG001|Overall Study|Death|0|||
157186063|NCT01736176|567423059|FG000|Overall Study|Adverse Event|3|||
157186064|NCT01736176|567423059|FG000|Overall Study|Withdrawal by Subject|4|||
157186065|NCT01736176|567423059|FG000|Overall Study|Lack of Efficacy|3|||
157186066|NCT01736176|567423059|FG000|Overall Study|Unable to Complete PEG Placement|1|||
157186067|NCT02145429|567423060|FG000|Overall Study|Death|4|||
157186068|NCT02145429|567423061|FG001|Overall Study|Death|5|||
157186069|NCT02145429|567423060|FG000|Overall Study|Lost to Follow-up|4|||
157186070|NCT02145429|567423061|FG001|Overall Study|Lost to Follow-up|3|||
157186071|NCT02145429|567423060|FG000|Overall Study|Withdrawal by Subject|8|||
157186072|NCT02145429|567423061|FG001|Overall Study|Withdrawal by Subject|3|||
157186073|NCT02943577|567423062|FG000|Overall Study|Protocol Violation|0|||
157186074|NCT02943577|567423063|FG001|Overall Study|Protocol Violation|1|||
157186075|NCT02943577|567423062|FG000|Overall Study|Adverse Event|3|||
157186076|NCT02943577|567423063|FG001|Overall Study|Adverse Event|2|||
157186077|NCT02943577|567423062|FG000|Overall Study|Lost to Follow-up|0|||
157186078|NCT02943577|567423063|FG001|Overall Study|Lost to Follow-up|1|||
157186079|NCT02943577|567423062|FG000|Overall Study|Withdrawal by Subject|1|||
157186080|NCT02943577|567423063|FG001|Overall Study|Withdrawal by Subject|1|||
157186081|NCT02943577|567423062|FG000|Overall Study|Pregnancy|1|||
157186082|NCT02943577|567423063|FG001|Overall Study|Pregnancy|0|||
157186083|NCT01944462|567423070|FG000|PPPP Educational Program|Lost to Follow-up|60|||
157186084|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
157186085|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
157186086|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
157186087|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
157186088|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Other|1|||
157186089|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Other|0|||
157186090|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Other|2|||
157186091|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Other|4|||
157186092|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
157186093|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
157186094|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
157186095|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
157186096|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Adverse Event|0|||
157186097|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Adverse Event|0|||
157186098|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Adverse Event|1|||
157186099|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Adverse Event|2|||
157186100|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
157186101|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
157186102|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
157186103|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
157186104|NCT00808028|567423071|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
157186105|NCT00808028|567423072|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
157186106|NCT00808028|567423073|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
157186107|NCT00808028|567423074|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
157186108|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
157186109|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
157186110|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
157186111|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
157186112|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
157186113|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
157186114|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
157186115|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
157186116|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
157186117|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
157066780|NCT02366143|567000477|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
157186118|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
157186119|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
157186120|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
157230169|NCT03629249|567588265|FG001|Overall Study|Subject decision|1|||
157230170|NCT03629249|567588266|FG002|Overall Study|Subject decision|3|||
157230171|NCT03629249|567588264|FG000|Overall Study|Adverse Event|1|||
157186121|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
157186122|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
157186123|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
157186124|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
157230172|NCT03629249|567588265|FG001|Overall Study|Adverse Event|1|||
156977316|NCT02690077|566670675|FG000|Overall Study|Withdrawal by Subject|0|||
156977317|NCT02690077|566670676|FG001|Overall Study|Withdrawal by Subject|5|||
156977318|NCT02690077|566670675|FG000|Overall Study|Excluded by IRB|0|||
156977319|NCT02690077|566670676|FG001|Overall Study|Excluded by IRB|2|||
156977320|NCT01845974|566670677|FG000|Overall Study|screen failure|1|||
156977321|NCT01845974|566670678|FG001|Overall Study|screen failure|0|||
156977322|NCT00594217|566670679|FG000|Overall Study|Withdrawal by Subject|1|||
156977323|NCT00594217|566670680|FG001|Overall Study|Withdrawal by Subject|3|||
156977324|NCT05672680|566670681|FG000|Overall Study|Patient Did Not Complete the Form|5|||
156977325|NCT05672680|566670682|FG001|Overall Study|Patient Did Not Complete the Form|4|||
156977326|NCT05672680|566670681|FG000|Overall Study|Procedure Aborted|1|||
156977327|NCT05672680|566670682|FG001|Overall Study|Procedure Aborted|0|||
156977328|NCT04186403|566670683|FG000|Overall Study|Adverse Event|1|||
156977329|NCT04186403|566670684|FG001|Overall Study|Adverse Event|8|||
156977330|NCT04186403|566670683|FG000|Overall Study|Lost to Follow-up|7|||
156977331|NCT04186403|566670684|FG001|Overall Study|Lost to Follow-up|3|||
156977332|NCT04186403|566670683|FG000|Overall Study|Physician Decision|1|||
156977333|NCT04186403|566670684|FG001|Overall Study|Physician Decision|0|||
156977334|NCT04186403|566670683|FG000|Overall Study|Withdrawal by Subject|7|||
156977335|NCT04186403|566670684|FG001|Overall Study|Withdrawal by Subject|8|||
156977336|NCT04186403|566670683|FG000|Overall Study|Other: Not Related to Covid-19|3|||
156977337|NCT04186403|566670684|FG001|Overall Study|Other: Not Related to Covid-19|0|||
156977338|NCT03929562|566670689|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
156977339|NCT03929562|566670690|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
156977340|NCT03929562|566670689|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
156977341|NCT03929562|566670690|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
156977342|NCT03929562|566670689|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
156977343|NCT03929562|566670690|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
156977344|NCT01407354|566670698|FG000|First Intervention|Withdrawal by Subject|0|||
156977345|NCT01407354|566670699|FG001|First Intervention|Withdrawal by Subject|2|||
156977346|NCT01407354|566670698|FG000|First Intervention|Adverse Event|1|||
156977347|NCT01407354|566670699|FG001|First Intervention|Adverse Event|0|||
156977348|NCT01407354|566670698|FG000|First Intervention|Physician Decision|1|||
156977349|NCT01407354|566670699|FG001|First Intervention|Physician Decision|0|||
156977350|NCT02778399|566670700|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
156977351|NCT02778399|566670701|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
156977352|NCT02778399|566670702|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
156977353|NCT02778399|566670703|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
156977354|NCT02778399|566670704|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
156977355|NCT02778399|566670705|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
156977356|NCT02778399|566670700|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
156977357|NCT02778399|566670701|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
156977358|NCT02778399|566670702|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
156977359|NCT02778399|566670703|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
156977360|NCT02778399|566670704|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
156977361|NCT02778399|566670705|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
156977362|NCT02778399|566670700|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
156977363|NCT02778399|566670701|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
156977364|NCT02778399|566670702|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
156977365|NCT02778399|566670703|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
156977366|NCT02778399|566670704|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
156977367|NCT02778399|566670705|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
156977368|NCT02778399|566670700|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
156977369|NCT02778399|566670701|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156977370|NCT02778399|566670702|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156977371|NCT02778399|566670703|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156977372|NCT02778399|566670704|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
156977373|NCT02778399|566670705|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
156977374|NCT02778399|566670700|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
156977375|NCT02778399|566670701|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
156977376|NCT02778399|566670702|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
156977377|NCT02778399|566670703|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
156977378|NCT02778399|566670704|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
156977379|NCT02778399|566670705|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
156977380|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
156977381|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
156977382|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
156977383|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
156977384|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
156977385|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
157066781|NCT02366143|567000478|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
157186125|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
157186126|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
157186127|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
157186128|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
157186129|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
157186130|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
157186131|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
157186132|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
157186133|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
157186134|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
157186135|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
157186136|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
157186137|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
157186138|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
157186139|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
157186140|NCT00808028|567423071|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
157186141|NCT00808028|567423072|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
157186142|NCT00808028|567423073|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
157186143|NCT00808028|567423074|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
157186144|NCT01222767|567423075|FG000|Overall Study|Progressive disease|13|||
157186145|NCT01222767|567423075|FG000|Overall Study|Adverse Event|2|||
157186146|NCT01222767|567423075|FG000|Overall Study|Surgical resection|1|||
157186147|NCT01222767|567423075|FG000|Overall Study|Never treated|1|||
157186148|NCT00081263|567423080|FG000|Overall Study|clerical error|1|||
157186149|NCT00081263|567423081|FG001|Overall Study|clerical error|0|||
157186150|NCT00081263|567423080|FG000|Overall Study|wrong cell type|7|||
157186151|NCT00081263|567423081|FG001|Overall Study|wrong cell type|5|||
157186152|NCT00081263|567423080|FG000|Overall Study|improper pre-protocol therapy|0|||
157186153|NCT00081263|567423081|FG001|Overall Study|improper pre-protocol therapy|1|||
157186154|NCT00081263|567423080|FG000|Overall Study|Inadequate pathology|0|||
157186155|NCT00081263|567423081|FG001|Overall Study|Inadequate pathology|1|||
157186156|NCT00081263|567423080|FG000|Overall Study|Never treated|4|||
157186157|NCT00081263|567423081|FG001|Overall Study|Never treated|5|||
157186158|NCT00081263|567423080|FG000|Overall Study|Inadequate data|5|||
157186159|NCT00081263|567423081|FG001|Overall Study|Inadequate data|10|||
157186160|NCT01852591|567423082|FG000|Overall Study|Withdrawal by Subject|2|||
157186161|NCT01852591|567423082|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
157186162|NCT01267955|567423089|FG000|Stage 1 (6 Months)|Death|3|||
157186163|NCT01267955|567423089|FG000|Stage 2 (6 Months)|Death|5|||
157186164|NCT01267955|567423089|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
157186165|NCT00729560|567423090|FG000|Overall Study|Withdrawal by Subject|3|||
157186166|NCT03233308|567423091|FG000|Overall Study|Adverse Event|1|||
157186167|NCT03233308|567423091|FG000|Overall Study|Protocol Violation|1|||
157186168|NCT03662789|567423092|FG000|Overall Study|Lost to Follow-up|1|||
157186169|NCT03662789|567423093|FG001|Overall Study|Lost to Follow-up|2|||
157186170|NCT03662789|567423092|FG000|Overall Study|Could not perform treadmill test|4|||
157186171|NCT03662789|567423093|FG001|Overall Study|Could not perform treadmill test|4|||
157186172|NCT03662789|567423092|FG000|Overall Study|Death|0|||
157186173|NCT03662789|567423093|FG001|Overall Study|Death|1|||
157186174|NCT02136134|567423094|FG000|Overall Study|Death|170|||
157186175|NCT02136134|567423095|FG001|Overall Study|Death|148|||
157186176|NCT02136134|567423094|FG000|Overall Study|Withdrawal by Subject|19|||
157186177|NCT02136134|567423095|FG001|Overall Study|Withdrawal by Subject|10|||
157186178|NCT02136134|567423094|FG000|Overall Study|Lost to Follow-up|3|||
157186179|NCT02136134|567423095|FG001|Overall Study|Lost to Follow-up|3|||
157186180|NCT02136134|567423094|FG000|Overall Study|Uspecified|55|||
157186181|NCT02136134|567423095|FG001|Overall Study|Uspecified|90|||
157186182|NCT00732472|567423096|FG000|Overall Study|Adverse Event|0|||
157186183|NCT00732472|567423097|FG001|Overall Study|Adverse Event|1|||
157186184|NCT00732472|567423098|FG002|Overall Study|Adverse Event|1|||
157186185|NCT00732472|567423099|FG003|Overall Study|Adverse Event|1|||
157186186|NCT00732472|567423096|FG000|Overall Study|Protocol Violation|0|||
157186187|NCT00732472|567423097|FG001|Overall Study|Protocol Violation|0|||
157186188|NCT00732472|567423098|FG002|Overall Study|Protocol Violation|0|||
157186189|NCT00732472|567423099|FG003|Overall Study|Protocol Violation|1|||
157186190|NCT00732472|567423096|FG000|Overall Study|Withdrawal by Subject|0|||
157186191|NCT00732472|567423097|FG001|Overall Study|Withdrawal by Subject|2|||
157186192|NCT00732472|567423098|FG002|Overall Study|Withdrawal by Subject|0|||
157186193|NCT00732472|567423099|FG003|Overall Study|Withdrawal by Subject|1|||
157186194|NCT02559115|567423101|FG000|Overall Study|Withdrawal by Subject|3|||
157186195|NCT00963820|567423108|FG000|Dose Escalation Phase|Progressive Disease|3|||
157186196|NCT00963820|567423109|FG001|Dose Escalation Phase|Progressive Disease|3|||
157186197|NCT00963820|567423110|FG002|Dose Escalation Phase|Progressive Disease|3|||
157186198|NCT00963820|567423111|FG003|Dose Escalation Phase|Progressive Disease|3|||
157186199|NCT00963820|567423112|FG004|Dose Escalation Phase|Progressive Disease|4|||
157186200|NCT00963820|567423113|FG005|Dose Escalation Phase|Progressive Disease|3|||
157186201|NCT00963820|567423114|FG006|Dose Escalation Phase|Progressive Disease|3|||
157186202|NCT00963820|567423115|FG007|Dose Escalation Phase|Progressive Disease|2|||
157186203|NCT00963820|567423116|FG008|Dose Escalation Phase|Progressive Disease|0|||
157186204|NCT00963820|567423117|FG009|Dose Escalation Phase|Progressive Disease|0|||
157186205|NCT00963820|567423118|FG010|Dose Escalation Phase|Progressive Disease|0|||
157186206|NCT00963820|567423119|FG011|Dose Escalation Phase|Progressive Disease|0|||
157186207|NCT00963820|567423108|FG000|Dose Escalation Phase|Adverse Event|0|||
157186208|NCT00963820|567423109|FG001|Dose Escalation Phase|Adverse Event|0|||
157186209|NCT00963820|567423110|FG002|Dose Escalation Phase|Adverse Event|0|||
157186210|NCT00963820|567423111|FG003|Dose Escalation Phase|Adverse Event|0|||
157186211|NCT00963820|567423112|FG004|Dose Escalation Phase|Adverse Event|0|||
157186212|NCT00963820|567423113|FG005|Dose Escalation Phase|Adverse Event|0|||
157186213|NCT00963820|567423114|FG006|Dose Escalation Phase|Adverse Event|3|||
157186214|NCT00963820|567423115|FG007|Dose Escalation Phase|Adverse Event|1|||
157186215|NCT00963820|567423116|FG008|Dose Escalation Phase|Adverse Event|0|||
157186216|NCT00963820|567423117|FG009|Dose Escalation Phase|Adverse Event|0|||
157186217|NCT00963820|567423118|FG010|Dose Escalation Phase|Adverse Event|0|||
157186218|NCT00963820|567423119|FG011|Dose Escalation Phase|Adverse Event|0|||
157186219|NCT00963820|567423108|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
157186220|NCT00963820|567423109|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
157186221|NCT00963820|567423110|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
157186222|NCT00963820|567423111|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
157186223|NCT00963820|567423112|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
157186224|NCT00963820|567423113|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
157186225|NCT00963820|567423114|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
157186226|NCT00963820|567423115|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
157186227|NCT00963820|567423116|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
157186228|NCT00963820|567423117|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
157186229|NCT00963820|567423118|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
157186230|NCT00963820|567423119|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
157186231|NCT00963820|567423108|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186232|NCT00963820|567423109|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186233|NCT00963820|567423110|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186234|NCT00963820|567423111|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186235|NCT00963820|567423112|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186236|NCT00963820|567423113|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186237|NCT00963820|567423114|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
157186238|NCT00963820|567423115|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186239|NCT00963820|567423116|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186240|NCT00963820|567423117|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186241|NCT00963820|567423118|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186242|NCT00963820|567423119|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
157186243|NCT00963820|567423108|FG000|Expansion Phase|Progressive Disease|0|||
157066782|NCT02366143|567000476|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
157066783|NCT02366143|567000477|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
157066784|NCT02366143|567000478|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
157066785|NCT02366143|567000476|FG000|Overall Study|Randomization Error|1|||
157066786|NCT02366143|567000477|FG001|Overall Study|Randomization Error|0|||
157066787|NCT02366143|567000478|FG002|Overall Study|Randomization Error|0|||
157066788|NCT02366143|567000476|FG000|Overall Study|PI Move and Site Closure|1|||
157066789|NCT02366143|567000477|FG001|Overall Study|PI Move and Site Closure|0|||
157066790|NCT02366143|567000478|FG002|Overall Study|PI Move and Site Closure|1|||
157066791|NCT02366143|567000476|FG000|Overall Study|Study Terminated By Sponsor|0|||
157066792|NCT02366143|567000477|FG001|Overall Study|Study Terminated By Sponsor|0|||
157066793|NCT02366143|567000478|FG002|Overall Study|Study Terminated By Sponsor|2|||
157066794|NCT02366143|567000476|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
157066795|NCT02366143|567000477|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
157066796|NCT02366143|567000478|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
157066797|NCT02366143|567000476|FG000|Overall Study|Patient moved to roll-over study|1|||
157066798|NCT02366143|567000477|FG001|Overall Study|Patient moved to roll-over study|19|||
157066799|NCT02366143|567000478|FG002|Overall Study|Patient moved to roll-over study|28|||
157066800|NCT02366143|567000476|FG000|Overall Study|Patient moved to commercial stock|0|||
157066801|NCT02366143|567000477|FG001|Overall Study|Patient moved to commercial stock|0|||
157066802|NCT02366143|567000478|FG002|Overall Study|Patient moved to commercial stock|1|||
157066803|NCT02366143|567000476|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
157066804|NCT02366143|567000477|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
157066805|NCT02366143|567000478|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
157066806|NCT02366143|567000476|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
157186244|NCT00963820|567423109|FG001|Expansion Phase|Progressive Disease|0|||
157186245|NCT00963820|567423110|FG002|Expansion Phase|Progressive Disease|0|||
157186246|NCT00963820|567423111|FG003|Expansion Phase|Progressive Disease|0|||
157186247|NCT00963820|567423112|FG004|Expansion Phase|Progressive Disease|0|||
157186248|NCT00963820|567423113|FG005|Expansion Phase|Progressive Disease|0|||
157186249|NCT00963820|567423114|FG006|Expansion Phase|Progressive Disease|0|||
157066807|NCT02366143|567000477|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
157066808|NCT02366143|567000478|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
157066809|NCT02366143|567000476|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
157066810|NCT02366143|567000477|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
157066811|NCT02366143|567000478|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
157066812|NCT02366143|567000476|FG000|Overall Study|Requester's instructions|1|||
157066813|NCT02366143|567000477|FG001|Overall Study|Requester's instructions|1|||
157066814|NCT02366143|567000478|FG002|Overall Study|Requester's instructions|1|||
157066815|NCT02366143|567000476|FG000|Overall Study|Uneligible|0|||
157066816|NCT02366143|567000477|FG001|Overall Study|Uneligible|1|||
157066817|NCT02366143|567000478|FG002|Overall Study|Uneligible|0|||
157066818|NCT02366143|567000476|FG000|Overall Study|Post Trial Migration|0|||
157066819|NCT02366143|567000477|FG001|Overall Study|Post Trial Migration|1|||
157066820|NCT02366143|567000478|FG002|Overall Study|Post Trial Migration|0|||
157066821|NCT02366143|567000476|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
157066822|NCT02366143|567000477|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
157066823|NCT02366143|567000478|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
157066824|NCT02366143|567000476|FG000|Overall Study|Patient switched to PTAP|0|||
157066825|NCT02366143|567000477|FG001|Overall Study|Patient switched to PTAP|1|||
157066826|NCT02366143|567000478|FG002|Overall Study|Patient switched to PTAP|0|||
157066827|NCT02366143|567000476|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
157066828|NCT02366143|567000477|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
157066829|NCT02366143|567000478|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
157066830|NCT00575042|567000479|FG000|Overall Study|Adverse Event|2|||
157066831|NCT00575042|567000479|FG000|Overall Study|Lost to Follow-up|1|||
157066832|NCT01266018|567000484|FG000|Overall Study|Physician Decision|1|||
157066833|NCT01266018|567000485|FG001|Overall Study|Physician Decision|0|||
157066834|NCT01266018|567000484|FG000|Overall Study|Progressive disease|0|||
157066835|NCT01266018|567000485|FG001|Overall Study|Progressive disease|1|||
157066836|NCT03167151|567000486|FG000|Overall Study|Withdrawal by Subject|1|||
157066837|NCT03167151|567000487|FG001|Overall Study|Withdrawal by Subject|0|||
157066838|NCT03167151|567000488|FG002|Overall Study|Withdrawal by Subject|0|||
157066839|NCT03167151|567000486|FG000|Overall Study|No evidence of tumour at surgery|0|||
157066840|NCT03167151|567000487|FG001|Overall Study|No evidence of tumour at surgery|1|||
157066841|NCT03167151|567000488|FG002|Overall Study|No evidence of tumour at surgery|1|||
157066842|NCT01458522|567000489|FG000|Overall Study|Withdrawal by Subject|2|||
157066843|NCT01458522|567000490|FG001|Overall Study|Withdrawal by Subject|2|||
157066844|NCT01458522|567000489|FG000|Overall Study|Physician Decision|1|||
157066845|NCT01458522|567000490|FG001|Overall Study|Physician Decision|9|||
157066846|NCT00516139|567000491|FG000|Overall Study|Adverse Event|27|||
157066847|NCT00516139|567000491|FG000|Overall Study|Lost to Follow-up|1|||
157066848|NCT00516139|567000491|FG000|Overall Study|Protocol Violation|1|||
157066849|NCT00516139|567000491|FG000|Overall Study|Withdrawal by Subject|8|||
157066850|NCT00516139|567000491|FG000|Overall Study|Lack of Efficacy|1|||
157066851|NCT00416598|567000492|FG000|Induction & Intensification|Adverse Event|38|||
157066852|NCT00416598|567000492|FG000|Induction & Intensification|Death|32|||
157066853|NCT00416598|567000492|FG000|Induction & Intensification|Withdrawal by Subject|46|||
157066854|NCT00416598|567000492|FG000|Induction & Intensification|Alternative Treatment|135|||
157066855|NCT00416598|567000492|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
157066856|NCT00416598|567000492|FG000|Induction & Intensification|Relapse/progression|29|||
157066857|NCT00416598|567000492|FG000|Induction & Intensification|Failed induction|87|||
157066858|NCT00416598|567000492|FG000|Decitabine Maintenance|Adverse Event|5|||
157066859|NCT00416598|567000492|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
157066860|NCT00416598|567000492|FG000|Decitabine Maintenance|Progression/relapse|38|||
157066861|NCT00416598|567000492|FG000|Decitabine Maintenance|Alternative treatment|2|||
157066862|NCT00416598|567000492|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
157066863|NCT02370251|567000493|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
157066864|NCT02370251|567000493|FG000|Overall Study|Death|4|||
157066865|NCT04469465|567000494|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
157066866|NCT04469465|567000495|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
157186250|NCT00963820|567423115|FG007|Expansion Phase|Progressive Disease|0|||
157066867|NCT04469465|567000494|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
157066868|NCT04469465|567000495|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
157066869|NCT04469465|567000494|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
157066870|NCT04469465|567000495|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
157066871|NCT04469465|567000494|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
157186251|NCT00963820|567423116|FG008|Expansion Phase|Progressive Disease|8|||
157186252|NCT00963820|567423117|FG009|Expansion Phase|Progressive Disease|6|||
157186253|NCT00963820|567423118|FG010|Expansion Phase|Progressive Disease|4|||
157186254|NCT00963820|567423119|FG011|Expansion Phase|Progressive Disease|2|||
157186255|NCT00963820|567423108|FG000|Expansion Phase|Adverse Event|0|||
157186256|NCT00963820|567423109|FG001|Expansion Phase|Adverse Event|0|||
157186257|NCT00963820|567423110|FG002|Expansion Phase|Adverse Event|0|||
157186258|NCT00963820|567423111|FG003|Expansion Phase|Adverse Event|0|||
157186259|NCT00963820|567423112|FG004|Expansion Phase|Adverse Event|0|||
157186260|NCT00963820|567423113|FG005|Expansion Phase|Adverse Event|0|||
157186261|NCT00963820|567423114|FG006|Expansion Phase|Adverse Event|0|||
157186262|NCT00963820|567423115|FG007|Expansion Phase|Adverse Event|0|||
157186263|NCT00963820|567423116|FG008|Expansion Phase|Adverse Event|1|||
157186264|NCT00963820|567423117|FG009|Expansion Phase|Adverse Event|3|||
157186265|NCT00963820|567423118|FG010|Expansion Phase|Adverse Event|0|||
157186266|NCT00963820|567423119|FG011|Expansion Phase|Adverse Event|0|||
157186267|NCT00963820|567423108|FG000|Expansion Phase|Withdrawal by Subject|0|||
157186268|NCT00963820|567423109|FG001|Expansion Phase|Withdrawal by Subject|0|||
157186269|NCT00963820|567423110|FG002|Expansion Phase|Withdrawal by Subject|0|||
157186270|NCT00963820|567423111|FG003|Expansion Phase|Withdrawal by Subject|0|||
157186271|NCT00963820|567423112|FG004|Expansion Phase|Withdrawal by Subject|0|||
157186272|NCT00963820|567423113|FG005|Expansion Phase|Withdrawal by Subject|0|||
157186273|NCT00963820|567423114|FG006|Expansion Phase|Withdrawal by Subject|0|||
157186274|NCT00963820|567423115|FG007|Expansion Phase|Withdrawal by Subject|0|||
157186275|NCT00963820|567423116|FG008|Expansion Phase|Withdrawal by Subject|1|||
157186276|NCT00963820|567423117|FG009|Expansion Phase|Withdrawal by Subject|0|||
157186277|NCT00963820|567423118|FG010|Expansion Phase|Withdrawal by Subject|1|||
157186278|NCT00963820|567423119|FG011|Expansion Phase|Withdrawal by Subject|1|||
157186279|NCT00963820|567423108|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186280|NCT00963820|567423109|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186281|NCT00963820|567423110|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186282|NCT00963820|567423111|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186283|NCT00963820|567423112|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186284|NCT00963820|567423113|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186285|NCT00963820|567423114|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186286|NCT00963820|567423115|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186287|NCT00963820|567423116|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186288|NCT00963820|567423117|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186289|NCT00963820|567423118|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
157186290|NCT00963820|567423119|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
157186291|NCT01426009|567423124|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
157186292|NCT01426009|567423124|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
157186293|NCT01426009|567423124|FG000|Washout 1|Withdrawal by Subject|1|||
157186294|NCT01426009|567423124|FG000|Washout 1|Personal Reasons|1|||
157186295|NCT01426009|567423124|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
157186296|NCT01426009|567423124|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
157186297|NCT01426009|567423124|FG000|Washout 2|electrive surgery|1|||
157186298|NCT01426009|567423124|FG000|Washout 3|personal reasons|1|||
157186299|NCT01426009|567423124|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
157186300|NCT01426009|567423124|FG000|Washout 4|Lost to Follow-up|1|||
157186301|NCT03342404|567423130|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
157186302|NCT03342404|567423131|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
157186303|NCT03342404|567423130|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
157186304|NCT03342404|567423131|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
157186305|NCT03342404|567423130|FG000|Blinded Treatment Phase|Adverse Event|5|||
157186306|NCT03342404|567423131|FG001|Blinded Treatment Phase|Adverse Event|4|||
157186307|NCT03342404|567423130|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
157186308|NCT03342404|567423131|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
157186309|NCT03342404|567423130|FG000|Blinded Treatment Phase|Other reasons|1|||
157186310|NCT03342404|567423131|FG001|Blinded Treatment Phase|Other reasons|0|||
157186311|NCT03342404|567423130|FG000|Blinded Treatment Phase|Physician Decision|1|||
157186312|NCT03342404|567423131|FG001|Blinded Treatment Phase|Physician Decision|0|||
157186313|NCT03342404|567423130|FG000|Blinded Treatment Phase|Death|1|||
157186314|NCT03342404|567423131|FG001|Blinded Treatment Phase|Death|0|||
157066872|NCT04469465|567000495|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
157066873|NCT04469465|567000494|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
157186315|NCT03342404|567423130|FG000|Open-Label Phase|Lost to Follow-up|0|||
157230173|NCT03629249|567588266|FG002|Overall Study|Adverse Event|0|||
157230174|NCT03629249|567588264|FG000|Overall Study|Death|1|||
157230175|NCT03629249|567588265|FG001|Overall Study|Death|0|||
157186316|NCT03342404|567423131|FG001|Open-Label Phase|Lost to Follow-up|1|||
157186317|NCT03342404|567423130|FG000|Open-Label Phase|Other reasons|0|||
157186318|NCT03342404|567423131|FG001|Open-Label Phase|Other reasons|1|||
157230176|NCT03629249|567588266|FG002|Overall Study|Death|0|||
157066874|NCT04469465|567000495|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
157066875|NCT04469465|567000494|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
157066876|NCT04469465|567000495|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
157066877|NCT04469465|567000494|FG000|Long-Term Extension (LTE)|Death|0|||
157066878|NCT04469465|567000495|FG001|Long-Term Extension (LTE)|Death|1|||
157066879|NCT04469465|567000494|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
157066880|NCT04469465|567000495|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
157066881|NCT01165177|567000496|FG000|Overall Study|Serious Adverse Event|227|||
157066882|NCT01165177|567000497|FG001|Overall Study|Serious Adverse Event|235|||
157066883|NCT01165177|567000496|FG000|Overall Study|Withdrawal by Subject|368|||
157066884|NCT01165177|567000497|FG001|Overall Study|Withdrawal by Subject|354|||
157066885|NCT01165177|567000496|FG000|Overall Study|Protocol Violation|19|||
157066886|NCT01165177|567000497|FG001|Overall Study|Protocol Violation|21|||
157066887|NCT01165177|567000496|FG000|Overall Study|Non-serious adverse event|30|||
157066888|NCT01165177|567000497|FG001|Overall Study|Non-serious adverse event|18|||
157066889|NCT01165177|567000496|FG000|Overall Study|Other unspecified reasons|47|||
157066890|NCT01165177|567000497|FG001|Overall Study|Other unspecified reasons|35|||
157066891|NCT01165177|567000496|FG000|Overall Study|Suspected HZ episode|0|||
157066892|NCT01165177|567000497|FG001|Overall Study|Suspected HZ episode|2|||
157066893|NCT01165177|567000496|FG000|Overall Study|Lost to Follow-up|183|||
157066894|NCT01165177|567000497|FG001|Overall Study|Lost to Follow-up|194|||
157066895|NCT01165177|567000496|FG000|Overall Study|Migrated/ moved from study area|48|||
157066896|NCT01165177|567000497|FG001|Overall Study|Migrated/ moved from study area|43|||
157066897|NCT00781937|567000499|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
157066898|NCT00781937|567000500|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
157066899|NCT00781937|567000499|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
157066900|NCT00781937|567000500|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
157066901|NCT00781937|567000499|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
157066902|NCT00781937|567000500|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
157066903|NCT00781937|567000499|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
157066904|NCT00781937|567000500|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
157066905|NCT00781937|567000499|FG000|Main Trial Period Through Week 56|Unclassified|10|||
157066906|NCT00781937|567000500|FG001|Main Trial Period Through Week 56|Unclassified|15|||
157066907|NCT00781937|567000499|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
157066908|NCT00781937|567000500|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
157066909|NCT00781937|567000499|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
157066910|NCT00781937|567000500|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
157066911|NCT00013611|567000501|FG000|Overall Study|Lost to Follow-up|91|||
157066912|NCT00013611|567000502|FG001|Overall Study|Lost to Follow-up|100|||
157066913|NCT01150045|567000503|FG000|Overall Study|Protocol Violation|0|||
157066914|NCT01150045|567000504|FG001|Overall Study|Protocol Violation|1|||
157066915|NCT01150045|567000505|FG002|Overall Study|Protocol Violation|0|||
157066916|NCT01150045|567000506|FG003|Overall Study|Protocol Violation|1|||
157066917|NCT01657799|567000507|FG000|Overall Study|Adverse Event Related to progression|6|||
157066918|NCT01657799|567000508|FG001|Overall Study|Adverse Event Related to progression|8|||
157066919|NCT01657799|567000509|FG002|Overall Study|Adverse Event Related to progression|12|||
157066920|NCT01657799|567000507|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
157066921|NCT01657799|567000508|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
157066922|NCT01657799|567000509|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
157066923|NCT01657799|567000507|FG000|Overall Study|Withdrawal by Subject|13|||
157066924|NCT01657799|567000508|FG001|Overall Study|Withdrawal by Subject|10|||
157066925|NCT01657799|567000509|FG002|Overall Study|Withdrawal by Subject|10|||
157066926|NCT01657799|567000507|FG000|Overall Study|Lost to Follow-up|1|||
157066927|NCT01657799|567000508|FG001|Overall Study|Lost to Follow-up|0|||
157066928|NCT01657799|567000509|FG002|Overall Study|Lost to Follow-up|1|||
157066929|NCT01657799|567000507|FG000|Overall Study|Disease Progression|2|||
157066930|NCT01657799|567000508|FG001|Overall Study|Disease Progression|4|||
157066931|NCT01657799|567000509|FG002|Overall Study|Disease Progression|4|||
157066932|NCT01657799|567000507|FG000|Overall Study|Progressive Disease Clinical|7|||
157066933|NCT01657799|567000508|FG001|Overall Study|Progressive Disease Clinical|4|||
157066934|NCT01657799|567000509|FG002|Overall Study|Progressive Disease Clinical|7|||
157186319|NCT03342404|567423130|FG000|Open-Label Phase|Adverse Event|0|||
157186320|NCT03342404|567423131|FG001|Open-Label Phase|Adverse Event|3|||
157066935|NCT01657799|567000507|FG000|Overall Study|Radiographic & Clinical Progression|16|||
157066936|NCT01657799|567000508|FG001|Overall Study|Radiographic & Clinical Progression|11|||
157066937|NCT01657799|567000509|FG002|Overall Study|Radiographic & Clinical Progression|15|||
157066938|NCT01657799|567000507|FG000|Overall Study|Other|52|||
157066939|NCT01657799|567000508|FG001|Overall Study|Other|62|||
157066940|NCT01657799|567000509|FG002|Overall Study|Other|49|||
157066941|NCT02229578|567000512|FG000|Overall Study|Withdrawal by Subject|1|||
157066942|NCT02229578|567000513|FG001|Overall Study|Withdrawal by Subject|3|||
157066943|NCT02229578|567000512|FG000|Overall Study|Protocol Violation|2|||
157186321|NCT03342404|567423130|FG000|Open-Label Phase|Withdrawal by Subject|0|||
157186322|NCT03342404|567423131|FG001|Open-Label Phase|Withdrawal by Subject|6|||
157186323|NCT02005211|567423137|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186324|NCT02005211|567423138|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186325|NCT02005211|567423139|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186326|NCT02005211|567423140|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186327|NCT02005211|567423141|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
157186328|NCT02005211|567423142|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186329|NCT02005211|567423143|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
157186330|NCT00397631|567423145|FG000|Overall Study|Adverse Event|5|||
157186331|NCT00397631|567423146|FG001|Overall Study|Adverse Event|6|||
157186332|NCT00397631|567423145|FG000|Overall Study|Lack of Efficacy|7|||
157186333|NCT00397631|567423146|FG001|Overall Study|Lack of Efficacy|10|||
157186334|NCT00397631|567423145|FG000|Overall Study|Lost to Follow-up|8|||
157186335|NCT00397631|567423146|FG001|Overall Study|Lost to Follow-up|9|||
157186336|NCT00397631|567423145|FG000|Overall Study|Physician Decision|2|||
157186337|NCT00397631|567423146|FG001|Overall Study|Physician Decision|0|||
157186338|NCT00397631|567423145|FG000|Overall Study|Protocol Violation|0|||
157186339|NCT00397631|567423146|FG001|Overall Study|Protocol Violation|1|||
157186340|NCT00397631|567423145|FG000|Overall Study|Withdrawal by Subject|7|||
157186341|NCT00397631|567423146|FG001|Overall Study|Withdrawal by Subject|14|||
157186342|NCT00397631|567423145|FG000|Overall Study|protocol discontinuation criteria|1|||
157186343|NCT00397631|567423146|FG001|Overall Study|protocol discontinuation criteria|4|||
157186344|NCT02202161|567423147|FG000|Overall Study|Adverse Event|1|||
157186345|NCT02202161|567423148|FG001|Overall Study|Adverse Event|1|||
157186346|NCT02202161|567423149|FG002|Overall Study|Adverse Event|0|||
157186347|NCT02202161|567423150|FG003|Overall Study|Adverse Event|0|||
157186348|NCT02202161|567423151|FG004|Overall Study|Adverse Event|0|||
157186349|NCT02202161|567423152|FG005|Overall Study|Adverse Event|1|||
157186350|NCT02202161|567423153|FG006|Overall Study|Adverse Event|0|||
157186351|NCT02202161|567423154|FG007|Overall Study|Adverse Event|0|||
157186352|NCT02202161|567423147|FG000|Overall Study|Did not meet continuation criteria|0|||
157186353|NCT02202161|567423148|FG001|Overall Study|Did not meet continuation criteria|0|||
157186354|NCT02202161|567423149|FG002|Overall Study|Did not meet continuation criteria|0|||
157186355|NCT02202161|567423150|FG003|Overall Study|Did not meet continuation criteria|0|||
157186356|NCT02202161|567423151|FG004|Overall Study|Did not meet continuation criteria|0|||
157186357|NCT02202161|567423152|FG005|Overall Study|Did not meet continuation criteria|0|||
157186358|NCT02202161|567423153|FG006|Overall Study|Did not meet continuation criteria|0|||
157186359|NCT02202161|567423154|FG007|Overall Study|Did not meet continuation criteria|3|||
157186360|NCT02202161|567423147|FG000|Overall Study|Physician Decision|0|||
157186361|NCT02202161|567423148|FG001|Overall Study|Physician Decision|0|||
157186362|NCT02202161|567423149|FG002|Overall Study|Physician Decision|0|||
157186363|NCT02202161|567423150|FG003|Overall Study|Physician Decision|0|||
157186364|NCT02202161|567423151|FG004|Overall Study|Physician Decision|0|||
157186365|NCT02202161|567423152|FG005|Overall Study|Physician Decision|0|||
157186366|NCT02202161|567423153|FG006|Overall Study|Physician Decision|0|||
157186367|NCT02202161|567423154|FG007|Overall Study|Physician Decision|3|||
157186368|NCT02202161|567423147|FG000|Overall Study|Withdrawal by Subject|0|||
157186369|NCT02202161|567423148|FG001|Overall Study|Withdrawal by Subject|0|||
157186370|NCT02202161|567423149|FG002|Overall Study|Withdrawal by Subject|0|||
157186371|NCT02202161|567423150|FG003|Overall Study|Withdrawal by Subject|0|||
157186372|NCT02202161|567423151|FG004|Overall Study|Withdrawal by Subject|1|||
157186373|NCT02202161|567423152|FG005|Overall Study|Withdrawal by Subject|0|||
157186374|NCT02202161|567423153|FG006|Overall Study|Withdrawal by Subject|0|||
157186375|NCT02202161|567423154|FG007|Overall Study|Withdrawal by Subject|0|||
157186376|NCT02750501|567423157|FG000|Overall Study|Adverse Event|4|||
157186377|NCT02750501|567423157|FG000|Overall Study|Physician Decision|1|||
157186378|NCT02750501|567423157|FG000|Overall Study|Protocol Violation|1|||
157186379|NCT02750501|567423157|FG000|Overall Study|G-tube came out|1|||
157186380|NCT02750501|567423157|FG000|Overall Study|Non-compliant use of PERT|1|||
157186381|NCT03797144|567423158|FG000|Enrollment|Protocol Violation|4|||
157186382|NCT03797144|567423159|FG001|Enrollment|Protocol Violation|1|||
157186383|NCT03797144|567423158|FG000|Surgery|Protocol Violation|1|||
157186384|NCT03797144|567423159|FG001|Surgery|Protocol Violation|0|||
157186385|NCT03797144|567423158|FG000|3 Month|Early termination cut-off date|2|||
157186386|NCT03797144|567423159|FG001|3 Month|Early termination cut-off date|0|||
157186387|NCT03797144|567423158|FG000|12 Month|Early termination cut-off date|8|||
157186388|NCT03797144|567423159|FG001|12 Month|Early termination cut-off date|9|||
157186389|NCT03797144|567423158|FG000|24 Month|Early termination cut-off date|1|||
157186390|NCT03797144|567423159|FG001|24 Month|Early termination cut-off date|1|||
157186391|NCT00403390|567423161|FG000|Overall Study|Withdrawal by Subject|1|||
157066944|NCT02229578|567000513|FG001|Overall Study|Protocol Violation|0|||
157186392|NCT00403390|567423162|FG001|Overall Study|Withdrawal by Subject|0|||
157066945|NCT03021551|567000514|FG000|Overall Study|Equipment Issues|2|||
157186393|NCT00403390|567423161|FG000|Overall Study|samples lost|1|||
157186394|NCT00403390|567423162|FG001|Overall Study|samples lost|0|||
157186395|NCT00403390|567423161|FG000|Overall Study|non-compliant|1|||
157186396|NCT00403390|567423162|FG001|Overall Study|non-compliant|0|||
157186397|NCT03299166|567423166|FG000|Overall Study|Adverse Event|9|||
157186398|NCT03299166|567423167|FG001|Overall Study|Adverse Event|4|||
157186399|NCT03299166|567423166|FG000|Overall Study|Withdrawal by Subject|6|||
157186400|NCT03299166|567423167|FG001|Overall Study|Withdrawal by Subject|5|||
157186401|NCT03299166|567423166|FG000|Overall Study|Physician Decision|1|||
157186402|NCT03299166|567423167|FG001|Overall Study|Physician Decision|1|||
157186403|NCT03299166|567423166|FG000|Overall Study|Sponsor Decision|3|||
157186404|NCT03299166|567423167|FG001|Overall Study|Sponsor Decision|0|||
157186405|NCT03299166|567423166|FG000|Overall Study|Lost to Follow-up|2|||
157186406|NCT03299166|567423167|FG001|Overall Study|Lost to Follow-up|4|||
157186407|NCT03299166|567423166|FG000|Overall Study|Randomization Error|0|||
157186408|NCT03299166|567423167|FG001|Overall Study|Randomization Error|1|||
157186409|NCT03299166|567423166|FG000|Overall Study|Subject unable to return due to COVID|1|||
157186410|NCT03299166|567423167|FG001|Overall Study|Subject unable to return due to COVID|0|||
157186411|NCT03299166|567423166|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
157186412|NCT03299166|567423167|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
157186413|NCT00423592|567423169|FG000|Overall Study|Adverse Event (through Week 12)|2|||
157186414|NCT00423592|567423169|FG000|Overall Study|Adverse Event (post Week 12)|5|||
157186415|NCT00062647|567423170|FG000|Overall Study|Death|2|||
157186416|NCT00062647|567423171|FG001|Overall Study|Death|2|||
157186417|NCT00062647|567423170|FG000|Overall Study|Adverse Event|1|||
157186418|NCT00062647|567423171|FG001|Overall Study|Adverse Event|1|||
157186419|NCT00062647|567423170|FG000|Overall Study|Withdrawal by Subject|2|||
157186420|NCT00062647|567423171|FG001|Overall Study|Withdrawal by Subject|1|||
157186421|NCT00062647|567423170|FG000|Overall Study|Protocol Violation|1|||
157186422|NCT00062647|567423171|FG001|Overall Study|Protocol Violation|0|||
157186423|NCT00062647|567423170|FG000|Overall Study|Lost to Follow-up|1|||
157186424|NCT00062647|567423171|FG001|Overall Study|Lost to Follow-up|2|||
157186425|NCT00062647|567423170|FG000|Overall Study|Failed continuation criteria|4|||
157186426|NCT00062647|567423171|FG001|Overall Study|Failed continuation criteria|2|||
157186427|NCT00062647|567423170|FG000|Overall Study|Other|4|||
157186428|NCT00062647|567423171|FG001|Overall Study|Other|4|||
157186429|NCT00062647|567423170|FG000|Overall Study|Never received study treatment|1|||
157186430|NCT00062647|567423171|FG001|Overall Study|Never received study treatment|1|||
157186431|NCT00002981|567423174|FG000|Overall Study|Inevaluable|6|||
157186432|NCT00255008|567423175|FG000|Overall Study|Adverse Event|1|||
157186433|NCT00255008|567423176|FG001|Overall Study|Adverse Event|1|||
157186434|NCT00255008|567423177|FG002|Overall Study|Adverse Event|2|||
157186435|NCT00255008|567423178|FG003|Overall Study|Adverse Event|0|||
157186436|NCT00255008|567423175|FG000|Overall Study|Lost to Follow-up|1|||
157186437|NCT00255008|567423176|FG001|Overall Study|Lost to Follow-up|0|||
157186438|NCT00255008|567423177|FG002|Overall Study|Lost to Follow-up|1|||
157186439|NCT00255008|567423178|FG003|Overall Study|Lost to Follow-up|2|||
157186440|NCT00255008|567423175|FG000|Overall Study|Did not meet viral reduction criteria|4|||
157186441|NCT00255008|567423176|FG001|Overall Study|Did not meet viral reduction criteria|5|||
157186442|NCT00255008|567423177|FG002|Overall Study|Did not meet viral reduction criteria|0|||
157186443|NCT00255008|567423178|FG003|Overall Study|Did not meet viral reduction criteria|1|||
157186444|NCT00255008|567423175|FG000|Overall Study|Withdrew consent|0|||
157186445|NCT00255008|567423176|FG001|Overall Study|Withdrew consent|0|||
157186446|NCT00255008|567423177|FG002|Overall Study|Withdrew consent|2|||
157186447|NCT00255008|567423178|FG003|Overall Study|Withdrew consent|0|||
157186448|NCT00255008|567423175|FG000|Overall Study|Sponsor request|18|||
157186449|NCT00255008|567423176|FG001|Overall Study|Sponsor request|3|||
157186450|NCT00255008|567423177|FG002|Overall Study|Sponsor request|8|||
157186451|NCT00255008|567423178|FG003|Overall Study|Sponsor request|17|||
157186452|NCT00255008|567423175|FG000|Overall Study|Adverse lab experience|1|||
157186453|NCT00255008|567423176|FG001|Overall Study|Adverse lab experience|0|||
157186454|NCT00255008|567423177|FG002|Overall Study|Adverse lab experience|0|||
157186455|NCT00255008|567423178|FG003|Overall Study|Adverse lab experience|0|||
157186456|NCT00255008|567423175|FG000|Overall Study|Other|7|||
157186457|NCT00255008|567423176|FG001|Overall Study|Other|0|||
157186458|NCT00255008|567423177|FG002|Overall Study|Other|3|||
157186459|NCT00255008|567423178|FG003|Overall Study|Other|2|||
157186460|NCT00322387|567423182|FG000|Treatment Period|Adverse Event|0|||
157186461|NCT00322387|567423183|FG001|Treatment Period|Adverse Event|1|||
157186462|NCT00322387|567423182|FG000|Follow-up Period|Final assessment not done|1|||
157186463|NCT00322387|567423183|FG001|Follow-up Period|Final assessment not done|3|||
157186464|NCT00322387|567423182|FG000|Follow-up Period|Death|1|||
157186465|NCT00322387|567423183|FG001|Follow-up Period|Death|0|||
157186466|NCT00707486|567423186|FG000|Overall Study|Withdrawal by Subject|1|||
157186467|NCT02299206|567423187|FG000|Overall Study|Lost to Follow-up|1|||
157186468|NCT02299206|567423187|FG000|Overall Study|Withdrawal by Subject|1|||
157186469|NCT00691054|567423188|FG000|Overall Study|Withdrawal by Subject|1|||
157186470|NCT01855919|567424944|FG000|Overall Study|Adverse Event|16|||
157186471|NCT01855919|567424945|FG001|Overall Study|Adverse Event|8|||
157186472|NCT01855919|567424944|FG000|Overall Study|Lack of Efficacy|1|||
157186473|NCT01855919|567424945|FG001|Overall Study|Lack of Efficacy|3|||
157186474|NCT01855919|567424944|FG000|Overall Study|Withdrawal by Subject|4|||
157186475|NCT01855919|567424945|FG001|Overall Study|Withdrawal by Subject|10|||
157186476|NCT01855919|567424944|FG000|Overall Study|Entry Criteria Not Met|1|||
157186477|NCT01855919|567424945|FG001|Overall Study|Entry Criteria Not Met|1|||
157186478|NCT01855919|567424944|FG000|Overall Study|Protocol Violation|1|||
157186479|NCT01855919|567424945|FG001|Overall Study|Protocol Violation|4|||
157186480|NCT02972658|567424952|FG000|Overall Study|Adverse Event|0|||
157186481|NCT02972658|567424953|FG001|Overall Study|Adverse Event|3|||
157186482|NCT02972658|567424954|FG002|Overall Study|Adverse Event|0|||
157186483|NCT02972658|567424955|FG003|Overall Study|Adverse Event|2|||
157186484|NCT02972658|567424952|FG000|Overall Study|Other-determined by Investigator|1|||
157186485|NCT02972658|567424953|FG001|Overall Study|Other-determined by Investigator|1|||
157186486|NCT02972658|567424954|FG002|Overall Study|Other-determined by Investigator|0|||
157186487|NCT02972658|567424955|FG003|Overall Study|Other-determined by Investigator|0|||
157186488|NCT02972658|567424952|FG000|Overall Study|Death|0|||
157186489|NCT02972658|567424953|FG001|Overall Study|Death|0|||
157186490|NCT02972658|567424954|FG002|Overall Study|Death|0|||
157186491|NCT02972658|567424955|FG003|Overall Study|Death|1|||
157186492|NCT02972658|567424952|FG000|Overall Study|Lost to Follow-up|0|||
157186493|NCT02972658|567424953|FG001|Overall Study|Lost to Follow-up|1|||
157186494|NCT02972658|567424954|FG002|Overall Study|Lost to Follow-up|1|||
157186495|NCT02972658|567424955|FG003|Overall Study|Lost to Follow-up|2|||
157186496|NCT02972658|567424952|FG000|Overall Study|Progressive Disease|0|||
157186497|NCT02972658|567424953|FG001|Overall Study|Progressive Disease|1|||
157186498|NCT02972658|567424954|FG002|Overall Study|Progressive Disease|0|||
157186499|NCT02972658|567424955|FG003|Overall Study|Progressive Disease|1|||
157186500|NCT02972658|567424952|FG000|Overall Study|Withdrawal by Subject|4|||
157186501|NCT02972658|567424953|FG001|Overall Study|Withdrawal by Subject|4|||
157186502|NCT02972658|567424954|FG002|Overall Study|Withdrawal by Subject|1|||
157186503|NCT02972658|567424955|FG003|Overall Study|Withdrawal by Subject|6|||
157186504|NCT02972658|567424952|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
157186505|NCT02972658|567424953|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
157186506|NCT02972658|567424954|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
157186507|NCT02972658|567424955|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
157186508|NCT02972658|567424952|FG000|Overall Study|Sponsor Decision|70|||
157186509|NCT02972658|567424953|FG001|Overall Study|Sponsor Decision|127|||
157186510|NCT02972658|567424954|FG002|Overall Study|Sponsor Decision|72|||
157186511|NCT02972658|567424955|FG003|Overall Study|Sponsor Decision|119|||
157186512|NCT03958149|567424960|FG000|Overall Study|Withdrawal by Subject|0|||
157186513|NCT03958149|567424961|FG001|Overall Study|Withdrawal by Subject|1|||
157186514|NCT02785588|567424962|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
157186515|NCT02785588|567424962|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
157186516|NCT03037489|567424963|FG000|Overall Study|Adverse Event|4|||
157186517|NCT03037489|567424964|FG001|Overall Study|Adverse Event|0|||
157186518|NCT03037489|567424963|FG000|Overall Study|Withdrawal by Subject|3|||
157186519|NCT03037489|567424964|FG001|Overall Study|Withdrawal by Subject|0|||
157186520|NCT00621764|567424966|FG000|Overall Study|Protocol Violation|0|||
157186521|NCT00621764|567424967|FG001|Overall Study|Protocol Violation|0|||
157186522|NCT00621764|567424968|FG002|Overall Study|Protocol Violation|0|||
157186523|NCT00621764|567424969|FG003|Overall Study|Protocol Violation|1|||
157186524|NCT02499172|567424970|FG000|Overall Study|Financial reason|0|||
157186525|NCT02499172|567424971|FG001|Overall Study|Financial reason|0|||
157186526|NCT02499172|567424972|FG002|Overall Study|Financial reason|523|||
157186527|NCT02499172|567424973|FG003|Overall Study|Financial reason|436|||
157186528|NCT02499172|567424970|FG000|Overall Study|Lost to Follow-up|65|||
157186529|NCT02499172|567424971|FG001|Overall Study|Lost to Follow-up|64|||
157186530|NCT02499172|567424972|FG002|Overall Study|Lost to Follow-up|0|||
157186531|NCT02499172|567424973|FG003|Overall Study|Lost to Follow-up|0|||
157186532|NCT01293123|567424974|FG000|Overall Study|Lost to Follow-up|0|||
157186533|NCT01293123|567424975|FG001|Overall Study|Lost to Follow-up|1|||
157186534|NCT00724243|567424978|FG000|Overall Study|Lack of Efficacy|10|||
157186535|NCT00724243|567424978|FG000|Overall Study|Adverse Event|5|||
157186536|NCT03031327|567424979|FG000|Overall Study|Withdrawal by Subject|0|||
157186537|NCT03031327|567424980|FG001|Overall Study|Withdrawal by Subject|1|||
157186538|NCT03031327|567424981|FG002|Overall Study|Withdrawal by Subject|1|||
157186539|NCT00686699|567424982|FG000|Treatment Period 1|Adverse Event|0|||
157186540|NCT00686699|567424983|FG001|Treatment Period 1|Adverse Event|2|||
157186541|NCT01888965|567424984|FG000|Overall Study|Adverse Event|5|||
157186542|NCT01888965|567424984|FG000|Overall Study|Lack of Efficacy|4|||
157186543|NCT00908895|567424985|FG000|Overall Study|Lost to Follow-up|1|||
157186544|NCT00908895|567424986|FG001|Overall Study|Lost to Follow-up|3|||
157186545|NCT00908895|567424985|FG000|Overall Study|algodystrophy|2|||
157186546|NCT00908895|567424986|FG001|Overall Study|algodystrophy|2|||
157186547|NCT00908895|567424985|FG000|Overall Study|Adverse Event|1|||
157186548|NCT00908895|567424986|FG001|Overall Study|Adverse Event|1|||
157186549|NCT03793010|567424987|FG000|Overall Study|Withdrawal by Subject|5|||
157186550|NCT03793010|567424988|FG001|Overall Study|Withdrawal by Subject|7|||
157186551|NCT03793010|567424987|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
157230177|NCT03629249|567588264|FG000|Overall Study|Physician Decision|1|||
157186552|NCT03793010|567424988|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
157186553|NCT03793010|567424987|FG000|Overall Study|Lost to Follow-up|1|||
157186554|NCT03793010|567424988|FG001|Overall Study|Lost to Follow-up|2|||
157186555|NCT03793010|567424987|FG000|Overall Study|Patient couldn't sit still for injection|1|||
157186556|NCT03793010|567424988|FG001|Overall Study|Patient couldn't sit still for injection|0|||
157186557|NCT03793010|567424987|FG000|Overall Study|Withdrew to pursue other treatment|1|||
157066946|NCT03021551|567000514|FG000|Overall Study|Protocol Violation|1|||
157066947|NCT00412880|567000517|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
157066948|NCT00412880|567000517|FG000|Overall Study|Consent withdrawn|1|||
157066949|NCT00412880|567000517|FG000|Overall Study|Adverse Event|1|||
157066950|NCT00412880|567000517|FG000|Overall Study|Progressive disease|20|||
157066951|NCT02232399|567000519|FG000|Overall Study|Adverse Event|1|||
157066952|NCT02232399|567000520|FG001|Overall Study|Adverse Event|0|||
157066953|NCT02232399|567000519|FG000|Overall Study|Withdrawal by Subject|0|||
157066954|NCT02232399|567000520|FG001|Overall Study|Withdrawal by Subject|1|||
157066955|NCT02706951|567000522|FG000|Period 1|Adverse Event|1|||
157066956|NCT02706951|567000523|FG001|Period 1|Adverse Event|5|||
157066957|NCT02706951|567000524|FG002|Period 1|Adverse Event|3|||
157066958|NCT02706951|567000525|FG003|Period 1|Adverse Event|0|||
157066959|NCT02706951|567000526|FG004|Period 1|Adverse Event|0|||
157066960|NCT02706951|567000522|FG000|Period 1|Withdrawal by Subject|10|||
157066961|NCT02706951|567000523|FG001|Period 1|Withdrawal by Subject|6|||
157066962|NCT02706951|567000524|FG002|Period 1|Withdrawal by Subject|6|||
157066963|NCT02706951|567000525|FG003|Period 1|Withdrawal by Subject|0|||
157066964|NCT02706951|567000526|FG004|Period 1|Withdrawal by Subject|0|||
157066965|NCT02706951|567000522|FG000|Period 1|Lost to Follow-up|0|||
157066966|NCT02706951|567000523|FG001|Period 1|Lost to Follow-up|4|||
157066967|NCT02706951|567000524|FG002|Period 1|Lost to Follow-up|1|||
157066968|NCT02706951|567000525|FG003|Period 1|Lost to Follow-up|0|||
157066969|NCT02706951|567000526|FG004|Period 1|Lost to Follow-up|0|||
157066970|NCT02706951|567000522|FG000|Period 1|Other|2|||
157066971|NCT02706951|567000523|FG001|Period 1|Other|1|||
157066972|NCT02706951|567000524|FG002|Period 1|Other|0|||
157066973|NCT02706951|567000525|FG003|Period 1|Other|0|||
157066974|NCT02706951|567000526|FG004|Period 1|Other|0|||
157066975|NCT02706951|567000522|FG000|Period 2|Adverse Event|0|||
157066976|NCT02706951|567000523|FG001|Period 2|Adverse Event|0|||
157066977|NCT02706951|567000524|FG002|Period 2|Adverse Event|0|||
157066978|NCT02706951|567000525|FG003|Period 2|Adverse Event|25|||
157066979|NCT02706951|567000526|FG004|Period 2|Adverse Event|34|||
157066980|NCT02706951|567000522|FG000|Period 2|Withdrawal by Subject|0|||
157066981|NCT02706951|567000523|FG001|Period 2|Withdrawal by Subject|0|||
157066982|NCT02706951|567000524|FG002|Period 2|Withdrawal by Subject|0|||
157066983|NCT02706951|567000525|FG003|Period 2|Withdrawal by Subject|38|||
157066984|NCT02706951|567000526|FG004|Period 2|Withdrawal by Subject|44|||
157066985|NCT02706951|567000522|FG000|Period 2|Lost to Follow-up|0|||
157066986|NCT02706951|567000523|FG001|Period 2|Lost to Follow-up|0|||
157066987|NCT02706951|567000524|FG002|Period 2|Lost to Follow-up|0|||
157066988|NCT02706951|567000525|FG003|Period 2|Lost to Follow-up|17|||
157066989|NCT02706951|567000526|FG004|Period 2|Lost to Follow-up|9|||
157066990|NCT02706951|567000522|FG000|Period 2|COVID-19 Related|0|||
157066991|NCT02706951|567000523|FG001|Period 2|COVID-19 Related|0|||
157066992|NCT02706951|567000524|FG002|Period 2|COVID-19 Related|0|||
157066993|NCT02706951|567000525|FG003|Period 2|COVID-19 Related|1|||
157066994|NCT02706951|567000526|FG004|Period 2|COVID-19 Related|2|||
157066995|NCT02706951|567000522|FG000|Period 2|Other|0|||
157066996|NCT02706951|567000523|FG001|Period 2|Other|0|||
157186558|NCT03793010|567424988|FG001|Overall Study|Withdrew to pursue other treatment|0|||
157186559|NCT03793010|567424987|FG000|Overall Study|Did not meet eligibility criteria|1|||
157186560|NCT03793010|567424988|FG001|Overall Study|Did not meet eligibility criteria|0|||
157186561|NCT00364611|567424991|FG000|Overall Study|Did not receive study medication|0|||
157186562|NCT00364611|567424992|FG001|Overall Study|Did not receive study medication|1|||
157186563|NCT00364611|567424991|FG000|Overall Study|Adverse Event|7|||
157186564|NCT00364611|567424992|FG001|Overall Study|Adverse Event|4|||
157066997|NCT02706951|567000524|FG002|Period 2|Other|0|||
157066998|NCT02706951|567000525|FG003|Period 2|Other|37|||
157066999|NCT02706951|567000526|FG004|Period 2|Other|31|||
157067000|NCT04799418|567000531|FG000|Overall Study|Death|1|||
157067001|NCT04799418|567000532|FG001|Overall Study|Death|1|||
157067002|NCT04799418|567000531|FG000|Overall Study|Lack of Efficacy|14|||
157067003|NCT04799418|567000532|FG001|Overall Study|Lack of Efficacy|14|||
157067004|NCT04799418|567000531|FG000|Overall Study|Withdrawal by Subject|10|||
157067005|NCT04799418|567000532|FG001|Overall Study|Withdrawal by Subject|7|||
157067006|NCT04799418|567000531|FG000|Overall Study|Adverse Event|3|||
157067007|NCT04799418|567000532|FG001|Overall Study|Adverse Event|2|||
157067008|NCT03297398|567000533|FG000|Overall Study|Sponsor's decision|6|||
157067009|NCT03297398|567000534|FG001|Overall Study|Sponsor's decision|9|||
157067010|NCT03297398|567000535|FG002|Overall Study|Sponsor's decision|7|||
157067011|NCT03297398|567000533|FG000|Overall Study|Adverse Event|1|||
157067012|NCT03297398|567000534|FG001|Overall Study|Adverse Event|4|||
157067013|NCT03297398|567000535|FG002|Overall Study|Adverse Event|4|||
157067014|NCT03297398|567000533|FG000|Overall Study|Withdrawal by Subject|1|||
157186565|NCT00364611|567424991|FG000|Overall Study|Participant's Request|3|||
157186566|NCT00364611|567424992|FG001|Overall Study|Participant's Request|4|||
157186567|NCT00364611|567424991|FG000|Overall Study|Disease Progression|38|||
157186568|NCT00364611|567424992|FG001|Overall Study|Disease Progression|8|||
157186569|NCT00364611|567424991|FG000|Overall Study|Investigator decision|2|||
157186570|NCT00364611|567424992|FG001|Overall Study|Investigator decision|2|||
157186571|NCT00364611|567424991|FG000|Overall Study|Found Ineligible|1|||
157186572|NCT00364611|567424992|FG001|Overall Study|Found Ineligible|0|||
157186573|NCT00364611|567424991|FG000|Overall Study|Presumed CR on Study|0|||
157186574|NCT00364611|567424992|FG001|Overall Study|Presumed CR on Study|1|||
157186575|NCT00364611|567424991|FG000|Overall Study|Receiving Liver Ablation|0|||
157186576|NCT00364611|567424992|FG001|Overall Study|Receiving Liver Ablation|1|||
157186577|NCT02059174|567425024|FG000|Period 1|Withdrawal by Subject|0|||
157186578|NCT02059174|567425025|FG001|Period 1|Withdrawal by Subject|2|||
157186579|NCT02059174|567425024|FG000|Period 2|Withdrawal by Subject|0|||
157186580|NCT02059174|567425025|FG001|Period 2|Withdrawal by Subject|2|||
157186581|NCT02059174|567425024|FG000|Period 2|Protocol Violation|1|||
157186582|NCT02059174|567425025|FG001|Period 2|Protocol Violation|0|||
157186583|NCT02059174|567425024|FG000|Period 3|Physician Decision|1|||
157186584|NCT02059174|567425025|FG001|Period 3|Physician Decision|0|||
157186585|NCT00087594|567425030|FG000|Overall Study|Adverse Event|2|||
157186586|NCT00087594|567425031|FG001|Overall Study|Adverse Event|3|||
157186587|NCT00087594|567425030|FG000|Overall Study|Lost to Follow-up|0|||
157186588|NCT00087594|567425031|FG001|Overall Study|Lost to Follow-up|2|||
157186589|NCT00087594|567425030|FG000|Overall Study|Withdrawal by Subject|4|||
157186590|NCT00087594|567425031|FG001|Overall Study|Withdrawal by Subject|2|||
157186591|NCT00087594|567425030|FG000|Overall Study|Lack of Efficacy|2|||
157186592|NCT00087594|567425031|FG001|Overall Study|Lack of Efficacy|5|||
157186593|NCT00768040|567425032|FG000|Overall Study|Adverse Event|3|||
157186594|NCT00768040|567425033|FG001|Overall Study|Adverse Event|2|||
157186595|NCT00768040|567425032|FG000|Overall Study|Abnormal laboratory value|1|||
157186596|NCT00768040|567425033|FG001|Overall Study|Abnormal laboratory value|1|||
157186597|NCT02274311|567425040|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
157186598|NCT00508001|567425041|FG000|Overall Study|Adverse Event|2|||
157186599|NCT00508001|567425042|FG001|Overall Study|Adverse Event|0|||
157186600|NCT00508001|567425043|FG002|Overall Study|Adverse Event|4|||
157186601|NCT00508001|567425041|FG000|Overall Study|condition under investigation worsened|13|||
157186602|NCT00508001|567425042|FG001|Overall Study|condition under investigation worsened|7|||
157186603|NCT00508001|567425043|FG002|Overall Study|condition under investigation worsened|1|||
157186604|NCT00508001|567425041|FG000|Overall Study|Death|0|||
157186605|NCT00508001|567425042|FG001|Overall Study|Death|1|||
157186606|NCT00508001|567425043|FG002|Overall Study|Death|1|||
157186607|NCT00508001|567425041|FG000|Overall Study|Withdrawal by Subject|4|||
157186608|NCT00508001|567425042|FG001|Overall Study|Withdrawal by Subject|4|||
157186609|NCT00508001|567425043|FG002|Overall Study|Withdrawal by Subject|1|||
157186610|NCT04437511|567425044|FG000|Overall Study|Adverse Event|50|||
157186611|NCT04437511|567425045|FG001|Overall Study|Adverse Event|21|||
157186612|NCT04437511|567425044|FG000|Overall Study|Death|15|||
157186613|NCT04437511|567425045|FG001|Overall Study|Death|10|||
157186614|NCT04437511|567425044|FG000|Overall Study|Lost to Follow-up|11|||
157186615|NCT04437511|567425045|FG001|Overall Study|Lost to Follow-up|11|||
157186616|NCT04437511|567425044|FG000|Overall Study|Physician Decision|19|||
157186617|NCT04437511|567425045|FG001|Overall Study|Physician Decision|10|||
157186618|NCT04437511|567425044|FG000|Overall Study|Progressive Disease|4|||
157186619|NCT04437511|567425045|FG001|Overall Study|Progressive Disease|7|||
157186620|NCT04437511|567425044|FG000|Overall Study|Withdrawal by Subject|111|||
157186621|NCT04437511|567425045|FG001|Overall Study|Withdrawal by Subject|94|||
157186622|NCT04437511|567425044|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
157186623|NCT04437511|567425045|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
157186624|NCT04437511|567425044|FG000|Overall Study|Continuing Study|7|||
157186625|NCT04437511|567425045|FG001|Overall Study|Continuing Study|5|||
157186626|NCT03093350|567425050|FG000|Overall Study|Death|1|||
157186627|NCT03093350|567425050|FG000|Overall Study|Signed consent, never began treartment|1|||
157186628|NCT01263470|567425054|FG000|Overall Study|Adverse Event|2|||
157230178|NCT03629249|567588265|FG001|Overall Study|Physician Decision|0|||
157067015|NCT03297398|567000534|FG001|Overall Study|Withdrawal by Subject|2|||
157067016|NCT03297398|567000535|FG002|Overall Study|Withdrawal by Subject|2|||
157067017|NCT03297398|567000533|FG000|Overall Study|Protocol Violation|0|||
157067018|NCT03297398|567000534|FG001|Overall Study|Protocol Violation|2|||
157067019|NCT03297398|567000535|FG002|Overall Study|Protocol Violation|0|||
157186629|NCT01263470|567425055|FG001|Overall Study|Adverse Event|2|||
157186630|NCT01263470|567425056|FG002|Overall Study|Adverse Event|1|||
157186631|NCT01263470|567425057|FG003|Overall Study|Adverse Event|1|||
157186632|NCT01263470|567425058|FG004|Overall Study|Adverse Event|2|||
157186633|NCT01263470|567425059|FG005|Overall Study|Adverse Event|2|||
157186634|NCT01263470|567425054|FG000|Overall Study|Protocol Violation|0|||
157186635|NCT01263470|567425055|FG001|Overall Study|Protocol Violation|1|||
157186636|NCT01263470|567425056|FG002|Overall Study|Protocol Violation|0|||
157067020|NCT03297398|567000533|FG000|Overall Study|Physician Decision|0|||
157067021|NCT03297398|567000534|FG001|Overall Study|Physician Decision|0|||
157067022|NCT03297398|567000535|FG002|Overall Study|Physician Decision|1|||
157067023|NCT03297398|567000533|FG000|Overall Study|Lost to Follow-up|0|||
157067024|NCT03297398|567000534|FG001|Overall Study|Lost to Follow-up|0|||
157067025|NCT03297398|567000535|FG002|Overall Study|Lost to Follow-up|1|||
157067026|NCT00611715|567000540|FG000|Overall Study|Disease Progression|24|||
157067027|NCT00611715|567000541|FG001|Overall Study|Disease Progression|4|||
157067028|NCT00611715|567000540|FG000|Overall Study|Withdrawal by Subject|5|||
157067029|NCT00611715|567000541|FG001|Overall Study|Withdrawal by Subject|1|||
157067030|NCT00611715|567000540|FG000|Overall Study|Adverse Event|9|||
157067031|NCT00611715|567000541|FG001|Overall Study|Adverse Event|1|||
157067032|NCT00611715|567000540|FG000|Overall Study|Death|1|||
157067033|NCT00611715|567000541|FG001|Overall Study|Death|0|||
157067034|NCT00611715|567000540|FG000|Overall Study|two patients are still on treatment|2|||
157067035|NCT00611715|567000541|FG001|Overall Study|two patients are still on treatment|0|||
157067036|NCT00107978|567000542|FG000|Overall Study|Adverse Event|1|||
157067037|NCT00107978|567000543|FG001|Overall Study|Adverse Event|5|||
157067038|NCT00107978|567000542|FG000|Overall Study|Death|3|||
157067039|NCT00107978|567000543|FG001|Overall Study|Death|3|||
157067040|NCT00107978|567000542|FG000|Overall Study|Lost to Follow-up|20|||
157067041|NCT00107978|567000543|FG001|Overall Study|Lost to Follow-up|28|||
157067042|NCT00107978|567000542|FG000|Overall Study|Withdrawal by Subject|4|||
157067043|NCT00107978|567000543|FG001|Overall Study|Withdrawal by Subject|9|||
157067044|NCT00107978|567000542|FG000|Overall Study|Protocol Violation|0|||
157067045|NCT00107978|567000543|FG001|Overall Study|Protocol Violation|1|||
157067046|NCT00107978|567000542|FG000|Overall Study|Other|5|||
157067047|NCT00107978|567000543|FG001|Overall Study|Other|4|||
157067048|NCT02669407|567000544|FG000|Overall Study|Physician Decision|3|||
157067049|NCT00350298|567000547|FG000|Overall Study|Death|7|||
157067050|NCT00350298|567000548|FG001|Overall Study|Death|8|||
157067051|NCT00350298|567000547|FG000|Overall Study|Lost to Follow-up|1|||
157067052|NCT00350298|567000548|FG001|Overall Study|Lost to Follow-up|2|||
157067053|NCT00350298|567000547|FG000|Overall Study|Withdrawal by Subject|1|||
157067054|NCT00350298|567000548|FG001|Overall Study|Withdrawal by Subject|3|||
157067055|NCT03634839|567000549|FG000|First Intervention (2 Hours)|Adverse Event|0|||
157067056|NCT03634839|567000550|FG001|First Intervention (2 Hours)|Adverse Event|2|||
157067057|NCT00233389|567000553|FG000|Overall Study|Adverse Event|5|||
157067058|NCT00233389|567000554|FG001|Overall Study|Adverse Event|5|||
157067059|NCT00233389|567000553|FG000|Overall Study|Lack of Efficacy|11|||
157067060|NCT00233389|567000554|FG001|Overall Study|Lack of Efficacy|8|||
157067061|NCT00233389|567000553|FG000|Overall Study|Lost to Follow-up|1|||
157067062|NCT00233389|567000554|FG001|Overall Study|Lost to Follow-up|1|||
157067063|NCT00233389|567000553|FG000|Overall Study|Physician Decision|1|||
157067064|NCT00233389|567000554|FG001|Overall Study|Physician Decision|0|||
157067065|NCT00233389|567000553|FG000|Overall Study|Protocol Violation|0|||
157067066|NCT00233389|567000554|FG001|Overall Study|Protocol Violation|1|||
157067067|NCT00233389|567000553|FG000|Overall Study|Withdrawal by Subject|0|||
157067068|NCT00233389|567000554|FG001|Overall Study|Withdrawal by Subject|1|||
157067069|NCT01588366|567000562|FG000|Overall Study|Adverse Event|0|||
157067070|NCT01588366|567000563|FG001|Overall Study|Adverse Event|1|||
157067071|NCT01588366|567000564|FG002|Overall Study|Adverse Event|0|||
157067072|NCT01588366|567000565|FG003|Overall Study|Adverse Event|1|||
157067073|NCT01588366|567000566|FG004|Overall Study|Adverse Event|0|||
157067074|NCT01588366|567000567|FG005|Overall Study|Adverse Event|2|||
157067075|NCT00719043|567000568|FG000|Overall Study|Adverse Event|5|||
157067076|NCT00719043|567000569|FG001|Overall Study|Adverse Event|1|||
157067077|NCT00719043|567000570|FG002|Overall Study|Adverse Event|2|||
157067078|NCT00719043|567000571|FG003|Overall Study|Adverse Event|2|||
157067079|NCT00719043|567000572|FG004|Overall Study|Adverse Event|1|||
157067080|NCT00719043|567000573|FG005|Overall Study|Adverse Event|4|||
157067081|NCT00719043|567000574|FG006|Overall Study|Adverse Event|4|||
157067082|NCT00719043|567000568|FG000|Overall Study|Lost to Follow-up|14|||
157067083|NCT00719043|567000569|FG001|Overall Study|Lost to Follow-up|10|||
157067084|NCT00719043|567000570|FG002|Overall Study|Lost to Follow-up|8|||
157067085|NCT00719043|567000571|FG003|Overall Study|Lost to Follow-up|9|||
157067086|NCT00719043|567000572|FG004|Overall Study|Lost to Follow-up|10|||
157067087|NCT00719043|567000573|FG005|Overall Study|Lost to Follow-up|9|||
157067088|NCT00719043|567000574|FG006|Overall Study|Lost to Follow-up|9|||
157067089|NCT00719043|567000568|FG000|Overall Study|Protocol Violation|0|||
157067090|NCT00719043|567000569|FG001|Overall Study|Protocol Violation|0|||
157067091|NCT00719043|567000570|FG002|Overall Study|Protocol Violation|0|||
157067092|NCT00719043|567000571|FG003|Overall Study|Protocol Violation|0|||
157067093|NCT00719043|567000572|FG004|Overall Study|Protocol Violation|0|||
157067094|NCT00719043|567000573|FG005|Overall Study|Protocol Violation|1|||
157067095|NCT00719043|567000574|FG006|Overall Study|Protocol Violation|0|||
157067096|NCT00719043|567000568|FG000|Overall Study|Other|1|||
157067097|NCT00719043|567000569|FG001|Overall Study|Other|0|||
157067098|NCT00719043|567000570|FG002|Overall Study|Other|1|||
157067099|NCT00719043|567000571|FG003|Overall Study|Other|2|||
157067100|NCT00719043|567000572|FG004|Overall Study|Other|0|||
157186637|NCT01263470|567425057|FG003|Overall Study|Protocol Violation|0|||
157186638|NCT01263470|567425058|FG004|Overall Study|Protocol Violation|0|||
157186639|NCT01263470|567425059|FG005|Overall Study|Protocol Violation|1|||
157186640|NCT01263470|567425054|FG000|Overall Study|Withdrawal by Subject|0|||
157186641|NCT01263470|567425055|FG001|Overall Study|Withdrawal by Subject|1|||
157186642|NCT01263470|567425056|FG002|Overall Study|Withdrawal by Subject|1|||
157186643|NCT01263470|567425057|FG003|Overall Study|Withdrawal by Subject|2|||
157186644|NCT01263470|567425058|FG004|Overall Study|Withdrawal by Subject|0|||
157186645|NCT01263470|567425059|FG005|Overall Study|Withdrawal by Subject|2|||
157186646|NCT01263470|567425054|FG000|Overall Study|Lack of Efficacy|0|||
157186647|NCT01263470|567425055|FG001|Overall Study|Lack of Efficacy|0|||
157186648|NCT01263470|567425056|FG002|Overall Study|Lack of Efficacy|2|||
157186649|NCT01263470|567425057|FG003|Overall Study|Lack of Efficacy|0|||
157186650|NCT01263470|567425058|FG004|Overall Study|Lack of Efficacy|0|||
157186651|NCT01263470|567425059|FG005|Overall Study|Lack of Efficacy|0|||
157186652|NCT01263470|567425054|FG000|Overall Study|Participant Unavailability|0|||
157186653|NCT01263470|567425055|FG001|Overall Study|Participant Unavailability|1|||
157186654|NCT01263470|567425056|FG002|Overall Study|Participant Unavailability|0|||
157186655|NCT01263470|567425057|FG003|Overall Study|Participant Unavailability|0|||
157186656|NCT01263470|567425058|FG004|Overall Study|Participant Unavailability|0|||
157186657|NCT01263470|567425059|FG005|Overall Study|Participant Unavailability|0|||
157186658|NCT01263470|567425054|FG000|Overall Study|Study Drug Non-compliance|0|||
157186659|NCT01263470|567425055|FG001|Overall Study|Study Drug Non-compliance|0|||
157186660|NCT01263470|567425056|FG002|Overall Study|Study Drug Non-compliance|0|||
157186661|NCT01263470|567425057|FG003|Overall Study|Study Drug Non-compliance|0|||
157186662|NCT01263470|567425058|FG004|Overall Study|Study Drug Non-compliance|1|||
157186663|NCT01263470|567425059|FG005|Overall Study|Study Drug Non-compliance|0|||
157186664|NCT00610714|567425060|FG000|Overall Study|Adverse Event|3|||
157186665|NCT00610714|567425061|FG001|Overall Study|Adverse Event|1|||
157186666|NCT00610714|567425060|FG000|Overall Study|Death|12|||
157186667|NCT00610714|567425061|FG001|Overall Study|Death|18|||
157186668|NCT00610714|567425060|FG000|Overall Study|Withdrawal by Subject|9|||
157186669|NCT00610714|567425061|FG001|Overall Study|Withdrawal by Subject|3|||
157186670|NCT00610714|567425060|FG000|Overall Study|Study completion at 120 PFS events|2|||
157186671|NCT00610714|567425061|FG001|Overall Study|Study completion at 120 PFS events|2|||
157186672|NCT01327573|567425062|FG000|Overall Study|Physician Decision|3|||
157186673|NCT01327573|567425063|FG001|Overall Study|Physician Decision|1|||
157186674|NCT01108263|567425064|FG000|Overall Study|Adverse Event|0|||
157186675|NCT01108263|567425065|FG001|Overall Study|Adverse Event|1|||
157186676|NCT00638989|567425066|FG000|Overall Study|Lost to Follow-up|0|||
157186677|NCT00638989|567425067|FG001|Overall Study|Lost to Follow-up|0|||
157186678|NCT00638989|567425068|FG002|Overall Study|Lost to Follow-up|1|||
157186679|NCT05245071|567425069|FG000|Overall Study|Progressive disease|18|||
157186680|NCT05245071|567425069|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
157186681|NCT05245071|567425069|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
157186682|NCT01602822|567425070|FG000|Overall Study|Adverse Event|11|||
157186683|NCT00853112|567425074|FG000|Overall Study|Randomized but not treated|0|||
157186684|NCT00853112|567425075|FG001|Overall Study|Randomized but not treated|1|||
157186685|NCT00853112|567425076|FG002|Overall Study|Randomized but not treated|0|||
157186686|NCT00853112|567425077|FG003|Overall Study|Randomized but not treated|2|||
157186687|NCT00853112|567425078|FG004|Overall Study|Randomized but not treated|0|||
157186688|NCT00853112|567425079|FG005|Overall Study|Randomized but not treated|0|||
157186689|NCT00853112|567425080|FG006|Overall Study|Randomized but not treated|1|||
157186690|NCT01553591|567425081|FG000|Overall Study|Voluntarily withdrew|94|||
157186691|NCT01553591|567425082|FG001|Overall Study|Voluntarily withdrew|79|||
157186692|NCT01553591|567425083|FG002|Overall Study|Voluntarily withdrew|96|||
157186693|NCT01553591|567425081|FG000|Overall Study|Adverse Event|36|||
157186694|NCT01553591|567425082|FG001|Overall Study|Adverse Event|45|||
157186695|NCT01553591|567425083|FG002|Overall Study|Adverse Event|16|||
157186696|NCT01553591|567425081|FG000|Overall Study|Lost to Follow-up|25|||
157186697|NCT01553591|567425082|FG001|Overall Study|Lost to Follow-up|23|||
157186698|NCT01553591|567425083|FG002|Overall Study|Lost to Follow-up|16|||
157186699|NCT01553591|567425081|FG000|Overall Study|Physician decision: other|11|||
157186700|NCT01553591|567425082|FG001|Overall Study|Physician decision: other|14|||
157186701|NCT01553591|567425083|FG002|Overall Study|Physician decision: other|16|||
157186702|NCT01553591|567425081|FG000|Overall Study|Physician decision: lack of efficacy|2|||
157186703|NCT01553591|567425082|FG001|Overall Study|Physician decision: lack of efficacy|3|||
157186704|NCT01553591|567425083|FG002|Overall Study|Physician decision: lack of efficacy|7|||
157186705|NCT01553591|567425081|FG000|Overall Study|Protocol Violation|3|||
157186706|NCT01553591|567425082|FG001|Overall Study|Protocol Violation|4|||
157067101|NCT00719043|567000573|FG005|Overall Study|Other|2|||
157067102|NCT00719043|567000574|FG006|Overall Study|Other|1|||
157186707|NCT01553591|567425083|FG002|Overall Study|Protocol Violation|4|||
157186708|NCT01553591|567425081|FG000|Overall Study|Sponsor decision|1|||
157186709|NCT01553591|567425082|FG001|Overall Study|Sponsor decision|0|||
157067103|NCT00719043|567000568|FG000|Overall Study|Withdrawal by Subject|12|||
157186710|NCT01553591|567425083|FG002|Overall Study|Sponsor decision|3|||
157067104|NCT00719043|567000569|FG001|Overall Study|Withdrawal by Subject|14|||
157067105|NCT00719043|567000570|FG002|Overall Study|Withdrawal by Subject|9|||
157067106|NCT00719043|567000571|FG003|Overall Study|Withdrawal by Subject|10|||
157067107|NCT00719043|567000572|FG004|Overall Study|Withdrawal by Subject|16|||
157067108|NCT00719043|567000573|FG005|Overall Study|Withdrawal by Subject|18|||
157067109|NCT00719043|567000574|FG006|Overall Study|Withdrawal by Subject|14|||
157067110|NCT00302159|567000575|FG000|Overall Study|pt declined before treatment started|1|||
157067111|NCT00302159|567000575|FG000|Overall Study|pt started Avastin|1|||
157067112|NCT04962698|567000578|FG000|Motor Imagery|Technical difficulty|1|||
157067113|NCT04962698|567000579|FG001|Motor Imagery|Technical difficulty|0|||
157067114|NCT04962698|567000578|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
157067115|NCT04962698|567000579|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
157067116|NCT04962698|567000578|FG000|Kinesthetic MI|Technical difficulty|1|||
157067117|NCT04962698|567000579|FG001|Kinesthetic MI|Technical difficulty|0|||
157067118|NCT04962698|567000578|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
157067119|NCT04962698|567000579|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
157067120|NCT04962698|567000578|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
157067121|NCT04962698|567000579|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
157067122|NCT04962698|567000578|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
157067123|NCT04962698|567000579|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
157067124|NCT04962698|567000578|FG000|Virtual-hand Interaction|Technical difficulty|1|||
157067125|NCT04962698|567000579|FG001|Virtual-hand Interaction|Technical difficulty|0|||
157067126|NCT04962698|567000578|FG000|Robotic Action Observation|Technical difficulty|1|||
157067127|NCT04962698|567000579|FG001|Robotic Action Observation|Technical difficulty|0|||
157067128|NCT04962698|567000578|FG000|Rest|Technical difficulty|1|||
157067129|NCT04962698|567000579|FG001|Rest|Technical difficulty|0|||
157067130|NCT04962698|567000578|FG000|Rest|Exclusion criteria met after enrollment|0|||
157067131|NCT04962698|567000579|FG001|Rest|Exclusion criteria met after enrollment|2|||
157067132|NCT00853229|567000580|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
157067133|NCT00853229|567000581|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
157067134|NCT00585975|567000585|FG000|Overall Study|Withdrawal by Subject|3|||
157067135|NCT00585975|567000586|FG001|Overall Study|Withdrawal by Subject|3|||
157067136|NCT00585975|567000585|FG000|Overall Study|Lost to Follow-up|2|||
157067137|NCT00585975|567000586|FG001|Overall Study|Lost to Follow-up|1|||
157067138|NCT00585975|567000585|FG000|Overall Study|Enrollment met/over-enrolled|10|||
157067139|NCT00585975|567000586|FG001|Overall Study|Enrollment met/over-enrolled|9|||
157067140|NCT03082612|567000587|FG000|Overall Study|Lost to Follow-up|2|||
157067141|NCT03082612|567000588|FG001|Overall Study|Lost to Follow-up|0|||
157067142|NCT00952848|567000593|FG000|Overall Study|Withdrawal by Subject|4|||
157067143|NCT02725567|567000594|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
157067144|NCT02725567|567000595|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
157067145|NCT02725567|567000594|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
157067146|NCT02725567|567000595|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
157067147|NCT02725567|567000594|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
157067148|NCT02725567|567000595|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
157067149|NCT02413593|567000596|FG000|Overall Study|Lost to Follow-up|3|||
157067150|NCT02413593|567000596|FG000|Overall Study|Adverse Event|1|||
157067151|NCT03845075|567000597|FG000|Part 1 - DB|Withdrawal by Subject|1|||
157067152|NCT03845075|567000598|FG001|Part 1 - DB|Withdrawal by Subject|1|||
157067153|NCT03845075|567000599|FG002|Part 1 - DB|Withdrawal by Subject|0|||
157067154|NCT03845075|567000600|FG003|Part 1 - DB|Withdrawal by Subject|0|||
157067155|NCT03845075|567000597|FG000|Part 1 - DB|Adverse Event|0|||
157067156|NCT03845075|567000598|FG001|Part 1 - DB|Adverse Event|1|||
157067157|NCT03845075|567000599|FG002|Part 1 - DB|Adverse Event|0|||
157067158|NCT03845075|567000600|FG003|Part 1 - DB|Adverse Event|0|||
157067159|NCT03845075|567000597|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
157067160|NCT03845075|567000598|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
157067161|NCT03845075|567000599|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
157067162|NCT03845075|567000600|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
157067163|NCT02564718|567000601|FG000|Overall Study|Withdrew from treatment|0|||
157067164|NCT02564718|567000602|FG001|Overall Study|Withdrew from treatment|1|||
157067165|NCT00104637|567000603|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
157067166|NCT00104637|567000604|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
157067167|NCT00857233|567000605|FG000|Overall Study|Adverse Event|24|||
157067168|NCT00857233|567000605|FG000|Overall Study|Lack of Efficacy|1|||
157067169|NCT00857233|567000605|FG000|Overall Study|Non-compliance|1|||
157067170|NCT00857233|567000605|FG000|Overall Study|Withdrawal of Consent|9|||
157067171|NCT00857233|567000605|FG000|Overall Study|Lost to Follow-up|4|||
157067172|NCT00857233|567000605|FG000|Overall Study|Nursing Home Placement|14|||
157067173|NCT00857233|567000605|FG000|Overall Study|Other Reasons|2|||
157067174|NCT00905359|567000610|FG000|Overall Study|Lost to Follow-up|17|||
157067175|NCT00905359|567000611|FG001|Overall Study|Lost to Follow-up|10|||
157186711|NCT01553591|567425081|FG000|Overall Study|Randomized and never dispensed drug|0|||
157186712|NCT01553591|567425082|FG001|Overall Study|Randomized and never dispensed drug|1|||
157186713|NCT01553591|567425083|FG002|Overall Study|Randomized and never dispensed drug|0|||
157186714|NCT02477800|567425084|FG000|Placebo-Controlled Period|Adverse Event|16|||
157186715|NCT02477800|567425085|FG001|Placebo-Controlled Period|Adverse Event|25|||
157186716|NCT02477800|567425086|FG002|Placebo-Controlled Period|Adverse Event|28|||
157186717|NCT02477800|567425087|FG003|Placebo-Controlled Period|Adverse Event|0|||
157186718|NCT02477800|567425088|FG004|Placebo-Controlled Period|Adverse Event|0|||
157186719|NCT02477800|567425089|FG005|Placebo-Controlled Period|Adverse Event|0|||
157186720|NCT02477800|567425090|FG006|Placebo-Controlled Period|Adverse Event|0|||
157186721|NCT02477800|567425084|FG000|Placebo-Controlled Period|Change of Treatment|1|||
157186722|NCT02477800|567425085|FG001|Placebo-Controlled Period|Change of Treatment|2|||
157186723|NCT02477800|567425086|FG002|Placebo-Controlled Period|Change of Treatment|1|||
157186724|NCT02477800|567425087|FG003|Placebo-Controlled Period|Change of Treatment|0|||
157186725|NCT02477800|567425088|FG004|Placebo-Controlled Period|Change of Treatment|0|||
157186726|NCT02477800|567425089|FG005|Placebo-Controlled Period|Change of Treatment|0|||
157186727|NCT02477800|567425090|FG006|Placebo-Controlled Period|Change of Treatment|0|||
157186728|NCT02477800|567425084|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
157186729|NCT02477800|567425085|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
157186730|NCT02477800|567425086|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
157186731|NCT02477800|567425087|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
157186732|NCT02477800|567425088|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
157186733|NCT02477800|567425089|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
157186734|NCT02477800|567425090|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
157186735|NCT02477800|567425084|FG000|Placebo-Controlled Period|Death|0|||
157186736|NCT02477800|567425085|FG001|Placebo-Controlled Period|Death|3|||
157186737|NCT02477800|567425086|FG002|Placebo-Controlled Period|Death|2|||
157186738|NCT02477800|567425087|FG003|Placebo-Controlled Period|Death|0|||
157186739|NCT02477800|567425088|FG004|Placebo-Controlled Period|Death|0|||
157186740|NCT02477800|567425089|FG005|Placebo-Controlled Period|Death|0|||
157186741|NCT02477800|567425090|FG006|Placebo-Controlled Period|Death|0|||
157186742|NCT02477800|567425084|FG000|Placebo-Controlled Period|Disease Progression|1|||
157186743|NCT02477800|567425085|FG001|Placebo-Controlled Period|Disease Progression|0|||
157186744|NCT02477800|567425086|FG002|Placebo-Controlled Period|Disease Progression|1|||
157186745|NCT02477800|567425087|FG003|Placebo-Controlled Period|Disease Progression|0|||
157186746|NCT02477800|567425088|FG004|Placebo-Controlled Period|Disease Progression|0|||
157186747|NCT02477800|567425089|FG005|Placebo-Controlled Period|Disease Progression|0|||
157186748|NCT02477800|567425090|FG006|Placebo-Controlled Period|Disease Progression|0|||
157186749|NCT02477800|567425084|FG000|Placebo-Controlled Period|Investigator Decision|3|||
157186750|NCT02477800|567425085|FG001|Placebo-Controlled Period|Investigator Decision|2|||
157186751|NCT02477800|567425086|FG002|Placebo-Controlled Period|Investigator Decision|1|||
157186752|NCT02477800|567425087|FG003|Placebo-Controlled Period|Investigator Decision|0|||
157186753|NCT02477800|567425088|FG004|Placebo-Controlled Period|Investigator Decision|0|||
157186754|NCT02477800|567425089|FG005|Placebo-Controlled Period|Investigator Decision|0|||
157186755|NCT02477800|567425090|FG006|Placebo-Controlled Period|Investigator Decision|0|||
157186756|NCT02477800|567425084|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
157186757|NCT02477800|567425085|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
157186758|NCT02477800|567425086|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
157186759|NCT02477800|567425087|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
157186760|NCT02477800|567425088|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
157186761|NCT02477800|567425089|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
157186762|NCT02477800|567425090|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
157186763|NCT02477800|567425084|FG000|Placebo-Controlled Period|Relocation|2|||
157186764|NCT02477800|567425085|FG001|Placebo-Controlled Period|Relocation|0|||
157186765|NCT02477800|567425086|FG002|Placebo-Controlled Period|Relocation|0|||
157186766|NCT02477800|567425087|FG003|Placebo-Controlled Period|Relocation|0|||
157067176|NCT00905359|567000610|FG000|Overall Study|Death|2|||
157067177|NCT00905359|567000611|FG001|Overall Study|Death|0|||
157067178|NCT00905359|567000610|FG000|Overall Study|Withdrawal consent|5|||
157067179|NCT00905359|567000611|FG001|Overall Study|Withdrawal consent|6|||
157067180|NCT04354168|567000613|FG000|Overall Study|Lost to Follow-up|22|||
157067181|NCT02804399|567000616|FG000|Period 2|Adverse Event|0|||
157067182|NCT02804399|567000617|FG001|Period 2|Adverse Event|1|||
157067183|NCT01174264|567000618|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
157067184|NCT01174264|567000619|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
157067185|NCT01174264|567000620|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
157067186|NCT01174264|567000618|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
157186767|NCT02477800|567425088|FG004|Placebo-Controlled Period|Relocation|0|||
157186768|NCT02477800|567425089|FG005|Placebo-Controlled Period|Relocation|0|||
157186769|NCT02477800|567425090|FG006|Placebo-Controlled Period|Relocation|0|||
157230179|NCT03629249|567588266|FG002|Overall Study|Physician Decision|0|||
157067187|NCT01174264|567000619|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
157067188|NCT01174264|567000620|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
157186770|NCT02477800|567425084|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
157186771|NCT02477800|567425085|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
157186772|NCT02477800|567425086|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
157186773|NCT02477800|567425087|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
157186774|NCT02477800|567425088|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
157186775|NCT02477800|567425089|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
157186776|NCT02477800|567425090|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
157186777|NCT02477800|567425084|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
157186778|NCT02477800|567425085|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
157186779|NCT02477800|567425086|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
157186780|NCT02477800|567425087|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
157186781|NCT02477800|567425088|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
157186782|NCT02477800|567425089|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
157186783|NCT02477800|567425090|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
157186784|NCT02477800|567425084|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
157186785|NCT02477800|567425085|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
157186786|NCT02477800|567425086|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
157186787|NCT02477800|567425087|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
157186788|NCT02477800|567425088|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
157186789|NCT02477800|567425089|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
157186790|NCT02477800|567425090|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
157186791|NCT02477800|567425084|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
157186792|NCT02477800|567425085|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
157186793|NCT02477800|567425086|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
157186794|NCT02477800|567425087|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157186795|NCT02477800|567425088|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157186796|NCT02477800|567425089|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157186797|NCT02477800|567425090|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
157186798|NCT02477800|567425084|FG000|Placebo-Controlled Period|Reason not Specified|161|||
157186799|NCT02477800|567425085|FG001|Placebo-Controlled Period|Reason not Specified|161|||
157186800|NCT02477800|567425086|FG002|Placebo-Controlled Period|Reason not Specified|189|||
157186801|NCT02477800|567425087|FG003|Placebo-Controlled Period|Reason not Specified|0|||
157186802|NCT02477800|567425088|FG004|Placebo-Controlled Period|Reason not Specified|0|||
157186803|NCT02477800|567425089|FG005|Placebo-Controlled Period|Reason not Specified|0|||
157186804|NCT02477800|567425090|FG006|Placebo-Controlled Period|Reason not Specified|0|||
157186805|NCT02477800|567425084|FG000|Long Term Extension Period|Adverse Event|0|||
157186806|NCT02477800|567425085|FG001|Long Term Extension Period|Adverse Event|0|||
157186807|NCT02477800|567425086|FG002|Long Term Extension Period|Adverse Event|0|||
157186808|NCT02477800|567425087|FG003|Long Term Extension Period|Adverse Event|6|||
157186809|NCT02477800|567425088|FG004|Long Term Extension Period|Adverse Event|2|||
157186810|NCT02477800|567425089|FG005|Long Term Extension Period|Adverse Event|4|||
157186811|NCT02477800|567425090|FG006|Long Term Extension Period|Adverse Event|3|||
157186812|NCT02477800|567425084|FG000|Long Term Extension Period|Death|0|||
157186813|NCT02477800|567425085|FG001|Long Term Extension Period|Death|0|||
157186814|NCT02477800|567425086|FG002|Long Term Extension Period|Death|0|||
157186815|NCT02477800|567425087|FG003|Long Term Extension Period|Death|1|||
157186816|NCT02477800|567425088|FG004|Long Term Extension Period|Death|1|||
157186817|NCT02477800|567425089|FG005|Long Term Extension Period|Death|1|||
157186818|NCT02477800|567425090|FG006|Long Term Extension Period|Death|2|||
157186819|NCT02477800|567425084|FG000|Long Term Extension Period|Consent Withdrawn|0|||
157186820|NCT02477800|567425085|FG001|Long Term Extension Period|Consent Withdrawn|0|||
157186821|NCT02477800|567425086|FG002|Long Term Extension Period|Consent Withdrawn|0|||
157186822|NCT02477800|567425087|FG003|Long Term Extension Period|Consent Withdrawn|10|||
157186823|NCT02477800|567425088|FG004|Long Term Extension Period|Consent Withdrawn|4|||
157186824|NCT02477800|567425089|FG005|Long Term Extension Period|Consent Withdrawn|13|||
157186825|NCT02477800|567425090|FG006|Long Term Extension Period|Consent Withdrawn|16|||
157186826|NCT02477800|567425084|FG000|Long Term Extension Period|Disease Progression|0|||
157186827|NCT02477800|567425085|FG001|Long Term Extension Period|Disease Progression|0|||
157186828|NCT02477800|567425086|FG002|Long Term Extension Period|Disease Progression|0|||
157186829|NCT02477800|567425087|FG003|Long Term Extension Period|Disease Progression|3|||
157186830|NCT02477800|567425088|FG004|Long Term Extension Period|Disease Progression|1|||
157186831|NCT02477800|567425089|FG005|Long Term Extension Period|Disease Progression|1|||
157186832|NCT02477800|567425090|FG006|Long Term Extension Period|Disease Progression|0|||
157186833|NCT02477800|567425084|FG000|Long Term Extension Period|Investigator Decision|0|||
157067189|NCT01174264|567000618|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
157067190|NCT01174264|567000619|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
157186834|NCT02477800|567425085|FG001|Long Term Extension Period|Investigator Decision|0|||
157186835|NCT02477800|567425086|FG002|Long Term Extension Period|Investigator Decision|0|||
157186836|NCT02477800|567425087|FG003|Long Term Extension Period|Investigator Decision|0|||
157186837|NCT02477800|567425088|FG004|Long Term Extension Period|Investigator Decision|0|||
157186838|NCT02477800|567425089|FG005|Long Term Extension Period|Investigator Decision|0|||
157186839|NCT02477800|567425090|FG006|Long Term Extension Period|Investigator Decision|2|||
157186840|NCT02477800|567425084|FG000|Long Term Extension Period|Lost to Follow-up|0|||
157186841|NCT02477800|567425085|FG001|Long Term Extension Period|Lost to Follow-up|0|||
157186842|NCT02477800|567425086|FG002|Long Term Extension Period|Lost to Follow-up|0|||
157186843|NCT02477800|567425087|FG003|Long Term Extension Period|Lost to Follow-up|0|||
157186844|NCT02477800|567425088|FG004|Long Term Extension Period|Lost to Follow-up|1|||
157186845|NCT02477800|567425089|FG005|Long Term Extension Period|Lost to Follow-up|3|||
157186846|NCT02477800|567425090|FG006|Long Term Extension Period|Lost to Follow-up|0|||
157186847|NCT02477800|567425084|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
157186848|NCT02477800|567425085|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
157186849|NCT02477800|567425086|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
157186850|NCT02477800|567425087|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
157186851|NCT02477800|567425088|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
157186852|NCT02477800|567425089|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
157186853|NCT02477800|567425090|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
157186854|NCT02477800|567425084|FG000|Long Term Extension Period|Study Visit Burden|0|||
157186855|NCT02477800|567425085|FG001|Long Term Extension Period|Study Visit Burden|0|||
157186856|NCT02477800|567425086|FG002|Long Term Extension Period|Study Visit Burden|0|||
157186857|NCT02477800|567425087|FG003|Long Term Extension Period|Study Visit Burden|3|||
157186858|NCT02477800|567425088|FG004|Long Term Extension Period|Study Visit Burden|0|||
157186859|NCT02477800|567425089|FG005|Long Term Extension Period|Study Visit Burden|2|||
157186860|NCT02477800|567425090|FG006|Long Term Extension Period|Study Visit Burden|2|||
157186861|NCT02477800|567425084|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
157186862|NCT02477800|567425085|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
157186863|NCT02477800|567425086|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
157186864|NCT02477800|567425087|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
157186865|NCT02477800|567425088|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
157186866|NCT02477800|567425089|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
157186867|NCT02477800|567425090|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
157186868|NCT02477800|567425084|FG000|Long Term Extension Period|Reason not Specified|0|||
157186869|NCT02477800|567425085|FG001|Long Term Extension Period|Reason not Specified|0|||
157186870|NCT02477800|567425086|FG002|Long Term Extension Period|Reason not Specified|0|||
157186871|NCT02477800|567425087|FG003|Long Term Extension Period|Reason not Specified|126|||
157186872|NCT02477800|567425088|FG004|Long Term Extension Period|Reason not Specified|140|||
157186873|NCT02477800|567425089|FG005|Long Term Extension Period|Reason not Specified|270|||
157186874|NCT02477800|567425090|FG006|Long Term Extension Period|Reason not Specified|224|||
157186875|NCT02871791|567425091|FG000|Phase 1b|Death|0|||
157186876|NCT02871791|567425092|FG001|Phase 1b|Death|1|||
157186877|NCT02871791|567425091|FG000|Phase 1b|progressive disease|6|||
157186878|NCT02871791|567425092|FG001|Phase 1b|progressive disease|2|||
157186879|NCT02871791|567425091|FG000|Phase 2|Death|1|||
157186880|NCT02871791|567425092|FG001|Phase 2|Death|0|||
157186881|NCT02871791|567425091|FG000|Phase 2|Lost to Follow-up|2|||
157186882|NCT02871791|567425092|FG001|Phase 2|Lost to Follow-up|0|||
157186883|NCT03685643|567425097|FG000|Overall Study|Lost to Follow-up|14|||
157186884|NCT03685643|567425098|FG001|Overall Study|Lost to Follow-up|22|||
157186885|NCT01833806|567425099|FG000|Overall Study|Alternative treatment|2|||
157186886|NCT01833806|567425099|FG000|Overall Study|Death|5|||
157186887|NCT01833806|567425099|FG000|Overall Study|Physician Decision|1|||
157186888|NCT01833806|567425099|FG000|Overall Study|Lost to Follow-up|1|||
157186889|NCT01885104|567425110|FG000|Overall Study|Withdrawal of Consent|1|||
157186890|NCT01885104|567425111|FG001|Overall Study|Withdrawal of Consent|0|||
157186891|NCT01885104|567425110|FG000|Overall Study|Lost to Follow-up|0|||
157186892|NCT01885104|567425111|FG001|Overall Study|Lost to Follow-up|1|||
157186893|NCT01885104|567425110|FG000|Overall Study|Physician Decision|1|||
157186894|NCT01885104|567425111|FG001|Overall Study|Physician Decision|0|||
157186895|NCT00126425|567425112|FG000|Overall Study|Withdrawal by Subject|17|||
157186896|NCT00126425|567425113|FG001|Overall Study|Withdrawal by Subject|1|||
157186897|NCT00126425|567425112|FG000|Overall Study|Lost to Follow-up|8|||
157186898|NCT00126425|567425113|FG001|Overall Study|Lost to Follow-up|4|||
157186899|NCT00126425|567425112|FG000|Overall Study|Protocol Violation|9|||
157186900|NCT00126425|567425113|FG001|Overall Study|Protocol Violation|6|||
157186901|NCT00126425|567425112|FG000|Overall Study|Adverse Event|1|||
157186902|NCT00126425|567425113|FG001|Overall Study|Adverse Event|0|||
157186903|NCT00126425|567425112|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
157186904|NCT00126425|567425113|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
157186905|NCT00126425|567425112|FG000|Overall Study|Other|5|||
157186906|NCT00126425|567425113|FG001|Overall Study|Other|0|||
157186907|NCT01894776|567425114|FG000|Overall Study|Withdrawal by Subject|1|||
157186908|NCT02415595|567425115|FG000|Overall Study|Administrative reason by sponsor|39|||
157186909|NCT02415595|567425116|FG001|Overall Study|Administrative reason by sponsor|40|||
157186910|NCT02415595|567425117|FG002|Overall Study|Administrative reason by sponsor|41|||
157186911|NCT02415595|567425118|FG003|Overall Study|Administrative reason by sponsor|39|||
157186912|NCT02415595|567425115|FG000|Overall Study|Adverse Event|1|||
157186913|NCT02415595|567425116|FG001|Overall Study|Adverse Event|3|||
157186914|NCT02415595|567425117|FG002|Overall Study|Adverse Event|5|||
157186915|NCT02415595|567425118|FG003|Overall Study|Adverse Event|10|||
157186916|NCT02415595|567425115|FG000|Overall Study|Lack of Efficacy|4|||
157186917|NCT02415595|567425116|FG001|Overall Study|Lack of Efficacy|4|||
157186918|NCT02415595|567425117|FG002|Overall Study|Lack of Efficacy|0|||
157186919|NCT02415595|567425118|FG003|Overall Study|Lack of Efficacy|0|||
157186920|NCT02415595|567425115|FG000|Overall Study|Lost to Follow-up|1|||
157186921|NCT02415595|567425116|FG001|Overall Study|Lost to Follow-up|3|||
157186922|NCT02415595|567425117|FG002|Overall Study|Lost to Follow-up|1|||
157186923|NCT02415595|567425118|FG003|Overall Study|Lost to Follow-up|1|||
157186924|NCT02415595|567425115|FG000|Overall Study|Poor/Non-compliance|1|||
157186925|NCT02415595|567425116|FG001|Overall Study|Poor/Non-compliance|0|||
157186926|NCT02415595|567425117|FG002|Overall Study|Poor/Non-compliance|1|||
157186927|NCT02415595|567425118|FG003|Overall Study|Poor/Non-compliance|0|||
157186928|NCT02415595|567425115|FG000|Overall Study|Reached stopping criteria|0|||
157186929|NCT02415595|567425116|FG001|Overall Study|Reached stopping criteria|1|||
157186930|NCT02415595|567425117|FG002|Overall Study|Reached stopping criteria|1|||
157186931|NCT02415595|567425118|FG003|Overall Study|Reached stopping criteria|0|||
157186932|NCT02415595|567425115|FG000|Overall Study|Withdrawal by Subject|4|||
157186933|NCT02415595|567425116|FG001|Overall Study|Withdrawal by Subject|0|||
157186934|NCT02415595|567425117|FG002|Overall Study|Withdrawal by Subject|1|||
157186935|NCT02415595|567425118|FG003|Overall Study|Withdrawal by Subject|3|||
157186936|NCT02415595|567425115|FG000|Overall Study|Other|0|||
157186937|NCT02415595|567425116|FG001|Overall Study|Other|1|||
157186938|NCT02415595|567425117|FG002|Overall Study|Other|1|||
157186939|NCT02415595|567425118|FG003|Overall Study|Other|0|||
157186940|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
157186941|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
157186942|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
157186943|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
157186944|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
157186945|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
157186946|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
157186947|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
157186948|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
157186949|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
157186950|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
157186951|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
157186952|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
157186953|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
157186954|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
157186955|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
157186956|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
157186957|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
157186958|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
157186959|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
157186960|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
157186961|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
157186962|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
157186963|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
157186964|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Screen failure|0|||
157186965|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Screen failure|1|||
157186966|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Screen failure|2|||
157186967|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Screen failure|0|||
157186968|NCT02614261|567425119|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
157186969|NCT02614261|567425120|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
157186970|NCT02614261|567425121|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
157186971|NCT02614261|567425122|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
157186972|NCT02614261|567425119|FG000|Open-Label Extension Phase|Adverse Event|23|||
157186973|NCT02614261|567425120|FG001|Open-Label Extension Phase|Adverse Event|12|||
157186974|NCT02614261|567425121|FG002|Open-Label Extension Phase|Adverse Event|11|||
157186975|NCT02614261|567425122|FG003|Open-Label Extension Phase|Adverse Event|0|||
157186976|NCT02614261|567425119|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
157186977|NCT02614261|567425120|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
157186978|NCT02614261|567425121|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
157186979|NCT02614261|567425122|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
157186980|NCT02614261|567425119|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
157186981|NCT02614261|567425120|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
157186982|NCT02614261|567425121|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
157186983|NCT02614261|567425122|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
157186984|NCT02614261|567425119|FG000|Open-Label Extension Phase|Physician Decision|2|||
157186985|NCT02614261|567425120|FG001|Open-Label Extension Phase|Physician Decision|0|||
157186986|NCT02614261|567425121|FG002|Open-Label Extension Phase|Physician Decision|0|||
157186987|NCT02614261|567425122|FG003|Open-Label Extension Phase|Physician Decision|0|||
157186988|NCT02614261|567425119|FG000|Open-Label Extension Phase|Pregnancy|1|||
157186989|NCT02614261|567425120|FG001|Open-Label Extension Phase|Pregnancy|2|||
157186990|NCT02614261|567425121|FG002|Open-Label Extension Phase|Pregnancy|1|||
157186991|NCT02614261|567425122|FG003|Open-Label Extension Phase|Pregnancy|0|||
157186992|NCT02614261|567425119|FG000|Open-Label Extension Phase|Protocol Violation|3|||
157186993|NCT02614261|567425120|FG001|Open-Label Extension Phase|Protocol Violation|4|||
157186994|NCT02614261|567425121|FG002|Open-Label Extension Phase|Protocol Violation|1|||
157186995|NCT02614261|567425122|FG003|Open-Label Extension Phase|Protocol Violation|0|||
157186996|NCT02614261|567425119|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
157186997|NCT02614261|567425120|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
157186998|NCT02614261|567425121|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
157186999|NCT02614261|567425122|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
157187000|NCT02614261|567425119|FG000|Follow-up Phase|Adverse Event|2|||
157187001|NCT02614261|567425120|FG001|Follow-up Phase|Adverse Event|0|||
157187002|NCT02614261|567425121|FG002|Follow-up Phase|Adverse Event|1|||
157187003|NCT02614261|567425122|FG003|Follow-up Phase|Adverse Event|0|||
157187004|NCT02614261|567425119|FG000|Follow-up Phase|Lost to Follow-up|12|||
157187005|NCT02614261|567425120|FG001|Follow-up Phase|Lost to Follow-up|5|||
157187006|NCT02614261|567425121|FG002|Follow-up Phase|Lost to Follow-up|2|||
157187007|NCT02614261|567425122|FG003|Follow-up Phase|Lost to Follow-up|0|||
157187008|NCT02614261|567425119|FG000|Follow-up Phase|Physician Decision|5|||
157187009|NCT02614261|567425120|FG001|Follow-up Phase|Physician Decision|1|||
157187010|NCT02614261|567425121|FG002|Follow-up Phase|Physician Decision|0|||
157187011|NCT02614261|567425122|FG003|Follow-up Phase|Physician Decision|0|||
157187012|NCT02614261|567425119|FG000|Follow-up Phase|Pregnancy|0|||
157187013|NCT02614261|567425120|FG001|Follow-up Phase|Pregnancy|1|||
157187014|NCT02614261|567425121|FG002|Follow-up Phase|Pregnancy|0|||
157187015|NCT02614261|567425122|FG003|Follow-up Phase|Pregnancy|0|||
157187016|NCT02614261|567425119|FG000|Follow-up Phase|Protocol Violation|1|||
157187017|NCT02614261|567425120|FG001|Follow-up Phase|Protocol Violation|0|||
157187018|NCT02614261|567425121|FG002|Follow-up Phase|Protocol Violation|0|||
157187019|NCT02614261|567425122|FG003|Follow-up Phase|Protocol Violation|0|||
157187020|NCT02614261|567425119|FG000|Follow-up Phase|Withdrawal by Subject|12|||
157067191|NCT01174264|567000620|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
157067192|NCT03432390|567000621|FG000|Apnea Period|Protocol Violation|2|||
157067193|NCT03432390|567000622|FG001|Apnea Period|Protocol Violation|2|||
157067194|NCT01774305|567000625|FG000|Overall Study|Physician Decision|1|||
157067195|NCT01774305|567000626|FG001|Overall Study|Physician Decision|0|||
157067196|NCT03738397|567000627|FG000|Overall Study|Adverse Event|3|||
157067197|NCT03738397|567000628|FG001|Overall Study|Adverse Event|7|||
157067198|NCT03738397|567000627|FG000|Overall Study|Withdrawal by Subject|8|||
157067199|NCT03738397|567000628|FG001|Overall Study|Withdrawal by Subject|11|||
157067200|NCT03738397|567000627|FG000|Overall Study|Lost to Follow-up|7|||
157067201|NCT03738397|567000628|FG001|Overall Study|Lost to Follow-up|5|||
157067202|NCT03738397|567000627|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
157067203|NCT03738397|567000628|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
157067204|NCT03738397|567000627|FG000|Overall Study|Other|4|||
157067205|NCT03738397|567000628|FG001|Overall Study|Other|6|||
157067206|NCT00691678|567000629|FG000|Overall Study|Adverse Event|5|||
157067207|NCT00691678|567000629|FG000|Overall Study|life events, pain|11|||
157067208|NCT03049306|567000630|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
157067209|NCT03049306|567000631|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
157067210|NCT00487825|567002509|FG000|Overall Study|Adverse Event|2|||
157067211|NCT00487825|567002510|FG001|Overall Study|Adverse Event|2|||
157067212|NCT00487825|567002509|FG000|Overall Study|Lack of Efficacy|1|||
157067213|NCT00487825|567002510|FG001|Overall Study|Lack of Efficacy|1|||
157067214|NCT00487825|567002509|FG000|Overall Study|Other|3|||
157067215|NCT00487825|567002510|FG001|Overall Study|Other|2|||
157067216|NCT01986114|567002511|FG000|Overall Study|Adverse Event|59|||
157067217|NCT01986114|567002511|FG000|Overall Study|Lack of Efficacy|23|||
157067218|NCT01986114|567002511|FG000|Overall Study|Withdrawal by Subject|58|||
157067219|NCT01986114|567002511|FG000|Overall Study|Noncompliance|3|||
157187021|NCT02614261|567425120|FG001|Follow-up Phase|Withdrawal by Subject|4|||
157187022|NCT02614261|567425121|FG002|Follow-up Phase|Withdrawal by Subject|11|||
157067220|NCT01986114|567002511|FG000|Overall Study|Protocol Violation|1|||
157067221|NCT01986114|567002511|FG000|Overall Study|Lost to Follow-up|5|||
157067222|NCT01986114|567002511|FG000|Overall Study|Other reason|7|||
157067223|NCT04411186|567002512|FG000|Overall Study|Withdrawn due to protocol violation|0|||
157187023|NCT02614261|567425122|FG003|Follow-up Phase|Withdrawal by Subject|0|||
157187024|NCT02614261|567425119|FG000|Israel Addendum|Withdrawal by Subject|0|||
157187025|NCT02614261|567425120|FG001|Israel Addendum|Withdrawal by Subject|0|||
157187026|NCT02614261|567425121|FG002|Israel Addendum|Withdrawal by Subject|0|||
157067224|NCT04411186|567002513|FG001|Overall Study|Withdrawn due to protocol violation|1|||
157187027|NCT02614261|567425122|FG003|Israel Addendum|Withdrawal by Subject|4|||
157187028|NCT04350372|567425126|FG000|Overall Study|Death|1|||
157187029|NCT03512275|567425127|FG000|Overall Study|Withdrawal by Subject|1|||
157187030|NCT03512275|567425128|FG001|Overall Study|Withdrawal by Subject|3|||
157187031|NCT03512275|567425127|FG000|Overall Study|Physician Decision|0|||
157187032|NCT03512275|567425128|FG001|Overall Study|Physician Decision|1|||
157187033|NCT03512275|567425127|FG000|Overall Study|Lost to Follow-up|0|||
157187034|NCT03512275|567425128|FG001|Overall Study|Lost to Follow-up|3|||
157187035|NCT03512275|567425127|FG000|Overall Study|Other|1|||
157187036|NCT03512275|567425128|FG001|Overall Study|Other|0|||
157187037|NCT00113555|567425129|FG000|Overall Study|Baseline Failure|59|||
157187038|NCT00113555|567425129|FG000|Overall Study|Permanently Explanted|7|||
157187039|NCT00113555|567425129|FG000|Overall Study|Death|1|||
157187040|NCT00113555|567425129|FG000|Overall Study|Missed Followup|4|||
157187041|NCT00113555|567425129|FG000|Overall Study|Lost to Follow-up|8|||
157187042|NCT04474366|567425130|FG000|Overall Study|Lost to Follow-up|2|||
157187043|NCT04474366|567425131|FG001|Overall Study|Lost to Follow-up|5|||
157187044|NCT01700140|567425132|FG000|Overall Study|Use of rescue drugs|3|||
157187045|NCT01700140|567425133|FG001|Overall Study|Use of rescue drugs|3|||
157187046|NCT01700140|567425134|FG002|Overall Study|Use of rescue drugs|1|||
157187047|NCT01700140|567425132|FG000|Overall Study|Discontinuation of radiotherapy|1|||
157187048|NCT01700140|567425133|FG001|Overall Study|Discontinuation of radiotherapy|0|||
157187049|NCT01700140|567425134|FG002|Overall Study|Discontinuation of radiotherapy|0|||
157187050|NCT01700140|567425132|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
157187051|NCT01700140|567425133|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
157187052|NCT01700140|567425134|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
157187053|NCT01700140|567425132|FG000|Overall Study|Aggravation of symptoms|1|||
157187054|NCT01700140|567425133|FG001|Overall Study|Aggravation of symptoms|0|||
157067225|NCT02172911|567002514|FG000|Overall Study|Serious Adverse Event|0|||
157067226|NCT02172911|567002515|FG001|Overall Study|Serious Adverse Event|1|||
157067227|NCT02172911|567002514|FG000|Overall Study|Progression of Disease|0|||
157067228|NCT02172911|567002515|FG001|Overall Study|Progression of Disease|1|||
157067229|NCT02172911|567002514|FG000|Overall Study|Loss of insurance coverage|1|||
157187055|NCT01700140|567425134|FG002|Overall Study|Aggravation of symptoms|0|||
157187056|NCT01700140|567425132|FG000|Overall Study|Adverse Event|0|||
157187057|NCT01700140|567425133|FG001|Overall Study|Adverse Event|1|||
157187058|NCT01700140|567425134|FG002|Overall Study|Adverse Event|0|||
157187059|NCT01700140|567425132|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
157187060|NCT01700140|567425133|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
157187061|NCT01700140|567425134|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
157187062|NCT03858686|567425137|FG000|Period 1|Adverse Event|1|||
157187063|NCT03858686|567425138|FG001|Period 1|Adverse Event|1|||
157187064|NCT03858686|567425137|FG000|Period 1|Lack of compliance|0|||
157187065|NCT03858686|567425138|FG001|Period 1|Lack of compliance|1|||
157187066|NCT03858686|567425137|FG000|Period 1|Adverse Event|0|||
157067230|NCT02172911|567002515|FG001|Overall Study|Loss of insurance coverage|0|||
157067231|NCT00589303|567002518|FG000|Overall Study|Withdrawal by Subject|2|||
157067232|NCT00589303|567002519|FG001|Overall Study|Withdrawal by Subject|1|||
157067233|NCT04836559|567002520|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
157067234|NCT04836559|567002521|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
157067235|NCT04836559|567002522|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
157187067|NCT03858686|567425138|FG001|Period 1|Adverse Event|1|||
157187068|NCT03858686|567425137|FG000|Period 2|Adverse Event|0|||
157187069|NCT03858686|567425138|FG001|Period 2|Adverse Event|1|||
157187070|NCT03455530|567426834|FG000|Overall Study|Withdrawal by Subject|9|||
157187071|NCT03455530|567426835|FG001|Overall Study|Withdrawal by Subject|1|||
157187072|NCT03455530|567426836|FG002|Overall Study|Withdrawal by Subject|3|||
157187073|NCT03455530|567426837|FG003|Overall Study|Withdrawal by Subject|3|||
157187074|NCT00669240|567426842|FG000|Overall Study|Lack of Efficacy|33|||
157187075|NCT00669240|567426842|FG000|Overall Study|Withdrawal by Subject|42|||
157230180|NCT00352690|567588267|FG000|Overall Study|Determined to be ineligible|2|||
157230181|NCT00352690|567588268|FG001|Overall Study|Determined to be ineligible|0|||
157230182|NCT03633721|567588271|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
157230183|NCT03633721|567588272|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
157067236|NCT04836559|567002523|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
157067237|NCT04836559|567002524|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
157067238|NCT04836559|567002525|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
157187076|NCT00669240|567426842|FG000|Overall Study|Lost to Follow-up|34|||
157187077|NCT00669240|567426842|FG000|Overall Study|Adverse Event|21|||
157187078|NCT00669240|567426842|FG000|Overall Study|Other|19|||
157187079|NCT00669240|567426842|FG000|Overall Study|Enrolled but not treated|15|||
157187080|NCT00669240|567426842|FG000|Overall Study|Enrolled but no dosing record|1|||
157187081|NCT02094612|567426843|FG000|Overall Study|Lost to Follow-up|47|||
157187082|NCT02094612|567426844|FG001|Overall Study|Lost to Follow-up|47|||
157187083|NCT02094612|567426843|FG000|Overall Study|Never started ADHD medication|32|||
157187084|NCT02094612|567426844|FG001|Overall Study|Never started ADHD medication|23|||
157187085|NCT04167514|567426845|FG000|Overall Study|Adverse event, not serious|0|||
157230184|NCT03633721|567588273|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
157067239|NCT04836559|567002526|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
157067240|NCT04836559|567002527|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
157067241|NCT04836559|567002520|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
157067242|NCT04836559|567002521|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
157067243|NCT04836559|567002522|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
157067244|NCT04836559|567002523|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
157067245|NCT04836559|567002524|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
157067246|NCT04836559|567002525|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
157067247|NCT04836559|567002526|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
157067248|NCT04836559|567002527|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
157067249|NCT04836559|567002520|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
157067250|NCT04836559|567002521|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067251|NCT04836559|567002522|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067252|NCT04836559|567002523|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067253|NCT04836559|567002524|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067254|NCT04836559|567002525|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067255|NCT04836559|567002526|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067256|NCT04836559|567002527|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
157067257|NCT04836559|567002520|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
157067258|NCT04836559|567002521|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067259|NCT04836559|567002522|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067260|NCT04836559|567002523|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067261|NCT04836559|567002524|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067262|NCT04836559|567002525|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067263|NCT04836559|567002526|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067264|NCT04836559|567002527|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
157067265|NCT04836559|567002520|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067266|NCT04836559|567002521|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067267|NCT04836559|567002522|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067268|NCT04836559|567002523|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
157067269|NCT04836559|567002524|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067270|NCT04836559|567002525|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067271|NCT04836559|567002526|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067272|NCT04836559|567002527|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
157067273|NCT04836559|567002520|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
157067274|NCT04836559|567002521|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
157067275|NCT04836559|567002522|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
157067276|NCT04836559|567002523|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
157067277|NCT04836559|567002524|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
157067278|NCT04836559|567002525|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
157067279|NCT04836559|567002526|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
157067280|NCT04836559|567002527|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
157067281|NCT04836559|567002520|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
157067282|NCT04836559|567002521|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
157067283|NCT04836559|567002522|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
157067284|NCT04836559|567002523|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
157067285|NCT04836559|567002524|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
157067286|NCT04836559|567002525|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
157067287|NCT04836559|567002526|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
157067288|NCT04836559|567002527|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
157067289|NCT04836559|567002520|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
157067290|NCT04836559|567002521|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
157067291|NCT04836559|567002522|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
157067292|NCT04836559|567002523|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
157067293|NCT04836559|567002524|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
157067294|NCT04836559|567002525|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
157067295|NCT04836559|567002526|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
157067296|NCT04836559|567002527|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
157067297|NCT04836559|567002520|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157067298|NCT04836559|567002521|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157067299|NCT04836559|567002522|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157067300|NCT04836559|567002523|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157187086|NCT04167514|567426846|FG001|Overall Study|Adverse event, not serious|1|||
157187087|NCT04167514|567426845|FG000|Overall Study|Lost to Follow-up|1|||
157187088|NCT04167514|567426846|FG001|Overall Study|Lost to Follow-up|0|||
157187089|NCT04167514|567426845|FG000|Overall Study|Participant Decision|2|||
157187090|NCT04167514|567426846|FG001|Overall Study|Participant Decision|4|||
157187091|NCT04167514|567426845|FG000|Overall Study|Physician Decision|3|||
157187092|NCT04167514|567426846|FG001|Overall Study|Physician Decision|2|||
157187093|NCT04167514|567426845|FG000|Overall Study|Death|14|||
157067301|NCT04836559|567002524|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157187094|NCT04167514|567426846|FG001|Overall Study|Death|18|||
157187095|NCT04167514|567426845|FG000|Overall Study|Enrolled but treatment not administered|2|||
157187096|NCT04167514|567426846|FG001|Overall Study|Enrolled but treatment not administered|0|||
157187097|NCT04167514|567426845|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
157187098|NCT04167514|567426846|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
157187099|NCT04167514|567426845|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
157187100|NCT04167514|567426846|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
157187101|NCT00290355|567426847|FG000|Overall Study|Serious adverse event|7|||
157187102|NCT00290355|567426848|FG001|Overall Study|Serious adverse event|4|||
157187103|NCT00290355|567426847|FG000|Overall Study|Study product reactogenicity|1|||
157187104|NCT00290355|567426848|FG001|Overall Study|Study product reactogenicity|0|||
157187105|NCT00290355|567426847|FG000|Overall Study|Protocol Violation|1|||
157187106|NCT00290355|567426848|FG001|Overall Study|Protocol Violation|0|||
157187107|NCT00290355|567426847|FG000|Overall Study|Withdrawal by Subject|2|||
157187108|NCT00290355|567426848|FG001|Overall Study|Withdrawal by Subject|0|||
157187109|NCT00290355|567426847|FG000|Overall Study|Migrated / moved from the study area|1|||
157187110|NCT00290355|567426848|FG001|Overall Study|Migrated / moved from the study area|0|||
157187111|NCT00290355|567426847|FG000|Overall Study|Lost to Follow-up|3|||
157187112|NCT00290355|567426848|FG001|Overall Study|Lost to Follow-up|1|||
157187113|NCT00290355|567426847|FG000|Overall Study|Other|2|||
157187114|NCT00290355|567426848|FG001|Overall Study|Other|0|||
157187115|NCT03345849|567426849|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
157187116|NCT03345849|567426850|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
157187117|NCT03345849|567426851|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
157187118|NCT03345849|567426852|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
157187119|NCT03345849|567426849|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
157187120|NCT03345849|567426850|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
157187121|NCT03345849|567426851|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
157187122|NCT03345849|567426852|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
157187123|NCT03345849|567426849|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
157187124|NCT03345849|567426850|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
157187125|NCT03345849|567426851|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
157187126|NCT03345849|567426852|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
157187127|NCT03345849|567426849|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
157187128|NCT03345849|567426850|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
157187129|NCT03345849|567426851|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
157187130|NCT03345849|567426852|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
157187131|NCT03345849|567426849|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
157187132|NCT03345849|567426850|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
157187133|NCT03345849|567426851|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
157187134|NCT03345849|567426852|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
157187135|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
157187136|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
157187137|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
157067302|NCT04836559|567002525|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157187138|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
157187139|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
157187140|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
157187141|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
157187142|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
157187143|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
157187144|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
157187145|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
157187146|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
157230185|NCT03633721|567588274|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
157187147|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
157187148|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
157067303|NCT04836559|567002526|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
157067304|NCT04836559|567002527|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
157067305|NCT00730015|567002528|FG000|Overall Study|Adverse Event|11|||
157067306|NCT00730015|567002529|FG001|Overall Study|Adverse Event|10|||
157067307|NCT00730015|567002530|FG002|Overall Study|Adverse Event|8|||
157067308|NCT00730015|567002528|FG000|Overall Study|Protocol Violation|2|||
157067309|NCT00730015|567002529|FG001|Overall Study|Protocol Violation|6|||
157067310|NCT00730015|567002530|FG002|Overall Study|Protocol Violation|4|||
157067311|NCT00730015|567002528|FG000|Overall Study|Withdrawal by Subject|12|||
157067312|NCT00730015|567002529|FG001|Overall Study|Withdrawal by Subject|12|||
157067313|NCT00730015|567002530|FG002|Overall Study|Withdrawal by Subject|8|||
157067314|NCT00730015|567002528|FG000|Overall Study|Lost to Follow-up|4|||
157067315|NCT00730015|567002529|FG001|Overall Study|Lost to Follow-up|10|||
157067316|NCT00730015|567002530|FG002|Overall Study|Lost to Follow-up|3|||
157067317|NCT00730015|567002528|FG000|Overall Study|Lack of Efficacy|1|||
157067318|NCT00730015|567002529|FG001|Overall Study|Lack of Efficacy|2|||
157067319|NCT00730015|567002530|FG002|Overall Study|Lack of Efficacy|8|||
157067320|NCT00730015|567002528|FG000|Overall Study|Other Reason|1|||
157067321|NCT00730015|567002529|FG001|Overall Study|Other Reason|0|||
157067322|NCT00730015|567002530|FG002|Overall Study|Other Reason|1|||
157067323|NCT04978350|567002531|FG000|Overall Study|Lost to Follow-up|6|||
157067324|NCT04120376|567002532|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
157067325|NCT04120376|567002533|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
157067326|NCT02053610|567002534|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
157067327|NCT02053610|567002535|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
157067328|NCT02053610|567002534|FG000|Overall Study|Withdrew Consent|2|||
157067329|NCT02053610|567002535|FG001|Overall Study|Withdrew Consent|9|||
157067330|NCT02053610|567002534|FG000|Overall Study|Death|5|||
157067331|NCT02053610|567002535|FG001|Overall Study|Death|5|||
157067332|NCT02053610|567002534|FG000|Overall Study|Administrative/Other|1|||
157067333|NCT02053610|567002535|FG001|Overall Study|Administrative/Other|1|||
157067334|NCT02053610|567002534|FG000|Overall Study|Disease Progression|2|||
157067335|NCT02053610|567002535|FG001|Overall Study|Disease Progression|3|||
157067336|NCT02053610|567002534|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
157067337|NCT02053610|567002535|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
157067338|NCT02053610|567002534|FG000|Overall Study|Did not Receive Treatment|4|||
157067339|NCT02053610|567002535|FG001|Overall Study|Did not Receive Treatment|2|||
157067340|NCT02053610|567002534|FG000|Overall Study|Insufficient Therapeutic Response|1|||
157067341|NCT02053610|567002535|FG001|Overall Study|Insufficient Therapeutic Response|1|||
157067342|NCT02053610|567002534|FG000|Overall Study|Violation of Selection Criteria|1|||
157067343|NCT02053610|567002535|FG001|Overall Study|Violation of Selection Criteria|0|||
157067344|NCT05499130|567002536|FG000|Overall Study|Adverse Event|2|||
157067345|NCT05499130|567002537|FG001|Overall Study|Adverse Event|0|||
157067346|NCT05499130|567002538|FG002|Overall Study|Adverse Event|1|||
157067347|NCT05499130|567002539|FG003|Overall Study|Adverse Event|0|||
157067348|NCT05499130|567002540|FG004|Overall Study|Adverse Event|1|||
157067349|NCT05499130|567002541|FG005|Overall Study|Adverse Event|4|||
157067350|NCT05499130|567002542|FG006|Overall Study|Adverse Event|1|||
157067351|NCT05499130|567002543|FG007|Overall Study|Adverse Event|0|||
157067352|NCT05499130|567002536|FG000|Overall Study|Lack of Efficacy|1|||
157067353|NCT05499130|567002537|FG001|Overall Study|Lack of Efficacy|0|||
157067354|NCT05499130|567002538|FG002|Overall Study|Lack of Efficacy|0|||
157067355|NCT05499130|567002539|FG003|Overall Study|Lack of Efficacy|0|||
157067356|NCT05499130|567002540|FG004|Overall Study|Lack of Efficacy|5|||
157067357|NCT05499130|567002541|FG005|Overall Study|Lack of Efficacy|0|||
157230186|NCT01475474|567588278|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
157230187|NCT01475474|567588278|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
157067358|NCT05499130|567002542|FG006|Overall Study|Lack of Efficacy|1|||
157067359|NCT05499130|567002543|FG007|Overall Study|Lack of Efficacy|0|||
157067360|NCT05499130|567002536|FG000|Overall Study|Withdrawal by Subject|2|||
157067361|NCT05499130|567002537|FG001|Overall Study|Withdrawal by Subject|0|||
157067362|NCT05499130|567002538|FG002|Overall Study|Withdrawal by Subject|0|||
157067363|NCT05499130|567002539|FG003|Overall Study|Withdrawal by Subject|0|||
157067364|NCT05499130|567002540|FG004|Overall Study|Withdrawal by Subject|1|||
157067365|NCT05499130|567002541|FG005|Overall Study|Withdrawal by Subject|2|||
157067366|NCT05499130|567002542|FG006|Overall Study|Withdrawal by Subject|0|||
157067367|NCT05499130|567002543|FG007|Overall Study|Withdrawal by Subject|0|||
157067368|NCT05499130|567002536|FG000|Overall Study|Lost to Follow-up|0|||
157067369|NCT05499130|567002537|FG001|Overall Study|Lost to Follow-up|0|||
157067370|NCT05499130|567002538|FG002|Overall Study|Lost to Follow-up|0|||
157067371|NCT05499130|567002539|FG003|Overall Study|Lost to Follow-up|0|||
157067372|NCT05499130|567002540|FG004|Overall Study|Lost to Follow-up|0|||
157067373|NCT05499130|567002541|FG005|Overall Study|Lost to Follow-up|2|||
157067374|NCT05499130|567002542|FG006|Overall Study|Lost to Follow-up|0|||
157067375|NCT05499130|567002543|FG007|Overall Study|Lost to Follow-up|0|||
157067376|NCT05499130|567002536|FG000|Overall Study|Other Than Specified|0|||
157067377|NCT05499130|567002537|FG001|Overall Study|Other Than Specified|0|||
157067378|NCT05499130|567002538|FG002|Overall Study|Other Than Specified|0|||
157067379|NCT05499130|567002539|FG003|Overall Study|Other Than Specified|0|||
157067380|NCT05499130|567002540|FG004|Overall Study|Other Than Specified|1|||
157067381|NCT05499130|567002541|FG005|Overall Study|Other Than Specified|1|||
157067382|NCT05499130|567002542|FG006|Overall Study|Other Than Specified|2|||
157067383|NCT05499130|567002543|FG007|Overall Study|Other Than Specified|0|||
157067384|NCT05499130|567002536|FG000|Overall Study|Protocol Violation|0|||
157067385|NCT05499130|567002537|FG001|Overall Study|Protocol Violation|0|||
157067386|NCT05499130|567002538|FG002|Overall Study|Protocol Violation|0|||
157067387|NCT05499130|567002539|FG003|Overall Study|Protocol Violation|0|||
157067388|NCT05499130|567002540|FG004|Overall Study|Protocol Violation|1|||
157067389|NCT05499130|567002541|FG005|Overall Study|Protocol Violation|0|||
157067390|NCT05499130|567002542|FG006|Overall Study|Protocol Violation|0|||
157067391|NCT05499130|567002543|FG007|Overall Study|Protocol Violation|0|||
157067392|NCT00126659|567002544|FG000|Overall Study|Adverse Event|0|||
157067393|NCT00126659|567002545|FG001|Overall Study|Adverse Event|0|||
157067394|NCT00126659|567002546|FG002|Overall Study|Adverse Event|2|||
157067395|NCT00490945|567002557|FG000|Overall Study|Adverse Event|0|||
157067396|NCT00490945|567002558|FG001|Overall Study|Adverse Event|1|||
157067397|NCT00490945|567002559|FG002|Overall Study|Adverse Event|0|||
157067398|NCT00490945|567002560|FG003|Overall Study|Adverse Event|0|||
157067399|NCT00490945|567002561|FG004|Overall Study|Adverse Event|0|||
157067400|NCT02312206|567002572|FG000|Overall Study|Adverse Event|3|||
157067401|NCT02312206|567002573|FG001|Overall Study|Adverse Event|6|||
157067402|NCT02312206|567002572|FG000|Overall Study|Withdrawal by Subject|6|||
157067403|NCT02312206|567002573|FG001|Overall Study|Withdrawal by Subject|6|||
157067404|NCT02312206|567002572|FG000|Overall Study|Physician Decision|7|||
157067405|NCT02312206|567002573|FG001|Overall Study|Physician Decision|6|||
157067406|NCT02312206|567002572|FG000|Overall Study|Death|31|||
157067407|NCT02312206|567002573|FG001|Overall Study|Death|36|||
157067408|NCT02312206|567002572|FG000|Overall Study|Study Terminated by Sponsor|81|||
157067409|NCT02312206|567002573|FG001|Overall Study|Study Terminated by Sponsor|74|||
157067410|NCT02312206|567002572|FG000|Overall Study|Patient transferred to hospice|0|||
157067411|NCT02312206|567002573|FG001|Overall Study|Patient transferred to hospice|1|||
157067412|NCT02312206|567002572|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
157067413|NCT02312206|567002573|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
157067414|NCT02312206|567002572|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
157067415|NCT02312206|567002573|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
157067416|NCT02312206|567002572|FG000|Overall Study|Disease Progression|1|||
157067417|NCT02312206|567002573|FG001|Overall Study|Disease Progression|0|||
157067418|NCT01006616|567002576|FG000|Period 1 (6 Months)|Adverse Event|10|||
157067419|NCT01006616|567002577|FG001|Period 1 (6 Months)|Adverse Event|31|||
157067420|NCT01006616|567002578|FG002|Period 1 (6 Months)|Adverse Event|37|||
157067421|NCT01006616|567002579|FG003|Period 1 (6 Months)|Adverse Event|9|||
157067422|NCT01006616|567002576|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
157067423|NCT01006616|567002577|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
157067424|NCT01006616|567002578|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
157067425|NCT01006616|567002579|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
157067426|NCT01006616|567002576|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
157067427|NCT01006616|567002577|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
157067428|NCT01006616|567002578|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
157067429|NCT01006616|567002579|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
157067430|NCT01006616|567002576|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
157067431|NCT01006616|567002577|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
157230188|NCT02343120|567588279|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
157230189|NCT02343120|567588280|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
157067432|NCT01006616|567002578|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
157067433|NCT01006616|567002579|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
157067434|NCT01006616|567002576|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
157067435|NCT01006616|567002577|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
157067436|NCT01006616|567002578|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
157067437|NCT01006616|567002579|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
157067438|NCT01006616|567002576|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
157067439|NCT01006616|567002577|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
157067440|NCT01006616|567002578|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
157067441|NCT01006616|567002579|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
157067442|NCT01006616|567002576|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
157067443|NCT01006616|567002577|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
157067444|NCT01006616|567002578|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
157067445|NCT01006616|567002579|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
157067446|NCT01006616|567002576|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
157067447|NCT01006616|567002577|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
157067448|NCT01006616|567002578|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
157187149|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
157187150|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
157187151|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
157187152|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
157187153|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
157187154|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
157187155|NCT03345849|567426849|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
157187156|NCT03345849|567426850|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
157187157|NCT03345849|567426851|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
157187158|NCT03345849|567426852|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
157187159|NCT03991936|567426853|FG000|Overall Study|Lost to Follow-up|1|||
157187160|NCT03991936|567426854|FG001|Overall Study|Lost to Follow-up|1|||
157187161|NCT03991936|567426855|FG002|Overall Study|Lost to Follow-up|1|||
157187162|NCT03991936|567426856|FG003|Overall Study|Lost to Follow-up|1|||
157187163|NCT03991936|567426857|FG004|Overall Study|Lost to Follow-up|1|||
157187164|NCT00939055|567426858|FG000|Overall Study|Discontinuation prior to procedure|4|||
157187165|NCT00939055|567426859|FG001|Overall Study|Discontinuation prior to procedure|0|||
157187166|NCT00584987|567426860|FG000|Overall Study|Protocol Violation|1|||
157187167|NCT00584987|567426861|FG001|Overall Study|Protocol Violation|1|||
157187168|NCT00584987|567426862|FG002|Overall Study|Protocol Violation|1|||
157187169|NCT00584987|567426863|FG003|Overall Study|Protocol Violation|0|||
157187170|NCT00584987|567426860|FG000|Overall Study|Adverse Event|0|||
157187171|NCT00584987|567426861|FG001|Overall Study|Adverse Event|0|||
157187172|NCT00584987|567426862|FG002|Overall Study|Adverse Event|0|||
157187173|NCT00584987|567426863|FG003|Overall Study|Adverse Event|1|||
157187174|NCT02773849|567426870|FG000|Overall Study|Lost to Follow-up|11|||
157187175|NCT02773849|567426870|FG000|Overall Study|Death|26|||
157187176|NCT02773849|567426870|FG000|Overall Study|Withdrawal by Subject|5|||
157187177|NCT02773849|567426870|FG000|Overall Study|Withdrawal of Consent|9|||
157187178|NCT02773849|567426870|FG000|Overall Study|Other: not due to lack of tolerability|11|||
157187179|NCT00723489|567426871|FG000|Overall Study|Physician Decision|0|||
157187180|NCT00723489|567426872|FG001|Overall Study|Physician Decision|1|||
157187181|NCT00723489|567426873|FG002|Overall Study|Physician Decision|0|||
157187182|NCT00723489|567426874|FG003|Overall Study|Physician Decision|0|||
157187183|NCT00723489|567426871|FG000|Overall Study|Pregnancy|0|||
157187184|NCT00723489|567426872|FG001|Overall Study|Pregnancy|0|||
157187185|NCT00723489|567426873|FG002|Overall Study|Pregnancy|0|||
157187186|NCT00723489|567426874|FG003|Overall Study|Pregnancy|1|||
157187187|NCT00723489|567426871|FG000|Overall Study|Withdrawal by Subject|0|||
157187188|NCT00723489|567426872|FG001|Overall Study|Withdrawal by Subject|0|||
157187189|NCT00723489|567426873|FG002|Overall Study|Withdrawal by Subject|0|||
157187190|NCT00723489|567426874|FG003|Overall Study|Withdrawal by Subject|1|||
157187191|NCT00723489|567426871|FG000|Overall Study|Seropositive at baseline|1|||
157187192|NCT00723489|567426872|FG001|Overall Study|Seropositive at baseline|0|||
157187193|NCT00723489|567426873|FG002|Overall Study|Seropositive at baseline|0|||
157187194|NCT00723489|567426874|FG003|Overall Study|Seropositive at baseline|0|||
157187195|NCT00723489|567426871|FG000|Overall Study|Prohibited Medication|0|||
157187196|NCT00723489|567426872|FG001|Overall Study|Prohibited Medication|0|||
157187197|NCT00723489|567426873|FG002|Overall Study|Prohibited Medication|0|||
157187198|NCT00723489|567426874|FG003|Overall Study|Prohibited Medication|1|||
157187199|NCT00723489|567426871|FG000|Overall Study|Samples Collected Out of Window|0|||
157187200|NCT00723489|567426872|FG001|Overall Study|Samples Collected Out of Window|3|||
157187201|NCT00723489|567426873|FG002|Overall Study|Samples Collected Out of Window|0|||
157187202|NCT00723489|567426874|FG003|Overall Study|Samples Collected Out of Window|0|||
157187203|NCT01599585|567426881|FG000|Overall Study|Withdrawal by Subject|16|||
157187204|NCT01599585|567426882|FG001|Overall Study|Withdrawal by Subject|9|||
157187205|NCT01599585|567426881|FG000|Overall Study|Lost to Follow-up|3|||
157187206|NCT01599585|567426882|FG001|Overall Study|Lost to Follow-up|5|||
157187207|NCT01599585|567426881|FG000|Overall Study|randomized did not start treatment|3|||
157187208|NCT01599585|567426882|FG001|Overall Study|randomized did not start treatment|3|||
157187209|NCT03657576|567426883|FG000|Overall Study|Death|0|||
157187210|NCT03657576|567426884|FG001|Overall Study|Death|1|||
157187211|NCT03657576|567426885|FG002|Overall Study|Death|1|||
157187212|NCT03657576|567426886|FG003|Overall Study|Death|0|||
157187213|NCT03657576|567426887|FG004|Overall Study|Death|0|||
157187214|NCT03657576|567426888|FG005|Overall Study|Death|0|||
157187215|NCT03657576|567426883|FG000|Overall Study|Withdrawal by Subject|0|||
157187216|NCT03657576|567426884|FG001|Overall Study|Withdrawal by Subject|0|||
157187217|NCT03657576|567426885|FG002|Overall Study|Withdrawal by Subject|0|||
157187218|NCT03657576|567426886|FG003|Overall Study|Withdrawal by Subject|1|||
157187219|NCT03657576|567426887|FG004|Overall Study|Withdrawal by Subject|0|||
157230190|NCT02343120|567588281|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
157230191|NCT02343120|567588282|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
157187220|NCT03657576|567426888|FG005|Overall Study|Withdrawal by Subject|0|||
157187221|NCT03657576|567426883|FG000|Overall Study|Screen Fail|0|||
157187222|NCT03657576|567426884|FG001|Overall Study|Screen Fail|0|||
157187223|NCT03657576|567426885|FG002|Overall Study|Screen Fail|0|||
157187224|NCT03657576|567426886|FG003|Overall Study|Screen Fail|0|||
157187225|NCT03657576|567426887|FG004|Overall Study|Screen Fail|0|||
157187226|NCT03657576|567426888|FG005|Overall Study|Screen Fail|5|||
157187227|NCT03657576|567426883|FG000|Overall Study|Disease Progression|1|||
157187228|NCT03657576|567426884|FG001|Overall Study|Disease Progression|1|||
157187229|NCT03657576|567426885|FG002|Overall Study|Disease Progression|0|||
157187230|NCT03657576|567426886|FG003|Overall Study|Disease Progression|5|||
157187231|NCT03657576|567426887|FG004|Overall Study|Disease Progression|0|||
157187232|NCT03657576|567426888|FG005|Overall Study|Disease Progression|0|||
157187233|NCT03657576|567426883|FG000|Overall Study|Insurance Coverage|0|||
157187234|NCT03657576|567426884|FG001|Overall Study|Insurance Coverage|0|||
157187235|NCT03657576|567426885|FG002|Overall Study|Insurance Coverage|0|||
157187236|NCT03657576|567426886|FG003|Overall Study|Insurance Coverage|1|||
157187237|NCT03657576|567426887|FG004|Overall Study|Insurance Coverage|0|||
157187238|NCT03657576|567426888|FG005|Overall Study|Insurance Coverage|0|||
157187239|NCT00777036|567426889|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
157187240|NCT00777036|567426890|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
157187241|NCT00777036|567426891|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
157187242|NCT00777036|567426892|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
157187243|NCT00777036|567426889|FG000|On Treatment|Administrative Reason By Sponsor|1|||
157187244|NCT00777036|567426890|FG001|On Treatment|Administrative Reason By Sponsor|0|||
157187245|NCT00777036|567426891|FG002|On Treatment|Administrative Reason By Sponsor|9|||
157187246|NCT00777036|567426892|FG003|On Treatment|Administrative Reason By Sponsor|0|||
157187247|NCT00777036|567426889|FG000|On Treatment|Failure to Meet Study Criteria|0|||
157187248|NCT00777036|567426890|FG001|On Treatment|Failure to Meet Study Criteria|1|||
157187249|NCT00777036|567426891|FG002|On Treatment|Failure to Meet Study Criteria|4|||
157187250|NCT00777036|567426892|FG003|On Treatment|Failure to Meet Study Criteria|0|||
157187251|NCT00777036|567426889|FG000|On Treatment|Pregnancy|1|||
157187252|NCT00777036|567426890|FG001|On Treatment|Pregnancy|0|||
157187253|NCT00777036|567426891|FG002|On Treatment|Pregnancy|1|||
157187254|NCT00777036|567426892|FG003|On Treatment|Pregnancy|0|||
157187255|NCT00777036|567426889|FG000|On Treatment|Non-compliance with Study Drug|1|||
157187256|NCT00777036|567426890|FG001|On Treatment|Non-compliance with Study Drug|0|||
157187257|NCT00777036|567426891|FG002|On Treatment|Non-compliance with Study Drug|1|||
157187258|NCT00777036|567426892|FG003|On Treatment|Non-compliance with Study Drug|0|||
157187259|NCT00777036|567426889|FG000|On Treatment|Maximum Clinical Benefit|2|||
157187260|NCT00777036|567426890|FG001|On Treatment|Maximum Clinical Benefit|0|||
157187261|NCT00777036|567426891|FG002|On Treatment|Maximum Clinical Benefit|5|||
157187262|NCT00777036|567426892|FG003|On Treatment|Maximum Clinical Benefit|0|||
157187263|NCT00777036|567426889|FG000|On Treatment|Withdrawal by Subject|0|||
157187264|NCT00777036|567426890|FG001|On Treatment|Withdrawal by Subject|2|||
157187265|NCT00777036|567426891|FG002|On Treatment|Withdrawal by Subject|2|||
157187266|NCT00777036|567426892|FG003|On Treatment|Withdrawal by Subject|0|||
157187267|NCT00777036|567426889|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
157187268|NCT00777036|567426890|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
157187269|NCT00777036|567426891|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
157187270|NCT00777036|567426892|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
157187271|NCT00777036|567426889|FG000|On Treatment|Death|0|||
157187272|NCT00777036|567426890|FG001|On Treatment|Death|2|||
157187273|NCT00777036|567426891|FG002|On Treatment|Death|0|||
157187274|NCT00777036|567426892|FG003|On Treatment|Death|0|||
157187275|NCT00777036|567426889|FG000|On Treatment|Study Drug Toxicity|1|||
157187276|NCT00777036|567426890|FG001|On Treatment|Study Drug Toxicity|0|||
157187277|NCT00777036|567426891|FG002|On Treatment|Study Drug Toxicity|4|||
157187278|NCT00777036|567426892|FG003|On Treatment|Study Drug Toxicity|0|||
157187279|NCT00777036|567426889|FG000|On Treatment|Progressive Disease|6|||
157230192|NCT02343120|567588283|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
157230193|NCT02343120|567588279|FG000|Part 1: Dose Escalation|Death|1|||
157230194|NCT02343120|567588280|FG001|Part 1: Dose Escalation|Death|2|||
157230195|NCT02343120|567588281|FG002|Part 1: Dose Escalation|Death|2|||
157230196|NCT02343120|567588282|FG003|Part 1: Dose Escalation|Death|2|||
157230197|NCT02343120|567588283|FG004|Part 1: Dose Escalation|Death|1|||
157187280|NCT00777036|567426890|FG001|On Treatment|Progressive Disease|4|||
157187281|NCT00777036|567426891|FG002|On Treatment|Progressive Disease|7|||
157187282|NCT00777036|567426892|FG003|On Treatment|Progressive Disease|0|||
157187283|NCT00777036|567426889|FG000|On Treatment|Not Reported|0|||
157230198|NCT02343120|567588279|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
157230199|NCT02343120|567588280|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
157187284|NCT00777036|567426890|FG001|On Treatment|Not Reported|0|||
157187285|NCT00777036|567426891|FG002|On Treatment|Not Reported|2|||
157187286|NCT00777036|567426892|FG003|On Treatment|Not Reported|0|||
157187287|NCT00777036|567426889|FG000|On Treatment|Site Closed|0|||
157187288|NCT00777036|567426890|FG001|On Treatment|Site Closed|1|||
157187289|NCT00777036|567426891|FG002|On Treatment|Site Closed|1|||
157230200|NCT02343120|567588281|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
157187290|NCT00777036|567426892|FG003|On Treatment|Site Closed|0|||
157187291|NCT00777036|567426889|FG000|Follow-Up|Withdrawal by Subject|0|||
157187292|NCT00777036|567426890|FG001|Follow-Up|Withdrawal by Subject|0|||
157187293|NCT00777036|567426891|FG002|Follow-Up|Withdrawal by Subject|5|||
157187294|NCT00777036|567426892|FG003|Follow-Up|Withdrawal by Subject|0|||
157187295|NCT00777036|567426889|FG000|Follow-Up|Death|1|||
157187296|NCT00777036|567426890|FG001|Follow-Up|Death|9|||
157187297|NCT00777036|567426891|FG002|Follow-Up|Death|0|||
157187298|NCT00777036|567426892|FG003|Follow-Up|Death|0|||
157187299|NCT00777036|567426889|FG000|Follow-Up|Lost to Follow-up|3|||
157187300|NCT00777036|567426890|FG001|Follow-Up|Lost to Follow-up|0|||
157187301|NCT00777036|567426891|FG002|Follow-Up|Lost to Follow-up|0|||
157187302|NCT00777036|567426892|FG003|Follow-Up|Lost to Follow-up|0|||
157187303|NCT00777036|567426889|FG000|Follow-Up|Reason Not Specified|4|||
157187304|NCT00777036|567426890|FG001|Follow-Up|Reason Not Specified|0|||
157187305|NCT00777036|567426891|FG002|Follow-Up|Reason Not Specified|13|||
157187306|NCT00777036|567426892|FG003|Follow-Up|Reason Not Specified|0|||
157187307|NCT00777036|567426889|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
157187308|NCT00777036|567426890|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
157187309|NCT00777036|567426891|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
157187310|NCT00777036|567426892|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
157187311|NCT05564039|567426895|FG000|Overall Study|Adverse Event|1|||
157187312|NCT05564039|567426896|FG001|Overall Study|Adverse Event|0|||
157187313|NCT05564039|567426895|FG000|Overall Study|Death|1|||
157187314|NCT05564039|567426896|FG001|Overall Study|Death|1|||
157187315|NCT05564039|567426895|FG000|Overall Study|Lost to Follow-up|3|||
157187316|NCT05564039|567426896|FG001|Overall Study|Lost to Follow-up|2|||
157187317|NCT05564039|567426895|FG000|Overall Study|Withdrawal by Subject|2|||
157187318|NCT05564039|567426896|FG001|Overall Study|Withdrawal by Subject|0|||
157187319|NCT05564039|567426895|FG000|Overall Study|Inadvertent enrollment|3|||
157187320|NCT05564039|567426896|FG001|Overall Study|Inadvertent enrollment|6|||
157187321|NCT01685372|567426897|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
157187322|NCT01685372|567426898|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
157187323|NCT00829010|567426901|FG000|Overall Study|Adverse Event|1|||
157187324|NCT00829010|567426902|FG001|Overall Study|Adverse Event|0|||
157187325|NCT00829010|567426903|FG002|Overall Study|Adverse Event|0|||
157187326|NCT00829010|567426904|FG003|Overall Study|Adverse Event|0|||
157187327|NCT00829010|567426905|FG004|Overall Study|Adverse Event|0|||
157187328|NCT00829010|567426901|FG000|Overall Study|Withdrawal by Subject|0|||
157187329|NCT00829010|567426902|FG001|Overall Study|Withdrawal by Subject|1|||
157187330|NCT00829010|567426903|FG002|Overall Study|Withdrawal by Subject|1|||
157187331|NCT00829010|567426904|FG003|Overall Study|Withdrawal by Subject|0|||
157187332|NCT00829010|567426905|FG004|Overall Study|Withdrawal by Subject|2|||
157187333|NCT00829010|567426901|FG000|Overall Study|Lost to Follow-up|1|||
157187334|NCT00829010|567426902|FG001|Overall Study|Lost to Follow-up|0|||
157187335|NCT00829010|567426903|FG002|Overall Study|Lost to Follow-up|2|||
157187336|NCT00829010|567426904|FG003|Overall Study|Lost to Follow-up|0|||
157187337|NCT00829010|567426905|FG004|Overall Study|Lost to Follow-up|0|||
157187338|NCT00829010|567426901|FG000|Overall Study|Fatality|5|||
157230201|NCT02343120|567588282|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
157230202|NCT02343120|567588283|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
157067449|NCT01006616|567002579|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
157067450|NCT01006616|567002576|FG000|Period 1 (6 Months)|Not Treated|0|||
157067451|NCT01006616|567002577|FG001|Period 1 (6 Months)|Not Treated|0|||
157067452|NCT01006616|567002578|FG002|Period 1 (6 Months)|Not Treated|1|||
157067453|NCT01006616|567002579|FG003|Period 1 (6 Months)|Not Treated|1|||
157067454|NCT01006616|567002576|FG000|Period 2 (18 Months)|Adverse Event|6|||
157067455|NCT01006616|567002577|FG001|Period 2 (18 Months)|Adverse Event|6|||
157067456|NCT01006616|567002578|FG002|Period 2 (18 Months)|Adverse Event|6|||
157067457|NCT01006616|567002579|FG003|Period 2 (18 Months)|Adverse Event|4|||
157067458|NCT01006616|567002576|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
157067459|NCT01006616|567002577|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
157187339|NCT00829010|567426902|FG001|Overall Study|Fatality|4|||
157187340|NCT00829010|567426903|FG002|Overall Study|Fatality|0|||
157187341|NCT00829010|567426904|FG003|Overall Study|Fatality|3|||
157187342|NCT00829010|567426905|FG004|Overall Study|Fatality|0|||
157187343|NCT00829010|567426901|FG000|Overall Study|Migrated/Moved from study area|3|||
157187344|NCT00829010|567426902|FG001|Overall Study|Migrated/Moved from study area|4|||
157187345|NCT00829010|567426903|FG002|Overall Study|Migrated/Moved from study area|0|||
157187346|NCT00829010|567426904|FG003|Overall Study|Migrated/Moved from study area|5|||
157187347|NCT00829010|567426905|FG004|Overall Study|Migrated/Moved from study area|0|||
157067460|NCT01006616|567002578|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
157067461|NCT01006616|567002579|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
157187348|NCT01029691|567426906|FG000|Continued APAP to Delivery|Death|0|||
157187349|NCT01029691|567426907|FG001|Continued APAP to Delivery|Death|0|||
157187350|NCT01029691|567426908|FG002|Continued APAP to Delivery|Death|1|||
157187351|NCT00137267|567426909|FG000|Overall Study|Lost to Follow-up|15|||
157187352|NCT00137267|567426910|FG001|Overall Study|Lost to Follow-up|21|||
157067462|NCT01006616|567002576|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
157067463|NCT01006616|567002577|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
157067464|NCT01006616|567002578|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
157187353|NCT00528840|567426913|FG000|Overall Study|Lost to Follow-up|10|||
157187354|NCT00528840|567426913|FG000|Overall Study|Adverse Event|1|||
157187355|NCT00528840|567426913|FG000|Overall Study|Withdrawal by Subject|17|||
157187356|NCT00528840|567426913|FG000|Overall Study|Death|2|||
157187357|NCT00528840|567426913|FG000|Overall Study|Administrative Reasons|1|||
157187358|NCT00528840|567426913|FG000|Overall Study|Other|2|||
157187359|NCT01603628|567426914|FG000|Overall Study|Personal Reasons|1|||
157187360|NCT01603628|567426915|FG001|Overall Study|Personal Reasons|1|||
157187361|NCT01603628|567426916|FG002|Overall Study|Personal Reasons|2|||
157187362|NCT01603628|567426914|FG000|Overall Study|Protocol Violation|1|||
157187363|NCT01603628|567426915|FG001|Overall Study|Protocol Violation|1|||
157187364|NCT01603628|567426916|FG002|Overall Study|Protocol Violation|0|||
157187365|NCT01603628|567426914|FG000|Overall Study|Lost to Follow-up|0|||
157187366|NCT01603628|567426915|FG001|Overall Study|Lost to Follow-up|1|||
157187367|NCT01603628|567426916|FG002|Overall Study|Lost to Follow-up|0|||
157187368|NCT01603628|567426914|FG000|Overall Study|Other Miscellaneous Reason|1|||
157187369|NCT01603628|567426915|FG001|Overall Study|Other Miscellaneous Reason|0|||
157187370|NCT01603628|567426916|FG002|Overall Study|Other Miscellaneous Reason|0|||
157187371|NCT01969565|567426917|FG000|Overall Study|Withdrawal by Subject|1|||
157187372|NCT00832091|567426918|FG000|Overall Study|Adverse Event|1|||
157187373|NCT00832091|567426919|FG001|Overall Study|Adverse Event|1|||
157187374|NCT00832091|567426918|FG000|Overall Study|Protocol Violation|1|||
157187375|NCT00832091|567426919|FG001|Overall Study|Protocol Violation|0|||
157187376|NCT00832091|567426918|FG000|Overall Study|Withdrawal by Subject|2|||
157187377|NCT00832091|567426919|FG001|Overall Study|Withdrawal by Subject|1|||
157187378|NCT00832091|567426918|FG000|Overall Study|Prohibited Medication|1|||
157187379|NCT00832091|567426919|FG001|Overall Study|Prohibited Medication|0|||
157187380|NCT00952588|567426920|FG000|Overall Study|Death|28|||
157187381|NCT00952588|567426921|FG001|Overall Study|Death|13|||
157187382|NCT00952588|567426920|FG000|Overall Study|Withdrawal by Subject|2|||
157187383|NCT00952588|567426921|FG001|Overall Study|Withdrawal by Subject|5|||
157187384|NCT00952588|567426920|FG000|Overall Study|Adverse Event|2|||
157187385|NCT00952588|567426921|FG001|Overall Study|Adverse Event|3|||
157187386|NCT00952588|567426920|FG000|Overall Study|Lost to Follow-up|2|||
157187387|NCT00952588|567426921|FG001|Overall Study|Lost to Follow-up|0|||
157187388|NCT00952588|567426920|FG000|Overall Study|Physician Decision|0|||
157187389|NCT00952588|567426921|FG001|Overall Study|Physician Decision|1|||
157187390|NCT00952588|567426920|FG000|Overall Study|Lack of Efficacy|2|||
157187391|NCT00952588|567426921|FG001|Overall Study|Lack of Efficacy|2|||
157187392|NCT00886587|567426922|FG000|Overall Study|Adverse Event|2|||
157187393|NCT00886587|567426923|FG001|Overall Study|Adverse Event|1|||
157187394|NCT00886587|567426922|FG000|Overall Study|Protocol Violation|2|||
157187395|NCT00886587|567426923|FG001|Overall Study|Protocol Violation|0|||
157187396|NCT00886587|567426922|FG000|Overall Study|Withdrawal by Subject|0|||
157187397|NCT00886587|567426923|FG001|Overall Study|Withdrawal by Subject|1|||
157067465|NCT01006616|567002579|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
157067466|NCT01006616|567002576|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
157067467|NCT01006616|567002577|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
157067468|NCT01006616|567002578|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
157067469|NCT01006616|567002579|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
157067470|NCT01006616|567002576|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
157067471|NCT01006616|567002577|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
157067472|NCT01006616|567002578|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
157067473|NCT01006616|567002579|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
157067474|NCT01006616|567002576|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
157067475|NCT01006616|567002577|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
157067476|NCT01006616|567002578|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
157067477|NCT01006616|567002579|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
157067478|NCT01006616|567002576|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
157067479|NCT01006616|567002577|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
157067480|NCT01006616|567002578|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
157067481|NCT01006616|567002579|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
157187398|NCT00696774|567426927|FG000|Period II|Adverse Event|0|||
157187399|NCT00696774|567426928|FG001|Period II|Adverse Event|0|||
157187400|NCT00696774|567426929|FG002|Period II|Adverse Event|15|||
157067482|NCT01006616|567002576|FG000|Period 2 (18 Months)|Study Terminated|63|||
157067483|NCT01006616|567002577|FG001|Period 2 (18 Months)|Study Terminated|46|||
157187401|NCT00696774|567426927|FG000|Period II|Lost to Follow-up|0|||
157187402|NCT00696774|567426928|FG001|Period II|Lost to Follow-up|0|||
157187403|NCT00696774|567426929|FG002|Period II|Lost to Follow-up|4|||
157187404|NCT00696774|567426927|FG000|Period II|Protocol Violation|0|||
157187405|NCT00696774|567426928|FG001|Period II|Protocol Violation|0|||
157187406|NCT00696774|567426929|FG002|Period II|Protocol Violation|11|||
157187407|NCT00696774|567426927|FG000|Period II|Withdrawal by Subject|0|||
157187408|NCT00696774|567426928|FG001|Period II|Withdrawal by Subject|0|||
157187409|NCT00696774|567426929|FG002|Period II|Withdrawal by Subject|4|||
157187410|NCT00696774|567426927|FG000|Period II|Sponsor Decision|0|||
157187411|NCT00696774|567426928|FG001|Period II|Sponsor Decision|0|||
157187412|NCT00696774|567426929|FG002|Period II|Sponsor Decision|0|||
157187413|NCT00696774|567426927|FG000|Period II|Lack of Efficacy|0|||
157187414|NCT00696774|567426928|FG001|Period II|Lack of Efficacy|0|||
157187415|NCT00696774|567426929|FG002|Period II|Lack of Efficacy|2|||
157187416|NCT00696774|567426927|FG000|Period III|Adverse Event|1|||
157187417|NCT00696774|567426928|FG001|Period III|Adverse Event|1|||
157187418|NCT00696774|567426929|FG002|Period III|Adverse Event|0|||
157187419|NCT00696774|567426927|FG000|Period III|Lost to Follow-up|2|||
157187420|NCT00696774|567426928|FG001|Period III|Lost to Follow-up|1|||
157187421|NCT00696774|567426929|FG002|Period III|Lost to Follow-up|0|||
157187422|NCT00696774|567426927|FG000|Period III|Protocol Violation|1|||
157187423|NCT00696774|567426928|FG001|Period III|Protocol Violation|1|||
157187424|NCT00696774|567426929|FG002|Period III|Protocol Violation|0|||
157067484|NCT01006616|567002578|FG002|Period 2 (18 Months)|Study Terminated|44|||
157067485|NCT01006616|567002579|FG003|Period 2 (18 Months)|Study Terminated|70|||
157067486|NCT03414047|567002580|FG000|Overall Study|Adverse Event|0|||
157067487|NCT03414047|567002581|FG001|Overall Study|Adverse Event|0|||
157067488|NCT03414047|567002582|FG002|Overall Study|Adverse Event|1|||
157067489|NCT03414047|567002583|FG003|Overall Study|Adverse Event|1|||
157067490|NCT03414047|567002580|FG000|Overall Study|Physician Decision|1|||
157067491|NCT03414047|567002581|FG001|Overall Study|Physician Decision|0|||
157067492|NCT03414047|567002582|FG002|Overall Study|Physician Decision|0|||
157067493|NCT03414047|567002583|FG003|Overall Study|Physician Decision|1|||
157067494|NCT03414047|567002580|FG000|Overall Study|Withdrawal by Subject|1|||
157067495|NCT03414047|567002581|FG001|Overall Study|Withdrawal by Subject|0|||
157067496|NCT03414047|567002582|FG002|Overall Study|Withdrawal by Subject|2|||
157067497|NCT03414047|567002583|FG003|Overall Study|Withdrawal by Subject|0|||
157067498|NCT04593823|567002584|FG000|Overall Study|Withdrawal by Subject|1|||
157067499|NCT04593823|567002585|FG001|Overall Study|Withdrawal by Subject|1|||
157067500|NCT04593823|567002584|FG000|Overall Study|Lost to Follow-up|0|||
157067501|NCT04593823|567002585|FG001|Overall Study|Lost to Follow-up|1|||
157067502|NCT00817336|567002591|FG000|Overall Study|Withdrawal by Subject|1|||
157067503|NCT00817336|567002592|FG001|Overall Study|Withdrawal by Subject|1|||
157067504|NCT01182181|567002600|FG000|First Intervention|Adverse Event|1|||
157067505|NCT01182181|567002601|FG001|First Intervention|Adverse Event|0|||
157067506|NCT01182181|567002600|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
157067507|NCT01182181|567002601|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
157067508|NCT04706793|567002605|FG000|Treatment|Disease worsening|10|||
157067509|NCT04706793|567002606|FG001|Treatment|Disease worsening|10|||
157067510|NCT04706793|567002605|FG000|Follow-up|Lack of Efficacy|1|||
157067511|NCT04706793|567002606|FG001|Follow-up|Lack of Efficacy|0|||
157187425|NCT00696774|567426927|FG000|Period III|Withdrawal by Subject|1|||
157187426|NCT00696774|567426928|FG001|Period III|Withdrawal by Subject|2|||
157067512|NCT04706793|567002605|FG000|Follow-up|Disease worsening|8|||
157067513|NCT04706793|567002606|FG001|Follow-up|Disease worsening|10|||
157067514|NCT04706793|567002605|FG000|Follow-up|Adverse Event|1|||
157067515|NCT04706793|567002606|FG001|Follow-up|Adverse Event|0|||
157067516|NCT00823836|567002609|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
157067517|NCT00823836|567002610|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
157067518|NCT00823836|567002609|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
157067519|NCT00823836|567002610|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
157067520|NCT00823836|567002609|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
157067521|NCT00823836|567002610|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
157067522|NCT00823836|567002609|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
157067523|NCT00823836|567002610|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
157067524|NCT00823836|567002609|FG000|Long-term Phase|Adverse Event|3|||
157067525|NCT00823836|567002610|FG001|Long-term Phase|Adverse Event|2|||
157067526|NCT00823836|567002609|FG000|Long-term Phase|Physician Decision|1|||
157067527|NCT00823836|567002610|FG001|Long-term Phase|Physician Decision|2|||
157067528|NCT00823836|567002609|FG000|Long-term Phase|Withdrawal by Subject|1|||
157067529|NCT00823836|567002610|FG001|Long-term Phase|Withdrawal by Subject|1|||
157067530|NCT01130168|567002611|FG000|Period 1|Withdrawal by Subject|0|||
157067531|NCT01130168|567002612|FG001|Period 1|Withdrawal by Subject|1|||
157067532|NCT01130168|567002613|FG002|Period 1|Withdrawal by Subject|0|||
157067533|NCT01130168|567002614|FG003|Period 1|Withdrawal by Subject|1|||
157067534|NCT01130168|567002615|FG004|Period 1|Withdrawal by Subject|0|||
157067535|NCT01130168|567002616|FG005|Period 1|Withdrawal by Subject|0|||
157067536|NCT01130168|567002611|FG000|Period 1|Discontinued For Other Reason|0|||
157187427|NCT00696774|567426929|FG002|Period III|Withdrawal by Subject|0|||
157187428|NCT00696774|567426927|FG000|Period III|Sponsor Decision|2|||
157187429|NCT00696774|567426928|FG001|Period III|Sponsor Decision|0|||
157187430|NCT00696774|567426929|FG002|Period III|Sponsor Decision|0|||
157187431|NCT00696774|567426927|FG000|Period III|Lack of Efficacy|0|||
157187432|NCT00696774|567426928|FG001|Period III|Lack of Efficacy|2|||
157067537|NCT01130168|567002612|FG001|Period 1|Discontinued For Other Reason|0|||
157067538|NCT01130168|567002613|FG002|Period 1|Discontinued For Other Reason|1|||
157067539|NCT01130168|567002614|FG003|Period 1|Discontinued For Other Reason|1|||
157067540|NCT01130168|567002615|FG004|Period 1|Discontinued For Other Reason|0|||
157067541|NCT01130168|567002616|FG005|Period 1|Discontinued For Other Reason|0|||
157067542|NCT01130168|567002611|FG000|Period 1|Adverse Event|0|||
157067543|NCT01130168|567002612|FG001|Period 1|Adverse Event|0|||
157067544|NCT01130168|567002613|FG002|Period 1|Adverse Event|0|||
157067545|NCT01130168|567002614|FG003|Period 1|Adverse Event|1|||
157067546|NCT01130168|567002615|FG004|Period 1|Adverse Event|0|||
157067547|NCT01130168|567002616|FG005|Period 1|Adverse Event|0|||
157067548|NCT02725528|567002617|FG000|Overall Study|Lost to Follow-up|1|||
157067549|NCT02725528|567002618|FG001|Overall Study|Lost to Follow-up|4|||
157067550|NCT02725528|567002617|FG000|Overall Study|Withdrawal by Subject|0|||
157067551|NCT02725528|567002618|FG001|Overall Study|Withdrawal by Subject|1|||
157067552|NCT00745498|567002621|FG000|Overall Study|Lost to Follow-up|1|||
157067553|NCT00745498|567002622|FG001|Overall Study|Lost to Follow-up|1|||
157067554|NCT00745498|567002623|FG002|Overall Study|Lost to Follow-up|3|||
157067555|NCT00745498|567002621|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
157067556|NCT00745498|567002622|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
157067557|NCT00745498|567002623|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
157067558|NCT00745498|567002621|FG000|Overall Study|Non-PDR related VH|0|||
157067559|NCT00745498|567002622|FG001|Overall Study|Non-PDR related VH|1|||
157067560|NCT00745498|567002623|FG002|Overall Study|Non-PDR related VH|1|||
157067561|NCT00745498|567002621|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
157067562|NCT00745498|567002622|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
157067563|NCT00745498|567002623|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
157067564|NCT02706847|567002624|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
157067565|NCT02706847|567002625|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
157067566|NCT02706847|567002626|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
157067567|NCT02706847|567002627|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
157067568|NCT02706847|567002624|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
157067569|NCT02706847|567002625|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
157067570|NCT02706847|567002626|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
157067571|NCT02706847|567002627|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
157067572|NCT02706847|567002624|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
157067573|NCT02706847|567002625|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
157067574|NCT02706847|567002626|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
157067575|NCT02706847|567002627|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
157067576|NCT02706847|567002624|FG000|Period 1: Day 1 to Week 12|Other|4|||
157067577|NCT02706847|567002625|FG001|Period 1: Day 1 to Week 12|Other|4|||
157067578|NCT02706847|567002626|FG002|Period 1: Day 1 to Week 12|Other|2|||
157067579|NCT02706847|567002627|FG003|Period 1: Day 1 to Week 12|Other|2|||
157067580|NCT02706847|567002624|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
157067581|NCT02706847|567002625|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
157067582|NCT02706847|567002626|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
157067583|NCT02706847|567002627|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
157067584|NCT02706847|567002624|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
157067585|NCT02706847|567002625|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
157067586|NCT02706847|567002626|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
157067587|NCT02706847|567002627|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
157067588|NCT02706847|567002624|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
157067589|NCT02706847|567002625|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
157187433|NCT00696774|567426929|FG002|Period III|Lack of Efficacy|0|||
157187434|NCT02943668|567426936|FG000|Overall Study|Disease Progression|1|||
157187435|NCT00572728|567426943|FG000|Overall Study|Withdrawal by Subject|10|||
157187436|NCT00572728|567426943|FG000|Overall Study|Ineligible|3|||
157187437|NCT00572728|567426943|FG000|Overall Study|Enrolled under Amendment 4|5|||
157187438|NCT00572728|567426943|FG000|Overall Study|Offstudy due to complicating disease|1|||
157187439|NCT00572728|567426943|FG000|Overall Study|FLT1 not completed|4|||
157187440|NCT00572728|567426943|FG000|Overall Study|First Chemotherapy not initiated|2|||
157187441|NCT00572728|567426943|FG000|Overall Study|FLT2 not completed|5|||
157187442|NCT00572728|567426943|FG000|Overall Study|Second chemotherapy not initiated|1|||
157067590|NCT02706847|567002626|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
157067591|NCT02706847|567002627|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
157067592|NCT02706847|567002624|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
157067593|NCT02706847|567002625|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
157067594|NCT02706847|567002626|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
157187443|NCT00572728|567426943|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
157067595|NCT02706847|567002627|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
157067596|NCT02706847|567002624|FG000|Period 1: Week 12 to Week 24|Other|1|||
157067597|NCT02706847|567002625|FG001|Period 1: Week 12 to Week 24|Other|0|||
157067598|NCT02706847|567002626|FG002|Period 1: Week 12 to Week 24|Other|1|||
157067599|NCT02706847|567002627|FG003|Period 1: Week 12 to Week 24|Other|4|||
157187444|NCT00572728|567426943|FG000|Overall Study|Pathology missing|1|||
157067600|NCT02706847|567002624|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
157067601|NCT02706847|567002625|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
157187445|NCT03457636|567426948|FG000|Overall Study|Lost to Follow-up|2|||
157187446|NCT01828567|567426951|FG000|Overall Study|Lost to Follow-up|27|||
157187447|NCT01828567|567426952|FG001|Overall Study|Lost to Follow-up|9|||
157187448|NCT01828567|567426951|FG000|Overall Study|Excluded - did not meet criteria|4|||
157187449|NCT01828567|567426952|FG001|Overall Study|Excluded - did not meet criteria|1|||
157187450|NCT02332876|567426961|FG000|Overall Study|Lost to Follow-up|1|||
157187451|NCT02332876|567426962|FG001|Overall Study|Lost to Follow-up|1|||
157187452|NCT03325010|567426965|FG000|Overall Study|Adverse Event|3|||
157187453|NCT03325010|567426966|FG001|Overall Study|Adverse Event|8|||
157187454|NCT03325010|567426965|FG000|Overall Study|Protocol Violation|1|||
157187455|NCT03325010|567426966|FG001|Overall Study|Protocol Violation|8|||
157187456|NCT03325010|567426965|FG000|Overall Study|Withdrawal by Subject|1|||
157187457|NCT03325010|567426966|FG001|Overall Study|Withdrawal by Subject|3|||
157187458|NCT03325010|567426965|FG000|Overall Study|Lost to Follow-up|1|||
157187459|NCT03325010|567426966|FG001|Overall Study|Lost to Follow-up|0|||
157187460|NCT03325010|567426965|FG000|Overall Study|Physician Decision|1|||
157187461|NCT03325010|567426966|FG001|Overall Study|Physician Decision|1|||
157187462|NCT03325010|567426965|FG000|Overall Study|Lack of Efficacy|2|||
157187463|NCT03325010|567426966|FG001|Overall Study|Lack of Efficacy|0|||
157187464|NCT04063865|567426969|FG000|Overall Study|Physician Decision|1|||
157187465|NCT04063865|567426970|FG001|Overall Study|Physician Decision|3|||
157187466|NCT04063865|567426969|FG000|Overall Study|Study Closed Prior to Completion|4|||
157187467|NCT04063865|567426970|FG001|Overall Study|Study Closed Prior to Completion|4|||
157187468|NCT04063865|567426969|FG000|Overall Study|Withdrawal by Subject|1|||
157187469|NCT04063865|567426970|FG001|Overall Study|Withdrawal by Subject|1|||
157187470|NCT00320190|567426971|FG000|First 12 Months|Completed but did not enter extension|5|||
157187471|NCT00320190|567426972|FG001|First 12 Months|Completed but did not enter extension|3|||
157187472|NCT00320190|567426971|FG000|First 12 Months|Sponsor terminated study|2|||
157187473|NCT00320190|567426972|FG001|First 12 Months|Sponsor terminated study|2|||
157187474|NCT00320190|567426971|FG000|First 12 Months|Lost to Follow-up|0|||
157187475|NCT00320190|567426972|FG001|First 12 Months|Lost to Follow-up|1|||
157187476|NCT00320190|567426971|FG000|First 12 Months|Enrollment failure|0|||
157187477|NCT00320190|567426972|FG001|First 12 Months|Enrollment failure|1|||
157187478|NCT00320190|567426971|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
157187479|NCT00320190|567426972|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
157187480|NCT00320190|567426971|FG000|First 12 Months|Investigator request|0|||
157187481|NCT00320190|567426972|FG001|First 12 Months|Investigator request|1|||
157187482|NCT00320190|567426971|FG000|First 12 Months|Study drug toxicity|0|||
157187483|NCT00320190|567426972|FG001|First 12 Months|Study drug toxicity|1|||
157187484|NCT00320190|567426971|FG000|First 12 Months|Withdrawal by Subject|0|||
157187485|NCT00320190|567426972|FG001|First 12 Months|Withdrawal by Subject|1|||
157187486|NCT00320190|567426971|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
157187487|NCT00320190|567426972|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
157187488|NCT00320190|567426971|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
157187489|NCT00320190|567426972|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
157187490|NCT00320190|567426971|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
157187491|NCT00320190|567426972|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
157187492|NCT01060124|567426973|FG000|Overall Study|Other|16|||
157187493|NCT01060124|567426973|FG000|Overall Study|Adverse Event|14|||
157187494|NCT01060124|567426973|FG000|Overall Study|Withdrawal by Subject|7|||
157187495|NCT00102804|567426975|FG000|Overall Study|Progressive Disease (PD)|307|||
157187496|NCT00102804|567426976|FG001|Overall Study|Progressive Disease (PD)|196|||
157187497|NCT00102804|567426975|FG000|Overall Study|Withdrawal by Subject|46|||
157187498|NCT00102804|567426976|FG001|Overall Study|Withdrawal by Subject|7|||
157187499|NCT00102804|567426975|FG000|Overall Study|Adverse Event|37|||
157187500|NCT00102804|567426976|FG001|Overall Study|Adverse Event|3|||
157187501|NCT00102804|567426975|FG000|Overall Study|Physician Decision|24|||
157187502|NCT00102804|567426976|FG001|Overall Study|Physician Decision|6|||
157187503|NCT00102804|567426975|FG000|Overall Study|Death|5|||
157067602|NCT02706847|567002626|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
157067603|NCT02706847|567002627|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
157067604|NCT02706847|567002624|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
157187504|NCT00102804|567426976|FG001|Overall Study|Death|6|||
157187505|NCT00102804|567426975|FG000|Overall Study|Enrollment Criteria Not Met|6|||
157187506|NCT00102804|567426976|FG001|Overall Study|Enrollment Criteria Not Met|0|||
157187507|NCT00102804|567426975|FG000|Overall Study|Lost to Follow-up|4|||
157187508|NCT00102804|567426976|FG001|Overall Study|Lost to Follow-up|1|||
157187509|NCT00102804|567426975|FG000|Overall Study|Protocol Violation|2|||
157187510|NCT00102804|567426976|FG001|Overall Study|Protocol Violation|1|||
157187511|NCT00102804|567426975|FG000|Overall Study|Satisfactory Response|2|||
157187512|NCT00102804|567426976|FG001|Overall Study|Satisfactory Response|0|||
157067605|NCT02706847|567002625|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
157067606|NCT02706847|567002626|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
157187513|NCT00102804|567426975|FG000|Overall Study|Sponsor Decision|1|||
157067607|NCT02706847|567002627|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
157067608|NCT02706847|567002624|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
157067609|NCT02706847|567002625|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
157067610|NCT02706847|567002626|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
157067611|NCT02706847|567002627|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
157067612|NCT02706847|567002624|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
157067613|NCT02706847|567002625|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
157067614|NCT02706847|567002626|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
157067615|NCT02706847|567002627|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
157067616|NCT02706847|567002624|FG000|Period 2: Week 24 to Week 260|Other|8|||
157067617|NCT02706847|567002625|FG001|Period 2: Week 24 to Week 260|Other|5|||
157067618|NCT02706847|567002626|FG002|Period 2: Week 24 to Week 260|Other|15|||
157067619|NCT02706847|567002627|FG003|Period 2: Week 24 to Week 260|Other|15|||
157067620|NCT02058836|567002628|FG000|Overall Study|Withdrawal by Subject|1|||
157067621|NCT02058836|567002629|FG001|Overall Study|Withdrawal by Subject|1|||
157067622|NCT00725543|567002631|FG000|Overall Study|Adverse Event|10|||
157067623|NCT00725543|567002631|FG000|Overall Study|Lack of Efficacy|3|||
157067624|NCT00725543|567002631|FG000|Overall Study|Withdrawal by Subject|10|||
157067625|NCT00725543|567002631|FG000|Overall Study|Physician Decision|5|||
157067626|NCT00725543|567002631|FG000|Overall Study|Lost to Follow-up|4|||
157067627|NCT00725543|567002631|FG000|Overall Study|Non-compliance|2|||
157067628|NCT00725543|567002631|FG000|Overall Study|Other|119|||
157067629|NCT01157377|567002632|FG000|Overall Study|Lost to Follow-up|0|||
157067630|NCT01157377|567002633|FG001|Overall Study|Lost to Follow-up|0|||
157067631|NCT01157377|567002634|FG002|Overall Study|Lost to Follow-up|1|||
157067632|NCT01157377|567002635|FG003|Overall Study|Lost to Follow-up|0|||
157067633|NCT01157377|567002636|FG004|Overall Study|Lost to Follow-up|1|||
157067634|NCT01157377|567002637|FG005|Overall Study|Lost to Follow-up|1|||
157067635|NCT01157377|567002638|FG006|Overall Study|Lost to Follow-up|0|||
157067636|NCT01157377|567002632|FG000|Overall Study|Personal Reasons|2|||
157067637|NCT01157377|567002633|FG001|Overall Study|Personal Reasons|1|||
157067638|NCT01157377|567002634|FG002|Overall Study|Personal Reasons|0|||
157067639|NCT01157377|567002635|FG003|Overall Study|Personal Reasons|1|||
157067640|NCT01157377|567002636|FG004|Overall Study|Personal Reasons|0|||
157067641|NCT01157377|567002637|FG005|Overall Study|Personal Reasons|0|||
157067642|NCT01157377|567002638|FG006|Overall Study|Personal Reasons|0|||
157067643|NCT01157377|567002632|FG000|Overall Study|Protocol Violation|0|||
157067644|NCT01157377|567002633|FG001|Overall Study|Protocol Violation|0|||
157067645|NCT01157377|567002634|FG002|Overall Study|Protocol Violation|0|||
157067646|NCT01157377|567002635|FG003|Overall Study|Protocol Violation|0|||
157067647|NCT01157377|567002636|FG004|Overall Study|Protocol Violation|0|||
157067648|NCT01157377|567002637|FG005|Overall Study|Protocol Violation|1|||
157067649|NCT01157377|567002638|FG006|Overall Study|Protocol Violation|0|||
157067650|NCT01157377|567002632|FG000|Overall Study|Lack of Efficacy|0|||
157067651|NCT01157377|567002633|FG001|Overall Study|Lack of Efficacy|0|||
157067652|NCT01157377|567002634|FG002|Overall Study|Lack of Efficacy|0|||
157067653|NCT01157377|567002635|FG003|Overall Study|Lack of Efficacy|0|||
157067654|NCT01157377|567002636|FG004|Overall Study|Lack of Efficacy|0|||
157067655|NCT01157377|567002637|FG005|Overall Study|Lack of Efficacy|0|||
157067656|NCT01157377|567002638|FG006|Overall Study|Lack of Efficacy|1|||
157067657|NCT01157377|567002632|FG000|Overall Study|Other Miscellaneous Reasons|0|||
157067658|NCT01157377|567002633|FG001|Overall Study|Other Miscellaneous Reasons|2|||
157067659|NCT01157377|567002634|FG002|Overall Study|Other Miscellaneous Reasons|0|||
157067660|NCT01157377|567002635|FG003|Overall Study|Other Miscellaneous Reasons|0|||
157067661|NCT01157377|567002636|FG004|Overall Study|Other Miscellaneous Reasons|1|||
157067662|NCT01157377|567002637|FG005|Overall Study|Other Miscellaneous Reasons|1|||
157067663|NCT01157377|567002638|FG006|Overall Study|Other Miscellaneous Reasons|1|||
157067664|NCT00087555|567002639|FG000|Overall Study|Adverse Event|3|||
157067665|NCT00087555|567002640|FG001|Overall Study|Adverse Event|6|||
157067666|NCT00087555|567002641|FG002|Overall Study|Adverse Event|14|||
157067667|NCT00087555|567002639|FG000|Overall Study|Lost to Follow-up|0|||
157067668|NCT00087555|567002640|FG001|Overall Study|Lost to Follow-up|1|||
157067669|NCT00087555|567002641|FG002|Overall Study|Lost to Follow-up|1|||
157067670|NCT00087555|567002639|FG000|Overall Study|Non - Compliance|1|||
157067671|NCT00087555|567002640|FG001|Overall Study|Non - Compliance|0|||
157067672|NCT00087555|567002641|FG002|Overall Study|Non - Compliance|0|||
157067673|NCT00087555|567002639|FG000|Overall Study|Protocol Violation|0|||
157067674|NCT00087555|567002640|FG001|Overall Study|Protocol Violation|0|||
157067675|NCT00087555|567002641|FG002|Overall Study|Protocol Violation|2|||
157067676|NCT00087555|567002639|FG000|Overall Study|Screen Failure|1|||
157067677|NCT00087555|567002640|FG001|Overall Study|Screen Failure|1|||
157067678|NCT00087555|567002641|FG002|Overall Study|Screen Failure|0|||
157067679|NCT00087555|567002639|FG000|Overall Study|Pregnancy|0|||
157067680|NCT00087555|567002640|FG001|Overall Study|Pregnancy|1|||
157067681|NCT00087555|567002641|FG002|Overall Study|Pregnancy|1|||
157067682|NCT00087555|567002639|FG000|Overall Study|Withdrawal by Subject|3|||
157187514|NCT00102804|567426976|FG001|Overall Study|Sponsor Decision|0|||
157187515|NCT00102804|567426975|FG000|Overall Study|Alive, Receiving Treatment|7|||
157187516|NCT00102804|567426976|FG001|Overall Study|Alive, Receiving Treatment|2|||
157187517|NCT00518336|567426981|FG000|Year 7|Lost to Follow-up|2|||
157187518|NCT00518336|567426982|FG001|Year 7|Lost to Follow-up|0|||
157187519|NCT00518336|567426981|FG000|Year 7|Could not attend in time|0|||
157187520|NCT00518336|567426982|FG001|Year 7|Could not attend in time|3|||
157187521|NCT00518336|567426981|FG000|Year 8|Lost to Follow-up|1|||
157187522|NCT00518336|567426982|FG001|Year 8|Lost to Follow-up|1|||
157187523|NCT00518336|567426981|FG000|Year 8|Could not attend in time|0|||
157187524|NCT00518336|567426982|FG001|Year 8|Could not attend in time|1|||
157187525|NCT00518336|567426981|FG000|Year 9|Migrated/moved from study area|1|||
157187526|NCT00518336|567426982|FG001|Year 9|Migrated/moved from study area|1|||
157187527|NCT00518336|567426981|FG000|Year 9|Lost to Follow-up|3|||
157187528|NCT00518336|567426982|FG001|Year 9|Lost to Follow-up|0|||
157187529|NCT00518336|567426981|FG000|Year 9|Personal reasons|1|||
157187530|NCT00518336|567426982|FG001|Year 9|Personal reasons|0|||
157187531|NCT03074318|567426983|FG000|Overall Study|Adverse Event|0|||
157187532|NCT03074318|567426984|FG001|Overall Study|Adverse Event|1|||
157187533|NCT03074318|567426985|FG002|Overall Study|Adverse Event|1|||
157187534|NCT03074318|567426986|FG003|Overall Study|Adverse Event|1|||
157187535|NCT03074318|567426983|FG000|Overall Study|Death|1|||
157187536|NCT03074318|567426984|FG001|Overall Study|Death|0|||
157187537|NCT03074318|567426985|FG002|Overall Study|Death|0|||
157187538|NCT03074318|567426986|FG003|Overall Study|Death|0|||
157187539|NCT03074318|567426983|FG000|Overall Study|Withdrawal by Subject|1|||
157187540|NCT03074318|567426984|FG001|Overall Study|Withdrawal by Subject|2|||
157187541|NCT03074318|567426985|FG002|Overall Study|Withdrawal by Subject|2|||
157187542|NCT03074318|567426986|FG003|Overall Study|Withdrawal by Subject|4|||
157187543|NCT03074318|567426983|FG000|Overall Study|Trial Closure|2|||
157187544|NCT03074318|567426984|FG001|Overall Study|Trial Closure|2|||
157187545|NCT03074318|567426985|FG002|Overall Study|Trial Closure|3|||
157187546|NCT03074318|567426986|FG003|Overall Study|Trial Closure|11|||
157187547|NCT03399786|567426987|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
157187548|NCT03399786|567426988|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
157187549|NCT03399786|567426989|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
157187550|NCT03399786|567426990|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
157187551|NCT03399786|567426987|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
157187552|NCT03399786|567426988|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
157187553|NCT03399786|567426989|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
157187554|NCT03399786|567426990|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
157187555|NCT03399786|567426987|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
157187556|NCT03399786|567426988|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
157187557|NCT03399786|567426989|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
157187558|NCT03399786|567426990|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
157187559|NCT03053180|567428592|FG000|Overall Study|Failure to Return|1|||
157187560|NCT01465958|567428597|FG000|Run-in Phase|Protocol Violation|1|||
157187561|NCT01465958|567428598|FG001|Run-in Phase|Protocol Violation|0|||
157187562|NCT01465958|567428597|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
157187563|NCT01465958|567428598|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
157187564|NCT04397757|567428601|FG000|Overall Study|Death|3|||
157187565|NCT04397757|567428602|FG001|Overall Study|Death|11|||
157187566|NCT04397757|567428601|FG000|Overall Study|Withdrawal by Subject|2|||
157187567|NCT04397757|567428602|FG001|Overall Study|Withdrawal by Subject|0|||
157187568|NCT04397757|567428601|FG000|Overall Study|Lost to Follow-up|4|||
157187569|NCT04397757|567428602|FG001|Overall Study|Lost to Follow-up|3|||
157187570|NCT05492877|567428607|FG000|Overall Study|Adverse Event|11|||
157187571|NCT05492877|567428608|FG001|Overall Study|Adverse Event|7|||
157187572|NCT05492877|567428607|FG000|Overall Study|Death|1|||
157187573|NCT05492877|567428608|FG001|Overall Study|Death|0|||
157187574|NCT05492877|567428607|FG000|Overall Study|Lost to Follow-up|1|||
157187575|NCT05492877|567428608|FG001|Overall Study|Lost to Follow-up|1|||
157187576|NCT05492877|567428607|FG000|Overall Study|Physician Decision|1|||
157187577|NCT05492877|567428608|FG001|Overall Study|Physician Decision|2|||
157187578|NCT05492877|567428607|FG000|Overall Study|Protocol Violation|1|||
157187579|NCT05492877|567428608|FG001|Overall Study|Protocol Violation|1|||
157187580|NCT05492877|567428607|FG000|Overall Study|Withdrawal by Subject|3|||
157187581|NCT05492877|567428608|FG001|Overall Study|Withdrawal by Subject|7|||
157187582|NCT05492877|567428607|FG000|Overall Study|Reason not specified|6|||
157187583|NCT05492877|567428608|FG001|Overall Study|Reason not specified|4|||
157187584|NCT00129376|567428609|FG000|Overall Study|Adverse Event|1|||
157187585|NCT00129376|567428609|FG000|Overall Study|Lack of Efficacy|1|||
157187586|NCT02561273|567428611|FG000|Overall Study|Protocol Violation|1|||
157187587|NCT02561273|567428612|FG001|Overall Study|Protocol Violation|0|||
157187588|NCT04554394|567428624|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
157187589|NCT04554394|567428625|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
157187590|NCT04554394|567428624|FG000|Overall Study|Withdrawal by Subject|2|||
157187591|NCT04554394|567428625|FG001|Overall Study|Withdrawal by Subject|2|||
157067683|NCT00087555|567002640|FG001|Overall Study|Withdrawal by Subject|2|||
157067684|NCT00087555|567002641|FG002|Overall Study|Withdrawal by Subject|1|||
157067685|NCT00087555|567002639|FG000|Overall Study|Lack of Efficacy|2|||
157067686|NCT00087555|567002640|FG001|Overall Study|Lack of Efficacy|0|||
157067687|NCT00087555|567002641|FG002|Overall Study|Lack of Efficacy|1|||
157067688|NCT00087555|567002639|FG000|Overall Study|Non Compliance|0|||
157067689|NCT00087555|567002640|FG001|Overall Study|Non Compliance|0|||
157067690|NCT00087555|567002641|FG002|Overall Study|Non Compliance|1|||
157067691|NCT00087555|567002639|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
157067692|NCT00087555|567002640|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
157067693|NCT00087555|567002641|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
157067694|NCT00087555|567002639|FG000|Overall Study|Patient wanted to go back on Med|1|||
157067695|NCT00087555|567002640|FG001|Overall Study|Patient wanted to go back on Med|0|||
157067696|NCT00087555|567002641|FG002|Overall Study|Patient wanted to go back on Med|0|||
157187592|NCT04554394|567428624|FG000|Overall Study|Lost to Follow-up|2|||
157187593|NCT04554394|567428625|FG001|Overall Study|Lost to Follow-up|2|||
157187594|NCT04554394|567428624|FG000|Overall Study|Physician Decision|1|||
157187595|NCT04554394|567428625|FG001|Overall Study|Physician Decision|1|||
157187596|NCT01766401|567428626|FG000|Overall Study|Adverse Event|7|||
157187597|NCT01766401|567428627|FG001|Overall Study|Adverse Event|22|||
157187598|NCT01766401|567428626|FG000|Overall Study|Lack of Efficacy|1|||
157187599|NCT01766401|567428627|FG001|Overall Study|Lack of Efficacy|2|||
157187600|NCT01766401|567428626|FG000|Overall Study|Protocol Violation|3|||
157187601|NCT01766401|567428627|FG001|Overall Study|Protocol Violation|8|||
157187602|NCT01766401|567428626|FG000|Overall Study|Withdrawal by Subject|15|||
157187603|NCT01766401|567428627|FG001|Overall Study|Withdrawal by Subject|12|||
157187604|NCT01766401|567428626|FG000|Overall Study|Lost to Follow-up|10|||
157187605|NCT01766401|567428627|FG001|Overall Study|Lost to Follow-up|11|||
157187606|NCT01766401|567428626|FG000|Overall Study|Pregnancy|1|||
157187607|NCT01766401|567428627|FG001|Overall Study|Pregnancy|1|||
157187608|NCT01108068|567428628|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
157187609|NCT01108068|567428629|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
157187610|NCT00398086|567428630|FG000|Overall Study|Unacceptable Toxicity|2|||
157187611|NCT00398086|567428631|FG001|Overall Study|Unacceptable Toxicity|8|||
157187612|NCT00398086|567428632|FG002|Overall Study|Unacceptable Toxicity|2|||
157187613|NCT00398086|567428630|FG000|Overall Study|Adverse Event|1|||
157187614|NCT00398086|567428631|FG001|Overall Study|Adverse Event|4|||
157187615|NCT00398086|567428632|FG002|Overall Study|Adverse Event|0|||
157187616|NCT00398086|567428630|FG000|Overall Study|Physician Decision|1|||
157187617|NCT00398086|567428631|FG001|Overall Study|Physician Decision|4|||
157187618|NCT00398086|567428632|FG002|Overall Study|Physician Decision|0|||
157187619|NCT00398086|567428630|FG000|Overall Study|Withdrawal by Subject|5|||
157187620|NCT00398086|567428631|FG001|Overall Study|Withdrawal by Subject|7|||
157187621|NCT00398086|567428632|FG002|Overall Study|Withdrawal by Subject|0|||
157187622|NCT01021553|567428633|FG000|Overall Study|Adverse Event|1|||
157187623|NCT01021553|567428634|FG001|Overall Study|Adverse Event|0|||
157187624|NCT01021553|567428635|FG002|Overall Study|Adverse Event|0|||
157187625|NCT01021553|567428633|FG000|Overall Study|Lack of Efficacy|2|||
157187626|NCT01021553|567428634|FG001|Overall Study|Lack of Efficacy|2|||
157187627|NCT01021553|567428635|FG002|Overall Study|Lack of Efficacy|0|||
157187628|NCT01021553|567428633|FG000|Overall Study|Protocol Violation|0|||
157187629|NCT01021553|567428634|FG001|Overall Study|Protocol Violation|2|||
157187630|NCT01021553|567428635|FG002|Overall Study|Protocol Violation|2|||
157187631|NCT01021553|567428633|FG000|Overall Study|Lost to Follow-up|0|||
157187632|NCT01021553|567428634|FG001|Overall Study|Lost to Follow-up|0|||
157187633|NCT01021553|567428635|FG002|Overall Study|Lost to Follow-up|1|||
157187634|NCT01021553|567428633|FG000|Overall Study|Withdrawal by Subject|1|||
157187635|NCT01021553|567428634|FG001|Overall Study|Withdrawal by Subject|1|||
157187636|NCT01021553|567428635|FG002|Overall Study|Withdrawal by Subject|0|||
157187637|NCT01950364|567428636|FG000|Overall Study|Adverse Event|3|||
157187638|NCT01950364|567428637|FG001|Overall Study|Adverse Event|0|||
157187639|NCT01950364|567428636|FG000|Overall Study|Stem Cell Transplant|2|||
157187640|NCT01950364|567428637|FG001|Overall Study|Stem Cell Transplant|6|||
157187641|NCT01950364|567428636|FG000|Overall Study|Disease Progression|5|||
157230203|NCT02343120|567588279|FG000|Part 2: Expansion|Sponsor decision|0|||
157067697|NCT01062971|567002642|FG000|Overall Study|Protocol Violation|1|||
157187642|NCT01950364|567428637|FG001|Overall Study|Disease Progression|2|||
157187643|NCT01950364|567428636|FG000|Overall Study|Withdrawal by Subject|0|||
157187644|NCT01950364|567428637|FG001|Overall Study|Withdrawal by Subject|1|||
157187645|NCT01950364|567428636|FG000|Overall Study|Protocol Violation|0|||
157187646|NCT01950364|567428637|FG001|Overall Study|Protocol Violation|1|||
157187647|NCT00033293|567428638|FG000|Overall Study|Death|0|||
157187648|NCT00033293|567428639|FG001|Overall Study|Death|1|||
157187649|NCT00033293|567428638|FG000|Overall Study|Lack of Efficacy|5|||
157067698|NCT01062971|567002643|FG001|Overall Study|Protocol Violation|3|||
157067699|NCT01062971|567002642|FG000|Overall Study|Lost to Follow-up|3|||
157187650|NCT00033293|567428639|FG001|Overall Study|Lack of Efficacy|8|||
157187651|NCT00033293|567428638|FG000|Overall Study|Lost to Follow-up|0|||
157067700|NCT01062971|567002643|FG001|Overall Study|Lost to Follow-up|4|||
157067701|NCT00904722|567002654|FG000|Overall Study|Physician Decision|1|||
157067702|NCT00661713|567002655|FG000|Overall Study|Death|1|||
157067703|NCT00661713|567002656|FG001|Overall Study|Death|0|||
157067704|NCT00661713|567002657|FG002|Overall Study|Death|0|||
157067705|NCT00661713|567002658|FG003|Overall Study|Death|0|||
157067706|NCT00661713|567002659|FG004|Overall Study|Death|1|||
157067707|NCT00661713|567002660|FG005|Overall Study|Death|0|||
157067708|NCT00661713|567002661|FG006|Overall Study|Death|0|||
157067709|NCT00661713|567002662|FG007|Overall Study|Death|0|||
157067710|NCT00661713|567002655|FG000|Overall Study|Unable to Classify|1|||
157067711|NCT00661713|567002656|FG001|Overall Study|Unable to Classify|0|||
157067712|NCT00661713|567002657|FG002|Overall Study|Unable to Classify|0|||
157067713|NCT00661713|567002658|FG003|Overall Study|Unable to Classify|0|||
157067714|NCT00661713|567002659|FG004|Overall Study|Unable to Classify|0|||
157067715|NCT00661713|567002660|FG005|Overall Study|Unable to Classify|0|||
157067716|NCT00661713|567002661|FG006|Overall Study|Unable to Classify|0|||
157067717|NCT00661713|567002662|FG007|Overall Study|Unable to Classify|0|||
157067718|NCT00661713|567002655|FG000|Overall Study|Protocol Violation|1|||
157067719|NCT00661713|567002656|FG001|Overall Study|Protocol Violation|6|||
157067720|NCT00661713|567002657|FG002|Overall Study|Protocol Violation|3|||
157067721|NCT00661713|567002658|FG003|Overall Study|Protocol Violation|3|||
157067722|NCT00661713|567002659|FG004|Overall Study|Protocol Violation|0|||
157067723|NCT00661713|567002660|FG005|Overall Study|Protocol Violation|2|||
157067724|NCT00661713|567002661|FG006|Overall Study|Protocol Violation|2|||
157067725|NCT00661713|567002662|FG007|Overall Study|Protocol Violation|1|||
157067726|NCT00661713|567002655|FG000|Overall Study|Withdrawal by Subject|11|||
157067727|NCT00661713|567002656|FG001|Overall Study|Withdrawal by Subject|25|||
157067728|NCT00661713|567002657|FG002|Overall Study|Withdrawal by Subject|12|||
157067729|NCT00661713|567002658|FG003|Overall Study|Withdrawal by Subject|21|||
157067730|NCT00661713|567002659|FG004|Overall Study|Withdrawal by Subject|12|||
157067731|NCT00661713|567002660|FG005|Overall Study|Withdrawal by Subject|26|||
157067732|NCT00661713|567002661|FG006|Overall Study|Withdrawal by Subject|45|||
157067733|NCT00661713|567002662|FG007|Overall Study|Withdrawal by Subject|9|||
157067734|NCT00661713|567002655|FG000|Overall Study|Lost to Follow-up|2|||
157067735|NCT00661713|567002656|FG001|Overall Study|Lost to Follow-up|7|||
157067736|NCT00661713|567002657|FG002|Overall Study|Lost to Follow-up|2|||
157067737|NCT00661713|567002658|FG003|Overall Study|Lost to Follow-up|2|||
157067738|NCT00661713|567002659|FG004|Overall Study|Lost to Follow-up|5|||
157067739|NCT00661713|567002660|FG005|Overall Study|Lost to Follow-up|7|||
157067740|NCT00661713|567002661|FG006|Overall Study|Lost to Follow-up|14|||
157067741|NCT00661713|567002662|FG007|Overall Study|Lost to Follow-up|1|||
157067742|NCT00661713|567002655|FG000|Overall Study|Administrative Reason|0|||
157067743|NCT00661713|567002656|FG001|Overall Study|Administrative Reason|1|||
157067744|NCT00661713|567002657|FG002|Overall Study|Administrative Reason|0|||
157067745|NCT00661713|567002658|FG003|Overall Study|Administrative Reason|2|||
157067746|NCT00661713|567002659|FG004|Overall Study|Administrative Reason|2|||
157067747|NCT00661713|567002660|FG005|Overall Study|Administrative Reason|2|||
157067748|NCT00661713|567002661|FG006|Overall Study|Administrative Reason|1|||
157067749|NCT00661713|567002662|FG007|Overall Study|Administrative Reason|0|||
157067750|NCT00661713|567002655|FG000|Overall Study|Adverse Event|0|||
157067751|NCT00661713|567002656|FG001|Overall Study|Adverse Event|0|||
157067752|NCT00661713|567002657|FG002|Overall Study|Adverse Event|0|||
157067753|NCT00661713|567002658|FG003|Overall Study|Adverse Event|0|||
157067754|NCT00661713|567002659|FG004|Overall Study|Adverse Event|0|||
157067755|NCT00661713|567002660|FG005|Overall Study|Adverse Event|0|||
157067756|NCT00661713|567002661|FG006|Overall Study|Adverse Event|1|||
157067757|NCT00661713|567002662|FG007|Overall Study|Adverse Event|0|||
157067758|NCT00661713|567002655|FG000|Overall Study|Inappropriate Enrollment|0|||
157067759|NCT00661713|567002656|FG001|Overall Study|Inappropriate Enrollment|0|||
157067760|NCT00661713|567002657|FG002|Overall Study|Inappropriate Enrollment|0|||
157067761|NCT00661713|567002658|FG003|Overall Study|Inappropriate Enrollment|0|||
157067762|NCT00661713|567002659|FG004|Overall Study|Inappropriate Enrollment|0|||
157067763|NCT00661713|567002660|FG005|Overall Study|Inappropriate Enrollment|0|||
157067764|NCT00661713|567002661|FG006|Overall Study|Inappropriate Enrollment|1|||
157187652|NCT00033293|567428639|FG001|Overall Study|Lost to Follow-up|1|||
157067765|NCT00661713|567002662|FG007|Overall Study|Inappropriate Enrollment|0|||
157067766|NCT01801982|567002663|FG000|Overall Study|Lost to Follow-up|1|||
157067767|NCT00727506|567002666|FG000|Overall Study|Adverse Event|0|||
157067768|NCT00727506|567002667|FG001|Overall Study|Adverse Event|0|||
157067769|NCT00727506|567002668|FG002|Overall Study|Adverse Event|4|||
157067770|NCT00727506|567002669|FG003|Overall Study|Adverse Event|4|||
157067771|NCT00727506|567002670|FG004|Overall Study|Adverse Event|1|||
157067772|NCT00727506|567002671|FG005|Overall Study|Adverse Event|8|||
157067773|NCT00727506|567002666|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
157067774|NCT00727506|567002667|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157067775|NCT00727506|567002668|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
157067776|NCT00727506|567002669|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157067777|NCT00727506|567002670|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157187653|NCT00033293|567428638|FG000|Overall Study|Physician Decision|3|||
157187654|NCT00033293|567428639|FG001|Overall Study|Physician Decision|1|||
157187655|NCT00033293|567428638|FG000|Overall Study|Withdrawal by Subject|1|||
157187656|NCT00033293|567428639|FG001|Overall Study|Withdrawal by Subject|0|||
157187657|NCT00033293|567428638|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
157187658|NCT00033293|567428639|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
157187659|NCT00033293|567428638|FG000|Overall Study|Treatment refused|0|||
157187660|NCT00033293|567428639|FG001|Overall Study|Treatment refused|6|||
157187661|NCT00935701|567428640|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
157187662|NCT02087241|567428641|FG000|Overall Study|Death|2|||
157187663|NCT02087241|567428642|FG001|Overall Study|Death|1|||
157187664|NCT02087241|567428643|FG002|Overall Study|Death|1|||
157187665|NCT02087241|567428644|FG003|Overall Study|Death|1|||
157187666|NCT02087241|567428641|FG000|Overall Study|Withdrawal by Subject|1|||
157187667|NCT02087241|567428642|FG001|Overall Study|Withdrawal by Subject|0|||
157187668|NCT02087241|567428643|FG002|Overall Study|Withdrawal by Subject|0|||
157187669|NCT02087241|567428644|FG003|Overall Study|Withdrawal by Subject|1|||
157187670|NCT02087241|567428641|FG000|Overall Study|Progressive Disease|0|||
157187671|NCT02087241|567428642|FG001|Overall Study|Progressive Disease|0|||
157187672|NCT02087241|567428643|FG002|Overall Study|Progressive Disease|0|||
157187673|NCT02087241|567428644|FG003|Overall Study|Progressive Disease|1|||
157187674|NCT02087241|567428641|FG000|Overall Study|Study Terminated by Sponsor|0|||
157187675|NCT02087241|567428642|FG001|Overall Study|Study Terminated by Sponsor|2|||
157187676|NCT02087241|567428643|FG002|Overall Study|Study Terminated by Sponsor|0|||
157187677|NCT02087241|567428644|FG003|Overall Study|Study Terminated by Sponsor|4|||
157187678|NCT01955005|567428645|FG000|Overall Study|Withdrawal by Subject|3|||
157187679|NCT01955005|567428646|FG001|Overall Study|Withdrawal by Subject|5|||
157187680|NCT00836953|567428647|FG000|Overall Study|Withdrawal by Subject|1|||
157187681|NCT00836953|567428647|FG000|Overall Study|Lost to Follow-up|1|||
157187682|NCT01200758|567428648|FG000|Stage I|Death|0|||
157187683|NCT01200758|567428649|FG001|Stage I|Death|1|||
157187684|NCT01200758|567428650|FG002|Stage I|Death|0|||
157187685|NCT01200758|567428651|FG003|Stage I|Death|0|||
157187686|NCT01200758|567428648|FG000|Stage I|Physician Decision|1|||
157187687|NCT01200758|567428649|FG001|Stage I|Physician Decision|1|||
157187688|NCT01200758|567428650|FG002|Stage I|Physician Decision|0|||
157187689|NCT01200758|567428651|FG003|Stage I|Physician Decision|0|||
157187690|NCT01200758|567428648|FG000|Stage I|Lack of Efficacy|2|||
157187691|NCT01200758|567428649|FG001|Stage I|Lack of Efficacy|1|||
157187692|NCT01200758|567428650|FG002|Stage I|Lack of Efficacy|0|||
157187693|NCT01200758|567428651|FG003|Stage I|Lack of Efficacy|0|||
157187694|NCT01200758|567428648|FG000|Stage I|Adverse Event|5|||
157187695|NCT01200758|567428649|FG001|Stage I|Adverse Event|5|||
157187696|NCT01200758|567428650|FG002|Stage I|Adverse Event|0|||
157187697|NCT01200758|567428651|FG003|Stage I|Adverse Event|0|||
157187698|NCT01200758|567428648|FG000|Stage I|Withdrawal by Subject|1|||
157187699|NCT01200758|567428649|FG001|Stage I|Withdrawal by Subject|2|||
157187700|NCT01200758|567428650|FG002|Stage I|Withdrawal by Subject|0|||
157187701|NCT01200758|567428651|FG003|Stage I|Withdrawal by Subject|0|||
157187702|NCT01200758|567428648|FG000|Stage I|Disease Progression|9|||
157187703|NCT01200758|567428649|FG001|Stage I|Disease Progression|7|||
157187704|NCT01200758|567428650|FG002|Stage I|Disease Progression|0|||
157187705|NCT01200758|567428651|FG003|Stage I|Disease Progression|0|||
157187706|NCT01200758|567428648|FG000|Stage 2|Disease Progression|0|||
157187707|NCT01200758|567428649|FG001|Stage 2|Disease Progression|0|||
157187708|NCT01200758|567428650|FG002|Stage 2|Disease Progression|16|||
157187709|NCT01200758|567428651|FG003|Stage 2|Disease Progression|21|||
157187710|NCT01200758|567428648|FG000|Stage 2|Lack of Efficacy|0|||
157187711|NCT01200758|567428649|FG001|Stage 2|Lack of Efficacy|0|||
157187712|NCT01200758|567428650|FG002|Stage 2|Lack of Efficacy|4|||
157187713|NCT01200758|567428651|FG003|Stage 2|Lack of Efficacy|2|||
157187714|NCT01200758|567428648|FG000|Stage 2|Physician Decision|0|||
157187715|NCT01200758|567428649|FG001|Stage 2|Physician Decision|0|||
157187716|NCT01200758|567428650|FG002|Stage 2|Physician Decision|5|||
157187717|NCT01200758|567428651|FG003|Stage 2|Physician Decision|7|||
157187718|NCT01200758|567428648|FG000|Stage 2|Adverse Event|0|||
157187719|NCT01200758|567428649|FG001|Stage 2|Adverse Event|0|||
157187720|NCT01200758|567428650|FG002|Stage 2|Adverse Event|5|||
157187721|NCT01200758|567428651|FG003|Stage 2|Adverse Event|9|||
157187722|NCT01200758|567428648|FG000|Stage 2|Withdrawal by Subject|0|||
157187723|NCT01200758|567428649|FG001|Stage 2|Withdrawal by Subject|0|||
157187724|NCT01200758|567428650|FG002|Stage 2|Withdrawal by Subject|4|||
157187725|NCT01200758|567428651|FG003|Stage 2|Withdrawal by Subject|1|||
157187726|NCT01200758|567428648|FG000|Stage 2|Lost to Follow-up|0|||
157187727|NCT01200758|567428649|FG001|Stage 2|Lost to Follow-up|0|||
157187728|NCT01200758|567428650|FG002|Stage 2|Lost to Follow-up|3|||
157187729|NCT01200758|567428651|FG003|Stage 2|Lost to Follow-up|1|||
157187730|NCT01200758|567428648|FG000|Stage 2|Protocol Violation|0|||
157187731|NCT01200758|567428649|FG001|Stage 2|Protocol Violation|0|||
157187732|NCT01200758|567428650|FG002|Stage 2|Protocol Violation|1|||
157187733|NCT01200758|567428651|FG003|Stage 2|Protocol Violation|4|||
157187734|NCT01200758|567428648|FG000|Stage 2|Death|0|||
157187735|NCT01200758|567428649|FG001|Stage 2|Death|0|||
157187736|NCT01200758|567428650|FG002|Stage 2|Death|3|||
157187737|NCT01200758|567428651|FG003|Stage 2|Death|5|||
157187738|NCT02201251|567428652|FG000|Overall Study|Adverse Event|1|||
157187739|NCT02201251|567428653|FG001|Overall Study|Adverse Event|1|||
157187740|NCT02201251|567428652|FG000|Overall Study|Protocol Violation|1|||
157187741|NCT02201251|567428653|FG001|Overall Study|Protocol Violation|0|||
157187742|NCT02201251|567428652|FG000|Overall Study|Noncompliance with Study Drug|0|||
157187743|NCT02201251|567428653|FG001|Overall Study|Noncompliance with Study Drug|1|||
157187744|NCT02201251|567428652|FG000|Overall Study|Withdrawal by Subject|2|||
157187745|NCT02201251|567428653|FG001|Overall Study|Withdrawal by Subject|1|||
157187746|NCT02711553|567428654|FG000|Overall Study|Withdrawal by Subject|2|||
157187747|NCT02711553|567428655|FG001|Overall Study|Withdrawal by Subject|1|||
157187748|NCT02711553|567428656|FG002|Overall Study|Withdrawal by Subject|1|||
157187749|NCT02711553|567428657|FG003|Overall Study|Withdrawal by Subject|0|||
157187750|NCT02711553|567428654|FG000|Overall Study|Lost to Follow-up|3|||
157187751|NCT02711553|567428655|FG001|Overall Study|Lost to Follow-up|3|||
157187752|NCT02711553|567428656|FG002|Overall Study|Lost to Follow-up|6|||
157187753|NCT02711553|567428657|FG003|Overall Study|Lost to Follow-up|3|||
157187754|NCT02711553|567428654|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
157187755|NCT02711553|567428655|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
157187756|NCT02711553|567428656|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
157187757|NCT02711553|567428657|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
157187758|NCT04048876|567428660|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
157187759|NCT04048876|567428661|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
157187760|NCT04048876|567428662|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
157187761|NCT04048876|567428663|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
157187762|NCT04048876|567428660|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
157187763|NCT04048876|567428661|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
157187764|NCT04048876|567428662|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
157187765|NCT04048876|567428663|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
157187766|NCT04048876|567428660|FG000|Placebo Controlled Phase|Adverse Event|0|||
157187767|NCT04048876|567428661|FG001|Placebo Controlled Phase|Adverse Event|1|||
157187768|NCT04048876|567428662|FG002|Placebo Controlled Phase|Adverse Event|0|||
157187769|NCT04048876|567428663|FG003|Placebo Controlled Phase|Adverse Event|0|||
157187770|NCT04048876|567428660|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
157187771|NCT04048876|567428661|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
157187772|NCT04048876|567428662|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
157187773|NCT04048876|567428663|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
157187774|NCT01197794|567428666|FG000|Overall Study|Adverse Event|3|||
157187775|NCT01197794|567428667|FG001|Overall Study|Adverse Event|2|||
157187776|NCT01197794|567428668|FG002|Overall Study|Adverse Event|4|||
157187777|NCT01197794|567428669|FG003|Overall Study|Adverse Event|4|||
157187778|NCT01197794|567428670|FG004|Overall Study|Adverse Event|4|||
157187779|NCT01197794|567428671|FG005|Overall Study|Adverse Event|2|||
157187780|NCT01197794|567428672|FG006|Overall Study|Adverse Event|3|||
157187781|NCT01197794|567428666|FG000|Overall Study|Protocol Violation|0|||
157187782|NCT01197794|567428667|FG001|Overall Study|Protocol Violation|0|||
157187783|NCT01197794|567428668|FG002|Overall Study|Protocol Violation|0|||
157187784|NCT01197794|567428669|FG003|Overall Study|Protocol Violation|0|||
157187785|NCT01197794|567428670|FG004|Overall Study|Protocol Violation|2|||
157187786|NCT01197794|567428671|FG005|Overall Study|Protocol Violation|0|||
157187787|NCT01197794|567428672|FG006|Overall Study|Protocol Violation|1|||
157187788|NCT01197794|567428666|FG000|Overall Study|Development of study withdrawal criteria|3|||
157187789|NCT01197794|567428667|FG001|Overall Study|Development of study withdrawal criteria|0|||
157187790|NCT01197794|567428668|FG002|Overall Study|Development of study withdrawal criteria|0|||
157187791|NCT01197794|567428669|FG003|Overall Study|Development of study withdrawal criteria|1|||
157187792|NCT01197794|567428670|FG004|Overall Study|Development of study withdrawal criteria|0|||
157187793|NCT01197794|567428671|FG005|Overall Study|Development of study withdrawal criteria|0|||
157187794|NCT01197794|567428672|FG006|Overall Study|Development of study withdrawal criteria|1|||
157187795|NCT01197794|567428666|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
157187796|NCT01197794|567428667|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
157187797|NCT01197794|567428668|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
157187798|NCT01197794|567428669|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
157187799|NCT01197794|567428670|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
157230204|NCT02343120|567588280|FG001|Part 2: Expansion|Sponsor decision|0|||
157230205|NCT02343120|567588281|FG002|Part 2: Expansion|Sponsor decision|0|||
157187800|NCT01197794|567428671|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
157187801|NCT01197794|567428672|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
157187802|NCT01197794|567428666|FG000|Overall Study|Withdrawal by Subject|3|||
157187803|NCT01197794|567428667|FG001|Overall Study|Withdrawal by Subject|3|||
157187804|NCT01197794|567428668|FG002|Overall Study|Withdrawal by Subject|4|||
157187805|NCT01197794|567428669|FG003|Overall Study|Withdrawal by Subject|1|||
157230206|NCT02343120|567588282|FG003|Part 2: Expansion|Sponsor decision|165|||
157187806|NCT01197794|567428670|FG004|Overall Study|Withdrawal by Subject|1|||
157187807|NCT01197794|567428671|FG005|Overall Study|Withdrawal by Subject|5|||
157187808|NCT01197794|567428672|FG006|Overall Study|Withdrawal by Subject|6|||
157187809|NCT01197794|567428666|FG000|Overall Study|Lost to Follow-up|1|||
157187810|NCT01197794|567428667|FG001|Overall Study|Lost to Follow-up|1|||
157187811|NCT01197794|567428668|FG002|Overall Study|Lost to Follow-up|0|||
157187812|NCT01197794|567428669|FG003|Overall Study|Lost to Follow-up|1|||
157187813|NCT01197794|567428670|FG004|Overall Study|Lost to Follow-up|0|||
157187814|NCT01197794|567428671|FG005|Overall Study|Lost to Follow-up|1|||
157187815|NCT01197794|567428672|FG006|Overall Study|Lost to Follow-up|0|||
157187816|NCT01197794|567428666|FG000|Overall Study|Other|1|||
157187817|NCT01197794|567428667|FG001|Overall Study|Other|1|||
157187818|NCT01197794|567428668|FG002|Overall Study|Other|3|||
157187819|NCT01197794|567428669|FG003|Overall Study|Other|0|||
157187820|NCT01197794|567428670|FG004|Overall Study|Other|2|||
157187821|NCT01197794|567428671|FG005|Overall Study|Other|2|||
157187822|NCT01197794|567428672|FG006|Overall Study|Other|4|||
157187823|NCT04055844|567428673|FG000|Overall Study|Adverse Event|12|||
157187824|NCT04055844|567428673|FG000|Overall Study|Poor Performance|1|||
157187825|NCT04055844|567428673|FG000|Overall Study|Death|1|||
157187826|NCT02724111|567428680|FG000|Overall Study|Protocol Violation|2|||
157187827|NCT02724111|567428681|FG001|Overall Study|Protocol Violation|5|||
157187828|NCT02996500|567428682|FG000|Overall Study|Adverse Event|1|||
157187829|NCT02996500|567428683|FG001|Overall Study|Adverse Event|1|||
157187830|NCT02996500|567428684|FG002|Overall Study|Adverse Event|4|||
157187831|NCT02996500|567428685|FG003|Overall Study|Adverse Event|3|||
157187832|NCT02996500|567428686|FG004|Overall Study|Adverse Event|1|||
157187833|NCT02996500|567428687|FG005|Overall Study|Adverse Event|2|||
157187834|NCT02996500|567428682|FG000|Overall Study|Lack of Efficacy|0|||
157067778|NCT00727506|567002671|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157067779|NCT00727506|567002666|FG000|Overall Study|Progressive disease|4|||
157067780|NCT00727506|567002667|FG001|Overall Study|Progressive disease|7|||
157067781|NCT00727506|567002668|FG002|Overall Study|Progressive disease|9|||
157067782|NCT00727506|567002669|FG003|Overall Study|Progressive disease|28|||
157067783|NCT00727506|567002670|FG004|Overall Study|Progressive disease|38|||
157067784|NCT00727506|567002671|FG005|Overall Study|Progressive disease|28|||
157067785|NCT00727506|567002666|FG000|Overall Study|Refused to continue medication|0|||
157067786|NCT00727506|567002667|FG001|Overall Study|Refused to continue medication|1|||
157067787|NCT00727506|567002668|FG002|Overall Study|Refused to continue medication|2|||
157067788|NCT00727506|567002669|FG003|Overall Study|Refused to continue medication|3|||
157067789|NCT00727506|567002670|FG004|Overall Study|Refused to continue medication|1|||
157067790|NCT00727506|567002671|FG005|Overall Study|Refused to continue medication|2|||
157067791|NCT00727506|567002666|FG000|Overall Study|Other reason not described above|0|||
157067792|NCT00727506|567002667|FG001|Overall Study|Other reason not described above|0|||
157067793|NCT00727506|567002668|FG002|Overall Study|Other reason not described above|1|||
157067794|NCT00727506|567002669|FG003|Overall Study|Other reason not described above|4|||
157067795|NCT00727506|567002670|FG004|Overall Study|Other reason not described above|1|||
157067796|NCT00727506|567002671|FG005|Overall Study|Other reason not described above|1|||
157067797|NCT02650466|567002673|FG000|Overall Study|Physician Decision|1|||
157067798|NCT02650466|567002673|FG000|Overall Study|Withdrawal by Subject|5|||
157067799|NCT02650466|567002673|FG000|Overall Study|Lost to Follow-up|1|||
157067800|NCT01214421|567002674|FG000|Overall Study|Lost to Follow-up|7|||
157067801|NCT01214421|567002675|FG001|Overall Study|Lost to Follow-up|3|||
157067802|NCT01214421|567002676|FG002|Overall Study|Lost to Follow-up|7|||
157067803|NCT01214421|567002677|FG003|Overall Study|Lost to Follow-up|3|||
157067804|NCT01214421|567002674|FG000|Overall Study|Adverse Event|16|||
157067805|NCT01214421|567002675|FG001|Overall Study|Adverse Event|35|||
157067806|NCT01214421|567002676|FG002|Overall Study|Adverse Event|14|||
157067807|NCT01214421|567002677|FG003|Overall Study|Adverse Event|3|||
157067808|NCT01214421|567002674|FG000|Overall Study|Sponsor Discontinued Site|1|||
157067809|NCT01214421|567002675|FG001|Overall Study|Sponsor Discontinued Site|2|||
157067810|NCT01214421|567002676|FG002|Overall Study|Sponsor Discontinued Site|0|||
157067811|NCT01214421|567002677|FG003|Overall Study|Sponsor Discontinued Site|0|||
157067812|NCT01214421|567002674|FG000|Overall Study|Withdrawal Criteria Met|3|||
157187835|NCT02996500|567428683|FG001|Overall Study|Lack of Efficacy|0|||
157187836|NCT02996500|567428684|FG002|Overall Study|Lack of Efficacy|0|||
157187837|NCT02996500|567428685|FG003|Overall Study|Lack of Efficacy|0|||
157187838|NCT02996500|567428686|FG004|Overall Study|Lack of Efficacy|2|||
157187839|NCT02996500|567428687|FG005|Overall Study|Lack of Efficacy|0|||
157187840|NCT02996500|567428682|FG000|Overall Study|Lost to Follow-up|1|||
157187841|NCT02996500|567428683|FG001|Overall Study|Lost to Follow-up|0|||
157187842|NCT02996500|567428684|FG002|Overall Study|Lost to Follow-up|0|||
157187843|NCT02996500|567428685|FG003|Overall Study|Lost to Follow-up|0|||
157067813|NCT01214421|567002675|FG001|Overall Study|Withdrawal Criteria Met|0|||
157067814|NCT01214421|567002676|FG002|Overall Study|Withdrawal Criteria Met|2|||
157067815|NCT01214421|567002677|FG003|Overall Study|Withdrawal Criteria Met|1|||
157067816|NCT01214421|567002674|FG000|Overall Study|Physician Decision|2|||
157067817|NCT01214421|567002675|FG001|Overall Study|Physician Decision|0|||
157187844|NCT02996500|567428686|FG004|Overall Study|Lost to Follow-up|0|||
157067818|NCT01214421|567002676|FG002|Overall Study|Physician Decision|4|||
157067819|NCT01214421|567002677|FG003|Overall Study|Physician Decision|0|||
157067820|NCT01214421|567002674|FG000|Overall Study|Withdrawal by Subject|21|||
157067821|NCT01214421|567002675|FG001|Overall Study|Withdrawal by Subject|18|||
157067822|NCT01214421|567002676|FG002|Overall Study|Withdrawal by Subject|11|||
157067823|NCT01214421|567002677|FG003|Overall Study|Withdrawal by Subject|2|||
157067824|NCT03783689|567002679|FG000|Overall Study|Adverse Event|2|||
157067825|NCT03783689|567002680|FG001|Overall Study|Adverse Event|0|||
157067826|NCT03783689|567002679|FG000|Overall Study|Lost to Follow-up|2|||
157067827|NCT03783689|567002680|FG001|Overall Study|Lost to Follow-up|1|||
157067828|NCT03783689|567002679|FG000|Overall Study|Physician Decision|2|||
157067829|NCT03783689|567002680|FG001|Overall Study|Physician Decision|1|||
157067830|NCT03783689|567002679|FG000|Overall Study|Withdrawal by Subject|3|||
157067831|NCT03783689|567002680|FG001|Overall Study|Withdrawal by Subject|3|||
157067832|NCT02392104|567002682|FG000|Overall Study|discontinuation of warfarin|3|||
157067833|NCT02392104|567002682|FG000|Overall Study|bleeding event|1|||
157067834|NCT02392104|567002682|FG000|Overall Study|transferred care to another doctor|2|||
157067835|NCT02392104|567002682|FG000|Overall Study|INR goal range changed|1|||
157067836|NCT02392104|567002682|FG000|Overall Study|admitted to skilled nursing facility|3|||
157067837|NCT02392104|567002682|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
157067838|NCT04887506|567002683|FG000|Overall Study|Death|1|||
157067839|NCT04887506|567002684|FG001|Overall Study|Death|1|||
157067840|NCT04887506|567002683|FG000|Overall Study|Withdrawal by Subject|0|||
157067841|NCT04887506|567002684|FG001|Overall Study|Withdrawal by Subject|3|||
157067842|NCT04887506|567002683|FG000|Overall Study|Adverse Event|4|||
157067843|NCT04887506|567002684|FG001|Overall Study|Adverse Event|3|||
157067844|NCT04887506|567002683|FG000|Overall Study|Other - Not Reported|1|||
157067845|NCT04887506|567002684|FG001|Overall Study|Other - Not Reported|1|||
157067846|NCT05093504|567002691|FG000|Overall Study|Death|0|||
157067847|NCT05093504|567002692|FG001|Overall Study|Death|1|||
157067848|NCT03151551|567002693|FG000|Open-Label Treatment Period|Adverse Event|0|||
157067849|NCT03151551|567002694|FG001|Open-Label Treatment Period|Adverse Event|2|||
157067850|NCT03151551|567002693|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
157067851|NCT03151551|567002694|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
157067852|NCT03151551|567002693|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
157067853|NCT03151551|567002694|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
157067854|NCT03151551|567002693|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
157067855|NCT03151551|567002694|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
157067856|NCT03151551|567002693|FG000|Open-Label Treatment Period|Physician Decision|3|||
157067857|NCT03151551|567002694|FG001|Open-Label Treatment Period|Physician Decision|0|||
157067858|NCT03151551|567002693|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
157067859|NCT03151551|567002694|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
157067860|NCT03151551|567002693|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
157067861|NCT03151551|567002694|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
157067862|NCT03151551|567002693|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
157067863|NCT03151551|567002694|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
157067864|NCT03151551|567002693|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
157067865|NCT03151551|567002694|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
157067866|NCT03151551|567002693|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
157067867|NCT03151551|567002694|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
157067868|NCT01190449|567002695|FG000|Overall Study|Ineligible|0|||
157067869|NCT01190449|567002696|FG001|Overall Study|Ineligible|4|||
157067870|NCT05347485|567002699|FG000|Overall Study|Death|14|||
157067871|NCT05347485|567002699|FG000|Overall Study|Lost to Follow-up|2|||
157067872|NCT05347485|567002699|FG000|Overall Study|Withdrawal by Subject|13|||
157067873|NCT05347485|567002699|FG000|Overall Study|Progressive Disease|1|||
157067874|NCT05347485|567002699|FG000|Overall Study|Study Terminated by Sponsor|49|||
157067875|NCT05347485|567002699|FG000|Overall Study|Other|1|||
157067876|NCT05347485|567002699|FG000|Overall Study|Enrolled (consented) but not treated|4|||
157067877|NCT05347485|567002699|FG000|Overall Study|Disease Relapse|2|||
157067878|NCT01190644|567004260|FG000|Overall Study|Death|2|||
157067879|NCT01190644|567004260|FG000|Overall Study|Disease progression|1|||
157067880|NCT04795336|567004263|FG000|Overall Study|Withdrawal by Subject|3|||
157067881|NCT04795336|567004264|FG001|Overall Study|Withdrawal by Subject|4|||
157067882|NCT04795336|567004265|FG002|Overall Study|Withdrawal by Subject|3|||
157067883|NCT04795336|567004266|FG003|Overall Study|Withdrawal by Subject|12|||
157067884|NCT04795336|567004263|FG000|Overall Study|Lost study logs|0|||
157067885|NCT04795336|567004264|FG001|Overall Study|Lost study logs|1|||
157067886|NCT04795336|567004265|FG002|Overall Study|Lost study logs|0|||
157067887|NCT04795336|567004266|FG003|Overall Study|Lost study logs|2|||
157067888|NCT04795336|567004263|FG000|Overall Study|Did not take study medication|2|||
157067889|NCT04795336|567004264|FG001|Overall Study|Did not take study medication|0|||
157067890|NCT04795336|567004265|FG002|Overall Study|Did not take study medication|0|||
157067891|NCT04795336|567004266|FG003|Overall Study|Did not take study medication|0|||
157067892|NCT04596995|567004269|FG000|Overall Study|Lack of Efficacy|8|||
157067893|NCT04596995|567004269|FG000|Overall Study|Lost to Follow-up|3|||
157067894|NCT04596995|567004269|FG000|Overall Study|Withdrawal by Subject|12|||
157067895|NCT04596995|567004269|FG000|Overall Study|Sponsor decision|3|||
157067896|NCT04596995|567004269|FG000|Overall Study|Enrolled in managed access program|3|||
157067897|NCT05382039|567004270|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
157067898|NCT05382039|567004271|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
157067899|NCT05382039|567004272|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
157067900|NCT05382039|567004270|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
157067901|NCT05382039|567004271|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
157067902|NCT05382039|567004272|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
157067903|NCT05382039|567004270|FG000|Overall Study|waiting for confirmation|0|||
157067904|NCT05382039|567004271|FG001|Overall Study|waiting for confirmation|0|||
157067905|NCT05382039|567004272|FG002|Overall Study|waiting for confirmation|1|||
157067906|NCT04464421|567004273|FG000|Overall Study|Lost to Follow-up|2|||
157067907|NCT04464421|567004274|FG001|Overall Study|Lost to Follow-up|2|||
157067908|NCT02577003|567004275|FG000|Overall Study|Adverse Event|2|||
157067909|NCT02577003|567004276|FG001|Overall Study|Adverse Event|4|||
157067910|NCT02577003|567004275|FG000|Overall Study|Withdrawal by Subject|0|||
157067911|NCT02577003|567004276|FG001|Overall Study|Withdrawal by Subject|1|||
157067912|NCT02786004|567004277|FG000|Overall Study|Withdrawal by Subject|0|||
157067913|NCT02786004|567004278|FG001|Overall Study|Withdrawal by Subject|1|||
157067914|NCT01234883|567004279|FG000|Overall Study|Early treatment release|8|||
157067915|NCT01234883|567004280|FG001|Overall Study|Early treatment release|10|||
157067916|NCT01234883|567004279|FG000|Overall Study|Parent/guardian withdrew consent|1|||
157067917|NCT01234883|567004280|FG001|Overall Study|Parent/guardian withdrew consent|2|||
157067918|NCT01234883|567004279|FG000|Overall Study|Technical difficulties with IV infusion|0|||
157067919|NCT01234883|567004280|FG001|Overall Study|Technical difficulties with IV infusion|1|||
157067920|NCT01234883|567004279|FG000|Overall Study|Inclusion/exclusion failure|1|||
157067921|NCT01234883|567004280|FG001|Overall Study|Inclusion/exclusion failure|0|||
157067922|NCT03210519|567004281|FG000|Overall Study|Adverse Event|2|||
157067923|NCT03210519|567004282|FG001|Overall Study|Adverse Event|0|||
157067924|NCT03865953|567004285|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
157067925|NCT03865953|567004286|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
157067926|NCT03865953|567004285|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
157067927|NCT03865953|567004286|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
157067928|NCT03865953|567004285|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
157067929|NCT03865953|567004286|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
157067930|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
157067931|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
157067932|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
157067933|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
157067934|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
157067935|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
157067936|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
157067937|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
157067938|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
157067939|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
157067940|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
157067941|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
157067942|NCT01216072|567004292|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
157067943|NCT01216072|567004293|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
157067944|NCT01216072|567004292|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
157067945|NCT01216072|567004293|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
157067946|NCT01216072|567004292|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
157067947|NCT01216072|567004293|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
157067948|NCT01216072|567004292|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
157067949|NCT01216072|567004293|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
157067950|NCT00992992|567004297|FG000|Overall Study|Lost to Follow-up|3|||
157067951|NCT00992992|567004297|FG000|Overall Study|Death|16|||
157067952|NCT00992992|567004297|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
157067953|NCT00992992|567004297|FG000|Overall Study|Sponsor Closed the Study|4|||
157067954|NCT00217022|567004299|FG000|Overall Study|Withdrawal by Subject|1|||
157067955|NCT00217022|567004300|FG001|Overall Study|Withdrawal by Subject|1|||
157187845|NCT02996500|567428687|FG005|Overall Study|Lost to Follow-up|1|||
157187846|NCT02996500|567428682|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
157187847|NCT02996500|567428683|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
157067956|NCT00458393|567004301|FG000|Overall Study|Withdrawal by Subject|67|||
157067957|NCT00458393|567004302|FG001|Overall Study|Withdrawal by Subject|80|||
157067958|NCT00458393|567004301|FG000|Overall Study|Physician Decision|31|||
157187848|NCT02996500|567428684|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
157187849|NCT02996500|567428685|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
157187850|NCT02996500|567428686|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
157187851|NCT02996500|567428687|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
157187852|NCT02996500|567428682|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157187853|NCT02996500|567428683|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157187854|NCT02996500|567428684|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157187855|NCT02996500|567428685|FG003|Overall Study|Non-Compliance With Study Drug|0|||
157187856|NCT02996500|567428686|FG004|Overall Study|Non-Compliance With Study Drug|0|||
157187857|NCT02996500|567428687|FG005|Overall Study|Non-Compliance With Study Drug|1|||
157187858|NCT02996500|567428682|FG000|Overall Study|Progressive Disease|1|||
157187859|NCT02996500|567428683|FG001|Overall Study|Progressive Disease|0|||
157187860|NCT02996500|567428684|FG002|Overall Study|Progressive Disease|0|||
157187861|NCT02996500|567428685|FG003|Overall Study|Progressive Disease|0|||
157187862|NCT02996500|567428686|FG004|Overall Study|Progressive Disease|0|||
157187863|NCT02996500|567428687|FG005|Overall Study|Progressive Disease|0|||
157187864|NCT02996500|567428682|FG000|Overall Study|Other|2|||
157187865|NCT02996500|567428683|FG001|Overall Study|Other|0|||
157187866|NCT02996500|567428684|FG002|Overall Study|Other|2|||
157187867|NCT02996500|567428685|FG003|Overall Study|Other|0|||
157187868|NCT02996500|567428686|FG004|Overall Study|Other|0|||
157187869|NCT02996500|567428687|FG005|Overall Study|Other|0|||
157187870|NCT02996500|567428682|FG000|Overall Study|Protocol Violation|0|||
157187871|NCT02996500|567428683|FG001|Overall Study|Protocol Violation|0|||
157187872|NCT02996500|567428684|FG002|Overall Study|Protocol Violation|0|||
157187873|NCT02996500|567428685|FG003|Overall Study|Protocol Violation|1|||
157187874|NCT02996500|567428686|FG004|Overall Study|Protocol Violation|0|||
157187875|NCT02996500|567428687|FG005|Overall Study|Protocol Violation|0|||
157187876|NCT02996500|567428682|FG000|Overall Study|Withdrawal by Subject|3|||
157187877|NCT02996500|567428683|FG001|Overall Study|Withdrawal by Subject|0|||
157187878|NCT02996500|567428684|FG002|Overall Study|Withdrawal by Subject|3|||
157187879|NCT02996500|567428685|FG003|Overall Study|Withdrawal by Subject|0|||
157187880|NCT02996500|567428686|FG004|Overall Study|Withdrawal by Subject|2|||
157187881|NCT02996500|567428687|FG005|Overall Study|Withdrawal by Subject|0|||
157187882|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
157187883|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157187884|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157187885|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157187886|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157187887|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
157187888|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
157187889|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157187890|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157187891|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157187892|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157187893|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
157187894|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
157187895|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157187896|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157187897|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157187898|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157187899|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
157187900|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Other|14|||
157187901|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Other|0|||
157187902|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Other|0|||
157187903|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Other|0|||
157187904|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Other|0|||
157187905|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Other|0|||
157187906|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
157187907|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
157187908|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
157187909|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
157067959|NCT00458393|567004302|FG001|Overall Study|Physician Decision|22|||
157187910|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
157187911|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
157187912|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
157187913|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157187914|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157187915|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157187916|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157187917|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
157067960|NCT00458393|567004301|FG000|Overall Study|Relocated|77|||
157187918|NCT02141854|567428694|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
157187919|NCT02141854|567428695|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157187920|NCT02141854|567428696|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157187921|NCT02141854|567428697|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157187922|NCT02141854|567428698|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157187923|NCT02141854|567428699|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
157187924|NCT02141854|567428694|FG000|Treatment Period|Protocol Violation|0|||
157187925|NCT02141854|567428695|FG001|Treatment Period|Protocol Violation|1|||
157187926|NCT02141854|567428696|FG002|Treatment Period|Protocol Violation|0|||
157187927|NCT02141854|567428697|FG003|Treatment Period|Protocol Violation|2|||
157187928|NCT02141854|567428698|FG004|Treatment Period|Protocol Violation|2|||
157187929|NCT02141854|567428699|FG005|Treatment Period|Protocol Violation|1|||
157187930|NCT02141854|567428694|FG000|Treatment Period|Noncompliance|0|||
157187931|NCT02141854|567428695|FG001|Treatment Period|Noncompliance|0|||
157187932|NCT02141854|567428696|FG002|Treatment Period|Noncompliance|0|||
157187933|NCT02141854|567428697|FG003|Treatment Period|Noncompliance|1|||
157187934|NCT02141854|567428698|FG004|Treatment Period|Noncompliance|0|||
157187935|NCT02141854|567428699|FG005|Treatment Period|Noncompliance|0|||
157187936|NCT02141854|567428694|FG000|Treatment Period|Lack of Efficacy|0|||
157187937|NCT02141854|567428695|FG001|Treatment Period|Lack of Efficacy|0|||
157187938|NCT02141854|567428696|FG002|Treatment Period|Lack of Efficacy|0|||
157187939|NCT02141854|567428697|FG003|Treatment Period|Lack of Efficacy|1|||
157187940|NCT02141854|567428698|FG004|Treatment Period|Lack of Efficacy|1|||
157187941|NCT02141854|567428699|FG005|Treatment Period|Lack of Efficacy|7|||
157187942|NCT02141854|567428694|FG000|Treatment Period|Pregnancy|0|||
157187943|NCT02141854|567428695|FG001|Treatment Period|Pregnancy|1|||
157187944|NCT02141854|567428696|FG002|Treatment Period|Pregnancy|0|||
157187945|NCT02141854|567428697|FG003|Treatment Period|Pregnancy|0|||
157187946|NCT02141854|567428698|FG004|Treatment Period|Pregnancy|0|||
157187947|NCT02141854|567428699|FG005|Treatment Period|Pregnancy|0|||
157187948|NCT02141854|567428694|FG000|Treatment Period|Other|0|||
157187949|NCT02141854|567428695|FG001|Treatment Period|Other|1|||
157187950|NCT02141854|567428696|FG002|Treatment Period|Other|2|||
157187951|NCT02141854|567428697|FG003|Treatment Period|Other|0|||
157187952|NCT02141854|567428698|FG004|Treatment Period|Other|1|||
157187953|NCT02141854|567428699|FG005|Treatment Period|Other|2|||
157187954|NCT02141854|567428694|FG000|Treatment Period|Adverse Event|0|||
157187955|NCT02141854|567428695|FG001|Treatment Period|Adverse Event|2|||
157187956|NCT02141854|567428696|FG002|Treatment Period|Adverse Event|2|||
157187957|NCT02141854|567428697|FG003|Treatment Period|Adverse Event|0|||
157187958|NCT02141854|567428698|FG004|Treatment Period|Adverse Event|2|||
157187959|NCT02141854|567428699|FG005|Treatment Period|Adverse Event|2|||
157187960|NCT02141854|567428694|FG000|Treatment Period|Withdrawal by Subject|0|||
157187961|NCT02141854|567428695|FG001|Treatment Period|Withdrawal by Subject|2|||
157187962|NCT02141854|567428696|FG002|Treatment Period|Withdrawal by Subject|3|||
157187963|NCT02141854|567428697|FG003|Treatment Period|Withdrawal by Subject|3|||
157187964|NCT02141854|567428698|FG004|Treatment Period|Withdrawal by Subject|4|||
157187965|NCT02141854|567428699|FG005|Treatment Period|Withdrawal by Subject|7|||
157187966|NCT02141854|567428694|FG000|Treatment Period|Disease progression|0|||
157187967|NCT02141854|567428695|FG001|Treatment Period|Disease progression|2|||
157187968|NCT02141854|567428696|FG002|Treatment Period|Disease progression|1|||
157187969|NCT02141854|567428697|FG003|Treatment Period|Disease progression|3|||
157187970|NCT02141854|567428698|FG004|Treatment Period|Disease progression|0|||
157187971|NCT02141854|567428699|FG005|Treatment Period|Disease progression|18|||
157187972|NCT02141854|567428694|FG000|Treatment Period|Lost to Follow-up|0|||
157187973|NCT02141854|567428695|FG001|Treatment Period|Lost to Follow-up|1|||
157187974|NCT02141854|567428696|FG002|Treatment Period|Lost to Follow-up|1|||
157187975|NCT02141854|567428697|FG003|Treatment Period|Lost to Follow-up|1|||
157187976|NCT02141854|567428698|FG004|Treatment Period|Lost to Follow-up|0|||
157187977|NCT02141854|567428699|FG005|Treatment Period|Lost to Follow-up|1|||
157187978|NCT03258762|567428700|FG000|Overall Study|Lost to Follow-up|0|||
157187979|NCT03258762|567428701|FG001|Overall Study|Lost to Follow-up|1|||
157187980|NCT01868594|567428702|FG000|Overall Study|Do not meet inclusion criteria|4|||
157187981|NCT01868594|567428703|FG001|Overall Study|Do not meet inclusion criteria|3|||
157187982|NCT01190020|567428706|FG000|Overall Study|Adverse Event|2|||
157187983|NCT01190020|567428707|FG001|Overall Study|Adverse Event|0|||
157187984|NCT01190020|567428706|FG000|Overall Study|Lost to Follow-up|2|||
157187985|NCT01190020|567428707|FG001|Overall Study|Lost to Follow-up|0|||
157187986|NCT01190020|567428706|FG000|Overall Study|Withdrawal by Subject|3|||
157187987|NCT01190020|567428707|FG001|Overall Study|Withdrawal by Subject|0|||
157187988|NCT00656799|567428708|FG000|Overall Study|Death|2|||
157187989|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
157187990|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
157187991|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
157187992|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
157187993|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
157187994|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
157067961|NCT00458393|567004302|FG001|Overall Study|Relocated|81|||
157067962|NCT00458393|567004301|FG000|Overall Study|Lost to Follow-up|115|||
157067963|NCT00458393|567004302|FG001|Overall Study|Lost to Follow-up|92|||
157067964|NCT00458393|567004301|FG000|Overall Study|Sites marked other on the form.|19|||
157067965|NCT00458393|567004302|FG001|Overall Study|Sites marked other on the form.|20|||
157067966|NCT02777242|567004304|FG000|Overall Study|Other|2|||
157067967|NCT02777242|567004304|FG000|Overall Study|Lost to Follow-up|1|||
157067968|NCT02777242|567004304|FG000|Overall Study|Multiple|1|||
157067969|NCT02777242|567004304|FG000|Overall Study|Sponsor's request|1|||
157067970|NCT02777242|567004304|FG000|Overall Study|Withdrawal by Subject|1|||
157067971|NCT05178979|567004305|FG000|Overall Study|Death|0|||
157067972|NCT05178979|567004306|FG001|Overall Study|Death|5|||
157067973|NCT05178979|567004307|FG002|Overall Study|Death|0|||
157067974|NCT05178979|567004308|FG003|Overall Study|Death|3|||
157067975|NCT05178979|567004305|FG000|Overall Study|Adverse Event|0|||
157067976|NCT05178979|567004306|FG001|Overall Study|Adverse Event|1|||
157067977|NCT05178979|567004307|FG002|Overall Study|Adverse Event|0|||
157067978|NCT05178979|567004308|FG003|Overall Study|Adverse Event|0|||
157067979|NCT05178979|567004305|FG000|Overall Study|Lost to Follow-up|1|||
157067980|NCT05178979|567004306|FG001|Overall Study|Lost to Follow-up|8|||
157067981|NCT05178979|567004307|FG002|Overall Study|Lost to Follow-up|3|||
157067982|NCT05178979|567004308|FG003|Overall Study|Lost to Follow-up|8|||
157067983|NCT01253447|567004310|FG000|Overall Study|Adverse Event|2|||
157067984|NCT02299427|567004311|FG000|Overall Study|Withdrawal by Subject|1|||
157067985|NCT02299427|567004312|FG001|Overall Study|Withdrawal by Subject|0|||
157067986|NCT02299427|567004311|FG000|Overall Study|Lost to Follow-up|1|||
157067987|NCT02299427|567004312|FG001|Overall Study|Lost to Follow-up|3|||
157067988|NCT02299427|567004311|FG000|Overall Study|not adherent to dog website use|21|||
157067989|NCT02299427|567004312|FG001|Overall Study|not adherent to dog website use|0|||
157067990|NCT02108652|567004313|FG000|Overall Study|Death|253|||
157067991|NCT02108652|567004313|FG000|Overall Study|Lost to Follow-up|2|||
157067992|NCT02108652|567004313|FG000|Overall Study|Withdrawal by Subject|16|||
157067993|NCT02108652|567004313|FG000|Overall Study|Study Terminated By Sponsor|31|||
157067994|NCT02108652|567004313|FG000|Overall Study|Non-Compliance|1|||
157067995|NCT02108652|567004313|FG000|Overall Study|Physician Decision|6|||
157067996|NCT02108652|567004313|FG000|Overall Study|Progression Of Disease|1|||
157067997|NCT01704547|567004314|FG000|Overall Study|Physician Decision|4|||
157067998|NCT01704547|567004314|FG000|Overall Study|Withdrawal by Subject|1|||
157067999|NCT01560871|567004315|FG000|Overall Study|transportation issues|2|||
157068000|NCT01560871|567004316|FG001|Overall Study|transportation issues|1|||
157068001|NCT01560871|567004315|FG000|Overall Study|relocation|1|||
157068002|NCT01560871|567004316|FG001|Overall Study|relocation|0|||
157068003|NCT01560871|567004315|FG000|Overall Study|readmission to a hospital|2|||
157068004|NCT01560871|567004316|FG001|Overall Study|readmission to a hospital|1|||
157068005|NCT01560871|567004315|FG000|Overall Study|Lost to Follow-up|1|||
157068006|NCT01560871|567004316|FG001|Overall Study|Lost to Follow-up|0|||
157068007|NCT00409409|567004317|FG000|Overall Study|Adverse Event|7|||
157068008|NCT00409409|567004318|FG001|Overall Study|Adverse Event|2|||
157068009|NCT00409409|567004317|FG000|Overall Study|Withdrawal by Subject|1|||
157068010|NCT00409409|567004318|FG001|Overall Study|Withdrawal by Subject|1|||
157068011|NCT00409409|567004317|FG000|Overall Study|Any other reason not above-mentioned|0|||
157068012|NCT00409409|567004318|FG001|Overall Study|Any other reason not above-mentioned|1|||
157068013|NCT03599622|567004319|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
157068014|NCT03599622|567004320|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
157068015|NCT03599622|567004321|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
157068016|NCT03599622|567004322|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
157068017|NCT03599622|567004319|FG000|Pre-Treatment Period|Other reasons|1|||
157068018|NCT03599622|567004320|FG001|Pre-Treatment Period|Other reasons|1|||
157068019|NCT03599622|567004321|FG002|Pre-Treatment Period|Other reasons|1|||
157068020|NCT03599622|567004322|FG003|Pre-Treatment Period|Other reasons|0|||
157068021|NCT03599622|567004319|FG000|Treatment Period|Adverse Event|11|||
157068022|NCT03599622|567004320|FG001|Treatment Period|Adverse Event|20|||
157068023|NCT03599622|567004321|FG002|Treatment Period|Adverse Event|18|||
157068024|NCT03599622|567004322|FG003|Treatment Period|Adverse Event|2|||
157068025|NCT03599622|567004319|FG000|Treatment Period|Lack of Efficacy|18|||
157068026|NCT03599622|567004320|FG001|Treatment Period|Lack of Efficacy|12|||
157068027|NCT03599622|567004321|FG002|Treatment Period|Lack of Efficacy|13|||
157068028|NCT03599622|567004322|FG003|Treatment Period|Lack of Efficacy|2|||
157068029|NCT03599622|567004319|FG000|Treatment Period|Withdrawal by Subject|5|||
157068030|NCT03599622|567004320|FG001|Treatment Period|Withdrawal by Subject|11|||
157068031|NCT03599622|567004321|FG002|Treatment Period|Withdrawal by Subject|16|||
157068032|NCT03599622|567004322|FG003|Treatment Period|Withdrawal by Subject|1|||
157068033|NCT03599622|567004319|FG000|Treatment Period|Other reasons|4|||
157068034|NCT03599622|567004320|FG001|Treatment Period|Other reasons|6|||
157068035|NCT03599622|567004321|FG002|Treatment Period|Other reasons|7|||
157068036|NCT03599622|567004322|FG003|Treatment Period|Other reasons|0|||
157068037|NCT03599622|567004319|FG000|Treatment Period|Lost to Follow-up|1|||
157068038|NCT03599622|567004320|FG001|Treatment Period|Lost to Follow-up|0|||
157187995|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
157187996|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
157187997|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
157187998|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
157187999|NCT02422186|567428709|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
157188000|NCT02422186|567428710|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
157188001|NCT02422186|567428709|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
157188002|NCT02422186|567428710|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
157188003|NCT02422186|567428709|FG000|Follow-up Phase (2 Weeks)|Other|3|||
157188004|NCT02422186|567428710|FG001|Follow-up Phase (2 Weeks)|Other|0|||
157188005|NCT00211536|567431386|FG000|Overall Study|Withdrawal by Subject|2|||
157188006|NCT00211536|567431387|FG001|Overall Study|Withdrawal by Subject|2|||
157188007|NCT00211536|567431386|FG000|Overall Study|Physician Decision|0|||
157188008|NCT00211536|567431387|FG001|Overall Study|Physician Decision|5|||
157188009|NCT00211536|567431386|FG000|Overall Study|Adverse Event|2|||
157188010|NCT00211536|567431387|FG001|Overall Study|Adverse Event|0|||
157188011|NCT02583399|567431388|FG000|Overall Study|Able to be discharged|3|||
157188012|NCT02583399|567431388|FG000|Overall Study|Wanted to use a restricted medication|3|||
157188013|NCT01004861|567431389|FG000|Overall Study|Disease progression|3|||
157188014|NCT01004861|567431390|FG001|Overall Study|Disease progression|4|||
157188015|NCT01004861|567431391|FG002|Overall Study|Disease progression|5|||
157188016|NCT01004861|567431392|FG003|Overall Study|Disease progression|4|||
157188017|NCT01004861|567431393|FG004|Overall Study|Disease progression|4|||
157188018|NCT01004861|567431394|FG005|Overall Study|Disease progression|4|||
157188019|NCT01004861|567431395|FG006|Overall Study|Disease progression|5|||
157188020|NCT01004861|567431396|FG007|Overall Study|Disease progression|1|||
157188021|NCT01004861|567431397|FG008|Overall Study|Disease progression|4|||
157188022|NCT01004861|567431398|FG009|Overall Study|Disease progression|7|||
157188023|NCT01004861|567431399|FG010|Overall Study|Disease progression|6|||
157188024|NCT01004861|567431400|FG011|Overall Study|Disease progression|3|||
157188025|NCT01004861|567431401|FG012|Overall Study|Disease progression|8|||
157188026|NCT01004861|567431389|FG000|Overall Study|Physician Decision|0|||
157188027|NCT01004861|567431390|FG001|Overall Study|Physician Decision|2|||
157188028|NCT01004861|567431391|FG002|Overall Study|Physician Decision|1|||
157188029|NCT01004861|567431392|FG003|Overall Study|Physician Decision|1|||
157188030|NCT01004861|567431393|FG004|Overall Study|Physician Decision|1|||
157188031|NCT01004861|567431394|FG005|Overall Study|Physician Decision|0|||
157188032|NCT01004861|567431395|FG006|Overall Study|Physician Decision|0|||
157188033|NCT01004861|567431396|FG007|Overall Study|Physician Decision|1|||
157188034|NCT01004861|567431397|FG008|Overall Study|Physician Decision|0|||
157188035|NCT01004861|567431398|FG009|Overall Study|Physician Decision|0|||
157188036|NCT01004861|567431399|FG010|Overall Study|Physician Decision|0|||
157188037|NCT01004861|567431400|FG011|Overall Study|Physician Decision|0|||
157188038|NCT01004861|567431401|FG012|Overall Study|Physician Decision|3|||
157188039|NCT01004861|567431389|FG000|Overall Study|Adverse Event|0|||
157188040|NCT01004861|567431390|FG001|Overall Study|Adverse Event|0|||
157188041|NCT01004861|567431391|FG002|Overall Study|Adverse Event|0|||
157188042|NCT01004861|567431392|FG003|Overall Study|Adverse Event|1|||
157188043|NCT01004861|567431393|FG004|Overall Study|Adverse Event|0|||
157188044|NCT01004861|567431394|FG005|Overall Study|Adverse Event|2|||
157188045|NCT01004861|567431395|FG006|Overall Study|Adverse Event|1|||
157188046|NCT01004861|567431396|FG007|Overall Study|Adverse Event|1|||
157188047|NCT01004861|567431397|FG008|Overall Study|Adverse Event|13|||
157188048|NCT01004861|567431398|FG009|Overall Study|Adverse Event|1|||
157188049|NCT01004861|567431399|FG010|Overall Study|Adverse Event|1|||
157188050|NCT01004861|567431400|FG011|Overall Study|Adverse Event|0|||
157188051|NCT01004861|567431401|FG012|Overall Study|Adverse Event|2|||
157188052|NCT01004861|567431389|FG000|Overall Study|Protocol Violation|0|||
157188053|NCT01004861|567431390|FG001|Overall Study|Protocol Violation|0|||
157188054|NCT01004861|567431391|FG002|Overall Study|Protocol Violation|0|||
157188055|NCT01004861|567431392|FG003|Overall Study|Protocol Violation|0|||
157188056|NCT01004861|567431393|FG004|Overall Study|Protocol Violation|1|||
157188057|NCT01004861|567431394|FG005|Overall Study|Protocol Violation|0|||
157188058|NCT01004861|567431395|FG006|Overall Study|Protocol Violation|0|||
157188059|NCT01004861|567431396|FG007|Overall Study|Protocol Violation|0|||
157188060|NCT01004861|567431397|FG008|Overall Study|Protocol Violation|0|||
157230207|NCT02343120|567588283|FG004|Part 2: Expansion|Sponsor decision|67|||
157188061|NCT01004861|567431398|FG009|Overall Study|Protocol Violation|0|||
157188062|NCT01004861|567431399|FG010|Overall Study|Protocol Violation|0|||
157188063|NCT01004861|567431400|FG011|Overall Study|Protocol Violation|0|||
157188064|NCT01004861|567431401|FG012|Overall Study|Protocol Violation|0|||
157188065|NCT01004861|567431389|FG000|Overall Study|Lost to Follow-up|0|||
157188066|NCT01004861|567431390|FG001|Overall Study|Lost to Follow-up|0|||
157188067|NCT01004861|567431391|FG002|Overall Study|Lost to Follow-up|0|||
157188068|NCT01004861|567431392|FG003|Overall Study|Lost to Follow-up|0|||
157188069|NCT01004861|567431393|FG004|Overall Study|Lost to Follow-up|0|||
157188070|NCT01004861|567431394|FG005|Overall Study|Lost to Follow-up|0|||
157188071|NCT01004861|567431395|FG006|Overall Study|Lost to Follow-up|0|||
157188072|NCT01004861|567431396|FG007|Overall Study|Lost to Follow-up|1|||
157188073|NCT01004861|567431397|FG008|Overall Study|Lost to Follow-up|3|||
157188074|NCT01004861|567431398|FG009|Overall Study|Lost to Follow-up|0|||
157188075|NCT01004861|567431399|FG010|Overall Study|Lost to Follow-up|0|||
157188076|NCT01004861|567431400|FG011|Overall Study|Lost to Follow-up|1|||
157188077|NCT01004861|567431401|FG012|Overall Study|Lost to Follow-up|0|||
157188078|NCT01004861|567431389|FG000|Overall Study|Non-compliance|0|||
157188079|NCT01004861|567431390|FG001|Overall Study|Non-compliance|0|||
157188080|NCT01004861|567431391|FG002|Overall Study|Non-compliance|0|||
157188081|NCT01004861|567431392|FG003|Overall Study|Non-compliance|0|||
157188082|NCT01004861|567431393|FG004|Overall Study|Non-compliance|0|||
157188083|NCT01004861|567431394|FG005|Overall Study|Non-compliance|0|||
157188084|NCT01004861|567431395|FG006|Overall Study|Non-compliance|0|||
157188085|NCT01004861|567431396|FG007|Overall Study|Non-compliance|0|||
157188086|NCT01004861|567431397|FG008|Overall Study|Non-compliance|5|||
157188087|NCT01004861|567431398|FG009|Overall Study|Non-compliance|0|||
157188088|NCT01004861|567431399|FG010|Overall Study|Non-compliance|0|||
157188089|NCT01004861|567431400|FG011|Overall Study|Non-compliance|0|||
157188090|NCT01004861|567431401|FG012|Overall Study|Non-compliance|1|||
157188091|NCT01004861|567431389|FG000|Overall Study|Other|0|||
157188092|NCT01004861|567431390|FG001|Overall Study|Other|0|||
157188093|NCT01004861|567431391|FG002|Overall Study|Other|0|||
157188094|NCT01004861|567431392|FG003|Overall Study|Other|0|||
157188095|NCT01004861|567431393|FG004|Overall Study|Other|0|||
157188096|NCT01004861|567431394|FG005|Overall Study|Other|0|||
157188097|NCT01004861|567431395|FG006|Overall Study|Other|0|||
157188098|NCT01004861|567431396|FG007|Overall Study|Other|0|||
157188099|NCT01004861|567431397|FG008|Overall Study|Other|0|||
157068039|NCT03599622|567004321|FG002|Treatment Period|Lost to Follow-up|0|||
157068040|NCT03599622|567004322|FG003|Treatment Period|Lost to Follow-up|0|||
157068041|NCT03599622|567004319|FG000|Treatment Period|Study terminated by sponsor|7|||
157188100|NCT01004861|567431398|FG009|Overall Study|Other|2|||
157188101|NCT01004861|567431399|FG010|Overall Study|Other|1|||
157188102|NCT01004861|567431400|FG011|Overall Study|Other|2|||
157188103|NCT01004861|567431401|FG012|Overall Study|Other|3|||
157188104|NCT01004861|567431389|FG000|Overall Study|Patient decision|0|||
157188105|NCT01004861|567431390|FG001|Overall Study|Patient decision|0|||
157188106|NCT01004861|567431391|FG002|Overall Study|Patient decision|0|||
157188107|NCT01004861|567431392|FG003|Overall Study|Patient decision|0|||
157188108|NCT01004861|567431393|FG004|Overall Study|Patient decision|1|||
157188109|NCT01004861|567431394|FG005|Overall Study|Patient decision|0|||
157188110|NCT01004861|567431395|FG006|Overall Study|Patient decision|1|||
157188111|NCT01004861|567431396|FG007|Overall Study|Patient decision|0|||
157188112|NCT01004861|567431397|FG008|Overall Study|Patient decision|7|||
157188113|NCT01004861|567431398|FG009|Overall Study|Patient decision|1|||
157188114|NCT01004861|567431399|FG010|Overall Study|Patient decision|1|||
157188115|NCT01004861|567431400|FG011|Overall Study|Patient decision|2|||
157188116|NCT01004861|567431401|FG012|Overall Study|Patient decision|3|||
157188117|NCT01004861|567431389|FG000|Overall Study|Transitioned to Phase 4 study|0|||
157188118|NCT01004861|567431390|FG001|Overall Study|Transitioned to Phase 4 study|0|||
157188119|NCT01004861|567431391|FG002|Overall Study|Transitioned to Phase 4 study|0|||
157188120|NCT01004861|567431392|FG003|Overall Study|Transitioned to Phase 4 study|0|||
157188121|NCT01004861|567431393|FG004|Overall Study|Transitioned to Phase 4 study|0|||
157188122|NCT01004861|567431394|FG005|Overall Study|Transitioned to Phase 4 study|0|||
157188123|NCT01004861|567431395|FG006|Overall Study|Transitioned to Phase 4 study|0|||
157188124|NCT01004861|567431396|FG007|Overall Study|Transitioned to Phase 4 study|0|||
157230208|NCT02343120|567588279|FG000|Part 2: Expansion|Death|0|||
157230209|NCT02343120|567588280|FG001|Part 2: Expansion|Death|0|||
157068042|NCT03599622|567004320|FG001|Treatment Period|Study terminated by sponsor|20|||
157068043|NCT03599622|567004321|FG002|Treatment Period|Study terminated by sponsor|15|||
157068044|NCT03599622|567004322|FG003|Treatment Period|Study terminated by sponsor|0|||
157068045|NCT03599622|567004319|FG000|Treatment Period|Site terminated by sponsor|0|||
157068046|NCT03599622|567004320|FG001|Treatment Period|Site terminated by sponsor|1|||
157068047|NCT03599622|567004321|FG002|Treatment Period|Site terminated by sponsor|0|||
157068048|NCT03599622|567004322|FG003|Treatment Period|Site terminated by sponsor|0|||
157188125|NCT01004861|567431397|FG008|Overall Study|Transitioned to Phase 4 study|2|||
157188126|NCT01004861|567431398|FG009|Overall Study|Transitioned to Phase 4 study|0|||
157188127|NCT01004861|567431399|FG010|Overall Study|Transitioned to Phase 4 study|0|||
157188128|NCT01004861|567431400|FG011|Overall Study|Transitioned to Phase 4 study|0|||
157068049|NCT01278615|567004323|FG000|Overall Study|Withdrawal by Subject|2|||
157068050|NCT02138253|567004324|FG000|Overall Study|Adverse Event|3|||
157068051|NCT02138253|567004325|FG001|Overall Study|Adverse Event|3|||
157188129|NCT01004861|567431401|FG012|Overall Study|Transitioned to Phase 4 study|0|||
157188130|NCT01004861|567431389|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188131|NCT01004861|567431390|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188132|NCT01004861|567431391|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188133|NCT01004861|567431392|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188134|NCT01004861|567431393|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188135|NCT01004861|567431394|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188136|NCT01004861|567431395|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188137|NCT01004861|567431396|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188138|NCT01004861|567431397|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
157188139|NCT01004861|567431398|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188140|NCT01004861|567431399|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188141|NCT01004861|567431400|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188142|NCT01004861|567431401|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
157188143|NCT01004861|567431389|FG000|Overall Study|Patient withdrew|0|||
157188144|NCT01004861|567431390|FG001|Overall Study|Patient withdrew|0|||
157188145|NCT01004861|567431391|FG002|Overall Study|Patient withdrew|0|||
157188146|NCT01004861|567431392|FG003|Overall Study|Patient withdrew|0|||
157188147|NCT01004861|567431393|FG004|Overall Study|Patient withdrew|0|||
157188148|NCT01004861|567431394|FG005|Overall Study|Patient withdrew|0|||
157188149|NCT01004861|567431395|FG006|Overall Study|Patient withdrew|0|||
157188150|NCT01004861|567431396|FG007|Overall Study|Patient withdrew|0|||
157188151|NCT01004861|567431397|FG008|Overall Study|Patient withdrew|1|||
157188152|NCT01004861|567431398|FG009|Overall Study|Patient withdrew|0|||
157188153|NCT01004861|567431399|FG010|Overall Study|Patient withdrew|0|||
157188154|NCT01004861|567431400|FG011|Overall Study|Patient withdrew|0|||
157188155|NCT01004861|567431401|FG012|Overall Study|Patient withdrew|0|||
157188156|NCT01004861|567431389|FG000|Overall Study|Surgical resection|0|||
157188157|NCT01004861|567431390|FG001|Overall Study|Surgical resection|0|||
157188158|NCT01004861|567431391|FG002|Overall Study|Surgical resection|0|||
157188159|NCT01004861|567431392|FG003|Overall Study|Surgical resection|0|||
157188160|NCT01004861|567431393|FG004|Overall Study|Surgical resection|0|||
157188161|NCT01004861|567431394|FG005|Overall Study|Surgical resection|0|||
157188162|NCT01004861|567431395|FG006|Overall Study|Surgical resection|0|||
157188163|NCT01004861|567431396|FG007|Overall Study|Surgical resection|0|||
157188164|NCT01004861|567431397|FG008|Overall Study|Surgical resection|1|||
157188165|NCT01004861|567431398|FG009|Overall Study|Surgical resection|0|||
157188166|NCT01004861|567431399|FG010|Overall Study|Surgical resection|0|||
157188167|NCT01004861|567431400|FG011|Overall Study|Surgical resection|0|||
157188168|NCT01004861|567431401|FG012|Overall Study|Surgical resection|0|||
157188169|NCT01004861|567431389|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188170|NCT01004861|567431390|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188171|NCT01004861|567431391|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188172|NCT01004861|567431392|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188173|NCT01004861|567431393|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188174|NCT01004861|567431394|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188175|NCT01004861|567431395|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188176|NCT01004861|567431396|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188177|NCT01004861|567431397|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
157188178|NCT01004861|567431398|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188179|NCT01004861|567431399|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188180|NCT01004861|567431400|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188181|NCT01004861|567431401|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
157188182|NCT01004861|567431389|FG000|Overall Study|Study termination by Sponsor|0|||
157188183|NCT01004861|567431390|FG001|Overall Study|Study termination by Sponsor|0|||
157188184|NCT01004861|567431391|FG002|Overall Study|Study termination by Sponsor|0|||
157188185|NCT01004861|567431392|FG003|Overall Study|Study termination by Sponsor|0|||
157188186|NCT01004861|567431393|FG004|Overall Study|Study termination by Sponsor|0|||
157188187|NCT01004861|567431394|FG005|Overall Study|Study termination by Sponsor|0|||
157188188|NCT01004861|567431395|FG006|Overall Study|Study termination by Sponsor|0|||
157188189|NCT01004861|567431396|FG007|Overall Study|Study termination by Sponsor|0|||
157188190|NCT01004861|567431397|FG008|Overall Study|Study termination by Sponsor|1|||
157188191|NCT01004861|567431398|FG009|Overall Study|Study termination by Sponsor|0|||
157188192|NCT01004861|567431399|FG010|Overall Study|Study termination by Sponsor|0|||
157188193|NCT01004861|567431400|FG011|Overall Study|Study termination by Sponsor|0|||
157188194|NCT01004861|567431401|FG012|Overall Study|Study termination by Sponsor|0|||
157188195|NCT04610827|567431403|FG000|Overall Study|Withdrawal by Subject|1|||
157188196|NCT04610827|567431404|FG001|Overall Study|Withdrawal by Subject|1|||
157188197|NCT04610827|567431405|FG002|Overall Study|Withdrawal by Subject|0|||
157188198|NCT01693562|567431406|FG000|Escalation Phase|Withdrawal by Subject|0|||
157188199|NCT01693562|567431407|FG001|Escalation Phase|Withdrawal by Subject|1|||
157188200|NCT01693562|567431408|FG002|Escalation Phase|Withdrawal by Subject|0|||
157068052|NCT02138253|567004324|FG000|Overall Study|Lost to Follow-up|2|||
157068053|NCT02138253|567004325|FG001|Overall Study|Lost to Follow-up|1|||
157068054|NCT02138253|567004324|FG000|Overall Study|Physician Decision|2|||
157068055|NCT02138253|567004325|FG001|Overall Study|Physician Decision|0|||
157068056|NCT02138253|567004324|FG000|Overall Study|Non compliance|1|||
157068057|NCT02138253|567004325|FG001|Overall Study|Non compliance|0|||
157068058|NCT02138253|567004324|FG000|Overall Study|Withdrawal by Subject|1|||
157068059|NCT02138253|567004325|FG001|Overall Study|Withdrawal by Subject|0|||
157068060|NCT01918371|567004326|FG000|Overall Study|Missing Data|1|||
157068061|NCT01918371|567004327|FG001|Overall Study|Missing Data|1|||
157068062|NCT01006889|567004328|FG000|Overall Study|Withdrawal by Subject|3|||
157068063|NCT00243022|567004329|FG000|Overall Study|Withdrawal by Subject|1|||
157068064|NCT00243022|567004330|FG001|Overall Study|Withdrawal by Subject|0|||
157068065|NCT00243022|567004329|FG000|Overall Study|Death|1|||
157068066|NCT00243022|567004330|FG001|Overall Study|Death|0|||
157068067|NCT00243022|567004329|FG000|Overall Study|Difficult Travel Distance|0|||
157068068|NCT00243022|567004330|FG001|Overall Study|Difficult Travel Distance|1|||
157068069|NCT01390441|567004335|FG000|Treatment Period|Protocol Violation|0|||
157068070|NCT01390441|567004336|FG001|Treatment Period|Protocol Violation|1|||
157188201|NCT01693562|567431409|FG003|Escalation Phase|Withdrawal by Subject|0|||
157068071|NCT01390441|567004337|FG002|Treatment Period|Protocol Violation|0|||
157068072|NCT01390441|567004338|FG003|Treatment Period|Protocol Violation|0|||
157188202|NCT01693562|567431410|FG004|Escalation Phase|Withdrawal by Subject|0|||
157188203|NCT01693562|567431411|FG005|Escalation Phase|Withdrawal by Subject|2|||
157188204|NCT01693562|567431412|FG006|Escalation Phase|Withdrawal by Subject|0|||
157188205|NCT01693562|567431413|FG007|Escalation Phase|Withdrawal by Subject|0|||
157188206|NCT01693562|567431414|FG008|Escalation Phase|Withdrawal by Subject|0|||
157188207|NCT01693562|567431415|FG009|Escalation Phase|Withdrawal by Subject|0|||
157188208|NCT01693562|567431416|FG010|Escalation Phase|Withdrawal by Subject|0|||
157188209|NCT01693562|567431417|FG011|Escalation Phase|Withdrawal by Subject|0|||
156977386|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
156977387|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156977388|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
156977389|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
156977390|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156977391|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
156977392|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156977393|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
156977394|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156977395|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156977396|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156977397|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
156977398|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
156977399|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
156977400|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
156977401|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
156977402|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
156977403|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
156977404|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
156977405|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156977406|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
156977407|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156977408|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156977409|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
156977410|NCT02778399|566670700|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156977411|NCT02778399|566670701|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156977412|NCT02778399|566670702|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156977413|NCT02778399|566670703|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
156977414|NCT02778399|566670704|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156977415|NCT02778399|566670705|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
156977416|NCT00405639|566670707|FG000|Overall Study|Withdrawal by Subject|1|||
156977417|NCT00405639|566670708|FG001|Overall Study|Withdrawal by Subject|0|||
156977418|NCT00405639|566670707|FG000|Overall Study|Adverse Event|1|||
156977419|NCT00405639|566670708|FG001|Overall Study|Adverse Event|0|||
156977420|NCT00405639|566670707|FG000|Overall Study|Seizure prior to receiving BNP|1|||
156977421|NCT00405639|566670708|FG001|Overall Study|Seizure prior to receiving BNP|0|||
156977422|NCT02130284|566670712|FG000|Overall Study|Withdrawal by Subject|3|||
157068073|NCT01390441|567004339|FG004|Treatment Period|Protocol Violation|0|||
157068074|NCT01390441|567004335|FG000|Treatment Period|Physician Decision|0|||
157068075|NCT01390441|567004336|FG001|Treatment Period|Physician Decision|0|||
157188210|NCT01693562|567431418|FG012|Escalation Phase|Withdrawal by Subject|0|||
157188211|NCT01693562|567431419|FG013|Escalation Phase|Withdrawal by Subject|0|||
157230210|NCT02343120|567588281|FG002|Part 2: Expansion|Death|0|||
157230211|NCT02343120|567588282|FG003|Part 2: Expansion|Death|74|||
157230212|NCT02343120|567588283|FG004|Part 2: Expansion|Death|17|||
157230213|NCT02343120|567588279|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
157230214|NCT02343120|567588280|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
157230215|NCT02343120|567588281|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
157230216|NCT02343120|567588282|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
157230217|NCT02343120|567588283|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
157230218|NCT02343120|567588279|FG000|Part 2: Expansion|Lost to Follow-up|0|||
157230219|NCT02343120|567588280|FG001|Part 2: Expansion|Lost to Follow-up|0|||
157230220|NCT02343120|567588281|FG002|Part 2: Expansion|Lost to Follow-up|0|||
157230221|NCT02343120|567588282|FG003|Part 2: Expansion|Lost to Follow-up|5|||
157230222|NCT02343120|567588283|FG004|Part 2: Expansion|Lost to Follow-up|2|||
157230223|NCT02343120|567588279|FG000|Part 2: Expansion|Other|0|||
157230224|NCT02343120|567588280|FG001|Part 2: Expansion|Other|0|||
157230225|NCT02343120|567588281|FG002|Part 2: Expansion|Other|0|||
157230226|NCT02343120|567588282|FG003|Part 2: Expansion|Other|1|||
157230227|NCT02343120|567588283|FG004|Part 2: Expansion|Other|5|||
157230228|NCT02343120|567588279|FG000|Part 2: Expansion|Adverse Event|0|||
157230229|NCT02343120|567588280|FG001|Part 2: Expansion|Adverse Event|0|||
157230230|NCT02343120|567588281|FG002|Part 2: Expansion|Adverse Event|0|||
157230231|NCT02343120|567588282|FG003|Part 2: Expansion|Adverse Event|1|||
157230232|NCT02343120|567588283|FG004|Part 2: Expansion|Adverse Event|1|||
157230233|NCT01766778|567588296|FG000|Overall Study|Adverse Event|4|||
157230234|NCT01766778|567588297|FG001|Overall Study|Adverse Event|4|||
157230235|NCT01766778|567588296|FG000|Overall Study|Withdrawal by Subject|1|||
157230236|NCT01766778|567588297|FG001|Overall Study|Withdrawal by Subject|0|||
157230237|NCT01054599|567588298|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
157230238|NCT01054599|567588299|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
157230239|NCT01054599|567588298|FG000|Overall Study|Protocol Violation|1|||
157230240|NCT01054599|567588299|FG001|Overall Study|Protocol Violation|0|||
157230241|NCT01054599|567588298|FG000|Overall Study|Spells/seizure-like episodes|1|||
157230242|NCT01054599|567588299|FG001|Overall Study|Spells/seizure-like episodes|1|||
157230243|NCT01054599|567588298|FG000|Overall Study|Timing/scheduling difficulties|1|||
157230244|NCT01054599|567588299|FG001|Overall Study|Timing/scheduling difficulties|1|||
157230245|NCT01054599|567588298|FG000|Overall Study|Visual impairment, WTAR <80|0|||
157230246|NCT01054599|567588299|FG001|Overall Study|Visual impairment, WTAR <80|1|||
157230247|NCT01054599|567588298|FG000|Overall Study|Lost to Follow-up|0|||
157230248|NCT01054599|567588299|FG001|Overall Study|Lost to Follow-up|2|||
157230249|NCT01054599|567588298|FG000|Overall Study|Adverse Event|0|||
157230250|NCT01054599|567588299|FG001|Overall Study|Adverse Event|1|||
157230251|NCT01054599|567588298|FG000|Overall Study|Withdrawal by Subject|0|||
157230252|NCT01054599|567588299|FG001|Overall Study|Withdrawal by Subject|1|||
157230253|NCT01104662|567588300|FG000|Overall Study|Adverse Event|2|||
157230254|NCT01104662|567588301|FG001|Overall Study|Adverse Event|2|||
157230255|NCT01104662|567588302|FG002|Overall Study|Adverse Event|0|||
157230256|NCT01104662|567588303|FG003|Overall Study|Adverse Event|1|||
157230257|NCT01104662|567588304|FG004|Overall Study|Adverse Event|1|||
157230258|NCT01104662|567588305|FG005|Overall Study|Adverse Event|1|||
157230259|NCT01104662|567588306|FG006|Overall Study|Adverse Event|0|||
157230260|NCT01104662|567588307|FG007|Overall Study|Adverse Event|0|||
157230261|NCT01104662|567588300|FG000|Overall Study|Clinical Failure|1|||
157230262|NCT01104662|567588301|FG001|Overall Study|Clinical Failure|0|||
157230263|NCT01104662|567588302|FG002|Overall Study|Clinical Failure|0|||
157230264|NCT01104662|567588303|FG003|Overall Study|Clinical Failure|0|||
157230265|NCT01104662|567588304|FG004|Overall Study|Clinical Failure|0|||
157230266|NCT01104662|567588305|FG005|Overall Study|Clinical Failure|1|||
157230267|NCT01104662|567588306|FG006|Overall Study|Clinical Failure|0|||
157230268|NCT01104662|567588307|FG007|Overall Study|Clinical Failure|0|||
157188212|NCT01693562|567431420|FG014|Escalation Phase|Withdrawal by Subject|0|||
157188213|NCT01693562|567431421|FG015|Escalation Phase|Withdrawal by Subject|0|||
157188214|NCT01693562|567431422|FG016|Escalation Phase|Withdrawal by Subject|0|||
157188215|NCT01693562|567431423|FG017|Escalation Phase|Withdrawal by Subject|0|||
157188216|NCT01693562|567431424|FG018|Escalation Phase|Withdrawal by Subject|0|||
157188217|NCT01693562|567431425|FG019|Escalation Phase|Withdrawal by Subject|0|||
157188218|NCT01693562|567431426|FG020|Escalation Phase|Withdrawal by Subject|0|||
157188219|NCT01693562|567431427|FG021|Escalation Phase|Withdrawal by Subject|0|||
157188220|NCT01693562|567431428|FG022|Escalation Phase|Withdrawal by Subject|0|||
157230269|NCT01104662|567588300|FG000|Overall Study|Participant left investigator's care|1|||
157230270|NCT01104662|567588301|FG001|Overall Study|Participant left investigator's care|1|||
157230271|NCT01104662|567588302|FG002|Overall Study|Participant left investigator's care|0|||
157188221|NCT01693562|567431406|FG000|Escalation Phase|Death|4|||
157188222|NCT01693562|567431407|FG001|Escalation Phase|Death|2|||
157230272|NCT01104662|567588303|FG003|Overall Study|Participant left investigator's care|0|||
157230273|NCT01104662|567588304|FG004|Overall Study|Participant left investigator's care|0|||
157230274|NCT01104662|567588305|FG005|Overall Study|Participant left investigator's care|0|||
157230275|NCT01104662|567588306|FG006|Overall Study|Participant left investigator's care|0|||
157188223|NCT01693562|567431408|FG002|Escalation Phase|Death|0|||
157188224|NCT01693562|567431409|FG003|Escalation Phase|Death|3|||
157188225|NCT01693562|567431410|FG004|Escalation Phase|Death|6|||
157188226|NCT01693562|567431411|FG005|Escalation Phase|Death|4|||
157188227|NCT01693562|567431412|FG006|Escalation Phase|Death|0|||
157188228|NCT01693562|567431413|FG007|Escalation Phase|Death|0|||
157188229|NCT01693562|567431414|FG008|Escalation Phase|Death|0|||
157188230|NCT01693562|567431415|FG009|Escalation Phase|Death|0|||
157188231|NCT01693562|567431416|FG010|Escalation Phase|Death|0|||
157188232|NCT01693562|567431417|FG011|Escalation Phase|Death|0|||
157188233|NCT01693562|567431418|FG012|Escalation Phase|Death|0|||
157188234|NCT01693562|567431419|FG013|Escalation Phase|Death|0|||
157188235|NCT01693562|567431420|FG014|Escalation Phase|Death|0|||
157188236|NCT01693562|567431421|FG015|Escalation Phase|Death|0|||
157188237|NCT01693562|567431422|FG016|Escalation Phase|Death|0|||
157188238|NCT01693562|567431423|FG017|Escalation Phase|Death|0|||
157188239|NCT01693562|567431424|FG018|Escalation Phase|Death|0|||
157188240|NCT01693562|567431425|FG019|Escalation Phase|Death|0|||
157188241|NCT01693562|567431426|FG020|Escalation Phase|Death|0|||
157188242|NCT01693562|567431427|FG021|Escalation Phase|Death|0|||
157188243|NCT01693562|567431428|FG022|Escalation Phase|Death|0|||
157188244|NCT01693562|567431406|FG000|Escalation Phase|Lost to Follow-up|0|||
157188245|NCT01693562|567431407|FG001|Escalation Phase|Lost to Follow-up|1|||
157188246|NCT01693562|567431408|FG002|Escalation Phase|Lost to Follow-up|1|||
157188247|NCT01693562|567431409|FG003|Escalation Phase|Lost to Follow-up|0|||
157188248|NCT01693562|567431410|FG004|Escalation Phase|Lost to Follow-up|0|||
157188249|NCT01693562|567431411|FG005|Escalation Phase|Lost to Follow-up|0|||
157188250|NCT01693562|567431412|FG006|Escalation Phase|Lost to Follow-up|0|||
157188251|NCT01693562|567431413|FG007|Escalation Phase|Lost to Follow-up|0|||
157188252|NCT01693562|567431414|FG008|Escalation Phase|Lost to Follow-up|0|||
157188253|NCT01693562|567431415|FG009|Escalation Phase|Lost to Follow-up|0|||
157188254|NCT01693562|567431416|FG010|Escalation Phase|Lost to Follow-up|0|||
157188255|NCT01693562|567431417|FG011|Escalation Phase|Lost to Follow-up|0|||
157188256|NCT01693562|567431418|FG012|Escalation Phase|Lost to Follow-up|0|||
157188257|NCT01693562|567431419|FG013|Escalation Phase|Lost to Follow-up|0|||
157188258|NCT01693562|567431420|FG014|Escalation Phase|Lost to Follow-up|0|||
157188259|NCT01693562|567431421|FG015|Escalation Phase|Lost to Follow-up|0|||
157188260|NCT01693562|567431422|FG016|Escalation Phase|Lost to Follow-up|0|||
157188261|NCT01693562|567431423|FG017|Escalation Phase|Lost to Follow-up|0|||
157188262|NCT01693562|567431424|FG018|Escalation Phase|Lost to Follow-up|0|||
157188263|NCT01693562|567431425|FG019|Escalation Phase|Lost to Follow-up|0|||
157188264|NCT01693562|567431426|FG020|Escalation Phase|Lost to Follow-up|0|||
157188265|NCT01693562|567431427|FG021|Escalation Phase|Lost to Follow-up|0|||
157188266|NCT01693562|567431428|FG022|Escalation Phase|Lost to Follow-up|0|||
157188267|NCT01693562|567431406|FG000|Escalation Phase|Other|0|||
157188268|NCT01693562|567431407|FG001|Escalation Phase|Other|0|||
157188269|NCT01693562|567431408|FG002|Escalation Phase|Other|2|||
157188270|NCT01693562|567431409|FG003|Escalation Phase|Other|0|||
157188271|NCT01693562|567431410|FG004|Escalation Phase|Other|0|||
157188272|NCT01693562|567431411|FG005|Escalation Phase|Other|1|||
157188273|NCT01693562|567431412|FG006|Escalation Phase|Other|0|||
157188274|NCT01693562|567431413|FG007|Escalation Phase|Other|0|||
157188275|NCT01693562|567431414|FG008|Escalation Phase|Other|0|||
157188276|NCT01693562|567431415|FG009|Escalation Phase|Other|0|||
157188277|NCT01693562|567431416|FG010|Escalation Phase|Other|0|||
157188278|NCT01693562|567431417|FG011|Escalation Phase|Other|0|||
157188279|NCT01693562|567431418|FG012|Escalation Phase|Other|0|||
157188280|NCT01693562|567431419|FG013|Escalation Phase|Other|0|||
157188281|NCT01693562|567431420|FG014|Escalation Phase|Other|0|||
157188282|NCT01693562|567431421|FG015|Escalation Phase|Other|0|||
157188283|NCT01693562|567431422|FG016|Escalation Phase|Other|0|||
157188284|NCT01693562|567431423|FG017|Escalation Phase|Other|0|||
157188285|NCT01693562|567431424|FG018|Escalation Phase|Other|0|||
157188286|NCT01693562|567431425|FG019|Escalation Phase|Other|0|||
157188287|NCT01693562|567431426|FG020|Escalation Phase|Other|0|||
157188288|NCT01693562|567431427|FG021|Escalation Phase|Other|0|||
157188289|NCT01693562|567431428|FG022|Escalation Phase|Other|0|||
157188290|NCT01693562|567431406|FG000|Exploration Phase|Withdrawal by Subject|0|||
157188291|NCT01693562|567431407|FG001|Exploration Phase|Withdrawal by Subject|0|||
157188292|NCT01693562|567431408|FG002|Exploration Phase|Withdrawal by Subject|0|||
157188293|NCT01693562|567431409|FG003|Exploration Phase|Withdrawal by Subject|0|||
157188294|NCT01693562|567431410|FG004|Exploration Phase|Withdrawal by Subject|0|||
157188295|NCT01693562|567431411|FG005|Exploration Phase|Withdrawal by Subject|0|||
157188296|NCT01693562|567431412|FG006|Exploration Phase|Withdrawal by Subject|2|||
157188297|NCT01693562|567431413|FG007|Exploration Phase|Withdrawal by Subject|0|||
157188298|NCT01693562|567431414|FG008|Exploration Phase|Withdrawal by Subject|0|||
157188299|NCT01693562|567431415|FG009|Exploration Phase|Withdrawal by Subject|0|||
157188300|NCT01693562|567431416|FG010|Exploration Phase|Withdrawal by Subject|0|||
157188301|NCT01693562|567431417|FG011|Exploration Phase|Withdrawal by Subject|0|||
157188302|NCT01693562|567431418|FG012|Exploration Phase|Withdrawal by Subject|0|||
157188303|NCT01693562|567431419|FG013|Exploration Phase|Withdrawal by Subject|0|||
157188304|NCT01693562|567431420|FG014|Exploration Phase|Withdrawal by Subject|0|||
157188305|NCT01693562|567431421|FG015|Exploration Phase|Withdrawal by Subject|0|||
157188306|NCT01693562|567431422|FG016|Exploration Phase|Withdrawal by Subject|0|||
157188307|NCT01693562|567431423|FG017|Exploration Phase|Withdrawal by Subject|0|||
157188308|NCT01693562|567431424|FG018|Exploration Phase|Withdrawal by Subject|0|||
157188309|NCT01693562|567431425|FG019|Exploration Phase|Withdrawal by Subject|0|||
157188310|NCT01693562|567431426|FG020|Exploration Phase|Withdrawal by Subject|0|||
157188311|NCT01693562|567431427|FG021|Exploration Phase|Withdrawal by Subject|0|||
157188312|NCT01693562|567431428|FG022|Exploration Phase|Withdrawal by Subject|0|||
157188313|NCT01693562|567431406|FG000|Exploration Phase|Death|0|||
157188314|NCT01693562|567431407|FG001|Exploration Phase|Death|0|||
157188315|NCT01693562|567431408|FG002|Exploration Phase|Death|0|||
157188316|NCT01693562|567431409|FG003|Exploration Phase|Death|0|||
157188317|NCT01693562|567431410|FG004|Exploration Phase|Death|0|||
157188318|NCT01693562|567431411|FG005|Exploration Phase|Death|0|||
157188319|NCT01693562|567431412|FG006|Exploration Phase|Death|17|||
157188320|NCT01693562|567431413|FG007|Exploration Phase|Death|0|||
157188321|NCT01693562|567431414|FG008|Exploration Phase|Death|0|||
157188322|NCT01693562|567431415|FG009|Exploration Phase|Death|0|||
157188323|NCT01693562|567431416|FG010|Exploration Phase|Death|0|||
157188324|NCT01693562|567431417|FG011|Exploration Phase|Death|0|||
157188325|NCT01693562|567431418|FG012|Exploration Phase|Death|0|||
157188326|NCT01693562|567431419|FG013|Exploration Phase|Death|0|||
157188327|NCT01693562|567431420|FG014|Exploration Phase|Death|0|||
157188328|NCT01693562|567431421|FG015|Exploration Phase|Death|0|||
157188329|NCT01693562|567431422|FG016|Exploration Phase|Death|0|||
157188330|NCT01693562|567431423|FG017|Exploration Phase|Death|0|||
157188331|NCT01693562|567431424|FG018|Exploration Phase|Death|0|||
157188332|NCT01693562|567431425|FG019|Exploration Phase|Death|0|||
157188333|NCT01693562|567431426|FG020|Exploration Phase|Death|0|||
157188334|NCT01693562|567431427|FG021|Exploration Phase|Death|0|||
157188335|NCT01693562|567431428|FG022|Exploration Phase|Death|0|||
157188336|NCT01693562|567431406|FG000|Exploration Phase|Other|0|||
157188337|NCT01693562|567431407|FG001|Exploration Phase|Other|0|||
157188338|NCT01693562|567431408|FG002|Exploration Phase|Other|0|||
157188339|NCT01693562|567431409|FG003|Exploration Phase|Other|0|||
157188340|NCT01693562|567431410|FG004|Exploration Phase|Other|0|||
157188341|NCT01693562|567431411|FG005|Exploration Phase|Other|0|||
157188342|NCT01693562|567431412|FG006|Exploration Phase|Other|2|||
157188343|NCT01693562|567431413|FG007|Exploration Phase|Other|0|||
157188344|NCT01693562|567431414|FG008|Exploration Phase|Other|0|||
157188345|NCT01693562|567431415|FG009|Exploration Phase|Other|0|||
157188346|NCT01693562|567431416|FG010|Exploration Phase|Other|0|||
157188347|NCT01693562|567431417|FG011|Exploration Phase|Other|0|||
157188348|NCT01693562|567431418|FG012|Exploration Phase|Other|0|||
157188349|NCT01693562|567431419|FG013|Exploration Phase|Other|0|||
157188350|NCT01693562|567431420|FG014|Exploration Phase|Other|0|||
157188351|NCT01693562|567431421|FG015|Exploration Phase|Other|0|||
157188352|NCT01693562|567431422|FG016|Exploration Phase|Other|0|||
157188353|NCT01693562|567431423|FG017|Exploration Phase|Other|0|||
157188354|NCT01693562|567431424|FG018|Exploration Phase|Other|0|||
157188355|NCT01693562|567431425|FG019|Exploration Phase|Other|0|||
157188356|NCT01693562|567431426|FG020|Exploration Phase|Other|0|||
157188357|NCT01693562|567431427|FG021|Exploration Phase|Other|0|||
157188358|NCT01693562|567431428|FG022|Exploration Phase|Other|0|||
157188359|NCT01693562|567431406|FG000|Expansion Phase|Withdrawal by Subject|0|||
157188360|NCT01693562|567431407|FG001|Expansion Phase|Withdrawal by Subject|0|||
157188361|NCT01693562|567431408|FG002|Expansion Phase|Withdrawal by Subject|0|||
157188362|NCT01693562|567431409|FG003|Expansion Phase|Withdrawal by Subject|0|||
157188363|NCT01693562|567431410|FG004|Expansion Phase|Withdrawal by Subject|0|||
157188364|NCT01693562|567431411|FG005|Expansion Phase|Withdrawal by Subject|0|||
157188365|NCT01693562|567431412|FG006|Expansion Phase|Withdrawal by Subject|0|||
157188366|NCT01693562|567431413|FG007|Expansion Phase|Withdrawal by Subject|16|||
157068076|NCT01390441|567004337|FG002|Treatment Period|Physician Decision|0|||
157068077|NCT01390441|567004338|FG003|Treatment Period|Physician Decision|1|||
157068078|NCT01390441|567004339|FG004|Treatment Period|Physician Decision|0|||
157188367|NCT01693562|567431414|FG008|Expansion Phase|Withdrawal by Subject|2|||
157230276|NCT01104662|567588307|FG007|Overall Study|Participant left investigator's care|0|||
157188368|NCT01693562|567431415|FG009|Expansion Phase|Withdrawal by Subject|54|||
157188369|NCT01693562|567431416|FG010|Expansion Phase|Withdrawal by Subject|2|||
157188370|NCT01693562|567431417|FG011|Expansion Phase|Withdrawal by Subject|2|||
157188371|NCT01693562|567431418|FG012|Expansion Phase|Withdrawal by Subject|3|||
157188372|NCT01693562|567431419|FG013|Expansion Phase|Withdrawal by Subject|5|||
157188373|NCT01693562|567431420|FG014|Expansion Phase|Withdrawal by Subject|16|||
157188374|NCT01693562|567431421|FG015|Expansion Phase|Withdrawal by Subject|7|||
157188375|NCT01693562|567431422|FG016|Expansion Phase|Withdrawal by Subject|40|||
157188376|NCT01693562|567431423|FG017|Expansion Phase|Withdrawal by Subject|4|||
157188377|NCT01693562|567431424|FG018|Expansion Phase|Withdrawal by Subject|8|||
157188378|NCT01693562|567431425|FG019|Expansion Phase|Withdrawal by Subject|3|||
157188379|NCT01693562|567431426|FG020|Expansion Phase|Withdrawal by Subject|1|||
157188380|NCT01693562|567431427|FG021|Expansion Phase|Withdrawal by Subject|8|||
157188381|NCT01693562|567431428|FG022|Expansion Phase|Withdrawal by Subject|1|||
157188382|NCT01693562|567431406|FG000|Expansion Phase|Death|0|||
157188383|NCT01693562|567431407|FG001|Expansion Phase|Death|0|||
157188384|NCT01693562|567431408|FG002|Expansion Phase|Death|0|||
157188385|NCT01693562|567431409|FG003|Expansion Phase|Death|0|||
157188386|NCT01693562|567431410|FG004|Expansion Phase|Death|0|||
157188387|NCT01693562|567431411|FG005|Expansion Phase|Death|0|||
157188388|NCT01693562|567431412|FG006|Expansion Phase|Death|0|||
157188389|NCT01693562|567431413|FG007|Expansion Phase|Death|42|||
157188390|NCT01693562|567431414|FG008|Expansion Phase|Death|17|||
157188391|NCT01693562|567431415|FG009|Expansion Phase|Death|208|||
157188392|NCT01693562|567431416|FG010|Expansion Phase|Death|30|||
157188393|NCT01693562|567431417|FG011|Expansion Phase|Death|8|||
157188394|NCT01693562|567431418|FG012|Expansion Phase|Death|19|||
157188395|NCT01693562|567431419|FG013|Expansion Phase|Death|42|||
157188396|NCT01693562|567431420|FG014|Expansion Phase|Death|23|||
157188397|NCT01693562|567431421|FG015|Expansion Phase|Death|23|||
157188398|NCT01693562|567431422|FG016|Expansion Phase|Death|128|||
157188399|NCT01693562|567431423|FG017|Expansion Phase|Death|16|||
157188400|NCT01693562|567431424|FG018|Expansion Phase|Death|36|||
157188401|NCT01693562|567431425|FG019|Expansion Phase|Death|16|||
157188402|NCT01693562|567431426|FG020|Expansion Phase|Death|17|||
157188403|NCT01693562|567431427|FG021|Expansion Phase|Death|35|||
157188404|NCT01693562|567431428|FG022|Expansion Phase|Death|7|||
157188405|NCT01693562|567431406|FG000|Expansion Phase|Lost to Follow-up|0|||
157188406|NCT01693562|567431407|FG001|Expansion Phase|Lost to Follow-up|0|||
157188407|NCT01693562|567431408|FG002|Expansion Phase|Lost to Follow-up|0|||
157188408|NCT01693562|567431409|FG003|Expansion Phase|Lost to Follow-up|0|||
157188409|NCT01693562|567431410|FG004|Expansion Phase|Lost to Follow-up|0|||
157188410|NCT01693562|567431411|FG005|Expansion Phase|Lost to Follow-up|0|||
157188411|NCT01693562|567431412|FG006|Expansion Phase|Lost to Follow-up|0|||
157188412|NCT01693562|567431413|FG007|Expansion Phase|Lost to Follow-up|1|||
157188413|NCT01693562|567431414|FG008|Expansion Phase|Lost to Follow-up|2|||
157188414|NCT01693562|567431415|FG009|Expansion Phase|Lost to Follow-up|10|||
157188415|NCT01693562|567431416|FG010|Expansion Phase|Lost to Follow-up|4|||
157188416|NCT01693562|567431417|FG011|Expansion Phase|Lost to Follow-up|4|||
157188417|NCT01693562|567431418|FG012|Expansion Phase|Lost to Follow-up|1|||
157188418|NCT01693562|567431419|FG013|Expansion Phase|Lost to Follow-up|3|||
157188419|NCT01693562|567431420|FG014|Expansion Phase|Lost to Follow-up|0|||
157188420|NCT01693562|567431421|FG015|Expansion Phase|Lost to Follow-up|1|||
157188421|NCT01693562|567431422|FG016|Expansion Phase|Lost to Follow-up|1|||
157188422|NCT01693562|567431423|FG017|Expansion Phase|Lost to Follow-up|0|||
157188423|NCT01693562|567431424|FG018|Expansion Phase|Lost to Follow-up|2|||
157188424|NCT01693562|567431425|FG019|Expansion Phase|Lost to Follow-up|1|||
157188425|NCT01693562|567431426|FG020|Expansion Phase|Lost to Follow-up|2|||
157188426|NCT01693562|567431427|FG021|Expansion Phase|Lost to Follow-up|2|||
157188427|NCT01693562|567431428|FG022|Expansion Phase|Lost to Follow-up|1|||
157188428|NCT01693562|567431406|FG000|Expansion Phase|Other|0|||
157188429|NCT01693562|567431407|FG001|Expansion Phase|Other|0|||
157188430|NCT01693562|567431408|FG002|Expansion Phase|Other|0|||
157188431|NCT01693562|567431409|FG003|Expansion Phase|Other|0|||
157188432|NCT01693562|567431410|FG004|Expansion Phase|Other|0|||
157188433|NCT01693562|567431411|FG005|Expansion Phase|Other|0|||
157188434|NCT01693562|567431412|FG006|Expansion Phase|Other|0|||
157188435|NCT01693562|567431413|FG007|Expansion Phase|Other|3|||
157188436|NCT01693562|567431414|FG008|Expansion Phase|Other|1|||
157188437|NCT01693562|567431415|FG009|Expansion Phase|Other|28|||
157188438|NCT01693562|567431416|FG010|Expansion Phase|Other|4|||
157188439|NCT01693562|567431417|FG011|Expansion Phase|Other|7|||
157188440|NCT01693562|567431418|FG012|Expansion Phase|Other|0|||
157188441|NCT01693562|567431419|FG013|Expansion Phase|Other|1|||
157188442|NCT01693562|567431420|FG014|Expansion Phase|Other|1|||
157188443|NCT01693562|567431421|FG015|Expansion Phase|Other|0|||
157188444|NCT01693562|567431422|FG016|Expansion Phase|Other|28|||
157188445|NCT01693562|567431423|FG017|Expansion Phase|Other|0|||
157188446|NCT01693562|567431424|FG018|Expansion Phase|Other|1|||
157188447|NCT01693562|567431425|FG019|Expansion Phase|Other|0|||
157188448|NCT01693562|567431426|FG020|Expansion Phase|Other|1|||
157188449|NCT01693562|567431427|FG021|Expansion Phase|Other|17|||
157188450|NCT01693562|567431428|FG022|Expansion Phase|Other|1|||
157230277|NCT01104662|567588300|FG000|Overall Study|Reason not specified|3|||
157230278|NCT01104662|567588301|FG001|Overall Study|Reason not specified|3|||
157230279|NCT01104662|567588302|FG002|Overall Study|Reason not specified|0|||
157188451|NCT02759939|567431429|FG000|Overall Study|Missing data on first outcome assessed|11|||
157230280|NCT01104662|567588303|FG003|Overall Study|Reason not specified|0|||
157188452|NCT02759939|567431430|FG001|Overall Study|Missing data on first outcome assessed|2|||
157188453|NCT02759939|567431431|FG002|Overall Study|Missing data on first outcome assessed|5|||
157188454|NCT02759939|567431432|FG003|Overall Study|Missing data on first outcome assessed|2|||
157188455|NCT02759939|567431429|FG000|Overall Study|Ineligible for T2 and T3|310|||
157068079|NCT01390441|567004335|FG000|Treatment Period|Lack of Efficacy|0|||
157188456|NCT02759939|567431430|FG001|Overall Study|Ineligible for T2 and T3|179|||
157188457|NCT02759939|567431431|FG002|Overall Study|Ineligible for T2 and T3|366|||
157188458|NCT02759939|567431432|FG003|Overall Study|Ineligible for T2 and T3|391|||
157188459|NCT02759939|567431429|FG000|Overall Study|Lost to Follow-up|735|||
157188460|NCT02759939|567431430|FG001|Overall Study|Lost to Follow-up|791|||
157068080|NCT01390441|567004336|FG001|Treatment Period|Lack of Efficacy|0|||
157068081|NCT01390441|567004337|FG002|Treatment Period|Lack of Efficacy|0|||
157068082|NCT01390441|567004338|FG003|Treatment Period|Lack of Efficacy|0|||
157068083|NCT01390441|567004339|FG004|Treatment Period|Lack of Efficacy|1|||
157068084|NCT01390441|567004335|FG000|Treatment Period|Unknown due to early stopping of study|0|||
157068085|NCT01390441|567004336|FG001|Treatment Period|Unknown due to early stopping of study|0|||
157068086|NCT01390441|567004337|FG002|Treatment Period|Unknown due to early stopping of study|8|||
157068087|NCT01390441|567004338|FG003|Treatment Period|Unknown due to early stopping of study|11|||
157068088|NCT01390441|567004339|FG004|Treatment Period|Unknown due to early stopping of study|7|||
157068089|NCT01390441|567004335|FG000|Treatment Period|Adverse Event|0|||
157068090|NCT01390441|567004336|FG001|Treatment Period|Adverse Event|0|||
157068091|NCT01390441|567004337|FG002|Treatment Period|Adverse Event|1|||
157068092|NCT01390441|567004338|FG003|Treatment Period|Adverse Event|1|||
157068093|NCT01390441|567004339|FG004|Treatment Period|Adverse Event|2|||
157068094|NCT01390441|567004335|FG000|Treatment Period|Withdrawal by Subject|0|||
157068095|NCT01390441|567004336|FG001|Treatment Period|Withdrawal by Subject|0|||
157068096|NCT01390441|567004337|FG002|Treatment Period|Withdrawal by Subject|1|||
157068097|NCT01390441|567004338|FG003|Treatment Period|Withdrawal by Subject|0|||
157068098|NCT01390441|567004339|FG004|Treatment Period|Withdrawal by Subject|1|||
157068099|NCT01390441|567004335|FG000|Treatment Period|Lost to Follow-up|1|||
157068100|NCT01390441|567004336|FG001|Treatment Period|Lost to Follow-up|0|||
157068101|NCT01390441|567004337|FG002|Treatment Period|Lost to Follow-up|0|||
157068102|NCT01390441|567004338|FG003|Treatment Period|Lost to Follow-up|0|||
157068103|NCT01390441|567004339|FG004|Treatment Period|Lost to Follow-up|0|||
157068104|NCT01390441|567004335|FG000|Extension Period|Protocol Violation|3|||
157068105|NCT01390441|567004336|FG001|Extension Period|Protocol Violation|1|||
157068106|NCT01390441|567004337|FG002|Extension Period|Protocol Violation|0|||
157068107|NCT01390441|567004338|FG003|Extension Period|Protocol Violation|1|||
157068108|NCT01390441|567004339|FG004|Extension Period|Protocol Violation|0|||
157068109|NCT03802617|567004340|FG000|Overall Study|Adverse Event|0|||
157068110|NCT03802617|567004341|FG001|Overall Study|Adverse Event|4|||
157068111|NCT03802617|567004342|FG002|Overall Study|Adverse Event|5|||
157068112|NCT03802617|567004343|FG003|Overall Study|Adverse Event|1|||
157068113|NCT03802617|567004340|FG000|Overall Study|Lack of Efficacy|0|||
157068114|NCT03802617|567004341|FG001|Overall Study|Lack of Efficacy|1|||
157068115|NCT03802617|567004342|FG002|Overall Study|Lack of Efficacy|0|||
157068116|NCT03802617|567004343|FG003|Overall Study|Lack of Efficacy|2|||
157068117|NCT03802617|567004340|FG000|Overall Study|Protocol Violation|1|||
157068118|NCT03802617|567004341|FG001|Overall Study|Protocol Violation|1|||
157068119|NCT03802617|567004342|FG002|Overall Study|Protocol Violation|1|||
157068120|NCT03802617|567004343|FG003|Overall Study|Protocol Violation|0|||
157068121|NCT03802617|567004340|FG000|Overall Study|Withdrawal by Subject|1|||
157068122|NCT03802617|567004341|FG001|Overall Study|Withdrawal by Subject|1|||
157068123|NCT03802617|567004342|FG002|Overall Study|Withdrawal by Subject|1|||
157068124|NCT03802617|567004343|FG003|Overall Study|Withdrawal by Subject|0|||
157068125|NCT03802617|567004340|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
157068126|NCT03802617|567004341|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
157068127|NCT03802617|567004342|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
157068128|NCT03802617|567004343|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
157068129|NCT00621192|567004344|FG000|Overall Study|Withdrawal by Subject|0|||
157068130|NCT00621192|567004345|FG001|Overall Study|Withdrawal by Subject|0|||
157068131|NCT00621192|567004346|FG002|Overall Study|Withdrawal by Subject|2|||
157068132|NCT00621192|567004347|FG003|Overall Study|Withdrawal by Subject|0|||
157068133|NCT00621192|567004344|FG000|Overall Study|Physician Decision|1|||
157068134|NCT00621192|567004345|FG001|Overall Study|Physician Decision|3|||
157068135|NCT00621192|567004346|FG002|Overall Study|Physician Decision|0|||
157068136|NCT00621192|567004347|FG003|Overall Study|Physician Decision|0|||
157068137|NCT00621192|567004344|FG000|Overall Study|Protocol Violation|1|||
157068138|NCT00621192|567004345|FG001|Overall Study|Protocol Violation|0|||
157068139|NCT00621192|567004346|FG002|Overall Study|Protocol Violation|0|||
157068140|NCT00621192|567004347|FG003|Overall Study|Protocol Violation|1|||
157068141|NCT00621192|567004344|FG000|Overall Study|Adverse Event|0|||
157068142|NCT00621192|567004345|FG001|Overall Study|Adverse Event|1|||
157068143|NCT00621192|567004346|FG002|Overall Study|Adverse Event|0|||
157068144|NCT00621192|567004347|FG003|Overall Study|Adverse Event|1|||
157068145|NCT00621192|567004344|FG000|Overall Study|Death|2|||
157068146|NCT00621192|567004345|FG001|Overall Study|Death|5|||
157068147|NCT00621192|567004346|FG002|Overall Study|Death|0|||
157068148|NCT00621192|567004347|FG003|Overall Study|Death|0|||
157068149|NCT00621192|567004344|FG000|Overall Study|Final Assessments not Completed|0|||
157068150|NCT00621192|567004345|FG001|Overall Study|Final Assessments not Completed|0|||
157068151|NCT00621192|567004346|FG002|Overall Study|Final Assessments not Completed|3|||
157068152|NCT00621192|567004347|FG003|Overall Study|Final Assessments not Completed|1|||
157068153|NCT01099579|567004348|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
157068154|NCT01099579|567004349|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
157068155|NCT01099579|567004350|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
157068156|NCT01099579|567004348|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
157068157|NCT01099579|567004349|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
157068158|NCT01099579|567004350|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
157068159|NCT01099579|567004348|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
157188461|NCT02759939|567431431|FG002|Overall Study|Lost to Follow-up|783|||
157188462|NCT02759939|567431432|FG003|Overall Study|Lost to Follow-up|650|||
157188463|NCT04735432|567431433|FG000|Overall Study|Other - due to personal reason|1|||
157188464|NCT04735432|567431434|FG001|Overall Study|Other - due to personal reason|0|||
157188465|NCT04735432|567431433|FG000|Overall Study|Adverse Event|2|||
157188466|NCT04735432|567431434|FG001|Overall Study|Adverse Event|0|||
157188467|NCT02306148|567431435|FG000|Overall Study|Adverse Event|12|||
157188468|NCT02306148|567431436|FG001|Overall Study|Adverse Event|6|||
157188469|NCT02306148|567431435|FG000|Overall Study|Lost to Follow-up|1|||
157188470|NCT02306148|567431436|FG001|Overall Study|Lost to Follow-up|4|||
157188471|NCT04657003|567431443|FG000|Overall Study|Adverse Event|5|||
157188472|NCT04657003|567431444|FG001|Overall Study|Adverse Event|1|||
157188473|NCT04657003|567431445|FG002|Overall Study|Adverse Event|5|||
157188474|NCT04657003|567431443|FG000|Overall Study|Death|0|||
157188475|NCT04657003|567431444|FG001|Overall Study|Death|2|||
157188476|NCT04657003|567431445|FG002|Overall Study|Death|0|||
157188477|NCT04657003|567431443|FG000|Overall Study|Lost to Follow-up|8|||
157188478|NCT04657003|567431444|FG001|Overall Study|Lost to Follow-up|4|||
157188479|NCT04657003|567431445|FG002|Overall Study|Lost to Follow-up|10|||
157188480|NCT04657003|567431443|FG000|Overall Study|Other - As Reported by Investigator|3|||
157188481|NCT04657003|567431444|FG001|Overall Study|Other - As Reported by Investigator|2|||
157188482|NCT04657003|567431445|FG002|Overall Study|Other - As Reported by Investigator|2|||
157188483|NCT04657003|567431443|FG000|Overall Study|Pregnancy|2|||
157188484|NCT04657003|567431444|FG001|Overall Study|Pregnancy|0|||
157188485|NCT04657003|567431445|FG002|Overall Study|Pregnancy|2|||
157188486|NCT04657003|567431443|FG000|Overall Study|Withdrawal by Subject|16|||
157188487|NCT04657003|567431444|FG001|Overall Study|Withdrawal by Subject|7|||
157188488|NCT04657003|567431445|FG002|Overall Study|Withdrawal by Subject|10|||
157188489|NCT01823991|567431448|FG000|Overall Study|Withdrawal by Subject|8|||
157188490|NCT01823991|567431449|FG001|Overall Study|Withdrawal by Subject|5|||
157188491|NCT05158244|567431450|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
157188492|NCT05158244|567431451|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
157188493|NCT05158244|567431452|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
157188494|NCT05158244|567431453|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
157188495|NCT05158244|567431454|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
157188496|NCT05158244|567431450|FG000|Overall Study|Withdrawal by Subject|0|||
157188497|NCT05158244|567431451|FG001|Overall Study|Withdrawal by Subject|0|||
157188498|NCT05158244|567431452|FG002|Overall Study|Withdrawal by Subject|1|||
157188499|NCT05158244|567431453|FG003|Overall Study|Withdrawal by Subject|0|||
157188500|NCT05158244|567431454|FG004|Overall Study|Withdrawal by Subject|0|||
157188501|NCT02408016|567431456|FG000|Overall Study|Death|6|||
157188502|NCT02408016|567431457|FG001|Overall Study|Death|1|||
157188503|NCT02408016|567431458|FG002|Overall Study|Death|0|||
157188504|NCT02408016|567431456|FG000|Overall Study|Physician Decision|0|||
157188505|NCT02408016|567431457|FG001|Overall Study|Physician Decision|2|||
157188506|NCT02408016|567431458|FG002|Overall Study|Physician Decision|0|||
157188507|NCT00805194|567431459|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
157188508|NCT00805194|567431460|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
157188509|NCT00805194|567431459|FG000|Overall Study|Worsening or AE of underlying disease|64|||
157188510|NCT00805194|567431460|FG001|Overall Study|Worsening or AE of underlying disease|70|||
157188511|NCT00805194|567431459|FG000|Overall Study|Other AE|84|||
157188512|NCT00805194|567431460|FG001|Overall Study|Other AE|73|||
157188513|NCT00805194|567431459|FG000|Overall Study|Protocol Violation|9|||
157188514|NCT00805194|567431460|FG001|Overall Study|Protocol Violation|9|||
157188515|NCT00805194|567431459|FG000|Overall Study|Lost to Follow-up|5|||
157068160|NCT01099579|567004349|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
157068161|NCT01099579|567004350|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
157188516|NCT00805194|567431460|FG001|Overall Study|Lost to Follow-up|5|||
157188517|NCT00805194|567431459|FG000|Overall Study|Withdrawal by Subject|60|||
157188518|NCT00805194|567431460|FG001|Overall Study|Withdrawal by Subject|42|||
157068162|NCT01099579|567004348|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
157068163|NCT01099579|567004349|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
157068164|NCT01099579|567004350|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
157188519|NCT00805194|567431459|FG000|Overall Study|Not treated|3|||
157188520|NCT00805194|567431460|FG001|Overall Study|Not treated|4|||
157188521|NCT00805194|567431459|FG000|Overall Study|Reasons other than stated above|20|||
157188522|NCT00805194|567431460|FG001|Overall Study|Reasons other than stated above|16|||
157188523|NCT02185040|567431464|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
157188524|NCT02185040|567431465|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
157188525|NCT02185040|567431466|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
157188526|NCT02185040|567431467|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
157188527|NCT02185040|567431468|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
157188528|NCT02185040|567431469|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
157188529|NCT02185040|567431470|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
157188530|NCT02185040|567431464|FG000|Part 1 Treatment Phase|Adverse Event|1|||
157188531|NCT02185040|567431465|FG001|Part 1 Treatment Phase|Adverse Event|0|||
157188532|NCT02185040|567431466|FG002|Part 1 Treatment Phase|Adverse Event|0|||
157188533|NCT02185040|567431467|FG003|Part 1 Treatment Phase|Adverse Event|2|||
157188534|NCT02185040|567431468|FG004|Part 1 Treatment Phase|Adverse Event|3|||
157188535|NCT02185040|567431469|FG005|Part 1 Treatment Phase|Adverse Event|0|||
157188536|NCT02185040|567431470|FG006|Part 1 Treatment Phase|Adverse Event|0|||
157188537|NCT02185040|567431464|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188538|NCT02185040|567431465|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
157188539|NCT02185040|567431466|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188540|NCT02185040|567431467|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188541|NCT02185040|567431468|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188542|NCT02185040|567431469|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188543|NCT02185040|567431470|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
157188544|NCT02185040|567431464|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188545|NCT02185040|567431465|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
157188546|NCT02185040|567431466|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188547|NCT02185040|567431467|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188548|NCT02185040|567431468|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188549|NCT02185040|567431469|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188550|NCT02185040|567431470|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
157188551|NCT02185040|567431464|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
157188552|NCT02185040|567431465|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
157188553|NCT02185040|567431466|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
157188554|NCT02185040|567431467|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
157188555|NCT02185040|567431468|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
157188556|NCT02185040|567431469|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
157188557|NCT02185040|567431470|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
157188558|NCT02185040|567431464|FG000|Active Treatment Extension Phase|Adverse Event|0|||
157188559|NCT02185040|567431465|FG001|Active Treatment Extension Phase|Adverse Event|0|||
157188560|NCT02185040|567431466|FG002|Active Treatment Extension Phase|Adverse Event|0|||
157188561|NCT02185040|567431467|FG003|Active Treatment Extension Phase|Adverse Event|0|||
157188562|NCT02185040|567431468|FG004|Active Treatment Extension Phase|Adverse Event|0|||
157188563|NCT02185040|567431469|FG005|Active Treatment Extension Phase|Adverse Event|1|||
157188564|NCT02185040|567431470|FG006|Active Treatment Extension Phase|Adverse Event|4|||
157188565|NCT02185040|567431464|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
157188566|NCT02185040|567431465|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
157188567|NCT02185040|567431466|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
157188568|NCT02185040|567431467|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
157188569|NCT02185040|567431468|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
157188570|NCT02185040|567431469|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
157188571|NCT02185040|567431470|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
157188572|NCT02185040|567431464|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188573|NCT02185040|567431465|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188574|NCT02185040|567431466|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188575|NCT02185040|567431467|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188576|NCT02185040|567431468|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188577|NCT02185040|567431469|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
157188578|NCT02185040|567431470|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
157188579|NCT02646891|567431475|FG000|Overall Study|Adverse Event|0|||
157188580|NCT02646891|567431476|FG001|Overall Study|Adverse Event|1|||
157188581|NCT02646891|567431477|FG002|Overall Study|Adverse Event|0|||
157188582|NCT02646891|567431478|FG003|Overall Study|Adverse Event|0|||
157188583|NCT02646891|567431479|FG004|Overall Study|Adverse Event|0|||
157188584|NCT02646891|567431480|FG005|Overall Study|Adverse Event|0|||
157188585|NCT02646891|567431481|FG006|Overall Study|Adverse Event|0|||
157188586|NCT02646891|567431482|FG007|Overall Study|Adverse Event|0|||
157188587|NCT02646891|567431483|FG008|Overall Study|Adverse Event|0|||
157188588|NCT02646891|567431484|FG009|Overall Study|Adverse Event|0|||
157188589|NCT02646891|567431475|FG000|Overall Study|Lost to Follow-up|0|||
157188590|NCT02646891|567431476|FG001|Overall Study|Lost to Follow-up|0|||
157188591|NCT02646891|567431477|FG002|Overall Study|Lost to Follow-up|0|||
157188592|NCT02646891|567431478|FG003|Overall Study|Lost to Follow-up|0|||
157188593|NCT02646891|567431479|FG004|Overall Study|Lost to Follow-up|0|||
157188594|NCT02646891|567431480|FG005|Overall Study|Lost to Follow-up|0|||
157188595|NCT02646891|567431481|FG006|Overall Study|Lost to Follow-up|2|||
157188596|NCT02646891|567431482|FG007|Overall Study|Lost to Follow-up|2|||
157188597|NCT02646891|567431483|FG008|Overall Study|Lost to Follow-up|2|||
157188598|NCT02646891|567431484|FG009|Overall Study|Lost to Follow-up|2|||
157188599|NCT02646891|567431475|FG000|Overall Study|Protocol Violation|0|||
157188600|NCT02646891|567431476|FG001|Overall Study|Protocol Violation|0|||
157188601|NCT02646891|567431477|FG002|Overall Study|Protocol Violation|0|||
157188602|NCT02646891|567431478|FG003|Overall Study|Protocol Violation|0|||
157188603|NCT02646891|567431479|FG004|Overall Study|Protocol Violation|0|||
157188604|NCT02646891|567431480|FG005|Overall Study|Protocol Violation|0|||
157188605|NCT02646891|567431481|FG006|Overall Study|Protocol Violation|1|||
157188606|NCT02646891|567431482|FG007|Overall Study|Protocol Violation|1|||
157188607|NCT02646891|567431483|FG008|Overall Study|Protocol Violation|0|||
157188608|NCT02646891|567431484|FG009|Overall Study|Protocol Violation|0|||
157188609|NCT02646891|567431475|FG000|Overall Study|Withdrawal by Subject|2|||
157188610|NCT02646891|567431476|FG001|Overall Study|Withdrawal by Subject|0|||
157188611|NCT02646891|567431477|FG002|Overall Study|Withdrawal by Subject|1|||
157188612|NCT02646891|567431478|FG003|Overall Study|Withdrawal by Subject|0|||
157188613|NCT02646891|567431479|FG004|Overall Study|Withdrawal by Subject|0|||
157188614|NCT02646891|567431480|FG005|Overall Study|Withdrawal by Subject|0|||
157188615|NCT02646891|567431481|FG006|Overall Study|Withdrawal by Subject|5|||
157188616|NCT02646891|567431482|FG007|Overall Study|Withdrawal by Subject|9|||
157188617|NCT02646891|567431483|FG008|Overall Study|Withdrawal by Subject|7|||
157188618|NCT02646891|567431484|FG009|Overall Study|Withdrawal by Subject|3|||
157188619|NCT02646891|567431475|FG000|Overall Study|Death|0|||
157188620|NCT02646891|567431476|FG001|Overall Study|Death|0|||
157188621|NCT02646891|567431477|FG002|Overall Study|Death|0|||
157188622|NCT02646891|567431478|FG003|Overall Study|Death|0|||
157188623|NCT02646891|567431479|FG004|Overall Study|Death|0|||
157188624|NCT02646891|567431480|FG005|Overall Study|Death|0|||
157188625|NCT02646891|567431481|FG006|Overall Study|Death|1|||
157188626|NCT02646891|567431482|FG007|Overall Study|Death|1|||
157188627|NCT02646891|567431483|FG008|Overall Study|Death|1|||
157188628|NCT02646891|567431484|FG009|Overall Study|Death|0|||
157188629|NCT01542632|567431485|FG000|Overall Study|Withdrawal of Consent|0|||
157188630|NCT01542632|567431486|FG001|Overall Study|Withdrawal of Consent|0|||
157188631|NCT01542632|567431487|FG002|Overall Study|Withdrawal of Consent|0|||
157188632|NCT01542632|567431488|FG003|Overall Study|Withdrawal of Consent|2|||
157188633|NCT01542632|567431489|FG004|Overall Study|Withdrawal of Consent|3|||
157188634|NCT01542632|567431490|FG005|Overall Study|Withdrawal of Consent|0|||
157188635|NCT01542632|567431485|FG000|Overall Study|Adverse Event|0|||
157188636|NCT01542632|567431486|FG001|Overall Study|Adverse Event|0|||
157188637|NCT01542632|567431487|FG002|Overall Study|Adverse Event|1|||
157188638|NCT01542632|567431488|FG003|Overall Study|Adverse Event|0|||
157188639|NCT01542632|567431489|FG004|Overall Study|Adverse Event|0|||
157188640|NCT01542632|567431490|FG005|Overall Study|Adverse Event|0|||
157188641|NCT01542632|567431485|FG000|Overall Study|Lost to Follow-up|0|||
157188642|NCT01542632|567431486|FG001|Overall Study|Lost to Follow-up|1|||
157188643|NCT01542632|567431487|FG002|Overall Study|Lost to Follow-up|0|||
157188644|NCT01542632|567431488|FG003|Overall Study|Lost to Follow-up|0|||
157188645|NCT01542632|567431489|FG004|Overall Study|Lost to Follow-up|0|||
157188646|NCT01542632|567431490|FG005|Overall Study|Lost to Follow-up|0|||
157188647|NCT01542632|567431485|FG000|Overall Study|Sponsor/Investigator Decision|0|||
157188648|NCT01542632|567431486|FG001|Overall Study|Sponsor/Investigator Decision|0|||
157188649|NCT01542632|567431487|FG002|Overall Study|Sponsor/Investigator Decision|0|||
157188650|NCT01542632|567431488|FG003|Overall Study|Sponsor/Investigator Decision|0|||
157188651|NCT01542632|567431489|FG004|Overall Study|Sponsor/Investigator Decision|1|||
157188652|NCT01542632|567431490|FG005|Overall Study|Sponsor/Investigator Decision|0|||
157188653|NCT00033514|567431491|FG000|Overall Study|Lost to Follow-up|1|||
157188654|NCT00033514|567431492|FG001|Overall Study|Lost to Follow-up|1|||
157188655|NCT00033514|567431491|FG000|Overall Study|Withdrawal by Subject|0|||
157188656|NCT00033514|567431492|FG001|Overall Study|Withdrawal by Subject|3|||
157188657|NCT03225833|567431493|FG000|Overall Study|Adverse Event|0|||
157188658|NCT03225833|567431494|FG001|Overall Study|Adverse Event|1|||
157188659|NCT03225833|567431495|FG002|Overall Study|Adverse Event|2|||
157188660|NCT03225833|567431496|FG003|Overall Study|Adverse Event|0|||
157188661|NCT03225833|567431497|FG004|Overall Study|Adverse Event|0|||
157188662|NCT03225833|567431498|FG005|Overall Study|Adverse Event|2|||
157188663|NCT03225833|567431493|FG000|Overall Study|Withdrawal by Subject|1|||
157188664|NCT03225833|567431494|FG001|Overall Study|Withdrawal by Subject|0|||
157188665|NCT03225833|567431495|FG002|Overall Study|Withdrawal by Subject|0|||
157188666|NCT03225833|567431496|FG003|Overall Study|Withdrawal by Subject|0|||
157188667|NCT03225833|567431497|FG004|Overall Study|Withdrawal by Subject|1|||
157188668|NCT03225833|567431498|FG005|Overall Study|Withdrawal by Subject|0|||
157188669|NCT03225833|567431493|FG000|Overall Study|Termination of Study by Sponsor|4|||
157188670|NCT03225833|567431494|FG001|Overall Study|Termination of Study by Sponsor|0|||
157188671|NCT03225833|567431495|FG002|Overall Study|Termination of Study by Sponsor|0|||
157188672|NCT03225833|567431496|FG003|Overall Study|Termination of Study by Sponsor|0|||
157188673|NCT03225833|567431497|FG004|Overall Study|Termination of Study by Sponsor|0|||
157188674|NCT03225833|567431498|FG005|Overall Study|Termination of Study by Sponsor|7|||
157188675|NCT03225833|567431493|FG000|Overall Study|Sponsor Decision|0|||
157188676|NCT03225833|567431494|FG001|Overall Study|Sponsor Decision|0|||
157068165|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
157068166|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
157068167|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
157068168|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
157068169|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
157068170|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
157068171|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
157068172|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
157068173|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
157068174|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
157068175|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
157068176|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
157068177|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
157068178|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
157068179|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
157068180|NCT01099579|567004348|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
157068181|NCT01099579|567004349|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
157068182|NCT01099579|567004350|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
157068183|NCT02569957|567004351|FG000|Overall Study|Withdrawal by Subject|0|||
157068184|NCT02569957|567004352|FG001|Overall Study|Withdrawal by Subject|1|||
157068185|NCT02635386|567004353|FG000|Overall Study|Pregnancy|2|||
157068186|NCT02635386|567004354|FG001|Overall Study|Pregnancy|0|||
157068187|NCT02635386|567004355|FG002|Overall Study|Pregnancy|0|||
157068188|NCT02635386|567004356|FG003|Overall Study|Pregnancy|0|||
157068189|NCT02635386|567004357|FG004|Overall Study|Pregnancy|2|||
157068190|NCT02635386|567004353|FG000|Overall Study|Withdrawal by Subject|1|||
157068191|NCT02635386|567004354|FG001|Overall Study|Withdrawal by Subject|1|||
157068192|NCT02635386|567004355|FG002|Overall Study|Withdrawal by Subject|0|||
157068193|NCT02635386|567004356|FG003|Overall Study|Withdrawal by Subject|1|||
157068194|NCT02635386|567004357|FG004|Overall Study|Withdrawal by Subject|0|||
157068195|NCT02635386|567004353|FG000|Overall Study|Physician Decision|0|||
157068196|NCT02635386|567004354|FG001|Overall Study|Physician Decision|1|||
157068197|NCT02635386|567004355|FG002|Overall Study|Physician Decision|0|||
157068198|NCT02635386|567004356|FG003|Overall Study|Physician Decision|0|||
157068199|NCT02635386|567004357|FG004|Overall Study|Physician Decision|0|||
157068200|NCT02635386|567004353|FG000|Overall Study|Moved Out of State|0|||
157068201|NCT02635386|567004354|FG001|Overall Study|Moved Out of State|1|||
157068202|NCT02635386|567004355|FG002|Overall Study|Moved Out of State|0|||
157068203|NCT02635386|567004356|FG003|Overall Study|Moved Out of State|0|||
157068204|NCT02635386|567004357|FG004|Overall Study|Moved Out of State|0|||
157068205|NCT02635386|567004353|FG000|Overall Study|Noncompliant|0|||
157068206|NCT02635386|567004354|FG001|Overall Study|Noncompliant|2|||
157068207|NCT02635386|567004355|FG002|Overall Study|Noncompliant|1|||
157068208|NCT02635386|567004356|FG003|Overall Study|Noncompliant|1|||
157068209|NCT02635386|567004357|FG004|Overall Study|Noncompliant|1|||
157068210|NCT02635386|567004353|FG000|Overall Study|side effects|0|||
157068211|NCT02635386|567004354|FG001|Overall Study|side effects|0|||
157068212|NCT02635386|567004355|FG002|Overall Study|side effects|1|||
157068213|NCT02635386|567004356|FG003|Overall Study|side effects|4|||
157068214|NCT02635386|567004357|FG004|Overall Study|side effects|6|||
157068215|NCT02635386|567004353|FG000|Overall Study|needed other major surgery|0|||
157068216|NCT02635386|567004354|FG001|Overall Study|needed other major surgery|1|||
157068217|NCT02635386|567004355|FG002|Overall Study|needed other major surgery|0|||
157068218|NCT02635386|567004356|FG003|Overall Study|needed other major surgery|0|||
157068219|NCT02635386|567004357|FG004|Overall Study|needed other major surgery|0|||
157068220|NCT02635386|567004353|FG000|Overall Study|Other medical problems not drug related|0|||
157068221|NCT02635386|567004354|FG001|Overall Study|Other medical problems not drug related|0|||
157068222|NCT02635386|567004355|FG002|Overall Study|Other medical problems not drug related|0|||
157068223|NCT02635386|567004356|FG003|Overall Study|Other medical problems not drug related|1|||
157068224|NCT02635386|567004357|FG004|Overall Study|Other medical problems not drug related|0|||
157068225|NCT03174782|567004358|FG000|Overall Study|Protocol Violation|1|||
157068226|NCT03174782|567004359|FG001|Overall Study|Protocol Violation|0|||
157068227|NCT03174782|567004358|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
157068228|NCT03174782|567004359|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
157068229|NCT03178045|567004360|FG000|Overall Study|Withdrawal by Subject|5|||
157068230|NCT03178045|567004361|FG001|Overall Study|Withdrawal by Subject|7|||
157188677|NCT03225833|567431495|FG002|Overall Study|Sponsor Decision|0|||
157188678|NCT03225833|567431496|FG003|Overall Study|Sponsor Decision|0|||
157068231|NCT03178045|567004360|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
157068232|NCT03178045|567004361|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
157068233|NCT03178045|567004360|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
157068234|NCT03178045|567004361|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
157068235|NCT01078922|567004362|FG000|Overall Study|Adverse Event|1|||
157068236|NCT00798304|567004363|FG000|Overall Study|Adverse Event|0|||
157068237|NCT00798304|567004364|FG001|Overall Study|Adverse Event|1|||
157188679|NCT03225833|567431497|FG004|Overall Study|Sponsor Decision|0|||
157188680|NCT03225833|567431498|FG005|Overall Study|Sponsor Decision|1|||
157188681|NCT04564027|567431500|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
157188682|NCT04564027|567431501|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
157188683|NCT04564027|567431502|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
157188684|NCT04564027|567431503|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
157188685|NCT05827978|567431504|FG000|Overall Study|Adverse Event|1|||
157188686|NCT05827978|567431505|FG001|Overall Study|Adverse Event|0|||
157188687|NCT05827978|567431506|FG002|Overall Study|Adverse Event|0|||
157188688|NCT05827978|567431507|FG003|Overall Study|Adverse Event|1|||
157188689|NCT05827978|567431508|FG004|Overall Study|Adverse Event|0|||
157188690|NCT05827978|567431509|FG005|Overall Study|Adverse Event|0|||
157188691|NCT05827978|567431504|FG000|Overall Study|Death|1|||
157188692|NCT05827978|567431505|FG001|Overall Study|Death|5|||
157188693|NCT05827978|567431506|FG002|Overall Study|Death|2|||
157188694|NCT05827978|567431507|FG003|Overall Study|Death|3|||
157188695|NCT05827978|567431508|FG004|Overall Study|Death|1|||
157188696|NCT05827978|567431509|FG005|Overall Study|Death|3|||
157188697|NCT05827978|567431504|FG000|Overall Study|Lost to Follow-up|57|||
157188698|NCT05827978|567431505|FG001|Overall Study|Lost to Follow-up|88|||
157188699|NCT05827978|567431506|FG002|Overall Study|Lost to Follow-up|54|||
157188700|NCT05827978|567431507|FG003|Overall Study|Lost to Follow-up|47|||
157188701|NCT05827978|567431508|FG004|Overall Study|Lost to Follow-up|25|||
157188702|NCT05827978|567431509|FG005|Overall Study|Lost to Follow-up|10|||
157188703|NCT05827978|567431504|FG000|Overall Study|Noncompliance with Study Procedures|0|||
157188704|NCT05827978|567431505|FG001|Overall Study|Noncompliance with Study Procedures|1|||
157188705|NCT05827978|567431506|FG002|Overall Study|Noncompliance with Study Procedures|1|||
157188706|NCT05827978|567431507|FG003|Overall Study|Noncompliance with Study Procedures|1|||
157188707|NCT05827978|567431508|FG004|Overall Study|Noncompliance with Study Procedures|1|||
157188708|NCT05827978|567431509|FG005|Overall Study|Noncompliance with Study Procedures|0|||
157188709|NCT05827978|567431504|FG000|Overall Study|Physician Decision|2|||
157188710|NCT05827978|567431505|FG001|Overall Study|Physician Decision|0|||
157188711|NCT05827978|567431506|FG002|Overall Study|Physician Decision|1|||
157188712|NCT05827978|567431507|FG003|Overall Study|Physician Decision|2|||
157188713|NCT05827978|567431508|FG004|Overall Study|Physician Decision|1|||
157188714|NCT05827978|567431509|FG005|Overall Study|Physician Decision|1|||
157188715|NCT05827978|567431504|FG000|Overall Study|Protocol Violation|5|||
157188716|NCT05827978|567431505|FG001|Overall Study|Protocol Violation|2|||
157188717|NCT05827978|567431506|FG002|Overall Study|Protocol Violation|0|||
157188718|NCT05827978|567431507|FG003|Overall Study|Protocol Violation|0|||
157188719|NCT05827978|567431508|FG004|Overall Study|Protocol Violation|0|||
157188720|NCT05827978|567431509|FG005|Overall Study|Protocol Violation|0|||
157188721|NCT05827978|567431504|FG000|Overall Study|Withdrawal by Subject|17|||
157188722|NCT05827978|567431505|FG001|Overall Study|Withdrawal by Subject|16|||
157188723|NCT05827978|567431506|FG002|Overall Study|Withdrawal by Subject|10|||
157188724|NCT05827978|567431507|FG003|Overall Study|Withdrawal by Subject|12|||
157188725|NCT05827978|567431508|FG004|Overall Study|Withdrawal by Subject|10|||
157188726|NCT05827978|567431509|FG005|Overall Study|Withdrawal by Subject|9|||
157188727|NCT05827978|567431504|FG000|Overall Study|Other Than Specified|0|||
157188728|NCT05827978|567431505|FG001|Overall Study|Other Than Specified|0|||
157188729|NCT05827978|567431506|FG002|Overall Study|Other Than Specified|1|||
157188730|NCT05827978|567431507|FG003|Overall Study|Other Than Specified|0|||
157188731|NCT05827978|567431508|FG004|Overall Study|Other Than Specified|2|||
157188732|NCT05827978|567431509|FG005|Overall Study|Other Than Specified|0|||
157188733|NCT04566445|567431510|FG000|Overall Study|Death|4|||
157188734|NCT04566445|567431511|FG001|Overall Study|Death|1|||
157188735|NCT04566445|567431512|FG002|Overall Study|Death|1|||
157188736|NCT04566445|567431510|FG000|Overall Study|Lost to Follow-up|3|||
157188737|NCT04566445|567431511|FG001|Overall Study|Lost to Follow-up|1|||
157188738|NCT04566445|567431512|FG002|Overall Study|Lost to Follow-up|1|||
157188739|NCT04566445|567431510|FG000|Overall Study|Study terminated by sponsor|11|||
157188740|NCT04566445|567431511|FG001|Overall Study|Study terminated by sponsor|17|||
157188741|NCT04566445|567431512|FG002|Overall Study|Study terminated by sponsor|32|||
157188742|NCT04566445|567431510|FG000|Overall Study|Withdrawal by Subject|12|||
157188743|NCT04566445|567431511|FG001|Overall Study|Withdrawal by Subject|14|||
157188744|NCT04566445|567431512|FG002|Overall Study|Withdrawal by Subject|13|||
157230281|NCT01104662|567588304|FG004|Overall Study|Reason not specified|0|||
157230282|NCT01104662|567588305|FG005|Overall Study|Reason not specified|1|||
157230283|NCT01104662|567588306|FG006|Overall Study|Reason not specified|0|||
157188745|NCT04566445|567431510|FG000|Overall Study|Randomized but not treated due to AE|2|||
157188746|NCT04566445|567431511|FG001|Overall Study|Randomized but not treated due to AE|1|||
157188747|NCT04566445|567431512|FG002|Overall Study|Randomized but not treated due to AE|0|||
157188748|NCT04566445|567431510|FG000|Overall Study|Adverse Event|1|||
157188749|NCT04566445|567431511|FG001|Overall Study|Adverse Event|1|||
157188750|NCT04566445|567431512|FG002|Overall Study|Adverse Event|0|||
157188751|NCT04785144|567431513|FG000|Overall Study|Withdrawal by Subject|4|||
157188752|NCT04785144|567431514|FG001|Overall Study|Withdrawal by Subject|1|||
157188753|NCT04785144|567431515|FG002|Overall Study|Withdrawal by Subject|0|||
157188754|NCT04785144|567431516|FG003|Overall Study|Withdrawal by Subject|0|||
157068238|NCT00798304|567004365|FG002|Overall Study|Adverse Event|1|||
157068239|NCT00798304|567004363|FG000|Overall Study|Discontinuation by Sponsor|14|||
157068240|NCT00798304|567004364|FG001|Overall Study|Discontinuation by Sponsor|21|||
157068241|NCT00798304|567004365|FG002|Overall Study|Discontinuation by Sponsor|9|||
157068242|NCT00547534|567004368|FG000|Overall Study|Adverse Event|7|||
157068243|NCT00547534|567004368|FG000|Overall Study|Disease Progression|4|||
157068244|NCT05523219|567004383|FG000|Overall Study|Wrong inclusion|1|||
157068245|NCT05523219|567004383|FG000|Overall Study|Lost to Follow-up|7|||
157068246|NCT02760485|567004384|FG000|Phase 1|Death|3|||
157068247|NCT02760485|567004385|FG001|Phase 1|Death|6|||
157068248|NCT02760485|567004386|FG002|Phase 1|Death|0|||
157068249|NCT02760485|567004384|FG000|Phase 1|Withdrawal by Subject|2|||
157068250|NCT02760485|567004385|FG001|Phase 1|Withdrawal by Subject|0|||
157068251|NCT02760485|567004386|FG002|Phase 1|Withdrawal by Subject|0|||
157068252|NCT02760485|567004384|FG000|Phase 1|Progressive Disease|1|||
157230284|NCT01104662|567588307|FG007|Overall Study|Reason not specified|0|||
157230285|NCT01104662|567588300|FG000|Overall Study|Randomized but not treated|3|||
157230286|NCT01104662|567588301|FG001|Overall Study|Randomized but not treated|4|||
157230287|NCT01104662|567588302|FG002|Overall Study|Randomized but not treated|1|||
157230288|NCT01104662|567588303|FG003|Overall Study|Randomized but not treated|0|||
157230289|NCT01104662|567588304|FG004|Overall Study|Randomized but not treated|0|||
157230290|NCT01104662|567588305|FG005|Overall Study|Randomized but not treated|1|||
157230291|NCT01104662|567588306|FG006|Overall Study|Randomized but not treated|0|||
157230292|NCT01104662|567588307|FG007|Overall Study|Randomized but not treated|0|||
157230293|NCT04349917|567590556|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
157230294|NCT04349917|567590557|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
157230295|NCT04349917|567590556|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
157230296|NCT04349917|567590557|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
157230297|NCT00745420|567590560|FG000|Overall Study|Ineligible|1|||
157230298|NCT04455633|567590570|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
157068253|NCT02760485|567004385|FG001|Phase 1|Progressive Disease|0|||
157068254|NCT02760485|567004386|FG002|Phase 1|Progressive Disease|0|||
157188755|NCT04785144|567431517|FG004|Overall Study|Withdrawal by Subject|0|||
157188756|NCT04785144|567431518|FG005|Overall Study|Withdrawal by Subject|2|||
157188757|NCT04785144|567431519|FG006|Overall Study|Withdrawal by Subject|2|||
157188758|NCT04785144|567431520|FG007|Overall Study|Withdrawal by Subject|0|||
157188759|NCT04785144|567431521|FG008|Overall Study|Withdrawal by Subject|1|||
157188760|NCT04785144|567431522|FG009|Overall Study|Withdrawal by Subject|0|||
157188761|NCT04785144|567431513|FG000|Overall Study|Lost to Follow-up|1|||
157188762|NCT04785144|567431514|FG001|Overall Study|Lost to Follow-up|0|||
157188763|NCT04785144|567431515|FG002|Overall Study|Lost to Follow-up|0|||
157188764|NCT04785144|567431516|FG003|Overall Study|Lost to Follow-up|0|||
157188765|NCT04785144|567431517|FG004|Overall Study|Lost to Follow-up|1|||
157188766|NCT04785144|567431518|FG005|Overall Study|Lost to Follow-up|2|||
157188767|NCT04785144|567431519|FG006|Overall Study|Lost to Follow-up|1|||
157188768|NCT04785144|567431520|FG007|Overall Study|Lost to Follow-up|2|||
157188769|NCT04785144|567431521|FG008|Overall Study|Lost to Follow-up|4|||
157188770|NCT04785144|567431522|FG009|Overall Study|Lost to Follow-up|1|||
157188771|NCT04785144|567431513|FG000|Overall Study|Protocol Violation|0|||
157188772|NCT04785144|567431514|FG001|Overall Study|Protocol Violation|0|||
157188773|NCT04785144|567431515|FG002|Overall Study|Protocol Violation|0|||
157188774|NCT04785144|567431516|FG003|Overall Study|Protocol Violation|0|||
157188775|NCT04785144|567431517|FG004|Overall Study|Protocol Violation|0|||
157188776|NCT04785144|567431518|FG005|Overall Study|Protocol Violation|0|||
157188777|NCT04785144|567431519|FG006|Overall Study|Protocol Violation|1|||
157188778|NCT04785144|567431520|FG007|Overall Study|Protocol Violation|0|||
157188779|NCT04785144|567431521|FG008|Overall Study|Protocol Violation|0|||
157188780|NCT04785144|567431522|FG009|Overall Study|Protocol Violation|0|||
157188781|NCT04785144|567431513|FG000|Overall Study|Physician Decision|0|||
157188782|NCT04785144|567431514|FG001|Overall Study|Physician Decision|0|||
157188783|NCT04785144|567431515|FG002|Overall Study|Physician Decision|0|||
157188784|NCT04785144|567431516|FG003|Overall Study|Physician Decision|0|||
157188785|NCT04785144|567431517|FG004|Overall Study|Physician Decision|0|||
157068255|NCT02760485|567004384|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
157068256|NCT02760485|567004385|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
157068257|NCT02760485|567004386|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
157068258|NCT02760485|567004384|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
157188786|NCT04785144|567431518|FG005|Overall Study|Physician Decision|0|||
157068259|NCT02760485|567004385|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
157068260|NCT02760485|567004386|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
157068261|NCT02760485|567004384|FG000|Phase 2|Death|0|||
157188787|NCT04785144|567431519|FG006|Overall Study|Physician Decision|0|||
157188788|NCT04785144|567431520|FG007|Overall Study|Physician Decision|0|||
157188789|NCT04785144|567431521|FG008|Overall Study|Physician Decision|0|||
157188790|NCT04785144|567431522|FG009|Overall Study|Physician Decision|1|||
157188791|NCT04785144|567431513|FG000|Overall Study|Unable to continue due to work schedule|0|||
157188792|NCT04785144|567431514|FG001|Overall Study|Unable to continue due to work schedule|0|||
157188793|NCT04785144|567431515|FG002|Overall Study|Unable to continue due to work schedule|0|||
157188794|NCT04785144|567431516|FG003|Overall Study|Unable to continue due to work schedule|0|||
157188795|NCT04785144|567431517|FG004|Overall Study|Unable to continue due to work schedule|0|||
157188796|NCT04785144|567431518|FG005|Overall Study|Unable to continue due to work schedule|0|||
157188797|NCT04785144|567431519|FG006|Overall Study|Unable to continue due to work schedule|0|||
157188798|NCT04785144|567431520|FG007|Overall Study|Unable to continue due to work schedule|0|||
157188799|NCT04785144|567431521|FG008|Overall Study|Unable to continue due to work schedule|0|||
157188800|NCT04785144|567431522|FG009|Overall Study|Unable to continue due to work schedule|1|||
157188801|NCT00712712|567431525|FG000|Overall Study|Protocol Violation|11|||
157188802|NCT00712712|567431525|FG000|Overall Study|Radiofrequency not done|3|||
157188803|NCT00712712|567431525|FG000|Overall Study|Death|8|||
157188804|NCT00712712|567431525|FG000|Overall Study|Withdrawal by Subject|1|||
157188805|NCT02061540|567431537|FG000|Overall Study|Adverse Event|2|||
157188806|NCT02061540|567431537|FG000|Overall Study|Withdrawal by Subject|2|||
157188807|NCT04005755|567431540|FG000|Overall Study|Adverse Event|6|||
157188808|NCT04005755|567431540|FG000|Overall Study|Physician Decision|3|||
157188809|NCT04005755|567431540|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
157188810|NCT04005755|567431540|FG000|Overall Study|Withdrawal by Subject|3|||
157188811|NCT04005755|567431540|FG000|Overall Study|Lost to Follow-up|1|||
157188812|NCT02289833|567431541|FG000|Overall Study|Study discontinuation|0|||
157188813|NCT02289833|567431542|FG001|Overall Study|Study discontinuation|1|||
157188814|NCT02289833|567431541|FG000|Overall Study|Lost to Follow-up|4|||
157188815|NCT02289833|567431542|FG001|Overall Study|Lost to Follow-up|0|||
157188816|NCT02289833|567431541|FG000|Overall Study|Death|23|||
157188817|NCT02289833|567431542|FG001|Overall Study|Death|16|||
157188818|NCT02723019|567431549|FG000|Overall Study|Death|17|||
157188819|NCT02723019|567431550|FG001|Overall Study|Death|13|||
157188820|NCT02723019|567431549|FG000|Overall Study|Withdrawal by Subject|11|||
157188821|NCT02723019|567431550|FG001|Overall Study|Withdrawal by Subject|7|||
157188822|NCT02723019|567431549|FG000|Overall Study|Lost to Follow-up|57|||
157188823|NCT02723019|567431550|FG001|Overall Study|Lost to Follow-up|70|||
157188824|NCT00611767|567431552|FG000|Overall Study|Withdrawal by Subject|4|||
157188825|NCT00611767|567431553|FG001|Overall Study|Withdrawal by Subject|1|||
157188826|NCT00611767|567431552|FG000|Overall Study|Thiopental not available|3|||
157188827|NCT00611767|567431553|FG001|Overall Study|Thiopental not available|0|||
157188828|NCT00611767|567431552|FG000|Overall Study|didn't like the medication|1|||
157188829|NCT00611767|567431553|FG001|Overall Study|didn't like the medication|1|||
157188830|NCT00611767|567431552|FG000|Overall Study|Physician Decision|1|||
157188831|NCT00611767|567431553|FG001|Overall Study|Physician Decision|0|||
157188832|NCT00808132|567431556|FG000|Overall Study|Adverse Event|34|||
157188833|NCT00808132|567431557|FG001|Overall Study|Adverse Event|33|||
157188834|NCT00808132|567431558|FG002|Overall Study|Adverse Event|16|||
157188835|NCT00808132|567431559|FG003|Overall Study|Adverse Event|31|||
157188836|NCT00808132|567431560|FG004|Overall Study|Adverse Event|33|||
157188837|NCT00808132|567431556|FG000|Overall Study|Death|0|||
157188838|NCT00808132|567431557|FG001|Overall Study|Death|0|||
157188839|NCT00808132|567431558|FG002|Overall Study|Death|0|||
157188840|NCT00808132|567431559|FG003|Overall Study|Death|0|||
157188841|NCT00808132|567431560|FG004|Overall Study|Death|1|||
157188842|NCT00808132|567431556|FG000|Overall Study|Physician Decision|0|||
157188843|NCT00808132|567431557|FG001|Overall Study|Physician Decision|1|||
157188844|NCT00808132|567431558|FG002|Overall Study|Physician Decision|0|||
157188845|NCT00808132|567431559|FG003|Overall Study|Physician Decision|0|||
157188846|NCT00808132|567431560|FG004|Overall Study|Physician Decision|0|||
157188847|NCT00808132|567431556|FG000|Overall Study|Lost to Follow-up|8|||
157188848|NCT00808132|567431557|FG001|Overall Study|Lost to Follow-up|10|||
157188849|NCT00808132|567431558|FG002|Overall Study|Lost to Follow-up|11|||
157188850|NCT00808132|567431559|FG003|Overall Study|Lost to Follow-up|8|||
157188851|NCT00808132|567431560|FG004|Overall Study|Lost to Follow-up|9|||
157188852|NCT00808132|567431556|FG000|Overall Study|Protocol Violation|8|||
157188853|NCT00808132|567431557|FG001|Overall Study|Protocol Violation|9|||
157188854|NCT00808132|567431558|FG002|Overall Study|Protocol Violation|4|||
157188855|NCT00808132|567431559|FG003|Overall Study|Protocol Violation|9|||
157188856|NCT00808132|567431560|FG004|Overall Study|Protocol Violation|5|||
157188857|NCT00808132|567431556|FG000|Overall Study|Withdrawal by Subject|27|||
157188858|NCT00808132|567431557|FG001|Overall Study|Withdrawal by Subject|18|||
157188859|NCT00808132|567431558|FG002|Overall Study|Withdrawal by Subject|2|||
157188860|NCT00808132|567431559|FG003|Overall Study|Withdrawal by Subject|7|||
157188861|NCT00808132|567431560|FG004|Overall Study|Withdrawal by Subject|16|||
157188862|NCT00808132|567431556|FG000|Overall Study|Other|6|||
157188863|NCT00808132|567431557|FG001|Overall Study|Other|4|||
157188864|NCT00808132|567431558|FG002|Overall Study|Other|6|||
157188865|NCT00808132|567431559|FG003|Overall Study|Other|2|||
157188866|NCT00808132|567431560|FG004|Overall Study|Other|15|||
157188867|NCT00808132|567431556|FG000|Overall Study|Randomized, but not treated|10|||
157188868|NCT00808132|567431557|FG001|Overall Study|Randomized, but not treated|7|||
157188869|NCT00808132|567431558|FG002|Overall Study|Randomized, but not treated|9|||
157188870|NCT00808132|567431559|FG003|Overall Study|Randomized, but not treated|8|||
157188871|NCT00808132|567431560|FG004|Overall Study|Randomized, but not treated|9|||
157188872|NCT00808132|567431556|FG000|Overall Study|Unsatisfactory response|5|||
157188873|NCT00808132|567431557|FG001|Overall Study|Unsatisfactory response|6|||
157188874|NCT00808132|567431558|FG002|Overall Study|Unsatisfactory response|6|||
157188875|NCT00808132|567431559|FG003|Overall Study|Unsatisfactory response|4|||
157188876|NCT00808132|567431560|FG004|Overall Study|Unsatisfactory response|12|||
157188877|NCT02795182|567431561|FG000|Overall Study|Death|5|||
157188878|NCT02795182|567431562|FG001|Overall Study|Death|4|||
157188879|NCT02795182|567431563|FG002|Overall Study|Death|4|||
157188880|NCT02795182|567431564|FG003|Overall Study|Death|18|||
157188881|NCT02795182|567431561|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
157188882|NCT02795182|567431562|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
157188883|NCT02795182|567431563|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
157188884|NCT02795182|567431564|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
157188885|NCT02795182|567431561|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
157188886|NCT02795182|567431562|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
157188887|NCT02795182|567431563|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
157188888|NCT02795182|567431564|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
157188889|NCT02795182|567431561|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
157188890|NCT02795182|567431562|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
157188891|NCT02795182|567431563|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
157188892|NCT02795182|567431564|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
157188893|NCT02795182|567431561|FG000|Overall Study|Withdrawal by Subject|4|||
157188894|NCT02795182|567431562|FG001|Overall Study|Withdrawal by Subject|0|||
157188895|NCT02795182|567431563|FG002|Overall Study|Withdrawal by Subject|0|||
157188896|NCT02795182|567431564|FG003|Overall Study|Withdrawal by Subject|3|||
157188897|NCT02795182|567431561|FG000|Overall Study|Lost to Follow-up|0|||
157188898|NCT02795182|567431562|FG001|Overall Study|Lost to Follow-up|0|||
157188899|NCT02795182|567431563|FG002|Overall Study|Lost to Follow-up|1|||
157188900|NCT02795182|567431564|FG003|Overall Study|Lost to Follow-up|1|||
157188901|NCT02795182|567431561|FG000|Overall Study|Roll Over to Long Term Extension|3|||
157188902|NCT02795182|567431562|FG001|Overall Study|Roll Over to Long Term Extension|3|||
157188903|NCT02795182|567431563|FG002|Overall Study|Roll Over to Long Term Extension|2|||
157188904|NCT02795182|567431564|FG003|Overall Study|Roll Over to Long Term Extension|5|||
157188905|NCT02795182|567431561|FG000|Overall Study|Progressive Disease|0|||
157188906|NCT02795182|567431562|FG001|Overall Study|Progressive Disease|1|||
157188907|NCT02795182|567431563|FG002|Overall Study|Progressive Disease|0|||
157188908|NCT02795182|567431564|FG003|Overall Study|Progressive Disease|4|||
157188909|NCT02795182|567431561|FG000|Overall Study|Physician Decision|0|||
157188910|NCT02795182|567431562|FG001|Overall Study|Physician Decision|0|||
157188911|NCT02795182|567431563|FG002|Overall Study|Physician Decision|0|||
157188912|NCT02795182|567431564|FG003|Overall Study|Physician Decision|1|||
157188913|NCT02187224|567431567|FG000|Overall Study|Did not show up for test day|1|||
157188914|NCT02187224|567431568|FG001|Overall Study|Did not show up for test day|0|||
157188915|NCT01347840|567431571|FG000|Overall Study|Withdrawal by Subject|1|||
157188916|NCT01010776|567431572|FG000|Main Phase|Withdrawal by Subject|14|||
157188917|NCT01010776|567431572|FG000|Main Phase|Lack of Efficacy|8|||
157188918|NCT01010776|567431572|FG000|Main Phase|Adverse Event|7|||
157188919|NCT01010776|567431572|FG000|Main Phase|Lost to Follow-up|6|||
157188920|NCT01010776|567431572|FG000|Main Phase|Non-compliance to study medication|5|||
157188921|NCT01010776|567431572|FG000|Main Phase|Selection failure|2|||
157188922|NCT01010776|567431572|FG000|Main Phase|Inform consent withdrawal|1|||
157188923|NCT01010776|567431572|FG000|Main Phase|Other|1|||
157188924|NCT01010776|567431572|FG000|Main Phase|Did not received study medication|5|||
157188925|NCT01010776|567431572|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
157188926|NCT01010776|567431572|FG000|Extension Phase|Other|3|||
157188927|NCT03231228|567431579|FG000|Overall Study|Lost to Follow-up|2|||
157188928|NCT03231228|567431580|FG001|Overall Study|Lost to Follow-up|0|||
157188929|NCT03231228|567431579|FG000|Overall Study|Physician Decision|1|||
157188930|NCT03231228|567431580|FG001|Overall Study|Physician Decision|0|||
157188931|NCT02382276|567431581|FG000|Overall Study|Withdrawal by Subject|4|||
157188932|NCT02382276|567431582|FG001|Overall Study|Withdrawal by Subject|8|||
157188933|NCT02382276|567431583|FG002|Overall Study|Withdrawal by Subject|5|||
157188934|NCT02382276|567431581|FG000|Overall Study|Adverse Event|7|||
157188935|NCT02382276|567431582|FG001|Overall Study|Adverse Event|2|||
157188936|NCT02382276|567431583|FG002|Overall Study|Adverse Event|32|||
157188937|NCT02382276|567431581|FG000|Overall Study|Physician Decision|0|||
157188938|NCT02382276|567431582|FG001|Overall Study|Physician Decision|0|||
157188939|NCT02382276|567431583|FG002|Overall Study|Physician Decision|2|||
157188940|NCT01222416|567431584|FG000|Overall Study|ineligible;metastasis|3|||
157188941|NCT01222416|567431585|FG001|Overall Study|ineligible;metastasis|0|||
157188942|NCT01222416|567431584|FG000|Overall Study|Adverse Event|4|||
157188943|NCT01222416|567431585|FG001|Overall Study|Adverse Event|0|||
157068262|NCT02760485|567004385|FG001|Phase 2|Death|0|||
157068263|NCT02760485|567004386|FG002|Phase 2|Death|12|||
157068264|NCT02760485|567004384|FG000|Phase 2|Withdrawal by Subject|0|||
157068265|NCT02760485|567004385|FG001|Phase 2|Withdrawal by Subject|0|||
157068266|NCT02760485|567004386|FG002|Phase 2|Withdrawal by Subject|3|||
157068267|NCT02760485|567004384|FG000|Phase 2|Progressive Disease|0|||
157068268|NCT02760485|567004385|FG001|Phase 2|Progressive Disease|0|||
157068269|NCT02760485|567004386|FG002|Phase 2|Progressive Disease|1|||
157068270|NCT02760485|567004384|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
157068271|NCT02760485|567004385|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
157068272|NCT02760485|567004386|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
157068273|NCT01182207|567004387|FG000|First Intervention|Positive Hepatitis Results|0|||
157068274|NCT01182207|567004388|FG001|First Intervention|Positive Hepatitis Results|1|||
157068275|NCT01182207|567004387|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
157068276|NCT01182207|567004388|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
157068277|NCT02918292|567004389|FG000|Study Enrollment Prior to Transplant|Death|1|||
157068278|NCT02918292|567004389|FG000|Study Follow up After Transplant|Death|6|||
157068279|NCT02636608|567004393|FG000|Overall Study|Failure to Return|4|||
157068280|NCT02636608|567004393|FG000|Overall Study|Insufficient Virological Response|1|||
157068281|NCT02636608|567004393|FG000|Overall Study|Death|3|||
157068282|NCT02636608|567004393|FG000|Overall Study|Other|2|||
157068283|NCT02636608|567004393|FG000|Overall Study|Did Not Receive Treatment|1|||
157068284|NCT03912532|567004394|FG000|Overall Study|Adverse Event|3|||
157068285|NCT03912532|567004395|FG001|Overall Study|Adverse Event|3|||
157068286|NCT03912532|567004396|FG002|Overall Study|Adverse Event|2|||
157068287|NCT03912532|567004397|FG003|Overall Study|Adverse Event|2|||
157068288|NCT03912532|567004394|FG000|Overall Study|Lost to Follow-up|3|||
157068289|NCT03912532|567004395|FG001|Overall Study|Lost to Follow-up|2|||
157068290|NCT03912532|567004396|FG002|Overall Study|Lost to Follow-up|1|||
157068291|NCT03912532|567004397|FG003|Overall Study|Lost to Follow-up|2|||
157068292|NCT03912532|567004394|FG000|Overall Study|Withdrawal by Subject|1|||
157068293|NCT03912532|567004395|FG001|Overall Study|Withdrawal by Subject|1|||
157068294|NCT03912532|567004396|FG002|Overall Study|Withdrawal by Subject|2|||
157068295|NCT03912532|567004397|FG003|Overall Study|Withdrawal by Subject|0|||
157068296|NCT03912532|567004394|FG000|Overall Study|Physician Decision|1|||
157068297|NCT03912532|567004395|FG001|Overall Study|Physician Decision|0|||
157068298|NCT03912532|567004396|FG002|Overall Study|Physician Decision|0|||
157068299|NCT03912532|567004397|FG003|Overall Study|Physician Decision|3|||
157068300|NCT03912532|567004394|FG000|Overall Study|Other|0|||
157068301|NCT03912532|567004395|FG001|Overall Study|Other|1|||
157068302|NCT03912532|567004396|FG002|Overall Study|Other|1|||
157068303|NCT03912532|567004397|FG003|Overall Study|Other|0|||
157068304|NCT03783871|567004400|FG000|Overall Study|Withdrawal by Subject|15|||
157068305|NCT03783871|567004400|FG000|Overall Study|Death|13|||
157068306|NCT03783871|567004400|FG000|Overall Study|Lost to Follow-up|2|||
157068307|NCT05990387|567004402|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
157068308|NCT05990387|567004403|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
157068309|NCT03522389|567004404|FG000|Overall Study|Lost to Follow-up|1|||
157068310|NCT03522389|567004405|FG001|Overall Study|Lost to Follow-up|1|||
157068311|NCT03522389|567004406|FG002|Overall Study|Lost to Follow-up|2|||
157068312|NCT03522389|567004404|FG000|Overall Study|had herniated nucleus pulposus|0|||
157068313|NCT03522389|567004405|FG001|Overall Study|had herniated nucleus pulposus|1|||
157068314|NCT03522389|567004406|FG002|Overall Study|had herniated nucleus pulposus|0|||
157068315|NCT03522389|567004404|FG000|Overall Study|go to work in other province|1|||
157068316|NCT03522389|567004405|FG001|Overall Study|go to work in other province|0|||
157068317|NCT03522389|567004406|FG002|Overall Study|go to work in other province|0|||
157068318|NCT00604188|567004407|FG000|Overall Study|Adverse Event|1|||
157068319|NCT00604188|567004408|FG001|Overall Study|Adverse Event|4|||
157068320|NCT00604188|567004407|FG000|Overall Study|Lost to Follow-up|17|||
157068321|NCT00604188|567004408|FG001|Overall Study|Lost to Follow-up|15|||
157068322|NCT00604188|567004407|FG000|Overall Study|Withdrawal by Subject|5|||
157068323|NCT00604188|567004408|FG001|Overall Study|Withdrawal by Subject|1|||
157068324|NCT00604188|567004407|FG000|Overall Study|Non-compliance with protocol|4|||
157068325|NCT00604188|567004408|FG001|Overall Study|Non-compliance with protocol|4|||
157068326|NCT00604188|567004407|FG000|Overall Study|Did not receive study drug|0|||
157068327|NCT00604188|567004408|FG001|Overall Study|Did not receive study drug|1|||
157188944|NCT01222416|567431584|FG000|Overall Study|Withdrawal by Subject|5|||
157188945|NCT01222416|567431585|FG001|Overall Study|Withdrawal by Subject|0|||
157188946|NCT01222416|567431584|FG000|Overall Study|scheduling|6|||
157068328|NCT02242643|567004409|FG000|Overall Study|Protocol Violation|1|||
157068329|NCT02242643|567004410|FG001|Overall Study|Protocol Violation|2|||
157068330|NCT02242643|567004409|FG000|Overall Study|Withdrawal by Subject|15|||
157068331|NCT02242643|567004410|FG001|Overall Study|Withdrawal by Subject|10|||
157068332|NCT02242643|567004409|FG000|Overall Study|Migrated/moved from study area|1|||
157068333|NCT02242643|567004410|FG001|Overall Study|Migrated/moved from study area|3|||
157068334|NCT02242643|567004409|FG000|Overall Study|Lost to Follow-up|54|||
157188947|NCT01222416|567431585|FG001|Overall Study|scheduling|0|||
157068335|NCT02242643|567004410|FG001|Overall Study|Lost to Follow-up|61|||
157068336|NCT02242643|567004409|FG000|Overall Study|Child placed in foster care by family|0|||
157068337|NCT02242643|567004410|FG001|Overall Study|Child placed in foster care by family|1|||
157068338|NCT02242643|567004409|FG000|Overall Study|Non-compliance|1|||
157068339|NCT02242643|567004410|FG001|Overall Study|Non-compliance|0|||
157068340|NCT02242643|567004409|FG000|Overall Study|Consent withdrawal by parent|1|||
157068341|NCT02242643|567004410|FG001|Overall Study|Consent withdrawal by parent|0|||
157068342|NCT02242643|567004409|FG000|Overall Study|Protocol requirements not followed|1|||
157068343|NCT02242643|567004410|FG001|Overall Study|Protocol requirements not followed|0|||
157068344|NCT02242643|567004409|FG000|Overall Study|Language barrier|1|||
157068345|NCT02242643|567004410|FG001|Overall Study|Language barrier|0|||
157068346|NCT02242643|567004409|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
157068347|NCT02242643|567004410|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
157068348|NCT01638390|567006021|FG000|Overall Study|screening failures|21|||
157068349|NCT01536587|567006022|FG000|Overall Study|Adverse Event|2|||
157068350|NCT02666664|567006023|FG000|Overall Study|Physician Decision|0|||
157068351|NCT02666664|567006024|FG001|Overall Study|Physician Decision|1|||
157068352|NCT02666664|567006023|FG000|Overall Study|Protocol Violation|0|||
157068353|NCT02666664|567006024|FG001|Overall Study|Protocol Violation|2|||
157068354|NCT02666664|567006023|FG000|Overall Study|Other|0|||
157068355|NCT02666664|567006024|FG001|Overall Study|Other|1|||
157068356|NCT02666664|567006023|FG000|Overall Study|Adverse Event|12|||
157068357|NCT02666664|567006024|FG001|Overall Study|Adverse Event|37|||
157068358|NCT02666664|567006023|FG000|Overall Study|Withdrawal by participant|23|||
157068359|NCT02666664|567006024|FG001|Overall Study|Withdrawal by participant|40|||
157068360|NCT02666664|567006023|FG000|Overall Study|Sponsor decision|0|||
157068361|NCT02666664|567006024|FG001|Overall Study|Sponsor decision|1|||
157068362|NCT02666664|567006023|FG000|Overall Study|Lost to Follow-up|1|||
157068363|NCT02666664|567006024|FG001|Overall Study|Lost to Follow-up|2|||
157068364|NCT03616964|567006025|FG000|Overall Study|Adverse Event|15|||
157068365|NCT03616964|567006026|FG001|Overall Study|Adverse Event|10|||
157068366|NCT03616964|567006027|FG002|Overall Study|Adverse Event|16|||
157068367|NCT03616964|567006025|FG000|Overall Study|Death|3|||
157068368|NCT03616964|567006026|FG001|Overall Study|Death|0|||
157068369|NCT03616964|567006027|FG002|Overall Study|Death|4|||
157068370|NCT03616964|567006025|FG000|Overall Study|Lack of Efficacy|4|||
157068371|NCT03616964|567006026|FG001|Overall Study|Lack of Efficacy|8|||
157068372|NCT03616964|567006027|FG002|Overall Study|Lack of Efficacy|8|||
157068373|NCT03616964|567006025|FG000|Overall Study|Lost to Follow-up|2|||
157068374|NCT03616964|567006026|FG001|Overall Study|Lost to Follow-up|1|||
157068375|NCT03616964|567006027|FG002|Overall Study|Lost to Follow-up|3|||
157068376|NCT03616964|567006025|FG000|Overall Study|Withdrawal by Subject|18|||
157068377|NCT03616964|567006026|FG001|Overall Study|Withdrawal by Subject|14|||
157068378|NCT03616964|567006027|FG002|Overall Study|Withdrawal by Subject|21|||
157068379|NCT03616964|567006025|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
157068380|NCT03616964|567006026|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
157068381|NCT03616964|567006027|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
157068382|NCT03616964|567006025|FG000|Overall Study|Sponsor's Decision|1|||
157068383|NCT03616964|567006026|FG001|Overall Study|Sponsor's Decision|0|||
157068384|NCT03616964|567006027|FG002|Overall Study|Sponsor's Decision|0|||
157068385|NCT03616964|567006025|FG000|Overall Study|Physician Decision|0|||
157068386|NCT03616964|567006026|FG001|Overall Study|Physician Decision|2|||
157068387|NCT03616964|567006027|FG002|Overall Study|Physician Decision|0|||
157068388|NCT03616964|567006025|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
157068389|NCT03616964|567006026|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
157068390|NCT03616964|567006027|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
157068391|NCT03616964|567006025|FG000|Overall Study|Protocol Violation|0|||
157068392|NCT03616964|567006026|FG001|Overall Study|Protocol Violation|1|||
157188948|NCT01222416|567431584|FG000|Overall Study|missed view/scan|1|||
157188949|NCT01222416|567431585|FG001|Overall Study|missed view/scan|0|||
157188950|NCT01222416|567431584|FG000|Overall Study|Death|1|||
157188951|NCT01222416|567431585|FG001|Overall Study|Death|0|||
157188952|NCT00281528|567431588|FG000|Overall Study|Progressive Disease|28|||
157188953|NCT00281528|567431589|FG001|Overall Study|Progressive Disease|18|||
157068393|NCT03616964|567006027|FG002|Overall Study|Protocol Violation|0|||
157068394|NCT03616964|567006025|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
157068395|NCT03616964|567006026|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
157068396|NCT03616964|567006027|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
157068397|NCT03616964|567006025|FG000|Overall Study|Randomized but Never Treated|1|||
157068398|NCT03616964|567006026|FG001|Overall Study|Randomized but Never Treated|1|||
157068399|NCT03616964|567006027|FG002|Overall Study|Randomized but Never Treated|1|||
157068400|NCT00129935|567006028|FG000|Overall Study|Adverse Event|18|||
157068401|NCT00129935|567006029|FG001|Overall Study|Adverse Event|56|||
157068402|NCT00129935|567006028|FG000|Overall Study|Death|1|||
157068403|NCT00129935|567006029|FG001|Overall Study|Death|1|||
157188954|NCT00281528|567431590|FG002|Overall Study|Progressive Disease|27|||
157188955|NCT00281528|567431588|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
157188956|NCT00281528|567431589|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
157188957|NCT00281528|567431590|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
157188958|NCT00281528|567431588|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
157188959|NCT00281528|567431589|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
157188960|NCT00281528|567431590|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
157188961|NCT00281528|567431588|FG000|Overall Study|Physician Decision|11|||
157188962|NCT00281528|567431589|FG001|Overall Study|Physician Decision|4|||
157188963|NCT00281528|567431590|FG002|Overall Study|Physician Decision|5|||
157188964|NCT00281528|567431588|FG000|Overall Study|Protocol Violation|1|||
157188965|NCT00281528|567431589|FG001|Overall Study|Protocol Violation|0|||
157188966|NCT00281528|567431590|FG002|Overall Study|Protocol Violation|1|||
157188967|NCT00281528|567431588|FG000|Overall Study|Withdrawal by Subject|5|||
157188968|NCT00281528|567431589|FG001|Overall Study|Withdrawal by Subject|5|||
157188969|NCT00281528|567431590|FG002|Overall Study|Withdrawal by Subject|7|||
157188970|NCT00281528|567431588|FG000|Overall Study|Other|6|||
157188971|NCT00281528|567431589|FG001|Overall Study|Other|3|||
157188972|NCT00281528|567431590|FG002|Overall Study|Other|5|||
157188973|NCT03049852|567431600|FG000|Overall Study|Lost to Follow-up|0|||
157188974|NCT03049852|567431601|FG001|Overall Study|Lost to Follow-up|1|||
157188975|NCT03049852|567431602|FG002|Overall Study|Lost to Follow-up|0|||
157188976|NCT02709889|567431603|FG000|Overall Study|Withdrawal by Subject|11|||
157188977|NCT02709889|567431604|FG001|Overall Study|Withdrawal by Subject|10|||
157188978|NCT02709889|567431605|FG002|Overall Study|Withdrawal by Subject|2|||
157188979|NCT02709889|567431606|FG003|Overall Study|Withdrawal by Subject|12|||
157188980|NCT02709889|567431603|FG000|Overall Study|Death|25|||
157188981|NCT02709889|567431604|FG001|Overall Study|Death|38|||
157188982|NCT02709889|567431605|FG002|Overall Study|Death|4|||
157188983|NCT02709889|567431606|FG003|Overall Study|Death|44|||
157188984|NCT02709889|567431603|FG000|Overall Study|Physician Decision|1|||
157188985|NCT02709889|567431604|FG001|Overall Study|Physician Decision|2|||
157188986|NCT02709889|567431605|FG002|Overall Study|Physician Decision|3|||
157188987|NCT02709889|567431606|FG003|Overall Study|Physician Decision|5|||
157188988|NCT02709889|567431603|FG000|Overall Study|Lost to Follow-up|2|||
157188989|NCT02709889|567431604|FG001|Overall Study|Lost to Follow-up|0|||
157188990|NCT02709889|567431605|FG002|Overall Study|Lost to Follow-up|0|||
157188991|NCT02709889|567431606|FG003|Overall Study|Lost to Follow-up|4|||
157188992|NCT02709889|567431603|FG000|Overall Study|Study Terminated by Sponsor|4|||
157188993|NCT02709889|567431604|FG001|Overall Study|Study Terminated by Sponsor|6|||
157188994|NCT02709889|567431605|FG002|Overall Study|Study Terminated by Sponsor|2|||
157188995|NCT02709889|567431606|FG003|Overall Study|Study Terminated by Sponsor|17|||
157188996|NCT02709889|567431603|FG000|Overall Study|Other, Not Specified|0|||
157188997|NCT02709889|567431604|FG001|Overall Study|Other, Not Specified|1|||
157188998|NCT02709889|567431605|FG002|Overall Study|Other, Not Specified|1|||
157188999|NCT02709889|567431606|FG003|Overall Study|Other, Not Specified|6|||
157189000|NCT00925522|567431611|FG000|Overall Study|study closed -- business decision|20|||
157189001|NCT02545049|567431616|FG000|Overall Study|Withdrawal by Subject|1|||
157189002|NCT02545049|567431617|FG001|Overall Study|Withdrawal by Subject|7|||
157189003|NCT02545049|567431616|FG000|Overall Study|Lost to Follow-up|4|||
157189004|NCT02545049|567431617|FG001|Overall Study|Lost to Follow-up|6|||
157189005|NCT02545049|567431616|FG000|Overall Study|GCP violations|37|||
157189006|NCT02545049|567431617|FG001|Overall Study|GCP violations|48|||
157189007|NCT05281094|567431621|FG000|Overall Study|Adverse Event|1|||
157189008|NCT05281094|567431622|FG001|Overall Study|Adverse Event|0|||
157189009|NCT05281094|567431621|FG000|Overall Study|Lost to Follow-up|29|||
157189010|NCT05281094|567431622|FG001|Overall Study|Lost to Follow-up|22|||
157189011|NCT05281094|567431621|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
157189012|NCT05281094|567431622|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
157189013|NCT05281094|567431621|FG000|Overall Study|Death|1|||
157189014|NCT05281094|567431622|FG001|Overall Study|Death|2|||
157189015|NCT05281094|567431621|FG000|Overall Study|Not pre-specified reason|8|||
157189016|NCT05281094|567431622|FG001|Overall Study|Not pre-specified reason|5|||
157189017|NCT04191096|567431623|FG000|Overall Study|Death|102|||
157189018|NCT04191096|567431624|FG001|Overall Study|Death|89|||
157189019|NCT04191096|567431623|FG000|Overall Study|Lost to Follow-up|1|||
157189020|NCT04191096|567431624|FG001|Overall Study|Lost to Follow-up|1|||
157189021|NCT04191096|567431623|FG000|Overall Study|Withdrawal by Subject|5|||
157189022|NCT04191096|567431624|FG001|Overall Study|Withdrawal by Subject|5|||
157189023|NCT04191096|567431623|FG000|Overall Study|Participants Ongoing|518|||
157189024|NCT04191096|567431624|FG001|Overall Study|Participants Ongoing|530|||
157189025|NCT04223778|567431625|FG000|Overall Study|Death|1|||
157230299|NCT04455633|567590571|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
157189026|NCT04223778|567431626|FG001|Overall Study|Death|1|||
157189027|NCT04223778|567431625|FG000|Overall Study|Lost to Follow-up|4|||
157189028|NCT04223778|567431626|FG001|Overall Study|Lost to Follow-up|5|||
157189029|NCT04223778|567431625|FG000|Overall Study|Physician Decision|10|||
157189030|NCT04223778|567431626|FG001|Overall Study|Physician Decision|6|||
157189031|NCT04223778|567431625|FG000|Overall Study|Withdrawal by Subject|35|||
157189032|NCT04223778|567431626|FG001|Overall Study|Withdrawal by Subject|17|||
157189033|NCT04223778|567431625|FG000|Overall Study|Not Reported|7|||
157189034|NCT04223778|567431626|FG001|Overall Study|Not Reported|8|||
157189035|NCT00027027|567433409|FG000|Overall Study|Adverse Event|0|||
157189036|NCT00027027|567433410|FG001|Overall Study|Adverse Event|0|||
157189037|NCT00027027|567433411|FG002|Overall Study|Adverse Event|1|||
157189038|NCT00027027|567433412|FG003|Overall Study|Adverse Event|0|||
157189039|NCT00027027|567433413|FG004|Overall Study|Adverse Event|1|||
157189040|NCT00027027|567433409|FG000|Overall Study|Admitted for Signs of PD|0|||
157189041|NCT00027027|567433410|FG001|Overall Study|Admitted for Signs of PD|0|||
157189042|NCT00027027|567433411|FG002|Overall Study|Admitted for Signs of PD|0|||
157189043|NCT00027027|567433412|FG003|Overall Study|Admitted for Signs of PD|0|||
157189044|NCT00027027|567433413|FG004|Overall Study|Admitted for Signs of PD|1|||
157189045|NCT00027027|567433409|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
157189046|NCT00027027|567433410|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
157189047|NCT00027027|567433411|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
157189048|NCT00027027|567433412|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
157189049|NCT00027027|567433413|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
157189050|NCT00027027|567433409|FG000|Overall Study|PD Requiring Surgery|0|||
157189051|NCT00027027|567433410|FG001|Overall Study|PD Requiring Surgery|0|||
157189052|NCT00027027|567433411|FG002|Overall Study|PD Requiring Surgery|1|||
157189053|NCT00027027|567433412|FG003|Overall Study|PD Requiring Surgery|0|||
157189054|NCT00027027|567433413|FG004|Overall Study|PD Requiring Surgery|0|||
157189055|NCT00027027|567433409|FG000|Overall Study|Physician Decision Due To PD|2|||
157189056|NCT00027027|567433410|FG001|Overall Study|Physician Decision Due To PD|3|||
157189057|NCT00027027|567433411|FG002|Overall Study|Physician Decision Due To PD|2|||
157189058|NCT00027027|567433412|FG003|Overall Study|Physician Decision Due To PD|3|||
157189059|NCT00027027|567433413|FG004|Overall Study|Physician Decision Due To PD|5|||
157189060|NCT00027027|567433409|FG000|Overall Study|Withdrawal by Subject|0|||
157189061|NCT00027027|567433410|FG001|Overall Study|Withdrawal by Subject|0|||
157189062|NCT00027027|567433411|FG002|Overall Study|Withdrawal by Subject|0|||
157189063|NCT00027027|567433412|FG003|Overall Study|Withdrawal by Subject|0|||
157189064|NCT00027027|567433413|FG004|Overall Study|Withdrawal by Subject|1|||
157189065|NCT05466240|567433418|FG000|Overall Study|Adverse Event|1|||
157189066|NCT05466240|567433419|FG001|Overall Study|Adverse Event|0|||
157189067|NCT05466240|567433418|FG000|Overall Study|Withdrawal by Subject|1|||
157189068|NCT05466240|567433419|FG001|Overall Study|Withdrawal by Subject|0|||
157189069|NCT03347279|567433420|FG000|Overall Study|Withdrawal by Subject|8|||
157189070|NCT03347279|567433421|FG001|Overall Study|Withdrawal by Subject|15|||
157189071|NCT03347279|567433420|FG000|Overall Study|Death|0|||
157189072|NCT03347279|567433421|FG001|Overall Study|Death|2|||
157189073|NCT03347279|567433420|FG000|Overall Study|Lost to Follow-up|5|||
157189074|NCT03347279|567433421|FG001|Overall Study|Lost to Follow-up|2|||
157189075|NCT03347279|567433420|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
157189076|NCT03347279|567433421|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
157189077|NCT00718887|567433422|FG000|Overall Study|Withdrawal by Subject|3|||
157189078|NCT00718887|567433423|FG001|Overall Study|Withdrawal by Subject|2|||
157189079|NCT00718887|567433422|FG000|Overall Study|Not identified|2|||
157189080|NCT00718887|567433423|FG001|Overall Study|Not identified|7|||
157189081|NCT00775138|567433426|FG000|Overall Study|Withdrawal by Subject|0|||
157189082|NCT00775138|567433427|FG001|Overall Study|Withdrawal by Subject|0|||
157189083|NCT00775138|567433428|FG002|Overall Study|Withdrawal by Subject|2|||
157189084|NCT00775138|567433429|FG003|Overall Study|Withdrawal by Subject|2|||
157189085|NCT00775138|567433426|FG000|Overall Study|Adverse Event|0|||
157189086|NCT00775138|567433427|FG001|Overall Study|Adverse Event|0|||
157189087|NCT00775138|567433428|FG002|Overall Study|Adverse Event|1|||
157230300|NCT04455633|567590572|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
157189088|NCT00775138|567433429|FG003|Overall Study|Adverse Event|0|||
157189089|NCT03557801|567433430|FG000|Overall Study|Protocol Violation|1|||
157230301|NCT04455633|567590570|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
157230302|NCT04455633|567590571|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
157068404|NCT00129935|567006028|FG000|Overall Study|Withdrawal by Subject|7|||
157068405|NCT00129935|567006029|FG001|Overall Study|Withdrawal by Subject|20|||
157068406|NCT00129935|567006028|FG000|Overall Study|Protocol Violation|0|||
157068407|NCT00129935|567006029|FG001|Overall Study|Protocol Violation|4|||
157068408|NCT00129935|567006028|FG000|Overall Study|Physician Decision|3|||
157068409|NCT00129935|567006029|FG001|Overall Study|Physician Decision|4|||
157189090|NCT03557801|567433431|FG001|Overall Study|Protocol Violation|0|||
157189091|NCT03557801|567433432|FG002|Overall Study|Protocol Violation|0|||
157068410|NCT00129935|567006028|FG000|Overall Study|Recurrence|1|||
157189092|NCT03557801|567433430|FG000|Overall Study|Withdrawal by Subject|1|||
157189093|NCT03557801|567433431|FG001|Overall Study|Withdrawal by Subject|0|||
157189094|NCT03557801|567433432|FG002|Overall Study|Withdrawal by Subject|3|||
157189095|NCT03557801|567433430|FG000|Overall Study|Lost to Follow-up|0|||
157189096|NCT03557801|567433431|FG001|Overall Study|Lost to Follow-up|1|||
157068411|NCT00129935|567006029|FG001|Overall Study|Recurrence|3|||
157068412|NCT00129935|567006028|FG000|Overall Study|Second primary|0|||
157068413|NCT00129935|567006029|FG001|Overall Study|Second primary|1|||
157068414|NCT00129935|567006028|FG000|Overall Study|Other|3|||
157068415|NCT00129935|567006029|FG001|Overall Study|Other|2|||
157068416|NCT00129935|567006028|FG000|Overall Study|Crossed to the other arm|2|||
157068417|NCT00129935|567006029|FG001|Overall Study|Crossed to the other arm|1|||
157068418|NCT00129935|567006028|FG000|Overall Study|Incorrect study treatment|1|||
157068419|NCT00129935|567006029|FG001|Overall Study|Incorrect study treatment|0|||
157068420|NCT04090528|567006035|FG000|Overall Study|participants still on study|9|||
157068421|NCT04090528|567006036|FG001|Overall Study|participants still on study|13|||
157068422|NCT02056626|567006037|FG000|Overall Study|patient did not follow directions|3|||
157068423|NCT02056626|567006038|FG001|Overall Study|patient did not follow directions|1|||
157068424|NCT02056626|567006039|FG002|Overall Study|patient did not follow directions|0|||
157068425|NCT02056626|567006040|FG003|Overall Study|patient did not follow directions|0|||
157068426|NCT04916002|567006044|FG000|Overall Study|Adverse Event|0|||
157068427|NCT04916002|567006045|FG001|Overall Study|Adverse Event|1|||
157068428|NCT04916002|567006046|FG002|Overall Study|Adverse Event|0|||
157068429|NCT04916002|567006047|FG003|Overall Study|Adverse Event|1|||
157068430|NCT04916002|567006048|FG004|Overall Study|Adverse Event|0|||
157068431|NCT04916002|567006044|FG000|Overall Study|Withdrawal by Subject|3|||
157068432|NCT04916002|567006045|FG001|Overall Study|Withdrawal by Subject|1|||
157068433|NCT04916002|567006046|FG002|Overall Study|Withdrawal by Subject|0|||
157068434|NCT04916002|567006047|FG003|Overall Study|Withdrawal by Subject|1|||
157068435|NCT04916002|567006048|FG004|Overall Study|Withdrawal by Subject|0|||
157068436|NCT04916002|567006044|FG000|Overall Study|Death|8|||
157068437|NCT04916002|567006045|FG001|Overall Study|Death|7|||
157068438|NCT04916002|567006046|FG002|Overall Study|Death|4|||
157068439|NCT04916002|567006047|FG003|Overall Study|Death|9|||
157068440|NCT04916002|567006048|FG004|Overall Study|Death|0|||
157068441|NCT04916002|567006044|FG000|Overall Study|Study Terminated by Sponsor|11|||
157068442|NCT04916002|567006045|FG001|Overall Study|Study Terminated by Sponsor|10|||
157068443|NCT04916002|567006046|FG002|Overall Study|Study Terminated by Sponsor|8|||
157068444|NCT04916002|567006047|FG003|Overall Study|Study Terminated by Sponsor|5|||
157068445|NCT04916002|567006048|FG004|Overall Study|Study Terminated by Sponsor|4|||
157068446|NCT04916002|567006044|FG000|Overall Study|End of trial|1|||
157068447|NCT04916002|567006045|FG001|Overall Study|End of trial|0|||
157068448|NCT04916002|567006046|FG002|Overall Study|End of trial|0|||
157068449|NCT04916002|567006047|FG003|Overall Study|End of trial|0|||
157068450|NCT04916002|567006048|FG004|Overall Study|End of trial|0|||
157068451|NCT04916002|567006044|FG000|Overall Study|Progressive disease|0|||
157068452|NCT04916002|567006045|FG001|Overall Study|Progressive disease|0|||
157068453|NCT04916002|567006046|FG002|Overall Study|Progressive disease|1|||
157068454|NCT04916002|567006047|FG003|Overall Study|Progressive disease|0|||
157068455|NCT04916002|567006048|FG004|Overall Study|Progressive disease|0|||
157068456|NCT04916002|567006044|FG000|Overall Study|Participant non-compliance|2|||
157068457|NCT04916002|567006045|FG001|Overall Study|Participant non-compliance|0|||
157068458|NCT04916002|567006046|FG002|Overall Study|Participant non-compliance|0|||
157068459|NCT04916002|567006047|FG003|Overall Study|Participant non-compliance|0|||
157068460|NCT04916002|567006048|FG004|Overall Study|Participant non-compliance|0|||
157068461|NCT05923112|567006049|FG000|Overall Study|Protocol Violation|4|||
157068462|NCT05923112|567006049|FG000|Overall Study|No informed consent on publication of study results|243|||
157068463|NCT04351269|567006050|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
157068464|NCT04351269|567006051|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
157189097|NCT03557801|567433432|FG002|Overall Study|Lost to Follow-up|0|||
157189098|NCT00535236|567433433|FG000|Overall Study|Adverse Event|1|||
157189099|NCT00535236|567433434|FG001|Overall Study|Adverse Event|0|||
157189100|NCT00535236|567433435|FG002|Overall Study|Adverse Event|9|||
157189101|NCT00535236|567433436|FG003|Overall Study|Adverse Event|3|||
157189102|NCT00535236|567433437|FG004|Overall Study|Adverse Event|3|||
157189103|NCT00535236|567433438|FG005|Overall Study|Adverse Event|0|||
157189104|NCT00535236|567433439|FG006|Overall Study|Adverse Event|5|||
157189105|NCT00535236|567433440|FG007|Overall Study|Adverse Event|1|||
157068465|NCT04351269|567006052|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
157068466|NCT04351269|567006050|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
157068467|NCT04351269|567006051|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
157068468|NCT04351269|567006052|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
157068469|NCT04351269|567006050|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
157068470|NCT04351269|567006051|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
157068471|NCT04351269|567006052|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
157068472|NCT04351269|567006050|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
157068473|NCT04351269|567006051|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
157189106|NCT00535236|567433441|FG008|Overall Study|Adverse Event|2|||
157068474|NCT04351269|567006052|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
157068475|NCT04351269|567006050|FG000|Overall Study|Lost to Follow-up|1|||
157068476|NCT04351269|567006051|FG001|Overall Study|Lost to Follow-up|3|||
157068477|NCT04351269|567006052|FG002|Overall Study|Lost to Follow-up|0|||
157068478|NCT04486313|567006053|FG000|Overall Study|Lost to Follow-up|7|||
157068479|NCT04486313|567006054|FG001|Overall Study|Lost to Follow-up|9|||
157068480|NCT04486313|567006053|FG000|Overall Study|Withdrawal by Subject|8|||
157068481|NCT04486313|567006054|FG001|Overall Study|Withdrawal by Subject|6|||
157068482|NCT04486313|567006053|FG000|Overall Study|Physician Decision|1|||
157068483|NCT04486313|567006054|FG001|Overall Study|Physician Decision|1|||
157068484|NCT04486313|567006053|FG000|Overall Study|Death|2|||
157068485|NCT04486313|567006054|FG001|Overall Study|Death|0|||
157068486|NCT04486313|567006053|FG000|Overall Study|Protocol Violation|1|||
157068487|NCT04486313|567006054|FG001|Overall Study|Protocol Violation|1|||
157068488|NCT01013961|567006058|FG000|Overall Study|Adverse Event|2|||
157068489|NCT01013961|567006059|FG001|Overall Study|Adverse Event|2|||
157068490|NCT01013961|567006058|FG000|Overall Study|Withdrawal by Subject|1|||
157068491|NCT01013961|567006059|FG001|Overall Study|Withdrawal by Subject|0|||
157068492|NCT01013961|567006058|FG000|Overall Study|Physician Decision|0|||
157068493|NCT01013961|567006059|FG001|Overall Study|Physician Decision|1|||
157068494|NCT01271504|567006060|FG000|Overall Study|Death|7|||
157068495|NCT01271504|567006061|FG001|Overall Study|Death|6|||
157068496|NCT01271504|567006062|FG002|Overall Study|Death|32|||
157068497|NCT01271504|567006063|FG003|Overall Study|Death|32|||
157068498|NCT01271504|567006060|FG000|Overall Study|Lost to Follow-up|0|||
157068499|NCT01271504|567006061|FG001|Overall Study|Lost to Follow-up|1|||
157068500|NCT01271504|567006062|FG002|Overall Study|Lost to Follow-up|3|||
157068501|NCT01271504|567006063|FG003|Overall Study|Lost to Follow-up|1|||
157068502|NCT01271504|567006060|FG000|Overall Study|Protocol Violation|0|||
157068503|NCT01271504|567006061|FG001|Overall Study|Protocol Violation|0|||
157068504|NCT01271504|567006062|FG002|Overall Study|Protocol Violation|0|||
157068505|NCT01271504|567006063|FG003|Overall Study|Protocol Violation|2|||
157068506|NCT01271504|567006060|FG000|Overall Study|Administrative Reasons|0|||
157068507|NCT01271504|567006061|FG001|Overall Study|Administrative Reasons|0|||
157068508|NCT01271504|567006062|FG002|Overall Study|Administrative Reasons|6|||
157068509|NCT01271504|567006063|FG003|Overall Study|Administrative Reasons|5|||
157068510|NCT01271504|567006060|FG000|Overall Study|Withdrawal by Subject|0|||
157068511|NCT01271504|567006061|FG001|Overall Study|Withdrawal by Subject|0|||
157068512|NCT01271504|567006062|FG002|Overall Study|Withdrawal by Subject|1|||
157068513|NCT01271504|567006063|FG003|Overall Study|Withdrawal by Subject|3|||
157068514|NCT01271504|567006060|FG000|Overall Study|Other|0|||
157068515|NCT01271504|567006061|FG001|Overall Study|Other|1|||
157068516|NCT01271504|567006062|FG002|Overall Study|Other|2|||
157068517|NCT01271504|567006063|FG003|Overall Study|Other|0|||
157068518|NCT01162135|567006072|FG000|Overall Study|Withdrawal by Subject|1|||
157068519|NCT01162135|567006072|FG000|Overall Study|Severe back pain|1|||
157068520|NCT01162135|567006072|FG000|Overall Study|Ineligible|1|||
157068521|NCT01777334|567006073|FG000|Overall Study|Adverse Event|18|||
157068522|NCT01777334|567006074|FG001|Overall Study|Adverse Event|14|||
157068523|NCT01777334|567006073|FG000|Overall Study|Lack of Efficacy|15|||
157068524|NCT01777334|567006074|FG001|Overall Study|Lack of Efficacy|29|||
157068525|NCT01777334|567006073|FG000|Overall Study|Protocol Violation|3|||
157068526|NCT01777334|567006074|FG001|Overall Study|Protocol Violation|7|||
157068527|NCT01777334|567006073|FG000|Overall Study|Lost to Follow-up|3|||
157068528|NCT01777334|567006074|FG001|Overall Study|Lost to Follow-up|2|||
157068529|NCT01777334|567006073|FG000|Overall Study|Withdrawal by Subject|14|||
157068530|NCT01777334|567006074|FG001|Overall Study|Withdrawal by Subject|11|||
157068531|NCT06136897|567006081|FG000|Overall Study|Ineligible|3|||
157068532|NCT06136897|567006081|FG000|Overall Study|Mutation status not confirmed|7|||
157068533|NCT06136897|567006081|FG000|Overall Study|Adverse Event|2|||
157189107|NCT00535236|567433442|FG009|Overall Study|Adverse Event|1|||
157189108|NCT00535236|567433433|FG000|Overall Study|Lost to Follow-up|1|||
157189109|NCT00535236|567433434|FG001|Overall Study|Lost to Follow-up|2|||
157068534|NCT06136897|567006081|FG000|Overall Study|Death|1|||
157068535|NCT06136897|567006081|FG000|Overall Study|Disease progression|18|||
157068536|NCT06136897|567006081|FG000|Overall Study|Other complicating disease|1|||
157068537|NCT06136897|567006081|FG000|Overall Study|Withdrawal by Subject|1|||
157068538|NCT06136897|567006081|FG000|Overall Study|Still on treatment|1|||
157068539|NCT06136897|567006081|FG000|Overall Study|Lost to Follow-up|1|||
157068540|NCT00756457|567006082|FG000|Overall Study|Lost to Follow-up|1|||
157068541|NCT00756457|567006083|FG001|Overall Study|Lost to Follow-up|2|||
157068542|NCT02947100|567006084|FG000|Overall Study|study terminated early|3|||
157068543|NCT02947100|567006084|FG000|Overall Study|did not meet inclusion criteria|1|||
157068544|NCT00822770|567006085|FG000|Overall Study|Not treated|1|||
157068545|NCT00822770|567006086|FG001|Overall Study|Not treated|0|||
157068546|NCT00822770|567006085|FG000|Overall Study|Complication/Incomplete treatment|1|||
157068547|NCT00822770|567006086|FG001|Overall Study|Complication/Incomplete treatment|0|||
157068548|NCT00822770|567006085|FG000|Overall Study|Death|1|||
157068549|NCT00822770|567006086|FG001|Overall Study|Death|1|||
157068550|NCT02402322|567006087|FG000|Pretreatment|Withdrawal by Subject|3|||
157068551|NCT02402322|567006088|FG001|Pretreatment|Withdrawal by Subject|1|||
157068552|NCT02402322|567006089|FG002|Pretreatment|Withdrawal by Subject|1|||
157068553|NCT02402322|567006087|FG000|Follow-up|Withdrawal by Subject|6|||
157068554|NCT02402322|567006088|FG001|Follow-up|Withdrawal by Subject|3|||
157068555|NCT02402322|567006089|FG002|Follow-up|Withdrawal by Subject|24|||
157068556|NCT02818998|567006090|FG000|Overall Study|Adverse Event|3|||
157068557|NCT02818998|567006091|FG001|Overall Study|Adverse Event|2|||
157068558|NCT02818998|567006092|FG002|Overall Study|Adverse Event|1|||
157068559|NCT02818998|567006090|FG000|Overall Study|Lost to Follow-up|4|||
157068560|NCT02818998|567006091|FG001|Overall Study|Lost to Follow-up|1|||
157068561|NCT02818998|567006092|FG002|Overall Study|Lost to Follow-up|2|||
157068562|NCT02818998|567006090|FG000|Overall Study|Withdrawal by sponsor|0|||
157068563|NCT02818998|567006091|FG001|Overall Study|Withdrawal by sponsor|1|||
157068564|NCT02818998|567006092|FG002|Overall Study|Withdrawal by sponsor|1|||
157068565|NCT02818998|567006090|FG000|Overall Study|Death|3|||
157068566|NCT02818998|567006091|FG001|Overall Study|Death|6|||
157068567|NCT02818998|567006092|FG002|Overall Study|Death|8|||
157068568|NCT02818998|567006090|FG000|Overall Study|Withdrawal by Subject|7|||
157068569|NCT02818998|567006091|FG001|Overall Study|Withdrawal by Subject|6|||
157068570|NCT02818998|567006092|FG002|Overall Study|Withdrawal by Subject|6|||
157068571|NCT02818998|567006090|FG000|Overall Study|Physician Decision|1|||
157068572|NCT02818998|567006091|FG001|Overall Study|Physician Decision|0|||
157068573|NCT02818998|567006092|FG002|Overall Study|Physician Decision|0|||
157068574|NCT00632021|567006097|FG000|Overall Study|Withdrawal/death|4|||
157068575|NCT00632021|567006098|FG001|Overall Study|Withdrawal/death|7|||
157068576|NCT01296555|567006099|FG000|Overall Study|Adverse Event|0|||
157068577|NCT01296555|567006100|FG001|Overall Study|Adverse Event|0|||
157068578|NCT01296555|567006101|FG002|Overall Study|Adverse Event|1|||
157068579|NCT01296555|567006102|FG003|Overall Study|Adverse Event|1|||
157068580|NCT01296555|567006103|FG004|Overall Study|Adverse Event|2|||
157068581|NCT01296555|567006104|FG005|Overall Study|Adverse Event|4|||
157068582|NCT01296555|567006105|FG006|Overall Study|Adverse Event|1|||
157068583|NCT01296555|567006106|FG007|Overall Study|Adverse Event|4|||
157068584|NCT01296555|567006107|FG008|Overall Study|Adverse Event|3|||
157068585|NCT01296555|567006108|FG009|Overall Study|Adverse Event|1|||
157068586|NCT01296555|567006109|FG010|Overall Study|Adverse Event|0|||
157068587|NCT01296555|567006110|FG011|Overall Study|Adverse Event|4|||
157068588|NCT01296555|567006111|FG012|Overall Study|Adverse Event|1|||
157068589|NCT01296555|567006112|FG013|Overall Study|Adverse Event|4|||
157068590|NCT01296555|567006113|FG014|Overall Study|Adverse Event|0|||
157068591|NCT01296555|567006114|FG015|Overall Study|Adverse Event|0|||
157068592|NCT01296555|567006115|FG016|Overall Study|Adverse Event|0|||
157068593|NCT01296555|567006116|FG017|Overall Study|Adverse Event|0|||
157068594|NCT01296555|567006117|FG018|Overall Study|Adverse Event|0|||
157068595|NCT01296555|567006118|FG019|Overall Study|Adverse Event|1|||
157068596|NCT01296555|567006119|FG020|Overall Study|Adverse Event|0|||
157068597|NCT01296555|567006120|FG021|Overall Study|Adverse Event|0|||
157068598|NCT01296555|567006121|FG022|Overall Study|Adverse Event|0|||
157068599|NCT01296555|567006122|FG023|Overall Study|Adverse Event|0|||
157068600|NCT01296555|567006123|FG024|Overall Study|Adverse Event|0|||
157068601|NCT01296555|567006124|FG025|Overall Study|Adverse Event|0|||
157068602|NCT01296555|567006125|FG026|Overall Study|Adverse Event|0|||
157068603|NCT01296555|567006126|FG027|Overall Study|Adverse Event|0|||
157068604|NCT01296555|567006127|FG028|Overall Study|Adverse Event|0|||
157068605|NCT01296555|567006099|FG000|Overall Study|Reason Not Specified|0|||
157068606|NCT01296555|567006100|FG001|Overall Study|Reason Not Specified|0|||
157068607|NCT01296555|567006101|FG002|Overall Study|Reason Not Specified|0|||
157068608|NCT01296555|567006102|FG003|Overall Study|Reason Not Specified|0|||
157068609|NCT01296555|567006103|FG004|Overall Study|Reason Not Specified|0|||
157068610|NCT01296555|567006104|FG005|Overall Study|Reason Not Specified|0|||
157068611|NCT01296555|567006105|FG006|Overall Study|Reason Not Specified|0|||
157068612|NCT01296555|567006106|FG007|Overall Study|Reason Not Specified|0|||
157068613|NCT01296555|567006107|FG008|Overall Study|Reason Not Specified|0|||
157068614|NCT01296555|567006108|FG009|Overall Study|Reason Not Specified|0|||
157068615|NCT01296555|567006109|FG010|Overall Study|Reason Not Specified|0|||
157068616|NCT01296555|567006110|FG011|Overall Study|Reason Not Specified|0|||
157068617|NCT01296555|567006111|FG012|Overall Study|Reason Not Specified|0|||
157068618|NCT01296555|567006112|FG013|Overall Study|Reason Not Specified|1|||
157068619|NCT01296555|567006113|FG014|Overall Study|Reason Not Specified|2|||
157068620|NCT01296555|567006114|FG015|Overall Study|Reason Not Specified|3|||
157068621|NCT01296555|567006115|FG016|Overall Study|Reason Not Specified|7|||
157068622|NCT01296555|567006116|FG017|Overall Study|Reason Not Specified|4|||
157068623|NCT01296555|567006117|FG018|Overall Study|Reason Not Specified|3|||
157068624|NCT01296555|567006118|FG019|Overall Study|Reason Not Specified|7|||
157068625|NCT01296555|567006119|FG020|Overall Study|Reason Not Specified|11|||
157068626|NCT01296555|567006120|FG021|Overall Study|Reason Not Specified|5|||
157068627|NCT01296555|567006121|FG022|Overall Study|Reason Not Specified|5|||
157068628|NCT01296555|567006122|FG023|Overall Study|Reason Not Specified|7|||
157068629|NCT01296555|567006123|FG024|Overall Study|Reason Not Specified|2|||
157068630|NCT01296555|567006124|FG025|Overall Study|Reason Not Specified|2|||
157068631|NCT01296555|567006125|FG026|Overall Study|Reason Not Specified|19|||
157068632|NCT01296555|567006126|FG027|Overall Study|Reason Not Specified|11|||
157068633|NCT01296555|567006127|FG028|Overall Study|Reason Not Specified|9|||
157068634|NCT01296555|567006099|FG000|Overall Study|Physician Decision|0|||
157068635|NCT01296555|567006100|FG001|Overall Study|Physician Decision|0|||
157068636|NCT01296555|567006101|FG002|Overall Study|Physician Decision|0|||
157068637|NCT01296555|567006102|FG003|Overall Study|Physician Decision|0|||
157068638|NCT01296555|567006103|FG004|Overall Study|Physician Decision|1|||
157068639|NCT01296555|567006104|FG005|Overall Study|Physician Decision|0|||
157068640|NCT01296555|567006105|FG006|Overall Study|Physician Decision|0|||
157068641|NCT01296555|567006106|FG007|Overall Study|Physician Decision|0|||
157068642|NCT01296555|567006107|FG008|Overall Study|Physician Decision|0|||
157068643|NCT01296555|567006108|FG009|Overall Study|Physician Decision|0|||
157068644|NCT01296555|567006109|FG010|Overall Study|Physician Decision|0|||
157068645|NCT01296555|567006110|FG011|Overall Study|Physician Decision|0|||
157068646|NCT01296555|567006111|FG012|Overall Study|Physician Decision|0|||
157068647|NCT01296555|567006112|FG013|Overall Study|Physician Decision|1|||
157068648|NCT01296555|567006113|FG014|Overall Study|Physician Decision|0|||
157068649|NCT01296555|567006114|FG015|Overall Study|Physician Decision|0|||
157068650|NCT01296555|567006115|FG016|Overall Study|Physician Decision|0|||
157068651|NCT01296555|567006116|FG017|Overall Study|Physician Decision|0|||
157068652|NCT01296555|567006117|FG018|Overall Study|Physician Decision|0|||
157068653|NCT01296555|567006118|FG019|Overall Study|Physician Decision|1|||
157068654|NCT01296555|567006119|FG020|Overall Study|Physician Decision|0|||
157068655|NCT01296555|567006120|FG021|Overall Study|Physician Decision|0|||
157068656|NCT01296555|567006121|FG022|Overall Study|Physician Decision|0|||
157068657|NCT01296555|567006122|FG023|Overall Study|Physician Decision|0|||
157068658|NCT01296555|567006123|FG024|Overall Study|Physician Decision|0|||
157068659|NCT01296555|567006124|FG025|Overall Study|Physician Decision|0|||
157068660|NCT01296555|567006125|FG026|Overall Study|Physician Decision|0|||
157068661|NCT01296555|567006126|FG027|Overall Study|Physician Decision|0|||
157068662|NCT01296555|567006127|FG028|Overall Study|Physician Decision|0|||
157189110|NCT00535236|567433435|FG002|Overall Study|Lost to Follow-up|0|||
157189111|NCT00535236|567433436|FG003|Overall Study|Lost to Follow-up|0|||
157189112|NCT00535236|567433437|FG004|Overall Study|Lost to Follow-up|2|||
157189113|NCT00535236|567433438|FG005|Overall Study|Lost to Follow-up|0|||
157189114|NCT00535236|567433439|FG006|Overall Study|Lost to Follow-up|0|||
157189115|NCT00535236|567433440|FG007|Overall Study|Lost to Follow-up|0|||
157189116|NCT00535236|567433441|FG008|Overall Study|Lost to Follow-up|6|||
157189117|NCT00535236|567433442|FG009|Overall Study|Lost to Follow-up|1|||
157189118|NCT00535236|567433433|FG000|Overall Study|Physician Decision|0|||
157189119|NCT00535236|567433434|FG001|Overall Study|Physician Decision|0|||
157189120|NCT00535236|567433435|FG002|Overall Study|Physician Decision|0|||
157189121|NCT00535236|567433436|FG003|Overall Study|Physician Decision|0|||
157189122|NCT00535236|567433437|FG004|Overall Study|Physician Decision|1|||
157189123|NCT00535236|567433438|FG005|Overall Study|Physician Decision|0|||
157189124|NCT00535236|567433439|FG006|Overall Study|Physician Decision|1|||
157189125|NCT00535236|567433440|FG007|Overall Study|Physician Decision|0|||
157189126|NCT00535236|567433441|FG008|Overall Study|Physician Decision|0|||
157189127|NCT00535236|567433442|FG009|Overall Study|Physician Decision|0|||
157189128|NCT00535236|567433433|FG000|Overall Study|Protocol Violation|2|||
157189129|NCT00535236|567433434|FG001|Overall Study|Protocol Violation|0|||
157189130|NCT00535236|567433435|FG002|Overall Study|Protocol Violation|1|||
157189131|NCT00535236|567433436|FG003|Overall Study|Protocol Violation|0|||
157189132|NCT00535236|567433437|FG004|Overall Study|Protocol Violation|0|||
157189133|NCT00535236|567433438|FG005|Overall Study|Protocol Violation|0|||
157189134|NCT00535236|567433439|FG006|Overall Study|Protocol Violation|0|||
157189135|NCT00535236|567433440|FG007|Overall Study|Protocol Violation|0|||
157189136|NCT00535236|567433441|FG008|Overall Study|Protocol Violation|1|||
157189137|NCT00535236|567433442|FG009|Overall Study|Protocol Violation|0|||
157189138|NCT00535236|567433433|FG000|Overall Study|Withdrawal by Subject|3|||
157189139|NCT00535236|567433434|FG001|Overall Study|Withdrawal by Subject|0|||
157189140|NCT00535236|567433435|FG002|Overall Study|Withdrawal by Subject|2|||
157189141|NCT00535236|567433436|FG003|Overall Study|Withdrawal by Subject|1|||
157068663|NCT01296555|567006099|FG000|Overall Study|Progressive Disease|6|||
157068664|NCT01296555|567006100|FG001|Overall Study|Progressive Disease|3|||
157068665|NCT01296555|567006101|FG002|Overall Study|Progressive Disease|3|||
157068666|NCT01296555|567006102|FG003|Overall Study|Progressive Disease|7|||
157068667|NCT01296555|567006103|FG004|Overall Study|Progressive Disease|6|||
157189142|NCT00535236|567433437|FG004|Overall Study|Withdrawal by Subject|6|||
157189143|NCT00535236|567433438|FG005|Overall Study|Withdrawal by Subject|1|||
157189144|NCT00535236|567433439|FG006|Overall Study|Withdrawal by Subject|5|||
157068668|NCT01296555|567006104|FG005|Overall Study|Progressive Disease|16|||
157068669|NCT01296555|567006105|FG006|Overall Study|Progressive Disease|16|||
157068670|NCT01296555|567006106|FG007|Overall Study|Progressive Disease|8|||
157068671|NCT01296555|567006107|FG008|Overall Study|Progressive Disease|7|||
157068672|NCT01296555|567006108|FG009|Overall Study|Progressive Disease|18|||
157068673|NCT01296555|567006109|FG010|Overall Study|Progressive Disease|7|||
157189145|NCT00535236|567433440|FG007|Overall Study|Withdrawal by Subject|0|||
157189146|NCT00535236|567433441|FG008|Overall Study|Withdrawal by Subject|4|||
157189147|NCT00535236|567433442|FG009|Overall Study|Withdrawal by Subject|2|||
157189148|NCT00141297|567433444|FG000|Overall Study|Adverse Event|0|||
157189149|NCT00141297|567433445|FG001|Overall Study|Adverse Event|0|||
157189150|NCT00141297|567433446|FG002|Overall Study|Adverse Event|1|||
157189151|NCT00141297|567433447|FG003|Overall Study|Adverse Event|0|||
157189152|NCT00141297|567433448|FG004|Overall Study|Adverse Event|1|||
157189153|NCT00141297|567433449|FG005|Overall Study|Adverse Event|1|||
157189154|NCT00141297|567433450|FG006|Overall Study|Adverse Event|0|||
157189155|NCT00141297|567433451|FG007|Overall Study|Adverse Event|1|||
157189156|NCT00141297|567433452|FG008|Overall Study|Adverse Event|1|||
157189157|NCT00141297|567433453|FG009|Overall Study|Adverse Event|0|||
157189158|NCT00141297|567433444|FG000|Overall Study|Death|1|||
157189159|NCT00141297|567433445|FG001|Overall Study|Death|0|||
157189160|NCT00141297|567433446|FG002|Overall Study|Death|0|||
157189161|NCT00141297|567433447|FG003|Overall Study|Death|0|||
157189162|NCT00141297|567433448|FG004|Overall Study|Death|0|||
157189163|NCT00141297|567433449|FG005|Overall Study|Death|0|||
157189164|NCT00141297|567433450|FG006|Overall Study|Death|0|||
157189165|NCT00141297|567433451|FG007|Overall Study|Death|0|||
157189166|NCT00141297|567433452|FG008|Overall Study|Death|1|||
157189167|NCT00141297|567433453|FG009|Overall Study|Death|0|||
157189168|NCT00141297|567433444|FG000|Overall Study|Withdrawal by Subject|0|||
157189169|NCT00141297|567433445|FG001|Overall Study|Withdrawal by Subject|0|||
157189170|NCT00141297|567433446|FG002|Overall Study|Withdrawal by Subject|0|||
157189171|NCT00141297|567433447|FG003|Overall Study|Withdrawal by Subject|0|||
157189172|NCT00141297|567433448|FG004|Overall Study|Withdrawal by Subject|0|||
157189173|NCT00141297|567433449|FG005|Overall Study|Withdrawal by Subject|0|||
157189174|NCT00141297|567433450|FG006|Overall Study|Withdrawal by Subject|0|||
157189175|NCT00141297|567433451|FG007|Overall Study|Withdrawal by Subject|0|||
157189176|NCT00141297|567433452|FG008|Overall Study|Withdrawal by Subject|1|||
157189177|NCT00141297|567433453|FG009|Overall Study|Withdrawal by Subject|0|||
157189178|NCT00141297|567433444|FG000|Overall Study|Other|0|||
157189179|NCT00141297|567433445|FG001|Overall Study|Other|0|||
157189180|NCT00141297|567433446|FG002|Overall Study|Other|0|||
157189181|NCT00141297|567433447|FG003|Overall Study|Other|1|||
157189182|NCT00141297|567433448|FG004|Overall Study|Other|5|||
157189183|NCT00141297|567433449|FG005|Overall Study|Other|0|||
157189184|NCT00141297|567433450|FG006|Overall Study|Other|0|||
157189185|NCT00141297|567433451|FG007|Overall Study|Other|0|||
157189186|NCT00141297|567433452|FG008|Overall Study|Other|2|||
157189187|NCT00141297|567433453|FG009|Overall Study|Other|0|||
157189188|NCT00141297|567433444|FG000|Overall Study|Progressive Disease|2|||
157189189|NCT00141297|567433445|FG001|Overall Study|Progressive Disease|3|||
157189190|NCT00141297|567433446|FG002|Overall Study|Progressive Disease|6|||
157189191|NCT00141297|567433447|FG003|Overall Study|Progressive Disease|2|||
157189192|NCT00141297|567433448|FG004|Overall Study|Progressive Disease|15|||
157189193|NCT00141297|567433449|FG005|Overall Study|Progressive Disease|2|||
157189194|NCT00141297|567433450|FG006|Overall Study|Progressive Disease|3|||
157189195|NCT00141297|567433451|FG007|Overall Study|Progressive Disease|3|||
157189196|NCT00141297|567433452|FG008|Overall Study|Progressive Disease|15|||
157189197|NCT00141297|567433453|FG009|Overall Study|Progressive Disease|6|||
157189198|NCT00141297|567433444|FG000|Overall Study|Transitioned|0|||
157189199|NCT00141297|567433445|FG001|Overall Study|Transitioned|0|||
157189200|NCT00141297|567433446|FG002|Overall Study|Transitioned|0|||
157189201|NCT00141297|567433447|FG003|Overall Study|Transitioned|0|||
157189202|NCT00141297|567433448|FG004|Overall Study|Transitioned|1|||
157189203|NCT00141297|567433449|FG005|Overall Study|Transitioned|0|||
157189204|NCT00141297|567433450|FG006|Overall Study|Transitioned|0|||
157189205|NCT00141297|567433451|FG007|Overall Study|Transitioned|0|||
157189206|NCT00141297|567433452|FG008|Overall Study|Transitioned|0|||
157189207|NCT00141297|567433453|FG009|Overall Study|Transitioned|0|||
157189208|NCT02987205|567433454|FG000|Overall Study|Adverse Event|1|||
157189209|NCT02987205|567433454|FG000|Overall Study|Withdrawal by Subject|3|||
157189210|NCT03558503|567433455|FG000|Overall Study|Adverse Event|1|||
157189211|NCT03558503|567433455|FG000|Overall Study|Death|1|||
157189212|NCT03558503|567433455|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
157068674|NCT01296555|567006110|FG011|Overall Study|Progressive Disease|14|||
157189213|NCT00958191|567433468|FG000|Overall Study|Death|4|||
157189214|NCT00958191|567433468|FG000|Overall Study|Lost to Follow-up|5|||
157189215|NCT00958191|567433468|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
157189216|NCT00958191|567433468|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
157189217|NCT00958191|567433468|FG000|Overall Study|Revision of study device|4|||
157189218|NCT00958191|567433468|FG000|Overall Study|Site termination|11|||
157189219|NCT00958191|567433468|FG000|Overall Study|No 5 yr x-rays|56|||
157068675|NCT01296555|567006111|FG012|Overall Study|Progressive Disease|5|||
157189220|NCT01642004|567433469|FG000|Randomization|Adverse Event unrelated to study drug|1|||
157189221|NCT01642004|567433470|FG001|Randomization|Adverse Event unrelated to study drug|0|||
157189222|NCT01642004|567433469|FG000|Randomization|Participant withdrew consent|1|||
157189223|NCT01642004|567433470|FG001|Randomization|Participant withdrew consent|6|||
157189224|NCT01642004|567433469|FG000|Randomization|No longer meets study criteria|2|||
157189225|NCT01642004|567433470|FG001|Randomization|No longer meets study criteria|2|||
157189226|NCT01642004|567433469|FG000|Treatment|Disease progression|95|||
157189227|NCT01642004|567433470|FG001|Treatment|Disease progression|79|||
157189228|NCT01642004|567433469|FG000|Treatment|Study drug toxicity|10|||
157189229|NCT01642004|567433470|FG001|Treatment|Study drug toxicity|13|||
157189230|NCT01642004|567433469|FG000|Treatment|Death|1|||
157189231|NCT01642004|567433470|FG001|Treatment|Death|1|||
157189232|NCT01642004|567433469|FG000|Treatment|Adverse event unrelated to study drug|9|||
157189233|NCT01642004|567433470|FG001|Treatment|Adverse event unrelated to study drug|13|||
157189234|NCT01642004|567433469|FG000|Treatment|Maximum clinical benefit|1|||
157189235|NCT01642004|567433470|FG001|Treatment|Maximum clinical benefit|9|||
157189236|NCT01642004|567433469|FG000|Treatment|Poor/non-compliance|1|||
157189237|NCT01642004|567433470|FG001|Treatment|Poor/non-compliance|0|||
157189238|NCT01642004|567433469|FG000|Treatment|No longer meets study criteria|1|||
157189239|NCT01642004|567433470|FG001|Treatment|No longer meets study criteria|2|||
157189240|NCT01642004|567433469|FG000|Treatment|Other reasons|2|||
157189241|NCT01642004|567433470|FG001|Treatment|Other reasons|0|||
157189242|NCT01642004|567433469|FG000|Treatment|Not reported|0|||
157189243|NCT01642004|567433470|FG001|Treatment|Not reported|3|||
157189244|NCT01642004|567433469|FG000|Treatment|Participant request to discontinue study treatment|6|||
157189245|NCT01642004|567433470|FG001|Treatment|Participant request to discontinue study treatment|4|||
157189246|NCT01642004|567433469|FG000|Treatment|Participant withdrew consent|5|||
157189247|NCT01642004|567433470|FG001|Treatment|Participant withdrew consent|5|||
157189248|NCT02718625|567433471|FG000|Overall Study|Adverse Event|0|||
157189249|NCT02718625|567433472|FG001|Overall Study|Adverse Event|1|||
157189250|NCT02718625|567433471|FG000|Overall Study|Termination of Study by Sponsor|0|||
157189251|NCT02718625|567433472|FG001|Overall Study|Termination of Study by Sponsor|1|||
157189252|NCT01818765|567433473|FG000|Overall Study|Death|2|||
157189253|NCT01562327|567433474|FG000|Overall Study|Adverse Event|2|||
157189254|NCT01562327|567433474|FG000|Overall Study|Lack of Efficacy|1|||
157189255|NCT01562327|567433474|FG000|Overall Study|Participant drop-out|1|||
157189256|NCT01562327|567433474|FG000|Overall Study|Infusion not received at 6 month window|4|||
157189257|NCT01947127|567433475|FG000|Overall Study|Protocol Violation|18|||
157189258|NCT01947127|567433476|FG001|Overall Study|Protocol Violation|38|||
157189259|NCT01947127|567433475|FG000|Overall Study|Withdrawal by Subject|1|||
157189260|NCT01947127|567433476|FG001|Overall Study|Withdrawal by Subject|1|||
157189261|NCT01947127|567433475|FG000|Overall Study|Data loss|4|||
157189262|NCT01947127|567433476|FG001|Overall Study|Data loss|4|||
157189263|NCT00170846|567433477|FG000|Overall Study|Subject withdrew Informed Consent|5|||
157189264|NCT00170846|567433478|FG001|Overall Study|Subject withdrew Informed Consent|12|||
157189265|NCT00170846|567433479|FG002|Overall Study|Subject withdrew Informed Consent|8|||
157189266|NCT00170846|567433477|FG000|Overall Study|Lost to Follow-up|6|||
157189267|NCT00170846|567433478|FG001|Overall Study|Lost to Follow-up|3|||
157189268|NCT00170846|567433479|FG002|Overall Study|Lost to Follow-up|2|||
157189269|NCT00170846|567433477|FG000|Overall Study|Death|0|||
157189270|NCT00170846|567433478|FG001|Overall Study|Death|3|||
157189271|NCT00170846|567433479|FG002|Overall Study|Death|3|||
157189272|NCT00170846|567433477|FG000|Overall Study|Reason Missing|0|||
157189273|NCT00170846|567433478|FG001|Overall Study|Reason Missing|1|||
157189274|NCT00170846|567433479|FG002|Overall Study|Reason Missing|0|||
157189275|NCT01756833|567433484|FG000|Overall Study|Withdrawal by Subject|4|||
157189276|NCT01756833|567433485|FG001|Overall Study|Withdrawal by Subject|3|||
157189277|NCT00887913|567433486|FG000|Overall Study|Withdrawal by Subject|6|||
157189278|NCT00415623|567433493|FG000|Overall Study|Adverse Event|3|||
157189279|NCT00415623|567433494|FG001|Overall Study|Adverse Event|4|||
157189280|NCT00415623|567433493|FG000|Overall Study|Death|1|||
157189281|NCT00415623|567433494|FG001|Overall Study|Death|0|||
157189282|NCT00415623|567433493|FG000|Overall Study|Withdrawal by Subject|1|||
157189283|NCT00415623|567433494|FG001|Overall Study|Withdrawal by Subject|1|||
157189284|NCT01708915|567433496|FG000|Overall Study|Adverse Event|1|||
157189285|NCT01708915|567433497|FG001|Overall Study|Adverse Event|0|||
157189286|NCT01708915|567433498|FG002|Overall Study|Adverse Event|9|||
157189287|NCT01708915|567433499|FG003|Overall Study|Adverse Event|13|||
157189288|NCT01708915|567433496|FG000|Overall Study|Lack of Efficacy|84|||
157189289|NCT01708915|567433497|FG001|Overall Study|Lack of Efficacy|60|||
157189290|NCT01708915|567433498|FG002|Overall Study|Lack of Efficacy|35|||
157189291|NCT01708915|567433499|FG003|Overall Study|Lack of Efficacy|15|||
157189292|NCT01708915|567433496|FG000|Overall Study|Protocol Violation|0|||
157189293|NCT01708915|567433497|FG001|Overall Study|Protocol Violation|0|||
157189294|NCT01708915|567433498|FG002|Overall Study|Protocol Violation|0|||
157189295|NCT01708915|567433499|FG003|Overall Study|Protocol Violation|1|||
157189296|NCT01708915|567433496|FG000|Overall Study|Withdrawal by Subject|0|||
157189297|NCT01708915|567433497|FG001|Overall Study|Withdrawal by Subject|1|||
157189298|NCT01708915|567433498|FG002|Overall Study|Withdrawal by Subject|2|||
157189299|NCT01708915|567433499|FG003|Overall Study|Withdrawal by Subject|2|||
157189300|NCT01708915|567433496|FG000|Overall Study|Other reasons than stated above|1|||
157189301|NCT01708915|567433497|FG001|Overall Study|Other reasons than stated above|1|||
157189302|NCT01708915|567433498|FG002|Overall Study|Other reasons than stated above|0|||
157189303|NCT01708915|567433499|FG003|Overall Study|Other reasons than stated above|2|||
157189304|NCT03267576|567433500|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
157189305|NCT03267576|567433501|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
157189306|NCT03267576|567433500|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
157189307|NCT03267576|567433501|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
157189308|NCT01369069|567433502|FG000|Overall Study|Lost to Follow-up|8|||
157189309|NCT01369069|567433503|FG001|Overall Study|Lost to Follow-up|9|||
157189310|NCT01369069|567433502|FG000|Overall Study|Withdrawal by Subject|9|||
157189311|NCT01369069|567433503|FG001|Overall Study|Withdrawal by Subject|7|||
157189312|NCT02573012|567433504|FG000|Overall Study|Adverse Event|5|||
157189313|NCT02573012|567433505|FG001|Overall Study|Adverse Event|5|||
157189314|NCT02573012|567433504|FG000|Overall Study|Lack of Efficacy|5|||
157189315|NCT02573012|567433505|FG001|Overall Study|Lack of Efficacy|4|||
157189316|NCT02573012|567433504|FG000|Overall Study|Non-compliance|1|||
157189317|NCT02573012|567433505|FG001|Overall Study|Non-compliance|2|||
157189318|NCT02573012|567433504|FG000|Overall Study|Withdrawal by Subject|2|||
157189319|NCT02573012|567433505|FG001|Overall Study|Withdrawal by Subject|2|||
157189320|NCT02573012|567433504|FG000|Overall Study|Study Ended per Protocol|1|||
157189321|NCT02573012|567433505|FG001|Overall Study|Study Ended per Protocol|0|||
157189322|NCT02573012|567433504|FG000|Overall Study|Physician Decision|1|||
157189323|NCT02573012|567433505|FG001|Overall Study|Physician Decision|2|||
157189324|NCT00882362|567433507|FG000|Overall Study|Adverse Event|13|||
157189325|NCT00882362|567433508|FG001|Overall Study|Adverse Event|10|||
157189326|NCT00882362|567433507|FG000|Overall Study|Withdrawal by Subject|13|||
157189327|NCT00882362|567433508|FG001|Overall Study|Withdrawal by Subject|10|||
157189328|NCT00882362|567433507|FG000|Overall Study|Lack of Efficacy|3|||
157189329|NCT00882362|567433508|FG001|Overall Study|Lack of Efficacy|0|||
157189330|NCT00882362|567433507|FG000|Overall Study|Protocol Violation|7|||
157189331|NCT00882362|567433508|FG001|Overall Study|Protocol Violation|2|||
157189332|NCT00882362|567433507|FG000|Overall Study|Pregnancy|1|||
157189333|NCT00882362|567433508|FG001|Overall Study|Pregnancy|0|||
157189334|NCT00882362|567433507|FG000|Overall Study|Physician Decision|5|||
157189335|NCT00882362|567433508|FG001|Overall Study|Physician Decision|1|||
157189336|NCT00882362|567433507|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
157189337|NCT00882362|567433508|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
157189338|NCT00882362|567433507|FG000|Overall Study|change of residence or other commitments|5|||
157189339|NCT00882362|567433508|FG001|Overall Study|change of residence or other commitments|0|||
157189340|NCT01846208|567433509|FG000|Overall Study|Withdrew prior to treatment|1|||
157189341|NCT01846208|567433510|FG001|Overall Study|Withdrew prior to treatment|1|||
157189342|NCT01846208|567433511|FG002|Overall Study|Withdrew prior to treatment|1|||
157189343|NCT01846208|567433509|FG000|Overall Study|Dosing Symptoms|1|||
157189344|NCT01846208|567433510|FG001|Overall Study|Dosing Symptoms|2|||
157189345|NCT01846208|567433511|FG002|Overall Study|Dosing Symptoms|6|||
157189346|NCT01846208|567433509|FG000|Overall Study|Withdrawal by Subject|5|||
157189347|NCT01846208|567433510|FG001|Overall Study|Withdrawal by Subject|0|||
157189348|NCT01846208|567433511|FG002|Overall Study|Withdrawal by Subject|0|||
157189349|NCT01846208|567433509|FG000|Overall Study|Non-compliance|1|||
157189350|NCT01846208|567433510|FG001|Overall Study|Non-compliance|1|||
157189351|NCT01846208|567433511|FG002|Overall Study|Non-compliance|0|||
157189352|NCT01846208|567433509|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
157189353|NCT01846208|567433510|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
157189354|NCT01846208|567433511|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
157189355|NCT01846208|567433509|FG000|Overall Study|Refused SU OFC|0|||
157189356|NCT01846208|567433510|FG001|Overall Study|Refused SU OFC|0|||
157189357|NCT01846208|567433511|FG002|Overall Study|Refused SU OFC|1|||
157189358|NCT01268514|567433512|FG000|Overall Study|Adverse Event|20|||
157189359|NCT01268514|567433512|FG000|Overall Study|Death|8|||
157189360|NCT01268514|567433512|FG000|Overall Study|Lost to Follow-up|5|||
157189361|NCT01268514|567433512|FG000|Overall Study|Withdrawal by Subject|3|||
157189362|NCT01268514|567433512|FG000|Overall Study|Withdrawal by Surgeon|5|||
157189363|NCT01424306|567433513|FG000|Overall Study|Protocol Violation|0|||
157189364|NCT01424306|567433514|FG001|Overall Study|Protocol Violation|0|||
157189365|NCT01424306|567433515|FG002|Overall Study|Protocol Violation|0|||
157189366|NCT01424306|567433516|FG003|Overall Study|Protocol Violation|0|||
157189367|NCT01424306|567433517|FG004|Overall Study|Protocol Violation|1|||
157189368|NCT01424306|567433518|FG005|Overall Study|Protocol Violation|0|||
157189369|NCT01432938|567433519|FG000|First Intervention|Protocol Violation|1|||
157189370|NCT01432938|567433520|FG001|First Intervention|Protocol Violation|0|||
157189371|NCT01432938|567433519|FG000|First Intervention|Physician Decision|1|||
157189372|NCT01432938|567433520|FG001|First Intervention|Physician Decision|0|||
157189373|NCT01432938|567433519|FG000|Second Intervention|Adverse Event|1|||
157189374|NCT01432938|567433520|FG001|Second Intervention|Adverse Event|0|||
157189375|NCT01601873|567433526|FG000|Overall Study|Lost to Follow-up|2|||
157189376|NCT01601873|567433527|FG001|Overall Study|Lost to Follow-up|3|||
157189377|NCT01875874|567433528|FG000|Overall Study|Death|3|||
157189378|NCT02096471|567433531|FG000|Overall Study|Adverse Event|1|||
157189379|NCT02096471|567433531|FG000|Overall Study|Lack of Efficacy|7|||
157189380|NCT02096471|567433531|FG000|Overall Study|Withdrawal by Subject|3|||
157068676|NCT01296555|567006112|FG013|Overall Study|Progressive Disease|12|||
157068677|NCT01296555|567006113|FG014|Overall Study|Progressive Disease|1|||
157068678|NCT01296555|567006114|FG015|Overall Study|Progressive Disease|1|||
157068679|NCT01296555|567006115|FG016|Overall Study|Progressive Disease|0|||
157068680|NCT01296555|567006116|FG017|Overall Study|Progressive Disease|0|||
157068681|NCT01296555|567006117|FG018|Overall Study|Progressive Disease|0|||
157068682|NCT01296555|567006118|FG019|Overall Study|Progressive Disease|1|||
157068683|NCT01296555|567006119|FG020|Overall Study|Progressive Disease|0|||
157068684|NCT01296555|567006120|FG021|Overall Study|Progressive Disease|0|||
157068685|NCT01296555|567006121|FG022|Overall Study|Progressive Disease|0|||
157189381|NCT02096471|567433531|FG000|Overall Study|Non-Compliant|2|||
157189382|NCT00374127|567433532|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
157189383|NCT00374127|567433532|FG000|Overall Study|Blood could not be drawn.|2|||
157189384|NCT00374127|567433532|FG000|Overall Study|Protocol Violation|5|||
157068686|NCT01296555|567006122|FG023|Overall Study|Progressive Disease|0|||
157068687|NCT01296555|567006123|FG024|Overall Study|Progressive Disease|1|||
157068688|NCT01296555|567006124|FG025|Overall Study|Progressive Disease|0|||
157068689|NCT01296555|567006125|FG026|Overall Study|Progressive Disease|5|||
157068690|NCT01296555|567006126|FG027|Overall Study|Progressive Disease|1|||
157068691|NCT01296555|567006127|FG028|Overall Study|Progressive Disease|0|||
157068692|NCT01296555|567006099|FG000|Overall Study|Protocol Violation|0|||
157068693|NCT01296555|567006100|FG001|Overall Study|Protocol Violation|0|||
157068694|NCT01296555|567006101|FG002|Overall Study|Protocol Violation|0|||
157068695|NCT01296555|567006102|FG003|Overall Study|Protocol Violation|0|||
157068696|NCT01296555|567006103|FG004|Overall Study|Protocol Violation|0|||
157068697|NCT01296555|567006104|FG005|Overall Study|Protocol Violation|0|||
157068698|NCT01296555|567006105|FG006|Overall Study|Protocol Violation|0|||
157068699|NCT01296555|567006106|FG007|Overall Study|Protocol Violation|0|||
157068700|NCT01296555|567006107|FG008|Overall Study|Protocol Violation|0|||
157068701|NCT01296555|567006108|FG009|Overall Study|Protocol Violation|0|||
157068702|NCT01296555|567006109|FG010|Overall Study|Protocol Violation|0|||
157068703|NCT01296555|567006110|FG011|Overall Study|Protocol Violation|0|||
157068704|NCT01296555|567006111|FG012|Overall Study|Protocol Violation|0|||
157068705|NCT01296555|567006112|FG013|Overall Study|Protocol Violation|1|||
157068706|NCT01296555|567006113|FG014|Overall Study|Protocol Violation|0|||
157068707|NCT01296555|567006114|FG015|Overall Study|Protocol Violation|0|||
157068708|NCT01296555|567006115|FG016|Overall Study|Protocol Violation|0|||
157068709|NCT01296555|567006116|FG017|Overall Study|Protocol Violation|0|||
157068710|NCT01296555|567006117|FG018|Overall Study|Protocol Violation|0|||
157068711|NCT01296555|567006118|FG019|Overall Study|Protocol Violation|0|||
157068712|NCT01296555|567006119|FG020|Overall Study|Protocol Violation|0|||
157068713|NCT01296555|567006120|FG021|Overall Study|Protocol Violation|0|||
157068714|NCT01296555|567006121|FG022|Overall Study|Protocol Violation|0|||
157068715|NCT01296555|567006122|FG023|Overall Study|Protocol Violation|0|||
157068716|NCT01296555|567006123|FG024|Overall Study|Protocol Violation|0|||
157068717|NCT01296555|567006124|FG025|Overall Study|Protocol Violation|0|||
157068718|NCT01296555|567006125|FG026|Overall Study|Protocol Violation|0|||
157068719|NCT01296555|567006126|FG027|Overall Study|Protocol Violation|0|||
157068720|NCT01296555|567006127|FG028|Overall Study|Protocol Violation|0|||
157068721|NCT01296555|567006099|FG000|Overall Study|Study Terminated By Sponsor|0|||
157068722|NCT01296555|567006100|FG001|Overall Study|Study Terminated By Sponsor|0|||
157068723|NCT01296555|567006101|FG002|Overall Study|Study Terminated By Sponsor|0|||
157068724|NCT01296555|567006102|FG003|Overall Study|Study Terminated By Sponsor|0|||
157068725|NCT01296555|567006103|FG004|Overall Study|Study Terminated By Sponsor|0|||
157068726|NCT01296555|567006104|FG005|Overall Study|Study Terminated By Sponsor|0|||
157068727|NCT01296555|567006105|FG006|Overall Study|Study Terminated By Sponsor|0|||
157068728|NCT01296555|567006106|FG007|Overall Study|Study Terminated By Sponsor|0|||
157068729|NCT01296555|567006107|FG008|Overall Study|Study Terminated By Sponsor|0|||
157068730|NCT01296555|567006108|FG009|Overall Study|Study Terminated By Sponsor|0|||
157068731|NCT01296555|567006109|FG010|Overall Study|Study Terminated By Sponsor|0|||
157068732|NCT01296555|567006110|FG011|Overall Study|Study Terminated By Sponsor|0|||
157068733|NCT01296555|567006111|FG012|Overall Study|Study Terminated By Sponsor|0|||
157068734|NCT01296555|567006112|FG013|Overall Study|Study Terminated By Sponsor|0|||
157068735|NCT01296555|567006113|FG014|Overall Study|Study Terminated By Sponsor|0|||
157189385|NCT00374127|567433532|FG000|Overall Study|Pregnancy|1|||
157068736|NCT01296555|567006114|FG015|Overall Study|Study Terminated By Sponsor|0|||
157189386|NCT03344562|567433533|FG000|Overall Study|Withdrawal by Subject|2|||
157189387|NCT03344562|567433534|FG001|Overall Study|Withdrawal by Subject|0|||
157068737|NCT01296555|567006115|FG016|Overall Study|Study Terminated By Sponsor|0|||
157068738|NCT01296555|567006116|FG017|Overall Study|Study Terminated By Sponsor|0|||
157068739|NCT01296555|567006117|FG018|Overall Study|Study Terminated By Sponsor|0|||
157068740|NCT01296555|567006118|FG019|Overall Study|Study Terminated By Sponsor|0|||
157068741|NCT01296555|567006119|FG020|Overall Study|Study Terminated By Sponsor|0|||
157068742|NCT01296555|567006120|FG021|Overall Study|Study Terminated By Sponsor|0|||
157068743|NCT01296555|567006121|FG022|Overall Study|Study Terminated By Sponsor|0|||
157068744|NCT01296555|567006122|FG023|Overall Study|Study Terminated By Sponsor|0|||
157068745|NCT01296555|567006123|FG024|Overall Study|Study Terminated By Sponsor|0|||
157068746|NCT01296555|567006124|FG025|Overall Study|Study Terminated By Sponsor|1|||
157068747|NCT01296555|567006125|FG026|Overall Study|Study Terminated By Sponsor|0|||
157189388|NCT02736474|567433541|FG000|Overall Study|Lost to Follow-up|0|||
157189389|NCT02736474|567433542|FG001|Overall Study|Lost to Follow-up|1|||
157189390|NCT02463331|567433543|FG000|Overall Study|Adverse Event|4|||
157189391|NCT02463331|567433544|FG001|Overall Study|Adverse Event|2|||
157189392|NCT02463331|567433543|FG000|Overall Study|Lost to Follow-up|1|||
157189393|NCT02463331|567433544|FG001|Overall Study|Lost to Follow-up|1|||
157189394|NCT02463331|567433543|FG000|Overall Study|Pregnancy|2|||
157189395|NCT02463331|567433544|FG001|Overall Study|Pregnancy|3|||
157189396|NCT02463331|567433543|FG000|Overall Study|Lack of Efficacy|6|||
157189397|NCT02463331|567433544|FG001|Overall Study|Lack of Efficacy|0|||
157189398|NCT02463331|567433543|FG000|Overall Study|Physician Decision|3|||
157189399|NCT02463331|567433544|FG001|Overall Study|Physician Decision|0|||
157189400|NCT00703781|567433545|FG000|Overall Study|Withdrawal by Subject|1|||
157189401|NCT00703781|567433546|FG001|Overall Study|Withdrawal by Subject|2|||
157189402|NCT00703781|567433545|FG000|Overall Study|Cancelled surgery|1|||
157189403|NCT00703781|567433546|FG001|Overall Study|Cancelled surgery|0|||
157189404|NCT01987609|567433553|FG000|Overall Study|Adverse Event|1|||
157189405|NCT00125268|567433554|FG000|Overall Study|Withdrawal by Subject|1|||
157189406|NCT00125268|567433555|FG001|Overall Study|Withdrawal by Subject|1|||
157189407|NCT02561572|567433556|FG000|Overall Study|Inadequate time before surgery|2|||
157189408|NCT02561572|567433557|FG001|Overall Study|Inadequate time before surgery|1|||
157189409|NCT02561572|567433556|FG000|Overall Study|Protocol Violation|0|||
157189410|NCT02561572|567433557|FG001|Overall Study|Protocol Violation|1|||
157189411|NCT02691468|567433558|FG000|Overall Study|Bronchial blocker use|2|||
157189412|NCT02691468|567433559|FG001|Overall Study|Bronchial blocker use|1|||
157189413|NCT02691468|567433558|FG000|Overall Study|Lost to Follow-up|2|||
157189414|NCT02691468|567433559|FG001|Overall Study|Lost to Follow-up|1|||
157189415|NCT02691468|567433558|FG000|Overall Study|Failure to advance FOB|2|||
157189416|NCT02691468|567433559|FG001|Overall Study|Failure to advance FOB|0|||
157189417|NCT02683668|567433562|FG000|Period 2|Withdrawal by Subject|0|||
157189418|NCT02683668|567433563|FG001|Period 2|Withdrawal by Subject|1|||
157189419|NCT02683668|567433564|FG002|Period 2|Withdrawal by Subject|0|||
157189420|NCT00631969|567433565|FG000|Overall Study|Adverse Event|3|||
157189421|NCT00631969|567433566|FG001|Overall Study|Adverse Event|1|||
157189422|NCT00631969|567433565|FG000|Overall Study|Lack of Efficacy|2|||
157189423|NCT00631969|567433566|FG001|Overall Study|Lack of Efficacy|8|||
157189424|NCT00631969|567433565|FG000|Overall Study|Lost to Follow-up|2|||
157189425|NCT00631969|567433566|FG001|Overall Study|Lost to Follow-up|1|||
157189426|NCT00631969|567433565|FG000|Overall Study|Protocol Violation|1|||
157189427|NCT00631969|567433566|FG001|Overall Study|Protocol Violation|1|||
157189428|NCT00631969|567433565|FG000|Overall Study|Consent Withdrawn|5|||
157189429|NCT00631969|567433566|FG001|Overall Study|Consent Withdrawn|7|||
157189430|NCT00631969|567433565|FG000|Overall Study|Noncompliant With Study Medication|0|||
157189431|NCT00631969|567433566|FG001|Overall Study|Noncompliant With Study Medication|1|||
157189432|NCT00631969|567433565|FG000|Overall Study|No Drug Exposure|2|||
157189433|NCT00631969|567433566|FG001|Overall Study|No Drug Exposure|2|||
157189434|NCT03893630|567433567|FG000|Overall Study|Lost to Follow-up|5|||
157189435|NCT03893630|567433568|FG001|Overall Study|Lost to Follow-up|4|||
157189436|NCT03893630|567433569|FG002|Overall Study|Lost to Follow-up|2|||
157189437|NCT03893630|567433567|FG000|Overall Study|Withdrawal by Subject|3|||
157189438|NCT03893630|567433568|FG001|Overall Study|Withdrawal by Subject|6|||
157189439|NCT03893630|567433569|FG002|Overall Study|Withdrawal by Subject|3|||
157189440|NCT03893630|567433567|FG000|Overall Study|Discontinued Intervention|0|||
157189441|NCT03893630|567433568|FG001|Overall Study|Discontinued Intervention|4|||
157189442|NCT03893630|567433569|FG002|Overall Study|Discontinued Intervention|2|||
157189443|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
157189444|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
157189445|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
157189446|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
157189447|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
157189448|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
157189449|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
157189450|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
157189451|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Death|0|||
157189452|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Death|0|||
157189453|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Death|0|||
157189454|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Death|1|||
157189455|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Death|1|||
157189456|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Death|0|||
157189457|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Death|2|||
157189458|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Death|0|||
157189459|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189460|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189461|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189462|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
157189463|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189464|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189465|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189466|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
157189467|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189468|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189469|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189470|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
157189471|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189472|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189473|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189474|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
157189475|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
157189476|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
157189477|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
157189478|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
157189479|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
157189480|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
157189481|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
157189482|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
157189483|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
157189484|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
157189485|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
157189486|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
157189487|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
157189488|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
157189489|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
157189490|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
157189491|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
157189492|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
157189493|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
157189494|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
157189495|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
157189496|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
157189497|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
157189498|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
157189499|NCT02442765|567435193|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189500|NCT02442765|567435194|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189501|NCT02442765|567435195|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189502|NCT02442765|567435196|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189503|NCT02442765|567435197|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
157189504|NCT02442765|567435198|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189505|NCT02442765|567435199|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
157189506|NCT02442765|567435200|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
157189507|NCT00003389|567435201|FG000|Overall Study|Disease progression|6|||
157189508|NCT00003389|567435202|FG001|Overall Study|Disease progression|1|||
157189509|NCT00003389|567435201|FG000|Overall Study|Adverse Event|13|||
157189510|NCT00003389|567435202|FG001|Overall Study|Adverse Event|2|||
157189511|NCT00003389|567435201|FG000|Overall Study|Death|0|||
157189512|NCT00003389|567435202|FG001|Overall Study|Death|3|||
157189513|NCT00003389|567435201|FG000|Overall Study|Withdrawal by Subject|12|||
157189514|NCT00003389|567435202|FG001|Overall Study|Withdrawal by Subject|5|||
157189515|NCT00003389|567435201|FG000|Overall Study|Alternative therapy|2|||
157189516|NCT00003389|567435202|FG001|Overall Study|Alternative therapy|1|||
157189517|NCT00003389|567435201|FG000|Overall Study|Complicating disease|1|||
157189518|NCT00003389|567435202|FG001|Overall Study|Complicating disease|0|||
157189519|NCT00003389|567435201|FG000|Overall Study|Off-treatment reason missing|31|||
157189520|NCT00003389|567435202|FG001|Overall Study|Off-treatment reason missing|21|||
157189521|NCT00003389|567435201|FG000|Overall Study|Ineligible|33|||
157189522|NCT00003389|567435202|FG001|Overall Study|Ineligible|27|||
157189523|NCT03818399|567435203|FG000|Overall Study|Lost to Follow-up|11|||
157189524|NCT03818399|567435203|FG000|Overall Study|Withdrawal by Subject|1|||
157189525|NCT03818399|567435203|FG000|Overall Study|Protocol Violation|2|||
157189526|NCT00561795|567435204|FG000|Overall Study|Adverse Event|3|||
157189527|NCT00561795|567435205|FG001|Overall Study|Adverse Event|3|||
157189528|NCT00561795|567435206|FG002|Overall Study|Adverse Event|0|||
157189529|NCT00561795|567435207|FG003|Overall Study|Adverse Event|0|||
157189530|NCT00561795|567435204|FG000|Overall Study|Study Closed/Terminated|0|||
157189531|NCT00561795|567435205|FG001|Overall Study|Study Closed/Terminated|3|||
157189532|NCT00561795|567435206|FG002|Overall Study|Study Closed/Terminated|0|||
157189533|NCT00561795|567435207|FG003|Overall Study|Study Closed/Terminated|0|||
157189534|NCT00561795|567435204|FG000|Overall Study|Physician Decision|1|||
157189535|NCT00561795|567435205|FG001|Overall Study|Physician Decision|0|||
157189536|NCT00561795|567435206|FG002|Overall Study|Physician Decision|0|||
157189537|NCT00561795|567435207|FG003|Overall Study|Physician Decision|0|||
157189538|NCT02807376|567435208|FG000|Overall Study|Intra-operative exclusion criteria|3|||
157189539|NCT02807376|567435209|FG001|Overall Study|Intra-operative exclusion criteria|0|||
157189540|NCT02807376|567435208|FG000|Overall Study|Lost to Follow-up|0|||
157189541|NCT02807376|567435209|FG001|Overall Study|Lost to Follow-up|1|||
157189542|NCT00948389|567435212|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
157189543|NCT00948389|567435213|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
157189544|NCT00948389|567435214|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
157189545|NCT00948389|567435215|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
157189546|NCT00948389|567435216|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
157189547|NCT00948389|567435212|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
157189548|NCT00948389|567435213|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
157189549|NCT00948389|567435214|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
157189550|NCT00948389|567435215|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
157189551|NCT00948389|567435216|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
157189552|NCT00948389|567435212|FG000|Overall Study|Both Progression and Toxicity|1|||
157189553|NCT00948389|567435213|FG001|Overall Study|Both Progression and Toxicity|0|||
157189554|NCT00948389|567435214|FG002|Overall Study|Both Progression and Toxicity|0|||
157189555|NCT00948389|567435215|FG003|Overall Study|Both Progression and Toxicity|0|||
157189556|NCT00948389|567435216|FG004|Overall Study|Both Progression and Toxicity|0|||
157189557|NCT01072500|567435223|FG000|Overall Study|Death|2|||
157189558|NCT01072500|567435224|FG001|Overall Study|Death|2|||
157189559|NCT01072500|567435223|FG000|Overall Study|Lost to Follow-up|5|||
157189560|NCT01072500|567435224|FG001|Overall Study|Lost to Follow-up|2|||
157189561|NCT01072500|567435223|FG000|Overall Study|Withdrawal by Subject|17|||
157189562|NCT01072500|567435224|FG001|Overall Study|Withdrawal by Subject|10|||
157189563|NCT03798366|567435225|FG000|Overall Study|Lost to Follow-up|0|||
157189564|NCT03798366|567435226|FG001|Overall Study|Lost to Follow-up|1|||
157189565|NCT00811395|567435227|FG000|Extension Treatment|Adverse Event|1|||
157189566|NCT00811395|567435228|FG001|Extension Treatment|Adverse Event|2|||
157189567|NCT00811395|567435229|FG002|Extension Treatment|Adverse Event|2|||
157189568|NCT00811395|567435230|FG003|Extension Treatment|Adverse Event|2|||
157189569|NCT00811395|567435231|FG004|Extension Treatment|Adverse Event|0|||
157189570|NCT00811395|567435232|FG005|Extension Treatment|Adverse Event|1|||
157189571|NCT00811395|567435227|FG000|Extension Treatment|Progressive disease|1|||
157189572|NCT00811395|567435228|FG001|Extension Treatment|Progressive disease|1|||
157189573|NCT00811395|567435229|FG002|Extension Treatment|Progressive disease|0|||
157189574|NCT00811395|567435230|FG003|Extension Treatment|Progressive disease|0|||
157189575|NCT00811395|567435231|FG004|Extension Treatment|Progressive disease|0|||
157189576|NCT00811395|567435232|FG005|Extension Treatment|Progressive disease|0|||
157189577|NCT00811395|567435227|FG000|Extension Treatment|Participant did not wish to continue|0|||
157189578|NCT00811395|567435228|FG001|Extension Treatment|Participant did not wish to continue|3|||
157189579|NCT00811395|567435229|FG002|Extension Treatment|Participant did not wish to continue|0|||
157189580|NCT00811395|567435230|FG003|Extension Treatment|Participant did not wish to continue|1|||
157189581|NCT00811395|567435231|FG004|Extension Treatment|Participant did not wish to continue|0|||
157189582|NCT00811395|567435232|FG005|Extension Treatment|Participant did not wish to continue|1|||
157189583|NCT00811395|567435227|FG000|Extension Treatment|Other than above|0|||
157189584|NCT00811395|567435228|FG001|Extension Treatment|Other than above|0|||
157189585|NCT00811395|567435229|FG002|Extension Treatment|Other than above|1|||
157189586|NCT00811395|567435230|FG003|Extension Treatment|Other than above|0|||
157189587|NCT00811395|567435231|FG004|Extension Treatment|Other than above|0|||
157189588|NCT00811395|567435232|FG005|Extension Treatment|Other than above|0|||
157189589|NCT04652102|567435237|FG000|Overall Study|Adverse Event|14|||
157189590|NCT04652102|567435238|FG001|Overall Study|Adverse Event|13|||
157189591|NCT04652102|567435237|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
157189592|NCT04652102|567435238|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
157189593|NCT04652102|567435237|FG000|Overall Study|Physician Decision|78|||
157189594|NCT04652102|567435238|FG001|Overall Study|Physician Decision|40|||
157189595|NCT04652102|567435237|FG000|Overall Study|Study Ended by Sponsor|64|||
157189596|NCT04652102|567435238|FG001|Overall Study|Study Ended by Sponsor|17|||
157189597|NCT04652102|567435237|FG000|Overall Study|Withdrawal by Subject|4625|||
157189598|NCT04652102|567435238|FG001|Overall Study|Withdrawal by Subject|5594|||
157189599|NCT04652102|567435237|FG000|Overall Study|Lost to Follow-up|2019|||
157189600|NCT04652102|567435238|FG001|Overall Study|Lost to Follow-up|1082|||
157189601|NCT04652102|567435237|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
157189602|NCT04652102|567435238|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
157189603|NCT04652102|567435237|FG000|Overall Study|Miscellaneous|80|||
157189604|NCT04652102|567435238|FG001|Overall Study|Miscellaneous|64|||
157189605|NCT01657253|567435239|FG000|Overall Study|Lost to Follow-up|6|||
157189606|NCT01657253|567435240|FG001|Overall Study|Lost to Follow-up|5|||
157189607|NCT01657253|567435239|FG000|Overall Study|Withdrawal by Subject|11|||
157189608|NCT01657253|567435240|FG001|Overall Study|Withdrawal by Subject|12|||
157189609|NCT01657253|567435239|FG000|Overall Study|Adverse Event|0|||
157189610|NCT01657253|567435240|FG001|Overall Study|Adverse Event|1|||
157189611|NCT02364999|567435241|FG000|Overall Study|Death|136|||
157068748|NCT01296555|567006126|FG027|Overall Study|Study Terminated By Sponsor|0|||
157068749|NCT01296555|567006127|FG028|Overall Study|Study Terminated By Sponsor|0|||
157068750|NCT01296555|567006099|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068751|NCT01296555|567006100|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068752|NCT01296555|567006101|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068753|NCT01296555|567006102|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068754|NCT01296555|567006103|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068755|NCT01296555|567006104|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068756|NCT01296555|567006105|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068757|NCT01296555|567006106|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068758|NCT01296555|567006107|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068759|NCT01296555|567006108|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068760|NCT01296555|567006109|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068761|NCT01296555|567006110|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068762|NCT01296555|567006111|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068763|NCT01296555|567006112|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068764|NCT01296555|567006113|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068765|NCT01296555|567006114|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068766|NCT01296555|567006115|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068767|NCT01296555|567006116|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068768|NCT01296555|567006117|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068769|NCT01296555|567006118|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
157068770|NCT01296555|567006119|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068771|NCT01296555|567006120|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068772|NCT01296555|567006121|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068773|NCT01296555|567006122|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068774|NCT01296555|567006123|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068775|NCT01296555|567006124|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068776|NCT01296555|567006125|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068777|NCT01296555|567006126|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068778|NCT01296555|567006127|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
157068779|NCT01296555|567006099|FG000|Overall Study|Death|0|||
157068780|NCT01296555|567006100|FG001|Overall Study|Death|0|||
157068781|NCT01296555|567006101|FG002|Overall Study|Death|0|||
157068782|NCT01296555|567006102|FG003|Overall Study|Death|2|||
157068783|NCT01296555|567006103|FG004|Overall Study|Death|1|||
157068784|NCT01296555|567006104|FG005|Overall Study|Death|0|||
157068785|NCT01296555|567006105|FG006|Overall Study|Death|2|||
157068786|NCT01296555|567006106|FG007|Overall Study|Death|0|||
157068787|NCT01296555|567006107|FG008|Overall Study|Death|0|||
157068788|NCT01296555|567006108|FG009|Overall Study|Death|1|||
157068789|NCT01296555|567006109|FG010|Overall Study|Death|0|||
157068790|NCT01296555|567006110|FG011|Overall Study|Death|1|||
157068791|NCT01296555|567006111|FG012|Overall Study|Death|0|||
157068792|NCT01296555|567006112|FG013|Overall Study|Death|2|||
157068793|NCT01296555|567006113|FG014|Overall Study|Death|27|||
157068794|NCT01296555|567006114|FG015|Overall Study|Death|15|||
157068795|NCT01296555|567006115|FG016|Overall Study|Death|11|||
157068796|NCT01296555|567006116|FG017|Overall Study|Death|11|||
157068797|NCT01296555|567006117|FG018|Overall Study|Death|17|||
157068798|NCT01296555|567006118|FG019|Overall Study|Death|12|||
157068799|NCT01296555|567006119|FG020|Overall Study|Death|13|||
157068800|NCT01296555|567006120|FG021|Overall Study|Death|12|||
157068801|NCT01296555|567006121|FG022|Overall Study|Death|12|||
157068802|NCT01296555|567006122|FG023|Overall Study|Death|13|||
157068803|NCT01296555|567006123|FG024|Overall Study|Death|7|||
157068804|NCT01296555|567006124|FG025|Overall Study|Death|7|||
157068805|NCT01296555|567006125|FG026|Overall Study|Death|35|||
157189612|NCT02364999|567435242|FG001|Overall Study|Death|138|||
157189613|NCT02364999|567435241|FG000|Overall Study|Lost to Follow-up|10|||
157189614|NCT02364999|567435242|FG001|Overall Study|Lost to Follow-up|15|||
157189615|NCT02364999|567435241|FG000|Overall Study|Protocol Violation|3|||
157189616|NCT02364999|567435242|FG001|Overall Study|Protocol Violation|2|||
157068806|NCT01296555|567006126|FG027|Overall Study|Death|92|||
157068807|NCT01296555|567006127|FG028|Overall Study|Death|44|||
157068808|NCT01296555|567006099|FG000|Overall Study|Lost to Follow-up|0|||
157068809|NCT01296555|567006100|FG001|Overall Study|Lost to Follow-up|0|||
157068810|NCT01296555|567006101|FG002|Overall Study|Lost to Follow-up|0|||
157189617|NCT02364999|567435241|FG000|Overall Study|Withdrawal by Subject|14|||
157068811|NCT01296555|567006102|FG003|Overall Study|Lost to Follow-up|0|||
157068812|NCT01296555|567006103|FG004|Overall Study|Lost to Follow-up|0|||
157068813|NCT01296555|567006104|FG005|Overall Study|Lost to Follow-up|0|||
157068814|NCT01296555|567006105|FG006|Overall Study|Lost to Follow-up|0|||
157068815|NCT01296555|567006106|FG007|Overall Study|Lost to Follow-up|0|||
157068816|NCT01296555|567006107|FG008|Overall Study|Lost to Follow-up|0|||
157068817|NCT01296555|567006108|FG009|Overall Study|Lost to Follow-up|0|||
157068818|NCT01296555|567006109|FG010|Overall Study|Lost to Follow-up|0|||
157068819|NCT01296555|567006110|FG011|Overall Study|Lost to Follow-up|0|||
157189618|NCT02364999|567435242|FG001|Overall Study|Withdrawal by Subject|14|||
157189619|NCT02364999|567435241|FG000|Overall Study|Other|0|||
157189620|NCT02364999|567435242|FG001|Overall Study|Other|1|||
157189621|NCT02364999|567435241|FG000|Overall Study|Randomized but did not receive treatment|2|||
157189622|NCT02364999|567435242|FG001|Overall Study|Randomized but did not receive treatment|3|||
157189623|NCT00550615|567435243|FG000|Overall Study|Withdrawal by Subject|0|||
157189624|NCT00550615|567435244|FG001|Overall Study|Withdrawal by Subject|0|||
157189625|NCT00550615|567435245|FG002|Overall Study|Withdrawal by Subject|2|||
157189626|NCT00550615|567435246|FG003|Overall Study|Withdrawal by Subject|3|||
157189627|NCT00550615|567435243|FG000|Overall Study|Not evaluable|0|||
157189628|NCT00550615|567435244|FG001|Overall Study|Not evaluable|0|||
157189629|NCT00550615|567435245|FG002|Overall Study|Not evaluable|2|||
157189630|NCT00550615|567435246|FG003|Overall Study|Not evaluable|7|||
157189631|NCT00890201|567435249|FG000|Overall Study|Protocol Violation|5|||
157189632|NCT00890201|567435250|FG001|Overall Study|Protocol Violation|56|||
157189633|NCT02181504|567435251|FG000|Overall Study|Adverse Event|1|||
157189634|NCT02181504|567435252|FG001|Overall Study|Adverse Event|1|||
157189635|NCT02181504|567435253|FG002|Overall Study|Adverse Event|1|||
157189636|NCT01469637|567435260|FG000|First Intervention|Unacceptable behavior|0|||
157189637|NCT01469637|567435261|FG001|First Intervention|Unacceptable behavior|1|||
157189638|NCT01469637|567435260|FG000|Second Intervention|Incarcerated|1|||
157189639|NCT01469637|567435261|FG001|Second Intervention|Incarcerated|0|||
157189640|NCT01371721|567435262|FG000|Overall Study|Adverse Event|5|||
157189641|NCT01371721|567435263|FG001|Overall Study|Adverse Event|4|||
157189642|NCT01371721|567435264|FG002|Overall Study|Adverse Event|5|||
157189643|NCT01371721|567435262|FG000|Overall Study|Protocol Violation|6|||
157189644|NCT01371721|567435263|FG001|Overall Study|Protocol Violation|4|||
157189645|NCT01371721|567435264|FG002|Overall Study|Protocol Violation|5|||
157189646|NCT01371721|567435262|FG000|Overall Study|Lost to Follow-up|8|||
157189647|NCT01371721|567435263|FG001|Overall Study|Lost to Follow-up|2|||
157189648|NCT01371721|567435264|FG002|Overall Study|Lost to Follow-up|6|||
157189649|NCT01371721|567435262|FG000|Overall Study|Withdrawal by Subject|5|||
157189650|NCT01371721|567435263|FG001|Overall Study|Withdrawal by Subject|7|||
157189651|NCT01371721|567435264|FG002|Overall Study|Withdrawal by Subject|11|||
157189652|NCT01371721|567435262|FG000|Overall Study|Other|2|||
157189653|NCT01371721|567435263|FG001|Overall Study|Other|3|||
157189654|NCT01371721|567435264|FG002|Overall Study|Other|0|||
157189655|NCT01371721|567435262|FG000|Overall Study|Lack of Efficacy|2|||
157068820|NCT01296555|567006111|FG012|Overall Study|Lost to Follow-up|0|||
157068821|NCT01296555|567006112|FG013|Overall Study|Lost to Follow-up|0|||
157068822|NCT01296555|567006113|FG014|Overall Study|Lost to Follow-up|2|||
157068823|NCT01296555|567006114|FG015|Overall Study|Lost to Follow-up|1|||
157068824|NCT01296555|567006115|FG016|Overall Study|Lost to Follow-up|0|||
157068825|NCT01296555|567006116|FG017|Overall Study|Lost to Follow-up|2|||
157068826|NCT01296555|567006117|FG018|Overall Study|Lost to Follow-up|0|||
157189656|NCT01371721|567435263|FG001|Overall Study|Lack of Efficacy|4|||
157189657|NCT01371721|567435264|FG002|Overall Study|Lack of Efficacy|3|||
157189658|NCT01371721|567435262|FG000|Overall Study|Randomized but not treated|1|||
157189659|NCT01371721|567435263|FG001|Overall Study|Randomized but not treated|0|||
157189660|NCT01371721|567435264|FG002|Overall Study|Randomized but not treated|0|||
157189661|NCT00545584|567435265|FG000|Overall Study|Only one reason for discontinuation|62|||
157189662|NCT00545584|567435266|FG001|Overall Study|Only one reason for discontinuation|61|||
157189663|NCT00545584|567435267|FG002|Overall Study|Only one reason for discontinuation|48|||
157189664|NCT00545584|567435265|FG000|Overall Study|Two or more reasons for discontinuation|17|||
157189665|NCT00545584|567435266|FG001|Overall Study|Two or more reasons for discontinuation|19|||
157189666|NCT00545584|567435267|FG002|Overall Study|Two or more reasons for discontinuation|8|||
157189667|NCT00135694|567435273|FG000|Overall Study|Adverse Event|17|||
157189668|NCT00135694|567435274|FG001|Overall Study|Adverse Event|4|||
157189669|NCT00135694|567435275|FG002|Overall Study|Adverse Event|0|||
157189670|NCT00135694|567435273|FG000|Overall Study|Death|14|||
157189671|NCT00135694|567435274|FG001|Overall Study|Death|1|||
157189672|NCT00135694|567435275|FG002|Overall Study|Death|2|||
157189673|NCT00135694|567435273|FG000|Overall Study|Lost to Follow-up|8|||
157189674|NCT00135694|567435274|FG001|Overall Study|Lost to Follow-up|7|||
157189675|NCT00135694|567435275|FG002|Overall Study|Lost to Follow-up|1|||
157189676|NCT00135694|567435273|FG000|Overall Study|Withdrawal by Subject|41|||
157189677|NCT00135694|567435274|FG001|Overall Study|Withdrawal by Subject|7|||
157189678|NCT00135694|567435275|FG002|Overall Study|Withdrawal by Subject|4|||
157189679|NCT00135694|567435273|FG000|Overall Study|Protocol Violation|19|||
157189680|NCT00135694|567435274|FG001|Overall Study|Protocol Violation|1|||
157189681|NCT00135694|567435275|FG002|Overall Study|Protocol Violation|0|||
157189682|NCT00135694|567435273|FG000|Overall Study|Hepatitis C related reasons|39|||
157189683|NCT00135694|567435274|FG001|Overall Study|Hepatitis C related reasons|1|||
157068827|NCT01296555|567006118|FG019|Overall Study|Lost to Follow-up|2|||
157189684|NCT00135694|567435275|FG002|Overall Study|Hepatitis C related reasons|0|||
157189685|NCT00135694|567435273|FG000|Overall Study|Ineligible for Random assignment|42|||
157068828|NCT01296555|567006119|FG020|Overall Study|Lost to Follow-up|3|||
157189686|NCT00135694|567435274|FG001|Overall Study|Ineligible for Random assignment|0|||
157189687|NCT00135694|567435275|FG002|Overall Study|Ineligible for Random assignment|0|||
157189688|NCT02584660|567435276|FG000|Overall Study|Adverse Event|4|||
157189689|NCT02584660|567435277|FG001|Overall Study|Adverse Event|0|||
157189690|NCT02584660|567435276|FG000|Overall Study|Lost to Follow-up|3|||
157189691|NCT02584660|567435277|FG001|Overall Study|Lost to Follow-up|4|||
157189692|NCT02584660|567435276|FG000|Overall Study|Protocol Violation|0|||
157189693|NCT02584660|567435277|FG001|Overall Study|Protocol Violation|1|||
157189694|NCT02584660|567435276|FG000|Overall Study|Withdrawal by Subject|0|||
157189695|NCT02584660|567435277|FG001|Overall Study|Withdrawal by Subject|2|||
157189696|NCT02584660|567435276|FG000|Overall Study|Other|0|||
157189697|NCT02584660|567435277|FG001|Overall Study|Other|1|||
157189698|NCT00461552|567435278|FG000|Overall Study|Drug Dispensing error|0|||
157189699|NCT00461552|567435279|FG001|Overall Study|Drug Dispensing error|2|||
157189700|NCT00660816|567435280|FG000|Overall Study|Adverse Event|1|||
157189701|NCT00660816|567435281|FG001|Overall Study|Adverse Event|2|||
157189702|NCT00660816|567435280|FG000|Overall Study|Withdrawal by Subject|1|||
157189703|NCT00660816|567435281|FG001|Overall Study|Withdrawal by Subject|0|||
157189704|NCT00660816|567435280|FG000|Overall Study|Death|0|||
157189705|NCT00660816|567435281|FG001|Overall Study|Death|2|||
157189706|NCT00660816|567435280|FG000|Overall Study|Lack of Efficacy|1|||
157189707|NCT00660816|567435281|FG001|Overall Study|Lack of Efficacy|0|||
157189708|NCT00660816|567435280|FG000|Overall Study|Physician Decision|0|||
157189709|NCT00660816|567435281|FG001|Overall Study|Physician Decision|2|||
157189710|NCT00660816|567435280|FG000|Overall Study|Protocol Violation|1|||
157189711|NCT00660816|567435281|FG001|Overall Study|Protocol Violation|0|||
157189712|NCT00660816|567435280|FG000|Overall Study|Disease Progression|16|||
157189713|NCT00660816|567435281|FG001|Overall Study|Disease Progression|12|||
157189714|NCT00660816|567435280|FG000|Overall Study|Complicating Disease|0|||
157189715|NCT00660816|567435281|FG001|Overall Study|Complicating Disease|1|||
157189716|NCT00374452|567435282|FG000|Overall Study|Left clinic before intervention started|4|||
157189717|NCT00374452|567435283|FG001|Overall Study|Left clinic before intervention started|1|||
157189718|NCT00374452|567435282|FG000|Overall Study|Change in job role before intervention|0|||
157189719|NCT00374452|567435283|FG001|Overall Study|Change in job role before intervention|1|||
157189720|NCT00374452|567435282|FG000|Overall Study|Left clinic after intervention started|1|||
157189721|NCT00374452|567435283|FG001|Overall Study|Left clinic after intervention started|1|||
157189722|NCT00374452|567435282|FG000|Overall Study|Withdrawal by Subject|0|||
157189723|NCT00374452|567435283|FG001|Overall Study|Withdrawal by Subject|2|||
157189724|NCT02877134|567435284|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189725|NCT02877134|567435285|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
157189726|NCT02877134|567435286|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189727|NCT02877134|567435287|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189728|NCT02877134|567435288|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189729|NCT02877134|567435289|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
157189730|NCT02877134|567435290|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189731|NCT02877134|567435291|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189732|NCT02877134|567435292|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189733|NCT02877134|567435293|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189734|NCT02877134|567435294|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189735|NCT02877134|567435295|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
157189736|NCT02877134|567435284|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189737|NCT02877134|567435285|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
157189738|NCT02877134|567435286|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189739|NCT02877134|567435287|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
157189740|NCT02877134|567435288|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189741|NCT02877134|567435289|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189742|NCT02877134|567435290|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
157189743|NCT02877134|567435291|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189744|NCT02877134|567435292|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189745|NCT02877134|567435293|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189746|NCT02877134|567435294|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189747|NCT02877134|567435295|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
157189748|NCT02877134|567435284|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
157189749|NCT02877134|567435285|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
157189750|NCT02877134|567435286|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
157189751|NCT02877134|567435287|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
157230303|NCT04455633|567590572|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
157189752|NCT02877134|567435288|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
157230304|NCT04455633|567590570|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
157189753|NCT02877134|567435289|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
157189754|NCT02877134|567435290|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
157189755|NCT02877134|567435291|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
157189756|NCT02877134|567435292|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
157189757|NCT02877134|567435293|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
157189758|NCT02877134|567435294|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
157189759|NCT02877134|567435295|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
157189760|NCT02877134|567435284|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
157189761|NCT02877134|567435285|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
157189762|NCT02877134|567435286|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
157189763|NCT02877134|567435287|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
157189764|NCT02877134|567435288|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
157230305|NCT04455633|567590571|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
157189765|NCT02877134|567435289|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
157189766|NCT02877134|567435290|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
157189767|NCT02877134|567435291|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
157189768|NCT02877134|567435292|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
157189769|NCT02877134|567435293|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
157189770|NCT02877134|567435294|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
157189771|NCT02877134|567435295|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
157189772|NCT02877134|567435284|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189773|NCT02877134|567435285|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189774|NCT02877134|567435286|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189775|NCT02877134|567435287|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189776|NCT02877134|567435288|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189777|NCT02877134|567435289|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189778|NCT02877134|567435290|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189779|NCT02877134|567435291|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189780|NCT02877134|567435292|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
157189781|NCT02877134|567435293|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189782|NCT02877134|567435294|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189783|NCT02877134|567435295|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
157189784|NCT02877134|567435284|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189785|NCT02877134|567435285|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189786|NCT02877134|567435286|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189787|NCT02877134|567435287|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189788|NCT02877134|567435288|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189789|NCT02877134|567435289|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189790|NCT02877134|567435290|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
157189791|NCT02877134|567435291|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
157189792|NCT02877134|567435292|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
157189793|NCT02877134|567435293|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
157189794|NCT02877134|567435294|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
157189795|NCT02877134|567435295|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
157189796|NCT02877134|567435284|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189797|NCT02877134|567435285|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189798|NCT02877134|567435286|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189799|NCT02877134|567435287|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189800|NCT02877134|567435288|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189801|NCT02877134|567435289|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189802|NCT02877134|567435290|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189803|NCT02877134|567435291|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
157189804|NCT02877134|567435292|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
157189805|NCT02877134|567435293|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
157189806|NCT02877134|567435294|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189807|NCT02877134|567435295|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
157189808|NCT02877134|567435284|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
157189809|NCT02877134|567435285|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
157189810|NCT02877134|567435286|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
157189811|NCT02877134|567435287|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
157189812|NCT02877134|567435288|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
157189813|NCT02877134|567435289|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
157189814|NCT02877134|567435290|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
157189815|NCT02877134|567435291|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
157189816|NCT02877134|567435292|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
157189817|NCT02877134|567435293|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
157189818|NCT02877134|567435294|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
157189819|NCT02877134|567435295|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
157189820|NCT00523744|567435296|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
157189821|NCT00523744|567435296|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
157189822|NCT00523744|567435296|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
157189823|NCT00523744|567435296|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
157189824|NCT00523744|567435296|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
157189825|NCT00523744|567435296|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
157189826|NCT01289028|567435297|FG000|Overall Study|Progressive Disease|49|||
157189827|NCT01289028|567435297|FG000|Overall Study|Adverse Event|14|||
157189828|NCT01289028|567435297|FG000|Overall Study|Withdrawal by Subject|6|||
157189829|NCT01289028|567435297|FG000|Overall Study|Death|4|||
157189830|NCT01289028|567435297|FG000|Overall Study|Lack of Efficacy|2|||
157189831|NCT01289028|567435297|FG000|Overall Study|No longer required|2|||
157189832|NCT01289028|567435297|FG000|Overall Study|Lost to Follow-up|2|||
157189833|NCT01289028|567435297|FG000|Overall Study|New Cancer Therapy|2|||
157189834|NCT01289028|567435297|FG000|Overall Study|Abnormal Lab Value|1|||
157189835|NCT01289028|567435297|FG000|Overall Study|Missing reason for discon|1|||
157189836|NCT01055457|567435298|FG000|Overall Study|Lost to Follow-up|0|||
157189837|NCT01055457|567435299|FG001|Overall Study|Lost to Follow-up|1|||
157189838|NCT01055457|567435300|FG002|Overall Study|Lost to Follow-up|0|||
157189839|NCT01055457|567435301|FG003|Overall Study|Lost to Follow-up|0|||
157189840|NCT01055457|567435302|FG004|Overall Study|Lost to Follow-up|0|||
157189841|NCT01055457|567435303|FG005|Overall Study|Lost to Follow-up|1|||
157189842|NCT01055457|567435304|FG006|Overall Study|Lost to Follow-up|0|||
157189843|NCT01055457|567435305|FG007|Overall Study|Lost to Follow-up|0|||
157189844|NCT01055457|567435306|FG008|Overall Study|Lost to Follow-up|0|||
157189845|NCT01055457|567435307|FG009|Overall Study|Lost to Follow-up|0|||
157189846|NCT01055457|567435298|FG000|Overall Study|Protocol Violation|0|||
157189847|NCT01055457|567435299|FG001|Overall Study|Protocol Violation|0|||
157189848|NCT01055457|567435300|FG002|Overall Study|Protocol Violation|1|||
157189849|NCT01055457|567435301|FG003|Overall Study|Protocol Violation|1|||
157189850|NCT01055457|567435302|FG004|Overall Study|Protocol Violation|1|||
157189851|NCT01055457|567435303|FG005|Overall Study|Protocol Violation|2|||
157189852|NCT01055457|567435304|FG006|Overall Study|Protocol Violation|1|||
157189853|NCT01055457|567435305|FG007|Overall Study|Protocol Violation|0|||
157189854|NCT01055457|567435306|FG008|Overall Study|Protocol Violation|0|||
157189855|NCT01055457|567435307|FG009|Overall Study|Protocol Violation|1|||
157189856|NCT01055457|567435298|FG000|Overall Study|Subject Disinterest|0|||
157189857|NCT01055457|567435299|FG001|Overall Study|Subject Disinterest|0|||
157189858|NCT01055457|567435300|FG002|Overall Study|Subject Disinterest|0|||
157189859|NCT01055457|567435301|FG003|Overall Study|Subject Disinterest|0|||
157189860|NCT01055457|567435302|FG004|Overall Study|Subject Disinterest|0|||
157189861|NCT01055457|567435303|FG005|Overall Study|Subject Disinterest|0|||
157189862|NCT01055457|567435304|FG006|Overall Study|Subject Disinterest|0|||
157189863|NCT01055457|567435305|FG007|Overall Study|Subject Disinterest|1|||
157189864|NCT01055457|567435306|FG008|Overall Study|Subject Disinterest|0|||
157189865|NCT01055457|567435307|FG009|Overall Study|Subject Disinterest|0|||
157189866|NCT01055457|567435298|FG000|Overall Study|Subject Ineligible|1|||
157189867|NCT01055457|567435299|FG001|Overall Study|Subject Ineligible|0|||
157189868|NCT01055457|567435300|FG002|Overall Study|Subject Ineligible|1|||
157189869|NCT01055457|567435301|FG003|Overall Study|Subject Ineligible|0|||
157189870|NCT01055457|567435302|FG004|Overall Study|Subject Ineligible|1|||
157189871|NCT01055457|567435303|FG005|Overall Study|Subject Ineligible|0|||
157189872|NCT01055457|567435304|FG006|Overall Study|Subject Ineligible|0|||
157189873|NCT01055457|567435305|FG007|Overall Study|Subject Ineligible|0|||
157189874|NCT01055457|567435306|FG008|Overall Study|Subject Ineligible|0|||
157189875|NCT01055457|567435307|FG009|Overall Study|Subject Ineligible|0|||
157189876|NCT01055457|567435298|FG000|Overall Study|Discomfort|0|||
157189877|NCT01055457|567435299|FG001|Overall Study|Discomfort|0|||
157189878|NCT01055457|567435300|FG002|Overall Study|Discomfort|0|||
157189879|NCT01055457|567435301|FG003|Overall Study|Discomfort|0|||
157189880|NCT01055457|567435302|FG004|Overall Study|Discomfort|1|||
157189881|NCT01055457|567435303|FG005|Overall Study|Discomfort|0|||
157189882|NCT01055457|567435304|FG006|Overall Study|Discomfort|0|||
157189883|NCT01055457|567435305|FG007|Overall Study|Discomfort|0|||
157189884|NCT01055457|567435306|FG008|Overall Study|Discomfort|0|||
157189885|NCT01055457|567435307|FG009|Overall Study|Discomfort|0|||
157189886|NCT01055457|567435298|FG000|Overall Study|Pregnancy|0|||
157189887|NCT01055457|567435299|FG001|Overall Study|Pregnancy|0|||
157189888|NCT01055457|567435300|FG002|Overall Study|Pregnancy|0|||
157189889|NCT01055457|567435301|FG003|Overall Study|Pregnancy|1|||
157189890|NCT01055457|567435302|FG004|Overall Study|Pregnancy|0|||
157189891|NCT01055457|567435303|FG005|Overall Study|Pregnancy|0|||
157189892|NCT01055457|567435304|FG006|Overall Study|Pregnancy|0|||
157189893|NCT01055457|567435305|FG007|Overall Study|Pregnancy|0|||
157230306|NCT04455633|567590572|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
157189894|NCT01055457|567435306|FG008|Overall Study|Pregnancy|0|||
157189895|NCT01055457|567435307|FG009|Overall Study|Pregnancy|0|||
157189896|NCT01055457|567435298|FG000|Overall Study|Adverse Event|0|||
157189897|NCT01055457|567435299|FG001|Overall Study|Adverse Event|0|||
157189898|NCT01055457|567435300|FG002|Overall Study|Adverse Event|0|||
157189899|NCT01055457|567435301|FG003|Overall Study|Adverse Event|1|||
157189900|NCT01055457|567435302|FG004|Overall Study|Adverse Event|0|||
157189901|NCT01055457|567435303|FG005|Overall Study|Adverse Event|0|||
157189902|NCT01055457|567435304|FG006|Overall Study|Adverse Event|0|||
157189903|NCT01055457|567435305|FG007|Overall Study|Adverse Event|0|||
157068829|NCT01296555|567006120|FG021|Overall Study|Lost to Follow-up|2|||
157068830|NCT01296555|567006121|FG022|Overall Study|Lost to Follow-up|0|||
157068831|NCT01296555|567006122|FG023|Overall Study|Lost to Follow-up|0|||
157068832|NCT01296555|567006123|FG024|Overall Study|Lost to Follow-up|0|||
157068833|NCT01296555|567006124|FG025|Overall Study|Lost to Follow-up|0|||
157068834|NCT01296555|567006125|FG026|Overall Study|Lost to Follow-up|3|||
157068835|NCT01296555|567006126|FG027|Overall Study|Lost to Follow-up|13|||
157068836|NCT01296555|567006127|FG028|Overall Study|Lost to Follow-up|5|||
157068837|NCT01296555|567006099|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157068838|NCT01296555|567006100|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157068839|NCT01296555|567006101|FG002|Overall Study|Non-Compliance With Study Drug|0|||
157068840|NCT01296555|567006102|FG003|Overall Study|Non-Compliance With Study Drug|0|||
157068841|NCT01296555|567006103|FG004|Overall Study|Non-Compliance With Study Drug|0|||
157068842|NCT01296555|567006104|FG005|Overall Study|Non-Compliance With Study Drug|0|||
157068843|NCT01296555|567006105|FG006|Overall Study|Non-Compliance With Study Drug|0|||
157068844|NCT01296555|567006106|FG007|Overall Study|Non-Compliance With Study Drug|1|||
157068845|NCT01296555|567006107|FG008|Overall Study|Non-Compliance With Study Drug|0|||
157068846|NCT01296555|567006108|FG009|Overall Study|Non-Compliance With Study Drug|0|||
157068847|NCT01296555|567006109|FG010|Overall Study|Non-Compliance With Study Drug|0|||
157068848|NCT01296555|567006110|FG011|Overall Study|Non-Compliance With Study Drug|0|||
157068849|NCT01296555|567006111|FG012|Overall Study|Non-Compliance With Study Drug|0|||
157068850|NCT01296555|567006112|FG013|Overall Study|Non-Compliance With Study Drug|0|||
157068851|NCT01296555|567006113|FG014|Overall Study|Non-Compliance With Study Drug|0|||
157068852|NCT01296555|567006114|FG015|Overall Study|Non-Compliance With Study Drug|0|||
157068853|NCT01296555|567006115|FG016|Overall Study|Non-Compliance With Study Drug|0|||
157068854|NCT01296555|567006116|FG017|Overall Study|Non-Compliance With Study Drug|0|||
157068855|NCT01296555|567006117|FG018|Overall Study|Non-Compliance With Study Drug|0|||
157068856|NCT01296555|567006118|FG019|Overall Study|Non-Compliance With Study Drug|0|||
157068857|NCT01296555|567006119|FG020|Overall Study|Non-Compliance With Study Drug|0|||
157068858|NCT01296555|567006120|FG021|Overall Study|Non-Compliance With Study Drug|0|||
157068859|NCT01296555|567006121|FG022|Overall Study|Non-Compliance With Study Drug|0|||
157068860|NCT01296555|567006122|FG023|Overall Study|Non-Compliance With Study Drug|0|||
157068861|NCT01296555|567006123|FG024|Overall Study|Non-Compliance With Study Drug|0|||
157068862|NCT01296555|567006124|FG025|Overall Study|Non-Compliance With Study Drug|0|||
157068863|NCT01296555|567006125|FG026|Overall Study|Non-Compliance With Study Drug|0|||
157068864|NCT01296555|567006126|FG027|Overall Study|Non-Compliance With Study Drug|0|||
157068865|NCT01296555|567006127|FG028|Overall Study|Non-Compliance With Study Drug|0|||
157068866|NCT01296555|567006099|FG000|Overall Study|Withdrawal by Subject|0|||
157068867|NCT01296555|567006100|FG001|Overall Study|Withdrawal by Subject|0|||
157068868|NCT01296555|567006101|FG002|Overall Study|Withdrawal by Subject|0|||
157068869|NCT01296555|567006102|FG003|Overall Study|Withdrawal by Subject|0|||
157068870|NCT01296555|567006103|FG004|Overall Study|Withdrawal by Subject|1|||
157068871|NCT01296555|567006104|FG005|Overall Study|Withdrawal by Subject|0|||
157068872|NCT01296555|567006105|FG006|Overall Study|Withdrawal by Subject|1|||
157068873|NCT01296555|567006106|FG007|Overall Study|Withdrawal by Subject|0|||
157068874|NCT01296555|567006107|FG008|Overall Study|Withdrawal by Subject|0|||
157068875|NCT01296555|567006108|FG009|Overall Study|Withdrawal by Subject|0|||
157068876|NCT01296555|567006109|FG010|Overall Study|Withdrawal by Subject|1|||
157068877|NCT01296555|567006110|FG011|Overall Study|Withdrawal by Subject|1|||
157068878|NCT01296555|567006111|FG012|Overall Study|Withdrawal by Subject|0|||
157068879|NCT01296555|567006112|FG013|Overall Study|Withdrawal by Subject|0|||
157068880|NCT01296555|567006113|FG014|Overall Study|Withdrawal by Subject|3|||
157068881|NCT01296555|567006114|FG015|Overall Study|Withdrawal by Subject|0|||
157068882|NCT01296555|567006115|FG016|Overall Study|Withdrawal by Subject|2|||
157068883|NCT01296555|567006116|FG017|Overall Study|Withdrawal by Subject|1|||
157068884|NCT01296555|567006117|FG018|Overall Study|Withdrawal by Subject|0|||
157068885|NCT01296555|567006118|FG019|Overall Study|Withdrawal by Subject|1|||
157068886|NCT01296555|567006119|FG020|Overall Study|Withdrawal by Subject|1|||
157068887|NCT01296555|567006120|FG021|Overall Study|Withdrawal by Subject|1|||
157068888|NCT01296555|567006121|FG022|Overall Study|Withdrawal by Subject|3|||
157068889|NCT01296555|567006122|FG023|Overall Study|Withdrawal by Subject|0|||
157068890|NCT01296555|567006123|FG024|Overall Study|Withdrawal by Subject|0|||
157068891|NCT01296555|567006124|FG025|Overall Study|Withdrawal by Subject|0|||
157068892|NCT01296555|567006125|FG026|Overall Study|Withdrawal by Subject|8|||
157068893|NCT01296555|567006126|FG027|Overall Study|Withdrawal by Subject|4|||
157068894|NCT01296555|567006127|FG028|Overall Study|Withdrawal by Subject|2|||
157068895|NCT02250534|567006128|FG000|Overall Study|Lost to Follow-up|18|||
157068896|NCT02250534|567006129|FG001|Overall Study|Lost to Follow-up|28|||
157068897|NCT02250534|567006130|FG002|Overall Study|Lost to Follow-up|33|||
157068898|NCT02250534|567006128|FG000|Overall Study|Personal reasons|7|||
157068899|NCT02250534|567006129|FG001|Overall Study|Personal reasons|8|||
157068900|NCT02250534|567006130|FG002|Overall Study|Personal reasons|14|||
157068901|NCT02250534|567006128|FG000|Overall Study|Adverse Event|6|||
157068902|NCT02250534|567006129|FG001|Overall Study|Adverse Event|3|||
157068903|NCT02250534|567006130|FG002|Overall Study|Adverse Event|8|||
157068904|NCT02250534|567006128|FG000|Overall Study|incarcerated|2|||
157068905|NCT02250534|567006129|FG001|Overall Study|incarcerated|1|||
157068906|NCT02250534|567006130|FG002|Overall Study|incarcerated|2|||
157068907|NCT02250534|567006128|FG000|Overall Study|Withdrawal by Subject|0|||
157068908|NCT02250534|567006129|FG001|Overall Study|Withdrawal by Subject|1|||
157068909|NCT02250534|567006130|FG002|Overall Study|Withdrawal by Subject|2|||
157068910|NCT02250534|567006128|FG000|Overall Study|Death|0|||
157068911|NCT02250534|567006129|FG001|Overall Study|Death|1|||
157068912|NCT02250534|567006130|FG002|Overall Study|Death|1|||
157068913|NCT02250534|567006128|FG000|Overall Study|Physician Decision|1|||
157068914|NCT02250534|567006129|FG001|Overall Study|Physician Decision|3|||
157068915|NCT02250534|567006130|FG002|Overall Study|Physician Decision|1|||
157068916|NCT02250534|567006128|FG000|Overall Study|Protocol Violation|1|||
157068917|NCT02250534|567006129|FG001|Overall Study|Protocol Violation|0|||
157068918|NCT02250534|567006130|FG002|Overall Study|Protocol Violation|1|||
157068919|NCT02250534|567006128|FG000|Overall Study|Reason unknown|1|||
157068920|NCT02250534|567006129|FG001|Overall Study|Reason unknown|0|||
157068921|NCT02250534|567006130|FG002|Overall Study|Reason unknown|0|||
157068922|NCT01101061|567006133|FG000|Overall Study|Adverse Event|0|||
157068923|NCT01101061|567006134|FG001|Overall Study|Adverse Event|0|||
157068924|NCT01101061|567006135|FG002|Overall Study|Adverse Event|1|||
157068925|NCT01101061|567006136|FG003|Overall Study|Adverse Event|0|||
157068926|NCT01101061|567006137|FG004|Overall Study|Adverse Event|0|||
157068927|NCT01101061|567006138|FG005|Overall Study|Adverse Event|0|||
157068928|NCT01587118|567006139|FG000|Overall Study|Adverse Event|3|||
157068929|NCT01587118|567006139|FG000|Overall Study|Lost to Follow-up|2|||
157068930|NCT01587118|567006139|FG000|Overall Study|Relocation|1|||
157068931|NCT01587118|567006139|FG000|Overall Study|nonresponse|1|||
157068932|NCT00537329|567006140|FG000|Overall Study|Death|10|||
157068933|NCT00537329|567006140|FG000|Overall Study|Adverse Event|3|||
157068934|NCT00537329|567006140|FG000|Overall Study|Lack of Efficacy|2|||
157068935|NCT00537329|567006140|FG000|Overall Study|Lost to Follow-up|6|||
157068936|NCT00537329|567006140|FG000|Overall Study|Withdrawal by Subject|4|||
157068937|NCT00537329|567006140|FG000|Overall Study|Other|1|||
157068938|NCT00778921|567006141|FG000|Overall Study|Adverse Event|9|||
157068939|NCT00778921|567006142|FG001|Overall Study|Adverse Event|10|||
157068940|NCT00778921|567006143|FG002|Overall Study|Adverse Event|14|||
157068941|NCT00778921|567006141|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
157068942|NCT00778921|567006142|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
157068943|NCT00778921|567006143|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
157068944|NCT00778921|567006141|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
157068945|NCT00778921|567006142|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
157068946|NCT00778921|567006143|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
157068947|NCT00778921|567006141|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
157068948|NCT00778921|567006142|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
157068949|NCT00778921|567006143|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
157068950|NCT00778921|567006141|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
157068951|NCT00778921|567006142|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
157068952|NCT00778921|567006143|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
157068953|NCT00778921|567006141|FG000|Overall Study|Patient withdrew request|3|||
157068954|NCT00778921|567006142|FG001|Overall Study|Patient withdrew request|1|||
157068955|NCT00778921|567006143|FG002|Overall Study|Patient withdrew request|6|||
157068956|NCT00778921|567006141|FG000|Overall Study|Lost to Follow-up|0|||
157068957|NCT00778921|567006142|FG001|Overall Study|Lost to Follow-up|2|||
157068958|NCT00778921|567006143|FG002|Overall Study|Lost to Follow-up|1|||
157068959|NCT00778921|567006141|FG000|Overall Study|Administrative Problems|1|||
157068960|NCT00778921|567006142|FG001|Overall Study|Administrative Problems|2|||
157068961|NCT00778921|567006143|FG002|Overall Study|Administrative Problems|0|||
157068962|NCT00778921|567006141|FG000|Overall Study|Protocol Violation|3|||
157068963|NCT00778921|567006142|FG001|Overall Study|Protocol Violation|0|||
157068964|NCT00778921|567006143|FG002|Overall Study|Protocol Violation|2|||
157068965|NCT00778921|567006141|FG000|Overall Study|Not treated|0|||
157068966|NCT00778921|567006142|FG001|Overall Study|Not treated|2|||
157068967|NCT00778921|567006143|FG002|Overall Study|Not treated|2|||
157068968|NCT00572533|567006144|FG000|Overall Study|Death|4|||
157068969|NCT00572533|567006145|FG001|Overall Study|Death|1|||
157068970|NCT00572533|567006144|FG000|Overall Study|Received Kidney Transplant|2|||
157068971|NCT00572533|567006145|FG001|Overall Study|Received Kidney Transplant|1|||
157068972|NCT00572533|567006144|FG000|Overall Study|Social Issues|1|||
157068973|NCT00572533|567006145|FG001|Overall Study|Social Issues|0|||
157068974|NCT00572533|567006144|FG000|Overall Study|Transfer out of Facility|0|||
157068975|NCT00572533|567006145|FG001|Overall Study|Transfer out of Facility|1|||
157230307|NCT04455633|567590570|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
157068976|NCT00003477|567006146|FG000|Overall Study|Not evalauable|4|||
157068977|NCT00267098|567006147|FG000|Overall Study|Death|0|||
157068978|NCT00267098|567006148|FG001|Overall Study|Death|0|||
157068979|NCT00267098|567006149|FG002|Overall Study|Death|57|||
157068980|NCT00267098|567006150|FG003|Overall Study|Death|66|||
157189904|NCT01055457|567435306|FG008|Overall Study|Adverse Event|0|||
157189905|NCT01055457|567435307|FG009|Overall Study|Adverse Event|0|||
157189906|NCT00998985|567435314|FG000|Overall Study|Withdrawal by Subject|0|||
157189907|NCT00998985|567435315|FG001|Overall Study|Withdrawal by Subject|0|||
157189908|NCT00998985|567435316|FG002|Overall Study|Withdrawal by Subject|0|||
157189909|NCT00998985|567435317|FG003|Overall Study|Withdrawal by Subject|0|||
157189910|NCT00998985|567435318|FG004|Overall Study|Withdrawal by Subject|0|||
157189911|NCT00998985|567435319|FG005|Overall Study|Withdrawal by Subject|0|||
157189912|NCT00998985|567435320|FG006|Overall Study|Withdrawal by Subject|0|||
157189913|NCT00998985|567435321|FG007|Overall Study|Withdrawal by Subject|0|||
157189914|NCT00998985|567435322|FG008|Overall Study|Withdrawal by Subject|1|||
157189915|NCT00998985|567435323|FG009|Overall Study|Withdrawal by Subject|0|||
157189916|NCT00998985|567435324|FG010|Overall Study|Withdrawal by Subject|0|||
157189917|NCT00998985|567435325|FG011|Overall Study|Withdrawal by Subject|0|||
157189918|NCT00998985|567435326|FG012|Overall Study|Withdrawal by Subject|0|||
157189919|NCT00998985|567435327|FG013|Overall Study|Withdrawal by Subject|0|||
157189920|NCT00998985|567435314|FG000|Overall Study|Protocol Violation|0|||
157189921|NCT00998985|567435315|FG001|Overall Study|Protocol Violation|0|||
157189922|NCT00998985|567435316|FG002|Overall Study|Protocol Violation|0|||
157189923|NCT00998985|567435317|FG003|Overall Study|Protocol Violation|0|||
157189924|NCT00998985|567435318|FG004|Overall Study|Protocol Violation|0|||
157189925|NCT00998985|567435319|FG005|Overall Study|Protocol Violation|1|||
157189926|NCT00998985|567435320|FG006|Overall Study|Protocol Violation|0|||
157189927|NCT00998985|567435321|FG007|Overall Study|Protocol Violation|0|||
157189928|NCT00998985|567435322|FG008|Overall Study|Protocol Violation|0|||
157189929|NCT00998985|567435323|FG009|Overall Study|Protocol Violation|0|||
157189930|NCT00998985|567435324|FG010|Overall Study|Protocol Violation|0|||
157189931|NCT00998985|567435325|FG011|Overall Study|Protocol Violation|0|||
157189932|NCT00998985|567435326|FG012|Overall Study|Protocol Violation|0|||
157189933|NCT00998985|567435327|FG013|Overall Study|Protocol Violation|0|||
157189934|NCT03147495|567435328|FG000|Overall Study|Physician Decision|0|||
157189935|NCT03147495|567435329|FG001|Overall Study|Physician Decision|6|||
157189936|NCT01024946|567435330|FG000|Overall Study|Screen Failure|3|||
157189937|NCT01024946|567435330|FG000|Overall Study|Withdrawal by Subject|1|||
157189938|NCT01024946|567435330|FG000|Overall Study|Adverse Event|1|||
157189939|NCT02483611|567435331|FG000|Overall Study|Protocol Violation|0|||
157189940|NCT02483611|567435332|FG001|Overall Study|Protocol Violation|0|||
157189941|NCT02483611|567435333|FG002|Overall Study|Protocol Violation|1|||
157189942|NCT02608892|567435334|FG000|Overall Study|Lost to Follow-up|1|||
157189943|NCT02608892|567435335|FG001|Overall Study|Lost to Follow-up|0|||
157189944|NCT00877890|567435336|FG000|Overall Study|Adverse Event|6|||
157189945|NCT00877890|567435337|FG001|Overall Study|Adverse Event|6|||
157189946|NCT00877890|567435336|FG000|Overall Study|Lost to Follow-up|5|||
157189947|NCT00877890|567435337|FG001|Overall Study|Lost to Follow-up|5|||
157189948|NCT00877890|567435336|FG000|Overall Study|Protocol Violation|0|||
157189949|NCT00877890|567435337|FG001|Overall Study|Protocol Violation|1|||
157189950|NCT00877890|567435336|FG000|Overall Study|Withdrawal of Consent|6|||
157189951|NCT00877890|567435337|FG001|Overall Study|Withdrawal of Consent|12|||
157189952|NCT00877890|567435336|FG000|Overall Study|Investigator Decision|0|||
157189953|NCT00877890|567435337|FG001|Overall Study|Investigator Decision|2|||
157189954|NCT00877890|567435336|FG000|Overall Study|Loss of Glucose Control|3|||
157189955|NCT00877890|567435337|FG001|Overall Study|Loss of Glucose Control|4|||
157189956|NCT00984009|567435338|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
157189957|NCT02520141|567435347|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
157189958|NCT02168816|567435350|FG000|Overall Study|Lost to Follow-up|2|||
157189959|NCT02168816|567435351|FG001|Overall Study|Lost to Follow-up|2|||
157189960|NCT01225211|567435352|FG000|Overall Study|Adverse Event|0|||
157189961|NCT01225211|567435353|FG001|Overall Study|Adverse Event|0|||
157189962|NCT01225211|567435354|FG002|Overall Study|Adverse Event|1|||
157189963|NCT01225211|567435355|FG003|Overall Study|Adverse Event|0|||
157189964|NCT01225211|567435356|FG004|Overall Study|Adverse Event|0|||
157189965|NCT01225211|567435357|FG005|Overall Study|Adverse Event|0|||
157189966|NCT01225211|567435358|FG006|Overall Study|Adverse Event|0|||
157068981|NCT00267098|567006151|FG004|Overall Study|Death|14|||
157068982|NCT00267098|567006152|FG005|Overall Study|Death|23|||
157189967|NCT01225211|567435359|FG007|Overall Study|Adverse Event|0|||
157189968|NCT01225211|567435360|FG008|Overall Study|Adverse Event|0|||
157189969|NCT01225211|567435361|FG009|Overall Study|Adverse Event|1|||
157189970|NCT01225211|567435352|FG000|Overall Study|Withdrawal by Subject|0|||
157068983|NCT00267098|567006153|FG006|Overall Study|Death|28|||
157068984|NCT00267098|567006154|FG007|Overall Study|Death|9|||
157189971|NCT01225211|567435353|FG001|Overall Study|Withdrawal by Subject|0|||
157189972|NCT01225211|567435354|FG002|Overall Study|Withdrawal by Subject|0|||
157189973|NCT01225211|567435355|FG003|Overall Study|Withdrawal by Subject|0|||
157189974|NCT01225211|567435356|FG004|Overall Study|Withdrawal by Subject|0|||
157189975|NCT01225211|567435357|FG005|Overall Study|Withdrawal by Subject|0|||
157189976|NCT01225211|567435358|FG006|Overall Study|Withdrawal by Subject|1|||
157189977|NCT01225211|567435359|FG007|Overall Study|Withdrawal by Subject|0|||
157068985|NCT00267098|567006147|FG000|Overall Study|Lost to Follow-up|0|||
157068986|NCT00267098|567006148|FG001|Overall Study|Lost to Follow-up|0|||
157068987|NCT00267098|567006149|FG002|Overall Study|Lost to Follow-up|6|||
157068988|NCT00267098|567006150|FG003|Overall Study|Lost to Follow-up|5|||
157068989|NCT00267098|567006151|FG004|Overall Study|Lost to Follow-up|2|||
157068990|NCT00267098|567006152|FG005|Overall Study|Lost to Follow-up|3|||
157189978|NCT01225211|567435360|FG008|Overall Study|Withdrawal by Subject|1|||
157189979|NCT01225211|567435361|FG009|Overall Study|Withdrawal by Subject|3|||
157189980|NCT01225211|567435352|FG000|Overall Study|Other|0|||
157189981|NCT01225211|567435353|FG001|Overall Study|Other|0|||
157189982|NCT01225211|567435354|FG002|Overall Study|Other|0|||
157189983|NCT01225211|567435355|FG003|Overall Study|Other|0|||
157189984|NCT01225211|567435356|FG004|Overall Study|Other|0|||
157189985|NCT01225211|567435357|FG005|Overall Study|Other|0|||
157189986|NCT01225211|567435358|FG006|Overall Study|Other|0|||
157189987|NCT01225211|567435359|FG007|Overall Study|Other|0|||
157189988|NCT01225211|567435360|FG008|Overall Study|Other|0|||
157189989|NCT01225211|567435361|FG009|Overall Study|Other|1|||
157189990|NCT00537810|567435366|FG000|Overall Study|Withdrawal by Subject|4|||
157189991|NCT00537810|567435367|FG001|Overall Study|Withdrawal by Subject|11|||
157189992|NCT00537810|567435368|FG002|Overall Study|Withdrawal by Subject|4|||
157189993|NCT00537810|567435369|FG003|Overall Study|Withdrawal by Subject|3|||
157189994|NCT00537810|567435366|FG000|Overall Study|Medically withdrawn|2|||
157189995|NCT00537810|567435367|FG001|Overall Study|Medically withdrawn|2|||
157189996|NCT00537810|567435368|FG002|Overall Study|Medically withdrawn|0|||
157189997|NCT00537810|567435369|FG003|Overall Study|Medically withdrawn|1|||
157189998|NCT01066546|567435370|FG000|Overall Study|Study terminated by sponsor|5|||
157189999|NCT03452397|567435371|FG000|Overall Study|Adverse Event|1|||
157190000|NCT03452397|567435372|FG001|Overall Study|Adverse Event|0|||
157190001|NCT03452397|567435373|FG002|Overall Study|Adverse Event|0|||
157190002|NCT03452397|567435374|FG003|Overall Study|Adverse Event|0|||
157190003|NCT03452397|567435371|FG000|Overall Study|Administrative reason|0|||
157190004|NCT03452397|567435372|FG001|Overall Study|Administrative reason|0|||
157190005|NCT03452397|567435373|FG002|Overall Study|Administrative reason|1|||
157190006|NCT03452397|567435374|FG003|Overall Study|Administrative reason|1|||
157190007|NCT03452397|567435371|FG000|Overall Study|Withdrawal by Subject|0|||
157190008|NCT03452397|567435372|FG001|Overall Study|Withdrawal by Subject|0|||
157190009|NCT03452397|567435373|FG002|Overall Study|Withdrawal by Subject|1|||
157190010|NCT03452397|567435374|FG003|Overall Study|Withdrawal by Subject|0|||
157190011|NCT00410514|567435375|FG000|Overall Study|Adverse Event|2|||
157190012|NCT00410514|567435376|FG001|Overall Study|Adverse Event|2|||
157190013|NCT00410514|567435377|FG002|Overall Study|Adverse Event|2|||
157190014|NCT00410514|567435375|FG000|Overall Study|Protocol Violation|0|||
157190015|NCT00410514|567435376|FG001|Overall Study|Protocol Violation|1|||
157190016|NCT00410514|567435377|FG002|Overall Study|Protocol Violation|1|||
157190017|NCT00410514|567435375|FG000|Overall Study|Lost to Follow-up|0|||
157190018|NCT00410514|567435376|FG001|Overall Study|Lost to Follow-up|0|||
157190019|NCT00410514|567435377|FG002|Overall Study|Lost to Follow-up|2|||
157190020|NCT00410514|567435375|FG000|Overall Study|Non-compliant with study procedures|0|||
157190021|NCT00410514|567435376|FG001|Overall Study|Non-compliant with study procedures|0|||
157190022|NCT00410514|567435377|FG002|Overall Study|Non-compliant with study procedures|2|||
157190023|NCT01436357|567435378|FG000|Overall Study|Death|5|||
157190024|NCT01436357|567435379|FG001|Overall Study|Death|1|||
157190025|NCT01436357|567435378|FG000|Overall Study|Enrolled but not vaccinated|1|||
157190026|NCT01436357|567435379|FG001|Overall Study|Enrolled but not vaccinated|1|||
157190027|NCT01436357|567435378|FG000|Overall Study|Incarceration|18|||
157190028|NCT01436357|567435379|FG001|Overall Study|Incarceration|20|||
157190029|NCT01436357|567435378|FG000|Overall Study|Lost to Follow-up|67|||
157190030|NCT01436357|567435379|FG001|Overall Study|Lost to Follow-up|61|||
157190031|NCT01436357|567435378|FG000|Overall Study|Protocol Violation|1|||
157190032|NCT01436357|567435379|FG001|Overall Study|Protocol Violation|0|||
157190033|NCT01436357|567435378|FG000|Overall Study|Withdrawal by Subject|26|||
157190034|NCT01436357|567435379|FG001|Overall Study|Withdrawal by Subject|38|||
157190035|NCT01436357|567435378|FG000|Overall Study|Physician Decision|3|||
157190036|NCT01436357|567435379|FG001|Overall Study|Physician Decision|4|||
157190037|NCT01436357|567435378|FG000|Overall Study|Moved out of area|1|||
157190038|NCT01436357|567435379|FG001|Overall Study|Moved out of area|2|||
157190039|NCT01436357|567435378|FG000|Overall Study|Subject in rehab|0|||
157190040|NCT01436357|567435379|FG001|Overall Study|Subject in rehab|1|||
157190041|NCT02390167|567436578|FG000|Overall Study|Lost to Follow-up|1|||
157190042|NCT01265719|567436580|FG000|Overall Study|Does not meet entrance criteria|0|||
157190043|NCT01265719|567436581|FG001|Overall Study|Does not meet entrance criteria|3|||
157190044|NCT01265719|567436580|FG000|Overall Study|Other reasons|2|||
157190045|NCT01265719|567436581|FG001|Overall Study|Other reasons|0|||
157068991|NCT00267098|567006153|FG006|Overall Study|Lost to Follow-up|1|||
157068992|NCT00267098|567006154|FG007|Overall Study|Lost to Follow-up|1|||
157190046|NCT01265719|567436580|FG000|Overall Study|Withdrawal by Subject|8|||
157190047|NCT01265719|567436581|FG001|Overall Study|Withdrawal by Subject|3|||
157190048|NCT01265719|567436580|FG000|Overall Study|Lost to Follow-up|2|||
157190049|NCT01265719|567436581|FG001|Overall Study|Lost to Follow-up|7|||
157068993|NCT00267098|567006147|FG000|Overall Study|Withdrawal by Subject|8|||
157068994|NCT00267098|567006148|FG001|Overall Study|Withdrawal by Subject|0|||
157068995|NCT00267098|567006149|FG002|Overall Study|Withdrawal by Subject|24|||
157068996|NCT00267098|567006150|FG003|Overall Study|Withdrawal by Subject|21|||
157068997|NCT00267098|567006151|FG004|Overall Study|Withdrawal by Subject|12|||
157068998|NCT00267098|567006152|FG005|Overall Study|Withdrawal by Subject|9|||
157068999|NCT00267098|567006153|FG006|Overall Study|Withdrawal by Subject|12|||
157069000|NCT00267098|567006154|FG007|Overall Study|Withdrawal by Subject|5|||
157069001|NCT00267098|567006147|FG000|Overall Study|Physician Decision|5|||
157069002|NCT00267098|567006148|FG001|Overall Study|Physician Decision|0|||
157069003|NCT00267098|567006149|FG002|Overall Study|Physician Decision|7|||
157069004|NCT00267098|567006150|FG003|Overall Study|Physician Decision|11|||
157069005|NCT00267098|567006151|FG004|Overall Study|Physician Decision|5|||
157069006|NCT00267098|567006152|FG005|Overall Study|Physician Decision|4|||
157069007|NCT00267098|567006153|FG006|Overall Study|Physician Decision|3|||
157069008|NCT00267098|567006154|FG007|Overall Study|Physician Decision|0|||
157069009|NCT00267098|567006147|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
157069010|NCT00267098|567006148|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069011|NCT00267098|567006149|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069012|NCT00267098|567006150|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069013|NCT00267098|567006151|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
157069014|NCT00267098|567006152|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069015|NCT00267098|567006153|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069016|NCT00267098|567006154|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
157069017|NCT00267098|567006147|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069018|NCT00267098|567006148|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
157069019|NCT00267098|567006149|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069020|NCT00267098|567006150|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069021|NCT00267098|567006151|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069022|NCT00267098|567006152|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069023|NCT00267098|567006153|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069024|NCT00267098|567006154|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
157069025|NCT00267098|567006147|FG000|Overall Study|Site closure|0|||
157069026|NCT00267098|567006148|FG001|Overall Study|Site closure|0|||
157069027|NCT00267098|567006149|FG002|Overall Study|Site closure|0|||
157069028|NCT00267098|567006150|FG003|Overall Study|Site closure|1|||
157069029|NCT00267098|567006151|FG004|Overall Study|Site closure|0|||
157069030|NCT00267098|567006152|FG005|Overall Study|Site closure|1|||
157069031|NCT00267098|567006153|FG006|Overall Study|Site closure|1|||
157069032|NCT00267098|567006154|FG007|Overall Study|Site closure|0|||
157069033|NCT00267098|567006147|FG000|Overall Study|Explanted Medtronic device|0|||
157069034|NCT00267098|567006148|FG001|Overall Study|Explanted Medtronic device|0|||
157069035|NCT00267098|567006149|FG002|Overall Study|Explanted Medtronic device|0|||
157069036|NCT00267098|567006150|FG003|Overall Study|Explanted Medtronic device|1|||
157069037|NCT00267098|567006151|FG004|Overall Study|Explanted Medtronic device|0|||
157069038|NCT00267098|567006152|FG005|Overall Study|Explanted Medtronic device|0|||
157069039|NCT00267098|567006153|FG006|Overall Study|Explanted Medtronic device|0|||
157069040|NCT00267098|567006154|FG007|Overall Study|Explanted Medtronic device|0|||
157069041|NCT00267098|567006147|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069042|NCT00267098|567006148|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069043|NCT00267098|567006149|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069044|NCT00267098|567006150|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069045|NCT00267098|567006151|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
157190050|NCT01265719|567436580|FG000|Overall Study|Adverse Event|2|||
157190051|NCT01265719|567436581|FG001|Overall Study|Adverse Event|0|||
157190052|NCT01451203|567436584|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
157190053|NCT01451203|567436585|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
157190054|NCT01451203|567436584|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
157190055|NCT01451203|567436585|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
157190056|NCT01451203|567436584|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
157190057|NCT01451203|567436585|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
157190058|NCT01451203|567436584|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
157190059|NCT01451203|567436585|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
157190060|NCT01451203|567436584|FG000|Double-blind Treatment Period|Adverse Event|6|||
157190061|NCT01451203|567436585|FG001|Double-blind Treatment Period|Adverse Event|9|||
157069046|NCT00267098|567006152|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069047|NCT00267098|567006153|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069048|NCT00267098|567006154|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
157069049|NCT00267098|567006147|FG000|Overall Study|Subject listed for heart transplant|0|||
157190062|NCT01451203|567436584|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
157190063|NCT01451203|567436585|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
157190064|NCT01451203|567436584|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
157190065|NCT01451203|567436585|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
157190066|NCT01451203|567436584|FG000|Double-blind Treatment Period|Investigator decision|2|||
157190067|NCT01451203|567436585|FG001|Double-blind Treatment Period|Investigator decision|0|||
157190068|NCT01451203|567436584|FG000|Post-treatment Period|Consent withdrawn|2|||
157190069|NCT01451203|567436585|FG001|Post-treatment Period|Consent withdrawn|4|||
157190070|NCT01451203|567436584|FG000|Post-treatment Period|Lack of Efficacy|12|||
157190071|NCT01451203|567436585|FG001|Post-treatment Period|Lack of Efficacy|28|||
157190072|NCT01451203|567436584|FG000|Post-treatment Period|Adverse Event|0|||
157190073|NCT01451203|567436585|FG001|Post-treatment Period|Adverse Event|1|||
157190074|NCT01451203|567436584|FG000|Post-treatment Period|Investigator decision|0|||
157190075|NCT01451203|567436585|FG001|Post-treatment Period|Investigator decision|1|||
157190076|NCT02554721|567436586|FG000|Overall Study|Adverse Event|1|||
157190077|NCT02554721|567436587|FG001|Overall Study|Adverse Event|0|||
157190078|NCT02554721|567436588|FG002|Overall Study|Adverse Event|0|||
157190079|NCT02554721|567436589|FG003|Overall Study|Adverse Event|0|||
157190080|NCT02554721|567436590|FG004|Overall Study|Adverse Event|1|||
157190081|NCT02554721|567436586|FG000|Overall Study|Noncompliance|0|||
157190082|NCT02554721|567436587|FG001|Overall Study|Noncompliance|0|||
157190083|NCT02554721|567436588|FG002|Overall Study|Noncompliance|0|||
157190084|NCT02554721|567436589|FG003|Overall Study|Noncompliance|0|||
157190085|NCT02554721|567436590|FG004|Overall Study|Noncompliance|1|||
157190086|NCT00626327|567436596|FG000|Overall Study|Withdrawal by Subject|21|||
157190087|NCT00626327|567436597|FG001|Overall Study|Withdrawal by Subject|29|||
157190088|NCT00626327|567436598|FG002|Overall Study|Withdrawal by Subject|30|||
157190089|NCT00626327|567436596|FG000|Overall Study|Adverse Event|1|||
157190090|NCT00626327|567436597|FG001|Overall Study|Adverse Event|0|||
157190091|NCT00626327|567436598|FG002|Overall Study|Adverse Event|0|||
157190092|NCT00626327|567436596|FG000|Overall Study|Lost to Follow-up|24|||
157190093|NCT00626327|567436597|FG001|Overall Study|Lost to Follow-up|21|||
157190094|NCT00626327|567436598|FG002|Overall Study|Lost to Follow-up|23|||
157190095|NCT00626327|567436596|FG000|Overall Study|Inappropriate enrollment|4|||
157190096|NCT00626327|567436597|FG001|Overall Study|Inappropriate enrollment|5|||
157190097|NCT00626327|567436598|FG002|Overall Study|Inappropriate enrollment|3|||
157190098|NCT00626327|567436596|FG000|Overall Study|Administrative Reason|2|||
157190099|NCT00626327|567436597|FG001|Overall Study|Administrative Reason|0|||
157190100|NCT00626327|567436598|FG002|Overall Study|Administrative Reason|6|||
157190101|NCT00626327|567436596|FG000|Overall Study|Protocol Violation|26|||
157190102|NCT00626327|567436597|FG001|Overall Study|Protocol Violation|4|||
157190103|NCT00626327|567436598|FG002|Overall Study|Protocol Violation|26|||
157190104|NCT00945945|567436599|FG000|Overall Study|Adverse Event|15|||
157190105|NCT00945945|567436600|FG001|Overall Study|Adverse Event|35|||
157190106|NCT00945945|567436599|FG000|Overall Study|Withdrawal by Subject|7|||
157190107|NCT00945945|567436600|FG001|Overall Study|Withdrawal by Subject|10|||
157190108|NCT00945945|567436599|FG000|Overall Study|Lost to Follow-up|4|||
157190109|NCT00945945|567436600|FG001|Overall Study|Lost to Follow-up|5|||
157190110|NCT00945945|567436599|FG000|Overall Study|Lack of Efficacy|6|||
157190111|NCT00945945|567436600|FG001|Overall Study|Lack of Efficacy|2|||
157190112|NCT00945945|567436599|FG000|Overall Study|Protocol Violation|4|||
157190113|NCT00945945|567436600|FG001|Overall Study|Protocol Violation|2|||
157190114|NCT00945945|567436599|FG000|Overall Study|Entry Criteria Not Met|0|||
157190115|NCT00945945|567436600|FG001|Overall Study|Entry Criteria Not Met|1|||
157190116|NCT04880642|567436603|FG000|Randomization|Withdrawal by Subject|2|||
157190117|NCT04880642|567436604|FG001|Randomization|Withdrawal by Subject|3|||
157190118|NCT04880642|567436603|FG000|Treatment Period|Adverse Event|0|||
157190119|NCT04880642|567436604|FG001|Treatment Period|Adverse Event|1|||
157190120|NCT04880642|567436603|FG000|Treatment Period|Death|6|||
157190121|NCT04880642|567436604|FG001|Treatment Period|Death|6|||
157190122|NCT04880642|567436603|FG000|Treatment Period|Lost to Follow-up|1|||
157190123|NCT04880642|567436604|FG001|Treatment Period|Lost to Follow-up|0|||
157190124|NCT04880642|567436603|FG000|Treatment Period|Protocol Violation|0|||
157190125|NCT04880642|567436604|FG001|Treatment Period|Protocol Violation|1|||
157190126|NCT04880642|567436603|FG000|Treatment Period|Withdrawal by Subject|5|||
157190127|NCT04880642|567436604|FG001|Treatment Period|Withdrawal by Subject|3|||
157190128|NCT04880642|567436603|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
157190129|NCT04880642|567436604|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
157190130|NCT04880642|567436603|FG000|Follow-up|Death|4|||
157190131|NCT04880642|567436604|FG001|Follow-up|Death|3|||
157190132|NCT04880642|567436603|FG000|Follow-up|Withdrawal by Subject|1|||
157190133|NCT04880642|567436604|FG001|Follow-up|Withdrawal by Subject|0|||
157190134|NCT04235959|567436606|FG000|Overall Study|Protocol Violation|0|||
157190135|NCT04235959|567436607|FG001|Overall Study|Protocol Violation|1|||
157190136|NCT04235959|567436608|FG002|Overall Study|Protocol Violation|0|||
157190137|NCT04235959|567436606|FG000|Overall Study|Adverse Event|1|||
157190138|NCT04235959|567436607|FG001|Overall Study|Adverse Event|0|||
157190139|NCT04235959|567436608|FG002|Overall Study|Adverse Event|0|||
157190140|NCT00125138|567436609|FG000|Overall Study|Adverse Event|1|||
157190141|NCT00125138|567436610|FG001|Overall Study|Adverse Event|0|||
157230308|NCT04455633|567590571|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
157230309|NCT04455633|567590572|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
157230310|NCT01648166|567590573|FG000|Overall Study|inadequate toenail samples|53|||
157230311|NCT01648166|567590574|FG001|Overall Study|inadequate toenail samples|100|||
157230312|NCT00883090|567590575|FG000|Overall Study|Sponsor's decision|1|||
157230313|NCT00883090|567590575|FG000|Overall Study|Withdrawal by Subject|1|||
157230314|NCT02532764|567590576|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230315|NCT02532764|567590577|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230316|NCT02532764|567590578|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230317|NCT02532764|567590579|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230318|NCT02532764|567590580|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230319|NCT02532764|567590581|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230320|NCT02532764|567590582|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
157230321|NCT02532764|567590583|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
157230322|NCT02532764|567590584|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
157230323|NCT02532764|567590585|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
157230324|NCT03527745|567590586|FG000|Overall Study|Lost to Follow-up|3|||
157069050|NCT00267098|567006148|FG001|Overall Study|Subject listed for heart transplant|0|||
157069051|NCT00267098|567006149|FG002|Overall Study|Subject listed for heart transplant|0|||
157069052|NCT00267098|567006150|FG003|Overall Study|Subject listed for heart transplant|0|||
157069053|NCT00267098|567006151|FG004|Overall Study|Subject listed for heart transplant|0|||
157069054|NCT00267098|567006152|FG005|Overall Study|Subject listed for heart transplant|0|||
157069055|NCT00267098|567006153|FG006|Overall Study|Subject listed for heart transplant|1|||
157069056|NCT00267098|567006154|FG007|Overall Study|Subject listed for heart transplant|0|||
157069057|NCT00267098|567006147|FG000|Overall Study|Sponsor withdrew subject|0|||
157069058|NCT00267098|567006148|FG001|Overall Study|Sponsor withdrew subject|0|||
157069059|NCT00267098|567006149|FG002|Overall Study|Sponsor withdrew subject|0|||
157069060|NCT00267098|567006150|FG003|Overall Study|Sponsor withdrew subject|1|||
157069061|NCT00267098|567006151|FG004|Overall Study|Sponsor withdrew subject|0|||
157069062|NCT00267098|567006152|FG005|Overall Study|Sponsor withdrew subject|0|||
157069063|NCT00267098|567006153|FG006|Overall Study|Sponsor withdrew subject|0|||
157069064|NCT00267098|567006154|FG007|Overall Study|Sponsor withdrew subject|0|||
157069065|NCT02031536|567006156|FG000|Overall Study|ineligible|1|||
157069066|NCT02031536|567006157|FG001|Overall Study|ineligible|0|||
157069067|NCT04211389|567006159|FG000|Overall Study|Adverse Event|1|||
157069068|NCT04211389|567006160|FG001|Overall Study|Adverse Event|2|||
157069069|NCT04211389|567006159|FG000|Overall Study|Lost to Follow-up|15|||
157069070|NCT04211389|567006160|FG001|Overall Study|Lost to Follow-up|7|||
157069071|NCT04211389|567006159|FG000|Overall Study|Protocol Violation|0|||
157069072|NCT04211389|567006160|FG001|Overall Study|Protocol Violation|1|||
157069073|NCT04211389|567006159|FG000|Overall Study|Withdrawal by Subject|10|||
157069074|NCT04211389|567006160|FG001|Overall Study|Withdrawal by Subject|11|||
157190142|NCT00125138|567436611|FG002|Overall Study|Adverse Event|3|||
157190143|NCT00125138|567436612|FG003|Overall Study|Adverse Event|2|||
157190144|NCT00125138|567436609|FG000|Overall Study|Withdrawal by Subject|2|||
157190145|NCT00125138|567436610|FG001|Overall Study|Withdrawal by Subject|3|||
157190146|NCT00125138|567436611|FG002|Overall Study|Withdrawal by Subject|1|||
157190147|NCT00125138|567436612|FG003|Overall Study|Withdrawal by Subject|1|||
157190148|NCT00125138|567436609|FG000|Overall Study|Lack of Efficacy|0|||
157190149|NCT00125138|567436610|FG001|Overall Study|Lack of Efficacy|0|||
157190150|NCT00125138|567436611|FG002|Overall Study|Lack of Efficacy|0|||
157190151|NCT00125138|567436612|FG003|Overall Study|Lack of Efficacy|1|||
157190152|NCT00125138|567436609|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
157190153|NCT00125138|567436610|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
157190154|NCT00125138|567436611|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
157190155|NCT00125138|567436612|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
157190156|NCT03228836|567436617|FG000|Overall Study|Adverse Event|3|||
157190157|NCT03228836|567436617|FG000|Overall Study|Withdrawal by Subject|1|||
157190158|NCT03228836|567436617|FG000|Overall Study|Death|1|||
157190159|NCT03228836|567436617|FG000|Overall Study|Physician Decision|1|||
157190160|NCT03228836|567436617|FG000|Overall Study|Disease Progression|7|||
157190161|NCT03228836|567436617|FG000|Overall Study|Other|4|||
157190162|NCT00103207|567436620|FG000|Overall Study|Adverse Event|3|||
157190163|NCT00103207|567436620|FG000|Overall Study|Death|1|||
157190164|NCT00103207|567436620|FG000|Overall Study|Withdrawal by Subject|2|||
157190165|NCT00103207|567436620|FG000|Overall Study|Other complicating disease|1|||
157069075|NCT04206085|567006161|FG000|Overall Study|Lost to Follow-up|0|||
157069076|NCT04206085|567006162|FG001|Overall Study|Lost to Follow-up|1|||
157069077|NCT04206085|567006163|FG002|Overall Study|Lost to Follow-up|0|||
157069078|NCT04206085|567006161|FG000|Overall Study|Lost to Follow-up|0|||
157190166|NCT00103207|567436620|FG000|Overall Study|Ineligible|4|||
157190167|NCT00103207|567436620|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
157190168|NCT01611558|567436621|FG000|Induction Phase|Study drug toxicity|15|||
157190169|NCT01611558|567436621|FG000|Induction Phase|Disease progression|18|||
157190170|NCT01611558|567436621|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
157190171|NCT01611558|567436621|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
157190172|NCT01611558|567436621|FG000|Induction Phase|Death|1|||
157190173|NCT01611558|567436621|FG000|Maintenance Phase|Withdrawal by Subject|1|||
157190174|NCT01611558|567436621|FG000|Maintenance Phase|Elevated Uric acid|1|||
157190175|NCT04005885|567436635|FG000|First Intervention|Withdrawal by Subject|1|||
157190176|NCT04005885|567436636|FG001|First Intervention|Withdrawal by Subject|1|||
157190177|NCT04005885|567436635|FG000|Second Intervention|Withdrawal by Subject|0|||
157190178|NCT04005885|567436636|FG001|Second Intervention|Withdrawal by Subject|2|||
157190179|NCT01412333|567436637|FG000|Overall Study|Adverse Event|40|||
157190180|NCT01412333|567436638|FG001|Overall Study|Adverse Event|42|||
157190181|NCT01412333|567436637|FG000|Overall Study|Death|5|||
157190182|NCT01412333|567436638|FG001|Overall Study|Death|6|||
157190183|NCT01412333|567436637|FG000|Overall Study|Lack of Efficacy|22|||
157190184|NCT01412333|567436638|FG001|Overall Study|Lack of Efficacy|10|||
157190185|NCT01412333|567436637|FG000|Overall Study|Lost to Follow-up|15|||
157190186|NCT01412333|567436638|FG001|Overall Study|Lost to Follow-up|12|||
157190187|NCT01412333|567436637|FG000|Overall Study|Non-Compliance|3|||
157190188|NCT01412333|567436638|FG001|Overall Study|Non-Compliance|7|||
157190189|NCT01412333|567436637|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157190190|NCT01412333|567436638|FG001|Overall Study|Non-Compliance With Study Drug|1|||
157190191|NCT01412333|567436637|FG000|Overall Study|Other|30|||
157190192|NCT01412333|567436638|FG001|Overall Study|Other|33|||
157190193|NCT01412333|567436637|FG000|Overall Study|Physician Decision|11|||
157190194|NCT01412333|567436638|FG001|Overall Study|Physician Decision|16|||
157190195|NCT01412333|567436637|FG000|Overall Study|Pregnancy|6|||
157190196|NCT01412333|567436638|FG001|Overall Study|Pregnancy|4|||
157190197|NCT01412333|567436637|FG000|Overall Study|Protocol Violation|1|||
157190198|NCT01412333|567436638|FG001|Overall Study|Protocol Violation|2|||
157190199|NCT01412333|567436637|FG000|Overall Study|Study Terminated By Sponsor|3|||
157190200|NCT01412333|567436638|FG001|Overall Study|Study Terminated By Sponsor|2|||
157190201|NCT01412333|567436637|FG000|Overall Study|Withdrawal by Subject|51|||
157190202|NCT01412333|567436638|FG001|Overall Study|Withdrawal by Subject|54|||
157190203|NCT01412333|567436637|FG000|Overall Study|Missing|1|||
157190204|NCT01412333|567436638|FG001|Overall Study|Missing|3|||
157190205|NCT00750867|567436641|FG000|Overall Study|Adverse Event|2|||
157190206|NCT00394654|567436642|FG000|Overall Study|Lost to Follow-up|1|||
157190207|NCT00394654|567436643|FG001|Overall Study|Lost to Follow-up|0|||
157190208|NCT00394654|567436642|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
157190209|NCT00394654|567436643|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
157190210|NCT00474539|567436644|FG000|Infant Series|Withdrawal by Subject|3|||
157190211|NCT00474539|567436645|FG001|Infant Series|Withdrawal by Subject|4|||
157190212|NCT00474539|567436644|FG000|Infant Series|Randomization error|5|||
157190213|NCT00474539|567436645|FG001|Infant Series|Randomization error|0|||
157190214|NCT00474539|567436644|FG000|Infant Series|Lost to Follow-up|2|||
157190215|NCT00474539|567436645|FG001|Infant Series|Lost to Follow-up|1|||
157190216|NCT00474539|567436644|FG000|Infant Series|Protocol Violation|0|||
157190217|NCT00474539|567436645|FG001|Infant Series|Protocol Violation|1|||
157190218|NCT00474539|567436644|FG000|After Infant Series|Lost to Follow-up|3|||
157190219|NCT00474539|567436645|FG001|After Infant Series|Lost to Follow-up|0|||
157190220|NCT00474539|567436644|FG000|After Infant Series|Withdrawal by Subject|1|||
157190221|NCT00474539|567436645|FG001|After Infant Series|Withdrawal by Subject|0|||
157190222|NCT00474539|567436644|FG000|Toddler Dose|Protocol Violation|1|||
157190223|NCT00474539|567436645|FG001|Toddler Dose|Protocol Violation|0|||
157190224|NCT03442595|567436646|FG000|Overall Study|Lost to Follow-up|94|||
157190225|NCT03442595|567436647|FG001|Overall Study|Lost to Follow-up|0|||
157190226|NCT03018340|567436650|FG000|Overall Study|Adverse Event|1|||
157190227|NCT03018340|567436651|FG001|Overall Study|Adverse Event|2|||
157190228|NCT03018340|567436650|FG000|Overall Study|Withdrawal by Subject|0|||
157190229|NCT03018340|567436651|FG001|Overall Study|Withdrawal by Subject|8|||
157190230|NCT03018340|567436650|FG000|Overall Study|Lack of Efficacy|0|||
157190231|NCT03018340|567436651|FG001|Overall Study|Lack of Efficacy|1|||
157190232|NCT03018340|567436650|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
157190233|NCT03018340|567436651|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
157190234|NCT03018340|567436650|FG000|Overall Study|Lost to Follow-up|1|||
157190235|NCT03018340|567436651|FG001|Overall Study|Lost to Follow-up|7|||
157190236|NCT03018340|567436650|FG000|Overall Study|Protocol Violation|3|||
157190237|NCT03018340|567436651|FG001|Overall Study|Protocol Violation|7|||
157190238|NCT03018340|567436650|FG000|Overall Study|Not further specified|0|||
157190239|NCT03018340|567436651|FG001|Overall Study|Not further specified|1|||
157190240|NCT01836549|567436652|FG000|Overall Study|Did not receive study drug|0|||
157190241|NCT01836549|567436653|FG001|Overall Study|Did not receive study drug|0|||
157190242|NCT01836549|567436654|FG002|Overall Study|Did not receive study drug|1|||
157190243|NCT01836549|567436655|FG003|Overall Study|Did not receive study drug|0|||
157190244|NCT01836549|567436656|FG004|Overall Study|Did not receive study drug|0|||
157190245|NCT01836549|567436657|FG005|Overall Study|Did not receive study drug|0|||
157190246|NCT01836549|567436658|FG006|Overall Study|Did not receive study drug|0|||
157190247|NCT01836549|567436652|FG000|Overall Study|Patient declared ineligible|0|||
157230325|NCT03527745|567590587|FG001|Overall Study|Lost to Follow-up|6|||
157230326|NCT03527745|567590588|FG002|Overall Study|Lost to Follow-up|7|||
157230327|NCT03527745|567590589|FG003|Overall Study|Lost to Follow-up|9|||
157230328|NCT03527745|567590590|FG004|Overall Study|Lost to Follow-up|0|||
157230329|NCT03527745|567590591|FG005|Overall Study|Lost to Follow-up|2|||
157230330|NCT03527745|567590592|FG006|Overall Study|Lost to Follow-up|3|||
157230331|NCT03527745|567590593|FG007|Overall Study|Lost to Follow-up|2|||
157230332|NCT03527745|567590594|FG008|Overall Study|Lost to Follow-up|3|||
157230333|NCT03527745|567590595|FG009|Overall Study|Lost to Follow-up|2|||
157230334|NCT03527745|567590596|FG010|Overall Study|Lost to Follow-up|1|||
157230335|NCT03527745|567590597|FG011|Overall Study|Lost to Follow-up|1|||
157230336|NCT03527745|567590598|FG012|Overall Study|Lost to Follow-up|0|||
157230337|NCT03527745|567590599|FG013|Overall Study|Lost to Follow-up|0|||
157230338|NCT03527745|567590600|FG014|Overall Study|Lost to Follow-up|0|||
157230339|NCT03527745|567590601|FG015|Overall Study|Lost to Follow-up|0|||
157230340|NCT03527745|567590602|FG016|Overall Study|Lost to Follow-up|1|||
157230341|NCT03527745|567590603|FG017|Overall Study|Lost to Follow-up|0|||
157230342|NCT03527745|567590604|FG018|Overall Study|Lost to Follow-up|0|||
157230343|NCT03527745|567590605|FG019|Overall Study|Lost to Follow-up|1|||
157230344|NCT03527745|567590606|FG020|Overall Study|Lost to Follow-up|1|||
157230345|NCT03527745|567590607|FG021|Overall Study|Lost to Follow-up|5|||
157230346|NCT03527745|567590608|FG022|Overall Study|Lost to Follow-up|6|||
157230347|NCT03527745|567590609|FG023|Overall Study|Lost to Follow-up|8|||
157230348|NCT03527745|567590610|FG024|Overall Study|Lost to Follow-up|1|||
157230349|NCT03527745|567590611|FG025|Overall Study|Lost to Follow-up|3|||
157230350|NCT01475838|567590615|FG000|Randomized Phase|Randomized but Not Treated|0|||
157230351|NCT01475838|567590616|FG001|Randomized Phase|Randomized but Not Treated|5|||
157230352|NCT01475838|567590615|FG000|Randomized Phase|Adverse Event|6|||
157230353|NCT01475838|567590616|FG001|Randomized Phase|Adverse Event|1|||
157230354|NCT01475838|567590615|FG000|Randomized Phase|Pregnancy|0|||
157230355|NCT01475838|567590616|FG001|Randomized Phase|Pregnancy|1|||
157230356|NCT01475838|567590615|FG000|Randomized Phase|Investigators Discretion|1|||
157230357|NCT01475838|567590616|FG001|Randomized Phase|Investigators Discretion|2|||
157230358|NCT01475838|567590615|FG000|Randomized Phase|Withdrew Consent|10|||
157230359|NCT01475838|567590616|FG001|Randomized Phase|Withdrew Consent|14|||
157230360|NCT01475838|567590615|FG000|Randomized Phase|Lost to Follow-up|3|||
157230361|NCT01475838|567590616|FG001|Randomized Phase|Lost to Follow-up|4|||
157230362|NCT01475838|567590615|FG000|Randomized Phase|Participant Noncompliance|1|||
157230363|NCT01475838|567590616|FG001|Randomized Phase|Participant Noncompliance|5|||
157230364|NCT01475838|567590615|FG000|Randomized Phase|Protocol Violation|9|||
157069079|NCT04206085|567006162|FG001|Overall Study|Lost to Follow-up|0|||
157069080|NCT04206085|567006163|FG002|Overall Study|Lost to Follow-up|1|||
157190248|NCT01836549|567436653|FG001|Overall Study|Patient declared ineligible|0|||
157190249|NCT01836549|567436654|FG002|Overall Study|Patient declared ineligible|0|||
157190250|NCT01836549|567436655|FG003|Overall Study|Patient declared ineligible|1|||
157190251|NCT01836549|567436656|FG004|Overall Study|Patient declared ineligible|0|||
157190252|NCT01836549|567436657|FG005|Overall Study|Patient declared ineligible|0|||
157190253|NCT01836549|567436658|FG006|Overall Study|Patient declared ineligible|0|||
157190254|NCT01836549|567436652|FG000|Overall Study|Patient inevaluable to start therapy|0|||
157190255|NCT01836549|567436653|FG001|Overall Study|Patient inevaluable to start therapy|0|||
157190256|NCT01836549|567436654|FG002|Overall Study|Patient inevaluable to start therapy|0|||
157190257|NCT01836549|567436655|FG003|Overall Study|Patient inevaluable to start therapy|0|||
157190258|NCT01836549|567436656|FG004|Overall Study|Patient inevaluable to start therapy|0|||
157190259|NCT01836549|567436657|FG005|Overall Study|Patient inevaluable to start therapy|0|||
157190260|NCT01836549|567436658|FG006|Overall Study|Patient inevaluable to start therapy|1|||
157190261|NCT02192190|567436659|FG000|Overall Study|Adverse Event|1|||
157190262|NCT02192190|567436660|FG001|Overall Study|Adverse Event|1|||
157190263|NCT02192190|567436661|FG002|Overall Study|Adverse Event|0|||
157190264|NCT02192190|567436662|FG003|Overall Study|Adverse Event|0|||
157190265|NCT02192190|567436663|FG004|Overall Study|Adverse Event|0|||
157190266|NCT02192190|567436664|FG005|Overall Study|Adverse Event|0|||
157190267|NCT02192190|567436659|FG000|Overall Study|Lost to Follow-up|3|||
157190268|NCT02192190|567436660|FG001|Overall Study|Lost to Follow-up|3|||
157190269|NCT02192190|567436661|FG002|Overall Study|Lost to Follow-up|2|||
157190270|NCT02192190|567436662|FG003|Overall Study|Lost to Follow-up|1|||
157190271|NCT02192190|567436663|FG004|Overall Study|Lost to Follow-up|4|||
157190272|NCT02192190|567436664|FG005|Overall Study|Lost to Follow-up|3|||
157190273|NCT02192190|567436659|FG000|Overall Study|Physician Decision|2|||
157230365|NCT01475838|567590616|FG001|Randomized Phase|Protocol Violation|4|||
157230366|NCT01475838|567590615|FG000|Extension Phase|Participant Noncompliance|1|||
157230367|NCT01475838|567590616|FG001|Extension Phase|Participant Noncompliance|0|||
157230368|NCT00048568|567590622|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
157230369|NCT00048568|567590623|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
157190274|NCT02192190|567436660|FG001|Overall Study|Physician Decision|0|||
157190275|NCT02192190|567436661|FG002|Overall Study|Physician Decision|0|||
157190276|NCT02192190|567436662|FG003|Overall Study|Physician Decision|0|||
157230370|NCT00048568|567590624|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
157190277|NCT02192190|567436663|FG004|Overall Study|Physician Decision|0|||
157190278|NCT02192190|567436664|FG005|Overall Study|Physician Decision|0|||
157190279|NCT02192190|567436659|FG000|Overall Study|Terminated by Sponsor|43|||
157190280|NCT02192190|567436660|FG001|Overall Study|Terminated by Sponsor|23|||
157190281|NCT02192190|567436661|FG002|Overall Study|Terminated by Sponsor|20|||
157190282|NCT02192190|567436662|FG003|Overall Study|Terminated by Sponsor|23|||
157190283|NCT02192190|567436663|FG004|Overall Study|Terminated by Sponsor|21|||
157190284|NCT02192190|567436664|FG005|Overall Study|Terminated by Sponsor|23|||
157190285|NCT02192190|567436659|FG000|Overall Study|Withdrawal by Subject|4|||
157190286|NCT02192190|567436660|FG001|Overall Study|Withdrawal by Subject|1|||
157190287|NCT02192190|567436661|FG002|Overall Study|Withdrawal by Subject|2|||
157190288|NCT02192190|567436662|FG003|Overall Study|Withdrawal by Subject|1|||
157190289|NCT02192190|567436663|FG004|Overall Study|Withdrawal by Subject|5|||
157190290|NCT02192190|567436664|FG005|Overall Study|Withdrawal by Subject|3|||
157190291|NCT02192190|567436659|FG000|Overall Study|Could not Keep Visit Schedule|1|||
157190292|NCT02192190|567436660|FG001|Overall Study|Could not Keep Visit Schedule|0|||
157190293|NCT02192190|567436661|FG002|Overall Study|Could not Keep Visit Schedule|0|||
157190294|NCT02192190|567436662|FG003|Overall Study|Could not Keep Visit Schedule|0|||
157190295|NCT02192190|567436663|FG004|Overall Study|Could not Keep Visit Schedule|0|||
157190296|NCT02192190|567436664|FG005|Overall Study|Could not Keep Visit Schedule|0|||
157190297|NCT02192190|567436659|FG000|Overall Study|Positive Drug Screen|0|||
157190298|NCT02192190|567436660|FG001|Overall Study|Positive Drug Screen|0|||
157190299|NCT02192190|567436661|FG002|Overall Study|Positive Drug Screen|0|||
157190300|NCT02192190|567436662|FG003|Overall Study|Positive Drug Screen|1|||
157190301|NCT02192190|567436663|FG004|Overall Study|Positive Drug Screen|0|||
157190302|NCT02192190|567436664|FG005|Overall Study|Positive Drug Screen|0|||
157190303|NCT02192190|567436659|FG000|Overall Study|Inadequate Pain Relief|0|||
157190304|NCT02192190|567436660|FG001|Overall Study|Inadequate Pain Relief|1|||
157190305|NCT02192190|567436661|FG002|Overall Study|Inadequate Pain Relief|1|||
157190306|NCT02192190|567436662|FG003|Overall Study|Inadequate Pain Relief|0|||
157190307|NCT02192190|567436663|FG004|Overall Study|Inadequate Pain Relief|0|||
157190308|NCT02192190|567436664|FG005|Overall Study|Inadequate Pain Relief|0|||
157190309|NCT00381706|567436665|FG000|Overall Study|Never treated|7|||
157190310|NCT00381706|567436666|FG001|Overall Study|Never treated|2|||
157190311|NCT00381706|567436667|FG002|Overall Study|Never treated|1|||
157190312|NCT00598585|567436668|FG000|Overall Study|Lost to Follow-up|1|||
157190313|NCT00598585|567436669|FG001|Overall Study|Lost to Follow-up|0|||
157190314|NCT00542425|567436670|FG000|Initial 24 Weeks|Administrative reasons|0|||
157190315|NCT00542425|567436671|FG001|Initial 24 Weeks|Administrative reasons|0|||
157190316|NCT00542425|567436672|FG002|Initial 24 Weeks|Administrative reasons|1|||
157190317|NCT00542425|567436673|FG003|Initial 24 Weeks|Administrative reasons|1|||
157190318|NCT00542425|567436674|FG004|Initial 24 Weeks|Administrative reasons|0|||
157190319|NCT00542425|567436670|FG000|Initial 24 Weeks|Adverse Event|0|||
157190320|NCT00542425|567436671|FG001|Initial 24 Weeks|Adverse Event|1|||
157190321|NCT00542425|567436672|FG002|Initial 24 Weeks|Adverse Event|1|||
157190322|NCT00542425|567436673|FG003|Initial 24 Weeks|Adverse Event|3|||
157190323|NCT00542425|567436674|FG004|Initial 24 Weeks|Adverse Event|2|||
157190324|NCT00542425|567436670|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
157190325|NCT00542425|567436671|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
157190326|NCT00542425|567436672|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
157190327|NCT00542425|567436673|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
157190328|NCT00542425|567436674|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
157190329|NCT00542425|567436670|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
157190330|NCT00542425|567436671|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
157190331|NCT00542425|567436672|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
157190332|NCT00542425|567436673|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
157190333|NCT00542425|567436674|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
157190334|NCT00542425|567436670|FG000|Initial 24 Weeks|Non-compliance|0|||
157190335|NCT00542425|567436671|FG001|Initial 24 Weeks|Non-compliance|0|||
157190336|NCT00542425|567436672|FG002|Initial 24 Weeks|Non-compliance|0|||
157190337|NCT00542425|567436673|FG003|Initial 24 Weeks|Non-compliance|1|||
157190338|NCT00542425|567436674|FG004|Initial 24 Weeks|Non-compliance|1|||
157190339|NCT00542425|567436670|FG000|Initial 24 Weeks|Protocol Violation|0|||
157190340|NCT00542425|567436671|FG001|Initial 24 Weeks|Protocol Violation|0|||
157190341|NCT00542425|567436672|FG002|Initial 24 Weeks|Protocol Violation|0|||
157190342|NCT00542425|567436673|FG003|Initial 24 Weeks|Protocol Violation|1|||
157190343|NCT00542425|567436674|FG004|Initial 24 Weeks|Protocol Violation|0|||
157190344|NCT00542425|567436670|FG000|Initial 24 Weeks|Refusal of treatment|2|||
157190345|NCT00542425|567436671|FG001|Initial 24 Weeks|Refusal of treatment|2|||
157190346|NCT00542425|567436672|FG002|Initial 24 Weeks|Refusal of treatment|1|||
157190347|NCT00542425|567436673|FG003|Initial 24 Weeks|Refusal of treatment|4|||
157190348|NCT00542425|567436674|FG004|Initial 24 Weeks|Refusal of treatment|1|||
157190349|NCT00542425|567436670|FG000|Initial 24 Weeks|Other|0|||
157190350|NCT00542425|567436671|FG001|Initial 24 Weeks|Other|2|||
157190351|NCT00542425|567436672|FG002|Initial 24 Weeks|Other|1|||
157230371|NCT00048568|567590622|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
157190352|NCT00542425|567436673|FG003|Initial 24 Weeks|Other|0|||
157190353|NCT00542425|567436674|FG004|Initial 24 Weeks|Other|0|||
157190354|NCT00542425|567436670|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
157190355|NCT00542425|567436671|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
157190356|NCT00542425|567436672|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
157190357|NCT00542425|567436673|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
157190358|NCT00542425|567436674|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
157190359|NCT00542425|567436670|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
157190360|NCT00542425|567436671|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
157190361|NCT00542425|567436672|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
157190362|NCT00542425|567436673|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
157190363|NCT00542425|567436674|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
157190364|NCT00542425|567436670|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
157190365|NCT00542425|567436671|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
157190366|NCT00542425|567436672|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
157190367|NCT00542425|567436673|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
157190368|NCT00542425|567436674|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
157190369|NCT00542425|567436670|FG000|Extended 24 Weeks of Treatment|Other|1|||
157190370|NCT00542425|567436671|FG001|Extended 24 Weeks of Treatment|Other|1|||
157190371|NCT00542425|567436672|FG002|Extended 24 Weeks of Treatment|Other|0|||
157190372|NCT00542425|567436673|FG003|Extended 24 Weeks of Treatment|Other|0|||
157190373|NCT00542425|567436674|FG004|Extended 24 Weeks of Treatment|Other|1|||
157190374|NCT00472043|567436675|FG000|Overall Study|Withdrawal by Subject|1|||
157190375|NCT00472043|567436676|FG001|Overall Study|Withdrawal by Subject|0|||
157190376|NCT00472043|567436675|FG000|Overall Study|Death|1|||
157190377|NCT00472043|567436676|FG001|Overall Study|Death|0|||
157190378|NCT02590406|567436679|FG000|Overall Study|Adverse Event|1|||
157190379|NCT02590406|567436680|FG001|Overall Study|Adverse Event|0|||
157190380|NCT02590406|567436679|FG000|Overall Study|Saturometer malfunction|0|||
157190381|NCT02590406|567436680|FG001|Overall Study|Saturometer malfunction|1|||
157190382|NCT03032523|567436681|FG000|Overall Study|Withdrawal by Subject|2|||
157190383|NCT03032523|567436682|FG001|Overall Study|Withdrawal by Subject|2|||
157190384|NCT03032523|567436681|FG000|Overall Study|Physician Decision|1|||
157190385|NCT03032523|567436682|FG001|Overall Study|Physician Decision|0|||
157190386|NCT00957723|567436683|FG000|Overall Study|Death|3|||
157190387|NCT00957723|567436683|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
157190388|NCT00957723|567436683|FG000|Overall Study|Lost to Follow-up|8|||
157190389|NCT00957723|567436683|FG000|Overall Study|Withdrawal by Subject|24|||
157190390|NCT00957723|567436683|FG000|Overall Study|Investigative Site Terminated|61|||
157190391|NCT00957723|567436683|FG000|Overall Study|Intercurrent Illness|2|||
157190392|NCT00957723|567436683|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
157190393|NCT05375838|567436684|FG000|Overall Study|Other|0|||
157190394|NCT05375838|567436685|FG001|Overall Study|Other|0|||
157190395|NCT05375838|567436686|FG002|Overall Study|Other|0|||
157190396|NCT05375838|567436687|FG003|Overall Study|Other|1|||
157190397|NCT05375838|567436688|FG004|Overall Study|Other|1|||
157190398|NCT05375838|567436689|FG005|Overall Study|Other|0|||
157190399|NCT05375838|567436684|FG000|Overall Study|Withdrawal by Subject|2|||
157190400|NCT05375838|567436685|FG001|Overall Study|Withdrawal by Subject|1|||
157190401|NCT05375838|567436686|FG002|Overall Study|Withdrawal by Subject|3|||
157190402|NCT05375838|567436687|FG003|Overall Study|Withdrawal by Subject|2|||
157190403|NCT05375838|567436688|FG004|Overall Study|Withdrawal by Subject|2|||
157190404|NCT05375838|567436689|FG005|Overall Study|Withdrawal by Subject|0|||
157190405|NCT05375838|567436684|FG000|Overall Study|Protocol Violation|0|||
157190406|NCT05375838|567436685|FG001|Overall Study|Protocol Violation|0|||
157190407|NCT05375838|567436686|FG002|Overall Study|Protocol Violation|0|||
157190408|NCT05375838|567436687|FG003|Overall Study|Protocol Violation|0|||
157190409|NCT05375838|567436688|FG004|Overall Study|Protocol Violation|1|||
157190410|NCT05375838|567436689|FG005|Overall Study|Protocol Violation|0|||
157190411|NCT05375838|567436684|FG000|Overall Study|Physician Decision|0|||
157190412|NCT05375838|567436685|FG001|Overall Study|Physician Decision|1|||
157190413|NCT05375838|567436686|FG002|Overall Study|Physician Decision|0|||
157190414|NCT05375838|567436687|FG003|Overall Study|Physician Decision|0|||
157190415|NCT05375838|567436688|FG004|Overall Study|Physician Decision|0|||
157190416|NCT05375838|567436689|FG005|Overall Study|Physician Decision|1|||
157190417|NCT05375838|567436684|FG000|Overall Study|Lost to Follow-up|2|||
157190418|NCT05375838|567436685|FG001|Overall Study|Lost to Follow-up|7|||
157190419|NCT05375838|567436686|FG002|Overall Study|Lost to Follow-up|0|||
157190420|NCT05375838|567436687|FG003|Overall Study|Lost to Follow-up|4|||
157190421|NCT05375838|567436688|FG004|Overall Study|Lost to Follow-up|2|||
157190422|NCT05375838|567436689|FG005|Overall Study|Lost to Follow-up|3|||
157190423|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
157190424|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
157190425|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
157230372|NCT00048568|567590623|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
157190426|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
157069081|NCT02168478|567006164|FG000|Overall Study|Withdrawal by Subject|1|||
157069082|NCT02168478|567006164|FG000|Overall Study|Did Not Consent to Participation|2|||
157069083|NCT02168478|567006164|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
157069084|NCT01530087|567006165|FG000|Overall Study|Physician Decision|2|||
157069085|NCT03845023|567006166|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
157069086|NCT03845023|567006167|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
157069087|NCT03845023|567006168|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
157069088|NCT03845023|567006169|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
157069089|NCT03845023|567006166|FG000|Follow-Up (14 Days)|Adverse Event|0|||
157069090|NCT03845023|567006167|FG001|Follow-Up (14 Days)|Adverse Event|0|||
157069091|NCT03845023|567006168|FG002|Follow-Up (14 Days)|Adverse Event|1|||
157069092|NCT03845023|567006169|FG003|Follow-Up (14 Days)|Adverse Event|1|||
157069093|NCT01087814|567006170|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
157069094|NCT01087814|567006171|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
157069095|NCT01087814|567006170|FG000|Second Intervention (5 Days)|Physician Decision|1|||
157069096|NCT01087814|567006171|FG001|Second Intervention (5 Days)|Physician Decision|0|||
157069097|NCT01427738|567006172|FG000|Overall Study|Death|12|||
157069098|NCT01427738|567006173|FG001|Overall Study|Death|9|||
157069099|NCT01427738|567006172|FG000|Overall Study|Severe debilitation, unable to continue|0|||
157069100|NCT01427738|567006173|FG001|Overall Study|Severe debilitation, unable to continue|1|||
157069101|NCT01427738|567006172|FG000|Overall Study|Subject unable to get to clinic|5|||
157069102|NCT01427738|567006173|FG001|Overall Study|Subject unable to get to clinic|2|||
157069103|NCT01427738|567006172|FG000|Overall Study|Withdrawal by Subject|0|||
157069104|NCT01427738|567006173|FG001|Overall Study|Withdrawal by Subject|2|||
157069105|NCT01427738|567006172|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
157069106|NCT01427738|567006173|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
157069107|NCT01427738|567006172|FG000|Overall Study|Lost to Follow-up|1|||
157069108|NCT01427738|567006173|FG001|Overall Study|Lost to Follow-up|5|||
157069109|NCT02353871|567006174|FG000|Overall Study|Protocol deviation|0|||
157069110|NCT02353871|567006175|FG001|Overall Study|Protocol deviation|1|||
157069111|NCT02353871|567006174|FG000|Overall Study|Consent withdrawn|1|||
157069112|NCT02353871|567006175|FG001|Overall Study|Consent withdrawn|8|||
157069113|NCT02353871|567006174|FG000|Overall Study|Lost to Follow-up|2|||
157069114|NCT02353871|567006175|FG001|Overall Study|Lost to Follow-up|0|||
157069115|NCT05314374|567006176|FG000|Overall Study|Adverse Event|2|||
157069116|NCT05314374|567006177|FG001|Overall Study|Adverse Event|2|||
157069117|NCT02658175|567006178|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
157069118|NCT02658175|567006179|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
157069119|NCT02658175|567006180|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
157069120|NCT02658175|567006178|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
157069121|NCT02658175|567006179|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
157069122|NCT02658175|567006180|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
157069123|NCT02658175|567006178|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
157069124|NCT02658175|567006179|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
157069125|NCT02658175|567006180|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
157069126|NCT02658175|567006178|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
157069127|NCT02658175|567006179|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
157069128|NCT02658175|567006180|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
157069129|NCT02658175|567006178|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
157069130|NCT02658175|567006179|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
157069131|NCT02658175|567006180|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
157069132|NCT02658175|567006178|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
157069133|NCT02658175|567006179|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
157069134|NCT02658175|567006180|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
157190427|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
157190428|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
157190429|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
157190430|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
157069135|NCT02658175|567006178|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
157069136|NCT02658175|567006179|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
157069137|NCT02658175|567006180|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
157069138|NCT02658175|567006178|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
157069139|NCT02658175|567006179|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
157069140|NCT02658175|567006180|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
157069141|NCT02658175|567006178|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
157069142|NCT02658175|567006179|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
157069143|NCT02658175|567006180|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
157190431|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
157190432|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
157190433|NCT02178592|567436690|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
157190434|NCT02178592|567436691|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
157190435|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
157190436|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
157190437|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
157190438|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
157190439|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
157190440|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
157190441|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
157190442|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
157190443|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
157190444|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
157190445|NCT02178592|567436690|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
157190446|NCT02178592|567436691|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
157190447|NCT02036476|567436694|FG000|Overall Study|Withdrawal by Subject|2|||
157190448|NCT02036476|567436694|FG000|Overall Study|Progressive Disease|4|||
157190449|NCT02036476|567436694|FG000|Overall Study|Unacceptable Toxicity|2|||
157190450|NCT01984294|567436697|FG000|Overall Study|Randomized but Never Treated|0|||
157190451|NCT01984294|567436698|FG001|Overall Study|Randomized but Never Treated|0|||
157190452|NCT01984294|567436699|FG002|Overall Study|Randomized but Never Treated|1|||
157190453|NCT01984294|567436697|FG000|Overall Study|Lack of Efficacy|4|||
157190454|NCT01984294|567436698|FG001|Overall Study|Lack of Efficacy|2|||
157190455|NCT01984294|567436699|FG002|Overall Study|Lack of Efficacy|6|||
157190456|NCT01984294|567436697|FG000|Overall Study|Adverse Event|0|||
157190457|NCT01984294|567436698|FG001|Overall Study|Adverse Event|1|||
157190458|NCT01984294|567436699|FG002|Overall Study|Adverse Event|0|||
157190459|NCT02698176|567436700|FG000|Overall Study|Progressive disease|4|||
157190460|NCT02698176|567436701|FG001|Overall Study|Progressive disease|3|||
157190461|NCT02698176|567436702|FG002|Overall Study|Progressive disease|1|||
157190462|NCT02698176|567436703|FG003|Overall Study|Progressive disease|0|||
157190463|NCT02698176|567436700|FG000|Overall Study|Adverse Event|2|||
157190464|NCT02698176|567436701|FG001|Overall Study|Adverse Event|0|||
157190465|NCT02698176|567436702|FG002|Overall Study|Adverse Event|0|||
157190466|NCT02698176|567436703|FG003|Overall Study|Adverse Event|0|||
157190467|NCT02698176|567436700|FG000|Overall Study|Clinical progression|3|||
157190468|NCT02698176|567436701|FG001|Overall Study|Clinical progression|0|||
157190469|NCT02698176|567436702|FG002|Overall Study|Clinical progression|0|||
157190470|NCT02698176|567436703|FG003|Overall Study|Clinical progression|0|||
157190471|NCT02985684|567436706|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
157190472|NCT02985684|567436706|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
157190473|NCT02985684|567436706|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
157190474|NCT02449915|567436707|FG000|Overall Study|Exclusion criteria - drug use|1|||
157190475|NCT02449915|567436708|FG001|Overall Study|Exclusion criteria - drug use|0|||
157190476|NCT02449915|567436707|FG000|Overall Study|Withdrawal by Subject|0|||
157190477|NCT02449915|567436708|FG001|Overall Study|Withdrawal by Subject|2|||
157190478|NCT02449915|567436707|FG000|Overall Study|Intraoperative surgical findings|1|||
157190479|NCT02449915|567436708|FG001|Overall Study|Intraoperative surgical findings|1|||
157190480|NCT02449915|567436707|FG000|Overall Study|Abnormal preop lab|0|||
157190481|NCT02449915|567436708|FG001|Overall Study|Abnormal preop lab|1|||
157190482|NCT01021293|567436713|FG000|Overall Study|Serious Adverse Event|2|||
157190483|NCT01021293|567436714|FG001|Overall Study|Serious Adverse Event|1|||
157190484|NCT01021293|567436713|FG000|Overall Study|Adverse Event|2|||
157190485|NCT01021293|567436714|FG001|Overall Study|Adverse Event|1|||
157190486|NCT01021293|567436713|FG000|Overall Study|Withdrawal by Subject|1|||
157190487|NCT01021293|567436714|FG001|Overall Study|Withdrawal by Subject|3|||
157190488|NCT01021293|567436713|FG000|Overall Study|Migrated/moved from study area|6|||
157190489|NCT01021293|567436714|FG001|Overall Study|Migrated/moved from study area|18|||
157190490|NCT01021293|567436713|FG000|Overall Study|Lost to Follow-up|1|||
157190491|NCT01021293|567436714|FG001|Overall Study|Lost to Follow-up|1|||
157190492|NCT01084096|567438258|FG000|Overall Study|Lost to Follow-up|1501|||
157190493|NCT01084096|567438259|FG001|Overall Study|Lost to Follow-up|1833|||
157190494|NCT01084096|567438258|FG000|Overall Study|Withdrawal by Subject|3|||
157190495|NCT01084096|567438259|FG001|Overall Study|Withdrawal by Subject|0|||
157190496|NCT01084096|567438258|FG000|Overall Study|Woman had a miscarriage|21|||
157190497|NCT01084096|567438259|FG001|Overall Study|Woman had a miscarriage|17|||
157190498|NCT04335929|567438260|FG000|Overall Study|Lost to Follow-up|10|||
157190499|NCT02967562|567438261|FG000|Overall Study|Consent not obtained|1|||
157190500|NCT02967562|567438262|FG001|Overall Study|Consent not obtained|0|||
157190501|NCT02967562|567438261|FG000|Overall Study|High leak precluding analysis|1|||
157190502|NCT02967562|567438262|FG001|Overall Study|High leak precluding analysis|1|||
157190503|NCT00286156|567438263|FG000|Overall Study|Missed 12 month visit|0|||
157190504|NCT00286156|567438264|FG001|Overall Study|Missed 12 month visit|0|||
157230373|NCT00048568|567590624|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
157230374|NCT00048568|567590622|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
157230375|NCT00048568|567590623|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
157230376|NCT00048568|567590624|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
157230377|NCT00048568|567590622|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
157230378|NCT00048568|567590623|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
157230379|NCT00048568|567590624|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
157230380|NCT00048568|567590622|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
157230381|NCT00048568|567590623|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
157230382|NCT00048568|567590624|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
157230383|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Death|1|||
157230384|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Death|1|||
157230385|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Death|0|||
157230386|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
157230387|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
157230388|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
157230389|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
157230390|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
157230391|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
157230392|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
157230393|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
157230394|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
157230395|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
157230396|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
157230397|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
157230398|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
157230399|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
157230400|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
157230401|NCT00048568|567590622|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
157230402|NCT00048568|567590623|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
157230403|NCT00048568|567590624|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
157230404|NCT00048568|567590622|FG000|Open-Label Period|Death|0|||
157230405|NCT00048568|567590623|FG001|Open-Label Period|Death|0|||
157230406|NCT00048568|567590624|FG002|Open-Label Period|Death|13|||
157230407|NCT00048568|567590622|FG000|Open-Label Period|Adverse Event|0|||
157230408|NCT00048568|567590623|FG001|Open-Label Period|Adverse Event|0|||
157230409|NCT00048568|567590624|FG002|Open-Label Period|Adverse Event|49|||
157230410|NCT00048568|567590622|FG000|Open-Label Period|Lack of Efficacy|0|||
157230411|NCT00048568|567590623|FG001|Open-Label Period|Lack of Efficacy|0|||
157230412|NCT00048568|567590624|FG002|Open-Label Period|Lack of Efficacy|32|||
157230413|NCT00048568|567590622|FG000|Open-Label Period|Withdrawal by Subject|0|||
157230414|NCT00048568|567590623|FG001|Open-Label Period|Withdrawal by Subject|0|||
157230415|NCT00048568|567590624|FG002|Open-Label Period|Withdrawal by Subject|26|||
157230416|NCT00048568|567590622|FG000|Open-Label Period|Pregnancy|0|||
157230417|NCT00048568|567590623|FG001|Open-Label Period|Pregnancy|0|||
157230418|NCT00048568|567590624|FG002|Open-Label Period|Pregnancy|5|||
157230419|NCT00048568|567590622|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
157230420|NCT00048568|567590623|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
157230421|NCT00048568|567590624|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
157230422|NCT00048568|567590622|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
157230423|NCT00048568|567590623|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
157230424|NCT00048568|567590624|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
157230425|NCT00048568|567590622|FG000|Open-Label Period|Unknown Reasons|0|||
157230426|NCT00048568|567590623|FG001|Open-Label Period|Unknown Reasons|0|||
157230427|NCT00048568|567590624|FG002|Open-Label Period|Unknown Reasons|25|||
157230428|NCT00048568|567590622|FG000|Open-Label Period|Lost to Follow-up|0|||
157230429|NCT00048568|567590623|FG001|Open-Label Period|Lost to Follow-up|0|||
157230430|NCT00048568|567590624|FG002|Open-Label Period|Lost to Follow-up|7|||
157230431|NCT01717976|567590625|FG000|Overall Study|Protocol Violation|0|||
157069144|NCT02658175|567006178|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
157069145|NCT02658175|567006179|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
157069146|NCT02658175|567006180|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
157069147|NCT04913948|567006188|FG000|Overall Study|Withdrawal by Subject|2|||
157069148|NCT04913948|567006188|FG000|Overall Study|Sample processing issues|1|||
157069149|NCT04913948|567006188|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
157230432|NCT01717976|567590626|FG001|Overall Study|Protocol Violation|1|||
157230433|NCT03831048|567590627|FG000|Overall Study|Protocol Violation|9|||
157230434|NCT03831048|567590628|FG001|Overall Study|Protocol Violation|3|||
157230435|NCT03831048|567590627|FG000|Overall Study|Death|4|||
157230436|NCT03831048|567590628|FG001|Overall Study|Death|9|||
157230437|NCT03831048|567590627|FG000|Overall Study|Re-transplant|0|||
157190505|NCT00286156|567438265|FG002|Overall Study|Missed 12 month visit|1|||
157190506|NCT00286156|567438263|FG000|Overall Study|AE: pulmonary embolus|0|||
157190507|NCT00286156|567438264|FG001|Overall Study|AE: pulmonary embolus|1|||
157190508|NCT00286156|567438265|FG002|Overall Study|AE: pulmonary embolus|0|||
157190509|NCT00286156|567438263|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
157190510|NCT00286156|567438264|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
157190511|NCT00286156|567438265|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
157190512|NCT00286156|567438263|FG000|Overall Study|AE: pneumonia|1|||
157190513|NCT00286156|567438264|FG001|Overall Study|AE: pneumonia|0|||
157190514|NCT00286156|567438265|FG002|Overall Study|AE: pneumonia|0|||
157190515|NCT02870348|567438269|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
157190516|NCT01051856|567438270|FG000|Overall Study|Withdrawal by Subject|1|||
157190517|NCT01051856|567438271|FG001|Overall Study|Withdrawal by Subject|0|||
157190518|NCT00672139|567438272|FG000|Overall Study|Death|14|||
157190519|NCT00672139|567438273|FG001|Overall Study|Death|23|||
157190520|NCT00672139|567438272|FG000|Overall Study|Withdrawal by Subject|2|||
157190521|NCT00672139|567438273|FG001|Overall Study|Withdrawal by Subject|11|||
157190522|NCT00672139|567438272|FG000|Overall Study|Adverse Event|4|||
157190523|NCT00672139|567438273|FG001|Overall Study|Adverse Event|7|||
157190524|NCT00672139|567438272|FG000|Overall Study|Physician Decision|2|||
157190525|NCT00672139|567438273|FG001|Overall Study|Physician Decision|0|||
157190526|NCT00672139|567438272|FG000|Overall Study|Lack of Efficacy|4|||
157190527|NCT00672139|567438273|FG001|Overall Study|Lack of Efficacy|1|||
157190528|NCT00672139|567438272|FG000|Overall Study|Protocol Violation|1|||
157190529|NCT00672139|567438273|FG001|Overall Study|Protocol Violation|1|||
157190530|NCT00672139|567438272|FG000|Overall Study|hospice discharge, caregiver requests|3|||
157190531|NCT00672139|567438273|FG001|Overall Study|hospice discharge, caregiver requests|2|||
157190532|NCT02381795|567438274|FG000|Overall Study|Withdrawal by Subject|1|||
157190533|NCT02381795|567438274|FG000|Overall Study|Study Terminated|2|||
157190534|NCT02176226|567438275|FG000|Overall Study|Lost to Follow-up|3|||
157190535|NCT02176226|567438275|FG000|Overall Study|Withdrew prior to treatment|6|||
157190536|NCT01488994|567438280|FG000|Overall Study|Withdrawal by Subject|0|||
157190537|NCT01488994|567438281|FG001|Overall Study|Withdrawal by Subject|1|||
157190538|NCT02908841|567438282|FG000|Overall Study|Physician Decision|4|||
157190539|NCT02908841|567438283|FG001|Overall Study|Physician Decision|0|||
157190540|NCT01117428|567438286|FG000|Overall Study|Lack of Efficacy|1|||
157190541|NCT01117428|567438287|FG001|Overall Study|Lack of Efficacy|0|||
157190542|NCT01117428|567438288|FG002|Overall Study|Lack of Efficacy|0|||
157190543|NCT01117428|567438289|FG003|Overall Study|Lack of Efficacy|0|||
157190544|NCT01117428|567438290|FG004|Overall Study|Lack of Efficacy|0|||
157190545|NCT01117428|567438291|FG005|Overall Study|Lack of Efficacy|0|||
157190546|NCT01117428|567438286|FG000|Overall Study|Adverse Event|4|||
157190547|NCT01117428|567438287|FG001|Overall Study|Adverse Event|0|||
157190548|NCT01117428|567438288|FG002|Overall Study|Adverse Event|0|||
157190549|NCT01117428|567438289|FG003|Overall Study|Adverse Event|0|||
157190550|NCT01117428|567438290|FG004|Overall Study|Adverse Event|1|||
157190551|NCT01117428|567438291|FG005|Overall Study|Adverse Event|2|||
157190552|NCT01117428|567438286|FG000|Overall Study|Death|0|||
157190553|NCT01117428|567438287|FG001|Overall Study|Death|1|||
157190554|NCT01117428|567438288|FG002|Overall Study|Death|2|||
157190555|NCT01117428|567438289|FG003|Overall Study|Death|0|||
157190556|NCT01117428|567438290|FG004|Overall Study|Death|0|||
157190557|NCT01117428|567438291|FG005|Overall Study|Death|1|||
157190558|NCT01117428|567438286|FG000|Overall Study|Physician Decision|0|||
157190559|NCT01117428|567438287|FG001|Overall Study|Physician Decision|1|||
157190560|NCT01117428|567438288|FG002|Overall Study|Physician Decision|0|||
157190561|NCT01117428|567438289|FG003|Overall Study|Physician Decision|0|||
157190562|NCT01117428|567438290|FG004|Overall Study|Physician Decision|0|||
157190563|NCT01117428|567438291|FG005|Overall Study|Physician Decision|0|||
157190564|NCT01117428|567438286|FG000|Overall Study|Withdrawal by Subject|0|||
157190565|NCT01117428|567438287|FG001|Overall Study|Withdrawal by Subject|0|||
157190566|NCT01117428|567438288|FG002|Overall Study|Withdrawal by Subject|1|||
157190567|NCT01117428|567438289|FG003|Overall Study|Withdrawal by Subject|0|||
157190568|NCT01117428|567438290|FG004|Overall Study|Withdrawal by Subject|0|||
157190569|NCT01117428|567438291|FG005|Overall Study|Withdrawal by Subject|0|||
157190570|NCT01117428|567438286|FG000|Overall Study|Progressive disease|15|||
157190571|NCT01117428|567438287|FG001|Overall Study|Progressive disease|27|||
157190572|NCT01117428|567438288|FG002|Overall Study|Progressive disease|10|||
157190573|NCT01117428|567438289|FG003|Overall Study|Progressive disease|12|||
157190574|NCT01117428|567438290|FG004|Overall Study|Progressive disease|16|||
157190575|NCT01117428|567438291|FG005|Overall Study|Progressive disease|17|||
157190576|NCT02519777|567438292|FG000|Overall Study|Death|1|||
157190577|NCT02519777|567438293|FG001|Overall Study|Death|0|||
157190578|NCT02519777|567438294|FG002|Overall Study|Death|0|||
157190579|NCT02519777|567438292|FG000|Overall Study|Lost to Follow-up|0|||
157190580|NCT02519777|567438293|FG001|Overall Study|Lost to Follow-up|4|||
157190581|NCT02519777|567438294|FG002|Overall Study|Lost to Follow-up|2|||
157190582|NCT02519777|567438292|FG000|Overall Study|Withdrawal by Subject|3|||
157190583|NCT02519777|567438293|FG001|Overall Study|Withdrawal by Subject|1|||
157190584|NCT02519777|567438294|FG002|Overall Study|Withdrawal by Subject|0|||
157190585|NCT02519777|567438292|FG000|Overall Study|Severe Debilitation|1|||
157190586|NCT02519777|567438293|FG001|Overall Study|Severe Debilitation|1|||
157190587|NCT02519777|567438294|FG002|Overall Study|Severe Debilitation|1|||
157190588|NCT02519777|567438292|FG000|Overall Study|Not able to get to clinic|1|||
157190589|NCT02519777|567438293|FG001|Overall Study|Not able to get to clinic|2|||
157190590|NCT02519777|567438294|FG002|Overall Study|Not able to get to clinic|1|||
157190591|NCT01038635|567438296|FG000|Overall Study|Disease Progression|2|||
157190592|NCT01038635|567438297|FG001|Overall Study|Disease Progression|0|||
157190593|NCT01038635|567438298|FG002|Overall Study|Disease Progression|0|||
157190594|NCT01038635|567438299|FG003|Overall Study|Disease Progression|0|||
157190595|NCT01038635|567438300|FG004|Overall Study|Disease Progression|0|||
157190596|NCT01038635|567438301|FG005|Overall Study|Disease Progression|0|||
157190597|NCT01038635|567438302|FG006|Overall Study|Disease Progression|1|||
157190598|NCT01038635|567438303|FG007|Overall Study|Disease Progression|4|||
157190599|NCT01038635|567438304|FG008|Overall Study|Disease Progression|0|||
157190600|NCT01038635|567438296|FG000|Overall Study|Death|0|||
157190601|NCT01038635|567438297|FG001|Overall Study|Death|0|||
157190602|NCT01038635|567438298|FG002|Overall Study|Death|0|||
157190603|NCT01038635|567438299|FG003|Overall Study|Death|0|||
157190604|NCT01038635|567438300|FG004|Overall Study|Death|1|||
157190605|NCT01038635|567438301|FG005|Overall Study|Death|0|||
157190606|NCT01038635|567438302|FG006|Overall Study|Death|1|||
157190607|NCT01038635|567438303|FG007|Overall Study|Death|1|||
157190608|NCT01038635|567438304|FG008|Overall Study|Death|2|||
157190609|NCT01227252|567438305|FG000|Overall Study|Sponsor Decision|0|||
157190610|NCT01227252|567438306|FG001|Overall Study|Sponsor Decision|1|||
157190611|NCT01227252|567438307|FG002|Overall Study|Sponsor Decision|0|||
157190612|NCT01227252|567438308|FG003|Overall Study|Sponsor Decision|0|||
157190613|NCT01227252|567438305|FG000|Overall Study|Lost to Follow-up|0|||
157190614|NCT01227252|567438306|FG001|Overall Study|Lost to Follow-up|1|||
157190615|NCT01227252|567438307|FG002|Overall Study|Lost to Follow-up|0|||
157190616|NCT01227252|567438308|FG003|Overall Study|Lost to Follow-up|0|||
157190617|NCT01227252|567438305|FG000|Overall Study|Withdrawal by Subject|0|||
157190618|NCT01227252|567438306|FG001|Overall Study|Withdrawal by Subject|1|||
157190619|NCT01227252|567438307|FG002|Overall Study|Withdrawal by Subject|0|||
157190620|NCT01227252|567438308|FG003|Overall Study|Withdrawal by Subject|0|||
157190621|NCT01034709|567438312|FG000|Overall Study|Protocol Violation|9|||
157190622|NCT01034709|567438313|FG001|Overall Study|Protocol Violation|16|||
157190623|NCT01060150|567438314|FG000|Overall Study|Adverse Event|6|||
157190624|NCT01060150|567438314|FG000|Overall Study|Lost to Follow-up|1|||
157190625|NCT01060150|567438314|FG000|Overall Study|Protocol Violation|6|||
157190626|NCT01060150|567438314|FG000|Overall Study|Withdrawal by Subject|8|||
157190627|NCT01060150|567438314|FG000|Overall Study|Enrolled, but not treated|2|||
157190628|NCT02447952|567438317|FG000|Overall Study|Adverse Event|2|||
157190629|NCT02447952|567438317|FG000|Overall Study|Physician Decision|1|||
157190630|NCT02447952|567438317|FG000|Overall Study|Withdrawal by Subject|4|||
157190631|NCT01970540|567438318|FG000|Overall Study|Non-treatment-related AE|0|||
157190632|NCT01970540|567438319|FG001|Overall Study|Non-treatment-related AE|0|||
157190633|NCT01970540|567438320|FG002|Overall Study|Non-treatment-related AE|1|||
157190634|NCT01970540|567438318|FG000|Overall Study|Progressive disease|55|||
157190635|NCT01970540|567438319|FG001|Overall Study|Progressive disease|23|||
157190636|NCT01970540|567438320|FG002|Overall Study|Progressive disease|10|||
157190637|NCT01970540|567438318|FG000|Overall Study|Treatment delay over protocol|0|||
157190638|NCT01970540|567438319|FG001|Overall Study|Treatment delay over protocol|0|||
157190639|NCT01970540|567438320|FG002|Overall Study|Treatment delay over protocol|1|||
157190640|NCT01970540|567438318|FG000|Overall Study|Physician Decision|7|||
157190641|NCT01970540|567438319|FG001|Overall Study|Physician Decision|2|||
157190642|NCT01970540|567438320|FG002|Overall Study|Physician Decision|0|||
157190643|NCT01970540|567438318|FG000|Overall Study|Clinical progression|0|||
157190644|NCT01970540|567438319|FG001|Overall Study|Clinical progression|1|||
157190645|NCT01970540|567438320|FG002|Overall Study|Clinical progression|1|||
157190646|NCT01970540|567438318|FG000|Overall Study|End of study|2|||
157190647|NCT01970540|567438319|FG001|Overall Study|End of study|0|||
157190648|NCT01970540|567438320|FG002|Overall Study|End of study|2|||
157190649|NCT01970540|567438318|FG000|Overall Study|Adverse Event|0|||
157190650|NCT01970540|567438319|FG001|Overall Study|Adverse Event|2|||
157190651|NCT01970540|567438320|FG002|Overall Study|Adverse Event|1|||
157190652|NCT01970540|567438318|FG000|Overall Study|Treatment-related AE|4|||
157190653|NCT01970540|567438319|FG001|Overall Study|Treatment-related AE|0|||
157190654|NCT01970540|567438320|FG002|Overall Study|Treatment-related AE|2|||
157190655|NCT01970540|567438318|FG000|Overall Study|Withdrawal by Subject|4|||
157230438|NCT03831048|567590628|FG001|Overall Study|Re-transplant|2|||
157069150|NCT00815919|567006191|FG000|Overall Study|Unrelated Fungal Infection|1|||
157190656|NCT01970540|567438319|FG001|Overall Study|Withdrawal by Subject|0|||
157069151|NCT00815919|567006191|FG000|Overall Study|AML Relapse|1|||
157190657|NCT01970540|567438320|FG002|Overall Study|Withdrawal by Subject|1|||
157190658|NCT01970540|567438318|FG000|Overall Study|Clinical deterioration|1|||
157190659|NCT01970540|567438319|FG001|Overall Study|Clinical deterioration|0|||
157190660|NCT01970540|567438320|FG002|Overall Study|Clinical deterioration|0|||
157190661|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Adverse Event|30|||
157190662|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Adverse Event|25|||
157190663|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Adverse Event|23|||
157190664|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Adverse Event|14|||
157190665|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Death|0|||
157190666|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Death|0|||
157190667|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Death|1|||
157190668|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Death|0|||
157190669|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Physician Decision|0|||
157190670|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Physician Decision|1|||
157190671|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Physician Decision|0|||
157190672|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Physician Decision|1|||
157190673|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
157190674|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
157190675|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
157190676|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
157190677|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Other|6|||
157190678|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Other|1|||
157190679|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Other|0|||
157190680|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Other|2|||
157190681|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
157190682|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
157190683|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
157190684|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
157190685|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
157190686|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
157190687|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
157190688|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
157190689|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
157190690|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
157190691|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
157190692|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
157190693|NCT00242710|567438322|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
157190694|NCT00242710|567438323|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
157190695|NCT00242710|567438324|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
157190696|NCT00242710|567438325|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
157190697|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Adverse Event|2|||
157190698|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Adverse Event|3|||
157190699|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Adverse Event|5|||
157190700|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Adverse Event|2|||
157190701|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Physician Decision|1|||
157190702|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Physician Decision|1|||
157190703|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Physician Decision|0|||
157190704|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Physician Decision|0|||
157190705|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Other|24|||
157190706|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Other|24|||
157190707|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Other|9|||
157190708|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Other|11|||
157190709|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Extension not Available|17|||
157190710|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Extension not Available|21|||
157190711|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Extension not Available|8|||
157190712|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Extension not Available|7|||
157190713|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
157069152|NCT00815919|567006191|FG000|Overall Study|Lack of Efficacy|2|||
157190714|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
157190715|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
157190716|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
157190717|NCT00242710|567438322|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
157190718|NCT00242710|567438323|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
157190719|NCT00242710|567438324|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
157190720|NCT00242710|567438325|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
157190721|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
157190722|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
157190723|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
157190724|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
157190725|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Death|0|||
157190726|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Death|0|||
157190727|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Death|0|||
157069153|NCT04680637|567006192|FG000|Overall Study|Lost to Follow-up|0|||
157190728|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Death|1|||
157190729|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
157190730|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
157190731|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
157190732|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
157190733|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Other|3|||
157190734|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Other|5|||
157190735|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Other|4|||
157190736|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Other|3|||
157190737|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
157190738|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
157190739|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
157190740|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
157190741|NCT00242710|567438322|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
157190742|NCT00242710|567438323|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
157190743|NCT00242710|567438324|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
157190744|NCT00242710|567438325|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
157190745|NCT01683058|567438326|FG000|Overall Study|Lost to Follow-up|9|||
157190746|NCT01683058|567438326|FG000|Overall Study|Adverse Event|6|||
157190747|NCT01683058|567438326|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
157190748|NCT01683058|567438326|FG000|Overall Study|Withdrawal by Subject|7|||
157190749|NCT01683058|567438326|FG000|Overall Study|Lack of Efficacy|2|||
157190750|NCT01057394|567438327|FG000|Overall Study|Not eligible|0|||
157190751|NCT01057394|567438328|FG001|Overall Study|Not eligible|2|||
157190752|NCT00579527|567438329|FG000|Overall Study|Death|4|||
157190753|NCT01195636|567438330|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
157190754|NCT01195636|567438331|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
157190755|NCT01195636|567438330|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
157190756|NCT01195636|567438331|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
157190757|NCT01195636|567438330|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
157190758|NCT01195636|567438331|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
157190759|NCT01195636|567438330|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
157190760|NCT01195636|567438331|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
157190761|NCT01195636|567438330|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
157190762|NCT01195636|567438331|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
157190763|NCT01195636|567438330|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
157190764|NCT01195636|567438331|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
157190765|NCT01195636|567438330|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
157190766|NCT01195636|567438331|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
157190767|NCT01195636|567438330|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
157190768|NCT01195636|567438331|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
157190769|NCT00203294|567438332|FG000|Overall Study|Withdrawal by Subject|8|||
157190770|NCT00203294|567438333|FG001|Overall Study|Withdrawal by Subject|13|||
157190771|NCT02177942|567438343|FG000|Overall Study|Adverse Event|1|||
157190772|NCT02177942|567438344|FG001|Overall Study|Adverse Event|0|||
157190773|NCT02177942|567438343|FG000|Overall Study|Lost to Follow-up|1|||
157190774|NCT02177942|567438344|FG001|Overall Study|Lost to Follow-up|1|||
157190775|NCT02177942|567438343|FG000|Overall Study|Protocol Violation|4|||
157190776|NCT02177942|567438344|FG001|Overall Study|Protocol Violation|6|||
157190777|NCT02177942|567438343|FG000|Overall Study|Withdrawal by Subject|71|||
157190778|NCT02177942|567438344|FG001|Overall Study|Withdrawal by Subject|81|||
157190779|NCT01566981|567438345|FG000|Overall Study|Lost to Follow-up|5|||
157190780|NCT01566981|567438346|FG001|Overall Study|Lost to Follow-up|8|||
157190781|NCT02405091|567438352|FG000|Overall Study|Adverse Event|16|||
157190782|NCT02405091|567438353|FG001|Overall Study|Adverse Event|10|||
157190783|NCT02405091|567438354|FG002|Overall Study|Adverse Event|0|||
157190784|NCT02405091|567438352|FG000|Overall Study|Protocol Violation|1|||
157190785|NCT02405091|567438353|FG001|Overall Study|Protocol Violation|0|||
157190786|NCT02405091|567438354|FG002|Overall Study|Protocol Violation|0|||
157069154|NCT04680637|567006193|FG001|Overall Study|Lost to Follow-up|1|||
157069155|NCT04680637|567006194|FG002|Overall Study|Lost to Follow-up|0|||
157069156|NCT04680637|567006195|FG003|Overall Study|Lost to Follow-up|1|||
157190787|NCT02405091|567438352|FG000|Overall Study|Noncompliance|1|||
157190788|NCT02405091|567438353|FG001|Overall Study|Noncompliance|6|||
157190789|NCT02405091|567438354|FG002|Overall Study|Noncompliance|2|||
157190790|NCT02405091|567438352|FG000|Overall Study|Withdrawal by Subject|4|||
157190791|NCT02405091|567438353|FG001|Overall Study|Withdrawal by Subject|8|||
157190792|NCT02405091|567438354|FG002|Overall Study|Withdrawal by Subject|0|||
157190793|NCT02405091|567438352|FG000|Overall Study|Death|0|||
157190794|NCT02405091|567438353|FG001|Overall Study|Death|1|||
157190795|NCT02405091|567438354|FG002|Overall Study|Death|0|||
157190796|NCT02405091|567438352|FG000|Overall Study|Lost to Follow-up|5|||
157190797|NCT02405091|567438353|FG001|Overall Study|Lost to Follow-up|6|||
157190798|NCT02405091|567438354|FG002|Overall Study|Lost to Follow-up|0|||
157190799|NCT02405091|567438352|FG000|Overall Study|Physician Decision|2|||
157190800|NCT02405091|567438353|FG001|Overall Study|Physician Decision|2|||
157190801|NCT02405091|567438354|FG002|Overall Study|Physician Decision|0|||
157190802|NCT01948791|567438362|FG000|Overall Study|Adverse Event|12|||
157190803|NCT01948791|567438362|FG000|Overall Study|Lack of Efficacy|3|||
157190804|NCT01948791|567438362|FG000|Overall Study|Protocol Violation|2|||
157190805|NCT01948791|567438362|FG000|Overall Study|Withdrawal by Subject|5|||
157190806|NCT01948791|567438362|FG000|Overall Study|Lost to Follow-up|6|||
157190807|NCT01948791|567438362|FG000|Overall Study|Management issues|1|||
157190808|NCT01948791|567438362|FG000|Overall Study|Others|7|||
157190809|NCT01948791|567438362|FG000|Overall Study|Screening failure|35|||
157190810|NCT01234337|567438363|FG000|Overall Study|Adverse Event|58|||
157190811|NCT01234337|567438364|FG001|Overall Study|Adverse Event|21|||
157190812|NCT01234337|567438363|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
157190813|NCT01234337|567438364|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
157190814|NCT01234337|567438363|FG000|Overall Study|Investi. decision not protocol driven|5|||
157190815|NCT01234337|567438364|FG001|Overall Study|Investi. decision not protocol driven|6|||
157190816|NCT01234337|567438363|FG000|Overall Study|Non-compliant with study medication|3|||
157190817|NCT01234337|567438364|FG001|Overall Study|Non-compliant with study medication|2|||
157190818|NCT01234337|567438363|FG000|Overall Study|Randomized but not treated|6|||
157190819|NCT01234337|567438364|FG001|Overall Study|Randomized but not treated|4|||
157190820|NCT01234337|567438363|FG000|Overall Study|Lost to Follow-up|0|||
157190821|NCT01234337|567438364|FG001|Overall Study|Lost to Follow-up|1|||
157190822|NCT01234337|567438363|FG000|Overall Study|Protocol Violation|2|||
157190823|NCT01234337|567438364|FG001|Overall Study|Protocol Violation|3|||
157190824|NCT01234337|567438363|FG000|Overall Study|Withdrawal by Subject|11|||
157190825|NCT01234337|567438364|FG001|Overall Study|Withdrawal by Subject|9|||
157190826|NCT01234337|567438363|FG000|Overall Study|Death|0|||
157190827|NCT01234337|567438364|FG001|Overall Study|Death|1|||
157190828|NCT01234337|567438363|FG000|Overall Study|Switch to commercial drug|0|||
157190829|NCT01234337|567438364|FG001|Overall Study|Switch to commercial drug|1|||
157190830|NCT00247962|567438372|FG000|Overall Study|Adverse Event|15|||
157190831|NCT00247962|567438373|FG001|Overall Study|Adverse Event|12|||
157190832|NCT00247962|567438372|FG000|Overall Study|Lost to Follow-up|3|||
157190833|NCT00247962|567438373|FG001|Overall Study|Lost to Follow-up|1|||
157190834|NCT00247962|567438372|FG000|Overall Study|Physician Decision|0|||
157190835|NCT00247962|567438373|FG001|Overall Study|Physician Decision|1|||
157190836|NCT00247962|567438372|FG000|Overall Study|Protocol Violation|1|||
157190837|NCT00247962|567438373|FG001|Overall Study|Protocol Violation|1|||
157190838|NCT00247962|567438372|FG000|Overall Study|Withdrawal by Subject|3|||
157190839|NCT00247962|567438373|FG001|Overall Study|Withdrawal by Subject|2|||
157190840|NCT00247962|567438372|FG000|Overall Study|Lack of Efficacy|4|||
157190841|NCT00247962|567438373|FG001|Overall Study|Lack of Efficacy|2|||
157190842|NCT02555722|567438374|FG000|Week 2|Adverse Event|0|||
157190843|NCT02555722|567438375|FG001|Week 2|Adverse Event|1|||
157190844|NCT02555722|567438374|FG000|Week 2|Withdrawal by Subject|1|||
157190845|NCT02555722|567438375|FG001|Week 2|Withdrawal by Subject|0|||
157190846|NCT02555722|567438374|FG000|Month 1|Lens Discomfort|1|||
157190847|NCT02555722|567438375|FG001|Month 1|Lens Discomfort|0|||
157190848|NCT02555722|567438374|FG000|Month 2|Withdrawal by Subject|3|||
157190849|NCT02555722|567438375|FG001|Month 2|Withdrawal by Subject|0|||
157190850|NCT02555722|567438374|FG000|Month 2|Lost to Follow-up|1|||
157190851|NCT02555722|567438375|FG001|Month 2|Lost to Follow-up|0|||
157190852|NCT00702949|567438376|FG000|Overall Study|Refusal|3|||
157190853|NCT00702949|567438377|FG001|Overall Study|Refusal|2|||
157190854|NCT00702949|567438378|FG002|Overall Study|Refusal|2|||
157190855|NCT00702949|567438376|FG000|Overall Study|Adverse Event|1|||
157190856|NCT00702949|567438377|FG001|Overall Study|Adverse Event|6|||
157190857|NCT00702949|567438378|FG002|Overall Study|Adverse Event|3|||
157190858|NCT00702949|567438376|FG000|Overall Study|Other Medical Reason/unknown|1|||
157190859|NCT00702949|567438377|FG001|Overall Study|Other Medical Reason/unknown|1|||
157190860|NCT00702949|567438378|FG002|Overall Study|Other Medical Reason/unknown|3|||
157190861|NCT03525613|567438383|FG000|Overall Study|Adverse Event|11|||
157190862|NCT03525613|567438384|FG001|Overall Study|Adverse Event|8|||
157190863|NCT03525613|567438385|FG002|Overall Study|Adverse Event|3|||
157190864|NCT03525613|567438386|FG003|Overall Study|Adverse Event|3|||
157190865|NCT03525613|567438383|FG000|Overall Study|Lost to Follow-up|4|||
157190866|NCT03525613|567438384|FG001|Overall Study|Lost to Follow-up|5|||
157190867|NCT03525613|567438385|FG002|Overall Study|Lost to Follow-up|3|||
157190868|NCT03525613|567438386|FG003|Overall Study|Lost to Follow-up|2|||
157190869|NCT03525613|567438383|FG000|Overall Study|Physician Decision|0|||
157190870|NCT03525613|567438384|FG001|Overall Study|Physician Decision|1|||
157190871|NCT03525613|567438385|FG002|Overall Study|Physician Decision|0|||
157190872|NCT03525613|567438386|FG003|Overall Study|Physician Decision|1|||
157190873|NCT03525613|567438383|FG000|Overall Study|Consent Withdrawal|25|||
157190874|NCT03525613|567438384|FG001|Overall Study|Consent Withdrawal|16|||
157190875|NCT03525613|567438385|FG002|Overall Study|Consent Withdrawal|12|||
157190876|NCT03525613|567438386|FG003|Overall Study|Consent Withdrawal|9|||
157190877|NCT03525613|567438383|FG000|Overall Study|Death|20|||
157230439|NCT03831048|567590627|FG000|Overall Study|Protocol violation and death|1|||
157230440|NCT03831048|567590628|FG001|Overall Study|Protocol violation and death|1|||
157230441|NCT00560235|567590629|FG000|Phase 1|Discontinued|8|||
157230442|NCT00560235|567590630|FG001|Phase 1|Discontinued|0|||
157230443|NCT00560235|567590631|FG002|Phase 1|Discontinued|0|||
157230444|NCT00560235|567590629|FG000|Phase 1B|Discontinued|0|||
157230445|NCT00560235|567590630|FG001|Phase 1B|Discontinued|19|||
157230446|NCT00560235|567590631|FG002|Phase 1B|Discontinued|0|||
157230447|NCT00560235|567590629|FG000|Phase 2|Discontinued|0|||
157230448|NCT00560235|567590630|FG001|Phase 2|Discontinued|0|||
157230449|NCT00560235|567590631|FG002|Phase 2|Discontinued|96|||
157230450|NCT00560235|567590629|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
157230451|NCT00560235|567590630|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
157230452|NCT00560235|567590631|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
157230453|NCT04015232|567590632|FG000|Overall Study|Withdrawal by Subject|7|||
157230454|NCT04015232|567590633|FG001|Overall Study|Withdrawal by Subject|4|||
157230455|NCT04015232|567590632|FG000|Overall Study|Protocol Violation|1|||
157230456|NCT04015232|567590633|FG001|Overall Study|Protocol Violation|0|||
157230457|NCT04015232|567590632|FG000|Overall Study|Medical Grounds|3|||
157230458|NCT04015232|567590633|FG001|Overall Study|Medical Grounds|3|||
157230459|NCT01087970|567590636|FG000|Overall Study|Protocol Violation|2|||
157230460|NCT03164772|567590637|FG000|Overall Study|Death|4|||
157230461|NCT03164772|567590638|FG001|Overall Study|Death|2|||
157230462|NCT03164772|567590637|FG000|Overall Study|Adverse Event|1|||
157230463|NCT03164772|567590638|FG001|Overall Study|Adverse Event|4|||
157190878|NCT03525613|567438384|FG001|Overall Study|Death|9|||
157190879|NCT03525613|567438385|FG002|Overall Study|Death|7|||
157190880|NCT03525613|567438386|FG003|Overall Study|Death|1|||
157190881|NCT03525613|567438383|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
157190882|NCT03525613|567438384|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
157190883|NCT03525613|567438385|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
157190884|NCT03525613|567438386|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
157190885|NCT01610414|567438391|FG000|Study Start - Month 13|Serious Adverse Event|65|||
157190886|NCT01610414|567438392|FG001|Study Start - Month 13|Serious Adverse Event|67|||
157190887|NCT01610414|567438391|FG000|Study Start - Month 13|Adverse Event|14|||
157190888|NCT01610414|567438392|FG001|Study Start - Month 13|Adverse Event|14|||
157190889|NCT01610414|567438391|FG000|Study Start - Month 13|Protocol Violation|3|||
157190890|NCT01610414|567438392|FG001|Study Start - Month 13|Protocol Violation|1|||
157190891|NCT01610414|567438391|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
157190892|NCT01610414|567438392|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
157190893|NCT01610414|567438391|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
157190894|NCT01610414|567438392|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
157190895|NCT01610414|567438391|FG000|Study Start - Month 13|Lost to Follow-up|4|||
157190896|NCT01610414|567438392|FG001|Study Start - Month 13|Lost to Follow-up|6|||
157190897|NCT01610414|567438391|FG000|Study Start - Month 13|Suspected HZ episode|1|||
157190898|NCT01610414|567438392|FG001|Study Start - Month 13|Suspected HZ episode|3|||
157190899|NCT01610414|567438391|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
157190900|NCT01610414|567438392|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
157190901|NCT01610414|567438391|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
157190902|NCT01610414|567438392|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
157190903|NCT01610414|567438391|FG000|Month 13 - Month 25|Adverse Event|8|||
157190904|NCT01610414|567438392|FG001|Month 13 - Month 25|Adverse Event|4|||
157190905|NCT01610414|567438391|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
157190906|NCT01610414|567438392|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
157190907|NCT01610414|567438391|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
157230464|NCT03164772|567590637|FG000|Overall Study|Progressive Disease|11|||
157230465|NCT03164772|567590638|FG001|Overall Study|Progressive Disease|21|||
157230466|NCT03164772|567590637|FG000|Overall Study|Physician Decision|2|||
157230467|NCT03164772|567590638|FG001|Overall Study|Physician Decision|0|||
157230468|NCT03164772|567590637|FG000|Overall Study|Withdrawal by Subject|0|||
157230469|NCT03164772|567590638|FG001|Overall Study|Withdrawal by Subject|4|||
157230470|NCT00849901|567590643|FG000|Acute Treatment Phase|Adverse Event|9|||
157230471|NCT00849901|567590644|FG001|Acute Treatment Phase|Adverse Event|1|||
157190908|NCT01610414|567438392|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
157230472|NCT00849901|567590645|FG002|Acute Treatment Phase|Adverse Event|3|||
157190909|NCT01610414|567438391|FG000|Month 13 - Month 25|Protocol Violation|0|||
157190910|NCT01610414|567438392|FG001|Month 13 - Month 25|Protocol Violation|2|||
157190911|NCT01610414|567438391|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
157190912|NCT01610414|567438392|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
157190913|NCT01610414|567438391|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
157230473|NCT00849901|567590643|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
157230474|NCT00849901|567590644|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
157069157|NCT04680637|567006192|FG000|Overall Study|Death|1|||
157230475|NCT00849901|567590645|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
157230476|NCT00849901|567590643|FG000|Acute Treatment Phase|Protocol Violation|0|||
157230477|NCT00849901|567590644|FG001|Acute Treatment Phase|Protocol Violation|2|||
157190914|NCT01610414|567438392|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
157190915|NCT01610414|567438391|FG000|After Month 25|Study end not reached|48|||
157190916|NCT01610414|567438392|FG001|After Month 25|Study end not reached|53|||
157190917|NCT04009824|567438393|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
157190918|NCT04009824|567438394|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
157190919|NCT04009824|567438395|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
157190920|NCT04009824|567438396|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
157190921|NCT04009824|567438397|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
157190922|NCT00392210|567438401|FG000|First Voiding Trial|Physician Decision|2|||
157190923|NCT00392210|567438402|FG001|First Voiding Trial|Physician Decision|2|||
157190924|NCT02067104|567438403|FG000|Overall Study|Study termination due to low accrual|4|||
157190925|NCT02067104|567438404|FG001|Overall Study|Study termination due to low accrual|5|||
157190926|NCT02610231|567438410|FG000|Overall Study|Withdrawal by Subject|27|||
157190927|NCT02610231|567438410|FG000|Overall Study|Adverse Event|20|||
157190928|NCT02610231|567438410|FG000|Overall Study|Death|5|||
157190929|NCT02610231|567438410|FG000|Overall Study|Surgery|2|||
157190930|NCT02610231|567438410|FG000|Overall Study|Physician Decision|1|||
157190931|NCT02610231|567438410|FG000|Overall Study|Non Compliance|2|||
157190932|NCT02610231|567438410|FG000|Overall Study|Other|3|||
157190933|NCT01279954|567438413|FG000|Overall Study|Lack of Efficacy|3|||
157190934|NCT01279954|567438414|FG001|Overall Study|Lack of Efficacy|4|||
157190935|NCT02140762|567438415|FG000|Overall Study|Adverse Event|1|||
157190936|NCT02140762|567438416|FG001|Overall Study|Adverse Event|1|||
157190937|NCT02140762|567438415|FG000|Overall Study|Lost to Follow-up|9|||
157190938|NCT02140762|567438416|FG001|Overall Study|Lost to Follow-up|5|||
157190939|NCT02140762|567438415|FG000|Overall Study|Protocol Violation|1|||
157190940|NCT02140762|567438416|FG001|Overall Study|Protocol Violation|1|||
157190941|NCT02140762|567438415|FG000|Overall Study|Withdrawal by Subject|6|||
157190942|NCT02140762|567438416|FG001|Overall Study|Withdrawal by Subject|4|||
157190943|NCT02140762|567438415|FG000|Overall Study|Other|0|||
157190944|NCT02140762|567438416|FG001|Overall Study|Other|1|||
157190945|NCT01711359|567438418|FG000|Treatment Period|Withdrawal by Subject|18|||
157190946|NCT01711359|567438419|FG001|Treatment Period|Withdrawal by Subject|7|||
157190947|NCT01711359|567438420|FG002|Treatment Period|Withdrawal by Subject|13|||
157190948|NCT01711359|567438418|FG000|Treatment Period|Lack of Efficacy|13|||
157190949|NCT01711359|567438419|FG001|Treatment Period|Lack of Efficacy|2|||
157190950|NCT01711359|567438420|FG002|Treatment Period|Lack of Efficacy|2|||
157190951|NCT01711359|567438418|FG000|Treatment Period|Adverse Event|8|||
157190952|NCT01711359|567438419|FG001|Treatment Period|Adverse Event|10|||
157190953|NCT01711359|567438420|FG002|Treatment Period|Adverse Event|24|||
157190954|NCT01711359|567438418|FG000|Treatment Period|Physician Decision|4|||
157190955|NCT01711359|567438419|FG001|Treatment Period|Physician Decision|3|||
157190956|NCT01711359|567438420|FG002|Treatment Period|Physician Decision|2|||
157190957|NCT01711359|567438418|FG000|Treatment Period|Death|3|||
157190958|NCT01711359|567438419|FG001|Treatment Period|Death|0|||
157190959|NCT01711359|567438420|FG002|Treatment Period|Death|0|||
157190960|NCT01711359|567438418|FG000|Treatment Period|Entry Criteria Not Met|1|||
157190961|NCT01711359|567438419|FG001|Treatment Period|Entry Criteria Not Met|0|||
157190962|NCT01711359|567438420|FG002|Treatment Period|Entry Criteria Not Met|0|||
157190963|NCT01711359|567438418|FG000|Treatment Period|Sponsor Decision|1|||
157190964|NCT01711359|567438419|FG001|Treatment Period|Sponsor Decision|0|||
157190965|NCT01711359|567438420|FG002|Treatment Period|Sponsor Decision|0|||
157190966|NCT01711359|567438418|FG000|Treatment Period|Lost to Follow-up|1|||
157190967|NCT01711359|567438419|FG001|Treatment Period|Lost to Follow-up|1|||
157190968|NCT01711359|567438420|FG002|Treatment Period|Lost to Follow-up|1|||
157230478|NCT00849901|567590645|FG002|Acute Treatment Phase|Protocol Violation|1|||
157190969|NCT01711359|567438418|FG000|Treatment Period|Randomized, Not Treated|3|||
157190970|NCT01711359|567438419|FG001|Treatment Period|Randomized, Not Treated|1|||
157190971|NCT01711359|567438420|FG002|Treatment Period|Randomized, Not Treated|0|||
157190972|NCT01385098|567438423|FG000|Overall Study|Adverse Event|10|||
157190973|NCT01385098|567438423|FG000|Overall Study|Lost to Follow-up|4|||
157190974|NCT02033369|567440602|FG000|Overall Study|Physician Decision|1|||
157190975|NCT02033369|567440603|FG001|Overall Study|Physician Decision|2|||
157190976|NCT02033369|567440602|FG000|Overall Study|Not a good demographic match|0|||
157190977|NCT02033369|567440603|FG001|Overall Study|Not a good demographic match|2|||
157190978|NCT02033369|567440602|FG000|Overall Study|Withdrawal by Subject|1|||
157190979|NCT02033369|567440603|FG001|Overall Study|Withdrawal by Subject|1|||
157190980|NCT02033369|567440602|FG000|Overall Study|Lost to Follow-up|1|||
157190981|NCT02033369|567440603|FG001|Overall Study|Lost to Follow-up|0|||
157190982|NCT02033369|567440602|FG000|Overall Study|Protocol Violation|2|||
157230479|NCT00849901|567590643|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
157230480|NCT00849901|567590644|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
157230481|NCT00849901|567590645|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
157190983|NCT02033369|567440603|FG001|Overall Study|Protocol Violation|0|||
157190984|NCT00303602|567440611|FG000|Overall Study|Adverse Event|2|||
157190985|NCT00303602|567440612|FG001|Overall Study|Adverse Event|2|||
157190986|NCT00303602|567440611|FG000|Overall Study|Withdrawal by Subject|5|||
157069158|NCT04680637|567006193|FG001|Overall Study|Death|0|||
157069159|NCT04680637|567006194|FG002|Overall Study|Death|0|||
157069160|NCT04680637|567006195|FG003|Overall Study|Death|0|||
157069161|NCT04680637|567006192|FG000|Overall Study|Withdrawal by Subject|7|||
157069162|NCT04680637|567006193|FG001|Overall Study|Withdrawal by Subject|10|||
157069163|NCT04680637|567006194|FG002|Overall Study|Withdrawal by Subject|17|||
157069164|NCT04680637|567006195|FG003|Overall Study|Withdrawal by Subject|15|||
157069165|NCT04680637|567006192|FG000|Overall Study|Decision by Sponsor|21|||
157190987|NCT00303602|567440612|FG001|Overall Study|Withdrawal by Subject|6|||
157190988|NCT00303602|567440611|FG000|Overall Study|Lost to Follow-up|5|||
157190989|NCT00303602|567440612|FG001|Overall Study|Lost to Follow-up|2|||
157190990|NCT00303602|567440611|FG000|Overall Study|Protocol entry criteria not met|2|||
157190991|NCT00303602|567440612|FG001|Overall Study|Protocol entry criteria not met|2|||
157190992|NCT00303602|567440611|FG000|Overall Study|Physician Decision|2|||
157190993|NCT00303602|567440612|FG001|Overall Study|Physician Decision|1|||
157190994|NCT00303602|567440611|FG000|Overall Study|Noncompliance|2|||
157190995|NCT00303602|567440612|FG001|Overall Study|Noncompliance|2|||
157190996|NCT00303602|567440611|FG000|Overall Study|Protocol Violation|1|||
157190997|NCT00303602|567440612|FG001|Overall Study|Protocol Violation|0|||
157190998|NCT02551874|567440619|FG000|Overall Study|Lost to Follow-up|0|||
157190999|NCT02551874|567440620|FG001|Overall Study|Lost to Follow-up|2|||
157191000|NCT02551874|567440619|FG000|Overall Study|Pregnancy|0|||
157191001|NCT02551874|567440620|FG001|Overall Study|Pregnancy|1|||
157191002|NCT02551874|567440619|FG000|Overall Study|Reason not reported|10|||
157191003|NCT02551874|567440620|FG001|Overall Study|Reason not reported|4|||
157191004|NCT02551874|567440619|FG000|Overall Study|Did not receive randomized treatment|0|||
157191005|NCT02551874|567440620|FG001|Overall Study|Did not receive randomized treatment|7|||
157191006|NCT02551874|567440619|FG000|Overall Study|Did not enter long-term study|18|||
157191007|NCT02551874|567440620|FG001|Overall Study|Did not enter long-term study|25|||
157191008|NCT02491463|567440621|FG000|Overall Study|Withdrawal by Subject|1|||
157191009|NCT02491463|567440622|FG001|Overall Study|Withdrawal by Subject|2|||
157191010|NCT02491463|567440623|FG002|Overall Study|Withdrawal by Subject|0|||
157191011|NCT02491463|567440624|FG003|Overall Study|Withdrawal by Subject|0|||
157191012|NCT02491463|567440621|FG000|Overall Study|Migrated/moved from study area|1|||
157191013|NCT02491463|567440622|FG001|Overall Study|Migrated/moved from study area|5|||
157191014|NCT02491463|567440623|FG002|Overall Study|Migrated/moved from study area|1|||
157191015|NCT02491463|567440624|FG003|Overall Study|Migrated/moved from study area|1|||
157191016|NCT02491463|567440621|FG000|Overall Study|Lost to Follow-up|0|||
157191017|NCT02491463|567440622|FG001|Overall Study|Lost to Follow-up|3|||
157191018|NCT02491463|567440623|FG002|Overall Study|Lost to Follow-up|3|||
157191019|NCT02491463|567440624|FG003|Overall Study|Lost to Follow-up|0|||
157191020|NCT01491802|567440625|FG000|Overall Study|Adverse Event|1|||
157191021|NCT01491802|567440626|FG001|Overall Study|Adverse Event|1|||
157191022|NCT01491802|567440625|FG000|Overall Study|Withdrawal by Subject|0|||
157191023|NCT01491802|567440626|FG001|Overall Study|Withdrawal by Subject|1|||
157191024|NCT01864746|567440629|FG000|Overall Study|Disease recurrence|25|||
157191025|NCT01864746|567440630|FG001|Overall Study|Disease recurrence|40|||
157191026|NCT01864746|567440629|FG000|Overall Study|Second primary invasive nonbreast|2|||
157191027|NCT01864746|567440630|FG001|Overall Study|Second primary invasive nonbreast|3|||
157191028|NCT01864746|567440629|FG000|Overall Study|Death|2|||
157191029|NCT01864746|567440630|FG001|Overall Study|Death|1|||
157191030|NCT01864746|567440629|FG000|Overall Study|Adverse Event|33|||
157191031|NCT01864746|567440630|FG001|Overall Study|Adverse Event|5|||
157191032|NCT01864746|567440629|FG000|Overall Study|Withdrawal by Subject|56|||
157191033|NCT01864746|567440630|FG001|Overall Study|Withdrawal by Subject|41|||
157191034|NCT01864746|567440629|FG000|Overall Study|Physician Decision|5|||
157191035|NCT01864746|567440630|FG001|Overall Study|Physician Decision|6|||
157191036|NCT00663208|567440631|FG000|Treatment Period|Lost to Follow-up|0|||
157191037|NCT00663208|567440632|FG001|Treatment Period|Lost to Follow-up|1|||
157191038|NCT00663208|567440633|FG002|Treatment Period|Lost to Follow-up|0|||
157191039|NCT00663208|567440634|FG003|Treatment Period|Lost to Follow-up|0|||
157191040|NCT00663208|567440635|FG004|Treatment Period|Lost to Follow-up|0|||
157191041|NCT00663208|567440636|FG005|Treatment Period|Lost to Follow-up|0|||
157191042|NCT00663208|567440637|FG006|Treatment Period|Lost to Follow-up|0|||
157069166|NCT04680637|567006193|FG001|Overall Study|Decision by Sponsor|15|||
157069167|NCT04680637|567006194|FG002|Overall Study|Decision by Sponsor|7|||
157069168|NCT04680637|567006195|FG003|Overall Study|Decision by Sponsor|32|||
157191043|NCT00663208|567440631|FG000|Follow-up Period|Lost to Follow-up|2|||
157191044|NCT00663208|567440632|FG001|Follow-up Period|Lost to Follow-up|0|||
157191045|NCT00663208|567440633|FG002|Follow-up Period|Lost to Follow-up|3|||
157191046|NCT00663208|567440634|FG003|Follow-up Period|Lost to Follow-up|2|||
157191047|NCT00663208|567440635|FG004|Follow-up Period|Lost to Follow-up|0|||
157191048|NCT00663208|567440636|FG005|Follow-up Period|Lost to Follow-up|0|||
157191049|NCT00663208|567440637|FG006|Follow-up Period|Lost to Follow-up|0|||
157069169|NCT01103232|567006198|FG000|Overall Study|Withdrawal by Subject|1|||
157191050|NCT00663208|567440631|FG000|Follow-up Period|Other reason|1|||
157191051|NCT00663208|567440632|FG001|Follow-up Period|Other reason|0|||
157191052|NCT00663208|567440633|FG002|Follow-up Period|Other reason|0|||
157191053|NCT00663208|567440634|FG003|Follow-up Period|Other reason|0|||
157191054|NCT00663208|567440635|FG004|Follow-up Period|Other reason|0|||
157191055|NCT00663208|567440636|FG005|Follow-up Period|Other reason|0|||
157191056|NCT00663208|567440637|FG006|Follow-up Period|Other reason|1|||
157191057|NCT01005966|567440638|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
157191058|NCT01005966|567440639|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
157191059|NCT01005966|567440640|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
157191060|NCT01005966|567440641|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
157191061|NCT01005966|567440642|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
157191062|NCT01005966|567440638|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
157191063|NCT01005966|567440639|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
157191064|NCT01005966|567440640|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
157191065|NCT01005966|567440641|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
157191066|NCT01005966|567440642|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
157191067|NCT01005966|567440638|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
157191068|NCT01005966|567440639|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
157191069|NCT01005966|567440640|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
157191070|NCT01005966|567440641|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
157191071|NCT01005966|567440642|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
157191072|NCT01005966|567440638|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
157191073|NCT01005966|567440639|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
157191074|NCT01005966|567440640|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
157191075|NCT01005966|567440641|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
157191076|NCT01005966|567440642|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
157191077|NCT01005966|567440638|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
157191078|NCT01005966|567440639|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
157191079|NCT01005966|567440640|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
157191080|NCT01005966|567440641|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
157191081|NCT01005966|567440642|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
157191082|NCT01005966|567440638|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
157191083|NCT01005966|567440639|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
157191084|NCT01005966|567440640|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
157191085|NCT01005966|567440641|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
157191086|NCT01005966|567440642|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
157191087|NCT01005966|567440638|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
157191088|NCT01005966|567440639|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
157191089|NCT01005966|567440640|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
157191090|NCT01005966|567440641|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
157191091|NCT01005966|567440642|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
157191092|NCT01005966|567440638|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
157191093|NCT01005966|567440639|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
157191094|NCT01005966|567440640|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
157191095|NCT01005966|567440641|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
157191096|NCT01005966|567440642|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
157191097|NCT01005966|567440638|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
157191098|NCT01005966|567440639|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
157191099|NCT01005966|567440640|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
157191100|NCT01005966|567440641|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
157191101|NCT01005966|567440642|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
157191102|NCT00039377|567440643|FG000|Initial Registration|Adverse Event|2|||
157191103|NCT00039377|567440644|FG001|Initial Registration|Adverse Event|0|||
157191104|NCT00039377|567440645|FG002|Initial Registration|Adverse Event|0|||
157191105|NCT00039377|567440646|FG003|Initial Registration|Adverse Event|0|||
157191106|NCT00039377|567440643|FG000|Initial Registration|Relapsed|6|||
157191107|NCT00039377|567440644|FG001|Initial Registration|Relapsed|0|||
157191108|NCT00039377|567440645|FG002|Initial Registration|Relapsed|0|||
157191109|NCT00039377|567440646|FG003|Initial Registration|Relapsed|0|||
157191110|NCT00039377|567440643|FG000|Initial Registration|Received non-protocol therapy|11|||
157191111|NCT00039377|567440644|FG001|Initial Registration|Received non-protocol therapy|0|||
157191112|NCT00039377|567440645|FG002|Initial Registration|Received non-protocol therapy|0|||
157191113|NCT00039377|567440646|FG003|Initial Registration|Received non-protocol therapy|0|||
157191114|NCT00039377|567440643|FG000|Initial Registration|Withdrawal by Subject|3|||
157191115|NCT00039377|567440644|FG001|Initial Registration|Withdrawal by Subject|0|||
157191116|NCT00039377|567440645|FG002|Initial Registration|Withdrawal by Subject|0|||
157191117|NCT00039377|567440646|FG003|Initial Registration|Withdrawal by Subject|0|||
157191118|NCT03890731|567440647|FG000|Overall Study|Progressive disease|1|||
157191119|NCT03890731|567440647|FG000|Overall Study|Patient's decision|1|||
157191120|NCT03890731|567440647|FG000|Overall Study|Adverse Event|4|||
157191121|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
157191122|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
157191123|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
157191124|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
157191125|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
157191126|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
157191127|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
157191128|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
157191129|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
157191130|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
157191131|NCT02528643|567440648|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
157191132|NCT02528643|567440649|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
157191133|NCT02528643|567440648|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
157191134|NCT02528643|567440649|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
157191135|NCT04144140|567440650|FG000|Overall Study|Other|0|||
157191136|NCT04144140|567440651|FG001|Overall Study|Other|0|||
157191137|NCT04144140|567440652|FG002|Overall Study|Other|0|||
157191138|NCT04144140|567440653|FG003|Overall Study|Other|0|||
157191139|NCT04144140|567440654|FG004|Overall Study|Other|0|||
157191140|NCT04144140|567440655|FG005|Overall Study|Other|1|||
157191141|NCT04144140|567440656|FG006|Overall Study|Other|0|||
157191142|NCT01640353|567440657|FG000|Overall Study|Withdrew prior to treatment|10|||
157191143|NCT01640353|567440657|FG000|Overall Study|Withdrawn from analysis at term site|12|||
157191144|NCT01640353|567440657|FG000|Overall Study|Withdrawal by Subject|5|||
157191145|NCT01640353|567440657|FG000|Overall Study|Death|2|||
157191146|NCT01640353|567440657|FG000|Overall Study|Early site termination|3|||
157191147|NCT01640353|567440657|FG000|Overall Study|Lost to Follow-up|12|||
157191148|NCT01640353|567440657|FG000|Overall Study|Physician Decision|1|||
157191149|NCT03758612|567440658|FG000|Washout Period|Withdrawal by Subject|0|||
157191150|NCT03758612|567440659|FG001|Washout Period|Withdrawal by Subject|0|||
157191151|NCT03758612|567440660|FG002|Washout Period|Withdrawal by Subject|2|||
157191152|NCT03758612|567440661|FG003|Washout Period|Withdrawal by Subject|0|||
157191153|NCT03758612|567440662|FG004|Washout Period|Withdrawal by Subject|0|||
157191154|NCT03758612|567440663|FG005|Washout Period|Withdrawal by Subject|0|||
157191155|NCT03758612|567440664|FG006|Washout Period|Withdrawal by Subject|0|||
157191156|NCT03758612|567440665|FG007|Washout Period|Withdrawal by Subject|0|||
157191157|NCT03758612|567440666|FG008|Washout Period|Withdrawal by Subject|0|||
157191158|NCT03758612|567440667|FG009|Washout Period|Withdrawal by Subject|0|||
157191159|NCT03758612|567440668|FG010|Washout Period|Withdrawal by Subject|0|||
157191160|NCT03758612|567440669|FG011|Washout Period|Withdrawal by Subject|0|||
157191161|NCT03758612|567440658|FG000|Period 2|Protocol Violation|0|||
157191162|NCT03758612|567440659|FG001|Period 2|Protocol Violation|0|||
157191163|NCT03758612|567440660|FG002|Period 2|Protocol Violation|0|||
157191164|NCT03758612|567440661|FG003|Period 2|Protocol Violation|0|||
157191165|NCT03758612|567440662|FG004|Period 2|Protocol Violation|1|||
157191166|NCT03758612|567440663|FG005|Period 2|Protocol Violation|0|||
157191167|NCT03758612|567440664|FG006|Period 2|Protocol Violation|0|||
157191168|NCT03758612|567440665|FG007|Period 2|Protocol Violation|0|||
157191169|NCT03758612|567440666|FG008|Period 2|Protocol Violation|0|||
157191170|NCT03758612|567440667|FG009|Period 2|Protocol Violation|0|||
157191171|NCT03758612|567440668|FG010|Period 2|Protocol Violation|0|||
157191172|NCT03758612|567440669|FG011|Period 2|Protocol Violation|0|||
157191173|NCT02679222|567440671|FG000|Overall Study|No time for project|1|||
157191174|NCT04354870|567440672|FG000|Overall Study|Lost to Follow-up|32|||
157191175|NCT04354870|567440673|FG001|Overall Study|Lost to Follow-up|12|||
157191176|NCT04354870|567440672|FG000|Overall Study|Withdrawal by Subject|10|||
157191177|NCT04354870|567440673|FG001|Overall Study|Withdrawal by Subject|16|||
157191178|NCT04354870|567440672|FG000|Overall Study|Did not complete all study visits|6|||
157191179|NCT04354870|567440673|FG001|Overall Study|Did not complete all study visits|5|||
157191180|NCT01066819|567440674|FG000|Overall Study|Adverse Event|18|||
157191181|NCT01066819|567440675|FG001|Overall Study|Adverse Event|1|||
157191182|NCT01066819|567440676|FG002|Overall Study|Adverse Event|6|||
157191183|NCT01066819|567440677|FG003|Overall Study|Adverse Event|0|||
157191184|NCT01066819|567440678|FG004|Overall Study|Adverse Event|0|||
157191185|NCT01066819|567440679|FG005|Overall Study|Adverse Event|0|||
157191186|NCT01066819|567440674|FG000|Overall Study|Death|5|||
157191187|NCT01066819|567440675|FG001|Overall Study|Death|0|||
157191188|NCT01066819|567440676|FG002|Overall Study|Death|1|||
157191189|NCT01066819|567440677|FG003|Overall Study|Death|0|||
157191190|NCT01066819|567440678|FG004|Overall Study|Death|0|||
157191191|NCT01066819|567440679|FG005|Overall Study|Death|0|||
157191192|NCT01066819|567440674|FG000|Overall Study|Lack of Efficacy|22|||
157191193|NCT01066819|567440675|FG001|Overall Study|Lack of Efficacy|1|||
157191194|NCT01066819|567440676|FG002|Overall Study|Lack of Efficacy|2|||
157191195|NCT01066819|567440677|FG003|Overall Study|Lack of Efficacy|1|||
157191196|NCT01066819|567440678|FG004|Overall Study|Lack of Efficacy|0|||
157191197|NCT01066819|567440679|FG005|Overall Study|Lack of Efficacy|0|||
157191198|NCT01066819|567440674|FG000|Overall Study|Physician Decision|6|||
157191199|NCT01066819|567440675|FG001|Overall Study|Physician Decision|2|||
157069170|NCT01103232|567006199|FG001|Overall Study|Withdrawal by Subject|1|||
157069171|NCT01103232|567006198|FG000|Overall Study|Protocol Violation|0|||
157069172|NCT01103232|567006199|FG001|Overall Study|Protocol Violation|1|||
157069173|NCT00443599|567006200|FG000|Overall Study|Physician Decision|2|||
157069174|NCT00443599|567006201|FG001|Overall Study|Physician Decision|1|||
157069175|NCT00443599|567006200|FG000|Overall Study|Death|1|||
157069176|NCT00443599|567006201|FG001|Overall Study|Death|1|||
157069177|NCT00443599|567006200|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
157069178|NCT00443599|567006201|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
157069179|NCT04991766|567007546|FG000|Overall Study|Withdrawal by Subject|2|||
157069180|NCT04991766|567007547|FG001|Overall Study|Withdrawal by Subject|0|||
157069181|NCT05765435|567007555|FG000|Overall Study|Lost to Follow-up|0|||
157069182|NCT05765435|567007556|FG001|Overall Study|Lost to Follow-up|1|||
157069183|NCT05765435|567007557|FG002|Overall Study|Lost to Follow-up|0|||
157069184|NCT05765435|567007555|FG000|Overall Study|Withdrawal by Subject|0|||
157069185|NCT05765435|567007556|FG001|Overall Study|Withdrawal by Subject|0|||
157069186|NCT05765435|567007557|FG002|Overall Study|Withdrawal by Subject|1|||
157069187|NCT01952847|567007558|FG000|Overall Study|Ineligible|1|||
157069188|NCT01952847|567007559|FG001|Overall Study|Ineligible|0|||
157069189|NCT01952847|567007560|FG002|Overall Study|Ineligible|0|||
157069190|NCT01952847|567007561|FG003|Overall Study|Ineligible|0|||
157069191|NCT01952847|567007558|FG000|Overall Study|Lack of Insurance Coverage|0|||
157069192|NCT01952847|567007559|FG001|Overall Study|Lack of Insurance Coverage|1|||
157069193|NCT01952847|567007560|FG002|Overall Study|Lack of Insurance Coverage|0|||
157069194|NCT01952847|567007561|FG003|Overall Study|Lack of Insurance Coverage|0|||
157069195|NCT01952847|567007558|FG000|Overall Study|Withdrawal by Subject|1|||
157069196|NCT01952847|567007559|FG001|Overall Study|Withdrawal by Subject|1|||
157069197|NCT01952847|567007560|FG002|Overall Study|Withdrawal by Subject|0|||
157069198|NCT01952847|567007561|FG003|Overall Study|Withdrawal by Subject|1|||
157069199|NCT00940875|567007562|FG000|Treatment Phase|Adverse Event|9|||
157069200|NCT00940875|567007563|FG001|Treatment Phase|Adverse Event|3|||
157069201|NCT00940875|567007562|FG000|Treatment Phase|Death|3|||
157069202|NCT00940875|567007563|FG001|Treatment Phase|Death|5|||
157069203|NCT00940875|567007562|FG000|Treatment Phase|Lack of Efficacy|1|||
157069204|NCT00940875|567007563|FG001|Treatment Phase|Lack of Efficacy|0|||
157069205|NCT00940875|567007562|FG000|Treatment Phase|Withdrawal by Subject|3|||
157069206|NCT00940875|567007563|FG001|Treatment Phase|Withdrawal by Subject|0|||
157069207|NCT00940875|567007562|FG000|Treatment Phase|Disease progression|9|||
157069208|NCT00940875|567007563|FG001|Treatment Phase|Disease progression|11|||
157069209|NCT00940875|567007562|FG000|Treatment Phase|Physician Decision|1|||
157069210|NCT00940875|567007563|FG001|Treatment Phase|Physician Decision|0|||
157069211|NCT00940875|567007562|FG000|Post-Study Treatment|Death|0|||
157069212|NCT00940875|567007563|FG001|Post-Study Treatment|Death|1|||
157069213|NCT00940875|567007562|FG000|Post-Study Treatment|Disease Progression|0|||
157069214|NCT00940875|567007563|FG001|Post-Study Treatment|Disease Progression|2|||
157069215|NCT03721705|567007564|FG000|Overall Study|Adverse Event|2|||
157069216|NCT03721705|567007565|FG001|Overall Study|Adverse Event|0|||
157069217|NCT03721705|567007564|FG000|Overall Study|Withdrawal by Subject|4|||
157069218|NCT03721705|567007565|FG001|Overall Study|Withdrawal by Subject|10|||
157069219|NCT03721705|567007564|FG000|Overall Study|No Suitable Study Partner|1|||
157069220|NCT03721705|567007565|FG001|Overall Study|No Suitable Study Partner|0|||
157069221|NCT03721705|567007564|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
157069222|NCT03721705|567007565|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
157069223|NCT03721705|567007564|FG000|Overall Study|Death|0|||
157069224|NCT03721705|567007565|FG001|Overall Study|Death|1|||
157069225|NCT05147350|567007567|FG000|Overall Study|Death|2|||
157069226|NCT05147350|567007568|FG001|Overall Study|Death|3|||
157069227|NCT05147350|567007569|FG002|Overall Study|Death|3|||
157069228|NCT05147350|567007570|FG003|Overall Study|Death|2|||
157069229|NCT05147350|567007571|FG004|Overall Study|Death|2|||
157069230|NCT05147350|567007572|FG005|Overall Study|Death|1|||
157069231|NCT05147350|567007573|FG006|Overall Study|Death|1|||
157069232|NCT05147350|567007574|FG007|Overall Study|Death|3|||
157069233|NCT05147350|567007567|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
157069234|NCT05147350|567007568|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
157069235|NCT05147350|567007569|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
157069236|NCT05147350|567007570|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
157069237|NCT05147350|567007571|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
157230482|NCT00849901|567590643|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
157069238|NCT05147350|567007572|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
157069239|NCT05147350|567007573|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
157069240|NCT05147350|567007574|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
157069241|NCT05147350|567007567|FG000|Overall Study|Withdrawal by Subject|0|||
157069242|NCT05147350|567007568|FG001|Overall Study|Withdrawal by Subject|0|||
157069243|NCT05147350|567007569|FG002|Overall Study|Withdrawal by Subject|3|||
157069244|NCT05147350|567007570|FG003|Overall Study|Withdrawal by Subject|1|||
157069245|NCT05147350|567007571|FG004|Overall Study|Withdrawal by Subject|1|||
157069246|NCT05147350|567007572|FG005|Overall Study|Withdrawal by Subject|0|||
157069247|NCT05147350|567007573|FG006|Overall Study|Withdrawal by Subject|1|||
157069248|NCT05147350|567007574|FG007|Overall Study|Withdrawal by Subject|0|||
157069249|NCT05147350|567007567|FG000|Overall Study|Other Reasons|0|||
157069250|NCT05147350|567007568|FG001|Overall Study|Other Reasons|0|||
157069251|NCT05147350|567007569|FG002|Overall Study|Other Reasons|2|||
157069252|NCT05147350|567007570|FG003|Overall Study|Other Reasons|0|||
157069253|NCT05147350|567007571|FG004|Overall Study|Other Reasons|0|||
157069254|NCT05147350|567007572|FG005|Overall Study|Other Reasons|2|||
157069255|NCT05147350|567007573|FG006|Overall Study|Other Reasons|1|||
157069256|NCT05147350|567007574|FG007|Overall Study|Other Reasons|1|||
157191200|NCT01066819|567440676|FG002|Overall Study|Physician Decision|3|||
157191201|NCT01066819|567440677|FG003|Overall Study|Physician Decision|0|||
157191202|NCT01066819|567440678|FG004|Overall Study|Physician Decision|0|||
157191203|NCT01066819|567440679|FG005|Overall Study|Physician Decision|0|||
157191204|NCT01066819|567440674|FG000|Overall Study|Protocol Violation|12|||
157191205|NCT01066819|567440675|FG001|Overall Study|Protocol Violation|6|||
157191206|NCT01066819|567440676|FG002|Overall Study|Protocol Violation|0|||
157191207|NCT01066819|567440677|FG003|Overall Study|Protocol Violation|0|||
157191208|NCT01066819|567440678|FG004|Overall Study|Protocol Violation|0|||
157191209|NCT01066819|567440679|FG005|Overall Study|Protocol Violation|0|||
157191210|NCT01066819|567440674|FG000|Overall Study|Withdrawal by Subject|29|||
157191211|NCT01066819|567440675|FG001|Overall Study|Withdrawal by Subject|11|||
157191212|NCT01066819|567440676|FG002|Overall Study|Withdrawal by Subject|6|||
157191213|NCT01066819|567440677|FG003|Overall Study|Withdrawal by Subject|0|||
157191214|NCT01066819|567440678|FG004|Overall Study|Withdrawal by Subject|0|||
157191215|NCT01066819|567440679|FG005|Overall Study|Withdrawal by Subject|0|||
157191216|NCT01066819|567440674|FG000|Overall Study|Administrative|6|||
157191217|NCT01066819|567440675|FG001|Overall Study|Administrative|4|||
157191218|NCT01066819|567440676|FG002|Overall Study|Administrative|2|||
157191219|NCT01066819|567440677|FG003|Overall Study|Administrative|0|||
157191220|NCT01066819|567440678|FG004|Overall Study|Administrative|0|||
157191221|NCT01066819|567440679|FG005|Overall Study|Administrative|0|||
157191222|NCT01066819|567440674|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
157191223|NCT01066819|567440675|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
157191224|NCT01066819|567440676|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
157191225|NCT01066819|567440677|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
157191226|NCT01066819|567440678|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
157191227|NCT01066819|567440679|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
157191228|NCT01066819|567440674|FG000|Overall Study|Early termination|2|||
157191229|NCT01066819|567440675|FG001|Overall Study|Early termination|0|||
157191230|NCT01066819|567440676|FG002|Overall Study|Early termination|0|||
157191231|NCT01066819|567440677|FG003|Overall Study|Early termination|0|||
157191232|NCT01066819|567440678|FG004|Overall Study|Early termination|0|||
157191233|NCT01066819|567440679|FG005|Overall Study|Early termination|0|||
157191234|NCT01066819|567440674|FG000|Overall Study|Failed to return|298|||
157191235|NCT01066819|567440675|FG001|Overall Study|Failed to return|107|||
157191236|NCT01066819|567440676|FG002|Overall Study|Failed to return|68|||
157191237|NCT01066819|567440677|FG003|Overall Study|Failed to return|7|||
157191238|NCT01066819|567440678|FG004|Overall Study|Failed to return|2|||
157191239|NCT01066819|567440679|FG005|Overall Study|Failed to return|3|||
157191240|NCT01066819|567440674|FG000|Overall Study|Lab test not done|9|||
157191241|NCT01066819|567440675|FG001|Overall Study|Lab test not done|0|||
157191242|NCT01066819|567440676|FG002|Overall Study|Lab test not done|2|||
157191243|NCT01066819|567440677|FG003|Overall Study|Lab test not done|1|||
157191244|NCT01066819|567440678|FG004|Overall Study|Lab test not done|0|||
157191245|NCT01066819|567440679|FG005|Overall Study|Lab test not done|0|||
157191246|NCT01066819|567440674|FG000|Overall Study|Miscellaneous|28|||
157191247|NCT01066819|567440675|FG001|Overall Study|Miscellaneous|10|||
157191248|NCT01066819|567440676|FG002|Overall Study|Miscellaneous|18|||
157191249|NCT01066819|567440677|FG003|Overall Study|Miscellaneous|1|||
157191250|NCT01066819|567440678|FG004|Overall Study|Miscellaneous|0|||
157191251|NCT01066819|567440679|FG005|Overall Study|Miscellaneous|0|||
157191252|NCT01066819|567440674|FG000|Overall Study|Non responders|123|||
157191253|NCT01066819|567440675|FG001|Overall Study|Non responders|2|||
157191254|NCT01066819|567440676|FG002|Overall Study|Non responders|7|||
157191255|NCT01066819|567440677|FG003|Overall Study|Non responders|2|||
157191256|NCT01066819|567440678|FG004|Overall Study|Non responders|0|||
157069257|NCT01080326|567007575|FG000|Overall Study|Patient deterioration prior to procedure|3|||
157069258|NCT01080326|567007575|FG000|Overall Study|Surgeon decision|1|||
157191257|NCT01066819|567440679|FG005|Overall Study|Non responders|1|||
157191258|NCT01066819|567440674|FG000|Overall Study|Not categorised|9|||
157191259|NCT01066819|567440675|FG001|Overall Study|Not categorised|2|||
157191260|NCT01066819|567440676|FG002|Overall Study|Not categorised|6|||
157191261|NCT01066819|567440677|FG003|Overall Study|Not categorised|1|||
157191262|NCT01066819|567440678|FG004|Overall Study|Not categorised|0|||
157191263|NCT01066819|567440679|FG005|Overall Study|Not categorised|0|||
157191264|NCT01066819|567440674|FG000|Overall Study|Relapse|16|||
157191265|NCT01066819|567440675|FG001|Overall Study|Relapse|4|||
157230483|NCT00849901|567590644|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
157230484|NCT00849901|567590645|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
157230485|NCT00849901|567590643|FG000|Acute Treatment Phase|Physician Decision|1|||
157230486|NCT00849901|567590644|FG001|Acute Treatment Phase|Physician Decision|1|||
157230487|NCT00849901|567590645|FG002|Acute Treatment Phase|Physician Decision|1|||
157230488|NCT00849901|567590643|FG000|Acute Treatment Phase|Sponsor Decision|1|||
157230489|NCT00849901|567590644|FG001|Acute Treatment Phase|Sponsor Decision|0|||
157230490|NCT00849901|567590645|FG002|Acute Treatment Phase|Sponsor Decision|0|||
157230491|NCT00849901|567590643|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
157230492|NCT00849901|567590644|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
157230493|NCT00849901|567590645|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
157230494|NCT00849901|567590643|FG000|Extension Phase|Adverse Event|2|||
157230495|NCT00849901|567590644|FG001|Extension Phase|Adverse Event|8|||
157230496|NCT00849901|567590645|FG002|Extension Phase|Adverse Event|4|||
157069259|NCT01628692|567007578|FG000|Overall Study|Lack of Efficacy|4|||
157191266|NCT01066819|567440676|FG002|Overall Study|Relapse|3|||
157191267|NCT01066819|567440677|FG003|Overall Study|Relapse|0|||
157191268|NCT01066819|567440678|FG004|Overall Study|Relapse|0|||
157191269|NCT01066819|567440679|FG005|Overall Study|Relapse|0|||
157191270|NCT01066819|567440674|FG000|Overall Study|Results not available|1|||
157191271|NCT01066819|567440675|FG001|Overall Study|Results not available|0|||
157191272|NCT01066819|567440676|FG002|Overall Study|Results not available|0|||
157191273|NCT01066819|567440677|FG003|Overall Study|Results not available|0|||
157191274|NCT01066819|567440678|FG004|Overall Study|Results not available|0|||
157191275|NCT01066819|567440679|FG005|Overall Study|Results not available|0|||
157191276|NCT01066819|567440674|FG000|Overall Study|Screen failure|1|||
157191277|NCT01066819|567440675|FG001|Overall Study|Screen failure|0|||
157191278|NCT01066819|567440676|FG002|Overall Study|Screen failure|0|||
157191279|NCT01066819|567440677|FG003|Overall Study|Screen failure|0|||
157191280|NCT01066819|567440678|FG004|Overall Study|Screen failure|0|||
157191281|NCT01066819|567440679|FG005|Overall Study|Screen failure|0|||
157191282|NCT01066819|567440674|FG000|Overall Study|Spontaneous cure|1|||
157191283|NCT01066819|567440675|FG001|Overall Study|Spontaneous cure|0|||
157191284|NCT01066819|567440676|FG002|Overall Study|Spontaneous cure|0|||
157191285|NCT01066819|567440677|FG003|Overall Study|Spontaneous cure|0|||
157191286|NCT01066819|567440678|FG004|Overall Study|Spontaneous cure|0|||
157191287|NCT01066819|567440679|FG005|Overall Study|Spontaneous cure|0|||
157191288|NCT01066819|567440674|FG000|Overall Study|Treatment never started|85|||
157191289|NCT01066819|567440675|FG001|Overall Study|Treatment never started|19|||
157191290|NCT01066819|567440676|FG002|Overall Study|Treatment never started|19|||
157191291|NCT01066819|567440677|FG003|Overall Study|Treatment never started|3|||
157191292|NCT01066819|567440678|FG004|Overall Study|Treatment never started|2|||
157191293|NCT01066819|567440679|FG005|Overall Study|Treatment never started|2|||
157191294|NCT01066819|567440674|FG000|Overall Study|Treatment stopped|12|||
157191295|NCT01066819|567440675|FG001|Overall Study|Treatment stopped|1|||
157191296|NCT01066819|567440676|FG002|Overall Study|Treatment stopped|2|||
157191297|NCT01066819|567440677|FG003|Overall Study|Treatment stopped|1|||
157191298|NCT01066819|567440678|FG004|Overall Study|Treatment stopped|0|||
157191299|NCT01066819|567440679|FG005|Overall Study|Treatment stopped|0|||
157191300|NCT01066819|567440674|FG000|Overall Study|Other|5|||
157191301|NCT01066819|567440675|FG001|Overall Study|Other|1|||
157191302|NCT01066819|567440676|FG002|Overall Study|Other|1|||
157191303|NCT01066819|567440677|FG003|Overall Study|Other|0|||
157191304|NCT01066819|567440678|FG004|Overall Study|Other|0|||
157191305|NCT01066819|567440679|FG005|Overall Study|Other|0|||
157191306|NCT00303719|567440680|FG000|Overall Study|Not evaluable, prior therapies|0|||
157191307|NCT00303719|567440681|FG001|Overall Study|Not evaluable, prior therapies|30|||
157191308|NCT00303719|567440680|FG000|Overall Study|Lost to Follow-up|0|||
157191309|NCT00303719|567440681|FG001|Overall Study|Lost to Follow-up|7|||
157191310|NCT01641952|567440682|FG000|Overall Study|Lost to Follow-up|28|||
157191311|NCT01641952|567440682|FG000|Overall Study|Adverse Event|6|||
157191312|NCT03633461|567440683|FG000|Overall Study|Lost to Follow-up|0|||
157191313|NCT03633461|567440684|FG001|Overall Study|Lost to Follow-up|1|||
157191314|NCT02516605|567440690|FG000|Overall Study|Protocol Violation|0|||
157191315|NCT02516605|567440691|FG001|Overall Study|Protocol Violation|0|||
157191316|NCT02516605|567440692|FG002|Overall Study|Protocol Violation|0|||
157191317|NCT02516605|567440693|FG003|Overall Study|Protocol Violation|0|||
157191318|NCT02516605|567440694|FG004|Overall Study|Protocol Violation|1|||
157191319|NCT02516605|567440690|FG000|Overall Study|Withdrawal by Subject|0|||
157191320|NCT02516605|567440691|FG001|Overall Study|Withdrawal by Subject|0|||
157191321|NCT02516605|567440692|FG002|Overall Study|Withdrawal by Subject|0|||
157191322|NCT02516605|567440693|FG003|Overall Study|Withdrawal by Subject|1|||
157191323|NCT02516605|567440694|FG004|Overall Study|Withdrawal by Subject|0|||
157191324|NCT02643420|567440695|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
157191325|NCT02643420|567440696|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
157191326|NCT02643420|567440695|FG000|Overall Study|Withdrawal by Subject|25|||
157191327|NCT02643420|567440696|FG001|Overall Study|Withdrawal by Subject|19|||
157230497|NCT00849901|567590643|FG000|Extension Phase|Lost to Follow-up|3|||
157230498|NCT00849901|567590644|FG001|Extension Phase|Lost to Follow-up|0|||
157230499|NCT00849901|567590645|FG002|Extension Phase|Lost to Follow-up|1|||
157230500|NCT00849901|567590643|FG000|Extension Phase|Protocol Violation|2|||
157230501|NCT00849901|567590644|FG001|Extension Phase|Protocol Violation|2|||
157230502|NCT00849901|567590645|FG002|Extension Phase|Protocol Violation|4|||
157230503|NCT00849901|567590643|FG000|Extension Phase|Withdrawal by Subject|7|||
157230504|NCT00849901|567590644|FG001|Extension Phase|Withdrawal by Subject|6|||
157230505|NCT00849901|567590645|FG002|Extension Phase|Withdrawal by Subject|3|||
157230506|NCT00849901|567590643|FG000|Extension Phase|Parent or Caregiver Decision|10|||
157230507|NCT00849901|567590644|FG001|Extension Phase|Parent or Caregiver Decision|4|||
157230508|NCT00849901|567590645|FG002|Extension Phase|Parent or Caregiver Decision|4|||
157230509|NCT00849901|567590643|FG000|Extension Phase|Physician Decision|1|||
157230510|NCT00849901|567590644|FG001|Extension Phase|Physician Decision|2|||
157230511|NCT00849901|567590645|FG002|Extension Phase|Physician Decision|0|||
157230512|NCT00849901|567590643|FG000|Extension Phase|Lack of Efficacy|2|||
157230513|NCT00849901|567590644|FG001|Extension Phase|Lack of Efficacy|4|||
157230514|NCT00849901|567590645|FG002|Extension Phase|Lack of Efficacy|1|||
157230515|NCT00262223|567590646|FG000|Treatment Phase|Withdrawal by Subject|3|||
157230516|NCT00262223|567590647|FG001|Treatment Phase|Withdrawal by Subject|6|||
157230517|NCT00262223|567590646|FG000|Treatment Phase|Adverse Event|1|||
157230518|NCT00262223|567590647|FG001|Treatment Phase|Adverse Event|2|||
157230519|NCT00262223|567590646|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
157230520|NCT00262223|567590647|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
157230521|NCT00262223|567590646|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
157230522|NCT00262223|567590647|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
157230523|NCT00262223|567590646|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
157230524|NCT00262223|567590647|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
157230525|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
157230526|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
157230527|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
157230528|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
157230529|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
157230530|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
157230531|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
157230532|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
157230533|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
157230534|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
157230535|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
157230536|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
157230537|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
157230538|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
157230539|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
157230540|NCT00437658|567590650|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
157230541|NCT00437658|567590651|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
157230542|NCT00437658|567590652|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
157230543|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
157230544|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
157230545|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
157230546|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
157230547|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
157230548|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
157230549|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
157230550|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
157230551|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
157230552|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
157230553|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
157230554|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
157230555|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
157230556|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
157230557|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
157230558|NCT00437658|567590650|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
157230559|NCT00437658|567590651|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
157230560|NCT00437658|567590652|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
157230561|NCT03952143|567590653|FG000|Lead-In Period|Adverse Event|2|||
157230562|NCT03952143|567590654|FG001|Lead-In Period|Adverse Event|0|||
157230563|NCT03952143|567590655|FG002|Lead-In Period|Adverse Event|0|||
157230564|NCT03952143|567590653|FG000|Lead-In Period|Lack of Efficacy|2|||
157230565|NCT03952143|567590654|FG001|Lead-In Period|Lack of Efficacy|0|||
157230566|NCT03952143|567590655|FG002|Lead-In Period|Lack of Efficacy|0|||
157230567|NCT03952143|567590653|FG000|Lead-In Period|Physician Decision|5|||
157230568|NCT03952143|567590654|FG001|Lead-In Period|Physician Decision|0|||
157230569|NCT03952143|567590655|FG002|Lead-In Period|Physician Decision|0|||
157191328|NCT02643420|567440695|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
157191329|NCT02643420|567440696|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
157191330|NCT02643420|567440695|FG000|Overall Study|Lost to Follow-up|6|||
157191331|NCT02643420|567440696|FG001|Overall Study|Lost to Follow-up|10|||
157191332|NCT02643420|567440695|FG000|Overall Study|Investigator Decision|2|||
157191333|NCT02643420|567440696|FG001|Overall Study|Investigator Decision|4|||
157191334|NCT02643420|567440695|FG000|Overall Study|Sponsor decision|1|||
157191335|NCT02643420|567440696|FG001|Overall Study|Sponsor decision|1|||
157191336|NCT02643420|567440695|FG000|Overall Study|Death|0|||
157191337|NCT02643420|567440696|FG001|Overall Study|Death|2|||
157191338|NCT02643420|567440695|FG000|Overall Study|Reason not Specified|8|||
157191339|NCT02643420|567440696|FG001|Overall Study|Reason not Specified|7|||
157191340|NCT01716585|567440697|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
157191341|NCT01716585|567440698|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
157191342|NCT01716585|567440697|FG000|Double-blind Treatment|Adverse Event|2|||
157191343|NCT01716585|567440698|FG001|Double-blind Treatment|Adverse Event|1|||
157191344|NCT01716585|567440697|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
157191345|NCT01716585|567440698|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
157191346|NCT01716585|567440697|FG000|Double-blind Treatment|Lost to Follow-up|2|||
157191347|NCT01716585|567440698|FG001|Double-blind Treatment|Lost to Follow-up|0|||
157191348|NCT01716585|567440697|FG000|Double-blind Treatment|Subject Noncompliant|1|||
157191349|NCT01716585|567440698|FG001|Double-blind Treatment|Subject Noncompliant|0|||
157191350|NCT01716585|567440697|FG000|Double-blind Treatment|Other|1|||
157191351|NCT01716585|567440698|FG001|Double-blind Treatment|Other|0|||
157191352|NCT01716585|567440697|FG000|Open-label Treatment|Adverse Event|0|||
157191353|NCT01716585|567440698|FG001|Open-label Treatment|Adverse Event|2|||
157191354|NCT01716585|567440697|FG000|Open-label Treatment|Virologic Failure|0|||
157191355|NCT01716585|567440698|FG001|Open-label Treatment|Virologic Failure|2|||
157191356|NCT01716585|567440697|FG000|Open-label Treatment|Withdrawal by Subject|0|||
157191357|NCT01716585|567440698|FG001|Open-label Treatment|Withdrawal by Subject|3|||
157191358|NCT02275052|567440699|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
157191359|NCT02275052|567440700|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
157191360|NCT02275052|567440701|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
157191361|NCT02275052|567440702|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
157191362|NCT02275052|567440699|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
157191363|NCT02275052|567440700|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
157191364|NCT02275052|567440701|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
157191365|NCT02275052|567440702|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
157191366|NCT02275052|567440699|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
157191367|NCT02275052|567440700|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
157191368|NCT02275052|567440701|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157191369|NCT02275052|567440702|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157191370|NCT02275052|567440699|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
157191371|NCT02275052|567440700|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
157191372|NCT02275052|567440701|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
157191373|NCT02275052|567440702|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
157191374|NCT02275052|567440699|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
157191375|NCT02275052|567440700|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
157191376|NCT02275052|567440701|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
157191377|NCT02275052|567440702|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
157191378|NCT02275052|567440699|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
157191379|NCT02275052|567440700|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
157191380|NCT02275052|567440701|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
157191381|NCT02275052|567440702|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
157191382|NCT02275052|567440699|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
157191383|NCT02275052|567440700|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
157191384|NCT02275052|567440701|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
157191385|NCT02275052|567440702|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
157191386|NCT02275052|567440699|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
157191387|NCT02275052|567440700|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
157191388|NCT02275052|567440701|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
157191389|NCT02275052|567440702|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
157191390|NCT02275052|567440699|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157191391|NCT02275052|567440700|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157191392|NCT02275052|567440701|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
157191393|NCT02275052|567440702|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
157191394|NCT02275052|567440699|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
157191395|NCT02275052|567440700|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
157069260|NCT01628692|567007579|FG001|Overall Study|Lack of Efficacy|4|||
157069261|NCT01628692|567007580|FG002|Overall Study|Lack of Efficacy|5|||
157069262|NCT01628692|567007581|FG003|Overall Study|Lack of Efficacy|1|||
157069263|NCT01628692|567007582|FG004|Overall Study|Lack of Efficacy|4|||
157069264|NCT01628692|567007583|FG005|Overall Study|Lack of Efficacy|7|||
157069265|NCT01628692|567007578|FG000|Overall Study|Adverse Event|2|||
157069266|NCT01628692|567007579|FG001|Overall Study|Adverse Event|0|||
157069267|NCT01628692|567007580|FG002|Overall Study|Adverse Event|2|||
157069268|NCT01628692|567007581|FG003|Overall Study|Adverse Event|0|||
157069269|NCT01628692|567007582|FG004|Overall Study|Adverse Event|0|||
157069270|NCT01628692|567007583|FG005|Overall Study|Adverse Event|0|||
157069271|NCT01628692|567007578|FG000|Overall Study|Withdrawal by Subject|0|||
157191396|NCT02275052|567440701|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
157191397|NCT02275052|567440702|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
157191398|NCT02275052|567440699|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
157191399|NCT02275052|567440700|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
157191400|NCT02275052|567440701|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
157191401|NCT02275052|567440702|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
157191402|NCT05102734|567440703|FG000|Overall Study|Did not require vasopressors|1|||
157191403|NCT05102734|567440704|FG001|Overall Study|Did not require vasopressors|0|||
157191404|NCT05102734|567440703|FG000|Overall Study|Did not have functioning PA catheter|1|||
157191405|NCT05102734|567440704|FG001|Overall Study|Did not have functioning PA catheter|0|||
157191406|NCT05102734|567440703|FG000|Overall Study|Inadequate video quality|2|||
157191407|NCT05102734|567440704|FG001|Overall Study|Inadequate video quality|0|||
157191408|NCT03055806|567440710|FG000|Overall Study|Adverse Event|0|||
157191409|NCT03055806|567440711|FG001|Overall Study|Adverse Event|0|||
157191410|NCT03055806|567440712|FG002|Overall Study|Adverse Event|1|||
157191411|NCT03055806|567440713|FG003|Overall Study|Adverse Event|1|||
157191412|NCT03055806|567440710|FG000|Overall Study|Lost to Follow-up|0|||
157191413|NCT03055806|567440711|FG001|Overall Study|Lost to Follow-up|3|||
157191414|NCT03055806|567440712|FG002|Overall Study|Lost to Follow-up|6|||
157191415|NCT03055806|567440713|FG003|Overall Study|Lost to Follow-up|7|||
157191416|NCT03055806|567440710|FG000|Overall Study|Physician Decision|1|||
157191417|NCT03055806|567440711|FG001|Overall Study|Physician Decision|0|||
157191418|NCT03055806|567440712|FG002|Overall Study|Physician Decision|0|||
157191419|NCT03055806|567440713|FG003|Overall Study|Physician Decision|1|||
157191420|NCT03055806|567440710|FG000|Overall Study|Protocol Violation|1|||
157191421|NCT03055806|567440711|FG001|Overall Study|Protocol Violation|0|||
157191422|NCT03055806|567440712|FG002|Overall Study|Protocol Violation|0|||
157191423|NCT03055806|567440713|FG003|Overall Study|Protocol Violation|0|||
157191424|NCT03055806|567440710|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
157191425|NCT03055806|567440711|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
157191426|NCT03055806|567440712|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
157191427|NCT03055806|567440713|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
157191428|NCT03055806|567440710|FG000|Overall Study|Withdrawal of consent to continue study|2|||
157191429|NCT03055806|567440711|FG001|Overall Study|Withdrawal of consent to continue study|3|||
157191430|NCT03055806|567440712|FG002|Overall Study|Withdrawal of consent to continue study|4|||
157191431|NCT03055806|567440713|FG003|Overall Study|Withdrawal of consent to continue study|6|||
157191432|NCT03055806|567440710|FG000|Overall Study|Partner not willing to try intercourse|1|||
157191433|NCT03055806|567440711|FG001|Overall Study|Partner not willing to try intercourse|0|||
157191434|NCT03055806|567440712|FG002|Overall Study|Partner not willing to try intercourse|0|||
157191435|NCT03055806|567440713|FG003|Overall Study|Partner not willing to try intercourse|0|||
157191436|NCT04601194|567440714|FG000|Overall Study|Lost to Follow-up|7|||
157191437|NCT02630459|567440715|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191438|NCT02630459|567440716|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
157191439|NCT02630459|567440717|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191440|NCT02630459|567440718|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
157191441|NCT02630459|567440719|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191442|NCT02630459|567440720|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191443|NCT02630459|567440721|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191444|NCT02630459|567440722|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
157191445|NCT02630459|567440715|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157191446|NCT02630459|567440716|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157191447|NCT02630459|567440717|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
157191448|NCT02630459|567440718|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157069272|NCT01628692|567007579|FG001|Overall Study|Withdrawal by Subject|1|||
157069273|NCT01628692|567007580|FG002|Overall Study|Withdrawal by Subject|1|||
157069274|NCT01628692|567007581|FG003|Overall Study|Withdrawal by Subject|0|||
157069275|NCT01628692|567007582|FG004|Overall Study|Withdrawal by Subject|0|||
157191449|NCT02630459|567440719|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157069276|NCT01628692|567007583|FG005|Overall Study|Withdrawal by Subject|0|||
157230570|NCT03952143|567590653|FG000|Lead-In Period|Protocol Violation|5|||
157230571|NCT03952143|567590654|FG001|Lead-In Period|Protocol Violation|0|||
157230572|NCT03952143|567590655|FG002|Lead-In Period|Protocol Violation|0|||
157230573|NCT03952143|567590653|FG000|Lead-In Period|Withdrawal by Subject|19|||
157230574|NCT03952143|567590654|FG001|Lead-In Period|Withdrawal by Subject|0|||
157230575|NCT03952143|567590655|FG002|Lead-In Period|Withdrawal by Subject|0|||
157230576|NCT03952143|567590653|FG000|Treatment Period|Adverse Event|0|||
157230577|NCT03952143|567590654|FG001|Treatment Period|Adverse Event|0|||
157230578|NCT03952143|567590655|FG002|Treatment Period|Adverse Event|1|||
157230579|NCT03952143|567590653|FG000|Treatment Period|Lost to Follow-up|0|||
157230580|NCT03952143|567590654|FG001|Treatment Period|Lost to Follow-up|2|||
157230581|NCT03952143|567590655|FG002|Treatment Period|Lost to Follow-up|0|||
157230582|NCT03952143|567590653|FG000|Treatment Period|Physician Decision|0|||
157230583|NCT03952143|567590654|FG001|Treatment Period|Physician Decision|0|||
157230584|NCT03952143|567590655|FG002|Treatment Period|Physician Decision|2|||
157230585|NCT03952143|567590653|FG000|Treatment Period|Protocol Violation|0|||
157230586|NCT03952143|567590654|FG001|Treatment Period|Protocol Violation|0|||
157230587|NCT03952143|567590655|FG002|Treatment Period|Protocol Violation|1|||
157230588|NCT03952143|567590653|FG000|Treatment Period|Withdrawal by Subject|0|||
157230589|NCT03952143|567590654|FG001|Treatment Period|Withdrawal by Subject|5|||
157230590|NCT03952143|567590655|FG002|Treatment Period|Withdrawal by Subject|26|||
157230591|NCT03952143|567590653|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
157230592|NCT03952143|567590654|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
157230593|NCT03952143|567590655|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
157230594|NCT03952143|567590653|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
157230595|NCT03952143|567590654|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
157230596|NCT03952143|567590655|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
157230597|NCT02152566|567590656|FG000|Overall Study|Lost to Follow-up|1|||
157230598|NCT02152566|567590656|FG000|Overall Study|Withdrawal by Subject|2|||
157230599|NCT00496964|567590657|FG000|Overall Study|Withdrawal by Subject|0|||
157230600|NCT00496964|567590658|FG001|Overall Study|Withdrawal by Subject|1|||
157230601|NCT02942264|567590659|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230602|NCT02942264|567590660|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
157230603|NCT02942264|567590661|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230604|NCT02942264|567590662|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230605|NCT02942264|567590663|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230606|NCT02942264|567590664|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230607|NCT02942264|567590665|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
157230608|NCT02942264|567590666|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230609|NCT02942264|567590667|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
157230610|NCT02942264|567590659|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230611|NCT02942264|567590660|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230612|NCT02942264|567590661|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230613|NCT02942264|567590662|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230614|NCT02942264|567590663|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230615|NCT02942264|567590664|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230616|NCT02942264|567590665|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230617|NCT02942264|567590666|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
157230618|NCT02942264|567590667|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
157230619|NCT01328093|567590668|FG000|Double-Blind Phase|Adverse Event|78|||
157230620|NCT01328093|567590669|FG001|Double-Blind Phase|Adverse Event|15|||
157230621|NCT01328093|567590668|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
157230622|NCT01328093|567590669|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
157230623|NCT01328093|567590668|FG000|Double-Blind Phase|Lost to Follow-up|39|||
157230624|NCT01328093|567590669|FG001|Double-Blind Phase|Lost to Follow-up|14|||
157230625|NCT01328093|567590668|FG000|Double-Blind Phase|Protocol Violation|30|||
157230626|NCT01328093|567590669|FG001|Double-Blind Phase|Protocol Violation|10|||
157230627|NCT01328093|567590668|FG000|Double-Blind Phase|Lack of Efficacy|55|||
157230628|NCT01328093|567590669|FG001|Double-Blind Phase|Lack of Efficacy|13|||
157230629|NCT01328093|567590668|FG000|Double-Blind Phase|Sponsor Decision|17|||
157230630|NCT01328093|567590669|FG001|Double-Blind Phase|Sponsor Decision|3|||
157230631|NCT01328093|567590668|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
157230632|NCT01328093|567590669|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
157230633|NCT01328093|567590668|FG000|Double-Blind Phase|Scheduling conflict|8|||
157230634|NCT01328093|567590669|FG001|Double-Blind Phase|Scheduling conflict|3|||
157230635|NCT01328093|567590668|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
157230636|NCT01328093|567590669|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
157230637|NCT01328093|567590668|FG000|Double-Blind Phase|Death|1|||
157230638|NCT01328093|567590669|FG001|Double-Blind Phase|Death|0|||
157230639|NCT01328093|567590668|FG000|Open-Label Phase|Sponsor Decision|98|||
157230640|NCT01328093|567590669|FG001|Open-Label Phase|Sponsor Decision|34|||
157230641|NCT01328093|567590668|FG000|Open-Label Phase|Protocol Violation|8|||
157230642|NCT01328093|567590669|FG001|Open-Label Phase|Protocol Violation|3|||
157069277|NCT01628692|567007578|FG000|Overall Study|Death|0|||
157069278|NCT01628692|567007579|FG001|Overall Study|Death|1|||
157069279|NCT01628692|567007580|FG002|Overall Study|Death|0|||
157069280|NCT01628692|567007581|FG003|Overall Study|Death|0|||
157069281|NCT01628692|567007582|FG004|Overall Study|Death|0|||
157069282|NCT01628692|567007583|FG005|Overall Study|Death|0|||
157069283|NCT01628692|567007578|FG000|Overall Study|Poor compliance/noncompliance|1|||
157069284|NCT01628692|567007579|FG001|Overall Study|Poor compliance/noncompliance|0|||
157069285|NCT01628692|567007580|FG002|Overall Study|Poor compliance/noncompliance|0|||
157069286|NCT01628692|567007581|FG003|Overall Study|Poor compliance/noncompliance|0|||
157069287|NCT01628692|567007582|FG004|Overall Study|Poor compliance/noncompliance|0|||
157069288|NCT01628692|567007583|FG005|Overall Study|Poor compliance/noncompliance|0|||
157069289|NCT01628692|567007578|FG000|Overall Study|Administrative reason by sponsor|0|||
157069290|NCT01628692|567007579|FG001|Overall Study|Administrative reason by sponsor|0|||
157069291|NCT01628692|567007580|FG002|Overall Study|Administrative reason by sponsor|0|||
157069292|NCT01628692|567007581|FG003|Overall Study|Administrative reason by sponsor|0|||
157069293|NCT01628692|567007582|FG004|Overall Study|Administrative reason by sponsor|0|||
157069294|NCT01628692|567007583|FG005|Overall Study|Administrative reason by sponsor|1|||
157069295|NCT01628692|567007578|FG000|Overall Study|Completed 12 Week only|0|||
157069296|NCT01628692|567007579|FG001|Overall Study|Completed 12 Week only|0|||
157069297|NCT01628692|567007580|FG002|Overall Study|Completed 12 Week only|0|||
157069298|NCT01628692|567007581|FG003|Overall Study|Completed 12 Week only|0|||
157069299|NCT01628692|567007582|FG004|Overall Study|Completed 12 Week only|0|||
157069300|NCT01628692|567007583|FG005|Overall Study|Completed 12 Week only|1|||
157069301|NCT02437071|567007584|FG000|Overall Study|Withdrawal by Subject|1|||
157069302|NCT02437071|567007585|FG001|Overall Study|Withdrawal by Subject|0|||
157069303|NCT03513068|567007590|FG000|Overall Study|Death|1|||
157069304|NCT03513068|567007591|FG001|Overall Study|Death|0|||
157069305|NCT03513068|567007590|FG000|Overall Study|Withdrawal by Subject|4|||
157069306|NCT03513068|567007591|FG001|Overall Study|Withdrawal by Subject|6|||
157069307|NCT04788511|567007592|FG000|Overall Study|Withdrawal by Subject|2|||
157069308|NCT04788511|567007593|FG001|Overall Study|Withdrawal by Subject|1|||
157069309|NCT04788511|567007592|FG000|Overall Study|Lost to Follow-up|2|||
157069310|NCT04788511|567007593|FG001|Overall Study|Lost to Follow-up|7|||
157069311|NCT04788511|567007592|FG000|Overall Study|Death|3|||
157069312|NCT04788511|567007593|FG001|Overall Study|Death|4|||
157069313|NCT03636373|567007594|FG000|Overall Study|Study closure due to Covid-19|1|||
157069314|NCT03636373|567007595|FG001|Overall Study|Study closure due to Covid-19|0|||
157069315|NCT02353468|567007596|FG000|Overall Study|Study terminated|3|||
157069316|NCT01236352|567007597|FG000|Overall Study|Death|0|||
157069317|NCT01236352|567007598|FG001|Overall Study|Death|0|||
157069318|NCT01236352|567007599|FG002|Overall Study|Death|0|||
157069319|NCT01236352|567007600|FG003|Overall Study|Death|0|||
157069320|NCT01236352|567007601|FG004|Overall Study|Death|0|||
157069321|NCT01236352|567007602|FG005|Overall Study|Death|0|||
157069322|NCT01236352|567007603|FG006|Overall Study|Death|0|||
157069323|NCT01236352|567007604|FG007|Overall Study|Death|1|||
157069324|NCT01236352|567007605|FG008|Overall Study|Death|0|||
157069325|NCT01236352|567007606|FG009|Overall Study|Death|0|||
157069326|NCT01236352|567007607|FG010|Overall Study|Death|0|||
157069327|NCT01236352|567007597|FG000|Overall Study|Withdrawal by Subject|0|||
157069328|NCT01236352|567007598|FG001|Overall Study|Withdrawal by Subject|0|||
157069329|NCT01236352|567007599|FG002|Overall Study|Withdrawal by Subject|0|||
157069330|NCT01236352|567007600|FG003|Overall Study|Withdrawal by Subject|0|||
157069331|NCT01236352|567007601|FG004|Overall Study|Withdrawal by Subject|0|||
157069332|NCT01236352|567007602|FG005|Overall Study|Withdrawal by Subject|0|||
157230643|NCT01328093|567590668|FG000|Open-Label Phase|Lost to Follow-up|10|||
157230644|NCT01328093|567590669|FG001|Open-Label Phase|Lost to Follow-up|1|||
157230645|NCT01328093|567590668|FG000|Open-Label Phase|Adverse Event|10|||
157230646|NCT01328093|567590669|FG001|Open-Label Phase|Adverse Event|4|||
157230647|NCT01328093|567590668|FG000|Open-Label Phase|Lack of Efficacy|5|||
157069333|NCT01236352|567007603|FG006|Overall Study|Withdrawal by Subject|0|||
157069334|NCT01236352|567007604|FG007|Overall Study|Withdrawal by Subject|0|||
157069335|NCT01236352|567007605|FG008|Overall Study|Withdrawal by Subject|0|||
157069336|NCT01236352|567007606|FG009|Overall Study|Withdrawal by Subject|2|||
157069337|NCT01236352|567007607|FG010|Overall Study|Withdrawal by Subject|1|||
157069338|NCT01236352|567007597|FG000|Overall Study|Adverse Event|0|||
157069339|NCT01236352|567007598|FG001|Overall Study|Adverse Event|0|||
157069340|NCT01236352|567007599|FG002|Overall Study|Adverse Event|0|||
157069341|NCT01236352|567007600|FG003|Overall Study|Adverse Event|0|||
157069342|NCT01236352|567007601|FG004|Overall Study|Adverse Event|0|||
157069343|NCT01236352|567007602|FG005|Overall Study|Adverse Event|0|||
157069344|NCT01236352|567007603|FG006|Overall Study|Adverse Event|2|||
157069345|NCT01236352|567007604|FG007|Overall Study|Adverse Event|0|||
157069346|NCT01236352|567007605|FG008|Overall Study|Adverse Event|0|||
157069347|NCT01236352|567007606|FG009|Overall Study|Adverse Event|4|||
157069348|NCT01236352|567007607|FG010|Overall Study|Adverse Event|1|||
157069349|NCT01236352|567007597|FG000|Overall Study|Study drug toxicity|0|||
157069350|NCT01236352|567007598|FG001|Overall Study|Study drug toxicity|0|||
157069351|NCT01236352|567007599|FG002|Overall Study|Study drug toxicity|0|||
157069352|NCT01236352|567007600|FG003|Overall Study|Study drug toxicity|0|||
157069353|NCT01236352|567007601|FG004|Overall Study|Study drug toxicity|0|||
157069354|NCT01236352|567007602|FG005|Overall Study|Study drug toxicity|1|||
157069355|NCT01236352|567007603|FG006|Overall Study|Study drug toxicity|1|||
157069356|NCT01236352|567007604|FG007|Overall Study|Study drug toxicity|0|||
157069357|NCT01236352|567007605|FG008|Overall Study|Study drug toxicity|0|||
157069358|NCT01236352|567007606|FG009|Overall Study|Study drug toxicity|2|||
157069359|NCT01236352|567007607|FG010|Overall Study|Study drug toxicity|2|||
157069360|NCT01236352|567007597|FG000|Overall Study|Disease progression|1|||
157069361|NCT01236352|567007598|FG001|Overall Study|Disease progression|2|||
157069362|NCT01236352|567007599|FG002|Overall Study|Disease progression|1|||
157069363|NCT01236352|567007600|FG003|Overall Study|Disease progression|2|||
157069364|NCT01236352|567007601|FG004|Overall Study|Disease progression|2|||
157069365|NCT01236352|567007602|FG005|Overall Study|Disease progression|2|||
157069366|NCT01236352|567007603|FG006|Overall Study|Disease progression|1|||
157069367|NCT01236352|567007604|FG007|Overall Study|Disease progression|3|||
157069368|NCT01236352|567007605|FG008|Overall Study|Disease progression|2|||
157069369|NCT01236352|567007606|FG009|Overall Study|Disease progression|2|||
157069370|NCT01236352|567007607|FG010|Overall Study|Disease progression|2|||
157069371|NCT01236352|567007597|FG000|Overall Study|Poor/Non-compliance|1|||
157069372|NCT01236352|567007598|FG001|Overall Study|Poor/Non-compliance|0|||
157069373|NCT01236352|567007599|FG002|Overall Study|Poor/Non-compliance|0|||
157069374|NCT01236352|567007600|FG003|Overall Study|Poor/Non-compliance|0|||
157069375|NCT01236352|567007601|FG004|Overall Study|Poor/Non-compliance|0|||
157069376|NCT01236352|567007602|FG005|Overall Study|Poor/Non-compliance|0|||
157069377|NCT01236352|567007603|FG006|Overall Study|Poor/Non-compliance|0|||
157069378|NCT01236352|567007604|FG007|Overall Study|Poor/Non-compliance|0|||
157069379|NCT01236352|567007605|FG008|Overall Study|Poor/Non-compliance|0|||
157069380|NCT01236352|567007606|FG009|Overall Study|Poor/Non-compliance|0|||
157069381|NCT01236352|567007607|FG010|Overall Study|Poor/Non-compliance|0|||
157069382|NCT01236352|567007597|FG000|Overall Study|Maximum clinical benefit|1|||
157069383|NCT01236352|567007598|FG001|Overall Study|Maximum clinical benefit|1|||
157069384|NCT01236352|567007599|FG002|Overall Study|Maximum clinical benefit|1|||
157069385|NCT01236352|567007600|FG003|Overall Study|Maximum clinical benefit|0|||
157069386|NCT01236352|567007601|FG004|Overall Study|Maximum clinical benefit|2|||
157069387|NCT01236352|567007602|FG005|Overall Study|Maximum clinical benefit|0|||
157069388|NCT01236352|567007603|FG006|Overall Study|Maximum clinical benefit|3|||
157069389|NCT01236352|567007604|FG007|Overall Study|Maximum clinical benefit|1|||
157069390|NCT01236352|567007605|FG008|Overall Study|Maximum clinical benefit|1|||
157069391|NCT01236352|567007606|FG009|Overall Study|Maximum clinical benefit|4|||
157069392|NCT01236352|567007607|FG010|Overall Study|Maximum clinical benefit|2|||
157069393|NCT01236352|567007597|FG000|Overall Study|Subject request to discontinue treatment|0|||
157069394|NCT01236352|567007598|FG001|Overall Study|Subject request to discontinue treatment|0|||
157069395|NCT01236352|567007599|FG002|Overall Study|Subject request to discontinue treatment|1|||
157069396|NCT01236352|567007600|FG003|Overall Study|Subject request to discontinue treatment|1|||
157069397|NCT01236352|567007601|FG004|Overall Study|Subject request to discontinue treatment|0|||
157069398|NCT01236352|567007602|FG005|Overall Study|Subject request to discontinue treatment|1|||
157069399|NCT01236352|567007603|FG006|Overall Study|Subject request to discontinue treatment|0|||
157069400|NCT01236352|567007604|FG007|Overall Study|Subject request to discontinue treatment|0|||
157069401|NCT01236352|567007605|FG008|Overall Study|Subject request to discontinue treatment|0|||
157069402|NCT01236352|567007606|FG009|Overall Study|Subject request to discontinue treatment|1|||
157069403|NCT01236352|567007607|FG010|Overall Study|Subject request to discontinue treatment|4|||
157069404|NCT01236352|567007597|FG000|Overall Study|Subject to receive drug via EAP|1|||
157069405|NCT01236352|567007598|FG001|Overall Study|Subject to receive drug via EAP|1|||
157069406|NCT01236352|567007599|FG002|Overall Study|Subject to receive drug via EAP|1|||
157069407|NCT01236352|567007600|FG003|Overall Study|Subject to receive drug via EAP|0|||
157069408|NCT01236352|567007601|FG004|Overall Study|Subject to receive drug via EAP|0|||
157069409|NCT01236352|567007602|FG005|Overall Study|Subject to receive drug via EAP|0|||
157069410|NCT01236352|567007603|FG006|Overall Study|Subject to receive drug via EAP|0|||
157069411|NCT01236352|567007604|FG007|Overall Study|Subject to receive drug via EAP|2|||
157069412|NCT01236352|567007605|FG008|Overall Study|Subject to receive drug via EAP|0|||
157191450|NCT02630459|567440720|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157230648|NCT01328093|567590669|FG001|Open-Label Phase|Lack of Efficacy|6|||
157069413|NCT01236352|567007606|FG009|Overall Study|Subject to receive drug via EAP|4|||
157069414|NCT01236352|567007607|FG010|Overall Study|Subject to receive drug via EAP|0|||
157069415|NCT01236352|567007597|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
157069416|NCT01236352|567007598|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
157069417|NCT01236352|567007599|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
157069418|NCT01236352|567007600|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
157069419|NCT01236352|567007601|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
157069420|NCT01236352|567007602|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
157069421|NCT01236352|567007603|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
157069422|NCT01236352|567007604|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
157069423|NCT01236352|567007605|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
157069424|NCT01236352|567007606|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
157069425|NCT01236352|567007607|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
157069426|NCT01236352|567007597|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069427|NCT01236352|567007598|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069428|NCT01236352|567007599|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069429|NCT01236352|567007600|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069430|NCT01236352|567007601|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069431|NCT01236352|567007602|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069432|NCT01236352|567007603|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069433|NCT01236352|567007604|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069434|NCT01236352|567007605|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069435|NCT01236352|567007606|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
157069436|NCT01236352|567007607|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
157069437|NCT01236352|567007597|FG000|Overall Study|Lack of response to drug|0|||
157069438|NCT01236352|567007598|FG001|Overall Study|Lack of response to drug|0|||
157069439|NCT01236352|567007599|FG002|Overall Study|Lack of response to drug|0|||
157069440|NCT01236352|567007600|FG003|Overall Study|Lack of response to drug|0|||
157069441|NCT01236352|567007601|FG004|Overall Study|Lack of response to drug|0|||
157069442|NCT01236352|567007602|FG005|Overall Study|Lack of response to drug|0|||
157069443|NCT01236352|567007603|FG006|Overall Study|Lack of response to drug|0|||
157069444|NCT01236352|567007604|FG007|Overall Study|Lack of response to drug|0|||
157069445|NCT01236352|567007605|FG008|Overall Study|Lack of response to drug|0|||
157069446|NCT01236352|567007606|FG009|Overall Study|Lack of response to drug|1|||
157069447|NCT01236352|567007607|FG010|Overall Study|Lack of response to drug|1|||
157069448|NCT01236352|567007597|FG000|Overall Study|Patient transferred to IST|0|||
157069449|NCT01236352|567007598|FG001|Overall Study|Patient transferred to IST|0|||
157069450|NCT01236352|567007599|FG002|Overall Study|Patient transferred to IST|0|||
157069451|NCT01236352|567007600|FG003|Overall Study|Patient transferred to IST|0|||
157191451|NCT02630459|567440721|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157191452|NCT02630459|567440722|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
157191453|NCT02630459|567440715|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
157191454|NCT02630459|567440716|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
157191455|NCT02630459|567440717|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
157191456|NCT02630459|567440718|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
157191457|NCT02630459|567440719|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
157191458|NCT02630459|567440720|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
157191459|NCT02630459|567440721|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
157191460|NCT02630459|567440722|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
157191461|NCT02630459|567440715|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
157191462|NCT02630459|567440716|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191463|NCT02630459|567440717|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191464|NCT02630459|567440718|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191465|NCT02630459|567440719|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191466|NCT02630459|567440720|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191467|NCT02630459|567440721|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191468|NCT02630459|567440722|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
157191469|NCT02630459|567440715|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191470|NCT02630459|567440716|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191471|NCT02630459|567440717|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191472|NCT02630459|567440718|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191473|NCT02630459|567440719|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
157191474|NCT02630459|567440720|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
157191475|NCT02630459|567440721|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191476|NCT02630459|567440722|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
157191477|NCT02630459|567440715|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157191478|NCT02630459|567440716|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157191479|NCT02630459|567440717|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157191480|NCT02630459|567440718|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157191481|NCT02630459|567440719|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
157191482|NCT02630459|567440720|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
157191483|NCT02630459|567440721|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157191484|NCT02630459|567440722|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
157230649|NCT01328093|567590668|FG000|Open-Label Phase|Withdrawal by Subject|4|||
157230650|NCT01328093|567590669|FG001|Open-Label Phase|Withdrawal by Subject|1|||
157230651|NCT01328093|567590668|FG000|Open-Label Phase|Scheduling conflict|2|||
157069452|NCT01236352|567007601|FG004|Overall Study|Patient transferred to IST|0|||
157069453|NCT01236352|567007602|FG005|Overall Study|Patient transferred to IST|0|||
157069454|NCT01236352|567007603|FG006|Overall Study|Patient transferred to IST|0|||
157069455|NCT01236352|567007604|FG007|Overall Study|Patient transferred to IST|0|||
157069456|NCT01236352|567007605|FG008|Overall Study|Patient transferred to IST|0|||
157069457|NCT01236352|567007606|FG009|Overall Study|Patient transferred to IST|2|||
157069458|NCT01236352|567007607|FG010|Overall Study|Patient transferred to IST|6|||
157069459|NCT01575873|567007608|FG000|Overall Study|Withdrawal by Subject|15|||
157069460|NCT01575873|567007609|FG001|Overall Study|Withdrawal by Subject|20|||
157069461|NCT01575873|567007610|FG002|Overall Study|Withdrawal by Subject|34|||
157069462|NCT01575873|567007611|FG003|Overall Study|Withdrawal by Subject|34|||
157069463|NCT01575873|567007608|FG000|Overall Study|Adverse Event|7|||
157069464|NCT01575873|567007609|FG001|Overall Study|Adverse Event|7|||
157069465|NCT01575873|567007610|FG002|Overall Study|Adverse Event|9|||
157069466|NCT01575873|567007611|FG003|Overall Study|Adverse Event|12|||
157069467|NCT01575873|567007608|FG000|Overall Study|Lost to Follow-up|1|||
157069468|NCT01575873|567007609|FG001|Overall Study|Lost to Follow-up|3|||
157069469|NCT01575873|567007610|FG002|Overall Study|Lost to Follow-up|13|||
157069470|NCT01575873|567007611|FG003|Overall Study|Lost to Follow-up|5|||
157069471|NCT01575873|567007608|FG000|Overall Study|Death|3|||
157069472|NCT01575873|567007609|FG001|Overall Study|Death|2|||
157069473|NCT01575873|567007610|FG002|Overall Study|Death|8|||
157069474|NCT01575873|567007611|FG003|Overall Study|Death|9|||
157069475|NCT01575873|567007608|FG000|Overall Study|Noncompliance|1|||
157069476|NCT01575873|567007609|FG001|Overall Study|Noncompliance|2|||
157069477|NCT01575873|567007610|FG002|Overall Study|Noncompliance|4|||
157069478|NCT01575873|567007611|FG003|Overall Study|Noncompliance|3|||
157069479|NCT01575873|567007608|FG000|Overall Study|Administrative decision|1|||
157069480|NCT01575873|567007609|FG001|Overall Study|Administrative decision|1|||
157069481|NCT01575873|567007610|FG002|Overall Study|Administrative decision|1|||
157069482|NCT01575873|567007611|FG003|Overall Study|Administrative decision|0|||
157069483|NCT01575873|567007608|FG000|Overall Study|Protocol deviation|0|||
157069484|NCT01575873|567007609|FG001|Overall Study|Protocol deviation|1|||
157069485|NCT01575873|567007610|FG002|Overall Study|Protocol deviation|0|||
157069486|NCT01575873|567007611|FG003|Overall Study|Protocol deviation|1|||
157069487|NCT01575873|567007608|FG000|Overall Study|Requirement for Alternative Therapy|0|||
157069488|NCT01575873|567007609|FG001|Overall Study|Requirement for Alternative Therapy|0|||
157069489|NCT01575873|567007610|FG002|Overall Study|Requirement for Alternative Therapy|1|||
157069490|NCT01575873|567007611|FG003|Overall Study|Requirement for Alternative Therapy|1|||
157069491|NCT01575873|567007608|FG000|Overall Study|Other|0|||
157069492|NCT01575873|567007609|FG001|Overall Study|Other|0|||
157069493|NCT01575873|567007610|FG002|Overall Study|Other|4|||
157069494|NCT01575873|567007611|FG003|Overall Study|Other|2|||
157069495|NCT00246090|567007612|FG000|Overall Study|Adverse Event|25|||
157069496|NCT00246090|567007612|FG000|Overall Study|Withdrawal by Subject|7|||
157069497|NCT00246090|567007612|FG000|Overall Study|Progressive Disease|212|||
157069498|NCT00246090|567007612|FG000|Overall Study|Clinical Progression|30|||
157069499|NCT00246090|567007612|FG000|Overall Study|Physician Decision|11|||
157069500|NCT00246090|567007612|FG000|Overall Study|Not Otherwise Specified|10|||
157069501|NCT02688530|567007616|FG000|Overall Study|Withdrawal by Subject|0|||
157069502|NCT02688530|567007617|FG001|Overall Study|Withdrawal by Subject|1|||
157069503|NCT02688530|567007618|FG002|Overall Study|Withdrawal by Subject|0|||
157069504|NCT02688530|567007619|FG003|Overall Study|Withdrawal by Subject|0|||
157069505|NCT02688530|567007616|FG000|Overall Study|Lost to Follow-up|0|||
157069506|NCT02688530|567007617|FG001|Overall Study|Lost to Follow-up|0|||
157069507|NCT02688530|567007618|FG002|Overall Study|Lost to Follow-up|2|||
157069508|NCT02688530|567007619|FG003|Overall Study|Lost to Follow-up|0|||
157069509|NCT01658020|567007620|FG000|Overall Study|Adverse Event|3|||
157069510|NCT01658020|567007621|FG001|Overall Study|Adverse Event|3|||
157069511|NCT01658020|567007620|FG000|Overall Study|Lost to Follow-up|1|||
157069512|NCT01658020|567007621|FG001|Overall Study|Lost to Follow-up|0|||
157069513|NCT01658020|567007620|FG000|Overall Study|Withdrawal by Subject|4|||
157069514|NCT01658020|567007621|FG001|Overall Study|Withdrawal by Subject|5|||
157069515|NCT01658020|567007620|FG000|Overall Study|Protocol Violation|0|||
157069516|NCT01658020|567007621|FG001|Overall Study|Protocol Violation|1|||
157069517|NCT02554383|567007627|FG000|Overall Study|Ineligible|3|||
157069518|NCT02554383|567007628|FG001|Overall Study|Ineligible|2|||
157069519|NCT02554383|567007627|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
157069520|NCT02554383|567007628|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
157069521|NCT02554383|567007627|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
157069522|NCT02554383|567007628|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
157069523|NCT02554383|567007627|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
157069524|NCT02554383|567007628|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
157069525|NCT02165826|567007629|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
157069526|NCT02165826|567007630|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
157069527|NCT02165826|567007631|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
157069528|NCT02165826|567007629|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
157069529|NCT02165826|567007630|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
157230652|NCT01328093|567590669|FG001|Open-Label Phase|Scheduling conflict|1|||
157230653|NCT01328093|567590668|FG000|Open-Label Phase|Subject is moving or has moved|2|||
157230654|NCT01328093|567590669|FG001|Open-Label Phase|Subject is moving or has moved|0|||
157230655|NCT01328093|567590668|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
157230656|NCT01328093|567590669|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
157230657|NCT03980483|567590672|FG000|Overall Study|Adverse Event|13|||
157230658|NCT03980483|567590673|FG001|Overall Study|Adverse Event|29|||
157230659|NCT03980483|567590674|FG002|Overall Study|Adverse Event|11|||
157230660|NCT03980483|567590675|FG003|Overall Study|Adverse Event|2|||
157230661|NCT03980483|567590676|FG004|Overall Study|Adverse Event|2|||
157230662|NCT03980483|567590677|FG005|Overall Study|Adverse Event|2|||
157230663|NCT03980483|567590672|FG000|Overall Study|Lack of Efficacy|7|||
157230664|NCT03980483|567590673|FG001|Overall Study|Lack of Efficacy|6|||
157230665|NCT03980483|567590674|FG002|Overall Study|Lack of Efficacy|0|||
157230666|NCT03980483|567590675|FG003|Overall Study|Lack of Efficacy|3|||
157230667|NCT03980483|567590676|FG004|Overall Study|Lack of Efficacy|1|||
157230668|NCT03980483|567590677|FG005|Overall Study|Lack of Efficacy|1|||
157230669|NCT03980483|567590672|FG000|Overall Study|Lost to Follow-up|2|||
157230670|NCT03980483|567590673|FG001|Overall Study|Lost to Follow-up|4|||
157069530|NCT02165826|567007631|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
157069531|NCT02165826|567007629|FG000|Main Treatment Period|Lost to Follow-up|4|||
157069532|NCT02165826|567007630|FG001|Main Treatment Period|Lost to Follow-up|2|||
157069533|NCT02165826|567007631|FG002|Main Treatment Period|Lost to Follow-up|1|||
157069534|NCT02165826|567007629|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
157069535|NCT02165826|567007630|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
157069536|NCT02165826|567007631|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
157069537|NCT02165826|567007629|FG000|Main Treatment Period|Lack of Efficacy|2|||
157069538|NCT02165826|567007630|FG001|Main Treatment Period|Lack of Efficacy|0|||
157069539|NCT02165826|567007631|FG002|Main Treatment Period|Lack of Efficacy|0|||
157069540|NCT02165826|567007629|FG000|Main Treatment Period|Reason Not Specified|8|||
157069541|NCT02165826|567007630|FG001|Main Treatment Period|Reason Not Specified|5|||
157069542|NCT02165826|567007631|FG002|Main Treatment Period|Reason Not Specified|16|||
157069543|NCT02165826|567007629|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
157069544|NCT02165826|567007630|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
157069545|NCT02165826|567007631|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
157069546|NCT02165826|567007629|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
157069547|NCT02165826|567007630|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
157069548|NCT02165826|567007631|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
157069549|NCT02165826|567007629|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
157069550|NCT02165826|567007630|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
157069551|NCT02165826|567007631|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
157069552|NCT02165826|567007629|FG000|Down-Titration Period|Reason Not Specified|1|||
157069553|NCT02165826|567007630|FG001|Down-Titration Period|Reason Not Specified|0|||
157069554|NCT02165826|567007631|FG002|Down-Titration Period|Reason Not Specified|2|||
157069555|NCT02581059|567007632|FG000|Study Treatment|Disease Progression|1|||
157069556|NCT02581059|567007633|FG001|Study Treatment|Disease Progression|1|||
157069557|NCT02581059|567007632|FG000|Study Treatment|Adverse Event|2|||
157069558|NCT02581059|567007633|FG001|Study Treatment|Adverse Event|1|||
157069559|NCT02581059|567007632|FG000|Study Treatment|Death|1|||
157069560|NCT02581059|567007633|FG001|Study Treatment|Death|1|||
157230671|NCT03980483|567590674|FG002|Overall Study|Lost to Follow-up|2|||
157230672|NCT03980483|567590675|FG003|Overall Study|Lost to Follow-up|1|||
157230673|NCT03980483|567590676|FG004|Overall Study|Lost to Follow-up|2|||
157230674|NCT03980483|567590677|FG005|Overall Study|Lost to Follow-up|0|||
157230675|NCT03980483|567590672|FG000|Overall Study|Protocol Violation|4|||
157230676|NCT03980483|567590673|FG001|Overall Study|Protocol Violation|2|||
157230677|NCT03980483|567590674|FG002|Overall Study|Protocol Violation|1|||
157230678|NCT03980483|567590675|FG003|Overall Study|Protocol Violation|1|||
157230679|NCT03980483|567590676|FG004|Overall Study|Protocol Violation|0|||
157230680|NCT03980483|567590677|FG005|Overall Study|Protocol Violation|0|||
157230681|NCT03980483|567590672|FG000|Overall Study|Physician Decision|14|||
157230682|NCT03980483|567590673|FG001|Overall Study|Physician Decision|10|||
157069561|NCT02581059|567007632|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
157069562|NCT02581059|567007633|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
157069563|NCT02581059|567007632|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
157069564|NCT02581059|567007633|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
157230683|NCT03980483|567590674|FG002|Overall Study|Physician Decision|7|||
157230684|NCT03980483|567590675|FG003|Overall Study|Physician Decision|4|||
157230685|NCT03980483|567590676|FG004|Overall Study|Physician Decision|4|||
157230686|NCT03980483|567590677|FG005|Overall Study|Physician Decision|2|||
157230687|NCT03980483|567590672|FG000|Overall Study|Withdrawal by Subject|38|||
157230688|NCT03980483|567590673|FG001|Overall Study|Withdrawal by Subject|21|||
157230689|NCT03980483|567590674|FG002|Overall Study|Withdrawal by Subject|15|||
157069565|NCT02581059|567007632|FG000|Follow up|Death|1|||
157069566|NCT02581059|567007633|FG001|Follow up|Death|3|||
157069567|NCT02581059|567007632|FG000|Follow up|study terminated|1|||
157069568|NCT02581059|567007633|FG001|Follow up|study terminated|1|||
157069569|NCT02581059|567007632|FG000|Follow up|screen failure|0|||
157069570|NCT02581059|567007633|FG001|Follow up|screen failure|1|||
157069571|NCT02581059|567007632|FG000|Follow up|Patient started new clinical trial|1|||
157069572|NCT02581059|567007633|FG001|Follow up|Patient started new clinical trial|0|||
157069573|NCT04590404|567007635|FG000|Overall Study|Death|16|||
157069574|NCT04590404|567007636|FG001|Overall Study|Death|17|||
157069575|NCT04590404|567007635|FG000|Overall Study|Withdrawal by Subject|7|||
157069576|NCT04590404|567007636|FG001|Overall Study|Withdrawal by Subject|2|||
157069577|NCT05903183|567007637|FG000|Main Trial Part (365 Days)|Death|1|||
157069578|NCT05903183|567007638|FG001|Main Trial Part (365 Days)|Death|0|||
157069579|NCT05903183|567007639|FG002|Main Trial Part (365 Days)|Death|0|||
157069580|NCT05903183|567007640|FG003|Main Trial Part (365 Days)|Death|0|||
157069581|NCT05903183|567007641|FG004|Main Trial Part (365 Days)|Death|0|||
157069582|NCT05903183|567007637|FG000|Main Trial Part (365 Days)|Other|1|||
157069583|NCT05903183|567007638|FG001|Main Trial Part (365 Days)|Other|2|||
157069584|NCT05903183|567007639|FG002|Main Trial Part (365 Days)|Other|1|||
157069585|NCT05903183|567007640|FG003|Main Trial Part (365 Days)|Other|0|||
157069586|NCT05903183|567007641|FG004|Main Trial Part (365 Days)|Other|0|||
157069587|NCT05903183|567007637|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
157069588|NCT05903183|567007638|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
157069589|NCT05903183|567007639|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
157069590|NCT05903183|567007640|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
157069591|NCT05903183|567007641|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
157069592|NCT05903183|567007637|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
157069593|NCT05903183|567007638|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
157069594|NCT05903183|567007639|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
157069595|NCT05903183|567007640|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
157069596|NCT05903183|567007641|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
157069597|NCT05903183|567007637|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
157069598|NCT05903183|567007638|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
157069599|NCT05903183|567007639|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
157069600|NCT05903183|567007640|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
157069601|NCT05903183|567007641|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
157069602|NCT05739994|567007642|FG000|Overall Study|Withdrawal by Subject|2|||
157069603|NCT05739994|567007643|FG001|Overall Study|Withdrawal by Subject|2|||
157069604|NCT05739994|567007644|FG002|Overall Study|Withdrawal by Subject|4|||
157069605|NCT04750577|567007645|FG000|Overall Study|Adverse Event|2|||
157069606|NCT04750577|567007646|FG001|Overall Study|Adverse Event|10|||
157069607|NCT04750577|567007647|FG002|Overall Study|Adverse Event|8|||
157069608|NCT04750577|567007648|FG003|Overall Study|Adverse Event|1|||
157069609|NCT04750577|567007645|FG000|Overall Study|Change of residence|0|||
157069610|NCT04750577|567007646|FG001|Overall Study|Change of residence|0|||
157069611|NCT04750577|567007647|FG002|Overall Study|Change of residence|1|||
157069612|NCT04750577|567007648|FG003|Overall Study|Change of residence|0|||
157069613|NCT04750577|567007645|FG000|Overall Study|Burden of study procedures|0|||
157069614|NCT04750577|567007646|FG001|Overall Study|Burden of study procedures|2|||
157069615|NCT04750577|567007647|FG002|Overall Study|Burden of study procedures|2|||
157069616|NCT04750577|567007648|FG003|Overall Study|Burden of study procedures|0|||
157069617|NCT04750577|567007645|FG000|Overall Study|Prematurely discontinued|0|||
157069618|NCT04750577|567007646|FG001|Overall Study|Prematurely discontinued|0|||
157069619|NCT04750577|567007647|FG002|Overall Study|Prematurely discontinued|0|||
157069620|NCT04750577|567007648|FG003|Overall Study|Prematurely discontinued|2|||
157069621|NCT04750577|567007645|FG000|Overall Study|Protocol deviation|1|||
157069622|NCT04750577|567007646|FG001|Overall Study|Protocol deviation|1|||
157069623|NCT04750577|567007647|FG002|Overall Study|Protocol deviation|1|||
157069624|NCT04750577|567007648|FG003|Overall Study|Protocol deviation|1|||
157069625|NCT04750577|567007645|FG000|Overall Study|Other than listed|3|||
157069626|NCT04750577|567007646|FG001|Overall Study|Other than listed|2|||
157069627|NCT04750577|567007647|FG002|Overall Study|Other than listed|2|||
157069628|NCT04750577|567007648|FG003|Overall Study|Other than listed|1|||
157069629|NCT04750577|567007645|FG000|Overall Study|Not treated|0|||
157069630|NCT04750577|567007646|FG001|Overall Study|Not treated|0|||
157191485|NCT02630459|567440715|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157191486|NCT02630459|567440716|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157191487|NCT02630459|567440717|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157069631|NCT04750577|567007647|FG002|Overall Study|Not treated|0|||
157069632|NCT04750577|567007648|FG003|Overall Study|Not treated|2|||
157069633|NCT02473042|567007649|FG000|Overall Study|Withdrawal by Subject|1|||
157069634|NCT02473042|567007650|FG001|Overall Study|Withdrawal by Subject|0|||
157069635|NCT02473042|567007649|FG000|Overall Study|Patient became ineligible after enrollment|2|||
157069636|NCT02473042|567007650|FG001|Overall Study|Patient became ineligible after enrollment|5|||
157069637|NCT02473042|567007649|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
157230690|NCT03980483|567590675|FG003|Overall Study|Withdrawal by Subject|5|||
157230691|NCT03980483|567590676|FG004|Overall Study|Withdrawal by Subject|3|||
157230692|NCT03980483|567590677|FG005|Overall Study|Withdrawal by Subject|4|||
157230693|NCT03980483|567590672|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
157069638|NCT02473042|567007650|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
157069639|NCT02473042|567007649|FG000|Overall Study|PACU data unable to be collected|3|||
157069640|NCT02473042|567007650|FG001|Overall Study|PACU data unable to be collected|0|||
157069641|NCT02647645|567007653|FG000|Overall Study|Lost to Follow-up|2|||
157069642|NCT02647645|567007654|FG001|Overall Study|Lost to Follow-up|1|||
157069643|NCT04599907|567007657|FG000|Overall Study|Withdrawal by Subject|1|||
157069644|NCT04599907|567007658|FG001|Overall Study|Withdrawal by Subject|7|||
157069645|NCT04599907|567007659|FG002|Overall Study|Withdrawal by Subject|6|||
157069646|NCT04599907|567007657|FG000|Overall Study|Lost to Follow-up|0|||
157069647|NCT04599907|567007658|FG001|Overall Study|Lost to Follow-up|1|||
157069648|NCT04599907|567007659|FG002|Overall Study|Lost to Follow-up|0|||
157069649|NCT03371823|567007660|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
157069650|NCT03371823|567007661|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
157069651|NCT01466790|567007662|FG000|Overall Study|Adverse Event|1|||
157069652|NCT01466790|567007663|FG001|Overall Study|Adverse Event|0|||
157069653|NCT01466790|567007664|FG002|Overall Study|Adverse Event|0|||
157069654|NCT01466790|567007665|FG003|Overall Study|Adverse Event|0|||
157069655|NCT01466790|567007666|FG004|Overall Study|Adverse Event|2|||
157069656|NCT01466790|567007667|FG005|Overall Study|Adverse Event|0|||
157069657|NCT01466790|567007668|FG006|Overall Study|Adverse Event|0|||
157069658|NCT01466790|567007669|FG007|Overall Study|Adverse Event|0|||
157069659|NCT01466790|567007662|FG000|Overall Study|Lost to Follow-up|2|||
157069660|NCT01466790|567007663|FG001|Overall Study|Lost to Follow-up|0|||
157069661|NCT01466790|567007664|FG002|Overall Study|Lost to Follow-up|0|||
157069662|NCT01466790|567007665|FG003|Overall Study|Lost to Follow-up|0|||
157069663|NCT01466790|567007666|FG004|Overall Study|Lost to Follow-up|0|||
157069664|NCT01466790|567007667|FG005|Overall Study|Lost to Follow-up|0|||
157069665|NCT01466790|567007668|FG006|Overall Study|Lost to Follow-up|0|||
157069666|NCT01466790|567007669|FG007|Overall Study|Lost to Follow-up|0|||
157069667|NCT01466790|567007662|FG000|Overall Study|Withdrawal by Subject|1|||
157069668|NCT01466790|567007663|FG001|Overall Study|Withdrawal by Subject|1|||
157069669|NCT01466790|567007664|FG002|Overall Study|Withdrawal by Subject|0|||
157069670|NCT01466790|567007665|FG003|Overall Study|Withdrawal by Subject|0|||
157069671|NCT01466790|567007666|FG004|Overall Study|Withdrawal by Subject|1|||
157069672|NCT01466790|567007667|FG005|Overall Study|Withdrawal by Subject|0|||
157069673|NCT01466790|567007668|FG006|Overall Study|Withdrawal by Subject|1|||
157069674|NCT01466790|567007669|FG007|Overall Study|Withdrawal by Subject|1|||
157069675|NCT00356811|567007670|FG000|Overall Study|Death|35|||
157069676|NCT00356811|567007670|FG000|Overall Study|Lost to Follow-up|2|||
157069677|NCT00356811|567007670|FG000|Overall Study|Withdrawal by Subject|6|||
157069678|NCT00356811|567007670|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
157069679|NCT00356811|567007670|FG000|Overall Study|Study Is Terminating|3|||
157069680|NCT00356811|567007670|FG000|Overall Study|Site Closed during Follow-up|2|||
157069681|NCT03668223|567007671|FG000|Overall Study|Death|10|||
157069682|NCT03668223|567007672|FG001|Overall Study|Death|5|||
157069683|NCT03668223|567007671|FG000|Overall Study|Lost to Follow-up|12|||
157069684|NCT03668223|567007672|FG001|Overall Study|Lost to Follow-up|12|||
157069685|NCT03668223|567007671|FG000|Overall Study|Withdrawal by Subject|8|||
157069686|NCT03668223|567007672|FG001|Overall Study|Withdrawal by Subject|3|||
157069687|NCT05502783|567007673|FG000|Overall Study|Lack of Efficacy|1|||
157069688|NCT04870957|567007674|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
157069689|NCT04870957|567007675|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
157069690|NCT04870957|567007676|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
157069691|NCT04870957|567007677|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
157069692|NCT04870957|567007678|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
157069693|NCT04870957|567007679|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
157069694|NCT04870957|567007674|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
157069695|NCT04870957|567007675|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
157069696|NCT04870957|567007676|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
157230694|NCT03980483|567590673|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
157230695|NCT03980483|567590674|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
157230696|NCT03980483|567590675|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
157069697|NCT04870957|567007677|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
157069698|NCT04870957|567007678|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
157069699|NCT04870957|567007679|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
157069700|NCT04870957|567007674|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
157069701|NCT04870957|567007675|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
157069702|NCT04870957|567007676|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
157069703|NCT04870957|567007677|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
157069704|NCT04870957|567007678|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
157069705|NCT04870957|567007679|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
157069706|NCT04870957|567007674|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
157069707|NCT04870957|567007675|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
157069708|NCT04870957|567007676|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
157069709|NCT04870957|567007677|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
157069710|NCT04870957|567007678|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
157069711|NCT04870957|567007679|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
157069712|NCT04870957|567007674|FG000|T2 (Randomization) - T3|Adverse Event|1|||
157069713|NCT04870957|567007675|FG001|T2 (Randomization) - T3|Adverse Event|1|||
157069714|NCT04870957|567007676|FG002|T2 (Randomization) - T3|Adverse Event|0|||
157069715|NCT04870957|567007677|FG003|T2 (Randomization) - T3|Adverse Event|0|||
157069716|NCT04870957|567007678|FG004|T2 (Randomization) - T3|Adverse Event|0|||
157069717|NCT04870957|567007679|FG005|T2 (Randomization) - T3|Adverse Event|0|||
157069718|NCT04870957|567007674|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
157069719|NCT04870957|567007675|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
157069720|NCT04870957|567007676|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
157069721|NCT04870957|567007677|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
157069722|NCT04870957|567007678|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
157069723|NCT04870957|567007679|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
157069724|NCT04870957|567007674|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
157069725|NCT04870957|567007675|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
157069726|NCT04870957|567007676|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
157069727|NCT04870957|567007677|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
157069728|NCT04870957|567007678|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
157069729|NCT04870957|567007679|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
157069730|NCT04870957|567007674|FG000|T2 (Randomization) - T3|Physician Decision|0|||
157069731|NCT04870957|567007675|FG001|T2 (Randomization) - T3|Physician Decision|0|||
157069732|NCT04870957|567007676|FG002|T2 (Randomization) - T3|Physician Decision|2|||
157069733|NCT04870957|567007677|FG003|T2 (Randomization) - T3|Physician Decision|1|||
157069734|NCT04870957|567007678|FG004|T2 (Randomization) - T3|Physician Decision|0|||
157069735|NCT04870957|567007679|FG005|T2 (Randomization) - T3|Physician Decision|0|||
157069736|NCT04870957|567007674|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
157069737|NCT04870957|567007675|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
157069738|NCT04870957|567007676|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
157069739|NCT04870957|567007677|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
157069740|NCT04870957|567007678|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
157069741|NCT04870957|567007679|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
157069742|NCT04870957|567007674|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
157069743|NCT04870957|567007675|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
157069744|NCT04870957|567007676|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
157069745|NCT04870957|567007677|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
157069746|NCT04870957|567007678|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
157069747|NCT04870957|567007679|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
157069748|NCT04870957|567007674|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
157069749|NCT04870957|567007675|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
157069750|NCT04870957|567007676|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
157069751|NCT04870957|567007677|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
157069752|NCT04870957|567007678|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
157069753|NCT04870957|567007679|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
157069754|NCT04870957|567007674|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
157069755|NCT04870957|567007675|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
157069756|NCT04870957|567007676|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
157069757|NCT04870957|567007677|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
157069758|NCT04870957|567007678|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
157069759|NCT04870957|567007679|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
157069760|NCT04870957|567007674|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
157069761|NCT04870957|567007675|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
157069762|NCT04870957|567007676|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
157069763|NCT04870957|567007677|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
157191488|NCT02630459|567440718|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157191489|NCT02630459|567440719|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
157191490|NCT02630459|567440720|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157069764|NCT04870957|567007678|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
157191491|NCT02630459|567440721|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157191492|NCT02630459|567440722|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
157191493|NCT00846027|567440723|FG000|Overall Study|Death|3|||
157191494|NCT00846027|567440723|FG000|Overall Study|Disease Progression|30|||
157069765|NCT04870957|567007679|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
157069766|NCT04870957|567007674|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
157191495|NCT00846027|567440723|FG000|Overall Study|Toxicity|12|||
157069767|NCT04870957|567007675|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
157069768|NCT04870957|567007676|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
157069769|NCT04870957|567007677|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
157069770|NCT04870957|567007678|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
157069771|NCT04870957|567007679|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
157069772|NCT04870957|567007674|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
157069773|NCT04870957|567007675|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
157069774|NCT04870957|567007676|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
157069775|NCT04870957|567007677|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
157069776|NCT04870957|567007678|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
157069777|NCT04870957|567007679|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
157069778|NCT04870957|567007674|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
157069779|NCT04870957|567007675|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
157069780|NCT04870957|567007676|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
157069781|NCT04870957|567007677|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
157069782|NCT04870957|567007678|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
157069783|NCT04870957|567007679|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
157069784|NCT04870957|567007674|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
157069785|NCT04870957|567007675|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
157069786|NCT04870957|567007676|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
157069787|NCT04870957|567007677|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
157069788|NCT04870957|567007678|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
157069789|NCT04870957|567007679|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
157069790|NCT05970640|567007680|FG000|Overall Study|Adverse Event|1|||
157069791|NCT05970640|567007681|FG001|Overall Study|Adverse Event|3|||
157069792|NCT05970640|567007682|FG002|Overall Study|Adverse Event|1|||
157069793|NCT05970640|567007683|FG003|Overall Study|Adverse Event|0|||
157069794|NCT05970640|567007680|FG000|Overall Study|Withdrawal by Subject|0|||
157069795|NCT05970640|567007681|FG001|Overall Study|Withdrawal by Subject|0|||
157069796|NCT05970640|567007682|FG002|Overall Study|Withdrawal by Subject|1|||
157069797|NCT05970640|567007683|FG003|Overall Study|Withdrawal by Subject|1|||
157069798|NCT05970640|567007680|FG000|Overall Study|Sponsor decision|0|||
157069799|NCT05970640|567007681|FG001|Overall Study|Sponsor decision|0|||
157069800|NCT05970640|567007682|FG002|Overall Study|Sponsor decision|1|||
157069801|NCT05970640|567007683|FG003|Overall Study|Sponsor decision|1|||
157069802|NCT04340843|567007684|FG000|Overall Study|Adverse Event|0|||
157069803|NCT04340843|567007685|FG001|Overall Study|Adverse Event|2|||
157069804|NCT04340843|567007684|FG000|Overall Study|Withdrawal by Subject|0|||
157069805|NCT04340843|567007685|FG001|Overall Study|Withdrawal by Subject|2|||
157069806|NCT03733899|567007688|FG000|Period 1|Protocol Violation|0|||
157069807|NCT03733899|567007689|FG001|Period 1|Protocol Violation|0|||
157069808|NCT03733899|567007690|FG002|Period 1|Protocol Violation|0|||
157069809|NCT03733899|567007691|FG003|Period 1|Protocol Violation|0|||
157069810|NCT03733899|567007692|FG004|Period 1|Protocol Violation|0|||
157069811|NCT03733899|567007693|FG005|Period 1|Protocol Violation|1|||
157069812|NCT03733899|567007688|FG000|Period 2|Unscuccessful Treatment|0|||
157069813|NCT03733899|567007689|FG001|Period 2|Unscuccessful Treatment|1|||
157069814|NCT03733899|567007690|FG002|Period 2|Unscuccessful Treatment|0|||
157069815|NCT03733899|567007691|FG003|Period 2|Unscuccessful Treatment|0|||
157069816|NCT03733899|567007692|FG004|Period 2|Unscuccessful Treatment|0|||
157069817|NCT03733899|567007693|FG005|Period 2|Unscuccessful Treatment|0|||
157069818|NCT03733899|567007688|FG000|Period 3|Withdrawal by Subject|1|||
157069819|NCT03733899|567007689|FG001|Period 3|Withdrawal by Subject|0|||
157069820|NCT03733899|567007690|FG002|Period 3|Withdrawal by Subject|0|||
157069821|NCT03733899|567007691|FG003|Period 3|Withdrawal by Subject|0|||
157069822|NCT03733899|567007692|FG004|Period 3|Withdrawal by Subject|0|||
157069823|NCT03733899|567007693|FG005|Period 3|Withdrawal by Subject|0|||
157069824|NCT04021043|567010161|FG000|Overall Study|Adverse Event|3|||
157069825|NCT04021043|567010162|FG001|Overall Study|Adverse Event|1|||
157191496|NCT00846027|567440723|FG000|Overall Study|Patient Decision|7|||
157191497|NCT00846027|567440723|FG000|Overall Study|Investigator Discretion|29|||
157191498|NCT00846027|567440723|FG000|Overall Study|Protocol Violation|2|||
157069826|NCT04021043|567010163|FG002|Overall Study|Adverse Event|1|||
157069827|NCT04021043|567010164|FG003|Overall Study|Adverse Event|0|||
157069828|NCT04021043|567010161|FG000|Overall Study|Death|2|||
157069829|NCT04021043|567010162|FG001|Overall Study|Death|3|||
157069830|NCT04021043|567010163|FG002|Overall Study|Death|1|||
157069831|NCT04021043|567010164|FG003|Overall Study|Death|3|||
157069832|NCT04021043|567010161|FG000|Overall Study|Withdrawal by Subject|1|||
157069833|NCT04021043|567010162|FG001|Overall Study|Withdrawal by Subject|1|||
157069834|NCT04021043|567010163|FG002|Overall Study|Withdrawal by Subject|1|||
157069835|NCT04021043|567010164|FG003|Overall Study|Withdrawal by Subject|6|||
157069836|NCT04021043|567010161|FG000|Overall Study|Discontinued due to disease progression|4|||
157069837|NCT04021043|567010162|FG001|Overall Study|Discontinued due to disease progression|5|||
157069838|NCT04021043|567010163|FG002|Overall Study|Discontinued due to disease progression|7|||
157069839|NCT04021043|567010164|FG003|Overall Study|Discontinued due to disease progression|10|||
157069840|NCT00826228|567010165|FG000|Overall Study|Withdrawal by Subject|1|||
157069841|NCT01246999|567010166|FG000|Overall Study|Lost to Follow-up|0|||
157069842|NCT01246999|567010167|FG001|Overall Study|Lost to Follow-up|1|||
157069843|NCT01246999|567010168|FG002|Overall Study|Lost to Follow-up|0|||
157069844|NCT01246999|567010169|FG003|Overall Study|Lost to Follow-up|0|||
157069845|NCT01246999|567010166|FG000|Overall Study|Withdrawal by Subject|0|||
157069846|NCT01246999|567010167|FG001|Overall Study|Withdrawal by Subject|0|||
157069847|NCT01246999|567010168|FG002|Overall Study|Withdrawal by Subject|0|||
157069848|NCT01246999|567010169|FG003|Overall Study|Withdrawal by Subject|2|||
157069849|NCT01867047|567010170|FG000|Overall Study|Lost to Follow-up|3|||
157069850|NCT01867047|567010171|FG001|Overall Study|Lost to Follow-up|3|||
157069851|NCT01867047|567010170|FG000|Overall Study|Withdrawal by Subject|2|||
157069852|NCT01867047|567010171|FG001|Overall Study|Withdrawal by Subject|0|||
157069853|NCT01867047|567010170|FG000|Overall Study|Physician Decision|2|||
157069854|NCT01867047|567010171|FG001|Overall Study|Physician Decision|0|||
157069855|NCT01867047|567010170|FG000|Overall Study|surgery not indicated in protocol|1|||
157069856|NCT01867047|567010171|FG001|Overall Study|surgery not indicated in protocol|2|||
157069857|NCT00307047|567010172|FG000|Overall Study|Lost to Follow-up|35|||
157069858|NCT00307047|567010173|FG001|Overall Study|Lost to Follow-up|24|||
157230697|NCT03980483|567590676|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
157230698|NCT03980483|567590677|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
157230699|NCT03980483|567590672|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
157230700|NCT03980483|567590673|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
157230701|NCT03980483|567590674|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
157230702|NCT03980483|567590675|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
157230703|NCT03980483|567590676|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
157230704|NCT03980483|567590677|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
157230705|NCT03980483|567590672|FG000|Overall Study|Other|0|||
157230706|NCT03980483|567590673|FG001|Overall Study|Other|1|||
157230707|NCT03980483|567590674|FG002|Overall Study|Other|0|||
157230708|NCT03980483|567590675|FG003|Overall Study|Other|0|||
157230709|NCT03980483|567590676|FG004|Overall Study|Other|0|||
157230710|NCT03980483|567590677|FG005|Overall Study|Other|0|||
157230711|NCT01225146|567590678|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
157230712|NCT01225146|567590679|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
157230713|NCT05150964|567590680|FG000|Overall Study|Lost to Follow-up|2|||
157230714|NCT00623779|567590681|FG000|Overall Study|Adverse Event|1|||
157230715|NCT00623779|567590682|FG001|Overall Study|Adverse Event|3|||
157230716|NCT00623779|567590683|FG002|Overall Study|Adverse Event|0|||
157230717|NCT00623779|567590681|FG000|Overall Study|Criteria from CSR|2|||
157230718|NCT00623779|567590682|FG001|Overall Study|Criteria from CSR|0|||
157230719|NCT00623779|567590683|FG002|Overall Study|Criteria from CSR|1|||
157230720|NCT00686959|567590684|FG000|Overall Study|Participants censored (no death events)|124|||
157230721|NCT00686959|567590685|FG001|Overall Study|Participants censored (no death events)|117|||
157230722|NCT03883906|567590690|FG000|Overall Study|Withdrawal by Subject|2|||
157230723|NCT03883906|567590690|FG000|Overall Study|Physician Decision|5|||
157230724|NCT03912337|567590696|FG000|Overall Study|Withdrawal of Consent From Study|1|||
157230725|NCT03912337|567590697|FG001|Overall Study|Withdrawal of Consent From Study|0|||
157230726|NCT03912337|567590696|FG000|Overall Study|Lost to Follow-up|1|||
157230727|NCT03912337|567590697|FG001|Overall Study|Lost to Follow-up|1|||
157230728|NCT02545998|567590698|FG000|Overall Study|Lost to Follow-up|12|||
157230729|NCT02545998|567590699|FG001|Overall Study|Lost to Follow-up|3|||
157230730|NCT02545998|567590698|FG000|Overall Study|Withdrawal by Subject|3|||
157230731|NCT02545998|567590699|FG001|Overall Study|Withdrawal by Subject|2|||
157230732|NCT05214560|567590706|FG000|Overall Study|Screening Failure|1|||
157230733|NCT05214560|567590706|FG000|Overall Study|Physician Decision|4|||
157230734|NCT05214560|567590706|FG000|Overall Study|Withdrawal by Subject|1|||
157230735|NCT05214560|567590706|FG000|Overall Study|Lost to Follow-up|2|||
157230736|NCT05214560|567590706|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
157230737|NCT05214560|567590706|FG000|Overall Study|Study physician not available for the anesthesia|3|||
157230738|NCT05214560|567590706|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
157230739|NCT05214560|567590706|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
157230740|NCT05214560|567590706|FG000|Overall Study|Surgery not performed|3|||
157230741|NCT04977336|567590707|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
157230742|NCT04977336|567590708|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
157230743|NCT04977336|567590709|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
157230744|NCT04977336|567590710|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
157230745|NCT04977336|567590711|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
157230746|NCT04977336|567590707|FG000|Overall Study|Lost to Follow-up|0|||
157230747|NCT04977336|567590708|FG001|Overall Study|Lost to Follow-up|0|||
157230748|NCT04977336|567590709|FG002|Overall Study|Lost to Follow-up|1|||
157069859|NCT00307047|567010172|FG000|Overall Study|Withdrawal by Subject|6|||
157069860|NCT00307047|567010173|FG001|Overall Study|Withdrawal by Subject|6|||
157069861|NCT00307047|567010172|FG000|Overall Study|Physician Decision|1|||
157069862|NCT00307047|567010173|FG001|Overall Study|Physician Decision|2|||
157230749|NCT04977336|567590710|FG003|Overall Study|Lost to Follow-up|0|||
157069863|NCT00307047|567010172|FG000|Overall Study|Lost to follow-up for other reasons|0|||
157069864|NCT00307047|567010173|FG001|Overall Study|Lost to follow-up for other reasons|1|||
157069865|NCT00307047|567010172|FG000|Overall Study|All death, all MI, all Revascularization|27|||
157069866|NCT00307047|567010173|FG001|Overall Study|All death, all MI, all Revascularization|16|||
157069867|NCT00379769|567010174|FG000|Main Study|Death|57|||
157069868|NCT00379769|567010175|FG001|Main Study|Death|67|||
157069869|NCT00379769|567010176|FG002|Main Study|Death|54|||
157069870|NCT00379769|567010177|FG003|Main Study|Death|72|||
157069871|NCT00379769|567010178|FG004|Main Study|Death|0|||
157069872|NCT00379769|567010179|FG005|Main Study|Death|0|||
157069873|NCT00379769|567010174|FG000|Main Study|Adverse Event|5|||
157069874|NCT00379769|567010175|FG001|Main Study|Adverse Event|8|||
157069875|NCT00379769|567010176|FG002|Main Study|Adverse Event|10|||
157069876|NCT00379769|567010177|FG003|Main Study|Adverse Event|11|||
157069877|NCT00379769|567010178|FG004|Main Study|Adverse Event|0|||
157069878|NCT00379769|567010179|FG005|Main Study|Adverse Event|0|||
157069879|NCT00379769|567010174|FG000|Main Study|Lost to Follow-up|29|||
157069880|NCT00379769|567010175|FG001|Main Study|Lost to Follow-up|29|||
157069881|NCT00379769|567010176|FG002|Main Study|Lost to Follow-up|25|||
157069882|NCT00379769|567010177|FG003|Main Study|Lost to Follow-up|26|||
157069883|NCT00379769|567010178|FG004|Main Study|Lost to Follow-up|0|||
157069884|NCT00379769|567010179|FG005|Main Study|Lost to Follow-up|0|||
157069885|NCT00379769|567010174|FG000|Main Study|Withdrawal by Subject|46|||
157069886|NCT00379769|567010175|FG001|Main Study|Withdrawal by Subject|56|||
157069887|NCT00379769|567010176|FG002|Main Study|Withdrawal by Subject|72|||
157069888|NCT00379769|567010177|FG003|Main Study|Withdrawal by Subject|70|||
157069889|NCT00379769|567010178|FG004|Main Study|Withdrawal by Subject|0|||
157069890|NCT00379769|567010179|FG005|Main Study|Withdrawal by Subject|0|||
157069891|NCT00379769|567010174|FG000|Main Study|Moved to survival status follow-up only|27|||
157069892|NCT00379769|567010175|FG001|Main Study|Moved to survival status follow-up only|25|||
157069893|NCT00379769|567010176|FG002|Main Study|Moved to survival status follow-up only|32|||
157069894|NCT00379769|567010177|FG003|Main Study|Moved to survival status follow-up only|36|||
157069895|NCT00379769|567010178|FG004|Main Study|Moved to survival status follow-up only|0|||
157069896|NCT00379769|567010179|FG005|Main Study|Moved to survival status follow-up only|0|||
157069897|NCT00379769|567010174|FG000|Main Study|Participant moved|3|||
157069898|NCT00379769|567010175|FG001|Main Study|Participant moved|2|||
157069899|NCT00379769|567010176|FG002|Main Study|Participant moved|3|||
157069900|NCT00379769|567010177|FG003|Main Study|Participant moved|3|||
157069901|NCT00379769|567010178|FG004|Main Study|Participant moved|0|||
157069902|NCT00379769|567010179|FG005|Main Study|Participant moved|0|||
157069903|NCT00379769|567010174|FG000|Main Study|Poor compliance|3|||
157069904|NCT00379769|567010175|FG001|Main Study|Poor compliance|2|||
157069905|NCT00379769|567010176|FG002|Main Study|Poor compliance|2|||
157069906|NCT00379769|567010177|FG003|Main Study|Poor compliance|1|||
157069907|NCT00379769|567010178|FG004|Main Study|Poor compliance|0|||
157069908|NCT00379769|567010179|FG005|Main Study|Poor compliance|0|||
157069909|NCT00379769|567010174|FG000|Main Study|Prohibited glucose lowering medication|0|||
157069910|NCT00379769|567010175|FG001|Main Study|Prohibited glucose lowering medication|3|||
157069911|NCT00379769|567010176|FG002|Main Study|Prohibited glucose lowering medication|0|||
157069912|NCT00379769|567010177|FG003|Main Study|Prohibited glucose lowering medication|1|||
157069913|NCT00379769|567010178|FG004|Main Study|Prohibited glucose lowering medication|0|||
157069914|NCT00379769|567010179|FG005|Main Study|Prohibited glucose lowering medication|0|||
157069915|NCT00379769|567010174|FG000|Main Study|Site closed|4|||
157069916|NCT00379769|567010175|FG001|Main Study|Site closed|4|||
157069917|NCT00379769|567010176|FG002|Main Study|Site closed|4|||
157069918|NCT00379769|567010177|FG003|Main Study|Site closed|8|||
157069919|NCT00379769|567010178|FG004|Main Study|Site closed|0|||
157069920|NCT00379769|567010179|FG005|Main Study|Site closed|0|||
157069921|NCT00379769|567010174|FG000|Main Study|Entry criteria violation|0|||
157069922|NCT00379769|567010175|FG001|Main Study|Entry criteria violation|0|||
157069923|NCT00379769|567010176|FG002|Main Study|Entry criteria violation|1|||
157069924|NCT00379769|567010177|FG003|Main Study|Entry criteria violation|1|||
157069925|NCT00379769|567010178|FG004|Main Study|Entry criteria violation|0|||
157069926|NCT00379769|567010179|FG005|Main Study|Entry criteria violation|0|||
157069927|NCT00379769|567010174|FG000|Main Study|Participant did not take study drug|0|||
157069928|NCT00379769|567010175|FG001|Main Study|Participant did not take study drug|0|||
157069929|NCT00379769|567010176|FG002|Main Study|Participant did not take study drug|1|||
157069930|NCT00379769|567010177|FG003|Main Study|Participant did not take study drug|0|||
157069931|NCT00379769|567010178|FG004|Main Study|Participant did not take study drug|0|||
157069932|NCT00379769|567010179|FG005|Main Study|Participant did not take study drug|0|||
157069933|NCT00379769|567010174|FG000|Main Study|Physician Decision|2|||
157069934|NCT00379769|567010175|FG001|Main Study|Physician Decision|2|||
157069935|NCT00379769|567010176|FG002|Main Study|Physician Decision|1|||
157069936|NCT00379769|567010177|FG003|Main Study|Physician Decision|1|||
157191499|NCT00846027|567440723|FG000|Overall Study|Subject Not Treated|7|||
157191500|NCT04905563|567440726|FG000|Overall Study|Withdrawal by Subject|1|||
157069937|NCT00379769|567010178|FG004|Main Study|Physician Decision|0|||
157191501|NCT04905563|567440727|FG001|Overall Study|Withdrawal by Subject|0|||
157069938|NCT00379769|567010179|FG005|Main Study|Physician Decision|0|||
157069939|NCT00379769|567010174|FG000|Main Study|Participant completed study at visit 27|1|||
157069940|NCT00379769|567010175|FG001|Main Study|Participant completed study at visit 27|0|||
157069941|NCT00379769|567010176|FG002|Main Study|Participant completed study at visit 27|0|||
157069942|NCT00379769|567010177|FG003|Main Study|Participant completed study at visit 27|0|||
157069943|NCT00379769|567010178|FG004|Main Study|Participant completed study at visit 27|0|||
157069944|NCT00379769|567010179|FG005|Main Study|Participant completed study at visit 27|0|||
157069945|NCT00379769|567010174|FG000|Main Study|Personal reasons|1|||
157069946|NCT00379769|567010175|FG001|Main Study|Personal reasons|0|||
157069947|NCT00379769|567010176|FG002|Main Study|Personal reasons|0|||
157069948|NCT00379769|567010177|FG003|Main Study|Personal reasons|0|||
157069949|NCT00379769|567010178|FG004|Main Study|Personal reasons|0|||
157069950|NCT00379769|567010179|FG005|Main Study|Personal reasons|0|||
157069951|NCT00379769|567010174|FG000|Main Study|Risk of heart failure|0|||
157069952|NCT00379769|567010175|FG001|Main Study|Risk of heart failure|1|||
157069953|NCT00379769|567010176|FG002|Main Study|Risk of heart failure|0|||
157069954|NCT00379769|567010177|FG003|Main Study|Risk of heart failure|0|||
157069955|NCT00379769|567010178|FG004|Main Study|Risk of heart failure|0|||
157069956|NCT00379769|567010179|FG005|Main Study|Risk of heart failure|0|||
157069957|NCT00379769|567010174|FG000|Main Study|Investigator refused to log temperature|0|||
157069958|NCT00379769|567010175|FG001|Main Study|Investigator refused to log temperature|0|||
157069959|NCT00379769|567010176|FG002|Main Study|Investigator refused to log temperature|1|||
157069960|NCT00379769|567010177|FG003|Main Study|Investigator refused to log temperature|0|||
157069961|NCT00379769|567010178|FG004|Main Study|Investigator refused to log temperature|0|||
157069962|NCT00379769|567010179|FG005|Main Study|Investigator refused to log temperature|0|||
157069963|NCT00379769|567010174|FG000|Main Study|Reason unspecified|0|||
157191502|NCT04905563|567440726|FG000|Overall Study|Standard of care orders entered by resident|1|||
157191503|NCT04905563|567440727|FG001|Overall Study|Standard of care orders entered by resident|0|||
157191504|NCT04905563|567440726|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
157191505|NCT04905563|567440727|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
157191506|NCT04905563|567440726|FG000|Overall Study|Withdrawal by Subject|0|||
157191507|NCT04905563|567440727|FG001|Overall Study|Withdrawal by Subject|1|||
157191508|NCT01797302|567440728|FG000|Overall Study|Lost to Follow-up|16|||
157191509|NCT01797302|567440729|FG001|Overall Study|Lost to Follow-up|23|||
157191510|NCT01797302|567440730|FG002|Overall Study|Lost to Follow-up|22|||
157191511|NCT01797302|567440728|FG000|Overall Study|Withdrawal by Subject|1|||
157191512|NCT01797302|567440729|FG001|Overall Study|Withdrawal by Subject|3|||
157191513|NCT01797302|567440730|FG002|Overall Study|Withdrawal by Subject|4|||
157191514|NCT00689611|567440733|FG000|Overall Study|Death|6|||
157191515|NCT00689611|567440734|FG001|Overall Study|Death|9|||
157191516|NCT00689611|567440733|FG000|Overall Study|Withdrawal by Subject|8|||
157191517|NCT00689611|567440734|FG001|Overall Study|Withdrawal by Subject|9|||
157191518|NCT00689611|567440733|FG000|Overall Study|Lost to Follow-up|27|||
157191519|NCT00689611|567440734|FG001|Overall Study|Lost to Follow-up|28|||
157191520|NCT00568399|567440736|FG000|Overall Study|Death|2|||
157191521|NCT00568399|567440736|FG000|Overall Study|Adverse Event|5|||
157191522|NCT00568399|567440736|FG000|Overall Study|Withdrawal by Subject|8|||
157191523|NCT00405756|567440737|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
157191524|NCT00405756|567440738|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
157191525|NCT00405756|567440739|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
157191526|NCT00405756|567440737|FG000|Double-blind Treatment|Adverse Event|31|||
157191527|NCT00405756|567440738|FG001|Double-blind Treatment|Adverse Event|27|||
157191528|NCT00405756|567440739|FG002|Double-blind Treatment|Adverse Event|12|||
157191529|NCT00405756|567440737|FG000|Double-blind Treatment|Disease Progression|47|||
157191530|NCT00405756|567440738|FG001|Double-blind Treatment|Disease Progression|81|||
157191531|NCT00405756|567440739|FG002|Double-blind Treatment|Disease Progression|102|||
157191532|NCT00405756|567440737|FG000|Double-blind Treatment|Lack of Efficacy|1|||
157191533|NCT00405756|567440738|FG001|Double-blind Treatment|Lack of Efficacy|4|||
157191534|NCT00405756|567440739|FG002|Double-blind Treatment|Lack of Efficacy|2|||
157191535|NCT00405756|567440737|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
157191536|NCT00405756|567440738|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
157191537|NCT00405756|567440739|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
157191538|NCT00405756|567440737|FG000|Double-blind Treatment|Lost to Follow-up|1|||
157191539|NCT00405756|567440738|FG001|Double-blind Treatment|Lost to Follow-up|0|||
157191540|NCT00405756|567440739|FG002|Double-blind Treatment|Lost to Follow-up|0|||
157191541|NCT00405756|567440737|FG000|Double-blind Treatment|Death|4|||
157191542|NCT00405756|567440738|FG001|Double-blind Treatment|Death|4|||
157069964|NCT00379769|567010175|FG001|Main Study|Reason unspecified|0|||
157069965|NCT00379769|567010176|FG002|Main Study|Reason unspecified|1|||
157069966|NCT00379769|567010177|FG003|Main Study|Reason unspecified|0|||
157069967|NCT00379769|567010178|FG004|Main Study|Reason unspecified|0|||
157069968|NCT00379769|567010179|FG005|Main Study|Reason unspecified|0|||
157069969|NCT00379769|567010174|FG000|Observational Follow-up|Death|0|||
157069970|NCT00379769|567010175|FG001|Observational Follow-up|Death|0|||
157069971|NCT00379769|567010176|FG002|Observational Follow-up|Death|0|||
157069972|NCT00379769|567010177|FG003|Observational Follow-up|Death|0|||
157069973|NCT00379769|567010178|FG004|Observational Follow-up|Death|78|||
157069974|NCT00379769|567010179|FG005|Observational Follow-up|Death|70|||
157069975|NCT00379769|567010174|FG000|Observational Follow-up|Adverse Event|0|||
157069976|NCT00379769|567010175|FG001|Observational Follow-up|Adverse Event|0|||
157069977|NCT00379769|567010176|FG002|Observational Follow-up|Adverse Event|0|||
157069978|NCT00379769|567010177|FG003|Observational Follow-up|Adverse Event|0|||
157069979|NCT00379769|567010178|FG004|Observational Follow-up|Adverse Event|1|||
157069980|NCT00379769|567010179|FG005|Observational Follow-up|Adverse Event|0|||
157069981|NCT00379769|567010174|FG000|Observational Follow-up|Lost to Follow-up|0|||
157069982|NCT00379769|567010175|FG001|Observational Follow-up|Lost to Follow-up|0|||
157069983|NCT00379769|567010176|FG002|Observational Follow-up|Lost to Follow-up|0|||
157069984|NCT00379769|567010177|FG003|Observational Follow-up|Lost to Follow-up|0|||
157069985|NCT00379769|567010178|FG004|Observational Follow-up|Lost to Follow-up|25|||
157069986|NCT00379769|567010179|FG005|Observational Follow-up|Lost to Follow-up|27|||
157069987|NCT00379769|567010174|FG000|Observational Follow-up|Withdrawal by Subject|0|||
157069988|NCT00379769|567010175|FG001|Observational Follow-up|Withdrawal by Subject|0|||
157069989|NCT00379769|567010176|FG002|Observational Follow-up|Withdrawal by Subject|0|||
157069990|NCT00379769|567010177|FG003|Observational Follow-up|Withdrawal by Subject|0|||
157069991|NCT00379769|567010178|FG004|Observational Follow-up|Withdrawal by Subject|12|||
157069992|NCT00379769|567010179|FG005|Observational Follow-up|Withdrawal by Subject|12|||
157069993|NCT00379769|567010174|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
157069994|NCT00379769|567010175|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
157069995|NCT00379769|567010176|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
157069996|NCT00379769|567010177|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
157069997|NCT00379769|567010178|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
157069998|NCT00379769|567010179|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
157069999|NCT00379769|567010174|FG000|Observational Follow-up|Physician Decision|0|||
157070000|NCT00379769|567010175|FG001|Observational Follow-up|Physician Decision|0|||
157070001|NCT00379769|567010176|FG002|Observational Follow-up|Physician Decision|0|||
157070002|NCT00379769|567010177|FG003|Observational Follow-up|Physician Decision|0|||
157070003|NCT00379769|567010178|FG004|Observational Follow-up|Physician Decision|8|||
157070004|NCT00379769|567010179|FG005|Observational Follow-up|Physician Decision|8|||
157070005|NCT00379769|567010174|FG000|Observational Follow-up|Site Closed Early|0|||
157070006|NCT00379769|567010175|FG001|Observational Follow-up|Site Closed Early|0|||
157070007|NCT00379769|567010176|FG002|Observational Follow-up|Site Closed Early|0|||
157070008|NCT00379769|567010177|FG003|Observational Follow-up|Site Closed Early|0|||
157070009|NCT00379769|567010178|FG004|Observational Follow-up|Site Closed Early|6|||
157070010|NCT00379769|567010179|FG005|Observational Follow-up|Site Closed Early|7|||
157070011|NCT00379769|567010174|FG000|Observational Follow-up|Participant Moved|0|||
157070012|NCT00379769|567010175|FG001|Observational Follow-up|Participant Moved|0|||
157070013|NCT00379769|567010176|FG002|Observational Follow-up|Participant Moved|0|||
157070014|NCT00379769|567010177|FG003|Observational Follow-up|Participant Moved|0|||
157070015|NCT00379769|567010178|FG004|Observational Follow-up|Participant Moved|0|||
157070016|NCT00379769|567010179|FG005|Observational Follow-up|Participant Moved|1|||
157070017|NCT00379769|567010174|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
157070018|NCT00379769|567010175|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
157070019|NCT00379769|567010176|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
157070020|NCT00379769|567010177|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
157070021|NCT00379769|567010178|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
157070022|NCT00379769|567010179|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
157070023|NCT02825251|567010180|FG000|Overall Study|Adverse Event|0|||
157070024|NCT02825251|567010181|FG001|Overall Study|Adverse Event|1|||
157070025|NCT02825251|567010180|FG000|Overall Study|Lost to Follow-up|0|||
157070026|NCT02825251|567010181|FG001|Overall Study|Lost to Follow-up|1|||
157070027|NCT02825251|567010180|FG000|Overall Study|Withdrawal by Subject|1|||
157070028|NCT02825251|567010181|FG001|Overall Study|Withdrawal by Subject|4|||
157070029|NCT02825251|567010180|FG000|Overall Study|Unclassified|2|||
157070030|NCT02825251|567010181|FG001|Overall Study|Unclassified|0|||
157070031|NCT01689363|567010188|FG000|Overall Study|Protocol Violation|0|||
157070032|NCT01689363|567010189|FG001|Overall Study|Protocol Violation|1|||
157070033|NCT01689363|567010190|FG002|Overall Study|Protocol Violation|0|||
157070034|NCT01689363|567010191|FG003|Overall Study|Protocol Violation|0|||
157070035|NCT01689363|567010192|FG004|Overall Study|Protocol Violation|0|||
157070036|NCT01689363|567010193|FG005|Overall Study|Protocol Violation|0|||
157070037|NCT01689363|567010194|FG006|Overall Study|Protocol Violation|0|||
157070038|NCT01689363|567010195|FG007|Overall Study|Protocol Violation|0|||
157070039|NCT00321685|567010196|FG000|Overall Study|Adverse Event|18|||
157070040|NCT00321685|567010196|FG000|Overall Study|Death|2|||
157070041|NCT00321685|567010196|FG000|Overall Study|Withdrawal by Subject|8|||
157070042|NCT00321685|567010196|FG000|Overall Study|Alternative therapy|1|||
157070043|NCT00321685|567010196|FG000|Overall Study|Complicating disese|1|||
157070044|NCT00321685|567010196|FG000|Overall Study|Other|5|||
157070045|NCT00321685|567010196|FG000|Overall Study|Not start protocol therapy|2|||
157070046|NCT00321685|567010196|FG000|Overall Study|Ineligible|2|||
157070047|NCT05064488|567010200|FG000|Overall Study|Withdrawal by Subject|2|||
157070048|NCT05064488|567010201|FG001|Overall Study|Withdrawal by Subject|0|||
157070049|NCT03023722|567010202|FG000|Overall Study|No follow-up assessment|4|||
157070050|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
157070051|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
157070052|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
157070053|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Death|4|||
157070054|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Death|2|||
157070055|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Death|3|||
157070056|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
157070057|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
157070058|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
157191543|NCT00405756|567440739|FG002|Double-blind Treatment|Death|4|||
157191544|NCT00405756|567440737|FG000|Double-blind Treatment|Protocol Violation|1|||
157191545|NCT00405756|567440738|FG001|Double-blind Treatment|Protocol Violation|0|||
157191546|NCT00405756|567440739|FG002|Double-blind Treatment|Protocol Violation|2|||
157191547|NCT00405756|567440737|FG000|Double-blind Treatment|Other|7|||
157191548|NCT00405756|567440738|FG001|Double-blind Treatment|Other|4|||
157191549|NCT00405756|567440739|FG002|Double-blind Treatment|Other|4|||
157191550|NCT00405756|567440737|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
157191551|NCT00405756|567440738|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
157191552|NCT00405756|567440739|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
157191553|NCT00405756|567440737|FG000|Open-label Extension|Adverse Event|1|||
157191554|NCT00405756|567440738|FG001|Open-label Extension|Adverse Event|3|||
157191555|NCT00405756|567440739|FG002|Open-label Extension|Adverse Event|7|||
157191556|NCT00405756|567440737|FG000|Open-label Extension|Disease Progression|8|||
157191557|NCT00405756|567440738|FG001|Open-label Extension|Disease Progression|23|||
157191558|NCT00405756|567440739|FG002|Open-label Extension|Disease Progression|26|||
157191559|NCT00405756|567440737|FG000|Open-label Extension|Withdrawal by Subject|2|||
157191560|NCT00405756|567440738|FG001|Open-label Extension|Withdrawal by Subject|3|||
157191561|NCT00405756|567440739|FG002|Open-label Extension|Withdrawal by Subject|3|||
157191562|NCT00405756|567440737|FG000|Open-label Extension|Death|1|||
157191563|NCT00405756|567440738|FG001|Open-label Extension|Death|2|||
157191564|NCT00405756|567440739|FG002|Open-label Extension|Death|4|||
157191565|NCT00405756|567440737|FG000|Open-label Extension|Other|0|||
157191566|NCT00405756|567440738|FG001|Open-label Extension|Other|1|||
157191567|NCT00405756|567440739|FG002|Open-label Extension|Other|7|||
157191568|NCT00405756|567440737|FG000|Follow-up|Ongoing in Follow-up Period|52|||
157191569|NCT00405756|567440738|FG001|Follow-up|Ongoing in Follow-up Period|51|||
157191570|NCT00405756|567440739|FG002|Follow-up|Ongoing in Follow-up Period|60|||
157191571|NCT00405756|567440737|FG000|Follow-up|Death|21|||
157191572|NCT00405756|567440738|FG001|Follow-up|Death|31|||
157191573|NCT00405756|567440739|FG002|Follow-up|Death|24|||
157191574|NCT00405756|567440737|FG000|Follow-up|Lost to Follow-up|2|||
157191575|NCT00405756|567440738|FG001|Follow-up|Lost to Follow-up|8|||
157191576|NCT00405756|567440739|FG002|Follow-up|Lost to Follow-up|4|||
157191577|NCT03480360|567440742|FG000|Overall Study|Death|2|||
157191578|NCT02120469|567440747|FG000|Overall Study|HER-2/neu-amplified|1|||
157191579|NCT02120469|567440748|FG001|Overall Study|HER-2/neu-amplified|0|||
157191580|NCT02120469|567440749|FG002|Overall Study|HER-2/neu-amplified|1|||
157191581|NCT01040728|567440750|FG000|Overall Study|Adverse Event|4|||
157191582|NCT01040728|567440751|FG001|Overall Study|Adverse Event|8|||
157191583|NCT01040728|567440752|FG002|Overall Study|Adverse Event|0|||
157191584|NCT01040728|567440753|FG003|Overall Study|Adverse Event|4|||
157191585|NCT01040728|567440750|FG000|Overall Study|Withdrawal by Subject|0|||
157191586|NCT01040728|567440751|FG001|Overall Study|Withdrawal by Subject|1|||
157191587|NCT01040728|567440752|FG002|Overall Study|Withdrawal by Subject|1|||
157191588|NCT01040728|567440753|FG003|Overall Study|Withdrawal by Subject|0|||
157191589|NCT01040728|567440750|FG000|Overall Study|Protocol Violation|0|||
157191590|NCT01040728|567440751|FG001|Overall Study|Protocol Violation|0|||
157191591|NCT01040728|567440752|FG002|Overall Study|Protocol Violation|0|||
157191592|NCT01040728|567440753|FG003|Overall Study|Protocol Violation|1|||
157070059|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
157070060|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
157191593|NCT01040728|567440750|FG000|Overall Study|Lack of Efficacy|0|||
157191594|NCT01040728|567440751|FG001|Overall Study|Lack of Efficacy|1|||
157191595|NCT01040728|567440752|FG002|Overall Study|Lack of Efficacy|0|||
157191596|NCT01040728|567440753|FG003|Overall Study|Lack of Efficacy|1|||
157070061|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
157070062|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
157191597|NCT01040728|567440750|FG000|Overall Study|Other reasons not listed above|0|||
157191598|NCT01040728|567440751|FG001|Overall Study|Other reasons not listed above|1|||
157191599|NCT01040728|567440752|FG002|Overall Study|Other reasons not listed above|0|||
157191600|NCT01040728|567440753|FG003|Overall Study|Other reasons not listed above|0|||
157070063|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
157230750|NCT04977336|567590711|FG004|Overall Study|Lost to Follow-up|0|||
157230751|NCT03298451|567590712|FG000|Overall Study|Death|275|||
157070064|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
157070065|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
157070066|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
157070067|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
157070068|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
157070069|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
157070070|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
157070071|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
157070072|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
157070073|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
157070074|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
157070075|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
157070076|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
157070077|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
157070078|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
157070079|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
157070080|NCT02783573|567010203|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
157070081|NCT02783573|567010204|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
157070082|NCT02783573|567010205|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
157070083|NCT02783573|567010203|FG000|Delayed-Start Period|Sponsor Decision|0|||
157070084|NCT02783573|567010204|FG001|Delayed-Start Period|Sponsor Decision|17|||
157070085|NCT02783573|567010205|FG002|Delayed-Start Period|Sponsor Decision|12|||
157070086|NCT00590564|567010206|FG000|Overall Study|Withdrawal by Subject|4|||
157070087|NCT00590564|567010206|FG000|Overall Study|Lost to Follow-up|6|||
157070088|NCT00590564|567010206|FG000|Overall Study|Protocol Violation|1|||
157070089|NCT00590564|567010206|FG000|Overall Study|Patient Found to be Ineligible|1|||
157070090|NCT00590564|567010206|FG000|Overall Study|Patient Non-compliance|6|||
157070091|NCT01434680|567010207|FG000|Overall Study|Withdrawal by Subject|1|||
157070092|NCT01434680|567010208|FG001|Overall Study|Withdrawal by Subject|0|||
157070093|NCT01434680|567010209|FG002|Overall Study|Withdrawal by Subject|2|||
157070094|NCT01434680|567010210|FG003|Overall Study|Withdrawal by Subject|0|||
157070095|NCT01434680|567010207|FG000|Overall Study|Lost to Follow-up|1|||
157070096|NCT01434680|567010208|FG001|Overall Study|Lost to Follow-up|1|||
157070097|NCT01434680|567010209|FG002|Overall Study|Lost to Follow-up|0|||
157070098|NCT01434680|567010210|FG003|Overall Study|Lost to Follow-up|0|||
157070099|NCT01434680|567010207|FG000|Overall Study|Protocol Violation|1|||
157070100|NCT01434680|567010208|FG001|Overall Study|Protocol Violation|1|||
157070101|NCT01434680|567010209|FG002|Overall Study|Protocol Violation|0|||
157070102|NCT01434680|567010210|FG003|Overall Study|Protocol Violation|0|||
157070103|NCT02684123|567010212|FG000|Phase 1|Lack of Efficacy|5|||
157070104|NCT02684123|567010213|FG001|Phase 1|Lack of Efficacy|0|||
157070105|NCT02684123|567010212|FG000|Phase 1|Adverse Event|3|||
157230752|NCT03298451|567590713|FG001|Overall Study|Death|260|||
157230753|NCT03298451|567590714|FG002|Overall Study|Death|122|||
157230754|NCT03298451|567590715|FG003|Overall Study|Death|280|||
157230755|NCT03298451|567590712|FG000|Overall Study|Lost to Follow-up|1|||
157230756|NCT03298451|567590713|FG001|Overall Study|Lost to Follow-up|1|||
157230757|NCT03298451|567590714|FG002|Overall Study|Lost to Follow-up|0|||
157230758|NCT03298451|567590715|FG003|Overall Study|Lost to Follow-up|7|||
157230759|NCT03298451|567590712|FG000|Overall Study|Withdrawal by Subject|9|||
157230760|NCT03298451|567590713|FG001|Overall Study|Withdrawal by Subject|7|||
157230761|NCT03298451|567590714|FG002|Overall Study|Withdrawal by Subject|1|||
157230762|NCT03298451|567590715|FG003|Overall Study|Withdrawal by Subject|20|||
157070106|NCT02684123|567010213|FG001|Phase 1|Adverse Event|0|||
157070107|NCT02684123|567010212|FG000|Phase 1|Lost to Follow-up|0|||
157070108|NCT02684123|567010213|FG001|Phase 1|Lost to Follow-up|1|||
157070109|NCT02684123|567010212|FG000|Phase 2|Lack of Efficacy|1|||
157230763|NCT02534493|567590719|FG000|Overall Study|Lost to Follow-up|1|||
157230764|NCT02534493|567590719|FG000|Overall Study|Withdrawal by Subject|1|||
157230765|NCT01478620|567590723|FG000|Overall Study|Lost to Follow-up|6|||
157230766|NCT02514174|567590729|FG000|Overall Study|Patient refused to continue medication|1|||
157230767|NCT02514174|567590729|FG000|Overall Study|Adverse Event|2|||
157230768|NCT02514174|567590729|FG000|Overall Study|Study closed by sponsor|9|||
157070110|NCT02684123|567010213|FG001|Phase 2|Lack of Efficacy|8|||
157070111|NCT01245140|567010216|FG000|Overall Study|Adverse Event|1|||
157070112|NCT01245140|567010217|FG001|Overall Study|Adverse Event|3|||
157070113|NCT01245140|567010216|FG000|Overall Study|Lack of Efficacy|2|||
157230769|NCT02514174|567590729|FG000|Overall Study|Progressive disease|11|||
157230770|NCT02514174|567590729|FG000|Overall Study|Treatment change|1|||
157230771|NCT02514174|567590729|FG000|Overall Study|Treated off study with Afatinib.|1|||
157230772|NCT02888171|567590732|FG000|Overall Study|Lost to Follow-up|2|||
157070114|NCT01245140|567010217|FG001|Overall Study|Lack of Efficacy|4|||
157070115|NCT01245140|567010216|FG000|Overall Study|Protocol Violation|0|||
157070116|NCT01245140|567010217|FG001|Overall Study|Protocol Violation|1|||
157070117|NCT01245140|567010216|FG000|Overall Study|Withdrawal by Subject|0|||
157070118|NCT01245140|567010217|FG001|Overall Study|Withdrawal by Subject|1|||
157070119|NCT01245140|567010216|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
157070120|NCT01245140|567010217|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
157070121|NCT02037477|567010218|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
157070122|NCT02037477|567010219|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
157070123|NCT02037477|567010220|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
157070124|NCT02037477|567010221|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
157070125|NCT02635360|567010222|FG000|Overall Study|Adverse Event|0|||
157070126|NCT02635360|567010223|FG001|Overall Study|Adverse Event|3|||
157070127|NCT02635360|567010222|FG000|Overall Study|Withdrawal by Subject|2|||
157070128|NCT02635360|567010223|FG001|Overall Study|Withdrawal by Subject|0|||
157070129|NCT02635360|567010222|FG000|Overall Study|Non-Compliance|3|||
157070130|NCT02635360|567010223|FG001|Overall Study|Non-Compliance|1|||
157070131|NCT02635360|567010222|FG000|Overall Study|Disease Progression|0|||
157070132|NCT02635360|567010223|FG001|Overall Study|Disease Progression|2|||
157070133|NCT02635360|567010222|FG000|Overall Study|Lost to Follow-up|1|||
157070134|NCT02635360|567010223|FG001|Overall Study|Lost to Follow-up|1|||
157070135|NCT04082429|567010224|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
157070136|NCT04082429|567010225|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
157070137|NCT04082429|567010226|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
157070138|NCT04082429|567010227|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
157070139|NCT04082429|567010228|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
157070140|NCT04082429|567010229|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
157070141|NCT04082429|567010230|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
157070142|NCT04082429|567010231|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
157070143|NCT04082429|567010232|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
157070144|NCT04082429|567010224|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070145|NCT04082429|567010225|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070146|NCT04082429|567010226|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070147|NCT04082429|567010227|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070148|NCT04082429|567010228|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
157070149|NCT04082429|567010229|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070150|NCT04082429|567010230|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070151|NCT04082429|567010231|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070152|NCT04082429|567010232|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
157070153|NCT04082429|567010224|FG000|Main Part (After the Treatment Pause)|Death|0|||
157070154|NCT04082429|567010225|FG001|Main Part (After the Treatment Pause)|Death|0|||
157070155|NCT04082429|567010226|FG002|Main Part (After the Treatment Pause)|Death|0|||
157070156|NCT04082429|567010227|FG003|Main Part (After the Treatment Pause)|Death|0|||
157070157|NCT04082429|567010228|FG004|Main Part (After the Treatment Pause)|Death|1|||
157070158|NCT04082429|567010229|FG005|Main Part (After the Treatment Pause)|Death|0|||
157070159|NCT04082429|567010230|FG006|Main Part (After the Treatment Pause)|Death|0|||
157070160|NCT04082429|567010231|FG007|Main Part (After the Treatment Pause)|Death|0|||
157070161|NCT04082429|567010232|FG008|Main Part (After the Treatment Pause)|Death|0|||
157070162|NCT04082429|567010224|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070163|NCT04082429|567010225|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070164|NCT04082429|567010226|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070165|NCT04082429|567010227|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
157070166|NCT04082429|567010228|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070167|NCT04082429|567010229|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
157070168|NCT04082429|567010230|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070169|NCT04082429|567010231|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070170|NCT04082429|567010232|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
157070171|NCT04082429|567010224|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
157191601|NCT01012037|567440754|FG000|Overall Study|Adverse Event|0|||
157191602|NCT01012037|567440755|FG001|Overall Study|Adverse Event|8|||
157191603|NCT01012037|567440756|FG002|Overall Study|Adverse Event|3|||
157191604|NCT01012037|567440754|FG000|Overall Study|Protocol Violation|0|||
157191605|NCT01012037|567440755|FG001|Overall Study|Protocol Violation|3|||
157191606|NCT01012037|567440756|FG002|Overall Study|Protocol Violation|5|||
157191607|NCT01012037|567440754|FG000|Overall Study|Withdrawal by Subject|0|||
157070172|NCT04082429|567010225|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
157070173|NCT04082429|567010226|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
157070174|NCT04082429|567010227|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
157070175|NCT04082429|567010228|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
157070176|NCT04082429|567010229|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
157070177|NCT04082429|567010230|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
157070178|NCT04082429|567010231|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
157070179|NCT04082429|567010232|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
157070180|NCT04082429|567010224|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
157070181|NCT04082429|567010225|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070182|NCT04082429|567010226|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070183|NCT04082429|567010227|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070184|NCT04082429|567010228|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070185|NCT04082429|567010229|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
157070186|NCT04082429|567010230|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070187|NCT04082429|567010231|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070188|NCT04082429|567010232|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
157070189|NCT04082429|567010224|FG000|Extension Part|Ongoing|0|||
157070190|NCT04082429|567010225|FG001|Extension Part|Ongoing|7|||
157070191|NCT04082429|567010226|FG002|Extension Part|Ongoing|17|||
157070192|NCT04082429|567010227|FG003|Extension Part|Ongoing|6|||
157070193|NCT04082429|567010228|FG004|Extension Part|Ongoing|45|||
157070194|NCT04082429|567010229|FG005|Extension Part|Ongoing|0|||
157070195|NCT04082429|567010230|FG006|Extension Part|Ongoing|10|||
157070196|NCT04082429|567010231|FG007|Extension Part|Ongoing|23|||
157070197|NCT04082429|567010232|FG008|Extension Part|Ongoing|25|||
157070198|NCT00334542|567010233|FG000|Overall Study|Adverse Event|3|||
157070199|NCT00334542|567010233|FG000|Overall Study|Withdrawal by Subject|1|||
157070200|NCT00334542|567010233|FG000|Overall Study|New cancer diagnosis|1|||
157070201|NCT03118050|567010234|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
157070202|NCT03118050|567010235|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
157070203|NCT03118050|567010236|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
157070204|NCT03118050|567010237|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
157070205|NCT03118050|567010238|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
157070206|NCT03118050|567010239|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
157070207|NCT03118050|567010240|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
157070208|NCT00943787|567010248|FG000|Overall Study|Physician Decision|4|||
157070209|NCT00943787|567010248|FG000|Overall Study|Withdrawal by Subject|3|||
157070210|NCT02125279|567010251|FG000|Overall Study|Lack of Efficacy|2|||
157070211|NCT02125279|567010251|FG000|Overall Study|Withdrawal by Subject|6|||
157070212|NCT02125279|567010251|FG000|Overall Study|Protocol Violation|1|||
157070213|NCT02125279|567010251|FG000|Overall Study|Lost to Follow-up|4|||
157070214|NCT01850589|567010252|FG000|Overall Study|Withdrawal by Subject|8|||
157070215|NCT01850589|567010253|FG001|Overall Study|Withdrawal by Subject|0|||
157070216|NCT01607879|567010254|FG000|Overall Study|Death|1|||
157070217|NCT01607879|567010255|FG001|Overall Study|Death|0|||
157070218|NCT03845140|567010256|FG000|Overall Study|Participant travelled outside study area|0|||
157070219|NCT03845140|567010257|FG001|Overall Study|Participant travelled outside study area|1|||
157070220|NCT03845140|567010258|FG002|Overall Study|Participant travelled outside study area|0|||
157070221|NCT03845140|567010259|FG003|Overall Study|Participant travelled outside study area|0|||
157070222|NCT03845140|567010260|FG004|Overall Study|Participant travelled outside study area|0|||
157070223|NCT03845140|567010261|FG005|Overall Study|Participant travelled outside study area|0|||
157070224|NCT01592045|567010264|FG000|Overall Study|Disease Progression|1|||
157070225|NCT01592045|567010265|FG001|Overall Study|Disease Progression|1|||
157070226|NCT01592045|567010264|FG000|Overall Study|Adverse Event|1|||
157070227|NCT01592045|567010265|FG001|Overall Study|Adverse Event|1|||
157070228|NCT01592045|567010264|FG000|Overall Study|Withdrawal by Subject|1|||
157070229|NCT01592045|567010265|FG001|Overall Study|Withdrawal by Subject|0|||
157070230|NCT01592045|567010264|FG000|Overall Study|Moved out of country|2|||
157070231|NCT01592045|567010265|FG001|Overall Study|Moved out of country|0|||
157070232|NCT01843777|567010266|FG000|Overall Study|Withdrawal by Subject|1|||
157070233|NCT01843777|567010267|FG001|Overall Study|Withdrawal by Subject|0|||
157070234|NCT02472145|567010270|FG000|Overall Study|Death|10|||
157070235|NCT02472145|567010271|FG001|Overall Study|Death|101|||
157070236|NCT02472145|567010272|FG002|Overall Study|Death|99|||
157070237|NCT02472145|567010270|FG000|Overall Study|Lost to Follow-up|0|||
157070238|NCT02472145|567010271|FG001|Overall Study|Lost to Follow-up|1|||
157070239|NCT02472145|567010272|FG002|Overall Study|Lost to Follow-up|0|||
157070240|NCT02472145|567010270|FG000|Overall Study|Withdrawal by Subject|0|||
157070241|NCT02472145|567010271|FG001|Overall Study|Withdrawal by Subject|9|||
157070242|NCT02472145|567010272|FG002|Overall Study|Withdrawal by Subject|13|||
157070243|NCT02472145|567010270|FG000|Overall Study|Sponsor decision|0|||
157070244|NCT02472145|567010271|FG001|Overall Study|Sponsor decision|3|||
157070245|NCT02472145|567010272|FG002|Overall Study|Sponsor decision|2|||
157070246|NCT02472145|567010270|FG000|Overall Study|Other|0|||
157070247|NCT02472145|567010271|FG001|Overall Study|Other|45|||
157070248|NCT02472145|567010272|FG002|Overall Study|Other|43|||
157070249|NCT02049515|567010273|FG000|Overall Study|Adverse Event|46|||
157070250|NCT02049515|567010274|FG001|Overall Study|Adverse Event|2|||
157070251|NCT02049515|567010273|FG000|Overall Study|Protocol-specified Disease Progression|23|||
157070252|NCT02049515|567010274|FG001|Overall Study|Protocol-specified Disease Progression|2|||
157070253|NCT02049515|567010273|FG000|Overall Study|Death|6|||
157070254|NCT02049515|567010274|FG001|Overall Study|Death|0|||
157070255|NCT02049515|567010273|FG000|Overall Study|Physician Decision|5|||
157070256|NCT02049515|567010274|FG001|Overall Study|Physician Decision|1|||
157070257|NCT02049515|567010273|FG000|Overall Study|Withdrawal by Subject|3|||
157070258|NCT02049515|567010274|FG001|Overall Study|Withdrawal by Subject|0|||
157070259|NCT02049515|567010273|FG000|Overall Study|Termination of the Study by Sponsor|2|||
157070260|NCT02049515|567010274|FG001|Overall Study|Termination of the Study by Sponsor|0|||
157070261|NCT02049515|567010273|FG000|Overall Study|Protocol Violation|1|||
157070262|NCT02049515|567010274|FG001|Overall Study|Protocol Violation|1|||
157070263|NCT02049515|567010273|FG000|Overall Study|Clinical Deterioration|1|||
157070264|NCT02049515|567010274|FG001|Overall Study|Clinical Deterioration|0|||
157070265|NCT02049515|567010273|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
157070266|NCT02049515|567010274|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
157070267|NCT02049515|567010273|FG000|Overall Study|Treatment Interruption >42 Days|1|||
157070268|NCT02049515|567010274|FG001|Overall Study|Treatment Interruption >42 Days|0|||
157070269|NCT02049515|567010273|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
157070270|NCT02049515|567010274|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
157070271|NCT00224029|567010276|FG000|Overall Study|Lost to Follow-up|1|||
157070272|NCT00224029|567010276|FG000|Overall Study|Withdrawal by Subject|4|||
157070273|NCT00224029|567010276|FG000|Overall Study|Other|1|||
157070274|NCT01850030|567010286|FG000|Overall Study|Adverse Event|64|||
157070275|NCT01850030|567010287|FG001|Overall Study|Adverse Event|82|||
157070276|NCT01850030|567010286|FG000|Overall Study|Lack of Efficacy|3|||
157070277|NCT01850030|567010287|FG001|Overall Study|Lack of Efficacy|1|||
157070278|NCT01850030|567010286|FG000|Overall Study|Lost to Follow-up|5|||
157070279|NCT01850030|567010287|FG001|Overall Study|Lost to Follow-up|5|||
157070280|NCT01850030|567010286|FG000|Overall Study|Withdrawal by Subject|3|||
157070281|NCT01850030|567010287|FG001|Overall Study|Withdrawal by Subject|4|||
157070282|NCT01850030|567010286|FG000|Overall Study|Protocol Violation|24|||
157070283|NCT01850030|567010287|FG001|Overall Study|Protocol Violation|28|||
157070284|NCT01850030|567010286|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
157070285|NCT01850030|567010287|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
157070286|NCT03332784|567010288|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070287|NCT03332784|567010289|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
157070288|NCT03332784|567010290|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070289|NCT03332784|567010291|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070290|NCT03332784|567010292|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070291|NCT03332784|567010293|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070292|NCT03332784|567010294|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070293|NCT03332784|567010295|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070294|NCT03332784|567010296|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070295|NCT03332784|567010297|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157191608|NCT01012037|567440755|FG001|Overall Study|Withdrawal by Subject|4|||
157191609|NCT01012037|567440756|FG002|Overall Study|Withdrawal by Subject|1|||
157191610|NCT01012037|567440754|FG000|Overall Study|Other reason (not specified)|1|||
157191611|NCT01012037|567440755|FG001|Overall Study|Other reason (not specified)|1|||
157191612|NCT01012037|567440756|FG002|Overall Study|Other reason (not specified)|1|||
157191613|NCT02583711|567440757|FG000|Overall Study|Withdrawal by Subject|0|||
157191614|NCT02583711|567440758|FG001|Overall Study|Withdrawal by Subject|10|||
157191615|NCT02583711|567440759|FG002|Overall Study|Withdrawal by Subject|0|||
157191616|NCT00590031|567440765|FG000|Overall Study|Adverse Event|3|||
157191617|NCT00590031|567440765|FG000|Overall Study|Withdrawal by Subject|1|||
157191618|NCT00590031|567440765|FG000|Overall Study|Metastatic Disease|1|||
157191619|NCT00590031|567440765|FG000|Overall Study|Admin Hold|1|||
157191620|NCT03196973|567440766|FG000|Overall Study|Adverse Event|1|||
157191621|NCT03196973|567440767|FG001|Overall Study|Adverse Event|1|||
157191622|NCT03196973|567440768|FG002|Overall Study|Adverse Event|2|||
157191623|NCT03196973|567440766|FG000|Overall Study|Lack of Efficacy|2|||
157191624|NCT03196973|567440767|FG001|Overall Study|Lack of Efficacy|6|||
157191625|NCT03196973|567440768|FG002|Overall Study|Lack of Efficacy|1|||
157191626|NCT03196973|567440766|FG000|Overall Study|Lost to Follow-up|4|||
157191627|NCT03196973|567440767|FG001|Overall Study|Lost to Follow-up|3|||
157191628|NCT03196973|567440768|FG002|Overall Study|Lost to Follow-up|2|||
157070296|NCT03332784|567010298|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070297|NCT03332784|567010299|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070298|NCT03332784|567010300|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070299|NCT03332784|567010301|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157191629|NCT03196973|567440766|FG000|Overall Study|Consent withdrawn|2|||
157191630|NCT03196973|567440767|FG001|Overall Study|Consent withdrawn|1|||
157191631|NCT03196973|567440768|FG002|Overall Study|Consent withdrawn|0|||
157191632|NCT03196973|567440766|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
157070300|NCT03332784|567010302|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
157070301|NCT03332784|567010303|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070302|NCT03332784|567010304|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070303|NCT03332784|567010305|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070304|NCT03332784|567010306|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070305|NCT03332784|567010307|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
157070306|NCT00763451|567010313|FG000|Overall Study|Adverse Event|4|||
157070307|NCT00763451|567010314|FG001|Overall Study|Adverse Event|6|||
157070308|NCT00763451|567010315|FG002|Overall Study|Adverse Event|19|||
157070309|NCT00763451|567010316|FG003|Overall Study|Adverse Event|14|||
157070310|NCT00763451|567010313|FG000|Overall Study|Lack of Efficacy|1|||
157070311|NCT00763451|567010314|FG001|Overall Study|Lack of Efficacy|4|||
157070312|NCT00763451|567010315|FG002|Overall Study|Lack of Efficacy|3|||
157070313|NCT00763451|567010316|FG003|Overall Study|Lack of Efficacy|2|||
157070314|NCT00763451|567010313|FG000|Overall Study|Withdrawal by Subject|1|||
157070315|NCT00763451|567010314|FG001|Overall Study|Withdrawal by Subject|6|||
157070316|NCT00763451|567010315|FG002|Overall Study|Withdrawal by Subject|9|||
157070317|NCT00763451|567010316|FG003|Overall Study|Withdrawal by Subject|7|||
157070318|NCT00763451|567010313|FG000|Overall Study|Protocol Violation|0|||
157070319|NCT00763451|567010314|FG001|Overall Study|Protocol Violation|0|||
157070320|NCT00763451|567010315|FG002|Overall Study|Protocol Violation|1|||
157070321|NCT00763451|567010316|FG003|Overall Study|Protocol Violation|0|||
157070322|NCT00763451|567010313|FG000|Overall Study|Poor Compliance to Protocol|1|||
157070323|NCT00763451|567010314|FG001|Overall Study|Poor Compliance to Protocol|1|||
157070324|NCT00763451|567010315|FG002|Overall Study|Poor Compliance to Protocol|2|||
157070325|NCT00763451|567010316|FG003|Overall Study|Poor Compliance to Protocol|2|||
157070326|NCT00763451|567010313|FG000|Overall Study|Familial and Personal Reasons|5|||
157070327|NCT00763451|567010314|FG001|Overall Study|Familial and Personal Reasons|3|||
157070328|NCT00763451|567010315|FG002|Overall Study|Familial and Personal Reasons|5|||
157070329|NCT00763451|567010316|FG003|Overall Study|Familial and Personal Reasons|4|||
157070330|NCT00763451|567010313|FG000|Overall Study|Randomized but not Treated|1|||
157070331|NCT00763451|567010314|FG001|Overall Study|Randomized but not Treated|1|||
157070332|NCT00763451|567010315|FG002|Overall Study|Randomized but not Treated|0|||
157070333|NCT00763451|567010316|FG003|Overall Study|Randomized but not Treated|0|||
157070334|NCT00763451|567010313|FG000|Overall Study|Study Site Reason|0|||
157070335|NCT00763451|567010314|FG001|Overall Study|Study Site Reason|1|||
157070336|NCT00763451|567010315|FG002|Overall Study|Study Site Reason|1|||
157070337|NCT00763451|567010316|FG003|Overall Study|Study Site Reason|1|||
157070338|NCT00115336|567010319|FG000|Overall Study|Hospital discharge before study drug|0|||
157070339|NCT00115336|567010320|FG001|Overall Study|Hospital discharge before study drug|1|||
157070340|NCT03698019|567010331|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
157070341|NCT03698019|567010332|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
157070342|NCT03698019|567010331|FG000|Step 1: Registration|Withdrawal by Subject|7|||
157070343|NCT03698019|567010332|FG001|Step 1: Registration|Withdrawal by Subject|2|||
157070344|NCT03698019|567010331|FG000|Step 1: Registration|Toxicity|0|||
157070345|NCT03698019|567010332|FG001|Step 1: Registration|Toxicity|1|||
157070346|NCT03698019|567010331|FG000|Step 1: Registration|Disease Progression|0|||
157070347|NCT03698019|567010332|FG001|Step 1: Registration|Disease Progression|12|||
157070348|NCT03698019|567010331|FG000|Step 1: Registration|Co-morbidities|0|||
157070349|NCT03698019|567010332|FG001|Step 1: Registration|Co-morbidities|1|||
157070350|NCT03698019|567010331|FG000|Step 1: Registration|Scheduling Issues|1|||
157070351|NCT03698019|567010332|FG001|Step 1: Registration|Scheduling Issues|0|||
157070352|NCT03698019|567010331|FG000|Step 1: Registration|Participant Refusal|0|||
157070353|NCT03698019|567010332|FG001|Step 1: Registration|Participant Refusal|1|||
157070354|NCT03698019|567010331|FG000|Step 2: Surgery|Participant Refusal|2|||
157070355|NCT03698019|567010332|FG001|Step 2: Surgery|Participant Refusal|1|||
157070356|NCT03698019|567010331|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
157070357|NCT03698019|567010332|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
157070358|NCT03698019|567010331|FG000|Step 2: Surgery|Metastatic Disease|16|||
157070359|NCT03698019|567010332|FG001|Step 2: Surgery|Metastatic Disease|9|||
157070360|NCT03698019|567010331|FG000|Step 2: Surgery|Residual Disease|2|||
157070361|NCT03698019|567010332|FG001|Step 2: Surgery|Residual Disease|1|||
157070362|NCT03698019|567010331|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
157070363|NCT03698019|567010332|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
157070364|NCT03698019|567010331|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
157070365|NCT03698019|567010332|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
157070366|NCT03698019|567010331|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
157070367|NCT03698019|567010332|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
157070368|NCT03698019|567010331|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
157070369|NCT03698019|567010332|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
157070370|NCT03698019|567010331|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
157070371|NCT03698019|567010332|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
157070372|NCT03698019|567010331|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
157230773|NCT02888171|567590733|FG001|Overall Study|Lost to Follow-up|1|||
157070373|NCT03698019|567010332|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
157070374|NCT03698019|567010331|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
157070375|NCT03698019|567010332|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
157070376|NCT03698019|567010331|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
157070377|NCT03698019|567010332|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
157070378|NCT00569127|567010333|FG000|Overall Study|Adverse Event|57|||
157070379|NCT00569127|567010334|FG001|Overall Study|Adverse Event|47|||
157070380|NCT00569127|567010333|FG000|Overall Study|Withdrawal by Subject|13|||
157070381|NCT00569127|567010334|FG001|Overall Study|Withdrawal by Subject|27|||
157070382|NCT00569127|567010333|FG000|Overall Study|Progression|99|||
157070383|NCT00569127|567010334|FG001|Overall Study|Progression|100|||
157070384|NCT00569127|567010333|FG000|Overall Study|Death|4|||
157070385|NCT00569127|567010334|FG001|Overall Study|Death|3|||
157070386|NCT00569127|567010333|FG000|Overall Study|Other|20|||
157070387|NCT00569127|567010334|FG001|Overall Study|Other|19|||
157070388|NCT00569127|567010333|FG000|Overall Study|Lost to Follow-up|0|||
157070389|NCT00569127|567010334|FG001|Overall Study|Lost to Follow-up|3|||
157070390|NCT00569127|567010333|FG000|Overall Study|Not Eligible|14|||
157070391|NCT00569127|567010334|FG001|Overall Study|Not Eligible|11|||
157070392|NCT00569127|567010333|FG000|Overall Study|Still on Treatment|7|||
157070393|NCT00569127|567010334|FG001|Overall Study|Still on Treatment|3|||
157070394|NCT03149029|567010349|FG000|Overall Study|Adverse Event|2|||
157070395|NCT03149029|567010350|FG001|Overall Study|Adverse Event|0|||
157070396|NCT03735121|567010351|FG000|Overall Study|Death|3|||
157070397|NCT03735121|567010352|FG001|Overall Study|Death|6|||
157070398|NCT03735121|567010353|FG002|Overall Study|Death|19|||
157070399|NCT03735121|567010354|FG003|Overall Study|Death|97|||
157070400|NCT03735121|567010355|FG004|Overall Study|Death|205|||
157070401|NCT03735121|567010351|FG000|Overall Study|Lost to Follow-up|0|||
157070402|NCT03735121|567010352|FG001|Overall Study|Lost to Follow-up|0|||
157070403|NCT03735121|567010353|FG002|Overall Study|Lost to Follow-up|0|||
157070404|NCT03735121|567010354|FG003|Overall Study|Lost to Follow-up|2|||
157070405|NCT03735121|567010355|FG004|Overall Study|Lost to Follow-up|3|||
157070406|NCT03735121|567010351|FG000|Overall Study|New Therapy|0|||
157070407|NCT03735121|567010352|FG001|Overall Study|New Therapy|1|||
157070408|NCT03735121|567010353|FG002|Overall Study|New Therapy|0|||
157070409|NCT03735121|567010354|FG003|Overall Study|New Therapy|0|||
157070410|NCT03735121|567010355|FG004|Overall Study|New Therapy|0|||
157070411|NCT03735121|567010351|FG000|Overall Study|Study Ended by Sponsor|1|||
157070412|NCT03735121|567010352|FG001|Overall Study|Study Ended by Sponsor|0|||
157070413|NCT03735121|567010353|FG002|Overall Study|Study Ended by Sponsor|1|||
157070414|NCT03735121|567010354|FG003|Overall Study|Study Ended by Sponsor|17|||
157070415|NCT03735121|567010355|FG004|Overall Study|Study Ended by Sponsor|28|||
157070416|NCT03735121|567010351|FG000|Overall Study|Withdrawal by Subject|1|||
157070417|NCT03735121|567010352|FG001|Overall Study|Withdrawal by Subject|1|||
157070418|NCT03735121|567010353|FG002|Overall Study|Withdrawal by Subject|6|||
157070419|NCT03735121|567010354|FG003|Overall Study|Withdrawal by Subject|8|||
157070420|NCT03735121|567010355|FG004|Overall Study|Withdrawal by Subject|11|||
157070421|NCT02037256|567010356|FG000|Overall Study|Protocol Violation|0|||
157070422|NCT02037256|567010357|FG001|Overall Study|Protocol Violation|1|||
157070423|NCT02037256|567010356|FG000|Overall Study|Withdrawn prior to Velcade|0|||
157070424|NCT02037256|567010357|FG001|Overall Study|Withdrawn prior to Velcade|2|||
157070425|NCT03007732|567010358|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
157070426|NCT03007732|567010359|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
157070427|NCT03007732|567010360|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
157070428|NCT03007732|567010361|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
157070429|NCT02386839|567010363|FG000|Overall Study|Death|1|||
157070430|NCT02386839|567010364|FG001|Overall Study|Death|0|||
157070431|NCT02386839|567010363|FG000|Overall Study|Withdrawal by Subject|9|||
157070432|NCT02386839|567010364|FG001|Overall Study|Withdrawal by Subject|10|||
157070433|NCT02386839|567010363|FG000|Overall Study|Lost to Follow-up|4|||
157070434|NCT02386839|567010364|FG001|Overall Study|Lost to Follow-up|4|||
157070435|NCT02386839|567010363|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
157070436|NCT02386839|567010364|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
157070437|NCT02386839|567010363|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
157070438|NCT02386839|567010364|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
157070439|NCT02386839|567010363|FG000|Overall Study|Other (unspecified)|1|||
157070440|NCT02386839|567010364|FG001|Overall Study|Other (unspecified)|0|||
157070441|NCT02101983|567010368|FG000|Overall Study|Physician Decision|1|||
157070442|NCT02101983|567010369|FG001|Overall Study|Physician Decision|0|||
157070443|NCT03725605|567010370|FG000|Overall Study|Unsuccessful TIL expansion|2|||
157070444|NCT01503086|567010371|FG000|Overall Study|Lost to Follow-up|0|||
157070445|NCT01503086|567010372|FG001|Overall Study|Lost to Follow-up|1|||
157070446|NCT01503086|567010373|FG002|Overall Study|Lost to Follow-up|0|||
157070447|NCT01503086|567010371|FG000|Overall Study|Did Not Start Treatment|4|||
157070448|NCT01503086|567010372|FG001|Overall Study|Did Not Start Treatment|3|||
157070449|NCT01503086|567010373|FG002|Overall Study|Did Not Start Treatment|3|||
157070450|NCT01503086|567010371|FG000|Overall Study|Progressive disease|3|||
157070451|NCT01503086|567010372|FG001|Overall Study|Progressive disease|1|||
157070452|NCT01503086|567010373|FG002|Overall Study|Progressive disease|0|||
157070453|NCT01503086|567010371|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
157070454|NCT01503086|567010372|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
157070455|NCT01503086|567010373|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
157070456|NCT01503086|567010371|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
157070457|NCT01503086|567010372|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
157070458|NCT01503086|567010373|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
157070459|NCT02859064|567011729|FG000|Overall Study|Progressive Disease|3|||
157070460|NCT02859064|567011729|FG000|Overall Study|Physician Decision|1|||
157070461|NCT02859064|567011729|FG000|Overall Study|Withdrawal by Subject|1|||
157070462|NCT02859064|567011729|FG000|Overall Study|Death|1|||
157070463|NCT00667459|567011733|FG000|Overall Study|Death|0|||
157070464|NCT00667459|567011734|FG001|Overall Study|Death|2|||
157070465|NCT00667459|567011733|FG000|Overall Study|Lost to Follow-up|8|||
157070466|NCT00667459|567011734|FG001|Overall Study|Lost to Follow-up|43|||
157070467|NCT02568397|567011735|FG000|Period 2|Withdrawal by Subject|0|||
157070468|NCT02568397|567011736|FG001|Period 2|Withdrawal by Subject|1|||
157070469|NCT02568397|567011735|FG000|Period 2|Physician Decision|0|||
157070470|NCT02568397|567011736|FG001|Period 2|Physician Decision|1|||
157070471|NCT00078377|567011737|FG000|Overall Study|Adverse Event|2|||
157070472|NCT00078377|567011738|FG001|Overall Study|Adverse Event|5|||
157070473|NCT00078377|567011739|FG002|Overall Study|Adverse Event|1|||
157070474|NCT00078377|567011737|FG000|Overall Study|Lack of Efficacy|2|||
157070475|NCT00078377|567011738|FG001|Overall Study|Lack of Efficacy|0|||
157070476|NCT00078377|567011739|FG002|Overall Study|Lack of Efficacy|2|||
157070477|NCT00078377|567011737|FG000|Overall Study|Lost to Follow-up|0|||
157070478|NCT00078377|567011738|FG001|Overall Study|Lost to Follow-up|1|||
157070479|NCT00078377|567011739|FG002|Overall Study|Lost to Follow-up|1|||
157070480|NCT00078377|567011737|FG000|Overall Study|Physician Decision|2|||
157070481|NCT00078377|567011738|FG001|Overall Study|Physician Decision|0|||
157070482|NCT00078377|567011739|FG002|Overall Study|Physician Decision|0|||
157070483|NCT00078377|567011737|FG000|Overall Study|Withdrawal by Subject|3|||
157070484|NCT00078377|567011738|FG001|Overall Study|Withdrawal by Subject|4|||
157070485|NCT00078377|567011739|FG002|Overall Study|Withdrawal by Subject|4|||
157070486|NCT00078377|567011737|FG000|Overall Study|Miscellaneous|2|||
157070487|NCT00078377|567011738|FG001|Overall Study|Miscellaneous|6|||
157070488|NCT00078377|567011739|FG002|Overall Study|Miscellaneous|1|||
157070489|NCT00581893|567011740|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
157070490|NCT00581893|567011741|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
157070491|NCT02550938|567011742|FG000|Overall Study|Lost to Follow-up|8|||
157070492|NCT02550938|567011743|FG001|Overall Study|Lost to Follow-up|7|||
157070493|NCT02550938|567011744|FG002|Overall Study|Lost to Follow-up|12|||
157070494|NCT02550938|567011745|FG003|Overall Study|Lost to Follow-up|11|||
157070495|NCT01367847|567011746|FG000|Overall Study|Withdrawal by Subject|2|||
157070496|NCT01367847|567011747|FG001|Overall Study|Withdrawal by Subject|2|||
157070497|NCT01454739|567011748|FG000|Overall Study|Protocol Violation|2|||
157070498|NCT01454739|567011749|FG001|Overall Study|Protocol Violation|3|||
157070499|NCT01454739|567011748|FG000|Overall Study|Withdrawal by Subject|2|||
157070500|NCT01454739|567011749|FG001|Overall Study|Withdrawal by Subject|6|||
157070501|NCT01454739|567011748|FG000|Overall Study|Other|3|||
157070502|NCT01454739|567011749|FG001|Overall Study|Other|5|||
157070503|NCT01454739|567011748|FG000|Overall Study|Physician Decision|0|||
157070504|NCT01454739|567011749|FG001|Overall Study|Physician Decision|5|||
157070505|NCT01454739|567011748|FG000|Overall Study|Lost to Follow-up|0|||
157070506|NCT01454739|567011749|FG001|Overall Study|Lost to Follow-up|1|||
157070507|NCT01454739|567011748|FG000|Overall Study|Adverse Event|0|||
157070508|NCT01454739|567011749|FG001|Overall Study|Adverse Event|1|||
157070509|NCT02980523|567011750|FG000|Overall Study|Lost to Follow-up|1|||
157070510|NCT02980523|567011751|FG001|Overall Study|Lost to Follow-up|4|||
157070511|NCT02980523|567011752|FG002|Overall Study|Lost to Follow-up|1|||
157230774|NCT02888171|567590732|FG000|Overall Study|Withdrawal by Subject|3|||
157230775|NCT02888171|567590733|FG001|Overall Study|Withdrawal by Subject|2|||
157070512|NCT02980523|567011753|FG003|Overall Study|Lost to Follow-up|2|||
157070513|NCT02980523|567011754|FG004|Overall Study|Lost to Follow-up|1|||
157070514|NCT02980523|567011750|FG000|Overall Study|Excluded from analysis|1|||
157070515|NCT02980523|567011751|FG001|Overall Study|Excluded from analysis|3|||
157070516|NCT02980523|567011752|FG002|Overall Study|Excluded from analysis|1|||
157070517|NCT02980523|567011753|FG003|Overall Study|Excluded from analysis|1|||
157070518|NCT02980523|567011754|FG004|Overall Study|Excluded from analysis|1|||
157070519|NCT02980523|567011750|FG000|Overall Study|Lack of Efficacy|1|||
157230776|NCT02888171|567590732|FG000|Overall Study|Adverse Event|0|||
157070520|NCT02980523|567011751|FG001|Overall Study|Lack of Efficacy|4|||
157070521|NCT02980523|567011752|FG002|Overall Study|Lack of Efficacy|4|||
157070522|NCT02980523|567011753|FG003|Overall Study|Lack of Efficacy|5|||
157070523|NCT02980523|567011754|FG004|Overall Study|Lack of Efficacy|8|||
157070524|NCT02980523|567011750|FG000|Overall Study|Did not receive intervention|0|||
157070525|NCT02980523|567011751|FG001|Overall Study|Did not receive intervention|0|||
157070526|NCT02980523|567011752|FG002|Overall Study|Did not receive intervention|0|||
157070527|NCT02980523|567011753|FG003|Overall Study|Did not receive intervention|1|||
157070528|NCT02980523|567011754|FG004|Overall Study|Did not receive intervention|0|||
157070529|NCT00633945|567011755|FG000|Overall Study|Physician Decision|2|||
157070530|NCT00882115|567011756|FG000|Overall Study|Withdrawal by Subject|3|||
157070531|NCT00882115|567011756|FG000|Overall Study|did not respond to DEP challe|6|||
157070532|NCT02552147|567011757|FG000|First Intervention (7 Days)|Protocol Violation|1|||
157070533|NCT02552147|567011758|FG001|First Intervention (7 Days)|Protocol Violation|0|||
157070534|NCT02552147|567011757|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
157070535|NCT02552147|567011758|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
157070536|NCT01547598|567011759|FG000|Overall Study|Withdrew consent|1|||
157070537|NCT01547598|567011760|FG001|Overall Study|Withdrew consent|1|||
157070538|NCT01547598|567011759|FG000|Overall Study|Lost to Follow-up|1|||
157070539|NCT01547598|567011760|FG001|Overall Study|Lost to Follow-up|1|||
157070540|NCT01547598|567011759|FG000|Overall Study|Adverse Event|1|||
157070541|NCT01547598|567011760|FG001|Overall Study|Adverse Event|1|||
157070542|NCT01547598|567011759|FG000|Overall Study|Protocol Violation|1|||
157070543|NCT01547598|567011760|FG001|Overall Study|Protocol Violation|1|||
157070544|NCT01547598|567011759|FG000|Overall Study|Other Miscellaneous Reasons|2|||
157070545|NCT01547598|567011760|FG001|Overall Study|Other Miscellaneous Reasons|1|||
157070546|NCT00872001|567011764|FG000|Overall Study|Adverse Event|34|||
157070547|NCT00872001|567011765|FG001|Overall Study|Adverse Event|23|||
157070548|NCT00872001|567011764|FG000|Overall Study|Protocol Defined Clinical Event|5|||
157070549|NCT00872001|567011765|FG001|Overall Study|Protocol Defined Clinical Event|7|||
157070550|NCT00872001|567011764|FG000|Overall Study|Lost to Follow-up|13|||
157070551|NCT00872001|567011765|FG001|Overall Study|Lost to Follow-up|12|||
157070552|NCT00872001|567011764|FG000|Overall Study|Withdrawal by Subject|18|||
157070553|NCT00872001|567011765|FG001|Overall Study|Withdrawal by Subject|30|||
157070554|NCT00872001|567011764|FG000|Overall Study|Protocol Violation|5|||
157070555|NCT00872001|567011765|FG001|Overall Study|Protocol Violation|8|||
157070556|NCT00872001|567011764|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
157070557|NCT00872001|567011765|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
157070558|NCT00872001|567011764|FG000|Overall Study|Administrative|23|||
157070559|NCT00872001|567011765|FG001|Overall Study|Administrative|15|||
157070560|NCT04071301|567011766|FG000|Overall Study|Withdrawal by Subject|6|||
157070561|NCT04071301|567011766|FG000|Overall Study|Death|1|||
157070562|NCT02879383|567011767|FG000|First 24 Weeks|Physician Decision|0|||
157070563|NCT02879383|567011768|FG001|First 24 Weeks|Physician Decision|1|||
157070564|NCT02879383|567011769|FG002|First 24 Weeks|Physician Decision|0|||
157070565|NCT02879383|567011770|FG003|First 24 Weeks|Physician Decision|0|||
157070566|NCT03912662|567011771|FG000|Overall Study|Adverse Event|3|||
157070567|NCT03912662|567011771|FG000|Overall Study|Adverse Event and Death|1|||
157070568|NCT03912662|567011771|FG000|Overall Study|Death|1|||
157070569|NCT03912662|567011771|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
157070570|NCT03912662|567011771|FG000|Overall Study|Mesh Removal|1|||
157070571|NCT03912662|567011771|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
157070572|NCT03912662|567011771|FG000|Overall Study|Early study termination|20|||
157070573|NCT01790295|567011779|FG000|Overall Study|Adverse Event|1|||
157070574|NCT01790295|567011779|FG000|Overall Study|Death|4|||
157070575|NCT01790295|567011779|FG000|Overall Study|Lack of Efficacy|2|||
157070576|NCT01790295|567011779|FG000|Overall Study|Study closure|4|||
157070577|NCT00420784|567011784|FG000|Overall Study|Adverse Event|11|||
157191633|NCT03196973|567440767|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
157191634|NCT03196973|567440768|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
157191635|NCT01809327|567440769|FG000|Overall Study|Lost to Follow-up|5|||
157191636|NCT01809327|567440770|FG001|Overall Study|Lost to Follow-up|2|||
157191637|NCT01809327|567440771|FG002|Overall Study|Lost to Follow-up|4|||
157191638|NCT01809327|567440772|FG003|Overall Study|Lost to Follow-up|2|||
157191639|NCT01809327|567440773|FG004|Overall Study|Lost to Follow-up|3|||
157191640|NCT01809327|567440769|FG000|Overall Study|Withdrawal by Subject|6|||
157191641|NCT01809327|567440770|FG001|Overall Study|Withdrawal by Subject|4|||
157230777|NCT02888171|567590733|FG001|Overall Study|Adverse Event|1|||
157070578|NCT00420784|567011785|FG001|Overall Study|Adverse Event|29|||
157070579|NCT00420784|567011786|FG002|Overall Study|Adverse Event|10|||
157070580|NCT00420784|567011787|FG003|Overall Study|Adverse Event|5|||
157070581|NCT00420784|567011784|FG000|Overall Study|Withdrawal by Subject|0|||
157070582|NCT00420784|567011785|FG001|Overall Study|Withdrawal by Subject|1|||
157070583|NCT00420784|567011786|FG002|Overall Study|Withdrawal by Subject|0|||
157070584|NCT00420784|567011787|FG003|Overall Study|Withdrawal by Subject|0|||
157070585|NCT00420784|567011784|FG000|Overall Study|Lost to Follow-up|0|||
157070586|NCT00420784|567011785|FG001|Overall Study|Lost to Follow-up|0|||
157070587|NCT00420784|567011786|FG002|Overall Study|Lost to Follow-up|2|||
157070588|NCT00420784|567011787|FG003|Overall Study|Lost to Follow-up|1|||
157191642|NCT01809327|567440771|FG002|Overall Study|Withdrawal by Subject|4|||
157070589|NCT00420784|567011784|FG000|Overall Study|Virologic Stopping Rule|17|||
157070590|NCT00420784|567011785|FG001|Overall Study|Virologic Stopping Rule|26|||
157070591|NCT00420784|567011786|FG002|Overall Study|Virologic Stopping Rule|41|||
157070592|NCT00420784|567011787|FG003|Overall Study|Virologic Stopping Rule|67|||
157070593|NCT00420784|567011784|FG000|Overall Study|Other|1|||
157070594|NCT00420784|567011785|FG001|Overall Study|Other|2|||
157070595|NCT00420784|567011786|FG002|Overall Study|Other|0|||
157070596|NCT00420784|567011787|FG003|Overall Study|Other|5|||
157070597|NCT00983853|567011790|FG000|Overall Study|Lost to Follow-up|1|||
157070598|NCT00983853|567011791|FG001|Overall Study|Lost to Follow-up|1|||
157070599|NCT00983853|567011792|FG002|Overall Study|Lost to Follow-up|2|||
157070600|NCT00983853|567011793|FG003|Overall Study|Lost to Follow-up|2|||
157070601|NCT00983853|567011794|FG004|Overall Study|Lost to Follow-up|2|||
157070602|NCT00983853|567011795|FG005|Overall Study|Lost to Follow-up|1|||
157070603|NCT00983853|567011790|FG000|Overall Study|Withdrawal by Subject|0|||
157070604|NCT00983853|567011791|FG001|Overall Study|Withdrawal by Subject|0|||
157070605|NCT00983853|567011792|FG002|Overall Study|Withdrawal by Subject|1|||
157070606|NCT00983853|567011793|FG003|Overall Study|Withdrawal by Subject|0|||
157070607|NCT00983853|567011794|FG004|Overall Study|Withdrawal by Subject|1|||
157070608|NCT00983853|567011795|FG005|Overall Study|Withdrawal by Subject|0|||
157070609|NCT00983853|567011790|FG000|Overall Study|Unable to come to study follow-up visits|0|||
157070610|NCT00983853|567011791|FG001|Overall Study|Unable to come to study follow-up visits|1|||
157070611|NCT00983853|567011792|FG002|Overall Study|Unable to come to study follow-up visits|0|||
157070612|NCT00983853|567011793|FG003|Overall Study|Unable to come to study follow-up visits|0|||
157070613|NCT00983853|567011794|FG004|Overall Study|Unable to come to study follow-up visits|0|||
157070614|NCT00983853|567011795|FG005|Overall Study|Unable to come to study follow-up visits|0|||
157070615|NCT02599688|567011796|FG000|Overall Study|Lack of Efficacy|1|||
157070616|NCT02599688|567011796|FG000|Overall Study|Withdrawal by Subject|1|||
157070617|NCT02599688|567011796|FG000|Overall Study|Termination by Sponsor|2|||
157070618|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
157070619|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
157070620|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
157070621|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
157070622|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
157070623|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
157070624|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
157070625|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
157070626|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
157070627|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
157070628|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
157070629|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
157070630|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
157070631|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
157070632|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
157070633|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
157070634|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
157070635|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
157070636|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Missing|2|||
157070637|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Missing|1|||
157070638|NCT00443209|567011800|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
157070639|NCT00443209|567011801|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
157070640|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
157070641|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
157070642|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
157070643|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
157070644|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
157070645|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
157070646|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
157070647|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
157070648|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
157070649|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
157070650|NCT00443209|567011800|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
157070651|NCT00443209|567011801|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
157070652|NCT01318876|567011802|FG000|Day 8 Survey|email address invalid|96|||
157070653|NCT01318876|567011802|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
157070654|NCT01318876|567011802|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
157070655|NCT00478205|567011805|FG000|Overall Study|Adverse Event|182|||
157070656|NCT00478205|567011806|FG001|Overall Study|Adverse Event|39|||
157070657|NCT00478205|567011805|FG000|Overall Study|Medication Non-compliance|9|||
157070658|NCT00478205|567011806|FG001|Overall Study|Medication Non-compliance|4|||
157070659|NCT00478205|567011805|FG000|Overall Study|Protocol Violation|15|||
157070660|NCT00478205|567011806|FG001|Overall Study|Protocol Violation|5|||
157070661|NCT00478205|567011805|FG000|Overall Study|Request of Investigator or Sponsor|4|||
157070662|NCT00478205|567011806|FG001|Overall Study|Request of Investigator or Sponsor|5|||
157070663|NCT00478205|567011805|FG000|Overall Study|Withdrawal by Subject|61|||
157070664|NCT00478205|567011806|FG001|Overall Study|Withdrawal by Subject|22|||
157070665|NCT00478205|567011805|FG000|Overall Study|Lack of Efficacy|1|||
157070666|NCT00478205|567011806|FG001|Overall Study|Lack of Efficacy|0|||
157070667|NCT00478205|567011805|FG000|Overall Study|Other|24|||
157070668|NCT00478205|567011806|FG001|Overall Study|Other|12|||
157070669|NCT01012947|567011807|FG000|Overall Study|Lost to Follow-up|131|||
157070670|NCT01012947|567011808|FG001|Overall Study|Lost to Follow-up|135|||
157070671|NCT01012947|567011809|FG002|Overall Study|Lost to Follow-up|130|||
157070672|NCT01012947|567011810|FG003|Overall Study|Lost to Follow-up|118|||
157070673|NCT01012947|567011811|FG004|Overall Study|Lost to Follow-up|142|||
157070674|NCT02127125|567011812|FG000|Overall Study|Lost to Follow-up|0|||
157070675|NCT02127125|567011813|FG001|Overall Study|Lost to Follow-up|0|||
157070676|NCT02127125|567011814|FG002|Overall Study|Lost to Follow-up|0|||
157070677|NCT02127125|567011815|FG003|Overall Study|Lost to Follow-up|0|||
157070678|NCT02127125|567011816|FG004|Overall Study|Lost to Follow-up|2|||
157070679|NCT02127125|567011817|FG005|Overall Study|Lost to Follow-up|1|||
157070680|NCT02127125|567011818|FG006|Overall Study|Lost to Follow-up|0|||
157070681|NCT02127125|567011819|FG007|Overall Study|Lost to Follow-up|0|||
157070682|NCT02127125|567011820|FG008|Overall Study|Lost to Follow-up|0|||
157070683|NCT02127125|567011812|FG000|Overall Study|Withdrawal by Subject|0|||
157070684|NCT02127125|567011813|FG001|Overall Study|Withdrawal by Subject|0|||
157070685|NCT02127125|567011814|FG002|Overall Study|Withdrawal by Subject|0|||
157070686|NCT02127125|567011815|FG003|Overall Study|Withdrawal by Subject|1|||
157070687|NCT02127125|567011816|FG004|Overall Study|Withdrawal by Subject|0|||
157070688|NCT02127125|567011817|FG005|Overall Study|Withdrawal by Subject|0|||
157070689|NCT02127125|567011818|FG006|Overall Study|Withdrawal by Subject|0|||
157070690|NCT02127125|567011819|FG007|Overall Study|Withdrawal by Subject|0|||
157070691|NCT02127125|567011820|FG008|Overall Study|Withdrawal by Subject|0|||
157070692|NCT02127125|567011812|FG000|Overall Study|Physician Decision|0|||
157070693|NCT02127125|567011813|FG001|Overall Study|Physician Decision|0|||
157070694|NCT02127125|567011814|FG002|Overall Study|Physician Decision|1|||
157070695|NCT02127125|567011815|FG003|Overall Study|Physician Decision|0|||
157070696|NCT02127125|567011816|FG004|Overall Study|Physician Decision|1|||
157070697|NCT02127125|567011817|FG005|Overall Study|Physician Decision|2|||
157070698|NCT02127125|567011818|FG006|Overall Study|Physician Decision|0|||
157070699|NCT02127125|567011819|FG007|Overall Study|Physician Decision|0|||
157070700|NCT02127125|567011820|FG008|Overall Study|Physician Decision|0|||
157070701|NCT00825305|567011830|FG000|Overall Study|Adverse Event|1|||
157070702|NCT00825305|567011831|FG001|Overall Study|Adverse Event|1|||
157070703|NCT00825305|567011830|FG000|Overall Study|Withdrawal by Subject|6|||
157070704|NCT00825305|567011831|FG001|Overall Study|Withdrawal by Subject|12|||
157070705|NCT00825305|567011830|FG000|Overall Study|Inappropriate inclusion|1|||
157191643|NCT01809327|567440772|FG003|Overall Study|Withdrawal by Subject|2|||
157191644|NCT01809327|567440773|FG004|Overall Study|Withdrawal by Subject|5|||
157191645|NCT01809327|567440769|FG000|Overall Study|Adverse Event|4|||
157191646|NCT01809327|567440770|FG001|Overall Study|Adverse Event|3|||
157191647|NCT01809327|567440771|FG002|Overall Study|Adverse Event|7|||
157191648|NCT01809327|567440772|FG003|Overall Study|Adverse Event|4|||
157191649|NCT01809327|567440773|FG004|Overall Study|Adverse Event|8|||
157191650|NCT01809327|567440769|FG000|Overall Study|Death|1|||
157191651|NCT01809327|567440770|FG001|Overall Study|Death|0|||
157191652|NCT01809327|567440771|FG002|Overall Study|Death|0|||
157191653|NCT01809327|567440772|FG003|Overall Study|Death|0|||
157191654|NCT01809327|567440773|FG004|Overall Study|Death|0|||
157191655|NCT01809327|567440769|FG000|Overall Study|Protocol Violation|0|||
157191656|NCT01809327|567440770|FG001|Overall Study|Protocol Violation|1|||
157191657|NCT01809327|567440771|FG002|Overall Study|Protocol Violation|0|||
157191658|NCT01809327|567440772|FG003|Overall Study|Protocol Violation|0|||
157191659|NCT01809327|567440773|FG004|Overall Study|Protocol Violation|0|||
157191660|NCT01809327|567440769|FG000|Overall Study|Physician Decision|1|||
157191661|NCT01809327|567440770|FG001|Overall Study|Physician Decision|1|||
157191662|NCT01809327|567440771|FG002|Overall Study|Physician Decision|0|||
157191663|NCT01809327|567440772|FG003|Overall Study|Physician Decision|0|||
157070706|NCT00825305|567011831|FG001|Overall Study|Inappropriate inclusion|0|||
157070707|NCT00825305|567011830|FG000|Overall Study|Protocol Violation|9|||
157070708|NCT00825305|567011831|FG001|Overall Study|Protocol Violation|9|||
157191664|NCT01809327|567440773|FG004|Overall Study|Physician Decision|0|||
157191665|NCT01809327|567440769|FG000|Overall Study|Pregnancy|1|||
157070709|NCT00825305|567011830|FG000|Overall Study|Can not be classified|0|||
157070710|NCT00825305|567011831|FG001|Overall Study|Can not be classified|1|||
157070711|NCT04016272|567011833|FG000|Overall Study|Withdrawal by Subject|1|||
157191666|NCT01809327|567440770|FG001|Overall Study|Pregnancy|0|||
157191667|NCT01809327|567440771|FG002|Overall Study|Pregnancy|0|||
157191668|NCT01809327|567440772|FG003|Overall Study|Pregnancy|0|||
157191669|NCT01809327|567440773|FG004|Overall Study|Pregnancy|0|||
157191670|NCT01809327|567440769|FG000|Overall Study|Other|14|||
157191671|NCT01809327|567440770|FG001|Overall Study|Other|15|||
157070712|NCT04016272|567011834|FG001|Overall Study|Withdrawal by Subject|2|||
157070713|NCT01827046|567011839|FG000|Overall Study|Lost to Follow-up|1|||
157070714|NCT01827046|567011840|FG001|Overall Study|Lost to Follow-up|5|||
157070715|NCT01827046|567011839|FG000|Overall Study|Withdrawal by Subject|0|||
157070716|NCT01827046|567011840|FG001|Overall Study|Withdrawal by Subject|4|||
157070717|NCT02282917|567011843|FG000|Overall Study|Withdrawal by Subject|1|||
157070718|NCT02282917|567011843|FG000|Overall Study|Screen Failure/Not Eligible|1|||
157070719|NCT00715117|567011846|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
157070720|NCT00715117|567011847|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
157070721|NCT01018732|567011851|FG000|Overall Study|Lost to Follow-up|0|||
157070722|NCT01018732|567011852|FG001|Overall Study|Lost to Follow-up|0|||
157070723|NCT01018732|567011853|FG002|Overall Study|Lost to Follow-up|3|||
157070724|NCT01018732|567011851|FG000|Overall Study|Protocol Violation|1|||
157070725|NCT01018732|567011852|FG001|Overall Study|Protocol Violation|1|||
157070726|NCT01018732|567011853|FG002|Overall Study|Protocol Violation|0|||
157070727|NCT01018732|567011851|FG000|Overall Study|Inappropriate Enrollment|0|||
157070728|NCT01018732|567011852|FG001|Overall Study|Inappropriate Enrollment|1|||
157070729|NCT01018732|567011853|FG002|Overall Study|Inappropriate Enrollment|0|||
157070730|NCT01018732|567011851|FG000|Overall Study|Unable to Classify|0|||
157070731|NCT01018732|567011852|FG001|Overall Study|Unable to Classify|0|||
157070732|NCT01018732|567011853|FG002|Overall Study|Unable to Classify|1|||
157070733|NCT00978562|567011854|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
157070734|NCT02394665|567011855|FG000|Overall Study|Physician Decision|1|||
157070735|NCT02394665|567011856|FG001|Overall Study|Physician Decision|0|||
157070736|NCT02394665|567011857|FG002|Overall Study|Physician Decision|0|||
157070737|NCT03569891|567011862|FG000|Lead-in|Ineligible during lead-in|8|||
157070738|NCT03569891|567011862|FG000|Lead-in|Withdrawal by Subject|3|||
157070739|NCT03569891|567011862|FG000|Lead-in|Risks related to COVID-19|2|||
157070740|NCT03569891|567011862|FG000|AMT-061|Adverse Event|1|||
157070741|NCT02176863|567011863|FG000|Overall Study|Physician Decision|1|||
157070742|NCT02176863|567011864|FG001|Overall Study|Physician Decision|0|||
157070743|NCT02176863|567011865|FG002|Overall Study|Physician Decision|0|||
157070744|NCT02176863|567011866|FG003|Overall Study|Physician Decision|0|||
157070745|NCT02176863|567011867|FG004|Overall Study|Physician Decision|0|||
157070746|NCT02176863|567011863|FG000|Overall Study|Adverse Event|10|||
157070747|NCT02176863|567011864|FG001|Overall Study|Adverse Event|4|||
157070748|NCT02176863|567011865|FG002|Overall Study|Adverse Event|4|||
157070749|NCT02176863|567011866|FG003|Overall Study|Adverse Event|1|||
157070750|NCT02176863|567011867|FG004|Overall Study|Adverse Event|1|||
157070751|NCT02176863|567011863|FG000|Overall Study|Protocol Violation|2|||
157070752|NCT02176863|567011864|FG001|Overall Study|Protocol Violation|0|||
157070753|NCT02176863|567011865|FG002|Overall Study|Protocol Violation|1|||
157070754|NCT02176863|567011866|FG003|Overall Study|Protocol Violation|1|||
157070755|NCT02176863|567011867|FG004|Overall Study|Protocol Violation|0|||
157070756|NCT02176863|567011863|FG000|Overall Study|Withdrawal by Subject|4|||
157070757|NCT02176863|567011864|FG001|Overall Study|Withdrawal by Subject|2|||
157070758|NCT02176863|567011865|FG002|Overall Study|Withdrawal by Subject|2|||
157070759|NCT02176863|567011866|FG003|Overall Study|Withdrawal by Subject|3|||
157070760|NCT02176863|567011867|FG004|Overall Study|Withdrawal by Subject|4|||
157070761|NCT02176863|567011863|FG000|Overall Study|Reason not specified|0|||
157070762|NCT02176863|567011864|FG001|Overall Study|Reason not specified|1|||
157070763|NCT02176863|567011865|FG002|Overall Study|Reason not specified|1|||
157070764|NCT02176863|567011866|FG003|Overall Study|Reason not specified|2|||
157070765|NCT02176863|567011867|FG004|Overall Study|Reason not specified|1|||
157070766|NCT02176863|567011863|FG000|Overall Study|Lost to Follow-up|0|||
157070767|NCT02176863|567011864|FG001|Overall Study|Lost to Follow-up|1|||
157070768|NCT02176863|567011865|FG002|Overall Study|Lost to Follow-up|1|||
157070769|NCT02176863|567011866|FG003|Overall Study|Lost to Follow-up|0|||
157070770|NCT02176863|567011867|FG004|Overall Study|Lost to Follow-up|0|||
157070771|NCT02035696|567013561|FG000|Overall Study|Lost to Follow-up|0|||
157070772|NCT02035696|567013562|FG001|Overall Study|Lost to Follow-up|3|||
157070773|NCT02035696|567013563|FG002|Overall Study|Lost to Follow-up|1|||
157070774|NCT02035696|567013564|FG003|Overall Study|Lost to Follow-up|2|||
157070775|NCT02035696|567013561|FG000|Overall Study|Withdrawal by Subject|3|||
157070776|NCT02035696|567013562|FG001|Overall Study|Withdrawal by Subject|0|||
157070777|NCT02035696|567013563|FG002|Overall Study|Withdrawal by Subject|2|||
157070778|NCT02035696|567013564|FG003|Overall Study|Withdrawal by Subject|1|||
157070779|NCT04650698|567013566|FG000|Overall Study|Protocol Violation|2|||
157070780|NCT04650698|567013567|FG001|Overall Study|Protocol Violation|1|||
157070781|NCT04650698|567013566|FG000|Overall Study|Withdrawal by Subject|0|||
157070782|NCT04650698|567013567|FG001|Overall Study|Withdrawal by Subject|1|||
157070783|NCT01090011|567013568|FG000|Overall Study|Progressive disease|128|||
157070784|NCT01090011|567013568|FG000|Overall Study|Adverse Event|32|||
157070785|NCT01090011|567013568|FG000|Overall Study|Protocol Violation|1|||
157070786|NCT01090011|567013568|FG000|Overall Study|Refusal to start/continue medication|5|||
157070787|NCT01090011|567013568|FG000|Overall Study|Other reason not defined above|5|||
157070788|NCT03778294|567013569|FG000|Overall Study|Death|1|||
157070789|NCT03778294|567013569|FG000|Overall Study|Issues with insurance|1|||
157070790|NCT03778294|567013569|FG000|Overall Study|disease progression before treatment|2|||
157070791|NCT02358668|567013571|FG000|Overall Study|Adverse Event|2|||
157070792|NCT02358668|567013572|FG001|Overall Study|Adverse Event|0|||
157070793|NCT02358668|567013573|FG002|Overall Study|Adverse Event|0|||
157070794|NCT02358668|567013571|FG000|Overall Study|Withdrawal by Subject|0|||
157070795|NCT02358668|567013572|FG001|Overall Study|Withdrawal by Subject|1|||
157070796|NCT02358668|567013573|FG002|Overall Study|Withdrawal by Subject|0|||
157070797|NCT02104505|567013574|FG000|First Intervention (14 Days)|Adverse Event|2|||
157070798|NCT02104505|567013575|FG001|First Intervention (14 Days)|Adverse Event|0|||
157070799|NCT02104505|567013574|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
157070800|NCT02104505|567013575|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
157070801|NCT02104505|567013574|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
157070802|NCT02104505|567013575|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
157070803|NCT02104505|567013574|FG000|First Intervention (14 Days)|exclusionary condition|0|||
157070804|NCT02104505|567013575|FG001|First Intervention (14 Days)|exclusionary condition|1|||
157070805|NCT02104505|567013574|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
157070806|NCT02104505|567013575|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
157070807|NCT02104505|567013574|FG000|Second Intervention (14 Days)|Adverse Event|2|||
157070808|NCT02104505|567013575|FG001|Second Intervention (14 Days)|Adverse Event|0|||
157070809|NCT01845805|567013576|FG000|Overall Study|Withdrawal by Subject|1|||
157070810|NCT01845805|567013577|FG001|Overall Study|Withdrawal by Subject|2|||
157070811|NCT01845805|567013576|FG000|Overall Study|Disease Progression|13|||
157070812|NCT01845805|567013577|FG001|Overall Study|Disease Progression|14|||
157070813|NCT01845805|567013576|FG000|Overall Study|Drug-related Toxicity|4|||
157070814|NCT01845805|567013577|FG001|Overall Study|Drug-related Toxicity|0|||
157070815|NCT02419417|567013578|FG000|Overall Study|Disease progression|5|||
157070816|NCT02419417|567013579|FG001|Overall Study|Disease progression|4|||
157070817|NCT02419417|567013580|FG002|Overall Study|Disease progression|13|||
157070818|NCT02419417|567013581|FG003|Overall Study|Disease progression|10|||
157070819|NCT02419417|567013582|FG004|Overall Study|Disease progression|10|||
157070820|NCT02419417|567013583|FG005|Overall Study|Disease progression|3|||
157070821|NCT02419417|567013584|FG006|Overall Study|Disease progression|4|||
157070822|NCT02419417|567013585|FG007|Overall Study|Disease progression|5|||
157070823|NCT02419417|567013586|FG008|Overall Study|Disease progression|13|||
157070824|NCT02419417|567013587|FG009|Overall Study|Disease progression|9|||
157070825|NCT02419417|567013588|FG010|Overall Study|Disease progression|0|||
157070826|NCT02419417|567013578|FG000|Overall Study|Study drug toxicity|0|||
157070827|NCT02419417|567013579|FG001|Overall Study|Study drug toxicity|0|||
157070828|NCT02419417|567013580|FG002|Overall Study|Study drug toxicity|0|||
157070829|NCT02419417|567013581|FG003|Overall Study|Study drug toxicity|0|||
157070830|NCT02419417|567013582|FG004|Overall Study|Study drug toxicity|1|||
157070831|NCT02419417|567013583|FG005|Overall Study|Study drug toxicity|0|||
157070832|NCT02419417|567013584|FG006|Overall Study|Study drug toxicity|0|||
157070833|NCT02419417|567013585|FG007|Overall Study|Study drug toxicity|0|||
157070834|NCT02419417|567013586|FG008|Overall Study|Study drug toxicity|0|||
157070835|NCT02419417|567013587|FG009|Overall Study|Study drug toxicity|0|||
157070836|NCT02419417|567013588|FG010|Overall Study|Study drug toxicity|0|||
157070837|NCT02419417|567013578|FG000|Overall Study|Adverse event unrelated to study drug|0|||
157070838|NCT02419417|567013579|FG001|Overall Study|Adverse event unrelated to study drug|0|||
157070839|NCT02419417|567013580|FG002|Overall Study|Adverse event unrelated to study drug|0|||
157070840|NCT02419417|567013581|FG003|Overall Study|Adverse event unrelated to study drug|0|||
157070841|NCT02419417|567013582|FG004|Overall Study|Adverse event unrelated to study drug|2|||
157070842|NCT02419417|567013583|FG005|Overall Study|Adverse event unrelated to study drug|1|||
157070843|NCT02419417|567013584|FG006|Overall Study|Adverse event unrelated to study drug|0|||
157070844|NCT02419417|567013585|FG007|Overall Study|Adverse event unrelated to study drug|1|||
157070845|NCT02419417|567013586|FG008|Overall Study|Adverse event unrelated to study drug|0|||
157070846|NCT02419417|567013587|FG009|Overall Study|Adverse event unrelated to study drug|0|||
157191672|NCT01809327|567440771|FG002|Overall Study|Other|7|||
157191673|NCT01809327|567440772|FG003|Overall Study|Other|4|||
157191674|NCT01809327|567440773|FG004|Overall Study|Other|9|||
157191675|NCT00826540|567440774|FG000|Overall Study|ineligible|3|||
157191676|NCT00826540|567440774|FG000|Overall Study|Withdrawal by Subject|1|||
157191677|NCT02802735|567440775|FG000|Overall Study|Withdrawal by Subject|0|||
157070847|NCT02419417|567013588|FG010|Overall Study|Adverse event unrelated to study drug|0|||
157070848|NCT02419417|567013578|FG000|Overall Study|Participant request to discontinue|0|||
157070849|NCT02419417|567013579|FG001|Overall Study|Participant request to discontinue|0|||
157070850|NCT02419417|567013580|FG002|Overall Study|Participant request to discontinue|0|||
157070851|NCT02419417|567013581|FG003|Overall Study|Participant request to discontinue|0|||
157070852|NCT02419417|567013582|FG004|Overall Study|Participant request to discontinue|0|||
157191678|NCT02802735|567440776|FG001|Overall Study|Withdrawal by Subject|1|||
157070853|NCT02419417|567013583|FG005|Overall Study|Participant request to discontinue|0|||
157070854|NCT02419417|567013584|FG006|Overall Study|Participant request to discontinue|0|||
157191679|NCT02802735|567440777|FG002|Overall Study|Withdrawal by Subject|0|||
157191680|NCT02802735|567440778|FG003|Overall Study|Withdrawal by Subject|0|||
157070855|NCT02419417|567013585|FG007|Overall Study|Participant request to discontinue|0|||
157070856|NCT02419417|567013586|FG008|Overall Study|Participant request to discontinue|0|||
157070857|NCT02419417|567013587|FG009|Overall Study|Participant request to discontinue|1|||
157070858|NCT02419417|567013588|FG010|Overall Study|Participant request to discontinue|0|||
157070859|NCT02419417|567013578|FG000|Overall Study|Withdrawal by Subject|0|||
157070860|NCT02419417|567013579|FG001|Overall Study|Withdrawal by Subject|0|||
157070861|NCT02419417|567013580|FG002|Overall Study|Withdrawal by Subject|0|||
157070862|NCT02419417|567013581|FG003|Overall Study|Withdrawal by Subject|0|||
157070863|NCT02419417|567013582|FG004|Overall Study|Withdrawal by Subject|0|||
157070864|NCT02419417|567013583|FG005|Overall Study|Withdrawal by Subject|0|||
157070865|NCT02419417|567013584|FG006|Overall Study|Withdrawal by Subject|0|||
157070866|NCT02419417|567013585|FG007|Overall Study|Withdrawal by Subject|0|||
157070867|NCT02419417|567013586|FG008|Overall Study|Withdrawal by Subject|0|||
157070868|NCT02419417|567013587|FG009|Overall Study|Withdrawal by Subject|0|||
157070869|NCT02419417|567013588|FG010|Overall Study|Withdrawal by Subject|1|||
157070870|NCT01240551|567013589|FG000|Overall Study|Refused further treatment|3|||
157070871|NCT01240551|567013590|FG001|Overall Study|Refused further treatment|2|||
157070872|NCT01240551|567013589|FG000|Overall Study|Lost to Follow-up|1|||
157070873|NCT01240551|567013590|FG001|Overall Study|Lost to Follow-up|1|||
157070874|NCT01730950|567013593|FG000|Overall Study|Protocol Violation|6|||
157070875|NCT01730950|567013594|FG001|Overall Study|Protocol Violation|6|||
157070876|NCT02737826|567013595|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
157070877|NCT02737826|567013596|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
157070878|NCT02737826|567013597|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
157070879|NCT02354651|567013598|FG000|Overall Study|Withdrawal by Subject|2|||
157070880|NCT02354651|567013598|FG000|Overall Study|Physician Decision|1|||
157070881|NCT01317875|567013599|FG000|Overall Study|Other|0|||
157070882|NCT01317875|567013600|FG001|Overall Study|Other|0|||
157070883|NCT01317875|567013601|FG002|Overall Study|Other|1|||
157070884|NCT01317875|567013602|FG003|Overall Study|Other|0|||
157070885|NCT01317875|567013603|FG004|Overall Study|Other|0|||
157070886|NCT01317875|567013604|FG005|Overall Study|Other|0|||
157070887|NCT01317875|567013605|FG006|Overall Study|Other|0|||
157070888|NCT01317875|567013606|FG007|Overall Study|Other|0|||
157070889|NCT01317875|567013607|FG008|Overall Study|Other|0|||
157070890|NCT01317875|567013608|FG009|Overall Study|Other|0|||
157070891|NCT01317875|567013599|FG000|Overall Study|Noncompliance with study drug|0|||
157070892|NCT01317875|567013600|FG001|Overall Study|Noncompliance with study drug|0|||
157070893|NCT01317875|567013601|FG002|Overall Study|Noncompliance with study drug|1|||
157070894|NCT01317875|567013602|FG003|Overall Study|Noncompliance with study drug|0|||
157070895|NCT01317875|567013603|FG004|Overall Study|Noncompliance with study drug|0|||
157070896|NCT01317875|567013604|FG005|Overall Study|Noncompliance with study drug|0|||
157070897|NCT01317875|567013605|FG006|Overall Study|Noncompliance with study drug|0|||
157070898|NCT01317875|567013606|FG007|Overall Study|Noncompliance with study drug|0|||
157070899|NCT01317875|567013607|FG008|Overall Study|Noncompliance with study drug|0|||
157070900|NCT01317875|567013608|FG009|Overall Study|Noncompliance with study drug|0|||
157191681|NCT02802735|567440779|FG004|Overall Study|Withdrawal by Subject|0|||
157191682|NCT01166386|567440780|FG000|Overall Study|Withdrawal by Subject|3|||
157191683|NCT01166386|567440781|FG001|Overall Study|Withdrawal by Subject|5|||
157191684|NCT03922711|567440784|FG000|Overall Study|Adverse Event|3|||
157191685|NCT03922711|567440785|FG001|Overall Study|Adverse Event|2|||
157191686|NCT03922711|567440786|FG002|Overall Study|Adverse Event|2|||
157191687|NCT03922711|567440784|FG000|Overall Study|Protocol Violation|1|||
157191688|NCT03922711|567440785|FG001|Overall Study|Protocol Violation|0|||
157191689|NCT03922711|567440786|FG002|Overall Study|Protocol Violation|0|||
157191690|NCT03922711|567440784|FG000|Overall Study|Withdrawal by Subject|0|||
157191691|NCT03922711|567440785|FG001|Overall Study|Withdrawal by Subject|3|||
157191692|NCT03922711|567440786|FG002|Overall Study|Withdrawal by Subject|1|||
157191693|NCT03922711|567440784|FG000|Overall Study|Not further specified|0|||
157191694|NCT03922711|567440785|FG001|Overall Study|Not further specified|0|||
157191695|NCT03922711|567440786|FG002|Overall Study|Not further specified|1|||
157191696|NCT02390362|567440789|FG000|Overall Study|Withdrawal by Subject|0|||
157191697|NCT02390362|567440790|FG001|Overall Study|Withdrawal by Subject|1|||
157191698|NCT02975206|567440791|FG000|Overall Study|Withdrawal by Subject|14|||
157070901|NCT01317875|567013599|FG000|Overall Study|Progressive Disease|1|||
157191699|NCT02975206|567440792|FG001|Overall Study|Withdrawal by Subject|11|||
157191700|NCT02975206|567440793|FG002|Overall Study|Withdrawal by Subject|11|||
157191701|NCT02975206|567440791|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
157191702|NCT02975206|567440792|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
157191703|NCT02975206|567440793|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
157070902|NCT01317875|567013600|FG001|Overall Study|Progressive Disease|0|||
157070903|NCT01317875|567013601|FG002|Overall Study|Progressive Disease|2|||
157070904|NCT01317875|567013602|FG003|Overall Study|Progressive Disease|0|||
157070905|NCT01317875|567013603|FG004|Overall Study|Progressive Disease|1|||
157070906|NCT01317875|567013604|FG005|Overall Study|Progressive Disease|0|||
157070907|NCT01317875|567013605|FG006|Overall Study|Progressive Disease|0|||
157070908|NCT01317875|567013606|FG007|Overall Study|Progressive Disease|1|||
157070909|NCT01317875|567013607|FG008|Overall Study|Progressive Disease|0|||
157070910|NCT01317875|567013608|FG009|Overall Study|Progressive Disease|0|||
157070911|NCT01317875|567013599|FG000|Overall Study|Withdrawal by Subject|0|||
157070912|NCT01317875|567013600|FG001|Overall Study|Withdrawal by Subject|0|||
157070913|NCT01317875|567013601|FG002|Overall Study|Withdrawal by Subject|0|||
157070914|NCT01317875|567013602|FG003|Overall Study|Withdrawal by Subject|0|||
157070915|NCT01317875|567013603|FG004|Overall Study|Withdrawal by Subject|1|||
157070916|NCT01317875|567013604|FG005|Overall Study|Withdrawal by Subject|0|||
157070917|NCT01317875|567013605|FG006|Overall Study|Withdrawal by Subject|0|||
157070918|NCT01317875|567013606|FG007|Overall Study|Withdrawal by Subject|3|||
157070919|NCT01317875|567013607|FG008|Overall Study|Withdrawal by Subject|0|||
157070920|NCT01317875|567013608|FG009|Overall Study|Withdrawal by Subject|0|||
157070921|NCT01317875|567013599|FG000|Overall Study|Physician Decision|0|||
157070922|NCT01317875|567013600|FG001|Overall Study|Physician Decision|1|||
157070923|NCT01317875|567013601|FG002|Overall Study|Physician Decision|1|||
157070924|NCT01317875|567013602|FG003|Overall Study|Physician Decision|0|||
157070925|NCT01317875|567013603|FG004|Overall Study|Physician Decision|2|||
157070926|NCT01317875|567013604|FG005|Overall Study|Physician Decision|0|||
157070927|NCT01317875|567013605|FG006|Overall Study|Physician Decision|0|||
157070928|NCT01317875|567013606|FG007|Overall Study|Physician Decision|2|||
157070929|NCT01317875|567013607|FG008|Overall Study|Physician Decision|0|||
157070930|NCT01317875|567013608|FG009|Overall Study|Physician Decision|0|||
157070931|NCT01317875|567013599|FG000|Overall Study|Death|0|||
157070932|NCT01317875|567013600|FG001|Overall Study|Death|0|||
157070933|NCT01317875|567013601|FG002|Overall Study|Death|2|||
157070934|NCT01317875|567013602|FG003|Overall Study|Death|1|||
157070935|NCT01317875|567013603|FG004|Overall Study|Death|0|||
157070936|NCT01317875|567013604|FG005|Overall Study|Death|1|||
157070937|NCT01317875|567013605|FG006|Overall Study|Death|0|||
157070938|NCT01317875|567013606|FG007|Overall Study|Death|4|||
157070939|NCT01317875|567013607|FG008|Overall Study|Death|0|||
157070940|NCT01317875|567013608|FG009|Overall Study|Death|0|||
157070941|NCT01317875|567013599|FG000|Overall Study|Adverse Event|2|||
157070942|NCT01317875|567013600|FG001|Overall Study|Adverse Event|1|||
157070943|NCT01317875|567013601|FG002|Overall Study|Adverse Event|2|||
157070944|NCT01317875|567013602|FG003|Overall Study|Adverse Event|1|||
157070945|NCT01317875|567013603|FG004|Overall Study|Adverse Event|5|||
157070946|NCT01317875|567013604|FG005|Overall Study|Adverse Event|1|||
157070947|NCT01317875|567013605|FG006|Overall Study|Adverse Event|2|||
157070948|NCT01317875|567013606|FG007|Overall Study|Adverse Event|5|||
157070949|NCT01317875|567013607|FG008|Overall Study|Adverse Event|0|||
157070950|NCT01317875|567013608|FG009|Overall Study|Adverse Event|0|||
157070951|NCT01381575|567013609|FG000|Overall Study|Serious Adverse Event|1|||
157070952|NCT01381575|567013610|FG001|Overall Study|Serious Adverse Event|0|||
157070953|NCT01381575|567013611|FG002|Overall Study|Serious Adverse Event|0|||
157070954|NCT01381575|567013609|FG000|Overall Study|Non-Serious Adverse Event|0|||
157070955|NCT01381575|567013610|FG001|Overall Study|Non-Serious Adverse Event|0|||
157070956|NCT01381575|567013611|FG002|Overall Study|Non-Serious Adverse Event|1|||
157070957|NCT01381575|567013609|FG000|Overall Study|Protocol Violation|0|||
157070958|NCT01381575|567013610|FG001|Overall Study|Protocol Violation|1|||
157070959|NCT01381575|567013611|FG002|Overall Study|Protocol Violation|1|||
157070960|NCT01381575|567013609|FG000|Overall Study|Withdrawal by Subject|15|||
157070961|NCT01381575|567013610|FG001|Overall Study|Withdrawal by Subject|9|||
157070962|NCT01381575|567013611|FG002|Overall Study|Withdrawal by Subject|7|||
157070963|NCT01381575|567013609|FG000|Overall Study|Migrated/moved from study area|2|||
157070964|NCT01381575|567013610|FG001|Overall Study|Migrated/moved from study area|12|||
157070965|NCT01381575|567013611|FG002|Overall Study|Migrated/moved from study area|2|||
157070966|NCT01381575|567013609|FG000|Overall Study|Lost to Follow-up|8|||
157070967|NCT01381575|567013610|FG001|Overall Study|Lost to Follow-up|17|||
157070968|NCT01381575|567013611|FG002|Overall Study|Lost to Follow-up|9|||
157070969|NCT01377389|567013612|FG000|Overall Study|Withdrawal by Subject|1|||
157070970|NCT01377389|567013612|FG000|Overall Study|Screen failure|2|||
157070971|NCT04546217|567013619|FG000|Overall Study|Withdrawal by Subject|2|||
157070972|NCT04546217|567013620|FG001|Overall Study|Withdrawal by Subject|0|||
157070973|NCT04546217|567013619|FG000|Overall Study|Uncontrolled hypertension|1|||
157070974|NCT04546217|567013620|FG001|Overall Study|Uncontrolled hypertension|0|||
157070975|NCT03020069|567013621|FG000|Overall Study|Lost to Follow-up|0|||
157070976|NCT03020069|567013622|FG001|Overall Study|Lost to Follow-up|1|||
157070977|NCT00863512|567013626|FG000|Overall Study|Adverse Event|2|||
157070978|NCT00863512|567013627|FG001|Overall Study|Adverse Event|0|||
157070979|NCT00863512|567013626|FG000|Overall Study|Withdrawal by Subject|11|||
157070980|NCT00863512|567013627|FG001|Overall Study|Withdrawal by Subject|0|||
157070981|NCT00863512|567013626|FG000|Overall Study|Physician Decision|1|||
157070982|NCT00863512|567013627|FG001|Overall Study|Physician Decision|0|||
157070983|NCT01437423|567013632|FG000|Overall Study|Lost to Follow-up|12|||
157070984|NCT01437423|567013632|FG000|Overall Study|Off label usage|3|||
157070985|NCT01375751|567013633|FG000|Overall Study|Other|0|||
157070986|NCT01375751|567013634|FG001|Overall Study|Other|1|||
157070987|NCT01375751|567013635|FG002|Overall Study|Other|0|||
157070988|NCT00121667|567013637|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
157070989|NCT00121667|567013638|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
157070990|NCT00121667|567013639|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
157070991|NCT00121667|567013640|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
157070992|NCT00121667|567013637|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
157070993|NCT00121667|567013638|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
157070994|NCT00121667|567013639|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
157070995|NCT00121667|567013640|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
157070996|NCT00121667|567013637|FG000|Short Term (ST) Period|Adverse Event|5|||
157070997|NCT00121667|567013638|FG001|Short Term (ST) Period|Adverse Event|6|||
157070998|NCT00121667|567013639|FG002|Short Term (ST) Period|Adverse Event|5|||
157070999|NCT00121667|567013640|FG003|Short Term (ST) Period|Adverse Event|3|||
157071000|NCT00121667|567013637|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
157071001|NCT00121667|567013638|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
157071002|NCT00121667|567013639|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
157071003|NCT00121667|567013640|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
157071004|NCT00121667|567013637|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
157071005|NCT00121667|567013638|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
157071006|NCT00121667|567013639|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
157071007|NCT00121667|567013640|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
157071008|NCT00121667|567013637|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
157071009|NCT00121667|567013638|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
157071010|NCT00121667|567013639|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
157071011|NCT00121667|567013640|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
157071012|NCT00121667|567013637|FG000|Short Term (ST) Period|Other Reason|3|||
157071013|NCT00121667|567013638|FG001|Short Term (ST) Period|Other Reason|0|||
157071014|NCT00121667|567013639|FG002|Short Term (ST) Period|Other Reason|0|||
157071015|NCT00121667|567013640|FG003|Short Term (ST) Period|Other Reason|0|||
157071016|NCT00121667|567013637|FG000|Short Term (ST) Period|Death|0|||
157071017|NCT00121667|567013638|FG001|Short Term (ST) Period|Death|0|||
157071018|NCT00121667|567013639|FG002|Short Term (ST) Period|Death|0|||
157071019|NCT00121667|567013640|FG003|Short Term (ST) Period|Death|1|||
157071020|NCT00121667|567013637|FG000|Short Term (ST) Period|Pregnancy|0|||
157071021|NCT00121667|567013638|FG001|Short Term (ST) Period|Pregnancy|0|||
157071022|NCT00121667|567013639|FG002|Short Term (ST) Period|Pregnancy|0|||
157071023|NCT00121667|567013640|FG003|Short Term (ST) Period|Pregnancy|1|||
157071024|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
157071025|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
157071026|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
157071027|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
157071028|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
157071029|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
157071030|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
157071031|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
157071032|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
157071033|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
157071034|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
157071035|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
157071036|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
157071037|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
157071038|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
157071039|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
157071040|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
157071041|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
157071042|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
157071043|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
157071044|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
157071045|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
157071046|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
157071047|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
157071048|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
157071049|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
157071050|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
157071051|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
157071052|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
157071053|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
157071054|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
157191704|NCT00554840|567440798|FG000|Overall Study|Physician Decision|0|||
157191705|NCT00554840|567440799|FG001|Overall Study|Physician Decision|1|||
157191706|NCT00795717|567440802|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
157191707|NCT00795717|567440803|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
157191708|NCT00795717|567440802|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
157191709|NCT00795717|567440803|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
157191710|NCT00795717|567440802|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
157071055|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
157071056|NCT00121667|567013637|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
157071057|NCT00121667|567013638|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
157071058|NCT00121667|567013639|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
157071059|NCT00121667|567013640|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
157071060|NCT05186311|567013641|FG000|Part A: Serum|Withdrawal by Subject|1|||
157071061|NCT04468230|567013649|FG000|Overall Study|Adverse Event|2|||
157071062|NCT03934099|567013653|FG000|Overall Study|Adverse Event|0|||
157071063|NCT03934099|567013654|FG001|Overall Study|Adverse Event|3|||
157071064|NCT03934099|567013655|FG002|Overall Study|Adverse Event|1|||
157071065|NCT03934099|567013656|FG003|Overall Study|Adverse Event|0|||
157071066|NCT03934099|567013653|FG000|Overall Study|Lost to Follow-up|1|||
157071067|NCT03934099|567013654|FG001|Overall Study|Lost to Follow-up|2|||
157071068|NCT03934099|567013655|FG002|Overall Study|Lost to Follow-up|1|||
157071069|NCT03934099|567013656|FG003|Overall Study|Lost to Follow-up|1|||
157071070|NCT03934099|567013653|FG000|Overall Study|Protocol Violation|1|||
157071071|NCT03934099|567013654|FG001|Overall Study|Protocol Violation|0|||
157071072|NCT03934099|567013655|FG002|Overall Study|Protocol Violation|0|||
157071073|NCT03934099|567013656|FG003|Overall Study|Protocol Violation|0|||
157071074|NCT03934099|567013653|FG000|Overall Study|Withdrawal by Subject|2|||
157071075|NCT03934099|567013654|FG001|Overall Study|Withdrawal by Subject|0|||
157071076|NCT03934099|567013655|FG002|Overall Study|Withdrawal by Subject|1|||
157071077|NCT03934099|567013656|FG003|Overall Study|Withdrawal by Subject|1|||
157071078|NCT03934099|567013653|FG000|Overall Study|Other reasons|0|||
157071079|NCT03934099|567013654|FG001|Overall Study|Other reasons|1|||
157071080|NCT03934099|567013655|FG002|Overall Study|Other reasons|0|||
157071081|NCT03934099|567013656|FG003|Overall Study|Other reasons|0|||
157071082|NCT02872012|567013668|FG000|Overall Study|Withdrawal by Subject|1|||
157071083|NCT02872012|567013669|FG001|Overall Study|Withdrawal by Subject|0|||
157071084|NCT02872012|567013670|FG002|Overall Study|Withdrawal by Subject|0|||
157071085|NCT02872012|567013671|FG003|Overall Study|Withdrawal by Subject|0|||
157071086|NCT02872012|567013672|FG004|Overall Study|Withdrawal by Subject|0|||
157071087|NCT03000348|567013673|FG000|Overall Study|Adverse Event|1|||
157071088|NCT03000348|567013674|FG001|Overall Study|Adverse Event|1|||
157071089|NCT03000348|567013675|FG002|Overall Study|Adverse Event|1|||
157071090|NCT03000348|567013676|FG003|Overall Study|Adverse Event|1|||
157071091|NCT03000348|567013677|FG004|Overall Study|Adverse Event|1|||
157071092|NCT03000348|567013678|FG005|Overall Study|Adverse Event|1|||
157071093|NCT03000348|567013673|FG000|Overall Study|Lost to Follow-up|0|||
157071094|NCT03000348|567013674|FG001|Overall Study|Lost to Follow-up|0|||
157071095|NCT03000348|567013675|FG002|Overall Study|Lost to Follow-up|1|||
157071096|NCT03000348|567013676|FG003|Overall Study|Lost to Follow-up|0|||
157071097|NCT03000348|567013677|FG004|Overall Study|Lost to Follow-up|0|||
157071098|NCT03000348|567013678|FG005|Overall Study|Lost to Follow-up|0|||
157071099|NCT03000348|567013673|FG000|Overall Study|Withdrawal by Subject|0|||
157071100|NCT03000348|567013674|FG001|Overall Study|Withdrawal by Subject|1|||
157071101|NCT03000348|567013675|FG002|Overall Study|Withdrawal by Subject|0|||
157071102|NCT03000348|567013676|FG003|Overall Study|Withdrawal by Subject|0|||
157071103|NCT03000348|567013677|FG004|Overall Study|Withdrawal by Subject|0|||
157071104|NCT03000348|567013678|FG005|Overall Study|Withdrawal by Subject|0|||
157071105|NCT03000348|567013673|FG000|Overall Study|Consent|0|||
157071106|NCT03000348|567013674|FG001|Overall Study|Consent|0|||
157071107|NCT03000348|567013675|FG002|Overall Study|Consent|0|||
157071108|NCT03000348|567013676|FG003|Overall Study|Consent|0|||
157071109|NCT03000348|567013677|FG004|Overall Study|Consent|1|||
157071110|NCT03000348|567013678|FG005|Overall Study|Consent|0|||
157071111|NCT03000348|567013673|FG000|Overall Study|Failure to expectorate sputum|1|||
157071112|NCT03000348|567013674|FG001|Overall Study|Failure to expectorate sputum|0|||
157071113|NCT03000348|567013675|FG002|Overall Study|Failure to expectorate sputum|1|||
157071114|NCT03000348|567013676|FG003|Overall Study|Failure to expectorate sputum|0|||
157071115|NCT03000348|567013677|FG004|Overall Study|Failure to expectorate sputum|1|||
157071116|NCT03000348|567013678|FG005|Overall Study|Failure to expectorate sputum|0|||
157071117|NCT03000348|567013673|FG000|Overall Study|No gram negative|1|||
157071118|NCT03000348|567013674|FG001|Overall Study|No gram negative|2|||
157071119|NCT03000348|567013675|FG002|Overall Study|No gram negative|1|||
157071120|NCT03000348|567013676|FG003|Overall Study|No gram negative|1|||
157071121|NCT03000348|567013677|FG004|Overall Study|No gram negative|1|||
157071122|NCT03000348|567013678|FG005|Overall Study|No gram negative|1|||
157071123|NCT03000348|567013673|FG000|Overall Study|Patient had no transport|0|||
157071124|NCT03000348|567013674|FG001|Overall Study|Patient had no transport|0|||
157071125|NCT03000348|567013675|FG002|Overall Study|Patient had no transport|0|||
157071126|NCT03000348|567013676|FG003|Overall Study|Patient had no transport|1|||
157071127|NCT03000348|567013677|FG004|Overall Study|Patient had no transport|0|||
157071128|NCT03000348|567013678|FG005|Overall Study|Patient had no transport|0|||
157071129|NCT03000348|567013673|FG000|Overall Study|Dosing|0|||
157071130|NCT03000348|567013674|FG001|Overall Study|Dosing|0|||
157071131|NCT03000348|567013675|FG002|Overall Study|Dosing|0|||
157071132|NCT03000348|567013676|FG003|Overall Study|Dosing|0|||
157071133|NCT03000348|567013677|FG004|Overall Study|Dosing|1|||
157071134|NCT03000348|567013678|FG005|Overall Study|Dosing|0|||
157071135|NCT00723125|567013679|FG000|Overall Study|Met Dx|1|||
157071136|NCT00723125|567013680|FG001|Overall Study|Met Dx|0|||
157071137|NCT00723125|567013679|FG000|Overall Study|Withdrawal by Subject|15|||
157071138|NCT00723125|567013680|FG001|Overall Study|Withdrawal by Subject|6|||
157071139|NCT00723125|567013679|FG000|Overall Study|Adverse Event|2|||
157071140|NCT00723125|567013680|FG001|Overall Study|Adverse Event|0|||
157071141|NCT01807182|567013681|FG000|Overall Study|Death|1|||
157071142|NCT01807182|567013681|FG000|Overall Study|New therapy|1|||
157071143|NCT01807182|567013681|FG000|Overall Study|Moved to hospice care|1|||
157071144|NCT01262092|567013684|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
157071145|NCT01262092|567013685|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
157071146|NCT01262092|567013684|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
157071147|NCT01262092|567013685|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
157071148|NCT01262092|567013684|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
157071149|NCT01262092|567013685|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
157071150|NCT01262092|567013684|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
157071151|NCT01262092|567013685|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
157071152|NCT03784820|567013686|FG000|Overall Study|Lost to Follow-up|5|||
157071153|NCT03784820|567013687|FG001|Overall Study|Lost to Follow-up|5|||
157071154|NCT03784820|567013688|FG002|Overall Study|Lost to Follow-up|3|||
157071155|NCT03784820|567013689|FG003|Overall Study|Lost to Follow-up|3|||
157071156|NCT02336425|567013690|FG000|Overall Study|Study terminated.|2|||
157071157|NCT02336425|567013691|FG001|Overall Study|Study terminated.|2|||
157071158|NCT02336425|567013692|FG002|Overall Study|Study terminated.|3|||
157071159|NCT02336425|567013693|FG003|Overall Study|Study terminated.|3|||
157071160|NCT01191008|567013694|FG000|Overall Study|Protocol Violation|7|||
157071161|NCT01191008|567013694|FG000|Overall Study|Lost to Follow-up|8|||
157071162|NCT03299959|567013697|FG000|Overall Study|Lost to Follow-up|7|||
157071163|NCT03299959|567013698|FG001|Overall Study|Lost to Follow-up|9|||
157071164|NCT03299959|567013697|FG000|Overall Study|Death|1|||
157071165|NCT03299959|567013698|FG001|Overall Study|Death|0|||
157071166|NCT03299959|567013697|FG000|Overall Study|Withdrawal by Subject|13|||
157071167|NCT03299959|567013698|FG001|Overall Study|Withdrawal by Subject|9|||
157071168|NCT03299959|567013697|FG000|Overall Study|Changes in study team and government regulations|1|||
157071169|NCT03299959|567013698|FG001|Overall Study|Changes in study team and government regulations|1|||
157071170|NCT03299959|567013697|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
157071171|NCT03299959|567013698|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
157071172|NCT01310699|567013699|FG000|Overall Study|Patients did not complete tandem.|4|||
157071173|NCT01310699|567013700|FG001|Overall Study|Patients did not complete tandem.|6|||
157071174|NCT00926575|567013701|FG000|Overall Study|Adverse Event|1|||
157071175|NCT00926575|567013702|FG001|Overall Study|Adverse Event|1|||
157071176|NCT00926575|567013701|FG000|Overall Study|Death|4|||
157071177|NCT00926575|567013702|FG001|Overall Study|Death|4|||
157071178|NCT00926575|567013701|FG000|Overall Study|Lost to Follow-up|1|||
157071179|NCT00926575|567013702|FG001|Overall Study|Lost to Follow-up|1|||
157071180|NCT00926575|567013701|FG000|Overall Study|Physician Decision|1|||
157071181|NCT00926575|567013702|FG001|Overall Study|Physician Decision|2|||
157071182|NCT00926575|567013701|FG000|Overall Study|Protocol Violation|1|||
157071183|NCT00926575|567013702|FG001|Overall Study|Protocol Violation|0|||
157071184|NCT00926575|567013701|FG000|Overall Study|Withdrawal by Subject|8|||
157071185|NCT00926575|567013702|FG001|Overall Study|Withdrawal by Subject|9|||
157071186|NCT00490698|567013703|FG000|Overall Study|Withdrawal by Subject|1|||
157071187|NCT00490698|567013703|FG000|Overall Study|Disease Progression|7|||
157071188|NCT00490698|567013703|FG000|Overall Study|Physician Decision|2|||
157071189|NCT00469859|567013705|FG000|Overall Study|Inevaluable|0|||
157071190|NCT00469859|567013706|FG001|Overall Study|Inevaluable|2|||
157071191|NCT04124471|567013707|FG000|Overall Study|screen failure|1|||
157071192|NCT02394925|567013710|FG000|Overall Study|Adverse Event|1|||
157071193|NCT02394925|567013710|FG000|Overall Study|Lens Discomfort|3|||
157071194|NCT02394925|567013710|FG000|Overall Study|Lens handling difficulities|5|||
157071195|NCT02394925|567013710|FG000|Overall Study|Lost to Follow-up|9|||
157071196|NCT02394925|567013710|FG000|Overall Study|Protocol Violation|5|||
157071197|NCT02394925|567013710|FG000|Overall Study|No longer meet eligibility criteria|1|||
157071198|NCT02394925|567013710|FG000|Overall Study|Unsatisfactory Visual Response|5|||
157071199|NCT03459846|567013714|FG000|Overall Study|Death|52|||
157071200|NCT03459846|567013715|FG001|Overall Study|Death|46|||
157071201|NCT03459846|567013714|FG000|Overall Study|Study terminated by sponsor|24|||
157071202|NCT03459846|567013715|FG001|Overall Study|Study terminated by sponsor|28|||
157071203|NCT03459846|567013714|FG000|Overall Study|Withdrawal by Subject|2|||
157071204|NCT03459846|567013715|FG001|Overall Study|Withdrawal by Subject|2|||
157071205|NCT03945773|567015301|FG000|Overall Study|Consent Withdrawn|1|||
157071206|NCT03945773|567015302|FG001|Overall Study|Consent Withdrawn|1|||
157071207|NCT03945773|567015301|FG000|Overall Study|Lost to Follow-up|1|||
157071208|NCT03945773|567015302|FG001|Overall Study|Lost to Follow-up|0|||
157071209|NCT03945773|567015301|FG000|Overall Study|Death|46|||
157071210|NCT03945773|567015302|FG001|Overall Study|Death|22|||
157071211|NCT03945773|567015301|FG000|Overall Study|Physician Decision|1|||
157071212|NCT03945773|567015302|FG001|Overall Study|Physician Decision|0|||
157071213|NCT03945773|567015301|FG000|Overall Study|Other|1|||
157071214|NCT03945773|567015302|FG001|Overall Study|Other|0|||
157071215|NCT03945773|567015301|FG000|Overall Study|Ongoing at the time of DCO|4|||
157071216|NCT03945773|567015302|FG001|Overall Study|Ongoing at the time of DCO|3|||
157071217|NCT00725712|567015303|FG000|Overall Study|Withdrawal by Subject|2|||
157071218|NCT00725712|567015304|FG001|Overall Study|Withdrawal by Subject|1|||
157071219|NCT00725712|567015303|FG000|Overall Study|Protocol Violation|1|||
157071220|NCT00725712|567015304|FG001|Overall Study|Protocol Violation|0|||
157071221|NCT00725712|567015303|FG000|Overall Study|Progressive disease|37|||
157071222|NCT00725712|567015304|FG001|Overall Study|Progressive disease|16|||
157071223|NCT00725712|567015303|FG000|Overall Study|Clinical progression not based on RECIST|0|||
157071224|NCT00725712|567015304|FG001|Overall Study|Clinical progression not based on RECIST|3|||
157071225|NCT00725712|567015303|FG000|Overall Study|Adverse Event|5|||
157071226|NCT00725712|567015304|FG001|Overall Study|Adverse Event|5|||
157071227|NCT00725712|567015303|FG000|Overall Study|Death|2|||
157071228|NCT00725712|567015304|FG001|Overall Study|Death|0|||
157071229|NCT00725712|567015303|FG000|Overall Study|Other: Death|1|||
157071230|NCT00725712|567015304|FG001|Overall Study|Other: Death|0|||
157071231|NCT00725712|567015303|FG000|Overall Study|Hospitalized, unable to continue|0|||
157071232|NCT00725712|567015304|FG001|Overall Study|Hospitalized, unable to continue|1|||
157071233|NCT03595124|567015308|FG000|Overall Study|Physician Decision|1|||
157071234|NCT03595124|567015309|FG001|Overall Study|Physician Decision|1|||
157071235|NCT03595124|567015310|FG002|Overall Study|Physician Decision|1|||
157071236|NCT03595124|567015308|FG000|Overall Study|Ineligible|1|||
157071237|NCT03595124|567015309|FG001|Overall Study|Ineligible|1|||
157071238|NCT03595124|567015310|FG002|Overall Study|Ineligible|0|||
157071239|NCT03595124|567015308|FG000|Overall Study|Disease Progression|4|||
157071240|NCT03595124|567015309|FG001|Overall Study|Disease Progression|1|||
157071241|NCT03595124|567015310|FG002|Overall Study|Disease Progression|4|||
157071242|NCT01439867|567015311|FG000|Overall Study|Non-compliance|0|||
157071243|NCT01439867|567015312|FG001|Overall Study|Non-compliance|1|||
157071244|NCT01439867|567015311|FG000|Overall Study|Withdrawal by Subject|1|||
157071245|NCT01439867|567015312|FG001|Overall Study|Withdrawal by Subject|2|||
157071246|NCT01439867|567015311|FG000|Overall Study|Administrative Decision|4|||
157071247|NCT01439867|567015312|FG001|Overall Study|Administrative Decision|5|||
157071248|NCT01439867|567015311|FG000|Overall Study|Protocol-specified Criteria|1|||
157071249|NCT01439867|567015312|FG001|Overall Study|Protocol-specified Criteria|0|||
157071250|NCT03607422|567015313|FG000|Overall Study|Adverse Event|7|||
157071251|NCT03607422|567015314|FG001|Overall Study|Adverse Event|3|||
157071252|NCT03607422|567015315|FG002|Overall Study|Adverse Event|2|||
157071253|NCT03607422|567015316|FG003|Overall Study|Adverse Event|0|||
157071254|NCT03607422|567015317|FG004|Overall Study|Adverse Event|2|||
157071255|NCT03607422|567015318|FG005|Overall Study|Adverse Event|0|||
157071256|NCT03607422|567015313|FG000|Overall Study|Withdrawal by Subject|11|||
157071257|NCT03607422|567015314|FG001|Overall Study|Withdrawal by Subject|3|||
157071258|NCT03607422|567015315|FG002|Overall Study|Withdrawal by Subject|6|||
157071259|NCT03607422|567015316|FG003|Overall Study|Withdrawal by Subject|2|||
157071260|NCT03607422|567015317|FG004|Overall Study|Withdrawal by Subject|0|||
157071261|NCT03607422|567015318|FG005|Overall Study|Withdrawal by Subject|0|||
157071262|NCT03607422|567015313|FG000|Overall Study|Lost to Follow-up|0|||
157071263|NCT03607422|567015314|FG001|Overall Study|Lost to Follow-up|0|||
157071264|NCT03607422|567015315|FG002|Overall Study|Lost to Follow-up|1|||
157071265|NCT03607422|567015316|FG003|Overall Study|Lost to Follow-up|0|||
157071266|NCT03607422|567015317|FG004|Overall Study|Lost to Follow-up|0|||
157071267|NCT03607422|567015318|FG005|Overall Study|Lost to Follow-up|0|||
157071268|NCT03607422|567015313|FG000|Overall Study|Other|12|||
157071269|NCT03607422|567015314|FG001|Overall Study|Other|4|||
157071270|NCT03607422|567015315|FG002|Overall Study|Other|1|||
157071271|NCT03607422|567015316|FG003|Overall Study|Other|2|||
157071272|NCT03607422|567015317|FG004|Overall Study|Other|0|||
157071273|NCT03607422|567015318|FG005|Overall Study|Other|2|||
157071274|NCT03607422|567015313|FG000|Overall Study|Ongoing at Time of Analysis|8|||
157071275|NCT03607422|567015314|FG001|Overall Study|Ongoing at Time of Analysis|0|||
157071276|NCT03607422|567015315|FG002|Overall Study|Ongoing at Time of Analysis|2|||
157071277|NCT03607422|567015316|FG003|Overall Study|Ongoing at Time of Analysis|1|||
157071278|NCT03607422|567015317|FG004|Overall Study|Ongoing at Time of Analysis|1|||
157071279|NCT03607422|567015318|FG005|Overall Study|Ongoing at Time of Analysis|1|||
157071280|NCT01920932|567015321|FG000|Overall Study|Death|1|||
157071281|NCT01920932|567015321|FG000|Overall Study|Withdrawal of consent|1|||
157071282|NCT01107899|567015322|FG000|Overall Study|Physician Decision|5|||
157071283|NCT01107899|567015323|FG001|Overall Study|Physician Decision|0|||
157071284|NCT01107899|567015324|FG002|Overall Study|Physician Decision|3|||
157071285|NCT01107899|567015322|FG000|Overall Study|Withdrawal by Subject|0|||
157071286|NCT01107899|567015323|FG001|Overall Study|Withdrawal by Subject|0|||
157071287|NCT01107899|567015324|FG002|Overall Study|Withdrawal by Subject|1|||
157071288|NCT03584152|567015325|FG000|Overall Study|Discontinued intervention|7|||
157071289|NCT03584152|567015326|FG001|Overall Study|Discontinued intervention|4|||
157071290|NCT04024462|567015327|FG000|Overall Study|Withdrawal by Subject|6|||
157071291|NCT04024462|567015328|FG001|Overall Study|Withdrawal by Subject|7|||
157071292|NCT04024462|567015327|FG000|Overall Study|Progressive Disease|0|||
157071293|NCT04024462|567015328|FG001|Overall Study|Progressive Disease|1|||
157071294|NCT04024462|567015327|FG000|Overall Study|Adverse Event|0|||
157071295|NCT04024462|567015328|FG001|Overall Study|Adverse Event|1|||
157071296|NCT04024462|567015327|FG000|Overall Study|Death|0|||
157071297|NCT04024462|567015328|FG001|Overall Study|Death|1|||
157071298|NCT04024462|567015327|FG000|Overall Study|Lost to Follow-up|1|||
157071299|NCT04024462|567015328|FG001|Overall Study|Lost to Follow-up|0|||
157071300|NCT04024462|567015327|FG000|Overall Study|Ongoing in the Study|94|||
157071301|NCT04024462|567015328|FG001|Overall Study|Ongoing in the Study|89|||
157071302|NCT05274750|567015332|FG000|Overall Study|Adverse Event|0|||
157071303|NCT05274750|567015333|FG001|Overall Study|Adverse Event|1|||
157071304|NCT05274750|567015332|FG000|Overall Study|Lost to Follow-up|2|||
157071305|NCT05274750|567015333|FG001|Overall Study|Lost to Follow-up|3|||
157071306|NCT05274750|567015332|FG000|Overall Study|Physician Decision|3|||
157071307|NCT05274750|567015333|FG001|Overall Study|Physician Decision|0|||
157071308|NCT05274750|567015332|FG000|Overall Study|Withdrawal by Subject|10|||
157071309|NCT05274750|567015333|FG001|Overall Study|Withdrawal by Subject|9|||
157071310|NCT05274750|567015332|FG000|Overall Study|GCP Violation|0|||
157071311|NCT05274750|567015333|FG001|Overall Study|GCP Violation|4|||
157071312|NCT05274750|567015332|FG000|Overall Study|Randomized, not treated|0|||
157071313|NCT05274750|567015333|FG001|Overall Study|Randomized, not treated|1|||
157071314|NCT01124097|567015334|FG000|Overall Study|Withdrawal by Subject|4|||
157071315|NCT01124097|567015335|FG001|Overall Study|Withdrawal by Subject|3|||
157071316|NCT01124097|567015336|FG002|Overall Study|Withdrawal by Subject|2|||
157071317|NCT01124097|567015337|FG003|Overall Study|Withdrawal by Subject|3|||
157071318|NCT01124097|567015334|FG000|Overall Study|Lack of Efficacy|2|||
157071319|NCT01124097|567015335|FG001|Overall Study|Lack of Efficacy|3|||
157071320|NCT01124097|567015336|FG002|Overall Study|Lack of Efficacy|1|||
157071321|NCT01124097|567015337|FG003|Overall Study|Lack of Efficacy|3|||
157071322|NCT01124097|567015334|FG000|Overall Study|Adverse Event|24|||
157071323|NCT01124097|567015335|FG001|Overall Study|Adverse Event|15|||
157071324|NCT01124097|567015336|FG002|Overall Study|Adverse Event|15|||
157071325|NCT01124097|567015337|FG003|Overall Study|Adverse Event|7|||
157071326|NCT01124097|567015334|FG000|Overall Study|Protocol Violation|2|||
157071327|NCT01124097|567015335|FG001|Overall Study|Protocol Violation|0|||
157071328|NCT01124097|567015336|FG002|Overall Study|Protocol Violation|2|||
157071329|NCT01124097|567015337|FG003|Overall Study|Protocol Violation|1|||
157071330|NCT01124097|567015334|FG000|Overall Study|Physician Decision|2|||
157071331|NCT01124097|567015335|FG001|Overall Study|Physician Decision|1|||
157071332|NCT01124097|567015336|FG002|Overall Study|Physician Decision|0|||
157071333|NCT01124097|567015337|FG003|Overall Study|Physician Decision|0|||
157071334|NCT05687032|567015338|FG000|Treatment Phase|Adverse Event|13|||
157071335|NCT05687032|567015338|FG000|Treatment Phase|Death|1|||
157071336|NCT05687032|567015338|FG000|Treatment Phase|Physician Decision|3|||
157071337|NCT05687032|567015338|FG000|Treatment Phase|Progressive disease|9|||
157071338|NCT05687032|567015338|FG000|Treatment Phase|Withdrawal by Subject|5|||
157071339|NCT05687032|567015338|FG000|Follow-Up Phase|Death|16|||
157071340|NCT05687032|567015338|FG000|Follow-Up Phase|Ongoing|26|||
157071341|NCT00079339|567015345|FG000|Overall Study|Adverse Event|1|||
157071342|NCT00079339|567015346|FG001|Overall Study|Adverse Event|7|||
157191711|NCT00795717|567440803|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
157191712|NCT00795717|567440802|FG000|Phase II|too busy|0|||
157191713|NCT00795717|567440803|FG001|Phase II|too busy|1|||
157071343|NCT00079339|567015347|FG002|Overall Study|Adverse Event|2|||
157191714|NCT04728815|567440806|FG000|Overall Study|Lost to Follow-up|3|||
157071344|NCT00079339|567015345|FG000|Overall Study|Death|1|||
157071345|NCT00079339|567015346|FG001|Overall Study|Death|0|||
157071346|NCT00079339|567015347|FG002|Overall Study|Death|0|||
157071347|NCT00079339|567015345|FG000|Overall Study|Non-compliance|0|||
157071348|NCT00079339|567015346|FG001|Overall Study|Non-compliance|0|||
157071349|NCT00079339|567015347|FG002|Overall Study|Non-compliance|1|||
157071350|NCT00079339|567015345|FG000|Overall Study|Withdrawal by Subject|0|||
157071351|NCT00079339|567015346|FG001|Overall Study|Withdrawal by Subject|4|||
157071352|NCT00079339|567015347|FG002|Overall Study|Withdrawal by Subject|1|||
157071353|NCT00079339|567015345|FG000|Overall Study|Disease progression|3|||
157071354|NCT00079339|567015346|FG001|Overall Study|Disease progression|28|||
157071355|NCT00079339|567015347|FG002|Overall Study|Disease progression|2|||
157071356|NCT01453023|567015352|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
157071357|NCT01453023|567015353|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
157230778|NCT01507051|567592389|FG000|Overall Study|Withdrawal by Subject|1|||
157230779|NCT01507051|567592390|FG001|Overall Study|Withdrawal by Subject|3|||
157230780|NCT01507051|567592391|FG002|Overall Study|Withdrawal by Subject|1|||
157230781|NCT01507051|567592392|FG003|Overall Study|Withdrawal by Subject|6|||
157230782|NCT01507051|567592389|FG000|Overall Study|Physician Decision|0|||
157230783|NCT01507051|567592390|FG001|Overall Study|Physician Decision|0|||
157230784|NCT01507051|567592391|FG002|Overall Study|Physician Decision|0|||
157230785|NCT01507051|567592392|FG003|Overall Study|Physician Decision|1|||
157230786|NCT01507051|567592389|FG000|Overall Study|Adverse Event|1|||
157230787|NCT01507051|567592390|FG001|Overall Study|Adverse Event|0|||
157230788|NCT01507051|567592391|FG002|Overall Study|Adverse Event|0|||
157230789|NCT01507051|567592392|FG003|Overall Study|Adverse Event|0|||
157230790|NCT01675622|567592393|FG000|Overall Study|Withdrawal by Subject|2|||
157230791|NCT01675622|567592394|FG001|Overall Study|Withdrawal by Subject|2|||
157230792|NCT01675622|567592393|FG000|Overall Study|Adverse Event|12|||
157230793|NCT01675622|567592394|FG001|Overall Study|Adverse Event|10|||
157230794|NCT01675622|567592393|FG000|Overall Study|Protocol Violation|4|||
157230795|NCT01675622|567592394|FG001|Overall Study|Protocol Violation|1|||
157230796|NCT01675622|567592393|FG000|Overall Study|Lack of Efficacy|2|||
157230797|NCT01675622|567592394|FG001|Overall Study|Lack of Efficacy|4|||
157230798|NCT01675622|567592393|FG000|Overall Study|Lost to Follow-up|1|||
157230799|NCT01675622|567592394|FG001|Overall Study|Lost to Follow-up|3|||
157230800|NCT01675622|567592393|FG000|Overall Study|Other|5|||
157230801|NCT01675622|567592394|FG001|Overall Study|Other|4|||
157230802|NCT02311361|567592395|FG000|Overall Study|Did not receive treatment|0|||
157230803|NCT02311361|567592396|FG001|Overall Study|Did not receive treatment|1|||
157230804|NCT02311361|567592397|FG002|Overall Study|Did not receive treatment|0|||
157230805|NCT02311361|567592398|FG003|Overall Study|Did not receive treatment|1|||
157230806|NCT05628675|567592399|FG000|Overall Study|Lost to Follow-up|2|||
157230807|NCT05628675|567592399|FG000|Overall Study|Withdrawal by Subject|1|||
157230808|NCT00365300|567592400|FG000|Open-label Phase|Adverse Event|4|||
157230809|NCT00365300|567592401|FG001|Open-label Phase|Adverse Event|0|||
157230810|NCT00365300|567592400|FG000|Open-label Phase|Failed to Return|1|||
157230811|NCT00365300|567592401|FG001|Open-label Phase|Failed to Return|0|||
157230812|NCT00365300|567592400|FG000|Open-label Phase|Physician Decision|1|||
157230813|NCT00365300|567592401|FG001|Open-label Phase|Physician Decision|0|||
157230814|NCT00365300|567592400|FG000|Open-label Phase|Noncompliance|9|||
157230815|NCT00365300|567592401|FG001|Open-label Phase|Noncompliance|0|||
157230816|NCT00365300|567592400|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
157230817|NCT00365300|567592401|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
157230818|NCT00365300|567592400|FG000|Open-label Phase|Protocol Violation|1|||
157230819|NCT00365300|567592401|FG001|Open-label Phase|Protocol Violation|0|||
157230820|NCT00365300|567592400|FG000|Open-label Phase|Lack of Efficacy|1|||
157230821|NCT00365300|567592401|FG001|Open-label Phase|Lack of Efficacy|0|||
157230822|NCT00365300|567592400|FG000|Open-label Phase|Patient skipped open label phase|1|||
157230823|NCT00365300|567592401|FG001|Open-label Phase|Patient skipped open label phase|0|||
157230824|NCT00365300|567592400|FG000|Double-blind Phase|Failed to return|1|||
157230825|NCT00365300|567592401|FG001|Double-blind Phase|Failed to return|0|||
157230826|NCT00365300|567592400|FG000|Double-blind Phase|Noncompliance|1|||
157230827|NCT00365300|567592401|FG001|Double-blind Phase|Noncompliance|1|||
157230828|NCT00365300|567592400|FG000|Double-blind Phase|Withdrawal by Subject|0|||
157230829|NCT00365300|567592401|FG001|Double-blind Phase|Withdrawal by Subject|1|||
157230830|NCT00365300|567592400|FG000|Double-blind Phase|Protocol Violation|3|||
157230831|NCT00365300|567592401|FG001|Double-blind Phase|Protocol Violation|1|||
157230832|NCT00365300|567592400|FG000|Double-blind Phase|Lack of Efficacy|6|||
157230833|NCT00365300|567592401|FG001|Double-blind Phase|Lack of Efficacy|6|||
157230834|NCT01991470|567592402|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
157230835|NCT01991470|567592402|FG000|Enlite 1 Period|Adverse Event|1|||
157230836|NCT01991470|567592402|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
157230837|NCT01991470|567592402|FG000|Enlite 3 Period|Lost to Follow-up|1|||
157230838|NCT01991470|567592402|FG000|Enlite 3 Period|Physician Decision|2|||
157230839|NCT01991470|567592402|FG000|Enlite 3 Period|Physician Decision|8|||
157230840|NCT01991470|567592402|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
157230841|NCT02896361|567592403|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
157230842|NCT02896361|567592404|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
157230843|NCT02896361|567592405|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
157230844|NCT02896361|567592403|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
157230845|NCT02896361|567592404|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
157230846|NCT02896361|567592405|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
157230847|NCT01029353|567592406|FG000|Overall Study|Lost to Follow-up|4|||
157230848|NCT01029353|567592407|FG001|Overall Study|Lost to Follow-up|5|||
157230849|NCT01029353|567592408|FG002|Overall Study|Lost to Follow-up|5|||
157230850|NCT01029353|567592409|FG003|Overall Study|Lost to Follow-up|4|||
157230851|NCT01029353|567592406|FG000|Overall Study|Consent Withdrawn|2|||
157230852|NCT01029353|567592407|FG001|Overall Study|Consent Withdrawn|0|||
157230853|NCT01029353|567592408|FG002|Overall Study|Consent Withdrawn|0|||
157230854|NCT01029353|567592409|FG003|Overall Study|Consent Withdrawn|0|||
157071358|NCT01453023|567015352|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
157071359|NCT01453023|567015353|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
157071360|NCT01453023|567015352|FG000|Treatment Period 2|Protocol Violation|0|||
157071361|NCT01453023|567015353|FG001|Treatment Period 2|Protocol Violation|1|||
157071362|NCT03721172|567015357|FG000|Placebo-controlled Phase|Adverse Event|7|||
157071363|NCT03721172|567015358|FG001|Placebo-controlled Phase|Adverse Event|7|||
157071364|NCT03721172|567015359|FG002|Placebo-controlled Phase|Adverse Event|0|||
157071365|NCT03721172|567015357|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
157071366|NCT03721172|567015358|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
157071367|NCT03721172|567015359|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
157071368|NCT03721172|567015357|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
157071369|NCT03721172|567015358|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
157071370|NCT03721172|567015359|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
157071371|NCT03721172|567015357|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
157071372|NCT03721172|567015358|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
157071373|NCT03721172|567015359|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
157071374|NCT03721172|567015357|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
157071375|NCT03721172|567015358|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
157071376|NCT03721172|567015359|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
157071377|NCT03721172|567015357|FG000|Placebo-controlled Phase|Other|3|||
157071378|NCT03721172|567015358|FG001|Placebo-controlled Phase|Other|0|||
157071379|NCT03721172|567015359|FG002|Placebo-controlled Phase|Other|0|||
157071380|NCT03721172|567015357|FG000|Apremilast Extension Phase|Adverse Event|0|||
157071381|NCT03721172|567015358|FG001|Apremilast Extension Phase|Adverse Event|0|||
157071382|NCT03721172|567015359|FG002|Apremilast Extension Phase|Adverse Event|10|||
157071383|NCT03721172|567015357|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
157071384|NCT03721172|567015358|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
157071385|NCT03721172|567015359|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
157071386|NCT03721172|567015357|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
157071387|NCT03721172|567015358|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
157071388|NCT03721172|567015359|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
157071389|NCT03721172|567015357|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
157071390|NCT03721172|567015358|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
157071391|NCT03721172|567015359|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
157071392|NCT03721172|567015357|FG000|Apremilast Extension Phase|Protocol Violation|0|||
157071393|NCT03721172|567015358|FG001|Apremilast Extension Phase|Protocol Violation|0|||
157071394|NCT03721172|567015359|FG002|Apremilast Extension Phase|Protocol Violation|1|||
157071395|NCT03721172|567015357|FG000|Apremilast Extension Phase|Physician Decision|0|||
157071396|NCT03721172|567015358|FG001|Apremilast Extension Phase|Physician Decision|0|||
157071397|NCT03721172|567015359|FG002|Apremilast Extension Phase|Physician Decision|1|||
157071398|NCT03721172|567015357|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
157071399|NCT03721172|567015358|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
157071400|NCT03721172|567015359|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
157071401|NCT03721172|567015357|FG000|Apremilast Extension Phase|Other|0|||
157071402|NCT03721172|567015358|FG001|Apremilast Extension Phase|Other|0|||
157071403|NCT03721172|567015359|FG002|Apremilast Extension Phase|Other|3|||
157071404|NCT03721172|567015357|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
157071405|NCT03721172|567015358|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
157071406|NCT03721172|567015359|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
157071407|NCT02417441|567015362|FG000|Overall Study|Inconclusive due to missing data|52|||
157071408|NCT02417441|567015363|FG001|Overall Study|Inconclusive due to missing data|19|||
157071409|NCT05628285|567015364|FG000|Overall Study|Lost to Follow-up|1|||
157071410|NCT02339506|567015365|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
157071411|NCT02339506|567015366|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
157071412|NCT02339506|567015365|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
157071413|NCT02339506|567015366|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
157071414|NCT02869867|567015369|FG000|Overall Study|Protocol Violation|1|||
157071415|NCT02869867|567015370|FG001|Overall Study|Protocol Violation|0|||
157071416|NCT02869867|567015369|FG000|Overall Study|Lost to Follow-up|5|||
157071417|NCT02869867|567015370|FG001|Overall Study|Lost to Follow-up|5|||
157071418|NCT05218499|567015371|FG000|Overall Study|Not treated|1|||
157071419|NCT05218499|567015372|FG001|Overall Study|Not treated|1|||
157071420|NCT05218499|567015373|FG002|Overall Study|Not treated|8|||
157071421|NCT05218499|567015371|FG000|Overall Study|Death|2|||
157071422|NCT05218499|567015372|FG001|Overall Study|Death|0|||
157071423|NCT05218499|567015373|FG002|Overall Study|Death|0|||
157191715|NCT04728815|567440807|FG001|Overall Study|Lost to Follow-up|0|||
157191716|NCT04728815|567440808|FG002|Overall Study|Lost to Follow-up|0|||
157191717|NCT04728815|567440809|FG003|Overall Study|Lost to Follow-up|1|||
157071424|NCT05218499|567015371|FG000|Overall Study|Other than listed|3|||
157071425|NCT05218499|567015372|FG001|Overall Study|Other than listed|7|||
157071426|NCT05218499|567015373|FG002|Overall Study|Other than listed|10|||
157071427|NCT05218499|567015371|FG000|Overall Study|Protocol deviation|5|||
157191718|NCT04728815|567440810|FG004|Overall Study|Lost to Follow-up|1|||
157230855|NCT01029353|567592406|FG000|Overall Study|Primary Outcome Indeterminate|1|||
157230856|NCT01029353|567592407|FG001|Overall Study|Primary Outcome Indeterminate|3|||
157230857|NCT01029353|567592408|FG002|Overall Study|Primary Outcome Indeterminate|2|||
157230858|NCT01029353|567592409|FG003|Overall Study|Primary Outcome Indeterminate|0|||
157230859|NCT00324168|567592410|FG000|Overall Study|Lost to Follow-up|19|||
157230860|NCT00324168|567592411|FG001|Overall Study|Lost to Follow-up|18|||
157230861|NCT00324168|567592410|FG000|Overall Study|Death|3|||
157230862|NCT00324168|567592411|FG001|Overall Study|Death|3|||
157230863|NCT00324168|567592410|FG000|Overall Study|Patient did not visit in f/u window|6|||
157230864|NCT00324168|567592411|FG001|Overall Study|Patient did not visit in f/u window|9|||
157230865|NCT01203878|567592412|FG000|Overall Study|Withdrawal by Subject|0|||
157230866|NCT01203878|567592413|FG001|Overall Study|Withdrawal by Subject|0|||
157230867|NCT01203878|567592414|FG002|Overall Study|Withdrawal by Subject|1|||
157230868|NCT01203878|567592412|FG000|Overall Study|Adverse Event|0|||
157230869|NCT01203878|567592413|FG001|Overall Study|Adverse Event|0|||
157230870|NCT01203878|567592414|FG002|Overall Study|Adverse Event|2|||
157230871|NCT01918397|567592416|FG000|Overall Study|Never started treatment|2|||
157230872|NCT01918397|567592417|FG001|Overall Study|Never started treatment|1|||
157230873|NCT01918397|567592418|FG002|Overall Study|Never started treatment|0|||
157230874|NCT01918397|567592419|FG003|Overall Study|Never started treatment|0|||
157230875|NCT01918397|567592416|FG000|Overall Study|Adverse Event|1|||
157230876|NCT01918397|567592417|FG001|Overall Study|Adverse Event|1|||
157230877|NCT01918397|567592418|FG002|Overall Study|Adverse Event|1|||
157230878|NCT01918397|567592419|FG003|Overall Study|Adverse Event|0|||
157230879|NCT01918397|567592416|FG000|Overall Study|Lack of compliance|2|||
157230880|NCT01918397|567592417|FG001|Overall Study|Lack of compliance|2|||
157230881|NCT01918397|567592418|FG002|Overall Study|Lack of compliance|3|||
157230882|NCT01918397|567592419|FG003|Overall Study|Lack of compliance|0|||
157230883|NCT01918397|567592416|FG000|Overall Study|Pregnancy|0|||
157230884|NCT01918397|567592417|FG001|Overall Study|Pregnancy|1|||
157230885|NCT01918397|567592418|FG002|Overall Study|Pregnancy|0|||
157230886|NCT01918397|567592419|FG003|Overall Study|Pregnancy|0|||
157230887|NCT01918397|567592416|FG000|Overall Study|Rifampin susceptible|0|||
157230888|NCT01918397|567592417|FG001|Overall Study|Rifampin susceptible|0|||
157230889|NCT01918397|567592418|FG002|Overall Study|Rifampin susceptible|0|||
157230890|NCT01918397|567592419|FG003|Overall Study|Rifampin susceptible|2|||
157230891|NCT01918397|567592416|FG000|Overall Study|Treatment failure|0|||
157071428|NCT05218499|567015372|FG001|Overall Study|Protocol deviation|6|||
157071429|NCT05218499|567015373|FG002|Overall Study|Protocol deviation|4|||
157071430|NCT05218499|567015371|FG000|Overall Study|Technical problems|0|||
157071431|NCT05218499|567015372|FG001|Overall Study|Technical problems|1|||
157071432|NCT05218499|567015373|FG002|Overall Study|Technical problems|0|||
157071433|NCT05218499|567015371|FG000|Overall Study|Burden of trial procedures|0|||
157071434|NCT05218499|567015372|FG001|Overall Study|Burden of trial procedures|1|||
157071435|NCT05218499|567015373|FG002|Overall Study|Burden of trial procedures|2|||
157071436|NCT05218499|567015371|FG000|Overall Study|Clinical disease progression|6|||
157071437|NCT05218499|567015372|FG001|Overall Study|Clinical disease progression|6|||
157071438|NCT05218499|567015373|FG002|Overall Study|Clinical disease progression|11|||
157071439|NCT05218499|567015371|FG000|Overall Study|Objective disease progression|44|||
157071440|NCT05218499|567015372|FG001|Overall Study|Objective disease progression|61|||
157071441|NCT05218499|567015373|FG002|Overall Study|Objective disease progression|42|||
157071442|NCT05218499|567015371|FG000|Overall Study|Adverse Event|11|||
157071443|NCT05218499|567015372|FG001|Overall Study|Adverse Event|36|||
157071444|NCT05218499|567015373|FG002|Overall Study|Adverse Event|9|||
157071445|NCT05218499|567015371|FG000|Overall Study|On treatment at time of snapshot|18|||
157071446|NCT05218499|567015372|FG001|Overall Study|On treatment at time of snapshot|29|||
157071447|NCT05218499|567015373|FG002|Overall Study|On treatment at time of snapshot|0|||
157071448|NCT05555615|567015378|FG000|Overall Study|Adverse Event|7|||
157071449|NCT05555615|567015378|FG000|Overall Study|Lack of Efficacy|12|||
157071450|NCT05555615|567015378|FG000|Overall Study|Lost to Follow-up|10|||
157071451|NCT05555615|567015378|FG000|Overall Study|Noncompliance with study drug|5|||
157071452|NCT05555615|567015378|FG000|Overall Study|Physician Decision|2|||
157071453|NCT05555615|567015378|FG000|Overall Study|Study terminated by sponsor|80|||
157071454|NCT05555615|567015378|FG000|Overall Study|Prohibited medication use|2|||
157230892|NCT01918397|567592417|FG001|Overall Study|Treatment failure|0|||
157230893|NCT01918397|567592418|FG002|Overall Study|Treatment failure|0|||
157230894|NCT01918397|567592419|FG003|Overall Study|Treatment failure|1|||
157230895|NCT01918397|567592416|FG000|Overall Study|Withdrawal by Subject|3|||
157230896|NCT01918397|567592417|FG001|Overall Study|Withdrawal by Subject|2|||
157230897|NCT01918397|567592418|FG002|Overall Study|Withdrawal by Subject|1|||
157230898|NCT01918397|567592419|FG003|Overall Study|Withdrawal by Subject|1|||
157230899|NCT01918397|567592416|FG000|Overall Study|XDR at baseline|0|||
157071455|NCT05555615|567015378|FG000|Overall Study|Withdrawal by Subject|20|||
157071456|NCT05555615|567015378|FG000|Overall Study|Not further specified|4|||
157071457|NCT03016598|567015379|FG000|Overall Study|Lost to Follow-up|0|||
157071458|NCT03016598|567015380|FG001|Overall Study|Lost to Follow-up|2|||
157071459|NCT01728623|567015384|FG000|Overall Study|Disease progression|26|||
157071460|NCT01728623|567015384|FG000|Overall Study|Adverse Event|1|||
157071461|NCT01728623|567015384|FG000|Overall Study|Withdrawal by Subject|1|||
157071462|NCT01667549|567015385|FG000|Overall Study|Withdrawal by Subject|3|||
157071463|NCT01667549|567015386|FG001|Overall Study|Withdrawal by Subject|5|||
157071464|NCT01667549|567015387|FG002|Overall Study|Withdrawal by Subject|7|||
157071465|NCT01667549|567015388|FG003|Overall Study|Withdrawal by Subject|6|||
157071466|NCT01667549|567015389|FG004|Overall Study|Withdrawal by Subject|1|||
157071467|NCT01407276|567015390|FG000|Overall Study|Withdrawal by Subject|0|||
157071468|NCT01407276|567015391|FG001|Overall Study|Withdrawal by Subject|0|||
157071469|NCT01407276|567015392|FG002|Overall Study|Withdrawal by Subject|0|||
157071470|NCT01407276|567015393|FG003|Overall Study|Withdrawal by Subject|0|||
157071471|NCT01407276|567015394|FG004|Overall Study|Withdrawal by Subject|0|||
157071472|NCT01407276|567015395|FG005|Overall Study|Withdrawal by Subject|0|||
157071473|NCT01407276|567015396|FG006|Overall Study|Withdrawal by Subject|0|||
157071474|NCT01407276|567015397|FG007|Overall Study|Withdrawal by Subject|1|||
157071475|NCT04092452|567015400|FG000|Overall Study|Adverse Event|1|||
157071476|NCT04092452|567015401|FG001|Overall Study|Adverse Event|3|||
157071477|NCT04092452|567015402|FG002|Overall Study|Adverse Event|3|||
157071478|NCT04092452|567015403|FG003|Overall Study|Adverse Event|7|||
157071479|NCT04092452|567015400|FG000|Overall Study|Lack of Efficacy|1|||
157071480|NCT04092452|567015401|FG001|Overall Study|Lack of Efficacy|1|||
157071481|NCT04092452|567015402|FG002|Overall Study|Lack of Efficacy|1|||
157071482|NCT04092452|567015403|FG003|Overall Study|Lack of Efficacy|0|||
157071483|NCT04092452|567015400|FG000|Overall Study|Lost to Follow-up|4|||
157071484|NCT04092452|567015401|FG001|Overall Study|Lost to Follow-up|3|||
157071485|NCT04092452|567015402|FG002|Overall Study|Lost to Follow-up|5|||
157071486|NCT04092452|567015403|FG003|Overall Study|Lost to Follow-up|1|||
157071487|NCT04092452|567015400|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157071488|NCT04092452|567015401|FG001|Overall Study|Non-Compliance With Study Drug|0|||
157071489|NCT04092452|567015402|FG002|Overall Study|Non-Compliance With Study Drug|1|||
157071490|NCT04092452|567015403|FG003|Overall Study|Non-Compliance With Study Drug|1|||
157071491|NCT04092452|567015400|FG000|Overall Study|Physician Decision|1|||
157071492|NCT04092452|567015401|FG001|Overall Study|Physician Decision|0|||
157071493|NCT04092452|567015402|FG002|Overall Study|Physician Decision|1|||
157071494|NCT04092452|567015403|FG003|Overall Study|Physician Decision|0|||
157071495|NCT04092452|567015400|FG000|Overall Study|Pregnancy|2|||
157071496|NCT04092452|567015401|FG001|Overall Study|Pregnancy|0|||
157071497|NCT04092452|567015402|FG002|Overall Study|Pregnancy|0|||
157071498|NCT04092452|567015403|FG003|Overall Study|Pregnancy|0|||
157071499|NCT04092452|567015400|FG000|Overall Study|Protocol Deviation|1|||
157071500|NCT04092452|567015401|FG001|Overall Study|Protocol Deviation|0|||
157071501|NCT04092452|567015402|FG002|Overall Study|Protocol Deviation|0|||
157071502|NCT04092452|567015403|FG003|Overall Study|Protocol Deviation|0|||
157071503|NCT04092452|567015400|FG000|Overall Study|Withdrawal by Subject|3|||
157071504|NCT04092452|567015401|FG001|Overall Study|Withdrawal by Subject|10|||
157071505|NCT04092452|567015402|FG002|Overall Study|Withdrawal by Subject|3|||
157071506|NCT04092452|567015403|FG003|Overall Study|Withdrawal by Subject|5|||
157071507|NCT04092452|567015400|FG000|Overall Study|Other|0|||
157071508|NCT04092452|567015401|FG001|Overall Study|Other|0|||
157071509|NCT04092452|567015402|FG002|Overall Study|Other|1|||
157071510|NCT04092452|567015403|FG003|Overall Study|Other|2|||
157191719|NCT04728815|567440811|FG005|Overall Study|Lost to Follow-up|0|||
157191720|NCT04728815|567440812|FG006|Overall Study|Lost to Follow-up|2|||
157191721|NCT04728815|567440813|FG007|Overall Study|Lost to Follow-up|0|||
157071511|NCT01791413|567015411|FG000|Overall Study|Lost to Follow-up|5|||
157071512|NCT01791413|567015412|FG001|Overall Study|Lost to Follow-up|1|||
157071513|NCT05594589|567015415|FG000|Overall Study|Other|0|||
157071514|NCT05594589|567015416|FG001|Overall Study|Other|1|||
157071515|NCT05594589|567015417|FG002|Overall Study|Other|0|||
157071516|NCT01536171|567015418|FG000|Overall Study|Withdrawal by Subject|1|||
157071517|NCT02201901|567015422|FG000|Overall Study|Randomized but never treated|0|||
157071518|NCT02201901|567015423|FG001|Overall Study|Randomized but never treated|1|||
157071519|NCT02201901|567015424|FG002|Overall Study|Randomized but never treated|0|||
157071520|NCT02201901|567015422|FG000|Overall Study|Lack of Efficacy|7|||
157071521|NCT02201901|567015423|FG001|Overall Study|Lack of Efficacy|1|||
157071522|NCT02201901|567015424|FG002|Overall Study|Lack of Efficacy|6|||
157071523|NCT02201901|567015422|FG000|Overall Study|Death|3|||
157071524|NCT02201901|567015423|FG001|Overall Study|Death|3|||
157071525|NCT02201901|567015424|FG002|Overall Study|Death|3|||
157071526|NCT02201901|567015422|FG000|Overall Study|Lost to Follow-up|2|||
157071527|NCT02201901|567015423|FG001|Overall Study|Lost to Follow-up|3|||
157071528|NCT02201901|567015424|FG002|Overall Study|Lost to Follow-up|2|||
157071529|NCT02201901|567015422|FG000|Overall Study|Withdrew Consent|2|||
157071530|NCT02201901|567015423|FG001|Overall Study|Withdrew Consent|0|||
157071531|NCT02201901|567015424|FG002|Overall Study|Withdrew Consent|2|||
157071532|NCT02201901|567015422|FG000|Overall Study|Adverse Event|1|||
157071533|NCT02201901|567015423|FG001|Overall Study|Adverse Event|1|||
157071534|NCT02201901|567015424|FG002|Overall Study|Adverse Event|0|||
157071535|NCT01431950|567015425|FG000|Overall Study|Study Site Closed/Terminated|7|||
157191722|NCT04728815|567440806|FG000|Overall Study|Physician Decision|0|||
157071536|NCT01431950|567015426|FG001|Overall Study|Study Site Closed/Terminated|3|||
157071537|NCT01431950|567015425|FG000|Overall Study|Withdrawal by Subject|4|||
157071538|NCT01431950|567015426|FG001|Overall Study|Withdrawal by Subject|3|||
157071539|NCT01431950|567015425|FG000|Overall Study|Protocol Violation|2|||
157071540|NCT01431950|567015426|FG001|Overall Study|Protocol Violation|3|||
157071541|NCT01431950|567015425|FG000|Overall Study|Adverse Event|2|||
157071542|NCT01431950|567015426|FG001|Overall Study|Adverse Event|2|||
157071543|NCT01431950|567015425|FG000|Overall Study|Physician Decision|2|||
157071544|NCT01431950|567015426|FG001|Overall Study|Physician Decision|1|||
157071545|NCT01431950|567015425|FG000|Overall Study|Lack of Efficacy|2|||
157071546|NCT01431950|567015426|FG001|Overall Study|Lack of Efficacy|1|||
157071547|NCT01431950|567015425|FG000|Overall Study|Lost to Follow-up|0|||
157071548|NCT01431950|567015426|FG001|Overall Study|Lost to Follow-up|1|||
157071549|NCT01431950|567015425|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
157071550|NCT01431950|567015426|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
157071551|NCT00738283|567015429|FG000|Overall Study|Death|1|||
157071552|NCT00738283|567015429|FG000|Overall Study|Transfer to another facility|2|||
157071553|NCT00738283|567015429|FG000|Overall Study|Discharge home prior to end of study|1|||
157071554|NCT01210651|567015430|FG000|Overall Study|Lost to Follow-up|1|||
157071555|NCT01210651|567015431|FG001|Overall Study|Lost to Follow-up|1|||
157071556|NCT01210651|567015430|FG000|Overall Study|schedule conflicts|1|||
157071557|NCT01210651|567015431|FG001|Overall Study|schedule conflicts|5|||
157071558|NCT01210651|567015430|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
157071559|NCT01210651|567015431|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
157071560|NCT01210651|567015430|FG000|Overall Study|Withdrawal by Subject|1|||
157071561|NCT01210651|567015431|FG001|Overall Study|Withdrawal by Subject|1|||
157071562|NCT01210651|567015430|FG000|Overall Study|Injury outside study|2|||
157071563|NCT01210651|567015431|FG001|Overall Study|Injury outside study|0|||
157071564|NCT03494985|567015432|FG000|Overall Study|Adverse Event|3|||
157071565|NCT03494985|567015433|FG001|Overall Study|Adverse Event|2|||
157071566|NCT03494985|567015434|FG002|Overall Study|Adverse Event|3|||
157071567|NCT03494985|567015435|FG003|Overall Study|Adverse Event|0|||
157071568|NCT03494985|567015432|FG000|Overall Study|Other (Withdrawal of consent)|2|||
157071569|NCT03494985|567015433|FG001|Overall Study|Other (Withdrawal of consent)|3|||
157071570|NCT03494985|567015434|FG002|Overall Study|Other (Withdrawal of consent)|2|||
157071571|NCT03494985|567015435|FG003|Overall Study|Other (Withdrawal of consent)|5|||
157071572|NCT03494985|567015432|FG000|Overall Study|Other (Not specified)|0|||
157071573|NCT03494985|567015433|FG001|Overall Study|Other (Not specified)|1|||
157071574|NCT03494985|567015434|FG002|Overall Study|Other (Not specified)|1|||
157071575|NCT03494985|567015435|FG003|Overall Study|Other (Not specified)|0|||
157071576|NCT04886518|567015436|FG000|Overall Study|Noncompliance with study drug|1|||
157071577|NCT04886518|567015437|FG001|Overall Study|Noncompliance with study drug|0|||
157071578|NCT04886518|567015438|FG002|Overall Study|Noncompliance with study drug|0|||
157071579|NCT04886518|567015436|FG000|Overall Study|Adverse Event|0|||
157071580|NCT04886518|567015437|FG001|Overall Study|Adverse Event|1|||
157071581|NCT04886518|567015438|FG002|Overall Study|Adverse Event|0|||
157071582|NCT04886518|567015436|FG000|Overall Study|Withdrawal by Subject|1|||
157071583|NCT04886518|567015437|FG001|Overall Study|Withdrawal by Subject|0|||
157071584|NCT04886518|567015438|FG002|Overall Study|Withdrawal by Subject|0|||
157071585|NCT04441905|567017704|FG000|Overall Study|Lost to Follow-up|1|||
157071586|NCT04441905|567017705|FG001|Overall Study|Lost to Follow-up|0|||
157071587|NCT04441905|567017706|FG002|Overall Study|Lost to Follow-up|0|||
157071588|NCT04441905|567017707|FG003|Overall Study|Lost to Follow-up|0|||
157071589|NCT04441905|567017708|FG004|Overall Study|Lost to Follow-up|0|||
157071590|NCT04441905|567017709|FG005|Overall Study|Lost to Follow-up|0|||
157071591|NCT04441905|567017704|FG000|Overall Study|Enrolled but treatment not administered|0|||
157071592|NCT04441905|567017705|FG001|Overall Study|Enrolled but treatment not administered|1|||
157071593|NCT04441905|567017706|FG002|Overall Study|Enrolled but treatment not administered|0|||
157071594|NCT04441905|567017707|FG003|Overall Study|Enrolled but treatment not administered|0|||
157071595|NCT04441905|567017708|FG004|Overall Study|Enrolled but treatment not administered|0|||
157071596|NCT04441905|567017709|FG005|Overall Study|Enrolled but treatment not administered|0|||
157230900|NCT01918397|567592417|FG001|Overall Study|XDR at baseline|0|||
157071597|NCT04441905|567017704|FG000|Overall Study|Became ineligible after enrollment|0|||
157071598|NCT04441905|567017705|FG001|Overall Study|Became ineligible after enrollment|0|||
157071599|NCT04441905|567017706|FG002|Overall Study|Became ineligible after enrollment|0|||
157071600|NCT04441905|567017707|FG003|Overall Study|Became ineligible after enrollment|0|||
157071601|NCT04441905|567017708|FG004|Overall Study|Became ineligible after enrollment|1|||
157071602|NCT04441905|567017709|FG005|Overall Study|Became ineligible after enrollment|0|||
157071603|NCT00127842|567017710|FG000|Overall Study|Adverse Event|15|||
157071604|NCT00127842|567017710|FG000|Overall Study|Withdrawal by Subject|3|||
157071605|NCT00127842|567017710|FG000|Overall Study|Lost to Follow-up|1|||
157071606|NCT00127842|567017710|FG000|Overall Study|Lack of Efficacy|12|||
157071607|NCT00127842|567017710|FG000|Overall Study|Noncompliance|2|||
157071608|NCT00127842|567017710|FG000|Overall Study|Protocol Violation|1|||
157071609|NCT00127842|567017710|FG000|Overall Study|Other|5|||
157071610|NCT01385748|567017711|FG000|Overall Study|Withdrawal by Subject|7|||
157071611|NCT01385748|567017712|FG001|Overall Study|Withdrawal by Subject|4|||
157071612|NCT01385748|567017713|FG002|Overall Study|Withdrawal by Subject|5|||
157071613|NCT01385748|567017711|FG000|Overall Study|Noncompliance|3|||
157071614|NCT01385748|567017712|FG001|Overall Study|Noncompliance|1|||
157071615|NCT01385748|567017713|FG002|Overall Study|Noncompliance|6|||
157071616|NCT01385748|567017711|FG000|Overall Study|Other|1|||
157071617|NCT01385748|567017712|FG001|Overall Study|Other|7|||
157071618|NCT01385748|567017713|FG002|Overall Study|Other|1|||
157071619|NCT01385748|567017711|FG000|Overall Study|Adverse Event|4|||
157071620|NCT01385748|567017712|FG001|Overall Study|Adverse Event|2|||
157071621|NCT01385748|567017713|FG002|Overall Study|Adverse Event|1|||
157071622|NCT01443403|567017714|FG000|Overall Study|Adverse Event|1|||
157071623|NCT01443403|567017715|FG001|Overall Study|Adverse Event|1|||
157071624|NCT01443403|567017716|FG002|Overall Study|Adverse Event|4|||
157071625|NCT01443403|567017717|FG003|Overall Study|Adverse Event|5|||
157071626|NCT01443403|567017714|FG000|Overall Study|Withdrawal by Subject|0|||
157071627|NCT01443403|567017715|FG001|Overall Study|Withdrawal by Subject|1|||
157071628|NCT01443403|567017716|FG002|Overall Study|Withdrawal by Subject|2|||
157071629|NCT01443403|567017717|FG003|Overall Study|Withdrawal by Subject|1|||
157071630|NCT01443403|567017714|FG000|Overall Study|Lost to Follow-up|0|||
157071631|NCT01443403|567017715|FG001|Overall Study|Lost to Follow-up|0|||
157071632|NCT01443403|567017716|FG002|Overall Study|Lost to Follow-up|0|||
157071633|NCT01443403|567017717|FG003|Overall Study|Lost to Follow-up|1|||
157071634|NCT01443403|567017714|FG000|Overall Study|Protocol Violation|2|||
157071635|NCT01443403|567017715|FG001|Overall Study|Protocol Violation|1|||
157071636|NCT01443403|567017716|FG002|Overall Study|Protocol Violation|1|||
157071637|NCT01443403|567017717|FG003|Overall Study|Protocol Violation|1|||
157071638|NCT01443403|567017714|FG000|Overall Study|Use of Prohibited Treatment|2|||
157071639|NCT01443403|567017715|FG001|Overall Study|Use of Prohibited Treatment|3|||
157071640|NCT01443403|567017716|FG002|Overall Study|Use of Prohibited Treatment|0|||
157071641|NCT01443403|567017717|FG003|Overall Study|Use of Prohibited Treatment|0|||
157071642|NCT01443403|567017714|FG000|Overall Study|Other - Miscellaneous|1|||
157071643|NCT01443403|567017715|FG001|Overall Study|Other - Miscellaneous|0|||
157071644|NCT01443403|567017716|FG002|Overall Study|Other - Miscellaneous|0|||
157071645|NCT01443403|567017717|FG003|Overall Study|Other - Miscellaneous|1|||
157071646|NCT02562235|567017718|FG000|Overall Study|Adverse Event|3|||
157071647|NCT01200342|567017719|FG000|Overall Study|Disease Progression|1|||
157071648|NCT03258723|567017724|FG000|Overall Study|COVID Interruption of study|54|||
157071649|NCT03258723|567017724|FG000|Overall Study|Lost to Follow-up|8|||
157071650|NCT04832971|567017725|FG000|Double-Blind (DB) Treatment Period|Death|1|||
157071651|NCT04832971|567017726|FG001|Double-Blind (DB) Treatment Period|Death|0|||
157071652|NCT04832971|567017727|FG002|Double-Blind (DB) Treatment Period|Death|0|||
157071653|NCT04832971|567017728|FG003|Double-Blind (DB) Treatment Period|Death|0|||
157071654|NCT04832971|567017729|FG004|Double-Blind (DB) Treatment Period|Death|0|||
157071655|NCT04832971|567017730|FG005|Double-Blind (DB) Treatment Period|Death|0|||
157071656|NCT04832971|567017731|FG006|Double-Blind (DB) Treatment Period|Death|0|||
157071657|NCT04832971|567017732|FG007|Double-Blind (DB) Treatment Period|Death|0|||
157071658|NCT04832971|567017733|FG008|Double-Blind (DB) Treatment Period|Death|0|||
157071659|NCT04832971|567017734|FG009|Double-Blind (DB) Treatment Period|Death|0|||
157071660|NCT04832971|567017725|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157071661|NCT04832971|567017726|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157071662|NCT04832971|567017727|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157071663|NCT04832971|567017728|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071664|NCT04832971|567017729|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071665|NCT04832971|567017730|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071666|NCT04832971|567017731|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071667|NCT04832971|567017732|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071668|NCT04832971|567017733|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071669|NCT04832971|567017734|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157071670|NCT04832971|567017725|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
157071671|NCT04832971|567017726|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
157071672|NCT04832971|567017727|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
157071673|NCT04832971|567017728|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
157071674|NCT04832971|567017729|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071675|NCT04832971|567017730|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071676|NCT04832971|567017731|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071677|NCT04832971|567017732|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071678|NCT04832971|567017733|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071679|NCT04832971|567017734|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157071680|NCT04832971|567017725|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071681|NCT04832971|567017726|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
157071682|NCT04832971|567017727|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071683|NCT04832971|567017728|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071684|NCT04832971|567017729|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071685|NCT04832971|567017730|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071686|NCT04832971|567017731|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071687|NCT04832971|567017732|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071688|NCT04832971|567017733|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071689|NCT04832971|567017734|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
157071690|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071691|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071692|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071693|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071694|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071695|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
157071696|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
157071697|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
157071698|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
157071699|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
157071700|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Death|0|||
157071701|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Death|0|||
157071702|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Death|0|||
157071703|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Death|0|||
157071704|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Death|0|||
157071705|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Death|0|||
157071706|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Death|0|||
157071707|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Death|1|||
157071708|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Death|0|||
157071709|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Death|0|||
157071710|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071711|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071712|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071713|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071714|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071715|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071716|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
157071717|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
157071718|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071719|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
157071720|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
157071721|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
157071722|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
157071723|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
157071724|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
157071725|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
157071726|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
157071727|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
157071728|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
157071729|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
157071730|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157071731|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157071732|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157071733|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157071734|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
157071735|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
157071736|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157071737|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
157071738|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
157071739|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
157071740|NCT04832971|567017725|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071741|NCT04832971|567017726|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071742|NCT04832971|567017727|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071743|NCT04832971|567017728|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071744|NCT04832971|567017729|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071745|NCT04832971|567017730|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071746|NCT04832971|567017731|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
157071747|NCT04832971|567017732|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
157071748|NCT04832971|567017733|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
157071749|NCT04832971|567017734|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
157071750|NCT00433511|567017739|FG000|Step 1|Adverse Event|50|||
157071751|NCT00433511|567017740|FG001|Step 1|Adverse Event|157|||
157071752|NCT00433511|567017741|FG002|Step 1|Adverse Event|153|||
157071753|NCT00433511|567017739|FG000|Step 1|Withdrawal by Subject|45|||
157071754|NCT00433511|567017740|FG001|Step 1|Withdrawal by Subject|143|||
157071755|NCT00433511|567017741|FG002|Step 1|Withdrawal by Subject|154|||
157071756|NCT00433511|567017739|FG000|Step 1|Death|3|||
157071757|NCT00433511|567017740|FG001|Step 1|Death|1|||
157071758|NCT00433511|567017741|FG002|Step 1|Death|1|||
157071759|NCT00433511|567017739|FG000|Step 1|Physician Decision|1|||
157071760|NCT00433511|567017740|FG001|Step 1|Physician Decision|4|||
157071761|NCT00433511|567017741|FG002|Step 1|Physician Decision|3|||
157071762|NCT00433511|567017739|FG000|Step 1|Never started protocol therapy|28|||
157071763|NCT00433511|567017740|FG001|Step 1|Never started protocol therapy|64|||
157071764|NCT00433511|567017741|FG002|Step 1|Never started protocol therapy|66|||
157071765|NCT00433511|567017739|FG000|Step 1|Alternative therapy|2|||
157071766|NCT00433511|567017740|FG001|Step 1|Alternative therapy|1|||
157071767|NCT00433511|567017741|FG002|Step 1|Alternative therapy|3|||
157071768|NCT00433511|567017739|FG000|Step 1|Disease progression, relapse|5|||
157071769|NCT00433511|567017740|FG001|Step 1|Disease progression, relapse|3|||
157071770|NCT00433511|567017741|FG002|Step 1|Disease progression, relapse|3|||
157071771|NCT00433511|567017739|FG000|Step 1|Other complicating disease|2|||
157071772|NCT00433511|567017740|FG001|Step 1|Other complicating disease|6|||
157071773|NCT00433511|567017741|FG002|Step 1|Other complicating disease|3|||
157071774|NCT00433511|567017739|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
157071775|NCT00433511|567017740|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
157071776|NCT00433511|567017741|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
157071777|NCT00433511|567017739|FG000|Step 1|Suspected recurrence|0|||
157071778|NCT00433511|567017740|FG001|Step 1|Suspected recurrence|1|||
157071779|NCT00433511|567017741|FG002|Step 1|Suspected recurrence|0|||
157071780|NCT00433511|567017739|FG000|Step 1|Insurance/drug distribution issues|0|||
157071781|NCT00433511|567017740|FG001|Step 1|Insurance/drug distribution issues|1|||
157071782|NCT00433511|567017741|FG002|Step 1|Insurance/drug distribution issues|2|||
157071783|NCT00433511|567017739|FG000|Step 1|Patient moved|0|||
157071784|NCT00433511|567017740|FG001|Step 1|Patient moved|0|||
157071785|NCT00433511|567017741|FG002|Step 1|Patient moved|1|||
157071786|NCT00433511|567017739|FG000|Step 2 (Arm D)|Adverse Event|0|||
157071787|NCT00433511|567017740|FG001|Step 2 (Arm D)|Adverse Event|0|||
157071788|NCT00433511|567017741|FG002|Step 2 (Arm D)|Adverse Event|135|||
157071789|NCT00433511|567017739|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
157071790|NCT00433511|567017740|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
157071791|NCT00433511|567017741|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
157071792|NCT00433511|567017739|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
157071793|NCT00433511|567017740|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
157071794|NCT00433511|567017741|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
157071795|NCT00433511|567017739|FG000|Step 2 (Arm D)|Physician Decision|0|||
157071796|NCT00433511|567017740|FG001|Step 2 (Arm D)|Physician Decision|0|||
157071797|NCT00433511|567017741|FG002|Step 2 (Arm D)|Physician Decision|9|||
157071798|NCT00433511|567017739|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
157071799|NCT00433511|567017740|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
157071800|NCT00433511|567017741|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
157071801|NCT00433511|567017739|FG000|Step 2 (Arm D)|Other complicating disease|0|||
157071802|NCT00433511|567017740|FG001|Step 2 (Arm D)|Other complicating disease|0|||
157071803|NCT00433511|567017741|FG002|Step 2 (Arm D)|Other complicating disease|3|||
157071804|NCT00433511|567017739|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
157071805|NCT00433511|567017740|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
157071806|NCT00433511|567017741|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
157071807|NCT00433511|567017739|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
157230901|NCT01918397|567592418|FG002|Overall Study|XDR at baseline|1|||
157230902|NCT01918397|567592419|FG003|Overall Study|XDR at baseline|0|||
157230903|NCT01918397|567592416|FG000|Overall Study|Lost to Follow-up|2|||
157230904|NCT01918397|567592417|FG001|Overall Study|Lost to Follow-up|1|||
157230905|NCT01918397|567592418|FG002|Overall Study|Lost to Follow-up|1|||
157230906|NCT01918397|567592419|FG003|Overall Study|Lost to Follow-up|1|||
157071808|NCT00433511|567017740|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
157071809|NCT00433511|567017741|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
157230907|NCT01918397|567592416|FG000|Overall Study|Increased QTc|1|||
157230908|NCT01918397|567592417|FG001|Overall Study|Increased QTc|0|||
157071810|NCT00433511|567017739|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
157071811|NCT00433511|567017740|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
157071812|NCT00433511|567017741|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
157071813|NCT00433511|567017739|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
157071814|NCT00433511|567017740|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
157071815|NCT00433511|567017741|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
157071816|NCT00983749|567017742|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
157071817|NCT00983749|567017743|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
157071818|NCT04292470|567017744|FG000|Overall Study|Withdrawal by Subject|0|||
157230909|NCT01918397|567592418|FG002|Overall Study|Increased QTc|0|||
157071819|NCT04292470|567017745|FG001|Overall Study|Withdrawal by Subject|1|||
157071820|NCT02906020|567017763|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
157071821|NCT02906020|567017764|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
157071822|NCT02906020|567017765|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
157071823|NCT02906020|567017766|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
157071824|NCT02906020|567017767|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
157071825|NCT02906020|567017768|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
157071826|NCT02906020|567017769|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
157071827|NCT02906020|567017770|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
157071828|NCT02906020|567017771|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
157071829|NCT02906020|567017772|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
157071830|NCT02906020|567017773|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
157071831|NCT02906020|567017774|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
157071832|NCT02906020|567017775|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
157071833|NCT02906020|567017776|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
157071834|NCT02906020|567017777|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
157071835|NCT02906020|567017778|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
157071836|NCT02906020|567017763|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071837|NCT02906020|567017764|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071838|NCT02906020|567017765|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071839|NCT02906020|567017766|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071840|NCT02906020|567017767|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071841|NCT02906020|567017768|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071842|NCT02906020|567017769|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071843|NCT02906020|567017770|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071844|NCT02906020|567017771|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
157071845|NCT02906020|567017772|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
157071846|NCT02906020|567017773|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071847|NCT02906020|567017774|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071848|NCT02906020|567017775|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071849|NCT02906020|567017776|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071850|NCT02906020|567017777|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071851|NCT02906020|567017778|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
157071852|NCT02906020|567017763|FG000|Part 2: Double-blind Treatment Period|Other|0|||
157071853|NCT02906020|567017764|FG001|Part 2: Double-blind Treatment Period|Other|0|||
157071854|NCT02906020|567017765|FG002|Part 2: Double-blind Treatment Period|Other|0|||
157071855|NCT02906020|567017766|FG003|Part 2: Double-blind Treatment Period|Other|0|||
157071856|NCT02906020|567017767|FG004|Part 2: Double-blind Treatment Period|Other|0|||
157071857|NCT02906020|567017768|FG005|Part 2: Double-blind Treatment Period|Other|0|||
157071858|NCT02906020|567017769|FG006|Part 2: Double-blind Treatment Period|Other|0|||
157071859|NCT02906020|567017770|FG007|Part 2: Double-blind Treatment Period|Other|0|||
157071860|NCT02906020|567017771|FG008|Part 2: Double-blind Treatment Period|Other|6|||
157071861|NCT02906020|567017772|FG009|Part 2: Double-blind Treatment Period|Other|10|||
157071862|NCT02906020|567017773|FG010|Part 2: Double-blind Treatment Period|Other|0|||
157071863|NCT02906020|567017774|FG011|Part 2: Double-blind Treatment Period|Other|0|||
157071864|NCT02906020|567017775|FG012|Part 2: Double-blind Treatment Period|Other|0|||
157071865|NCT02906020|567017776|FG013|Part 2: Double-blind Treatment Period|Other|0|||
157071866|NCT02906020|567017777|FG014|Part 2: Double-blind Treatment Period|Other|0|||
157071867|NCT02906020|567017778|FG015|Part 2: Double-blind Treatment Period|Other|0|||
157071868|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071869|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071870|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157191723|NCT04728815|567440807|FG001|Overall Study|Physician Decision|0|||
157191724|NCT04728815|567440808|FG002|Overall Study|Physician Decision|1|||
157191725|NCT04728815|567440809|FG003|Overall Study|Physician Decision|0|||
157191726|NCT04728815|567440810|FG004|Overall Study|Physician Decision|0|||
157191727|NCT04728815|567440811|FG005|Overall Study|Physician Decision|0|||
157191728|NCT04728815|567440812|FG006|Overall Study|Physician Decision|0|||
157191729|NCT04728815|567440813|FG007|Overall Study|Physician Decision|0|||
157191730|NCT04728815|567440806|FG000|Overall Study|Treatment drop|0|||
157191731|NCT04728815|567440807|FG001|Overall Study|Treatment drop|2|||
157191732|NCT04728815|567440808|FG002|Overall Study|Treatment drop|1|||
157191733|NCT04728815|567440809|FG003|Overall Study|Treatment drop|0|||
157230910|NCT01918397|567592419|FG003|Overall Study|Increased QTc|1|||
157071871|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071872|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071873|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071874|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157191734|NCT04728815|567440810|FG004|Overall Study|Treatment drop|3|||
157191735|NCT04728815|567440811|FG005|Overall Study|Treatment drop|1|||
157230911|NCT01918397|567592416|FG000|Overall Study|Death|0|||
157071875|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071876|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071877|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071878|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071879|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071880|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
157071881|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
157071882|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071883|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
157071884|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071885|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071886|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071887|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071888|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071889|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071890|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071891|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071892|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071893|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071894|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071895|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071896|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
157071897|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
157071898|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
157071899|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
157071900|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071901|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071902|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071903|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071904|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071905|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071906|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071907|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071908|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071909|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071910|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071911|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071912|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
157071913|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
157071914|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071915|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
157071916|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071917|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071918|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071919|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071920|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071921|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071922|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071923|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071924|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071925|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071926|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071927|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071928|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
157071929|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
157071930|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071931|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
157071932|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071933|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071934|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071935|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157191736|NCT04728815|567440812|FG006|Overall Study|Treatment drop|3|||
157191737|NCT04728815|567440813|FG007|Overall Study|Treatment drop|0|||
157191738|NCT04728815|567440806|FG000|Overall Study|Study drop|0|||
157191739|NCT04728815|567440807|FG001|Overall Study|Study drop|3|||
157191740|NCT04728815|567440808|FG002|Overall Study|Study drop|3|||
157071936|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071937|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071938|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071939|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071940|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071941|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071942|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071943|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
157071944|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
157071945|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
157071946|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
157071947|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
157071948|NCT02906020|567017763|FG000|Part 2: Long-term Follow-up Period|Other|0|||
157071949|NCT02906020|567017764|FG001|Part 2: Long-term Follow-up Period|Other|0|||
157071950|NCT02906020|567017765|FG002|Part 2: Long-term Follow-up Period|Other|0|||
157071951|NCT02906020|567017766|FG003|Part 2: Long-term Follow-up Period|Other|0|||
157071952|NCT02906020|567017767|FG004|Part 2: Long-term Follow-up Period|Other|0|||
157071953|NCT02906020|567017768|FG005|Part 2: Long-term Follow-up Period|Other|0|||
157071954|NCT02906020|567017769|FG006|Part 2: Long-term Follow-up Period|Other|0|||
157071955|NCT02906020|567017770|FG007|Part 2: Long-term Follow-up Period|Other|0|||
157071956|NCT02906020|567017771|FG008|Part 2: Long-term Follow-up Period|Other|0|||
157071957|NCT02906020|567017772|FG009|Part 2: Long-term Follow-up Period|Other|0|||
157071958|NCT02906020|567017773|FG010|Part 2: Long-term Follow-up Period|Other|0|||
157071959|NCT02906020|567017774|FG011|Part 2: Long-term Follow-up Period|Other|0|||
157071960|NCT02906020|567017775|FG012|Part 2: Long-term Follow-up Period|Other|13|||
157071961|NCT02906020|567017776|FG013|Part 2: Long-term Follow-up Period|Other|8|||
157071962|NCT02906020|567017777|FG014|Part 2: Long-term Follow-up Period|Other|3|||
157071963|NCT02906020|567017778|FG015|Part 2: Long-term Follow-up Period|Other|2|||
157071964|NCT01375673|567017784|FG000|Overall Study|Withdrawal by Subject|0|||
157071965|NCT01375673|567017785|FG001|Overall Study|Withdrawal by Subject|1|||
157071966|NCT04328623|567017790|FG000|Overall Study|Protocol Violation|0|||
157071967|NCT04328623|567017791|FG001|Overall Study|Protocol Violation|1|||
157071968|NCT04340947|567017792|FG000|7-day Washout Period|Lost to Follow-up|5|||
157071969|NCT04340947|567017793|FG001|7-day Washout Period|Lost to Follow-up|4|||
157071970|NCT04698915|567017794|FG000|Overall Study|Adverse Event|2|||
157071971|NCT04698915|567017795|FG001|Overall Study|Adverse Event|0|||
157071972|NCT04698915|567017794|FG000|Overall Study|Death|23|||
157071973|NCT04698915|567017795|FG001|Overall Study|Death|20|||
157071974|NCT04698915|567017794|FG000|Overall Study|Physician Decision|1|||
157071975|NCT04698915|567017795|FG001|Overall Study|Physician Decision|1|||
157071976|NCT04698915|567017794|FG000|Overall Study|Lost to Follow-up|1|||
157071977|NCT04698915|567017795|FG001|Overall Study|Lost to Follow-up|0|||
157071978|NCT04698915|567017794|FG000|Overall Study|Study Terminated by Sponsor|55|||
157071979|NCT04698915|567017795|FG001|Overall Study|Study Terminated by Sponsor|60|||
157071980|NCT04698915|567017794|FG000|Overall Study|Withdrawal by Subject|2|||
157071981|NCT04698915|567017795|FG001|Overall Study|Withdrawal by Subject|3|||
157071982|NCT01907906|567017796|FG000|Overall Study|Withdrawal by Subject|1|||
157071983|NCT01907906|567017797|FG001|Overall Study|Withdrawal by Subject|0|||
157071984|NCT01907906|567017796|FG000|Overall Study|Physician Decision|3|||
157071985|NCT01907906|567017797|FG001|Overall Study|Physician Decision|1|||
157071986|NCT02312557|567017798|FG000|Overall Study|Survival follow-up|4|||
157071987|NCT00979953|567017799|FG000|Overall Study|Adverse Event|5|||
157071988|NCT00979953|567017800|FG001|Overall Study|Adverse Event|2|||
157191741|NCT04728815|567440809|FG003|Overall Study|Study drop|0|||
157191742|NCT04728815|567440810|FG004|Overall Study|Study drop|0|||
157191743|NCT04728815|567440811|FG005|Overall Study|Study drop|0|||
157191744|NCT04728815|567440812|FG006|Overall Study|Study drop|7|||
157191745|NCT04728815|567440813|FG007|Overall Study|Study drop|0|||
157191746|NCT00957034|567440814|FG000|Overall Study|Adverse Event|0|||
157071989|NCT00979953|567017801|FG002|Overall Study|Adverse Event|17|||
157071990|NCT00979953|567017802|FG003|Overall Study|Adverse Event|4|||
157071991|NCT00979953|567017799|FG000|Overall Study|Lack of Efficacy|1|||
157071992|NCT00979953|567017800|FG001|Overall Study|Lack of Efficacy|2|||
157071993|NCT00979953|567017801|FG002|Overall Study|Lack of Efficacy|0|||
157071994|NCT00979953|567017802|FG003|Overall Study|Lack of Efficacy|0|||
157071995|NCT00979953|567017799|FG000|Overall Study|Lost to Follow-up|1|||
157191747|NCT00957034|567440815|FG001|Overall Study|Adverse Event|1|||
157191748|NCT00957034|567440816|FG002|Overall Study|Adverse Event|1|||
157071996|NCT00979953|567017800|FG001|Overall Study|Lost to Follow-up|1|||
157071997|NCT00979953|567017801|FG002|Overall Study|Lost to Follow-up|1|||
157071998|NCT00979953|567017802|FG003|Overall Study|Lost to Follow-up|0|||
157071999|NCT00979953|567017799|FG000|Overall Study|Withdrawal by Subject|0|||
157072000|NCT00979953|567017800|FG001|Overall Study|Withdrawal by Subject|0|||
157072001|NCT00979953|567017801|FG002|Overall Study|Withdrawal by Subject|2|||
157191749|NCT00957034|567440814|FG000|Overall Study|Sponsor Terminated Study|6|||
157230912|NCT01918397|567592417|FG001|Overall Study|Death|0|||
157072002|NCT00979953|567017802|FG003|Overall Study|Withdrawal by Subject|1|||
157072003|NCT00979953|567017799|FG000|Overall Study|Protocol Violation|1|||
157072004|NCT00979953|567017800|FG001|Overall Study|Protocol Violation|0|||
157072005|NCT00979953|567017801|FG002|Overall Study|Protocol Violation|2|||
157072006|NCT00979953|567017802|FG003|Overall Study|Protocol Violation|2|||
157072007|NCT04829747|567017808|FG000|Overall Study|Protocol Violation|1|||
157072008|NCT02367352|567017811|FG000|Overall Study|Progressive disease|7|||
157072009|NCT02367352|567017812|FG001|Overall Study|Progressive disease|0|||
157072010|NCT02367352|567017813|FG002|Overall Study|Progressive disease|0|||
157072011|NCT02367352|567017811|FG000|Overall Study|Participant Received Alternative Therapy|1|||
157072012|NCT02367352|567017812|FG001|Overall Study|Participant Received Alternative Therapy|0|||
157072013|NCT02367352|567017813|FG002|Overall Study|Participant Received Alternative Therapy|0|||
157072014|NCT02367352|567017811|FG000|Overall Study|Adverse Event|1|||
157072015|NCT02367352|567017812|FG001|Overall Study|Adverse Event|0|||
157072016|NCT02367352|567017813|FG002|Overall Study|Adverse Event|0|||
157072017|NCT05878873|567017814|FG000|Overall Study|Lost to Follow-up|2|||
157072018|NCT05878873|567017815|FG001|Overall Study|Lost to Follow-up|0|||
157072019|NCT02375347|567017822|FG000|Overall Study|Protocol Violation|1|||
157072020|NCT00193479|567017823|FG000|Induction Chemotherapy|Adverse Event|2|||
157072021|NCT00193479|567017823|FG000|Induction Chemotherapy|Disease Progression|1|||
157072022|NCT00193479|567017823|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
157072023|NCT00193479|567017823|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
157072024|NCT00425607|567017824|FG000|Overall Study|Death|1|||
157072025|NCT00425607|567017824|FG000|Overall Study|Withdrawal by Subject|1|||
157072026|NCT00559377|567017825|FG000|Overall Study|Withdrawal by Subject|9|||
157072027|NCT02563548|567017826|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
157072028|NCT02563548|567017827|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
157072029|NCT02563548|567017828|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
157072030|NCT02563548|567017829|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
157072031|NCT02563548|567017830|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
157072032|NCT02563548|567017831|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
157072033|NCT02563548|567017826|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
157072034|NCT02563548|567017827|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
157072035|NCT02563548|567017828|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
157072036|NCT02563548|567017829|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
157072037|NCT02563548|567017830|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
157072038|NCT02563548|567017831|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
157072039|NCT02563548|567017826|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
157072040|NCT02563548|567017827|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
157072041|NCT02563548|567017828|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
157072042|NCT02563548|567017829|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
157072043|NCT02563548|567017830|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
157072044|NCT02563548|567017831|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
157072045|NCT02563548|567017826|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
157072046|NCT02563548|567017827|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
157072047|NCT02563548|567017828|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
157072048|NCT02563548|567017829|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
157072049|NCT02563548|567017830|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
157072050|NCT02563548|567017831|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
157072051|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
157072052|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
157072053|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
157072054|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
157072055|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
157072056|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
157072057|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
157072058|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
157072059|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
157072060|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
157072061|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
157230913|NCT01918397|567592418|FG002|Overall Study|Death|1|||
157230914|NCT01918397|567592419|FG003|Overall Study|Death|0|||
157072062|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
157072063|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
157072064|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
157072065|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
157072066|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
157072067|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
157072068|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
157072069|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
157072070|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
157072071|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
157072072|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
157072073|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
157072074|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
157072075|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
157072076|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
157072077|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
157072078|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
157072079|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
157072080|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
157072081|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
157072082|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
157072083|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
157072084|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
157072085|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
157072086|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
157072087|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
157072088|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
157072089|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
157072090|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
157072091|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
157072092|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
157072093|NCT02563548|567017826|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
157072094|NCT02563548|567017827|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
157072095|NCT02563548|567017828|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
157072096|NCT02563548|567017829|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
157072097|NCT02563548|567017830|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
157072098|NCT02563548|567017831|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
157072099|NCT00203047|567017834|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
157072100|NCT00203047|567017835|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
157072101|NCT00203047|567017834|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
157072102|NCT00203047|567017835|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
157072103|NCT00203047|567017834|FG000|Overall Study|Withdrawal by Subject|13|||
157072104|NCT00203047|567017835|FG001|Overall Study|Withdrawal by Subject|47|||
157072105|NCT00203047|567017834|FG000|Overall Study|Teva requested participant withdrawal|1|||
157072106|NCT00203047|567017835|FG001|Overall Study|Teva requested participant withdrawal|1|||
157072107|NCT00203047|567017834|FG000|Overall Study|Physician Decision|8|||
157072108|NCT00203047|567017835|FG001|Overall Study|Physician Decision|7|||
157072109|NCT00203047|567017834|FG000|Overall Study|Non-compliance|4|||
157072110|NCT00203047|567017835|FG001|Overall Study|Non-compliance|8|||
157072111|NCT00203047|567017834|FG000|Overall Study|Protocol Violation|1|||
157072112|NCT00203047|567017835|FG001|Overall Study|Protocol Violation|0|||
157072113|NCT00203047|567017834|FG000|Overall Study|Lost to Follow-up|11|||
157072114|NCT00203047|567017835|FG001|Overall Study|Lost to Follow-up|5|||
157072115|NCT00203047|567017834|FG000|Overall Study|Adverse Event|8|||
157072116|NCT00203047|567017835|FG001|Overall Study|Adverse Event|18|||
157072117|NCT00203047|567017834|FG000|Overall Study|Death|1|||
157072118|NCT00203047|567017835|FG001|Overall Study|Death|2|||
157072119|NCT00203047|567017834|FG000|Overall Study|Pregnancy|3|||
157072120|NCT00203047|567017835|FG001|Overall Study|Pregnancy|0|||
157072121|NCT00203047|567017834|FG000|Overall Study|Other|5|||
157072122|NCT00203047|567017835|FG001|Overall Study|Other|5|||
157072123|NCT02229227|567017836|FG000|Overall Study|Adverse Event|14|||
157072124|NCT02229227|567017837|FG001|Overall Study|Adverse Event|9|||
157230915|NCT01918397|567592416|FG000|Overall Study|Involved in another investigative trial|0|||
157230916|NCT01918397|567592417|FG001|Overall Study|Involved in another investigative trial|0|||
157230917|NCT01918397|567592418|FG002|Overall Study|Involved in another investigative trial|0|||
157230918|NCT01918397|567592419|FG003|Overall Study|Involved in another investigative trial|1|||
157072125|NCT02229227|567017836|FG000|Overall Study|Lack of Efficacy|3|||
157072126|NCT02229227|567017837|FG001|Overall Study|Lack of Efficacy|3|||
157072127|NCT02229227|567017836|FG000|Overall Study|Protocol Violation|6|||
157072128|NCT02229227|567017837|FG001|Overall Study|Protocol Violation|8|||
157072129|NCT02229227|567017836|FG000|Overall Study|Protocol defined stopping criteria|1|||
157072130|NCT02229227|567017837|FG001|Overall Study|Protocol defined stopping criteria|3|||
157072131|NCT02229227|567017836|FG000|Overall Study|Lost to Follow-up|3|||
157072132|NCT02229227|567017837|FG001|Overall Study|Lost to Follow-up|3|||
157072133|NCT02229227|567017836|FG000|Overall Study|Study terminated by sponsor|11|||
157072134|NCT02229227|567017837|FG001|Overall Study|Study terminated by sponsor|11|||
157072135|NCT02229227|567017836|FG000|Overall Study|Withdrawal by Subject|8|||
157072136|NCT02229227|567017837|FG001|Overall Study|Withdrawal by Subject|12|||
157072137|NCT02229227|567017836|FG000|Overall Study|Other|0|||
157072138|NCT02229227|567017837|FG001|Overall Study|Other|1|||
157072139|NCT02229227|567017836|FG000|Overall Study|Physician Decision|5|||
157072140|NCT02229227|567017837|FG001|Overall Study|Physician Decision|12|||
157072141|NCT00340704|567017840|FG000|PK Study|Adverse Event|0|||
157072142|NCT00340704|567017841|FG001|PK Study|Adverse Event|1|||
157072143|NCT00340704|567017842|FG002|PK Study|Adverse Event|0|||
157072144|NCT00340704|567017843|FG003|PK Study|Adverse Event|0|||
157072145|NCT00340704|567017844|FG004|PK Study|Adverse Event|0|||
157072146|NCT00340704|567017845|FG005|PK Study|Adverse Event|0|||
157072147|NCT00340704|567017846|FG006|PK Study|Adverse Event|0|||
157072148|NCT00340704|567017847|FG007|PK Study|Adverse Event|0|||
157072149|NCT00340704|567017848|FG008|PK Study|Adverse Event|0|||
157072150|NCT00340704|567017840|FG000|PK Study|Not treated|0|||
157072151|NCT00340704|567017841|FG001|PK Study|Not treated|0|||
157072152|NCT00340704|567017842|FG002|PK Study|Not treated|1|||
157072153|NCT00340704|567017843|FG003|PK Study|Not treated|0|||
157072154|NCT00340704|567017844|FG004|PK Study|Not treated|0|||
157072155|NCT00340704|567017845|FG005|PK Study|Not treated|0|||
157072156|NCT00340704|567017846|FG006|PK Study|Not treated|0|||
157072157|NCT00340704|567017847|FG007|PK Study|Not treated|0|||
157072158|NCT00340704|567017848|FG008|PK Study|Not treated|0|||
157072159|NCT00340704|567017840|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
157072160|NCT00340704|567017841|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
157072161|NCT00340704|567017842|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
157072162|NCT00340704|567017843|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
157072163|NCT00340704|567017844|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
157072164|NCT00340704|567017845|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
157072165|NCT00340704|567017846|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
157072166|NCT00340704|567017847|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
157072167|NCT00340704|567017848|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
157072168|NCT00340704|567017840|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072169|NCT00340704|567017841|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072170|NCT00340704|567017842|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072171|NCT00340704|567017843|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072172|NCT00340704|567017844|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072173|NCT00340704|567017845|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
157072174|NCT00340704|567017846|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072175|NCT00340704|567017847|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072176|NCT00340704|567017848|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
157072177|NCT00340704|567017840|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072178|NCT00340704|567017841|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072179|NCT00340704|567017842|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072180|NCT00340704|567017843|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072181|NCT00340704|567017844|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
157072182|NCT00340704|567017845|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
157072183|NCT00340704|567017846|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072184|NCT00340704|567017847|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072185|NCT00340704|567017848|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
157072186|NCT00340704|567017840|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
157072187|NCT00340704|567017841|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
157072188|NCT00340704|567017842|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
157072189|NCT00340704|567017843|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
157072190|NCT00340704|567017844|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
157072191|NCT00340704|567017845|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
157072192|NCT00340704|567017846|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
157072193|NCT00340704|567017847|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
157072194|NCT00340704|567017848|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
157072195|NCT03880019|567017853|FG000|Overall Study|Competing disease|1|||
157072196|NCT03635086|567017859|FG000|Overall Study|Withdrawal of consent|0|||
157072197|NCT03635086|567017860|FG001|Overall Study|Withdrawal of consent|0|||
157072198|NCT03635086|567017861|FG002|Overall Study|Withdrawal of consent|1|||
157072199|NCT03635086|567017862|FG003|Overall Study|Withdrawal of consent|0|||
157072200|NCT03635086|567017863|FG004|Overall Study|Withdrawal of consent|0|||
157072201|NCT03635086|567017859|FG000|Overall Study|Adverse Event|0|||
157191750|NCT00957034|567440815|FG001|Overall Study|Sponsor Terminated Study|1|||
157191751|NCT00957034|567440816|FG002|Overall Study|Sponsor Terminated Study|5|||
157191752|NCT00957034|567440814|FG000|Overall Study|Withdrawal by Subject|0|||
157191753|NCT00957034|567440815|FG001|Overall Study|Withdrawal by Subject|2|||
157072202|NCT03635086|567017860|FG001|Overall Study|Adverse Event|1|||
157072203|NCT03635086|567017861|FG002|Overall Study|Adverse Event|0|||
157072204|NCT03635086|567017862|FG003|Overall Study|Adverse Event|0|||
157072205|NCT03635086|567017863|FG004|Overall Study|Adverse Event|0|||
157072206|NCT03635086|567017859|FG000|Overall Study|Lost to Follow-up|1|||
157072207|NCT03635086|567017860|FG001|Overall Study|Lost to Follow-up|0|||
157072208|NCT03635086|567017861|FG002|Overall Study|Lost to Follow-up|0|||
157072209|NCT03635086|567017862|FG003|Overall Study|Lost to Follow-up|0|||
157072210|NCT03635086|567017863|FG004|Overall Study|Lost to Follow-up|0|||
157072211|NCT02196077|567017864|FG000|Overall Study|Adverse Event|4|||
157072212|NCT02196077|567017864|FG000|Overall Study|Lack of Efficacy|1|||
157072213|NCT02196077|567017864|FG000|Overall Study|Withdrawal by Subject|14|||
157072214|NCT02196077|567017864|FG000|Overall Study|Physician Decision|1|||
157072215|NCT02196077|567017864|FG000|Overall Study|Lost to Follow-up|3|||
157072216|NCT02196077|567017864|FG000|Overall Study|Protocol Violation|24|||
157072217|NCT03482752|567017869|FG000|Overall Study|Withdrawal by Subject|2|||
157072218|NCT03482752|567017869|FG000|Overall Study|Lost to Follow-up|1|||
157072219|NCT03482752|567017869|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
157072220|NCT02689453|567017870|FG000|Overall Study|Progressive disease|0|||
157072221|NCT02689453|567017871|FG001|Overall Study|Progressive disease|1|||
157072222|NCT02689453|567017872|FG002|Overall Study|Progressive disease|1|||
157072223|NCT03566979|567017876|FG000|Overall Study|Withdrawal by Subject|2|||
157072224|NCT03566979|567017877|FG001|Overall Study|Withdrawal by Subject|0|||
157072225|NCT03566979|567017878|FG002|Overall Study|Withdrawal by Subject|1|||
157072226|NCT03566979|567017879|FG003|Overall Study|Withdrawal by Subject|1|||
157072227|NCT03566979|567017876|FG000|Overall Study|Lost to Follow-up|2|||
157072228|NCT03566979|567017877|FG001|Overall Study|Lost to Follow-up|7|||
157072229|NCT03566979|567017878|FG002|Overall Study|Lost to Follow-up|9|||
157072230|NCT03566979|567017879|FG003|Overall Study|Lost to Follow-up|5|||
157072231|NCT03566979|567017876|FG000|Overall Study|Adverse Event|1|||
157072232|NCT03566979|567017877|FG001|Overall Study|Adverse Event|0|||
157072233|NCT03566979|567017878|FG002|Overall Study|Adverse Event|0|||
157072234|NCT03566979|567017879|FG003|Overall Study|Adverse Event|0|||
157072235|NCT00658606|567017880|FG000|Overall Study|Adverse Event|2|||
157072236|NCT00658606|567017881|FG001|Overall Study|Adverse Event|1|||
157072237|NCT00658606|567017880|FG000|Overall Study|Lack of Efficacy|6|||
157072238|NCT00658606|567017881|FG001|Overall Study|Lack of Efficacy|3|||
157072239|NCT00658606|567017880|FG000|Overall Study|Lost to Follow-up|1|||
157072240|NCT00658606|567017881|FG001|Overall Study|Lost to Follow-up|0|||
157072241|NCT00658606|567017880|FG000|Overall Study|Withdrawal by Subject|7|||
157072242|NCT00658606|567017881|FG001|Overall Study|Withdrawal by Subject|16|||
157072243|NCT00658606|567017880|FG000|Overall Study|Lack of Compliance|0|||
157072244|NCT00658606|567017881|FG001|Overall Study|Lack of Compliance|3|||
157072245|NCT01056263|567017882|FG000|Overall Study|Adverse Event|12|||
157072246|NCT01056263|567017882|FG000|Overall Study|Death|1|||
157072247|NCT01056263|567017882|FG000|Overall Study|Withdrawal by Subject|1|||
157230919|NCT00760266|567592427|FG000|Overall Study|Adverse Event|13|||
157230920|NCT00760266|567592428|FG001|Overall Study|Adverse Event|7|||
157230921|NCT00760266|567592427|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157230922|NCT00760266|567592428|FG001|Overall Study|Abnormal laboratory value(s)|0|||
157230923|NCT00760266|567592427|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157230924|NCT00760266|567592428|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157230925|NCT00760266|567592427|FG000|Overall Study|Lack of Efficacy|2|||
157230926|NCT00760266|567592428|FG001|Overall Study|Lack of Efficacy|2|||
157230927|NCT00760266|567592427|FG000|Overall Study|Protocol deviation|2|||
157230928|NCT00760266|567592428|FG001|Overall Study|Protocol deviation|4|||
157230929|NCT00760266|567592427|FG000|Overall Study|Patient withdrew consent|3|||
157230930|NCT00760266|567592428|FG001|Overall Study|Patient withdrew consent|3|||
157230931|NCT00760266|567592427|FG000|Overall Study|Lost to Follow-up|2|||
157230932|NCT00760266|567592428|FG001|Overall Study|Lost to Follow-up|1|||
157230933|NCT00760266|567592427|FG000|Overall Study|Administrative Problems|0|||
157230934|NCT00760266|567592428|FG001|Overall Study|Administrative Problems|1|||
157230935|NCT01239121|567592429|FG000|Overall Study|Withdrawal by Subject|2|||
157230936|NCT01239121|567592430|FG001|Overall Study|Withdrawal by Subject|4|||
157072248|NCT01056263|567017882|FG000|Overall Study|Lack of Efficacy|29|||
157072249|NCT01056263|567017882|FG000|Overall Study|Progressive disease|2|||
157072250|NCT01056263|567017882|FG000|Overall Study|Neoplasm progression|1|||
157072251|NCT01056263|567017882|FG000|Overall Study|Objective progression or relapse|1|||
157072252|NCT01056263|567017882|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
157072253|NCT03348631|567017883|FG000|Overall Study|Not Eligible, No treatment|0|||
157072254|NCT03348631|567017884|FG001|Overall Study|Not Eligible, No treatment|1|||
157072255|NCT03348631|567017883|FG000|Overall Study|Not Eligible, Treated|2|||
157072256|NCT03348631|567017884|FG001|Overall Study|Not Eligible, Treated|0|||
157230937|NCT01239121|567592431|FG002|Overall Study|Withdrawal by Subject|0|||
157072257|NCT03348631|567017883|FG000|Overall Study|Eligible, No Treatment|1|||
157230938|NCT03657160|567592432|FG000|Overall Study|Adverse Event|5|||
157230939|NCT03657160|567592433|FG001|Overall Study|Adverse Event|6|||
157072258|NCT03348631|567017884|FG001|Overall Study|Eligible, No Treatment|0|||
157072259|NCT01068210|567017885|FG000|Overall Study|Lost to Follow-up|1|||
157230940|NCT03657160|567592432|FG000|Overall Study|Protocol Deviation|3|||
157072260|NCT01068210|567017886|FG001|Overall Study|Lost to Follow-up|2|||
157072261|NCT01068210|567017887|FG002|Overall Study|Lost to Follow-up|2|||
157072262|NCT01068210|567017888|FG003|Overall Study|Lost to Follow-up|1|||
157072263|NCT01068210|567017885|FG000|Overall Study|Second cancer|0|||
157072264|NCT01068210|567017886|FG001|Overall Study|Second cancer|1|||
157072265|NCT01068210|567017887|FG002|Overall Study|Second cancer|0|||
157072266|NCT01068210|567017888|FG003|Overall Study|Second cancer|0|||
157072267|NCT01068210|567017885|FG000|Overall Study|Disease progression|0|||
157072268|NCT01068210|567017886|FG001|Overall Study|Disease progression|0|||
157072269|NCT01068210|567017887|FG002|Overall Study|Disease progression|0|||
157072270|NCT01068210|567017888|FG003|Overall Study|Disease progression|2|||
157072271|NCT01358331|567017893|FG000|Overall Study|Lost to Follow-up|0|||
157072272|NCT01358331|567017894|FG001|Overall Study|Lost to Follow-up|0|||
157072273|NCT01358331|567017895|FG002|Overall Study|Lost to Follow-up|0|||
157072274|NCT01358331|567017896|FG003|Overall Study|Lost to Follow-up|1|||
157072275|NCT01358331|567017897|FG004|Overall Study|Lost to Follow-up|0|||
157072276|NCT01358331|567017898|FG005|Overall Study|Lost to Follow-up|0|||
157072277|NCT01358331|567017893|FG000|Overall Study|Withdrawal by Subject|0|||
157072278|NCT01358331|567017894|FG001|Overall Study|Withdrawal by Subject|0|||
157072279|NCT01358331|567017895|FG002|Overall Study|Withdrawal by Subject|0|||
157072280|NCT01358331|567017896|FG003|Overall Study|Withdrawal by Subject|1|||
157072281|NCT01358331|567017897|FG004|Overall Study|Withdrawal by Subject|1|||
157072282|NCT01358331|567017898|FG005|Overall Study|Withdrawal by Subject|1|||
157072283|NCT01358331|567017893|FG000|Overall Study|Adverse Events|1|||
157072284|NCT01358331|567017894|FG001|Overall Study|Adverse Events|1|||
157072285|NCT01358331|567017895|FG002|Overall Study|Adverse Events|1|||
157072286|NCT01358331|567017896|FG003|Overall Study|Adverse Events|0|||
157072287|NCT01358331|567017897|FG004|Overall Study|Adverse Events|1|||
157072288|NCT01358331|567017898|FG005|Overall Study|Adverse Events|5|||
157072289|NCT01358331|567017893|FG000|Overall Study|Symptomatic Deterioration|0|||
157072290|NCT01358331|567017894|FG001|Overall Study|Symptomatic Deterioration|0|||
157072291|NCT01358331|567017895|FG002|Overall Study|Symptomatic Deterioration|0|||
157072292|NCT01358331|567017896|FG003|Overall Study|Symptomatic Deterioration|0|||
157072293|NCT01358331|567017897|FG004|Overall Study|Symptomatic Deterioration|1|||
157072294|NCT01358331|567017898|FG005|Overall Study|Symptomatic Deterioration|0|||
157072295|NCT01358331|567017893|FG000|Overall Study|Participants did not wish to continue|0|||
157072296|NCT01358331|567017894|FG001|Overall Study|Participants did not wish to continue|0|||
157072297|NCT01358331|567017895|FG002|Overall Study|Participants did not wish to continue|0|||
157072298|NCT01358331|567017896|FG003|Overall Study|Participants did not wish to continue|0|||
157072299|NCT01358331|567017897|FG004|Overall Study|Participants did not wish to continue|1|||
157072300|NCT01358331|567017898|FG005|Overall Study|Participants did not wish to continue|0|||
157072301|NCT01358331|567017893|FG000|Overall Study|Progress of disease under investigation|1|||
157072302|NCT01358331|567017894|FG001|Overall Study|Progress of disease under investigation|2|||
157072303|NCT01358331|567017895|FG002|Overall Study|Progress of disease under investigation|3|||
157072304|NCT01358331|567017896|FG003|Overall Study|Progress of disease under investigation|1|||
157072305|NCT01358331|567017897|FG004|Overall Study|Progress of disease under investigation|3|||
157072306|NCT01358331|567017898|FG005|Overall Study|Progress of disease under investigation|0|||
157072307|NCT03170518|567017901|FG000|Overall Study|Lost to Follow-up|4|||
157072308|NCT03170518|567017902|FG001|Overall Study|Lost to Follow-up|1|||
157072309|NCT03170518|567017903|FG002|Overall Study|Lost to Follow-up|0|||
157072310|NCT03170518|567017901|FG000|Overall Study|Physician Decision|1|||
157072311|NCT03170518|567017902|FG001|Overall Study|Physician Decision|0|||
157072312|NCT03170518|567017903|FG002|Overall Study|Physician Decision|0|||
157072313|NCT03170518|567017901|FG000|Overall Study|Withdrawal by Subject|4|||
157072314|NCT03170518|567017902|FG001|Overall Study|Withdrawal by Subject|5|||
157072315|NCT03170518|567017903|FG002|Overall Study|Withdrawal by Subject|2|||
157072316|NCT03170518|567017901|FG000|Overall Study|Site terminated by sponsor|0|||
157072317|NCT03170518|567017902|FG001|Overall Study|Site terminated by sponsor|1|||
157072318|NCT03170518|567017903|FG002|Overall Study|Site terminated by sponsor|0|||
157072319|NCT03170518|567017901|FG000|Overall Study|Non-compliance with study drug|1|||
157072320|NCT03170518|567017902|FG001|Overall Study|Non-compliance with study drug|0|||
157191754|NCT00957034|567440816|FG002|Overall Study|Withdrawal by Subject|0|||
157072321|NCT03170518|567017903|FG002|Overall Study|Non-compliance with study drug|1|||
157072322|NCT03170518|567017901|FG000|Overall Study|Withdrawal by parent/guardian|2|||
157072323|NCT03170518|567017902|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157072324|NCT03170518|567017903|FG002|Overall Study|Withdrawal by parent/guardian|0|||
157072325|NCT00546078|567017904|FG000|Overall Study|Lost to Follow-up|1|||
157191755|NCT05315297|567440817|FG000|Overall Study|Lost to Follow-up|6|||
157191756|NCT05315297|567440818|FG001|Overall Study|Lost to Follow-up|4|||
157072326|NCT00546078|567017905|FG001|Overall Study|Lost to Follow-up|3|||
157072327|NCT00546078|567017904|FG000|Overall Study|Withdrawal by Subject|2|||
157072328|NCT00546078|567017905|FG001|Overall Study|Withdrawal by Subject|3|||
157072329|NCT00546078|567017904|FG000|Overall Study|Other reason|1|||
157072330|NCT00546078|567017905|FG001|Overall Study|Other reason|1|||
157072331|NCT02559310|567017910|FG000|Overall Study|Death|4|||
157072332|NCT02559310|567017911|FG001|Overall Study|Death|3|||
157072333|NCT02559310|567017910|FG000|Overall Study|Lost to Follow-up|5|||
157072334|NCT02559310|567017911|FG001|Overall Study|Lost to Follow-up|3|||
157072335|NCT02559310|567017910|FG000|Overall Study|Physician Decision|2|||
157072336|NCT02559310|567017911|FG001|Overall Study|Physician Decision|1|||
157072337|NCT02559310|567017910|FG000|Overall Study|Withdrawal by Subject|13|||
157072338|NCT02559310|567017911|FG001|Overall Study|Withdrawal by Subject|9|||
157072339|NCT02559310|567017910|FG000|Overall Study|Sponsor Decision|0|||
157072340|NCT02559310|567017911|FG001|Overall Study|Sponsor Decision|1|||
157072341|NCT02559310|567017910|FG000|Overall Study|Randomized but not treated|3|||
157072342|NCT02559310|567017911|FG001|Overall Study|Randomized but not treated|2|||
157072343|NCT03595878|567017912|FG000|Overall Study|Death|2|||
157072344|NCT03595878|567017913|FG001|Overall Study|Death|1|||
157072345|NCT03595878|567017914|FG002|Overall Study|Death|0|||
157072346|NCT03595878|567017912|FG000|Overall Study|Disease progression|2|||
157072347|NCT03595878|567017913|FG001|Overall Study|Disease progression|1|||
157072348|NCT03595878|567017914|FG002|Overall Study|Disease progression|2|||
157072349|NCT03036124|567017915|FG000|Overall Study|Lost to Follow-up|0|||
157072350|NCT03036124|567017916|FG001|Overall Study|Lost to Follow-up|2|||
157072351|NCT03036124|567017915|FG000|Overall Study|Withdrawal by Subject|5|||
157072352|NCT03036124|567017916|FG001|Overall Study|Withdrawal by Subject|4|||
157072353|NCT02282059|567017917|FG000|Overall Study|Other|15|||
157072354|NCT02282059|567017918|FG001|Overall Study|Other|3|||
157072355|NCT02282059|567017917|FG000|Overall Study|Participant refused further follow-up|8|||
157072356|NCT02282059|567017918|FG001|Overall Study|Participant refused further follow-up|4|||
157072357|NCT02282059|567017917|FG000|Overall Study|Lost to Follow-up|19|||
157072358|NCT02282059|567017918|FG001|Overall Study|Lost to Follow-up|3|||
157072359|NCT02282059|567017917|FG000|Overall Study|Death|40|||
157072360|NCT02282059|567017918|FG001|Overall Study|Death|8|||
157072361|NCT00742326|567019722|FG000|Overall Study|Physician Decision|0|||
157072362|NCT00742326|567019723|FG001|Overall Study|Physician Decision|1|||
157072363|NCT00965497|567019724|FG000|Overall Study|Physician Decision|1|||
157072364|NCT02878603|567019725|FG000|Overall Study|Lost to Follow-up|4|||
157072365|NCT02878603|567019726|FG001|Overall Study|Lost to Follow-up|1|||
157072366|NCT02878603|567019725|FG000|Overall Study|Withdrawal by Subject|1|||
157072367|NCT02878603|567019726|FG001|Overall Study|Withdrawal by Subject|1|||
157072368|NCT02878603|567019725|FG000|Overall Study|Death|1|||
157072369|NCT02878603|567019726|FG001|Overall Study|Death|0|||
157072370|NCT02878603|567019725|FG000|Overall Study|Physician Decision|0|||
157072371|NCT02878603|567019726|FG001|Overall Study|Physician Decision|3|||
157072372|NCT01162486|567019727|FG000|Overall Study|low ANC|1|||
157072373|NCT01162486|567019728|FG001|Overall Study|low ANC|0|||
157072374|NCT01162486|567019729|FG002|Overall Study|low ANC|0|||
157072375|NCT01162486|567019730|FG003|Overall Study|low ANC|0|||
157072376|NCT01162486|567019731|FG004|Overall Study|low ANC|0|||
157072377|NCT01162486|567019727|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
157072378|NCT01162486|567019728|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
157072379|NCT01162486|567019729|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
157072380|NCT01162486|567019730|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
157072381|NCT01162486|567019731|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
157072382|NCT01162486|567019727|FG000|Overall Study|elevated LFTs|0|||
157072383|NCT01162486|567019728|FG001|Overall Study|elevated LFTs|0|||
157072384|NCT01162486|567019729|FG002|Overall Study|elevated LFTs|1|||
157072385|NCT01162486|567019730|FG003|Overall Study|elevated LFTs|0|||
157072386|NCT01162486|567019731|FG004|Overall Study|elevated LFTs|0|||
157072387|NCT01162486|567019727|FG000|Overall Study|Pregnancy|0|||
157072388|NCT01162486|567019728|FG001|Overall Study|Pregnancy|0|||
157072389|NCT01162486|567019729|FG002|Overall Study|Pregnancy|0|||
157072390|NCT01162486|567019730|FG003|Overall Study|Pregnancy|1|||
157072391|NCT01162486|567019731|FG004|Overall Study|Pregnancy|0|||
157072392|NCT00794924|567019732|FG000|Overall Study|Lost to Follow-up|6|||
157072393|NCT00794924|567019733|FG001|Overall Study|Lost to Follow-up|8|||
157072394|NCT00794924|567019732|FG000|Overall Study|Withdrawal by Subject|48|||
157191757|NCT05315297|567440817|FG000|Overall Study|Withdrawal by Subject|0|||
157191758|NCT05315297|567440818|FG001|Overall Study|Withdrawal by Subject|1|||
157072395|NCT00794924|567019733|FG001|Overall Study|Withdrawal by Subject|60|||
157072396|NCT00794924|567019732|FG000|Overall Study|Adverse Event|6|||
157072397|NCT00794924|567019733|FG001|Overall Study|Adverse Event|2|||
157072398|NCT00953615|567019734|FG000|Overall Study|Adverse Event|1|||
157072399|NCT03274895|567019735|FG000|Overall Study|Lack of Efficacy|1|||
157072400|NCT03274895|567019736|FG001|Overall Study|Lack of Efficacy|0|||
157072401|NCT03274895|567019735|FG000|Overall Study|Adverse Event|8|||
157072402|NCT03274895|567019736|FG001|Overall Study|Adverse Event|7|||
157072403|NCT03274895|567019735|FG000|Overall Study|Lost to Follow-up|1|||
157072404|NCT03274895|567019736|FG001|Overall Study|Lost to Follow-up|0|||
157191759|NCT00027846|567443390|FG000|Overall Study|Lost to Follow-up|0|||
157072405|NCT03274895|567019735|FG000|Overall Study|Diagnosis not confirmed|3|||
157072406|NCT03274895|567019736|FG001|Overall Study|Diagnosis not confirmed|4|||
157072407|NCT01969851|567019737|FG000|Overall Study|Adverse Event|0|||
157072408|NCT01969851|567019738|FG001|Overall Study|Adverse Event|0|||
157072409|NCT01969851|567019739|FG002|Overall Study|Adverse Event|3|||
157072410|NCT01969851|567019737|FG000|Overall Study|Lack of Efficacy|0|||
157072411|NCT01969851|567019738|FG001|Overall Study|Lack of Efficacy|3|||
157072412|NCT01969851|567019739|FG002|Overall Study|Lack of Efficacy|1|||
157072413|NCT01969851|567019737|FG000|Overall Study|Withdrawal by Subject|1|||
157072414|NCT01969851|567019738|FG001|Overall Study|Withdrawal by Subject|0|||
157072415|NCT01969851|567019739|FG002|Overall Study|Withdrawal by Subject|1|||
157072416|NCT01969851|567019737|FG000|Overall Study|No effective dose in Titration period|0|||
157072417|NCT01969851|567019738|FG001|Overall Study|No effective dose in Titration period|0|||
157072418|NCT01969851|567019739|FG002|Overall Study|No effective dose in Titration period|1|||
157072419|NCT01969851|567019737|FG000|Overall Study|Sponsor decision|0|||
157072420|NCT01969851|567019738|FG001|Overall Study|Sponsor decision|0|||
157072421|NCT01969851|567019739|FG002|Overall Study|Sponsor decision|1|||
157072422|NCT01294436|567019744|FG000|Overall Study|Adverse Event|10|||
157072423|NCT01294436|567019745|FG001|Overall Study|Adverse Event|17|||
157072424|NCT01294436|567019744|FG000|Overall Study|Withdrawal by Subject|11|||
157072425|NCT01294436|567019745|FG001|Overall Study|Withdrawal by Subject|28|||
157072426|NCT01294436|567019744|FG000|Overall Study|subject no longer meets study criteria|5|||
157072427|NCT01294436|567019745|FG001|Overall Study|subject no longer meets study criteria|20|||
157072428|NCT01294436|567019744|FG000|Overall Study|poor/non-compliance|2|||
157072429|NCT01294436|567019745|FG001|Overall Study|poor/non-compliance|5|||
157072430|NCT02389764|567019746|FG000|Overall Study|Lack of Efficacy|9|||
157072431|NCT02498236|567019753|FG000|Overall Study|Did not show for testing|1|||
157072432|NCT02498236|567019754|FG001|Overall Study|Did not show for testing|0|||
157072433|NCT02498236|567019755|FG002|Overall Study|Did not show for testing|0|||
157072434|NCT02498236|567019756|FG003|Overall Study|Did not show for testing|0|||
157072435|NCT02498236|567019757|FG004|Overall Study|Did not show for testing|0|||
157072436|NCT02498236|567019758|FG005|Overall Study|Did not show for testing|0|||
157072437|NCT02498236|567019759|FG006|Overall Study|Did not show for testing|0|||
157072438|NCT02498236|567019760|FG007|Overall Study|Did not show for testing|1|||
157072439|NCT02498236|567019753|FG000|Overall Study|Equipment failure|0|||
157072440|NCT02498236|567019754|FG001|Overall Study|Equipment failure|0|||
157072441|NCT02498236|567019755|FG002|Overall Study|Equipment failure|0|||
157072442|NCT02498236|567019756|FG003|Overall Study|Equipment failure|0|||
157072443|NCT02498236|567019757|FG004|Overall Study|Equipment failure|0|||
157072444|NCT02498236|567019758|FG005|Overall Study|Equipment failure|0|||
157072445|NCT02498236|567019759|FG006|Overall Study|Equipment failure|1|||
157072446|NCT02498236|567019760|FG007|Overall Study|Equipment failure|0|||
157072447|NCT02498236|567019753|FG000|Overall Study|Withdrawal by Subject|0|||
157072448|NCT02498236|567019754|FG001|Overall Study|Withdrawal by Subject|0|||
157072449|NCT02498236|567019755|FG002|Overall Study|Withdrawal by Subject|0|||
157072450|NCT02498236|567019756|FG003|Overall Study|Withdrawal by Subject|0|||
157072451|NCT02498236|567019757|FG004|Overall Study|Withdrawal by Subject|1|||
157072452|NCT02498236|567019758|FG005|Overall Study|Withdrawal by Subject|0|||
157072453|NCT02498236|567019759|FG006|Overall Study|Withdrawal by Subject|0|||
157072454|NCT02498236|567019760|FG007|Overall Study|Withdrawal by Subject|0|||
157072455|NCT02296892|567019761|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
157072456|NCT02296892|567019762|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
157072457|NCT02296892|567019763|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
157072458|NCT02296892|567019761|FG000|Overall Study|Lost to Follow-up|5|||
157072459|NCT02296892|567019762|FG001|Overall Study|Lost to Follow-up|0|||
157072460|NCT02296892|567019763|FG002|Overall Study|Lost to Follow-up|1|||
157072461|NCT00585078|567019764|FG000|Overall Study|Withdrawal by Subject|4|||
157072462|NCT00585078|567019764|FG000|Overall Study|Poor performance status|1|||
157072463|NCT00585078|567019764|FG000|Overall Study|Disease Progression|24|||
157072464|NCT00585078|567019764|FG000|Overall Study|Adverse Event|10|||
157072465|NCT00585078|567019764|FG000|Overall Study|Death|1|||
157072466|NCT01814072|567019769|FG000|Overall Study|Lost to Follow-up|2|||
157072467|NCT01814072|567019770|FG001|Overall Study|Lost to Follow-up|2|||
157072468|NCT01814072|567019771|FG002|Overall Study|Lost to Follow-up|2|||
157072469|NCT01814072|567019772|FG003|Overall Study|Lost to Follow-up|0|||
157072470|NCT01814072|567019773|FG004|Overall Study|Lost to Follow-up|2|||
157072471|NCT01814072|567019774|FG005|Overall Study|Lost to Follow-up|3|||
157072472|NCT01814072|567019775|FG006|Overall Study|Lost to Follow-up|3|||
157072473|NCT01814072|567019776|FG007|Overall Study|Lost to Follow-up|1|||
157072474|NCT01814072|567019777|FG008|Overall Study|Lost to Follow-up|2|||
157072475|NCT01814072|567019778|FG009|Overall Study|Lost to Follow-up|3|||
157072476|NCT01814072|567019779|FG010|Overall Study|Lost to Follow-up|1|||
157072477|NCT01814072|567019780|FG011|Overall Study|Lost to Follow-up|2|||
157072478|NCT01814072|567019781|FG012|Overall Study|Lost to Follow-up|2|||
157072479|NCT01814072|567019782|FG013|Overall Study|Lost to Follow-up|1|||
157072480|NCT01814072|567019783|FG014|Overall Study|Lost to Follow-up|2|||
157072481|NCT01814072|567019784|FG015|Overall Study|Lost to Follow-up|1|||
157072482|NCT01814072|567019785|FG016|Overall Study|Lost to Follow-up|3|||
157072483|NCT01814072|567019786|FG017|Overall Study|Lost to Follow-up|1|||
157072484|NCT01814072|567019787|FG018|Overall Study|Lost to Follow-up|3|||
157072485|NCT01814072|567019788|FG019|Overall Study|Lost to Follow-up|3|||
157072486|NCT01814072|567019789|FG020|Overall Study|Lost to Follow-up|2|||
157072487|NCT01814072|567019790|FG021|Overall Study|Lost to Follow-up|1|||
157072488|NCT01814072|567019791|FG022|Overall Study|Lost to Follow-up|3|||
157072489|NCT01814072|567019792|FG023|Overall Study|Lost to Follow-up|1|||
157072490|NCT01814072|567019793|FG024|Overall Study|Lost to Follow-up|4|||
157072491|NCT01814072|567019794|FG025|Overall Study|Lost to Follow-up|1|||
157072492|NCT01814072|567019795|FG026|Overall Study|Lost to Follow-up|1|||
157072493|NCT01814072|567019796|FG027|Overall Study|Lost to Follow-up|2|||
157072494|NCT01814072|567019797|FG028|Overall Study|Lost to Follow-up|3|||
157072495|NCT01814072|567019798|FG029|Overall Study|Lost to Follow-up|3|||
157072496|NCT01814072|567019799|FG030|Overall Study|Lost to Follow-up|2|||
157072497|NCT01814072|567019800|FG031|Overall Study|Lost to Follow-up|0|||
157072498|NCT01814072|567019769|FG000|Overall Study|Withdrawal by Subject|2|||
157072499|NCT01814072|567019770|FG001|Overall Study|Withdrawal by Subject|0|||
157072500|NCT01814072|567019771|FG002|Overall Study|Withdrawal by Subject|1|||
157072501|NCT01814072|567019772|FG003|Overall Study|Withdrawal by Subject|0|||
157072502|NCT01814072|567019773|FG004|Overall Study|Withdrawal by Subject|2|||
157072503|NCT01814072|567019774|FG005|Overall Study|Withdrawal by Subject|3|||
157072504|NCT01814072|567019775|FG006|Overall Study|Withdrawal by Subject|1|||
157072505|NCT01814072|567019776|FG007|Overall Study|Withdrawal by Subject|0|||
157072506|NCT01814072|567019777|FG008|Overall Study|Withdrawal by Subject|1|||
157072507|NCT01814072|567019778|FG009|Overall Study|Withdrawal by Subject|2|||
157072508|NCT01814072|567019779|FG010|Overall Study|Withdrawal by Subject|0|||
157072509|NCT01814072|567019780|FG011|Overall Study|Withdrawal by Subject|0|||
157072510|NCT01814072|567019781|FG012|Overall Study|Withdrawal by Subject|1|||
157072511|NCT01814072|567019782|FG013|Overall Study|Withdrawal by Subject|1|||
157072512|NCT01814072|567019783|FG014|Overall Study|Withdrawal by Subject|1|||
157072513|NCT01814072|567019784|FG015|Overall Study|Withdrawal by Subject|1|||
157072514|NCT01814072|567019785|FG016|Overall Study|Withdrawal by Subject|0|||
157230941|NCT03657160|567592433|FG001|Overall Study|Protocol Deviation|0|||
157230942|NCT03657160|567592432|FG000|Overall Study|Withdrawal by Subject|18|||
157230943|NCT03657160|567592433|FG001|Overall Study|Withdrawal by Subject|16|||
157230944|NCT03657160|567592432|FG000|Overall Study|Site Termination|1|||
157230945|NCT03657160|567592433|FG001|Overall Study|Site Termination|0|||
157230946|NCT03657160|567592432|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
157230947|NCT03657160|567592433|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
157230948|NCT03657160|567592432|FG000|Overall Study|Death|33|||
157230949|NCT03657160|567592433|FG001|Overall Study|Death|26|||
157230950|NCT03657160|567592432|FG000|Overall Study|Death (COVID-19-Related)|1|||
157230951|NCT03657160|567592433|FG001|Overall Study|Death (COVID-19-Related)|0|||
157230952|NCT03657160|567592432|FG000|Overall Study|Reason Not Specified|5|||
157230953|NCT03657160|567592433|FG001|Overall Study|Reason Not Specified|5|||
157230954|NCT03657160|567592432|FG000|Overall Study|Other (COVID-19-Related)|0|||
157230955|NCT03657160|567592433|FG001|Overall Study|Other (COVID-19-Related)|1|||
157230956|NCT04006171|567592438|FG000|Overall Study|Withdrawal by Subject|8|||
157230957|NCT04006171|567592439|FG001|Overall Study|Withdrawal by Subject|7|||
157230958|NCT04006171|567592438|FG000|Overall Study|missing serum samples|2|||
157230959|NCT04006171|567592439|FG001|Overall Study|missing serum samples|2|||
157230960|NCT04006171|567592438|FG000|Overall Study|insufficient sample volume|2|||
157230961|NCT04006171|567592439|FG001|Overall Study|insufficient sample volume|3|||
157230962|NCT01062256|567592442|FG000|Overall Study|Adverse Event|1|||
157230963|NCT01062256|567592443|FG001|Overall Study|Adverse Event|0|||
157230964|NCT01062256|567592444|FG002|Overall Study|Adverse Event|0|||
157230965|NCT01062256|567592442|FG000|Overall Study|Withdrawal by Subject|1|||
157230966|NCT01062256|567592443|FG001|Overall Study|Withdrawal by Subject|1|||
157230967|NCT01062256|567592444|FG002|Overall Study|Withdrawal by Subject|1|||
157230968|NCT01062256|567592442|FG000|Overall Study|Ineligible|1|||
157230969|NCT01062256|567592443|FG001|Overall Study|Ineligible|4|||
157230970|NCT01062256|567592444|FG002|Overall Study|Ineligible|3|||
157230971|NCT01062256|567592442|FG000|Overall Study|Administrative|0|||
157230972|NCT01062256|567592443|FG001|Overall Study|Administrative|2|||
157230973|NCT01062256|567592444|FG002|Overall Study|Administrative|0|||
157230974|NCT03049488|567592445|FG000|Overall Study|Lost to Follow-up|1|||
157230975|NCT03049488|567592446|FG001|Overall Study|Lost to Follow-up|1|||
157230976|NCT03049488|567592447|FG002|Overall Study|Lost to Follow-up|0|||
157230977|NCT03049488|567592448|FG003|Overall Study|Lost to Follow-up|0|||
157230978|NCT03049488|567592449|FG004|Overall Study|Lost to Follow-up|0|||
157072515|NCT01814072|567019786|FG017|Overall Study|Withdrawal by Subject|0|||
157072516|NCT01814072|567019787|FG018|Overall Study|Withdrawal by Subject|0|||
157230979|NCT03049488|567592450|FG005|Overall Study|Lost to Follow-up|0|||
157230980|NCT03049488|567592445|FG000|Overall Study|Moved from Area|1|||
157072517|NCT01814072|567019788|FG019|Overall Study|Withdrawal by Subject|2|||
157072518|NCT01814072|567019789|FG020|Overall Study|Withdrawal by Subject|0|||
157072519|NCT01814072|567019790|FG021|Overall Study|Withdrawal by Subject|0|||
157072520|NCT01814072|567019791|FG022|Overall Study|Withdrawal by Subject|1|||
157072521|NCT01814072|567019792|FG023|Overall Study|Withdrawal by Subject|0|||
157072522|NCT01814072|567019793|FG024|Overall Study|Withdrawal by Subject|2|||
157230981|NCT03049488|567592446|FG001|Overall Study|Moved from Area|0|||
157230982|NCT03049488|567592447|FG002|Overall Study|Moved from Area|0|||
157191760|NCT00027846|567443391|FG001|Overall Study|Lost to Follow-up|41|||
157191761|NCT00027846|567443392|FG002|Overall Study|Lost to Follow-up|9|||
157191762|NCT00027846|567443390|FG000|Overall Study|Withdrawal by Subject|0|||
157072523|NCT01814072|567019794|FG025|Overall Study|Withdrawal by Subject|1|||
157072524|NCT01814072|567019795|FG026|Overall Study|Withdrawal by Subject|1|||
157072525|NCT01814072|567019796|FG027|Overall Study|Withdrawal by Subject|2|||
157072526|NCT01814072|567019797|FG028|Overall Study|Withdrawal by Subject|1|||
157072527|NCT01814072|567019798|FG029|Overall Study|Withdrawal by Subject|0|||
157072528|NCT01814072|567019799|FG030|Overall Study|Withdrawal by Subject|0|||
157072529|NCT01814072|567019800|FG031|Overall Study|Withdrawal by Subject|0|||
157072530|NCT00250432|567019806|FG000|Overall Study|Adverse Event|25|||
157072531|NCT00250432|567019807|FG001|Overall Study|Adverse Event|29|||
157072532|NCT00250432|567019806|FG000|Overall Study|Lack of Efficacy|2|||
157072533|NCT00250432|567019807|FG001|Overall Study|Lack of Efficacy|1|||
157072534|NCT00250432|567019806|FG000|Overall Study|Lost to Follow-up|6|||
157072535|NCT00250432|567019807|FG001|Overall Study|Lost to Follow-up|5|||
157072536|NCT00250432|567019806|FG000|Overall Study|Patient Moved|0|||
157072537|NCT00250432|567019807|FG001|Overall Study|Patient Moved|1|||
157072538|NCT00250432|567019806|FG000|Overall Study|Protocol Violation|0|||
157072539|NCT00250432|567019807|FG001|Overall Study|Protocol Violation|3|||
157072540|NCT00250432|567019806|FG000|Overall Study|Withdrawal by Subject|6|||
157072541|NCT00250432|567019807|FG001|Overall Study|Withdrawal by Subject|2|||
157072542|NCT00250432|567019806|FG000|Overall Study|Pt died out of posttherapy report period|6|||
157072543|NCT00250432|567019807|FG001|Overall Study|Pt died out of posttherapy report period|5|||
157072544|NCT00250432|567019806|FG000|Overall Study|Pt was considered untreatable|0|||
157072545|NCT00250432|567019807|FG001|Overall Study|Pt was considered untreatable|1|||
157072546|NCT01011868|567019808|FG000|After Week 18 Follow-up|Adverse Event|8|||
157072547|NCT01011868|567019809|FG001|After Week 18 Follow-up|Adverse Event|6|||
157072548|NCT01011868|567019810|FG002|After Week 18 Follow-up|Adverse Event|13|||
157072549|NCT01011868|567019808|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
157072550|NCT01011868|567019809|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
157072551|NCT01011868|567019810|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
157072552|NCT01011868|567019808|FG000|After Week 18 Follow-up|Protocol Violation|1|||
157072553|NCT01011868|567019809|FG001|After Week 18 Follow-up|Protocol Violation|1|||
157072554|NCT01011868|567019810|FG002|After Week 18 Follow-up|Protocol Violation|1|||
157072555|NCT01011868|567019808|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
157072556|NCT01011868|567019809|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
157072557|NCT01011868|567019810|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
157072558|NCT01011868|567019808|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
157072559|NCT01011868|567019809|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
157072560|NCT01011868|567019810|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
157072561|NCT01011868|567019808|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
157072562|NCT01011868|567019809|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
157072563|NCT01011868|567019810|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
157072564|NCT01011868|567019808|FG000|After Week 78 Follow-up|Adverse Event|14|||
157072565|NCT01011868|567019809|FG001|After Week 78 Follow-up|Adverse Event|18|||
157072566|NCT01011868|567019810|FG002|After Week 78 Follow-up|Adverse Event|21|||
157072567|NCT01011868|567019808|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
157072568|NCT01011868|567019809|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
157072569|NCT01011868|567019810|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
157072570|NCT01011868|567019808|FG000|After Week 78 Follow-up|Protocol Violation|9|||
157072571|NCT01011868|567019809|FG001|After Week 78 Follow-up|Protocol Violation|1|||
157072572|NCT01011868|567019810|FG002|After Week 78 Follow-up|Protocol Violation|2|||
157072573|NCT01011868|567019808|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
157072574|NCT01011868|567019809|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
157072575|NCT01011868|567019810|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
157072576|NCT01011868|567019808|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
157072577|NCT01011868|567019809|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
157072578|NCT01011868|567019810|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
157072579|NCT01011868|567019808|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
157072580|NCT01011868|567019809|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
157072581|NCT01011868|567019810|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
157072582|NCT01255761|567019811|FG000|Overall Study|Adverse Event|29|||
157072583|NCT01255761|567019812|FG001|Overall Study|Adverse Event|43|||
157072584|NCT01255761|567019811|FG000|Overall Study|Lack of Efficacy|86|||
157072585|NCT01255761|567019812|FG001|Overall Study|Lack of Efficacy|74|||
157072586|NCT01255761|567019811|FG000|Overall Study|Protocol Violation|9|||
157072587|NCT01255761|567019812|FG001|Overall Study|Protocol Violation|5|||
157072588|NCT01255761|567019811|FG000|Overall Study|Lost to Follow-up|10|||
157072589|NCT01255761|567019812|FG001|Overall Study|Lost to Follow-up|8|||
157072590|NCT01255761|567019811|FG000|Overall Study|Withdrawal by Subject|11|||
157072591|NCT01255761|567019812|FG001|Overall Study|Withdrawal by Subject|27|||
157072592|NCT01255761|567019811|FG000|Overall Study|Other Reasons|37|||
157072593|NCT01255761|567019812|FG001|Overall Study|Other Reasons|18|||
157191763|NCT00027846|567443391|FG001|Overall Study|Withdrawal by Subject|14|||
157072594|NCT04147858|567019813|FG000|Overall Study|Adverse Event|6|||
157072595|NCT04147858|567019814|FG001|Overall Study|Adverse Event|6|||
157072596|NCT04147858|567019815|FG002|Overall Study|Adverse Event|6|||
157072597|NCT04147858|567019813|FG000|Overall Study|Lack of Efficacy|3|||
157072598|NCT04147858|567019814|FG001|Overall Study|Lack of Efficacy|3|||
157072599|NCT04147858|567019815|FG002|Overall Study|Lack of Efficacy|1|||
157072600|NCT04147858|567019813|FG000|Overall Study|Lost to Follow-up|1|||
157072601|NCT04147858|567019814|FG001|Overall Study|Lost to Follow-up|6|||
157072602|NCT04147858|567019815|FG002|Overall Study|Lost to Follow-up|2|||
157072603|NCT04147858|567019813|FG000|Overall Study|Withdrawal by Subject|3|||
157072604|NCT04147858|567019814|FG001|Overall Study|Withdrawal by Subject|4|||
157072605|NCT04147858|567019815|FG002|Overall Study|Withdrawal by Subject|10|||
157072606|NCT04147858|567019813|FG000|Overall Study|Subject Noncompliance, Other|4|||
157072607|NCT04147858|567019814|FG001|Overall Study|Subject Noncompliance, Other|3|||
157072608|NCT04147858|567019815|FG002|Overall Study|Subject Noncompliance, Other|1|||
157072609|NCT02615938|567019818|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
157072610|NCT02615938|567019819|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
157072611|NCT02615938|567019820|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
157072612|NCT02615938|567019821|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
157072613|NCT02615938|567019818|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
157072614|NCT02615938|567019819|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
157072615|NCT02615938|567019820|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
157072616|NCT02615938|567019821|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
157072617|NCT02615938|567019818|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
157072618|NCT02615938|567019819|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
157072619|NCT02615938|567019820|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
157072620|NCT02615938|567019821|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
157072621|NCT04905849|567019823|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
157072622|NCT04905849|567019824|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
157072623|NCT00838929|567019834|FG000|Overall Study|Protocol Violation|0|||
157072624|NCT00838929|567019835|FG001|Overall Study|Protocol Violation|1|||
157072625|NCT00838929|567019836|FG002|Overall Study|Protocol Violation|0|||
157072626|NCT00838929|567019834|FG000|Overall Study|Disease progression|0|||
157072627|NCT00838929|567019835|FG001|Overall Study|Disease progression|2|||
157072628|NCT00838929|567019836|FG002|Overall Study|Disease progression|1|||
157072629|NCT03375320|567019843|FG000|Overall Study|Adverse Event|34|||
157072630|NCT03375320|567019844|FG001|Overall Study|Adverse Event|9|||
157072631|NCT03375320|567019845|FG002|Overall Study|Adverse Event|10|||
157072632|NCT03375320|567019846|FG003|Overall Study|Adverse Event|0|||
157072633|NCT03375320|567019843|FG000|Overall Study|Death|6|||
157072634|NCT03375320|567019844|FG001|Overall Study|Death|3|||
157072635|NCT03375320|567019845|FG002|Overall Study|Death|0|||
157072636|NCT03375320|567019846|FG003|Overall Study|Death|0|||
157072637|NCT03375320|567019843|FG000|Overall Study|Withdrawal by Subject|7|||
157072638|NCT03375320|567019844|FG001|Overall Study|Withdrawal by Subject|4|||
157072639|NCT03375320|567019845|FG002|Overall Study|Withdrawal by Subject|5|||
157072640|NCT03375320|567019846|FG003|Overall Study|Withdrawal by Subject|4|||
157072641|NCT03375320|567019843|FG000|Overall Study|Progressive disease|55|||
157072642|NCT03375320|567019844|FG001|Overall Study|Progressive disease|41|||
157072643|NCT03375320|567019845|FG002|Overall Study|Progressive disease|29|||
157072644|NCT03375320|567019846|FG003|Overall Study|Progressive disease|24|||
157072645|NCT03375320|567019843|FG000|Overall Study|Alternative treatment|6|||
157072646|NCT03375320|567019844|FG001|Overall Study|Alternative treatment|1|||
157072647|NCT03375320|567019845|FG002|Overall Study|Alternative treatment|1|||
157072648|NCT03375320|567019846|FG003|Overall Study|Alternative treatment|0|||
157072649|NCT03375320|567019843|FG000|Overall Study|Other disease|1|||
157072650|NCT03375320|567019844|FG001|Overall Study|Other disease|1|||
157072651|NCT03375320|567019845|FG002|Overall Study|Other disease|3|||
157072652|NCT03375320|567019846|FG003|Overall Study|Other disease|0|||
157072653|NCT03375320|567019843|FG000|Overall Study|Withdrawal prior to initiation|2|||
157072654|NCT03375320|567019844|FG001|Overall Study|Withdrawal prior to initiation|2|||
157072655|NCT03375320|567019845|FG002|Overall Study|Withdrawal prior to initiation|1|||
157072656|NCT03375320|567019846|FG003|Overall Study|Withdrawal prior to initiation|0|||
157072657|NCT03375320|567019843|FG000|Overall Study|Physician Decision|1|||
157072658|NCT03375320|567019844|FG001|Overall Study|Physician Decision|1|||
157072659|NCT03375320|567019845|FG002|Overall Study|Physician Decision|1|||
157072660|NCT03375320|567019846|FG003|Overall Study|Physician Decision|1|||
157072661|NCT03375320|567019843|FG000|Overall Study|Non-compliance|1|||
157072662|NCT03375320|567019844|FG001|Overall Study|Non-compliance|0|||
157072663|NCT03375320|567019845|FG002|Overall Study|Non-compliance|0|||
157072664|NCT03375320|567019846|FG003|Overall Study|Non-compliance|0|||
157072665|NCT04199052|567019849|FG000|Overall Study|Lost to Follow-up|11|||
157072666|NCT04199052|567019850|FG001|Overall Study|Lost to Follow-up|18|||
157072667|NCT00699842|567019851|FG000|Overall Study|Death|0|||
157072668|NCT00699842|567019852|FG001|Overall Study|Death|1|||
157072669|NCT00699842|567019853|FG002|Overall Study|Death|0|||
157072670|NCT04907357|567019854|FG000|Overall Study|Death|0|||
157072671|NCT04907357|567019855|FG001|Overall Study|Death|1|||
157072672|NCT04907357|567019854|FG000|Overall Study|Lost to Follow-up|9|||
157072673|NCT04907357|567019855|FG001|Overall Study|Lost to Follow-up|18|||
157072674|NCT04907357|567019854|FG000|Overall Study|Physician Decision|1|||
157191764|NCT00027846|567443392|FG002|Overall Study|Withdrawal by Subject|7|||
157191765|NCT00027846|567443390|FG000|Overall Study|Ineligible for study|2|||
157191766|NCT00027846|567443391|FG001|Overall Study|Ineligible for study|6|||
157191767|NCT00027846|567443392|FG002|Overall Study|Ineligible for study|14|||
157191768|NCT00027846|567443390|FG000|Overall Study|Entry into another COG therapeutic study|0|||
157191769|NCT00027846|567443391|FG001|Overall Study|Entry into another COG therapeutic study|5|||
157191770|NCT00027846|567443392|FG002|Overall Study|Entry into another COG therapeutic study|2|||
157191771|NCT00027846|567443390|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
157191772|NCT00027846|567443391|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
157191773|NCT00027846|567443392|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
157191774|NCT01503229|567443393|FG000|Overall Study|Withdrew consent|1|||
157191775|NCT01354964|567443394|FG000|Overall Study|Lost to Follow-up|2|||
157191776|NCT01354964|567443395|FG001|Overall Study|Lost to Follow-up|0|||
157191777|NCT01354964|567443394|FG000|Overall Study|IV access issues|1|||
157191778|NCT01354964|567443395|FG001|Overall Study|IV access issues|1|||
157191779|NCT01354964|567443394|FG000|Overall Study|Physician Decision|1|||
157191780|NCT01354964|567443395|FG001|Overall Study|Physician Decision|0|||
157072675|NCT04907357|567019855|FG001|Overall Study|Physician Decision|0|||
157072676|NCT04907357|567019854|FG000|Overall Study|Withdrawal by Subject|0|||
157072677|NCT04907357|567019855|FG001|Overall Study|Withdrawal by Subject|1|||
157072678|NCT04907357|567019854|FG000|Overall Study|Unable to attend visits|1|||
157072679|NCT04907357|567019855|FG001|Overall Study|Unable to attend visits|0|||
157072680|NCT04907357|567019854|FG000|Overall Study|Incarcerated|1|||
157072681|NCT04907357|567019855|FG001|Overall Study|Incarcerated|1|||
157072682|NCT03342196|567019856|FG000|Overall Study|Physician Decision|1|||
157072683|NCT03512197|567019859|FG000|Overall Study|Guardian decision|1|||
157072684|NCT03512197|567019860|FG001|Overall Study|Guardian decision|1|||
157072685|NCT03512197|567019859|FG000|Overall Study|Lack of Efficacy|19|||
157072686|NCT03512197|567019860|FG001|Overall Study|Lack of Efficacy|11|||
157072687|NCT03512197|567019859|FG000|Overall Study|New Therapy for Study Indication|16|||
157072688|NCT03512197|567019860|FG001|Overall Study|New Therapy for Study Indication|16|||
157072689|NCT03512197|567019859|FG000|Overall Study|Physician Decision|60|||
157072690|NCT03512197|567019860|FG001|Overall Study|Physician Decision|60|||
157072691|NCT03512197|567019859|FG000|Overall Study|Protocol Violation|0|||
157072692|NCT03512197|567019860|FG001|Overall Study|Protocol Violation|2|||
157072693|NCT03512197|567019859|FG000|Overall Study|Terminated by Sponsored|46|||
157072694|NCT03512197|567019860|FG001|Overall Study|Terminated by Sponsored|50|||
157072695|NCT03512197|567019859|FG000|Overall Study|Subject Decision|15|||
157072696|NCT03512197|567019860|FG001|Overall Study|Subject Decision|12|||
157072697|NCT03512197|567019859|FG000|Overall Study|Withdrawal of informed consent|20|||
157072698|NCT03512197|567019860|FG001|Overall Study|Withdrawal of informed consent|14|||
157072699|NCT03512197|567019859|FG000|Overall Study|Adverse Event|30|||
157072700|NCT03512197|567019860|FG001|Overall Study|Adverse Event|34|||
157072701|NCT03512197|567019859|FG000|Overall Study|Death|14|||
157072702|NCT03512197|567019860|FG001|Overall Study|Death|9|||
157072703|NCT03512197|567019859|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
157072704|NCT03512197|567019860|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
157072705|NCT03512197|567019859|FG000|Overall Study|Missing|3|||
157072706|NCT03512197|567019860|FG001|Overall Study|Missing|13|||
157072707|NCT01806389|567019861|FG000|Overall Study|Withdrawal by Subject|4|||
157072708|NCT03842436|567019862|FG000|Overall Study|Lost to Follow-up|1|||
157072709|NCT01948076|567019863|FG000|Overall Study|Withdrawal by Subject|0|||
157072710|NCT01948076|567019864|FG001|Overall Study|Withdrawal by Subject|1|||
157072711|NCT03358238|567019867|FG000|Overall Study|Withdrawal by Subject|0|||
157072712|NCT03358238|567019868|FG001|Overall Study|Withdrawal by Subject|1|||
157072713|NCT00486252|567019871|FG000|Overall Study|Adverse Event|7|||
157072714|NCT00486252|567019871|FG000|Overall Study|Lack of Efficacy|9|||
157072715|NCT00486252|567019871|FG000|Overall Study|Lost to Follow-up|24|||
157072716|NCT00486252|567019871|FG000|Overall Study|Other|18|||
157072717|NCT04596540|567019872|FG000|Overall Study|Withdrawal by Subject|9|||
157191781|NCT00711009|567443396|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
157191782|NCT00711009|567443397|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
157191783|NCT00711009|567443396|FG000|Overall Study|Withdrawal by Subject|4|||
157191784|NCT00711009|567443397|FG001|Overall Study|Withdrawal by Subject|2|||
157072718|NCT04596540|567019873|FG001|Overall Study|Withdrawal by Subject|8|||
157072719|NCT04596540|567019874|FG002|Overall Study|Withdrawal by Subject|5|||
157072720|NCT04596540|567019872|FG000|Overall Study|Lost to Follow-up|1|||
157072721|NCT04596540|567019873|FG001|Overall Study|Lost to Follow-up|2|||
157072722|NCT04596540|567019874|FG002|Overall Study|Lost to Follow-up|1|||
157072723|NCT04596540|567019872|FG000|Overall Study|Sponsor Decision|2|||
157072724|NCT04596540|567019873|FG001|Overall Study|Sponsor Decision|0|||
157072725|NCT04596540|567019874|FG002|Overall Study|Sponsor Decision|0|||
157072726|NCT04596540|567019872|FG000|Overall Study|Physician Decision|0|||
157191785|NCT00711009|567443396|FG000|Overall Study|Lost to Follow-up|3|||
157230983|NCT03049488|567592448|FG003|Overall Study|Moved from Area|1|||
157230984|NCT03049488|567592449|FG004|Overall Study|Moved from Area|1|||
157230985|NCT03049488|567592450|FG005|Overall Study|Moved from Area|0|||
157230986|NCT03049488|567592445|FG000|Overall Study|Physician Decision|0|||
157230987|NCT03049488|567592446|FG001|Overall Study|Physician Decision|1|||
157230988|NCT03049488|567592447|FG002|Overall Study|Physician Decision|0|||
157230989|NCT03049488|567592448|FG003|Overall Study|Physician Decision|0|||
157230990|NCT03049488|567592449|FG004|Overall Study|Physician Decision|0|||
157230991|NCT03049488|567592450|FG005|Overall Study|Physician Decision|0|||
157230992|NCT03049488|567592445|FG000|Overall Study|Withdrawal by Subject|0|||
157230993|NCT03049488|567592446|FG001|Overall Study|Withdrawal by Subject|0|||
157230994|NCT03049488|567592447|FG002|Overall Study|Withdrawal by Subject|0|||
157230995|NCT03049488|567592448|FG003|Overall Study|Withdrawal by Subject|1|||
157230996|NCT03049488|567592449|FG004|Overall Study|Withdrawal by Subject|1|||
157230997|NCT03049488|567592450|FG005|Overall Study|Withdrawal by Subject|0|||
157230998|NCT03099538|567592452|FG000|Overall Study|Lack of Efficacy|3|||
157230999|NCT00440557|567592453|FG000|Overall Study|Withdrawal by Subject|10|||
157231000|NCT00440557|567592454|FG001|Overall Study|Withdrawal by Subject|5|||
157231001|NCT00440557|567592455|FG002|Overall Study|Withdrawal by Subject|11|||
157231002|NCT00440557|567592453|FG000|Overall Study|Lost to Follow-up|1|||
157231003|NCT00440557|567592454|FG001|Overall Study|Lost to Follow-up|2|||
157231004|NCT00440557|567592455|FG002|Overall Study|Lost to Follow-up|6|||
157231005|NCT00440557|567592453|FG000|Overall Study|Adverse Event|3|||
157231006|NCT00440557|567592454|FG001|Overall Study|Adverse Event|3|||
157231007|NCT00440557|567592455|FG002|Overall Study|Adverse Event|5|||
157231008|NCT00440557|567592453|FG000|Overall Study|Death|2|||
157231009|NCT00440557|567592454|FG001|Overall Study|Death|6|||
157231010|NCT00440557|567592455|FG002|Overall Study|Death|3|||
157231011|NCT00440557|567592453|FG000|Overall Study|Began Dialysis|4|||
157231012|NCT00440557|567592454|FG001|Overall Study|Began Dialysis|1|||
157231013|NCT00440557|567592455|FG002|Overall Study|Began Dialysis|4|||
157231014|NCT00440557|567592453|FG000|Overall Study|Principal Investigator decision|0|||
157231015|NCT00440557|567592454|FG001|Overall Study|Principal Investigator decision|3|||
157231016|NCT00440557|567592455|FG002|Overall Study|Principal Investigator decision|1|||
157231017|NCT00440557|567592453|FG000|Overall Study|Patient moved|1|||
157231018|NCT00440557|567592454|FG001|Overall Study|Patient moved|2|||
157231019|NCT00440557|567592455|FG002|Overall Study|Patient moved|1|||
157231020|NCT00440557|567592453|FG000|Overall Study|Principal Investigator's office closed|3|||
157231021|NCT00440557|567592454|FG001|Overall Study|Principal Investigator's office closed|6|||
157231022|NCT00440557|567592455|FG002|Overall Study|Principal Investigator's office closed|4|||
157231023|NCT00440557|567592453|FG000|Overall Study|Patient transferred to nursing home|0|||
157231024|NCT00440557|567592454|FG001|Overall Study|Patient transferred to nursing home|1|||
157231025|NCT00440557|567592455|FG002|Overall Study|Patient transferred to nursing home|0|||
157231026|NCT00440557|567592453|FG000|Overall Study|Patient had surgery|1|||
157231027|NCT00440557|567592454|FG001|Overall Study|Patient had surgery|0|||
157231028|NCT00440557|567592455|FG002|Overall Study|Patient had surgery|0|||
157231029|NCT02107092|567592465|FG000|Overall Study|Miscellaneous|3|||
157191786|NCT00711009|567443397|FG001|Overall Study|Lost to Follow-up|9|||
157191787|NCT00711009|567443396|FG000|Overall Study|Participant Noncompliant|0|||
157191788|NCT00711009|567443397|FG001|Overall Study|Participant Noncompliant|1|||
157191789|NCT00711009|567443396|FG000|Overall Study|Virologic Failure|2|||
157191790|NCT00711009|567443397|FG001|Overall Study|Virologic Failure|1|||
157191791|NCT00711009|567443396|FG000|Overall Study|Pregnancy|1|||
157191792|NCT00711009|567443397|FG001|Overall Study|Pregnancy|0|||
157191793|NCT00711009|567443396|FG000|Overall Study|Site closing|0|||
157191794|NCT00711009|567443397|FG001|Overall Study|Site closing|1|||
157191795|NCT00711009|567443396|FG000|Overall Study|Dose adjustment|1|||
157191796|NCT00711009|567443397|FG001|Overall Study|Dose adjustment|0|||
157191797|NCT02534324|567443399|FG000|Overall Study|Protocol Violation|4|||
157191798|NCT02534324|567443400|FG001|Overall Study|Protocol Violation|1|||
157191799|NCT02534324|567443399|FG000|Overall Study|Lost to Follow-up|20|||
157191800|NCT02534324|567443400|FG001|Overall Study|Lost to Follow-up|7|||
157191801|NCT02534324|567443399|FG000|Overall Study|Adverse Event|1|||
157191802|NCT02534324|567443400|FG001|Overall Study|Adverse Event|0|||
157191803|NCT05604781|567443401|FG000|Overall Study|Lost to Follow-up|3|||
157191804|NCT05604781|567443401|FG000|Overall Study|Adverse Event|1|||
157191805|NCT01459016|567443402|FG000|Overall Study|Withdrawal by Subject|11|||
157191806|NCT01459016|567443402|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
157191807|NCT03922945|567443416|FG000|Overall Study|Adverse Event|1|||
157191808|NCT03922945|567443417|FG001|Overall Study|Adverse Event|1|||
157191809|NCT03922945|567443418|FG002|Overall Study|Adverse Event|2|||
157191810|NCT03922945|567443416|FG000|Overall Study|Lost to Follow-up|13|||
157231030|NCT02107092|567592465|FG000|Overall Study|Subject compliance|3|||
157231031|NCT02107092|567592465|FG000|Overall Study|Hypo-or hyperkalemia|2|||
157072727|NCT04596540|567019873|FG001|Overall Study|Physician Decision|1|||
157231032|NCT02107092|567592465|FG000|Overall Study|Met ECG withdrawal criteria|3|||
157072728|NCT04596540|567019874|FG002|Overall Study|Physician Decision|1|||
157072729|NCT04596540|567019872|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
157072730|NCT04596540|567019873|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
157072731|NCT04596540|567019874|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
157072732|NCT04596540|567019872|FG000|Overall Study|Other Than Specified|5|||
157072733|NCT04596540|567019873|FG001|Overall Study|Other Than Specified|5|||
157072734|NCT04596540|567019874|FG002|Overall Study|Other Than Specified|2|||
157072735|NCT02633397|567019875|FG000|Overall Study|Adverse Event|8|||
157072736|NCT02633397|567019876|FG001|Overall Study|Adverse Event|8|||
157072737|NCT02633397|567019875|FG000|Overall Study|Study Burden|4|||
157072738|NCT02633397|567019876|FG001|Overall Study|Study Burden|1|||
157072739|NCT02633397|567019875|FG000|Overall Study|Treatment interruption|2|||
157072740|NCT02633397|567019876|FG001|Overall Study|Treatment interruption|5|||
157072741|NCT02633397|567019875|FG000|Overall Study|Death|2|||
157072742|NCT02633397|567019876|FG001|Overall Study|Death|2|||
157072743|NCT02633397|567019875|FG000|Overall Study|Physician Decision|0|||
157072744|NCT02633397|567019876|FG001|Overall Study|Physician Decision|1|||
157072745|NCT01340014|567019879|FG000|Period 1, First 7 Days|Adverse Event|1|||
157072746|NCT01340014|567019880|FG001|Period 1, First 7 Days|Adverse Event|0|||
157072747|NCT01340014|567019879|FG000|Period 1, First 7 Days|Personal Reasons|1|||
157072748|NCT01340014|567019880|FG001|Period 1, First 7 Days|Personal Reasons|0|||
157072749|NCT01340014|567019879|FG000|Period 2, Second 7 Days|Adverse Event|0|||
157072750|NCT01340014|567019880|FG001|Period 2, Second 7 Days|Adverse Event|1|||
157072751|NCT02520310|567019881|FG000|At 6 Months Clinical Follow-up|Death|1|||
157072752|NCT02520310|567019881|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
157072753|NCT02520310|567019881|FG000|AT 3 Year Clinical Follow-up|Death|2|||
157072754|NCT02520310|567019881|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
157072755|NCT02520310|567019881|FG000|AT 4 Year Clinical Follow-up|Death|1|||
157072756|NCT02520310|567019881|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
157072757|NCT05101993|567019884|FG000|Overall Study|Withdrawal by Subject|1|||
157072758|NCT04577573|567019885|FG000|Overall Study|Technical - invalid protocol|0|||
157072759|NCT04577573|567019886|FG001|Overall Study|Technical - invalid protocol|2|||
157072760|NCT04577573|567019887|FG002|Overall Study|Technical - invalid protocol|0|||
157072761|NCT04526665|567019890|FG000|Overall Study|Withdrawal by Subject|6|||
157072762|NCT04526665|567019891|FG001|Overall Study|Withdrawal by Subject|3|||
157072763|NCT04526665|567019890|FG000|Overall Study|Adverse Event|4|||
157072764|NCT04526665|567019891|FG001|Overall Study|Adverse Event|1|||
157072765|NCT04526665|567019890|FG000|Overall Study|Physician Decision|2|||
157072766|NCT04526665|567019891|FG001|Overall Study|Physician Decision|2|||
157072767|NCT04526665|567019890|FG000|Overall Study|Death|2|||
157072768|NCT04526665|567019891|FG001|Overall Study|Death|0|||
157072769|NCT04526665|567019890|FG000|Overall Study|Other|0|||
157072770|NCT04526665|567019891|FG001|Overall Study|Other|1|||
157072771|NCT02065882|567019893|FG000|Part I: PK/PD|Screening failure|5|||
157072772|NCT02065882|567019893|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
157072773|NCT02065882|567019893|FG000|Part I: PK/PD|Adverse Event|1|||
157072774|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|Screening failure|7|||
157072775|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
157072776|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
157072777|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
157072778|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
157072779|NCT02065882|567019893|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
157072780|NCT04949802|567021347|FG000|Overall Study|Lost to Follow-up|3|||
157072781|NCT01020877|567021350|FG000|Second Intervention|Withdrawal by Subject|1|||
157072782|NCT01020877|567021351|FG001|Second Intervention|Withdrawal by Subject|0|||
157072783|NCT01784523|567021352|FG000|Overall Study|Study closed early|7|||
157072784|NCT01784523|567021353|FG001|Overall Study|Study closed early|4|||
157072785|NCT00709228|567021354|FG000|Overall Study|Not treated|14|||
157072786|NCT00709228|567021354|FG000|Overall Study|Eligibility criteria not met|281|||
157072787|NCT00709228|567021354|FG000|Overall Study|Adverse events|2|||
157072788|NCT00709228|567021354|FG000|Overall Study|Discontinued treatment|14|||
157072789|NCT00709228|567021354|FG000|Overall Study|Did not enter follow-up|4|||
157072790|NCT00709228|567021354|FG000|Overall Study|Discontinued follow-up|5|||
157072791|NCT00709228|567021354|FG000|Overall Study|Disease progression|1|||
157072792|NCT00709228|567021354|FG000|Overall Study|Lost to Follow-up|6|||
157072793|NCT00709228|567021354|FG000|Overall Study|Non-compliance|5|||
157072794|NCT02179177|567021357|FG000|Overall Study|Lost to Follow-up|1|||
157072795|NCT02179177|567021358|FG001|Overall Study|Lost to Follow-up|1|||
157072796|NCT02179177|567021357|FG000|Overall Study|Withdrawal by Subject|1|||
157072797|NCT02179177|567021358|FG001|Overall Study|Withdrawal by Subject|1|||
157072798|NCT00022659|567021359|FG000|Overall Study|Ineligible: wrong primary|1|||
157072799|NCT00022659|567021359|FG000|Overall Study|Never treated|1|||
157072800|NCT00884650|567021362|FG000|Overall Study|Did not return complete pain diaries|7|||
157072801|NCT00884650|567021363|FG001|Overall Study|Did not return complete pain diaries|7|||
157072802|NCT00884650|567021362|FG000|Overall Study|Admitted Post-Op|1|||
157072803|NCT00884650|567021363|FG001|Overall Study|Admitted Post-Op|0|||
157191811|NCT03922945|567443417|FG001|Overall Study|Lost to Follow-up|9|||
157231033|NCT02107092|567592465|FG000|Overall Study|Physician Decision|3|||
157231034|NCT02107092|567592465|FG000|Overall Study|Lost to Follow-up|2|||
157231035|NCT02107092|567592465|FG000|Overall Study|Withdrawal by Subject|9|||
157231036|NCT02107092|567592465|FG000|Overall Study|Adverse Event|7|||
157231037|NCT02107092|567592465|FG000|Overall Study|Expected progression of CKD|12|||
157231038|NCT00537030|567592466|FG000|Overall Study|Physician Decision|2|||
157231039|NCT00537030|567592466|FG000|Overall Study|Withdrawal by Subject|2|||
157231040|NCT00537030|567592466|FG000|Overall Study|≥ Grade 2 allergy|7|||
157072804|NCT00884650|567021362|FG000|Overall Study|Femoral Stress Fracture|1|||
157072805|NCT00884650|567021363|FG001|Overall Study|Femoral Stress Fracture|0|||
157072806|NCT00884650|567021362|FG000|Overall Study|Pain Pump Complication|0|||
157072807|NCT00884650|567021363|FG001|Overall Study|Pain Pump Complication|1|||
157072808|NCT04052425|567021364|FG000|24-Week Double-blind Period|Adverse Event|0|||
157072809|NCT04052425|567021365|FG001|24-Week Double-blind Period|Adverse Event|1|||
157072810|NCT04052425|567021366|FG002|24-Week Double-blind Period|Adverse Event|0|||
157072811|NCT04052425|567021367|FG003|24-Week Double-blind Period|Adverse Event|0|||
157072812|NCT04052425|567021364|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
157072813|NCT04052425|567021365|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
157072814|NCT04052425|567021366|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
157072815|NCT04052425|567021367|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
157072816|NCT04052425|567021364|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
157072817|NCT04052425|567021365|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
157072818|NCT04052425|567021366|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
157072819|NCT04052425|567021367|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
157072820|NCT04052425|567021364|FG000|24-Week Double-blind Period|Physician Decision|1|||
157072821|NCT04052425|567021365|FG001|24-Week Double-blind Period|Physician Decision|0|||
157072822|NCT04052425|567021366|FG002|24-Week Double-blind Period|Physician Decision|0|||
157072823|NCT04052425|567021367|FG003|24-Week Double-blind Period|Physician Decision|0|||
157072824|NCT04052425|567021364|FG000|24-Week Double-blind Period|Protocol Violation|1|||
157072825|NCT04052425|567021365|FG001|24-Week Double-blind Period|Protocol Violation|0|||
157072826|NCT04052425|567021366|FG002|24-Week Double-blind Period|Protocol Violation|0|||
157072827|NCT04052425|567021367|FG003|24-Week Double-blind Period|Protocol Violation|0|||
157072828|NCT04052425|567021364|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
157072829|NCT04052425|567021365|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
157072830|NCT04052425|567021366|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
157072831|NCT04052425|567021367|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
157072832|NCT04052425|567021364|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
157072833|NCT04052425|567021365|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
157072834|NCT04052425|567021366|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
157072835|NCT04052425|567021367|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
157072836|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
157072837|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
157072838|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
157072839|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
157072840|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
157072841|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
157072842|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
157072843|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
157072844|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
157072845|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
157072846|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
157072847|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
157072848|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
157072849|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
157072850|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
157072851|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
157072852|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
157072853|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
157072854|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
157072855|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
157072856|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
157072857|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
157072858|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
157072859|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
157072860|NCT04052425|567021364|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
157072861|NCT04052425|567021365|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
157231041|NCT00537030|567592466|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
157231042|NCT00537030|567592466|FG000|Overall Study|Ineligible|2|||
157231043|NCT00537030|567592466|FG000|Overall Study|Inevaluable|2|||
157072862|NCT04052425|567021366|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
157072863|NCT04052425|567021367|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
157072864|NCT04334278|567021368|FG000|Overall Study|Lost to Follow-up|0|||
157072865|NCT04334278|567021369|FG001|Overall Study|Lost to Follow-up|3|||
157072866|NCT04334278|567021368|FG000|Overall Study|Withdrawal by Subject|4|||
157072867|NCT04334278|567021369|FG001|Overall Study|Withdrawal by Subject|2|||
157072868|NCT01732549|567021372|FG000|Overall Study|Adverse Event|13|||
157072869|NCT01732549|567021373|FG001|Overall Study|Adverse Event|3|||
157072870|NCT01732549|567021372|FG000|Overall Study|Consent withdrawn|13|||
157072871|NCT01732549|567021373|FG001|Overall Study|Consent withdrawn|6|||
157072872|NCT01732549|567021372|FG000|Overall Study|Disease progression|37|||
157072873|NCT01732549|567021373|FG001|Overall Study|Disease progression|50|||
157072874|NCT01732549|567021372|FG000|Overall Study|Other|8|||
157072875|NCT01732549|567021373|FG001|Overall Study|Other|14|||
157072876|NCT01516749|567021374|FG000|Active Therapy|Lost to Follow-up|1|||
157072877|NCT01516749|567021374|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
157072878|NCT03994731|567021376|FG000|Pegloticase + IMM Period|Death|2|||
157072879|NCT03994731|567021377|FG001|Pegloticase + IMM Period|Death|0|||
157072880|NCT03994731|567021376|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
157072881|NCT03994731|567021377|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
157072882|NCT03994731|567021376|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
157072883|NCT03994731|567021377|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
157072884|NCT01681992|567021380|FG000|Overall Study|Adverse Event|3|||
157072885|NCT01681992|567021381|FG001|Overall Study|Adverse Event|2|||
157072886|NCT01681992|567021382|FG002|Overall Study|Adverse Event|3|||
157072887|NCT01681992|567021380|FG000|Overall Study|Lost to Follow-up|36|||
157072888|NCT01681992|567021381|FG001|Overall Study|Lost to Follow-up|38|||
157072889|NCT01681992|567021382|FG002|Overall Study|Lost to Follow-up|53|||
157072890|NCT01681992|567021380|FG000|Overall Study|As Per Sponsor Decision|0|||
157072891|NCT01681992|567021381|FG001|Overall Study|As Per Sponsor Decision|0|||
157072892|NCT01681992|567021382|FG002|Overall Study|As Per Sponsor Decision|1|||
157072893|NCT01681992|567021380|FG000|Overall Study|Protocol Violation|0|||
157072894|NCT01681992|567021381|FG001|Overall Study|Protocol Violation|0|||
157072895|NCT01681992|567021382|FG002|Overall Study|Protocol Violation|1|||
157072896|NCT01681992|567021380|FG000|Overall Study|Withdrawal by Subject|27|||
157072897|NCT01681992|567021381|FG001|Overall Study|Withdrawal by Subject|30|||
157072898|NCT01681992|567021382|FG002|Overall Study|Withdrawal by Subject|25|||
157072899|NCT00447590|567021387|FG000|Overall Study|Withdrawal by Subject|26|||
157072900|NCT00447590|567021387|FG000|Overall Study|Lost to Follow-up|24|||
157072901|NCT00447590|567021387|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
157072902|NCT03377361|567021388|FG000|Pre-Treatment|Subject withdrew consent|0|||
157072903|NCT03377361|567021389|FG001|Pre-Treatment|Subject withdrew consent|0|||
157072904|NCT03377361|567021390|FG002|Pre-Treatment|Subject withdrew consent|0|||
157072905|NCT03377361|567021391|FG003|Pre-Treatment|Subject withdrew consent|0|||
157072906|NCT03377361|567021392|FG004|Pre-Treatment|Subject withdrew consent|0|||
157072907|NCT03377361|567021393|FG005|Pre-Treatment|Subject withdrew consent|0|||
157072908|NCT03377361|567021394|FG006|Pre-Treatment|Subject withdrew consent|0|||
157072909|NCT03377361|567021395|FG007|Pre-Treatment|Subject withdrew consent|3|||
157072910|NCT03377361|567021396|FG008|Pre-Treatment|Subject withdrew consent|1|||
157072911|NCT03377361|567021397|FG009|Pre-Treatment|Subject withdrew consent|0|||
157072912|NCT03377361|567021388|FG000|Pre-Treatment|Not Reported|0|||
157072913|NCT03377361|567021389|FG001|Pre-Treatment|Not Reported|0|||
157072914|NCT03377361|567021390|FG002|Pre-Treatment|Not Reported|0|||
157072915|NCT03377361|567021391|FG003|Pre-Treatment|Not Reported|0|||
157072916|NCT03377361|567021392|FG004|Pre-Treatment|Not Reported|0|||
157072917|NCT03377361|567021393|FG005|Pre-Treatment|Not Reported|0|||
157072918|NCT03377361|567021394|FG006|Pre-Treatment|Not Reported|0|||
157072919|NCT03377361|567021395|FG007|Pre-Treatment|Not Reported|0|||
157072920|NCT03377361|567021396|FG008|Pre-Treatment|Not Reported|3|||
157072921|NCT03377361|567021397|FG009|Pre-Treatment|Not Reported|0|||
157072922|NCT03377361|567021388|FG000|Treatment Period|Disease Progression|3|||
157072923|NCT03377361|567021389|FG001|Treatment Period|Disease Progression|2|||
157072924|NCT03377361|567021390|FG002|Treatment Period|Disease Progression|5|||
157072925|NCT03377361|567021391|FG003|Treatment Period|Disease Progression|3|||
157072926|NCT03377361|567021392|FG004|Treatment Period|Disease Progression|3|||
157072927|NCT03377361|567021393|FG005|Treatment Period|Disease Progression|3|||
157072928|NCT03377361|567021394|FG006|Treatment Period|Disease Progression|6|||
157072929|NCT03377361|567021395|FG007|Treatment Period|Disease Progression|106|||
157072930|NCT03377361|567021396|FG008|Treatment Period|Disease Progression|48|||
157072931|NCT03377361|567021397|FG009|Treatment Period|Disease Progression|59|||
157072932|NCT03377361|567021388|FG000|Treatment Period|Study Drug Toxicity|0|||
157072933|NCT03377361|567021389|FG001|Treatment Period|Study Drug Toxicity|0|||
157072934|NCT03377361|567021390|FG002|Treatment Period|Study Drug Toxicity|0|||
157072935|NCT03377361|567021391|FG003|Treatment Period|Study Drug Toxicity|1|||
157072936|NCT03377361|567021392|FG004|Treatment Period|Study Drug Toxicity|0|||
157072937|NCT03377361|567021393|FG005|Treatment Period|Study Drug Toxicity|0|||
157072938|NCT03377361|567021394|FG006|Treatment Period|Study Drug Toxicity|0|||
157072939|NCT03377361|567021395|FG007|Treatment Period|Study Drug Toxicity|7|||
157072940|NCT03377361|567021396|FG008|Treatment Period|Study Drug Toxicity|2|||
157072941|NCT03377361|567021397|FG009|Treatment Period|Study Drug Toxicity|16|||
157072942|NCT03377361|567021388|FG000|Treatment Period|Death|0|||
157072943|NCT03377361|567021389|FG001|Treatment Period|Death|0|||
157072944|NCT03377361|567021390|FG002|Treatment Period|Death|1|||
157072945|NCT03377361|567021391|FG003|Treatment Period|Death|0|||
157072946|NCT03377361|567021392|FG004|Treatment Period|Death|0|||
157072947|NCT03377361|567021393|FG005|Treatment Period|Death|0|||
157072948|NCT03377361|567021394|FG006|Treatment Period|Death|0|||
157072949|NCT03377361|567021395|FG007|Treatment Period|Death|2|||
157072950|NCT03377361|567021396|FG008|Treatment Period|Death|1|||
157072951|NCT03377361|567021397|FG009|Treatment Period|Death|3|||
157072952|NCT03377361|567021388|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157072953|NCT03377361|567021389|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157072954|NCT03377361|567021390|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157191812|NCT03922945|567443418|FG002|Overall Study|Lost to Follow-up|20|||
157191813|NCT03922945|567443416|FG000|Overall Study|Lack of Efficacy|2|||
157191814|NCT03922945|567443417|FG001|Overall Study|Lack of Efficacy|0|||
157191815|NCT03922945|567443418|FG002|Overall Study|Lack of Efficacy|1|||
157191816|NCT03922945|567443416|FG000|Overall Study|Protocol Non-Compliance|0|||
157191817|NCT03922945|567443417|FG001|Overall Study|Protocol Non-Compliance|0|||
157191818|NCT03922945|567443418|FG002|Overall Study|Protocol Non-Compliance|1|||
157191819|NCT03922945|567443416|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
157191820|NCT03922945|567443417|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
157191821|NCT03922945|567443418|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
157191822|NCT03922945|567443416|FG000|Overall Study|All Other Personal Reasons|1|||
157191823|NCT03922945|567443417|FG001|Overall Study|All Other Personal Reasons|1|||
157191824|NCT03922945|567443418|FG002|Overall Study|All Other Personal Reasons|2|||
157191825|NCT02889861|567443419|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
157191826|NCT00313716|567443420|FG000|Overall Study|Death|3|||
157191827|NCT00313716|567443421|FG001|Overall Study|Death|2|||
157191828|NCT00313716|567443422|FG002|Overall Study|Death|9|||
157191829|NCT00313716|567443423|FG003|Overall Study|Death|3|||
157191830|NCT00313716|567443424|FG004|Overall Study|Death|5|||
157191831|NCT00313716|567443425|FG005|Overall Study|Death|9|||
157191832|NCT00313716|567443420|FG000|Overall Study|Lost to Follow-up|2|||
157191833|NCT00313716|567443421|FG001|Overall Study|Lost to Follow-up|5|||
157191834|NCT00313716|567443422|FG002|Overall Study|Lost to Follow-up|2|||
157191835|NCT00313716|567443423|FG003|Overall Study|Lost to Follow-up|1|||
157191836|NCT00313716|567443424|FG004|Overall Study|Lost to Follow-up|0|||
157191837|NCT00313716|567443425|FG005|Overall Study|Lost to Follow-up|4|||
157191838|NCT00313716|567443420|FG000|Overall Study|Withdrawal by Subject|0|||
157191839|NCT00313716|567443421|FG001|Overall Study|Withdrawal by Subject|1|||
157191840|NCT00313716|567443422|FG002|Overall Study|Withdrawal by Subject|1|||
157191841|NCT00313716|567443423|FG003|Overall Study|Withdrawal by Subject|0|||
157191842|NCT00313716|567443424|FG004|Overall Study|Withdrawal by Subject|1|||
157191843|NCT00313716|567443425|FG005|Overall Study|Withdrawal by Subject|0|||
157191844|NCT04067310|567443431|FG000|Overall Study|Physician Decision|2|||
157191845|NCT04067310|567443432|FG001|Overall Study|Physician Decision|6|||
157191846|NCT04067310|567443431|FG000|Overall Study|Lost to Follow-up|0|||
157191847|NCT04067310|567443432|FG001|Overall Study|Lost to Follow-up|1|||
157191848|NCT04067310|567443431|FG000|Overall Study|Withdrawal by Subject|3|||
157191849|NCT04067310|567443432|FG001|Overall Study|Withdrawal by Subject|0|||
157191850|NCT01041027|567443433|FG000|Overall Study|Withdrawal by Subject|2|||
157191851|NCT01041027|567443433|FG000|Overall Study|Protocol Violation|1|||
157191852|NCT01041027|567443433|FG000|Overall Study|Delayed Radiation Therapy|1|||
157191853|NCT01041027|567443433|FG000|Overall Study|Adverse Event|4|||
157191854|NCT01347931|567443434|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
157191855|NCT01249404|567443435|FG000|Overall Study|Study treatment not received|0|||
157191856|NCT01249404|567443436|FG001|Overall Study|Study treatment not received|1|||
157191857|NCT01249404|567443437|FG002|Overall Study|Study treatment not received|2|||
157191858|NCT01249404|567443435|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
157191859|NCT01249404|567443436|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
157191860|NCT01249404|567443437|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
157072955|NCT03377361|567021391|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157072956|NCT03377361|567021392|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157191861|NCT01249404|567443435|FG000|Overall Study|Adverse Event|2|||
157191862|NCT01249404|567443436|FG001|Overall Study|Adverse Event|2|||
157191863|NCT01249404|567443437|FG002|Overall Study|Adverse Event|2|||
157191864|NCT01249404|567443435|FG000|Overall Study|Withdrawal by Subject|2|||
157191865|NCT01249404|567443436|FG001|Overall Study|Withdrawal by Subject|2|||
157191866|NCT01249404|567443437|FG002|Overall Study|Withdrawal by Subject|0|||
157191867|NCT01249404|567443435|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
157191868|NCT01249404|567443436|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
157191869|NCT01249404|567443437|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
157072957|NCT03377361|567021393|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157072958|NCT03377361|567021394|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
157072959|NCT03377361|567021395|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
157072960|NCT03377361|567021396|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
157072961|NCT03377361|567021397|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
157072962|NCT03377361|567021388|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
157072963|NCT03377361|567021389|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
157072964|NCT03377361|567021390|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
157072965|NCT03377361|567021391|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
157072966|NCT03377361|567021392|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
157072967|NCT03377361|567021393|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
157072968|NCT03377361|567021394|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
157072969|NCT03377361|567021395|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
157072970|NCT03377361|567021396|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
157072971|NCT03377361|567021397|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
157072972|NCT03377361|567021388|FG000|Treatment Period|Subject Withdrew Consent|0|||
157072973|NCT03377361|567021389|FG001|Treatment Period|Subject Withdrew Consent|0|||
157072974|NCT03377361|567021390|FG002|Treatment Period|Subject Withdrew Consent|0|||
157072975|NCT03377361|567021391|FG003|Treatment Period|Subject Withdrew Consent|0|||
157072976|NCT03377361|567021392|FG004|Treatment Period|Subject Withdrew Consent|0|||
157072977|NCT03377361|567021393|FG005|Treatment Period|Subject Withdrew Consent|0|||
157072978|NCT03377361|567021394|FG006|Treatment Period|Subject Withdrew Consent|0|||
157072979|NCT03377361|567021395|FG007|Treatment Period|Subject Withdrew Consent|0|||
157072980|NCT03377361|567021396|FG008|Treatment Period|Subject Withdrew Consent|2|||
157072981|NCT03377361|567021397|FG009|Treatment Period|Subject Withdrew Consent|1|||
157072982|NCT03377361|567021388|FG000|Treatment Period|No longer meets study criteria|0|||
157072983|NCT03377361|567021389|FG001|Treatment Period|No longer meets study criteria|1|||
157072984|NCT03377361|567021390|FG002|Treatment Period|No longer meets study criteria|0|||
157072985|NCT03377361|567021391|FG003|Treatment Period|No longer meets study criteria|0|||
157072986|NCT03377361|567021392|FG004|Treatment Period|No longer meets study criteria|0|||
157072987|NCT03377361|567021393|FG005|Treatment Period|No longer meets study criteria|0|||
157072988|NCT03377361|567021394|FG006|Treatment Period|No longer meets study criteria|0|||
157072989|NCT03377361|567021395|FG007|Treatment Period|No longer meets study criteria|1|||
157072990|NCT03377361|567021396|FG008|Treatment Period|No longer meets study criteria|0|||
157072991|NCT03377361|567021397|FG009|Treatment Period|No longer meets study criteria|0|||
157072992|NCT03377361|567021388|FG000|Treatment Period|Other Reasons|0|||
157191870|NCT01249404|567443435|FG000|Overall Study|Non compliance to visit schedule|0|||
157191871|NCT01249404|567443436|FG001|Overall Study|Non compliance to visit schedule|1|||
157191872|NCT01249404|567443437|FG002|Overall Study|Non compliance to visit schedule|0|||
157191873|NCT02493712|567443438|FG000|Overall Study|Withdrawal by Subject|1|||
157191874|NCT02493712|567443439|FG001|Overall Study|Withdrawal by Subject|0|||
157191875|NCT02493712|567443440|FG002|Overall Study|Withdrawal by Subject|2|||
157191876|NCT02493712|567443438|FG000|Overall Study|Protocol Violation|0|||
157191877|NCT02493712|567443439|FG001|Overall Study|Protocol Violation|0|||
157191878|NCT02493712|567443440|FG002|Overall Study|Protocol Violation|1|||
157191879|NCT02493712|567443438|FG000|Overall Study|Lost to Follow-up|1|||
157191880|NCT02493712|567443439|FG001|Overall Study|Lost to Follow-up|0|||
157191881|NCT02493712|567443440|FG002|Overall Study|Lost to Follow-up|0|||
157191882|NCT02493712|567443438|FG000|Overall Study|Physician Decision|0|||
157191883|NCT02493712|567443439|FG001|Overall Study|Physician Decision|1|||
157191884|NCT02493712|567443440|FG002|Overall Study|Physician Decision|0|||
157191885|NCT02493712|567443438|FG000|Overall Study|Lack of Efficacy|0|||
157191886|NCT02493712|567443439|FG001|Overall Study|Lack of Efficacy|5|||
157191887|NCT02493712|567443440|FG002|Overall Study|Lack of Efficacy|3|||
157191888|NCT02058940|567443441|FG000|Overall Study|Discharged from Critical Care Unit|1|||
157191889|NCT02039687|567443442|FG000|Overall Study|Adverse Event|0|||
157191890|NCT02039687|567443443|FG001|Overall Study|Adverse Event|0|||
157191891|NCT02039687|567443444|FG002|Overall Study|Adverse Event|1|||
157191892|NCT02039687|567443445|FG003|Overall Study|Adverse Event|0|||
157191893|NCT02039687|567443442|FG000|Overall Study|Withdrawal by Subject|0|||
157191894|NCT02039687|567443443|FG001|Overall Study|Withdrawal by Subject|1|||
157191895|NCT02039687|567443444|FG002|Overall Study|Withdrawal by Subject|0|||
157191896|NCT02039687|567443445|FG003|Overall Study|Withdrawal by Subject|0|||
157191897|NCT02039687|567443442|FG000|Overall Study|treatment assignment could not be confir|0|||
157191898|NCT02039687|567443443|FG001|Overall Study|treatment assignment could not be confir|0|||
157191899|NCT02039687|567443444|FG002|Overall Study|treatment assignment could not be confir|2|||
157191900|NCT02039687|567443445|FG003|Overall Study|treatment assignment could not be confir|0|||
157191901|NCT00443534|567443448|FG000|Overall Study|Lack of Efficacy|67|||
157191902|NCT00443534|567443448|FG000|Overall Study|Adverse Event|16|||
157191903|NCT00443534|567443448|FG000|Overall Study|Death|9|||
157191904|NCT00443534|567443448|FG000|Overall Study|Withdrawal by Subject|8|||
157191905|NCT00443534|567443448|FG000|Overall Study|Study Terminated by Sponsor|12|||
157072993|NCT03377361|567021389|FG001|Treatment Period|Other Reasons|0|||
157072994|NCT03377361|567021390|FG002|Treatment Period|Other Reasons|0|||
157072995|NCT03377361|567021391|FG003|Treatment Period|Other Reasons|3|||
157072996|NCT03377361|567021392|FG004|Treatment Period|Other Reasons|0|||
157072997|NCT03377361|567021393|FG005|Treatment Period|Other Reasons|0|||
157072998|NCT03377361|567021394|FG006|Treatment Period|Other Reasons|0|||
157072999|NCT03377361|567021395|FG007|Treatment Period|Other Reasons|2|||
157073000|NCT03377361|567021396|FG008|Treatment Period|Other Reasons|0|||
157073001|NCT03377361|567021397|FG009|Treatment Period|Other Reasons|1|||
157073002|NCT03698994|567021398|FG000|Overall Study|Adverse Event|2|||
157073003|NCT03698994|567021398|FG000|Overall Study|Death|1|||
157073004|NCT03698994|567021398|FG000|Overall Study|Physician Decision|1|||
157073005|NCT03698994|567021398|FG000|Overall Study|Withdrawal by Subject|3|||
157073006|NCT03698994|567021398|FG000|Overall Study|Progressive Disease|12|||
157073007|NCT04042077|567021399|FG000|Overall Study|Adverse Event|0|||
157073008|NCT04042077|567021400|FG001|Overall Study|Adverse Event|1|||
157073009|NCT04042077|567021399|FG000|Overall Study|Death|2|||
157073010|NCT04042077|567021400|FG001|Overall Study|Death|1|||
157073011|NCT04042077|567021399|FG000|Overall Study|Physician Decision|2|||
157073012|NCT04042077|567021400|FG001|Overall Study|Physician Decision|0|||
157073013|NCT04042077|567021399|FG000|Overall Study|Withdrawal by Subject|3|||
157073014|NCT04042077|567021400|FG001|Overall Study|Withdrawal by Subject|2|||
157073015|NCT04042077|567021399|FG000|Overall Study|Lack of Efficacy|0|||
157073016|NCT04042077|567021400|FG001|Overall Study|Lack of Efficacy|1|||
157073017|NCT01080300|567021401|FG000|Overall Study|Adverse Event|49|||
157073018|NCT01080300|567021402|FG001|Overall Study|Adverse Event|35|||
157073019|NCT01080300|567021401|FG000|Overall Study|Lack of Efficacy|12|||
157073020|NCT01080300|567021402|FG001|Overall Study|Lack of Efficacy|15|||
157073021|NCT01080300|567021401|FG000|Overall Study|Protocol Violation|7|||
157073022|NCT01080300|567021402|FG001|Overall Study|Protocol Violation|13|||
157073023|NCT01080300|567021401|FG000|Overall Study|Lost to Follow-up|10|||
157073024|NCT01080300|567021402|FG001|Overall Study|Lost to Follow-up|6|||
157073025|NCT01080300|567021401|FG000|Overall Study|Death|0|||
157073026|NCT01080300|567021402|FG001|Overall Study|Death|1|||
157073027|NCT01080300|567021401|FG000|Overall Study|Withdrawal by Subject|12|||
157073028|NCT01080300|567021402|FG001|Overall Study|Withdrawal by Subject|28|||
157073029|NCT01080300|567021401|FG000|Overall Study|Reasons not specified|4|||
157073030|NCT01080300|567021402|FG001|Overall Study|Reasons not specified|6|||
157073031|NCT02844777|567021403|FG000|Overall Study|Withdrawal by Subject|2|||
157073032|NCT02844777|567021404|FG001|Overall Study|Withdrawal by Subject|0|||
157073033|NCT02844777|567021405|FG002|Overall Study|Withdrawal by Subject|0|||
157073034|NCT01776008|567021406|FG000|Overall Study|ineligible|2|||
157073035|NCT00150618|567021408|FG000|Overall Study|Adverse Event|2|||
157073036|NCT00150618|567021409|FG001|Overall Study|Adverse Event|2|||
157073037|NCT00150618|567021410|FG002|Overall Study|Adverse Event|6|||
157073038|NCT00150618|567021411|FG003|Overall Study|Adverse Event|9|||
157073039|NCT00150618|567021412|FG004|Overall Study|Adverse Event|5|||
157073040|NCT00150618|567021408|FG000|Overall Study|Withdrawal by Subject|6|||
157073041|NCT00150618|567021409|FG001|Overall Study|Withdrawal by Subject|8|||
157073042|NCT00150618|567021410|FG002|Overall Study|Withdrawal by Subject|8|||
157073043|NCT00150618|567021411|FG003|Overall Study|Withdrawal by Subject|4|||
157073044|NCT00150618|567021412|FG004|Overall Study|Withdrawal by Subject|5|||
157073045|NCT00150618|567021408|FG000|Overall Study|Lost to Follow-up|4|||
157073046|NCT00150618|567021409|FG001|Overall Study|Lost to Follow-up|1|||
157073047|NCT00150618|567021410|FG002|Overall Study|Lost to Follow-up|5|||
157073048|NCT00150618|567021411|FG003|Overall Study|Lost to Follow-up|8|||
157073049|NCT00150618|567021412|FG004|Overall Study|Lost to Follow-up|4|||
157073050|NCT00150618|567021408|FG000|Overall Study|Protocol Violation|1|||
157073051|NCT00150618|567021409|FG001|Overall Study|Protocol Violation|0|||
157073052|NCT00150618|567021410|FG002|Overall Study|Protocol Violation|0|||
157073053|NCT00150618|567021411|FG003|Overall Study|Protocol Violation|0|||
157073054|NCT00150618|567021412|FG004|Overall Study|Protocol Violation|1|||
157191906|NCT00443534|567443448|FG000|Overall Study|Other|10|||
157191907|NCT00443534|567443448|FG000|Overall Study|Enrolled, Not Treated|1|||
157191908|NCT03419741|567443449|FG000|Overall Study|Adverse Event|1|||
157191909|NCT03419741|567443450|FG001|Overall Study|Adverse Event|0|||
157073055|NCT00150618|567021408|FG000|Overall Study|Lack of Efficacy|1|||
157073056|NCT00150618|567021409|FG001|Overall Study|Lack of Efficacy|4|||
157073057|NCT00150618|567021410|FG002|Overall Study|Lack of Efficacy|7|||
157073058|NCT00150618|567021411|FG003|Overall Study|Lack of Efficacy|4|||
157073059|NCT00150618|567021412|FG004|Overall Study|Lack of Efficacy|6|||
157073060|NCT00150618|567021408|FG000|Overall Study|No study meds|0|||
157073061|NCT00150618|567021409|FG001|Overall Study|No study meds|0|||
157191910|NCT03419741|567443449|FG000|Overall Study|Withdrawal by Subject|1|||
157073062|NCT00150618|567021410|FG002|Overall Study|No study meds|0|||
157073063|NCT00150618|567021411|FG003|Overall Study|No study meds|0|||
157073064|NCT00150618|567021412|FG004|Overall Study|No study meds|2|||
157073065|NCT00150618|567021408|FG000|Overall Study|Physician Decision|0|||
157073066|NCT00150618|567021409|FG001|Overall Study|Physician Decision|2|||
157073067|NCT00150618|567021410|FG002|Overall Study|Physician Decision|0|||
157073068|NCT00150618|567021411|FG003|Overall Study|Physician Decision|0|||
157073069|NCT00150618|567021412|FG004|Overall Study|Physician Decision|1|||
157073070|NCT00150618|567021408|FG000|Overall Study|Lack of compliance|2|||
157073071|NCT00150618|567021409|FG001|Overall Study|Lack of compliance|1|||
157073072|NCT00150618|567021410|FG002|Overall Study|Lack of compliance|1|||
157073073|NCT00150618|567021411|FG003|Overall Study|Lack of compliance|0|||
157073074|NCT00150618|567021412|FG004|Overall Study|Lack of compliance|1|||
157073075|NCT00150618|567021408|FG000|Overall Study|Abnormal ECG|1|||
157073076|NCT00150618|567021409|FG001|Overall Study|Abnormal ECG|0|||
157073077|NCT00150618|567021410|FG002|Overall Study|Abnormal ECG|0|||
157073078|NCT00150618|567021411|FG003|Overall Study|Abnormal ECG|0|||
157073079|NCT00150618|567021412|FG004|Overall Study|Abnormal ECG|0|||
157073080|NCT00150618|567021408|FG000|Overall Study|Sponsor's decision|0|||
157073081|NCT00150618|567021409|FG001|Overall Study|Sponsor's decision|0|||
157073082|NCT00150618|567021410|FG002|Overall Study|Sponsor's decision|0|||
157073083|NCT00150618|567021411|FG003|Overall Study|Sponsor's decision|1|||
157073084|NCT00150618|567021412|FG004|Overall Study|Sponsor's decision|0|||
157073085|NCT01163474|567021413|FG000|Overall Study|Withdrawal by Subject|1|||
157073086|NCT01163474|567021413|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
157073087|NCT01163474|567021413|FG000|Overall Study|Lost to Follow-up|3|||
157073088|NCT02493946|567021414|FG000|DB Period|Withdrawal by Subject|8|||
157073089|NCT02493946|567021415|FG001|DB Period|Withdrawal by Subject|5|||
157073090|NCT02493946|567021416|FG002|DB Period|Withdrawal by Subject|0|||
157073091|NCT02493946|567021414|FG000|Open Label Period|Withdrawal by Subject|0|||
157073092|NCT02493946|567021415|FG001|Open Label Period|Withdrawal by Subject|0|||
157073093|NCT02493946|567021416|FG002|Open Label Period|Withdrawal by Subject|74|||
157073094|NCT02493946|567021414|FG000|Open Label Period|Adverse Event|0|||
157073095|NCT02493946|567021415|FG001|Open Label Period|Adverse Event|0|||
157073096|NCT02493946|567021416|FG002|Open Label Period|Adverse Event|4|||
157073097|NCT02493946|567021414|FG000|Open Label Period|Lost to Follow-up|0|||
157073098|NCT02493946|567021415|FG001|Open Label Period|Lost to Follow-up|0|||
157073099|NCT02493946|567021416|FG002|Open Label Period|Lost to Follow-up|1|||
157073100|NCT02493946|567021414|FG000|Open Label Period|Investigator decision, non-compliance|0|||
157073101|NCT02493946|567021415|FG001|Open Label Period|Investigator decision, non-compliance|0|||
157073102|NCT02493946|567021416|FG002|Open Label Period|Investigator decision, non-compliance|2|||
157073103|NCT02493946|567021414|FG000|Open Label Period|Investigator decision, non-availability|0|||
157073104|NCT02493946|567021415|FG001|Open Label Period|Investigator decision, non-availability|0|||
157073105|NCT02493946|567021416|FG002|Open Label Period|Investigator decision, non-availability|1|||
157073106|NCT02493946|567021414|FG000|Open Label Period|Pregnancy|0|||
157073107|NCT02493946|567021415|FG001|Open Label Period|Pregnancy|0|||
157073108|NCT02493946|567021416|FG002|Open Label Period|Pregnancy|3|||
157073109|NCT02493946|567021414|FG000|Open Label Period|Site error|0|||
157073110|NCT02493946|567021415|FG001|Open Label Period|Site error|0|||
157073111|NCT02493946|567021416|FG002|Open Label Period|Site error|1|||
157073112|NCT02838134|567021417|FG000|Overall Study|Lost to Follow-up|1|||
157073113|NCT02838134|567021418|FG001|Overall Study|Lost to Follow-up|2|||
157073114|NCT02838134|567021417|FG000|Overall Study|logistic problems|1|||
157073115|NCT02838134|567021418|FG001|Overall Study|logistic problems|1|||
157073116|NCT00383123|567021419|FG000|Overall Study|Adverse Event|1|||
157073117|NCT00383123|567021420|FG001|Overall Study|Adverse Event|0|||
157073118|NCT00383123|567021419|FG000|Overall Study|Lost to Follow-up|68|||
157073119|NCT00383123|567021420|FG001|Overall Study|Lost to Follow-up|61|||
157073120|NCT00383123|567021419|FG000|Overall Study|Protocol Violation|5|||
157073121|NCT00383123|567021420|FG001|Overall Study|Protocol Violation|1|||
157073122|NCT00383123|567021419|FG000|Overall Study|Withdrawal by Subject|27|||
157073123|NCT00383123|567021420|FG001|Overall Study|Withdrawal by Subject|18|||
157073124|NCT00383123|567021419|FG000|Overall Study|Other reason|10|||
157073125|NCT00383123|567021420|FG001|Overall Study|Other reason|6|||
157073126|NCT02781311|567021421|FG000|Overall Study|Adverse Event|2|||
157073127|NCT02781311|567021422|FG001|Overall Study|Adverse Event|6|||
157073128|NCT02781311|567021423|FG002|Overall Study|Adverse Event|1|||
157073129|NCT02781311|567021421|FG000|Overall Study|Withdrawal of Consent|11|||
157073130|NCT02781311|567021422|FG001|Overall Study|Withdrawal of Consent|12|||
157073131|NCT02781311|567021423|FG002|Overall Study|Withdrawal of Consent|2|||
157073132|NCT02781311|567021421|FG000|Overall Study|Lost to Follow-up|11|||
157073133|NCT02781311|567021422|FG001|Overall Study|Lost to Follow-up|8|||
157073134|NCT02781311|567021423|FG002|Overall Study|Lost to Follow-up|1|||
157073135|NCT02781311|567021421|FG000|Overall Study|Non-Compliance with Study Drug|2|||
157231044|NCT00906347|567592469|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
157073136|NCT02781311|567021422|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157073137|NCT02781311|567021423|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157073138|NCT04547023|567021426|FG000|Overall Study|Did Not Receive Intervention|3|||
157073139|NCT04547023|567021427|FG001|Overall Study|Did Not Receive Intervention|2|||
157073140|NCT04547023|567021426|FG000|Overall Study|Lost to Follow-up|1|||
157073141|NCT04547023|567021427|FG001|Overall Study|Lost to Follow-up|1|||
157073142|NCT01637077|567021428|FG000|Overall Study|Cancel|1|||
157073143|NCT01637077|567021429|FG001|Overall Study|Cancel|1|||
157073144|NCT01637077|567021428|FG000|Overall Study|Withdrawal by Subject|1|||
157073145|NCT01637077|567021429|FG001|Overall Study|Withdrawal by Subject|0|||
157073146|NCT01637077|567021428|FG000|Overall Study|No cycle 1 questionnaire data|2|||
157073147|NCT01637077|567021429|FG001|Overall Study|No cycle 1 questionnaire data|0|||
157073148|NCT02638103|567021430|FG000|Overall Study|Adverse Event|13|||
157073149|NCT02638103|567021431|FG001|Overall Study|Adverse Event|12|||
157073150|NCT02638103|567021432|FG002|Overall Study|Adverse Event|19|||
157073151|NCT02638103|567021433|FG003|Overall Study|Adverse Event|12|||
157073152|NCT02638103|567021430|FG000|Overall Study|Withdrawal by Subject|43|||
157073153|NCT02638103|567021431|FG001|Overall Study|Withdrawal by Subject|53|||
157073154|NCT02638103|567021432|FG002|Overall Study|Withdrawal by Subject|30|||
157073155|NCT02638103|567021433|FG003|Overall Study|Withdrawal by Subject|61|||
157073156|NCT02638103|567021430|FG000|Overall Study|Protocol Violation|1|||
157073157|NCT02638103|567021431|FG001|Overall Study|Protocol Violation|2|||
157073158|NCT02638103|567021432|FG002|Overall Study|Protocol Violation|1|||
157073159|NCT02638103|567021433|FG003|Overall Study|Protocol Violation|4|||
157073160|NCT02638103|567021430|FG000|Overall Study|Pregnancy|2|||
157073161|NCT02638103|567021431|FG001|Overall Study|Pregnancy|3|||
157073162|NCT02638103|567021432|FG002|Overall Study|Pregnancy|0|||
157073163|NCT02638103|567021433|FG003|Overall Study|Pregnancy|1|||
157073164|NCT02638103|567021430|FG000|Overall Study|Non-compliance to Study Procedures|2|||
157073165|NCT02638103|567021431|FG001|Overall Study|Non-compliance to Study Procedures|1|||
157073166|NCT02638103|567021432|FG002|Overall Study|Non-compliance to Study Procedures|1|||
157073167|NCT02638103|567021433|FG003|Overall Study|Non-compliance to Study Procedures|1|||
157073168|NCT02638103|567021430|FG000|Overall Study|Lost to Follow-up|26|||
157073169|NCT02638103|567021431|FG001|Overall Study|Lost to Follow-up|33|||
157073170|NCT02638103|567021432|FG002|Overall Study|Lost to Follow-up|20|||
157073171|NCT02638103|567021433|FG003|Overall Study|Lost to Follow-up|37|||
157073172|NCT02638103|567021430|FG000|Overall Study|Lack of Efficacy|14|||
157073173|NCT02638103|567021431|FG001|Overall Study|Lack of Efficacy|10|||
157073174|NCT02638103|567021432|FG002|Overall Study|Lack of Efficacy|12|||
157073175|NCT02638103|567021433|FG003|Overall Study|Lack of Efficacy|22|||
157073176|NCT02638103|567021430|FG000|Overall Study|Other than specified|5|||
157073177|NCT02638103|567021431|FG001|Overall Study|Other than specified|4|||
157073178|NCT02638103|567021432|FG002|Overall Study|Other than specified|2|||
157073179|NCT02638103|567021433|FG003|Overall Study|Other than specified|4|||
157073180|NCT00365547|567021437|FG000|Overall Study|Insurance did not cover Avastin|1|||
157073181|NCT00365547|567021437|FG000|Overall Study|Screen failure|1|||
157073182|NCT00365547|567021437|FG000|Overall Study|Withdrawal by Subject|1|||
157073183|NCT03692052|567021438|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
157073184|NCT03692052|567021438|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
157073185|NCT03692052|567021438|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
157073186|NCT03692052|567021438|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
157073187|NCT02257918|567021439|FG000|Overall Study|Lost to Follow-up|4|||
157073188|NCT02257918|567021440|FG001|Overall Study|Lost to Follow-up|1|||
157073189|NCT02257918|567021441|FG002|Overall Study|Lost to Follow-up|0|||
157073190|NCT02257918|567021439|FG000|Overall Study|Withdrawal by Subject|0|||
157073191|NCT02257918|567021440|FG001|Overall Study|Withdrawal by Subject|0|||
157073192|NCT02257918|567021441|FG002|Overall Study|Withdrawal by Subject|1|||
157073193|NCT02257918|567021439|FG000|Overall Study|Pregnancy|0|||
157073194|NCT02257918|567021440|FG001|Overall Study|Pregnancy|0|||
157073195|NCT02257918|567021441|FG002|Overall Study|Pregnancy|1|||
157073196|NCT01151423|567021442|FG000|Overall Study|Study terminated by Sponsor|9|||
157073197|NCT01151423|567021443|FG001|Overall Study|Study terminated by Sponsor|10|||
157073198|NCT01151423|567021442|FG000|Overall Study|Protocol Violation|0|||
157073199|NCT01151423|567021443|FG001|Overall Study|Protocol Violation|1|||
157073200|NCT01151423|567021442|FG000|Overall Study|Physician Decision|1|||
157073201|NCT01151423|567021443|FG001|Overall Study|Physician Decision|1|||
157073202|NCT01151423|567021442|FG000|Overall Study|Pregnancy|0|||
157073203|NCT01151423|567021443|FG001|Overall Study|Pregnancy|1|||
157073204|NCT01151423|567021442|FG000|Overall Study|Death|0|||
157073205|NCT01151423|567021443|FG001|Overall Study|Death|1|||
157231045|NCT00906347|567592470|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
157073206|NCT01151423|567021442|FG000|Overall Study|Adverse Event|3|||
157073207|NCT01151423|567021443|FG001|Overall Study|Adverse Event|0|||
157073208|NCT01151423|567021442|FG000|Overall Study|Withdrawal by Subject|1|||
157073209|NCT01151423|567021443|FG001|Overall Study|Withdrawal by Subject|3|||
157073210|NCT01151423|567021442|FG000|Overall Study|Lost to Follow-up|1|||
157073211|NCT01151423|567021443|FG001|Overall Study|Lost to Follow-up|0|||
157073212|NCT01151423|567021442|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
157073213|NCT01151423|567021443|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
157073214|NCT01151423|567021442|FG000|Overall Study|Participated in other clinical trial|1|||
157073215|NCT01151423|567021443|FG001|Overall Study|Participated in other clinical trial|0|||
157073216|NCT01263054|567021445|FG000|Overall Study|Death|1|||
157073217|NCT01263054|567021446|FG001|Overall Study|Death|0|||
157073218|NCT01263054|567021445|FG000|Overall Study|Lost to Follow-up|2|||
157073219|NCT01263054|567021446|FG001|Overall Study|Lost to Follow-up|2|||
157073220|NCT01263054|567021445|FG000|Overall Study|Withdrawal by Subject|1|||
157073221|NCT01263054|567021446|FG001|Overall Study|Withdrawal by Subject|3|||
157073222|NCT01263054|567021445|FG000|Overall Study|Qualification Violation|1|||
157073223|NCT01263054|567021446|FG001|Overall Study|Qualification Violation|0|||
157073224|NCT01263054|567021445|FG000|Overall Study|Other|0|||
157073225|NCT01263054|567021446|FG001|Overall Study|Other|1|||
157073226|NCT00936598|567021447|FG000|Overall Study|Withdrawal by Subject|1|||
157073227|NCT00936598|567021448|FG001|Overall Study|Withdrawal by Subject|0|||
157073228|NCT00936598|567021447|FG000|Overall Study|Ineligible after consent|1|||
157073229|NCT00936598|567021448|FG001|Overall Study|Ineligible after consent|0|||
157073230|NCT01261247|567021453|FG000|Overall Study|Ineligible|2|||
157073231|NCT01740154|567021454|FG000|Overall Study|Adverse Event|1|||
157073232|NCT03358472|567021458|FG000|Overall Study|Death|6|||
157073233|NCT03358472|567021459|FG001|Overall Study|Death|3|||
157073234|NCT03358472|567021460|FG002|Overall Study|Death|10|||
157073235|NCT03358472|567021458|FG000|Overall Study|Physician Decision|0|||
157073236|NCT03358472|567021459|FG001|Overall Study|Physician Decision|1|||
157073237|NCT03358472|567021460|FG002|Overall Study|Physician Decision|0|||
157073238|NCT03358472|567021458|FG000|Overall Study|Withdrawal by Subject|0|||
157073239|NCT03358472|567021459|FG001|Overall Study|Withdrawal by Subject|0|||
157073240|NCT03358472|567021460|FG002|Overall Study|Withdrawal by Subject|1|||
157073241|NCT03358472|567021458|FG000|Overall Study|On-going at clinical cut off date|9|||
157073242|NCT03358472|567021459|FG001|Overall Study|On-going at clinical cut off date|6|||
157073243|NCT03358472|567021460|FG002|Overall Study|On-going at clinical cut off date|5|||
157073244|NCT04013971|567021463|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
157073245|NCT04013971|567021464|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
157073246|NCT04013971|567021463|FG000|Overall Study|Missing biomechanical data|0|||
157073247|NCT04013971|567021464|FG001|Overall Study|Missing biomechanical data|1|||
157073248|NCT01124838|567021469|FG000|Overall Study|Miscellaneous|4|||
157073249|NCT01124838|567021470|FG001|Overall Study|Miscellaneous|2|||
157073250|NCT01124838|567021469|FG000|Overall Study|Adverse Event|7|||
157073251|NCT01124838|567021470|FG001|Overall Study|Adverse Event|11|||
157073252|NCT01124838|567021469|FG000|Overall Study|Lack of Efficacy|2|||
157073253|NCT01124838|567021470|FG001|Overall Study|Lack of Efficacy|0|||
157073254|NCT01124838|567021469|FG000|Overall Study|Withdrawal by Subject|3|||
157073255|NCT01124838|567021470|FG001|Overall Study|Withdrawal by Subject|2|||
157073256|NCT01124838|567021469|FG000|Overall Study|Lost to Follow-up|2|||
157073257|NCT01124838|567021470|FG001|Overall Study|Lost to Follow-up|0|||
157073258|NCT06719986|567021471|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
157073259|NCT06719986|567021472|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
157073260|NCT06719986|567021473|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
157073261|NCT06719986|567021471|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
157073262|NCT06719986|567021472|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
157073263|NCT06719986|567021473|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
157073264|NCT01183390|567022351|FG000|First Intervention|Adverse Event|0|||
157073265|NCT01183390|567022352|FG001|First Intervention|Adverse Event|1|||
157073266|NCT00233480|567022355|FG000|Overall Study|Underwent status II heart transplant|0|||
157073267|NCT00233480|567022356|FG001|Overall Study|Underwent status II heart transplant|1|||
157073268|NCT02521363|567022360|FG000|Overall Study|Withdrawal by Subject|1|||
157073269|NCT02521363|567022361|FG001|Overall Study|Withdrawal by Subject|2|||
157073270|NCT00974259|567022365|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
157073271|NCT00974259|567022366|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
157073272|NCT02963090|567022367|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
157073273|NCT02963090|567022368|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
157073274|NCT00732992|567022374|FG000|Overall Study|Adverse Event|1|||
157073275|NCT00732992|567022375|FG001|Overall Study|Adverse Event|1|||
157073276|NCT00732992|567022374|FG000|Overall Study|Objective Progression or Relapse|3|||
157073277|NCT00732992|567022375|FG001|Overall Study|Objective Progression or Relapse|5|||
157073278|NCT00732992|567022374|FG000|Overall Study|Global Deterioration of Health Status|1|||
157073279|NCT00732992|567022375|FG001|Overall Study|Global Deterioration of Health Status|0|||
157073280|NCT00732992|567022374|FG000|Overall Study|Withdrawal by Subject|1|||
157073281|NCT00732992|567022375|FG001|Overall Study|Withdrawal by Subject|0|||
157073282|NCT00762476|567022382|FG000|Overall Study|Adverse Event|7|||
157191911|NCT03419741|567443450|FG001|Overall Study|Withdrawal by Subject|2|||
157191912|NCT04450394|567443451|FG000|Overall Study|Adverse Event|2|||
157073283|NCT00762476|567022383|FG001|Overall Study|Adverse Event|1|||
157073284|NCT00762476|567022382|FG000|Overall Study|Lost to Follow-up|2|||
157191913|NCT04450394|567443452|FG001|Overall Study|Adverse Event|0|||
157191914|NCT04450394|567443453|FG002|Overall Study|Adverse Event|0|||
157191915|NCT04450394|567443451|FG000|Overall Study|Death|0|||
157073285|NCT00762476|567022383|FG001|Overall Study|Lost to Follow-up|0|||
157073286|NCT00762476|567022382|FG000|Overall Study|Protocol Violation|5|||
157073287|NCT00762476|567022383|FG001|Overall Study|Protocol Violation|6|||
157073288|NCT00762476|567022382|FG000|Overall Study|Physician Decision|2|||
157073289|NCT00762476|567022383|FG001|Overall Study|Physician Decision|14|||
157073290|NCT00762476|567022382|FG000|Overall Study|Withdrawal by Subject|6|||
157191916|NCT04450394|567443452|FG001|Overall Study|Death|1|||
157073291|NCT00762476|567022383|FG001|Overall Study|Withdrawal by Subject|12|||
157073292|NCT00762476|567022382|FG000|Overall Study|antibiotic use|0|||
157073293|NCT00762476|567022383|FG001|Overall Study|antibiotic use|1|||
157073294|NCT00762476|567022382|FG000|Overall Study|non-compliance with study visits|0|||
157073295|NCT00762476|567022383|FG001|Overall Study|non-compliance with study visits|2|||
157073296|NCT00762476|567022382|FG000|Overall Study|Seasonal allergies|1|||
157073297|NCT00762476|567022383|FG001|Overall Study|Seasonal allergies|0|||
157073298|NCT00856245|567022385|FG000|Overall Study|Was not transplanted|5|||
157073299|NCT04674189|567022389|FG000|Overall Study|Adverse Event|0|||
157073300|NCT04674189|567022390|FG001|Overall Study|Adverse Event|0|||
157073301|NCT04674189|567022391|FG002|Overall Study|Adverse Event|1|||
157073302|NCT04674189|567022389|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
157073303|NCT04674189|567022390|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
157073304|NCT04674189|567022391|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
157073305|NCT04674189|567022389|FG000|Overall Study|Physician Decision|1|||
157073306|NCT04674189|567022390|FG001|Overall Study|Physician Decision|0|||
157073307|NCT04674189|567022391|FG002|Overall Study|Physician Decision|0|||
157073308|NCT04674189|567022389|FG000|Overall Study|Withdrawal by Participant|83|||
157073309|NCT04674189|567022390|FG001|Overall Study|Withdrawal by Participant|71|||
157073310|NCT04674189|567022391|FG002|Overall Study|Withdrawal by Participant|142|||
157073311|NCT04674189|567022389|FG000|Overall Study|Lost to Follow-up|55|||
157073312|NCT04674189|567022390|FG001|Overall Study|Lost to Follow-up|53|||
157073313|NCT04674189|567022391|FG002|Overall Study|Lost to Follow-up|44|||
157073314|NCT04674189|567022389|FG000|Overall Study|Miscellaneous|27|||
157073315|NCT04674189|567022390|FG001|Overall Study|Miscellaneous|23|||
157073316|NCT04674189|567022391|FG002|Overall Study|Miscellaneous|207|||
157073317|NCT04674189|567022389|FG000|Overall Study|Did Not Receive Treatment|3|||
157073318|NCT04674189|567022390|FG001|Overall Study|Did Not Receive Treatment|1|||
157073319|NCT04674189|567022391|FG002|Overall Study|Did Not Receive Treatment|2|||
157073320|NCT04946942|567022394|FG000|Overall Study|Lost to Follow-up|6|||
157073321|NCT04946942|567022395|FG001|Overall Study|Lost to Follow-up|2|||
157073322|NCT04946942|567022396|FG002|Overall Study|Lost to Follow-up|0|||
157073323|NCT03023423|567022397|FG000|Overall Study|Death|5|||
157073324|NCT03023423|567022398|FG001|Overall Study|Death|12|||
157073325|NCT03023423|567022399|FG002|Overall Study|Death|20|||
157073326|NCT03023423|567022397|FG000|Overall Study|Other|0|||
157073327|NCT03023423|567022398|FG001|Overall Study|Other|2|||
157073328|NCT03023423|567022399|FG002|Overall Study|Other|2|||
157073329|NCT03023423|567022397|FG000|Overall Study|Ongoing|2|||
157073330|NCT03023423|567022398|FG001|Overall Study|Ongoing|32|||
157073331|NCT03023423|567022399|FG002|Overall Study|Ongoing|24|||
157073332|NCT00681668|567022400|FG000|Overall Study|Protocol Violation|1|||
157073333|NCT00681668|567022400|FG000|Overall Study|Withdrawal by Subject|1|||
157073334|NCT04277507|567022403|FG000|Overall Study|Lost to Follow-up|17|||
157073335|NCT04277507|567022403|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
157073336|NCT04277507|567022403|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
157073337|NCT04277507|567022403|FG000|Overall Study|Withdrawal by Subject|3|||
157073338|NCT04277507|567022403|FG000|Overall Study|Death due to COVID-19|1|||
157073339|NCT04277507|567022403|FG000|Overall Study|Data missing for full evaluation|5|||
157073340|NCT00583947|567022404|FG000|Cross-over Period|Adverse Event|2|||
157073341|NCT00583947|567022405|FG001|Cross-over Period|Adverse Event|0|||
157073342|NCT00583947|567022404|FG000|Cross-over Period|Withdrawal by Subject|2|||
157073343|NCT00583947|567022405|FG001|Cross-over Period|Withdrawal by Subject|0|||
157073344|NCT00583947|567022404|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
157073345|NCT00583947|567022405|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
157073346|NCT00583947|567022404|FG000|Cross-over Period|Other|1|||
157073347|NCT00583947|567022405|FG001|Cross-over Period|Other|1|||
157073348|NCT05226130|567022406|FG000|Overall Study|Lost to Follow-up|0|||
157073349|NCT05226130|567022407|FG001|Overall Study|Lost to Follow-up|1|||
157073350|NCT05226130|567022406|FG000|Overall Study|Not treatment adherent|0|||
157073351|NCT05226130|567022407|FG001|Overall Study|Not treatment adherent|2|||
157191917|NCT04450394|567443453|FG002|Overall Study|Death|0|||
157073352|NCT03974022|567022408|FG000|Overall Study|Death|0|||
157073353|NCT03974022|567022409|FG001|Overall Study|Death|1|||
157073354|NCT03974022|567022410|FG002|Overall Study|Death|0|||
157191918|NCT04450394|567443451|FG000|Overall Study|Lost to Follow-up|0|||
157191919|NCT04450394|567443452|FG001|Overall Study|Lost to Follow-up|3|||
157073355|NCT03974022|567022411|FG003|Overall Study|Death|2|||
157073356|NCT03974022|567022412|FG004|Overall Study|Death|0|||
157073357|NCT03974022|567022413|FG005|Overall Study|Death|1|||
157073358|NCT03974022|567022414|FG006|Overall Study|Death|0|||
157073359|NCT03974022|567022415|FG007|Overall Study|Death|2|||
157073360|NCT03974022|567022416|FG008|Overall Study|Death|1|||
157073361|NCT03974022|567022417|FG009|Overall Study|Death|4|||
157073362|NCT03974022|567022418|FG010|Overall Study|Death|0|||
157073363|NCT03974022|567022419|FG011|Overall Study|Death|0|||
157073364|NCT03974022|567022420|FG012|Overall Study|Death|0|||
157073365|NCT03974022|567022421|FG013|Overall Study|Death|33|||
157073366|NCT03974022|567022422|FG014|Overall Study|Death|40|||
157073367|NCT03974022|567022408|FG000|Overall Study|Withdrawal by Subject|0|||
157073368|NCT03974022|567022409|FG001|Overall Study|Withdrawal by Subject|0|||
157073369|NCT03974022|567022410|FG002|Overall Study|Withdrawal by Subject|0|||
157073370|NCT03974022|567022411|FG003|Overall Study|Withdrawal by Subject|0|||
157073371|NCT03974022|567022412|FG004|Overall Study|Withdrawal by Subject|0|||
157073372|NCT03974022|567022413|FG005|Overall Study|Withdrawal by Subject|4|||
157073373|NCT03974022|567022414|FG006|Overall Study|Withdrawal by Subject|4|||
157073374|NCT03974022|567022415|FG007|Overall Study|Withdrawal by Subject|2|||
157073375|NCT03974022|567022416|FG008|Overall Study|Withdrawal by Subject|2|||
157073376|NCT03974022|567022417|FG009|Overall Study|Withdrawal by Subject|3|||
157073377|NCT03974022|567022418|FG010|Overall Study|Withdrawal by Subject|0|||
157073378|NCT03974022|567022419|FG011|Overall Study|Withdrawal by Subject|1|||
157073379|NCT03974022|567022420|FG012|Overall Study|Withdrawal by Subject|0|||
157073380|NCT03974022|567022421|FG013|Overall Study|Withdrawal by Subject|3|||
157073381|NCT03974022|567022422|FG014|Overall Study|Withdrawal by Subject|9|||
157073382|NCT03974022|567022408|FG000|Overall Study|Lost to Follow-up|0|||
157073383|NCT03974022|567022409|FG001|Overall Study|Lost to Follow-up|0|||
157073384|NCT03974022|567022410|FG002|Overall Study|Lost to Follow-up|0|||
157073385|NCT03974022|567022411|FG003|Overall Study|Lost to Follow-up|0|||
157073386|NCT03974022|567022412|FG004|Overall Study|Lost to Follow-up|0|||
157073387|NCT03974022|567022413|FG005|Overall Study|Lost to Follow-up|0|||
157073388|NCT03974022|567022414|FG006|Overall Study|Lost to Follow-up|1|||
157073389|NCT03974022|567022415|FG007|Overall Study|Lost to Follow-up|0|||
157073390|NCT03974022|567022416|FG008|Overall Study|Lost to Follow-up|0|||
157073391|NCT03974022|567022417|FG009|Overall Study|Lost to Follow-up|0|||
157073392|NCT03974022|567022418|FG010|Overall Study|Lost to Follow-up|0|||
157073393|NCT03974022|567022419|FG011|Overall Study|Lost to Follow-up|0|||
157073394|NCT03974022|567022420|FG012|Overall Study|Lost to Follow-up|0|||
157073395|NCT03974022|567022421|FG013|Overall Study|Lost to Follow-up|1|||
157073396|NCT03974022|567022422|FG014|Overall Study|Lost to Follow-up|1|||
157073397|NCT03974022|567022408|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
157073398|NCT03974022|567022409|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
157073399|NCT03974022|567022410|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
157073400|NCT03974022|567022411|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
157073401|NCT03974022|567022412|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
157073402|NCT03974022|567022413|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
157073403|NCT03974022|567022414|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
157073404|NCT03974022|567022415|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
157073405|NCT03974022|567022416|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
157073406|NCT03974022|567022417|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
157073407|NCT03974022|567022418|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
157073408|NCT03974022|567022419|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
157073409|NCT03974022|567022420|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
157073410|NCT03974022|567022421|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
157073411|NCT03974022|567022422|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
157073412|NCT04704219|567022425|FG000|Overall Study|Screen Failure|1|||
157073413|NCT04704219|567022425|FG000|Overall Study|Withdrawal by Subject|1|||
157073414|NCT04704219|567022425|FG000|Overall Study|Death|78|||
157073415|NCT04704219|567022425|FG000|Overall Study|Participants Ongoing|80|||
157073416|NCT02600897|567022426|FG000|Overall Study|Death|1|||
157073417|NCT02600897|567022427|FG001|Overall Study|Death|2|||
157073418|NCT02600897|567022428|FG002|Overall Study|Death|1|||
157073419|NCT02600897|567022429|FG003|Overall Study|Death|2|||
157073420|NCT02600897|567022430|FG004|Overall Study|Death|3|||
157073421|NCT02600897|567022431|FG005|Overall Study|Death|2|||
157073422|NCT02600897|567022432|FG006|Overall Study|Death|10|||
157073423|NCT02600897|567022433|FG007|Overall Study|Death|7|||
157073424|NCT02600897|567022434|FG008|Overall Study|Death|20|||
157073425|NCT02600897|567022426|FG000|Overall Study|Lost to Follow-up|1|||
157073426|NCT02600897|567022427|FG001|Overall Study|Lost to Follow-up|0|||
157073427|NCT02600897|567022428|FG002|Overall Study|Lost to Follow-up|0|||
157073428|NCT02600897|567022429|FG003|Overall Study|Lost to Follow-up|0|||
157073429|NCT02600897|567022430|FG004|Overall Study|Lost to Follow-up|0|||
157073430|NCT02600897|567022431|FG005|Overall Study|Lost to Follow-up|0|||
157073431|NCT02600897|567022432|FG006|Overall Study|Lost to Follow-up|0|||
157191920|NCT04450394|567443453|FG002|Overall Study|Lost to Follow-up|0|||
157191921|NCT04450394|567443451|FG000|Overall Study|Physician Decision|0|||
157073432|NCT02600897|567022433|FG007|Overall Study|Lost to Follow-up|1|||
157191922|NCT04450394|567443452|FG001|Overall Study|Physician Decision|1|||
157191923|NCT04450394|567443453|FG002|Overall Study|Physician Decision|0|||
157073433|NCT02600897|567022434|FG008|Overall Study|Lost to Follow-up|0|||
157073434|NCT02600897|567022426|FG000|Overall Study|Withdrawal by Subject|0|||
157073435|NCT02600897|567022427|FG001|Overall Study|Withdrawal by Subject|0|||
157073436|NCT02600897|567022428|FG002|Overall Study|Withdrawal by Subject|0|||
157073437|NCT02600897|567022429|FG003|Overall Study|Withdrawal by Subject|0|||
157191924|NCT04450394|567443451|FG000|Overall Study|Protocol Violation|2|||
157073438|NCT02600897|567022430|FG004|Overall Study|Withdrawal by Subject|0|||
157073439|NCT02600897|567022431|FG005|Overall Study|Withdrawal by Subject|0|||
157073440|NCT02600897|567022432|FG006|Overall Study|Withdrawal by Subject|0|||
157073441|NCT02600897|567022433|FG007|Overall Study|Withdrawal by Subject|4|||
157073442|NCT02600897|567022434|FG008|Overall Study|Withdrawal by Subject|2|||
157073443|NCT02600897|567022426|FG000|Overall Study|Reason Not Specified|0|||
157073444|NCT02600897|567022427|FG001|Overall Study|Reason Not Specified|0|||
157073445|NCT02600897|567022428|FG002|Overall Study|Reason Not Specified|0|||
157073446|NCT02600897|567022429|FG003|Overall Study|Reason Not Specified|0|||
157073447|NCT02600897|567022430|FG004|Overall Study|Reason Not Specified|0|||
157073448|NCT02600897|567022431|FG005|Overall Study|Reason Not Specified|0|||
157073449|NCT02600897|567022432|FG006|Overall Study|Reason Not Specified|0|||
157073450|NCT02600897|567022433|FG007|Overall Study|Reason Not Specified|0|||
157073451|NCT02600897|567022434|FG008|Overall Study|Reason Not Specified|1|||
157073452|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
157073453|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
157073454|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
157073455|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
157073456|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
157073457|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
157073458|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
157073459|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
157073460|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
157073461|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
157073462|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
157073463|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
157073464|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
157073465|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
157073466|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
157073467|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
157073468|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
157073469|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
157073470|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
157073471|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
157073472|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
157073473|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
157073474|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
157073475|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
157073476|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
157073477|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
157073478|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
157073479|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
157073480|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
157073481|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
157073482|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
157073483|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
157073484|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
157073485|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
157073486|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
157073487|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
157073488|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
157073489|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
157073490|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
157073491|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
157073492|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
157073493|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
157073494|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
157073495|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
157073496|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
157073497|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
157073498|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
157073499|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
157073500|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
157073501|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
157073502|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
157073503|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
157073504|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
157073505|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
157073506|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
157073507|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
157073508|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
157073509|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
157073510|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
157073511|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
157073512|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
157073513|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
157073514|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
157073515|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
157073516|NCT00217737|567022435|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
157073517|NCT00217737|567022436|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
157073518|NCT00217737|567022437|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
157073519|NCT00217737|567022438|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
157073520|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
157073521|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
157073522|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
157073523|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
157073524|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
157073525|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
157073526|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
157073527|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
157073528|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Study suspension|0|||
157073529|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Study suspension|45|||
157073530|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Study suspension|0|||
157073531|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Study suspension|0|||
157073532|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
157073533|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
157073534|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
157073535|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
157073536|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Death|2|||
157073537|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Death|3|||
157073538|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Death|0|||
157073539|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Death|0|||
157073540|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
157073541|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
157073542|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
157073543|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
157073544|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
157073545|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
157073546|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
157073547|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
157073548|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
157073549|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
157073550|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
157073551|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
157073552|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
157073553|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
157073554|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
157073555|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
157073556|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
157073557|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
157073558|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
157073559|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
157073560|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
157073561|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
157073562|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
157073563|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
157073564|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
157191925|NCT04450394|567443452|FG001|Overall Study|Protocol Violation|0|||
157191926|NCT04450394|567443453|FG002|Overall Study|Protocol Violation|0|||
157191927|NCT04450394|567443451|FG000|Overall Study|Withdrawal by Subject|6|||
157191928|NCT04450394|567443452|FG001|Overall Study|Withdrawal by Subject|9|||
157191929|NCT04450394|567443453|FG002|Overall Study|Withdrawal by Subject|0|||
157073565|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
157073566|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
157073567|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
157073568|NCT00217737|567022435|FG000|Step 2 Randomization/Registration|Other|1|||
157073569|NCT00217737|567022436|FG001|Step 2 Randomization/Registration|Other|2|||
157073570|NCT00217737|567022437|FG002|Step 2 Randomization/Registration|Other|0|||
157073571|NCT00217737|567022438|FG003|Step 2 Randomization/Registration|Other|0|||
157073572|NCT03213704|567022440|FG000|Overall Study|Physician Decision|3|||
157073573|NCT03213704|567022440|FG000|Overall Study|Protocol Violation|1|||
157073574|NCT03213704|567022440|FG000|Overall Study|Progressive disease|4|||
157073575|NCT04680533|567022451|FG000|Overall Study|Screen failure|1|||
157073576|NCT00474526|567024405|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
157073577|NCT00474526|567024406|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
157073578|NCT00474526|567024407|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
157073579|NCT00474526|567024408|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
157073580|NCT00474526|567024409|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
157073581|NCT00474526|567024410|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
157073582|NCT00474526|567024411|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
157073583|NCT00474526|567024412|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
157073584|NCT00474526|567024413|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
157073585|NCT00474526|567024414|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
157073586|NCT00474526|567024415|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
157073587|NCT00474526|567024416|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
157073588|NCT00474526|567024417|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
157073589|NCT00474526|567024418|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
157073590|NCT00474526|567024419|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
157073591|NCT00474526|567024420|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
157073592|NCT00474526|567024421|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
157073593|NCT00474526|567024405|FG000|Overall Study|Adverse Event|2|||
157073594|NCT00474526|567024406|FG001|Overall Study|Adverse Event|0|||
157073595|NCT00474526|567024407|FG002|Overall Study|Adverse Event|2|||
157191930|NCT02500901|567443456|FG000|Overall Study|Disease ProgressionDD|2|||
157191931|NCT01710709|567443468|FG000|Overall Study|Lost to Follow-up|29|||
157191932|NCT01710709|567443468|FG000|Overall Study|Adverse Event|48|||
157191933|NCT01710709|567443468|FG000|Overall Study|Participant met withdrawal criteria|33|||
157191934|NCT01710709|567443468|FG000|Overall Study|Participant withdrawn by investigator|2|||
157191935|NCT01710709|567443468|FG000|Overall Study|Withdrawal by Subject|53|||
157191936|NCT01710709|567443468|FG000|Overall Study|Protocol Violation|5|||
157191937|NCT01710709|567443468|FG000|Overall Study|Lack of Efficacy|3|||
157191938|NCT01398176|567443470|FG000|Overall Study|Lost to Follow-up|1|||
157191939|NCT01398176|567443471|FG001|Overall Study|Lost to Follow-up|3|||
157191940|NCT01398176|567443470|FG000|Overall Study|Physician Decision|2|||
157191941|NCT01398176|567443471|FG001|Overall Study|Physician Decision|3|||
157191942|NCT00542321|567443472|FG000|Overall Study|Death|0|||
157191943|NCT00542321|567443473|FG001|Overall Study|Death|1|||
157191944|NCT00253747|567443476|FG000|Overall Study|Lost to Follow-up|13|||
157191945|NCT00253747|567443477|FG001|Overall Study|Lost to Follow-up|14|||
157191946|NCT00253747|567443476|FG000|Overall Study|Withdrawal by Subject|10|||
157191947|NCT00253747|567443477|FG001|Overall Study|Withdrawal by Subject|11|||
157191948|NCT00253747|567443476|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
157191949|NCT00253747|567443477|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
157191950|NCT00348686|567443480|FG000|Overall Study|Withdrawal by Subject|45|||
157191951|NCT00348686|567443480|FG000|Overall Study|Adverse Event|5|||
157191952|NCT00348686|567443480|FG000|Overall Study|Protocol Violation|6|||
157191953|NCT00348686|567443480|FG000|Overall Study|Lost to Follow-up|2|||
157191954|NCT00348686|567443480|FG000|Overall Study|Multiple Reasons|8|||
157191955|NCT01258738|567443481|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
157191956|NCT01258738|567443482|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
157191957|NCT01258738|567443481|FG000|Double-blind Period|Withdrawal by Subject|2|||
157191958|NCT01258738|567443482|FG001|Double-blind Period|Withdrawal by Subject|2|||
157191959|NCT01258738|567443481|FG000|Double-blind Period|Protocol Violation|1|||
157191960|NCT01258738|567443482|FG001|Double-blind Period|Protocol Violation|1|||
157191961|NCT01258738|567443481|FG000|Double-blind Period|Adverse Event|3|||
157191962|NCT01258738|567443482|FG001|Double-blind Period|Adverse Event|1|||
157191963|NCT01258738|567443481|FG000|Open-label Period|Did not meet inclusion criteria|0|||
157191964|NCT01258738|567443482|FG001|Open-label Period|Did not meet inclusion criteria|1|||
157073596|NCT00474526|567024408|FG003|Overall Study|Adverse Event|4|||
157073597|NCT00474526|567024409|FG004|Overall Study|Adverse Event|2|||
157073598|NCT00474526|567024410|FG005|Overall Study|Adverse Event|1|||
157073599|NCT00474526|567024411|FG006|Overall Study|Adverse Event|1|||
157073600|NCT00474526|567024412|FG007|Overall Study|Adverse Event|0|||
157073601|NCT00474526|567024413|FG008|Overall Study|Adverse Event|0|||
157073602|NCT00474526|567024414|FG009|Overall Study|Adverse Event|0|||
157191965|NCT01258738|567443481|FG000|Open-label Period|Insufficient clinical response|5|||
157191966|NCT01258738|567443482|FG001|Open-label Period|Insufficient clinical response|3|||
157191967|NCT01258738|567443481|FG000|Open-label Period|Lost to Follow-up|0|||
157073603|NCT00474526|567024415|FG010|Overall Study|Adverse Event|0|||
157073604|NCT00474526|567024416|FG011|Overall Study|Adverse Event|0|||
157073605|NCT00474526|567024417|FG012|Overall Study|Adverse Event|0|||
157073606|NCT00474526|567024418|FG013|Overall Study|Adverse Event|0|||
157073607|NCT00474526|567024419|FG014|Overall Study|Adverse Event|1|||
157073608|NCT00474526|567024420|FG015|Overall Study|Adverse Event|1|||
157073609|NCT00474526|567024421|FG016|Overall Study|Adverse Event|0|||
157073610|NCT00474526|567024405|FG000|Overall Study|Death|0|||
157073611|NCT00474526|567024406|FG001|Overall Study|Death|0|||
157073612|NCT00474526|567024407|FG002|Overall Study|Death|0|||
157073613|NCT00474526|567024408|FG003|Overall Study|Death|0|||
157073614|NCT00474526|567024409|FG004|Overall Study|Death|0|||
157073615|NCT00474526|567024410|FG005|Overall Study|Death|0|||
157073616|NCT00474526|567024411|FG006|Overall Study|Death|0|||
157073617|NCT00474526|567024412|FG007|Overall Study|Death|0|||
157073618|NCT00474526|567024413|FG008|Overall Study|Death|0|||
157073619|NCT00474526|567024414|FG009|Overall Study|Death|0|||
157073620|NCT00474526|567024415|FG010|Overall Study|Death|0|||
157073621|NCT00474526|567024416|FG011|Overall Study|Death|0|||
157073622|NCT00474526|567024417|FG012|Overall Study|Death|0|||
157073623|NCT00474526|567024418|FG013|Overall Study|Death|3|||
157073624|NCT00474526|567024419|FG014|Overall Study|Death|0|||
157073625|NCT00474526|567024420|FG015|Overall Study|Death|0|||
157073626|NCT00474526|567024421|FG016|Overall Study|Death|0|||
157073627|NCT00474526|567024405|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073628|NCT00474526|567024406|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
157073629|NCT00474526|567024407|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073630|NCT00474526|567024408|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
157073631|NCT00474526|567024409|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
157073632|NCT00474526|567024410|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073633|NCT00474526|567024411|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073634|NCT00474526|567024412|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073635|NCT00474526|567024413|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073636|NCT00474526|567024414|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073637|NCT00474526|567024415|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073638|NCT00474526|567024416|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073639|NCT00474526|567024417|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073640|NCT00474526|567024418|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
157073641|NCT00474526|567024419|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
157073642|NCT00474526|567024420|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073643|NCT00474526|567024421|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
157073644|NCT00474526|567024405|FG000|Overall Study|Lost to Follow-up|8|||
157073645|NCT00474526|567024406|FG001|Overall Study|Lost to Follow-up|6|||
157073646|NCT00474526|567024407|FG002|Overall Study|Lost to Follow-up|13|||
157073647|NCT00474526|567024408|FG003|Overall Study|Lost to Follow-up|29|||
157073648|NCT00474526|567024409|FG004|Overall Study|Lost to Follow-up|11|||
157073649|NCT00474526|567024410|FG005|Overall Study|Lost to Follow-up|5|||
157073650|NCT00474526|567024411|FG006|Overall Study|Lost to Follow-up|8|||
157073651|NCT00474526|567024412|FG007|Overall Study|Lost to Follow-up|1|||
157073652|NCT00474526|567024413|FG008|Overall Study|Lost to Follow-up|0|||
157073653|NCT00474526|567024414|FG009|Overall Study|Lost to Follow-up|6|||
157073654|NCT00474526|567024415|FG010|Overall Study|Lost to Follow-up|2|||
157073655|NCT00474526|567024416|FG011|Overall Study|Lost to Follow-up|4|||
157073656|NCT00474526|567024417|FG012|Overall Study|Lost to Follow-up|6|||
157073657|NCT00474526|567024418|FG013|Overall Study|Lost to Follow-up|74|||
157073658|NCT00474526|567024419|FG014|Overall Study|Lost to Follow-up|29|||
157073659|NCT00474526|567024420|FG015|Overall Study|Lost to Follow-up|4|||
157073660|NCT00474526|567024421|FG016|Overall Study|Lost to Follow-up|5|||
157073661|NCT00474526|567024405|FG000|Overall Study|Protocol Violation|2|||
157073662|NCT00474526|567024406|FG001|Overall Study|Protocol Violation|6|||
157073663|NCT00474526|567024407|FG002|Overall Study|Protocol Violation|4|||
157073664|NCT00474526|567024408|FG003|Overall Study|Protocol Violation|12|||
157073665|NCT00474526|567024409|FG004|Overall Study|Protocol Violation|3|||
157073666|NCT00474526|567024410|FG005|Overall Study|Protocol Violation|1|||
157073667|NCT00474526|567024411|FG006|Overall Study|Protocol Violation|3|||
157073668|NCT00474526|567024412|FG007|Overall Study|Protocol Violation|0|||
157073669|NCT00474526|567024413|FG008|Overall Study|Protocol Violation|0|||
157191968|NCT01258738|567443482|FG001|Open-label Period|Lost to Follow-up|2|||
157073670|NCT00474526|567024414|FG009|Overall Study|Protocol Violation|4|||
157073671|NCT00474526|567024415|FG010|Overall Study|Protocol Violation|2|||
157073672|NCT00474526|567024416|FG011|Overall Study|Protocol Violation|2|||
157073673|NCT00474526|567024417|FG012|Overall Study|Protocol Violation|4|||
157191969|NCT01258738|567443481|FG000|Open-label Period|Withdrawal by Subject|5|||
157073674|NCT00474526|567024418|FG013|Overall Study|Protocol Violation|19|||
157073675|NCT00474526|567024419|FG014|Overall Study|Protocol Violation|9|||
157073676|NCT00474526|567024420|FG015|Overall Study|Protocol Violation|6|||
157073677|NCT00474526|567024421|FG016|Overall Study|Protocol Violation|2|||
157073678|NCT00474526|567024405|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
157073679|NCT00474526|567024406|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
157073680|NCT00474526|567024407|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
157073681|NCT00474526|567024408|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
157073682|NCT00474526|567024409|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
157073683|NCT00474526|567024410|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
157073684|NCT00474526|567024411|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
157073685|NCT00474526|567024412|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
157073686|NCT00474526|567024413|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
157073687|NCT00474526|567024414|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
157073688|NCT00474526|567024415|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
157073689|NCT00474526|567024416|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
157073690|NCT00474526|567024417|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
157073691|NCT00474526|567024418|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
157073692|NCT00474526|567024419|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
157073693|NCT00474526|567024420|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
157073694|NCT00474526|567024421|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
157073695|NCT00474526|567024405|FG000|Overall Study|Withdrawal by Subject|9|||
157073696|NCT00474526|567024406|FG001|Overall Study|Withdrawal by Subject|24|||
157073697|NCT00474526|567024407|FG002|Overall Study|Withdrawal by Subject|21|||
157073698|NCT00474526|567024408|FG003|Overall Study|Withdrawal by Subject|52|||
157073699|NCT00474526|567024409|FG004|Overall Study|Withdrawal by Subject|38|||
157073700|NCT00474526|567024410|FG005|Overall Study|Withdrawal by Subject|6|||
157073701|NCT00474526|567024411|FG006|Overall Study|Withdrawal by Subject|12|||
157073702|NCT00474526|567024412|FG007|Overall Study|Withdrawal by Subject|4|||
157073703|NCT00474526|567024413|FG008|Overall Study|Withdrawal by Subject|4|||
157073704|NCT00474526|567024414|FG009|Overall Study|Withdrawal by Subject|13|||
157073705|NCT00474526|567024415|FG010|Overall Study|Withdrawal by Subject|5|||
157073706|NCT00474526|567024416|FG011|Overall Study|Withdrawal by Subject|4|||
157073707|NCT00474526|567024417|FG012|Overall Study|Withdrawal by Subject|4|||
157073708|NCT00474526|567024418|FG013|Overall Study|Withdrawal by Subject|37|||
157073709|NCT00474526|567024419|FG014|Overall Study|Withdrawal by Subject|22|||
157073710|NCT00474526|567024420|FG015|Overall Study|Withdrawal by Subject|1|||
157073711|NCT00474526|567024421|FG016|Overall Study|Withdrawal by Subject|1|||
157073712|NCT00953147|567024422|FG000|Overall Study|Adverse Event|8|||
157073713|NCT00953147|567024423|FG001|Overall Study|Adverse Event|16|||
157073714|NCT00953147|567024424|FG002|Overall Study|Adverse Event|6|||
157073715|NCT00953147|567024422|FG000|Overall Study|Protocol Violation|2|||
157073716|NCT00953147|567024423|FG001|Overall Study|Protocol Violation|8|||
157073717|NCT00953147|567024424|FG002|Overall Study|Protocol Violation|4|||
157073718|NCT00953147|567024422|FG000|Overall Study|Withdrawal by Subject|13|||
157073719|NCT00953147|567024423|FG001|Overall Study|Withdrawal by Subject|15|||
157073720|NCT00953147|567024424|FG002|Overall Study|Withdrawal by Subject|12|||
157073721|NCT00953147|567024422|FG000|Overall Study|Lost to Follow-up|8|||
157073722|NCT00953147|567024423|FG001|Overall Study|Lost to Follow-up|9|||
157073723|NCT00953147|567024424|FG002|Overall Study|Lost to Follow-up|4|||
157073724|NCT00953147|567024422|FG000|Overall Study|Physician Decision|2|||
157073725|NCT00953147|567024423|FG001|Overall Study|Physician Decision|7|||
157073726|NCT00953147|567024424|FG002|Overall Study|Physician Decision|3|||
157073727|NCT00953147|567024422|FG000|Overall Study|Other|4|||
157073728|NCT00953147|567024423|FG001|Overall Study|Other|11|||
157073729|NCT00953147|567024424|FG002|Overall Study|Other|13|||
157073730|NCT01484431|567024425|FG000|Period 1: High Dose|Physician Decision|0|||
157073731|NCT01484431|567024426|FG001|Period 1: High Dose|Physician Decision|1|||
157073732|NCT01484431|567024427|FG002|Period 1: High Dose|Physician Decision|0|||
157073733|NCT01484431|567024425|FG000|Period 2|Death|0|||
157073734|NCT01484431|567024426|FG001|Period 2|Death|1|||
157073735|NCT01484431|567024427|FG002|Period 2|Death|1|||
157073736|NCT01484431|567024425|FG000|Period 2|Physician Decision|0|||
157073737|NCT01484431|567024426|FG001|Period 2|Physician Decision|0|||
157073738|NCT01484431|567024427|FG002|Period 2|Physician Decision|1|||
157073739|NCT01484431|567024425|FG000|Period 2|Non-Compliance with Study Drug|1|||
157191970|NCT01258738|567443482|FG001|Open-label Period|Withdrawal by Subject|6|||
157191971|NCT01258738|567443481|FG000|Open-label Period|Protocol Violation|2|||
157073740|NCT01484431|567024426|FG001|Period 2|Non-Compliance with Study Drug|0|||
157073741|NCT01484431|567024427|FG002|Period 2|Non-Compliance with Study Drug|0|||
157073742|NCT01251770|567024428|FG000|Overall Study|Protocol Violation|13|||
157073743|NCT01251770|567024429|FG001|Overall Study|Protocol Violation|7|||
157073744|NCT02113124|567024430|FG000|Overall Study|Unable to retrieve blood sample|1|||
157073745|NCT02113124|567024431|FG001|Overall Study|Unable to retrieve blood sample|1|||
157073746|NCT02763215|567024432|FG000|Overall Study|Participants withdrew from study|3|||
157073747|NCT02763215|567024432|FG000|Overall Study|Missed visit|1|||
157073748|NCT02763215|567024432|FG000|Overall Study|Visit outside visit-window|1|||
157073749|NCT02763215|567024432|FG000|Overall Study|Death|1|||
157073750|NCT02763215|567024432|FG000|Overall Study|Lost to Follow-up|1|||
157073751|NCT02980042|567024433|FG000|Overall Study|Lost to Follow-up|5|||
157073752|NCT02980042|567024434|FG001|Overall Study|Lost to Follow-up|0|||
157073753|NCT02980042|567024433|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
157073754|NCT02980042|567024434|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
157073755|NCT00953771|567024435|FG000|Overall Study|Death|1|||
157073756|NCT00953771|567024436|FG001|Overall Study|Death|0|||
157073757|NCT00944229|567024439|FG000|Overall Study|Withdrawal by Subject|11|||
157073758|NCT00944229|567024439|FG000|Overall Study|Physician Decision|14|||
157073759|NCT01270828|567024440|FG000|Pregabalin CR SB|Reason Unspecified|0|||
157073760|NCT01270828|567024441|FG001|Pregabalin CR SB|Reason Unspecified|0|||
157073761|NCT01270828|567024442|FG002|Pregabalin CR SB|Reason Unspecified|8|||
157073762|NCT01270828|567024440|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
157073763|NCT01270828|567024441|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
157073764|NCT01270828|567024442|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
157073765|NCT01270828|567024440|FG000|Pregabalin CR SB|Related adverse event|0|||
157073766|NCT01270828|567024441|FG001|Pregabalin CR SB|Related adverse event|0|||
157073767|NCT01270828|567024442|FG002|Pregabalin CR SB|Related adverse event|46|||
157073768|NCT01270828|567024440|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
157073769|NCT01270828|567024441|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
157073770|NCT01270828|567024442|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
157073771|NCT01270828|567024440|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
157073772|NCT01270828|567024441|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
157073773|NCT01270828|567024442|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
157073774|NCT01270828|567024440|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
157073775|NCT01270828|567024441|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
157073776|NCT01270828|567024442|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
157073777|NCT01270828|567024440|FG000|Pregabalin CR SB|Unrelated AE|0|||
157073778|NCT01270828|567024441|FG001|Pregabalin CR SB|Unrelated AE|0|||
157073779|NCT01270828|567024442|FG002|Pregabalin CR SB|Unrelated AE|8|||
157073780|NCT01270828|567024440|FG000|Pregabalin CR SB|Protocol Violation|0|||
157073781|NCT01270828|567024441|FG001|Pregabalin CR SB|Protocol Violation|0|||
157073782|NCT01270828|567024442|FG002|Pregabalin CR SB|Protocol Violation|8|||
157073783|NCT01270828|567024440|FG000|Double Blind Phase|Death|0|||
157073784|NCT01270828|567024441|FG001|Double Blind Phase|Death|1|||
157073785|NCT01270828|567024442|FG002|Double Blind Phase|Death|0|||
157073786|NCT01270828|567024440|FG000|Double Blind Phase|Protocol Violation|0|||
157073787|NCT01270828|567024441|FG001|Double Blind Phase|Protocol Violation|1|||
157073788|NCT01270828|567024442|FG002|Double Blind Phase|Protocol Violation|0|||
157073789|NCT01270828|567024440|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
157073790|NCT01270828|567024441|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
157073791|NCT01270828|567024442|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
157073792|NCT01270828|567024440|FG000|Double Blind Phase|Reason Unspecified|7|||
157073793|NCT01270828|567024441|FG001|Double Blind Phase|Reason Unspecified|4|||
157073794|NCT01270828|567024442|FG002|Double Blind Phase|Reason Unspecified|0|||
157073795|NCT01270828|567024440|FG000|Double Blind Phase|Withdrawal by Subject|6|||
157073796|NCT01270828|567024441|FG001|Double Blind Phase|Withdrawal by Subject|15|||
157073797|NCT01270828|567024442|FG002|Double Blind Phase|Withdrawal by Subject|0|||
157073798|NCT01270828|567024440|FG000|Double Blind Phase|Lost to Follow-up|1|||
157073799|NCT01270828|567024441|FG001|Double Blind Phase|Lost to Follow-up|2|||
157073800|NCT01270828|567024442|FG002|Double Blind Phase|Lost to Follow-up|0|||
157073801|NCT01270828|567024440|FG000|Double Blind Phase|Lack of Efficacy|2|||
157073802|NCT01270828|567024441|FG001|Double Blind Phase|Lack of Efficacy|11|||
157073803|NCT01270828|567024442|FG002|Double Blind Phase|Lack of Efficacy|0|||
157073804|NCT01270828|567024440|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
157073805|NCT01270828|567024441|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
157073806|NCT01270828|567024442|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
157073807|NCT01270828|567024440|FG000|Double Blind Phase|Adverse event related to study drug|5|||
157073808|NCT01270828|567024441|FG001|Double Blind Phase|Adverse event related to study drug|7|||
157073809|NCT01270828|567024442|FG002|Double Blind Phase|Adverse event related to study drug|0|||
157191972|NCT01258738|567443482|FG001|Open-label Period|Protocol Violation|2|||
157191973|NCT01258738|567443481|FG000|Open-label Period|Adverse Event|4|||
157191974|NCT01258738|567443482|FG001|Open-label Period|Adverse Event|5|||
157073810|NCT02870972|567024443|FG000|Overall Study|Adverse Event|1|||
157073811|NCT02870972|567024444|FG001|Overall Study|Adverse Event|0|||
157073812|NCT02870972|567024445|FG002|Overall Study|Adverse Event|0|||
157073813|NCT02870972|567024446|FG003|Overall Study|Adverse Event|0|||
157073814|NCT02870972|567024447|FG004|Overall Study|Adverse Event|0|||
157073815|NCT04400487|567024448|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
157073816|NCT04400487|567024448|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
157073817|NCT04400487|567024448|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
157073818|NCT01821937|567024455|FG000|Overall Study|Adverse Event|0|||
157073819|NCT01821937|567024456|FG001|Overall Study|Adverse Event|3|||
157073820|NCT01677299|567024457|FG000|Overall Study|Adverse Event|0|||
157073821|NCT01677299|567024458|FG001|Overall Study|Adverse Event|2|||
157073822|NCT01677299|567024459|FG002|Overall Study|Adverse Event|1|||
157073823|NCT01677299|567024460|FG003|Overall Study|Adverse Event|0|||
157073824|NCT01677299|567024457|FG000|Overall Study|Withdrawal by Subject|0|||
157073825|NCT01677299|567024458|FG001|Overall Study|Withdrawal by Subject|1|||
157073826|NCT01677299|567024459|FG002|Overall Study|Withdrawal by Subject|0|||
157073827|NCT01677299|567024460|FG003|Overall Study|Withdrawal by Subject|1|||
157073828|NCT03445533|567024461|FG000|Overall Study|Progressive Disease|48|||
157073829|NCT03445533|567024462|FG001|Overall Study|Progressive Disease|81|||
157073830|NCT03445533|567024461|FG000|Overall Study|Adverse Event|60|||
157073831|NCT03445533|567024462|FG001|Overall Study|Adverse Event|64|||
157073832|NCT03445533|567024461|FG000|Overall Study|Death|9|||
157073833|NCT03445533|567024462|FG001|Overall Study|Death|19|||
157073834|NCT03445533|567024461|FG000|Overall Study|Miscellaneous|0|||
157073835|NCT03445533|567024462|FG001|Overall Study|Miscellaneous|16|||
157073836|NCT03445533|567024461|FG000|Overall Study|Withdrawal by Subject|3|||
157073837|NCT03445533|567024462|FG001|Overall Study|Withdrawal by Subject|4|||
157073838|NCT03445533|567024461|FG000|Overall Study|Physician Decision|1|||
157073839|NCT03445533|567024462|FG001|Overall Study|Physician Decision|3|||
157073840|NCT03445533|567024461|FG000|Overall Study|Sponsor Decision|0|||
157073841|NCT03445533|567024462|FG001|Overall Study|Sponsor Decision|1|||
157073842|NCT03445533|567024461|FG000|Overall Study|Lost to Follow-up|0|||
157073843|NCT03445533|567024462|FG001|Overall Study|Lost to Follow-up|1|||
157073844|NCT03445533|567024461|FG000|Overall Study|Never Received any Study Treatment|7|||
157073845|NCT03445533|567024462|FG001|Overall Study|Never Received any Study Treatment|4|||
157073846|NCT02615509|567024463|FG000|Overall Study|Lost to Follow-up|134|||
157073847|NCT02615509|567024463|FG000|Overall Study|Death|4|||
157073848|NCT02615509|567024463|FG000|Overall Study|Withdrawal by Subject|8|||
157073849|NCT03334253|567024464|FG000|Overall Study|Withdrawal by Subject|1|||
157073850|NCT03334253|567024465|FG001|Overall Study|Withdrawal by Subject|0|||
157073851|NCT03334253|567024464|FG000|Overall Study|Lost to Follow-up|4|||
157073852|NCT03334253|567024465|FG001|Overall Study|Lost to Follow-up|3|||
157073853|NCT03334253|567024464|FG000|Overall Study|Moved residence|2|||
157073854|NCT03334253|567024465|FG001|Overall Study|Moved residence|2|||
157073855|NCT03274453|567024466|FG000|Overall Study|Lost to Follow-up|2|||
157073856|NCT03274453|567024467|FG001|Overall Study|Lost to Follow-up|5|||
157073857|NCT03274453|567024468|FG002|Overall Study|Lost to Follow-up|4|||
157073858|NCT03274453|567024469|FG003|Overall Study|Lost to Follow-up|1|||
157073859|NCT03274453|567024466|FG000|Overall Study|Physician Decision|2|||
157073860|NCT03274453|567024467|FG001|Overall Study|Physician Decision|0|||
157073861|NCT03274453|567024468|FG002|Overall Study|Physician Decision|0|||
157073862|NCT03274453|567024469|FG003|Overall Study|Physician Decision|3|||
157073863|NCT03274453|567024466|FG000|Overall Study|Surgery Cancelled|0|||
157073864|NCT03274453|567024467|FG001|Overall Study|Surgery Cancelled|1|||
157073865|NCT03274453|567024468|FG002|Overall Study|Surgery Cancelled|0|||
157073866|NCT03274453|567024469|FG003|Overall Study|Surgery Cancelled|0|||
157073867|NCT00945672|567024470|FG000|Overall Study|Withdrawal by Subject|0|||
157073868|NCT00945672|567024471|FG001|Overall Study|Withdrawal by Subject|0|||
157073869|NCT00945672|567024472|FG002|Overall Study|Withdrawal by Subject|0|||
157073870|NCT00945672|567024473|FG003|Overall Study|Withdrawal by Subject|1|||
157073871|NCT00968526|567024474|FG000|Overall Study|Adverse Event|2|||
157073872|NCT00968526|567024475|FG001|Overall Study|Adverse Event|0|||
157073873|NCT00968526|567024474|FG000|Overall Study|Migrated/moved from study area|1|||
157073874|NCT00968526|567024475|FG001|Overall Study|Migrated/moved from study area|0|||
157073875|NCT02030002|567024479|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
157073876|NCT02030002|567024479|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
157073877|NCT02030002|567024479|FG000|Follow-up|Lost to Follow-up|2|||
157073878|NCT00609947|567024480|FG000|Overall Study|Death|1|||
157231046|NCT00906347|567592469|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
157231047|NCT00906347|567592470|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
157231048|NCT00906347|567592469|FG000|Received Study Drug|Refused study drug|1|||
157231049|NCT00906347|567592470|FG001|Received Study Drug|Refused study drug|0|||
157231050|NCT00906347|567592469|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
157231051|NCT00906347|567592470|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
157231052|NCT01939197|567592476|FG000|Overall Study|Withdrawal by Subject|1|||
157231053|NCT01939197|567592477|FG001|Overall Study|Withdrawal by Subject|0|||
157073879|NCT00504075|567024481|FG000|Overall Study|Adverse Event|1|||
157073880|NCT00504075|567024481|FG000|Overall Study|Lost to Follow-up|5|||
157073881|NCT00504075|567024481|FG000|Overall Study|Withdrawal by Subject|1|||
157073882|NCT00504075|567024481|FG000|Overall Study|Required other therapeutic intervention|1|||
157073883|NCT02406248|567024482|FG000|Overall Study|Death|7|||
157073884|NCT02406248|567024482|FG000|Overall Study|Withdrawal by Subject|2|||
157073885|NCT01689857|567024484|FG000|Overall Study|Lost to Follow-up|5|||
157073886|NCT01689857|567024485|FG001|Overall Study|Lost to Follow-up|2|||
157231054|NCT01939197|567592478|FG002|Overall Study|Withdrawal by Subject|0|||
157231055|NCT01939197|567592479|FG003|Overall Study|Withdrawal by Subject|0|||
157231056|NCT01939197|567592480|FG004|Overall Study|Withdrawal by Subject|1|||
157231057|NCT01939197|567592481|FG005|Overall Study|Withdrawal by Subject|0|||
157231058|NCT01939197|567592482|FG006|Overall Study|Withdrawal by Subject|0|||
157073887|NCT02643628|567024492|FG000|Overall Study|Lost to Follow-up|1|||
157073888|NCT02643628|567024493|FG001|Overall Study|Lost to Follow-up|4|||
157073889|NCT02643628|567024492|FG000|Overall Study|Withdrawal by Subject|0|||
157073890|NCT02643628|567024493|FG001|Overall Study|Withdrawal by Subject|1|||
157073891|NCT02643628|567024492|FG000|Overall Study|Relocated out of state|0|||
157073892|NCT02643628|567024493|FG001|Overall Study|Relocated out of state|1|||
157073893|NCT02362503|567024494|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
157073894|NCT02362503|567024495|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
157073895|NCT02362503|567024496|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
157073896|NCT02362503|567024494|FG000|Double-blind Period-Up to 8 Days|Death|1|||
157073897|NCT02362503|567024495|FG001|Double-blind Period-Up to 8 Days|Death|0|||
157073898|NCT02362503|567024496|FG002|Double-blind Period-Up to 8 Days|Death|0|||
157073899|NCT02362503|567024494|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
157073900|NCT02362503|567024495|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
157073901|NCT02362503|567024496|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
157073902|NCT02362503|567024494|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
157073903|NCT02362503|567024495|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
157073904|NCT02362503|567024496|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
157073905|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
157073906|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
157073907|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
157073908|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
157073909|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
157073910|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
157191975|NCT01258738|567443481|FG000|Open-label Period|Other Reasons|0|||
157191976|NCT01258738|567443482|FG001|Open-label Period|Other Reasons|1|||
157191977|NCT01258738|567443481|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
157191978|NCT01258738|567443482|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
157191979|NCT02418000|567443483|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
157191980|NCT02418000|567443484|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191981|NCT02418000|567443485|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191982|NCT02418000|567443486|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191983|NCT02418000|567443487|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191984|NCT02418000|567443483|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
157191985|NCT02418000|567443484|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
157191986|NCT02418000|567443485|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
157191987|NCT02418000|567443486|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
157191988|NCT02418000|567443487|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
157191989|NCT02418000|567443483|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
157191990|NCT02418000|567443484|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
157191991|NCT02418000|567443485|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
157191992|NCT02418000|567443486|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
157191993|NCT02418000|567443487|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
157191994|NCT02418000|567443483|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191995|NCT02418000|567443484|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
157191996|NCT02418000|567443485|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191997|NCT02418000|567443486|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191998|NCT02418000|567443487|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
157191999|NCT02418000|567443483|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
157192000|NCT02418000|567443484|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
157192001|NCT02418000|567443485|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
157192002|NCT02418000|567443486|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
157192003|NCT02418000|567443487|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
157192004|NCT02418000|567443483|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192005|NCT02418000|567443484|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192006|NCT02418000|567443485|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
157192007|NCT02418000|567443486|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192008|NCT02418000|567443487|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192009|NCT02418000|567443483|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192010|NCT02418000|567443484|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192011|NCT02418000|567443485|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192012|NCT02418000|567443486|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
157192013|NCT02418000|567443487|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192014|NCT02418000|567443483|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
157192015|NCT02418000|567443484|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
157192016|NCT02418000|567443485|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
157192017|NCT02418000|567443486|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
157192018|NCT02418000|567443487|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
157192019|NCT02418000|567443483|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192020|NCT02418000|567443484|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192021|NCT02418000|567443485|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157073911|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
157073912|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
157073913|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
157073914|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
157073915|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
157073916|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
157073917|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
157073918|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
157073919|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
157073920|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
157073921|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
157073922|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
157073923|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
157073924|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
157073925|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
157073926|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
157073927|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
157073928|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
157073929|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
157073930|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
157073931|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
157073932|NCT02362503|567024494|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
157073933|NCT02362503|567024495|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
157073934|NCT02362503|567024496|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
157073935|NCT04148651|567024502|FG000|Overall Study|Lost to Follow-up|2|||
157073936|NCT03392168|567024505|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
157073937|NCT03392168|567024506|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
157073938|NCT03392168|567024507|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
157073939|NCT03392168|567024508|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
157073940|NCT03392168|567024505|FG000|Period 2: Cohort 2|Other|0|||
157073941|NCT03392168|567024506|FG001|Period 2: Cohort 2|Other|1|||
157073942|NCT03392168|567024507|FG002|Period 2: Cohort 2|Other|0|||
157073943|NCT03392168|567024508|FG003|Period 2: Cohort 2|Other|0|||
157073944|NCT02609672|567024510|FG000|Overall Study|Lost to Follow-up|3|||
157073945|NCT02609672|567024511|FG001|Overall Study|Lost to Follow-up|1|||
157073946|NCT01441635|567024512|FG000|Overall Study|Adverse Event|4|||
157073947|NCT01441635|567024513|FG001|Overall Study|Adverse Event|3|||
157073948|NCT01441635|567024514|FG002|Overall Study|Adverse Event|1|||
157073949|NCT01441635|567024515|FG003|Overall Study|Adverse Event|5|||
157073950|NCT01441635|567024516|FG004|Overall Study|Adverse Event|1|||
157073951|NCT01441635|567024517|FG005|Overall Study|Adverse Event|2|||
157073952|NCT01441635|567024518|FG006|Overall Study|Adverse Event|2|||
157073953|NCT01441635|567024519|FG007|Overall Study|Adverse Event|2|||
157073954|NCT01441635|567024520|FG008|Overall Study|Adverse Event|1|||
157073955|NCT01441635|567024521|FG009|Overall Study|Adverse Event|0|||
157073956|NCT01441635|567024512|FG000|Overall Study|Withdrawal by Subject|1|||
157073957|NCT01441635|567024513|FG001|Overall Study|Withdrawal by Subject|1|||
157073958|NCT01441635|567024514|FG002|Overall Study|Withdrawal by Subject|0|||
157073959|NCT01441635|567024515|FG003|Overall Study|Withdrawal by Subject|1|||
157073960|NCT01441635|567024516|FG004|Overall Study|Withdrawal by Subject|0|||
157073961|NCT01441635|567024517|FG005|Overall Study|Withdrawal by Subject|0|||
157073962|NCT01441635|567024518|FG006|Overall Study|Withdrawal by Subject|2|||
157073963|NCT01441635|567024519|FG007|Overall Study|Withdrawal by Subject|0|||
157073964|NCT01441635|567024520|FG008|Overall Study|Withdrawal by Subject|1|||
157073965|NCT01441635|567024521|FG009|Overall Study|Withdrawal by Subject|1|||
157073966|NCT01441635|567024512|FG000|Overall Study|Lost to Follow-up|0|||
157073967|NCT01441635|567024513|FG001|Overall Study|Lost to Follow-up|1|||
157073968|NCT01441635|567024514|FG002|Overall Study|Lost to Follow-up|1|||
157073969|NCT01441635|567024515|FG003|Overall Study|Lost to Follow-up|1|||
157073970|NCT01441635|567024516|FG004|Overall Study|Lost to Follow-up|1|||
157073971|NCT01441635|567024517|FG005|Overall Study|Lost to Follow-up|3|||
157073972|NCT01441635|567024518|FG006|Overall Study|Lost to Follow-up|1|||
157192022|NCT02418000|567443486|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
157192023|NCT02418000|567443487|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
157192024|NCT00106626|567443492|FG000|Overall Study|Adverse Event|5|||
157073973|NCT01441635|567024519|FG007|Overall Study|Lost to Follow-up|1|||
157073974|NCT01441635|567024520|FG008|Overall Study|Lost to Follow-up|0|||
157073975|NCT01441635|567024521|FG009|Overall Study|Lost to Follow-up|1|||
157073976|NCT01441635|567024512|FG000|Overall Study|Noncompliance|0|||
157073977|NCT01441635|567024513|FG001|Overall Study|Noncompliance|1|||
157073978|NCT01441635|567024514|FG002|Overall Study|Noncompliance|0|||
157073979|NCT01441635|567024515|FG003|Overall Study|Noncompliance|0|||
157073980|NCT01441635|567024516|FG004|Overall Study|Noncompliance|0|||
157073981|NCT01441635|567024517|FG005|Overall Study|Noncompliance|0|||
157073982|NCT01441635|567024518|FG006|Overall Study|Noncompliance|1|||
157073983|NCT01441635|567024519|FG007|Overall Study|Noncompliance|0|||
157073984|NCT01441635|567024520|FG008|Overall Study|Noncompliance|0|||
157192025|NCT00106626|567443493|FG001|Overall Study|Adverse Event|4|||
157073985|NCT01441635|567024521|FG009|Overall Study|Noncompliance|0|||
157073986|NCT01441635|567024512|FG000|Overall Study|Surgery or Invasive Intervention|0|||
157073987|NCT01441635|567024513|FG001|Overall Study|Surgery or Invasive Intervention|0|||
157073988|NCT01441635|567024514|FG002|Overall Study|Surgery or Invasive Intervention|1|||
157073989|NCT01441635|567024515|FG003|Overall Study|Surgery or Invasive Intervention|0|||
157073990|NCT01441635|567024516|FG004|Overall Study|Surgery or Invasive Intervention|0|||
157073991|NCT01441635|567024517|FG005|Overall Study|Surgery or Invasive Intervention|0|||
157073992|NCT01441635|567024518|FG006|Overall Study|Surgery or Invasive Intervention|0|||
157073993|NCT01441635|567024519|FG007|Overall Study|Surgery or Invasive Intervention|0|||
157073994|NCT01441635|567024520|FG008|Overall Study|Surgery or Invasive Intervention|0|||
157073995|NCT01441635|567024521|FG009|Overall Study|Surgery or Invasive Intervention|0|||
157073996|NCT01441635|567024512|FG000|Overall Study|Received Exclusionary Medication|1|||
157073997|NCT01441635|567024513|FG001|Overall Study|Received Exclusionary Medication|0|||
157073998|NCT01441635|567024514|FG002|Overall Study|Received Exclusionary Medication|0|||
157073999|NCT01441635|567024515|FG003|Overall Study|Received Exclusionary Medication|0|||
157074000|NCT01441635|567024516|FG004|Overall Study|Received Exclusionary Medication|0|||
157074001|NCT01441635|567024517|FG005|Overall Study|Received Exclusionary Medication|0|||
157074002|NCT01441635|567024518|FG006|Overall Study|Received Exclusionary Medication|0|||
157074003|NCT01441635|567024519|FG007|Overall Study|Received Exclusionary Medication|0|||
157074004|NCT01441635|567024520|FG008|Overall Study|Received Exclusionary Medication|0|||
157074005|NCT01441635|567024521|FG009|Overall Study|Received Exclusionary Medication|0|||
157074006|NCT01441635|567024512|FG000|Overall Study|Other|0|||
157074007|NCT01441635|567024513|FG001|Overall Study|Other|0|||
157074008|NCT01441635|567024514|FG002|Overall Study|Other|0|||
157074009|NCT01441635|567024515|FG003|Overall Study|Other|0|||
157074010|NCT01441635|567024516|FG004|Overall Study|Other|0|||
157074011|NCT01441635|567024517|FG005|Overall Study|Other|0|||
157074012|NCT01441635|567024518|FG006|Overall Study|Other|0|||
157074013|NCT01441635|567024519|FG007|Overall Study|Other|1|||
157074014|NCT01441635|567024520|FG008|Overall Study|Other|0|||
157074015|NCT01441635|567024521|FG009|Overall Study|Other|0|||
157074016|NCT01912404|567024525|FG000|Overall Study|Due to personal reasons|1|||
157074017|NCT01912404|567024526|FG001|Overall Study|Due to personal reasons|0|||
157074018|NCT02269423|567024533|FG000|Overall Study|Discontinued due to change in residence|0|||
157074019|NCT02269423|567024534|FG001|Overall Study|Discontinued due to change in residence|1|||
157074020|NCT02269423|567024535|FG002|Overall Study|Discontinued due to change in residence|0|||
157074021|NCT02269423|567024536|FG003|Overall Study|Discontinued due to change in residence|1|||
157074022|NCT01430468|567024537|FG000|Overall Study|Physician Decision|2|||
157074023|NCT01430468|567024538|FG001|Overall Study|Physician Decision|1|||
157074024|NCT01430468|567024537|FG000|Overall Study|Withdrawal by Subject|5|||
157074025|NCT01430468|567024538|FG001|Overall Study|Withdrawal by Subject|5|||
157074026|NCT01281839|567024539|FG000|Overall Study|Lost to Follow-up|6|||
157074027|NCT01281839|567024540|FG001|Overall Study|Lost to Follow-up|3|||
157074028|NCT01281839|567024539|FG000|Overall Study|Withdrawal by Subject|4|||
157074029|NCT01281839|567024540|FG001|Overall Study|Withdrawal by Subject|10|||
157074030|NCT01281839|567024539|FG000|Overall Study|Reason not specified|0|||
157074031|NCT01281839|567024540|FG001|Overall Study|Reason not specified|1|||
157074032|NCT01305239|567024541|FG000|Overall Study|Adverse Event|22|||
157074033|NCT01305239|567024541|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
157074034|NCT01754753|567024543|FG000|Overall Study|Study close|43|||
157074035|NCT01754753|567024544|FG001|Overall Study|Study close|44|||
157074036|NCT01754753|567024543|FG000|Overall Study|Lost to Follow-up|9|||
157074037|NCT01754753|567024544|FG001|Overall Study|Lost to Follow-up|5|||
157074038|NCT03229486|567024545|FG000|Overall Study|Protocol Violation|0|||
157074039|NCT03229486|567024546|FG001|Overall Study|Protocol Violation|1|||
157074040|NCT01443923|567024547|FG000|Overall Study|Adverse Event|1|||
157074041|NCT01443923|567024548|FG001|Overall Study|Adverse Event|0|||
157074042|NCT01245374|567024551|FG000|Overall Study|Protocol Violation|1|||
157074043|NCT01245374|567024551|FG000|Overall Study|Withdrawal by Subject|3|||
157074044|NCT01782690|567024553|FG000|Overall Study|Not reported|7|||
157074045|NCT01782690|567024553|FG000|Overall Study|Toxicity of gemcitabine|1|||
157074046|NCT01782690|567024553|FG000|Overall Study|Toxicity of erlotinib|1|||
157192026|NCT00106626|567443494|FG002|Overall Study|Adverse Event|3|||
157192027|NCT00106626|567443495|FG003|Overall Study|Adverse Event|3|||
157192028|NCT00106626|567443492|FG000|Overall Study|Progressive Disease|4|||
157192029|NCT00106626|567443493|FG001|Overall Study|Progressive Disease|1|||
157074047|NCT01782690|567024553|FG000|Overall Study|Lost to Follow-up|31|||
157074048|NCT01782690|567024553|FG000|Overall Study|Withdrawal of informed consent|2|||
157074049|NCT01782690|567024553|FG000|Overall Study|Absent rash|9|||
157074050|NCT01782690|567024553|FG000|Overall Study|Physician Decision|13|||
157074051|NCT01782690|567024553|FG000|Overall Study|Patient's wish|21|||
157074052|NCT01782690|567024553|FG000|Overall Study|Tumor progression|74|||
157074053|NCT01782690|567024553|FG000|Overall Study|Death|133|||
157074054|NCT01782690|567024553|FG000|Overall Study|Study completion unknown|7|||
157074055|NCT05032066|567024561|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
157074056|NCT05032066|567024562|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
157192030|NCT00106626|567443494|FG002|Overall Study|Progressive Disease|9|||
157192031|NCT00106626|567443495|FG003|Overall Study|Progressive Disease|10|||
157192032|NCT00106626|567443492|FG000|Overall Study|Received radiation on new therapy|1|||
157192033|NCT00106626|567443493|FG001|Overall Study|Received radiation on new therapy|0|||
157192034|NCT00106626|567443494|FG002|Overall Study|Received radiation on new therapy|0|||
157192035|NCT00106626|567443495|FG003|Overall Study|Received radiation on new therapy|0|||
157192036|NCT00106626|567443492|FG000|Overall Study|> 14 day delay in therapy start|0|||
157192037|NCT00106626|567443493|FG001|Overall Study|> 14 day delay in therapy start|1|||
157192038|NCT00106626|567443494|FG002|Overall Study|> 14 day delay in therapy start|0|||
157192039|NCT00106626|567443495|FG003|Overall Study|> 14 day delay in therapy start|0|||
157192040|NCT03018028|567443500|FG000|Overall Study|Withdrawal by Subject|3|||
157192041|NCT03018028|567443501|FG001|Overall Study|Withdrawal by Subject|0|||
157192042|NCT03018028|567443502|FG002|Overall Study|Withdrawal by Subject|1|||
157192043|NCT03018028|567443503|FG003|Overall Study|Withdrawal by Subject|2|||
157192044|NCT03018028|567443504|FG004|Overall Study|Withdrawal by Subject|0|||
157192045|NCT02195531|567443507|FG000|Overall Study|Withdrawal by Subject|1|||
157192046|NCT02195531|567443508|FG001|Overall Study|Withdrawal by Subject|1|||
157192047|NCT02195531|567443509|FG002|Overall Study|Withdrawal by Subject|1|||
157192048|NCT01284127|567443510|FG000|Overall Study|Adverse Event|2|||
157192049|NCT01284127|567443510|FG000|Overall Study|Withdrawal by Subject|4|||
157192050|NCT01284127|567443510|FG000|Overall Study|Physician Decision|1|||
157192051|NCT02516306|567443513|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
157192052|NCT02516306|567443514|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
157192053|NCT02607865|567443518|FG000|Overall Study|Lost to Follow-up|9|||
157192054|NCT02607865|567443519|FG001|Overall Study|Lost to Follow-up|7|||
157192055|NCT02607865|567443520|FG002|Overall Study|Lost to Follow-up|7|||
157192056|NCT02607865|567443521|FG003|Overall Study|Lost to Follow-up|5|||
157192057|NCT02607865|567443518|FG000|Overall Study|Withdrawal by Subject|18|||
157192058|NCT02607865|567443519|FG001|Overall Study|Withdrawal by Subject|18|||
157192059|NCT02607865|567443520|FG002|Overall Study|Withdrawal by Subject|17|||
157192060|NCT02607865|567443521|FG003|Overall Study|Withdrawal by Subject|8|||
157192061|NCT02607865|567443518|FG000|Overall Study|Death|5|||
157192062|NCT02607865|567443519|FG001|Overall Study|Death|4|||
157192063|NCT02607865|567443520|FG002|Overall Study|Death|1|||
157192064|NCT02607865|567443521|FG003|Overall Study|Death|3|||
157192065|NCT02607865|567443518|FG000|Overall Study|Unclassified|1|||
157192066|NCT02607865|567443519|FG001|Overall Study|Unclassified|1|||
157192067|NCT02607865|567443520|FG002|Overall Study|Unclassified|2|||
157192068|NCT02607865|567443521|FG003|Overall Study|Unclassified|0|||
157192069|NCT03227692|567443522|FG000|Overall Study|Protocol Violation|1|||
157192070|NCT03227692|567443523|FG001|Overall Study|Protocol Violation|1|||
157192071|NCT03227692|567443522|FG000|Overall Study|Lost to Follow-up|4|||
157192072|NCT03227692|567443523|FG001|Overall Study|Lost to Follow-up|2|||
157192073|NCT03227692|567443522|FG000|Overall Study|Adverse Event|0|||
157192074|NCT03227692|567443523|FG001|Overall Study|Adverse Event|2|||
157192075|NCT01351415|567443525|FG000|Overall Study|Withdrawal by Subject|15|||
157192076|NCT01351415|567443526|FG001|Overall Study|Withdrawal by Subject|17|||
157192077|NCT01351415|567443525|FG000|Overall Study|Trial termination by the Sponsor|28|||
157192078|NCT01351415|567443526|FG001|Overall Study|Trial termination by the Sponsor|19|||
157192079|NCT01351415|567443525|FG000|Overall Study|Lost to Follow-up|5|||
157192080|NCT01351415|567443526|FG001|Overall Study|Lost to Follow-up|7|||
157192081|NCT01351415|567443525|FG000|Overall Study|Death|190|||
157192082|NCT01351415|567443526|FG001|Overall Study|Death|187|||
157192083|NCT01351415|567443525|FG000|Overall Study|Physician Decision|2|||
157192084|NCT01351415|567443526|FG001|Overall Study|Physician Decision|3|||
157192085|NCT01351415|567443525|FG000|Overall Study|Reason unknown|0|||
157192086|NCT01351415|567443526|FG001|Overall Study|Reason unknown|2|||
157192087|NCT01351415|567443525|FG000|Overall Study|Never Started|5|||
157192088|NCT01351415|567443526|FG001|Overall Study|Never Started|5|||
157192089|NCT00994890|567443534|FG000|Overall Study|Adverse Event|13|||
157192090|NCT00994890|567443535|FG001|Overall Study|Adverse Event|9|||
157192091|NCT00994890|567443536|FG002|Overall Study|Adverse Event|11|||
157192092|NCT00994890|567443534|FG000|Overall Study|Lack of Efficacy|0|||
157192093|NCT00994890|567443535|FG001|Overall Study|Lack of Efficacy|0|||
157192094|NCT00994890|567443536|FG002|Overall Study|Lack of Efficacy|1|||
157192095|NCT00994890|567443534|FG000|Overall Study|Lost to Follow-up|6|||
157192096|NCT00994890|567443535|FG001|Overall Study|Lost to Follow-up|1|||
157192097|NCT00994890|567443536|FG002|Overall Study|Lost to Follow-up|3|||
157192098|NCT00994890|567443534|FG000|Overall Study|No longer willing to participate|8|||
157192099|NCT00994890|567443535|FG001|Overall Study|No longer willing to participate|5|||
157192100|NCT00994890|567443536|FG002|Overall Study|No longer willing to participate|13|||
157192101|NCT00994890|567443534|FG000|Overall Study|Protocol Violation|2|||
157192102|NCT00994890|567443535|FG001|Overall Study|Protocol Violation|4|||
157192103|NCT00994890|567443536|FG002|Overall Study|Protocol Violation|0|||
157192104|NCT00994890|567443534|FG000|Overall Study|Study terminated by sponsor|199|||
157074057|NCT05032066|567024563|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
157074058|NCT05032066|567024561|FG000|Part 1: Core Phase|Physician Decision|0|||
157074059|NCT05032066|567024562|FG001|Part 1: Core Phase|Physician Decision|1|||
157074060|NCT05032066|567024563|FG002|Part 1: Core Phase|Physician Decision|1|||
157074061|NCT05032066|567024561|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
157074062|NCT05032066|567024562|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
157074063|NCT05032066|567024563|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
157074064|NCT05032066|567024561|FG000|Part 1: Core Phase|Death|3|||
157074065|NCT05032066|567024562|FG001|Part 1: Core Phase|Death|4|||
157074066|NCT05032066|567024563|FG002|Part 1: Core Phase|Death|2|||
157074067|NCT05032066|567024561|FG000|Part 1: Core Phase|Adverse Event|2|||
157074068|NCT05032066|567024562|FG001|Part 1: Core Phase|Adverse Event|3|||
157074069|NCT05032066|567024563|FG002|Part 1: Core Phase|Adverse Event|0|||
157074070|NCT05032066|567024561|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
157074071|NCT05032066|567024562|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
157074072|NCT05032066|567024563|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
157074073|NCT05032066|567024561|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
157074074|NCT05032066|567024562|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
157074075|NCT05032066|567024563|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
157074076|NCT05032066|567024561|FG000|Part 2: Extension Phase|Physician Decision|1|||
157074077|NCT05032066|567024562|FG001|Part 2: Extension Phase|Physician Decision|2|||
157074078|NCT05032066|567024563|FG002|Part 2: Extension Phase|Physician Decision|0|||
157074079|NCT05032066|567024561|FG000|Part 2: Extension Phase|Death|2|||
157074080|NCT05032066|567024562|FG001|Part 2: Extension Phase|Death|4|||
157074081|NCT05032066|567024563|FG002|Part 2: Extension Phase|Death|5|||
157074082|NCT04297618|567024564|FG000|Overall Study|Adverse Event|1|||
157074083|NCT04297618|567024564|FG000|Overall Study|Withdrawal by Subject|1|||
157074084|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Adverse Event|10|||
157074085|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Adverse Event|9|||
157074086|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Adverse Event|7|||
157074087|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
157074088|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
157074089|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
157074090|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
157074091|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
157074092|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
157074093|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Physician Decision|7|||
157074094|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Physician Decision|3|||
157074095|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Physician Decision|2|||
157074096|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Pregnancy|2|||
157074097|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Pregnancy|1|||
157074098|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Pregnancy|3|||
157074099|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
157074100|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
157074101|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
157074102|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
157074103|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
157074104|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
157074105|NCT02614183|567024567|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
157074106|NCT02614183|567024568|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
157074107|NCT02614183|567024569|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
157074108|NCT02614183|567024567|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
157074109|NCT02614183|567024568|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
157074110|NCT02614183|567024569|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
157074111|NCT02614183|567024567|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
157074112|NCT02614183|567024568|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
157074113|NCT02614183|567024569|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
157074114|NCT02614183|567024567|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
157074115|NCT02614183|567024568|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
157192105|NCT00994890|567443535|FG001|Overall Study|Study terminated by sponsor|201|||
157192106|NCT00994890|567443536|FG002|Overall Study|Study terminated by sponsor|197|||
157192107|NCT00994890|567443534|FG000|Overall Study|Randomized, but not treated|1|||
157074116|NCT02614183|567024569|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
157192108|NCT00994890|567443535|FG001|Overall Study|Randomized, but not treated|0|||
157192109|NCT00994890|567443536|FG002|Overall Study|Randomized, but not treated|0|||
157192110|NCT00994890|567443534|FG000|Overall Study|Other|2|||
157074117|NCT02614183|567024567|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
157074118|NCT02614183|567024568|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
157074119|NCT02614183|567024569|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
157074120|NCT05992922|567024570|FG000|Overall Study|Adverse Event|6|||
157074121|NCT05992922|567024571|FG001|Overall Study|Adverse Event|0|||
157074122|NCT05992922|567024570|FG000|Overall Study|Sponsor Termination of Study|14|||
157074123|NCT05992922|567024571|FG001|Overall Study|Sponsor Termination of Study|20|||
157074124|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Adverse Event|2|||
157074125|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Adverse Event|0|||
157074126|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Adverse Event|0|||
157074127|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Adverse Event|0|||
157074128|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
157074129|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
157074130|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
157231059|NCT01939197|567592476|FG000|Overall Study|Lost to Follow-up|0|||
157231060|NCT01939197|567592477|FG001|Overall Study|Lost to Follow-up|1|||
157231061|NCT01939197|567592478|FG002|Overall Study|Lost to Follow-up|0|||
157231062|NCT01939197|567592479|FG003|Overall Study|Lost to Follow-up|1|||
157231063|NCT01939197|567592480|FG004|Overall Study|Lost to Follow-up|3|||
157231064|NCT01939197|567592481|FG005|Overall Study|Lost to Follow-up|1|||
157231065|NCT01939197|567592482|FG006|Overall Study|Lost to Follow-up|2|||
157231066|NCT00680121|567592483|FG000|Overall Study|Lost to Follow-up|27|||
157231067|NCT00680121|567592484|FG001|Overall Study|Lost to Follow-up|23|||
157231068|NCT02849652|567592489|FG000|Overall Study|Lost to Follow-up|104|||
157231069|NCT02849652|567592490|FG001|Overall Study|Lost to Follow-up|35|||
157231070|NCT02849652|567592491|FG002|Overall Study|Lost to Follow-up|116|||
157231071|NCT02849652|567592492|FG003|Overall Study|Lost to Follow-up|22|||
157231072|NCT02849652|567592489|FG000|Overall Study|Withdrawal by Subject|10|||
157231073|NCT02849652|567592490|FG001|Overall Study|Withdrawal by Subject|2|||
157231074|NCT02849652|567592491|FG002|Overall Study|Withdrawal by Subject|8|||
157231075|NCT02849652|567592492|FG003|Overall Study|Withdrawal by Subject|4|||
157231076|NCT00472290|567592493|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
157231077|NCT00472290|567592493|FG000|Overall Study|Protocol Specified Criteria|7|||
157231078|NCT00472290|567592493|FG000|Overall Study|Administrative Decision|37|||
157231079|NCT00472290|567592493|FG000|Overall Study|Death|3|||
157231080|NCT00472290|567592493|FG000|Overall Study|Lost to Follow-up|1|||
157231081|NCT00472290|567592493|FG000|Overall Study|Lack of Efficacy|1|||
157231082|NCT00472290|567592493|FG000|Overall Study|Disease Progression|4|||
157231083|NCT00472290|567592493|FG000|Overall Study|Withdrawal by Subject|5|||
157231084|NCT00472290|567592493|FG000|Overall Study|Adverse Event|6|||
157231085|NCT00472290|567592493|FG000|Overall Study|Requirement for alternative therapy|7|||
157231086|NCT00777829|567592495|FG000|Overall Study|Withdrawal by Subject|0|||
157231087|NCT00777829|567592496|FG001|Overall Study|Withdrawal by Subject|2|||
157231088|NCT00745095|567592497|FG000|Overall Study|Declined to participate|1|||
157231089|NCT00745095|567592498|FG001|Overall Study|Declined to participate|0|||
157231090|NCT00745095|567592499|FG002|Overall Study|Declined to participate|0|||
157231091|NCT00745095|567592500|FG003|Overall Study|Declined to participate|0|||
157231092|NCT00745095|567592501|FG004|Overall Study|Declined to participate|92|||
157231093|NCT00745095|567592502|FG005|Overall Study|Declined to participate|95|||
157231094|NCT00745095|567592497|FG000|Overall Study|Ineligible due to GFR criteria|0|||
157231095|NCT00745095|567592498|FG001|Overall Study|Ineligible due to GFR criteria|2|||
157231096|NCT00745095|567592499|FG002|Overall Study|Ineligible due to GFR criteria|3|||
157231097|NCT00745095|567592500|FG003|Overall Study|Ineligible due to GFR criteria|3|||
157231098|NCT00745095|567592501|FG004|Overall Study|Ineligible due to GFR criteria|30|||
157231099|NCT00745095|567592502|FG005|Overall Study|Ineligible due to GFR criteria|28|||
157231100|NCT00408902|567592507|FG000|Overall Study|Lack of Efficacy|7|||
157231101|NCT00408902|567592507|FG000|Overall Study|Adverse Event|3|||
157231102|NCT02457832|567592510|FG000|Training|Lost to Follow-up|10|||
157231103|NCT02457832|567592511|FG001|Training|Lost to Follow-up|6|||
157231104|NCT02457832|567592512|FG002|Training|Lost to Follow-up|3|||
157231105|NCT02457832|567592510|FG000|One Month Washout|Lost to Follow-up|0|||
157231106|NCT02457832|567592511|FG001|One Month Washout|Lost to Follow-up|1|||
157231107|NCT02457832|567592512|FG002|One Month Washout|Lost to Follow-up|1|||
157231108|NCT01030965|567592513|FG000|Overall Study|Lack of Efficacy|3|||
157231109|NCT01030965|567592514|FG001|Overall Study|Lack of Efficacy|2|||
157231110|NCT01030965|567592515|FG002|Overall Study|Lack of Efficacy|0|||
157231111|NCT01030965|567592516|FG003|Overall Study|Lack of Efficacy|3|||
157231112|NCT01030965|567592513|FG000|Overall Study|Protocol Violation|1|||
157231113|NCT01030965|567592514|FG001|Overall Study|Protocol Violation|1|||
157231114|NCT01030965|567592515|FG002|Overall Study|Protocol Violation|1|||
157231115|NCT01030965|567592516|FG003|Overall Study|Protocol Violation|1|||
157231116|NCT01030965|567592513|FG000|Overall Study|Adverse Event|0|||
157074131|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
157074132|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
157231117|NCT01030965|567592514|FG001|Overall Study|Adverse Event|1|||
157231118|NCT01030965|567592515|FG002|Overall Study|Adverse Event|2|||
157231119|NCT01030965|567592516|FG003|Overall Study|Adverse Event|1|||
157231120|NCT01030965|567592513|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
157231121|NCT01030965|567592514|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
157231122|NCT01030965|567592515|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
157231123|NCT01030965|567592516|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
157231124|NCT01030965|567592513|FG000|Overall Study|Withdrawal by Subject|0|||
157074133|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
157074134|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
157074135|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
157074136|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Physician Decision|1|||
157074137|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Physician Decision|0|||
157074138|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Physician Decision|0|||
157074139|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Physician Decision|0|||
157074140|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Pregnancy|1|||
157074141|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Pregnancy|0|||
157074142|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Pregnancy|0|||
157074143|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Pregnancy|0|||
157074144|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
157074145|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
157074146|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
157074147|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
157074148|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
157074149|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
157074150|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
157074151|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
157074152|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
157074153|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
157074154|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
157074155|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
157074156|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
157074157|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
157074158|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
157074159|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
157074160|NCT04057573|567026677|FG000|24-Week Double-Blind Period|Not Treated|1|||
157074161|NCT04057573|567026678|FG001|24-Week Double-Blind Period|Not Treated|0|||
157074162|NCT04057573|567026679|FG002|24-Week Double-Blind Period|Not Treated|0|||
157074163|NCT04057573|567026680|FG003|24-Week Double-Blind Period|Not Treated|0|||
157074164|NCT04057573|567026677|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
157074165|NCT04057573|567026678|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
157074166|NCT04057573|567026679|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
157074167|NCT04057573|567026680|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
157074168|NCT04057573|567026677|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
157074169|NCT04057573|567026678|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
157074170|NCT04057573|567026679|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
157074171|NCT04057573|567026680|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
157074172|NCT04057573|567026677|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
157074173|NCT04057573|567026678|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
157074174|NCT04057573|567026679|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
157074175|NCT04057573|567026680|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
157074176|NCT04057573|567026677|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
157074177|NCT04057573|567026678|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
157074178|NCT04057573|567026679|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
157074179|NCT04057573|567026680|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
157074180|NCT04057573|567026677|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
157074181|NCT04057573|567026678|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
157074182|NCT04057573|567026679|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
157074183|NCT04057573|567026680|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
157074184|NCT04991753|567026681|FG000|Overall Study|Withdrawal by Subject|0|||
157074185|NCT04991753|567026682|FG001|Overall Study|Withdrawal by Subject|1|||
157074186|NCT02797522|567026685|FG000|Overall Study|Study Terminated by Sponsor|0|||
157074187|NCT02797522|567026686|FG001|Overall Study|Study Terminated by Sponsor|0|||
157074188|NCT02797522|567026687|FG002|Overall Study|Study Terminated by Sponsor|0|||
157074189|NCT02797522|567026688|FG003|Overall Study|Study Terminated by Sponsor|0|||
157192111|NCT00994890|567443535|FG001|Overall Study|Other|2|||
157192112|NCT00994890|567443536|FG002|Overall Study|Other|1|||
157192113|NCT00699582|567443537|FG000|Overall Study|Adverse Event|4|||
157192114|NCT00699582|567443538|FG001|Overall Study|Adverse Event|11|||
157192115|NCT00699582|567443539|FG002|Overall Study|Adverse Event|23|||
157192116|NCT00699582|567443537|FG000|Overall Study|Withdrawal by Subject|6|||
157192117|NCT00699582|567443538|FG001|Overall Study|Withdrawal by Subject|7|||
157192118|NCT00699582|567443539|FG002|Overall Study|Withdrawal by Subject|4|||
157192119|NCT00699582|567443537|FG000|Overall Study|Lack of Efficacy|1|||
157231125|NCT01030965|567592514|FG001|Overall Study|Withdrawal by Subject|1|||
157231126|NCT01030965|567592515|FG002|Overall Study|Withdrawal by Subject|0|||
157074190|NCT02797522|567026689|FG004|Overall Study|Study Terminated by Sponsor|0|||
157074191|NCT02797522|567026690|FG005|Overall Study|Study Terminated by Sponsor|0|||
157074192|NCT02797522|567026691|FG006|Overall Study|Study Terminated by Sponsor|0|||
157074193|NCT02797522|567026692|FG007|Overall Study|Study Terminated by Sponsor|4|||
157074194|NCT02797522|567026693|FG008|Overall Study|Study Terminated by Sponsor|2|||
157074195|NCT02797522|567026694|FG009|Overall Study|Study Terminated by Sponsor|4|||
157074196|NCT02797522|567026695|FG010|Overall Study|Study Terminated by Sponsor|1|||
157074197|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
157074198|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
157074199|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
157074200|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
157074201|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
157074202|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
157074203|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
157074204|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
157074205|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
157074206|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
157074207|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
157074208|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
157074209|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
157074210|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
157074211|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
157074212|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
157074213|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
157074214|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
157074215|NCT00132678|567026698|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
157074216|NCT00132678|567026699|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
157074217|NCT00132678|567026700|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
157074218|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Death|2|||
157074219|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Death|0|||
157074220|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Death|0|||
157074221|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
157074222|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
157074223|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
157074224|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
157074225|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
157074226|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
157074227|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
157074228|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
157192120|NCT00699582|567443538|FG001|Overall Study|Lack of Efficacy|0|||
157192121|NCT00699582|567443539|FG002|Overall Study|Lack of Efficacy|1|||
157192122|NCT00699582|567443537|FG000|Overall Study|Progressive Disease|1|||
157192123|NCT00699582|567443538|FG001|Overall Study|Progressive Disease|0|||
157192124|NCT00699582|567443539|FG002|Overall Study|Progressive Disease|0|||
157192125|NCT00699582|567443537|FG000|Overall Study|Administrative/Other|4|||
157192126|NCT00699582|567443538|FG001|Overall Study|Administrative/Other|3|||
157192127|NCT00699582|567443539|FG002|Overall Study|Administrative/Other|0|||
157192128|NCT00699582|567443537|FG000|Overall Study|Randomized, Not Treated|2|||
157192129|NCT00699582|567443538|FG001|Overall Study|Randomized, Not Treated|1|||
157192130|NCT00699582|567443539|FG002|Overall Study|Randomized, Not Treated|0|||
157192131|NCT03117309|567443542|FG000|Overall Study|Not meeting inclusion criteria|0|||
157192132|NCT03117309|567443543|FG001|Overall Study|Not meeting inclusion criteria|1|||
157192133|NCT00420212|567443557|FG000|Overall Study|Adverse Event|22|||
157192134|NCT00420212|567443558|FG001|Overall Study|Adverse Event|40|||
157192135|NCT00420212|567443559|FG002|Overall Study|Adverse Event|36|||
157192136|NCT00420212|567443557|FG000|Overall Study|Lost to Follow-up|9|||
157192137|NCT00420212|567443558|FG001|Overall Study|Lost to Follow-up|11|||
157192138|NCT00420212|567443559|FG002|Overall Study|Lost to Follow-up|11|||
157192139|NCT00420212|567443557|FG000|Overall Study|Withdrawal by Subject|31|||
157192140|NCT00420212|567443558|FG001|Overall Study|Withdrawal by Subject|22|||
157192141|NCT00420212|567443559|FG002|Overall Study|Withdrawal by Subject|19|||
157192142|NCT00420212|567443557|FG000|Overall Study|Physician Decision|4|||
157192143|NCT00420212|567443558|FG001|Overall Study|Physician Decision|4|||
157192144|NCT00420212|567443559|FG002|Overall Study|Physician Decision|3|||
157192145|NCT00420212|567443557|FG000|Overall Study|Protocol Violation|4|||
157192146|NCT00420212|567443558|FG001|Overall Study|Protocol Violation|4|||
157192147|NCT00420212|567443559|FG002|Overall Study|Protocol Violation|8|||
157231127|NCT01030965|567592516|FG003|Overall Study|Withdrawal by Subject|2|||
157192148|NCT00420212|567443557|FG000|Overall Study|Death|0|||
157192149|NCT00420212|567443558|FG001|Overall Study|Death|0|||
157192150|NCT00420212|567443559|FG002|Overall Study|Death|1|||
157074229|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
157074230|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
157074231|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
157074232|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
157074233|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
157074234|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
157074235|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
157074236|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
157074237|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
157074238|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
157074239|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
157074240|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
157074241|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
157074242|NCT00132678|567026698|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
157074243|NCT00132678|567026699|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
157074244|NCT00132678|567026700|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
157074245|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
157074246|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
157074247|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
157074248|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
157074249|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
157074250|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
157074251|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
157074252|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
157074253|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
157074254|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
157074255|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
157074256|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
157074257|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
157074258|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
157074259|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
157074260|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
157074261|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
157074262|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
157074263|NCT00132678|567026698|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
157074264|NCT00132678|567026699|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
157074265|NCT00132678|567026700|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
157074266|NCT02514239|567026703|FG000|Overall Study|Refused to continue trial medication|0|||
157074267|NCT02514239|567026704|FG001|Overall Study|Refused to continue trial medication|0|||
157074268|NCT02514239|567026705|FG002|Overall Study|Refused to continue trial medication|0|||
157074269|NCT02514239|567026706|FG003|Overall Study|Refused to continue trial medication|0|||
157074270|NCT02514239|567026707|FG004|Overall Study|Refused to continue trial medication|0|||
157074271|NCT02514239|567026708|FG005|Overall Study|Refused to continue trial medication|0|||
157074272|NCT02514239|567026709|FG006|Overall Study|Refused to continue trial medication|0|||
157074273|NCT02514239|567026710|FG007|Overall Study|Refused to continue trial medication|0|||
157074274|NCT02514239|567026711|FG008|Overall Study|Refused to continue trial medication|0|||
157074275|NCT02514239|567026712|FG009|Overall Study|Refused to continue trial medication|1|||
157074276|NCT02514239|567026703|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074277|NCT02514239|567026704|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074278|NCT02514239|567026705|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074279|NCT02514239|567026706|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074280|NCT02514239|567026707|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074281|NCT02514239|567026708|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074282|NCT02514239|567026709|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074283|NCT02514239|567026710|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
157074284|NCT02514239|567026711|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
157074285|NCT02514239|567026712|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
157074286|NCT02514239|567026703|FG000|Overall Study|Not treated|0|||
157074287|NCT02514239|567026704|FG001|Overall Study|Not treated|1|||
157074288|NCT02514239|567026705|FG002|Overall Study|Not treated|0|||
157192151|NCT00420212|567443557|FG000|Overall Study|Other-Unspecified|21|||
157074289|NCT02514239|567026706|FG003|Overall Study|Not treated|0|||
157074290|NCT02514239|567026707|FG004|Overall Study|Not treated|0|||
157074291|NCT02514239|567026708|FG005|Overall Study|Not treated|0|||
157074292|NCT02514239|567026709|FG006|Overall Study|Not treated|0|||
157192152|NCT00420212|567443558|FG001|Overall Study|Other-Unspecified|14|||
157192153|NCT00420212|567443559|FG002|Overall Study|Other-Unspecified|18|||
157192154|NCT01142791|567443569|FG000|Overall Study|Alternative Treatment|1|||
157074293|NCT02514239|567026710|FG007|Overall Study|Not treated|0|||
157074294|NCT02514239|567026711|FG008|Overall Study|Not treated|0|||
157074295|NCT02514239|567026712|FG009|Overall Study|Not treated|0|||
157074296|NCT02514239|567026703|FG000|Overall Study|Other Adverse Events|2|||
157074297|NCT02514239|567026704|FG001|Overall Study|Other Adverse Events|0|||
157074298|NCT02514239|567026705|FG002|Overall Study|Other Adverse Events|0|||
157074299|NCT02514239|567026706|FG003|Overall Study|Other Adverse Events|1|||
157074300|NCT02514239|567026707|FG004|Overall Study|Other Adverse Events|0|||
157074301|NCT02514239|567026708|FG005|Overall Study|Other Adverse Events|1|||
157074302|NCT02514239|567026709|FG006|Overall Study|Other Adverse Events|0|||
157074303|NCT02514239|567026710|FG007|Overall Study|Other Adverse Events|1|||
157074304|NCT02514239|567026711|FG008|Overall Study|Other Adverse Events|2|||
157074305|NCT02514239|567026712|FG009|Overall Study|Other Adverse Events|0|||
157074306|NCT02514239|567026703|FG000|Overall Study|Progressive disease|3|||
157074307|NCT02514239|567026704|FG001|Overall Study|Progressive disease|3|||
157074308|NCT02514239|567026705|FG002|Overall Study|Progressive disease|2|||
157074309|NCT02514239|567026706|FG003|Overall Study|Progressive disease|2|||
157074310|NCT02514239|567026707|FG004|Overall Study|Progressive disease|3|||
157074311|NCT02514239|567026708|FG005|Overall Study|Progressive disease|3|||
157074312|NCT02514239|567026709|FG006|Overall Study|Progressive disease|4|||
157074313|NCT02514239|567026710|FG007|Overall Study|Progressive disease|2|||
157074314|NCT02514239|567026711|FG008|Overall Study|Progressive disease|5|||
157074315|NCT02514239|567026712|FG009|Overall Study|Progressive disease|0|||
157074316|NCT03299049|567026713|FG000|Overall Study|On-going|486|||
157074317|NCT03299049|567026714|FG001|Overall Study|On-going|481|||
157074318|NCT03299049|567026713|FG000|Overall Study|Withdrawal by Subject|6|||
157074319|NCT03299049|567026714|FG001|Overall Study|Withdrawal by Subject|21|||
157074320|NCT03299049|567026713|FG000|Overall Study|Physician Decision|5|||
157074321|NCT03299049|567026714|FG001|Overall Study|Physician Decision|1|||
157074322|NCT03299049|567026713|FG000|Overall Study|Lost to Follow-up|2|||
157074323|NCT03299049|567026714|FG001|Overall Study|Lost to Follow-up|0|||
157074324|NCT03299049|567026713|FG000|Overall Study|Pregnancy|1|||
157074325|NCT03299049|567026714|FG001|Overall Study|Pregnancy|3|||
157074326|NCT03299049|567026713|FG000|Overall Study|Protocol Violation|1|||
157074327|NCT03299049|567026714|FG001|Overall Study|Protocol Violation|1|||
157074328|NCT03299049|567026713|FG000|Overall Study|Lack of Efficacy|9|||
157074329|NCT03299049|567026714|FG001|Overall Study|Lack of Efficacy|3|||
157074330|NCT03299049|567026713|FG000|Overall Study|Adverse Event|12|||
157074331|NCT03299049|567026714|FG001|Overall Study|Adverse Event|13|||
157074332|NCT01901419|567026715|FG000|Overall Study|Protocol Violation|2|||
157074333|NCT01901419|567026716|FG001|Overall Study|Protocol Violation|6|||
157074334|NCT01901419|567026715|FG000|Overall Study|unavailable researchers|6|||
157074335|NCT01901419|567026716|FG001|Overall Study|unavailable researchers|3|||
157074336|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
157074337|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
157074338|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
157074339|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
157074340|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
157074341|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
157074342|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
157074343|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
157074344|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
157074345|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
157074346|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
157074347|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
157074348|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
157074349|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
157074350|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074351|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074352|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074353|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074354|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074355|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
157074356|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
157074357|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
157074358|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
157074359|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
157074360|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
157074361|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
157074362|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
157074363|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
157074364|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157192155|NCT01142791|567443570|FG001|Overall Study|Alternative Treatment|0|||
157074365|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157192156|NCT01142791|567443569|FG000|Overall Study|Lost to Follow-up|1|||
157074366|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157074367|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157074368|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
157074369|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157074370|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
157074371|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074372|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
157074373|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074374|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074375|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074376|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074377|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
157074378|NCT01888874|567026717|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
157074379|NCT01888874|567026718|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
157074380|NCT01888874|567026719|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
157074381|NCT01888874|567026720|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
157074382|NCT01888874|567026721|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
157074383|NCT01888874|567026722|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
157074384|NCT01888874|567026723|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
157074385|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
157074386|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
157074387|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
157074388|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
157074389|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
157074390|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
157074391|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
157074392|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074393|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074394|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074395|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074396|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
157074397|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074398|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
157074399|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
157074400|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
157074401|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
157074402|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
157074403|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
157074404|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
157074405|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
157074406|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074407|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074408|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
157074409|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074410|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074411|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074412|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
157074413|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
157074414|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
157074415|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
157074416|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
157074417|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
157074418|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
157074419|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
157074420|NCT01888874|567026717|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
157074421|NCT01888874|567026718|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
157074422|NCT01888874|567026719|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
157192157|NCT01142791|567443570|FG001|Overall Study|Lost to Follow-up|0|||
157192158|NCT01142791|567443569|FG000|Overall Study|Withdrawal by Subject|5|||
157192159|NCT01142791|567443570|FG001|Overall Study|Withdrawal by Subject|0|||
157192160|NCT01142791|567443569|FG000|Overall Study|Received only 1 sonication|0|||
157192161|NCT01142791|567443570|FG001|Overall Study|Received only 1 sonication|6|||
157192162|NCT01981096|567443573|FG000|Overall Study|Parent illness|1|||
157192163|NCT01981096|567443574|FG001|Overall Study|Parent illness|0|||
157074423|NCT01888874|567026720|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
157074424|NCT01888874|567026721|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
157074425|NCT01888874|567026722|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
157074426|NCT01888874|567026723|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
157074427|NCT00475644|567026725|FG000|Overall Study|Protocol Violation|13|||
157074428|NCT01411241|567026728|FG000|Overall Study|Protocol Violation|0|||
157074429|NCT01411241|567026729|FG001|Overall Study|Protocol Violation|5|||
157074430|NCT01411241|567026728|FG000|Overall Study|Withdrawal by Subject|9|||
157074431|NCT01411241|567026729|FG001|Overall Study|Withdrawal by Subject|10|||
157074432|NCT01411241|567026728|FG000|Overall Study|Serious Adverse Event|0|||
157074433|NCT01411241|567026729|FG001|Overall Study|Serious Adverse Event|3|||
157074434|NCT01411241|567026728|FG000|Overall Study|Lost to Follow-up|2|||
157074435|NCT01411241|567026729|FG001|Overall Study|Lost to Follow-up|4|||
157074436|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
157074437|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
157074438|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
157074439|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
157074440|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
157074441|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
157074442|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
157074443|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
157074444|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
157074445|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
157074446|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
157074447|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
157074448|NCT00790400|567026736|FG000|Double-blind Period (Core Phase)|Death|1|||
157074449|NCT00790400|567026737|FG001|Double-blind Period (Core Phase)|Death|0|||
157074450|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
157074451|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
157074452|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
157074453|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
157074454|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
157074455|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
157074456|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
157074457|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
157074458|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
157074459|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
157074460|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Death|1|||
157074461|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Death|0|||
157074462|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
157074463|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
157074464|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
157074465|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
157074466|NCT00790400|567026736|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
157074467|NCT00790400|567026737|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
157074468|NCT00699153|567026739|FG000|Overall Study|Lost to Follow-up|1|||
157074469|NCT00699153|567026740|FG001|Overall Study|Lost to Follow-up|0|||
157074470|NCT00699153|567026739|FG000|Overall Study|Adverse Event|0|||
157074471|NCT00699153|567026740|FG001|Overall Study|Adverse Event|2|||
157074472|NCT00699153|567026739|FG000|Overall Study|Protocol Violation|1|||
157074473|NCT00699153|567026740|FG001|Overall Study|Protocol Violation|0|||
157074474|NCT00699153|567026739|FG000|Overall Study|Travel Problem|1|||
157074475|NCT00699153|567026740|FG001|Overall Study|Travel Problem|0|||
157074476|NCT02412735|567026743|FG000|Overall Study|Adverse Event|0|||
157192164|NCT01981096|567443573|FG000|Overall Study|Withdrawal by Subject|0|||
157192165|NCT01981096|567443574|FG001|Overall Study|Withdrawal by Subject|1|||
157192166|NCT01981096|567443573|FG000|Overall Study|Lost to Follow-up|2|||
157192167|NCT01981096|567443574|FG001|Overall Study|Lost to Follow-up|0|||
157192168|NCT04129242|567443576|FG000|Overall Study|Physician Decision|1|||
157192169|NCT04129242|567443577|FG001|Overall Study|Physician Decision|1|||
157192170|NCT04129242|567443576|FG000|Overall Study|Protocol Violation|0|||
157192171|NCT04129242|567443577|FG001|Overall Study|Protocol Violation|1|||
157074477|NCT02412735|567026744|FG001|Overall Study|Adverse Event|1|||
157074478|NCT02412735|567026745|FG002|Overall Study|Adverse Event|2|||
157074479|NCT02412735|567026743|FG000|Overall Study|Withdrawal by Subject|23|||
157074480|NCT02412735|567026744|FG001|Overall Study|Withdrawal by Subject|27|||
157074481|NCT02412735|567026745|FG002|Overall Study|Withdrawal by Subject|22|||
157074482|NCT02412735|567026743|FG000|Overall Study|Investigator Decision|3|||
157074483|NCT02412735|567026744|FG001|Overall Study|Investigator Decision|3|||
157074484|NCT02412735|567026745|FG002|Overall Study|Investigator Decision|2|||
157074485|NCT02412735|567026743|FG000|Overall Study|Lost to Follow-up|17|||
157074486|NCT02412735|567026744|FG001|Overall Study|Lost to Follow-up|11|||
157074487|NCT02412735|567026745|FG002|Overall Study|Lost to Follow-up|18|||
157074488|NCT02412735|567026743|FG000|Overall Study|Reason not Specified|3|||
157074489|NCT02412735|567026744|FG001|Overall Study|Reason not Specified|2|||
157074490|NCT02412735|567026745|FG002|Overall Study|Reason not Specified|2|||
157074491|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
157074492|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
157074493|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
157074494|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
157074495|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Death|13|||
157074496|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Death|12|||
157074497|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Progression|257|||
157074498|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Progression|218|||
157074499|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
157074500|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
157074501|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
157074502|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
157074503|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
157074504|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
157074505|NCT01006980|567026747|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
157074506|NCT01006980|567026748|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
157074507|NCT01006980|567026747|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
157074508|NCT01006980|567026748|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
157074509|NCT01006980|567026747|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
157074510|NCT01006980|567026748|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
157074511|NCT01006980|567026747|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
157074512|NCT01006980|567026748|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
157074513|NCT01006980|567026747|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
157074514|NCT01006980|567026748|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
157074515|NCT01006980|567026747|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
157231128|NCT02097290|567592517|FG000|Overall Study|Death|6|||
157231129|NCT02097290|567592517|FG000|Overall Study|Total Withdrawals|3|||
157231130|NCT02097290|567592517|FG000|Overall Study|Attempt|8|||
157231131|NCT05277389|567592518|FG000|Overall Study|Lost to Follow-up|1|||
157231132|NCT05277389|567592519|FG001|Overall Study|Lost to Follow-up|4|||
157231133|NCT03069937|567592520|FG000|Overall Study|Second primary malignancy noted|1|||
157231134|NCT03144687|567592525|FG000|Overall Study|Death|0|||
157231135|NCT03144687|567592526|FG001|Overall Study|Death|2|||
157231136|NCT03144687|567592525|FG000|Overall Study|Lost to Follow-up|0|||
157231137|NCT03144687|567592526|FG001|Overall Study|Lost to Follow-up|1|||
157231138|NCT03144687|567592525|FG000|Overall Study|Physician Decision|0|||
157231139|NCT03144687|567592526|FG001|Overall Study|Physician Decision|1|||
157231140|NCT03144687|567592525|FG000|Overall Study|Withdrawal by Subject|1|||
157231141|NCT03144687|567592526|FG001|Overall Study|Withdrawal by Subject|3|||
157231142|NCT03144687|567592525|FG000|Overall Study|Not Reported|2|||
157231143|NCT03144687|567592526|FG001|Overall Study|Not Reported|0|||
157231144|NCT00683293|567592529|FG000|Overall Study|Withdrawal by Subject|2|||
157231145|NCT00683293|567592530|FG001|Overall Study|Withdrawal by Subject|3|||
157231146|NCT02079532|567592535|FG000|Overall Study|Adverse Event|7|||
157231147|NCT02079532|567592535|FG000|Overall Study|Additional or changed therapy|2|||
157231148|NCT02079532|567592535|FG000|Overall Study|Lack of Efficacy|9|||
157231149|NCT02079532|567592535|FG000|Overall Study|Protocol Violation|3|||
157231150|NCT02079532|567592535|FG000|Overall Study|Withdrawal by Subject|1|||
157231151|NCT02079532|567592535|FG000|Overall Study|Administrative problems|1|||
157231152|NCT02079532|567592535|FG000|Overall Study|Inclusion into ReFIRST|3|||
157231153|NCT02079532|567592535|FG000|Overall Study|Other|3|||
157231154|NCT02920996|567592536|FG000|Overall Study|Adverse Event|8|||
157231155|NCT02920996|567592537|FG001|Overall Study|Adverse Event|0|||
157231156|NCT02920996|567592536|FG000|Overall Study|Physician Decision|1|||
157231157|NCT02920996|567592537|FG001|Overall Study|Physician Decision|0|||
157231158|NCT02920996|567592536|FG000|Overall Study|Death|1|||
157074516|NCT01006980|567026748|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
157074517|NCT00078338|567026749|FG000|Overall Study|Adverse Event|31|||
157074518|NCT00078338|567026750|FG001|Overall Study|Adverse Event|24|||
157074519|NCT00078338|567026749|FG000|Overall Study|Lost to Follow-up|17|||
157231159|NCT02920996|567592537|FG001|Overall Study|Death|0|||
157231160|NCT02920996|567592536|FG000|Overall Study|Missing|1|||
157074520|NCT00078338|567026750|FG001|Overall Study|Lost to Follow-up|2|||
157074521|NCT00078338|567026749|FG000|Overall Study|Protocol Violation|2|||
157231161|NCT02920996|567592537|FG001|Overall Study|Missing|0|||
157231162|NCT02920996|567592536|FG000|Overall Study|Subject Non-Compliance|1|||
157231163|NCT02920996|567592537|FG001|Overall Study|Subject Non-Compliance|0|||
157231164|NCT00591630|567592538|FG000|Overall Study|Death|0|||
157231165|NCT00591630|567592539|FG001|Overall Study|Death|0|||
157074522|NCT00078338|567026750|FG001|Overall Study|Protocol Violation|2|||
157074523|NCT00078338|567026749|FG000|Overall Study|Disease Progression|4|||
157231166|NCT00591630|567592540|FG002|Overall Study|Death|1|||
157074524|NCT00078338|567026750|FG001|Overall Study|Disease Progression|7|||
157074525|NCT00078338|567026749|FG000|Overall Study|Other|28|||
157074526|NCT00078338|567026750|FG001|Overall Study|Other|16|||
157074527|NCT00078338|567026749|FG000|Overall Study|Subjects randomized, but not treated|3|||
157074528|NCT00078338|567026750|FG001|Overall Study|Subjects randomized, but not treated|3|||
157074529|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
157074530|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
157074531|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
157074532|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
157074533|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157074534|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
157074535|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
157074536|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
157074537|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
157074538|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157074539|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
157074540|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157074541|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
157074542|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
157074543|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157074544|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
157074545|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
157074546|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
157074547|NCT00603525|567026751|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
157074548|NCT00603525|567026752|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
157074549|NCT00603525|567026753|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
157074550|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
157074551|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
157074552|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
157074553|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
157074554|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
157074555|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
157074556|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
157074557|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
157074558|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
157074559|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
157074560|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
157074561|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
157074562|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
157074563|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
157074564|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
157074565|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
157074566|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
157074567|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
157074568|NCT00603525|567026751|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
157074569|NCT00603525|567026752|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
157074570|NCT00603525|567026753|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
157074571|NCT00603525|567026751|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
157074572|NCT00603525|567026752|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
157074573|NCT00603525|567026753|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
157074574|NCT01483144|567026754|FG000|Overall Study|Adverse Event|9|||
157074575|NCT01483144|567026755|FG001|Overall Study|Adverse Event|4|||
157074576|NCT01483144|567026756|FG002|Overall Study|Adverse Event|6|||
157074577|NCT01483144|567026754|FG000|Overall Study|Withdrawal by Subject|0|||
157074578|NCT01483144|567026755|FG001|Overall Study|Withdrawal by Subject|2|||
157231167|NCT00591630|567592541|FG003|Overall Study|Death|0|||
157231168|NCT01691248|567592542|FG000|Overall Study|Protocol Violation|43|||
157231169|NCT01691248|567592543|FG001|Overall Study|Protocol Violation|27|||
157231170|NCT01691248|567592542|FG000|Overall Study|Adverse Event|24|||
157231171|NCT01691248|567592543|FG001|Overall Study|Adverse Event|22|||
157231172|NCT01691248|567592542|FG000|Overall Study|Withdrawal by Subject|20|||
157231173|NCT01691248|567592543|FG001|Overall Study|Withdrawal by Subject|18|||
157074579|NCT01483144|567026756|FG002|Overall Study|Withdrawal by Subject|5|||
157074580|NCT01483144|567026754|FG000|Overall Study|Physician Decision|1|||
157074581|NCT01483144|567026755|FG001|Overall Study|Physician Decision|0|||
157074582|NCT01483144|567026756|FG002|Overall Study|Physician Decision|0|||
157074583|NCT01483144|567026754|FG000|Overall Study|Lost to Follow-up|2|||
157074584|NCT01483144|567026755|FG001|Overall Study|Lost to Follow-up|4|||
157231174|NCT01691248|567592542|FG000|Overall Study|Confirmed CDAD|14|||
157231175|NCT01691248|567592543|FG001|Overall Study|Confirmed CDAD|31|||
157231176|NCT01691248|567592542|FG000|Overall Study|Lost to Follow-up|2|||
157231177|NCT01691248|567592543|FG001|Overall Study|Lost to Follow-up|5|||
157231178|NCT01691248|567592542|FG000|Overall Study|Reason not provided|4|||
157231179|NCT01691248|567592543|FG001|Overall Study|Reason not provided|4|||
157231180|NCT01691248|567592542|FG000|Overall Study|Not Treated|4|||
157231181|NCT01691248|567592543|FG001|Overall Study|Not Treated|7|||
157231182|NCT02863575|567592544|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
157231183|NCT02863575|567592545|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
157231184|NCT02863575|567592546|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
157231185|NCT02863575|567592544|FG000|Overall Study|Withdrawal by Subject|0|||
157231186|NCT02863575|567592545|FG001|Overall Study|Withdrawal by Subject|1|||
157231187|NCT02863575|567592546|FG002|Overall Study|Withdrawal by Subject|1|||
157231188|NCT02863575|567592544|FG000|Overall Study|Adverse Event|0|||
157231189|NCT02863575|567592545|FG001|Overall Study|Adverse Event|1|||
157231190|NCT02863575|567592546|FG002|Overall Study|Adverse Event|0|||
157231191|NCT01387737|567593865|FG000|Overall Study|Adverse Event|20|||
157231192|NCT01387737|567593866|FG001|Overall Study|Adverse Event|30|||
157231193|NCT01387737|567593865|FG000|Overall Study|Lack of Efficacy|1|||
157231194|NCT01387737|567593866|FG001|Overall Study|Lack of Efficacy|0|||
157231195|NCT01387737|567593865|FG000|Overall Study|Physician Decision|3|||
157231196|NCT01387737|567593866|FG001|Overall Study|Physician Decision|10|||
157231197|NCT01387737|567593865|FG000|Overall Study|Withdrawal by Subject|27|||
157231198|NCT01387737|567593866|FG001|Overall Study|Withdrawal by Subject|31|||
157231199|NCT01387737|567593865|FG000|Overall Study|Clearly not eligible for the study|1|||
157231200|NCT01387737|567593866|FG001|Overall Study|Clearly not eligible for the study|3|||
157231201|NCT01248247|567593868|FG000|Overall Study|Adverse Event|2|||
157231202|NCT01248247|567593869|FG001|Overall Study|Adverse Event|4|||
157231203|NCT01248247|567593870|FG002|Overall Study|Adverse Event|4|||
157231204|NCT01248247|567593871|FG003|Overall Study|Adverse Event|2|||
157231205|NCT01248247|567593868|FG000|Overall Study|Death|0|||
157231206|NCT01248247|567593869|FG001|Overall Study|Death|1|||
157231207|NCT01248247|567593870|FG002|Overall Study|Death|4|||
157231208|NCT01248247|567593871|FG003|Overall Study|Death|7|||
157231209|NCT01248247|567593868|FG000|Overall Study|Lost to Follow-up|0|||
157231210|NCT01248247|567593869|FG001|Overall Study|Lost to Follow-up|1|||
157231211|NCT01248247|567593870|FG002|Overall Study|Lost to Follow-up|1|||
157231212|NCT01248247|567593871|FG003|Overall Study|Lost to Follow-up|0|||
157231213|NCT01248247|567593868|FG000|Overall Study|Alternative treatment|0|||
157231214|NCT01248247|567593869|FG001|Overall Study|Alternative treatment|1|||
157231215|NCT01248247|567593870|FG002|Overall Study|Alternative treatment|0|||
157231216|NCT01248247|567593871|FG003|Overall Study|Alternative treatment|0|||
157231217|NCT01248247|567593868|FG000|Overall Study|Other|2|||
157231218|NCT01248247|567593869|FG001|Overall Study|Other|8|||
157231219|NCT01248247|567593870|FG002|Overall Study|Other|8|||
157231220|NCT01248247|567593871|FG003|Overall Study|Other|5|||
157231221|NCT01248247|567593868|FG000|Overall Study|Progression|18|||
157231222|NCT01248247|567593869|FG001|Overall Study|Progression|27|||
157231223|NCT01248247|567593870|FG002|Overall Study|Progression|56|||
157231224|NCT01248247|567593871|FG003|Overall Study|Progression|44|||
157231225|NCT01248247|567593868|FG000|Overall Study|Refuse further treatment|0|||
157231226|NCT01248247|567593869|FG001|Overall Study|Refuse further treatment|0|||
157231227|NCT01248247|567593870|FG002|Overall Study|Refuse further treatment|1|||
157231228|NCT01248247|567593871|FG003|Overall Study|Refuse further treatment|2|||
157231229|NCT01248247|567593868|FG000|Overall Study|Complicating disease|0|||
157231230|NCT01248247|567593869|FG001|Overall Study|Complicating disease|0|||
157231231|NCT01248247|567593870|FG002|Overall Study|Complicating disease|1|||
157231232|NCT01248247|567593871|FG003|Overall Study|Complicating disease|1|||
157231233|NCT02817841|567593872|FG000|Overall Study|Lost to Follow-up|287|||
157231234|NCT02817841|567593872|FG000|Overall Study|Withdrawal by Subject|183|||
157231235|NCT02817841|567593872|FG000|Overall Study|Adverse event not related to bleeding|131|||
157231236|NCT02817841|567593872|FG000|Overall Study|Adverse event related to bleeding|51|||
157231237|NCT02817841|567593872|FG000|Overall Study|Pregnancy|32|||
157231238|NCT02817841|567593872|FG000|Overall Study|Pregnancy wish|17|||
157231239|NCT02817841|567593872|FG000|Overall Study|Other reasons|53|||
157231240|NCT02817841|567593872|FG000|Overall Study|Protocol Violation|94|||
157231241|NCT00705536|567593873|FG000|Start Period 1|Withdrawal by Subject|0|||
157074585|NCT01483144|567026756|FG002|Overall Study|Lost to Follow-up|1|||
157231242|NCT00705536|567593874|FG001|Start Period 1|Withdrawal by Subject|0|||
157231243|NCT00705536|567593875|FG002|Start Period 1|Withdrawal by Subject|0|||
157231244|NCT00705536|567593876|FG003|Start Period 1|Withdrawal by Subject|1|||
157231245|NCT04188106|567593877|FG000|Overall Study|Lost to Follow-up|5|||
157231246|NCT04188106|567593877|FG000|Overall Study|Non-Compliance|1|||
157231247|NCT01746017|567593880|FG000|Period 1|Withdrawal by Subject|0|||
157231248|NCT01746017|567593881|FG001|Period 1|Withdrawal by Subject|0|||
157231249|NCT01746017|567593882|FG002|Period 1|Withdrawal by Subject|0|||
157231250|NCT01746017|567593883|FG003|Period 1|Withdrawal by Subject|0|||
157231251|NCT01746017|567593884|FG004|Period 1|Withdrawal by Subject|0|||
157231252|NCT01746017|567593885|FG005|Period 1|Withdrawal by Subject|0|||
157231253|NCT01746017|567593886|FG006|Period 1|Withdrawal by Subject|1|||
157074586|NCT01483144|567026754|FG000|Overall Study|Protocol Violation|3|||
157074587|NCT01483144|567026755|FG001|Overall Study|Protocol Violation|3|||
157074588|NCT01483144|567026756|FG002|Overall Study|Protocol Violation|3|||
157074589|NCT02460575|567026757|FG000|Overall Study|Lost to Follow-up|1|||
157074590|NCT02460575|567026758|FG001|Overall Study|Lost to Follow-up|0|||
157074591|NCT02124811|567026759|FG000|Overall Study|Early termination|2|||
157074592|NCT02124811|567026760|FG001|Overall Study|Early termination|2|||
157074593|NCT02124811|567026759|FG000|Overall Study|Withdrawal by Subject|1|||
157074594|NCT02124811|567026760|FG001|Overall Study|Withdrawal by Subject|0|||
157074595|NCT04043143|567026761|FG000|Overall Study|Lost to Follow-up|5|||
157074596|NCT04043143|567026762|FG001|Overall Study|Lost to Follow-up|5|||
157074597|NCT04043143|567026761|FG000|Overall Study|screen failure|1|||
157074598|NCT04043143|567026762|FG001|Overall Study|screen failure|0|||
157074599|NCT04896008|567026768|FG000|Overall Study|Ongoing|70|||
157074600|NCT04896008|567026769|FG001|Overall Study|Ongoing|38|||
157074601|NCT04896008|567026768|FG000|Overall Study|Adverse Event|0|||
157074602|NCT04896008|567026769|FG001|Overall Study|Adverse Event|2|||
157074603|NCT04896008|567026768|FG000|Overall Study|Death|5|||
157074604|NCT04896008|567026769|FG001|Overall Study|Death|10|||
157074605|NCT04896008|567026768|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
157074606|NCT04896008|567026769|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
157074607|NCT04896008|567026768|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
157074608|NCT04896008|567026769|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
157231254|NCT01746017|567593887|FG007|Period 1|Withdrawal by Subject|0|||
157231255|NCT01746017|567593888|FG008|Period 1|Withdrawal by Subject|0|||
157231256|NCT01746017|567593889|FG009|Period 1|Withdrawal by Subject|0|||
157231257|NCT01746017|567593890|FG010|Period 1|Withdrawal by Subject|0|||
157231258|NCT01746017|567593880|FG000|Period 3|Withdrawal by Subject|0|||
157231259|NCT01746017|567593881|FG001|Period 3|Withdrawal by Subject|0|||
157231260|NCT01746017|567593882|FG002|Period 3|Withdrawal by Subject|0|||
157231261|NCT01746017|567593883|FG003|Period 3|Withdrawal by Subject|0|||
157231262|NCT01746017|567593884|FG004|Period 3|Withdrawal by Subject|0|||
157231263|NCT01746017|567593885|FG005|Period 3|Withdrawal by Subject|1|||
157231264|NCT01746017|567593886|FG006|Period 3|Withdrawal by Subject|0|||
157231265|NCT01746017|567593887|FG007|Period 3|Withdrawal by Subject|0|||
157231266|NCT01746017|567593888|FG008|Period 3|Withdrawal by Subject|0|||
157231267|NCT01746017|567593889|FG009|Period 3|Withdrawal by Subject|0|||
157231268|NCT01746017|567593890|FG010|Period 3|Withdrawal by Subject|0|||
157231269|NCT04032977|567593891|FG000|Overall Study|Withdrawal by Subject|6|||
157231270|NCT04032977|567593892|FG001|Overall Study|Withdrawal by Subject|1|||
157231271|NCT04032977|567593891|FG000|Overall Study|Lost to Follow-up|2|||
157231272|NCT04032977|567593892|FG001|Overall Study|Lost to Follow-up|7|||
157231273|NCT04032977|567593891|FG000|Overall Study|Pregnancy|1|||
157231274|NCT04032977|567593892|FG001|Overall Study|Pregnancy|0|||
157231275|NCT01101022|567593893|FG000|Overall Study|Adverse Event|6|||
157231276|NCT01101022|567593894|FG001|Overall Study|Adverse Event|2|||
157231277|NCT01101022|567593893|FG000|Overall Study|Protocol Violation|4|||
157231278|NCT01101022|567593894|FG001|Overall Study|Protocol Violation|3|||
157231279|NCT01101022|567593893|FG000|Overall Study|Withdrawal by Subject|3|||
157231280|NCT01101022|567593894|FG001|Overall Study|Withdrawal by Subject|8|||
157231281|NCT01101022|567593893|FG000|Overall Study|Lost to Follow-up|1|||
157231282|NCT01101022|567593894|FG001|Overall Study|Lost to Follow-up|4|||
157231283|NCT01101022|567593893|FG000|Overall Study|Lack of Efficacy|0|||
157231284|NCT01101022|567593894|FG001|Overall Study|Lack of Efficacy|7|||
157231285|NCT01101022|567593893|FG000|Overall Study|Sponsor decision|1|||
157231286|NCT01101022|567593894|FG001|Overall Study|Sponsor decision|1|||
157231287|NCT01101022|567593893|FG000|Overall Study|Non-compliance|1|||
157231288|NCT01101022|567593894|FG001|Overall Study|Non-compliance|0|||
157231289|NCT01101022|567593893|FG000|Overall Study|Work schedule|1|||
157231290|NCT01101022|567593894|FG001|Overall Study|Work schedule|1|||
157074609|NCT04896008|567026768|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
157074610|NCT04896008|567026769|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
157074611|NCT04896008|567026768|FG000|Overall Study|Withdrawal by Subject|1|||
157074612|NCT04896008|567026769|FG001|Overall Study|Withdrawal by Subject|4|||
157074613|NCT04896008|567026768|FG000|Overall Study|Investigator Decision|2|||
157074614|NCT04896008|567026769|FG001|Overall Study|Investigator Decision|0|||
157074615|NCT04896008|567026768|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
157074616|NCT04896008|567026769|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
157074617|NCT04201288|567026772|FG000|Overall Study|Death|1|||
157074618|NCT04201288|567026773|FG001|Overall Study|Death|1|||
157231291|NCT01101022|567593893|FG000|Overall Study|Vacation|0|||
157231292|NCT01101022|567593894|FG001|Overall Study|Vacation|1|||
157231293|NCT03075761|567593895|FG000|Overall Study|Lost to Follow-up|1|||
157231294|NCT03075761|567593896|FG001|Overall Study|Lost to Follow-up|6|||
157231295|NCT01519661|567593897|FG000|Overall Study|Protocol deviation|6|||
157231296|NCT01519661|567593897|FG000|Overall Study|Lost to Follow-up|3|||
157231297|NCT01519661|567593897|FG000|Overall Study|Withdrawal by Subject|17|||
157231298|NCT01519661|567593897|FG000|Overall Study|Lack of Efficacy|6|||
157231299|NCT01519661|567593897|FG000|Overall Study|Adverse Event|29|||
157231300|NCT01139047|567593898|FG000|Overall Study|Withdrawal by Subject|1|||
157231301|NCT00420303|567593904|FG000|Overall Study|Serious Adverse Event|1|||
157231302|NCT00420303|567593905|FG001|Overall Study|Serious Adverse Event|0|||
157231303|NCT00420303|567593904|FG000|Overall Study|Lack of Efficacy|0|||
157231304|NCT00420303|567593905|FG001|Overall Study|Lack of Efficacy|3|||
157231305|NCT00420303|567593904|FG000|Overall Study|Physician Decision|0|||
157231306|NCT00420303|567593905|FG001|Overall Study|Physician Decision|1|||
157231307|NCT00840632|567593906|FG000|First Intervention|Withdrawal by Subject|0|||
157231308|NCT00840632|567593907|FG001|First Intervention|Withdrawal by Subject|1|||
157231309|NCT00840632|567593906|FG000|Washout|Withdrawal by Subject|1|||
157231310|NCT00840632|567593907|FG001|Washout|Withdrawal by Subject|1|||
157231311|NCT05017480|567593908|FG000|Stage 1 Study|Withdrawal by Subject|8|||
157231312|NCT05017480|567593909|FG001|Stage 1 Study|Withdrawal by Subject|6|||
157231313|NCT05017480|567593910|FG002|Stage 1 Study|Withdrawal by Subject|0|||
157231314|NCT05017480|567593911|FG003|Stage 1 Study|Withdrawal by Subject|0|||
157231315|NCT05017480|567593912|FG004|Stage 1 Study|Withdrawal by Subject|0|||
157231316|NCT05017480|567593908|FG000|Stage 1 Study|Adverse Event|1|||
157231317|NCT05017480|567593909|FG001|Stage 1 Study|Adverse Event|1|||
157231318|NCT05017480|567593910|FG002|Stage 1 Study|Adverse Event|0|||
157231319|NCT05017480|567593911|FG003|Stage 1 Study|Adverse Event|0|||
157231320|NCT05017480|567593912|FG004|Stage 1 Study|Adverse Event|0|||
157231321|NCT05017480|567593908|FG000|Stage 1 Study|Poor Compliance|1|||
157231322|NCT05017480|567593909|FG001|Stage 1 Study|Poor Compliance|1|||
157231323|NCT05017480|567593910|FG002|Stage 1 Study|Poor Compliance|0|||
157231324|NCT05017480|567593911|FG003|Stage 1 Study|Poor Compliance|0|||
157231325|NCT05017480|567593912|FG004|Stage 1 Study|Poor Compliance|0|||
157231326|NCT05017480|567593908|FG000|Stage 1 Study|Physician Decision|0|||
157231327|NCT05017480|567593909|FG001|Stage 1 Study|Physician Decision|1|||
157231328|NCT05017480|567593910|FG002|Stage 1 Study|Physician Decision|0|||
157231329|NCT05017480|567593911|FG003|Stage 1 Study|Physician Decision|0|||
157231330|NCT05017480|567593912|FG004|Stage 1 Study|Physician Decision|0|||
157231331|NCT05017480|567593908|FG000|Stage 2 Study|Withdrawal by Subject|0|||
157231332|NCT05017480|567593909|FG001|Stage 2 Study|Withdrawal by Subject|0|||
157231333|NCT05017480|567593910|FG002|Stage 2 Study|Withdrawal by Subject|6|||
157231334|NCT05017480|567593911|FG003|Stage 2 Study|Withdrawal by Subject|9|||
157231335|NCT05017480|567593912|FG004|Stage 2 Study|Withdrawal by Subject|11|||
157231336|NCT05017480|567593908|FG000|Stage 2 Study|Lost to Follow-up|0|||
157231337|NCT05017480|567593909|FG001|Stage 2 Study|Lost to Follow-up|0|||
157231338|NCT05017480|567593910|FG002|Stage 2 Study|Lost to Follow-up|0|||
157231339|NCT05017480|567593911|FG003|Stage 2 Study|Lost to Follow-up|2|||
157231340|NCT05017480|567593912|FG004|Stage 2 Study|Lost to Follow-up|1|||
157231341|NCT05017480|567593908|FG000|Stage 2 Study|Adverse Event|0|||
157231342|NCT05017480|567593909|FG001|Stage 2 Study|Adverse Event|0|||
157231343|NCT05017480|567593910|FG002|Stage 2 Study|Adverse Event|0|||
157231344|NCT05017480|567593911|FG003|Stage 2 Study|Adverse Event|1|||
157231345|NCT05017480|567593912|FG004|Stage 2 Study|Adverse Event|0|||
157231346|NCT05017480|567593908|FG000|Stage 2 Study|COVID-19|0|||
157231347|NCT05017480|567593909|FG001|Stage 2 Study|COVID-19|0|||
157231348|NCT05017480|567593910|FG002|Stage 2 Study|COVID-19|0|||
157231349|NCT05017480|567593911|FG003|Stage 2 Study|COVID-19|1|||
157231350|NCT05017480|567593912|FG004|Stage 2 Study|COVID-19|0|||
157231351|NCT05017480|567593908|FG000|Stage 2 Study|Pregnancy|0|||
157231352|NCT05017480|567593909|FG001|Stage 2 Study|Pregnancy|0|||
157231353|NCT05017480|567593910|FG002|Stage 2 Study|Pregnancy|0|||
157231354|NCT05017480|567593911|FG003|Stage 2 Study|Pregnancy|0|||
157231355|NCT05017480|567593912|FG004|Stage 2 Study|Pregnancy|1|||
157231356|NCT00485472|567593913|FG000|Overall Study|Adverse Event|8|||
157231357|NCT00485472|567593914|FG001|Overall Study|Adverse Event|5|||
157231358|NCT00485472|567593913|FG000|Overall Study|Lack of Efficacy|5|||
157231359|NCT00485472|567593914|FG001|Overall Study|Lack of Efficacy|4|||
157231360|NCT00485472|567593913|FG000|Overall Study|Withdrawal by Subject|1|||
157231361|NCT00485472|567593914|FG001|Overall Study|Withdrawal by Subject|0|||
157231362|NCT00485472|567593913|FG000|Overall Study|Protocol Violation|0|||
157231363|NCT00485472|567593914|FG001|Overall Study|Protocol Violation|1|||
157231364|NCT00485472|567593913|FG000|Overall Study|Other|2|||
157231365|NCT00485472|567593914|FG001|Overall Study|Other|1|||
157231366|NCT00485472|567593913|FG000|Overall Study|Lost to Follow-up|0|||
157231367|NCT00485472|567593914|FG001|Overall Study|Lost to Follow-up|1|||
157231368|NCT01492361|567593916|FG000|Overall Study|Withdrawal by Subject|281|||
157231369|NCT01492361|567593917|FG001|Overall Study|Withdrawal by Subject|297|||
157231370|NCT01492361|567593916|FG000|Overall Study|Physician Decision|12|||
157231371|NCT01492361|567593917|FG001|Overall Study|Physician Decision|12|||
157231372|NCT01492361|567593916|FG000|Overall Study|Lost to Follow-up|6|||
157231373|NCT01492361|567593917|FG001|Overall Study|Lost to Follow-up|13|||
157231374|NCT01492361|567593916|FG000|Overall Study|Other than specified above|106|||
157231375|NCT01492361|567593917|FG001|Overall Study|Other than specified above|138|||
157231376|NCT03227445|567593922|FG000|Period 1 (28 Days)|Adverse Event|1|||
157231377|NCT03227445|567593923|FG001|Period 1 (28 Days)|Adverse Event|2|||
157231378|NCT03227445|567593924|FG002|Period 1 (28 Days)|Adverse Event|0|||
157192172|NCT01899729|567443580|FG000|Overall Study|Adverse Event|1|||
157192173|NCT01899729|567443581|FG001|Overall Study|Adverse Event|0|||
157192174|NCT01899729|567443582|FG002|Overall Study|Adverse Event|0|||
157192175|NCT01899729|567443583|FG003|Overall Study|Adverse Event|0|||
157192176|NCT01899729|567443584|FG004|Overall Study|Adverse Event|1|||
157192177|NCT01899729|567443580|FG000|Overall Study|Withdrawal by Subject|1|||
157192178|NCT01899729|567443581|FG001|Overall Study|Withdrawal by Subject|2|||
157192179|NCT01899729|567443582|FG002|Overall Study|Withdrawal by Subject|0|||
157192180|NCT01899729|567443583|FG003|Overall Study|Withdrawal by Subject|0|||
157192181|NCT01899729|567443584|FG004|Overall Study|Withdrawal by Subject|0|||
157192182|NCT01899729|567443580|FG000|Overall Study|Lack of Efficacy|0|||
157192183|NCT01899729|567443581|FG001|Overall Study|Lack of Efficacy|0|||
157192184|NCT01899729|567443582|FG002|Overall Study|Lack of Efficacy|2|||
157192185|NCT01899729|567443583|FG003|Overall Study|Lack of Efficacy|0|||
157192186|NCT01899729|567443584|FG004|Overall Study|Lack of Efficacy|1|||
157192187|NCT01454531|567443585|FG000|Overall Study|Adverse Event|14|||
157192188|NCT01454531|567443585|FG000|Overall Study|Withdrawal by Subject|5|||
157192189|NCT01454531|567443585|FG000|Overall Study|Lost to Follow-up|1|||
157192190|NCT01454531|567443585|FG000|Overall Study|Physician Decision|1|||
157192191|NCT01454531|567443585|FG000|Overall Study|Delay in IMP administration|1|||
157192192|NCT01454531|567443585|FG000|Overall Study|Other|1|||
157192193|NCT01277666|567443586|FG000|Overall Study|Adverse Event|26|||
157192194|NCT01277666|567443587|FG001|Overall Study|Adverse Event|25|||
157192195|NCT01277666|567443588|FG002|Overall Study|Adverse Event|20|||
157192196|NCT01277666|567443586|FG000|Overall Study|Lack of Efficacy|8|||
157192197|NCT01277666|567443587|FG001|Overall Study|Lack of Efficacy|20|||
157192198|NCT01277666|567443588|FG002|Overall Study|Lack of Efficacy|12|||
157192199|NCT01277666|567443586|FG000|Overall Study|Protocol Violation|2|||
157192200|NCT01277666|567443587|FG001|Overall Study|Protocol Violation|3|||
157192201|NCT01277666|567443588|FG002|Overall Study|Protocol Violation|2|||
157192202|NCT01277666|567443586|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
157192203|NCT01277666|567443587|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
157192204|NCT01277666|567443588|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
157192205|NCT01277666|567443586|FG000|Overall Study|Lost to Follow-up|1|||
157192206|NCT01277666|567443587|FG001|Overall Study|Lost to Follow-up|1|||
157192207|NCT01277666|567443588|FG002|Overall Study|Lost to Follow-up|2|||
157192208|NCT01277666|567443586|FG000|Overall Study|Withdrawal by Subject|7|||
157192209|NCT01277666|567443587|FG001|Overall Study|Withdrawal by Subject|8|||
157192210|NCT01277666|567443588|FG002|Overall Study|Withdrawal by Subject|6|||
157192211|NCT01277666|567443586|FG000|Overall Study|Death|0|||
157192212|NCT01277666|567443587|FG001|Overall Study|Death|0|||
157192213|NCT01277666|567443588|FG002|Overall Study|Death|1|||
157192214|NCT01021423|567443589|FG000|Overall Study|Study terminated|4|||
157192215|NCT01021423|567443590|FG001|Overall Study|Study terminated|5|||
157192216|NCT00122317|567443591|FG000|Overall Study|Death|3|||
157192217|NCT00122317|567443591|FG000|Overall Study|Adverse Event|4|||
157192218|NCT00122317|567443591|FG000|Overall Study|Physician Decision|2|||
157192219|NCT00122317|567443591|FG000|Overall Study|patient non-compliance|1|||
157192220|NCT00122317|567443591|FG000|Overall Study|Withdrawal by Subject|1|||
157192221|NCT03756285|567443592|FG000|Overall Study|Lost to Follow-up|0|||
157192222|NCT03756285|567443593|FG001|Overall Study|Lost to Follow-up|1|||
157192223|NCT03756285|567443592|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
157192224|NCT03756285|567443593|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
157192225|NCT03756285|567443592|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
157192226|NCT03756285|567443593|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
157192227|NCT06334055|567443594|FG000|Overall Study|Adverse Event|4|||
157192228|NCT06334055|567443594|FG000|Overall Study|Disqualified|72|||
157192229|NCT02146274|567444949|FG000|Overall Study|Protocol Violation|73|||
157192230|NCT00959192|567444971|FG000|Overall Study|Adverse Event|1|||
157192231|NCT00959192|567444972|FG001|Overall Study|Adverse Event|1|||
157192232|NCT00959192|567444973|FG002|Overall Study|Adverse Event|1|||
157192233|NCT00959192|567444974|FG003|Overall Study|Adverse Event|0|||
157192234|NCT00959192|567444971|FG000|Overall Study|Investigator Request|1|||
157192235|NCT00959192|567444972|FG001|Overall Study|Investigator Request|0|||
157192236|NCT00959192|567444973|FG002|Overall Study|Investigator Request|0|||
157192237|NCT00959192|567444974|FG003|Overall Study|Investigator Request|0|||
157192238|NCT00959192|567444971|FG000|Overall Study|Caregiver Request|0|||
157192239|NCT00959192|567444972|FG001|Overall Study|Caregiver Request|0|||
157192240|NCT00959192|567444973|FG002|Overall Study|Caregiver Request|2|||
157192241|NCT00959192|567444974|FG003|Overall Study|Caregiver Request|1|||
157192242|NCT00532441|567444975|FG000|Overall Study|Death|1|||
157192243|NCT00532441|567444976|FG001|Overall Study|Death|0|||
157192244|NCT01967134|567444977|FG000|Overall Study|Lost to Follow-up|0|||
157192245|NCT01967134|567444978|FG001|Overall Study|Lost to Follow-up|1|||
157192246|NCT01967134|567444979|FG002|Overall Study|Lost to Follow-up|0|||
157192247|NCT01603615|567444980|FG000|Overall Study|Did not Receive Treatment|7|||
157192248|NCT01603615|567444980|FG000|Overall Study|Lost to Follow-up|9|||
157074619|NCT04201288|567026772|FG000|Overall Study|Lost to Follow-up|5|||
157074620|NCT04201288|567026773|FG001|Overall Study|Lost to Follow-up|3|||
157074621|NCT04201288|567026772|FG000|Overall Study|Withdrawal by Subject|1|||
157074622|NCT04201288|567026773|FG001|Overall Study|Withdrawal by Subject|0|||
157074623|NCT00592293|567026774|FG000|Overall Study|Withdrawal by Subject|1|||
157074624|NCT01606319|567026775|FG000|Overall Study|Lost to Follow-up|17|||
157074625|NCT01606319|567026776|FG001|Overall Study|Lost to Follow-up|14|||
157074626|NCT01606319|567026775|FG000|Overall Study|Withdrawal by Subject|9|||
157074627|NCT01606319|567026776|FG001|Overall Study|Withdrawal by Subject|12|||
157074628|NCT01606319|567026775|FG000|Overall Study|Physician Decision|1|||
157074629|NCT01606319|567026776|FG001|Overall Study|Physician Decision|2|||
157074630|NCT01606319|567026775|FG000|Overall Study|Lack of Efficacy|6|||
157074631|NCT01606319|567026776|FG001|Overall Study|Lack of Efficacy|8|||
157074632|NCT01606319|567026775|FG000|Overall Study|Adverse Event|1|||
157074633|NCT01606319|567026776|FG001|Overall Study|Adverse Event|4|||
157074634|NCT01810939|567026779|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
157074635|NCT01810939|567026780|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
157074636|NCT01810939|567026781|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
157074637|NCT01810939|567026779|FG000|Part A Treatment Period|Protocol Violation|2|||
157074638|NCT01810939|567026780|FG001|Part A Treatment Period|Protocol Violation|0|||
157074639|NCT01810939|567026781|FG002|Part A Treatment Period|Protocol Violation|0|||
157074640|NCT01810939|567026779|FG000|Part A Treatment Period|Adverse Event|10|||
157074641|NCT01810939|567026780|FG001|Part A Treatment Period|Adverse Event|0|||
157074642|NCT01810939|567026781|FG002|Part A Treatment Period|Adverse Event|0|||
157074643|NCT01810939|567026779|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
157074644|NCT01810939|567026780|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
157074645|NCT01810939|567026781|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
157192249|NCT01603615|567444980|FG000|Overall Study|Personal Reasons|17|||
157192250|NCT01603615|567444980|FG000|Overall Study|Other Miscellaneous|1|||
157192251|NCT00305773|567444981|FG000|Overall Study|Death|3|||
157192252|NCT00305773|567444982|FG001|Overall Study|Death|2|||
157192253|NCT00305773|567444981|FG000|Overall Study|Adverse Event|1|||
157192254|NCT00305773|567444982|FG001|Overall Study|Adverse Event|2|||
157192255|NCT00305773|567444981|FG000|Overall Study|Alternative Treatment|4|||
157192256|NCT00305773|567444982|FG001|Overall Study|Alternative Treatment|4|||
157192257|NCT00305773|567444981|FG000|Overall Study|Physician Decision|1|||
157192258|NCT00305773|567444982|FG001|Overall Study|Physician Decision|1|||
157192259|NCT00305773|567444981|FG000|Overall Study|Withdrawal by Subject|1|||
157192260|NCT00305773|567444982|FG001|Overall Study|Withdrawal by Subject|4|||
157192261|NCT00305773|567444981|FG000|Overall Study|Disease Progression|1|||
157192262|NCT00305773|567444982|FG001|Overall Study|Disease Progression|3|||
157192263|NCT00305773|567444981|FG000|Overall Study|All other reasons|3|||
157192264|NCT00305773|567444982|FG001|Overall Study|All other reasons|2|||
157192265|NCT03384316|567444983|FG000|Overall Study|Screen failure|0|||
157192266|NCT03384316|567444984|FG001|Overall Study|Screen failure|1|||
157192267|NCT00413231|567444985|FG000|0 to 30-day Post Treatment|Death|5|||
157192268|NCT00413231|567444985|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
157192269|NCT00413231|567444985|FG000|30-day to 365-day Post Treatment|Death|13|||
157192270|NCT00413231|567444985|FG000|365-day to 60-month Post Treatment|Death|36|||
157192271|NCT00413231|567444985|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
157192272|NCT00413231|567444985|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
157192273|NCT00413231|567444985|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
157192274|NCT02194699|567444994|FG000|Randomised|Did not receive treatment|1|||
157192275|NCT02194699|567444995|FG001|Randomised|Did not receive treatment|5|||
157192276|NCT02194699|567444994|FG000|Randomised|Without potential for 52 weeks of IP|5|||
157192277|NCT02194699|567444995|FG001|Randomised|Without potential for 52 weeks of IP|5|||
157192278|NCT02194699|567444994|FG000|Randomised|Duplicate patient|2|||
157192279|NCT02194699|567444995|FG001|Randomised|Duplicate patient|1|||
157192280|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
157192281|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
157192282|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
157192283|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
157192284|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
157192285|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
157192286|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
157074646|NCT01810939|567026779|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
157074647|NCT01810939|567026780|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
157074648|NCT01810939|567026781|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
157074649|NCT01810939|567026779|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
157192287|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
157192288|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
157192289|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
157192290|NCT02194699|567444994|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
157231379|NCT03227445|567593925|FG003|Period 1 (28 Days)|Adverse Event|1|||
157231380|NCT03227445|567593922|FG000|Period 1 (28 Days)|Protocol Violation|1|||
157231381|NCT03227445|567593923|FG001|Period 1 (28 Days)|Protocol Violation|0|||
157231382|NCT03227445|567593924|FG002|Period 1 (28 Days)|Protocol Violation|0|||
157231383|NCT03227445|567593925|FG003|Period 1 (28 Days)|Protocol Violation|0|||
157231384|NCT03227445|567593922|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
157231385|NCT03227445|567593923|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
157231386|NCT03227445|567593924|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
157231387|NCT03227445|567593925|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
157231388|NCT03227445|567593922|FG000|Period 2 (28 Days)|Adverse Event|1|||
157231389|NCT03227445|567593923|FG001|Period 2 (28 Days)|Adverse Event|0|||
157231390|NCT03227445|567593924|FG002|Period 2 (28 Days)|Adverse Event|2|||
157231391|NCT03227445|567593925|FG003|Period 2 (28 Days)|Adverse Event|1|||
157231392|NCT03227445|567593922|FG000|Period 2 (28 Days)|Protocol Violation|0|||
157231393|NCT03227445|567593923|FG001|Period 2 (28 Days)|Protocol Violation|0|||
157231394|NCT03227445|567593924|FG002|Period 2 (28 Days)|Protocol Violation|0|||
157231395|NCT03227445|567593925|FG003|Period 2 (28 Days)|Protocol Violation|1|||
157231396|NCT03227445|567593922|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
157231397|NCT03227445|567593923|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
157074650|NCT01810939|567026780|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
157074651|NCT01810939|567026781|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
157074652|NCT01810939|567026779|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
157074653|NCT01810939|567026780|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
157074654|NCT01810939|567026781|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
157074655|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
157074656|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
157074657|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
157074658|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
157074659|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
157074660|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
157074661|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
157074662|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
157074663|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
157074664|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
157074665|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
157231398|NCT03227445|567593924|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
157231399|NCT03227445|567593925|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
157231400|NCT01179048|567593928|FG000|Overall Study|Withdrawn - does not allow contact|4|||
157231401|NCT01179048|567593929|FG001|Overall Study|Withdrawn - does not allow contact|8|||
157231402|NCT01179048|567593928|FG000|Overall Study|Lost to Follow-up|8|||
157231403|NCT01179048|567593929|FG001|Overall Study|Lost to Follow-up|9|||
157074666|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
157074667|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
157074668|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
157074669|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
157074670|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
157074671|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
157074672|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
157074673|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
157074674|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
157074675|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
157074676|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
157074677|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
157074678|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
157231404|NCT01179048|567593928|FG000|Overall Study|Alive|127|||
157231405|NCT01179048|567593929|FG001|Overall Study|Alive|142|||
157231406|NCT01900730|567593930|FG000|Overall Study|Withdrawal by Subject|1|||
157231407|NCT01900730|567593931|FG001|Overall Study|Withdrawal by Subject|0|||
157231408|NCT01900730|567593930|FG000|Overall Study|Screen Failure|1|||
157231409|NCT01900730|567593931|FG001|Overall Study|Screen Failure|0|||
157231410|NCT03203447|567593936|FG000|Overall Study|Withdrawal by Subject|2|||
157231411|NCT03203447|567593937|FG001|Overall Study|Withdrawal by Subject|1|||
157231412|NCT03203447|567593936|FG000|Overall Study|Lost to Follow-up|1|||
157231413|NCT03203447|567593937|FG001|Overall Study|Lost to Follow-up|10|||
157231414|NCT03203447|567593936|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
157231415|NCT03203447|567593937|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
157231416|NCT00274937|567593938|FG000|Overall Study|Physician Decision|10|||
157231417|NCT00274937|567593938|FG000|Overall Study|Withdrawal by Subject|6|||
157231418|NCT00274937|567593938|FG000|Overall Study|Progressive Disease|4|||
157231419|NCT00445003|567593939|FG000|Overall Study|Death|1|||
157231420|NCT00445003|567593940|FG001|Overall Study|Death|2|||
157231421|NCT00445003|567593941|FG002|Overall Study|Death|1|||
157231422|NCT00445003|567593939|FG000|Overall Study|Missed Visit|3|||
157231423|NCT00445003|567593940|FG001|Overall Study|Missed Visit|5|||
157231424|NCT00445003|567593941|FG002|Overall Study|Missed Visit|1|||
157231425|NCT00445003|567593939|FG000|Overall Study|Dropped|1|||
157231426|NCT00445003|567593940|FG001|Overall Study|Dropped|3|||
157231427|NCT00445003|567593941|FG002|Overall Study|Dropped|2|||
157231428|NCT00528606|567593942|FG000|Overall Study|Withdrew consent|4|||
157231429|NCT00528606|567593943|FG001|Overall Study|Withdrew consent|3|||
157231430|NCT00528606|567593942|FG000|Overall Study|Lost to Follow-up|4|||
157231431|NCT00528606|567593943|FG001|Overall Study|Lost to Follow-up|1|||
157231432|NCT00528606|567593942|FG000|Overall Study|Adverse Event|3|||
157231433|NCT00528606|567593943|FG001|Overall Study|Adverse Event|0|||
157074679|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
157074680|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
157074681|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
157074682|NCT01810939|567026779|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
157074683|NCT01810939|567026780|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
157074684|NCT01810939|567026781|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
157074685|NCT04497389|567026784|FG000|Overall Study|Withdrawal by Subject|1|||
157074686|NCT04497389|567026785|FG001|Overall Study|Withdrawal by Subject|0|||
157074687|NCT03322540|567026791|FG000|Overall Study|Death|21|||
157074688|NCT03322540|567026792|FG001|Overall Study|Death|28|||
157074689|NCT03322540|567026791|FG000|Overall Study|Lost to Follow-up|0|||
157231434|NCT00528606|567593942|FG000|Overall Study|Other|2|||
157231435|NCT00528606|567593943|FG001|Overall Study|Other|0|||
157231436|NCT02475954|567593944|FG000|Overall Study|Withdrawal by Subject|2|||
157231437|NCT02475954|567593945|FG001|Overall Study|Withdrawal by Subject|2|||
157231438|NCT02475954|567593944|FG000|Overall Study|Lost to Follow-up|11|||
157231439|NCT02475954|567593945|FG001|Overall Study|Lost to Follow-up|9|||
157231440|NCT02475954|567593944|FG000|Overall Study|Death|1|||
157231441|NCT02475954|567593945|FG001|Overall Study|Death|1|||
157231442|NCT00880568|567593949|FG000|Overall Study|Disease progression|3|||
157231443|NCT00880568|567593950|FG001|Overall Study|Disease progression|3|||
157074690|NCT03322540|567026792|FG001|Overall Study|Lost to Follow-up|1|||
157074691|NCT03322540|567026791|FG000|Overall Study|Physician Decision|7|||
157074692|NCT03322540|567026792|FG001|Overall Study|Physician Decision|6|||
157074693|NCT03322540|567026791|FG000|Overall Study|Withdrawal by Subject|3|||
157074694|NCT03322540|567026792|FG001|Overall Study|Withdrawal by Subject|1|||
157074695|NCT03322540|567026791|FG000|Overall Study|Study terminated by sponsor|0|||
157074696|NCT03322540|567026792|FG001|Overall Study|Study terminated by sponsor|1|||
157074697|NCT01594827|567026793|FG000|Overall Study|Adverse Event|1|||
157074698|NCT01594827|567026794|FG001|Overall Study|Adverse Event|0|||
157074699|NCT01594827|567026793|FG000|Overall Study|Physician Decision|3|||
157074700|NCT01594827|567026794|FG001|Overall Study|Physician Decision|0|||
157074701|NCT02153905|567026795|FG000|Overall Study|Death|1|||
157074702|NCT02153905|567026796|FG001|Overall Study|Death|0|||
157074703|NCT00520845|567026797|FG000|Overall Study|Death|3|||
157074704|NCT00520845|567026797|FG000|Overall Study|Adverse Event|4|||
157074705|NCT00520845|567026797|FG000|Overall Study|Disease Progression, relapse|13|||
157074706|NCT00520845|567026797|FG000|Overall Study|Withdrawal by Subject|1|||
157074707|NCT00520845|567026797|FG000|Overall Study|Alternative Therapy|1|||
157074708|NCT00351377|567026798|FG000|Overall Study|Adverse Event|5|||
157074709|NCT00351377|567026798|FG000|Overall Study|Death|1|||
157074710|NCT00351377|567026798|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157074711|NCT02493062|567026800|FG000|Overall Study|Physician Decision|12|||
157074712|NCT01327612|567026801|FG000|Overall Study|Withdrawal by Subject|0|||
157074713|NCT01327612|567026802|FG001|Overall Study|Withdrawal by Subject|0|||
157074714|NCT01327612|567026803|FG002|Overall Study|Withdrawal by Subject|0|||
157074715|NCT01327612|567026804|FG003|Overall Study|Withdrawal by Subject|0|||
157074716|NCT01327612|567026805|FG004|Overall Study|Withdrawal by Subject|0|||
157074717|NCT01327612|567026806|FG005|Overall Study|Withdrawal by Subject|1|||
157074718|NCT01327612|567026807|FG006|Overall Study|Withdrawal by Subject|0|||
157074719|NCT01327612|567026801|FG000|Overall Study|Disease Progression|1|||
157231444|NCT00880568|567593951|FG002|Overall Study|Disease progression|3|||
157231445|NCT00880568|567593952|FG003|Overall Study|Disease progression|1|||
157074720|NCT01327612|567026802|FG001|Overall Study|Disease Progression|1|||
157074721|NCT01327612|567026803|FG002|Overall Study|Disease Progression|1|||
157074722|NCT01327612|567026804|FG003|Overall Study|Disease Progression|0|||
157074723|NCT01327612|567026805|FG004|Overall Study|Disease Progression|1|||
157074724|NCT01327612|567026806|FG005|Overall Study|Disease Progression|2|||
157231446|NCT00880568|567593953|FG004|Overall Study|Disease progression|3|||
157231447|NCT00880568|567593954|FG005|Overall Study|Disease progression|3|||
157231448|NCT00880568|567593955|FG006|Overall Study|Disease progression|5|||
157231449|NCT00880568|567593956|FG007|Overall Study|Disease progression|0|||
157074725|NCT01327612|567026807|FG006|Overall Study|Disease Progression|2|||
157231450|NCT00880568|567593957|FG008|Overall Study|Disease progression|3|||
157231451|NCT00880568|567593949|FG000|Overall Study|Adverse Event|0|||
157074726|NCT01327612|567026801|FG000|Overall Study|Administrative Decision|0|||
157074727|NCT01327612|567026802|FG001|Overall Study|Administrative Decision|0|||
157074728|NCT01327612|567026803|FG002|Overall Study|Administrative Decision|0|||
157074729|NCT01327612|567026804|FG003|Overall Study|Administrative Decision|1|||
157074730|NCT01327612|567026805|FG004|Overall Study|Administrative Decision|0|||
157074731|NCT01327612|567026806|FG005|Overall Study|Administrative Decision|0|||
157074732|NCT01327612|567026807|FG006|Overall Study|Administrative Decision|0|||
157074733|NCT01327612|567026801|FG000|Overall Study|Death|0|||
157074734|NCT01327612|567026802|FG001|Overall Study|Death|0|||
157074735|NCT01327612|567026803|FG002|Overall Study|Death|0|||
157074736|NCT01327612|567026804|FG003|Overall Study|Death|0|||
157074737|NCT01327612|567026805|FG004|Overall Study|Death|1|||
157074738|NCT01327612|567026806|FG005|Overall Study|Death|0|||
157074739|NCT01327612|567026807|FG006|Overall Study|Death|0|||
157074740|NCT01294397|567026808|FG000|Overall Study|Withdrawal by Subject|1|||
157074741|NCT01294397|567026808|FG000|Overall Study|Administrative Decision|1|||
157074742|NCT01967069|567026810|FG000|Overall Study|Adverse Event|2|||
157074743|NCT01967069|567026811|FG001|Overall Study|Adverse Event|2|||
157074744|NCT01967069|567026810|FG000|Overall Study|Lost to Follow-up|5|||
157074745|NCT01967069|567026811|FG001|Overall Study|Lost to Follow-up|2|||
157074746|NCT01967069|567026810|FG000|Overall Study|Withdrawal by Subject|1|||
157074747|NCT01967069|567026811|FG001|Overall Study|Withdrawal by Subject|3|||
157074748|NCT01967069|567026810|FG000|Overall Study|Lack of Efficacy|0|||
157074749|NCT01967069|567026811|FG001|Overall Study|Lack of Efficacy|1|||
157074750|NCT05569421|567026812|FG000|Overall Study|Withdrawal by Subject|1|||
157074751|NCT05569421|567026813|FG001|Overall Study|Withdrawal by Subject|0|||
157074752|NCT05569421|567026814|FG002|Overall Study|Withdrawal by Subject|0|||
157074753|NCT03812029|567026816|FG000|Overall Study|Protocol Violation|1|||
157074754|NCT03812029|567026817|FG001|Overall Study|Protocol Violation|0|||
157074755|NCT03812029|567026818|FG002|Overall Study|Protocol Violation|0|||
157074756|NCT03812029|567026819|FG003|Overall Study|Protocol Violation|1|||
157074757|NCT03812029|567026820|FG004|Overall Study|Protocol Violation|0|||
157074758|NCT03812029|567026816|FG000|Overall Study|Withdrawal by Subject|1|||
157074759|NCT03812029|567026817|FG001|Overall Study|Withdrawal by Subject|0|||
157074760|NCT03812029|567026818|FG002|Overall Study|Withdrawal by Subject|0|||
157074761|NCT03812029|567026819|FG003|Overall Study|Withdrawal by Subject|2|||
157074762|NCT03812029|567026820|FG004|Overall Study|Withdrawal by Subject|2|||
157074763|NCT03812029|567026816|FG000|Overall Study|Stopping rules|0|||
157074764|NCT03812029|567026817|FG001|Overall Study|Stopping rules|1|||
157074765|NCT03812029|567026818|FG002|Overall Study|Stopping rules|0|||
157074766|NCT03812029|567026819|FG003|Overall Study|Stopping rules|0|||
157074767|NCT03812029|567026820|FG004|Overall Study|Stopping rules|0|||
157074768|NCT03812029|567026816|FG000|Overall Study|Adverse Event|0|||
157074769|NCT03812029|567026817|FG001|Overall Study|Adverse Event|9|||
157074770|NCT03812029|567026818|FG002|Overall Study|Adverse Event|0|||
157074771|NCT03812029|567026819|FG003|Overall Study|Adverse Event|3|||
157074772|NCT03812029|567026820|FG004|Overall Study|Adverse Event|5|||
157074773|NCT03812029|567026816|FG000|Overall Study|Lost to Follow-up|0|||
157074774|NCT03812029|567026817|FG001|Overall Study|Lost to Follow-up|0|||
157074775|NCT03812029|567026818|FG002|Overall Study|Lost to Follow-up|0|||
157074776|NCT03812029|567026819|FG003|Overall Study|Lost to Follow-up|0|||
157074777|NCT03812029|567026820|FG004|Overall Study|Lost to Follow-up|3|||
157074778|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
157074779|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
157074780|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
157074781|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
157074782|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
157074783|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
157074784|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
157074785|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
157074786|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
157074787|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
157074788|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
157074789|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
157074790|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
157074791|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
157074792|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
157074793|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
157074794|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
157074795|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
157074796|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
157074797|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
157074798|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
157074799|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
157192291|NCT02194699|567444995|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
157192292|NCT02719028|567444999|FG000|Overall Study|Adverse Event|2|||
157192293|NCT02719028|567445000|FG001|Overall Study|Adverse Event|1|||
157192294|NCT02719028|567445001|FG002|Overall Study|Adverse Event|4|||
157192295|NCT02719028|567445002|FG003|Overall Study|Adverse Event|8|||
157192296|NCT02719028|567444999|FG000|Overall Study|Physician Decision|0|||
157192297|NCT02719028|567445000|FG001|Overall Study|Physician Decision|1|||
157192298|NCT02719028|567445001|FG002|Overall Study|Physician Decision|1|||
157192299|NCT02719028|567445002|FG003|Overall Study|Physician Decision|1|||
157192300|NCT02719028|567444999|FG000|Overall Study|Use of prohibited medication|0|||
157192301|NCT02719028|567445000|FG001|Overall Study|Use of prohibited medication|0|||
157192302|NCT02719028|567445001|FG002|Overall Study|Use of prohibited medication|1|||
157192303|NCT02719028|567445002|FG003|Overall Study|Use of prohibited medication|0|||
157192304|NCT02719028|567444999|FG000|Overall Study|Protocol Violation|0|||
157192305|NCT02719028|567445000|FG001|Overall Study|Protocol Violation|0|||
157192306|NCT02719028|567445001|FG002|Overall Study|Protocol Violation|0|||
157192307|NCT02719028|567445002|FG003|Overall Study|Protocol Violation|1|||
157192308|NCT01539720|567445004|FG000|Overall Study|Screen Fail|15|||
157192309|NCT01539720|567445005|FG001|Overall Study|Screen Fail|3|||
157192310|NCT01539720|567445004|FG000|Overall Study|Lost to Follow-up|14|||
157192311|NCT01539720|567445005|FG001|Overall Study|Lost to Follow-up|7|||
157192312|NCT00298766|567445006|FG000|Overall Study|Adverse Event|18|||
157192313|NCT00298766|567445006|FG000|Overall Study|Death|2|||
157192314|NCT00298766|567445006|FG000|Overall Study|Withdrawal by Subject|9|||
157192315|NCT00298766|567445006|FG000|Overall Study|Treatment ongoing|4|||
157192316|NCT00298766|567445006|FG000|Overall Study|Progression of amyloid markers|4|||
157192317|NCT00298766|567445006|FG000|Overall Study|Deterioration in KPS and organ function|1|||
157192318|NCT00298766|567445006|FG000|Overall Study|Subjects overall condition deterioration|4|||
157192319|NCT00298766|567445006|FG000|Overall Study|Other|4|||
157192320|NCT03287960|567445013|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
157192321|NCT03287960|567445013|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
157192322|NCT03812224|567445016|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
157192323|NCT03812224|567445017|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
157192324|NCT03812224|567445016|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
157192325|NCT03812224|567445017|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
157192326|NCT03812224|567445016|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
157192327|NCT03812224|567445017|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
157192328|NCT03812224|567445016|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
157192329|NCT03812224|567445017|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
157192330|NCT00656136|567445020|FG000|Overall Study|Progressive disease|177|||
157192331|NCT00656136|567445021|FG001|Overall Study|Progressive disease|322|||
157192332|NCT00656136|567445020|FG000|Overall Study|Other Adverse Event|5|||
157192333|NCT00656136|567445021|FG001|Overall Study|Other Adverse Event|51|||
157192334|NCT00656136|567445020|FG000|Overall Study|Protocol Violation|2|||
157192335|NCT00656136|567445021|FG001|Overall Study|Protocol Violation|3|||
157192336|NCT00656136|567445020|FG000|Overall Study|Patient refused to take study medication|7|||
157192337|NCT00656136|567445021|FG001|Overall Study|Patient refused to take study medication|10|||
157192338|NCT00656136|567445020|FG000|Overall Study|Unknown and others|4|||
157192339|NCT00656136|567445021|FG001|Overall Study|Unknown and others|4|||
157192340|NCT01191190|567445022|FG000|Overall Study|Withdrawal by Subject|1|||
157192341|NCT01667731|567445024|FG000|Overall Study|Enrolled but not treated|0|||
157192342|NCT01667731|567445025|FG001|Overall Study|Enrolled but not treated|0|||
157192343|NCT01667731|567445026|FG002|Overall Study|Enrolled but not treated|0|||
157192344|NCT01667731|567445027|FG003|Overall Study|Enrolled but not treated|0|||
157192345|NCT01667731|567445028|FG004|Overall Study|Enrolled but not treated|1|||
157192346|NCT01667731|567445024|FG000|Overall Study|Efficacy Failure|1|||
157192347|NCT01667731|567445025|FG001|Overall Study|Efficacy Failure|12|||
157192348|NCT01667731|567445026|FG002|Overall Study|Efficacy Failure|0|||
157192349|NCT01667731|567445027|FG003|Overall Study|Efficacy Failure|1|||
157192350|NCT01667731|567445028|FG004|Overall Study|Efficacy Failure|24|||
157192351|NCT01667731|567445024|FG000|Overall Study|Lost to Follow-up|2|||
157192352|NCT01667731|567445025|FG001|Overall Study|Lost to Follow-up|3|||
157192353|NCT01667731|567445026|FG002|Overall Study|Lost to Follow-up|1|||
157192354|NCT01667731|567445027|FG003|Overall Study|Lost to Follow-up|1|||
157192355|NCT01667731|567445028|FG004|Overall Study|Lost to Follow-up|2|||
157192356|NCT01667731|567445024|FG000|Overall Study|Subject Withdrew Consent|2|||
157192357|NCT01667731|567445025|FG001|Overall Study|Subject Withdrew Consent|0|||
157192358|NCT01667731|567445026|FG002|Overall Study|Subject Withdrew Consent|1|||
157192359|NCT01667731|567445027|FG003|Overall Study|Subject Withdrew Consent|0|||
157192360|NCT01667731|567445028|FG004|Overall Study|Subject Withdrew Consent|1|||
157192361|NCT01667731|567445024|FG000|Overall Study|Death|0|||
157192362|NCT01667731|567445025|FG001|Overall Study|Death|1|||
157192363|NCT01667731|567445026|FG002|Overall Study|Death|0|||
157192364|NCT01667731|567445027|FG003|Overall Study|Death|0|||
157192365|NCT01667731|567445028|FG004|Overall Study|Death|0|||
157192366|NCT02127970|567445036|FG000|Overall Study|Adverse Event|2|||
157192367|NCT02127970|567445037|FG001|Overall Study|Adverse Event|1|||
157074800|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
157074801|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
157074802|NCT00479882|567026821|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
157074803|NCT00479882|567026822|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
157074804|NCT00479882|567026823|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
157074805|NCT00479882|567026824|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
157074806|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
157074807|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
157074808|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
157074809|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
157074810|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
157074811|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
157074812|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
157074813|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
157074814|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
157074815|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
157074816|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
157074817|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
157074818|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
157074819|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
157231452|NCT00880568|567593950|FG001|Overall Study|Adverse Event|0|||
157074820|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
157074821|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
157074822|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
157074823|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
157074824|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
157074825|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
157074826|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
157074827|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
157074828|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
157074829|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
157074830|NCT00479882|567026821|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
157074831|NCT00479882|567026822|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
157074832|NCT00479882|567026823|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
157074833|NCT00479882|567026824|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
157074834|NCT03106753|567026825|FG000|Overall Study|Withdrawal by Subject|0|||
157074835|NCT03106753|567026826|FG001|Overall Study|Withdrawal by Subject|1|||
157074836|NCT01643044|567026828|FG000|Overall Study|Lost to Follow-up|1|||
157074837|NCT01643044|567026829|FG001|Overall Study|Lost to Follow-up|1|||
157074838|NCT01643044|567026828|FG000|Overall Study|Miscarried baby|2|||
157074839|NCT01643044|567026829|FG001|Overall Study|Miscarried baby|2|||
157074840|NCT01643044|567026828|FG000|Overall Study|Delivered outside of hospital|1|||
157074841|NCT01643044|567026829|FG001|Overall Study|Delivered outside of hospital|2|||
157074842|NCT03149042|567026830|FG000|Overall Study|Invasive FFR not performed|21|||
157074843|NCT03149042|567026830|FG000|Overall Study|Poor CT Image Quality|1|||
157074844|NCT03149042|567026830|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
157074845|NCT01023958|567026837|FG000|Overall Study|Progressive disease|48|||
157074846|NCT01023958|567026837|FG000|Overall Study|Other adverse event|1|||
157074847|NCT01023958|567026837|FG000|Overall Study|Refused to continue medication|1|||
157074848|NCT03939689|567028947|FG000|Overall Study|Radiographic progression|14|||
157074849|NCT03939689|567028948|FG001|Overall Study|Radiographic progression|17|||
157074850|NCT03939689|567028947|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
157192368|NCT02127970|567445036|FG000|Overall Study|Death|1|||
157192369|NCT02127970|567445037|FG001|Overall Study|Death|1|||
157192370|NCT02127970|567445036|FG000|Overall Study|Lost to Follow-up|14|||
157192371|NCT02127970|567445037|FG001|Overall Study|Lost to Follow-up|14|||
157192372|NCT02127970|567445036|FG000|Overall Study|Reason not Specified|4|||
157192373|NCT02127970|567445037|FG001|Overall Study|Reason not Specified|7|||
157192374|NCT02127970|567445036|FG000|Overall Study|Pregnancy|0|||
157192375|NCT02127970|567445037|FG001|Overall Study|Pregnancy|1|||
157192376|NCT02127970|567445036|FG000|Overall Study|Subject Withdrew Consent|5|||
157192377|NCT02127970|567445037|FG001|Overall Study|Subject Withdrew Consent|3|||
157192378|NCT01871870|567445041|FG000|Overall Study|Hardware issues|7|||
157192379|NCT01871870|567445041|FG000|Overall Study|hyperglycemia|2|||
157192380|NCT01731951|567445045|FG000|Overall Study|Documented Disease Progression|1|||
157192381|NCT01731951|567445046|FG001|Overall Study|Documented Disease Progression|0|||
157192382|NCT01731951|567445047|FG002|Overall Study|Documented Disease Progression|0|||
157192383|NCT01731951|567445048|FG003|Overall Study|Documented Disease Progression|0|||
157192384|NCT01731951|567445049|FG004|Overall Study|Documented Disease Progression|0|||
157231453|NCT00880568|567593951|FG002|Overall Study|Adverse Event|0|||
157192385|NCT01731951|567445050|FG005|Overall Study|Documented Disease Progression|0|||
157192386|NCT01731951|567445045|FG000|Overall Study|Lost to Follow-up|2|||
157192387|NCT01731951|567445046|FG001|Overall Study|Lost to Follow-up|0|||
157192388|NCT01731951|567445047|FG002|Overall Study|Lost to Follow-up|0|||
157192389|NCT01731951|567445048|FG003|Overall Study|Lost to Follow-up|1|||
157192390|NCT01731951|567445049|FG004|Overall Study|Lost to Follow-up|3|||
157192391|NCT01731951|567445050|FG005|Overall Study|Lost to Follow-up|1|||
157192392|NCT01731951|567445045|FG000|Overall Study|Withdrawal of Consent|1|||
157192393|NCT01731951|567445046|FG001|Overall Study|Withdrawal of Consent|0|||
157192394|NCT01731951|567445047|FG002|Overall Study|Withdrawal of Consent|0|||
157192395|NCT01731951|567445048|FG003|Overall Study|Withdrawal of Consent|0|||
157192396|NCT01731951|567445049|FG004|Overall Study|Withdrawal of Consent|0|||
157192397|NCT01731951|567445050|FG005|Overall Study|Withdrawal of Consent|2|||
157192398|NCT01731951|567445045|FG000|Overall Study|Death|13|||
157192399|NCT01731951|567445046|FG001|Overall Study|Death|15|||
157192400|NCT01731951|567445047|FG002|Overall Study|Death|9|||
157192401|NCT01731951|567445048|FG003|Overall Study|Death|8|||
157192402|NCT01731951|567445049|FG004|Overall Study|Death|9|||
157192403|NCT01731951|567445050|FG005|Overall Study|Death|6|||
157192404|NCT00490815|567445051|FG000|Overall Study|Adverse Event|2|||
157192405|NCT00490815|567445052|FG001|Overall Study|Adverse Event|3|||
157192406|NCT00490815|567445051|FG000|Overall Study|Withdrawal by Subject|4|||
157192407|NCT00490815|567445052|FG001|Overall Study|Withdrawal by Subject|0|||
157192408|NCT00490815|567445051|FG000|Overall Study|Lost to Follow-up|1|||
157192409|NCT00490815|567445052|FG001|Overall Study|Lost to Follow-up|3|||
157192410|NCT00490815|567445051|FG000|Overall Study|Death|1|||
157192411|NCT00490815|567445052|FG001|Overall Study|Death|3|||
157192412|NCT02242305|567445057|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
157192413|NCT02242305|567445058|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
157192414|NCT02242305|567445057|FG000|Overall Study|Adverse Event|1|||
157192415|NCT02242305|567445058|FG001|Overall Study|Adverse Event|0|||
157192416|NCT02242305|567445057|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
157192417|NCT02242305|567445058|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
157192418|NCT02242305|567445057|FG000|Overall Study|Subject withdraws inform consent|0|||
157192419|NCT02242305|567445058|FG001|Overall Study|Subject withdraws inform consent|4|||
157192420|NCT02242305|567445057|FG000|Overall Study|Lost to Follow-up|2|||
157192421|NCT02242305|567445058|FG001|Overall Study|Lost to Follow-up|0|||
157192422|NCT01756846|567445062|FG000|Overall Study|Lost to Follow-up|5|||
157192423|NCT01756846|567445063|FG001|Overall Study|Lost to Follow-up|10|||
157192424|NCT01756846|567445062|FG000|Overall Study|Withdrawal by Subject|1|||
157192425|NCT01756846|567445063|FG001|Overall Study|Withdrawal by Subject|2|||
157192426|NCT00256204|567445066|FG000|Overall Study|Adverse Event|10|||
157192427|NCT00256204|567445067|FG001|Overall Study|Adverse Event|14|||
157192428|NCT00256204|567445068|FG002|Overall Study|Adverse Event|16|||
157192429|NCT00256204|567445069|FG003|Overall Study|Adverse Event|14|||
157192430|NCT00256204|567445066|FG000|Overall Study|Death|0|||
157192431|NCT00256204|567445067|FG001|Overall Study|Death|1|||
157192432|NCT00256204|567445068|FG002|Overall Study|Death|0|||
157192433|NCT00256204|567445069|FG003|Overall Study|Death|0|||
157192434|NCT00256204|567445066|FG000|Overall Study|Lost to Follow-up|1|||
157192435|NCT00256204|567445067|FG001|Overall Study|Lost to Follow-up|1|||
157192436|NCT00256204|567445068|FG002|Overall Study|Lost to Follow-up|1|||
157192437|NCT00256204|567445069|FG003|Overall Study|Lost to Follow-up|2|||
157231454|NCT00880568|567593952|FG003|Overall Study|Adverse Event|0|||
157074851|NCT03939689|567028948|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
157074852|NCT03939689|567028947|FG000|Overall Study|Adverse Event|1|||
157074853|NCT03939689|567028948|FG001|Overall Study|Adverse Event|8|||
157074854|NCT03939689|567028947|FG000|Overall Study|Unequivocal clinical progression|2|||
157074855|NCT03939689|567028948|FG001|Overall Study|Unequivocal clinical progression|5|||
157074856|NCT03939689|567028947|FG000|Overall Study|Other|1|||
157074857|NCT03939689|567028948|FG001|Overall Study|Other|4|||
157074858|NCT03939689|567028947|FG000|Overall Study|Death|0|||
157074859|NCT03939689|567028948|FG001|Overall Study|Death|3|||
157074860|NCT03939689|567028947|FG000|Overall Study|Participant decision|0|||
157074861|NCT03939689|567028948|FG001|Overall Study|Participant decision|3|||
157074862|NCT03939689|567028947|FG000|Overall Study|Withdrawal of consent|2|||
157074863|NCT03939689|567028948|FG001|Overall Study|Withdrawal of consent|1|||
157192438|NCT00256204|567445066|FG000|Overall Study|Protocol Violation|1|||
157192439|NCT00256204|567445067|FG001|Overall Study|Protocol Violation|0|||
157192440|NCT00256204|567445068|FG002|Overall Study|Protocol Violation|2|||
157192441|NCT00256204|567445069|FG003|Overall Study|Protocol Violation|1|||
157192442|NCT00256204|567445066|FG000|Overall Study|Physician Decision|0|||
157192443|NCT00256204|567445067|FG001|Overall Study|Physician Decision|0|||
157192444|NCT00256204|567445068|FG002|Overall Study|Physician Decision|1|||
157192445|NCT00256204|567445069|FG003|Overall Study|Physician Decision|2|||
157192446|NCT00256204|567445066|FG000|Overall Study|Withdrawal by Subject|17|||
157192447|NCT00256204|567445067|FG001|Overall Study|Withdrawal by Subject|6|||
157192448|NCT00256204|567445068|FG002|Overall Study|Withdrawal by Subject|7|||
157192449|NCT00256204|567445069|FG003|Overall Study|Withdrawal by Subject|5|||
157231455|NCT00880568|567593953|FG004|Overall Study|Adverse Event|0|||
157231456|NCT00880568|567593954|FG005|Overall Study|Adverse Event|0|||
157231457|NCT00880568|567593955|FG006|Overall Study|Adverse Event|1|||
157231458|NCT00880568|567593956|FG007|Overall Study|Adverse Event|1|||
157231459|NCT00880568|567593957|FG008|Overall Study|Adverse Event|0|||
157231460|NCT00880568|567593949|FG000|Overall Study|Withdrawal by Subject|0|||
157231461|NCT00880568|567593950|FG001|Overall Study|Withdrawal by Subject|0|||
157231462|NCT00880568|567593951|FG002|Overall Study|Withdrawal by Subject|0|||
157231463|NCT00880568|567593952|FG003|Overall Study|Withdrawal by Subject|0|||
157231464|NCT00880568|567593953|FG004|Overall Study|Withdrawal by Subject|0|||
157231465|NCT00880568|567593954|FG005|Overall Study|Withdrawal by Subject|0|||
157231466|NCT00880568|567593955|FG006|Overall Study|Withdrawal by Subject|0|||
157231467|NCT00880568|567593956|FG007|Overall Study|Withdrawal by Subject|1|||
157231468|NCT00880568|567593957|FG008|Overall Study|Withdrawal by Subject|0|||
157231469|NCT00620022|567593958|FG000|Treatment Period 1|Adverse Event|4|||
157231470|NCT00620022|567593959|FG001|Treatment Period 1|Adverse Event|6|||
157231471|NCT00620022|567593958|FG000|Treatment Period 1|Subject withdrew consent|1|||
157231472|NCT00620022|567593959|FG001|Treatment Period 1|Subject withdrew consent|0|||
157231473|NCT00620022|567593958|FG000|Treatment Period 2|Adverse Event|2|||
157231474|NCT00620022|567593959|FG001|Treatment Period 2|Adverse Event|2|||
157231475|NCT00891293|567593960|FG000|Overall Study|Adverse Event|2|||
157231476|NCT00891293|567593960|FG000|Overall Study|Protocol Violation|2|||
157231477|NCT00891293|567593960|FG000|Overall Study|Laboratory abnormality|4|||
157231478|NCT00891293|567593960|FG000|Overall Study|Lost to Follow-up|7|||
157231479|NCT00891293|567593960|FG000|Overall Study|Subject withdrew consent|7|||
157231480|NCT00891293|567593960|FG000|Overall Study|Sponsor termination|62|||
157231481|NCT02178722|567593961|FG000|Overall Study|Withdrawal by Subject|0|||
157231482|NCT02178722|567593962|FG001|Overall Study|Withdrawal by Subject|0|||
157231483|NCT02178722|567593963|FG002|Overall Study|Withdrawal by Subject|0|||
157231484|NCT02178722|567593964|FG003|Overall Study|Withdrawal by Subject|2|||
157231485|NCT02178722|567593965|FG004|Overall Study|Withdrawal by Subject|33|||
157231486|NCT02178722|567593961|FG000|Overall Study|Death|2|||
157231487|NCT02178722|567593962|FG001|Overall Study|Death|13|||
157231488|NCT02178722|567593963|FG002|Overall Study|Death|12|||
157231489|NCT02178722|567593964|FG003|Overall Study|Death|12|||
157231490|NCT02178722|567593965|FG004|Overall Study|Death|205|||
157231491|NCT02178722|567593961|FG000|Overall Study|Lost to Follow-up|0|||
157231492|NCT02178722|567593962|FG001|Overall Study|Lost to Follow-up|0|||
157231493|NCT02178722|567593963|FG002|Overall Study|Lost to Follow-up|0|||
157231494|NCT02178722|567593964|FG003|Overall Study|Lost to Follow-up|2|||
157231495|NCT02178722|567593965|FG004|Overall Study|Lost to Follow-up|11|||
157231496|NCT02178722|567593961|FG000|Overall Study|Study terminated by Sponsor|2|||
157231497|NCT02178722|567593962|FG001|Overall Study|Study terminated by Sponsor|7|||
157231498|NCT02178722|567593963|FG002|Overall Study|Study terminated by Sponsor|6|||
157231499|NCT02178722|567593964|FG003|Overall Study|Study terminated by Sponsor|4|||
157231500|NCT02178722|567593965|FG004|Overall Study|Study terminated by Sponsor|128|||
157231501|NCT02178722|567593961|FG000|Overall Study|Physician Decision|0|||
157231502|NCT02178722|567593962|FG001|Overall Study|Physician Decision|0|||
157231503|NCT02178722|567593963|FG002|Overall Study|Physician Decision|0|||
157231504|NCT02178722|567593964|FG003|Overall Study|Physician Decision|0|||
157231505|NCT02178722|567593965|FG004|Overall Study|Physician Decision|3|||
157231506|NCT02178722|567593961|FG000|Overall Study|Other|0|||
157231507|NCT02178722|567593962|FG001|Overall Study|Other|0|||
157231508|NCT02178722|567593963|FG002|Overall Study|Other|0|||
157231509|NCT02178722|567593964|FG003|Overall Study|Other|0|||
157231510|NCT02178722|567593965|FG004|Overall Study|Other|2|||
157231511|NCT01572948|567593966|FG000|Overall Study|Lost to Follow-up|1|||
157231512|NCT01572948|567593967|FG001|Overall Study|Lost to Follow-up|0|||
157231513|NCT01572948|567593966|FG000|Overall Study|unable to contact|0|||
157231514|NCT01572948|567593967|FG001|Overall Study|unable to contact|1|||
157231515|NCT01126736|567593973|FG000|Overall Study|Death|2|||
157074864|NCT03939689|567028947|FG000|Overall Study|Investigator decision|1|||
157074865|NCT03939689|567028948|FG001|Overall Study|Investigator decision|0|||
157231516|NCT01126736|567593974|FG001|Overall Study|Death|2|||
157231517|NCT01126736|567593975|FG002|Overall Study|Death|1|||
157231518|NCT01126736|567593976|FG003|Overall Study|Death|19|||
157231519|NCT01126736|567593977|FG004|Overall Study|Death|19|||
157231520|NCT01126736|567593973|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
157231521|NCT01126736|567593974|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
157231522|NCT01126736|567593975|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
157231523|NCT01126736|567593976|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
157231524|NCT01126736|567593977|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
157231525|NCT01126736|567593973|FG000|Overall Study|Lost to Follow-up|0|||
157231526|NCT01126736|567593974|FG001|Overall Study|Lost to Follow-up|0|||
157231527|NCT01126736|567593975|FG002|Overall Study|Lost to Follow-up|0|||
157231528|NCT01126736|567593976|FG003|Overall Study|Lost to Follow-up|1|||
157231529|NCT01126736|567593977|FG004|Overall Study|Lost to Follow-up|1|||
157231530|NCT01126736|567593973|FG000|Overall Study|Administrative reasons|0|||
157231531|NCT01126736|567593974|FG001|Overall Study|Administrative reasons|0|||
157192450|NCT00256204|567445066|FG000|Overall Study|Need for additional prohibited treatment|38|||
157192451|NCT00256204|567445067|FG001|Overall Study|Need for additional prohibited treatment|28|||
157192452|NCT00256204|567445068|FG002|Overall Study|Need for additional prohibited treatment|27|||
157192453|NCT00256204|567445069|FG003|Overall Study|Need for additional prohibited treatment|25|||
157192454|NCT03490734|567445072|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
157192455|NCT03490734|567445073|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
157192456|NCT03490734|567445074|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
157192457|NCT03490734|567445075|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
157192458|NCT03490734|567445072|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
157192459|NCT03490734|567445073|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
157192460|NCT03490734|567445074|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
157192461|NCT03490734|567445075|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
157192462|NCT03490734|567445072|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
157192463|NCT03490734|567445073|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
157192464|NCT03490734|567445074|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
157192465|NCT03490734|567445075|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
157192466|NCT03490734|567445072|FG000|Post-intervention Scan Visit|Adverse Event|2|||
157192467|NCT03490734|567445073|FG001|Post-intervention Scan Visit|Adverse Event|0|||
157192468|NCT03490734|567445074|FG002|Post-intervention Scan Visit|Adverse Event|0|||
157192469|NCT03490734|567445075|FG003|Post-intervention Scan Visit|Adverse Event|0|||
157192470|NCT03490734|567445072|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
157192471|NCT03490734|567445073|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
157192472|NCT03490734|567445074|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
157192473|NCT03490734|567445075|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
157192474|NCT03490734|567445072|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
157192475|NCT03490734|567445073|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
157192476|NCT03490734|567445074|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
157192477|NCT03490734|567445075|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
157192478|NCT01326910|567445080|FG000|Overall Study|Withdrawal by Subject|3|||
157192479|NCT01326910|567445081|FG001|Overall Study|Withdrawal by Subject|2|||
157192480|NCT01326910|567445080|FG000|Overall Study|Protocol Violation|1|||
157192481|NCT01326910|567445081|FG001|Overall Study|Protocol Violation|1|||
157192482|NCT00866606|567445088|FG000|Overall Study|Lost to Follow-up|3|||
157192483|NCT00866606|567445088|FG000|Overall Study|Adverse Event|1|||
157192484|NCT02886338|567445089|FG000|Overall Study|Withdrawal by Subject|1|||
157192485|NCT01524900|567447073|FG000|Overall Study|Lost to Follow-up|3|||
157192486|NCT01524900|567447074|FG001|Overall Study|Lost to Follow-up|12|||
157192487|NCT01524900|567447075|FG002|Overall Study|Lost to Follow-up|1|||
157192488|NCT01524900|567447076|FG003|Overall Study|Lost to Follow-up|0|||
157192489|NCT01524900|567447077|FG004|Overall Study|Lost to Follow-up|0|||
157192490|NCT01524900|567447073|FG000|Overall Study|Other reason than stated above|1|||
157192491|NCT01524900|567447074|FG001|Overall Study|Other reason than stated above|1|||
157192492|NCT01524900|567447075|FG002|Overall Study|Other reason than stated above|0|||
157192493|NCT01524900|567447076|FG003|Overall Study|Other reason than stated above|0|||
157192494|NCT01524900|567447077|FG004|Overall Study|Other reason than stated above|0|||
157192495|NCT01524900|567447073|FG000|Overall Study|No reason documented|2|||
157192496|NCT01524900|567447074|FG001|Overall Study|No reason documented|1|||
157192497|NCT01524900|567447075|FG002|Overall Study|No reason documented|0|||
157192498|NCT01524900|567447076|FG003|Overall Study|No reason documented|1|||
157192499|NCT01524900|567447077|FG004|Overall Study|No reason documented|0|||
157192500|NCT00303329|567447078|FG000|Overall Study|Adverse Event|7|||
157192501|NCT00303329|567447079|FG001|Overall Study|Adverse Event|14|||
157192502|NCT00303329|567447078|FG000|Overall Study|Abnormal Laboratory Values|0|||
157192503|NCT00303329|567447079|FG001|Overall Study|Abnormal Laboratory Values|1|||
157192504|NCT00303329|567447078|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
157192505|NCT00303329|567447079|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157192506|NCT00303329|567447078|FG000|Overall Study|Condition no longer requires study drug|0|||
157192507|NCT00303329|567447079|FG001|Overall Study|Condition no longer requires study drug|8|||
157192508|NCT00303329|567447078|FG000|Overall Study|Protocol Violation|3|||
157192509|NCT00303329|567447079|FG001|Overall Study|Protocol Violation|0|||
157192510|NCT00303329|567447078|FG000|Overall Study|Withdrawal by Subject|9|||
157192511|NCT00303329|567447079|FG001|Overall Study|Withdrawal by Subject|15|||
157192512|NCT00303329|567447078|FG000|Overall Study|Lost to Follow-up|0|||
157192513|NCT00303329|567447079|FG001|Overall Study|Lost to Follow-up|1|||
157192514|NCT00303329|567447078|FG000|Overall Study|Administrative problems|1|||
157192515|NCT00303329|567447079|FG001|Overall Study|Administrative problems|0|||
157192516|NCT00303329|567447078|FG000|Overall Study|Death|2|||
157192517|NCT00303329|567447079|FG001|Overall Study|Death|12|||
157192518|NCT00303329|567447078|FG000|Overall Study|Stopped at end of core|3|||
157192519|NCT00303329|567447079|FG001|Overall Study|Stopped at end of core|9|||
157192520|NCT00303329|567447078|FG000|Overall Study|Stopped at end of extension 1|1|||
157192521|NCT00303329|567447079|FG001|Overall Study|Stopped at end of extension 1|0|||
157192522|NCT00561912|567447082|FG000|Overall Study|ineligible|1|||
157231532|NCT01126736|567593975|FG002|Overall Study|Administrative reasons|0|||
157231533|NCT01126736|567593976|FG003|Overall Study|Administrative reasons|0|||
157231534|NCT01126736|567593977|FG004|Overall Study|Administrative reasons|1|||
157231535|NCT01126736|567593973|FG000|Overall Study|Progressive disease|0|||
157231536|NCT01126736|567593974|FG001|Overall Study|Progressive disease|0|||
157231537|NCT01126736|567593975|FG002|Overall Study|Progressive disease|0|||
157231538|NCT01126736|567593976|FG003|Overall Study|Progressive disease|2|||
157231539|NCT01126736|567593977|FG004|Overall Study|Progressive disease|1|||
157231540|NCT01126736|567593973|FG000|Overall Study|Withdrawal by Subject|0|||
157231541|NCT01126736|567593974|FG001|Overall Study|Withdrawal by Subject|0|||
157231542|NCT01126736|567593975|FG002|Overall Study|Withdrawal by Subject|0|||
157231543|NCT01126736|567593976|FG003|Overall Study|Withdrawal by Subject|1|||
157231544|NCT01126736|567593977|FG004|Overall Study|Withdrawal by Subject|1|||
157231545|NCT01126736|567593973|FG000|Overall Study|Other|2|||
157231546|NCT01126736|567593974|FG001|Overall Study|Other|4|||
157231547|NCT01126736|567593975|FG002|Overall Study|Other|4|||
157231548|NCT01126736|567593976|FG003|Overall Study|Other|16|||
157231549|NCT01126736|567593977|FG004|Overall Study|Other|15|||
157231550|NCT00874237|567593978|FG000|Overall Study|Physician Decision|0|||
157231551|NCT00874237|567593979|FG001|Overall Study|Physician Decision|1|||
157231552|NCT00874237|567593980|FG002|Overall Study|Physician Decision|0|||
157231553|NCT00874237|567593981|FG003|Overall Study|Physician Decision|0|||
157231554|NCT00874237|567593982|FG004|Overall Study|Physician Decision|0|||
157231555|NCT00874237|567593983|FG005|Overall Study|Physician Decision|0|||
157231556|NCT00874237|567593978|FG000|Overall Study|Withdrawal by Subject|0|||
157231557|NCT00874237|567593979|FG001|Overall Study|Withdrawal by Subject|0|||
157231558|NCT00874237|567593980|FG002|Overall Study|Withdrawal by Subject|1|||
157231559|NCT00874237|567593981|FG003|Overall Study|Withdrawal by Subject|0|||
157231560|NCT00874237|567593982|FG004|Overall Study|Withdrawal by Subject|0|||
157231561|NCT00874237|567593983|FG005|Overall Study|Withdrawal by Subject|0|||
157231562|NCT01496183|567593985|FG000|Overall Study|Physician Decision|3|||
157231563|NCT01496183|567593986|FG001|Overall Study|Physician Decision|1|||
157231564|NCT01496183|567593985|FG000|Overall Study|Withdrawal by Subject|0|||
157231565|NCT01496183|567593986|FG001|Overall Study|Withdrawal by Subject|1|||
157231566|NCT00669864|567593989|FG000|Overall Study|Lost to Follow-up|2|||
157231567|NCT00669864|567593989|FG000|Overall Study|Protocol Violation|2|||
157231568|NCT00669864|567593989|FG000|Overall Study|Withdrawal by Subject|3|||
157231569|NCT00669864|567593989|FG000|Overall Study|Other|2|||
157231570|NCT01629381|567593990|FG000|Overall Study|Withdrawal by Subject|2|||
157231571|NCT01629381|567593991|FG001|Overall Study|Withdrawal by Subject|5|||
157231572|NCT03991494|567594000|FG000|Overall Study|Progressive Disease|4|||
157231573|NCT00743197|567594004|FG000|Overall Study|Study terminated due to departure of PI.|1|||
157231574|NCT00743197|567594005|FG001|Overall Study|Study terminated due to departure of PI.|2|||
157231575|NCT00824265|567594006|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
157231576|NCT00824265|567594007|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
157231577|NCT00824265|567594006|FG000|Treatment Phase|Protocol Violation|1|||
157231578|NCT00824265|567594007|FG001|Treatment Phase|Protocol Violation|0|||
157231579|NCT00824265|567594006|FG000|Treatment Phase|Lost to Follow-up|1|||
157231580|NCT00824265|567594007|FG001|Treatment Phase|Lost to Follow-up|1|||
157231581|NCT00824265|567594006|FG000|Treatment Phase|Physician Decision|6|||
157231582|NCT00824265|567594007|FG001|Treatment Phase|Physician Decision|12|||
157231583|NCT00824265|567594006|FG000|Treatment Phase|Withdrawal by Subject|6|||
157231584|NCT00824265|567594007|FG001|Treatment Phase|Withdrawal by Subject|15|||
157231585|NCT00824265|567594006|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
157231586|NCT00824265|567594007|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
157231587|NCT00824265|567594006|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
157074866|NCT04427280|567028949|FG000|Overall Study|Withdrawal by Subject|0|||
157074867|NCT04427280|567028950|FG001|Overall Study|Withdrawal by Subject|2|||
157074868|NCT01667926|567028964|FG000|Overall Study|Withdrawal by Subject|1|||
157192523|NCT03938857|567447083|FG000|Overall Study|Physician Decision|1|||
157192524|NCT03938857|567447084|FG001|Overall Study|Physician Decision|0|||
157192525|NCT03938857|567447085|FG002|Overall Study|Physician Decision|0|||
157192526|NCT03938857|567447086|FG003|Overall Study|Physician Decision|0|||
157192527|NCT02988115|567447087|FG000|Overall Study|Adverse Event|6|||
157192528|NCT02988115|567447088|FG001|Overall Study|Adverse Event|1|||
157192529|NCT02988115|567447087|FG000|Overall Study|Sponsor Decision|5|||
157192530|NCT02988115|567447088|FG001|Overall Study|Sponsor Decision|2|||
157192531|NCT02988115|567447087|FG000|Overall Study|Withdrawal by Subject|1|||
157192532|NCT02988115|567447088|FG001|Overall Study|Withdrawal by Subject|1|||
157192533|NCT02988115|567447087|FG000|Overall Study|Withdrawn by Mistake|1|||
157192534|NCT02988115|567447088|FG001|Overall Study|Withdrawn by Mistake|0|||
157192535|NCT02988115|567447087|FG000|Overall Study|Lost to Follow-up|1|||
157192536|NCT02988115|567447088|FG001|Overall Study|Lost to Follow-up|0|||
157192537|NCT01977651|567447089|FG000|4 Month Treatment Period|Adverse Event|34|||
157192538|NCT01977651|567447089|FG000|4 Month Treatment Period|Death|3|||
157192539|NCT01977651|567447089|FG000|4 Month Treatment Period|Progressive Disease|43|||
157192540|NCT01977651|567447089|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
157231588|NCT00824265|567594007|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
157231589|NCT01411332|567594008|FG000|Enrollment|Protocol Violation|0|||
157231590|NCT01411332|567594009|FG001|Enrollment|Protocol Violation|1|||
157231591|NCT01411332|567594008|FG000|Enrollment|Withdrawal by Subject|0|||
157231592|NCT01411332|567594009|FG001|Enrollment|Withdrawal by Subject|1|||
157231593|NCT01411332|567594008|FG000|Treatment|Lost to Follow-up|1|||
157231594|NCT01411332|567594009|FG001|Treatment|Lost to Follow-up|0|||
157231595|NCT01471522|567594010|FG000|Overall Study|Withdrawal by Subject|28|||
157231596|NCT01471522|567594011|FG001|Overall Study|Withdrawal by Subject|22|||
157231597|NCT01471522|567594010|FG000|Overall Study|Lost to Follow-up|36|||
157231598|NCT01471522|567594011|FG001|Overall Study|Lost to Follow-up|26|||
157231599|NCT01432171|567594012|FG000|Overall Study|Death|1|||
157231600|NCT01432171|567594013|FG001|Overall Study|Death|2|||
157231601|NCT01432171|567594012|FG000|Overall Study|Lost to Follow-up|6|||
157231602|NCT01432171|567594013|FG001|Overall Study|Lost to Follow-up|5|||
157231603|NCT01432171|567594012|FG000|Overall Study|Withdrawal by Subject|3|||
157231604|NCT01432171|567594013|FG001|Overall Study|Withdrawal by Subject|1|||
157231605|NCT01432171|567594012|FG000|Overall Study|Noncompliance|2|||
157231606|NCT01432171|567594013|FG001|Overall Study|Noncompliance|3|||
157231607|NCT01432171|567594012|FG000|Overall Study|Insurance denial trial coverage|1|||
157231608|NCT01432171|567594013|FG001|Overall Study|Insurance denial trial coverage|0|||
157231609|NCT01432171|567594012|FG000|Overall Study|Patient moved to palliative care|1|||
157231610|NCT01432171|567594013|FG001|Overall Study|Patient moved to palliative care|0|||
157231611|NCT01706926|567594014|FG000|Overall Study|Lost to Follow-up|0|||
157231612|NCT01706926|567594015|FG001|Overall Study|Lost to Follow-up|0|||
157231613|NCT01706926|567594016|FG002|Overall Study|Lost to Follow-up|1|||
157231614|NCT01706926|567594017|FG003|Overall Study|Lost to Follow-up|0|||
157231615|NCT01706926|567594014|FG000|Overall Study|Withdrawal by Subject|2|||
157231616|NCT01706926|567594015|FG001|Overall Study|Withdrawal by Subject|0|||
157231617|NCT01706926|567594016|FG002|Overall Study|Withdrawal by Subject|1|||
157231618|NCT01706926|567594017|FG003|Overall Study|Withdrawal by Subject|2|||
157231619|NCT01706926|567594014|FG000|Overall Study|Other|4|||
157231620|NCT01706926|567594015|FG001|Overall Study|Other|4|||
157231621|NCT01706926|567594016|FG002|Overall Study|Other|4|||
157231622|NCT01706926|567594017|FG003|Overall Study|Other|3|||
157231623|NCT00549718|567595313|FG000|Overall Study|Insufficient clinical response|20|||
157231624|NCT00549718|567595314|FG001|Overall Study|Insufficient clinical response|7|||
157231625|NCT00549718|567595315|FG002|Overall Study|Insufficient clinical response|18|||
157231626|NCT00549718|567595316|FG003|Overall Study|Insufficient clinical response|32|||
157231627|NCT00549718|567595313|FG000|Overall Study|Adverse Event|6|||
157231628|NCT00549718|567595314|FG001|Overall Study|Adverse Event|8|||
157231629|NCT00549718|567595315|FG002|Overall Study|Adverse Event|7|||
157231630|NCT00549718|567595316|FG003|Overall Study|Adverse Event|3|||
157231631|NCT00549718|567595313|FG000|Overall Study|Lost to Follow-up|4|||
157074869|NCT01667926|567028965|FG001|Overall Study|Withdrawal by Subject|2|||
157074870|NCT01667926|567028966|FG002|Overall Study|Withdrawal by Subject|2|||
157074871|NCT01667926|567028964|FG000|Overall Study|Physician Decision|0|||
157074872|NCT01667926|567028965|FG001|Overall Study|Physician Decision|0|||
157074873|NCT01667926|567028966|FG002|Overall Study|Physician Decision|1|||
157074874|NCT01667926|567028964|FG000|Overall Study|Time committment|0|||
157231632|NCT00549718|567595314|FG001|Overall Study|Lost to Follow-up|2|||
157231633|NCT00549718|567595315|FG002|Overall Study|Lost to Follow-up|0|||
157231634|NCT00549718|567595316|FG003|Overall Study|Lost to Follow-up|6|||
157074875|NCT01667926|567028965|FG001|Overall Study|Time committment|0|||
157074876|NCT01667926|567028966|FG002|Overall Study|Time committment|2|||
157074877|NCT01667926|567028964|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
157074878|NCT01667926|567028965|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
157074879|NCT01667926|567028966|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
157074880|NCT01667926|567028964|FG000|Overall Study|Lost to Follow-up|1|||
157074881|NCT01667926|567028965|FG001|Overall Study|Lost to Follow-up|2|||
157074882|NCT01667926|567028966|FG002|Overall Study|Lost to Follow-up|1|||
157074883|NCT01667926|567028964|FG000|Overall Study|Side effects|3|||
157074884|NCT01667926|567028965|FG001|Overall Study|Side effects|0|||
157074885|NCT01667926|567028966|FG002|Overall Study|Side effects|0|||
157074886|NCT04307940|567028967|FG000|Overall Study|Adverse Event|1|||
157074887|NCT04307940|567028968|FG001|Overall Study|Adverse Event|0|||
157074888|NCT04307940|567028969|FG002|Overall Study|Adverse Event|0|||
157074889|NCT04307940|567028967|FG000|Overall Study|Withdrawal by Subject|2|||
157074890|NCT04307940|567028968|FG001|Overall Study|Withdrawal by Subject|3|||
157074891|NCT04307940|567028969|FG002|Overall Study|Withdrawal by Subject|1|||
157231635|NCT00549718|567595313|FG000|Overall Study|Withdrawal by Subject|9|||
157074892|NCT04307940|567028967|FG000|Overall Study|Lost to Follow-up|2|||
157074893|NCT04307940|567028968|FG001|Overall Study|Lost to Follow-up|0|||
157074894|NCT04307940|567028969|FG002|Overall Study|Lost to Follow-up|1|||
157074895|NCT04624243|567028973|FG000|Overall Study|Death|0|||
157074896|NCT04624243|567028974|FG001|Overall Study|Death|1|||
157074897|NCT04624243|567028975|FG002|Overall Study|Death|0|||
157231636|NCT00549718|567595314|FG001|Overall Study|Withdrawal by Subject|18|||
157231637|NCT00549718|567595315|FG002|Overall Study|Withdrawal by Subject|12|||
157192541|NCT01977651|567447089|FG000|4 Month Treatment Period|Physician Decision|4|||
157192542|NCT01977651|567447089|FG000|1 Year Extension Period|Adverse Event|14|||
157192543|NCT01977651|567447089|FG000|1 Year Extension Period|Death|10|||
157192544|NCT01977651|567447089|FG000|1 Year Extension Period|Lost to Follow-up|2|||
157192545|NCT01977651|567447089|FG000|1 Year Extension Period|Progressive Disease|86|||
157192546|NCT01977651|567447089|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
157192547|NCT01977651|567447089|FG000|1 Year Extension Period|Physician Decision|6|||
157192548|NCT01977651|567447089|FG000|1 Year Extension Period|Miscellaneous|1|||
157192549|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Adverse Event|5|||
157192550|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Death|13|||
157192551|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
157192552|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
157192553|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Physician Decision|4|||
157192554|NCT01977651|567447089|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
157192555|NCT03287089|567447095|FG000|Overall Study|Lost to Follow-up|0|||
157192556|NCT03287089|567447096|FG001|Overall Study|Lost to Follow-up|2|||
157192557|NCT03287089|567447095|FG000|Overall Study|Physician Decision|0|||
157192558|NCT03287089|567447096|FG001|Overall Study|Physician Decision|2|||
157192559|NCT03287089|567447095|FG000|Overall Study|Withdrawal by Subject|0|||
157192560|NCT03287089|567447096|FG001|Overall Study|Withdrawal by Subject|2|||
157192561|NCT01729559|567447104|FG000|Overall Study|Protocol Violation|31|||
157192562|NCT01729559|567447105|FG001|Overall Study|Protocol Violation|28|||
157192563|NCT00104299|567447110|FG000|Overall Study|Adverse Event|3|||
157192564|NCT00104299|567447111|FG001|Overall Study|Adverse Event|1|||
157192565|NCT00104299|567447110|FG000|Overall Study|Death|2|||
157192566|NCT00104299|567447111|FG001|Overall Study|Death|2|||
157192567|NCT00104299|567447110|FG000|Overall Study|Withdrawal by Subject|2|||
157192568|NCT00104299|567447111|FG001|Overall Study|Withdrawal by Subject|6|||
157192569|NCT00104299|567447110|FG000|Overall Study|Physician Decision|1|||
157192570|NCT00104299|567447111|FG001|Overall Study|Physician Decision|1|||
157192571|NCT00104299|567447110|FG000|Overall Study|To have renal transplant|1|||
157192572|NCT00104299|567447111|FG001|Overall Study|To have renal transplant|0|||
157192573|NCT02452034|567447112|FG000|Overall Study|Adverse Event|0|||
157192574|NCT02452034|567447113|FG001|Overall Study|Adverse Event|0|||
157192575|NCT02452034|567447114|FG002|Overall Study|Adverse Event|0|||
157192576|NCT02452034|567447115|FG003|Overall Study|Adverse Event|0|||
157192577|NCT02452034|567447116|FG004|Overall Study|Adverse Event|0|||
157192578|NCT02452034|567447117|FG005|Overall Study|Adverse Event|1|||
157192579|NCT02452034|567447112|FG000|Overall Study|Death|0|||
157192580|NCT02452034|567447113|FG001|Overall Study|Death|0|||
157192581|NCT02452034|567447114|FG002|Overall Study|Death|0|||
157192582|NCT02452034|567447115|FG003|Overall Study|Death|0|||
157192583|NCT02452034|567447116|FG004|Overall Study|Death|1|||
157192584|NCT02452034|567447117|FG005|Overall Study|Death|1|||
157192585|NCT02452034|567447112|FG000|Overall Study|Physician Decision|0|||
157192586|NCT02452034|567447113|FG001|Overall Study|Physician Decision|1|||
157192587|NCT02452034|567447114|FG002|Overall Study|Physician Decision|1|||
157192588|NCT02452034|567447115|FG003|Overall Study|Physician Decision|0|||
157192589|NCT02452034|567447116|FG004|Overall Study|Physician Decision|0|||
157192590|NCT02452034|567447117|FG005|Overall Study|Physician Decision|0|||
157192591|NCT02452034|567447112|FG000|Overall Study|Protocol Violation|0|||
157192592|NCT02452034|567447113|FG001|Overall Study|Protocol Violation|0|||
157192593|NCT02452034|567447114|FG002|Overall Study|Protocol Violation|0|||
157192594|NCT02452034|567447115|FG003|Overall Study|Protocol Violation|0|||
157192595|NCT02452034|567447116|FG004|Overall Study|Protocol Violation|0|||
157192596|NCT02452034|567447117|FG005|Overall Study|Protocol Violation|1|||
157192597|NCT02452034|567447112|FG000|Overall Study|Screen Failure|1|||
157192598|NCT02452034|567447113|FG001|Overall Study|Screen Failure|0|||
157192599|NCT02452034|567447114|FG002|Overall Study|Screen Failure|0|||
157192600|NCT02452034|567447115|FG003|Overall Study|Screen Failure|1|||
157192601|NCT02452034|567447116|FG004|Overall Study|Screen Failure|0|||
157192602|NCT02452034|567447117|FG005|Overall Study|Screen Failure|0|||
157192603|NCT02452034|567447112|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
157192604|NCT02452034|567447113|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
157192605|NCT02452034|567447114|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
157192606|NCT02452034|567447115|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
157192607|NCT02452034|567447116|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
157192608|NCT02452034|567447117|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
157192609|NCT03672006|567447121|FG000|Overall Study|exclusion criteria met|0|||
157192610|NCT03672006|567447122|FG001|Overall Study|exclusion criteria met|1|||
157192611|NCT03288987|567447123|FG000|Overall Study|Protocol Violation|10|||
157192612|NCT03288987|567447124|FG001|Overall Study|Protocol Violation|4|||
157192613|NCT02764229|567447126|FG000|Overall Study|Withdrawal by Subject|15|||
157192614|NCT02764229|567447126|FG000|Overall Study|Adverse Event|9|||
157192615|NCT02764229|567447126|FG000|Overall Study|Physician Decision|5|||
157192616|NCT02764229|567447126|FG000|Overall Study|Lost to Follow-up|3|||
157192617|NCT02764229|567447126|FG000|Overall Study|Lack of Efficacy|1|||
157192618|NCT02764229|567447126|FG000|Overall Study|Study Stopped by Sponsor|69|||
157074898|NCT04624243|567028976|FG003|Overall Study|Death|0|||
157074899|NCT04624243|567028977|FG004|Overall Study|Death|0|||
157074900|NCT04624243|567028973|FG000|Overall Study|Lost to Follow-up|2|||
157074901|NCT04624243|567028974|FG001|Overall Study|Lost to Follow-up|3|||
157074902|NCT04624243|567028975|FG002|Overall Study|Lost to Follow-up|7|||
157074903|NCT04624243|567028976|FG003|Overall Study|Lost to Follow-up|1|||
157074904|NCT04624243|567028977|FG004|Overall Study|Lost to Follow-up|3|||
157074905|NCT04624243|567028973|FG000|Overall Study|Physician Decision|3|||
157074906|NCT04624243|567028974|FG001|Overall Study|Physician Decision|8|||
157074907|NCT04624243|567028975|FG002|Overall Study|Physician Decision|15|||
157074908|NCT04624243|567028976|FG003|Overall Study|Physician Decision|2|||
157074909|NCT04624243|567028977|FG004|Overall Study|Physician Decision|11|||
157074910|NCT04624243|567028973|FG000|Overall Study|Withdrawal by Subject|19|||
157074911|NCT04624243|567028974|FG001|Overall Study|Withdrawal by Subject|44|||
157074912|NCT04624243|567028975|FG002|Overall Study|Withdrawal by Subject|40|||
157074913|NCT04624243|567028976|FG003|Overall Study|Withdrawal by Subject|21|||
157074914|NCT04624243|567028977|FG004|Overall Study|Withdrawal by Subject|39|||
157074915|NCT04624243|567028973|FG000|Overall Study|Miscellaneous|3|||
157074916|NCT04624243|567028974|FG001|Overall Study|Miscellaneous|12|||
157074917|NCT04624243|567028975|FG002|Overall Study|Miscellaneous|9|||
157074918|NCT04624243|567028976|FG003|Overall Study|Miscellaneous|4|||
157074919|NCT04624243|567028977|FG004|Overall Study|Miscellaneous|6|||
157074920|NCT04996004|567028978|FG000|Phase I|Death|1|||
157074921|NCT04996004|567028979|FG001|Phase I|Death|2|||
157074922|NCT04996004|567028980|FG002|Phase I|Death|1|||
157074923|NCT04996004|567028981|FG003|Phase I|Death|0|||
157074924|NCT04996004|567028982|FG004|Phase I|Death|0|||
157074925|NCT04996004|567028983|FG005|Phase I|Death|0|||
157074926|NCT04996004|567028978|FG000|Phase I|Study terminated by sponsor|2|||
157074927|NCT04996004|567028979|FG001|Phase I|Study terminated by sponsor|1|||
157074928|NCT04996004|567028980|FG002|Phase I|Study terminated by sponsor|2|||
157074929|NCT04996004|567028981|FG003|Phase I|Study terminated by sponsor|0|||
157074930|NCT04996004|567028982|FG004|Phase I|Study terminated by sponsor|0|||
157074931|NCT04996004|567028983|FG005|Phase I|Study terminated by sponsor|0|||
157074932|NCT04996004|567028978|FG000|Phase II|Study terminated by sponsor|0|||
157074933|NCT04996004|567028979|FG001|Phase II|Study terminated by sponsor|0|||
157074934|NCT04996004|567028980|FG002|Phase II|Study terminated by sponsor|0|||
157074935|NCT04996004|567028981|FG003|Phase II|Study terminated by sponsor|20|||
157074936|NCT04996004|567028982|FG004|Phase II|Study terminated by sponsor|10|||
157074937|NCT04996004|567028983|FG005|Phase II|Study terminated by sponsor|10|||
157074938|NCT04996004|567028978|FG000|Phase II|Withdrawal by Subject|0|||
157074939|NCT04996004|567028979|FG001|Phase II|Withdrawal by Subject|0|||
157074940|NCT04996004|567028980|FG002|Phase II|Withdrawal by Subject|0|||
157074941|NCT04996004|567028981|FG003|Phase II|Withdrawal by Subject|0|||
157074942|NCT04996004|567028982|FG004|Phase II|Withdrawal by Subject|1|||
157074943|NCT04996004|567028983|FG005|Phase II|Withdrawal by Subject|2|||
157074944|NCT04996004|567028978|FG000|Phase II|Death|0|||
157074945|NCT04996004|567028979|FG001|Phase II|Death|0|||
157074946|NCT04996004|567028980|FG002|Phase II|Death|0|||
157074947|NCT04996004|567028981|FG003|Phase II|Death|12|||
157074948|NCT04996004|567028982|FG004|Phase II|Death|2|||
157074949|NCT04996004|567028983|FG005|Phase II|Death|9|||
157074950|NCT04996004|567028978|FG000|Phase II|Other|0|||
157074951|NCT04996004|567028979|FG001|Phase II|Other|0|||
157074952|NCT04996004|567028980|FG002|Phase II|Other|0|||
157074953|NCT04996004|567028981|FG003|Phase II|Other|0|||
157074954|NCT04996004|567028982|FG004|Phase II|Other|0|||
157074955|NCT04996004|567028983|FG005|Phase II|Other|1|||
157074956|NCT05543174|567028984|FG000|Overall Study|Ongoing|7|||
157074957|NCT03374488|567028986|FG000|Overall Study|Death|13|||
157074958|NCT03374488|567028987|FG001|Overall Study|Death|13|||
157074959|NCT03374488|567028986|FG000|Overall Study|Withdrawal by Subject|3|||
157074960|NCT03374488|567028987|FG001|Overall Study|Withdrawal by Subject|1|||
157074961|NCT03374488|567028986|FG000|Overall Study|Physician Decision|3|||
157074962|NCT03374488|567028987|FG001|Overall Study|Physician Decision|0|||
157074963|NCT03104075|567028988|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
157074964|NCT03104075|567028989|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
157192619|NCT00672490|567447127|FG000|Overall Study|Withdrawal by Subject|8|||
157192620|NCT00672490|567447128|FG001|Overall Study|Withdrawal by Subject|8|||
157074965|NCT00789360|567028992|FG000|Overall Study|Protocol Violation|3|||
157074966|NCT00789360|567028993|FG001|Overall Study|Protocol Violation|1|||
157074967|NCT03559062|567028994|FG000|Overall Study|Other|0|||
157074968|NCT03559062|567028995|FG001|Overall Study|Other|1|||
157074969|NCT03559062|567028996|FG002|Overall Study|Other|0|||
157074970|NCT01757197|567028997|FG000|Overall Study|Death|2|||
157074971|NCT00874731|567028998|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
157074972|NCT00874731|567028999|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
157074973|NCT00874731|567029000|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
157074974|NCT00874731|567028998|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
157074975|NCT00874731|567028999|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
157192621|NCT00672490|567447127|FG000|Overall Study|Lack of Compliance|2|||
157074976|NCT00874731|567029000|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
157074977|NCT00874731|567028998|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
157074978|NCT00874731|567028999|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
157074979|NCT00874731|567029000|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
157074980|NCT05105087|567029001|FG000|Overall Study|Withdrawal by Subject|2|||
157074981|NCT05105087|567029001|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
157074982|NCT00581477|567029006|FG000|Overall Study|Physician Decision|2|||
157074983|NCT00790205|567029009|FG000|Overall Study|Lost to Follow-up|61|||
157074984|NCT00790205|567029010|FG001|Overall Study|Lost to Follow-up|71|||
157074985|NCT00790205|567029009|FG000|Overall Study|Withdrawal by Subject|299|||
157074986|NCT00790205|567029010|FG001|Overall Study|Withdrawal by Subject|363|||
157074987|NCT03443414|567029011|FG000|Overall Study|Adverse Event|6|||
157074988|NCT03443414|567029012|FG001|Overall Study|Adverse Event|0|||
157074989|NCT03443414|567029013|FG002|Overall Study|Adverse Event|4|||
157074990|NCT03443414|567029014|FG003|Overall Study|Adverse Event|2|||
157074991|NCT03443414|567029015|FG004|Overall Study|Adverse Event|3|||
157074992|NCT03443414|567029011|FG000|Overall Study|Withdrawal by Subject|3|||
157074993|NCT03443414|567029012|FG001|Overall Study|Withdrawal by Subject|2|||
157074994|NCT03443414|567029013|FG002|Overall Study|Withdrawal by Subject|2|||
157074995|NCT03443414|567029014|FG003|Overall Study|Withdrawal by Subject|2|||
157074996|NCT03443414|567029015|FG004|Overall Study|Withdrawal by Subject|1|||
157074997|NCT03443414|567029011|FG000|Overall Study|Death|0|||
157074998|NCT03443414|567029012|FG001|Overall Study|Death|1|||
157074999|NCT03443414|567029013|FG002|Overall Study|Death|0|||
157075000|NCT03443414|567029014|FG003|Overall Study|Death|1|||
157075001|NCT03443414|567029015|FG004|Overall Study|Death|0|||
157075002|NCT03443414|567029011|FG000|Overall Study|Reason not specified|2|||
157075003|NCT03443414|567029012|FG001|Overall Study|Reason not specified|0|||
157075004|NCT03443414|567029013|FG002|Overall Study|Reason not specified|0|||
157075005|NCT03443414|567029014|FG003|Overall Study|Reason not specified|0|||
157075006|NCT03443414|567029015|FG004|Overall Study|Reason not specified|1|||
157075007|NCT03933462|567029016|FG000|Overall Study|Adverse Event|2|||
157075008|NCT03933462|567029017|FG001|Overall Study|Adverse Event|0|||
157075009|NCT01266161|567029024|FG000|Overall Study|Ineligible|1|||
157075010|NCT01266161|567029025|FG001|Overall Study|Ineligible|0|||
157075011|NCT01266161|567029024|FG000|Overall Study|Lack of Efficacy|0|||
157075012|NCT01266161|567029025|FG001|Overall Study|Lack of Efficacy|1|||
157075013|NCT01266161|567029024|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
157075014|NCT01266161|567029025|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
157075015|NCT04805073|567029031|FG000|Overall Study|study personnel not available|2|||
157075016|NCT04805073|567029032|FG001|Overall Study|study personnel not available|0|||
157075017|NCT04805073|567029031|FG000|Overall Study|spinal anesthesia failure|0|||
157075018|NCT04805073|567029032|FG001|Overall Study|spinal anesthesia failure|1|||
157075019|NCT04805073|567029031|FG000|Overall Study|Lost to Follow-up|0|||
157075020|NCT04805073|567029032|FG001|Overall Study|Lost to Follow-up|2|||
157075021|NCT01485120|567029036|FG000|Overall Study|Withdrawal by Subject|2|||
157075022|NCT00422734|567029037|FG000|Overall Study|Physician Decision|1|||
157075023|NCT00422734|567029038|FG001|Overall Study|Physician Decision|1|||
157075024|NCT00422734|567029037|FG000|Overall Study|Protocol Violation|1|||
157075025|NCT00422734|567029038|FG001|Overall Study|Protocol Violation|6|||
157075026|NCT00422734|567029037|FG000|Overall Study|Withdrawal by Subject|12|||
157075027|NCT00422734|567029038|FG001|Overall Study|Withdrawal by Subject|8|||
157075028|NCT00422734|567029037|FG000|Overall Study|Adverse Event|0|||
157075029|NCT00422734|567029038|FG001|Overall Study|Adverse Event|3|||
157075030|NCT00422734|567029037|FG000|Overall Study|Partner Decision|0|||
157075031|NCT00422734|567029038|FG001|Overall Study|Partner Decision|3|||
157075032|NCT02344342|567029039|FG000|Overall Study|Industry partner dropped out|11|||
157075033|NCT02344342|567029040|FG001|Overall Study|Industry partner dropped out|9|||
157075034|NCT02344342|567029041|FG002|Overall Study|Industry partner dropped out|14|||
157075035|NCT02344342|567029042|FG003|Overall Study|Industry partner dropped out|10|||
157075036|NCT00848484|567029043|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
157075037|NCT00848484|567029044|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
157075038|NCT00848484|567029043|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
157075039|NCT00848484|567029044|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
157075040|NCT00848484|567029043|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
157075041|NCT00848484|567029044|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
157075042|NCT00848484|567029043|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
157075043|NCT00848484|567029044|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
157075044|NCT00848484|567029043|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
157075045|NCT00848484|567029044|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
157075046|NCT03355209|567029045|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
157075047|NCT03355209|567029046|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
157075048|NCT03355209|567029047|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
157075049|NCT03355209|567029048|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
157075050|NCT03355209|567029049|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
157075051|NCT03355209|567029050|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
157075052|NCT03355209|567029045|FG000|Part 1: Double-Blind Period|Death|0|||
157075053|NCT03355209|567029046|FG001|Part 1: Double-Blind Period|Death|0|||
157075054|NCT03355209|567029047|FG002|Part 1: Double-Blind Period|Death|1|||
157075055|NCT03355209|567029048|FG003|Part 1: Double-Blind Period|Death|0|||
157075056|NCT03355209|567029049|FG004|Part 1: Double-Blind Period|Death|0|||
157075057|NCT03355209|567029050|FG005|Part 1: Double-Blind Period|Death|0|||
157075058|NCT03355209|567029045|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
157075059|NCT03355209|567029046|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
157075060|NCT03355209|567029047|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
157075061|NCT03355209|567029048|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
157075062|NCT03355209|567029049|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
157075063|NCT03355209|567029050|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
157075064|NCT03355209|567029045|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
157075065|NCT03355209|567029046|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
157075066|NCT03355209|567029047|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
157075067|NCT03355209|567029048|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
157075068|NCT03355209|567029049|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
157075069|NCT03355209|567029050|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
157075070|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
157075071|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
157075072|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
157075073|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
157075074|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
157075075|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
157075076|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
157075077|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
157075078|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
157075079|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
157075080|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
157075081|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
157075082|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
157075083|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
157075084|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
157075085|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
157075086|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
157075087|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
157075088|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
157075089|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
157075090|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
157075091|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
157075092|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
157075093|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
157075094|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
157075095|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
157075096|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
157075097|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157075098|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
157075099|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
157075100|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
157075101|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
157075102|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
157075103|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
157075104|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
157075105|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
157075106|NCT03355209|567029045|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
157075107|NCT03355209|567029046|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
157075108|NCT03355209|567029047|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
157075109|NCT03355209|567029048|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
157075110|NCT03355209|567029049|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
157075111|NCT03355209|567029050|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
157075112|NCT01081886|567029051|FG000|Overall Study|Study termination|11|||
157075113|NCT01081886|567029052|FG001|Overall Study|Study termination|13|||
157075114|NCT03017742|567029055|FG000|Overall Study|Protocol Violation|36|||
157075115|NCT03017742|567029055|FG000|Overall Study|Withdrawal by Subject|37|||
157075116|NCT02975102|567029056|FG000|Overall Study|Adverse Event|2|||
157075117|NCT02975102|567029057|FG001|Overall Study|Adverse Event|1|||
157075118|NCT05262751|567029060|FG000|Washout Period 2|Adverse Event|1|||
157075119|NCT05262751|567029061|FG001|Washout Period 2|Adverse Event|0|||
157075120|NCT05262751|567029062|FG002|Washout Period 2|Adverse Event|0|||
157075121|NCT05262751|567029063|FG003|Washout Period 2|Adverse Event|0|||
157075122|NCT05262751|567029064|FG004|Washout Period 2|Adverse Event|0|||
157075123|NCT05262751|567029065|FG005|Washout Period 2|Adverse Event|0|||
157075124|NCT05262751|567029060|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
157075125|NCT05262751|567029061|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
157075126|NCT05262751|567029062|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
157075127|NCT05262751|567029063|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
157075128|NCT05262751|567029064|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
157075129|NCT05262751|567029065|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
157075130|NCT03690427|567029066|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
157075131|NCT03690427|567029067|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
157075132|NCT03519204|567029070|FG000|Overall Study|Lost to Follow-up|3|||
157075133|NCT03519204|567029071|FG001|Overall Study|Lost to Follow-up|8|||
157075134|NCT03519204|567029070|FG000|Overall Study|Withdrawal by Subject|9|||
157075135|NCT03519204|567029071|FG001|Overall Study|Withdrawal by Subject|7|||
157075136|NCT03519204|567029070|FG000|Overall Study|Other Miscellaneous Reasons|1|||
157075137|NCT03519204|567029071|FG001|Overall Study|Other Miscellaneous Reasons|0|||
157075138|NCT02956837|567029072|FG000|Overall Study|Serious Adverse Events|0|||
157075139|NCT02956837|567029073|FG001|Overall Study|Serious Adverse Events|1|||
157075140|NCT02956837|567029074|FG002|Overall Study|Serious Adverse Events|0|||
157075141|NCT02956837|567029075|FG003|Overall Study|Serious Adverse Events|0|||
157075142|NCT02956837|567029072|FG000|Overall Study|Withdrawal by Subject|0|||
157075143|NCT02956837|567029073|FG001|Overall Study|Withdrawal by Subject|1|||
157075144|NCT02956837|567029074|FG002|Overall Study|Withdrawal by Subject|0|||
157075145|NCT02956837|567029075|FG003|Overall Study|Withdrawal by Subject|3|||
157075146|NCT02956837|567029072|FG000|Overall Study|Lost to Follow-up|0|||
157075147|NCT02956837|567029073|FG001|Overall Study|Lost to Follow-up|1|||
157075148|NCT02956837|567029074|FG002|Overall Study|Lost to Follow-up|2|||
157075149|NCT02956837|567029075|FG003|Overall Study|Lost to Follow-up|0|||
157075150|NCT02597712|567029076|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
157075151|NCT02597712|567029077|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
157075152|NCT02597712|567029076|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
157075153|NCT02597712|567029077|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
157075154|NCT02597712|567029076|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
157075155|NCT02597712|567029077|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
157075156|NCT01727505|567029085|FG000|First 24 Hours|Adverse Event|0|||
157075157|NCT01727505|567029086|FG001|First 24 Hours|Adverse Event|1|||
157075158|NCT01727505|567029085|FG000|Second 24 Hours|Missing data|0|||
157075159|NCT01727505|567029086|FG001|Second 24 Hours|Missing data|1|||
157075160|NCT02637323|567029088|FG000|Overall Study|Lost to Follow-up|2|||
157075161|NCT02637323|567029089|FG001|Overall Study|Lost to Follow-up|0|||
157075162|NCT02637323|567029088|FG000|Overall Study|Protocol Violation|0|||
157075163|NCT02637323|567029089|FG001|Overall Study|Protocol Violation|1|||
157075164|NCT01154140|567029090|FG000|Overall Study|Death|71|||
157075165|NCT01154140|567029091|FG001|Overall Study|Death|81|||
157075166|NCT01154140|567029090|FG000|Overall Study|Lost to Follow-up|4|||
157075167|NCT01154140|567029091|FG001|Overall Study|Lost to Follow-up|5|||
157075168|NCT01154140|567029090|FG000|Overall Study|Withdrawal by Subject|12|||
157075169|NCT01154140|567029091|FG001|Overall Study|Withdrawal by Subject|13|||
157075170|NCT01154140|567029090|FG000|Overall Study|Other|3|||
157075171|NCT01154140|567029091|FG001|Overall Study|Other|1|||
157075172|NCT01154140|567029090|FG000|Overall Study|Randomized but not treated|1|||
157075173|NCT01154140|567029091|FG001|Overall Study|Randomized but not treated|2|||
157075174|NCT00358644|567029092|FG000|Overall Study|Progressive Disease|21|||
157075175|NCT00358644|567029092|FG000|Overall Study|Adverse Event|7|||
157075176|NCT00358644|567029092|FG000|Overall Study|Death|11|||
157075177|NCT00358644|567029092|FG000|Overall Study|Withdrawal by Subject|4|||
157075178|NCT00358644|567029092|FG000|Overall Study|Physician Decision|6|||
157075179|NCT00358644|567029092|FG000|Overall Study|Patient not eligible for study|1|||
157075180|NCT00513708|567029093|FG000|Overall Study|Lost to Follow-up|4|||
157075181|NCT00513708|567029094|FG001|Overall Study|Lost to Follow-up|4|||
157075182|NCT00513708|567029095|FG002|Overall Study|Lost to Follow-up|4|||
157075183|NCT03327831|567029096|FG000|Overall Study|Lost to Follow-up|2|||
157075184|NCT00368875|567029097|FG000|Overall Study|Adverse Event|0|||
157075185|NCT00368875|567029098|FG001|Overall Study|Adverse Event|12|||
157075186|NCT00368875|567029097|FG000|Overall Study|Progressive disease|3|||
157075187|NCT00368875|567029098|FG001|Overall Study|Progressive disease|27|||
157075188|NCT00368875|567029097|FG000|Overall Study|Withdrawal by Subject|2|||
157075189|NCT00368875|567029098|FG001|Overall Study|Withdrawal by Subject|6|||
157075190|NCT00368875|567029097|FG000|Overall Study|Other Reason|0|||
157075191|NCT00368875|567029098|FG001|Overall Study|Other Reason|2|||
157075192|NCT00368875|567029097|FG000|Overall Study|Alternative Therapy|1|||
157075193|NCT00368875|567029098|FG001|Overall Study|Alternative Therapy|1|||
157075194|NCT01564277|567029099|FG000|Overall Study|Protocol Violation|0|||
157075195|NCT01564277|567029100|FG001|Overall Study|Protocol Violation|1|||
157075196|NCT01564277|567029099|FG000|Overall Study|Physician Decision|1|||
157075197|NCT01564277|567029100|FG001|Overall Study|Physician Decision|0|||
157075198|NCT02595372|567029101|FG000|Overall Study|Adverse Event|6|||
157075199|NCT02595372|567029101|FG000|Overall Study|Physician Decision|2|||
157075200|NCT02595372|567029101|FG000|Overall Study|Disease Progression|1|||
157075201|NCT01594970|567029104|FG000|Overall Study|Non-Adverse Event Related|4|||
157075202|NCT01594970|567029105|FG001|Overall Study|Non-Adverse Event Related|5|||
157075203|NCT01594970|567029106|FG002|Overall Study|Non-Adverse Event Related|6|||
157075204|NCT01594970|567029104|FG000|Overall Study|Adverse Event|17|||
157075205|NCT01594970|567029105|FG001|Overall Study|Adverse Event|23|||
157075206|NCT01594970|567029106|FG002|Overall Study|Adverse Event|23|||
157075207|NCT01594970|567029104|FG000|Overall Study|Lost to Follow-up|54|||
157075208|NCT01594970|567029105|FG001|Overall Study|Lost to Follow-up|54|||
157075209|NCT01594970|567029106|FG002|Overall Study|Lost to Follow-up|37|||
157075210|NCT00401258|567029107|FG000|Overall Study|Adverse Event|7|||
157075211|NCT00243074|567029110|FG000|Overall Study|Ineligible|6|||
157075212|NCT00243074|567029110|FG000|Overall Study|Adverse Event|6|||
157075213|NCT00243074|567029110|FG000|Overall Study|Withdrawal by Subject|2|||
157075214|NCT00243074|567029110|FG000|Overall Study|Lack of Efficacy|36|||
157075215|NCT00243074|567029110|FG000|Overall Study|Death|2|||
157075216|NCT00243074|567029110|FG000|Overall Study|not protocol specified|1|||
157075217|NCT00243074|567029110|FG000|Overall Study|Did not receive any treatment|1|||
157075218|NCT00344032|567029111|FG000|Overall Study|Adverse Event|0|||
157075219|NCT00344032|567029112|FG001|Overall Study|Adverse Event|1|||
157075220|NCT00344032|567029111|FG000|Overall Study|Withdrawal by Subject|6|||
157075221|NCT00344032|567029112|FG001|Overall Study|Withdrawal by Subject|2|||
157075222|NCT00344032|567029111|FG000|Overall Study|Lost to Follow-up|4|||
157075223|NCT00344032|567029112|FG001|Overall Study|Lost to Follow-up|6|||
157075224|NCT00344032|567029111|FG000|Overall Study|Physician Decision|4|||
157075225|NCT00344032|567029112|FG001|Overall Study|Physician Decision|1|||
157075226|NCT05131477|567029115|FG000|PART 1|Withdrawal by Subject|2|||
157075227|NCT05131477|567029116|FG001|PART 1|Withdrawal by Subject|9|||
157075228|NCT05131477|567029117|FG002|PART 1|Withdrawal by Subject|6|||
157075229|NCT05131477|567029118|FG003|PART 1|Withdrawal by Subject|2|||
157075230|NCT05131477|567029119|FG004|PART 1|Withdrawal by Subject|8|||
157075231|NCT05131477|567029120|FG005|PART 1|Withdrawal by Subject|0|||
157075232|NCT05131477|567029121|FG006|PART 1|Withdrawal by Subject|0|||
157075233|NCT05131477|567029122|FG007|PART 1|Withdrawal by Subject|0|||
157075234|NCT05131477|567029123|FG008|PART 1|Withdrawal by Subject|0|||
157075235|NCT05131477|567029124|FG009|PART 1|Withdrawal by Subject|0|||
157075236|NCT05131477|567029125|FG010|PART 1|Withdrawal by Subject|0|||
157075237|NCT05131477|567029126|FG011|PART 1|Withdrawal by Subject|0|||
157075238|NCT05131477|567029127|FG012|PART 1|Withdrawal by Subject|0|||
157075239|NCT05131477|567029128|FG013|PART 1|Withdrawal by Subject|0|||
157075240|NCT05131477|567029115|FG000|PART 1|Physician Decision|1|||
157075241|NCT05131477|567029116|FG001|PART 1|Physician Decision|0|||
157075242|NCT05131477|567029117|FG002|PART 1|Physician Decision|0|||
157075243|NCT05131477|567029118|FG003|PART 1|Physician Decision|0|||
157075244|NCT05131477|567029119|FG004|PART 1|Physician Decision|0|||
157075245|NCT05131477|567029120|FG005|PART 1|Physician Decision|0|||
157075246|NCT05131477|567029121|FG006|PART 1|Physician Decision|0|||
157075247|NCT05131477|567029122|FG007|PART 1|Physician Decision|0|||
157075248|NCT05131477|567029123|FG008|PART 1|Physician Decision|0|||
157075249|NCT05131477|567029124|FG009|PART 1|Physician Decision|0|||
157075250|NCT05131477|567029125|FG010|PART 1|Physician Decision|0|||
157075251|NCT05131477|567029126|FG011|PART 1|Physician Decision|0|||
157075252|NCT05131477|567029127|FG012|PART 1|Physician Decision|0|||
157075253|NCT05131477|567029128|FG013|PART 1|Physician Decision|0|||
157075254|NCT05131477|567029115|FG000|PART 1|Adverse Event|3|||
157075255|NCT05131477|567029116|FG001|PART 1|Adverse Event|5|||
157075256|NCT05131477|567029117|FG002|PART 1|Adverse Event|1|||
157075257|NCT05131477|567029118|FG003|PART 1|Adverse Event|6|||
157075258|NCT05131477|567029119|FG004|PART 1|Adverse Event|4|||
157075259|NCT05131477|567029120|FG005|PART 1|Adverse Event|0|||
157075260|NCT05131477|567029121|FG006|PART 1|Adverse Event|0|||
157075261|NCT05131477|567029122|FG007|PART 1|Adverse Event|0|||
157075262|NCT05131477|567029123|FG008|PART 1|Adverse Event|0|||
157075263|NCT05131477|567029124|FG009|PART 1|Adverse Event|0|||
157075264|NCT05131477|567029125|FG010|PART 1|Adverse Event|0|||
157075265|NCT05131477|567029126|FG011|PART 1|Adverse Event|0|||
157075266|NCT05131477|567029127|FG012|PART 1|Adverse Event|0|||
157075267|NCT05131477|567029128|FG013|PART 1|Adverse Event|0|||
157075268|NCT05131477|567029115|FG000|PART 1|unclassified|1|||
157075269|NCT05131477|567029116|FG001|PART 1|unclassified|1|||
157075270|NCT05131477|567029117|FG002|PART 1|unclassified|0|||
157075271|NCT05131477|567029118|FG003|PART 1|unclassified|0|||
157075272|NCT05131477|567029119|FG004|PART 1|unclassified|4|||
157075273|NCT05131477|567029120|FG005|PART 1|unclassified|0|||
157075274|NCT05131477|567029121|FG006|PART 1|unclassified|0|||
157075275|NCT05131477|567029122|FG007|PART 1|unclassified|0|||
157075276|NCT05131477|567029123|FG008|PART 1|unclassified|0|||
157075277|NCT05131477|567029124|FG009|PART 1|unclassified|0|||
157075278|NCT05131477|567029125|FG010|PART 1|unclassified|0|||
157075279|NCT05131477|567029126|FG011|PART 1|unclassified|0|||
157075280|NCT05131477|567029127|FG012|PART 1|unclassified|0|||
157075281|NCT05131477|567029128|FG013|PART 1|unclassified|0|||
157075282|NCT05131477|567029115|FG000|PART 1|Randomized and not treated|0|||
157075283|NCT05131477|567029116|FG001|PART 1|Randomized and not treated|0|||
157075284|NCT05131477|567029117|FG002|PART 1|Randomized and not treated|0|||
157075285|NCT05131477|567029118|FG003|PART 1|Randomized and not treated|1|||
157075286|NCT05131477|567029119|FG004|PART 1|Randomized and not treated|1|||
157075287|NCT05131477|567029120|FG005|PART 1|Randomized and not treated|0|||
157075288|NCT05131477|567029121|FG006|PART 1|Randomized and not treated|0|||
157075289|NCT05131477|567029122|FG007|PART 1|Randomized and not treated|0|||
157075290|NCT05131477|567029123|FG008|PART 1|Randomized and not treated|0|||
157075291|NCT05131477|567029124|FG009|PART 1|Randomized and not treated|0|||
157075292|NCT05131477|567029125|FG010|PART 1|Randomized and not treated|0|||
157075293|NCT05131477|567029126|FG011|PART 1|Randomized and not treated|0|||
157075294|NCT05131477|567029127|FG012|PART 1|Randomized and not treated|0|||
157075295|NCT05131477|567029128|FG013|PART 1|Randomized and not treated|0|||
157075296|NCT05131477|567029115|FG000|PART 1|Protocol Violation|2|||
157075297|NCT05131477|567029116|FG001|PART 1|Protocol Violation|0|||
157075298|NCT05131477|567029117|FG002|PART 1|Protocol Violation|0|||
157075299|NCT05131477|567029118|FG003|PART 1|Protocol Violation|1|||
157075300|NCT05131477|567029119|FG004|PART 1|Protocol Violation|0|||
157075301|NCT05131477|567029120|FG005|PART 1|Protocol Violation|0|||
157075302|NCT05131477|567029121|FG006|PART 1|Protocol Violation|0|||
157075303|NCT05131477|567029122|FG007|PART 1|Protocol Violation|0|||
157075304|NCT05131477|567029123|FG008|PART 1|Protocol Violation|0|||
157075305|NCT05131477|567029124|FG009|PART 1|Protocol Violation|0|||
157075306|NCT05131477|567029125|FG010|PART 1|Protocol Violation|0|||
157075307|NCT05131477|567029126|FG011|PART 1|Protocol Violation|0|||
157075308|NCT05131477|567029127|FG012|PART 1|Protocol Violation|0|||
157075309|NCT05131477|567029128|FG013|PART 1|Protocol Violation|0|||
157075310|NCT05131477|567029115|FG000|PART 1|Lack of Efficacy|0|||
157075311|NCT05131477|567029116|FG001|PART 1|Lack of Efficacy|1|||
157075312|NCT05131477|567029117|FG002|PART 1|Lack of Efficacy|1|||
157075313|NCT05131477|567029118|FG003|PART 1|Lack of Efficacy|2|||
157075314|NCT05131477|567029119|FG004|PART 1|Lack of Efficacy|5|||
157075315|NCT05131477|567029120|FG005|PART 1|Lack of Efficacy|0|||
157075316|NCT05131477|567029121|FG006|PART 1|Lack of Efficacy|0|||
157075317|NCT05131477|567029122|FG007|PART 1|Lack of Efficacy|0|||
157075318|NCT05131477|567029123|FG008|PART 1|Lack of Efficacy|0|||
157075319|NCT05131477|567029124|FG009|PART 1|Lack of Efficacy|0|||
157075320|NCT05131477|567029125|FG010|PART 1|Lack of Efficacy|0|||
157075321|NCT05131477|567029126|FG011|PART 1|Lack of Efficacy|0|||
157075322|NCT05131477|567029127|FG012|PART 1|Lack of Efficacy|0|||
157075323|NCT05131477|567029128|FG013|PART 1|Lack of Efficacy|0|||
157075324|NCT05131477|567029115|FG000|PART 2|Withdrawal by Subject|0|||
157075325|NCT05131477|567029116|FG001|PART 2|Withdrawal by Subject|0|||
157075326|NCT05131477|567029117|FG002|PART 2|Withdrawal by Subject|0|||
157075327|NCT05131477|567029118|FG003|PART 2|Withdrawal by Subject|0|||
157075328|NCT05131477|567029119|FG004|PART 2|Withdrawal by Subject|0|||
157075329|NCT05131477|567029120|FG005|PART 2|Withdrawal by Subject|0|||
157075330|NCT05131477|567029121|FG006|PART 2|Withdrawal by Subject|2|||
157075331|NCT05131477|567029122|FG007|PART 2|Withdrawal by Subject|0|||
157075332|NCT05131477|567029123|FG008|PART 2|Withdrawal by Subject|0|||
157075333|NCT05131477|567029124|FG009|PART 2|Withdrawal by Subject|0|||
157075334|NCT05131477|567029125|FG010|PART 2|Withdrawal by Subject|2|||
157075335|NCT05131477|567029126|FG011|PART 2|Withdrawal by Subject|0|||
157075336|NCT05131477|567029127|FG012|PART 2|Withdrawal by Subject|2|||
157075337|NCT05131477|567029128|FG013|PART 2|Withdrawal by Subject|2|||
157075338|NCT05131477|567029115|FG000|PART 2|Other|0|||
157075339|NCT05131477|567029116|FG001|PART 2|Other|0|||
157075340|NCT05131477|567029117|FG002|PART 2|Other|0|||
157075341|NCT05131477|567029118|FG003|PART 2|Other|0|||
157075342|NCT05131477|567029119|FG004|PART 2|Other|0|||
157075343|NCT05131477|567029120|FG005|PART 2|Other|0|||
157075344|NCT05131477|567029121|FG006|PART 2|Other|0|||
157075345|NCT05131477|567029122|FG007|PART 2|Other|0|||
157075346|NCT05131477|567029123|FG008|PART 2|Other|1|||
157075347|NCT05131477|567029124|FG009|PART 2|Other|1|||
157075348|NCT05131477|567029125|FG010|PART 2|Other|0|||
157075349|NCT05131477|567029126|FG011|PART 2|Other|0|||
157075350|NCT05131477|567029127|FG012|PART 2|Other|1|||
157075351|NCT05131477|567029128|FG013|PART 2|Other|0|||
157075352|NCT05131477|567029115|FG000|PART 2|Lack of Efficacy|0|||
157075353|NCT05131477|567029116|FG001|PART 2|Lack of Efficacy|0|||
157075354|NCT05131477|567029117|FG002|PART 2|Lack of Efficacy|0|||
157075355|NCT05131477|567029118|FG003|PART 2|Lack of Efficacy|0|||
157075356|NCT05131477|567029119|FG004|PART 2|Lack of Efficacy|0|||
157075357|NCT05131477|567029120|FG005|PART 2|Lack of Efficacy|1|||
157075358|NCT05131477|567029121|FG006|PART 2|Lack of Efficacy|1|||
157075359|NCT05131477|567029122|FG007|PART 2|Lack of Efficacy|0|||
157075360|NCT05131477|567029123|FG008|PART 2|Lack of Efficacy|3|||
157075361|NCT05131477|567029124|FG009|PART 2|Lack of Efficacy|0|||
157075362|NCT05131477|567029125|FG010|PART 2|Lack of Efficacy|1|||
157075363|NCT05131477|567029126|FG011|PART 2|Lack of Efficacy|0|||
157075364|NCT05131477|567029127|FG012|PART 2|Lack of Efficacy|2|||
157075365|NCT05131477|567029128|FG013|PART 2|Lack of Efficacy|0|||
157075366|NCT05131477|567029115|FG000|PART 2|Unclassified|0|||
157075367|NCT05131477|567029116|FG001|PART 2|Unclassified|0|||
157075368|NCT05131477|567029117|FG002|PART 2|Unclassified|0|||
157075369|NCT05131477|567029118|FG003|PART 2|Unclassified|0|||
157075370|NCT05131477|567029119|FG004|PART 2|Unclassified|0|||
157075371|NCT05131477|567029120|FG005|PART 2|Unclassified|0|||
157075372|NCT05131477|567029121|FG006|PART 2|Unclassified|0|||
157075373|NCT05131477|567029122|FG007|PART 2|Unclassified|0|||
157075374|NCT05131477|567029123|FG008|PART 2|Unclassified|0|||
157075375|NCT05131477|567029124|FG009|PART 2|Unclassified|0|||
157075376|NCT05131477|567029125|FG010|PART 2|Unclassified|1|||
157075377|NCT05131477|567029126|FG011|PART 2|Unclassified|0|||
157075378|NCT05131477|567029127|FG012|PART 2|Unclassified|0|||
157075379|NCT05131477|567029128|FG013|PART 2|Unclassified|0|||
157075380|NCT05131477|567029115|FG000|PART 2|Re-randomized and not treated|0|||
157075381|NCT05131477|567029116|FG001|PART 2|Re-randomized and not treated|0|||
157075382|NCT05131477|567029117|FG002|PART 2|Re-randomized and not treated|0|||
157075383|NCT05131477|567029118|FG003|PART 2|Re-randomized and not treated|0|||
157075384|NCT05131477|567029119|FG004|PART 2|Re-randomized and not treated|0|||
157075385|NCT05131477|567029120|FG005|PART 2|Re-randomized and not treated|0|||
157075386|NCT05131477|567029121|FG006|PART 2|Re-randomized and not treated|0|||
157075387|NCT05131477|567029122|FG007|PART 2|Re-randomized and not treated|1|||
157075388|NCT05131477|567029123|FG008|PART 2|Re-randomized and not treated|0|||
157075389|NCT05131477|567029124|FG009|PART 2|Re-randomized and not treated|0|||
157075390|NCT05131477|567029125|FG010|PART 2|Re-randomized and not treated|1|||
157075391|NCT05131477|567029126|FG011|PART 2|Re-randomized and not treated|0|||
157075392|NCT05131477|567029127|FG012|PART 2|Re-randomized and not treated|1|||
157075393|NCT05131477|567029128|FG013|PART 2|Re-randomized and not treated|1|||
157075394|NCT02194829|567029129|FG000|Overall Study|Adverse Event|2|||
157075395|NCT02194829|567029130|FG001|Overall Study|Adverse Event|2|||
157075396|NCT02194829|567029129|FG000|Overall Study|Death|0|||
157075397|NCT02194829|567029130|FG001|Overall Study|Death|1|||
157075398|NCT02194829|567029129|FG000|Overall Study|Disease progression|0|||
157075399|NCT02194829|567029130|FG001|Overall Study|Disease progression|1|||
157075400|NCT02194829|567029129|FG000|Overall Study|Withdrawal by Subject|0|||
157075401|NCT02194829|567029130|FG001|Overall Study|Withdrawal by Subject|1|||
157075402|NCT02194829|567029129|FG000|Overall Study|Never started protocol therapy|0|||
157075403|NCT02194829|567029130|FG001|Overall Study|Never started protocol therapy|1|||
157075404|NCT02473965|567030656|FG000|Overall Study|Adverse Event|6|||
157075405|NCT02473965|567030657|FG001|Overall Study|Adverse Event|4|||
157075406|NCT02473965|567030656|FG000|Overall Study|MG worsening|4|||
157075407|NCT02473965|567030657|FG001|Overall Study|MG worsening|1|||
157075408|NCT02473965|567030656|FG000|Overall Study|Withdrawal by Subject|2|||
157075409|NCT02473965|567030657|FG001|Overall Study|Withdrawal by Subject|3|||
157075410|NCT02473965|567030656|FG000|Overall Study|Physician Decision|0|||
157075411|NCT02473965|567030657|FG001|Overall Study|Physician Decision|2|||
157075412|NCT03816761|567030658|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
157075413|NCT03816761|567030659|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
157075414|NCT03816761|567030660|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
157075415|NCT03816761|567030661|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
157075416|NCT03816761|567030662|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
157075417|NCT03816761|567030663|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
157075418|NCT03816761|567030658|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
157075419|NCT03816761|567030659|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
157075420|NCT03816761|567030660|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
157075421|NCT03816761|567030661|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
157075422|NCT03816761|567030662|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
157075423|NCT03816761|567030663|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
157075424|NCT01920477|567030664|FG000|Overall Study|Adverse Event|0|||
157075425|NCT01920477|567030665|FG001|Overall Study|Adverse Event|1|||
157075426|NCT01920477|567030664|FG000|Overall Study|Lack of Efficacy|1|||
157075427|NCT01920477|567030665|FG001|Overall Study|Lack of Efficacy|0|||
157075428|NCT01920477|567030664|FG000|Overall Study|Study closed/terminated|14|||
157075429|NCT01920477|567030665|FG001|Overall Study|Study closed/terminated|15|||
157075430|NCT01920477|567030664|FG000|Overall Study|Withdrawal by Subject|0|||
157075431|NCT01920477|567030665|FG001|Overall Study|Withdrawal by Subject|1|||
157075432|NCT03926195|567030674|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
157075433|NCT03926195|567030675|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
157075434|NCT03926195|567030674|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
157231638|NCT00549718|567595316|FG003|Overall Study|Withdrawal by Subject|13|||
157231639|NCT00549718|567595313|FG000|Overall Study|Administrative|2|||
157075435|NCT03926195|567030675|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
157075436|NCT03926195|567030674|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
157075437|NCT03926195|567030675|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
157075438|NCT03926195|567030674|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
157075439|NCT03926195|567030675|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
157075440|NCT03926195|567030674|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
157075441|NCT03926195|567030675|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
157075442|NCT03926195|567030674|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
157075443|NCT03926195|567030675|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
157075444|NCT03054337|567030676|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
157075445|NCT03054337|567030677|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
157075446|NCT03054337|567030678|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
157075447|NCT03054337|567030679|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
157075448|NCT03054337|567030680|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
157075449|NCT03054337|567030681|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
157075450|NCT01661205|567030684|FG000|Overall Study|Physician Decision|2|||
157075451|NCT00955708|567030686|FG000|Overall Study|Death|269|||
157075452|NCT00955708|567030686|FG000|Overall Study|Lost to Follow-up|72|||
157075453|NCT00955708|567030686|FG000|Overall Study|Physician Decision|36|||
157075454|NCT00955708|567030686|FG000|Overall Study|Protocol Violation|134|||
157075455|NCT00955708|567030686|FG000|Overall Study|Registry Conclusion|186|||
157075456|NCT00955708|567030686|FG000|Overall Study|Product removed from service|94|||
157075457|NCT00955708|567030686|FG000|Overall Study|Patient Refused to participate further|116|||
157075458|NCT00955708|567030686|FG000|Overall Study|Closure of study location|60|||
157075459|NCT00955708|567030686|FG000|Overall Study|Patient changed care provider/moved|91|||
157075460|NCT01736540|567030687|FG000|Overall Study|Did not complete scan within 45 days|2|||
157075461|NCT01736540|567030687|FG000|Overall Study|Death|1|||
157075462|NCT01736540|567030687|FG000|Overall Study|Abnormal test procedure|1|||
157075463|NCT01736540|567030687|FG000|Overall Study|Withdrawal by Subject|5|||
157075464|NCT01736540|567030687|FG000|Overall Study|Protocol Violation|1|||
157075465|NCT01736540|567030687|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
157075466|NCT01736540|567030687|FG000|Overall Study|No show for MRI appointment|1|||
157075467|NCT01736540|567030687|FG000|Overall Study|Unable to make MRI appointment|3|||
157075468|NCT01735175|567030688|FG000|Overall Study|Withdrawal by Subject|9|||
157075469|NCT01735175|567030689|FG001|Overall Study|Withdrawal by Subject|2|||
157075470|NCT01735175|567030688|FG000|Overall Study|Lost to Follow-up|4|||
157075471|NCT01735175|567030689|FG001|Overall Study|Lost to Follow-up|2|||
157075472|NCT01735175|567030688|FG000|Overall Study|Death|3|||
157075473|NCT01735175|567030689|FG001|Overall Study|Death|2|||
157075474|NCT01735175|567030688|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
157075475|NCT01735175|567030689|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
157075476|NCT01031628|567030690|FG000|Overall Study|Study terminated early|0|||
157075477|NCT01031628|567030691|FG001|Overall Study|Study terminated early|1|||
157075478|NCT01031628|567030692|FG002|Overall Study|Study terminated early|3|||
157075479|NCT01031628|567030693|FG003|Overall Study|Study terminated early|0|||
157075480|NCT00755417|567030695|FG000|Overall Study|Adverse Event|28|||
157075481|NCT00755417|567030696|FG001|Overall Study|Adverse Event|20|||
157075482|NCT00755417|567030697|FG002|Overall Study|Adverse Event|7|||
157075483|NCT00755417|567030695|FG000|Overall Study|Lack of Efficacy|8|||
157075484|NCT00755417|567030696|FG001|Overall Study|Lack of Efficacy|4|||
157075485|NCT00755417|567030697|FG002|Overall Study|Lack of Efficacy|9|||
157075486|NCT00755417|567030695|FG000|Overall Study|Protocol Violation|2|||
157075487|NCT00755417|567030696|FG001|Overall Study|Protocol Violation|1|||
157075488|NCT00755417|567030697|FG002|Overall Study|Protocol Violation|1|||
157075489|NCT00755417|567030695|FG000|Overall Study|Lost to Follow-up|3|||
157075490|NCT00755417|567030696|FG001|Overall Study|Lost to Follow-up|0|||
157075491|NCT00755417|567030697|FG002|Overall Study|Lost to Follow-up|1|||
157075492|NCT00755417|567030695|FG000|Overall Study|Withdrawal by Subject|12|||
157075493|NCT00755417|567030696|FG001|Overall Study|Withdrawal by Subject|12|||
157075494|NCT00755417|567030697|FG002|Overall Study|Withdrawal by Subject|12|||
157075495|NCT00755417|567030695|FG000|Overall Study|Not specified or missing data|9|||
157075496|NCT00755417|567030696|FG001|Overall Study|Not specified or missing data|18|||
157075497|NCT00755417|567030697|FG002|Overall Study|Not specified or missing data|12|||
157075498|NCT02803593|567030699|FG000|Overall Study|Lost to Follow-up|17|||
157075499|NCT02803593|567030700|FG001|Overall Study|Lost to Follow-up|35|||
157075500|NCT05143138|567030701|FG000|Overall Study|Death|5|||
157075501|NCT05143138|567030702|FG001|Overall Study|Death|35|||
157075502|NCT05143138|567030703|FG002|Overall Study|Death|1|||
157075503|NCT05143138|567030701|FG000|Overall Study|Lost to Follow-up|2|||
157075504|NCT05143138|567030702|FG001|Overall Study|Lost to Follow-up|4|||
157075505|NCT05143138|567030703|FG002|Overall Study|Lost to Follow-up|0|||
157075506|NCT05143138|567030701|FG000|Overall Study|withdrawal|1|||
157075507|NCT05143138|567030702|FG001|Overall Study|withdrawal|1|||
157075508|NCT05143138|567030703|FG002|Overall Study|withdrawal|0|||
157075509|NCT04245345|567030706|FG000|Overall Study|Death|1|||
157075510|NCT04245345|567030706|FG000|Overall Study|Exited prior to implant|5|||
157075511|NCT04245345|567030706|FG000|Overall Study|Exited prior to 1-month|9|||
157075512|NCT04245345|567030706|FG000|Overall Study|Missed 1-month visit|3|||
157192622|NCT00672490|567447128|FG001|Overall Study|Lack of Compliance|7|||
157075513|NCT04245345|567030706|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
157075514|NCT04245345|567030706|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
157075515|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
157075516|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
157075517|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
157075518|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
157075519|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
157075520|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
157075521|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
157075522|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
157075523|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
157075524|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
157075525|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
157075526|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
157075527|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
157075528|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
157075529|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
157075530|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
157075531|NCT04210843|567030707|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
157075532|NCT04210843|567030708|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
157075533|NCT04210843|567030707|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
157075534|NCT04210843|567030708|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
157075535|NCT04210843|567030707|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
157075536|NCT04210843|567030708|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
157075537|NCT04210843|567030707|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
157075538|NCT04210843|567030708|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
157075539|NCT04210843|567030707|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
157075540|NCT04210843|567030708|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
157075541|NCT04210843|567030707|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
157075542|NCT04210843|567030708|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
157075543|NCT04210843|567030707|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
157075544|NCT04210843|567030708|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
157075545|NCT04210843|567030707|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
157192623|NCT00672490|567447127|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
157192624|NCT00672490|567447128|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
157192625|NCT00672490|567447127|FG000|Overall Study|Adverse Event|5|||
157192626|NCT00672490|567447128|FG001|Overall Study|Adverse Event|8|||
157192627|NCT00672490|567447127|FG000|Overall Study|Violation of Concomitant Medicine|1|||
157192628|NCT00672490|567447128|FG001|Overall Study|Violation of Concomitant Medicine|0|||
157192629|NCT00672490|567447127|FG000|Overall Study|Intolerance|0|||
157192630|NCT00672490|567447128|FG001|Overall Study|Intolerance|2|||
157192631|NCT00672490|567447127|FG000|Overall Study|Lost to Follow-up|1|||
157192632|NCT00672490|567447128|FG001|Overall Study|Lost to Follow-up|5|||
157192633|NCT00672490|567447127|FG000|Overall Study|No reason was provided|6|||
157192634|NCT00672490|567447128|FG001|Overall Study|No reason was provided|2|||
157192635|NCT01904760|567447135|FG000|Overall Study|Protocol Violation|1|||
157192636|NCT01904760|567447136|FG001|Overall Study|Protocol Violation|0|||
157192637|NCT04249076|567447148|FG000|Overall Study|Adverse Event|1|||
157192638|NCT04249076|567447149|FG001|Overall Study|Adverse Event|1|||
157192639|NCT04249076|567447148|FG000|Overall Study|Protocol Violation|1|||
157192640|NCT04249076|567447149|FG001|Overall Study|Protocol Violation|2|||
157192641|NCT04249076|567447148|FG000|Overall Study|Lack of Efficacy|0|||
157192642|NCT04249076|567447149|FG001|Overall Study|Lack of Efficacy|1|||
157192643|NCT04249076|567447148|FG000|Overall Study|Withdrawal by Subject|0|||
157192644|NCT04249076|567447149|FG001|Overall Study|Withdrawal by Subject|1|||
157192645|NCT00783263|567447150|FG000|Overall Study|Adverse Event|3|||
157192646|NCT00783263|567447151|FG001|Overall Study|Adverse Event|0|||
157192647|NCT00783263|567447152|FG002|Overall Study|Adverse Event|2|||
157192648|NCT00783263|567447153|FG003|Overall Study|Adverse Event|1|||
157192649|NCT00783263|567447150|FG000|Overall Study|Lost to Follow-up|1|||
157192650|NCT00783263|567447151|FG001|Overall Study|Lost to Follow-up|1|||
157231640|NCT00549718|567595314|FG001|Overall Study|Administrative|2|||
157231641|NCT00549718|567595315|FG002|Overall Study|Administrative|2|||
157231642|NCT00549718|567595316|FG003|Overall Study|Administrative|1|||
157075546|NCT04210843|567030708|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
157192651|NCT00783263|567447152|FG002|Overall Study|Lost to Follow-up|0|||
157192652|NCT00783263|567447153|FG003|Overall Study|Lost to Follow-up|0|||
157192653|NCT00783263|567447150|FG000|Overall Study|Withdrawal by Subject|0|||
157192654|NCT00783263|567447151|FG001|Overall Study|Withdrawal by Subject|1|||
157192655|NCT00783263|567447152|FG002|Overall Study|Withdrawal by Subject|1|||
157192656|NCT00783263|567447153|FG003|Overall Study|Withdrawal by Subject|2|||
157231643|NCT00746798|567595317|FG000|Overall Study|Protocol Violation|0|||
157075547|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
157075548|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
157075549|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
157075550|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
157075551|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
157075552|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
157075553|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
157075554|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
157075555|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
157075556|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
157075557|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
157075558|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
157075559|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
157075560|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
157075561|NCT04210843|567030707|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
157075562|NCT04210843|567030708|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
157075563|NCT01436305|567030709|FG000|Overall Study|Death|1|||
157075564|NCT01436305|567030710|FG001|Overall Study|Death|0|||
157075565|NCT01436305|567030711|FG002|Overall Study|Death|0|||
157075566|NCT01436305|567030709|FG000|Overall Study|Lost to Follow-up|0|||
157075567|NCT01436305|567030710|FG001|Overall Study|Lost to Follow-up|1|||
157075568|NCT01436305|567030711|FG002|Overall Study|Lost to Follow-up|0|||
157075569|NCT01436305|567030709|FG000|Overall Study|Withdrawal by Subject|1|||
157075570|NCT01436305|567030710|FG001|Overall Study|Withdrawal by Subject|3|||
157075571|NCT01436305|567030711|FG002|Overall Study|Withdrawal by Subject|0|||
157075572|NCT01261000|567030712|FG000|Overall Study|Screen failure|1|||
157075573|NCT01151215|567030713|FG000|Overall Study|Worsening of condition under study|1|||
157075574|NCT01151215|567030714|FG001|Overall Study|Worsening of condition under study|1|||
157075575|NCT01151215|567030715|FG002|Overall Study|Worsening of condition under study|1|||
157075576|NCT01151215|567030713|FG000|Overall Study|Death|16|||
157075577|NCT01151215|567030714|FG001|Overall Study|Death|20|||
157075578|NCT01151215|567030715|FG002|Overall Study|Death|11|||
157075579|NCT01151215|567030713|FG000|Overall Study|Lost to Follow-up|0|||
157075580|NCT01151215|567030714|FG001|Overall Study|Lost to Follow-up|0|||
157075581|NCT01151215|567030715|FG002|Overall Study|Lost to Follow-up|3|||
157075582|NCT01151215|567030713|FG000|Overall Study|Withdrawal by Subject|3|||
157075583|NCT01151215|567030714|FG001|Overall Study|Withdrawal by Subject|1|||
157075584|NCT01151215|567030715|FG002|Overall Study|Withdrawal by Subject|2|||
157075585|NCT01151215|567030713|FG000|Overall Study|Disease progression|0|||
157075586|NCT01151215|567030714|FG001|Overall Study|Disease progression|1|||
157075587|NCT01151215|567030715|FG002|Overall Study|Disease progression|1|||
157075588|NCT01151215|567030713|FG000|Overall Study|Safety as judged by the investigator|0|||
157075589|NCT01151215|567030714|FG001|Overall Study|Safety as judged by the investigator|0|||
157075590|NCT01151215|567030715|FG002|Overall Study|Safety as judged by the investigator|1|||
157075591|NCT01721954|567030719|FG000|Overall Study|Death|58|||
157075592|NCT01721954|567030720|FG001|Overall Study|Death|64|||
157075593|NCT01721954|567030719|FG000|Overall Study|Withdrawal by Subject|8|||
157075594|NCT01721954|567030720|FG001|Overall Study|Withdrawal by Subject|4|||
157075595|NCT01721954|567030719|FG000|Overall Study|Adverse Event|2|||
157075596|NCT01721954|567030720|FG001|Overall Study|Adverse Event|0|||
157075597|NCT01721954|567030719|FG000|Overall Study|Lost to Follow-up|2|||
157075598|NCT01721954|567030720|FG001|Overall Study|Lost to Follow-up|1|||
157075599|NCT04276051|567030725|FG000|Overall Study|Lost to Follow-up|0|||
157075600|NCT04276051|567030726|FG001|Overall Study|Lost to Follow-up|1|||
157075601|NCT04276051|567030725|FG000|Overall Study|Physician Decision|0|||
157075602|NCT04276051|567030726|FG001|Overall Study|Physician Decision|1|||
157192657|NCT00732199|567447154|FG000|Overall Study|Withdrawal by Subject|25|||
157192658|NCT00732199|567447155|FG001|Overall Study|Withdrawal by Subject|18|||
157192659|NCT00732199|567447154|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
157192660|NCT00732199|567447155|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
157192661|NCT02543801|567447167|FG000|Overall Study|Protocol Violation|1|||
157192662|NCT02543801|567447168|FG001|Overall Study|Protocol Violation|2|||
157192663|NCT02543801|567447169|FG002|Overall Study|Protocol Violation|0|||
157192664|NCT02543801|567447170|FG003|Overall Study|Protocol Violation|0|||
157192665|NCT00545740|567447171|FG000|Overall Study|Lack of Efficacy|34|||
157075603|NCT04276051|567030725|FG000|Overall Study|Withdrawal by Subject|1|||
157075604|NCT04276051|567030726|FG001|Overall Study|Withdrawal by Subject|1|||
157075605|NCT01374568|567030727|FG000|Overall Study|Lab unable to analyze BTM|0|||
157075606|NCT01374568|567030728|FG001|Overall Study|Lab unable to analyze BTM|2|||
157075607|NCT01299480|567030729|FG000|Overall Study|No longer willing to participate|19|||
157075608|NCT01299480|567030730|FG001|Overall Study|No longer willing to participate|17|||
157075609|NCT01299480|567030731|FG002|Overall Study|No longer willing to participate|14|||
157075610|NCT01299480|567030732|FG003|Overall Study|No longer willing to participate|13|||
157192666|NCT00545740|567447172|FG001|Overall Study|Lack of Efficacy|35|||
157075611|NCT01299480|567030733|FG004|Overall Study|No longer willing to participate|10|||
157075612|NCT01299480|567030729|FG000|Overall Study|Protocol Violation|7|||
157075613|NCT01299480|567030730|FG001|Overall Study|Protocol Violation|5|||
157075614|NCT01299480|567030731|FG002|Overall Study|Protocol Violation|8|||
157075615|NCT01299480|567030732|FG003|Overall Study|Protocol Violation|1|||
157075616|NCT01299480|567030733|FG004|Overall Study|Protocol Violation|1|||
157075617|NCT01299480|567030729|FG000|Overall Study|Withdrawal by Subject|3|||
157075618|NCT01299480|567030730|FG001|Overall Study|Withdrawal by Subject|4|||
157075619|NCT01299480|567030731|FG002|Overall Study|Withdrawal by Subject|7|||
157075620|NCT01299480|567030732|FG003|Overall Study|Withdrawal by Subject|3|||
157075621|NCT01299480|567030733|FG004|Overall Study|Withdrawal by Subject|4|||
157075622|NCT01299480|567030729|FG000|Overall Study|Adverse Event|6|||
157075623|NCT01299480|567030730|FG001|Overall Study|Adverse Event|4|||
157075624|NCT01299480|567030731|FG002|Overall Study|Adverse Event|5|||
157075625|NCT01299480|567030732|FG003|Overall Study|Adverse Event|4|||
157075626|NCT01299480|567030733|FG004|Overall Study|Adverse Event|0|||
157075627|NCT01299480|567030729|FG000|Overall Study|Withdrawal due to pregnancy|0|||
157075628|NCT01299480|567030730|FG001|Overall Study|Withdrawal due to pregnancy|1|||
157075629|NCT01299480|567030731|FG002|Overall Study|Withdrawal due to pregnancy|1|||
157075630|NCT01299480|567030732|FG003|Overall Study|Withdrawal due to pregnancy|0|||
157075631|NCT01299480|567030733|FG004|Overall Study|Withdrawal due to pregnancy|0|||
157075632|NCT01299480|567030729|FG000|Overall Study|Physician Decision|1|||
157075633|NCT01299480|567030730|FG001|Overall Study|Physician Decision|1|||
157075634|NCT01299480|567030731|FG002|Overall Study|Physician Decision|0|||
157075635|NCT01299480|567030732|FG003|Overall Study|Physician Decision|2|||
157075636|NCT01299480|567030733|FG004|Overall Study|Physician Decision|0|||
157075637|NCT01299480|567030729|FG000|Overall Study|Lost to Follow-up|3|||
157075638|NCT01299480|567030730|FG001|Overall Study|Lost to Follow-up|1|||
157075639|NCT01299480|567030731|FG002|Overall Study|Lost to Follow-up|2|||
157075640|NCT01299480|567030732|FG003|Overall Study|Lost to Follow-up|1|||
157075641|NCT01299480|567030733|FG004|Overall Study|Lost to Follow-up|2|||
157075642|NCT01299480|567030729|FG000|Overall Study|Other|3|||
157075643|NCT01299480|567030730|FG001|Overall Study|Other|2|||
157075644|NCT01299480|567030731|FG002|Overall Study|Other|3|||
157075645|NCT01299480|567030732|FG003|Overall Study|Other|0|||
157075646|NCT01299480|567030733|FG004|Overall Study|Other|3|||
157075647|NCT01299480|567030729|FG000|Overall Study|Started, but not vaccinated|0|||
157075648|NCT01299480|567030730|FG001|Overall Study|Started, but not vaccinated|0|||
157075649|NCT01299480|567030731|FG002|Overall Study|Started, but not vaccinated|1|||
157075650|NCT01299480|567030732|FG003|Overall Study|Started, but not vaccinated|1|||
157075651|NCT01299480|567030733|FG004|Overall Study|Started, but not vaccinated|0|||
157075652|NCT00617929|567030736|FG000|Overall Study|Physician Decision|1|||
157075653|NCT00760747|567030739|FG000|Study Period II|Adverse Event|3|||
157075654|NCT00760747|567030740|FG001|Study Period II|Adverse Event|4|||
157075655|NCT00760747|567030739|FG000|Study Period II|Lack of Efficacy|0|||
157075656|NCT00760747|567030740|FG001|Study Period II|Lack of Efficacy|6|||
157075657|NCT00760747|567030739|FG000|Study Period II|Parent/Caregiver Decision|3|||
157075658|NCT00760747|567030740|FG001|Study Period II|Parent/Caregiver Decision|0|||
157075659|NCT00760747|567030739|FG000|Study Period II|Protocol Violation|6|||
157075660|NCT00760747|567030740|FG001|Study Period II|Protocol Violation|3|||
157075661|NCT00760747|567030739|FG000|Study Period II|Withdrawal by Subject|1|||
157075662|NCT00760747|567030740|FG001|Study Period II|Withdrawal by Subject|0|||
157075663|NCT00760747|567030739|FG000|Study Period II|No drug administered|0|||
157192667|NCT00545740|567447173|FG002|Overall Study|Lack of Efficacy|47|||
157192668|NCT00545740|567447174|FG003|Overall Study|Lack of Efficacy|36|||
157192669|NCT00545740|567447171|FG000|Overall Study|Withdrawal by Subject|17|||
157192670|NCT00545740|567447172|FG001|Overall Study|Withdrawal by Subject|15|||
157192671|NCT00545740|567447173|FG002|Overall Study|Withdrawal by Subject|16|||
157192672|NCT00545740|567447174|FG003|Overall Study|Withdrawal by Subject|18|||
157192673|NCT00545740|567447171|FG000|Overall Study|Adverse Event|10|||
157192674|NCT00545740|567447172|FG001|Overall Study|Adverse Event|18|||
157192675|NCT00545740|567447173|FG002|Overall Study|Adverse Event|19|||
157192676|NCT00545740|567447174|FG003|Overall Study|Adverse Event|9|||
157192677|NCT00545740|567447171|FG000|Overall Study|Lost to Follow-up|7|||
157192678|NCT00545740|567447172|FG001|Overall Study|Lost to Follow-up|5|||
157192679|NCT00545740|567447173|FG002|Overall Study|Lost to Follow-up|5|||
157075664|NCT00760747|567030740|FG001|Study Period II|No drug administered|1|||
157075665|NCT00760747|567030739|FG000|Study Period III|Adverse Event|1|||
157075666|NCT00760747|567030740|FG001|Study Period III|Adverse Event|0|||
157075667|NCT00760747|567030739|FG000|Study Period III|Lack of Efficacy|1|||
157075668|NCT00760747|567030740|FG001|Study Period III|Lack of Efficacy|0|||
157075669|NCT00760747|567030739|FG000|Study Period III|Parent/Caregiver Decision|0|||
157075670|NCT00760747|567030740|FG001|Study Period III|Parent/Caregiver Decision|1|||
157075671|NCT00760747|567030739|FG000|Study Period III|Protocol Violation|1|||
157075672|NCT00760747|567030740|FG001|Study Period III|Protocol Violation|1|||
157075673|NCT00760747|567030739|FG000|Study Period III|Physician Decision|0|||
157192680|NCT00545740|567447174|FG003|Overall Study|Lost to Follow-up|6|||
157192681|NCT00545740|567447171|FG000|Overall Study|Protocol Violation|1|||
157192682|NCT00545740|567447172|FG001|Overall Study|Protocol Violation|3|||
157075674|NCT00760747|567030740|FG001|Study Period III|Physician Decision|1|||
157075675|NCT04160988|567030741|FG000|Overall Study|poor image quality|28|||
157075676|NCT00844597|567030742|FG000|Overall Study|Adverse Event|0|||
157075677|NCT00844597|567030743|FG001|Overall Study|Adverse Event|0|||
157075678|NCT00844597|567030744|FG002|Overall Study|Adverse Event|0|||
157075679|NCT00844597|567030745|FG003|Overall Study|Adverse Event|1|||
157075680|NCT00844597|567030746|FG004|Overall Study|Adverse Event|0|||
157075681|NCT00844597|567030747|FG005|Overall Study|Adverse Event|0|||
157075682|NCT01250509|567030748|FG000|Overall Study|Lost to Follow-up|5|||
157075683|NCT01250509|567030749|FG001|Overall Study|Lost to Follow-up|2|||
157075684|NCT01228175|567030751|FG000|Overall Study|Lost to Follow-up|64|||
157075685|NCT01228175|567030752|FG001|Overall Study|Lost to Follow-up|50|||
157075686|NCT01228175|567030751|FG000|Overall Study|Withdrawal by Subject|1|||
157075687|NCT01228175|567030752|FG001|Overall Study|Withdrawal by Subject|2|||
157075688|NCT01228175|567030751|FG000|Overall Study|Physician Decision|1|||
157075689|NCT01228175|567030752|FG001|Overall Study|Physician Decision|1|||
157075690|NCT00108745|567030753|FG000|Overall Study|Withdrawal by Subject|19|||
157075691|NCT00108745|567030754|FG001|Overall Study|Withdrawal by Subject|12|||
157075692|NCT00108745|567030755|FG002|Overall Study|Withdrawal by Subject|12|||
157075693|NCT00108745|567030753|FG000|Overall Study|Never Treated|8|||
157075694|NCT00108745|567030754|FG001|Overall Study|Never Treated|10|||
157075695|NCT00108745|567030755|FG002|Overall Study|Never Treated|12|||
157075696|NCT00108745|567030753|FG000|Overall Study|Ineligible|7|||
157075697|NCT00108745|567030754|FG001|Overall Study|Ineligible|13|||
157075698|NCT00108745|567030755|FG002|Overall Study|Ineligible|13|||
157075699|NCT00402051|567030757|FG000|Overall Study|Progressive Disease|13|||
157075700|NCT00402051|567030758|FG001|Overall Study|Progressive Disease|20|||
157075701|NCT00402051|567030757|FG000|Overall Study|Adverse Event|11|||
157075702|NCT00402051|567030758|FG001|Overall Study|Adverse Event|4|||
157075703|NCT00402051|567030757|FG000|Overall Study|Physician Decision|7|||
157075704|NCT00402051|567030758|FG001|Overall Study|Physician Decision|3|||
157075705|NCT00402051|567030757|FG000|Overall Study|Withdrawal by Subject|3|||
157075706|NCT00402051|567030758|FG001|Overall Study|Withdrawal by Subject|3|||
157075707|NCT00402051|567030757|FG000|Overall Study|Death - Related to Study Drug|1|||
157075708|NCT00402051|567030758|FG001|Overall Study|Death - Related to Study Drug|2|||
157075709|NCT00402051|567030757|FG000|Overall Study|Death Due to Study Disease|2|||
157075710|NCT00402051|567030758|FG001|Overall Study|Death Due to Study Disease|1|||
157075711|NCT00402051|567030757|FG000|Overall Study|Death Due to Adverse Event|0|||
157075712|NCT00402051|567030758|FG001|Overall Study|Death Due to Adverse Event|2|||
157075713|NCT00402051|567030757|FG000|Overall Study|Lost to Follow-up|1|||
157075714|NCT00402051|567030758|FG001|Overall Study|Lost to Follow-up|0|||
157075715|NCT00277095|567030759|FG000|Overall Study|Death|2|||
157075716|NCT00277095|567030759|FG000|Overall Study|Explanted|7|||
157075717|NCT00277095|567030759|FG000|Overall Study|Lost to Follow-up|2|||
157075718|NCT00277095|567030759|FG000|Overall Study|Missed Follow-up|9|||
157075719|NCT00277095|567030759|FG000|Overall Study|Physician Decision|1|||
157075720|NCT05415748|567030763|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
157075721|NCT05415748|567030764|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
157075722|NCT05415748|567030765|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
157075723|NCT05415748|567030766|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
157075724|NCT05415748|567030763|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
157075725|NCT05415748|567030764|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
157075726|NCT05415748|567030765|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
157075727|NCT05415748|567030766|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
157075728|NCT03075527|567030767|FG000|Overall Study|Death|1|||
157075729|NCT03075527|567030767|FG000|Overall Study|Withdrawal by Subject|1|||
157075730|NCT03075527|567030767|FG000|Overall Study|Physician Decision|3|||
157075731|NCT03075527|567030767|FG000|Overall Study|Progression/Relapse|14|||
157075732|NCT04463680|567030771|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
157075733|NCT04463680|567030771|FG000|Overall Study|Not eligible due to implant duration of use|1|||
157075734|NCT04463680|567030771|FG000|Overall Study|Withdrawal by Subject|3|||
157075735|NCT02592707|567030774|FG000|Overall Study|Consent Withdrawn|0|||
157075736|NCT02592707|567030775|FG001|Overall Study|Consent Withdrawn|1|||
157075737|NCT02592707|567030776|FG002|Overall Study|Consent Withdrawn|2|||
157075738|NCT02592707|567030777|FG003|Overall Study|Consent Withdrawn|0|||
157075739|NCT02592707|567030774|FG000|Overall Study|Death|1|||
157075740|NCT02592707|567030775|FG001|Overall Study|Death|0|||
157075741|NCT02592707|567030776|FG002|Overall Study|Death|0|||
157075742|NCT02592707|567030777|FG003|Overall Study|Death|0|||
157075743|NCT02592707|567030774|FG000|Overall Study|Progressive Disease|4|||
157075744|NCT02592707|567030775|FG001|Overall Study|Progressive Disease|4|||
157192683|NCT00545740|567447173|FG002|Overall Study|Protocol Violation|1|||
157075745|NCT02592707|567030776|FG002|Overall Study|Progressive Disease|3|||
157075746|NCT02592707|567030777|FG003|Overall Study|Progressive Disease|3|||
157075747|NCT02592707|567030774|FG000|Overall Study|Other|0|||
157075748|NCT02592707|567030775|FG001|Overall Study|Other|0|||
157075749|NCT02592707|567030776|FG002|Overall Study|Other|1|||
157075750|NCT02592707|567030777|FG003|Overall Study|Other|2|||
157192684|NCT00545740|567447174|FG003|Overall Study|Protocol Violation|0|||
157075751|NCT02592707|567030774|FG000|Overall Study|Never entered LTFU period|1|||
157075752|NCT02592707|567030775|FG001|Overall Study|Never entered LTFU period|0|||
157075753|NCT02592707|567030776|FG002|Overall Study|Never entered LTFU period|0|||
157075754|NCT02592707|567030777|FG003|Overall Study|Never entered LTFU period|2|||
157075755|NCT02998476|567030780|FG000|Overall Study|Lost to Follow-up|1|||
157075756|NCT02998476|567030781|FG001|Overall Study|Lost to Follow-up|0|||
157075757|NCT02998476|567030780|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
157075758|NCT02998476|567030781|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
157075759|NCT02998476|567030780|FG000|Overall Study|Withdrawal by Subject|1|||
157075760|NCT02998476|567030781|FG001|Overall Study|Withdrawal by Subject|2|||
157075761|NCT02998476|567030780|FG000|Overall Study|Death|45|||
157075762|NCT02998476|567030781|FG001|Overall Study|Death|2|||
157075763|NCT02998476|567030780|FG000|Overall Study|Other|6|||
157075764|NCT02998476|567030781|FG001|Overall Study|Other|1|||
157075765|NCT03832595|567030782|FG000|Overall Study|Death|142|||
157075766|NCT03832595|567030783|FG001|Overall Study|Death|130|||
157075767|NCT03832595|567030782|FG000|Overall Study|Medical management without dialysis|37|||
157075768|NCT03832595|567030783|FG001|Overall Study|Medical management without dialysis|1|||
157075769|NCT03277352|567030784|FG000|Overall Study|Study Terminated By Sponsor|2|||
157075770|NCT03277352|567030784|FG000|Overall Study|Withdrawal by Subject|4|||
157075771|NCT03277352|567030784|FG000|Overall Study|Death|4|||
157075772|NCT06840769|567030793|FG000|Overall Study|Withdrawal by Subject|1|||
157075773|NCT06840769|567030794|FG001|Overall Study|Withdrawal by Subject|0|||
157075774|NCT06840769|567030795|FG002|Overall Study|Withdrawal by Subject|0|||
157075775|NCT06840769|567030796|FG003|Overall Study|Withdrawal by Subject|0|||
157075776|NCT06840769|567030797|FG004|Overall Study|Withdrawal by Subject|0|||
157075777|NCT02726945|567030798|FG000|Overall Study|Withdrawal by Subject|0|||
157075778|NCT02726945|567030799|FG001|Overall Study|Withdrawal by Subject|0|||
157075779|NCT02726945|567030800|FG002|Overall Study|Withdrawal by Subject|1|||
157075780|NCT02726945|567030798|FG000|Overall Study|Elected to have total knee replacement|0|||
157075781|NCT02726945|567030799|FG001|Overall Study|Elected to have total knee replacement|1|||
157075782|NCT02726945|567030800|FG002|Overall Study|Elected to have total knee replacement|0|||
157075783|NCT01681277|567032537|FG000|Overall Study|Adverse Event|1|||
157075784|NCT01681277|567032538|FG001|Overall Study|Adverse Event|0|||
157075785|NCT01681277|567032539|FG002|Overall Study|Adverse Event|0|||
157075786|NCT01681277|567032540|FG003|Overall Study|Adverse Event|0|||
157075787|NCT01681277|567032541|FG004|Overall Study|Adverse Event|0|||
157075788|NCT03838731|567032542|FG000|Overall Study|Pregnancy|0|||
157075789|NCT03838731|567032543|FG001|Overall Study|Pregnancy|1|||
157075790|NCT03838731|567032542|FG000|Overall Study|Withdrawal of consent|1|||
157075791|NCT03838731|567032543|FG001|Overall Study|Withdrawal of consent|0|||
157075792|NCT02271984|567032546|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075793|NCT02271984|567032547|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075794|NCT02271984|567032548|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075795|NCT02271984|567032549|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075796|NCT02271984|567032550|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075797|NCT02271984|567032551|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
157075798|NCT02271984|567032552|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075799|NCT02271984|567032553|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
157075800|NCT02271984|567032554|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075801|NCT02271984|567032555|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075802|NCT02271984|567032556|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075803|NCT02271984|567032557|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
157075804|NCT01088984|567032558|FG000|Phase 1|Death|2|||
157075805|NCT01088984|567032559|FG001|Phase 1|Death|1|||
157075806|NCT01088984|567032558|FG000|Phase 1|Disease Progression|2|||
157075807|NCT01088984|567032559|FG001|Phase 1|Disease Progression|4|||
157075808|NCT01088984|567032558|FG000|Phase 1|Other|1|||
157075809|NCT01088984|567032559|FG001|Phase 1|Other|1|||
157075810|NCT01088984|567032558|FG000|Phase 2|Death|0|||
157075811|NCT01088984|567032559|FG001|Phase 2|Death|5|||
157075812|NCT01088984|567032558|FG000|Phase 2|Withdrawal by Subject|0|||
157231644|NCT00746798|567595318|FG001|Overall Study|Protocol Violation|1|||
157075813|NCT01088984|567032559|FG001|Phase 2|Withdrawal by Subject|1|||
157075814|NCT01088984|567032558|FG000|Phase 2|DIsease Progression|0|||
157075815|NCT01088984|567032559|FG001|Phase 2|DIsease Progression|25|||
157075816|NCT01088984|567032558|FG000|Phase 2|Other|0|||
157075817|NCT01088984|567032559|FG001|Phase 2|Other|1|||
157075818|NCT01228318|567032560|FG000|Overall Study|Clinic no show to receive intervention|1|||
157075819|NCT01228318|567032561|FG001|Overall Study|Clinic no show to receive intervention|0|||
157075820|NCT01228318|567032560|FG000|Overall Study|Unable to contact|2|||
157075821|NCT01228318|567032561|FG001|Overall Study|Unable to contact|5|||
157075822|NCT01228318|567032560|FG000|Overall Study|Moved|0|||
157231645|NCT00746798|567595319|FG002|Overall Study|Protocol Violation|0|||
157231646|NCT00746798|567595320|FG003|Overall Study|Protocol Violation|0|||
157075823|NCT01228318|567032561|FG001|Overall Study|Moved|2|||
157075824|NCT01228318|567032560|FG000|Overall Study|Incarcerated|1|||
157075825|NCT01228318|567032561|FG001|Overall Study|Incarcerated|0|||
157075826|NCT00770029|567032566|FG000|Overall Study|Lost to Follow-up|2|||
157075827|NCT00770029|567032567|FG001|Overall Study|Lost to Follow-up|0|||
157075828|NCT00770029|567032566|FG000|Overall Study|Withdrawal by Subject|3|||
157075829|NCT00770029|567032567|FG001|Overall Study|Withdrawal by Subject|3|||
157075830|NCT00770029|567032566|FG000|Overall Study|Adverse Event|1|||
157075831|NCT00770029|567032567|FG001|Overall Study|Adverse Event|0|||
157075832|NCT03480932|567032568|FG000|Overall Study|Death|1|||
157075833|NCT03480932|567032569|FG001|Overall Study|Death|1|||
157075834|NCT03480932|567032570|FG002|Overall Study|Death|0|||
157075835|NCT03480932|567032568|FG000|Overall Study|Lost to Follow-up|0|||
157075836|NCT03480932|567032569|FG001|Overall Study|Lost to Follow-up|2|||
157075837|NCT03480932|567032570|FG002|Overall Study|Lost to Follow-up|3|||
157075838|NCT03480932|567032568|FG000|Overall Study|Incarcerated|2|||
157075839|NCT03480932|567032569|FG001|Overall Study|Incarcerated|2|||
157075840|NCT03480932|567032570|FG002|Overall Study|Incarcerated|2|||
157075841|NCT03412773|567032573|FG000|Overall Study|Lost to Follow-up|0|||
157075842|NCT03412773|567032574|FG001|Overall Study|Lost to Follow-up|7|||
157075843|NCT03412773|567032575|FG002|Overall Study|Lost to Follow-up|6|||
157075844|NCT03412773|567032573|FG000|Overall Study|Withdrawal by Subject|0|||
157075845|NCT03412773|567032574|FG001|Overall Study|Withdrawal by Subject|15|||
157075846|NCT03412773|567032575|FG002|Overall Study|Withdrawal by Subject|19|||
157075847|NCT03412773|567032573|FG000|Overall Study|Study Closed By Sponsor|3|||
157075848|NCT03412773|567032574|FG001|Overall Study|Study Closed By Sponsor|46|||
157075849|NCT03412773|567032575|FG002|Overall Study|Study Closed By Sponsor|33|||
157075850|NCT03412773|567032573|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
157075851|NCT03412773|567032574|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
157075852|NCT03412773|567032575|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
157075853|NCT03412773|567032573|FG000|Overall Study|Death|7|||
157075854|NCT03412773|567032574|FG001|Overall Study|Death|259|||
157075855|NCT03412773|567032575|FG002|Overall Study|Death|273|||
157075856|NCT03412773|567032573|FG000|Overall Study|Physician Decision|0|||
157075857|NCT03412773|567032574|FG001|Overall Study|Physician Decision|0|||
157075858|NCT03412773|567032575|FG002|Overall Study|Physician Decision|1|||
157075859|NCT03057847|567032578|FG000|Overall Study|Lost to Follow-up|16|||
157075860|NCT02138786|567032582|FG000|Overall Study|Adverse Event|0|||
157075861|NCT02138786|567032583|FG001|Overall Study|Adverse Event|2|||
157075862|NCT02138786|567032584|FG002|Overall Study|Adverse Event|1|||
157075863|NCT02138786|567032582|FG000|Overall Study|Death|1|||
157075864|NCT02138786|567032583|FG001|Overall Study|Death|7|||
157075865|NCT02138786|567032584|FG002|Overall Study|Death|2|||
157075866|NCT02138786|567032582|FG000|Overall Study|Disease Progression|1|||
157075867|NCT02138786|567032583|FG001|Overall Study|Disease Progression|1|||
157075868|NCT02138786|567032584|FG002|Overall Study|Disease Progression|3|||
157075869|NCT02138786|567032582|FG000|Overall Study|Withdrawal by Subject|1|||
157075870|NCT02138786|567032583|FG001|Overall Study|Withdrawal by Subject|2|||
157075871|NCT02138786|567032584|FG002|Overall Study|Withdrawal by Subject|0|||
157075872|NCT02138786|567032582|FG000|Overall Study|Patient's Wish|0|||
157075873|NCT02138786|567032583|FG001|Overall Study|Patient's Wish|2|||
157075874|NCT02138786|567032584|FG002|Overall Study|Patient's Wish|0|||
157075875|NCT02138786|567032582|FG000|Overall Study|Sponsor Terminated Study|0|||
157075876|NCT02138786|567032583|FG001|Overall Study|Sponsor Terminated Study|1|||
157075877|NCT02138786|567032584|FG002|Overall Study|Sponsor Terminated Study|1|||
157075878|NCT02138786|567032582|FG000|Overall Study|Non-Compliance|0|||
157075879|NCT02138786|567032583|FG001|Overall Study|Non-Compliance|0|||
157075880|NCT02138786|567032584|FG002|Overall Study|Non-Compliance|1|||
157075881|NCT02088957|567032585|FG000|Overall Study|Lack of Efficacy|1|||
157075882|NCT02088957|567032586|FG001|Overall Study|Lack of Efficacy|0|||
157075883|NCT00426127|567032590|FG000|Overall Study|Adverse Event|1|||
157075884|NCT00426127|567032590|FG000|Overall Study|Removed due to disease progression|1|||
157075885|NCT03111095|567032593|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
157075886|NCT03111095|567032594|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
157075887|NCT03111095|567032593|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
157075888|NCT03111095|567032594|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
157075889|NCT01016262|567032601|FG000|Double-blind Phase|Adverse Event|0|||
157075890|NCT01016262|567032602|FG001|Double-blind Phase|Adverse Event|0|||
157075891|NCT01016262|567032603|FG002|Double-blind Phase|Adverse Event|1|||
157075892|NCT01016262|567032604|FG003|Double-blind Phase|Adverse Event|0|||
157075893|NCT01016262|567032605|FG004|Double-blind Phase|Adverse Event|0|||
157075894|NCT01016262|567032606|FG005|Double-blind Phase|Adverse Event|0|||
157075895|NCT01016262|567032601|FG000|Double-blind Phase|Lack of Efficacy|1|||
157075896|NCT01016262|567032602|FG001|Double-blind Phase|Lack of Efficacy|0|||
157075897|NCT01016262|567032603|FG002|Double-blind Phase|Lack of Efficacy|5|||
157075898|NCT01016262|567032604|FG003|Double-blind Phase|Lack of Efficacy|0|||
157075899|NCT01016262|567032605|FG004|Double-blind Phase|Lack of Efficacy|0|||
157075900|NCT01016262|567032606|FG005|Double-blind Phase|Lack of Efficacy|0|||
157075901|NCT01016262|567032601|FG000|Double-blind Phase|Disease Progression|0|||
157075902|NCT01016262|567032602|FG001|Double-blind Phase|Disease Progression|1|||
157075903|NCT01016262|567032603|FG002|Double-blind Phase|Disease Progression|2|||
157075904|NCT01016262|567032604|FG003|Double-blind Phase|Disease Progression|0|||
157075905|NCT01016262|567032605|FG004|Double-blind Phase|Disease Progression|0|||
157075906|NCT01016262|567032606|FG005|Double-blind Phase|Disease Progression|0|||
157075907|NCT01016262|567032601|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
157075908|NCT01016262|567032602|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
157075909|NCT01016262|567032603|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
157075910|NCT01016262|567032604|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
157075911|NCT01016262|567032605|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
157075912|NCT01016262|567032606|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
157075913|NCT01016262|567032601|FG000|Open-Label Phase|Adverse Event|0|||
157075914|NCT01016262|567032602|FG001|Open-Label Phase|Adverse Event|0|||
157075915|NCT01016262|567032603|FG002|Open-Label Phase|Adverse Event|0|||
157075916|NCT01016262|567032604|FG003|Open-Label Phase|Adverse Event|1|||
157075917|NCT01016262|567032605|FG004|Open-Label Phase|Adverse Event|0|||
157075918|NCT01016262|567032606|FG005|Open-Label Phase|Adverse Event|0|||
157075919|NCT01016262|567032601|FG000|Open-Label Phase|Lost to Follow-up|0|||
157075920|NCT01016262|567032602|FG001|Open-Label Phase|Lost to Follow-up|0|||
157075921|NCT01016262|567032603|FG002|Open-Label Phase|Lost to Follow-up|0|||
157075922|NCT01016262|567032604|FG003|Open-Label Phase|Lost to Follow-up|0|||
157075923|NCT01016262|567032605|FG004|Open-Label Phase|Lost to Follow-up|1|||
157075924|NCT01016262|567032606|FG005|Open-Label Phase|Lost to Follow-up|0|||
157075925|NCT01016262|567032601|FG000|Open-Label Phase|Lack of Efficacy|0|||
157075926|NCT01016262|567032602|FG001|Open-Label Phase|Lack of Efficacy|0|||
157075927|NCT01016262|567032603|FG002|Open-Label Phase|Lack of Efficacy|0|||
157075928|NCT01016262|567032604|FG003|Open-Label Phase|Lack of Efficacy|1|||
157075929|NCT01016262|567032605|FG004|Open-Label Phase|Lack of Efficacy|0|||
157075930|NCT01016262|567032606|FG005|Open-Label Phase|Lack of Efficacy|0|||
157075931|NCT01016262|567032601|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
157075932|NCT01016262|567032602|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
157075933|NCT01016262|567032603|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
157075934|NCT01016262|567032604|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
157075935|NCT01016262|567032605|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
157075936|NCT01016262|567032606|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
157075937|NCT03738475|567032608|FG000|Overall Study|Participant Non-Compliance|1|||
157075938|NCT03738475|567032609|FG001|Overall Study|Participant Non-Compliance|0|||
157075939|NCT00677534|567032610|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
157075940|NCT00677534|567032610|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
157075941|NCT00677534|567032610|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
157075942|NCT01730378|567032611|FG000|Overall Study|Lost to Follow-up|1|||
157075943|NCT01730378|567032612|FG001|Overall Study|Lost to Follow-up|0|||
157075944|NCT02687035|567032613|FG000|Overall Study|Withdrawal by Subject|1|||
157075945|NCT02687035|567032613|FG000|Overall Study|Death|87|||
157075946|NCT02687035|567032613|FG000|Overall Study|Lost to Follow-up|1|||
157075947|NCT02687035|567032613|FG000|Overall Study|Missed Visit|87|||
157075948|NCT02687035|567032613|FG000|Overall Study|Did not receive Study Device|8|||
157075949|NCT05000216|567032615|FG000|Stage 1|Lost to Follow-up|0|||
157075950|NCT05000216|567032616|FG001|Stage 1|Lost to Follow-up|0|||
157075951|NCT05000216|567032617|FG002|Stage 1|Lost to Follow-up|0|||
157075952|NCT05000216|567032618|FG003|Stage 1|Lost to Follow-up|0|||
157075953|NCT05000216|567032619|FG004|Stage 1|Lost to Follow-up|0|||
157075954|NCT05000216|567032620|FG005|Stage 1|Lost to Follow-up|0|||
157075955|NCT05000216|567032621|FG006|Stage 1|Lost to Follow-up|1|||
157075956|NCT05000216|567032622|FG007|Stage 1|Lost to Follow-up|1|||
157075957|NCT05000216|567032623|FG008|Stage 1|Lost to Follow-up|0|||
157075958|NCT05000216|567032624|FG009|Stage 1|Lost to Follow-up|2|||
157075959|NCT05000216|567032625|FG010|Stage 1|Lost to Follow-up|3|||
157075960|NCT05000216|567032626|FG011|Stage 1|Lost to Follow-up|0|||
157075961|NCT05000216|567032627|FG012|Stage 1|Lost to Follow-up|0|||
157075962|NCT05000216|567032628|FG013|Stage 1|Lost to Follow-up|0|||
157075963|NCT05000216|567032629|FG014|Stage 1|Lost to Follow-up|0|||
157075964|NCT05000216|567032630|FG015|Stage 1|Lost to Follow-up|0|||
157075965|NCT05000216|567032631|FG016|Stage 1|Lost to Follow-up|0|||
157075966|NCT05000216|567032632|FG017|Stage 1|Lost to Follow-up|0|||
157075967|NCT05000216|567032633|FG018|Stage 1|Lost to Follow-up|0|||
157075968|NCT05000216|567032634|FG019|Stage 1|Lost to Follow-up|0|||
157075969|NCT05000216|567032635|FG020|Stage 1|Lost to Follow-up|0|||
157075970|NCT05000216|567032636|FG021|Stage 1|Lost to Follow-up|0|||
157075971|NCT05000216|567032615|FG000|Stage 1|Physician Decision|0|||
157075972|NCT05000216|567032616|FG001|Stage 1|Physician Decision|0|||
157075973|NCT05000216|567032617|FG002|Stage 1|Physician Decision|0|||
157192685|NCT00545740|567447171|FG000|Overall Study|Non-compliance|0|||
157075974|NCT05000216|567032618|FG003|Stage 1|Physician Decision|0|||
157075975|NCT05000216|567032619|FG004|Stage 1|Physician Decision|0|||
157075976|NCT05000216|567032620|FG005|Stage 1|Physician Decision|0|||
157075977|NCT05000216|567032621|FG006|Stage 1|Physician Decision|0|||
157075978|NCT05000216|567032622|FG007|Stage 1|Physician Decision|1|||
157075979|NCT05000216|567032623|FG008|Stage 1|Physician Decision|1|||
157075980|NCT05000216|567032624|FG009|Stage 1|Physician Decision|0|||
157192686|NCT00545740|567447172|FG001|Overall Study|Non-compliance|2|||
157075981|NCT05000216|567032625|FG010|Stage 1|Physician Decision|0|||
157075982|NCT05000216|567032626|FG011|Stage 1|Physician Decision|0|||
157075983|NCT05000216|567032627|FG012|Stage 1|Physician Decision|0|||
157075984|NCT05000216|567032628|FG013|Stage 1|Physician Decision|0|||
157075985|NCT05000216|567032629|FG014|Stage 1|Physician Decision|0|||
157075986|NCT05000216|567032630|FG015|Stage 1|Physician Decision|0|||
157075987|NCT05000216|567032631|FG016|Stage 1|Physician Decision|0|||
157075988|NCT05000216|567032632|FG017|Stage 1|Physician Decision|0|||
157075989|NCT05000216|567032633|FG018|Stage 1|Physician Decision|0|||
157075990|NCT05000216|567032634|FG019|Stage 1|Physician Decision|0|||
157075991|NCT05000216|567032635|FG020|Stage 1|Physician Decision|0|||
157075992|NCT05000216|567032636|FG021|Stage 1|Physician Decision|0|||
157075993|NCT05000216|567032615|FG000|Stage 1|Withdrawal by Subject|0|||
157075994|NCT05000216|567032616|FG001|Stage 1|Withdrawal by Subject|1|||
157075995|NCT05000216|567032617|FG002|Stage 1|Withdrawal by Subject|0|||
157075996|NCT05000216|567032618|FG003|Stage 1|Withdrawal by Subject|0|||
157075997|NCT05000216|567032619|FG004|Stage 1|Withdrawal by Subject|0|||
157075998|NCT05000216|567032620|FG005|Stage 1|Withdrawal by Subject|0|||
157075999|NCT05000216|567032621|FG006|Stage 1|Withdrawal by Subject|0|||
157076000|NCT05000216|567032622|FG007|Stage 1|Withdrawal by Subject|0|||
157076001|NCT05000216|567032623|FG008|Stage 1|Withdrawal by Subject|0|||
157076002|NCT05000216|567032624|FG009|Stage 1|Withdrawal by Subject|3|||
157076003|NCT05000216|567032625|FG010|Stage 1|Withdrawal by Subject|10|||
157076004|NCT05000216|567032626|FG011|Stage 1|Withdrawal by Subject|0|||
157076005|NCT05000216|567032627|FG012|Stage 1|Withdrawal by Subject|0|||
157076006|NCT05000216|567032628|FG013|Stage 1|Withdrawal by Subject|0|||
157076007|NCT05000216|567032629|FG014|Stage 1|Withdrawal by Subject|0|||
157076008|NCT05000216|567032630|FG015|Stage 1|Withdrawal by Subject|0|||
157076009|NCT05000216|567032631|FG016|Stage 1|Withdrawal by Subject|0|||
157076010|NCT05000216|567032632|FG017|Stage 1|Withdrawal by Subject|0|||
157076011|NCT05000216|567032633|FG018|Stage 1|Withdrawal by Subject|0|||
157076012|NCT05000216|567032634|FG019|Stage 1|Withdrawal by Subject|0|||
157076013|NCT05000216|567032635|FG020|Stage 1|Withdrawal by Subject|0|||
157076014|NCT05000216|567032636|FG021|Stage 1|Withdrawal by Subject|0|||
157076015|NCT05000216|567032615|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
157076016|NCT05000216|567032616|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
157076017|NCT05000216|567032617|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
157076018|NCT05000216|567032618|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
157076019|NCT05000216|567032619|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
157076020|NCT05000216|567032620|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
157076021|NCT05000216|567032621|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
157076022|NCT05000216|567032622|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
157076023|NCT05000216|567032623|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
157076024|NCT05000216|567032624|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
157076025|NCT05000216|567032625|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
157076026|NCT05000216|567032626|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
157076027|NCT05000216|567032627|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
157076028|NCT05000216|567032628|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
157076029|NCT05000216|567032629|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
157076030|NCT05000216|567032630|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
157076031|NCT05000216|567032631|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
157076032|NCT05000216|567032632|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
157076033|NCT05000216|567032633|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
157076034|NCT05000216|567032634|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
157076035|NCT05000216|567032635|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
157076036|NCT05000216|567032636|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
157076037|NCT05000216|567032615|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076038|NCT05000216|567032616|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076039|NCT05000216|567032617|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076040|NCT05000216|567032618|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076041|NCT05000216|567032619|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076042|NCT05000216|567032620|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076043|NCT05000216|567032621|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076044|NCT05000216|567032622|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076045|NCT05000216|567032623|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
157076046|NCT05000216|567032624|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076047|NCT05000216|567032625|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076048|NCT05000216|567032626|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076049|NCT05000216|567032627|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076050|NCT05000216|567032628|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076051|NCT05000216|567032629|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076052|NCT05000216|567032630|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076053|NCT05000216|567032631|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076054|NCT05000216|567032632|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076055|NCT05000216|567032633|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076056|NCT05000216|567032634|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157231647|NCT00746798|567595317|FG000|Overall Study|Withdrawal by Subject|0|||
157231648|NCT00746798|567595318|FG001|Overall Study|Withdrawal by Subject|1|||
157231649|NCT00746798|567595319|FG002|Overall Study|Withdrawal by Subject|1|||
157231650|NCT00746798|567595320|FG003|Overall Study|Withdrawal by Subject|0|||
157231651|NCT00746798|567595317|FG000|Overall Study|Death|0|||
157076057|NCT05000216|567032635|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076058|NCT05000216|567032636|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
157076059|NCT05000216|567032615|FG000|Stage 1|Other|0|||
157076060|NCT05000216|567032616|FG001|Stage 1|Other|0|||
157076061|NCT05000216|567032617|FG002|Stage 1|Other|0|||
157076062|NCT05000216|567032618|FG003|Stage 1|Other|0|||
157231652|NCT00746798|567595318|FG001|Overall Study|Death|0|||
157231653|NCT00746798|567595319|FG002|Overall Study|Death|2|||
157231654|NCT00746798|567595320|FG003|Overall Study|Death|0|||
157231655|NCT00746798|567595317|FG000|Overall Study|Participant unable to return for visit|1|||
157231656|NCT00746798|567595318|FG001|Overall Study|Participant unable to return for visit|0|||
157231657|NCT00746798|567595319|FG002|Overall Study|Participant unable to return for visit|0|||
157076063|NCT05000216|567032619|FG004|Stage 1|Other|1|||
157076064|NCT05000216|567032620|FG005|Stage 1|Other|0|||
157076065|NCT05000216|567032621|FG006|Stage 1|Other|0|||
157076066|NCT05000216|567032622|FG007|Stage 1|Other|2|||
157076067|NCT05000216|567032623|FG008|Stage 1|Other|0|||
157076068|NCT05000216|567032624|FG009|Stage 1|Other|0|||
157076069|NCT05000216|567032625|FG010|Stage 1|Other|1|||
157076070|NCT05000216|567032626|FG011|Stage 1|Other|1|||
157076071|NCT05000216|567032627|FG012|Stage 1|Other|0|||
157076072|NCT05000216|567032628|FG013|Stage 1|Other|0|||
157076073|NCT05000216|567032629|FG014|Stage 1|Other|0|||
157076074|NCT05000216|567032630|FG015|Stage 1|Other|0|||
157076075|NCT05000216|567032631|FG016|Stage 1|Other|0|||
157076076|NCT05000216|567032632|FG017|Stage 1|Other|0|||
157076077|NCT05000216|567032633|FG018|Stage 1|Other|0|||
157076078|NCT05000216|567032634|FG019|Stage 1|Other|0|||
157076079|NCT05000216|567032635|FG020|Stage 1|Other|0|||
157076080|NCT05000216|567032636|FG021|Stage 1|Other|0|||
157076081|NCT05000216|567032615|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
157076082|NCT05000216|567032616|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
157076083|NCT05000216|567032617|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
157076084|NCT05000216|567032618|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
157076085|NCT05000216|567032619|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
157076086|NCT05000216|567032620|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
157076087|NCT05000216|567032621|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
157076088|NCT05000216|567032622|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
157076089|NCT05000216|567032623|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
157076090|NCT05000216|567032624|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
157076091|NCT05000216|567032625|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
157076092|NCT05000216|567032626|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
157076093|NCT05000216|567032627|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
157076094|NCT05000216|567032628|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
157076095|NCT05000216|567032629|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
157076096|NCT05000216|567032630|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
157076097|NCT05000216|567032631|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
157076098|NCT05000216|567032632|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
157076099|NCT05000216|567032633|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
157076100|NCT05000216|567032634|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
157076101|NCT05000216|567032635|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
157076102|NCT05000216|567032636|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
157076103|NCT05000216|567032615|FG000|Stage 2|Lost to Follow-up|0|||
157076104|NCT05000216|567032616|FG001|Stage 2|Lost to Follow-up|0|||
157076105|NCT05000216|567032617|FG002|Stage 2|Lost to Follow-up|0|||
157076106|NCT05000216|567032618|FG003|Stage 2|Lost to Follow-up|0|||
157076107|NCT05000216|567032619|FG004|Stage 2|Lost to Follow-up|0|||
157076108|NCT05000216|567032620|FG005|Stage 2|Lost to Follow-up|0|||
157076109|NCT05000216|567032621|FG006|Stage 2|Lost to Follow-up|0|||
157076110|NCT05000216|567032622|FG007|Stage 2|Lost to Follow-up|0|||
157076111|NCT05000216|567032623|FG008|Stage 2|Lost to Follow-up|0|||
157231658|NCT00746798|567595320|FG003|Overall Study|Participant unable to return for visit|0|||
157076112|NCT05000216|567032624|FG009|Stage 2|Lost to Follow-up|0|||
157076113|NCT05000216|567032625|FG010|Stage 2|Lost to Follow-up|0|||
157076114|NCT05000216|567032626|FG011|Stage 2|Lost to Follow-up|0|||
157076115|NCT05000216|567032627|FG012|Stage 2|Lost to Follow-up|0|||
157076116|NCT05000216|567032628|FG013|Stage 2|Lost to Follow-up|0|||
157076117|NCT05000216|567032629|FG014|Stage 2|Lost to Follow-up|0|||
157076118|NCT05000216|567032630|FG015|Stage 2|Lost to Follow-up|0|||
157076119|NCT05000216|567032631|FG016|Stage 2|Lost to Follow-up|4|||
157076120|NCT05000216|567032632|FG017|Stage 2|Lost to Follow-up|0|||
157076121|NCT05000216|567032633|FG018|Stage 2|Lost to Follow-up|0|||
157076122|NCT05000216|567032634|FG019|Stage 2|Lost to Follow-up|0|||
157076123|NCT05000216|567032635|FG020|Stage 2|Lost to Follow-up|0|||
157076124|NCT05000216|567032636|FG021|Stage 2|Lost to Follow-up|0|||
157076125|NCT05000216|567032615|FG000|Stage 2|Physician Decision|0|||
157076126|NCT05000216|567032616|FG001|Stage 2|Physician Decision|0|||
157076127|NCT05000216|567032617|FG002|Stage 2|Physician Decision|0|||
157076128|NCT05000216|567032618|FG003|Stage 2|Physician Decision|0|||
157076129|NCT05000216|567032619|FG004|Stage 2|Physician Decision|0|||
157076130|NCT05000216|567032620|FG005|Stage 2|Physician Decision|0|||
157076131|NCT05000216|567032621|FG006|Stage 2|Physician Decision|0|||
157076132|NCT05000216|567032622|FG007|Stage 2|Physician Decision|0|||
157076133|NCT05000216|567032623|FG008|Stage 2|Physician Decision|0|||
157076134|NCT05000216|567032624|FG009|Stage 2|Physician Decision|0|||
157076135|NCT05000216|567032625|FG010|Stage 2|Physician Decision|0|||
157076136|NCT05000216|567032626|FG011|Stage 2|Physician Decision|0|||
157076137|NCT05000216|567032627|FG012|Stage 2|Physician Decision|1|||
157076138|NCT05000216|567032628|FG013|Stage 2|Physician Decision|0|||
157076139|NCT05000216|567032629|FG014|Stage 2|Physician Decision|0|||
157076140|NCT05000216|567032630|FG015|Stage 2|Physician Decision|0|||
157076141|NCT05000216|567032631|FG016|Stage 2|Physician Decision|0|||
157076142|NCT05000216|567032632|FG017|Stage 2|Physician Decision|0|||
157076143|NCT05000216|567032633|FG018|Stage 2|Physician Decision|0|||
157076144|NCT05000216|567032634|FG019|Stage 2|Physician Decision|0|||
157076145|NCT05000216|567032635|FG020|Stage 2|Physician Decision|0|||
157076146|NCT05000216|567032636|FG021|Stage 2|Physician Decision|0|||
157076147|NCT05000216|567032615|FG000|Stage 2|Withdrawal by Subject|0|||
157076148|NCT05000216|567032616|FG001|Stage 2|Withdrawal by Subject|0|||
157076149|NCT05000216|567032617|FG002|Stage 2|Withdrawal by Subject|0|||
157076150|NCT05000216|567032618|FG003|Stage 2|Withdrawal by Subject|0|||
157076151|NCT05000216|567032619|FG004|Stage 2|Withdrawal by Subject|0|||
157076152|NCT05000216|567032620|FG005|Stage 2|Withdrawal by Subject|0|||
157076153|NCT05000216|567032621|FG006|Stage 2|Withdrawal by Subject|0|||
157076154|NCT05000216|567032622|FG007|Stage 2|Withdrawal by Subject|0|||
157076155|NCT05000216|567032623|FG008|Stage 2|Withdrawal by Subject|0|||
157076156|NCT05000216|567032624|FG009|Stage 2|Withdrawal by Subject|0|||
157076157|NCT05000216|567032625|FG010|Stage 2|Withdrawal by Subject|0|||
157076158|NCT05000216|567032626|FG011|Stage 2|Withdrawal by Subject|0|||
157076159|NCT05000216|567032627|FG012|Stage 2|Withdrawal by Subject|0|||
157076160|NCT05000216|567032628|FG013|Stage 2|Withdrawal by Subject|0|||
157076161|NCT05000216|567032629|FG014|Stage 2|Withdrawal by Subject|2|||
157076162|NCT05000216|567032630|FG015|Stage 2|Withdrawal by Subject|0|||
157076163|NCT05000216|567032631|FG016|Stage 2|Withdrawal by Subject|9|||
157076164|NCT05000216|567032632|FG017|Stage 2|Withdrawal by Subject|0|||
157076165|NCT05000216|567032633|FG018|Stage 2|Withdrawal by Subject|0|||
157076166|NCT05000216|567032634|FG019|Stage 2|Withdrawal by Subject|0|||
157076167|NCT05000216|567032635|FG020|Stage 2|Withdrawal by Subject|0|||
157076168|NCT05000216|567032636|FG021|Stage 2|Withdrawal by Subject|0|||
157076169|NCT05000216|567032615|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
157076170|NCT05000216|567032616|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
157076171|NCT05000216|567032617|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
157076172|NCT05000216|567032618|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
157076173|NCT05000216|567032619|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
157076174|NCT05000216|567032620|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
157076175|NCT05000216|567032621|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
157076176|NCT05000216|567032622|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
157076177|NCT05000216|567032623|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
157076178|NCT05000216|567032624|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
157076179|NCT05000216|567032625|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
157076180|NCT05000216|567032626|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
157076181|NCT05000216|567032627|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
157076182|NCT05000216|567032628|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
157076183|NCT05000216|567032629|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
157076184|NCT05000216|567032630|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
157076185|NCT05000216|567032631|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
157076186|NCT05000216|567032632|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
157076187|NCT05000216|567032633|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
157076188|NCT05000216|567032634|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
157076189|NCT05000216|567032635|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
157076190|NCT05000216|567032636|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
157076191|NCT05000216|567032615|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076192|NCT05000216|567032616|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076193|NCT05000216|567032617|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076194|NCT05000216|567032618|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157192687|NCT00545740|567447173|FG002|Overall Study|Non-compliance|1|||
157192688|NCT00545740|567447174|FG003|Overall Study|Non-compliance|0|||
157192689|NCT00545740|567447171|FG000|Overall Study|Moved|2|||
157192690|NCT00545740|567447172|FG001|Overall Study|Moved|0|||
157192691|NCT00545740|567447173|FG002|Overall Study|Moved|1|||
157192692|NCT00545740|567447174|FG003|Overall Study|Moved|0|||
157192693|NCT00545740|567447171|FG000|Overall Study|Diverticulitis attack|0|||
157192694|NCT00545740|567447172|FG001|Overall Study|Diverticulitis attack|0|||
157192695|NCT00545740|567447173|FG002|Overall Study|Diverticulitis attack|1|||
157192696|NCT00545740|567447174|FG003|Overall Study|Diverticulitis attack|1|||
157076195|NCT05000216|567032619|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076196|NCT05000216|567032620|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076197|NCT05000216|567032621|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076198|NCT05000216|567032622|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076199|NCT05000216|567032623|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076200|NCT05000216|567032624|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076201|NCT05000216|567032625|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076202|NCT05000216|567032626|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076203|NCT05000216|567032627|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076204|NCT05000216|567032628|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076205|NCT05000216|567032629|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
157076206|NCT05000216|567032630|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076207|NCT05000216|567032631|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
157076208|NCT05000216|567032632|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076209|NCT05000216|567032633|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076210|NCT05000216|567032634|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076211|NCT05000216|567032635|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076212|NCT05000216|567032636|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
157076213|NCT05000216|567032615|FG000|Stage 2|Other reason|0|||
157076214|NCT05000216|567032616|FG001|Stage 2|Other reason|0|||
157076215|NCT05000216|567032617|FG002|Stage 2|Other reason|0|||
157076216|NCT05000216|567032618|FG003|Stage 2|Other reason|0|||
157076217|NCT05000216|567032619|FG004|Stage 2|Other reason|0|||
157076218|NCT05000216|567032620|FG005|Stage 2|Other reason|0|||
157076219|NCT05000216|567032621|FG006|Stage 2|Other reason|0|||
157076220|NCT05000216|567032622|FG007|Stage 2|Other reason|0|||
157076221|NCT05000216|567032623|FG008|Stage 2|Other reason|0|||
157076222|NCT05000216|567032624|FG009|Stage 2|Other reason|0|||
157076223|NCT05000216|567032625|FG010|Stage 2|Other reason|0|||
157076224|NCT05000216|567032626|FG011|Stage 2|Other reason|0|||
157076225|NCT05000216|567032627|FG012|Stage 2|Other reason|0|||
157076226|NCT05000216|567032628|FG013|Stage 2|Other reason|0|||
157076227|NCT05000216|567032629|FG014|Stage 2|Other reason|0|||
157076228|NCT05000216|567032630|FG015|Stage 2|Other reason|0|||
157076229|NCT05000216|567032631|FG016|Stage 2|Other reason|1|||
157076230|NCT05000216|567032632|FG017|Stage 2|Other reason|0|||
157076231|NCT05000216|567032633|FG018|Stage 2|Other reason|0|||
157076232|NCT05000216|567032634|FG019|Stage 2|Other reason|0|||
157076233|NCT05000216|567032635|FG020|Stage 2|Other reason|0|||
157076234|NCT05000216|567032636|FG021|Stage 2|Other reason|0|||
157076235|NCT05000216|567032615|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
157076236|NCT05000216|567032616|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
157076237|NCT05000216|567032617|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
157076238|NCT05000216|567032618|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
157076239|NCT05000216|567032619|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
157076240|NCT05000216|567032620|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
157076241|NCT05000216|567032621|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
157076242|NCT05000216|567032622|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
157076243|NCT05000216|567032623|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
157076244|NCT05000216|567032624|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
157076245|NCT05000216|567032625|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
157076246|NCT05000216|567032626|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
157076247|NCT05000216|567032627|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
157076248|NCT05000216|567032628|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
157076249|NCT05000216|567032629|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
157076250|NCT05000216|567032630|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
157076251|NCT05000216|567032631|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
157076252|NCT05000216|567032632|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
157076253|NCT05000216|567032633|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
157076254|NCT05000216|567032634|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
157076255|NCT05000216|567032635|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
157076256|NCT05000216|567032636|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
157076257|NCT05000216|567032615|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076258|NCT05000216|567032616|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076259|NCT05000216|567032617|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076260|NCT05000216|567032618|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076261|NCT05000216|567032619|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076262|NCT05000216|567032620|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076263|NCT05000216|567032621|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
157231659|NCT00633594|567595323|FG000|Overall Study|Adverse Event|0|||
157076264|NCT05000216|567032622|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076265|NCT05000216|567032623|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076266|NCT05000216|567032624|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076267|NCT05000216|567032625|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076268|NCT05000216|567032626|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076269|NCT05000216|567032627|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076270|NCT05000216|567032628|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076271|NCT05000216|567032629|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076272|NCT05000216|567032630|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
157231660|NCT00633594|567595324|FG001|Overall Study|Adverse Event|4|||
157231661|NCT00633594|567595325|FG002|Overall Study|Adverse Event|7|||
157231662|NCT00633594|567595323|FG000|Overall Study|Death|0|||
157076273|NCT05000216|567032631|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076274|NCT05000216|567032632|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076275|NCT05000216|567032633|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076276|NCT05000216|567032634|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076277|NCT05000216|567032635|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
157231663|NCT00633594|567595324|FG001|Overall Study|Death|1|||
157231664|NCT00633594|567595325|FG002|Overall Study|Death|2|||
157231665|NCT00633594|567595323|FG000|Overall Study|Disease Progression|0|||
157231666|NCT00633594|567595324|FG001|Overall Study|Disease Progression|0|||
157231667|NCT00633594|567595325|FG002|Overall Study|Disease Progression|1|||
157231668|NCT02028715|567595326|FG000|Overall Study|Adverse Event|2|||
157231669|NCT02028715|567595327|FG001|Overall Study|Adverse Event|2|||
157231670|NCT02028715|567595326|FG000|Overall Study|Physician Decision|1|||
157231671|NCT02028715|567595327|FG001|Overall Study|Physician Decision|0|||
157231672|NCT02028715|567595326|FG000|Overall Study|Did not complete satisfaction surveys|2|||
157231673|NCT02028715|567595327|FG001|Overall Study|Did not complete satisfaction surveys|2|||
157231674|NCT01315249|567595328|FG000|Overall Study|Adverse Event|22|||
157231675|NCT01315249|567595329|FG001|Overall Study|Adverse Event|26|||
157231676|NCT01315249|567595328|FG000|Overall Study|Withdrawal by Subject|11|||
157231677|NCT01315249|567595329|FG001|Overall Study|Withdrawal by Subject|10|||
157076278|NCT05000216|567032636|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
157076279|NCT05000216|567032615|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076280|NCT05000216|567032616|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076281|NCT05000216|567032617|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076282|NCT05000216|567032618|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076283|NCT05000216|567032619|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076284|NCT05000216|567032620|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076285|NCT05000216|567032621|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076286|NCT05000216|567032622|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076287|NCT05000216|567032623|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076288|NCT05000216|567032624|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076289|NCT05000216|567032625|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076290|NCT05000216|567032626|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076291|NCT05000216|567032627|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076292|NCT05000216|567032628|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
157076293|NCT05000216|567032629|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076294|NCT05000216|567032630|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
157076295|NCT05000216|567032631|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076296|NCT05000216|567032632|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076297|NCT05000216|567032633|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
157076298|NCT05000216|567032634|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076299|NCT05000216|567032635|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076300|NCT05000216|567032636|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
157076301|NCT04638660|567032637|FG000|Overall Study|Withdrawal by Subject|2|||
157076302|NCT04638660|567032638|FG001|Overall Study|Withdrawal by Subject|0|||
157076303|NCT04638660|567032637|FG000|Overall Study|Lost to Follow-up|1|||
157076304|NCT04638660|567032638|FG001|Overall Study|Lost to Follow-up|0|||
157076305|NCT03199469|567032645|FG000|Overall Study|Randomized, not treated|0|||
157076306|NCT03199469|567032646|FG001|Overall Study|Randomized, not treated|3|||
157076307|NCT03199469|567032645|FG000|Overall Study|Withdrawal by Subject|1|||
157076308|NCT03199469|567032646|FG001|Overall Study|Withdrawal by Subject|0|||
157076309|NCT03199469|567032645|FG000|Overall Study|Death|1|||
157076310|NCT03199469|567032646|FG001|Overall Study|Death|3|||
157076311|NCT03199469|567032645|FG000|Overall Study|Ongoing|5|||
157076312|NCT03199469|567032646|FG001|Overall Study|Ongoing|14|||
157076313|NCT03080493|567032647|FG000|Overall Study|Did not provide NRS pain results|1|||
157076314|NCT03080493|567032648|FG001|Overall Study|Did not provide NRS pain results|0|||
157076315|NCT03080493|567032647|FG000|Overall Study|Adverse Event|0|||
157076316|NCT03080493|567032648|FG001|Overall Study|Adverse Event|1|||
157076317|NCT03080493|567032647|FG000|Overall Study|Randomization error (parity group)|0|||
157076318|NCT03080493|567032648|FG001|Overall Study|Randomization error (parity group)|1|||
157076319|NCT01304498|567032649|FG000|Overall Study|Adverse Event|1|||
157076320|NCT01304498|567032650|FG001|Overall Study|Adverse Event|1|||
157076321|NCT01304498|567032649|FG000|Overall Study|Withdrawal by Subject|2|||
157076322|NCT01304498|567032650|FG001|Overall Study|Withdrawal by Subject|3|||
157076323|NCT01304498|567032649|FG000|Overall Study|Protocol Violation|1|||
157076324|NCT01304498|567032650|FG001|Overall Study|Protocol Violation|0|||
157076325|NCT01304498|567032649|FG000|Overall Study|Lost to Follow-up|2|||
157076326|NCT01304498|567032650|FG001|Overall Study|Lost to Follow-up|1|||
157231678|NCT01315249|567595328|FG000|Overall Study|Protocol Violation|8|||
157231679|NCT01315249|567595329|FG001|Overall Study|Protocol Violation|5|||
157231680|NCT01315249|567595328|FG000|Overall Study|Abnormal test results|1|||
157231681|NCT01315249|567595329|FG001|Overall Study|Abnormal test results|2|||
157231682|NCT01315249|567595328|FG000|Overall Study|Administrative problems|1|||
157231683|NCT01315249|567595329|FG001|Overall Study|Administrative problems|0|||
157231684|NCT01315249|567595328|FG000|Overall Study|inability to use device|1|||
157231685|NCT01315249|567595329|FG001|Overall Study|inability to use device|0|||
157231686|NCT01315249|567595328|FG000|Overall Study|Lack of Efficacy|0|||
157231687|NCT01315249|567595329|FG001|Overall Study|Lack of Efficacy|1|||
157231688|NCT01315249|567595328|FG000|Overall Study|Lost to Follow-up|0|||
157231689|NCT01315249|567595329|FG001|Overall Study|Lost to Follow-up|2|||
157231690|NCT01315249|567595328|FG000|Overall Study|Death|0|||
157231691|NCT01315249|567595329|FG001|Overall Study|Death|1|||
157231692|NCT01287013|567595330|FG000|Overall Study|Non-evaluable|3|||
157231693|NCT01287013|567595331|FG001|Overall Study|Non-evaluable|5|||
157231694|NCT01287013|567595332|FG002|Overall Study|Non-evaluable|21|||
157076327|NCT02522728|567032658|FG000|Overall Study|Withdrawal by Subject|6|||
157076328|NCT02522728|567032659|FG001|Overall Study|Withdrawal by Subject|6|||
157231695|NCT03247556|567595333|FG000|Overall Study|Adverse Event|1|||
157231696|NCT03247556|567595334|FG001|Overall Study|Adverse Event|4|||
157231697|NCT03247556|567595335|FG002|Overall Study|Adverse Event|5|||
157076329|NCT02522728|567032658|FG000|Overall Study|Death|4|||
157076330|NCT02522728|567032659|FG001|Overall Study|Death|3|||
157076331|NCT02522728|567032658|FG000|Overall Study|Adverse Event|2|||
157076332|NCT02522728|567032659|FG001|Overall Study|Adverse Event|1|||
157231698|NCT03247556|567595333|FG000|Overall Study|Lost to Follow-up|5|||
157231699|NCT03247556|567595334|FG001|Overall Study|Lost to Follow-up|5|||
157231700|NCT03247556|567595335|FG002|Overall Study|Lost to Follow-up|4|||
157231701|NCT03247556|567595333|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
157231702|NCT03247556|567595334|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
157231703|NCT03247556|567595335|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
157231704|NCT03247556|567595333|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
157231705|NCT03247556|567595334|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
157076333|NCT02522728|567032658|FG000|Overall Study|Did not receive randomized study device|0|||
157076334|NCT02522728|567032659|FG001|Overall Study|Did not receive randomized study device|1|||
157076335|NCT01099917|567032660|FG000|Overall Study|Adverse Event|3|||
157076336|NCT01099917|567032660|FG000|Overall Study|Not Treated|24|||
157076337|NCT02990468|567032661|FG000|Phase 2: MTD|Change in treatment|0|||
157076338|NCT02990468|567032662|FG001|Phase 2: MTD|Change in treatment|0|||
157076339|NCT02990468|567032663|FG002|Phase 2: MTD|Change in treatment|1|||
157076340|NCT02567708|567032665|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
157076341|NCT02567708|567032666|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
157076342|NCT02567708|567032665|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
157076343|NCT02567708|567032666|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
157076344|NCT02567708|567032665|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
157076345|NCT02567708|567032666|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
157076346|NCT02567708|567032665|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
157076347|NCT02567708|567032666|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
157076348|NCT00706654|567032667|FG000|Conversion Phase|Lost to Follow-up|4|||
157076349|NCT00706654|567032668|FG001|Conversion Phase|Lost to Follow-up|0|||
157076350|NCT00706654|567032669|FG002|Conversion Phase|Lost to Follow-up|0|||
157076351|NCT00706654|567032670|FG003|Conversion Phase|Lost to Follow-up|0|||
157076352|NCT00706654|567032667|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
157076353|NCT00706654|567032668|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
157076354|NCT00706654|567032669|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
157076355|NCT00706654|567032670|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
157076356|NCT00706654|567032667|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
157076357|NCT00706654|567032668|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
157076358|NCT00706654|567032669|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
157076359|NCT00706654|567032670|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
157076360|NCT00706654|567032667|FG000|Conversion Phase|Withdrawn by Investigator|14|||
157076361|NCT00706654|567032668|FG001|Conversion Phase|Withdrawn by Investigator|0|||
157076362|NCT00706654|567032669|FG002|Conversion Phase|Withdrawn by Investigator|0|||
157076363|NCT00706654|567032670|FG003|Conversion Phase|Withdrawn by Investigator|0|||
157076364|NCT00706654|567032667|FG000|Conversion Phase|Withdrew Consent|38|||
157076365|NCT00706654|567032668|FG001|Conversion Phase|Withdrew Consent|0|||
157076366|NCT00706654|567032669|FG002|Conversion Phase|Withdrew Consent|0|||
157231706|NCT03247556|567595335|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
157231707|NCT03247556|567595333|FG000|Overall Study|Protocol Violation|2|||
157231708|NCT03247556|567595334|FG001|Overall Study|Protocol Violation|0|||
157231709|NCT03247556|567595335|FG002|Overall Study|Protocol Violation|1|||
157076367|NCT00706654|567032670|FG003|Conversion Phase|Withdrew Consent|0|||
157076368|NCT00706654|567032667|FG000|Conversion Phase|Adverse Event|18|||
157231710|NCT03247556|567595333|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
157231711|NCT03247556|567595334|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
157076369|NCT00706654|567032668|FG001|Conversion Phase|Adverse Event|0|||
157076370|NCT00706654|567032669|FG002|Conversion Phase|Adverse Event|0|||
157076371|NCT00706654|567032670|FG003|Conversion Phase|Adverse Event|0|||
157076372|NCT00706654|567032667|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
157076373|NCT00706654|567032668|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
157076374|NCT00706654|567032669|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
157076375|NCT00706654|567032670|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
157076376|NCT00706654|567032667|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
157076377|NCT00706654|567032668|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
157076378|NCT00706654|567032669|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
157076379|NCT00706654|567032670|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
157076380|NCT00706654|567032667|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
157076381|NCT00706654|567032668|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
157076382|NCT00706654|567032669|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
157076383|NCT00706654|567032670|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
157076384|NCT00706654|567032667|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
157076385|NCT00706654|567032668|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
157076386|NCT00706654|567032669|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
157076387|NCT00706654|567032670|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
157076388|NCT00706654|567032667|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
157076389|NCT00706654|567032668|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
157076390|NCT00706654|567032669|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
157076391|NCT00706654|567032670|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
157076392|NCT00706654|567032667|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
157076393|NCT00706654|567032668|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
157076394|NCT00706654|567032669|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
157076395|NCT00706654|567032670|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
157076396|NCT00706654|567032667|FG000|Oral Stabilization Phase|Withdrew consent|55|||
157076397|NCT00706654|567032668|FG001|Oral Stabilization Phase|Withdrew consent|0|||
157076398|NCT00706654|567032669|FG002|Oral Stabilization Phase|Withdrew consent|0|||
157076399|NCT00706654|567032670|FG003|Oral Stabilization Phase|Withdrew consent|0|||
157076400|NCT00706654|567032667|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
157076401|NCT00706654|567032668|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
157076402|NCT00706654|567032669|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
157076403|NCT00706654|567032670|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
157076404|NCT00706654|567032667|FG000|Oral Stabilization Phase|Adverse Event|21|||
157076405|NCT00706654|567032668|FG001|Oral Stabilization Phase|Adverse Event|0|||
157076406|NCT00706654|567032669|FG002|Oral Stabilization Phase|Adverse Event|0|||
157076407|NCT00706654|567032670|FG003|Oral Stabilization Phase|Adverse Event|0|||
157076408|NCT00706654|567032667|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
157076409|NCT00706654|567032668|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157076410|NCT00706654|567032669|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157076411|NCT00706654|567032670|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
157076412|NCT00706654|567032667|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
157076413|NCT00706654|567032668|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157076414|NCT00706654|567032669|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157076415|NCT00706654|567032670|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
157076416|NCT00706654|567032667|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
157076417|NCT00706654|567032668|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
157076418|NCT00706654|567032669|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
157076419|NCT00706654|567032670|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
157076420|NCT00706654|567032667|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
157076421|NCT00706654|567032668|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
157076422|NCT00706654|567032669|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
157076423|NCT00706654|567032670|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
157076424|NCT00706654|567032667|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
157076425|NCT00706654|567032668|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
157076426|NCT00706654|567032669|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
157076427|NCT00706654|567032670|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
157076428|NCT00706654|567032667|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
157076429|NCT00706654|567032668|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
157076430|NCT00706654|567032669|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
157076431|NCT00706654|567032670|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
157076432|NCT00706654|567032667|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
157076433|NCT00706654|567032668|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
157076434|NCT00706654|567032669|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
157076435|NCT00706654|567032670|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
157076436|NCT00706654|567032667|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
157076437|NCT00706654|567032668|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
157076438|NCT00706654|567032669|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
157076439|NCT00706654|567032670|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
157076440|NCT00706654|567032667|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
157076441|NCT00706654|567032668|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
157076442|NCT00706654|567032669|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
157076443|NCT00706654|567032670|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
157076444|NCT00706654|567032667|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
157076445|NCT00706654|567032668|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
157076446|NCT00706654|567032669|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
157076447|NCT00706654|567032670|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
157076448|NCT01001390|567032671|FG000|Overall Study|Failure to wear AFO device|2|||
157076449|NCT01001390|567032672|FG001|Overall Study|Failure to wear AFO device|0|||
157076450|NCT01825577|567032673|FG000|Overall Study|Physician Decision|2|||
157076451|NCT01825577|567032673|FG000|Overall Study|Withdrawal by Subject|1|||
157076452|NCT01825577|567032673|FG000|Overall Study|Withdrawn by family members|2|||
157076453|NCT01825577|567032673|FG000|Overall Study|Lack of Efficacy|3|||
157076454|NCT01427725|567032676|FG000|Overall Study|Lost to Follow-up|17|||
157076455|NCT01427725|567032676|FG000|Overall Study|Protocol Violation|1|||
157076456|NCT01427725|567032676|FG000|Overall Study|Drug not administered|1|||
157076457|NCT01427725|567032676|FG000|Overall Study|Failure to visit|7|||
157076458|NCT01427725|567032676|FG000|Overall Study|Adverse Event|46|||
157076459|NCT01427725|567032676|FG000|Overall Study|Failure to visit after administration|40|||
157076460|NCT01427725|567032676|FG000|Overall Study|Patient's rejection|27|||
157076461|NCT01427725|567032676|FG000|Overall Study|Transfer to a different hospital|17|||
157076462|NCT01427725|567032676|FG000|Overall Study|Lack of Efficacy|8|||
157076463|NCT01427725|567032676|FG000|Overall Study|Death|7|||
157076464|NCT01427725|567032676|FG000|Overall Study|Symptom improvement|6|||
157076465|NCT01427725|567032676|FG000|Overall Study|AE and Patient's rejection|5|||
157076466|NCT01427725|567032676|FG000|Overall Study|Physician Decision|5|||
157076467|NCT01427725|567032676|FG000|Overall Study|Exacerbation of underlying disease|5|||
157076468|NCT01427725|567032676|FG000|Overall Study|Oral feeding difficulty|5|||
157076469|NCT01427725|567032676|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
157076470|NCT01427725|567032676|FG000|Overall Study|Forgetting prescription|1|||
157076471|NCT01427725|567032676|FG000|Overall Study|Other|2|||
157076472|NCT04230122|567032677|FG000|Overall Study|Lost to Follow-up|1|||
157076473|NCT04230122|567032678|FG001|Overall Study|Lost to Follow-up|0|||
157076474|NCT00604708|567032685|FG000|Overall Study|Withdrawal by Subject|9|||
157076475|NCT00604708|567032686|FG001|Overall Study|Withdrawal by Subject|10|||
157076476|NCT00604708|567032685|FG000|Overall Study|Protocol Violation|2|||
157076477|NCT00604708|567032686|FG001|Overall Study|Protocol Violation|8|||
157076478|NCT00604708|567032685|FG000|Overall Study|Lost to Follow-up|5|||
157076479|NCT00604708|567032686|FG001|Overall Study|Lost to Follow-up|5|||
157076480|NCT00604708|567032685|FG000|Overall Study|administrative reasons|9|||
157076481|NCT00604708|567032686|FG001|Overall Study|administrative reasons|11|||
157076482|NCT00604708|567032685|FG000|Overall Study|Adverse Event|6|||
157076483|NCT00604708|567032686|FG001|Overall Study|Adverse Event|6|||
157076484|NCT01277887|567032688|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
157076485|NCT01277887|567032689|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
157076486|NCT01277887|567032688|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
157076487|NCT01277887|567032689|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
157076488|NCT01277887|567032688|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
157076489|NCT01277887|567032689|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
157076490|NCT00415051|567032690|FG000|Overall Study|Protocol Violation|1|||
157076491|NCT04916730|567032691|FG000|Overall Study|Withdrawal by Subject|4|||
157076492|NCT04916730|567032692|FG001|Overall Study|Withdrawal by Subject|2|||
157076493|NCT04916730|567032691|FG000|Overall Study|Lost to Follow-up|0|||
157076494|NCT04916730|567032692|FG001|Overall Study|Lost to Follow-up|2|||
157076495|NCT04916730|567032691|FG000|Overall Study|Physician Decision|1|||
157076496|NCT04916730|567032692|FG001|Overall Study|Physician Decision|0|||
157076497|NCT01447576|567032707|FG000|Overall Study|Lost to Follow-up|52|||
157076498|NCT01447576|567032707|FG000|Overall Study|Adverse Event|127|||
157076499|NCT01447576|567032707|FG000|Overall Study|Participant met withdrawal criteria|40|||
157076500|NCT01447576|567032707|FG000|Overall Study|Withdrawal by Subject|100|||
157076501|NCT01447576|567032707|FG000|Overall Study|Protocol deviation|83|||
157076502|NCT01447576|567032707|FG000|Overall Study|Lack of Efficacy|68|||
157076503|NCT01447576|567032707|FG000|Overall Study|Physician Decision|6|||
157076504|NCT03128671|567032708|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
157076505|NCT03128671|567032709|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
157076506|NCT03128671|567032708|FG000|Allocation|Death|1|||
157076507|NCT03128671|567032709|FG001|Allocation|Death|0|||
157076508|NCT03128671|567032708|FG000|Allocation|Withdrawal by Subject|4|||
157076509|NCT03128671|567032709|FG001|Allocation|Withdrawal by Subject|0|||
157076510|NCT03128671|567032708|FG000|Intervention|Withdrawal by Subject|11|||
157076511|NCT03128671|567032709|FG001|Intervention|Withdrawal by Subject|10|||
157076512|NCT03128671|567032708|FG000|Intervention|Palliative/hospice care initiated|9|||
157076513|NCT03128671|567032709|FG001|Intervention|Palliative/hospice care initiated|10|||
157076514|NCT03128671|567032708|FG000|Intervention|Death|13|||
157076515|NCT03128671|567032709|FG001|Intervention|Death|11|||
157076516|NCT03128671|567032708|FG000|Intervention|Interrupted by hurricane|1|||
157076517|NCT03128671|567032709|FG001|Intervention|Interrupted by hurricane|0|||
157076518|NCT03128671|567032708|FG000|Intervention|Physician Decision|2|||
157076519|NCT03128671|567032709|FG001|Intervention|Physician Decision|3|||
157076520|NCT05239598|567032713|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
157076521|NCT05239598|567032714|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
157076522|NCT05239598|567032713|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
157076523|NCT05239598|567032714|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
157076524|NCT04855734|567032715|FG000|Overall Study|Lost to Follow-up|2|||
157076525|NCT04855734|567032716|FG001|Overall Study|Lost to Follow-up|2|||
157076526|NCT04535544|567032717|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
157076527|NCT04535544|567032718|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
157076528|NCT04535544|567032719|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
157076529|NCT04535544|567032720|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
157076530|NCT04535544|567032717|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
157076531|NCT04535544|567032718|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
157076532|NCT04535544|567032719|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
157076533|NCT04535544|567032720|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
157076534|NCT04535544|567032717|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
157076535|NCT04535544|567032718|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
157076536|NCT04535544|567032719|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
157076537|NCT04535544|567032720|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
157076538|NCT04535544|567032717|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
157076539|NCT04535544|567032718|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
157076540|NCT04535544|567032719|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
157076541|NCT04535544|567032720|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
157076542|NCT04535544|567032717|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
157076543|NCT04535544|567032718|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
157076544|NCT04535544|567032719|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
157076545|NCT04535544|567032720|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
157076546|NCT04535544|567032717|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
157076547|NCT04535544|567032718|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
157076548|NCT04535544|567032719|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
157076549|NCT04535544|567032720|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
157076550|NCT04535544|567032717|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
157076551|NCT04535544|567032718|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
157076552|NCT04535544|567032719|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
157076553|NCT04535544|567032720|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
157076554|NCT04535544|567032717|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
157076555|NCT04535544|567032718|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
157076556|NCT04535544|567032719|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
157076557|NCT04535544|567032720|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
157076558|NCT02706405|567034583|FG000|Overall Study|Death|3|||
157076559|NCT02706405|567034584|FG001|Overall Study|Death|2|||
157076560|NCT02706405|567034585|FG002|Overall Study|Death|0|||
157076561|NCT02706405|567034586|FG003|Overall Study|Death|1|||
157076562|NCT02706405|567034587|FG004|Overall Study|Death|0|||
157076563|NCT02706405|567034588|FG005|Overall Study|Death|0|||
157076564|NCT02706405|567034589|FG006|Overall Study|Death|3|||
157076565|NCT02706405|567034590|FG007|Overall Study|Death|4|||
157076566|NCT02706405|567034583|FG000|Overall Study|Disease progression|0|||
157076567|NCT02706405|567034584|FG001|Overall Study|Disease progression|0|||
157076568|NCT02706405|567034585|FG002|Overall Study|Disease progression|0|||
157076569|NCT02706405|567034586|FG003|Overall Study|Disease progression|0|||
157076570|NCT02706405|567034587|FG004|Overall Study|Disease progression|0|||
157076571|NCT02706405|567034588|FG005|Overall Study|Disease progression|0|||
157076572|NCT02706405|567034589|FG006|Overall Study|Disease progression|0|||
157076573|NCT02706405|567034590|FG007|Overall Study|Disease progression|1|||
157076574|NCT02706405|567034583|FG000|Overall Study|Pt moved to new therapy|0|||
157076575|NCT02706405|567034584|FG001|Overall Study|Pt moved to new therapy|0|||
157076576|NCT02706405|567034585|FG002|Overall Study|Pt moved to new therapy|0|||
157076577|NCT02706405|567034586|FG003|Overall Study|Pt moved to new therapy|0|||
157076578|NCT02706405|567034587|FG004|Overall Study|Pt moved to new therapy|0|||
157076579|NCT02706405|567034588|FG005|Overall Study|Pt moved to new therapy|1|||
157076580|NCT02706405|567034589|FG006|Overall Study|Pt moved to new therapy|0|||
157076581|NCT02706405|567034590|FG007|Overall Study|Pt moved to new therapy|1|||
157076582|NCT02706405|567034583|FG000|Overall Study|Physician Decision|1|||
157076583|NCT02706405|567034584|FG001|Overall Study|Physician Decision|0|||
157076584|NCT02706405|567034585|FG002|Overall Study|Physician Decision|0|||
157076585|NCT02706405|567034586|FG003|Overall Study|Physician Decision|0|||
157076586|NCT02706405|567034587|FG004|Overall Study|Physician Decision|0|||
157076587|NCT02706405|567034588|FG005|Overall Study|Physician Decision|0|||
157076588|NCT02706405|567034589|FG006|Overall Study|Physician Decision|0|||
157076589|NCT02706405|567034590|FG007|Overall Study|Physician Decision|0|||
157076590|NCT02304705|567034591|FG000|Overall Study|Withdrawal by Subject|2|||
157076591|NCT02304705|567034592|FG001|Overall Study|Withdrawal by Subject|0|||
157231712|NCT03247556|567595335|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
157231713|NCT02109042|567595337|FG000|Overall Study|Sponsor Decision|15|||
157231714|NCT02189941|567595338|FG000|Overall Study|Non-compliance|0|||
157231715|NCT02189941|567595339|FG001|Overall Study|Non-compliance|0|||
157231716|NCT02189941|567595340|FG002|Overall Study|Non-compliance|1|||
157231717|NCT03478397|567595346|FG000|Overall Study|Refused to participate|31|||
157231718|NCT03478397|567595347|FG001|Overall Study|Refused to participate|7|||
157231719|NCT04206332|567595348|FG000|Part A|Lost to Follow-up|0|||
157231720|NCT04206332|567595349|FG001|Part A|Lost to Follow-up|1|||
157231721|NCT04206332|567595350|FG002|Part A|Lost to Follow-up|0|||
157231722|NCT04206332|567595351|FG003|Part A|Lost to Follow-up|0|||
157076592|NCT02304705|567034591|FG000|Overall Study|Physician Decision|2|||
157076593|NCT02304705|567034592|FG001|Overall Study|Physician Decision|4|||
157076594|NCT02304705|567034591|FG000|Overall Study|Death|0|||
157076595|NCT02304705|567034592|FG001|Overall Study|Death|1|||
157076596|NCT02304705|567034591|FG000|Overall Study|Lost to Follow-up|0|||
157076597|NCT02304705|567034592|FG001|Overall Study|Lost to Follow-up|2|||
157076598|NCT03140280|567034593|FG000|Overall Study|Physician Decision|5|||
157076599|NCT05602727|567034604|FG000|Overall Study|Physician Decision|0|||
157076600|NCT05602727|567034605|FG001|Overall Study|Physician Decision|1|||
157076601|NCT05602727|567034606|FG002|Overall Study|Physician Decision|0|||
157076602|NCT05602727|567034604|FG000|Overall Study|Randomized by mistake without study medication|1|||
157076603|NCT05602727|567034605|FG001|Overall Study|Randomized by mistake without study medication|0|||
157076604|NCT05602727|567034606|FG002|Overall Study|Randomized by mistake without study medication|0|||
157231723|NCT04206332|567595352|FG004|Part A|Lost to Follow-up|0|||
157231724|NCT04206332|567595353|FG005|Part A|Lost to Follow-up|0|||
157076605|NCT05602727|567034604|FG000|Overall Study|Study termination by Sponsor|18|||
157076606|NCT05602727|567034605|FG001|Overall Study|Study termination by Sponsor|15|||
157076607|NCT05602727|567034606|FG002|Overall Study|Study termination by Sponsor|19|||
157076608|NCT05602727|567034604|FG000|Overall Study|Withdrawal by Subject|2|||
157076609|NCT05602727|567034605|FG001|Overall Study|Withdrawal by Subject|1|||
157076610|NCT05602727|567034606|FG002|Overall Study|Withdrawal by Subject|1|||
157076611|NCT05602727|567034604|FG000|Overall Study|Various reasons|1|||
157076612|NCT05602727|567034605|FG001|Overall Study|Various reasons|6|||
157076613|NCT05602727|567034606|FG002|Overall Study|Various reasons|1|||
157076614|NCT02038842|567034607|FG000|Overall Study|Withdrawal by Subject|2|||
157076615|NCT02038842|567034608|FG001|Overall Study|Withdrawal by Subject|2|||
157076616|NCT02038842|567034609|FG002|Overall Study|Withdrawal by Subject|0|||
157076617|NCT02038842|567034610|FG003|Overall Study|Withdrawal by Subject|0|||
157076618|NCT02038842|567034607|FG000|Overall Study|Participant decision|0|||
157076619|NCT02038842|567034608|FG001|Overall Study|Participant decision|0|||
157076620|NCT02038842|567034609|FG002|Overall Study|Participant decision|2|||
157076621|NCT02038842|567034610|FG003|Overall Study|Participant decision|1|||
157076622|NCT02038842|567034607|FG000|Overall Study|Adverse Event|0|||
157076623|NCT02038842|567034608|FG001|Overall Study|Adverse Event|0|||
157076624|NCT02038842|567034609|FG002|Overall Study|Adverse Event|3|||
157076625|NCT02038842|567034610|FG003|Overall Study|Adverse Event|1|||
157076626|NCT02038842|567034607|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
157076627|NCT02038842|567034608|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
157076628|NCT02038842|567034609|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
157076629|NCT02038842|567034610|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
157076630|NCT02643303|567034613|FG000|Overall Study|Progressive Disease|4|||
157076631|NCT02643303|567034614|FG001|Overall Study|Progressive Disease|4|||
157076632|NCT02643303|567034615|FG002|Overall Study|Progressive Disease|1|||
157076633|NCT02643303|567034616|FG003|Overall Study|Progressive Disease|12|||
157076634|NCT02643303|567034617|FG004|Overall Study|Progressive Disease|6|||
157076635|NCT02643303|567034618|FG005|Overall Study|Progressive Disease|4|||
157076636|NCT02643303|567034619|FG006|Overall Study|Progressive Disease|8|||
157076637|NCT02643303|567034620|FG007|Overall Study|Progressive Disease|2|||
157076638|NCT02643303|567034621|FG008|Overall Study|Progressive Disease|6|||
157076639|NCT02643303|567034613|FG000|Overall Study|Adverse Event|0|||
157076640|NCT02643303|567034614|FG001|Overall Study|Adverse Event|1|||
157076641|NCT02643303|567034615|FG002|Overall Study|Adverse Event|0|||
157076642|NCT02643303|567034616|FG003|Overall Study|Adverse Event|0|||
157076643|NCT02643303|567034617|FG004|Overall Study|Adverse Event|1|||
157076644|NCT02643303|567034618|FG005|Overall Study|Adverse Event|0|||
157076645|NCT02643303|567034619|FG006|Overall Study|Adverse Event|0|||
157231725|NCT04206332|567595354|FG006|Part A|Lost to Follow-up|0|||
157076646|NCT02643303|567034620|FG007|Overall Study|Adverse Event|0|||
157076647|NCT02643303|567034621|FG008|Overall Study|Adverse Event|0|||
157076648|NCT02643303|567034613|FG000|Overall Study|Withdrawal by Subject|0|||
157076649|NCT02643303|567034614|FG001|Overall Study|Withdrawal by Subject|0|||
157076650|NCT02643303|567034615|FG002|Overall Study|Withdrawal by Subject|0|||
157231726|NCT04206332|567595355|FG007|Part A|Lost to Follow-up|0|||
157231727|NCT04206332|567595356|FG008|Part A|Lost to Follow-up|0|||
157076651|NCT02643303|567034616|FG003|Overall Study|Withdrawal by Subject|1|||
157076652|NCT02643303|567034617|FG004|Overall Study|Withdrawal by Subject|0|||
157076653|NCT02643303|567034618|FG005|Overall Study|Withdrawal by Subject|0|||
157076654|NCT02643303|567034619|FG006|Overall Study|Withdrawal by Subject|1|||
157076655|NCT02643303|567034620|FG007|Overall Study|Withdrawal by Subject|1|||
157076656|NCT02643303|567034621|FG008|Overall Study|Withdrawal by Subject|1|||
157076657|NCT05332912|567034622|FG000|Overall Study|Withdrawal by Subject|0|||
157076658|NCT05332912|567034623|FG001|Overall Study|Withdrawal by Subject|1|||
157076659|NCT05332912|567034624|FG002|Overall Study|Withdrawal by Subject|2|||
157076660|NCT05332912|567034625|FG003|Overall Study|Withdrawal by Subject|0|||
157076661|NCT05332912|567034622|FG000|Overall Study|Lost to Follow-up|0|||
157076662|NCT05332912|567034623|FG001|Overall Study|Lost to Follow-up|0|||
157076663|NCT05332912|567034624|FG002|Overall Study|Lost to Follow-up|1|||
157076664|NCT05332912|567034625|FG003|Overall Study|Lost to Follow-up|0|||
157076665|NCT01174446|567034626|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
157076666|NCT01174446|567034627|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
157076667|NCT01174446|567034628|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
157076668|NCT01174446|567034629|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
157076669|NCT01174446|567034626|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
157076670|NCT01174446|567034627|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
157076671|NCT01174446|567034628|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
157076672|NCT01174446|567034629|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
157076673|NCT01174446|567034626|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
157076674|NCT01174446|567034627|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
157076675|NCT01174446|567034628|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
157231728|NCT04206332|567595357|FG009|Part A|Lost to Follow-up|0|||
157231729|NCT04206332|567595358|FG010|Part A|Lost to Follow-up|0|||
157231730|NCT04206332|567595359|FG011|Part A|Lost to Follow-up|0|||
157231731|NCT04206332|567595360|FG012|Part A|Lost to Follow-up|0|||
157231732|NCT04206332|567595361|FG013|Part A|Lost to Follow-up|0|||
157231733|NCT04206332|567595362|FG014|Part A|Lost to Follow-up|0|||
157231734|NCT04206332|567595363|FG015|Part A|Lost to Follow-up|0|||
157076676|NCT01174446|567034629|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
157076677|NCT01174446|567034626|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
157076678|NCT01174446|567034627|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
157076679|NCT01174446|567034628|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
157076680|NCT01174446|567034629|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
157076681|NCT00847626|567034632|FG000|Overall Study|Adverse Event|10|||
157076682|NCT00847626|567034633|FG001|Overall Study|Adverse Event|10|||
157231735|NCT04206332|567595364|FG016|Part A|Lost to Follow-up|0|||
157231736|NCT04206332|567595348|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157076683|NCT00847626|567034634|FG002|Overall Study|Adverse Event|6|||
157076684|NCT00847626|567034635|FG003|Overall Study|Adverse Event|19|||
157231737|NCT04206332|567595349|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231738|NCT04206332|567595350|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231739|NCT04206332|567595351|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231740|NCT04206332|567595352|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231741|NCT04206332|567595353|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
157231742|NCT04206332|567595354|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157076685|NCT00847626|567034636|FG004|Overall Study|Adverse Event|11|||
157076686|NCT00847626|567034637|FG005|Overall Study|Adverse Event|22|||
157076687|NCT00847626|567034638|FG006|Overall Study|Adverse Event|4|||
157076688|NCT00847626|567034639|FG007|Overall Study|Adverse Event|6|||
157076689|NCT00847626|567034640|FG008|Overall Study|Adverse Event|3|||
157076690|NCT00847626|567034641|FG009|Overall Study|Adverse Event|6|||
157076691|NCT00847626|567034642|FG010|Overall Study|Adverse Event|6|||
157076692|NCT00847626|567034632|FG000|Overall Study|Protocol Violation|2|||
157231743|NCT04206332|567595355|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231744|NCT04206332|567595356|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231745|NCT04206332|567595357|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231746|NCT04206332|567595358|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231747|NCT04206332|567595359|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231748|NCT04206332|567595360|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231749|NCT04206332|567595361|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231750|NCT04206332|567595362|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231751|NCT04206332|567595363|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231752|NCT04206332|567595364|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
157231753|NCT04206332|567595348|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231754|NCT04206332|567595349|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231755|NCT04206332|567595350|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231756|NCT04206332|567595351|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231757|NCT04206332|567595352|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231758|NCT04206332|567595353|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231759|NCT04206332|567595354|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231760|NCT04206332|567595355|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
157231761|NCT04206332|567595356|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231762|NCT04206332|567595357|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231763|NCT04206332|567595358|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
157231764|NCT04206332|567595359|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231765|NCT04206332|567595360|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231766|NCT04206332|567595361|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231767|NCT04206332|567595362|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231768|NCT04206332|567595363|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231769|NCT04206332|567595364|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231770|NCT04206332|567595348|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231771|NCT04206332|567595349|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231772|NCT04206332|567595350|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231773|NCT04206332|567595351|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231774|NCT04206332|567595352|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231775|NCT04206332|567595353|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231776|NCT04206332|567595354|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231777|NCT04206332|567595355|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231778|NCT04206332|567595356|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231779|NCT04206332|567595357|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231780|NCT04206332|567595358|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231781|NCT04206332|567595359|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231782|NCT04206332|567595360|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231783|NCT04206332|567595361|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231784|NCT04206332|567595362|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231785|NCT04206332|567595363|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
157231786|NCT04206332|567595364|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
157231787|NCT04206332|567595348|FG000|Part C|Withdrawal by Subject|0|||
157231788|NCT04206332|567595349|FG001|Part C|Withdrawal by Subject|0|||
157231789|NCT04206332|567595350|FG002|Part C|Withdrawal by Subject|0|||
157231790|NCT04206332|567595351|FG003|Part C|Withdrawal by Subject|0|||
157231791|NCT04206332|567595352|FG004|Part C|Withdrawal by Subject|0|||
157231792|NCT04206332|567595353|FG005|Part C|Withdrawal by Subject|0|||
157231793|NCT04206332|567595354|FG006|Part C|Withdrawal by Subject|0|||
157231794|NCT04206332|567595355|FG007|Part C|Withdrawal by Subject|0|||
157231795|NCT04206332|567595356|FG008|Part C|Withdrawal by Subject|0|||
157231796|NCT04206332|567595357|FG009|Part C|Withdrawal by Subject|0|||
157231797|NCT04206332|567595358|FG010|Part C|Withdrawal by Subject|0|||
157231798|NCT04206332|567595359|FG011|Part C|Withdrawal by Subject|0|||
157231799|NCT04206332|567595360|FG012|Part C|Withdrawal by Subject|0|||
157231800|NCT04206332|567595361|FG013|Part C|Withdrawal by Subject|0|||
157231801|NCT04206332|567595362|FG014|Part C|Withdrawal by Subject|2|||
157231802|NCT04206332|567595363|FG015|Part C|Withdrawal by Subject|0|||
157231803|NCT04206332|567595364|FG016|Part C|Withdrawal by Subject|0|||
157076693|NCT00847626|567034633|FG001|Overall Study|Protocol Violation|1|||
157076694|NCT00847626|567034634|FG002|Overall Study|Protocol Violation|2|||
157076695|NCT00847626|567034635|FG003|Overall Study|Protocol Violation|1|||
157231804|NCT03988803|567595365|FG000|Period 2|Prematurely discontinued from medication|2|||
157231805|NCT03988803|567595365|FG000|Period 2|Adverse Event|1|||
157231806|NCT01617668|567595366|FG000|Overall Study|Adverse Event|7|||
157231807|NCT01617668|567595367|FG001|Overall Study|Adverse Event|0|||
157231808|NCT01617668|567595368|FG002|Overall Study|Adverse Event|12|||
157231809|NCT01617668|567595369|FG003|Overall Study|Adverse Event|5|||
157231810|NCT01617668|567595366|FG000|Overall Study|Physician Decision|1|||
157231811|NCT01617668|567595367|FG001|Overall Study|Physician Decision|2|||
157231812|NCT01617668|567595368|FG002|Overall Study|Physician Decision|3|||
157231813|NCT01617668|567595369|FG003|Overall Study|Physician Decision|0|||
157231814|NCT01617668|567595366|FG000|Overall Study|Progressive Disease|4|||
157231815|NCT01617668|567595367|FG001|Overall Study|Progressive Disease|4|||
157231816|NCT01617668|567595368|FG002|Overall Study|Progressive Disease|6|||
157231817|NCT01617668|567595369|FG003|Overall Study|Progressive Disease|9|||
157231818|NCT01617668|567595366|FG000|Overall Study|Subject/guardian decision|1|||
157231819|NCT01617668|567595367|FG001|Overall Study|Subject/guardian decision|3|||
157231820|NCT01617668|567595368|FG002|Overall Study|Subject/guardian decision|2|||
157231821|NCT01617668|567595369|FG003|Overall Study|Subject/guardian decision|1|||
157231822|NCT02017964|567595370|FG000|Overall Study|Patient deemed ineligible|1|||
157231823|NCT00925769|567595371|FG000|Overall Study|Major toxicity|1|||
157231824|NCT00925769|567595372|FG001|Overall Study|Major toxicity|0|||
157231825|NCT00925769|567595373|FG002|Overall Study|Major toxicity|1|||
157231826|NCT00925769|567595374|FG003|Overall Study|Major toxicity|1|||
157231827|NCT00925769|567595375|FG004|Overall Study|Major toxicity|0|||
157231828|NCT00925769|567595376|FG005|Overall Study|Major toxicity|0|||
157231829|NCT00925769|567595371|FG000|Overall Study|Disease progression|4|||
157231830|NCT00925769|567595372|FG001|Overall Study|Disease progression|5|||
157231831|NCT00925769|567595373|FG002|Overall Study|Disease progression|3|||
157231832|NCT00925769|567595374|FG003|Overall Study|Disease progression|4|||
157231833|NCT00925769|567595375|FG004|Overall Study|Disease progression|2|||
157231834|NCT00925769|567595376|FG005|Overall Study|Disease progression|3|||
157231835|NCT00925769|567595371|FG000|Overall Study|Death|0|||
157231836|NCT00925769|567595372|FG001|Overall Study|Death|0|||
157231837|NCT00925769|567595373|FG002|Overall Study|Death|1|||
157231838|NCT00925769|567595374|FG003|Overall Study|Death|0|||
157231839|NCT00925769|567595375|FG004|Overall Study|Death|0|||
157231840|NCT00925769|567595376|FG005|Overall Study|Death|0|||
157231841|NCT00925769|567595371|FG000|Overall Study|Physician Decision|1|||
157231842|NCT00925769|567595372|FG001|Overall Study|Physician Decision|0|||
157231843|NCT00925769|567595373|FG002|Overall Study|Physician Decision|0|||
157231844|NCT00925769|567595374|FG003|Overall Study|Physician Decision|0|||
157231845|NCT00925769|567595375|FG004|Overall Study|Physician Decision|0|||
157231846|NCT00925769|567595376|FG005|Overall Study|Physician Decision|0|||
157231847|NCT00925769|567595371|FG000|Overall Study|Missing documentation|0|||
157231848|NCT00925769|567595372|FG001|Overall Study|Missing documentation|1|||
157231849|NCT00925769|567595373|FG002|Overall Study|Missing documentation|0|||
157231850|NCT00925769|567595374|FG003|Overall Study|Missing documentation|0|||
157231851|NCT00925769|567595375|FG004|Overall Study|Missing documentation|0|||
157231852|NCT00925769|567595376|FG005|Overall Study|Missing documentation|0|||
157231853|NCT00925769|567595371|FG000|Overall Study|End of study visit not done|0|||
157231854|NCT00925769|567595372|FG001|Overall Study|End of study visit not done|0|||
157231855|NCT00925769|567595373|FG002|Overall Study|End of study visit not done|1|||
157231856|NCT00925769|567595374|FG003|Overall Study|End of study visit not done|0|||
157231857|NCT00925769|567595375|FG004|Overall Study|End of study visit not done|0|||
157231858|NCT00925769|567595376|FG005|Overall Study|End of study visit not done|0|||
157231859|NCT00925769|567595371|FG000|Overall Study|Participant is unable to swallow drug|0|||
157231860|NCT00925769|567595372|FG001|Overall Study|Participant is unable to swallow drug|0|||
157231861|NCT00925769|567595373|FG002|Overall Study|Participant is unable to swallow drug|0|||
157231862|NCT00925769|567595374|FG003|Overall Study|Participant is unable to swallow drug|1|||
157231863|NCT00925769|567595375|FG004|Overall Study|Participant is unable to swallow drug|0|||
157231864|NCT00925769|567595376|FG005|Overall Study|Participant is unable to swallow drug|0|||
157231865|NCT00925769|567595371|FG000|Overall Study|Adverse Event|0|||
157231866|NCT00925769|567595372|FG001|Overall Study|Adverse Event|0|||
157231867|NCT00925769|567595373|FG002|Overall Study|Adverse Event|0|||
157231868|NCT00925769|567595374|FG003|Overall Study|Adverse Event|0|||
157231869|NCT00925769|567595375|FG004|Overall Study|Adverse Event|1|||
157231870|NCT00925769|567595376|FG005|Overall Study|Adverse Event|0|||
157231871|NCT01434693|567595381|FG000|Overall Study|Adverse Event|1|||
157076696|NCT00847626|567034636|FG004|Overall Study|Protocol Violation|1|||
157076697|NCT00847626|567034637|FG005|Overall Study|Protocol Violation|1|||
157231872|NCT01434693|567595382|FG001|Overall Study|Adverse Event|0|||
157231873|NCT01434693|567595383|FG002|Overall Study|Adverse Event|0|||
157231874|NCT01434693|567595384|FG003|Overall Study|Adverse Event|0|||
157231875|NCT01434693|567595381|FG000|Overall Study|Withdrawal by Subject|1|||
157231876|NCT01434693|567595382|FG001|Overall Study|Withdrawal by Subject|0|||
157231877|NCT01434693|567595383|FG002|Overall Study|Withdrawal by Subject|1|||
157231878|NCT01434693|567595384|FG003|Overall Study|Withdrawal by Subject|1|||
157231879|NCT01434693|567595381|FG000|Overall Study|Lost to Follow-up|1|||
157076698|NCT00847626|567034638|FG006|Overall Study|Protocol Violation|1|||
157076699|NCT00847626|567034639|FG007|Overall Study|Protocol Violation|1|||
157076700|NCT00847626|567034640|FG008|Overall Study|Protocol Violation|0|||
157076701|NCT00847626|567034641|FG009|Overall Study|Protocol Violation|1|||
157076702|NCT00847626|567034642|FG010|Overall Study|Protocol Violation|1|||
157076703|NCT00847626|567034632|FG000|Overall Study|Lost to Follow-up|0|||
157076704|NCT00847626|567034633|FG001|Overall Study|Lost to Follow-up|1|||
157076705|NCT00847626|567034634|FG002|Overall Study|Lost to Follow-up|1|||
157076706|NCT00847626|567034635|FG003|Overall Study|Lost to Follow-up|1|||
157076707|NCT00847626|567034636|FG004|Overall Study|Lost to Follow-up|0|||
157076708|NCT00847626|567034637|FG005|Overall Study|Lost to Follow-up|3|||
157076709|NCT00847626|567034638|FG006|Overall Study|Lost to Follow-up|1|||
157076710|NCT00847626|567034639|FG007|Overall Study|Lost to Follow-up|3|||
157076711|NCT00847626|567034640|FG008|Overall Study|Lost to Follow-up|1|||
157076712|NCT00847626|567034641|FG009|Overall Study|Lost to Follow-up|0|||
157076713|NCT00847626|567034642|FG010|Overall Study|Lost to Follow-up|1|||
157076714|NCT00847626|567034632|FG000|Overall Study|Withdrawal by Subject|5|||
157076715|NCT00847626|567034633|FG001|Overall Study|Withdrawal by Subject|5|||
157076716|NCT00847626|567034634|FG002|Overall Study|Withdrawal by Subject|3|||
157076717|NCT00847626|567034635|FG003|Overall Study|Withdrawal by Subject|8|||
157076718|NCT00847626|567034636|FG004|Overall Study|Withdrawal by Subject|12|||
157076719|NCT00847626|567034637|FG005|Overall Study|Withdrawal by Subject|9|||
157076720|NCT00847626|567034638|FG006|Overall Study|Withdrawal by Subject|8|||
157076721|NCT00847626|567034639|FG007|Overall Study|Withdrawal by Subject|4|||
157076722|NCT00847626|567034640|FG008|Overall Study|Withdrawal by Subject|4|||
157076723|NCT00847626|567034641|FG009|Overall Study|Withdrawal by Subject|5|||
157076724|NCT00847626|567034642|FG010|Overall Study|Withdrawal by Subject|2|||
157076725|NCT00847626|567034632|FG000|Overall Study|Lack of Efficacy|3|||
157076726|NCT00847626|567034633|FG001|Overall Study|Lack of Efficacy|1|||
157076727|NCT00847626|567034634|FG002|Overall Study|Lack of Efficacy|0|||
157076728|NCT00847626|567034635|FG003|Overall Study|Lack of Efficacy|1|||
157076729|NCT00847626|567034636|FG004|Overall Study|Lack of Efficacy|2|||
157076730|NCT00847626|567034637|FG005|Overall Study|Lack of Efficacy|0|||
157076731|NCT00847626|567034638|FG006|Overall Study|Lack of Efficacy|6|||
157192697|NCT00545740|567447171|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
157192698|NCT00545740|567447172|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
157192699|NCT00545740|567447173|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
157192700|NCT00545740|567447174|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
157192701|NCT00545740|567447171|FG000|Overall Study|Site closure|1|||
157192702|NCT00545740|567447172|FG001|Overall Study|Site closure|0|||
157192703|NCT00545740|567447173|FG002|Overall Study|Site closure|0|||
157192704|NCT00545740|567447174|FG003|Overall Study|Site closure|0|||
157192705|NCT00545740|567447171|FG000|Overall Study|Missed visit|1|||
157192706|NCT00545740|567447172|FG001|Overall Study|Missed visit|0|||
157192707|NCT00545740|567447173|FG002|Overall Study|Missed visit|0|||
157192708|NCT00545740|567447174|FG003|Overall Study|Missed visit|0|||
157192709|NCT00545740|567447171|FG000|Overall Study|Physician Decision|0|||
157192710|NCT00545740|567447172|FG001|Overall Study|Physician Decision|0|||
157192711|NCT00545740|567447173|FG002|Overall Study|Physician Decision|3|||
157192712|NCT00545740|567447174|FG003|Overall Study|Physician Decision|0|||
157192713|NCT00545740|567447171|FG000|Overall Study|Accepted only monthly telephone calls|1|||
157192714|NCT00545740|567447172|FG001|Overall Study|Accepted only monthly telephone calls|0|||
157192715|NCT00545740|567447173|FG002|Overall Study|Accepted only monthly telephone calls|0|||
157192716|NCT00545740|567447174|FG003|Overall Study|Accepted only monthly telephone calls|0|||
157192717|NCT00545740|567447171|FG000|Overall Study|Sponsor decision|0|||
157192718|NCT00545740|567447172|FG001|Overall Study|Sponsor decision|1|||
157192719|NCT00545740|567447173|FG002|Overall Study|Sponsor decision|0|||
157192720|NCT00545740|567447174|FG003|Overall Study|Sponsor decision|0|||
157192721|NCT00545740|567447171|FG000|Overall Study|Lack of time|0|||
157192722|NCT00545740|567447172|FG001|Overall Study|Lack of time|1|||
157192723|NCT00545740|567447173|FG002|Overall Study|Lack of time|0|||
157192724|NCT00545740|567447174|FG003|Overall Study|Lack of time|0|||
157192725|NCT00545740|567447171|FG000|Overall Study|Non-adherence to visits|0|||
157192726|NCT00545740|567447172|FG001|Overall Study|Non-adherence to visits|1|||
157192727|NCT00545740|567447173|FG002|Overall Study|Non-adherence to visits|0|||
157192728|NCT00545740|567447174|FG003|Overall Study|Non-adherence to visits|0|||
157192729|NCT00545740|567447171|FG000|Overall Study|Patient difficulties|0|||
157231880|NCT01434693|567595382|FG001|Overall Study|Lost to Follow-up|0|||
157231881|NCT01434693|567595383|FG002|Overall Study|Lost to Follow-up|0|||
157076732|NCT00847626|567034639|FG007|Overall Study|Lack of Efficacy|2|||
157076733|NCT00847626|567034640|FG008|Overall Study|Lack of Efficacy|5|||
157076734|NCT00847626|567034641|FG009|Overall Study|Lack of Efficacy|1|||
157192730|NCT00545740|567447172|FG001|Overall Study|Patient difficulties|1|||
157192731|NCT00545740|567447173|FG002|Overall Study|Patient difficulties|0|||
157192732|NCT00545740|567447174|FG003|Overall Study|Patient difficulties|0|||
157192733|NCT00545740|567447171|FG000|Overall Study|Husband against study|0|||
157192734|NCT00545740|567447172|FG001|Overall Study|Husband against study|0|||
157192735|NCT00545740|567447173|FG002|Overall Study|Husband against study|1|||
157076735|NCT00847626|567034642|FG010|Overall Study|Lack of Efficacy|7|||
157076736|NCT00847626|567034632|FG000|Overall Study|Other|1|||
157076737|NCT00847626|567034633|FG001|Overall Study|Other|5|||
157076738|NCT00847626|567034634|FG002|Overall Study|Other|4|||
157076739|NCT00847626|567034635|FG003|Overall Study|Other|1|||
157076740|NCT00847626|567034636|FG004|Overall Study|Other|2|||
157076741|NCT00847626|567034637|FG005|Overall Study|Other|2|||
157076742|NCT00847626|567034638|FG006|Overall Study|Other|2|||
157076743|NCT00847626|567034639|FG007|Overall Study|Other|3|||
157076744|NCT00847626|567034640|FG008|Overall Study|Other|1|||
157076745|NCT00847626|567034641|FG009|Overall Study|Other|1|||
157076746|NCT00847626|567034642|FG010|Overall Study|Other|3|||
157076747|NCT00335140|567034645|FG000|Overall Study|Ineligible|1|||
157076748|NCT00737477|567034646|FG000|Overall Study|Adverse Event|9|||
157076749|NCT00737477|567034646|FG000|Overall Study|Death|9|||
157076750|NCT00737477|567034646|FG000|Overall Study|Treatment Refusal|1|||
157076751|NCT00737477|567034646|FG000|Overall Study|Withdrawal by Subject|1|||
157076752|NCT00737477|567034646|FG000|Overall Study|Renal Transplantation|10|||
157076753|NCT00737477|567034646|FG000|Overall Study|Other|4|||
157076754|NCT01132820|567034647|FG000|Overall Study|Ineligible: wrong cell type|1|||
157076755|NCT01132820|567034647|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
157076756|NCT01132820|567034647|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
157076757|NCT01132820|567034647|FG000|Overall Study|Never treated|1|||
157076758|NCT01132820|567034647|FG000|Overall Study|Inadequate data|1|||
157076759|NCT01370655|567034648|FG000|Period 1|Adverse Event|2|||
157076760|NCT01370655|567034649|FG001|Period 1|Adverse Event|0|||
157076761|NCT01370655|567034650|FG002|Period 1|Adverse Event|0|||
157076762|NCT01370655|567034651|FG003|Period 1|Adverse Event|0|||
157076763|NCT01370655|567034652|FG004|Period 1|Adverse Event|0|||
157076764|NCT01370655|567034653|FG005|Period 1|Adverse Event|0|||
157076765|NCT01370655|567034654|FG006|Period 1|Adverse Event|1|||
157076766|NCT01370655|567034655|FG007|Period 1|Adverse Event|0|||
157076767|NCT01370655|567034656|FG008|Period 1|Adverse Event|0|||
157076768|NCT01370655|567034657|FG009|Period 1|Adverse Event|0|||
157076769|NCT01370655|567034658|FG010|Period 1|Adverse Event|0|||
157076770|NCT01370655|567034659|FG011|Period 1|Adverse Event|0|||
157076771|NCT01370655|567034648|FG000|Period 2|Adverse Event|0|||
157076772|NCT01370655|567034649|FG001|Period 2|Adverse Event|0|||
157076773|NCT01370655|567034650|FG002|Period 2|Adverse Event|1|||
157076774|NCT01370655|567034651|FG003|Period 2|Adverse Event|0|||
157076775|NCT01370655|567034652|FG004|Period 2|Adverse Event|1|||
157076776|NCT01370655|567034653|FG005|Period 2|Adverse Event|0|||
157076777|NCT01370655|567034654|FG006|Period 2|Adverse Event|0|||
157076778|NCT01370655|567034655|FG007|Period 2|Adverse Event|1|||
157076779|NCT01370655|567034656|FG008|Period 2|Adverse Event|0|||
157076780|NCT01370655|567034657|FG009|Period 2|Adverse Event|0|||
157076781|NCT01370655|567034658|FG010|Period 2|Adverse Event|0|||
157076782|NCT01370655|567034659|FG011|Period 2|Adverse Event|0|||
157076783|NCT01370655|567034648|FG000|Period 2|met protocol specified stopping criteria|0|||
157076784|NCT01370655|567034649|FG001|Period 2|met protocol specified stopping criteria|0|||
157076785|NCT01370655|567034650|FG002|Period 2|met protocol specified stopping criteria|1|||
157076786|NCT01370655|567034651|FG003|Period 2|met protocol specified stopping criteria|0|||
157076787|NCT01370655|567034652|FG004|Period 2|met protocol specified stopping criteria|0|||
157076788|NCT01370655|567034653|FG005|Period 2|met protocol specified stopping criteria|0|||
157076789|NCT01370655|567034654|FG006|Period 2|met protocol specified stopping criteria|1|||
157076790|NCT01370655|567034655|FG007|Period 2|met protocol specified stopping criteria|0|||
157076791|NCT01370655|567034656|FG008|Period 2|met protocol specified stopping criteria|1|||
157076792|NCT01370655|567034657|FG009|Period 2|met protocol specified stopping criteria|0|||
157231882|NCT01434693|567595384|FG003|Overall Study|Lost to Follow-up|0|||
157231883|NCT00912288|567595385|FG000|Overall Study|Death|0|||
157231884|NCT00912288|567595386|FG001|Overall Study|Death|1|||
157231885|NCT00912288|567595385|FG000|Overall Study|Adverse Event|1|||
157231886|NCT00912288|567595386|FG001|Overall Study|Adverse Event|1|||
157231887|NCT00912288|567595385|FG000|Overall Study|Lost to Follow-up|1|||
157231888|NCT00912288|567595386|FG001|Overall Study|Lost to Follow-up|0|||
157076793|NCT01370655|567034658|FG010|Period 2|met protocol specified stopping criteria|1|||
157076794|NCT01370655|567034659|FG011|Period 2|met protocol specified stopping criteria|0|||
157076795|NCT01370655|567034648|FG000|Period 2|Withdrawal by Subject|0|||
157076796|NCT01370655|567034649|FG001|Period 2|Withdrawal by Subject|0|||
157076797|NCT01370655|567034650|FG002|Period 2|Withdrawal by Subject|0|||
157231889|NCT00912288|567595385|FG000|Overall Study|Protocol Violation|1|||
157231890|NCT00912288|567595386|FG001|Overall Study|Protocol Violation|0|||
157076798|NCT01370655|567034651|FG003|Period 2|Withdrawal by Subject|0|||
157076799|NCT01370655|567034652|FG004|Period 2|Withdrawal by Subject|0|||
157076800|NCT01370655|567034653|FG005|Period 2|Withdrawal by Subject|0|||
157231891|NCT00912288|567595385|FG000|Overall Study|Withdrawal by Subject|3|||
157231892|NCT00912288|567595386|FG001|Overall Study|Withdrawal by Subject|3|||
157076801|NCT01370655|567034654|FG006|Period 2|Withdrawal by Subject|0|||
157076802|NCT01370655|567034655|FG007|Period 2|Withdrawal by Subject|0|||
157076803|NCT01370655|567034656|FG008|Period 2|Withdrawal by Subject|1|||
157076804|NCT01370655|567034657|FG009|Period 2|Withdrawal by Subject|0|||
157076805|NCT01370655|567034658|FG010|Period 2|Withdrawal by Subject|0|||
157076806|NCT01370655|567034659|FG011|Period 2|Withdrawal by Subject|0|||
157076807|NCT00667394|567034663|FG000|Overall Study|Adverse Event|3|||
157076808|NCT00667394|567034664|FG001|Overall Study|Adverse Event|0|||
157076809|NCT00667394|567034663|FG000|Overall Study|Progressive disease|1|||
157076810|NCT00667394|567034664|FG001|Overall Study|Progressive disease|0|||
157076811|NCT04076943|567034668|FG000|Overall Study|Withdrawal by Subject|12|||
157076812|NCT04076943|567034668|FG000|Overall Study|Adverse Event|1|||
157076813|NCT04076943|567034668|FG000|Overall Study|Progressive Disease|2|||
157076814|NCT04076943|567034668|FG000|Overall Study|Death|13|||
157076815|NCT04076943|567034668|FG000|Overall Study|Other than specified|6|||
157076816|NCT02224703|567034671|FG000|Overall Study|Adverse Event|0|||
157076817|NCT02224703|567034672|FG001|Overall Study|Adverse Event|5|||
157076818|NCT02224703|567034673|FG002|Overall Study|Adverse Event|0|||
157076819|NCT02224703|567034671|FG000|Overall Study|Withdrawn by investigator|1|||
157076820|NCT02224703|567034672|FG001|Overall Study|Withdrawn by investigator|0|||
157076821|NCT02224703|567034673|FG002|Overall Study|Withdrawn by investigator|0|||
157076822|NCT02224703|567034671|FG000|Overall Study|Advised by medical monitor|1|||
157076823|NCT02224703|567034672|FG001|Overall Study|Advised by medical monitor|0|||
157076824|NCT02224703|567034673|FG002|Overall Study|Advised by medical monitor|0|||
157076825|NCT02224703|567034671|FG000|Overall Study|Withdrawn by parent/guardian|0|||
157076826|NCT02224703|567034672|FG001|Overall Study|Withdrawn by parent/guardian|1|||
157076827|NCT02224703|567034673|FG002|Overall Study|Withdrawn by parent/guardian|0|||
157076828|NCT02224703|567034671|FG000|Overall Study|Lack of Efficacy|1|||
157076829|NCT02224703|567034672|FG001|Overall Study|Lack of Efficacy|0|||
157076830|NCT02224703|567034673|FG002|Overall Study|Lack of Efficacy|0|||
157076831|NCT00332462|567034674|FG000|Overall Study|Adverse Event|5|||
157076832|NCT00332462|567034674|FG000|Overall Study|Abnormal Lab Value|1|||
157076833|NCT00332462|567034674|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
157076834|NCT00332462|567034674|FG000|Overall Study|no longer requires study drug|1|||
157076835|NCT00332462|567034674|FG000|Overall Study|Death|3|||
157076836|NCT00332462|567034674|FG000|Overall Study|Graft Loss|2|||
157076837|NCT00863681|567034677|FG000|Overall Study|Other|2|||
157076838|NCT00863681|567034678|FG001|Overall Study|Other|0|||
157076839|NCT00863681|567034679|FG002|Overall Study|Other|0|||
157076840|NCT00863681|567034677|FG000|Overall Study|Missing|1|||
157076841|NCT00863681|567034678|FG001|Overall Study|Missing|0|||
157076842|NCT00863681|567034679|FG002|Overall Study|Missing|0|||
157076843|NCT00863681|567034677|FG000|Overall Study|Death|40|||
157076844|NCT00863681|567034678|FG001|Overall Study|Death|23|||
157076845|NCT00863681|567034679|FG002|Overall Study|Death|6|||
157076846|NCT00863681|567034677|FG000|Overall Study|Withdrawal by Subject|12|||
157076847|NCT00863681|567034678|FG001|Overall Study|Withdrawal by Subject|5|||
157076848|NCT00863681|567034679|FG002|Overall Study|Withdrawal by Subject|2|||
157076849|NCT00863681|567034677|FG000|Overall Study|Protocol Violation|2|||
157076850|NCT00863681|567034678|FG001|Overall Study|Protocol Violation|0|||
157076851|NCT00863681|567034679|FG002|Overall Study|Protocol Violation|0|||
157076852|NCT00863681|567034677|FG000|Overall Study|Lost to Follow-up|3|||
157076853|NCT00863681|567034678|FG001|Overall Study|Lost to Follow-up|0|||
157076854|NCT00863681|567034679|FG002|Overall Study|Lost to Follow-up|3|||
157076855|NCT00863681|567034677|FG000|Overall Study|Adverse Event|28|||
157076856|NCT00863681|567034678|FG001|Overall Study|Adverse Event|10|||
157076857|NCT00863681|567034679|FG002|Overall Study|Adverse Event|6|||
157076858|NCT00863681|567034677|FG000|Overall Study|Lack of Efficacy|2|||
157076859|NCT00863681|567034678|FG001|Overall Study|Lack of Efficacy|2|||
157076860|NCT00863681|567034679|FG002|Overall Study|Lack of Efficacy|1|||
157076861|NCT00863681|567034677|FG000|Overall Study|Non-compliance with study drug|1|||
157076862|NCT00863681|567034678|FG001|Overall Study|Non-compliance with study drug|3|||
157076863|NCT00863681|567034679|FG002|Overall Study|Non-compliance with study drug|0|||
157076864|NCT02922023|567034680|FG000|Overall Study|Lost to Follow-up|2|||
157076865|NCT02922023|567034681|FG001|Overall Study|Lost to Follow-up|0|||
157076866|NCT00659880|567034688|FG000|Overall Study|Lost to Follow-up|5|||
157076867|NCT01853475|567034689|FG000|Overall Study|Withdrawal by Subject|0|||
157076868|NCT01853475|567034690|FG001|Overall Study|Withdrawal by Subject|1|||
157076869|NCT01853475|567034691|FG002|Overall Study|Withdrawal by Subject|0|||
157076870|NCT02159040|567034692|FG000|Overall Study|Death|1|||
157076871|NCT02766777|567034696|FG000|Overall Study|Adverse Event|12|||
157076872|NCT02766777|567034696|FG000|Overall Study|Lost to Follow-up|16|||
157192736|NCT00545740|567447174|FG003|Overall Study|Husband against study|0|||
157076873|NCT02766777|567034696|FG000|Overall Study|Non-Compliance With Study Drug|1|||
157076874|NCT02766777|567034696|FG000|Overall Study|Protocol Violation|1|||
157076875|NCT02766777|567034696|FG000|Overall Study|Withdrawal by Subject|4|||
157076876|NCT01886287|567034697|FG000|Overall Study|Radiographic disease progression|1|||
157076877|NCT01886287|567034697|FG000|Overall Study|Clinical progression due to disease|1|||
157076878|NCT01834586|567034706|FG000|Overall Study|Adverse Event|1|||
157076879|NCT03325777|567034709|FG000|Overall Study|Lost to Follow-up|9|||
157076880|NCT03325777|567034710|FG001|Overall Study|Lost to Follow-up|12|||
157076881|NCT03004404|567034711|FG000|Period 2|Adverse Event|0|||
157076882|NCT03004404|567034712|FG001|Period 2|Adverse Event|0|||
157076883|NCT03004404|567034713|FG002|Period 2|Adverse Event|0|||
157076884|NCT03004404|567034714|FG003|Period 2|Adverse Event|0|||
157076885|NCT03004404|567034715|FG004|Period 2|Adverse Event|0|||
157076886|NCT03004404|567034716|FG005|Period 2|Adverse Event|0|||
157076887|NCT03004404|567034717|FG006|Period 2|Adverse Event|0|||
157076888|NCT03004404|567034718|FG007|Period 2|Adverse Event|0|||
157076889|NCT03004404|567034719|FG008|Period 2|Adverse Event|1|||
157076890|NCT03004404|567034720|FG009|Period 2|Adverse Event|0|||
157076891|NCT03004404|567034721|FG010|Period 2|Adverse Event|0|||
157076892|NCT03004404|567034722|FG011|Period 2|Adverse Event|0|||
157076893|NCT03004404|567034723|FG012|Period 2|Adverse Event|0|||
157076894|NCT03004404|567034724|FG013|Period 2|Adverse Event|0|||
157076895|NCT03004404|567034725|FG014|Period 2|Adverse Event|0|||
157076896|NCT03004404|567034726|FG015|Period 2|Adverse Event|1|||
157076897|NCT01602510|567034729|FG000|Open Label Phase|Adverse Event|46|||
157076898|NCT01602510|567034730|FG001|Open Label Phase|Adverse Event|0|||
157076899|NCT01602510|567034731|FG002|Open Label Phase|Adverse Event|0|||
157076900|NCT01602510|567034729|FG000|Open Label Phase|Lack of Efficacy|22|||
157076901|NCT01602510|567034730|FG001|Open Label Phase|Lack of Efficacy|0|||
157076902|NCT01602510|567034731|FG002|Open Label Phase|Lack of Efficacy|0|||
157076903|NCT01602510|567034729|FG000|Open Label Phase|Protocol Violation|15|||
157076904|NCT01602510|567034730|FG001|Open Label Phase|Protocol Violation|0|||
157076905|NCT01602510|567034731|FG002|Open Label Phase|Protocol Violation|0|||
157076906|NCT01602510|567034729|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
157076907|NCT01602510|567034730|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
157076908|NCT01602510|567034731|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
157076909|NCT01602510|567034729|FG000|Open Label Phase|Lost to Follow-up|22|||
157076910|NCT01602510|567034730|FG001|Open Label Phase|Lost to Follow-up|0|||
157076911|NCT01602510|567034731|FG002|Open Label Phase|Lost to Follow-up|0|||
157076912|NCT01602510|567034729|FG000|Open Label Phase|Physician Decision|19|||
157076913|NCT01602510|567034730|FG001|Open Label Phase|Physician Decision|0|||
157076914|NCT01602510|567034731|FG002|Open Label Phase|Physician Decision|0|||
157076915|NCT01602510|567034729|FG000|Open Label Phase|Withdrawal by Subject|57|||
157076916|NCT01602510|567034730|FG001|Open Label Phase|Withdrawal by Subject|0|||
157076917|NCT01602510|567034731|FG002|Open Label Phase|Withdrawal by Subject|0|||
157076918|NCT01602510|567034729|FG000|Randomized Phase|Adverse Event|0|||
157076919|NCT01602510|567034730|FG001|Randomized Phase|Adverse Event|2|||
157076920|NCT01602510|567034731|FG002|Randomized Phase|Adverse Event|6|||
157076921|NCT01602510|567034729|FG000|Randomized Phase|Lack of Efficacy|0|||
157076922|NCT01602510|567034730|FG001|Randomized Phase|Lack of Efficacy|4|||
157076923|NCT01602510|567034731|FG002|Randomized Phase|Lack of Efficacy|4|||
157076924|NCT01602510|567034729|FG000|Randomized Phase|Protocol Violation|0|||
157076925|NCT01602510|567034730|FG001|Randomized Phase|Protocol Violation|3|||
157076926|NCT01602510|567034731|FG002|Randomized Phase|Protocol Violation|3|||
157076927|NCT01602510|567034729|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
157076928|NCT01602510|567034730|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
157076929|NCT01602510|567034731|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
157076930|NCT01602510|567034729|FG000|Randomized Phase|Lost to Follow-up|0|||
157076931|NCT01602510|567034730|FG001|Randomized Phase|Lost to Follow-up|1|||
157076932|NCT01602510|567034731|FG002|Randomized Phase|Lost to Follow-up|3|||
157076933|NCT01602510|567034729|FG000|Randomized Phase|Physician Decision|0|||
157076934|NCT01602510|567034730|FG001|Randomized Phase|Physician Decision|0|||
157076935|NCT01602510|567034731|FG002|Randomized Phase|Physician Decision|2|||
157076936|NCT01602510|567034729|FG000|Randomized Phase|Withdrawal by Subject|0|||
157076937|NCT01602510|567034730|FG001|Randomized Phase|Withdrawal by Subject|6|||
157076938|NCT01602510|567034731|FG002|Randomized Phase|Withdrawal by Subject|7|||
157076939|NCT01195623|567034732|FG000|Overall Study|Lost to Follow-up|35|||
157076940|NCT01195623|567034733|FG001|Overall Study|Lost to Follow-up|37|||
157076941|NCT00534495|567034734|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
157076942|NCT00534495|567034735|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
157076943|NCT00534495|567034736|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
157076944|NCT00534495|567034734|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
157076945|NCT00534495|567034735|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
157076946|NCT00534495|567034736|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
157076947|NCT00534495|567034734|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
157076948|NCT00534495|567034735|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
157076949|NCT00534495|567034736|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
157076950|NCT00534495|567034734|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
157076951|NCT00534495|567034735|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
157076952|NCT00534495|567034736|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
157076953|NCT00534495|567034734|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
157076954|NCT00534495|567034735|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
157076955|NCT00534495|567034736|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
157076956|NCT00534495|567034734|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
157076957|NCT00534495|567034735|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
157192737|NCT02117024|567447175|FG000|Overall Study|Progressive Disease|26|||
157076958|NCT00534495|567034736|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
157076959|NCT00534495|567034734|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
157076960|NCT00534495|567034735|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
157076961|NCT00534495|567034736|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
157076962|NCT00534495|567034734|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
157076963|NCT00534495|567034735|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
157076964|NCT00534495|567034736|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
157076965|NCT00534495|567034734|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
157076966|NCT00534495|567034735|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
157076967|NCT00534495|567034736|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
157076968|NCT02920970|567034740|FG000|First Intervention|Protocol Violation|0|||
157076969|NCT02920970|567034741|FG001|First Intervention|Protocol Violation|1|||
157076970|NCT02920970|567034740|FG000|First Intervention|Adverse Event|0|||
157076971|NCT02920970|567034741|FG001|First Intervention|Adverse Event|1|||
157231893|NCT00912288|567595385|FG000|Overall Study|Study terminated by sponsor|34|||
157231894|NCT00912288|567595386|FG001|Overall Study|Study terminated by sponsor|35|||
157076972|NCT02920970|567034740|FG000|Second Intervention|Poor Lens Fit|1|||
157076973|NCT02920970|567034741|FG001|Second Intervention|Poor Lens Fit|0|||
157076974|NCT01711853|567034742|FG000|Overall Study|Not treated|3|||
157076975|NCT04191616|567034743|FG000|Pre-assignment Period|Did not receive study treatment|2|||
157076976|NCT04191616|567034743|FG000|Treatment Period|Death|37|||
157076977|NCT04191616|567034743|FG000|Treatment Period|Sponsor decision|11|||
157076978|NCT04191616|567034743|FG000|Treatment Period|Withdrawal by Subject|4|||
157076979|NCT01361594|567034744|FG000|Overall Study|Withdrawal by Subject|1|||
157076980|NCT01361594|567034745|FG001|Overall Study|Withdrawal by Subject|2|||
157076981|NCT03651700|567034749|FG000|Overall Study|Withdrawal by Subject|1|||
157076982|NCT03651700|567034750|FG001|Overall Study|Withdrawal by Subject|0|||
157076983|NCT02670122|567034753|FG000|Overall Study|Lost to Follow-up|4|||
157076984|NCT02762903|567034755|FG000|Overall Study|Lost to Follow-up|0|||
157076985|NCT02762903|567034756|FG001|Overall Study|Lost to Follow-up|1|||
157076986|NCT03041792|567034757|FG000|Overall Study|Adverse Event|4|||
157076987|NCT03041792|567034758|FG001|Overall Study|Adverse Event|0|||
157076988|NCT03041792|567034757|FG000|Overall Study|Death in the family|0|||
157076989|NCT03041792|567034758|FG001|Overall Study|Death in the family|2|||
157076990|NCT03041792|567034757|FG000|Overall Study|Randomized but not treated|0|||
157076991|NCT03041792|567034758|FG001|Overall Study|Randomized but not treated|1|||
157076992|NCT04978090|567034759|FG000|Overall Study|unable to adequately fit device|2|||
157076993|NCT02227992|567034764|FG000|Overall Study|Lost to Follow-up|1|||
157076994|NCT02227992|567034765|FG001|Overall Study|Lost to Follow-up|1|||
157076995|NCT00935532|567034766|FG000|Overall Study|Adverse Event|11|||
157076996|NCT00935532|567034767|FG001|Overall Study|Adverse Event|6|||
157076997|NCT00935532|567034766|FG000|Overall Study|Death|1|||
157076998|NCT00935532|567034767|FG001|Overall Study|Death|0|||
157076999|NCT00935532|567034766|FG000|Overall Study|Lost to Follow-up|1|||
157077000|NCT00935532|567034767|FG001|Overall Study|Lost to Follow-up|0|||
157077001|NCT00935532|567034766|FG000|Overall Study|Physician Decision|1|||
157077002|NCT00935532|567034767|FG001|Overall Study|Physician Decision|2|||
157077003|NCT00935532|567034766|FG000|Overall Study|Protocol Violation|2|||
157077004|NCT00935532|567034767|FG001|Overall Study|Protocol Violation|1|||
157077005|NCT00935532|567034766|FG000|Overall Study|Subject Decision|2|||
157077006|NCT00935532|567034767|FG001|Overall Study|Subject Decision|1|||
157077007|NCT00935532|567034766|FG000|Overall Study|Sponsor Decision|0|||
157077008|NCT00935532|567034767|FG001|Overall Study|Sponsor Decision|1|||
157077009|NCT00935532|567034766|FG000|Overall Study|Loss Glucose Control|4|||
157077010|NCT00935532|567034767|FG001|Overall Study|Loss Glucose Control|0|||
157077011|NCT01371708|567034770|FG000|Overall Study|Insufficient clinical response|3|||
157077012|NCT01371708|567034771|FG001|Overall Study|Insufficient clinical response|2|||
157077013|NCT01371708|567034772|FG002|Overall Study|Insufficient clinical response|0|||
157077014|NCT01371708|567034770|FG000|Overall Study|Lost to Follow-up|5|||
157077015|NCT01371708|567034771|FG001|Overall Study|Lost to Follow-up|9|||
157077016|NCT01371708|567034772|FG002|Overall Study|Lost to Follow-up|7|||
157077017|NCT01371708|567034770|FG000|Overall Study|Protocol Violation|2|||
157231895|NCT00912288|567595385|FG000|Overall Study|Other|1|||
157077018|NCT01371708|567034771|FG001|Overall Study|Protocol Violation|1|||
157077019|NCT01371708|567034772|FG002|Overall Study|Protocol Violation|2|||
157077020|NCT01371708|567034770|FG000|Overall Study|No longer willing to participate|7|||
157077021|NCT01371708|567034771|FG001|Overall Study|No longer willing to participate|7|||
157077022|NCT01371708|567034772|FG002|Overall Study|No longer willing to participate|13|||
157077023|NCT01371708|567034770|FG000|Overall Study|Medication error/not related to AE|0|||
157077024|NCT01371708|567034771|FG001|Overall Study|Medication error/not related to AE|1|||
157077025|NCT01371708|567034772|FG002|Overall Study|Medication error/not related to AE|0|||
157077026|NCT01371708|567034770|FG000|Overall Study|Other|3|||
157077027|NCT01371708|567034771|FG001|Overall Study|Other|2|||
157077028|NCT01371708|567034772|FG002|Overall Study|Other|4|||
157077029|NCT01371708|567034770|FG000|Overall Study|Adverse Event|5|||
157231896|NCT00912288|567595386|FG001|Overall Study|Other|0|||
157077030|NCT01371708|567034771|FG001|Overall Study|Adverse Event|8|||
157077031|NCT01371708|567034772|FG002|Overall Study|Adverse Event|12|||
157077032|NCT01371708|567034770|FG000|Overall Study|Started but did not receive treatment|1|||
157077033|NCT01371708|567034771|FG001|Overall Study|Started but did not receive treatment|0|||
157077034|NCT01371708|567034772|FG002|Overall Study|Started but did not receive treatment|1|||
157077035|NCT04641962|567034773|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
157077036|NCT04641962|567034774|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
157077037|NCT04641962|567034775|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
157077038|NCT04641962|567034776|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
157077039|NCT04641962|567034777|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
157077040|NCT04641962|567034773|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
157077041|NCT04641962|567034774|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
157077042|NCT04641962|567034775|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
157077043|NCT04641962|567034776|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
157077044|NCT04641962|567034777|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
157077045|NCT04641962|567034773|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
157077046|NCT04641962|567034774|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
157077047|NCT04641962|567034775|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
157077048|NCT04641962|567034776|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
157077049|NCT04641962|567034777|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
157077050|NCT04641962|567034773|FG000|DBT Period: Up to 52 Weeks|Death|1|||
157077051|NCT04641962|567034774|FG001|DBT Period: Up to 52 Weeks|Death|0|||
157077052|NCT04641962|567034775|FG002|DBT Period: Up to 52 Weeks|Death|0|||
157077053|NCT04641962|567034776|FG003|DBT Period: Up to 52 Weeks|Death|0|||
157077054|NCT04641962|567034777|FG004|DBT Period: Up to 52 Weeks|Death|0|||
157077055|NCT04641962|567034773|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
157077056|NCT04641962|567034774|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
157077057|NCT04641962|567034775|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
157077058|NCT04641962|567034776|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
157077059|NCT04641962|567034777|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
157077060|NCT04641962|567034773|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
157077061|NCT04641962|567034774|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
157077062|NCT04641962|567034775|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
157077063|NCT04641962|567034776|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
157077064|NCT04641962|567034777|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
157077065|NCT04641962|567034773|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
157077066|NCT04641962|567034774|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
157077067|NCT04641962|567034775|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
157077068|NCT04641962|567034776|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
157077069|NCT04641962|567034777|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
157077070|NCT01182441|567036793|FG000|Overall Study|Patient Still in Follow-up|152|||
157077071|NCT01182441|567036794|FG001|Overall Study|Patient Still in Follow-up|72|||
157077072|NCT01182441|567036793|FG000|Overall Study|Death|37|||
157077073|NCT01182441|567036794|FG001|Overall Study|Death|25|||
157077074|NCT01182441|567036793|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
157077075|NCT01182441|567036794|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
157077076|NCT01182441|567036793|FG000|Overall Study|Lost to Follow-up|5|||
157077077|NCT01182441|567036794|FG001|Overall Study|Lost to Follow-up|8|||
157077078|NCT01182441|567036793|FG000|Overall Study|Withdrawal by Subject|6|||
157077079|NCT01182441|567036794|FG001|Overall Study|Withdrawal by Subject|13|||
157077080|NCT01182441|567036793|FG000|Overall Study|Implant Not Attempted|4|||
157077081|NCT01182441|567036794|FG001|Overall Study|Implant Not Attempted|0|||
157077082|NCT01182441|567036793|FG000|Overall Study|Adverse Event|2|||
157077083|NCT01182441|567036794|FG001|Overall Study|Adverse Event|0|||
157077084|NCT01182441|567036793|FG000|Overall Study|Physician Decision|1|||
157077085|NCT01182441|567036794|FG001|Overall Study|Physician Decision|1|||
157077086|NCT00663702|567036795|FG000|Overall Study|Adverse Event|8|||
157077087|NCT00663702|567036796|FG001|Overall Study|Adverse Event|4|||
157077088|NCT00663702|567036795|FG000|Overall Study|Withdrawal by Subject|3|||
157077089|NCT00663702|567036796|FG001|Overall Study|Withdrawal by Subject|1|||
157077090|NCT00663702|567036795|FG000|Overall Study|Pregnancy|0|||
157077091|NCT00663702|567036796|FG001|Overall Study|Pregnancy|1|||
157077092|NCT00663702|567036795|FG000|Overall Study|Lost to Follow-up|3|||
157077093|NCT00663702|567036796|FG001|Overall Study|Lost to Follow-up|0|||
157077094|NCT00663702|567036795|FG000|Overall Study|Death|1|||
157077095|NCT00663702|567036796|FG001|Overall Study|Death|1|||
157077096|NCT00663702|567036795|FG000|Overall Study|Lack of Efficacy|3|||
157077097|NCT00663702|567036796|FG001|Overall Study|Lack of Efficacy|3|||
157077098|NCT03056300|567036797|FG000|Overall Study|Surgical reason per study protocol|3|||
157077099|NCT04079868|567036804|FG000|Overall Study|Lost to Follow-up|100|||
157077100|NCT04079868|567036805|FG001|Overall Study|Lost to Follow-up|200|||
157077101|NCT04079868|567036804|FG000|Overall Study|Physician Decision|100|||
157077102|NCT04079868|567036805|FG001|Overall Study|Physician Decision|0|||
157077103|NCT05262517|567036806|FG000|Overall Study|Randomized but not treated|5|||
157077104|NCT05262517|567036807|FG001|Overall Study|Randomized but not treated|11|||
157077105|NCT05620108|567036808|FG000|Overall Study|Physician Decision|1|||
157077106|NCT05620108|567036809|FG001|Overall Study|Physician Decision|2|||
157077107|NCT03301155|567036813|FG000|Overall Study|Сompliance with exclusion criteria|8|||
157077108|NCT03301155|567036814|FG001|Overall Study|Сompliance with exclusion criteria|7|||
157077109|NCT03510455|567036815|FG000|Overall Study|Physician Decision|1|||
157077110|NCT00384189|567036816|FG000|Overall Study|Reason Not Specified|50|||
157077111|NCT00384189|567036817|FG001|Overall Study|Reason Not Specified|57|||
157077112|NCT00384189|567036818|FG002|Overall Study|Reason Not Specified|58|||
157077113|NCT00384189|567036819|FG003|Overall Study|Reason Not Specified|40|||
157077114|NCT04958642|567036820|FG000|Overall Study|Transferred to OLEX program|3|||
157077115|NCT04958642|567036821|FG001|Overall Study|Transferred to OLEX program|0|||
157077116|NCT04958642|567036822|FG002|Overall Study|Transferred to OLEX program|5|||
157077117|NCT04958642|567036820|FG000|Overall Study|Death|0|||
157077118|NCT04958642|567036821|FG001|Overall Study|Death|0|||
157077119|NCT04958642|567036822|FG002|Overall Study|Death|1|||
157077120|NCT04958642|567036820|FG000|Overall Study|Withdrawal by Subject|4|||
157077121|NCT04958642|567036821|FG001|Overall Study|Withdrawal by Subject|9|||
157077122|NCT04958642|567036822|FG002|Overall Study|Withdrawal by Subject|13|||
157077123|NCT04958642|567036820|FG000|Overall Study|Investigator's Decision|0|||
157077124|NCT04958642|567036821|FG001|Overall Study|Investigator's Decision|0|||
157077125|NCT04958642|567036822|FG002|Overall Study|Investigator's Decision|1|||
157077126|NCT04958642|567036820|FG000|Overall Study|Adverse Event|1|||
157077127|NCT04958642|567036821|FG001|Overall Study|Adverse Event|0|||
157077128|NCT04958642|567036822|FG002|Overall Study|Adverse Event|1|||
157077129|NCT04958642|567036820|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
157077130|NCT04958642|567036821|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
157077131|NCT04958642|567036822|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
157077132|NCT04958642|567036820|FG000|Overall Study|Lost to Follow-up|1|||
157231897|NCT02087904|567595388|FG000|Overall Study|Did Not Receive Study Drug|0|||
157231898|NCT02087904|567595389|FG001|Overall Study|Did Not Receive Study Drug|0|||
157231899|NCT02087904|567595390|FG002|Overall Study|Did Not Receive Study Drug|2|||
157231900|NCT02087904|567595391|FG003|Overall Study|Did Not Receive Study Drug|1|||
157231901|NCT02087904|567595388|FG000|Overall Study|Adverse Event|8|||
157231902|NCT02087904|567595389|FG001|Overall Study|Adverse Event|4|||
157231903|NCT02087904|567595390|FG002|Overall Study|Adverse Event|4|||
157231904|NCT02087904|567595391|FG003|Overall Study|Adverse Event|12|||
157231905|NCT02087904|567595388|FG000|Overall Study|Lack of Efficacy|3|||
157231906|NCT02087904|567595389|FG001|Overall Study|Lack of Efficacy|6|||
157231907|NCT02087904|567595390|FG002|Overall Study|Lack of Efficacy|3|||
157231908|NCT02087904|567595391|FG003|Overall Study|Lack of Efficacy|2|||
157231909|NCT02087904|567595388|FG000|Overall Study|Other|6|||
157231910|NCT02087904|567595389|FG001|Overall Study|Other|2|||
157231911|NCT02087904|567595390|FG002|Overall Study|Other|4|||
157231912|NCT02087904|567595391|FG003|Overall Study|Other|4|||
157231913|NCT02087904|567595388|FG000|Overall Study|Withdrawal by Subject|8|||
157231914|NCT02087904|567595389|FG001|Overall Study|Withdrawal by Subject|3|||
157231915|NCT02087904|567595390|FG002|Overall Study|Withdrawal by Subject|7|||
157231916|NCT02087904|567595391|FG003|Overall Study|Withdrawal by Subject|4|||
157077133|NCT04958642|567036821|FG001|Overall Study|Lost to Follow-up|0|||
157077134|NCT04958642|567036822|FG002|Overall Study|Lost to Follow-up|0|||
157077135|NCT04958642|567036820|FG000|Overall Study|Transferred to EAP following study termination|0|||
157077136|NCT04958642|567036821|FG001|Overall Study|Transferred to EAP following study termination|0|||
157077137|NCT04958642|567036822|FG002|Overall Study|Transferred to EAP following study termination|1|||
157077138|NCT04958642|567036820|FG000|Overall Study|Transferred to Expanded Access Program|1|||
157077139|NCT04958642|567036821|FG001|Overall Study|Transferred to Expanded Access Program|0|||
157077140|NCT04958642|567036822|FG002|Overall Study|Transferred to Expanded Access Program|0|||
157077141|NCT02942004|567036823|FG000|Overall Study|Withdrawal by Subject|0|||
157077142|NCT02942004|567036824|FG001|Overall Study|Withdrawal by Subject|2|||
157077143|NCT02942004|567036825|FG002|Overall Study|Withdrawal by Subject|3|||
157077144|NCT02942004|567036823|FG000|Overall Study|Lost to Follow-up|1|||
157077145|NCT02942004|567036824|FG001|Overall Study|Lost to Follow-up|1|||
157077146|NCT02942004|567036825|FG002|Overall Study|Lost to Follow-up|2|||
157077147|NCT02942004|567036823|FG000|Overall Study|Randomized but not dosed|3|||
157077148|NCT02942004|567036824|FG001|Overall Study|Randomized but not dosed|9|||
157231917|NCT02087904|567595388|FG000|Overall Study|Lost to Follow-up|0|||
157231918|NCT02087904|567595389|FG001|Overall Study|Lost to Follow-up|4|||
157231919|NCT02087904|567595390|FG002|Overall Study|Lost to Follow-up|2|||
157077149|NCT02942004|567036825|FG002|Overall Study|Randomized but not dosed|4|||
157077150|NCT05627258|567036826|FG000|Overall Study|Lost to Follow-up|1|||
157077151|NCT05627258|567036827|FG001|Overall Study|Lost to Follow-up|0|||
157077152|NCT05627258|567036828|FG002|Overall Study|Lost to Follow-up|0|||
157077153|NCT05627258|567036829|FG003|Overall Study|Lost to Follow-up|0|||
157077154|NCT05627258|567036830|FG004|Overall Study|Lost to Follow-up|0|||
157077155|NCT05627258|567036831|FG005|Overall Study|Lost to Follow-up|0|||
157077156|NCT05627258|567036826|FG000|Overall Study|Withdrawal by Subject|0|||
157231920|NCT02087904|567595391|FG003|Overall Study|Lost to Follow-up|2|||
157231921|NCT01735630|567595392|FG000|Overall Study|Adverse Event|8|||
157077157|NCT05627258|567036827|FG001|Overall Study|Withdrawal by Subject|0|||
157077158|NCT05627258|567036828|FG002|Overall Study|Withdrawal by Subject|0|||
157077159|NCT05627258|567036829|FG003|Overall Study|Withdrawal by Subject|0|||
157077160|NCT05627258|567036830|FG004|Overall Study|Withdrawal by Subject|2|||
157077161|NCT05627258|567036831|FG005|Overall Study|Withdrawal by Subject|0|||
157077162|NCT05627258|567036826|FG000|Overall Study|Enrolled, but product not administered|1|||
157077163|NCT05627258|567036827|FG001|Overall Study|Enrolled, but product not administered|0|||
157077164|NCT05627258|567036828|FG002|Overall Study|Enrolled, but product not administered|0|||
157077165|NCT05627258|567036829|FG003|Overall Study|Enrolled, but product not administered|0|||
157231922|NCT01735630|567595393|FG001|Overall Study|Adverse Event|7|||
157231923|NCT01735630|567595392|FG000|Overall Study|Lost to Follow-up|1|||
157231924|NCT01735630|567595393|FG001|Overall Study|Lost to Follow-up|0|||
157231925|NCT01735630|567595392|FG000|Overall Study|Physician Decision|0|||
157231926|NCT01735630|567595393|FG001|Overall Study|Physician Decision|1|||
157231927|NCT01735630|567595392|FG000|Overall Study|Sponsor Decision|2|||
157231928|NCT01735630|567595393|FG001|Overall Study|Sponsor Decision|1|||
157231929|NCT01735630|567595392|FG000|Overall Study|Withdrawal by Subject|7|||
157231930|NCT01735630|567595393|FG001|Overall Study|Withdrawal by Subject|9|||
157231931|NCT00877032|567595399|FG000|Overall Study|Did not meet entrance criteria|0|||
157077166|NCT05627258|567036830|FG004|Overall Study|Enrolled, but product not administered|0|||
157077167|NCT05627258|567036831|FG005|Overall Study|Enrolled, but product not administered|0|||
157077168|NCT05627258|567036826|FG000|Overall Study|Other subject illness/injury|1|||
157077169|NCT05627258|567036827|FG001|Overall Study|Other subject illness/injury|0|||
157077170|NCT05627258|567036828|FG002|Overall Study|Other subject illness/injury|0|||
157077171|NCT05627258|567036829|FG003|Overall Study|Other subject illness/injury|0|||
157231932|NCT00877032|567595400|FG001|Overall Study|Did not meet entrance criteria|0|||
157231933|NCT00877032|567595401|FG002|Overall Study|Did not meet entrance criteria|0|||
157231934|NCT00877032|567595402|FG003|Overall Study|Did not meet entrance criteria|1|||
157231935|NCT00877032|567595403|FG004|Overall Study|Did not meet entrance criteria|0|||
157231936|NCT00877032|567595404|FG005|Overall Study|Did not meet entrance criteria|0|||
157231937|NCT00877032|567595405|FG006|Overall Study|Did not meet entrance criteria|2|||
157231938|NCT00813293|567595406|FG000|Overall Study|Intercurrent illness|1|||
157231939|NCT00813293|567595407|FG001|Overall Study|Intercurrent illness|0|||
157231940|NCT00813293|567595406|FG000|Overall Study|Adverse Event|0|||
157231941|NCT00813293|567595407|FG001|Overall Study|Adverse Event|1|||
157231942|NCT00533273|567595408|FG000|Double-blind|Withdrew consent|0|||
157231943|NCT00533273|567595409|FG001|Double-blind|Withdrew consent|2|||
157231944|NCT00533273|567595408|FG000|Open-label|Withdrawal by Subject|6|||
157231945|NCT00533273|567595409|FG001|Open-label|Withdrawal by Subject|0|||
157231946|NCT02794974|567595412|FG000|Overall Study|Physician Decision|0|||
157077172|NCT05627258|567036830|FG004|Overall Study|Other subject illness/injury|0|||
157077173|NCT05627258|567036831|FG005|Overall Study|Other subject illness/injury|0|||
157077174|NCT05627258|567036826|FG000|Overall Study|Subject moved from area|0|||
157077175|NCT05627258|567036827|FG001|Overall Study|Subject moved from area|0|||
157077176|NCT05627258|567036828|FG002|Overall Study|Subject moved from area|1|||
157077177|NCT05627258|567036829|FG003|Overall Study|Subject moved from area|0|||
157231947|NCT02794974|567595413|FG001|Overall Study|Physician Decision|1|||
157231948|NCT02202850|567595415|FG000|Overall Study|Other|2|||
157231949|NCT02202850|567595416|FG001|Overall Study|Other|2|||
157231950|NCT02202850|567595415|FG000|Overall Study|Enbrel treatment discontinued|15|||
157231951|NCT02202850|567595416|FG001|Overall Study|Enbrel treatment discontinued|3|||
157231952|NCT02202850|567595415|FG000|Overall Study|Lost to Follow-up|7|||
157231953|NCT02202850|567595416|FG001|Overall Study|Lost to Follow-up|1|||
157231954|NCT00615069|567595417|FG000|Overall Study|Death|10|||
157231955|NCT00615069|567595417|FG000|Overall Study|Physician Decision|2|||
157231956|NCT00615069|567595417|FG000|Overall Study|Withdrawal by Subject|4|||
157231957|NCT00669942|567595418|FG000|Parts 2 and 3|Adverse Event|0|||
157231958|NCT00669942|567595419|FG001|Parts 2 and 3|Adverse Event|0|||
157231959|NCT00669942|567595420|FG002|Parts 2 and 3|Adverse Event|0|||
157077178|NCT05627258|567036830|FG004|Overall Study|Subject moved from area|0|||
157077179|NCT05627258|567036831|FG005|Overall Study|Subject moved from area|0|||
157077180|NCT04517669|567036832|FG000|Overall Study|Lost to Follow-up|2|||
157077181|NCT04517669|567036832|FG000|Overall Study|Withdrawal by Subject|3|||
157077182|NCT04517669|567036832|FG000|Overall Study|Drug withdrawn|44|||
157077183|NCT04517669|567036832|FG000|Overall Study|Other|1|||
157231960|NCT00669942|567595421|FG003|Parts 2 and 3|Adverse Event|0|||
157231961|NCT00669942|567595422|FG004|Parts 2 and 3|Adverse Event|0|||
157231962|NCT00669942|567595423|FG005|Parts 2 and 3|Adverse Event|0|||
157231963|NCT00669942|567595424|FG006|Parts 2 and 3|Adverse Event|0|||
157231964|NCT00669942|567595425|FG007|Parts 2 and 3|Adverse Event|2|||
157231965|NCT00669942|567595426|FG008|Parts 2 and 3|Adverse Event|1|||
157077184|NCT04517669|567036832|FG000|Overall Study|Eligibility criteria not met|4|||
157077185|NCT04517669|567036832|FG000|Overall Study|Did not receive treatment|3|||
157077186|NCT01199068|567036833|FG000|Overall Study|Unacceptable toxicity|0|||
157231966|NCT00669942|567595427|FG009|Parts 2 and 3|Adverse Event|0|||
157231967|NCT00669942|567595428|FG010|Parts 2 and 3|Adverse Event|0|||
157077187|NCT01199068|567036834|FG001|Overall Study|Unacceptable toxicity|0|||
157077188|NCT01199068|567036835|FG002|Overall Study|Unacceptable toxicity|2|||
157077189|NCT01199068|567036833|FG000|Overall Study|Progressive disease|3|||
157077190|NCT01199068|567036834|FG001|Overall Study|Progressive disease|3|||
157077191|NCT01199068|567036835|FG002|Overall Study|Progressive disease|6|||
157077192|NCT01199068|567036833|FG000|Overall Study|Withdrawal by Subject|0|||
157077193|NCT01199068|567036834|FG001|Overall Study|Withdrawal by Subject|0|||
157077194|NCT01199068|567036835|FG002|Overall Study|Withdrawal by Subject|1|||
157077195|NCT00678301|567036836|FG000|Overall Study|Non-compliance with study procedures|0|||
157077196|NCT00678301|567036837|FG001|Overall Study|Non-compliance with study procedures|1|||
157077197|NCT00678301|567036836|FG000|Overall Study|Adverse Event|1|||
157077198|NCT00678301|567036837|FG001|Overall Study|Adverse Event|0|||
157077199|NCT00678301|567036836|FG000|Overall Study|Withdrawal by Subject|4|||
157077200|NCT00678301|567036837|FG001|Overall Study|Withdrawal by Subject|0|||
157077201|NCT00678301|567036836|FG000|Overall Study|Lost to Follow-up|3|||
157077202|NCT00678301|567036837|FG001|Overall Study|Lost to Follow-up|1|||
157077203|NCT05048238|567036838|FG000|Overall Study|Withdrawal by Subject|1|||
157077204|NCT04481373|567036844|FG000|Overall Study|Protocol Violation|1|||
157077205|NCT04481373|567036845|FG001|Overall Study|Protocol Violation|0|||
157077206|NCT04481373|567036844|FG000|Overall Study|Viral load in hospital not over 1000|2|||
157077207|NCT04481373|567036845|FG001|Overall Study|Viral load in hospital not over 1000|1|||
157077208|NCT04481373|567036844|FG000|Overall Study|Death before hospital discharge|1|||
157077209|NCT04481373|567036845|FG001|Overall Study|Death before hospital discharge|0|||
157077210|NCT01685229|567036850|FG000|Overall Study|Subjects missing Study Exit form|3|||
157077211|NCT01685229|567036851|FG001|Overall Study|Subjects missing Study Exit form|1|||
157077212|NCT01685229|567036850|FG000|Overall Study|Lost to Follow-up|16|||
157077213|NCT01685229|567036851|FG001|Overall Study|Lost to Follow-up|10|||
157077214|NCT01685229|567036850|FG000|Overall Study|Withdrawal by Subject|6|||
157077215|NCT01685229|567036851|FG001|Overall Study|Withdrawal by Subject|5|||
157077216|NCT01685229|567036850|FG000|Overall Study|Death|1|||
157077217|NCT01685229|567036851|FG001|Overall Study|Death|0|||
157077218|NCT01371825|567036860|FG000|Overall Study|Death|4|||
157077219|NCT00895895|567036861|FG000|Period 1|Adverse Event|7|||
157077220|NCT00895895|567036862|FG001|Period 1|Adverse Event|6|||
157077221|NCT00895895|567036863|FG002|Period 1|Adverse Event|4|||
157077222|NCT00895895|567036864|FG003|Period 1|Adverse Event|6|||
157077223|NCT00895895|567036865|FG004|Period 1|Adverse Event|7|||
157077224|NCT00895895|567036861|FG000|Period 1|Death|0|||
157077225|NCT00895895|567036862|FG001|Period 1|Death|0|||
157077226|NCT00895895|567036863|FG002|Period 1|Death|0|||
157077227|NCT00895895|567036864|FG003|Period 1|Death|0|||
157077228|NCT00895895|567036865|FG004|Period 1|Death|1|||
157077229|NCT00895895|567036861|FG000|Period 1|discontinued by sponsor|2|||
157077230|NCT00895895|567036862|FG001|Period 1|discontinued by sponsor|1|||
157077231|NCT00895895|567036863|FG002|Period 1|discontinued by sponsor|2|||
157077232|NCT00895895|567036864|FG003|Period 1|discontinued by sponsor|1|||
157077233|NCT00895895|567036865|FG004|Period 1|discontinued by sponsor|1|||
157077234|NCT00895895|567036861|FG000|Period 1|failed to return|0|||
157077235|NCT00895895|567036862|FG001|Period 1|failed to return|0|||
157077236|NCT00895895|567036863|FG002|Period 1|failed to return|1|||
157077237|NCT00895895|567036864|FG003|Period 1|failed to return|0|||
157077238|NCT00895895|567036865|FG004|Period 1|failed to return|1|||
157077239|NCT00895895|567036861|FG000|Period 1|investigator request|0|||
157077240|NCT00895895|567036862|FG001|Period 1|investigator request|1|||
157077241|NCT00895895|567036863|FG002|Period 1|investigator request|0|||
157077242|NCT00895895|567036864|FG003|Period 1|investigator request|0|||
157077243|NCT00895895|567036865|FG004|Period 1|investigator request|0|||
157077244|NCT00895895|567036861|FG000|Period 1|Lost to Follow-up|2|||
157077245|NCT00895895|567036862|FG001|Period 1|Lost to Follow-up|1|||
157231968|NCT00669942|567595429|FG011|Parts 2 and 3|Adverse Event|0|||
157231969|NCT00669942|567595418|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
157231970|NCT00669942|567595419|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
157231971|NCT00669942|567595420|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
157231972|NCT00669942|567595421|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
157077246|NCT00895895|567036863|FG002|Period 1|Lost to Follow-up|3|||
157077247|NCT00895895|567036864|FG003|Period 1|Lost to Follow-up|2|||
157077248|NCT00895895|567036865|FG004|Period 1|Lost to Follow-up|3|||
157077249|NCT00895895|567036861|FG000|Period 1|Other|1|||
157077250|NCT00895895|567036862|FG001|Period 1|Other|2|||
157077251|NCT00895895|567036863|FG002|Period 1|Other|1|||
157077252|NCT00895895|567036864|FG003|Period 1|Other|1|||
157077253|NCT00895895|567036865|FG004|Period 1|Other|1|||
157077254|NCT00895895|567036861|FG000|Period 1|Protocol Violation|0|||
157077255|NCT00895895|567036862|FG001|Period 1|Protocol Violation|1|||
157077256|NCT00895895|567036863|FG002|Period 1|Protocol Violation|0|||
157077257|NCT00895895|567036864|FG003|Period 1|Protocol Violation|0|||
157077258|NCT00895895|567036865|FG004|Period 1|Protocol Violation|0|||
157077259|NCT00895895|567036861|FG000|Period 1|Withdrawal by Subject|6|||
157077260|NCT00895895|567036862|FG001|Period 1|Withdrawal by Subject|6|||
157077261|NCT00895895|567036863|FG002|Period 1|Withdrawal by Subject|8|||
157077262|NCT00895895|567036864|FG003|Period 1|Withdrawal by Subject|2|||
157231973|NCT00669942|567595422|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
157231974|NCT00669942|567595423|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
157231975|NCT00669942|567595424|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
157231976|NCT00669942|567595425|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
157231977|NCT00669942|567595426|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
157231978|NCT00669942|567595427|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
157077263|NCT00895895|567036865|FG004|Period 1|Withdrawal by Subject|4|||
157077264|NCT00895895|567036861|FG000|Period 1|unsatisfactory response-efficacy|2|||
157231979|NCT00669942|567595428|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
157231980|NCT00669942|567595429|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
157231981|NCT00669942|567595418|FG000|Parts 2 and 3|Protocol Violation|0|||
157231982|NCT00669942|567595419|FG001|Parts 2 and 3|Protocol Violation|0|||
157077265|NCT00895895|567036862|FG001|Period 1|unsatisfactory response-efficacy|0|||
157077266|NCT00895895|567036863|FG002|Period 1|unsatisfactory response-efficacy|0|||
157077267|NCT00895895|567036864|FG003|Period 1|unsatisfactory response-efficacy|0|||
157077268|NCT00895895|567036865|FG004|Period 1|unsatisfactory response-efficacy|0|||
157077269|NCT00895895|567036861|FG000|Period 1|randomized and not treated|1|||
157077270|NCT00895895|567036862|FG001|Period 1|randomized and not treated|3|||
157077271|NCT00895895|567036863|FG002|Period 1|randomized and not treated|1|||
157077272|NCT00895895|567036864|FG003|Period 1|randomized and not treated|1|||
157077273|NCT00895895|567036865|FG004|Period 1|randomized and not treated|2|||
157077274|NCT00895895|567036861|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
157077275|NCT00895895|567036862|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
157077276|NCT00895895|567036863|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
157077277|NCT00895895|567036864|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
157077278|NCT00895895|567036865|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
157077279|NCT00895895|567036861|FG000|After Period 1, Prior to Period 2|Other|0|||
157077280|NCT00895895|567036862|FG001|After Period 1, Prior to Period 2|Other|0|||
157077281|NCT00895895|567036863|FG002|After Period 1, Prior to Period 2|Other|1|||
157077282|NCT00895895|567036864|FG003|After Period 1, Prior to Period 2|Other|0|||
157077283|NCT00895895|567036865|FG004|After Period 1, Prior to Period 2|Other|0|||
157077284|NCT00895895|567036861|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
157077285|NCT00895895|567036862|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
157077286|NCT00895895|567036863|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
157077287|NCT00895895|567036864|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
157077288|NCT00895895|567036865|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
157077289|NCT00895895|567036861|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
157077290|NCT00895895|567036862|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
157077291|NCT00895895|567036863|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
157077292|NCT00895895|567036864|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
157077293|NCT00895895|567036865|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
157077294|NCT00895895|567036861|FG000|Period 2|Adverse Event|3|||
157077295|NCT00895895|567036862|FG001|Period 2|Adverse Event|3|||
157231983|NCT00669942|567595420|FG002|Parts 2 and 3|Protocol Violation|0|||
157231984|NCT00669942|567595421|FG003|Parts 2 and 3|Protocol Violation|0|||
157231985|NCT00669942|567595422|FG004|Parts 2 and 3|Protocol Violation|0|||
157231986|NCT00669942|567595423|FG005|Parts 2 and 3|Protocol Violation|1|||
157077296|NCT00895895|567036863|FG002|Period 2|Adverse Event|5|||
157077297|NCT00895895|567036864|FG003|Period 2|Adverse Event|2|||
157077298|NCT00895895|567036865|FG004|Period 2|Adverse Event|5|||
157077299|NCT00895895|567036861|FG000|Period 2|Death|0|||
157077300|NCT00895895|567036862|FG001|Period 2|Death|0|||
157077301|NCT00895895|567036863|FG002|Period 2|Death|1|||
157077302|NCT00895895|567036864|FG003|Period 2|Death|0|||
157077303|NCT00895895|567036865|FG004|Period 2|Death|0|||
157077304|NCT00895895|567036861|FG000|Period 2|discontinued by sponsor|44|||
157077305|NCT00895895|567036862|FG001|Period 2|discontinued by sponsor|44|||
157231987|NCT00669942|567595424|FG006|Parts 2 and 3|Protocol Violation|0|||
157231988|NCT00669942|567595425|FG007|Parts 2 and 3|Protocol Violation|0|||
157077306|NCT00895895|567036863|FG002|Period 2|discontinued by sponsor|38|||
157077307|NCT00895895|567036864|FG003|Period 2|discontinued by sponsor|46|||
157077308|NCT00895895|567036865|FG004|Period 2|discontinued by sponsor|37|||
157077309|NCT00895895|567036861|FG000|Period 2|failed to return|2|||
157077310|NCT00895895|567036862|FG001|Period 2|failed to return|0|||
157077311|NCT00895895|567036863|FG002|Period 2|failed to return|0|||
157077312|NCT00895895|567036864|FG003|Period 2|failed to return|0|||
157077313|NCT00895895|567036865|FG004|Period 2|failed to return|0|||
157077314|NCT00895895|567036861|FG000|Period 2|investigator request|2|||
157077315|NCT00895895|567036862|FG001|Period 2|investigator request|0|||
157077316|NCT00895895|567036863|FG002|Period 2|investigator request|0|||
157231989|NCT00669942|567595426|FG008|Parts 2 and 3|Protocol Violation|0|||
157077317|NCT00895895|567036864|FG003|Period 2|investigator request|0|||
157077318|NCT00895895|567036865|FG004|Period 2|investigator request|0|||
157077319|NCT00895895|567036861|FG000|Period 2|Lost to Follow-up|1|||
157231990|NCT00669942|567595427|FG009|Parts 2 and 3|Protocol Violation|0|||
157231991|NCT00669942|567595428|FG010|Parts 2 and 3|Protocol Violation|0|||
157231992|NCT00669942|567595429|FG011|Parts 2 and 3|Protocol Violation|0|||
157231993|NCT03752528|567595430|FG000|Part A|Lost to Follow-up|1|||
157077320|NCT00895895|567036862|FG001|Period 2|Lost to Follow-up|2|||
157077321|NCT00895895|567036863|FG002|Period 2|Lost to Follow-up|1|||
157077322|NCT00895895|567036864|FG003|Period 2|Lost to Follow-up|1|||
157077323|NCT00895895|567036865|FG004|Period 2|Lost to Follow-up|0|||
157077324|NCT00895895|567036861|FG000|Period 2|Other|1|||
157077325|NCT00895895|567036862|FG001|Period 2|Other|1|||
157077326|NCT00895895|567036863|FG002|Period 2|Other|3|||
157077327|NCT00895895|567036864|FG003|Period 2|Other|1|||
157077328|NCT00895895|567036865|FG004|Period 2|Other|1|||
157077329|NCT00895895|567036861|FG000|Period 2|Protocol Violation|1|||
157077330|NCT00895895|567036862|FG001|Period 2|Protocol Violation|0|||
157077331|NCT00895895|567036863|FG002|Period 2|Protocol Violation|1|||
157077332|NCT00895895|567036864|FG003|Period 2|Protocol Violation|1|||
157077333|NCT00895895|567036865|FG004|Period 2|Protocol Violation|1|||
157231994|NCT03752528|567595430|FG000|Part A|Protocol Violation|1|||
157231995|NCT03752528|567595430|FG000|Part B|Protocol Violation|1|||
157231996|NCT03752528|567595430|FG000|Part B|Study terminated by sponsor|3|||
157231997|NCT04213326|567595433|FG000|Overall Study|Consent withdrawn|51|||
157231998|NCT04213326|567595434|FG001|Overall Study|Consent withdrawn|241|||
157231999|NCT04213326|567595433|FG000|Overall Study|Lost to Follow-up|50|||
157077334|NCT00895895|567036861|FG000|Period 2|Withdrawal by Subject|0|||
157077335|NCT00895895|567036862|FG001|Period 2|Withdrawal by Subject|2|||
157077336|NCT00895895|567036863|FG002|Period 2|Withdrawal by Subject|0|||
157077337|NCT00895895|567036864|FG003|Period 2|Withdrawal by Subject|3|||
157077338|NCT00895895|567036865|FG004|Period 2|Withdrawal by Subject|5|||
157077339|NCT00895895|567036861|FG000|Period 2|unsatisfactory response-efficacy|2|||
157077340|NCT00895895|567036862|FG001|Period 2|unsatisfactory response-efficacy|1|||
157077341|NCT00895895|567036863|FG002|Period 2|unsatisfactory response-efficacy|0|||
157077342|NCT00895895|567036864|FG003|Period 2|unsatisfactory response-efficacy|0|||
157077343|NCT00895895|567036865|FG004|Period 2|unsatisfactory response-efficacy|0|||
157077344|NCT03019640|567036866|FG000|Overall Study|Screen Failures|4|||
157077345|NCT03019640|567036866|FG000|Overall Study|Adverse Event|3|||
157077346|NCT03019640|567036866|FG000|Overall Study|Participant Relapsed|1|||
157077347|NCT01889069|567036867|FG000|Overall Study|Death|18|||
157077348|NCT01889069|567036867|FG000|Overall Study|Progression of Disease|14|||
157077349|NCT01889069|567036867|FG000|Overall Study|Lost to Follow-up|6|||
157077350|NCT01889069|567036867|FG000|Overall Study|Other|4|||
157077351|NCT01889069|567036867|FG000|Overall Study|Consent Withdrawal|3|||
157077352|NCT01426347|567036871|FG000|Overall Study|Lost to Follow-up|0|||
157077353|NCT01426347|567036872|FG001|Overall Study|Lost to Follow-up|3|||
157077354|NCT01426347|567036871|FG000|Overall Study|Protocol Violation|2|||
157077355|NCT01426347|567036872|FG001|Overall Study|Protocol Violation|0|||
157077356|NCT01426347|567036871|FG000|Overall Study|Withdrawal by Subject|5|||
157077357|NCT01426347|567036872|FG001|Overall Study|Withdrawal by Subject|0|||
157077358|NCT00455741|567036873|FG000|Overall Study|Physician Decision|0|||
157077359|NCT00455741|567036874|FG001|Overall Study|Physician Decision|1|||
157077360|NCT01509547|567036875|FG000|Overall Study|Lost to Follow-up|24|||
157077361|NCT01509547|567036876|FG001|Overall Study|Lost to Follow-up|14|||
157077362|NCT01509547|567036875|FG000|Overall Study|Withdrawal by Subject|11|||
157077363|NCT01509547|567036876|FG001|Overall Study|Withdrawal by Subject|24|||
157077364|NCT01509547|567036875|FG000|Overall Study|Physician Decision|0|||
157077365|NCT01509547|567036876|FG001|Overall Study|Physician Decision|1|||
157077366|NCT02514551|567036877|FG000|Overall Study|Lost to Follow-up|0|||
157077367|NCT02514551|567036878|FG001|Overall Study|Lost to Follow-up|1|||
157077368|NCT02514551|567036877|FG000|Overall Study|Participant Never Treated|0|||
157077369|NCT02514551|567036878|FG001|Overall Study|Participant Never Treated|2|||
157077370|NCT01399918|567036889|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
157077371|NCT03197766|567036890|FG000|Overall Study|Withdrawal by Subject|2|||
157077372|NCT03197766|567036891|FG001|Overall Study|Withdrawal by Subject|0|||
157077373|NCT00996606|567036892|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
157077374|NCT00996606|567036892|FG000|Overall Study|Insufficient Therapeutic Response|2|||
157077375|NCT00996606|567036892|FG000|Overall Study|Protocol Violation|1|||
157077376|NCT00996606|567036892|FG000|Overall Study|Withdrawal by Subject|3|||
157077377|NCT00632502|567036896|FG000|Overall Study|Adverse Event|0|||
157232000|NCT04213326|567595434|FG001|Overall Study|Lost to Follow-up|902|||
157077378|NCT00632502|567036897|FG001|Overall Study|Adverse Event|1|||
157077379|NCT00632502|567036896|FG000|Overall Study|Randomized not treated|3|||
157077380|NCT00632502|567036897|FG001|Overall Study|Randomized not treated|0|||
157077381|NCT00570908|567036898|FG000|Overall Study|Adverse Event|5|||
157077382|NCT00570908|567036898|FG000|Overall Study|Withdrawal by Subject|2|||
157077383|NCT01213524|567036899|FG000|Baseline|Withdrawal by Subject|5|||
157077384|NCT01213524|567036899|FG000|Baseline|high breath alcohol levels|1|||
157077385|NCT01213524|567036899|FG000|Baseline|Physician Decision|1|||
157077386|NCT01213524|567036899|FG000|Session 2|Withdrawal by Subject|5|||
157077387|NCT01213524|567036899|FG000|Session 3|Withdrawal by Subject|4|||
157077388|NCT01213524|567036899|FG000|Session 4|Physician Decision|1|||
157077389|NCT01213524|567036899|FG000|Session 4|Withdrawal by Subject|2|||
157077390|NCT02519348|567036905|FG000|Overall Study|Death|31|||
157077391|NCT02519348|567036906|FG001|Overall Study|Death|74|||
157077392|NCT02519348|567036907|FG002|Overall Study|Death|47|||
157077393|NCT02519348|567036908|FG003|Overall Study|Death|54|||
157077394|NCT02519348|567036909|FG004|Overall Study|Death|63|||
157077395|NCT02519348|567036910|FG005|Overall Study|Death|18|||
157077396|NCT02519348|567036911|FG006|Overall Study|Death|2|||
157077397|NCT02519348|567036912|FG007|Overall Study|Death|5|||
157077398|NCT02519348|567036913|FG008|Overall Study|Death|5|||
157077399|NCT02519348|567036905|FG000|Overall Study|Withdrawal by Subject|4|||
157077400|NCT02519348|567036906|FG001|Overall Study|Withdrawal by Subject|7|||
157077401|NCT02519348|567036907|FG002|Overall Study|Withdrawal by Subject|4|||
157077402|NCT02519348|567036908|FG003|Overall Study|Withdrawal by Subject|3|||
157077403|NCT02519348|567036909|FG004|Overall Study|Withdrawal by Subject|3|||
157077404|NCT02519348|567036910|FG005|Overall Study|Withdrawal by Subject|2|||
157077405|NCT02519348|567036911|FG006|Overall Study|Withdrawal by Subject|0|||
157077406|NCT02519348|567036912|FG007|Overall Study|Withdrawal by Subject|0|||
157077407|NCT02519348|567036913|FG008|Overall Study|Withdrawal by Subject|1|||
157077408|NCT02519348|567036905|FG000|Overall Study|Lost to Follow-up|0|||
157077409|NCT02519348|567036906|FG001|Overall Study|Lost to Follow-up|0|||
157077410|NCT02519348|567036907|FG002|Overall Study|Lost to Follow-up|1|||
157077411|NCT02519348|567036908|FG003|Overall Study|Lost to Follow-up|0|||
157077412|NCT02519348|567036909|FG004|Overall Study|Lost to Follow-up|2|||
157077413|NCT02519348|567036910|FG005|Overall Study|Lost to Follow-up|1|||
157077414|NCT02519348|567036911|FG006|Overall Study|Lost to Follow-up|1|||
157077415|NCT02519348|567036912|FG007|Overall Study|Lost to Follow-up|0|||
157077416|NCT02519348|567036913|FG008|Overall Study|Lost to Follow-up|0|||
157077417|NCT02519348|567036905|FG000|Overall Study|Other|0|||
157077418|NCT02519348|567036906|FG001|Overall Study|Other|3|||
157077419|NCT02519348|567036907|FG002|Overall Study|Other|0|||
157077420|NCT02519348|567036908|FG003|Overall Study|Other|0|||
157077421|NCT02519348|567036909|FG004|Overall Study|Other|1|||
157077422|NCT02519348|567036910|FG005|Overall Study|Other|0|||
157077423|NCT02519348|567036911|FG006|Overall Study|Other|0|||
157077424|NCT02519348|567036912|FG007|Overall Study|Other|0|||
157077425|NCT02519348|567036913|FG008|Overall Study|Other|0|||
157077426|NCT02519348|567036905|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
157077427|NCT02519348|567036906|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
157077428|NCT02519348|567036907|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
157077429|NCT02519348|567036908|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
157077430|NCT02519348|567036909|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
157077431|NCT02519348|567036910|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
157077432|NCT02519348|567036911|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
157077433|NCT02519348|567036912|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
157077434|NCT02519348|567036913|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
157077435|NCT00669877|567036914|FG000|Overall Study|Disease Progression/Death|4|||
157077436|NCT01110408|567036915|FG000|Overall Study|Protocol Violation|1|||
157077437|NCT01110408|567036916|FG001|Overall Study|Protocol Violation|0|||
157077438|NCT04103892|567036922|FG000|Overall Study|Adverse Event|0|||
157077439|NCT04103892|567036923|FG001|Overall Study|Adverse Event|0|||
157077440|NCT04103892|567036924|FG002|Overall Study|Adverse Event|0|||
157077441|NCT04103892|567036925|FG003|Overall Study|Adverse Event|3|||
157077442|NCT04103892|567036922|FG000|Overall Study|Lost to Follow-up|0|||
157077443|NCT04103892|567036923|FG001|Overall Study|Lost to Follow-up|0|||
157077444|NCT04103892|567036924|FG002|Overall Study|Lost to Follow-up|2|||
157077445|NCT04103892|567036925|FG003|Overall Study|Lost to Follow-up|0|||
157077446|NCT04103892|567036922|FG000|Overall Study|Protocol Violation|0|||
157077447|NCT04103892|567036923|FG001|Overall Study|Protocol Violation|0|||
157077448|NCT04103892|567036924|FG002|Overall Study|Protocol Violation|1|||
157077449|NCT04103892|567036925|FG003|Overall Study|Protocol Violation|1|||
157077450|NCT04103892|567036922|FG000|Overall Study|Withdrawal by Subject|1|||
157077451|NCT04103892|567036923|FG001|Overall Study|Withdrawal by Subject|0|||
157077452|NCT04103892|567036924|FG002|Overall Study|Withdrawal by Subject|2|||
157077453|NCT04103892|567036925|FG003|Overall Study|Withdrawal by Subject|5|||
157077454|NCT04103892|567036922|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
157077455|NCT04103892|567036923|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
157077456|NCT04103892|567036924|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
157077457|NCT04103892|567036925|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
157077458|NCT00281320|567036926|FG000|Overall Study|Adverse Event|12|||
157077459|NCT00281320|567036927|FG001|Overall Study|Adverse Event|9|||
157077460|NCT00281320|567036926|FG000|Overall Study|Lack of Efficacy|4|||
157077461|NCT00281320|567036927|FG001|Overall Study|Lack of Efficacy|3|||
157077462|NCT00281320|567036926|FG000|Overall Study|Withdrawal by Subject|5|||
157077463|NCT00281320|567036927|FG001|Overall Study|Withdrawal by Subject|6|||
157077464|NCT00281320|567036926|FG000|Overall Study|Lost to Follow-up|1|||
157077465|NCT00281320|567036927|FG001|Overall Study|Lost to Follow-up|2|||
157077466|NCT00281320|567036926|FG000|Overall Study|Other|3|||
157077467|NCT00281320|567036927|FG001|Overall Study|Other|1|||
157077468|NCT03008005|567036930|FG000|Overall Study|Physician Decision|1|||
157077469|NCT03008005|567036931|FG001|Overall Study|Physician Decision|0|||
157077470|NCT03008005|567036932|FG002|Overall Study|Physician Decision|0|||
157077471|NCT03008005|567036930|FG000|Overall Study|Withdrawal by Subject|1|||
157077472|NCT03008005|567036931|FG001|Overall Study|Withdrawal by Subject|0|||
157077473|NCT03008005|567036932|FG002|Overall Study|Withdrawal by Subject|0|||
157077474|NCT03008005|567036930|FG000|Overall Study|Ineligible|0|||
157077475|NCT03008005|567036931|FG001|Overall Study|Ineligible|1|||
157232001|NCT04213326|567595433|FG000|Overall Study|Protocol Violation|3|||
157232002|NCT04213326|567595434|FG001|Overall Study|Protocol Violation|25|||
157232003|NCT04213326|567595433|FG000|Overall Study|Participant eligibility changed|106|||
157232004|NCT04213326|567595434|FG001|Overall Study|Participant eligibility changed|19|||
157232005|NCT04213326|567595433|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
157232006|NCT04213326|567595434|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
157232007|NCT04213326|567595433|FG000|Overall Study|Incomplete study visit|0|||
157232008|NCT04213326|567595434|FG001|Overall Study|Incomplete study visit|367|||
157232009|NCT00854308|567595441|FG000|Overall Study|Disease progression|42|||
157232010|NCT00854308|567595442|FG001|Overall Study|Disease progression|50|||
157232011|NCT00854308|567595441|FG000|Overall Study|Adverse Event|8|||
157232012|NCT00854308|567595442|FG001|Overall Study|Adverse Event|3|||
157232013|NCT00854308|567595441|FG000|Overall Study|Death|2|||
157232014|NCT00854308|567595442|FG001|Overall Study|Death|5|||
157232015|NCT00854308|567595441|FG000|Overall Study|Physician Decision|6|||
157232016|NCT00854308|567595442|FG001|Overall Study|Physician Decision|6|||
157232017|NCT00854308|567595441|FG000|Overall Study|Withdrawal by Subject|4|||
157232018|NCT00854308|567595442|FG001|Overall Study|Withdrawal by Subject|2|||
157232019|NCT00854308|567595441|FG000|Overall Study|Sponsor's decision to terminate study|0|||
157232020|NCT00854308|567595442|FG001|Overall Study|Sponsor's decision to terminate study|1|||
157232021|NCT02079766|567595445|FG000|Overall Study|Physician Decision|1|||
157232022|NCT02079766|567595446|FG001|Overall Study|Physician Decision|0|||
157232023|NCT02079766|567595445|FG000|Overall Study|Withdrawal by Subject|1|||
157232024|NCT02079766|567595446|FG001|Overall Study|Withdrawal by Subject|0|||
157232025|NCT02781727|567595447|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
157232026|NCT02781727|567595448|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
157232027|NCT02781727|567595447|FG000|Treatment Period|Withdrawal by Subject|1|||
157232028|NCT02781727|567595448|FG001|Treatment Period|Withdrawal by Subject|0|||
157232029|NCT02781727|567595447|FG000|Treatment Period|Lost to Follow-up|0|||
157232030|NCT02781727|567595448|FG001|Treatment Period|Lost to Follow-up|1|||
157232031|NCT01044732|567595450|FG000|Overall Study|Lost to Follow-up|2|||
157232032|NCT01044732|567595451|FG001|Overall Study|Lost to Follow-up|1|||
157232033|NCT01044732|567595450|FG000|Overall Study|Physician Decision|5|||
157232034|NCT01044732|567595451|FG001|Overall Study|Physician Decision|3|||
157232035|NCT01044732|567595450|FG000|Overall Study|Protocol Violation|11|||
157232036|NCT01044732|567595451|FG001|Overall Study|Protocol Violation|12|||
157232037|NCT01044732|567595450|FG000|Overall Study|Withdrawal by Subject|0|||
157232038|NCT01044732|567595451|FG001|Overall Study|Withdrawal by Subject|1|||
157232039|NCT01044732|567595450|FG000|Overall Study|Inadequate bowel preparation|11|||
157232040|NCT01044732|567595451|FG001|Overall Study|Inadequate bowel preparation|17|||
157232041|NCT01044732|567595450|FG000|Overall Study|Inability to reach cecum|5|||
157232042|NCT01044732|567595451|FG001|Overall Study|Inability to reach cecum|2|||
157232043|NCT01044732|567595450|FG000|Overall Study|Technical error or malfunction|15|||
157232044|NCT01044732|567595451|FG001|Overall Study|Technical error or malfunction|14|||
157232045|NCT02170688|567595452|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
157232046|NCT02170688|567595453|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
157232047|NCT02170688|567595454|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
157232048|NCT02170688|567595455|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
157232049|NCT02170688|567595456|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
157232050|NCT02170688|567595452|FG000|Overall Study|Full dose not received|0|||
157232051|NCT02170688|567595453|FG001|Overall Study|Full dose not received|1|||
157232052|NCT02170688|567595454|FG002|Overall Study|Full dose not received|0|||
157232053|NCT02170688|567595455|FG003|Overall Study|Full dose not received|0|||
157232054|NCT02170688|567595456|FG004|Overall Study|Full dose not received|0|||
157232055|NCT02170688|567595452|FG000|Overall Study|Physician Decision|0|||
157232056|NCT02170688|567595453|FG001|Overall Study|Physician Decision|0|||
157232057|NCT02170688|567595454|FG002|Overall Study|Physician Decision|1|||
157232058|NCT02170688|567595455|FG003|Overall Study|Physician Decision|0|||
157232059|NCT02170688|567595456|FG004|Overall Study|Physician Decision|0|||
157232060|NCT01402947|567595457|FG000|First Intervention|Adverse Event|0|||
157232061|NCT01402947|567595458|FG001|First Intervention|Adverse Event|1|||
157077476|NCT03008005|567036932|FG002|Overall Study|Ineligible|0|||
157077477|NCT00475228|567036933|FG000|Overall Study|Lost to Follow-up|17|||
157232062|NCT00397488|567596778|FG000|Overall Study|Withdrawal by Subject|3|||
157077478|NCT00475228|567036934|FG001|Overall Study|Lost to Follow-up|17|||
157232063|NCT00397488|567596778|FG000|Overall Study|Adverse Event|3|||
157232064|NCT00397488|567596778|FG000|Overall Study|Death|1|||
157232065|NCT02424097|567596779|FG000|Overall Study|Lost to Follow-up|1|||
157232066|NCT02424097|567596780|FG001|Overall Study|Lost to Follow-up|2|||
157232067|NCT02880761|567596782|FG000|Overall Study|Death|6|||
157232068|NCT02880761|567596783|FG001|Overall Study|Death|8|||
157077479|NCT02209181|567036936|FG000|Overall Study|Adverse Event|1|||
157232069|NCT02880761|567596782|FG000|Overall Study|Withdrawal by Subject|3|||
157232070|NCT02880761|567596783|FG001|Overall Study|Withdrawal by Subject|6|||
157232071|NCT02880761|567596782|FG000|Overall Study|Protocol Violation|4|||
157077480|NCT02209181|567036937|FG001|Overall Study|Adverse Event|0|||
157077481|NCT02209181|567036938|FG002|Overall Study|Adverse Event|1|||
157077482|NCT02209181|567036939|FG003|Overall Study|Adverse Event|0|||
157077483|NCT02209181|567036936|FG000|Overall Study|Withdrawal by Subject|0|||
157077484|NCT02209181|567036937|FG001|Overall Study|Withdrawal by Subject|1|||
157077485|NCT02209181|567036938|FG002|Overall Study|Withdrawal by Subject|0|||
157077486|NCT02209181|567036939|FG003|Overall Study|Withdrawal by Subject|0|||
157077487|NCT00975676|567036940|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
157192738|NCT02117024|567447176|FG001|Overall Study|Progressive Disease|9|||
157192739|NCT02117024|567447175|FG000|Overall Study|Significant Clinical Progression|7|||
157192740|NCT02117024|567447176|FG001|Overall Study|Significant Clinical Progression|4|||
157192741|NCT02117024|567447175|FG000|Overall Study|Death|5|||
157192742|NCT02117024|567447176|FG001|Overall Study|Death|0|||
157192743|NCT02117024|567447175|FG000|Overall Study|Withdrawal by Subject|3|||
157192744|NCT02117024|567447176|FG001|Overall Study|Withdrawal by Subject|1|||
157192745|NCT02117024|567447175|FG000|Overall Study|Protocol Violation|1|||
157192746|NCT02117024|567447176|FG001|Overall Study|Protocol Violation|0|||
157192747|NCT02117024|567447175|FG000|Overall Study|Adverse Event|1|||
157192748|NCT02117024|567447176|FG001|Overall Study|Adverse Event|2|||
157192749|NCT02117024|567447175|FG000|Overall Study|Randomized in Error|1|||
157192750|NCT02117024|567447176|FG001|Overall Study|Randomized in Error|0|||
157192751|NCT02117024|567447175|FG000|Overall Study|Patient returned to primary oncologist|0|||
157077488|NCT00975676|567036941|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
157077489|NCT02548078|567036942|FG000|Overall Study|Serious adverse event/Adverse event|1|||
157077490|NCT02548078|567036943|FG001|Overall Study|Serious adverse event/Adverse event|0|||
157077491|NCT02548078|567036942|FG000|Overall Study|Moved from study area|3|||
157077492|NCT02548078|567036943|FG001|Overall Study|Moved from study area|3|||
157077493|NCT02548078|567036942|FG000|Overall Study|Lost to Follow-up|1|||
157077494|NCT02548078|567036943|FG001|Overall Study|Lost to Follow-up|3|||
157077495|NCT02579772|567036944|FG000|Overall Study|Withdrawal by Subject|0|||
157077496|NCT02579772|567036945|FG001|Overall Study|Withdrawal by Subject|1|||
157077497|NCT02579772|567036944|FG000|Overall Study|Usage of additional antioxidants|1|||
157077498|NCT02579772|567036945|FG001|Overall Study|Usage of additional antioxidants|0|||
157077499|NCT02579772|567036944|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
157192752|NCT02117024|567447176|FG001|Overall Study|Patient returned to primary oncologist|1|||
157192753|NCT02117024|567447175|FG000|Overall Study|Patient took treatment break|0|||
157192754|NCT02117024|567447176|FG001|Overall Study|Patient took treatment break|1|||
157192755|NCT02117024|567447175|FG000|Overall Study|Physician Decision|0|||
157192756|NCT02117024|567447176|FG001|Overall Study|Physician Decision|2|||
157192757|NCT00082628|567447184|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
157192758|NCT00082628|567447185|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
157192759|NCT00082628|567447186|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
157192760|NCT00082628|567447187|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
157192761|NCT00082628|567447188|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
157192762|NCT00082628|567447184|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
157192763|NCT00082628|567447185|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
157192764|NCT00082628|567447186|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
157192765|NCT00082628|567447187|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
157192766|NCT00082628|567447188|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
157192767|NCT00082628|567447184|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
157192768|NCT00082628|567447185|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
157192769|NCT00082628|567447186|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
157192770|NCT00082628|567447187|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
157192771|NCT00082628|567447188|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
157192772|NCT00082628|567447184|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
157192773|NCT00082628|567447185|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
157192774|NCT00082628|567447186|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
157192775|NCT00082628|567447187|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
157192776|NCT00082628|567447188|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
157192777|NCT00082628|567447184|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
157192778|NCT00082628|567447185|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
157232072|NCT02880761|567596783|FG001|Overall Study|Protocol Violation|3|||
157077500|NCT02579772|567036945|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
157077501|NCT00862836|567036946|FG000|Overall Study|Withdrawal by Subject|1|||
157232073|NCT02880761|567596782|FG000|Overall Study|Lost to Follow-up|3|||
157077502|NCT05855967|567036947|FG000|Overall Study|Withdrawal by Subject|7|||
157077503|NCT05855967|567036948|FG001|Overall Study|Withdrawal by Subject|5|||
157077504|NCT05855967|567036947|FG000|Overall Study|Lost to Follow-up|2|||
157077505|NCT05855967|567036948|FG001|Overall Study|Lost to Follow-up|1|||
157077506|NCT04147195|567036949|FG000|Overall Study|Adverse Event|0|||
157077507|NCT04147195|567036950|FG001|Overall Study|Adverse Event|3|||
157077508|NCT04147195|567036949|FG000|Overall Study|Study Terminated by Sponsor|4|||
157077509|NCT04147195|567036950|FG001|Overall Study|Study Terminated by Sponsor|2|||
157077510|NCT04147195|567036949|FG000|Overall Study|Withdrawal by Subject|0|||
157077511|NCT04147195|567036950|FG001|Overall Study|Withdrawal by Subject|1|||
157077512|NCT05823012|567036951|FG000|Titration Period|Adverse Event|1|||
157077513|NCT05823012|567036951|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
157077514|NCT05823012|567036951|FG000|Maintenance Period|Adverse Event|1|||
157077515|NCT05823012|567036951|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
157077516|NCT05823012|567036951|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
157077517|NCT01424813|567036952|FG000|Overall Study|Withdrawal by Subject|3|||
157077518|NCT01424813|567036953|FG001|Overall Study|Withdrawal by Subject|0|||
157077519|NCT01424813|567036952|FG000|Overall Study|Protocol Violation|1|||
157077520|NCT01424813|567036953|FG001|Overall Study|Protocol Violation|0|||
157077521|NCT01424813|567036952|FG000|Overall Study|Other|1|||
157077522|NCT01424813|567036953|FG001|Overall Study|Other|2|||
157077523|NCT03554629|567038996|FG000|Overall Study|Inadequate data|6|||
157077524|NCT01195948|567038999|FG000|Overall Study|Lost to Follow-up|0|||
157077525|NCT01195948|567039000|FG001|Overall Study|Lost to Follow-up|1|||
157077526|NCT01195948|567039001|FG002|Overall Study|Lost to Follow-up|2|||
157077527|NCT05577715|567039002|FG000|Overall Study|Withdrawal by Subject|1|||
157077528|NCT05577715|567039002|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
157077529|NCT05577715|567039002|FG000|Overall Study|Lost to Follow-up|1|||
157077530|NCT05577715|567039002|FG000|Overall Study|Death|6|||
157077531|NCT00626197|567039005|FG000|Overall Study|Did not cooperate|2|||
157077532|NCT00626197|567039006|FG001|Overall Study|Did not cooperate|6|||
157077533|NCT00626197|567039007|FG002|Overall Study|Did not cooperate|1|||
157077534|NCT00626197|567039005|FG000|Overall Study|Failure to return|6|||
157077535|NCT00626197|567039006|FG001|Overall Study|Failure to return|5|||
157077536|NCT00626197|567039007|FG002|Overall Study|Failure to return|6|||
157077537|NCT00626197|567039005|FG000|Overall Study|Adverse event, serious fatal|3|||
157077538|NCT00626197|567039006|FG001|Overall Study|Adverse event, serious fatal|6|||
157077539|NCT00626197|567039007|FG002|Overall Study|Adverse event, serious fatal|6|||
157077540|NCT00626197|567039005|FG000|Overall Study|Adverse Event|1|||
157077541|NCT00626197|567039006|FG001|Overall Study|Adverse Event|1|||
157077542|NCT00626197|567039007|FG002|Overall Study|Adverse Event|2|||
157077543|NCT00626197|567039005|FG000|Overall Study|Withdrawal by Subject|17|||
157077544|NCT00626197|567039006|FG001|Overall Study|Withdrawal by Subject|17|||
157077545|NCT00626197|567039007|FG002|Overall Study|Withdrawal by Subject|7|||
157077546|NCT00626197|567039005|FG000|Overall Study|Administrative reasons|15|||
157077547|NCT00626197|567039006|FG001|Overall Study|Administrative reasons|19|||
157077548|NCT00626197|567039007|FG002|Overall Study|Administrative reasons|55|||
157077549|NCT05282121|567039012|FG000|Overall Study|Adverse Event|1|||
157077550|NCT05282121|567039013|FG001|Overall Study|Adverse Event|1|||
157077551|NCT05282121|567039014|FG002|Overall Study|Adverse Event|4|||
157077552|NCT05282121|567039015|FG003|Overall Study|Adverse Event|1|||
157077553|NCT05282121|567039012|FG000|Overall Study|Study Terminated by Sponsor|1|||
157077554|NCT05282121|567039013|FG001|Overall Study|Study Terminated by Sponsor|2|||
157077555|NCT05282121|567039014|FG002|Overall Study|Study Terminated by Sponsor|2|||
157077556|NCT05282121|567039015|FG003|Overall Study|Study Terminated by Sponsor|2|||
157077557|NCT05282121|567039012|FG000|Overall Study|Other than listed|0|||
157077558|NCT05282121|567039013|FG001|Overall Study|Other than listed|0|||
157077559|NCT05282121|567039014|FG002|Overall Study|Other than listed|1|||
157077560|NCT05282121|567039015|FG003|Overall Study|Other than listed|0|||
157077561|NCT05282121|567039012|FG000|Overall Study|No reason available|0|||
157077562|NCT05282121|567039013|FG001|Overall Study|No reason available|0|||
157077563|NCT05282121|567039014|FG002|Overall Study|No reason available|1|||
157077564|NCT05282121|567039015|FG003|Overall Study|No reason available|0|||
157077565|NCT01077128|567039022|FG000|Overall Study|Adverse Event|8|||
157077566|NCT01077128|567039022|FG000|Overall Study|Lack of Efficacy|1|||
157077567|NCT01077128|567039022|FG000|Overall Study|Disease exacerbation|1|||
157077568|NCT01077128|567039022|FG000|Overall Study|Adverse event and consent withdrawal|1|||
157077569|NCT01077128|567039022|FG000|Overall Study|Adverse event and disease exacerbation|1|||
157077570|NCT01077128|567039022|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
157077571|NCT01077128|567039022|FG000|Overall Study|Other|54|||
157077572|NCT01923662|567039029|FG000|Overall Study|Withdrawal by Subject|1|||
157077573|NCT01250925|567039030|FG000|Overall Study|Lost to Follow-up|1|||
157077574|NCT01250925|567039031|FG001|Overall Study|Lost to Follow-up|1|||
157077575|NCT01250925|567039032|FG002|Overall Study|Lost to Follow-up|0|||
157077576|NCT01250925|567039030|FG000|Overall Study|Withdrawal by Subject|2|||
157077577|NCT01250925|567039031|FG001|Overall Study|Withdrawal by Subject|0|||
157077578|NCT01250925|567039032|FG002|Overall Study|Withdrawal by Subject|0|||
157077579|NCT01250925|567039030|FG000|Overall Study|Protocol Violation|2|||
157077580|NCT01250925|567039031|FG001|Overall Study|Protocol Violation|0|||
157077581|NCT01250925|567039032|FG002|Overall Study|Protocol Violation|0|||
157077582|NCT01250925|567039030|FG000|Overall Study|Physician Decision|0|||
157077583|NCT01250925|567039031|FG001|Overall Study|Physician Decision|2|||
157077584|NCT01250925|567039032|FG002|Overall Study|Physician Decision|1|||
157077585|NCT01250925|567039030|FG000|Overall Study|Adverse Event|0|||
157077586|NCT01250925|567039031|FG001|Overall Study|Adverse Event|0|||
157077587|NCT01250925|567039032|FG002|Overall Study|Adverse Event|1|||
157077588|NCT03338296|567039033|FG000|Overall Study|Adverse Event|0|||
157077589|NCT03338296|567039034|FG001|Overall Study|Adverse Event|1|||
157077590|NCT03338296|567039033|FG000|Overall Study|Withdrawal by Subject|14|||
157077591|NCT03338296|567039034|FG001|Overall Study|Withdrawal by Subject|13|||
157077592|NCT03338296|567039033|FG000|Overall Study|Lost to Follow-up|10|||
157077593|NCT03338296|567039034|FG001|Overall Study|Lost to Follow-up|10|||
157077594|NCT03338296|567039033|FG000|Overall Study|Study Terminated by Sponsor|77|||
157077595|NCT03338296|567039034|FG001|Overall Study|Study Terminated by Sponsor|76|||
157077596|NCT03338296|567039033|FG000|Overall Study|Other|2|||
157077597|NCT03338296|567039034|FG001|Overall Study|Other|7|||
157077598|NCT03338296|567039033|FG000|Overall Study|Missing|0|||
157077599|NCT03338296|567039034|FG001|Overall Study|Missing|1|||
157077600|NCT01939353|567039035|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
157077601|NCT01939353|567039035|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
157077602|NCT01939353|567039035|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
157077603|NCT01939353|567039035|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
157077604|NCT01939353|567039035|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
157077605|NCT02175641|567039037|FG000|Overall Study|Death|3|||
157077606|NCT02175641|567039038|FG001|Overall Study|Death|4|||
157077607|NCT02175641|567039037|FG000|Overall Study|Lost to Follow-up|4|||
157077608|NCT02175641|567039038|FG001|Overall Study|Lost to Follow-up|4|||
157077609|NCT02175641|567039037|FG000|Overall Study|Withdrawal by Subject|7|||
157077610|NCT02175641|567039038|FG001|Overall Study|Withdrawal by Subject|4|||
157077611|NCT02175641|567039037|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
157077612|NCT02175641|567039038|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
157077613|NCT02175641|567039037|FG000|Overall Study|Developed Contraindicated Condition|8|||
157077614|NCT02175641|567039038|FG001|Overall Study|Developed Contraindicated Condition|0|||
157077615|NCT02057575|567039039|FG000|Overall Study|Adverse Event|0|||
157077616|NCT02057575|567039040|FG001|Overall Study|Adverse Event|2|||
157077617|NCT02057575|567039041|FG002|Overall Study|Adverse Event|0|||
157077618|NCT02057575|567039042|FG003|Overall Study|Adverse Event|1|||
157077619|NCT02057575|567039039|FG000|Overall Study|Withdrawal by Subject|1|||
157077620|NCT02057575|567039040|FG001|Overall Study|Withdrawal by Subject|0|||
157077621|NCT02057575|567039041|FG002|Overall Study|Withdrawal by Subject|0|||
157077622|NCT02057575|567039042|FG003|Overall Study|Withdrawal by Subject|0|||
157077623|NCT02057575|567039039|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
157077624|NCT02057575|567039040|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
157077625|NCT02057575|567039041|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
157077626|NCT02057575|567039042|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
157077627|NCT02057575|567039039|FG000|Overall Study|Protocol Violation|0|||
157077628|NCT02057575|567039040|FG001|Overall Study|Protocol Violation|1|||
157077629|NCT02057575|567039041|FG002|Overall Study|Protocol Violation|0|||
157077630|NCT02057575|567039042|FG003|Overall Study|Protocol Violation|0|||
157077631|NCT02979249|567039044|FG000|Overall Study|Lost to Follow-up|2|||
157077632|NCT02979249|567039044|FG000|Overall Study|Withdrawal by Subject|4|||
157077633|NCT01125046|567039045|FG000|First 6 Months of Treatment|Death|1|||
157077634|NCT01125046|567039045|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
157077635|NCT01125046|567039045|FG000|First 6 Months of Treatment|Non-compliance|1|||
157077636|NCT01125046|567039045|FG000|First 6 Months of Treatment|Surgery|1|||
157077637|NCT01125046|567039045|FG000|First 6 Months of Treatment|Progressive Disease|7|||
157077638|NCT01125046|567039045|FG000|First 6 Months of Treatment|Adverse Event|2|||
157077639|NCT01125046|567039045|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
157077640|NCT01125046|567039045|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
157077641|NCT01125046|567039045|FG000|Follow-up/Data Cut Off Point|Death|29|||
157077642|NCT01125046|567039045|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
157077643|NCT03596762|567039051|FG000|Overall Study|Protocol Violation|0|||
157077644|NCT03596762|567039052|FG001|Overall Study|Protocol Violation|0|||
157077645|NCT03596762|567039053|FG002|Overall Study|Protocol Violation|0|||
157077646|NCT03596762|567039054|FG003|Overall Study|Protocol Violation|0|||
157077647|NCT03596762|567039055|FG004|Overall Study|Protocol Violation|1|||
157077648|NCT03596762|567039051|FG000|Overall Study|Adverse Event|2|||
157232074|NCT02880761|567596783|FG001|Overall Study|Lost to Follow-up|4|||
157077649|NCT03596762|567039052|FG001|Overall Study|Adverse Event|0|||
157077650|NCT03596762|567039053|FG002|Overall Study|Adverse Event|1|||
157077651|NCT03596762|567039054|FG003|Overall Study|Adverse Event|0|||
157077652|NCT03596762|567039055|FG004|Overall Study|Adverse Event|5|||
157077653|NCT03596762|567039051|FG000|Overall Study|Withdrawal by Subject|2|||
157077654|NCT03596762|567039052|FG001|Overall Study|Withdrawal by Subject|1|||
157077655|NCT03596762|567039053|FG002|Overall Study|Withdrawal by Subject|0|||
157077656|NCT03596762|567039054|FG003|Overall Study|Withdrawal by Subject|1|||
157077657|NCT03596762|567039055|FG004|Overall Study|Withdrawal by Subject|1|||
157077658|NCT03842228|567039056|FG000|Overall Study|Adverse Event|1|||
157077659|NCT03842228|567039057|FG001|Overall Study|Adverse Event|1|||
157077660|NCT03842228|567039058|FG002|Overall Study|Adverse Event|1|||
157077661|NCT03842228|567039059|FG003|Overall Study|Adverse Event|0|||
157077662|NCT03842228|567039060|FG004|Overall Study|Adverse Event|0|||
157077663|NCT03842228|567039061|FG005|Overall Study|Adverse Event|0|||
157077664|NCT03842228|567039062|FG006|Overall Study|Adverse Event|0|||
157232075|NCT03597256|567596784|FG000|Overall Study|Lost to Follow-up|3|||
157232076|NCT03597256|567596785|FG001|Overall Study|Lost to Follow-up|1|||
157077665|NCT03842228|567039056|FG000|Overall Study|Death|0|||
157232077|NCT03597256|567596784|FG000|Overall Study|Withdrawal by Subject|0|||
157232078|NCT03597256|567596785|FG001|Overall Study|Withdrawal by Subject|1|||
157232079|NCT03597256|567596784|FG000|Overall Study|Could not return for treatment|0|||
157232080|NCT03597256|567596785|FG001|Overall Study|Could not return for treatment|1|||
157232081|NCT03597256|567596784|FG000|Overall Study|Moved from location|0|||
157232082|NCT03597256|567596785|FG001|Overall Study|Moved from location|1|||
157232083|NCT03597256|567596784|FG000|Overall Study|Not accepted the treatment|0|||
157232084|NCT03597256|567596785|FG001|Overall Study|Not accepted the treatment|1|||
157232085|NCT02943447|567596786|FG000|Blinded Study Phase|Withdrew Consent|1|||
157232086|NCT02943447|567596787|FG001|Blinded Study Phase|Withdrew Consent|2|||
157232087|NCT02943447|567596788|FG002|Blinded Study Phase|Withdrew Consent|1|||
157232088|NCT02943447|567596786|FG000|Blinded Study Phase|Adverse Event|3|||
157232089|NCT02943447|567596787|FG001|Blinded Study Phase|Adverse Event|0|||
157232090|NCT02943447|567596788|FG002|Blinded Study Phase|Adverse Event|0|||
157232091|NCT02943447|567596786|FG000|Blinded Study Phase|Investigator's discretion|1|||
157232092|NCT02943447|567596787|FG001|Blinded Study Phase|Investigator's discretion|0|||
157232093|NCT02943447|567596788|FG002|Blinded Study Phase|Investigator's discretion|0|||
157232094|NCT02943447|567596786|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
157232095|NCT02943447|567596787|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
157232096|NCT02943447|567596788|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
157232097|NCT02943447|567596786|FG000|Open-Label Extension Phase|Adverse Event|4|||
157232098|NCT02943447|567596787|FG001|Open-Label Extension Phase|Adverse Event|7|||
157232099|NCT02943447|567596788|FG002|Open-Label Extension Phase|Adverse Event|3|||
157232100|NCT02943447|567596786|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
157232101|NCT02943447|567596787|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
157232102|NCT02943447|567596788|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
157232103|NCT02943447|567596786|FG000|Open-Label Extension Phase|Withdrew consent|1|||
157232104|NCT02943447|567596787|FG001|Open-Label Extension Phase|Withdrew consent|1|||
157232105|NCT02943447|567596788|FG002|Open-Label Extension Phase|Withdrew consent|1|||
157077666|NCT03842228|567039057|FG001|Overall Study|Death|1|||
157077667|NCT03842228|567039058|FG002|Overall Study|Death|0|||
157077668|NCT03842228|567039059|FG003|Overall Study|Death|0|||
157077669|NCT03842228|567039060|FG004|Overall Study|Death|0|||
157077670|NCT03842228|567039061|FG005|Overall Study|Death|0|||
157077671|NCT03842228|567039062|FG006|Overall Study|Death|0|||
157077672|NCT03842228|567039056|FG000|Overall Study|Withdrawal by Subject|0|||
157077673|NCT03842228|567039057|FG001|Overall Study|Withdrawal by Subject|0|||
157077674|NCT03842228|567039058|FG002|Overall Study|Withdrawal by Subject|2|||
157077675|NCT03842228|567039059|FG003|Overall Study|Withdrawal by Subject|1|||
157077676|NCT03842228|567039060|FG004|Overall Study|Withdrawal by Subject|0|||
157077677|NCT03842228|567039061|FG005|Overall Study|Withdrawal by Subject|0|||
157077678|NCT03842228|567039062|FG006|Overall Study|Withdrawal by Subject|2|||
157077679|NCT03842228|567039056|FG000|Overall Study|Progression|8|||
157077680|NCT03842228|567039057|FG001|Overall Study|Progression|1|||
157077681|NCT03842228|567039058|FG002|Overall Study|Progression|7|||
157077682|NCT03842228|567039059|FG003|Overall Study|Progression|5|||
157077683|NCT03842228|567039060|FG004|Overall Study|Progression|4|||
157077684|NCT03842228|567039061|FG005|Overall Study|Progression|2|||
157077685|NCT03842228|567039062|FG006|Overall Study|Progression|3|||
157077686|NCT00504777|567039063|FG000|Overall Study|Adverse Event|1|||
157077687|NCT01572740|567039064|FG000|Overall Study|Adverse Event|1|||
157077688|NCT01572740|567039065|FG001|Overall Study|Adverse Event|1|||
157077689|NCT01572740|567039064|FG000|Overall Study|Withdrawal by Subject|1|||
157232106|NCT02943447|567596786|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
157232107|NCT02943447|567596787|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
157077690|NCT01572740|567039065|FG001|Overall Study|Withdrawal by Subject|1|||
157077691|NCT01572740|567039064|FG000|Overall Study|unclassified|4|||
157077692|NCT01572740|567039065|FG001|Overall Study|unclassified|3|||
157077693|NCT01818531|567039071|FG000|Overall Study|Withdrawn for case delay after block|1|||
157077694|NCT01818531|567039072|FG001|Overall Study|Withdrawn for case delay after block|0|||
157077695|NCT01818531|567039071|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
157077696|NCT01818531|567039072|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
157077697|NCT01818531|567039071|FG000|Overall Study|Withdrawn for failure to place block|0|||
157077698|NCT01818531|567039072|FG001|Overall Study|Withdrawn for failure to place block|1|||
157077699|NCT00214019|567039073|FG000|Overall Study|Lost to Follow-up|11|||
157077700|NCT00214019|567039073|FG000|Overall Study|Withdrawal by Subject|2|||
157077701|NCT00214019|567039073|FG000|Overall Study|Screen Failed prior to randomization|17|||
157077702|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
157077703|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
157077704|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
157077705|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
157077706|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
157077707|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
157077708|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
157077709|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
157077710|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
157077711|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
157077712|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077713|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077714|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
157077715|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
157077716|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077717|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077718|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077719|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
157077720|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
157077721|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077722|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077723|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077724|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
157077725|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077726|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077727|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077728|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
157077729|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
157077730|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
157077731|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
157077732|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
157077733|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
157077734|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
157077735|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
157077736|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
157077737|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
157077738|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
157077739|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
157077740|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
157077741|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
157077742|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
157077743|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
157077744|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
157077745|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
157077746|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
157077747|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
157077748|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
157077749|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
157077750|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
157077751|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
157077752|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
157077753|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
157077754|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
157077755|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
157077756|NCT00477490|567039074|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
157077757|NCT00477490|567039075|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
157077758|NCT00477490|567039076|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
157192779|NCT00082628|567447186|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
157192780|NCT00082628|567447187|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
157077759|NCT00477490|567039077|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
157077760|NCT00477490|567039078|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
157077761|NCT00477490|567039079|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
157077762|NCT00477490|567039080|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
157077763|NCT00477490|567039081|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
157077764|NCT00477490|567039082|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
157077765|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
157077766|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
157077767|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
157077768|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
157077769|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
157077770|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
157077771|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
157077772|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
157077773|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
157077774|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
157077775|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
157077776|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
157077777|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
157077778|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
157077779|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
157077780|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
157077781|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
157077782|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
157077783|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
157077784|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
157232108|NCT02943447|567596788|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
157232109|NCT02106156|567596789|FG000|Overall Study|Patient Died|19|||
157077785|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
157077786|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
157077787|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
157077788|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
157077789|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
157077790|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
157077791|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
157077792|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077793|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077794|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077795|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077796|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
157077797|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077798|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
157077799|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
157077800|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
157077801|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077802|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
157077803|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077804|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077805|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077806|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077807|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077808|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077809|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
157077810|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
157077811|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
157077812|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
157077813|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
157077814|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
157077815|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
157077816|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
157077817|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
157077818|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
157077819|NCT00477490|567039074|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077820|NCT00477490|567039075|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
157077821|NCT00477490|567039076|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
157192781|NCT00082628|567447188|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
157192782|NCT00082628|567447184|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
157192783|NCT00082628|567447185|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
157192784|NCT00082628|567447186|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
157192785|NCT00082628|567447187|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
157192786|NCT00082628|567447188|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
157192787|NCT00082628|567447184|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
157077822|NCT00477490|567039077|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077823|NCT00477490|567039078|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
157077824|NCT00477490|567039079|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077825|NCT00477490|567039080|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077826|NCT00477490|567039081|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077827|NCT00477490|567039082|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
157077828|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
157077829|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
157077830|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
157077831|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
157077832|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077833|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077834|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077835|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077836|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077837|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077838|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077839|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
157077840|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
157077841|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
157077842|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
157077843|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
157077844|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077845|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077846|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077847|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077848|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077849|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077850|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077851|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
157077852|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
157077853|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
157077854|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
157077855|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
157077856|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077857|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077858|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077859|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077860|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077861|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077862|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077863|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
157077864|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
157077865|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
157077866|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
157077867|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
157077868|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077869|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077870|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077871|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077872|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077873|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077874|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077875|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
157077876|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077877|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077878|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
157077879|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
157077880|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077881|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077882|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077883|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077884|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077885|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077886|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077887|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
157077888|NCT01646177|567039085|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
157077889|NCT01646177|567039086|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
157077890|NCT01646177|567039087|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
157077891|NCT01646177|567039088|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077892|NCT01646177|567039089|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077893|NCT01646177|567039090|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077894|NCT01646177|567039091|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077895|NCT01646177|567039092|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077896|NCT01646177|567039093|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077897|NCT01646177|567039094|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077898|NCT01646177|567039095|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077899|NCT01646177|567039096|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
157077900|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077901|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077902|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077903|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077904|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
157077905|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
157077906|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
157077907|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
157077908|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077909|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077910|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077911|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
157077912|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077913|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077914|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077915|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077916|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
157077917|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
157077918|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
157077919|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
157077920|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077921|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077922|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077923|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
157077924|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077925|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077926|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077927|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077928|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
157077929|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
157077930|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
157077931|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
157077932|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077933|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077934|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077935|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
157077936|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077937|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077938|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077939|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077940|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
157077941|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
157077942|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
157077943|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
157077944|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077945|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077946|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077947|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
157077948|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077949|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077950|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077951|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077952|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
157077953|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
157077954|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
157077955|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
157077956|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077957|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077958|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077959|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
157077960|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077961|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077962|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077963|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077964|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
157077965|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
157077966|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077967|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
157077968|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077969|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077970|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077971|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
157077972|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077973|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077974|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077975|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077976|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
157077977|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
157077978|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
157077979|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
157077980|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077981|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077982|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077983|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
157077984|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
157077985|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
157077986|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
157077987|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
157077988|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
157077989|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
157077990|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
157077991|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
157077992|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
157077993|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
157077994|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
157077995|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
157077996|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157077997|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157077998|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157077999|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157078000|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
157078001|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
157078002|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
157078003|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
157078004|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157078005|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157078006|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157078007|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
157078008|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078009|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078010|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157192788|NCT00082628|567447185|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
157192789|NCT00082628|567447186|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
157192790|NCT00082628|567447187|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
157192791|NCT00082628|567447188|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
157078011|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078012|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078013|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078014|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078015|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
157078016|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078017|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078018|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078019|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
157078020|NCT01646177|567039085|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078021|NCT01646177|567039086|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078022|NCT01646177|567039087|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078023|NCT01646177|567039088|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078024|NCT01646177|567039089|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078025|NCT01646177|567039090|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
157078026|NCT01646177|567039091|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
157078027|NCT01646177|567039092|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
157078028|NCT01646177|567039093|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078029|NCT01646177|567039094|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078030|NCT01646177|567039095|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078031|NCT01646177|567039096|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
157078032|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078033|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078034|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078035|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078036|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078037|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078038|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078039|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
157078040|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
157078041|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
157078042|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
157078043|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
157078044|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078045|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078046|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078047|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078048|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078049|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078050|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078051|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
157078052|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
157078053|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
157078054|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
157078055|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
157078056|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078057|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078058|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078059|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078060|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078061|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078062|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078063|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
157078064|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
157078065|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
157078066|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
157078067|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
157078068|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078069|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078070|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078071|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157232110|NCT02106156|567596790|FG001|Overall Study|Patient Died|0|||
157232111|NCT02106156|567596791|FG002|Overall Study|Patient Died|0|||
157078072|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078073|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078074|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078075|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
157078076|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
157078077|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
157078078|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
157078079|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
157078080|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078081|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078082|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078083|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078084|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078085|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078086|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078087|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
157078088|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
157078089|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
157078090|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
157078091|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
157078092|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078093|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078094|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078095|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078096|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078097|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078098|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078099|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
157078100|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
157078101|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
157078102|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
157078103|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
157078104|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078105|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078106|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078107|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078108|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078109|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078110|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078111|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078112|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
157078113|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
157078114|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
157078115|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
157078116|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078117|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078118|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078119|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078120|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078121|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078122|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078123|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078124|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
157078125|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
157078126|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
157078127|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
157078128|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078129|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078130|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078131|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078132|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078133|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078134|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078135|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157192792|NCT03481634|567447196|FG000|Overall Study|Withdrawal by Subject|16|||
157192793|NCT03481634|567447197|FG001|Overall Study|Withdrawal by Subject|19|||
157078136|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
157078137|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
157078138|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
157078139|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
157078140|NCT01646177|567039085|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078141|NCT01646177|567039086|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078142|NCT01646177|567039087|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078143|NCT01646177|567039088|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078144|NCT01646177|567039089|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078145|NCT01646177|567039090|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078146|NCT01646177|567039091|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078147|NCT01646177|567039092|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078148|NCT01646177|567039093|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078149|NCT01646177|567039094|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
157078150|NCT01646177|567039095|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
157078151|NCT01646177|567039096|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
157078152|NCT01465763|567039097|FG000|Overall Study|Withdrawal by Subject|4|||
157078153|NCT01465763|567039098|FG001|Overall Study|Withdrawal by Subject|0|||
157078154|NCT01465763|567039099|FG002|Overall Study|Withdrawal by Subject|1|||
157078155|NCT01465763|567039097|FG000|Overall Study|Insufficient Clinical Response|11|||
157078156|NCT01465763|567039098|FG001|Overall Study|Insufficient Clinical Response|0|||
157078157|NCT01465763|567039099|FG002|Overall Study|Insufficient Clinical Response|1|||
157078158|NCT01465763|567039097|FG000|Overall Study|Adverse Event|9|||
157078159|NCT01465763|567039098|FG001|Overall Study|Adverse Event|0|||
157078160|NCT01465763|567039099|FG002|Overall Study|Adverse Event|1|||
157078161|NCT01465763|567039097|FG000|Overall Study|Other|2|||
157078162|NCT01465763|567039098|FG001|Overall Study|Other|0|||
157078163|NCT01465763|567039099|FG002|Overall Study|Other|0|||
157078164|NCT01465763|567039097|FG000|Overall Study|Protocol Violation|4|||
157078165|NCT01465763|567039098|FG001|Overall Study|Protocol Violation|1|||
157078166|NCT01465763|567039099|FG002|Overall Study|Protocol Violation|1|||
157078167|NCT01465763|567039097|FG000|Overall Study|Death|1|||
157078168|NCT01465763|567039098|FG001|Overall Study|Death|0|||
157078169|NCT01465763|567039099|FG002|Overall Study|Death|0|||
157078170|NCT01038427|567039102|FG000|Overall Study|Lost to follow up|1|||
157078171|NCT01038427|567039103|FG001|Overall Study|Lost to follow up|1|||
157078172|NCT01038427|567039104|FG002|Overall Study|Lost to follow up|0|||
157078173|NCT01038427|567039102|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
157078174|NCT01038427|567039103|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
157078175|NCT01038427|567039104|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
157078176|NCT01038427|567039102|FG000|Overall Study|Withdrew consent|0|||
157078177|NCT01038427|567039103|FG001|Overall Study|Withdrew consent|0|||
157078178|NCT01038427|567039104|FG002|Overall Study|Withdrew consent|1|||
157078179|NCT01038427|567039102|FG000|Overall Study|Adverse Event|2|||
157078180|NCT01038427|567039103|FG001|Overall Study|Adverse Event|2|||
157078181|NCT01038427|567039104|FG002|Overall Study|Adverse Event|1|||
157078182|NCT01038427|567039102|FG000|Overall Study|Enrolled in error|0|||
157078183|NCT01038427|567039103|FG001|Overall Study|Enrolled in error|1|||
157078184|NCT01038427|567039104|FG002|Overall Study|Enrolled in error|1|||
157078185|NCT01038427|567039102|FG000|Overall Study|Other|0|||
157078186|NCT01038427|567039103|FG001|Overall Study|Other|2|||
157078187|NCT01038427|567039104|FG002|Overall Study|Other|0|||
157078188|NCT00820170|567039105|FG000|Overall Study|Adverse Event|0|||
157078189|NCT00820170|567039106|FG001|Overall Study|Adverse Event|0|||
157078190|NCT00820170|567039107|FG002|Overall Study|Adverse Event|0|||
157078191|NCT00820170|567039108|FG003|Overall Study|Adverse Event|0|||
157078192|NCT00820170|567039109|FG004|Overall Study|Adverse Event|2|||
157078193|NCT00820170|567039105|FG000|Overall Study|Progressive Disease|0|||
157078194|NCT00820170|567039106|FG001|Overall Study|Progressive Disease|0|||
157078195|NCT00820170|567039107|FG002|Overall Study|Progressive Disease|0|||
157078196|NCT00820170|567039108|FG003|Overall Study|Progressive Disease|0|||
157078197|NCT00820170|567039109|FG004|Overall Study|Progressive Disease|2|||
157078198|NCT05479734|567039110|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
157078199|NCT05479734|567039111|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
157078200|NCT05479734|567039110|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
157078201|NCT05479734|567039111|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
157078202|NCT05479734|567039110|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
157078203|NCT05479734|567039111|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
157078204|NCT05479734|567039110|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
157078205|NCT05479734|567039111|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
157078206|NCT00664534|567039112|FG000|Overall Study|Adverse Event|2|||
157078207|NCT00664534|567039113|FG001|Overall Study|Adverse Event|3|||
157078208|NCT00664534|567039112|FG000|Overall Study|Lost to Follow-up|6|||
157078209|NCT00664534|567039113|FG001|Overall Study|Lost to Follow-up|10|||
157078210|NCT00664534|567039112|FG000|Overall Study|Protocol Violation|10|||
157078211|NCT00664534|567039113|FG001|Overall Study|Protocol Violation|8|||
157078212|NCT00664534|567039112|FG000|Overall Study|Withdrawal by Subject|7|||
157078213|NCT00664534|567039113|FG001|Overall Study|Withdrawal by Subject|6|||
157078214|NCT00664534|567039112|FG000|Overall Study|Physician Decision|8|||
157078215|NCT00664534|567039113|FG001|Overall Study|Physician Decision|0|||
157078216|NCT00664534|567039112|FG000|Overall Study|Sponsor decision|8|||
157078217|NCT00664534|567039113|FG001|Overall Study|Sponsor decision|6|||
157078218|NCT01436253|567039119|FG000|Overall Study|Lost to Follow-up|182|||
157078219|NCT01436253|567039119|FG000|Overall Study|Not meeting all eligibility criteria|117|||
157078220|NCT03083665|567039121|FG000|Double-Blind Period|Adverse Event|5|||
157078221|NCT03083665|567039122|FG001|Double-Blind Period|Adverse Event|4|||
157078222|NCT03083665|567039123|FG002|Double-Blind Period|Adverse Event|5|||
157078223|NCT03083665|567039124|FG003|Double-Blind Period|Adverse Event|0|||
157078224|NCT03083665|567039125|FG004|Double-Blind Period|Adverse Event|0|||
157078225|NCT03083665|567039126|FG005|Double-Blind Period|Adverse Event|0|||
157078226|NCT03083665|567039121|FG000|Double-Blind Period|Lack of Efficacy|0|||
157078227|NCT03083665|567039122|FG001|Double-Blind Period|Lack of Efficacy|0|||
157078228|NCT03083665|567039123|FG002|Double-Blind Period|Lack of Efficacy|1|||
157078229|NCT03083665|567039124|FG003|Double-Blind Period|Lack of Efficacy|0|||
157078230|NCT03083665|567039125|FG004|Double-Blind Period|Lack of Efficacy|0|||
157078231|NCT03083665|567039126|FG005|Double-Blind Period|Lack of Efficacy|0|||
157078232|NCT03083665|567039121|FG000|Double-Blind Period|Protocol Violation|1|||
157078233|NCT03083665|567039122|FG001|Double-Blind Period|Protocol Violation|0|||
157078234|NCT03083665|567039123|FG002|Double-Blind Period|Protocol Violation|1|||
157078235|NCT03083665|567039124|FG003|Double-Blind Period|Protocol Violation|0|||
157078236|NCT03083665|567039125|FG004|Double-Blind Period|Protocol Violation|0|||
157078237|NCT03083665|567039126|FG005|Double-Blind Period|Protocol Violation|0|||
157078238|NCT03083665|567039121|FG000|Double-Blind Period|Lost to Follow-up|1|||
157078239|NCT03083665|567039122|FG001|Double-Blind Period|Lost to Follow-up|0|||
157078240|NCT03083665|567039123|FG002|Double-Blind Period|Lost to Follow-up|1|||
157078241|NCT03083665|567039124|FG003|Double-Blind Period|Lost to Follow-up|0|||
157078242|NCT03083665|567039125|FG004|Double-Blind Period|Lost to Follow-up|0|||
157078243|NCT03083665|567039126|FG005|Double-Blind Period|Lost to Follow-up|0|||
157078244|NCT03083665|567039121|FG000|Double-Blind Period|Withdrawal by Subject|3|||
157078245|NCT03083665|567039122|FG001|Double-Blind Period|Withdrawal by Subject|0|||
157078246|NCT03083665|567039123|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157078247|NCT03083665|567039124|FG003|Double-Blind Period|Withdrawal by Subject|0|||
157078248|NCT03083665|567039125|FG004|Double-Blind Period|Withdrawal by Subject|0|||
157078249|NCT03083665|567039126|FG005|Double-Blind Period|Withdrawal by Subject|0|||
157078250|NCT03083665|567039121|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
157078251|NCT03083665|567039122|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
157078252|NCT03083665|567039123|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
157078253|NCT03083665|567039124|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
157078254|NCT03083665|567039125|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
157078255|NCT03083665|567039126|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
157078256|NCT03083665|567039121|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
157078257|NCT03083665|567039122|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
157078258|NCT03083665|567039123|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
157078259|NCT03083665|567039124|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
157078260|NCT03083665|567039125|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
157078261|NCT03083665|567039126|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
157078262|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
157078263|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
157078264|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
157078265|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
157078266|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
157078267|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
157078268|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
157078269|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
157078270|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
157078271|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
157078272|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
157192794|NCT03481634|567447198|FG002|Overall Study|Withdrawal by Subject|14|||
157078273|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
157078274|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
157078275|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
157078276|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
157078277|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
157192795|NCT03481634|567447196|FG000|Overall Study|Protocol Violation|1|||
157078278|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
157078279|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
157078280|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
157078281|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
157078282|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
157078283|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
157078284|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
157078285|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
157078286|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
157078287|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
157078288|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
157078289|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
157078290|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
157078291|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
157078292|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
157078293|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
157078294|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
157078295|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
157078296|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
157078297|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
157078298|NCT03083665|567039121|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
157078299|NCT03083665|567039122|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
157078300|NCT03083665|567039123|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
157078301|NCT03083665|567039124|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
157078302|NCT03083665|567039125|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
157078303|NCT03083665|567039126|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
157078304|NCT04844879|567039127|FG000|Overall Study|Death|1|||
157078305|NCT04844879|567039127|FG000|Overall Study|Withdrawal by Subject|1|||
157078306|NCT04844879|567039127|FG000|Overall Study|Adverse Event|1|||
157078307|NCT05576662|567039128|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
157078308|NCT05576662|567039129|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
157078309|NCT05576662|567039128|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
157078310|NCT05576662|567039129|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
157078311|NCT05576662|567039128|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
157078312|NCT05576662|567039129|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
157078313|NCT05576662|567039128|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
157078314|NCT05576662|567039129|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
157078315|NCT01040169|567039131|FG000|Overall Study|Lost to Follow-up|3|||
157078316|NCT01040169|567039132|FG001|Overall Study|Lost to Follow-up|8|||
157078317|NCT00350727|567039133|FG000|Phase I: Dose Escalation|Adverse Event|4|||
157078318|NCT00350727|567039134|FG001|Phase I: Dose Escalation|Adverse Event|0|||
157078319|NCT00350727|567039135|FG002|Phase I: Dose Escalation|Adverse Event|0|||
157078320|NCT00350727|567039133|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
157078321|NCT00350727|567039134|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
157078322|NCT00350727|567039135|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
157078323|NCT00350727|567039133|FG000|Phase I: Dose Escalation|Death|1|||
157078324|NCT00350727|567039134|FG001|Phase I: Dose Escalation|Death|0|||
157078325|NCT00350727|567039135|FG002|Phase I: Dose Escalation|Death|0|||
157078326|NCT00350727|567039133|FG000|Phase I: Dose Escalation|Physician Decision|1|||
157078327|NCT00350727|567039134|FG001|Phase I: Dose Escalation|Physician Decision|0|||
157078328|NCT00350727|567039135|FG002|Phase I: Dose Escalation|Physician Decision|0|||
157078329|NCT00350727|567039133|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
157078330|NCT00350727|567039134|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
157232112|NCT02106156|567596789|FG000|Overall Study|Lack of Tolerability|305|||
157232113|NCT02106156|567596790|FG001|Overall Study|Lack of Tolerability|3|||
157232114|NCT02106156|567596791|FG002|Overall Study|Lack of Tolerability|0|||
157232115|NCT02106156|567596789|FG000|Overall Study|Lack of Virological Response|1044|||
157078331|NCT00350727|567039135|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
157078332|NCT00350727|567039133|FG000|Phase II|Disease Progression|0|||
157078333|NCT00350727|567039134|FG001|Phase II|Disease Progression|15|||
157078334|NCT00350727|567039135|FG002|Phase II|Disease Progression|16|||
157078335|NCT00350727|567039133|FG000|Phase II|Clinical Deterioration|0|||
157078336|NCT00350727|567039134|FG001|Phase II|Clinical Deterioration|1|||
157232116|NCT02106156|567596790|FG001|Overall Study|Lack of Virological Response|8|||
157232117|NCT02106156|567596791|FG002|Overall Study|Lack of Virological Response|0|||
157078337|NCT00350727|567039135|FG002|Phase II|Clinical Deterioration|0|||
157078338|NCT00350727|567039133|FG000|Phase II|Withdrawal by Subject|0|||
157078339|NCT00350727|567039134|FG001|Phase II|Withdrawal by Subject|2|||
157078340|NCT00350727|567039135|FG002|Phase II|Withdrawal by Subject|1|||
157078341|NCT00350727|567039133|FG000|Phase II|Adverse Event|0|||
157078342|NCT00350727|567039134|FG001|Phase II|Adverse Event|1|||
157078343|NCT00350727|567039135|FG002|Phase II|Adverse Event|1|||
157078344|NCT00350727|567039133|FG000|Phase II|Death|0|||
157078345|NCT00350727|567039134|FG001|Phase II|Death|0|||
157078346|NCT00350727|567039135|FG002|Phase II|Death|2|||
157078347|NCT00350727|567039133|FG000|Phase II|Sponsor Terminated Study|0|||
157078348|NCT00350727|567039134|FG001|Phase II|Sponsor Terminated Study|0|||
157078349|NCT00350727|567039135|FG002|Phase II|Sponsor Terminated Study|1|||
157078350|NCT00350727|567039133|FG000|Phase II|Enrolled in Rollover Study|0|||
157078351|NCT00350727|567039134|FG001|Phase II|Enrolled in Rollover Study|0|||
157078352|NCT00350727|567039135|FG002|Phase II|Enrolled in Rollover Study|1|||
157078353|NCT03633799|567039143|FG000|Overall Study|Adverse Event|349|||
157078354|NCT03633799|567039143|FG000|Overall Study|Withdrawal by Subject|288|||
157078355|NCT03633799|567039143|FG000|Overall Study|Lost to Follow-up|97|||
157078356|NCT03633799|567039143|FG000|Overall Study|Physician Decision|9|||
157078357|NCT03633799|567039143|FG000|Overall Study|Protocol Violation|4|||
157078358|NCT03633799|567039143|FG000|Overall Study|Pregnancy|20|||
157078359|NCT03633799|567039143|FG000|Overall Study|other|39|||
157078360|NCT03633799|567039143|FG000|Overall Study|ongoing within third year of study|106|||
157078361|NCT03633799|567039143|FG000|Overall Study|unsuccessful study drug placement|19|||
157078362|NCT02477618|567039144|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
157078363|NCT02477618|567039145|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
157078364|NCT02477618|567039144|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
157078365|NCT02477618|567039145|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
157078366|NCT02477618|567039144|FG000|Overall Study|Adverse Event|1|||
157078367|NCT02477618|567039145|FG001|Overall Study|Adverse Event|1|||
157078368|NCT02477618|567039144|FG000|Overall Study|Transferred Away from Study Site|1|||
157078369|NCT02477618|567039145|FG001|Overall Study|Transferred Away from Study Site|0|||
157078370|NCT02477618|567039144|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
157078371|NCT02477618|567039145|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
157078372|NCT02446821|567039146|FG000|Overall Study|Adverse Event|28|||
157078373|NCT02446821|567039146|FG000|Overall Study|Withdrawal by Subject|6|||
157078374|NCT02446821|567039146|FG000|Overall Study|Lost to Follow-up|22|||
157078375|NCT02446821|567039146|FG000|Overall Study|other|9|||
157078376|NCT02446821|567039146|FG000|Overall Study|insertion failure|3|||
157078377|NCT03841526|567039148|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
157078378|NCT03841526|567039149|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
157078379|NCT03841526|567039150|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
157078380|NCT03841526|567039151|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
157078381|NCT03841526|567039152|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
157078382|NCT03841526|567039153|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
157078383|NCT03841526|567039148|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
157078384|NCT03841526|567039149|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
157078385|NCT03841526|567039150|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
157078386|NCT03841526|567039151|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
157078387|NCT03841526|567039152|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
157078388|NCT03841526|567039153|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
157078389|NCT03841526|567039148|FG000|Outpatient Phase Treatment|Physician Decision|0|||
157078390|NCT03841526|567039149|FG001|Outpatient Phase Treatment|Physician Decision|1|||
157078391|NCT03841526|567039150|FG002|Outpatient Phase Treatment|Physician Decision|0|||
157078392|NCT03841526|567039151|FG003|Outpatient Phase Treatment|Physician Decision|0|||
157078393|NCT03841526|567039152|FG004|Outpatient Phase Treatment|Physician Decision|0|||
157078394|NCT03841526|567039153|FG005|Outpatient Phase Treatment|Physician Decision|0|||
157078395|NCT03841526|567039148|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
157078396|NCT03841526|567039149|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
157078397|NCT03841526|567039150|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
157078398|NCT03841526|567039151|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
157078399|NCT03841526|567039152|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
157078400|NCT03841526|567039153|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
157078401|NCT03238963|567039155|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
157078402|NCT03238963|567039156|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
157078403|NCT03238963|567039155|FG000|Overall Study|Withdrawal by Subject|1|||
157078404|NCT03238963|567039156|FG001|Overall Study|Withdrawal by Subject|1|||
157078405|NCT03238963|567039155|FG000|Overall Study|Lost to Follow-up|1|||
157078406|NCT03238963|567039156|FG001|Overall Study|Lost to Follow-up|0|||
157078407|NCT03238963|567039155|FG000|Overall Study|Protocol Violation|1|||
157078408|NCT03238963|567039156|FG001|Overall Study|Protocol Violation|1|||
157078409|NCT03238963|567039155|FG000|Overall Study|Adverse Event|1|||
157078410|NCT03238963|567039156|FG001|Overall Study|Adverse Event|0|||
157078411|NCT07149155|567039160|FG000|Overall Study|Lost to Follow-up|10|||
157078412|NCT01123070|567041264|FG000|Part B Double Blind Period|Protocol Violation|0|||
157078413|NCT01123070|567041265|FG001|Part B Double Blind Period|Protocol Violation|0|||
157078414|NCT01123070|567041266|FG002|Part B Double Blind Period|Protocol Violation|0|||
157078415|NCT01123070|567041267|FG003|Part B Double Blind Period|Protocol Violation|1|||
157078416|NCT01123070|567041264|FG000|Part B Double Blind Period|Adverse Event|0|||
157078417|NCT01123070|567041265|FG001|Part B Double Blind Period|Adverse Event|0|||
157078418|NCT01123070|567041266|FG002|Part B Double Blind Period|Adverse Event|2|||
157078419|NCT01123070|567041267|FG003|Part B Double Blind Period|Adverse Event|0|||
157078420|NCT01123070|567041264|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
157078421|NCT01123070|567041265|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
157078422|NCT01123070|567041266|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
157078423|NCT01123070|567041267|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
157078424|NCT04942366|567041268|FG000|Overall Study|Withdrawal by Subject|5|||
157078425|NCT04942366|567041269|FG001|Overall Study|Withdrawal by Subject|5|||
157078426|NCT00747227|567041276|FG000|Overall Study|Death|3|||
157078427|NCT00747227|567041277|FG001|Overall Study|Death|1|||
157078428|NCT00747227|567041276|FG000|Overall Study|Withdrawal by Subject|1|||
157078429|NCT00747227|567041277|FG001|Overall Study|Withdrawal by Subject|0|||
157078430|NCT00747227|567041276|FG000|Overall Study|Lost to Follow-up|1|||
157078431|NCT00747227|567041277|FG001|Overall Study|Lost to Follow-up|2|||
157078432|NCT00747227|567041276|FG000|Overall Study|Illness|1|||
157078433|NCT00747227|567041277|FG001|Overall Study|Illness|1|||
157078434|NCT03284229|567041278|FG000|Overall Study|Lost to Follow-up|3|||
157078435|NCT04707664|567041279|FG000|Overall Study|Adverse Event|2|||
157078436|NCT04707664|567041280|FG001|Overall Study|Adverse Event|0|||
157078437|NCT04707664|567041279|FG000|Overall Study|Death|1|||
157078438|NCT04707664|567041280|FG001|Overall Study|Death|2|||
157078439|NCT04707664|567041279|FG000|Overall Study|Withdrawal by Subject|13|||
157078440|NCT04707664|567041280|FG001|Overall Study|Withdrawal by Subject|21|||
157078441|NCT04707664|567041279|FG000|Overall Study|Lost to Follow-up|11|||
157078442|NCT04707664|567041280|FG001|Overall Study|Lost to Follow-up|13|||
157078443|NCT04707664|567041279|FG000|Overall Study|Not treated|2|||
157078444|NCT04707664|567041280|FG001|Overall Study|Not treated|0|||
157078445|NCT01498887|567041289|FG000|Overall Study|Administrative problems|1|||
157078446|NCT01498887|567041290|FG001|Overall Study|Administrative problems|0|||
157078447|NCT01498887|567041289|FG000|Overall Study|Lost to Follow-up|1|||
157078448|NCT01498887|567041290|FG001|Overall Study|Lost to Follow-up|1|||
157078449|NCT01498887|567041289|FG000|Overall Study|Withdrawal by Subject|1|||
157078450|NCT01498887|567041290|FG001|Overall Study|Withdrawal by Subject|0|||
157078451|NCT01498887|567041289|FG000|Overall Study|Protocol Violation|1|||
157078452|NCT01498887|567041290|FG001|Overall Study|Protocol Violation|3|||
157078453|NCT01498887|567041289|FG000|Overall Study|Lack of Efficacy|5|||
157078454|NCT01498887|567041290|FG001|Overall Study|Lack of Efficacy|3|||
157078455|NCT01498887|567041289|FG000|Overall Study|Abnormal result from test procedure|1|||
157078456|NCT01498887|567041290|FG001|Overall Study|Abnormal result from test procedure|1|||
157078457|NCT01498887|567041289|FG000|Overall Study|Abnormal laboratory value|2|||
157078458|NCT01498887|567041290|FG001|Overall Study|Abnormal laboratory value|2|||
157078459|NCT01498887|567041289|FG000|Overall Study|Adverse Event|4|||
157078460|NCT01498887|567041290|FG001|Overall Study|Adverse Event|1|||
157078461|NCT04335591|567041291|FG000|Overall Study|Adverse Event|5|||
157078462|NCT04335591|567041292|FG001|Overall Study|Adverse Event|2|||
157078463|NCT04335591|567041293|FG002|Overall Study|Adverse Event|3|||
157078464|NCT04335591|567041294|FG003|Overall Study|Adverse Event|2|||
157078465|NCT04335591|567041291|FG000|Overall Study|Protocol Violation|1|||
157078466|NCT04335591|567041292|FG001|Overall Study|Protocol Violation|0|||
157078467|NCT04335591|567041293|FG002|Overall Study|Protocol Violation|0|||
157078468|NCT04335591|567041294|FG003|Overall Study|Protocol Violation|0|||
157078469|NCT04335591|567041291|FG000|Overall Study|Withdrawal by Subject|8|||
157078470|NCT04335591|567041292|FG001|Overall Study|Withdrawal by Subject|4|||
157078471|NCT04335591|567041293|FG002|Overall Study|Withdrawal by Subject|4|||
157078472|NCT04335591|567041294|FG003|Overall Study|Withdrawal by Subject|5|||
157078473|NCT04335591|567041291|FG000|Overall Study|Subject planning pregnancy|0|||
157078474|NCT04335591|567041292|FG001|Overall Study|Subject planning pregnancy|1|||
157078475|NCT04335591|567041293|FG002|Overall Study|Subject planning pregnancy|0|||
157078476|NCT04335591|567041294|FG003|Overall Study|Subject planning pregnancy|0|||
157078477|NCT04335591|567041291|FG000|Overall Study|Ukrainian Russian war conflict|4|||
157078478|NCT04335591|567041292|FG001|Overall Study|Ukrainian Russian war conflict|5|||
157078479|NCT04335591|567041293|FG002|Overall Study|Ukrainian Russian war conflict|2|||
157078480|NCT04335591|567041294|FG003|Overall Study|Ukrainian Russian war conflict|0|||
157078481|NCT02476175|567041296|FG000|Overall Study|Adverse Event|2|||
157078482|NCT04421950|567041299|FG000|Overall Study|Dropped or lost to follow up|4|||
157078483|NCT04421950|567041300|FG001|Overall Study|Dropped or lost to follow up|2|||
157078484|NCT04546425|567041303|FG000|Overall Study|Protocol Violation|1|||
157078485|NCT04546425|567041304|FG001|Overall Study|Protocol Violation|1|||
157078486|NCT04546425|567041305|FG002|Overall Study|Protocol Violation|0|||
157078487|NCT04546425|567041306|FG003|Overall Study|Protocol Violation|0|||
157078488|NCT04546425|567041303|FG000|Overall Study|Adverse Event|3|||
157078489|NCT04546425|567041304|FG001|Overall Study|Adverse Event|0|||
157078490|NCT04546425|567041305|FG002|Overall Study|Adverse Event|0|||
157078491|NCT04546425|567041306|FG003|Overall Study|Adverse Event|0|||
157078492|NCT04546425|567041303|FG000|Overall Study|Lost to Follow-up|5|||
157078493|NCT04546425|567041304|FG001|Overall Study|Lost to Follow-up|4|||
157078494|NCT04546425|567041305|FG002|Overall Study|Lost to Follow-up|0|||
157078495|NCT04546425|567041306|FG003|Overall Study|Lost to Follow-up|0|||
157078496|NCT04546425|567041303|FG000|Overall Study|No Longer met eligibility criteria|3|||
157078497|NCT04546425|567041304|FG001|Overall Study|No Longer met eligibility criteria|3|||
157078498|NCT04546425|567041305|FG002|Overall Study|No Longer met eligibility criteria|1|||
157078499|NCT04546425|567041306|FG003|Overall Study|No Longer met eligibility criteria|1|||
157078500|NCT04546425|567041303|FG000|Overall Study|Withdrawal by parent/guardian|6|||
157078501|NCT04546425|567041304|FG001|Overall Study|Withdrawal by parent/guardian|5|||
157078502|NCT04546425|567041305|FG002|Overall Study|Withdrawal by parent/guardian|1|||
157078503|NCT04546425|567041306|FG003|Overall Study|Withdrawal by parent/guardian|1|||
157078504|NCT03435692|567041309|FG000|Overall Study|Lack of Efficacy|2|||
157078505|NCT03435692|567041310|FG001|Overall Study|Lack of Efficacy|2|||
157078506|NCT03435692|567041311|FG002|Overall Study|Lack of Efficacy|0|||
157078507|NCT02964325|567041312|FG000|Overall Study|Lost to Follow-up|3|||
157078508|NCT02964325|567041313|FG001|Overall Study|Lost to Follow-up|3|||
157078509|NCT02964325|567041312|FG000|Overall Study|Physician Decision|5|||
157078510|NCT02964325|567041313|FG001|Overall Study|Physician Decision|4|||
157078511|NCT02964325|567041312|FG000|Overall Study|Death|1|||
157078512|NCT02964325|567041313|FG001|Overall Study|Death|3|||
157078513|NCT02964325|567041312|FG000|Overall Study|Withdrawal by Subject|2|||
157078514|NCT02964325|567041313|FG001|Overall Study|Withdrawal by Subject|1|||
157078515|NCT02964325|567041312|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
157078516|NCT02964325|567041313|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
157078517|NCT02510040|567041314|FG000|Overall Study|Deemed no longer eligible|18|||
157078518|NCT02510040|567041315|FG001|Overall Study|Deemed no longer eligible|3|||
157078519|NCT02510040|567041316|FG002|Overall Study|Deemed no longer eligible|1|||
157078520|NCT02195479|567041317|FG000|Overall Study|Lost to Follow-up|18|||
157078521|NCT02195479|567041318|FG001|Overall Study|Lost to Follow-up|15|||
157078522|NCT02195479|567041317|FG000|Overall Study|Death|217|||
157078523|NCT02195479|567041318|FG001|Overall Study|Death|171|||
157078524|NCT02195479|567041317|FG000|Overall Study|Physician Decision|1|||
157078525|NCT02195479|567041318|FG001|Overall Study|Physician Decision|0|||
157078526|NCT02195479|567041317|FG000|Overall Study|Withdrawal by Subject|30|||
157078527|NCT02195479|567041318|FG001|Overall Study|Withdrawal by Subject|30|||
157078528|NCT02195479|567041317|FG000|Overall Study|Other|3|||
157078529|NCT02195479|567041318|FG001|Overall Study|Other|4|||
157078530|NCT02195479|567041317|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
157078531|NCT02195479|567041318|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
157078532|NCT01263509|567041319|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
157078533|NCT01263509|567041320|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
157078534|NCT01263509|567041321|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
157078535|NCT01263509|567041322|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
157078536|NCT01263509|567041319|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
157078537|NCT01263509|567041320|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
157078538|NCT01263509|567041321|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
157078539|NCT01263509|567041322|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
157078540|NCT01263509|567041319|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
157078541|NCT01263509|567041320|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
157078542|NCT01263509|567041321|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
157078543|NCT01263509|567041322|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
157078544|NCT01263509|567041319|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
157078545|NCT01263509|567041320|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
157078546|NCT01263509|567041321|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157078547|NCT01263509|567041322|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
157078548|NCT01263509|567041319|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
157078549|NCT01263509|567041320|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
157078550|NCT01263509|567041321|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
157078551|NCT01263509|567041322|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
157078552|NCT00967005|567041323|FG000|Overall Study|Lost to Follow-up|7|||
157078553|NCT00967005|567041324|FG001|Overall Study|Lost to Follow-up|10|||
157078554|NCT05071053|567041325|FG000|Overall Study|Progressive disease|30|||
157078555|NCT05071053|567041325|FG000|Overall Study|Adverse Event|5|||
157078556|NCT02593123|567041326|FG000|Overall Study|Physician Decision|2|||
157078557|NCT02593123|567041327|FG001|Overall Study|Physician Decision|1|||
157078558|NCT02593123|567041326|FG000|Overall Study|Relapse|1|||
157078559|NCT02593123|567041327|FG001|Overall Study|Relapse|1|||
157078560|NCT04868539|567041338|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
157078561|NCT04868539|567041339|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
157078562|NCT01401153|567041340|FG000|First Test Day|Learning disabilities; illness|1|||
157078563|NCT01401153|567041341|FG001|First Test Day|Learning disabilities; illness|10|||
157078564|NCT01401153|567041340|FG000|Second Test Day|illness|0|||
157078565|NCT01401153|567041341|FG001|Second Test Day|illness|5|||
157078566|NCT01677767|567041344|FG000|Overall Study|Adverse Event|1|||
157078567|NCT01677767|567041344|FG000|Overall Study|Death|4|||
157078568|NCT01677767|567041344|FG000|Overall Study|Protocol Violation|4|||
157078569|NCT01677767|567041344|FG000|Overall Study|Withdrawal by Subject|10|||
157078570|NCT01677767|567041344|FG000|Overall Study|Non-compliance by the participants|3|||
157078571|NCT00842244|567041345|FG000|Overall Study|Death|3|||
157078572|NCT00842244|567041345|FG000|Overall Study|Withdrawal by Subject|1|||
157078573|NCT00842244|567041345|FG000|Overall Study|Other|17|||
157078574|NCT00588692|567041348|FG000|Overall Study|Withdrawal by Subject|4|||
157078575|NCT00588692|567041349|FG001|Overall Study|Withdrawal by Subject|2|||
157078576|NCT00588692|567041348|FG000|Overall Study|Hip Surgery|0|||
157078577|NCT00588692|567041349|FG001|Overall Study|Hip Surgery|1|||
157078578|NCT00588692|567041348|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
157078579|NCT00588692|567041349|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
157078580|NCT00588692|567041348|FG000|Overall Study|Cancer|1|||
157078581|NCT00588692|567041349|FG001|Overall Study|Cancer|0|||
157078582|NCT00588692|567041348|FG000|Overall Study|Death|1|||
157078583|NCT00588692|567041349|FG001|Overall Study|Death|0|||
157078584|NCT03538938|567041351|FG000|Overall Study|Death|0|||
157078585|NCT03538938|567041352|FG001|Overall Study|Death|0|||
157078586|NCT03538938|567041353|FG002|Overall Study|Death|2|||
157078587|NCT03538938|567041354|FG003|Overall Study|Death|0|||
157078588|NCT03538938|567041355|FG004|Overall Study|Death|0|||
157078589|NCT03538938|567041356|FG005|Overall Study|Death|1|||
157078590|NCT03538938|567041357|FG006|Overall Study|Death|0|||
157078591|NCT03538938|567041358|FG007|Overall Study|Death|1|||
157078592|NCT03538938|567041359|FG008|Overall Study|Death|1|||
157078593|NCT03538938|567041360|FG009|Overall Study|Death|1|||
157078594|NCT03538938|567041361|FG010|Overall Study|Death|0|||
157078595|NCT03538938|567041362|FG011|Overall Study|Death|0|||
157078596|NCT03538938|567041363|FG012|Overall Study|Death|1|||
157078597|NCT03538938|567041364|FG013|Overall Study|Death|1|||
157078598|NCT03538938|567041365|FG014|Overall Study|Death|0|||
157078599|NCT03538938|567041366|FG015|Overall Study|Death|1|||
157078600|NCT03538938|567041351|FG000|Overall Study|Withdrawal by Subject|4|||
157078601|NCT03538938|567041352|FG001|Overall Study|Withdrawal by Subject|6|||
157078602|NCT03538938|567041353|FG002|Overall Study|Withdrawal by Subject|5|||
157078603|NCT03538938|567041354|FG003|Overall Study|Withdrawal by Subject|3|||
157078604|NCT03538938|567041355|FG004|Overall Study|Withdrawal by Subject|0|||
157078605|NCT03538938|567041356|FG005|Overall Study|Withdrawal by Subject|0|||
157078606|NCT03538938|567041357|FG006|Overall Study|Withdrawal by Subject|3|||
157078607|NCT03538938|567041358|FG007|Overall Study|Withdrawal by Subject|1|||
157078608|NCT03538938|567041359|FG008|Overall Study|Withdrawal by Subject|5|||
157078609|NCT03538938|567041360|FG009|Overall Study|Withdrawal by Subject|1|||
157078610|NCT03538938|567041361|FG010|Overall Study|Withdrawal by Subject|2|||
157078611|NCT03538938|567041362|FG011|Overall Study|Withdrawal by Subject|1|||
157078612|NCT03538938|567041363|FG012|Overall Study|Withdrawal by Subject|3|||
157078613|NCT03538938|567041364|FG013|Overall Study|Withdrawal by Subject|0|||
157078614|NCT03538938|567041365|FG014|Overall Study|Withdrawal by Subject|2|||
157078615|NCT03538938|567041366|FG015|Overall Study|Withdrawal by Subject|4|||
157078616|NCT03538938|567041351|FG000|Overall Study|Incarcerated|0|||
157078617|NCT03538938|567041352|FG001|Overall Study|Incarcerated|0|||
157078618|NCT03538938|567041353|FG002|Overall Study|Incarcerated|0|||
157078619|NCT03538938|567041354|FG003|Overall Study|Incarcerated|0|||
157078620|NCT03538938|567041355|FG004|Overall Study|Incarcerated|0|||
157192796|NCT03481634|567447197|FG001|Overall Study|Protocol Violation|0|||
157192797|NCT03481634|567447198|FG002|Overall Study|Protocol Violation|1|||
157192798|NCT03481634|567447196|FG000|Overall Study|Progressive disease|0|||
157192799|NCT03481634|567447197|FG001|Overall Study|Progressive disease|1|||
157192800|NCT03481634|567447198|FG002|Overall Study|Progressive disease|0|||
157192801|NCT03481634|567447196|FG000|Overall Study|Physician Decision|3|||
157192802|NCT03481634|567447197|FG001|Overall Study|Physician Decision|0|||
157192803|NCT03481634|567447198|FG002|Overall Study|Physician Decision|1|||
157078621|NCT03538938|567041356|FG005|Overall Study|Incarcerated|0|||
157078622|NCT03538938|567041357|FG006|Overall Study|Incarcerated|0|||
157078623|NCT03538938|567041358|FG007|Overall Study|Incarcerated|0|||
157078624|NCT03538938|567041359|FG008|Overall Study|Incarcerated|0|||
157078625|NCT03538938|567041360|FG009|Overall Study|Incarcerated|0|||
157192804|NCT03481634|567447196|FG000|Overall Study|Lost to Follow-up|3|||
157078626|NCT03538938|567041361|FG010|Overall Study|Incarcerated|0|||
157078627|NCT03538938|567041362|FG011|Overall Study|Incarcerated|1|||
157078628|NCT03538938|567041363|FG012|Overall Study|Incarcerated|0|||
157078629|NCT03538938|567041364|FG013|Overall Study|Incarcerated|0|||
157078630|NCT03538938|567041365|FG014|Overall Study|Incarcerated|0|||
157078631|NCT03538938|567041366|FG015|Overall Study|Incarcerated|0|||
157078632|NCT00755105|567041367|FG000|Overall Study|Withdrawal by Subject|9|||
157078633|NCT00755105|567041368|FG001|Overall Study|Withdrawal by Subject|11|||
157078634|NCT00755105|567041369|FG002|Overall Study|Withdrawal by Subject|4|||
157078635|NCT03995316|567041370|FG000|Overall Study|Lost to Follow-up|10|||
157078636|NCT03995316|567041371|FG001|Overall Study|Lost to Follow-up|3|||
157232118|NCT02106156|567596789|FG000|Overall Study|Concomitant Disease|74|||
157232119|NCT02106156|567596790|FG001|Overall Study|Concomitant Disease|2|||
157232120|NCT02106156|567596791|FG002|Overall Study|Concomitant Disease|0|||
157232121|NCT02106156|567596789|FG000|Overall Study|Lack of Compliance|211|||
157232122|NCT02106156|567596790|FG001|Overall Study|Lack of Compliance|7|||
157232123|NCT02106156|567596791|FG002|Overall Study|Lack of Compliance|0|||
157232124|NCT02106156|567596789|FG000|Overall Study|Patients Request|307|||
157232125|NCT02106156|567596790|FG001|Overall Study|Patients Request|9|||
157232126|NCT02106156|567596791|FG002|Overall Study|Patients Request|0|||
157232127|NCT02106156|567596789|FG000|Overall Study|Lost to Follow-up|451|||
157232128|NCT02106156|567596790|FG001|Overall Study|Lost to Follow-up|8|||
157232129|NCT02106156|567596791|FG002|Overall Study|Lost to Follow-up|0|||
157232130|NCT02106156|567596789|FG000|Overall Study|Unplanned Event|82|||
157232131|NCT02106156|567596790|FG001|Overall Study|Unplanned Event|2|||
157232132|NCT02106156|567596791|FG002|Overall Study|Unplanned Event|0|||
157232133|NCT02106156|567596789|FG000|Overall Study|Change of Laboratory Parameter|10|||
157232134|NCT02106156|567596790|FG001|Overall Study|Change of Laboratory Parameter|0|||
157232135|NCT02106156|567596791|FG002|Overall Study|Change of Laboratory Parameter|0|||
157232136|NCT02106156|567596789|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
157232137|NCT02106156|567596790|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
157232138|NCT02106156|567596791|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
157232139|NCT02106156|567596789|FG000|Overall Study|Relocation/Change of Physician|40|||
157232140|NCT02106156|567596790|FG001|Overall Study|Relocation/Change of Physician|1|||
157078637|NCT02202785|567041372|FG000|Overall Study|Study Terminated by Sponsor|1|||
157078638|NCT02202785|567041373|FG001|Overall Study|Study Terminated by Sponsor|6|||
157078639|NCT02202785|567041374|FG002|Overall Study|Study Terminated by Sponsor|4|||
157078640|NCT02202785|567041372|FG000|Overall Study|Withdrawal by Subject|0|||
157078641|NCT02202785|567041373|FG001|Overall Study|Withdrawal by Subject|1|||
157078642|NCT02202785|567041374|FG002|Overall Study|Withdrawal by Subject|0|||
157078643|NCT02202785|567041372|FG000|Overall Study|Lost to Follow-up|0|||
157078644|NCT02202785|567041373|FG001|Overall Study|Lost to Follow-up|1|||
157078645|NCT02202785|567041374|FG002|Overall Study|Lost to Follow-up|0|||
157078646|NCT02202785|567041372|FG000|Overall Study|Reason not Specified|10|||
157078647|NCT02202785|567041373|FG001|Overall Study|Reason not Specified|7|||
157078648|NCT02202785|567041374|FG002|Overall Study|Reason not Specified|13|||
157078649|NCT02180243|567041375|FG000|Overall Study|Withdrawal by Subject|12|||
157232141|NCT02106156|567596791|FG002|Overall Study|Relocation/Change of Physician|0|||
157232142|NCT01136382|567596797|FG000|Overall Study|Other|8|||
157232143|NCT01136382|567596798|FG001|Overall Study|Other|3|||
157232144|NCT01136382|567596797|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
157232145|NCT01136382|567596798|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
157232146|NCT01136382|567596797|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
157232147|NCT01136382|567596798|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
157232148|NCT01136382|567596797|FG000|Overall Study|Withdrawal by Subject|4|||
157232149|NCT01136382|567596798|FG001|Overall Study|Withdrawal by Subject|1|||
157232150|NCT01725529|567596808|FG000|Overall Study|Adverse Event|1|||
157078650|NCT02180243|567041376|FG001|Overall Study|Withdrawal by Subject|12|||
157078651|NCT02180243|567041375|FG000|Overall Study|Lost to Follow-up|12|||
157078652|NCT02180243|567041376|FG001|Overall Study|Lost to Follow-up|2|||
157078653|NCT01137578|567041377|FG000|Overall Study|Participant requested to Discontinue|3|||
157078654|NCT01137578|567041378|FG001|Overall Study|Participant requested to Discontinue|0|||
157078655|NCT01137578|567041379|FG002|Overall Study|Participant requested to Discontinue|0|||
157078656|NCT01137578|567041377|FG000|Overall Study|Withdrawal by Subject|1|||
157078657|NCT01137578|567041378|FG001|Overall Study|Withdrawal by Subject|0|||
157078658|NCT01137578|567041379|FG002|Overall Study|Withdrawal by Subject|0|||
157078659|NCT01137578|567041377|FG000|Overall Study|Other|12|||
157078660|NCT01137578|567041378|FG001|Overall Study|Other|2|||
157078661|NCT01137578|567041379|FG002|Overall Study|Other|6|||
157078662|NCT01461005|567041380|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
157078663|NCT00600613|567041381|FG000|Overall Study|Protocol Deviation|1|||
157078664|NCT04954326|567041382|FG000|Overall Study|Protocol Violation|0|||
157078665|NCT04954326|567041383|FG001|Overall Study|Protocol Violation|1|||
157078666|NCT04954326|567041382|FG000|Overall Study|Death|0|||
157078667|NCT04954326|567041383|FG001|Overall Study|Death|2|||
157078668|NCT04954326|567041382|FG000|Overall Study|Physician Decision|0|||
157078669|NCT04954326|567041383|FG001|Overall Study|Physician Decision|1|||
157078670|NCT01495598|567041384|FG000|Overall Study|Death during follow up period|2|||
157078671|NCT01495598|567041384|FG000|Overall Study|Death on study|1|||
157078672|NCT01495598|567041384|FG000|Overall Study|Lost to Follow-up|3|||
157232151|NCT01725529|567596809|FG001|Overall Study|Adverse Event|0|||
157232152|NCT01725529|567596810|FG002|Overall Study|Adverse Event|0|||
157232153|NCT01725529|567596808|FG000|Overall Study|Lost to Follow-up|2|||
157232154|NCT01725529|567596809|FG001|Overall Study|Lost to Follow-up|1|||
157232155|NCT01725529|567596810|FG002|Overall Study|Lost to Follow-up|1|||
157232156|NCT01725529|567596808|FG000|Overall Study|Protocol Violation|0|||
157078673|NCT01495598|567041384|FG000|Overall Study|Physician Decision|8|||
157078674|NCT03635099|567041385|FG000|Period 1|Adverse Event|1|||
157078675|NCT03635099|567041386|FG001|Period 1|Adverse Event|0|||
157078676|NCT03635099|567041387|FG002|Period 1|Adverse Event|0|||
157078677|NCT03635099|567041388|FG003|Period 1|Adverse Event|1|||
157078678|NCT03635099|567041389|FG004|Period 1|Adverse Event|0|||
157078679|NCT03635099|567041390|FG005|Period 1|Adverse Event|0|||
157078680|NCT03635099|567041391|FG006|Period 1|Adverse Event|0|||
157078681|NCT03635099|567041392|FG007|Period 1|Adverse Event|0|||
157078682|NCT03635099|567041385|FG000|Period 1|Protocol Violation|0|||
157078683|NCT03635099|567041386|FG001|Period 1|Protocol Violation|0|||
157078684|NCT03635099|567041387|FG002|Period 1|Protocol Violation|1|||
157078685|NCT03635099|567041388|FG003|Period 1|Protocol Violation|0|||
157078686|NCT03635099|567041389|FG004|Period 1|Protocol Violation|0|||
157078687|NCT03635099|567041390|FG005|Period 1|Protocol Violation|0|||
157078688|NCT03635099|567041391|FG006|Period 1|Protocol Violation|0|||
157078689|NCT03635099|567041392|FG007|Period 1|Protocol Violation|0|||
157078690|NCT03635099|567041385|FG000|Period 1|Lost to Follow-up|0|||
157078691|NCT03635099|567041386|FG001|Period 1|Lost to Follow-up|0|||
157078692|NCT03635099|567041387|FG002|Period 1|Lost to Follow-up|1|||
157078693|NCT03635099|567041388|FG003|Period 1|Lost to Follow-up|2|||
157078694|NCT03635099|567041389|FG004|Period 1|Lost to Follow-up|1|||
157078695|NCT03635099|567041390|FG005|Period 1|Lost to Follow-up|0|||
157078696|NCT03635099|567041391|FG006|Period 1|Lost to Follow-up|1|||
157078697|NCT03635099|567041392|FG007|Period 1|Lost to Follow-up|2|||
157078698|NCT03635099|567041385|FG000|Period 1|Withdrawal by Subject|3|||
157078699|NCT03635099|567041386|FG001|Period 1|Withdrawal by Subject|3|||
157078700|NCT03635099|567041387|FG002|Period 1|Withdrawal by Subject|5|||
157078701|NCT03635099|567041388|FG003|Period 1|Withdrawal by Subject|2|||
157078702|NCT03635099|567041389|FG004|Period 1|Withdrawal by Subject|2|||
157078703|NCT03635099|567041390|FG005|Period 1|Withdrawal by Subject|0|||
157078704|NCT03635099|567041391|FG006|Period 1|Withdrawal by Subject|3|||
157078705|NCT03635099|567041392|FG007|Period 1|Withdrawal by Subject|0|||
157078706|NCT03635099|567041385|FG000|Period 1|History of suicidal ideation|0|||
157078707|NCT03635099|567041386|FG001|Period 1|History of suicidal ideation|0|||
157078708|NCT03635099|567041387|FG002|Period 1|History of suicidal ideation|1|||
157078709|NCT03635099|567041388|FG003|Period 1|History of suicidal ideation|0|||
157078710|NCT03635099|567041389|FG004|Period 1|History of suicidal ideation|0|||
157078711|NCT03635099|567041390|FG005|Period 1|History of suicidal ideation|0|||
157078712|NCT03635099|567041391|FG006|Period 1|History of suicidal ideation|0|||
157078713|NCT03635099|567041392|FG007|Period 1|History of suicidal ideation|0|||
157078714|NCT03635099|567041385|FG000|Period 1|pursue other treatment options|0|||
157078715|NCT03635099|567041386|FG001|Period 1|pursue other treatment options|0|||
157078716|NCT03635099|567041387|FG002|Period 1|pursue other treatment options|0|||
157078717|NCT03635099|567041388|FG003|Period 1|pursue other treatment options|0|||
157078718|NCT03635099|567041389|FG004|Period 1|pursue other treatment options|0|||
157078719|NCT03635099|567041390|FG005|Period 1|pursue other treatment options|1|||
157078720|NCT03635099|567041391|FG006|Period 1|pursue other treatment options|0|||
157078721|NCT03635099|567041392|FG007|Period 1|pursue other treatment options|0|||
157078722|NCT03635099|567041385|FG000|Not Eligible for Period 2|Pregnancy|0|||
157078723|NCT03635099|567041386|FG001|Not Eligible for Period 2|Pregnancy|0|||
157078724|NCT03635099|567041387|FG002|Not Eligible for Period 2|Pregnancy|0|||
157078725|NCT03635099|567041388|FG003|Not Eligible for Period 2|Pregnancy|1|||
157078726|NCT03635099|567041389|FG004|Not Eligible for Period 2|Pregnancy|0|||
157078727|NCT03635099|567041390|FG005|Not Eligible for Period 2|Pregnancy|0|||
157078728|NCT03635099|567041391|FG006|Not Eligible for Period 2|Pregnancy|0|||
157078729|NCT03635099|567041392|FG007|Not Eligible for Period 2|Pregnancy|0|||
157078730|NCT03635099|567041385|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
157078731|NCT03635099|567041386|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078732|NCT03635099|567041387|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078733|NCT03635099|567041388|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078734|NCT03635099|567041389|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078735|NCT03635099|567041390|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078736|NCT03635099|567041391|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078737|NCT03635099|567041392|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
157078738|NCT03635099|567041385|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
157078739|NCT03635099|567041386|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
157192805|NCT03481634|567447197|FG001|Overall Study|Lost to Follow-up|4|||
157192806|NCT03481634|567447198|FG002|Overall Study|Lost to Follow-up|4|||
157078740|NCT03635099|567041387|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
157078741|NCT03635099|567041388|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
157192807|NCT03481634|567447196|FG000|Overall Study|Death|4|||
157078742|NCT03635099|567041389|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
157078743|NCT03635099|567041390|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
157078744|NCT03635099|567041391|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
157192808|NCT03481634|567447197|FG001|Overall Study|Death|8|||
157078745|NCT03635099|567041392|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
157078746|NCT03635099|567041385|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
157078747|NCT03635099|567041386|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
157078748|NCT03635099|567041387|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
157078749|NCT03635099|567041388|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
157078750|NCT03635099|567041389|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
157078751|NCT03635099|567041390|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
157078752|NCT03635099|567041391|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
157078753|NCT03635099|567041392|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
157078754|NCT03635099|567041385|FG000|Period 2|Adverse Event|0|||
157078755|NCT03635099|567041386|FG001|Period 2|Adverse Event|0|||
157078756|NCT03635099|567041387|FG002|Period 2|Adverse Event|1|||
157078757|NCT03635099|567041388|FG003|Period 2|Adverse Event|0|||
157078758|NCT03635099|567041389|FG004|Period 2|Adverse Event|1|||
157078759|NCT03635099|567041390|FG005|Period 2|Adverse Event|0|||
157078760|NCT03635099|567041391|FG006|Period 2|Adverse Event|0|||
157078761|NCT03635099|567041392|FG007|Period 2|Adverse Event|0|||
157078762|NCT03635099|567041385|FG000|Period 2|Lost to Follow-up|0|||
157078763|NCT03635099|567041386|FG001|Period 2|Lost to Follow-up|0|||
157078764|NCT03635099|567041387|FG002|Period 2|Lost to Follow-up|1|||
157078765|NCT03635099|567041388|FG003|Period 2|Lost to Follow-up|0|||
157078766|NCT03635099|567041389|FG004|Period 2|Lost to Follow-up|4|||
157078767|NCT03635099|567041390|FG005|Period 2|Lost to Follow-up|0|||
157078768|NCT03635099|567041391|FG006|Period 2|Lost to Follow-up|0|||
157078769|NCT03635099|567041392|FG007|Period 2|Lost to Follow-up|0|||
157078770|NCT03635099|567041385|FG000|Period 2|Withdrawal by Subject|0|||
157078771|NCT03635099|567041386|FG001|Period 2|Withdrawal by Subject|0|||
157078772|NCT03635099|567041387|FG002|Period 2|Withdrawal by Subject|7|||
157078773|NCT03635099|567041388|FG003|Period 2|Withdrawal by Subject|4|||
157078774|NCT03635099|567041389|FG004|Period 2|Withdrawal by Subject|7|||
157078775|NCT03635099|567041390|FG005|Period 2|Withdrawal by Subject|0|||
157078776|NCT03635099|567041391|FG006|Period 2|Withdrawal by Subject|0|||
157078777|NCT03635099|567041392|FG007|Period 2|Withdrawal by Subject|0|||
157078778|NCT01289210|567041393|FG000|Overall Study|Adverse Event|1|||
157078779|NCT06285240|567041394|FG000|Overall Study|Withdrawal by Subject|2|||
157078780|NCT06285240|567041395|FG001|Overall Study|Withdrawal by Subject|0|||
157078781|NCT06285240|567041396|FG002|Overall Study|Withdrawal by Subject|0|||
157078782|NCT06285240|567041397|FG003|Overall Study|Withdrawal by Subject|0|||
157078783|NCT06285240|567041394|FG000|Overall Study|Serious Adverse Event|0|||
157078784|NCT06285240|567041395|FG001|Overall Study|Serious Adverse Event|0|||
157078785|NCT06285240|567041396|FG002|Overall Study|Serious Adverse Event|1|||
157078786|NCT06285240|567041397|FG003|Overall Study|Serious Adverse Event|0|||
157078787|NCT05140915|567041400|FG000|Overall Study|Lost to Follow-up|2|||
157078788|NCT05140915|567041401|FG001|Overall Study|Lost to Follow-up|1|||
157078789|NCT04520659|567041402|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
157078790|NCT04520659|567041403|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
157078791|NCT04520659|567041404|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
157078792|NCT04520659|567041405|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
157078793|NCT04485611|567041410|FG000|Prehabilitation|Physician Decision|1|||
157078794|NCT04879849|567041411|FG000|Overall Study|Lost to Follow-up|0|||
157078795|NCT04879849|567041412|FG001|Overall Study|Lost to Follow-up|0|||
157078796|NCT04879849|567041413|FG002|Overall Study|Lost to Follow-up|0|||
157078797|NCT04879849|567041414|FG003|Overall Study|Lost to Follow-up|1|||
157078798|NCT04879849|567041415|FG004|Overall Study|Lost to Follow-up|0|||
157078799|NCT04879849|567041416|FG005|Overall Study|Lost to Follow-up|0|||
157078800|NCT04879849|567041417|FG006|Overall Study|Lost to Follow-up|0|||
157078801|NCT04879849|567041418|FG007|Overall Study|Lost to Follow-up|0|||
157078802|NCT04879849|567041411|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
157078803|NCT04879849|567041412|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
157078804|NCT04879849|567041413|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
157078805|NCT04879849|567041414|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
157078806|NCT04879849|567041415|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
157078807|NCT04879849|567041416|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
157078808|NCT04879849|567041417|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
157078809|NCT04879849|567041418|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
157078810|NCT04879849|567041411|FG000|Overall Study|Withdrawal by Subject|0|||
157078811|NCT04879849|567041412|FG001|Overall Study|Withdrawal by Subject|0|||
157078812|NCT04879849|567041413|FG002|Overall Study|Withdrawal by Subject|0|||
157192809|NCT03481634|567447198|FG002|Overall Study|Death|7|||
157192810|NCT03481634|567447196|FG000|Overall Study|Adverse Event|6|||
157078813|NCT04879849|567041414|FG003|Overall Study|Withdrawal by Subject|0|||
157078814|NCT04879849|567041415|FG004|Overall Study|Withdrawal by Subject|2|||
157078815|NCT04879849|567041416|FG005|Overall Study|Withdrawal by Subject|0|||
157078816|NCT04879849|567041417|FG006|Overall Study|Withdrawal by Subject|1|||
157078817|NCT04879849|567041418|FG007|Overall Study|Withdrawal by Subject|0|||
157078818|NCT04879849|567041411|FG000|Overall Study|Progressive Disease|0|||
157078819|NCT04879849|567041412|FG001|Overall Study|Progressive Disease|0|||
157078820|NCT04879849|567041413|FG002|Overall Study|Progressive Disease|1|||
157078821|NCT04879849|567041414|FG003|Overall Study|Progressive Disease|0|||
157078822|NCT04879849|567041415|FG004|Overall Study|Progressive Disease|0|||
157078823|NCT04879849|567041416|FG005|Overall Study|Progressive Disease|0|||
157078824|NCT04879849|567041417|FG006|Overall Study|Progressive Disease|0|||
157078825|NCT04879849|567041418|FG007|Overall Study|Progressive Disease|0|||
157078826|NCT04879849|567041411|FG000|Overall Study|Death|0|||
157078827|NCT04879849|567041412|FG001|Overall Study|Death|0|||
157078828|NCT04879849|567041413|FG002|Overall Study|Death|1|||
157078829|NCT04879849|567041414|FG003|Overall Study|Death|1|||
157078830|NCT04879849|567041415|FG004|Overall Study|Death|1|||
157078831|NCT04879849|567041416|FG005|Overall Study|Death|2|||
157078832|NCT04879849|567041417|FG006|Overall Study|Death|1|||
157078833|NCT04879849|567041418|FG007|Overall Study|Death|2|||
157078834|NCT04879849|567041411|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
157078835|NCT04879849|567041412|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
157078836|NCT04879849|567041413|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
157078837|NCT04879849|567041414|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
157078838|NCT04879849|567041415|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
157078839|NCT04879849|567041416|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
157078840|NCT04879849|567041417|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
157078841|NCT04879849|567041418|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
157078842|NCT04879849|567041411|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078843|NCT04879849|567041412|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078844|NCT04879849|567041413|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078845|NCT04879849|567041414|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078846|NCT04879849|567041415|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078847|NCT04879849|567041416|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078848|NCT04879849|567041417|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
157078849|NCT04879849|567041418|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
157078850|NCT04879849|567041411|FG000|Overall Study|Reason Not Specified|1|||
157078851|NCT04879849|567041412|FG001|Overall Study|Reason Not Specified|0|||
157078852|NCT04879849|567041413|FG002|Overall Study|Reason Not Specified|0|||
157078853|NCT04879849|567041414|FG003|Overall Study|Reason Not Specified|0|||
157078854|NCT04879849|567041415|FG004|Overall Study|Reason Not Specified|0|||
157078855|NCT04879849|567041416|FG005|Overall Study|Reason Not Specified|0|||
157078856|NCT04879849|567041417|FG006|Overall Study|Reason Not Specified|0|||
157078857|NCT04879849|567041418|FG007|Overall Study|Reason Not Specified|0|||
157078858|NCT03361865|567041419|FG000|Overall Study|Death|17|||
157078859|NCT03361865|567041420|FG001|Overall Study|Death|18|||
157078860|NCT03361865|567041419|FG000|Overall Study|Physician Decision|1|||
157078861|NCT03361865|567041420|FG001|Overall Study|Physician Decision|9|||
157078862|NCT03361865|567041419|FG000|Overall Study|Withdrawal by Subject|1|||
157078863|NCT03361865|567041420|FG001|Overall Study|Withdrawal by Subject|0|||
157078864|NCT02819024|567041422|FG000|Overall Study|Withdrawal by Subject|1|||
157078865|NCT05217641|567041427|FG000|Overall Study|Lost to Follow-up|1|||
157078866|NCT05217641|567041428|FG001|Overall Study|Lost to Follow-up|1|||
157078867|NCT05217641|567041429|FG002|Overall Study|Lost to Follow-up|0|||
157078868|NCT05217641|567041430|FG003|Overall Study|Lost to Follow-up|1|||
157078869|NCT05217641|567041431|FG004|Overall Study|Lost to Follow-up|1|||
157078870|NCT05217641|567041432|FG005|Overall Study|Lost to Follow-up|0|||
157078871|NCT05217641|567041427|FG000|Overall Study|Withdrawal by Subject|0|||
157078872|NCT05217641|567041428|FG001|Overall Study|Withdrawal by Subject|0|||
157078873|NCT05217641|567041429|FG002|Overall Study|Withdrawal by Subject|0|||
157078874|NCT05217641|567041430|FG003|Overall Study|Withdrawal by Subject|3|||
157078875|NCT05217641|567041431|FG004|Overall Study|Withdrawal by Subject|1|||
157078876|NCT05217641|567041432|FG005|Overall Study|Withdrawal by Subject|0|||
157078877|NCT05217641|567041427|FG000|Overall Study|Other: participant did not specify reason|0|||
157078878|NCT05217641|567041428|FG001|Overall Study|Other: participant did not specify reason|0|||
157078879|NCT05217641|567041429|FG002|Overall Study|Other: participant did not specify reason|0|||
157078880|NCT05217641|567041430|FG003|Overall Study|Other: participant did not specify reason|0|||
157078881|NCT05217641|567041431|FG004|Overall Study|Other: participant did not specify reason|1|||
157078882|NCT05217641|567041432|FG005|Overall Study|Other: participant did not specify reason|0|||
157078883|NCT05217641|567041427|FG000|Overall Study|Extended Follow up|1|||
157078884|NCT05217641|567041428|FG001|Overall Study|Extended Follow up|1|||
157078885|NCT05217641|567041429|FG002|Overall Study|Extended Follow up|0|||
157078886|NCT05217641|567041430|FG003|Overall Study|Extended Follow up|0|||
157078887|NCT05217641|567041431|FG004|Overall Study|Extended Follow up|1|||
157078888|NCT05217641|567041432|FG005|Overall Study|Extended Follow up|0|||
157078889|NCT05292586|567041433|FG000|Overall Study|Withdrawal by Subject|3|||
157078890|NCT05292586|567041434|FG001|Overall Study|Withdrawal by Subject|10|||
157078891|NCT05292586|567041433|FG000|Overall Study|Randomization error|3|||
157078892|NCT05292586|567041434|FG001|Overall Study|Randomization error|7|||
157078893|NCT05292586|567041433|FG000|Overall Study|Adverse Event|3|||
157078894|NCT05292586|567041434|FG001|Overall Study|Adverse Event|0|||
157078895|NCT05292586|567041433|FG000|Overall Study|Lost to Follow-up|0|||
157078896|NCT05292586|567041434|FG001|Overall Study|Lost to Follow-up|1|||
157078897|NCT05292586|567041433|FG000|Overall Study|Patient refused treatment|1|||
157078898|NCT05292586|567041434|FG001|Overall Study|Patient refused treatment|0|||
157078899|NCT05292586|567041433|FG000|Overall Study|Patient could not travel to the study site|1|||
157078900|NCT05292586|567041434|FG001|Overall Study|Patient could not travel to the study site|0|||
157078901|NCT05292586|567041433|FG000|Overall Study|Technical issues with the masterscope|0|||
157078902|NCT05292586|567041434|FG001|Overall Study|Technical issues with the masterscope|3|||
157078903|NCT05292586|567041433|FG000|Overall Study|Patient moved to a different state|0|||
157078904|NCT05292586|567041434|FG001|Overall Study|Patient moved to a different state|1|||
157078905|NCT03551691|567041450|FG000|Overall Study|Withdrawal by Subject|3|||
157078906|NCT03551691|567041451|FG001|Overall Study|Withdrawal by Subject|3|||
157078907|NCT02367040|567041452|FG000|Overall Study|Lost to Follow-up|1|||
157078908|NCT02367040|567041453|FG001|Overall Study|Lost to Follow-up|1|||
157078909|NCT02367040|567041452|FG000|Overall Study|Lack of Efficacy|1|||
157078910|NCT02367040|567041453|FG001|Overall Study|Lack of Efficacy|0|||
157078911|NCT02367040|567041452|FG000|Overall Study|Additional primary malignancy|1|||
157078912|NCT02367040|567041453|FG001|Overall Study|Additional primary malignancy|1|||
157078913|NCT02367040|567041452|FG000|Overall Study|AE not associated with clinical disease progression|117|||
157078914|NCT02367040|567041453|FG001|Overall Study|AE not associated with clinical disease progression|12|||
157078915|NCT02367040|567041452|FG000|Overall Study|AE associated with clinical disease progression|1|||
157078916|NCT02367040|567041453|FG001|Overall Study|AE associated with clinical disease progression|4|||
157078917|NCT02367040|567041452|FG000|Overall Study|Physician Decision|2|||
157078918|NCT02367040|567041453|FG001|Overall Study|Physician Decision|8|||
157078919|NCT02367040|567041452|FG000|Overall Study|Non-compliance to study drug|1|||
157078920|NCT02367040|567041453|FG001|Overall Study|Non-compliance to study drug|0|||
157078921|NCT02367040|567041452|FG000|Overall Study|Failure to meet continuation criteria|1|||
157078922|NCT02367040|567041453|FG001|Overall Study|Failure to meet continuation criteria|0|||
157078923|NCT02367040|567041452|FG000|Overall Study|Switching to other therapy|2|||
157078924|NCT02367040|567041453|FG001|Overall Study|Switching to other therapy|0|||
157078925|NCT02367040|567041452|FG000|Overall Study|Withdrawal by Subject|51|||
157078926|NCT02367040|567041453|FG001|Overall Study|Withdrawal by Subject|16|||
157078927|NCT02367040|567041452|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
157078928|NCT02367040|567041453|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157078929|NCT02367040|567041452|FG000|Overall Study|Patient decision|40|||
157078930|NCT02367040|567041453|FG001|Overall Study|Patient decision|14|||
157078931|NCT02367040|567041452|FG000|Overall Study|Required procedure failed|1|||
157078932|NCT02367040|567041453|FG001|Overall Study|Required procedure failed|0|||
157078933|NCT02367040|567041452|FG000|Overall Study|Randomized by mistake with study treatment|1|||
157078934|NCT02367040|567041453|FG001|Overall Study|Randomized by mistake with study treatment|0|||
157078935|NCT02367040|567041452|FG000|Overall Study|Protocol Violation|1|||
157078936|NCT02367040|567041453|FG001|Overall Study|Protocol Violation|0|||
157078937|NCT02367040|567041452|FG000|Overall Study|Progressive disease - radiological progression|54|||
157078938|NCT02367040|567041453|FG001|Overall Study|Progressive disease - radiological progression|80|||
157078939|NCT02367040|567041452|FG000|Overall Study|Progressive disease - clinical progression|6|||
157078940|NCT02367040|567041453|FG001|Overall Study|Progressive disease - clinical progression|6|||
157078941|NCT02367040|567041452|FG000|Overall Study|Drug not administered|3|||
157078942|NCT02367040|567041453|FG001|Overall Study|Drug not administered|2|||
157078943|NCT02367040|567041452|FG000|Overall Study|Progressive disease|0|||
157078944|NCT02367040|567041453|FG001|Overall Study|Progressive disease|1|||
157078945|NCT02367040|567041452|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
157078946|NCT02367040|567041453|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
157078947|NCT02367040|567041452|FG000|Overall Study|Death|2|||
157078948|NCT02367040|567041453|FG001|Overall Study|Death|0|||
157078949|NCT02367040|567041452|FG000|Overall Study|Study terminated by sponsor|19|||
157078950|NCT02367040|567041453|FG001|Overall Study|Study terminated by sponsor|2|||
157078951|NCT03007420|567041454|FG000|Overall Study|Withdrawal by Subject|0|||
157078952|NCT03007420|567041455|FG001|Overall Study|Withdrawal by Subject|2|||
157078953|NCT03007420|567041454|FG000|Overall Study|Physician Decision|0|||
157192811|NCT03481634|567447197|FG001|Overall Study|Adverse Event|3|||
157192812|NCT03481634|567447198|FG002|Overall Study|Adverse Event|7|||
157192813|NCT01849289|567447202|FG000|Overall Study|Adverse Event|3|||
157078954|NCT03007420|567041455|FG001|Overall Study|Physician Decision|1|||
157078955|NCT02284009|567041458|FG000|Overall Study|Adverse Event|3|||
157192814|NCT01849289|567447203|FG001|Overall Study|Adverse Event|3|||
157192815|NCT01849289|567447202|FG000|Overall Study|Protocol Violation|3|||
157078956|NCT02284009|567041459|FG001|Overall Study|Adverse Event|0|||
157078957|NCT02284009|567041458|FG000|Overall Study|Lost to Follow-up|1|||
157078958|NCT02284009|567041459|FG001|Overall Study|Lost to Follow-up|3|||
157078959|NCT02284009|567041458|FG000|Overall Study|Physician Decision|0|||
157078960|NCT02284009|567041459|FG001|Overall Study|Physician Decision|2|||
157078961|NCT02284009|567041458|FG000|Overall Study|Withdrawal by Subject|2|||
157078962|NCT02284009|567041459|FG001|Overall Study|Withdrawal by Subject|5|||
157078963|NCT01435772|567041460|FG000|Overall Study|Adverse Event|1|||
157078964|NCT01435772|567041461|FG001|Overall Study|Adverse Event|0|||
157078965|NCT01435772|567041462|FG002|Overall Study|Adverse Event|2|||
157078966|NCT01435772|567041460|FG000|Overall Study|Withdrawal by Subject|0|||
157078967|NCT01435772|567041461|FG001|Overall Study|Withdrawal by Subject|1|||
157078968|NCT01435772|567041462|FG002|Overall Study|Withdrawal by Subject|3|||
157078969|NCT01435772|567041460|FG000|Overall Study|Other - study termination|2|||
157078970|NCT01435772|567041461|FG001|Overall Study|Other - study termination|2|||
157078971|NCT01435772|567041462|FG002|Overall Study|Other - study termination|10|||
157078972|NCT03345576|567041463|FG000|Overall Study|Withdrawal by Subject|2|||
157078973|NCT03345576|567041464|FG001|Overall Study|Withdrawal by Subject|2|||
157078974|NCT03345576|567041463|FG000|Overall Study|Adverse Event|1|||
157078975|NCT03345576|567041464|FG001|Overall Study|Adverse Event|0|||
157078976|NCT01876082|567043752|FG000|Overall Study|Withdrawal by Subject|0|||
157078977|NCT01876082|567043753|FG001|Overall Study|Withdrawal by Subject|2|||
157078978|NCT01876082|567043752|FG000|Overall Study|Protocol Violation|1|||
157078979|NCT01876082|567043753|FG001|Overall Study|Protocol Violation|0|||
157078980|NCT01876082|567043752|FG000|Overall Study|Adverse Event|1|||
157078981|NCT01876082|567043753|FG001|Overall Study|Adverse Event|1|||
157078982|NCT01876082|567043752|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
157078983|NCT01876082|567043753|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
157078984|NCT03829501|567043762|FG000|Overall Study|Withdrawal of Consent|2|||
157078985|NCT03829501|567043763|FG001|Overall Study|Withdrawal of Consent|0|||
157078986|NCT03829501|567043764|FG002|Overall Study|Withdrawal of Consent|3|||
157078987|NCT03829501|567043765|FG003|Overall Study|Withdrawal of Consent|0|||
157078988|NCT03829501|567043766|FG004|Overall Study|Withdrawal of Consent|1|||
157078989|NCT03829501|567043767|FG005|Overall Study|Withdrawal of Consent|1|||
157078990|NCT03829501|567043768|FG006|Overall Study|Withdrawal of Consent|0|||
157078991|NCT03829501|567043769|FG007|Overall Study|Withdrawal of Consent|10|||
157078992|NCT03829501|567043770|FG008|Overall Study|Withdrawal of Consent|10|||
157078993|NCT03829501|567043771|FG009|Overall Study|Withdrawal of Consent|3|||
157078994|NCT03829501|567043772|FG010|Overall Study|Withdrawal of Consent|4|||
157078995|NCT03829501|567043773|FG011|Overall Study|Withdrawal of Consent|4|||
157078996|NCT03829501|567043774|FG012|Overall Study|Withdrawal of Consent|4|||
157078997|NCT03829501|567043775|FG013|Overall Study|Withdrawal of Consent|0|||
157078998|NCT03829501|567043776|FG014|Overall Study|Withdrawal of Consent|3|||
157078999|NCT03829501|567043777|FG015|Overall Study|Withdrawal of Consent|0|||
157079000|NCT03829501|567043778|FG016|Overall Study|Withdrawal of Consent|1|||
157079001|NCT03829501|567043779|FG017|Overall Study|Withdrawal of Consent|1|||
157079002|NCT03829501|567043780|FG018|Overall Study|Withdrawal of Consent|0|||
157079003|NCT03829501|567043781|FG019|Overall Study|Withdrawal of Consent|0|||
157079004|NCT03829501|567043782|FG020|Overall Study|Withdrawal of Consent|3|||
157079005|NCT03829501|567043783|FG021|Overall Study|Withdrawal of Consent|0|||
157079006|NCT03829501|567043784|FG022|Overall Study|Withdrawal of Consent|1|||
157079007|NCT03829501|567043762|FG000|Overall Study|PD|0|||
157079008|NCT03829501|567043763|FG001|Overall Study|PD|0|||
157079009|NCT03829501|567043764|FG002|Overall Study|PD|0|||
157079010|NCT03829501|567043765|FG003|Overall Study|PD|2|||
157079011|NCT03829501|567043766|FG004|Overall Study|PD|0|||
157079012|NCT03829501|567043767|FG005|Overall Study|PD|0|||
157079013|NCT03829501|567043768|FG006|Overall Study|PD|0|||
157079014|NCT03829501|567043769|FG007|Overall Study|PD|0|||
157079015|NCT03829501|567043770|FG008|Overall Study|PD|0|||
157079016|NCT03829501|567043771|FG009|Overall Study|PD|0|||
157079017|NCT03829501|567043772|FG010|Overall Study|PD|0|||
157079018|NCT03829501|567043773|FG011|Overall Study|PD|0|||
157079019|NCT03829501|567043774|FG012|Overall Study|PD|0|||
157079020|NCT03829501|567043775|FG013|Overall Study|PD|0|||
157079021|NCT03829501|567043776|FG014|Overall Study|PD|0|||
157079022|NCT03829501|567043777|FG015|Overall Study|PD|1|||
157079023|NCT03829501|567043778|FG016|Overall Study|PD|0|||
157079024|NCT03829501|567043779|FG017|Overall Study|PD|0|||
157079025|NCT03829501|567043780|FG018|Overall Study|PD|0|||
157079026|NCT03829501|567043781|FG019|Overall Study|PD|0|||
157079027|NCT03829501|567043782|FG020|Overall Study|PD|1|||
157079028|NCT03829501|567043783|FG021|Overall Study|PD|0|||
157079029|NCT03829501|567043784|FG022|Overall Study|PD|0|||
157079030|NCT03829501|567043762|FG000|Overall Study|Study Terminated by Sponsor|0|||
157079031|NCT03829501|567043763|FG001|Overall Study|Study Terminated by Sponsor|0|||
157079032|NCT03829501|567043764|FG002|Overall Study|Study Terminated by Sponsor|0|||
157079033|NCT03829501|567043765|FG003|Overall Study|Study Terminated by Sponsor|0|||
157079034|NCT03829501|567043766|FG004|Overall Study|Study Terminated by Sponsor|0|||
157079035|NCT03829501|567043767|FG005|Overall Study|Study Terminated by Sponsor|0|||
157079036|NCT03829501|567043768|FG006|Overall Study|Study Terminated by Sponsor|0|||
157079037|NCT03829501|567043769|FG007|Overall Study|Study Terminated by Sponsor|3|||
157079038|NCT03829501|567043770|FG008|Overall Study|Study Terminated by Sponsor|1|||
157079039|NCT03829501|567043771|FG009|Overall Study|Study Terminated by Sponsor|0|||
157079040|NCT03829501|567043772|FG010|Overall Study|Study Terminated by Sponsor|0|||
157079041|NCT03829501|567043773|FG011|Overall Study|Study Terminated by Sponsor|0|||
157079042|NCT03829501|567043774|FG012|Overall Study|Study Terminated by Sponsor|0|||
157079043|NCT03829501|567043775|FG013|Overall Study|Study Terminated by Sponsor|0|||
157079044|NCT03829501|567043776|FG014|Overall Study|Study Terminated by Sponsor|3|||
157079045|NCT03829501|567043777|FG015|Overall Study|Study Terminated by Sponsor|2|||
157079046|NCT03829501|567043778|FG016|Overall Study|Study Terminated by Sponsor|2|||
157079047|NCT03829501|567043779|FG017|Overall Study|Study Terminated by Sponsor|0|||
157079048|NCT03829501|567043780|FG018|Overall Study|Study Terminated by Sponsor|0|||
157079049|NCT03829501|567043781|FG019|Overall Study|Study Terminated by Sponsor|0|||
157079050|NCT03829501|567043782|FG020|Overall Study|Study Terminated by Sponsor|1|||
157079051|NCT03829501|567043783|FG021|Overall Study|Study Terminated by Sponsor|0|||
157079052|NCT03829501|567043784|FG022|Overall Study|Study Terminated by Sponsor|3|||
157079053|NCT03829501|567043762|FG000|Overall Study|Lost to Follow Up|0|||
157079054|NCT03829501|567043763|FG001|Overall Study|Lost to Follow Up|0|||
157079055|NCT03829501|567043764|FG002|Overall Study|Lost to Follow Up|0|||
157079056|NCT03829501|567043765|FG003|Overall Study|Lost to Follow Up|0|||
157079057|NCT03829501|567043766|FG004|Overall Study|Lost to Follow Up|1|||
157079058|NCT03829501|567043767|FG005|Overall Study|Lost to Follow Up|0|||
157079059|NCT03829501|567043768|FG006|Overall Study|Lost to Follow Up|0|||
157079060|NCT03829501|567043769|FG007|Overall Study|Lost to Follow Up|2|||
157079061|NCT03829501|567043770|FG008|Overall Study|Lost to Follow Up|2|||
157079062|NCT03829501|567043771|FG009|Overall Study|Lost to Follow Up|0|||
157079063|NCT03829501|567043772|FG010|Overall Study|Lost to Follow Up|2|||
157079064|NCT03829501|567043773|FG011|Overall Study|Lost to Follow Up|1|||
157079065|NCT03829501|567043774|FG012|Overall Study|Lost to Follow Up|0|||
157079066|NCT03829501|567043775|FG013|Overall Study|Lost to Follow Up|1|||
157079067|NCT03829501|567043776|FG014|Overall Study|Lost to Follow Up|1|||
157079068|NCT03829501|567043777|FG015|Overall Study|Lost to Follow Up|0|||
157079069|NCT03829501|567043778|FG016|Overall Study|Lost to Follow Up|0|||
157079070|NCT03829501|567043779|FG017|Overall Study|Lost to Follow Up|0|||
157079071|NCT03829501|567043780|FG018|Overall Study|Lost to Follow Up|0|||
157079072|NCT03829501|567043781|FG019|Overall Study|Lost to Follow Up|0|||
157079073|NCT03829501|567043782|FG020|Overall Study|Lost to Follow Up|0|||
157079074|NCT03829501|567043783|FG021|Overall Study|Lost to Follow Up|0|||
157079075|NCT03829501|567043784|FG022|Overall Study|Lost to Follow Up|1|||
157079076|NCT03829501|567043762|FG000|Overall Study|Death|2|||
157079077|NCT03829501|567043763|FG001|Overall Study|Death|4|||
157079078|NCT03829501|567043764|FG002|Overall Study|Death|5|||
157079079|NCT03829501|567043765|FG003|Overall Study|Death|6|||
157079080|NCT03829501|567043766|FG004|Overall Study|Death|5|||
157079081|NCT03829501|567043767|FG005|Overall Study|Death|4|||
157079082|NCT03829501|567043768|FG006|Overall Study|Death|5|||
157079083|NCT03829501|567043769|FG007|Overall Study|Death|24|||
157079084|NCT03829501|567043770|FG008|Overall Study|Death|22|||
157079085|NCT03829501|567043771|FG009|Overall Study|Death|6|||
157079086|NCT03829501|567043772|FG010|Overall Study|Death|3|||
157079087|NCT03829501|567043773|FG011|Overall Study|Death|10|||
157079088|NCT03829501|567043774|FG012|Overall Study|Death|10|||
157079089|NCT03829501|567043775|FG013|Overall Study|Death|5|||
157079090|NCT03829501|567043776|FG014|Overall Study|Death|7|||
157079091|NCT03829501|567043777|FG015|Overall Study|Death|2|||
157079092|NCT03829501|567043778|FG016|Overall Study|Death|2|||
157079093|NCT03829501|567043779|FG017|Overall Study|Death|1|||
157079094|NCT03829501|567043780|FG018|Overall Study|Death|1|||
157079095|NCT03829501|567043781|FG019|Overall Study|Death|1|||
157079096|NCT03829501|567043782|FG020|Overall Study|Death|1|||
157079097|NCT03829501|567043783|FG021|Overall Study|Death|2|||
157079098|NCT03829501|567043784|FG022|Overall Study|Death|3|||
157079099|NCT03829501|567043762|FG000|Overall Study|Miscellaneous|0|||
157079100|NCT03829501|567043763|FG001|Overall Study|Miscellaneous|0|||
157079101|NCT03829501|567043764|FG002|Overall Study|Miscellaneous|1|||
157079102|NCT03829501|567043765|FG003|Overall Study|Miscellaneous|0|||
157079103|NCT03829501|567043766|FG004|Overall Study|Miscellaneous|0|||
157079104|NCT03829501|567043767|FG005|Overall Study|Miscellaneous|0|||
157079105|NCT03829501|567043768|FG006|Overall Study|Miscellaneous|0|||
157079106|NCT03829501|567043769|FG007|Overall Study|Miscellaneous|1|||
157079107|NCT03829501|567043770|FG008|Overall Study|Miscellaneous|0|||
157079108|NCT03829501|567043771|FG009|Overall Study|Miscellaneous|0|||
157079109|NCT03829501|567043772|FG010|Overall Study|Miscellaneous|0|||
157079110|NCT03829501|567043773|FG011|Overall Study|Miscellaneous|0|||
157079111|NCT03829501|567043774|FG012|Overall Study|Miscellaneous|0|||
157079112|NCT03829501|567043775|FG013|Overall Study|Miscellaneous|0|||
157079113|NCT03829501|567043776|FG014|Overall Study|Miscellaneous|0|||
157079114|NCT03829501|567043777|FG015|Overall Study|Miscellaneous|0|||
157079115|NCT03829501|567043778|FG016|Overall Study|Miscellaneous|0|||
157079116|NCT03829501|567043779|FG017|Overall Study|Miscellaneous|0|||
157079117|NCT03829501|567043780|FG018|Overall Study|Miscellaneous|0|||
157079118|NCT03829501|567043781|FG019|Overall Study|Miscellaneous|0|||
157079119|NCT03829501|567043782|FG020|Overall Study|Miscellaneous|0|||
157079120|NCT03829501|567043783|FG021|Overall Study|Miscellaneous|0|||
157079121|NCT03829501|567043784|FG022|Overall Study|Miscellaneous|1|||
157079122|NCT02964013|567043785|FG000|Overall Study|Death|58|||
157079123|NCT02964013|567043786|FG001|Overall Study|Death|239|||
157079124|NCT02964013|567043787|FG002|Overall Study|Death|38|||
157079125|NCT02964013|567043788|FG003|Overall Study|Death|10|||
157079126|NCT02964013|567043789|FG004|Overall Study|Death|33|||
157079127|NCT02964013|567043785|FG000|Overall Study|Lost to Follow-up|1|||
157079128|NCT02964013|567043786|FG001|Overall Study|Lost to Follow-up|4|||
157079129|NCT02964013|567043787|FG002|Overall Study|Lost to Follow-up|2|||
157079130|NCT02964013|567043788|FG003|Overall Study|Lost to Follow-up|0|||
157079131|NCT02964013|567043789|FG004|Overall Study|Lost to Follow-up|0|||
157079132|NCT02964013|567043785|FG000|Overall Study|Physician Decision|0|||
157079133|NCT02964013|567043786|FG001|Overall Study|Physician Decision|1|||
157079134|NCT02964013|567043787|FG002|Overall Study|Physician Decision|0|||
157079135|NCT02964013|567043788|FG003|Overall Study|Physician Decision|0|||
157079136|NCT02964013|567043789|FG004|Overall Study|Physician Decision|0|||
157079137|NCT02964013|567043785|FG000|Overall Study|Sponsor Decision|3|||
157079138|NCT02964013|567043786|FG001|Overall Study|Sponsor Decision|22|||
157079139|NCT02964013|567043787|FG002|Overall Study|Sponsor Decision|11|||
157079140|NCT02964013|567043788|FG003|Overall Study|Sponsor Decision|0|||
157079141|NCT02964013|567043789|FG004|Overall Study|Sponsor Decision|7|||
157079142|NCT02964013|567043785|FG000|Overall Study|Withdrawal by Subject|6|||
157079143|NCT02964013|567043786|FG001|Overall Study|Withdrawal by Subject|27|||
157079144|NCT02964013|567043787|FG002|Overall Study|Withdrawal by Subject|9|||
157079145|NCT02964013|567043788|FG003|Overall Study|Withdrawal by Subject|0|||
157079146|NCT02964013|567043789|FG004|Overall Study|Withdrawal by Subject|0|||
157079147|NCT02964013|567043785|FG000|Overall Study|Not Treated|0|||
157079148|NCT02964013|567043786|FG001|Overall Study|Not Treated|2|||
157079149|NCT02964013|567043787|FG002|Overall Study|Not Treated|0|||
157079150|NCT02964013|567043788|FG003|Overall Study|Not Treated|1|||
157079151|NCT02964013|567043789|FG004|Overall Study|Not Treated|0|||
157079152|NCT00918879|567043791|FG000|Overall Study|Withdrawal by Subject|4|||
157079153|NCT00918879|567043792|FG001|Overall Study|Withdrawal by Subject|4|||
157079154|NCT00918879|567043791|FG000|Overall Study|Lost to Follow-up|1|||
157079155|NCT00918879|567043792|FG001|Overall Study|Lost to Follow-up|1|||
157079156|NCT00918879|567043791|FG000|Overall Study|Severe non-compliance to protocol|1|||
157079157|NCT00918879|567043792|FG001|Overall Study|Severe non-compliance to protocol|1|||
157079158|NCT00357110|567043793|FG000|Overall Study|Early study termination|5|||
157079159|NCT00357110|567043794|FG001|Overall Study|Early study termination|5|||
157079160|NCT03339245|567043801|FG000|Overall Study|Adverse Event|1|||
157079161|NCT03339245|567043802|FG001|Overall Study|Adverse Event|1|||
157079162|NCT03339245|567043801|FG000|Overall Study|Withdrawal by Subject|1|||
157079163|NCT03339245|567043802|FG001|Overall Study|Withdrawal by Subject|0|||
157079164|NCT00515671|567043803|FG000|Overall Study|Lost to Follow-up|13|||
157079165|NCT00515671|567043804|FG001|Overall Study|Lost to Follow-up|10|||
157079166|NCT00515671|567043803|FG000|Overall Study|Withdrawal by Subject|3|||
157079167|NCT00515671|567043804|FG001|Overall Study|Withdrawal by Subject|5|||
157079168|NCT00515671|567043803|FG000|Overall Study|incarcerated|1|||
157079169|NCT00515671|567043804|FG001|Overall Study|incarcerated|2|||
157079170|NCT00288639|567043809|FG000|Overall Study|Adverse Event|5|||
157079171|NCT00288639|567043809|FG000|Overall Study|Lack of Efficacy|4|||
157079172|NCT00288639|567043809|FG000|Overall Study|Withdrawal by Subject|2|||
157079173|NCT00288639|567043809|FG000|Overall Study|Other|1|||
157079174|NCT02815579|567043815|FG000|Overall Study|Non-payment of loan down-payment|16|||
157079175|NCT02815579|567043816|FG001|Overall Study|Non-payment of loan down-payment|0|||
157079176|NCT02815579|567043815|FG000|Overall Study|Withdrawal by Subject|7|||
157079177|NCT02815579|567043816|FG001|Overall Study|Withdrawal by Subject|1|||
157079178|NCT02815579|567043815|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
157079179|NCT02815579|567043816|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
157079180|NCT02815579|567043815|FG000|Overall Study|Lost to Follow-up|7|||
157079181|NCT02815579|567043816|FG001|Overall Study|Lost to Follow-up|4|||
157079182|NCT02815579|567043815|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
157079183|NCT02815579|567043816|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
157079184|NCT02815579|567043815|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
157079185|NCT02815579|567043816|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
157079186|NCT02815579|567043815|FG000|Overall Study|Death|5|||
157079187|NCT02815579|567043816|FG001|Overall Study|Death|4|||
157079188|NCT02815579|567043815|FG000|Overall Study|Imprisoned|0|||
157079189|NCT02815579|567043816|FG001|Overall Study|Imprisoned|2|||
157079190|NCT02815579|567043815|FG000|Overall Study|Did not meet enrollment criteria|0|||
157079191|NCT02815579|567043816|FG001|Overall Study|Did not meet enrollment criteria|1|||
157079192|NCT00264303|567043817|FG000|Overall Study|Adverse Event|4|||
157079193|NCT00264303|567043818|FG001|Overall Study|Adverse Event|3|||
157079194|NCT00264303|567043817|FG000|Overall Study|Lack of Efficacy|10|||
157079195|NCT00264303|567043818|FG001|Overall Study|Lack of Efficacy|13|||
157079196|NCT00264303|567043817|FG000|Overall Study|Lost to Follow-up|3|||
157079197|NCT00264303|567043818|FG001|Overall Study|Lost to Follow-up|3|||
157079198|NCT00264303|567043817|FG000|Overall Study|Withdrawal by Subject|2|||
157079199|NCT00264303|567043818|FG001|Overall Study|Withdrawal by Subject|3|||
157079200|NCT00264303|567043817|FG000|Overall Study|Various reasons listed in study report|6|||
157079201|NCT00264303|567043818|FG001|Overall Study|Various reasons listed in study report|7|||
157079202|NCT02311673|567043819|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
157079203|NCT02311673|567043820|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
157079204|NCT02311673|567043821|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
157079205|NCT02311673|567043822|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
157079206|NCT01977677|567043830|FG000|Overall Study|Unrelated Adverse Event|0|||
157079207|NCT01977677|567043831|FG001|Overall Study|Unrelated Adverse Event|0|||
157079208|NCT01977677|567043832|FG002|Overall Study|Unrelated Adverse Event|1|||
157079209|NCT04325282|567043835|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
157079210|NCT04325282|567043836|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
157079211|NCT04325282|567043835|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
157079212|NCT04325282|567043836|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
157079213|NCT04020185|567043837|FG000|Overall Study|Death|0|||
157079214|NCT04020185|567043838|FG001|Overall Study|Death|0|||
157079215|NCT04020185|567043839|FG002|Overall Study|Death|1|||
157079216|NCT04020185|567043840|FG003|Overall Study|Death|2|||
157079217|NCT04020185|567043841|FG004|Overall Study|Death|1|||
157079218|NCT04020185|567043842|FG005|Overall Study|Death|0|||
157079219|NCT04020185|567043843|FG006|Overall Study|Death|1|||
157079220|NCT04020185|567043844|FG007|Overall Study|Death|0|||
157079221|NCT04020185|567043837|FG000|Overall Study|Consent withdrawn|1|||
157079222|NCT04020185|567043838|FG001|Overall Study|Consent withdrawn|0|||
157079223|NCT04020185|567043839|FG002|Overall Study|Consent withdrawn|0|||
157079224|NCT04020185|567043840|FG003|Overall Study|Consent withdrawn|0|||
157079225|NCT04020185|567043841|FG004|Overall Study|Consent withdrawn|2|||
157079226|NCT04020185|567043842|FG005|Overall Study|Consent withdrawn|0|||
157079227|NCT04020185|567043843|FG006|Overall Study|Consent withdrawn|1|||
157079228|NCT04020185|567043844|FG007|Overall Study|Consent withdrawn|1|||
157079229|NCT04020185|567043837|FG000|Overall Study|Patient in hospice|0|||
157079230|NCT04020185|567043838|FG001|Overall Study|Patient in hospice|1|||
157079231|NCT04020185|567043839|FG002|Overall Study|Patient in hospice|0|||
157079232|NCT04020185|567043840|FG003|Overall Study|Patient in hospice|0|||
157079233|NCT04020185|567043841|FG004|Overall Study|Patient in hospice|0|||
157079234|NCT04020185|567043842|FG005|Overall Study|Patient in hospice|0|||
157079235|NCT04020185|567043843|FG006|Overall Study|Patient in hospice|0|||
157079236|NCT04020185|567043844|FG007|Overall Study|Patient in hospice|0|||
157079237|NCT04020185|567043837|FG000|Overall Study|Continuing on expanded access|0|||
157079238|NCT04020185|567043838|FG001|Overall Study|Continuing on expanded access|0|||
157079239|NCT04020185|567043839|FG002|Overall Study|Continuing on expanded access|0|||
157079240|NCT04020185|567043840|FG003|Overall Study|Continuing on expanded access|0|||
157079241|NCT04020185|567043841|FG004|Overall Study|Continuing on expanded access|0|||
157079242|NCT04020185|567043842|FG005|Overall Study|Continuing on expanded access|0|||
157079243|NCT04020185|567043843|FG006|Overall Study|Continuing on expanded access|1|||
157079244|NCT04020185|567043844|FG007|Overall Study|Continuing on expanded access|1|||
157079245|NCT00527787|567043846|FG000|Overall Study|Adverse Event|14|||
157079246|NCT00527787|567043847|FG001|Overall Study|Adverse Event|24|||
157079247|NCT00527787|567043846|FG000|Overall Study|Withdrawal by Subject|13|||
157079248|NCT00527787|567043847|FG001|Overall Study|Withdrawal by Subject|25|||
157079249|NCT00527787|567043846|FG000|Overall Study|Lost to Follow-up|5|||
157079250|NCT00527787|567043847|FG001|Overall Study|Lost to Follow-up|2|||
157079251|NCT00527787|567043846|FG000|Overall Study|Duodenal Ulcer|1|||
157079252|NCT00527787|567043847|FG001|Overall Study|Duodenal Ulcer|10|||
157079253|NCT00527787|567043846|FG000|Overall Study|misc|5|||
157079254|NCT00527787|567043847|FG001|Overall Study|misc|2|||
157079255|NCT04833127|567043848|FG000|Overall Study|Lost to Follow-up|1|||
157079256|NCT04833127|567043849|FG001|Overall Study|Lost to Follow-up|1|||
157079257|NCT01499303|567043854|FG000|Overall Study|Ongoing|2|||
157079258|NCT01499303|567043855|FG001|Overall Study|Ongoing|1|||
157079259|NCT01499303|567043854|FG000|Overall Study|Withdrawal by Subject|0|||
157079260|NCT01499303|567043855|FG001|Overall Study|Withdrawal by Subject|1|||
157079261|NCT01499303|567043854|FG000|Overall Study|Adverse Event|1|||
157079262|NCT01499303|567043855|FG001|Overall Study|Adverse Event|4|||
157079263|NCT01499303|567043854|FG000|Overall Study|Other|0|||
157079264|NCT01499303|567043855|FG001|Overall Study|Other|1|||
157079265|NCT00461981|567043856|FG000|Overall Study|Lost to Follow-up|9|||
157079266|NCT00461981|567043857|FG001|Overall Study|Lost to Follow-up|6|||
157079267|NCT00461981|567043856|FG000|Overall Study|Withdrawal by Subject|2|||
157079268|NCT00461981|567043857|FG001|Overall Study|Withdrawal by Subject|3|||
157079269|NCT01706705|567043861|FG000|Overall Study|Death|1|||
157079270|NCT01706705|567043861|FG000|Overall Study|Lack of Efficacy|13|||
157192816|NCT01849289|567447203|FG001|Overall Study|Protocol Violation|3|||
157079271|NCT01706705|567043861|FG000|Overall Study|Non-clinical|6|||
157079272|NCT01252355|567043864|FG000|Overall Study|Adverse Event|9|||
157079273|NCT01252355|567043865|FG001|Overall Study|Adverse Event|17|||
157079274|NCT01252355|567043866|FG002|Overall Study|Adverse Event|22|||
157079275|NCT01252355|567043864|FG000|Overall Study|Lack of Efficacy|6|||
157079276|NCT01252355|567043865|FG001|Overall Study|Lack of Efficacy|4|||
157079277|NCT01252355|567043866|FG002|Overall Study|Lack of Efficacy|2|||
157079278|NCT01252355|567043864|FG000|Overall Study|Lost to Follow-up|0|||
157079279|NCT01252355|567043865|FG001|Overall Study|Lost to Follow-up|0|||
157079280|NCT01252355|567043866|FG002|Overall Study|Lost to Follow-up|1|||
157079281|NCT01252355|567043864|FG000|Overall Study|Poor Compliance to Protocol|1|||
157079282|NCT01252355|567043865|FG001|Overall Study|Poor Compliance to Protocol|1|||
157079283|NCT01252355|567043866|FG002|Overall Study|Poor Compliance to Protocol|1|||
157079284|NCT01252355|567043864|FG000|Overall Study|Progressive Disease|2|||
157079285|NCT01252355|567043865|FG001|Overall Study|Progressive Disease|0|||
157079286|NCT01252355|567043866|FG002|Overall Study|Progressive Disease|0|||
157079287|NCT01252355|567043864|FG000|Overall Study|Sponsor Early Termination of Study|149|||
157079288|NCT01252355|567043865|FG001|Overall Study|Sponsor Early Termination of Study|149|||
157079289|NCT01252355|567043866|FG002|Overall Study|Sponsor Early Termination of Study|146|||
157079290|NCT01252355|567043864|FG000|Overall Study|Randomized but not Treated|2|||
157079291|NCT01252355|567043865|FG001|Overall Study|Randomized but not Treated|0|||
157079292|NCT01252355|567043866|FG002|Overall Study|Randomized but not Treated|0|||
157079293|NCT01252355|567043864|FG000|Overall Study|Other Than Above|8|||
157079294|NCT01252355|567043865|FG001|Overall Study|Other Than Above|7|||
157079295|NCT01252355|567043866|FG002|Overall Study|Other Than Above|7|||
157079296|NCT02242097|567043867|FG000|Ibrutinib Treatment|Adverse Event|16|||
157079297|NCT02242097|567043867|FG000|Ibrutinib Treatment|Physician Decision|1|||
157079298|NCT02242097|567043867|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
157079299|NCT02242097|567043867|FG000|Ibrutinib Treatment|Death|1|||
157079300|NCT02242097|567043867|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
157079301|NCT02242097|567043867|FG000|Post Therapy Follow Up|Death|3|||
157079302|NCT02242097|567043867|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
157079303|NCT03031496|567043869|FG000|Period 1|Adverse Event|2|||
157079304|NCT03031496|567043870|FG001|Period 1|Adverse Event|0|||
157079305|NCT03031496|567043869|FG000|Period 1|Withdrawal by Subject|0|||
157079306|NCT03031496|567043870|FG001|Period 1|Withdrawal by Subject|2|||
157079307|NCT03868787|567043872|FG000|Overall Study|Withdrawal by Subject|2|||
157079308|NCT03868787|567043873|FG001|Overall Study|Withdrawal by Subject|1|||
157079309|NCT01399697|567043874|FG000|Overall Study|Adverse Event|13|||
157079310|NCT01399697|567043875|FG001|Overall Study|Adverse Event|3|||
157079311|NCT01399697|567043876|FG002|Overall Study|Adverse Event|1|||
157079312|NCT01399697|567043874|FG000|Overall Study|Lost to Follow-up|2|||
157079313|NCT01399697|567043875|FG001|Overall Study|Lost to Follow-up|0|||
157079314|NCT01399697|567043876|FG002|Overall Study|Lost to Follow-up|0|||
157079315|NCT01399697|567043874|FG000|Overall Study|Withdrawal by Subject|8|||
157079316|NCT01399697|567043875|FG001|Overall Study|Withdrawal by Subject|0|||
157079317|NCT01399697|567043876|FG002|Overall Study|Withdrawal by Subject|0|||
157079318|NCT01399697|567043874|FG000|Overall Study|Investigator Decisión|1|||
157079319|NCT01399697|567043875|FG001|Overall Study|Investigator Decisión|0|||
157079320|NCT01399697|567043876|FG002|Overall Study|Investigator Decisión|2|||
157079321|NCT01399697|567043874|FG000|Overall Study|Lack of Efficacy|9|||
157079322|NCT01399697|567043875|FG001|Overall Study|Lack of Efficacy|0|||
157079323|NCT01399697|567043876|FG002|Overall Study|Lack of Efficacy|1|||
157079324|NCT01399697|567043874|FG000|Overall Study|Protocol Violation|2|||
157079325|NCT01399697|567043875|FG001|Overall Study|Protocol Violation|0|||
157079326|NCT01399697|567043876|FG002|Overall Study|Protocol Violation|0|||
157079327|NCT01399697|567043874|FG000|Overall Study|Non-Compliant|1|||
157079328|NCT01399697|567043875|FG001|Overall Study|Non-Compliant|0|||
157079329|NCT01399697|567043876|FG002|Overall Study|Non-Compliant|0|||
157079330|NCT01399697|567043874|FG000|Overall Study|Inclusion Error|2|||
157079331|NCT01399697|567043875|FG001|Overall Study|Inclusion Error|0|||
157079332|NCT01399697|567043876|FG002|Overall Study|Inclusion Error|0|||
157079333|NCT01399697|567043874|FG000|Overall Study|Positive result for hepatitis B|1|||
157079334|NCT01399697|567043875|FG001|Overall Study|Positive result for hepatitis B|0|||
157079335|NCT01399697|567043876|FG002|Overall Study|Positive result for hepatitis B|0|||
157079336|NCT01399697|567043874|FG000|Overall Study|Clinical RA remission|1|||
157079337|NCT01399697|567043875|FG001|Overall Study|Clinical RA remission|0|||
157079338|NCT01399697|567043876|FG002|Overall Study|Clinical RA remission|0|||
157079339|NCT01399697|567043874|FG000|Overall Study|Sponsor Decision|1|||
157079340|NCT01399697|567043875|FG001|Overall Study|Sponsor Decision|0|||
157079341|NCT01399697|567043876|FG002|Overall Study|Sponsor Decision|0|||
157079342|NCT04313608|567043877|FG000|Overall Study|Death|12|||
157079343|NCT04313608|567043878|FG001|Overall Study|Death|3|||
157079344|NCT01712061|567043880|FG000|Overall Study|Adverse Event|4|||
157079345|NCT01712061|567043881|FG001|Overall Study|Adverse Event|9|||
157079346|NCT01712061|567043882|FG002|Overall Study|Adverse Event|5|||
157079347|NCT01712061|567043880|FG000|Overall Study|Death|0|||
157079348|NCT01712061|567043881|FG001|Overall Study|Death|0|||
157079349|NCT01712061|567043882|FG002|Overall Study|Death|1|||
157079350|NCT01712061|567043880|FG000|Overall Study|Lost to Follow-up|1|||
157079351|NCT01712061|567043881|FG001|Overall Study|Lost to Follow-up|0|||
157079352|NCT01712061|567043882|FG002|Overall Study|Lost to Follow-up|1|||
157079353|NCT01712061|567043880|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
157079354|NCT01712061|567043881|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
157079355|NCT01712061|567043882|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
157079356|NCT01712061|567043880|FG000|Overall Study|Medication Error Without Associated AE|0|||
157079357|NCT01712061|567043881|FG001|Overall Study|Medication Error Without Associated AE|1|||
157079358|NCT01712061|567043882|FG002|Overall Study|Medication Error Without Associated AE|0|||
157079359|NCT01712061|567043880|FG000|Overall Study|Withdrawal by Subject|1|||
157079360|NCT01712061|567043881|FG001|Overall Study|Withdrawal by Subject|7|||
157079361|NCT01712061|567043882|FG002|Overall Study|Withdrawal by Subject|1|||
157079362|NCT01712061|567043880|FG000|Overall Study|Other|0|||
157079363|NCT01712061|567043881|FG001|Overall Study|Other|3|||
157079364|NCT01712061|567043882|FG002|Overall Study|Other|0|||
157079365|NCT01068665|567043887|FG000|Overall Study|Adverse Event|5|||
157079366|NCT01068665|567043888|FG001|Overall Study|Adverse Event|4|||
157079367|NCT01068665|567043887|FG000|Overall Study|Lack of Efficacy|0|||
157079368|NCT01068665|567043888|FG001|Overall Study|Lack of Efficacy|2|||
157079369|NCT01068665|567043887|FG000|Overall Study|Protocol Violation|5|||
157079370|NCT01068665|567043888|FG001|Overall Study|Protocol Violation|2|||
157079371|NCT01068665|567043887|FG000|Overall Study|Withdrawal Criteria|3|||
157079372|NCT01068665|567043888|FG001|Overall Study|Withdrawal Criteria|9|||
157079373|NCT01068665|567043887|FG000|Overall Study|Other|17|||
157079374|NCT01068665|567043888|FG001|Overall Study|Other|12|||
157079375|NCT02807272|567043889|FG000|Overall Study|Death|9|||
157079376|NCT02807272|567043890|FG001|Overall Study|Death|5|||
157079377|NCT02807272|567043891|FG002|Overall Study|Death|2|||
157079378|NCT02807272|567043892|FG003|Overall Study|Death|0|||
157079379|NCT02807272|567043893|FG004|Overall Study|Death|1|||
157079380|NCT02807272|567043889|FG000|Overall Study|Lost to Follow-up|1|||
157079381|NCT02807272|567043890|FG001|Overall Study|Lost to Follow-up|0|||
157079382|NCT02807272|567043891|FG002|Overall Study|Lost to Follow-up|0|||
157079383|NCT02807272|567043892|FG003|Overall Study|Lost to Follow-up|0|||
157079384|NCT02807272|567043893|FG004|Overall Study|Lost to Follow-up|0|||
157079385|NCT02807272|567043889|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
157079386|NCT02807272|567043890|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
157192817|NCT01849289|567447202|FG000|Overall Study|Withdrawal criteria|1|||
157192818|NCT01849289|567447203|FG001|Overall Study|Withdrawal criteria|0|||
157192819|NCT01849289|567447202|FG000|Overall Study|Unclassified|25|||
157192820|NCT01849289|567447203|FG001|Overall Study|Unclassified|18|||
157192821|NCT04491591|567447204|FG000|Overall Study|Accidently randomized|3|||
157192822|NCT04491591|567447205|FG001|Overall Study|Accidently randomized|1|||
157192823|NCT04491591|567447206|FG002|Overall Study|Accidently randomized|0|||
157192824|NCT04491591|567447204|FG000|Overall Study|Did not complete survey|28|||
157192825|NCT04491591|567447205|FG001|Overall Study|Did not complete survey|20|||
157192826|NCT04491591|567447206|FG002|Overall Study|Did not complete survey|3|||
157192827|NCT02692560|567447208|FG000|Overall Study|Withdrawal by Subject|0|||
157192828|NCT02692560|567447209|FG001|Overall Study|Withdrawal by Subject|6|||
157192829|NCT00715949|567447212|FG000|Overall Study|could not finish first test|4|||
157192830|NCT02274766|567447213|FG000|Overall Study|Withdrawal by Subject|3|||
157192831|NCT02274766|567447214|FG001|Overall Study|Withdrawal by Subject|6|||
157192832|NCT02274766|567447213|FG000|Overall Study|Did Not Receive Study Drug|1|||
157192833|NCT02274766|567447214|FG001|Overall Study|Did Not Receive Study Drug|1|||
157192834|NCT02274766|567447213|FG000|Overall Study|Subject Unwilling to Proceed|0|||
157192835|NCT02274766|567447214|FG001|Overall Study|Subject Unwilling to Proceed|1|||
157192836|NCT02274766|567447213|FG000|Overall Study|Adverse Event|0|||
157192837|NCT02274766|567447214|FG001|Overall Study|Adverse Event|1|||
157192838|NCT02394028|567447215|FG000|Induction Phase|Adverse Event|2|||
157192839|NCT02394028|567447216|FG001|Induction Phase|Adverse Event|4|||
157192840|NCT02394028|567447217|FG002|Induction Phase|Adverse Event|1|||
157192841|NCT02394028|567447218|FG003|Induction Phase|Adverse Event|2|||
157192842|NCT02394028|567447219|FG004|Induction Phase|Adverse Event|5|||
157192843|NCT02394028|567447220|FG005|Induction Phase|Adverse Event|2|||
157192844|NCT02394028|567447221|FG006|Induction Phase|Adverse Event|0|||
157192845|NCT02394028|567447222|FG007|Induction Phase|Adverse Event|0|||
157192846|NCT02394028|567447223|FG008|Induction Phase|Adverse Event|0|||
157192847|NCT02394028|567447224|FG009|Induction Phase|Adverse Event|0|||
157192848|NCT02394028|567447225|FG010|Induction Phase|Adverse Event|0|||
157192849|NCT02394028|567447215|FG000|Induction Phase|Lack of Efficacy|3|||
157192850|NCT02394028|567447216|FG001|Induction Phase|Lack of Efficacy|6|||
157192851|NCT02394028|567447217|FG002|Induction Phase|Lack of Efficacy|2|||
157192852|NCT02394028|567447218|FG003|Induction Phase|Lack of Efficacy|17|||
157192853|NCT02394028|567447219|FG004|Induction Phase|Lack of Efficacy|14|||
157079387|NCT02807272|567043891|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
157079388|NCT02807272|567043892|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
157192854|NCT02394028|567447220|FG005|Induction Phase|Lack of Efficacy|8|||
157192855|NCT02394028|567447221|FG006|Induction Phase|Lack of Efficacy|17|||
157192856|NCT02394028|567447222|FG007|Induction Phase|Lack of Efficacy|23|||
157192857|NCT02394028|567447223|FG008|Induction Phase|Lack of Efficacy|0|||
157079389|NCT02807272|567043893|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
157079390|NCT02807272|567043889|FG000|Overall Study|Protocol-defined Disease Progression|0|||
157079391|NCT02807272|567043890|FG001|Overall Study|Protocol-defined Disease Progression|1|||
157079392|NCT02807272|567043891|FG002|Overall Study|Protocol-defined Disease Progression|0|||
157079393|NCT02807272|567043892|FG003|Overall Study|Protocol-defined Disease Progression|0|||
157079394|NCT02807272|567043893|FG004|Overall Study|Protocol-defined Disease Progression|1|||
157079395|NCT02807272|567043889|FG000|Overall Study|Study Terminated by Sponsor|1|||
157079396|NCT02807272|567043890|FG001|Overall Study|Study Terminated by Sponsor|0|||
157079397|NCT02807272|567043891|FG002|Overall Study|Study Terminated by Sponsor|0|||
157079398|NCT02807272|567043892|FG003|Overall Study|Study Terminated by Sponsor|1|||
157079399|NCT02807272|567043893|FG004|Overall Study|Study Terminated by Sponsor|0|||
157079400|NCT02807272|567043889|FG000|Overall Study|Other|1|||
157079401|NCT02807272|567043890|FG001|Overall Study|Other|0|||
157079402|NCT02807272|567043891|FG002|Overall Study|Other|0|||
157079403|NCT02807272|567043892|FG003|Overall Study|Other|0|||
157079404|NCT02807272|567043893|FG004|Overall Study|Other|1|||
157079405|NCT01162863|567043895|FG000|Overall Study|Lack of Efficacy|1|||
157079406|NCT01162863|567043896|FG001|Overall Study|Lack of Efficacy|0|||
157079407|NCT01162863|567043897|FG002|Overall Study|Lack of Efficacy|0|||
157079408|NCT01162863|567043895|FG000|Overall Study|Adverse Event|0|||
157079409|NCT01162863|567043896|FG001|Overall Study|Adverse Event|1|||
157079410|NCT01162863|567043897|FG002|Overall Study|Adverse Event|0|||
157079411|NCT02992691|567043898|FG000|Overall Study|Adverse Event|2|||
157079412|NCT02992691|567043898|FG000|Overall Study|Withdrawal by Subject|1|||
157079413|NCT00392925|567043899|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
157079414|NCT00392925|567043900|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
157079415|NCT00392925|567043901|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
157232157|NCT01725529|567596809|FG001|Overall Study|Protocol Violation|1|||
157232158|NCT01725529|567596810|FG002|Overall Study|Protocol Violation|1|||
157232159|NCT01725529|567596808|FG000|Overall Study|Withdrawal by Subject|12|||
157232160|NCT01725529|567596809|FG001|Overall Study|Withdrawal by Subject|14|||
157232161|NCT01725529|567596810|FG002|Overall Study|Withdrawal by Subject|8|||
157232162|NCT02653664|567596816|FG000|Post-Treatment|Withdrawal by Subject|6|||
157232163|NCT02653664|567596817|FG001|Post-Treatment|Withdrawal by Subject|5|||
157232164|NCT02653664|567596818|FG002|Post-Treatment|Withdrawal by Subject|7|||
157232165|NCT02653664|567596816|FG000|Post-Treatment|Lost to Follow-up|8|||
157232166|NCT02653664|567596817|FG001|Post-Treatment|Lost to Follow-up|1|||
157232167|NCT02653664|567596818|FG002|Post-Treatment|Lost to Follow-up|7|||
157232168|NCT02653664|567596816|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
157232169|NCT02653664|567596817|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
157079416|NCT00392925|567043902|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
157079417|NCT00392925|567043899|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
157079418|NCT00392925|567043900|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
157079419|NCT00392925|567043901|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
157079420|NCT00392925|567043902|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
157079421|NCT00392925|567043899|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
157079422|NCT00392925|567043900|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
157079423|NCT00392925|567043901|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
157079424|NCT00392925|567043902|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
157079425|NCT00392925|567043899|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
157079426|NCT00392925|567043900|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
157079427|NCT00392925|567043901|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
157079428|NCT00392925|567043902|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
157079429|NCT00392925|567043899|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
157079430|NCT00392925|567043900|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
157079431|NCT00392925|567043901|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
157079432|NCT00392925|567043902|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
157079433|NCT00392925|567043899|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
157232170|NCT02653664|567596818|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
157079434|NCT00392925|567043900|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
157079435|NCT00392925|567043901|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
157232171|NCT02653664|567596816|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
157232172|NCT02653664|567596817|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
157079436|NCT00392925|567043902|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
157079437|NCT00392925|567043899|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
157079438|NCT00392925|567043900|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
157232173|NCT02653664|567596818|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
157232174|NCT02653664|567596816|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
157079439|NCT00392925|567043901|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
157079440|NCT00392925|567043902|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
157079441|NCT00392925|567043899|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
157079442|NCT00392925|567043900|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
157079443|NCT00392925|567043901|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
157079444|NCT00392925|567043902|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
157079445|NCT00392925|567043899|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
157079446|NCT00392925|567043900|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
157079447|NCT00392925|567043901|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
157079448|NCT00392925|567043902|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
157079449|NCT03945825|567043910|FG000|Overall Study|Enrolled but treatment not administered|0|||
157079450|NCT03945825|567043911|FG001|Overall Study|Enrolled but treatment not administered|0|||
157079451|NCT03945825|567043912|FG002|Overall Study|Enrolled but treatment not administered|0|||
157079452|NCT03945825|567043913|FG003|Overall Study|Enrolled but treatment not administered|0|||
157079453|NCT03945825|567043914|FG004|Overall Study|Enrolled but treatment not administered|1|||
157079454|NCT03945825|567043915|FG005|Overall Study|Enrolled but treatment not administered|0|||
157079455|NCT03945825|567043910|FG000|Overall Study|Lost to Follow-up|1|||
157079456|NCT03945825|567043911|FG001|Overall Study|Lost to Follow-up|5|||
157079457|NCT03945825|567043912|FG002|Overall Study|Lost to Follow-up|0|||
157079458|NCT03945825|567043913|FG003|Overall Study|Lost to Follow-up|1|||
157079459|NCT03945825|567043914|FG004|Overall Study|Lost to Follow-up|2|||
157079460|NCT03945825|567043915|FG005|Overall Study|Lost to Follow-up|2|||
157079461|NCT03945825|567043910|FG000|Overall Study|Withdrawal by Subject|1|||
157079462|NCT03945825|567043911|FG001|Overall Study|Withdrawal by Subject|0|||
157079463|NCT03945825|567043912|FG002|Overall Study|Withdrawal by Subject|1|||
157079464|NCT03945825|567043913|FG003|Overall Study|Withdrawal by Subject|1|||
157079465|NCT03945825|567043914|FG004|Overall Study|Withdrawal by Subject|0|||
157079466|NCT03945825|567043915|FG005|Overall Study|Withdrawal by Subject|1|||
157079467|NCT00203268|567043916|FG000|Early Treatment|only treated one headache|2|||
157079468|NCT00203268|567043916|FG000|Early Treatment|Lost to Follow-up|1|||
157079469|NCT00203268|567043916|FG000|Early Treatment|Withdrawal by Subject|1|||
157079470|NCT01067846|567043920|FG000|Overall Study|Lost to Follow-up|17|||
157079471|NCT01067846|567043921|FG001|Overall Study|Lost to Follow-up|19|||
157079472|NCT01067846|567043920|FG000|Overall Study|Withdrawal by Subject|1|||
157079473|NCT01067846|567043921|FG001|Overall Study|Withdrawal by Subject|0|||
157079474|NCT01067846|567043920|FG000|Overall Study|participation in other tx study|1|||
157079475|NCT01067846|567043921|FG001|Overall Study|participation in other tx study|0|||
157079476|NCT02817906|567043922|FG000|Overall Study|Adverse Event|3|||
157079477|NCT02817906|567043923|FG001|Overall Study|Adverse Event|0|||
157079478|NCT02817906|567043922|FG000|Overall Study|Lack of Efficacy|1|||
157079479|NCT02817906|567043923|FG001|Overall Study|Lack of Efficacy|0|||
157079480|NCT02817906|567043922|FG000|Overall Study|Protocol Violation|1|||
157079481|NCT02817906|567043923|FG001|Overall Study|Protocol Violation|1|||
157079482|NCT02817906|567043922|FG000|Overall Study|Study Terminated by Sponsor|2|||
157079483|NCT02817906|567043923|FG001|Overall Study|Study Terminated by Sponsor|2|||
157079484|NCT02817906|567043922|FG000|Overall Study|Withdrawal by Subject|7|||
157079485|NCT02817906|567043923|FG001|Overall Study|Withdrawal by Subject|0|||
157079486|NCT02817906|567043922|FG000|Overall Study|Other|2|||
157079487|NCT02817906|567043923|FG001|Overall Study|Other|2|||
157079488|NCT03686423|567043926|FG000|Overall Study|Withdrawal by Subject|9|||
157079489|NCT03686423|567043926|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
157079490|NCT02994069|567043930|FG000|Overall Study|Death|7|||
157079491|NCT02994069|567043931|FG001|Overall Study|Death|13|||
157079492|NCT02994069|567043930|FG000|Overall Study|Adverse Event|1|||
157079493|NCT02994069|567043931|FG001|Overall Study|Adverse Event|0|||
157079494|NCT02994069|567043930|FG000|Overall Study|Other|2|||
157079495|NCT02994069|567043931|FG001|Overall Study|Other|0|||
157079496|NCT02994069|567043930|FG000|Overall Study|still on follow up/treatment|5|||
157079497|NCT02994069|567043931|FG001|Overall Study|still on follow up/treatment|6|||
157079498|NCT01253135|567045485|FG000|Original Protocol|Protocol Amendment|15|||
157079499|NCT01253135|567045485|FG000|Amended Protocol|Non-compliance|1|||
157079500|NCT00833261|567045490|FG000|Overall Study|Withdrawal by Subject|4|||
157079501|NCT01255631|567045491|FG000|Overall Study|poor enrollment, no data analyzed|9|||
157079502|NCT01255631|567045492|FG001|Overall Study|poor enrollment, no data analyzed|6|||
157079503|NCT04165031|567045495|FG000|Overall Study|Adverse Event|1|||
157079504|NCT04165031|567045496|FG001|Overall Study|Adverse Event|1|||
157079505|NCT04165031|567045497|FG002|Overall Study|Adverse Event|0|||
157079506|NCT04165031|567045498|FG003|Overall Study|Adverse Event|0|||
157232175|NCT02653664|567596817|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
157079507|NCT04165031|567045499|FG004|Overall Study|Adverse Event|0|||
157079508|NCT04165031|567045500|FG005|Overall Study|Adverse Event|0|||
157079509|NCT04165031|567045495|FG000|Overall Study|Withdrawal by Subject|0|||
157079510|NCT04165031|567045496|FG001|Overall Study|Withdrawal by Subject|0|||
157079511|NCT04165031|567045497|FG002|Overall Study|Withdrawal by Subject|1|||
157079512|NCT04165031|567045498|FG003|Overall Study|Withdrawal by Subject|0|||
157079513|NCT04165031|567045499|FG004|Overall Study|Withdrawal by Subject|0|||
157079514|NCT04165031|567045500|FG005|Overall Study|Withdrawal by Subject|0|||
157079515|NCT00818168|567045501|FG000|Overall Study|Lack of Efficacy|18|||
157079516|NCT00818168|567045501|FG000|Overall Study|Pregnancy|2|||
157079517|NCT00818168|567045501|FG000|Overall Study|Withdrawal by Subject|16|||
157079518|NCT00818168|567045501|FG000|Overall Study|Lost to Follow-up|7|||
157079519|NCT00818168|567045501|FG000|Overall Study|Adverse Event|19|||
157079520|NCT00818168|567045501|FG000|Overall Study|Reason for Non-completion Not reported|6|||
157079521|NCT00818168|567045501|FG000|Overall Study|Participant Moved|2|||
157079522|NCT02993406|567045504|FG000|Overall Study|Withdrawal by Subject|170|||
157079523|NCT02993406|567045505|FG001|Overall Study|Withdrawal by Subject|196|||
157079524|NCT02993406|567045504|FG000|Overall Study|Physician Decision|3|||
157079525|NCT02993406|567045505|FG001|Overall Study|Physician Decision|5|||
157079526|NCT02993406|567045504|FG000|Overall Study|Lost to Follow-up|12|||
157079527|NCT02993406|567045505|FG001|Overall Study|Lost to Follow-up|13|||
157079528|NCT02993406|567045504|FG000|Overall Study|Unclassifiable Response|105|||
157079529|NCT02993406|567045505|FG001|Overall Study|Unclassifiable Response|139|||
157079530|NCT02993406|567045504|FG000|Overall Study|Administrative decision|1|||
157079531|NCT02993406|567045505|FG001|Overall Study|Administrative decision|0|||
157079532|NCT02993406|567045504|FG000|Overall Study|Sponsor decision|4|||
157079533|NCT02993406|567045505|FG001|Overall Study|Sponsor decision|5|||
157079534|NCT02248818|567045506|FG000|Screening|Protocol Violation|0|||
157079535|NCT02248818|567045507|FG001|Screening|Protocol Violation|0|||
157079536|NCT02248818|567045508|FG002|Screening|Protocol Violation|0|||
157079537|NCT02248818|567045509|FG003|Screening|Protocol Violation|0|||
157079538|NCT02248818|567045510|FG004|Screening|Protocol Violation|0|||
157079539|NCT02248818|567045511|FG005|Screening|Protocol Violation|0|||
157079540|NCT02248818|567045512|FG006|Screening|Protocol Violation|0|||
157079541|NCT02248818|567045513|FG007|Screening|Protocol Violation|0|||
157079542|NCT02248818|567045514|FG008|Screening|Protocol Violation|7|||
157079543|NCT02248818|567045506|FG000|Screening|Study fully enrolled|0|||
157079544|NCT02248818|567045507|FG001|Screening|Study fully enrolled|0|||
157079545|NCT02248818|567045508|FG002|Screening|Study fully enrolled|0|||
157079546|NCT02248818|567045509|FG003|Screening|Study fully enrolled|0|||
157079547|NCT02248818|567045510|FG004|Screening|Study fully enrolled|0|||
157079548|NCT02248818|567045511|FG005|Screening|Study fully enrolled|0|||
157079549|NCT02248818|567045512|FG006|Screening|Study fully enrolled|0|||
157079550|NCT02248818|567045513|FG007|Screening|Study fully enrolled|0|||
157079551|NCT02248818|567045514|FG008|Screening|Study fully enrolled|14|||
157079552|NCT02248818|567045506|FG000|Screening|Physician Decision|0|||
157079553|NCT02248818|567045507|FG001|Screening|Physician Decision|0|||
157079554|NCT02248818|567045508|FG002|Screening|Physician Decision|0|||
157079555|NCT02248818|567045509|FG003|Screening|Physician Decision|0|||
157079556|NCT02248818|567045510|FG004|Screening|Physician Decision|0|||
157079557|NCT02248818|567045511|FG005|Screening|Physician Decision|0|||
157079558|NCT02248818|567045512|FG006|Screening|Physician Decision|0|||
157079559|NCT02248818|567045513|FG007|Screening|Physician Decision|0|||
157079560|NCT02248818|567045514|FG008|Screening|Physician Decision|73|||
157079561|NCT02248818|567045506|FG000|Screening|Withdrawal by Subject|0|||
157079562|NCT02248818|567045507|FG001|Screening|Withdrawal by Subject|0|||
157079563|NCT02248818|567045508|FG002|Screening|Withdrawal by Subject|0|||
157079564|NCT02248818|567045509|FG003|Screening|Withdrawal by Subject|0|||
157079565|NCT02248818|567045510|FG004|Screening|Withdrawal by Subject|0|||
157079566|NCT02248818|567045511|FG005|Screening|Withdrawal by Subject|0|||
157079567|NCT02248818|567045512|FG006|Screening|Withdrawal by Subject|0|||
157079568|NCT02248818|567045513|FG007|Screening|Withdrawal by Subject|0|||
157079569|NCT02248818|567045514|FG008|Screening|Withdrawal by Subject|6|||
157079570|NCT02248818|567045506|FG000|Screening|Lost to Follow-up|0|||
157079571|NCT02248818|567045507|FG001|Screening|Lost to Follow-up|0|||
157079572|NCT02248818|567045508|FG002|Screening|Lost to Follow-up|0|||
157079573|NCT02248818|567045509|FG003|Screening|Lost to Follow-up|0|||
157079574|NCT02248818|567045510|FG004|Screening|Lost to Follow-up|0|||
157079575|NCT02248818|567045511|FG005|Screening|Lost to Follow-up|0|||
157079576|NCT02248818|567045512|FG006|Screening|Lost to Follow-up|0|||
157079577|NCT02248818|567045513|FG007|Screening|Lost to Follow-up|0|||
157079578|NCT02248818|567045514|FG008|Screening|Lost to Follow-up|7|||
157079579|NCT02248818|567045506|FG000|Randomised Study|Administrative - randomization error|0|||
157079580|NCT02248818|567045507|FG001|Randomised Study|Administrative - randomization error|0|||
157079581|NCT02248818|567045508|FG002|Randomised Study|Administrative - randomization error|0|||
157079582|NCT02248818|567045509|FG003|Randomised Study|Administrative - randomization error|0|||
157079583|NCT02248818|567045510|FG004|Randomised Study|Administrative - randomization error|0|||
157079584|NCT02248818|567045511|FG005|Randomised Study|Administrative - randomization error|8|||
157192858|NCT02394028|567447224|FG009|Induction Phase|Lack of Efficacy|0|||
157192859|NCT02394028|567447225|FG010|Induction Phase|Lack of Efficacy|0|||
157192860|NCT02394028|567447215|FG000|Induction Phase|Lost to Follow-up|1|||
157079585|NCT02248818|567045512|FG006|Randomised Study|Administrative - randomization error|0|||
157079586|NCT02248818|567045513|FG007|Randomised Study|Administrative - randomization error|0|||
157079587|NCT02248818|567045514|FG008|Randomised Study|Administrative - randomization error|0|||
157079588|NCT02942277|567045515|FG000|Year 1|Withdrawal by Subject|0|||
157192861|NCT02394028|567447216|FG001|Induction Phase|Lost to Follow-up|0|||
157079589|NCT02942277|567045516|FG001|Year 1|Withdrawal by Subject|0|||
157079590|NCT02942277|567045517|FG002|Year 1|Withdrawal by Subject|0|||
157079591|NCT02942277|567045518|FG003|Year 1|Withdrawal by Subject|0|||
157079592|NCT02942277|567045519|FG004|Year 1|Withdrawal by Subject|1|||
157079593|NCT02942277|567045520|FG005|Year 1|Withdrawal by Subject|3|||
157079594|NCT02942277|567045521|FG006|Year 1|Withdrawal by Subject|0|||
157079595|NCT02942277|567045522|FG007|Year 1|Withdrawal by Subject|1|||
157079596|NCT02942277|567045523|FG008|Year 1|Withdrawal by Subject|0|||
157079597|NCT02942277|567045524|FG009|Year 1|Withdrawal by Subject|0|||
157079598|NCT02942277|567045525|FG010|Year 1|Withdrawal by Subject|3|||
157079599|NCT02942277|567045515|FG000|Year 1|Travel|0|||
157079600|NCT02942277|567045516|FG001|Year 1|Travel|1|||
157079601|NCT02942277|567045517|FG002|Year 1|Travel|0|||
157079602|NCT02942277|567045518|FG003|Year 1|Travel|0|||
157079603|NCT02942277|567045519|FG004|Year 1|Travel|4|||
157079604|NCT02942277|567045520|FG005|Year 1|Travel|5|||
157079605|NCT02942277|567045521|FG006|Year 1|Travel|0|||
157079606|NCT02942277|567045522|FG007|Year 1|Travel|0|||
157079607|NCT02942277|567045523|FG008|Year 1|Travel|0|||
157079608|NCT02942277|567045524|FG009|Year 1|Travel|0|||
157079609|NCT02942277|567045525|FG010|Year 1|Travel|8|||
157079610|NCT02942277|567045515|FG000|Year 1|Joined Army|0|||
157079611|NCT02942277|567045516|FG001|Year 1|Joined Army|1|||
157079612|NCT02942277|567045517|FG002|Year 1|Joined Army|0|||
157079613|NCT02942277|567045518|FG003|Year 1|Joined Army|0|||
157079614|NCT02942277|567045519|FG004|Year 1|Joined Army|0|||
157079615|NCT02942277|567045520|FG005|Year 1|Joined Army|0|||
157079616|NCT02942277|567045521|FG006|Year 1|Joined Army|0|||
157079617|NCT02942277|567045522|FG007|Year 1|Joined Army|0|||
157079618|NCT02942277|567045523|FG008|Year 1|Joined Army|0|||
157079619|NCT02942277|567045524|FG009|Year 1|Joined Army|0|||
157079620|NCT02942277|567045525|FG010|Year 1|Joined Army|0|||
157079621|NCT02942277|567045515|FG000|Year 1|Subject met withdrawal criteria|0|||
157079622|NCT02942277|567045516|FG001|Year 1|Subject met withdrawal criteria|0|||
157079623|NCT02942277|567045517|FG002|Year 1|Subject met withdrawal criteria|0|||
157079624|NCT02942277|567045518|FG003|Year 1|Subject met withdrawal criteria|1|||
157079625|NCT02942277|567045519|FG004|Year 1|Subject met withdrawal criteria|0|||
157079626|NCT02942277|567045520|FG005|Year 1|Subject met withdrawal criteria|0|||
157079627|NCT02942277|567045521|FG006|Year 1|Subject met withdrawal criteria|0|||
157079628|NCT02942277|567045522|FG007|Year 1|Subject met withdrawal criteria|0|||
157079629|NCT02942277|567045523|FG008|Year 1|Subject met withdrawal criteria|0|||
157079630|NCT02942277|567045524|FG009|Year 1|Subject met withdrawal criteria|0|||
157079631|NCT02942277|567045525|FG010|Year 1|Subject met withdrawal criteria|0|||
157079632|NCT02942277|567045515|FG000|Year 1|Lost to Follow-up|0|||
157079633|NCT02942277|567045516|FG001|Year 1|Lost to Follow-up|0|||
157079634|NCT02942277|567045517|FG002|Year 1|Lost to Follow-up|0|||
157079635|NCT02942277|567045518|FG003|Year 1|Lost to Follow-up|0|||
157079636|NCT02942277|567045519|FG004|Year 1|Lost to Follow-up|1|||
157079637|NCT02942277|567045520|FG005|Year 1|Lost to Follow-up|0|||
157079638|NCT02942277|567045521|FG006|Year 1|Lost to Follow-up|0|||
157079639|NCT02942277|567045522|FG007|Year 1|Lost to Follow-up|0|||
157079640|NCT02942277|567045523|FG008|Year 1|Lost to Follow-up|0|||
157079641|NCT02942277|567045524|FG009|Year 1|Lost to Follow-up|0|||
157079642|NCT02942277|567045525|FG010|Year 1|Lost to Follow-up|2|||
157079643|NCT02942277|567045515|FG000|Year 1|Protocol Violation|0|||
157079644|NCT02942277|567045516|FG001|Year 1|Protocol Violation|0|||
157079645|NCT02942277|567045517|FG002|Year 1|Protocol Violation|0|||
157079646|NCT02942277|567045518|FG003|Year 1|Protocol Violation|0|||
157079647|NCT02942277|567045519|FG004|Year 1|Protocol Violation|1|||
157079648|NCT02942277|567045520|FG005|Year 1|Protocol Violation|1|||
157079649|NCT02942277|567045521|FG006|Year 1|Protocol Violation|0|||
157079650|NCT02942277|567045522|FG007|Year 1|Protocol Violation|0|||
157079651|NCT02942277|567045523|FG008|Year 1|Protocol Violation|0|||
157079652|NCT02942277|567045524|FG009|Year 1|Protocol Violation|0|||
157079653|NCT02942277|567045525|FG010|Year 1|Protocol Violation|2|||
157079654|NCT02942277|567045515|FG000|Year 1|Pregnancy|0|||
157079655|NCT02942277|567045516|FG001|Year 1|Pregnancy|0|||
157079656|NCT02942277|567045517|FG002|Year 1|Pregnancy|0|||
157079657|NCT02942277|567045518|FG003|Year 1|Pregnancy|0|||
157079658|NCT02942277|567045519|FG004|Year 1|Pregnancy|0|||
157079659|NCT02942277|567045520|FG005|Year 1|Pregnancy|1|||
157079660|NCT02942277|567045521|FG006|Year 1|Pregnancy|0|||
157079661|NCT02942277|567045522|FG007|Year 1|Pregnancy|0|||
157079662|NCT02942277|567045523|FG008|Year 1|Pregnancy|0|||
157079663|NCT02942277|567045524|FG009|Year 1|Pregnancy|0|||
157079664|NCT02942277|567045525|FG010|Year 1|Pregnancy|0|||
157079665|NCT02942277|567045515|FG000|Year 2|Lost to Follow-up|0|||
157079666|NCT02942277|567045516|FG001|Year 2|Lost to Follow-up|0|||
157079667|NCT02942277|567045517|FG002|Year 2|Lost to Follow-up|0|||
157079668|NCT02942277|567045518|FG003|Year 2|Lost to Follow-up|0|||
157079669|NCT02942277|567045519|FG004|Year 2|Lost to Follow-up|2|||
157079670|NCT02942277|567045520|FG005|Year 2|Lost to Follow-up|1|||
157079671|NCT02942277|567045521|FG006|Year 2|Lost to Follow-up|0|||
157079672|NCT02942277|567045522|FG007|Year 2|Lost to Follow-up|0|||
157079673|NCT02942277|567045523|FG008|Year 2|Lost to Follow-up|0|||
157079674|NCT02942277|567045524|FG009|Year 2|Lost to Follow-up|0|||
157079675|NCT02942277|567045525|FG010|Year 2|Lost to Follow-up|0|||
157079676|NCT02942277|567045515|FG000|Year 2|Did not rescreen|0|||
157079677|NCT02942277|567045516|FG001|Year 2|Did not rescreen|0|||
157079678|NCT02942277|567045517|FG002|Year 2|Did not rescreen|1|||
157079679|NCT02942277|567045518|FG003|Year 2|Did not rescreen|1|||
157079680|NCT02942277|567045519|FG004|Year 2|Did not rescreen|9|||
157079681|NCT02942277|567045520|FG005|Year 2|Did not rescreen|6|||
157079682|NCT02942277|567045521|FG006|Year 2|Did not rescreen|0|||
157232176|NCT02653664|567596818|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
157232177|NCT02653664|567596816|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
157232178|NCT02653664|567596817|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
157232179|NCT02653664|567596818|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
157232180|NCT02653664|567596816|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
157232181|NCT02653664|567596817|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
157232182|NCT02653664|567596818|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
157079683|NCT02942277|567045522|FG007|Year 2|Did not rescreen|1|||
157079684|NCT02942277|567045523|FG008|Year 2|Did not rescreen|0|||
157079685|NCT02942277|567045524|FG009|Year 2|Did not rescreen|0|||
157079686|NCT02942277|567045525|FG010|Year 2|Did not rescreen|21|||
157079687|NCT02942277|567045515|FG000|Year 2|Met withdrawal criteria|0|||
157079688|NCT02942277|567045516|FG001|Year 2|Met withdrawal criteria|0|||
157079689|NCT02942277|567045517|FG002|Year 2|Met withdrawal criteria|0|||
157079690|NCT02942277|567045518|FG003|Year 2|Met withdrawal criteria|0|||
157079691|NCT02942277|567045519|FG004|Year 2|Met withdrawal criteria|1|||
157079692|NCT02942277|567045520|FG005|Year 2|Met withdrawal criteria|2|||
157079693|NCT02942277|567045521|FG006|Year 2|Met withdrawal criteria|0|||
157079694|NCT02942277|567045522|FG007|Year 2|Met withdrawal criteria|0|||
157079695|NCT02942277|567045523|FG008|Year 2|Met withdrawal criteria|0|||
157079696|NCT02942277|567045524|FG009|Year 2|Met withdrawal criteria|0|||
157079697|NCT02942277|567045525|FG010|Year 2|Met withdrawal criteria|1|||
157079698|NCT02942277|567045515|FG000|Year 2|Travel|0|||
157079699|NCT02942277|567045516|FG001|Year 2|Travel|1|||
157079700|NCT02942277|567045517|FG002|Year 2|Travel|0|||
157079701|NCT02942277|567045518|FG003|Year 2|Travel|0|||
157079702|NCT02942277|567045519|FG004|Year 2|Travel|0|||
157079703|NCT02942277|567045520|FG005|Year 2|Travel|1|||
157079704|NCT02942277|567045521|FG006|Year 2|Travel|0|||
157079705|NCT02942277|567045522|FG007|Year 2|Travel|0|||
157079706|NCT02942277|567045523|FG008|Year 2|Travel|0|||
157079707|NCT02942277|567045524|FG009|Year 2|Travel|1|||
157079708|NCT02942277|567045525|FG010|Year 2|Travel|3|||
157079709|NCT02942277|567045515|FG000|Year 2|Non-compliant|0|||
157079710|NCT02942277|567045516|FG001|Year 2|Non-compliant|0|||
157079711|NCT02942277|567045517|FG002|Year 2|Non-compliant|0|||
157079712|NCT02942277|567045518|FG003|Year 2|Non-compliant|0|||
157079713|NCT02942277|567045519|FG004|Year 2|Non-compliant|1|||
157079714|NCT02942277|567045520|FG005|Year 2|Non-compliant|1|||
157079715|NCT02942277|567045521|FG006|Year 2|Non-compliant|0|||
157079716|NCT02942277|567045522|FG007|Year 2|Non-compliant|0|||
157079717|NCT02942277|567045523|FG008|Year 2|Non-compliant|0|||
157079718|NCT02942277|567045524|FG009|Year 2|Non-compliant|0|||
157079719|NCT02942277|567045525|FG010|Year 2|Non-compliant|0|||
157079720|NCT02942277|567045515|FG000|Year 2|Withdrawal by Subject|0|||
157079721|NCT02942277|567045516|FG001|Year 2|Withdrawal by Subject|0|||
157079722|NCT02942277|567045517|FG002|Year 2|Withdrawal by Subject|0|||
157079723|NCT02942277|567045518|FG003|Year 2|Withdrawal by Subject|0|||
157079724|NCT02942277|567045519|FG004|Year 2|Withdrawal by Subject|0|||
157079725|NCT02942277|567045520|FG005|Year 2|Withdrawal by Subject|0|||
157079726|NCT02942277|567045521|FG006|Year 2|Withdrawal by Subject|1|||
157079727|NCT02942277|567045522|FG007|Year 2|Withdrawal by Subject|0|||
157079728|NCT02942277|567045523|FG008|Year 2|Withdrawal by Subject|0|||
157079729|NCT02942277|567045524|FG009|Year 2|Withdrawal by Subject|0|||
157079730|NCT02942277|567045525|FG010|Year 2|Withdrawal by Subject|0|||
157079731|NCT02187159|567045526|FG000|Overall Study|Protocol Violation|4|||
157232183|NCT02653664|567596816|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
157079732|NCT02187159|567045527|FG001|Overall Study|Protocol Violation|6|||
157079733|NCT02187159|567045528|FG002|Overall Study|Protocol Violation|3|||
157079734|NCT02187159|567045529|FG003|Overall Study|Protocol Violation|4|||
157079735|NCT02187159|567045526|FG000|Overall Study|Lack of Efficacy|10|||
157079736|NCT02187159|567045527|FG001|Overall Study|Lack of Efficacy|5|||
157079737|NCT02187159|567045528|FG002|Overall Study|Lack of Efficacy|4|||
157079738|NCT02187159|567045529|FG003|Overall Study|Lack of Efficacy|7|||
157079739|NCT02187159|567045526|FG000|Overall Study|Adverse Event|28|||
157079740|NCT02187159|567045527|FG001|Overall Study|Adverse Event|33|||
157079741|NCT02187159|567045528|FG002|Overall Study|Adverse Event|42|||
157079742|NCT02187159|567045529|FG003|Overall Study|Adverse Event|50|||
157079743|NCT02187159|567045526|FG000|Overall Study|Withdrawal by Subject|24|||
157079744|NCT02187159|567045527|FG001|Overall Study|Withdrawal by Subject|28|||
157079745|NCT02187159|567045528|FG002|Overall Study|Withdrawal by Subject|25|||
157079746|NCT02187159|567045529|FG003|Overall Study|Withdrawal by Subject|26|||
157079747|NCT02187159|567045526|FG000|Overall Study|Other|3|||
157079748|NCT02187159|567045527|FG001|Overall Study|Other|7|||
157079749|NCT02187159|567045528|FG002|Overall Study|Other|3|||
157079750|NCT02187159|567045529|FG003|Overall Study|Other|9|||
157079751|NCT00608868|567045538|FG000|Overall Study|Withdrawal by Subject|7|||
157079752|NCT00608868|567045538|FG000|Overall Study|Protocol Violation|3|||
157079753|NCT00608868|567045538|FG000|Overall Study|Lost to Follow-up|2|||
157079754|NCT00608868|567045538|FG000|Overall Study|Adverse Event|1|||
157079755|NCT00608868|567045538|FG000|Overall Study|Physician Decision|2|||
157079756|NCT00702962|567045539|FG000|Overall Study|Progressive disease|0|||
157079757|NCT00702962|567045540|FG001|Overall Study|Progressive disease|1|||
157079758|NCT00702962|567045539|FG000|Overall Study|Hospitalized for other health disorder|1|||
157079759|NCT00702962|567045540|FG001|Overall Study|Hospitalized for other health disorder|0|||
157079760|NCT01923467|567045544|FG000|Overall Study|Lost to Follow-up|62|||
157079761|NCT01923467|567045544|FG000|Overall Study|Subject non-interest|479|||
157079762|NCT01876901|567045545|FG000|Overall Study|Protocol Violation|10|||
157079763|NCT01876901|567045546|FG001|Overall Study|Protocol Violation|2|||
157079764|NCT01876901|567045545|FG000|Overall Study|No or other surgical intervention|7|||
157079765|NCT01876901|567045546|FG001|Overall Study|No or other surgical intervention|5|||
157079766|NCT01145898|567045547|FG000|3-year Treatment|medication change by treating physician|3|||
157079767|NCT01145898|567045548|FG001|3-year Treatment|medication change by treating physician|16|||
157079768|NCT00879775|567045549|FG000|Overall Study|Lost to Follow-up|2|||
157079769|NCT00879775|567045550|FG001|Overall Study|Lost to Follow-up|1|||
157079770|NCT02440425|567045551|FG000|Overall Study|Death likely due to disease progression|1|||
157079771|NCT02440425|567045551|FG000|Overall Study|Withdrawal by Subject|2|||
157079772|NCT02440425|567045551|FG000|Overall Study|Adverse Event|1|||
157079773|NCT02440425|567045551|FG000|Overall Study|Adverse Event/Ineligible|1|||
157079774|NCT03552523|567045557|FG000|Overall Study|Withdrawal by Subject|1|||
157079775|NCT03552523|567045558|FG001|Overall Study|Withdrawal by Subject|1|||
157079776|NCT04145700|567045559|FG000|Overall Study|Withdrawal by Subject|8|||
157079777|NCT04145700|567045560|FG001|Overall Study|Withdrawal by Subject|3|||
157079778|NCT00780559|567045561|FG000|Overall Study|Lost to Follow-up|2|||
157079779|NCT00780559|567045562|FG001|Overall Study|Lost to Follow-up|7|||
157079780|NCT00780559|567045561|FG000|Overall Study|Death|1|||
157079781|NCT00780559|567045562|FG001|Overall Study|Death|0|||
157079782|NCT01840410|567045564|FG000|Overall Study|Physician Decision|1|||
157079783|NCT01840410|567045565|FG001|Overall Study|Physician Decision|2|||
157079784|NCT01840410|567045564|FG000|Overall Study|Pregnancy|1|||
157079785|NCT01840410|567045565|FG001|Overall Study|Pregnancy|0|||
157079786|NCT01840410|567045564|FG000|Overall Study|Protocol deviation|1|||
157079787|NCT01840410|567045565|FG001|Overall Study|Protocol deviation|0|||
157079788|NCT01840410|567045564|FG000|Overall Study|Lost to Follow-up|1|||
157079789|NCT01840410|567045565|FG001|Overall Study|Lost to Follow-up|0|||
157079790|NCT01840410|567045564|FG000|Overall Study|Withdrawal by Subject|2|||
157079791|NCT01840410|567045565|FG001|Overall Study|Withdrawal by Subject|1|||
157079792|NCT01840410|567045564|FG000|Overall Study|Adverse Event|1|||
157079793|NCT01840410|567045565|FG001|Overall Study|Adverse Event|1|||
157079794|NCT00839956|567045566|FG000|Overall Study|Adverse Event|2|||
157079795|NCT00839956|567045566|FG000|Overall Study|Lack of Efficacy|6|||
157079796|NCT00839956|567045566|FG000|Overall Study|Physician Decision|1|||
157079797|NCT00839956|567045566|FG000|Overall Study|Withdrawal by Subject|3|||
157079798|NCT00594880|567045567|FG000|Overall Study|Withdrawal by Subject|1|||
157079799|NCT00594880|567045568|FG001|Overall Study|Withdrawal by Subject|1|||
157232184|NCT02653664|567596817|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
157232185|NCT02653664|567596818|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
157232186|NCT02653664|567596816|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
157079800|NCT00594880|567045567|FG000|Overall Study|Lost to Follow-up|1|||
157079801|NCT00594880|567045568|FG001|Overall Study|Lost to Follow-up|0|||
157079802|NCT02206061|567045569|FG000|Overall Study|Withdrawal by Subject|4|||
157079803|NCT02206061|567045570|FG001|Overall Study|Withdrawal by Subject|7|||
157079804|NCT02206061|567045571|FG002|Overall Study|Withdrawal by Subject|1|||
157079805|NCT02206061|567045569|FG000|Overall Study|Lost to Follow-up|14|||
157079806|NCT02206061|567045570|FG001|Overall Study|Lost to Follow-up|7|||
157079807|NCT02206061|567045571|FG002|Overall Study|Lost to Follow-up|20|||
157079808|NCT00694109|567045572|FG000|Overall Study|Physician Decision|3|||
157232187|NCT02653664|567596817|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
157079809|NCT00694109|567045572|FG000|Overall Study|Adverse Event|74|||
157079810|NCT00694109|567045572|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
157079811|NCT00694109|567045572|FG000|Overall Study|Lack of Efficacy|2|||
157079812|NCT00694109|567045572|FG000|Overall Study|Withdrawal by Subject|13|||
157079813|NCT00694109|567045572|FG000|Overall Study|Pregnancy|1|||
157079814|NCT00694109|567045572|FG000|Overall Study|Enrolled but not treated|1|||
157079815|NCT00694109|567045572|FG000|Overall Study|Other|2|||
157079816|NCT00694109|567045572|FG000|Overall Study|Consented but no additional treatment|3|||
157079817|NCT00846807|567045573|FG000|Overall Study|Adverse Event|270|||
157079818|NCT00846807|567045573|FG000|Overall Study|Lost to Follow-up|94|||
157079819|NCT00846807|567045573|FG000|Overall Study|Withdrawal by Subject|56|||
157079820|NCT00846807|567045573|FG000|Overall Study|Non compliant with European label|7|||
157079821|NCT00846807|567045573|FG000|Overall Study|Switch to other anticoagulants|89|||
157079822|NCT00846807|567045573|FG000|Overall Study|No prescription after hospital discharge|56|||
157079823|NCT00846807|567045573|FG000|Overall Study|Other|60|||
157079824|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
157079825|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
157079826|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
157079827|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
157079828|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
157079829|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
157079830|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
157079831|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
157079832|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
157232188|NCT02653664|567596818|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
157232189|NCT02653664|567596816|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
157232190|NCT02653664|567596817|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
157232191|NCT02653664|567596818|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
157232192|NCT04915755|567596821|FG000|Overall Study|Physician Decision|3|||
157232193|NCT04915755|567596822|FG001|Overall Study|Physician Decision|2|||
157232194|NCT04915755|567596821|FG000|Overall Study|Withdrawal by Subject|1|||
157232195|NCT04915755|567596822|FG001|Overall Study|Withdrawal by Subject|1|||
157232196|NCT04915755|567596821|FG000|Overall Study|Ongoing for PACT|3|||
157232197|NCT04915755|567596822|FG001|Overall Study|Ongoing for PACT|2|||
157232198|NCT04915755|567596821|FG000|Overall Study|Other|7|||
157232199|NCT04915755|567596822|FG001|Overall Study|Other|11|||
157232200|NCT03655106|567596824|FG000|Overall Study|Withdrawal by Subject|3|||
157232201|NCT03655106|567596825|FG001|Overall Study|Withdrawal by Subject|2|||
157232202|NCT03655106|567596824|FG000|Overall Study|Lost to Follow-up|2|||
157232203|NCT03655106|567596825|FG001|Overall Study|Lost to Follow-up|1|||
157232204|NCT03655106|567596824|FG000|Overall Study|Duplicate Enrollment|1|||
157232205|NCT03655106|567596825|FG001|Overall Study|Duplicate Enrollment|1|||
157232206|NCT03655106|567596824|FG000|Overall Study|Protocol Violation|3|||
157232207|NCT03655106|567596825|FG001|Overall Study|Protocol Violation|0|||
157232208|NCT00051025|567596831|FG000|Overall Study|Progressive Disease|1|||
157232209|NCT00051025|567596832|FG001|Overall Study|Progressive Disease|1|||
157232210|NCT00051025|567596831|FG000|Overall Study|Adverse Event|1|||
157232211|NCT00051025|567596832|FG001|Overall Study|Adverse Event|1|||
157232212|NCT00051025|567596831|FG000|Overall Study|Withdrawal by Subject|0|||
157232213|NCT00051025|567596832|FG001|Overall Study|Withdrawal by Subject|1|||
157232214|NCT00051025|567596831|FG000|Overall Study|Death|0|||
157232215|NCT00051025|567596832|FG001|Overall Study|Death|1|||
157232216|NCT01471093|567596835|FG000|Overall Study|Adverse Event|1|||
157232217|NCT01471093|567596836|FG001|Overall Study|Adverse Event|0|||
157232218|NCT01471093|567596837|FG002|Overall Study|Adverse Event|0|||
157079833|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
157192862|NCT02394028|567447217|FG002|Induction Phase|Lost to Follow-up|0|||
157192863|NCT02394028|567447218|FG003|Induction Phase|Lost to Follow-up|1|||
157192864|NCT02394028|567447219|FG004|Induction Phase|Lost to Follow-up|0|||
157192865|NCT02394028|567447220|FG005|Induction Phase|Lost to Follow-up|0|||
157192866|NCT02394028|567447221|FG006|Induction Phase|Lost to Follow-up|1|||
157192867|NCT02394028|567447222|FG007|Induction Phase|Lost to Follow-up|0|||
157192868|NCT02394028|567447223|FG008|Induction Phase|Lost to Follow-up|0|||
157192869|NCT02394028|567447224|FG009|Induction Phase|Lost to Follow-up|0|||
157192870|NCT02394028|567447225|FG010|Induction Phase|Lost to Follow-up|0|||
157192871|NCT02394028|567447215|FG000|Induction Phase|Non-compliance|0|||
157192872|NCT02394028|567447216|FG001|Induction Phase|Non-compliance|1|||
157192873|NCT02394028|567447217|FG002|Induction Phase|Non-compliance|3|||
157192874|NCT02394028|567447218|FG003|Induction Phase|Non-compliance|1|||
157192875|NCT02394028|567447219|FG004|Induction Phase|Non-compliance|3|||
157192876|NCT02394028|567447220|FG005|Induction Phase|Non-compliance|0|||
157192877|NCT02394028|567447221|FG006|Induction Phase|Non-compliance|1|||
157192878|NCT02394028|567447222|FG007|Induction Phase|Non-compliance|1|||
157192879|NCT02394028|567447223|FG008|Induction Phase|Non-compliance|0|||
157192880|NCT02394028|567447224|FG009|Induction Phase|Non-compliance|0|||
157192881|NCT02394028|567447225|FG010|Induction Phase|Non-compliance|0|||
157192882|NCT02394028|567447215|FG000|Induction Phase|Physician Decision|0|||
157192883|NCT02394028|567447216|FG001|Induction Phase|Physician Decision|0|||
157192884|NCT02394028|567447217|FG002|Induction Phase|Physician Decision|1|||
157192885|NCT02394028|567447218|FG003|Induction Phase|Physician Decision|4|||
157192886|NCT02394028|567447219|FG004|Induction Phase|Physician Decision|0|||
157192887|NCT02394028|567447220|FG005|Induction Phase|Physician Decision|2|||
157192888|NCT02394028|567447221|FG006|Induction Phase|Physician Decision|1|||
157192889|NCT02394028|567447222|FG007|Induction Phase|Physician Decision|0|||
157192890|NCT02394028|567447223|FG008|Induction Phase|Physician Decision|0|||
157232219|NCT01471093|567596838|FG003|Overall Study|Adverse Event|0|||
157232220|NCT00358449|567596839|FG000|Overall Study|Adverse Event|1|||
157232221|NCT00358449|567596840|FG001|Overall Study|Adverse Event|0|||
157232222|NCT00358449|567596841|FG002|Overall Study|Adverse Event|1|||
157232223|NCT00358449|567596839|FG000|Overall Study|Lost to Follow-up|1|||
157232224|NCT00358449|567596840|FG001|Overall Study|Lost to Follow-up|0|||
157232225|NCT00358449|567596841|FG002|Overall Study|Lost to Follow-up|0|||
157232226|NCT00358449|567596839|FG000|Overall Study|Withdrawal by Subject|2|||
157232227|NCT00358449|567596840|FG001|Overall Study|Withdrawal by Subject|0|||
157232228|NCT00358449|567596841|FG002|Overall Study|Withdrawal by Subject|0|||
157232229|NCT00358449|567596839|FG000|Overall Study|Lack of Efficacy|0|||
157232230|NCT00358449|567596840|FG001|Overall Study|Lack of Efficacy|1|||
157232231|NCT00358449|567596841|FG002|Overall Study|Lack of Efficacy|0|||
157232232|NCT00358449|567596839|FG000|Overall Study|Steriod Inhaler was Increased|0|||
157232233|NCT00358449|567596840|FG001|Overall Study|Steriod Inhaler was Increased|0|||
157232234|NCT00358449|567596841|FG002|Overall Study|Steriod Inhaler was Increased|1|||
157232235|NCT01804270|567596842|FG000|Overall Study|Withdrawal by Subject|1|||
157232236|NCT01804270|567596843|FG001|Overall Study|Withdrawal by Subject|1|||
157232237|NCT01367457|567596847|FG000|Overall Study|Death|2|||
157232238|NCT01367457|567596848|FG001|Overall Study|Death|0|||
157232239|NCT01367457|567596849|FG002|Overall Study|Death|0|||
157232240|NCT01367457|567596847|FG000|Overall Study|Investigator's decision|2|||
157232241|NCT01367457|567596848|FG001|Overall Study|Investigator's decision|0|||
157232242|NCT01367457|567596849|FG002|Overall Study|Investigator's decision|0|||
157232243|NCT01367457|567596847|FG000|Overall Study|Clinical decline (CD)|2|||
157232244|NCT01367457|567596848|FG001|Overall Study|Clinical decline (CD)|0|||
157232245|NCT01367457|567596849|FG002|Overall Study|Clinical decline (CD)|0|||
157232246|NCT01367457|567596847|FG000|Overall Study|Progression and death|8|||
157232247|NCT01367457|567596848|FG001|Overall Study|Progression and death|0|||
157232248|NCT01367457|567596849|FG002|Overall Study|Progression and death|0|||
157232249|NCT01367457|567596847|FG000|Overall Study|Toxicity|16|||
157232250|NCT01367457|567596848|FG001|Overall Study|Toxicity|0|||
157232251|NCT01367457|567596849|FG002|Overall Study|Toxicity|0|||
157232252|NCT01367457|567596847|FG000|Overall Study|Progression|137|||
157232253|NCT01367457|567596848|FG001|Overall Study|Progression|0|||
157232254|NCT01367457|567596849|FG002|Overall Study|Progression|0|||
157232255|NCT01367457|567596847|FG000|Overall Study|Patient asks for rest + slow progression|1|||
157232256|NCT01367457|567596848|FG001|Overall Study|Patient asks for rest + slow progression|0|||
157232257|NCT01367457|567596849|FG002|Overall Study|Patient asks for rest + slow progression|0|||
157232258|NCT01367457|567596847|FG000|Overall Study|Investigator's opinion, stable disease|1|||
157232259|NCT01367457|567596848|FG001|Overall Study|Investigator's opinion, stable disease|0|||
157232260|NCT01367457|567596849|FG002|Overall Study|Investigator's opinion, stable disease|0|||
157232261|NCT01367457|567596847|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
157232262|NCT01367457|567596848|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
157232263|NCT01367457|567596849|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
157232264|NCT01367457|567596847|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
157232265|NCT01367457|567596848|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
157232266|NCT01367457|567596849|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
157232267|NCT01367457|567596847|FG000|Overall Study|low grade toxicities + stable disease|1|||
157232268|NCT01367457|567596848|FG001|Overall Study|low grade toxicities + stable disease|0|||
157232269|NCT01367457|567596849|FG002|Overall Study|low grade toxicities + stable disease|0|||
157232270|NCT01367457|567596847|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
157232271|NCT01367457|567596848|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
157232272|NCT01367457|567596849|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
157232273|NCT01367457|567596847|FG000|Overall Study|Withdrawal by Subject|1|||
157232274|NCT01367457|567596848|FG001|Overall Study|Withdrawal by Subject|0|||
157232275|NCT01367457|567596849|FG002|Overall Study|Withdrawal by Subject|0|||
157232276|NCT01367457|567596847|FG000|Overall Study|CD, associated leukaemia|1|||
157232277|NCT01367457|567596848|FG001|Overall Study|CD, associated leukaemia|0|||
157232278|NCT01367457|567596849|FG002|Overall Study|CD, associated leukaemia|0|||
157232279|NCT01367457|567596847|FG000|Overall Study|Uncontrolled pain|1|||
157232280|NCT01367457|567596848|FG001|Overall Study|Uncontrolled pain|0|||
157232281|NCT01367457|567596849|FG002|Overall Study|Uncontrolled pain|0|||
157232282|NCT01367457|567596847|FG000|Overall Study|Overall status worsens to grade 4|1|||
157232283|NCT01367457|567596848|FG001|Overall Study|Overall status worsens to grade 4|0|||
157232284|NCT01367457|567596849|FG002|Overall Study|Overall status worsens to grade 4|0|||
157232285|NCT01367457|567596847|FG000|Overall Study|Stabilisation + frequent infections|1|||
157232286|NCT01367457|567596848|FG001|Overall Study|Stabilisation + frequent infections|0|||
157232287|NCT01367457|567596849|FG002|Overall Study|Stabilisation + frequent infections|0|||
157232288|NCT01367457|567596847|FG000|Overall Study|No clinical benefit|1|||
157232289|NCT01367457|567596848|FG001|Overall Study|No clinical benefit|0|||
157232290|NCT01367457|567596849|FG002|Overall Study|No clinical benefit|0|||
157232291|NCT01367457|567596847|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
157232292|NCT01367457|567596848|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
157232293|NCT01367457|567596849|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
157232294|NCT01367457|567596847|FG000|Overall Study|Overall decline|1|||
157232295|NCT01367457|567596848|FG001|Overall Study|Overall decline|0|||
157232296|NCT01367457|567596849|FG002|Overall Study|Overall decline|0|||
157232297|NCT01367457|567596847|FG000|Overall Study|Rejection of treatment|1|||
157232298|NCT01367457|567596848|FG001|Overall Study|Rejection of treatment|0|||
157232299|NCT01367457|567596849|FG002|Overall Study|Rejection of treatment|0|||
157232300|NCT01367457|567596847|FG000|Overall Study|Lost to Follow-up|1|||
157232301|NCT01367457|567596848|FG001|Overall Study|Lost to Follow-up|0|||
157232302|NCT01367457|567596849|FG002|Overall Study|Lost to Follow-up|0|||
157232303|NCT01367457|567596847|FG000|Overall Study|Death from septic shock|1|||
157232304|NCT01367457|567596848|FG001|Overall Study|Death from septic shock|0|||
157232305|NCT01367457|567596849|FG002|Overall Study|Death from septic shock|0|||
157232306|NCT01367457|567596847|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
157232307|NCT01367457|567596848|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
157232308|NCT01367457|567596849|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
157232309|NCT01367457|567596847|FG000|Overall Study|Patient's Wish|1|||
157232310|NCT01367457|567596848|FG001|Overall Study|Patient's Wish|0|||
157232311|NCT01367457|567596849|FG002|Overall Study|Patient's Wish|0|||
157232312|NCT01367457|567596847|FG000|Overall Study|Palliative. Overall decline|1|||
157232313|NCT01367457|567596848|FG001|Overall Study|Palliative. Overall decline|0|||
157232314|NCT01367457|567596849|FG002|Overall Study|Palliative. Overall decline|0|||
157232315|NCT01367457|567596847|FG000|Overall Study|Suspected DP/suspected active infection|1|||
157232316|NCT01367457|567596848|FG001|Overall Study|Suspected DP/suspected active infection|0|||
157232317|NCT01367457|567596849|FG002|Overall Study|Suspected DP/suspected active infection|0|||
157232318|NCT02188303|567596850|FG000|Overall Study|Adverse Event|0|||
157232319|NCT02188303|567596851|FG001|Overall Study|Adverse Event|0|||
157232320|NCT02188303|567596852|FG002|Overall Study|Adverse Event|0|||
157232321|NCT02188303|567596853|FG003|Overall Study|Adverse Event|0|||
157232322|NCT02188303|567596854|FG004|Overall Study|Adverse Event|0|||
157232323|NCT02188303|567596855|FG005|Overall Study|Adverse Event|2|||
157232324|NCT02188303|567596856|FG006|Overall Study|Adverse Event|0|||
157232325|NCT02188303|567596857|FG007|Overall Study|Adverse Event|2|||
157232326|NCT02188303|567596850|FG000|Overall Study|Dose Termination Criteria Met|0|||
157232327|NCT02188303|567596851|FG001|Overall Study|Dose Termination Criteria Met|0|||
157232328|NCT02188303|567596852|FG002|Overall Study|Dose Termination Criteria Met|0|||
157232329|NCT02188303|567596853|FG003|Overall Study|Dose Termination Criteria Met|0|||
157232330|NCT02188303|567596854|FG004|Overall Study|Dose Termination Criteria Met|0|||
157232331|NCT02188303|567596855|FG005|Overall Study|Dose Termination Criteria Met|0|||
157232332|NCT02188303|567596856|FG006|Overall Study|Dose Termination Criteria Met|2|||
157232333|NCT02188303|567596857|FG007|Overall Study|Dose Termination Criteria Met|4|||
157232334|NCT02334722|567596859|FG000|Overall Study|Lost to Follow-up|4|||
157232335|NCT02334722|567596860|FG001|Overall Study|Lost to Follow-up|0|||
157232336|NCT02334722|567596859|FG000|Overall Study|6 week questionnaire not completed|2|||
157232337|NCT02334722|567596860|FG001|Overall Study|6 week questionnaire not completed|0|||
157232338|NCT02334722|567596859|FG000|Overall Study|Unable to obtain medication|1|||
157232339|NCT02334722|567596860|FG001|Overall Study|Unable to obtain medication|1|||
157232340|NCT02334722|567596859|FG000|Overall Study|Withdrawal by Subject|0|||
157232341|NCT02334722|567596860|FG001|Overall Study|Withdrawal by Subject|3|||
157232342|NCT02334722|567596859|FG000|Overall Study|Adverse Event|0|||
157232343|NCT02334722|567596860|FG001|Overall Study|Adverse Event|2|||
157232344|NCT02334722|567596859|FG000|Overall Study|Physician Decision|0|||
157232345|NCT02334722|567596860|FG001|Overall Study|Physician Decision|1|||
157232346|NCT04000815|567596868|FG000|Overall Study|Lost to Follow-up|9|||
157232347|NCT04000815|567596869|FG001|Overall Study|Lost to Follow-up|2|||
157232348|NCT04000815|567596870|FG002|Overall Study|Lost to Follow-up|3|||
157232349|NCT04000815|567596868|FG000|Overall Study|Withdrawal by Subject|4|||
157232350|NCT04000815|567596869|FG001|Overall Study|Withdrawal by Subject|3|||
157232351|NCT04000815|567596870|FG002|Overall Study|Withdrawal by Subject|2|||
157232352|NCT04000815|567596868|FG000|Overall Study|Right ovarian cyst occured|1|||
157232353|NCT04000815|567596869|FG001|Overall Study|Right ovarian cyst occured|0|||
157232354|NCT04000815|567596870|FG002|Overall Study|Right ovarian cyst occured|0|||
157232355|NCT04000815|567596868|FG000|Overall Study|Hypertension occured on follow up|0|||
157232356|NCT04000815|567596869|FG001|Overall Study|Hypertension occured on follow up|0|||
157232357|NCT04000815|567596870|FG002|Overall Study|Hypertension occured on follow up|2|||
157232358|NCT00239577|567596871|FG000|Primary Phase|Adverse Event|0|||
157232359|NCT00239577|567596872|FG001|Primary Phase|Adverse Event|0|||
157232360|NCT00239577|567596873|FG002|Primary Phase|Adverse Event|1|||
157232361|NCT00239577|567596874|FG003|Primary Phase|Adverse Event|0|||
157232362|NCT00239577|567596871|FG000|Primary Phase|Other|5|||
157232363|NCT00239577|567596872|FG001|Primary Phase|Other|3|||
157232364|NCT00239577|567596873|FG002|Primary Phase|Other|2|||
157232365|NCT00239577|567596874|FG003|Primary Phase|Other|0|||
157232366|NCT01391793|567596875|FG000|Overall Study|Ineligible|3|||
157232367|NCT01391793|567596876|FG001|Overall Study|Ineligible|0|||
157232368|NCT01391793|567596875|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
157232369|NCT01391793|567596876|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
157232370|NCT01391793|567596875|FG000|Overall Study|No DMSA|73|||
157232371|NCT01391793|567596876|FG001|Overall Study|No DMSA|57|||
157232372|NCT01666730|567596879|FG000|Overall Study|Adverse Event|16|||
157232373|NCT01666730|567596879|FG000|Overall Study|Death|2|||
157232374|NCT01666730|567596879|FG000|Overall Study|Physician Decision|5|||
157232375|NCT01666730|567596879|FG000|Overall Study|Withdrawal by Subject|9|||
157232376|NCT01666730|567596879|FG000|Overall Study|Disease progression/relapse|18|||
157232377|NCT01449630|567596880|FG000|Period 1|Physician Decision|1|||
157232378|NCT01449630|567596881|FG001|Period 1|Physician Decision|0|||
157232379|NCT01449630|567596882|FG002|Period 1|Physician Decision|0|||
157232380|NCT01449630|567596883|FG003|Period 1|Physician Decision|1|||
157232381|NCT01449630|567596884|FG004|Period 1|Physician Decision|0|||
157232382|NCT01449630|567596885|FG005|Period 1|Physician Decision|0|||
157232383|NCT01449630|567596886|FG006|Period 1|Physician Decision|0|||
157232384|NCT01449630|567596887|FG007|Period 1|Physician Decision|0|||
157232385|NCT01449630|567596888|FG008|Period 1|Physician Decision|0|||
157232386|NCT01449630|567596880|FG000|Period 1|Sponsor Decision|0|||
157232387|NCT01449630|567596881|FG001|Period 1|Sponsor Decision|0|||
157232388|NCT01449630|567596882|FG002|Period 1|Sponsor Decision|0|||
157232389|NCT01449630|567596883|FG003|Period 1|Sponsor Decision|0|||
157232390|NCT01449630|567596884|FG004|Period 1|Sponsor Decision|0|||
157232391|NCT01449630|567596885|FG005|Period 1|Sponsor Decision|1|||
157232392|NCT01449630|567596886|FG006|Period 1|Sponsor Decision|0|||
157232393|NCT01449630|567596887|FG007|Period 1|Sponsor Decision|0|||
157232394|NCT01449630|567596888|FG008|Period 1|Sponsor Decision|0|||
157232395|NCT01449630|567596880|FG000|Period 2|Sponsor Decision|0|||
157232396|NCT01449630|567596881|FG001|Period 2|Sponsor Decision|0|||
157232397|NCT01449630|567596882|FG002|Period 2|Sponsor Decision|0|||
157232398|NCT01449630|567596883|FG003|Period 2|Sponsor Decision|0|||
157232399|NCT01449630|567596884|FG004|Period 2|Sponsor Decision|0|||
157232400|NCT01449630|567596885|FG005|Period 2|Sponsor Decision|0|||
157232401|NCT01449630|567596886|FG006|Period 2|Sponsor Decision|1|||
157232402|NCT01449630|567596887|FG007|Period 2|Sponsor Decision|0|||
157232403|NCT01449630|567596888|FG008|Period 2|Sponsor Decision|0|||
157232404|NCT03340727|567596889|FG000|Overall Study|Death|1|||
157232405|NCT03340727|567596890|FG001|Overall Study|Death|0|||
157232406|NCT03340727|567596889|FG000|Overall Study|Lost to Follow-up|31|||
157232407|NCT03340727|567596890|FG001|Overall Study|Lost to Follow-up|35|||
157232408|NCT03340727|567596889|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
157232409|NCT03340727|567596890|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
157232410|NCT03340727|567596889|FG000|Overall Study|Transferred to another facility|10|||
157232411|NCT03340727|567596890|FG001|Overall Study|Transferred to another facility|7|||
157232412|NCT03340727|567596889|FG000|Overall Study|Withdrawal by Subject|28|||
157232413|NCT03340727|567596890|FG001|Overall Study|Withdrawal by Subject|17|||
157232414|NCT03553823|567596891|FG000|Overall Study|Physician Decision|0|||
157232415|NCT03553823|567596892|FG001|Overall Study|Physician Decision|1|||
157232416|NCT01720264|567596893|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
157232417|NCT01720264|567596893|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
157232418|NCT01720264|567596893|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
157232419|NCT01873586|567596894|FG000|Overall Study|Lost to Follow-up|3|||
157232420|NCT00282048|567596895|FG000|Overall Study|Lack of Efficacy|30|||
157232421|NCT00282048|567596895|FG000|Overall Study|Adverse Event|22|||
157232422|NCT00282048|567596895|FG000|Overall Study|Withdrawal by Subject|1|||
157232423|NCT00282048|567596895|FG000|Overall Study|Other|8|||
157232424|NCT00282048|567596895|FG000|Overall Study|Ongoing|1|||
157232425|NCT03522675|567596897|FG000|Overall Study|Screen fail|1|||
157232426|NCT03522675|567596897|FG000|Overall Study|Non-reactive to histamine|1|||
157232427|NCT02674477|567596898|FG000|Overall Study|Protocol Violation|8|||
157232428|NCT02674477|567596899|FG001|Overall Study|Protocol Violation|2|||
157232429|NCT02549092|567596903|FG000|Treatment Period|Adverse Event|2|||
157232430|NCT02549092|567596904|FG001|Treatment Period|Adverse Event|2|||
157232431|NCT02549092|567596903|FG000|Treatment Period|Withdrawal by Subject|1|||
157232432|NCT02549092|567596904|FG001|Treatment Period|Withdrawal by Subject|3|||
157232433|NCT02549092|567596903|FG000|Treatment Period|Lack of Efficacy|0|||
157232434|NCT02549092|567596904|FG001|Treatment Period|Lack of Efficacy|2|||
157232435|NCT02549092|567596903|FG000|Extension/Transition Period|Adverse Event|1|||
157232436|NCT02549092|567596904|FG001|Extension/Transition Period|Adverse Event|1|||
157232437|NCT02549092|567596903|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
157232438|NCT02549092|567596904|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
157232439|NCT02549092|567596903|FG000|Extension/Transition Period|Other, Not Specified|4|||
157232440|NCT02549092|567596904|FG001|Extension/Transition Period|Other, Not Specified|2|||
157232441|NCT03002077|567596911|FG000|Overall Study|Non-compliance with Study Drug|4|||
157232442|NCT03002077|567596911|FG000|Overall Study|Non-compliance w/Background ADT|1|||
157232443|NCT03002077|567596911|FG000|Overall Study|Study Terminated by Sponsor|257|||
157232444|NCT03002077|567596911|FG000|Overall Study|Site Terminated by Sponsor|5|||
157232445|NCT03002077|567596911|FG000|Overall Study|Miscellaneous Reasons|10|||
157232446|NCT03002077|567596911|FG000|Overall Study|Adverse Event|23|||
157232447|NCT03002077|567596911|FG000|Overall Study|Lack of Efficacy|20|||
157232448|NCT03002077|567596911|FG000|Overall Study|Withdrawal by Subject|72|||
157232449|NCT03002077|567596911|FG000|Overall Study|Lost to Follow-up|21|||
157232450|NCT03002077|567596911|FG000|Overall Study|Pregnancy|4|||
157232451|NCT03002077|567596911|FG000|Overall Study|Protocol Violation|21|||
157232452|NCT01173692|567596914|FG000|Overall Study|Adverse Event|1|||
157232453|NCT01173692|567596915|FG001|Overall Study|Adverse Event|2|||
157232454|NCT01173692|567596914|FG000|Overall Study|Withdrawal by Subject|1|||
157232455|NCT01173692|567596915|FG001|Overall Study|Withdrawal by Subject|3|||
157232456|NCT04625114|567596918|FG000|Overall Study|Adverse Event|3|||
157232457|NCT04625114|567596919|FG001|Overall Study|Adverse Event|1|||
157232458|NCT04625114|567596918|FG000|Overall Study|Withdrawal by Subject|2|||
157232459|NCT04625114|567596919|FG001|Overall Study|Withdrawal by Subject|0|||
157232460|NCT01390844|567596922|FG000|Treatment Phase|Adverse Event|12|||
157232461|NCT01390844|567596923|FG001|Treatment Phase|Adverse Event|2|||
157232462|NCT01390844|567596924|FG002|Treatment Phase|Adverse Event|3|||
157232463|NCT01390844|567596925|FG003|Treatment Phase|Adverse Event|2|||
157232464|NCT01390844|567596922|FG000|Treatment Phase|Treatment Failure|23|||
157232465|NCT01390844|567596923|FG001|Treatment Phase|Treatment Failure|25|||
157232466|NCT01390844|567596924|FG002|Treatment Phase|Treatment Failure|10|||
157232467|NCT01390844|567596925|FG003|Treatment Phase|Treatment Failure|13|||
157232468|NCT01390844|567596922|FG000|Treatment Phase|Non-Medical Reasons|5|||
157232469|NCT01390844|567596923|FG001|Treatment Phase|Non-Medical Reasons|1|||
157232470|NCT01390844|567596924|FG002|Treatment Phase|Non-Medical Reasons|8|||
157232471|NCT01390844|567596925|FG003|Treatment Phase|Non-Medical Reasons|1|||
157232472|NCT01390844|567596922|FG000|Treatment Phase|Non-GCP Compliant|0|||
157232473|NCT01390844|567596923|FG001|Treatment Phase|Non-GCP Compliant|0|||
157232474|NCT01390844|567596924|FG002|Treatment Phase|Non-GCP Compliant|10|||
157232475|NCT01390844|567596925|FG003|Treatment Phase|Non-GCP Compliant|3|||
157232476|NCT01390844|567596922|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
157232477|NCT01390844|567596923|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
157232478|NCT01390844|567596924|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
157232479|NCT01390844|567596925|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
157232480|NCT03048500|567596928|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
157232481|NCT03048500|567596928|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
157232482|NCT03048500|567596928|FG000|Reached 1st Response/Continued Treatment|Death|1|||
157232483|NCT03048500|567596928|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
157232484|NCT03048500|567596928|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
157232485|NCT03048500|567596928|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
157232486|NCT03048500|567596928|FG000|Follow up for 3 Years|Death|12|||
157232487|NCT01479439|567596931|FG000|Overall Study|Adverse Event|1|||
157192891|NCT02394028|567447224|FG009|Induction Phase|Physician Decision|0|||
157192892|NCT02394028|567447225|FG010|Induction Phase|Physician Decision|0|||
157192893|NCT02394028|567447215|FG000|Induction Phase|Protocol Violation|0|||
157192894|NCT02394028|567447216|FG001|Induction Phase|Protocol Violation|2|||
157192895|NCT02394028|567447217|FG002|Induction Phase|Protocol Violation|0|||
157192896|NCT02394028|567447218|FG003|Induction Phase|Protocol Violation|3|||
157192897|NCT02394028|567447219|FG004|Induction Phase|Protocol Violation|0|||
157192898|NCT02394028|567447220|FG005|Induction Phase|Protocol Violation|1|||
157192899|NCT02394028|567447221|FG006|Induction Phase|Protocol Violation|1|||
157192900|NCT02394028|567447222|FG007|Induction Phase|Protocol Violation|0|||
157192901|NCT02394028|567447223|FG008|Induction Phase|Protocol Violation|0|||
157192902|NCT02394028|567447224|FG009|Induction Phase|Protocol Violation|0|||
157192903|NCT02394028|567447225|FG010|Induction Phase|Protocol Violation|0|||
157192904|NCT02394028|567447215|FG000|Induction Phase|Withdrawal by Subject|1|||
157192905|NCT02394028|567447216|FG001|Induction Phase|Withdrawal by Subject|2|||
157192906|NCT02394028|567447217|FG002|Induction Phase|Withdrawal by Subject|4|||
157192907|NCT02394028|567447218|FG003|Induction Phase|Withdrawal by Subject|6|||
157192908|NCT02394028|567447219|FG004|Induction Phase|Withdrawal by Subject|7|||
157192909|NCT02394028|567447220|FG005|Induction Phase|Withdrawal by Subject|4|||
157192910|NCT02394028|567447221|FG006|Induction Phase|Withdrawal by Subject|3|||
157192911|NCT02394028|567447222|FG007|Induction Phase|Withdrawal by Subject|6|||
157192912|NCT02394028|567447223|FG008|Induction Phase|Withdrawal by Subject|0|||
157192913|NCT02394028|567447224|FG009|Induction Phase|Withdrawal by Subject|0|||
157192914|NCT02394028|567447225|FG010|Induction Phase|Withdrawal by Subject|0|||
157192915|NCT02394028|567447215|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192916|NCT02394028|567447216|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192917|NCT02394028|567447217|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192918|NCT02394028|567447218|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192919|NCT02394028|567447219|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192920|NCT02394028|567447220|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192921|NCT02394028|567447221|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
157232488|NCT01479439|567596932|FG001|Overall Study|Adverse Event|0|||
157232489|NCT01479439|567596933|FG002|Overall Study|Adverse Event|0|||
157232490|NCT01479439|567596931|FG000|Overall Study|Lost to Follow-up|0|||
157232491|NCT01479439|567596932|FG001|Overall Study|Lost to Follow-up|1|||
157232492|NCT01479439|567596933|FG002|Overall Study|Lost to Follow-up|0|||
157232493|NCT01479439|567596931|FG000|Overall Study|Protocol Violation|0|||
157192922|NCT02394028|567447222|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192923|NCT02394028|567447223|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192924|NCT02394028|567447224|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
157232494|NCT01479439|567596932|FG001|Overall Study|Protocol Violation|0|||
157232495|NCT01479439|567596933|FG002|Overall Study|Protocol Violation|2|||
157232496|NCT03018249|567596935|FG000|Overall Study|Withdrawal by Subject|2|||
157232497|NCT03018249|567596936|FG001|Overall Study|Withdrawal by Subject|2|||
157232498|NCT02507375|567596939|FG000|Overall Study|Progressive Disease|4|||
157079834|NCT00245960|567045574|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
157232499|NCT02507375|567596940|FG001|Overall Study|Progressive Disease|5|||
157232500|NCT02507375|567596939|FG000|Overall Study|Death|0|||
157232501|NCT02507375|567596940|FG001|Overall Study|Death|1|||
157232502|NCT02507375|567596939|FG000|Overall Study|Refused treatment|0|||
157232503|NCT02507375|567596940|FG001|Overall Study|Refused treatment|1|||
157232504|NCT02507375|567596939|FG000|Overall Study|Adverse Event|0|||
157232505|NCT02507375|567596940|FG001|Overall Study|Adverse Event|1|||
157232506|NCT02158936|567596941|FG000|Overall Study|Study closed/ terminated|57|||
157232507|NCT02158936|567596942|FG001|Overall Study|Study closed/ terminated|77|||
157232508|NCT02158936|567596941|FG000|Overall Study|Azacitidine tx discontinued|53|||
157232509|NCT02158936|567596942|FG001|Overall Study|Azacitidine tx discontinued|46|||
157232510|NCT02158936|567596941|FG000|Overall Study|Adverse Event|39|||
157232511|NCT02158936|567596942|FG001|Overall Study|Adverse Event|24|||
157232512|NCT02158936|567596941|FG000|Overall Study|Withdrawal by Subject|15|||
157232513|NCT02158936|567596942|FG001|Overall Study|Withdrawal by Subject|16|||
157232514|NCT02158936|567596941|FG000|Overall Study|Physician Decision|15|||
157232515|NCT02158936|567596942|FG001|Overall Study|Physician Decision|13|||
157232516|NCT02158936|567596941|FG000|Overall Study|Lost to Follow-up|0|||
157232517|NCT02158936|567596942|FG001|Overall Study|Lost to Follow-up|1|||
157232518|NCT00522457|567596943|FG000|Overall Study|Due to disease progression|16|||
157232519|NCT00522457|567596943|FG000|Overall Study|Adverse Event|2|||
157232520|NCT01215981|567598986|FG000|Overall Study|Physician Decision|0|||
157232521|NCT01215981|567598987|FG001|Overall Study|Physician Decision|1|||
157232522|NCT01215981|567598986|FG000|Overall Study|Protocol Violation|1|||
157232523|NCT01215981|567598987|FG001|Overall Study|Protocol Violation|0|||
157232524|NCT01215981|567598986|FG000|Overall Study|Withdrawal by Subject|1|||
157232525|NCT01215981|567598987|FG001|Overall Study|Withdrawal by Subject|0|||
157232526|NCT04657770|567598988|FG000|Overall Study|Withdrawal by Subject|3|||
157232527|NCT04657770|567598988|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
157232528|NCT00727571|567598990|FG000|Overall Study|Ineligibility determined|1|||
157232529|NCT00727571|567598991|FG001|Overall Study|Ineligibility determined|1|||
157232530|NCT00727571|567598992|FG002|Overall Study|Ineligibility determined|1|||
157232531|NCT00727571|567598993|FG003|Overall Study|Ineligibility determined|0|||
157232532|NCT00727571|567598990|FG000|Overall Study|Death|0|||
157232533|NCT00727571|567598991|FG001|Overall Study|Death|19|||
157232534|NCT00727571|567598992|FG002|Overall Study|Death|5|||
157232535|NCT00727571|567598993|FG003|Overall Study|Death|1|||
157232536|NCT00727571|567598990|FG000|Overall Study|Physician Decision|0|||
157232537|NCT00727571|567598991|FG001|Overall Study|Physician Decision|5|||
157232538|NCT00727571|567598992|FG002|Overall Study|Physician Decision|0|||
157232539|NCT00727571|567598993|FG003|Overall Study|Physician Decision|0|||
157232540|NCT00727571|567598990|FG000|Overall Study|Withdrawal by Subject|0|||
157232541|NCT00727571|567598991|FG001|Overall Study|Withdrawal by Subject|10|||
157232542|NCT00727571|567598992|FG002|Overall Study|Withdrawal by Subject|11|||
157232543|NCT00727571|567598993|FG003|Overall Study|Withdrawal by Subject|0|||
157232544|NCT00727571|567598990|FG000|Overall Study|Subject Non Compliance|0|||
157232545|NCT00727571|567598991|FG001|Overall Study|Subject Non Compliance|6|||
157232546|NCT00727571|567598992|FG002|Overall Study|Subject Non Compliance|0|||
157232547|NCT00727571|567598993|FG003|Overall Study|Subject Non Compliance|4|||
157232548|NCT00727571|567598990|FG000|Overall Study|Dismissed from nursing home|0|||
157232549|NCT00727571|567598991|FG001|Overall Study|Dismissed from nursing home|9|||
157232550|NCT00727571|567598992|FG002|Overall Study|Dismissed from nursing home|5|||
157232551|NCT00727571|567598993|FG003|Overall Study|Dismissed from nursing home|0|||
157232552|NCT00727571|567598990|FG000|Overall Study|Hospitalization|0|||
157232553|NCT00727571|567598991|FG001|Overall Study|Hospitalization|1|||
157232554|NCT00727571|567598992|FG002|Overall Study|Hospitalization|0|||
157232555|NCT00727571|567598993|FG003|Overall Study|Hospitalization|1|||
157232556|NCT00727571|567598990|FG000|Overall Study|AE not leading to hospitalization|0|||
157079835|NCT00245960|567045575|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
157079836|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
157079837|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
157232557|NCT00727571|567598991|FG001|Overall Study|AE not leading to hospitalization|0|||
157079838|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
157232558|NCT00727571|567598992|FG002|Overall Study|AE not leading to hospitalization|2|||
157232559|NCT00727571|567598993|FG003|Overall Study|AE not leading to hospitalization|0|||
157232560|NCT00727571|567598990|FG000|Overall Study|Other|0|||
157079839|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
157232561|NCT00727571|567598991|FG001|Overall Study|Other|4|||
157232562|NCT00727571|567598992|FG002|Overall Study|Other|6|||
157232563|NCT00727571|567598993|FG003|Overall Study|Other|0|||
157232564|NCT01710657|567598994|FG000|Overall Study|Lost to Follow-up|2|||
157079840|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
157079841|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
157079842|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
157079843|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
157079844|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
157079845|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
157079846|NCT00245960|567045574|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
157079847|NCT00245960|567045575|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
157079848|NCT00737698|567045576|FG000|Overall Study|Withdrawal by Subject|6|||
157079849|NCT00737698|567045577|FG001|Overall Study|Withdrawal by Subject|5|||
157079850|NCT00737698|567045578|FG002|Overall Study|Withdrawal by Subject|3|||
157079851|NCT00737698|567045576|FG000|Overall Study|Death|0|||
157079852|NCT00737698|567045577|FG001|Overall Study|Death|0|||
157079853|NCT00737698|567045578|FG002|Overall Study|Death|1|||
157079854|NCT02833077|567045585|FG000|Overall Study|Adverse Event|1|||
157079855|NCT02833077|567045586|FG001|Overall Study|Adverse Event|2|||
157079856|NCT02833077|567045585|FG000|Overall Study|Lost to Follow-up|10|||
157079857|NCT02833077|567045586|FG001|Overall Study|Lost to Follow-up|1|||
157079858|NCT02833077|567045585|FG000|Overall Study|Personal Reasons|6|||
157079859|NCT02833077|567045586|FG001|Overall Study|Personal Reasons|4|||
157079860|NCT02833077|567045585|FG000|Overall Study|Protocol Deviation|0|||
157079861|NCT02833077|567045586|FG001|Overall Study|Protocol Deviation|1|||
157079862|NCT04958200|567045587|FG000|Overall Study|Withdrawal by Subject|0|||
157079863|NCT04958200|567045588|FG001|Overall Study|Withdrawal by Subject|2|||
157079864|NCT04958200|567045587|FG000|Overall Study|Lost to Follow-up|3|||
157079865|NCT04958200|567045588|FG001|Overall Study|Lost to Follow-up|2|||
157079866|NCT00316017|567045591|FG000|Overall Study|Protocol Violation|11|||
157079867|NCT00316017|567045592|FG001|Overall Study|Protocol Violation|13|||
157079868|NCT00316017|567045593|FG002|Overall Study|Protocol Violation|19|||
157079869|NCT04157400|567045594|FG000|Overall Study|Withdrawal by Subject|1|||
157079870|NCT04157400|567045594|FG000|Overall Study|Lost to Follow-up|3|||
157079871|NCT03852719|567045596|FG000|Overall Study|Withdrawal of consent|8|||
157079872|NCT03852719|567045597|FG001|Overall Study|Withdrawal of consent|8|||
157079873|NCT03852719|567045598|FG002|Overall Study|Withdrawal of consent|9|||
157079874|NCT03852719|567045596|FG000|Overall Study|Physician Decision|5|||
157079875|NCT03852719|567045597|FG001|Overall Study|Physician Decision|4|||
157079876|NCT03852719|567045598|FG002|Overall Study|Physician Decision|1|||
157079877|NCT03852719|567045596|FG000|Overall Study|Pregnancy|2|||
157079878|NCT03852719|567045597|FG001|Overall Study|Pregnancy|1|||
157079879|NCT03852719|567045598|FG002|Overall Study|Pregnancy|0|||
157079880|NCT03852719|567045596|FG000|Overall Study|Death|1|||
157079881|NCT03852719|567045597|FG001|Overall Study|Death|0|||
157079882|NCT03852719|567045598|FG002|Overall Study|Death|0|||
157079883|NCT03852719|567045596|FG000|Overall Study|Reason not Specified|3|||
157079884|NCT03852719|567045597|FG001|Overall Study|Reason not Specified|3|||
157079885|NCT03852719|567045598|FG002|Overall Study|Reason not Specified|5|||
157079886|NCT03852719|567045596|FG000|Overall Study|Adverse Event|2|||
157079887|NCT03852719|567045597|FG001|Overall Study|Adverse Event|1|||
157079888|NCT03852719|567045598|FG002|Overall Study|Adverse Event|4|||
157079889|NCT03852719|567045596|FG000|Overall Study|Progressive disease|1|||
157079890|NCT03852719|567045597|FG001|Overall Study|Progressive disease|4|||
157079891|NCT03852719|567045598|FG002|Overall Study|Progressive disease|1|||
157079892|NCT03852719|567045596|FG000|Overall Study|Lost to Follow-up|1|||
157079893|NCT03852719|567045597|FG001|Overall Study|Lost to Follow-up|0|||
157079894|NCT03852719|567045598|FG002|Overall Study|Lost to Follow-up|0|||
157079895|NCT04201262|567045599|FG000|Primary Treatment Period|Adverse Event|1|||
157079896|NCT04201262|567045600|FG001|Primary Treatment Period|Adverse Event|2|||
157079897|NCT04201262|567045599|FG000|Primary Treatment Period|Physician Decision|1|||
157079898|NCT04201262|567045600|FG001|Primary Treatment Period|Physician Decision|1|||
157079899|NCT04201262|567045599|FG000|Long-term Extension Period|Death|1|||
157079900|NCT04201262|567045600|FG001|Long-term Extension Period|Death|0|||
157079901|NCT01647542|567045601|FG000|Overall Study|Major Protocol Deviation|1|||
157079902|NCT01647542|567045602|FG001|Overall Study|Major Protocol Deviation|0|||
157079903|NCT01647542|567045603|FG002|Overall Study|Major Protocol Deviation|0|||
157079904|NCT01647542|567045601|FG000|Overall Study|Adverse Event|4|||
157079905|NCT01647542|567045602|FG001|Overall Study|Adverse Event|5|||
157079906|NCT01647542|567045603|FG002|Overall Study|Adverse Event|4|||
157079907|NCT01647542|567045601|FG000|Overall Study|Lost to Follow-up|0|||
157079908|NCT01647542|567045602|FG001|Overall Study|Lost to Follow-up|2|||
157079909|NCT01647542|567045603|FG002|Overall Study|Lost to Follow-up|2|||
157079910|NCT01647542|567045601|FG000|Overall Study|Withdrawal by Subject|6|||
157079911|NCT01647542|567045602|FG001|Overall Study|Withdrawal by Subject|4|||
157079912|NCT01647542|567045603|FG002|Overall Study|Withdrawal by Subject|0|||
157079913|NCT01647542|567045601|FG000|Overall Study|Study Termination|64|||
157079914|NCT01647542|567045602|FG001|Overall Study|Study Termination|61|||
157079915|NCT01647542|567045603|FG002|Overall Study|Study Termination|65|||
157079916|NCT01647542|567045601|FG000|Overall Study|Lack of Efficacy|1|||
157079917|NCT01647542|567045602|FG001|Overall Study|Lack of Efficacy|1|||
157079918|NCT01647542|567045603|FG002|Overall Study|Lack of Efficacy|0|||
157079919|NCT01647542|567045601|FG000|Overall Study|Death|0|||
157079920|NCT01647542|567045602|FG001|Overall Study|Death|0|||
157079921|NCT01647542|567045603|FG002|Overall Study|Death|1|||
157079922|NCT03682185|567045607|FG000|Overall Study|Lost to Follow-up|4|||
157079923|NCT03682185|567045608|FG001|Overall Study|Lost to Follow-up|7|||
157079924|NCT03682185|567045609|FG002|Overall Study|Lost to Follow-up|4|||
157079925|NCT03682185|567045610|FG003|Overall Study|Lost to Follow-up|7|||
157079926|NCT03682185|567045611|FG004|Overall Study|Lost to Follow-up|1|||
157079927|NCT03682185|567045607|FG000|Overall Study|Withdrawal by Subject|7|||
157079928|NCT03682185|567045608|FG001|Overall Study|Withdrawal by Subject|3|||
157079929|NCT03682185|567045609|FG002|Overall Study|Withdrawal by Subject|7|||
157079930|NCT03682185|567045610|FG003|Overall Study|Withdrawal by Subject|3|||
157079931|NCT03682185|567045611|FG004|Overall Study|Withdrawal by Subject|0|||
157079932|NCT02397447|567045613|FG000|Overall Study|Lost to Follow-up|2|||
157079933|NCT02397447|567045614|FG001|Overall Study|Lost to Follow-up|2|||
157079934|NCT06926673|567045617|FG000|Overall Study|Lost to Follow-up|0|||
157079935|NCT06926673|567045618|FG001|Overall Study|Lost to Follow-up|0|||
157079936|NCT06926673|567045619|FG002|Overall Study|Lost to Follow-up|0|||
157079937|NCT06926673|567045620|FG003|Overall Study|Lost to Follow-up|1|||
157079938|NCT06926673|567045621|FG004|Overall Study|Lost to Follow-up|0|||
157079939|NCT06926673|567045622|FG005|Overall Study|Lost to Follow-up|0|||
157079940|NCT06926673|567045623|FG006|Overall Study|Lost to Follow-up|0|||
157079941|NCT06926673|567045617|FG000|Overall Study|Physician Decision|0|||
157079942|NCT06926673|567045618|FG001|Overall Study|Physician Decision|0|||
157079943|NCT06926673|567045619|FG002|Overall Study|Physician Decision|0|||
157079944|NCT06926673|567045620|FG003|Overall Study|Physician Decision|0|||
157079945|NCT06926673|567045621|FG004|Overall Study|Physician Decision|0|||
157079946|NCT06926673|567045622|FG005|Overall Study|Physician Decision|0|||
157079947|NCT06926673|567045623|FG006|Overall Study|Physician Decision|1|||
157079948|NCT06926673|567045617|FG000|Overall Study|Withdrawal by Subject|0|||
157079949|NCT06926673|567045618|FG001|Overall Study|Withdrawal by Subject|3|||
157079950|NCT06926673|567045619|FG002|Overall Study|Withdrawal by Subject|2|||
157079951|NCT06926673|567045620|FG003|Overall Study|Withdrawal by Subject|1|||
157079952|NCT06926673|567045621|FG004|Overall Study|Withdrawal by Subject|0|||
157079953|NCT06926673|567045622|FG005|Overall Study|Withdrawal by Subject|2|||
157079954|NCT06926673|567045623|FG006|Overall Study|Withdrawal by Subject|0|||
157079955|NCT05718466|567046613|FG000|Overall Study|Withdrawal by Subject|1|||
157079956|NCT05718466|567046614|FG001|Overall Study|Withdrawal by Subject|2|||
157079957|NCT05718466|567046613|FG000|Overall Study|Death|0|||
157079958|NCT05718466|567046614|FG001|Overall Study|Death|1|||
157079959|NCT02389452|567046620|FG000|Overall Study|Lost to Follow-up|13|||
157079960|NCT02389452|567046620|FG000|Overall Study|Adverse Event|1|||
157079961|NCT02389452|567046620|FG000|Overall Study|Withdrawal by Subject|5|||
157079962|NCT02389452|567046620|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
157079963|NCT01014208|567046626|FG000|Overall Study|Lost to Follow-up|2|||
157079964|NCT01014208|567046627|FG001|Overall Study|Lost to Follow-up|5|||
157079965|NCT01014208|567046626|FG000|Overall Study|Participant Withdrew Consent|12|||
157079966|NCT01014208|567046627|FG001|Overall Study|Participant Withdrew Consent|12|||
157079967|NCT01014208|567046626|FG000|Overall Study|Did Not Receive Study Drug|2|||
157079968|NCT01014208|567046627|FG001|Overall Study|Did Not Receive Study Drug|0|||
157079969|NCT01014208|567046626|FG000|Overall Study|Study Closed/terminated|78|||
157079970|NCT01014208|567046627|FG001|Overall Study|Study Closed/terminated|83|||
157079971|NCT00414908|567046628|FG000|Overall Study|Protocol Violation|1|||
157079972|NCT00414908|567046629|FG001|Overall Study|Protocol Violation|1|||
157079973|NCT01076153|567046630|FG000|Overall Study|Symptoms improved/resolved|10|||
157079974|NCT01076153|567046630|FG000|Overall Study|Adverse Event|1|||
157079975|NCT00667225|567046633|FG000|Overall Study|Subject had no more lesions to treat.|1|||
157079976|NCT00667225|567046634|FG001|Overall Study|Subject had no more lesions to treat.|0|||
157079977|NCT00667225|567046633|FG000|Overall Study|Lost to Follow-up|0|||
157079978|NCT00667225|567046634|FG001|Overall Study|Lost to Follow-up|1|||
157079979|NCT03563157|567046639|FG000|Overall Study|Progressive Disease|2|||
157079980|NCT01283152|567046642|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
157079981|NCT01283152|567046643|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
157079982|NCT01283152|567046642|FG000|Overall Study|Refused HESA|1|||
157079983|NCT01283152|567046643|FG001|Overall Study|Refused HESA|0|||
157079984|NCT00567567|567046644|FG000|Overall Study|Adverse Event|0|||
157192925|NCT02394028|567447225|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
157192926|NCT02394028|567447215|FG000|Induction Phase|Sponsor decision|0|||
157192927|NCT02394028|567447216|FG001|Induction Phase|Sponsor decision|1|||
157192928|NCT02394028|567447217|FG002|Induction Phase|Sponsor decision|2|||
157192929|NCT02394028|567447218|FG003|Induction Phase|Sponsor decision|0|||
157192930|NCT02394028|567447219|FG004|Induction Phase|Sponsor decision|0|||
157192931|NCT02394028|567447220|FG005|Induction Phase|Sponsor decision|0|||
157192932|NCT02394028|567447221|FG006|Induction Phase|Sponsor decision|0|||
157192933|NCT02394028|567447222|FG007|Induction Phase|Sponsor decision|0|||
157192934|NCT02394028|567447223|FG008|Induction Phase|Sponsor decision|0|||
157079985|NCT00567567|567046645|FG001|Overall Study|Adverse Event|2|||
157232565|NCT01710657|567598995|FG001|Overall Study|Lost to Follow-up|0|||
157232566|NCT01710657|567598996|FG002|Overall Study|Lost to Follow-up|1|||
157232567|NCT01710657|567598994|FG000|Overall Study|Protocol Violation|2|||
157232568|NCT01710657|567598995|FG001|Overall Study|Protocol Violation|2|||
157232569|NCT01710657|567598996|FG002|Overall Study|Protocol Violation|0|||
157232570|NCT01710657|567598994|FG000|Overall Study|Adverse Event|14|||
157232571|NCT01710657|567598995|FG001|Overall Study|Adverse Event|8|||
157232572|NCT01710657|567598996|FG002|Overall Study|Adverse Event|28|||
157232573|NCT01710657|567598994|FG000|Overall Study|Withdrawal by Subject|0|||
157232574|NCT01710657|567598995|FG001|Overall Study|Withdrawal by Subject|1|||
157232575|NCT01710657|567598996|FG002|Overall Study|Withdrawal by Subject|2|||
157232576|NCT01710657|567598994|FG000|Overall Study|Lack of Efficacy|0|||
157232577|NCT01710657|567598995|FG001|Overall Study|Lack of Efficacy|1|||
157232578|NCT01710657|567598996|FG002|Overall Study|Lack of Efficacy|1|||
157232579|NCT02495857|567599003|FG000|Overall Study|Adverse Event|5|||
157232580|NCT02495857|567599004|FG001|Overall Study|Adverse Event|0|||
157232581|NCT02495857|567599005|FG002|Overall Study|Adverse Event|1|||
157232582|NCT02495857|567599003|FG000|Overall Study|Withdrawal by Subject|9|||
157232583|NCT02495857|567599004|FG001|Overall Study|Withdrawal by Subject|6|||
157232584|NCT02495857|567599005|FG002|Overall Study|Withdrawal by Subject|10|||
157232585|NCT02495857|567599003|FG000|Overall Study|Physician Decision|0|||
157232586|NCT02495857|567599004|FG001|Overall Study|Physician Decision|1|||
157232587|NCT02495857|567599005|FG002|Overall Study|Physician Decision|0|||
157232588|NCT02495857|567599003|FG000|Overall Study|Protocol Violation|1|||
157232589|NCT02495857|567599004|FG001|Overall Study|Protocol Violation|1|||
157232590|NCT02495857|567599005|FG002|Overall Study|Protocol Violation|2|||
157232591|NCT02495857|567599003|FG000|Overall Study|Lost to Follow-up|4|||
157232592|NCT02495857|567599004|FG001|Overall Study|Lost to Follow-up|5|||
157232593|NCT02495857|567599005|FG002|Overall Study|Lost to Follow-up|3|||
157232594|NCT02495857|567599003|FG000|Overall Study|Other|3|||
157232595|NCT02495857|567599004|FG001|Overall Study|Other|3|||
157232596|NCT02495857|567599005|FG002|Overall Study|Other|2|||
157232597|NCT04407806|567599008|FG000|Overall Study|Withdrawal by Subject|1|||
157232598|NCT04407806|567599009|FG001|Overall Study|Withdrawal by Subject|2|||
157232599|NCT03447262|567599010|FG000|Overall Study|Adverse Event|7|||
157232600|NCT03447262|567599010|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
157232601|NCT03447262|567599010|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
157232602|NCT03447262|567599010|FG000|Overall Study|Death|2|||
157232603|NCT03447262|567599010|FG000|Overall Study|Study Termination by Sponsor|455|||
157232604|NCT03447262|567599010|FG000|Overall Study|Other|4|||
157232605|NCT02058498|567599012|FG000|Overall Study|Withdrawal by Subject|4|||
157232606|NCT05327491|567599013|FG000|Periods 1 & 2|Miscellaneous|0|||
157232607|NCT05327491|567599014|FG001|Periods 1 & 2|Miscellaneous|1|||
157232608|NCT05327491|567599015|FG002|Periods 1 & 2|Miscellaneous|0|||
157232609|NCT05327491|567599016|FG003|Periods 1 & 2|Miscellaneous|0|||
157232610|NCT05327491|567599013|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
157232611|NCT05327491|567599014|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
157232612|NCT05327491|567599015|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
157232613|NCT05327491|567599016|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
157232614|NCT05612724|567599017|FG000|Overall Study|Lost to Follow-up|4|||
157232615|NCT02422264|567599020|FG000|Overall Study|Serious Adverse Event|1|||
157232616|NCT02422264|567599021|FG001|Overall Study|Serious Adverse Event|0|||
157232617|NCT02422264|567599020|FG000|Overall Study|Withdrawal by Subject|1|||
157232618|NCT02422264|567599021|FG001|Overall Study|Withdrawal by Subject|2|||
157232619|NCT02422264|567599020|FG000|Overall Study|Migrated/moved from study area|3|||
157232620|NCT02422264|567599021|FG001|Overall Study|Migrated/moved from study area|1|||
157232621|NCT02422264|567599020|FG000|Overall Study|Subject vaccinated outside of the study|0|||
157232622|NCT02422264|567599021|FG001|Overall Study|Subject vaccinated outside of the study|1|||
157232623|NCT00856388|567599024|FG000|Overall Study|Other|1|||
157232624|NCT01038856|567599028|FG000|Overall Study|Adverse Event|2|||
157232625|NCT02300103|567599029|FG000|Overall Study|Lack of Efficacy|3|||
157232626|NCT02300103|567599029|FG000|Overall Study|Protocol Violation|1|||
157232627|NCT02300103|567599029|FG000|Overall Study|Withdrew Consent|2|||
157232628|NCT04091971|567599030|FG000|Overall Study|Withdrawal by Subject|1|||
157079986|NCT00567567|567046646|FG002|Overall Study|Adverse Event|5|||
157079987|NCT00567567|567046644|FG000|Overall Study|Death|8|||
157079988|NCT00567567|567046645|FG001|Overall Study|Death|1|||
157232629|NCT04091971|567599030|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
157232630|NCT04091971|567599030|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
157232631|NCT00150462|567599031|FG000|Overall Study|Disease Progression or Relapse|3|||
157232632|NCT00150462|567599032|FG001|Overall Study|Disease Progression or Relapse|1|||
157232633|NCT00150462|567599033|FG002|Overall Study|Disease Progression or Relapse|2|||
157232634|NCT00150462|567599034|FG003|Overall Study|Disease Progression or Relapse|1|||
157232635|NCT00150462|567599035|FG004|Overall Study|Disease Progression or Relapse|2|||
157232636|NCT00150462|567599036|FG005|Overall Study|Disease Progression or Relapse|2|||
157079989|NCT00567567|567046646|FG002|Overall Study|Death|5|||
157079990|NCT00567567|567046644|FG000|Overall Study|Lack of Efficacy|16|||
157232637|NCT00150462|567599037|FG006|Overall Study|Disease Progression or Relapse|3|||
157232638|NCT00150462|567599038|FG007|Overall Study|Disease Progression or Relapse|5|||
157232639|NCT00150462|567599039|FG008|Overall Study|Disease Progression or Relapse|5|||
157232640|NCT00150462|567599040|FG009|Overall Study|Disease Progression or Relapse|3|||
157232641|NCT00150462|567599041|FG010|Overall Study|Disease Progression or Relapse|2|||
157232642|NCT00150462|567599031|FG000|Overall Study|Withdrawal by Subject|0|||
157232643|NCT00150462|567599032|FG001|Overall Study|Withdrawal by Subject|1|||
157232644|NCT00150462|567599033|FG002|Overall Study|Withdrawal by Subject|1|||
157232645|NCT00150462|567599034|FG003|Overall Study|Withdrawal by Subject|0|||
157232646|NCT00150462|567599035|FG004|Overall Study|Withdrawal by Subject|1|||
157232647|NCT00150462|567599036|FG005|Overall Study|Withdrawal by Subject|2|||
157232648|NCT00150462|567599037|FG006|Overall Study|Withdrawal by Subject|0|||
157232649|NCT00150462|567599038|FG007|Overall Study|Withdrawal by Subject|1|||
157232650|NCT00150462|567599039|FG008|Overall Study|Withdrawal by Subject|0|||
157232651|NCT00150462|567599040|FG009|Overall Study|Withdrawal by Subject|1|||
157232652|NCT00150462|567599041|FG010|Overall Study|Withdrawal by Subject|0|||
157232653|NCT00150462|567599031|FG000|Overall Study|Death|0|||
157232654|NCT00150462|567599032|FG001|Overall Study|Death|1|||
157232655|NCT00150462|567599033|FG002|Overall Study|Death|0|||
157232656|NCT00150462|567599034|FG003|Overall Study|Death|0|||
157232657|NCT00150462|567599035|FG004|Overall Study|Death|0|||
157232658|NCT00150462|567599036|FG005|Overall Study|Death|0|||
157232659|NCT00150462|567599037|FG006|Overall Study|Death|0|||
157232660|NCT00150462|567599038|FG007|Overall Study|Death|0|||
157232661|NCT00150462|567599039|FG008|Overall Study|Death|1|||
157232662|NCT00150462|567599040|FG009|Overall Study|Death|0|||
157232663|NCT00150462|567599041|FG010|Overall Study|Death|0|||
157232664|NCT00150462|567599031|FG000|Overall Study|Adverse Event|0|||
157232665|NCT00150462|567599032|FG001|Overall Study|Adverse Event|0|||
157232666|NCT00150462|567599033|FG002|Overall Study|Adverse Event|0|||
157232667|NCT00150462|567599034|FG003|Overall Study|Adverse Event|1|||
157232668|NCT00150462|567599035|FG004|Overall Study|Adverse Event|0|||
157232669|NCT00150462|567599036|FG005|Overall Study|Adverse Event|0|||
157232670|NCT00150462|567599037|FG006|Overall Study|Adverse Event|0|||
157232671|NCT00150462|567599038|FG007|Overall Study|Adverse Event|2|||
157232672|NCT00150462|567599039|FG008|Overall Study|Adverse Event|0|||
157232673|NCT00150462|567599040|FG009|Overall Study|Adverse Event|1|||
157232674|NCT00150462|567599041|FG010|Overall Study|Adverse Event|0|||
157232675|NCT00150462|567599031|FG000|Overall Study|Physician Decision|0|||
157232676|NCT00150462|567599032|FG001|Overall Study|Physician Decision|0|||
157232677|NCT00150462|567599033|FG002|Overall Study|Physician Decision|1|||
157232678|NCT00150462|567599034|FG003|Overall Study|Physician Decision|1|||
157232679|NCT00150462|567599035|FG004|Overall Study|Physician Decision|0|||
157232680|NCT00150462|567599036|FG005|Overall Study|Physician Decision|0|||
157232681|NCT00150462|567599037|FG006|Overall Study|Physician Decision|0|||
157232682|NCT00150462|567599038|FG007|Overall Study|Physician Decision|0|||
157232683|NCT00150462|567599039|FG008|Overall Study|Physician Decision|0|||
157232684|NCT00150462|567599040|FG009|Overall Study|Physician Decision|0|||
157232685|NCT00150462|567599041|FG010|Overall Study|Physician Decision|0|||
157232686|NCT00150462|567599031|FG000|Overall Study|Other|0|||
157232687|NCT00150462|567599032|FG001|Overall Study|Other|0|||
157232688|NCT00150462|567599033|FG002|Overall Study|Other|0|||
157232689|NCT00150462|567599034|FG003|Overall Study|Other|0|||
157232690|NCT00150462|567599035|FG004|Overall Study|Other|0|||
157232691|NCT00150462|567599036|FG005|Overall Study|Other|0|||
157232692|NCT00150462|567599037|FG006|Overall Study|Other|0|||
157232693|NCT00150462|567599038|FG007|Overall Study|Other|0|||
157232694|NCT00150462|567599039|FG008|Overall Study|Other|0|||
157232695|NCT00150462|567599040|FG009|Overall Study|Other|1|||
157232696|NCT00150462|567599041|FG010|Overall Study|Other|1|||
157232697|NCT04638153|567599042|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157232698|NCT04638153|567599043|FG001|Overall Study|Withdrawal by parent/guardian|0|||
157232699|NCT04638153|567599044|FG002|Overall Study|Withdrawal by parent/guardian|1|||
157232700|NCT04638153|567599042|FG000|Overall Study|Study terminated by sponsor|4|||
157232701|NCT04638153|567599043|FG001|Overall Study|Study terminated by sponsor|2|||
157232702|NCT04638153|567599044|FG002|Overall Study|Study terminated by sponsor|14|||
157232703|NCT01440283|567599047|FG000|Overall Study|Death|3|||
157232704|NCT01440283|567599047|FG000|Overall Study|Withdrawal by Subject|4|||
157232705|NCT01440283|567599047|FG000|Overall Study|Physician Decision|3|||
157232706|NCT01389102|567599048|FG000|Overall Study|Adverse Event|1|||
157232707|NCT01389102|567599049|FG001|Overall Study|Adverse Event|3|||
157232708|NCT01389102|567599050|FG002|Overall Study|Adverse Event|2|||
157232709|NCT01389102|567599051|FG003|Overall Study|Adverse Event|2|||
157232710|NCT01389102|567599052|FG004|Overall Study|Adverse Event|2|||
157232711|NCT01389102|567599053|FG005|Overall Study|Adverse Event|2|||
157232712|NCT01389102|567599048|FG000|Overall Study|Hurricane Katrina|4|||
157232713|NCT01389102|567599049|FG001|Overall Study|Hurricane Katrina|2|||
157232714|NCT01389102|567599050|FG002|Overall Study|Hurricane Katrina|3|||
157232715|NCT01389102|567599051|FG003|Overall Study|Hurricane Katrina|0|||
157232716|NCT01389102|567599052|FG004|Overall Study|Hurricane Katrina|3|||
157232717|NCT01389102|567599053|FG005|Overall Study|Hurricane Katrina|1|||
157192935|NCT02394028|567447224|FG009|Induction Phase|Sponsor decision|0|||
157192936|NCT02394028|567447225|FG010|Induction Phase|Sponsor decision|0|||
157192937|NCT02394028|567447215|FG000|Induction Phase|Technical reason|0|||
157192938|NCT02394028|567447216|FG001|Induction Phase|Technical reason|0|||
157192939|NCT02394028|567447217|FG002|Induction Phase|Technical reason|0|||
157192940|NCT02394028|567447218|FG003|Induction Phase|Technical reason|1|||
157192941|NCT02394028|567447219|FG004|Induction Phase|Technical reason|0|||
157192942|NCT02394028|567447220|FG005|Induction Phase|Technical reason|0|||
157192943|NCT02394028|567447221|FG006|Induction Phase|Technical reason|0|||
157192944|NCT02394028|567447222|FG007|Induction Phase|Technical reason|0|||
157192945|NCT02394028|567447223|FG008|Induction Phase|Technical reason|0|||
157192946|NCT02394028|567447224|FG009|Induction Phase|Technical reason|0|||
157192947|NCT02394028|567447225|FG010|Induction Phase|Technical reason|0|||
157192948|NCT02394028|567447215|FG000|Induction Phase|:ack of calculation|0|||
157192949|NCT02394028|567447216|FG001|Induction Phase|:ack of calculation|0|||
157192950|NCT02394028|567447217|FG002|Induction Phase|:ack of calculation|0|||
157192951|NCT02394028|567447218|FG003|Induction Phase|:ack of calculation|0|||
157192952|NCT02394028|567447219|FG004|Induction Phase|:ack of calculation|0|||
157192953|NCT02394028|567447220|FG005|Induction Phase|:ack of calculation|0|||
157192954|NCT02394028|567447221|FG006|Induction Phase|:ack of calculation|0|||
157192955|NCT02394028|567447222|FG007|Induction Phase|:ack of calculation|1|||
157192956|NCT02394028|567447223|FG008|Induction Phase|:ack of calculation|0|||
157192957|NCT02394028|567447224|FG009|Induction Phase|:ack of calculation|0|||
157192958|NCT02394028|567447225|FG010|Induction Phase|:ack of calculation|0|||
157192959|NCT02394028|567447215|FG000|Maintenance Phase|Protocol Violation|0|||
157192960|NCT02394028|567447216|FG001|Maintenance Phase|Protocol Violation|0|||
157192961|NCT02394028|567447217|FG002|Maintenance Phase|Protocol Violation|0|||
157192962|NCT02394028|567447218|FG003|Maintenance Phase|Protocol Violation|0|||
157192963|NCT02394028|567447219|FG004|Maintenance Phase|Protocol Violation|0|||
157192964|NCT02394028|567447220|FG005|Maintenance Phase|Protocol Violation|0|||
157192965|NCT02394028|567447221|FG006|Maintenance Phase|Protocol Violation|0|||
157192966|NCT02394028|567447222|FG007|Maintenance Phase|Protocol Violation|0|||
157192967|NCT02394028|567447223|FG008|Maintenance Phase|Protocol Violation|0|||
157192968|NCT02394028|567447224|FG009|Maintenance Phase|Protocol Violation|0|||
157192969|NCT02394028|567447225|FG010|Maintenance Phase|Protocol Violation|1|||
157192970|NCT02394028|567447215|FG000|Maintenance Phase|Physician Decision|0|||
157192971|NCT02394028|567447216|FG001|Maintenance Phase|Physician Decision|0|||
157192972|NCT02394028|567447217|FG002|Maintenance Phase|Physician Decision|0|||
157192973|NCT02394028|567447218|FG003|Maintenance Phase|Physician Decision|0|||
157192974|NCT02394028|567447219|FG004|Maintenance Phase|Physician Decision|0|||
157192975|NCT02394028|567447220|FG005|Maintenance Phase|Physician Decision|0|||
157192976|NCT02394028|567447221|FG006|Maintenance Phase|Physician Decision|0|||
157192977|NCT02394028|567447222|FG007|Maintenance Phase|Physician Decision|0|||
157192978|NCT02394028|567447223|FG008|Maintenance Phase|Physician Decision|1|||
157192979|NCT02394028|567447224|FG009|Maintenance Phase|Physician Decision|3|||
157192980|NCT02394028|567447225|FG010|Maintenance Phase|Physician Decision|2|||
157192981|NCT02394028|567447215|FG000|Maintenance Phase|Lack of Efficacy|0|||
157192982|NCT02394028|567447216|FG001|Maintenance Phase|Lack of Efficacy|0|||
157192983|NCT02394028|567447217|FG002|Maintenance Phase|Lack of Efficacy|0|||
157192984|NCT02394028|567447218|FG003|Maintenance Phase|Lack of Efficacy|0|||
157192985|NCT02394028|567447219|FG004|Maintenance Phase|Lack of Efficacy|0|||
157192986|NCT02394028|567447220|FG005|Maintenance Phase|Lack of Efficacy|0|||
157192987|NCT02394028|567447221|FG006|Maintenance Phase|Lack of Efficacy|0|||
157192988|NCT02394028|567447222|FG007|Maintenance Phase|Lack of Efficacy|0|||
157192989|NCT02394028|567447223|FG008|Maintenance Phase|Lack of Efficacy|7|||
157192990|NCT02394028|567447224|FG009|Maintenance Phase|Lack of Efficacy|25|||
157192991|NCT02394028|567447225|FG010|Maintenance Phase|Lack of Efficacy|33|||
157192992|NCT02394028|567447215|FG000|Maintenance Phase|Death|0|||
157192993|NCT02394028|567447216|FG001|Maintenance Phase|Death|0|||
157192994|NCT02394028|567447217|FG002|Maintenance Phase|Death|0|||
157192995|NCT02394028|567447218|FG003|Maintenance Phase|Death|0|||
157192996|NCT02394028|567447219|FG004|Maintenance Phase|Death|0|||
157192997|NCT02394028|567447220|FG005|Maintenance Phase|Death|0|||
157192998|NCT02394028|567447221|FG006|Maintenance Phase|Death|0|||
157192999|NCT02394028|567447222|FG007|Maintenance Phase|Death|0|||
157193000|NCT02394028|567447223|FG008|Maintenance Phase|Death|0|||
157193001|NCT02394028|567447224|FG009|Maintenance Phase|Death|0|||
157193002|NCT02394028|567447225|FG010|Maintenance Phase|Death|1|||
157193003|NCT02394028|567447215|FG000|Maintenance Phase|Adverse Event|0|||
157193004|NCT02394028|567447216|FG001|Maintenance Phase|Adverse Event|0|||
157193005|NCT02394028|567447217|FG002|Maintenance Phase|Adverse Event|0|||
157193006|NCT02394028|567447218|FG003|Maintenance Phase|Adverse Event|0|||
157193007|NCT02394028|567447219|FG004|Maintenance Phase|Adverse Event|0|||
157193008|NCT02394028|567447220|FG005|Maintenance Phase|Adverse Event|0|||
157193009|NCT02394028|567447221|FG006|Maintenance Phase|Adverse Event|0|||
157193010|NCT02394028|567447222|FG007|Maintenance Phase|Adverse Event|0|||
157193011|NCT02394028|567447223|FG008|Maintenance Phase|Adverse Event|1|||
157193012|NCT02394028|567447224|FG009|Maintenance Phase|Adverse Event|1|||
157193013|NCT02394028|567447225|FG010|Maintenance Phase|Adverse Event|3|||
157232718|NCT01389102|567599048|FG000|Overall Study|Lost to Follow-up|4|||
157232719|NCT01389102|567599049|FG001|Overall Study|Lost to Follow-up|1|||
157232720|NCT01389102|567599050|FG002|Overall Study|Lost to Follow-up|1|||
157232721|NCT01389102|567599051|FG003|Overall Study|Lost to Follow-up|2|||
157232722|NCT01389102|567599052|FG004|Overall Study|Lost to Follow-up|4|||
157232723|NCT01389102|567599053|FG005|Overall Study|Lost to Follow-up|1|||
157079991|NCT00567567|567046645|FG001|Overall Study|Lack of Efficacy|17|||
157079992|NCT00567567|567046646|FG002|Overall Study|Lack of Efficacy|48|||
157079993|NCT00567567|567046644|FG000|Overall Study|Lost to Follow-up|0|||
157079994|NCT00567567|567046645|FG001|Overall Study|Lost to Follow-up|0|||
157079995|NCT00567567|567046646|FG002|Overall Study|Lost to Follow-up|1|||
157079996|NCT00567567|567046644|FG000|Overall Study|Physician Decision|16|||
157079997|NCT00567567|567046645|FG001|Overall Study|Physician Decision|18|||
157079998|NCT00567567|567046646|FG002|Overall Study|Physician Decision|84|||
157079999|NCT00567567|567046644|FG000|Overall Study|Withdrawal by Subject|0|||
157080000|NCT00567567|567046645|FG001|Overall Study|Withdrawal by Subject|0|||
157080001|NCT00567567|567046646|FG002|Overall Study|Withdrawal by Subject|2|||
157080002|NCT00567567|567046644|FG000|Overall Study|Ineligible|4|||
157080003|NCT00567567|567046645|FG001|Overall Study|Ineligible|0|||
157080004|NCT00567567|567046646|FG002|Overall Study|Ineligible|9|||
157080005|NCT00567567|567046644|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
157080006|NCT00567567|567046645|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
157080007|NCT00567567|567046646|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
157080008|NCT00567567|567046644|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
157080009|NCT00567567|567046645|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
157080010|NCT00567567|567046646|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
157080011|NCT00567567|567046644|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
157080012|NCT00567567|567046645|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
157080013|NCT00567567|567046646|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
157080014|NCT03433677|567046647|FG000|Period 1|Protocol Violation|1|||
157080015|NCT03433677|567046648|FG001|Period 1|Protocol Violation|0|||
157080016|NCT03433677|567046647|FG000|Period 2|Withdrawal by Subject|1|||
157080017|NCT03433677|567046648|FG001|Period 2|Withdrawal by Subject|1|||
157080018|NCT03330405|567046649|FG000|Overall Study|Other|1|||
157080019|NCT03330405|567046650|FG001|Overall Study|Other|3|||
157080020|NCT03330405|567046651|FG002|Overall Study|Other|1|||
157080021|NCT03330405|567046652|FG003|Overall Study|Other|0|||
157080022|NCT03330405|567046653|FG004|Overall Study|Other|2|||
157080023|NCT03330405|567046654|FG005|Overall Study|Other|0|||
157080024|NCT03330405|567046655|FG006|Overall Study|Other|1|||
157080025|NCT03330405|567046656|FG007|Overall Study|Other|0|||
157080026|NCT03330405|567046657|FG008|Overall Study|Other|0|||
157080027|NCT03330405|567046658|FG009|Overall Study|Other|0|||
157080028|NCT03330405|567046659|FG010|Overall Study|Other|0|||
157080029|NCT03330405|567046649|FG000|Overall Study|Progressive disease|8|||
157080030|NCT03330405|567046650|FG001|Overall Study|Progressive disease|27|||
157080031|NCT03330405|567046651|FG002|Overall Study|Progressive disease|4|||
157080032|NCT03330405|567046652|FG003|Overall Study|Progressive disease|18|||
157080033|NCT03330405|567046653|FG004|Overall Study|Progressive disease|16|||
157080034|NCT03330405|567046654|FG005|Overall Study|Progressive disease|14|||
157080035|NCT03330405|567046655|FG006|Overall Study|Progressive disease|7|||
157080036|NCT03330405|567046656|FG007|Overall Study|Progressive disease|29|||
157080037|NCT03330405|567046657|FG008|Overall Study|Progressive disease|9|||
157080038|NCT03330405|567046658|FG009|Overall Study|Progressive disease|11|||
157080039|NCT03330405|567046659|FG010|Overall Study|Progressive disease|5|||
157080040|NCT03330405|567046649|FG000|Overall Study|Withdrawal by Subject|1|||
157080041|NCT03330405|567046650|FG001|Overall Study|Withdrawal by Subject|4|||
157080042|NCT03330405|567046651|FG002|Overall Study|Withdrawal by Subject|0|||
157080043|NCT03330405|567046652|FG003|Overall Study|Withdrawal by Subject|1|||
157080044|NCT03330405|567046653|FG004|Overall Study|Withdrawal by Subject|1|||
157080045|NCT03330405|567046654|FG005|Overall Study|Withdrawal by Subject|1|||
157080046|NCT03330405|567046655|FG006|Overall Study|Withdrawal by Subject|0|||
157080047|NCT03330405|567046656|FG007|Overall Study|Withdrawal by Subject|2|||
157080048|NCT03330405|567046657|FG008|Overall Study|Withdrawal by Subject|2|||
157080049|NCT03330405|567046658|FG009|Overall Study|Withdrawal by Subject|1|||
157080050|NCT03330405|567046659|FG010|Overall Study|Withdrawal by Subject|1|||
157080051|NCT03330405|567046649|FG000|Overall Study|Global deterioration of health status|2|||
157080052|NCT03330405|567046650|FG001|Overall Study|Global deterioration of health status|3|||
157080053|NCT03330405|567046651|FG002|Overall Study|Global deterioration of health status|0|||
157080054|NCT03330405|567046652|FG003|Overall Study|Global deterioration of health status|2|||
157080055|NCT03330405|567046653|FG004|Overall Study|Global deterioration of health status|3|||
157080056|NCT03330405|567046654|FG005|Overall Study|Global deterioration of health status|3|||
157080057|NCT03330405|567046655|FG006|Overall Study|Global deterioration of health status|0|||
157080058|NCT03330405|567046656|FG007|Overall Study|Global deterioration of health status|2|||
157232724|NCT01389102|567599048|FG000|Overall Study|Protocol Violation|0|||
157232725|NCT01389102|567599049|FG001|Overall Study|Protocol Violation|0|||
157232726|NCT01389102|567599050|FG002|Overall Study|Protocol Violation|3|||
157080059|NCT03330405|567046657|FG008|Overall Study|Global deterioration of health status|8|||
157080060|NCT03330405|567046658|FG009|Overall Study|Global deterioration of health status|4|||
157080061|NCT03330405|567046659|FG010|Overall Study|Global deterioration of health status|1|||
157080062|NCT03330405|567046649|FG000|Overall Study|Adverse Event|0|||
157080063|NCT03330405|567046650|FG001|Overall Study|Adverse Event|1|||
157080064|NCT03330405|567046651|FG002|Overall Study|Adverse Event|0|||
157080065|NCT03330405|567046652|FG003|Overall Study|Adverse Event|1|||
157080066|NCT03330405|567046653|FG004|Overall Study|Adverse Event|1|||
157080067|NCT03330405|567046654|FG005|Overall Study|Adverse Event|1|||
157080068|NCT03330405|567046655|FG006|Overall Study|Adverse Event|3|||
157080069|NCT03330405|567046656|FG007|Overall Study|Adverse Event|4|||
157080070|NCT03330405|567046657|FG008|Overall Study|Adverse Event|2|||
157080071|NCT03330405|567046658|FG009|Overall Study|Adverse Event|2|||
157080072|NCT03330405|567046659|FG010|Overall Study|Adverse Event|2|||
157080073|NCT03330405|567046649|FG000|Overall Study|Death|0|||
157080074|NCT03330405|567046650|FG001|Overall Study|Death|4|||
157080075|NCT03330405|567046651|FG002|Overall Study|Death|0|||
157080076|NCT03330405|567046652|FG003|Overall Study|Death|0|||
157080077|NCT03330405|567046653|FG004|Overall Study|Death|0|||
157080078|NCT03330405|567046654|FG005|Overall Study|Death|1|||
157080079|NCT03330405|567046655|FG006|Overall Study|Death|0|||
157080080|NCT03330405|567046656|FG007|Overall Study|Death|2|||
157080081|NCT03330405|567046657|FG008|Overall Study|Death|0|||
157080082|NCT03330405|567046658|FG009|Overall Study|Death|0|||
157080083|NCT03330405|567046659|FG010|Overall Study|Death|0|||
157080084|NCT03330405|567046649|FG000|Overall Study|Physician Decision|0|||
157080085|NCT03330405|567046650|FG001|Overall Study|Physician Decision|0|||
157080086|NCT03330405|567046651|FG002|Overall Study|Physician Decision|0|||
157080087|NCT03330405|567046652|FG003|Overall Study|Physician Decision|0|||
157080088|NCT03330405|567046653|FG004|Overall Study|Physician Decision|0|||
157080089|NCT03330405|567046654|FG005|Overall Study|Physician Decision|0|||
157080090|NCT03330405|567046655|FG006|Overall Study|Physician Decision|0|||
157080091|NCT03330405|567046656|FG007|Overall Study|Physician Decision|1|||
157080092|NCT03330405|567046657|FG008|Overall Study|Physician Decision|0|||
157080093|NCT03330405|567046658|FG009|Overall Study|Physician Decision|0|||
157080094|NCT03330405|567046659|FG010|Overall Study|Physician Decision|0|||
157080095|NCT01736189|567046660|FG000|Overall Study|Violation of registration criteria|41|||
157080096|NCT01736189|567046660|FG000|Overall Study|Protocol Violation|4|||
157080097|NCT01736189|567046660|FG000|Overall Study|Criteria and protocol violations|1|||
157080098|NCT04608773|567046673|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
157080099|NCT04608773|567046674|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
157080100|NCT04608773|567046673|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
157080101|NCT04608773|567046674|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
157080102|NCT04608773|567046673|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
157080103|NCT04608773|567046674|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
157080104|NCT04608773|567046673|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
157080105|NCT04608773|567046674|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
157080106|NCT04608773|567046673|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
157080107|NCT04608773|567046674|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
157080108|NCT00972322|567046677|FG000|Overall Study|Adverse Event|2|||
157080109|NCT00972322|567046678|FG001|Overall Study|Adverse Event|1|||
157080110|NCT00972322|567046677|FG000|Overall Study|Positive drug screen|0|||
157080111|NCT00972322|567046678|FG001|Overall Study|Positive drug screen|1|||
157080112|NCT00972322|567046677|FG000|Overall Study|Lost to Follow-up|0|||
157080113|NCT00972322|567046678|FG001|Overall Study|Lost to Follow-up|1|||
157080114|NCT00972322|567046677|FG000|Overall Study|Consistently high glucose values|1|||
157080115|NCT00972322|567046678|FG001|Overall Study|Consistently high glucose values|0|||
157080116|NCT01077518|567046679|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
157080117|NCT01077518|567046680|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
157080118|NCT01077518|567046681|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
157080119|NCT01077518|567046679|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
157080120|NCT01077518|567046680|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
157080121|NCT01077518|567046681|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
157080122|NCT01077518|567046679|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
157080123|NCT01077518|567046680|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
157080124|NCT01077518|567046681|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
157080125|NCT01077518|567046679|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
157080126|NCT01077518|567046680|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
157080127|NCT01077518|567046681|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
157080128|NCT01077518|567046679|FG000|Optional Ofa Phase|Physician Decision|0|||
157080129|NCT01077518|567046680|FG001|Optional Ofa Phase|Physician Decision|0|||
157080130|NCT01077518|567046681|FG002|Optional Ofa Phase|Physician Decision|1|||
157080131|NCT01077518|567046679|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
157080132|NCT01077518|567046680|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
157080133|NCT01077518|567046681|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
157080134|NCT01077518|567046679|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
157080135|NCT01077518|567046680|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
157080136|NCT01077518|567046681|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
157080137|NCT00623805|567046688|FG000|Overall Study|Adverse Event|9|||
157080138|NCT00623805|567046689|FG001|Overall Study|Adverse Event|6|||
157080139|NCT00623805|567046688|FG000|Overall Study|Death|2|||
157080140|NCT00623805|567046689|FG001|Overall Study|Death|0|||
157080141|NCT00623805|567046688|FG000|Overall Study|Lack of Efficacy|3|||
157080142|NCT00623805|567046689|FG001|Overall Study|Lack of Efficacy|7|||
157080143|NCT00623805|567046688|FG000|Overall Study|Lost to Follow-up|2|||
157080144|NCT00623805|567046689|FG001|Overall Study|Lost to Follow-up|2|||
157080145|NCT00623805|567046688|FG000|Overall Study|Protocol Violation|1|||
157080146|NCT00623805|567046689|FG001|Overall Study|Protocol Violation|1|||
157080147|NCT00623805|567046688|FG000|Overall Study|Reason not Specified|3|||
157080148|NCT00623805|567046689|FG001|Overall Study|Reason not Specified|6|||
157080149|NCT01803282|567046694|FG000|Overall Study|Progressive Disease|4|||
157080150|NCT01803282|567046695|FG001|Overall Study|Progressive Disease|3|||
157080151|NCT01803282|567046696|FG002|Overall Study|Progressive Disease|6|||
157080152|NCT01803282|567046697|FG003|Overall Study|Progressive Disease|22|||
157080153|NCT01803282|567046698|FG004|Overall Study|Progressive Disease|5|||
157080154|NCT01803282|567046699|FG005|Overall Study|Progressive Disease|8|||
157080155|NCT01803282|567046700|FG006|Overall Study|Progressive Disease|23|||
157080156|NCT01803282|567046701|FG007|Overall Study|Progressive Disease|24|||
157080157|NCT01803282|567046702|FG008|Overall Study|Progressive Disease|3|||
157080158|NCT01803282|567046703|FG009|Overall Study|Progressive Disease|29|||
157080159|NCT01803282|567046704|FG010|Overall Study|Progressive Disease|6|||
157080160|NCT01803282|567046705|FG011|Overall Study|Progressive Disease|11|||
157080161|NCT01803282|567046694|FG000|Overall Study|Death|0|||
157080162|NCT01803282|567046695|FG001|Overall Study|Death|0|||
157080163|NCT01803282|567046696|FG002|Overall Study|Death|0|||
157080164|NCT01803282|567046697|FG003|Overall Study|Death|0|||
157080165|NCT01803282|567046698|FG004|Overall Study|Death|2|||
157080166|NCT01803282|567046699|FG005|Overall Study|Death|1|||
157080167|NCT01803282|567046700|FG006|Overall Study|Death|1|||
157080168|NCT01803282|567046701|FG007|Overall Study|Death|5|||
157080169|NCT01803282|567046702|FG008|Overall Study|Death|1|||
157080170|NCT01803282|567046703|FG009|Overall Study|Death|1|||
157080171|NCT01803282|567046704|FG010|Overall Study|Death|0|||
157080172|NCT01803282|567046705|FG011|Overall Study|Death|0|||
157080173|NCT01803282|567046694|FG000|Overall Study|Withdrew Consent|0|||
157080174|NCT01803282|567046695|FG001|Overall Study|Withdrew Consent|0|||
157080175|NCT01803282|567046696|FG002|Overall Study|Withdrew Consent|0|||
157080176|NCT01803282|567046697|FG003|Overall Study|Withdrew Consent|6|||
157080177|NCT01803282|567046698|FG004|Overall Study|Withdrew Consent|1|||
157080178|NCT01803282|567046699|FG005|Overall Study|Withdrew Consent|0|||
157080179|NCT01803282|567046700|FG006|Overall Study|Withdrew Consent|8|||
157080180|NCT01803282|567046701|FG007|Overall Study|Withdrew Consent|3|||
157080181|NCT01803282|567046702|FG008|Overall Study|Withdrew Consent|1|||
157080182|NCT01803282|567046703|FG009|Overall Study|Withdrew Consent|5|||
157080183|NCT01803282|567046704|FG010|Overall Study|Withdrew Consent|0|||
157080184|NCT01803282|567046705|FG011|Overall Study|Withdrew Consent|1|||
157080185|NCT01803282|567046694|FG000|Overall Study|Investigator's Discretion|0|||
157080186|NCT01803282|567046695|FG001|Overall Study|Investigator's Discretion|0|||
157080187|NCT01803282|567046696|FG002|Overall Study|Investigator's Discretion|0|||
157080188|NCT01803282|567046697|FG003|Overall Study|Investigator's Discretion|7|||
157080189|NCT01803282|567046698|FG004|Overall Study|Investigator's Discretion|2|||
157080190|NCT01803282|567046699|FG005|Overall Study|Investigator's Discretion|1|||
157080191|NCT01803282|567046700|FG006|Overall Study|Investigator's Discretion|7|||
157080192|NCT01803282|567046701|FG007|Overall Study|Investigator's Discretion|10|||
157080193|NCT01803282|567046702|FG008|Overall Study|Investigator's Discretion|6|||
157080194|NCT01803282|567046703|FG009|Overall Study|Investigator's Discretion|7|||
157080195|NCT01803282|567046704|FG010|Overall Study|Investigator's Discretion|1|||
157080196|NCT01803282|567046705|FG011|Overall Study|Investigator's Discretion|0|||
157080197|NCT01803282|567046694|FG000|Overall Study|Adverse Event|0|||
157080198|NCT01803282|567046695|FG001|Overall Study|Adverse Event|0|||
157080199|NCT01803282|567046696|FG002|Overall Study|Adverse Event|0|||
157080200|NCT01803282|567046697|FG003|Overall Study|Adverse Event|0|||
157080201|NCT01803282|567046698|FG004|Overall Study|Adverse Event|0|||
157080202|NCT01803282|567046699|FG005|Overall Study|Adverse Event|0|||
157080203|NCT01803282|567046700|FG006|Overall Study|Adverse Event|1|||
157080204|NCT01803282|567046701|FG007|Overall Study|Adverse Event|2|||
157080205|NCT01803282|567046702|FG008|Overall Study|Adverse Event|0|||
157080206|NCT01803282|567046703|FG009|Overall Study|Adverse Event|1|||
157080207|NCT01803282|567046704|FG010|Overall Study|Adverse Event|0|||
157080208|NCT01803282|567046705|FG011|Overall Study|Adverse Event|3|||
157080209|NCT01803282|567046694|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157080210|NCT01803282|567046695|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157080211|NCT01803282|567046696|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157080212|NCT01803282|567046697|FG003|Overall Study|Non-Compliance with Study Drug|1|||
157080213|NCT01803282|567046698|FG004|Overall Study|Non-Compliance with Study Drug|0|||
157080214|NCT01803282|567046699|FG005|Overall Study|Non-Compliance with Study Drug|0|||
157080215|NCT01803282|567046700|FG006|Overall Study|Non-Compliance with Study Drug|0|||
157080216|NCT01803282|567046701|FG007|Overall Study|Non-Compliance with Study Drug|0|||
157080217|NCT01803282|567046702|FG008|Overall Study|Non-Compliance with Study Drug|0|||
157080218|NCT01803282|567046703|FG009|Overall Study|Non-Compliance with Study Drug|0|||
157080219|NCT01803282|567046704|FG010|Overall Study|Non-Compliance with Study Drug|0|||
157080220|NCT01803282|567046705|FG011|Overall Study|Non-Compliance with Study Drug|0|||
157080221|NCT01803282|567046694|FG000|Overall Study|Unknown Reason|0|||
157080222|NCT01803282|567046695|FG001|Overall Study|Unknown Reason|0|||
157080223|NCT01803282|567046696|FG002|Overall Study|Unknown Reason|0|||
157080224|NCT01803282|567046697|FG003|Overall Study|Unknown Reason|0|||
157080225|NCT01803282|567046698|FG004|Overall Study|Unknown Reason|0|||
157080226|NCT01803282|567046699|FG005|Overall Study|Unknown Reason|0|||
157080227|NCT01803282|567046700|FG006|Overall Study|Unknown Reason|0|||
157080228|NCT01803282|567046701|FG007|Overall Study|Unknown Reason|1|||
157080229|NCT01803282|567046702|FG008|Overall Study|Unknown Reason|0|||
157080230|NCT01803282|567046703|FG009|Overall Study|Unknown Reason|0|||
157080231|NCT01803282|567046704|FG010|Overall Study|Unknown Reason|0|||
157080232|NCT01803282|567046705|FG011|Overall Study|Unknown Reason|0|||
157080233|NCT01803282|567046694|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
157080234|NCT01803282|567046695|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
157080235|NCT01803282|567046696|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
157080236|NCT01803282|567046697|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
157080237|NCT01803282|567046698|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
157080238|NCT01803282|567046699|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
157080239|NCT01803282|567046700|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
157080240|NCT01803282|567046701|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
157080241|NCT01803282|567046702|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
157080242|NCT01803282|567046703|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
157080243|NCT01803282|567046704|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
157080244|NCT01803282|567046705|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
157080245|NCT01803282|567046694|FG000|Overall Study|Enrolled but Never Treated|0|||
157080246|NCT01803282|567046695|FG001|Overall Study|Enrolled but Never Treated|0|||
157080247|NCT01803282|567046696|FG002|Overall Study|Enrolled but Never Treated|0|||
157080248|NCT01803282|567046697|FG003|Overall Study|Enrolled but Never Treated|0|||
157080249|NCT01803282|567046698|FG004|Overall Study|Enrolled but Never Treated|1|||
157080250|NCT01803282|567046699|FG005|Overall Study|Enrolled but Never Treated|0|||
157080251|NCT01803282|567046700|FG006|Overall Study|Enrolled but Never Treated|1|||
157080252|NCT01803282|567046701|FG007|Overall Study|Enrolled but Never Treated|1|||
157080253|NCT01803282|567046702|FG008|Overall Study|Enrolled but Never Treated|0|||
157080254|NCT01803282|567046703|FG009|Overall Study|Enrolled but Never Treated|1|||
157080255|NCT01803282|567046704|FG010|Overall Study|Enrolled but Never Treated|0|||
157080256|NCT01803282|567046705|FG011|Overall Study|Enrolled but Never Treated|0|||
157080257|NCT02671500|567046707|FG000|Overall Study|Lack of Efficacy|12|||
157080258|NCT02671500|567046707|FG000|Overall Study|Lost to Follow-up|2|||
157080259|NCT05235269|567046709|FG000|Overall Study|Adverse Event|1|||
157080260|NCT05235269|567046709|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
157080261|NCT05235269|567046709|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
157080262|NCT03810235|567046712|FG000|Overall Study|Withdrawal by Subject|2|||
157080263|NCT03810235|567046713|FG001|Overall Study|Withdrawal by Subject|0|||
157080264|NCT03548220|567046714|FG000|Overall Study|Lost to Follow-up|1|||
157080265|NCT03548220|567046715|FG001|Overall Study|Lost to Follow-up|0|||
157080266|NCT03548220|567046716|FG002|Overall Study|Lost to Follow-up|0|||
157080267|NCT03548220|567046717|FG003|Overall Study|Lost to Follow-up|0|||
157080268|NCT01127893|567048102|FG000|Overall Study|Study Termination by the Sponsor|1|||
157080269|NCT02787044|567048103|FG000|Overall Study|Lost to Follow-up|15|||
157080270|NCT02787044|567048104|FG001|Overall Study|Lost to Follow-up|19|||
157080271|NCT03482466|567048106|FG000|Overall Study|Protocol Violation|2|||
157080272|NCT04552899|567048107|FG000|Overall Study|Adverse Event|4|||
157080273|NCT04552899|567048108|FG001|Overall Study|Adverse Event|3|||
157080274|NCT04552899|567048107|FG000|Overall Study|Death|4|||
157080275|NCT04552899|567048108|FG001|Overall Study|Death|4|||
157080276|NCT04552899|567048107|FG000|Overall Study|Lost to Follow-up|8|||
157232727|NCT01389102|567599051|FG003|Overall Study|Protocol Violation|0|||
157232728|NCT01389102|567599052|FG004|Overall Study|Protocol Violation|1|||
157232729|NCT01389102|567599053|FG005|Overall Study|Protocol Violation|1|||
157080277|NCT04552899|567048108|FG001|Overall Study|Lost to Follow-up|13|||
157080278|NCT04552899|567048107|FG000|Overall Study|Lung Transplant|4|||
157080279|NCT04552899|567048108|FG001|Overall Study|Lung Transplant|3|||
157080280|NCT04552899|567048107|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
157080281|NCT04552899|567048108|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
157080282|NCT04552899|567048107|FG000|Overall Study|Physician Decision|3|||
157080283|NCT04552899|567048108|FG001|Overall Study|Physician Decision|4|||
157080284|NCT04552899|567048107|FG000|Overall Study|Study Terminated By Sponsor|237|||
157232730|NCT01389102|567599048|FG000|Overall Study|Withdrawal by Subject|7|||
157080285|NCT04552899|567048108|FG001|Overall Study|Study Terminated By Sponsor|239|||
157080286|NCT04552899|567048107|FG000|Overall Study|Withdrawal by Subject|15|||
157080287|NCT04552899|567048108|FG001|Overall Study|Withdrawal by Subject|17|||
157080288|NCT02383940|567048111|FG000|Overall Study|Adverse Event|1|||
157080289|NCT02383940|567048112|FG001|Overall Study|Adverse Event|0|||
157080290|NCT02383940|567048111|FG000|Overall Study|Lost to Follow-up|2|||
157080291|NCT02383940|567048112|FG001|Overall Study|Lost to Follow-up|2|||
157080292|NCT02383940|567048111|FG000|Overall Study|Physician Decision|2|||
157080293|NCT02383940|567048112|FG001|Overall Study|Physician Decision|0|||
157080294|NCT02383940|567048111|FG000|Overall Study|Withdrawal by Subject|1|||
157080295|NCT02383940|567048112|FG001|Overall Study|Withdrawal by Subject|1|||
157080296|NCT02383940|567048111|FG000|Overall Study|Randomized but not treated|2|||
157080297|NCT02383940|567048112|FG001|Overall Study|Randomized but not treated|0|||
157080298|NCT02383940|567048111|FG000|Overall Study|Other than specified above|1|||
157080299|NCT02383940|567048112|FG001|Overall Study|Other than specified above|0|||
157080300|NCT00565773|567048113|FG000|Overall Study|Withdrawal by Subject|1|||
157080301|NCT00565773|567048113|FG000|Overall Study|Physician Decision|1|||
157080302|NCT03853551|567048114|FG000|Overall Study|Death|2|||
157080303|NCT03853551|567048114|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
157080304|NCT01075958|567048115|FG000|Overall Study|Blood sample could not be obtained|44|||
157080305|NCT01240915|567048118|FG000|Overall Study|Adverse Event|0|||
157080306|NCT01240915|567048119|FG001|Overall Study|Adverse Event|0|||
157080307|NCT01240915|567048120|FG002|Overall Study|Adverse Event|0|||
157080308|NCT01240915|567048121|FG003|Overall Study|Adverse Event|1|||
157080309|NCT01240915|567048122|FG004|Overall Study|Adverse Event|0|||
157080310|NCT01240915|567048123|FG005|Overall Study|Adverse Event|2|||
157080311|NCT01240915|567048124|FG006|Overall Study|Adverse Event|0|||
157080312|NCT01240915|567048125|FG007|Overall Study|Adverse Event|0|||
157080313|NCT01240915|567048126|FG008|Overall Study|Adverse Event|1|||
157080314|NCT01240915|567048118|FG000|Overall Study|Lost to Follow-up|0|||
157080315|NCT01240915|567048119|FG001|Overall Study|Lost to Follow-up|0|||
157080316|NCT01240915|567048120|FG002|Overall Study|Lost to Follow-up|0|||
157080317|NCT01240915|567048121|FG003|Overall Study|Lost to Follow-up|0|||
157080318|NCT01240915|567048122|FG004|Overall Study|Lost to Follow-up|1|||
157080319|NCT01240915|567048123|FG005|Overall Study|Lost to Follow-up|1|||
157080320|NCT01240915|567048124|FG006|Overall Study|Lost to Follow-up|0|||
157080321|NCT01240915|567048125|FG007|Overall Study|Lost to Follow-up|1|||
157080322|NCT01240915|567048126|FG008|Overall Study|Lost to Follow-up|1|||
157080323|NCT01240915|567048118|FG000|Overall Study|Withdrawal by Subject|2|||
157080324|NCT01240915|567048119|FG001|Overall Study|Withdrawal by Subject|1|||
157080325|NCT01240915|567048120|FG002|Overall Study|Withdrawal by Subject|0|||
157080326|NCT01240915|567048121|FG003|Overall Study|Withdrawal by Subject|2|||
157080327|NCT01240915|567048122|FG004|Overall Study|Withdrawal by Subject|0|||
157080328|NCT01240915|567048123|FG005|Overall Study|Withdrawal by Subject|4|||
157080329|NCT01240915|567048124|FG006|Overall Study|Withdrawal by Subject|2|||
157080330|NCT01240915|567048125|FG007|Overall Study|Withdrawal by Subject|3|||
157080331|NCT01240915|567048126|FG008|Overall Study|Withdrawal by Subject|3|||
157080332|NCT01240915|567048118|FG000|Overall Study|Other|0|||
157080333|NCT01240915|567048119|FG001|Overall Study|Other|0|||
157080334|NCT01240915|567048120|FG002|Overall Study|Other|0|||
157080335|NCT01240915|567048121|FG003|Overall Study|Other|0|||
157080336|NCT01240915|567048122|FG004|Overall Study|Other|2|||
157080337|NCT01240915|567048123|FG005|Overall Study|Other|0|||
157080338|NCT01240915|567048124|FG006|Overall Study|Other|0|||
157080339|NCT01240915|567048125|FG007|Overall Study|Other|0|||
157080340|NCT01240915|567048126|FG008|Overall Study|Other|0|||
157080341|NCT01240915|567048118|FG000|Overall Study|Insufficient Clinical Response|0|||
157080342|NCT01240915|567048119|FG001|Overall Study|Insufficient Clinical Response|0|||
157080343|NCT01240915|567048120|FG002|Overall Study|Insufficient Clinical Response|0|||
157080344|NCT01240915|567048121|FG003|Overall Study|Insufficient Clinical Response|0|||
157080345|NCT01240915|567048122|FG004|Overall Study|Insufficient Clinical Response|1|||
157080346|NCT01240915|567048123|FG005|Overall Study|Insufficient Clinical Response|3|||
157080347|NCT01240915|567048124|FG006|Overall Study|Insufficient Clinical Response|6|||
157080348|NCT01240915|567048125|FG007|Overall Study|Insufficient Clinical Response|0|||
157080349|NCT01240915|567048126|FG008|Overall Study|Insufficient Clinical Response|3|||
157080350|NCT02574845|567048128|FG000|Overall Study|Consent withdrawn further participation|0|||
157080351|NCT02574845|567048129|FG001|Overall Study|Consent withdrawn further participation|0|||
157080352|NCT02574845|567048130|FG002|Overall Study|Consent withdrawn further participation|0|||
157080353|NCT02574845|567048131|FG003|Overall Study|Consent withdrawn further participation|0|||
157080354|NCT02574845|567048132|FG004|Overall Study|Consent withdrawn further participation|1|||
157080355|NCT02574845|567048133|FG005|Overall Study|Consent withdrawn further participation|0|||
157080356|NCT02574845|567048128|FG000|Overall Study|Adverse Event|0|||
157080357|NCT02574845|567048129|FG001|Overall Study|Adverse Event|1|||
157080358|NCT02574845|567048130|FG002|Overall Study|Adverse Event|0|||
157080359|NCT02574845|567048131|FG003|Overall Study|Adverse Event|0|||
157080360|NCT02574845|567048132|FG004|Overall Study|Adverse Event|0|||
157080361|NCT02574845|567048133|FG005|Overall Study|Adverse Event|1|||
157080362|NCT01867333|567048138|FG000|Overall Study|Withdrawal by Subject|1|||
157080363|NCT01867333|567048139|FG001|Overall Study|Withdrawal by Subject|0|||
157080364|NCT01867333|567048138|FG000|Overall Study|Adverse Event|1|||
157080365|NCT01867333|567048139|FG001|Overall Study|Adverse Event|0|||
157080366|NCT01867333|567048138|FG000|Overall Study|Participant choice|1|||
157080367|NCT01867333|567048139|FG001|Overall Study|Participant choice|2|||
157080368|NCT01867333|567048138|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
157080369|NCT01867333|567048139|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
157080370|NCT01867333|567048138|FG000|Overall Study|Death|0|||
157080371|NCT01867333|567048139|FG001|Overall Study|Death|1|||
157080372|NCT01867333|567048138|FG000|Overall Study|Physician Decision|3|||
157080373|NCT01867333|567048139|FG001|Overall Study|Physician Decision|2|||
157080374|NCT01867333|567048138|FG000|Overall Study|Switched to alternative treatment|1|||
157080375|NCT01867333|567048139|FG001|Overall Study|Switched to alternative treatment|0|||
157080376|NCT03101462|567048140|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
157080377|NCT03101462|567048141|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
157080378|NCT01696045|567048145|FG000|Overall Study|Study drug toxicity|1|||
157080379|NCT01696045|567048146|FG001|Overall Study|Study drug toxicity|5|||
157080380|NCT01696045|567048145|FG000|Overall Study|Disease progression|2|||
157080381|NCT01696045|567048146|FG001|Overall Study|Disease progression|2|||
157080382|NCT01559129|567048147|FG000|Treatment Phase|Adverse Event|0|||
157080383|NCT01559129|567048148|FG001|Treatment Phase|Adverse Event|2|||
157080384|NCT01559129|567048147|FG000|Treatment Phase|Progressive Disease|1|||
157080385|NCT01559129|567048148|FG001|Treatment Phase|Progressive Disease|1|||
157080386|NCT01559129|567048147|FG000|Treatment Phase|Lack of Efficacy|0|||
157080387|NCT01559129|567048148|FG001|Treatment Phase|Lack of Efficacy|1|||
157080388|NCT01559129|567048147|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
157080389|NCT01559129|567048148|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
157080390|NCT01559129|567048147|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
157080391|NCT01559129|567048148|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
157080392|NCT01559129|567048147|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
157080393|NCT01559129|567048148|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
157080394|NCT01559129|567048147|FG000|Open-label Extension Period|Adverse Event|1|||
157080395|NCT01559129|567048148|FG001|Open-label Extension Period|Adverse Event|0|||
157080396|NCT01559129|567048147|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
157080397|NCT01559129|567048148|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
157080398|NCT03525392|567048149|FG000|Overall Study|Adverse Event|1|||
157080399|NCT03525392|567048150|FG001|Overall Study|Adverse Event|0|||
157080400|NCT03525392|567048151|FG002|Overall Study|Adverse Event|2|||
157080401|NCT03525392|567048152|FG003|Overall Study|Adverse Event|0|||
157080402|NCT03525392|567048153|FG004|Overall Study|Adverse Event|0|||
157080403|NCT03525392|567048149|FG000|Overall Study|Progressive disease|0|||
157080404|NCT03525392|567048150|FG001|Overall Study|Progressive disease|1|||
157080405|NCT03525392|567048151|FG002|Overall Study|Progressive disease|1|||
157080406|NCT03525392|567048152|FG003|Overall Study|Progressive disease|3|||
157080407|NCT03525392|567048153|FG004|Overall Study|Progressive disease|1|||
157080408|NCT00831129|567048156|FG000|Overall Study|Adverse Event|0|||
157080409|NCT00831129|567048157|FG001|Overall Study|Adverse Event|1|||
157080410|NCT00831129|567048156|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
157080411|NCT00831129|567048157|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
157080412|NCT01669577|567048158|FG000|Overall Study|Death|22|||
157080413|NCT01669577|567048158|FG000|Overall Study|Lost to Follow-up|78|||
157080414|NCT01669577|567048158|FG000|Overall Study|Physician Decision|34|||
157080415|NCT04462289|567048161|FG000|Overall Study|Lost to Follow-up|4|||
157080416|NCT04462289|567048162|FG001|Overall Study|Lost to Follow-up|5|||
157080417|NCT04462289|567048161|FG000|Overall Study|Death|0|||
157080418|NCT04462289|567048162|FG001|Overall Study|Death|3|||
157080419|NCT04462289|567048161|FG000|Overall Study|Withdrawal by Subject|1|||
157080420|NCT04462289|567048162|FG001|Overall Study|Withdrawal by Subject|3|||
157080421|NCT00818779|567048163|FG000|Overall Study|Protocol Violation|1|||
157080422|NCT00818779|567048164|FG001|Overall Study|Protocol Violation|0|||
157080423|NCT00818779|567048163|FG000|Overall Study|Lost to Follow-up|1|||
157080424|NCT00818779|567048164|FG001|Overall Study|Lost to Follow-up|0|||
157080425|NCT00818779|567048163|FG000|Overall Study|Adverse Event|4|||
157080426|NCT00818779|567048164|FG001|Overall Study|Adverse Event|1|||
157080427|NCT01518153|567048165|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
157080428|NCT01518153|567048166|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
157080429|NCT01518153|567048167|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
157080430|NCT01518153|567048165|FG000|Stem Cell Transplant|Death|2|||
157080431|NCT01518153|567048166|FG001|Stem Cell Transplant|Death|0|||
157080432|NCT01518153|567048167|FG002|Stem Cell Transplant|Death|0|||
157080433|NCT01518153|567048165|FG000|Stem Cell Transplant|Secondary graft failure|1|||
157080434|NCT01518153|567048166|FG001|Stem Cell Transplant|Secondary graft failure|0|||
157080435|NCT01518153|567048167|FG002|Stem Cell Transplant|Secondary graft failure|0|||
157080436|NCT01518153|567048165|FG000|Stem Cell Transplant|Adverse Event|1|||
157080437|NCT01518153|567048166|FG001|Stem Cell Transplant|Adverse Event|0|||
157080438|NCT01518153|567048167|FG002|Stem Cell Transplant|Adverse Event|0|||
157080439|NCT01518153|567048165|FG000|Donor Lymphocyte Infusion|Death|0|||
157080440|NCT01518153|567048166|FG001|Donor Lymphocyte Infusion|Death|2|||
157080441|NCT01518153|567048167|FG002|Donor Lymphocyte Infusion|Death|1|||
157080442|NCT00132873|567048168|FG000|Overall Study|Adverse Event|3|||
157080443|NCT00132873|567048168|FG000|Overall Study|Lost to Follow-up|1|||
157080444|NCT00132873|567048168|FG000|Overall Study|Lack of Efficacy|1|||
157080445|NCT00132873|567048168|FG000|Overall Study|Withdrawal by Subject|3|||
157080446|NCT00132873|567048168|FG000|Overall Study|Planned Pregnancy|1|||
157080447|NCT04276415|567048169|FG000|Overall Study|Adverse Event|0|||
157080448|NCT04276415|567048170|FG001|Overall Study|Adverse Event|0|||
157080449|NCT04276415|567048171|FG002|Overall Study|Adverse Event|0|||
157080450|NCT04276415|567048172|FG003|Overall Study|Adverse Event|3|||
157080451|NCT04276415|567048173|FG004|Overall Study|Adverse Event|0|||
157080452|NCT04276415|567048174|FG005|Overall Study|Adverse Event|0|||
157080453|NCT04276415|567048169|FG000|Overall Study|Clinical progression|1|||
157080454|NCT04276415|567048170|FG001|Overall Study|Clinical progression|1|||
157080455|NCT04276415|567048171|FG002|Overall Study|Clinical progression|0|||
157080456|NCT04276415|567048172|FG003|Overall Study|Clinical progression|0|||
157080457|NCT04276415|567048173|FG004|Overall Study|Clinical progression|1|||
157080458|NCT04276415|567048174|FG005|Overall Study|Clinical progression|0|||
157080459|NCT04276415|567048169|FG000|Overall Study|Other|0|||
157080460|NCT04276415|567048170|FG001|Overall Study|Other|0|||
157080461|NCT04276415|567048171|FG002|Overall Study|Other|0|||
157080462|NCT04276415|567048172|FG003|Overall Study|Other|1|||
157080463|NCT04276415|567048173|FG004|Overall Study|Other|0|||
157080464|NCT04276415|567048174|FG005|Overall Study|Other|0|||
157080465|NCT04276415|567048169|FG000|Overall Study|Physician Decision|0|||
157080466|NCT04276415|567048170|FG001|Overall Study|Physician Decision|0|||
157080467|NCT04276415|567048171|FG002|Overall Study|Physician Decision|1|||
157080468|NCT04276415|567048172|FG003|Overall Study|Physician Decision|3|||
157080469|NCT04276415|567048173|FG004|Overall Study|Physician Decision|2|||
157080470|NCT04276415|567048174|FG005|Overall Study|Physician Decision|0|||
157080471|NCT04276415|567048169|FG000|Overall Study|Progressive disease|3|||
157080472|NCT04276415|567048170|FG001|Overall Study|Progressive disease|3|||
157080473|NCT04276415|567048171|FG002|Overall Study|Progressive disease|4|||
157080474|NCT04276415|567048172|FG003|Overall Study|Progressive disease|5|||
157080475|NCT04276415|567048173|FG004|Overall Study|Progressive disease|1|||
157080476|NCT04276415|567048174|FG005|Overall Study|Progressive disease|2|||
157080477|NCT04276415|567048169|FG000|Overall Study|Withdrawal by patient|0|||
157080478|NCT04276415|567048170|FG001|Overall Study|Withdrawal by patient|0|||
157080479|NCT04276415|567048171|FG002|Overall Study|Withdrawal by patient|0|||
157080480|NCT04276415|567048172|FG003|Overall Study|Withdrawal by patient|1|||
157080481|NCT04276415|567048173|FG004|Overall Study|Withdrawal by patient|2|||
157080482|NCT04276415|567048174|FG005|Overall Study|Withdrawal by patient|0|||
157080483|NCT03309813|567048175|FG000|Main Randomized Study|Withdrawal by Subject|1|||
157080484|NCT03309813|567048176|FG001|Main Randomized Study|Withdrawal by Subject|0|||
157080485|NCT04978493|567048177|FG000|Overall Study|No reason available|0|||
157080486|NCT04978493|567048178|FG001|Overall Study|No reason available|1|||
157080487|NCT04978493|567048177|FG000|Overall Study|Adverse Event|1|||
157080488|NCT04978493|567048178|FG001|Overall Study|Adverse Event|0|||
157080489|NCT01896726|567048179|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
157080490|NCT01896726|567048179|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
157080491|NCT00208325|567048180|FG000|Overall Study|Death|18|||
157080492|NCT00208325|567048181|FG001|Overall Study|Death|19|||
157080493|NCT00208325|567048182|FG002|Overall Study|Death|7|||
157080494|NCT00208325|567048183|FG003|Overall Study|Death|5|||
157080495|NCT00208325|567048180|FG000|Overall Study|Withdrawal by Subject|0|||
157080496|NCT00208325|567048181|FG001|Overall Study|Withdrawal by Subject|1|||
157080497|NCT00208325|567048182|FG002|Overall Study|Withdrawal by Subject|0|||
157080498|NCT00208325|567048183|FG003|Overall Study|Withdrawal by Subject|0|||
157080499|NCT00208325|567048180|FG000|Overall Study|Revision|4|||
157080500|NCT00208325|567048181|FG001|Overall Study|Revision|1|||
157080501|NCT00208325|567048182|FG002|Overall Study|Revision|0|||
157080502|NCT00208325|567048183|FG003|Overall Study|Revision|4|||
157080503|NCT00208325|567048180|FG000|Overall Study|Lost to Follow-up|1|||
157080504|NCT00208325|567048181|FG001|Overall Study|Lost to Follow-up|0|||
157080505|NCT00208325|567048182|FG002|Overall Study|Lost to Follow-up|2|||
157080506|NCT00208325|567048183|FG003|Overall Study|Lost to Follow-up|0|||
157080507|NCT00208325|567048180|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
157080508|NCT00208325|567048181|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
157080509|NCT00208325|567048182|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
157080510|NCT00208325|567048183|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
157080511|NCT00208325|567048180|FG000|Overall Study|Does not wish to Continue in Study|5|||
157193014|NCT02394028|567447215|FG000|Maintenance Phase|Site closure|0|||
157080512|NCT00208325|567048181|FG001|Overall Study|Does not wish to Continue in Study|8|||
157080513|NCT00208325|567048182|FG002|Overall Study|Does not wish to Continue in Study|3|||
157080514|NCT00208325|567048183|FG003|Overall Study|Does not wish to Continue in Study|2|||
157080515|NCT00208325|567048180|FG000|Overall Study|Other|2|||
157080516|NCT00208325|567048181|FG001|Overall Study|Other|1|||
157080517|NCT00208325|567048182|FG002|Overall Study|Other|1|||
157080518|NCT00208325|567048183|FG003|Overall Study|Other|0|||
157080519|NCT00208325|567048180|FG000|Overall Study|Mis-Randomized|17|||
157080520|NCT00208325|567048181|FG001|Overall Study|Mis-Randomized|20|||
157080521|NCT00208325|567048182|FG002|Overall Study|Mis-Randomized|0|||
157080522|NCT00208325|567048183|FG003|Overall Study|Mis-Randomized|0|||
157080523|NCT01327846|567048184|FG000|Core Phase|Subject decision (vital status: missing)|1|||
157080524|NCT01327846|567048185|FG001|Core Phase|Subject decision (vital status: missing)|2|||
157080525|NCT01327846|567048186|FG002|Core Phase|Subject decision (vital status: missing)|2|||
157080526|NCT01327846|567048187|FG003|Core Phase|Subject decision (vital status: missing)|1|||
157080527|NCT01327846|567048184|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
157080528|NCT01327846|567048185|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
157080529|NCT01327846|567048186|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
157080530|NCT01327846|567048187|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
157080531|NCT01327846|567048184|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
157080532|NCT01327846|567048185|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
157080533|NCT01327846|567048186|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
157080534|NCT01327846|567048187|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
157080535|NCT01327846|567048184|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
157080536|NCT01327846|567048185|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
157080537|NCT01327846|567048186|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
157080538|NCT01327846|567048187|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
157080539|NCT01327846|567048184|FG000|Core Phase|Lost to Follow-up|3|||
157080540|NCT01327846|567048185|FG001|Core Phase|Lost to Follow-up|3|||
157080541|NCT01327846|567048186|FG002|Core Phase|Lost to Follow-up|4|||
157080542|NCT01327846|567048187|FG003|Core Phase|Lost to Follow-up|5|||
157080543|NCT01327846|567048184|FG000|Extension Phase|Study terminated by sponsor|1073|||
157080544|NCT01327846|567048185|FG001|Extension Phase|Study terminated by sponsor|1124|||
157080545|NCT01327846|567048186|FG002|Extension Phase|Study terminated by sponsor|1067|||
157080546|NCT01327846|567048187|FG003|Extension Phase|Study terminated by sponsor|1660|||
157080547|NCT01327846|567048184|FG000|Extension Phase|Withdrawal by Subject|20|||
157080548|NCT01327846|567048185|FG001|Extension Phase|Withdrawal by Subject|13|||
157080549|NCT01327846|567048186|FG002|Extension Phase|Withdrawal by Subject|19|||
157080550|NCT01327846|567048187|FG003|Extension Phase|Withdrawal by Subject|37|||
157080551|NCT01327846|567048184|FG000|Extension Phase|Lost to Follow-up|4|||
157080552|NCT01327846|567048185|FG001|Extension Phase|Lost to Follow-up|3|||
157080553|NCT01327846|567048186|FG002|Extension Phase|Lost to Follow-up|4|||
157080554|NCT01327846|567048187|FG003|Extension Phase|Lost to Follow-up|7|||
157080555|NCT01327846|567048184|FG000|Extension Phase|Technical Problems|2|||
157080556|NCT01327846|567048185|FG001|Extension Phase|Technical Problems|4|||
157080557|NCT01327846|567048186|FG002|Extension Phase|Technical Problems|2|||
157080558|NCT01327846|567048187|FG003|Extension Phase|Technical Problems|2|||
157080559|NCT04662931|567048188|FG000|Overall Study|Withdrawal by Subject|17|||
157080560|NCT04662931|567048188|FG000|Overall Study|Death|3|||
157080561|NCT04662931|567048188|FG000|Overall Study|Lost to Follow-up|3|||
157080562|NCT04662931|567048188|FG000|Overall Study|Guardian Decision|1|||
157080563|NCT04343976|567048192|FG000|Overall Study|Withdrawal by Subject|0|||
157080564|NCT04343976|567048193|FG001|Overall Study|Withdrawal by Subject|1|||
157080565|NCT02807883|567048194|FG000|Overall Study|Withdrawal by Subject|2|||
157080566|NCT02406677|567048195|FG000|Overall Study|Death|16|||
157080567|NCT02406677|567048196|FG001|Overall Study|Death|8|||
157080568|NCT02406677|567048195|FG000|Overall Study|Discharged without P2Y12|1|||
157080569|NCT02406677|567048196|FG001|Overall Study|Discharged without P2Y12|3|||
157080570|NCT02406677|567048195|FG000|Overall Study|Discharged on prasugrel|283|||
157080571|NCT02406677|567048196|FG001|Overall Study|Discharged on prasugrel|587|||
157080572|NCT02406677|567048195|FG000|Overall Study|Withdrawal by Subject|1|||
157080573|NCT02406677|567048196|FG001|Overall Study|Withdrawal by Subject|0|||
157080574|NCT02145468|567048199|FG000|Overall Study|Withdrawal by Subject|5|||
157080575|NCT02145468|567048200|FG001|Overall Study|Withdrawal by Subject|8|||
157080576|NCT01217437|567048206|FG000|Overall Study|Adverse Event|0|||
157080577|NCT01217437|567048207|FG001|Overall Study|Adverse Event|8|||
157193015|NCT02394028|567447216|FG001|Maintenance Phase|Site closure|0|||
157193016|NCT02394028|567447217|FG002|Maintenance Phase|Site closure|0|||
157193017|NCT02394028|567447218|FG003|Maintenance Phase|Site closure|0|||
157080578|NCT01217437|567048206|FG000|Overall Study|Death|5|||
157080579|NCT01217437|567048207|FG001|Overall Study|Death|0|||
157080580|NCT01217437|567048206|FG000|Overall Study|Lack of Efficacy|29|||
157080581|NCT01217437|567048207|FG001|Overall Study|Lack of Efficacy|25|||
157080582|NCT01217437|567048206|FG000|Overall Study|Physician Decision|8|||
157080583|NCT01217437|567048207|FG001|Overall Study|Physician Decision|5|||
157080584|NCT01217437|567048206|FG000|Overall Study|Withdrawal by Subject|0|||
157080585|NCT01217437|567048207|FG001|Overall Study|Withdrawal by Subject|2|||
157080586|NCT01217437|567048206|FG000|Overall Study|Ineligible|1|||
157080587|NCT01217437|567048207|FG001|Overall Study|Ineligible|1|||
157080588|NCT04908631|567048210|FG000|Overall Study|Lost to Follow-up|1|||
157080589|NCT04908631|567048210|FG000|Overall Study|Physician Decision|1|||
157193018|NCT02394028|567447219|FG004|Maintenance Phase|Site closure|0|||
157080590|NCT04908631|567048210|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
157080591|NCT06655558|567048211|FG000|Overall Study|Protocol Violation|1|||
157080592|NCT00387426|567049463|FG000|Overall Study|Lack of Response|7|||
157080593|NCT00387426|567049463|FG000|Overall Study|Toxicities|4|||
157080594|NCT00387426|567049463|FG000|Overall Study|Disease Progression|3|||
157080595|NCT00890695|567049466|FG000|Overall Study|Protocol Violation|1|||
157080596|NCT00890695|567049467|FG001|Overall Study|Protocol Violation|0|||
157080597|NCT02314780|567049470|FG000|Overall Study|organizational reasons|0|||
157080598|NCT02314780|567049471|FG001|Overall Study|organizational reasons|2|||
157080599|NCT02314780|567049472|FG002|Overall Study|organizational reasons|0|||
157080600|NCT02314780|567049470|FG000|Overall Study|Adverse Event|0|||
157080601|NCT02314780|567049471|FG001|Overall Study|Adverse Event|1|||
157080602|NCT02314780|567049472|FG002|Overall Study|Adverse Event|0|||
157080603|NCT00379288|567049475|FG000|Overall Study|Adverse Event|5|||
157080604|NCT00379288|567049476|FG001|Overall Study|Adverse Event|6|||
157080605|NCT00379288|567049477|FG002|Overall Study|Adverse Event|2|||
157080606|NCT00379288|567049478|FG003|Overall Study|Adverse Event|0|||
157080607|NCT00379288|567049475|FG000|Overall Study|Treatment Failure|0|||
157080608|NCT00379288|567049476|FG001|Overall Study|Treatment Failure|1|||
157080609|NCT00379288|567049477|FG002|Overall Study|Treatment Failure|0|||
157080610|NCT00379288|567049478|FG003|Overall Study|Treatment Failure|1|||
157080611|NCT00379288|567049475|FG000|Overall Study|Lost to Follow-up|3|||
157080612|NCT00379288|567049476|FG001|Overall Study|Lost to Follow-up|3|||
157080613|NCT00379288|567049477|FG002|Overall Study|Lost to Follow-up|2|||
157080614|NCT00379288|567049478|FG003|Overall Study|Lost to Follow-up|0|||
157080615|NCT00379288|567049475|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
157080616|NCT00379288|567049476|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
157080617|NCT00379288|567049477|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
157080618|NCT00379288|567049478|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
157080619|NCT00379288|567049475|FG000|Overall Study|Subject withdrew-related to study drug|1|||
157080620|NCT00379288|567049476|FG001|Overall Study|Subject withdrew-related to study drug|0|||
157080621|NCT00379288|567049477|FG002|Overall Study|Subject withdrew-related to study drug|0|||
157080622|NCT00379288|567049478|FG003|Overall Study|Subject withdrew-related to study drug|1|||
157080623|NCT00379288|567049475|FG000|Overall Study|Noncompliance with protocol|8|||
157080624|NCT00379288|567049476|FG001|Overall Study|Noncompliance with protocol|6|||
157080625|NCT00379288|567049477|FG002|Overall Study|Noncompliance with protocol|2|||
157080626|NCT00379288|567049478|FG003|Overall Study|Noncompliance with protocol|1|||
157080627|NCT00379288|567049475|FG000|Overall Study|Did not meet protocol eligibility|0|||
157080628|NCT00379288|567049476|FG001|Overall Study|Did not meet protocol eligibility|1|||
157080629|NCT00379288|567049477|FG002|Overall Study|Did not meet protocol eligibility|0|||
157080630|NCT00379288|567049478|FG003|Overall Study|Did not meet protocol eligibility|2|||
157080631|NCT00379288|567049475|FG000|Overall Study|Administrative|2|||
157080632|NCT00379288|567049476|FG001|Overall Study|Administrative|2|||
157080633|NCT00379288|567049477|FG002|Overall Study|Administrative|0|||
157080634|NCT00379288|567049478|FG003|Overall Study|Administrative|1|||
157080635|NCT04396366|567049479|FG000|Overall Study|Adverse Event|1|||
157080636|NCT04396366|567049480|FG001|Overall Study|Adverse Event|0|||
157080637|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
157080638|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
157080639|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
157080640|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
157080641|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
157080642|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
157080643|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
157080644|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
157080645|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
157080646|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
157080647|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
157080648|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
157080649|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Death|1|||
157080650|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Death|2|||
157080651|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Death|2|||
157080652|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Death|0|||
157080653|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Death|0|||
157080654|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Death|0|||
157080655|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
157080656|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
157193019|NCT02394028|567447220|FG005|Maintenance Phase|Site closure|0|||
157193020|NCT02394028|567447221|FG006|Maintenance Phase|Site closure|0|||
157193021|NCT02394028|567447222|FG007|Maintenance Phase|Site closure|0|||
157193022|NCT02394028|567447223|FG008|Maintenance Phase|Site closure|0|||
157193023|NCT02394028|567447224|FG009|Maintenance Phase|Site closure|1|||
157193024|NCT02394028|567447225|FG010|Maintenance Phase|Site closure|0|||
157080657|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
157080658|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
157080659|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
157080660|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
157080661|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
157080662|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
157080663|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
157080664|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
157080665|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
157080666|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
157080667|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
157080668|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
157080669|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
157080670|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
157080671|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
157080672|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
157080673|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
157080674|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
157080675|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
157080676|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
157080677|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
157080678|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
157080679|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
157080680|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
157080681|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
157080682|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
157080683|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
157080684|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
157080685|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
157080686|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
157080687|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
157080688|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
157080689|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
157080690|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
157080691|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
157080692|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
157080693|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
157080694|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
157080695|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
157080696|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
157080697|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Site closure|0|||
157080698|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Site closure|0|||
157080699|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Site closure|1|||
157080700|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Site closure|0|||
157080701|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Site closure|0|||
157080702|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Site closure|0|||
157080703|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
157080704|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
157080705|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
157080706|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
157080707|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
157080708|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
157080709|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
157080710|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
157080711|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
157080712|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
157080713|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
157080714|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
157080715|NCT03439254|567049483|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
157080716|NCT03439254|567049484|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
157080717|NCT03439254|567049485|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
157080718|NCT03439254|567049486|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
157080719|NCT03439254|567049487|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
157080720|NCT03439254|567049488|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
157080721|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
157080722|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
157080723|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
157080724|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
157080725|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
157080726|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
157080727|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
157080728|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
157080729|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
157080730|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
157080731|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
157080732|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
157080733|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
157080734|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
157080735|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
157080736|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
157080737|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
157080738|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
157080739|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
157080740|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
157080741|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
157080742|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
157080743|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
157080744|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
157080745|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
157080746|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
157080747|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
157080748|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
157080749|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
157080750|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
157080751|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
157080752|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
157080753|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
157080754|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
157080755|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
157080756|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
157080757|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
157080758|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
157080759|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
157080760|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
157080761|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
157080762|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
157080763|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
157080764|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
157080765|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
157080766|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
157080767|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
157080768|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
157080769|NCT03439254|567049483|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
157080770|NCT03439254|567049484|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
157080771|NCT03439254|567049485|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
157080772|NCT03439254|567049486|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
157080773|NCT03439254|567049487|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
157080774|NCT03439254|567049488|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
157232731|NCT01389102|567599049|FG001|Overall Study|Withdrawal by Subject|4|||
157232732|NCT01389102|567599050|FG002|Overall Study|Withdrawal by Subject|9|||
157232733|NCT01389102|567599051|FG003|Overall Study|Withdrawal by Subject|2|||
157232734|NCT01389102|567599052|FG004|Overall Study|Withdrawal by Subject|3|||
157232735|NCT01389102|567599053|FG005|Overall Study|Withdrawal by Subject|3|||
157232736|NCT01389102|567599048|FG000|Overall Study|Subject Traveling Out of Country|0|||
157080775|NCT01531673|567049489|FG000|Overall Study|Non-Compliance|0|||
157080776|NCT01531673|567049490|FG001|Overall Study|Non-Compliance|0|||
157080777|NCT01531673|567049491|FG002|Overall Study|Non-Compliance|0|||
157080778|NCT01531673|567049492|FG003|Overall Study|Non-Compliance|0|||
157080779|NCT01531673|567049493|FG004|Overall Study|Non-Compliance|0|||
157080780|NCT01531673|567049494|FG005|Overall Study|Non-Compliance|1|||
157080781|NCT01531673|567049495|FG006|Overall Study|Non-Compliance|0|||
157080782|NCT01531673|567049496|FG007|Overall Study|Non-Compliance|0|||
157080783|NCT01531673|567049497|FG008|Overall Study|Non-Compliance|0|||
157080784|NCT01531673|567049498|FG009|Overall Study|Non-Compliance|0|||
157080785|NCT01531673|567049499|FG010|Overall Study|Non-Compliance|0|||
157080786|NCT01531673|567049500|FG011|Overall Study|Non-Compliance|0|||
157080787|NCT01531673|567049501|FG012|Overall Study|Non-Compliance|0|||
157080788|NCT01531673|567049489|FG000|Overall Study|Adverse Event|0|||
157080789|NCT01531673|567049490|FG001|Overall Study|Adverse Event|1|||
157080790|NCT01531673|567049491|FG002|Overall Study|Adverse Event|0|||
157080791|NCT01531673|567049492|FG003|Overall Study|Adverse Event|0|||
157080792|NCT01531673|567049493|FG004|Overall Study|Adverse Event|0|||
157080793|NCT01531673|567049494|FG005|Overall Study|Adverse Event|0|||
157080794|NCT01531673|567049495|FG006|Overall Study|Adverse Event|0|||
157080795|NCT01531673|567049496|FG007|Overall Study|Adverse Event|0|||
157080796|NCT01531673|567049497|FG008|Overall Study|Adverse Event|0|||
157080797|NCT01531673|567049498|FG009|Overall Study|Adverse Event|0|||
157080798|NCT01531673|567049499|FG010|Overall Study|Adverse Event|0|||
157080799|NCT01531673|567049500|FG011|Overall Study|Adverse Event|0|||
157080800|NCT01531673|567049501|FG012|Overall Study|Adverse Event|0|||
157080801|NCT01531673|567049489|FG000|Overall Study|Lost to Follow-up|0|||
157080802|NCT01531673|567049490|FG001|Overall Study|Lost to Follow-up|0|||
157080803|NCT01531673|567049491|FG002|Overall Study|Lost to Follow-up|0|||
157080804|NCT01531673|567049492|FG003|Overall Study|Lost to Follow-up|0|||
157080805|NCT01531673|567049493|FG004|Overall Study|Lost to Follow-up|1|||
157080806|NCT01531673|567049494|FG005|Overall Study|Lost to Follow-up|0|||
157080807|NCT01531673|567049495|FG006|Overall Study|Lost to Follow-up|0|||
157080808|NCT01531673|567049496|FG007|Overall Study|Lost to Follow-up|0|||
157080809|NCT01531673|567049497|FG008|Overall Study|Lost to Follow-up|0|||
157080810|NCT01531673|567049498|FG009|Overall Study|Lost to Follow-up|0|||
157080811|NCT01531673|567049499|FG010|Overall Study|Lost to Follow-up|0|||
157080812|NCT01531673|567049500|FG011|Overall Study|Lost to Follow-up|0|||
157080813|NCT01531673|567049501|FG012|Overall Study|Lost to Follow-up|0|||
157080814|NCT01531673|567049489|FG000|Overall Study|Other|0|||
157080815|NCT01531673|567049490|FG001|Overall Study|Other|0|||
157080816|NCT01531673|567049491|FG002|Overall Study|Other|0|||
157080817|NCT01531673|567049492|FG003|Overall Study|Other|1|||
157080818|NCT01531673|567049493|FG004|Overall Study|Other|0|||
157080819|NCT01531673|567049494|FG005|Overall Study|Other|0|||
157080820|NCT01531673|567049495|FG006|Overall Study|Other|0|||
157080821|NCT01531673|567049496|FG007|Overall Study|Other|0|||
157080822|NCT01531673|567049497|FG008|Overall Study|Other|0|||
157080823|NCT01531673|567049498|FG009|Overall Study|Other|1|||
157080824|NCT01531673|567049499|FG010|Overall Study|Other|0|||
157080825|NCT01531673|567049500|FG011|Overall Study|Other|0|||
157080826|NCT01531673|567049501|FG012|Overall Study|Other|0|||
157080827|NCT04476251|567049502|FG000|Overall Study|Not treated|1|||
157080828|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Physician Decision|2|||
157080829|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Physician Decision|0|||
157080830|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Physician Decision|0|||
157080831|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Adverse Event|33|||
157080832|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Adverse Event|0|||
157080833|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Adverse Event|0|||
157080834|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
157080835|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
157080836|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
157080837|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
157080838|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
157080839|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
157080840|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
157080841|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
157080842|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
157080843|NCT01008553|567049503|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
157080844|NCT01008553|567049504|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
157080845|NCT01008553|567049505|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
157080846|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
157080847|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
157080848|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
157080849|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
157080850|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
157080851|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
157080852|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
157080853|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
157080854|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
157080855|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
157080856|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
157080857|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
157080858|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
157080859|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
157080860|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
157080861|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
157080862|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
157080863|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
157080864|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
157080865|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
157080866|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
157080867|NCT01008553|567049503|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
157080868|NCT01008553|567049504|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
157080869|NCT01008553|567049505|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
157080870|NCT01008410|567049509|FG000|Overall Study|Adverse Event|13|||
157080871|NCT01008410|567049510|FG001|Overall Study|Adverse Event|7|||
157080872|NCT01008410|567049509|FG000|Overall Study|Withdrawal by Subject|6|||
157080873|NCT01008410|567049510|FG001|Overall Study|Withdrawal by Subject|2|||
157080874|NCT01008410|567049509|FG000|Overall Study|Lost to Follow-up|1|||
157080875|NCT01008410|567049510|FG001|Overall Study|Lost to Follow-up|0|||
157080876|NCT01008410|567049509|FG000|Overall Study|Noncompliance|1|||
157080877|NCT01008410|567049510|FG001|Overall Study|Noncompliance|0|||
157080878|NCT01008410|567049509|FG000|Overall Study|Low Cortisol|2|||
157080879|NCT01008410|567049510|FG001|Overall Study|Low Cortisol|0|||
157080880|NCT01008410|567049509|FG000|Overall Study|Lack of Efficacy|2|||
157080881|NCT01008410|567049510|FG001|Overall Study|Lack of Efficacy|6|||
157080882|NCT01008410|567049509|FG000|Overall Study|Met Exclusion Criterion|0|||
157080883|NCT01008410|567049510|FG001|Overall Study|Met Exclusion Criterion|1|||
157080884|NCT00297427|567049511|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
157080885|NCT00297427|567049512|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
157080886|NCT00297427|567049511|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
157080887|NCT00297427|567049512|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
157080888|NCT00297427|567049511|FG000|Phase 1: Initial Intervention|Death|0|||
157080889|NCT00297427|567049512|FG001|Phase 1: Initial Intervention|Death|1|||
157080890|NCT00297427|567049511|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
157080891|NCT00297427|567049512|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
157080892|NCT00297427|567049511|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
157080893|NCT00297427|567049512|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
157080894|NCT00297427|567049511|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
157080895|NCT00297427|567049512|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
157080896|NCT00297427|567049511|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
157080897|NCT00297427|567049512|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
157080898|NCT00297427|567049511|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
157080899|NCT00297427|567049512|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
157080900|NCT01262677|567049513|FG000|Overall Study|Does not meet entrance criteria|0|||
157080901|NCT01262677|567049514|FG001|Overall Study|Does not meet entrance criteria|2|||
157080902|NCT01262677|567049515|FG002|Overall Study|Does not meet entrance criteria|0|||
157080903|NCT01262677|567049513|FG000|Overall Study|Insufficient clinical response|0|||
157080904|NCT01262677|567049514|FG001|Overall Study|Insufficient clinical response|0|||
157080905|NCT01262677|567049515|FG002|Overall Study|Insufficient clinical response|1|||
157080906|NCT01262677|567049513|FG000|Overall Study|Lost to Follow-up|1|||
157080907|NCT01262677|567049514|FG001|Overall Study|Lost to Follow-up|0|||
157080908|NCT01262677|567049515|FG002|Overall Study|Lost to Follow-up|2|||
157080909|NCT01262677|567049513|FG000|Overall Study|No longer willing to participate|3|||
157232737|NCT01389102|567599049|FG001|Overall Study|Subject Traveling Out of Country|0|||
157080910|NCT01262677|567049514|FG001|Overall Study|No longer willing to participate|3|||
157080911|NCT01262677|567049515|FG002|Overall Study|No longer willing to participate|2|||
157080912|NCT01262677|567049513|FG000|Overall Study|Reason not provided|2|||
157080913|NCT01262677|567049514|FG001|Overall Study|Reason not provided|1|||
157080914|NCT01262677|567049515|FG002|Overall Study|Reason not provided|3|||
157080915|NCT01262677|567049513|FG000|Overall Study|Protocol Violation|0|||
157080916|NCT01262677|567049514|FG001|Overall Study|Protocol Violation|1|||
157080917|NCT01262677|567049515|FG002|Overall Study|Protocol Violation|1|||
157080918|NCT01262677|567049513|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
157080919|NCT01262677|567049514|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
157080920|NCT01262677|567049515|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
157080921|NCT01638429|567049518|FG000|Overall Study|Withdrawal by Subject|1|||
157080922|NCT03889704|567049519|FG000|Overall Study|Study terminated due to pandemic|1|||
157080923|NCT02591953|567049522|FG000|Overall Study|Lost to Follow-up|6|||
157080924|NCT02591953|567049523|FG001|Overall Study|Lost to Follow-up|6|||
157080925|NCT02060370|567049524|FG000|Overall Study|Physician Decision|1|||
157080926|NCT01896557|567049525|FG000|Clopidogrel Alone|Adverse Event|1|||
157080927|NCT01896557|567049526|FG001|Clopidogrel Alone|Adverse Event|0|||
157080928|NCT01896557|567049525|FG000|Clopidogrel + GI Protector|low adherence|1|||
157080929|NCT01896557|567049526|FG001|Clopidogrel + GI Protector|low adherence|1|||
157080930|NCT01896557|567049525|FG000|Clopidogrel + GI Protector|Reading error|1|||
157080931|NCT01896557|567049526|FG001|Clopidogrel + GI Protector|Reading error|3|||
157080932|NCT01517295|567049527|FG000|Overall Study|Physician Decision|1|||
157080933|NCT01517295|567049528|FG001|Overall Study|Physician Decision|0|||
157080934|NCT00743431|567049535|FG000|Overall Study|Toxicity|6|||
157080935|NCT00743431|567049535|FG000|Overall Study|Tumor progression|56|||
157080936|NCT00743431|567049535|FG000|Overall Study|Withdrawal by Subject|13|||
157080937|NCT00743431|567049535|FG000|Overall Study|Death|9|||
157080938|NCT00743431|567049535|FG000|Overall Study|Reason for discontinuation not specified|29|||
157080939|NCT00743431|567049535|FG000|Overall Study|No documentation available|13|||
157080940|NCT03291288|567049536|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
157080941|NCT03291288|567049537|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
157080942|NCT03291288|567049536|FG000|Drug-drug Interaction Phase|Disease progression|1|||
157080943|NCT03291288|567049537|FG001|Drug-drug Interaction Phase|Disease progression|0|||
157080944|NCT03291288|567049536|FG000|Drug-drug Interaction Phase|Other|3|||
157080945|NCT03291288|567049537|FG001|Drug-drug Interaction Phase|Other|0|||
157080946|NCT03291288|567049536|FG000|Pexidartinib Only|Ongoing|0|||
157080947|NCT03291288|567049537|FG001|Pexidartinib Only|Ongoing|2|||
157080948|NCT01128114|567049538|FG000|Overall Study|Treatment Withdrawn|6|||
157080949|NCT01128114|567049538|FG000|Overall Study|Screening Failed|2|||
157080950|NCT01254747|567049539|FG000|Overall Study|Unacceptable subjective vision|0|||
157080951|NCT01254747|567049540|FG001|Overall Study|Unacceptable subjective vision|0|||
157080952|NCT01254747|567049541|FG002|Overall Study|Unacceptable subjective vision|0|||
157080953|NCT01254747|567049542|FG003|Overall Study|Unacceptable subjective vision|2|||
157080954|NCT01254747|567049539|FG000|Overall Study|Difficult removal handling|0|||
157080955|NCT01254747|567049540|FG001|Overall Study|Difficult removal handling|0|||
157080956|NCT01254747|567049541|FG002|Overall Study|Difficult removal handling|1|||
157080957|NCT01254747|567049542|FG003|Overall Study|Difficult removal handling|0|||
157080958|NCT01254747|567049539|FG000|Overall Study|Symptoms and problems|0|||
157080959|NCT01254747|567049540|FG001|Overall Study|Symptoms and problems|2|||
157080960|NCT01254747|567049541|FG002|Overall Study|Symptoms and problems|1|||
157080961|NCT01254747|567049542|FG003|Overall Study|Symptoms and problems|0|||
157080962|NCT01254747|567049539|FG000|Overall Study|Lost to Follow-up|0|||
157080963|NCT01254747|567049540|FG001|Overall Study|Lost to Follow-up|0|||
157080964|NCT01254747|567049541|FG002|Overall Study|Lost to Follow-up|1|||
157080965|NCT01254747|567049542|FG003|Overall Study|Lost to Follow-up|0|||
157080966|NCT01254747|567049539|FG000|Overall Study|Biomicroscopy|0|||
157080967|NCT01254747|567049540|FG001|Overall Study|Biomicroscopy|0|||
157080968|NCT01254747|567049541|FG002|Overall Study|Biomicroscopy|1|||
157080969|NCT01254747|567049542|FG003|Overall Study|Biomicroscopy|0|||
157080970|NCT01254747|567049539|FG000|Overall Study|Discomfort|0|||
157080971|NCT01254747|567049540|FG001|Overall Study|Discomfort|4|||
157080972|NCT01254747|567049541|FG002|Overall Study|Discomfort|0|||
157080973|NCT01254747|567049542|FG003|Overall Study|Discomfort|0|||
157080974|NCT04187326|567049543|FG000|Overall Study|Lost to Follow-up|2|||
157080975|NCT04187326|567049544|FG001|Overall Study|Lost to Follow-up|1|||
157080976|NCT04187326|567049543|FG000|Overall Study|Computer error- task was only partially completed.|0|||
157080977|NCT04187326|567049544|FG001|Overall Study|Computer error- task was only partially completed.|1|||
157080978|NCT02387970|567049547|FG000|Overall Study|Did not complete 1-year follow up|1|||
157080979|NCT02387970|567049548|FG001|Overall Study|Did not complete 1-year follow up|2|||
157080980|NCT04531098|567049549|FG000|Stage I|Adverse Event|0|||
157080981|NCT04531098|567049550|FG001|Stage I|Adverse Event|0|||
157232738|NCT01389102|567599050|FG002|Overall Study|Subject Traveling Out of Country|0|||
157232739|NCT01389102|567599051|FG003|Overall Study|Subject Traveling Out of Country|1|||
157080982|NCT04531098|567049551|FG002|Stage I|Adverse Event|3|||
157080983|NCT04531098|567049549|FG000|Stage I|Protocol Violation|0|||
157080984|NCT04531098|567049550|FG001|Stage I|Protocol Violation|0|||
157080985|NCT04531098|567049551|FG002|Stage I|Protocol Violation|5|||
157080986|NCT04531098|567049549|FG000|Stage I|Withdrawal by Subject|0|||
157080987|NCT04531098|567049550|FG001|Stage I|Withdrawal by Subject|5|||
157232740|NCT01389102|567599052|FG004|Overall Study|Subject Traveling Out of Country|0|||
157232741|NCT01389102|567599053|FG005|Overall Study|Subject Traveling Out of Country|0|||
157080988|NCT04531098|567049551|FG002|Stage I|Withdrawal by Subject|10|||
157080989|NCT04531098|567049549|FG000|Stage II|Adverse Event|1|||
157080990|NCT04531098|567049550|FG001|Stage II|Adverse Event|2|||
157080991|NCT04531098|567049551|FG002|Stage II|Adverse Event|0|||
157080992|NCT04531098|567049549|FG000|Stage II|Protocol Violation|1|||
157080993|NCT04531098|567049550|FG001|Stage II|Protocol Violation|2|||
157080994|NCT04531098|567049551|FG002|Stage II|Protocol Violation|0|||
157080995|NCT04531098|567049549|FG000|Stage II|Withdrawal by Subject|3|||
157080996|NCT04531098|567049550|FG001|Stage II|Withdrawal by Subject|1|||
157080997|NCT04531098|567049551|FG002|Stage II|Withdrawal by Subject|0|||
157080998|NCT04531098|567049549|FG000|Stage II|Moved from study area|8|||
157080999|NCT04531098|567049550|FG001|Stage II|Moved from study area|5|||
157081000|NCT04531098|567049551|FG002|Stage II|Moved from study area|0|||
157081001|NCT00586612|567049552|FG000|Primary Phase|Protocol Violation|1|||
157081002|NCT00586612|567049553|FG001|Primary Phase|Protocol Violation|0|||
157081003|NCT00586612|567049552|FG000|Primary Phase|Lost to Follow-up|0|||
157081004|NCT00586612|567049553|FG001|Primary Phase|Lost to Follow-up|1|||
157081005|NCT00586612|567049552|FG000|Primary Phase|Withdrawal by Subject|0|||
157081006|NCT00586612|567049553|FG001|Primary Phase|Withdrawal by Subject|2|||
157081007|NCT00586612|567049552|FG000|Booster Phase|Lost to Follow-up|3|||
157081008|NCT00586612|567049553|FG001|Booster Phase|Lost to Follow-up|1|||
157081009|NCT05543707|567049558|FG000|Overall Study|Study drug non-compliance/|5|||
157081010|NCT05543707|567049559|FG001|Overall Study|Study drug non-compliance/|0|||
157081011|NCT05543707|567049558|FG000|Overall Study|Withdrawal by Subject|1|||
157081012|NCT05543707|567049559|FG001|Overall Study|Withdrawal by Subject|1|||
157081013|NCT05543707|567049558|FG000|Overall Study|Adverse Event|1|||
157081014|NCT05543707|567049559|FG001|Overall Study|Adverse Event|0|||
157081015|NCT05543707|567049558|FG000|Overall Study|concurrent illness|0|||
157081016|NCT05543707|567049559|FG001|Overall Study|concurrent illness|1|||
157081017|NCT05543707|567049558|FG000|Overall Study|Pregnancy|1|||
157081018|NCT05543707|567049559|FG001|Overall Study|Pregnancy|1|||
157081019|NCT04777864|567049560|FG000|Overall Study|Lost to Follow-up|8|||
157081020|NCT04777864|567049561|FG001|Overall Study|Lost to Follow-up|19|||
157081021|NCT03086655|567049562|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
157081022|NCT03086655|567049563|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
157081023|NCT03086655|567049562|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
157081024|NCT03086655|567049563|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
157081025|NCT03086655|567049562|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
157081026|NCT03086655|567049563|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
157081027|NCT03086655|567049562|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
157081028|NCT03086655|567049563|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
157081029|NCT03086655|567049562|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
157081030|NCT03086655|567049563|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
157081031|NCT03086655|567049562|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
157081032|NCT03086655|567049563|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
157081033|NCT03086655|567049562|FG000|12 Month Follow-up = Final Assessment|Death|0|||
157081034|NCT03086655|567049563|FG001|12 Month Follow-up = Final Assessment|Death|1|||
157081035|NCT00798434|567049564|FG000|Double-Blind|Adverse Event|22|||
157081036|NCT00798434|567049565|FG001|Double-Blind|Adverse Event|46|||
157081037|NCT00798434|567049564|FG000|Double-Blind|Death|0|||
157081038|NCT00798434|567049565|FG001|Double-Blind|Death|1|||
157081039|NCT00798434|567049564|FG000|Double-Blind|Lost to Follow-up|1|||
157081040|NCT00798434|567049565|FG001|Double-Blind|Lost to Follow-up|0|||
157232742|NCT01389102|567599048|FG000|Overall Study|Subject Moved|2|||
157081041|NCT00798434|567049564|FG000|Double-Blind|Lack of Efficacy|8|||
157081042|NCT00798434|567049565|FG001|Double-Blind|Lack of Efficacy|12|||
157081043|NCT00798434|567049564|FG000|Double-Blind|Withdrawal by Subject|17|||
157081044|NCT00798434|567049565|FG001|Double-Blind|Withdrawal by Subject|14|||
157081045|NCT00798434|567049564|FG000|Double-Blind|Protocol Violation|1|||
157081046|NCT00798434|567049565|FG001|Double-Blind|Protocol Violation|4|||
157081047|NCT00798434|567049564|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
157081048|NCT00798434|567049565|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
157081049|NCT00798434|567049564|FG000|Double-Blind|Other|1|||
157081050|NCT00798434|567049565|FG001|Double-Blind|Other|0|||
157081051|NCT00798434|567049564|FG000|Double-Blind|Not Treated|3|||
157081052|NCT00798434|567049565|FG001|Double-Blind|Not Treated|6|||
157081053|NCT00798434|567049564|FG000|Open-Label|Adverse Event|33|||
157081054|NCT00798434|567049565|FG001|Open-Label|Adverse Event|11|||
157081055|NCT00798434|567049564|FG000|Open-Label|Lack of Efficacy|5|||
157081056|NCT00798434|567049565|FG001|Open-Label|Lack of Efficacy|11|||
157081057|NCT00798434|567049564|FG000|Open-Label|Withdrawal by Subject|2|||
157081058|NCT00798434|567049565|FG001|Open-Label|Withdrawal by Subject|7|||
157081059|NCT00798434|567049564|FG000|Open-Label|Protocol Violation|1|||
157081060|NCT00798434|567049565|FG001|Open-Label|Protocol Violation|0|||
157081061|NCT00798434|567049564|FG000|Open-Label|Other|1|||
157081062|NCT00798434|567049565|FG001|Open-Label|Other|2|||
157081063|NCT00798434|567049564|FG000|Open-Label|Not Treated|0|||
157081064|NCT00798434|567049565|FG001|Open-Label|Not Treated|1|||
157081065|NCT04998812|567049573|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
157081066|NCT04998812|567049574|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
157081067|NCT04998812|567049573|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
157081068|NCT04998812|567049574|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
157081069|NCT04998812|567049573|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
157081070|NCT04998812|567049574|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
157081071|NCT04998812|567049573|FG000|Vaccination Period|Ongoing in study|23|||
157081072|NCT04998812|567049574|FG001|Vaccination Period|Ongoing in study|23|||
157081073|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
157081074|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
157081075|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
157081076|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
157081077|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
157081078|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
157081079|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
157081080|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
157081081|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
157081082|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
157081083|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
157081084|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
157081085|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
157081086|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
157081087|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
157081088|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
157081089|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
157081090|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
157081091|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
157081092|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
157081093|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
157081094|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
157081095|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
157081096|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
157081097|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
157081098|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
157081099|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
157081100|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
157081101|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
157081102|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
157081103|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
157081104|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
157081105|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
157081106|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
157081107|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
157081108|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
157081109|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
157081110|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
157081111|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
157081112|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
157081113|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
157081114|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
157081115|NCT03524092|567049578|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
157081116|NCT03524092|567049579|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
157081117|NCT03524092|567049580|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
157081118|NCT03524092|567049581|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
157081119|NCT03524092|567049582|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
157081120|NCT03524092|567049583|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
157081121|NCT03524092|567049578|FG000|Loss of Response Rescue Period|Adverse Event|0|||
157081122|NCT03524092|567049579|FG001|Loss of Response Rescue Period|Adverse Event|0|||
157081123|NCT03524092|567049580|FG002|Loss of Response Rescue Period|Adverse Event|0|||
157232743|NCT01389102|567599049|FG001|Overall Study|Subject Moved|0|||
157232744|NCT01389102|567599050|FG002|Overall Study|Subject Moved|1|||
157232745|NCT01389102|567599051|FG003|Overall Study|Subject Moved|0|||
157232746|NCT01389102|567599052|FG004|Overall Study|Subject Moved|0|||
157232747|NCT01389102|567599053|FG005|Overall Study|Subject Moved|0|||
157232748|NCT01389102|567599048|FG000|Overall Study|Unavailable due to husband's illness|0|||
157081124|NCT03524092|567049581|FG003|Loss of Response Rescue Period|Adverse Event|2|||
157081125|NCT03524092|567049582|FG004|Loss of Response Rescue Period|Adverse Event|0|||
157081126|NCT03524092|567049583|FG005|Loss of Response Rescue Period|Adverse Event|0|||
157232749|NCT01389102|567599049|FG001|Overall Study|Unavailable due to husband's illness|1|||
157081127|NCT03524092|567049578|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
157081128|NCT03524092|567049579|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
157081129|NCT03524092|567049580|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
157081130|NCT03524092|567049581|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
157081131|NCT03524092|567049582|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
157081132|NCT03524092|567049583|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
157081133|NCT03524092|567049578|FG000|Loss of Response Rescue Period|Pregnancy|0|||
157081134|NCT03524092|567049579|FG001|Loss of Response Rescue Period|Pregnancy|0|||
157081135|NCT03524092|567049580|FG002|Loss of Response Rescue Period|Pregnancy|0|||
157081136|NCT03524092|567049581|FG003|Loss of Response Rescue Period|Pregnancy|1|||
157081137|NCT03524092|567049582|FG004|Loss of Response Rescue Period|Pregnancy|0|||
157081138|NCT03524092|567049583|FG005|Loss of Response Rescue Period|Pregnancy|0|||
157081139|NCT03524092|567049578|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
157081140|NCT03524092|567049579|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
157081141|NCT03524092|567049580|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
157081142|NCT03524092|567049581|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
157081143|NCT03524092|567049582|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
157081144|NCT03524092|567049583|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
157081145|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
157081146|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
157081147|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
157081148|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
157081149|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
157081150|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
157081151|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
157081152|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
157081153|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
157081154|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
157081155|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
157081156|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
157081157|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
157081158|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
157081159|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
157081160|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
157081161|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
157081162|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
157081163|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
157081164|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
157081165|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
157081166|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
157081167|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
157081168|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
157081169|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
157081170|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
157081171|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
157081172|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
157081173|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
157081174|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
157081175|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
157081176|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
157081177|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
157081178|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
157081179|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
157081180|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
157081181|NCT03524092|567049578|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
157081182|NCT03524092|567049579|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
157081183|NCT03524092|567049580|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
157081184|NCT03524092|567049581|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
157081185|NCT03524092|567049582|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
157081186|NCT03524092|567049583|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
157081187|NCT03524092|567049578|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
157081188|NCT03524092|567049579|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
157081189|NCT03524092|567049580|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
157081190|NCT03524092|567049581|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
157081191|NCT03524092|567049582|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
157081192|NCT03524092|567049583|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
157081193|NCT03524092|567049578|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
157081194|NCT03524092|567049579|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
157081195|NCT03524092|567049580|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
157081196|NCT03524092|567049581|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
157081197|NCT03524092|567049582|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
157081198|NCT03524092|567049583|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
157081199|NCT03524092|567049578|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
157081200|NCT03524092|567049579|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
157081201|NCT03524092|567049580|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
157081202|NCT03524092|567049581|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
157081203|NCT03524092|567049582|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
157081204|NCT03524092|567049583|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
157081205|NCT03524092|567049578|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
157081206|NCT03524092|567049579|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
157081207|NCT03524092|567049580|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
157081208|NCT03524092|567049581|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
157081209|NCT03524092|567049582|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
157081210|NCT03524092|567049583|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
157081211|NCT04303780|567049584|FG000|Overall Study|Death|104|||
157081212|NCT04303780|567049585|FG001|Overall Study|Death|85|||
157081213|NCT04303780|567049584|FG000|Overall Study|Lost to Follow-up|5|||
157081214|NCT04303780|567049585|FG001|Overall Study|Lost to Follow-up|2|||
157081215|NCT04303780|567049584|FG000|Overall Study|Withdrawal by Subject|12|||
157081216|NCT04303780|567049585|FG001|Overall Study|Withdrawal by Subject|39|||
157081217|NCT04303780|567049584|FG000|Overall Study|Ongoing in study|50|||
157081218|NCT04303780|567049585|FG001|Overall Study|Ongoing in study|45|||
157081219|NCT03826030|567049586|FG000|Overall Study|Withdrawal by Subject|2|||
157081220|NCT03826030|567049587|FG001|Overall Study|Withdrawal by Subject|0|||
157081221|NCT03826030|567049588|FG002|Overall Study|Withdrawal by Subject|1|||
157081222|NCT03826030|567049586|FG000|Overall Study|Lost to Follow-up|1|||
157081223|NCT03826030|567049587|FG001|Overall Study|Lost to Follow-up|1|||
157081224|NCT03826030|567049588|FG002|Overall Study|Lost to Follow-up|1|||
157081225|NCT03826030|567049586|FG000|Overall Study|Too busy to return for visits|1|||
157081226|NCT03826030|567049587|FG001|Overall Study|Too busy to return for visits|0|||
157081227|NCT03826030|567049588|FG002|Overall Study|Too busy to return for visits|0|||
157081228|NCT04893460|567049591|FG000|Overall Study|Lost to Follow-up|18|||
157081229|NCT06748729|567049593|FG000|Overall Study|Withdrawal by Subject|1|||
157081230|NCT03578887|567049594|FG000|Overall Study|Withdrawal by Subject|7|||
157081231|NCT03578887|567049595|FG001|Overall Study|Withdrawal by Subject|2|||
157081232|NCT03578887|567049596|FG002|Overall Study|Withdrawal by Subject|1|||
157081233|NCT03578887|567049594|FG000|Overall Study|Lost to Follow-up|13|||
157081234|NCT03578887|567049595|FG001|Overall Study|Lost to Follow-up|1|||
157081235|NCT03578887|567049596|FG002|Overall Study|Lost to Follow-up|4|||
157081236|NCT03578887|567049594|FG000|Overall Study|Physician Decision|0|||
157081237|NCT03578887|567049595|FG001|Overall Study|Physician Decision|1|||
157081238|NCT03578887|567049596|FG002|Overall Study|Physician Decision|1|||
157081239|NCT04500769|567051822|FG000|Overall Study|Withdrawal by Subject|5|||
157081240|NCT01967147|567051823|FG000|Overall Study|Adverse Event|5|||
157081241|NCT01967147|567051824|FG001|Overall Study|Adverse Event|2|||
157081242|NCT01967147|567051823|FG000|Overall Study|Lack of Efficacy|1|||
157081243|NCT01967147|567051824|FG001|Overall Study|Lack of Efficacy|4|||
157081244|NCT01967147|567051823|FG000|Overall Study|Lost to Follow-up|1|||
157081245|NCT01967147|567051824|FG001|Overall Study|Lost to Follow-up|2|||
157081246|NCT01967147|567051823|FG000|Overall Study|Withdrawal by Subject|2|||
157081247|NCT01967147|567051824|FG001|Overall Study|Withdrawal by Subject|4|||
157081248|NCT01967147|567051823|FG000|Overall Study|Non-compliance with Study Drug|0|||
157081249|NCT01967147|567051824|FG001|Overall Study|Non-compliance with Study Drug|3|||
157081250|NCT01967147|567051823|FG000|Overall Study|Other|4|||
157081251|NCT01967147|567051824|FG001|Overall Study|Other|5|||
157081252|NCT03843554|567051825|FG000|Overall Study|Physician Decision|0|||
157081253|NCT03843554|567051826|FG001|Overall Study|Physician Decision|2|||
157081254|NCT02218606|567051828|FG000|Overall Study|Adverse Event|1|||
157081255|NCT02218606|567051829|FG001|Overall Study|Adverse Event|1|||
157081256|NCT02218606|567051828|FG000|Overall Study|Death|15|||
157081257|NCT02218606|567051829|FG001|Overall Study|Death|28|||
157081258|NCT02218606|567051828|FG000|Overall Study|Physician Decision|0|||
157081259|NCT02218606|567051829|FG001|Overall Study|Physician Decision|1|||
157081260|NCT02218606|567051828|FG000|Overall Study|Withdrawal by Subject|4|||
157081261|NCT02218606|567051829|FG001|Overall Study|Withdrawal by Subject|0|||
157081262|NCT02218606|567051828|FG000|Overall Study|Noncompliance|1|||
157081263|NCT02218606|567051829|FG001|Overall Study|Noncompliance|0|||
157081264|NCT02218606|567051828|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
157081265|NCT02218606|567051829|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
157081266|NCT02218606|567051828|FG000|Overall Study|Other|2|||
157081267|NCT02218606|567051829|FG001|Overall Study|Other|1|||
157081268|NCT02218606|567051828|FG000|Overall Study|Never started treatment|0|||
157081269|NCT02218606|567051829|FG001|Overall Study|Never started treatment|1|||
157081270|NCT03203473|567051830|FG000|Induction Phase|Never started primary treatment|2|||
157081271|NCT03203473|567051831|FG001|Induction Phase|Never started primary treatment|0|||
157081272|NCT03203473|567051832|FG002|Induction Phase|Never started primary treatment|0|||
157081273|NCT03203473|567051830|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
157081274|NCT03203473|567051831|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
157081275|NCT03203473|567051832|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
157081276|NCT03203473|567051830|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
157081277|NCT03203473|567051831|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
157081278|NCT03203473|567051832|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
157081279|NCT03203473|567051830|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
157081280|NCT03203473|567051831|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
157081281|NCT03203473|567051832|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
157081282|NCT03203473|567051830|FG000|Arm Allocation Phase|started salvage therapy|0|||
157081283|NCT03203473|567051831|FG001|Arm Allocation Phase|started salvage therapy|5|||
157081284|NCT03203473|567051832|FG002|Arm Allocation Phase|started salvage therapy|0|||
157081285|NCT03203473|567051830|FG000|Arm Allocation Phase|Disease progression|0|||
157081286|NCT03203473|567051831|FG001|Arm Allocation Phase|Disease progression|0|||
157081287|NCT03203473|567051832|FG002|Arm Allocation Phase|Disease progression|37|||
157081288|NCT03203473|567051830|FG000|Arm Allocation Phase|Adverse Event|0|||
157081289|NCT03203473|567051831|FG001|Arm Allocation Phase|Adverse Event|0|||
157081290|NCT03203473|567051832|FG002|Arm Allocation Phase|Adverse Event|11|||
157081291|NCT03203473|567051830|FG000|Arm Allocation Phase|Physician Decision|0|||
157081292|NCT03203473|567051831|FG001|Arm Allocation Phase|Physician Decision|0|||
157081293|NCT03203473|567051832|FG002|Arm Allocation Phase|Physician Decision|3|||
157081294|NCT03203473|567051830|FG000|Arm Allocation Phase|Death|0|||
157081295|NCT03203473|567051831|FG001|Arm Allocation Phase|Death|0|||
157081296|NCT03203473|567051832|FG002|Arm Allocation Phase|Death|1|||
157081297|NCT03203473|567051830|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
157081298|NCT03203473|567051831|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
157081299|NCT03203473|567051832|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
157081300|NCT03203473|567051830|FG000|Arm Allocation Phase|Intercurrent illness|0|||
157081301|NCT03203473|567051831|FG001|Arm Allocation Phase|Intercurrent illness|0|||
157081302|NCT03203473|567051832|FG002|Arm Allocation Phase|Intercurrent illness|1|||
157081303|NCT03203473|567051830|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
157081304|NCT03203473|567051831|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
157081305|NCT03203473|567051832|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
157081306|NCT01901432|567051835|FG000|Overall Study|Adverse Event|0|||
157081307|NCT01901432|567051836|FG001|Overall Study|Adverse Event|1|||
157081308|NCT01901432|567051837|FG002|Overall Study|Adverse Event|1|||
157081309|NCT01901432|567051838|FG003|Overall Study|Adverse Event|0|||
157081310|NCT01901432|567051839|FG004|Overall Study|Adverse Event|1|||
157081311|NCT01901432|567051835|FG000|Overall Study|Withdrawal by Subject|0|||
157081312|NCT01901432|567051836|FG001|Overall Study|Withdrawal by Subject|0|||
157081313|NCT01901432|567051837|FG002|Overall Study|Withdrawal by Subject|1|||
157081314|NCT01901432|567051838|FG003|Overall Study|Withdrawal by Subject|0|||
157081315|NCT01901432|567051839|FG004|Overall Study|Withdrawal by Subject|5|||
157081316|NCT01901432|567051835|FG000|Overall Study|Physician Decision|0|||
157081317|NCT01901432|567051836|FG001|Overall Study|Physician Decision|0|||
157081318|NCT01901432|567051837|FG002|Overall Study|Physician Decision|0|||
157081319|NCT01901432|567051838|FG003|Overall Study|Physician Decision|0|||
157081320|NCT01901432|567051839|FG004|Overall Study|Physician Decision|2|||
157081321|NCT01901432|567051835|FG000|Overall Study|Patient decision to stop study drug|0|||
157081322|NCT01901432|567051836|FG001|Overall Study|Patient decision to stop study drug|0|||
157081323|NCT01901432|567051837|FG002|Overall Study|Patient decision to stop study drug|0|||
157081324|NCT01901432|567051838|FG003|Overall Study|Patient decision to stop study drug|0|||
157081325|NCT01901432|567051839|FG004|Overall Study|Patient decision to stop study drug|1|||
157081326|NCT03986944|567051842|FG000|Overall Study|Adverse Event|1|||
157081327|NCT03986944|567051843|FG001|Overall Study|Adverse Event|2|||
157081328|NCT03986944|567051844|FG002|Overall Study|Adverse Event|3|||
157081329|NCT03986944|567051842|FG000|Overall Study|Protocol Violation|0|||
157081330|NCT03986944|567051843|FG001|Overall Study|Protocol Violation|1|||
157081331|NCT03986944|567051844|FG002|Overall Study|Protocol Violation|1|||
157081332|NCT03986944|567051842|FG000|Overall Study|Withdrawal by Subject|3|||
157081333|NCT03986944|567051843|FG001|Overall Study|Withdrawal by Subject|5|||
157081334|NCT03986944|567051844|FG002|Overall Study|Withdrawal by Subject|5|||
157081335|NCT03986944|567051842|FG000|Overall Study|Study termination|10|||
157081336|NCT03986944|567051843|FG001|Overall Study|Study termination|10|||
157081337|NCT03986944|567051844|FG002|Overall Study|Study termination|10|||
157081338|NCT03986944|567051842|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
157081339|NCT03986944|567051843|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
157081340|NCT03986944|567051844|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
157081341|NCT03986944|567051842|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
157081342|NCT03986944|567051843|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
157081343|NCT03986944|567051844|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
157081344|NCT03002220|567051845|FG000|Overall Study|Lack of Efficacy|2|||
157081345|NCT03002220|567051845|FG000|Overall Study|Withdrawal by Subject|3|||
157081346|NCT03002220|567051845|FG000|Overall Study|Adverse Event|2|||
157081347|NCT03002220|567051845|FG000|Overall Study|Disease progression|13|||
157081348|NCT03002220|567051845|FG000|Overall Study|Physician Decision|1|||
157081349|NCT01015560|567051846|FG000|Overall Study|Adverse Event|1|||
157081350|NCT01015560|567051846|FG000|Overall Study|Not protocol specified|1|||
157081351|NCT01015560|567051846|FG000|Overall Study|Withdrawal by Subject|1|||
157081352|NCT00128102|567051849|FG000|Overall Study|Site Discontinued|3|||
157081353|NCT00128102|567051850|FG001|Overall Study|Site Discontinued|6|||
157081354|NCT00128102|567051849|FG000|Overall Study|Other|0|||
157081355|NCT00128102|567051850|FG001|Overall Study|Other|1|||
157081356|NCT00128102|567051849|FG000|Overall Study|Progressive Disease|255|||
157081357|NCT00128102|567051850|FG001|Overall Study|Progressive Disease|285|||
157081358|NCT00128102|567051849|FG000|Overall Study|Adverse Event|34|||
157081359|NCT00128102|567051850|FG001|Overall Study|Adverse Event|11|||
157081360|NCT00128102|567051849|FG000|Overall Study|Death|12|||
157081361|NCT00128102|567051850|FG001|Overall Study|Death|13|||
157081362|NCT00128102|567051849|FG000|Overall Study|Physician Decision|3|||
157081363|NCT00128102|567051850|FG001|Overall Study|Physician Decision|3|||
157081364|NCT00128102|567051849|FG000|Overall Study|Withdrawal by Subject|19|||
157081365|NCT00128102|567051850|FG001|Overall Study|Withdrawal by Subject|11|||
157081366|NCT00128102|567051849|FG000|Overall Study|Protocol Violation|2|||
157081367|NCT00128102|567051850|FG001|Overall Study|Protocol Violation|2|||
157081368|NCT00568178|567051851|FG000|Double Blind Base Study|Adverse Event|0|||
157081369|NCT00568178|567051852|FG001|Double Blind Base Study|Adverse Event|2|||
157081370|NCT00568178|567051853|FG002|Double Blind Base Study|Adverse Event|1|||
157081371|NCT00568178|567051854|FG003|Double Blind Base Study|Adverse Event|2|||
157081372|NCT00568178|567051855|FG004|Double Blind Base Study|Adverse Event|0|||
157081373|NCT00568178|567051856|FG005|Double Blind Base Study|Adverse Event|0|||
157081374|NCT00568178|567051851|FG000|Double Blind Base Study|Lost to Follow-up|1|||
157081375|NCT00568178|567051852|FG001|Double Blind Base Study|Lost to Follow-up|0|||
157081376|NCT00568178|567051853|FG002|Double Blind Base Study|Lost to Follow-up|0|||
157081377|NCT00568178|567051854|FG003|Double Blind Base Study|Lost to Follow-up|1|||
157081378|NCT00568178|567051855|FG004|Double Blind Base Study|Lost to Follow-up|0|||
157081379|NCT00568178|567051856|FG005|Double Blind Base Study|Lost to Follow-up|0|||
157081380|NCT00568178|567051851|FG000|Double Blind Base Study|Physician Decision|1|||
157081381|NCT00568178|567051852|FG001|Double Blind Base Study|Physician Decision|1|||
157081382|NCT00568178|567051853|FG002|Double Blind Base Study|Physician Decision|0|||
157081383|NCT00568178|567051854|FG003|Double Blind Base Study|Physician Decision|1|||
157081384|NCT00568178|567051855|FG004|Double Blind Base Study|Physician Decision|0|||
157081385|NCT00568178|567051856|FG005|Double Blind Base Study|Physician Decision|0|||
157081386|NCT00568178|567051851|FG000|Double Blind Base Study|Protocol Violation|3|||
157081387|NCT00568178|567051852|FG001|Double Blind Base Study|Protocol Violation|2|||
157081388|NCT00568178|567051853|FG002|Double Blind Base Study|Protocol Violation|0|||
157081389|NCT00568178|567051854|FG003|Double Blind Base Study|Protocol Violation|0|||
157081390|NCT00568178|567051855|FG004|Double Blind Base Study|Protocol Violation|0|||
157081391|NCT00568178|567051856|FG005|Double Blind Base Study|Protocol Violation|0|||
157081392|NCT00568178|567051851|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
157232750|NCT01389102|567599050|FG002|Overall Study|Unavailable due to husband's illness|0|||
157232751|NCT01389102|567599051|FG003|Overall Study|Unavailable due to husband's illness|0|||
157081393|NCT00568178|567051852|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
157081394|NCT00568178|567051853|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
157081395|NCT00568178|567051854|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
157081396|NCT00568178|567051855|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
157081397|NCT00568178|567051856|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
157081398|NCT00568178|567051851|FG000|Double Blind Base Study|Progressive Disease|0|||
157081399|NCT00568178|567051852|FG001|Double Blind Base Study|Progressive Disease|0|||
157081400|NCT00568178|567051853|FG002|Double Blind Base Study|Progressive Disease|0|||
157081401|NCT00568178|567051854|FG003|Double Blind Base Study|Progressive Disease|1|||
157081402|NCT00568178|567051855|FG004|Double Blind Base Study|Progressive Disease|0|||
157081403|NCT00568178|567051856|FG005|Double Blind Base Study|Progressive Disease|0|||
157081404|NCT00568178|567051851|FG000|Open Label Extension|Adverse Event|0|||
157081405|NCT00568178|567051852|FG001|Open Label Extension|Adverse Event|0|||
157081406|NCT00568178|567051853|FG002|Open Label Extension|Adverse Event|0|||
157081407|NCT00568178|567051854|FG003|Open Label Extension|Adverse Event|0|||
157081408|NCT00568178|567051855|FG004|Open Label Extension|Adverse Event|11|||
157081409|NCT00568178|567051856|FG005|Open Label Extension|Adverse Event|8|||
157081410|NCT00568178|567051851|FG000|Open Label Extension|Protocol Violation|0|||
157081411|NCT00568178|567051852|FG001|Open Label Extension|Protocol Violation|0|||
157081412|NCT00568178|567051853|FG002|Open Label Extension|Protocol Violation|0|||
157081413|NCT00568178|567051854|FG003|Open Label Extension|Protocol Violation|0|||
157081414|NCT00568178|567051855|FG004|Open Label Extension|Protocol Violation|1|||
157081415|NCT00568178|567051856|FG005|Open Label Extension|Protocol Violation|0|||
157081416|NCT00568178|567051851|FG000|Open Label Extension|Lost to Follow-up|0|||
157081417|NCT00568178|567051852|FG001|Open Label Extension|Lost to Follow-up|0|||
157081418|NCT00568178|567051853|FG002|Open Label Extension|Lost to Follow-up|0|||
157081419|NCT00568178|567051854|FG003|Open Label Extension|Lost to Follow-up|0|||
157081420|NCT00568178|567051855|FG004|Open Label Extension|Lost to Follow-up|6|||
157081421|NCT00568178|567051856|FG005|Open Label Extension|Lost to Follow-up|11|||
157081422|NCT00568178|567051851|FG000|Open Label Extension|Physician Decision|0|||
157081423|NCT00568178|567051852|FG001|Open Label Extension|Physician Decision|0|||
157081424|NCT00568178|567051853|FG002|Open Label Extension|Physician Decision|0|||
157081425|NCT00568178|567051854|FG003|Open Label Extension|Physician Decision|0|||
157081426|NCT00568178|567051855|FG004|Open Label Extension|Physician Decision|9|||
157081427|NCT00568178|567051856|FG005|Open Label Extension|Physician Decision|8|||
157081428|NCT00568178|567051851|FG000|Open Label Extension|Pregnancy|0|||
157081429|NCT00568178|567051852|FG001|Open Label Extension|Pregnancy|0|||
157081430|NCT00568178|567051853|FG002|Open Label Extension|Pregnancy|0|||
157081431|NCT00568178|567051854|FG003|Open Label Extension|Pregnancy|0|||
157081432|NCT00568178|567051855|FG004|Open Label Extension|Pregnancy|0|||
157081433|NCT00568178|567051856|FG005|Open Label Extension|Pregnancy|1|||
157081434|NCT00568178|567051851|FG000|Open Label Extension|Progressive Disease|0|||
157081435|NCT00568178|567051852|FG001|Open Label Extension|Progressive Disease|0|||
157081436|NCT00568178|567051853|FG002|Open Label Extension|Progressive Disease|0|||
157081437|NCT00568178|567051854|FG003|Open Label Extension|Progressive Disease|0|||
157081438|NCT00568178|567051855|FG004|Open Label Extension|Progressive Disease|3|||
157081439|NCT00568178|567051856|FG005|Open Label Extension|Progressive Disease|1|||
157081440|NCT00568178|567051851|FG000|Open Label Extension|Termination of Trial|0|||
157081441|NCT00568178|567051852|FG001|Open Label Extension|Termination of Trial|0|||
157081442|NCT00568178|567051853|FG002|Open Label Extension|Termination of Trial|0|||
157081443|NCT00568178|567051854|FG003|Open Label Extension|Termination of Trial|0|||
157081444|NCT00568178|567051855|FG004|Open Label Extension|Termination of Trial|45|||
157081445|NCT00568178|567051856|FG005|Open Label Extension|Termination of Trial|47|||
157081446|NCT00568178|567051851|FG000|Open Label Extension|Withdrawal by Subject|0|||
157081447|NCT00568178|567051852|FG001|Open Label Extension|Withdrawal by Subject|0|||
157081448|NCT00568178|567051853|FG002|Open Label Extension|Withdrawal by Subject|0|||
157081449|NCT00568178|567051854|FG003|Open Label Extension|Withdrawal by Subject|0|||
157081450|NCT00568178|567051855|FG004|Open Label Extension|Withdrawal by Subject|4|||
157081451|NCT00568178|567051856|FG005|Open Label Extension|Withdrawal by Subject|4|||
157081452|NCT00837694|567051857|FG000|Overall Study|Lost to Follow-up|2|||
157081453|NCT00837694|567051858|FG001|Overall Study|Lost to Follow-up|0|||
157081454|NCT00837694|567051859|FG002|Overall Study|Lost to Follow-up|2|||
157081455|NCT00837694|567051860|FG003|Overall Study|Lost to Follow-up|1|||
157081456|NCT00837694|567051861|FG004|Overall Study|Lost to Follow-up|1|||
157081457|NCT00837694|567051862|FG005|Overall Study|Lost to Follow-up|1|||
157081458|NCT01332630|567051863|FG000|Overall Study|Withdrawal by Subject|3|||
157081459|NCT00581555|567051881|FG000|Overall Study|Adverse Event|4|||
157081460|NCT00581555|567051882|FG001|Overall Study|Adverse Event|3|||
157081461|NCT00581555|567051881|FG000|Overall Study|Physician Decision|3|||
157081462|NCT00581555|567051882|FG001|Overall Study|Physician Decision|2|||
157081463|NCT00581555|567051881|FG000|Overall Study|Withdrawal by Subject|18|||
157081464|NCT00581555|567051882|FG001|Overall Study|Withdrawal by Subject|9|||
157081465|NCT00581555|567051881|FG000|Overall Study|Lost to Follow-up|2|||
157081466|NCT00581555|567051882|FG001|Overall Study|Lost to Follow-up|2|||
157081467|NCT00581555|567051881|FG000|Overall Study|Other reasons|16|||
157081468|NCT00581555|567051882|FG001|Overall Study|Other reasons|4|||
157081469|NCT00201643|567051888|FG000|Overall Study|Withdrawal by Subject|5|||
157081470|NCT00201643|567051889|FG001|Overall Study|Withdrawal by Subject|4|||
157081471|NCT03446781|567051890|FG000|Overall Study|Lost to Follow-up|11|||
157193025|NCT02394028|567447215|FG000|Maintenance Phase|Withdrawal by Subject|0|||
157193026|NCT02394028|567447216|FG001|Maintenance Phase|Withdrawal by Subject|0|||
157081472|NCT03446781|567051891|FG001|Overall Study|Lost to Follow-up|5|||
157081473|NCT03446781|567051890|FG000|Overall Study|Withdrawal by Subject|9|||
157193027|NCT02394028|567447217|FG002|Maintenance Phase|Withdrawal by Subject|0|||
157193028|NCT02394028|567447218|FG003|Maintenance Phase|Withdrawal by Subject|0|||
157081474|NCT03446781|567051891|FG001|Overall Study|Withdrawal by Subject|7|||
157081475|NCT03446781|567051890|FG000|Overall Study|Adverse Event|8|||
157081476|NCT03446781|567051891|FG001|Overall Study|Adverse Event|2|||
157081477|NCT03446781|567051890|FG000|Overall Study|Protocol Violation|0|||
157081478|NCT03446781|567051891|FG001|Overall Study|Protocol Violation|3|||
157081479|NCT00731133|567051899|FG000|Overall Study|Withdrawal by Subject|10|||
157081480|NCT02672852|567051905|FG000|Part A1|Disease Worsening|1|||
157081481|NCT02672852|567051906|FG001|Part A1|Disease Worsening|0|||
157081482|NCT02672852|567051907|FG002|Part A1|Disease Worsening|0|||
157081483|NCT02672852|567051908|FG003|Part A1|Disease Worsening|0|||
157081484|NCT02672852|567051909|FG004|Part A1|Disease Worsening|0|||
157081485|NCT02672852|567051910|FG005|Part A1|Disease Worsening|0|||
157081486|NCT02672852|567051911|FG006|Part A1|Disease Worsening|0|||
157081487|NCT02672852|567051905|FG000|Part A1|Adverse Event|0|||
157081488|NCT02672852|567051906|FG001|Part A1|Adverse Event|1|||
157081489|NCT02672852|567051907|FG002|Part A1|Adverse Event|0|||
157081490|NCT02672852|567051908|FG003|Part A1|Adverse Event|0|||
157081491|NCT02672852|567051909|FG004|Part A1|Adverse Event|0|||
157081492|NCT02672852|567051910|FG005|Part A1|Adverse Event|0|||
157081493|NCT02672852|567051911|FG006|Part A1|Adverse Event|0|||
157081494|NCT02672852|567051905|FG000|Part A1|Lost to Follow-up|1|||
157081495|NCT02672852|567051906|FG001|Part A1|Lost to Follow-up|2|||
157081496|NCT02672852|567051907|FG002|Part A1|Lost to Follow-up|0|||
157081497|NCT02672852|567051908|FG003|Part A1|Lost to Follow-up|0|||
157081498|NCT02672852|567051909|FG004|Part A1|Lost to Follow-up|0|||
157081499|NCT02672852|567051910|FG005|Part A1|Lost to Follow-up|0|||
157081500|NCT02672852|567051911|FG006|Part A1|Lost to Follow-up|0|||
157081501|NCT02672852|567051905|FG000|Part A1|Withdrawal by Subject|1|||
157081502|NCT02672852|567051906|FG001|Part A1|Withdrawal by Subject|1|||
157081503|NCT02672852|567051907|FG002|Part A1|Withdrawal by Subject|0|||
157081504|NCT02672852|567051908|FG003|Part A1|Withdrawal by Subject|0|||
157081505|NCT02672852|567051909|FG004|Part A1|Withdrawal by Subject|0|||
157081506|NCT02672852|567051910|FG005|Part A1|Withdrawal by Subject|0|||
157081507|NCT02672852|567051911|FG006|Part A1|Withdrawal by Subject|0|||
157081508|NCT02672852|567051905|FG000|Part A2|Disease worsening|0|||
157081509|NCT02672852|567051906|FG001|Part A2|Disease worsening|0|||
157081510|NCT02672852|567051907|FG002|Part A2|Disease worsening|1|||
157081511|NCT02672852|567051908|FG003|Part A2|Disease worsening|0|||
157081512|NCT02672852|567051909|FG004|Part A2|Disease worsening|0|||
157081513|NCT02672852|567051910|FG005|Part A2|Disease worsening|0|||
157081514|NCT02672852|567051911|FG006|Part A2|Disease worsening|0|||
157081515|NCT02672852|567051905|FG000|Part A2|Adverse Event|0|||
157081516|NCT02672852|567051906|FG001|Part A2|Adverse Event|0|||
157081517|NCT02672852|567051907|FG002|Part A2|Adverse Event|3|||
157081518|NCT02672852|567051908|FG003|Part A2|Adverse Event|0|||
157081519|NCT02672852|567051909|FG004|Part A2|Adverse Event|0|||
157081520|NCT02672852|567051910|FG005|Part A2|Adverse Event|0|||
157081521|NCT02672852|567051911|FG006|Part A2|Adverse Event|0|||
157081522|NCT02672852|567051905|FG000|Part A2|Lost to Follow-up|0|||
157081523|NCT02672852|567051906|FG001|Part A2|Lost to Follow-up|0|||
157081524|NCT02672852|567051907|FG002|Part A2|Lost to Follow-up|2|||
157081525|NCT02672852|567051908|FG003|Part A2|Lost to Follow-up|0|||
157081526|NCT02672852|567051909|FG004|Part A2|Lost to Follow-up|0|||
157081527|NCT02672852|567051910|FG005|Part A2|Lost to Follow-up|0|||
157081528|NCT02672852|567051911|FG006|Part A2|Lost to Follow-up|0|||
157081529|NCT02672852|567051905|FG000|Part A2|Withdrawal by Subject|0|||
157081530|NCT02672852|567051906|FG001|Part A2|Withdrawal by Subject|0|||
157081531|NCT02672852|567051907|FG002|Part A2|Withdrawal by Subject|1|||
157081532|NCT02672852|567051908|FG003|Part A2|Withdrawal by Subject|0|||
157081533|NCT02672852|567051909|FG004|Part A2|Withdrawal by Subject|0|||
157081534|NCT02672852|567051910|FG005|Part A2|Withdrawal by Subject|0|||
157081535|NCT02672852|567051911|FG006|Part A2|Withdrawal by Subject|0|||
157081536|NCT02672852|567051905|FG000|Part A2|Other|0|||
157081537|NCT02672852|567051906|FG001|Part A2|Other|0|||
157081538|NCT02672852|567051907|FG002|Part A2|Other|3|||
157081539|NCT02672852|567051908|FG003|Part A2|Other|0|||
157081540|NCT02672852|567051909|FG004|Part A2|Other|0|||
157081541|NCT02672852|567051910|FG005|Part A2|Other|0|||
157081542|NCT02672852|567051911|FG006|Part A2|Other|0|||
157081543|NCT02672852|567051905|FG000|Part A2|Not entered in Part B|0|||
157081544|NCT02672852|567051906|FG001|Part A2|Not entered in Part B|0|||
157081545|NCT02672852|567051907|FG002|Part A2|Not entered in Part B|0|||
157081546|NCT02672852|567051908|FG003|Part A2|Not entered in Part B|4|||
157081547|NCT02672852|567051909|FG004|Part A2|Not entered in Part B|0|||
157081548|NCT02672852|567051910|FG005|Part A2|Not entered in Part B|0|||
157081549|NCT02672852|567051911|FG006|Part A2|Not entered in Part B|0|||
157081550|NCT02672852|567051905|FG000|Part B|Disease worsening|0|||
157081551|NCT02672852|567051906|FG001|Part B|Disease worsening|0|||
157081552|NCT02672852|567051907|FG002|Part B|Disease worsening|0|||
157081553|NCT02672852|567051908|FG003|Part B|Disease worsening|0|||
157081554|NCT02672852|567051909|FG004|Part B|Disease worsening|1|||
157081555|NCT02672852|567051910|FG005|Part B|Disease worsening|0|||
157081556|NCT02672852|567051911|FG006|Part B|Disease worsening|1|||
157081557|NCT02672852|567051905|FG000|Part B|Worsening pre-existing condition|0|||
157081558|NCT02672852|567051906|FG001|Part B|Worsening pre-existing condition|0|||
157081559|NCT02672852|567051907|FG002|Part B|Worsening pre-existing condition|0|||
157081560|NCT02672852|567051908|FG003|Part B|Worsening pre-existing condition|0|||
157081561|NCT02672852|567051909|FG004|Part B|Worsening pre-existing condition|0|||
157081562|NCT02672852|567051910|FG005|Part B|Worsening pre-existing condition|1|||
157081563|NCT02672852|567051911|FG006|Part B|Worsening pre-existing condition|0|||
157081564|NCT02672852|567051905|FG000|Part B|Other adverse event|0|||
157081565|NCT02672852|567051906|FG001|Part B|Other adverse event|0|||
157081566|NCT02672852|567051907|FG002|Part B|Other adverse event|0|||
157081567|NCT02672852|567051908|FG003|Part B|Other adverse event|0|||
157081568|NCT02672852|567051909|FG004|Part B|Other adverse event|3|||
157081569|NCT02672852|567051910|FG005|Part B|Other adverse event|5|||
157081570|NCT02672852|567051911|FG006|Part B|Other adverse event|1|||
157081571|NCT02672852|567051905|FG000|Part B|Lost to Follow-up|0|||
157081572|NCT02672852|567051906|FG001|Part B|Lost to Follow-up|0|||
157081573|NCT02672852|567051907|FG002|Part B|Lost to Follow-up|0|||
157081574|NCT02672852|567051908|FG003|Part B|Lost to Follow-up|0|||
157081575|NCT02672852|567051909|FG004|Part B|Lost to Follow-up|3|||
157081576|NCT02672852|567051910|FG005|Part B|Lost to Follow-up|4|||
157081577|NCT02672852|567051911|FG006|Part B|Lost to Follow-up|1|||
157081578|NCT02672852|567051905|FG000|Part B|Withdrawal by Subject|0|||
157081579|NCT02672852|567051906|FG001|Part B|Withdrawal by Subject|0|||
157081580|NCT02672852|567051907|FG002|Part B|Withdrawal by Subject|0|||
157081581|NCT02672852|567051908|FG003|Part B|Withdrawal by Subject|0|||
157081582|NCT02672852|567051909|FG004|Part B|Withdrawal by Subject|5|||
157081583|NCT02672852|567051910|FG005|Part B|Withdrawal by Subject|0|||
157081584|NCT02672852|567051911|FG006|Part B|Withdrawal by Subject|7|||
157081585|NCT02672852|567051905|FG000|Part B|Other|0|||
157081586|NCT02672852|567051906|FG001|Part B|Other|0|||
157081587|NCT02672852|567051907|FG002|Part B|Other|0|||
157081588|NCT02672852|567051908|FG003|Part B|Other|0|||
157081589|NCT02672852|567051909|FG004|Part B|Other|4|||
157081590|NCT02672852|567051910|FG005|Part B|Other|1|||
157081591|NCT02672852|567051911|FG006|Part B|Other|2|||
157081592|NCT02182947|567051912|FG000|Overall Study|Withdrawal by Subject|7|||
157081593|NCT02182947|567051912|FG000|Overall Study|Lost to Follow-up|3|||
157081594|NCT02182947|567051912|FG000|Overall Study|Failed screening activities|8|||
157081595|NCT03248882|567051913|FG000|Overall Study|Adverse Event|3|||
157081596|NCT03248882|567051914|FG001|Overall Study|Adverse Event|3|||
157081597|NCT03248882|567051915|FG002|Overall Study|Adverse Event|2|||
157081598|NCT03248882|567051916|FG003|Overall Study|Adverse Event|6|||
157081599|NCT03248882|567051917|FG004|Overall Study|Adverse Event|9|||
157081600|NCT03248882|567051913|FG000|Overall Study|Lost to Follow-up|0|||
157081601|NCT03248882|567051914|FG001|Overall Study|Lost to Follow-up|0|||
157081602|NCT03248882|567051915|FG002|Overall Study|Lost to Follow-up|0|||
157081603|NCT03248882|567051916|FG003|Overall Study|Lost to Follow-up|0|||
157081604|NCT03248882|567051917|FG004|Overall Study|Lost to Follow-up|1|||
157081605|NCT03248882|567051913|FG000|Overall Study|Protocol Violation|2|||
157081606|NCT03248882|567051914|FG001|Overall Study|Protocol Violation|0|||
157081607|NCT03248882|567051915|FG002|Overall Study|Protocol Violation|2|||
157081608|NCT03248882|567051916|FG003|Overall Study|Protocol Violation|0|||
157081609|NCT03248882|567051917|FG004|Overall Study|Protocol Violation|1|||
157081610|NCT03248882|567051913|FG000|Overall Study|Withdrawal by Subject|2|||
157081611|NCT03248882|567051914|FG001|Overall Study|Withdrawal by Subject|2|||
157081612|NCT03248882|567051915|FG002|Overall Study|Withdrawal by Subject|3|||
157081613|NCT03248882|567051916|FG003|Overall Study|Withdrawal by Subject|4|||
157081614|NCT03248882|567051917|FG004|Overall Study|Withdrawal by Subject|2|||
157081615|NCT04308590|567051918|FG000|Overall Study|Adverse Event|12|||
157081616|NCT04308590|567051919|FG001|Overall Study|Adverse Event|2|||
157081617|NCT04308590|567051918|FG000|Overall Study|Withdrawal by Subject|10|||
157081618|NCT04308590|567051919|FG001|Overall Study|Withdrawal by Subject|4|||
157081619|NCT04308590|567051918|FG000|Overall Study|Death|1|||
157081620|NCT04308590|567051919|FG001|Overall Study|Death|0|||
157081621|NCT04308590|567051918|FG000|Overall Study|Lost to Follow-up|1|||
157081622|NCT04308590|567051919|FG001|Overall Study|Lost to Follow-up|1|||
157081623|NCT04308590|567051918|FG000|Overall Study|Physician Decision|1|||
157081624|NCT04308590|567051919|FG001|Overall Study|Physician Decision|0|||
157081625|NCT04308590|567051918|FG000|Overall Study|Subject does not want to continue with Pi|0|||
157081626|NCT04308590|567051919|FG001|Overall Study|Subject does not want to continue with Pi|1|||
157232752|NCT01389102|567599052|FG004|Overall Study|Unavailable due to husband's illness|0|||
157081627|NCT01156376|567051921|FG000|Overall Study|Adverse Event|1|||
157081628|NCT01156376|567051922|FG001|Overall Study|Adverse Event|0|||
157081629|NCT01156376|567051923|FG002|Overall Study|Adverse Event|1|||
157081630|NCT01156376|567051921|FG000|Overall Study|Withdrawal by Subject|0|||
157081631|NCT01156376|567051922|FG001|Overall Study|Withdrawal by Subject|0|||
157081632|NCT01156376|567051923|FG002|Overall Study|Withdrawal by Subject|3|||
157232753|NCT01389102|567599053|FG005|Overall Study|Unavailable due to husband's illness|0|||
157081633|NCT01493427|567051924|FG000|Overall Study|Adverse Event|10|||
157081634|NCT01493427|567051924|FG000|Overall Study|Personal Reasons|4|||
157081635|NCT01493427|567051924|FG000|Overall Study|Lost to Follow-up|2|||
157081636|NCT01493427|567051924|FG000|Overall Study|Inability to Follow Instructions|2|||
157081637|NCT01493427|567051924|FG000|Overall Study|Other|2|||
157081638|NCT01598662|567051925|FG000|Overall Study|Lost to Follow-up|10|||
157081639|NCT01598662|567051926|FG001|Overall Study|Lost to Follow-up|17|||
157081640|NCT01598662|567051925|FG000|Overall Study|Physician Decision|1|||
157081641|NCT01598662|567051926|FG001|Overall Study|Physician Decision|2|||
157081642|NCT01598662|567051925|FG000|Overall Study|IUD expelled before month 6|0|||
157081643|NCT01598662|567051926|FG001|Overall Study|IUD expelled before month 6|2|||
157081644|NCT02075073|567051927|FG000|Overall Study|Withdrawal by Subject|0|||
157081645|NCT02075073|567051928|FG001|Overall Study|Withdrawal by Subject|1|||
157081646|NCT02075073|567051929|FG002|Overall Study|Withdrawal by Subject|0|||
157081647|NCT02683785|567051945|FG000|Overall Study|Withdrawal by Subject|1|||
157081648|NCT02683785|567051946|FG001|Overall Study|Withdrawal by Subject|1|||
157081649|NCT02683785|567051945|FG000|Overall Study|Lost to Follow-up|0|||
157081650|NCT02683785|567051946|FG001|Overall Study|Lost to Follow-up|1|||
157081651|NCT02683785|567051945|FG000|Overall Study|Adverse Event|0|||
157081652|NCT02683785|567051946|FG001|Overall Study|Adverse Event|2|||
157081653|NCT01305408|567051947|FG000|Overall Study|Adverse Event|10|||
157081654|NCT01305408|567051948|FG001|Overall Study|Adverse Event|7|||
157081655|NCT01305408|567051947|FG000|Overall Study|Lack of Efficacy|3|||
157081656|NCT01305408|567051948|FG001|Overall Study|Lack of Efficacy|4|||
157081657|NCT01305408|567051947|FG000|Overall Study|Withdrawal by Subject|9|||
157081658|NCT01305408|567051948|FG001|Overall Study|Withdrawal by Subject|9|||
157081659|NCT01305408|567051947|FG000|Overall Study|Protocol Violation|4|||
157081660|NCT01305408|567051948|FG001|Overall Study|Protocol Violation|6|||
157081661|NCT01305408|567051947|FG000|Overall Study|Lost to Follow-up|5|||
157081662|NCT01305408|567051948|FG001|Overall Study|Lost to Follow-up|3|||
157081663|NCT01305408|567051947|FG000|Overall Study|Noncompliance with study medication|0|||
157081664|NCT01305408|567051948|FG001|Overall Study|Noncompliance with study medication|1|||
157081665|NCT01305408|567051947|FG000|Overall Study|Noncompliance with study procedures|0|||
157081666|NCT01305408|567051948|FG001|Overall Study|Noncompliance with study procedures|1|||
157081667|NCT01305408|567051947|FG000|Overall Study|Other|1|||
157081668|NCT01305408|567051948|FG001|Overall Study|Other|0|||
157081669|NCT02530970|567051949|FG000|Overall Study|Adverse Event|8|||
157081670|NCT02530970|567051949|FG000|Overall Study|Lost to Follow-up|88|||
157081671|NCT02530970|567051949|FG000|Overall Study|Physician Decision|5|||
157081672|NCT02530970|567051949|FG000|Overall Study|Withdrawal by Subject|14|||
157081673|NCT02530970|567051949|FG000|Overall Study|Death|6|||
157081674|NCT02530970|567051949|FG000|Overall Study|Hospitalization|1|||
157081675|NCT02530970|567051949|FG000|Overall Study|Insurance|2|||
157081676|NCT02530970|567051949|FG000|Overall Study|Explant|2|||
157081677|NCT02530970|567051949|FG000|Overall Study|Change in Provider|5|||
157081678|NCT02530970|567051949|FG000|Overall Study|Relocation|3|||
157081679|NCT02770612|567051953|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
157081680|NCT03846453|567051954|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
157081681|NCT03846453|567051955|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
157081682|NCT03846453|567051956|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
157081683|NCT03846453|567051954|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
157081684|NCT03846453|567051955|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
157081685|NCT03846453|567051956|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
157081686|NCT03846453|567051954|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
157081687|NCT03846453|567051955|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
157081688|NCT03846453|567051956|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
157081689|NCT03846453|567051954|FG000|Placebo Run-in (14 Days)|Other|2|||
157081690|NCT03846453|567051955|FG001|Placebo Run-in (14 Days)|Other|0|||
157081691|NCT03846453|567051956|FG002|Placebo Run-in (14 Days)|Other|0|||
157081692|NCT03846453|567051954|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
157081693|NCT03846453|567051955|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
157081694|NCT03846453|567051956|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
157081695|NCT03846453|567051954|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
157081696|NCT03846453|567051955|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
157081697|NCT03846453|567051956|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
157081698|NCT03846453|567051954|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
157081699|NCT03846453|567051955|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
157081700|NCT03846453|567051956|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
157081701|NCT03846453|567051954|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
157081702|NCT03846453|567051955|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
157081703|NCT03846453|567051956|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
157081704|NCT03846453|567051954|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
157081705|NCT03846453|567051955|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
157081706|NCT03846453|567051956|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
157081707|NCT02636725|567051957|FG000|Overall Study|Adverse Event|1|||
157081708|NCT00886795|567051958|FG000|Overall Study|Lack of Efficacy|1|||
157081709|NCT01283516|567051959|FG000|Overall Study|Adverse Event|0|||
157081710|NCT01283516|567051960|FG001|Overall Study|Adverse Event|0|||
157081711|NCT01283516|567051961|FG002|Overall Study|Adverse Event|0|||
157081712|NCT01283516|567051962|FG003|Overall Study|Adverse Event|0|||
157081713|NCT01283516|567051963|FG004|Overall Study|Adverse Event|0|||
157081714|NCT01283516|567051964|FG005|Overall Study|Adverse Event|0|||
157081715|NCT01283516|567051965|FG006|Overall Study|Adverse Event|2|||
157081716|NCT01283516|567051966|FG007|Overall Study|Adverse Event|0|||
157081717|NCT01283516|567051967|FG008|Overall Study|Adverse Event|28|||
157232754|NCT01389102|567599048|FG000|Overall Study|Investigator Judgement|0|||
157081718|NCT01283516|567051959|FG000|Overall Study|Death|0|||
157081719|NCT01283516|567051960|FG001|Overall Study|Death|0|||
157081720|NCT01283516|567051961|FG002|Overall Study|Death|0|||
157081721|NCT01283516|567051962|FG003|Overall Study|Death|0|||
157081722|NCT01283516|567051963|FG004|Overall Study|Death|0|||
157081723|NCT01283516|567051964|FG005|Overall Study|Death|1|||
157081724|NCT01283516|567051965|FG006|Overall Study|Death|0|||
157081725|NCT01283516|567051966|FG007|Overall Study|Death|1|||
157081726|NCT01283516|567051967|FG008|Overall Study|Death|12|||
157081727|NCT01283516|567051959|FG000|Overall Study|Disease Progression|2|||
157081728|NCT01283516|567051960|FG001|Overall Study|Disease Progression|2|||
157081729|NCT01283516|567051961|FG002|Overall Study|Disease Progression|3|||
157081730|NCT01283516|567051962|FG003|Overall Study|Disease Progression|3|||
157081731|NCT01283516|567051963|FG004|Overall Study|Disease Progression|13|||
157081732|NCT01283516|567051964|FG005|Overall Study|Disease Progression|8|||
157081733|NCT01283516|567051965|FG006|Overall Study|Disease Progression|6|||
157081734|NCT01283516|567051966|FG007|Overall Study|Disease Progression|3|||
157081735|NCT01283516|567051967|FG008|Overall Study|Disease Progression|139|||
157081736|NCT01283516|567051959|FG000|Overall Study|Withdrawal by Subject|0|||
157081737|NCT01283516|567051960|FG001|Overall Study|Withdrawal by Subject|0|||
157081738|NCT01283516|567051961|FG002|Overall Study|Withdrawal by Subject|0|||
157081739|NCT01283516|567051962|FG003|Overall Study|Withdrawal by Subject|0|||
157081740|NCT01283516|567051963|FG004|Overall Study|Withdrawal by Subject|1|||
157081741|NCT01283516|567051964|FG005|Overall Study|Withdrawal by Subject|0|||
157081742|NCT01283516|567051965|FG006|Overall Study|Withdrawal by Subject|1|||
157081743|NCT01283516|567051966|FG007|Overall Study|Withdrawal by Subject|0|||
157081744|NCT01283516|567051967|FG008|Overall Study|Withdrawal by Subject|36|||
157081745|NCT01283516|567051959|FG000|Overall Study|Administrative problems|0|||
157081746|NCT01283516|567051960|FG001|Overall Study|Administrative problems|0|||
157081747|NCT01283516|567051961|FG002|Overall Study|Administrative problems|0|||
157081748|NCT01283516|567051962|FG003|Overall Study|Administrative problems|0|||
157081749|NCT01283516|567051963|FG004|Overall Study|Administrative problems|0|||
157081750|NCT01283516|567051964|FG005|Overall Study|Administrative problems|1|||
157081751|NCT01283516|567051965|FG006|Overall Study|Administrative problems|1|||
157081752|NCT01283516|567051966|FG007|Overall Study|Administrative problems|1|||
157081753|NCT01283516|567051967|FG008|Overall Study|Administrative problems|39|||
157081754|NCT01283516|567051959|FG000|Overall Study|Lost to Follow-up|0|||
157081755|NCT01283516|567051960|FG001|Overall Study|Lost to Follow-up|0|||
157081756|NCT01283516|567051961|FG002|Overall Study|Lost to Follow-up|0|||
157081757|NCT01283516|567051962|FG003|Overall Study|Lost to Follow-up|0|||
157081758|NCT01283516|567051963|FG004|Overall Study|Lost to Follow-up|0|||
157081759|NCT01283516|567051964|FG005|Overall Study|Lost to Follow-up|0|||
157081760|NCT01283516|567051965|FG006|Overall Study|Lost to Follow-up|0|||
157081761|NCT01283516|567051966|FG007|Overall Study|Lost to Follow-up|0|||
157081762|NCT01283516|567051967|FG008|Overall Study|Lost to Follow-up|1|||
157081763|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
157081764|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
157081765|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
157081766|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
157081767|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
157081768|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
157081769|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
157081770|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
157081771|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
157081772|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
157081773|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Adverse Event|0|||
157081774|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Adverse Event|0|||
157081775|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Adverse Event|3|||
157081776|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Adverse Event|2|||
157081777|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Adverse Event|13|||
157081778|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
157081779|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
157081780|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
157081781|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
157081782|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
157081783|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Patient's wish|0|||
157081784|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Patient's wish|0|||
157081785|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Patient's wish|19|||
157081786|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Patient's wish|9|||
157081787|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Patient's wish|20|||
157081788|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
157081789|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
157081790|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
157081791|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
157081792|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
157081793|NCT00444275|567051968|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
157081794|NCT00444275|567051969|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
157081795|NCT00444275|567051970|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
157081796|NCT00444275|567051971|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
157081797|NCT00444275|567051972|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
157081798|NCT02628028|567051976|FG000|Dosing Period|Withdrawal by Subject|0|||
157081799|NCT02628028|567051977|FG001|Dosing Period|Withdrawal by Subject|0|||
157081800|NCT02628028|567051978|FG002|Dosing Period|Withdrawal by Subject|1|||
157081801|NCT02628028|567051979|FG003|Dosing Period|Withdrawal by Subject|0|||
157081802|NCT02628028|567051980|FG004|Dosing Period|Withdrawal by Subject|2|||
157081803|NCT02628028|567051981|FG005|Dosing Period|Withdrawal by Subject|4|||
157081804|NCT02628028|567051982|FG006|Dosing Period|Withdrawal by Subject|1|||
157081805|NCT02628028|567051983|FG007|Dosing Period|Withdrawal by Subject|1|||
157081806|NCT02628028|567051976|FG000|Dosing Period|Adverse Event|0|||
157081807|NCT02628028|567051977|FG001|Dosing Period|Adverse Event|0|||
157081808|NCT02628028|567051978|FG002|Dosing Period|Adverse Event|0|||
157081809|NCT02628028|567051979|FG003|Dosing Period|Adverse Event|0|||
157081810|NCT02628028|567051980|FG004|Dosing Period|Adverse Event|2|||
157081811|NCT02628028|567051981|FG005|Dosing Period|Adverse Event|1|||
157081812|NCT02628028|567051982|FG006|Dosing Period|Adverse Event|3|||
157232755|NCT01389102|567599049|FG001|Overall Study|Investigator Judgement|1|||
157232756|NCT01389102|567599050|FG002|Overall Study|Investigator Judgement|0|||
157232757|NCT01389102|567599051|FG003|Overall Study|Investigator Judgement|0|||
157232758|NCT01389102|567599052|FG004|Overall Study|Investigator Judgement|0|||
157081813|NCT02628028|567051983|FG007|Dosing Period|Adverse Event|2|||
157081814|NCT02628028|567051976|FG000|Dosing Period|Death|0|||
157081815|NCT02628028|567051977|FG001|Dosing Period|Death|0|||
157081816|NCT02628028|567051978|FG002|Dosing Period|Death|0|||
157081817|NCT02628028|567051979|FG003|Dosing Period|Death|0|||
157081818|NCT02628028|567051980|FG004|Dosing Period|Death|0|||
157081819|NCT02628028|567051981|FG005|Dosing Period|Death|0|||
157081820|NCT02628028|567051982|FG006|Dosing Period|Death|0|||
157081821|NCT02628028|567051983|FG007|Dosing Period|Death|1|||
157081822|NCT02628028|567051976|FG000|Dosing Period|Lack of Efficacy|0|||
157081823|NCT02628028|567051977|FG001|Dosing Period|Lack of Efficacy|0|||
157081824|NCT02628028|567051978|FG002|Dosing Period|Lack of Efficacy|0|||
157081825|NCT02628028|567051979|FG003|Dosing Period|Lack of Efficacy|0|||
157081826|NCT02628028|567051980|FG004|Dosing Period|Lack of Efficacy|3|||
157081827|NCT02628028|567051981|FG005|Dosing Period|Lack of Efficacy|0|||
157081828|NCT02628028|567051982|FG006|Dosing Period|Lack of Efficacy|1|||
157081829|NCT02628028|567051983|FG007|Dosing Period|Lack of Efficacy|0|||
157081830|NCT02628028|567051976|FG000|Dosing Period|Study Terminated by Sponsor|0|||
157081831|NCT02628028|567051977|FG001|Dosing Period|Study Terminated by Sponsor|0|||
157081832|NCT02628028|567051978|FG002|Dosing Period|Study Terminated by Sponsor|0|||
157081833|NCT02628028|567051979|FG003|Dosing Period|Study Terminated by Sponsor|0|||
157081834|NCT02628028|567051980|FG004|Dosing Period|Study Terminated by Sponsor|7|||
157081835|NCT02628028|567051981|FG005|Dosing Period|Study Terminated by Sponsor|6|||
157081836|NCT02628028|567051982|FG006|Dosing Period|Study Terminated by Sponsor|7|||
157081837|NCT02628028|567051983|FG007|Dosing Period|Study Terminated by Sponsor|7|||
157081838|NCT02628028|567051976|FG000|Dosing Period|Physician Decision|0|||
157081839|NCT02628028|567051977|FG001|Dosing Period|Physician Decision|0|||
157081840|NCT02628028|567051978|FG002|Dosing Period|Physician Decision|0|||
157081841|NCT02628028|567051979|FG003|Dosing Period|Physician Decision|0|||
157081842|NCT02628028|567051980|FG004|Dosing Period|Physician Decision|0|||
157081843|NCT02628028|567051981|FG005|Dosing Period|Physician Decision|1|||
157081844|NCT02628028|567051982|FG006|Dosing Period|Physician Decision|0|||
157081845|NCT02628028|567051983|FG007|Dosing Period|Physician Decision|0|||
157081846|NCT02628028|567051976|FG000|Dosing Period|Site Terminated by Sponsor|0|||
157081847|NCT02628028|567051977|FG001|Dosing Period|Site Terminated by Sponsor|0|||
157081848|NCT02628028|567051978|FG002|Dosing Period|Site Terminated by Sponsor|0|||
157081849|NCT02628028|567051979|FG003|Dosing Period|Site Terminated by Sponsor|0|||
157081850|NCT02628028|567051980|FG004|Dosing Period|Site Terminated by Sponsor|0|||
157081851|NCT02628028|567051981|FG005|Dosing Period|Site Terminated by Sponsor|1|||
157081852|NCT02628028|567051982|FG006|Dosing Period|Site Terminated by Sponsor|1|||
157081853|NCT02628028|567051983|FG007|Dosing Period|Site Terminated by Sponsor|0|||
157081854|NCT02628028|567051976|FG000|Dosing Period|Lost to Follow-up|0|||
157081855|NCT02628028|567051977|FG001|Dosing Period|Lost to Follow-up|0|||
157232759|NCT01389102|567599053|FG005|Overall Study|Investigator Judgement|0|||
157232760|NCT01661686|567599054|FG000|Overall Study|Lost to Follow-up|2|||
157232761|NCT01661686|567599055|FG001|Overall Study|Lost to Follow-up|1|||
157081856|NCT02628028|567051978|FG002|Dosing Period|Lost to Follow-up|0|||
157081857|NCT02628028|567051979|FG003|Dosing Period|Lost to Follow-up|0|||
157081858|NCT02628028|567051980|FG004|Dosing Period|Lost to Follow-up|0|||
157081859|NCT02628028|567051981|FG005|Dosing Period|Lost to Follow-up|0|||
157081860|NCT02628028|567051982|FG006|Dosing Period|Lost to Follow-up|1|||
157081861|NCT02628028|567051983|FG007|Dosing Period|Lost to Follow-up|0|||
157081862|NCT02628028|567051976|FG000|Dosing Period|Other|0|||
157081863|NCT02628028|567051977|FG001|Dosing Period|Other|0|||
157081864|NCT02628028|567051978|FG002|Dosing Period|Other|0|||
157081865|NCT02628028|567051979|FG003|Dosing Period|Other|0|||
157081866|NCT02628028|567051980|FG004|Dosing Period|Other|2|||
157081867|NCT02628028|567051981|FG005|Dosing Period|Other|1|||
157081868|NCT02628028|567051982|FG006|Dosing Period|Other|2|||
157081869|NCT02628028|567051983|FG007|Dosing Period|Other|4|||
157081870|NCT02628028|567051976|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
157081871|NCT02628028|567051977|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
157081872|NCT02628028|567051978|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
157081873|NCT02628028|567051979|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
157081874|NCT02628028|567051980|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
157081875|NCT02628028|567051981|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
157081876|NCT02628028|567051982|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
157081877|NCT02628028|567051983|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
157081878|NCT02628028|567051976|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081879|NCT02628028|567051977|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081880|NCT02628028|567051978|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081881|NCT02628028|567051979|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081882|NCT02628028|567051980|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081883|NCT02628028|567051981|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
157081884|NCT02628028|567051982|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
157081885|NCT02628028|567051983|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
157081886|NCT02628028|567051976|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
157081887|NCT02628028|567051977|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
157081888|NCT02628028|567051978|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
157081889|NCT02628028|567051979|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
157081890|NCT02628028|567051980|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
157081891|NCT02628028|567051981|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
157081892|NCT02628028|567051982|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
157081893|NCT02628028|567051983|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
157081894|NCT02628028|567051976|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
157081895|NCT02628028|567051977|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
157081896|NCT02628028|567051978|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
157081897|NCT02628028|567051979|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
157081898|NCT02628028|567051980|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
157081899|NCT02628028|567051981|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
157081900|NCT02628028|567051982|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
157081901|NCT02628028|567051983|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
157081902|NCT02628028|567051976|FG000|Long-term Extension (LTE) Period|Other|0|||
157081903|NCT02628028|567051977|FG001|Long-term Extension (LTE) Period|Other|0|||
157081904|NCT02628028|567051978|FG002|Long-term Extension (LTE) Period|Other|0|||
157081905|NCT02628028|567051979|FG003|Long-term Extension (LTE) Period|Other|0|||
157081906|NCT02628028|567051980|FG004|Long-term Extension (LTE) Period|Other|0|||
157081907|NCT02628028|567051981|FG005|Long-term Extension (LTE) Period|Other|3|||
157081908|NCT02628028|567051982|FG006|Long-term Extension (LTE) Period|Other|4|||
157081909|NCT02628028|567051983|FG007|Long-term Extension (LTE) Period|Other|3|||
157081910|NCT00186888|567051989|FG000|Overall Study|Toxicity|0|||
157081911|NCT00186888|567051990|FG001|Overall Study|Toxicity|1|||
157081912|NCT00186888|567051991|FG002|Overall Study|Toxicity|0|||
157081913|NCT00186888|567051989|FG000|Overall Study|Relapse or progression of disease|4|||
157081914|NCT00186888|567051990|FG001|Overall Study|Relapse or progression of disease|2|||
157081915|NCT00186888|567051991|FG002|Overall Study|Relapse or progression of disease|0|||
157081916|NCT05511038|567051992|FG000|Overall|Withdrawal by Subject|5|||
157081917|NCT05511038|567051993|FG001|Overall|Withdrawal by Subject|3|||
157081918|NCT05511038|567051992|FG000|Overall|Screen Failure|20|||
157081919|NCT05511038|567051993|FG001|Overall|Screen Failure|1|||
157081920|NCT05511038|567051992|FG000|Overall|Physician Decision|3|||
157081921|NCT05511038|567051993|FG001|Overall|Physician Decision|0|||
157081922|NCT05511038|567051992|FG000|Overall|Lost to Follow-up|3|||
157081923|NCT05511038|567051993|FG001|Overall|Lost to Follow-up|0|||
157081924|NCT05511038|567051992|FG000|Overall|Death|1|||
157081925|NCT05511038|567051993|FG001|Overall|Death|0|||
157081926|NCT05511038|567051992|FG000|Screening|Withdrawal by Subject|1|||
157081927|NCT05511038|567051993|FG001|Screening|Withdrawal by Subject|0|||
157081928|NCT05511038|567051992|FG000|Screening|Lost to Follow Up (1 participant)|1|||
157081929|NCT05511038|567051993|FG001|Screening|Lost to Follow Up (1 participant)|0|||
157081930|NCT05511038|567051992|FG000|Screening|Screen Failure|3|||
157081931|NCT05511038|567051993|FG001|Screening|Screen Failure|0|||
157081932|NCT05511038|567051992|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
157081933|NCT05511038|567051993|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
157081934|NCT05511038|567051992|FG000|Treatment|Withdrawal by Subject|5|||
157081935|NCT05511038|567051993|FG001|Treatment|Withdrawal by Subject|3|||
157081936|NCT05511038|567051992|FG000|Treatment|Physician Decision|4|||
157081937|NCT05511038|567051993|FG001|Treatment|Physician Decision|0|||
157081938|NCT05511038|567051992|FG000|Treatment|Lost to Follow-up|2|||
157081939|NCT05511038|567051993|FG001|Treatment|Lost to Follow-up|0|||
157081940|NCT05511038|567051992|FG000|Treatment|Death|1|||
157081941|NCT05511038|567051993|FG001|Treatment|Death|0|||
157081942|NCT05511038|567051992|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
157081943|NCT05511038|567051993|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
157081944|NCT05511038|567051992|FG000|Treatment|Refuse by subject|1|||
157081945|NCT05511038|567051993|FG001|Treatment|Refuse by subject|0|||
157081946|NCT05511038|567051992|FG000|Treatment|Subject did not go to the site for visit|1|||
157081947|NCT05511038|567051993|FG001|Treatment|Subject did not go to the site for visit|0|||
157081948|NCT02108964|567051994|FG000|Overall Study|Progressive disease|15|||
157081949|NCT02108964|567051995|FG001|Overall Study|Progressive disease|31|||
157081950|NCT02108964|567051996|FG002|Overall Study|Progressive disease|54|||
157081951|NCT02108964|567051997|FG003|Overall Study|Progressive disease|7|||
157081952|NCT02108964|567051998|FG004|Overall Study|Progressive disease|20|||
157081953|NCT02108964|567051999|FG005|Overall Study|Progressive disease|4|||
157081954|NCT02108964|567052000|FG006|Overall Study|Progressive disease|6|||
157081955|NCT02108964|567052001|FG007|Overall Study|Progressive disease|33|||
157081956|NCT02108964|567051994|FG000|Overall Study|Physician Decision|1|||
157081957|NCT02108964|567051995|FG001|Overall Study|Physician Decision|5|||
157081958|NCT02108964|567051996|FG002|Overall Study|Physician Decision|7|||
157081959|NCT02108964|567051997|FG003|Overall Study|Physician Decision|1|||
157081960|NCT02108964|567051998|FG004|Overall Study|Physician Decision|2|||
157081961|NCT02108964|567051999|FG005|Overall Study|Physician Decision|1|||
157081962|NCT02108964|567052000|FG006|Overall Study|Physician Decision|1|||
157081963|NCT02108964|567052001|FG007|Overall Study|Physician Decision|3|||
157081964|NCT02108964|567051994|FG000|Overall Study|Adverse Event|0|||
157081965|NCT02108964|567051995|FG001|Overall Study|Adverse Event|0|||
157081966|NCT02108964|567051996|FG002|Overall Study|Adverse Event|4|||
157081967|NCT02108964|567051997|FG003|Overall Study|Adverse Event|0|||
157081968|NCT02108964|567051998|FG004|Overall Study|Adverse Event|1|||
157081969|NCT02108964|567051999|FG005|Overall Study|Adverse Event|0|||
157081970|NCT02108964|567052000|FG006|Overall Study|Adverse Event|3|||
157081971|NCT02108964|567052001|FG007|Overall Study|Adverse Event|2|||
157081972|NCT02108964|567051994|FG000|Overall Study|Death|1|||
157081973|NCT02108964|567051995|FG001|Overall Study|Death|1|||
157081974|NCT02108964|567051996|FG002|Overall Study|Death|4|||
157081975|NCT02108964|567051997|FG003|Overall Study|Death|0|||
157081976|NCT02108964|567051998|FG004|Overall Study|Death|3|||
157081977|NCT02108964|567051999|FG005|Overall Study|Death|0|||
157081978|NCT02108964|567052000|FG006|Overall Study|Death|0|||
157081979|NCT02108964|567052001|FG007|Overall Study|Death|2|||
157081980|NCT02108964|567051994|FG000|Overall Study|Subject/Guardian decision|0|||
157081981|NCT02108964|567051995|FG001|Overall Study|Subject/Guardian decision|1|||
157081982|NCT02108964|567051996|FG002|Overall Study|Subject/Guardian decision|4|||
157081983|NCT02108964|567051997|FG003|Overall Study|Subject/Guardian decision|0|||
157081984|NCT02108964|567051998|FG004|Overall Study|Subject/Guardian decision|2|||
157081985|NCT02108964|567051999|FG005|Overall Study|Subject/Guardian decision|0|||
157081986|NCT02108964|567052000|FG006|Overall Study|Subject/Guardian decision|1|||
157081987|NCT02108964|567052001|FG007|Overall Study|Subject/Guardian decision|2|||
157081988|NCT02108964|567051994|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081989|NCT02108964|567051995|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081990|NCT02108964|567051996|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081991|NCT02108964|567051997|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081992|NCT02108964|567051998|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081993|NCT02108964|567051999|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081994|NCT02108964|567052000|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
157081995|NCT02108964|567052001|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
157081996|NCT00384397|567052002|FG000|Overall Study|Adverse Event|0|||
157081997|NCT00384397|567052003|FG001|Overall Study|Adverse Event|1|||
157081998|NCT00384397|567052004|FG002|Overall Study|Adverse Event|2|||
157081999|NCT00384397|567052002|FG000|Overall Study|Protocol Violation|7|||
157082000|NCT00384397|567052003|FG001|Overall Study|Protocol Violation|15|||
157082001|NCT00384397|567052004|FG002|Overall Study|Protocol Violation|13|||
157082002|NCT00384397|567052002|FG000|Overall Study|Lost to Follow-up|11|||
157082003|NCT00384397|567052003|FG001|Overall Study|Lost to Follow-up|13|||
157193029|NCT02394028|567447219|FG004|Maintenance Phase|Withdrawal by Subject|0|||
157082004|NCT00384397|567052004|FG002|Overall Study|Lost to Follow-up|3|||
157082005|NCT00384397|567052002|FG000|Overall Study|Withdrawal by Subject|14|||
157082006|NCT00384397|567052003|FG001|Overall Study|Withdrawal by Subject|17|||
157082007|NCT00384397|567052004|FG002|Overall Study|Withdrawal by Subject|15|||
157082008|NCT02336451|567052005|FG000|Overall Study|Adverse Event|1|||
157082009|NCT02336451|567052006|FG001|Overall Study|Adverse Event|2|||
157082010|NCT02336451|567052007|FG002|Overall Study|Adverse Event|0|||
157082011|NCT02336451|567052008|FG003|Overall Study|Adverse Event|6|||
157082012|NCT02336451|567052009|FG004|Overall Study|Adverse Event|4|||
157082013|NCT02336451|567052005|FG000|Overall Study|Death|6|||
157082014|NCT02336451|567052006|FG001|Overall Study|Death|2|||
157082015|NCT02336451|567052007|FG002|Overall Study|Death|3|||
157082016|NCT02336451|567052008|FG003|Overall Study|Death|6|||
157082017|NCT02336451|567052009|FG004|Overall Study|Death|6|||
157082018|NCT02336451|567052005|FG000|Overall Study|Physician Decision|9|||
157082019|NCT02336451|567052006|FG001|Overall Study|Physician Decision|6|||
157082020|NCT02336451|567052007|FG002|Overall Study|Physician Decision|7|||
157082021|NCT02336451|567052008|FG003|Overall Study|Physician Decision|16|||
157082022|NCT02336451|567052009|FG004|Overall Study|Physician Decision|3|||
157082023|NCT02336451|567052005|FG000|Overall Study|Progressive disease|23|||
157082024|NCT02336451|567052006|FG001|Overall Study|Progressive disease|26|||
157082025|NCT02336451|567052007|FG002|Overall Study|Progressive disease|2|||
157082026|NCT02336451|567052008|FG003|Overall Study|Progressive disease|14|||
157082027|NCT02336451|567052009|FG004|Overall Study|Progressive disease|4|||
157082028|NCT02336451|567052005|FG000|Overall Study|Protocol Violation|1|||
157082029|NCT02336451|567052006|FG001|Overall Study|Protocol Violation|0|||
157082030|NCT02336451|567052007|FG002|Overall Study|Protocol Violation|0|||
157082031|NCT02336451|567052008|FG003|Overall Study|Protocol Violation|0|||
157082032|NCT02336451|567052009|FG004|Overall Study|Protocol Violation|0|||
157082033|NCT02336451|567052005|FG000|Overall Study|Patient/guardian decision|2|||
157082034|NCT02336451|567052006|FG001|Overall Study|Patient/guardian decision|4|||
157082035|NCT02336451|567052007|FG002|Overall Study|Patient/guardian decision|0|||
157082036|NCT02336451|567052008|FG003|Overall Study|Patient/guardian decision|2|||
157082037|NCT02336451|567052009|FG004|Overall Study|Patient/guardian decision|1|||
157082038|NCT04531982|567052012|FG000|Overall Study|Withdrawal by Subject|10|||
157082039|NCT04531982|567052013|FG001|Overall Study|Withdrawal by Subject|11|||
157082040|NCT04531982|567052012|FG000|Overall Study|Adverse Event|6|||
157082041|NCT04531982|567052013|FG001|Overall Study|Adverse Event|14|||
157082042|NCT04531982|567052012|FG000|Overall Study|Protocol Violation|6|||
157082043|NCT04531982|567052013|FG001|Overall Study|Protocol Violation|9|||
157082044|NCT04531982|567052012|FG000|Overall Study|Non-compliance with study drug|3|||
157082045|NCT04531982|567052013|FG001|Overall Study|Non-compliance with study drug|2|||
157082046|NCT04531982|567052012|FG000|Overall Study|Use of prohibited medication|2|||
157082047|NCT04531982|567052013|FG001|Overall Study|Use of prohibited medication|0|||
157082048|NCT04531982|567052012|FG000|Overall Study|Lost to Follow-up|0|||
157082049|NCT04531982|567052013|FG001|Overall Study|Lost to Follow-up|1|||
157082050|NCT04531982|567052012|FG000|Overall Study|Geopolitical conflict|2|||
157082051|NCT04531982|567052013|FG001|Overall Study|Geopolitical conflict|0|||
157082052|NCT04531982|567052012|FG000|Overall Study|Lack of Efficacy|3|||
157082053|NCT04531982|567052013|FG001|Overall Study|Lack of Efficacy|1|||
157082054|NCT01099215|567054436|FG000|Overall Study|Withdrawal by Subject|1|||
157082055|NCT01099215|567054437|FG001|Overall Study|Withdrawal by Subject|0|||
157082056|NCT01099215|567054436|FG000|Overall Study|Adverse Event|0|||
157082057|NCT01099215|567054437|FG001|Overall Study|Adverse Event|1|||
157082058|NCT01732822|567054438|FG000|Overall Study|Withdrawal by Subject|123|||
157082059|NCT01732822|567054439|FG001|Overall Study|Withdrawal by Subject|113|||
157082060|NCT01077271|567054443|FG000|Overall Study|Parental desire|8|||
157082061|NCT01077271|567054443|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
157082062|NCT01077271|567054443|FG000|Overall Study|Noncompliance|2|||
157082063|NCT01077271|567054443|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
157082064|NCT01077271|567054443|FG000|Overall Study|Changed doctors|2|||
157082065|NCT01077271|567054443|FG000|Overall Study|Parents thought too many injections|2|||
157082066|NCT01077271|567054443|FG000|Overall Study|End of RSV season nearly reached|1|||
157082067|NCT01077271|567054443|FG000|Overall Study|Mother unconvinced of the necessity|1|||
157082068|NCT00215137|567054444|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
157082069|NCT00215137|567054445|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
157082070|NCT00215137|567054446|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
157082071|NCT00215137|567054444|FG000|Randomization Period|Lost to Follow-up|0|||
157082072|NCT00215137|567054445|FG001|Randomization Period|Lost to Follow-up|1|||
157082073|NCT00215137|567054446|FG002|Randomization Period|Lost to Follow-up|0|||
157082074|NCT00215137|567054444|FG000|Randomization Period|Withdrawal by Subject|0|||
157082075|NCT00215137|567054445|FG001|Randomization Period|Withdrawal by Subject|1|||
157082076|NCT00215137|567054446|FG002|Randomization Period|Withdrawal by Subject|0|||
157082077|NCT03333876|567054447|FG000|Screening Period|Screen Failure|4|||
157082078|NCT03333876|567054447|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
157082079|NCT03333876|567054447|FG000|Mandibular Advancement|Adverse Event|2|||
157082080|NCT03333876|567054447|FG000|Mandibular Advancement|Product Damage|2|||
157082081|NCT00095498|567054449|FG000|Overall Study|Physician Decision|9|||
157082082|NCT00095498|567054450|FG001|Overall Study|Physician Decision|10|||
157082083|NCT00095498|567054451|FG002|Overall Study|Physician Decision|8|||
157082084|NCT00095498|567054449|FG000|Overall Study|Adverse Event|1|||
157082085|NCT00095498|567054450|FG001|Overall Study|Adverse Event|0|||
157082086|NCT00095498|567054451|FG002|Overall Study|Adverse Event|1|||
157082087|NCT00095498|567054449|FG000|Overall Study|Withdrawal by Subject|15|||
157082088|NCT00095498|567054450|FG001|Overall Study|Withdrawal by Subject|16|||
157082089|NCT00095498|567054451|FG002|Overall Study|Withdrawal by Subject|15|||
157082090|NCT00095498|567054449|FG000|Overall Study|Disease progression|0|||
157082091|NCT00095498|567054450|FG001|Overall Study|Disease progression|1|||
157082092|NCT00095498|567054451|FG002|Overall Study|Disease progression|1|||
157082093|NCT00095498|567054449|FG000|Overall Study|Ineligibility determined|3|||
157082094|NCT00095498|567054450|FG001|Overall Study|Ineligibility determined|0|||
157082095|NCT00095498|567054451|FG002|Overall Study|Ineligibility determined|2|||
157082096|NCT00095498|567054449|FG000|Overall Study|Lost to Follow-up|1|||
157082097|NCT00095498|567054450|FG001|Overall Study|Lost to Follow-up|1|||
157082098|NCT00095498|567054451|FG002|Overall Study|Lost to Follow-up|2|||
157082099|NCT00095498|567054449|FG000|Overall Study|Noncompliance|1|||
157082100|NCT00095498|567054450|FG001|Overall Study|Noncompliance|0|||
157082101|NCT00095498|567054451|FG002|Overall Study|Noncompliance|1|||
157082102|NCT00095498|567054449|FG000|Overall Study|Other|6|||
157082103|NCT00095498|567054450|FG001|Overall Study|Other|7|||
157082104|NCT00095498|567054451|FG002|Overall Study|Other|6|||
157082105|NCT00095498|567054449|FG000|Overall Study|Protocol Violation|0|||
157082106|NCT00095498|567054450|FG001|Overall Study|Protocol Violation|0|||
157082107|NCT00095498|567054451|FG002|Overall Study|Protocol Violation|1|||
157082108|NCT00095498|567054449|FG000|Overall Study|Requirement for alternative therapy|1|||
157082109|NCT00095498|567054450|FG001|Overall Study|Requirement for alternative therapy|0|||
157082110|NCT00095498|567054451|FG002|Overall Study|Requirement for alternative therapy|2|||
157082111|NCT05020327|567054453|FG000|Overall Study|Physician Decision|3|||
157082112|NCT05020327|567054454|FG001|Overall Study|Physician Decision|0|||
157082113|NCT05020327|567054455|FG002|Overall Study|Physician Decision|0|||
157082114|NCT05020327|567054453|FG000|Overall Study|Withdrawal by Subject|1|||
157082115|NCT05020327|567054454|FG001|Overall Study|Withdrawal by Subject|1|||
157082116|NCT05020327|567054455|FG002|Overall Study|Withdrawal by Subject|0|||
157082117|NCT05020327|567054453|FG000|Overall Study|personal/cultural, ineligible|12|||
157082118|NCT05020327|567054454|FG001|Overall Study|personal/cultural, ineligible|0|||
157082119|NCT05020327|567054455|FG002|Overall Study|personal/cultural, ineligible|0|||
157082120|NCT00166712|567054456|FG000|Overall Study|Death|0|||
157082121|NCT00166712|567054457|FG001|Overall Study|Death|1|||
157082122|NCT00166712|567054456|FG000|Overall Study|Adverse Event|1|||
157082123|NCT00166712|567054457|FG001|Overall Study|Adverse Event|0|||
157082124|NCT00166712|567054456|FG000|Overall Study|Withdrawal by Subject|1|||
157082125|NCT00166712|567054457|FG001|Overall Study|Withdrawal by Subject|2|||
157082126|NCT00166712|567054456|FG000|Overall Study|Physician Decision|0|||
157082127|NCT00166712|567054457|FG001|Overall Study|Physician Decision|2|||
157082128|NCT04684394|567054458|FG000|Overall Study|Death|1|||
157082129|NCT04684394|567054459|FG001|Overall Study|Death|2|||
157082130|NCT04684394|567054458|FG000|Overall Study|Lost to Follow-up|1|||
157082131|NCT04684394|567054459|FG001|Overall Study|Lost to Follow-up|0|||
157082132|NCT04684394|567054458|FG000|Overall Study|Withdrawal by Subject|2|||
157082133|NCT04684394|567054459|FG001|Overall Study|Withdrawal by Subject|0|||
157082134|NCT04684394|567054458|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
157082135|NCT04684394|567054459|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
157082136|NCT00591370|567054462|FG000|Overall Study|Not Treated|2|||
157082137|NCT00640133|567054463|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
157082138|NCT00640133|567054464|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
157082139|NCT00640133|567054463|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
157082140|NCT00640133|567054464|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
157082141|NCT00640133|567054463|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
157082142|NCT00640133|567054464|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
157082143|NCT01183260|567054465|FG000|Overall Study|Intraop screen failure|2|||
157082144|NCT01183260|567054466|FG001|Overall Study|Intraop screen failure|0|||
157082145|NCT01183260|567054465|FG000|Overall Study|Withdrawal by Subject|1|||
157082146|NCT01183260|567054466|FG001|Overall Study|Withdrawal by Subject|1|||
157082147|NCT01183260|567054465|FG000|Overall Study|Revised within 30 days|0|||
157082148|NCT01183260|567054466|FG001|Overall Study|Revised within 30 days|1|||
157082149|NCT01183260|567054465|FG000|Overall Study|Death|1|||
157082150|NCT01183260|567054466|FG001|Overall Study|Death|0|||
157082151|NCT01202903|567054469|FG000|Overall Study|Administrative Probelms|1|||
157082152|NCT01202903|567054470|FG001|Overall Study|Administrative Probelms|4|||
157082153|NCT01202903|567054469|FG000|Overall Study|Protocol Violation|0|||
157082154|NCT01202903|567054470|FG001|Overall Study|Protocol Violation|1|||
157082155|NCT01202903|567054469|FG000|Overall Study|Death|1|||
157082156|NCT01202903|567054470|FG001|Overall Study|Death|0|||
157082157|NCT01202903|567054469|FG000|Overall Study|Lost to Follow-up|1|||
157082158|NCT01202903|567054470|FG001|Overall Study|Lost to Follow-up|1|||
157082159|NCT01202903|567054469|FG000|Overall Study|Lack of Efficacy|1|||
157082160|NCT01202903|567054470|FG001|Overall Study|Lack of Efficacy|3|||
157082161|NCT01202903|567054469|FG000|Overall Study|Adverse Event|3|||
157082162|NCT01202903|567054470|FG001|Overall Study|Adverse Event|3|||
157082163|NCT01202903|567054469|FG000|Overall Study|Withdrawal by Subject|4|||
157082164|NCT01202903|567054470|FG001|Overall Study|Withdrawal by Subject|4|||
157082165|NCT01302080|567054471|FG000|Overall Study|Withdrew Consent|92|||
157082166|NCT01302080|567054472|FG001|Overall Study|Withdrew Consent|39|||
157082167|NCT01302080|567054471|FG000|Overall Study|Patient/Family Moved|28|||
157082168|NCT01302080|567054472|FG001|Overall Study|Patient/Family Moved|3|||
157082169|NCT01302080|567054471|FG000|Overall Study|Lost to Follow-up|192|||
157082170|NCT01302080|567054472|FG001|Overall Study|Lost to Follow-up|93|||
157082171|NCT01302080|567054471|FG000|Overall Study|Death|1|||
157082172|NCT01302080|567054472|FG001|Overall Study|Death|0|||
157082173|NCT01302080|567054471|FG000|Overall Study|Other|52|||
157082174|NCT01302080|567054472|FG001|Overall Study|Other|8|||
157082175|NCT01302080|567054471|FG000|Overall Study|Reason Missing For Discontinuation|1|||
157082176|NCT01302080|567054472|FG001|Overall Study|Reason Missing For Discontinuation|0|||
157082177|NCT00503139|567054475|FG000|Overall Study|Case Report Forms were not collected|4|||
157082178|NCT00503139|567054475|FG000|Overall Study|Protocol Violation|4|||
157082179|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
157082180|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
157082181|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
157082182|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
157082183|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
157082184|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
157082185|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
157082186|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
157082187|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
157082188|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
157082189|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082190|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082191|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
157082192|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
157082193|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
157082194|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
157082195|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
157082196|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
157082197|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
157082198|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
157082199|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
157082200|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
157082201|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
157082202|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
157082203|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
157082204|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082205|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
157082206|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082207|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082208|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082209|NCT00833833|567054479|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
157082210|NCT00833833|567054480|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
157082211|NCT00833833|567054481|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
157082212|NCT00833833|567054482|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
157082213|NCT00833833|567054483|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
157082214|NCT00833833|567054484|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
157082215|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
157082216|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
157082217|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
157082218|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
157082219|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
157082220|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
157082221|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
157082222|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
157082223|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
157082224|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
157082225|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
157082226|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
157082227|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
157082228|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
157082229|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
157082230|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
157082231|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
157082232|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
157082233|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082234|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082235|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082236|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
157082237|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
157082238|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
157082239|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082240|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082241|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082242|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
157082243|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
157082244|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
157082245|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
157082246|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
157082247|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
157082248|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
157082249|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
157082250|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
157082251|NCT00833833|567054479|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
157082252|NCT00833833|567054480|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
157082253|NCT00833833|567054481|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
157082254|NCT00833833|567054482|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
157082255|NCT00833833|567054483|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
157082256|NCT00833833|567054484|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
157082257|NCT02040259|567054485|FG000|Overall Study|Death|280|||
157082258|NCT02040259|567054485|FG000|Overall Study|Lost to Follow-up|76|||
157082259|NCT02040259|567054485|FG000|Overall Study|Assessment not completed|3|||
157082260|NCT02040259|567054485|FG000|Overall Study|Withdrawal by Subject|4|||
157082261|NCT00316602|567054486|FG000|Overall Study|Withdrawal by Subject|3|||
157082262|NCT00316602|567054487|FG001|Overall Study|Withdrawal by Subject|2|||
157082263|NCT00316602|567054486|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
157082264|NCT00316602|567054487|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
157082265|NCT00316602|567054486|FG000|Overall Study|Adverse Event|1|||
157082266|NCT00316602|567054487|FG001|Overall Study|Adverse Event|0|||
157082267|NCT00316602|567054486|FG000|Overall Study|Other|3|||
157082268|NCT00316602|567054487|FG001|Overall Study|Other|6|||
157082269|NCT01142232|567054488|FG000|Overall Study|Adverse Event|1|||
157082270|NCT01142232|567054489|FG001|Overall Study|Adverse Event|2|||
157082271|NCT01142232|567054490|FG002|Overall Study|Adverse Event|1|||
157082272|NCT01142232|567054491|FG003|Overall Study|Adverse Event|0|||
157082273|NCT01142232|567054492|FG004|Overall Study|Adverse Event|4|||
157082274|NCT01142232|567054488|FG000|Overall Study|Death|0|||
157082275|NCT01142232|567054489|FG001|Overall Study|Death|0|||
157082276|NCT01142232|567054490|FG002|Overall Study|Death|0|||
157082277|NCT01142232|567054491|FG003|Overall Study|Death|0|||
157082278|NCT01142232|567054492|FG004|Overall Study|Death|1|||
157082279|NCT01142232|567054488|FG000|Overall Study|Disease Progression|2|||
157082280|NCT01142232|567054489|FG001|Overall Study|Disease Progression|0|||
157082281|NCT01142232|567054490|FG002|Overall Study|Disease Progression|1|||
157082282|NCT01142232|567054491|FG003|Overall Study|Disease Progression|2|||
157082283|NCT01142232|567054492|FG004|Overall Study|Disease Progression|12|||
157082284|NCT01142232|567054488|FG000|Overall Study|Withdrawal by Subject|0|||
157082285|NCT01142232|567054489|FG001|Overall Study|Withdrawal by Subject|0|||
157082286|NCT01142232|567054490|FG002|Overall Study|Withdrawal by Subject|0|||
157082287|NCT01142232|567054491|FG003|Overall Study|Withdrawal by Subject|1|||
157082288|NCT01142232|567054492|FG004|Overall Study|Withdrawal by Subject|3|||
157082289|NCT01142232|567054488|FG000|Overall Study|Physician Decision|0|||
157082290|NCT01142232|567054489|FG001|Overall Study|Physician Decision|1|||
157082291|NCT01142232|567054490|FG002|Overall Study|Physician Decision|0|||
157082292|NCT01142232|567054491|FG003|Overall Study|Physician Decision|2|||
157082293|NCT01142232|567054492|FG004|Overall Study|Physician Decision|10|||
157082294|NCT01142232|567054488|FG000|Overall Study|Alternative Therapy|0|||
157082295|NCT01142232|567054489|FG001|Overall Study|Alternative Therapy|1|||
157082296|NCT01142232|567054490|FG002|Overall Study|Alternative Therapy|1|||
157082297|NCT01142232|567054491|FG003|Overall Study|Alternative Therapy|0|||
157082298|NCT01142232|567054492|FG004|Overall Study|Alternative Therapy|1|||
157193030|NCT02394028|567447220|FG005|Maintenance Phase|Withdrawal by Subject|0|||
157082299|NCT01142232|567054488|FG000|Overall Study|Off Trt for other complicating disease|0|||
157082300|NCT01142232|567054489|FG001|Overall Study|Off Trt for other complicating disease|0|||
157082301|NCT01142232|567054490|FG002|Overall Study|Off Trt for other complicating disease|0|||
157082302|NCT01142232|567054491|FG003|Overall Study|Off Trt for other complicating disease|0|||
157082303|NCT01142232|567054492|FG004|Overall Study|Off Trt for other complicating disease|1|||
157082304|NCT01142232|567054488|FG000|Overall Study|Noncompliance|0|||
157082305|NCT01142232|567054489|FG001|Overall Study|Noncompliance|0|||
157082306|NCT01142232|567054490|FG002|Overall Study|Noncompliance|0|||
157082307|NCT01142232|567054491|FG003|Overall Study|Noncompliance|0|||
157082308|NCT01142232|567054492|FG004|Overall Study|Noncompliance|2|||
157082309|NCT00626990|567054493|FG000|Overall Study|Lack of Efficacy|6|||
157082310|NCT00626990|567054494|FG001|Overall Study|Lack of Efficacy|7|||
157082311|NCT00626990|567054495|FG002|Overall Study|Lack of Efficacy|49|||
157082312|NCT00626990|567054496|FG003|Overall Study|Lack of Efficacy|40|||
157082313|NCT00626990|567054493|FG000|Overall Study|Adverse Event|1|||
157082314|NCT00626990|567054494|FG001|Overall Study|Adverse Event|7|||
157082315|NCT00626990|567054495|FG002|Overall Study|Adverse Event|14|||
157082316|NCT00626990|567054496|FG003|Overall Study|Adverse Event|28|||
157082317|NCT00626990|567054493|FG000|Overall Study|Death|0|||
157082318|NCT00626990|567054494|FG001|Overall Study|Death|1|||
157082319|NCT00626990|567054495|FG002|Overall Study|Death|0|||
157082320|NCT00626990|567054496|FG003|Overall Study|Death|0|||
157082321|NCT00626990|567054493|FG000|Overall Study|Withdrawal by Subject|3|||
157082322|NCT00626990|567054494|FG001|Overall Study|Withdrawal by Subject|1|||
157082323|NCT00626990|567054495|FG002|Overall Study|Withdrawal by Subject|5|||
157082324|NCT00626990|567054496|FG003|Overall Study|Withdrawal by Subject|11|||
157082325|NCT00626990|567054493|FG000|Overall Study|Protocol Violation|0|||
157082326|NCT00626990|567054494|FG001|Overall Study|Protocol Violation|1|||
157082327|NCT00626990|567054495|FG002|Overall Study|Protocol Violation|1|||
157082328|NCT00626990|567054496|FG003|Overall Study|Protocol Violation|0|||
157082329|NCT00626990|567054493|FG000|Overall Study|Various different reasons/missing|4|||
157082330|NCT00626990|567054494|FG001|Overall Study|Various different reasons/missing|8|||
157082331|NCT00626990|567054495|FG002|Overall Study|Various different reasons/missing|8|||
157082332|NCT00626990|567054496|FG003|Overall Study|Various different reasons/missing|16|||
157082333|NCT04138576|567054497|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
157082334|NCT01994837|567054498|FG000|Overall Study|Progressive disease per protocol|23|||
157082335|NCT01994837|567054498|FG000|Overall Study|Adv event related to progressive disease|3|||
157082336|NCT01994837|567054498|FG000|Overall Study|Fatal progressive disease|2|||
157082337|NCT01994837|567054498|FG000|Overall Study|Adverse event not related to progression|1|||
157082338|NCT01994837|567054498|FG000|Overall Study|Chose palliative care|1|||
157082339|NCT01994837|567054498|FG000|Overall Study|Proceeded to transplant|1|||
157082340|NCT01994837|567054498|FG000|Overall Study|Removed from study due to no response|1|||
157082341|NCT00574873|567054499|FG000|Overall Study|Withdrawal by Subject|18|||
157082342|NCT00574873|567054500|FG001|Overall Study|Withdrawal by Subject|19|||
157082343|NCT00574873|567054499|FG000|Overall Study|Investigator request|18|||
157082344|NCT00574873|567054500|FG001|Overall Study|Investigator request|8|||
157082345|NCT00574873|567054499|FG000|Overall Study|Death|15|||
157082346|NCT00574873|567054500|FG001|Overall Study|Death|14|||
157082347|NCT00574873|567054499|FG000|Overall Study|Lost to Follow-up|14|||
157082348|NCT00574873|567054500|FG001|Overall Study|Lost to Follow-up|5|||
157082349|NCT00574873|567054499|FG000|Overall Study|Other|40|||
157082350|NCT00574873|567054500|FG001|Overall Study|Other|4|||
157082351|NCT00574873|567054499|FG000|Overall Study|Discontinuation of study by sponsor|5|||
157082352|NCT00574873|567054500|FG001|Overall Study|Discontinuation of study by sponsor|199|||
157082353|NCT00574873|567054499|FG000|Overall Study|Blank, site closed per local regulations|2|||
157082354|NCT00574873|567054500|FG001|Overall Study|Blank, site closed per local regulations|2|||
157082355|NCT00574873|567054499|FG000|Overall Study|Extension Study|126|||
157082356|NCT00574873|567054500|FG001|Overall Study|Extension Study|0|||
157082357|NCT05816330|567054501|FG000|Overall Study|Withdrawal by Subject|4|||
157082358|NCT05816330|567054502|FG001|Overall Study|Withdrawal by Subject|1|||
157082359|NCT02898077|567054503|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
157082360|NCT02898077|567054504|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
157082361|NCT02898077|567054503|FG000|Overall Study|Lost to Follow-up|4|||
157082362|NCT02898077|567054504|FG001|Overall Study|Lost to Follow-up|3|||
157082363|NCT02898077|567054503|FG000|Overall Study|Physician Decision|0|||
157082364|NCT02898077|567054504|FG001|Overall Study|Physician Decision|2|||
157082365|NCT02898077|567054503|FG000|Overall Study|Sponsor Decision|32|||
157082366|NCT02898077|567054504|FG001|Overall Study|Sponsor Decision|13|||
157082367|NCT02898077|567054503|FG000|Overall Study|Withdrawal by Subject|6|||
157082368|NCT02898077|567054504|FG001|Overall Study|Withdrawal by Subject|3|||
157082369|NCT02898077|567054503|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
157082370|NCT02898077|567054504|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
157082371|NCT02898077|567054503|FG000|Overall Study|Ended extension period|3|||
157082372|NCT02898077|567054504|FG001|Overall Study|Ended extension period|0|||
157082373|NCT02040584|567054505|FG000|Overall Study|Adverse Event|13|||
157082374|NCT02040584|567054506|FG001|Overall Study|Adverse Event|6|||
157082375|NCT02040584|567054505|FG000|Overall Study|Protocol Violation|9|||
157082376|NCT02040584|567054506|FG001|Overall Study|Protocol Violation|11|||
157082377|NCT02040584|567054505|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157082378|NCT02040584|567054506|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
157082379|NCT02040584|567054505|FG000|Overall Study|Death|6|||
157082380|NCT02040584|567054506|FG001|Overall Study|Death|3|||
157082381|NCT02040584|567054505|FG000|Overall Study|Transplant rejection/retransplant|0|||
157082382|NCT02040584|567054506|FG001|Overall Study|Transplant rejection/retransplant|1|||
157082383|NCT02040584|567054505|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
157082384|NCT02040584|567054506|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
157082385|NCT00996476|567054507|FG000|Overall Study|Withdrawal by Subject|1|||
157082386|NCT00996476|567054508|FG001|Overall Study|Withdrawal by Subject|2|||
157082387|NCT00996476|567054509|FG002|Overall Study|Withdrawal by Subject|1|||
157082388|NCT00996476|567054510|FG003|Overall Study|Withdrawal by Subject|0|||
157082389|NCT00996476|567054511|FG004|Overall Study|Withdrawal by Subject|1|||
157082390|NCT00996476|567054507|FG000|Overall Study|Adverse Event|0|||
157082391|NCT00996476|567054508|FG001|Overall Study|Adverse Event|1|||
157082392|NCT00996476|567054509|FG002|Overall Study|Adverse Event|0|||
157082393|NCT00996476|567054510|FG003|Overall Study|Adverse Event|0|||
157082394|NCT00996476|567054511|FG004|Overall Study|Adverse Event|1|||
157082395|NCT01802567|567054512|FG000|Overall Study|Withdrawal by Subject|2|||
157082396|NCT01802567|567054512|FG000|Overall Study|Physician Decision|1|||
157082397|NCT01802567|567054512|FG000|Overall Study|Lack of Efficacy|7|||
157082398|NCT01802567|567054512|FG000|Overall Study|Consented but did not start therapy|7|||
157082399|NCT01802567|567054512|FG000|Overall Study|Protocol Violation|1|||
157082400|NCT01940939|567054513|FG000|Overall Study|Withdrawal by Subject|2|||
157082401|NCT01940939|567054514|FG001|Overall Study|Withdrawal by Subject|8|||
157082402|NCT01470001|567054515|FG000|Overall Study|Lost to Follow-up|1|||
157082403|NCT01470001|567054516|FG001|Overall Study|Lost to Follow-up|1|||
157082404|NCT01470001|567054515|FG000|Overall Study|Physician Decision|2|||
157082405|NCT01470001|567054516|FG001|Overall Study|Physician Decision|0|||
157082406|NCT01470001|567054515|FG000|Overall Study|Withdrawal by Subject|2|||
157082407|NCT01470001|567054516|FG001|Overall Study|Withdrawal by Subject|1|||
157082408|NCT01895101|567054517|FG000|Overall Study|OPCAB procedure|1|||
157082409|NCT01895101|567054518|FG001|Overall Study|OPCAB procedure|1|||
157082410|NCT01895101|567054519|FG002|Overall Study|OPCAB procedure|3|||
157082411|NCT01895101|567054517|FG000|Overall Study|Withdrawal by Subject|0|||
157082412|NCT01895101|567054518|FG001|Overall Study|Withdrawal by Subject|1|||
157082413|NCT01895101|567054519|FG002|Overall Study|Withdrawal by Subject|2|||
157082414|NCT01895101|567054517|FG000|Overall Study|another study, enrolled in other study|0|||
157082415|NCT01895101|567054518|FG001|Overall Study|another study, enrolled in other study|1|||
157082416|NCT01895101|567054519|FG002|Overall Study|another study, enrolled in other study|0|||
157082417|NCT01895101|567054517|FG000|Overall Study|Death|0|||
157082418|NCT01895101|567054518|FG001|Overall Study|Death|1|||
157082419|NCT01895101|567054519|FG002|Overall Study|Death|0|||
157082420|NCT01895101|567054517|FG000|Overall Study|coagulation disorder|0|||
157082421|NCT01895101|567054518|FG001|Overall Study|coagulation disorder|1|||
157082422|NCT01895101|567054519|FG002|Overall Study|coagulation disorder|0|||
157082423|NCT03268603|567054520|FG000|Overall Study|Withdrawal by Subject|6|||
157082424|NCT03268603|567054520|FG000|Overall Study|Physician Decision|1|||
157082425|NCT03268603|567054520|FG000|Overall Study|Withdrawn due to disease progression|2|||
157082426|NCT04939701|567054524|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
157082427|NCT04939701|567054525|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
157082428|NCT04939701|567054526|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
157082429|NCT04939701|567054524|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
157082430|NCT04939701|567054525|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
157082431|NCT04939701|567054526|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
157082432|NCT04939701|567054524|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
157082433|NCT04939701|567054525|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
157082434|NCT04939701|567054526|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
157082435|NCT04939701|567054524|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
157082436|NCT04939701|567054525|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
157082437|NCT04939701|567054526|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
157082438|NCT04939701|567054524|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
157082439|NCT04939701|567054525|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
157082440|NCT04939701|567054526|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
157082441|NCT04939701|567054524|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
157082442|NCT04939701|567054525|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
157082443|NCT04939701|567054526|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
157082444|NCT04939701|567054524|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
157082445|NCT04939701|567054525|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
157082446|NCT04939701|567054526|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
157082447|NCT01353859|567054527|FG000|Overall Study|Adverse Event|3|||
157082448|NCT01353859|567054527|FG000|Overall Study|Lack of Efficacy|1|||
157082449|NCT01725126|567054528|FG000|Overall Study|Protocol Violation|0|||
157082450|NCT01725126|567054529|FG001|Overall Study|Protocol Violation|1|||
157082451|NCT01725126|567054530|FG002|Overall Study|Protocol Violation|0|||
157082452|NCT01725126|567054531|FG003|Overall Study|Protocol Violation|0|||
157082453|NCT01725126|567054532|FG004|Overall Study|Protocol Violation|0|||
157082454|NCT01725126|567054533|FG005|Overall Study|Protocol Violation|0|||
157193031|NCT02394028|567447221|FG006|Maintenance Phase|Withdrawal by Subject|0|||
157082455|NCT01725126|567054528|FG000|Overall Study|Withdrawal by Subject|0|||
157082456|NCT01725126|567054529|FG001|Overall Study|Withdrawal by Subject|0|||
157193032|NCT02394028|567447222|FG007|Maintenance Phase|Withdrawal by Subject|0|||
157082457|NCT01725126|567054530|FG002|Overall Study|Withdrawal by Subject|0|||
157082458|NCT01725126|567054531|FG003|Overall Study|Withdrawal by Subject|1|||
157082459|NCT01725126|567054532|FG004|Overall Study|Withdrawal by Subject|0|||
157082460|NCT01725126|567054533|FG005|Overall Study|Withdrawal by Subject|0|||
157082461|NCT03733314|567054534|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
157082462|NCT03733314|567054535|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
157082463|NCT03733314|567054534|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
157082464|NCT03733314|567054535|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
157082465|NCT03733314|567054534|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
157082466|NCT03733314|567054535|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
157082467|NCT03733314|567054534|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
157082468|NCT03733314|567054535|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
157082469|NCT03733314|567054534|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
157082470|NCT03733314|567054535|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
157082471|NCT03733314|567054534|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
157082472|NCT03733314|567054535|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
157082473|NCT03214640|567054536|FG000|Overall Study|Protocol Violation|1|||
157082474|NCT03214640|567054537|FG001|Overall Study|Protocol Violation|2|||
157082475|NCT03214640|567054538|FG002|Overall Study|Protocol Violation|1|||
157082476|NCT03214640|567054539|FG003|Overall Study|Protocol Violation|4|||
157082477|NCT02233803|567054545|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
157082478|NCT02233803|567054546|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
157082479|NCT02233803|567054545|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
157082480|NCT02233803|567054546|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
157082481|NCT02233803|567054545|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
157082482|NCT02233803|567054546|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
157082483|NCT02233803|567054545|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
157082484|NCT02233803|567054546|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
157082485|NCT02233803|567054545|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
157082486|NCT02233803|567054546|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
157082487|NCT02233803|567054545|FG000|Washout Period (4-Wks)|Physician Decision|1|||
157082488|NCT02233803|567054546|FG001|Washout Period (4-Wks)|Physician Decision|0|||
157082489|NCT02233803|567054545|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
157082490|NCT02233803|567054546|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
157082491|NCT02233803|567054545|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
157082492|NCT02233803|567054546|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
157082493|NCT02233803|567054545|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
157082494|NCT02233803|567054546|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
157082495|NCT00468143|567054547|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
157082496|NCT00468143|567054548|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
157082497|NCT00468143|567054547|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
157082498|NCT00468143|567054548|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
157082499|NCT01204710|567054555|FG000|Randomization Treatment|Lost to Follow-up|1|||
157082500|NCT01204710|567054556|FG001|Randomization Treatment|Lost to Follow-up|0|||
157082501|NCT01204710|567054555|FG000|Randomization Treatment|Withdrawal by Subject|6|||
157082502|NCT01204710|567054556|FG001|Randomization Treatment|Withdrawal by Subject|5|||
157082503|NCT01204710|567054555|FG000|Randomization Treatment|Physician Decision|3|||
157082504|NCT01204710|567054556|FG001|Randomization Treatment|Physician Decision|2|||
157082505|NCT01204710|567054555|FG000|Randomization Treatment|Entry criteria not met|0|||
157082506|NCT01204710|567054556|FG001|Randomization Treatment|Entry criteria not met|1|||
157082507|NCT01204710|567054555|FG000|Randomization Treatment|Adverse Event|4|||
157082508|NCT01204710|567054556|FG001|Randomization Treatment|Adverse Event|2|||
157082509|NCT01204710|567054555|FG000|Randomization Treatment|Sponsor Decision|0|||
157082510|NCT01204710|567054556|FG001|Randomization Treatment|Sponsor Decision|1|||
157082511|NCT01204710|567054555|FG000|Randomization Treatment|Worsening of General condition|0|||
157082512|NCT01204710|567054556|FG001|Randomization Treatment|Worsening of General condition|1|||
157082513|NCT01204710|567054555|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
157082514|NCT01204710|567054556|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
157082515|NCT01204710|567054555|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
157082516|NCT01204710|567054556|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
157082517|NCT01204710|567054555|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
157082518|NCT01204710|567054556|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
157082519|NCT01204710|567054555|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
157082520|NCT01204710|567054556|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
157082521|NCT02738853|567054559|FG000|Enrollment|Inclusion/Exclusion not met|21|||
157082522|NCT02738853|567054559|FG000|Enrollment|Withdrawal by Subject|3|||
157082523|NCT02738853|567054559|FG000|Enrollment|Subject treated with commercially available device|6|||
157082524|NCT02738853|567054559|FG000|Enrollment|Study Enrollment Closed|3|||
157082525|NCT02738853|567054559|FG000|Procedure|Death|1|||
157082526|NCT02738853|567054559|FG000|1 Month|Death|2|||
157082527|NCT02738853|567054559|FG000|6 Month|Death|4|||
157082528|NCT02738853|567054559|FG000|6 Month|Withdrawal by Subject|2|||
157082529|NCT02738853|567054559|FG000|1 Year|Death|6|||
157082530|NCT02738853|567054559|FG000|1 Year|Withdrawal by Subject|1|||
157082531|NCT02738853|567054559|FG000|2 Year|Death|2|||
157082532|NCT02738853|567054559|FG000|2 Year|Lost to Follow-up|1|||
157082533|NCT02738853|567054559|FG000|3 Year|Death|2|||
157082534|NCT02738853|567054559|FG000|3 Year|Withdrawal by Subject|1|||
157082535|NCT02738853|567054559|FG000|4 Year|Death|9|||
157082536|NCT02738853|567054559|FG000|5 Year|Lost to Follow-up|4|||
157082537|NCT00653523|567054562|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
157082538|NCT00653523|567054562|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
157082539|NCT00653523|567054562|FG000|Overall Study|Adverse Event|7|||
157082540|NCT00653523|567054562|FG000|Overall Study|Withdrawal by Subject|6|||
157082541|NCT00653523|567054562|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
157082542|NCT00653523|567054562|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
157082543|NCT03006848|567054565|FG000|Overall Study|Adverse Event|1|||
157082544|NCT03006848|567054565|FG000|Overall Study|Physician Decision|1|||
157082545|NCT03006848|567054565|FG000|Overall Study|Lack of Efficacy|16|||
157082546|NCT05543187|567054566|FG000|Overall Study|Ongoing|3|||
157082547|NCT05543187|567054567|FG001|Overall Study|Ongoing|2|||
157082548|NCT03520712|567054568|FG000|Overall Study|Early termination of the study by Sponsor|2|||
157082549|NCT04047862|567054573|FG000|Overall Study|Death|0|||
157082550|NCT04047862|567054574|FG001|Overall Study|Death|0|||
157082551|NCT04047862|567054575|FG002|Overall Study|Death|4|||
157082552|NCT04047862|567054576|FG003|Overall Study|Death|7|||
157082553|NCT04047862|567054577|FG004|Overall Study|Death|2|||
157082554|NCT04047862|567054578|FG005|Overall Study|Death|4|||
157082555|NCT04047862|567054579|FG006|Overall Study|Death|3|||
157082556|NCT04047862|567054580|FG007|Overall Study|Death|24|||
157082557|NCT04047862|567054581|FG008|Overall Study|Death|24|||
157082558|NCT04047862|567054582|FG009|Overall Study|Death|22|||
157082559|NCT04047862|567054583|FG010|Overall Study|Death|35|||
157082560|NCT04047862|567054584|FG011|Overall Study|Death|18|||
157082561|NCT04047862|567054585|FG012|Overall Study|Death|14|||
157082562|NCT04047862|567054586|FG013|Overall Study|Death|6|||
157082563|NCT04047862|567054587|FG014|Overall Study|Death|19|||
157082564|NCT04047862|567054588|FG015|Overall Study|Death|42|||
157082565|NCT04047862|567054589|FG016|Overall Study|Death|9|||
157082566|NCT04047862|567054590|FG017|Overall Study|Death|8|||
157082567|NCT04047862|567054591|FG018|Overall Study|Death|10|||
157082568|NCT04047862|567054573|FG000|Overall Study|Withdrawal by Subject|0|||
157082569|NCT04047862|567054574|FG001|Overall Study|Withdrawal by Subject|0|||
157082570|NCT04047862|567054575|FG002|Overall Study|Withdrawal by Subject|0|||
157082571|NCT04047862|567054576|FG003|Overall Study|Withdrawal by Subject|5|||
157082572|NCT04047862|567054577|FG004|Overall Study|Withdrawal by Subject|2|||
157082573|NCT04047862|567054578|FG005|Overall Study|Withdrawal by Subject|0|||
157082574|NCT04047862|567054579|FG006|Overall Study|Withdrawal by Subject|1|||
157082575|NCT04047862|567054580|FG007|Overall Study|Withdrawal by Subject|0|||
157082576|NCT04047862|567054581|FG008|Overall Study|Withdrawal by Subject|4|||
157082577|NCT04047862|567054582|FG009|Overall Study|Withdrawal by Subject|4|||
157082578|NCT04047862|567054583|FG010|Overall Study|Withdrawal by Subject|4|||
157082579|NCT04047862|567054584|FG011|Overall Study|Withdrawal by Subject|2|||
157082580|NCT04047862|567054585|FG012|Overall Study|Withdrawal by Subject|3|||
157082581|NCT04047862|567054586|FG013|Overall Study|Withdrawal by Subject|0|||
157082582|NCT04047862|567054587|FG014|Overall Study|Withdrawal by Subject|9|||
157082583|NCT04047862|567054588|FG015|Overall Study|Withdrawal by Subject|5|||
157082584|NCT04047862|567054589|FG016|Overall Study|Withdrawal by Subject|1|||
157082585|NCT04047862|567054590|FG017|Overall Study|Withdrawal by Subject|3|||
157082586|NCT04047862|567054591|FG018|Overall Study|Withdrawal by Subject|1|||
157082587|NCT04047862|567054573|FG000|Overall Study|Lost to Follow-up|0|||
157082588|NCT04047862|567054574|FG001|Overall Study|Lost to Follow-up|0|||
157082589|NCT04047862|567054575|FG002|Overall Study|Lost to Follow-up|1|||
157082590|NCT04047862|567054576|FG003|Overall Study|Lost to Follow-up|0|||
157193033|NCT02394028|567447223|FG008|Maintenance Phase|Withdrawal by Subject|3|||
157082591|NCT04047862|567054577|FG004|Overall Study|Lost to Follow-up|0|||
157082592|NCT04047862|567054578|FG005|Overall Study|Lost to Follow-up|0|||
157082593|NCT04047862|567054579|FG006|Overall Study|Lost to Follow-up|0|||
157082594|NCT04047862|567054580|FG007|Overall Study|Lost to Follow-up|1|||
157082595|NCT04047862|567054581|FG008|Overall Study|Lost to Follow-up|0|||
157082596|NCT04047862|567054582|FG009|Overall Study|Lost to Follow-up|1|||
157082597|NCT04047862|567054583|FG010|Overall Study|Lost to Follow-up|0|||
157082598|NCT04047862|567054584|FG011|Overall Study|Lost to Follow-up|3|||
157193034|NCT02394028|567447224|FG009|Maintenance Phase|Withdrawal by Subject|12|||
157082599|NCT04047862|567054585|FG012|Overall Study|Lost to Follow-up|0|||
157082600|NCT04047862|567054586|FG013|Overall Study|Lost to Follow-up|0|||
157082601|NCT04047862|567054587|FG014|Overall Study|Lost to Follow-up|2|||
157082602|NCT04047862|567054588|FG015|Overall Study|Lost to Follow-up|2|||
157082603|NCT04047862|567054589|FG016|Overall Study|Lost to Follow-up|1|||
157082604|NCT04047862|567054590|FG017|Overall Study|Lost to Follow-up|0|||
157193035|NCT02394028|567447225|FG010|Maintenance Phase|Withdrawal by Subject|12|||
157082605|NCT04047862|567054591|FG018|Overall Study|Lost to Follow-up|0|||
157082606|NCT04047862|567054573|FG000|Overall Study|Physician Decision|0|||
157082607|NCT04047862|567054574|FG001|Overall Study|Physician Decision|0|||
157082608|NCT04047862|567054575|FG002|Overall Study|Physician Decision|0|||
157082609|NCT04047862|567054576|FG003|Overall Study|Physician Decision|1|||
157082610|NCT04047862|567054577|FG004|Overall Study|Physician Decision|0|||
157082611|NCT04047862|567054578|FG005|Overall Study|Physician Decision|0|||
157082612|NCT04047862|567054579|FG006|Overall Study|Physician Decision|0|||
157082613|NCT04047862|567054580|FG007|Overall Study|Physician Decision|0|||
157082614|NCT04047862|567054581|FG008|Overall Study|Physician Decision|0|||
157082615|NCT04047862|567054582|FG009|Overall Study|Physician Decision|0|||
157082616|NCT04047862|567054583|FG010|Overall Study|Physician Decision|0|||
157082617|NCT04047862|567054584|FG011|Overall Study|Physician Decision|0|||
157082618|NCT04047862|567054585|FG012|Overall Study|Physician Decision|0|||
157082619|NCT04047862|567054586|FG013|Overall Study|Physician Decision|0|||
157082620|NCT04047862|567054587|FG014|Overall Study|Physician Decision|1|||
157082621|NCT04047862|567054588|FG015|Overall Study|Physician Decision|0|||
157082622|NCT04047862|567054589|FG016|Overall Study|Physician Decision|1|||
157082623|NCT04047862|567054590|FG017|Overall Study|Physician Decision|0|||
157082624|NCT04047862|567054591|FG018|Overall Study|Physician Decision|0|||
157082625|NCT04047862|567054573|FG000|Overall Study|Completed all Assessments|1|||
157082626|NCT04047862|567054574|FG001|Overall Study|Completed all Assessments|3|||
157082627|NCT04047862|567054575|FG002|Overall Study|Completed all Assessments|1|||
157082628|NCT04047862|567054576|FG003|Overall Study|Completed all Assessments|3|||
157082629|NCT04047862|567054577|FG004|Overall Study|Completed all Assessments|2|||
157082630|NCT04047862|567054578|FG005|Overall Study|Completed all Assessments|5|||
157082631|NCT04047862|567054579|FG006|Overall Study|Completed all Assessments|7|||
157082632|NCT04047862|567054580|FG007|Overall Study|Completed all Assessments|0|||
157082633|NCT04047862|567054581|FG008|Overall Study|Completed all Assessments|0|||
157082634|NCT04047862|567054582|FG009|Overall Study|Completed all Assessments|0|||
157082635|NCT04047862|567054583|FG010|Overall Study|Completed all Assessments|0|||
157082636|NCT04047862|567054584|FG011|Overall Study|Completed all Assessments|0|||
157082637|NCT04047862|567054585|FG012|Overall Study|Completed all Assessments|0|||
157082638|NCT04047862|567054586|FG013|Overall Study|Completed all Assessments|0|||
157082639|NCT04047862|567054587|FG014|Overall Study|Completed all Assessments|0|||
157082640|NCT04047862|567054588|FG015|Overall Study|Completed all Assessments|0|||
157082641|NCT04047862|567054589|FG016|Overall Study|Completed all Assessments|0|||
157082642|NCT04047862|567054590|FG017|Overall Study|Completed all Assessments|0|||
157082643|NCT04047862|567054591|FG018|Overall Study|Completed all Assessments|0|||
157082644|NCT04047862|567054573|FG000|Overall Study|Sponsor Decision|0|||
157082645|NCT04047862|567054574|FG001|Overall Study|Sponsor Decision|0|||
157082646|NCT04047862|567054575|FG002|Overall Study|Sponsor Decision|0|||
157082647|NCT04047862|567054576|FG003|Overall Study|Sponsor Decision|0|||
157082648|NCT04047862|567054577|FG004|Overall Study|Sponsor Decision|0|||
157082649|NCT04047862|567054578|FG005|Overall Study|Sponsor Decision|0|||
157082650|NCT04047862|567054579|FG006|Overall Study|Sponsor Decision|0|||
157082651|NCT04047862|567054580|FG007|Overall Study|Sponsor Decision|13|||
157082652|NCT04047862|567054581|FG008|Overall Study|Sponsor Decision|10|||
157082653|NCT04047862|567054582|FG009|Overall Study|Sponsor Decision|18|||
157082654|NCT04047862|567054583|FG010|Overall Study|Sponsor Decision|3|||
157082655|NCT04047862|567054584|FG011|Overall Study|Sponsor Decision|3|||
157082656|NCT04047862|567054585|FG012|Overall Study|Sponsor Decision|4|||
157082657|NCT04047862|567054586|FG013|Overall Study|Sponsor Decision|0|||
157082658|NCT04047862|567054587|FG014|Overall Study|Sponsor Decision|7|||
157082659|NCT04047862|567054588|FG015|Overall Study|Sponsor Decision|8|||
157082660|NCT04047862|567054589|FG016|Overall Study|Sponsor Decision|9|||
157082661|NCT04047862|567054590|FG017|Overall Study|Sponsor Decision|7|||
157082662|NCT04047862|567054591|FG018|Overall Study|Sponsor Decision|8|||
157082663|NCT04047862|567054573|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082664|NCT04047862|567054574|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082665|NCT04047862|567054575|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082666|NCT04047862|567054576|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082667|NCT04047862|567054577|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082668|NCT04047862|567054578|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082669|NCT04047862|567054579|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082670|NCT04047862|567054580|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
157082671|NCT04047862|567054581|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
157082672|NCT04047862|567054582|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082673|NCT04047862|567054583|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
157082674|NCT04047862|567054584|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082675|NCT04047862|567054585|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082676|NCT04047862|567054586|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
157082677|NCT04047862|567054587|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
157193036|NCT02993783|567447226|FG000|Overall Study|Reason not Specified|6|||
157193037|NCT02993783|567447227|FG001|Overall Study|Reason not Specified|9|||
157082678|NCT04047862|567054588|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
157082679|NCT04047862|567054589|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
157082680|NCT04047862|567054590|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
157082681|NCT04047862|567054591|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
157082682|NCT04047862|567054573|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082683|NCT04047862|567054574|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082684|NCT04047862|567054575|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082685|NCT04047862|567054576|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082686|NCT04047862|567054577|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082687|NCT04047862|567054578|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082688|NCT04047862|567054579|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082689|NCT04047862|567054580|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082690|NCT04047862|567054581|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082691|NCT04047862|567054582|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082692|NCT04047862|567054583|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082693|NCT04047862|567054584|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082694|NCT04047862|567054585|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082695|NCT04047862|567054586|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082696|NCT04047862|567054587|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082697|NCT04047862|567054588|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
157082698|NCT04047862|567054589|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082699|NCT04047862|567054590|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
157082700|NCT04047862|567054591|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
157082701|NCT04047862|567054573|FG000|Overall Study|Other|0|||
157082702|NCT04047862|567054574|FG001|Overall Study|Other|0|||
157082703|NCT04047862|567054575|FG002|Overall Study|Other|0|||
157082704|NCT04047862|567054576|FG003|Overall Study|Other|0|||
157082705|NCT04047862|567054577|FG004|Overall Study|Other|0|||
157082706|NCT04047862|567054578|FG005|Overall Study|Other|0|||
157082707|NCT04047862|567054579|FG006|Overall Study|Other|0|||
157082708|NCT04047862|567054580|FG007|Overall Study|Other|0|||
157082709|NCT04047862|567054581|FG008|Overall Study|Other|0|||
157082710|NCT04047862|567054582|FG009|Overall Study|Other|0|||
157082711|NCT04047862|567054583|FG010|Overall Study|Other|0|||
157082712|NCT04047862|567054584|FG011|Overall Study|Other|0|||
157082713|NCT04047862|567054585|FG012|Overall Study|Other|0|||
157082714|NCT04047862|567054586|FG013|Overall Study|Other|0|||
157082715|NCT04047862|567054587|FG014|Overall Study|Other|2|||
157082716|NCT04047862|567054588|FG015|Overall Study|Other|1|||
157082717|NCT04047862|567054589|FG016|Overall Study|Other|1|||
157082718|NCT04047862|567054590|FG017|Overall Study|Other|1|||
157082719|NCT04047862|567054591|FG018|Overall Study|Other|0|||
157082720|NCT00095056|567056259|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
157082721|NCT00095056|567056260|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
157082722|NCT00095056|567056259|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
157082723|NCT00095056|567056260|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
157082724|NCT00095056|567056259|FG000|Phase A (Weeks 0-12)|Death|1|||
157082725|NCT00095056|567056260|FG001|Phase A (Weeks 0-12)|Death|0|||
157082726|NCT00095056|567056259|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
157082727|NCT00095056|567056260|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
157082728|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
157082729|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
157082730|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
157082731|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
157082732|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
157082733|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
157082734|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
157082735|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
157082736|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Death|3|||
157082737|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Death|1|||
157082738|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
157082739|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
157082740|NCT00095056|567056259|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
157082741|NCT00095056|567056260|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
157082742|NCT00306670|567056261|FG000|Overall Study|patients recruited; Genentech, the st|0|||
157082743|NCT00306670|567056262|FG001|Overall Study|patients recruited; Genentech, the st|2|||
157082744|NCT00091169|567056266|FG000|Overall Study|Disease progression|3|||
157082745|NCT00091169|567056267|FG001|Overall Study|Disease progression|1|||
157193038|NCT03480841|567447228|FG000|Overall Study|Lost to Follow-up|2|||
157082746|NCT00091169|567056266|FG000|Overall Study|Adverse Event|11|||
157082747|NCT00091169|567056267|FG001|Overall Study|Adverse Event|17|||
157082748|NCT00091169|567056266|FG000|Overall Study|Death|4|||
157082749|NCT00091169|567056267|FG001|Overall Study|Death|1|||
157082750|NCT00091169|567056266|FG000|Overall Study|Withdrawal by Subject|10|||
157082751|NCT00091169|567056267|FG001|Overall Study|Withdrawal by Subject|13|||
157082752|NCT00091169|567056266|FG000|Overall Study|Other|3|||
157082753|NCT00091169|567056267|FG001|Overall Study|Other|4|||
157082754|NCT00091169|567056266|FG000|Overall Study|Not start protocol therapy|26|||
157082755|NCT00091169|567056267|FG001|Overall Study|Not start protocol therapy|17|||
157082756|NCT02735577|567056268|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
157082757|NCT02735577|567056268|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
157082758|NCT04410523|567056273|FG000|Overall Study|Study terminated by sponsor|1|||
157082759|NCT04410523|567056274|FG001|Overall Study|Study terminated by sponsor|3|||
157082760|NCT04410523|567056275|FG002|Overall Study|Study terminated by sponsor|2|||
157082761|NCT04410523|567056276|FG003|Overall Study|Study terminated by sponsor|6|||
157082762|NCT04410523|567056277|FG004|Overall Study|Study terminated by sponsor|3|||
157082763|NCT04410523|567056278|FG005|Overall Study|Study terminated by sponsor|4|||
157082764|NCT04410523|567056273|FG000|Overall Study|Adverse Event|1|||
157082765|NCT04410523|567056274|FG001|Overall Study|Adverse Event|0|||
157082766|NCT04410523|567056275|FG002|Overall Study|Adverse Event|0|||
157082767|NCT04410523|567056276|FG003|Overall Study|Adverse Event|0|||
157082768|NCT04410523|567056277|FG004|Overall Study|Adverse Event|0|||
157082769|NCT04410523|567056278|FG005|Overall Study|Adverse Event|2|||
157082770|NCT04410523|567056273|FG000|Overall Study|Lost to Follow-up|0|||
157082771|NCT04410523|567056274|FG001|Overall Study|Lost to Follow-up|1|||
157082772|NCT04410523|567056275|FG002|Overall Study|Lost to Follow-up|0|||
157082773|NCT04410523|567056276|FG003|Overall Study|Lost to Follow-up|0|||
157082774|NCT04410523|567056277|FG004|Overall Study|Lost to Follow-up|0|||
157082775|NCT04410523|567056278|FG005|Overall Study|Lost to Follow-up|0|||
157082776|NCT04410523|567056273|FG000|Overall Study|Physician Decision|0|||
157082777|NCT04410523|567056274|FG001|Overall Study|Physician Decision|1|||
157082778|NCT04410523|567056275|FG002|Overall Study|Physician Decision|0|||
157082779|NCT04410523|567056276|FG003|Overall Study|Physician Decision|0|||
157082780|NCT04410523|567056277|FG004|Overall Study|Physician Decision|0|||
157082781|NCT04410523|567056278|FG005|Overall Study|Physician Decision|0|||
157082782|NCT04410523|567056273|FG000|Overall Study|Pregnancy|0|||
157082783|NCT04410523|567056274|FG001|Overall Study|Pregnancy|0|||
157082784|NCT04410523|567056275|FG002|Overall Study|Pregnancy|0|||
157082785|NCT04410523|567056276|FG003|Overall Study|Pregnancy|0|||
157082786|NCT04410523|567056277|FG004|Overall Study|Pregnancy|0|||
157082787|NCT04410523|567056278|FG005|Overall Study|Pregnancy|1|||
157082788|NCT04410523|567056273|FG000|Overall Study|Protocol deviation|0|||
157082789|NCT04410523|567056274|FG001|Overall Study|Protocol deviation|0|||
157082790|NCT04410523|567056275|FG002|Overall Study|Protocol deviation|0|||
157082791|NCT04410523|567056276|FG003|Overall Study|Protocol deviation|0|||
157082792|NCT04410523|567056277|FG004|Overall Study|Protocol deviation|0|||
157082793|NCT04410523|567056278|FG005|Overall Study|Protocol deviation|2|||
157082794|NCT04410523|567056273|FG000|Overall Study|Subject decision|2|||
157082795|NCT04410523|567056274|FG001|Overall Study|Subject decision|0|||
157082796|NCT04410523|567056275|FG002|Overall Study|Subject decision|0|||
157082797|NCT04410523|567056276|FG003|Overall Study|Subject decision|1|||
157082798|NCT04410523|567056277|FG004|Overall Study|Subject decision|0|||
157082799|NCT04410523|567056278|FG005|Overall Study|Subject decision|1|||
157082800|NCT00490490|567056281|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
157082801|NCT00490490|567056281|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
157082802|NCT03207451|567056282|FG000|Overall Study|scheduling conflict|1|||
157082803|NCT03207451|567056283|FG001|Overall Study|scheduling conflict|0|||
157082804|NCT03207451|567056284|FG002|Overall Study|scheduling conflict|2|||
157082805|NCT03207451|567056285|FG003|Overall Study|scheduling conflict|2|||
157082806|NCT03207451|567056282|FG000|Overall Study|Adverse Event|0|||
157082807|NCT03207451|567056283|FG001|Overall Study|Adverse Event|0|||
157082808|NCT03207451|567056284|FG002|Overall Study|Adverse Event|0|||
157082809|NCT03207451|567056285|FG003|Overall Study|Adverse Event|1|||
157082810|NCT03896152|567056286|FG000|Overall Study|Patient/guardian decision|1|||
157082811|NCT03896152|567056287|FG001|Overall Study|Patient/guardian decision|1|||
157082812|NCT03896152|567056286|FG000|Overall Study|Adverse Event|0|||
157082813|NCT03896152|567056287|FG001|Overall Study|Adverse Event|1|||
157082814|NCT03896152|567056286|FG000|Overall Study|Physician Decision|1|||
157082815|NCT03896152|567056287|FG001|Overall Study|Physician Decision|0|||
157082816|NCT03896152|567056286|FG000|Overall Study|Technical problems|1|||
157082817|NCT03896152|567056287|FG001|Overall Study|Technical problems|0|||
157082818|NCT00436852|567056288|FG000|Overall Study|Death|23|||
157082819|NCT00436852|567056289|FG001|Overall Study|Death|34|||
157193039|NCT00606021|567447229|FG000|Induction Phase|Death|73|||
157193040|NCT00606021|567447230|FG001|Induction Phase|Death|0|||
157082820|NCT00436852|567056288|FG000|Overall Study|Lack of Efficacy|9|||
157193041|NCT00606021|567447231|FG002|Induction Phase|Death|0|||
157193042|NCT00606021|567447229|FG000|Induction Phase|Physician Decision|2|||
157082821|NCT00436852|567056289|FG001|Overall Study|Lack of Efficacy|7|||
157082822|NCT00436852|567056288|FG000|Overall Study|Withdrawal by Subject|2|||
157082823|NCT00436852|567056289|FG001|Overall Study|Withdrawal by Subject|4|||
157082824|NCT00436852|567056288|FG000|Overall Study|Ineligible|1|||
157082825|NCT00436852|567056289|FG001|Overall Study|Ineligible|0|||
157082826|NCT00370682|567056290|FG000|Overall Study|Moved from area|0|||
157082827|NCT00370682|567056291|FG001|Overall Study|Moved from area|2|||
157082828|NCT00370682|567056292|FG002|Overall Study|Moved from area|0|||
157082829|NCT00370682|567056290|FG000|Overall Study|Lost to Follow-up|0|||
157082830|NCT00370682|567056291|FG001|Overall Study|Lost to Follow-up|1|||
157082831|NCT00370682|567056292|FG002|Overall Study|Lost to Follow-up|1|||
157082832|NCT03167359|567056293|FG000|Overall Study|Physician Decision|1|||
157082833|NCT03167359|567056293|FG000|Overall Study|Lost to Follow-up|1|||
157082834|NCT03339583|567056294|FG000|First Intervention (14 Days)|Adverse Event|1|||
157082835|NCT03339583|567056295|FG001|First Intervention (14 Days)|Adverse Event|0|||
157082836|NCT03339583|567056294|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
157082837|NCT03339583|567056295|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
157082838|NCT03339583|567056294|FG000|Second Intervention (14 Days)|Adverse Event|0|||
157082839|NCT03339583|567056295|FG001|Second Intervention (14 Days)|Adverse Event|1|||
157082840|NCT03339583|567056294|FG000|Follow-up (14 Days)|Physician Decision|6|||
157082841|NCT03339583|567056295|FG001|Follow-up (14 Days)|Physician Decision|3|||
157082842|NCT00943852|567056296|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082843|NCT00943852|567056297|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082844|NCT00943852|567056298|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082845|NCT00943852|567056299|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
157082846|NCT00943852|567056300|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082847|NCT00943852|567056301|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082848|NCT00943852|567056302|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082849|NCT00943852|567056303|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082850|NCT00943852|567056304|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082851|NCT00943852|567056305|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
157082852|NCT00943852|567056296|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082853|NCT00943852|567056297|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082854|NCT00943852|567056298|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082855|NCT00943852|567056299|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082856|NCT00943852|567056300|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082857|NCT00943852|567056301|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
157082858|NCT00943852|567056302|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082859|NCT00943852|567056303|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082860|NCT00943852|567056304|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082861|NCT00943852|567056305|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
157082862|NCT00943852|567056296|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082863|NCT00943852|567056297|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082864|NCT00943852|567056298|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082865|NCT00943852|567056299|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082866|NCT00943852|567056300|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082867|NCT00943852|567056301|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082868|NCT00943852|567056302|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
157082869|NCT00943852|567056303|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082870|NCT00943852|567056304|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082871|NCT00943852|567056305|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
157082872|NCT00943852|567056296|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082873|NCT00943852|567056297|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082874|NCT00943852|567056298|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082875|NCT00943852|567056299|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082876|NCT00943852|567056300|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082877|NCT00943852|567056301|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082878|NCT00943852|567056302|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082879|NCT00943852|567056303|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
157082880|NCT00943852|567056304|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082881|NCT00943852|567056305|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
157082882|NCT00943852|567056296|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
157082883|NCT00943852|567056297|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082884|NCT00943852|567056298|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
157082885|NCT00943852|567056299|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
157082886|NCT00943852|567056300|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082887|NCT00943852|567056301|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082888|NCT00943852|567056302|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
157082889|NCT00943852|567056303|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082890|NCT00943852|567056304|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082891|NCT00943852|567056305|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
157082892|NCT02141620|567056306|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
157082893|NCT02141620|567056307|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
157082894|NCT00772330|567056308|FG000|Overall Study|Lost to Follow-up|3|||
157082895|NCT00734591|567056309|FG000|Screening for Prospective Period|Site did not participate|1604|||
157082896|NCT00734591|567056310|FG001|Screening for Prospective Period|Site did not participate|1488|||
157082897|NCT00734591|567056309|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
157082898|NCT00734591|567056310|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
157082899|NCT00734591|567056309|FG000|Prospective Period|Withdrawal by Subject|11|||
157082900|NCT00734591|567056310|FG001|Prospective Period|Withdrawal by Subject|9|||
157082901|NCT00734591|567056309|FG000|Prospective Period|Lost to Follow-up|37|||
157082902|NCT00734591|567056310|FG001|Prospective Period|Lost to Follow-up|33|||
157082903|NCT00734591|567056309|FG000|Prospective Period|Study Terminated|1|||
157082904|NCT00734591|567056310|FG001|Prospective Period|Study Terminated|0|||
157082905|NCT00734591|567056309|FG000|Prospective Period|Other|2|||
157082906|NCT00734591|567056310|FG001|Prospective Period|Other|2|||
157082907|NCT01656200|567056313|FG000|Overall Study|Withdrawal by Subject|1|||
157082908|NCT02236988|567056314|FG000|Overall Study|Lost to Follow-up|0|||
157082909|NCT02236988|567056315|FG001|Overall Study|Lost to Follow-up|0|||
157082910|NCT02236988|567056316|FG002|Overall Study|Lost to Follow-up|0|||
157082911|NCT02236988|567056317|FG003|Overall Study|Lost to Follow-up|1|||
157082912|NCT02236988|567056314|FG000|Overall Study|Unable to Comply with Study Visits|0|||
157082913|NCT02236988|567056315|FG001|Overall Study|Unable to Comply with Study Visits|0|||
157082914|NCT02236988|567056316|FG002|Overall Study|Unable to Comply with Study Visits|0|||
157082915|NCT02236988|567056317|FG003|Overall Study|Unable to Comply with Study Visits|2|||
157082916|NCT05775991|567056320|FG000|Overall Study|Withdrawal by Subject|0|||
157082917|NCT05775991|567056321|FG001|Overall Study|Withdrawal by Subject|0|||
157082918|NCT05775991|567056322|FG002|Overall Study|Withdrawal by Subject|2|||
157082919|NCT03921723|567056325|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
157082920|NCT03921723|567056325|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
157082921|NCT01461811|567056326|FG000|Overall Study|Adverse Event|2|||
157082922|NCT01461811|567056327|FG001|Overall Study|Adverse Event|1|||
157082923|NCT01461811|567056326|FG000|Overall Study|Subject decision unrelated to an AE|1|||
157082924|NCT01461811|567056327|FG001|Overall Study|Subject decision unrelated to an AE|1|||
157082925|NCT01461811|567056326|FG000|Overall Study|Noncompliance|1|||
157082926|NCT01461811|567056327|FG001|Overall Study|Noncompliance|1|||
157082927|NCT03015129|567056328|FG000|Overall Study|Death|2|||
157082928|NCT03015129|567056329|FG001|Overall Study|Death|2|||
157082929|NCT03015129|567056328|FG000|Overall Study|Lost to Follow-up|0|||
157082930|NCT03015129|567056329|FG001|Overall Study|Lost to Follow-up|1|||
157082931|NCT03015129|567056328|FG000|Overall Study|Progression of disease|38|||
157082932|NCT03015129|567056329|FG001|Overall Study|Progression of disease|33|||
157082933|NCT03015129|567056328|FG000|Overall Study|Adverse Event|0|||
157082934|NCT03015129|567056329|FG001|Overall Study|Adverse Event|4|||
157082935|NCT01072630|567056331|FG000|Overall Study|Adverse Event|11|||
157082936|NCT01072630|567056332|FG001|Overall Study|Adverse Event|19|||
157082937|NCT01072630|567056333|FG002|Overall Study|Adverse Event|2|||
157082938|NCT01072630|567056331|FG000|Overall Study|Lack of Efficacy|10|||
157082939|NCT01072630|567056332|FG001|Overall Study|Lack of Efficacy|10|||
157082940|NCT01072630|567056333|FG002|Overall Study|Lack of Efficacy|1|||
157082941|NCT01072630|567056331|FG000|Overall Study|Withdrawal by Subject|8|||
157082942|NCT01072630|567056332|FG001|Overall Study|Withdrawal by Subject|7|||
157082943|NCT01072630|567056333|FG002|Overall Study|Withdrawal by Subject|2|||
157082944|NCT01072630|567056331|FG000|Overall Study|Protocol Violation|10|||
157082945|NCT01072630|567056332|FG001|Overall Study|Protocol Violation|8|||
157082946|NCT01072630|567056333|FG002|Overall Study|Protocol Violation|4|||
157082947|NCT01072630|567056331|FG000|Overall Study|Lost to Follow-up|11|||
157082948|NCT01072630|567056332|FG001|Overall Study|Lost to Follow-up|11|||
157082949|NCT01072630|567056333|FG002|Overall Study|Lost to Follow-up|1|||
157082950|NCT01072630|567056331|FG000|Overall Study|Noncompliance with study medication|1|||
157082951|NCT01072630|567056332|FG001|Overall Study|Noncompliance with study medication|1|||
157082952|NCT01072630|567056333|FG002|Overall Study|Noncompliance with study medication|1|||
157082953|NCT01072630|567056331|FG000|Overall Study|Noncompliance with study procedures|1|||
157082954|NCT01072630|567056332|FG001|Overall Study|Noncompliance with study procedures|2|||
157082955|NCT01072630|567056333|FG002|Overall Study|Noncompliance with study procedures|1|||
157082956|NCT01072630|567056331|FG000|Overall Study|Other|3|||
157082957|NCT01072630|567056332|FG001|Overall Study|Other|2|||
157193043|NCT00606021|567447230|FG001|Induction Phase|Physician Decision|0|||
157082958|NCT01072630|567056333|FG002|Overall Study|Other|1|||
157082959|NCT03046121|567056334|FG000|Overall Study|Death|32|||
157082960|NCT03046121|567056335|FG001|Overall Study|Death|60|||
157082961|NCT03046121|567056334|FG000|Overall Study|Withdrawal by Subject|14|||
157082962|NCT03046121|567056335|FG001|Overall Study|Withdrawal by Subject|12|||
157082963|NCT04155047|567056336|FG000|Overall Study|Adverse Event|1|||
157082964|NCT04155047|567056337|FG001|Overall Study|Adverse Event|0|||
157082965|NCT04155047|567056336|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
157082966|NCT04155047|567056337|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
157082967|NCT04514510|567056338|FG000|Overall Study|Lost to Follow-up|0|||
157082968|NCT04514510|567056339|FG001|Overall Study|Lost to Follow-up|1|||
157082969|NCT04514510|567056338|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
157082970|NCT04514510|567056339|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
157082971|NCT02781090|567056340|FG000|3-Month Follow-Up|Missed Visit|20|||
157082972|NCT02781090|567056341|FG001|3-Month Follow-Up|Missed Visit|20|||
157082973|NCT02781090|567056340|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
157082974|NCT02781090|567056341|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
157082975|NCT02781090|567056340|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
157082976|NCT02781090|567056341|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
157082977|NCT02781090|567056340|FG000|3-Month Follow-Up|Death|1|||
157082978|NCT02781090|567056341|FG001|3-Month Follow-Up|Death|0|||
157082979|NCT02781090|567056340|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
157082980|NCT02781090|567056341|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
157082981|NCT02781090|567056340|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
157082982|NCT02781090|567056341|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
157082983|NCT02781090|567056340|FG000|6-Month Follow-Up|Death|0|||
157082984|NCT02781090|567056341|FG001|6-Month Follow-Up|Death|1|||
157082985|NCT00643617|567056342|FG000|Overall Study|Death|6|||
157082986|NCT00643617|567056343|FG001|Overall Study|Death|9|||
157082987|NCT00643617|567056342|FG000|Overall Study|Lost to Follow-up|42|||
157082988|NCT00643617|567056343|FG001|Overall Study|Lost to Follow-up|51|||
157082989|NCT01208103|567056344|FG000|Overall Study|Adverse Event|1|||
157082990|NCT01208103|567056344|FG000|Overall Study|Withdrawal by Subject|1|||
157082991|NCT00416195|567056347|FG000|Overall Study|Adverse Event|1|||
157082992|NCT00416195|567056348|FG001|Overall Study|Adverse Event|2|||
157082993|NCT00416195|567056347|FG000|Overall Study|Protocol Violation|1|||
157082994|NCT00416195|567056348|FG001|Overall Study|Protocol Violation|1|||
157082995|NCT00416195|567056347|FG000|Overall Study|Other|0|||
157082996|NCT00416195|567056348|FG001|Overall Study|Other|1|||
157082997|NCT01606670|567056355|FG000|Overall Study|Adverse Event|6|||
157082998|NCT01606670|567056355|FG000|Overall Study|Lack of Efficacy|2|||
157082999|NCT01606670|567056355|FG000|Overall Study|Lost to Follow-up|3|||
157083000|NCT01606670|567056355|FG000|Overall Study|Withdrawal by Subject|3|||
157083001|NCT01606670|567056355|FG000|Overall Study|Other Reason|2|||
157083002|NCT03653208|567056358|FG000|Overall Study|Withdrawal by Subject|0|||
157083003|NCT03653208|567056359|FG001|Overall Study|Withdrawal by Subject|0|||
157083004|NCT03653208|567056360|FG002|Overall Study|Withdrawal by Subject|0|||
157083005|NCT03653208|567056361|FG003|Overall Study|Withdrawal by Subject|0|||
157083006|NCT03653208|567056362|FG004|Overall Study|Withdrawal by Subject|1|||
157083007|NCT03653208|567056363|FG005|Overall Study|Withdrawal by Subject|0|||
157083008|NCT03653208|567056364|FG006|Overall Study|Withdrawal by Subject|0|||
157083009|NCT03653208|567056365|FG007|Overall Study|Withdrawal by Subject|1|||
157083010|NCT03653208|567056366|FG008|Overall Study|Withdrawal by Subject|1|||
157083011|NCT00368927|567056367|FG000|Overall Study|Lost to Follow-up|2|||
157083012|NCT00368927|567056368|FG001|Overall Study|Lost to Follow-up|0|||
157083013|NCT00368927|567056367|FG000|Overall Study|Adverse Event|1|||
157083014|NCT00368927|567056368|FG001|Overall Study|Adverse Event|1|||
157083015|NCT00368927|567056367|FG000|Overall Study|Withdrawal by Subject|1|||
157083016|NCT00368927|567056368|FG001|Overall Study|Withdrawal by Subject|2|||
157083017|NCT00368927|567056367|FG000|Overall Study|Physician Decision|1|||
157083018|NCT00368927|567056368|FG001|Overall Study|Physician Decision|0|||
157083019|NCT01877239|567056369|FG000|Overall Study|Adverse Event|4|||
157083020|NCT01877239|567056369|FG000|Overall Study|Disease Remission|1|||
157083021|NCT01877239|567056369|FG000|Overall Study|Withdrawal by Subject|4|||
157083022|NCT01877239|567056369|FG000|Overall Study|Other|2|||
157083023|NCT01877239|567056369|FG000|Overall Study|Lack of Efficacy|4|||
157083024|NCT01877239|567056369|FG000|Overall Study|Data not available|35|||
157083025|NCT01989169|567056375|FG000|Period 2|Adverse Event|0|||
157083026|NCT01989169|567056376|FG001|Period 2|Adverse Event|1|||
157083027|NCT01114880|567056377|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
157083028|NCT01114880|567056378|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
157193044|NCT00606021|567447231|FG002|Induction Phase|Physician Decision|0|||
157193045|NCT00606021|567447229|FG000|Induction Phase|Withdrawal by Subject|2|||
157193046|NCT00606021|567447230|FG001|Induction Phase|Withdrawal by Subject|0|||
157193047|NCT00606021|567447231|FG002|Induction Phase|Withdrawal by Subject|0|||
157193048|NCT00606021|567447229|FG000|Induction Phase|Lost to Follow-up|10|||
157193049|NCT00606021|567447230|FG001|Induction Phase|Lost to Follow-up|0|||
157193050|NCT00606021|567447231|FG002|Induction Phase|Lost to Follow-up|0|||
157083029|NCT01114880|567056377|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
157083030|NCT01114880|567056378|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
157193051|NCT00606021|567447229|FG000|Maintenance Phase|Death|0|||
157083031|NCT01114880|567056377|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
157083032|NCT01114880|567056378|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
157083033|NCT01114880|567056377|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
157083034|NCT01114880|567056378|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
157083035|NCT01114880|567056377|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
157083036|NCT01114880|567056378|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
157083037|NCT01114880|567056377|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
157083038|NCT01114880|567056378|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
157083039|NCT04531904|567056380|FG000|Overall Study|Lost to Follow-up|1|||
157083040|NCT04531904|567056380|FG000|Overall Study|Death|14|||
157083041|NCT00283244|567056381|FG000|Overall Study|Adverse Event|0|||
157083042|NCT00283244|567056382|FG001|Overall Study|Adverse Event|8|||
157083043|NCT00283244|567056383|FG002|Overall Study|Adverse Event|11|||
157083044|NCT00283244|567056381|FG000|Overall Study|Death|4|||
157083045|NCT00283244|567056382|FG001|Overall Study|Death|3|||
157083046|NCT00283244|567056383|FG002|Overall Study|Death|2|||
157083047|NCT00283244|567056381|FG000|Overall Study|Lack of Efficacy|8|||
157083048|NCT00283244|567056382|FG001|Overall Study|Lack of Efficacy|32|||
157083049|NCT00283244|567056383|FG002|Overall Study|Lack of Efficacy|26|||
157083050|NCT00283244|567056381|FG000|Overall Study|Withdrawal by Subject|1|||
157083051|NCT00283244|567056382|FG001|Overall Study|Withdrawal by Subject|2|||
157083052|NCT00283244|567056383|FG002|Overall Study|Withdrawal by Subject|2|||
157083053|NCT00283244|567056381|FG000|Overall Study|Physician Decision|0|||
157083054|NCT00283244|567056382|FG001|Overall Study|Physician Decision|0|||
157083055|NCT00283244|567056383|FG002|Overall Study|Physician Decision|1|||
157083056|NCT00283244|567056381|FG000|Overall Study|Medical illness (other complicating dz)|4|||
157083057|NCT00283244|567056382|FG001|Overall Study|Medical illness (other complicating dz)|3|||
157083058|NCT00283244|567056383|FG002|Overall Study|Medical illness (other complicating dz)|6|||
157083059|NCT00283244|567056381|FG000|Overall Study|Clinical deterioration|1|||
157083060|NCT00283244|567056382|FG001|Overall Study|Clinical deterioration|3|||
157083061|NCT00283244|567056383|FG002|Overall Study|Clinical deterioration|3|||
157083062|NCT01585155|567056384|FG000|Overall Study|Adverse Event|1|||
157083063|NCT01585155|567056384|FG000|Overall Study|Lack of Efficacy|2|||
157083064|NCT01585155|567056384|FG000|Overall Study|Worsening ulcerative colitis|2|||
157083065|NCT01743989|567056385|FG000|Treatment Phase|Unstable MR4.0|0|||
157083066|NCT01743989|567056386|FG001|Treatment Phase|Unstable MR4.0|6|||
157083067|NCT01743989|567056387|FG002|Treatment Phase|Unstable MR4.0|263|||
157083068|NCT01743989|567056385|FG000|Treatment Phase|Adverse Event|0|||
157083069|NCT01743989|567056386|FG001|Treatment Phase|Adverse Event|4|||
157083070|NCT01743989|567056387|FG002|Treatment Phase|Adverse Event|67|||
157083071|NCT01743989|567056385|FG000|Treatment Phase|Withdrawal by Subject|1|||
157083072|NCT01743989|567056386|FG001|Treatment Phase|Withdrawal by Subject|3|||
157083073|NCT01743989|567056387|FG002|Treatment Phase|Withdrawal by Subject|28|||
157083074|NCT01743989|567056385|FG000|Treatment Phase|Death|0|||
157083075|NCT01743989|567056386|FG001|Treatment Phase|Death|1|||
157083076|NCT01743989|567056387|FG002|Treatment Phase|Death|3|||
157083077|NCT01743989|567056385|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
157083078|NCT01743989|567056386|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
157083079|NCT01743989|567056387|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
157083080|NCT01743989|567056385|FG000|Treatment Phase|Protocol deviation|0|||
157083081|NCT01743989|567056386|FG001|Treatment Phase|Protocol deviation|0|||
157083082|NCT01743989|567056387|FG002|Treatment Phase|Protocol deviation|3|||
157083083|NCT01743989|567056385|FG000|Treatment Phase|Pregnancy|0|||
157083084|NCT01743989|567056386|FG001|Treatment Phase|Pregnancy|0|||
157083085|NCT01743989|567056387|FG002|Treatment Phase|Pregnancy|2|||
157083086|NCT01743989|567056385|FG000|Treatment Phase|Lost to Follow-up|0|||
157083087|NCT01743989|567056386|FG001|Treatment Phase|Lost to Follow-up|0|||
157083088|NCT01743989|567056387|FG002|Treatment Phase|Lost to Follow-up|2|||
157083089|NCT01743989|567056385|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
157083090|NCT01743989|567056386|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
157083091|NCT01743989|567056387|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
157083092|NCT01743989|567056385|FG000|Treatment Phase|Administrative problems|0|||
157083093|NCT01743989|567056386|FG001|Treatment Phase|Administrative problems|0|||
157083094|NCT01743989|567056387|FG002|Treatment Phase|Administrative problems|1|||
157083095|NCT01743989|567056385|FG000|Treatment Phase|New cancer (CML) therapy|0|||
157083096|NCT01743989|567056386|FG001|Treatment Phase|New cancer (CML) therapy|1|||
157083097|NCT01743989|567056387|FG002|Treatment Phase|New cancer (CML) therapy|0|||
157083098|NCT01743989|567056385|FG000|Treatment Phase|Physician Decision|0|||
157083099|NCT01743989|567056386|FG001|Treatment Phase|Physician Decision|0|||
157083100|NCT01743989|567056387|FG002|Treatment Phase|Physician Decision|3|||
157083101|NCT01743989|567056385|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
157083102|NCT01743989|567056386|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
157083103|NCT01743989|567056387|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
157083104|NCT01743989|567056385|FG000|Treatment Phase|Not randomized by mistake|0|||
157083105|NCT01743989|567056386|FG001|Treatment Phase|Not randomized by mistake|0|||
157083106|NCT01743989|567056387|FG002|Treatment Phase|Not randomized by mistake|1|||
157083107|NCT01743989|567056385|FG000|Treatment Phase|Included by mistake|0|||
157083108|NCT01743989|567056386|FG001|Treatment Phase|Included by mistake|0|||
157083109|NCT01743989|567056387|FG002|Treatment Phase|Included by mistake|1|||
157083110|NCT01743989|567056385|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
157083111|NCT01743989|567056386|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
157083112|NCT01743989|567056387|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
157083113|NCT01743989|567056385|FG000|TFR Phase|Adverse Event|0|||
157083114|NCT01743989|567056386|FG001|TFR Phase|Adverse Event|1|||
157083115|NCT01743989|567056387|FG002|TFR Phase|Adverse Event|0|||
157083116|NCT01743989|567056385|FG000|TFR Phase|Lost to Follow-up|0|||
157083117|NCT01743989|567056386|FG001|TFR Phase|Lost to Follow-up|2|||
157083118|NCT01743989|567056387|FG002|TFR Phase|Lost to Follow-up|0|||
157083119|NCT01743989|567056385|FG000|TFR Phase|Physician Decision|0|||
157083120|NCT01743989|567056386|FG001|TFR Phase|Physician Decision|1|||
157083121|NCT01743989|567056387|FG002|TFR Phase|Physician Decision|0|||
157083122|NCT01743989|567056385|FG000|TFR Phase|Logistical problems|0|||
157083123|NCT01743989|567056386|FG001|TFR Phase|Logistical problems|2|||
157083124|NCT01743989|567056387|FG002|TFR Phase|Logistical problems|0|||
157083125|NCT01743989|567056385|FG000|TFR Phase|Protocol deviation|0|||
157083126|NCT01743989|567056386|FG001|TFR Phase|Protocol deviation|1|||
157083127|NCT01743989|567056387|FG002|TFR Phase|Protocol deviation|0|||
157083128|NCT01743989|567056385|FG000|TFR Phase|Withdrawal by Subject|0|||
157083129|NCT01743989|567056386|FG001|TFR Phase|Withdrawal by Subject|2|||
157083130|NCT01743989|567056387|FG002|TFR Phase|Withdrawal by Subject|0|||
157083131|NCT01743989|567056385|FG000|Re-treatment Phase|Adverse Event|8|||
157083132|NCT01743989|567056386|FG001|Re-treatment Phase|Adverse Event|4|||
157083133|NCT01743989|567056387|FG002|Re-treatment Phase|Adverse Event|0|||
157083134|NCT01743989|567056385|FG000|Re-treatment Phase|Death|1|||
157083135|NCT01743989|567056386|FG001|Re-treatment Phase|Death|1|||
157083136|NCT01743989|567056387|FG002|Re-treatment Phase|Death|0|||
157083137|NCT01743989|567056385|FG000|Re-treatment Phase|Administrative problems|1|||
157083138|NCT01743989|567056386|FG001|Re-treatment Phase|Administrative problems|1|||
157083139|NCT01743989|567056387|FG002|Re-treatment Phase|Administrative problems|0|||
157083140|NCT01743989|567056385|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
157083141|NCT01743989|567056386|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
157083142|NCT01743989|567056387|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
157083143|NCT01743989|567056385|FG000|Re-treatment Phase|Unstable MR|1|||
157083144|NCT01743989|567056386|FG001|Re-treatment Phase|Unstable MR|0|||
157083145|NCT01743989|567056387|FG002|Re-treatment Phase|Unstable MR|0|||
157083146|NCT01743989|567056385|FG000|Re-treatment Phase|Physician Decision|0|||
157083147|NCT01743989|567056386|FG001|Re-treatment Phase|Physician Decision|1|||
157083148|NCT01743989|567056387|FG002|Re-treatment Phase|Physician Decision|0|||
157083149|NCT01743989|567056385|FG000|Re-treatment Phase|Lost to Follow-up|0|||
157083150|NCT01743989|567056386|FG001|Re-treatment Phase|Lost to Follow-up|1|||
157083151|NCT01743989|567056387|FG002|Re-treatment Phase|Lost to Follow-up|0|||
157083152|NCT02235311|567056388|FG000|Overall Study|Lost to Follow-up|0|||
157083153|NCT02235311|567056389|FG001|Overall Study|Lost to Follow-up|1|||
157083154|NCT02235311|567056388|FG000|Overall Study|Protocol Violation|0|||
157083155|NCT02235311|567056389|FG001|Overall Study|Protocol Violation|1|||
157083156|NCT04655027|567056390|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
157083157|NCT04655027|567056391|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
157083158|NCT00658788|567056392|FG000|Overall Study|Adverse Event|11|||
157083159|NCT00658788|567056392|FG000|Overall Study|Withdrawal by Subject|13|||
157083160|NCT00658788|567056392|FG000|Overall Study|Lost to Follow-up|18|||
157083161|NCT00658788|567056392|FG000|Overall Study|Treatment Discontinuation|32|||
157083162|NCT03519997|567056393|FG000|Overall Study|Adverse Event|4|||
157083163|NCT03519997|567056393|FG000|Overall Study|Withdrawal by Subject|2|||
157083164|NCT03519997|567056393|FG000|Overall Study|Protocol Violation|1|||
157083165|NCT03361605|567056394|FG000|Overall Study|Analyzable data not available|3|||
157083166|NCT03898167|567056395|FG000|Overall Study|Terminated phone call early|7|||
157083167|NCT03898167|567056396|FG001|Overall Study|Terminated phone call early|0|||
157083168|NCT03898167|567056397|FG002|Overall Study|Terminated phone call early|0|||
157083169|NCT03898167|567056395|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
157083170|NCT03898167|567056396|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
157232762|NCT01661686|567599054|FG000|Overall Study|did not receive allocated intervention|0|||
157232763|NCT01661686|567599055|FG001|Overall Study|did not receive allocated intervention|1|||
157232764|NCT04869787|567599060|FG000|Screening|Physician Decision|1|||
157083171|NCT03898167|567056397|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
157083172|NCT02906007|567056399|FG000|Overall Study|Physician Decision|0|||
157083173|NCT02906007|567056400|FG001|Overall Study|Physician Decision|0|||
157083174|NCT02906007|567056401|FG002|Overall Study|Physician Decision|1|||
157083175|NCT02906007|567056399|FG000|Overall Study|Died|1|||
157083176|NCT02906007|567056400|FG001|Overall Study|Died|0|||
157083177|NCT02906007|567056401|FG002|Overall Study|Died|0|||
157083178|NCT04372121|567056411|FG000|Overall Study|Lost to Follow-up|0|||
157083179|NCT04372121|567056412|FG001|Overall Study|Lost to Follow-up|0|||
157083180|NCT04372121|567056413|FG002|Overall Study|Lost to Follow-up|0|||
157083181|NCT04372121|567056414|FG003|Overall Study|Lost to Follow-up|1|||
157083182|NCT04372121|567056411|FG000|Overall Study|Protocol Violation|0|||
157083183|NCT04372121|567056412|FG001|Overall Study|Protocol Violation|0|||
157083184|NCT04372121|567056413|FG002|Overall Study|Protocol Violation|1|||
157083185|NCT04372121|567056414|FG003|Overall Study|Protocol Violation|0|||
157083186|NCT04372121|567056411|FG000|Overall Study|Withdrawal by Subject|3|||
157083187|NCT04372121|567056412|FG001|Overall Study|Withdrawal by Subject|1|||
157083188|NCT04372121|567056413|FG002|Overall Study|Withdrawal by Subject|0|||
157083189|NCT04372121|567056414|FG003|Overall Study|Withdrawal by Subject|0|||
157083190|NCT04372121|567056411|FG000|Overall Study|Study termination|6|||
157083191|NCT04372121|567056412|FG001|Overall Study|Study termination|5|||
157083192|NCT04372121|567056413|FG002|Overall Study|Study termination|1|||
157083193|NCT04372121|567056414|FG003|Overall Study|Study termination|1|||
157083194|NCT04372121|567056411|FG000|Overall Study|Hysterectomy planned|1|||
157083195|NCT04372121|567056412|FG001|Overall Study|Hysterectomy planned|0|||
157083196|NCT04372121|567056413|FG002|Overall Study|Hysterectomy planned|0|||
157083197|NCT04372121|567056414|FG003|Overall Study|Hysterectomy planned|0|||
157083198|NCT02344290|567056415|FG000|Overall Study|Withdrawal by Subject|315|||
157083199|NCT02344290|567056416|FG001|Overall Study|Withdrawal by Subject|324|||
157083200|NCT02344290|567056415|FG000|Overall Study|Lost to Follow-up|258|||
157083201|NCT02344290|567056416|FG001|Overall Study|Lost to Follow-up|249|||
157083202|NCT02344290|567056415|FG000|Overall Study|Unable to get to clinic|69|||
157083203|NCT02344290|567056416|FG001|Overall Study|Unable to get to clinic|60|||
157083204|NCT02344290|567056415|FG000|Overall Study|Physician Decision|25|||
157083205|NCT02344290|567056416|FG001|Overall Study|Physician Decision|25|||
157083206|NCT02344290|567056415|FG000|Overall Study|Site Closure|15|||
157083207|NCT02344290|567056416|FG001|Overall Study|Site Closure|19|||
157083208|NCT02344290|567056415|FG000|Overall Study|Other|5|||
157083209|NCT02344290|567056416|FG001|Overall Study|Other|3|||
157083210|NCT03900416|567057843|FG000|Six Week Follow-up|Lost to Follow-up|1|||
157083211|NCT03900416|567057844|FG001|Six Week Follow-up|Lost to Follow-up|0|||
157083212|NCT03900416|567057843|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
157083213|NCT03900416|567057844|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
157083214|NCT03900416|567057843|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
157083215|NCT03900416|567057844|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
157083216|NCT03900416|567057843|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
157083217|NCT03900416|567057844|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
157083218|NCT03900416|567057843|FG000|Twelve Week Follow-up|Adverse Event|1|||
157083219|NCT03900416|567057844|FG001|Twelve Week Follow-up|Adverse Event|1|||
157083220|NCT03900416|567057843|FG000|Six Month Follow-up|Lost to Follow-up|4|||
157083221|NCT03900416|567057844|FG001|Six Month Follow-up|Lost to Follow-up|3|||
157083222|NCT03900416|567057843|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
157083223|NCT03900416|567057844|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
157083224|NCT00730275|567057845|FG000|Overall Study|Withdrawal by Subject|0|||
157083225|NCT00730275|567057846|FG001|Overall Study|Withdrawal by Subject|0|||
157083226|NCT00730275|567057847|FG002|Overall Study|Withdrawal by Subject|0|||
157083227|NCT00730275|567057848|FG003|Overall Study|Withdrawal by Subject|1|||
157083228|NCT00356408|567057849|FG000|Overall Study|Adverse Event|9|||
157083229|NCT00356408|567057849|FG000|Overall Study|Lack of Efficacy|36|||
157083230|NCT00356408|567057849|FG000|Overall Study|Lost to Follow-up|2|||
157083231|NCT00356408|567057849|FG000|Overall Study|Withdrawal by Subject|6|||
157083232|NCT00356408|567057849|FG000|Overall Study|Other: Principal investigator discretion|3|||
157083233|NCT00356408|567057849|FG000|Overall Study|Other: Sponsor request|1|||
157083234|NCT00356408|567057849|FG000|Overall Study|Other: Azathioprine stopped|1|||
157083235|NCT00356408|567057849|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
157083236|NCT00356408|567057849|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
157083237|NCT05487586|567057850|FG000|Overall Study|Death|22|||
157083238|NCT05487586|567057850|FG000|Overall Study|Physician Decision|1|||
157083239|NCT05487586|567057850|FG000|Overall Study|Transfer to another hospital|4|||
157083240|NCT05487586|567057850|FG000|Overall Study|Other|1|||
157083241|NCT00939822|567057855|FG000|Overall Study|Lost to Follow-up|1|||
157083242|NCT00939822|567057856|FG001|Overall Study|Lost to Follow-up|0|||
157083243|NCT00939822|567057855|FG000|Overall Study|withdrew from study due to busy schedule|1|||
157083244|NCT00939822|567057856|FG001|Overall Study|withdrew from study due to busy schedule|1|||
157083245|NCT00939822|567057855|FG000|Overall Study|Mental health issues|0|||
157083246|NCT00939822|567057856|FG001|Overall Study|Mental health issues|2|||
157083247|NCT05032872|567057857|FG000|Overall Study|Adverse Event|1|||
157083248|NCT05032872|567057858|FG001|Overall Study|Adverse Event|0|||
157083249|NCT05032872|567057857|FG000|Overall Study|Lost to Follow-up|2|||
157083250|NCT05032872|567057858|FG001|Overall Study|Lost to Follow-up|4|||
157083251|NCT05032872|567057857|FG000|Overall Study|Withdrawal by Subject|4|||
157083252|NCT05032872|567057858|FG001|Overall Study|Withdrawal by Subject|3|||
157083253|NCT00338962|567057859|FG000|Overall Study|Lost to Follow-up|3|||
157083254|NCT00338962|567057860|FG001|Overall Study|Lost to Follow-up|3|||
157083255|NCT00338962|567057861|FG002|Overall Study|Lost to Follow-up|2|||
157083256|NCT00338962|567057862|FG003|Overall Study|Lost to Follow-up|3|||
157083257|NCT00338962|567057859|FG000|Overall Study|Withdrawal by Subject|1|||
157083258|NCT00338962|567057860|FG001|Overall Study|Withdrawal by Subject|0|||
157083259|NCT00338962|567057861|FG002|Overall Study|Withdrawal by Subject|0|||
157083260|NCT00338962|567057862|FG003|Overall Study|Withdrawal by Subject|0|||
157083261|NCT00338962|567057859|FG000|Overall Study|No Transportation|2|||
157083262|NCT00338962|567057860|FG001|Overall Study|No Transportation|0|||
157083263|NCT00338962|567057861|FG002|Overall Study|No Transportation|0|||
157083264|NCT00338962|567057862|FG003|Overall Study|No Transportation|0|||
157083265|NCT00338962|567057859|FG000|Overall Study|Time Constraint|2|||
157083266|NCT00338962|567057860|FG001|Overall Study|Time Constraint|0|||
157083267|NCT00338962|567057861|FG002|Overall Study|Time Constraint|0|||
157083268|NCT00338962|567057862|FG003|Overall Study|Time Constraint|0|||
157083269|NCT00338962|567057859|FG000|Overall Study|Moved|0|||
157083270|NCT00338962|567057860|FG001|Overall Study|Moved|1|||
157083271|NCT00338962|567057861|FG002|Overall Study|Moved|0|||
157083272|NCT00338962|567057862|FG003|Overall Study|Moved|0|||
157083273|NCT00338962|567057859|FG000|Overall Study|Adverse Event|0|||
157083274|NCT00338962|567057860|FG001|Overall Study|Adverse Event|0|||
157083275|NCT00338962|567057861|FG002|Overall Study|Adverse Event|2|||
157083276|NCT00338962|567057862|FG003|Overall Study|Adverse Event|0|||
157083277|NCT00338962|567057859|FG000|Overall Study|Poor Compliance|0|||
157083278|NCT00338962|567057860|FG001|Overall Study|Poor Compliance|0|||
157083279|NCT00338962|567057861|FG002|Overall Study|Poor Compliance|2|||
157083280|NCT00338962|567057862|FG003|Overall Study|Poor Compliance|0|||
157083281|NCT00910039|567057863|FG000|Overall Study|Physician Decision|1|||
157083282|NCT00406692|567057874|FG000|Overall Study|Withdrawal by Subject|4|||
157083283|NCT00406692|567057874|FG000|Overall Study|Physician Decision|1|||
157083284|NCT00406692|567057874|FG000|Overall Study|Adverse Event|1|||
157083285|NCT00406692|567057874|FG000|Overall Study|Lack of Efficacy|1|||
157083286|NCT00821587|567057875|FG000|Overall Study|Physician Decision|0|||
157083287|NCT00821587|567057876|FG001|Overall Study|Physician Decision|1|||
157083288|NCT04488770|567057877|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083289|NCT04488770|567057878|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083290|NCT04488770|567057879|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083291|NCT04488770|567057880|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
157083292|NCT04488770|567057881|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083293|NCT04488770|567057882|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083294|NCT04488770|567057883|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083295|NCT04488770|567057884|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083296|NCT04488770|567057885|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083297|NCT04488770|567057886|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083298|NCT04488770|567057887|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083299|NCT04488770|567057888|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083300|NCT04488770|567057889|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
157083301|NCT04488770|567057877|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
157083302|NCT04488770|567057878|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083303|NCT04488770|567057879|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083304|NCT04488770|567057880|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083305|NCT04488770|567057881|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083306|NCT04488770|567057882|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083307|NCT04488770|567057883|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083308|NCT04488770|567057884|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083309|NCT04488770|567057885|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083310|NCT04488770|567057886|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083311|NCT04488770|567057887|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083312|NCT04488770|567057888|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083313|NCT04488770|567057889|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
157083314|NCT04488770|567057877|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083315|NCT04488770|567057878|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083316|NCT04488770|567057879|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157232765|NCT04869787|567599060|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
157232766|NCT00454909|567599061|FG000|Overall Study|Withdrawal by Subject|1|||
157232767|NCT00454909|567599062|FG001|Overall Study|Withdrawal by Subject|0|||
157232768|NCT00454909|567599063|FG002|Overall Study|Withdrawal by Subject|0|||
157232769|NCT00454909|567599061|FG000|Overall Study|Migrated/moved from study area|0|||
157083317|NCT04488770|567057880|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083318|NCT04488770|567057881|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083319|NCT04488770|567057882|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
157083320|NCT04488770|567057883|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
157083321|NCT04488770|567057884|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083322|NCT04488770|567057885|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083323|NCT04488770|567057886|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083324|NCT04488770|567057887|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083325|NCT04488770|567057888|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083326|NCT04488770|567057889|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
157083327|NCT04488770|567057877|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083328|NCT04488770|567057878|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083329|NCT04488770|567057879|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083330|NCT04488770|567057880|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083331|NCT04488770|567057881|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
157083332|NCT04488770|567057882|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083333|NCT04488770|567057883|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083334|NCT04488770|567057884|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083335|NCT04488770|567057885|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083336|NCT04488770|567057886|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083337|NCT04488770|567057887|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083338|NCT04488770|567057888|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083339|NCT04488770|567057889|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
157083340|NCT03547739|567057890|FG000|Overall Study|Death|0|||
157083341|NCT03547739|567057891|FG001|Overall Study|Death|1|||
157083342|NCT03547739|567057892|FG002|Overall Study|Death|5|||
157083343|NCT03547739|567057890|FG000|Overall Study|Adverse Event|24|||
157083344|NCT03547739|567057891|FG001|Overall Study|Adverse Event|11|||
157083345|NCT03547739|567057892|FG002|Overall Study|Adverse Event|13|||
157083346|NCT03547739|567057890|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
157083347|NCT03547739|567057891|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
157083348|NCT03547739|567057892|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
157083349|NCT03547739|567057890|FG000|Overall Study|Lost to Follow-up|80|||
157083350|NCT03547739|567057891|FG001|Overall Study|Lost to Follow-up|84|||
157083351|NCT03547739|567057892|FG002|Overall Study|Lost to Follow-up|116|||
157083352|NCT01744392|567057897|FG000|Overall Study|Physician Decision|1|||
157083353|NCT00635661|567057900|FG000|Overall Study|Withdrawal by Subject|4|||
157083354|NCT01696955|567057904|FG000|Main Study|Protocol Violation|1|||
157083355|NCT01696955|567057905|FG001|Main Study|Protocol Violation|0|||
157083356|NCT01696955|567057904|FG000|Main Study|Withdrawal by Subject|1|||
157083357|NCT01696955|567057905|FG001|Main Study|Withdrawal by Subject|1|||
157083358|NCT03192475|567057912|FG000|Overall Study|Death|0|||
157083359|NCT03192475|567057913|FG001|Overall Study|Death|1|||
157083360|NCT03192475|567057912|FG000|Overall Study|Lost to Follow-up|13|||
157083361|NCT03192475|567057913|FG001|Overall Study|Lost to Follow-up|8|||
157083362|NCT03980808|567057914|FG000|Overall Study|Lost to Follow-up|2|||
157083363|NCT03980808|567057915|FG001|Overall Study|Lost to Follow-up|2|||
157083364|NCT03014011|567057918|FG000|First Intervention|Withdrawal by Subject|1|||
157083365|NCT03014011|567057919|FG001|First Intervention|Withdrawal by Subject|0|||
157083366|NCT03014011|567057918|FG000|Washout|Withdrawal by Subject|1|||
157083367|NCT03014011|567057919|FG001|Washout|Withdrawal by Subject|0|||
157083368|NCT02755818|567057920|FG000|Overall Study|Withdrawal by Subject|0|||
157083369|NCT02755818|567057921|FG001|Overall Study|Withdrawal by Subject|0|||
157083370|NCT02755818|567057922|FG002|Overall Study|Withdrawal by Subject|0|||
157083371|NCT02755818|567057923|FG003|Overall Study|Withdrawal by Subject|2|||
157083372|NCT02755818|567057920|FG000|Overall Study|withdrawal by PI|0|||
157083373|NCT02755818|567057921|FG001|Overall Study|withdrawal by PI|0|||
157083374|NCT02755818|567057922|FG002|Overall Study|withdrawal by PI|1|||
157083375|NCT02755818|567057923|FG003|Overall Study|withdrawal by PI|1|||
157083376|NCT00573859|567057926|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
157083377|NCT00573859|567057926|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
157083378|NCT01152814|567057927|FG000|Overall Study|Lost to Follow-up|2|||
157083379|NCT00532493|567057928|FG000|Overall Study|Death|1|||
157083380|NCT00532493|567057929|FG001|Overall Study|Death|1|||
157083381|NCT00532493|567057928|FG000|Overall Study|Lost to Follow-up|10|||
157083382|NCT00532493|567057929|FG001|Overall Study|Lost to Follow-up|7|||
157083383|NCT00532493|567057928|FG000|Overall Study|Withdrawal by Subject|7|||
157083384|NCT00532493|567057929|FG001|Overall Study|Withdrawal by Subject|9|||
157083385|NCT00532493|567057928|FG000|Overall Study|Physician Decision|1|||
157083386|NCT00532493|567057929|FG001|Overall Study|Physician Decision|6|||
157083387|NCT00532493|567057928|FG000|Overall Study|Adverse Event|6|||
157083388|NCT00532493|567057929|FG001|Overall Study|Adverse Event|5|||
157083389|NCT00532493|567057928|FG000|Overall Study|Protocol Deviation|1|||
157083390|NCT00532493|567057929|FG001|Overall Study|Protocol Deviation|0|||
157083391|NCT00532493|567057928|FG000|Overall Study|Subject Moved Away|3|||
157083392|NCT00532493|567057929|FG001|Overall Study|Subject Moved Away|1|||
157083393|NCT00532493|567057928|FG000|Overall Study|Contraindicative Medication|1|||
157083394|NCT00532493|567057929|FG001|Overall Study|Contraindicative Medication|0|||
157083395|NCT00775463|567059989|FG000|Overall Study|Withdrawal by Subject|0|||
157083396|NCT00775463|567059990|FG001|Overall Study|Withdrawal by Subject|1|||
157083397|NCT00775463|567059989|FG000|Overall Study|Adverse Event|7|||
157083398|NCT00775463|567059990|FG001|Overall Study|Adverse Event|9|||
157083399|NCT00775463|567059989|FG000|Overall Study|Protocol Violation|2|||
157083400|NCT00775463|567059990|FG001|Overall Study|Protocol Violation|2|||
157083401|NCT00775463|567059989|FG000|Overall Study|Lost to Follow-up|1|||
157083402|NCT00775463|567059990|FG001|Overall Study|Lost to Follow-up|0|||
157083403|NCT00775463|567059989|FG000|Overall Study|Lack of Efficacy|1|||
157083404|NCT00775463|567059990|FG001|Overall Study|Lack of Efficacy|1|||
157083405|NCT02980731|567059991|FG000|Overall Study|Death|63|||
157083406|NCT02980731|567059991|FG000|Overall Study|Withdrawal by Subject|6|||
157083407|NCT02980731|567059991|FG000|Overall Study|Lost to Follow-up|5|||
157083408|NCT02980731|567059991|FG000|Overall Study|Study terminated by Sponsor|4|||
157083409|NCT02980731|567059991|FG000|Overall Study|Completed survival follow-up period|65|||
157083410|NCT02980731|567059991|FG000|Overall Study|COVID-19 infection|1|||
157083411|NCT02980731|567059991|FG000|Overall Study|Other, not specified|66|||
157083412|NCT01789567|567059992|FG000|Overall Study|Death|6|||
157083413|NCT00872989|567059993|FG000|Overall Study|Adverse Event|7|||
157083414|NCT00872989|567059994|FG001|Overall Study|Adverse Event|15|||
157083415|NCT00872989|567059993|FG000|Overall Study|Withdrawal by Subject|8|||
157083416|NCT00872989|567059994|FG001|Overall Study|Withdrawal by Subject|5|||
157083417|NCT00872989|567059993|FG000|Overall Study|Progression/relapse|47|||
157083418|NCT00872989|567059994|FG001|Overall Study|Progression/relapse|35|||
157083419|NCT00872989|567059993|FG000|Overall Study|Not protocol specified|3|||
157083420|NCT00872989|567059994|FG001|Overall Study|Not protocol specified|8|||
157083421|NCT00307684|567060000|FG000|Open Label Phase|Lack of Efficacy|0|||
157083422|NCT00307684|567060001|FG001|Open Label Phase|Lack of Efficacy|0|||
157083423|NCT00307684|567060002|FG002|Open Label Phase|Lack of Efficacy|3|||
157083424|NCT00307684|567060000|FG000|Open Label Phase|Adverse Event|0|||
157083425|NCT00307684|567060001|FG001|Open Label Phase|Adverse Event|0|||
157083426|NCT00307684|567060002|FG002|Open Label Phase|Adverse Event|16|||
157083427|NCT00307684|567060000|FG000|Open Label Phase|Withdrawal by Subject|0|||
157083428|NCT00307684|567060001|FG001|Open Label Phase|Withdrawal by Subject|0|||
157083429|NCT00307684|567060002|FG002|Open Label Phase|Withdrawal by Subject|15|||
157083430|NCT00307684|567060000|FG000|Open Label Phase|Lost to Follow-up|0|||
157083431|NCT00307684|567060001|FG001|Open Label Phase|Lost to Follow-up|0|||
157083432|NCT00307684|567060002|FG002|Open Label Phase|Lost to Follow-up|11|||
157083433|NCT00307684|567060000|FG000|Open Label Phase|non compliance|0|||
157083434|NCT00307684|567060001|FG001|Open Label Phase|non compliance|0|||
157083435|NCT00307684|567060002|FG002|Open Label Phase|non compliance|5|||
157083436|NCT00307684|567060000|FG000|Open Label Phase|other|0|||
157083437|NCT00307684|567060001|FG001|Open Label Phase|other|0|||
157083438|NCT00307684|567060002|FG002|Open Label Phase|other|6|||
157083439|NCT00307684|567060000|FG000|Double Blind Phase|Lack of Efficacy|2|||
157083440|NCT00307684|567060001|FG001|Double Blind Phase|Lack of Efficacy|5|||
157083441|NCT00307684|567060002|FG002|Double Blind Phase|Lack of Efficacy|0|||
157083442|NCT00224887|567060003|FG000|Overall Study|Pregnancy|6|||
157083443|NCT00224887|567060004|FG001|Overall Study|Pregnancy|6|||
157083444|NCT00299494|567060012|FG000|Overall Study|Withdrawal by Subject|0|||
157083445|NCT00299494|567060013|FG001|Overall Study|Withdrawal by Subject|0|||
157083446|NCT00299494|567060014|FG002|Overall Study|Withdrawal by Subject|0|||
157083447|NCT00299494|567060015|FG003|Overall Study|Withdrawal by Subject|3|||
157083448|NCT00299494|567060016|FG004|Overall Study|Withdrawal by Subject|1|||
157083449|NCT00299494|567060017|FG005|Overall Study|Withdrawal by Subject|4|||
157083450|NCT00299494|567060012|FG000|Overall Study|Physician Decision|0|||
157083451|NCT00299494|567060013|FG001|Overall Study|Physician Decision|0|||
157083452|NCT00299494|567060014|FG002|Overall Study|Physician Decision|0|||
157083453|NCT00299494|567060015|FG003|Overall Study|Physician Decision|0|||
157083454|NCT00299494|567060016|FG004|Overall Study|Physician Decision|1|||
157083455|NCT00299494|567060017|FG005|Overall Study|Physician Decision|0|||
157083456|NCT00299494|567060012|FG000|Overall Study|Death|3|||
157083457|NCT00299494|567060013|FG001|Overall Study|Death|1|||
157083458|NCT00299494|567060014|FG002|Overall Study|Death|4|||
157083459|NCT00299494|567060015|FG003|Overall Study|Death|6|||
157083460|NCT00299494|567060016|FG004|Overall Study|Death|18|||
157083461|NCT00299494|567060017|FG005|Overall Study|Death|19|||
157083462|NCT00299494|567060012|FG000|Overall Study|Lost to Follow-up|0|||
157083463|NCT00299494|567060013|FG001|Overall Study|Lost to Follow-up|0|||
157083464|NCT00299494|567060014|FG002|Overall Study|Lost to Follow-up|0|||
157083465|NCT00299494|567060015|FG003|Overall Study|Lost to Follow-up|0|||
157083466|NCT00299494|567060016|FG004|Overall Study|Lost to Follow-up|3|||
157083467|NCT00299494|567060017|FG005|Overall Study|Lost to Follow-up|1|||
157083468|NCT00299494|567060012|FG000|Overall Study|Other - Unspecified|0|||
157083469|NCT00299494|567060013|FG001|Overall Study|Other - Unspecified|0|||
157083470|NCT00299494|567060014|FG002|Overall Study|Other - Unspecified|0|||
157083471|NCT00299494|567060015|FG003|Overall Study|Other - Unspecified|0|||
157083472|NCT00299494|567060016|FG004|Overall Study|Other - Unspecified|3|||
157083473|NCT00299494|567060017|FG005|Overall Study|Other - Unspecified|1|||
157083474|NCT00299494|567060012|FG000|Overall Study|Other - site closure|0|||
157083475|NCT00299494|567060013|FG001|Overall Study|Other - site closure|0|||
157083476|NCT00299494|567060014|FG002|Overall Study|Other - site closure|0|||
157083477|NCT00299494|567060015|FG003|Overall Study|Other - site closure|1|||
157083478|NCT00299494|567060016|FG004|Overall Study|Other - site closure|1|||
157083479|NCT00299494|567060017|FG005|Overall Study|Other - site closure|1|||
157083480|NCT00403767|567060023|FG000|Overall Study|Adverse Event|993|||
157083481|NCT00403767|567060024|FG001|Overall Study|Adverse Event|919|||
157083482|NCT00403767|567060023|FG000|Overall Study|Non-compliant with study medication|134|||
157083483|NCT00403767|567060024|FG001|Overall Study|Non-compliant with study medication|164|||
157083484|NCT00403767|567060023|FG000|Overall Study|Consent withdrawn|671|||
157083485|NCT00403767|567060024|FG001|Overall Study|Consent withdrawn|673|||
157083486|NCT00403767|567060023|FG000|Overall Study|Investigator dec./not protocol-related|191|||
157083487|NCT00403767|567060024|FG001|Overall Study|Investigator dec./not protocol-related|178|||
157083488|NCT00403767|567060023|FG000|Overall Study|Lost to Follow-up|6|||
157083489|NCT00403767|567060024|FG001|Overall Study|Lost to Follow-up|8|||
157083490|NCT00403767|567060023|FG000|Overall Study|Protocol Violation|142|||
157083491|NCT00403767|567060024|FG001|Overall Study|Protocol Violation|124|||
157083492|NCT00403767|567060023|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
157083493|NCT00403767|567060024|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
157083494|NCT00403767|567060023|FG000|Overall Study|Study terminated by sponsor|82|||
157083495|NCT00403767|567060024|FG001|Overall Study|Study terminated by sponsor|69|||
157083496|NCT00403767|567060023|FG000|Overall Study|Missing/incomplete data|1|||
157083497|NCT00403767|567060024|FG001|Overall Study|Missing/incomplete data|1|||
157083498|NCT01641159|567060025|FG000|Overall Study|Lost to Follow-up|2|||
157083499|NCT01641159|567060026|FG001|Overall Study|Lost to Follow-up|1|||
157083500|NCT01641159|567060025|FG000|Overall Study|Withdrawal by Subject|0|||
157083501|NCT01641159|567060026|FG001|Overall Study|Withdrawal by Subject|1|||
157083502|NCT00798590|567060027|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
157083503|NCT00798590|567060028|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
157083504|NCT05330676|567060032|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
157083505|NCT05330676|567060033|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
157083506|NCT00436605|567060034|FG000|Overall Study|Protocol Violation|3|||
157083507|NCT02416453|567060037|FG000|Overall Study|Adverse Event|0|||
157083508|NCT02416453|567060038|FG001|Overall Study|Adverse Event|0|||
157083509|NCT02416453|567060039|FG002|Overall Study|Adverse Event|0|||
157083510|NCT02416453|567060040|FG003|Overall Study|Adverse Event|2|||
157083511|NCT02416453|567060041|FG004|Overall Study|Adverse Event|0|||
157083512|NCT02416453|567060042|FG005|Overall Study|Adverse Event|1|||
157083513|NCT02416453|567060043|FG006|Overall Study|Adverse Event|0|||
157083514|NCT02416453|567060044|FG007|Overall Study|Adverse Event|0|||
157083515|NCT02416453|567060045|FG008|Overall Study|Adverse Event|0|||
157083516|NCT02416453|567060046|FG009|Overall Study|Adverse Event|0|||
157083517|NCT02416453|567060047|FG010|Overall Study|Adverse Event|0|||
157083518|NCT02416453|567060037|FG000|Overall Study|Lost to Follow-up|1|||
157083519|NCT02416453|567060038|FG001|Overall Study|Lost to Follow-up|3|||
157083520|NCT02416453|567060039|FG002|Overall Study|Lost to Follow-up|0|||
157083521|NCT02416453|567060040|FG003|Overall Study|Lost to Follow-up|8|||
157083522|NCT02416453|567060041|FG004|Overall Study|Lost to Follow-up|0|||
157083523|NCT02416453|567060042|FG005|Overall Study|Lost to Follow-up|5|||
157083524|NCT02416453|567060043|FG006|Overall Study|Lost to Follow-up|1|||
157083525|NCT02416453|567060044|FG007|Overall Study|Lost to Follow-up|3|||
157083526|NCT02416453|567060045|FG008|Overall Study|Lost to Follow-up|1|||
157083527|NCT02416453|567060046|FG009|Overall Study|Lost to Follow-up|0|||
157083528|NCT02416453|567060047|FG010|Overall Study|Lost to Follow-up|0|||
157083529|NCT02416453|567060037|FG000|Overall Study|Physician Decision|0|||
157083530|NCT02416453|567060038|FG001|Overall Study|Physician Decision|0|||
157083531|NCT02416453|567060039|FG002|Overall Study|Physician Decision|0|||
157083532|NCT02416453|567060040|FG003|Overall Study|Physician Decision|0|||
157083533|NCT02416453|567060041|FG004|Overall Study|Physician Decision|0|||
157083534|NCT02416453|567060042|FG005|Overall Study|Physician Decision|1|||
157083535|NCT02416453|567060043|FG006|Overall Study|Physician Decision|1|||
157083536|NCT02416453|567060044|FG007|Overall Study|Physician Decision|1|||
157083537|NCT02416453|567060045|FG008|Overall Study|Physician Decision|0|||
157083538|NCT02416453|567060046|FG009|Overall Study|Physician Decision|0|||
157083539|NCT02416453|567060047|FG010|Overall Study|Physician Decision|0|||
157083540|NCT02416453|567060037|FG000|Overall Study|Withdrawal by Subject|2|||
157083541|NCT02416453|567060038|FG001|Overall Study|Withdrawal by Subject|0|||
157083542|NCT02416453|567060039|FG002|Overall Study|Withdrawal by Subject|0|||
157083543|NCT02416453|567060040|FG003|Overall Study|Withdrawal by Subject|5|||
157083544|NCT02416453|567060041|FG004|Overall Study|Withdrawal by Subject|1|||
157083545|NCT02416453|567060042|FG005|Overall Study|Withdrawal by Subject|8|||
157083546|NCT02416453|567060043|FG006|Overall Study|Withdrawal by Subject|0|||
157083547|NCT02416453|567060044|FG007|Overall Study|Withdrawal by Subject|8|||
157083548|NCT02416453|567060045|FG008|Overall Study|Withdrawal by Subject|4|||
157083549|NCT02416453|567060046|FG009|Overall Study|Withdrawal by Subject|0|||
157083550|NCT02416453|567060047|FG010|Overall Study|Withdrawal by Subject|0|||
157083551|NCT02416453|567060037|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083552|NCT02416453|567060038|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083553|NCT02416453|567060039|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
157083554|NCT02416453|567060040|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083555|NCT02416453|567060041|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083556|NCT02416453|567060042|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083557|NCT02416453|567060043|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083558|NCT02416453|567060044|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083559|NCT02416453|567060045|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083560|NCT02416453|567060046|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083561|NCT02416453|567060047|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
157083562|NCT02416453|567060037|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083563|NCT02416453|567060038|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083564|NCT02416453|567060039|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083565|NCT02416453|567060040|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083566|NCT02416453|567060041|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083567|NCT02416453|567060042|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
157083568|NCT02416453|567060043|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083569|NCT02416453|567060044|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083570|NCT02416453|567060045|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083571|NCT02416453|567060046|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083572|NCT02416453|567060047|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
157083573|NCT03223662|567060052|FG000|Overall Study|Physician Decision|1|||
157083574|NCT03223662|567060052|FG000|Overall Study|Study closure|1|||
157083575|NCT01280357|567060053|FG000|Overall Study|Excluded no internal monitoring|14|||
157083576|NCT01280357|567060053|FG000|Overall Study|IInsufficient data/No data supplied|12|||
157083577|NCT02229851|567060054|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
157083578|NCT02229851|567060055|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
157083579|NCT02229851|567060056|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
157083580|NCT02229851|567060057|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
157083581|NCT02229851|567060058|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
157083582|NCT02229851|567060059|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
157083583|NCT02229851|567060060|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
157083584|NCT02229851|567060054|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083585|NCT02229851|567060055|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
157083586|NCT02229851|567060056|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083587|NCT02229851|567060057|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083588|NCT02229851|567060058|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083589|NCT02229851|567060059|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083590|NCT02229851|567060060|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
157083591|NCT02229851|567060054|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
157083592|NCT02229851|567060055|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
157083593|NCT02229851|567060056|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
157083594|NCT02229851|567060057|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
157083595|NCT02229851|567060058|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
157083596|NCT02229851|567060059|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
157083597|NCT02229851|567060060|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
157083598|NCT02229851|567060054|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083599|NCT02229851|567060055|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083600|NCT02229851|567060056|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
157083601|NCT02229851|567060057|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083602|NCT02229851|567060058|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083603|NCT02229851|567060059|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083604|NCT02229851|567060060|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
157083605|NCT02229851|567060054|FG000|Main Phase (Double-blind Phase)|Death|1|||
157083606|NCT02229851|567060055|FG001|Main Phase (Double-blind Phase)|Death|1|||
157083607|NCT02229851|567060056|FG002|Main Phase (Double-blind Phase)|Death|0|||
157083608|NCT02229851|567060057|FG003|Main Phase (Double-blind Phase)|Death|0|||
157083609|NCT02229851|567060058|FG004|Main Phase (Double-blind Phase)|Death|0|||
157083610|NCT02229851|567060059|FG005|Main Phase (Double-blind Phase)|Death|0|||
157083611|NCT02229851|567060060|FG006|Main Phase (Double-blind Phase)|Death|0|||
157083612|NCT02229851|567060054|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
157083613|NCT02229851|567060055|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
157083614|NCT02229851|567060056|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
157083615|NCT02229851|567060057|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
157083616|NCT02229851|567060058|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
157083617|NCT02229851|567060059|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
157083618|NCT02229851|567060060|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
157083619|NCT02229851|567060054|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
157083620|NCT02229851|567060055|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
157193052|NCT00606021|567447230|FG001|Maintenance Phase|Death|17|||
157083621|NCT02229851|567060056|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
157083622|NCT02229851|567060057|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
157083623|NCT02229851|567060058|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
157083624|NCT02229851|567060059|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
157083625|NCT02229851|567060060|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
157083626|NCT02229851|567060054|FG000|Extension Phase (Open-label Phase)|Death|0|||
157083627|NCT02229851|567060055|FG001|Extension Phase (Open-label Phase)|Death|0|||
157083628|NCT02229851|567060056|FG002|Extension Phase (Open-label Phase)|Death|0|||
157083629|NCT02229851|567060057|FG003|Extension Phase (Open-label Phase)|Death|1|||
157083630|NCT02229851|567060058|FG004|Extension Phase (Open-label Phase)|Death|0|||
157083631|NCT02229851|567060059|FG005|Extension Phase (Open-label Phase)|Death|1|||
157083632|NCT02229851|567060060|FG006|Extension Phase (Open-label Phase)|Death|1|||
157083633|NCT03284203|567060061|FG000|Overall Study|Lost to Follow-up|3|||
157083634|NCT00992225|567060062|FG000|Overall Study|Entry Criteria Not Met|8|||
157083635|NCT00992225|567060062|FG000|Overall Study|Adverse Event|2|||
157083636|NCT03466073|567060063|FG000|Overall Study|Death|1|||
157083637|NCT03466073|567060064|FG001|Overall Study|Death|0|||
157083638|NCT03466073|567060065|FG002|Overall Study|Death|0|||
157083639|NCT03466073|567060066|FG003|Overall Study|Death|0|||
157083640|NCT03466073|567060067|FG004|Overall Study|Death|0|||
157083641|NCT03466073|567060068|FG005|Overall Study|Death|1|||
157083642|NCT00744757|567060069|FG000|Overall Study|Objective disease progression|7|||
157083643|NCT00744757|567060069|FG000|Overall Study|Physician Decision|5|||
157083644|NCT00744757|567060069|FG000|Overall Study|Withdrawal by Subject|1|||
157083645|NCT00744757|567060069|FG000|Overall Study|Death|6|||
157083646|NCT00744757|567060069|FG000|Overall Study|Adverse Event|2|||
157083647|NCT02045875|567060073|FG000|Overall Study|Lost to Follow-up|3|||
157083648|NCT02045875|567060074|FG001|Overall Study|Lost to Follow-up|0|||
157083649|NCT02045875|567060073|FG000|Overall Study|Withdrawal by Subject|4|||
157083650|NCT02045875|567060074|FG001|Overall Study|Withdrawal by Subject|3|||
157083651|NCT01769326|567060078|FG000|Overall Study|Lost to Follow-up|1|||
157083652|NCT01769326|567060079|FG001|Overall Study|Lost to Follow-up|2|||
157083653|NCT01769326|567060080|FG002|Overall Study|Lost to Follow-up|0|||
157083654|NCT01769326|567060081|FG003|Overall Study|Lost to Follow-up|0|||
157083655|NCT01769326|567060078|FG000|Overall Study|unrelated injry|1|||
157083656|NCT01769326|567060079|FG001|Overall Study|unrelated injry|1|||
157083657|NCT01769326|567060080|FG002|Overall Study|unrelated injry|0|||
157083658|NCT01769326|567060081|FG003|Overall Study|unrelated injry|0|||
157083659|NCT01769326|567060078|FG000|Overall Study|got a job|0|||
157083660|NCT01769326|567060079|FG001|Overall Study|got a job|1|||
157083661|NCT01769326|567060080|FG002|Overall Study|got a job|0|||
157083662|NCT01769326|567060081|FG003|Overall Study|got a job|0|||
157083663|NCT01769326|567060078|FG000|Overall Study|Got sick and could not complete study|0|||
157083664|NCT01769326|567060079|FG001|Overall Study|Got sick and could not complete study|0|||
157083665|NCT01769326|567060080|FG002|Overall Study|Got sick and could not complete study|1|||
157083666|NCT01769326|567060081|FG003|Overall Study|Got sick and could not complete study|0|||
157083667|NCT01036438|567060082|FG000|Overall Study|Adverse Event|7|||
157083668|NCT01036438|567060083|FG001|Overall Study|Adverse Event|8|||
157083669|NCT01036438|567060082|FG000|Overall Study|Death|0|||
157083670|NCT01036438|567060083|FG001|Overall Study|Death|1|||
157083671|NCT01036438|567060082|FG000|Overall Study|No effect of study treatment|3|||
157083672|NCT01036438|567060083|FG001|Overall Study|No effect of study treatment|1|||
157083673|NCT03459443|567060084|FG000|Overall Study|Lack of Efficacy|3|||
157083674|NCT03459443|567060084|FG000|Overall Study|Adverse Event|1|||
157193053|NCT00606021|567447231|FG002|Maintenance Phase|Death|15|||
157193054|NCT00606021|567447229|FG000|Maintenance Phase|Physician Decision|0|||
157193055|NCT00606021|567447230|FG001|Maintenance Phase|Physician Decision|1|||
157193056|NCT00606021|567447231|FG002|Maintenance Phase|Physician Decision|0|||
157193057|NCT00606021|567447229|FG000|Maintenance Phase|Lost to Follow-up|0|||
157193058|NCT00606021|567447230|FG001|Maintenance Phase|Lost to Follow-up|5|||
157193059|NCT00606021|567447231|FG002|Maintenance Phase|Lost to Follow-up|2|||
157193060|NCT01362049|567447234|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
157193061|NCT01362049|567447235|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
157193062|NCT01362049|567447236|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
157193063|NCT01362049|567447237|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
157193064|NCT01362049|567447234|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
157193065|NCT01362049|567447235|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
157193066|NCT01362049|567447236|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
157193067|NCT01362049|567447237|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
157193068|NCT00806494|567447241|FG000|Overall Study|Adverse Event|29|||
157193069|NCT00806494|567447241|FG000|Overall Study|Lack of Efficacy|6|||
157193070|NCT00806494|567447241|FG000|Overall Study|Lost to Follow-up|10|||
157193071|NCT00806494|567447241|FG000|Overall Study|Other|30|||
157193072|NCT00806494|567447241|FG000|Overall Study|Withdrawal by Subject|5|||
157193073|NCT02417935|567447244|FG000|Treatment Period|Adverse Event|12|||
157193074|NCT02417935|567447245|FG001|Treatment Period|Adverse Event|10|||
157193075|NCT02417935|567447244|FG000|Treatment Period|Lost to Follow-up|1|||
157193076|NCT02417935|567447245|FG001|Treatment Period|Lost to Follow-up|0|||
157193077|NCT02417935|567447244|FG000|Treatment Period|Entry Criteria not met|0|||
157193078|NCT02417935|567447245|FG001|Treatment Period|Entry Criteria not met|1|||
157193079|NCT02417935|567447244|FG000|Treatment Period|Protocol Violation|2|||
157193080|NCT02417935|567447245|FG001|Treatment Period|Protocol Violation|1|||
157193081|NCT02417935|567447244|FG000|Treatment Period|Withdrawal by Subject|3|||
157193082|NCT02417935|567447245|FG001|Treatment Period|Withdrawal by Subject|3|||
157193083|NCT02417935|567447244|FG000|Treatment Period|Physician Decision|3|||
157193084|NCT02417935|567447245|FG001|Treatment Period|Physician Decision|1|||
157193085|NCT02504424|567447247|FG000|Overall Study|Withdrawal by Subject|2|||
157193086|NCT00426842|567447248|FG000|Overall Study|Lost to Follow-up|1|||
157193087|NCT01230827|567447249|FG000|Overall Study|Lost to Follow-up|0|||
157193088|NCT01230827|567447250|FG001|Overall Study|Lost to Follow-up|0|||
157193089|NCT01230827|567447251|FG002|Overall Study|Lost to Follow-up|1|||
157193090|NCT01230827|567447252|FG003|Overall Study|Lost to Follow-up|3|||
157193091|NCT01230827|567447249|FG000|Overall Study|Withdrawal by Subject|1|||
157193092|NCT01230827|567447250|FG001|Overall Study|Withdrawal by Subject|0|||
157193093|NCT01230827|567447251|FG002|Overall Study|Withdrawal by Subject|3|||
157193094|NCT01230827|567447252|FG003|Overall Study|Withdrawal by Subject|2|||
157193095|NCT01230827|567447249|FG000|Overall Study|Lack of Efficacy|14|||
157193096|NCT01230827|567447250|FG001|Overall Study|Lack of Efficacy|1|||
157193097|NCT01230827|567447251|FG002|Overall Study|Lack of Efficacy|2|||
157193098|NCT01230827|567447252|FG003|Overall Study|Lack of Efficacy|3|||
157193099|NCT01230827|567447249|FG000|Overall Study|Adverse Event|4|||
157193100|NCT01230827|567447250|FG001|Overall Study|Adverse Event|2|||
157193101|NCT01230827|567447251|FG002|Overall Study|Adverse Event|3|||
157193102|NCT01230827|567447252|FG003|Overall Study|Adverse Event|7|||
157193103|NCT01230827|567447249|FG000|Overall Study|Recovery|0|||
157193104|NCT01230827|567447250|FG001|Overall Study|Recovery|6|||
157193105|NCT01230827|567447251|FG002|Overall Study|Recovery|0|||
157193106|NCT01230827|567447252|FG003|Overall Study|Recovery|0|||
157193107|NCT01230827|567447249|FG000|Overall Study|Study terminated by Sponsor|0|||
157193108|NCT01230827|567447250|FG001|Overall Study|Study terminated by Sponsor|2|||
157193109|NCT01230827|567447251|FG002|Overall Study|Study terminated by Sponsor|56|||
157193110|NCT01230827|567447252|FG003|Overall Study|Study terminated by Sponsor|63|||
157193111|NCT00983827|567447253|FG000|Overall Study|Withdrawal by Subject|1|||
157193112|NCT00805142|567447255|FG000|Titration Period|Adverse Event|3|||
157193113|NCT00805142|567447256|FG001|Titration Period|Adverse Event|3|||
157193114|NCT00805142|567447255|FG000|Titration Period|Lack of Efficacy|1|||
157193115|NCT00805142|567447256|FG001|Titration Period|Lack of Efficacy|1|||
157193116|NCT00805142|567447255|FG000|Titration Period|Lost to Follow-up|0|||
157193117|NCT00805142|567447256|FG001|Titration Period|Lost to Follow-up|1|||
157193118|NCT00805142|567447255|FG000|Titration Period|Disease Progression|2|||
157193119|NCT00805142|567447256|FG001|Titration Period|Disease Progression|1|||
157193120|NCT00805142|567447255|FG000|Titration Period|Withdrawal of consent|0|||
157193121|NCT00805142|567447256|FG001|Titration Period|Withdrawal of consent|1|||
157193122|NCT00805142|567447255|FG000|Titration Period|Other|0|||
157193123|NCT00805142|567447256|FG001|Titration Period|Other|3|||
157193124|NCT00805142|567447255|FG000|Maintenance Period|Adverse Event|0|||
157193125|NCT00805142|567447256|FG001|Maintenance Period|Adverse Event|1|||
157193126|NCT00805142|567447255|FG000|Maintenance Period|Other|0|||
157193127|NCT00805142|567447256|FG001|Maintenance Period|Other|1|||
157193128|NCT02312934|567447257|FG000|Overall Study|Lost to Follow-up|1|||
157193129|NCT02312934|567447258|FG001|Overall Study|Lost to Follow-up|0|||
157193130|NCT02312934|567447257|FG000|Overall Study|Physician Decision|1|||
157193131|NCT02312934|567447258|FG001|Overall Study|Physician Decision|0|||
157193132|NCT01156012|567447259|FG000|Overall Study|Adverse Event|3|||
157193133|NCT01156012|567447260|FG001|Overall Study|Adverse Event|1|||
157193134|NCT01156012|567447259|FG000|Overall Study|Lost to Follow-up|1|||
157193135|NCT01156012|567447260|FG001|Overall Study|Lost to Follow-up|0|||
157193136|NCT01156012|567447259|FG000|Overall Study|Withdrawal by Subject|1|||
157193137|NCT01156012|567447260|FG001|Overall Study|Withdrawal by Subject|0|||
157193138|NCT01156012|567447259|FG000|Overall Study|use of commercial drug instead of study|0|||
157193139|NCT01156012|567447260|FG001|Overall Study|use of commercial drug instead of study|1|||
157193140|NCT01156012|567447259|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
157193141|NCT01156012|567447260|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
157193142|NCT03395704|567447261|FG000|Overall Study|Adverse Event|2|||
157193143|NCT03395704|567447262|FG001|Overall Study|Adverse Event|1|||
157193144|NCT03395704|567447261|FG000|Overall Study|Withdrawal by Subject|2|||
157193145|NCT03395704|567447262|FG001|Overall Study|Withdrawal by Subject|1|||
157193146|NCT03395704|567447261|FG000|Overall Study|Physician Decision|0|||
157193147|NCT03395704|567447262|FG001|Overall Study|Physician Decision|1|||
157193148|NCT00424463|567447263|FG000|Overall Study|Adverse Event|2|||
157193149|NCT00424463|567447264|FG001|Overall Study|Adverse Event|3|||
157193150|NCT00424463|567447265|FG002|Overall Study|Adverse Event|2|||
157193151|NCT00424463|567447263|FG000|Overall Study|Physician Decision|0|||
157193152|NCT00424463|567447264|FG001|Overall Study|Physician Decision|2|||
157193153|NCT00424463|567447265|FG002|Overall Study|Physician Decision|2|||
157232770|NCT00454909|567599062|FG001|Overall Study|Migrated/moved from study area|0|||
157232771|NCT00454909|567599063|FG002|Overall Study|Migrated/moved from study area|1|||
157083675|NCT03459443|567060084|FG000|Overall Study|Sponsor's decision to close the study|18|||
157083676|NCT01276379|567060085|FG000|Overall Study|Screening failure|40|||
157083677|NCT02729831|567060087|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
157083678|NCT02729831|567060088|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
157083679|NCT02729831|567060089|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
157083680|NCT02729831|567060090|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
157083681|NCT02729831|567060087|FG000|1 Week Post-visit|Lost to Follow-up|43|||
157083682|NCT02729831|567060088|FG001|1 Week Post-visit|Lost to Follow-up|40|||
157083683|NCT02729831|567060089|FG002|1 Week Post-visit|Lost to Follow-up|38|||
157083684|NCT02729831|567060090|FG003|1 Week Post-visit|Lost to Follow-up|36|||
157083685|NCT02729831|567060087|FG000|6 Month Follow-up|Lost to Follow-up|54|||
157083686|NCT02729831|567060088|FG001|6 Month Follow-up|Lost to Follow-up|51|||
157083687|NCT02729831|567060089|FG002|6 Month Follow-up|Lost to Follow-up|48|||
157083688|NCT02729831|567060090|FG003|6 Month Follow-up|Lost to Follow-up|42|||
157083689|NCT02729831|567060087|FG000|6 Month Follow-up|Death|1|||
157083690|NCT02729831|567060088|FG001|6 Month Follow-up|Death|3|||
157083691|NCT02729831|567060089|FG002|6 Month Follow-up|Death|0|||
157083692|NCT02729831|567060090|FG003|6 Month Follow-up|Death|1|||
157083693|NCT00864253|567060091|FG000|Overall Study|Adverse Event|56|||
157083694|NCT00864253|567060092|FG001|Overall Study|Adverse Event|11|||
157083695|NCT00864253|567060091|FG000|Overall Study|Unrelated Adverse Event|3|||
157083696|NCT00864253|567060092|FG001|Overall Study|Unrelated Adverse Event|1|||
157083697|NCT00864253|567060091|FG000|Overall Study|Physician Decision|11|||
157083698|NCT00864253|567060092|FG001|Overall Study|Physician Decision|15|||
157083699|NCT00864253|567060091|FG000|Overall Study|Protocol Violation|0|||
157083700|NCT00864253|567060092|FG001|Overall Study|Protocol Violation|2|||
157083701|NCT00864253|567060091|FG000|Overall Study|Lost to Follow-up|1|||
157083702|NCT00864253|567060092|FG001|Overall Study|Lost to Follow-up|1|||
157083703|NCT00864253|567060091|FG000|Overall Study|Withdrawal by Subject|18|||
157083704|NCT00864253|567060092|FG001|Overall Study|Withdrawal by Subject|18|||
157083705|NCT00864253|567060091|FG000|Overall Study|Death|1|||
157083706|NCT00864253|567060092|FG001|Overall Study|Death|0|||
157083707|NCT00864253|567060091|FG000|Overall Study|Ongoing|2|||
157083708|NCT00864253|567060092|FG001|Overall Study|Ongoing|3|||
157083709|NCT00864253|567060091|FG000|Overall Study|Untreated|7|||
157083710|NCT00864253|567060092|FG001|Overall Study|Untreated|7|||
157083711|NCT01111240|567060093|FG000|Overall Study|Adverse Event|190|||
157083712|NCT01111240|567060093|FG000|Overall Study|Lack of Efficacy|545|||
157083713|NCT01111240|567060093|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
157083714|NCT01111240|567060093|FG000|Overall Study|Other|312|||
157083715|NCT01747551|567060094|FG000|Overall Study|Progressive Disease|24|||
157083716|NCT01747551|567060095|FG001|Overall Study|Progressive Disease|17|||
157083717|NCT01747551|567060094|FG000|Overall Study|Death|3|||
157083718|NCT01747551|567060095|FG001|Overall Study|Death|1|||
157083719|NCT01747551|567060094|FG000|Overall Study|Adverse Event|7|||
157083720|NCT01747551|567060095|FG001|Overall Study|Adverse Event|1|||
157083721|NCT01747551|567060094|FG000|Overall Study|Prolonged Treatment Delay|2|||
157083722|NCT01747551|567060095|FG001|Overall Study|Prolonged Treatment Delay|0|||
157083723|NCT01747551|567060094|FG000|Overall Study|Withdrawal by Subject|3|||
157083724|NCT01747551|567060095|FG001|Overall Study|Withdrawal by Subject|1|||
157083725|NCT01747551|567060094|FG000|Overall Study|Physician Decision|2|||
157083726|NCT01747551|567060095|FG001|Overall Study|Physician Decision|1|||
157083727|NCT01747551|567060094|FG000|Overall Study|Other|2|||
157083728|NCT01747551|567060095|FG001|Overall Study|Other|0|||
157083729|NCT01607476|567060096|FG000|Overall Study|Withdrawal by Subject|1|||
157083730|NCT01607476|567060097|FG001|Overall Study|Withdrawal by Subject|0|||
157083731|NCT01607476|567060098|FG002|Overall Study|Withdrawal by Subject|1|||
157083732|NCT01607476|567060096|FG000|Overall Study|Lost to Follow-up|0|||
157083733|NCT01607476|567060097|FG001|Overall Study|Lost to Follow-up|0|||
157083734|NCT01607476|567060098|FG002|Overall Study|Lost to Follow-up|2|||
157083735|NCT04445987|567060099|FG000|Overall Study|Adverse Event|0|||
157083736|NCT04445987|567060100|FG001|Overall Study|Adverse Event|0|||
157083737|NCT04445987|567060101|FG002|Overall Study|Adverse Event|1|||
157083738|NCT04445987|567060102|FG003|Overall Study|Adverse Event|0|||
157083739|NCT04445987|567060103|FG004|Overall Study|Adverse Event|4|||
157083740|NCT04445987|567060104|FG005|Overall Study|Adverse Event|0|||
157083741|NCT04445987|567060099|FG000|Overall Study|Lost to Follow-up|4|||
157083742|NCT04445987|567060100|FG001|Overall Study|Lost to Follow-up|3|||
157083743|NCT04445987|567060101|FG002|Overall Study|Lost to Follow-up|1|||
157083744|NCT04445987|567060102|FG003|Overall Study|Lost to Follow-up|1|||
157083745|NCT04445987|567060103|FG004|Overall Study|Lost to Follow-up|29|||
157083746|NCT04445987|567060104|FG005|Overall Study|Lost to Follow-up|0|||
157083747|NCT04445987|567060099|FG000|Overall Study|Physician Decision|0|||
157083748|NCT04445987|567060100|FG001|Overall Study|Physician Decision|0|||
157083749|NCT04445987|567060101|FG002|Overall Study|Physician Decision|0|||
157083750|NCT04445987|567060102|FG003|Overall Study|Physician Decision|0|||
157083751|NCT04445987|567060103|FG004|Overall Study|Physician Decision|1|||
157083752|NCT04445987|567060104|FG005|Overall Study|Physician Decision|0|||
157083753|NCT04445987|567060099|FG000|Overall Study|Protocol Violation|1|||
157083754|NCT04445987|567060100|FG001|Overall Study|Protocol Violation|0|||
157083755|NCT04445987|567060101|FG002|Overall Study|Protocol Violation|0|||
157083756|NCT04445987|567060102|FG003|Overall Study|Protocol Violation|0|||
157083757|NCT04445987|567060103|FG004|Overall Study|Protocol Violation|2|||
157083758|NCT04445987|567060104|FG005|Overall Study|Protocol Violation|0|||
157193154|NCT00424463|567447263|FG000|Overall Study|Withdrawal by Subject|4|||
157193155|NCT00424463|567447264|FG001|Overall Study|Withdrawal by Subject|2|||
157193156|NCT00424463|567447265|FG002|Overall Study|Withdrawal by Subject|5|||
157193157|NCT00424463|567447263|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
157193158|NCT00424463|567447264|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
157193159|NCT00424463|567447265|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
157193160|NCT00424463|567447263|FG000|Overall Study|Patient's convenience|0|||
157193161|NCT00424463|567447264|FG001|Overall Study|Patient's convenience|0|||
157193162|NCT00424463|567447265|FG002|Overall Study|Patient's convenience|1|||
157193163|NCT02927990|567449270|FG000|Overall Study|Protocol Violation|4|||
157193164|NCT02927990|567449270|FG000|Overall Study|Physician Decision|9|||
157193165|NCT02927990|567449270|FG000|Overall Study|Room switched and therefore no study device available|15|||
157193166|NCT02927990|567449270|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
157193167|NCT00960323|567449271|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
157193168|NCT00772031|567449275|FG000|Overall Study|Early termination of trial|12|||
157193169|NCT00772031|567449276|FG001|Overall Study|Early termination of trial|10|||
157193170|NCT00772031|567449275|FG000|Overall Study|Lost to Follow-up|20|||
157193171|NCT00772031|567449276|FG001|Overall Study|Lost to Follow-up|33|||
157193172|NCT01856920|567449277|FG000|Overall Study|Disease Progression On Study|3|||
157193173|NCT01856920|567449278|FG001|Overall Study|Disease Progression On Study|4|||
157193174|NCT01856920|567449277|FG000|Overall Study|Disease Progression before Treatment|1|||
157193175|NCT01856920|567449278|FG001|Overall Study|Disease Progression before Treatment|0|||
157193176|NCT01856920|567449277|FG000|Overall Study|Ineligible|0|||
157193177|NCT01856920|567449278|FG001|Overall Study|Ineligible|1|||
157193178|NCT01856920|567449277|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
157193179|NCT01856920|567449278|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
157193180|NCT01856920|567449277|FG000|Overall Study|Refused further Treatment|5|||
157193181|NCT01856920|567449278|FG001|Overall Study|Refused further Treatment|1|||
157193182|NCT01856920|567449277|FG000|Overall Study|Other Reasons|0|||
157193183|NCT01856920|567449278|FG001|Overall Study|Other Reasons|1|||
157193184|NCT01856920|567449277|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
157193185|NCT01856920|567449278|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
157193186|NCT02906644|567449279|FG000|First 2 Weeks|Withdrawal by Subject|0|||
157193187|NCT02906644|567449280|FG001|First 2 Weeks|Withdrawal by Subject|2|||
157193188|NCT02906644|567449279|FG000|First 2 Weeks|Physician Decision|1|||
157193189|NCT02906644|567449280|FG001|First 2 Weeks|Physician Decision|1|||
157193190|NCT02906644|567449279|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
157193191|NCT02906644|567449280|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
157193192|NCT02906644|567449279|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
157193193|NCT02906644|567449280|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
157193194|NCT02030067|567449282|FG000|Overall Study|Disease Progression|1|||
157193195|NCT02030067|567449283|FG001|Overall Study|Disease Progression|1|||
157193196|NCT02030067|567449284|FG002|Overall Study|Disease Progression|2|||
157193197|NCT02030067|567449285|FG003|Overall Study|Disease Progression|2|||
157193198|NCT02030067|567449286|FG004|Overall Study|Disease Progression|3|||
157193199|NCT02030067|567449287|FG005|Overall Study|Disease Progression|2|||
157193200|NCT02030067|567449288|FG006|Overall Study|Disease Progression|3|||
157193201|NCT02030067|567449289|FG007|Overall Study|Disease Progression|3|||
157193202|NCT02030067|567449290|FG008|Overall Study|Disease Progression|4|||
157193203|NCT02030067|567449291|FG009|Overall Study|Disease Progression|3|||
157193204|NCT02030067|567449292|FG010|Overall Study|Disease Progression|7|||
157193205|NCT02030067|567449293|FG011|Overall Study|Disease Progression|2|||
157193206|NCT02030067|567449294|FG012|Overall Study|Disease Progression|59|||
157232772|NCT00454909|567599061|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
157232773|NCT00454909|567599062|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
157083759|NCT04445987|567060099|FG000|Overall Study|Withdrawal by Subject|4|||
157083760|NCT04445987|567060100|FG001|Overall Study|Withdrawal by Subject|0|||
157083761|NCT04445987|567060101|FG002|Overall Study|Withdrawal by Subject|1|||
157193207|NCT02030067|567449282|FG000|Overall Study|Withdrawal by Subject|0|||
157193208|NCT02030067|567449283|FG001|Overall Study|Withdrawal by Subject|0|||
157193209|NCT02030067|567449284|FG002|Overall Study|Withdrawal by Subject|0|||
157193210|NCT02030067|567449285|FG003|Overall Study|Withdrawal by Subject|1|||
157193211|NCT02030067|567449286|FG004|Overall Study|Withdrawal by Subject|0|||
157193212|NCT02030067|567449287|FG005|Overall Study|Withdrawal by Subject|0|||
157193213|NCT02030067|567449288|FG006|Overall Study|Withdrawal by Subject|0|||
157083762|NCT04445987|567060102|FG003|Overall Study|Withdrawal by Subject|0|||
157193214|NCT02030067|567449289|FG007|Overall Study|Withdrawal by Subject|1|||
157083763|NCT04445987|567060103|FG004|Overall Study|Withdrawal by Subject|18|||
157083764|NCT04445987|567060104|FG005|Overall Study|Withdrawal by Subject|1|||
157083765|NCT04445987|567060099|FG000|Overall Study|Other reason|0|||
157083766|NCT04445987|567060100|FG001|Overall Study|Other reason|0|||
157083767|NCT04445987|567060101|FG002|Overall Study|Other reason|1|||
157083768|NCT04445987|567060102|FG003|Overall Study|Other reason|0|||
157083769|NCT04445987|567060103|FG004|Overall Study|Other reason|2|||
157083770|NCT04445987|567060104|FG005|Overall Study|Other reason|0|||
157083771|NCT01609062|567060110|FG000|Extension Phase|Terminated by Sponsor|14|||
157083772|NCT01609062|567060111|FG001|Extension Phase|Terminated by Sponsor|9|||
157083773|NCT01609062|567060110|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
157083774|NCT01609062|567060111|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
157083775|NCT01609062|567060110|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
157083776|NCT01609062|567060111|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
157083777|NCT00680992|567060112|FG000|Overall Study|Complete Resection (as per protocol)|25|||
157232774|NCT00454909|567599063|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
157232775|NCT00454909|567599061|FG000|Overall Study|Others|1|||
157232776|NCT00454909|567599062|FG001|Overall Study|Others|0|||
157232777|NCT00454909|567599063|FG002|Overall Study|Others|0|||
157232778|NCT02996682|567599064|FG000|Overall Study|Death|0|||
157232779|NCT02996682|567599065|FG001|Overall Study|Death|3|||
157232780|NCT01981720|567599066|FG000|Overall Study|Adverse Event|1|||
157232781|NCT01981720|567599066|FG000|Overall Study|Withdrawal by Subject|3|||
157232782|NCT01981720|567599066|FG000|Overall Study|Pregnancy|1|||
157232783|NCT00259012|567599067|FG000|Overall Study|Adverse Event|0|||
157232784|NCT00259012|567599068|FG001|Overall Study|Adverse Event|1|||
157232785|NCT00259012|567599067|FG000|Overall Study|Withdrawal by Subject|1|||
157232786|NCT00259012|567599068|FG001|Overall Study|Withdrawal by Subject|0|||
157232787|NCT00259012|567599067|FG000|Overall Study|Physician Decision|0|||
157232788|NCT00259012|567599068|FG001|Overall Study|Physician Decision|1|||
157232789|NCT00259012|567599067|FG000|Overall Study|Lost to Follow-up|0|||
157232790|NCT00259012|567599068|FG001|Overall Study|Lost to Follow-up|1|||
157232791|NCT00259012|567599067|FG000|Overall Study|Protocol Violation|1|||
157232792|NCT00259012|567599068|FG001|Overall Study|Protocol Violation|1|||
157232793|NCT00707161|567599069|FG000|Overall Study|Physician Decision|6|||
157232794|NCT00450190|567599070|FG000|Overall Study|Withdrawal by Subject|2|||
157232795|NCT01376167|567599071|FG000|Overall Study|Lost to Follow-up|2|||
157232796|NCT01376167|567599072|FG001|Overall Study|Lost to Follow-up|4|||
157232797|NCT01376167|567599073|FG002|Overall Study|Lost to Follow-up|2|||
157232798|NCT01376167|567599071|FG000|Overall Study|Physician Decision|1|||
157232799|NCT01376167|567599072|FG001|Overall Study|Physician Decision|1|||
157232800|NCT01376167|567599073|FG002|Overall Study|Physician Decision|0|||
157232801|NCT01376167|567599071|FG000|Overall Study|Withdrawal by Subject|1|||
157232802|NCT01376167|567599072|FG001|Overall Study|Withdrawal by Subject|5|||
157232803|NCT01376167|567599073|FG002|Overall Study|Withdrawal by Subject|4|||
157232804|NCT02193165|567599074|FG000|4 Week Product Use|Lost to Follow-up|1|||
157232805|NCT02193165|567599075|FG001|4 Week Product Use|Lost to Follow-up|1|||
157232806|NCT02193165|567599076|FG002|4 Week Product Use|Lost to Follow-up|1|||
157232807|NCT02193165|567599074|FG000|6 Week Product Use|Lost to Follow-up|0|||
157232808|NCT02193165|567599075|FG001|6 Week Product Use|Lost to Follow-up|1|||
157232809|NCT02193165|567599076|FG002|6 Week Product Use|Lost to Follow-up|0|||
157232810|NCT00986245|567599083|FG000|First Intervention|Poor compliance|8|||
157232811|NCT00986245|567599084|FG001|First Intervention|Poor compliance|4|||
157232812|NCT00986245|567599083|FG000|First Intervention|Lack of Efficacy|1|||
157232813|NCT00986245|567599084|FG001|First Intervention|Lack of Efficacy|2|||
157232814|NCT00986245|567599083|FG000|First Intervention|Withdrawal by Subject|0|||
157083778|NCT00680992|567060113|FG001|Overall Study|Complete Resection (as per protocol)|121|||
157083779|NCT00680992|567060114|FG002|Overall Study|Complete Resection (as per protocol)|0|||
157083780|NCT00680992|567060112|FG000|Overall Study|Administrative Decision|83|||
157232815|NCT00986245|567599084|FG001|First Intervention|Withdrawal by Subject|1|||
157232816|NCT00986245|567599083|FG000|First Intervention|Protocol Violation|0|||
157232817|NCT00986245|567599084|FG001|First Intervention|Protocol Violation|1|||
157232818|NCT00986245|567599083|FG000|First Intervention|Out of indication|1|||
157232819|NCT00986245|567599084|FG001|First Intervention|Out of indication|0|||
157232820|NCT00986245|567599083|FG000|Second Intervention|Poor compliance|1|||
157232821|NCT00986245|567599084|FG001|Second Intervention|Poor compliance|0|||
157232822|NCT00986245|567599083|FG000|Second Intervention|Lost to Follow-up|1|||
157083781|NCT00680992|567060113|FG001|Overall Study|Administrative Decision|42|||
157232823|NCT00986245|567599084|FG001|Second Intervention|Lost to Follow-up|0|||
157232824|NCT00986245|567599083|FG000|Second Intervention|Protocol Violation|0|||
157232825|NCT00986245|567599084|FG001|Second Intervention|Protocol Violation|1|||
157232826|NCT01941030|567599087|FG000|Overall Study|Death|3|||
157232827|NCT01941030|567599088|FG001|Overall Study|Death|2|||
157232828|NCT01941030|567599087|FG000|Overall Study|Lost to Follow-up|6|||
157232829|NCT01941030|567599088|FG001|Overall Study|Lost to Follow-up|5|||
157232830|NCT01941030|567599087|FG000|Overall Study|Withdrawal by Subject|4|||
157083782|NCT00680992|567060114|FG002|Overall Study|Administrative Decision|5|||
157232831|NCT01941030|567599088|FG001|Overall Study|Withdrawal by Subject|6|||
157232832|NCT03693430|567599091|FG000|Overall Study|Lost to Follow-up|3|||
157232833|NCT03693430|567599092|FG001|Overall Study|Lost to Follow-up|14|||
157232834|NCT03693430|567599091|FG000|Overall Study|Death|1|||
157232835|NCT03693430|567599092|FG001|Overall Study|Death|0|||
157232836|NCT03693430|567599091|FG000|Overall Study|Withdrawal by Subject|0|||
157232837|NCT03693430|567599092|FG001|Overall Study|Withdrawal by Subject|4|||
157232838|NCT05067647|567599095|FG000|Overall Study|Lost to Follow-up|1|||
157232839|NCT00870870|567599098|FG000|Overall Study|Withdrawal by Subject|0|||
157232840|NCT00870870|567599099|FG001|Overall Study|Withdrawal by Subject|1|||
157232841|NCT00870870|567599100|FG002|Overall Study|Withdrawal by Subject|1|||
157232842|NCT00870870|567599101|FG003|Overall Study|Withdrawal by Subject|3|||
157232843|NCT00870870|567599098|FG000|Overall Study|Adverse Event|0|||
157232844|NCT00870870|567599099|FG001|Overall Study|Adverse Event|0|||
157232845|NCT00870870|567599100|FG002|Overall Study|Adverse Event|2|||
157232846|NCT00870870|567599101|FG003|Overall Study|Adverse Event|2|||
157232847|NCT03639311|567599106|FG000|Maintenance Phase|Lost to Follow-up|1|||
157232848|NCT03639311|567599107|FG001|Maintenance Phase|Lost to Follow-up|0|||
157232849|NCT03639311|567599108|FG002|Maintenance Phase|Lost to Follow-up|0|||
157232850|NCT03639311|567599106|FG000|Maintenance Phase|Adverse Event|1|||
157232851|NCT03639311|567599107|FG001|Maintenance Phase|Adverse Event|0|||
157232852|NCT03639311|567599108|FG002|Maintenance Phase|Adverse Event|0|||
157232853|NCT03639311|567599106|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
157232854|NCT03639311|567599107|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
157232855|NCT03639311|567599108|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
157232856|NCT03639311|567599106|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
157232857|NCT03639311|567599107|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
157232858|NCT03639311|567599108|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
157232859|NCT03639311|567599106|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
157232860|NCT03639311|567599107|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
157232861|NCT03639311|567599108|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
157232862|NCT03639311|567599106|FG000|Maintenance Phase|Lack of Efficacy|1|||
157232863|NCT03639311|567599107|FG001|Maintenance Phase|Lack of Efficacy|0|||
157232864|NCT03639311|567599108|FG002|Maintenance Phase|Lack of Efficacy|0|||
157232865|NCT00855738|567599115|FG000|Overall Study|Lost to Follow-up|2|||
157232866|NCT00855738|567599115|FG000|Overall Study|Adverse Event|1|||
157232867|NCT00855738|567599115|FG000|Overall Study|Subject Defaulted|1|||
157232868|NCT00855738|567599115|FG000|Overall Study|Death|1|||
157232869|NCT00304083|567599119|FG000|Overall Study|Withdrawal by Subject|4|||
157232870|NCT00304083|567599120|FG001|Overall Study|Withdrawal by Subject|2|||
157232871|NCT00304083|567599119|FG000|Overall Study|Physician Decision|8|||
157232872|NCT00304083|567599120|FG001|Overall Study|Physician Decision|3|||
157232873|NCT00304083|567599119|FG000|Overall Study|Disease Progression|5|||
157232874|NCT00304083|567599120|FG001|Overall Study|Disease Progression|1|||
157232875|NCT00304083|567599119|FG000|Overall Study|Other|5|||
157232876|NCT00304083|567599120|FG001|Overall Study|Other|2|||
157232877|NCT03929393|567599121|FG000|Overall Study|Death|1|||
157232878|NCT03929393|567599122|FG001|Overall Study|Death|0|||
157232879|NCT03929393|567599121|FG000|Overall Study|Time Commitment|2|||
157232880|NCT03929393|567599122|FG001|Overall Study|Time Commitment|5|||
157232881|NCT03929393|567599121|FG000|Overall Study|Motor Vehicle Accident|0|||
157232882|NCT03929393|567599122|FG001|Overall Study|Motor Vehicle Accident|1|||
157232883|NCT03929393|567599121|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
157232884|NCT03929393|567599122|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
157232885|NCT03929393|567599121|FG000|Overall Study|Other|1|||
157232886|NCT03929393|567599122|FG001|Overall Study|Other|3|||
157232887|NCT01569152|567599132|FG000|Phase IIa, Period 1|Early Escape|5|||
157232888|NCT01569152|567599133|FG001|Phase IIa, Period 1|Early Escape|22|||
157232889|NCT01569152|567599134|FG002|Phase IIa, Period 1|Early Escape|0|||
157232890|NCT01569152|567599132|FG000|Phase IIa, Period 1|Adverse Event|4|||
157232891|NCT01569152|567599133|FG001|Phase IIa, Period 1|Adverse Event|0|||
157232892|NCT01569152|567599134|FG002|Phase IIa, Period 1|Adverse Event|0|||
157232893|NCT01569152|567599132|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
157232894|NCT01569152|567599133|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
157232895|NCT01569152|567599134|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
157232896|NCT01569152|567599132|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
157083783|NCT00680992|567060112|FG000|Overall Study|End of Trial|32|||
157232897|NCT01569152|567599133|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
157232898|NCT01569152|567599134|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
157232899|NCT01569152|567599132|FG000|Phase IIa, Period 1|Protocol Violation|0|||
157232900|NCT01569152|567599133|FG001|Phase IIa, Period 1|Protocol Violation|1|||
157232901|NCT01569152|567599134|FG002|Phase IIa, Period 1|Protocol Violation|0|||
157232902|NCT01569152|567599132|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
157232903|NCT01569152|567599133|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
157232904|NCT01569152|567599134|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
157232905|NCT01569152|567599132|FG000|Safety Extension, Period 3|Adverse Event|0|||
157083784|NCT00680992|567060113|FG001|Overall Study|End of Trial|12|||
157083785|NCT00680992|567060114|FG002|Overall Study|End of Trial|3|||
157083786|NCT00680992|567060112|FG000|Overall Study|Withdrawal by Subject|33|||
157083787|NCT00680992|567060113|FG001|Overall Study|Withdrawal by Subject|11|||
157083788|NCT00680992|567060114|FG002|Overall Study|Withdrawal by Subject|1|||
157083789|NCT00680992|567060112|FG000|Overall Study|Adverse Event|21|||
157083790|NCT00680992|567060113|FG001|Overall Study|Adverse Event|19|||
157083791|NCT00680992|567060114|FG002|Overall Study|Adverse Event|1|||
157083792|NCT00680992|567060112|FG000|Overall Study|Other|19|||
157083793|NCT00680992|567060113|FG001|Overall Study|Other|14|||
157083794|NCT00680992|567060114|FG002|Overall Study|Other|1|||
157083795|NCT00680992|567060112|FG000|Overall Study|Disease Progression|21|||
157083796|NCT00680992|567060113|FG001|Overall Study|Disease Progression|9|||
157083797|NCT00680992|567060114|FG002|Overall Study|Disease Progression|0|||
157083798|NCT00680992|567060112|FG000|Overall Study|Lost to Follow-up|12|||
157083799|NCT00680992|567060113|FG001|Overall Study|Lost to Follow-up|14|||
157083800|NCT00680992|567060114|FG002|Overall Study|Lost to Follow-up|0|||
157083801|NCT00680992|567060112|FG000|Overall Study|Noncompliance|4|||
157083802|NCT00680992|567060113|FG001|Overall Study|Noncompliance|6|||
157083803|NCT00680992|567060114|FG002|Overall Study|Noncompliance|0|||
157083804|NCT00680992|567060112|FG000|Overall Study|Requirement for Alternative Therapy|8|||
157083805|NCT00680992|567060113|FG001|Overall Study|Requirement for Alternative Therapy|2|||
157083806|NCT00680992|567060114|FG002|Overall Study|Requirement for Alternative Therapy|0|||
157083807|NCT00680992|567060112|FG000|Overall Study|Pregnancy|5|||
157083808|NCT00680992|567060113|FG001|Overall Study|Pregnancy|0|||
157083809|NCT00680992|567060114|FG002|Overall Study|Pregnancy|1|||
157083810|NCT00680992|567060112|FG000|Overall Study|Death|5|||
157083811|NCT00680992|567060113|FG001|Overall Study|Death|1|||
157083812|NCT00680992|567060114|FG002|Overall Study|Death|0|||
157083813|NCT00680992|567060112|FG000|Overall Study|Ineligibility Determined|0|||
157083814|NCT00680992|567060113|FG001|Overall Study|Ineligibility Determined|1|||
157083815|NCT00680992|567060114|FG002|Overall Study|Ineligibility Determined|0|||
157083816|NCT03772587|567060115|FG000|Overall Study|COVID-19|0|||
157083817|NCT03772587|567060116|FG001|Overall Study|COVID-19|0|||
157083818|NCT03772587|567060117|FG002|Overall Study|COVID-19|1|||
157083819|NCT03772587|567060118|FG003|Overall Study|COVID-19|1|||
157083820|NCT03772587|567060119|FG004|Overall Study|COVID-19|0|||
157083821|NCT03772587|567060115|FG000|Overall Study|Withdrawal by Subject|1|||
157083822|NCT03772587|567060116|FG001|Overall Study|Withdrawal by Subject|0|||
157083823|NCT03772587|567060117|FG002|Overall Study|Withdrawal by Subject|0|||
157083824|NCT03772587|567060118|FG003|Overall Study|Withdrawal by Subject|0|||
157083825|NCT03772587|567060119|FG004|Overall Study|Withdrawal by Subject|0|||
157083826|NCT02425904|567060124|FG000|Overall Study|Lost to Follow-up|1|||
157083827|NCT02425904|567060125|FG001|Overall Study|Lost to Follow-up|0|||
157083828|NCT02425904|567060124|FG000|Overall Study|Withdrawal by Subject|2|||
157083829|NCT02425904|567060125|FG001|Overall Study|Withdrawal by Subject|0|||
157083830|NCT02425904|567060124|FG000|Overall Study|Death|0|||
157083831|NCT02425904|567060125|FG001|Overall Study|Death|3|||
157083832|NCT05260021|567060126|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
157083833|NCT05260021|567060127|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
157083834|NCT05260021|567060128|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
157083835|NCT05260021|567060126|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
157083836|NCT05260021|567060127|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
157083837|NCT05260021|567060128|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
157083838|NCT05260021|567060126|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
157083839|NCT05260021|567060127|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
157083840|NCT05260021|567060128|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
157083841|NCT05260021|567060126|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
157083842|NCT05260021|567060127|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
157083843|NCT05260021|567060128|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
157083844|NCT05260021|567060126|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
157083845|NCT05260021|567060127|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
157193215|NCT02030067|567449290|FG008|Overall Study|Withdrawal by Subject|0|||
157193216|NCT02030067|567449291|FG009|Overall Study|Withdrawal by Subject|0|||
157193217|NCT02030067|567449292|FG010|Overall Study|Withdrawal by Subject|3|||
157193218|NCT02030067|567449293|FG011|Overall Study|Withdrawal by Subject|0|||
157193219|NCT02030067|567449294|FG012|Overall Study|Withdrawal by Subject|6|||
157193220|NCT02030067|567449282|FG000|Overall Study|Physician Decision|0|||
157193221|NCT02030067|567449283|FG001|Overall Study|Physician Decision|0|||
157193222|NCT02030067|567449284|FG002|Overall Study|Physician Decision|0|||
157193223|NCT02030067|567449285|FG003|Overall Study|Physician Decision|0|||
157193224|NCT02030067|567449286|FG004|Overall Study|Physician Decision|0|||
157193225|NCT02030067|567449287|FG005|Overall Study|Physician Decision|0|||
157193226|NCT02030067|567449288|FG006|Overall Study|Physician Decision|0|||
157193227|NCT02030067|567449289|FG007|Overall Study|Physician Decision|0|||
157193228|NCT02030067|567449290|FG008|Overall Study|Physician Decision|0|||
157193229|NCT02030067|567449291|FG009|Overall Study|Physician Decision|0|||
157232906|NCT01569152|567599133|FG001|Safety Extension, Period 3|Adverse Event|0|||
157232907|NCT01569152|567599134|FG002|Safety Extension, Period 3|Adverse Event|4|||
157232908|NCT01569152|567599132|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
157232909|NCT01569152|567599133|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
157232910|NCT01569152|567599134|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
157232911|NCT01569152|567599132|FG000|Safety Extension, Period 3|Physician Decision|0|||
157232912|NCT01569152|567599133|FG001|Safety Extension, Period 3|Physician Decision|0|||
157232913|NCT01569152|567599134|FG002|Safety Extension, Period 3|Physician Decision|2|||
157232914|NCT01569152|567599132|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
157232915|NCT01569152|567599133|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
157232916|NCT01569152|567599134|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
157232917|NCT03544138|567599135|FG000|Overall Study|Lost to Follow-up|29|||
157232918|NCT03497897|567601006|FG000|Overall Study|Adverse Event|1|||
157232919|NCT03497897|567601007|FG001|Overall Study|Adverse Event|1|||
157232920|NCT03497897|567601008|FG002|Overall Study|Adverse Event|1|||
157232921|NCT03497897|567601006|FG000|Overall Study|Lost to Follow-up|2|||
157232922|NCT03497897|567601007|FG001|Overall Study|Lost to Follow-up|0|||
157232923|NCT03497897|567601008|FG002|Overall Study|Lost to Follow-up|2|||
157232924|NCT03497897|567601006|FG000|Overall Study|Physician Decision|1|||
157232925|NCT03497897|567601007|FG001|Overall Study|Physician Decision|0|||
157232926|NCT03497897|567601008|FG002|Overall Study|Physician Decision|0|||
157232927|NCT03497897|567601006|FG000|Overall Study|Subject/Guardian Decision|2|||
157232928|NCT03497897|567601007|FG001|Overall Study|Subject/Guardian Decision|1|||
157232929|NCT03497897|567601008|FG002|Overall Study|Subject/Guardian Decision|3|||
157232930|NCT04605094|567601012|FG000|Overall Study|Adverse Event|2|||
157232931|NCT04605094|567601013|FG001|Overall Study|Adverse Event|2|||
157232932|NCT04605094|567601012|FG000|Overall Study|Lost to Follow-up|1|||
157232933|NCT04605094|567601013|FG001|Overall Study|Lost to Follow-up|4|||
157232934|NCT04605094|567601012|FG000|Overall Study|Physician Decision|2|||
157232935|NCT04605094|567601013|FG001|Overall Study|Physician Decision|2|||
157232936|NCT04605094|567601012|FG000|Overall Study|Study terminated by Sponsor|31|||
157232937|NCT04605094|567601013|FG001|Overall Study|Study terminated by Sponsor|33|||
157232938|NCT04605094|567601012|FG000|Overall Study|Withdrawal by Subject|22|||
157232939|NCT04605094|567601013|FG001|Overall Study|Withdrawal by Subject|19|||
157232940|NCT04605094|567601012|FG000|Overall Study|Other|1|||
157232941|NCT04605094|567601013|FG001|Overall Study|Other|1|||
157232942|NCT02724462|567601014|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
157232943|NCT02724462|567601015|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
157232944|NCT02724462|567601014|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
157232945|NCT02724462|567601015|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
157232946|NCT02724462|567601014|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
157232947|NCT02724462|567601015|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
157232948|NCT02724462|567601014|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
157232949|NCT02724462|567601015|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
157232950|NCT02724462|567601014|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
157232951|NCT02724462|567601015|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
157232952|NCT02724462|567601014|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
157232953|NCT02724462|567601015|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
157232954|NCT00469417|567601018|FG000|Overall Study|Treatment failure all lesions|18|||
157232955|NCT00469417|567601019|FG001|Overall Study|Treatment failure all lesions|11|||
157232956|NCT00469417|567601018|FG000|Overall Study|Consent withdrawn|1|||
157232957|NCT00469417|567601019|FG001|Overall Study|Consent withdrawn|1|||
157083846|NCT05260021|567060128|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
157083847|NCT03842358|567060129|FG000|Overall Study|Poor DOT probe contact with breast|2|||
157083848|NCT03842358|567060129|FG000|Overall Study|DOT system problem|1|||
157232958|NCT00469417|567601018|FG000|Overall Study|Adverse Event|8|||
157232959|NCT00469417|567601019|FG001|Overall Study|Adverse Event|2|||
157232960|NCT00469417|567601018|FG000|Overall Study|Lost to Follow-up|1|||
157232961|NCT00469417|567601019|FG001|Overall Study|Lost to Follow-up|2|||
157232962|NCT00469417|567601018|FG000|Overall Study|Intercurrent disease|0|||
157232963|NCT00469417|567601019|FG001|Overall Study|Intercurrent disease|1|||
157232964|NCT00469417|567601018|FG000|Overall Study|Randomized but not treated|2|||
157232965|NCT00469417|567601019|FG001|Overall Study|Randomized but not treated|0|||
157232966|NCT03021018|567601023|FG000|Overall Study|Adverse Event|1|||
157232967|NCT03021018|567601024|FG001|Overall Study|Adverse Event|0|||
157083849|NCT03842358|567060129|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
157083850|NCT03842358|567060129|FG000|Overall Study|No biopsy after physician review|4|||
157232968|NCT03021018|567601025|FG002|Overall Study|Adverse Event|0|||
157232969|NCT03021018|567601023|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
157232970|NCT03021018|567601024|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
157232971|NCT03021018|567601025|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
157232972|NCT05038293|567601034|FG000|Overall Study|device was not operating properly for one subject.|1|||
157232973|NCT05038293|567601035|FG001|Overall Study|device was not operating properly for one subject.|0|||
157232974|NCT05038293|567601034|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
157232975|NCT05038293|567601035|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
157232976|NCT01171989|567601037|FG000|Overall Study|Lost to Follow-up|0|||
157232977|NCT01171989|567601038|FG001|Overall Study|Lost to Follow-up|0|||
157232978|NCT01171989|567601039|FG002|Overall Study|Lost to Follow-up|1|||
157232979|NCT01247701|567601041|FG000|Overall Study|Death|2|||
157232980|NCT01247701|567601041|FG000|Overall Study|Relapsed|8|||
157232981|NCT01838941|567601042|FG000|Overall Study|Adverse Event|1|||
157232982|NCT01838941|567601042|FG000|Overall Study|Withdrawal by Subject|1|||
157232983|NCT01034358|567601043|FG000|Overall Study|Withdrawal by Subject|1|||
157232984|NCT01034358|567601043|FG000|Overall Study|Protocol Violation|1|||
157232985|NCT00377260|567601046|FG000|Overall Study|Lost to Follow-up|0|||
157232986|NCT00377260|567601047|FG001|Overall Study|Lost to Follow-up|1|||
157232987|NCT00377260|567601046|FG000|Overall Study|Withdrawal by Subject|2|||
157232988|NCT00377260|567601047|FG001|Overall Study|Withdrawal by Subject|4|||
157232989|NCT00829530|567601048|FG000|First Intervention|Adverse Event|0|||
157232990|NCT00829530|567601049|FG001|First Intervention|Adverse Event|1|||
157232991|NCT00829530|567601048|FG000|First Intervention|Intolerance to Venopuncture|0|||
157232992|NCT00829530|567601049|FG001|First Intervention|Intolerance to Venopuncture|1|||
157232993|NCT00829530|567601048|FG000|Second Intervention|Intolerance to Venopuncture|1|||
157232994|NCT00829530|567601049|FG001|Second Intervention|Intolerance to Venopuncture|0|||
157232995|NCT00569374|567601050|FG000|Overall Study|Withdrawal by Subject|4|||
157232996|NCT00105196|567601057|FG000|Overall Study|Lack of Efficacy|2|||
157232997|NCT00105196|567601058|FG001|Overall Study|Lack of Efficacy|3|||
157232998|NCT00105196|567601057|FG000|Overall Study|Adverse Event|11|||
157232999|NCT00105196|567601058|FG001|Overall Study|Adverse Event|3|||
157233000|NCT00105196|567601057|FG000|Overall Study|Withdrawal by Subject|6|||
157233001|NCT00105196|567601058|FG001|Overall Study|Withdrawal by Subject|6|||
157233002|NCT00105196|567601057|FG000|Overall Study|Lost to Follow-up|3|||
157233003|NCT00105196|567601058|FG001|Overall Study|Lost to Follow-up|2|||
157233004|NCT00105196|567601057|FG000|Overall Study|Poor/noncompliance|3|||
157233005|NCT00105196|567601058|FG001|Overall Study|Poor/noncompliance|4|||
157233006|NCT00105196|567601057|FG000|Overall Study|Protocol Violation|5|||
157233007|NCT00105196|567601058|FG001|Overall Study|Protocol Violation|2|||
157233008|NCT00105196|567601057|FG000|Overall Study|pending surgery|0|||
157233009|NCT00105196|567601058|FG001|Overall Study|pending surgery|1|||
157233010|NCT00105196|567601057|FG000|Overall Study|marijuana use|0|||
157233011|NCT00105196|567601058|FG001|Overall Study|marijuana use|1|||
157233012|NCT00105196|567601057|FG000|Overall Study|Subject became unblinded|0|||
157233013|NCT00105196|567601058|FG001|Overall Study|Subject became unblinded|1|||
157233014|NCT01196052|567601059|FG000|Overall Study|Adverse Event|9|||
157233015|NCT01196052|567601059|FG000|Overall Study|Lost to Follow-up|1|||
157233016|NCT01196052|567601059|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
157233017|NCT01196052|567601059|FG000|Overall Study|Reason not Specified|5|||
157233018|NCT01196052|567601059|FG000|Overall Study|Withdrawal by Subject|6|||
157233019|NCT03603314|567601060|FG000|Overall Study|Lost to Follow-up|0|||
157233020|NCT03603314|567601061|FG001|Overall Study|Lost to Follow-up|3|||
157233021|NCT03603314|567601062|FG002|Overall Study|Lost to Follow-up|0|||
157233022|NCT03603314|567601060|FG000|Overall Study|Protocol Violation|0|||
157233023|NCT03603314|567601061|FG001|Overall Study|Protocol Violation|1|||
157233024|NCT03603314|567601062|FG002|Overall Study|Protocol Violation|0|||
157233025|NCT03603314|567601060|FG000|Overall Study|Adverse Event|2|||
157233026|NCT03603314|567601061|FG001|Overall Study|Adverse Event|0|||
157233027|NCT03603314|567601062|FG002|Overall Study|Adverse Event|0|||
157233028|NCT03603314|567601060|FG000|Overall Study|Physician Decision|1|||
157233029|NCT03603314|567601061|FG001|Overall Study|Physician Decision|1|||
157233030|NCT03603314|567601062|FG002|Overall Study|Physician Decision|0|||
157233031|NCT03603314|567601060|FG000|Overall Study|Withdrawal by Subject|4|||
157233032|NCT03603314|567601061|FG001|Overall Study|Withdrawal by Subject|5|||
157233033|NCT03603314|567601062|FG002|Overall Study|Withdrawal by Subject|3|||
157233034|NCT03603314|567601060|FG000|Overall Study|Other|0|||
157233035|NCT03603314|567601061|FG001|Overall Study|Other|1|||
157233036|NCT03603314|567601062|FG002|Overall Study|Other|0|||
157233037|NCT00893464|567601063|FG000|Overall Study|Did not complete therapy/experience PD|0|||
157233038|NCT00893464|567601064|FG001|Overall Study|Did not complete therapy/experience PD|0|||
157233039|NCT00893464|567601065|FG002|Overall Study|Did not complete therapy/experience PD|0|||
157233040|NCT00893464|567601066|FG003|Overall Study|Did not complete therapy/experience PD|0|||
157233041|NCT00893464|567601067|FG004|Overall Study|Did not complete therapy/experience PD|0|||
157233042|NCT00893464|567601068|FG005|Overall Study|Did not complete therapy/experience PD|0|||
157233043|NCT00893464|567601069|FG006|Overall Study|Did not complete therapy/experience PD|2|||
157233044|NCT00893464|567601070|FG007|Overall Study|Did not complete therapy/experience PD|2|||
157233045|NCT03450070|567601071|FG000|Overall Study|Withdrawal by Subject|8|||
157233046|NCT00050778|567601072|FG000|Overall Study|Adverse Event|13|||
157233047|NCT00050778|567601073|FG001|Overall Study|Adverse Event|3|||
157233048|NCT00050778|567601074|FG002|Overall Study|Adverse Event|2|||
157233049|NCT00050778|567601072|FG000|Overall Study|Death|0|||
157233050|NCT00050778|567601073|FG001|Overall Study|Death|1|||
157233051|NCT00050778|567601074|FG002|Overall Study|Death|1|||
157233052|NCT00050778|567601072|FG000|Overall Study|Lack of Efficacy|16|||
157233053|NCT00050778|567601073|FG001|Overall Study|Lack of Efficacy|2|||
157233054|NCT00050778|567601074|FG002|Overall Study|Lack of Efficacy|2|||
157233055|NCT00050778|567601072|FG000|Overall Study|Lost to Follow-up|0|||
157233056|NCT00050778|567601073|FG001|Overall Study|Lost to Follow-up|2|||
157233057|NCT00050778|567601074|FG002|Overall Study|Lost to Follow-up|4|||
157233058|NCT00050778|567601072|FG000|Overall Study|Physician Decision|3|||
157233059|NCT00050778|567601073|FG001|Overall Study|Physician Decision|0|||
157233060|NCT00050778|567601074|FG002|Overall Study|Physician Decision|2|||
157233061|NCT00050778|567601072|FG000|Overall Study|Protocol Violation|2|||
157233062|NCT00050778|567601073|FG001|Overall Study|Protocol Violation|0|||
157233063|NCT00050778|567601074|FG002|Overall Study|Protocol Violation|1|||
157233064|NCT00050778|567601072|FG000|Overall Study|Withdrawal by Subject|6|||
157233065|NCT00050778|567601073|FG001|Overall Study|Withdrawal by Subject|8|||
157233066|NCT00050778|567601074|FG002|Overall Study|Withdrawal by Subject|4|||
157233067|NCT00050778|567601072|FG000|Overall Study|Randomized but not treated|4|||
157233068|NCT00050778|567601073|FG001|Overall Study|Randomized but not treated|5|||
157233069|NCT00050778|567601074|FG002|Overall Study|Randomized but not treated|2|||
157233070|NCT00050778|567601072|FG000|Overall Study|Familial and personal reasons|1|||
157233071|NCT00050778|567601073|FG001|Overall Study|Familial and personal reasons|0|||
157233072|NCT00050778|567601074|FG002|Overall Study|Familial and personal reasons|0|||
157233073|NCT02910037|567601075|FG000|Overall Study|Withdrawal by Subject|4|||
157233074|NCT02910037|567601075|FG000|Overall Study|Lost to Follow-up|6|||
157233075|NCT01035060|567601078|FG000|Overall Study|Lost to Follow-up|0|||
157233076|NCT01035060|567601079|FG001|Overall Study|Lost to Follow-up|7|||
157233077|NCT01035060|567601078|FG000|Overall Study|Did not quality after 2nd screening|14|||
157233078|NCT01035060|567601079|FG001|Overall Study|Did not quality after 2nd screening|1|||
157233079|NCT01035060|567601078|FG000|Overall Study|Withdrawal by Subject|8|||
157233080|NCT01035060|567601079|FG001|Overall Study|Withdrawal by Subject|6|||
157233081|NCT01035060|567601078|FG000|Overall Study|Physician Decision|2|||
157233082|NCT01035060|567601079|FG001|Overall Study|Physician Decision|0|||
157233083|NCT00064753|567601080|FG000|Overall Study|Death|251|||
157233084|NCT00064753|567601081|FG001|Overall Study|Death|242|||
157233085|NCT00064753|567601080|FG000|Overall Study|Withdrawal by Subject|198|||
157233086|NCT00064753|567601081|FG001|Overall Study|Withdrawal by Subject|171|||
157233087|NCT00064753|567601080|FG000|Overall Study|Lost to Follow-up|225|||
157233088|NCT00064753|567601081|FG001|Overall Study|Lost to Follow-up|235|||
157233089|NCT02193880|567601084|FG000|Overall Study|patients did not collect enough HPC|3|||
157233090|NCT02914600|567601088|FG000|Overall Study|Adverse Event|298|||
157233091|NCT02914600|567601089|FG001|Overall Study|Adverse Event|35|||
157233092|NCT02914600|567601090|FG002|Overall Study|Adverse Event|25|||
157233093|NCT02914600|567601088|FG000|Overall Study|Sponsors decision|287|||
157233094|NCT02914600|567601089|FG001|Overall Study|Sponsors decision|41|||
157233095|NCT02914600|567601090|FG002|Overall Study|Sponsors decision|12|||
157233096|NCT02914600|567601088|FG000|Overall Study|Withdrawal by Subject|158|||
157233097|NCT02914600|567601089|FG001|Overall Study|Withdrawal by Subject|20|||
157233098|NCT02914600|567601090|FG002|Overall Study|Withdrawal by Subject|18|||
157233099|NCT02914600|567601088|FG000|Overall Study|Investigators discretion|169|||
157233100|NCT02914600|567601089|FG001|Overall Study|Investigators discretion|14|||
157233101|NCT02914600|567601090|FG002|Overall Study|Investigators discretion|13|||
157233102|NCT02914600|567601088|FG000|Overall Study|Lost to Follow-up|10|||
157233103|NCT02914600|567601089|FG001|Overall Study|Lost to Follow-up|4|||
157233104|NCT02914600|567601090|FG002|Overall Study|Lost to Follow-up|0|||
157233105|NCT02914600|567601088|FG000|Overall Study|Pregnancy|8|||
157233106|NCT02914600|567601089|FG001|Overall Study|Pregnancy|0|||
157083851|NCT03842358|567060129|FG000|Overall Study|Patient withdrew|2|||
157083852|NCT05384938|567060130|FG000|Overall Study|Withdrawal by Subject|8|||
157233107|NCT02914600|567601090|FG002|Overall Study|Pregnancy|0|||
157233108|NCT02914600|567601088|FG000|Overall Study|Protocol Violation|5|||
157233109|NCT02914600|567601089|FG001|Overall Study|Protocol Violation|3|||
157233110|NCT02914600|567601090|FG002|Overall Study|Protocol Violation|0|||
157233111|NCT02914600|567601088|FG000|Overall Study|Non-compliance with study drug|6|||
157233112|NCT02914600|567601089|FG001|Overall Study|Non-compliance with study drug|1|||
157233113|NCT02914600|567601090|FG002|Overall Study|Non-compliance with study drug|0|||
157233114|NCT02914600|567601088|FG000|Overall Study|Death|3|||
157233115|NCT02914600|567601089|FG001|Overall Study|Death|1|||
157233116|NCT02914600|567601090|FG002|Overall Study|Death|1|||
157233117|NCT02914600|567601088|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
157233118|NCT02914600|567601089|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
157233119|NCT02914600|567601090|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
157083853|NCT05384938|567060130|FG000|Overall Study|Lost to Follow-up|6|||
157083854|NCT05384938|567060130|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
157233120|NCT02914600|567601088|FG000|Overall Study|Enrolled but not treated|1|||
157233121|NCT02914600|567601089|FG001|Overall Study|Enrolled but not treated|0|||
157233122|NCT02914600|567601090|FG002|Overall Study|Enrolled but not treated|0|||
157193230|NCT02030067|567449292|FG010|Overall Study|Physician Decision|1|||
157193231|NCT02030067|567449293|FG011|Overall Study|Physician Decision|0|||
157193232|NCT02030067|567449294|FG012|Overall Study|Physician Decision|3|||
157193233|NCT02030067|567449282|FG000|Overall Study|other reasons|0|||
157193234|NCT02030067|567449283|FG001|Overall Study|other reasons|0|||
157193235|NCT02030067|567449284|FG002|Overall Study|other reasons|0|||
157193236|NCT02030067|567449285|FG003|Overall Study|other reasons|0|||
157193237|NCT02030067|567449286|FG004|Overall Study|other reasons|0|||
157193238|NCT02030067|567449287|FG005|Overall Study|other reasons|1|||
157193239|NCT02030067|567449288|FG006|Overall Study|other reasons|0|||
157193240|NCT02030067|567449289|FG007|Overall Study|other reasons|0|||
157193241|NCT02030067|567449290|FG008|Overall Study|other reasons|2|||
157193242|NCT02030067|567449291|FG009|Overall Study|other reasons|0|||
157193243|NCT02030067|567449292|FG010|Overall Study|other reasons|0|||
157193244|NCT02030067|567449293|FG011|Overall Study|other reasons|0|||
157193245|NCT02030067|567449294|FG012|Overall Study|other reasons|4|||
157193246|NCT02030067|567449282|FG000|Overall Study|Adverse Event|0|||
157193247|NCT02030067|567449283|FG001|Overall Study|Adverse Event|0|||
157193248|NCT02030067|567449284|FG002|Overall Study|Adverse Event|0|||
157193249|NCT02030067|567449285|FG003|Overall Study|Adverse Event|0|||
157193250|NCT02030067|567449286|FG004|Overall Study|Adverse Event|0|||
157193251|NCT02030067|567449287|FG005|Overall Study|Adverse Event|0|||
157193252|NCT02030067|567449288|FG006|Overall Study|Adverse Event|0|||
157193253|NCT02030067|567449289|FG007|Overall Study|Adverse Event|0|||
157193254|NCT02030067|567449290|FG008|Overall Study|Adverse Event|0|||
157193255|NCT02030067|567449291|FG009|Overall Study|Adverse Event|0|||
157193256|NCT02030067|567449292|FG010|Overall Study|Adverse Event|0|||
157193257|NCT02030067|567449293|FG011|Overall Study|Adverse Event|1|||
157193258|NCT02030067|567449294|FG012|Overall Study|Adverse Event|8|||
157193259|NCT00265382|567449295|FG000|Overall Study|Adverse Event|21|||
157193260|NCT00265382|567449295|FG000|Overall Study|Laboratory Abnormality|1|||
157193261|NCT00265382|567449295|FG000|Overall Study|Lost to Follow-up|3|||
157193262|NCT00265382|567449295|FG000|Overall Study|Lack of Efficacy|6|||
157193263|NCT00265382|567449295|FG000|Overall Study|Miscellaneous|6|||
157193264|NCT00265382|567449295|FG000|Overall Study|Withdrawal by Subject|13|||
157193265|NCT00265382|567449295|FG000|Overall Study|Study terminated by sponsor|94|||
157193266|NCT00265382|567449295|FG000|Overall Study|Death|1|||
157193267|NCT00565721|567449303|FG000|Overall Study|Screen Failure|2|||
157193268|NCT00565721|567449303|FG000|Overall Study|Lost to Follow-up|6|||
157193269|NCT00565721|567449303|FG000|Overall Study|Technical Problems|1|||
157193270|NCT00565721|567449303|FG000|Overall Study|Physician Decision|2|||
157193271|NCT00565721|567449303|FG000|Overall Study|Other reasons|6|||
157193272|NCT04062240|567449306|FG000|Overall Study|equipment malfunction|1|||
157193273|NCT00352027|567449312|FG000|Overall Study|Progressive disease|3|||
157193274|NCT04118127|567449314|FG000|Overall Study|Trial terminated by sponsor|0|||
157193275|NCT04118127|567449315|FG001|Overall Study|Trial terminated by sponsor|12|||
157193276|NCT04118127|567449314|FG000|Overall Study|Adverse Event|1|||
157193277|NCT04118127|567449315|FG001|Overall Study|Adverse Event|2|||
157193278|NCT04118127|567449314|FG000|Overall Study|Physician Decision|0|||
157193279|NCT04118127|567449315|FG001|Overall Study|Physician Decision|1|||
157193280|NCT04118127|567449314|FG000|Overall Study|Withdrawal by Subject|2|||
157193281|NCT04118127|567449315|FG001|Overall Study|Withdrawal by Subject|1|||
157193282|NCT01874288|567449318|FG000|Overall Study|Withdrawal by Subject|1|||
157193283|NCT01874288|567449319|FG001|Overall Study|Withdrawal by Subject|0|||
157193284|NCT01874288|567449320|FG002|Overall Study|Withdrawal by Subject|2|||
157193285|NCT01874288|567449321|FG003|Overall Study|Withdrawal by Subject|1|||
157193286|NCT01874288|567449322|FG004|Overall Study|Withdrawal by Subject|1|||
157083855|NCT02626455|567060131|FG000|Overall Study|Other|1|||
157083856|NCT02626455|567060132|FG001|Overall Study|Other|1|||
157083857|NCT02626455|567060133|FG002|Overall Study|Other|0|||
157083858|NCT02626455|567060134|FG003|Overall Study|Other|0|||
157083859|NCT02626455|567060135|FG004|Overall Study|Other|0|||
157083860|NCT02626455|567060136|FG005|Overall Study|Other|17|||
157083861|NCT02626455|567060137|FG006|Overall Study|Other|23|||
157083862|NCT02626455|567060131|FG000|Overall Study|Withdrawal by Subject|1|||
157083863|NCT02626455|567060132|FG001|Overall Study|Withdrawal by Subject|0|||
157193287|NCT01874288|567449318|FG000|Overall Study|Physician Decision|0|||
157193288|NCT01874288|567449319|FG001|Overall Study|Physician Decision|0|||
157193289|NCT01874288|567449320|FG002|Overall Study|Physician Decision|0|||
157193290|NCT01874288|567449321|FG003|Overall Study|Physician Decision|1|||
157193291|NCT01874288|567449322|FG004|Overall Study|Physician Decision|0|||
157193292|NCT01874288|567449318|FG000|Overall Study|Progressive disease|2|||
157193293|NCT01874288|567449319|FG001|Overall Study|Progressive disease|0|||
157193294|NCT01874288|567449320|FG002|Overall Study|Progressive disease|3|||
157193295|NCT01874288|567449321|FG003|Overall Study|Progressive disease|5|||
157193296|NCT01874288|567449322|FG004|Overall Study|Progressive disease|1|||
157233123|NCT02457520|567601091|FG000|Active Treatment Phase|Adverse Event|10|||
157083864|NCT02626455|567060133|FG002|Overall Study|Withdrawal by Subject|0|||
157083865|NCT02626455|567060134|FG003|Overall Study|Withdrawal by Subject|0|||
157193297|NCT04212221|567449323|FG000|Overall Study|Remained on Treatment|0|||
157233124|NCT02457520|567601091|FG000|Active Treatment Phase|Lost to Follow-up|8|||
157233125|NCT02457520|567601091|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
157233126|NCT02457520|567601091|FG000|Active Treatment Phase|other|4|||
157233127|NCT02457520|567601091|FG000|Active Treatment Phase|Physician Decision|1|||
157233128|NCT02457520|567601091|FG000|Active Treatment Phase|Protocol Violation|1|||
157233129|NCT02457520|567601091|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
157233130|NCT02457520|567601091|FG000|Post-treatment Period|Other: Retreatment Required|7|||
157233131|NCT02457520|567601091|FG000|Post-treatment Period|Lost to Follow-up|23|||
157233132|NCT02457520|567601091|FG000|Post-treatment Period|Other|3|||
157233133|NCT02457520|567601091|FG000|Post-treatment Period|Physician Decision|1|||
157233134|NCT02457520|567601091|FG000|Post-treatment Period|Withdrawal by Subject|14|||
157233135|NCT02336165|567601096|FG000|Overall Study|Death|3|||
157233136|NCT02336165|567601097|FG001|Overall Study|Death|0|||
157233137|NCT02336165|567601098|FG002|Overall Study|Death|0|||
157233138|NCT02336165|567601099|FG003|Overall Study|Death|0|||
157233139|NCT02336165|567601100|FG004|Overall Study|Death|1|||
157233140|NCT02336165|567601096|FG000|Overall Study|Physician Decision|2|||
157233141|NCT02336165|567601097|FG001|Overall Study|Physician Decision|2|||
157233142|NCT02336165|567601098|FG002|Overall Study|Physician Decision|1|||
157233143|NCT02336165|567601099|FG003|Overall Study|Physician Decision|1|||
157233144|NCT02336165|567601100|FG004|Overall Study|Physician Decision|0|||
157233145|NCT02336165|567601096|FG000|Overall Study|Withdrawal by Subject|0|||
157233146|NCT02336165|567601097|FG001|Overall Study|Withdrawal by Subject|0|||
157233147|NCT02336165|567601098|FG002|Overall Study|Withdrawal by Subject|1|||
157233148|NCT02336165|567601099|FG003|Overall Study|Withdrawal by Subject|0|||
157233149|NCT02336165|567601100|FG004|Overall Study|Withdrawal by Subject|1|||
157233150|NCT02336165|567601096|FG000|Overall Study|Adverse Event|4|||
157233151|NCT02336165|567601097|FG001|Overall Study|Adverse Event|1|||
157233152|NCT02336165|567601098|FG002|Overall Study|Adverse Event|2|||
157233153|NCT02336165|567601099|FG003|Overall Study|Adverse Event|4|||
157233154|NCT02336165|567601100|FG004|Overall Study|Adverse Event|1|||
157233155|NCT02336165|567601096|FG000|Overall Study|Progressive disease|23|||
157233156|NCT02336165|567601097|FG001|Overall Study|Progressive disease|22|||
157233157|NCT02336165|567601098|FG002|Overall Study|Progressive disease|27|||
157233158|NCT02336165|567601099|FG003|Overall Study|Progressive disease|24|||
157233159|NCT02336165|567601100|FG004|Overall Study|Progressive disease|19|||
157233160|NCT02336165|567601096|FG000|Overall Study|Non-compliance|1|||
157233161|NCT02336165|567601097|FG001|Overall Study|Non-compliance|0|||
157233162|NCT02336165|567601098|FG002|Overall Study|Non-compliance|0|||
157233163|NCT02336165|567601099|FG003|Overall Study|Non-compliance|1|||
157233164|NCT02336165|567601100|FG004|Overall Study|Non-compliance|0|||
157233165|NCT02336165|567601096|FG000|Overall Study|Other|1|||
157233166|NCT02336165|567601097|FG001|Overall Study|Other|0|||
157233167|NCT02336165|567601098|FG002|Overall Study|Other|0|||
157233168|NCT02336165|567601099|FG003|Overall Study|Other|1|||
157233169|NCT02336165|567601100|FG004|Overall Study|Other|0|||
157233170|NCT00910663|567601103|FG000|Period 1|Withdrawal by Subject|0|||
157233171|NCT00910663|567601104|FG001|Period 1|Withdrawal by Subject|1|||
157083866|NCT02626455|567060135|FG004|Overall Study|Withdrawal by Subject|0|||
157233172|NCT01772537|567601105|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
157233173|NCT01772537|567601106|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
157233174|NCT01772537|567601107|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
157233175|NCT02511782|567601108|FG000|Overall Study|Withdrawal by Subject|1|||
157233176|NCT02511782|567601109|FG001|Overall Study|Withdrawal by Subject|0|||
157233177|NCT02511782|567601110|FG002|Overall Study|Withdrawal by Subject|0|||
157233178|NCT01536574|567601111|FG000|Overall Study|Adverse Event|4|||
157233179|NCT01536574|567601112|FG001|Overall Study|Adverse Event|5|||
157233180|NCT01536574|567601111|FG000|Overall Study|Withdrawal by Subject|1|||
157233181|NCT01536574|567601112|FG001|Overall Study|Withdrawal by Subject|2|||
157233182|NCT01536574|567601111|FG000|Overall Study|Lack of Efficacy|1|||
157233183|NCT01536574|567601112|FG001|Overall Study|Lack of Efficacy|0|||
157233184|NCT00834756|567601113|FG000|First Intervention|Adverse Event|1|||
157233185|NCT00834756|567601114|FG001|First Intervention|Adverse Event|0|||
157233186|NCT00834756|567601113|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
157233187|NCT00834756|567601114|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
157233188|NCT00579670|567601117|FG000|Overall Study|Death|1|||
157233189|NCT00579670|567601118|FG001|Overall Study|Death|0|||
157233190|NCT00579670|567601119|FG002|Overall Study|Death|0|||
157233191|NCT00579670|567601120|FG003|Overall Study|Death|0|||
157233192|NCT00579670|567601121|FG004|Overall Study|Death|0|||
157233193|NCT00579670|567601117|FG000|Overall Study|Adverse Event|1|||
157233194|NCT00579670|567601118|FG001|Overall Study|Adverse Event|0|||
157233195|NCT00579670|567601119|FG002|Overall Study|Adverse Event|1|||
157233196|NCT00579670|567601120|FG003|Overall Study|Adverse Event|2|||
157233197|NCT00579670|567601121|FG004|Overall Study|Adverse Event|0|||
157233198|NCT00579670|567601117|FG000|Overall Study|Lack of Efficacy|0|||
157233199|NCT00579670|567601118|FG001|Overall Study|Lack of Efficacy|0|||
157233200|NCT00579670|567601119|FG002|Overall Study|Lack of Efficacy|1|||
157233201|NCT00579670|567601120|FG003|Overall Study|Lack of Efficacy|14|||
157233202|NCT00579670|567601121|FG004|Overall Study|Lack of Efficacy|0|||
157083867|NCT02626455|567060136|FG005|Overall Study|Withdrawal by Subject|10|||
157083868|NCT02626455|567060137|FG006|Overall Study|Withdrawal by Subject|6|||
157083869|NCT02626455|567060131|FG000|Overall Study|Physician Decision|0|||
157083870|NCT02626455|567060132|FG001|Overall Study|Physician Decision|2|||
157083871|NCT02626455|567060133|FG002|Overall Study|Physician Decision|2|||
157083872|NCT02626455|567060134|FG003|Overall Study|Physician Decision|2|||
157083873|NCT02626455|567060135|FG004|Overall Study|Physician Decision|1|||
157083874|NCT02626455|567060136|FG005|Overall Study|Physician Decision|10|||
157083875|NCT02626455|567060137|FG006|Overall Study|Physician Decision|3|||
157083876|NCT02626455|567060131|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083877|NCT02626455|567060132|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083878|NCT02626455|567060133|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083879|NCT02626455|567060134|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083880|NCT02626455|567060135|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083881|NCT02626455|567060136|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
157083882|NCT02626455|567060137|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
157083883|NCT02626455|567060131|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083884|NCT02626455|567060132|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083885|NCT02626455|567060133|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083886|NCT02626455|567060134|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083887|NCT02626455|567060135|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083888|NCT02626455|567060136|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
157083889|NCT02626455|567060137|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
157083890|NCT02626455|567060131|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
157083891|NCT02626455|567060132|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
157083892|NCT02626455|567060133|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
157083893|NCT02626455|567060134|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
157083894|NCT02626455|567060135|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
157083895|NCT02626455|567060136|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
157083896|NCT02626455|567060137|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
157083897|NCT02626455|567060131|FG000|Overall Study|Patient decision|0|||
157083898|NCT02626455|567060132|FG001|Overall Study|Patient decision|1|||
157083899|NCT02626455|567060133|FG002|Overall Study|Patient decision|0|||
157083900|NCT02626455|567060134|FG003|Overall Study|Patient decision|0|||
157083901|NCT02626455|567060135|FG004|Overall Study|Patient decision|1|||
157083902|NCT02626455|567060136|FG005|Overall Study|Patient decision|36|||
157083903|NCT02626455|567060137|FG006|Overall Study|Patient decision|22|||
157083904|NCT02626455|567060131|FG000|Overall Study|Protocol Violation|0|||
157083905|NCT02626455|567060132|FG001|Overall Study|Protocol Violation|0|||
157083906|NCT02626455|567060133|FG002|Overall Study|Protocol Violation|0|||
157083907|NCT02626455|567060134|FG003|Overall Study|Protocol Violation|0|||
157083908|NCT02626455|567060135|FG004|Overall Study|Protocol Violation|0|||
157083909|NCT02626455|567060136|FG005|Overall Study|Protocol Violation|0|||
157083910|NCT02626455|567060137|FG006|Overall Study|Protocol Violation|1|||
157083911|NCT02626455|567060131|FG000|Overall Study|Progressive disease - radiological progression|0|||
157083912|NCT02626455|567060132|FG001|Overall Study|Progressive disease - radiological progression|0|||
157083913|NCT02626455|567060133|FG002|Overall Study|Progressive disease - radiological progression|0|||
157083914|NCT02626455|567060134|FG003|Overall Study|Progressive disease - radiological progression|0|||
157083915|NCT02626455|567060135|FG004|Overall Study|Progressive disease - radiological progression|0|||
157083916|NCT02626455|567060136|FG005|Overall Study|Progressive disease - radiological progression|11|||
157083917|NCT02626455|567060137|FG006|Overall Study|Progressive disease - radiological progression|22|||
157083918|NCT02626455|567060131|FG000|Overall Study|Progressive disease - clinical progression|0|||
157083919|NCT02626455|567060132|FG001|Overall Study|Progressive disease - clinical progression|0|||
157083920|NCT02626455|567060133|FG002|Overall Study|Progressive disease - clinical progression|0|||
157083921|NCT02626455|567060134|FG003|Overall Study|Progressive disease - clinical progression|0|||
157083922|NCT02626455|567060135|FG004|Overall Study|Progressive disease - clinical progression|0|||
157083923|NCT02626455|567060136|FG005|Overall Study|Progressive disease - clinical progression|1|||
157083924|NCT02626455|567060137|FG006|Overall Study|Progressive disease - clinical progression|2|||
157083925|NCT02626455|567060131|FG000|Overall Study|Lost to Follow-up|0|||
157083926|NCT02626455|567060132|FG001|Overall Study|Lost to Follow-up|0|||
157083927|NCT02626455|567060133|FG002|Overall Study|Lost to Follow-up|0|||
157083928|NCT02626455|567060134|FG003|Overall Study|Lost to Follow-up|0|||
157083929|NCT02626455|567060135|FG004|Overall Study|Lost to Follow-up|0|||
157083930|NCT02626455|567060136|FG005|Overall Study|Lost to Follow-up|1|||
157083931|NCT02626455|567060137|FG006|Overall Study|Lost to Follow-up|0|||
157083932|NCT02626455|567060131|FG000|Overall Study|AE not associated with clinical disease progression|1|||
157083933|NCT02626455|567060132|FG001|Overall Study|AE not associated with clinical disease progression|1|||
157083934|NCT02626455|567060133|FG002|Overall Study|AE not associated with clinical disease progression|0|||
157083935|NCT02626455|567060134|FG003|Overall Study|AE not associated with clinical disease progression|2|||
157233203|NCT00579670|567601117|FG000|Overall Study|Lost to Follow-up|0|||
157233204|NCT00579670|567601118|FG001|Overall Study|Lost to Follow-up|1|||
157233205|NCT00579670|567601119|FG002|Overall Study|Lost to Follow-up|0|||
157233206|NCT00579670|567601120|FG003|Overall Study|Lost to Follow-up|4|||
157233207|NCT00579670|567601121|FG004|Overall Study|Lost to Follow-up|0|||
157233208|NCT00579670|567601117|FG000|Overall Study|Other|0|||
157233209|NCT00579670|567601118|FG001|Overall Study|Other|0|||
157233210|NCT00579670|567601119|FG002|Overall Study|Other|1|||
157233211|NCT00579670|567601120|FG003|Overall Study|Other|2|||
157233212|NCT00579670|567601121|FG004|Overall Study|Other|0|||
157233213|NCT00579670|567601117|FG000|Overall Study|Withdrawal by Subject|0|||
157233214|NCT00579670|567601118|FG001|Overall Study|Withdrawal by Subject|0|||
157233215|NCT00579670|567601119|FG002|Overall Study|Withdrawal by Subject|1|||
157233216|NCT00579670|567601120|FG003|Overall Study|Withdrawal by Subject|0|||
157233217|NCT00579670|567601121|FG004|Overall Study|Withdrawal by Subject|0|||
157233218|NCT00296647|567601125|FG000|Overall Study|Death|4|||
157233219|NCT00296647|567601126|FG001|Overall Study|Death|1|||
157233220|NCT00296647|567601127|FG002|Overall Study|Death|2|||
157233221|NCT00296647|567601128|FG003|Overall Study|Death|1|||
157233222|NCT00296647|567601129|FG004|Overall Study|Death|1|||
157233223|NCT00296647|567601125|FG000|Overall Study|Withdrawal by Subject|28|||
157233224|NCT00296647|567601126|FG001|Overall Study|Withdrawal by Subject|27|||
157233225|NCT00296647|567601127|FG002|Overall Study|Withdrawal by Subject|32|||
157233226|NCT00296647|567601128|FG003|Overall Study|Withdrawal by Subject|16|||
157233227|NCT00296647|567601129|FG004|Overall Study|Withdrawal by Subject|19|||
157233228|NCT01863745|567601130|FG000|Overall Study|Disease Progression|9|||
157233229|NCT01863745|567601130|FG000|Overall Study|Adverse Event|2|||
157233230|NCT01863745|567601130|FG000|Overall Study|Death|1|||
157233231|NCT01863745|567601130|FG000|Overall Study|Withdrawal by Subject|1|||
157233232|NCT00610363|567601132|FG000|Overall Study|Non-compliance with protocol|0|||
157233233|NCT00610363|567601133|FG001|Overall Study|Non-compliance with protocol|1|||
157233234|NCT00610363|567601132|FG000|Overall Study|Adverse Event|3|||
157233235|NCT00610363|567601133|FG001|Overall Study|Adverse Event|1|||
157233236|NCT00610363|567601132|FG000|Overall Study|Lack of Efficacy|2|||
157233237|NCT00610363|567601133|FG001|Overall Study|Lack of Efficacy|0|||
157233238|NCT00610363|567601132|FG000|Overall Study|Lost to Follow-up|4|||
157233239|NCT00610363|567601133|FG001|Overall Study|Lost to Follow-up|0|||
157233240|NCT00610363|567601132|FG000|Overall Study|Withdrawal by Subject|1|||
157233241|NCT00610363|567601133|FG001|Overall Study|Withdrawal by Subject|0|||
157233242|NCT00610363|567601132|FG000|Overall Study|Other than specified above|1|||
157233243|NCT00610363|567601133|FG001|Overall Study|Other than specified above|1|||
157233244|NCT05093205|567601134|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
157233245|NCT05093205|567601135|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
157233246|NCT05093205|567601136|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
157233247|NCT05093205|567601137|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
157233248|NCT05093205|567601138|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
157233249|NCT05093205|567601139|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
157233250|NCT05093205|567601140|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
157233251|NCT05093205|567601141|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
157233252|NCT05093205|567601142|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
157233253|NCT05093205|567601143|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
157233254|NCT05093205|567601144|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
157233255|NCT05093205|567601145|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
157233256|NCT05093205|567601146|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
157233257|NCT05093205|567601134|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233258|NCT05093205|567601135|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233259|NCT05093205|567601136|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
157233260|NCT05093205|567601137|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233261|NCT05093205|567601138|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233262|NCT05093205|567601139|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233263|NCT05093205|567601140|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233264|NCT05093205|567601141|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233265|NCT05093205|567601142|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233266|NCT05093205|567601143|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233267|NCT05093205|567601144|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233268|NCT05093205|567601145|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233269|NCT05093205|567601146|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
157233270|NCT05093205|567601134|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
157233271|NCT05093205|567601135|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
157233272|NCT05093205|567601136|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
157233273|NCT05093205|567601137|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
157233274|NCT05093205|567601138|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
157233275|NCT05093205|567601139|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
157233276|NCT05093205|567601140|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
157233277|NCT05093205|567601141|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
157233278|NCT05093205|567601142|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
157233279|NCT05093205|567601143|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
157083936|NCT02626455|567060135|FG004|Overall Study|AE not associated with clinical disease progression|1|||
157083937|NCT02626455|567060136|FG005|Overall Study|AE not associated with clinical disease progression|65|||
157233280|NCT05093205|567601144|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
157233281|NCT05093205|567601145|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
157233282|NCT05093205|567601146|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
157233283|NCT05093205|567601134|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
157233284|NCT05093205|567601135|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
157233285|NCT05093205|567601136|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
157233286|NCT05093205|567601137|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
157233287|NCT05093205|567601138|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
157233288|NCT05093205|567601139|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
157233289|NCT05093205|567601140|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
157233290|NCT05093205|567601141|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
157233291|NCT05093205|567601142|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
157233292|NCT05093205|567601143|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
157233293|NCT05093205|567601144|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
157233294|NCT05093205|567601145|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
157083938|NCT02626455|567060137|FG006|Overall Study|AE not associated with clinical disease progression|21|||
157083939|NCT02626455|567060131|FG000|Overall Study|AE associated with clinical disease progression|0|||
157083940|NCT02626455|567060132|FG001|Overall Study|AE associated with clinical disease progression|0|||
157083941|NCT02626455|567060133|FG002|Overall Study|AE associated with clinical disease progression|0|||
157083942|NCT02626455|567060134|FG003|Overall Study|AE associated with clinical disease progression|0|||
157083943|NCT02626455|567060135|FG004|Overall Study|AE associated with clinical disease progression|0|||
157083944|NCT02626455|567060136|FG005|Overall Study|AE associated with clinical disease progression|1|||
157083945|NCT02626455|567060137|FG006|Overall Study|AE associated with clinical disease progression|2|||
157083946|NCT02626455|567060131|FG000|Overall Study|Study intervention never administered|0|||
157083947|NCT02626455|567060132|FG001|Overall Study|Study intervention never administered|0|||
157083948|NCT02626455|567060133|FG002|Overall Study|Study intervention never administered|0|||
157083949|NCT02626455|567060134|FG003|Overall Study|Study intervention never administered|0|||
157083950|NCT02626455|567060135|FG004|Overall Study|Study intervention never administered|0|||
157083951|NCT02626455|567060136|FG005|Overall Study|Study intervention never administered|1|||
157083952|NCT02626455|567060137|FG006|Overall Study|Study intervention never administered|3|||
157083953|NCT05148962|567060138|FG000|Overall Study|Withdrawal by Subject|1|||
157083954|NCT05148962|567060139|FG001|Overall Study|Withdrawal by Subject|1|||
157083955|NCT05148962|567060140|FG002|Overall Study|Withdrawal by Subject|0|||
157083956|NCT05148962|567060141|FG003|Overall Study|Withdrawal by Subject|1|||
157083957|NCT05148962|567060142|FG004|Overall Study|Withdrawal by Subject|0|||
157083958|NCT05148962|567060138|FG000|Overall Study|Participant was early terminated per protocol|0|||
157083959|NCT05148962|567060139|FG001|Overall Study|Participant was early terminated per protocol|0|||
157083960|NCT05148962|567060140|FG002|Overall Study|Participant was early terminated per protocol|3|||
157083961|NCT05148962|567060141|FG003|Overall Study|Participant was early terminated per protocol|5|||
157083962|NCT05148962|567060142|FG004|Overall Study|Participant was early terminated per protocol|2|||
157083963|NCT05148962|567060138|FG000|Overall Study|Miscellaneous|0|||
157083964|NCT05148962|567060139|FG001|Overall Study|Miscellaneous|0|||
157083965|NCT05148962|567060140|FG002|Overall Study|Miscellaneous|0|||
157083966|NCT05148962|567060141|FG003|Overall Study|Miscellaneous|1|||
157083967|NCT05148962|567060142|FG004|Overall Study|Miscellaneous|0|||
157083968|NCT06665919|567060143|FG000|Overall Study|Withdrawal by Subject|4|||
157083969|NCT06665919|567060144|FG001|Overall Study|Withdrawal by Subject|4|||
157083970|NCT06665919|567060145|FG002|Overall Study|Withdrawal by Subject|4|||
157083971|NCT06665919|567060143|FG000|Overall Study|Non-compliance to Treatment|4|||
157083972|NCT06665919|567060144|FG001|Overall Study|Non-compliance to Treatment|1|||
157083973|NCT06665919|567060145|FG002|Overall Study|Non-compliance to Treatment|6|||
157083974|NCT06665919|567060143|FG000|Overall Study|Lost to Follow-up|3|||
157083975|NCT06665919|567060144|FG001|Overall Study|Lost to Follow-up|0|||
157083976|NCT06665919|567060145|FG002|Overall Study|Lost to Follow-up|2|||
157083977|NCT06665919|567060143|FG000|Overall Study|Physician Decision|4|||
157083978|NCT06665919|567060144|FG001|Overall Study|Physician Decision|0|||
157083979|NCT06665919|567060145|FG002|Overall Study|Physician Decision|1|||
157083980|NCT01144377|567060146|FG000|52 Week Treatment Period|Adverse Event|0|||
157083981|NCT01144377|567060147|FG001|52 Week Treatment Period|Adverse Event|0|||
157083982|NCT01144377|567060148|FG002|52 Week Treatment Period|Adverse Event|3|||
157083983|NCT01144377|567060149|FG003|52 Week Treatment Period|Adverse Event|2|||
157083984|NCT01144377|567060150|FG004|52 Week Treatment Period|Adverse Event|1|||
157083985|NCT01144377|567060146|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
157083986|NCT01144377|567060147|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
157233295|NCT05093205|567601146|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
157233296|NCT05093205|567601134|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
157233297|NCT05093205|567601135|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
157233298|NCT05093205|567601136|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
157233299|NCT05093205|567601137|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
157233300|NCT05093205|567601138|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
157233301|NCT05093205|567601139|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
157233302|NCT05093205|567601140|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
157233303|NCT05093205|567601141|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
157233304|NCT05093205|567601142|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
157233305|NCT05093205|567601143|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
157233306|NCT05093205|567601144|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
157233307|NCT05093205|567601145|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
157233308|NCT05093205|567601146|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
157233309|NCT05093205|567601134|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
157233310|NCT05093205|567601135|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
157233311|NCT05093205|567601136|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
157233312|NCT05093205|567601137|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
157233313|NCT05093205|567601138|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
157233314|NCT05093205|567601139|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
157233315|NCT05093205|567601140|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
157233316|NCT05093205|567601141|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
157233317|NCT05093205|567601142|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
157233318|NCT05093205|567601143|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
157233319|NCT05093205|567601144|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
157233320|NCT05093205|567601145|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
157233321|NCT05093205|567601146|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
157233322|NCT05093205|567601134|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
157233323|NCT05093205|567601135|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
157233324|NCT05093205|567601136|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
157233325|NCT05093205|567601137|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
157233326|NCT05093205|567601138|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
157233327|NCT05093205|567601139|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
157233328|NCT05093205|567601140|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
157233329|NCT05093205|567601141|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
157233330|NCT05093205|567601142|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
157233331|NCT05093205|567601143|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
157233332|NCT05093205|567601144|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
157233333|NCT05093205|567601145|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
157233334|NCT05093205|567601146|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
157233335|NCT05093205|567601134|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
157233336|NCT05093205|567601135|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
157233337|NCT05093205|567601136|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
157233338|NCT05093205|567601137|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
157233339|NCT05093205|567601138|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
157233340|NCT05093205|567601139|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
157233341|NCT05093205|567601140|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
157233342|NCT05093205|567601141|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
157233343|NCT05093205|567601142|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
157233344|NCT05093205|567601143|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
157233345|NCT05093205|567601144|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
157233346|NCT05093205|567601145|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
157233347|NCT05093205|567601146|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
157233348|NCT05093205|567601134|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233349|NCT05093205|567601135|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157083987|NCT01144377|567060148|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
157083988|NCT01144377|567060149|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
157233350|NCT05093205|567601136|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233351|NCT05093205|567601137|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233352|NCT05093205|567601138|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233353|NCT05093205|567601139|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233354|NCT05093205|567601140|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233355|NCT05093205|567601141|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233356|NCT05093205|567601142|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233357|NCT05093205|567601143|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
157233358|NCT05093205|567601144|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233359|NCT05093205|567601145|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233360|NCT05093205|567601146|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
157233361|NCT05093205|567601134|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
157233362|NCT05093205|567601135|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
157233363|NCT05093205|567601136|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
157233364|NCT05093205|567601137|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
157233365|NCT05093205|567601138|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
157233366|NCT05093205|567601139|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
157233367|NCT05093205|567601140|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
157233368|NCT05093205|567601141|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
157233369|NCT05093205|567601142|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
157233370|NCT05093205|567601143|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
157233371|NCT05093205|567601144|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
157233372|NCT05093205|567601145|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
157233373|NCT05093205|567601146|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
157233374|NCT05093205|567601134|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233375|NCT05093205|567601135|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233376|NCT05093205|567601136|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233377|NCT05093205|567601137|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233378|NCT05093205|567601138|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233379|NCT05093205|567601139|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233380|NCT05093205|567601140|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233381|NCT05093205|567601141|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233382|NCT05093205|567601142|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233383|NCT05093205|567601143|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233384|NCT05093205|567601144|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
157233385|NCT05093205|567601145|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233386|NCT05093205|567601146|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
157233387|NCT05093205|567601134|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233388|NCT05093205|567601135|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233389|NCT05093205|567601136|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233390|NCT05093205|567601137|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233391|NCT05093205|567601138|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233392|NCT05093205|567601139|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233393|NCT05093205|567601140|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233394|NCT05093205|567601141|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233395|NCT05093205|567601142|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233396|NCT05093205|567601143|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233397|NCT05093205|567601144|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233398|NCT05093205|567601145|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
157233399|NCT05093205|567601146|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
157233400|NCT05093205|567601134|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
157083989|NCT01144377|567060150|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
157083990|NCT01144377|567060146|FG000|52 Week Treatment Period|Protocol Violation|0|||
157083991|NCT01144377|567060147|FG001|52 Week Treatment Period|Protocol Violation|0|||
157083992|NCT01144377|567060148|FG002|52 Week Treatment Period|Protocol Violation|0|||
157083993|NCT01144377|567060149|FG003|52 Week Treatment Period|Protocol Violation|0|||
157083994|NCT01144377|567060150|FG004|52 Week Treatment Period|Protocol Violation|1|||
157083995|NCT01144377|567060146|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
157083996|NCT01144377|567060147|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
157083997|NCT01144377|567060148|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
157083998|NCT01144377|567060149|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
157083999|NCT01144377|567060150|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
157084000|NCT01144377|567060146|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
157084001|NCT01144377|567060147|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
157084002|NCT01144377|567060148|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
157084003|NCT01144377|567060149|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
157084004|NCT01144377|567060150|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
157084005|NCT01144377|567060146|FG000|52 Week Treatment Period|Sponsor Decision|0|||
157084006|NCT01144377|567060147|FG001|52 Week Treatment Period|Sponsor Decision|0|||
157084007|NCT01144377|567060148|FG002|52 Week Treatment Period|Sponsor Decision|0|||
157084008|NCT01144377|567060149|FG003|52 Week Treatment Period|Sponsor Decision|0|||
157084009|NCT01144377|567060150|FG004|52 Week Treatment Period|Sponsor Decision|1|||
157084010|NCT01144377|567060146|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
157084011|NCT01144377|567060147|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
157084012|NCT01144377|567060148|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
157084013|NCT01144377|567060149|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
157084014|NCT01144377|567060150|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
157084015|NCT01144377|567060146|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
157084016|NCT01144377|567060147|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
157084017|NCT01144377|567060148|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
157084018|NCT01144377|567060149|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
157233401|NCT05093205|567601135|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
157233402|NCT05093205|567601136|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
157233403|NCT05093205|567601137|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
157233404|NCT05093205|567601138|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
157233405|NCT05093205|567601139|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
157233406|NCT05093205|567601140|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
157233407|NCT05093205|567601141|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
157233408|NCT05093205|567601142|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
157233409|NCT05093205|567601143|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
157084019|NCT01144377|567060150|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
157084020|NCT01144377|567060146|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
157084021|NCT01144377|567060147|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
157084022|NCT01144377|567060148|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
157084023|NCT01144377|567060149|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
157084024|NCT01144377|567060150|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
157084025|NCT01525238|567060151|FG000|Overall Study|Withdrawal by Subject|1|||
157084026|NCT01525238|567060152|FG001|Overall Study|Withdrawal by Subject|0|||
157084027|NCT01525238|567060153|FG002|Overall Study|Withdrawal by Subject|0|||
157084028|NCT00607724|567060154|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
157084029|NCT00607724|567060155|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
157084030|NCT00607724|567060156|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
157084031|NCT00607724|567060157|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
157084032|NCT00607724|567060158|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
157084033|NCT00607724|567060159|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
157084034|NCT00607724|567060160|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
157084035|NCT00607724|567060154|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
157084036|NCT00607724|567060155|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
157084037|NCT00607724|567060156|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
157084038|NCT00607724|567060157|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
157084039|NCT00607724|567060158|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
157084040|NCT00607724|567060159|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
157084041|NCT00607724|567060160|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
157084042|NCT00607724|567060154|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
157084043|NCT00607724|567060155|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
157084044|NCT00607724|567060156|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
157084045|NCT00607724|567060157|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
157084046|NCT00607724|567060158|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
157084047|NCT00607724|567060159|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
157084048|NCT00607724|567060160|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
157084049|NCT00607724|567060154|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
157084050|NCT00607724|567060155|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
157084051|NCT00607724|567060156|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
157084052|NCT00607724|567060157|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
157084053|NCT00607724|567060158|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
157084054|NCT00607724|567060159|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
157084055|NCT00607724|567060160|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
157084056|NCT00607724|567060154|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157084057|NCT00607724|567060155|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157084058|NCT00607724|567060156|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157193298|NCT04212221|567449324|FG001|Overall Study|Remained on Treatment|0|||
157193299|NCT04212221|567449325|FG002|Overall Study|Remained on Treatment|0|||
157193300|NCT04212221|567449326|FG003|Overall Study|Remained on Treatment|1|||
157193301|NCT04212221|567449327|FG004|Overall Study|Remained on Treatment|0|||
157193302|NCT04212221|567449328|FG005|Overall Study|Remained on Treatment|0|||
157193303|NCT04212221|567449329|FG006|Overall Study|Remained on Treatment|3|||
157193304|NCT04212221|567449330|FG007|Overall Study|Remained on Treatment|9|||
157193305|NCT04212221|567449323|FG000|Overall Study|Adverse Event|0|||
157193306|NCT04212221|567449324|FG001|Overall Study|Adverse Event|0|||
157193307|NCT04212221|567449325|FG002|Overall Study|Adverse Event|0|||
157193308|NCT04212221|567449326|FG003|Overall Study|Adverse Event|0|||
157193309|NCT04212221|567449327|FG004|Overall Study|Adverse Event|0|||
157193310|NCT04212221|567449328|FG005|Overall Study|Adverse Event|0|||
157193311|NCT04212221|567449329|FG006|Overall Study|Adverse Event|2|||
157193312|NCT04212221|567449330|FG007|Overall Study|Adverse Event|3|||
157193313|NCT04212221|567449323|FG000|Overall Study|Death|0|||
157193314|NCT04212221|567449324|FG001|Overall Study|Death|0|||
157193315|NCT04212221|567449325|FG002|Overall Study|Death|0|||
157193316|NCT04212221|567449326|FG003|Overall Study|Death|0|||
157084059|NCT00607724|567060157|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
157084060|NCT00607724|567060158|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157084061|NCT00607724|567060159|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157084062|NCT00607724|567060160|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
157084063|NCT00151281|567060161|FG000|Overall Study|Not evaluable|3|||
157084064|NCT04696653|567060162|FG000|Overall Study|left organization|18|||
157084065|NCT04696653|567060162|FG000|Overall Study|Lost to Follow-up|3|||
157084066|NCT04349631|567060166|FG000|Overall Study|Lost to Follow-up|3|||
157193317|NCT04212221|567449327|FG004|Overall Study|Death|0|||
157193318|NCT04212221|567449328|FG005|Overall Study|Death|0|||
157193319|NCT04212221|567449329|FG006|Overall Study|Death|0|||
157193320|NCT04212221|567449330|FG007|Overall Study|Death|2|||
157193321|NCT04212221|567449323|FG000|Overall Study|Disease progression according to irRECIST|1|||
157084067|NCT04349631|567060166|FG000|Overall Study|Withdrawal by Subject|7|||
157084068|NCT03037931|567061624|FG000|Overall Study|Death|354|||
157084069|NCT03037931|567061625|FG001|Overall Study|Death|367|||
157084070|NCT03037931|567061624|FG000|Overall Study|Lost to Follow-up|7|||
157084071|NCT03037931|567061625|FG001|Overall Study|Lost to Follow-up|4|||
157084072|NCT03037931|567061624|FG000|Overall Study|Withdrawal by Subject|48|||
157084073|NCT03037931|567061625|FG001|Overall Study|Withdrawal by Subject|41|||
157084074|NCT02075476|567061626|FG000|Overall Study|Death|2|||
157084075|NCT02075476|567061627|FG001|Overall Study|Death|2|||
157193322|NCT04212221|567449324|FG001|Overall Study|Disease progression according to irRECIST|2|||
157193323|NCT04212221|567449325|FG002|Overall Study|Disease progression according to irRECIST|3|||
157193324|NCT04212221|567449326|FG003|Overall Study|Disease progression according to irRECIST|3|||
157193325|NCT04212221|567449327|FG004|Overall Study|Disease progression according to irRECIST|2|||
157193326|NCT04212221|567449328|FG005|Overall Study|Disease progression according to irRECIST|2|||
157193327|NCT04212221|567449329|FG006|Overall Study|Disease progression according to irRECIST|21|||
157193328|NCT04212221|567449330|FG007|Overall Study|Disease progression according to irRECIST|17|||
157193329|NCT04212221|567449323|FG000|Overall Study|Global Deterioration of Health Status|0|||
157193330|NCT04212221|567449324|FG001|Overall Study|Global Deterioration of Health Status|0|||
157193331|NCT04212221|567449325|FG002|Overall Study|Global Deterioration of Health Status|0|||
157193332|NCT04212221|567449326|FG003|Overall Study|Global Deterioration of Health Status|0|||
157193333|NCT04212221|567449327|FG004|Overall Study|Global Deterioration of Health Status|0|||
157193334|NCT04212221|567449328|FG005|Overall Study|Global Deterioration of Health Status|0|||
157193335|NCT04212221|567449329|FG006|Overall Study|Global Deterioration of Health Status|0|||
157193336|NCT04212221|567449330|FG007|Overall Study|Global Deterioration of Health Status|2|||
157193337|NCT04212221|567449323|FG000|Overall Study|Investigator's Decision|0|||
157193338|NCT04212221|567449324|FG001|Overall Study|Investigator's Decision|0|||
157193339|NCT04212221|567449325|FG002|Overall Study|Investigator's Decision|0|||
157193340|NCT04212221|567449326|FG003|Overall Study|Investigator's Decision|1|||
157193341|NCT04212221|567449327|FG004|Overall Study|Investigator's Decision|0|||
157193342|NCT04212221|567449328|FG005|Overall Study|Investigator's Decision|0|||
157193343|NCT04212221|567449329|FG006|Overall Study|Investigator's Decision|3|||
157193344|NCT04212221|567449330|FG007|Overall Study|Investigator's Decision|0|||
157193345|NCT04212221|567449323|FG000|Overall Study|Participant refused to continue treatment|0|||
157193346|NCT04212221|567449324|FG001|Overall Study|Participant refused to continue treatment|1|||
157193347|NCT04212221|567449325|FG002|Overall Study|Participant refused to continue treatment|0|||
157193348|NCT04212221|567449326|FG003|Overall Study|Participant refused to continue treatment|1|||
157193349|NCT04212221|567449327|FG004|Overall Study|Participant refused to continue treatment|1|||
157193350|NCT04212221|567449328|FG005|Overall Study|Participant refused to continue treatment|2|||
157193351|NCT04212221|567449329|FG006|Overall Study|Participant refused to continue treatment|4|||
157193352|NCT04212221|567449330|FG007|Overall Study|Participant refused to continue treatment|2|||
157193353|NCT04212221|567449323|FG000|Overall Study|Protocol Violation|0|||
157193354|NCT04212221|567449324|FG001|Overall Study|Protocol Violation|0|||
157193355|NCT04212221|567449325|FG002|Overall Study|Protocol Violation|0|||
157193356|NCT04212221|567449326|FG003|Overall Study|Protocol Violation|0|||
157193357|NCT04212221|567449327|FG004|Overall Study|Protocol Violation|0|||
157193358|NCT04212221|567449328|FG005|Overall Study|Protocol Violation|0|||
157193359|NCT04212221|567449329|FG006|Overall Study|Protocol Violation|0|||
157193360|NCT04212221|567449330|FG007|Overall Study|Protocol Violation|1|||
157193361|NCT03099304|567449334|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
157193362|NCT03099304|567449335|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
157193363|NCT03099304|567449336|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
157193364|NCT03099304|567449337|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
157193365|NCT03099304|567449338|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
157193366|NCT03099304|567449339|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
157193367|NCT03099304|567449334|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
157193368|NCT03099304|567449335|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
157193369|NCT03099304|567449336|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
157193370|NCT03099304|567449337|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
157193371|NCT03099304|567449338|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
157193372|NCT03099304|567449339|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
157193373|NCT03099304|567449334|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
157193374|NCT03099304|567449335|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
157193375|NCT03099304|567449336|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
157193376|NCT03099304|567449337|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
157193377|NCT03099304|567449338|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
157193378|NCT03099304|567449339|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
157193379|NCT03099304|567449334|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
157233410|NCT05093205|567601144|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
157084076|NCT02075476|567061626|FG000|Overall Study|Lost to Follow-up|1|||
157084077|NCT02075476|567061627|FG001|Overall Study|Lost to Follow-up|3|||
157084078|NCT02914275|567061633|FG000|Overall Study|Lost to Follow-up|84|||
157084079|NCT02914275|567061634|FG001|Overall Study|Lost to Follow-up|29|||
157084080|NCT02914275|567061633|FG000|Overall Study|Withdrawal by Subject|26|||
157084081|NCT02914275|567061634|FG001|Overall Study|Withdrawal by Subject|10|||
157084082|NCT02914275|567061633|FG000|Overall Study|Protocol Violation|1|||
157084083|NCT02914275|567061634|FG001|Overall Study|Protocol Violation|1|||
157084084|NCT02914275|567061633|FG000|Overall Study|Physician Decision|3|||
157084085|NCT02914275|567061634|FG001|Overall Study|Physician Decision|1|||
157084086|NCT02914275|567061633|FG000|Overall Study|Other|4|||
157084087|NCT02914275|567061634|FG001|Overall Study|Other|1|||
157084088|NCT02914275|567061633|FG000|Overall Study|Excluded due to invalid informed consent|3|||
157084089|NCT02914275|567061634|FG001|Overall Study|Excluded due to invalid informed consent|0|||
157084090|NCT02731690|567061635|FG000|Overall Study|Adverse Event|1|||
157084091|NCT02731690|567061635|FG000|Overall Study|Withdrawal by Subject|3|||
157084092|NCT02731690|567061635|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
157084093|NCT02407990|567061636|FG000|Overall Study|Death|2|||
157084094|NCT02407990|567061637|FG001|Overall Study|Death|22|||
157084095|NCT02407990|567061638|FG002|Overall Study|Death|23|||
157084096|NCT02407990|567061639|FG003|Overall Study|Death|7|||
157084097|NCT02407990|567061640|FG004|Overall Study|Death|17|||
157084098|NCT02407990|567061641|FG005|Overall Study|Death|16|||
157084099|NCT02407990|567061642|FG006|Overall Study|Death|10|||
157084100|NCT02407990|567061643|FG007|Overall Study|Death|248|||
157084101|NCT02407990|567061636|FG000|Overall Study|Lost to Follow-up|0|||
157084102|NCT02407990|567061637|FG001|Overall Study|Lost to Follow-up|1|||
157084103|NCT02407990|567061638|FG002|Overall Study|Lost to Follow-up|0|||
157084104|NCT02407990|567061639|FG003|Overall Study|Lost to Follow-up|0|||
157084105|NCT02407990|567061640|FG004|Overall Study|Lost to Follow-up|0|||
157084106|NCT02407990|567061641|FG005|Overall Study|Lost to Follow-up|0|||
157084107|NCT02407990|567061642|FG006|Overall Study|Lost to Follow-up|0|||
157084108|NCT02407990|567061643|FG007|Overall Study|Lost to Follow-up|17|||
157084109|NCT02407990|567061636|FG000|Overall Study|Progressive Disease|0|||
157084110|NCT02407990|567061637|FG001|Overall Study|Progressive Disease|0|||
157084111|NCT02407990|567061638|FG002|Overall Study|Progressive Disease|0|||
157084112|NCT02407990|567061639|FG003|Overall Study|Progressive Disease|0|||
157084113|NCT02407990|567061640|FG004|Overall Study|Progressive Disease|0|||
157084114|NCT02407990|567061641|FG005|Overall Study|Progressive Disease|0|||
157084115|NCT02407990|567061642|FG006|Overall Study|Progressive Disease|0|||
157084116|NCT02407990|567061643|FG007|Overall Study|Progressive Disease|1|||
157084117|NCT02407990|567061636|FG000|Overall Study|Withdrawal by Subject|0|||
157084118|NCT02407990|567061637|FG001|Overall Study|Withdrawal by Subject|0|||
157084119|NCT02407990|567061638|FG002|Overall Study|Withdrawal by Subject|0|||
157084120|NCT02407990|567061639|FG003|Overall Study|Withdrawal by Subject|0|||
157084121|NCT02407990|567061640|FG004|Overall Study|Withdrawal by Subject|1|||
157084122|NCT02407990|567061641|FG005|Overall Study|Withdrawal by Subject|0|||
157084123|NCT02407990|567061642|FG006|Overall Study|Withdrawal by Subject|0|||
157084124|NCT02407990|567061643|FG007|Overall Study|Withdrawal by Subject|30|||
157084125|NCT02407990|567061636|FG000|Overall Study|Study Terminated by Sponsor|1|||
157084126|NCT02407990|567061637|FG001|Overall Study|Study Terminated by Sponsor|3|||
157084127|NCT02407990|567061638|FG002|Overall Study|Study Terminated by Sponsor|3|||
157084128|NCT02407990|567061639|FG003|Overall Study|Study Terminated by Sponsor|0|||
157084129|NCT02407990|567061640|FG004|Overall Study|Study Terminated by Sponsor|3|||
157084130|NCT02407990|567061641|FG005|Overall Study|Study Terminated by Sponsor|4|||
157084131|NCT02407990|567061642|FG006|Overall Study|Study Terminated by Sponsor|3|||
157084132|NCT02407990|567061643|FG007|Overall Study|Study Terminated by Sponsor|37|||
157084133|NCT02407990|567061636|FG000|Overall Study|Logistics|0|||
157084134|NCT02407990|567061637|FG001|Overall Study|Logistics|0|||
157084135|NCT02407990|567061638|FG002|Overall Study|Logistics|0|||
157084136|NCT02407990|567061639|FG003|Overall Study|Logistics|0|||
157084137|NCT02407990|567061640|FG004|Overall Study|Logistics|0|||
157084138|NCT02407990|567061641|FG005|Overall Study|Logistics|0|||
157084139|NCT02407990|567061642|FG006|Overall Study|Logistics|0|||
157084140|NCT02407990|567061643|FG007|Overall Study|Logistics|1|||
157084141|NCT02407990|567061636|FG000|Overall Study|Rolled into long-term extension study|0|||
157084142|NCT02407990|567061637|FG001|Overall Study|Rolled into long-term extension study|0|||
157084143|NCT02407990|567061638|FG002|Overall Study|Rolled into long-term extension study|0|||
157084144|NCT02407990|567061639|FG003|Overall Study|Rolled into long-term extension study|0|||
157084145|NCT02407990|567061640|FG004|Overall Study|Rolled into long-term extension study|0|||
157084146|NCT02407990|567061641|FG005|Overall Study|Rolled into long-term extension study|0|||
157084147|NCT02407990|567061642|FG006|Overall Study|Rolled into long-term extension study|0|||
157084148|NCT02407990|567061643|FG007|Overall Study|Rolled into long-term extension study|1|||
157084149|NCT00923260|567061644|FG000|Overall Study|Lost to Follow-up|1|||
157084150|NCT00923260|567061645|FG001|Overall Study|Lost to Follow-up|1|||
157084151|NCT01238900|567061646|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
157084152|NCT01238900|567061646|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
157084153|NCT03241927|567061647|FG000|Overall Study|study terminated|1|||
157084154|NCT03241927|567061648|FG001|Overall Study|study terminated|0|||
157084155|NCT01198756|567061649|FG000|Overall Study|Adverse Event|0|||
157084156|NCT01198756|567061650|FG001|Overall Study|Adverse Event|0|||
157084157|NCT01198756|567061651|FG002|Overall Study|Adverse Event|0|||
157233411|NCT05093205|567601145|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
157233412|NCT05093205|567601146|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
157233413|NCT05093205|567601134|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233414|NCT05093205|567601135|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233415|NCT05093205|567601136|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233416|NCT05093205|567601137|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233417|NCT05093205|567601138|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233418|NCT05093205|567601139|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233419|NCT05093205|567601140|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233420|NCT05093205|567601141|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233421|NCT05093205|567601142|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233422|NCT05093205|567601143|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233423|NCT05093205|567601144|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233424|NCT05093205|567601145|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
157233425|NCT05093205|567601146|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
157233426|NCT03361228|567601156|FG000|Overall Study|Other|1|||
157233427|NCT03361228|567601157|FG001|Overall Study|Other|1|||
157233428|NCT03361228|567601156|FG000|Overall Study|Death|3|||
157233429|NCT03361228|567601157|FG001|Overall Study|Death|0|||
157233430|NCT02979353|567601162|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
157233431|NCT02979353|567601163|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
157233432|NCT02979353|567601162|FG000|Overall Study|Withdrawal by Subject|16|||
157233433|NCT02979353|567601163|FG001|Overall Study|Withdrawal by Subject|12|||
157233434|NCT02979353|567601162|FG000|Overall Study|Death|10|||
157233435|NCT02979353|567601163|FG001|Overall Study|Death|11|||
157233436|NCT02979353|567601162|FG000|Overall Study|Transfer to Hospice Care|19|||
157233437|NCT02979353|567601163|FG001|Overall Study|Transfer to Hospice Care|14|||
157233438|NCT02979353|567601162|FG000|Overall Study|Lost to Follow-up|1|||
157233439|NCT02979353|567601163|FG001|Overall Study|Lost to Follow-up|5|||
157233440|NCT01722877|567601164|FG000|Overall Study|Death|1|||
157233441|NCT01722877|567601164|FG000|Overall Study|Lost to Follow-up|1|||
157233442|NCT00585689|567601165|FG000|Overall Study|Received different ABI-007 schedule|3|||
157233443|NCT00585689|567601165|FG000|Overall Study|Adverse Event|1|||
157233444|NCT00585689|567601165|FG000|Overall Study|Patient Declined Surgery|1|||
157233445|NCT00585689|567601165|FG000|Overall Study|Patient had unresectable disease|1|||
157233446|NCT00585689|567601165|FG000|Overall Study|Death|1|||
157233447|NCT02930005|567601166|FG000|Overall Study|Lost to Follow-up|1|||
157233448|NCT02930005|567601167|FG001|Overall Study|Lost to Follow-up|5|||
157233449|NCT02373098|567601169|FG000|Overall Study|Lost to Follow-up|1|||
157233450|NCT02373098|567601170|FG001|Overall Study|Lost to Follow-up|0|||
157233451|NCT02373098|567601169|FG000|Overall Study|Protocol Violation|3|||
157233452|NCT02373098|567601170|FG001|Overall Study|Protocol Violation|0|||
157233453|NCT02373098|567601169|FG000|Overall Study|Withdrawal by Subject|5|||
157233454|NCT02373098|567601170|FG001|Overall Study|Withdrawal by Subject|0|||
157233455|NCT02373098|567601169|FG000|Overall Study|Adverse Event|3|||
157233456|NCT02373098|567601170|FG001|Overall Study|Adverse Event|0|||
157233457|NCT00694551|567601174|FG000|Overall Study|Disease Progression|1|||
157233458|NCT00694551|567601175|FG001|Overall Study|Disease Progression|0|||
157233459|NCT00694551|567601176|FG002|Overall Study|Disease Progression|1|||
157233460|NCT01937390|567601179|FG000|Overall Study|Death|2|||
157233461|NCT01937390|567601179|FG000|Overall Study|Lost to Follow-up|7|||
157233462|NCT01937390|567601179|FG000|Overall Study|Withdrawal by Subject|5|||
157233463|NCT01937390|567601179|FG000|Overall Study|Fail to return|21|||
157233464|NCT04753437|567601191|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
157233465|NCT04753437|567601192|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
157233466|NCT04753437|567601191|FG000|Overall Study|Liver Function Test Abnormalities|2|||
157233467|NCT04753437|567601192|FG001|Overall Study|Liver Function Test Abnormalities|4|||
157233468|NCT00385684|567601195|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
157233469|NCT00385684|567601196|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
157233470|NCT00385684|567601195|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
157233471|NCT00385684|567601196|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
157233472|NCT00385684|567601195|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
157233473|NCT00385684|567601196|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
157233474|NCT00154102|567601197|FG000|Overall Study|investigational study phase ongoing|7|||
157233475|NCT00154102|567601198|FG001|Overall Study|investigational study phase ongoing|2|||
157233476|NCT00463606|567601199|FG000|Overall Study|Adverse Event|21|||
157233477|NCT00463606|567601200|FG001|Overall Study|Adverse Event|18|||
157233478|NCT00463606|567601201|FG002|Overall Study|Adverse Event|11|||
157233479|NCT00463606|567601199|FG000|Overall Study|Withdrawal by Subject|11|||
157233480|NCT00463606|567601200|FG001|Overall Study|Withdrawal by Subject|11|||
157233481|NCT00463606|567601201|FG002|Overall Study|Withdrawal by Subject|5|||
157233482|NCT00463606|567601199|FG000|Overall Study|Lost to Follow-up|2|||
157233483|NCT00463606|567601200|FG001|Overall Study|Lost to Follow-up|2|||
157233484|NCT00463606|567601201|FG002|Overall Study|Lost to Follow-up|3|||
157233485|NCT00463606|567601199|FG000|Overall Study|Subject noncompliance|1|||
157233486|NCT00463606|567601200|FG001|Overall Study|Subject noncompliance|1|||
157233487|NCT00463606|567601201|FG002|Overall Study|Subject noncompliance|0|||
157233488|NCT00463606|567601199|FG000|Overall Study|Subject moved out of town|1|||
157233489|NCT00463606|567601200|FG001|Overall Study|Subject moved out of town|0|||
157233490|NCT00463606|567601201|FG002|Overall Study|Subject moved out of town|0|||
157233491|NCT00463606|567601199|FG000|Overall Study|Physician Decision|0|||
157233492|NCT00463606|567601200|FG001|Overall Study|Physician Decision|1|||
157233493|NCT00463606|567601201|FG002|Overall Study|Physician Decision|0|||
157233494|NCT00463606|567601199|FG000|Overall Study|Sponsor request|0|||
157233495|NCT00463606|567601200|FG001|Overall Study|Sponsor request|1|||
157233496|NCT00463606|567601201|FG002|Overall Study|Sponsor request|0|||
157233497|NCT00463606|567601199|FG000|Overall Study|Exclusion criteria violation|2|||
157233498|NCT00463606|567601200|FG001|Overall Study|Exclusion criteria violation|0|||
157233499|NCT00463606|567601201|FG002|Overall Study|Exclusion criteria violation|0|||
157233500|NCT00463606|567601199|FG000|Overall Study|Coordinator error|1|||
157233501|NCT00463606|567601200|FG001|Overall Study|Coordinator error|0|||
157233502|NCT00463606|567601201|FG002|Overall Study|Coordinator error|0|||
157233503|NCT00463606|567601199|FG000|Overall Study|Patient randomized in error|1|||
157233504|NCT00463606|567601200|FG001|Overall Study|Patient randomized in error|0|||
157233505|NCT00463606|567601201|FG002|Overall Study|Patient randomized in error|0|||
157233506|NCT00463606|567601199|FG000|Overall Study|Participation in another ABT-335 trial|1|||
157233507|NCT00463606|567601200|FG001|Overall Study|Participation in another ABT-335 trial|0|||
157233508|NCT00463606|567601201|FG002|Overall Study|Participation in another ABT-335 trial|0|||
157233509|NCT00463606|567601199|FG000|Overall Study|Protocol Violation|0|||
157233510|NCT00463606|567601200|FG001|Overall Study|Protocol Violation|0|||
157084158|NCT01198756|567061652|FG003|Overall Study|Adverse Event|1|||
157084159|NCT01198756|567061649|FG000|Overall Study|Protocol Violation|0|||
157084160|NCT01198756|567061650|FG001|Overall Study|Protocol Violation|0|||
157233511|NCT00463606|567601201|FG002|Overall Study|Protocol Violation|1|||
157233512|NCT02682602|567601203|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
157233513|NCT02682602|567601204|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
157233514|NCT02682602|567601203|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
157233515|NCT02682602|567601204|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
157233516|NCT03567174|567601205|FG000|Overall Study|Death|24|||
157233517|NCT03567174|567601206|FG001|Overall Study|Death|31|||
157233518|NCT03567174|567601205|FG000|Overall Study|Lost to Follow-up|165|||
157233519|NCT03567174|567601206|FG001|Overall Study|Lost to Follow-up|174|||
157233520|NCT02140060|567601207|FG000|Overall Study|Adverse Event|0|||
157233521|NCT02140060|567601208|FG001|Overall Study|Adverse Event|0|||
157233522|NCT02140060|567601209|FG002|Overall Study|Adverse Event|0|||
157233523|NCT02140060|567601210|FG003|Overall Study|Adverse Event|1|||
157233524|NCT02140060|567601211|FG004|Overall Study|Adverse Event|1|||
157233525|NCT02140060|567601212|FG005|Overall Study|Adverse Event|1|||
157233526|NCT02140060|567601207|FG000|Overall Study|Lack of Efficacy|0|||
157233527|NCT02140060|567601208|FG001|Overall Study|Lack of Efficacy|0|||
157233528|NCT02140060|567601209|FG002|Overall Study|Lack of Efficacy|0|||
157233529|NCT02140060|567601210|FG003|Overall Study|Lack of Efficacy|1|||
157233530|NCT02140060|567601211|FG004|Overall Study|Lack of Efficacy|0|||
157233531|NCT02140060|567601212|FG005|Overall Study|Lack of Efficacy|0|||
157233532|NCT00723528|567602536|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233533|NCT00723528|567602537|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233534|NCT00723528|567602538|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
157233535|NCT00723528|567602539|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233536|NCT00723528|567602540|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233537|NCT00723528|567602541|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233538|NCT00723528|567602542|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
157233539|NCT00723528|567602536|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
157084161|NCT01198756|567061651|FG002|Overall Study|Protocol Violation|0|||
157233540|NCT00723528|567602537|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157233541|NCT00723528|567602538|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157233542|NCT00723528|567602539|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157233543|NCT00723528|567602540|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157084162|NCT01198756|567061652|FG003|Overall Study|Protocol Violation|2|||
157084163|NCT01198756|567061649|FG000|Overall Study|Withdrawal by Subject|9|||
157233544|NCT00723528|567602541|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157233545|NCT00723528|567602542|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
157233546|NCT00723528|567602536|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233547|NCT00723528|567602537|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233548|NCT00723528|567602538|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
157233549|NCT00723528|567602539|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233550|NCT00723528|567602540|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233551|NCT00723528|567602541|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233552|NCT00723528|567602542|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
157233553|NCT00723528|567602536|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157084164|NCT01198756|567061650|FG001|Overall Study|Withdrawal by Subject|4|||
157084165|NCT01198756|567061651|FG002|Overall Study|Withdrawal by Subject|7|||
157084166|NCT01198756|567061652|FG003|Overall Study|Withdrawal by Subject|5|||
157084167|NCT01198756|567061649|FG000|Overall Study|Lost to Follow-up|29|||
157084168|NCT01198756|567061650|FG001|Overall Study|Lost to Follow-up|36|||
157084169|NCT01198756|567061651|FG002|Overall Study|Lost to Follow-up|23|||
157084170|NCT01198756|567061652|FG003|Overall Study|Lost to Follow-up|18|||
157084171|NCT02915302|567061653|FG000|Overall Study|Adverse Event|3|||
157084172|NCT02915302|567061654|FG001|Overall Study|Adverse Event|0|||
157084173|NCT02915302|567061653|FG000|Overall Study|Protocol Violation|20|||
157084174|NCT02915302|567061654|FG001|Overall Study|Protocol Violation|27|||
157084175|NCT02915302|567061653|FG000|Overall Study|Lost to Follow-up|19|||
157084176|NCT02915302|567061654|FG001|Overall Study|Lost to Follow-up|22|||
157084177|NCT02915302|567061653|FG000|Overall Study|Withdrawal by Subject|22|||
157084178|NCT02915302|567061654|FG001|Overall Study|Withdrawal by Subject|29|||
157084179|NCT02915302|567061653|FG000|Overall Study|Other|1|||
157084180|NCT02915302|567061654|FG001|Overall Study|Other|0|||
157084181|NCT04343872|567061657|FG000|Overall Study|Lost to Follow-up|6|||
157084182|NCT04343872|567061658|FG001|Overall Study|Lost to Follow-up|3|||
157084183|NCT01850446|567061659|FG000|Overall Study|Lack of Efficacy|1|||
157084184|NCT01850446|567061660|FG001|Overall Study|Lack of Efficacy|0|||
157084185|NCT01850446|567061659|FG000|Overall Study|Withdrawal by Subject|4|||
157084186|NCT01850446|567061660|FG001|Overall Study|Withdrawal by Subject|0|||
157084187|NCT01850446|567061659|FG000|Overall Study|Protocol Violation|0|||
157084188|NCT01850446|567061660|FG001|Overall Study|Protocol Violation|2|||
157084189|NCT00591721|567061661|FG000|Overall Study|Withdrawal by Subject|10|||
157084190|NCT00591721|567061662|FG001|Overall Study|Withdrawal by Subject|10|||
157084191|NCT00591721|567061661|FG000|Overall Study|Lost to Follow-up|1|||
157084192|NCT00591721|567061662|FG001|Overall Study|Lost to Follow-up|4|||
157084193|NCT00591721|567061661|FG000|Overall Study|Intervention not received|10|||
157084194|NCT00591721|567061662|FG001|Overall Study|Intervention not received|8|||
157084195|NCT02134977|567061663|FG000|Overall Study|Protocol Deviation|102|||
157084196|NCT03651622|567061668|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
157084197|NCT03651622|567061669|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
157084198|NCT03651622|567061670|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
157084199|NCT03651622|567061668|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
157084200|NCT03651622|567061669|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
157084201|NCT03651622|567061670|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
157084202|NCT03651622|567061668|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
157084203|NCT03651622|567061669|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
157084204|NCT03651622|567061670|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
157084205|NCT03651622|567061668|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
157084206|NCT03651622|567061669|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
157084207|NCT03651622|567061670|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
157084208|NCT03651622|567061668|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
157084209|NCT03651622|567061669|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
157084210|NCT03651622|567061670|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
157084211|NCT01519089|567061671|FG000|Overall Study|Adverse Event|4|||
157084212|NCT01519089|567061672|FG001|Overall Study|Adverse Event|4|||
157084213|NCT01519089|567061671|FG000|Overall Study|Lack of Efficacy|0|||
157084214|NCT01519089|567061672|FG001|Overall Study|Lack of Efficacy|2|||
157084215|NCT01519089|567061671|FG000|Overall Study|Lost to Follow-up|1|||
157084216|NCT01519089|567061672|FG001|Overall Study|Lost to Follow-up|0|||
157084217|NCT01519089|567061671|FG000|Overall Study|Withdrawal by Subject|0|||
157084218|NCT01519089|567061672|FG001|Overall Study|Withdrawal by Subject|2|||
157084219|NCT01519089|567061671|FG000|Overall Study|Other|2|||
157084220|NCT01519089|567061672|FG001|Overall Study|Other|6|||
157084221|NCT01519089|567061671|FG000|Overall Study|Not received study drug|0|||
157084222|NCT01519089|567061672|FG001|Overall Study|Not received study drug|1|||
157084223|NCT00127205|567061673|FG000|Overall Study|Adverse Event|228|||
157084224|NCT00127205|567061674|FG001|Overall Study|Adverse Event|387|||
157084225|NCT00127205|567061675|FG002|Overall Study|Adverse Event|273|||
157084226|NCT00127205|567061673|FG000|Overall Study|Death|8|||
157084227|NCT00127205|567061674|FG001|Overall Study|Death|6|||
157084228|NCT00127205|567061675|FG002|Overall Study|Death|5|||
157084229|NCT00127205|567061673|FG000|Overall Study|Withdrawal by Subject|318|||
157084230|NCT00127205|567061674|FG001|Overall Study|Withdrawal by Subject|310|||
157084231|NCT00127205|567061675|FG002|Overall Study|Withdrawal by Subject|172|||
157084232|NCT00127205|567061673|FG000|Overall Study|Other-non protocol specified|142|||
157084233|NCT00127205|567061674|FG001|Overall Study|Other-non protocol specified|129|||
157084234|NCT00127205|567061675|FG002|Overall Study|Other-non protocol specified|77|||
157084235|NCT00127205|567061673|FG000|Overall Study|Data not reported|6|||
157084236|NCT00127205|567061674|FG001|Overall Study|Data not reported|10|||
157084237|NCT00127205|567061675|FG002|Overall Study|Data not reported|1|||
157084238|NCT00127205|567061673|FG000|Overall Study|Progression|127|||
157084239|NCT00127205|567061674|FG001|Overall Study|Progression|131|||
157084240|NCT00127205|567061675|FG002|Overall Study|Progression|84|||
157233554|NCT00723528|567602537|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157233555|NCT00723528|567602538|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
157233556|NCT00723528|567602539|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157233557|NCT00723528|567602540|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157233558|NCT00723528|567602541|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157233559|NCT00723528|567602542|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
157233560|NCT00723528|567602536|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
157233561|NCT00723528|567602537|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
157233562|NCT00723528|567602538|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
157233563|NCT00723528|567602539|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
157233564|NCT00723528|567602540|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
157233565|NCT00723528|567602541|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
157233566|NCT00723528|567602542|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
157233567|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
157233568|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
157233569|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
157233570|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
157233571|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
157084241|NCT03527550|567061678|FG000|Overall Study|Lost to Follow-up|4|||
157084242|NCT03527550|567061679|FG001|Overall Study|Lost to Follow-up|2|||
157084243|NCT03527550|567061678|FG000|Overall Study|Withdrawal by Subject|4|||
157084244|NCT03527550|567061679|FG001|Overall Study|Withdrawal by Subject|1|||
157084245|NCT03527550|567061678|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
157084246|NCT03527550|567061679|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
157084247|NCT02683876|567061682|FG000|Overall Study|samples damaged during shipping|2|||
157084248|NCT02683876|567061683|FG001|Overall Study|samples damaged during shipping|0|||
157084249|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Adverse Event|1|||
157084250|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Adverse Event|1|||
157084251|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Adverse Event|2|||
157084252|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Adverse Event|5|||
157084253|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Adverse Event|0|||
157084254|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
157084255|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
157084256|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
157084257|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
157084258|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
157084259|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
157084260|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
157084261|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
157084262|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
157084263|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
157084264|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
157084265|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
157193380|NCT03099304|567449335|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
157193381|NCT03099304|567449336|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
157193382|NCT03099304|567449337|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
157193383|NCT03099304|567449338|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
157193384|NCT03099304|567449339|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
157193385|NCT03099304|567449334|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
157193386|NCT03099304|567449335|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
157193387|NCT03099304|567449336|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
157193388|NCT03099304|567449337|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
157193389|NCT03099304|567449338|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
157193390|NCT03099304|567449339|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
157193391|NCT03099304|567449334|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
157193392|NCT03099304|567449335|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
157193393|NCT03099304|567449336|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
157193394|NCT03099304|567449337|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
157193395|NCT03099304|567449338|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
157193396|NCT03099304|567449339|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
157193397|NCT03099304|567449334|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
157193398|NCT03099304|567449335|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
157193399|NCT03099304|567449336|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
157193400|NCT03099304|567449337|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
157193401|NCT03099304|567449338|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
157193402|NCT03099304|567449339|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
157193403|NCT03099304|567449334|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
157084266|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
157084267|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
157084268|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
157233572|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
157233573|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
157233574|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233575|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233576|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233577|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233578|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233579|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
157233580|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
157233581|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Other|0|||
157233582|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Other|0|||
157233583|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Other|0|||
157233584|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Other|0|||
157233585|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Other|1|||
157233586|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Other|4|||
157233587|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Other|0|||
157233588|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Adverse Event|0|||
157233589|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Adverse Event|0|||
157233590|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Adverse Event|0|||
157233591|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Adverse Event|0|||
157233592|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Adverse Event|1|||
157233593|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Adverse Event|0|||
157233594|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Adverse Event|1|||
157233595|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157084269|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
157084270|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
157084271|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
157084272|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
157193404|NCT03099304|567449335|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
157193405|NCT03099304|567449336|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
157193406|NCT03099304|567449337|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
157193407|NCT03099304|567449338|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
157193408|NCT03099304|567449339|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
157193409|NCT03099304|567449334|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
157193410|NCT03099304|567449335|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
157193411|NCT03099304|567449336|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
157193412|NCT03099304|567449337|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
157193413|NCT03099304|567449338|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
157193414|NCT03099304|567449339|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
157193415|NCT03099304|567449334|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
157193416|NCT03099304|567449335|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
157193417|NCT03099304|567449336|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
157193418|NCT03099304|567449337|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
157193419|NCT03099304|567449338|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
157193420|NCT03099304|567449339|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
157193421|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
157193422|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
157193423|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
157193424|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
157193425|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
157193426|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
157193427|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
157193428|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
157193429|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
157193430|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
157193431|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
157193432|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
157193433|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
157193434|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
157233596|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157233597|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157233598|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157233599|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157233600|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
157084273|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
157084274|NCT00951015|567061687|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
157084275|NCT00951015|567061688|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
157084276|NCT00951015|567061689|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
157084277|NCT00951015|567061690|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
157084278|NCT00951015|567061691|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
157084279|NCT00951015|567061687|FG000|Open-label Phase|Adverse Event|0|||
157084280|NCT00951015|567061688|FG001|Open-label Phase|Adverse Event|0|||
157084281|NCT00951015|567061689|FG002|Open-label Phase|Adverse Event|0|||
157084282|NCT00951015|567061690|FG003|Open-label Phase|Adverse Event|0|||
157084283|NCT00951015|567061691|FG004|Open-label Phase|Adverse Event|3|||
157084284|NCT00951015|567061687|FG000|Open-label Phase|Lack of Efficacy|0|||
157084285|NCT00951015|567061688|FG001|Open-label Phase|Lack of Efficacy|0|||
157084286|NCT00951015|567061689|FG002|Open-label Phase|Lack of Efficacy|0|||
157084287|NCT00951015|567061690|FG003|Open-label Phase|Lack of Efficacy|0|||
157084288|NCT00951015|567061691|FG004|Open-label Phase|Lack of Efficacy|1|||
157084289|NCT00951015|567061687|FG000|Open-label Phase|Protocol Violation|0|||
157084290|NCT00951015|567061688|FG001|Open-label Phase|Protocol Violation|0|||
157084291|NCT00951015|567061689|FG002|Open-label Phase|Protocol Violation|0|||
157084292|NCT00951015|567061690|FG003|Open-label Phase|Protocol Violation|0|||
157084293|NCT00951015|567061691|FG004|Open-label Phase|Protocol Violation|12|||
157084294|NCT00951015|567061687|FG000|Open-label Phase|Lost to Follow-up|0|||
157084295|NCT00951015|567061688|FG001|Open-label Phase|Lost to Follow-up|0|||
157084296|NCT00951015|567061689|FG002|Open-label Phase|Lost to Follow-up|0|||
157084297|NCT00951015|567061690|FG003|Open-label Phase|Lost to Follow-up|0|||
157084298|NCT00951015|567061691|FG004|Open-label Phase|Lost to Follow-up|12|||
157084299|NCT00951015|567061687|FG000|Open-label Phase|Withdrawal by Subject|0|||
157084300|NCT00951015|567061688|FG001|Open-label Phase|Withdrawal by Subject|0|||
157084301|NCT00951015|567061689|FG002|Open-label Phase|Withdrawal by Subject|0|||
157084302|NCT00951015|567061690|FG003|Open-label Phase|Withdrawal by Subject|0|||
157084303|NCT00951015|567061691|FG004|Open-label Phase|Withdrawal by Subject|14|||
157084304|NCT00951015|567061687|FG000|Open-label Phase|Physician Decision|0|||
157084305|NCT00951015|567061688|FG001|Open-label Phase|Physician Decision|0|||
157084306|NCT00951015|567061689|FG002|Open-label Phase|Physician Decision|0|||
157084307|NCT00951015|567061690|FG003|Open-label Phase|Physician Decision|0|||
157084308|NCT00951015|567061691|FG004|Open-label Phase|Physician Decision|8|||
157084309|NCT01417104|567061692|FG000|Overall Study|Withdrawal by Subject|5|||
157084310|NCT01417104|567061693|FG001|Overall Study|Withdrawal by Subject|1|||
157084311|NCT01417104|567061692|FG000|Overall Study|Failure to make contact|0|||
157084312|NCT01417104|567061693|FG001|Overall Study|Failure to make contact|1|||
157084313|NCT01417104|567061692|FG000|Overall Study|Adverse Event|1|||
157084314|NCT01417104|567061693|FG001|Overall Study|Adverse Event|0|||
157193435|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
157193436|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
157193437|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
157193438|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
157193439|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
157193440|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
157193441|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
157193442|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
157193443|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
157193444|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
157193445|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
157193446|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
157193447|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
157193448|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
157193449|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
157193450|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
157193451|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
157193452|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
157193453|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
157193454|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
157193455|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
157193456|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
157193457|NCT03099304|567449334|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
157193458|NCT03099304|567449335|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
157193459|NCT03099304|567449336|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
157193460|NCT03099304|567449337|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
157084315|NCT01416389|567061694|FG000|Overall Study|Lost to Follow-up|1|||
157084316|NCT01416389|567061695|FG001|Overall Study|Lost to Follow-up|0|||
157084317|NCT01416389|567061694|FG000|Overall Study|Started New Therapy|2|||
157233601|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
157233602|NCT00723528|567602536|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233603|NCT00723528|567602537|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233604|NCT00723528|567602538|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233605|NCT00723528|567602539|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233606|NCT00723528|567602540|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233607|NCT00723528|567602541|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
157233608|NCT00723528|567602542|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
157233609|NCT00667862|567602544|FG000|Overall Study|Adverse Event|9|||
157233610|NCT00667862|567602544|FG000|Overall Study|Death|1|||
157233611|NCT00667862|567602544|FG000|Overall Study|Disease Progression|22|||
157233612|NCT00667862|567602544|FG000|Overall Study|Withdrawal by Subject|3|||
157233613|NCT00667095|567602548|FG000|Overall Study|Withdrawal by Subject|0|||
157233614|NCT00667095|567602549|FG001|Overall Study|Withdrawal by Subject|1|||
157233615|NCT01520909|567602550|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
157233616|NCT01520909|567602551|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
157233617|NCT01520909|567602552|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
157233618|NCT01520909|567602550|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
157233619|NCT01520909|567602551|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
157233620|NCT01520909|567602552|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
157233621|NCT01520909|567602550|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
157233622|NCT01520909|567602551|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
157233623|NCT01520909|567602552|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
157233624|NCT01520909|567602550|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
157233625|NCT01520909|567602551|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
157233626|NCT01520909|567602552|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
157233627|NCT01435265|567602553|FG000|Overall Study|Lost to Follow-up|0|||
157233628|NCT01435265|567602554|FG001|Overall Study|Lost to Follow-up|1|||
157233629|NCT02128997|567602555|FG000|Overall Study|Lost to Follow-up|6|||
157233630|NCT02128997|567602556|FG001|Overall Study|Lost to Follow-up|11|||
157233631|NCT04123548|567602557|FG000|Overall Study|Withdrawal by Subject|1|||
157233632|NCT04123548|567602557|FG000|Overall Study|Lost to Follow-up|8|||
157233633|NCT04123548|567602557|FG000|Overall Study|Death|4|||
157233634|NCT04123548|567602557|FG000|Overall Study|Reason Not Specified|1|||
157233635|NCT04166630|567602559|FG000|Overall Study|Withdrawal by Subject|0|||
157233636|NCT04166630|567602560|FG001|Overall Study|Withdrawal by Subject|1|||
157233637|NCT00096447|567602561|FG000|Overall Study|Never treated|1|||
157233638|NCT02822235|567602562|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
157233639|NCT02822235|567602563|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
157233640|NCT02822235|567602562|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
157233641|NCT02822235|567602563|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
157233642|NCT02822235|567602562|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
157233643|NCT02822235|567602563|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
157233644|NCT02822235|567602562|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
157233645|NCT02822235|567602563|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
157233646|NCT02822235|567602562|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
157233647|NCT02822235|567602563|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
157233648|NCT02822235|567602562|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
157233649|NCT02822235|567602563|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
157233650|NCT01015625|567602568|FG000|Overall Study|Lost to Follow-up|3|||
157233651|NCT01015625|567602569|FG001|Overall Study|Lost to Follow-up|1|||
157233652|NCT01015625|567602568|FG000|Overall Study|Withdrawal by Subject|2|||
157233653|NCT01015625|567602569|FG001|Overall Study|Withdrawal by Subject|3|||
157233654|NCT01015625|567602568|FG000|Overall Study|Physician Decision|2|||
157233655|NCT01015625|567602569|FG001|Overall Study|Physician Decision|0|||
157233656|NCT01015625|567602568|FG000|Overall Study|Death|30|||
157233657|NCT01015625|567602569|FG001|Overall Study|Death|22|||
157233658|NCT04112823|567602570|FG000|Overall Study|Lost to Follow-up|2|||
157233659|NCT04112823|567602571|FG001|Overall Study|Lost to Follow-up|3|||
157233660|NCT04466111|567602574|FG000|Prior to Trial Phase|Physician Decision|1|||
157233661|NCT02015390|567602580|FG000|Overall Study|Lost to Follow-up|1|||
157233662|NCT02015390|567602581|FG001|Overall Study|Lost to Follow-up|0|||
157233663|NCT02015390|567602580|FG000|Overall Study|Adverse Event|0|||
157233664|NCT02015390|567602581|FG001|Overall Study|Adverse Event|3|||
157233665|NCT02015390|567602580|FG000|Overall Study|Physician Decision|0|||
157233666|NCT02015390|567602581|FG001|Overall Study|Physician Decision|1|||
157233667|NCT02661295|567602582|FG000|Overall Study|Death|1|||
157233668|NCT02661295|567602582|FG000|Overall Study|Transferred Out|1|||
157233669|NCT02661295|567602582|FG000|Overall Study|Kidney Transplant|1|||
157233670|NCT02661295|567602582|FG000|Overall Study|Withdrawn due to side effects|8|||
157233671|NCT02661295|567602582|FG000|Overall Study|Withdrawn due to access type|1|||
157084318|NCT01416389|567061695|FG001|Overall Study|Started New Therapy|0|||
157084319|NCT01365481|567061701|FG000|Overall Study|Adverse Event|6|||
157084320|NCT01365481|567061702|FG001|Overall Study|Adverse Event|9|||
157193461|NCT03099304|567449338|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
157193462|NCT03099304|567449339|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
157193463|NCT00636506|567449340|FG000|Overall Study|Lost to Follow-up|8|||
157193464|NCT00636506|567449340|FG000|Overall Study|Explanted|1|||
157193465|NCT00636506|567449340|FG000|Overall Study|Withdrawal by Subject|6|||
157193466|NCT00636506|567449340|FG000|Overall Study|Procedure aborted|1|||
157193467|NCT01624974|567449341|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
157193468|NCT01624974|567449342|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
157193469|NCT01624974|567449341|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
157193470|NCT01624974|567449342|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
157193471|NCT01624974|567449341|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
157193472|NCT01624974|567449342|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
157193473|NCT01624974|567449341|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
157193474|NCT01624974|567449342|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
157193475|NCT01624974|567449341|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
157193476|NCT01624974|567449342|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
157193477|NCT01624974|567449341|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
157193478|NCT01624974|567449342|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
157193479|NCT01624974|567449341|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
157193480|NCT01624974|567449342|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
157193481|NCT01624974|567449341|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
157193482|NCT01624974|567449342|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
157193483|NCT01624974|567449341|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
157193484|NCT01624974|567449342|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
157193485|NCT01624974|567449341|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
157193486|NCT01624974|567449342|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
157193487|NCT01624974|567449341|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
157193488|NCT01624974|567449342|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
157193489|NCT01624974|567449341|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
157084321|NCT01365481|567061703|FG002|Overall Study|Adverse Event|0|||
157084322|NCT01365481|567061704|FG003|Overall Study|Adverse Event|2|||
157084323|NCT01365481|567061701|FG000|Overall Study|Withdrawal by Subject|0|||
157084324|NCT01365481|567061702|FG001|Overall Study|Withdrawal by Subject|2|||
157084325|NCT01365481|567061703|FG002|Overall Study|Withdrawal by Subject|1|||
157084326|NCT01365481|567061704|FG003|Overall Study|Withdrawal by Subject|1|||
157084327|NCT01365481|567061701|FG000|Overall Study|Lost to Follow-up|1|||
157084328|NCT01365481|567061702|FG001|Overall Study|Lost to Follow-up|1|||
157084329|NCT01365481|567061703|FG002|Overall Study|Lost to Follow-up|2|||
157084330|NCT01365481|567061704|FG003|Overall Study|Lost to Follow-up|3|||
157084331|NCT01365481|567061701|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157084332|NCT01365481|567061702|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157084333|NCT01365481|567061703|FG002|Overall Study|Abnormal laboratory value(s)|0|||
157084334|NCT01365481|567061704|FG003|Overall Study|Abnormal laboratory value(s)|0|||
157084335|NCT01365481|567061701|FG000|Overall Study|Administrative problems|0|||
157084336|NCT01365481|567061702|FG001|Overall Study|Administrative problems|1|||
157084337|NCT01365481|567061703|FG002|Overall Study|Administrative problems|0|||
157084338|NCT01365481|567061704|FG003|Overall Study|Administrative problems|0|||
157084339|NCT01365481|567061701|FG000|Overall Study|Protocol deviation|0|||
157084340|NCT01365481|567061702|FG001|Overall Study|Protocol deviation|1|||
157084341|NCT01365481|567061703|FG002|Overall Study|Protocol deviation|0|||
157084342|NCT01365481|567061704|FG003|Overall Study|Protocol deviation|1|||
157084343|NCT01365481|567061701|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157084344|NCT01365481|567061702|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157084345|NCT01365481|567061703|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
157084346|NCT01365481|567061704|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
157084347|NCT00757627|567061705|FG000|Overall Study|Adverse Event|15|||
157084348|NCT00757627|567061705|FG000|Overall Study|Lack of Efficacy|10|||
157084349|NCT00757627|567061705|FG000|Overall Study|Lost to Follow-up|28|||
157084350|NCT00757627|567061705|FG000|Overall Study|Withdrawal by Subject|27|||
157084351|NCT00757627|567061705|FG000|Overall Study|Other|1|||
157084352|NCT00858364|567061708|FG000|Overall Study|Administrative Decision|3|||
157084353|NCT00858364|567061709|FG001|Overall Study|Administrative Decision|2|||
157084354|NCT00858364|567061708|FG000|Overall Study|Adverse Event|5|||
157193490|NCT01624974|567449342|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
157193491|NCT01681836|567449345|FG000|Second Intervention|Withdrawal by Subject|0|||
157193492|NCT01681836|567449346|FG001|Second Intervention|Withdrawal by Subject|1|||
157084355|NCT00858364|567061709|FG001|Overall Study|Adverse Event|2|||
157084356|NCT00858364|567061708|FG000|Overall Study|Withdrawal by Subject|44|||
157084357|NCT00858364|567061709|FG001|Overall Study|Withdrawal by Subject|118|||
157084358|NCT00858364|567061708|FG000|Overall Study|Ineligibility Determined|1|||
157084359|NCT00858364|567061709|FG001|Overall Study|Ineligibility Determined|10|||
157084360|NCT00858364|567061708|FG000|Overall Study|Lost to Follow-up|24|||
157084361|NCT00858364|567061709|FG001|Overall Study|Lost to Follow-up|54|||
157084362|NCT00858364|567061708|FG000|Overall Study|Noncompliance|3|||
157084363|NCT00858364|567061709|FG001|Overall Study|Noncompliance|4|||
157084364|NCT00858364|567061708|FG000|Overall Study|Protocol Deviation|0|||
157084365|NCT00858364|567061709|FG001|Overall Study|Protocol Deviation|2|||
157084366|NCT00858364|567061708|FG000|Overall Study|Other|9|||
157084367|NCT00858364|567061709|FG001|Overall Study|Other|17|||
157084368|NCT00858364|567061708|FG000|Overall Study|Missing|1|||
157084369|NCT00858364|567061709|FG001|Overall Study|Missing|1|||
157084370|NCT00858364|567061708|FG000|Overall Study|Still on-study|114|||
157084371|NCT00858364|567061709|FG001|Overall Study|Still on-study|247|||
157084372|NCT03682302|567061712|FG000|Overall Study|Lost to Follow-up|1|||
157084373|NCT03682302|567061713|FG001|Overall Study|Lost to Follow-up|2|||
157084374|NCT03682302|567061714|FG002|Overall Study|Lost to Follow-up|0|||
157084375|NCT03682302|567061715|FG003|Overall Study|Lost to Follow-up|1|||
157084376|NCT03682302|567061712|FG000|Overall Study|Study drug was not administered|0|||
157084377|NCT03682302|567061713|FG001|Overall Study|Study drug was not administered|0|||
157084378|NCT03682302|567061714|FG002|Overall Study|Study drug was not administered|1|||
157084379|NCT03682302|567061715|FG003|Overall Study|Study drug was not administered|1|||
157084380|NCT01489891|567061717|FG000|Overall Study|Endoscopy failure|1|||
157084381|NCT01489891|567061718|FG001|Overall Study|Endoscopy failure|0|||
157084382|NCT00948766|567061721|FG000|Core Study|Adverse Event|73|||
157084383|NCT00948766|567061722|FG001|Core Study|Adverse Event|51|||
157084384|NCT00948766|567061721|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
157084385|NCT00948766|567061722|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
157084386|NCT00948766|567061721|FG000|Core Study|Patient Withdrew Consent|27|||
157084387|NCT00948766|567061722|FG001|Core Study|Patient Withdrew Consent|46|||
157084388|NCT00948766|567061721|FG000|Core Study|Lost to Follow-up|3|||
157084389|NCT00948766|567061722|FG001|Core Study|Lost to Follow-up|2|||
157084390|NCT00948766|567061721|FG000|Core Study|Administrative Problems|2|||
157084391|NCT00948766|567061722|FG001|Core Study|Administrative Problems|2|||
157084392|NCT00948766|567061721|FG000|Core Study|Death|1|||
157084393|NCT00948766|567061722|FG001|Core Study|Death|1|||
157084394|NCT00948766|567061721|FG000|Core Study|Protocol Deviation|8|||
157084395|NCT00948766|567061722|FG001|Core Study|Protocol Deviation|10|||
157084396|NCT00948766|567061721|FG000|Extension Study|Adverse Event|43|||
157084397|NCT00948766|567061722|FG001|Extension Study|Adverse Event|0|||
157084398|NCT00948766|567061721|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
157084399|NCT00948766|567061722|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
157084400|NCT00948766|567061721|FG000|Extension Study|Study Drug No Longer Required|1|||
157084401|NCT00948766|567061722|FG001|Extension Study|Study Drug No Longer Required|0|||
157084402|NCT00948766|567061721|FG000|Extension Study|Patient Withdrew Consent|32|||
157084403|NCT00948766|567061722|FG001|Extension Study|Patient Withdrew Consent|0|||
157084404|NCT00948766|567061721|FG000|Extension Study|Lost to Follow-up|8|||
157084405|NCT00948766|567061722|FG001|Extension Study|Lost to Follow-up|0|||
157084406|NCT00948766|567061721|FG000|Extension Study|Administrative Problems|1|||
157084407|NCT00948766|567061722|FG001|Extension Study|Administrative Problems|0|||
157084408|NCT00948766|567061721|FG000|Extension Study|Death|4|||
157084409|NCT00948766|567061722|FG001|Extension Study|Death|0|||
157084410|NCT00888927|567061723|FG000|Overall Study|Adverse Event|0|||
157084411|NCT00888927|567061724|FG001|Overall Study|Adverse Event|0|||
157084412|NCT00888927|567061725|FG002|Overall Study|Adverse Event|0|||
157084413|NCT00888927|567061726|FG003|Overall Study|Adverse Event|1|||
157084414|NCT00888927|567061723|FG000|Overall Study|Withdrawal of consent|0|||
157084415|NCT00888927|567061724|FG001|Overall Study|Withdrawal of consent|0|||
157084416|NCT00888927|567061725|FG002|Overall Study|Withdrawal of consent|0|||
157084417|NCT00888927|567061726|FG003|Overall Study|Withdrawal of consent|1|||
157084418|NCT02153073|567061727|FG000|Overall Study|Case Report Forms Uncollected|230|||
157084419|NCT02153073|567061727|FG000|Overall Study|Protocol Deviation|68|||
157084420|NCT03189745|567061728|FG000|Overall Study|Conflict in work schedule of participant|1|||
157084421|NCT03189745|567061729|FG001|Overall Study|Conflict in work schedule of participant|1|||
157084422|NCT03702231|567061730|FG000|Overall Study|Withdrawal by Subject|1|||
157084423|NCT03702231|567061731|FG001|Overall Study|Withdrawal by Subject|0|||
157084424|NCT03702231|567061732|FG002|Overall Study|Withdrawal by Subject|0|||
157084425|NCT03702231|567061730|FG000|Overall Study|Protocol Violation|0|||
157084426|NCT03702231|567061731|FG001|Overall Study|Protocol Violation|0|||
157084427|NCT03702231|567061732|FG002|Overall Study|Protocol Violation|1|||
157084428|NCT03702231|567061730|FG000|Overall Study|Change in CLL Treatment|0|||
157084429|NCT03702231|567061731|FG001|Overall Study|Change in CLL Treatment|0|||
157084430|NCT03702231|567061732|FG002|Overall Study|Change in CLL Treatment|1|||
157084431|NCT03702231|567061730|FG000|Overall Study|COVID Pandemic|1|||
157084432|NCT03702231|567061731|FG001|Overall Study|COVID Pandemic|4|||
157084433|NCT03702231|567061732|FG002|Overall Study|COVID Pandemic|1|||
157084434|NCT03702231|567061730|FG000|Overall Study|Non-compliance|0|||
157084435|NCT03702231|567061731|FG001|Overall Study|Non-compliance|0|||
157084436|NCT03702231|567061732|FG002|Overall Study|Non-compliance|1|||
157233672|NCT02661295|567602582|FG000|Overall Study|Withdrawn due to allergies|1|||
157233673|NCT02661295|567602582|FG000|Overall Study|Withdrawn due to non-compliance|1|||
157233674|NCT02661295|567602582|FG000|Overall Study|Withdrawal by Subject|3|||
157233675|NCT02661295|567602582|FG000|Overall Study|Failed screening|2|||
157233676|NCT02726581|567602583|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
157233677|NCT02726581|567602584|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
157233678|NCT02726581|567602585|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
157233679|NCT02726581|567602583|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
157233680|NCT02726581|567602584|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
157233681|NCT02726581|567602585|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
157233682|NCT02726581|567602583|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
157233683|NCT02726581|567602584|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157233684|NCT02726581|567602585|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
157233685|NCT02726581|567602583|FG000|Treatment Period|Disease progression|47|||
157233686|NCT02726581|567602584|FG001|Treatment Period|Disease progression|50|||
157233687|NCT02726581|567602585|FG002|Treatment Period|Disease progression|16|||
157233688|NCT02726581|567602583|FG000|Treatment Period|Other reasons|9|||
157233689|NCT02726581|567602584|FG001|Treatment Period|Other reasons|8|||
157233690|NCT02726581|567602585|FG002|Treatment Period|Other reasons|2|||
157233691|NCT02726581|567602583|FG000|Treatment Period|Study drug toxicity|6|||
157233692|NCT02726581|567602584|FG001|Treatment Period|Study drug toxicity|3|||
157233693|NCT02726581|567602585|FG002|Treatment Period|Study drug toxicity|2|||
157233694|NCT02726581|567602583|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
157233695|NCT02726581|567602584|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
157233696|NCT02726581|567602585|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
157233697|NCT02726581|567602583|FG000|Treatment Period|Participant withdrew consent|3|||
157233698|NCT02726581|567602584|FG001|Treatment Period|Participant withdrew consent|1|||
157233699|NCT02726581|567602585|FG002|Treatment Period|Participant withdrew consent|1|||
157233700|NCT02726581|567602583|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
157233701|NCT02726581|567602584|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
157233702|NCT02726581|567602585|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
157233703|NCT02726581|567602583|FG000|Treatment Period|Maximum clinical benefit|0|||
157233704|NCT02726581|567602584|FG001|Treatment Period|Maximum clinical benefit|2|||
157233705|NCT02726581|567602585|FG002|Treatment Period|Maximum clinical benefit|0|||
157233706|NCT02726581|567602583|FG000|Treatment Period|Death|1|||
157233707|NCT02726581|567602584|FG001|Treatment Period|Death|0|||
157233708|NCT02726581|567602585|FG002|Treatment Period|Death|0|||
157233709|NCT02726581|567602583|FG000|Treatment Period|Poor/non-compliance|1|||
157233710|NCT02726581|567602584|FG001|Treatment Period|Poor/non-compliance|0|||
157233711|NCT02726581|567602585|FG002|Treatment Period|Poor/non-compliance|0|||
157233712|NCT02726581|567602583|FG000|Treatment Period|Participant no longer meets study criteria|0|||
157233713|NCT02726581|567602584|FG001|Treatment Period|Participant no longer meets study criteria|1|||
157233714|NCT02726581|567602585|FG002|Treatment Period|Participant no longer meets study criteria|0|||
157233715|NCT01844375|567602589|FG000|Overall Study|Protocol Violation|1|||
157233716|NCT01844375|567602590|FG001|Overall Study|Protocol Violation|1|||
157233717|NCT00112463|567602591|FG000|Overall Study|Physician Decision|1|||
157233718|NCT00112463|567602591|FG000|Overall Study|Progression|30|||
157233719|NCT00112463|567602591|FG000|Overall Study|Second Primary|1|||
157233720|NCT00112463|567602591|FG000|Overall Study|Toxicity|3|||
157233721|NCT00112463|567602591|FG000|Overall Study|Withdrawal by Subject|2|||
157233722|NCT00112463|567602591|FG000|Overall Study|Never started treatment|2|||
157233723|NCT00678639|567602592|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
157233724|NCT00678639|567602593|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
157233725|NCT01546545|567602596|FG000|Overall Study|Withdrawal by Subject|1|||
157233726|NCT01214850|567602597|FG000|Overall Study|Withdrawal by Subject|38|||
157233727|NCT01214850|567602598|FG001|Overall Study|Withdrawal by Subject|31|||
157233728|NCT01214850|567602599|FG002|Overall Study|Withdrawal by Subject|28|||
157233729|NCT01214850|567602597|FG000|Overall Study|Lost to Follow-up|124|||
157233730|NCT01214850|567602598|FG001|Overall Study|Lost to Follow-up|98|||
157233731|NCT01214850|567602599|FG002|Overall Study|Lost to Follow-up|123|||
157233732|NCT01214850|567602597|FG000|Overall Study|Protocol Violation|5|||
157233733|NCT01214850|567602598|FG001|Overall Study|Protocol Violation|5|||
157233734|NCT01214850|567602599|FG002|Overall Study|Protocol Violation|6|||
157233735|NCT01214850|567602597|FG000|Overall Study|Adverse event or death|11|||
157233736|NCT01214850|567602598|FG001|Overall Study|Adverse event or death|8|||
157233737|NCT01214850|567602599|FG002|Overall Study|Adverse event or death|3|||
157233738|NCT01214850|567602597|FG000|Overall Study|Inappropriate enrollment|2|||
157233739|NCT01214850|567602598|FG001|Overall Study|Inappropriate enrollment|1|||
157233740|NCT01214850|567602599|FG002|Overall Study|Inappropriate enrollment|0|||
157233741|NCT01214850|567602597|FG000|Overall Study|Administrative reason|1|||
157084437|NCT01278173|567061733|FG000|Overall Study|Lack of Efficacy|13|||
157233742|NCT01214850|567602598|FG001|Overall Study|Administrative reason|0|||
157233743|NCT01214850|567602599|FG002|Overall Study|Administrative reason|0|||
157084438|NCT01278173|567061733|FG000|Overall Study|Adverse Event|8|||
157084439|NCT01278173|567061733|FG000|Overall Study|Administrative or other reason|4|||
157084440|NCT01278173|567061733|FG000|Overall Study|Protocol Violation|1|||
157084441|NCT01278173|567061733|FG000|Overall Study|Withdrawal by Subject|1|||
157084442|NCT01200290|567061736|FG000|Treatment Period|Adverse Event|1|||
157084443|NCT01200290|567061736|FG000|Post-Treatment Follow-Up Period|Death|2|||
157193493|NCT02142712|567449347|FG000|Overall Study|Lost to Follow-up|1|||
157193494|NCT02142712|567449348|FG001|Overall Study|Lost to Follow-up|1|||
157193495|NCT02142712|567449349|FG002|Overall Study|Lost to Follow-up|1|||
157193496|NCT02142712|567449350|FG003|Overall Study|Lost to Follow-up|0|||
157193497|NCT01058356|567449368|FG000|Overall Study|Adverse Event|5|||
157193498|NCT01058356|567449368|FG000|Overall Study|Administration of contraindicated drugs|12|||
157193499|NCT01058356|567449368|FG000|Overall Study|Withdrawal by Subject|21|||
157193500|NCT01058356|567449368|FG000|Overall Study|Lost to Follow-up|4|||
157193501|NCT02850276|567449369|FG000|Overall Study|screen failure|43|||
157193502|NCT02850276|567449369|FG000|Overall Study|Withdrawal by Subject|14|||
157193503|NCT02850276|567449369|FG000|Overall Study|Physician Decision|2|||
157193504|NCT02850276|567449369|FG000|Overall Study|Lost to Follow-up|2|||
157193505|NCT04815291|567449370|FG000|Overall Study|Lost to Follow-up|1|||
157193506|NCT04815291|567449370|FG000|Overall Study|Physician Decision|4|||
157193507|NCT04815291|567449370|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
157193508|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
157193509|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
157193510|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
157193511|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
157193512|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
157193513|NCT00989664|567449372|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
157193514|NCT00989664|567449372|FG000|Long-Term Follow-Up|Death|3|||
157193515|NCT00095836|567449373|FG000|Overall Study|Lost to Follow-up|1|||
157193516|NCT00095836|567449373|FG000|Overall Study|Adverse Event|1|||
157193517|NCT00095836|567449373|FG000|Overall Study|Death|2|||
157193518|NCT00962780|567449377|FG000|Overall Study|Death|0|||
157193519|NCT00962780|567449378|FG001|Overall Study|Death|1|||
157193520|NCT00962780|567449377|FG000|Overall Study|Protocol Violation|9|||
157193521|NCT00962780|567449378|FG001|Overall Study|Protocol Violation|4|||
157193522|NCT00962780|567449377|FG000|Overall Study|Withdrawal by Subject|1|||
157193523|NCT00962780|567449378|FG001|Overall Study|Withdrawal by Subject|8|||
157193524|NCT00962780|567449377|FG000|Overall Study|Other|0|||
157193525|NCT00962780|567449378|FG001|Overall Study|Other|1|||
157193526|NCT02646332|567449381|FG000|Overall Study|Lost to Follow-up|0|||
157193527|NCT02646332|567449382|FG001|Overall Study|Lost to Follow-up|3|||
157193528|NCT02363322|567449388|FG000|Overall Study|Lost to Follow-up|1|||
157193529|NCT02363322|567449389|FG001|Overall Study|Lost to Follow-up|0|||
157193530|NCT01882439|567449390|FG000|Overall Study|Adverse event related to study drug|3|||
157193531|NCT01882439|567449391|FG001|Overall Study|Adverse event related to study drug|8|||
157193532|NCT01882439|567449392|FG002|Overall Study|Adverse event related to study drug|1|||
157193533|NCT01882439|567449393|FG003|Overall Study|Adverse event related to study drug|2|||
157193534|NCT01882439|567449390|FG000|Overall Study|Pregnancy|0|||
157193535|NCT01882439|567449391|FG001|Overall Study|Pregnancy|1|||
157193536|NCT01882439|567449392|FG002|Overall Study|Pregnancy|0|||
157193537|NCT01882439|567449393|FG003|Overall Study|Pregnancy|0|||
157193538|NCT01882439|567449390|FG000|Overall Study|Protocol Violation|2|||
157193539|NCT01882439|567449391|FG001|Overall Study|Protocol Violation|2|||
157193540|NCT01882439|567449392|FG002|Overall Study|Protocol Violation|0|||
157193541|NCT01882439|567449393|FG003|Overall Study|Protocol Violation|1|||
157193542|NCT01882439|567449390|FG000|Overall Study|No longer willing to participate|1|||
157193543|NCT01882439|567449391|FG001|Overall Study|No longer willing to participate|4|||
157193544|NCT01882439|567449392|FG002|Overall Study|No longer willing to participate|2|||
157193545|NCT01882439|567449393|FG003|Overall Study|No longer willing to participate|3|||
157084444|NCT01241604|567061738|FG000|Screening Period|Screen Failure|3|||
157193546|NCT01882439|567449390|FG000|Overall Study|Medication error with no associated AE|0|||
157193547|NCT01882439|567449391|FG001|Overall Study|Medication error with no associated AE|0|||
157193548|NCT01882439|567449392|FG002|Overall Study|Medication error with no associated AE|2|||
157193549|NCT01882439|567449393|FG003|Overall Study|Medication error with no associated AE|0|||
157084445|NCT01241604|567061739|FG001|Screening Period|Screen Failure|0|||
157084446|NCT01241604|567061740|FG002|Screening Period|Screen Failure|0|||
157193550|NCT01882439|567449390|FG000|Overall Study|Insufficient clinical response|1|||
157193551|NCT01882439|567449391|FG001|Overall Study|Insufficient clinical response|4|||
157193552|NCT01882439|567449392|FG002|Overall Study|Insufficient clinical response|4|||
157193553|NCT01882439|567449393|FG003|Overall Study|Insufficient clinical response|2|||
157193554|NCT01882439|567449390|FG000|Overall Study|Adverse event unrelated to study drug|2|||
157193555|NCT01882439|567449391|FG001|Overall Study|Adverse event unrelated to study drug|2|||
157193556|NCT01882439|567449392|FG002|Overall Study|Adverse event unrelated to study drug|1|||
157193557|NCT01882439|567449393|FG003|Overall Study|Adverse event unrelated to study drug|1|||
157193558|NCT01775995|567449396|FG000|Overall Study|Lost to Follow-up|1|||
157084447|NCT01214642|567061741|FG000|Overall Study|Progressive Disease|3|||
157084448|NCT01214642|567061742|FG001|Overall Study|Progressive Disease|2|||
157084449|NCT01214642|567061743|FG002|Overall Study|Progressive Disease|3|||
157084450|NCT01214642|567061744|FG003|Overall Study|Progressive Disease|5|||
157084451|NCT01214642|567061745|FG004|Overall Study|Progressive Disease|5|||
157084452|NCT01214642|567061746|FG005|Overall Study|Progressive Disease|3|||
157193559|NCT01775995|567449397|FG001|Overall Study|Lost to Follow-up|1|||
157193560|NCT01657903|567449399|FG000|Overall Study|Lost to Follow-up|1|||
157193561|NCT01657903|567449399|FG000|Overall Study|Withdrawal by Subject|1|||
157193562|NCT00620815|567449400|FG000|Overall Study|Adverse Event|1|||
157193563|NCT00620815|567449401|FG001|Overall Study|Adverse Event|1|||
157193564|NCT00620815|567449402|FG002|Overall Study|Adverse Event|2|||
157193565|NCT00620815|567449400|FG000|Overall Study|Withdrawal by Subject|1|||
157193566|NCT00620815|567449401|FG001|Overall Study|Withdrawal by Subject|2|||
157193567|NCT00620815|567449402|FG002|Overall Study|Withdrawal by Subject|0|||
157193568|NCT00620815|567449400|FG000|Overall Study|Lost to Follow-up|1|||
157193569|NCT00620815|567449401|FG001|Overall Study|Lost to Follow-up|6|||
157193570|NCT00620815|567449402|FG002|Overall Study|Lost to Follow-up|3|||
157193571|NCT00620815|567449400|FG000|Overall Study|Inappropriate enrolment|0|||
157193572|NCT00620815|567449401|FG001|Overall Study|Inappropriate enrolment|0|||
157193573|NCT00620815|567449402|FG002|Overall Study|Inappropriate enrolment|1|||
157193574|NCT00620815|567449400|FG000|Overall Study|Protocol Violation|1|||
157193575|NCT00620815|567449401|FG001|Overall Study|Protocol Violation|2|||
157193576|NCT00620815|567449402|FG002|Overall Study|Protocol Violation|1|||
157193577|NCT00422942|567449406|FG000|Overall Study|Study terminated by Sponsor|3|||
157193578|NCT02828982|567449409|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
157193579|NCT02828982|567449410|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
157193580|NCT03458234|567449411|FG000|Overall Study|Withdrawal by Subject|1|||
157193581|NCT01266967|567451510|FG000|Overall Study|Death|69|||
157193582|NCT01266967|567451511|FG001|Overall Study|Death|61|||
157193583|NCT01266967|567451510|FG000|Overall Study|Study Closed/Terminated|15|||
157193584|NCT01266967|567451511|FG001|Overall Study|Study Closed/Terminated|17|||
157193585|NCT01266967|567451510|FG000|Overall Study|Lost to Follow-up|2|||
157193586|NCT01266967|567451511|FG001|Overall Study|Lost to Follow-up|1|||
157193587|NCT01266967|567451510|FG000|Overall Study|Physician Decision|0|||
157193588|NCT01266967|567451511|FG001|Overall Study|Physician Decision|1|||
157193589|NCT01266967|567451510|FG000|Overall Study|Withdrawal by Subject|3|||
157193590|NCT01266967|567451511|FG001|Overall Study|Withdrawal by Subject|3|||
157193591|NCT01519700|567451512|FG000|Overall Study|Death|1|||
157193592|NCT01519700|567451513|FG001|Overall Study|Death|0|||
157193593|NCT01519700|567451514|FG002|Overall Study|Death|0|||
157193594|NCT01519700|567451515|FG003|Overall Study|Death|0|||
157193595|NCT01519700|567451512|FG000|Overall Study|Lost to Follow-up|0|||
157193596|NCT01519700|567451513|FG001|Overall Study|Lost to Follow-up|0|||
157193597|NCT01519700|567451514|FG002|Overall Study|Lost to Follow-up|1|||
157193598|NCT01519700|567451515|FG003|Overall Study|Lost to Follow-up|1|||
157193599|NCT01519700|567451512|FG000|Overall Study|Physician Decision|1|||
157193600|NCT01519700|567451513|FG001|Overall Study|Physician Decision|1|||
157193601|NCT01519700|567451514|FG002|Overall Study|Physician Decision|3|||
157193602|NCT01519700|567451515|FG003|Overall Study|Physician Decision|0|||
157193603|NCT01519700|567451512|FG000|Overall Study|Withdrawal by Subject|5|||
157193604|NCT01519700|567451513|FG001|Overall Study|Withdrawal by Subject|3|||
157233744|NCT01214850|567602597|FG000|Overall Study|Unable to classify|2|||
157084453|NCT01214642|567061747|FG006|Overall Study|Progressive Disease|5|||
157084454|NCT01214642|567061748|FG007|Overall Study|Progressive Disease|3|||
157084455|NCT01214642|567061749|FG008|Overall Study|Progressive Disease|10|||
157084456|NCT01214642|567061750|FG009|Overall Study|Progressive Disease|2|||
157084457|NCT01214642|567061751|FG010|Overall Study|Progressive Disease|1|||
157084458|NCT01214642|567061752|FG011|Overall Study|Progressive Disease|4|||
157084459|NCT01214642|567061741|FG000|Overall Study|Adverse Event|0|||
157084460|NCT01214642|567061742|FG001|Overall Study|Adverse Event|1|||
157084461|NCT01214642|567061743|FG002|Overall Study|Adverse Event|0|||
157084462|NCT01214642|567061744|FG003|Overall Study|Adverse Event|0|||
157084463|NCT01214642|567061745|FG004|Overall Study|Adverse Event|0|||
157084464|NCT01214642|567061746|FG005|Overall Study|Adverse Event|0|||
157084465|NCT01214642|567061747|FG006|Overall Study|Adverse Event|1|||
157084466|NCT01214642|567061748|FG007|Overall Study|Adverse Event|0|||
157084467|NCT01214642|567061749|FG008|Overall Study|Adverse Event|0|||
157084468|NCT01214642|567061750|FG009|Overall Study|Adverse Event|1|||
157084469|NCT01214642|567061751|FG010|Overall Study|Adverse Event|1|||
157193605|NCT01519700|567451514|FG002|Overall Study|Withdrawal by Subject|3|||
157193606|NCT01519700|567451515|FG003|Overall Study|Withdrawal by Subject|2|||
157193607|NCT01519700|567451512|FG000|Overall Study|Other Reason|2|||
157193608|NCT01519700|567451513|FG001|Overall Study|Other Reason|2|||
157084470|NCT01214642|567061752|FG011|Overall Study|Adverse Event|0|||
157193609|NCT01519700|567451514|FG002|Overall Study|Other Reason|0|||
157193610|NCT01519700|567451515|FG003|Overall Study|Other Reason|4|||
157193611|NCT05111548|567451516|FG000|Overall Study|Withdrawal by Subject|2|||
157193612|NCT05111548|567451517|FG001|Overall Study|Withdrawal by Subject|1|||
157193613|NCT05111548|567451516|FG000|Overall Study|Adverse Event|1|||
157084471|NCT01214642|567061741|FG000|Overall Study|Death|0|||
157084472|NCT01214642|567061742|FG001|Overall Study|Death|0|||
157084473|NCT01214642|567061743|FG002|Overall Study|Death|1|||
157084474|NCT01214642|567061744|FG003|Overall Study|Death|0|||
157084475|NCT01214642|567061745|FG004|Overall Study|Death|0|||
157084476|NCT01214642|567061746|FG005|Overall Study|Death|0|||
157084477|NCT01214642|567061747|FG006|Overall Study|Death|0|||
157084478|NCT01214642|567061748|FG007|Overall Study|Death|0|||
157084479|NCT01214642|567061749|FG008|Overall Study|Death|0|||
157084480|NCT01214642|567061750|FG009|Overall Study|Death|0|||
157084481|NCT01214642|567061751|FG010|Overall Study|Death|1|||
157084482|NCT01214642|567061752|FG011|Overall Study|Death|0|||
157084483|NCT01214642|567061741|FG000|Overall Study|Withdrawal by Subject|0|||
157084484|NCT01214642|567061742|FG001|Overall Study|Withdrawal by Subject|0|||
157084485|NCT01214642|567061743|FG002|Overall Study|Withdrawal by Subject|1|||
157084486|NCT01214642|567061744|FG003|Overall Study|Withdrawal by Subject|0|||
157084487|NCT01214642|567061745|FG004|Overall Study|Withdrawal by Subject|0|||
157084488|NCT01214642|567061746|FG005|Overall Study|Withdrawal by Subject|0|||
157084489|NCT01214642|567061747|FG006|Overall Study|Withdrawal by Subject|0|||
157084490|NCT01214642|567061748|FG007|Overall Study|Withdrawal by Subject|0|||
157084491|NCT01214642|567061749|FG008|Overall Study|Withdrawal by Subject|3|||
157084492|NCT01214642|567061750|FG009|Overall Study|Withdrawal by Subject|1|||
157084493|NCT01214642|567061751|FG010|Overall Study|Withdrawal by Subject|1|||
157084494|NCT01214642|567061752|FG011|Overall Study|Withdrawal by Subject|0|||
157233745|NCT01214850|567602598|FG001|Overall Study|Unable to classify|1|||
157233746|NCT01214850|567602599|FG002|Overall Study|Unable to classify|1|||
157233747|NCT00565448|567602602|FG000|Overall Study|Adverse Event|1|||
157233748|NCT00565448|567602603|FG001|Overall Study|Adverse Event|2|||
157233749|NCT00565448|567602602|FG000|Overall Study|Disease progression|1|||
157233750|NCT00565448|567602603|FG001|Overall Study|Disease progression|0|||
157233751|NCT00565448|567602602|FG000|Overall Study|Withdrawal by Subject|1|||
157233752|NCT00565448|567602603|FG001|Overall Study|Withdrawal by Subject|0|||
157233753|NCT00193609|567602604|FG000|Overall Study|Lack of Efficacy|2|||
157233754|NCT00193609|567602604|FG000|Overall Study|Adverse Event|2|||
157233755|NCT00735904|567602605|FG000|Overall Study|Adverse Event|3|||
157233756|NCT00735904|567602605|FG000|Overall Study|Death|20|||
157233757|NCT00735904|567602605|FG000|Overall Study|Protocol Violation|1|||
157233758|NCT00735904|567602605|FG000|Overall Study|Withdrawal by Subject|1|||
157233759|NCT00735904|567602605|FG000|Overall Study|Study Terminated by Sponsor|5|||
157233760|NCT00735904|567602605|FG000|Overall Study|Other|8|||
157233761|NCT00822926|567602611|FG000|Second Injection Visit|Lost to Follow-up|1|||
157233762|NCT00822926|567602612|FG001|Second Injection Visit|Lost to Follow-up|0|||
157233763|NCT00822926|567602611|FG000|Second Injection Visit|Withdrawal by Subject|0|||
157233764|NCT00822926|567602612|FG001|Second Injection Visit|Withdrawal by Subject|1|||
157233765|NCT01378975|567602613|FG000|Overall Study|Death|77|||
157233766|NCT01378975|567602614|FG001|Overall Study|Death|46|||
157233767|NCT01378975|567602613|FG000|Overall Study|Investigator Request|1|||
157233768|NCT01378975|567602614|FG001|Overall Study|Investigator Request|0|||
157233769|NCT01378975|567602613|FG000|Overall Study|Lost to Follow-up|4|||
157233770|NCT01378975|567602614|FG001|Overall Study|Lost to Follow-up|1|||
157233771|NCT01378975|567602613|FG000|Overall Study|Withdrew Consent|4|||
157233772|NCT01378975|567602614|FG001|Overall Study|Withdrew Consent|3|||
157233773|NCT00319735|567602617|FG000|Overall Study|Death|2|||
157233774|NCT03125200|567602622|FG000|Overall Study|Study Termination|0|||
157233775|NCT03125200|567602623|FG001|Overall Study|Study Termination|0|||
157233776|NCT03125200|567602624|FG002|Overall Study|Study Termination|0|||
157233777|NCT03125200|567602625|FG003|Overall Study|Study Termination|1|||
157233778|NCT03125200|567602626|FG004|Overall Study|Study Termination|1|||
157233779|NCT03125200|567602627|FG005|Overall Study|Study Termination|2|||
157233780|NCT03125200|567602628|FG006|Overall Study|Study Termination|1|||
157233781|NCT03125200|567602622|FG000|Overall Study|Clinical Progression|0|||
157233782|NCT03125200|567602623|FG001|Overall Study|Clinical Progression|0|||
157233783|NCT03125200|567602624|FG002|Overall Study|Clinical Progression|0|||
157233784|NCT03125200|567602625|FG003|Overall Study|Clinical Progression|1|||
157233785|NCT03125200|567602626|FG004|Overall Study|Clinical Progression|0|||
157233786|NCT03125200|567602627|FG005|Overall Study|Clinical Progression|1|||
157233787|NCT03125200|567602628|FG006|Overall Study|Clinical Progression|0|||
157233788|NCT03125200|567602622|FG000|Overall Study|Progressive Disease|2|||
157233789|NCT03125200|567602623|FG001|Overall Study|Progressive Disease|1|||
157084495|NCT01214642|567061741|FG000|Overall Study|Physician Decision|0|||
157084496|NCT01214642|567061742|FG001|Overall Study|Physician Decision|0|||
157084497|NCT01214642|567061743|FG002|Overall Study|Physician Decision|1|||
157084498|NCT01214642|567061744|FG003|Overall Study|Physician Decision|1|||
157084499|NCT01214642|567061745|FG004|Overall Study|Physician Decision|1|||
157084500|NCT01214642|567061746|FG005|Overall Study|Physician Decision|0|||
157084501|NCT01214642|567061747|FG006|Overall Study|Physician Decision|0|||
157233790|NCT03125200|567602624|FG002|Overall Study|Progressive Disease|2|||
157233791|NCT03125200|567602625|FG003|Overall Study|Progressive Disease|1|||
157233792|NCT03125200|567602626|FG004|Overall Study|Progressive Disease|2|||
157233793|NCT03125200|567602627|FG005|Overall Study|Progressive Disease|0|||
157084502|NCT01214642|567061748|FG007|Overall Study|Physician Decision|0|||
157084503|NCT01214642|567061749|FG008|Overall Study|Physician Decision|0|||
157084504|NCT01214642|567061750|FG009|Overall Study|Physician Decision|0|||
157084505|NCT01214642|567061751|FG010|Overall Study|Physician Decision|0|||
157084506|NCT01214642|567061752|FG011|Overall Study|Physician Decision|2|||
157084507|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Adverse Event|6|||
157084508|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Adverse Event|6|||
157084509|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Death|1|||
157084510|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Death|1|||
157084511|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
157084512|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
157084513|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
157084514|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
157084515|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Physician Decision|1|||
157084516|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Physician Decision|4|||
157084517|NCT03828747|567063514|FG000|Double-Blind Treatment Period|Various reasons|5|||
157084518|NCT03828747|567063515|FG001|Double-Blind Treatment Period|Various reasons|3|||
157084519|NCT03828747|567063514|FG000|Open-Label Extension|Adverse Event|9|||
157084520|NCT03828747|567063515|FG001|Open-Label Extension|Adverse Event|7|||
157084521|NCT03828747|567063514|FG000|Open-Label Extension|Death|0|||
157084522|NCT03828747|567063515|FG001|Open-Label Extension|Death|2|||
157084523|NCT03828747|567063514|FG000|Open-Label Extension|Lost to Follow-up|4|||
157084524|NCT03828747|567063515|FG001|Open-Label Extension|Lost to Follow-up|0|||
157084525|NCT03828747|567063514|FG000|Open-Label Extension|Withdrawal by Subject|31|||
157084526|NCT03828747|567063515|FG001|Open-Label Extension|Withdrawal by Subject|30|||
157084527|NCT03828747|567063514|FG000|Open-Label Extension|Various reasons|4|||
157193614|NCT05111548|567451517|FG001|Overall Study|Adverse Event|0|||
157084528|NCT03828747|567063515|FG001|Open-Label Extension|Various reasons|4|||
157084529|NCT03828747|567063514|FG000|Open-Label Extension|Physician Decision|6|||
157084530|NCT03828747|567063515|FG001|Open-Label Extension|Physician Decision|2|||
157084531|NCT03646656|567063516|FG000|Overall Study|Lost to Follow-up|1|||
157084532|NCT03646656|567063517|FG001|Overall Study|Lost to Follow-up|0|||
157084533|NCT03646656|567063516|FG000|Overall Study|Withdrawal by Subject|2|||
157084534|NCT03646656|567063517|FG001|Overall Study|Withdrawal by Subject|0|||
157084535|NCT03507777|567063518|FG000|Overall Study|Lost to Follow-up|5|||
157084536|NCT03507777|567063519|FG001|Overall Study|Lost to Follow-up|7|||
157193615|NCT00386152|567451518|FG000|Overall Study|Adverse Event|6|||
157193616|NCT00386152|567451519|FG001|Overall Study|Adverse Event|5|||
157193617|NCT00386152|567451520|FG002|Overall Study|Adverse Event|4|||
157193618|NCT00386152|567451518|FG000|Overall Study|Chang from original chemo stratification|4|||
157193619|NCT00386152|567451519|FG001|Overall Study|Chang from original chemo stratification|5|||
157193620|NCT00386152|567451520|FG002|Overall Study|Chang from original chemo stratification|6|||
157193621|NCT00386152|567451518|FG000|Overall Study|Death|3|||
157193622|NCT00386152|567451519|FG001|Overall Study|Death|0|||
157193623|NCT00386152|567451520|FG002|Overall Study|Death|1|||
157193624|NCT00386152|567451518|FG000|Overall Study|Disease progression|7|||
157193625|NCT00386152|567451519|FG001|Overall Study|Disease progression|4|||
157193626|NCT00386152|567451520|FG002|Overall Study|Disease progression|5|||
157193627|NCT00386152|567451518|FG000|Overall Study|Physician Decision|13|||
157193628|NCT00386152|567451519|FG001|Overall Study|Physician Decision|10|||
157193629|NCT00386152|567451520|FG002|Overall Study|Physician Decision|4|||
157193630|NCT00386152|567451518|FG000|Overall Study|Lost to Follow-up|1|||
157193631|NCT00386152|567451519|FG001|Overall Study|Lost to Follow-up|0|||
157193632|NCT00386152|567451520|FG002|Overall Study|Lost to Follow-up|0|||
157193633|NCT00386152|567451518|FG000|Overall Study|Completed chemotherapy|4|||
157193634|NCT00386152|567451519|FG001|Overall Study|Completed chemotherapy|5|||
157193635|NCT00386152|567451520|FG002|Overall Study|Completed chemotherapy|1|||
157193636|NCT00386152|567451518|FG000|Overall Study|Protocol Violation|3|||
157193637|NCT00386152|567451519|FG001|Overall Study|Protocol Violation|5|||
157193638|NCT00386152|567451520|FG002|Overall Study|Protocol Violation|2|||
157193639|NCT00386152|567451518|FG000|Overall Study|Withdrawal by Subject|3|||
157193640|NCT00386152|567451519|FG001|Overall Study|Withdrawal by Subject|6|||
157193641|NCT00386152|567451520|FG002|Overall Study|Withdrawal by Subject|10|||
157193642|NCT01101321|567451521|FG000|Period 1|Withdrawal by Subject|1|||
157193643|NCT01101321|567451522|FG001|Period 1|Withdrawal by Subject|1|||
157193644|NCT01101321|567451521|FG000|Period 1|Adverse Event|3|||
157193645|NCT01101321|567451522|FG001|Period 1|Adverse Event|3|||
157193646|NCT02577107|567451526|FG000|Overall Study|Protocol deviation|0|||
157193647|NCT02577107|567451527|FG001|Overall Study|Protocol deviation|1|||
157193648|NCT00577382|567451528|FG000|Overall Study|Adverse Event|0|||
157193649|NCT00577382|567451529|FG001|Overall Study|Adverse Event|6|||
157193650|NCT00577382|567451528|FG000|Overall Study|Withdrawal by Subject|0|||
157193651|NCT00577382|567451529|FG001|Overall Study|Withdrawal by Subject|1|||
157193652|NCT00577382|567451528|FG000|Overall Study|Progressive Disease|17|||
157193653|NCT00577382|567451529|FG001|Overall Study|Progressive Disease|19|||
157193654|NCT00577382|567451528|FG000|Overall Study|Intercurrent Illness|1|||
157233794|NCT03125200|567602628|FG006|Overall Study|Progressive Disease|1|||
157233795|NCT03125200|567602622|FG000|Overall Study|Lack of Efficacy|0|||
157233796|NCT03125200|567602623|FG001|Overall Study|Lack of Efficacy|0|||
157233797|NCT03125200|567602624|FG002|Overall Study|Lack of Efficacy|0|||
157233798|NCT03125200|567602625|FG003|Overall Study|Lack of Efficacy|1|||
157233799|NCT03125200|567602626|FG004|Overall Study|Lack of Efficacy|0|||
157233800|NCT03125200|567602627|FG005|Overall Study|Lack of Efficacy|0|||
157233801|NCT03125200|567602628|FG006|Overall Study|Lack of Efficacy|0|||
157233802|NCT03125200|567602622|FG000|Overall Study|Toxicity|0|||
157233803|NCT03125200|567602623|FG001|Overall Study|Toxicity|0|||
157233804|NCT03125200|567602624|FG002|Overall Study|Toxicity|0|||
157233805|NCT03125200|567602625|FG003|Overall Study|Toxicity|1|||
157233806|NCT03125200|567602626|FG004|Overall Study|Toxicity|0|||
157233807|NCT03125200|567602627|FG005|Overall Study|Toxicity|0|||
157233808|NCT03125200|567602628|FG006|Overall Study|Toxicity|0|||
157233809|NCT03125200|567602622|FG000|Overall Study|Consent Withdrawn by Subject|0|||
157233810|NCT03125200|567602623|FG001|Overall Study|Consent Withdrawn by Subject|1|||
157233811|NCT03125200|567602624|FG002|Overall Study|Consent Withdrawn by Subject|0|||
157233812|NCT03125200|567602625|FG003|Overall Study|Consent Withdrawn by Subject|0|||
157233813|NCT03125200|567602626|FG004|Overall Study|Consent Withdrawn by Subject|1|||
157233814|NCT03125200|567602627|FG005|Overall Study|Consent Withdrawn by Subject|0|||
157233815|NCT03125200|567602628|FG006|Overall Study|Consent Withdrawn by Subject|1|||
157233816|NCT00119379|567602629|FG000|Overall Study|Adverse Event|4|||
157233817|NCT00119379|567602630|FG001|Overall Study|Adverse Event|1|||
157233818|NCT02216071|567602639|FG000|Overall Study|Withdrawal by Subject|7|||
157233819|NCT02216071|567602640|FG001|Overall Study|Withdrawal by Subject|2|||
157233820|NCT02216071|567602639|FG000|Overall Study|Lost to Follow-up|3|||
157233821|NCT02216071|567602640|FG001|Overall Study|Lost to Follow-up|3|||
157233822|NCT02216071|567602639|FG000|Overall Study|Protocol Violation|3|||
157233823|NCT02216071|567602640|FG001|Overall Study|Protocol Violation|5|||
157233824|NCT02216071|567602639|FG000|Overall Study|Other|2|||
157233825|NCT02216071|567602640|FG001|Overall Study|Other|2|||
157233826|NCT01706536|567602641|FG000|Overall Study|Withdrawal by Subject|1|||
157233827|NCT01706536|567602642|FG001|Overall Study|Withdrawal by Subject|0|||
157233828|NCT01706536|567602643|FG002|Overall Study|Withdrawal by Subject|1|||
157233829|NCT01706536|567602644|FG003|Overall Study|Withdrawal by Subject|0|||
157233830|NCT01706536|567602645|FG004|Overall Study|Withdrawal by Subject|0|||
157233831|NCT01706536|567602641|FG000|Overall Study|Adverse Event|2|||
157233832|NCT01706536|567602642|FG001|Overall Study|Adverse Event|3|||
157233833|NCT01706536|567602643|FG002|Overall Study|Adverse Event|4|||
157233834|NCT01706536|567602644|FG003|Overall Study|Adverse Event|3|||
157233835|NCT01706536|567602645|FG004|Overall Study|Adverse Event|2|||
157233836|NCT01706536|567602641|FG000|Overall Study|Lack of Efficacy|1|||
157233837|NCT01706536|567602642|FG001|Overall Study|Lack of Efficacy|0|||
157233838|NCT01706536|567602643|FG002|Overall Study|Lack of Efficacy|0|||
157233839|NCT01706536|567602644|FG003|Overall Study|Lack of Efficacy|1|||
157233840|NCT01706536|567602645|FG004|Overall Study|Lack of Efficacy|0|||
157233841|NCT01706536|567602641|FG000|Overall Study|non compliance|0|||
157233842|NCT01706536|567602642|FG001|Overall Study|non compliance|1|||
157233843|NCT01706536|567602643|FG002|Overall Study|non compliance|0|||
157233844|NCT01706536|567602644|FG003|Overall Study|non compliance|0|||
157233845|NCT01706536|567602645|FG004|Overall Study|non compliance|0|||
157233846|NCT03262012|567602646|FG000|Overall Study|Withdrawal by Subject|15|||
157233847|NCT03262012|567602647|FG001|Overall Study|Withdrawal by Subject|13|||
157233848|NCT03262012|567602648|FG002|Overall Study|Withdrawal by Subject|8|||
157233849|NCT03262012|567602649|FG003|Overall Study|Withdrawal by Subject|7|||
157233850|NCT03262012|567602646|FG000|Overall Study|Adverse Event|10|||
157233851|NCT03262012|567602647|FG001|Overall Study|Adverse Event|12|||
157233852|NCT03262012|567602648|FG002|Overall Study|Adverse Event|4|||
157233853|NCT03262012|567602649|FG003|Overall Study|Adverse Event|6|||
157233854|NCT03262012|567602646|FG000|Overall Study|Physician Decision|2|||
157233855|NCT03262012|567602647|FG001|Overall Study|Physician Decision|5|||
157233856|NCT03262012|567602648|FG002|Overall Study|Physician Decision|1|||
157233857|NCT03262012|567602649|FG003|Overall Study|Physician Decision|0|||
157233858|NCT03262012|567602646|FG000|Overall Study|Lack of Efficacy|0|||
157233859|NCT03262012|567602647|FG001|Overall Study|Lack of Efficacy|5|||
157233860|NCT03262012|567602648|FG002|Overall Study|Lack of Efficacy|1|||
157233861|NCT03262012|567602649|FG003|Overall Study|Lack of Efficacy|2|||
157233862|NCT03262012|567602646|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
157233863|NCT03262012|567602647|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
157233864|NCT03262012|567602648|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
157233865|NCT03262012|567602649|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
157233866|NCT01066143|567604816|FG000|Overall Study|ineligible for the study|8|||
157233867|NCT01294787|567604817|FG000|Period 1|Adverse Event|0|||
157233868|NCT01294787|567604818|FG001|Period 1|Adverse Event|0|||
157233869|NCT01294787|567604819|FG002|Period 1|Adverse Event|0|||
157233870|NCT01294787|567604820|FG003|Period 1|Adverse Event|0|||
157233871|NCT01294787|567604821|FG004|Period 1|Adverse Event|1|||
157233872|NCT01294787|567604822|FG005|Period 1|Adverse Event|0|||
157233873|NCT01294787|567604817|FG000|Period 1|Withdrawal by Subject|0|||
157233874|NCT01294787|567604818|FG001|Period 1|Withdrawal by Subject|0|||
157233875|NCT01294787|567604819|FG002|Period 1|Withdrawal by Subject|0|||
157233876|NCT01294787|567604820|FG003|Period 1|Withdrawal by Subject|1|||
157233877|NCT01294787|567604821|FG004|Period 1|Withdrawal by Subject|1|||
157233878|NCT01294787|567604822|FG005|Period 1|Withdrawal by Subject|1|||
157233879|NCT01294787|567604817|FG000|Period 1|Administrative problem|0|||
157233880|NCT01294787|567604818|FG001|Period 1|Administrative problem|0|||
157233881|NCT01294787|567604819|FG002|Period 1|Administrative problem|1|||
157233882|NCT01294787|567604820|FG003|Period 1|Administrative problem|0|||
157233883|NCT01294787|567604821|FG004|Period 1|Administrative problem|0|||
157233884|NCT01294787|567604822|FG005|Period 1|Administrative problem|1|||
157233885|NCT01294787|567604817|FG000|Period 2|Adverse Event|0|||
157233886|NCT01294787|567604818|FG001|Period 2|Adverse Event|3|||
157233887|NCT01294787|567604819|FG002|Period 2|Adverse Event|0|||
157233888|NCT01294787|567604820|FG003|Period 2|Adverse Event|1|||
157233889|NCT01294787|567604821|FG004|Period 2|Adverse Event|0|||
157233890|NCT01294787|567604822|FG005|Period 2|Adverse Event|0|||
157233891|NCT01294787|567604817|FG000|Period 2|No longer needs study drug|0|||
157233892|NCT01294787|567604818|FG001|Period 2|No longer needs study drug|0|||
157233893|NCT01294787|567604819|FG002|Period 2|No longer needs study drug|0|||
157233894|NCT01294787|567604820|FG003|Period 2|No longer needs study drug|1|||
157233895|NCT01294787|567604821|FG004|Period 2|No longer needs study drug|0|||
157233896|NCT01294787|567604822|FG005|Period 2|No longer needs study drug|0|||
157233897|NCT01294787|567604817|FG000|Period 3|Adverse Event|0|||
157233898|NCT01294787|567604818|FG001|Period 3|Adverse Event|0|||
157233899|NCT01294787|567604819|FG002|Period 3|Adverse Event|0|||
157233900|NCT01294787|567604820|FG003|Period 3|Adverse Event|0|||
157233901|NCT01294787|567604821|FG004|Period 3|Adverse Event|1|||
157233902|NCT01294787|567604822|FG005|Period 3|Adverse Event|0|||
157233903|NCT01900691|567604823|FG000|Overall Study|Death|7|||
157233904|NCT01900691|567604823|FG000|Overall Study|Lost to Follow-up|4|||
157233905|NCT01900691|567604823|FG000|Overall Study|Study Device Not Placed|3|||
157233906|NCT01900691|567604823|FG000|Overall Study|Non study stent placed|2|||
157233907|NCT01900691|567604823|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
157233908|NCT01900691|567604823|FG000|Overall Study|Complete stent migration through digestive tract|1|||
157233909|NCT01149473|567604824|FG000|First Intervention|Adverse Event|1|||
157233910|NCT01149473|567604825|FG001|First Intervention|Adverse Event|1|||
157233911|NCT01149473|567604824|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
157233912|NCT01149473|567604825|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
157233913|NCT01954394|567604826|FG000|Overall Study|Enrolled but not treated|1|||
157233914|NCT01954394|567604827|FG001|Overall Study|Enrolled but not treated|0|||
157233915|NCT01954394|567604826|FG000|Overall Study|Adverse Event|10|||
157233916|NCT01954394|567604827|FG001|Overall Study|Adverse Event|23|||
157233917|NCT01954394|567604826|FG000|Overall Study|Poor compliance to protocol|7|||
157233918|NCT01954394|567604827|FG001|Overall Study|Poor compliance to protocol|7|||
157233919|NCT01954394|567604826|FG000|Overall Study|Participant Moved|0|||
157233920|NCT01954394|567604827|FG001|Overall Study|Participant Moved|4|||
157233921|NCT01954394|567604826|FG000|Overall Study|Related to Study Drug administration|2|||
157233922|NCT01954394|567604827|FG001|Overall Study|Related to Study Drug administration|2|||
157233923|NCT01954394|567604826|FG000|Overall Study|Other than specified above|10|||
157233924|NCT01954394|567604827|FG001|Overall Study|Other than specified above|21|||
157233925|NCT03107091|567604830|FG000|Overall Study|Physician Decision|1|||
157233926|NCT03025880|567604835|FG000|Overall Study|Adverse Event|1|||
157233927|NCT03025880|567604836|FG001|Overall Study|Adverse Event|0|||
157233928|NCT03025880|567604835|FG000|Overall Study|Death|1|||
157233929|NCT03025880|567604836|FG001|Overall Study|Death|1|||
157233930|NCT03025880|567604835|FG000|Overall Study|Withdrawal by Subject|0|||
157233931|NCT03025880|567604836|FG001|Overall Study|Withdrawal by Subject|1|||
157233932|NCT03025880|567604835|FG000|Overall Study|Physician Decision|0|||
157233933|NCT03025880|567604836|FG001|Overall Study|Physician Decision|1|||
157233934|NCT03025880|567604835|FG000|Overall Study|Progressive Disease|12|||
157233935|NCT03025880|567604836|FG001|Overall Study|Progressive Disease|19|||
157233936|NCT00436553|567604837|FG000|Overall Study|Adverse Event|4|||
157233937|NCT00436553|567604838|FG001|Overall Study|Adverse Event|3|||
157233938|NCT00436553|567604839|FG002|Overall Study|Adverse Event|4|||
157233939|NCT00436553|567604837|FG000|Overall Study|Death|3|||
157233940|NCT00436553|567604838|FG001|Overall Study|Death|1|||
157233941|NCT00436553|567604839|FG002|Overall Study|Death|3|||
157233942|NCT00436553|567604837|FG000|Overall Study|Lost to Follow-up|0|||
157233943|NCT00436553|567604838|FG001|Overall Study|Lost to Follow-up|2|||
157233944|NCT00436553|567604839|FG002|Overall Study|Lost to Follow-up|0|||
157233945|NCT00436553|567604837|FG000|Overall Study|Protocol Violation|1|||
157233946|NCT00436553|567604838|FG001|Overall Study|Protocol Violation|0|||
157233947|NCT00436553|567604839|FG002|Overall Study|Protocol Violation|0|||
157233948|NCT00436553|567604837|FG000|Overall Study|Withdrawal by Subject|5|||
157233949|NCT00436553|567604838|FG001|Overall Study|Withdrawal by Subject|6|||
157233950|NCT00436553|567604839|FG002|Overall Study|Withdrawal by Subject|3|||
157233951|NCT00625443|567604845|FG000|Overall Study|Adverse Event|1|||
157233952|NCT00625443|567604846|FG001|Overall Study|Adverse Event|4|||
157233953|NCT00625443|567604847|FG002|Overall Study|Adverse Event|0|||
157233954|NCT00625443|567604845|FG000|Overall Study|Non-compliance with protocol|0|||
157233955|NCT00625443|567604846|FG001|Overall Study|Non-compliance with protocol|1|||
157233956|NCT00625443|567604847|FG002|Overall Study|Non-compliance with protocol|0|||
157233957|NCT00625443|567604845|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
157233958|NCT00625443|567604846|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
157233959|NCT00625443|567604847|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
157233960|NCT00625443|567604845|FG000|Overall Study|Withdrawal by Subject|0|||
157233961|NCT00625443|567604846|FG001|Overall Study|Withdrawal by Subject|1|||
157233962|NCT00625443|567604847|FG002|Overall Study|Withdrawal by Subject|2|||
157233963|NCT00625443|567604845|FG000|Overall Study|Physician Decision|0|||
157233964|NCT00625443|567604846|FG001|Overall Study|Physician Decision|4|||
157233965|NCT00625443|567604847|FG002|Overall Study|Physician Decision|2|||
157233966|NCT00625443|567604845|FG000|Overall Study|Other|0|||
157233967|NCT00625443|567604846|FG001|Overall Study|Other|1|||
157233968|NCT00625443|567604847|FG002|Overall Study|Other|1|||
157233969|NCT03136380|567604848|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157233970|NCT03136380|567604849|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
157233971|NCT03136380|567604850|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157233972|NCT03136380|567604851|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157233973|NCT03136380|567604852|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157233974|NCT02728102|567604853|FG000|Overall Study|Death|3|||
157233975|NCT02728102|567604854|FG001|Overall Study|Death|0|||
157233976|NCT02728102|567604855|FG002|Overall Study|Death|1|||
157233977|NCT02728102|567604853|FG000|Overall Study|Withdrawal by Subject|0|||
157233978|NCT02728102|567604854|FG001|Overall Study|Withdrawal by Subject|2|||
157233979|NCT02728102|567604855|FG002|Overall Study|Withdrawal by Subject|3|||
157233980|NCT02728102|567604853|FG000|Overall Study|Physician Decision|1|||
157233981|NCT02728102|567604854|FG001|Overall Study|Physician Decision|1|||
157233982|NCT02728102|567604855|FG002|Overall Study|Physician Decision|0|||
157233983|NCT02728102|567604853|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
157233984|NCT02728102|567604854|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
157233985|NCT02728102|567604855|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
157233986|NCT02728102|567604853|FG000|Overall Study|Covid|0|||
157233987|NCT02728102|567604854|FG001|Overall Study|Covid|0|||
157233988|NCT02728102|567604855|FG002|Overall Study|Covid|1|||
157233989|NCT02419937|567604859|FG000|Overall Study|Lost to Follow-up|1|||
157233990|NCT02419937|567604860|FG001|Overall Study|Lost to Follow-up|0|||
157233991|NCT00553280|567604862|FG000|Overall Study|Adverse Event|19|||
157233992|NCT00553280|567604862|FG000|Overall Study|Lack of Efficacy|3|||
157233993|NCT00553280|567604862|FG000|Overall Study|Withdrawal by Subject|3|||
157233994|NCT00553280|567604862|FG000|Overall Study|Physician Decision|1|||
157233995|NCT01182415|567604863|FG000|Overall Study|Lost to Follow-up|1|||
157233996|NCT01544127|567604864|FG000|Overall Study|Lost to Follow-up|4|||
157233997|NCT01544127|567604865|FG001|Overall Study|Lost to Follow-up|2|||
157233998|NCT01544127|567604866|FG002|Overall Study|Lost to Follow-up|9|||
157233999|NCT01544127|567604864|FG000|Overall Study|Withdrawal by Subject|2|||
157234000|NCT01544127|567604865|FG001|Overall Study|Withdrawal by Subject|2|||
157234001|NCT01544127|567604866|FG002|Overall Study|Withdrawal by Subject|1|||
157234002|NCT01544127|567604864|FG000|Overall Study|Discharged out of catchment area|1|||
157234003|NCT01544127|567604865|FG001|Overall Study|Discharged out of catchment area|1|||
157234004|NCT01544127|567604866|FG002|Overall Study|Discharged out of catchment area|1|||
157234005|NCT01544127|567604864|FG000|Overall Study|Death|1|||
157234006|NCT01544127|567604865|FG001|Overall Study|Death|0|||
157234007|NCT01544127|567604866|FG002|Overall Study|Death|0|||
157234008|NCT01544127|567604864|FG000|Overall Study|Jail or Prison|1|||
157234009|NCT01544127|567604865|FG001|Overall Study|Jail or Prison|1|||
157234010|NCT01544127|567604866|FG002|Overall Study|Jail or Prison|2|||
157234011|NCT01544127|567604864|FG000|Overall Study|Became Psychotic|1|||
157234012|NCT01544127|567604865|FG001|Overall Study|Became Psychotic|0|||
157234013|NCT01544127|567604866|FG002|Overall Study|Became Psychotic|0|||
157234014|NCT01544127|567604864|FG000|Overall Study|Researcher withdrew|1|||
157234015|NCT01544127|567604865|FG001|Overall Study|Researcher withdrew|0|||
157234016|NCT01544127|567604866|FG002|Overall Study|Researcher withdrew|0|||
157234017|NCT01544127|567604864|FG000|Overall Study|Went active duty|0|||
157234018|NCT01544127|567604865|FG001|Overall Study|Went active duty|0|||
157234019|NCT01544127|567604866|FG002|Overall Study|Went active duty|1|||
157234020|NCT01256684|567604869|FG000|Overall Study|Adverse Event|1|||
157234021|NCT01256684|567604870|FG001|Overall Study|Adverse Event|4|||
157234022|NCT01256684|567604871|FG002|Overall Study|Adverse Event|2|||
157234023|NCT01256684|567604869|FG000|Overall Study|Withdrawal by Subject|4|||
157234024|NCT01256684|567604870|FG001|Overall Study|Withdrawal by Subject|0|||
157234025|NCT01256684|567604871|FG002|Overall Study|Withdrawal by Subject|2|||
157234026|NCT01256684|567604869|FG000|Overall Study|Physician Decision|0|||
157234027|NCT01256684|567604870|FG001|Overall Study|Physician Decision|1|||
157234028|NCT01256684|567604871|FG002|Overall Study|Physician Decision|0|||
157234029|NCT01256684|567604869|FG000|Overall Study|Lack of Efficacy|0|||
157234030|NCT01256684|567604870|FG001|Overall Study|Lack of Efficacy|1|||
157193655|NCT00577382|567451529|FG001|Overall Study|Intercurrent Illness|2|||
157193656|NCT00577382|567451528|FG000|Overall Study|Death|1|||
157193657|NCT00577382|567451529|FG001|Overall Study|Death|1|||
157193658|NCT00577382|567451528|FG000|Overall Study|Lost to Follow-up|2|||
157193659|NCT00577382|567451529|FG001|Overall Study|Lost to Follow-up|2|||
157193660|NCT01345162|567451530|FG000|Overall Study|Protocol Violation|2|||
157193661|NCT01345162|567451531|FG001|Overall Study|Protocol Violation|4|||
157193662|NCT03007472|567451533|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
157193663|NCT03007472|567451533|FG000|Overall Study|Death|2|||
157193664|NCT03007472|567451533|FG000|Overall Study|Loss to Follow Up|1|||
157193665|NCT00649220|567451540|FG000|Overall Study|Adverse Event|2|||
157193666|NCT00649220|567451540|FG000|Overall Study|Withdrawal by Subject|1|||
157193667|NCT00525499|567451541|FG000|Overall Study|Lost to Follow-up|2|||
157193668|NCT00525499|567451542|FG001|Overall Study|Lost to Follow-up|4|||
157193669|NCT00525499|567451543|FG002|Overall Study|Lost to Follow-up|1|||
157193670|NCT00525499|567451544|FG003|Overall Study|Lost to Follow-up|4|||
157193671|NCT00525499|567451541|FG000|Overall Study|Adverse Event|0|||
157193672|NCT00525499|567451542|FG001|Overall Study|Adverse Event|1|||
157193673|NCT00525499|567451543|FG002|Overall Study|Adverse Event|0|||
157193674|NCT00525499|567451544|FG003|Overall Study|Adverse Event|1|||
157193675|NCT00525499|567451541|FG000|Overall Study|Withdrawal by Subject|5|||
157193676|NCT00525499|567451542|FG001|Overall Study|Withdrawal by Subject|1|||
157193677|NCT00525499|567451543|FG002|Overall Study|Withdrawal by Subject|5|||
157193678|NCT00525499|567451544|FG003|Overall Study|Withdrawal by Subject|2|||
157193679|NCT00525499|567451541|FG000|Overall Study|Protocol Violation|0|||
157193680|NCT00525499|567451542|FG001|Overall Study|Protocol Violation|1|||
157193681|NCT00525499|567451543|FG002|Overall Study|Protocol Violation|1|||
157193682|NCT00525499|567451544|FG003|Overall Study|Protocol Violation|0|||
157193683|NCT03339999|567451545|FG000|Overall Study|Adverse Event|1|||
157193684|NCT03339999|567451546|FG001|Overall Study|Adverse Event|2|||
157193685|NCT03339999|567451547|FG002|Overall Study|Adverse Event|2|||
157193686|NCT03339999|567451548|FG003|Overall Study|Adverse Event|1|||
157193687|NCT03339999|567451545|FG000|Overall Study|Lack of Efficacy|0|||
157193688|NCT03339999|567451546|FG001|Overall Study|Lack of Efficacy|1|||
157193689|NCT03339999|567451547|FG002|Overall Study|Lack of Efficacy|0|||
157193690|NCT03339999|567451548|FG003|Overall Study|Lack of Efficacy|0|||
157193691|NCT03339999|567451545|FG000|Overall Study|Lost to Follow-up|0|||
157193692|NCT03339999|567451546|FG001|Overall Study|Lost to Follow-up|0|||
157193693|NCT03339999|567451547|FG002|Overall Study|Lost to Follow-up|0|||
157193694|NCT03339999|567451548|FG003|Overall Study|Lost to Follow-up|1|||
157193695|NCT03339999|567451545|FG000|Overall Study|Study Terminated by Sponsor|6|||
157193696|NCT03339999|567451546|FG001|Overall Study|Study Terminated by Sponsor|3|||
157193697|NCT03339999|567451547|FG002|Overall Study|Study Terminated by Sponsor|4|||
157193698|NCT03339999|567451548|FG003|Overall Study|Study Terminated by Sponsor|3|||
157193699|NCT00608426|567451549|FG000|Overall Study|Death|32|||
157193700|NCT00608426|567451550|FG001|Overall Study|Death|36|||
157193701|NCT00608426|567451549|FG000|Overall Study|Lost to Follow-up|485|||
157193702|NCT00608426|567451550|FG001|Overall Study|Lost to Follow-up|521|||
157193703|NCT00608426|567451549|FG000|Overall Study|refused, health issues, wrong address|319|||
157193704|NCT00608426|567451550|FG001|Overall Study|refused, health issues, wrong address|348|||
157193705|NCT00761891|567451551|FG000|Overall Study|Withdrawal by Subject|10|||
157193706|NCT01453439|567451555|FG000|Treatment Phase|Withdrawal by Subject|13|||
157193707|NCT01453439|567451556|FG001|Treatment Phase|Withdrawal by Subject|10|||
157193708|NCT01453439|567451555|FG000|Treatment Phase|Suicidal Ideation|2|||
157193709|NCT01453439|567451556|FG001|Treatment Phase|Suicidal Ideation|0|||
157193710|NCT01453439|567451555|FG000|Treatment Phase|Need for higher level of care|1|||
157193711|NCT01453439|567451556|FG001|Treatment Phase|Need for higher level of care|1|||
157193712|NCT01453439|567451555|FG000|Treatment Phase|Therapist conflict of interest|1|||
157193713|NCT01453439|567451556|FG001|Treatment Phase|Therapist conflict of interest|0|||
157193714|NCT01453439|567451555|FG000|Follow-up|Withdrawal by Subject|0|||
157193715|NCT01453439|567451556|FG001|Follow-up|Withdrawal by Subject|1|||
157193716|NCT01453439|567451555|FG000|Follow-up|Lost to Follow-up|5|||
157193717|NCT01453439|567451556|FG001|Follow-up|Lost to Follow-up|10|||
157193718|NCT01014442|567451557|FG000|Overall Study|Adverse Event|0|||
157193719|NCT01014442|567451558|FG001|Overall Study|Adverse Event|8|||
157193720|NCT01014442|567451557|FG000|Overall Study|Withdrawal by Subject|4|||
157193721|NCT01014442|567451558|FG001|Overall Study|Withdrawal by Subject|4|||
157193722|NCT01014442|567451557|FG000|Overall Study|Protocol Violation|2|||
157193723|NCT01014442|567451558|FG001|Overall Study|Protocol Violation|5|||
157193724|NCT01014442|567451557|FG000|Overall Study|Lack of Compliance|0|||
157193725|NCT01014442|567451558|FG001|Overall Study|Lack of Compliance|1|||
157193726|NCT01014442|567451557|FG000|Overall Study|Unspecified Reason|1|||
157193727|NCT01014442|567451558|FG001|Overall Study|Unspecified Reason|1|||
157193728|NCT02074059|567451559|FG000|Overall Study|Death|0|||
157193729|NCT02074059|567451560|FG001|Overall Study|Death|0|||
157193730|NCT02074059|567451561|FG002|Overall Study|Death|0|||
157193731|NCT02074059|567451562|FG003|Overall Study|Death|0|||
157193732|NCT02074059|567451563|FG004|Overall Study|Death|1|||
157193733|NCT02074059|567451564|FG005|Overall Study|Death|1|||
157193734|NCT02135848|567451570|FG000|Overall Study|Adverse Event|2|||
157193735|NCT02135848|567451571|FG001|Overall Study|Adverse Event|0|||
157193736|NCT02135848|567451570|FG000|Overall Study|Withdrawal by Subject|1|||
157193737|NCT02135848|567451571|FG001|Overall Study|Withdrawal by Subject|1|||
157193738|NCT03258710|567451572|FG000|Overall Study|Adverse Event|1|||
157193739|NCT03258710|567451572|FG000|Overall Study|Protocol-defined stopping criteria|1|||
157193740|NCT03258710|567451572|FG000|Overall Study|Physician Decision|1|||
157193741|NCT02813681|567451573|FG000|Overall Study|Physician Decision|5|||
157193742|NCT02813681|567451574|FG001|Overall Study|Physician Decision|5|||
157193743|NCT02813681|567451575|FG002|Overall Study|Physician Decision|0|||
157193744|NCT02813681|567451573|FG000|Overall Study|Lost to Follow-up|0|||
157193745|NCT02813681|567451574|FG001|Overall Study|Lost to Follow-up|1|||
157193746|NCT02813681|567451575|FG002|Overall Study|Lost to Follow-up|0|||
157193747|NCT03961529|567451578|FG000|Overall Study|Adverse Event|13|||
157193748|NCT03961529|567451579|FG001|Overall Study|Adverse Event|5|||
157193749|NCT03961529|567451580|FG002|Overall Study|Adverse Event|2|||
157193750|NCT03961529|567451578|FG000|Overall Study|Withdrawal by Subject|17|||
157193751|NCT03961529|567451579|FG001|Overall Study|Withdrawal by Subject|2|||
157193752|NCT03961529|567451580|FG002|Overall Study|Withdrawal by Subject|1|||
157193753|NCT03961529|567451578|FG000|Overall Study|Withdrawal by parent/guardian|0|||
157193754|NCT03961529|567451579|FG001|Overall Study|Withdrawal by parent/guardian|7|||
157193755|NCT03961529|567451580|FG002|Overall Study|Withdrawal by parent/guardian|0|||
157193756|NCT03961529|567451578|FG000|Overall Study|Physician Decision|2|||
157193757|NCT03961529|567451579|FG001|Overall Study|Physician Decision|1|||
157193758|NCT03961529|567451580|FG002|Overall Study|Physician Decision|1|||
157193759|NCT03961529|567451578|FG000|Overall Study|Lost to Follow-up|2|||
157193760|NCT03961529|567451579|FG001|Overall Study|Lost to Follow-up|1|||
157193761|NCT03961529|567451580|FG002|Overall Study|Lost to Follow-up|0|||
157193762|NCT03961529|567451578|FG000|Overall Study|Lack of Efficacy|2|||
157193763|NCT03961529|567451579|FG001|Overall Study|Lack of Efficacy|0|||
157193764|NCT03961529|567451580|FG002|Overall Study|Lack of Efficacy|1|||
157193765|NCT03961529|567451578|FG000|Overall Study|Other|6|||
157193766|NCT03961529|567451579|FG001|Overall Study|Other|1|||
157193767|NCT03961529|567451580|FG002|Overall Study|Other|0|||
157193768|NCT03644173|567451581|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
157193769|NCT03644173|567451581|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
157193770|NCT03644173|567451581|FG000|Participants at the 1-month Follow up|Death|2|||
157193771|NCT03644173|567451581|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
157193772|NCT03323385|567451582|FG000|Overall Study|Withdrawal by Subject|1|||
157193773|NCT03323385|567451583|FG001|Overall Study|Withdrawal by Subject|2|||
157193774|NCT03323385|567451582|FG000|Overall Study|Noncompliance|0|||
157193775|NCT03323385|567451583|FG001|Overall Study|Noncompliance|1|||
157193776|NCT02607735|567451584|FG000|Primary Study|Randomized but Never Treated|1|||
157193777|NCT02607735|567451585|FG001|Primary Study|Randomized but Never Treated|0|||
157193778|NCT02607735|567451586|FG002|Primary Study|Randomized but Never Treated|0|||
157193779|NCT02607735|567451584|FG000|Primary Study|Lost to Follow-up|4|||
157193780|NCT02607735|567451585|FG001|Primary Study|Lost to Follow-up|0|||
157193781|NCT02607735|567451586|FG002|Primary Study|Lost to Follow-up|0|||
157193782|NCT02607735|567451584|FG000|Primary Study|Withdrew Consent|2|||
157193783|NCT02607735|567451585|FG001|Primary Study|Withdrew Consent|0|||
157193784|NCT02607735|567451586|FG002|Primary Study|Withdrew Consent|0|||
157193785|NCT02607735|567451584|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
157193786|NCT02607735|567451585|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
157193787|NCT02607735|567451586|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
157193788|NCT02607735|567451584|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
157193789|NCT02607735|567451585|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
157193790|NCT02607735|567451586|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
157193791|NCT01997333|567451592|FG000|Randomization and Treatment|Disease Progression|70|||
157193792|NCT01997333|567451593|FG001|Randomization and Treatment|Disease Progression|159|||
157193793|NCT01997333|567451592|FG000|Randomization and Treatment|Adverse Event|10|||
157193794|NCT01997333|567451593|FG001|Randomization and Treatment|Adverse Event|32|||
157193795|NCT01997333|567451592|FG000|Randomization and Treatment|Physician Decision|0|||
157193796|NCT01997333|567451593|FG001|Randomization and Treatment|Physician Decision|4|||
157193797|NCT01997333|567451592|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
157193798|NCT01997333|567451593|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
157193799|NCT01997333|567451592|FG000|Randomization and Treatment|Did not receive treatment|17|||
157193800|NCT01997333|567451593|FG001|Randomization and Treatment|Did not receive treatment|5|||
157193801|NCT01997333|567451592|FG000|Survival Follow up|Withdrawal by Subject|15|||
157234031|NCT01256684|567604871|FG002|Overall Study|Lack of Efficacy|1|||
157193802|NCT01997333|567451593|FG001|Survival Follow up|Withdrawal by Subject|6|||
157193803|NCT01997333|567451592|FG000|Survival Follow up|Lost to Follow-up|0|||
157193804|NCT01997333|567451593|FG001|Survival Follow up|Lost to Follow-up|6|||
157193805|NCT01997333|567451592|FG000|Survival Follow up|Various|1|||
157193806|NCT01997333|567451593|FG001|Survival Follow up|Various|2|||
157193807|NCT02269709|567451594|FG000|Time of Enrollment|Withdrawal by Subject|3|||
157234032|NCT01256684|567604869|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
157234033|NCT01256684|567604870|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
157234034|NCT01256684|567604871|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
157234035|NCT02587962|567604875|FG000|Overall Study|Adverse Event|0|||
157234036|NCT02587962|567604876|FG001|Overall Study|Adverse Event|0|||
157234037|NCT02587962|567604877|FG002|Overall Study|Adverse Event|1|||
157234038|NCT02587962|567604878|FG003|Overall Study|Adverse Event|0|||
157234039|NCT02587962|567604879|FG004|Overall Study|Adverse Event|0|||
157234040|NCT02587962|567604875|FG000|Overall Study|Withdrawal by Subject|0|||
157234041|NCT02587962|567604876|FG001|Overall Study|Withdrawal by Subject|0|||
157234042|NCT02587962|567604877|FG002|Overall Study|Withdrawal by Subject|1|||
157234043|NCT02587962|567604878|FG003|Overall Study|Withdrawal by Subject|1|||
157234044|NCT02587962|567604879|FG004|Overall Study|Withdrawal by Subject|4|||
157234045|NCT02587962|567604875|FG000|Overall Study|Radiological progression|2|||
157234046|NCT02587962|567604876|FG001|Overall Study|Radiological progression|2|||
157234047|NCT02587962|567604877|FG002|Overall Study|Radiological progression|2|||
157234048|NCT02587962|567604878|FG003|Overall Study|Radiological progression|5|||
157234049|NCT02587962|567604879|FG004|Overall Study|Radiological progression|10|||
157234050|NCT02587962|567604875|FG000|Overall Study|Clinical progression|0|||
157234051|NCT02587962|567604876|FG001|Overall Study|Clinical progression|1|||
157234052|NCT02587962|567604877|FG002|Overall Study|Clinical progression|2|||
157234053|NCT02587962|567604878|FG003|Overall Study|Clinical progression|0|||
157234054|NCT02587962|567604879|FG004|Overall Study|Clinical progression|1|||
157234055|NCT01185548|567604880|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
157234056|NCT00086996|567604881|FG000|Overall Study|Adverse Event|29|||
157234057|NCT00086996|567604881|FG000|Overall Study|Death|4|||
157234058|NCT00086996|567604881|FG000|Overall Study|progression/relapse|7|||
157234059|NCT00086996|567604881|FG000|Overall Study|Withdrawal by Subject|13|||
157234060|NCT00086996|567604881|FG000|Overall Study|Other|6|||
157234061|NCT00086996|567604881|FG000|Overall Study|not eligible|5|||
157234062|NCT01422538|567604883|FG000|Overall Study|Lost to Follow-up|0|||
157234063|NCT01422538|567604884|FG001|Overall Study|Lost to Follow-up|1|||
157234064|NCT01422538|567604885|FG002|Overall Study|Lost to Follow-up|1|||
157234065|NCT01422538|567604883|FG000|Overall Study|Missed visit|0|||
157234066|NCT01422538|567604884|FG001|Overall Study|Missed visit|1|||
157234067|NCT01422538|567604885|FG002|Overall Study|Missed visit|1|||
157234068|NCT00184600|567604886|FG000|Overall Study|Adverse Event|9|||
157234069|NCT00184600|567604887|FG001|Overall Study|Adverse Event|0|||
157234070|NCT00184600|567604888|FG002|Overall Study|Adverse Event|5|||
157234071|NCT00184600|567604886|FG000|Overall Study|Death|3|||
157234072|NCT00184600|567604887|FG001|Overall Study|Death|9|||
157234073|NCT00184600|567604888|FG002|Overall Study|Death|7|||
157234074|NCT00184600|567604886|FG000|Overall Study|Lack of Efficacy|3|||
157234075|NCT00184600|567604887|FG001|Overall Study|Lack of Efficacy|1|||
157234076|NCT00184600|567604888|FG002|Overall Study|Lack of Efficacy|3|||
157234077|NCT00184600|567604886|FG000|Overall Study|Lost to Follow-up|4|||
157234078|NCT00184600|567604887|FG001|Overall Study|Lost to Follow-up|6|||
157234079|NCT00184600|567604888|FG002|Overall Study|Lost to Follow-up|1|||
157234080|NCT00184600|567604886|FG000|Overall Study|Protocol Violation|2|||
157234081|NCT00184600|567604887|FG001|Overall Study|Protocol Violation|2|||
157234082|NCT00184600|567604888|FG002|Overall Study|Protocol Violation|3|||
157234083|NCT00184600|567604886|FG000|Overall Study|Withdrawal by Subject|20|||
157234084|NCT00184600|567604887|FG001|Overall Study|Withdrawal by Subject|28|||
157234085|NCT00184600|567604888|FG002|Overall Study|Withdrawal by Subject|12|||
157234086|NCT00184600|567604886|FG000|Overall Study|Unclassified|4|||
157234087|NCT00184600|567604887|FG001|Overall Study|Unclassified|5|||
157234088|NCT00184600|567604888|FG002|Overall Study|Unclassified|3|||
157234089|NCT00624065|567604891|FG000|Overall Study|Adverse Event|5|||
157234090|NCT00624065|567604892|FG001|Overall Study|Adverse Event|6|||
157234091|NCT00624065|567604891|FG000|Overall Study|Lost to Follow-up|4|||
157234092|NCT00624065|567604892|FG001|Overall Study|Lost to Follow-up|1|||
157234093|NCT00624065|567604891|FG000|Overall Study|Consent withdrawn|6|||
157084537|NCT03507777|567063518|FG000|Overall Study|Withdrawal by Subject|6|||
157084538|NCT03507777|567063519|FG001|Overall Study|Withdrawal by Subject|11|||
157084539|NCT03507777|567063518|FG000|Overall Study|Death|30|||
157234094|NCT00624065|567604892|FG001|Overall Study|Consent withdrawn|5|||
157084540|NCT03507777|567063519|FG001|Overall Study|Death|44|||
157084541|NCT03507777|567063518|FG000|Overall Study|Other Reasons|3|||
157084542|NCT03507777|567063519|FG001|Overall Study|Other Reasons|8|||
157084543|NCT01879722|567063520|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
157234095|NCT00624065|567604891|FG000|Overall Study|Lack of Efficacy|0|||
157234096|NCT00624065|567604892|FG001|Overall Study|Lack of Efficacy|3|||
157234097|NCT00624065|567604891|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
157234098|NCT00624065|567604892|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
157234099|NCT02770820|567604893|FG000|Overall Study|Death|1|||
157234100|NCT02770820|567604893|FG000|Overall Study|Physician Decision|2|||
157234101|NCT00696020|567604894|FG000|Overall Study|Adverse Event|3|||
157234102|NCT00696020|567604895|FG001|Overall Study|Adverse Event|1|||
157234103|NCT00696020|567604896|FG002|Overall Study|Adverse Event|2|||
157234104|NCT00696020|567604897|FG003|Overall Study|Adverse Event|1|||
157234105|NCT00696020|567604894|FG000|Overall Study|Lack of Efficacy|1|||
157234106|NCT00696020|567604895|FG001|Overall Study|Lack of Efficacy|0|||
157234107|NCT00696020|567604896|FG002|Overall Study|Lack of Efficacy|0|||
157234108|NCT00696020|567604897|FG003|Overall Study|Lack of Efficacy|0|||
157234109|NCT00696020|567604894|FG000|Overall Study|Protocol Violation|0|||
157234110|NCT00696020|567604895|FG001|Overall Study|Protocol Violation|0|||
157234111|NCT00696020|567604896|FG002|Overall Study|Protocol Violation|0|||
157234112|NCT00696020|567604897|FG003|Overall Study|Protocol Violation|1|||
157234113|NCT00696020|567604894|FG000|Overall Study|Withdrawal by Subject|0|||
157234114|NCT00696020|567604895|FG001|Overall Study|Withdrawal by Subject|1|||
157234115|NCT00696020|567604896|FG002|Overall Study|Withdrawal by Subject|0|||
157234116|NCT00696020|567604897|FG003|Overall Study|Withdrawal by Subject|1|||
157234117|NCT00696020|567604894|FG000|Overall Study|Other not stated above|0|||
157234118|NCT00696020|567604895|FG001|Overall Study|Other not stated above|0|||
157234119|NCT00696020|567604896|FG002|Overall Study|Other not stated above|1|||
157234120|NCT00696020|567604897|FG003|Overall Study|Other not stated above|1|||
157234121|NCT01387022|567604898|FG000|Overall Study|Death|1|||
157234122|NCT01387022|567604899|FG001|Overall Study|Death|1|||
157234123|NCT01387022|567604898|FG000|Overall Study|Lost to Follow-up|0|||
157234124|NCT01387022|567604899|FG001|Overall Study|Lost to Follow-up|3|||
157234125|NCT02076022|567604901|FG000|Overall Study|Withdrawal by Subject|2|||
157234126|NCT02076022|567604902|FG001|Overall Study|Withdrawal by Subject|0|||
157234127|NCT03627091|567604905|FG000|Overall Study|Adverse Event|0|||
157234128|NCT03627091|567604906|FG001|Overall Study|Adverse Event|0|||
157234129|NCT03627091|567604907|FG002|Overall Study|Adverse Event|2|||
157234130|NCT03627091|567604905|FG000|Overall Study|Withdrawal by Subject|2|||
157234131|NCT03627091|567604906|FG001|Overall Study|Withdrawal by Subject|0|||
157234132|NCT03627091|567604907|FG002|Overall Study|Withdrawal by Subject|2|||
157234133|NCT03627091|567604905|FG000|Overall Study|Physician Decision|2|||
157234134|NCT03627091|567604906|FG001|Overall Study|Physician Decision|0|||
157234135|NCT03627091|567604907|FG002|Overall Study|Physician Decision|0|||
157234136|NCT03627091|567604905|FG000|Overall Study|Site terminated by sponsor|0|||
157234137|NCT03627091|567604906|FG001|Overall Study|Site terminated by sponsor|1|||
157234138|NCT03627091|567604907|FG002|Overall Study|Site terminated by sponsor|0|||
157234139|NCT03627091|567604905|FG000|Overall Study|Disease relapse|7|||
157234140|NCT03627091|567604906|FG001|Overall Study|Disease relapse|5|||
157234141|NCT03627091|567604907|FG002|Overall Study|Disease relapse|1|||
157234142|NCT03627091|567604905|FG000|Overall Study|Other|1|||
157234143|NCT03627091|567604906|FG001|Overall Study|Other|0|||
157234144|NCT03627091|567604907|FG002|Overall Study|Other|0|||
157234145|NCT00102440|567604908|FG000|Overall Study|Lost to Follow-up|25|||
157234146|NCT00102440|567604909|FG001|Overall Study|Lost to Follow-up|18|||
157234147|NCT00102440|567604910|FG002|Overall Study|Lost to Follow-up|21|||
157234148|NCT00102440|567604908|FG000|Overall Study|Adverse Event|16|||
157234149|NCT00102440|567604909|FG001|Overall Study|Adverse Event|23|||
157234150|NCT00102440|567604910|FG002|Overall Study|Adverse Event|8|||
157234151|NCT00102440|567604908|FG000|Overall Study|Gout Flare|10|||
157234152|NCT00102440|567604909|FG001|Overall Study|Gout Flare|28|||
157234153|NCT00102440|567604910|FG002|Overall Study|Gout Flare|9|||
157234154|NCT00102440|567604908|FG000|Overall Study|Personal Reason(s)|19|||
157234155|NCT00102440|567604909|FG001|Overall Study|Personal Reason(s)|13|||
157234156|NCT00102440|567604910|FG002|Overall Study|Personal Reason(s)|13|||
157234157|NCT00102440|567604908|FG000|Overall Study|Other|11|||
157234158|NCT00102440|567604909|FG001|Overall Study|Other|14|||
157234159|NCT00102440|567604910|FG002|Overall Study|Other|14|||
157234160|NCT00102440|567604908|FG000|Overall Study|Protocol Violation|7|||
157234161|NCT00102440|567604909|FG001|Overall Study|Protocol Violation|2|||
157234162|NCT00102440|567604910|FG002|Overall Study|Protocol Violation|1|||
157234163|NCT04239872|567604911|FG000|Overall Study|Lost to Follow-up|0|||
157234164|NCT04239872|567604912|FG001|Overall Study|Lost to Follow-up|1|||
157234165|NCT01498120|567604916|FG000|Overall Study|Lost to Follow-up|1|||
157234166|NCT01498120|567604916|FG000|Overall Study|Withdrawal by Subject|5|||
157234167|NCT01498120|567604916|FG000|Overall Study|AE, non-serious non-fatal|3|||
157234168|NCT01498120|567604916|FG000|Overall Study|Other|4|||
157234169|NCT01472341|567604917|FG000|Overall Study|Started insulin therapy|55|||
157234170|NCT01472341|567604917|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
157234171|NCT01472341|567604917|FG000|Overall Study|Withdrawal by Subject|39|||
157234172|NCT01472341|567604917|FG000|Overall Study|Lost to Follow-up|52|||
157234173|NCT01472341|567604917|FG000|Overall Study|Laboratory parameters unavailable|25|||
157234174|NCT01472341|567604917|FG000|Overall Study|Death|9|||
157234175|NCT04060147|567604918|FG000|Overall Study|Withdrew consent|1|||
157234176|NCT03204539|567604919|FG000|Overall Study|Loss of funding|0|||
157234177|NCT03204539|567604920|FG001|Overall Study|Loss of funding|1|||
157234178|NCT01171963|567604921|FG000|Overall Study|Adverse Event|10|||
157234179|NCT01171963|567604922|FG001|Overall Study|Adverse Event|15|||
157234180|NCT01171963|567604921|FG000|Overall Study|Lost to Follow-up|23|||
157234181|NCT01171963|567604922|FG001|Overall Study|Lost to Follow-up|24|||
157234182|NCT01171963|567604921|FG000|Overall Study|Other - diarrhoea|1|||
157234183|NCT01171963|567604922|FG001|Overall Study|Other - diarrhoea|0|||
157234184|NCT01171963|567604921|FG000|Overall Study|Withdrawal by Subject|114|||
157084544|NCT01879722|567063521|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
157084545|NCT01879722|567063522|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
157084546|NCT01879722|567063523|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
157084547|NCT01879722|567063524|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
157084548|NCT01879722|567063525|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
157084549|NCT01879722|567063526|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
157084550|NCT01879722|567063527|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
157084551|NCT01879722|567063528|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
157084552|NCT01879722|567063529|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
157084553|NCT01879722|567063520|FG000|Overall Study|Voluntary Withdrawal|0|||
157084554|NCT01879722|567063521|FG001|Overall Study|Voluntary Withdrawal|0|||
157193808|NCT02269709|567451594|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
157193809|NCT02269709|567451594|FG000|Six Month Follow-up|Lost to Follow-up|12|||
157193810|NCT02909504|567451595|FG000|Overall Study|Adverse Event|2|||
157193811|NCT02909504|567451595|FG000|Overall Study|Lack of Efficacy|3|||
157193812|NCT02909504|567451595|FG000|Overall Study|Withdrawal by Subject|4|||
157193813|NCT02909504|567451595|FG000|Overall Study|Pregnancy|1|||
157193814|NCT02909504|567451595|FG000|Overall Study|Subject moved|1|||
157193815|NCT02909504|567451595|FG000|Overall Study|Lost to Follow-up|1|||
157193816|NCT02055976|567451596|FG000|Overall Study|Other|0|||
157193817|NCT02055976|567451597|FG001|Overall Study|Other|0|||
157193818|NCT02055976|567451598|FG002|Overall Study|Other|1|||
157193819|NCT02055976|567451599|FG003|Overall Study|Other|0|||
157193820|NCT02055976|567451600|FG004|Overall Study|Other|0|||
157193821|NCT02055976|567451601|FG005|Overall Study|Other|0|||
157193822|NCT02055976|567451602|FG006|Overall Study|Other|0|||
157193823|NCT02055976|567451603|FG007|Overall Study|Other|0|||
157193824|NCT02055976|567451604|FG008|Overall Study|Other|0|||
157193825|NCT02055976|567451596|FG000|Overall Study|Adverse Event|0|||
157193826|NCT02055976|567451597|FG001|Overall Study|Adverse Event|0|||
157193827|NCT02055976|567451598|FG002|Overall Study|Adverse Event|0|||
157193828|NCT02055976|567451599|FG003|Overall Study|Adverse Event|0|||
157193829|NCT02055976|567451600|FG004|Overall Study|Adverse Event|0|||
157193830|NCT02055976|567451601|FG005|Overall Study|Adverse Event|1|||
157193831|NCT02055976|567451602|FG006|Overall Study|Adverse Event|1|||
157193832|NCT02055976|567451603|FG007|Overall Study|Adverse Event|0|||
157193833|NCT02055976|567451604|FG008|Overall Study|Adverse Event|0|||
157193834|NCT02055976|567451596|FG000|Overall Study|Does not meet entrance criteria|0|||
157193835|NCT02055976|567451597|FG001|Overall Study|Does not meet entrance criteria|0|||
157193836|NCT02055976|567451598|FG002|Overall Study|Does not meet entrance criteria|0|||
157193837|NCT02055976|567451599|FG003|Overall Study|Does not meet entrance criteria|0|||
157193838|NCT02055976|567451600|FG004|Overall Study|Does not meet entrance criteria|0|||
157193839|NCT02055976|567451601|FG005|Overall Study|Does not meet entrance criteria|0|||
157193840|NCT02055976|567451602|FG006|Overall Study|Does not meet entrance criteria|1|||
157193841|NCT02055976|567451603|FG007|Overall Study|Does not meet entrance criteria|0|||
157193842|NCT02055976|567451604|FG008|Overall Study|Does not meet entrance criteria|0|||
157193843|NCT02055976|567451596|FG000|Overall Study|Lost to Follow-up|0|||
157193844|NCT02055976|567451597|FG001|Overall Study|Lost to Follow-up|0|||
157193845|NCT02055976|567451598|FG002|Overall Study|Lost to Follow-up|0|||
157193846|NCT02055976|567451599|FG003|Overall Study|Lost to Follow-up|1|||
157193847|NCT02055976|567451600|FG004|Overall Study|Lost to Follow-up|0|||
157193848|NCT02055976|567451601|FG005|Overall Study|Lost to Follow-up|0|||
157193849|NCT02055976|567451602|FG006|Overall Study|Lost to Follow-up|0|||
157193850|NCT02055976|567451603|FG007|Overall Study|Lost to Follow-up|0|||
157193851|NCT02055976|567451604|FG008|Overall Study|Lost to Follow-up|0|||
157193852|NCT00982111|567451610|FG000|Overall Study|Adverse Event|1|||
157193853|NCT00982111|567451611|FG001|Overall Study|Adverse Event|1|||
157193854|NCT00982111|567451610|FG000|Overall Study|Progressive Disease|46|||
157193855|NCT00982111|567451611|FG001|Overall Study|Progressive Disease|39|||
157193856|NCT00982111|567451610|FG000|Overall Study|Lost to Follow-up|9|||
157193857|NCT00982111|567451611|FG001|Overall Study|Lost to Follow-up|6|||
157193858|NCT00982111|567451610|FG000|Overall Study|New Anti-Cancer Therapy|5|||
157193859|NCT00982111|567451611|FG001|Overall Study|New Anti-Cancer Therapy|5|||
157193860|NCT00982111|567451610|FG000|Overall Study|Medical Decision|1|||
157193861|NCT00982111|567451611|FG001|Overall Study|Medical Decision|0|||
157193862|NCT00982111|567451610|FG000|Overall Study|Withdrawal by Subject|17|||
157193863|NCT00982111|567451611|FG001|Overall Study|Withdrawal by Subject|19|||
157193864|NCT00982111|567451610|FG000|Overall Study|Global Study End|0|||
157193865|NCT00982111|567451611|FG001|Overall Study|Global Study End|1|||
157193866|NCT00982111|567451610|FG000|Overall Study|Sponsor's Decision|0|||
157193867|NCT00982111|567451611|FG001|Overall Study|Sponsor's Decision|1|||
157193868|NCT03769753|567451612|FG000|Overall Study|Not Treated|6|||
157084555|NCT01879722|567063522|FG002|Overall Study|Voluntary Withdrawal|0|||
157084556|NCT01879722|567063523|FG003|Overall Study|Voluntary Withdrawal|0|||
157193869|NCT03769753|567451612|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
157193870|NCT01070381|567451613|FG000|Period 2, 1 Week of Wear|Handling|0|||
157193871|NCT01070381|567451614|FG001|Period 2, 1 Week of Wear|Handling|1|||
157193872|NCT01070381|567451613|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
157193873|NCT01070381|567451614|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
157193874|NCT00684073|567451615|FG000|Selection|Selection/non-selection criteria|3|||
157193875|NCT00684073|567451615|FG000|Selection|Death|1|||
157193876|NCT00684073|567451615|FG000|Selection|noncompliance|1|||
157193877|NCT00684073|567451615|FG000|Selection|Lost to Follow-up|1|||
157193878|NCT00684073|567451615|FG000|Selection|request of the sponsor|1|||
157193879|NCT00684073|567451615|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
157193880|NCT01259388|567451616|FG000|Overall Study|Adverse Event|3|||
157193881|NCT01259388|567451617|FG001|Overall Study|Adverse Event|0|||
157193882|NCT01259388|567451616|FG000|Overall Study|Withdrawal by Subject|1|||
157193883|NCT01259388|567451617|FG001|Overall Study|Withdrawal by Subject|1|||
157193884|NCT01259388|567451616|FG000|Overall Study|Physician Decision|1|||
157193885|NCT01259388|567451617|FG001|Overall Study|Physician Decision|0|||
157193886|NCT01888367|567451620|FG000|Overall Study|Physician Decision|3|||
157193887|NCT01888367|567451621|FG001|Overall Study|Physician Decision|4|||
157193888|NCT01888367|567451622|FG002|Overall Study|Physician Decision|2|||
157193889|NCT01888367|567451620|FG000|Overall Study|Death|2|||
157193890|NCT01888367|567451621|FG001|Overall Study|Death|0|||
157193891|NCT01888367|567451622|FG002|Overall Study|Death|1|||
157193892|NCT01888367|567451620|FG000|Overall Study|Withdrawal by Subject|1|||
157193893|NCT01888367|567451621|FG001|Overall Study|Withdrawal by Subject|0|||
157193894|NCT01888367|567451622|FG002|Overall Study|Withdrawal by Subject|1|||
157193895|NCT01888367|567451620|FG000|Overall Study|Lost to Follow-up|1|||
157193896|NCT01888367|567451621|FG001|Overall Study|Lost to Follow-up|1|||
157193897|NCT01888367|567451622|FG002|Overall Study|Lost to Follow-up|0|||
157193898|NCT01888367|567451620|FG000|Overall Study|Protocol Violation|0|||
157193899|NCT01888367|567451621|FG001|Overall Study|Protocol Violation|0|||
157193900|NCT01888367|567451622|FG002|Overall Study|Protocol Violation|1|||
157193901|NCT01888367|567451620|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
157193902|NCT01888367|567451621|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
157193903|NCT01888367|567451622|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
157193904|NCT01854918|567451623|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
157193905|NCT01854918|567451624|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
157193906|NCT01854918|567451623|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
157193907|NCT01854918|567451624|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
157193908|NCT01854918|567451623|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
157193909|NCT01854918|567451624|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
157193910|NCT01854918|567451623|FG000|SOC-controlled Period (Year 1)|Death|5|||
157193911|NCT01854918|567451624|FG001|SOC-controlled Period (Year 1)|Death|5|||
157193912|NCT01854918|567451623|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
157193913|NCT01854918|567451624|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
157193914|NCT01854918|567451623|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
157193915|NCT01854918|567451624|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
157193916|NCT01854918|567451623|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
157193917|NCT01854918|567451624|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
157193918|NCT01854918|567451623|FG000|All-IP Period (Years 2 and 3)|Death|5|||
157193919|NCT01854918|567451624|FG001|All-IP Period (Years 2 and 3)|Death|16|||
157193920|NCT01920061|567451626|FG000|Overall Study|Death|1|||
157193921|NCT01920061|567451627|FG001|Overall Study|Death|1|||
157193922|NCT01920061|567451628|FG002|Overall Study|Death|0|||
157193923|NCT01920061|567451629|FG003|Overall Study|Death|1|||
157193924|NCT01920061|567451630|FG004|Overall Study|Death|1|||
157193925|NCT01920061|567451631|FG005|Overall Study|Death|0|||
157193926|NCT01920061|567451632|FG006|Overall Study|Death|0|||
157193927|NCT01920061|567451633|FG007|Overall Study|Death|1|||
157193928|NCT01920061|567451634|FG008|Overall Study|Death|0|||
157193929|NCT01920061|567451635|FG009|Overall Study|Death|1|||
157193930|NCT01920061|567451636|FG010|Overall Study|Death|0|||
157193931|NCT01920061|567451637|FG011|Overall Study|Death|1|||
157193932|NCT01920061|567451638|FG012|Overall Study|Death|0|||
157193933|NCT01920061|567451639|FG013|Overall Study|Death|2|||
157193934|NCT01920061|567451640|FG014|Overall Study|Death|0|||
157193935|NCT01920061|567451641|FG015|Overall Study|Death|0|||
157193936|NCT01920061|567451642|FG016|Overall Study|Death|0|||
157193937|NCT01920061|567451643|FG017|Overall Study|Death|0|||
157193938|NCT01920061|567451644|FG018|Overall Study|Death|1|||
157193939|NCT01920061|567451645|FG019|Overall Study|Death|0|||
157193940|NCT01920061|567451626|FG000|Overall Study|Lost to Follow-up|0|||
157193941|NCT01920061|567451627|FG001|Overall Study|Lost to Follow-up|2|||
157193942|NCT01920061|567451628|FG002|Overall Study|Lost to Follow-up|0|||
157193943|NCT01920061|567451629|FG003|Overall Study|Lost to Follow-up|0|||
157193944|NCT01920061|567451630|FG004|Overall Study|Lost to Follow-up|0|||
157193945|NCT01920061|567451631|FG005|Overall Study|Lost to Follow-up|0|||
157193946|NCT01920061|567451632|FG006|Overall Study|Lost to Follow-up|1|||
157193947|NCT01920061|567451633|FG007|Overall Study|Lost to Follow-up|0|||
157193948|NCT01920061|567451634|FG008|Overall Study|Lost to Follow-up|0|||
157193949|NCT01920061|567451635|FG009|Overall Study|Lost to Follow-up|0|||
157193950|NCT01920061|567451636|FG010|Overall Study|Lost to Follow-up|3|||
157193951|NCT01920061|567451637|FG011|Overall Study|Lost to Follow-up|0|||
157234185|NCT01171963|567604922|FG001|Overall Study|Withdrawal by Subject|129|||
157234186|NCT00268905|567604930|FG000|Overall Study|Adverse Event|3|||
157234187|NCT00268905|567604931|FG001|Overall Study|Adverse Event|0|||
157234188|NCT00268905|567604932|FG002|Overall Study|Adverse Event|4|||
157234189|NCT00268905|567604930|FG000|Overall Study|Lost to Follow-up|0|||
157234190|NCT00268905|567604931|FG001|Overall Study|Lost to Follow-up|1|||
157234191|NCT00268905|567604932|FG002|Overall Study|Lost to Follow-up|0|||
157234192|NCT00268905|567604930|FG000|Overall Study|Withdrawal by Subject|0|||
157234193|NCT00268905|567604931|FG001|Overall Study|Withdrawal by Subject|0|||
157234194|NCT00268905|567604932|FG002|Overall Study|Withdrawal by Subject|3|||
157234195|NCT00268905|567604930|FG000|Overall Study|Progressive Disease|28|||
157234196|NCT00268905|567604931|FG001|Overall Study|Progressive Disease|4|||
157234197|NCT00268905|567604932|FG002|Overall Study|Progressive Disease|3|||
157234198|NCT00268905|567604930|FG000|Overall Study|Physician Decision|3|||
157234199|NCT00268905|567604931|FG001|Overall Study|Physician Decision|0|||
157234200|NCT00268905|567604932|FG002|Overall Study|Physician Decision|1|||
157234201|NCT00268905|567604930|FG000|Overall Study|Clinical Progression|9|||
157234202|NCT00268905|567604931|FG001|Overall Study|Clinical Progression|4|||
157234203|NCT00268905|567604932|FG002|Overall Study|Clinical Progression|1|||
157234204|NCT00617305|567604933|FG000|Overall Study|Adverse Event|4|||
157234205|NCT00617305|567604934|FG001|Overall Study|Adverse Event|0|||
157234206|NCT00617305|567604935|FG002|Overall Study|Adverse Event|0|||
157234207|NCT00617305|567604933|FG000|Overall Study|Death|1|||
157234208|NCT00617305|567604934|FG001|Overall Study|Death|0|||
157234209|NCT00617305|567604935|FG002|Overall Study|Death|0|||
157234210|NCT00617305|567604933|FG000|Overall Study|Physician Decision|1|||
157234211|NCT00617305|567604934|FG001|Overall Study|Physician Decision|0|||
157234212|NCT00617305|567604935|FG002|Overall Study|Physician Decision|0|||
157234213|NCT00617305|567604933|FG000|Overall Study|Protocol Violation|1|||
157234214|NCT00617305|567604934|FG001|Overall Study|Protocol Violation|0|||
157234215|NCT00617305|567604935|FG002|Overall Study|Protocol Violation|1|||
157234216|NCT00617305|567604933|FG000|Overall Study|Withdrawal by Subject|1|||
157234217|NCT00617305|567604934|FG001|Overall Study|Withdrawal by Subject|0|||
157234218|NCT00617305|567604935|FG002|Overall Study|Withdrawal by Subject|0|||
157234219|NCT00857623|567604936|FG000|Overall Study|Adverse Event|5|||
157234220|NCT00857623|567604937|FG001|Overall Study|Adverse Event|2|||
157234221|NCT00857623|567604936|FG000|Overall Study|Study-specific discontinuation criteria|5|||
157234222|NCT00857623|567604937|FG001|Overall Study|Study-specific discontinuation criteria|3|||
157234223|NCT00857623|567604936|FG000|Overall Study|Withdrawal by Subject|2|||
157234224|NCT00857623|567604937|FG001|Overall Study|Withdrawal by Subject|1|||
157234225|NCT00857623|567604936|FG000|Overall Study|Lack of Efficacy|1|||
157234226|NCT00857623|567604937|FG001|Overall Study|Lack of Efficacy|1|||
157234227|NCT00857623|567604936|FG000|Overall Study|Severe non-compliance to protocol|1|||
157234228|NCT00857623|567604937|FG001|Overall Study|Severe non-compliance to protocol|1|||
157234229|NCT00857623|567604936|FG000|Overall Study|Intake of prohibited medication|0|||
157234230|NCT00857623|567604937|FG001|Overall Study|Intake of prohibited medication|1|||
157234231|NCT00857623|567604936|FG000|Overall Study|Positive for HEP C|0|||
157234232|NCT00857623|567604937|FG001|Overall Study|Positive for HEP C|1|||
157234233|NCT04185909|567604938|FG000|Overall Study|Lost to Follow-up|1|||
157234234|NCT02193178|567604939|FG000|Overall Study|Lost to Follow-up|1|||
157234235|NCT02193178|567604939|FG000|Overall Study|Dry eyes|1|||
157234236|NCT04510285|567604940|FG000|Overall Study|Death|1|||
157234237|NCT00048581|567604941|FG000|Double-Blind Period|Adverse Event|9|||
157234238|NCT00048581|567604942|FG001|Double-Blind Period|Adverse Event|5|||
157234239|NCT00048581|567604943|FG002|Double-Blind Period|Adverse Event|0|||
157234240|NCT00048581|567604941|FG000|Double-Blind Period|Lack of Efficacy|14|||
157234241|NCT00048581|567604942|FG001|Double-Blind Period|Lack of Efficacy|27|||
157234242|NCT00048581|567604943|FG002|Double-Blind Period|Lack of Efficacy|0|||
157234243|NCT00048581|567604941|FG000|Double-Blind Period|Lost to Follow-up|5|||
157084557|NCT01879722|567063524|FG004|Overall Study|Voluntary Withdrawal|0|||
157234244|NCT00048581|567604942|FG001|Double-Blind Period|Lost to Follow-up|0|||
157234245|NCT00048581|567604943|FG002|Double-Blind Period|Lost to Follow-up|0|||
157234246|NCT00048581|567604941|FG000|Double-Blind Period|Withdrawal by Subject|5|||
157234247|NCT00048581|567604942|FG001|Double-Blind Period|Withdrawal by Subject|2|||
157234248|NCT00048581|567604943|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157234249|NCT00048581|567604941|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
157234250|NCT00048581|567604942|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
157234251|NCT00048581|567604943|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
157234252|NCT00048581|567604941|FG000|Double-Blind Period|Investigator Decision|1|||
157234253|NCT00048581|567604942|FG001|Double-Blind Period|Investigator Decision|0|||
157234254|NCT00048581|567604943|FG002|Double-Blind Period|Investigator Decision|0|||
157234255|NCT00048581|567604941|FG000|Open-Label Period|Death|0|||
157234256|NCT00048581|567604942|FG001|Open-Label Period|Death|0|||
157234257|NCT00048581|567604943|FG002|Open-Label Period|Death|4|||
157234258|NCT00048581|567604941|FG000|Open-Label Period|Adverse Event|0|||
157234259|NCT00048581|567604942|FG001|Open-Label Period|Adverse Event|0|||
157234260|NCT00048581|567604943|FG002|Open-Label Period|Adverse Event|37|||
157234261|NCT00048581|567604941|FG000|Open-Label Period|Lack of Efficacy|0|||
157234262|NCT00048581|567604942|FG001|Open-Label Period|Lack of Efficacy|0|||
157234263|NCT00048581|567604943|FG002|Open-Label Period|Lack of Efficacy|69|||
157234264|NCT00048581|567604941|FG000|Open-Label Period|Lost to Follow-up|0|||
157234265|NCT00048581|567604942|FG001|Open-Label Period|Lost to Follow-up|0|||
157234266|NCT00048581|567604943|FG002|Open-Label Period|Lost to Follow-up|14|||
157234267|NCT00048581|567604941|FG000|Open-Label Period|Withdrawal by Subject|0|||
157234268|NCT00048581|567604942|FG001|Open-Label Period|Withdrawal by Subject|0|||
157234269|NCT00048581|567604943|FG002|Open-Label Period|Withdrawal by Subject|20|||
157234270|NCT00048581|567604941|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
157234271|NCT00048581|567604942|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
157234272|NCT00048581|567604943|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
157234273|NCT00048581|567604941|FG000|Open-Label Period|Poor/Non-compliance|0|||
157234274|NCT00048581|567604942|FG001|Open-Label Period|Poor/Non-compliance|0|||
157234275|NCT00048581|567604943|FG002|Open-Label Period|Poor/Non-compliance|5|||
157234276|NCT00048581|567604941|FG000|Open-Label Period|Pregnancy|0|||
157234277|NCT00048581|567604942|FG001|Open-Label Period|Pregnancy|0|||
157234278|NCT00048581|567604943|FG002|Open-Label Period|Pregnancy|7|||
157234279|NCT00048581|567604941|FG000|Open-Label Period|Study Site Closure|0|||
157234280|NCT00048581|567604942|FG001|Open-Label Period|Study Site Closure|0|||
157234281|NCT00048581|567604943|FG002|Open-Label Period|Study Site Closure|2|||
157084558|NCT01879722|567063525|FG005|Overall Study|Voluntary Withdrawal|0|||
157084559|NCT01879722|567063526|FG006|Overall Study|Voluntary Withdrawal|0|||
157084560|NCT01879722|567063527|FG007|Overall Study|Voluntary Withdrawal|0|||
157084561|NCT01879722|567063528|FG008|Overall Study|Voluntary Withdrawal|1|||
157084562|NCT01879722|567063529|FG009|Overall Study|Voluntary Withdrawal|0|||
157084563|NCT00774930|567063530|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
157084564|NCT00774930|567063531|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
157193952|NCT01920061|567451638|FG012|Overall Study|Lost to Follow-up|0|||
157193953|NCT01920061|567451639|FG013|Overall Study|Lost to Follow-up|0|||
157193954|NCT01920061|567451640|FG014|Overall Study|Lost to Follow-up|0|||
157193955|NCT01920061|567451641|FG015|Overall Study|Lost to Follow-up|0|||
157193956|NCT01920061|567451642|FG016|Overall Study|Lost to Follow-up|0|||
157193957|NCT01920061|567451643|FG017|Overall Study|Lost to Follow-up|1|||
157193958|NCT01920061|567451644|FG018|Overall Study|Lost to Follow-up|4|||
157193959|NCT01920061|567451645|FG019|Overall Study|Lost to Follow-up|3|||
157193960|NCT01920061|567451626|FG000|Overall Study|Other|1|||
157193961|NCT01920061|567451627|FG001|Overall Study|Other|1|||
157193962|NCT01920061|567451628|FG002|Overall Study|Other|2|||
157193963|NCT01920061|567451629|FG003|Overall Study|Other|1|||
157193964|NCT01920061|567451630|FG004|Overall Study|Other|0|||
157193965|NCT01920061|567451631|FG005|Overall Study|Other|1|||
157193966|NCT01920061|567451632|FG006|Overall Study|Other|0|||
157193967|NCT01920061|567451633|FG007|Overall Study|Other|0|||
157193968|NCT01920061|567451634|FG008|Overall Study|Other|0|||
157193969|NCT01920061|567451635|FG009|Overall Study|Other|1|||
157193970|NCT01920061|567451636|FG010|Overall Study|Other|1|||
157193971|NCT01920061|567451637|FG011|Overall Study|Other|2|||
157193972|NCT01920061|567451638|FG012|Overall Study|Other|1|||
157193973|NCT01920061|567451639|FG013|Overall Study|Other|4|||
157193974|NCT01920061|567451640|FG014|Overall Study|Other|0|||
157193975|NCT01920061|567451641|FG015|Overall Study|Other|1|||
157193976|NCT01920061|567451642|FG016|Overall Study|Other|1|||
157193977|NCT01920061|567451643|FG017|Overall Study|Other|0|||
157193978|NCT01920061|567451644|FG018|Overall Study|Other|1|||
157193979|NCT01920061|567451645|FG019|Overall Study|Other|1|||
157193980|NCT01920061|567451626|FG000|Overall Study|Participant refused further follow-up|0|||
157193981|NCT01920061|567451627|FG001|Overall Study|Participant refused further follow-up|0|||
157193982|NCT01920061|567451628|FG002|Overall Study|Participant refused further follow-up|0|||
157193983|NCT01920061|567451629|FG003|Overall Study|Participant refused further follow-up|0|||
157193984|NCT01920061|567451630|FG004|Overall Study|Participant refused further follow-up|1|||
157193985|NCT01920061|567451631|FG005|Overall Study|Participant refused further follow-up|1|||
157193986|NCT01920061|567451632|FG006|Overall Study|Participant refused further follow-up|0|||
157193987|NCT01920061|567451633|FG007|Overall Study|Participant refused further follow-up|0|||
157193988|NCT01920061|567451634|FG008|Overall Study|Participant refused further follow-up|1|||
157193989|NCT01920061|567451635|FG009|Overall Study|Participant refused further follow-up|0|||
157084565|NCT00774930|567063530|FG000|DB Phase|Adverse Event|1|||
157084566|NCT00774930|567063531|FG001|DB Phase|Adverse Event|2|||
157084567|NCT00774930|567063530|FG000|DB Phase|Subject Decision|1|||
157084568|NCT00774930|567063531|FG001|DB Phase|Subject Decision|5|||
157084569|NCT00774930|567063530|FG000|DB Phase|Sponsor Decision|0|||
157193990|NCT01920061|567451636|FG010|Overall Study|Participant refused further follow-up|1|||
157193991|NCT01920061|567451637|FG011|Overall Study|Participant refused further follow-up|0|||
157193992|NCT01920061|567451638|FG012|Overall Study|Participant refused further follow-up|1|||
157193993|NCT01920061|567451639|FG013|Overall Study|Participant refused further follow-up|0|||
157234282|NCT00048581|567604941|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
157234283|NCT00048581|567604942|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
157234284|NCT00048581|567604943|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
157193994|NCT01920061|567451640|FG014|Overall Study|Participant refused further follow-up|1|||
157193995|NCT01920061|567451641|FG015|Overall Study|Participant refused further follow-up|2|||
157193996|NCT01920061|567451642|FG016|Overall Study|Participant refused further follow-up|1|||
157193997|NCT01920061|567451643|FG017|Overall Study|Participant refused further follow-up|1|||
157193998|NCT01920061|567451644|FG018|Overall Study|Participant refused further follow-up|0|||
157193999|NCT01920061|567451645|FG019|Overall Study|Participant refused further follow-up|0|||
157194000|NCT02918006|567451647|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
157194001|NCT02918006|567451648|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
157194002|NCT02918006|567451649|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
157194003|NCT02918006|567451647|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
157194004|NCT02918006|567451648|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
157194005|NCT02918006|567451649|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
157194006|NCT02918006|567451647|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
157194007|NCT02918006|567451648|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
157194008|NCT02918006|567451649|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
157194009|NCT02918006|567451647|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
157194010|NCT02918006|567451648|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
157194011|NCT02918006|567451649|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
157194012|NCT02918006|567451647|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
157194013|NCT02918006|567451648|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
157194014|NCT02918006|567451649|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
157194015|NCT02918006|567451647|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
157194016|NCT02918006|567451648|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
157194017|NCT02918006|567451649|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
157194018|NCT02918006|567451647|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
157194019|NCT02918006|567451648|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
157194020|NCT02918006|567451649|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
157194021|NCT02918006|567451647|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
157194022|NCT02918006|567451648|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
157194023|NCT02918006|567451649|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
157194024|NCT02918006|567451647|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
157194025|NCT02918006|567451648|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
157194026|NCT02918006|567451649|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
157194027|NCT00453349|567451650|FG000|Randomized|Adverse Event|12|||
157194028|NCT00453349|567451651|FG001|Randomized|Adverse Event|11|||
157194029|NCT00453349|567451650|FG000|Randomized|Lack of Efficacy|2|||
157194030|NCT00453349|567451651|FG001|Randomized|Lack of Efficacy|1|||
157194031|NCT00453349|567451650|FG000|Randomized|Lost to Follow-up|7|||
157194032|NCT00453349|567451651|FG001|Randomized|Lost to Follow-up|5|||
157194033|NCT00453349|567451650|FG000|Randomized|Protocol Violation|1|||
157194034|NCT00453349|567451651|FG001|Randomized|Protocol Violation|1|||
157194035|NCT00453349|567451650|FG000|Randomized|Withdrawal by Subject|3|||
157194036|NCT00453349|567451651|FG001|Randomized|Withdrawal by Subject|5|||
157194037|NCT00453349|567451650|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
157194038|NCT00453349|567451651|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
157194039|NCT00453349|567451650|FG000|Completed Study|Adverse Event|12|||
157194040|NCT00453349|567451651|FG001|Completed Study|Adverse Event|11|||
157194041|NCT00453349|567451650|FG000|Completed Study|Lack of Efficacy|2|||
157194042|NCT00453349|567451651|FG001|Completed Study|Lack of Efficacy|1|||
157194043|NCT00453349|567451650|FG000|Completed Study|Lost to Follow-up|7|||
157194044|NCT00453349|567451651|FG001|Completed Study|Lost to Follow-up|5|||
157194045|NCT00453349|567451650|FG000|Completed Study|Protocol Violation|1|||
157194046|NCT00453349|567451651|FG001|Completed Study|Protocol Violation|1|||
157194047|NCT00453349|567451650|FG000|Completed Study|Withdrawal by Subject|3|||
157194048|NCT00453349|567451651|FG001|Completed Study|Withdrawal by Subject|5|||
157194049|NCT00453349|567451650|FG000|Completed Study|Lost to follow up after study treatment|2|||
157194050|NCT00453349|567451651|FG001|Completed Study|Lost to follow up after study treatment|11|||
157194051|NCT02475564|567451655|FG000|Overall Study|Withdrawal by Subject|1|||
157194052|NCT02475564|567451656|FG001|Overall Study|Withdrawal by Subject|0|||
157194053|NCT02475564|567451655|FG000|Overall Study|Lost to Follow-up|2|||
157194054|NCT02475564|567451656|FG001|Overall Study|Lost to Follow-up|1|||
157194055|NCT02475564|567451655|FG000|Overall Study|Intense Menstrual bleeding|1|||
157194056|NCT02475564|567451656|FG001|Overall Study|Intense Menstrual bleeding|0|||
157194057|NCT02705755|567451657|FG000|Part A (6 Days)|Adverse Event|1|||
157194058|NCT02705755|567451658|FG001|Part A (6 Days)|Adverse Event|0|||
157194059|NCT02705755|567451659|FG002|Part A (6 Days)|Adverse Event|0|||
157194060|NCT02705755|567451660|FG003|Part A (6 Days)|Adverse Event|0|||
157194061|NCT02705755|567451657|FG000|Part A (6 Days)|Physician Decision|3|||
157194062|NCT02705755|567451658|FG001|Part A (6 Days)|Physician Decision|0|||
157194063|NCT02705755|567451659|FG002|Part A (6 Days)|Physician Decision|0|||
157194064|NCT02705755|567451660|FG003|Part A (6 Days)|Physician Decision|0|||
157194065|NCT02705755|567451657|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
157194066|NCT02705755|567451658|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
157194067|NCT02705755|567451659|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
157194068|NCT02705755|567451660|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
157194069|NCT02705755|567451657|FG000|Part C (20 Weeks)|Physician Decision|0|||
157194070|NCT02705755|567451658|FG001|Part C (20 Weeks)|Physician Decision|0|||
157194071|NCT02705755|567451659|FG002|Part C (20 Weeks)|Physician Decision|0|||
157194072|NCT02705755|567451660|FG003|Part C (20 Weeks)|Physician Decision|2|||
157194073|NCT02705755|567451657|FG000|Part C (20 Weeks)|Adverse Event|0|||
157194074|NCT02705755|567451658|FG001|Part C (20 Weeks)|Adverse Event|0|||
157194075|NCT02705755|567451659|FG002|Part C (20 Weeks)|Adverse Event|0|||
157194076|NCT02705755|567451660|FG003|Part C (20 Weeks)|Adverse Event|6|||
157194077|NCT02705755|567451657|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
157194078|NCT02705755|567451658|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
157194079|NCT02705755|567451659|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
157194080|NCT02705755|567451660|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
157194081|NCT01906489|567451661|FG000|Overall Study|Adverse Event|10|||
157194082|NCT01906489|567451662|FG001|Overall Study|Adverse Event|3|||
157194083|NCT01906489|567451661|FG000|Overall Study|Worsening of CKD|6|||
157194084|NCT01906489|567451662|FG001|Overall Study|Worsening of CKD|4|||
157194085|NCT01906489|567451661|FG000|Overall Study|Withdrawal by Subject|5|||
157194086|NCT01906489|567451662|FG001|Overall Study|Withdrawal by Subject|0|||
157194087|NCT01906489|567451661|FG000|Overall Study|Worsening of Anemia|1|||
157194088|NCT01906489|567451662|FG001|Overall Study|Worsening of Anemia|0|||
157194089|NCT01906489|567451661|FG000|Overall Study|Protocol Violation|0|||
157194090|NCT01906489|567451662|FG001|Overall Study|Protocol Violation|1|||
157194091|NCT01906489|567451661|FG000|Overall Study|Non- Compliance|1|||
157194092|NCT01906489|567451662|FG001|Overall Study|Non- Compliance|0|||
157194093|NCT01906489|567451661|FG000|Overall Study|Sponsor Decision|1|||
157194094|NCT01906489|567451662|FG001|Overall Study|Sponsor Decision|0|||
157194095|NCT01906489|567451661|FG000|Overall Study|Lost to Follow-up|1|||
157194096|NCT01906489|567451662|FG001|Overall Study|Lost to Follow-up|1|||
157194097|NCT01906489|567451661|FG000|Overall Study|Other|1|||
157194098|NCT01906489|567451662|FG001|Overall Study|Other|0|||
157194099|NCT04823494|567453953|FG000|Overall Study|Programming software malfunction.|1|||
157194100|NCT04823494|567453954|FG001|Overall Study|Programming software malfunction.|0|||
157194101|NCT04823494|567453953|FG000|Overall Study|Withdrawal by Subject|1|||
157194102|NCT04823494|567453954|FG001|Overall Study|Withdrawal by Subject|0|||
157194103|NCT04823494|567453953|FG000|Overall Study|Devices lost|0|||
157194104|NCT04823494|567453954|FG001|Overall Study|Devices lost|1|||
157194105|NCT03691831|567453955|FG000|Overall Study|Lost to Follow-up|16|||
157194106|NCT03691831|567453956|FG001|Overall Study|Lost to Follow-up|12|||
157194107|NCT03691831|567453955|FG000|Overall Study|Withdrawal by Subject|9|||
157194108|NCT03691831|567453956|FG001|Overall Study|Withdrawal by Subject|17|||
157194109|NCT03691831|567453955|FG000|Overall Study|Investigator Decision|2|||
157194110|NCT03691831|567453956|FG001|Overall Study|Investigator Decision|2|||
157194111|NCT02198040|567453957|FG000|Overall Study|Work reasons|0|||
157194112|NCT02198040|567453958|FG001|Overall Study|Work reasons|1|||
157194113|NCT02198040|567453959|FG002|Overall Study|Work reasons|0|||
157194114|NCT02198040|567453957|FG000|Overall Study|Withdrawal by Subject|0|||
157194115|NCT02198040|567453958|FG001|Overall Study|Withdrawal by Subject|0|||
157194116|NCT02198040|567453959|FG002|Overall Study|Withdrawal by Subject|1|||
157194117|NCT04524663|567453960|FG000|Overall Study|Withdrawal by Subject|0|||
157194118|NCT04524663|567453961|FG001|Overall Study|Withdrawal by Subject|2|||
157194119|NCT00337935|567453962|FG000|Overall Study|Adverse Event|2|||
157194120|NCT00337935|567453963|FG001|Overall Study|Adverse Event|5|||
157194121|NCT00337935|567453962|FG000|Overall Study|Death|2|||
157194122|NCT00337935|567453963|FG001|Overall Study|Death|8|||
157194123|NCT00337935|567453962|FG000|Overall Study|Physician Decision|1|||
157194124|NCT00337935|567453963|FG001|Overall Study|Physician Decision|1|||
157194125|NCT00337935|567453962|FG000|Overall Study|Lost to Follow-up|0|||
157194126|NCT00337935|567453963|FG001|Overall Study|Lost to Follow-up|1|||
157194127|NCT00337935|567453962|FG000|Overall Study|Protocol Violation|4|||
157194128|NCT00337935|567453963|FG001|Overall Study|Protocol Violation|3|||
157194129|NCT00337935|567453962|FG000|Overall Study|Withdrawal by Subject|1|||
157234285|NCT00048581|567604941|FG000|Open-Label Period|Problem With Transportation To Site|0|||
157194130|NCT00337935|567453963|FG001|Overall Study|Withdrawal by Subject|7|||
157194131|NCT00337935|567453962|FG000|Overall Study|Other|0|||
157194132|NCT00337935|567453963|FG001|Overall Study|Other|1|||
157194133|NCT00337935|567453962|FG000|Overall Study|Lack of Efficacy|0|||
157194134|NCT00337935|567453963|FG001|Overall Study|Lack of Efficacy|1|||
157194135|NCT01884675|567453964|FG000|Overall Study|Study closed/terminated|3|||
157194136|NCT01884675|567453965|FG001|Overall Study|Study closed/terminated|2|||
157194137|NCT03359811|567453966|FG000|Overall Study|Protocol Violation|2|||
157194138|NCT03359811|567453967|FG001|Overall Study|Protocol Violation|0|||
157194139|NCT01189201|567453974|FG000|Overall Study|Adverse Event|1|||
157194140|NCT01682876|567453975|FG000|Overall Study|Administrative reason|4|||
157194141|NCT01682876|567453976|FG001|Overall Study|Administrative reason|4|||
157194142|NCT01682876|567453977|FG002|Overall Study|Administrative reason|0|||
157194143|NCT01682876|567453978|FG003|Overall Study|Administrative reason|3|||
157194144|NCT01682876|567453975|FG000|Overall Study|Adverse Event|0|||
157234286|NCT00048581|567604942|FG001|Open-Label Period|Problem With Transportation To Site|0|||
157234287|NCT00048581|567604943|FG002|Open-Label Period|Problem With Transportation To Site|1|||
157234288|NCT00048581|567604941|FG000|Open-Label Period|Primary Investigator Retired|0|||
157234289|NCT00048581|567604942|FG001|Open-Label Period|Primary Investigator Retired|0|||
157234290|NCT00048581|567604943|FG002|Open-Label Period|Primary Investigator Retired|2|||
157234291|NCT00048581|567604941|FG000|Open-Label Period|Study Ended By Sponsor|0|||
157234292|NCT00048581|567604942|FG001|Open-Label Period|Study Ended By Sponsor|0|||
157194145|NCT01682876|567453976|FG001|Overall Study|Adverse Event|0|||
157194146|NCT01682876|567453977|FG002|Overall Study|Adverse Event|0|||
157194147|NCT01682876|567453978|FG003|Overall Study|Adverse Event|1|||
157194148|NCT01682876|567453975|FG000|Overall Study|Lost to Follow-up|11|||
157194149|NCT01682876|567453976|FG001|Overall Study|Lost to Follow-up|15|||
157194150|NCT01682876|567453977|FG002|Overall Study|Lost to Follow-up|9|||
157194151|NCT01682876|567453978|FG003|Overall Study|Lost to Follow-up|11|||
157194152|NCT01682876|567453975|FG000|Overall Study|Protocol Violation|1|||
157194153|NCT01682876|567453976|FG001|Overall Study|Protocol Violation|1|||
157194154|NCT01682876|567453977|FG002|Overall Study|Protocol Violation|1|||
157194155|NCT01682876|567453978|FG003|Overall Study|Protocol Violation|1|||
157194156|NCT01682876|567453975|FG000|Overall Study|Withdrawal by Subject|4|||
157194157|NCT01682876|567453976|FG001|Overall Study|Withdrawal by Subject|0|||
157194158|NCT01682876|567453977|FG002|Overall Study|Withdrawal by Subject|0|||
157194159|NCT01682876|567453978|FG003|Overall Study|Withdrawal by Subject|2|||
157194160|NCT01682876|567453975|FG000|Overall Study|Other|1|||
157194161|NCT01682876|567453976|FG001|Overall Study|Other|0|||
157194162|NCT01682876|567453977|FG002|Overall Study|Other|1|||
157194163|NCT01682876|567453978|FG003|Overall Study|Other|1|||
157194164|NCT01277757|567453979|FG000|Overall Study|Disease Progression|1|||
157194165|NCT01277757|567453979|FG000|Overall Study|Withdrawal by Subject|1|||
157194166|NCT00911508|567453983|FG000|Overall Study|Lost to Follow-up|27|||
157194167|NCT00911508|567453984|FG001|Overall Study|Lost to Follow-up|18|||
157194168|NCT00911508|567453983|FG000|Overall Study|Withdrawal by Subject|79|||
157194169|NCT00911508|567453984|FG001|Overall Study|Withdrawal by Subject|112|||
157194170|NCT00240331|567453987|FG000|Overall Study|Withdrawal by Subject|125|||
157194171|NCT00240331|567453988|FG001|Overall Study|Withdrawal by Subject|132|||
157194172|NCT00240331|567453987|FG000|Overall Study|Option selected by investigator|1|||
157194173|NCT00240331|567453988|FG001|Overall Study|Option selected by investigator|2|||
157194174|NCT01409382|567453989|FG000|Overall Study|Lost to Follow-up|1|||
157194175|NCT01409382|567453990|FG001|Overall Study|Lost to Follow-up|1|||
157194176|NCT01409382|567453989|FG000|Overall Study|Protocol Violation|0|||
157194177|NCT01409382|567453990|FG001|Overall Study|Protocol Violation|3|||
157194178|NCT01409382|567453989|FG000|Overall Study|Multiple pregnancy|2|||
157194179|NCT01409382|567453990|FG001|Overall Study|Multiple pregnancy|4|||
157194180|NCT01409382|567453989|FG000|Overall Study|Still pregnant when study ended|13|||
157194181|NCT01409382|567453990|FG001|Overall Study|Still pregnant when study ended|2|||
157194182|NCT01409382|567453989|FG000|Overall Study|Did not manage to get pregnant|64|||
157194183|NCT01409382|567453990|FG001|Overall Study|Did not manage to get pregnant|70|||
157194184|NCT01409382|567453989|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
157194185|NCT01409382|567453990|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
157194186|NCT01233076|567453991|FG000|Period 2, One Week|Lost to Follow-up|1|||
157194187|NCT01233076|567453992|FG001|Period 2, One Week|Lost to Follow-up|0|||
157234293|NCT00048581|567604943|FG002|Open-Label Period|Study Ended By Sponsor|1|||
157234294|NCT03897088|567604944|FG000|Overall Study|Withdrawal by Subject|12|||
157234295|NCT03897088|567604945|FG001|Overall Study|Withdrawal by Subject|12|||
157234296|NCT03897088|567604944|FG000|Overall Study|Lost to Follow-up|7|||
157194188|NCT04308668|567453993|FG000|Overall Study|Lost to Follow-up|32|||
157194189|NCT04308668|567453994|FG001|Overall Study|Lost to Follow-up|38|||
157194190|NCT04308668|567453993|FG000|Overall Study|Withdrawal by Subject|4|||
157194191|NCT04308668|567453994|FG001|Overall Study|Withdrawal by Subject|4|||
157194192|NCT04563845|567453995|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194193|NCT04563845|567453996|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194194|NCT04563845|567453997|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194195|NCT04563845|567453998|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194196|NCT04563845|567453999|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194197|NCT04563845|567454000|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194198|NCT04563845|567454001|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194199|NCT04563845|567454002|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
157194200|NCT04563845|567454003|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194201|NCT04563845|567454004|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194202|NCT04563845|567454005|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194203|NCT04563845|567454006|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194204|NCT04563845|567454007|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157194205|NCT04563845|567454008|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
157234297|NCT03897088|567604945|FG001|Overall Study|Lost to Follow-up|15|||
157234298|NCT03897088|567604944|FG000|Overall Study|Sponsor Decision|1|||
157234299|NCT03897088|567604945|FG001|Overall Study|Sponsor Decision|2|||
157234300|NCT03897088|567604944|FG000|Overall Study|COVID-19|2|||
157234301|NCT03897088|567604945|FG001|Overall Study|COVID-19|0|||
157234302|NCT03897088|567604944|FG000|Overall Study|Other|3|||
157234303|NCT03897088|567604945|FG001|Overall Study|Other|0|||
157234304|NCT03897088|567604944|FG000|Overall Study|Non-compliance with Study Drug|1|||
157234305|NCT03897088|567604945|FG001|Overall Study|Non-compliance with Study Drug|1|||
157234306|NCT03897088|567604944|FG000|Overall Study|Pregnancy|0|||
157234307|NCT03897088|567604945|FG001|Overall Study|Pregnancy|1|||
157234308|NCT04320849|567604954|FG000|Overall Study|Withdrawal by Subject|4|||
157234309|NCT04320849|567604954|FG000|Overall Study|Imaging data unavailable|2|||
157234310|NCT04320849|567604954|FG000|Overall Study|Incomplete imaging|2|||
157234311|NCT03555305|567604955|FG000|Period 1|Physician Decision|0|||
157234312|NCT03555305|567604956|FG001|Period 1|Physician Decision|1|||
157234313|NCT03555305|567604955|FG000|Period 1|Adverse Event|0|||
157234314|NCT03555305|567604956|FG001|Period 1|Adverse Event|1|||
157234315|NCT03135834|567604959|FG000|Stage 1|Adverse Event|1|||
157234316|NCT03135834|567604960|FG001|Stage 1|Adverse Event|2|||
157234317|NCT03135834|567604961|FG002|Stage 1|Adverse Event|2|||
157234318|NCT03135834|567604962|FG003|Stage 1|Adverse Event|1|||
157234319|NCT03135834|567604959|FG000|Stage 1|Death|1|||
157234320|NCT03135834|567604960|FG001|Stage 1|Death|0|||
157234321|NCT03135834|567604961|FG002|Stage 1|Death|0|||
157234322|NCT03135834|567604962|FG003|Stage 1|Death|0|||
157234323|NCT03135834|567604959|FG000|Stage 1|Lost to Follow-up|17|||
157234324|NCT03135834|567604960|FG001|Stage 1|Lost to Follow-up|24|||
157234325|NCT03135834|567604961|FG002|Stage 1|Lost to Follow-up|21|||
157234326|NCT03135834|567604962|FG003|Stage 1|Lost to Follow-up|38|||
157234327|NCT03135834|567604959|FG000|Stage 1|No longer met eligibility criteria|1|||
157194206|NCT04563845|567453995|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194207|NCT04563845|567453996|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194208|NCT04563845|567453997|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194209|NCT04563845|567453998|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194210|NCT04563845|567453999|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
157194211|NCT04563845|567454000|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194212|NCT04563845|567454001|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194213|NCT04563845|567454002|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194214|NCT04563845|567454003|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194215|NCT04563845|567454004|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194216|NCT04563845|567454005|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194217|NCT04563845|567454006|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194218|NCT04563845|567454007|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194219|NCT04563845|567454008|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
157194220|NCT01020812|567454009|FG000|Overall Study|Physician Decision|1|||
157194221|NCT01020812|567454009|FG000|Overall Study|Withdrawal by Subject|1|||
157194222|NCT01020812|567454009|FG000|Overall Study|Protocol Violation|1|||
157194223|NCT03380091|567454023|FG000|Overall Study|Withdrawal by Subject|2|||
157194224|NCT03380091|567454024|FG001|Overall Study|Withdrawal by Subject|1|||
157194225|NCT03802331|567454026|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
157194226|NCT03802331|567454027|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
157194227|NCT00368069|567454029|FG000|Overall Study|Adverse Event|5|||
157194228|NCT00368069|567454030|FG001|Overall Study|Adverse Event|2|||
157194229|NCT00368069|567454029|FG000|Overall Study|Lack of Efficacy|0|||
157194230|NCT00368069|567454030|FG001|Overall Study|Lack of Efficacy|1|||
157194231|NCT00368069|567454029|FG000|Overall Study|Lost to Follow-up|1|||
157194232|NCT00368069|567454030|FG001|Overall Study|Lost to Follow-up|0|||
157194233|NCT00368069|567454029|FG000|Overall Study|Protocol Violation|0|||
157194234|NCT00368069|567454030|FG001|Overall Study|Protocol Violation|2|||
157194235|NCT00368069|567454029|FG000|Overall Study|Withdrawal of Consent|2|||
157194236|NCT00368069|567454030|FG001|Overall Study|Withdrawal of Consent|1|||
157194237|NCT00368069|567454029|FG000|Overall Study|no blood sampling possible|0|||
157194238|NCT00368069|567454030|FG001|Overall Study|no blood sampling possible|1|||
157194239|NCT03432819|567454034|FG000|Overall Study|Lost to Follow-up|2|||
157194240|NCT03432819|567454035|FG001|Overall Study|Lost to Follow-up|2|||
157194241|NCT03432819|567454034|FG000|Overall Study|Withdrawal by Subject|5|||
157194242|NCT03432819|567454035|FG001|Overall Study|Withdrawal by Subject|3|||
157194243|NCT00083616|567454036|FG000|Overall Study|Disease Progression|16|||
157194244|NCT00083616|567454036|FG000|Overall Study|Lost to Follow-up|1|||
157194245|NCT00083616|567454036|FG000|Overall Study|Physician Decision|2|||
157194246|NCT00083616|567454036|FG000|Overall Study|Withdrawal by Subject|3|||
157234328|NCT03135834|567604960|FG001|Stage 1|No longer met eligibility criteria|6|||
157234329|NCT03135834|567604961|FG002|Stage 1|No longer met eligibility criteria|2|||
157234330|NCT03135834|567604962|FG003|Stage 1|No longer met eligibility criteria|5|||
157234331|NCT03135834|567604959|FG000|Stage 1|Other|0|||
157234332|NCT03135834|567604960|FG001|Stage 1|Other|2|||
157234333|NCT03135834|567604961|FG002|Stage 1|Other|1|||
157234334|NCT03135834|567604962|FG003|Stage 1|Other|0|||
157084570|NCT00774930|567063531|FG001|DB Phase|Sponsor Decision|1|||
157084571|NCT00774930|567063530|FG000|DB Phase|Disease Progression|1|||
157084572|NCT00774930|567063531|FG001|DB Phase|Disease Progression|1|||
157084573|NCT00774930|567063530|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
157084574|NCT00774930|567063531|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
157084575|NCT00774930|567063530|FG000|IOL Phase|Adverse Event|1|||
157084576|NCT00774930|567063531|FG001|IOL Phase|Adverse Event|1|||
157084577|NCT00774930|567063530|FG000|IOL Phase|Subject Decision|4|||
157084578|NCT00774930|567063531|FG001|IOL Phase|Subject Decision|3|||
157084579|NCT00774930|567063530|FG000|IOL Phase|Physician Decision|3|||
157084580|NCT00774930|567063531|FG001|IOL Phase|Physician Decision|2|||
157084581|NCT00774930|567063530|FG000|IOL Phase|Sponsor Decision|1|||
157084582|NCT00774930|567063531|FG001|IOL Phase|Sponsor Decision|0|||
157084583|NCT00774930|567063530|FG000|IOL Phase|Disease Progression|2|||
157084584|NCT00774930|567063531|FG001|IOL Phase|Disease Progression|1|||
157194247|NCT00083616|567454036|FG000|Overall Study|Ineligibility determined|2|||
157194248|NCT00083616|567454036|FG000|Overall Study|Non-compliance|1|||
157194249|NCT00083616|567454036|FG000|Overall Study|Other|6|||
157194250|NCT01474993|567454037|FG000|Overall Study|Lost to Follow-up|1|||
157194251|NCT01474993|567454038|FG001|Overall Study|Lost to Follow-up|2|||
157194252|NCT01474993|567454037|FG000|Overall Study|Adverse Event|0|||
157194253|NCT01474993|567454038|FG001|Overall Study|Adverse Event|1|||
157194254|NCT00760994|567454039|FG000|Overall Study|Lost to Follow-up|4|||
157194255|NCT00760994|567454040|FG001|Overall Study|Lost to Follow-up|4|||
157194256|NCT00760994|567454041|FG002|Overall Study|Lost to Follow-up|3|||
157194257|NCT03451630|567454042|FG000|Overall Study|Death|15|||
157194258|NCT03451630|567454043|FG001|Overall Study|Death|16|||
157194259|NCT03451630|567454044|FG002|Overall Study|Death|11|||
157194260|NCT03451630|567454042|FG000|Overall Study|Lost to Follow-up|9|||
157194261|NCT03451630|567454043|FG001|Overall Study|Lost to Follow-up|0|||
157194262|NCT03451630|567454044|FG002|Overall Study|Lost to Follow-up|4|||
157194263|NCT03451630|567454042|FG000|Overall Study|Withdrawal by Subject|0|||
157194264|NCT03451630|567454043|FG001|Overall Study|Withdrawal by Subject|3|||
157194265|NCT03451630|567454044|FG002|Overall Study|Withdrawal by Subject|0|||
157194266|NCT03451630|567454042|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
157194267|NCT03451630|567454043|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
157194268|NCT03451630|567454044|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
157194269|NCT02041533|567454045|FG000|Pre-Treatment Period|Disease Progression|1|||
157194270|NCT02041533|567454046|FG001|Pre-Treatment Period|Disease Progression|1|||
157194271|NCT02041533|567454045|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
157194272|NCT02041533|567454046|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
157194273|NCT02041533|567454045|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
157194274|NCT02041533|567454046|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
157194275|NCT02041533|567454045|FG000|Treatment Period|Disease progression|189|||
157194276|NCT02041533|567454046|FG001|Treatment Period|Disease progression|146|||
157194277|NCT02041533|567454045|FG000|Treatment Period|Study drug toxicity|30|||
157194278|NCT02041533|567454046|FG001|Treatment Period|Study drug toxicity|34|||
157194279|NCT02041533|567454045|FG000|Treatment Period|Death|1|||
157194280|NCT02041533|567454046|FG001|Treatment Period|Death|0|||
157194281|NCT02041533|567454045|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
157194282|NCT02041533|567454046|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
157194283|NCT02041533|567454045|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
157194284|NCT02041533|567454046|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
157194285|NCT02041533|567454045|FG000|Treatment Period|Participant withdrew consent|2|||
157194286|NCT02041533|567454046|FG001|Treatment Period|Participant withdrew consent|2|||
157194287|NCT02041533|567454045|FG000|Treatment Period|Maximum clinical benefit|0|||
157194288|NCT02041533|567454046|FG001|Treatment Period|Maximum clinical benefit|18|||
157194289|NCT02041533|567454045|FG000|Treatment Period|Poor/Non-compliance|1|||
157194290|NCT02041533|567454046|FG001|Treatment Period|Poor/Non-compliance|0|||
157194291|NCT02041533|567454045|FG000|Treatment Period|Administrative reason by sponsor|1|||
157194292|NCT02041533|567454046|FG001|Treatment Period|Administrative reason by sponsor|0|||
157194293|NCT02041533|567454045|FG000|Treatment Period|Other reasons|9|||
157234335|NCT03135834|567604959|FG000|Stage 1|Physician Decision|0|||
157234336|NCT03135834|567604960|FG001|Stage 1|Physician Decision|1|||
157234337|NCT03135834|567604961|FG002|Stage 1|Physician Decision|0|||
157084585|NCT00774930|567063530|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
157084586|NCT00774930|567063531|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
157084587|NCT00774930|567063530|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
157084588|NCT00774930|567063531|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
157084589|NCT00774930|567063530|FG000|IOL Phase|Other|1|||
157084590|NCT00774930|567063531|FG001|IOL Phase|Other|0|||
157084591|NCT00774930|567063530|FG000|IOL Phase|Brain radiation|0|||
157084592|NCT00774930|567063531|FG001|IOL Phase|Brain radiation|1|||
157084593|NCT00774930|567063530|FG000|LTOLE Phase|Adverse Event|7|||
157084594|NCT00774930|567063531|FG001|LTOLE Phase|Adverse Event|3|||
157234338|NCT03135834|567604962|FG003|Stage 1|Physician Decision|0|||
157234339|NCT03135834|567604959|FG000|Stage 1|Pregnancy|0|||
157234340|NCT03135834|567604960|FG001|Stage 1|Pregnancy|4|||
157234341|NCT03135834|567604961|FG002|Stage 1|Pregnancy|2|||
157234342|NCT03135834|567604962|FG003|Stage 1|Pregnancy|4|||
157234343|NCT03135834|567604959|FG000|Stage 1|Protocol Violation|1|||
157234344|NCT03135834|567604960|FG001|Stage 1|Protocol Violation|1|||
157234345|NCT03135834|567604961|FG002|Stage 1|Protocol Violation|2|||
157234346|NCT03135834|567604962|FG003|Stage 1|Protocol Violation|1|||
157234347|NCT03135834|567604959|FG000|Stage 1|Withdrawal by parent/guardian|2|||
157234348|NCT03135834|567604960|FG001|Stage 1|Withdrawal by parent/guardian|10|||
157234349|NCT03135834|567604961|FG002|Stage 1|Withdrawal by parent/guardian|2|||
157234350|NCT03135834|567604962|FG003|Stage 1|Withdrawal by parent/guardian|1|||
157234351|NCT03135834|567604959|FG000|Stage 1|Withdrawal by Subject|16|||
157234352|NCT03135834|567604960|FG001|Stage 1|Withdrawal by Subject|22|||
157234353|NCT03135834|567604961|FG002|Stage 1|Withdrawal by Subject|7|||
157234354|NCT03135834|567604962|FG003|Stage 1|Withdrawal by Subject|10|||
157234355|NCT03135834|567604959|FG000|Stage 1|Randomized but not Vaccinated|0|||
157234356|NCT03135834|567604960|FG001|Stage 1|Randomized but not Vaccinated|3|||
157234357|NCT03135834|567604961|FG002|Stage 1|Randomized but not Vaccinated|1|||
157234358|NCT03135834|567604962|FG003|Stage 1|Randomized but not Vaccinated|6|||
157234359|NCT03135834|567604959|FG000|Stage 2|Lost to Follow-up|0|||
157234360|NCT03135834|567604960|FG001|Stage 2|Lost to Follow-up|1|||
157234361|NCT03135834|567604961|FG002|Stage 2|Lost to Follow-up|0|||
157234362|NCT03135834|567604962|FG003|Stage 2|Lost to Follow-up|0|||
157234363|NCT03135834|567604959|FG000|Stage 2|Withdrawal by Subject|0|||
157234364|NCT03135834|567604960|FG001|Stage 2|Withdrawal by Subject|1|||
157234365|NCT03135834|567604961|FG002|Stage 2|Withdrawal by Subject|0|||
157234366|NCT03135834|567604962|FG003|Stage 2|Withdrawal by Subject|0|||
157234367|NCT03135834|567604959|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
157234368|NCT03135834|567604960|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
157234369|NCT03135834|567604961|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
157234370|NCT03135834|567604962|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
157234371|NCT03135834|567604959|FG000|Stage 2|Did not receive Booster Vaccination|1|||
157234372|NCT03135834|567604960|FG001|Stage 2|Did not receive Booster Vaccination|1|||
157234373|NCT03135834|567604961|FG002|Stage 2|Did not receive Booster Vaccination|0|||
157234374|NCT03135834|567604962|FG003|Stage 2|Did not receive Booster Vaccination|0|||
157234375|NCT03966365|567604963|FG000|Overall Study|Protocol Violation|1|||
157234376|NCT03966365|567604964|FG001|Overall Study|Protocol Violation|0|||
157234377|NCT02421952|567604965|FG000|Overall Study|Diary Not Returned|93|||
157234378|NCT02421952|567604965|FG000|Overall Study|Failed seriation task|13|||
157234379|NCT02421952|567604965|FG000|Overall Study|Subject uncooperative for baseline test|2|||
157234380|NCT02421952|567604965|FG000|Overall Study|Surgery cancelled|1|||
157234381|NCT01469546|567604968|FG000|Received 5 mg Dose|Adverse Event|13|||
157234382|NCT01469546|567604968|FG000|Received 5 mg Dose|Death|2|||
157234383|NCT01469546|567604968|FG000|Received 5 mg Dose|Protocol Violation|2|||
157084595|NCT00774930|567063530|FG000|LTOLE Phase|Subject decision|0|||
157084596|NCT00774930|567063531|FG001|LTOLE Phase|Subject decision|5|||
157084597|NCT00774930|567063530|FG000|LTOLE Phase|Physician Decision|4|||
157084598|NCT00774930|567063531|FG001|LTOLE Phase|Physician Decision|1|||
157084599|NCT00774930|567063530|FG000|LTOLE Phase|Sponsor decision|2|||
157084600|NCT00774930|567063531|FG001|LTOLE Phase|Sponsor decision|1|||
157084601|NCT00774930|567063530|FG000|LTOLE Phase|Disease Progression|2|||
157084602|NCT00774930|567063531|FG001|LTOLE Phase|Disease Progression|5|||
157084603|NCT00774930|567063530|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
157084604|NCT00774930|567063531|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
157084605|NCT00774930|567063530|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
157084606|NCT00774930|567063531|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
157084607|NCT04032613|567063536|FG000|Overall Study|Did not complete post-program assessment|5|||
157084608|NCT04032613|567063537|FG001|Overall Study|Did not complete post-program assessment|2|||
157084609|NCT01659853|567063538|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
157084610|NCT01659853|567063539|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
157084611|NCT01659853|567063538|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
157084612|NCT01659853|567063539|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
157084613|NCT03053518|567063540|FG000|Overall Study|Withdrawal by Subject|3|||
157084614|NCT03053518|567063540|FG000|Overall Study|Lost to Follow-up|2|||
157084615|NCT03053518|567063540|FG000|Overall Study|Ineligible|5|||
157084616|NCT02071290|567063541|FG000|Overall Study|Death|1|||
157234384|NCT01469546|567604968|FG000|Received 5 mg Dose|Progressive Disease|3|||
157234385|NCT01469546|567604968|FG000|Received 5 mg Dose|Physician Decision|3|||
157234386|NCT02801877|567604969|FG000|Overall Study|Lost to Follow-up|1|||
157234387|NCT02801877|567604970|FG001|Overall Study|Lost to Follow-up|1|||
157234388|NCT02801877|567604971|FG002|Overall Study|Lost to Follow-up|2|||
157084617|NCT02071290|567063542|FG001|Overall Study|Death|0|||
157234389|NCT02801877|567604972|FG003|Overall Study|Lost to Follow-up|0|||
157234390|NCT02801877|567604969|FG000|Overall Study|Never Started Treatment|2|||
157234391|NCT02801877|567604970|FG001|Overall Study|Never Started Treatment|0|||
157234392|NCT02801877|567604971|FG002|Overall Study|Never Started Treatment|4|||
157234393|NCT02801877|567604972|FG003|Overall Study|Never Started Treatment|0|||
157234394|NCT04934722|567606582|FG000|Overall Study|Death|4|||
157234395|NCT04934722|567606583|FG001|Overall Study|Death|3|||
157234396|NCT04934722|567606582|FG000|Overall Study|Participants Ongoing|88|||
157234397|NCT04934722|567606583|FG001|Overall Study|Participants Ongoing|91|||
157234398|NCT06358820|567606584|FG000|Overall Study|Adverse Event|11|||
157234399|NCT06358820|567606584|FG000|Overall Study|kidney transplantation|3|||
157234400|NCT06358820|567606584|FG000|Overall Study|patient voluntary withdrawal|6|||
157234401|NCT06358820|567606584|FG000|Overall Study|Physician Decision|1|||
157234402|NCT05376319|567606585|FG000|Overall Study|Funding termination|2|||
157234403|NCT05376319|567606586|FG001|Overall Study|Funding termination|4|||
157234404|NCT01124175|567606587|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
157234405|NCT01124175|567606588|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
157234406|NCT00942968|567606589|FG000|Overall Study|Adverse Event|60|||
157234407|NCT00942968|567606589|FG000|Overall Study|Death|76|||
157234408|NCT00942968|567606589|FG000|Overall Study|Protocol Violation|9|||
157234409|NCT00942968|567606589|FG000|Overall Study|Lost to Follow-up|4|||
157234410|NCT00942968|567606589|FG000|Overall Study|Withdrawal by Subject|44|||
157234411|NCT00942968|567606589|FG000|Overall Study|Sponsor request|5|||
157234412|NCT00942968|567606589|FG000|Overall Study|Physician Decision|11|||
157234413|NCT00942968|567606589|FG000|Overall Study|Progression of disease|12|||
157234414|NCT00942968|567606589|FG000|Overall Study|Inferior vena cava filter placement|4|||
157234415|NCT00942968|567606589|FG000|Overall Study|Pulmonary embolism (PE)|1|||
157234416|NCT00942968|567606589|FG000|Overall Study|Participant required pancreatic biopsy|1|||
157234417|NCT00942968|567606589|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
157234418|NCT01948258|567606590|FG000|Overall Study|Pregnancy|41|||
157234419|NCT01948258|567606590|FG000|Overall Study|Did not complete by cut-off date|35|||
157234420|NCT01948258|567606590|FG000|Overall Study|Lost to Follow-up|27|||
157234421|NCT01948258|567606590|FG000|Overall Study|Withdrawal by SPD|8|||
157234422|NCT01948258|567606590|FG000|Overall Study|Withdrawal by Subject|6|||
157234423|NCT01948258|567606590|FG000|Overall Study|Health Care Professional|43|||
157234424|NCT01948258|567606590|FG000|Overall Study|Removed from statistical analysis|2|||
157234425|NCT01340495|567606597|FG000|Overall Study|Withdrawal by Subject|1|||
157234426|NCT01811953|567606598|FG000|Overall Study|Adverse Event|0|||
157234427|NCT01811953|567606599|FG001|Overall Study|Adverse Event|0|||
157234428|NCT01811953|567606600|FG002|Overall Study|Adverse Event|0|||
157234429|NCT01811953|567606601|FG003|Overall Study|Adverse Event|1|||
157234430|NCT01811953|567606602|FG004|Overall Study|Adverse Event|0|||
157234431|NCT01811953|567606603|FG005|Overall Study|Adverse Event|1|||
157234432|NCT01811953|567606598|FG000|Overall Study|Protocol Violation|0|||
157234433|NCT01811953|567606599|FG001|Overall Study|Protocol Violation|0|||
157234434|NCT01811953|567606600|FG002|Overall Study|Protocol Violation|0|||
157234435|NCT01811953|567606601|FG003|Overall Study|Protocol Violation|0|||
157234436|NCT01811953|567606602|FG004|Overall Study|Protocol Violation|1|||
157234437|NCT01811953|567606603|FG005|Overall Study|Protocol Violation|0|||
157234438|NCT00070291|567606605|FG000|Step 1|Withdrawal by Subject|1|||
157234439|NCT00070291|567606605|FG000|Step 1|Adverse Event|1|||
157234440|NCT00070291|567606605|FG000|Step 2|Adverse Event|1|||
157234441|NCT00520130|567606606|FG000|Overall Study|Disease progression on study|4|||
157234442|NCT00520130|567606607|FG001|Overall Study|Disease progression on study|0|||
157234443|NCT00520130|567606606|FG000|Overall Study|Physician Decision|1|||
157234444|NCT00520130|567606607|FG001|Overall Study|Physician Decision|1|||
157234445|NCT02533258|567606610|FG000|Overall Study|Adverse Event|1|||
157234446|NCT02533258|567606610|FG000|Overall Study|Death|2|||
157234447|NCT02533258|567606610|FG000|Overall Study|Other|1|||
157234448|NCT02533258|567606610|FG000|Overall Study|Economic factor|1|||
157234449|NCT02533258|567606610|FG000|Overall Study|Progression of pleural effusion|1|||
157234450|NCT02533258|567606610|FG000|Overall Study|Lack of Efficacy|2|||
157234451|NCT01045096|567606611|FG000|Overall Study|Withdrawal by Subject|2|||
157084618|NCT02071290|567063541|FG000|Overall Study|Withdrawal by Subject|0|||
157084619|NCT02071290|567063542|FG001|Overall Study|Withdrawal by Subject|1|||
157084620|NCT02071290|567063541|FG000|Overall Study|Protocol Violation|3|||
157084621|NCT02071290|567063542|FG001|Overall Study|Protocol Violation|5|||
157234452|NCT01045096|567606612|FG001|Overall Study|Withdrawal by Subject|0|||
157084622|NCT02071290|567063541|FG000|Overall Study|Physician Decision|0|||
157084623|NCT02071290|567063542|FG001|Overall Study|Physician Decision|1|||
157234453|NCT01045096|567606613|FG002|Overall Study|Withdrawal by Subject|0|||
157234454|NCT01045096|567606611|FG000|Overall Study|Other|1|||
157234455|NCT01045096|567606612|FG001|Overall Study|Other|0|||
157234456|NCT01045096|567606613|FG002|Overall Study|Other|0|||
157234457|NCT01511939|567606615|FG000|Overall Study|Withdrawal by Subject|2|||
157234458|NCT01511939|567606616|FG001|Overall Study|Withdrawal by Subject|1|||
157234459|NCT01511939|567606617|FG002|Overall Study|Withdrawal by Subject|0|||
157234460|NCT03785548|567606623|FG000|Overall Study|age > 80|1|||
157234461|NCT03785548|567606624|FG001|Overall Study|age > 80|0|||
157234462|NCT03785548|567606623|FG000|Overall Study|no Postop queries|1|||
157234463|NCT03785548|567606624|FG001|Overall Study|no Postop queries|0|||
157234464|NCT01993030|567606625|FG000|Overall Study|Adverse Event|0|||
157234465|NCT01993030|567606626|FG001|Overall Study|Adverse Event|4|||
157234466|NCT00396279|567606628|FG000|Overall Study|Ongoing in study|26|||
157234467|NCT00396279|567606628|FG000|Overall Study|Disease progression|2|||
157234468|NCT00396279|567606628|FG000|Overall Study|Withdrawal by Subject|1|||
157234469|NCT00396279|567606628|FG000|Overall Study|Physician Decision|1|||
157234470|NCT02883452|567606629|FG000|Overall Study|Withdrawal by Subject|1|||
157234471|NCT02883452|567606630|FG001|Overall Study|Withdrawal by Subject|1|||
157234472|NCT02883452|567606631|FG002|Overall Study|Withdrawal by Subject|3|||
157234473|NCT02883452|567606632|FG003|Overall Study|Withdrawal by Subject|0|||
157234474|NCT02883452|567606633|FG004|Overall Study|Withdrawal by Subject|2|||
157234475|NCT02883452|567606634|FG005|Overall Study|Withdrawal by Subject|5|||
157234476|NCT02883452|567606629|FG000|Overall Study|Disease progression|1|||
157234477|NCT02883452|567606630|FG001|Overall Study|Disease progression|0|||
157234478|NCT02883452|567606631|FG002|Overall Study|Disease progression|0|||
157234479|NCT02883452|567606632|FG003|Overall Study|Disease progression|1|||
157234480|NCT02883452|567606633|FG004|Overall Study|Disease progression|4|||
157234481|NCT02883452|567606634|FG005|Overall Study|Disease progression|5|||
157234482|NCT02883452|567606629|FG000|Overall Study|Adverse Event|2|||
157234483|NCT02883452|567606630|FG001|Overall Study|Adverse Event|1|||
157234484|NCT02883452|567606631|FG002|Overall Study|Adverse Event|1|||
157234485|NCT02883452|567606632|FG003|Overall Study|Adverse Event|1|||
157234486|NCT02883452|567606633|FG004|Overall Study|Adverse Event|1|||
157234487|NCT02883452|567606634|FG005|Overall Study|Adverse Event|3|||
157234488|NCT02883452|567606629|FG000|Overall Study|Physician Decision|0|||
157234489|NCT02883452|567606630|FG001|Overall Study|Physician Decision|0|||
157234490|NCT02883452|567606631|FG002|Overall Study|Physician Decision|0|||
157234491|NCT02883452|567606632|FG003|Overall Study|Physician Decision|0|||
157234492|NCT02883452|567606633|FG004|Overall Study|Physician Decision|4|||
157234493|NCT02883452|567606634|FG005|Overall Study|Physician Decision|1|||
157234494|NCT02883452|567606629|FG000|Overall Study|Death|1|||
157194294|NCT02041533|567454046|FG001|Treatment Period|Other reasons|2|||
157194295|NCT02041533|567454045|FG000|Treatment Period|Not Reported|0|||
157194296|NCT02041533|567454046|FG001|Treatment Period|Not Reported|1|||
157194297|NCT02500706|567454047|FG000|Overall Study|Adverse Event|0|||
157194298|NCT02500706|567454048|FG001|Overall Study|Adverse Event|0|||
157194299|NCT02500706|567454049|FG002|Overall Study|Adverse Event|1|||
157194300|NCT02500706|567454047|FG000|Overall Study|Lost to Follow-up|0|||
157194301|NCT02500706|567454048|FG001|Overall Study|Lost to Follow-up|1|||
157194302|NCT02500706|567454049|FG002|Overall Study|Lost to Follow-up|1|||
157194303|NCT02500706|567454047|FG000|Overall Study|Withdrawal by Subject|4|||
157194304|NCT02500706|567454048|FG001|Overall Study|Withdrawal by Subject|6|||
157194305|NCT02500706|567454049|FG002|Overall Study|Withdrawal by Subject|4|||
157194306|NCT02500706|567454047|FG000|Overall Study|Unclassified|0|||
157194307|NCT02500706|567454048|FG001|Overall Study|Unclassified|0|||
157194308|NCT02500706|567454049|FG002|Overall Study|Unclassified|1|||
157194309|NCT00529152|567454050|FG000|Overall Study|Adverse Event|2|||
157194310|NCT00529152|567454050|FG000|Overall Study|Withdrawal by Subject|2|||
157194311|NCT00529152|567454050|FG000|Overall Study|Lost to Follow-up|1|||
157194312|NCT01957111|567454054|FG000|Overall Study|Withdrawal by Subject|1|||
157194313|NCT01957111|567454055|FG001|Overall Study|Withdrawal by Subject|1|||
157194314|NCT03500419|567454056|FG000|Overall Study|Withdrawal by Subject|2|||
157194315|NCT03500419|567454057|FG001|Overall Study|Withdrawal by Subject|25|||
157194316|NCT01497899|567454058|FG000|Double-Blind Phase|Randomized but not Treated|1|||
157194317|NCT01497899|567454059|FG001|Double-Blind Phase|Randomized but not Treated|0|||
157194318|NCT01497899|567454060|FG002|Double-Blind Phase|Randomized but not Treated|0|||
157194319|NCT01497899|567454061|FG003|Double-Blind Phase|Randomized but not Treated|0|||
157194320|NCT01497899|567454058|FG000|Double-Blind Phase|Adverse Event|1|||
157194321|NCT01497899|567454059|FG001|Double-Blind Phase|Adverse Event|0|||
157194322|NCT01497899|567454060|FG002|Double-Blind Phase|Adverse Event|0|||
157194323|NCT01497899|567454061|FG003|Double-Blind Phase|Adverse Event|0|||
157194324|NCT01497899|567454058|FG000|Double-Blind Phase|Lack of Efficacy|0|||
157194325|NCT01497899|567454059|FG001|Double-Blind Phase|Lack of Efficacy|1|||
157194326|NCT01497899|567454060|FG002|Double-Blind Phase|Lack of Efficacy|0|||
157194327|NCT01497899|567454061|FG003|Double-Blind Phase|Lack of Efficacy|0|||
157234495|NCT02883452|567606630|FG001|Overall Study|Death|0|||
157234496|NCT02883452|567606631|FG002|Overall Study|Death|1|||
157234497|NCT02883452|567606632|FG003|Overall Study|Death|0|||
157234498|NCT02883452|567606633|FG004|Overall Study|Death|0|||
157194328|NCT01497899|567454058|FG000|Double-Blind Phase|Investigator's Discretion|1|||
157194329|NCT01497899|567454059|FG001|Double-Blind Phase|Investigator's Discretion|0|||
157194330|NCT01497899|567454060|FG002|Double-Blind Phase|Investigator's Discretion|0|||
157194331|NCT01497899|567454061|FG003|Double-Blind Phase|Investigator's Discretion|0|||
157194332|NCT01497899|567454058|FG000|Double-Blind Phase|Withdrew Consent|0|||
157234499|NCT02883452|567606634|FG005|Overall Study|Death|0|||
157234500|NCT02883452|567606629|FG000|Overall Study|Other|0|||
157234501|NCT02883452|567606630|FG001|Overall Study|Other|0|||
157234502|NCT02883452|567606631|FG002|Overall Study|Other|0|||
157234503|NCT02883452|567606632|FG003|Overall Study|Other|0|||
157234504|NCT02883452|567606633|FG004|Overall Study|Other|0|||
157234505|NCT02883452|567606634|FG005|Overall Study|Other|1|||
157194333|NCT01497899|567454059|FG001|Double-Blind Phase|Withdrew Consent|1|||
157194334|NCT01497899|567454060|FG002|Double-Blind Phase|Withdrew Consent|0|||
157194335|NCT01497899|567454061|FG003|Double-Blind Phase|Withdrew Consent|0|||
157194336|NCT01497899|567454058|FG000|Double-Blind Phase|Lost to Follow-up|3|||
157194337|NCT01497899|567454059|FG001|Double-Blind Phase|Lost to Follow-up|2|||
157194338|NCT01497899|567454060|FG002|Double-Blind Phase|Lost to Follow-up|0|||
157194339|NCT01497899|567454061|FG003|Double-Blind Phase|Lost to Follow-up|0|||
157194340|NCT01497899|567454058|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
157194341|NCT01497899|567454059|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
157194342|NCT01497899|567454060|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
157194343|NCT01497899|567454061|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
157194344|NCT01497899|567454058|FG000|Open-Label Extension Phase|Adverse Event|1|||
157194345|NCT01497899|567454059|FG001|Open-Label Extension Phase|Adverse Event|0|||
157194346|NCT01497899|567454060|FG002|Open-Label Extension Phase|Adverse Event|0|||
157194347|NCT01497899|567454061|FG003|Open-Label Extension Phase|Adverse Event|0|||
157194348|NCT01497899|567454058|FG000|Open-Label Extension Phase|Death|1|||
157194349|NCT01497899|567454059|FG001|Open-Label Extension Phase|Death|0|||
157194350|NCT01497899|567454060|FG002|Open-Label Extension Phase|Death|0|||
157194351|NCT01497899|567454061|FG003|Open-Label Extension Phase|Death|0|||
157194352|NCT01497899|567454058|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
157194353|NCT01497899|567454059|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
157194354|NCT01497899|567454060|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
157194355|NCT01497899|567454061|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
157194356|NCT01497899|567454058|FG000|Open-Label Extension Phase|Pregnancy|0|||
157194357|NCT01497899|567454059|FG001|Open-Label Extension Phase|Pregnancy|1|||
157194358|NCT01497899|567454060|FG002|Open-Label Extension Phase|Pregnancy|1|||
157194359|NCT01497899|567454061|FG003|Open-Label Extension Phase|Pregnancy|0|||
157194360|NCT01497899|567454058|FG000|Open-Label Extension Phase|Protocol Violation|0|||
157194361|NCT01497899|567454059|FG001|Open-Label Extension Phase|Protocol Violation|0|||
157194362|NCT01497899|567454060|FG002|Open-Label Extension Phase|Protocol Violation|1|||
157194363|NCT01497899|567454061|FG003|Open-Label Extension Phase|Protocol Violation|0|||
157194364|NCT01497899|567454058|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
157194365|NCT01497899|567454059|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
157194366|NCT01497899|567454060|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
157194367|NCT01497899|567454061|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
157194368|NCT01000311|567454062|FG000|Overall Study|Adverse Event|2|||
157194369|NCT01000311|567454063|FG001|Overall Study|Adverse Event|5|||
157194370|NCT01000311|567454062|FG000|Overall Study|Withdrawal by Subject|16|||
157194371|NCT01000311|567454063|FG001|Overall Study|Withdrawal by Subject|24|||
157194372|NCT01000311|567454062|FG000|Overall Study|Lost to Follow-up|15|||
157194373|NCT01000311|567454063|FG001|Overall Study|Lost to Follow-up|24|||
157194374|NCT01000311|567454062|FG000|Overall Study|Protocol Violation|1|||
157194375|NCT01000311|567454063|FG001|Overall Study|Protocol Violation|2|||
157194376|NCT01000311|567454062|FG000|Overall Study|Inappropriate enrollment|2|||
157194377|NCT01000311|567454063|FG001|Overall Study|Inappropriate enrollment|0|||
157194378|NCT01000311|567454062|FG000|Overall Study|Administrative reason|9|||
157194379|NCT01000311|567454063|FG001|Overall Study|Administrative reason|15|||
157194380|NCT01376908|567454064|FG000|Overall Study|Protocol Violation|1|||
157194381|NCT01376908|567454065|FG001|Overall Study|Protocol Violation|1|||
157194382|NCT01376908|567454064|FG000|Overall Study|Withdrawal by Subject|1|||
157194383|NCT01376908|567454065|FG001|Overall Study|Withdrawal by Subject|2|||
157194384|NCT01646255|567454066|FG000|Overall Study|Adverse Event|7|||
157194385|NCT01646255|567454067|FG001|Overall Study|Adverse Event|8|||
157194386|NCT01646255|567454066|FG000|Overall Study|Lack of Efficacy|2|||
157194387|NCT01646255|567454067|FG001|Overall Study|Lack of Efficacy|0|||
157194388|NCT01646255|567454066|FG000|Overall Study|Withdrawal by Subject|10|||
157194389|NCT01646255|567454067|FG001|Overall Study|Withdrawal by Subject|6|||
157194390|NCT01646255|567454066|FG000|Overall Study|Compliance is not well|1|||
157194391|NCT01646255|567454067|FG001|Overall Study|Compliance is not well|0|||
157194392|NCT01646255|567454066|FG000|Overall Study|Inclusion Criteria Deviation|1|||
157194393|NCT01646255|567454067|FG001|Overall Study|Inclusion Criteria Deviation|0|||
157194394|NCT00742391|567454068|FG000|Overall Study|Adverse Event|2|||
157194395|NCT00742391|567454069|FG001|Overall Study|Adverse Event|1|||
157194396|NCT00742391|567454068|FG000|Overall Study|Lost to Follow-up|1|||
157194397|NCT00742391|567454069|FG001|Overall Study|Lost to Follow-up|0|||
157194398|NCT00742391|567454068|FG000|Overall Study|Protocol Violation|1|||
157234506|NCT01882257|567606643|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
157194399|NCT00742391|567454069|FG001|Overall Study|Protocol Violation|0|||
157194400|NCT01241318|567454070|FG000|Overall Study|Woman: false pregnancies|27|||
157234507|NCT01882257|567606644|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
157234508|NCT01882257|567606645|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
157194401|NCT01241318|567454071|FG001|Overall Study|Woman: false pregnancies|15|||
157194402|NCT01241318|567454070|FG000|Overall Study|Woman: miscarriage/abortion|46|||
157194403|NCT01241318|567454071|FG001|Overall Study|Woman: miscarriage/abortion|38|||
157194404|NCT01241318|567454070|FG000|Overall Study|Withdrawal by Subject|175|||
157194405|NCT01241318|567454071|FG001|Overall Study|Withdrawal by Subject|46|||
157194406|NCT01241318|567454070|FG000|Overall Study|Lost to Follow-up|740|||
157194407|NCT01241318|567454071|FG001|Overall Study|Lost to Follow-up|455|||
157194408|NCT01241318|567454070|FG000|Overall Study|Death|2|||
157194409|NCT01241318|567454071|FG001|Overall Study|Death|4|||
157194410|NCT01241318|567454070|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
157194411|NCT01241318|567454071|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
157194412|NCT01241318|567454070|FG000|Overall Study|Woman: Stillborn infant|129|||
157194413|NCT01241318|567454071|FG001|Overall Study|Woman: Stillborn infant|146|||
157194414|NCT02355665|567454072|FG000|Overall Study|Adverse Event|16|||
157194415|NCT02355665|567454073|FG001|Overall Study|Adverse Event|24|||
157194416|NCT02355665|567454072|FG000|Overall Study|Protocol Violation|2|||
157194417|NCT02355665|567454073|FG001|Overall Study|Protocol Violation|0|||
157194418|NCT02355665|567454072|FG000|Overall Study|Withdrawal by Subject|90|||
157194419|NCT02355665|567454073|FG001|Overall Study|Withdrawal by Subject|100|||
157194420|NCT02355665|567454072|FG000|Overall Study|Lost to Follow-up|131|||
157194421|NCT02355665|567454073|FG001|Overall Study|Lost to Follow-up|103|||
157194422|NCT02355665|567454072|FG000|Overall Study|Death|4|||
157194423|NCT02355665|567454073|FG001|Overall Study|Death|2|||
157194424|NCT02355665|567454072|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
157194425|NCT02355665|567454073|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
157194426|NCT00266695|567454074|FG000|Overall Study|Adverse Event|1|||
157194427|NCT00266695|567454074|FG000|Overall Study|Death|9|||
157194428|NCT00266695|567454074|FG000|Overall Study|Physician Decision|1|||
157194429|NCT00266695|567454074|FG000|Overall Study|Lost to Follow-up|3|||
157194430|NCT00266695|567454074|FG000|Overall Study|Withdrawal by Subject|15|||
157194431|NCT02380703|567454075|FG000|Overall Study|Withdrawal by Subject|12|||
157194432|NCT02380703|567454076|FG001|Overall Study|Withdrawal by Subject|9|||
157194433|NCT02380703|567454075|FG000|Overall Study|Lost to Follow-up|12|||
157194434|NCT02380703|567454076|FG001|Overall Study|Lost to Follow-up|12|||
157194435|NCT02380703|567454075|FG000|Overall Study|Caregiver death|1|||
157194436|NCT02380703|567454076|FG001|Overall Study|Caregiver death|0|||
157194437|NCT02380703|567454075|FG000|Overall Study|Person with dementia (PWD) death|7|||
157194438|NCT02380703|567454076|FG001|Overall Study|Person with dementia (PWD) death|8|||
157194439|NCT02380703|567454075|FG000|Overall Study|Entered Long-term Care|4|||
157194440|NCT02380703|567454076|FG001|Overall Study|Entered Long-term Care|7|||
157194441|NCT03607994|567454077|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
157194442|NCT03607994|567454078|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
157194443|NCT04490499|567454084|FG000|Overall Study|Withdrawal by Subject|2|||
157194444|NCT03125902|567454087|FG000|Overall Study|Adverse Event|0|||
157194445|NCT03125902|567454088|FG001|Overall Study|Adverse Event|1|||
157194446|NCT03125902|567454087|FG000|Overall Study|Death|119|||
157194447|NCT03125902|567454088|FG001|Overall Study|Death|229|||
157194448|NCT03125902|567454087|FG000|Overall Study|Lost to Follow-up|4|||
157194449|NCT03125902|567454088|FG001|Overall Study|Lost to Follow-up|13|||
157194450|NCT03125902|567454087|FG000|Overall Study|Other|0|||
157194451|NCT03125902|567454088|FG001|Overall Study|Other|4|||
157194452|NCT03125902|567454087|FG000|Overall Study|Physician Decision|2|||
157194453|NCT03125902|567454088|FG001|Overall Study|Physician Decision|1|||
157194454|NCT03125902|567454087|FG000|Overall Study|Progressive Disease|0|||
157194455|NCT03125902|567454088|FG001|Overall Study|Progressive Disease|3|||
157194456|NCT03125902|567454087|FG000|Overall Study|Study Terminated By Sponsor|74|||
157194457|NCT03125902|567454088|FG001|Overall Study|Study Terminated By Sponsor|143|||
157194458|NCT03125902|567454087|FG000|Overall Study|Withdrawal by Subject|21|||
157194459|NCT03125902|567454088|FG001|Overall Study|Withdrawal by Subject|37|||
157194460|NCT04411472|567454089|FG000|Overall Study|Adverse Event|5|||
157194461|NCT04411472|567454090|FG001|Overall Study|Adverse Event|10|||
157194462|NCT04411472|567454091|FG002|Overall Study|Adverse Event|1|||
157194463|NCT04411472|567454092|FG003|Overall Study|Adverse Event|0|||
157194464|NCT04411472|567454093|FG004|Overall Study|Adverse Event|0|||
157194465|NCT04411472|567454094|FG005|Overall Study|Adverse Event|0|||
157194466|NCT04411472|567454089|FG000|Overall Study|Protocol Violation|1|||
157194467|NCT04411472|567454090|FG001|Overall Study|Protocol Violation|0|||
157234509|NCT01882257|567606643|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
157194468|NCT04411472|567454091|FG002|Overall Study|Protocol Violation|0|||
157194469|NCT04411472|567454092|FG003|Overall Study|Protocol Violation|0|||
157194470|NCT04411472|567454093|FG004|Overall Study|Protocol Violation|0|||
157194471|NCT04411472|567454094|FG005|Overall Study|Protocol Violation|0|||
157194472|NCT04411472|567454089|FG000|Overall Study|Withdrawal by Subject|0|||
157234510|NCT01882257|567606644|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
157194473|NCT04411472|567454090|FG001|Overall Study|Withdrawal by Subject|1|||
157194474|NCT04411472|567454091|FG002|Overall Study|Withdrawal by Subject|0|||
157194475|NCT04411472|567454092|FG003|Overall Study|Withdrawal by Subject|1|||
157194476|NCT04411472|567454093|FG004|Overall Study|Withdrawal by Subject|0|||
157194477|NCT04411472|567454094|FG005|Overall Study|Withdrawal by Subject|0|||
157194478|NCT04411472|567454089|FG000|Overall Study|Physician Decision|1|||
157234511|NCT01882257|567606645|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
157234512|NCT00830206|567606646|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
157234513|NCT00830206|567606647|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
157234514|NCT03351335|567606651|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
157234515|NCT03351335|567606652|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
157234516|NCT03351335|567606653|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
157234517|NCT00909610|567606654|FG000|Period: First Intervention|Adverse Event|0|||
157234518|NCT00909610|567606655|FG001|Period: First Intervention|Adverse Event|1|||
157234519|NCT00909610|567606654|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
157234520|NCT00909610|567606655|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
157234521|NCT00909610|567606654|FG000|Period: Second Intervention|Adverse Event|1|||
157234522|NCT00909610|567606655|FG001|Period: Second Intervention|Adverse Event|0|||
157234523|NCT02736721|567606663|FG000|Overall Study|Adverse Event|8|||
157234524|NCT02736721|567606663|FG000|Overall Study|Lost to Follow-up|3|||
157234525|NCT02736721|567606663|FG000|Overall Study|Other|5|||
157234526|NCT00418184|567606668|FG000|Double-blind Phase|Withdrawal by Subject|22|||
157234527|NCT00418184|567606669|FG001|Double-blind Phase|Withdrawal by Subject|9|||
157234528|NCT00418184|567606668|FG000|Double-blind Phase|Adverse Event|2|||
157234529|NCT00418184|567606669|FG001|Double-blind Phase|Adverse Event|1|||
157234530|NCT00418184|567606668|FG000|Double-blind Phase|Poor compliance|3|||
157234531|NCT00418184|567606669|FG001|Double-blind Phase|Poor compliance|1|||
157234532|NCT00834249|567606670|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
157234533|NCT00834249|567606671|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
157234534|NCT00834249|567606670|FG000|Second Intervention|Adverse Event|1|||
157234535|NCT00834249|567606671|FG001|Second Intervention|Adverse Event|0|||
157234536|NCT00851877|567606672|FG000|Phase I-1|Death|1|||
157234537|NCT00851877|567606673|FG001|Phase I-1|Death|0|||
157234538|NCT00851877|567606674|FG002|Phase I-1|Death|0|||
157234539|NCT00851877|567606672|FG000|Phase II|Withdrawal by Subject|0|||
157234540|NCT00851877|567606673|FG001|Phase II|Withdrawal by Subject|0|||
157084624|NCT00964886|567063549|FG000|Overall Study|Lost to Follow-up|2|||
157194479|NCT04411472|567454090|FG001|Overall Study|Physician Decision|0|||
157194480|NCT04411472|567454091|FG002|Overall Study|Physician Decision|0|||
157194481|NCT04411472|567454092|FG003|Overall Study|Physician Decision|0|||
157194482|NCT04411472|567454093|FG004|Overall Study|Physician Decision|0|||
157194483|NCT04411472|567454094|FG005|Overall Study|Physician Decision|0|||
157194484|NCT04411472|567454089|FG000|Overall Study|Study terminated by sponsor|17|||
157194485|NCT04411472|567454090|FG001|Overall Study|Study terminated by sponsor|20|||
157194486|NCT04411472|567454091|FG002|Overall Study|Study terminated by sponsor|3|||
157194487|NCT04411472|567454092|FG003|Overall Study|Study terminated by sponsor|0|||
157194488|NCT04411472|567454093|FG004|Overall Study|Study terminated by sponsor|0|||
157194489|NCT04411472|567454094|FG005|Overall Study|Study terminated by sponsor|0|||
157194490|NCT00362297|567454095|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
157194491|NCT00362297|567454096|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
157194492|NCT00819052|567454097|FG000|Overall Study|Adverse Event|0|||
157194493|NCT00819052|567454098|FG001|Overall Study|Adverse Event|5|||
157194494|NCT00819052|567454097|FG000|Overall Study|Protocol Violation|1|||
157194495|NCT00819052|567454098|FG001|Overall Study|Protocol Violation|2|||
157194496|NCT00819052|567454097|FG000|Overall Study|Lost to Follow-up|1|||
157194497|NCT00819052|567454098|FG001|Overall Study|Lost to Follow-up|2|||
157194498|NCT00819052|567454097|FG000|Overall Study|Withdrawal by Subject|1|||
157194499|NCT00819052|567454098|FG001|Overall Study|Withdrawal by Subject|2|||
157194500|NCT00819052|567454097|FG000|Overall Study|Lack of Efficacy|1|||
157194501|NCT00819052|567454098|FG001|Overall Study|Lack of Efficacy|1|||
157194502|NCT00819052|567454097|FG000|Overall Study|Pregnancy|1|||
157194503|NCT00819052|567454098|FG001|Overall Study|Pregnancy|2|||
157194504|NCT00819052|567454097|FG000|Overall Study|Death or events leading to death|1|||
157084625|NCT00964886|567063550|FG001|Overall Study|Lost to Follow-up|2|||
157084626|NCT00964886|567063551|FG002|Overall Study|Lost to Follow-up|6|||
157084627|NCT00964886|567063552|FG003|Overall Study|Lost to Follow-up|4|||
157084628|NCT00964886|567063549|FG000|Overall Study|Withdrawal by Subject|6|||
157084629|NCT00964886|567063550|FG001|Overall Study|Withdrawal by Subject|2|||
157084630|NCT00964886|567063551|FG002|Overall Study|Withdrawal by Subject|5|||
157084631|NCT00964886|567063552|FG003|Overall Study|Withdrawal by Subject|3|||
157194505|NCT00819052|567454098|FG001|Overall Study|Death or events leading to death|0|||
157234541|NCT00851877|567606674|FG002|Phase II|Withdrawal by Subject|3|||
157234542|NCT00620074|567606675|FG000|Overall Study|Adverse Event|1|||
157234543|NCT00627016|567606676|FG000|Overall Study|Adverse Event|1|||
157234544|NCT00627016|567606677|FG001|Overall Study|Adverse Event|1|||
157234545|NCT00627016|567606676|FG000|Overall Study|Protocol Violation|0|||
157234546|NCT00627016|567606677|FG001|Overall Study|Protocol Violation|2|||
157194506|NCT00591786|567454101|FG000|Overall Study|Withdrawal of Informed Consent|0|||
157194507|NCT00591786|567454102|FG001|Overall Study|Withdrawal of Informed Consent|0|||
157194508|NCT00591786|567454103|FG002|Overall Study|Withdrawal of Informed Consent|1|||
157194509|NCT00591786|567454104|FG003|Overall Study|Withdrawal of Informed Consent|0|||
157234547|NCT00627016|567606676|FG000|Overall Study|Lost to Follow-up|0|||
157084632|NCT00964886|567063549|FG000|Overall Study|Adverse Event|3|||
157084633|NCT00964886|567063550|FG001|Overall Study|Adverse Event|1|||
157084634|NCT00964886|567063551|FG002|Overall Study|Adverse Event|5|||
157084635|NCT00964886|567063552|FG003|Overall Study|Adverse Event|2|||
157084636|NCT00964886|567063549|FG000|Overall Study|Protocol Violation|0|||
157194510|NCT00591786|567454105|FG004|Overall Study|Withdrawal of Informed Consent|0|||
157194511|NCT00591786|567454106|FG005|Overall Study|Withdrawal of Informed Consent|0|||
157194512|NCT00591786|567454107|FG006|Overall Study|Withdrawal of Informed Consent|0|||
157194513|NCT00591786|567454108|FG007|Overall Study|Withdrawal of Informed Consent|0|||
157194514|NCT00591786|567454109|FG008|Overall Study|Withdrawal of Informed Consent|0|||
157194515|NCT00591786|567454110|FG009|Overall Study|Withdrawal of Informed Consent|0|||
157194516|NCT02146352|567454113|FG000|Overall Study|Death|1|||
157194517|NCT02146352|567454113|FG000|Overall Study|Patient entered hospice care|1|||
157194518|NCT03091920|567454117|FG000|Overall Study|Adverse Event|0|||
157194519|NCT03091920|567454118|FG001|Overall Study|Adverse Event|1|||
157194520|NCT03091920|567454119|FG002|Overall Study|Adverse Event|0|||
157194521|NCT01513460|567454120|FG000|Overall Study|Death|0|||
157194522|NCT01513460|567454121|FG001|Overall Study|Death|0|||
157194523|NCT01513460|567454122|FG002|Overall Study|Death|1|||
157194524|NCT01513460|567454120|FG000|Overall Study|Lost to Follow-up|0|||
157194525|NCT01513460|567454121|FG001|Overall Study|Lost to Follow-up|0|||
157084637|NCT00964886|567063550|FG001|Overall Study|Protocol Violation|2|||
157084638|NCT00964886|567063551|FG002|Overall Study|Protocol Violation|0|||
157084639|NCT00964886|567063552|FG003|Overall Study|Protocol Violation|0|||
157084640|NCT05560243|567063553|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
157084641|NCT01232738|567063554|FG000|Overall Study|Death|3|||
157084642|NCT01232738|567063554|FG000|Overall Study|Physician Decision|2|||
157084643|NCT01232738|567063554|FG000|Overall Study|Lost to Follow-up|1|||
157084644|NCT01232738|567063554|FG000|Overall Study|Withdrawal by Subject|2|||
157084645|NCT01232738|567063554|FG000|Overall Study|Adverse Event|5|||
157084646|NCT03231800|567063559|FG000|Overall Study|Lost to Follow-up|0|||
157084647|NCT03231800|567063560|FG001|Overall Study|Lost to Follow-up|2|||
157084648|NCT03231800|567063559|FG000|Overall Study|Protocol Violation|1|||
157084649|NCT03231800|567063560|FG001|Overall Study|Protocol Violation|1|||
157084650|NCT03231800|567063559|FG000|Overall Study|reason not provided|2|||
157084651|NCT03231800|567063560|FG001|Overall Study|reason not provided|0|||
157084652|NCT00859222|567063561|FG000|Overall Study|Adverse Event|2|||
157084653|NCT00859222|567063562|FG001|Overall Study|Adverse Event|3|||
157084654|NCT00859222|567063563|FG002|Overall Study|Adverse Event|6|||
157084655|NCT00859222|567063564|FG003|Overall Study|Adverse Event|24|||
157084656|NCT00859222|567063565|FG004|Overall Study|Adverse Event|15|||
157084657|NCT00859222|567063561|FG000|Overall Study|DLT|1|||
157084658|NCT00859222|567063562|FG001|Overall Study|DLT|0|||
157084659|NCT00859222|567063563|FG002|Overall Study|DLT|0|||
157084660|NCT00859222|567063564|FG003|Overall Study|DLT|0|||
157084661|NCT00859222|567063565|FG004|Overall Study|DLT|0|||
157084662|NCT00488475|567063566|FG000|Overall Study|Other|1754|||
157084663|NCT00400725|567063577|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
157084664|NCT00400725|567063578|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
157194526|NCT01513460|567454122|FG002|Overall Study|Lost to Follow-up|2|||
157194527|NCT01513460|567454120|FG000|Overall Study|Abnormal laboratory value|1|||
157194528|NCT01513460|567454121|FG001|Overall Study|Abnormal laboratory value|0|||
157194529|NCT01513460|567454122|FG002|Overall Study|Abnormal laboratory value|1|||
157194530|NCT01513460|567454120|FG000|Overall Study|Lack of Efficacy|1|||
157194531|NCT01513460|567454121|FG001|Overall Study|Lack of Efficacy|2|||
157194532|NCT01513460|567454122|FG002|Overall Study|Lack of Efficacy|5|||
157194533|NCT01513460|567454120|FG000|Overall Study|Protocol deviations|3|||
157194534|NCT01513460|567454121|FG001|Overall Study|Protocol deviations|4|||
157194535|NCT01513460|567454122|FG002|Overall Study|Protocol deviations|3|||
157194536|NCT01513460|567454120|FG000|Overall Study|Withdrawal by Subject|7|||
157194537|NCT01513460|567454121|FG001|Overall Study|Withdrawal by Subject|8|||
157194538|NCT01513460|567454122|FG002|Overall Study|Withdrawal by Subject|21|||
157194539|NCT01513460|567454120|FG000|Overall Study|Adverse Event|16|||
157194540|NCT01513460|567454121|FG001|Overall Study|Adverse Event|18|||
157194541|NCT01513460|567454122|FG002|Overall Study|Adverse Event|23|||
157194542|NCT01513460|567454120|FG000|Overall Study|Abnormal test procedure|1|||
157194543|NCT01513460|567454121|FG001|Overall Study|Abnormal test procedure|0|||
157194544|NCT01513460|567454122|FG002|Overall Study|Abnormal test procedure|0|||
157194545|NCT00489216|567454126|FG000|Overall Study|Adverse Event|1|||
157194546|NCT04120116|567455616|FG000|Overall Study|Lost to Follow-up|0|||
157194547|NCT04120116|567455617|FG001|Overall Study|Lost to Follow-up|1|||
157084665|NCT00400725|567063579|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
157084666|NCT00400725|567063577|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
157194548|NCT04120116|567455618|FG002|Overall Study|Lost to Follow-up|0|||
157194549|NCT04120116|567455619|FG003|Overall Study|Lost to Follow-up|2|||
157194550|NCT04120116|567455616|FG000|Overall Study|Withdrawal by Subject|1|||
157194551|NCT04120116|567455617|FG001|Overall Study|Withdrawal by Subject|0|||
157194552|NCT04120116|567455618|FG002|Overall Study|Withdrawal by Subject|1|||
157084667|NCT00400725|567063578|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
157194553|NCT04120116|567455619|FG003|Overall Study|Withdrawal by Subject|1|||
157234548|NCT00627016|567606677|FG001|Overall Study|Lost to Follow-up|1|||
157234549|NCT00627016|567606676|FG000|Overall Study|Withdrawal by Subject|2|||
157234550|NCT00627016|567606677|FG001|Overall Study|Withdrawal by Subject|1|||
157234551|NCT00627016|567606676|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
157234552|NCT00627016|567606677|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
157234553|NCT00627016|567606676|FG000|Overall Study|Lack of Efficacy|1|||
157234554|NCT00627016|567606677|FG001|Overall Study|Lack of Efficacy|0|||
157234555|NCT00627016|567606676|FG000|Overall Study|Placed on Excluded Drugs|1|||
157234556|NCT00627016|567606677|FG001|Overall Study|Placed on Excluded Drugs|0|||
157234557|NCT00627016|567606676|FG000|Overall Study|Pregnancy|1|||
157234558|NCT00627016|567606677|FG001|Overall Study|Pregnancy|0|||
157234559|NCT01534663|567606678|FG000|Overall Study|Lost to Follow-up|0|||
157234560|NCT01534663|567606679|FG001|Overall Study|Lost to Follow-up|2|||
157234561|NCT01534663|567606678|FG000|Overall Study|Adverse Event|2|||
157234562|NCT01534663|567606679|FG001|Overall Study|Adverse Event|1|||
157234563|NCT04088760|567606680|FG000|Overall Study|Physician Decision|1|||
157234564|NCT00286754|567606681|FG000|Overall Study|Adverse Event|2|||
157234565|NCT00286754|567606682|FG001|Overall Study|Adverse Event|2|||
157234566|NCT00286754|567606683|FG002|Overall Study|Adverse Event|3|||
157234567|NCT00286754|567606681|FG000|Overall Study|Withdrawal by Subject|6|||
157234568|NCT00286754|567606682|FG001|Overall Study|Withdrawal by Subject|2|||
157234569|NCT00286754|567606683|FG002|Overall Study|Withdrawal by Subject|0|||
157234570|NCT00286754|567606681|FG000|Overall Study|Lost to Follow-up|12|||
157234571|NCT00286754|567606682|FG001|Overall Study|Lost to Follow-up|14|||
157234572|NCT00286754|567606683|FG002|Overall Study|Lost to Follow-up|6|||
157234573|NCT00286754|567606681|FG000|Overall Study|Moved out of state|0|||
157234574|NCT00286754|567606682|FG001|Overall Study|Moved out of state|0|||
157234575|NCT00286754|567606683|FG002|Overall Study|Moved out of state|1|||
157234576|NCT01536405|567606684|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
157234577|NCT01536405|567606685|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
157234578|NCT01536405|567606684|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
157234579|NCT01536405|567606685|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
157234580|NCT01536405|567606684|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
157234581|NCT01536405|567606685|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
157234582|NCT01536405|567606684|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
157234583|NCT01536405|567606685|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
157234584|NCT01536405|567606684|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
157234585|NCT01536405|567606685|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
157234586|NCT01536405|567606684|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
157234587|NCT01536405|567606685|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
157234588|NCT01536405|567606684|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
157234589|NCT01536405|567606685|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
157234590|NCT01536405|567606684|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
157234591|NCT01536405|567606685|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
157234592|NCT01536405|567606684|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
157234593|NCT01536405|567606685|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
157234594|NCT01536405|567606684|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
157234595|NCT01536405|567606685|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
157234596|NCT01536405|567606684|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
157234597|NCT01536405|567606685|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
157234598|NCT01536405|567606684|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
157234599|NCT01536405|567606685|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
157234600|NCT01536405|567606684|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
157234601|NCT01536405|567606685|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
157234602|NCT04786184|567606687|FG000|Overall Study|Adverse Event|4|||
157234603|NCT04786184|567606688|FG001|Overall Study|Adverse Event|0|||
157234604|NCT04786184|567606687|FG000|Overall Study|Withdrawal by Subject|3|||
157234605|NCT04786184|567606688|FG001|Overall Study|Withdrawal by Subject|1|||
157234606|NCT04786184|567606687|FG000|Overall Study|Lost to Follow-up|4|||
157234607|NCT04786184|567606688|FG001|Overall Study|Lost to Follow-up|2|||
157234608|NCT02514122|567606689|FG000|Overall Study|Withdrawal by Subject|2|||
157234609|NCT02514122|567606690|FG001|Overall Study|Withdrawal by Subject|0|||
157234610|NCT01792635|567606691|FG000|Part B|Adverse Event|0|||
157234611|NCT01792635|567606692|FG001|Part B|Adverse Event|0|||
157234612|NCT01792635|567606693|FG002|Part B|Adverse Event|1|||
157234613|NCT01792635|567606691|FG000|Part B|Study terminated|0|||
157234614|NCT01792635|567606692|FG001|Part B|Study terminated|4|||
157234615|NCT01792635|567606693|FG002|Part B|Study terminated|3|||
157234616|NCT01010542|567606694|FG000|Overall Study|Adverse Event|0|||
157234617|NCT01010542|567606695|FG001|Overall Study|Adverse Event|1|||
157234618|NCT01010542|567606696|FG002|Overall Study|Adverse Event|0|||
157234619|NCT01010542|567606694|FG000|Overall Study|Lost to Follow-up|0|||
157234620|NCT01010542|567606695|FG001|Overall Study|Lost to Follow-up|1|||
157234621|NCT01010542|567606696|FG002|Overall Study|Lost to Follow-up|0|||
157234622|NCT01010542|567606694|FG000|Overall Study|Withdrawal by Subject|0|||
157194554|NCT04120116|567455616|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
157194555|NCT04120116|567455617|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
157194556|NCT04120116|567455618|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
157194557|NCT04120116|567455619|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
157194558|NCT00965458|567455620|FG000|Overall Study|Adverse Event|1|||
157194559|NCT00965458|567455621|FG001|Overall Study|Adverse Event|0|||
157194560|NCT00965458|567455620|FG000|Overall Study|Lost to Follow-up|1|||
157194561|NCT00965458|567455621|FG001|Overall Study|Lost to Follow-up|3|||
157194562|NCT00965458|567455620|FG000|Overall Study|Withdrawal by Subject|0|||
157194563|NCT00965458|567455621|FG001|Overall Study|Withdrawal by Subject|1|||
157194564|NCT01846039|567455624|FG000|Overall Study|Protocol Violation|1|||
157194565|NCT01846039|567455624|FG000|Overall Study|Subject Withdrew Consent|1|||
157194566|NCT02528331|567455635|FG000|Overall Study|Withdrawal by Subject|2|||
157194567|NCT03824704|567455640|FG000|Overall Study|Study Terminated by Sponsor|1|||
157194568|NCT02155660|567455648|FG000|Overall Study|Other Reason|8|||
157194569|NCT02155660|567455649|FG001|Overall Study|Other Reason|6|||
157194570|NCT02155660|567455650|FG002|Overall Study|Other Reason|10|||
157194571|NCT02155660|567455651|FG003|Overall Study|Other Reason|10|||
157194572|NCT02155660|567455648|FG000|Overall Study|Study-specific withdrawal criteria|0|||
157194573|NCT02155660|567455649|FG001|Overall Study|Study-specific withdrawal criteria|1|||
157194574|NCT02155660|567455650|FG002|Overall Study|Study-specific withdrawal criteria|1|||
157194575|NCT02155660|567455651|FG003|Overall Study|Study-specific withdrawal criteria|1|||
157194576|NCT02155660|567455648|FG000|Overall Study|Severe non-compliance|0|||
157194577|NCT02155660|567455649|FG001|Overall Study|Severe non-compliance|4|||
157194578|NCT02155660|567455650|FG002|Overall Study|Severe non-compliance|0|||
157194579|NCT02155660|567455651|FG003|Overall Study|Severe non-compliance|1|||
157194580|NCT02155660|567455648|FG000|Overall Study|Adverse Event|2|||
157194581|NCT02155660|567455649|FG001|Overall Study|Adverse Event|6|||
157194582|NCT02155660|567455650|FG002|Overall Study|Adverse Event|3|||
157194583|NCT02155660|567455651|FG003|Overall Study|Adverse Event|1|||
157194584|NCT02155660|567455648|FG000|Overall Study|Lost to Follow-up|3|||
157194585|NCT02155660|567455649|FG001|Overall Study|Lost to Follow-up|6|||
157194586|NCT02155660|567455650|FG002|Overall Study|Lost to Follow-up|5|||
157194587|NCT02155660|567455651|FG003|Overall Study|Lost to Follow-up|8|||
157194588|NCT02155660|567455648|FG000|Overall Study|Death|17|||
157194589|NCT02155660|567455649|FG001|Overall Study|Death|19|||
157194590|NCT02155660|567455650|FG002|Overall Study|Death|17|||
157194591|NCT02155660|567455651|FG003|Overall Study|Death|19|||
157194592|NCT02155660|567455648|FG000|Overall Study|Withdrawal by Subject|28|||
157194593|NCT02155660|567455649|FG001|Overall Study|Withdrawal by Subject|31|||
157194594|NCT02155660|567455650|FG002|Overall Study|Withdrawal by Subject|24|||
157194595|NCT02155660|567455651|FG003|Overall Study|Withdrawal by Subject|21|||
157194596|NCT03730987|567455652|FG000|Overall Study|Lost to Follow-up|2|||
157194597|NCT03730987|567455653|FG001|Overall Study|Lost to Follow-up|0|||
157194598|NCT03730987|567455654|FG002|Overall Study|Lost to Follow-up|2|||
157194599|NCT03730987|567455655|FG003|Overall Study|Lost to Follow-up|0|||
157194600|NCT02505945|567455656|FG000|Overall Study|Withdrawal by Subject|13|||
157194601|NCT02505945|567455657|FG001|Overall Study|Withdrawal by Subject|2|||
157194602|NCT02505945|567455656|FG000|Overall Study|Adverse Event|1|||
157194603|NCT02505945|567455657|FG001|Overall Study|Adverse Event|0|||
157194604|NCT02505945|567455656|FG000|Overall Study|Physician Decision|2|||
157194605|NCT02505945|567455657|FG001|Overall Study|Physician Decision|1|||
157194606|NCT02505945|567455656|FG000|Overall Study|Lost to Follow-up|6|||
157194607|NCT02505945|567455657|FG001|Overall Study|Lost to Follow-up|1|||
157194608|NCT00883896|567455663|FG000|Overall Study|Lost to Follow-up|0|||
157194609|NCT00883896|567455664|FG001|Overall Study|Lost to Follow-up|0|||
157194610|NCT00883896|567455665|FG002|Overall Study|Lost to Follow-up|0|||
157194611|NCT00883896|567455666|FG003|Overall Study|Lost to Follow-up|2|||
157194612|NCT00883896|567455663|FG000|Overall Study|Withdrawal by Subject|5|||
157194613|NCT00883896|567455664|FG001|Overall Study|Withdrawal by Subject|0|||
157194614|NCT00883896|567455665|FG002|Overall Study|Withdrawal by Subject|1|||
157194615|NCT00883896|567455666|FG003|Overall Study|Withdrawal by Subject|3|||
157194616|NCT00883896|567455663|FG000|Overall Study|Lack of Efficacy|0|||
157194617|NCT00883896|567455664|FG001|Overall Study|Lack of Efficacy|0|||
157194618|NCT00883896|567455665|FG002|Overall Study|Lack of Efficacy|0|||
157194619|NCT00883896|567455666|FG003|Overall Study|Lack of Efficacy|2|||
157194620|NCT00883896|567455663|FG000|Overall Study|Other|1|||
157194621|NCT00883896|567455664|FG001|Overall Study|Other|0|||
157194622|NCT00883896|567455665|FG002|Overall Study|Other|0|||
157194623|NCT00883896|567455666|FG003|Overall Study|Other|0|||
157194624|NCT02546193|567455667|FG000|Overall Study|Withdrawal by Subject|2|||
157194625|NCT02546193|567455668|FG001|Overall Study|Withdrawal by Subject|0|||
157194626|NCT02546193|567455669|FG002|Overall Study|Withdrawal by Subject|1|||
157194627|NCT02546193|567455670|FG003|Overall Study|Withdrawal by Subject|0|||
157194628|NCT02546193|567455667|FG000|Overall Study|Not eligible at time of induction|4|||
157194629|NCT02546193|567455668|FG001|Overall Study|Not eligible at time of induction|6|||
157234623|NCT01010542|567606695|FG001|Overall Study|Withdrawal by Subject|3|||
157234624|NCT01010542|567606696|FG002|Overall Study|Withdrawal by Subject|2|||
157234625|NCT05615935|567606701|FG000|Overall Study|Lost to Follow-up|1|||
157234626|NCT05615935|567606702|FG001|Overall Study|Lost to Follow-up|1|||
157234627|NCT00302952|567606705|FG000|Overall Study|Physician Decision|1|||
157234628|NCT00302952|567606706|FG001|Overall Study|Physician Decision|1|||
157234629|NCT00302952|567606705|FG000|Overall Study|Withdrawal by Subject|2|||
157234630|NCT00302952|567606706|FG001|Overall Study|Withdrawal by Subject|3|||
157234631|NCT00302952|567606705|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
157234632|NCT00302952|567606706|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
157234633|NCT00336479|567606707|FG000|Overall Study|Adverse Event|8|||
157234634|NCT00336479|567606708|FG001|Overall Study|Adverse Event|11|||
157234635|NCT00336479|567606709|FG002|Overall Study|Adverse Event|18|||
157234636|NCT00336479|567606710|FG003|Overall Study|Adverse Event|4|||
157234637|NCT00336479|567606707|FG000|Overall Study|Noncompliant|1|||
157234638|NCT00336479|567606708|FG001|Overall Study|Noncompliant|7|||
157234639|NCT00336479|567606709|FG002|Overall Study|Noncompliant|3|||
157234640|NCT00336479|567606710|FG003|Overall Study|Noncompliant|0|||
157234641|NCT00336479|567606707|FG000|Overall Study|Physician Decision|2|||
157234642|NCT00336479|567606708|FG001|Overall Study|Physician Decision|3|||
157234643|NCT00336479|567606709|FG002|Overall Study|Physician Decision|1|||
157234644|NCT00336479|567606710|FG003|Overall Study|Physician Decision|0|||
157234645|NCT00336479|567606707|FG000|Overall Study|Lost to Follow-up|3|||
157234646|NCT00336479|567606708|FG001|Overall Study|Lost to Follow-up|2|||
157234647|NCT00336479|567606709|FG002|Overall Study|Lost to Follow-up|0|||
157234648|NCT00336479|567606710|FG003|Overall Study|Lost to Follow-up|0|||
157234649|NCT00336479|567606707|FG000|Overall Study|Withdrawal by Subject|3|||
157234650|NCT00336479|567606708|FG001|Overall Study|Withdrawal by Subject|2|||
157234651|NCT00336479|567606709|FG002|Overall Study|Withdrawal by Subject|3|||
157234652|NCT00336479|567606710|FG003|Overall Study|Withdrawal by Subject|0|||
157234653|NCT00336479|567606707|FG000|Overall Study|Other|0|||
157234654|NCT00336479|567606708|FG001|Overall Study|Other|0|||
157234655|NCT00336479|567606709|FG002|Overall Study|Other|1|||
157234656|NCT00336479|567606710|FG003|Overall Study|Other|0|||
157234657|NCT00336479|567606707|FG000|Overall Study|Virologic Stopping Rule|20|||
157234658|NCT00336479|567606708|FG001|Overall Study|Virologic Stopping Rule|0|||
157234659|NCT00336479|567606709|FG002|Overall Study|Virologic Stopping Rule|0|||
157234660|NCT00336479|567606710|FG003|Overall Study|Virologic Stopping Rule|0|||
157234661|NCT00550537|567606713|FG000|Overall Study|Death|18|||
157234662|NCT00550537|567606713|FG000|Overall Study|Adverse Event|20|||
157234663|NCT00550537|567606713|FG000|Overall Study|Disease progression before|46|||
157234664|NCT00550537|567606713|FG000|Overall Study|Withdrawal by Subject|7|||
157234665|NCT00550537|567606713|FG000|Overall Study|Change in treatment plan|4|||
157234666|NCT00550537|567606713|FG000|Overall Study|Other complicating ilness|3|||
157234667|NCT00550537|567606713|FG000|Overall Study|Declining performance status|2|||
157234668|NCT00550537|567606713|FG000|Overall Study|Treated closer to home|4|||
157234669|NCT02008565|567606714|FG000|Overall Study|Protocol Violation|1|||
157234670|NCT02008565|567606715|FG001|Overall Study|Protocol Violation|1|||
157234671|NCT02008565|567606716|FG002|Overall Study|Protocol Violation|2|||
157234672|NCT02008565|567606717|FG003|Overall Study|Protocol Violation|0|||
157234673|NCT03435081|567606718|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
157234674|NCT03435081|567606719|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
157234675|NCT03435081|567606720|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
157234676|NCT03435081|567606718|FG000|Week 0 to Week 16|Adverse Event|2|||
157234677|NCT03435081|567606719|FG001|Week 0 to Week 16|Adverse Event|2|||
157234678|NCT03435081|567606720|FG002|Week 0 to Week 16|Adverse Event|2|||
157234679|NCT03435081|567606718|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
157234680|NCT03435081|567606719|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
157234681|NCT03435081|567606720|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
157234682|NCT03435081|567606718|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
157234683|NCT03435081|567606719|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
157234684|NCT03435081|567606720|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
157234685|NCT03435081|567606718|FG000|Week 0 to Week 16|Pregnancy|1|||
157234686|NCT03435081|567606719|FG001|Week 0 to Week 16|Pregnancy|0|||
157234687|NCT03435081|567606720|FG002|Week 0 to Week 16|Pregnancy|0|||
157234688|NCT03435081|567606718|FG000|Week 0 to Week 16|Non-compliance|1|||
157234689|NCT03435081|567606719|FG001|Week 0 to Week 16|Non-compliance|0|||
157234690|NCT03435081|567606720|FG002|Week 0 to Week 16|Non-compliance|2|||
157234691|NCT03435081|567606718|FG000|Week 0 to Week 16|Inadequate Response|0|||
157234692|NCT03435081|567606719|FG001|Week 0 to Week 16|Inadequate Response|1|||
157234693|NCT03435081|567606720|FG002|Week 0 to Week 16|Inadequate Response|0|||
157234694|NCT03435081|567606718|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
157234695|NCT03435081|567606719|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
157234696|NCT03435081|567606720|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
157234697|NCT03435081|567606718|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
157234698|NCT03435081|567606719|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
157234699|NCT03435081|567606720|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
157234700|NCT03435081|567606718|FG000|Week 16 to Week 104|Adverse Event|1|||
157234701|NCT03435081|567606719|FG001|Week 16 to Week 104|Adverse Event|0|||
157234702|NCT03435081|567606720|FG002|Week 16 to Week 104|Adverse Event|2|||
157234703|NCT03435081|567606718|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
157234704|NCT03435081|567606719|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
157234705|NCT03435081|567606720|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
157234706|NCT03435081|567606718|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
157234707|NCT03435081|567606719|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
157234708|NCT03435081|567606720|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
157234709|NCT03435081|567606718|FG000|Week 16 to Week 104|Non--Compliance|0|||
157234710|NCT03435081|567606719|FG001|Week 16 to Week 104|Non--Compliance|0|||
157234711|NCT03435081|567606720|FG002|Week 16 to Week 104|Non--Compliance|1|||
157234712|NCT02601560|567606721|FG000|Overall Study|Other|0|||
157234713|NCT02601560|567606722|FG001|Overall Study|Other|0|||
157234714|NCT02601560|567606723|FG002|Overall Study|Other|0|||
157234715|NCT02601560|567606724|FG003|Overall Study|Other|0|||
157234716|NCT02601560|567606725|FG004|Overall Study|Other|0|||
157234717|NCT02601560|567606726|FG005|Overall Study|Other|0|||
157234718|NCT02601560|567606727|FG006|Overall Study|Other|1|||
157234719|NCT02601560|567606728|FG007|Overall Study|Other|0|||
157234720|NCT00420238|567606729|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
157234721|NCT00420238|567606730|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
157234722|NCT00420238|567606729|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
157234723|NCT00420238|567606730|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
157234724|NCT00420238|567606729|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
157234725|NCT00420238|567606730|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
157234726|NCT00420238|567606729|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
157234727|NCT00420238|567606730|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
157234728|NCT00420238|567606729|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
157234729|NCT00420238|567606730|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
157084668|NCT00400725|567063579|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
157234730|NCT00420238|567606729|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
157234731|NCT00420238|567606730|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
157234732|NCT01406795|567606731|FG000|Overall Study|Withdrawal by Subject|1|||
157234733|NCT00905346|567608187|FG000|Period 1|Withdrawal by Subject|1|||
157084669|NCT00400725|567063577|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
157084670|NCT00400725|567063578|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
157084671|NCT00400725|567063579|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
157084672|NCT00400725|567063577|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
157084673|NCT00400725|567063578|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
157084674|NCT00400725|567063579|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
157084675|NCT00400725|567063577|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
157084676|NCT00400725|567063578|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
157084677|NCT00400725|567063579|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
157084678|NCT00400725|567063577|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
157084679|NCT00400725|567063578|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
157084680|NCT00400725|567063579|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
157084681|NCT00400725|567063577|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
157084682|NCT00400725|567063578|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
157084683|NCT00400725|567063579|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
157084684|NCT00400725|567063577|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
157084685|NCT00400725|567063578|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
157084686|NCT00400725|567063579|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
157084687|NCT00400725|567063577|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
157084688|NCT00400725|567063578|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
157084689|NCT00400725|567063579|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
157084690|NCT04075994|567063582|FG000|Overall Study|Withdrawal by Subject|8|||
157084691|NCT04075994|567063583|FG001|Overall Study|Withdrawal by Subject|9|||
157084692|NCT04075994|567063582|FG000|Overall Study|Adverse Event|2|||
157084693|NCT04075994|567063583|FG001|Overall Study|Adverse Event|2|||
157084694|NCT04075994|567063582|FG000|Overall Study|Investigator withdrew|3|||
157084695|NCT04075994|567063583|FG001|Overall Study|Investigator withdrew|1|||
157084696|NCT01941719|567063588|FG000|Overall Study|Lost to Follow-up|20|||
157084697|NCT01941719|567063589|FG001|Overall Study|Lost to Follow-up|19|||
157084698|NCT00252577|567063590|FG000|Overall Study|Lost to Follow-up|20|||
157084699|NCT02797080|567063593|FG000|Overall Study|Lost to Follow-up|1|||
157084700|NCT02797080|567063593|FG000|Overall Study|Withdrawal by Subject|1|||
157084701|NCT04035499|567063594|FG000|Overall Study|Death|2|||
157084702|NCT04035499|567063594|FG000|Overall Study|Withdrawal by Subject|1|||
157084703|NCT03819634|567063596|FG000|Overall Study|Physician Decision|2|||
157084704|NCT00958841|567063597|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157084705|NCT00958841|567063597|FG000|Overall Study|Abnormal test procedure result(s)|3|||
157084706|NCT00958841|567063597|FG000|Overall Study|Administrative problems|1|||
157234734|NCT00905346|567608188|FG001|Period 1|Withdrawal by Subject|0|||
157234735|NCT04089735|567608189|FG000|Overall Study|Adverse Event|1|||
157234736|NCT04089735|567608190|FG001|Overall Study|Adverse Event|0|||
157234737|NCT04089735|567608191|FG002|Overall Study|Adverse Event|1|||
157234738|NCT04089735|567608192|FG003|Overall Study|Adverse Event|1|||
157234739|NCT04089735|567608193|FG004|Overall Study|Adverse Event|0|||
157234740|NCT04089735|567608194|FG005|Overall Study|Adverse Event|0|||
157234741|NCT04089735|567608189|FG000|Overall Study|Physician Decision|0|||
157234742|NCT04089735|567608190|FG001|Overall Study|Physician Decision|3|||
157234743|NCT04089735|567608191|FG002|Overall Study|Physician Decision|0|||
157234744|NCT04089735|567608192|FG003|Overall Study|Physician Decision|0|||
157234745|NCT04089735|567608193|FG004|Overall Study|Physician Decision|0|||
157234746|NCT04089735|567608194|FG005|Overall Study|Physician Decision|0|||
157234747|NCT04089735|567608189|FG000|Overall Study|Withdrawal by Subject|0|||
157234748|NCT04089735|567608190|FG001|Overall Study|Withdrawal by Subject|0|||
157234749|NCT04089735|567608191|FG002|Overall Study|Withdrawal by Subject|1|||
157234750|NCT04089735|567608192|FG003|Overall Study|Withdrawal by Subject|0|||
157234751|NCT04089735|567608193|FG004|Overall Study|Withdrawal by Subject|0|||
157234752|NCT04089735|567608194|FG005|Overall Study|Withdrawal by Subject|0|||
157234753|NCT04089735|567608189|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
157234754|NCT04089735|567608190|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
157234755|NCT04089735|567608191|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
157234756|NCT04089735|567608192|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
157234757|NCT04089735|567608193|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
157234758|NCT04089735|567608194|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
157234759|NCT00312663|567608200|FG000|Immunization Phase|Adverse Event|0|||
157234760|NCT00312663|567608201|FG001|Immunization Phase|Adverse Event|1|||
157234761|NCT00312663|567608202|FG002|Immunization Phase|Adverse Event|0|||
157234762|NCT00376623|567608203|FG000|Overall Study|Progressive disease|35|||
157234763|NCT00376623|567608204|FG001|Overall Study|Progressive disease|22|||
157234764|NCT00376623|567608205|FG002|Overall Study|Progressive disease|17|||
157234765|NCT00376623|567608203|FG000|Overall Study|Lost to Follow-up|0|||
157234766|NCT00376623|567608204|FG001|Overall Study|Lost to Follow-up|1|||
157234767|NCT00376623|567608205|FG002|Overall Study|Lost to Follow-up|0|||
157234768|NCT00376623|567608203|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
157234769|NCT00376623|567608204|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
157234770|NCT00376623|567608205|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
157234771|NCT00376623|567608203|FG000|Overall Study|Not treated with BI 2536|1|||
157234772|NCT00376623|567608204|FG001|Overall Study|Not treated with BI 2536|0|||
157194630|NCT02546193|567455669|FG002|Overall Study|Not eligible at time of induction|1|||
157194631|NCT02546193|567455670|FG003|Overall Study|Not eligible at time of induction|0|||
157194632|NCT01287403|567455674|FG000|1st Intervention (1 Day)|Adverse Event|1|||
157194633|NCT01098266|567455675|FG000|Overall Study|Physician Decision|1|||
157194634|NCT01098266|567455676|FG001|Overall Study|Physician Decision|0|||
157194635|NCT01098266|567455675|FG000|Overall Study|Death|3|||
157194636|NCT01098266|567455676|FG001|Overall Study|Death|2|||
157194637|NCT01098266|567455675|FG000|Overall Study|Withdrawal by Subject|3|||
157194638|NCT01098266|567455676|FG001|Overall Study|Withdrawal by Subject|5|||
157194639|NCT00438815|567455680|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
157194640|NCT00438815|567455680|FG000|Overall Study|3-month follow-up no longer required|12|||
157194641|NCT00438815|567455680|FG000|Overall Study|Noncompliance with protocol requirements|9|||
157194642|NCT00438815|567455680|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
157194643|NCT00438815|567455680|FG000|Overall Study|Lost to Follow-up|6|||
157194644|NCT00438815|567455680|FG000|Overall Study|Withdrawal by Subject|6|||
157194645|NCT00438815|567455680|FG000|Overall Study|Death|1|||
157194646|NCT01733758|567455681|FG000|Overall Study|Adverse Event|5|||
157194647|NCT01733758|567455682|FG001|Overall Study|Adverse Event|7|||
157194648|NCT01733758|567455683|FG002|Overall Study|Adverse Event|8|||
157194649|NCT01733758|567455684|FG003|Overall Study|Adverse Event|1|||
157194650|NCT01733758|567455681|FG000|Overall Study|Withdrawal by Subject|1|||
157194651|NCT01733758|567455682|FG001|Overall Study|Withdrawal by Subject|1|||
157234773|NCT00376623|567608205|FG002|Overall Study|Not treated with BI 2536|0|||
157234774|NCT00376623|567608203|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
157194652|NCT01733758|567455683|FG002|Overall Study|Withdrawal by Subject|5|||
157194653|NCT01733758|567455684|FG003|Overall Study|Withdrawal by Subject|3|||
157194654|NCT01733758|567455681|FG000|Overall Study|Persistent Hyperglycemia|3|||
157194655|NCT01733758|567455682|FG001|Overall Study|Persistent Hyperglycemia|2|||
157194656|NCT01733758|567455683|FG002|Overall Study|Persistent Hyperglycemia|0|||
157194657|NCT01733758|567455684|FG003|Overall Study|Persistent Hyperglycemia|0|||
157194658|NCT01733758|567455681|FG000|Overall Study|Protocol Violation|0|||
157234775|NCT00376623|567608204|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
157234776|NCT00376623|567608205|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
157084707|NCT00958841|567063597|FG000|Overall Study|Adverse Event|8|||
157084708|NCT00958841|567063597|FG000|Overall Study|New cancer therapy|5|||
157084709|NCT00958841|567063597|FG000|Overall Study|Withdrawal by Subject|1|||
157084710|NCT00958841|567063597|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
157084711|NCT00958841|567063597|FG000|Overall Study|Completed M6/did not enter extension|27|||
157084712|NCT00958841|567063597|FG000|Overall Study|Discontinued prior to M*|28|||
157084713|NCT01655693|567063598|FG000|Overall Study|Progression of Disease|92|||
157084714|NCT01655693|567063599|FG001|Overall Study|Progression of Disease|76|||
157084715|NCT01655693|567063600|FG002|Overall Study|Progression of Disease|58|||
157084716|NCT01655693|567063598|FG000|Overall Study|Death|8|||
157084717|NCT01655693|567063599|FG001|Overall Study|Death|9|||
157084718|NCT01655693|567063600|FG002|Overall Study|Death|12|||
157084719|NCT01655693|567063598|FG000|Overall Study|Serious Adverse Event|3|||
157084720|NCT01655693|567063599|FG001|Overall Study|Serious Adverse Event|15|||
157084721|NCT01655693|567063600|FG002|Overall Study|Serious Adverse Event|11|||
157084722|NCT01655693|567063598|FG000|Overall Study|Withdrawal by Subject|3|||
157084723|NCT01655693|567063599|FG001|Overall Study|Withdrawal by Subject|2|||
157084724|NCT01655693|567063600|FG002|Overall Study|Withdrawal by Subject|20|||
157084725|NCT01655693|567063598|FG000|Overall Study|Adverse Event|3|||
157084726|NCT01655693|567063599|FG001|Overall Study|Adverse Event|11|||
157084727|NCT01655693|567063600|FG002|Overall Study|Adverse Event|3|||
157084728|NCT01655693|567063598|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
157084729|NCT01655693|567063599|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
157084730|NCT01655693|567063600|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
157084731|NCT01655693|567063598|FG000|Overall Study|Non-Compliance|0|||
157084732|NCT01655693|567063599|FG001|Overall Study|Non-Compliance|0|||
157084733|NCT01655693|567063600|FG002|Overall Study|Non-Compliance|7|||
157084734|NCT01655693|567063598|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
157084735|NCT01655693|567063599|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
157084736|NCT01655693|567063600|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
157084737|NCT01655693|567063598|FG000|Overall Study|Protocol Violation|1|||
157084738|NCT01655693|567063599|FG001|Overall Study|Protocol Violation|0|||
157084739|NCT01655693|567063600|FG002|Overall Study|Protocol Violation|3|||
157084740|NCT01655693|567063598|FG000|Overall Study|Lost to Follow-up|1|||
157084741|NCT01655693|567063599|FG001|Overall Study|Lost to Follow-up|0|||
157084742|NCT01655693|567063600|FG002|Overall Study|Lost to Follow-up|1|||
157084743|NCT01655693|567063598|FG000|Overall Study|Screening Failure|1|||
157084744|NCT01655693|567063599|FG001|Overall Study|Screening Failure|0|||
157084745|NCT01655693|567063600|FG002|Overall Study|Screening Failure|0|||
157084746|NCT01655693|567063598|FG000|Overall Study|Other|8|||
157084747|NCT01655693|567063599|FG001|Overall Study|Other|6|||
157084748|NCT01655693|567063600|FG002|Overall Study|Other|15|||
157084749|NCT02535091|567063601|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
157084750|NCT02535091|567063602|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
157084751|NCT02535091|567063603|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
157084752|NCT02535091|567063601|FG000|Overall Study|Withdrawal by Subject|14|||
157084753|NCT02535091|567063602|FG001|Overall Study|Withdrawal by Subject|5|||
157084754|NCT02535091|567063603|FG002|Overall Study|Withdrawal by Subject|121|||
157084755|NCT02535091|567063601|FG000|Overall Study|Adverse Event|9|||
157084756|NCT02535091|567063602|FG001|Overall Study|Adverse Event|4|||
157084757|NCT02535091|567063603|FG002|Overall Study|Adverse Event|170|||
157084758|NCT02535091|567063601|FG000|Overall Study|Other|4|||
157084759|NCT02535091|567063602|FG001|Overall Study|Other|3|||
157084760|NCT02535091|567063603|FG002|Overall Study|Other|81|||
157084761|NCT02535091|567063601|FG000|Overall Study|Lost to Follow-up|0|||
157084762|NCT02535091|567063602|FG001|Overall Study|Lost to Follow-up|1|||
157084763|NCT02535091|567063603|FG002|Overall Study|Lost to Follow-up|19|||
157084764|NCT02535091|567063601|FG000|Overall Study|Protocol Violation|0|||
157084765|NCT02535091|567063602|FG001|Overall Study|Protocol Violation|1|||
157084766|NCT02535091|567063603|FG002|Overall Study|Protocol Violation|11|||
157084767|NCT02535091|567063601|FG000|Overall Study|Pregnancy|0|||
157084768|NCT02535091|567063602|FG001|Overall Study|Pregnancy|0|||
157084769|NCT02535091|567063603|FG002|Overall Study|Pregnancy|7|||
157084770|NCT01259089|567063614|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
157084771|NCT01259089|567063615|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
157084772|NCT01259089|567063616|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
157084773|NCT01259089|567063617|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
157084774|NCT01259089|567063618|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
157084775|NCT01259089|567063619|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
157084776|NCT01259089|567063614|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
157084777|NCT01259089|567063615|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
157084778|NCT01259089|567063616|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
157084779|NCT01259089|567063617|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
157234777|NCT00376623|567608203|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
157234778|NCT00376623|567608204|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
157234779|NCT00376623|567608205|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
157234780|NCT00376623|567608203|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
157234781|NCT00376623|567608204|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
157234782|NCT00376623|567608205|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
157234783|NCT00376623|567608203|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
157234784|NCT00376623|567608204|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
157234785|NCT00376623|567608205|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
157234786|NCT00376623|567608203|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
157234787|NCT00376623|567608204|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
157234788|NCT00376623|567608205|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
157234789|NCT00376623|567608203|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
157234790|NCT00376623|567608204|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
157234791|NCT00376623|567608205|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
157234792|NCT00376623|567608203|FG000|Overall Study|Increase of tumour markers|0|||
157234793|NCT00376623|567608204|FG001|Overall Study|Increase of tumour markers|1|||
157234794|NCT00376623|567608205|FG002|Overall Study|Increase of tumour markers|0|||
157234795|NCT00376623|567608203|FG000|Overall Study|Bone metastasis|1|||
157234796|NCT00376623|567608204|FG001|Overall Study|Bone metastasis|0|||
157234797|NCT00376623|567608205|FG002|Overall Study|Bone metastasis|0|||
157234798|NCT00301366|567608208|FG000|Overall Study|Adverse Event|1|||
157234799|NCT01313273|567608211|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
157234800|NCT01313273|567608212|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
157234801|NCT01313273|567608211|FG000|Overall Study|Withdrawal by Subject|1|||
157234802|NCT01313273|567608212|FG001|Overall Study|Withdrawal by Subject|0|||
157234803|NCT01313273|567608211|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
157234804|NCT01313273|567608212|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
157234805|NCT03687736|567608217|FG000|Overall Study|Lost to Follow-up|7|||
157234806|NCT03687736|567608217|FG000|Overall Study|Withdrawal by Subject|3|||
157234807|NCT02098876|567608219|FG000|Overall Study|Withdrawal by Subject|5|||
157234808|NCT02098876|567608220|FG001|Overall Study|Withdrawal by Subject|5|||
157234809|NCT01263704|567608221|FG000|Overall Study|Progressive disease|18|||
157234810|NCT01263704|567608221|FG000|Overall Study|Adverse Event|3|||
157234811|NCT01263704|567608221|FG000|Overall Study|Death|2|||
157234812|NCT01263704|567608221|FG000|Overall Study|Patient withdrew consent|2|||
157234813|NCT01263704|567608221|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
157234814|NCT01263704|567608221|FG000|Overall Study|Lost to Follow-up|1|||
157234815|NCT01263704|567608221|FG000|Overall Study|Colon metastases|1|||
157234816|NCT01263704|567608221|FG000|Overall Study|Principal Investigator (PI) decision|1|||
157234817|NCT03496623|567608224|FG000|Run-In Period (2 Weeks)|Death|1|||
157234818|NCT03496623|567608225|FG001|Run-In Period (2 Weeks)|Death|0|||
157234819|NCT03496623|567608226|FG002|Run-In Period (2 Weeks)|Death|0|||
157234820|NCT03496623|567608227|FG003|Run-In Period (2 Weeks)|Death|0|||
157234821|NCT03496623|567608228|FG004|Run-In Period (2 Weeks)|Death|0|||
157234822|NCT03496623|567608224|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
157234823|NCT03496623|567608225|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
157234824|NCT03496623|567608226|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
157234825|NCT03496623|567608227|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
157234826|NCT03496623|567608228|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
157234827|NCT03496623|567608224|FG000|Period 1 (12 Weeks)|Death|0|||
157234828|NCT03496623|567608225|FG001|Period 1 (12 Weeks)|Death|3|||
157234829|NCT03496623|567608226|FG002|Period 1 (12 Weeks)|Death|0|||
157234830|NCT03496623|567608227|FG003|Period 1 (12 Weeks)|Death|0|||
157234831|NCT03496623|567608228|FG004|Period 1 (12 Weeks)|Death|0|||
157234832|NCT03496623|567608224|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
157234833|NCT03496623|567608225|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
157234834|NCT03496623|567608226|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
157234835|NCT03496623|567608227|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
157234836|NCT03496623|567608228|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
157234837|NCT03496623|567608224|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157234838|NCT03496623|567608225|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
157234839|NCT03496623|567608226|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
157234840|NCT03496623|567608227|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157234841|NCT03496623|567608228|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
157234842|NCT03496623|567608224|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
157234843|NCT03496623|567608225|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
157234844|NCT03496623|567608226|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
157234845|NCT03496623|567608227|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
157234846|NCT03496623|567608228|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
157234847|NCT03496623|567608224|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
157234848|NCT03496623|567608225|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
157234849|NCT03496623|567608226|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
157234850|NCT03496623|567608227|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
157234851|NCT03496623|567608228|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
157234852|NCT03496623|567608224|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
157234853|NCT03496623|567608225|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
157194659|NCT01733758|567455682|FG001|Overall Study|Protocol Violation|1|||
157194660|NCT01733758|567455683|FG002|Overall Study|Protocol Violation|2|||
157194661|NCT01733758|567455684|FG003|Overall Study|Protocol Violation|2|||
157194662|NCT01733758|567455681|FG000|Overall Study|Non-compliance|1|||
157194663|NCT01733758|567455682|FG001|Overall Study|Non-compliance|0|||
157194664|NCT01733758|567455683|FG002|Overall Study|Non-compliance|0|||
157194665|NCT01733758|567455684|FG003|Overall Study|Non-compliance|0|||
157194666|NCT01733758|567455681|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
157194667|NCT01733758|567455682|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
157194668|NCT01733758|567455683|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
157194669|NCT01733758|567455684|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
157194670|NCT01733758|567455681|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
157194671|NCT01733758|567455682|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
157194672|NCT01733758|567455683|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
157194673|NCT01733758|567455684|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
157194674|NCT02545270|567455689|FG000|Overall Study|technical difficulties|0|||
157194675|NCT02545270|567455690|FG001|Overall Study|technical difficulties|1|||
157194676|NCT02545270|567455691|FG002|Overall Study|technical difficulties|0|||
157194677|NCT02545270|567455689|FG000|Overall Study|Videos being too similar to other|0|||
157194678|NCT02545270|567455690|FG001|Overall Study|Videos being too similar to other|0|||
157194679|NCT02545270|567455691|FG002|Overall Study|Videos being too similar to other|2|||
157194680|NCT00727246|567455692|FG000|Overall Study|could not complete MRI|0|||
157194681|NCT00727246|567455693|FG001|Overall Study|could not complete MRI|1|||
157194682|NCT00727246|567455694|FG002|Overall Study|could not complete MRI|0|||
157194683|NCT00727246|567455695|FG003|Overall Study|could not complete MRI|1|||
157194684|NCT00727246|567455692|FG000|Overall Study|incidental finding|0|||
157194685|NCT00727246|567455693|FG001|Overall Study|incidental finding|0|||
157194686|NCT00727246|567455694|FG002|Overall Study|incidental finding|0|||
157194687|NCT00727246|567455695|FG003|Overall Study|incidental finding|1|||
157194688|NCT00727246|567455692|FG000|Overall Study|withdrawn|0|||
157234854|NCT03496623|567608226|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
157234855|NCT03496623|567608227|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
157234856|NCT03496623|567608228|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
157234857|NCT03496623|567608224|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157234858|NCT03496623|567608225|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
157234859|NCT03496623|567608226|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
157234860|NCT03496623|567608227|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157234861|NCT03496623|567608228|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
157234862|NCT01061866|567608229|FG000|Overall Study|Adverse Event|2|||
157234863|NCT01270503|567608230|FG000|Overall Study|Lost to Follow-up|1|||
157234864|NCT02543203|567608231|FG000|Overall Study|Unpalatable Fragrance|2|||
157234865|NCT02543203|567608232|FG001|Overall Study|Unpalatable Fragrance|2|||
157234866|NCT02543203|567608231|FG000|Overall Study|Lost to Follow-up|1|||
157234867|NCT02543203|567608232|FG001|Overall Study|Lost to Follow-up|0|||
157234868|NCT02543203|567608231|FG000|Overall Study|Increased Irritability|1|||
157234869|NCT02543203|567608232|FG001|Overall Study|Increased Irritability|0|||
157234870|NCT02543203|567608231|FG000|Overall Study|Family|1|||
157234871|NCT02543203|567608232|FG001|Overall Study|Family|2|||
157234872|NCT02543203|567608231|FG000|Overall Study|Negative Behavior|1|||
157234873|NCT02543203|567608232|FG001|Overall Study|Negative Behavior|0|||
157234874|NCT02543203|567608231|FG000|Overall Study|Withdrawal by Subject|0|||
157234875|NCT02543203|567608232|FG001|Overall Study|Withdrawal by Subject|1|||
157234876|NCT02255097|567608233|FG000|Overall Study|Death|151|||
157234877|NCT02255097|567608233|FG000|Overall Study|Lost to Follow-up|5|||
157234878|NCT02255097|567608233|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
157234879|NCT02255097|567608233|FG000|Overall Study|Withdrawal by Subject|7|||
157234880|NCT02255097|567608233|FG000|Overall Study|Allocated but not treated|1|||
157234881|NCT01118312|567608234|FG000|Overall Study|Lost to Follow-up|33|||
157234882|NCT01118312|567608235|FG001|Overall Study|Lost to Follow-up|32|||
157234883|NCT01118312|567608234|FG000|Overall Study|Withdrawal by Subject|1|||
157234884|NCT01118312|567608235|FG001|Overall Study|Withdrawal by Subject|3|||
157234885|NCT03965091|567608236|FG000|Overall Study|Adverse Event|0|||
157234886|NCT03965091|567608237|FG001|Overall Study|Adverse Event|2|||
157234887|NCT03965091|567608238|FG002|Overall Study|Adverse Event|3|||
157234888|NCT03965091|567608236|FG000|Overall Study|Withdrawal by Subject|11|||
157194689|NCT00727246|567455693|FG001|Overall Study|withdrawn|0|||
157194690|NCT00727246|567455694|FG002|Overall Study|withdrawn|1|||
157194691|NCT00727246|567455695|FG003|Overall Study|withdrawn|0|||
157194692|NCT04594213|567455696|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
157194693|NCT04594213|567455697|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
157194694|NCT04594213|567455698|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
157194695|NCT04594213|567455699|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
157194696|NCT04594213|567455700|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
157194697|NCT04594213|567455701|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
157194698|NCT04594213|567455696|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
157194699|NCT04594213|567455697|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
157194700|NCT04594213|567455698|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
157194701|NCT04594213|567455699|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
157194702|NCT04594213|567455700|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
157194703|NCT04594213|567455701|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
157194704|NCT04594213|567455696|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
157194705|NCT04594213|567455697|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
157194706|NCT04594213|567455698|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
157194707|NCT04594213|567455699|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
157194708|NCT04594213|567455700|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
157194709|NCT04594213|567455701|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
157194710|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
157194711|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
157194712|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
157194713|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
157194714|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
157194715|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
157194716|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
157194717|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
157194718|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
157194719|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
157194720|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
157194721|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
157194722|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
157194723|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
157194724|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
157194725|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
157194726|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
157194727|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
157194728|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
157194729|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
157194730|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
157194731|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
157194732|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
157194733|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
157194734|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
157194735|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
157194736|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
157194737|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
157194738|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
157194739|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
157194740|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
157194741|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
157194742|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
157194743|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
157194744|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
157194745|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
157194746|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
157194747|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
157194748|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
157194749|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
157194750|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
157194751|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
157194752|NCT04594213|567455696|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
157194753|NCT04594213|567455697|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
157194754|NCT04594213|567455698|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
157194755|NCT04594213|567455699|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
157194756|NCT04594213|567455700|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
157194757|NCT04594213|567455701|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
157194758|NCT01980056|567455702|FG000|Overall Study|Death|1|||
157234889|NCT03965091|567608237|FG001|Overall Study|Withdrawal by Subject|3|||
157234890|NCT03965091|567608238|FG002|Overall Study|Withdrawal by Subject|5|||
157234891|NCT03965091|567608236|FG000|Overall Study|Non-compliance with study drug|0|||
157234892|NCT03965091|567608237|FG001|Overall Study|Non-compliance with study drug|0|||
157234893|NCT03965091|567608238|FG002|Overall Study|Non-compliance with study drug|1|||
157234894|NCT03965091|567608236|FG000|Overall Study|Lost to Follow-up|1|||
157234895|NCT03965091|567608237|FG001|Overall Study|Lost to Follow-up|1|||
157234896|NCT03965091|567608238|FG002|Overall Study|Lost to Follow-up|1|||
157234897|NCT03965091|567608236|FG000|Overall Study|Lack of Efficacy|2|||
157234898|NCT03965091|567608237|FG001|Overall Study|Lack of Efficacy|0|||
157234899|NCT03965091|567608238|FG002|Overall Study|Lack of Efficacy|0|||
157234900|NCT03965091|567608236|FG000|Overall Study|Other than specified|9|||
157234901|NCT03965091|567608237|FG001|Overall Study|Other than specified|11|||
157234902|NCT03965091|567608238|FG002|Overall Study|Other than specified|8|||
157234903|NCT01185821|567608241|FG000|Overall Study|Abnormal laboratory value(s)|1|||
157234904|NCT01185821|567608242|FG001|Overall Study|Abnormal laboratory value(s)|2|||
157234905|NCT01185821|567608243|FG002|Overall Study|Abnormal laboratory value(s)|1|||
157234906|NCT01185821|567608244|FG003|Overall Study|Abnormal laboratory value(s)|0|||
157234907|NCT01185821|567608245|FG004|Overall Study|Abnormal laboratory value(s)|0|||
157234908|NCT01185821|567608241|FG000|Overall Study|Protocol Violation|0|||
157234909|NCT01185821|567608242|FG001|Overall Study|Protocol Violation|0|||
157234910|NCT01185821|567608243|FG002|Overall Study|Protocol Violation|0|||
157234911|NCT01185821|567608244|FG003|Overall Study|Protocol Violation|1|||
157234912|NCT01185821|567608245|FG004|Overall Study|Protocol Violation|1|||
157234913|NCT01185821|567608241|FG000|Overall Study|Abnormal test procedure result|0|||
157234914|NCT01185821|567608242|FG001|Overall Study|Abnormal test procedure result|0|||
157234915|NCT01185821|567608243|FG002|Overall Study|Abnormal test procedure result|0|||
157234916|NCT01185821|567608244|FG003|Overall Study|Abnormal test procedure result|0|||
157234917|NCT01185821|567608245|FG004|Overall Study|Abnormal test procedure result|1|||
157234918|NCT01185821|567608241|FG000|Overall Study|Death|0|||
157234919|NCT01185821|567608242|FG001|Overall Study|Death|1|||
157234920|NCT01185821|567608243|FG002|Overall Study|Death|0|||
157234921|NCT01185821|567608244|FG003|Overall Study|Death|0|||
157234922|NCT01185821|567608245|FG004|Overall Study|Death|0|||
157234923|NCT01185821|567608241|FG000|Overall Study|Condition no longer required study drug|0|||
157234924|NCT01185821|567608242|FG001|Overall Study|Condition no longer required study drug|0|||
157234925|NCT01185821|567608243|FG002|Overall Study|Condition no longer required study drug|0|||
157234926|NCT01185821|567608244|FG003|Overall Study|Condition no longer required study drug|0|||
157234927|NCT01185821|567608245|FG004|Overall Study|Condition no longer required study drug|1|||
157234928|NCT01185821|567608241|FG000|Overall Study|Adverse Event|2|||
157234929|NCT01185821|567608242|FG001|Overall Study|Adverse Event|3|||
157234930|NCT01185821|567608243|FG002|Overall Study|Adverse Event|1|||
157234931|NCT01185821|567608244|FG003|Overall Study|Adverse Event|2|||
157234932|NCT01185821|567608245|FG004|Overall Study|Adverse Event|5|||
157234933|NCT01185821|567608241|FG000|Overall Study|Lack of Efficacy|0|||
157234934|NCT01185821|567608242|FG001|Overall Study|Lack of Efficacy|0|||
157234935|NCT01185821|567608243|FG002|Overall Study|Lack of Efficacy|3|||
157234936|NCT01185821|567608244|FG003|Overall Study|Lack of Efficacy|0|||
157234937|NCT01185821|567608245|FG004|Overall Study|Lack of Efficacy|9|||
157234938|NCT01185821|567608241|FG000|Overall Study|Withdrawal by Subject|3|||
157234939|NCT01185821|567608242|FG001|Overall Study|Withdrawal by Subject|2|||
157234940|NCT01185821|567608243|FG002|Overall Study|Withdrawal by Subject|2|||
157234941|NCT01185821|567608244|FG003|Overall Study|Withdrawal by Subject|1|||
157234942|NCT01185821|567608245|FG004|Overall Study|Withdrawal by Subject|3|||
157234943|NCT01185821|567608241|FG000|Overall Study|Lost to Follow-up|1|||
157234944|NCT01185821|567608242|FG001|Overall Study|Lost to Follow-up|1|||
157234945|NCT01185821|567608243|FG002|Overall Study|Lost to Follow-up|2|||
157234946|NCT01185821|567608244|FG003|Overall Study|Lost to Follow-up|1|||
157234947|NCT01185821|567608245|FG004|Overall Study|Lost to Follow-up|2|||
157234948|NCT01185821|567608241|FG000|Overall Study|Administrative problems|0|||
157234949|NCT01185821|567608242|FG001|Overall Study|Administrative problems|0|||
157234950|NCT01185821|567608243|FG002|Overall Study|Administrative problems|1|||
157234951|NCT01185821|567608244|FG003|Overall Study|Administrative problems|1|||
157234952|NCT01185821|567608245|FG004|Overall Study|Administrative problems|2|||
157234953|NCT01534520|567608247|FG000|Overall Study|Adverse Event|0|||
157234954|NCT01534520|567608248|FG001|Overall Study|Adverse Event|1|||
157234955|NCT00537979|567608252|FG000|Overall Study|Adverse Event|2|||
157234956|NCT00537979|567608253|FG001|Overall Study|Adverse Event|2|||
157234957|NCT00537979|567608252|FG000|Overall Study|Withdrawal by Subject|1|||
157234958|NCT00537979|567608253|FG001|Overall Study|Withdrawal by Subject|4|||
157234959|NCT00537979|567608252|FG000|Overall Study|Lost to Follow-up|1|||
157234960|NCT00537979|567608253|FG001|Overall Study|Lost to Follow-up|4|||
157234961|NCT00537979|567608252|FG000|Overall Study|Lack of Efficacy|0|||
157234962|NCT00537979|567608253|FG001|Overall Study|Lack of Efficacy|1|||
157234963|NCT00537979|567608252|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
157234964|NCT00537979|567608253|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
157234965|NCT00537979|567608252|FG000|Overall Study|Death|0|||
157234966|NCT00537979|567608253|FG001|Overall Study|Death|3|||
157194759|NCT01980056|567455703|FG001|Overall Study|Death|1|||
157194760|NCT01980056|567455704|FG002|Overall Study|Death|0|||
157194761|NCT01707667|567455707|FG000|Period 1|expulsion of colonic sensor catheter|1|||
157194762|NCT01707667|567455708|FG001|Period 1|expulsion of colonic sensor catheter|0|||
157194763|NCT01616173|567455710|FG000|Overall Study|Lost to Follow-up|0|||
157194764|NCT01616173|567455711|FG001|Overall Study|Lost to Follow-up|2|||
157194765|NCT01616173|567455712|FG002|Overall Study|Lost to Follow-up|0|||
157194766|NCT04382066|567455715|FG000|Overall Study|Adverse Event|1|||
157194767|NCT04382066|567455716|FG001|Overall Study|Adverse Event|0|||
157194768|NCT04382066|567455717|FG002|Overall Study|Adverse Event|0|||
157194769|NCT04382066|567455715|FG000|Overall Study|Death|1|||
157194770|NCT04382066|567455716|FG001|Overall Study|Death|0|||
157194771|NCT04382066|567455717|FG002|Overall Study|Death|1|||
157194772|NCT01430559|567455718|FG000|Overall Study|Adverse Event|7|||
157194773|NCT01430559|567455719|FG001|Overall Study|Adverse Event|3|||
157194774|NCT01430559|567455718|FG000|Overall Study|Entry criteria not met|1|||
157194775|NCT01430559|567455719|FG001|Overall Study|Entry criteria not met|1|||
157194776|NCT01430559|567455718|FG000|Overall Study|Lost to Follow-up|1|||
157194777|NCT01430559|567455719|FG001|Overall Study|Lost to Follow-up|0|||
157194778|NCT01430559|567455718|FG000|Overall Study|Medication error|1|||
157194779|NCT01430559|567455719|FG001|Overall Study|Medication error|0|||
157194780|NCT01430559|567455718|FG000|Overall Study|Withdrawal by Subject|3|||
157194781|NCT01430559|567455719|FG001|Overall Study|Withdrawal by Subject|2|||
157194782|NCT01430559|567455718|FG000|Overall Study|Protocol Violation|1|||
157194783|NCT01430559|567455719|FG001|Overall Study|Protocol Violation|0|||
157194784|NCT01430559|567455718|FG000|Overall Study|Other|3|||
157194785|NCT01430559|567455719|FG001|Overall Study|Other|3|||
157194786|NCT01430559|567455718|FG000|Overall Study|Randomized, Not Treated|3|||
157194787|NCT01430559|567455719|FG001|Overall Study|Randomized, Not Treated|3|||
157194788|NCT00504595|567455721|FG000|Overall Study|Lack of Efficacy|1|||
157194789|NCT00504595|567455722|FG001|Overall Study|Lack of Efficacy|0|||
157194790|NCT00504595|567455723|FG002|Overall Study|Lack of Efficacy|0|||
157194791|NCT00504595|567455724|FG003|Overall Study|Lack of Efficacy|0|||
157194792|NCT00504595|567455721|FG000|Overall Study|Other|0|||
157194793|NCT00504595|567455722|FG001|Overall Study|Other|0|||
157194794|NCT00504595|567455723|FG002|Overall Study|Other|2|||
157194795|NCT00504595|567455724|FG003|Overall Study|Other|0|||
157194796|NCT03742271|567455735|FG000|Overall Study|Unsatisfactory Visual Response|1|||
157194797|NCT03742271|567455735|FG000|Overall Study|Withdrawal by Subject|3|||
157194798|NCT03742271|567455735|FG000|Overall Study|Lost to Follow-up|4|||
157194799|NCT03742271|567455735|FG000|Overall Study|Failed Insertion & removal|3|||
157194800|NCT03742271|567455735|FG000|Overall Study|Protocol Violation|1|||
157194801|NCT01468844|567455736|FG000|Overall Study|Adverse Event|1|||
157194802|NCT01468844|567455737|FG001|Overall Study|Adverse Event|0|||
157194803|NCT01468844|567455736|FG000|Overall Study|Withdrawal by Subject|1|||
157194804|NCT01468844|567455737|FG001|Overall Study|Withdrawal by Subject|0|||
157194805|NCT02853318|567455740|FG000|Overall Study|Withdrawal by Subject|1|||
157194806|NCT01843933|567455741|FG000|Overall Study|Data lost|6|||
157194807|NCT01843933|567455742|FG001|Overall Study|Data lost|4|||
157194808|NCT05060003|567455745|FG000|Overall Study|ctDNA negative|7|||
157194809|NCT00440232|567455746|FG000|Overall Study|Lost to Follow-up|1|||
157194810|NCT00440232|567455747|FG001|Overall Study|Lost to Follow-up|1|||
157194811|NCT00440232|567455746|FG000|Overall Study|Unable to treat within allowed time|0|||
157194812|NCT00440232|567455747|FG001|Overall Study|Unable to treat within allowed time|1|||
157194813|NCT00440232|567455746|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
157194814|NCT00440232|567455747|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
157194815|NCT01747655|567455748|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
157194816|NCT01747655|567455749|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
157194817|NCT01747655|567455748|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
157194818|NCT01747655|567455749|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
157194819|NCT01747655|567455748|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
157194820|NCT01747655|567455749|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
157194821|NCT02728804|567455756|FG000|Overall Study|Ineligible|3|||
157194822|NCT02728804|567455756|FG000|Overall Study|Did not complete baseline questionnaire|9|||
157194823|NCT02728804|567455756|FG000|Overall Study|Death|99|||
157194824|NCT00554229|567455757|FG000|Overall Study|Lost to Follow-up|3|||
157194825|NCT00554229|567455758|FG001|Overall Study|Lost to Follow-up|6|||
157194826|NCT00554229|567455757|FG000|Overall Study|Withdrawal by Subject|29|||
157194827|NCT00554229|567455758|FG001|Overall Study|Withdrawal by Subject|37|||
157194828|NCT00554229|567455757|FG000|Overall Study|Adverse Event|71|||
157194829|NCT00554229|567455758|FG001|Overall Study|Adverse Event|39|||
157194830|NCT00554229|567455757|FG000|Overall Study|Protocol Violation|3|||
157194831|NCT00554229|567455758|FG001|Overall Study|Protocol Violation|3|||
157194832|NCT00554229|567455757|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
157194833|NCT00554229|567455758|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
157194834|NCT00554229|567455757|FG000|Overall Study|Randomised but no treatment received|1|||
157194835|NCT00554229|567455758|FG001|Overall Study|Randomised but no treatment received|0|||
157084780|NCT01259089|567063618|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
157084781|NCT01259089|567063619|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
157084782|NCT01259089|567063614|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
157084783|NCT01259089|567063615|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
157084784|NCT01259089|567063616|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
157084785|NCT01259089|567063617|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
157084786|NCT01259089|567063618|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
157194836|NCT03969589|567455759|FG000|Overall Study|Lost to Follow-up|3|||
157194837|NCT03969589|567455760|FG001|Overall Study|Lost to Follow-up|2|||
157194838|NCT03969589|567455759|FG000|Overall Study|Declined Follow-Up|0|||
157194839|NCT03969589|567455760|FG001|Overall Study|Declined Follow-Up|1|||
157194840|NCT01078389|567457354|FG000|Overall Study|Adverse Event|10|||
157194841|NCT01078389|567457355|FG001|Overall Study|Adverse Event|6|||
157194842|NCT01078389|567457354|FG000|Overall Study|Major Protocol Deviation|2|||
157194843|NCT01078389|567457355|FG001|Overall Study|Major Protocol Deviation|0|||
157194844|NCT01078389|567457354|FG000|Overall Study|Lost to Follow-up|23|||
157194845|NCT01078389|567457355|FG001|Overall Study|Lost to Follow-up|23|||
157194846|NCT01078389|567457354|FG000|Overall Study|Voluntary Withdrawal|20|||
157194847|NCT01078389|567457355|FG001|Overall Study|Voluntary Withdrawal|36|||
157194848|NCT01078389|567457354|FG000|Overall Study|Other|9|||
157194849|NCT01078389|567457355|FG001|Overall Study|Other|2|||
157194850|NCT02361307|567457356|FG000|Overall Study|Unstable medical condition.|0|||
157194851|NCT02361307|567457357|FG001|Overall Study|Unstable medical condition.|1|||
157194852|NCT01858701|567457358|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
157194853|NCT01858701|567457359|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
157194854|NCT01858701|567457358|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
157194855|NCT01858701|567457359|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
157194856|NCT01858701|567457358|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
157194857|NCT01858701|567457359|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
157194858|NCT01858701|567457358|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
157194859|NCT01858701|567457359|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
157194860|NCT01674010|567457360|FG000|Open Treatment Phase 1|Adverse Event|10|||
157194861|NCT01674010|567457361|FG001|Open Treatment Phase 1|Adverse Event|0|||
157194862|NCT01674010|567457362|FG002|Open Treatment Phase 1|Adverse Event|0|||
157194863|NCT01674010|567457360|FG000|Open Treatment Phase 1|Death|1|||
157194864|NCT01674010|567457361|FG001|Open Treatment Phase 1|Death|0|||
157194865|NCT01674010|567457362|FG002|Open Treatment Phase 1|Death|0|||
157194866|NCT01674010|567457360|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
157194867|NCT01674010|567457361|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
157194868|NCT01674010|567457362|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
157194869|NCT01674010|567457360|FG000|Open Treatment Phase 1|Physician Decision|9|||
157194870|NCT01674010|567457361|FG001|Open Treatment Phase 1|Physician Decision|0|||
157194871|NCT01674010|567457362|FG002|Open Treatment Phase 1|Physician Decision|0|||
157194872|NCT01674010|567457360|FG000|Open Treatment Phase 1|Protocol Violation|7|||
157194873|NCT01674010|567457361|FG001|Open Treatment Phase 1|Protocol Violation|0|||
157194874|NCT01674010|567457362|FG002|Open Treatment Phase 1|Protocol Violation|0|||
157194875|NCT01674010|567457360|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
157194876|NCT01674010|567457361|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
157194877|NCT01674010|567457362|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
157194878|NCT01674010|567457360|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
157194879|NCT01674010|567457361|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
157194880|NCT01674010|567457362|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
157194881|NCT01674010|567457360|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
157194882|NCT01674010|567457361|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
157194883|NCT01674010|567457362|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
157194884|NCT01674010|567457360|FG000|Randomization Phase 2|Adverse Event|0|||
157194885|NCT01674010|567457361|FG001|Randomization Phase 2|Adverse Event|1|||
157194886|NCT01674010|567457362|FG002|Randomization Phase 2|Adverse Event|1|||
157194887|NCT01674010|567457360|FG000|Randomization Phase 2|Lost to Follow-up|0|||
157194888|NCT01674010|567457361|FG001|Randomization Phase 2|Lost to Follow-up|1|||
157194889|NCT01674010|567457362|FG002|Randomization Phase 2|Lost to Follow-up|2|||
157194890|NCT01674010|567457360|FG000|Randomization Phase 2|Mood episode recurrence|0|||
157194891|NCT01674010|567457361|FG001|Randomization Phase 2|Mood episode recurrence|8|||
157194892|NCT01674010|567457362|FG002|Randomization Phase 2|Mood episode recurrence|2|||
157194893|NCT01674010|567457360|FG000|Randomization Phase 2|Physician Decision|0|||
157194894|NCT01674010|567457361|FG001|Randomization Phase 2|Physician Decision|0|||
157194895|NCT01674010|567457362|FG002|Randomization Phase 2|Physician Decision|2|||
157194896|NCT01674010|567457360|FG000|Randomization Phase 2|Pregnancy|0|||
157194897|NCT01674010|567457361|FG001|Randomization Phase 2|Pregnancy|1|||
157194898|NCT01674010|567457362|FG002|Randomization Phase 2|Pregnancy|1|||
157194899|NCT01674010|567457360|FG000|Randomization Phase 2|Protocol Violation|0|||
157194900|NCT01674010|567457361|FG001|Randomization Phase 2|Protocol Violation|1|||
157194901|NCT01674010|567457362|FG002|Randomization Phase 2|Protocol Violation|1|||
157194902|NCT01674010|567457360|FG000|Randomization Phase 2|Sponsor Decision|0|||
157084787|NCT01259089|567063619|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
157084788|NCT01259089|567063614|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
157084789|NCT01259089|567063615|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
157084790|NCT01259089|567063616|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
157084791|NCT01259089|567063617|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
157084792|NCT01259089|567063618|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
157084793|NCT01259089|567063619|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
157084794|NCT01259089|567063614|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
157084795|NCT01259089|567063615|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
157084796|NCT01259089|567063616|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
157084797|NCT01259089|567063617|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
157084798|NCT01259089|567063618|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
157084799|NCT01259089|567063619|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
157084800|NCT01259089|567063614|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
157084801|NCT01259089|567063615|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
157084802|NCT01259089|567063616|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
157084803|NCT01259089|567063617|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
157084804|NCT01259089|567063618|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
157084805|NCT01259089|567063619|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
157084806|NCT01259089|567063614|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
157084807|NCT01259089|567063615|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
157084808|NCT01259089|567063616|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
157084809|NCT01259089|567063617|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
157084810|NCT01259089|567063618|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
157084811|NCT01259089|567063619|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
157084812|NCT01259089|567063614|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
157084813|NCT01259089|567063615|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
157084814|NCT01259089|567063616|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
157084815|NCT01259089|567063617|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
157084816|NCT01259089|567063618|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
157084817|NCT01259089|567063619|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
157084818|NCT01259089|567063614|FG000|Survival Follow up for Two Years|Death|3|||
157084819|NCT01259089|567063615|FG001|Survival Follow up for Two Years|Death|2|||
157084820|NCT01259089|567063616|FG002|Survival Follow up for Two Years|Death|2|||
157084821|NCT01259089|567063617|FG003|Survival Follow up for Two Years|Death|3|||
157084822|NCT01259089|567063618|FG004|Survival Follow up for Two Years|Death|6|||
157084823|NCT01259089|567063619|FG005|Survival Follow up for Two Years|Death|13|||
157084824|NCT01259089|567063614|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
157084825|NCT01259089|567063615|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
157084826|NCT01259089|567063616|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
157084827|NCT01259089|567063617|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
157084828|NCT01259089|567063618|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
157084829|NCT01259089|567063619|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
157084830|NCT01259089|567063614|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
157084831|NCT01259089|567063615|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
157084832|NCT01259089|567063616|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
157084833|NCT01259089|567063617|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
157084834|NCT01259089|567063618|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
157084835|NCT01259089|567063619|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
157084836|NCT00688870|567063620|FG000|Infant Series|Parent or legal guardian request|4|||
157084837|NCT00688870|567063621|FG001|Infant Series|Parent or legal guardian request|0|||
157084838|NCT00528931|567063622|FG000|Overall Study|Lost to Follow-up|1|||
157084839|NCT01151410|567063623|FG000|Overall Study|Withdrawal by Subject|3|||
157084840|NCT01151410|567063624|FG001|Overall Study|Withdrawal by Subject|5|||
157084841|NCT01151410|567063623|FG000|Overall Study|Lost to Follow-up|3|||
157084842|NCT01151410|567063624|FG001|Overall Study|Lost to Follow-up|4|||
157084843|NCT01151410|567063623|FG000|Overall Study|Adverse Event|1|||
157084844|NCT01151410|567063624|FG001|Overall Study|Adverse Event|2|||
157084845|NCT01151410|567063623|FG000|Overall Study|Protocol deviation|2|||
157194903|NCT01674010|567457361|FG001|Randomization Phase 2|Sponsor Decision|42|||
157194904|NCT01674010|567457362|FG002|Randomization Phase 2|Sponsor Decision|45|||
157194905|NCT01674010|567457360|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
157194906|NCT01674010|567457361|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
157194907|NCT01674010|567457362|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
157194908|NCT01801475|567457369|FG000|Overall Study|Withdrawal by Subject|0|||
157194909|NCT01801475|567457370|FG001|Overall Study|Withdrawal by Subject|0|||
157194910|NCT01801475|567457371|FG002|Overall Study|Withdrawal by Subject|0|||
157194911|NCT01801475|567457372|FG003|Overall Study|Withdrawal by Subject|0|||
157194912|NCT01801475|567457373|FG004|Overall Study|Withdrawal by Subject|1|||
157234967|NCT00537979|567608252|FG000|Overall Study|Kidney transplant|0|||
157234968|NCT00537979|567608253|FG001|Overall Study|Kidney transplant|3|||
157234969|NCT00537979|567608252|FG000|Overall Study|Heart failure|0|||
157234970|NCT00537979|567608253|FG001|Overall Study|Heart failure|1|||
157234971|NCT00626548|567608256|FG000|Overall Study|Adverse Event|164|||
157234972|NCT00626548|567608257|FG001|Overall Study|Adverse Event|44|||
157234973|NCT00626548|567608256|FG000|Overall Study|Withdrawal by Subject|42|||
157234974|NCT00626548|567608257|FG001|Overall Study|Withdrawal by Subject|46|||
157234975|NCT00626548|567608256|FG000|Overall Study|Protocol Violation|4|||
157234976|NCT00626548|567608257|FG001|Overall Study|Protocol Violation|11|||
157234977|NCT00626548|567608256|FG000|Overall Study|Lost to Follow-up|2|||
157234978|NCT00626548|567608257|FG001|Overall Study|Lost to Follow-up|2|||
157234979|NCT00626548|567608256|FG000|Overall Study|Other termination reason|493|||
157234980|NCT00626548|567608257|FG001|Overall Study|Other termination reason|613|||
157234981|NCT01059903|567608259|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
157234982|NCT01059903|567608260|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
157234983|NCT04384978|567608263|FG000|Overall Study|Withdrawal by Subject|4|||
157234984|NCT04384978|567608264|FG001|Overall Study|Withdrawal by Subject|0|||
157234985|NCT00385593|567608265|FG000|Overall Study|Adverse Event|3|||
157234986|NCT00385593|567608266|FG001|Overall Study|Adverse Event|2|||
157234987|NCT00385593|567608265|FG000|Overall Study|Withdrawal by Subject|17|||
157234988|NCT00385593|567608266|FG001|Overall Study|Withdrawal by Subject|7|||
157234989|NCT00385593|567608265|FG000|Overall Study|Lost to Follow-up|12|||
157234990|NCT00385593|567608266|FG001|Overall Study|Lost to Follow-up|8|||
157234991|NCT00385593|567608265|FG000|Overall Study|Protocol Violation|7|||
157234992|NCT00385593|567608266|FG001|Overall Study|Protocol Violation|4|||
157234993|NCT00385593|567608265|FG000|Overall Study|Several reasons|17|||
157234994|NCT00385593|567608266|FG001|Overall Study|Several reasons|15|||
157234995|NCT00385593|567608265|FG000|Overall Study|Incorrect inclusion|2|||
157234996|NCT00385593|567608266|FG001|Overall Study|Incorrect inclusion|0|||
157234997|NCT00385593|567608265|FG000|Overall Study|Incorrect randomization|0|||
157234998|NCT00385593|567608266|FG001|Overall Study|Incorrect randomization|1|||
157234999|NCT00854100|567608288|FG000|Overall Study|Inability to complete the study visits|0|||
157235000|NCT00854100|567608289|FG001|Overall Study|Inability to complete the study visits|0|||
157235001|NCT00854100|567608290|FG002|Overall Study|Inability to complete the study visits|1|||
157235002|NCT00854100|567608288|FG000|Overall Study|Lost to Follow-up|2|||
157235003|NCT00854100|567608289|FG001|Overall Study|Lost to Follow-up|0|||
157235004|NCT00854100|567608290|FG002|Overall Study|Lost to Follow-up|3|||
157235005|NCT00854100|567608288|FG000|Overall Study|Withdrawal by Subject|3|||
157235006|NCT00854100|567608289|FG001|Overall Study|Withdrawal by Subject|1|||
157235007|NCT00854100|567608290|FG002|Overall Study|Withdrawal by Subject|2|||
157235008|NCT00854100|567608288|FG000|Overall Study|Protocol Violation|2|||
157235009|NCT00854100|567608289|FG001|Overall Study|Protocol Violation|4|||
157235010|NCT00854100|567608290|FG002|Overall Study|Protocol Violation|3|||
157235011|NCT00854100|567608288|FG000|Overall Study|Adverse Event|2|||
157235012|NCT00854100|567608289|FG001|Overall Study|Adverse Event|1|||
157235013|NCT00854100|567608290|FG002|Overall Study|Adverse Event|2|||
157235014|NCT03616106|567608292|FG000|Overall Study|Removed by PI|6|||
157235015|NCT03616106|567608293|FG001|Overall Study|Removed by PI|0|||
157235016|NCT03616106|567608292|FG000|Overall Study|Withdrawal by Subject|1|||
157235017|NCT03616106|567608293|FG001|Overall Study|Withdrawal by Subject|1|||
157235018|NCT03616106|567608292|FG000|Overall Study|Lost to Follow-up|7|||
157235019|NCT03616106|567608293|FG001|Overall Study|Lost to Follow-up|0|||
157235020|NCT01880593|567608296|FG000|Overall Study|Adverse Event|1|||
157235021|NCT01880593|567608297|FG001|Overall Study|Adverse Event|0|||
157235022|NCT01880593|567608296|FG000|Overall Study|Lack of Efficacy|1|||
157235023|NCT01880593|567608297|FG001|Overall Study|Lack of Efficacy|5|||
157235024|NCT01880593|567608296|FG000|Overall Study|Withdrawal by Subject|6|||
157235025|NCT01880593|567608297|FG001|Overall Study|Withdrawal by Subject|1|||
157235026|NCT05275205|567608298|FG000|Overall Study|Adverse Event|1|||
157235027|NCT05275205|567608299|FG001|Overall Study|Adverse Event|2|||
157235028|NCT05275205|567608298|FG000|Overall Study|Physician Decision|1|||
157235029|NCT05275205|567608299|FG001|Overall Study|Physician Decision|1|||
157235030|NCT05275205|567608298|FG000|Overall Study|Withdrawal by Subject|2|||
157235031|NCT05275205|567608299|FG001|Overall Study|Withdrawal by Subject|3|||
157235032|NCT05275205|567608298|FG000|Overall Study|Death|1|||
157235033|NCT05275205|567608299|FG001|Overall Study|Death|0|||
157235034|NCT05275205|567608298|FG000|Overall Study|Patient unable to attend visits|1|||
157235035|NCT05275205|567608299|FG001|Overall Study|Patient unable to attend visits|0|||
157235036|NCT01223365|567608301|FG000|Open-label Titration Period|Enrolled but not treated|1|||
157235037|NCT01223365|567608301|FG000|Open-label Titration Period|Adverse Event|23|||
157235038|NCT01223365|567608301|FG000|Open-label Titration Period|Lack of Efficacy|3|||
157235039|NCT01223365|567608301|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
157235040|NCT01223365|567608301|FG000|Open-label Titration Period|Protocol Violation|1|||
157235041|NCT01223365|567608301|FG000|Open-label Titration Period|Lost to Follow-up|2|||
157235042|NCT01223365|567608301|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
157235043|NCT01223365|567608301|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
157235044|NCT01223365|567608301|FG000|Open-label Titration Period|Starting physical therapy|1|||
157235045|NCT01223365|567608301|FG000|Open-label Treatment Period|Adverse Event|39|||
157235046|NCT01223365|567608301|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
157235047|NCT01223365|567608301|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
157235048|NCT01223365|567608301|FG000|Open-label Treatment Period|Protocol Violation|15|||
157235049|NCT01223365|567608301|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
157235050|NCT01223365|567608301|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
157235051|NCT01223365|567608301|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
157235052|NCT01223365|567608301|FG000|Open-label Treatment Period|Moved out of area|2|||
157235053|NCT01223365|567608301|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
157235054|NCT01223365|567608301|FG000|Open-label Treatment Period|"Out of window"|1|||
157235055|NCT01223365|567608301|FG000|Open-label Treatment Period|Starting physical therapy|1|||
157235056|NCT01223365|567608301|FG000|Open-label Treatment Period|Physician Decision|2|||
157235057|NCT03041025|567608303|FG000|Overall Study|Adverse Event|0|||
157235058|NCT03041025|567608304|FG001|Overall Study|Adverse Event|0|||
157235059|NCT03041025|567608305|FG002|Overall Study|Adverse Event|1|||
157235060|NCT03041025|567608303|FG000|Overall Study|Lost to Follow-up|1|||
157235061|NCT03041025|567608304|FG001|Overall Study|Lost to Follow-up|0|||
157235062|NCT03041025|567608305|FG002|Overall Study|Lost to Follow-up|0|||
157084846|NCT01151410|567063624|FG001|Overall Study|Protocol deviation|1|||
157084847|NCT01151410|567063623|FG000|Overall Study|Administrative problems|1|||
157084848|NCT01151410|567063624|FG001|Overall Study|Administrative problems|1|||
157084849|NCT01151410|567063623|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157084850|NCT01151410|567063624|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
157084851|NCT01151410|567063623|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157084852|NCT01151410|567063624|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157084853|NCT01253018|567063625|FG000|Overall Study|Lost to Follow-up|1|||
157084854|NCT01253018|567063626|FG001|Overall Study|Lost to Follow-up|1|||
157084855|NCT01253018|567063625|FG000|Overall Study|Robot Repair Issues|2|||
157084856|NCT01253018|567063626|FG001|Overall Study|Robot Repair Issues|0|||
157084857|NCT01253018|567063625|FG000|Overall Study|Withdrawal by Subject|1|||
157084858|NCT01253018|567063626|FG001|Overall Study|Withdrawal by Subject|1|||
157084859|NCT01820585|567063627|FG000|Overall Study|Adverse Event|9|||
157084860|NCT01820585|567063628|FG001|Overall Study|Adverse Event|13|||
157084861|NCT01820585|567063629|FG002|Overall Study|Adverse Event|23|||
157084862|NCT01820585|567063630|FG003|Overall Study|Adverse Event|34|||
157084863|NCT01820585|567063627|FG000|Overall Study|Lack of Efficacy|9|||
157084864|NCT01820585|567063628|FG001|Overall Study|Lack of Efficacy|7|||
157084865|NCT01820585|567063629|FG002|Overall Study|Lack of Efficacy|5|||
157084866|NCT01820585|567063630|FG003|Overall Study|Lack of Efficacy|1|||
157084867|NCT01820585|567063627|FG000|Overall Study|Withdrawal by Subject|3|||
157084868|NCT01820585|567063628|FG001|Overall Study|Withdrawal by Subject|7|||
157084869|NCT01820585|567063629|FG002|Overall Study|Withdrawal by Subject|3|||
157084870|NCT01820585|567063630|FG003|Overall Study|Withdrawal by Subject|8|||
157084871|NCT01820585|567063627|FG000|Overall Study|Lost to Follow-up|3|||
157084872|NCT01820585|567063628|FG001|Overall Study|Lost to Follow-up|3|||
157084873|NCT01820585|567063629|FG002|Overall Study|Lost to Follow-up|0|||
157084874|NCT01820585|567063630|FG003|Overall Study|Lost to Follow-up|3|||
157084875|NCT01820585|567063627|FG000|Overall Study|Protocol Violation|3|||
157084876|NCT01820585|567063628|FG001|Overall Study|Protocol Violation|1|||
157084877|NCT01820585|567063629|FG002|Overall Study|Protocol Violation|1|||
157084878|NCT01820585|567063630|FG003|Overall Study|Protocol Violation|1|||
157084879|NCT01820585|567063627|FG000|Overall Study|Subject non-compliance|0|||
157084880|NCT01820585|567063628|FG001|Overall Study|Subject non-compliance|0|||
157194913|NCT00421928|567457376|FG000|Overall Study|Adverse Event|61|||
157194914|NCT00421928|567457377|FG001|Overall Study|Adverse Event|140|||
157194915|NCT00421928|567457378|FG002|Overall Study|Adverse Event|22|||
157194916|NCT00421928|567457376|FG000|Overall Study|Lost to Follow-up|5|||
157194917|NCT00421928|567457377|FG001|Overall Study|Lost to Follow-up|0|||
157194918|NCT00421928|567457378|FG002|Overall Study|Lost to Follow-up|3|||
157194919|NCT00421928|567457376|FG000|Overall Study|Withdrawal by Subject|50|||
157194920|NCT00421928|567457377|FG001|Overall Study|Withdrawal by Subject|48|||
157194921|NCT00421928|567457378|FG002|Overall Study|Withdrawal by Subject|43|||
157194922|NCT00421928|567457376|FG000|Overall Study|Lack of Efficacy|15|||
157194923|NCT00421928|567457377|FG001|Overall Study|Lack of Efficacy|7|||
157194924|NCT00421928|567457378|FG002|Overall Study|Lack of Efficacy|35|||
157194925|NCT00421928|567457376|FG000|Overall Study|Study drug non-compliant|6|||
157194926|NCT00421928|567457377|FG001|Overall Study|Study drug non-compliant|7|||
157194927|NCT00421928|567457378|FG002|Overall Study|Study drug non-compliant|4|||
157194928|NCT00421928|567457376|FG000|Overall Study|All other|26|||
157194929|NCT00421928|567457377|FG001|Overall Study|All other|21|||
157194930|NCT00421928|567457378|FG002|Overall Study|All other|27|||
157194931|NCT00421928|567457376|FG000|Overall Study|Death|0|||
157194932|NCT00421928|567457377|FG001|Overall Study|Death|1|||
157194933|NCT00421928|567457378|FG002|Overall Study|Death|0|||
157194934|NCT02946515|567457385|FG000|Overall Study|Lost to Follow-up|2|||
157194935|NCT02946515|567457386|FG001|Overall Study|Lost to Follow-up|1|||
157194936|NCT04177862|567457392|FG000|Overall Study|Protocol Violation|2|||
157194937|NCT04177862|567457393|FG001|Overall Study|Protocol Violation|7|||
157194938|NCT05637515|567457394|FG000|Overall Study|Withdrawal by Subject|17|||
157194939|NCT05637515|567457395|FG001|Overall Study|Withdrawal by Subject|17|||
157194940|NCT02087085|567457397|FG000|Overall Study|Adverse Event|10|||
157194941|NCT02087085|567457398|FG001|Overall Study|Adverse Event|14|||
157194942|NCT02087085|567457397|FG000|Overall Study|Lack of Efficacy|4|||
157194943|NCT02087085|567457398|FG001|Overall Study|Lack of Efficacy|3|||
157194944|NCT02087085|567457397|FG000|Overall Study|Lost to Follow-up|6|||
157194945|NCT02087085|567457398|FG001|Overall Study|Lost to Follow-up|4|||
157194946|NCT02087085|567457397|FG000|Overall Study|Withdrawal by Subject|9|||
157194947|NCT02087085|567457398|FG001|Overall Study|Withdrawal by Subject|11|||
157194948|NCT02087085|567457397|FG000|Overall Study|Protocol Violation|1|||
157194949|NCT02087085|567457398|FG001|Overall Study|Protocol Violation|0|||
157194950|NCT02087085|567457397|FG000|Overall Study|Study Terminated by Sponsor|87|||
157194951|NCT02087085|567457398|FG001|Overall Study|Study Terminated by Sponsor|80|||
157194952|NCT02087085|567457397|FG000|Overall Study|Other Miscellaneous Reasons|3|||
157194953|NCT02087085|567457398|FG001|Overall Study|Other Miscellaneous Reasons|4|||
157194954|NCT00635804|567457399|FG000|Overall Study|Adverse Event|0|||
157194955|NCT00635804|567457400|FG001|Overall Study|Adverse Event|0|||
157194956|NCT00635804|567457401|FG002|Overall Study|Adverse Event|0|||
157194957|NCT00635804|567457402|FG003|Overall Study|Adverse Event|0|||
157194958|NCT00635804|567457403|FG004|Overall Study|Adverse Event|0|||
157194959|NCT00635804|567457404|FG005|Overall Study|Adverse Event|1|||
157194960|NCT00635804|567457405|FG006|Overall Study|Adverse Event|0|||
157194961|NCT00635804|567457406|FG007|Overall Study|Adverse Event|0|||
157194962|NCT00635804|567457399|FG000|Overall Study|Withdrawal by Subject|1|||
157194963|NCT00635804|567457400|FG001|Overall Study|Withdrawal by Subject|0|||
157194964|NCT00635804|567457401|FG002|Overall Study|Withdrawal by Subject|0|||
157194965|NCT00635804|567457402|FG003|Overall Study|Withdrawal by Subject|0|||
157194966|NCT00635804|567457403|FG004|Overall Study|Withdrawal by Subject|0|||
157194967|NCT00635804|567457404|FG005|Overall Study|Withdrawal by Subject|0|||
157194968|NCT00635804|567457405|FG006|Overall Study|Withdrawal by Subject|0|||
157194969|NCT00635804|567457406|FG007|Overall Study|Withdrawal by Subject|0|||
157194970|NCT01425268|567457413|FG000|Overall Study|Withdrawal by Subject|2|||
157194971|NCT01425268|567457414|FG001|Overall Study|Withdrawal by Subject|0|||
157194972|NCT01425268|567457413|FG000|Overall Study|Sponsor Decision|5|||
157194973|NCT01425268|567457414|FG001|Overall Study|Sponsor Decision|0|||
157194974|NCT01425268|567457413|FG000|Overall Study|Physician Decision|1|||
157194975|NCT01425268|567457414|FG001|Overall Study|Physician Decision|0|||
157194976|NCT00719706|567457415|FG000|Overall Study|Adverse Event|5|||
157194977|NCT00719706|567457416|FG001|Overall Study|Adverse Event|4|||
157194978|NCT00719706|567457415|FG000|Overall Study|Withdrawal by Subject|1|||
157194979|NCT00719706|567457416|FG001|Overall Study|Withdrawal by Subject|2|||
157194980|NCT00719706|567457415|FG000|Overall Study|Protocol Violation|3|||
157194981|NCT00719706|567457416|FG001|Overall Study|Protocol Violation|0|||
157194982|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
157194983|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
157194984|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
157194985|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
157194986|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
157194987|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
157194988|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
157194989|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
157194990|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
157194991|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
157194992|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
157194993|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
157194994|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
157194995|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
157194996|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
157194997|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|Other|6|||
157194998|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|Other|6|||
157194999|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|Other|7|||
157195000|NCT02681094|567457417|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
157195001|NCT02681094|567457418|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
157195002|NCT02681094|567457419|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
157195003|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Participant decision|7|||
157195004|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Participant decision|10|||
157195005|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Participant decision|9|||
157195006|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
157235063|NCT03041025|567608303|FG000|Overall Study|Withdrawal by Subject|0|||
157235064|NCT03041025|567608304|FG001|Overall Study|Withdrawal by Subject|0|||
157235065|NCT03041025|567608305|FG002|Overall Study|Withdrawal by Subject|1|||
157235066|NCT02963259|567608307|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
157235067|NCT02963259|567608307|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
157235068|NCT02963259|567608307|FG000|Overall Study|Death|1|||
157235069|NCT02963259|567608307|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
157235070|NCT03243630|567608309|FG000|Overall Study|Protocol Violation|1|||
157235071|NCT03243630|567608309|FG000|Overall Study|Physician Decision|1|||
157235072|NCT00939003|567608311|FG000|Double-blind Treatment Period|Adverse Event|1|||
157235073|NCT00939003|567608312|FG001|Double-blind Treatment Period|Adverse Event|1|||
157235074|NCT00939003|567608311|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
157235075|NCT00939003|567608312|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
157235076|NCT00939003|567608311|FG000|Double-blind Treatment Period|Pregnancy|0|||
157235077|NCT00939003|567608312|FG001|Double-blind Treatment Period|Pregnancy|1|||
157235078|NCT00939003|567608311|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
157235079|NCT00939003|567608312|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
157235080|NCT00939003|567608311|FG000|Open-label Treatment Period|Adverse Event|4|||
157235081|NCT00939003|567608312|FG001|Open-label Treatment Period|Adverse Event|8|||
157235082|NCT00939003|567608311|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
157235083|NCT00939003|567608312|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
157235084|NCT00939003|567608311|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
157235085|NCT00939003|567608312|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
157235086|NCT00939003|567608311|FG000|Open-label Treatment Period|Pregnancy|1|||
157235087|NCT00939003|567608312|FG001|Open-label Treatment Period|Pregnancy|1|||
157235088|NCT00939003|567608311|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
157235089|NCT00939003|567608312|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
157235090|NCT00939003|567608311|FG000|Open-label Treatment Period|Site Closure|3|||
157235091|NCT00939003|567608312|FG001|Open-label Treatment Period|Site Closure|4|||
157235092|NCT03707912|567608313|FG000|Overall Study|Violation of inclusion criteria|1|||
157235093|NCT03707912|567608314|FG001|Overall Study|Violation of inclusion criteria|0|||
157235094|NCT02131129|567608315|FG000|Overall Study|Withdrawal by Subject|1|||
157235095|NCT02131129|567608316|FG001|Overall Study|Withdrawal by Subject|0|||
157235096|NCT02865122|567608317|FG000|Overall Study|Adverse Event|1|||
157235097|NCT02865122|567608318|FG001|Overall Study|Adverse Event|0|||
157235098|NCT02865122|567608319|FG002|Overall Study|Adverse Event|0|||
157235099|NCT03880266|567608320|FG000|Overall Study|Withdrawal by Subject|0|||
157235100|NCT03880266|567608321|FG001|Overall Study|Withdrawal by Subject|1|||
157235101|NCT03880266|567608322|FG002|Overall Study|Withdrawal by Subject|1|||
157235102|NCT03880266|567608323|FG003|Overall Study|Withdrawal by Subject|0|||
157235103|NCT03880266|567608324|FG004|Overall Study|Withdrawal by Subject|0|||
157235104|NCT03880266|567608325|FG005|Overall Study|Withdrawal by Subject|0|||
157235105|NCT03880266|567608326|FG006|Overall Study|Withdrawal by Subject|0|||
157235106|NCT03880266|567608327|FG007|Overall Study|Withdrawal by Subject|0|||
157235107|NCT05369208|567609909|FG000|Core Phase|Prohibited Medication Required|2|||
157235108|NCT05369208|567609909|FG000|Core Phase|Adverse Event|1|||
157235109|NCT05369208|567609909|FG000|Core Phase|Lack of Efficacy|1|||
157235110|NCT03235739|567609912|FG000|Overall Study|Withdrawal by Subject|2|||
157235111|NCT03235739|567609913|FG001|Overall Study|Withdrawal by Subject|2|||
157195007|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
157195008|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
157195009|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
157195010|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
157195011|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
157195012|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
157195013|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
157195014|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
157195015|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
157195016|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
157195017|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
157195018|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|Other|6|||
157195019|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|Other|6|||
157195020|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|Other|7|||
157195021|NCT02681094|567457417|FG000|2 - Enrolled Participants Set|No treatment given|0|||
157195022|NCT02681094|567457418|FG001|2 - Enrolled Participants Set|No treatment given|1|||
157235112|NCT03235739|567609912|FG000|Overall Study|Physician Decision|0|||
157235113|NCT03235739|567609913|FG001|Overall Study|Physician Decision|1|||
157235114|NCT00467896|567609914|FG000|Overall Study|Consent Withdrawal|18|||
157235115|NCT00467896|567609914|FG000|Overall Study|Adverse Event|7|||
157235116|NCT00467896|567609914|FG000|Overall Study|Serious Adverse Event|13|||
157235117|NCT00467896|567609914|FG000|Overall Study|Non-compliance|3|||
157235118|NCT00467896|567609914|FG000|Overall Study|Changed therapy|2|||
157084881|NCT01820585|567063629|FG002|Overall Study|Subject non-compliance|1|||
157084882|NCT01820585|567063630|FG003|Overall Study|Subject non-compliance|2|||
157084883|NCT01820585|567063627|FG000|Overall Study|at sponsor request|0|||
157084884|NCT01820585|567063628|FG001|Overall Study|at sponsor request|0|||
157084885|NCT01820585|567063629|FG002|Overall Study|at sponsor request|1|||
157084886|NCT01820585|567063630|FG003|Overall Study|at sponsor request|0|||
157084887|NCT01820585|567063627|FG000|Overall Study|Pregnancy|0|||
157084888|NCT01820585|567063628|FG001|Overall Study|Pregnancy|1|||
157084889|NCT01820585|567063629|FG002|Overall Study|Pregnancy|0|||
157084890|NCT01820585|567063630|FG003|Overall Study|Pregnancy|0|||
157195023|NCT02681094|567457419|FG002|2 - Enrolled Participants Set|No treatment given|1|||
157195024|NCT02406586|567457420|FG000|Overall Study|Lost to Follow-up|0|||
157195025|NCT02406586|567457421|FG001|Overall Study|Lost to Follow-up|4|||
157195026|NCT02406586|567457422|FG002|Overall Study|Lost to Follow-up|2|||
157195027|NCT02406586|567457420|FG000|Overall Study|Withdrawal by Subject|1|||
157195028|NCT02406586|567457421|FG001|Overall Study|Withdrawal by Subject|0|||
157195029|NCT02406586|567457422|FG002|Overall Study|Withdrawal by Subject|0|||
157195030|NCT01072175|567457423|FG000|Part A (Drug-Drug Interaction)|Death|1|||
157195031|NCT01072175|567457424|FG001|Part A (Drug-Drug Interaction)|Death|0|||
157195032|NCT01072175|567457425|FG002|Part A (Drug-Drug Interaction)|Death|0|||
157195033|NCT01072175|567457426|FG003|Part A (Drug-Drug Interaction)|Death|0|||
157195034|NCT01072175|567457427|FG004|Part A (Drug-Drug Interaction)|Death|0|||
157195035|NCT01072175|567457428|FG005|Part A (Drug-Drug Interaction)|Death|0|||
157195036|NCT01072175|567457429|FG006|Part A (Drug-Drug Interaction)|Death|0|||
157195037|NCT01072175|567457430|FG007|Part A (Drug-Drug Interaction)|Death|0|||
157195038|NCT01072175|567457431|FG008|Part A (Drug-Drug Interaction)|Death|0|||
157195039|NCT01072175|567457432|FG009|Part A (Drug-Drug Interaction)|Death|0|||
157195040|NCT01072175|567457433|FG010|Part A (Drug-Drug Interaction)|Death|0|||
157195041|NCT01072175|567457434|FG011|Part A (Drug-Drug Interaction)|Death|0|||
157195042|NCT01072175|567457435|FG012|Part A (Drug-Drug Interaction)|Death|0|||
157195043|NCT01072175|567457423|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
157195044|NCT01072175|567457424|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195045|NCT01072175|567457425|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195046|NCT01072175|567457426|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195047|NCT01072175|567457427|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195048|NCT01072175|567457428|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195049|NCT01072175|567457429|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195050|NCT01072175|567457430|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195051|NCT01072175|567457431|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195052|NCT01072175|567457432|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195053|NCT01072175|567457433|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195054|NCT01072175|567457434|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195055|NCT01072175|567457435|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
157195056|NCT01072175|567457423|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
157195057|NCT01072175|567457424|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195058|NCT01072175|567457425|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195059|NCT01072175|567457426|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195060|NCT01072175|567457427|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195061|NCT01072175|567457428|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195062|NCT01072175|567457429|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195063|NCT01072175|567457430|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195064|NCT01072175|567457431|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195065|NCT01072175|567457432|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195066|NCT01072175|567457433|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195067|NCT01072175|567457434|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195068|NCT01072175|567457435|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
157195069|NCT01072175|567457423|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
157195070|NCT01072175|567457424|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
157195071|NCT01072175|567457425|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
157195072|NCT01072175|567457426|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
157195073|NCT01072175|567457427|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
157195074|NCT01072175|567457428|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
157195075|NCT01072175|567457429|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
157195076|NCT01072175|567457430|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
157195077|NCT01072175|567457431|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
157195078|NCT01072175|567457432|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
157195079|NCT01072175|567457433|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
157195080|NCT01072175|567457434|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
157195081|NCT01072175|567457435|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
157084891|NCT00548262|567063631|FG000|Overall Study|Death|21|||
157084892|NCT00548262|567063631|FG000|Overall Study|Adverse Event|2|||
157084893|NCT00548262|567063631|FG000|Overall Study|Lack of Efficacy|4|||
157235119|NCT00467896|567609914|FG000|Overall Study|Patient received transplant|2|||
157235120|NCT00467896|567609914|FG000|Overall Study|Patient had atrial septostomy|1|||
157235121|NCT00467896|567609914|FG000|Overall Study|Patient weaned off iloprost|1|||
157235122|NCT00467896|567609914|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
157235123|NCT00467896|567609914|FG000|Overall Study|Started intravenous prostacyclin|1|||
157235124|NCT00467896|567609914|FG000|Overall Study|Started inhaled Remodulin|1|||
157235125|NCT00467896|567609914|FG000|Overall Study|Patient had no improvement|1|||
157235126|NCT03818581|567609919|FG000|Overall Study|Adverse Event|1|||
157235127|NCT03818581|567609920|FG001|Overall Study|Adverse Event|0|||
157235128|NCT03818581|567609921|FG002|Overall Study|Adverse Event|0|||
157084894|NCT00548262|567063631|FG000|Overall Study|Lost to Follow-up|1|||
157084895|NCT00548262|567063631|FG000|Overall Study|Other|3|||
157084896|NCT00548262|567063631|FG000|Overall Study|Withdrawal by Subject|1|||
157084897|NCT01712659|567063632|FG000|Dose Escalation|Physician Decision|0|||
157084898|NCT01712659|567063633|FG001|Dose Escalation|Physician Decision|1|||
157084899|NCT01712659|567063634|FG002|Dose Escalation|Physician Decision|0|||
157084900|NCT01712659|567063635|FG003|Dose Escalation|Physician Decision|0|||
157084901|NCT01712659|567063636|FG004|Dose Escalation|Physician Decision|0|||
157084902|NCT01712659|567063632|FG000|Dose Escalation|Unable to take study drug|0|||
157084903|NCT01712659|567063633|FG001|Dose Escalation|Unable to take study drug|1|||
157084904|NCT01712659|567063634|FG002|Dose Escalation|Unable to take study drug|0|||
157084905|NCT01712659|567063635|FG003|Dose Escalation|Unable to take study drug|0|||
157084906|NCT01712659|567063636|FG004|Dose Escalation|Unable to take study drug|0|||
157084907|NCT01712659|567063632|FG000|Dose Expansion|Early disease progression|1|||
157084908|NCT01712659|567063633|FG001|Dose Expansion|Early disease progression|0|||
157084909|NCT01712659|567063634|FG002|Dose Expansion|Early disease progression|0|||
157084910|NCT01712659|567063635|FG003|Dose Expansion|Early disease progression|0|||
157084911|NCT01712659|567063636|FG004|Dose Expansion|Early disease progression|0|||
157084912|NCT01712659|567063632|FG000|Dose Expansion|Physician Decision|1|||
157084913|NCT01712659|567063633|FG001|Dose Expansion|Physician Decision|0|||
157084914|NCT01712659|567063634|FG002|Dose Expansion|Physician Decision|0|||
157084915|NCT01712659|567063635|FG003|Dose Expansion|Physician Decision|0|||
157084916|NCT01712659|567063636|FG004|Dose Expansion|Physician Decision|0|||
157084917|NCT02091206|567063641|FG000|Treatment Period|Adverse Event|0|||
157084918|NCT02091206|567063642|FG001|Treatment Period|Adverse Event|1|||
157084919|NCT02091206|567063643|FG002|Treatment Period|Adverse Event|0|||
157084920|NCT02091206|567063644|FG003|Treatment Period|Adverse Event|0|||
157084921|NCT02091206|567063641|FG000|Treatment Period|Met withdrawal criteria|0|||
157084922|NCT02091206|567063642|FG001|Treatment Period|Met withdrawal criteria|0|||
157084923|NCT02091206|567063643|FG002|Treatment Period|Met withdrawal criteria|1|||
157084924|NCT02091206|567063644|FG003|Treatment Period|Met withdrawal criteria|0|||
157084925|NCT02091206|567063641|FG000|Taper Period|Participant refused study drug|1|||
157084926|NCT02091206|567063642|FG001|Taper Period|Participant refused study drug|0|||
157084927|NCT02091206|567063643|FG002|Taper Period|Participant refused study drug|0|||
157084928|NCT02091206|567063644|FG003|Taper Period|Participant refused study drug|1|||
157084929|NCT02091206|567063641|FG000|Taper Period|Lost to Follow-up|0|||
157084930|NCT02091206|567063642|FG001|Taper Period|Lost to Follow-up|0|||
157084931|NCT02091206|567063643|FG002|Taper Period|Lost to Follow-up|0|||
157084932|NCT02091206|567063644|FG003|Taper Period|Lost to Follow-up|1|||
157084933|NCT00293059|567063645|FG000|Overall Study|Adverse Event|12|||
157084934|NCT00293059|567063646|FG001|Overall Study|Adverse Event|4|||
157084935|NCT00293059|567063645|FG000|Overall Study|Lack of Efficacy|2|||
157084936|NCT00293059|567063646|FG001|Overall Study|Lack of Efficacy|0|||
157084937|NCT00293059|567063645|FG000|Overall Study|Lost to Follow-up|2|||
157084938|NCT00293059|567063646|FG001|Overall Study|Lost to Follow-up|3|||
157084939|NCT00293059|567063645|FG000|Overall Study|Pregnancy|1|||
157084940|NCT00293059|567063646|FG001|Overall Study|Pregnancy|1|||
157235129|NCT03818581|567609922|FG003|Overall Study|Adverse Event|0|||
157235130|NCT03818581|567609923|FG004|Overall Study|Adverse Event|0|||
157235131|NCT03818581|567609919|FG000|Overall Study|Covid-19|2|||
157235132|NCT03818581|567609920|FG001|Overall Study|Covid-19|0|||
157235133|NCT03818581|567609921|FG002|Overall Study|Covid-19|0|||
157084941|NCT00293059|567063645|FG000|Overall Study|Protocol Violation|2|||
157084942|NCT00293059|567063646|FG001|Overall Study|Protocol Violation|0|||
157084943|NCT00293059|567063645|FG000|Overall Study|Withdrawal by Subject|11|||
157235134|NCT03818581|567609922|FG003|Overall Study|Covid-19|0|||
157084944|NCT00293059|567063646|FG001|Overall Study|Withdrawal by Subject|5|||
157235135|NCT03818581|567609923|FG004|Overall Study|Covid-19|1|||
157235136|NCT03818581|567609919|FG000|Overall Study|Withdrawal by Subject|0|||
157235137|NCT03818581|567609920|FG001|Overall Study|Withdrawal by Subject|0|||
157235138|NCT03818581|567609921|FG002|Overall Study|Withdrawal by Subject|0|||
157235139|NCT03818581|567609922|FG003|Overall Study|Withdrawal by Subject|0|||
157084945|NCT00293059|567063645|FG000|Overall Study|Participant moved out of state|1|||
157084946|NCT00293059|567063646|FG001|Overall Study|Participant moved out of state|0|||
157084947|NCT00293059|567063645|FG000|Overall Study|Participant stopped study drug|1|||
157084948|NCT00293059|567063646|FG001|Overall Study|Participant stopped study drug|0|||
157235140|NCT03818581|567609923|FG004|Overall Study|Withdrawal by Subject|1|||
157235141|NCT03818581|567609919|FG000|Overall Study|No longer met study criteria|0|||
157235142|NCT03818581|567609920|FG001|Overall Study|No longer met study criteria|0|||
157235143|NCT03818581|567609921|FG002|Overall Study|No longer met study criteria|0|||
157235144|NCT03818581|567609922|FG003|Overall Study|No longer met study criteria|0|||
157235145|NCT03818581|567609923|FG004|Overall Study|No longer met study criteria|1|||
157235146|NCT01466166|567609929|FG000|Overall Study|Death|1|||
157235147|NCT01466166|567609929|FG000|Overall Study|Lost to Follow-up|7|||
157235148|NCT01466166|567609929|FG000|Overall Study|Infusion Reaction (IR)|27|||
157235149|NCT01466166|567609929|FG000|Overall Study|Adverse Event (Other than IR)|11|||
157235150|NCT01466166|567609929|FG000|Overall Study|Elevated Serum Uric Acid|78|||
157235151|NCT01466166|567609929|FG000|Overall Study|Withdrawal by Subject|13|||
157235152|NCT01466166|567609929|FG000|Overall Study|Sponsor Decision|4|||
157235153|NCT01466166|567609929|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
157235154|NCT01466166|567609929|FG000|Overall Study|Other|20|||
157235155|NCT02262377|567609930|FG000|Overall Study|Lost to Follow-up|5|||
157235156|NCT02262377|567609931|FG001|Overall Study|Lost to Follow-up|6|||
157235157|NCT02262377|567609930|FG000|Overall Study|Found ineligible after enrollment|3|||
157235158|NCT02262377|567609931|FG001|Overall Study|Found ineligible after enrollment|0|||
157235159|NCT02262377|567609930|FG000|Overall Study|Withdrawal by Subject|4|||
157235160|NCT02262377|567609931|FG001|Overall Study|Withdrawal by Subject|0|||
157235161|NCT00371839|567609932|FG000|Overall Study|Death|4|||
157235162|NCT00371839|567609933|FG001|Overall Study|Death|0|||
157235163|NCT00371839|567609934|FG002|Overall Study|Death|0|||
157235164|NCT00371839|567609932|FG000|Overall Study|Withdrawal by Subject|7|||
157235165|NCT00371839|567609933|FG001|Overall Study|Withdrawal by Subject|4|||
157235166|NCT00371839|567609934|FG002|Overall Study|Withdrawal by Subject|0|||
157235167|NCT00371839|567609932|FG000|Overall Study|Lost to Follow-up|6|||
157235168|NCT00371839|567609933|FG001|Overall Study|Lost to Follow-up|3|||
157235169|NCT00371839|567609934|FG002|Overall Study|Lost to Follow-up|2|||
157235170|NCT02096211|567609936|FG000|Overall Study|Death|2|||
157235171|NCT02096211|567609936|FG000|Overall Study|Withdrawal by Subject|8|||
157235172|NCT02096211|567609936|FG000|Overall Study|Revision of implant|7|||
157235173|NCT02096211|567609936|FG000|Overall Study|Lost to Follow-up|43|||
157235174|NCT01591785|567609937|FG000|Overall Study|worsening condition|1|||
157235175|NCT01591785|567609938|FG001|Overall Study|worsening condition|2|||
157235176|NCT01591785|567609937|FG000|Overall Study|Protocol Violation|2|||
157235177|NCT01591785|567609938|FG001|Overall Study|Protocol Violation|0|||
157235178|NCT01591785|567609937|FG000|Overall Study|Lost to Follow-up|1|||
157235179|NCT01591785|567609938|FG001|Overall Study|Lost to Follow-up|0|||
157235180|NCT01049334|567609939|FG000|Overall Study|Withdrawal by Subject|5|||
157235181|NCT01049334|567609940|FG001|Overall Study|Withdrawal by Subject|3|||
157235182|NCT01049334|567609939|FG000|Overall Study|Adverse Event|2|||
157235183|NCT01049334|567609940|FG001|Overall Study|Adverse Event|3|||
157235184|NCT01049334|567609939|FG000|Overall Study|Physician Decision|2|||
157235185|NCT01049334|567609940|FG001|Overall Study|Physician Decision|0|||
157235186|NCT01049334|567609939|FG000|Overall Study|Protocol Violation|0|||
157235187|NCT01049334|567609940|FG001|Overall Study|Protocol Violation|1|||
157235188|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
157235189|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
157235190|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Death|2|||
157235191|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Death|1|||
157084949|NCT00293059|567063645|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
157084950|NCT00293059|567063646|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
157084951|NCT00293059|567063645|FG000|Overall Study|missing|3|||
157084952|NCT00293059|567063646|FG001|Overall Study|missing|5|||
157084953|NCT02297139|567063649|FG000|Overall Study|Disease progression|0|||
157084954|NCT02297139|567063650|FG001|Overall Study|Disease progression|1|||
157084955|NCT02297139|567063649|FG000|Overall Study|Study drug toxicity|0|||
157084956|NCT02297139|567063650|FG001|Overall Study|Study drug toxicity|4|||
157084957|NCT02297139|567063649|FG000|Overall Study|Participant request to discontinue study treatment|0|||
157084958|NCT02297139|567063650|FG001|Overall Study|Participant request to discontinue study treatment|1|||
157235192|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
157235193|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
157235194|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
157084959|NCT02297139|567063649|FG000|Overall Study|Maximum clinical benefit|1|||
157084960|NCT02297139|567063650|FG001|Overall Study|Maximum clinical benefit|0|||
157235195|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
157235196|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Other|8|||
157235197|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Other|13|||
157235198|NCT01439880|567609949|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
157235199|NCT01439880|567609950|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
157235200|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
157235201|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
157235202|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
157084961|NCT02297139|567063649|FG000|Overall Study|Administrative reason by sponsor|0|||
157235203|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
157084962|NCT02297139|567063650|FG001|Overall Study|Administrative reason by sponsor|2|||
157084963|NCT02297139|567063649|FG000|Overall Study|Other reasons|0|||
157084964|NCT02297139|567063650|FG001|Overall Study|Other reasons|8|||
157235204|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Death|3|||
157235205|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Death|13|||
157235206|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
157084965|NCT05051462|567063656|FG000|Overall Study|Lost to Follow-up|1|||
157084966|NCT05051462|567063657|FG001|Overall Study|Lost to Follow-up|8|||
157084967|NCT05051462|567063656|FG000|Overall Study|Withdrawal by Subject|1|||
157084968|NCT05051462|567063657|FG001|Overall Study|Withdrawal by Subject|0|||
157084969|NCT05051462|567063656|FG000|Overall Study|Protocol Violation|0|||
157084970|NCT05051462|567063657|FG001|Overall Study|Protocol Violation|2|||
157084971|NCT05597787|567063658|FG000|Overall Study|Withdrawal by Subject|0|||
157084972|NCT05597787|567063659|FG001|Overall Study|Withdrawal by Subject|0|||
157084973|NCT05597787|567063660|FG002|Overall Study|Withdrawal by Subject|1|||
157084974|NCT01593787|567063661|FG000|Overall Study|Adverse Event|1|||
157084975|NCT01593787|567063662|FG001|Overall Study|Adverse Event|0|||
157084976|NCT01593787|567063663|FG002|Overall Study|Adverse Event|0|||
157084977|NCT01133418|567063666|FG000|Overall Study|Lost to Follow-up|5|||
157084978|NCT01133418|567063667|FG001|Overall Study|Lost to Follow-up|6|||
157084979|NCT04150068|567063673|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
157084980|NCT04150068|567063674|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
157084981|NCT04150068|567063675|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
157084982|NCT04150068|567063673|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
157084983|NCT04150068|567063674|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
157084984|NCT04150068|567063675|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
157084985|NCT05316701|567063676|FG000|Overall Study|Adverse Event|0|||
157084986|NCT05316701|567063677|FG001|Overall Study|Adverse Event|1|||
157084987|NCT05316701|567063676|FG000|Overall Study|Death|3|||
157084988|NCT05316701|567063677|FG001|Overall Study|Death|9|||
157084989|NCT05316701|567063676|FG000|Overall Study|Lost to Follow-up|1|||
157084990|NCT05316701|567063677|FG001|Overall Study|Lost to Follow-up|0|||
157084991|NCT05316701|567063676|FG000|Overall Study|Physician Decision|1|||
157084992|NCT05316701|567063677|FG001|Overall Study|Physician Decision|4|||
157084993|NCT05316701|567063676|FG000|Overall Study|Withdrawal by Subject|3|||
157084994|NCT05316701|567063677|FG001|Overall Study|Withdrawal by Subject|5|||
157084995|NCT05316701|567063676|FG000|Overall Study|Progression/Relapse|14|||
157084996|NCT05316701|567063677|FG001|Overall Study|Progression/Relapse|9|||
157084997|NCT05316701|567063676|FG000|Overall Study|Received Standard of Care|1|||
157084998|NCT05316701|567063677|FG001|Overall Study|Received Standard of Care|0|||
157084999|NCT05316701|567063676|FG000|Overall Study|Ongoing|70|||
157085000|NCT05316701|567063677|FG001|Overall Study|Ongoing|64|||
157085001|NCT01946529|567063678|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
157085002|NCT01946529|567063679|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
157085003|NCT01946529|567063680|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
157085004|NCT01946529|567063678|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
157085005|NCT01946529|567063679|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
157085006|NCT01946529|567063680|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
157085007|NCT04679935|567063681|FG000|Overall Study|Death|0|||
157085008|NCT04679935|567063682|FG001|Overall Study|Death|1|||
157085009|NCT04362189|567063683|FG000|Overall Study|Lost to Follow-up|0|||
157085010|NCT04362189|567063684|FG001|Overall Study|Lost to Follow-up|1|||
157085011|NCT04362189|567063683|FG000|Overall Study|Withdrawal by Subject|1|||
157085012|NCT04362189|567063684|FG001|Overall Study|Withdrawal by Subject|0|||
157085013|NCT04362189|567063683|FG000|Overall Study|FDA Clinical Hold|7|||
157085014|NCT04362189|567063684|FG001|Overall Study|FDA Clinical Hold|2|||
157085015|NCT04362189|567063683|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
157085016|NCT04362189|567063684|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
157085017|NCT04362189|567063683|FG000|Overall Study|Adverse Event|0|||
157085018|NCT04362189|567063684|FG001|Overall Study|Adverse Event|2|||
157085019|NCT04362189|567063683|FG000|Overall Study|Death|4|||
157085020|NCT04362189|567063684|FG001|Overall Study|Death|1|||
157085021|NCT02111681|567063685|FG000|Overall Study|Death|5|||
157085022|NCT02111681|567063685|FG000|Overall Study|Lack of Efficacy|2|||
157085023|NCT02111681|567063685|FG000|Overall Study|Progression of disease|4|||
157085024|NCT00037830|567065265|FG000|Overall Study|Adverse Event|2|||
157085025|NCT00037830|567065266|FG001|Overall Study|Adverse Event|0|||
157085026|NCT00037830|567065267|FG002|Overall Study|Adverse Event|0|||
157085027|NCT00037830|567065265|FG000|Overall Study|Withdrawal by Subject|4|||
157085028|NCT00037830|567065266|FG001|Overall Study|Withdrawal by Subject|5|||
157085029|NCT00037830|567065267|FG002|Overall Study|Withdrawal by Subject|1|||
157085030|NCT00037830|567065265|FG000|Overall Study|Protocol Violation|2|||
157085031|NCT00037830|567065266|FG001|Overall Study|Protocol Violation|2|||
157085032|NCT00037830|567065267|FG002|Overall Study|Protocol Violation|0|||
157085033|NCT00037830|567065265|FG000|Overall Study|Unrelated Medical Problem|2|||
157085034|NCT00037830|567065266|FG001|Overall Study|Unrelated Medical Problem|0|||
157085035|NCT00037830|567065267|FG002|Overall Study|Unrelated Medical Problem|0|||
157085036|NCT01327495|567065268|FG000|Overall Study|Adverse Event|2|||
157085037|NCT01327495|567065269|FG001|Overall Study|Adverse Event|1|||
157085038|NCT01327495|567065270|FG002|Overall Study|Adverse Event|1|||
157085039|NCT01327495|567065271|FG003|Overall Study|Adverse Event|0|||
157085040|NCT01327495|567065272|FG004|Overall Study|Adverse Event|0|||
157085041|NCT01327495|567065273|FG005|Overall Study|Adverse Event|2|||
157195082|NCT01072175|567457423|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195083|NCT01072175|567457424|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195084|NCT01072175|567457425|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
157195085|NCT01072175|567457426|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195086|NCT01072175|567457427|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
157195087|NCT01072175|567457428|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195088|NCT01072175|567457429|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195089|NCT01072175|567457430|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195090|NCT01072175|567457431|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195091|NCT01072175|567457432|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195092|NCT01072175|567457433|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195093|NCT01072175|567457434|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195094|NCT01072175|567457435|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
157195095|NCT01072175|567457423|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195096|NCT01072175|567457424|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
157195097|NCT01072175|567457425|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195098|NCT01072175|567457426|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
157195099|NCT01072175|567457427|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
157195100|NCT01072175|567457428|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195101|NCT01072175|567457429|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195102|NCT01072175|567457430|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157235207|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
157235208|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Other|14|||
157235209|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Other|31|||
157235210|NCT01439880|567609949|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
157235211|NCT01439880|567609950|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
157235212|NCT00328926|567609951|FG000|Overall Study|Pregnancy|2|||
157085042|NCT01327495|567065268|FG000|Overall Study|Withdrawal by Subject|0|||
157085043|NCT01327495|567065269|FG001|Overall Study|Withdrawal by Subject|1|||
157085044|NCT01327495|567065270|FG002|Overall Study|Withdrawal by Subject|1|||
157085045|NCT01327495|567065271|FG003|Overall Study|Withdrawal by Subject|0|||
157085046|NCT01327495|567065272|FG004|Overall Study|Withdrawal by Subject|1|||
157085047|NCT01327495|567065273|FG005|Overall Study|Withdrawal by Subject|0|||
157085048|NCT01327495|567065268|FG000|Overall Study|Physician Decision|0|||
157085049|NCT01327495|567065269|FG001|Overall Study|Physician Decision|0|||
157085050|NCT01327495|567065270|FG002|Overall Study|Physician Decision|0|||
157085051|NCT01327495|567065271|FG003|Overall Study|Physician Decision|0|||
157085052|NCT01327495|567065272|FG004|Overall Study|Physician Decision|2|||
157085053|NCT01327495|567065273|FG005|Overall Study|Physician Decision|0|||
157085054|NCT03377699|567065274|FG000|Overall Study|Withdrawal by Subject|2|||
157085055|NCT03377699|567065275|FG001|Overall Study|Withdrawal by Subject|9|||
157085056|NCT03377699|567065274|FG000|Overall Study|Lost to Follow-up|1|||
157085057|NCT03377699|567065275|FG001|Overall Study|Lost to Follow-up|1|||
157085058|NCT03377699|567065274|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
157085059|NCT03377699|567065275|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
157085060|NCT03377699|567065274|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
157085061|NCT03377699|567065275|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
157085062|NCT03377699|567065274|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
157085063|NCT03377699|567065275|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
157085064|NCT03377699|567065274|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
157085065|NCT03377699|567065275|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
157085066|NCT02580305|567065279|FG000|Overall Study|Adverse Event|15|||
157085067|NCT02580305|567065280|FG001|Overall Study|Adverse Event|19|||
157085068|NCT02580305|567065281|FG002|Overall Study|Adverse Event|10|||
157085069|NCT02580305|567065279|FG000|Overall Study|Lack of Efficacy|5|||
157085070|NCT02580305|567065280|FG001|Overall Study|Lack of Efficacy|0|||
157085071|NCT02580305|567065281|FG002|Overall Study|Lack of Efficacy|2|||
157085072|NCT02580305|567065279|FG000|Overall Study|Protocol Violation|4|||
157085073|NCT02580305|567065280|FG001|Overall Study|Protocol Violation|9|||
157085074|NCT02580305|567065281|FG002|Overall Study|Protocol Violation|6|||
157085075|NCT02580305|567065279|FG000|Overall Study|Lost to Follow-up|4|||
157085076|NCT02580305|567065280|FG001|Overall Study|Lost to Follow-up|4|||
157085077|NCT02580305|567065281|FG002|Overall Study|Lost to Follow-up|2|||
157235213|NCT00328926|567609952|FG001|Overall Study|Pregnancy|1|||
157235214|NCT00328926|567609953|FG002|Overall Study|Pregnancy|0|||
157235215|NCT00328926|567609951|FG000|Overall Study|Lost to Follow-up|0|||
157235216|NCT00328926|567609952|FG001|Overall Study|Lost to Follow-up|1|||
157235217|NCT00328926|567609953|FG002|Overall Study|Lost to Follow-up|0|||
157235218|NCT00328926|567609951|FG000|Overall Study|Death|0|||
157235219|NCT00328926|567609952|FG001|Overall Study|Death|0|||
157235220|NCT00328926|567609953|FG002|Overall Study|Death|1|||
157235221|NCT00328926|567609951|FG000|Overall Study|In vitro fertilization treatment|0|||
157235222|NCT00328926|567609952|FG001|Overall Study|In vitro fertilization treatment|0|||
157235223|NCT00328926|567609953|FG002|Overall Study|In vitro fertilization treatment|1|||
157235224|NCT00328926|567609951|FG000|Overall Study|Lack of ovarian response|0|||
157235225|NCT00328926|567609952|FG001|Overall Study|Lack of ovarian response|1|||
157235226|NCT00328926|567609953|FG002|Overall Study|Lack of ovarian response|0|||
157235227|NCT02269657|567609954|FG000|Overall Study|Protocol Violation|3|||
157235228|NCT02956460|567609957|FG000|Lens 1|Lost to Follow-up|1|||
157235229|NCT02956460|567609958|FG001|Lens 1|Lost to Follow-up|0|||
157235230|NCT00829673|567609959|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
157235231|NCT00829673|567609960|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
157235232|NCT00272779|567609961|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
157235233|NCT00272779|567609962|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
157235234|NCT00272779|567609961|FG000|Baseline Through Week 48|Death before Week 48|4|||
157235235|NCT00272779|567609962|FG001|Baseline Through Week 48|Death before Week 48|4|||
157235236|NCT00272779|567609961|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
157235237|NCT00272779|567609962|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
157235238|NCT00272779|567609961|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
157235239|NCT00272779|567609962|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
157235240|NCT00272779|567609961|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
157235241|NCT00272779|567609962|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
157235242|NCT00272779|567609961|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
157235243|NCT00272779|567609962|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
157235244|NCT00272779|567609961|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
157235245|NCT00272779|567609962|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
157235246|NCT00272779|567609961|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
157235247|NCT00272779|567609962|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
157235248|NCT00272779|567609961|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
157235249|NCT00272779|567609962|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
157235250|NCT00272779|567609961|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
157235251|NCT00272779|567609962|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
157235252|NCT00272779|567609961|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
157235253|NCT00272779|567609962|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
157235254|NCT00272779|567609961|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
157235255|NCT00272779|567609962|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
157235256|NCT00272779|567609961|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
157235257|NCT00272779|567609962|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
157235258|NCT00272779|567609961|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
157235259|NCT00272779|567609962|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
157235260|NCT00272779|567609961|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
157235261|NCT00272779|567609962|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
157235262|NCT00272779|567609961|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
157235263|NCT00272779|567609962|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
157235264|NCT00272779|567609961|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
157235265|NCT00272779|567609962|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
157235266|NCT00272779|567609961|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
157235267|NCT00272779|567609962|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
157235268|NCT00272779|567609961|FG000|Baseline Through Week 48|Continuing treatment|385|||
157235269|NCT00272779|567609962|FG001|Baseline Through Week 48|Continuing treatment|368|||
157235270|NCT00272779|567609961|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
157235271|NCT00272779|567609962|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
157235272|NCT00272779|567609961|FG000|Baseline Through Week 48|Never treated|2|||
157235273|NCT00272779|567609962|FG001|Baseline Through Week 48|Never treated|3|||
157235274|NCT00272779|567609961|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
157235275|NCT00272779|567609962|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
157235276|NCT00272779|567609961|FG000|Baseline Through Week 96|Death before Week 96|6|||
157235277|NCT00272779|567609962|FG001|Baseline Through Week 96|Death before Week 96|5|||
157235278|NCT00272779|567609961|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
157235279|NCT00272779|567609962|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
157235280|NCT00272779|567609961|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
157085078|NCT02580305|567065279|FG000|Overall Study|Withdrawal by Subject|11|||
157085079|NCT02580305|567065280|FG001|Overall Study|Withdrawal by Subject|9|||
157085080|NCT02580305|567065281|FG002|Overall Study|Withdrawal by Subject|7|||
157085081|NCT02580305|567065279|FG000|Overall Study|Randomized in error and never treated|4|||
157085082|NCT02580305|567065280|FG001|Overall Study|Randomized in error and never treated|8|||
157085083|NCT02580305|567065281|FG002|Overall Study|Randomized in error and never treated|5|||
157195103|NCT01072175|567457431|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195104|NCT01072175|567457432|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195105|NCT01072175|567457433|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195106|NCT01072175|567457434|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195107|NCT01072175|567457435|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
157195108|NCT01072175|567457423|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195109|NCT01072175|567457424|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195110|NCT01072175|567457425|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
157195111|NCT01072175|567457426|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
157195112|NCT01072175|567457427|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
157195113|NCT01072175|567457428|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195114|NCT01072175|567457429|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195115|NCT01072175|567457430|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195116|NCT01072175|567457431|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195117|NCT01072175|567457432|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195118|NCT01072175|567457433|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195119|NCT01072175|567457434|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195120|NCT01072175|567457435|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
157195121|NCT01072175|567457423|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195122|NCT01072175|567457424|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
157195123|NCT01072175|567457425|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195124|NCT01072175|567457426|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
157195125|NCT01072175|567457427|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
157195126|NCT01072175|567457428|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195127|NCT01072175|567457429|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195128|NCT01072175|567457430|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195129|NCT01072175|567457431|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195130|NCT01072175|567457432|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195131|NCT01072175|567457433|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195132|NCT01072175|567457434|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195133|NCT01072175|567457435|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
157195134|NCT01072175|567457423|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
157195135|NCT01072175|567457424|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
157195136|NCT01072175|567457425|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
157195137|NCT01072175|567457426|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
157195138|NCT01072175|567457427|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
157195139|NCT01072175|567457428|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
157195140|NCT01072175|567457429|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
157195141|NCT01072175|567457430|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
157195142|NCT01072175|567457431|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
157195143|NCT01072175|567457432|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
157195144|NCT01072175|567457433|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
157195145|NCT01072175|567457434|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
157195146|NCT01072175|567457435|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
157195147|NCT01072175|567457423|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195148|NCT01072175|567457424|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195149|NCT01072175|567457425|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195150|NCT01072175|567457426|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195151|NCT01072175|567457427|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195152|NCT01072175|567457428|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
157195153|NCT01072175|567457429|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
157195154|NCT01072175|567457430|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
157195155|NCT01072175|567457431|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195156|NCT01072175|567457432|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195157|NCT01072175|567457433|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195158|NCT01072175|567457434|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157085084|NCT03582943|567065282|FG000|Allocated to Groups|Withdrawal by Subject|1|||
157085085|NCT03582943|567065283|FG001|Allocated to Groups|Withdrawal by Subject|1|||
157195159|NCT01072175|567457435|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
157195160|NCT01072175|567457423|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195161|NCT01072175|567457424|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195162|NCT01072175|567457425|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195163|NCT01072175|567457426|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195164|NCT01072175|567457427|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195165|NCT01072175|567457428|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195166|NCT01072175|567457429|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
157195167|NCT01072175|567457430|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
157195168|NCT01072175|567457431|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195169|NCT01072175|567457432|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195170|NCT01072175|567457433|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195171|NCT01072175|567457434|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195172|NCT01072175|567457435|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
157195173|NCT01072175|567457423|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195174|NCT01072175|567457424|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195175|NCT01072175|567457425|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195176|NCT01072175|567457426|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195177|NCT01072175|567457427|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195178|NCT01072175|567457428|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
157195179|NCT01072175|567457429|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
157195180|NCT01072175|567457430|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
157195181|NCT01072175|567457431|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195182|NCT01072175|567457432|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195183|NCT01072175|567457433|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195184|NCT01072175|567457434|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195185|NCT01072175|567457435|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
157195186|NCT01072175|567457423|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195187|NCT01072175|567457424|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195188|NCT01072175|567457425|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195189|NCT01072175|567457426|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195190|NCT01072175|567457427|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195191|NCT01072175|567457428|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
157195192|NCT01072175|567457429|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
157195193|NCT01072175|567457430|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195194|NCT01072175|567457431|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195195|NCT01072175|567457432|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195196|NCT01072175|567457433|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195197|NCT01072175|567457434|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195198|NCT01072175|567457435|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
157195199|NCT01072175|567457423|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195200|NCT01072175|567457424|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195201|NCT01072175|567457425|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195202|NCT01072175|567457426|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195203|NCT01072175|567457427|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195204|NCT01072175|567457428|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195205|NCT01072175|567457429|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195206|NCT01072175|567457430|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195207|NCT01072175|567457431|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
157195208|NCT01072175|567457432|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195209|NCT01072175|567457433|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195210|NCT01072175|567457434|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195211|NCT01072175|567457435|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
157195212|NCT01072175|567457423|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195213|NCT01072175|567457424|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195214|NCT01072175|567457425|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195215|NCT01072175|567457426|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195216|NCT01072175|567457427|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195217|NCT01072175|567457428|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195218|NCT01072175|567457429|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195219|NCT01072175|567457430|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195220|NCT01072175|567457431|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
157195221|NCT01072175|567457432|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195222|NCT01072175|567457433|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195223|NCT01072175|567457434|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157195224|NCT01072175|567457435|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
157085086|NCT03582943|567065282|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
157085087|NCT03582943|567065283|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
157085088|NCT03582943|567065282|FG000|Analyzed|Protocol Violation|4|||
157085089|NCT03582943|567065283|FG001|Analyzed|Protocol Violation|1|||
157085090|NCT01153321|567065290|FG000|Overall Study|Development of study withdrawal criteria|0|||
157085091|NCT01153321|567065291|FG001|Overall Study|Development of study withdrawal criteria|1|||
157085092|NCT01153321|567065290|FG000|Overall Study|Withdrawal by Subject|0|||
157085093|NCT01153321|567065291|FG001|Overall Study|Withdrawal by Subject|1|||
157085094|NCT01153321|567065290|FG000|Overall Study|Adverse Event|1|||
157085095|NCT01153321|567065291|FG001|Overall Study|Adverse Event|1|||
157085096|NCT01177800|567065292|FG000|Overall Study|Adverse Event|9|||
157085097|NCT01177800|567065293|FG001|Overall Study|Adverse Event|3|||
157085098|NCT01177800|567065292|FG000|Overall Study|Protocol Violation|0|||
157085099|NCT01177800|567065293|FG001|Overall Study|Protocol Violation|1|||
157085100|NCT01177800|567065292|FG000|Overall Study|Physician Decision|1|||
157085101|NCT01177800|567065293|FG001|Overall Study|Physician Decision|0|||
157085102|NCT01177800|567065292|FG000|Overall Study|Withdrawal of informed consent|0|||
157085103|NCT01177800|567065293|FG001|Overall Study|Withdrawal of informed consent|1|||
157085104|NCT05870228|567065300|FG000|Overall Study|Lost to Follow-up|2|||
157085105|NCT05870228|567065301|FG001|Overall Study|Lost to Follow-up|0|||
157085106|NCT05870228|567065300|FG000|Overall Study|Withdrawal by Subject|1|||
157085107|NCT05870228|567065301|FG001|Overall Study|Withdrawal by Subject|0|||
157085108|NCT03500159|567065303|FG000|Overall Study|Study Terminated|2|||
157085109|NCT03500159|567065304|FG001|Overall Study|Study Terminated|1|||
157085110|NCT00560066|567065307|FG000|Overall Study|Death|2|||
157085111|NCT00560066|567065308|FG001|Overall Study|Death|1|||
157085112|NCT00560066|567065307|FG000|Overall Study|Withdrawal by Subject|0|||
157085113|NCT00560066|567065308|FG001|Overall Study|Withdrawal by Subject|3|||
157085114|NCT00560066|567065307|FG000|Overall Study|Lost to Follow-up|4|||
157085115|NCT00560066|567065308|FG001|Overall Study|Lost to Follow-up|10|||
157085116|NCT00560066|567065307|FG000|Overall Study|Protocol Violation|0|||
157085117|NCT00560066|567065308|FG001|Overall Study|Protocol Violation|1|||
157085118|NCT00560066|567065307|FG000|Overall Study|Administrative reason|0|||
157085119|NCT00560066|567065308|FG001|Overall Study|Administrative reason|5|||
157085120|NCT00560066|567065307|FG000|Overall Study|Missing primary reason|0|||
157085121|NCT00560066|567065308|FG001|Overall Study|Missing primary reason|2|||
157085122|NCT01125514|567065310|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
157085123|NCT01125514|567065310|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
157085124|NCT01125514|567065310|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
157085125|NCT01125514|567065310|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
157085126|NCT01125514|567065310|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
157085127|NCT01125514|567065310|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
157085128|NCT00929110|567065313|FG000|Overall Study|Adverse Event|40|||
157085129|NCT00929110|567065314|FG001|Overall Study|Adverse Event|29|||
157085130|NCT00929110|567065315|FG002|Overall Study|Adverse Event|18|||
157085131|NCT00929110|567065313|FG000|Overall Study|Subject withdrew consent|40|||
157085132|NCT00929110|567065314|FG001|Overall Study|Subject withdrew consent|23|||
157085133|NCT00929110|567065315|FG002|Overall Study|Subject withdrew consent|26|||
157085134|NCT00929110|567065313|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
157085135|NCT00929110|567065314|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
157085136|NCT00929110|567065315|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
157085137|NCT00929110|567065313|FG000|Overall Study|Lost to Follow-up|7|||
157085138|NCT00929110|567065314|FG001|Overall Study|Lost to Follow-up|7|||
157085139|NCT00929110|567065315|FG002|Overall Study|Lost to Follow-up|3|||
157085140|NCT00929110|567065313|FG000|Overall Study|Protocol deviation|5|||
157085141|NCT00929110|567065314|FG001|Overall Study|Protocol deviation|2|||
157085142|NCT00929110|567065315|FG002|Overall Study|Protocol deviation|4|||
157085143|NCT00929110|567065313|FG000|Overall Study|Administrative problems|4|||
157085144|NCT00929110|567065314|FG001|Overall Study|Administrative problems|1|||
157085145|NCT00929110|567065315|FG002|Overall Study|Administrative problems|2|||
157085146|NCT00929110|567065313|FG000|Overall Study|Death|2|||
157085147|NCT00929110|567065314|FG001|Overall Study|Death|2|||
157085148|NCT00929110|567065315|FG002|Overall Study|Death|2|||
157085149|NCT00929110|567065313|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157085150|NCT00929110|567065314|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157085151|NCT00929110|567065315|FG002|Overall Study|Abnormal laboratory value(s)|0|||
157085152|NCT00929110|567065313|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157085153|NCT00929110|567065314|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157085154|NCT00929110|567065315|FG002|Overall Study|Abnormal test procedure result(s)|1|||
157085155|NCT00929110|567065313|FG000|Overall Study|Patient inability to use the device|0|||
157085156|NCT00929110|567065314|FG001|Overall Study|Patient inability to use the device|1|||
157085157|NCT00929110|567065315|FG002|Overall Study|Patient inability to use the device|0|||
157085158|NCT01163292|567065319|FG000|Overall Study|Lack of Efficacy|9|||
157085159|NCT01163292|567065320|FG001|Overall Study|Lack of Efficacy|0|||
157085160|NCT01163292|567065319|FG000|Overall Study|Adverse Event|6|||
157085161|NCT01163292|567065320|FG001|Overall Study|Adverse Event|0|||
157085162|NCT01163292|567065319|FG000|Overall Study|Initiation of biological therapy|0|||
157085163|NCT01163292|567065320|FG001|Overall Study|Initiation of biological therapy|15|||
157085164|NCT01163292|567065319|FG000|Overall Study|Sufficient response to adalimumab|8|||
157085165|NCT01163292|567065320|FG001|Overall Study|Sufficient response to adalimumab|0|||
157085166|NCT01163292|567065319|FG000|Overall Study|Refusal to receive adalimumab|7|||
157085167|NCT01163292|567065320|FG001|Overall Study|Refusal to receive adalimumab|0|||
157085168|NCT01163292|567065319|FG000|Overall Study|Economic reasons|6|||
157085169|NCT01163292|567065320|FG001|Overall Study|Economic reasons|0|||
157085170|NCT01163292|567065319|FG000|Overall Study|No further visits|5|||
157085171|NCT01163292|567065320|FG001|Overall Study|No further visits|7|||
157085172|NCT02643472|567065324|FG000|Overall Study|Death|2|||
157085173|NCT02643472|567065325|FG001|Overall Study|Death|5|||
157085174|NCT02643472|567065324|FG000|Overall Study|Withdrawal by Subject|3|||
157085175|NCT02643472|567065325|FG001|Overall Study|Withdrawal by Subject|2|||
157085176|NCT02643472|567065324|FG000|Overall Study|Protocol Violation|0|||
157085177|NCT02643472|567065325|FG001|Overall Study|Protocol Violation|1|||
157085178|NCT02643472|567065324|FG000|Overall Study|Lost to Follow-up|22|||
157085179|NCT02643472|567065325|FG001|Overall Study|Lost to Follow-up|26|||
157085180|NCT01258595|567065326|FG000|Overall Study|Lost to Follow-up|1|||
157085181|NCT01258595|567065327|FG001|Overall Study|Lost to Follow-up|0|||
157085182|NCT01258595|567065326|FG000|Overall Study|Withdrawal by Subject|0|||
157085183|NCT01258595|567065327|FG001|Overall Study|Withdrawal by Subject|1|||
157085184|NCT01215188|567065328|FG000|Overall Study|Lost to Follow-up|22|||
157085185|NCT01215188|567065329|FG001|Overall Study|Lost to Follow-up|22|||
157085186|NCT01215188|567065330|FG002|Overall Study|Lost to Follow-up|16|||
157085187|NCT01215188|567065328|FG000|Overall Study|Adverse Event|1|||
157085188|NCT01215188|567065329|FG001|Overall Study|Adverse Event|1|||
157085189|NCT01215188|567065330|FG002|Overall Study|Adverse Event|3|||
157085190|NCT01215188|567065328|FG000|Overall Study|Physician Decision|2|||
157085191|NCT01215188|567065329|FG001|Overall Study|Physician Decision|1|||
157085192|NCT01215188|567065330|FG002|Overall Study|Physician Decision|0|||
157085193|NCT01215188|567065328|FG000|Overall Study|Lack of Efficacy|0|||
157195225|NCT01072175|567457423|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195226|NCT01072175|567457424|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195227|NCT01072175|567457425|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195228|NCT01072175|567457426|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195229|NCT01072175|567457427|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195230|NCT01072175|567457428|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195231|NCT01072175|567457429|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195232|NCT01072175|567457430|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195233|NCT01072175|567457431|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
157195234|NCT01072175|567457432|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195235|NCT01072175|567457433|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195236|NCT01072175|567457434|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195237|NCT01072175|567457435|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
157195238|NCT01072175|567457423|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195239|NCT01072175|567457424|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195240|NCT01072175|567457425|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195241|NCT01072175|567457426|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195242|NCT01072175|567457427|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195243|NCT01072175|567457428|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195244|NCT01072175|567457429|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195245|NCT01072175|567457430|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195246|NCT01072175|567457431|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
157195247|NCT01072175|567457432|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195248|NCT01072175|567457433|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157235281|NCT00272779|567609962|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
157235282|NCT00272779|567609961|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
157235283|NCT00272779|567609962|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
157085194|NCT01215188|567065329|FG001|Overall Study|Lack of Efficacy|0|||
157085195|NCT01215188|567065330|FG002|Overall Study|Lack of Efficacy|1|||
157085196|NCT01215188|567065328|FG000|Overall Study|Protocol Violation|1|||
157085197|NCT01215188|567065329|FG001|Overall Study|Protocol Violation|1|||
157085198|NCT01215188|567065330|FG002|Overall Study|Protocol Violation|1|||
157085199|NCT01215188|567065328|FG000|Overall Study|Withdrawal by Subject|32|||
157085200|NCT01215188|567065329|FG001|Overall Study|Withdrawal by Subject|34|||
157085201|NCT01215188|567065330|FG002|Overall Study|Withdrawal by Subject|31|||
157195249|NCT01072175|567457434|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195250|NCT01072175|567457435|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
157195251|NCT01072175|567457423|FG000|Part D (HPMC Capsules)|Death|0|||
157195252|NCT01072175|567457424|FG001|Part D (HPMC Capsules)|Death|0|||
157235284|NCT00272779|567609961|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
157235285|NCT00272779|567609962|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
157235286|NCT00272779|567609961|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
157235287|NCT00272779|567609962|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
157235288|NCT00272779|567609961|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
157235289|NCT00272779|567609962|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
157235290|NCT00272779|567609961|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
157235291|NCT00272779|567609962|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
157235292|NCT00272779|567609961|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
157235293|NCT00272779|567609962|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
157235294|NCT00272779|567609961|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
157235295|NCT00272779|567609962|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
157235296|NCT00272779|567609961|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
157235297|NCT00272779|567609962|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
157235298|NCT00272779|567609961|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
157235299|NCT00272779|567609962|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
157235300|NCT00272779|567609961|FG000|Baseline Through Week 96|Never treated|2|||
157235301|NCT00272779|567609962|FG001|Baseline Through Week 96|Never treated|3|||
157235302|NCT00272779|567609961|FG000|Baseline Through Week 96|Continuing on treatment|61|||
157235303|NCT00272779|567609962|FG001|Baseline Through Week 96|Continuing on treatment|38|||
157235304|NCT02440711|567609963|FG000|Second Intervention|Lost to Follow-up|1|||
157235305|NCT02440711|567609964|FG001|Second Intervention|Lost to Follow-up|0|||
157235306|NCT03450057|567609965|FG000|Overall Study|Death|17|||
157235307|NCT03450057|567609965|FG000|Overall Study|ICF withdrawal|4|||
157235308|NCT03450057|567609965|FG000|Overall Study|Lost to Follow-up|2|||
157235309|NCT04129346|567609966|FG000|Overall Study|Death|1|||
157235310|NCT04129346|567609967|FG001|Overall Study|Death|0|||
157235311|NCT05755282|567609968|FG000|Overall Study|Protocol Violation|0|||
157235312|NCT05755282|567609969|FG001|Overall Study|Protocol Violation|1|||
157235313|NCT00573066|567609970|FG000|Overall Study|Exclusion criteria|18|||
157235314|NCT00573066|567609970|FG000|Overall Study|IV malfunction|1|||
157235315|NCT00573066|567609970|FG000|Overall Study|Postoperative bleeding|1|||
157235316|NCT00829790|567609974|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
157235317|NCT00829790|567609975|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
157235318|NCT00834743|567609976|FG000|Second Intervention|Withdrawal by Subject|1|||
157235319|NCT00834743|567609977|FG001|Second Intervention|Withdrawal by Subject|0|||
157235320|NCT01693523|567609980|FG000|Overall Study|Adverse Event|2|||
157235321|NCT01693523|567609981|FG001|Overall Study|Adverse Event|1|||
157235322|NCT01693523|567609982|FG002|Overall Study|Adverse Event|0|||
157235323|NCT01693523|567609980|FG000|Overall Study|Death|0|||
157235324|NCT01693523|567609981|FG001|Overall Study|Death|1|||
157235325|NCT01693523|567609982|FG002|Overall Study|Death|1|||
157235326|NCT01693523|567609980|FG000|Overall Study|Lost to Follow-up|0|||
157235327|NCT01693523|567609981|FG001|Overall Study|Lost to Follow-up|0|||
157235328|NCT01693523|567609982|FG002|Overall Study|Lost to Follow-up|4|||
157235329|NCT01693523|567609980|FG000|Overall Study|Physician Decision|0|||
157235330|NCT01693523|567609981|FG001|Overall Study|Physician Decision|0|||
157235331|NCT01693523|567609982|FG002|Overall Study|Physician Decision|1|||
157235332|NCT01693523|567609980|FG000|Overall Study|Withdrawal by Subject|1|||
157235333|NCT01693523|567609981|FG001|Overall Study|Withdrawal by Subject|2|||
157235334|NCT01693523|567609982|FG002|Overall Study|Withdrawal by Subject|2|||
157235335|NCT01693523|567609980|FG000|Overall Study|Lack of compliance study medication|1|||
157235336|NCT01693523|567609981|FG001|Overall Study|Lack of compliance study medication|2|||
157235337|NCT01693523|567609982|FG002|Overall Study|Lack of compliance study medication|0|||
157235338|NCT01693523|567609980|FG000|Overall Study|Chemotherapy was held|1|||
157235339|NCT01693523|567609981|FG001|Overall Study|Chemotherapy was held|2|||
157235340|NCT01693523|567609982|FG002|Overall Study|Chemotherapy was held|0|||
157235341|NCT02924883|567609985|FG000|Overall Study|Death|39|||
157235342|NCT02924883|567609986|FG001|Overall Study|Death|20|||
157235343|NCT02924883|567609985|FG000|Overall Study|Lost to Follow-up|1|||
157235344|NCT02924883|567609986|FG001|Overall Study|Lost to Follow-up|0|||
157235345|NCT02924883|567609985|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
157235346|NCT02924883|567609986|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
157235347|NCT02924883|567609985|FG000|Overall Study|Protocol Violation|1|||
157235348|NCT02924883|567609986|FG001|Overall Study|Protocol Violation|0|||
157235349|NCT02924883|567609985|FG000|Overall Study|Withdrawal by Subject|22|||
157235350|NCT02924883|567609986|FG001|Overall Study|Withdrawal by Subject|16|||
157235351|NCT02924883|567609985|FG000|Overall Study|Progressive Disease|1|||
157235352|NCT02924883|567609986|FG001|Overall Study|Progressive Disease|0|||
157235353|NCT02924883|567609985|FG000|Overall Study|Study Terminated by Sponsor|69|||
157235354|NCT02924883|567609986|FG001|Overall Study|Study Terminated by Sponsor|32|||
157235355|NCT00004562|567609987|FG000|Overall Study|Lost to Follow-up|102|||
157235356|NCT00004562|567609988|FG001|Overall Study|Lost to Follow-up|91|||
157235357|NCT02331394|567609989|FG000|Overall Study|Disease progression|1|||
157235358|NCT04247282|567609990|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
157085202|NCT01012414|567065331|FG000|Overall Study|Withdrawal by Subject|2|||
157085203|NCT01012414|567065331|FG000|Overall Study|Lost to Follow-up|1|||
157085204|NCT01012414|567065331|FG000|Overall Study|Trial was stopped before completed|7|||
157085205|NCT02310100|567065332|FG000|Overall Study|Physician Decision|3|||
157085206|NCT02310100|567065332|FG000|Overall Study|Withdrawal by Subject|10|||
157085207|NCT02310100|567065332|FG000|Overall Study|Enrollment closure|1|||
157085208|NCT02310100|567065332|FG000|Overall Study|Unapproved ablation operator|1|||
157085209|NCT02310100|567065332|FG000|Overall Study|Visit compliance|1|||
157085210|NCT02310100|567065332|FG000|Overall Study|Lost to Follow-up|2|||
157085211|NCT02601300|567065333|FG000|Induction Phase|Lack of Efficacy|2|||
157085212|NCT02601300|567065333|FG000|Induction Phase|Protocol Violation|1|||
157195253|NCT01072175|567457425|FG002|Part D (HPMC Capsules)|Death|0|||
157195254|NCT01072175|567457426|FG003|Part D (HPMC Capsules)|Death|0|||
157195255|NCT01072175|567457427|FG004|Part D (HPMC Capsules)|Death|0|||
157195256|NCT01072175|567457428|FG005|Part D (HPMC Capsules)|Death|0|||
157195257|NCT01072175|567457429|FG006|Part D (HPMC Capsules)|Death|0|||
157195258|NCT01072175|567457430|FG007|Part D (HPMC Capsules)|Death|0|||
157195259|NCT01072175|567457431|FG008|Part D (HPMC Capsules)|Death|0|||
157195260|NCT01072175|567457432|FG009|Part D (HPMC Capsules)|Death|10|||
157195261|NCT01072175|567457433|FG010|Part D (HPMC Capsules)|Death|12|||
157195262|NCT01072175|567457434|FG011|Part D (HPMC Capsules)|Death|28|||
157195263|NCT01072175|567457435|FG012|Part D (HPMC Capsules)|Death|26|||
157195264|NCT01072175|567457423|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
157195265|NCT01072175|567457424|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
157195266|NCT01072175|567457425|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
157195267|NCT01072175|567457426|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
157195268|NCT01072175|567457427|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
157195269|NCT01072175|567457428|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
157195270|NCT01072175|567457429|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
157195271|NCT01072175|567457430|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
157195272|NCT01072175|567457431|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
157195273|NCT01072175|567457432|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
157195274|NCT01072175|567457433|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
157195275|NCT01072175|567457434|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
157195276|NCT01072175|567457435|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
157195277|NCT01072175|567457423|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195278|NCT01072175|567457424|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195279|NCT01072175|567457425|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195280|NCT01072175|567457426|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195281|NCT01072175|567457427|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195282|NCT01072175|567457428|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195283|NCT01072175|567457429|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195284|NCT01072175|567457430|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195285|NCT01072175|567457431|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195286|NCT01072175|567457432|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
157195287|NCT01072175|567457433|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
157195288|NCT01072175|567457434|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
157195289|NCT01072175|567457435|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
157195290|NCT01072175|567457423|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195291|NCT01072175|567457424|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195292|NCT01072175|567457425|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195293|NCT01072175|567457426|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195294|NCT01072175|567457427|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195295|NCT01072175|567457428|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195296|NCT01072175|567457429|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195297|NCT01072175|567457430|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195298|NCT01072175|567457431|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
157195299|NCT01072175|567457432|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
157195300|NCT01072175|567457433|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
157195301|NCT01072175|567457434|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
157195302|NCT01072175|567457435|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
157195303|NCT01072175|567457423|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195304|NCT01072175|567457424|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157085213|NCT02601300|567065333|FG000|Extension Phase|Withdrawal by Subject|3|||
157085214|NCT02601300|567065333|FG000|Extension Phase|Adverse Event|4|||
157195305|NCT01072175|567457425|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157085215|NCT02601300|567065333|FG000|Extension Phase|Lack of Efficacy|10|||
157195306|NCT01072175|567457426|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195307|NCT01072175|567457427|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195308|NCT01072175|567457428|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195309|NCT01072175|567457429|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195310|NCT01072175|567457430|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195311|NCT01072175|567457431|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195312|NCT01072175|567457432|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195313|NCT01072175|567457433|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
157195314|NCT01072175|567457434|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
157195315|NCT01072175|567457435|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
157195316|NCT02839330|567457436|FG000|Overall Study|Adverse Event|0|||
157195317|NCT02839330|567457437|FG001|Overall Study|Adverse Event|1|||
157195318|NCT02839330|567457438|FG002|Overall Study|Adverse Event|2|||
157195319|NCT02839330|567457439|FG003|Overall Study|Adverse Event|2|||
157195320|NCT02839330|567457436|FG000|Overall Study|Death|4|||
157195321|NCT02839330|567457437|FG001|Overall Study|Death|6|||
157195322|NCT02839330|567457438|FG002|Overall Study|Death|1|||
157195323|NCT02839330|567457439|FG003|Overall Study|Death|1|||
157195324|NCT02839330|567457436|FG000|Overall Study|Withdrawal by Subject|27|||
157195325|NCT02839330|567457437|FG001|Overall Study|Withdrawal by Subject|19|||
157195326|NCT02839330|567457438|FG002|Overall Study|Withdrawal by Subject|11|||
157195327|NCT02839330|567457439|FG003|Overall Study|Withdrawal by Subject|13|||
157195328|NCT02839330|567457436|FG000|Overall Study|Lost to Follow-up|22|||
157195329|NCT02839330|567457437|FG001|Overall Study|Lost to Follow-up|27|||
157195330|NCT02839330|567457438|FG002|Overall Study|Lost to Follow-up|29|||
157195331|NCT02839330|567457439|FG003|Overall Study|Lost to Follow-up|25|||
157195332|NCT02839330|567457436|FG000|Overall Study|Administrative Reason|0|||
157195333|NCT02839330|567457437|FG001|Overall Study|Administrative Reason|0|||
157195334|NCT02839330|567457438|FG002|Overall Study|Administrative Reason|0|||
157195335|NCT02839330|567457439|FG003|Overall Study|Administrative Reason|1|||
157195336|NCT02839330|567457436|FG000|Overall Study|Protocol Violation|1|||
157195337|NCT02839330|567457437|FG001|Overall Study|Protocol Violation|2|||
157195338|NCT02839330|567457438|FG002|Overall Study|Protocol Violation|2|||
157195339|NCT02839330|567457439|FG003|Overall Study|Protocol Violation|3|||
157195340|NCT02839330|567457436|FG000|Overall Study|Other reason, not specified|4|||
157195341|NCT02839330|567457437|FG001|Overall Study|Other reason, not specified|3|||
157195342|NCT02839330|567457438|FG002|Overall Study|Other reason, not specified|3|||
157195343|NCT02839330|567457439|FG003|Overall Study|Other reason, not specified|6|||
157195344|NCT00682539|567457440|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
157195345|NCT00682539|567457441|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
157195346|NCT00682539|567457442|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
157195347|NCT00682539|567457440|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
157195348|NCT00682539|567457441|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
157195349|NCT00682539|567457442|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
157195350|NCT02477215|567457447|FG000|Dose Escalation Phase|Physician Decision|1|||
157195351|NCT02477215|567457448|FG001|Dose Escalation Phase|Physician Decision|2|||
157195352|NCT02477215|567457449|FG002|Dose Escalation Phase|Physician Decision|0|||
157195353|NCT02477215|567457447|FG000|Fixed Dose Phase|Physician Decision|0|||
157195354|NCT02477215|567457448|FG001|Fixed Dose Phase|Physician Decision|7|||
157195355|NCT02477215|567457449|FG002|Fixed Dose Phase|Physician Decision|0|||
157195356|NCT00508872|567457450|FG000|Overall Study|Lost to Follow-up|1|||
157195357|NCT00508872|567457450|FG000|Overall Study|Physician Decision|1|||
157195358|NCT02210559|567457451|FG000|Overall Study|Progressive Disease|3|||
157195359|NCT02210559|567457452|FG001|Overall Study|Progressive Disease|2|||
157195360|NCT02210559|567457451|FG000|Overall Study|Adverse Event|2|||
157195361|NCT02210559|567457452|FG001|Overall Study|Adverse Event|2|||
157195362|NCT02210559|567457451|FG000|Overall Study|Physician Decision|1|||
157195363|NCT02210559|567457452|FG001|Overall Study|Physician Decision|0|||
157195364|NCT02210559|567457451|FG000|Overall Study|Withdrawal by Subject|0|||
157195365|NCT02210559|567457452|FG001|Overall Study|Withdrawal by Subject|1|||
157195366|NCT02210559|567457451|FG000|Overall Study|Other than specified|0|||
157195367|NCT02210559|567457452|FG001|Overall Study|Other than specified|1|||
157195368|NCT00310440|567457453|FG000|Overall Study|Lost to Follow-up|17|||
157195369|NCT00310440|567457454|FG001|Overall Study|Lost to Follow-up|8|||
157195370|NCT00310440|567457453|FG000|Overall Study|Withdrawal by Subject|2|||
157195371|NCT00310440|567457454|FG001|Overall Study|Withdrawal by Subject|1|||
157195372|NCT00310440|567457453|FG000|Overall Study|Missed 12 Month Visit|7|||
157195373|NCT00310440|567457454|FG001|Overall Study|Missed 12 Month Visit|4|||
157195374|NCT00792467|567457455|FG000|Overall Study|progression of disease|17|||
157235359|NCT04247282|567609991|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
157195375|NCT00792467|567457455|FG000|Overall Study|Adverse Event|1|||
157195376|NCT00792467|567457455|FG000|Overall Study|patient request|1|||
157195377|NCT00792467|567457455|FG000|Overall Study|Lost to Follow-up|1|||
157195378|NCT00792467|567457455|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
157195379|NCT00792467|567457455|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
157195380|NCT00661362|567457460|FG000|Overall Study|Adverse Event|5|||
157195381|NCT00661362|567457461|FG001|Overall Study|Adverse Event|4|||
157195382|NCT00661362|567457460|FG000|Overall Study|Incorrect enrollment|2|||
157195383|NCT00661362|567457461|FG001|Overall Study|Incorrect enrollment|0|||
157195384|NCT00661362|567457460|FG000|Overall Study|Study specific discontinuation criteria|4|||
157195385|NCT00661362|567457461|FG001|Overall Study|Study specific discontinuation criteria|11|||
157195386|NCT00661362|567457460|FG000|Overall Study|Withdrawal by Subject|13|||
157195387|NCT00661362|567457461|FG001|Overall Study|Withdrawal by Subject|23|||
157195388|NCT00661362|567457460|FG000|Overall Study|Lost to Follow-up|3|||
157085216|NCT01127763|567065337|FG000|Overall Study|Adverse Event|2|||
157085217|NCT01127763|567065337|FG000|Overall Study|Withdrawal by Subject|1|||
157085218|NCT01127763|567065337|FG000|Overall Study|Physician Decision|2|||
157085219|NCT03122223|567065342|FG000|Overall Study|Withdrawal by Subject|2|||
157085220|NCT03122223|567065343|FG001|Overall Study|Withdrawal by Subject|2|||
157085221|NCT03122223|567065344|FG002|Overall Study|Withdrawal by Subject|1|||
157085222|NCT03122223|567065345|FG003|Overall Study|Withdrawal by Subject|0|||
157085223|NCT03122223|567065342|FG000|Overall Study|Lost to Follow-up|0|||
157085224|NCT03122223|567065343|FG001|Overall Study|Lost to Follow-up|2|||
157085225|NCT03122223|567065344|FG002|Overall Study|Lost to Follow-up|2|||
157085226|NCT03122223|567065345|FG003|Overall Study|Lost to Follow-up|0|||
157085227|NCT03122223|567065342|FG000|Overall Study|Participant unable to adhere|1|||
157085228|NCT03122223|567065343|FG001|Overall Study|Participant unable to adhere|1|||
157085229|NCT03122223|567065344|FG002|Overall Study|Participant unable to adhere|1|||
157085230|NCT03122223|567065345|FG003|Overall Study|Participant unable to adhere|0|||
157085231|NCT00291642|567065349|FG000|Overall Study|Adverse Event|1|||
157085232|NCT00291642|567065350|FG001|Overall Study|Adverse Event|0|||
157085233|NCT00291642|567065351|FG002|Overall Study|Adverse Event|1|||
157085234|NCT00291642|567065352|FG003|Overall Study|Adverse Event|0|||
157085235|NCT00291642|567065353|FG004|Overall Study|Adverse Event|1|||
157085236|NCT00291642|567065349|FG000|Overall Study|Patient missed visit|0|||
157085237|NCT00291642|567065350|FG001|Overall Study|Patient missed visit|0|||
157085238|NCT00291642|567065351|FG002|Overall Study|Patient missed visit|1|||
157085239|NCT00291642|567065352|FG003|Overall Study|Patient missed visit|0|||
157085240|NCT00291642|567065353|FG004|Overall Study|Patient missed visit|0|||
157085241|NCT00291642|567065349|FG000|Overall Study|Intake of prohibited medication|1|||
157085242|NCT00291642|567065350|FG001|Overall Study|Intake of prohibited medication|0|||
157085243|NCT00291642|567065351|FG002|Overall Study|Intake of prohibited medication|0|||
157085244|NCT00291642|567065352|FG003|Overall Study|Intake of prohibited medication|0|||
157085245|NCT00291642|567065353|FG004|Overall Study|Intake of prohibited medication|0|||
157195389|NCT00661362|567457461|FG001|Overall Study|Lost to Follow-up|1|||
157195390|NCT00661362|567457460|FG000|Overall Study|Severe non-compliance to protocol|0|||
157195391|NCT00661362|567457461|FG001|Overall Study|Severe non-compliance to protocol|1|||
157195392|NCT00661362|567457460|FG000|Overall Study|Safety reasons|1|||
157235360|NCT04247282|567609992|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
157195393|NCT00661362|567457461|FG001|Overall Study|Safety reasons|0|||
157195394|NCT00661362|567457460|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
157195395|NCT00661362|567457461|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
157195396|NCT00535262|567457464|FG000|Overall Study|No funding|3|||
157195397|NCT01654666|567457465|FG000|Overall Study|Protocol Violation|7|||
157195398|NCT01654666|567457466|FG001|Overall Study|Protocol Violation|4|||
157195399|NCT01654666|567457467|FG002|Overall Study|Protocol Violation|8|||
157195400|NCT01654666|567457465|FG000|Overall Study|Lost to Follow-up|4|||
157195401|NCT01654666|567457466|FG001|Overall Study|Lost to Follow-up|5|||
157195402|NCT01654666|567457467|FG002|Overall Study|Lost to Follow-up|5|||
157195403|NCT01654666|567457465|FG000|Overall Study|Withdrawal by Subject|4|||
157195404|NCT01654666|567457466|FG001|Overall Study|Withdrawal by Subject|4|||
157195405|NCT01654666|567457467|FG002|Overall Study|Withdrawal by Subject|1|||
157195406|NCT01220024|567457474|FG000|Overall Study|Lost to Follow-up|1|||
157195407|NCT01220024|567457475|FG001|Overall Study|Lost to Follow-up|1|||
157195408|NCT00174460|567457478|FG000|Overall Study|Withdrawal by Subject|0|||
157195409|NCT00174460|567457479|FG001|Overall Study|Withdrawal by Subject|1|||
157195410|NCT04225026|567457480|FG000|Overall Study|Withdrawal by Subject|4|||
157195411|NCT04225026|567457480|FG000|Overall Study|Adverse Event|1|||
157195412|NCT04225026|567457480|FG000|Overall Study|Other|1|||
157195413|NCT04225026|567457480|FG000|Overall Study|Death|11|||
157195414|NCT04225026|567457480|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
157195415|NCT00579059|567457483|FG000|Overall Study|Study Canceled at 1 Year|21|||
157235361|NCT04247282|567609993|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
157235362|NCT04247282|567609990|FG000|Overall Study|Refused further treatment|0|||
157235363|NCT04247282|567609991|FG001|Overall Study|Refused further treatment|1|||
157235364|NCT04247282|567609992|FG002|Overall Study|Refused further treatment|0|||
157235365|NCT04247282|567609993|FG003|Overall Study|Refused further treatment|0|||
157235366|NCT00552669|567609994|FG000|Overall Study|Death|3|||
157085246|NCT02285153|567065354|FG000|Overall Study|Adverse Event|1|||
157085247|NCT02285153|567065355|FG001|Overall Study|Adverse Event|0|||
157085248|NCT03592745|567065361|FG000|Overall Study|Adverse Event|0|||
157195416|NCT00579059|567457484|FG001|Overall Study|Study Canceled at 1 Year|10|||
157195417|NCT04738123|567457487|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
157195418|NCT04738123|567457488|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
157085249|NCT03592745|567065362|FG001|Overall Study|Adverse Event|2|||
157085250|NCT03592745|567065361|FG000|Overall Study|Lost to Follow-up|2|||
157195419|NCT04738123|567457487|FG000|Overall Study|Progressive Disease|0|||
157235367|NCT00552669|567609995|FG001|Overall Study|Death|7|||
157195420|NCT04738123|567457488|FG001|Overall Study|Progressive Disease|4|||
157235368|NCT03195491|567609998|FG000|Overall Study|Study drug toxicity|25|||
157235369|NCT03195491|567609999|FG001|Overall Study|Study drug toxicity|3|||
157235370|NCT03195491|567609998|FG000|Overall Study|Maximum clinical benefit|5|||
157235371|NCT03195491|567609999|FG001|Overall Study|Maximum clinical benefit|0|||
157235372|NCT03195491|567609998|FG000|Overall Study|Lost to Follow-up|1|||
157235373|NCT03195491|567609999|FG001|Overall Study|Lost to Follow-up|0|||
157235374|NCT03195491|567609998|FG000|Overall Study|Death|3|||
157235375|NCT03195491|567609999|FG001|Overall Study|Death|0|||
157235376|NCT03195491|567609998|FG000|Overall Study|Adverse event unrelated to study drug|19|||
157235377|NCT03195491|567609999|FG001|Overall Study|Adverse event unrelated to study drug|2|||
157235378|NCT03195491|567609998|FG000|Overall Study|Disease progression|266|||
157235379|NCT03195491|567609999|FG001|Overall Study|Disease progression|8|||
157235380|NCT03195491|567609998|FG000|Overall Study|Other reasons|10|||
157235381|NCT03195491|567609999|FG001|Overall Study|Other reasons|0|||
157235382|NCT03195491|567609998|FG000|Overall Study|Participant withdrew consent|8|||
157235383|NCT03195491|567609999|FG001|Overall Study|Participant withdrew consent|1|||
157235384|NCT03195491|567609998|FG000|Overall Study|Participant no longer meets study criteria|0|||
157235385|NCT03195491|567609999|FG001|Overall Study|Participant no longer meets study criteria|1|||
157235386|NCT03195491|567609998|FG000|Overall Study|Participant request to discontinue study treatment|10|||
157235387|NCT03195491|567609999|FG001|Overall Study|Participant request to discontinue study treatment|0|||
157235388|NCT02459951|567610000|FG000|Overall Study|Unable to meet holding requirement|1|||
157235389|NCT00252720|567610003|FG000|Overall Study|Withdrawal by Subject|95|||
157235390|NCT00252720|567610004|FG001|Overall Study|Withdrawal by Subject|97|||
157235391|NCT00252720|567610003|FG000|Overall Study|Death|7|||
157235392|NCT00252720|567610004|FG001|Overall Study|Death|8|||
157235393|NCT00252720|567610003|FG000|Overall Study|Moving|23|||
157235394|NCT00252720|567610004|FG001|Overall Study|Moving|42|||
157235395|NCT00252720|567610003|FG000|Overall Study|Mainly patients lost to follow-up|7|||
157235396|NCT00252720|567610004|FG001|Overall Study|Mainly patients lost to follow-up|18|||
157235397|NCT02481830|567610007|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
157235398|NCT02481830|567610008|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
157235399|NCT02481830|567610007|FG000|Pre-treatment|Withdrawal by Subject|0|||
157235400|NCT02481830|567610008|FG001|Pre-treatment|Withdrawal by Subject|10|||
157235401|NCT02481830|567610007|FG000|Pre-treatment|Disease Progression|1|||
157235402|NCT02481830|567610008|FG001|Pre-treatment|Disease Progression|1|||
157235403|NCT02481830|567610007|FG000|Pre-treatment|Other reasons|0|||
157235404|NCT02481830|567610008|FG001|Pre-treatment|Other reasons|1|||
157235405|NCT02481830|567610007|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
157235406|NCT02481830|567610008|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
157235407|NCT02481830|567610007|FG000|Treatment|Disease Progression|233|||
157235408|NCT02481830|567610008|FG001|Treatment|Disease Progression|171|||
157235409|NCT02481830|567610007|FG000|Treatment|Study drug toxicity|18|||
157235410|NCT02481830|567610008|FG001|Treatment|Study drug toxicity|38|||
157235411|NCT02481830|567610007|FG000|Treatment|Death|1|||
157235412|NCT02481830|567610008|FG001|Treatment|Death|1|||
157235413|NCT02481830|567610007|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
157235414|NCT02481830|567610008|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
157235415|NCT02481830|567610007|FG000|Treatment|Participants request to discontinue Study treatment|6|||
157235416|NCT02481830|567610008|FG001|Treatment|Participants request to discontinue Study treatment|34|||
157235417|NCT02481830|567610007|FG000|Treatment|Withdrawal by Subject|2|||
157235418|NCT02481830|567610008|FG001|Treatment|Withdrawal by Subject|3|||
157235419|NCT02481830|567610007|FG000|Treatment|Lost to Follow-up|1|||
157235420|NCT02481830|567610008|FG001|Treatment|Lost to Follow-up|0|||
157235421|NCT02481830|567610007|FG000|Treatment|Maximum Clinical Benefit|0|||
157235422|NCT02481830|567610008|FG001|Treatment|Maximum Clinical Benefit|5|||
157235423|NCT02481830|567610007|FG000|Treatment|Administrative reason by sponsor|1|||
157235424|NCT02481830|567610008|FG001|Treatment|Administrative reason by sponsor|1|||
157235425|NCT02481830|567610007|FG000|Treatment|Other reasons|6|||
157235426|NCT02481830|567610008|FG001|Treatment|Other reasons|1|||
157235427|NCT00772941|567610009|FG000|Overall Study|CRFs not available|195|||
157235428|NCT00772941|567610009|FG000|Overall Study|Study not completed|16|||
157235429|NCT00772941|567610009|FG000|Overall Study|Missed Visits|374|||
157085251|NCT03592745|567065362|FG001|Overall Study|Lost to Follow-up|0|||
157085252|NCT03592745|567065361|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
157235430|NCT00772941|567610009|FG000|Overall Study|Poor Compliance|7|||
157235431|NCT00772941|567610009|FG000|Overall Study|GPSP Violation|90|||
157235432|NCT01745120|567610019|FG000|Overall Study|Investigator decision|1|||
157235433|NCT01745120|567610020|FG001|Overall Study|Investigator decision|0|||
157235434|NCT03956862|567610021|FG000|Overall Study|Lost to Follow-up|1|||
157235435|NCT03956862|567610022|FG001|Overall Study|Lost to Follow-up|1|||
157235436|NCT03956862|567610021|FG000|Overall Study|Withdrawal by Subject|1|||
157235437|NCT03956862|567610022|FG001|Overall Study|Withdrawal by Subject|1|||
157235438|NCT02714062|567610023|FG000|Overall Study|Adverse Event|0|||
157235439|NCT02714062|567610024|FG001|Overall Study|Adverse Event|0|||
157235440|NCT02714062|567610025|FG002|Overall Study|Adverse Event|2|||
157235441|NCT02714062|567610023|FG000|Overall Study|Withdrawal by Subject|1|||
157235442|NCT02714062|567610024|FG001|Overall Study|Withdrawal by Subject|0|||
157235443|NCT02714062|567610025|FG002|Overall Study|Withdrawal by Subject|1|||
157235444|NCT02714062|567610023|FG000|Overall Study|Protocol Violation|0|||
157235445|NCT02714062|567610024|FG001|Overall Study|Protocol Violation|1|||
157235446|NCT02714062|567610025|FG002|Overall Study|Protocol Violation|0|||
157085253|NCT03592745|567065362|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
157085254|NCT02270515|567065363|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
157085255|NCT02270515|567065363|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
157085256|NCT02270515|567065363|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
157085257|NCT02270515|567065363|FG000|Intervention Period 1: 0-6 Months|Death|7|||
157085258|NCT02270515|567065363|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
157085259|NCT02270515|567065363|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
157085260|NCT02270515|567065363|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
157085261|NCT02270515|567065363|FG000|Intervention Period 2: 6-12 Months|Death|5|||
157085262|NCT02270515|567065363|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
157085263|NCT02270515|567065363|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
157085264|NCT02270515|567065363|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
157085265|NCT02270515|567065363|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
157085266|NCT02270515|567065363|FG000|Intervention Period 3: 12-18 Months|Death|3|||
157085267|NCT02270515|567065363|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
157085268|NCT03590366|567065364|FG000|Overall Study|Adverse Event|0|||
157085269|NCT03590366|567065365|FG001|Overall Study|Adverse Event|3|||
157085270|NCT03590366|567065364|FG000|Overall Study|Lost to Follow-up|3|||
157085271|NCT03590366|567065365|FG001|Overall Study|Lost to Follow-up|3|||
157085272|NCT03590366|567065364|FG000|Overall Study|Withdrawal by Subject|0|||
157085273|NCT03590366|567065365|FG001|Overall Study|Withdrawal by Subject|2|||
157085274|NCT03026075|567065370|FG000|Overall Study|Physician Decision|1|||
157085275|NCT03381339|567065371|FG000|Overall Study|Protocol Violation|4|||
157085276|NCT03381339|567065372|FG001|Overall Study|Protocol Violation|3|||
157085277|NCT03381339|567065371|FG000|Overall Study|Lost to Follow-up|0|||
157085278|NCT03381339|567065372|FG001|Overall Study|Lost to Follow-up|1|||
157085279|NCT01468181|567065373|FG000|Overall Study|Adverse Event|8|||
157085280|NCT01468181|567065374|FG001|Overall Study|Adverse Event|1|||
157085281|NCT01468181|567065375|FG002|Overall Study|Adverse Event|6|||
157085282|NCT01468181|567065376|FG003|Overall Study|Adverse Event|2|||
157085283|NCT01468181|567065377|FG004|Overall Study|Adverse Event|2|||
157085284|NCT01468181|567065373|FG000|Overall Study|Protocol Violation|2|||
157085285|NCT01468181|567065374|FG001|Overall Study|Protocol Violation|0|||
157085286|NCT01468181|567065375|FG002|Overall Study|Protocol Violation|1|||
157085287|NCT01468181|567065376|FG003|Overall Study|Protocol Violation|0|||
157085288|NCT01468181|567065377|FG004|Overall Study|Protocol Violation|1|||
157085289|NCT01468181|567065373|FG000|Overall Study|Physician Decision|0|||
157085290|NCT01468181|567065374|FG001|Overall Study|Physician Decision|0|||
157085291|NCT01468181|567065375|FG002|Overall Study|Physician Decision|0|||
157085292|NCT01468181|567065376|FG003|Overall Study|Physician Decision|1|||
157085293|NCT01468181|567065377|FG004|Overall Study|Physician Decision|1|||
157085294|NCT01468181|567065373|FG000|Overall Study|Lost to Follow-up|0|||
157085295|NCT01468181|567065374|FG001|Overall Study|Lost to Follow-up|0|||
157085296|NCT01468181|567065375|FG002|Overall Study|Lost to Follow-up|1|||
157085297|NCT01468181|567065376|FG003|Overall Study|Lost to Follow-up|0|||
157085298|NCT01468181|567065377|FG004|Overall Study|Lost to Follow-up|1|||
157085299|NCT01468181|567065373|FG000|Overall Study|Withdrawal by Subject|0|||
157085300|NCT01468181|567065374|FG001|Overall Study|Withdrawal by Subject|1|||
157085301|NCT01468181|567065375|FG002|Overall Study|Withdrawal by Subject|0|||
157085302|NCT01468181|567065376|FG003|Overall Study|Withdrawal by Subject|0|||
157085303|NCT01468181|567065377|FG004|Overall Study|Withdrawal by Subject|0|||
157085304|NCT00969709|567066834|FG000|Overall Study|Adverse Event|3|||
157085305|NCT00969709|567066835|FG001|Overall Study|Adverse Event|13|||
157085306|NCT00969709|567066836|FG002|Overall Study|Adverse Event|26|||
157085307|NCT00969709|567066837|FG003|Overall Study|Adverse Event|12|||
157085308|NCT00969709|567066834|FG000|Overall Study|Lack of Efficacy|7|||
157085309|NCT00969709|567066835|FG001|Overall Study|Lack of Efficacy|4|||
157085310|NCT00969709|567066836|FG002|Overall Study|Lack of Efficacy|1|||
157235447|NCT02294604|567610026|FG000|Overall Study|Did not provide samples for culture|0|||
157085311|NCT00969709|567066837|FG003|Overall Study|Lack of Efficacy|3|||
157085312|NCT00969709|567066834|FG000|Overall Study|Protocol Violation|9|||
157085313|NCT00969709|567066835|FG001|Overall Study|Protocol Violation|5|||
157085314|NCT00969709|567066836|FG002|Overall Study|Protocol Violation|9|||
157085315|NCT00969709|567066837|FG003|Overall Study|Protocol Violation|10|||
157085316|NCT00969709|567066834|FG000|Overall Study|Withdrawal by Subject|9|||
157085317|NCT00969709|567066835|FG001|Overall Study|Withdrawal by Subject|12|||
157085318|NCT00969709|567066836|FG002|Overall Study|Withdrawal by Subject|11|||
157085319|NCT00969709|567066837|FG003|Overall Study|Withdrawal by Subject|23|||
157085320|NCT00969709|567066834|FG000|Overall Study|Lost to Follow-up|10|||
157085321|NCT00969709|567066835|FG001|Overall Study|Lost to Follow-up|14|||
157235448|NCT02294604|567610027|FG001|Overall Study|Did not provide samples for culture|1|||
157085322|NCT00969709|567066836|FG002|Overall Study|Lost to Follow-up|8|||
157085323|NCT00969709|567066837|FG003|Overall Study|Lost to Follow-up|15|||
157085324|NCT00969709|567066834|FG000|Overall Study|Other reasons|0|||
157085325|NCT00969709|567066835|FG001|Overall Study|Other reasons|0|||
157085326|NCT00969709|567066836|FG002|Overall Study|Other reasons|3|||
157085327|NCT00969709|567066837|FG003|Overall Study|Other reasons|0|||
157085328|NCT02516332|567066838|FG000|Overall Study|Withdrawal by Subject|2|||
157085329|NCT02516332|567066839|FG001|Overall Study|Withdrawal by Subject|1|||
157085330|NCT02516332|567066840|FG002|Overall Study|Withdrawal by Subject|2|||
157085331|NCT03695237|567066841|FG000|Overall Study|Withdrawal by Subject|1|||
157085332|NCT03695237|567066842|FG001|Overall Study|Withdrawal by Subject|3|||
157085333|NCT03695237|567066841|FG000|Overall Study|Lost to Follow-up|1|||
157085334|NCT03695237|567066842|FG001|Overall Study|Lost to Follow-up|2|||
157085335|NCT03695237|567066841|FG000|Overall Study|Other, Not Specified|8|||
157085336|NCT03695237|567066842|FG001|Overall Study|Other, Not Specified|2|||
157085337|NCT00055601|567066843|FG000|Overall Study|Protocol Violation|1|||
157085338|NCT00055601|567066844|FG001|Overall Study|Protocol Violation|1|||
157195421|NCT04738123|567457487|FG000|Overall Study|Adverse Event|8|||
157195422|NCT04738123|567457488|FG001|Overall Study|Adverse Event|7|||
157195423|NCT04738123|567457487|FG000|Overall Study|Other Reasons|0|||
157195424|NCT04738123|567457488|FG001|Overall Study|Other Reasons|1|||
157195425|NCT04738123|567457487|FG000|Overall Study|Suicidal or assaultive behavior|0|||
157195426|NCT04738123|567457488|FG001|Overall Study|Suicidal or assaultive behavior|2|||
157195427|NCT04738123|567457487|FG000|Overall Study|Protocol Violation|2|||
157195428|NCT04738123|567457488|FG001|Overall Study|Protocol Violation|2|||
157195429|NCT04738123|567457487|FG000|Overall Study|Consent Withdrawn|35|||
157195430|NCT04738123|567457488|FG001|Overall Study|Consent Withdrawn|22|||
157195431|NCT00779506|567457489|FG000|Overall Study|Screening Failed|2|||
157195432|NCT00779506|567457489|FG000|Overall Study|Adverse Event|4|||
157195433|NCT00779506|567457489|FG000|Overall Study|Lack of Efficacy|11|||
157195434|NCT00779506|567457489|FG000|Overall Study|Protocol Violation|5|||
157195435|NCT00779506|567457489|FG000|Overall Study|Withdrawal by Subject|6|||
157195436|NCT00779506|567457489|FG000|Overall Study|Lost to Follow-up|1|||
157195437|NCT03982069|567457490|FG000|Overall Study|Lost to Follow-up|5|||
157195438|NCT03982069|567457491|FG001|Overall Study|Lost to Follow-up|5|||
157195439|NCT03982069|567457492|FG002|Overall Study|Lost to Follow-up|3|||
157195440|NCT03982069|567457493|FG003|Overall Study|Lost to Follow-up|5|||
157195441|NCT03982069|567457490|FG000|Overall Study|Physician Decision|0|||
157195442|NCT03982069|567457491|FG001|Overall Study|Physician Decision|1|||
157195443|NCT03982069|567457492|FG002|Overall Study|Physician Decision|0|||
157195444|NCT03982069|567457493|FG003|Overall Study|Physician Decision|0|||
157195445|NCT03982069|567457490|FG000|Overall Study|Withdrawal by Subject|2|||
157195446|NCT03982069|567457491|FG001|Overall Study|Withdrawal by Subject|1|||
157195447|NCT03982069|567457492|FG002|Overall Study|Withdrawal by Subject|5|||
157195448|NCT03982069|567457493|FG003|Overall Study|Withdrawal by Subject|2|||
157195449|NCT03982069|567457490|FG000|Overall Study|Specimen loss|3|||
157195450|NCT03982069|567457491|FG001|Overall Study|Specimen loss|3|||
157195451|NCT03982069|567457492|FG002|Overall Study|Specimen loss|1|||
157195452|NCT03982069|567457493|FG003|Overall Study|Specimen loss|1|||
157195453|NCT01218477|567457494|FG000|Overall Study|Disease progression|2|||
157195454|NCT01218477|567457495|FG001|Overall Study|Disease progression|3|||
157195455|NCT01218477|567457496|FG002|Overall Study|Disease progression|6|||
157195456|NCT01218477|567457497|FG003|Overall Study|Disease progression|2|||
157195457|NCT01218477|567457494|FG000|Overall Study|Study drug toxicity|0|||
157195458|NCT01218477|567457495|FG001|Overall Study|Study drug toxicity|2|||
157195459|NCT01218477|567457496|FG002|Overall Study|Study drug toxicity|5|||
157195460|NCT01218477|567457497|FG003|Overall Study|Study drug toxicity|0|||
157195461|NCT01218477|567457494|FG000|Overall Study|No longer meets study criteria|1|||
157195462|NCT01218477|567457495|FG001|Overall Study|No longer meets study criteria|0|||
157195463|NCT01218477|567457496|FG002|Overall Study|No longer meets study criteria|0|||
157195464|NCT01218477|567457497|FG003|Overall Study|No longer meets study criteria|0|||
157195465|NCT01218477|567457494|FG000|Overall Study|Withdrawal by Subject|0|||
157195466|NCT01218477|567457495|FG001|Overall Study|Withdrawal by Subject|0|||
157195467|NCT01218477|567457496|FG002|Overall Study|Withdrawal by Subject|1|||
157195468|NCT01218477|567457497|FG003|Overall Study|Withdrawal by Subject|0|||
157085339|NCT00055601|567066843|FG000|Overall Study|No protocol treatment received|1|||
157085340|NCT00055601|567066844|FG001|Overall Study|No protocol treatment received|1|||
157085341|NCT02217332|567066845|FG000|Overall Study|Adverse Event|3|||
157085342|NCT02217332|567066845|FG000|Overall Study|Dose interruption >1 month|1|||
157085343|NCT02217332|567066845|FG000|Overall Study|Protocol Violation (eligibility)|1|||
157195469|NCT01218477|567457494|FG000|Overall Study|Prepared for cell transplantation|0|||
157195470|NCT01218477|567457495|FG001|Overall Study|Prepared for cell transplantation|1|||
157195471|NCT01218477|567457496|FG002|Overall Study|Prepared for cell transplantation|1|||
157195472|NCT01218477|567457497|FG003|Overall Study|Prepared for cell transplantation|0|||
157195473|NCT01218477|567457494|FG000|Overall Study|Administrative reason by sponsor|0|||
157195474|NCT01218477|567457495|FG001|Overall Study|Administrative reason by sponsor|0|||
157195475|NCT01218477|567457496|FG002|Overall Study|Administrative reason by sponsor|1|||
157235449|NCT02294604|567610028|FG002|Overall Study|Did not provide samples for culture|0|||
157235450|NCT02294604|567610026|FG000|Overall Study|Culture contamination|1|||
157235451|NCT02294604|567610027|FG001|Overall Study|Culture contamination|2|||
157235452|NCT02294604|567610028|FG002|Overall Study|Culture contamination|0|||
157235453|NCT01417078|567610043|FG000|Overall Study|Withdrawal by Subject|1|||
157235454|NCT02392000|567610046|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
157235455|NCT02392000|567610046|FG000|Overall Study|Withdrawal by Subject|1|||
157235456|NCT02392000|567610046|FG000|Overall Study|Lost to Follow-up|8|||
157235457|NCT00858845|567610052|FG000|Overall Study|Patient underwent heart transplant.|0|||
157235458|NCT00858845|567610053|FG001|Overall Study|Patient underwent heart transplant.|1|||
157235459|NCT02100228|567610054|FG000|Overall Study|Other|19|||
157235460|NCT02100228|567610055|FG001|Overall Study|Other|19|||
157235461|NCT02100228|567610054|FG000|Overall Study|Administrative reason|0|||
157235462|NCT02100228|567610055|FG001|Overall Study|Administrative reason|1|||
157235463|NCT02100228|567610054|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
157235464|NCT02100228|567610055|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
157235465|NCT02100228|567610054|FG000|Overall Study|Non-compliance|0|||
157235466|NCT02100228|567610055|FG001|Overall Study|Non-compliance|3|||
157235467|NCT02100228|567610054|FG000|Overall Study|Lost to Follow-up|0|||
157235468|NCT02100228|567610055|FG001|Overall Study|Lost to Follow-up|1|||
157235469|NCT02100228|567610054|FG000|Overall Study|Withdrawal by Subject|27|||
157235470|NCT02100228|567610055|FG001|Overall Study|Withdrawal by Subject|37|||
157235471|NCT02100228|567610054|FG000|Overall Study|Adverse Event|16|||
157235472|NCT02100228|567610055|FG001|Overall Study|Adverse Event|12|||
157235473|NCT02100228|567610054|FG000|Overall Study|Death|1|||
157235474|NCT02100228|567610055|FG001|Overall Study|Death|1|||
157235475|NCT00214422|567610056|FG000|Overall Study|Physician Decision|2|||
157235476|NCT00214422|567610057|FG001|Overall Study|Physician Decision|0|||
157235477|NCT00214422|567610058|FG002|Overall Study|Physician Decision|0|||
157235478|NCT00214422|567610056|FG000|Overall Study|Developed esophageal ca|1|||
157235479|NCT00214422|567610057|FG001|Overall Study|Developed esophageal ca|0|||
157235480|NCT00214422|567610058|FG002|Overall Study|Developed esophageal ca|0|||
157235481|NCT00214422|567610056|FG000|Overall Study|Pt taken off study|1|||
157235482|NCT00214422|567610057|FG001|Overall Study|Pt taken off study|1|||
157235483|NCT00214422|567610058|FG002|Overall Study|Pt taken off study|0|||
157235484|NCT00214422|567610056|FG000|Overall Study|Disease progression on study|1|||
157235485|NCT00214422|567610057|FG001|Overall Study|Disease progression on study|0|||
157235486|NCT00214422|567610058|FG002|Overall Study|Disease progression on study|0|||
157235487|NCT00214422|567610056|FG000|Overall Study|Unable to make a radiation treatment|0|||
157235488|NCT00214422|567610057|FG001|Overall Study|Unable to make a radiation treatment|0|||
157235489|NCT00214422|567610058|FG002|Overall Study|Unable to make a radiation treatment|1|||
157235490|NCT00389064|567610059|FG000|Overall Study|Adverse Event|11|||
157235491|NCT00389064|567610060|FG001|Overall Study|Adverse Event|3|||
157235492|NCT00389064|567610059|FG000|Overall Study|Lack of Efficacy|3|||
157235493|NCT00389064|567610060|FG001|Overall Study|Lack of Efficacy|14|||
157235494|NCT00389064|567610059|FG000|Overall Study|Withdrawal by Subject|17|||
157235495|NCT00389064|567610060|FG001|Overall Study|Withdrawal by Subject|27|||
157235496|NCT00389064|567610059|FG000|Overall Study|Physician Decision|2|||
157235497|NCT00389064|567610060|FG001|Overall Study|Physician Decision|2|||
157235498|NCT00389064|567610059|FG000|Overall Study|Lost to Follow-up|1|||
157235499|NCT00389064|567610060|FG001|Overall Study|Lost to Follow-up|2|||
157235500|NCT00389064|567610059|FG000|Overall Study|Protocol Violation|2|||
157235501|NCT00389064|567610060|FG001|Overall Study|Protocol Violation|0|||
157235502|NCT00389064|567610059|FG000|Overall Study|Multiple Reasons|9|||
157235503|NCT00389064|567610060|FG001|Overall Study|Multiple Reasons|11|||
157085344|NCT02217332|567066845|FG000|Overall Study|Withdrawal by Subject|1|||
157085345|NCT02217332|567066845|FG000|Overall Study|Lost to Follow-up|1|||
157085346|NCT03573583|567066848|FG000|Overall Study|Lost to Follow-up|1|||
157235504|NCT05472038|567611586|FG000|Overall Study|Adverse Event|0|||
157235505|NCT05472038|567611587|FG001|Overall Study|Adverse Event|0|||
157235506|NCT05472038|567611588|FG002|Overall Study|Adverse Event|1|||
157235507|NCT05472038|567611589|FG003|Overall Study|Adverse Event|0|||
157235508|NCT05472038|567611590|FG004|Overall Study|Adverse Event|0|||
157085347|NCT03573583|567066849|FG001|Overall Study|Lost to Follow-up|0|||
157085348|NCT03573583|567066848|FG000|Overall Study|Withdrawal by Subject|1|||
157235509|NCT05472038|567611591|FG005|Overall Study|Adverse Event|0|||
157235510|NCT05472038|567611592|FG006|Overall Study|Adverse Event|0|||
157235511|NCT05472038|567611593|FG007|Overall Study|Adverse Event|0|||
157235512|NCT05472038|567611594|FG008|Overall Study|Adverse Event|0|||
157235513|NCT05472038|567611595|FG009|Overall Study|Adverse Event|0|||
157235514|NCT05472038|567611596|FG010|Overall Study|Adverse Event|0|||
157235515|NCT05472038|567611597|FG011|Overall Study|Adverse Event|0|||
157085349|NCT03573583|567066849|FG001|Overall Study|Withdrawal by Subject|1|||
157085350|NCT01227577|567066859|FG000|Overall Study|Protocol deviation|3|||
157235516|NCT05472038|567611586|FG000|Overall Study|Death|0|||
157235517|NCT05472038|567611587|FG001|Overall Study|Death|0|||
157235518|NCT05472038|567611588|FG002|Overall Study|Death|0|||
157235519|NCT05472038|567611589|FG003|Overall Study|Death|0|||
157235520|NCT05472038|567611590|FG004|Overall Study|Death|0|||
157235521|NCT05472038|567611591|FG005|Overall Study|Death|1|||
157235522|NCT05472038|567611592|FG006|Overall Study|Death|0|||
157235523|NCT05472038|567611593|FG007|Overall Study|Death|0|||
157235524|NCT05472038|567611594|FG008|Overall Study|Death|0|||
157235525|NCT05472038|567611595|FG009|Overall Study|Death|0|||
157235526|NCT05472038|567611596|FG010|Overall Study|Death|0|||
157235527|NCT05472038|567611597|FG011|Overall Study|Death|0|||
157235528|NCT05472038|567611586|FG000|Overall Study|Lost to Follow-up|1|||
157235529|NCT05472038|567611587|FG001|Overall Study|Lost to Follow-up|3|||
157235530|NCT05472038|567611588|FG002|Overall Study|Lost to Follow-up|3|||
157235531|NCT05472038|567611589|FG003|Overall Study|Lost to Follow-up|9|||
157235532|NCT05472038|567611590|FG004|Overall Study|Lost to Follow-up|2|||
157235533|NCT05472038|567611591|FG005|Overall Study|Lost to Follow-up|2|||
157235534|NCT05472038|567611592|FG006|Overall Study|Lost to Follow-up|1|||
157235535|NCT05472038|567611593|FG007|Overall Study|Lost to Follow-up|0|||
157235536|NCT05472038|567611594|FG008|Overall Study|Lost to Follow-up|1|||
157235537|NCT05472038|567611595|FG009|Overall Study|Lost to Follow-up|0|||
157235538|NCT05472038|567611596|FG010|Overall Study|Lost to Follow-up|2|||
157235539|NCT05472038|567611597|FG011|Overall Study|Lost to Follow-up|1|||
157235540|NCT05472038|567611586|FG000|Overall Study|Physician Decision|0|||
157235541|NCT05472038|567611587|FG001|Overall Study|Physician Decision|0|||
157235542|NCT05472038|567611588|FG002|Overall Study|Physician Decision|0|||
157235543|NCT05472038|567611589|FG003|Overall Study|Physician Decision|0|||
157235544|NCT05472038|567611590|FG004|Overall Study|Physician Decision|1|||
157235545|NCT05472038|567611591|FG005|Overall Study|Physician Decision|0|||
157235546|NCT05472038|567611592|FG006|Overall Study|Physician Decision|0|||
157235547|NCT05472038|567611593|FG007|Overall Study|Physician Decision|0|||
157235548|NCT05472038|567611594|FG008|Overall Study|Physician Decision|0|||
157235549|NCT05472038|567611595|FG009|Overall Study|Physician Decision|0|||
157235550|NCT05472038|567611596|FG010|Overall Study|Physician Decision|0|||
157235551|NCT05472038|567611597|FG011|Overall Study|Physician Decision|0|||
157235552|NCT05472038|567611586|FG000|Overall Study|Withdrawal by Subject|1|||
157235553|NCT05472038|567611587|FG001|Overall Study|Withdrawal by Subject|3|||
157235554|NCT05472038|567611588|FG002|Overall Study|Withdrawal by Subject|1|||
157235555|NCT05472038|567611589|FG003|Overall Study|Withdrawal by Subject|6|||
157235556|NCT05472038|567611590|FG004|Overall Study|Withdrawal by Subject|1|||
157235557|NCT05472038|567611591|FG005|Overall Study|Withdrawal by Subject|3|||
157235558|NCT05472038|567611592|FG006|Overall Study|Withdrawal by Subject|0|||
157235559|NCT05472038|567611593|FG007|Overall Study|Withdrawal by Subject|2|||
157235560|NCT05472038|567611594|FG008|Overall Study|Withdrawal by Subject|3|||
157235561|NCT05472038|567611595|FG009|Overall Study|Withdrawal by Subject|1|||
157235562|NCT05472038|567611596|FG010|Overall Study|Withdrawal by Subject|2|||
157235563|NCT05472038|567611597|FG011|Overall Study|Withdrawal by Subject|2|||
157235564|NCT05472038|567611586|FG000|Overall Study|Protocol Violation|0|||
157235565|NCT05472038|567611587|FG001|Overall Study|Protocol Violation|0|||
157235566|NCT05472038|567611588|FG002|Overall Study|Protocol Violation|0|||
157235567|NCT05472038|567611589|FG003|Overall Study|Protocol Violation|0|||
157235568|NCT05472038|567611590|FG004|Overall Study|Protocol Violation|0|||
157235569|NCT05472038|567611591|FG005|Overall Study|Protocol Violation|0|||
157235570|NCT05472038|567611592|FG006|Overall Study|Protocol Violation|0|||
157235571|NCT05472038|567611593|FG007|Overall Study|Protocol Violation|1|||
157235572|NCT05472038|567611594|FG008|Overall Study|Protocol Violation|1|||
157235573|NCT05472038|567611595|FG009|Overall Study|Protocol Violation|1|||
157085351|NCT01227577|567066859|FG000|Overall Study|Death|3|||
157085352|NCT01227577|567066859|FG000|Overall Study|Administrative problems|2|||
157085353|NCT01227577|567066859|FG000|Overall Study|Lost to Follow-up|1|||
157235574|NCT05472038|567611596|FG010|Overall Study|Protocol Violation|1|||
157235575|NCT05472038|567611597|FG011|Overall Study|Protocol Violation|1|||
157235576|NCT05472038|567611586|FG000|Overall Study|Not vaccinated|0|||
157235577|NCT05472038|567611587|FG001|Overall Study|Not vaccinated|0|||
157235578|NCT05472038|567611588|FG002|Overall Study|Not vaccinated|0|||
157235579|NCT05472038|567611589|FG003|Overall Study|Not vaccinated|1|||
157235580|NCT05472038|567611590|FG004|Overall Study|Not vaccinated|0|||
157235581|NCT05472038|567611591|FG005|Overall Study|Not vaccinated|0|||
157235582|NCT05472038|567611592|FG006|Overall Study|Not vaccinated|0|||
157235583|NCT05472038|567611593|FG007|Overall Study|Not vaccinated|0|||
157235584|NCT05472038|567611594|FG008|Overall Study|Not vaccinated|0|||
157235585|NCT05472038|567611595|FG009|Overall Study|Not vaccinated|0|||
157235586|NCT05472038|567611596|FG010|Overall Study|Not vaccinated|0|||
157235587|NCT05472038|567611597|FG011|Overall Study|Not vaccinated|0|||
157085354|NCT01227577|567066859|FG000|Overall Study|Withdrawal by Subject|4|||
157235588|NCT02378935|567611600|FG000|Overall Study|Lack of Efficacy|10|||
157235589|NCT02378935|567611601|FG001|Overall Study|Lack of Efficacy|0|||
157235590|NCT02378935|567611602|FG002|Overall Study|Lack of Efficacy|2|||
157235591|NCT02378935|567611603|FG003|Overall Study|Lack of Efficacy|6|||
157235592|NCT02378935|567611604|FG004|Overall Study|Lack of Efficacy|0|||
157235593|NCT02378935|567611605|FG005|Overall Study|Lack of Efficacy|0|||
157235594|NCT02378935|567611606|FG006|Overall Study|Lack of Efficacy|0|||
157235595|NCT02378935|567611600|FG000|Overall Study|Death|0|||
157235596|NCT02378935|567611601|FG001|Overall Study|Death|0|||
157235597|NCT02378935|567611602|FG002|Overall Study|Death|1|||
157235598|NCT02378935|567611603|FG003|Overall Study|Death|0|||
157235599|NCT02378935|567611604|FG004|Overall Study|Death|0|||
157235600|NCT02378935|567611605|FG005|Overall Study|Death|0|||
157235601|NCT02378935|567611606|FG006|Overall Study|Death|0|||
157235602|NCT03214952|567611613|FG000|Overall Study|Protocol Deviation|45|||
157235603|NCT03214952|567611613|FG000|Overall Study|Case Report Forms Uncollected|13|||
157235604|NCT03935880|567611614|FG000|Overall Study|Lost to Follow-up|0|||
157235605|NCT03935880|567611615|FG001|Overall Study|Lost to Follow-up|1|||
157235606|NCT02476994|567611616|FG000|Overall Study|Based on feedback from FDA|1|||
157235607|NCT02476994|567611617|FG001|Overall Study|Based on feedback from FDA|0|||
157235608|NCT02246166|567611618|FG000|Overall Study|Protocol Violation|1|||
157235609|NCT02246166|567611619|FG001|Overall Study|Protocol Violation|0|||
157235610|NCT02563561|567611620|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
157235611|NCT02563561|567611621|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
157235612|NCT02563561|567611622|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
157235613|NCT02563561|567611620|FG000|Overall Study|Withdrew of Consent|1|||
157235614|NCT02563561|567611621|FG001|Overall Study|Withdrew of Consent|1|||
157235615|NCT02563561|567611622|FG002|Overall Study|Withdrew of Consent|2|||
157235616|NCT02563561|567611620|FG000|Overall Study|Lost to Follow-up|1|||
157235617|NCT02563561|567611621|FG001|Overall Study|Lost to Follow-up|1|||
157235618|NCT02563561|567611622|FG002|Overall Study|Lost to Follow-up|0|||
157235619|NCT02563561|567611620|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
157235620|NCT02563561|567611621|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
157235621|NCT02563561|567611622|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
157235622|NCT02563561|567611620|FG000|Overall Study|Investigator Decision|3|||
157235623|NCT02563561|567611621|FG001|Overall Study|Investigator Decision|4|||
157235624|NCT02563561|567611622|FG002|Overall Study|Investigator Decision|2|||
157235625|NCT02563561|567611620|FG000|Overall Study|Sponsor Decision|5|||
157235626|NCT02563561|567611621|FG001|Overall Study|Sponsor Decision|2|||
157235627|NCT02563561|567611622|FG002|Overall Study|Sponsor Decision|4|||
157235628|NCT02563561|567611620|FG000|Overall Study|Other|1|||
157235629|NCT02563561|567611621|FG001|Overall Study|Other|5|||
157235630|NCT02563561|567611622|FG002|Overall Study|Other|2|||
157235631|NCT03769896|567611623|FG000|Open-label Phase|Lack of Efficacy|5|||
157235632|NCT03769896|567611624|FG001|Open-label Phase|Lack of Efficacy|0|||
157235633|NCT03769896|567611623|FG000|Open-label Phase|Adverse Event|3|||
157235634|NCT03769896|567611624|FG001|Open-label Phase|Adverse Event|0|||
157235635|NCT03769896|567611623|FG000|Open-label Phase|Withdrawal by Subject|1|||
157235636|NCT03769896|567611624|FG001|Open-label Phase|Withdrawal by Subject|0|||
157235637|NCT01015703|567611625|FG000|Overall Study|Withdrawal by Subject|0|||
157235638|NCT01015703|567611626|FG001|Overall Study|Withdrawal by Subject|1|||
157235639|NCT01015703|567611627|FG002|Overall Study|Withdrawal by Subject|0|||
157235640|NCT01015703|567611628|FG003|Overall Study|Withdrawal by Subject|0|||
157235641|NCT01015703|567611629|FG004|Overall Study|Withdrawal by Subject|0|||
157235642|NCT01015703|567611625|FG000|Overall Study|Adverse Event|1|||
157235643|NCT01015703|567611626|FG001|Overall Study|Adverse Event|0|||
157235644|NCT01015703|567611627|FG002|Overall Study|Adverse Event|0|||
157235645|NCT01015703|567611628|FG003|Overall Study|Adverse Event|0|||
157235646|NCT01015703|567611629|FG004|Overall Study|Adverse Event|0|||
157235647|NCT01015703|567611625|FG000|Overall Study|Protocol Violation|1|||
157235648|NCT01015703|567611626|FG001|Overall Study|Protocol Violation|0|||
157235649|NCT01015703|567611627|FG002|Overall Study|Protocol Violation|0|||
157235650|NCT01015703|567611628|FG003|Overall Study|Protocol Violation|0|||
157085355|NCT01227577|567066859|FG000|Overall Study|Lack of Efficacy|5|||
157085356|NCT01227577|567066859|FG000|Overall Study|Adverse Event|17|||
157085357|NCT03809429|567066860|FG000|Overall Study|Withdrawal by Subject|7|||
157085358|NCT03809429|567066861|FG001|Overall Study|Withdrawal by Subject|3|||
157235651|NCT01015703|567611629|FG004|Overall Study|Protocol Violation|0|||
157235652|NCT03122535|567611630|FG000|Overall Study|Lost to Follow-up|68|||
157235653|NCT03122535|567611631|FG001|Overall Study|Lost to Follow-up|68|||
157235654|NCT03122535|567611630|FG000|Overall Study|Physician Decision|3|||
157235655|NCT03122535|567611631|FG001|Overall Study|Physician Decision|3|||
157235656|NCT03122535|567611630|FG000|Overall Study|Withdrawal by Subject|2|||
157235657|NCT03122535|567611631|FG001|Overall Study|Withdrawal by Subject|2|||
157085359|NCT03809429|567066860|FG000|Overall Study|Adverse Event|6|||
157085360|NCT03809429|567066861|FG001|Overall Study|Adverse Event|9|||
157235658|NCT02646124|567611632|FG000|Overall Study|Lost to Follow-up|0|||
157235659|NCT02646124|567611633|FG001|Overall Study|Lost to Follow-up|2|||
157235660|NCT02865850|567611636|FG000|Overall Study|Death|15|||
157235661|NCT02865850|567611637|FG001|Overall Study|Death|19|||
157235662|NCT02865850|567611636|FG000|Overall Study|Withdrawal by Subject|3|||
157235663|NCT02865850|567611637|FG001|Overall Study|Withdrawal by Subject|2|||
157235664|NCT02865850|567611636|FG000|Overall Study|Lost to Follow-up|3|||
157085361|NCT03809429|567066860|FG000|Overall Study|COVID-19|3|||
157235665|NCT02865850|567611637|FG001|Overall Study|Lost to Follow-up|2|||
157235666|NCT00467363|567611638|FG000|Overall Study|Lost to Follow-up|80|||
157235667|NCT00467363|567611639|FG001|Overall Study|Lost to Follow-up|70|||
157235668|NCT04533594|567611640|FG000|Overall Study|Death|26|||
157235669|NCT02017223|567611641|FG000|Overall Study|Algorithm problems|2|||
157235670|NCT01401647|567611642|FG000|Overall Study|Withdrawal by Subject|1|||
157235671|NCT01401647|567611643|FG001|Overall Study|Withdrawal by Subject|5|||
157235672|NCT01401647|567611644|FG002|Overall Study|Withdrawal by Subject|2|||
157235673|NCT01401647|567611642|FG000|Overall Study|Lost to Follow-up|3|||
157235674|NCT01401647|567611643|FG001|Overall Study|Lost to Follow-up|3|||
157235675|NCT01401647|567611644|FG002|Overall Study|Lost to Follow-up|1|||
157235676|NCT01675765|567611645|FG000|Overall Study|Progressive disease|4|||
157085362|NCT03809429|567066861|FG001|Overall Study|COVID-19|1|||
157085363|NCT03809429|567066860|FG000|Overall Study|Participant was discontinued by investigator|12|||
157085364|NCT03809429|567066861|FG001|Overall Study|Participant was discontinued by investigator|7|||
157085365|NCT01119105|567066862|FG000|Overall Study|Withdrawal by Subject|1|||
157235677|NCT01675765|567611646|FG001|Overall Study|Progressive disease|4|||
157235678|NCT01675765|567611645|FG000|Overall Study|Adverse Event|1|||
157085366|NCT01119105|567066863|FG001|Overall Study|Withdrawal by Subject|1|||
157085367|NCT01119105|567066864|FG002|Overall Study|Withdrawal by Subject|1|||
157085368|NCT01119105|567066862|FG000|Overall Study|Lost to Follow-up|0|||
157085369|NCT01119105|567066863|FG001|Overall Study|Lost to Follow-up|2|||
157085370|NCT01119105|567066864|FG002|Overall Study|Lost to Follow-up|5|||
157085371|NCT01119105|567066862|FG000|Overall Study|Adverse Event|1|||
157085372|NCT01119105|567066863|FG001|Overall Study|Adverse Event|0|||
157085373|NCT01119105|567066864|FG002|Overall Study|Adverse Event|1|||
157085374|NCT01119105|567066862|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
157085375|NCT01119105|567066863|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
157085376|NCT01119105|567066864|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
157085377|NCT01119105|567066862|FG000|Overall Study|Other|1|||
157085378|NCT01119105|567066863|FG001|Overall Study|Other|1|||
157085379|NCT01119105|567066864|FG002|Overall Study|Other|0|||
157085380|NCT01639495|567066865|FG000|Overall Study|Lost to Follow-up|6|||
157085381|NCT01639495|567066865|FG000|Overall Study|Consented but didn't have study catheter|4|||
157085382|NCT01639495|567066865|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
157085383|NCT01639495|567066865|FG000|Overall Study|No radiofrequency energy applied|2|||
157085384|NCT01658150|567066866|FG000|Overall Study|Withdrawal by Subject|1|||
157085385|NCT04187989|567066867|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
157085386|NCT04187989|567066868|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
157085387|NCT04187989|567066867|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
157085388|NCT04187989|567066868|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
157085389|NCT02245737|567066869|FG000|Overall Study|Adverse Event|23|||
157085390|NCT02245737|567066870|FG001|Overall Study|Adverse Event|26|||
157085391|NCT02245737|567066871|FG002|Overall Study|Adverse Event|33|||
157085392|NCT02245737|567066869|FG000|Overall Study|Condition Worsened|9|||
157085393|NCT02245737|567066870|FG001|Overall Study|Condition Worsened|10|||
157085394|NCT02245737|567066871|FG002|Overall Study|Condition Worsened|9|||
157085395|NCT02245737|567066869|FG000|Overall Study|Death|2|||
157085396|NCT02245737|567066870|FG001|Overall Study|Death|4|||
157085397|NCT02245737|567066871|FG002|Overall Study|Death|4|||
157085398|NCT02245737|567066869|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
157085399|NCT02245737|567066870|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
157085400|NCT02245737|567066871|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
157085401|NCT02245737|567066869|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
157085402|NCT02245737|567066870|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
157085403|NCT02245737|567066871|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
157085404|NCT02245737|567066869|FG000|Overall Study|Lost to Follow-up|2|||
157085405|NCT02245737|567066870|FG001|Overall Study|Lost to Follow-up|5|||
157085406|NCT02245737|567066871|FG002|Overall Study|Lost to Follow-up|4|||
157085407|NCT02245737|567066869|FG000|Overall Study|Other-determined by Investigator|9|||
157085408|NCT02245737|567066870|FG001|Overall Study|Other-determined by Investigator|10|||
157085409|NCT02245737|567066871|FG002|Overall Study|Other-determined by Investigator|10|||
157085410|NCT02245737|567066869|FG000|Overall Study|Physician Decision|6|||
157085411|NCT02245737|567066870|FG001|Overall Study|Physician Decision|3|||
157085412|NCT02245737|567066871|FG002|Overall Study|Physician Decision|6|||
157085413|NCT02245737|567066869|FG000|Overall Study|Protocol Violation|3|||
157085414|NCT02245737|567066870|FG001|Overall Study|Protocol Violation|2|||
157085415|NCT02245737|567066871|FG002|Overall Study|Protocol Violation|3|||
157085416|NCT02245737|567066869|FG000|Overall Study|Withdrawal by Subject|40|||
157085417|NCT02245737|567066870|FG001|Overall Study|Withdrawal by Subject|41|||
157085418|NCT02245737|567066871|FG002|Overall Study|Withdrawal by Subject|44|||
157085419|NCT02245737|567066869|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
157085420|NCT02245737|567066870|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
157085421|NCT02245737|567066871|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
157085422|NCT02245737|567066869|FG000|Overall Study|Sponsor Decision|445|||
157085423|NCT02245737|567066870|FG001|Overall Study|Sponsor Decision|430|||
157085424|NCT02245737|567066871|FG002|Overall Study|Sponsor Decision|432|||
157085425|NCT02366468|567066876|FG000|Overall Study|Adverse Event|2|||
157235679|NCT01675765|567611646|FG001|Overall Study|Adverse Event|2|||
157235680|NCT01675765|567611645|FG000|Overall Study|Withdrawal by Subject|2|||
157235681|NCT01675765|567611646|FG001|Overall Study|Withdrawal by Subject|0|||
157235682|NCT01675765|567611645|FG000|Overall Study|Death|1|||
157235683|NCT01675765|567611646|FG001|Overall Study|Death|0|||
157235684|NCT01675765|567611645|FG000|Overall Study|Clinical progression|3|||
157235685|NCT01675765|567611646|FG001|Overall Study|Clinical progression|2|||
157235686|NCT02057458|567611656|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
157235687|NCT02057458|567611657|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
157235688|NCT02057458|567611658|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
157235689|NCT02057458|567611656|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
157235690|NCT02057458|567611657|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
157235691|NCT02057458|567611658|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
157235692|NCT02057458|567611656|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
157235693|NCT02057458|567611657|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
157235694|NCT02057458|567611658|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
157235695|NCT04263649|567611659|FG000|Overall Study|Adverse Event|53|||
157235696|NCT04263649|567611659|FG000|Overall Study|Lost to Follow-up|3|||
157235697|NCT04263649|567611659|FG000|Overall Study|Death|29|||
157235698|NCT04263649|567611659|FG000|Overall Study|Device deficiency|19|||
157235699|NCT04263649|567611659|FG000|Overall Study|other reasons|11|||
157235700|NCT05169710|567611661|FG000|Overall Study|Adverse Event|1|||
157235701|NCT05169710|567611662|FG001|Overall Study|Adverse Event|2|||
157235702|NCT05169710|567611663|FG002|Overall Study|Adverse Event|2|||
157235703|NCT05169710|567611661|FG000|Overall Study|Lost to Follow-up|0|||
157235704|NCT05169710|567611662|FG001|Overall Study|Lost to Follow-up|0|||
157235705|NCT05169710|567611663|FG002|Overall Study|Lost to Follow-up|1|||
157235706|NCT05169710|567611661|FG000|Overall Study|Withdrawal by Subject|2|||
157235707|NCT05169710|567611662|FG001|Overall Study|Withdrawal by Subject|1|||
157235708|NCT05169710|567611663|FG002|Overall Study|Withdrawal by Subject|0|||
157235709|NCT05169710|567611661|FG000|Overall Study|Other Study Discontinuation Reason|0|||
157235710|NCT05169710|567611662|FG001|Overall Study|Other Study Discontinuation Reason|2|||
157235711|NCT05169710|567611663|FG002|Overall Study|Other Study Discontinuation Reason|0|||
157235712|NCT00836056|567611671|FG000|First Intervention|Adverse Event|1|||
157235713|NCT00836056|567611672|FG001|First Intervention|Adverse Event|0|||
157235714|NCT00846495|567611676|FG000|Overall Study|Lost to Follow-up|1|||
157235715|NCT00846495|567611677|FG001|Overall Study|Lost to Follow-up|0|||
157235716|NCT00846495|567611676|FG000|Overall Study|Adverse Event|5|||
157235717|NCT00846495|567611677|FG001|Overall Study|Adverse Event|1|||
157235718|NCT00846495|567611676|FG000|Overall Study|Lack of Efficacy|1|||
157235719|NCT00846495|567611677|FG001|Overall Study|Lack of Efficacy|2|||
157235720|NCT00846495|567611676|FG000|Overall Study|Physician Decision|1|||
157235721|NCT00846495|567611677|FG001|Overall Study|Physician Decision|0|||
157235722|NCT01079988|567611678|FG000|Overall Study|Lost to Follow-up|0|||
157235723|NCT01079988|567611679|FG001|Overall Study|Lost to Follow-up|0|||
157235724|NCT01079988|567611680|FG002|Overall Study|Lost to Follow-up|0|||
157235725|NCT01079988|567611681|FG003|Overall Study|Lost to Follow-up|1|||
157235726|NCT01079988|567611682|FG004|Overall Study|Lost to Follow-up|0|||
157235727|NCT01079988|567611678|FG000|Overall Study|Lack of Efficacy|1|||
157235728|NCT01079988|567611679|FG001|Overall Study|Lack of Efficacy|0|||
157235729|NCT01079988|567611680|FG002|Overall Study|Lack of Efficacy|0|||
157235730|NCT01079988|567611681|FG003|Overall Study|Lack of Efficacy|0|||
157235731|NCT01079988|567611682|FG004|Overall Study|Lack of Efficacy|0|||
157235732|NCT01079988|567611678|FG000|Overall Study|Other|0|||
157235733|NCT01079988|567611679|FG001|Overall Study|Other|0|||
157235734|NCT01079988|567611680|FG002|Overall Study|Other|0|||
157235735|NCT01079988|567611681|FG003|Overall Study|Other|2|||
157235736|NCT01079988|567611682|FG004|Overall Study|Other|1|||
157235737|NCT03546842|567611683|FG000|Overall Study|Protocol Violation|1|||
157235738|NCT03546842|567611683|FG000|Overall Study|Withdrawal by Subject|2|||
157235739|NCT01265056|567611685|FG000|Initial Study Period|Withdrawal by Subject|1|||
157085426|NCT02366468|567066877|FG001|Overall Study|Adverse Event|0|||
157085427|NCT02366468|567066876|FG000|Overall Study|Withdrawal by Subject|1|||
157085428|NCT02366468|567066877|FG001|Overall Study|Withdrawal by Subject|5|||
157085429|NCT02366468|567066876|FG000|Overall Study|Lost to Follow-up|2|||
157085430|NCT02366468|567066877|FG001|Overall Study|Lost to Follow-up|0|||
157085431|NCT02366468|567066876|FG000|Overall Study|Death|1|||
157235740|NCT01265056|567611686|FG001|Initial Study Period|Withdrawal by Subject|1|||
157235741|NCT01265056|567611685|FG000|Initial Study Period|Withdrawal by Subject|1|||
157235742|NCT01265056|567611686|FG001|Initial Study Period|Withdrawal by Subject|1|||
157235743|NCT01265056|567611685|FG000|Follow up|Lost to Follow-up|7|||
157235744|NCT01265056|567611686|FG001|Follow up|Lost to Follow-up|3|||
157235745|NCT02711852|567611687|FG000|Overall Study|Death|5|||
157235746|NCT02711852|567611687|FG000|Overall Study|Lost to Follow-up|1|||
157085432|NCT02366468|567066877|FG001|Overall Study|Death|2|||
157235747|NCT02711852|567611687|FG000|Overall Study|Completed follow-up|3|||
157235748|NCT02711852|567611687|FG000|Overall Study|Withdrawal by Subject|1|||
157235749|NCT03459807|567611691|FG000|Overall Study|Withdrawal due to transplant|0|||
157235750|NCT03459807|567611692|FG001|Overall Study|Withdrawal due to transplant|1|||
157235751|NCT00576056|567611693|FG000|Overall Study|Adverse Event|1|||
157235752|NCT00576056|567611693|FG000|Overall Study|Death|1|||
157235753|NCT00576056|567611693|FG000|Overall Study|Lack of Efficacy|1|||
157235754|NCT00576056|567611693|FG000|Overall Study|Withdrawal by Subject|2|||
157235755|NCT00576056|567611693|FG000|Overall Study|did not meet eligibility criteria|8|||
157235756|NCT00576056|567611693|FG000|Overall Study|Physician Decision|1|||
157235757|NCT03197883|567611694|FG000|Overall Study|Adverse Event|1|||
157235758|NCT03197883|567611695|FG001|Overall Study|Adverse Event|1|||
157235759|NCT03197883|567611694|FG000|Overall Study|Lost to Follow-up|1|||
157235760|NCT03197883|567611695|FG001|Overall Study|Lost to Follow-up|0|||
157235761|NCT03197883|567611694|FG000|Overall Study|Protocol Violation|1|||
157235762|NCT03197883|567611695|FG001|Overall Study|Protocol Violation|0|||
157235763|NCT03197883|567611694|FG000|Overall Study|Other (Not Specified)|0|||
157235764|NCT03197883|567611695|FG001|Overall Study|Other (Not Specified)|5|||
157235765|NCT03031847|567611696|FG000|Overall Study|Death|1|||
157235766|NCT03031847|567611697|FG001|Overall Study|Death|1|||
157235767|NCT03031847|567611698|FG002|Overall Study|Death|2|||
157235768|NCT03031847|567611699|FG003|Overall Study|Death|3|||
157235769|NCT03031847|567611696|FG000|Overall Study|Lost to Follow-up|1|||
157235770|NCT03031847|567611697|FG001|Overall Study|Lost to Follow-up|1|||
157235771|NCT03031847|567611698|FG002|Overall Study|Lost to Follow-up|2|||
157235772|NCT03031847|567611699|FG003|Overall Study|Lost to Follow-up|3|||
157195476|NCT01218477|567457497|FG003|Overall Study|Administrative reason by sponsor|0|||
157195477|NCT01218477|567457494|FG000|Overall Study|Maximum clinical benefit|0|||
157195478|NCT01218477|567457495|FG001|Overall Study|Maximum clinical benefit|2|||
157195479|NCT01218477|567457496|FG002|Overall Study|Maximum clinical benefit|0|||
157195480|NCT01218477|567457497|FG003|Overall Study|Maximum clinical benefit|0|||
157195481|NCT00787527|567457498|FG000|Overall Study|Toxicity|3|||
157195482|NCT03137433|567457501|FG000|Overall Study|Withdrawal by Subject|11|||
157195483|NCT03137433|567457502|FG001|Overall Study|Withdrawal by Subject|11|||
157195484|NCT03137433|567457501|FG000|Overall Study|Lost to Follow-up|5|||
157195485|NCT03137433|567457502|FG001|Overall Study|Lost to Follow-up|6|||
157195486|NCT03137433|567457501|FG000|Overall Study|Physician Decision|2|||
157195487|NCT03137433|567457502|FG001|Overall Study|Physician Decision|0|||
157195488|NCT03137433|567457501|FG000|Overall Study|Moved out of study area|1|||
157195489|NCT03137433|567457502|FG001|Overall Study|Moved out of study area|0|||
157195490|NCT03137433|567457501|FG000|Overall Study|Too far out of window due to COVID|0|||
157195491|NCT03137433|567457502|FG001|Overall Study|Too far out of window due to COVID|1|||
157195492|NCT00914940|567457503|FG000|D0 to D100 Post-transplant|Death|2|||
157195493|NCT00914940|567457503|FG000|D101 to 2 Years Post-transplant|Death|8|||
157195494|NCT00914940|567457503|FG000|2 Years to 5 Years Post-transplant|Death|3|||
157195495|NCT01853397|567457504|FG000|Overall Study|Withdrawal by Subject|0|||
157195496|NCT01853397|567457505|FG001|Overall Study|Withdrawal by Subject|0|||
157195497|NCT01853397|567457506|FG002|Overall Study|Withdrawal by Subject|0|||
157195498|NCT01853397|567457507|FG003|Overall Study|Withdrawal by Subject|1|||
157195499|NCT01853397|567457504|FG000|Overall Study|Subject Noncompliance|0|||
157195500|NCT01853397|567457505|FG001|Overall Study|Subject Noncompliance|0|||
157195501|NCT01853397|567457506|FG002|Overall Study|Subject Noncompliance|0|||
157195502|NCT01853397|567457507|FG003|Overall Study|Subject Noncompliance|1|||
157195503|NCT01724021|567457508|FG000|Overall Study|Adverse Event|11|||
157195504|NCT01724021|567457509|FG001|Overall Study|Adverse Event|6|||
157195505|NCT01724021|567457508|FG000|Overall Study|Death|46|||
157195506|NCT01724021|567457509|FG001|Overall Study|Death|58|||
157195507|NCT01724021|567457508|FG000|Overall Study|Participant request/ Withdrew consent|18|||
157195508|NCT01724021|567457509|FG001|Overall Study|Participant request/ Withdrew consent|14|||
157195509|NCT01724021|567457508|FG000|Overall Study|Lost to Follow-up|15|||
157195510|NCT01724021|567457509|FG001|Overall Study|Lost to Follow-up|15|||
157195511|NCT01724021|567457508|FG000|Overall Study|Reason Not Specified|36|||
157195512|NCT01724021|567457509|FG001|Overall Study|Reason Not Specified|39|||
157195513|NCT01724021|567457508|FG000|Overall Study|Missing|1|||
157195514|NCT01724021|567457509|FG001|Overall Study|Missing|1|||
157195515|NCT01373294|567457514|FG000|Overall Study|Adverse Event|1|||
157195516|NCT01373294|567457515|FG001|Overall Study|Adverse Event|0|||
157195517|NCT03512028|567457516|FG000|Overall Study|Withdrawal by Subject|2|||
157195518|NCT03512028|567457517|FG001|Overall Study|Withdrawal by Subject|0|||
157195519|NCT03512028|567457516|FG000|Overall Study|Protocol Violation|2|||
157195520|NCT03512028|567457517|FG001|Overall Study|Protocol Violation|0|||
157195521|NCT03529162|567457518|FG000|Overall Study|Lost to Follow-up|2|||
157195522|NCT03529162|567457519|FG001|Overall Study|Lost to Follow-up|2|||
157235773|NCT03273153|567611700|FG000|Overall Study|Adverse Event|1|||
157235774|NCT03273153|567611701|FG001|Overall Study|Adverse Event|2|||
157235775|NCT03273153|567611700|FG000|Overall Study|Missing|0|||
157235776|NCT03273153|567611701|FG001|Overall Study|Missing|2|||
157235777|NCT03273153|567611700|FG000|Overall Study|Other|3|||
157235778|NCT03273153|567611701|FG001|Overall Study|Other|2|||
157235779|NCT03273153|567611700|FG000|Overall Study|Symptomatic Deterioration|0|||
157235780|NCT03273153|567611701|FG001|Overall Study|Symptomatic Deterioration|1|||
157195523|NCT00517634|567457524|FG000|Second Treatment Period|Withdrawal by Subject|0|||
157195524|NCT00517634|567457525|FG001|Second Treatment Period|Withdrawal by Subject|0|||
157085433|NCT02366468|567066876|FG000|Overall Study|Other|0|||
157085434|NCT02366468|567066877|FG001|Overall Study|Other|2|||
157085435|NCT00446043|567066878|FG000|Overall Study|Adverse Event|9|||
157085436|NCT00446043|567066878|FG000|Overall Study|Withdrawal by Subject|70|||
157085437|NCT00446043|567066878|FG000|Overall Study|Protocol Violation|2|||
157085438|NCT00446043|567066878|FG000|Overall Study|Lost to Follow-up|42|||
157085439|NCT00446043|567066878|FG000|Overall Study|Pregnancy|2|||
157085440|NCT05540717|567066881|FG000|Overall Study|Lost to Follow-up|2|||
157085441|NCT05540717|567066882|FG001|Overall Study|Lost to Follow-up|5|||
157085442|NCT05540717|567066881|FG000|Overall Study|Withdrawal by Subject|6|||
157085443|NCT05540717|567066882|FG001|Overall Study|Withdrawal by Subject|6|||
157085444|NCT05540717|567066881|FG000|Overall Study|Sponsor request|1|||
157085445|NCT05540717|567066882|FG001|Overall Study|Sponsor request|0|||
157085446|NCT05540717|567066881|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
157085447|NCT05540717|567066882|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
157085448|NCT05540717|567066881|FG000|Overall Study|Other|0|||
157085449|NCT05540717|567066882|FG001|Overall Study|Other|1|||
157085450|NCT01631227|567066883|FG000|Overall Study|withdrawn consent|27|||
157085451|NCT01631227|567066884|FG001|Overall Study|withdrawn consent|21|||
157085452|NCT01631227|567066883|FG000|Overall Study|Adverse Event|1|||
157085453|NCT01631227|567066884|FG001|Overall Study|Adverse Event|0|||
157085454|NCT01631227|567066883|FG000|Overall Study|administrative|2|||
157085455|NCT01631227|567066884|FG001|Overall Study|administrative|1|||
157085456|NCT03292432|567066885|FG000|Overall Study|Lost to Follow-up|11|||
157085457|NCT03292432|567066886|FG001|Overall Study|Lost to Follow-up|8|||
157085458|NCT03292432|567066885|FG000|Overall Study|Death|2|||
157085459|NCT03292432|567066886|FG001|Overall Study|Death|1|||
157085460|NCT03292432|567066885|FG000|Overall Study|Withdrawal by Subject|1|||
157085461|NCT03292432|567066886|FG001|Overall Study|Withdrawal by Subject|2|||
157085462|NCT03292432|567066885|FG000|Overall Study|Site closed before any data collected|1|||
157085463|NCT03292432|567066886|FG001|Overall Study|Site closed before any data collected|0|||
157085464|NCT03020576|567066887|FG000|Overall Study|Withdrawal by Subject|1|||
157195525|NCT00517634|567457526|FG002|Second Treatment Period|Withdrawal by Subject|0|||
157195526|NCT00517634|567457527|FG003|Second Treatment Period|Withdrawal by Subject|0|||
157195527|NCT00517634|567457528|FG004|Second Treatment Period|Withdrawal by Subject|1|||
157195528|NCT00517634|567457529|FG005|Second Treatment Period|Withdrawal by Subject|0|||
157195529|NCT03143855|567457530|FG000|Overall Study|Withdrawal by Subject|4|||
157195530|NCT03143855|567457531|FG001|Overall Study|Withdrawal by Subject|3|||
157195531|NCT03143855|567457530|FG000|Overall Study|Protocol Violation|1|||
157195532|NCT03143855|567457531|FG001|Overall Study|Protocol Violation|0|||
157195533|NCT03143855|567457530|FG000|Overall Study|Participant experienced withdrawal|0|||
157195534|NCT03143855|567457531|FG001|Overall Study|Participant experienced withdrawal|1|||
157195535|NCT00701064|567457534|FG000|Overall Study|Protocol Violation|1|||
157195536|NCT00701064|567457535|FG001|Overall Study|Protocol Violation|1|||
157195537|NCT00701064|567457534|FG000|Overall Study|Withdrawal by Subject|1|||
157195538|NCT00701064|567457535|FG001|Overall Study|Withdrawal by Subject|1|||
157195539|NCT00701064|567457534|FG000|Overall Study|initiated other PTSD treatment|2|||
157195540|NCT00701064|567457535|FG001|Overall Study|initiated other PTSD treatment|2|||
157195541|NCT02098733|567457536|FG000|Overall Study|Data Not Available|5|||
157195542|NCT02098733|567457536|FG000|Overall Study|Lost to Follow-up|5|||
157195543|NCT00939094|567457537|FG000|Overall Study|Adverse Event|9|||
157195544|NCT00939094|567457538|FG001|Overall Study|Adverse Event|0|||
157195545|NCT00939094|567457537|FG000|Overall Study|Withdrawal by Subject|1|||
157195546|NCT00939094|567457538|FG001|Overall Study|Withdrawal by Subject|6|||
157195547|NCT00939094|567457537|FG000|Overall Study|Lost to Follow-up|1|||
157195548|NCT00939094|567457538|FG001|Overall Study|Lost to Follow-up|1|||
157195549|NCT00939094|567457537|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
157195550|NCT00939094|567457538|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
157195551|NCT00939094|567457537|FG000|Overall Study|Severe non-compliance to protocol|0|||
157195552|NCT00939094|567457538|FG001|Overall Study|Severe non-compliance to protocol|1|||
157195553|NCT00939094|567457537|FG000|Overall Study|Study stopped by sponsor|0|||
157195554|NCT00939094|567457538|FG001|Overall Study|Study stopped by sponsor|2|||
157195555|NCT00939094|567457537|FG000|Overall Study|Abnormal ECG findings|1|||
157195556|NCT00939094|567457538|FG001|Overall Study|Abnormal ECG findings|0|||
157085465|NCT03020576|567066888|FG001|Overall Study|Withdrawal by Subject|2|||
157085466|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
157085467|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
157085468|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
157195557|NCT01786707|567459677|FG000|Overall Study|Lost to Follow-up|1|||
157195558|NCT01786707|567459678|FG001|Overall Study|Lost to Follow-up|1|||
157085469|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
157085470|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
157085471|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
157085472|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
157195559|NCT00346775|567459679|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
157085473|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
157085474|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
157085475|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
157085476|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
157085477|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
157085478|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
157085479|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
157085480|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
157085481|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
157085482|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
157085483|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
157085484|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
157085485|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
157085486|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
157085487|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
157085488|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
157235781|NCT03273153|567611700|FG000|Overall Study|Progressive Disease|6|||
157235782|NCT03273153|567611701|FG001|Overall Study|Progressive Disease|5|||
157235783|NCT03273153|567611700|FG000|Overall Study|Physician Decision|1|||
157235784|NCT03273153|567611701|FG001|Overall Study|Physician Decision|3|||
157235785|NCT03273153|567611700|FG000|Overall Study|Study Terminated by Sponsor|112|||
157235786|NCT03273153|567611701|FG001|Overall Study|Study Terminated by Sponsor|102|||
157235787|NCT03273153|567611700|FG000|Overall Study|Withdrawal by Subject|26|||
157235788|NCT03273153|567611701|FG001|Overall Study|Withdrawal by Subject|25|||
157085489|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
157085490|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
157085491|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
157085492|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
157085493|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
157085494|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
157195560|NCT00346775|567459680|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
157195561|NCT00346775|567459679|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
157195562|NCT00346775|567459680|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
157195563|NCT00346775|567459679|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
157195564|NCT00346775|567459680|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
157195565|NCT01096017|567459681|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
157195566|NCT01096017|567459682|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
157195567|NCT01545375|567459685|FG000|Overall Study|Adverse Event|2|||
157195568|NCT01545375|567459686|FG001|Overall Study|Adverse Event|1|||
157195569|NCT01545375|567459685|FG000|Overall Study|Lost to Follow-up|34|||
157195570|NCT01545375|567459686|FG001|Overall Study|Lost to Follow-up|31|||
157195571|NCT01545375|567459685|FG000|Overall Study|Protocol Violation|3|||
157195572|NCT01545375|567459686|FG001|Overall Study|Protocol Violation|3|||
157195573|NCT01545375|567459685|FG000|Overall Study|Withdrawal by Subject|58|||
157195574|NCT01545375|567459686|FG001|Overall Study|Withdrawal by Subject|55|||
157195575|NCT00594958|567459688|FG000|Overall Study|Withdrawal by Subject|1|||
157195576|NCT00594958|567459689|FG001|Overall Study|Withdrawal by Subject|0|||
157195577|NCT00594958|567459690|FG002|Overall Study|Withdrawal by Subject|1|||
157195578|NCT00594958|567459688|FG000|Overall Study|Adverse Event|4|||
157195579|NCT00594958|567459689|FG001|Overall Study|Adverse Event|1|||
157195580|NCT00594958|567459690|FG002|Overall Study|Adverse Event|2|||
157195581|NCT00594958|567459688|FG000|Overall Study|Pregnancy|0|||
157195582|NCT00594958|567459689|FG001|Overall Study|Pregnancy|2|||
157195583|NCT00594958|567459690|FG002|Overall Study|Pregnancy|0|||
157195584|NCT00594958|567459688|FG000|Overall Study|Protocol Violation|1|||
157195585|NCT00594958|567459689|FG001|Overall Study|Protocol Violation|0|||
157195586|NCT00594958|567459690|FG002|Overall Study|Protocol Violation|2|||
157195587|NCT00594958|567459688|FG000|Overall Study|Lost to Follow-up|5|||
157195588|NCT00594958|567459689|FG001|Overall Study|Lost to Follow-up|0|||
157195589|NCT00594958|567459690|FG002|Overall Study|Lost to Follow-up|3|||
157195590|NCT00594958|567459688|FG000|Overall Study|administrative|3|||
157195591|NCT00594958|567459689|FG001|Overall Study|administrative|0|||
157195592|NCT00594958|567459690|FG002|Overall Study|administrative|2|||
157195593|NCT03233009|567459691|FG000|Overall Study|Lost to Follow-up|1|||
157195594|NCT04516291|567459692|FG000|Treatment Period (24 Weeks)|Other|1|||
157195595|NCT04516291|567459693|FG001|Treatment Period (24 Weeks)|Other|0|||
157195596|NCT04516291|567459694|FG002|Treatment Period (24 Weeks)|Other|0|||
157195597|NCT04516291|567459695|FG003|Treatment Period (24 Weeks)|Other|2|||
157195598|NCT04516291|567459696|FG004|Treatment Period (24 Weeks)|Other|2|||
157235789|NCT03273153|567611700|FG000|Overall Study|Protocol Deviation|3|||
157235790|NCT03273153|567611701|FG001|Overall Study|Protocol Deviation|0|||
157235791|NCT03273153|567611700|FG000|Overall Study|Lost to Follow-up|6|||
157085495|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
157085496|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
157085497|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
157085498|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
157085499|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
157085500|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
157085501|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
157085502|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
157085503|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
157085504|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
157085505|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
157085506|NCT00700427|567066889|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
157085507|NCT00700427|567066890|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
157085508|NCT00700427|567066891|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
157085509|NCT00700427|567066892|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
157085510|NCT00700427|567066893|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
157085511|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
157085512|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
157085513|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
157085514|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
157085515|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
157085516|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
157085517|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
157085518|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
157085519|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
157085520|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
157085521|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
157085522|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
157085523|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
157085524|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
157085525|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
157085526|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
157085527|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
157085528|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
157085529|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
157085530|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
157085531|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
157085532|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
157085533|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
157085534|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
157085535|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
157085536|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
157085537|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
157085538|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
157085539|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
157085540|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
157085541|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
157085542|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
157085543|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
157085544|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
157085545|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
157235792|NCT03273153|567611701|FG001|Overall Study|Lost to Follow-up|11|||
157235793|NCT03273153|567611700|FG000|Overall Study|Death|66|||
157235794|NCT03273153|567611701|FG001|Overall Study|Death|69|||
157235795|NCT00838539|567611704|FG000|Overall Study|Disease Progression|2|||
157235796|NCT00838539|567611705|FG001|Overall Study|Disease Progression|4|||
157235797|NCT00838539|567611706|FG002|Overall Study|Disease Progression|3|||
157235798|NCT00838539|567611707|FG003|Overall Study|Disease Progression|2|||
157235799|NCT00838539|567611708|FG004|Overall Study|Disease Progression|4|||
157235800|NCT00838539|567611709|FG005|Overall Study|Disease Progression|2|||
157235801|NCT00838539|567611710|FG006|Overall Study|Disease Progression|3|||
157235802|NCT00838539|567611711|FG007|Overall Study|Disease Progression|4|||
157235803|NCT00838539|567611712|FG008|Overall Study|Disease Progression|4|||
157235804|NCT00838539|567611713|FG009|Overall Study|Disease Progression|5|||
157235805|NCT00838539|567611714|FG010|Overall Study|Disease Progression|1|||
157235806|NCT00838539|567611715|FG011|Overall Study|Disease Progression|4|||
157235807|NCT00838539|567611704|FG000|Overall Study|Adverse Event|1|||
157235808|NCT00838539|567611705|FG001|Overall Study|Adverse Event|1|||
157085546|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
157085547|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
157085548|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
157085549|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
157085550|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
157085551|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
157085552|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
157085553|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
157085554|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
157085555|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
157085556|NCT00700427|567066889|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
157085557|NCT00700427|567066890|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
157085558|NCT00700427|567066891|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
157195599|NCT04516291|567459697|FG005|Treatment Period (24 Weeks)|Other|4|||
157195600|NCT04516291|567459698|FG006|Treatment Period (24 Weeks)|Other|2|||
157195601|NCT04516291|567459699|FG007|Treatment Period (24 Weeks)|Other|0|||
157195602|NCT04516291|567459692|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157195603|NCT04516291|567459693|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
157195604|NCT04516291|567459694|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
157195605|NCT04516291|567459695|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157195606|NCT04516291|567459696|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
157195607|NCT04516291|567459697|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157195608|NCT04516291|567459698|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157195609|NCT04516291|567459699|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
157195610|NCT04516291|567459692|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195611|NCT04516291|567459693|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195612|NCT04516291|567459694|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195613|NCT04516291|567459695|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
157195614|NCT04516291|567459696|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195615|NCT04516291|567459697|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195616|NCT04516291|567459698|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195617|NCT04516291|567459699|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
157195618|NCT04516291|567459692|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195619|NCT04516291|567459693|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
157195620|NCT04516291|567459694|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195621|NCT04516291|567459695|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195622|NCT04516291|567459696|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195623|NCT04516291|567459697|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195624|NCT04516291|567459698|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195625|NCT04516291|567459699|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
157195626|NCT04516291|567459692|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
157195627|NCT04516291|567459693|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
157195628|NCT04516291|567459694|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
157195629|NCT04516291|567459695|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
157195630|NCT04516291|567459696|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
157195631|NCT04516291|567459697|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
157195632|NCT04516291|567459698|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
157195633|NCT04516291|567459699|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
157195634|NCT04516291|567459692|FG000|Follow-up Period (12 Weeks)|Other|0|||
157195635|NCT04516291|567459693|FG001|Follow-up Period (12 Weeks)|Other|1|||
157195636|NCT04516291|567459694|FG002|Follow-up Period (12 Weeks)|Other|0|||
157195637|NCT04516291|567459695|FG003|Follow-up Period (12 Weeks)|Other|2|||
157195638|NCT04516291|567459696|FG004|Follow-up Period (12 Weeks)|Other|0|||
157195639|NCT04516291|567459697|FG005|Follow-up Period (12 Weeks)|Other|0|||
157195640|NCT04516291|567459698|FG006|Follow-up Period (12 Weeks)|Other|0|||
157195641|NCT04516291|567459699|FG007|Follow-up Period (12 Weeks)|Other|0|||
157195642|NCT04516291|567459692|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195643|NCT04516291|567459693|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195644|NCT04516291|567459694|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195645|NCT04516291|567459695|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195646|NCT04516291|567459696|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
157195647|NCT04516291|567459697|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195648|NCT04516291|567459698|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195649|NCT04516291|567459699|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
157195650|NCT04516291|567459692|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
157195651|NCT04516291|567459693|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
157085559|NCT00700427|567066892|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
157085560|NCT00700427|567066893|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
157195652|NCT04516291|567459694|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
157195653|NCT04516291|567459695|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
157195654|NCT04516291|567459696|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
157195655|NCT04516291|567459697|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
157195656|NCT04516291|567459698|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
157195657|NCT04516291|567459699|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
157195658|NCT03039686|567459700|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
157195659|NCT03039686|567459701|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
157195660|NCT03039686|567459702|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
157195661|NCT03039686|567459700|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
157195662|NCT03039686|567459701|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
157195663|NCT03039686|567459702|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
157195664|NCT03039686|567459700|FG000|Double-blind Period|Withdrawal by Subject|2|||
157195665|NCT03039686|567459701|FG001|Double-blind Period|Withdrawal by Subject|2|||
157195666|NCT03039686|567459702|FG002|Double-blind Period|Withdrawal by Subject|1|||
157195667|NCT03039686|567459700|FG000|Double-blind Period|Death|0|||
157195668|NCT03039686|567459701|FG001|Double-blind Period|Death|0|||
157195669|NCT03039686|567459702|FG002|Double-blind Period|Death|1|||
157195670|NCT03039686|567459700|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
157195671|NCT03039686|567459701|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
157195672|NCT03039686|567459702|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
157195673|NCT03039686|567459700|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
157195674|NCT03039686|567459701|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
157195675|NCT03039686|567459702|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
157195676|NCT03039686|567459700|FG000|Open Label Period|Withdrawal by Subject|0|||
157195677|NCT03039686|567459701|FG001|Open Label Period|Withdrawal by Subject|3|||
157195678|NCT03039686|567459702|FG002|Open Label Period|Withdrawal by Subject|1|||
157195679|NCT02158949|567459703|FG000|Overall Study|Withdrawal by Subject|1|||
157195680|NCT02158949|567459704|FG001|Overall Study|Withdrawal by Subject|0|||
157195681|NCT02158949|567459703|FG000|Overall Study|Lost to Follow-up|5|||
157195682|NCT02158949|567459704|FG001|Overall Study|Lost to Follow-up|11|||
157195683|NCT01855607|567459705|FG000|Overall Study|Withdrawal by Subject|1|||
157195684|NCT01855607|567459705|FG000|Overall Study|Study was terminated|11|||
157195685|NCT02181634|567459706|FG000|Overall Study|Lack of Efficacy|33|||
157195686|NCT02181634|567459706|FG000|Overall Study|Adverse Event|17|||
157195687|NCT02181634|567459706|FG000|Overall Study|Physician Decision|8|||
157195688|NCT02181634|567459706|FG000|Overall Study|Withdrawal by Subject|5|||
157195689|NCT02181634|567459706|FG000|Overall Study|Death|2|||
157195690|NCT02181634|567459706|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
157195691|NCT02181634|567459706|FG000|Overall Study|Ineligible|1|||
157195692|NCT02181634|567459706|FG000|Overall Study|Max number of dose reduction|1|||
157195693|NCT02181634|567459706|FG000|Overall Study|Symptomatic progression|1|||
157195694|NCT02181634|567459706|FG000|Overall Study|Patient opted to proceed to surgery|1|||
157195695|NCT02392078|567459711|FG000|Overall Study|Did not have procedure|32|||
157195696|NCT02392078|567459712|FG001|Overall Study|Did not have procedure|43|||
157195697|NCT02392078|567459713|FG002|Overall Study|Did not have procedure|20|||
157195698|NCT02392078|567459714|FG003|Overall Study|Did not have procedure|1|||
157195699|NCT02079077|567459715|FG000|Overall Study|Lost to Follow-up|5|||
157195700|NCT02079077|567459716|FG001|Overall Study|Lost to Follow-up|7|||
157195701|NCT02079077|567459715|FG000|Overall Study|Became STIs Positive|1|||
157195702|NCT02079077|567459716|FG001|Overall Study|Became STIs Positive|2|||
157195703|NCT00134563|567459724|FG000|Overall Study|Not treated due to protocol violation|0|||
157195704|NCT00134563|567459725|FG001|Overall Study|Not treated due to protocol violation|1|||
157195705|NCT00134563|567459726|FG002|Overall Study|Not treated due to protocol violation|1|||
157195706|NCT00134563|567459724|FG000|Overall Study|Adverse Event|29|||
157195707|NCT00134563|567459725|FG001|Overall Study|Adverse Event|37|||
157195708|NCT00134563|567459726|FG002|Overall Study|Adverse Event|38|||
157195709|NCT00134563|567459724|FG000|Overall Study|Lack of Efficacy|24|||
157195710|NCT00134563|567459725|FG001|Overall Study|Lack of Efficacy|14|||
157195711|NCT00134563|567459726|FG002|Overall Study|Lack of Efficacy|17|||
157195712|NCT00134563|567459724|FG000|Overall Study|Protocol Violation|3|||
157195713|NCT00134563|567459725|FG001|Overall Study|Protocol Violation|2|||
157195714|NCT00134563|567459726|FG002|Overall Study|Protocol Violation|5|||
157195715|NCT00134563|567459724|FG000|Overall Study|Lost to Follow-up|4|||
157195716|NCT00134563|567459725|FG001|Overall Study|Lost to Follow-up|0|||
157195717|NCT00134563|567459726|FG002|Overall Study|Lost to Follow-up|2|||
157195718|NCT00134563|567459724|FG000|Overall Study|progressive disease|11|||
157195719|NCT00134563|567459725|FG001|Overall Study|progressive disease|4|||
157195720|NCT00134563|567459726|FG002|Overall Study|progressive disease|2|||
157195721|NCT00134563|567459724|FG000|Overall Study|did not wish to continue|33|||
157195722|NCT00134563|567459725|FG001|Overall Study|did not wish to continue|32|||
157195723|NCT00134563|567459726|FG002|Overall Study|did not wish to continue|26|||
157195724|NCT00134563|567459724|FG000|Overall Study|Reason other than above|0|||
157195725|NCT00134563|567459725|FG001|Overall Study|Reason other than above|2|||
157195726|NCT00134563|567459726|FG002|Overall Study|Reason other than above|5|||
157195727|NCT03382639|567459727|FG000|Overall Study|Adverse Event|2|||
157195728|NCT03382639|567459728|FG001|Overall Study|Adverse Event|0|||
157195729|NCT03382639|567459729|FG002|Overall Study|Adverse Event|1|||
157235809|NCT00838539|567611706|FG002|Overall Study|Adverse Event|1|||
157235810|NCT00838539|567611707|FG003|Overall Study|Adverse Event|1|||
157235811|NCT00838539|567611708|FG004|Overall Study|Adverse Event|2|||
157235812|NCT00838539|567611709|FG005|Overall Study|Adverse Event|1|||
157235813|NCT00838539|567611710|FG006|Overall Study|Adverse Event|0|||
157235814|NCT00838539|567611711|FG007|Overall Study|Adverse Event|2|||
157235815|NCT00838539|567611712|FG008|Overall Study|Adverse Event|0|||
157235816|NCT00838539|567611713|FG009|Overall Study|Adverse Event|1|||
157235817|NCT00838539|567611714|FG010|Overall Study|Adverse Event|2|||
157235818|NCT00838539|567611715|FG011|Overall Study|Adverse Event|0|||
157235819|NCT00838539|567611704|FG000|Overall Study|Withdrawal by Subject|0|||
157235820|NCT00838539|567611705|FG001|Overall Study|Withdrawal by Subject|1|||
157235821|NCT00838539|567611706|FG002|Overall Study|Withdrawal by Subject|0|||
157235822|NCT00838539|567611707|FG003|Overall Study|Withdrawal by Subject|0|||
157235823|NCT00838539|567611708|FG004|Overall Study|Withdrawal by Subject|0|||
157235824|NCT00838539|567611709|FG005|Overall Study|Withdrawal by Subject|0|||
157235825|NCT00838539|567611710|FG006|Overall Study|Withdrawal by Subject|0|||
157235826|NCT00838539|567611711|FG007|Overall Study|Withdrawal by Subject|0|||
157235827|NCT00838539|567611712|FG008|Overall Study|Withdrawal by Subject|0|||
157235828|NCT00838539|567611713|FG009|Overall Study|Withdrawal by Subject|1|||
157235829|NCT00838539|567611714|FG010|Overall Study|Withdrawal by Subject|2|||
157235830|NCT00838539|567611715|FG011|Overall Study|Withdrawal by Subject|0|||
157235831|NCT00838539|567611704|FG000|Overall Study|Death|0|||
157235832|NCT00838539|567611705|FG001|Overall Study|Death|0|||
157235833|NCT00838539|567611706|FG002|Overall Study|Death|0|||
157235834|NCT00838539|567611707|FG003|Overall Study|Death|0|||
157235835|NCT00838539|567611708|FG004|Overall Study|Death|0|||
157235836|NCT00838539|567611709|FG005|Overall Study|Death|0|||
157235837|NCT00838539|567611710|FG006|Overall Study|Death|1|||
157235838|NCT00838539|567611711|FG007|Overall Study|Death|0|||
157235839|NCT00838539|567611712|FG008|Overall Study|Death|0|||
157235840|NCT00838539|567611713|FG009|Overall Study|Death|0|||
157235841|NCT00838539|567611714|FG010|Overall Study|Death|0|||
157235842|NCT00838539|567611715|FG011|Overall Study|Death|0|||
157235843|NCT00838539|567611704|FG000|Overall Study|Physician Decision|0|||
157235844|NCT00838539|567611705|FG001|Overall Study|Physician Decision|0|||
157235845|NCT00838539|567611706|FG002|Overall Study|Physician Decision|0|||
157235846|NCT00838539|567611707|FG003|Overall Study|Physician Decision|0|||
157235847|NCT00838539|567611708|FG004|Overall Study|Physician Decision|0|||
157235848|NCT00838539|567611709|FG005|Overall Study|Physician Decision|0|||
157235849|NCT00838539|567611710|FG006|Overall Study|Physician Decision|0|||
157235850|NCT00838539|567611711|FG007|Overall Study|Physician Decision|0|||
157235851|NCT00838539|567611712|FG008|Overall Study|Physician Decision|1|||
157235852|NCT00838539|567611713|FG009|Overall Study|Physician Decision|0|||
157235853|NCT00838539|567611714|FG010|Overall Study|Physician Decision|0|||
157235854|NCT00838539|567611715|FG011|Overall Study|Physician Decision|0|||
157235855|NCT00838539|567611704|FG000|Overall Study|Clinical Progression|0|||
157235856|NCT00838539|567611705|FG001|Overall Study|Clinical Progression|0|||
157235857|NCT00838539|567611706|FG002|Overall Study|Clinical Progression|0|||
157235858|NCT00838539|567611707|FG003|Overall Study|Clinical Progression|0|||
157235859|NCT00838539|567611708|FG004|Overall Study|Clinical Progression|0|||
157235860|NCT00838539|567611709|FG005|Overall Study|Clinical Progression|0|||
157235861|NCT00838539|567611710|FG006|Overall Study|Clinical Progression|1|||
157235862|NCT00838539|567611711|FG007|Overall Study|Clinical Progression|0|||
157235863|NCT00838539|567611712|FG008|Overall Study|Clinical Progression|0|||
157235864|NCT00838539|567611713|FG009|Overall Study|Clinical Progression|0|||
157235865|NCT00838539|567611714|FG010|Overall Study|Clinical Progression|0|||
157235866|NCT00838539|567611715|FG011|Overall Study|Clinical Progression|0|||
157235867|NCT00838539|567611704|FG000|Overall Study|Symptomatic Deterioration|0|||
157235868|NCT00838539|567611705|FG001|Overall Study|Symptomatic Deterioration|0|||
157235869|NCT00838539|567611706|FG002|Overall Study|Symptomatic Deterioration|1|||
157235870|NCT00838539|567611707|FG003|Overall Study|Symptomatic Deterioration|1|||
157235871|NCT00838539|567611708|FG004|Overall Study|Symptomatic Deterioration|0|||
157235872|NCT00838539|567611709|FG005|Overall Study|Symptomatic Deterioration|1|||
157235873|NCT00838539|567611710|FG006|Overall Study|Symptomatic Deterioration|0|||
157235874|NCT00838539|567611711|FG007|Overall Study|Symptomatic Deterioration|0|||
157235875|NCT00838539|567611712|FG008|Overall Study|Symptomatic Deterioration|0|||
157235876|NCT00838539|567611713|FG009|Overall Study|Symptomatic Deterioration|1|||
157235877|NCT00838539|567611714|FG010|Overall Study|Symptomatic Deterioration|0|||
157235878|NCT00838539|567611715|FG011|Overall Study|Symptomatic Deterioration|0|||
157235879|NCT01908205|567611716|FG000|Overall Study|Lost to Follow-up|2|||
157235880|NCT01908205|567611717|FG001|Overall Study|Lost to Follow-up|0|||
157235881|NCT01908205|567611716|FG000|Overall Study|Withdrawal by Subject|3|||
157235882|NCT01908205|567611717|FG001|Overall Study|Withdrawal by Subject|1|||
157235883|NCT02612337|567611719|FG000|Overall Study|Lack of Efficacy|1|||
157235884|NCT02612337|567611720|FG001|Overall Study|Lack of Efficacy|0|||
157235885|NCT02612337|567611719|FG000|Overall Study|Withdrawal by Subject|2|||
157235886|NCT02612337|567611720|FG001|Overall Study|Withdrawal by Subject|2|||
157235887|NCT02612337|567611719|FG000|Overall Study|Did not receive study drug|0|||
157085561|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
157085562|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
157085563|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
157085564|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
157085565|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
157085566|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
157085567|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
157085568|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
157085569|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
157085570|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
157085571|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
157085572|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
157085573|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
157085574|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
157085575|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
157085576|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
157085577|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
157085578|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
157085579|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
157085580|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
157085581|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
157085582|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
157085583|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
157085584|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
157085585|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
157085586|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
157085587|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
157085588|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
157085589|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
157085590|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
157085591|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
157085592|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
157085593|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
157085594|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
157085595|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
157085596|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
157085597|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
157085598|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
157085599|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
157085600|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
157085601|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
157085602|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
157085603|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
157085604|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
157085605|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
157085606|NCT00700427|567066889|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
157085607|NCT00700427|567066890|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
157085608|NCT00700427|567066891|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
157085609|NCT00700427|567066892|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
157085610|NCT00700427|567066893|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
157085611|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
157085612|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
157085613|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
157085614|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
157085615|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
157085616|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
157085617|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
157085618|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
157085619|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
157085620|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
157085621|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
157085622|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
157195730|NCT03382639|567459730|FG003|Overall Study|Adverse Event|1|||
157195731|NCT03382639|567459727|FG000|Overall Study|Lost to Follow-up|1|||
157195732|NCT03382639|567459728|FG001|Overall Study|Lost to Follow-up|0|||
157195733|NCT03382639|567459729|FG002|Overall Study|Lost to Follow-up|0|||
157195734|NCT03382639|567459730|FG003|Overall Study|Lost to Follow-up|0|||
157195735|NCT03382639|567459727|FG000|Overall Study|Withdrawal by Subject|4|||
157195736|NCT03382639|567459728|FG001|Overall Study|Withdrawal by Subject|3|||
157195737|NCT03382639|567459729|FG002|Overall Study|Withdrawal by Subject|2|||
157195738|NCT03382639|567459730|FG003|Overall Study|Withdrawal by Subject|3|||
157195739|NCT03382639|567459727|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
157195740|NCT03382639|567459728|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
157195741|NCT03382639|567459729|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
157195742|NCT03382639|567459730|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
157195743|NCT03382639|567459727|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
157195744|NCT03382639|567459728|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
157195745|NCT03382639|567459729|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
157195746|NCT03382639|567459730|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
157195747|NCT03382639|567459727|FG000|Overall Study|Other|2|||
157195748|NCT03382639|567459728|FG001|Overall Study|Other|0|||
157195749|NCT03382639|567459729|FG002|Overall Study|Other|0|||
157195750|NCT03382639|567459730|FG003|Overall Study|Other|3|||
157195751|NCT00285857|567459733|FG000|Overall Study|Withdrawal by Subject|2|||
157195752|NCT00285857|567459733|FG000|Overall Study|Inadequate initial breast cytology|1|||
157195753|NCT00285857|567459733|FG000|Overall Study|Adverse Event|1|||
157195754|NCT00917553|567459738|FG000|Overall Study|Lost to Follow-up|2|||
157195755|NCT00917553|567459739|FG001|Overall Study|Lost to Follow-up|1|||
157195756|NCT03172026|567459741|FG000|Overall Study|Withdrawal by Subject|1|||
157195757|NCT03172026|567459742|FG001|Overall Study|Withdrawal by Subject|0|||
157195758|NCT03172026|567459741|FG000|Overall Study|COVID restrictions|1|||
157195759|NCT03172026|567459742|FG001|Overall Study|COVID restrictions|0|||
157195760|NCT01177943|567459743|FG000|First Intervention|Withdrawal by Subject|2|||
157195761|NCT01177943|567459744|FG001|First Intervention|Withdrawal by Subject|0|||
157195762|NCT01303159|567459747|FG000|Overall Study|Death|16|||
157195763|NCT01303159|567459747|FG000|Overall Study|Study Termination|7|||
157195764|NCT00496782|567459753|FG000|Overall Study|Protocol Violation|1|||
157195765|NCT00496782|567459754|FG001|Overall Study|Protocol Violation|2|||
157195766|NCT01288911|567459758|FG000|Double-blind Period|Death|11|||
157195767|NCT01288911|567459759|FG001|Double-blind Period|Death|7|||
157195768|NCT01288911|567459758|FG000|Double-blind Period|Lost to Follow-up|0|||
157195769|NCT01288911|567459759|FG001|Double-blind Period|Lost to Follow-up|2|||
157195770|NCT01288911|567459758|FG000|Double-blind Period|Progressive Disease|75|||
157195771|NCT01288911|567459759|FG001|Double-blind Period|Progressive Disease|103|||
157195772|NCT01288911|567459758|FG000|Double-blind Period|Protocol Violation|1|||
157195773|NCT01288911|567459759|FG001|Double-blind Period|Protocol Violation|0|||
157195774|NCT01288911|567459758|FG000|Double-blind Period|Withdrawal by Subject|25|||
157195775|NCT01288911|567459759|FG001|Double-blind Period|Withdrawal by Subject|26|||
157195776|NCT01288911|567459758|FG000|Double-blind Period|Miscellaneous Reason|29|||
157195777|NCT01288911|567459759|FG001|Double-blind Period|Miscellaneous Reason|42|||
157195778|NCT01288911|567459758|FG000|Double-blind Period|Randomized but never received study drug|1|||
157195779|NCT01288911|567459759|FG001|Double-blind Period|Randomized but never received study drug|2|||
157195780|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Death|0|||
157195781|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Death|1|||
157195782|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
157195783|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
157195784|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
157195785|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
157195786|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
157195787|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
157195788|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
157195789|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
157195790|NCT01288911|567459758|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
157195791|NCT01288911|567459759|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
157195792|NCT02132312|567459760|FG000|Overall Study|Adverse Event|2|||
157195793|NCT02132312|567459761|FG001|Overall Study|Adverse Event|0|||
157195794|NCT02132312|567459760|FG000|Overall Study|Physician Decision|1|||
157195795|NCT02132312|567459761|FG001|Overall Study|Physician Decision|1|||
157195796|NCT02132312|567459760|FG000|Overall Study|Protocol Violation|0|||
157195797|NCT02132312|567459761|FG001|Overall Study|Protocol Violation|1|||
157195798|NCT02132312|567459760|FG000|Overall Study|Withdrawal by Subject|1|||
157195799|NCT02132312|567459761|FG001|Overall Study|Withdrawal by Subject|0|||
157195800|NCT02132312|567459760|FG000|Overall Study|Lost to Follow-up|2|||
157195801|NCT02132312|567459761|FG001|Overall Study|Lost to Follow-up|1|||
157195802|NCT01632345|567459762|FG000|Treatment: Part I|Adverse Event|1|||
157195803|NCT01632345|567459763|FG001|Treatment: Part I|Adverse Event|4|||
157195804|NCT01632345|567459764|FG002|Treatment: Part I|Adverse Event|2|||
157195805|NCT01632345|567459765|FG003|Treatment: Part I|Adverse Event|1|||
157195806|NCT01632345|567459766|FG004|Treatment: Part I|Adverse Event|3|||
157195807|NCT01632345|567459767|FG005|Treatment: Part I|Adverse Event|0|||
157085623|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
157085624|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
157085625|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
157085626|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
157085627|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
157085628|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
157085629|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
157085630|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
157085631|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
157085632|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
157085633|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
157085634|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
157085635|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
157085636|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
157085637|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
157085638|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
157085639|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
157085640|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
157085641|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
157085642|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
157085643|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
157085644|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
157085645|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
157085646|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
157195808|NCT01632345|567459768|FG006|Treatment: Part I|Adverse Event|0|||
157195809|NCT01632345|567459762|FG000|Treatment: Part I|Lack of Efficacy|0|||
157195810|NCT01632345|567459763|FG001|Treatment: Part I|Lack of Efficacy|1|||
157195811|NCT01632345|567459764|FG002|Treatment: Part I|Lack of Efficacy|0|||
157195812|NCT01632345|567459765|FG003|Treatment: Part I|Lack of Efficacy|1|||
157195813|NCT01632345|567459766|FG004|Treatment: Part I|Lack of Efficacy|1|||
157195814|NCT01632345|567459767|FG005|Treatment: Part I|Lack of Efficacy|0|||
157195815|NCT01632345|567459768|FG006|Treatment: Part I|Lack of Efficacy|0|||
157195816|NCT01632345|567459762|FG000|Treatment: Part I|Lost to Follow-up|3|||
157195817|NCT01632345|567459763|FG001|Treatment: Part I|Lost to Follow-up|2|||
157195818|NCT01632345|567459764|FG002|Treatment: Part I|Lost to Follow-up|1|||
157195819|NCT01632345|567459765|FG003|Treatment: Part I|Lost to Follow-up|3|||
157195820|NCT01632345|567459766|FG004|Treatment: Part I|Lost to Follow-up|4|||
157195821|NCT01632345|567459767|FG005|Treatment: Part I|Lost to Follow-up|0|||
157195822|NCT01632345|567459768|FG006|Treatment: Part I|Lost to Follow-up|0|||
157195823|NCT01632345|567459762|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
157195824|NCT01632345|567459763|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
157195825|NCT01632345|567459764|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
157195826|NCT01632345|567459765|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
157195827|NCT01632345|567459766|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
157195828|NCT01632345|567459767|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
157195829|NCT01632345|567459768|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
157195830|NCT01632345|567459762|FG000|Treatment: Part I|Physician Decision|2|||
157195831|NCT01632345|567459763|FG001|Treatment: Part I|Physician Decision|1|||
157195832|NCT01632345|567459764|FG002|Treatment: Part I|Physician Decision|0|||
157195833|NCT01632345|567459765|FG003|Treatment: Part I|Physician Decision|0|||
157195834|NCT01632345|567459766|FG004|Treatment: Part I|Physician Decision|1|||
157195835|NCT01632345|567459767|FG005|Treatment: Part I|Physician Decision|0|||
157195836|NCT01632345|567459768|FG006|Treatment: Part I|Physician Decision|0|||
157195837|NCT01632345|567459762|FG000|Treatment: Part I|Pregnancy|0|||
157195838|NCT01632345|567459763|FG001|Treatment: Part I|Pregnancy|1|||
157195839|NCT01632345|567459764|FG002|Treatment: Part I|Pregnancy|0|||
157195840|NCT01632345|567459765|FG003|Treatment: Part I|Pregnancy|0|||
157195841|NCT01632345|567459766|FG004|Treatment: Part I|Pregnancy|0|||
157195842|NCT01632345|567459767|FG005|Treatment: Part I|Pregnancy|0|||
157195843|NCT01632345|567459768|FG006|Treatment: Part I|Pregnancy|0|||
157195844|NCT01632345|567459762|FG000|Treatment: Part I|Protocol Deviation|0|||
157195845|NCT01632345|567459763|FG001|Treatment: Part I|Protocol Deviation|0|||
157195846|NCT01632345|567459764|FG002|Treatment: Part I|Protocol Deviation|1|||
157195847|NCT01632345|567459765|FG003|Treatment: Part I|Protocol Deviation|1|||
157195848|NCT01632345|567459766|FG004|Treatment: Part I|Protocol Deviation|0|||
157195849|NCT01632345|567459767|FG005|Treatment: Part I|Protocol Deviation|0|||
157195850|NCT01632345|567459768|FG006|Treatment: Part I|Protocol Deviation|0|||
157195851|NCT01632345|567459762|FG000|Treatment: Part I|Withdrawal by Subject|3|||
157195852|NCT01632345|567459763|FG001|Treatment: Part I|Withdrawal by Subject|4|||
157085647|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
157085648|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
157085649|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
157085650|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
157085651|NCT00700427|567066889|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
157085652|NCT00700427|567066890|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
157085653|NCT00700427|567066891|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
157085654|NCT00700427|567066892|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
157195853|NCT01632345|567459764|FG002|Treatment: Part I|Withdrawal by Subject|4|||
157195854|NCT01632345|567459765|FG003|Treatment: Part I|Withdrawal by Subject|1|||
157195855|NCT01632345|567459766|FG004|Treatment: Part I|Withdrawal by Subject|4|||
157195856|NCT01632345|567459767|FG005|Treatment: Part I|Withdrawal by Subject|0|||
157195857|NCT01632345|567459768|FG006|Treatment: Part I|Withdrawal by Subject|0|||
157195858|NCT01632345|567459762|FG000|Treatment: Part II|Adverse Event|0|||
157195859|NCT01632345|567459763|FG001|Treatment: Part II|Adverse Event|0|||
157195860|NCT01632345|567459764|FG002|Treatment: Part II|Adverse Event|0|||
157195861|NCT01632345|567459765|FG003|Treatment: Part II|Adverse Event|0|||
157195862|NCT01632345|567459766|FG004|Treatment: Part II|Adverse Event|0|||
157195863|NCT01632345|567459767|FG005|Treatment: Part II|Adverse Event|3|||
157195864|NCT01632345|567459768|FG006|Treatment: Part II|Adverse Event|8|||
157195865|NCT01632345|567459762|FG000|Treatment: Part II|Lost to Follow-up|0|||
157195866|NCT01632345|567459763|FG001|Treatment: Part II|Lost to Follow-up|0|||
157195867|NCT01632345|567459764|FG002|Treatment: Part II|Lost to Follow-up|0|||
157195868|NCT01632345|567459765|FG003|Treatment: Part II|Lost to Follow-up|0|||
157195869|NCT01632345|567459766|FG004|Treatment: Part II|Lost to Follow-up|0|||
157195870|NCT01632345|567459767|FG005|Treatment: Part II|Lost to Follow-up|3|||
157195871|NCT01632345|567459768|FG006|Treatment: Part II|Lost to Follow-up|1|||
157195872|NCT01632345|567459762|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195873|NCT01632345|567459763|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195874|NCT01632345|567459764|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195875|NCT01632345|567459765|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195876|NCT01632345|567459766|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195877|NCT01632345|567459767|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
157195878|NCT01632345|567459768|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
157195879|NCT01632345|567459762|FG000|Treatment: Part II|Withdrawal by Subject|0|||
157195880|NCT01632345|567459763|FG001|Treatment: Part II|Withdrawal by Subject|0|||
157195881|NCT01632345|567459764|FG002|Treatment: Part II|Withdrawal by Subject|0|||
157195882|NCT01632345|567459765|FG003|Treatment: Part II|Withdrawal by Subject|0|||
157195883|NCT01632345|567459766|FG004|Treatment: Part II|Withdrawal by Subject|0|||
157195884|NCT01632345|567459767|FG005|Treatment: Part II|Withdrawal by Subject|2|||
157195885|NCT01632345|567459768|FG006|Treatment: Part II|Withdrawal by Subject|2|||
157195886|NCT00089505|567459769|FG000|Overall Study|Death|4|||
157195887|NCT00089505|567459770|FG001|Overall Study|Death|1|||
157195888|NCT00089505|567459771|FG002|Overall Study|Death|5|||
157195889|NCT00089505|567459772|FG003|Overall Study|Death|8|||
157195890|NCT00089505|567459769|FG000|Overall Study|Withdrawal by Subject|3|||
157085655|NCT00700427|567066893|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
157085656|NCT00424385|567066896|FG000|Cohort 0|Withdrawal by Subject|5|||
157085657|NCT00424385|567066896|FG000|Cohort 0|Physician Decision|1|||
157085658|NCT00424385|567066896|FG000|Cohort 1|Withdrawal by Subject|1|||
157085659|NCT02057523|567066897|FG000|Overall Study|Withdrawal by Subject|1|||
157085660|NCT02057523|567066897|FG000|Overall Study|Lack of Efficacy|1|||
157085661|NCT00941070|567066899|FG000|Overall Study|Patient non-compliant|1|||
157085662|NCT03174431|567066900|FG000|Overall Study|Withdrawal by Subject|14|||
157085663|NCT03174431|567066901|FG001|Overall Study|Withdrawal by Subject|11|||
157085664|NCT03174431|567066900|FG000|Overall Study|alternative treatment|2|||
157085665|NCT03174431|567066901|FG001|Overall Study|alternative treatment|0|||
157085666|NCT03174431|567066900|FG000|Overall Study|Lost to Follow-up|1|||
157085667|NCT03174431|567066901|FG001|Overall Study|Lost to Follow-up|5|||
157085668|NCT04811131|567066909|FG000|Overall Study|Adverse Event|0|||
157085669|NCT04811131|567066910|FG001|Overall Study|Adverse Event|0|||
157085670|NCT04811131|567066911|FG002|Overall Study|Adverse Event|1|||
157085671|NCT04811131|567066912|FG003|Overall Study|Adverse Event|0|||
157085672|NCT04811131|567066909|FG000|Overall Study|Lack of Efficacy|0|||
157085673|NCT04811131|567066910|FG001|Overall Study|Lack of Efficacy|0|||
157195891|NCT00089505|567459770|FG001|Overall Study|Withdrawal by Subject|0|||
157195892|NCT00089505|567459771|FG002|Overall Study|Withdrawal by Subject|6|||
157195893|NCT00089505|567459772|FG003|Overall Study|Withdrawal by Subject|6|||
157195894|NCT00089505|567459769|FG000|Overall Study|Lost to Follow-up|1|||
157195895|NCT00089505|567459770|FG001|Overall Study|Lost to Follow-up|1|||
157195896|NCT00089505|567459771|FG002|Overall Study|Lost to Follow-up|9|||
157195897|NCT00089505|567459772|FG003|Overall Study|Lost to Follow-up|7|||
157195898|NCT00089505|567459769|FG000|Overall Study|Physician Decision|1|||
157195899|NCT00089505|567459770|FG001|Overall Study|Physician Decision|0|||
157195900|NCT00089505|567459771|FG002|Overall Study|Physician Decision|0|||
157195901|NCT00089505|567459772|FG003|Overall Study|Physician Decision|0|||
157085674|NCT04811131|567066911|FG002|Overall Study|Lack of Efficacy|0|||
157085675|NCT04811131|567066912|FG003|Overall Study|Lack of Efficacy|1|||
157085676|NCT04811131|567066909|FG000|Overall Study|Lost to Follow-up|0|||
157085677|NCT04811131|567066910|FG001|Overall Study|Lost to Follow-up|1|||
157085678|NCT04811131|567066911|FG002|Overall Study|Lost to Follow-up|0|||
157085679|NCT04811131|567066912|FG003|Overall Study|Lost to Follow-up|0|||
157085680|NCT04811131|567066909|FG000|Overall Study|Sponsor request|31|||
157085681|NCT04811131|567066910|FG001|Overall Study|Sponsor request|35|||
157085682|NCT04811131|567066911|FG002|Overall Study|Sponsor request|27|||
157085683|NCT04811131|567066912|FG003|Overall Study|Sponsor request|10|||
157085684|NCT04811131|567066909|FG000|Overall Study|Withdrawal by Subject|3|||
157085685|NCT04811131|567066910|FG001|Overall Study|Withdrawal by Subject|1|||
157085686|NCT04811131|567066911|FG002|Overall Study|Withdrawal by Subject|3|||
157085687|NCT04811131|567066912|FG003|Overall Study|Withdrawal by Subject|1|||
157085688|NCT00506441|567066913|FG000|Period 1; Open-label Period|Adverse Event|21|||
157085689|NCT00506441|567066914|FG001|Period 1; Open-label Period|Adverse Event|0|||
157085690|NCT00506441|567066913|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
157085691|NCT00506441|567066914|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
157085692|NCT00506441|567066913|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
157085693|NCT00506441|567066914|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
157085694|NCT00506441|567066913|FG000|Period 1; Open-label Period|Physician Decision|5|||
157085695|NCT00506441|567066914|FG001|Period 1; Open-label Period|Physician Decision|0|||
157085696|NCT00506441|567066913|FG000|Period 1; Open-label Period|Protocol Violation|9|||
157085697|NCT00506441|567066914|FG001|Period 1; Open-label Period|Protocol Violation|0|||
157085698|NCT00506441|567066913|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
157085699|NCT00506441|567066914|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
157085700|NCT00506441|567066913|FG000|Period 1; Open-label Period|Other Reasons|13|||
157085701|NCT00506441|567066914|FG001|Period 1; Open-label Period|Other Reasons|0|||
157085702|NCT00506441|567066913|FG000|Period 2; Double-blind Period|Adverse Event|0|||
157085703|NCT00506441|567066914|FG001|Period 2; Double-blind Period|Adverse Event|1|||
157085704|NCT00506441|567066913|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
157085705|NCT00506441|567066914|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
157085706|NCT00506441|567066913|FG000|Period 2; Double-blind Period|Physician Decision|1|||
157085707|NCT00506441|567066914|FG001|Period 2; Double-blind Period|Physician Decision|1|||
157195902|NCT00089505|567459769|FG000|Overall Study|Protocol Violation|0|||
157195903|NCT00089505|567459770|FG001|Overall Study|Protocol Violation|0|||
157195904|NCT00089505|567459771|FG002|Overall Study|Protocol Violation|1|||
157195905|NCT00089505|567459772|FG003|Overall Study|Protocol Violation|0|||
157195906|NCT02431559|567459773|FG000|Overall Study|Adverse Event|0|||
157195907|NCT02431559|567459774|FG001|Overall Study|Adverse Event|1|||
157195908|NCT02431559|567459775|FG002|Overall Study|Adverse Event|0|||
157195909|NCT02431559|567459776|FG003|Overall Study|Adverse Event|4|||
157195910|NCT02431559|567459773|FG000|Overall Study|Progressive disease|2|||
157195911|NCT02431559|567459774|FG001|Overall Study|Progressive disease|1|||
157195912|NCT02431559|567459775|FG002|Overall Study|Progressive disease|4|||
157195913|NCT02431559|567459776|FG003|Overall Study|Progressive disease|22|||
157195914|NCT02431559|567459773|FG000|Overall Study|Withdrawal by Subject|0|||
157195915|NCT02431559|567459774|FG001|Overall Study|Withdrawal by Subject|1|||
157195916|NCT02431559|567459775|FG002|Overall Study|Withdrawal by Subject|0|||
157195917|NCT02431559|567459776|FG003|Overall Study|Withdrawal by Subject|4|||
157195918|NCT02431559|567459773|FG000|Overall Study|Physician Decision|0|||
157195919|NCT02431559|567459774|FG001|Overall Study|Physician Decision|0|||
157195920|NCT02431559|567459775|FG002|Overall Study|Physician Decision|0|||
157195921|NCT02431559|567459776|FG003|Overall Study|Physician Decision|1|||
157195922|NCT02543918|567459777|FG000|Overall Study|Never treated|0|||
157195923|NCT02543918|567459778|FG001|Overall Study|Never treated|1|||
157195924|NCT02543918|567459777|FG000|Overall Study|Lost to Follow-up|1|||
157195925|NCT02543918|567459778|FG001|Overall Study|Lost to Follow-up|1|||
157195926|NCT02543918|567459777|FG000|Overall Study|Withdrawal by Subject|1|||
157195927|NCT02543918|567459778|FG001|Overall Study|Withdrawal by Subject|1|||
157195928|NCT02543918|567459777|FG000|Overall Study|Adverse Event|1|||
157195929|NCT02543918|567459778|FG001|Overall Study|Adverse Event|1|||
157195930|NCT00486720|567459781|FG000|Overall Study|Adverse Event|1|||
157195931|NCT00486720|567459782|FG001|Overall Study|Adverse Event|2|||
157195932|NCT00486720|567459781|FG000|Overall Study|Lack of Efficacy|4|||
157195933|NCT00486720|567459782|FG001|Overall Study|Lack of Efficacy|6|||
157195934|NCT00486720|567459781|FG000|Overall Study|Physician Decision|1|||
157195935|NCT00486720|567459782|FG001|Overall Study|Physician Decision|2|||
157195936|NCT00486720|567459781|FG000|Overall Study|Protocol Violation|1|||
157195937|NCT00486720|567459782|FG001|Overall Study|Protocol Violation|0|||
157195938|NCT00486720|567459781|FG000|Overall Study|Withdrawal by Subject|3|||
157195939|NCT00486720|567459782|FG001|Overall Study|Withdrawal by Subject|1|||
157195940|NCT00486720|567459781|FG000|Overall Study|Progressive Disease|0|||
157195941|NCT00486720|567459782|FG001|Overall Study|Progressive Disease|1|||
157195942|NCT02452892|567459785|FG000|Week 1 Initial Randommization|Adverse Event|1|||
157195943|NCT02452892|567459786|FG001|Week 1 Initial Randommization|Adverse Event|0|||
157195944|NCT02452892|567459787|FG002|Week 1 Initial Randommization|Adverse Event|0|||
157085708|NCT00506441|567066913|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
157085709|NCT00506441|567066914|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
157085710|NCT00506441|567066913|FG000|Period 2; Double-blind Period|Other Reason|1|||
157085711|NCT00506441|567066914|FG001|Period 2; Double-blind Period|Other Reason|1|||
157085712|NCT00735475|567066915|FG000|Overall Study|Adverse Event|0|||
157085713|NCT00735475|567066916|FG001|Overall Study|Adverse Event|1|||
157085714|NCT00735475|567066915|FG000|Overall Study|Death|1|||
157085715|NCT00735475|567066916|FG001|Overall Study|Death|1|||
157085716|NCT00735475|567066915|FG000|Overall Study|Lost to Follow-up|3|||
157085717|NCT00735475|567066916|FG001|Overall Study|Lost to Follow-up|3|||
157085718|NCT00735475|567066915|FG000|Overall Study|Physician Decision|0|||
157085719|NCT00735475|567066916|FG001|Overall Study|Physician Decision|1|||
157085720|NCT00735475|567066915|FG000|Overall Study|Withdrawal by Subject|4|||
157085721|NCT00735475|567066916|FG001|Overall Study|Withdrawal by Subject|5|||
157085722|NCT02544451|567066919|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
157085723|NCT02544451|567066920|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
157085724|NCT02544451|567066921|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
157085725|NCT02544451|567066922|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
157085726|NCT02544451|567066919|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
157085727|NCT02544451|567066920|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
157085728|NCT02544451|567066921|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
157085729|NCT02544451|567066922|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
157085730|NCT02544451|567066919|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
157085731|NCT02544451|567066920|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
157085732|NCT02544451|567066921|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
157085733|NCT02544451|567066922|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
157085734|NCT02544451|567066919|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
157085735|NCT02544451|567066920|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
157085736|NCT02544451|567066921|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
157085737|NCT02544451|567066922|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
157085738|NCT02544451|567066919|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
157085739|NCT02544451|567066920|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
157085740|NCT02544451|567066921|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
157085741|NCT02544451|567066922|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
157085742|NCT02544451|567066919|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
157085743|NCT02544451|567066920|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
157085744|NCT02544451|567066921|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
157085745|NCT02544451|567066922|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
157085746|NCT00844532|567066923|FG000|Overall Study|Death|16|||
157085747|NCT00844532|567066923|FG000|Overall Study|Withdrawal by Subject|16|||
157085748|NCT00844532|567066923|FG000|Overall Study|Lost to Follow-up|7|||
157085749|NCT05086276|567066924|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
157085750|NCT05086276|567066925|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
157085751|NCT00738894|567066926|FG000|Overall Study|Lost to Follow-up|23|||
157085752|NCT00738894|567066927|FG001|Overall Study|Lost to Follow-up|13|||
157085753|NCT00738894|567066926|FG000|Overall Study|Withdrawal by Subject|10|||
157085754|NCT00738894|567066927|FG001|Overall Study|Withdrawal by Subject|15|||
157085755|NCT00738894|567066926|FG000|Overall Study|Physician Decision|4|||
157085756|NCT00738894|567066927|FG001|Overall Study|Physician Decision|5|||
157085757|NCT00738894|567066926|FG000|Overall Study|Death|2|||
157085758|NCT00738894|567066927|FG001|Overall Study|Death|0|||
157085759|NCT05017103|567066928|FG000|Overall Study|Death|2|||
157085760|NCT02656329|567066929|FG000|Overall Study|Lost to Follow-up|2|||
157195945|NCT02452892|567459788|FG003|Week 1 Initial Randommization|Adverse Event|0|||
157195946|NCT02452892|567459785|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
157195947|NCT02452892|567459786|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
157195948|NCT02452892|567459787|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
157195949|NCT02452892|567459788|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
157195950|NCT02452892|567459785|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
157195951|NCT02452892|567459786|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
157195952|NCT02452892|567459787|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
157195953|NCT02452892|567459788|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
157085761|NCT02656329|567066930|FG001|Overall Study|Lost to Follow-up|3|||
157085762|NCT02656329|567066929|FG000|Overall Study|Withdrawal by Subject|7|||
157085763|NCT02656329|567066930|FG001|Overall Study|Withdrawal by Subject|6|||
157085764|NCT02656329|567066929|FG000|Overall Study|Study termination by Sponsor|150|||
157195954|NCT02452892|567459785|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
157085765|NCT02656329|567066930|FG001|Overall Study|Study termination by Sponsor|142|||
157085766|NCT02656329|567066929|FG000|Overall Study|Other than specified above|5|||
157085767|NCT02656329|567066930|FG001|Overall Study|Other than specified above|6|||
157085768|NCT01081665|567066932|FG000|Overall Study|Death|41|||
157085769|NCT01081665|567066932|FG000|Overall Study|Lost to Follow-up|18|||
157085770|NCT01081665|567066932|FG000|Overall Study|Withdrawal by Subject|17|||
157085771|NCT01081665|567066932|FG000|Overall Study|Change of dialysis unit|10|||
157085772|NCT01081665|567066932|FG000|Overall Study|Regulation of iPTH|5|||
157085773|NCT01081665|567066932|FG000|Overall Study|Change in renal replacement therapy|2|||
157085774|NCT01081665|567066932|FG000|Overall Study|Adverse Event|1|||
157085775|NCT01081665|567066932|FG000|Overall Study|Lack of Efficacy|1|||
157085776|NCT01413503|567066941|FG000|Overall Study|Lost to Follow-up|1|||
157085777|NCT02546921|567066942|FG000|Overall Study|Adverse Event|0|||
157085778|NCT02546921|567066943|FG001|Overall Study|Adverse Event|5|||
157085779|NCT02546921|567066944|FG002|Overall Study|Adverse Event|2|||
157085780|NCT02546921|567066945|FG003|Overall Study|Adverse Event|0|||
157085781|NCT02546921|567066946|FG004|Overall Study|Adverse Event|0|||
157085782|NCT02546921|567066947|FG005|Overall Study|Adverse Event|0|||
157085783|NCT02546921|567066948|FG006|Overall Study|Adverse Event|0|||
157085784|NCT02546921|567066942|FG000|Overall Study|Evidence of Disease Progression|1|||
157085785|NCT02546921|567066943|FG001|Overall Study|Evidence of Disease Progression|0|||
157085786|NCT02546921|567066944|FG002|Overall Study|Evidence of Disease Progression|0|||
157085787|NCT02546921|567066945|FG003|Overall Study|Evidence of Disease Progression|0|||
157085788|NCT02546921|567066946|FG004|Overall Study|Evidence of Disease Progression|1|||
157085789|NCT02546921|567066947|FG005|Overall Study|Evidence of Disease Progression|0|||
157085790|NCT02546921|567066948|FG006|Overall Study|Evidence of Disease Progression|0|||
157085791|NCT02546921|567066942|FG000|Overall Study|Patient Choice|0|||
157085792|NCT02546921|567066943|FG001|Overall Study|Patient Choice|1|||
157085793|NCT02546921|567066944|FG002|Overall Study|Patient Choice|0|||
157085794|NCT02546921|567066945|FG003|Overall Study|Patient Choice|0|||
157085795|NCT02546921|567066946|FG004|Overall Study|Patient Choice|0|||
157085796|NCT02546921|567066947|FG005|Overall Study|Patient Choice|1|||
157085797|NCT02546921|567066948|FG006|Overall Study|Patient Choice|0|||
157085798|NCT01373151|567066949|FG000|Period 1|Lack of Efficacy|3|||
157085799|NCT01373151|567066950|FG001|Period 1|Lack of Efficacy|0|||
157085800|NCT01373151|567066951|FG002|Period 1|Lack of Efficacy|0|||
157085801|NCT01373151|567066952|FG003|Period 1|Lack of Efficacy|0|||
157085802|NCT01373151|567066953|FG004|Period 1|Lack of Efficacy|1|||
157085803|NCT01373151|567066954|FG005|Period 1|Lack of Efficacy|0|||
157085804|NCT01373151|567066955|FG006|Period 1|Lack of Efficacy|0|||
157085805|NCT01373151|567066949|FG000|Period 1|Adverse Event|0|||
157085806|NCT01373151|567066950|FG001|Period 1|Adverse Event|0|||
157195955|NCT02452892|567459786|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
157195956|NCT02452892|567459787|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
157195957|NCT02452892|567459788|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
157195958|NCT02452892|567459785|FG000|Follow-up|Withdrawal by Subject|0|||
157195959|NCT02452892|567459786|FG001|Follow-up|Withdrawal by Subject|0|||
157195960|NCT02452892|567459787|FG002|Follow-up|Withdrawal by Subject|0|||
157195961|NCT02452892|567459788|FG003|Follow-up|Withdrawal by Subject|1|||
157195962|NCT02452892|567459785|FG000|Follow-up|Subject left town on Day 42|1|||
157195963|NCT02452892|567459786|FG001|Follow-up|Subject left town on Day 42|0|||
157195964|NCT02452892|567459787|FG002|Follow-up|Subject left town on Day 42|0|||
157195965|NCT02452892|567459788|FG003|Follow-up|Subject left town on Day 42|0|||
157195966|NCT01005875|567459794|FG000|Overall Study|Death|3|||
157195967|NCT00606931|567459795|FG000|Overall Study|Withdrawal by Subject|3|||
157195968|NCT05047601|567459796|FG000|Overall Study|Lost to Follow-up|9|||
157195969|NCT05047601|567459797|FG001|Overall Study|Lost to Follow-up|11|||
157195970|NCT05047601|567459798|FG002|Overall Study|Lost to Follow-up|7|||
157195971|NCT05047601|567459796|FG000|Overall Study|Withdrawal by Subject|25|||
157195972|NCT05047601|567459797|FG001|Overall Study|Withdrawal by Subject|36|||
157195973|NCT05047601|567459798|FG002|Overall Study|Withdrawal by Subject|23|||
157195974|NCT05047601|567459796|FG000|Overall Study|Other|10|||
157195975|NCT05047601|567459797|FG001|Overall Study|Other|6|||
157195976|NCT05047601|567459798|FG002|Overall Study|Other|5|||
157195977|NCT00286234|567459799|FG000|Overall Study|Protocol Violation|1|||
157235888|NCT02612337|567611720|FG001|Overall Study|Did not receive study drug|1|||
157085807|NCT01373151|567066951|FG002|Period 1|Adverse Event|1|||
157085808|NCT01373151|567066952|FG003|Period 1|Adverse Event|0|||
157085809|NCT01373151|567066953|FG004|Period 1|Adverse Event|4|||
157085810|NCT01373151|567066954|FG005|Period 1|Adverse Event|3|||
157085811|NCT01373151|567066955|FG006|Period 1|Adverse Event|0|||
157235889|NCT03420300|567611721|FG000|Overall Study|Death|2|||
157235890|NCT02242201|567611729|FG000|Overall Study|preoperative identified neuropathy|2|||
157085812|NCT01373151|567066949|FG000|Period 1|Withdrawal by Subject|2|||
157085813|NCT01373151|567066950|FG001|Period 1|Withdrawal by Subject|0|||
157085814|NCT01373151|567066951|FG002|Period 1|Withdrawal by Subject|3|||
157085815|NCT01373151|567066952|FG003|Period 1|Withdrawal by Subject|1|||
157085816|NCT01373151|567066953|FG004|Period 1|Withdrawal by Subject|0|||
157085817|NCT01373151|567066954|FG005|Period 1|Withdrawal by Subject|1|||
157085818|NCT01373151|567066955|FG006|Period 1|Withdrawal by Subject|0|||
157085819|NCT01373151|567066949|FG000|Period 2|Lack of Efficacy|9|||
157195978|NCT00286234|567459800|FG001|Overall Study|Protocol Violation|2|||
157195979|NCT00286234|567459801|FG002|Overall Study|Protocol Violation|0|||
157195980|NCT00286234|567459802|FG003|Overall Study|Protocol Violation|1|||
157085820|NCT01373151|567066950|FG001|Period 2|Lack of Efficacy|0|||
157085821|NCT01373151|567066951|FG002|Period 2|Lack of Efficacy|0|||
157085822|NCT01373151|567066952|FG003|Period 2|Lack of Efficacy|1|||
157235891|NCT02242201|567611730|FG001|Overall Study|preoperative identified neuropathy|0|||
157235892|NCT02242201|567611731|FG002|Overall Study|preoperative identified neuropathy|0|||
157235893|NCT02242201|567611729|FG000|Overall Study|planned post-op anticoagulation|1|||
157235894|NCT02242201|567611730|FG001|Overall Study|planned post-op anticoagulation|0|||
157235895|NCT02242201|567611731|FG002|Overall Study|planned post-op anticoagulation|0|||
157235896|NCT02242201|567611729|FG000|Overall Study|changed surgical procedure|1|||
157235897|NCT02242201|567611730|FG001|Overall Study|changed surgical procedure|0|||
157235898|NCT02242201|567611731|FG002|Overall Study|changed surgical procedure|0|||
157235899|NCT02242201|567611729|FG000|Overall Study|postponed surgery|0|||
157235900|NCT02242201|567611730|FG001|Overall Study|postponed surgery|0|||
157235901|NCT02242201|567611731|FG002|Overall Study|postponed surgery|1|||
157235902|NCT02242201|567611729|FG000|Overall Study|preoperative opioid consumption|0|||
157235903|NCT02242201|567611730|FG001|Overall Study|preoperative opioid consumption|1|||
157235904|NCT02242201|567611731|FG002|Overall Study|preoperative opioid consumption|0|||
157235905|NCT04149964|567611732|FG000|Overall Study|Lost to Follow-up|19|||
157235906|NCT04149964|567611733|FG001|Overall Study|Lost to Follow-up|18|||
157235907|NCT01697696|567611736|FG000|Overall Study|Study terminated by sponsor|0|||
157235908|NCT01697696|567611737|FG001|Overall Study|Study terminated by sponsor|3|||
157235909|NCT01697696|567611736|FG000|Overall Study|Protocol deviation|1|||
157235910|NCT01697696|567611737|FG001|Overall Study|Protocol deviation|0|||
157235911|NCT01697696|567611736|FG000|Overall Study|Physician Decision|1|||
157235912|NCT01697696|567611737|FG001|Overall Study|Physician Decision|0|||
157235913|NCT01697696|567611736|FG000|Overall Study|Death|4|||
157235914|NCT01697696|567611737|FG001|Overall Study|Death|2|||
157235915|NCT01697696|567611736|FG000|Overall Study|Lost to Follow-up|10|||
157235916|NCT01697696|567611737|FG001|Overall Study|Lost to Follow-up|7|||
157235917|NCT01697696|567611736|FG000|Overall Study|Subject/guardian decision|31|||
157235918|NCT01697696|567611737|FG001|Overall Study|Subject/guardian decision|35|||
157235919|NCT01424644|567611738|FG000|Overall Study|Adverse Event|2|||
157235920|NCT01424644|567611739|FG001|Overall Study|Adverse Event|0|||
157235921|NCT01424644|567611738|FG000|Overall Study|Withdrawal by Subject|9|||
157235922|NCT01424644|567611739|FG001|Overall Study|Withdrawal by Subject|12|||
157235923|NCT01424644|567611738|FG000|Overall Study|Lost to Follow-up|16|||
157235924|NCT01424644|567611739|FG001|Overall Study|Lost to Follow-up|12|||
157235925|NCT01424644|567611738|FG000|Overall Study|Protocol Violation|4|||
157235926|NCT01424644|567611739|FG001|Overall Study|Protocol Violation|3|||
157085823|NCT01373151|567066953|FG004|Period 2|Lack of Efficacy|2|||
157085824|NCT01373151|567066954|FG005|Period 2|Lack of Efficacy|0|||
157085825|NCT01373151|567066955|FG006|Period 2|Lack of Efficacy|3|||
157085826|NCT01373151|567066949|FG000|Period 2|Adverse Event|0|||
157085827|NCT01373151|567066950|FG001|Period 2|Adverse Event|0|||
157085828|NCT01373151|567066951|FG002|Period 2|Adverse Event|3|||
157085829|NCT01373151|567066952|FG003|Period 2|Adverse Event|3|||
157235927|NCT01424644|567611738|FG000|Overall Study|Administrative Reason|1|||
157235928|NCT01424644|567611739|FG001|Overall Study|Administrative Reason|0|||
157235929|NCT01424644|567611738|FG000|Overall Study|Unable to Classify|1|||
157235930|NCT01424644|567611739|FG001|Overall Study|Unable to Classify|0|||
157235931|NCT01577381|567611747|FG000|Overall Study|Discontinued|2|||
157235932|NCT01577381|567611748|FG001|Overall Study|Discontinued|1|||
157235933|NCT01577381|567611749|FG002|Overall Study|Discontinued|2|||
157235934|NCT01577381|567611750|FG003|Overall Study|Discontinued|2|||
157235935|NCT01577381|567611747|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
157085830|NCT01373151|567066953|FG004|Period 2|Adverse Event|0|||
157085831|NCT01373151|567066954|FG005|Period 2|Adverse Event|0|||
157085832|NCT01373151|567066955|FG006|Period 2|Adverse Event|1|||
157085833|NCT01373151|567066949|FG000|Period 2|subject request to discontinue|0|||
157085834|NCT01373151|567066950|FG001|Period 2|subject request to discontinue|1|||
157085835|NCT01373151|567066951|FG002|Period 2|subject request to discontinue|0|||
157085836|NCT01373151|567066952|FG003|Period 2|subject request to discontinue|0|||
157085837|NCT01373151|567066953|FG004|Period 2|subject request to discontinue|0|||
157085838|NCT01373151|567066954|FG005|Period 2|subject request to discontinue|0|||
157085839|NCT01373151|567066955|FG006|Period 2|subject request to discontinue|0|||
157085840|NCT01373151|567066949|FG000|Period 2|Withdrawal by Subject|0|||
157085841|NCT01373151|567066950|FG001|Period 2|Withdrawal by Subject|0|||
157085842|NCT01373151|567066951|FG002|Period 2|Withdrawal by Subject|0|||
157085843|NCT01373151|567066952|FG003|Period 2|Withdrawal by Subject|1|||
157085844|NCT01373151|567066953|FG004|Period 2|Withdrawal by Subject|0|||
157085845|NCT01373151|567066954|FG005|Period 2|Withdrawal by Subject|0|||
157085846|NCT01373151|567066955|FG006|Period 2|Withdrawal by Subject|0|||
157085847|NCT01373151|567066949|FG000|Period 2|Other|0|||
157085848|NCT01373151|567066950|FG001|Period 2|Other|0|||
157085849|NCT01373151|567066951|FG002|Period 2|Other|1|||
157085850|NCT01373151|567066952|FG003|Period 2|Other|0|||
157085851|NCT01373151|567066953|FG004|Period 2|Other|0|||
157085852|NCT01373151|567066954|FG005|Period 2|Other|0|||
157085853|NCT01373151|567066955|FG006|Period 2|Other|1|||
157085854|NCT02001064|567066960|FG000|Overall Study|Withdrawal by Subject|2|||
157085855|NCT02001064|567066961|FG001|Overall Study|Withdrawal by Subject|1|||
157085856|NCT00513305|567066962|FG000|Overall Study|Adverse Event|6|||
157085857|NCT00513305|567066963|FG001|Overall Study|Adverse Event|2|||
157085858|NCT00513305|567066962|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
157085859|NCT00513305|567066963|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
157085860|NCT00513305|567066962|FG000|Overall Study|Lack of Efficacy|8|||
157085861|NCT00513305|567066963|FG001|Overall Study|Lack of Efficacy|13|||
157085862|NCT00513305|567066962|FG000|Overall Study|Withdrawal by Subject|1|||
157085863|NCT00513305|567066963|FG001|Overall Study|Withdrawal by Subject|2|||
157085864|NCT00513305|567066962|FG000|Overall Study|Disease progression|8|||
157085865|NCT00513305|567066963|FG001|Overall Study|Disease progression|5|||
157085866|NCT00513305|567066962|FG000|Overall Study|Eligible for stem cell transplant|1|||
157085867|NCT00513305|567066963|FG001|Overall Study|Eligible for stem cell transplant|0|||
157085868|NCT00513305|567066962|FG000|Overall Study|Hematologic counts did not recover|1|||
157085869|NCT00513305|567066963|FG001|Overall Study|Hematologic counts did not recover|0|||
157085870|NCT00513305|567066962|FG000|Overall Study|Physician Decision|1|||
157235936|NCT01577381|567611748|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
157235937|NCT01577381|567611749|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
157235938|NCT01577381|567611750|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
157235939|NCT01313780|567611751|FG000|Overall Study|Lack of Efficacy|4|||
157235940|NCT01313780|567611752|FG001|Overall Study|Lack of Efficacy|2|||
157085871|NCT00513305|567066963|FG001|Overall Study|Physician Decision|0|||
157085872|NCT00513305|567066962|FG000|Overall Study|Persistent hypocellularity|0|||
157085873|NCT00513305|567066963|FG001|Overall Study|Persistent hypocellularity|1|||
157085874|NCT00513305|567066962|FG000|Overall Study|Sponsor Decision|0|||
157085875|NCT00513305|567066963|FG001|Overall Study|Sponsor Decision|2|||
157085876|NCT02101385|567066971|FG000|Study Treatment|Disease Progression|9|||
157085877|NCT02101385|567066972|FG001|Study Treatment|Disease Progression|3|||
157085878|NCT02101385|567066971|FG000|Study Treatment|Alternative therapy|0|||
157085879|NCT02101385|567066972|FG001|Study Treatment|Alternative therapy|1|||
157085880|NCT02101385|567066971|FG000|Study Treatment|No treatment, per protocol criteria|0|||
157085881|NCT02101385|567066972|FG001|Study Treatment|No treatment, per protocol criteria|4|||
157235941|NCT01313780|567611751|FG000|Overall Study|Adverse Event|6|||
157235942|NCT01313780|567611752|FG001|Overall Study|Adverse Event|11|||
157235943|NCT01313780|567611751|FG000|Overall Study|Withdrawal by Subject|2|||
157235944|NCT01313780|567611752|FG001|Overall Study|Withdrawal by Subject|8|||
157085882|NCT02101385|567066971|FG000|Study Treatment|Patient Non compliance|0|||
157085883|NCT02101385|567066972|FG001|Study Treatment|Patient Non compliance|2|||
157085884|NCT02101385|567066971|FG000|Study Treatment|Withdrawal by Subject|5|||
157085885|NCT02101385|567066972|FG001|Study Treatment|Withdrawal by Subject|2|||
157085886|NCT02101385|567066971|FG000|Study Treatment|screen failure|1|||
157195981|NCT00286234|567459799|FG000|Overall Study|Physician Decision|1|||
157195982|NCT00286234|567459800|FG001|Overall Study|Physician Decision|0|||
157195983|NCT00286234|567459801|FG002|Overall Study|Physician Decision|0|||
157195984|NCT00286234|567459802|FG003|Overall Study|Physician Decision|1|||
157195985|NCT00286234|567459799|FG000|Overall Study|Adverse Event|0|||
157195986|NCT00286234|567459800|FG001|Overall Study|Adverse Event|0|||
157195987|NCT00286234|567459801|FG002|Overall Study|Adverse Event|0|||
157195988|NCT00286234|567459802|FG003|Overall Study|Adverse Event|1|||
157195989|NCT00286234|567459799|FG000|Overall Study|Adverse Event|0|||
157195990|NCT00286234|567459800|FG001|Overall Study|Adverse Event|0|||
157195991|NCT00286234|567459801|FG002|Overall Study|Adverse Event|0|||
157195992|NCT00286234|567459802|FG003|Overall Study|Adverse Event|1|||
157195993|NCT03137173|567459817|FG000|Overall Study|Withdrawal by Subject|8|||
157195994|NCT03137173|567459818|FG001|Overall Study|Withdrawal by Subject|13|||
157195995|NCT03137173|567459817|FG000|Overall Study|Death|1|||
157195996|NCT03137173|567459818|FG001|Overall Study|Death|3|||
157195997|NCT03137173|567459817|FG000|Overall Study|Physician Decision|1|||
157195998|NCT03137173|567459818|FG001|Overall Study|Physician Decision|0|||
157195999|NCT03137173|567459817|FG000|Overall Study|Lost to Follow-up|13|||
157196000|NCT03137173|567459818|FG001|Overall Study|Lost to Follow-up|18|||
157196001|NCT03137173|567459817|FG000|Overall Study|Other reasons|3|||
157196002|NCT03137173|567459818|FG001|Overall Study|Other reasons|2|||
157196003|NCT03524664|567459819|FG000|Overall Study|Withdrawal by Subject|1|||
157196004|NCT03524664|567459820|FG001|Overall Study|Withdrawal by Subject|2|||
157196005|NCT03524664|567459819|FG000|Overall Study|Lost to Follow-up|4|||
157196006|NCT03524664|567459820|FG001|Overall Study|Lost to Follow-up|13|||
157196007|NCT01482598|567459821|FG000|Overall Study|Death|7|||
157196008|NCT01482598|567459822|FG001|Overall Study|Death|10|||
157196009|NCT01482598|567459821|FG000|Overall Study|Physician Decision|0|||
157196010|NCT01482598|567459822|FG001|Overall Study|Physician Decision|3|||
157196011|NCT01482598|567459821|FG000|Overall Study|Withdrawal by Subject|4|||
157196012|NCT01482598|567459822|FG001|Overall Study|Withdrawal by Subject|5|||
157196013|NCT01482598|567459821|FG000|Overall Study|Lost to Follow-up|5|||
157235945|NCT01313780|567611751|FG000|Overall Study|Protocol Violation|10|||
157085887|NCT02101385|567066972|FG001|Study Treatment|screen failure|0|||
157196014|NCT01482598|567459822|FG001|Overall Study|Lost to Follow-up|4|||
157196015|NCT02694562|567459823|FG000|Overall Study|Death|8|||
157196016|NCT02694562|567459823|FG000|Overall Study|Protocol Violation|4|||
157085888|NCT02101385|567066971|FG000|Study Treatment|AE/Side Effects/Complications|8|||
157085889|NCT02101385|567066972|FG001|Study Treatment|AE/Side Effects/Complications|0|||
157085890|NCT02101385|567066971|FG000|Study Treatment|Lost to Follow-up|1|||
157085891|NCT02101385|567066972|FG001|Study Treatment|Lost to Follow-up|0|||
157085892|NCT02101385|567066971|FG000|Study Treatment|Disease Progression before treatment|1|||
157085893|NCT02101385|567066972|FG001|Study Treatment|Disease Progression before treatment|0|||
157085894|NCT02101385|567066971|FG000|Study Treatment|Death|1|||
157085895|NCT02101385|567066972|FG001|Study Treatment|Death|0|||
157085896|NCT02101385|567066971|FG000|Follow up|Lost to Follow-up|4|||
157085897|NCT02101385|567066972|FG001|Follow up|Lost to Follow-up|9|||
157085898|NCT02101385|567066971|FG000|Follow up|Refused to follow up|5|||
157085899|NCT02101385|567066972|FG001|Follow up|Refused to follow up|4|||
157085900|NCT02101385|567066971|FG000|Follow up|Death|21|||
157085901|NCT02101385|567066972|FG001|Follow up|Death|39|||
157085902|NCT02101385|567066971|FG000|Follow up|study completed|33|||
157085903|NCT02101385|567066972|FG001|Follow up|study completed|52|||
157085904|NCT02101385|567066971|FG000|Follow up|screen failure|2|||
157085905|NCT02101385|567066972|FG001|Follow up|screen failure|0|||
157085906|NCT02101385|567066971|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
157085907|NCT02101385|567066972|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
157085908|NCT02101385|567066971|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
157085909|NCT02101385|567066972|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
157085910|NCT02101385|567066971|FG000|Follow up|Withdrawal by Subject|2|||
157085911|NCT02101385|567066972|FG001|Follow up|Withdrawal by Subject|2|||
157085912|NCT02101385|567066971|FG000|Follow up|PI requested closure of site|0|||
157085913|NCT02101385|567066972|FG001|Follow up|PI requested closure of site|5|||
157085914|NCT03973931|567066979|FG000|Overall Study|Lost to Follow-up|47|||
157085915|NCT03973931|567066980|FG001|Overall Study|Lost to Follow-up|63|||
157085916|NCT03973931|567066981|FG002|Overall Study|Lost to Follow-up|51|||
157085917|NCT03973931|567066982|FG003|Overall Study|Lost to Follow-up|54|||
157085918|NCT03973931|567066979|FG000|Overall Study|opted out|6|||
157085919|NCT03973931|567066980|FG001|Overall Study|opted out|5|||
157085920|NCT03973931|567066981|FG002|Overall Study|opted out|5|||
157085921|NCT03973931|567066982|FG003|Overall Study|opted out|1|||
157085922|NCT01982448|567066983|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
157085923|NCT01982448|567066984|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
157085924|NCT01982448|567066983|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
157085925|NCT01982448|567066984|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
157085926|NCT01982448|567066983|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
157085927|NCT01982448|567066984|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
157085928|NCT01982448|567066983|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
157085929|NCT01982448|567066984|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
157085930|NCT00978627|567068518|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
157085931|NCT00978627|567068519|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
157085932|NCT00978627|567068518|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
157085933|NCT00978627|567068519|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
157085934|NCT00978627|567068518|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
157085935|NCT00978627|567068519|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
157196017|NCT02694562|567459823|FG000|Overall Study|Lost to Follow-up|3|||
157196018|NCT02694562|567459823|FG000|Overall Study|Screen Failure|2|||
157196019|NCT02694562|567459823|FG000|Overall Study|Physician Decision|1|||
157196020|NCT00423267|567459824|FG000|Period A|Withdrawal by Subject|0|||
157196021|NCT00423267|567459825|FG001|Period A|Withdrawal by Subject|1|||
157196022|NCT00423267|567459824|FG000|Period A|Non-compliance with protocol|1|||
157196023|NCT00423267|567459825|FG001|Period A|Non-compliance with protocol|0|||
157196024|NCT00423267|567459824|FG000|Period A|Administrative|1|||
157196025|NCT00423267|567459825|FG001|Period A|Administrative|0|||
157196026|NCT03702166|567459826|FG000|Overall Study|Lost to Follow-up|1|||
157196027|NCT03702166|567459826|FG000|Overall Study|Withdrawal by Subject|1|||
157196028|NCT01333865|567459827|FG000|Overall Study|Adverse Event|2|||
157196029|NCT01521494|567459834|FG000|Overall Study|Adverse Event|1|||
157196030|NCT01521494|567459835|FG001|Overall Study|Adverse Event|2|||
157235946|NCT01313780|567611752|FG001|Overall Study|Protocol Violation|4|||
157085936|NCT00978627|567068518|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
157085937|NCT00978627|567068519|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
157085938|NCT00978627|567068518|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
157085939|NCT00978627|567068519|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
157085940|NCT00978627|567068518|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
157085941|NCT00978627|567068519|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
157085942|NCT00978627|567068518|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
157196031|NCT01521494|567459836|FG002|Overall Study|Adverse Event|9|||
157196032|NCT01521494|567459837|FG003|Overall Study|Adverse Event|6|||
157196033|NCT01521494|567459838|FG004|Overall Study|Adverse Event|2|||
157085943|NCT00978627|567068519|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
157085944|NCT00978627|567068518|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
157085945|NCT00978627|567068519|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
157085946|NCT00978627|567068518|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
157085947|NCT00978627|567068519|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
157085948|NCT02738203|567068526|FG000|Overall Study|Failed IUD Insertion|2|||
157085949|NCT02738203|567068527|FG001|Overall Study|Failed IUD Insertion|2|||
157085950|NCT02738203|567068526|FG000|Overall Study|Protocol Violation|0|||
157085951|NCT02738203|567068527|FG001|Overall Study|Protocol Violation|1|||
157085952|NCT05087979|567068528|FG000|Overall Study|Converted to general anesthesia|1|||
157085953|NCT05087979|567068529|FG001|Overall Study|Converted to general anesthesia|0|||
157085954|NCT01290315|567068530|FG000|Overall Study|Adverse Event|0|||
157085955|NCT01290315|567068531|FG001|Overall Study|Adverse Event|0|||
157085956|NCT01290315|567068532|FG002|Overall Study|Adverse Event|0|||
157085957|NCT01290315|567068533|FG003|Overall Study|Adverse Event|3|||
157085958|NCT01290315|567068530|FG000|Overall Study|Selection criteria/compliance|2|||
157085959|NCT01290315|567068531|FG001|Overall Study|Selection criteria/compliance|1|||
157085960|NCT01290315|567068532|FG002|Overall Study|Selection criteria/compliance|0|||
157085961|NCT01290315|567068533|FG003|Overall Study|Selection criteria/compliance|2|||
157085962|NCT01290315|567068530|FG000|Overall Study|Lost to Follow-up|0|||
157085963|NCT01290315|567068531|FG001|Overall Study|Lost to Follow-up|1|||
157085964|NCT01290315|567068532|FG002|Overall Study|Lost to Follow-up|0|||
157085965|NCT01290315|567068533|FG003|Overall Study|Lost to Follow-up|0|||
157085966|NCT01290315|567068530|FG000|Overall Study|Withdrawal by Subject|1|||
157085967|NCT01290315|567068531|FG001|Overall Study|Withdrawal by Subject|1|||
157085968|NCT01290315|567068532|FG002|Overall Study|Withdrawal by Subject|0|||
157085969|NCT01290315|567068533|FG003|Overall Study|Withdrawal by Subject|0|||
157085970|NCT03725085|567068534|FG000|Overall Study|Lost to Follow-up|2|||
157085971|NCT00705679|567068535|FG000|Overall Study|Adverse Event|1|||
157085972|NCT00705679|567068536|FG001|Overall Study|Adverse Event|1|||
157085973|NCT00705679|567068537|FG002|Overall Study|Adverse Event|0|||
157085974|NCT00705679|567068538|FG003|Overall Study|Adverse Event|0|||
157085975|NCT00705679|567068539|FG004|Overall Study|Adverse Event|0|||
157085976|NCT00705679|567068535|FG000|Overall Study|Death|0|||
157085977|NCT00705679|567068536|FG001|Overall Study|Death|0|||
157085978|NCT00705679|567068537|FG002|Overall Study|Death|3|||
157085979|NCT00705679|567068538|FG003|Overall Study|Death|2|||
157085980|NCT00705679|567068539|FG004|Overall Study|Death|1|||
157085981|NCT00705679|567068535|FG000|Overall Study|Lost to Follow-up|32|||
157085982|NCT00705679|567068536|FG001|Overall Study|Lost to Follow-up|60|||
157085983|NCT00705679|567068537|FG002|Overall Study|Lost to Follow-up|44|||
157085984|NCT00705679|567068538|FG003|Overall Study|Lost to Follow-up|30|||
157085985|NCT00705679|567068539|FG004|Overall Study|Lost to Follow-up|35|||
157085986|NCT00705679|567068535|FG000|Overall Study|Physician Decision|0|||
157085987|NCT00705679|567068536|FG001|Overall Study|Physician Decision|1|||
157085988|NCT00705679|567068537|FG002|Overall Study|Physician Decision|0|||
157085989|NCT00705679|567068538|FG003|Overall Study|Physician Decision|1|||
157085990|NCT00705679|567068539|FG004|Overall Study|Physician Decision|0|||
157085991|NCT00705679|567068535|FG000|Overall Study|Withdrawal by Subject|32|||
157085992|NCT00705679|567068536|FG001|Overall Study|Withdrawal by Subject|77|||
157085993|NCT00705679|567068537|FG002|Overall Study|Withdrawal by Subject|68|||
157085994|NCT00705679|567068538|FG003|Overall Study|Withdrawal by Subject|47|||
157085995|NCT00705679|567068539|FG004|Overall Study|Withdrawal by Subject|33|||
157085996|NCT02704754|567068540|FG000|Overall Study|Lost to Follow-up|1|||
157085997|NCT02704754|567068541|FG001|Overall Study|Lost to Follow-up|1|||
157085998|NCT02704754|567068540|FG000|Overall Study|Lack of Efficacy|1|||
157085999|NCT02704754|567068541|FG001|Overall Study|Lack of Efficacy|0|||
157086000|NCT02704754|567068540|FG000|Overall Study|Withdrawal by Subject|1|||
157086001|NCT02704754|567068541|FG001|Overall Study|Withdrawal by Subject|0|||
157086002|NCT00423943|567068544|FG000|Overall Study|Withdrawal by Subject|3|||
157086003|NCT00423943|567068545|FG001|Overall Study|Withdrawal by Subject|1|||
157086004|NCT03730480|567068546|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
157086005|NCT01248780|567068547|FG000|Overall Study|Lack of Efficacy|2|||
157086006|NCT01248780|567068548|FG001|Overall Study|Lack of Efficacy|0|||
157235947|NCT01313780|567611751|FG000|Overall Study|missing data|3|||
157086007|NCT01248780|567068547|FG000|Overall Study|Lost to Follow-up|0|||
157086008|NCT01248780|567068548|FG001|Overall Study|Lost to Follow-up|1|||
157086009|NCT01248780|567068547|FG000|Overall Study|Death|0|||
157086010|NCT01248780|567068548|FG001|Overall Study|Death|1|||
157086011|NCT01248780|567068547|FG000|Overall Study|Adverse Event|2|||
157086012|NCT01248780|567068548|FG001|Overall Study|Adverse Event|7|||
157086013|NCT01248780|567068547|FG000|Overall Study|Protocol Violation|1|||
157086014|NCT01248780|567068548|FG001|Overall Study|Protocol Violation|1|||
157086015|NCT01248780|567068547|FG000|Overall Study|Withdrawal by Subject|4|||
157086016|NCT01248780|567068548|FG001|Overall Study|Withdrawal by Subject|4|||
157235948|NCT01313780|567611752|FG001|Overall Study|missing data|3|||
157086017|NCT01248780|567068547|FG000|Overall Study|Not treated|0|||
157086018|NCT01248780|567068548|FG001|Overall Study|Not treated|1|||
157086019|NCT00107120|567068555|FG000|Overall Study|Adverse Event|4|||
157086020|NCT00107120|567068556|FG001|Overall Study|Adverse Event|1|||
157086021|NCT00107120|567068555|FG000|Overall Study|Lack of Efficacy|5|||
157086022|NCT00107120|567068556|FG001|Overall Study|Lack of Efficacy|5|||
157086023|NCT00107120|567068555|FG000|Overall Study|Protocol Violation|3|||
157086024|NCT00107120|567068556|FG001|Overall Study|Protocol Violation|0|||
157086025|NCT00107120|567068555|FG000|Overall Study|Withdrawal by Subject|8|||
157086026|NCT00107120|567068556|FG001|Overall Study|Withdrawal by Subject|9|||
157086027|NCT00107120|567068555|FG000|Overall Study|Lost to Follow-up|8|||
157086028|NCT00107120|567068556|FG001|Overall Study|Lost to Follow-up|6|||
157086029|NCT00107120|567068555|FG000|Overall Study|Pregnancy|0|||
157086030|NCT00107120|567068556|FG001|Overall Study|Pregnancy|1|||
157086031|NCT00107120|567068555|FG000|Overall Study|moving away from site|1|||
157086032|NCT00107120|567068556|FG001|Overall Study|moving away from site|1|||
157086033|NCT00107120|567068555|FG000|Overall Study|death of parent|0|||
157086034|NCT00107120|567068556|FG001|Overall Study|death of parent|1|||
157086035|NCT04214600|567068559|FG000|Overall Study|Lost to Follow-up|9|||
157086036|NCT04214600|567068560|FG001|Overall Study|Lost to Follow-up|14|||
157086037|NCT01635920|567068561|FG000|Overall Study|Adverse Event|1|||
157086038|NCT01635920|567068562|FG001|Overall Study|Adverse Event|0|||
157086039|NCT01635920|567068561|FG000|Overall Study|Lost to Follow-up|0|||
157086040|NCT01635920|567068562|FG001|Overall Study|Lost to Follow-up|1|||
157086041|NCT01635920|567068561|FG000|Overall Study|Subject decision|2|||
157086042|NCT01635920|567068562|FG001|Overall Study|Subject decision|0|||
157086043|NCT00836745|567068564|FG000|Overall Study|Death|2|||
157086044|NCT00836745|567068564|FG000|Overall Study|Lost to Follow-up|10|||
157086045|NCT00836745|567068564|FG000|Overall Study|Adverse Event|3|||
157086046|NCT00836745|567068564|FG000|Overall Study|Objective progression or relapse|4|||
157086047|NCT00836745|567068564|FG000|Overall Study|Other|2|||
157086048|NCT01144052|567068565|FG000|Overall Study|Withdrawal by Subject|1|||
157086049|NCT01144052|567068566|FG001|Overall Study|Withdrawal by Subject|1|||
157086050|NCT03836716|567068570|FG000|Overall Study|Adverse Event|3|||
157086051|NCT03836716|567068570|FG000|Overall Study|Death|22|||
157086052|NCT03836716|567068570|FG000|Overall Study|Withdrawal by Subject|8|||
157086053|NCT03836716|567068570|FG000|Overall Study|Study terminated by sponsor|87|||
157086054|NCT01983254|567068571|FG000|Overall Study|Death|6|||
157086055|NCT01983254|567068572|FG001|Overall Study|Death|6|||
157086056|NCT01983254|567068571|FG000|Overall Study|Lost to Follow-up|17|||
157086057|NCT01983254|567068572|FG001|Overall Study|Lost to Follow-up|16|||
157086058|NCT01983254|567068571|FG000|Overall Study|too ill|11|||
157086059|NCT01983254|567068572|FG001|Overall Study|too ill|8|||
157086060|NCT01699503|567068575|FG000|Overall Study|Death|31|||
157086061|NCT01699503|567068576|FG001|Overall Study|Death|40|||
157086062|NCT01699503|567068575|FG000|Overall Study|Withdrawal by Subject|65|||
157086063|NCT01699503|567068576|FG001|Overall Study|Withdrawal by Subject|57|||
157086064|NCT01699503|567068575|FG000|Overall Study|Lost to Follow-up|121|||
157086065|NCT01699503|567068576|FG001|Overall Study|Lost to Follow-up|117|||
157086066|NCT01699503|567068575|FG000|Overall Study|Excluded due to quality|783|||
157086067|NCT01699503|567068576|FG001|Overall Study|Excluded due to quality|791|||
157086068|NCT01639560|567068579|FG000|Overall Study|Withdrawal by Subject|9|||
157086069|NCT01639560|567068580|FG001|Overall Study|Withdrawal by Subject|14|||
157086070|NCT01639560|567068579|FG000|Overall Study|Lack of Efficacy|1|||
157086071|NCT01639560|567068580|FG001|Overall Study|Lack of Efficacy|2|||
157086072|NCT01639560|567068579|FG000|Overall Study|Lost to Follow-up|9|||
157086073|NCT01639560|567068580|FG001|Overall Study|Lost to Follow-up|11|||
157086074|NCT01639560|567068579|FG000|Overall Study|Adverse Event|0|||
157086075|NCT01639560|567068580|FG001|Overall Study|Adverse Event|2|||
157086076|NCT00766363|567068582|FG000|Overall Study|Withdrawal by Subject|1|||
157086077|NCT00766363|567068583|FG001|Overall Study|Withdrawal by Subject|0|||
157086078|NCT00766363|567068584|FG002|Overall Study|Withdrawal by Subject|0|||
157196034|NCT01521494|567459834|FG000|Overall Study|Lack of Efficacy|0|||
157196035|NCT01521494|567459835|FG001|Overall Study|Lack of Efficacy|0|||
157086079|NCT00766363|567068585|FG003|Overall Study|Withdrawal by Subject|0|||
157086080|NCT00766363|567068582|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
157086081|NCT00766363|567068583|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
157086082|NCT00766363|567068584|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
157086083|NCT00766363|567068585|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
157086084|NCT00911937|567068586|FG000|Overall Study|Death|1|||
157086085|NCT00911937|567068587|FG001|Overall Study|Death|0|||
157086086|NCT00911937|567068586|FG000|Overall Study|Lost to Follow-up|8|||
157086087|NCT00911937|567068587|FG001|Overall Study|Lost to Follow-up|5|||
157086088|NCT00911937|567068586|FG000|Overall Study|Withdrawal by Subject|10|||
157086089|NCT00911937|567068587|FG001|Overall Study|Withdrawal by Subject|7|||
157086090|NCT00911937|567068586|FG000|Overall Study|Withdrawn due to pregnancy|1|||
157086091|NCT00911937|567068587|FG001|Overall Study|Withdrawn due to pregnancy|0|||
157086092|NCT00911937|567068586|FG000|Overall Study|Adverse Event|11|||
157196036|NCT01521494|567459836|FG002|Overall Study|Lack of Efficacy|0|||
157196037|NCT01521494|567459837|FG003|Overall Study|Lack of Efficacy|0|||
157196038|NCT01521494|567459838|FG004|Overall Study|Lack of Efficacy|2|||
157086093|NCT00911937|567068587|FG001|Overall Study|Adverse Event|25|||
157086094|NCT00911937|567068586|FG000|Overall Study|Lack of Efficacy|11|||
157086095|NCT00911937|567068587|FG001|Overall Study|Lack of Efficacy|6|||
157086096|NCT00911937|567068586|FG000|Overall Study|Did not meet inclusion criteria|9|||
157086097|NCT00911937|567068587|FG001|Overall Study|Did not meet inclusion criteria|11|||
157086098|NCT00911937|567068586|FG000|Overall Study|Protocol Violation|14|||
157086099|NCT00911937|567068587|FG001|Overall Study|Protocol Violation|23|||
157086100|NCT00911937|567068586|FG000|Overall Study|Randomized but not treated|13|||
157086101|NCT00911937|567068587|FG001|Overall Study|Randomized but not treated|13|||
157086102|NCT00911937|567068586|FG000|Overall Study|Other|9|||
157086103|NCT00911937|567068587|FG001|Overall Study|Other|5|||
157086104|NCT01498679|567068588|FG000|Overall Study|Adverse Event|1|||
157086105|NCT01498679|567068589|FG001|Overall Study|Adverse Event|4|||
157086106|NCT01498679|567068588|FG000|Overall Study|Lack of Efficacy|72|||
157086107|NCT01498679|567068589|FG001|Overall Study|Lack of Efficacy|12|||
157086108|NCT01498679|567068588|FG000|Overall Study|Protocol Violation|4|||
157086109|NCT01498679|567068589|FG001|Overall Study|Protocol Violation|0|||
157086110|NCT01498679|567068588|FG000|Overall Study|Physician Decision|0|||
157086111|NCT01498679|567068589|FG001|Overall Study|Physician Decision|2|||
157086112|NCT01498679|567068588|FG000|Overall Study|Withdrawal by Subject|12|||
157086113|NCT01498679|567068589|FG001|Overall Study|Withdrawal by Subject|4|||
157086114|NCT01871805|567068593|FG000|Phase I|Death|7|||
157086115|NCT01871805|567068594|FG001|Phase I|Death|4|||
157086116|NCT01871805|567068595|FG002|Phase I|Death|6|||
157086117|NCT01871805|567068596|FG003|Phase I|Death|2|||
157086118|NCT01871805|567068597|FG004|Phase I|Death|9|||
157086119|NCT01871805|567068598|FG005|Phase I|Death|0|||
157086120|NCT01871805|567068593|FG000|Phase I|Alive in Survival Follow-up|0|||
157086121|NCT01871805|567068594|FG001|Phase I|Alive in Survival Follow-up|2|||
157086122|NCT01871805|567068595|FG002|Phase I|Alive in Survival Follow-up|4|||
157086123|NCT01871805|567068596|FG003|Phase I|Alive in Survival Follow-up|5|||
157086124|NCT01871805|567068597|FG004|Phase I|Alive in Survival Follow-up|4|||
157086125|NCT01871805|567068598|FG005|Phase I|Alive in Survival Follow-up|0|||
157086126|NCT01871805|567068593|FG000|Phase I|Lost to Follow-up|0|||
157086127|NCT01871805|567068594|FG001|Phase I|Lost to Follow-up|1|||
157086128|NCT01871805|567068595|FG002|Phase I|Lost to Follow-up|3|||
157086129|NCT01871805|567068596|FG003|Phase I|Lost to Follow-up|0|||
157086130|NCT01871805|567068597|FG004|Phase I|Lost to Follow-up|0|||
157086131|NCT01871805|567068598|FG005|Phase I|Lost to Follow-up|0|||
157086132|NCT01871805|567068593|FG000|Phase II|Death|0|||
157086133|NCT01871805|567068594|FG001|Phase II|Death|0|||
157086134|NCT01871805|567068595|FG002|Phase II|Death|0|||
157086135|NCT01871805|567068596|FG003|Phase II|Death|0|||
157086136|NCT01871805|567068597|FG004|Phase II|Death|0|||
157086137|NCT01871805|567068598|FG005|Phase II|Death|45|||
157086138|NCT01871805|567068593|FG000|Phase II|Alive in Survival Follow-up|0|||
157086139|NCT01871805|567068594|FG001|Phase II|Alive in Survival Follow-up|0|||
157086140|NCT01871805|567068595|FG002|Phase II|Alive in Survival Follow-up|0|||
157086141|NCT01871805|567068596|FG003|Phase II|Alive in Survival Follow-up|0|||
157086142|NCT01871805|567068597|FG004|Phase II|Alive in Survival Follow-up|0|||
157086143|NCT01871805|567068598|FG005|Phase II|Alive in Survival Follow-up|29|||
157086144|NCT01871805|567068593|FG000|Phase II|Lost to Follow-up|0|||
157086145|NCT01871805|567068594|FG001|Phase II|Lost to Follow-up|0|||
157086146|NCT01871805|567068595|FG002|Phase II|Lost to Follow-up|0|||
157086147|NCT01871805|567068596|FG003|Phase II|Lost to Follow-up|0|||
157086148|NCT01871805|567068597|FG004|Phase II|Lost to Follow-up|0|||
157086149|NCT01871805|567068598|FG005|Phase II|Lost to Follow-up|13|||
157086150|NCT03484273|567068607|FG000|Overall Study|Equipment Malfunction|1|||
157086151|NCT03484273|567068607|FG000|Overall Study|Data excluded from analysis|1|||
157086152|NCT00468104|567068613|FG000|First Intervention|Protocol Violation|2|||
157086153|NCT00468104|567068614|FG001|First Intervention|Protocol Violation|1|||
157086154|NCT00468104|567068613|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
157086155|NCT00468104|567068614|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
157086156|NCT00468104|567068613|FG000|First Intervention|died within 3 weeks|1|||
157086157|NCT00468104|567068614|FG001|First Intervention|died within 3 weeks|0|||
157086158|NCT00468104|567068613|FG000|First Intervention|malposition/blocked chest tube tube|2|||
157086159|NCT00468104|567068614|FG001|First Intervention|malposition/blocked chest tube tube|0|||
157086160|NCT00468104|567068613|FG000|First Intervention|large lung mass with minimal effusion|1|||
157086161|NCT00468104|567068614|FG001|First Intervention|large lung mass with minimal effusion|0|||
157086162|NCT00468104|567068613|FG000|First Intervention|associated prolonged pneumothorax|1|||
157086163|NCT00468104|567068614|FG001|First Intervention|associated prolonged pneumothorax|0|||
157086164|NCT00468104|567068613|FG000|First Intervention|trapped lung|1|||
157086165|NCT00468104|567068614|FG001|First Intervention|trapped lung|0|||
157086166|NCT00468104|567068613|FG000|Second Intervention|Withdrawal by Subject|5|||
157086167|NCT00468104|567068614|FG001|Second Intervention|Withdrawal by Subject|2|||
157086168|NCT00468104|567068613|FG000|Second Intervention|discarded for malposition of chest tube|0|||
157086169|NCT00468104|567068614|FG001|Second Intervention|discarded for malposition of chest tube|2|||
157086170|NCT01263665|567068615|FG000|Overall Study|Withdrew Consent|1|||
157086171|NCT01263665|567068615|FG000|Overall Study|Lost to Follow-up|3|||
157086172|NCT01263665|567068615|FG000|Overall Study|Death|2|||
157086173|NCT01263665|567068615|FG000|Overall Study|Amputation above the ankle|1|||
157086174|NCT01263665|567068615|FG000|Overall Study|Surgical Bypass|2|||
157086175|NCT02706899|567068620|FG000|Overall Study|Withdrawal by Subject|1|||
157086176|NCT02706899|567068621|FG001|Overall Study|Withdrawal by Subject|0|||
157086177|NCT02706899|567068620|FG000|Overall Study|Death|8|||
157086178|NCT02706899|567068621|FG001|Overall Study|Death|0|||
157086179|NCT02706899|567068620|FG000|Overall Study|Study Termination by Sponsor|4|||
157086180|NCT02706899|567068621|FG001|Overall Study|Study Termination by Sponsor|6|||
157086181|NCT00324675|567068622|FG000|Overall Study|Adverse Event|1|||
157086182|NCT00324675|567068623|FG001|Overall Study|Adverse Event|0|||
157086183|NCT00381615|567068624|FG000|Overall Study|Withdrawal by Subject|1|||
157086184|NCT00381615|567068625|FG001|Overall Study|Withdrawal by Subject|3|||
157086185|NCT00381615|567068626|FG002|Overall Study|Withdrawal by Subject|0|||
157086186|NCT00381615|567068627|FG003|Overall Study|Withdrawal by Subject|1|||
157086187|NCT00381615|567068624|FG000|Overall Study|Lost to Follow-up|3|||
157086188|NCT00381615|567068625|FG001|Overall Study|Lost to Follow-up|2|||
157086189|NCT00381615|567068626|FG002|Overall Study|Lost to Follow-up|0|||
157086190|NCT00381615|567068627|FG003|Overall Study|Lost to Follow-up|1|||
157086191|NCT00381615|567068624|FG000|Overall Study|Protocol Violation|0|||
157086192|NCT00381615|567068625|FG001|Overall Study|Protocol Violation|0|||
157086193|NCT00381615|567068626|FG002|Overall Study|Protocol Violation|1|||
157086194|NCT00381615|567068627|FG003|Overall Study|Protocol Violation|0|||
157086195|NCT03181789|567068635|FG000|Overall Study|Withdrawal by Subject|0|||
157086196|NCT03181789|567068636|FG001|Overall Study|Withdrawal by Subject|1|||
157086197|NCT03181789|567068637|FG002|Overall Study|Withdrawal by Subject|1|||
157086198|NCT03181789|567068638|FG003|Overall Study|Withdrawal by Subject|0|||
157086199|NCT03181789|567068635|FG000|Overall Study|Lost to Follow-up|7|||
157086200|NCT03181789|567068636|FG001|Overall Study|Lost to Follow-up|1|||
157086201|NCT03181789|567068637|FG002|Overall Study|Lost to Follow-up|0|||
157086202|NCT03181789|567068638|FG003|Overall Study|Lost to Follow-up|0|||
157086203|NCT03181789|567068635|FG000|Overall Study|Participant unable to adhere to visit|0|||
157086204|NCT03181789|567068636|FG001|Overall Study|Participant unable to adhere to visit|1|||
157086205|NCT03181789|567068637|FG002|Overall Study|Participant unable to adhere to visit|0|||
157086206|NCT03181789|567068638|FG003|Overall Study|Participant unable to adhere to visit|0|||
157086207|NCT01131182|567068639|FG000|Overall Study|Withdrawal by Subject|1|||
157086208|NCT01131182|567068640|FG001|Overall Study|Withdrawal by Subject|1|||
157086209|NCT01131182|567068639|FG000|Overall Study|Lost to Follow-up|14|||
157086210|NCT01131182|567068640|FG001|Overall Study|Lost to Follow-up|15|||
157086211|NCT01131182|567068639|FG000|Overall Study|Other Reason|1|||
157086212|NCT01131182|567068640|FG001|Overall Study|Other Reason|0|||
157086213|NCT03001076|567068641|FG000|Overall Study|Withdrawal by patient|2|||
157086214|NCT03001076|567068642|FG001|Overall Study|Withdrawal by patient|0|||
157086215|NCT03001076|567068641|FG000|Overall Study|Other|1|||
157086216|NCT03001076|567068642|FG001|Overall Study|Other|0|||
157086217|NCT03001076|567068641|FG000|Overall Study|Adverse Event|3|||
157086218|NCT03001076|567068642|FG001|Overall Study|Adverse Event|3|||
157086219|NCT03001076|567068641|FG000|Overall Study|Sponsor decision|1|||
157086220|NCT03001076|567068642|FG001|Overall Study|Sponsor decision|0|||
157086221|NCT03001076|567068641|FG000|Overall Study|Lost to Follow-up|0|||
157086222|NCT03001076|567068642|FG001|Overall Study|Lost to Follow-up|2|||
157086223|NCT04602221|567068643|FG000|Overall Study|Discontinuation of trial treatment|0|||
157086224|NCT04602221|567068644|FG001|Overall Study|Discontinuation of trial treatment|0|||
157086225|NCT04602221|567068645|FG002|Overall Study|Discontinuation of trial treatment|1|||
157086226|NCT04602221|567068646|FG003|Overall Study|Discontinuation of trial treatment|0|||
157086227|NCT04602221|567068647|FG004|Overall Study|Discontinuation of trial treatment|0|||
157086228|NCT04602221|567068648|FG005|Overall Study|Discontinuation of trial treatment|0|||
157086229|NCT04602221|567068649|FG006|Overall Study|Discontinuation of trial treatment|0|||
157086230|NCT04602221|567068650|FG007|Overall Study|Discontinuation of trial treatment|0|||
157086231|NCT04602221|567068651|FG008|Overall Study|Discontinuation of trial treatment|0|||
157086232|NCT04602221|567068652|FG009|Overall Study|Discontinuation of trial treatment|0|||
157086233|NCT04602221|567068653|FG010|Overall Study|Discontinuation of trial treatment|0|||
157086234|NCT04602221|567068654|FG011|Overall Study|Discontinuation of trial treatment|0|||
157196039|NCT01521494|567459834|FG000|Overall Study|Withdrawal by Subject|1|||
157196040|NCT01521494|567459835|FG001|Overall Study|Withdrawal by Subject|1|||
157086235|NCT04602221|567068655|FG012|Overall Study|Discontinuation of trial treatment|0|||
157086236|NCT04602221|567068656|FG013|Overall Study|Discontinuation of trial treatment|0|||
157086237|NCT04602221|567068657|FG014|Overall Study|Discontinuation of trial treatment|0|||
157086238|NCT04602221|567068658|FG015|Overall Study|Discontinuation of trial treatment|0|||
157086239|NCT04602221|567068659|FG016|Overall Study|Discontinuation of trial treatment|0|||
157086240|NCT04602221|567068660|FG017|Overall Study|Discontinuation of trial treatment|0|||
157086241|NCT04602221|567068643|FG000|Overall Study|Other than listed|0|||
157086242|NCT04602221|567068644|FG001|Overall Study|Other than listed|0|||
157086243|NCT04602221|567068645|FG002|Overall Study|Other than listed|0|||
157196041|NCT01521494|567459836|FG002|Overall Study|Withdrawal by Subject|0|||
157086244|NCT04602221|567068646|FG003|Overall Study|Other than listed|0|||
157086245|NCT04602221|567068647|FG004|Overall Study|Other than listed|0|||
157086246|NCT04602221|567068648|FG005|Overall Study|Other than listed|0|||
157086247|NCT04602221|567068649|FG006|Overall Study|Other than listed|0|||
157086248|NCT04602221|567068650|FG007|Overall Study|Other than listed|0|||
157086249|NCT04602221|567068651|FG008|Overall Study|Other than listed|0|||
157086250|NCT04602221|567068652|FG009|Overall Study|Other than listed|0|||
157086251|NCT04602221|567068653|FG010|Overall Study|Other than listed|0|||
157086252|NCT04602221|567068654|FG011|Overall Study|Other than listed|0|||
157086253|NCT04602221|567068655|FG012|Overall Study|Other than listed|0|||
157086254|NCT04602221|567068656|FG013|Overall Study|Other than listed|0|||
157086255|NCT04602221|567068657|FG014|Overall Study|Other than listed|0|||
157086256|NCT04602221|567068658|FG015|Overall Study|Other than listed|1|||
157086257|NCT04602221|567068659|FG016|Overall Study|Other than listed|0|||
157086258|NCT04602221|567068660|FG017|Overall Study|Other than listed|1|||
157086259|NCT04602221|567068643|FG000|Overall Study|Withdrawal by Subject|0|||
157086260|NCT04602221|567068644|FG001|Overall Study|Withdrawal by Subject|0|||
157086261|NCT04602221|567068645|FG002|Overall Study|Withdrawal by Subject|0|||
157086262|NCT04602221|567068646|FG003|Overall Study|Withdrawal by Subject|0|||
157086263|NCT04602221|567068647|FG004|Overall Study|Withdrawal by Subject|0|||
157086264|NCT04602221|567068648|FG005|Overall Study|Withdrawal by Subject|0|||
157086265|NCT04602221|567068649|FG006|Overall Study|Withdrawal by Subject|0|||
157086266|NCT04602221|567068650|FG007|Overall Study|Withdrawal by Subject|0|||
157086267|NCT04602221|567068651|FG008|Overall Study|Withdrawal by Subject|0|||
157086268|NCT04602221|567068652|FG009|Overall Study|Withdrawal by Subject|0|||
157086269|NCT04602221|567068653|FG010|Overall Study|Withdrawal by Subject|0|||
157086270|NCT04602221|567068654|FG011|Overall Study|Withdrawal by Subject|0|||
157086271|NCT04602221|567068655|FG012|Overall Study|Withdrawal by Subject|1|||
157086272|NCT04602221|567068656|FG013|Overall Study|Withdrawal by Subject|0|||
157086273|NCT04602221|567068657|FG014|Overall Study|Withdrawal by Subject|0|||
157086274|NCT04602221|567068658|FG015|Overall Study|Withdrawal by Subject|0|||
157086275|NCT04602221|567068659|FG016|Overall Study|Withdrawal by Subject|0|||
157086276|NCT04602221|567068660|FG017|Overall Study|Withdrawal by Subject|0|||
157086277|NCT04602221|567068643|FG000|Overall Study|Lost to Follow-up|0|||
157086278|NCT04602221|567068644|FG001|Overall Study|Lost to Follow-up|0|||
157086279|NCT04602221|567068645|FG002|Overall Study|Lost to Follow-up|0|||
157086280|NCT04602221|567068646|FG003|Overall Study|Lost to Follow-up|0|||
157086281|NCT04602221|567068647|FG004|Overall Study|Lost to Follow-up|0|||
157086282|NCT04602221|567068648|FG005|Overall Study|Lost to Follow-up|1|||
157086283|NCT04602221|567068649|FG006|Overall Study|Lost to Follow-up|0|||
157086284|NCT04602221|567068650|FG007|Overall Study|Lost to Follow-up|0|||
157086285|NCT04602221|567068651|FG008|Overall Study|Lost to Follow-up|0|||
157086286|NCT04602221|567068652|FG009|Overall Study|Lost to Follow-up|0|||
157086287|NCT04602221|567068653|FG010|Overall Study|Lost to Follow-up|0|||
157086288|NCT04602221|567068654|FG011|Overall Study|Lost to Follow-up|0|||
157086289|NCT04602221|567068655|FG012|Overall Study|Lost to Follow-up|0|||
157086290|NCT04602221|567068656|FG013|Overall Study|Lost to Follow-up|0|||
157086291|NCT04602221|567068657|FG014|Overall Study|Lost to Follow-up|0|||
157086292|NCT04602221|567068658|FG015|Overall Study|Lost to Follow-up|0|||
157086293|NCT04602221|567068659|FG016|Overall Study|Lost to Follow-up|0|||
157086294|NCT04602221|567068660|FG017|Overall Study|Lost to Follow-up|0|||
157086295|NCT02576587|567068661|FG000|Baseline|Equipment failure|0|||
157086296|NCT02576587|567068662|FG001|Baseline|Equipment failure|1|||
157086297|NCT02576587|567068661|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
157086298|NCT02576587|567068662|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
157086299|NCT02576587|567068661|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
157086300|NCT02576587|567068662|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
157086301|NCT02576587|567068661|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
157086302|NCT02576587|567068662|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
157086303|NCT01080716|567068663|FG000|Part 1|Physician Decision|1|||
157086304|NCT01080716|567068664|FG001|Part 1|Physician Decision|0|||
157086305|NCT01080716|567068665|FG002|Part 1|Physician Decision|0|||
157086306|NCT01080716|567068666|FG003|Part 1|Physician Decision|0|||
157086307|NCT01056718|567068667|FG000|Overall Study|Withdrawal by Subject|2|||
157086308|NCT01056718|567068667|FG000|Overall Study|Ischemia on baseline stress test|1|||
157086309|NCT00777088|567068668|FG000|Overall Study|PED Treatment not attempted|1|||
157086310|NCT01011153|567068673|FG000|Overall Study|Less than 78 cases completed|8|||
157196042|NCT01521494|567459837|FG003|Overall Study|Withdrawal by Subject|2|||
157196043|NCT01521494|567459838|FG004|Overall Study|Withdrawal by Subject|0|||
157196044|NCT01521494|567459834|FG000|Overall Study|Decrease in serum phosphate|0|||
157086311|NCT01011153|567068674|FG001|Overall Study|Less than 78 cases completed|11|||
157086312|NCT01011153|567068675|FG002|Overall Study|Less than 78 cases completed|9|||
157086313|NCT03738423|567068679|FG000|Overall Study|Withdrawal by Subject|9|||
157196045|NCT01521494|567459835|FG001|Overall Study|Decrease in serum phosphate|2|||
157196046|NCT01521494|567459836|FG002|Overall Study|Decrease in serum phosphate|3|||
157086314|NCT03738423|567068680|FG001|Overall Study|Withdrawal by Subject|12|||
157086315|NCT03738423|567068681|FG002|Overall Study|Withdrawal by Subject|9|||
157086316|NCT03738423|567068682|FG003|Overall Study|Withdrawal by Subject|12|||
157086317|NCT03738423|567068683|FG004|Overall Study|Withdrawal by Subject|10|||
157086318|NCT03738423|567068679|FG000|Overall Study|Lack of Efficacy|3|||
157086319|NCT03738423|567068680|FG001|Overall Study|Lack of Efficacy|1|||
157086320|NCT03738423|567068681|FG002|Overall Study|Lack of Efficacy|1|||
157086321|NCT03738423|567068682|FG003|Overall Study|Lack of Efficacy|1|||
157086322|NCT03738423|567068683|FG004|Overall Study|Lack of Efficacy|2|||
157086323|NCT03738423|567068679|FG000|Overall Study|Lost to Follow-up|1|||
157086324|NCT03738423|567068680|FG001|Overall Study|Lost to Follow-up|0|||
157086325|NCT03738423|567068681|FG002|Overall Study|Lost to Follow-up|1|||
157086326|NCT03738423|567068682|FG003|Overall Study|Lost to Follow-up|1|||
157086327|NCT03738423|567068683|FG004|Overall Study|Lost to Follow-up|0|||
157086328|NCT03738423|567068679|FG000|Overall Study|Protocol Violation|1|||
157086329|NCT03738423|567068680|FG001|Overall Study|Protocol Violation|0|||
157086330|NCT03738423|567068681|FG002|Overall Study|Protocol Violation|0|||
157086331|NCT03738423|567068682|FG003|Overall Study|Protocol Violation|0|||
157086332|NCT03738423|567068683|FG004|Overall Study|Protocol Violation|1|||
157086333|NCT03738423|567068679|FG000|Overall Study|Physician Decision|0|||
157086334|NCT03738423|567068680|FG001|Overall Study|Physician Decision|0|||
157086335|NCT03738423|567068681|FG002|Overall Study|Physician Decision|1|||
157086336|NCT03738423|567068682|FG003|Overall Study|Physician Decision|0|||
157086337|NCT03738423|567068683|FG004|Overall Study|Physician Decision|1|||
157086338|NCT03738423|567068679|FG000|Overall Study|Death|0|||
157086339|NCT03738423|567068680|FG001|Overall Study|Death|0|||
157086340|NCT03738423|567068681|FG002|Overall Study|Death|0|||
157086341|NCT03738423|567068682|FG003|Overall Study|Death|0|||
157086342|NCT03738423|567068683|FG004|Overall Study|Death|1|||
157086343|NCT03738423|567068679|FG000|Overall Study|Randomized but never treated|0|||
157086344|NCT03738423|567068680|FG001|Overall Study|Randomized but never treated|0|||
157086345|NCT03738423|567068681|FG002|Overall Study|Randomized but never treated|1|||
157086346|NCT03738423|567068682|FG003|Overall Study|Randomized but never treated|1|||
157086347|NCT03738423|567068683|FG004|Overall Study|Randomized but never treated|0|||
157086348|NCT00611975|567068689|FG000|Overall Study|Withdrawal by Subject|3|||
157086349|NCT00611975|567068690|FG001|Overall Study|Withdrawal by Subject|7|||
157086350|NCT00611975|567068689|FG000|Overall Study|Pregnancy|2|||
157086351|NCT00611975|567068690|FG001|Overall Study|Pregnancy|1|||
157086352|NCT03981861|567068691|FG000|Overall Study|Withdrawal by Subject|3|||
157086353|NCT05618912|567068692|FG000|Overall Study|Lost to Follow-up|14|||
157086354|NCT05618912|567068693|FG001|Overall Study|Lost to Follow-up|19|||
157086355|NCT01022112|567068694|FG000|Overall Study|Adverse Event|1|||
157086356|NCT01022112|567068695|FG001|Overall Study|Adverse Event|2|||
157086357|NCT01022112|567068696|FG002|Overall Study|Adverse Event|0|||
157086358|NCT01022112|567068697|FG003|Overall Study|Adverse Event|1|||
157086359|NCT01022112|567068698|FG004|Overall Study|Adverse Event|0|||
157086360|NCT01022112|567068694|FG000|Overall Study|Lack of Efficacy|1|||
157086361|NCT01022112|567068695|FG001|Overall Study|Lack of Efficacy|0|||
157086362|NCT01022112|567068696|FG002|Overall Study|Lack of Efficacy|0|||
157086363|NCT01022112|567068697|FG003|Overall Study|Lack of Efficacy|0|||
157086364|NCT01022112|567068698|FG004|Overall Study|Lack of Efficacy|1|||
157086365|NCT01022112|567068694|FG000|Overall Study|Physician Decision|0|||
157235949|NCT00857454|567612910|FG000|Overall Study|Withdrawal by Subject|2|||
157086366|NCT01022112|567068695|FG001|Overall Study|Physician Decision|0|||
157086367|NCT01022112|567068696|FG002|Overall Study|Physician Decision|1|||
157086368|NCT01022112|567068697|FG003|Overall Study|Physician Decision|0|||
157086369|NCT01022112|567068698|FG004|Overall Study|Physician Decision|1|||
157086370|NCT01022112|567068694|FG000|Overall Study|Withdrawal by Subject|0|||
157086371|NCT01022112|567068695|FG001|Overall Study|Withdrawal by Subject|1|||
157086372|NCT01022112|567068696|FG002|Overall Study|Withdrawal by Subject|2|||
157086373|NCT01022112|567068697|FG003|Overall Study|Withdrawal by Subject|2|||
157086374|NCT01022112|567068698|FG004|Overall Study|Withdrawal by Subject|1|||
157086375|NCT01022112|567068694|FG000|Overall Study|Fasting plasma glucose level increased|1|||
157086376|NCT01022112|567068695|FG001|Overall Study|Fasting plasma glucose level increased|0|||
157086377|NCT01022112|567068696|FG002|Overall Study|Fasting plasma glucose level increased|0|||
157086378|NCT01022112|567068697|FG003|Overall Study|Fasting plasma glucose level increased|0|||
157086379|NCT01022112|567068698|FG004|Overall Study|Fasting plasma glucose level increased|7|||
157086380|NCT03541174|567069935|FG000|Part 1 Double-Blind|Adverse Event|6|||
157086381|NCT03541174|567069936|FG001|Part 1 Double-Blind|Adverse Event|5|||
157086382|NCT03541174|567069937|FG002|Part 1 Double-Blind|Adverse Event|2|||
157086383|NCT03541174|567069938|FG003|Part 1 Double-Blind|Adverse Event|0|||
157086384|NCT03541174|567069939|FG004|Part 1 Double-Blind|Adverse Event|0|||
157086385|NCT03541174|567069940|FG005|Part 1 Double-Blind|Adverse Event|0|||
157086386|NCT03541174|567069935|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
157086387|NCT03541174|567069936|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
157086388|NCT03541174|567069937|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
157086389|NCT03541174|567069938|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
157086390|NCT03541174|567069939|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
157086391|NCT03541174|567069940|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
157086392|NCT03541174|567069935|FG000|Part 1 Double-Blind|Other reasons|3|||
157086393|NCT03541174|567069936|FG001|Part 1 Double-Blind|Other reasons|2|||
157086394|NCT03541174|567069937|FG002|Part 1 Double-Blind|Other reasons|3|||
157086395|NCT03541174|567069938|FG003|Part 1 Double-Blind|Other reasons|0|||
157086396|NCT03541174|567069939|FG004|Part 1 Double-Blind|Other reasons|0|||
157086397|NCT03541174|567069940|FG005|Part 1 Double-Blind|Other reasons|0|||
157086398|NCT03541174|567069935|FG000|Part 2 Single-Blind|Adverse Event|0|||
157086399|NCT03541174|567069936|FG001|Part 2 Single-Blind|Adverse Event|0|||
157086400|NCT03541174|567069937|FG002|Part 2 Single-Blind|Adverse Event|0|||
157086401|NCT03541174|567069938|FG003|Part 2 Single-Blind|Adverse Event|25|||
157086402|NCT03541174|567069939|FG004|Part 2 Single-Blind|Adverse Event|0|||
157086403|NCT03541174|567069940|FG005|Part 2 Single-Blind|Adverse Event|0|||
157086404|NCT03541174|567069935|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
157086405|NCT03541174|567069936|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
157086406|NCT03541174|567069937|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
157086407|NCT03541174|567069938|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
157086408|NCT03541174|567069939|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
157086409|NCT03541174|567069940|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
157086410|NCT03541174|567069935|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
157086411|NCT03541174|567069936|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
157086412|NCT03541174|567069937|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
157086413|NCT03541174|567069938|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
157086414|NCT03541174|567069939|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
157086415|NCT03541174|567069940|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
157086416|NCT03541174|567069935|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
157086417|NCT03541174|567069936|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
157086418|NCT03541174|567069937|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
157086419|NCT03541174|567069938|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
157086420|NCT03541174|567069939|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
157086421|NCT03541174|567069940|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
157086422|NCT03541174|567069935|FG000|Part 2 Single-Blind|Death|0|||
157086423|NCT03541174|567069936|FG001|Part 2 Single-Blind|Death|0|||
157086424|NCT03541174|567069937|FG002|Part 2 Single-Blind|Death|0|||
157086425|NCT03541174|567069938|FG003|Part 2 Single-Blind|Death|5|||
157086426|NCT03541174|567069939|FG004|Part 2 Single-Blind|Death|0|||
157086427|NCT03541174|567069940|FG005|Part 2 Single-Blind|Death|0|||
157086428|NCT03541174|567069935|FG000|Part 2 Single-Blind|Pregnancy|0|||
157086429|NCT03541174|567069936|FG001|Part 2 Single-Blind|Pregnancy|0|||
157086430|NCT03541174|567069937|FG002|Part 2 Single-Blind|Pregnancy|0|||
157086431|NCT03541174|567069938|FG003|Part 2 Single-Blind|Pregnancy|1|||
157086432|NCT03541174|567069939|FG004|Part 2 Single-Blind|Pregnancy|0|||
157086433|NCT03541174|567069940|FG005|Part 2 Single-Blind|Pregnancy|0|||
157086434|NCT03541174|567069935|FG000|Part 2 Single-Blind|Other reasons|0|||
157086435|NCT03541174|567069936|FG001|Part 2 Single-Blind|Other reasons|0|||
157086436|NCT03541174|567069937|FG002|Part 2 Single-Blind|Other reasons|0|||
157086437|NCT03541174|567069938|FG003|Part 2 Single-Blind|Other reasons|32|||
157086438|NCT03541174|567069939|FG004|Part 2 Single-Blind|Other reasons|0|||
157086439|NCT03541174|567069940|FG005|Part 2 Single-Blind|Other reasons|0|||
157086440|NCT03541174|567069935|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
157086441|NCT03541174|567069936|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
157086442|NCT03541174|567069937|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
157086443|NCT03541174|567069938|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
157086444|NCT03541174|567069939|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
157086445|NCT03541174|567069940|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
157086446|NCT03541174|567069935|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
157086447|NCT03541174|567069936|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
157086448|NCT03541174|567069937|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
157086449|NCT03541174|567069938|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
157086450|NCT03541174|567069939|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
157086451|NCT03541174|567069940|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
157086452|NCT03541174|567069935|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
157086453|NCT03541174|567069936|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
157196047|NCT01521494|567459837|FG003|Overall Study|Decrease in serum phosphate|12|||
157196048|NCT01521494|567459838|FG004|Overall Study|Decrease in serum phosphate|0|||
157196049|NCT01521494|567459834|FG000|Overall Study|Decrease in serum calcium|0|||
157086454|NCT03541174|567069937|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
157086455|NCT03541174|567069938|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
157086456|NCT03541174|567069939|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
157086457|NCT03541174|567069940|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
157086458|NCT03541174|567069935|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
157086459|NCT03541174|567069936|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
157086460|NCT03541174|567069937|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
157086461|NCT03541174|567069938|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
157086462|NCT03541174|567069939|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
157086463|NCT03541174|567069940|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
157086464|NCT03541174|567069935|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
157086465|NCT03541174|567069936|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
157086466|NCT03541174|567069937|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
157086467|NCT03541174|567069938|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
157086468|NCT03541174|567069939|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
157086469|NCT03541174|567069940|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
157086470|NCT00605215|567069941|FG000|Overall Study|Death|0|||
157086471|NCT00605215|567069942|FG001|Overall Study|Death|0|||
157086472|NCT00605215|567069943|FG002|Overall Study|Death|1|||
157086473|NCT00605215|567069941|FG000|Overall Study|Adverse Event|19|||
157086474|NCT00605215|567069942|FG001|Overall Study|Adverse Event|21|||
157086475|NCT00605215|567069943|FG002|Overall Study|Adverse Event|26|||
157086476|NCT00605215|567069941|FG000|Overall Study|Refusal to sign the re-consent form|8|||
157086477|NCT00605215|567069942|FG001|Overall Study|Refusal to sign the re-consent form|3|||
157086478|NCT00605215|567069943|FG002|Overall Study|Refusal to sign the re-consent form|3|||
157086479|NCT00605215|567069941|FG000|Overall Study|Withdrawal by Subject|39|||
157086480|NCT00605215|567069942|FG001|Overall Study|Withdrawal by Subject|37|||
157086481|NCT00605215|567069943|FG002|Overall Study|Withdrawal by Subject|27|||
157086482|NCT00605215|567069941|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
157086483|NCT00605215|567069942|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
157086484|NCT00605215|567069943|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
157086485|NCT00605215|567069941|FG000|Overall Study|Protocol Violation|3|||
157086486|NCT00605215|567069942|FG001|Overall Study|Protocol Violation|4|||
157086487|NCT00605215|567069943|FG002|Overall Study|Protocol Violation|1|||
157086488|NCT00605215|567069941|FG000|Overall Study|Pregnancy|8|||
157086489|NCT00605215|567069942|FG001|Overall Study|Pregnancy|5|||
157086490|NCT00605215|567069943|FG002|Overall Study|Pregnancy|4|||
157086491|NCT00605215|567069941|FG000|Overall Study|Lost to Follow-up|8|||
157086492|NCT00605215|567069942|FG001|Overall Study|Lost to Follow-up|5|||
157086493|NCT00605215|567069943|FG002|Overall Study|Lost to Follow-up|2|||
157086494|NCT00605215|567069941|FG000|Overall Study|Other than specified|0|||
157086495|NCT00605215|567069942|FG001|Overall Study|Other than specified|2|||
157086496|NCT00605215|567069943|FG002|Overall Study|Other than specified|1|||
157086497|NCT00275262|567069944|FG000|Overall Study|Adverse Event|2|||
157086498|NCT00275262|567069945|FG001|Overall Study|Adverse Event|0|||
157086499|NCT00275262|567069944|FG000|Overall Study|Disease progression|2|||
157086500|NCT00275262|567069945|FG001|Overall Study|Disease progression|5|||
157086501|NCT00275262|567069944|FG000|Overall Study|Lost to Follow-up|0|||
157086502|NCT00275262|567069945|FG001|Overall Study|Lost to Follow-up|2|||
157086503|NCT00275262|567069944|FG000|Overall Study|Protocol Violation|0|||
157086504|NCT00275262|567069945|FG001|Overall Study|Protocol Violation|2|||
157086505|NCT00275262|567069944|FG000|Overall Study|Death|1|||
157086506|NCT00275262|567069945|FG001|Overall Study|Death|0|||
157086507|NCT00275262|567069944|FG000|Overall Study|Started Chemotherapy|1|||
157086508|NCT00275262|567069945|FG001|Overall Study|Started Chemotherapy|0|||
157086509|NCT04058366|567069948|FG000|Overall Study|Adverse Event|14|||
157086510|NCT04058366|567069948|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
157086511|NCT04058366|567069948|FG000|Overall Study|Commercial drug is available for participants|6|||
157086512|NCT04058366|567069948|FG000|Overall Study|Death|1|||
157086513|NCT04058366|567069948|FG000|Overall Study|Other non-compliance|2|||
157086514|NCT04058366|567069948|FG000|Overall Study|Other|6|||
157086515|NCT02594163|567069949|FG000|Treatment Period|Progressive disease|2|||
157086516|NCT02594163|567069950|FG001|Treatment Period|Progressive disease|3|||
157086517|NCT02594163|567069949|FG000|Treatment Period|Adverse Event|1|||
157196050|NCT01521494|567459835|FG001|Overall Study|Decrease in serum calcium|0|||
157196051|NCT01521494|567459836|FG002|Overall Study|Decrease in serum calcium|0|||
157196052|NCT01521494|567459837|FG003|Overall Study|Decrease in serum calcium|1|||
157196053|NCT01521494|567459838|FG004|Overall Study|Decrease in serum calcium|1|||
157196054|NCT01521494|567459834|FG000|Overall Study|Physician Decision|0|||
157196055|NCT01521494|567459835|FG001|Overall Study|Physician Decision|0|||
157196056|NCT01521494|567459836|FG002|Overall Study|Physician Decision|0|||
157196057|NCT01521494|567459837|FG003|Overall Study|Physician Decision|0|||
157196058|NCT01521494|567459838|FG004|Overall Study|Physician Decision|2|||
157196059|NCT00784836|567459840|FG000|Overall Study|Early Study Termination|3|||
157196060|NCT03417999|567459842|FG000|Overall Study|Withdrawal by Subject|1|||
157086518|NCT02594163|567069950|FG001|Treatment Period|Adverse Event|5|||
157086519|NCT02594163|567069949|FG000|Treatment Period|Physician Decision|1|||
157086520|NCT02594163|567069950|FG001|Treatment Period|Physician Decision|3|||
157086521|NCT02594163|567069949|FG000|Treatment Period|Study termination by sponsor|2|||
157086522|NCT02594163|567069950|FG001|Treatment Period|Study termination by sponsor|1|||
157086523|NCT02594163|567069949|FG000|Treatment Period|Other, Non-AE|1|||
157086524|NCT02594163|567069950|FG001|Treatment Period|Other, Non-AE|0|||
157196061|NCT03417999|567459843|FG001|Overall Study|Withdrawal by Subject|0|||
157196062|NCT03417999|567459844|FG002|Overall Study|Withdrawal by Subject|0|||
157196063|NCT03417999|567459842|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
157196064|NCT03417999|567459843|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
157086525|NCT02594163|567069949|FG000|Follow-up Period|Withdrawal by Subject|0|||
157086526|NCT02594163|567069950|FG001|Follow-up Period|Withdrawal by Subject|1|||
157086527|NCT02594163|567069949|FG000|Follow-up Period|Study Termination by Sponsor|6|||
157086528|NCT02594163|567069950|FG001|Follow-up Period|Study Termination by Sponsor|4|||
157086529|NCT02594163|567069949|FG000|Follow-up Period|Lost to Follow-up|1|||
157086530|NCT02594163|567069950|FG001|Follow-up Period|Lost to Follow-up|0|||
157086531|NCT02594163|567069949|FG000|Follow-up Period|Death|2|||
157086532|NCT02594163|567069950|FG001|Follow-up Period|Death|5|||
157086533|NCT02594163|567069949|FG000|Follow-up Period|Adverse Event|0|||
157086534|NCT02594163|567069950|FG001|Follow-up Period|Adverse Event|1|||
157086535|NCT02594163|567069949|FG000|Follow-up Period|Progressive Disease|2|||
157086536|NCT02594163|567069950|FG001|Follow-up Period|Progressive Disease|0|||
157086537|NCT02594163|567069949|FG000|Follow-up Period|Physician Decision|0|||
157086538|NCT02594163|567069950|FG001|Follow-up Period|Physician Decision|1|||
157086539|NCT01342341|567069951|FG000|Overall Study|Lost to Follow-up|4|||
157086540|NCT01342341|567069952|FG001|Overall Study|Lost to Follow-up|4|||
157086541|NCT03527173|567069953|FG000|Overall Study|Lost to Follow-up|4|||
157086542|NCT03527173|567069954|FG001|Overall Study|Lost to Follow-up|2|||
157086543|NCT03527173|567069953|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
157086544|NCT03527173|567069954|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
157086545|NCT03527173|567069953|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
157086546|NCT03527173|567069954|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
157086547|NCT03527173|567069953|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
157086548|NCT03527173|567069954|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
157086549|NCT04097301|567069955|FG000|Overall Study|Death|1|||
157086550|NCT04097301|567069955|FG000|Overall Study|Withdrawal by Subject|1|||
157086551|NCT04097301|567069955|FG000|Overall Study|Screening Failure|5|||
157086552|NCT00901186|567069956|FG000|Overall Study|Lack of Efficacy|0|||
157086553|NCT00901186|567069957|FG001|Overall Study|Lack of Efficacy|1|||
157086554|NCT00901186|567069956|FG000|Overall Study|Abnormal laboratory values|0|||
157086555|NCT00901186|567069957|FG001|Overall Study|Abnormal laboratory values|1|||
157086556|NCT00901186|567069956|FG000|Overall Study|Lost to Follow-up|2|||
157086557|NCT00901186|567069957|FG001|Overall Study|Lost to Follow-up|0|||
157086558|NCT00901186|567069956|FG000|Overall Study|Adverse Event|2|||
157086559|NCT00901186|567069957|FG001|Overall Study|Adverse Event|4|||
157086560|NCT00901186|567069956|FG000|Overall Study|Administration problems|0|||
157086561|NCT00901186|567069957|FG001|Overall Study|Administration problems|1|||
157086562|NCT00901186|567069956|FG000|Overall Study|Protocol deviations|5|||
157086563|NCT00901186|567069957|FG001|Overall Study|Protocol deviations|4|||
157086564|NCT00896051|567069958|FG000|Overall Study|Adverse Event|2|||
157086565|NCT00896051|567069959|FG001|Overall Study|Adverse Event|1|||
157086566|NCT00896051|567069958|FG000|Overall Study|Lost to Follow-up|3|||
157086567|NCT00896051|567069959|FG001|Overall Study|Lost to Follow-up|2|||
157086568|NCT00896051|567069958|FG000|Overall Study|Withdrawal by Subject|3|||
157086569|NCT00896051|567069959|FG001|Overall Study|Withdrawal by Subject|2|||
157086570|NCT00896051|567069958|FG000|Overall Study|Subject noncompliant|1|||
157086571|NCT00896051|567069959|FG001|Overall Study|Subject noncompliant|3|||
157086572|NCT00896051|567069958|FG000|Overall Study|Other|1|||
157086573|NCT00896051|567069959|FG001|Overall Study|Other|1|||
157086574|NCT02935452|567069960|FG000|Overall Study|work and life commintment|3|||
157086575|NCT02935452|567069961|FG001|Overall Study|work and life commintment|1|||
157086576|NCT01813929|567069962|FG000|Overall Study|Withdrawal by Subject|0|||
157086577|NCT01813929|567069963|FG001|Overall Study|Withdrawal by Subject|1|||
157086578|NCT00007345|567069964|FG000|Overall Study|Refused further treatment|0|||
157086579|NCT00007345|567069965|FG001|Overall Study|Refused further treatment|7|||
157086580|NCT00007345|567069964|FG000|Overall Study|Switched to alternative treatment|0|||
157086581|NCT00007345|567069965|FG001|Overall Study|Switched to alternative treatment|3|||
157086582|NCT00007345|567069964|FG000|Overall Study|Intercurrent illness|1|||
157086583|NCT00007345|567069965|FG001|Overall Study|Intercurrent illness|0|||
157086584|NCT00007345|567069964|FG000|Overall Study|Death on study|1|||
157086585|NCT00007345|567069965|FG001|Overall Study|Death on study|1|||
157086586|NCT04433585|567069966|FG000|Overall Study|Withdrawal by Subject|15|||
157086587|NCT04433585|567069967|FG001|Overall Study|Withdrawal by Subject|3|||
157086588|NCT04433585|567069968|FG002|Overall Study|Withdrawal by Subject|15|||
157086589|NCT04433585|567069969|FG003|Overall Study|Withdrawal by Subject|6|||
157086590|NCT04433585|567069966|FG000|Overall Study|Adverse Event|10|||
157086591|NCT04433585|567069967|FG001|Overall Study|Adverse Event|4|||
157086592|NCT04433585|567069968|FG002|Overall Study|Adverse Event|1|||
157086593|NCT04433585|567069969|FG003|Overall Study|Adverse Event|0|||
157086594|NCT04433585|567069966|FG000|Overall Study|Due to the conflict in Ukraine|2|||
157086595|NCT04433585|567069967|FG001|Overall Study|Due to the conflict in Ukraine|1|||
157086596|NCT04433585|567069968|FG002|Overall Study|Due to the conflict in Ukraine|1|||
157086597|NCT04433585|567069969|FG003|Overall Study|Due to the conflict in Ukraine|2|||
157086598|NCT04433585|567069966|FG000|Overall Study|Physician Decision|1|||
157086599|NCT04433585|567069967|FG001|Overall Study|Physician Decision|2|||
157086600|NCT04433585|567069968|FG002|Overall Study|Physician Decision|0|||
157086601|NCT04433585|567069969|FG003|Overall Study|Physician Decision|0|||
157086602|NCT04433585|567069966|FG000|Overall Study|Lost to Follow-up|1|||
157086603|NCT04433585|567069967|FG001|Overall Study|Lost to Follow-up|1|||
157086604|NCT04433585|567069968|FG002|Overall Study|Lost to Follow-up|1|||
157086605|NCT04433585|567069969|FG003|Overall Study|Lost to Follow-up|0|||
157086606|NCT04433585|567069966|FG000|Overall Study|Lack of Efficacy|0|||
157086607|NCT04433585|567069967|FG001|Overall Study|Lack of Efficacy|1|||
157086608|NCT04433585|567069968|FG002|Overall Study|Lack of Efficacy|1|||
157086609|NCT04433585|567069969|FG003|Overall Study|Lack of Efficacy|1|||
157086610|NCT04433585|567069966|FG000|Overall Study|Death|0|||
157086611|NCT04433585|567069967|FG001|Overall Study|Death|1|||
157086612|NCT04433585|567069968|FG002|Overall Study|Death|0|||
157086613|NCT04433585|567069969|FG003|Overall Study|Death|0|||
157086614|NCT01239043|567069974|FG000|Overall Study|Protocol Violation|2|||
157086615|NCT01239043|567069975|FG001|Overall Study|Protocol Violation|1|||
157086616|NCT02929329|567069976|FG000|Overall Study|Withdrawal by Subject|24|||
157086617|NCT02929329|567069977|FG001|Overall Study|Withdrawal by Subject|21|||
157086618|NCT02929329|567069976|FG000|Overall Study|Lost to Follow-up|26|||
157086619|NCT02929329|567069977|FG001|Overall Study|Lost to Follow-up|20|||
157086620|NCT02929329|567069976|FG000|Overall Study|Death|1054|||
157086621|NCT02929329|567069977|FG001|Overall Study|Death|1051|||
157086622|NCT02121301|567069978|FG000|Overall Study|Protocol Violation|1|||
157086623|NCT02121301|567069979|FG001|Overall Study|Protocol Violation|4|||
157086624|NCT02121301|567069980|FG002|Overall Study|Protocol Violation|1|||
157086625|NCT00434213|567069988|FG000|Overall Study|Adverse Event|12|||
157086626|NCT00434213|567069988|FG000|Overall Study|Lack of Efficacy|9|||
157086627|NCT00434213|567069988|FG000|Overall Study|Lost to Follow-up|14|||
157086628|NCT00434213|567069988|FG000|Overall Study|Withdrawal by Subject|7|||
157086629|NCT00434213|567069988|FG000|Overall Study|Protocol Violation|3|||
157086630|NCT00434213|567069988|FG000|Overall Study|Unable to comply with study visit window|2|||
157086631|NCT00434213|567069988|FG000|Overall Study|Application site reaction|1|||
157086632|NCT00434213|567069988|FG000|Overall Study|Non-compliant to study schedule|1|||
157086633|NCT01139580|567069989|FG000|Overall Study|Adverse Event|5|||
157086634|NCT01139580|567069990|FG001|Overall Study|Adverse Event|4|||
157086635|NCT01139580|567069989|FG000|Overall Study|Lost to Follow-up|9|||
157086636|NCT01139580|567069990|FG001|Overall Study|Lost to Follow-up|1|||
157086637|NCT01139580|567069989|FG000|Overall Study|Lack of Efficacy|0|||
157086638|NCT01139580|567069990|FG001|Overall Study|Lack of Efficacy|2|||
157086639|NCT01139580|567069989|FG000|Overall Study|Withdrawal by Subject|6|||
157086640|NCT01139580|567069990|FG001|Overall Study|Withdrawal by Subject|9|||
157086641|NCT01139580|567069989|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
157086642|NCT01139580|567069990|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
157086643|NCT01139580|567069989|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
157086644|NCT01139580|567069990|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
157086645|NCT01139580|567069989|FG000|Overall Study|Misrandomized|1|||
157086646|NCT01139580|567069990|FG001|Overall Study|Misrandomized|0|||
157086647|NCT01139580|567069989|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
157086648|NCT01139580|567069990|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
157086649|NCT01139580|567069989|FG000|Overall Study|Participant Randomization in Error|0|||
157086650|NCT01139580|567069990|FG001|Overall Study|Participant Randomization in Error|1|||
157086651|NCT00633880|567069991|FG000|Open Label Titration|Lack of Efficacy|1|||
157086652|NCT00633880|567069992|FG001|Open Label Titration|Lack of Efficacy|0|||
157086653|NCT00633880|567069993|FG002|Open Label Titration|Lack of Efficacy|0|||
157086654|NCT00633880|567069991|FG000|Open Label Titration|Adverse Event|13|||
157086655|NCT00633880|567069992|FG001|Open Label Titration|Adverse Event|0|||
157086656|NCT00633880|567069993|FG002|Open Label Titration|Adverse Event|0|||
157086657|NCT00633880|567069991|FG000|Open Label Titration|Treatment Failure|55|||
157086658|NCT00633880|567069992|FG001|Open Label Titration|Treatment Failure|0|||
157086659|NCT00633880|567069993|FG002|Open Label Titration|Treatment Failure|0|||
157196065|NCT03417999|567459844|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
157196066|NCT03417999|567459842|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
157196067|NCT03417999|567459843|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
157196068|NCT03417999|567459844|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
157196069|NCT03417999|567459842|FG000|Overall Study|Inadequate study staff available to process samples|0|||
157196070|NCT03417999|567459843|FG001|Overall Study|Inadequate study staff available to process samples|0|||
157086660|NCT00633880|567069991|FG000|Open Label Titration|Protocol Violation|6|||
157086661|NCT00633880|567069992|FG001|Open Label Titration|Protocol Violation|0|||
157086662|NCT00633880|567069993|FG002|Open Label Titration|Protocol Violation|0|||
157086663|NCT00633880|567069991|FG000|Open Label Titration|Physician Decision|1|||
157086664|NCT00633880|567069992|FG001|Open Label Titration|Physician Decision|0|||
157086665|NCT00633880|567069993|FG002|Open Label Titration|Physician Decision|0|||
157086666|NCT00633880|567069991|FG000|Open Label Titration|Withdrawal by Subject|4|||
157086667|NCT00633880|567069992|FG001|Open Label Titration|Withdrawal by Subject|0|||
157086668|NCT00633880|567069993|FG002|Open Label Titration|Withdrawal by Subject|0|||
157086669|NCT00700778|567069994|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
157086670|NCT03117998|567069997|FG000|Overall Study|Adverse Event|1|||
157086671|NCT03117998|567069998|FG001|Overall Study|Adverse Event|0|||
157086672|NCT03117998|567069999|FG002|Overall Study|Adverse Event|0|||
157086673|NCT03117998|567070000|FG003|Overall Study|Adverse Event|0|||
157086674|NCT03117998|567070001|FG004|Overall Study|Adverse Event|0|||
157086675|NCT03117998|567070002|FG005|Overall Study|Adverse Event|0|||
157086676|NCT03117998|567069997|FG000|Overall Study|Withdrawal by Subject|0|||
157086677|NCT03117998|567069998|FG001|Overall Study|Withdrawal by Subject|0|||
157086678|NCT03117998|567069999|FG002|Overall Study|Withdrawal by Subject|2|||
157235950|NCT00857454|567612910|FG000|Overall Study|Lost to Follow-up|1|||
157235951|NCT00857454|567612910|FG000|Overall Study|Adverse Event|2|||
157235952|NCT00857454|567612910|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
157235953|NCT00857454|567612910|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
157235954|NCT00857454|567612910|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
157235955|NCT03154047|567612911|FG000|Overall Study|Death|1|||
157235956|NCT03154047|567612911|FG000|Overall Study|Study terminated by sponsor|76|||
157235957|NCT03154047|567612911|FG000|Overall Study|Withdrawal by Subject|3|||
157235958|NCT00365365|567612912|FG000|Overall Study|Randomized but not treated|0|||
157235959|NCT00365365|567612913|FG001|Overall Study|Randomized but not treated|2|||
157235960|NCT00365365|567612914|FG002|Overall Study|Randomized but not treated|0|||
157235961|NCT00365365|567612912|FG000|Overall Study|Poor compliance to protocol|0|||
157235962|NCT00365365|567612913|FG001|Overall Study|Poor compliance to protocol|1|||
157086679|NCT03117998|567070000|FG003|Overall Study|Withdrawal by Subject|3|||
157086680|NCT03117998|567070001|FG004|Overall Study|Withdrawal by Subject|3|||
157086681|NCT03117998|567070002|FG005|Overall Study|Withdrawal by Subject|0|||
157086682|NCT03117998|567069997|FG000|Overall Study|Physician Decision|0|||
157086683|NCT03117998|567069998|FG001|Overall Study|Physician Decision|1|||
157086684|NCT03117998|567069999|FG002|Overall Study|Physician Decision|1|||
157086685|NCT03117998|567070000|FG003|Overall Study|Physician Decision|0|||
157086686|NCT03117998|567070001|FG004|Overall Study|Physician Decision|0|||
157086687|NCT03117998|567070002|FG005|Overall Study|Physician Decision|0|||
157086688|NCT03117998|567069997|FG000|Overall Study|Lost to Follow-up|0|||
157086689|NCT03117998|567069998|FG001|Overall Study|Lost to Follow-up|0|||
157086690|NCT03117998|567069999|FG002|Overall Study|Lost to Follow-up|0|||
157086691|NCT03117998|567070000|FG003|Overall Study|Lost to Follow-up|1|||
157086692|NCT03117998|567070001|FG004|Overall Study|Lost to Follow-up|4|||
157086693|NCT03117998|567070002|FG005|Overall Study|Lost to Follow-up|0|||
157086694|NCT03117998|567069997|FG000|Overall Study|Subject noncompliance|0|||
157086695|NCT03117998|567069998|FG001|Overall Study|Subject noncompliance|0|||
157086696|NCT03117998|567069999|FG002|Overall Study|Subject noncompliance|1|||
157086697|NCT03117998|567070000|FG003|Overall Study|Subject noncompliance|0|||
157086698|NCT03117998|567070001|FG004|Overall Study|Subject noncompliance|0|||
157086699|NCT03117998|567070002|FG005|Overall Study|Subject noncompliance|2|||
157086700|NCT03117998|567069997|FG000|Overall Study|Protocol Violation|0|||
157086701|NCT03117998|567069998|FG001|Overall Study|Protocol Violation|0|||
157086702|NCT03117998|567069999|FG002|Overall Study|Protocol Violation|0|||
157086703|NCT03117998|567070000|FG003|Overall Study|Protocol Violation|0|||
157196071|NCT03417999|567459844|FG002|Overall Study|Inadequate study staff available to process samples|1|||
157196072|NCT02613910|567459845|FG000|Overall Study|Termination of study|1|||
157196073|NCT00695318|567459846|FG000|Overall Study|Lost to Follow-up|1|||
157196074|NCT00695318|567459847|FG001|Overall Study|Lost to Follow-up|0|||
157196075|NCT00695318|567459846|FG000|Overall Study|Withdrawal by Subject|2|||
157196076|NCT00695318|567459847|FG001|Overall Study|Withdrawal by Subject|0|||
157196077|NCT00695318|567459846|FG000|Overall Study|Death|1|||
157196078|NCT00695318|567459847|FG001|Overall Study|Death|1|||
157196079|NCT00695318|567459846|FG000|Overall Study|Study Terminated|1|||
157196080|NCT00695318|567459847|FG001|Overall Study|Study Terminated|0|||
157196081|NCT03726320|567461382|FG000|Overall Study|Lost to Follow-up|2|||
157196082|NCT03726320|567461383|FG001|Overall Study|Lost to Follow-up|4|||
157196083|NCT03726320|567461384|FG002|Overall Study|Lost to Follow-up|0|||
157196084|NCT03726320|567461382|FG000|Overall Study|Time Constraints|4|||
157196085|NCT03726320|567461383|FG001|Overall Study|Time Constraints|1|||
157196086|NCT03726320|567461384|FG002|Overall Study|Time Constraints|0|||
157196087|NCT03726320|567461382|FG000|Overall Study|Ineligible after enrollment|3|||
157196088|NCT03726320|567461383|FG001|Overall Study|Ineligible after enrollment|3|||
157196089|NCT03726320|567461384|FG002|Overall Study|Ineligible after enrollment|0|||
157235963|NCT00365365|567612914|FG002|Overall Study|Poor compliance to protocol|0|||
157235964|NCT00365365|567612912|FG000|Overall Study|Lost to Follow-up|3|||
157086704|NCT03117998|567070001|FG004|Overall Study|Protocol Violation|0|||
157196090|NCT03726320|567461382|FG000|Overall Study|Clinic / insurance issue|2|||
157196091|NCT03726320|567461383|FG001|Overall Study|Clinic / insurance issue|0|||
157235965|NCT00365365|567612913|FG001|Overall Study|Lost to Follow-up|3|||
157235966|NCT00365365|567612914|FG002|Overall Study|Lost to Follow-up|3|||
157086705|NCT03117998|567070002|FG005|Overall Study|Protocol Violation|1|||
157086706|NCT04828837|567070006|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
157086707|NCT04828837|567070007|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
157086708|NCT04828837|567070006|FG000|Overall Study|Lost to Follow-up|2|||
157086709|NCT04828837|567070007|FG001|Overall Study|Lost to Follow-up|6|||
157086710|NCT04828837|567070006|FG000|Overall Study|Lack of Efficacy|1|||
157086711|NCT04828837|567070007|FG001|Overall Study|Lack of Efficacy|0|||
157086712|NCT04828837|567070006|FG000|Overall Study|Admitted due to pneumothorax.|1|||
157086713|NCT04828837|567070007|FG001|Overall Study|Admitted due to pneumothorax.|0|||
157086714|NCT04828837|567070006|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
157086715|NCT04828837|567070007|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
157086716|NCT00320528|567070008|FG000|Study Period II|Adverse Event|3|||
157086717|NCT00320528|567070009|FG001|Study Period II|Adverse Event|4|||
157086718|NCT00320528|567070010|FG002|Study Period II|Adverse Event|8|||
157086719|NCT00320528|567070008|FG000|Study Period II|Parent/Caregiver Decision|8|||
157086720|NCT00320528|567070009|FG001|Study Period II|Parent/Caregiver Decision|3|||
157086721|NCT00320528|567070010|FG002|Study Period II|Parent/Caregiver Decision|11|||
157086722|NCT00320528|567070008|FG000|Study Period II|Withdrawal by Subject|0|||
157086723|NCT00320528|567070009|FG001|Study Period II|Withdrawal by Subject|1|||
157086724|NCT00320528|567070010|FG002|Study Period II|Withdrawal by Subject|1|||
157086725|NCT00320528|567070008|FG000|Study Period II|Entry Criteria Exclusion|0|||
157086726|NCT00320528|567070009|FG001|Study Period II|Entry Criteria Exclusion|2|||
157086727|NCT00320528|567070010|FG002|Study Period II|Entry Criteria Exclusion|2|||
157086728|NCT00320528|567070008|FG000|Study Period III|Adverse Event|1|||
157086729|NCT00320528|567070009|FG001|Study Period III|Adverse Event|0|||
157086730|NCT00320528|567070010|FG002|Study Period III|Adverse Event|0|||
157086731|NCT00320528|567070008|FG000|Study Period III|Lost to Follow-up|1|||
157086732|NCT00320528|567070009|FG001|Study Period III|Lost to Follow-up|0|||
157086733|NCT00320528|567070010|FG002|Study Period III|Lost to Follow-up|0|||
157086734|NCT00320528|567070008|FG000|Study Period III|Withdrawal by Subject|1|||
157086735|NCT00320528|567070009|FG001|Study Period III|Withdrawal by Subject|1|||
157086736|NCT00320528|567070010|FG002|Study Period III|Withdrawal by Subject|2|||
157086737|NCT00320528|567070008|FG000|Study Period III|Lack of Efficacy|2|||
157086738|NCT00320528|567070009|FG001|Study Period III|Lack of Efficacy|0|||
157086739|NCT00320528|567070010|FG002|Study Period III|Lack of Efficacy|0|||
157086740|NCT00320528|567070008|FG000|Study Period III|Parent/Caregiver Decision|14|||
157086741|NCT00320528|567070009|FG001|Study Period III|Parent/Caregiver Decision|3|||
157086742|NCT00320528|567070010|FG002|Study Period III|Parent/Caregiver Decision|11|||
157086743|NCT00320528|567070008|FG000|Study Period III|Protocol Violation|0|||
157086744|NCT00320528|567070009|FG001|Study Period III|Protocol Violation|1|||
157086745|NCT00320528|567070010|FG002|Study Period III|Protocol Violation|0|||
157086746|NCT00320528|567070008|FG000|Study Period III|Physician Decision|0|||
157086747|NCT00320528|567070009|FG001|Study Period III|Physician Decision|1|||
157086748|NCT00320528|567070010|FG002|Study Period III|Physician Decision|2|||
157086749|NCT00320528|567070008|FG000|Study Period III|Sponsor Decision|0|||
157086750|NCT00320528|567070009|FG001|Study Period III|Sponsor Decision|0|||
157086751|NCT00320528|567070010|FG002|Study Period III|Sponsor Decision|1|||
157086752|NCT00320528|567070008|FG000|Study Period III|Atomoxetine Commercially Available|68|||
157086753|NCT00320528|567070009|FG001|Study Period III|Atomoxetine Commercially Available|25|||
157086754|NCT00320528|567070010|FG002|Study Period III|Atomoxetine Commercially Available|90|||
157086755|NCT01397422|567070011|FG000|Overall Study|Adverse Event|0|||
157086756|NCT01397422|567070012|FG001|Overall Study|Adverse Event|3|||
157086757|NCT01397422|567070013|FG002|Overall Study|Adverse Event|3|||
157086758|NCT01397422|567070014|FG003|Overall Study|Adverse Event|8|||
157086759|NCT01397422|567070011|FG000|Overall Study|Withdrawal by Subject|1|||
157086760|NCT01397422|567070012|FG001|Overall Study|Withdrawal by Subject|0|||
157086761|NCT01397422|567070013|FG002|Overall Study|Withdrawal by Subject|0|||
157086762|NCT01397422|567070014|FG003|Overall Study|Withdrawal by Subject|0|||
157086763|NCT01397422|567070011|FG000|Overall Study|Increased bradykinesia related to PD|1|||
157086764|NCT01397422|567070012|FG001|Overall Study|Increased bradykinesia related to PD|0|||
157086765|NCT01397422|567070013|FG002|Overall Study|Increased bradykinesia related to PD|0|||
157086766|NCT01397422|567070014|FG003|Overall Study|Increased bradykinesia related to PD|0|||
157086767|NCT00545753|567070015|FG000|Overall Study|Withdrawal by Subject|0|||
157086768|NCT00545753|567070016|FG001|Overall Study|Withdrawal by Subject|1|||
157086769|NCT00545753|567070017|FG002|Overall Study|Withdrawal by Subject|10|||
157086770|NCT00545753|567070015|FG000|Overall Study|Lost to Follow-up|13|||
157086771|NCT00545753|567070016|FG001|Overall Study|Lost to Follow-up|3|||
157086772|NCT00545753|567070017|FG002|Overall Study|Lost to Follow-up|12|||
157196092|NCT03726320|567461384|FG002|Overall Study|Clinic / insurance issue|0|||
157196093|NCT03726320|567461382|FG000|Overall Study|Language barrier|1|||
157196094|NCT03726320|567461383|FG001|Overall Study|Language barrier|0|||
157196095|NCT03726320|567461384|FG002|Overall Study|Language barrier|0|||
157196096|NCT03726320|567461382|FG000|Overall Study|Provider left the clinic|0|||
157196097|NCT03726320|567461383|FG001|Overall Study|Provider left the clinic|0|||
157086773|NCT00545753|567070015|FG000|Overall Study|Protocol Violation|3|||
157086774|NCT00545753|567070016|FG001|Overall Study|Protocol Violation|1|||
157196098|NCT03726320|567461384|FG002|Overall Study|Provider left the clinic|1|||
157086775|NCT00545753|567070017|FG002|Overall Study|Protocol Violation|4|||
157086776|NCT00760474|567070018|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
157086777|NCT00760474|567070019|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
157086778|NCT00760474|567070018|FG000|Placebo Washout Period|Other|0|||
157196099|NCT02028182|567461387|FG000|Overall Study|Protocol Violation|2|||
157086779|NCT00760474|567070019|FG001|Placebo Washout Period|Other|1|||
157086780|NCT00760474|567070018|FG000|Period 2 (P2)|Lost to Follow-up|1|||
157086781|NCT00760474|567070019|FG001|Period 2 (P2)|Lost to Follow-up|0|||
157086782|NCT00760474|567070018|FG000|Period 2 (P2)|Adverse Event|0|||
157086783|NCT00760474|567070019|FG001|Period 2 (P2)|Adverse Event|1|||
157086784|NCT04664400|567070020|FG000|Overall Study|Withdrawal by Subject|2|||
157086785|NCT01262027|567070021|FG000|Overall Study|Adverse Event|1|||
157086786|NCT01262027|567070021|FG000|Overall Study|Withdrawal by Subject|3|||
157086787|NCT01262027|567070021|FG000|Overall Study|Protocol Violation|1|||
157086788|NCT03014479|567070023|FG000|Overall Study|Adverse Event|0|||
157086789|NCT03014479|567070024|FG001|Overall Study|Adverse Event|1|||
157086790|NCT03014479|567070023|FG000|Overall Study|Voluntary Withdrawal|0|||
157086791|NCT03014479|567070024|FG001|Overall Study|Voluntary Withdrawal|2|||
157086792|NCT03014479|567070023|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
157086793|NCT03014479|567070024|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
157086794|NCT01394978|567070034|FG000|Overall Study|Withdrawal by Subject|2|||
157086795|NCT01394978|567070035|FG001|Overall Study|Withdrawal by Subject|4|||
157086796|NCT01394978|567070034|FG000|Overall Study|Lost to Follow-up|13|||
157086797|NCT01394978|567070035|FG001|Overall Study|Lost to Follow-up|20|||
157086798|NCT01394978|567070034|FG000|Overall Study|Death|6|||
157086799|NCT01394978|567070035|FG001|Overall Study|Death|7|||
157086800|NCT01081132|567070036|FG000|Overall Study|Lack of Efficacy|25|||
157086801|NCT01081132|567070037|FG001|Overall Study|Lack of Efficacy|9|||
157086802|NCT01081132|567070036|FG000|Overall Study|Withdrawal by Subject|13|||
157086803|NCT01081132|567070037|FG001|Overall Study|Withdrawal by Subject|16|||
157086804|NCT01081132|567070036|FG000|Overall Study|Lost to Follow-up|4|||
157086805|NCT01081132|567070037|FG001|Overall Study|Lost to Follow-up|11|||
157086806|NCT01081132|567070036|FG000|Overall Study|Adverse Event|3|||
157086807|NCT01081132|567070037|FG001|Overall Study|Adverse Event|9|||
157086808|NCT01081132|567070036|FG000|Overall Study|Non Compliance|4|||
157086809|NCT01081132|567070037|FG001|Overall Study|Non Compliance|2|||
157086810|NCT01081132|567070036|FG000|Overall Study|Lack Of Compliance|0|||
157086811|NCT01081132|567070037|FG001|Overall Study|Lack Of Compliance|1|||
157086812|NCT01081132|567070036|FG000|Overall Study|Missed Visits|1|||
157086813|NCT01081132|567070037|FG001|Overall Study|Missed Visits|1|||
157086814|NCT01081132|567070036|FG000|Overall Study|Stopped Taking Meds|2|||
157086815|NCT01081132|567070037|FG001|Overall Study|Stopped Taking Meds|0|||
157086816|NCT01081132|567070036|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
157086817|NCT01081132|567070037|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
157086818|NCT01081132|567070036|FG000|Overall Study|Declined Taper Phase|0|||
157086819|NCT01081132|567070037|FG001|Overall Study|Declined Taper Phase|1|||
157086820|NCT01081132|567070036|FG000|Overall Study|Protocol Violation|3|||
157086821|NCT01081132|567070037|FG001|Overall Study|Protocol Violation|1|||
157086822|NCT01758900|567070051|FG000|Overall Study|difficulty for further intubation|7|||
157086823|NCT01758900|567070052|FG001|Overall Study|difficulty for further intubation|8|||
157086824|NCT03762200|567070054|FG000|Overall Study|Death|2|||
157086825|NCT02489968|567070055|FG000|Open-label Treatment Period|Adverse Event|14|||
157086826|NCT02489968|567070056|FG001|Open-label Treatment Period|Adverse Event|7|||
157086827|NCT02489968|567070057|FG002|Open-label Treatment Period|Adverse Event|0|||
157086828|NCT02489968|567070058|FG003|Open-label Treatment Period|Adverse Event|0|||
157086829|NCT02489968|567070059|FG004|Open-label Treatment Period|Adverse Event|0|||
157086830|NCT02489968|567070060|FG005|Open-label Treatment Period|Adverse Event|0|||
157086831|NCT02489968|567070055|FG000|Open-label Treatment Period|Protocol Violation|2|||
157086832|NCT02489968|567070056|FG001|Open-label Treatment Period|Protocol Violation|2|||
157086833|NCT02489968|567070057|FG002|Open-label Treatment Period|Protocol Violation|0|||
157086834|NCT02489968|567070058|FG003|Open-label Treatment Period|Protocol Violation|0|||
157086835|NCT02489968|567070059|FG004|Open-label Treatment Period|Protocol Violation|0|||
157086836|NCT02489968|567070060|FG005|Open-label Treatment Period|Protocol Violation|0|||
157086837|NCT02489968|567070055|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
157086838|NCT02489968|567070056|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
157086839|NCT02489968|567070057|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
157086840|NCT02489968|567070058|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
157086841|NCT02489968|567070059|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
157086842|NCT02489968|567070060|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
157086843|NCT02489968|567070055|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
157086844|NCT02489968|567070056|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
157086845|NCT02489968|567070057|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
157086846|NCT02489968|567070058|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
157086847|NCT02489968|567070059|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
157086848|NCT02489968|567070060|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
157086849|NCT02489968|567070055|FG000|Open-label Treatment Period|Other than specified above|204|||
157086850|NCT02489968|567070056|FG001|Open-label Treatment Period|Other than specified above|189|||
157086851|NCT02489968|567070057|FG002|Open-label Treatment Period|Other than specified above|0|||
157086852|NCT02489968|567070058|FG003|Open-label Treatment Period|Other than specified above|0|||
157086853|NCT02489968|567070059|FG004|Open-label Treatment Period|Other than specified above|0|||
157086854|NCT02489968|567070060|FG005|Open-label Treatment Period|Other than specified above|0|||
157086855|NCT02489968|567070055|FG000|Double-blind Treatment Period|Adverse Event|0|||
157086856|NCT02489968|567070056|FG001|Double-blind Treatment Period|Adverse Event|0|||
157086857|NCT02489968|567070057|FG002|Double-blind Treatment Period|Adverse Event|2|||
157086858|NCT02489968|567070058|FG003|Double-blind Treatment Period|Adverse Event|6|||
157086859|NCT02489968|567070059|FG004|Double-blind Treatment Period|Adverse Event|4|||
157086860|NCT02489968|567070060|FG005|Double-blind Treatment Period|Adverse Event|5|||
157086861|NCT02489968|567070055|FG000|Double-blind Treatment Period|Protocol Violation|0|||
157086862|NCT02489968|567070056|FG001|Double-blind Treatment Period|Protocol Violation|0|||
157086863|NCT02489968|567070057|FG002|Double-blind Treatment Period|Protocol Violation|0|||
157086864|NCT02489968|567070058|FG003|Double-blind Treatment Period|Protocol Violation|0|||
157086865|NCT02489968|567070059|FG004|Double-blind Treatment Period|Protocol Violation|1|||
157086866|NCT02489968|567070060|FG005|Double-blind Treatment Period|Protocol Violation|1|||
157086867|NCT02489968|567070055|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
157086868|NCT02489968|567070056|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
157086869|NCT02489968|567070057|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157086870|NCT02489968|567070058|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
157086871|NCT02489968|567070059|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
157086872|NCT02489968|567070060|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
157086873|NCT02489968|567070055|FG000|Double-blind Treatment Period|Other than specified above|0|||
157086874|NCT02489968|567070056|FG001|Double-blind Treatment Period|Other than specified above|0|||
157086875|NCT02489968|567070057|FG002|Double-blind Treatment Period|Other than specified above|0|||
157086876|NCT02489968|567070058|FG003|Double-blind Treatment Period|Other than specified above|0|||
157086877|NCT02489968|567070059|FG004|Double-blind Treatment Period|Other than specified above|1|||
157086878|NCT02489968|567070060|FG005|Double-blind Treatment Period|Other than specified above|0|||
157086879|NCT04577001|567070061|FG000|Overall Study|Subject became ineligible|0|||
157086880|NCT04577001|567070062|FG001|Overall Study|Subject became ineligible|1|||
157086881|NCT01865747|567070065|FG000|Overall Study (ITT)|Adverse Event|32|||
157086882|NCT01865747|567070066|FG001|Overall Study (ITT)|Adverse Event|31|||
157086883|NCT01865747|567070065|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
157086884|NCT01865747|567070066|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
157086885|NCT01865747|567070065|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
157086886|NCT01865747|567070066|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
157086887|NCT01865747|567070065|FG000|Overall Study (ITT)|Protocol Violation|1|||
157086888|NCT01865747|567070066|FG001|Overall Study (ITT)|Protocol Violation|1|||
157086889|NCT01865747|567070065|FG000|Overall Study (ITT)|Physician Decision|5|||
157086890|NCT01865747|567070066|FG001|Overall Study (ITT)|Physician Decision|2|||
157086891|NCT01865747|567070065|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
157086892|NCT01865747|567070066|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
157086893|NCT01865747|567070065|FG000|Overall Study (ITT)|Sponsor Decision|0|||
157086894|NCT01865747|567070066|FG001|Overall Study (ITT)|Sponsor Decision|1|||
157086895|NCT01865747|567070065|FG000|Overall Study (ITT)|Progressive Disease|122|||
157086896|NCT01865747|567070066|FG001|Overall Study (ITT)|Progressive Disease|158|||
157086897|NCT01865747|567070065|FG000|Overall Study (ITT)|Reason Not Provided|0|||
157086898|NCT01865747|567070066|FG001|Overall Study (ITT)|Reason Not Provided|1|||
157086899|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
157086900|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
157086901|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
157086902|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
157086903|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
157086904|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
157086905|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
157086906|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
157086907|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
157086908|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
157086909|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
157086910|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
157086911|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
157086912|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
157086913|NCT01865747|567070065|FG000|Primary Intent to Treat (PITT)|Other|0|||
157086914|NCT01865747|567070066|FG001|Primary Intent to Treat (PITT)|Other|1|||
157086915|NCT04625413|567070069|FG000|Overall Study|Hospice|2|||
157086916|NCT04625413|567070069|FG000|Overall Study|Distress|1|||
157086917|NCT04625413|567070069|FG000|Overall Study|Not feeling well|1|||
157086918|NCT00432666|567072041|FG000|Main Period|Adverse Event|1|||
157086919|NCT00432666|567072042|FG001|Main Period|Adverse Event|1|||
157086920|NCT00432666|567072041|FG000|Main Period|Consent Withdrawn|1|||
157086921|NCT00432666|567072042|FG001|Main Period|Consent Withdrawn|0|||
157086922|NCT00432666|567072041|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
157086923|NCT00432666|567072042|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
157086924|NCT00432666|567072041|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
157086925|NCT00432666|567072042|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
157086926|NCT00432666|567072041|FG000|Open-Label Extension Period|Adverse Event|5|||
157086927|NCT00432666|567072042|FG001|Open-Label Extension Period|Adverse Event|0|||
157086928|NCT00432666|567072041|FG000|Open-Label Extension Period|Consent withdrawn|10|||
157086929|NCT00432666|567072042|FG001|Open-Label Extension Period|Consent withdrawn|0|||
157086930|NCT00432666|567072041|FG000|Open-Label Extension Period|Physician Decision|3|||
157086931|NCT00432666|567072042|FG001|Open-Label Extension Period|Physician Decision|0|||
157086932|NCT01506453|567072043|FG000|Overall Study|Withdrawal prior to treatment|0|||
157086933|NCT01506453|567072044|FG001|Overall Study|Withdrawal prior to treatment|2|||
157086934|NCT03694275|567072045|FG000|Overall Study|Adverse Event|0|||
157086935|NCT03694275|567072046|FG001|Overall Study|Adverse Event|1|||
157086936|NCT03694275|567072045|FG000|Overall Study|Reason not Specified|0|||
157086937|NCT03694275|567072046|FG001|Overall Study|Reason not Specified|1|||
157086938|NCT01022268|567072049|FG000|Overall Study|Withdrawal by Subject|1|||
157086939|NCT01022268|567072050|FG001|Overall Study|Withdrawal by Subject|0|||
157086940|NCT01022268|567072049|FG000|Overall Study|Withdrawal by Subject|1|||
157086941|NCT01022268|567072050|FG001|Overall Study|Withdrawal by Subject|0|||
157086942|NCT00734097|567072051|FG000|Screening|Protocol Violation|12|||
157086943|NCT00734097|567072051|FG000|Screening|Withdrawal by Subject|5|||
157086944|NCT00734097|567072051|FG000|Screening|Lost to Follow-up|2|||
157086945|NCT00734097|567072051|FG000|Screening|Unconfirmed pregnancy|1|||
157086946|NCT00734097|567072051|FG000|Open Label|Lost to Follow-up|7|||
157086947|NCT00734097|567072051|FG000|Open Label|Withdrawal by Subject|5|||
157086948|NCT00734097|567072051|FG000|Open Label|Protocol Violation|4|||
157086949|NCT02233543|567072054|FG000|Period 1|Withdrawal by Subject|1|||
157086950|NCT02233543|567072055|FG001|Period 1|Withdrawal by Subject|0|||
157086951|NCT02233543|567072054|FG000|Period 1|Participants required other treatment.|2|||
157086952|NCT02233543|567072055|FG001|Period 1|Participants required other treatment.|3|||
157086953|NCT02233543|567072054|FG000|Period 2|Adverse Event|1|||
157086954|NCT02233543|567072055|FG001|Period 2|Adverse Event|0|||
157086955|NCT02233543|567072054|FG000|Period 2|Participant required other treatment.|0|||
157086956|NCT02233543|567072055|FG001|Period 2|Participant required other treatment.|1|||
157086957|NCT02233543|567072054|FG000|Period 2|COPD exacerbation|1|||
157086958|NCT02233543|567072055|FG001|Period 2|COPD exacerbation|0|||
157086959|NCT01302067|567072056|FG000|Overall Study|Death|0|||
157086960|NCT01302067|567072057|FG001|Overall Study|Death|0|||
157086961|NCT01302067|567072058|FG002|Overall Study|Death|1|||
157086962|NCT01302067|567072056|FG000|Overall Study|Physician Decision|9|||
157086963|NCT01302067|567072057|FG001|Overall Study|Physician Decision|5|||
157086964|NCT01302067|567072058|FG002|Overall Study|Physician Decision|14|||
157086965|NCT01302067|567072056|FG000|Overall Study|Lack of Efficacy|8|||
157086966|NCT01302067|567072057|FG001|Overall Study|Lack of Efficacy|4|||
157086967|NCT01302067|567072058|FG002|Overall Study|Lack of Efficacy|2|||
157086968|NCT01302067|567072056|FG000|Overall Study|Lost to Follow-up|9|||
157086969|NCT01302067|567072057|FG001|Overall Study|Lost to Follow-up|4|||
157086970|NCT01302067|567072058|FG002|Overall Study|Lost to Follow-up|15|||
157086971|NCT01302067|567072056|FG000|Overall Study|Withdrawal by Subject|13|||
157086972|NCT01302067|567072057|FG001|Overall Study|Withdrawal by Subject|6|||
157086973|NCT01302067|567072058|FG002|Overall Study|Withdrawal by Subject|10|||
157086974|NCT01302067|567072056|FG000|Overall Study|Other|1|||
157086975|NCT01302067|567072057|FG001|Overall Study|Other|1|||
157086976|NCT01302067|567072058|FG002|Overall Study|Other|3|||
157086977|NCT01302067|567072056|FG000|Overall Study|Protocol Violation|11|||
157086978|NCT01302067|567072057|FG001|Overall Study|Protocol Violation|0|||
157086979|NCT01302067|567072058|FG002|Overall Study|Protocol Violation|8|||
157086980|NCT01302067|567072056|FG000|Overall Study|Adverse Event|27|||
157086981|NCT01302067|567072057|FG001|Overall Study|Adverse Event|14|||
157086982|NCT01302067|567072058|FG002|Overall Study|Adverse Event|45|||
157086983|NCT00603304|567072059|FG000|Overall Study|Lost to Follow-up|5|||
157086984|NCT00603304|567072060|FG001|Overall Study|Lost to Follow-up|7|||
157086985|NCT00603304|567072059|FG000|Overall Study|Withdrawal by Subject|8|||
157086986|NCT00603304|567072060|FG001|Overall Study|Withdrawal by Subject|5|||
157086987|NCT00603304|567072059|FG000|Overall Study|Protocol Violation|1|||
157086988|NCT00603304|567072060|FG001|Overall Study|Protocol Violation|0|||
157086989|NCT00603304|567072059|FG000|Overall Study|Adverse Event|4|||
157086990|NCT00603304|567072060|FG001|Overall Study|Adverse Event|2|||
157086991|NCT00603304|567072059|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
157086992|NCT00603304|567072060|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
157086993|NCT00603304|567072059|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
157086994|NCT00603304|567072060|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
157086995|NCT00603304|567072059|FG000|Overall Study|Exclusionary Medication|2|||
157086996|NCT00603304|567072060|FG001|Overall Study|Exclusionary Medication|3|||
157086997|NCT00603304|567072059|FG000|Overall Study|Non-Compliant|0|||
157086998|NCT00603304|567072060|FG001|Overall Study|Non-Compliant|1|||
157086999|NCT00603304|567072059|FG000|Overall Study|Moved Away|0|||
157087000|NCT00603304|567072060|FG001|Overall Study|Moved Away|2|||
157087001|NCT00603304|567072059|FG000|Overall Study|Other|2|||
157087002|NCT00603304|567072060|FG001|Overall Study|Other|0|||
157087003|NCT00603304|567072059|FG000|Overall Study|Patient Decision|2|||
157087004|NCT00603304|567072060|FG001|Overall Study|Patient Decision|0|||
157087005|NCT01076192|567072061|FG000|Overall Study|Other|197|||
157087006|NCT01034176|567072062|FG000|Overall Study|Physician Decision|2|||
157087007|NCT01034176|567072063|FG001|Overall Study|Physician Decision|0|||
157087008|NCT01034176|567072062|FG000|Overall Study|Withdrawal by Subject|0|||
157087009|NCT01034176|567072063|FG001|Overall Study|Withdrawal by Subject|1|||
157087010|NCT01034176|567072062|FG000|Overall Study|Lost to Follow-up|0|||
157087011|NCT01034176|567072063|FG001|Overall Study|Lost to Follow-up|1|||
157087012|NCT00266227|567072066|FG000|Initial Treatment|Adverse Event|0|||
157087013|NCT00266227|567072067|FG001|Initial Treatment|Adverse Event|0|||
157087014|NCT00266227|567072068|FG002|Initial Treatment|Adverse Event|13|||
157087015|NCT00266227|567072066|FG000|Initial Treatment|Lost to Follow-up|0|||
157087016|NCT00266227|567072067|FG001|Initial Treatment|Lost to Follow-up|0|||
157087017|NCT00266227|567072068|FG002|Initial Treatment|Lost to Follow-up|6|||
157087018|NCT00266227|567072066|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
157087019|NCT00266227|567072067|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
157087020|NCT00266227|567072068|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
157087021|NCT00266227|567072066|FG000|Initial Treatment|Physician decision to withdraw|0|||
157087022|NCT00266227|567072067|FG001|Initial Treatment|Physician decision to withdraw|0|||
157087023|NCT00266227|567072068|FG002|Initial Treatment|Physician decision to withdraw|12|||
157087024|NCT00266227|567072066|FG000|Initial Treatment|Pregnancy|0|||
157087025|NCT00266227|567072067|FG001|Initial Treatment|Pregnancy|0|||
157087026|NCT00266227|567072068|FG002|Initial Treatment|Pregnancy|1|||
157087027|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Death|1|||
157087028|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Death|0|||
157087029|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Death|0|||
157087030|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
157087031|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
157087032|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
157087033|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
157087034|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
157087035|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
157087036|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
157087037|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
157087038|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
157087039|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
157087040|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
157087041|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
157087042|NCT00266227|567072066|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
157087043|NCT00266227|567072067|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
157087044|NCT00266227|567072068|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
157087045|NCT00266227|567072066|FG000|Retreatment: Week 48 to Week 72|Death|1|||
157087046|NCT00266227|567072067|FG001|Retreatment: Week 48 to Week 72|Death|1|||
157087047|NCT00266227|567072068|FG002|Retreatment: Week 48 to Week 72|Death|0|||
157087048|NCT00266227|567072066|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
157087049|NCT00266227|567072067|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
157087050|NCT00266227|567072068|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
157087051|NCT00266227|567072066|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
157087052|NCT00266227|567072067|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
157087053|NCT00266227|567072068|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
157087054|NCT00266227|567072066|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
157087055|NCT00266227|567072067|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
157087056|NCT00266227|567072068|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
157087057|NCT00266227|567072066|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
157087058|NCT00266227|567072067|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
157087059|NCT00266227|567072068|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
157087060|NCT02680002|567072070|FG000|Overall Study|Lost to Follow-up|5|||
157087061|NCT02680002|567072071|FG001|Overall Study|Lost to Follow-up|1|||
157087062|NCT02680002|567072072|FG002|Overall Study|Lost to Follow-up|4|||
157087063|NCT02680002|567072073|FG003|Overall Study|Lost to Follow-up|2|||
157087064|NCT02680002|567072074|FG004|Overall Study|Lost to Follow-up|0|||
157087065|NCT02680002|567072075|FG005|Overall Study|Lost to Follow-up|2|||
157087066|NCT02680002|567072070|FG000|Overall Study|Physician Decision|5|||
157087067|NCT02680002|567072071|FG001|Overall Study|Physician Decision|1|||
157087068|NCT02680002|567072072|FG002|Overall Study|Physician Decision|1|||
157087069|NCT02680002|567072073|FG003|Overall Study|Physician Decision|1|||
157087070|NCT02680002|567072074|FG004|Overall Study|Physician Decision|1|||
157087071|NCT02680002|567072075|FG005|Overall Study|Physician Decision|1|||
157087072|NCT02680002|567072070|FG000|Overall Study|Protocol Violation|1|||
157087073|NCT02680002|567072071|FG001|Overall Study|Protocol Violation|0|||
157087074|NCT02680002|567072072|FG002|Overall Study|Protocol Violation|1|||
157087075|NCT02680002|567072073|FG003|Overall Study|Protocol Violation|0|||
157087076|NCT02680002|567072074|FG004|Overall Study|Protocol Violation|1|||
157235967|NCT00365365|567612912|FG000|Overall Study|Death|1|||
157087077|NCT02680002|567072075|FG005|Overall Study|Protocol Violation|2|||
157087078|NCT02680002|567072070|FG000|Overall Study|Withdrawal by Subject|0|||
157087079|NCT02680002|567072071|FG001|Overall Study|Withdrawal by Subject|0|||
157087080|NCT02680002|567072072|FG002|Overall Study|Withdrawal by Subject|1|||
157087081|NCT02680002|567072073|FG003|Overall Study|Withdrawal by Subject|0|||
157087082|NCT02680002|567072074|FG004|Overall Study|Withdrawal by Subject|2|||
157087083|NCT02680002|567072075|FG005|Overall Study|Withdrawal by Subject|2|||
157087084|NCT02680002|567072070|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
157087085|NCT02680002|567072071|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
157087086|NCT02680002|567072072|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
157087087|NCT02680002|567072073|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
157087088|NCT02680002|567072074|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
157087089|NCT02680002|567072075|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
157087090|NCT02680002|567072070|FG000|Overall Study|Other|0|||
157087091|NCT02680002|567072071|FG001|Overall Study|Other|1|||
157087092|NCT02680002|567072072|FG002|Overall Study|Other|0|||
157087093|NCT02680002|567072073|FG003|Overall Study|Other|0|||
157087094|NCT02680002|567072074|FG004|Overall Study|Other|1|||
157087095|NCT02680002|567072075|FG005|Overall Study|Other|0|||
157087096|NCT02680002|567072070|FG000|Overall Study|Adverse Event|0|||
157087097|NCT02680002|567072071|FG001|Overall Study|Adverse Event|0|||
157087098|NCT02680002|567072072|FG002|Overall Study|Adverse Event|0|||
157087099|NCT02680002|567072073|FG003|Overall Study|Adverse Event|0|||
157087100|NCT02680002|567072074|FG004|Overall Study|Adverse Event|1|||
157087101|NCT02680002|567072075|FG005|Overall Study|Adverse Event|2|||
157087102|NCT02383056|567072078|FG000|Overall Study|Adverse Event|1|||
157087103|NCT02383056|567072079|FG001|Overall Study|Adverse Event|0|||
157087104|NCT02383056|567072078|FG000|Overall Study|Lost to Follow-up|0|||
157087105|NCT02383056|567072079|FG001|Overall Study|Lost to Follow-up|2|||
157087106|NCT01775475|567072080|FG000|Overall Study|Death|3|||
157087107|NCT01775475|567072081|FG001|Overall Study|Death|3|||
157087108|NCT02074553|567072089|FG000|Intervention Period 1|Family Emergency|0|||
157087109|NCT02074553|567072090|FG001|Intervention Period 1|Family Emergency|0|||
157087110|NCT02074553|567072091|FG002|Intervention Period 1|Family Emergency|0|||
157087111|NCT02074553|567072092|FG003|Intervention Period 1|Family Emergency|1|||
157087112|NCT02074553|567072093|FG004|Intervention Period 1|Family Emergency|0|||
157087113|NCT02074553|567072094|FG005|Intervention Period 1|Family Emergency|0|||
157087114|NCT02074553|567072095|FG006|Intervention Period 1|Family Emergency|0|||
157087115|NCT02074553|567072096|FG007|Intervention Period 1|Family Emergency|0|||
157087116|NCT02074553|567072089|FG000|Washout Period 1|Adverse Event|1|||
157087117|NCT02074553|567072090|FG001|Washout Period 1|Adverse Event|0|||
157087118|NCT02074553|567072091|FG002|Washout Period 1|Adverse Event|0|||
157087119|NCT02074553|567072092|FG003|Washout Period 1|Adverse Event|0|||
157087120|NCT02074553|567072093|FG004|Washout Period 1|Adverse Event|0|||
157087121|NCT02074553|567072094|FG005|Washout Period 1|Adverse Event|0|||
157087122|NCT02074553|567072095|FG006|Washout Period 1|Adverse Event|0|||
157087123|NCT02074553|567072096|FG007|Washout Period 1|Adverse Event|0|||
157087124|NCT02074553|567072089|FG000|Washout Period 1|Physician Decision|0|||
157087125|NCT02074553|567072090|FG001|Washout Period 1|Physician Decision|0|||
157235968|NCT00365365|567612913|FG001|Overall Study|Death|3|||
157235969|NCT00365365|567612914|FG002|Overall Study|Death|0|||
157235970|NCT00365365|567612912|FG000|Overall Study|Subject's request|11|||
157235971|NCT00365365|567612913|FG001|Overall Study|Subject's request|13|||
157235972|NCT00365365|567612914|FG002|Overall Study|Subject's request|1|||
157235973|NCT00365365|567612912|FG000|Overall Study|Disease progression/relapse|9|||
157235974|NCT00365365|567612913|FG001|Overall Study|Disease progression/relapse|6|||
157235975|NCT00365365|567612914|FG002|Overall Study|Disease progression/relapse|7|||
157235976|NCT00365365|567612912|FG000|Overall Study|Adverse Event|6|||
157235977|NCT00365365|567612913|FG001|Overall Study|Adverse Event|6|||
157235978|NCT00365365|567612914|FG002|Overall Study|Adverse Event|3|||
157087126|NCT02074553|567072091|FG002|Washout Period 1|Physician Decision|0|||
157087127|NCT02074553|567072092|FG003|Washout Period 1|Physician Decision|1|||
157235979|NCT00365365|567612912|FG000|Overall Study|Moved|2|||
157235980|NCT00365365|567612913|FG001|Overall Study|Moved|0|||
157235981|NCT00365365|567612914|FG002|Overall Study|Moved|0|||
157235982|NCT00365365|567612912|FG000|Overall Study|New cancer|1|||
157235983|NCT00365365|567612913|FG001|Overall Study|New cancer|0|||
157235984|NCT00365365|567612914|FG002|Overall Study|New cancer|0|||
157235985|NCT00365365|567612912|FG000|Overall Study|Withdrew consent|1|||
157087128|NCT02074553|567072093|FG004|Washout Period 1|Physician Decision|0|||
157087129|NCT02074553|567072094|FG005|Washout Period 1|Physician Decision|0|||
157235986|NCT00365365|567612913|FG001|Overall Study|Withdrew consent|1|||
157087130|NCT02074553|567072095|FG006|Washout Period 1|Physician Decision|0|||
157087131|NCT02074553|567072096|FG007|Washout Period 1|Physician Decision|0|||
157087132|NCT02074553|567072089|FG000|Washout Period 1|Other|0|||
157087133|NCT02074553|567072090|FG001|Washout Period 1|Other|0|||
157087134|NCT02074553|567072091|FG002|Washout Period 1|Other|0|||
157235987|NCT00365365|567612914|FG002|Overall Study|Withdrew consent|0|||
157235988|NCT00365365|567612912|FG000|Overall Study|Second malignancy|0|||
157087135|NCT02074553|567072092|FG003|Washout Period 1|Other|0|||
157087136|NCT02074553|567072093|FG004|Washout Period 1|Other|0|||
157087137|NCT02074553|567072094|FG005|Washout Period 1|Other|1|||
157087138|NCT02074553|567072095|FG006|Washout Period 1|Other|0|||
157087139|NCT02074553|567072096|FG007|Washout Period 1|Other|0|||
157087140|NCT02074553|567072089|FG000|Washout Period 2|Adverse Event|0|||
157087141|NCT02074553|567072090|FG001|Washout Period 2|Adverse Event|0|||
157087142|NCT02074553|567072091|FG002|Washout Period 2|Adverse Event|0|||
157087143|NCT02074553|567072092|FG003|Washout Period 2|Adverse Event|0|||
157087144|NCT02074553|567072093|FG004|Washout Period 2|Adverse Event|0|||
157087145|NCT02074553|567072094|FG005|Washout Period 2|Adverse Event|0|||
157087146|NCT02074553|567072095|FG006|Washout Period 2|Adverse Event|1|||
157087147|NCT02074553|567072096|FG007|Washout Period 2|Adverse Event|0|||
157087148|NCT02074553|567072089|FG000|Washout Period 2|Physician Decision|0|||
157087149|NCT02074553|567072090|FG001|Washout Period 2|Physician Decision|0|||
157087150|NCT02074553|567072091|FG002|Washout Period 2|Physician Decision|0|||
157087151|NCT02074553|567072092|FG003|Washout Period 2|Physician Decision|0|||
157087152|NCT02074553|567072093|FG004|Washout Period 2|Physician Decision|0|||
157087153|NCT02074553|567072094|FG005|Washout Period 2|Physician Decision|1|||
157087154|NCT02074553|567072095|FG006|Washout Period 2|Physician Decision|0|||
157087155|NCT02074553|567072096|FG007|Washout Period 2|Physician Decision|0|||
157087156|NCT02074553|567072089|FG000|Washout Period 2|Lost to Follow-up|0|||
157087157|NCT02074553|567072090|FG001|Washout Period 2|Lost to Follow-up|0|||
157087158|NCT02074553|567072091|FG002|Washout Period 2|Lost to Follow-up|1|||
157087159|NCT02074553|567072092|FG003|Washout Period 2|Lost to Follow-up|0|||
157087160|NCT02074553|567072093|FG004|Washout Period 2|Lost to Follow-up|0|||
157087161|NCT02074553|567072094|FG005|Washout Period 2|Lost to Follow-up|0|||
157087162|NCT02074553|567072095|FG006|Washout Period 2|Lost to Follow-up|0|||
157087163|NCT02074553|567072096|FG007|Washout Period 2|Lost to Follow-up|0|||
157087164|NCT02074553|567072089|FG000|Washout Period 3|Physician Decision|0|||
157087165|NCT02074553|567072090|FG001|Washout Period 3|Physician Decision|0|||
157087166|NCT02074553|567072091|FG002|Washout Period 3|Physician Decision|0|||
157087167|NCT02074553|567072092|FG003|Washout Period 3|Physician Decision|0|||
157087168|NCT02074553|567072093|FG004|Washout Period 3|Physician Decision|0|||
157087169|NCT02074553|567072094|FG005|Washout Period 3|Physician Decision|0|||
157087170|NCT02074553|567072095|FG006|Washout Period 3|Physician Decision|0|||
157087171|NCT02074553|567072096|FG007|Washout Period 3|Physician Decision|1|||
157087172|NCT00194987|567072097|FG000|Overall Study|Withdrawal by Subject|0|||
157087173|NCT00194987|567072098|FG001|Overall Study|Withdrawal by Subject|3|||
157087174|NCT01664598|567072099|FG000|Overall Study|Sponsor Decision|1|||
157087175|NCT01664598|567072099|FG000|Overall Study|Withdrawal of Informed Consent|4|||
157087176|NCT01664598|567072099|FG000|Overall Study|Adverse Event|1|||
157087177|NCT02342743|567072100|FG000|Baseline Period|Withdrawal by Subject|3|||
157087178|NCT02342743|567072100|FG000|Baseline Period|Lost to Follow-up|2|||
157087179|NCT02342743|567072100|FG000|Baseline Period|Change in prophylactic medication|3|||
157087180|NCT02342743|567072100|FG000|Baseline Period|Screening failure regarding baseline|7|||
157087181|NCT02342743|567072100|FG000|Treatment Period|Withdrawal by Subject|2|||
157087182|NCT02342743|567072100|FG000|Treatment Period|Lost to Follow-up|8|||
157087183|NCT02342743|567072100|FG000|Treatment Period|Change in prophylactic medication|1|||
157087184|NCT00686725|567072101|FG000|Overall Study|Adverse Event|1|||
157087185|NCT00686725|567072102|FG001|Overall Study|Adverse Event|1|||
157087186|NCT00686725|567072101|FG000|Overall Study|Progressive Disease|17|||
157087187|NCT00686725|567072102|FG001|Overall Study|Progressive Disease|23|||
157087188|NCT00686725|567072101|FG000|Overall Study|Lost to Follow-up|7|||
157087189|NCT00686725|567072102|FG001|Overall Study|Lost to Follow-up|5|||
157087190|NCT00686725|567072101|FG000|Overall Study|Death|6|||
157087191|NCT00686725|567072102|FG001|Overall Study|Death|3|||
157087192|NCT00686725|567072101|FG000|Overall Study|Withdrawal by Subject|13|||
157087193|NCT00686725|567072102|FG001|Overall Study|Withdrawal by Subject|4|||
157087194|NCT00686725|567072101|FG000|Overall Study|Protocol Violation|1|||
157087195|NCT00686725|567072102|FG001|Overall Study|Protocol Violation|3|||
157087196|NCT00686725|567072101|FG000|Overall Study|Other|1|||
157087197|NCT00686725|567072102|FG001|Overall Study|Other|3|||
157087198|NCT03602066|567072103|FG000|Overall Study|Withdrawal by Subject|2|||
157087199|NCT03602066|567072104|FG001|Overall Study|Withdrawal by Subject|0|||
157087200|NCT03602066|567072103|FG000|Overall Study|Physician Decision|1|||
157087201|NCT03602066|567072104|FG001|Overall Study|Physician Decision|0|||
157087202|NCT00092495|567072105|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
157087203|NCT00092495|567072106|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
157087204|NCT00092495|567072107|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157087205|NCT00092495|567072108|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
157087206|NCT00092495|567072109|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
157087207|NCT00092495|567072105|FG000|Base Study Vaccination Period|Extended|0|||
157087208|NCT00092495|567072106|FG001|Base Study Vaccination Period|Extended|0|||
157087209|NCT00092495|567072107|FG002|Base Study Vaccination Period|Extended|0|||
157087210|NCT00092495|567072108|FG003|Base Study Vaccination Period|Extended|1|||
157087211|NCT00092495|567072109|FG004|Base Study Vaccination Period|Extended|0|||
157235989|NCT00365365|567612913|FG001|Overall Study|Second malignancy|1|||
157235990|NCT00365365|567612914|FG002|Overall Study|Second malignancy|0|||
157235991|NCT00365365|567612912|FG000|Overall Study|Patient/physician decision|0|||
157235992|NCT00365365|567612913|FG001|Overall Study|Patient/physician decision|0|||
157235993|NCT00365365|567612914|FG002|Overall Study|Patient/physician decision|1|||
157235994|NCT00984022|567612915|FG000|Overall Study|Lost to Follow-up|10|||
157235995|NCT00984022|567612916|FG001|Overall Study|Lost to Follow-up|14|||
157235996|NCT00573443|567612920|FG000|Double-Blind Phase|Lost to Follow-up|1|||
157235997|NCT00573443|567612921|FG001|Double-Blind Phase|Lost to Follow-up|3|||
157235998|NCT00573443|567612922|FG002|Double-Blind Phase|Lost to Follow-up|2|||
157087212|NCT00092495|567072105|FG000|Base Study Vaccination Period|*Clinical AE|1|||
157087213|NCT00092495|567072106|FG001|Base Study Vaccination Period|*Clinical AE|0|||
157087214|NCT00092495|567072107|FG002|Base Study Vaccination Period|*Clinical AE|1|||
157087215|NCT00092495|567072108|FG003|Base Study Vaccination Period|*Clinical AE|2|||
157087216|NCT00092495|567072109|FG004|Base Study Vaccination Period|*Clinical AE|0|||
157087217|NCT00092495|567072105|FG000|Base Study Vaccination Period|*Other reasons|1|||
157087218|NCT00092495|567072106|FG001|Base Study Vaccination Period|*Other reasons|0|||
157087219|NCT00092495|567072107|FG002|Base Study Vaccination Period|*Other reasons|0|||
157235999|NCT00573443|567612920|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
157236000|NCT00573443|567612921|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
157236001|NCT00573443|567612922|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
157236002|NCT00573443|567612920|FG000|Double-Blind Phase|Adverse Event|1|||
157236003|NCT00573443|567612921|FG001|Double-Blind Phase|Adverse Event|5|||
157236004|NCT00573443|567612922|FG002|Double-Blind Phase|Adverse Event|0|||
157236005|NCT00573443|567612920|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
157236006|NCT00573443|567612921|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
157236007|NCT00573443|567612922|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
157236008|NCT00573443|567612920|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
157236009|NCT00573443|567612921|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
157236010|NCT00573443|567612922|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
157236011|NCT00573443|567612920|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
157236012|NCT00573443|567612921|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
157236013|NCT00573443|567612922|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
157236014|NCT00573443|567612920|FG000|Double-Blind Phase|Protocol Violation|0|||
157236015|NCT00573443|567612921|FG001|Double-Blind Phase|Protocol Violation|2|||
157236016|NCT00573443|567612922|FG002|Double-Blind Phase|Protocol Violation|1|||
157236017|NCT00573443|567612920|FG000|Double-Blind Phase|Other|0|||
157236018|NCT00573443|567612921|FG001|Double-Blind Phase|Other|2|||
157236019|NCT00573443|567612922|FG002|Double-Blind Phase|Other|3|||
157236020|NCT00573443|567612920|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
157236021|NCT00573443|567612921|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
157236022|NCT00573443|567612922|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
157087220|NCT00092495|567072108|FG003|Base Study Vaccination Period|*Other reasons|1|||
157087221|NCT00092495|567072109|FG004|Base Study Vaccination Period|*Other reasons|0|||
157087222|NCT00092495|567072105|FG000|Base Study Vaccination Period|*Pregnancy|0|||
157087223|NCT00092495|567072106|FG001|Base Study Vaccination Period|*Pregnancy|2|||
157087224|NCT00092495|567072107|FG002|Base Study Vaccination Period|*Pregnancy|5|||
157087225|NCT00092495|567072108|FG003|Base Study Vaccination Period|*Pregnancy|7|||
157087226|NCT00092495|567072109|FG004|Base Study Vaccination Period|*Pregnancy|0|||
157236023|NCT00573443|567612920|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
157236024|NCT00573443|567612921|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
157236025|NCT00573443|567612922|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
157236026|NCT00573443|567612920|FG000|Open-Label Extension Phase|Adverse Event|3|||
157087227|NCT00092495|567072105|FG000|Base Study Vaccination Period|Adverse Event|1|||
157087228|NCT00092495|567072106|FG001|Base Study Vaccination Period|Adverse Event|0|||
157087229|NCT00092495|567072107|FG002|Base Study Vaccination Period|Adverse Event|0|||
157087230|NCT00092495|567072108|FG003|Base Study Vaccination Period|Adverse Event|3|||
157087231|NCT00092495|567072109|FG004|Base Study Vaccination Period|Adverse Event|0|||
157087232|NCT00092495|567072105|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
157087233|NCT00092495|567072106|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
157087234|NCT00092495|567072107|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
157087235|NCT00092495|567072108|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
157087236|NCT00092495|567072109|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
157087237|NCT00092495|567072105|FG000|Base Study Vaccination Period|Moved|3|||
157087238|NCT00092495|567072106|FG001|Base Study Vaccination Period|Moved|1|||
157236027|NCT00573443|567612921|FG001|Open-Label Extension Phase|Adverse Event|0|||
157236028|NCT00573443|567612922|FG002|Open-Label Extension Phase|Adverse Event|0|||
157236029|NCT00573443|567612920|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
157087239|NCT00092495|567072107|FG002|Base Study Vaccination Period|Moved|2|||
157087240|NCT00092495|567072108|FG003|Base Study Vaccination Period|Moved|2|||
157087241|NCT00092495|567072109|FG004|Base Study Vaccination Period|Moved|0|||
157087242|NCT00092495|567072105|FG000|Base Study Vaccination Period|Other|1|||
157087243|NCT00092495|567072106|FG001|Base Study Vaccination Period|Other|1|||
157087244|NCT00092495|567072107|FG002|Base Study Vaccination Period|Other|0|||
157087245|NCT00092495|567072108|FG003|Base Study Vaccination Period|Other|2|||
157087246|NCT00092495|567072109|FG004|Base Study Vaccination Period|Other|0|||
157087247|NCT00092495|567072105|FG000|Base Study Vaccination Period|Pregnancy|2|||
157087248|NCT00092495|567072106|FG001|Base Study Vaccination Period|Pregnancy|0|||
157236030|NCT00573443|567612921|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
157236031|NCT00573443|567612922|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
157236032|NCT00573443|567612920|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
157236033|NCT00573443|567612921|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
157236034|NCT00573443|567612922|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
157236035|NCT00573443|567612920|FG000|Open-Label Extension Phase|Protocol Violation|2|||
157236036|NCT00573443|567612921|FG001|Open-Label Extension Phase|Protocol Violation|0|||
157236037|NCT00573443|567612922|FG002|Open-Label Extension Phase|Protocol Violation|0|||
157236038|NCT00573443|567612920|FG000|Open-Label Extension Phase|Other|2|||
157236039|NCT00573443|567612921|FG001|Open-Label Extension Phase|Other|0|||
157236040|NCT00573443|567612922|FG002|Open-Label Extension Phase|Other|0|||
157236041|NCT03020615|567612924|FG000|Overall Study|Physician Decision|3|||
157236042|NCT03020615|567612925|FG001|Overall Study|Physician Decision|1|||
157236043|NCT03020615|567612926|FG002|Overall Study|Physician Decision|2|||
157236044|NCT03020615|567612924|FG000|Overall Study|Parent/guardian/patient choice|3|||
157236045|NCT03020615|567612925|FG001|Overall Study|Parent/guardian/patient choice|0|||
157236046|NCT03020615|567612926|FG002|Overall Study|Parent/guardian/patient choice|4|||
157087249|NCT00092495|567072107|FG002|Base Study Vaccination Period|Pregnancy|0|||
157087250|NCT00092495|567072108|FG003|Base Study Vaccination Period|Pregnancy|0|||
157196100|NCT01684930|567461390|FG000|Overall Study|Withdrawal by Subject|3|||
157196101|NCT01684930|567461391|FG001|Overall Study|Withdrawal by Subject|1|||
157196102|NCT01336647|567461393|FG000|Overall Study|Lost to Follow-up|4|||
157196103|NCT01336647|567461394|FG001|Overall Study|Lost to Follow-up|1|||
157196104|NCT01336647|567461395|FG002|Overall Study|Lost to Follow-up|3|||
157196105|NCT03808298|567461396|FG000|Overall Study|Adverse Event|3|||
157196106|NCT03808298|567461396|FG000|Overall Study|Physician Decision|1|||
157196107|NCT03808298|567461396|FG000|Overall Study|Withdrawal by Subject|1|||
157196108|NCT03808298|567461396|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
157196109|NCT01004822|567461397|FG000|Overall Study|Objective progression or relapse|3|||
157196110|NCT01004822|567461398|FG001|Overall Study|Objective progression or relapse|3|||
157196111|NCT01004822|567461399|FG002|Overall Study|Objective progression or relapse|0|||
157196112|NCT01004822|567461400|FG003|Overall Study|Objective progression or relapse|1|||
157196113|NCT01004822|567461401|FG004|Overall Study|Objective progression or relapse|2|||
157196114|NCT01004822|567461402|FG005|Overall Study|Objective progression or relapse|2|||
157196115|NCT01004822|567461403|FG006|Overall Study|Objective progression or relapse|1|||
157196116|NCT01004822|567461404|FG007|Overall Study|Objective progression or relapse|4|||
157196117|NCT01004822|567461397|FG000|Overall Study|Global deterioration of health status|0|||
157196118|NCT01004822|567461398|FG001|Overall Study|Global deterioration of health status|0|||
157196119|NCT01004822|567461399|FG002|Overall Study|Global deterioration of health status|0|||
157196120|NCT01004822|567461400|FG003|Overall Study|Global deterioration of health status|1|||
157196121|NCT01004822|567461401|FG004|Overall Study|Global deterioration of health status|0|||
157196122|NCT01004822|567461402|FG005|Overall Study|Global deterioration of health status|0|||
157196123|NCT01004822|567461403|FG006|Overall Study|Global deterioration of health status|1|||
157196124|NCT01004822|567461404|FG007|Overall Study|Global deterioration of health status|0|||
157196125|NCT01004822|567461397|FG000|Overall Study|No longer willing to continue|0|||
157196126|NCT01004822|567461398|FG001|Overall Study|No longer willing to continue|0|||
157196127|NCT01004822|567461399|FG002|Overall Study|No longer willing to continue|0|||
157196128|NCT01004822|567461400|FG003|Overall Study|No longer willing to continue|1|||
157196129|NCT01004822|567461401|FG004|Overall Study|No longer willing to continue|2|||
157196130|NCT01004822|567461402|FG005|Overall Study|No longer willing to continue|1|||
157196131|NCT01004822|567461403|FG006|Overall Study|No longer willing to continue|1|||
157196132|NCT01004822|567461404|FG007|Overall Study|No longer willing to continue|0|||
157196133|NCT01004822|567461397|FG000|Overall Study|Adverse Event|0|||
157196134|NCT01004822|567461398|FG001|Overall Study|Adverse Event|0|||
157196135|NCT01004822|567461399|FG002|Overall Study|Adverse Event|0|||
157196136|NCT01004822|567461400|FG003|Overall Study|Adverse Event|0|||
157196137|NCT01004822|567461401|FG004|Overall Study|Adverse Event|0|||
157196138|NCT01004822|567461402|FG005|Overall Study|Adverse Event|0|||
157236047|NCT03020615|567612924|FG000|Overall Study|Screen failure|0|||
157236048|NCT03020615|567612925|FG001|Overall Study|Screen failure|0|||
157236049|NCT03020615|567612926|FG002|Overall Study|Screen failure|1|||
157236050|NCT03020615|567612924|FG000|Overall Study|Death|1|||
157087251|NCT00092495|567072109|FG004|Base Study Vaccination Period|Pregnancy|0|||
157196139|NCT01004822|567461403|FG006|Overall Study|Adverse Event|1|||
157196140|NCT01004822|567461404|FG007|Overall Study|Adverse Event|1|||
157196141|NCT01004822|567461397|FG000|Overall Study|Other|0|||
157196142|NCT01004822|567461398|FG001|Overall Study|Other|0|||
157196143|NCT01004822|567461399|FG002|Overall Study|Other|4|||
157196144|NCT01004822|567461400|FG003|Overall Study|Other|1|||
157236051|NCT03020615|567612925|FG001|Overall Study|Death|0|||
157236052|NCT03020615|567612926|FG002|Overall Study|Death|0|||
157087252|NCT00092495|567072105|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
157087253|NCT00092495|567072106|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
157087254|NCT00092495|567072107|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
157087255|NCT00092495|567072108|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
157087256|NCT00092495|567072109|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
157087257|NCT00092495|567072105|FG000|Base Study Vaccination Period|Protocol Violation|1|||
157087258|NCT00092495|567072106|FG001|Base Study Vaccination Period|Protocol Violation|0|||
157236053|NCT03020615|567612924|FG000|Overall Study|Lost to Follow-up|0|||
157236054|NCT03020615|567612925|FG001|Overall Study|Lost to Follow-up|1|||
157236055|NCT03020615|567612926|FG002|Overall Study|Lost to Follow-up|0|||
157236056|NCT01273805|567612927|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
157236057|NCT01273805|567612928|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
157236058|NCT02647944|567612929|FG000|Overall Study|Withdrawal by Subject|0|||
157236059|NCT02647944|567612930|FG001|Overall Study|Withdrawal by Subject|3|||
157236060|NCT02647944|567612929|FG000|Overall Study|Adverse Event|2|||
157236061|NCT02647944|567612930|FG001|Overall Study|Adverse Event|0|||
157236062|NCT02077465|567612932|FG000|Overall Study|Withdrew Consent|0|||
157236063|NCT02077465|567612933|FG001|Overall Study|Withdrew Consent|1|||
157236064|NCT02077465|567612932|FG000|Overall Study|Lost to Follow-up|1|||
157236065|NCT02077465|567612933|FG001|Overall Study|Lost to Follow-up|0|||
157087259|NCT00092495|567072107|FG002|Base Study Vaccination Period|Protocol Violation|0|||
157087260|NCT00092495|567072108|FG003|Base Study Vaccination Period|Protocol Violation|0|||
157087261|NCT00092495|567072109|FG004|Base Study Vaccination Period|Protocol Violation|0|||
157087262|NCT00092495|567072105|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
157087263|NCT00092495|567072106|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
157087264|NCT00092495|567072107|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
157087265|NCT00092495|567072108|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
157236066|NCT04627038|567612934|FG000|Overall Study|Adverse Event|36|||
157236067|NCT04627038|567612935|FG001|Overall Study|Adverse Event|8|||
157236068|NCT04627038|567612934|FG000|Overall Study|Lost to Follow-up|1|||
157236069|NCT04627038|567612935|FG001|Overall Study|Lost to Follow-up|0|||
157236070|NCT04627038|567612934|FG000|Overall Study|Physician Decision|0|||
157236071|NCT04627038|567612935|FG001|Overall Study|Physician Decision|1|||
157236072|NCT04627038|567612934|FG000|Overall Study|Protocol Violation|3|||
157236073|NCT04627038|567612935|FG001|Overall Study|Protocol Violation|1|||
157236074|NCT04627038|567612934|FG000|Overall Study|Withdrawal by Subject|13|||
157236075|NCT04627038|567612935|FG001|Overall Study|Withdrawal by Subject|3|||
157236076|NCT04627038|567612934|FG000|Overall Study|Non-compliance with study drug|0|||
157236077|NCT04627038|567612935|FG001|Overall Study|Non-compliance with study drug|1|||
157236078|NCT04627038|567612934|FG000|Overall Study|Prohibited Concomitant Medication|1|||
157236079|NCT04627038|567612935|FG001|Overall Study|Prohibited Concomitant Medication|0|||
157236080|NCT02760368|567612936|FG000|Overall Study|Withdrawal by Subject|8|||
157236081|NCT02760368|567612937|FG001|Overall Study|Withdrawal by Subject|12|||
157236082|NCT02760368|567612938|FG002|Overall Study|Withdrawal by Subject|9|||
157236083|NCT02760368|567612936|FG000|Overall Study|Screen Failure|0|||
157236084|NCT02760368|567612937|FG001|Overall Study|Screen Failure|0|||
157236085|NCT02760368|567612938|FG002|Overall Study|Screen Failure|1|||
157236086|NCT02760368|567612936|FG000|Overall Study|Death|0|||
157236087|NCT02760368|567612937|FG001|Overall Study|Death|1|||
157236088|NCT02760368|567612938|FG002|Overall Study|Death|0|||
157236089|NCT02760368|567612936|FG000|Overall Study|Withdrawal by Sponsor|0|||
157236090|NCT02760368|567612937|FG001|Overall Study|Withdrawal by Sponsor|0|||
157236091|NCT02760368|567612938|FG002|Overall Study|Withdrawal by Sponsor|1|||
157236092|NCT00794963|567612939|FG000|Overall Study|Withdrawal by Subject|1|||
157236093|NCT00794963|567612940|FG001|Overall Study|Withdrawal by Subject|4|||
157236094|NCT01037114|567612941|FG000|Year 20|Others|1|||
157087266|NCT00092495|567072109|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
157236095|NCT01602419|567612942|FG000|Overall Study|Not treated with Wilate|9|||
157236096|NCT01602419|567612942|FG000|Overall Study|Adverse Drug Reaction|4|||
157236097|NCT01602419|567612942|FG000|Overall Study|Insurance issues|3|||
157236098|NCT01602419|567612942|FG000|Overall Study|Changed treatment centre|1|||
157236099|NCT01602419|567612942|FG000|Overall Study|Treatment centre closed|1|||
157236100|NCT01602419|567612942|FG000|Overall Study|Withdrawal by Subject|5|||
157236101|NCT01602419|567612942|FG000|Overall Study|Lost to Follow-up|6|||
157236102|NCT02682784|567612954|FG000|Overall Study|Withdrawal by Subject|0|||
157236103|NCT02682784|567612955|FG001|Overall Study|Withdrawal by Subject|2|||
157236104|NCT02682784|567612956|FG002|Overall Study|Withdrawal by Subject|1|||
157087267|NCT00092495|567072105|FG000|Base Study Follow-up Period|Extended|0|||
157087268|NCT00092495|567072106|FG001|Base Study Follow-up Period|Extended|0|||
157087269|NCT00092495|567072107|FG002|Base Study Follow-up Period|Extended|1|||
157236105|NCT02682784|567612957|FG003|Overall Study|Withdrawal by Subject|2|||
157236106|NCT02682784|567612954|FG000|Overall Study|Physician Decision|1|||
157236107|NCT02682784|567612955|FG001|Overall Study|Physician Decision|0|||
157236108|NCT02682784|567612956|FG002|Overall Study|Physician Decision|1|||
157087270|NCT00092495|567072108|FG003|Base Study Follow-up Period|Extended|2|||
157087271|NCT00092495|567072109|FG004|Base Study Follow-up Period|Extended|0|||
157087272|NCT00092495|567072105|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
157087273|NCT00092495|567072106|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
157087274|NCT00092495|567072107|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
157087275|NCT00092495|567072108|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
157087276|NCT00092495|567072109|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
157087277|NCT00092495|567072105|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
157087278|NCT00092495|567072106|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
157087279|NCT00092495|567072107|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
157087280|NCT00092495|567072108|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
157087281|NCT00092495|567072109|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
157087282|NCT00938470|567072114|FG000|Overall Study|Disease Progression|3|||
157087283|NCT00938470|567072115|FG001|Overall Study|Disease Progression|0|||
157087284|NCT00938470|567072114|FG000|Overall Study|Alternate Treatment|1|||
157087285|NCT00938470|567072115|FG001|Overall Study|Alternate Treatment|0|||
157087286|NCT00938470|567072114|FG000|Overall Study|Death|3|||
157087287|NCT00938470|567072115|FG001|Overall Study|Death|2|||
157087288|NCT00938470|567072114|FG000|Overall Study|Other Reason|0|||
157087289|NCT00938470|567072115|FG001|Overall Study|Other Reason|1|||
157087290|NCT04988867|567072126|FG000|Overall Study|Study terminated by Sponsor|12|||
157087291|NCT04988867|567072126|FG000|Overall Study|Adverse Event|2|||
157087292|NCT04988867|567072126|FG000|Overall Study|Study drug noncompliance|1|||
157087293|NCT01097707|567072129|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157087294|NCT01097707|567072130|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
157087295|NCT01097707|567072131|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157087296|NCT01097707|567072132|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157087297|NCT01097707|567072133|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
157087298|NCT01097707|567072129|FG000|Overall Study|Adverse Event|4|||
157087299|NCT01097707|567072130|FG001|Overall Study|Adverse Event|2|||
157087300|NCT01097707|567072131|FG002|Overall Study|Adverse Event|3|||
157087301|NCT01097707|567072132|FG003|Overall Study|Adverse Event|1|||
157087302|NCT01097707|567072133|FG004|Overall Study|Adverse Event|3|||
157087303|NCT01097707|567072129|FG000|Overall Study|Entry Criteria Not Met|2|||
157087304|NCT01097707|567072130|FG001|Overall Study|Entry Criteria Not Met|1|||
157087305|NCT01097707|567072131|FG002|Overall Study|Entry Criteria Not Met|1|||
157087306|NCT01097707|567072132|FG003|Overall Study|Entry Criteria Not Met|0|||
157087307|NCT01097707|567072133|FG004|Overall Study|Entry Criteria Not Met|1|||
157087308|NCT01097707|567072129|FG000|Overall Study|Lack of Efficacy|1|||
157087309|NCT01097707|567072130|FG001|Overall Study|Lack of Efficacy|0|||
157087310|NCT01097707|567072131|FG002|Overall Study|Lack of Efficacy|0|||
157087311|NCT01097707|567072132|FG003|Overall Study|Lack of Efficacy|1|||
157087312|NCT01097707|567072133|FG004|Overall Study|Lack of Efficacy|0|||
157087313|NCT01097707|567072129|FG000|Overall Study|Lost to Follow-up|1|||
157087314|NCT01097707|567072130|FG001|Overall Study|Lost to Follow-up|1|||
157087315|NCT01097707|567072131|FG002|Overall Study|Lost to Follow-up|2|||
157087316|NCT01097707|567072132|FG003|Overall Study|Lost to Follow-up|0|||
157087317|NCT01097707|567072133|FG004|Overall Study|Lost to Follow-up|3|||
157087318|NCT01097707|567072129|FG000|Overall Study|Protocol Violation|2|||
157087319|NCT01097707|567072130|FG001|Overall Study|Protocol Violation|2|||
157196145|NCT01004822|567461401|FG004|Overall Study|Other|0|||
157196146|NCT01004822|567461402|FG005|Overall Study|Other|1|||
157196147|NCT01004822|567461403|FG006|Overall Study|Other|0|||
157196148|NCT01004822|567461404|FG007|Overall Study|Other|0|||
157196149|NCT02600559|567461407|FG000|Overall Study|Withdrawal by Subject|3|||
157196150|NCT02600559|567461407|FG000|Overall Study|Lost to Follow-up|20|||
157196151|NCT03868410|567461413|FG000|Overall Study|Physician Decision|0|||
157196152|NCT03868410|567461414|FG001|Overall Study|Physician Decision|1|||
157196153|NCT02624713|567461418|FG000|Overall Study|Lost to Follow-up|14|||
157196154|NCT02624713|567461419|FG001|Overall Study|Lost to Follow-up|0|||
157196155|NCT00148109|567461420|FG000|Overall Study|Lack of Efficacy|10|||
157196156|NCT00148109|567461421|FG001|Overall Study|Lack of Efficacy|18|||
157196157|NCT00148109|567461420|FG000|Overall Study|Adverse Event|0|||
157196158|NCT00148109|567461421|FG001|Overall Study|Adverse Event|2|||
157087320|NCT01097707|567072131|FG002|Overall Study|Protocol Violation|3|||
157196159|NCT00148109|567461420|FG000|Overall Study|Withdrawal by Subject|2|||
157196160|NCT00148109|567461421|FG001|Overall Study|Withdrawal by Subject|0|||
157087321|NCT01097707|567072132|FG003|Overall Study|Protocol Violation|2|||
157087322|NCT01097707|567072133|FG004|Overall Study|Protocol Violation|2|||
157196161|NCT00679354|567461427|FG000|Overall Study|Death|3|||
157196162|NCT00679354|567461427|FG000|Overall Study|Lack of Efficacy|22|||
157196163|NCT00679354|567461427|FG000|Overall Study|Physician Decision|4|||
157196164|NCT00679354|567461427|FG000|Overall Study|Ineligible|1|||
157196165|NCT03764813|567461428|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
157236109|NCT02682784|567612957|FG003|Overall Study|Physician Decision|1|||
157087323|NCT01097707|567072129|FG000|Overall Study|Sponsor Decision|31|||
157087324|NCT01097707|567072130|FG001|Overall Study|Sponsor Decision|31|||
157087325|NCT01097707|567072131|FG002|Overall Study|Sponsor Decision|34|||
157087326|NCT01097707|567072132|FG003|Overall Study|Sponsor Decision|35|||
157087327|NCT01097707|567072133|FG004|Overall Study|Sponsor Decision|36|||
157087328|NCT01097707|567072129|FG000|Overall Study|Withdrawal by Subject|3|||
157087329|NCT01097707|567072130|FG001|Overall Study|Withdrawal by Subject|6|||
157087330|NCT01097707|567072131|FG002|Overall Study|Withdrawal by Subject|1|||
157087331|NCT01097707|567072132|FG003|Overall Study|Withdrawal by Subject|4|||
157087332|NCT01097707|567072133|FG004|Overall Study|Withdrawal by Subject|3|||
157087333|NCT01097707|567072129|FG000|Overall Study|Reason unknown|0|||
157087334|NCT01097707|567072130|FG001|Overall Study|Reason unknown|0|||
157087335|NCT01097707|567072131|FG002|Overall Study|Reason unknown|0|||
157087336|NCT01097707|567072132|FG003|Overall Study|Reason unknown|0|||
157087337|NCT01097707|567072133|FG004|Overall Study|Reason unknown|1|||
157087338|NCT03212989|567072134|FG000|Overall Study|Physician Decision|8|||
157087339|NCT01236534|567072137|FG000|Overall Study|Adverse Event|3|||
157087340|NCT01236534|567072138|FG001|Overall Study|Adverse Event|0|||
157087341|NCT01844687|567072141|FG000|Visit 1|Protocol Violation|3|||
157087342|NCT01844687|567072141|FG000|Visit 1|Lost to Follow-up|5|||
157087343|NCT01844687|567072141|FG000|Visit 2|Withdrawal by Subject|1|||
157087344|NCT01844687|567072141|FG000|Visit 2|Protocol Violation|1|||
157087345|NCT01844687|567072141|FG000|Visit 3|Lost to Follow-up|1|||
157087346|NCT01844687|567072141|FG000|Visit 3|Withdrawal by Subject|3|||
157087347|NCT01844687|567072141|FG000|Visit 3|child care problems|1|||
157087348|NCT01844687|567072141|FG000|Visit 4|Pregnancy|1|||
157087349|NCT01844687|567072141|FG000|Visit 4|Lost to Follow-up|1|||
157087350|NCT01844687|567072141|FG000|Visit 4|Withdrawal by Subject|2|||
157087351|NCT00158860|567072150|FG000|Overall Study|Adverse Event|3|||
157087352|NCT00158860|567072151|FG001|Overall Study|Adverse Event|6|||
157087353|NCT00158860|567072150|FG000|Overall Study|Lost to Follow-up|11|||
157087354|NCT00158860|567072151|FG001|Overall Study|Lost to Follow-up|17|||
157087355|NCT00158860|567072150|FG000|Overall Study|Protocol Violation|8|||
157087356|NCT00158860|567072151|FG001|Overall Study|Protocol Violation|23|||
157087357|NCT00158860|567072150|FG000|Overall Study|Withdrawal by Subject|7|||
157087358|NCT00158860|567072151|FG001|Overall Study|Withdrawal by Subject|17|||
157087359|NCT00158860|567072150|FG000|Overall Study|MOVING OUT OF STATE|1|||
157087360|NCT00158860|567072151|FG001|Overall Study|MOVING OUT OF STATE|0|||
157087361|NCT00158860|567072150|FG000|Overall Study|Pregnancy|3|||
157087362|NCT00158860|567072151|FG001|Overall Study|Pregnancy|3|||
157087363|NCT00158860|567072150|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
157087364|NCT00158860|567072151|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
157087365|NCT00158860|567072150|FG000|Overall Study|SPONSOR REQUEST|0|||
157087366|NCT00158860|567072151|FG001|Overall Study|SPONSOR REQUEST|1|||
157087367|NCT00158860|567072150|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
157087368|NCT00158860|567072151|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
157087369|NCT00158860|567072150|FG000|Overall Study|Closed per sponsor|0|||
157087370|NCT00158860|567072151|FG001|Overall Study|Closed per sponsor|1|||
157087371|NCT04638920|567072152|FG000|Overall Study|Withdrawal by Subject|5|||
157087372|NCT03775434|567072153|FG000|Overall Study|Adverse Event|2|||
157087373|NCT03775434|567072153|FG000|Overall Study|Withdrawal by Subject|1|||
157087374|NCT01435616|567072156|FG000|Overall Study|Adverse Event|39|||
157087375|NCT01435616|567072157|FG001|Overall Study|Adverse Event|21|||
157087376|NCT01435616|567072156|FG000|Overall Study|Death|7|||
157087377|NCT01435616|567072157|FG001|Overall Study|Death|2|||
157087378|NCT01435616|567072156|FG000|Overall Study|Lost to Follow-up|22|||
157087379|NCT01435616|567072157|FG001|Overall Study|Lost to Follow-up|13|||
157087380|NCT01435616|567072156|FG000|Overall Study|Protocol Violation|16|||
157087381|NCT01435616|567072157|FG001|Overall Study|Protocol Violation|13|||
157087382|NCT01435616|567072156|FG000|Overall Study|Withdrawal by Subject|66|||
157087383|NCT01435616|567072157|FG001|Overall Study|Withdrawal by Subject|24|||
157087384|NCT01435616|567072156|FG000|Overall Study|Physician Decision|20|||
157087385|NCT01435616|567072157|FG001|Overall Study|Physician Decision|7|||
157087386|NCT01435616|567072156|FG000|Overall Study|Sponsor Decision|1|||
157087387|NCT01435616|567072157|FG001|Overall Study|Sponsor Decision|0|||
157087388|NCT02217475|567072158|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
157087389|NCT02217475|567072159|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
157087390|NCT02217475|567072160|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
157087391|NCT02217475|567072158|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
157087392|NCT02217475|567072159|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
157087393|NCT02217475|567072160|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
157087394|NCT02217475|567072158|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
157087395|NCT02217475|567072159|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
157087396|NCT02217475|567072160|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
157087397|NCT02217475|567072158|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
157087398|NCT02217475|567072159|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
157087399|NCT02217475|567072160|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
157087400|NCT02217475|567072158|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
157087401|NCT02217475|567072159|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
157087402|NCT02217475|567072160|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
157087403|NCT02217475|567072158|FG000|Discontinued After Period 1|Adverse Event|1|||
157087404|NCT02217475|567072159|FG001|Discontinued After Period 1|Adverse Event|2|||
157087405|NCT02217475|567072160|FG002|Discontinued After Period 1|Adverse Event|0|||
157087406|NCT02217475|567072158|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
157087407|NCT02217475|567072159|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
157087408|NCT02217475|567072160|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
157087409|NCT02217475|567072158|FG000|Discontinued After Period 1|Physician Decision|0|||
157087410|NCT02217475|567072159|FG001|Discontinued After Period 1|Physician Decision|0|||
157087411|NCT02217475|567072160|FG002|Discontinued After Period 1|Physician Decision|1|||
157087412|NCT02217475|567072158|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
157087413|NCT02217475|567072159|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
157087414|NCT02217475|567072160|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
157087415|NCT02217475|567072158|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
157087416|NCT02217475|567072159|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
157087417|NCT02217475|567072160|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
157087418|NCT02217475|567072158|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
157087419|NCT02217475|567072159|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
157087420|NCT02217475|567072160|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
157087421|NCT02217475|567072158|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
157087422|NCT02217475|567072159|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
157087423|NCT02217475|567072160|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
157087424|NCT02217475|567072158|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
157087425|NCT02217475|567072159|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
157087426|NCT02217475|567072160|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
157087427|NCT04738292|567072165|FG000|Overall Study|Death|1|||
157087428|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|Death|1|||
157087429|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|Death|1|||
157087430|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
157087431|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
157087432|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
157087433|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
157087434|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
157087435|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
157087436|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
157087437|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
157087438|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
157087439|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
157087440|NCT00371683|567072166|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
157087441|NCT00371683|567072167|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
157087442|NCT00371683|567072166|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
157087443|NCT00371683|567072167|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
157087444|NCT00371683|567072166|FG000|Follow-Up Period - Randomized Patients|Death|0|||
157087445|NCT00371683|567072167|FG001|Follow-Up Period - Randomized Patients|Death|2|||
157087446|NCT00371683|567072166|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
157087447|NCT00371683|567072167|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
157087448|NCT00371683|567072166|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
157087449|NCT00371683|567072167|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
157087450|NCT02971761|567072168|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
157087451|NCT02442336|567072169|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
157087452|NCT02442336|567072169|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
157087453|NCT02442336|567072169|FG000|Overall Study|Lost to Follow-up|11|||
157087454|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
157196166|NCT03764813|567461429|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
157196167|NCT03764813|567461430|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
157196168|NCT03764813|567461431|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
157196169|NCT00408408|567461432|FG000|Overall Study|No follow up data|2|||
157196170|NCT00408408|567461433|FG001|Overall Study|No follow up data|3|||
157087455|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
157087456|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
157196171|NCT00408408|567461434|FG002|Overall Study|No follow up data|0|||
157196172|NCT00408408|567461435|FG003|Overall Study|No follow up data|7|||
157196173|NCT00408408|567461436|FG004|Overall Study|No follow up data|5|||
157087457|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
157087458|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
157087459|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
157196174|NCT00408408|567461437|FG005|Overall Study|No follow up data|3|||
157196175|NCT02898662|567461442|FG000|Overall Study|Adverse Event|1|||
157087460|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
157087461|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
157087462|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
157087463|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
157087464|NCT01237587|567072170|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
157087465|NCT01237587|567072171|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
157087466|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
157087467|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
157087468|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
157087469|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
157087470|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
157087471|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
157087472|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
157087473|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
157087474|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
157087475|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
157087476|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
157087477|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
157087478|NCT01237587|567072170|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
157087479|NCT01237587|567072171|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
157087480|NCT01237587|567072170|FG000|Taper Phase|Adverse Event|0|||
157087481|NCT01237587|567072171|FG001|Taper Phase|Adverse Event|2|||
157087482|NCT01237587|567072170|FG000|Taper Phase|Protocol Violation|2|||
157087483|NCT01237587|567072171|FG001|Taper Phase|Protocol Violation|0|||
157087484|NCT01237587|567072170|FG000|Taper Phase|Lack of Efficacy|2|||
157087485|NCT01237587|567072171|FG001|Taper Phase|Lack of Efficacy|5|||
157087486|NCT01237587|567072170|FG000|Taper Phase|Parent/Guardian Decision|0|||
157087487|NCT01237587|567072171|FG001|Taper Phase|Parent/Guardian Decision|2|||
157087488|NCT01237587|567072170|FG000|Taper Phase|Sponsor Decision|1|||
157087489|NCT01237587|567072171|FG001|Taper Phase|Sponsor Decision|0|||
157087490|NCT01237587|567072170|FG000|Taper Phase|Withdrawal by Subject|0|||
157087491|NCT01237587|567072171|FG001|Taper Phase|Withdrawal by Subject|1|||
157087492|NCT01011387|567072172|FG000|Overall Study|Withdrawal by Subject|3|||
157087493|NCT01011387|567072172|FG000|Overall Study|Adverse Event|2|||
157087494|NCT01011387|567072172|FG000|Overall Study|Protocol Violation|1|||
157087495|NCT01285609|567072173|FG000|Randomized|Progressive Disease|41|||
157087496|NCT01285609|567072174|FG001|Randomized|Progressive Disease|61|||
157087497|NCT01285609|567072173|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
157087498|NCT01285609|567072174|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
157087499|NCT01285609|567072173|FG000|Randomized|Study Drug Toxicity|13|||
157087500|NCT01285609|567072174|FG001|Randomized|Study Drug Toxicity|14|||
157087501|NCT01285609|567072173|FG000|Randomized|Death|5|||
157087502|NCT01285609|567072174|FG001|Randomized|Death|7|||
157087503|NCT01285609|567072173|FG000|Randomized|Withdrawal by Subject|8|||
157087504|NCT01285609|567072174|FG001|Randomized|Withdrawal by Subject|11|||
157087505|NCT01285609|567072173|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
157087506|NCT01285609|567072174|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
157087507|NCT01285609|567072173|FG000|Randomized|Undisclosed Reasons|1|||
157087508|NCT01285609|567072174|FG001|Randomized|Undisclosed Reasons|0|||
157087509|NCT01285609|567072173|FG000|Randomized|Randomized but not Treated|4|||
157087510|NCT01285609|567072174|FG001|Randomized|Randomized but not Treated|4|||
157087511|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
157087512|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
157087513|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
157087514|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
157087515|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
157087516|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
157087517|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
157087518|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
157087519|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Death|11|||
157087520|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Death|3|||
157087521|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
157087522|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
157087523|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Not Reported|0|||
157087524|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Not Reported|2|||
157087525|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
157087526|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
157196176|NCT02898662|567461443|FG001|Overall Study|Adverse Event|0|||
157196177|NCT02898662|567461442|FG000|Overall Study|Loss of asthma control|23|||
157087527|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
157087528|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
157087529|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
157087530|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
157087531|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
157087532|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
157087533|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
157087534|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
157087535|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
157087536|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
157087537|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
157087538|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
157087539|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
157087540|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
157087541|NCT01285609|567072173|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
157087542|NCT01285609|567072174|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
157087543|NCT01285609|567072173|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
157087544|NCT01285609|567072174|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
157087545|NCT01142115|567072175|FG000|First Intervention|Lack of Efficacy|1|||
157087546|NCT01142115|567072176|FG001|First Intervention|Lack of Efficacy|1|||
157087547|NCT01142115|567072175|FG000|First Intervention|Adverse Event|1|||
157087548|NCT01142115|567072176|FG001|First Intervention|Adverse Event|0|||
157087549|NCT04927247|567072179|FG000|Overall Study|Other|2|||
157087550|NCT04927247|567072180|FG001|Overall Study|Other|1|||
157087551|NCT04927247|567072179|FG000|Overall Study|Physician Decision|0|||
157087552|NCT04927247|567072180|FG001|Overall Study|Physician Decision|1|||
157087553|NCT04927247|567072179|FG000|Overall Study|Adverse Event|1|||
157087554|NCT04927247|567072180|FG001|Overall Study|Adverse Event|0|||
157087555|NCT00350103|567072181|FG000|Overall Study|Adverse Event|12|||
157087556|NCT00350103|567072182|FG001|Overall Study|Adverse Event|29|||
157087557|NCT00350103|567072183|FG002|Overall Study|Adverse Event|17|||
157087558|NCT00350103|567072181|FG000|Overall Study|Lack of Efficacy|5|||
157087559|NCT00350103|567072182|FG001|Overall Study|Lack of Efficacy|1|||
157087560|NCT00350103|567072183|FG002|Overall Study|Lack of Efficacy|3|||
157087561|NCT00350103|567072181|FG000|Overall Study|Withdrawal by Subject|6|||
157087562|NCT00350103|567072182|FG001|Overall Study|Withdrawal by Subject|6|||
157087563|NCT00350103|567072183|FG002|Overall Study|Withdrawal by Subject|8|||
157087564|NCT00350103|567072181|FG000|Overall Study|Protocol Violation|0|||
157087565|NCT00350103|567072182|FG001|Overall Study|Protocol Violation|0|||
157087566|NCT00350103|567072183|FG002|Overall Study|Protocol Violation|1|||
157087567|NCT00350103|567072181|FG000|Overall Study|Unsatisfactory Compliance|2|||
157087568|NCT00350103|567072182|FG001|Overall Study|Unsatisfactory Compliance|2|||
157087569|NCT00350103|567072183|FG002|Overall Study|Unsatisfactory Compliance|1|||
157087570|NCT00350103|567072181|FG000|Overall Study|Investigator´s decision|1|||
157087571|NCT00350103|567072182|FG001|Overall Study|Investigator´s decision|1|||
157087572|NCT00350103|567072183|FG002|Overall Study|Investigator´s decision|0|||
157087573|NCT00350103|567072181|FG000|Overall Study|Exclusion criteria met|0|||
157087574|NCT00350103|567072182|FG001|Overall Study|Exclusion criteria met|0|||
157087575|NCT00350103|567072183|FG002|Overall Study|Exclusion criteria met|1|||
157087576|NCT00350103|567072181|FG000|Overall Study|Patient relocated|0|||
157087577|NCT00350103|567072182|FG001|Overall Study|Patient relocated|0|||
157087578|NCT00350103|567072183|FG002|Overall Study|Patient relocated|1|||
157087579|NCT00350103|567072181|FG000|Overall Study|Need for prohibited medication|1|||
157087580|NCT00350103|567072182|FG001|Overall Study|Need for prohibited medication|0|||
157087581|NCT00350103|567072183|FG002|Overall Study|Need for prohibited medication|0|||
157087582|NCT00350103|567072181|FG000|Overall Study|Personal reasons|0|||
157087583|NCT00350103|567072182|FG001|Overall Study|Personal reasons|0|||
157087584|NCT00350103|567072183|FG002|Overall Study|Personal reasons|1|||
157087585|NCT00350103|567072181|FG000|Overall Study|Patient stopped feeling pain|1|||
157087586|NCT00350103|567072182|FG001|Overall Study|Patient stopped feeling pain|0|||
157087587|NCT00350103|567072183|FG002|Overall Study|Patient stopped feeling pain|0|||
157087588|NCT00350103|567072181|FG000|Overall Study|PR greater than 250ms|0|||
157087589|NCT00350103|567072182|FG001|Overall Study|PR greater than 250ms|0|||
157087590|NCT00350103|567072183|FG002|Overall Study|PR greater than 250ms|1|||
157087591|NCT00350103|567072181|FG000|Overall Study|Wrong calculation of QT interval|0|||
157087592|NCT00350103|567072182|FG001|Overall Study|Wrong calculation of QT interval|0|||
157087593|NCT00350103|567072183|FG002|Overall Study|Wrong calculation of QT interval|1|||
157087594|NCT00350103|567072181|FG000|Overall Study|Sponsor mistake|1|||
157087595|NCT00350103|567072182|FG001|Overall Study|Sponsor mistake|0|||
157087596|NCT00350103|567072183|FG002|Overall Study|Sponsor mistake|0|||
157087597|NCT00350103|567072181|FG000|Overall Study|Randomization mistake|0|||
157236110|NCT01702987|567612958|FG000|Overall Study|Withdrawal by Subject|1|||
157087598|NCT00350103|567072182|FG001|Overall Study|Randomization mistake|1|||
157087599|NCT00350103|567072183|FG002|Overall Study|Randomization mistake|1|||
157087600|NCT00350103|567072181|FG000|Overall Study|Sponsor´s decision|0|||
157087601|NCT00350103|567072182|FG001|Overall Study|Sponsor´s decision|1|||
157087602|NCT00350103|567072183|FG002|Overall Study|Sponsor´s decision|0|||
157087603|NCT00350103|567072181|FG000|Overall Study|Lost, Reason unknown|1|||
157087604|NCT00350103|567072182|FG001|Overall Study|Lost, Reason unknown|1|||
157087605|NCT00350103|567072183|FG002|Overall Study|Lost, Reason unknown|0|||
157087606|NCT02842151|567072184|FG000|Overall Study|Adverse Event|1|||
157087607|NCT02842151|567072184|FG000|Overall Study|Subject moved too far away|1|||
157087608|NCT00438672|567072185|FG000|Overall Study|Lost to Follow-up|7|||
157087609|NCT00438672|567072186|FG001|Overall Study|Lost to Follow-up|9|||
157087610|NCT02559895|567072187|FG000|Overall Study|Adverse Event|3|||
157087611|NCT02559895|567072188|FG001|Overall Study|Adverse Event|3|||
157087612|NCT02559895|567072189|FG002|Overall Study|Adverse Event|2|||
157087613|NCT02559895|567072190|FG003|Overall Study|Adverse Event|1|||
157087614|NCT02559895|567072187|FG000|Overall Study|Lack of Efficacy|2|||
157087615|NCT02559895|567072188|FG001|Overall Study|Lack of Efficacy|3|||
157087616|NCT02559895|567072189|FG002|Overall Study|Lack of Efficacy|2|||
157087617|NCT02559895|567072190|FG003|Overall Study|Lack of Efficacy|8|||
157087618|NCT02559895|567072187|FG000|Overall Study|Lost to Follow-up|22|||
157087619|NCT02559895|567072188|FG001|Overall Study|Lost to Follow-up|16|||
157087620|NCT02559895|567072189|FG002|Overall Study|Lost to Follow-up|12|||
157087621|NCT02559895|567072190|FG003|Overall Study|Lost to Follow-up|17|||
157087622|NCT02559895|567072187|FG000|Overall Study|Physician Decision|1|||
157087623|NCT02559895|567072188|FG001|Overall Study|Physician Decision|1|||
157087624|NCT02559895|567072189|FG002|Overall Study|Physician Decision|3|||
157087625|NCT02559895|567072190|FG003|Overall Study|Physician Decision|0|||
157087626|NCT02559895|567072187|FG000|Overall Study|Withdrawal by Subject|16|||
157087627|NCT02559895|567072188|FG001|Overall Study|Withdrawal by Subject|9|||
157087628|NCT02559895|567072189|FG002|Overall Study|Withdrawal by Subject|20|||
157087629|NCT02559895|567072190|FG003|Overall Study|Withdrawal by Subject|9|||
157087630|NCT02559895|567072187|FG000|Overall Study|Study Burden|10|||
157087631|NCT02559895|567072188|FG001|Overall Study|Study Burden|16|||
157087632|NCT02559895|567072189|FG002|Overall Study|Study Burden|12|||
157087633|NCT02559895|567072190|FG003|Overall Study|Study Burden|22|||
157087634|NCT02559895|567072187|FG000|Overall Study|Other|1|||
157087635|NCT02559895|567072188|FG001|Overall Study|Other|5|||
157087636|NCT02559895|567072189|FG002|Overall Study|Other|3|||
157087637|NCT02559895|567072190|FG003|Overall Study|Other|3|||
157087638|NCT04540887|567072196|FG000|Overall Study|Withdrawal by Subject|2|||
157087639|NCT01905150|567072198|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
157087640|NCT01905150|567072199|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
157087641|NCT00932113|567074157|FG000|Overall Study|Lost to Follow-up|1|||
157087642|NCT00932113|567074158|FG001|Overall Study|Lost to Follow-up|0|||
157087643|NCT01403610|567074161|FG000|Overall Study|Withdrawal by Subject|2|||
157087644|NCT01403610|567074162|FG001|Overall Study|Withdrawal by Subject|0|||
157087645|NCT01403610|567074163|FG002|Overall Study|Withdrawal by Subject|0|||
157087646|NCT01403610|567074164|FG003|Overall Study|Withdrawal by Subject|0|||
157087647|NCT01403610|567074161|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
157087648|NCT01403610|567074162|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
157087649|NCT01403610|567074163|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
157087650|NCT01403610|567074164|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
157087651|NCT03103763|567074165|FG000|Overall Study|Death|15|||
157087652|NCT03103763|567074166|FG001|Overall Study|Death|5|||
157087653|NCT03103763|567074167|FG002|Overall Study|Death|5|||
157087654|NCT03103763|567074165|FG000|Overall Study|Withdrawal by Subject|0|||
157087655|NCT03103763|567074166|FG001|Overall Study|Withdrawal by Subject|3|||
157087656|NCT03103763|567074167|FG002|Overall Study|Withdrawal by Subject|2|||
157087657|NCT03245151|567074168|FG000|Overall Study|Withdrawal by Subject|2|||
157087658|NCT03245151|567074169|FG001|Overall Study|Withdrawal by Subject|0|||
157087659|NCT03245151|567074170|FG002|Overall Study|Withdrawal by Subject|0|||
157087660|NCT03245151|567074171|FG003|Overall Study|Withdrawal by Subject|2|||
157087661|NCT03245151|567074172|FG004|Overall Study|Withdrawal by Subject|1|||
157087662|NCT03245151|567074168|FG000|Overall Study|Death|3|||
157087663|NCT03245151|567074169|FG001|Overall Study|Death|14|||
157087664|NCT03245151|567074170|FG002|Overall Study|Death|9|||
157087665|NCT03245151|567074171|FG003|Overall Study|Death|16|||
157087666|NCT03245151|567074172|FG004|Overall Study|Death|7|||
157087667|NCT03245151|567074168|FG000|Overall Study|Sponsor's decision|0|||
157087668|NCT03245151|567074169|FG001|Overall Study|Sponsor's decision|1|||
157087669|NCT03245151|567074170|FG002|Overall Study|Sponsor's decision|0|||
157087670|NCT03245151|567074171|FG003|Overall Study|Sponsor's decision|0|||
157087671|NCT03245151|567074172|FG004|Overall Study|Sponsor's decision|0|||
157087672|NCT01970345|567074173|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
157087673|NCT01970345|567074174|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
157087674|NCT01970345|567074173|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
157087675|NCT01970345|567074174|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
157087676|NCT01346475|567074175|FG000|First Intervention|Lost to Follow-up|4|||
157087677|NCT01346475|567074176|FG001|First Intervention|Lost to Follow-up|3|||
157087678|NCT01552603|567074177|FG000|Overall Study|Physician Decision|1|||
157087679|NCT00618618|567074178|FG000|Overall Study|Patient Request|0|||
157087680|NCT00618618|567074179|FG001|Overall Study|Patient Request|0|||
157087681|NCT00618618|567074180|FG002|Overall Study|Patient Request|2|||
157087682|NCT00618618|567074181|FG003|Overall Study|Patient Request|0|||
157087683|NCT00618618|567074178|FG000|Overall Study|Inability to Complete Study Procedures|0|||
157087684|NCT00618618|567074179|FG001|Overall Study|Inability to Complete Study Procedures|1|||
157087685|NCT00618618|567074180|FG002|Overall Study|Inability to Complete Study Procedures|0|||
157087686|NCT00618618|567074181|FG003|Overall Study|Inability to Complete Study Procedures|0|||
157087687|NCT00618618|567074178|FG000|Overall Study|Lost to Follow-up|3|||
157087688|NCT00618618|567074179|FG001|Overall Study|Lost to Follow-up|0|||
157087689|NCT00618618|567074180|FG002|Overall Study|Lost to Follow-up|0|||
157087690|NCT00618618|567074181|FG003|Overall Study|Lost to Follow-up|1|||
157087691|NCT00618618|567074178|FG000|Overall Study|Non-compliance|1|||
157087692|NCT00618618|567074179|FG001|Overall Study|Non-compliance|1|||
157087693|NCT00618618|567074180|FG002|Overall Study|Non-compliance|0|||
157087694|NCT00618618|567074181|FG003|Overall Study|Non-compliance|0|||
157087695|NCT00618618|567074178|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
157087696|NCT00618618|567074179|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
157087697|NCT00618618|567074180|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
157087698|NCT00618618|567074181|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
157087699|NCT00618618|567074178|FG000|Overall Study|Death|0|||
157087700|NCT00618618|567074179|FG001|Overall Study|Death|1|||
157087701|NCT00618618|567074180|FG002|Overall Study|Death|0|||
157087702|NCT00618618|567074181|FG003|Overall Study|Death|0|||
157087703|NCT00621777|567074185|FG000|Open Phase|Adverse Event|20|||
157087704|NCT00621777|567074186|FG001|Open Phase|Adverse Event|0|||
157087705|NCT00621777|567074185|FG000|Open Phase|Did not abstain during open phase|56|||
157087706|NCT00621777|567074186|FG001|Open Phase|Did not abstain during open phase|0|||
157087707|NCT00621777|567074185|FG000|Open Phase|Withdrawal by Subject|17|||
157087708|NCT00621777|567074186|FG001|Open Phase|Withdrawal by Subject|0|||
157087709|NCT00621777|567074185|FG000|Open Phase|administrative|13|||
157087710|NCT00621777|567074186|FG001|Open Phase|administrative|0|||
157087711|NCT00621777|567074185|FG000|Open Phase|Lost to Follow-up|10|||
157087712|NCT00621777|567074186|FG001|Open Phase|Lost to Follow-up|0|||
157087713|NCT00621777|567074185|FG000|Randomized Phase|Adverse Event|3|||
157087714|NCT00621777|567074186|FG001|Randomized Phase|Adverse Event|3|||
157087715|NCT00621777|567074185|FG000|Randomized Phase|Lost to Follow-up|3|||
157087716|NCT00621777|567074186|FG001|Randomized Phase|Lost to Follow-up|3|||
157087717|NCT00621777|567074185|FG000|Randomized Phase|Withdrawal by Subject|1|||
157087718|NCT00621777|567074186|FG001|Randomized Phase|Withdrawal by Subject|9|||
157087719|NCT00621777|567074185|FG000|Randomized Phase|administrative|0|||
157087720|NCT00621777|567074186|FG001|Randomized Phase|administrative|3|||
157087721|NCT00621777|567074185|FG000|Randomized Phase|Death|0|||
157087722|NCT00621777|567074186|FG001|Randomized Phase|Death|1|||
157087723|NCT04797650|567074189|FG000|Overall Study|Reason Not Specified|5|||
157087724|NCT04797650|567074190|FG001|Overall Study|Reason Not Specified|12|||
157087725|NCT04797650|567074191|FG002|Overall Study|Reason Not Specified|5|||
157087726|NCT04797650|567074189|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
157087727|NCT04797650|567074190|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
157087728|NCT04797650|567074191|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
157087729|NCT04797650|567074189|FG000|Overall Study|Lack of Efficacy|1|||
157087730|NCT04797650|567074190|FG001|Overall Study|Lack of Efficacy|0|||
157087731|NCT04797650|567074191|FG002|Overall Study|Lack of Efficacy|1|||
157087732|NCT04797650|567074189|FG000|Overall Study|Non-compliance with Study Drug|0|||
157087733|NCT04797650|567074190|FG001|Overall Study|Non-compliance with Study Drug|0|||
157087734|NCT04797650|567074191|FG002|Overall Study|Non-compliance with Study Drug|2|||
157087735|NCT04797650|567074189|FG000|Overall Study|Lost to Follow-up|4|||
157087736|NCT04797650|567074190|FG001|Overall Study|Lost to Follow-up|6|||
157087737|NCT04797650|567074191|FG002|Overall Study|Lost to Follow-up|1|||
157087738|NCT00700258|567074192|FG000|Overall Study|Premature discontinuation of documentation|136|||
157087739|NCT00700258|567074192|FG000|Overall Study|Type of study end not documented|1|||
157087740|NCT00700258|567074192|FG000|Overall Study|Lost to Follow-up|81|||
157087741|NCT00700258|567074192|FG000|Overall Study|Premature discontinuation of therapy|1013|||
157087742|NCT00473265|567074194|FG000|Overall Study|Unrelated adverse event|5|||
157087743|NCT00473265|567074194|FG000|Overall Study|Off treatment early|15|||
157087744|NCT00309959|567074198|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
157087745|NCT02663518|567074199|FG000|Part 1: Phase 1a Escalation|Death|0|||
157087746|NCT02663518|567074200|FG001|Part 1: Phase 1a Escalation|Death|0|||
157087747|NCT02663518|567074201|FG002|Part 1: Phase 1a Escalation|Death|1|||
157087748|NCT02663518|567074202|FG003|Part 1: Phase 1a Escalation|Death|0|||
157087749|NCT02663518|567074203|FG004|Part 1: Phase 1a Escalation|Death|0|||
157087750|NCT02663518|567074204|FG005|Part 1: Phase 1a Escalation|Death|0|||
157087751|NCT02663518|567074205|FG006|Part 1: Phase 1a Escalation|Death|0|||
157087752|NCT02663518|567074206|FG007|Part 1: Phase 1a Escalation|Death|0|||
157087753|NCT02663518|567074207|FG008|Part 1: Phase 1a Escalation|Death|0|||
157087754|NCT02663518|567074208|FG009|Part 1: Phase 1a Escalation|Death|0|||
157087755|NCT02663518|567074209|FG010|Part 1: Phase 1a Escalation|Death|0|||
157087756|NCT02663518|567074210|FG011|Part 1: Phase 1a Escalation|Death|0|||
157087757|NCT02663518|567074211|FG012|Part 1: Phase 1a Escalation|Death|0|||
157087758|NCT02663518|567074212|FG013|Part 1: Phase 1a Escalation|Death|0|||
157087759|NCT02663518|567074199|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087760|NCT02663518|567074200|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087761|NCT02663518|567074201|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
157087762|NCT02663518|567074202|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087763|NCT02663518|567074203|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087764|NCT02663518|567074204|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087765|NCT02663518|567074205|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087766|NCT02663518|567074206|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087767|NCT02663518|567074207|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087768|NCT02663518|567074208|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087769|NCT02663518|567074209|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087770|NCT02663518|567074210|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087771|NCT02663518|567074211|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087772|NCT02663518|567074212|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
157087773|NCT02663518|567074199|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
157087774|NCT02663518|567074200|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
157087775|NCT02663518|567074201|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
157196178|NCT02898662|567461443|FG001|Overall Study|Loss of asthma control|24|||
157196179|NCT02898662|567461442|FG000|Overall Study|Withdrawal by Subject|4|||
157196180|NCT02898662|567461443|FG001|Overall Study|Withdrawal by Subject|1|||
157196181|NCT02898662|567461442|FG000|Overall Study|Technical issue|0|||
157196182|NCT02898662|567461443|FG001|Overall Study|Technical issue|1|||
157196183|NCT02898662|567461442|FG000|Overall Study|Randomized in error|0|||
157196184|NCT02898662|567461443|FG001|Overall Study|Randomized in error|1|||
157196185|NCT02898662|567461442|FG000|Overall Study|Subject decision|1|||
157196186|NCT02898662|567461443|FG001|Overall Study|Subject decision|0|||
157196187|NCT02898662|567461442|FG000|Overall Study|Other|0|||
157196188|NCT02898662|567461443|FG001|Overall Study|Other|1|||
157196189|NCT00399542|567461444|FG000|Overall Study|Adverse Event|18|||
157196190|NCT00399542|567461445|FG001|Overall Study|Adverse Event|15|||
157196191|NCT00399542|567461444|FG000|Overall Study|Protocol Violation|13|||
157196192|NCT00399542|567461445|FG001|Overall Study|Protocol Violation|3|||
157196193|NCT00399542|567461444|FG000|Overall Study|Withdrawal by Subject|28|||
157196194|NCT00399542|567461445|FG001|Overall Study|Withdrawal by Subject|10|||
157196195|NCT00399542|567461444|FG000|Overall Study|Lack of Efficacy|18|||
157196196|NCT00399542|567461445|FG001|Overall Study|Lack of Efficacy|8|||
157196197|NCT00399542|567461444|FG000|Overall Study|Lost to Follow-up|6|||
157196198|NCT00399542|567461445|FG001|Overall Study|Lost to Follow-up|6|||
157196199|NCT00399542|567461444|FG000|Overall Study|Other|1|||
157196200|NCT00399542|567461445|FG001|Overall Study|Other|0|||
157196201|NCT00399542|567461444|FG000|Overall Study|Physician Decision|0|||
157196202|NCT00399542|567461445|FG001|Overall Study|Physician Decision|1|||
157196203|NCT00779142|567461446|FG000|Overall Study|Screen Failures|3|||
157196204|NCT04652245|567461447|FG000|Wash-Out Period|Adverse Event|0|||
157196205|NCT04652245|567461448|FG001|Wash-Out Period|Adverse Event|2|||
157196206|NCT04652245|567461447|FG000|Wash-Out Period|Withdrawal by Subject|0|||
157196207|NCT04652245|567461448|FG001|Wash-Out Period|Withdrawal by Subject|2|||
157196208|NCT02924129|567461453|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
157196209|NCT02924129|567461454|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
157196210|NCT02924129|567461453|FG000|Overall Study|Withdrawal by Subject|2|||
157196211|NCT02924129|567461454|FG001|Overall Study|Withdrawal by Subject|2|||
157196212|NCT02924129|567461453|FG000|Overall Study|Physician Decision|1|||
157196213|NCT02924129|567461454|FG001|Overall Study|Physician Decision|0|||
157196214|NCT02924129|567461453|FG000|Overall Study|Missed Visit|0|||
157196215|NCT02924129|567461454|FG001|Overall Study|Missed Visit|1|||
157196216|NCT00302731|567461458|FG000|Overall Study|Lost to Follow-up|1|||
157196217|NCT00302731|567461459|FG001|Overall Study|Lost to Follow-up|2|||
157196218|NCT00302731|567461460|FG002|Overall Study|Lost to Follow-up|0|||
157196219|NCT00302731|567461461|FG003|Overall Study|Lost to Follow-up|0|||
157196220|NCT00302731|567461458|FG000|Overall Study|Adverse Event|0|||
157196221|NCT00302731|567461459|FG001|Overall Study|Adverse Event|2|||
157196222|NCT00302731|567461460|FG002|Overall Study|Adverse Event|2|||
157196223|NCT00302731|567461461|FG003|Overall Study|Adverse Event|0|||
157196224|NCT00302731|567461458|FG000|Overall Study|Withdrawal by Subject|1|||
157196225|NCT00302731|567461459|FG001|Overall Study|Withdrawal by Subject|1|||
157196226|NCT00302731|567461460|FG002|Overall Study|Withdrawal by Subject|0|||
157196227|NCT00302731|567461461|FG003|Overall Study|Withdrawal by Subject|0|||
157196228|NCT00302731|567461458|FG000|Overall Study|Protocol Violation|1|||
157087776|NCT02663518|567074202|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
157087777|NCT02663518|567074203|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157196229|NCT00302731|567461459|FG001|Overall Study|Protocol Violation|0|||
157196230|NCT00302731|567461460|FG002|Overall Study|Protocol Violation|0|||
157196231|NCT00302731|567461461|FG003|Overall Study|Protocol Violation|0|||
157236111|NCT01702987|567612959|FG001|Overall Study|Withdrawal by Subject|0|||
157236112|NCT03181594|567612960|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
157236113|NCT03181594|567612960|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
157236114|NCT03181594|567612960|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
157236115|NCT03181594|567612960|FG000|Initial Study Protocol (12-month FU)|Death|1|||
157236116|NCT03181594|567612960|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
157236117|NCT03181594|567612960|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
157236118|NCT00473330|567612967|FG000|Core Study|Adverse Event|4|||
157236119|NCT00473330|567612968|FG001|Core Study|Adverse Event|4|||
157236120|NCT00473330|567612969|FG002|Core Study|Adverse Event|1|||
157236121|NCT00473330|567612967|FG000|Core Study|Death|6|||
157236122|NCT00473330|567612968|FG001|Core Study|Death|4|||
157236123|NCT00473330|567612969|FG002|Core Study|Death|4|||
157236124|NCT00473330|567612967|FG000|Core Study|Lost to Follow-up|5|||
157236125|NCT00473330|567612968|FG001|Core Study|Lost to Follow-up|5|||
157236126|NCT00473330|567612969|FG002|Core Study|Lost to Follow-up|10|||
157236127|NCT00473330|567612967|FG000|Core Study|Physician Decision|2|||
157236128|NCT00473330|567612968|FG001|Core Study|Physician Decision|1|||
157236129|NCT00473330|567612969|FG002|Core Study|Physician Decision|3|||
157236130|NCT00473330|567612967|FG000|Core Study|Subject Non-compliance|1|||
157236131|NCT00473330|567612968|FG001|Core Study|Subject Non-compliance|2|||
157236132|NCT00473330|567612969|FG002|Core Study|Subject Non-compliance|1|||
157236133|NCT00473330|567612967|FG000|Core Study|Subject Required Other Therapy|0|||
157236134|NCT00473330|567612968|FG001|Core Study|Subject Required Other Therapy|1|||
157236135|NCT00473330|567612969|FG002|Core Study|Subject Required Other Therapy|3|||
157236136|NCT00473330|567612967|FG000|Core Study|Subject's Decision|9|||
157236137|NCT00473330|567612968|FG001|Core Study|Subject's Decision|8|||
157236138|NCT00473330|567612969|FG002|Core Study|Subject's Decision|19|||
157236139|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
157236140|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
157236141|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
157236142|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Death|2|||
157236143|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Death|0|||
157236144|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Death|0|||
157236145|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
157236146|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
157236147|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
157236148|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
157236149|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
157236150|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
157236151|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
157236152|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
157236153|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
157236154|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
157236155|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
157236156|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
157236157|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
157236158|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
157236159|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
157236160|NCT00473330|567612967|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
157236161|NCT00473330|567612968|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
157236162|NCT00473330|567612969|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
157236163|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
157236164|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
157236165|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
157236166|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Death|2|||
157236167|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Death|2|||
157236168|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Death|1|||
157236169|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
157236170|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
157236171|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
157236172|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
157236173|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
157236174|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
157236175|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
157236176|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
157236177|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
157236178|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
157248010|NCT02531126|567651774|FG001|Overall Study|Switched to commercial drug|4|||
157236179|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
157236180|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
157236181|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
157236182|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
157236183|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
157236184|NCT00473330|567612967|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
157236185|NCT00473330|567612968|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
157236186|NCT00473330|567612969|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
157236187|NCT01975948|567612971|FG000|Overall Study|Withdrawal by Subject|17|||
157236188|NCT01975948|567612972|FG001|Overall Study|Withdrawal by Subject|21|||
157236189|NCT01975948|567612973|FG002|Overall Study|Withdrawal by Subject|7|||
157236190|NCT01975948|567612974|FG003|Overall Study|Withdrawal by Subject|6|||
157236191|NCT00365846|567612975|FG000|Overall Study|Lost to Follow-up|1|||
157236192|NCT00904215|567612976|FG000|Overall Study|Adverse Event|25|||
157236193|NCT00904215|567612976|FG000|Overall Study|Protocol Violation|10|||
157236194|NCT00904215|567612976|FG000|Overall Study|Lost to Follow-up|63|||
157236195|NCT00904215|567612976|FG000|Overall Study|Withdrawal by Subject|9|||
157236196|NCT00904215|567612976|FG000|Overall Study|Other|28|||
157236197|NCT00640562|567612977|FG000|Overall Study|Adverse Event|8|||
157236198|NCT00640562|567612978|FG001|Overall Study|Adverse Event|5|||
157236199|NCT00640562|567612977|FG000|Overall Study|Lack of Efficacy|1|||
157236200|NCT00640562|567612978|FG001|Overall Study|Lack of Efficacy|4|||
157236201|NCT00640562|567612977|FG000|Overall Study|Protocol Violation|2|||
157236202|NCT00640562|567612978|FG001|Overall Study|Protocol Violation|4|||
157236203|NCT00640562|567612977|FG000|Overall Study|Withdrawal by Subject|6|||
157236204|NCT00640562|567612978|FG001|Overall Study|Withdrawal by Subject|10|||
157236205|NCT00640562|567612977|FG000|Overall Study|Known risperidone intolerance|0|||
157236206|NCT00640562|567612978|FG001|Overall Study|Known risperidone intolerance|1|||
157236207|NCT00640562|567612977|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
157236208|NCT00640562|567612978|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
157236209|NCT00640562|567612977|FG000|Overall Study|Low study drug dose|0|||
157236210|NCT00640562|567612978|FG001|Overall Study|Low study drug dose|1|||
157236211|NCT00640562|567612977|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
157236212|NCT00640562|567612978|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
157236213|NCT00448591|567612979|FG000|Overall Study|Withdrawal by Subject|178|||
157236214|NCT00448591|567612979|FG000|Overall Study|Progressive Disease|1382|||
157236215|NCT00448591|567612979|FG000|Overall Study|Adverse Event|382|||
157236216|NCT00448591|567612979|FG000|Overall Study|Protocol Violation|41|||
157236217|NCT00448591|567612979|FG000|Overall Study|Lost to Follow-up|19|||
157236218|NCT00448591|567612979|FG000|Overall Study|Treatment Regimen Completed|70|||
157236219|NCT00448591|567612979|FG000|Overall Study|Other|154|||
157236220|NCT00448591|567612979|FG000|Overall Study|Termination of Study|70|||
157236221|NCT02937870|567612980|FG000|Overall Study|Adverse Event|1|||
157236222|NCT02937870|567612980|FG000|Overall Study|Protocol Deviation|2|||
157236223|NCT00244764|567612981|FG000|Overall Study|Adverse Event|37|||
157236224|NCT00244764|567612981|FG000|Overall Study|Lost to Follow-up|23|||
157236225|NCT00244764|567612981|FG000|Overall Study|Withdrawal by Subject|12|||
157236226|NCT00244764|567612981|FG000|Overall Study|Disease Progression|13|||
157236227|NCT00244764|567612981|FG000|Overall Study|Protocol Violation|2|||
157236228|NCT00244764|567612981|FG000|Overall Study|Death|1|||
157236229|NCT00244764|567612981|FG000|Overall Study|Off Study Medication for >21 Days|1|||
157236230|NCT00244764|567612981|FG000|Overall Study|Declining Performance Status|1|||
157236231|NCT00244764|567612981|FG000|Overall Study|Participant was Hospitalized until Death|1|||
157236232|NCT00244764|567612981|FG000|Overall Study|Primary Investigator Discretion|2|||
157236233|NCT00244764|567612981|FG000|Overall Study|Sponsor Terminated Study|2|||
157236234|NCT00244764|567612981|FG000|Overall Study|Developed Secondary Malignancy|1|||
157236235|NCT03017885|567612982|FG000|Overall Study|Adverse Event|2|||
157236236|NCT03017885|567612983|FG001|Overall Study|Adverse Event|0|||
157236237|NCT03017885|567612984|FG002|Overall Study|Adverse Event|0|||
157236238|NCT03017885|567612985|FG003|Overall Study|Adverse Event|0|||
157236239|NCT03017885|567612986|FG004|Overall Study|Adverse Event|0|||
157236240|NCT03017885|567612987|FG005|Overall Study|Adverse Event|0|||
157236241|NCT03017885|567612982|FG000|Overall Study|Progression of disease|4|||
157236242|NCT03017885|567612983|FG001|Overall Study|Progression of disease|3|||
157236243|NCT03017885|567612984|FG002|Overall Study|Progression of disease|4|||
157236244|NCT03017885|567612985|FG003|Overall Study|Progression of disease|0|||
157236245|NCT03017885|567612986|FG004|Overall Study|Progression of disease|0|||
157236246|NCT03017885|567612987|FG005|Overall Study|Progression of disease|0|||
157236247|NCT03017885|567612982|FG000|Overall Study|Other than listed|1|||
157236248|NCT03017885|567612983|FG001|Overall Study|Other than listed|2|||
157236249|NCT03017885|567612984|FG002|Overall Study|Other than listed|1|||
157236250|NCT03017885|567612985|FG003|Overall Study|Other than listed|0|||
157236251|NCT03017885|567612986|FG004|Overall Study|Other than listed|0|||
157236252|NCT03017885|567612987|FG005|Overall Study|Other than listed|0|||
157236253|NCT03017885|567612982|FG000|Overall Study|Lost to Follow-up|2|||
157087778|NCT02663518|567074204|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087779|NCT02663518|567074205|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087780|NCT02663518|567074206|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087781|NCT02663518|567074207|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087782|NCT02663518|567074208|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087783|NCT02663518|567074209|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087784|NCT02663518|567074210|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087785|NCT02663518|567074211|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087786|NCT02663518|567074212|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
157087787|NCT02663518|567074199|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
157087788|NCT02663518|567074200|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087789|NCT02663518|567074201|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
157087790|NCT02663518|567074202|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
157087791|NCT02663518|567074203|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087792|NCT02663518|567074204|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087793|NCT02663518|567074205|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087794|NCT02663518|567074206|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087795|NCT02663518|567074207|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087796|NCT02663518|567074208|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087797|NCT02663518|567074209|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087798|NCT02663518|567074210|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087799|NCT02663518|567074211|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087800|NCT02663518|567074212|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
157087801|NCT02663518|567074199|FG000|Part 1: Phase 1a Escalation|Other|0|||
157087802|NCT02663518|567074200|FG001|Part 1: Phase 1a Escalation|Other|0|||
157087803|NCT02663518|567074201|FG002|Part 1: Phase 1a Escalation|Other|2|||
157087804|NCT02663518|567074202|FG003|Part 1: Phase 1a Escalation|Other|0|||
157087805|NCT02663518|567074203|FG004|Part 1: Phase 1a Escalation|Other|0|||
157087806|NCT02663518|567074204|FG005|Part 1: Phase 1a Escalation|Other|0|||
157087807|NCT02663518|567074205|FG006|Part 1: Phase 1a Escalation|Other|0|||
157087808|NCT02663518|567074206|FG007|Part 1: Phase 1a Escalation|Other|0|||
157087809|NCT02663518|567074207|FG008|Part 1: Phase 1a Escalation|Other|0|||
157087810|NCT02663518|567074208|FG009|Part 1: Phase 1a Escalation|Other|0|||
157087811|NCT02663518|567074209|FG010|Part 1: Phase 1a Escalation|Other|0|||
157087812|NCT02663518|567074210|FG011|Part 1: Phase 1a Escalation|Other|0|||
157087813|NCT02663518|567074211|FG012|Part 1: Phase 1a Escalation|Other|0|||
157087814|NCT02663518|567074212|FG013|Part 1: Phase 1a Escalation|Other|0|||
157087815|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087816|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087817|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087818|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087819|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
157087820|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087821|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
157087822|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
157087823|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087824|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087825|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087826|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087827|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087828|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
157087829|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087830|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087831|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087832|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087833|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
157087834|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087835|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
157087836|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
157087837|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087838|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087839|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087840|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087841|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087842|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
157087843|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087844|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087845|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087846|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087847|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
157236254|NCT03017885|567612983|FG001|Overall Study|Lost to Follow-up|0|||
157087848|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087849|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157196232|NCT00302731|567461458|FG000|Overall Study|cancer unrelated to study discovered|1|||
157087850|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087851|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087852|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087853|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087854|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087855|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087856|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
157087857|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087858|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087859|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087860|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087861|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
157087862|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
157087863|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
157087864|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
157087865|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087866|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087867|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087868|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087869|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087870|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
157087871|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087872|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087873|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087874|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087875|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
157087876|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087877|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
157087878|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087879|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087880|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087881|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087882|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087883|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087884|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
157087885|NCT02663518|567074199|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087886|NCT02663518|567074200|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087887|NCT02663518|567074201|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087888|NCT02663518|567074202|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087889|NCT02663518|567074203|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087890|NCT02663518|567074204|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087891|NCT02663518|567074205|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
157087892|NCT02663518|567074206|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087893|NCT02663518|567074207|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087894|NCT02663518|567074208|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087895|NCT02663518|567074209|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087896|NCT02663518|567074210|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087897|NCT02663518|567074211|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087898|NCT02663518|567074212|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
157087899|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
157087900|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
157087901|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
157087902|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
157087903|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
157087904|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
157087905|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
157087906|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
157087907|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
157087908|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
157087909|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
157087910|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
157087911|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
157087912|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
157087913|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157236255|NCT03017885|567612984|FG002|Overall Study|Lost to Follow-up|3|||
157087914|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087915|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087916|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157236256|NCT03017885|567612985|FG003|Overall Study|Lost to Follow-up|0|||
157236257|NCT03017885|567612986|FG004|Overall Study|Lost to Follow-up|0|||
157236258|NCT03017885|567612987|FG005|Overall Study|Lost to Follow-up|0|||
157236259|NCT03017885|567612982|FG000|Overall Study|Change to other anti-cancer therapy|0|||
157236260|NCT03017885|567612983|FG001|Overall Study|Change to other anti-cancer therapy|0|||
157236261|NCT03017885|567612984|FG002|Overall Study|Change to other anti-cancer therapy|1|||
157236262|NCT03017885|567612985|FG003|Overall Study|Change to other anti-cancer therapy|0|||
157236263|NCT03017885|567612986|FG004|Overall Study|Change to other anti-cancer therapy|0|||
157236264|NCT03017885|567612987|FG005|Overall Study|Change to other anti-cancer therapy|0|||
157236265|NCT02158663|567612990|FG000|Overall Study|Withdrawal by Subject|5|||
157236266|NCT02158663|567612991|FG001|Overall Study|Withdrawal by Subject|4|||
157236267|NCT03586726|567612996|FG000|Overall Study|Withdrawal by Subject|1|||
157236268|NCT00965185|567612997|FG000|Overall Study|Lost to Follow-up|2|||
157236269|NCT00965185|567612998|FG001|Overall Study|Lost to Follow-up|0|||
157236270|NCT00965185|567612997|FG000|Overall Study|Withdrawal by Subject|0|||
157236271|NCT00965185|567612998|FG001|Overall Study|Withdrawal by Subject|1|||
157236272|NCT05323396|567612999|FG000|Overall Study|Lost to Follow-up|1|||
157236273|NCT05323396|567613000|FG001|Overall Study|Lost to Follow-up|35|||
157236274|NCT05323396|567612999|FG000|Overall Study|Pregnancy|1|||
157236275|NCT05323396|567613000|FG001|Overall Study|Pregnancy|0|||
157236276|NCT03681470|567613001|FG000|Overall Study|Lack of Efficacy|3|||
157236277|NCT03681470|567613001|FG000|Overall Study|Lost to Follow-up|1|||
157236278|NCT03681470|567613001|FG000|Overall Study|Protocol Violation|3|||
157236279|NCT03681470|567613001|FG000|Overall Study|Withdrawal by Subject|1|||
157236280|NCT03500692|567613002|FG000|Overall Study|Death|163|||
157236281|NCT03500692|567613002|FG000|Overall Study|Lost to Follow-up|75|||
157236282|NCT03500692|567613002|FG000|Overall Study|Termination Reasons|3|||
157236283|NCT02305758|567613003|FG000|Overall Study|Death|27|||
157236284|NCT02305758|567613004|FG001|Overall Study|Death|27|||
157236285|NCT02305758|567613003|FG000|Overall Study|Withdrew consent|9|||
157236286|NCT02305758|567613004|FG001|Overall Study|Withdrew consent|2|||
157236287|NCT02305758|567613003|FG000|Overall Study|Lost to Follow-up|6|||
157236288|NCT02305758|567613004|FG001|Overall Study|Lost to Follow-up|1|||
157236289|NCT02305758|567613003|FG000|Overall Study|Study Terminated by Sponsor|21|||
157236290|NCT02305758|567613004|FG001|Overall Study|Study Terminated by Sponsor|34|||
157236291|NCT02305758|567613003|FG000|Overall Study|Other, not specified|2|||
157236292|NCT02305758|567613004|FG001|Overall Study|Other, not specified|1|||
157236293|NCT05593965|567613005|FG000|1st Intervention (1 Day)|Technical error|1|||
157236294|NCT05593965|567613006|FG001|1st Intervention (1 Day)|Technical error|0|||
157236295|NCT02272777|567613007|FG000|Overall Study|Adverse Event|0|||
157236296|NCT02272777|567613008|FG001|Overall Study|Adverse Event|1|||
157236297|NCT02272777|567613007|FG000|Overall Study|Withdrawal by Subject|0|||
157236298|NCT02272777|567613008|FG001|Overall Study|Withdrawal by Subject|3|||
157236299|NCT02272777|567613007|FG000|Overall Study|Lost to Follow-up|2|||
157236300|NCT02272777|567613008|FG001|Overall Study|Lost to Follow-up|0|||
157236301|NCT02272777|567613007|FG000|Overall Study|Other|2|||
157236302|NCT02272777|567613008|FG001|Overall Study|Other|0|||
157236303|NCT02066922|567613011|FG000|Overall Study|Adverse Event|1|||
157236304|NCT00440297|567613012|FG000|Overall Study|Adverse Event|8|||
157087917|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087918|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087919|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087920|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087921|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087922|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087923|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087924|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157087925|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
157236305|NCT00440297|567613013|FG001|Overall Study|Adverse Event|5|||
157236306|NCT00440297|567613012|FG000|Overall Study|Lost to Follow-up|1|||
157236307|NCT00440297|567613013|FG001|Overall Study|Lost to Follow-up|0|||
157236308|NCT00440297|567613012|FG000|Overall Study|Physician Decision|1|||
157236309|NCT00440297|567613013|FG001|Overall Study|Physician Decision|0|||
157087926|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
157236310|NCT00440297|567613012|FG000|Overall Study|Protocol Violation|11|||
157236311|NCT00440297|567613013|FG001|Overall Study|Protocol Violation|7|||
157236312|NCT00440297|567613012|FG000|Overall Study|Withdrawal by Subject|1|||
157236313|NCT00440297|567613013|FG001|Overall Study|Withdrawal by Subject|6|||
157236314|NCT00440297|567613012|FG000|Overall Study|Randomized by mistake|1|||
157236315|NCT00440297|567613013|FG001|Overall Study|Randomized by mistake|0|||
157236316|NCT03206177|567613014|FG000|Overall Study|Withdrawal by Subject|1|||
157236317|NCT02024932|567613015|FG000|Overall Study|Adverse Event|2|||
157236318|NCT02024932|567613016|FG001|Overall Study|Adverse Event|3|||
157236319|NCT02024932|567613017|FG002|Overall Study|Adverse Event|0|||
157236320|NCT02024932|567613018|FG003|Overall Study|Adverse Event|0|||
157236321|NCT02024932|567613019|FG004|Overall Study|Adverse Event|2|||
157236322|NCT02024932|567613020|FG005|Overall Study|Adverse Event|0|||
157236323|NCT02024932|567613015|FG000|Overall Study|Abnormal laboratory value|0|||
157236324|NCT02024932|567613016|FG001|Overall Study|Abnormal laboratory value|0|||
157236325|NCT02024932|567613017|FG002|Overall Study|Abnormal laboratory value|0|||
157236326|NCT02024932|567613018|FG003|Overall Study|Abnormal laboratory value|2|||
157236327|NCT02024932|567613019|FG004|Overall Study|Abnormal laboratory value|0|||
157236328|NCT02024932|567613020|FG005|Overall Study|Abnormal laboratory value|0|||
157236329|NCT02445339|567613021|FG000|Overall Study|Physician Decision|1|||
157236330|NCT02445339|567613022|FG001|Overall Study|Physician Decision|0|||
157236331|NCT02445339|567613021|FG000|Overall Study|Lost to Follow-up|11|||
157236332|NCT02445339|567613022|FG001|Overall Study|Lost to Follow-up|15|||
157236333|NCT03020641|567613023|FG000|Overall Study|Lost to Follow-up|0|||
157236334|NCT03020641|567613024|FG001|Overall Study|Lost to Follow-up|1|||
157236335|NCT03020641|567613023|FG000|Overall Study|Converted to open surgery|2|||
157236336|NCT03020641|567613024|FG001|Overall Study|Converted to open surgery|1|||
157236337|NCT03020641|567613023|FG000|Overall Study|for surgery not performed|0|||
157236338|NCT03020641|567613024|FG001|Overall Study|for surgery not performed|1|||
157236339|NCT00727961|567613025|FG000|Overall Study|Lost to Follow-up|1|||
157236340|NCT00727961|567613025|FG000|Overall Study|Adverse Event|4|||
157236341|NCT00727961|567613025|FG000|Overall Study|Patient's refusal|2|||
157236342|NCT00727961|567613025|FG000|Overall Study|Progression|30|||
157236343|NCT03238781|567613026|FG000|Overall Study|Adverse Event|1|||
157236344|NCT03238781|567613027|FG001|Overall Study|Adverse Event|1|||
157236345|NCT03238781|567613028|FG002|Overall Study|Adverse Event|2|||
157236346|NCT03238781|567613026|FG000|Overall Study|Lost to Follow-up|2|||
157236347|NCT03238781|567613027|FG001|Overall Study|Lost to Follow-up|1|||
157236348|NCT03238781|567613028|FG002|Overall Study|Lost to Follow-up|2|||
157236349|NCT03238781|567613026|FG000|Overall Study|Withdrawal by Subject|23|||
157236350|NCT03238781|567613027|FG001|Overall Study|Withdrawal by Subject|14|||
157236351|NCT03238781|567613028|FG002|Overall Study|Withdrawal by Subject|16|||
157236352|NCT03238781|567613026|FG000|Overall Study|Decision by sponsor|0|||
157236353|NCT03238781|567613027|FG001|Overall Study|Decision by sponsor|1|||
157236354|NCT03238781|567613028|FG002|Overall Study|Decision by sponsor|0|||
157087927|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157236355|NCT03161405|567613029|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
157236356|NCT00837486|567613030|FG000|Blinded-treatment Phase|Physician Decision|1|||
157236357|NCT00837486|567613031|FG001|Blinded-treatment Phase|Physician Decision|0|||
157236358|NCT00837486|567613030|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
157236359|NCT00837486|567613031|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
157236360|NCT00837486|567613030|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
157236361|NCT00837486|567613031|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
157236362|NCT00837486|567613030|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
157236363|NCT00837486|567613031|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
157236364|NCT02186821|567613032|FG000|Overall Study|Adverse Event|9|||
157236365|NCT02186821|567613032|FG000|Overall Study|Death|2|||
157236366|NCT02186821|567613032|FG000|Overall Study|Disease progression|32|||
157087928|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087929|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087930|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087931|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087932|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087933|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087934|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087935|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087936|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087937|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087938|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
157087939|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087940|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
157087941|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087942|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157236367|NCT02186821|567613032|FG000|Overall Study|Protocol Violation|1|||
157236368|NCT02186821|567613032|FG000|Overall Study|Physician Decision|1|||
157236369|NCT02186821|567613032|FG000|Overall Study|Study terminated by sponsor|2|||
157236370|NCT01421277|567613033|FG000|Overall Study|Lack of qualifying event|0|||
157236371|NCT01421277|567613034|FG001|Overall Study|Lack of qualifying event|61|||
157236372|NCT01421277|567613033|FG000|Overall Study|Incomplete baseline data|0|||
157236373|NCT01421277|567613034|FG001|Overall Study|Incomplete baseline data|31|||
157236374|NCT02039908|567613035|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
157236375|NCT02039908|567613036|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
157236376|NCT02039908|567613037|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
157236377|NCT02039908|567613038|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
157236378|NCT02039908|567613035|FG000|Phase 1-Summer|Protocol Violation|6|||
157236379|NCT02039908|567613036|FG001|Phase 1-Summer|Protocol Violation|0|||
157236380|NCT02039908|567613037|FG002|Phase 1-Summer|Protocol Violation|0|||
157236381|NCT02039908|567613038|FG003|Phase 1-Summer|Protocol Violation|0|||
157236382|NCT02039908|567613035|FG000|Phase 2-School Year|Lost to Follow-up|0|||
157236383|NCT02039908|567613036|FG001|Phase 2-School Year|Lost to Follow-up|0|||
157236384|NCT02039908|567613037|FG002|Phase 2-School Year|Lost to Follow-up|1|||
157236385|NCT02039908|567613038|FG003|Phase 2-School Year|Lost to Follow-up|3|||
157236386|NCT02039908|567613035|FG000|Phase 2-School Year|Protocol Violation|0|||
157236387|NCT02039908|567613036|FG001|Phase 2-School Year|Protocol Violation|0|||
157236388|NCT02039908|567613037|FG002|Phase 2-School Year|Protocol Violation|3|||
157236389|NCT02039908|567613038|FG003|Phase 2-School Year|Protocol Violation|0|||
157236390|NCT02039908|567613035|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
157236391|NCT02039908|567613036|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
157236392|NCT02039908|567613037|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
157236393|NCT02039908|567613038|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
157236394|NCT00731783|567613039|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
157087943|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087944|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087945|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087946|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087947|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087948|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087949|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087950|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
157087951|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
157087952|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
157087953|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
157087954|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
157236395|NCT00731783|567613040|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
157087955|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
157087956|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
157087957|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
157087958|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
157087959|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
157087960|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
157087961|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
157087962|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
157087963|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
157087964|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
157087965|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
157087966|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
157087967|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
157087968|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
157087969|NCT02663518|567074199|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087970|NCT02663518|567074200|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087971|NCT02663518|567074201|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087972|NCT02663518|567074202|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087973|NCT02663518|567074203|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087974|NCT02663518|567074204|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087975|NCT02663518|567074205|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087976|NCT02663518|567074206|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087977|NCT02663518|567074207|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087978|NCT02663518|567074208|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087979|NCT02663518|567074209|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087980|NCT02663518|567074210|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087981|NCT02663518|567074211|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
157087982|NCT02663518|567074212|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
157087983|NCT00006011|567074214|FG000|Overall Study|Disease progression|13|||
157087984|NCT00006011|567074215|FG001|Overall Study|Disease progression|6|||
157087985|NCT00006011|567074216|FG002|Overall Study|Disease progression|26|||
157087986|NCT00006011|567074214|FG000|Overall Study|Refused further treatment|15|||
157087987|NCT00006011|567074215|FG001|Overall Study|Refused further treatment|13|||
157087988|NCT00006011|567074216|FG002|Overall Study|Refused further treatment|26|||
157087989|NCT00006011|567074214|FG000|Overall Study|Adverse Event|15|||
157087990|NCT00006011|567074215|FG001|Overall Study|Adverse Event|39|||
157087991|NCT00006011|567074216|FG002|Overall Study|Adverse Event|5|||
157087992|NCT00006011|567074214|FG000|Overall Study|Death|0|||
157087993|NCT00006011|567074215|FG001|Overall Study|Death|1|||
157087994|NCT00006011|567074216|FG002|Overall Study|Death|2|||
157087995|NCT00006011|567074214|FG000|Overall Study|Other|4|||
157087996|NCT00006011|567074215|FG001|Overall Study|Other|2|||
157087997|NCT00006011|567074216|FG002|Overall Study|Other|5|||
157087998|NCT00006011|567074214|FG000|Overall Study|Ineligible|18|||
157087999|NCT00006011|567074215|FG001|Overall Study|Ineligible|16|||
157088000|NCT00006011|567074216|FG002|Overall Study|Ineligible|9|||
157196233|NCT00302731|567461459|FG001|Overall Study|cancer unrelated to study discovered|0|||
157196234|NCT00302731|567461460|FG002|Overall Study|cancer unrelated to study discovered|1|||
157196235|NCT00302731|567461461|FG003|Overall Study|cancer unrelated to study discovered|0|||
157196236|NCT01610752|567461462|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
157196237|NCT01610752|567461463|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
157196238|NCT01610752|567461464|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
157196239|NCT00283062|567461465|FG000|Overall Study|Did not receive any study medication|5|||
157196240|NCT00283062|567461466|FG001|Overall Study|Did not receive any study medication|4|||
157196241|NCT00283062|567461467|FG002|Overall Study|Did not receive any study medication|36|||
157196242|NCT00283062|567461468|FG003|Overall Study|Did not receive any study medication|45|||
157196243|NCT00283062|567461465|FG000|Overall Study|Adverse Event|2|||
157196244|NCT00283062|567461466|FG001|Overall Study|Adverse Event|0|||
157196245|NCT00283062|567461467|FG002|Overall Study|Adverse Event|1|||
157196246|NCT00283062|567461468|FG003|Overall Study|Adverse Event|0|||
157196247|NCT00283062|567461465|FG000|Overall Study|Lost to Follow-up|1|||
157196248|NCT00283062|567461466|FG001|Overall Study|Lost to Follow-up|0|||
157196249|NCT00283062|567461467|FG002|Overall Study|Lost to Follow-up|1|||
157196250|NCT00283062|567461468|FG003|Overall Study|Lost to Follow-up|0|||
157196251|NCT00283062|567461465|FG000|Overall Study|Progressive disease|0|||
157196252|NCT00283062|567461466|FG001|Overall Study|Progressive disease|0|||
157196253|NCT00283062|567461467|FG002|Overall Study|Progressive disease|1|||
157196254|NCT00283062|567461468|FG003|Overall Study|Progressive disease|0|||
157196255|NCT00283062|567461465|FG000|Overall Study|Participant did not wish to continue|3|||
157196256|NCT00283062|567461466|FG001|Overall Study|Participant did not wish to continue|2|||
157196257|NCT00283062|567461467|FG002|Overall Study|Participant did not wish to continue|1|||
157196258|NCT00283062|567461468|FG003|Overall Study|Participant did not wish to continue|0|||
157196259|NCT00283062|567461465|FG000|Overall Study|Undefined|0|||
157196260|NCT00283062|567461466|FG001|Overall Study|Undefined|1|||
157196261|NCT00283062|567461467|FG002|Overall Study|Undefined|1|||
157196262|NCT00283062|567461468|FG003|Overall Study|Undefined|4|||
157196263|NCT00283062|567461465|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
157196264|NCT00283062|567461466|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
157196265|NCT00283062|567461467|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
157196266|NCT00283062|567461468|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
157196267|NCT00252499|567461469|FG000|Overall Study|Lost to Follow-up|1|||
157196268|NCT00252499|567461470|FG001|Overall Study|Lost to Follow-up|0|||
157196269|NCT00252499|567461471|FG002|Overall Study|Lost to Follow-up|0|||
157196270|NCT01535638|567461472|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
157196271|NCT01535638|567461473|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
157196272|NCT01535638|567461474|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
157196273|NCT01535638|567461475|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
157196274|NCT01535638|567461476|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
157196275|NCT01535638|567461477|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
157196276|NCT01535638|567461472|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
157196277|NCT01535638|567461473|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
157196278|NCT01535638|567461474|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
157196279|NCT01535638|567461475|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
157196280|NCT01535638|567461476|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
157196281|NCT01535638|567461477|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
157196282|NCT00827112|567461478|FG000|Overall Study|Adverse Event|2|||
157196283|NCT00827112|567461479|FG001|Overall Study|Adverse Event|0|||
157196284|NCT00827112|567461478|FG000|Overall Study|Lack of Efficacy|2|||
157196285|NCT00827112|567461479|FG001|Overall Study|Lack of Efficacy|0|||
157196286|NCT00827112|567461478|FG000|Overall Study|Lost to Follow-up|3|||
157236396|NCT00731783|567613039|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
157196287|NCT00827112|567461479|FG001|Overall Study|Lost to Follow-up|2|||
157196288|NCT00827112|567461478|FG000|Overall Study|Pregnancy|0|||
157196289|NCT00827112|567461479|FG001|Overall Study|Pregnancy|1|||
157196290|NCT00827112|567461478|FG000|Overall Study|Protocol Violation|0|||
157196291|NCT00827112|567461479|FG001|Overall Study|Protocol Violation|2|||
157236397|NCT00731783|567613040|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
157196292|NCT00827112|567461478|FG000|Overall Study|Withdrawal by Subject|2|||
157196293|NCT00827112|567461479|FG001|Overall Study|Withdrawal by Subject|1|||
157196294|NCT00827112|567461478|FG000|Overall Study|Randomized but not treated|5|||
157196295|NCT00827112|567461479|FG001|Overall Study|Randomized but not treated|3|||
157088001|NCT03047395|567074226|FG000|Overall Study|Adverse Event|142|||
157088002|NCT03047395|567074226|FG000|Overall Study|Withdrawal by Subject|155|||
157236398|NCT00731783|567613039|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
157236399|NCT00731783|567613040|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
157236400|NCT00731783|567613039|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
157088003|NCT03047395|567074226|FG000|Overall Study|Lost to Follow-up|144|||
157088004|NCT03047395|567074226|FG000|Overall Study|COVID-19 Infection|2|||
157088005|NCT03047395|567074226|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
157088006|NCT03047395|567074226|FG000|Overall Study|Other, Not Specified|117|||
157088007|NCT01157676|567074232|FG000|Randomization|Death|1|||
157088008|NCT01157676|567074233|FG001|Randomization|Death|1|||
157088009|NCT01157676|567074232|FG000|Randomization|unresectable|2|||
157088010|NCT01157676|567074233|FG001|Randomization|unresectable|3|||
157088011|NCT01157676|567074232|FG000|Randomization|Withdrawal by Subject|17|||
157088012|NCT01157676|567074233|FG001|Randomization|Withdrawal by Subject|13|||
157236401|NCT00731783|567613040|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
157236402|NCT02847650|567614268|FG000|Overall Study|Adverse Event|2|||
157236403|NCT02847650|567614269|FG001|Overall Study|Adverse Event|4|||
157236404|NCT02847650|567614268|FG000|Overall Study|Lost to Follow-up|1|||
157236405|NCT02847650|567614269|FG001|Overall Study|Lost to Follow-up|0|||
157236406|NCT02847650|567614268|FG000|Overall Study|Protocol Violation|0|||
157236407|NCT02847650|567614269|FG001|Overall Study|Protocol Violation|1|||
157236408|NCT02847650|567614268|FG000|Overall Study|Withdrawal by Subject|1|||
157236409|NCT02847650|567614269|FG001|Overall Study|Withdrawal by Subject|1|||
157236410|NCT03772522|567614270|FG000|Pre-intervention|Withdrawal by Subject|3|||
157236411|NCT03772522|567614271|FG001|Pre-intervention|Withdrawal by Subject|4|||
157236412|NCT03772522|567614270|FG000|Intervention|Withdrawal by Subject|1|||
157236413|NCT03772522|567614271|FG001|Intervention|Withdrawal by Subject|0|||
157236414|NCT03772522|567614270|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
157236415|NCT03772522|567614271|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
157236416|NCT03071575|567614272|FG000|Overall Study|Death|0|||
157236417|NCT03071575|567614273|FG001|Overall Study|Death|1|||
157236418|NCT03071575|567614272|FG000|Overall Study|Lost to Follow-up|5|||
157236419|NCT03071575|567614273|FG001|Overall Study|Lost to Follow-up|11|||
157236420|NCT03071575|567614272|FG000|Overall Study|Withdrawal by Subject|4|||
157236421|NCT03071575|567614273|FG001|Overall Study|Withdrawal by Subject|2|||
157236422|NCT00218257|567614274|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
157236423|NCT00218257|567614275|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
157236424|NCT00579345|567614276|FG000|Overall Study|Withdrawal by Subject|2|||
157236425|NCT00579345|567614277|FG001|Overall Study|Withdrawal by Subject|0|||
157236426|NCT00579345|567614278|FG002|Overall Study|Withdrawal by Subject|0|||
157236427|NCT00579345|567614279|FG003|Overall Study|Withdrawal by Subject|0|||
157236428|NCT00579345|567614280|FG004|Overall Study|Withdrawal by Subject|0|||
157236429|NCT00579345|567614281|FG005|Overall Study|Withdrawal by Subject|0|||
157236430|NCT00579345|567614282|FG006|Overall Study|Withdrawal by Subject|0|||
157236431|NCT00579345|567614283|FG007|Overall Study|Withdrawal by Subject|1|||
157236432|NCT00579345|567614276|FG000|Overall Study|Lost to Follow-up|1|||
157236433|NCT00579345|567614277|FG001|Overall Study|Lost to Follow-up|0|||
157236434|NCT00579345|567614278|FG002|Overall Study|Lost to Follow-up|0|||
157236435|NCT00579345|567614279|FG003|Overall Study|Lost to Follow-up|0|||
157236436|NCT00579345|567614280|FG004|Overall Study|Lost to Follow-up|0|||
157236437|NCT00579345|567614281|FG005|Overall Study|Lost to Follow-up|0|||
157236438|NCT00579345|567614282|FG006|Overall Study|Lost to Follow-up|0|||
157236439|NCT00579345|567614283|FG007|Overall Study|Lost to Follow-up|0|||
157236440|NCT00579345|567614276|FG000|Overall Study|Adverse Event|0|||
157236441|NCT00579345|567614277|FG001|Overall Study|Adverse Event|0|||
157236442|NCT00579345|567614278|FG002|Overall Study|Adverse Event|1|||
157236443|NCT00579345|567614279|FG003|Overall Study|Adverse Event|0|||
157236444|NCT00579345|567614280|FG004|Overall Study|Adverse Event|0|||
157236445|NCT00579345|567614281|FG005|Overall Study|Adverse Event|0|||
157236446|NCT00579345|567614282|FG006|Overall Study|Adverse Event|0|||
157236447|NCT00579345|567614283|FG007|Overall Study|Adverse Event|0|||
157236448|NCT00579345|567614276|FG000|Overall Study|Protocol Violation|1|||
157236449|NCT00579345|567614277|FG001|Overall Study|Protocol Violation|0|||
157236450|NCT00579345|567614278|FG002|Overall Study|Protocol Violation|0|||
157088013|NCT01157676|567074232|FG000|Randomization|Physician Decision|1|||
157236451|NCT00579345|567614279|FG003|Overall Study|Protocol Violation|0|||
157236452|NCT00579345|567614280|FG004|Overall Study|Protocol Violation|0|||
157236453|NCT00579345|567614281|FG005|Overall Study|Protocol Violation|0|||
157236454|NCT00579345|567614282|FG006|Overall Study|Protocol Violation|0|||
157236455|NCT00579345|567614283|FG007|Overall Study|Protocol Violation|1|||
157088014|NCT01157676|567074233|FG001|Randomization|Physician Decision|0|||
157236456|NCT00579345|567614276|FG000|Overall Study|Death|1|||
157088015|NCT01157676|567074232|FG000|Surgery|underwent open cystectomy|0|||
157236457|NCT00579345|567614277|FG001|Overall Study|Death|1|||
157236458|NCT00579345|567614278|FG002|Overall Study|Death|1|||
157236459|NCT00579345|567614279|FG003|Overall Study|Death|1|||
157236460|NCT00579345|567614280|FG004|Overall Study|Death|0|||
157236461|NCT00579345|567614281|FG005|Overall Study|Death|0|||
157236462|NCT00579345|567614282|FG006|Overall Study|Death|0|||
157236463|NCT00579345|567614283|FG007|Overall Study|Death|0|||
157088016|NCT01157676|567074233|FG001|Surgery|underwent open cystectomy|4|||
157088017|NCT01157676|567074232|FG000|Surgery|converted to open procedure|0|||
157088018|NCT01157676|567074233|FG001|Surgery|converted to open procedure|5|||
157088019|NCT01157676|567074232|FG000|Surgery|underwent robotic cystectomy|1|||
157088020|NCT01157676|567074233|FG001|Surgery|underwent robotic cystectomy|0|||
157088021|NCT00682890|567074234|FG000|Overall Study|Lost to Follow-up|1|||
157088022|NCT00682890|567074235|FG001|Overall Study|Lost to Follow-up|1|||
157088023|NCT00682890|567074234|FG000|Overall Study|subject moved away|0|||
157088024|NCT00682890|567074235|FG001|Overall Study|subject moved away|1|||
157088025|NCT00682890|567074234|FG000|Overall Study|heavy menstrual bleeding|1|||
157088026|NCT00682890|567074235|FG001|Overall Study|heavy menstrual bleeding|0|||
157088027|NCT00141219|567074238|FG000|Overall Study|Protocol violations|5|||
157088028|NCT00141219|567074239|FG001|Overall Study|Protocol violations|4|||
157088029|NCT00141219|567074238|FG000|Overall Study|Adverse Event|8|||
157088030|NCT00141219|567074239|FG001|Overall Study|Adverse Event|6|||
157088031|NCT00141219|567074238|FG000|Overall Study|Lack of Efficacy|5|||
157088032|NCT00141219|567074239|FG001|Overall Study|Lack of Efficacy|4|||
157088033|NCT00141219|567074238|FG000|Overall Study|Withdrawal by Subject|6|||
157088034|NCT00141219|567074239|FG001|Overall Study|Withdrawal by Subject|2|||
157088035|NCT01577745|567074241|FG000|Overall Study|Withdrawal by Subject|0|||
157088036|NCT01577745|567074242|FG001|Overall Study|Withdrawal by Subject|1|||
157088037|NCT01577745|567074243|FG002|Overall Study|Withdrawal by Subject|0|||
157088038|NCT01577745|567074244|FG003|Overall Study|Withdrawal by Subject|3|||
157088039|NCT01577745|567074245|FG004|Overall Study|Withdrawal by Subject|2|||
157196296|NCT00827112|567461478|FG000|Overall Study|Other|1|||
157196297|NCT00827112|567461479|FG001|Overall Study|Other|3|||
157196298|NCT00689728|567461480|FG000|Double-Blind Treatment|Adverse Event|1|||
157196299|NCT00689728|567461481|FG001|Double-Blind Treatment|Adverse Event|0|||
157196300|NCT00689728|567461482|FG002|Double-Blind Treatment|Adverse Event|0|||
157196301|NCT00689728|567461480|FG000|Double-Blind Treatment|Protocol Violation|0|||
157196302|NCT00689728|567461481|FG001|Double-Blind Treatment|Protocol Violation|0|||
157196303|NCT00689728|567461482|FG002|Double-Blind Treatment|Protocol Violation|1|||
157196304|NCT00689728|567461480|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
157196305|NCT00689728|567461481|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
157196306|NCT00689728|567461482|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
157196307|NCT00689728|567461480|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
157196308|NCT00689728|567461481|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
157196309|NCT00689728|567461482|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
157196310|NCT00689728|567461480|FG000|Rescue|Adverse Event|0|||
157196311|NCT00689728|567461481|FG001|Rescue|Adverse Event|1|||
157196312|NCT00689728|567461482|FG002|Rescue|Adverse Event|0|||
157196313|NCT00689728|567461480|FG000|Rescue|Withdrawal by Subject|1|||
157196314|NCT00689728|567461481|FG001|Rescue|Withdrawal by Subject|1|||
157196315|NCT00689728|567461482|FG002|Rescue|Withdrawal by Subject|1|||
157196316|NCT00689728|567461480|FG000|Optional Follow-Up|Adverse Event|1|||
157196317|NCT00689728|567461481|FG001|Optional Follow-Up|Adverse Event|0|||
157196318|NCT00689728|567461482|FG002|Optional Follow-Up|Adverse Event|0|||
157196319|NCT00689728|567461480|FG000|Optional Follow-Up|Lack of Efficacy|0|||
157196320|NCT00689728|567461481|FG001|Optional Follow-Up|Lack of Efficacy|1|||
157196321|NCT00689728|567461482|FG002|Optional Follow-Up|Lack of Efficacy|1|||
157196322|NCT00689728|567461480|FG000|Optional Follow-Up|Lost to Follow-up|0|||
157196323|NCT00689728|567461481|FG001|Optional Follow-Up|Lost to Follow-up|1|||
157196324|NCT00689728|567461482|FG002|Optional Follow-Up|Lost to Follow-up|1|||
157196325|NCT00689728|567461480|FG000|Optional Follow-Up|Protocol Violation|0|||
157196326|NCT00689728|567461481|FG001|Optional Follow-Up|Protocol Violation|0|||
157196327|NCT00689728|567461482|FG002|Optional Follow-Up|Protocol Violation|1|||
157196328|NCT00689728|567461480|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
157196329|NCT00689728|567461481|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
157196330|NCT00689728|567461482|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
157196331|NCT00842829|567461487|FG000|Dose Titration Period|Adverse Event|11|||
157196332|NCT00842829|567461488|FG001|Dose Titration Period|Adverse Event|10|||
157196333|NCT00842829|567461489|FG002|Dose Titration Period|Adverse Event|0|||
157196334|NCT00842829|567461487|FG000|Dose Titration Period|Lack of Efficacy|4|||
157196335|NCT00842829|567461488|FG001|Dose Titration Period|Lack of Efficacy|1|||
157196336|NCT00842829|567461489|FG002|Dose Titration Period|Lack of Efficacy|0|||
157196337|NCT00842829|567461487|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
157196338|NCT00842829|567461488|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
157196339|NCT00842829|567461489|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
157196340|NCT00842829|567461487|FG000|Dose Titration Period|Withdrawal by Subject|2|||
157196341|NCT00842829|567461488|FG001|Dose Titration Period|Withdrawal by Subject|6|||
157088040|NCT01577745|567074246|FG005|Overall Study|Withdrawal by Subject|0|||
157088041|NCT01577745|567074241|FG000|Overall Study|Death|3|||
157196342|NCT00842829|567461489|FG002|Dose Titration Period|Withdrawal by Subject|0|||
157196343|NCT00842829|567461487|FG000|Dose Titration Period|Other|5|||
157196344|NCT00842829|567461488|FG001|Dose Titration Period|Other|4|||
157196345|NCT00842829|567461489|FG002|Dose Titration Period|Other|0|||
157236464|NCT02267187|567614289|FG000|Overall Study|Physician Decision|2|||
157088042|NCT01577745|567074242|FG001|Overall Study|Death|2|||
157088043|NCT01577745|567074243|FG002|Overall Study|Death|2|||
157088044|NCT01577745|567074244|FG003|Overall Study|Death|1|||
157088045|NCT01577745|567074245|FG004|Overall Study|Death|1|||
157088046|NCT01577745|567074246|FG005|Overall Study|Death|3|||
157196346|NCT00842829|567461487|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
157088047|NCT01577745|567074241|FG000|Overall Study|Physician Decision|0|||
157088048|NCT01577745|567074242|FG001|Overall Study|Physician Decision|0|||
157088049|NCT01577745|567074243|FG002|Overall Study|Physician Decision|0|||
157088050|NCT01577745|567074244|FG003|Overall Study|Physician Decision|1|||
157088051|NCT01577745|567074245|FG004|Overall Study|Physician Decision|1|||
157088052|NCT01577745|567074246|FG005|Overall Study|Physician Decision|0|||
157088053|NCT01577745|567074241|FG000|Overall Study|Lost to Follow-up|0|||
157088054|NCT01577745|567074242|FG001|Overall Study|Lost to Follow-up|0|||
157088055|NCT01577745|567074243|FG002|Overall Study|Lost to Follow-up|0|||
157088056|NCT01577745|567074244|FG003|Overall Study|Lost to Follow-up|0|||
157088057|NCT01577745|567074245|FG004|Overall Study|Lost to Follow-up|0|||
157088058|NCT01577745|567074246|FG005|Overall Study|Lost to Follow-up|1|||
157088059|NCT01577745|567074241|FG000|Overall Study|Alternative Therapy|0|||
157088060|NCT01577745|567074242|FG001|Overall Study|Alternative Therapy|0|||
157088061|NCT01577745|567074243|FG002|Overall Study|Alternative Therapy|0|||
157088062|NCT01577745|567074244|FG003|Overall Study|Alternative Therapy|1|||
157088063|NCT01577745|567074245|FG004|Overall Study|Alternative Therapy|1|||
157088064|NCT01577745|567074246|FG005|Overall Study|Alternative Therapy|0|||
157088065|NCT02595073|567074247|FG000|Overall Study|Progressive Disease|0|||
157088066|NCT02595073|567074248|FG001|Overall Study|Progressive Disease|1|||
157088067|NCT02595073|567074247|FG000|Overall Study|Protocol Violation|2|||
157088068|NCT02595073|567074248|FG001|Overall Study|Protocol Violation|0|||
157088069|NCT04860297|567074249|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
157088070|NCT04860297|567074250|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
157088071|NCT04860297|567074251|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
157088072|NCT04860297|567074252|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
157088073|NCT04860297|567074253|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
157088074|NCT04860297|567074254|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
157088075|NCT04860297|567074255|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
157088076|NCT04860297|567074256|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
157088077|NCT04860297|567074249|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
157088078|NCT04860297|567074250|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
157088079|NCT04860297|567074251|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
157088080|NCT04860297|567074252|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
157088081|NCT04860297|567074253|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
157088082|NCT04860297|567074254|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
157088083|NCT04860297|567074255|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
157088084|NCT04860297|567074256|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
157088085|NCT04860297|567074249|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
157088086|NCT04860297|567074250|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
157088087|NCT04860297|567074251|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
157088088|NCT04860297|567074252|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
157088089|NCT04860297|567074253|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
157088090|NCT04860297|567074254|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
157088091|NCT04860297|567074255|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
157088092|NCT04860297|567074256|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
157088093|NCT04860297|567074249|FG000|Part B (Booster Dose)|Other Than Specified|0|||
157088094|NCT04860297|567074250|FG001|Part B (Booster Dose)|Other Than Specified|0|||
157088095|NCT04860297|567074251|FG002|Part B (Booster Dose)|Other Than Specified|0|||
157088096|NCT04860297|567074252|FG003|Part B (Booster Dose)|Other Than Specified|0|||
157088097|NCT04860297|567074253|FG004|Part B (Booster Dose)|Other Than Specified|0|||
157088098|NCT04860297|567074254|FG005|Part B (Booster Dose)|Other Than Specified|1|||
157088099|NCT04860297|567074255|FG006|Part B (Booster Dose)|Other Than Specified|1|||
157088100|NCT04860297|567074256|FG007|Part B (Booster Dose)|Other Than Specified|0|||
157088101|NCT04860297|567074249|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088102|NCT04860297|567074250|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088103|NCT04860297|567074251|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088104|NCT04860297|567074252|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088105|NCT04860297|567074253|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088106|NCT04860297|567074254|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
157088107|NCT04860297|567074255|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
157088108|NCT04860297|567074256|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
157088109|NCT04860297|567074249|FG000|Part B (Booster Dose)|Death|0|||
157088110|NCT04860297|567074250|FG001|Part B (Booster Dose)|Death|0|||
157088111|NCT04860297|567074251|FG002|Part B (Booster Dose)|Death|0|||
157088112|NCT04860297|567074252|FG003|Part B (Booster Dose)|Death|0|||
157088113|NCT04860297|567074253|FG004|Part B (Booster Dose)|Death|1|||
157088114|NCT04860297|567074254|FG005|Part B (Booster Dose)|Death|2|||
157088115|NCT04860297|567074255|FG006|Part B (Booster Dose)|Death|1|||
157088116|NCT04860297|567074256|FG007|Part B (Booster Dose)|Death|0|||
157236465|NCT02267187|567614289|FG000|Overall Study|Screen fail|3|||
157236466|NCT03255733|567614290|FG000|Overall Study|Lost to Follow-up|4|||
157236467|NCT03874715|567614295|FG000|Overall Study|Adverse Event|2|||
157236468|NCT03874715|567614296|FG001|Overall Study|Adverse Event|0|||
157236469|NCT03874715|567614295|FG000|Overall Study|Poor compliance to protocol|5|||
157236470|NCT03874715|567614296|FG001|Overall Study|Poor compliance to protocol|1|||
157236471|NCT03874715|567614295|FG000|Overall Study|Withdrawal by Subject|1|||
157236472|NCT03874715|567614296|FG001|Overall Study|Withdrawal by Subject|0|||
157236473|NCT03874715|567614295|FG000|Overall Study|Other-unspecified|1|||
157236474|NCT03874715|567614296|FG001|Overall Study|Other-unspecified|0|||
157236475|NCT00934050|567614297|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
157236476|NCT00934050|567614298|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
157236477|NCT00934050|567614299|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
157236478|NCT00934050|567614300|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
157236479|NCT00934050|567614301|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
157236480|NCT00934050|567614302|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
157236481|NCT00934050|567614297|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
157236482|NCT00934050|567614298|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
157236483|NCT00934050|567614299|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
157236484|NCT00934050|567614300|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
157236485|NCT00934050|567614301|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
157236486|NCT00934050|567614302|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
157236487|NCT00934050|567614297|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
157236488|NCT00934050|567614298|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
157236489|NCT00934050|567614299|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
157236490|NCT00934050|567614300|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
157236491|NCT00934050|567614301|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
157236492|NCT00934050|567614302|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
157236493|NCT00934050|567614297|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
157236494|NCT00934050|567614298|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
157236495|NCT00934050|567614299|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
157236496|NCT00934050|567614300|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
157236497|NCT00934050|567614301|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
157236498|NCT00934050|567614302|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
157236499|NCT00934050|567614297|FG000|Enrolled After 15 Dec 2009|Death|0|||
157236500|NCT00934050|567614298|FG001|Enrolled After 15 Dec 2009|Death|0|||
157236501|NCT00934050|567614299|FG002|Enrolled After 15 Dec 2009|Death|0|||
157236502|NCT00934050|567614300|FG003|Enrolled After 15 Dec 2009|Death|0|||
157236503|NCT00934050|567614301|FG004|Enrolled After 15 Dec 2009|Death|0|||
157236504|NCT00934050|567614302|FG005|Enrolled After 15 Dec 2009|Death|1|||
157236505|NCT00934050|567614297|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
157236506|NCT00934050|567614298|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
157236507|NCT00934050|567614299|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
157088117|NCT04860297|567074249|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
157088118|NCT04860297|567074250|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
157088119|NCT04860297|567074251|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
157088120|NCT04860297|567074252|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
157088121|NCT04860297|567074253|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
157088122|NCT04860297|567074254|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
157088123|NCT04860297|567074255|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
157088124|NCT04860297|567074256|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
157088125|NCT00620282|567074265|FG000|Overall Study|Adverse Event|0|||
157088126|NCT00620282|567074266|FG001|Overall Study|Adverse Event|1|||
157088127|NCT00620282|567074267|FG002|Overall Study|Adverse Event|0|||
157088128|NCT00620282|567074265|FG000|Overall Study|Arterial line unable to be placed|0|||
157088129|NCT00620282|567074266|FG001|Overall Study|Arterial line unable to be placed|0|||
157088130|NCT00620282|567074267|FG002|Overall Study|Arterial line unable to be placed|1|||
157088131|NCT00620282|567074265|FG000|Overall Study|Withdrawal by Subject|0|||
157088132|NCT00620282|567074266|FG001|Overall Study|Withdrawal by Subject|1|||
157088133|NCT00620282|567074267|FG002|Overall Study|Withdrawal by Subject|0|||
157088134|NCT03208036|567074270|FG000|Baseline Assessment|Withdrawal by Subject|1|||
157088135|NCT03208036|567074271|FG001|Baseline Assessment|Withdrawal by Subject|1|||
157236508|NCT00934050|567614300|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
157088136|NCT03208036|567074270|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
157236509|NCT00934050|567614301|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
157236510|NCT00934050|567614302|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
157236511|NCT00934050|567614297|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
157088137|NCT03208036|567074271|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
157088138|NCT03208036|567074270|FG000|Intervention|Withdrawal by Subject|3|||
157088139|NCT03208036|567074271|FG001|Intervention|Withdrawal by Subject|2|||
157236512|NCT00934050|567614298|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
157236513|NCT00934050|567614299|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
157236514|NCT00934050|567614300|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
157088140|NCT03208036|567074270|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
157088141|NCT03208036|567074271|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
157196347|NCT00842829|567461488|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
157196348|NCT00842829|567461489|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
157196349|NCT00842829|567461487|FG000|Dose Titration Period|Non-compliance to study drug|2|||
157196350|NCT00842829|567461488|FG001|Dose Titration Period|Non-compliance to study drug|1|||
157196351|NCT00842829|567461489|FG002|Dose Titration Period|Non-compliance to study drug|0|||
157196352|NCT00842829|567461487|FG000|Treatment Period|Adverse Event|0|||
157196353|NCT00842829|567461488|FG001|Treatment Period|Adverse Event|0|||
157196354|NCT00842829|567461489|FG002|Treatment Period|Adverse Event|15|||
157196355|NCT00842829|567461487|FG000|Treatment Period|Lack of Efficacy|0|||
157196356|NCT00842829|567461488|FG001|Treatment Period|Lack of Efficacy|0|||
157196357|NCT00842829|567461489|FG002|Treatment Period|Lack of Efficacy|6|||
157196358|NCT00842829|567461487|FG000|Treatment Period|Unstable persistent cancer pain|0|||
157196359|NCT00842829|567461488|FG001|Treatment Period|Unstable persistent cancer pain|0|||
157196360|NCT00842829|567461489|FG002|Treatment Period|Unstable persistent cancer pain|5|||
157196361|NCT00842829|567461487|FG000|Treatment Period|Withdrawal by Subject|0|||
157196362|NCT00842829|567461488|FG001|Treatment Period|Withdrawal by Subject|0|||
157196363|NCT00842829|567461489|FG002|Treatment Period|Withdrawal by Subject|11|||
157196364|NCT00842829|567461487|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
157196365|NCT00842829|567461488|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
157196366|NCT00842829|567461489|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
157196367|NCT00842829|567461487|FG000|Treatment Period|Protocol Violation|0|||
157196368|NCT00842829|567461488|FG001|Treatment Period|Protocol Violation|0|||
157196369|NCT00842829|567461489|FG002|Treatment Period|Protocol Violation|2|||
157196370|NCT00842829|567461487|FG000|Treatment Period|Other|0|||
157196371|NCT00842829|567461488|FG001|Treatment Period|Other|0|||
157196372|NCT00842829|567461489|FG002|Treatment Period|Other|18|||
157196373|NCT00842829|567461487|FG000|Treatment Period|Non-compliance to study procedures|0|||
157088142|NCT01879553|567074272|FG000|Overall Study|Withdrawal by Subject|1|||
157088143|NCT01879553|567074273|FG001|Overall Study|Withdrawal by Subject|0|||
157088144|NCT02217501|567074279|FG000|Overall Study|Death|3|||
157088145|NCT02217501|567074280|FG001|Overall Study|Death|4|||
157088146|NCT02019667|567074281|FG000|First Intervention (6 Months)|Adverse Event|0|||
157088147|NCT02019667|567074282|FG001|First Intervention (6 Months)|Adverse Event|1|||
157088148|NCT02019667|567074281|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
157088149|NCT02019667|567074282|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
157088150|NCT02019667|567074281|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
157088151|NCT02019667|567074282|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
157088152|NCT02432196|567074283|FG000|Overall Study|Exit - did not receive study device|1|||
157088153|NCT02432196|567074283|FG000|Overall Study|Death|2|||
157088154|NCT02432196|567074283|FG000|Overall Study|Reoperation|3|||
157088155|NCT01942785|567074288|FG000|Overall Study|Adverse Event|2|||
157088156|NCT01942785|567074288|FG000|Overall Study|Withdrawal by Subject|1|||
157088157|NCT01942785|567074288|FG000|Overall Study|Protocol Violation|1|||
157088158|NCT05038163|567074292|FG000|Stage 1|Did not complete survey|374|||
157088159|NCT05038163|567074293|FG001|Stage 1|Did not complete survey|0|||
157088160|NCT05038163|567074294|FG002|Stage 1|Did not complete survey|0|||
157088161|NCT05038163|567074295|FG003|Stage 1|Did not complete survey|0|||
157088162|NCT05038163|567074296|FG004|Stage 1|Did not complete survey|0|||
157088163|NCT05038163|567074297|FG005|Stage 1|Did not complete survey|0|||
157088164|NCT05038163|567074292|FG000|Stage 2|Did not complete Stage 2 survey|0|||
157088165|NCT05038163|567074293|FG001|Stage 2|Did not complete Stage 2 survey|29|||
157088166|NCT05038163|567074294|FG002|Stage 2|Did not complete Stage 2 survey|30|||
157088167|NCT05038163|567074295|FG003|Stage 2|Did not complete Stage 2 survey|24|||
157088168|NCT05038163|567074296|FG004|Stage 2|Did not complete Stage 2 survey|21|||
157088169|NCT05038163|567074297|FG005|Stage 2|Did not complete Stage 2 survey|100|||
157088170|NCT05453201|567074298|FG000|Overall Study|Withdrawal by Subject|1|||
157088171|NCT03562975|567074299|FG000|Overall Study|Death|1|||
157088172|NCT03562975|567074299|FG000|Overall Study|Lost to Follow-up|1|||
157088173|NCT03562975|567074299|FG000|Overall Study|Withdrawal by Subject|1|||
157088174|NCT01934790|567074300|FG000|Treatment|Adverse Event|3|||
157088175|NCT01934790|567074300|FG000|Treatment|Clinical progression|6|||
157088176|NCT01934790|567074300|FG000|Treatment|Radiological progression|4|||
157088177|NCT01934790|567074300|FG000|Treatment|Withdrawal by Subject|2|||
157088178|NCT01934790|567074300|FG000|Treatment|Study drug never administered|1|||
157088179|NCT01934790|567074300|FG000|Active Follow up|Death|20|||
157088180|NCT01934790|567074300|FG000|Active Follow up|Physician Decision|2|||
157088181|NCT01934790|567074300|FG000|Active Follow up|Progressive disease|1|||
157088182|NCT01934790|567074300|FG000|Active Follow up|Other reason|1|||
157088183|NCT00552929|567074303|FG000|Overall Study|Lost to Follow-up|0|||
157088184|NCT00552929|567074304|FG001|Overall Study|Lost to Follow-up|0|||
157088185|NCT00552929|567074305|FG002|Overall Study|Lost to Follow-up|0|||
157088186|NCT00552929|567074306|FG003|Overall Study|Lost to Follow-up|0|||
157088187|NCT00552929|567074307|FG004|Overall Study|Lost to Follow-up|0|||
157088188|NCT00552929|567074308|FG005|Overall Study|Lost to Follow-up|0|||
157088189|NCT00552929|567074309|FG006|Overall Study|Lost to Follow-up|0|||
157088190|NCT00552929|567074310|FG007|Overall Study|Lost to Follow-up|0|||
157088191|NCT00552929|567074311|FG008|Overall Study|Lost to Follow-up|1|||
157088192|NCT00552929|567074312|FG009|Overall Study|Lost to Follow-up|0|||
157088193|NCT00552929|567074303|FG000|Overall Study|Not Eligible|0|||
157088194|NCT00552929|567074304|FG001|Overall Study|Not Eligible|0|||
157088195|NCT00552929|567074305|FG002|Overall Study|Not Eligible|0|||
157088196|NCT00552929|567074306|FG003|Overall Study|Not Eligible|0|||
157088197|NCT00552929|567074307|FG004|Overall Study|Not Eligible|0|||
157088198|NCT00552929|567074308|FG005|Overall Study|Not Eligible|1|||
157088199|NCT00552929|567074309|FG006|Overall Study|Not Eligible|0|||
157088200|NCT00552929|567074310|FG007|Overall Study|Not Eligible|0|||
157088201|NCT00552929|567074311|FG008|Overall Study|Not Eligible|0|||
157088202|NCT00552929|567074312|FG009|Overall Study|Not Eligible|0|||
157088203|NCT01147536|567074313|FG000|Overall Study|Administrative study close|2|||
157088204|NCT01147536|567074313|FG000|Overall Study|Death|1|||
157088205|NCT00935818|567074314|FG000|Overall Study|Withdrawal by Subject|45|||
157088206|NCT00935818|567074315|FG001|Overall Study|Withdrawal by Subject|50|||
157088207|NCT00935818|567074314|FG000|Overall Study|Lost to Follow-up|40|||
157088208|NCT00935818|567074315|FG001|Overall Study|Lost to Follow-up|42|||
157088209|NCT00935818|567074314|FG000|Overall Study|Adverse Event|6|||
157196374|NCT00842829|567461488|FG001|Treatment Period|Non-compliance to study procedures|0|||
157196375|NCT00842829|567461489|FG002|Treatment Period|Non-compliance to study procedures|4|||
157196376|NCT00842829|567461487|FG000|Treatment Period|Unclear completion status|0|||
157196377|NCT00842829|567461488|FG001|Treatment Period|Unclear completion status|0|||
157196378|NCT00842829|567461489|FG002|Treatment Period|Unclear completion status|1|||
157196379|NCT00842829|567461487|FG000|Continuation Period|Adverse Event|0|||
157196380|NCT00842829|567461488|FG001|Continuation Period|Adverse Event|0|||
157196381|NCT00842829|567461489|FG002|Continuation Period|Adverse Event|32|||
157196382|NCT00842829|567461487|FG000|Continuation Period|Lack of Efficacy|0|||
157196383|NCT00842829|567461488|FG001|Continuation Period|Lack of Efficacy|0|||
157196384|NCT00842829|567461489|FG002|Continuation Period|Lack of Efficacy|6|||
157196385|NCT00842829|567461487|FG000|Continuation Period|Unstable persistent cancer pain|0|||
157196386|NCT00842829|567461488|FG001|Continuation Period|Unstable persistent cancer pain|0|||
157196387|NCT00842829|567461489|FG002|Continuation Period|Unstable persistent cancer pain|3|||
157196388|NCT00842829|567461487|FG000|Continuation Period|Withdrawal by Subject|0|||
157196389|NCT00842829|567461488|FG001|Continuation Period|Withdrawal by Subject|0|||
157196390|NCT00842829|567461489|FG002|Continuation Period|Withdrawal by Subject|10|||
157196391|NCT00842829|567461487|FG000|Continuation Period|Other|0|||
157196392|NCT00842829|567461488|FG001|Continuation Period|Other|0|||
157196393|NCT00842829|567461489|FG002|Continuation Period|Other|7|||
157196394|NCT00842829|567461487|FG000|Continuation Period|Non-compliance to study procedures|0|||
157196395|NCT00842829|567461488|FG001|Continuation Period|Non-compliance to study procedures|0|||
157196396|NCT00842829|567461489|FG002|Continuation Period|Non-compliance to study procedures|2|||
157196397|NCT00842829|567461487|FG000|Continuation Period|Non-compliance to study drug|0|||
157196398|NCT00842829|567461488|FG001|Continuation Period|Non-compliance to study drug|0|||
157196399|NCT00842829|567461489|FG002|Continuation Period|Non-compliance to study drug|1|||
157196400|NCT02612194|567461497|FG000|Overall Study|Death|5|||
157196401|NCT02612194|567461498|FG001|Overall Study|Death|0|||
157196402|NCT02612194|567461499|FG002|Overall Study|Death|2|||
157196403|NCT02612194|567461497|FG000|Overall Study|Early Study Termination|1|||
157196404|NCT02612194|567461498|FG001|Overall Study|Early Study Termination|0|||
157196405|NCT02612194|567461499|FG002|Overall Study|Early Study Termination|0|||
157196406|NCT02539160|567461500|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
157196407|NCT02539160|567461501|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
157196408|NCT02539160|567461502|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
157196409|NCT02539160|567461503|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
157196410|NCT02539160|567461500|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
157196411|NCT02539160|567461501|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
157196412|NCT02539160|567461502|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
157196413|NCT02539160|567461503|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
157196414|NCT02539160|567461500|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
157196415|NCT02539160|567461501|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
157088210|NCT00935818|567074315|FG001|Overall Study|Adverse Event|7|||
157088211|NCT00935818|567074314|FG000|Overall Study|Physician Decision|0|||
157088212|NCT00935818|567074315|FG001|Overall Study|Physician Decision|1|||
157088213|NCT02592876|567074318|FG000|Overall Study|Withdrawal by Subject|3|||
157196416|NCT02539160|567461502|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
157196417|NCT02539160|567461503|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
157196418|NCT01681004|567461504|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
157196419|NCT01681004|567461505|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
157196420|NCT01681004|567461504|FG000|Study Completion|Lost to Follow-up|8|||
157196421|NCT01681004|567461505|FG001|Study Completion|Lost to Follow-up|3|||
157196422|NCT01681004|567461504|FG000|Study Completion|Physician Decision|1|||
157088214|NCT02592876|567074319|FG001|Overall Study|Withdrawal by Subject|3|||
157088215|NCT02592876|567074318|FG000|Overall Study|Study Termination by Sponsor|32|||
157088216|NCT02592876|567074319|FG001|Overall Study|Study Termination by Sponsor|27|||
157088217|NCT02592876|567074318|FG000|Overall Study|Lost to Follow-up|0|||
157088218|NCT02592876|567074319|FG001|Overall Study|Lost to Follow-up|1|||
157088219|NCT02592876|567074318|FG000|Overall Study|Death|6|||
157088220|NCT02592876|567074319|FG001|Overall Study|Death|9|||
157088221|NCT00867308|567074320|FG000|Overall Study|Death|1|||
157088222|NCT00867308|567074321|FG001|Overall Study|Death|0|||
157088223|NCT00867308|567074320|FG000|Overall Study|Adverse Event|1|||
157088224|NCT00867308|567074321|FG001|Overall Study|Adverse Event|4|||
157088225|NCT00867308|567074320|FG000|Overall Study|Lack of Efficacy|6|||
157088226|NCT00867308|567074321|FG001|Overall Study|Lack of Efficacy|12|||
157088227|NCT00867308|567074320|FG000|Overall Study|Withdrawal by Subject|1|||
157088228|NCT00867308|567074321|FG001|Overall Study|Withdrawal by Subject|2|||
157088229|NCT00604825|567074322|FG000|Overall Study|Adverse Event|2|||
157088230|NCT00604825|567074323|FG001|Overall Study|Adverse Event|6|||
157088231|NCT00604825|567074324|FG002|Overall Study|Adverse Event|7|||
157088232|NCT00604825|567074325|FG003|Overall Study|Adverse Event|4|||
157088233|NCT00604825|567074322|FG000|Overall Study|Lost to Follow-up|0|||
157088234|NCT00604825|567074323|FG001|Overall Study|Lost to Follow-up|3|||
157088235|NCT00604825|567074324|FG002|Overall Study|Lost to Follow-up|1|||
157088236|NCT00604825|567074325|FG003|Overall Study|Lost to Follow-up|0|||
157088237|NCT00604825|567074322|FG000|Overall Study|Protocol Violation|0|||
157088238|NCT00604825|567074323|FG001|Overall Study|Protocol Violation|1|||
157088239|NCT00604825|567074324|FG002|Overall Study|Protocol Violation|0|||
157088240|NCT00604825|567074325|FG003|Overall Study|Protocol Violation|0|||
157088241|NCT00604825|567074322|FG000|Overall Study|Withdrawal by Subject|4|||
157088242|NCT00604825|567074323|FG001|Overall Study|Withdrawal by Subject|3|||
157088243|NCT00604825|567074324|FG002|Overall Study|Withdrawal by Subject|5|||
157088244|NCT00604825|567074325|FG003|Overall Study|Withdrawal by Subject|5|||
157236515|NCT00934050|567614301|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
157236516|NCT00934050|567614302|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
157236517|NCT03570749|567614305|FG000|Overall Study|Ongoing|26|||
157236518|NCT03570749|567614306|FG001|Overall Study|Ongoing|25|||
157236519|NCT03570749|567614307|FG002|Overall Study|Ongoing|25|||
157236520|NCT03570749|567614308|FG003|Overall Study|Ongoing|26|||
157236521|NCT03570749|567614309|FG004|Overall Study|Ongoing|140|||
157236522|NCT03570749|567614310|FG005|Overall Study|Ongoing|142|||
157236523|NCT03570749|567614311|FG006|Overall Study|Ongoing|220|||
157236524|NCT03570749|567614305|FG000|Overall Study|Adverse Event|0|||
157236525|NCT03570749|567614306|FG001|Overall Study|Adverse Event|0|||
157236526|NCT03570749|567614307|FG002|Overall Study|Adverse Event|0|||
157236527|NCT03570749|567614308|FG003|Overall Study|Adverse Event|0|||
157236528|NCT03570749|567614309|FG004|Overall Study|Adverse Event|2|||
157236529|NCT03570749|567614310|FG005|Overall Study|Adverse Event|3|||
157236530|NCT03570749|567614311|FG006|Overall Study|Adverse Event|6|||
157236531|NCT03570749|567614305|FG000|Overall Study|Lack of Efficacy|0|||
157236532|NCT03570749|567614306|FG001|Overall Study|Lack of Efficacy|0|||
157236533|NCT03570749|567614307|FG002|Overall Study|Lack of Efficacy|0|||
157236534|NCT03570749|567614308|FG003|Overall Study|Lack of Efficacy|0|||
157236535|NCT03570749|567614309|FG004|Overall Study|Lack of Efficacy|8|||
157236536|NCT03570749|567614310|FG005|Overall Study|Lack of Efficacy|2|||
157236537|NCT03570749|567614311|FG006|Overall Study|Lack of Efficacy|7|||
157236538|NCT03570749|567614305|FG000|Overall Study|Lost to Follow-up|0|||
157236539|NCT03570749|567614306|FG001|Overall Study|Lost to Follow-up|0|||
157236540|NCT03570749|567614307|FG002|Overall Study|Lost to Follow-up|0|||
157236541|NCT03570749|567614308|FG003|Overall Study|Lost to Follow-up|0|||
157236542|NCT03570749|567614309|FG004|Overall Study|Lost to Follow-up|5|||
157236543|NCT03570749|567614310|FG005|Overall Study|Lost to Follow-up|10|||
157236544|NCT03570749|567614311|FG006|Overall Study|Lost to Follow-up|10|||
157236545|NCT03570749|567614305|FG000|Overall Study|Pregnancy|0|||
157236546|NCT03570749|567614306|FG001|Overall Study|Pregnancy|0|||
157236547|NCT03570749|567614307|FG002|Overall Study|Pregnancy|0|||
157236548|NCT03570749|567614308|FG003|Overall Study|Pregnancy|0|||
157088245|NCT00604825|567074322|FG000|Overall Study|Lack of Efficacy|3|||
157088246|NCT00604825|567074323|FG001|Overall Study|Lack of Efficacy|2|||
157088247|NCT00604825|567074324|FG002|Overall Study|Lack of Efficacy|1|||
157088248|NCT00604825|567074325|FG003|Overall Study|Lack of Efficacy|0|||
157088249|NCT00604825|567074322|FG000|Overall Study|Did not meet eligibility criteria|0|||
157088250|NCT00604825|567074323|FG001|Overall Study|Did not meet eligibility criteria|0|||
157088251|NCT00604825|567074324|FG002|Overall Study|Did not meet eligibility criteria|2|||
157088252|NCT00604825|567074325|FG003|Overall Study|Did not meet eligibility criteria|0|||
157088253|NCT00604825|567074322|FG000|Overall Study|Physician Decision|0|||
157088254|NCT00604825|567074323|FG001|Overall Study|Physician Decision|0|||
157088255|NCT00604825|567074324|FG002|Overall Study|Physician Decision|0|||
157236549|NCT03570749|567614309|FG004|Overall Study|Pregnancy|0|||
157236550|NCT03570749|567614310|FG005|Overall Study|Pregnancy|1|||
157236551|NCT03570749|567614311|FG006|Overall Study|Pregnancy|1|||
157236552|NCT03570749|567614305|FG000|Overall Study|Screen Fail|0|||
157236553|NCT03570749|567614306|FG001|Overall Study|Screen Fail|0|||
157236554|NCT03570749|567614307|FG002|Overall Study|Screen Fail|0|||
157236555|NCT03570749|567614308|FG003|Overall Study|Screen Fail|0|||
157236556|NCT03570749|567614309|FG004|Overall Study|Screen Fail|0|||
157236557|NCT03570749|567614310|FG005|Overall Study|Screen Fail|0|||
157236558|NCT03570749|567614311|FG006|Overall Study|Screen Fail|1|||
157236559|NCT03570749|567614305|FG000|Overall Study|Withdrawal by Subject|2|||
157236560|NCT03570749|567614306|FG001|Overall Study|Withdrawal by Subject|3|||
157236561|NCT03570749|567614307|FG002|Overall Study|Withdrawal by Subject|2|||
157236562|NCT03570749|567614308|FG003|Overall Study|Withdrawal by Subject|1|||
157236563|NCT03570749|567614309|FG004|Overall Study|Withdrawal by Subject|17|||
157236564|NCT03570749|567614310|FG005|Overall Study|Withdrawal by Subject|12|||
157236565|NCT03570749|567614311|FG006|Overall Study|Withdrawal by Subject|15|||
157236566|NCT03570749|567614305|FG000|Overall Study|Other|0|||
157236567|NCT03570749|567614306|FG001|Overall Study|Other|0|||
157236568|NCT03570749|567614307|FG002|Overall Study|Other|0|||
157236569|NCT03570749|567614308|FG003|Overall Study|Other|0|||
157236570|NCT03570749|567614309|FG004|Overall Study|Other|17|||
157236571|NCT03570749|567614310|FG005|Overall Study|Other|14|||
157236572|NCT03570749|567614311|FG006|Overall Study|Other|21|||
157236573|NCT01796171|567614314|FG000|Enrolled|Death|0|||
157236574|NCT01796171|567614315|FG001|Enrolled|Death|0|||
157236575|NCT01796171|567614316|FG002|Enrolled|Death|0|||
157236576|NCT01796171|567614317|FG003|Enrolled|Death|0|||
157236577|NCT01796171|567614318|FG004|Enrolled|Death|0|||
157236578|NCT01796171|567614319|FG005|Enrolled|Death|0|||
157236579|NCT01796171|567614320|FG006|Enrolled|Death|0|||
157236580|NCT01796171|567614321|FG007|Enrolled|Death|0|||
157236581|NCT01796171|567614322|FG008|Enrolled|Death|0|||
157236582|NCT01796171|567614323|FG009|Enrolled|Death|0|||
157236583|NCT01796171|567614324|FG010|Enrolled|Death|0|||
157236584|NCT01796171|567614325|FG011|Enrolled|Death|0|||
157236585|NCT01796171|567614326|FG012|Enrolled|Death|0|||
157236586|NCT01796171|567614327|FG013|Enrolled|Death|0|||
157236587|NCT01796171|567614328|FG014|Enrolled|Death|1|||
157236588|NCT01796171|567614314|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
157236589|NCT01796171|567614315|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
157236590|NCT01796171|567614316|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
157236591|NCT01796171|567614317|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
157236592|NCT01796171|567614318|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
157236593|NCT01796171|567614319|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
157236594|NCT01796171|567614320|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
157236595|NCT01796171|567614321|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
157236596|NCT01796171|567614322|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
157236597|NCT01796171|567614323|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
157236598|NCT01796171|567614324|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
157236599|NCT01796171|567614325|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
157236600|NCT01796171|567614326|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
157236601|NCT01796171|567614327|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
157236602|NCT01796171|567614328|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
157236603|NCT01796171|567614314|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236604|NCT01796171|567614315|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236605|NCT01796171|567614316|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236606|NCT01796171|567614317|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236607|NCT01796171|567614318|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236608|NCT01796171|567614319|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236609|NCT01796171|567614320|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236610|NCT01796171|567614321|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236611|NCT01796171|567614322|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236612|NCT01796171|567614323|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236613|NCT01796171|567614324|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236614|NCT01796171|567614325|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236615|NCT01796171|567614326|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236616|NCT01796171|567614327|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
157236617|NCT01796171|567614328|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
157236618|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Progressive disease|0|||
157236619|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Progressive disease|1|||
157236620|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Progressive disease|0|||
157236621|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Progressive disease|0|||
157236622|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Progressive disease|0|||
157236623|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Progressive disease|0|||
157236624|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Progressive disease|0|||
157236625|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Progressive disease|0|||
157236626|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Progressive disease|0|||
157236627|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Progressive disease|0|||
157236628|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Progressive disease|0|||
157236629|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Progressive disease|0|||
157236630|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Progressive disease|0|||
157236631|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Progressive disease|0|||
157236632|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Progressive disease|0|||
157236633|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236634|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236635|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236636|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236637|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236638|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236639|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236640|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236641|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
157236642|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236643|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
157236644|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
157236645|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236646|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236647|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
157236648|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Physician Decision|0|||
157236649|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Physician Decision|0|||
157236650|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Physician Decision|0|||
157236651|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Physician Decision|0|||
157236652|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Physician Decision|0|||
157236653|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Physician Decision|0|||
157236654|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Physician Decision|0|||
157236655|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Physician Decision|0|||
157236656|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Physician Decision|0|||
157236657|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Physician Decision|0|||
157236658|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Physician Decision|5|||
157088256|NCT00604825|567074325|FG003|Overall Study|Physician Decision|1|||
157088257|NCT00604825|567074322|FG000|Overall Study|Exclusion criterion met|0|||
157088258|NCT00604825|567074323|FG001|Overall Study|Exclusion criterion met|0|||
157088259|NCT00604825|567074324|FG002|Overall Study|Exclusion criterion met|0|||
157088260|NCT00604825|567074325|FG003|Overall Study|Exclusion criterion met|1|||
157088261|NCT03465904|567074326|FG000|Overall Study|Withdrawal by Subject|9|||
157088262|NCT03465904|567074327|FG001|Overall Study|Withdrawal by Subject|5|||
157088263|NCT03465904|567074326|FG000|Overall Study|Lost to Follow-up|11|||
157088264|NCT03465904|567074327|FG001|Overall Study|Lost to Follow-up|9|||
157088265|NCT03465904|567074326|FG000|Overall Study|Protocol Violation|20|||
157236659|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Physician Decision|1|||
157236660|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Physician Decision|1|||
157236661|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Physician Decision|0|||
157236662|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Physician Decision|0|||
157236663|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Death|0|||
157236664|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Death|0|||
157236665|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Death|0|||
157236666|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Death|0|||
157236667|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Death|0|||
157236668|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Death|0|||
157088266|NCT03465904|567074327|FG001|Overall Study|Protocol Violation|15|||
157088267|NCT01305200|567074328|FG000|Overall Study|Physician Decision|4|||
157088268|NCT01305200|567074329|FG001|Overall Study|Physician Decision|6|||
157088269|NCT01305200|567074330|FG002|Overall Study|Physician Decision|1|||
157088270|NCT01305200|567074328|FG000|Overall Study|Withdrawal by Subject|24|||
157088271|NCT01305200|567074329|FG001|Overall Study|Withdrawal by Subject|21|||
157088272|NCT01305200|567074330|FG002|Overall Study|Withdrawal by Subject|1|||
157088273|NCT01305200|567074328|FG000|Overall Study|Ineligible|1|||
157088274|NCT01305200|567074329|FG001|Overall Study|Ineligible|2|||
157088275|NCT01305200|567074330|FG002|Overall Study|Ineligible|1|||
157088276|NCT01305200|567074328|FG000|Overall Study|Death|0|||
157088277|NCT01305200|567074329|FG001|Overall Study|Death|2|||
157088278|NCT01305200|567074330|FG002|Overall Study|Death|0|||
157088279|NCT00925353|567074331|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
157088280|NCT03647488|567076290|FG000|Overall Study|Progressive disease|10|||
157088281|NCT03647488|567076291|FG001|Overall Study|Progressive disease|0|||
157088282|NCT03647488|567076292|FG002|Overall Study|Progressive disease|0|||
157088283|NCT03647488|567076290|FG000|Overall Study|Adverse Event|5|||
157088284|NCT03647488|567076291|FG001|Overall Study|Adverse Event|0|||
157088285|NCT03647488|567076292|FG002|Overall Study|Adverse Event|0|||
157088286|NCT03647488|567076290|FG000|Overall Study|Clinical progression|2|||
157088287|NCT03647488|567076291|FG001|Overall Study|Clinical progression|0|||
157088288|NCT03647488|567076292|FG002|Overall Study|Clinical progression|0|||
157088289|NCT03647488|567076290|FG000|Overall Study|Participant refused to take investigational product|1|||
157088290|NCT03647488|567076291|FG001|Overall Study|Participant refused to take investigational product|0|||
157088291|NCT03647488|567076292|FG002|Overall Study|Participant refused to take investigational product|0|||
157088292|NCT00812331|567076293|FG000|Overall Study|Adverse Event|1|||
157088293|NCT00812331|567076294|FG001|Overall Study|Adverse Event|0|||
157088294|NCT00812331|567076295|FG002|Overall Study|Adverse Event|0|||
157088295|NCT00812331|567076296|FG003|Overall Study|Adverse Event|0|||
157088296|NCT00812331|567076297|FG004|Overall Study|Adverse Event|0|||
157088297|NCT02502799|567076298|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
157088298|NCT02502799|567076299|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
157088299|NCT02502799|567076300|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
157088300|NCT02502799|567076301|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
157088301|NCT02502799|567076298|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
157088302|NCT02502799|567076299|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
157088303|NCT02502799|567076300|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
157088304|NCT02502799|567076301|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
157088305|NCT02502799|567076298|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
157088306|NCT02502799|567076299|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
157088307|NCT02502799|567076300|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
157088308|NCT02502799|567076301|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
157088309|NCT02502799|567076298|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
157088310|NCT02502799|567076299|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
157088311|NCT02502799|567076300|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
157088312|NCT02502799|567076301|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
157088313|NCT02502799|567076298|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
157088314|NCT02502799|567076299|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
157088315|NCT02502799|567076300|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
157088316|NCT02502799|567076301|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
157236669|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Death|0|||
157236670|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Death|0|||
157236671|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Death|0|||
157236672|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Death|0|||
157236673|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Death|2|||
157236674|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Death|0|||
157088317|NCT00153062|567076307|FG000|Overall Study|Death|360|||
157088318|NCT00153062|567076308|FG001|Overall Study|Death|352|||
157088319|NCT00153062|567076309|FG002|Overall Study|Death|369|||
157088320|NCT00153062|567076310|FG003|Overall Study|Death|365|||
157088321|NCT00153062|567076307|FG000|Overall Study|Withdrawal by Subject|14|||
157088322|NCT00153062|567076308|FG001|Overall Study|Withdrawal by Subject|30|||
157088323|NCT00153062|567076309|FG002|Overall Study|Withdrawal by Subject|27|||
157088324|NCT00153062|567076310|FG003|Overall Study|Withdrawal by Subject|28|||
157088325|NCT00153062|567076307|FG000|Overall Study|Lost to Follow-up|12|||
157088326|NCT00153062|567076308|FG001|Overall Study|Lost to Follow-up|20|||
157088327|NCT00153062|567076309|FG002|Overall Study|Lost to Follow-up|15|||
157088328|NCT00153062|567076310|FG003|Overall Study|Lost to Follow-up|16|||
157088329|NCT00153062|567076307|FG000|Overall Study|Adverse Event|0|||
157088330|NCT00153062|567076308|FG001|Overall Study|Adverse Event|1|||
157088331|NCT00153062|567076309|FG002|Overall Study|Adverse Event|1|||
157088332|NCT00153062|567076310|FG003|Overall Study|Adverse Event|0|||
157088333|NCT00153062|567076307|FG000|Overall Study|Protocol Violation|0|||
157088334|NCT00153062|567076308|FG001|Overall Study|Protocol Violation|2|||
157088335|NCT00153062|567076309|FG002|Overall Study|Protocol Violation|1|||
157088336|NCT00153062|567076310|FG003|Overall Study|Protocol Violation|1|||
157088337|NCT00153062|567076307|FG000|Overall Study|No disposition data available|1|||
157088338|NCT00153062|567076308|FG001|Overall Study|No disposition data available|1|||
157088339|NCT00153062|567076309|FG002|Overall Study|No disposition data available|1|||
157088340|NCT00153062|567076310|FG003|Overall Study|No disposition data available|1|||
157088341|NCT00153062|567076307|FG000|Overall Study|Other|0|||
157088342|NCT00153062|567076308|FG001|Overall Study|Other|0|||
157088343|NCT00153062|567076309|FG002|Overall Study|Other|1|||
157088344|NCT00153062|567076310|FG003|Overall Study|Other|0|||
157088345|NCT01589237|567076313|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
157088346|NCT01589237|567076314|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
157236675|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Death|0|||
157088347|NCT01589237|567076315|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
157088348|NCT01589237|567076316|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
157088349|NCT01589237|567076313|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
157088350|NCT01589237|567076314|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
157088351|NCT01589237|567076315|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
157236676|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Death|0|||
157236677|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Death|0|||
157236678|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
157088352|NCT01589237|567076316|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
157088353|NCT01589237|567076313|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
157088354|NCT01589237|567076314|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
157088355|NCT01589237|567076315|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
157088356|NCT01589237|567076316|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
157088357|NCT01589237|567076313|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
157088358|NCT01589237|567076314|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
157088359|NCT01589237|567076315|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
157088360|NCT01589237|567076316|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
157088361|NCT00117845|567076317|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
157088362|NCT00616902|567076318|FG000|Overall Study|Termination of study|6|||
157088363|NCT00616902|567076319|FG001|Overall Study|Termination of study|6|||
157088364|NCT03207009|567076320|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
157088365|NCT02924428|567076321|FG000|Overall Study|Adverse Event|1|||
157088366|NCT02924428|567076322|FG001|Overall Study|Adverse Event|0|||
157088367|NCT02924428|567076321|FG000|Overall Study|Physician Decision|1|||
157088368|NCT02924428|567076322|FG001|Overall Study|Physician Decision|0|||
157088369|NCT02924428|567076321|FG000|Overall Study|Lost to Follow-up|2|||
157088370|NCT02924428|567076322|FG001|Overall Study|Lost to Follow-up|4|||
157196423|NCT01681004|567461505|FG001|Study Completion|Physician Decision|3|||
157196424|NCT01681004|567461504|FG000|Study Completion|Site Termination|2|||
157196425|NCT01681004|567461505|FG001|Study Completion|Site Termination|1|||
157196426|NCT01681004|567461504|FG000|Study Completion|Death|1|||
157196427|NCT01681004|567461505|FG001|Study Completion|Death|1|||
157196428|NCT00372905|567461506|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
157196429|NCT00372905|567461507|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
157196430|NCT00372905|567461508|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
157196431|NCT00372905|567461509|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
157196432|NCT00372905|567461506|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
157196433|NCT00372905|567461507|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
157196434|NCT00372905|567461508|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
157196435|NCT00372905|567461509|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
157196436|NCT00372905|567461506|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
157196437|NCT00372905|567461507|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
157196438|NCT00372905|567461508|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
157196439|NCT00372905|567461509|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
157196440|NCT00372905|567461506|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
157196441|NCT00372905|567461507|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
157196442|NCT00372905|567461508|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
157196443|NCT00372905|567461509|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
157196444|NCT00372905|567461506|FG000|Follow up Until Relapse or Progression|Study closed|0|||
157196445|NCT00372905|567461507|FG001|Follow up Until Relapse or Progression|Study closed|0|||
157196446|NCT00372905|567461508|FG002|Follow up Until Relapse or Progression|Study closed|0|||
157196447|NCT00372905|567461509|FG003|Follow up Until Relapse or Progression|Study closed|3|||
157196448|NCT00372905|567461506|FG000|Follow up Until Relapse or Progression|Other|0|||
157196449|NCT00372905|567461507|FG001|Follow up Until Relapse or Progression|Other|1|||
157196450|NCT00372905|567461508|FG002|Follow up Until Relapse or Progression|Other|0|||
157196451|NCT00372905|567461509|FG003|Follow up Until Relapse or Progression|Other|0|||
157196452|NCT01728454|567461510|FG000|Stage 1 and 2|Pregnancy|1|||
157196453|NCT01728454|567461511|FG001|Stage 1 and 2|Pregnancy|0|||
157196454|NCT01728454|567461512|FG002|Stage 1 and 2|Pregnancy|0|||
157196455|NCT01728454|567461510|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
157196456|NCT01728454|567461511|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
157196457|NCT01728454|567461512|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
157196458|NCT01728454|567461510|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
157196459|NCT01728454|567461511|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
157196460|NCT01728454|567461512|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
157196461|NCT01728454|567461510|FG000|Stage 1 and 2|Lost to Follow-up|1|||
157196462|NCT01728454|567461511|FG001|Stage 1 and 2|Lost to Follow-up|1|||
157196463|NCT01728454|567461512|FG002|Stage 1 and 2|Lost to Follow-up|0|||
157196464|NCT01728454|567461510|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
157196465|NCT01728454|567461511|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
157196466|NCT01728454|567461512|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
157196467|NCT01728454|567461510|FG000|Stage 3|Reason Missing|0|||
157196468|NCT01728454|567461511|FG001|Stage 3|Reason Missing|0|||
157196469|NCT01728454|567461512|FG002|Stage 3|Reason Missing|1|||
157196470|NCT01728454|567461510|FG000|Stage 3|Subject Required Other Treatment|0|||
157196471|NCT01728454|567461511|FG001|Stage 3|Subject Required Other Treatment|1|||
157196472|NCT01728454|567461512|FG002|Stage 3|Subject Required Other Treatment|0|||
157196473|NCT01728454|567461510|FG000|Stage 3|Pregnancy|1|||
157196474|NCT01728454|567461511|FG001|Stage 3|Pregnancy|0|||
157196475|NCT01728454|567461512|FG002|Stage 3|Pregnancy|0|||
157236679|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
157236680|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
157236681|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
157236682|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
157088371|NCT02924428|567076321|FG000|Overall Study|Pregnancy|0|||
157088372|NCT02924428|567076322|FG001|Overall Study|Pregnancy|1|||
157088373|NCT01877837|567076323|FG000|Overall Study|Lost to Follow-up|1|||
157088374|NCT01877837|567076323|FG000|Overall Study|Ineligible|4|||
157088375|NCT00645801|567076324|FG000|Overall Study|unclear if patient took all the medication.|1|||
157088376|NCT00645801|567076325|FG001|Overall Study|unclear if patient took all the medication.|0|||
157088377|NCT00645801|567076324|FG000|Overall Study|Lost to Follow-up|19|||
157088378|NCT00645801|567076325|FG001|Overall Study|Lost to Follow-up|15|||
157088379|NCT00759915|567076326|FG000|Overall Study|Withdrawal by Subject|1|||
157088380|NCT00759915|567076327|FG001|Overall Study|Withdrawal by Subject|0|||
157236683|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
157236684|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
157236685|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
157236686|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
157236687|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
157236688|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
157236689|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
157236690|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
157236691|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
157236692|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
157236693|NCT01796171|567614314|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236694|NCT01796171|567614315|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236695|NCT01796171|567614316|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236696|NCT01796171|567614317|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236697|NCT01796171|567614318|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236698|NCT01796171|567614319|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236699|NCT01796171|567614320|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236700|NCT01796171|567614321|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236701|NCT01796171|567614322|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236702|NCT01796171|567614323|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236703|NCT01796171|567614324|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
157236704|NCT01796171|567614325|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
157236705|NCT01796171|567614326|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236706|NCT01796171|567614327|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236707|NCT01796171|567614328|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
157236708|NCT01796171|567614314|FG000|Follow-up Period|Start of further anticancer therapy|4|||
157236709|NCT01796171|567614315|FG001|Follow-up Period|Start of further anticancer therapy|25|||
157236710|NCT01796171|567614316|FG002|Follow-up Period|Start of further anticancer therapy|2|||
157236711|NCT01796171|567614317|FG003|Follow-up Period|Start of further anticancer therapy|1|||
157236712|NCT01796171|567614318|FG004|Follow-up Period|Start of further anticancer therapy|2|||
157236713|NCT01796171|567614319|FG005|Follow-up Period|Start of further anticancer therapy|2|||
157236714|NCT01796171|567614320|FG006|Follow-up Period|Start of further anticancer therapy|1|||
157236715|NCT01796171|567614321|FG007|Follow-up Period|Start of further anticancer therapy|15|||
157236716|NCT01796171|567614322|FG008|Follow-up Period|Start of further anticancer therapy|2|||
157236717|NCT01796171|567614323|FG009|Follow-up Period|Start of further anticancer therapy|0|||
157236718|NCT01796171|567614324|FG010|Follow-up Period|Start of further anticancer therapy|0|||
157236719|NCT01796171|567614325|FG011|Follow-up Period|Start of further anticancer therapy|0|||
157236720|NCT01796171|567614326|FG012|Follow-up Period|Start of further anticancer therapy|0|||
157236721|NCT01796171|567614327|FG013|Follow-up Period|Start of further anticancer therapy|0|||
157236722|NCT01796171|567614328|FG014|Follow-up Period|Start of further anticancer therapy|0|||
157236723|NCT01796171|567614314|FG000|Follow-up Period|Progressive disease|0|||
157236724|NCT01796171|567614315|FG001|Follow-up Period|Progressive disease|1|||
157236725|NCT01796171|567614316|FG002|Follow-up Period|Progressive disease|0|||
157236726|NCT01796171|567614317|FG003|Follow-up Period|Progressive disease|0|||
157236727|NCT01796171|567614318|FG004|Follow-up Period|Progressive disease|0|||
157236728|NCT01796171|567614319|FG005|Follow-up Period|Progressive disease|0|||
157236729|NCT01796171|567614320|FG006|Follow-up Period|Progressive disease|0|||
157236730|NCT01796171|567614321|FG007|Follow-up Period|Progressive disease|3|||
157088381|NCT00759915|567076326|FG000|Overall Study|Adverse Event|0|||
157088382|NCT00759915|567076327|FG001|Overall Study|Adverse Event|1|||
157088383|NCT01773291|567076328|FG000|Overall Study|Protocol Violation|1|||
157088384|NCT01773291|567076329|FG001|Overall Study|Protocol Violation|0|||
157088385|NCT01773291|567076330|FG002|Overall Study|Protocol Violation|0|||
157088386|NCT01773291|567076328|FG000|Overall Study|Withdrawal by Subject|0|||
157088387|NCT01773291|567076329|FG001|Overall Study|Withdrawal by Subject|0|||
157088388|NCT01773291|567076330|FG002|Overall Study|Withdrawal by Subject|1|||
157236731|NCT01796171|567614322|FG008|Follow-up Period|Progressive disease|0|||
157236732|NCT01796171|567614323|FG009|Follow-up Period|Progressive disease|0|||
157236733|NCT01796171|567614324|FG010|Follow-up Period|Progressive disease|0|||
157236734|NCT01796171|567614325|FG011|Follow-up Period|Progressive disease|0|||
157236735|NCT01796171|567614326|FG012|Follow-up Period|Progressive disease|0|||
157236736|NCT01796171|567614327|FG013|Follow-up Period|Progressive disease|0|||
157236737|NCT01796171|567614328|FG014|Follow-up Period|Progressive disease|0|||
157236738|NCT01796171|567614314|FG000|Follow-up Period|Physician Decision|0|||
157236739|NCT01796171|567614315|FG001|Follow-up Period|Physician Decision|2|||
157236740|NCT01796171|567614316|FG002|Follow-up Period|Physician Decision|0|||
157236741|NCT01796171|567614317|FG003|Follow-up Period|Physician Decision|0|||
157236742|NCT01796171|567614318|FG004|Follow-up Period|Physician Decision|0|||
157236743|NCT01796171|567614319|FG005|Follow-up Period|Physician Decision|0|||
157236744|NCT01796171|567614320|FG006|Follow-up Period|Physician Decision|0|||
157236745|NCT01796171|567614321|FG007|Follow-up Period|Physician Decision|0|||
157236746|NCT01796171|567614322|FG008|Follow-up Period|Physician Decision|0|||
157236747|NCT01796171|567614323|FG009|Follow-up Period|Physician Decision|0|||
157236748|NCT01796171|567614324|FG010|Follow-up Period|Physician Decision|5|||
157236749|NCT01796171|567614325|FG011|Follow-up Period|Physician Decision|0|||
157236750|NCT01796171|567614326|FG012|Follow-up Period|Physician Decision|0|||
157236751|NCT01796171|567614327|FG013|Follow-up Period|Physician Decision|0|||
157236752|NCT01796171|567614328|FG014|Follow-up Period|Physician Decision|0|||
157236753|NCT01796171|567614314|FG000|Follow-up Period|Withdrawal by Subject|0|||
157236754|NCT01796171|567614315|FG001|Follow-up Period|Withdrawal by Subject|1|||
157236755|NCT01796171|567614316|FG002|Follow-up Period|Withdrawal by Subject|0|||
157236756|NCT01796171|567614317|FG003|Follow-up Period|Withdrawal by Subject|0|||
157236757|NCT01796171|567614318|FG004|Follow-up Period|Withdrawal by Subject|0|||
157236758|NCT01796171|567614319|FG005|Follow-up Period|Withdrawal by Subject|1|||
157236759|NCT01796171|567614320|FG006|Follow-up Period|Withdrawal by Subject|0|||
157236760|NCT01796171|567614321|FG007|Follow-up Period|Withdrawal by Subject|0|||
157236761|NCT01796171|567614322|FG008|Follow-up Period|Withdrawal by Subject|0|||
157236762|NCT01796171|567614323|FG009|Follow-up Period|Withdrawal by Subject|0|||
157236763|NCT01796171|567614324|FG010|Follow-up Period|Withdrawal by Subject|3|||
157236764|NCT01796171|567614325|FG011|Follow-up Period|Withdrawal by Subject|1|||
157236765|NCT01796171|567614326|FG012|Follow-up Period|Withdrawal by Subject|0|||
157236766|NCT01796171|567614327|FG013|Follow-up Period|Withdrawal by Subject|0|||
157236767|NCT01796171|567614328|FG014|Follow-up Period|Withdrawal by Subject|0|||
157236768|NCT01796171|567614314|FG000|Follow-up Period|Death|0|||
157236769|NCT01796171|567614315|FG001|Follow-up Period|Death|0|||
157236770|NCT01796171|567614316|FG002|Follow-up Period|Death|0|||
157236771|NCT01796171|567614317|FG003|Follow-up Period|Death|0|||
157236772|NCT01796171|567614318|FG004|Follow-up Period|Death|0|||
157236773|NCT01796171|567614319|FG005|Follow-up Period|Death|0|||
157236774|NCT01796171|567614320|FG006|Follow-up Period|Death|1|||
157236775|NCT01796171|567614321|FG007|Follow-up Period|Death|0|||
157236776|NCT01796171|567614322|FG008|Follow-up Period|Death|0|||
157236777|NCT01796171|567614323|FG009|Follow-up Period|Death|0|||
157236778|NCT01796171|567614324|FG010|Follow-up Period|Death|17|||
157236779|NCT01796171|567614325|FG011|Follow-up Period|Death|9|||
157236780|NCT01796171|567614326|FG012|Follow-up Period|Death|1|||
157236781|NCT01796171|567614327|FG013|Follow-up Period|Death|0|||
157236782|NCT01796171|567614328|FG014|Follow-up Period|Death|0|||
157236783|NCT01796171|567614314|FG000|Follow-up Period|Patient transferred to other hospital|0|||
157236784|NCT01796171|567614315|FG001|Follow-up Period|Patient transferred to other hospital|1|||
157236785|NCT01796171|567614316|FG002|Follow-up Period|Patient transferred to other hospital|0|||
157236786|NCT01796171|567614317|FG003|Follow-up Period|Patient transferred to other hospital|0|||
157236787|NCT01796171|567614318|FG004|Follow-up Period|Patient transferred to other hospital|0|||
157236788|NCT01796171|567614319|FG005|Follow-up Period|Patient transferred to other hospital|0|||
157236789|NCT01796171|567614320|FG006|Follow-up Period|Patient transferred to other hospital|0|||
157236790|NCT01796171|567614321|FG007|Follow-up Period|Patient transferred to other hospital|0|||
157236791|NCT01796171|567614322|FG008|Follow-up Period|Patient transferred to other hospital|0|||
157236792|NCT01796171|567614323|FG009|Follow-up Period|Patient transferred to other hospital|0|||
157236793|NCT01796171|567614324|FG010|Follow-up Period|Patient transferred to other hospital|0|||
157236794|NCT01796171|567614325|FG011|Follow-up Period|Patient transferred to other hospital|0|||
157236795|NCT01796171|567614326|FG012|Follow-up Period|Patient transferred to other hospital|0|||
157236796|NCT01796171|567614327|FG013|Follow-up Period|Patient transferred to other hospital|0|||
157236797|NCT01796171|567614328|FG014|Follow-up Period|Patient transferred to other hospital|0|||
157236798|NCT01796171|567614314|FG000|Follow-up Period|Sponsor Decision|0|||
157236799|NCT01796171|567614315|FG001|Follow-up Period|Sponsor Decision|0|||
157236800|NCT01796171|567614316|FG002|Follow-up Period|Sponsor Decision|0|||
157236801|NCT01796171|567614317|FG003|Follow-up Period|Sponsor Decision|0|||
157236802|NCT01796171|567614318|FG004|Follow-up Period|Sponsor Decision|0|||
157236803|NCT01796171|567614319|FG005|Follow-up Period|Sponsor Decision|0|||
157236804|NCT01796171|567614320|FG006|Follow-up Period|Sponsor Decision|0|||
157236805|NCT01796171|567614321|FG007|Follow-up Period|Sponsor Decision|0|||
157236806|NCT01796171|567614322|FG008|Follow-up Period|Sponsor Decision|0|||
157236807|NCT01796171|567614323|FG009|Follow-up Period|Sponsor Decision|0|||
157236808|NCT01796171|567614324|FG010|Follow-up Period|Sponsor Decision|40|||
157236809|NCT01796171|567614325|FG011|Follow-up Period|Sponsor Decision|15|||
157236810|NCT01796171|567614326|FG012|Follow-up Period|Sponsor Decision|7|||
157236811|NCT01796171|567614327|FG013|Follow-up Period|Sponsor Decision|0|||
157236812|NCT01796171|567614328|FG014|Follow-up Period|Sponsor Decision|0|||
157236813|NCT00418561|567614329|FG000|Overall Study|Participant's (guardian's) decision|0|||
157236814|NCT00418561|567614330|FG001|Overall Study|Participant's (guardian's) decision|1|||
157236815|NCT00418561|567614331|FG002|Overall Study|Participant's (guardian's) decision|0|||
157236816|NCT00829309|567614332|FG000|Washout: 7 Days|Protocol Violation|1|||
157236817|NCT00829309|567614333|FG001|Washout: 7 Days|Protocol Violation|0|||
157236818|NCT01083693|567614336|FG000|Overall Study|Adverse Event|1|||
157236819|NCT01083693|567614337|FG001|Overall Study|Adverse Event|1|||
157236820|NCT01083693|567614338|FG002|Overall Study|Adverse Event|0|||
157236821|NCT01083693|567614336|FG000|Overall Study|Lost to Follow-up|2|||
157236822|NCT01083693|567614337|FG001|Overall Study|Lost to Follow-up|0|||
157236823|NCT01083693|567614338|FG002|Overall Study|Lost to Follow-up|2|||
157236824|NCT01083693|567614336|FG000|Overall Study|Lack of effectiveness|13|||
157236825|NCT01083693|567614337|FG001|Overall Study|Lack of effectiveness|2|||
157236826|NCT01083693|567614338|FG002|Overall Study|Lack of effectiveness|2|||
157236827|NCT01083693|567614336|FG000|Overall Study|Patient Moved|0|||
157236828|NCT01083693|567614337|FG001|Overall Study|Patient Moved|1|||
157236829|NCT01083693|567614338|FG002|Overall Study|Patient Moved|0|||
157236830|NCT01083693|567614336|FG000|Overall Study|Complete remission|0|||
157236831|NCT01083693|567614337|FG001|Overall Study|Complete remission|1|||
157236832|NCT01083693|567614338|FG002|Overall Study|Complete remission|0|||
157236833|NCT01083693|567614336|FG000|Overall Study|Other medical condition/surgery|1|||
157236834|NCT01083693|567614337|FG001|Overall Study|Other medical condition/surgery|1|||
157236835|NCT01083693|567614338|FG002|Overall Study|Other medical condition/surgery|0|||
157236836|NCT01083693|567614336|FG000|Overall Study|Withdrawal by Subject|3|||
157236837|NCT01083693|567614337|FG001|Overall Study|Withdrawal by Subject|0|||
157236838|NCT01083693|567614338|FG002|Overall Study|Withdrawal by Subject|2|||
157236839|NCT01083693|567614336|FG000|Overall Study|Reason unknown|0|||
157236840|NCT01083693|567614337|FG001|Overall Study|Reason unknown|0|||
157236841|NCT01083693|567614338|FG002|Overall Study|Reason unknown|1|||
157236842|NCT00834418|567614339|FG000|Overall Study|Adverse Event|0|||
157236843|NCT00834418|567614340|FG001|Overall Study|Adverse Event|2|||
157236844|NCT01705574|567614341|FG000|Double-Blind Phase|Lost to Follow-up|12|||
157236845|NCT01705574|567614342|FG001|Double-Blind Phase|Lost to Follow-up|16|||
157236846|NCT01705574|567614343|FG002|Double-Blind Phase|Lost to Follow-up|0|||
157236847|NCT01705574|567614344|FG003|Double-Blind Phase|Lost to Follow-up|0|||
157236848|NCT01705574|567614341|FG000|Double-Blind Phase|Adverse Event|3|||
157236849|NCT01705574|567614342|FG001|Double-Blind Phase|Adverse Event|10|||
157236850|NCT01705574|567614343|FG002|Double-Blind Phase|Adverse Event|0|||
157236851|NCT01705574|567614344|FG003|Double-Blind Phase|Adverse Event|0|||
157236852|NCT01705574|567614341|FG000|Double-Blind Phase|Withdrew Consent|8|||
157236853|NCT01705574|567614342|FG001|Double-Blind Phase|Withdrew Consent|5|||
157236854|NCT01705574|567614343|FG002|Double-Blind Phase|Withdrew Consent|0|||
157236855|NCT01705574|567614344|FG003|Double-Blind Phase|Withdrew Consent|0|||
157236856|NCT01705574|567614341|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
157236857|NCT01705574|567614342|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
157236858|NCT01705574|567614343|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
157236859|NCT01705574|567614344|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
157236860|NCT01705574|567614341|FG000|Double-Blind Phase|Pregnancy|1|||
157236861|NCT01705574|567614342|FG001|Double-Blind Phase|Pregnancy|1|||
157236862|NCT01705574|567614343|FG002|Double-Blind Phase|Pregnancy|0|||
157236863|NCT01705574|567614344|FG003|Double-Blind Phase|Pregnancy|0|||
157236864|NCT01705574|567614341|FG000|Double-Blind Phase|Protocol Violation|1|||
157236865|NCT01705574|567614342|FG001|Double-Blind Phase|Protocol Violation|0|||
157236866|NCT01705574|567614343|FG002|Double-Blind Phase|Protocol Violation|0|||
157236867|NCT01705574|567614344|FG003|Double-Blind Phase|Protocol Violation|0|||
157236868|NCT01705574|567614341|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
157236869|NCT01705574|567614342|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
157088389|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
157236870|NCT01705574|567614343|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
157236871|NCT01705574|567614344|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
157088390|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
157236872|NCT01705574|567614341|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
157236873|NCT01705574|567614342|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
157236874|NCT01705574|567614343|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
157236875|NCT01705574|567614344|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
157236876|NCT01705574|567614341|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
157236877|NCT01705574|567614342|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
157236878|NCT01705574|567614343|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
157236879|NCT01705574|567614344|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
157088391|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
157088392|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
157088393|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
157088394|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
157088395|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
157088396|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
157088397|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
157088398|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
157088399|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
157088400|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
157088401|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
157088402|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
157088403|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
157088404|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
157088405|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
157088406|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
157088407|NCT02480153|567076331|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
157088408|NCT02480153|567076332|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
157088409|NCT02480153|567076333|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
157088410|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
157088411|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
157088412|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
157088413|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
157088414|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
157088415|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
157088416|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
157088417|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
157088418|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
157088419|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
157088420|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
157088421|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
157088422|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
157088423|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
157088424|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
157088425|NCT02480153|567076331|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
157088426|NCT02480153|567076332|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
157088427|NCT02480153|567076333|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
157088428|NCT02480153|567076331|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
157088429|NCT02480153|567076332|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
157088430|NCT02480153|567076333|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
157088431|NCT02480153|567076331|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
157088432|NCT02480153|567076332|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
157088433|NCT02480153|567076333|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
157088434|NCT02480153|567076331|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
157088435|NCT02480153|567076332|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
157088436|NCT02480153|567076333|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
157088437|NCT02480153|567076331|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
157088438|NCT02480153|567076332|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
157088439|NCT02480153|567076333|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
157088440|NCT02480153|567076331|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
157088441|NCT02480153|567076332|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
157088442|NCT02480153|567076333|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
157088443|NCT00203476|567076334|FG000|Overall Study|Lost to Follow-up|1|||
157088444|NCT00203476|567076335|FG001|Overall Study|Lost to Follow-up|0|||
157196476|NCT01728454|567461510|FG000|Stage 3|Withdrew Consent|1|||
157196477|NCT01728454|567461511|FG001|Stage 3|Withdrew Consent|0|||
157196478|NCT01728454|567461512|FG002|Stage 3|Withdrew Consent|1|||
157196479|NCT01728454|567461510|FG000|Stage 3|Non-compliance with Protocol|0|||
157196480|NCT01728454|567461511|FG001|Stage 3|Non-compliance with Protocol|0|||
157196481|NCT01728454|567461512|FG002|Stage 3|Non-compliance with Protocol|1|||
157196482|NCT01728454|567461510|FG000|Stage 3|Lost to Follow-up|0|||
157196483|NCT01728454|567461511|FG001|Stage 3|Lost to Follow-up|3|||
157196484|NCT01728454|567461512|FG002|Stage 3|Lost to Follow-up|1|||
157196485|NCT01728454|567461510|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
157196486|NCT01728454|567461511|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
157196487|NCT01728454|567461512|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
157196488|NCT00689299|567461515|FG000|Overall Study|Adverse Event|2|||
157196489|NCT00689299|567461516|FG001|Overall Study|Adverse Event|1|||
157088445|NCT00203476|567076336|FG002|Overall Study|Lost to Follow-up|0|||
157088446|NCT00203476|567076334|FG000|Overall Study|Withdrawal by Subject|0|||
157088447|NCT00203476|567076335|FG001|Overall Study|Withdrawal by Subject|1|||
157088448|NCT00203476|567076336|FG002|Overall Study|Withdrawal by Subject|0|||
157088449|NCT01190514|567076337|FG000|First Intervention (Period 1)|Adverse Event|1|||
157088450|NCT01190514|567076338|FG001|First Intervention (Period 1)|Adverse Event|0|||
157088451|NCT01190514|567076339|FG002|First Intervention (Period 1)|Adverse Event|0|||
157088452|NCT01190514|567076340|FG003|First Intervention (Period 1)|Adverse Event|0|||
157088453|NCT01190514|567076337|FG000|Third Intervention (Period 3)|Adverse Event|1|||
157088454|NCT01190514|567076338|FG001|Third Intervention (Period 3)|Adverse Event|0|||
157088455|NCT01190514|567076339|FG002|Third Intervention (Period 3)|Adverse Event|0|||
157088456|NCT01190514|567076340|FG003|Third Intervention (Period 3)|Adverse Event|0|||
157088457|NCT00512317|567076342|FG000|Overall Study|Insufficient clinical response|36|||
157088458|NCT00512317|567076342|FG000|Overall Study|Withdrawal by Subject|23|||
157088459|NCT00512317|567076342|FG000|Overall Study|Sponsor closure of study|21|||
157088460|NCT00512317|567076342|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
157088461|NCT00512317|567076342|FG000|Overall Study|Adverse Event|13|||
157088462|NCT00512317|567076342|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
157088463|NCT00512317|567076342|FG000|Overall Study|Lost to Follow-up|2|||
157088464|NCT00512317|567076342|FG000|Overall Study|Other|2|||
157088465|NCT01491672|567076343|FG000|Overall Study|Lost to Follow-up|0|||
157088466|NCT01491672|567076344|FG001|Overall Study|Lost to Follow-up|4|||
157088467|NCT01491672|567076345|FG002|Overall Study|Lost to Follow-up|1|||
157088468|NCT01491672|567076343|FG000|Overall Study|Withdrawal by Subject|6|||
157088469|NCT01491672|567076344|FG001|Overall Study|Withdrawal by Subject|7|||
157088470|NCT01491672|567076345|FG002|Overall Study|Withdrawal by Subject|0|||
157088471|NCT01491672|567076343|FG000|Overall Study|Adverse Event|8|||
157088472|NCT01491672|567076344|FG001|Overall Study|Adverse Event|10|||
157088473|NCT01491672|567076345|FG002|Overall Study|Adverse Event|4|||
157088474|NCT01491672|567076343|FG000|Overall Study|Disease progression|42|||
157088475|NCT01491672|567076344|FG001|Overall Study|Disease progression|34|||
157088476|NCT01491672|567076345|FG002|Overall Study|Disease progression|6|||
157088477|NCT01491672|567076343|FG000|Overall Study|Protocol deviation|0|||
157088478|NCT01491672|567076344|FG001|Overall Study|Protocol deviation|1|||
157088479|NCT01491672|567076345|FG002|Overall Study|Protocol deviation|0|||
157088480|NCT01491672|567076343|FG000|Overall Study|Death|0|||
157088481|NCT01491672|567076344|FG001|Overall Study|Death|4|||
157088482|NCT01491672|567076345|FG002|Overall Study|Death|0|||
157088483|NCT03241225|567076346|FG000|Overall Study|Lost to Follow-up|2|||
157088484|NCT03241225|567076347|FG001|Overall Study|Lost to Follow-up|1|||
157088485|NCT03241225|567076346|FG000|Overall Study|Protocol Violation|4|||
157088486|NCT03241225|567076347|FG001|Overall Study|Protocol Violation|1|||
157088487|NCT03241225|567076346|FG000|Overall Study|Withdrawal by Subject|1|||
157088488|NCT03241225|567076347|FG001|Overall Study|Withdrawal by Subject|0|||
157088489|NCT00852540|567076350|FG000|Overall Study|Adverse Event|10|||
157088490|NCT00852540|567076351|FG001|Overall Study|Adverse Event|3|||
157088491|NCT00852540|567076350|FG000|Overall Study|Lack of Efficacy|15|||
157088492|NCT00852540|567076351|FG001|Overall Study|Lack of Efficacy|3|||
157088493|NCT00852540|567076350|FG000|Overall Study|Protocol Violation|1|||
157088494|NCT00852540|567076351|FG001|Overall Study|Protocol Violation|2|||
157088495|NCT00852540|567076350|FG000|Overall Study|Lost to Follow-up|2|||
157196490|NCT00689299|567461517|FG002|Overall Study|Adverse Event|1|||
157196491|NCT00689299|567461515|FG000|Overall Study|Lost to Follow-up|0|||
157196492|NCT00689299|567461516|FG001|Overall Study|Lost to Follow-up|1|||
157196493|NCT00689299|567461517|FG002|Overall Study|Lost to Follow-up|1|||
157196494|NCT00689299|567461515|FG000|Overall Study|Withdrawal by Subject|4|||
157196495|NCT00689299|567461516|FG001|Overall Study|Withdrawal by Subject|1|||
157196496|NCT00689299|567461517|FG002|Overall Study|Withdrawal by Subject|3|||
157196497|NCT00689299|567461515|FG000|Overall Study|Protocol Violation|1|||
157196498|NCT00689299|567461516|FG001|Overall Study|Protocol Violation|0|||
157196499|NCT00689299|567461517|FG002|Overall Study|Protocol Violation|0|||
157196500|NCT01190839|567461520|FG000|Overall Study|Adverse Event|32|||
157196501|NCT01190839|567461521|FG001|Overall Study|Adverse Event|41|||
157196502|NCT01190839|567461520|FG000|Overall Study|Protocol Violation|2|||
157196503|NCT01190839|567461521|FG001|Overall Study|Protocol Violation|2|||
157196504|NCT01190839|567461520|FG000|Overall Study|Lost to Follow-up|7|||
157196505|NCT01190839|567461521|FG001|Overall Study|Lost to Follow-up|1|||
157196506|NCT01190839|567461520|FG000|Overall Study|Death|1|||
157088496|NCT00852540|567076351|FG001|Overall Study|Lost to Follow-up|3|||
157088497|NCT00852540|567076350|FG000|Overall Study|Investigator Discretion|2|||
157088498|NCT00852540|567076351|FG001|Overall Study|Investigator Discretion|3|||
157088499|NCT00852540|567076350|FG000|Overall Study|Withdrawal by Subject|3|||
157088500|NCT00852540|567076351|FG001|Overall Study|Withdrawal by Subject|1|||
157196507|NCT01190839|567461521|FG001|Overall Study|Death|0|||
157088501|NCT00852540|567076350|FG000|Overall Study|Did Not Receive Study Drug|3|||
157088502|NCT00852540|567076351|FG001|Overall Study|Did Not Receive Study Drug|3|||
157088503|NCT04875676|567076355|FG000|Overall Study|Lost to Follow-up|1|||
157088504|NCT04875676|567076356|FG001|Overall Study|Lost to Follow-up|0|||
157088505|NCT04875676|567076357|FG002|Overall Study|Lost to Follow-up|0|||
157088506|NCT03064035|567076358|FG000|Overall Study|Did not receive allocated intervention|4|||
157088507|NCT03064035|567076359|FG001|Overall Study|Did not receive allocated intervention|2|||
157088508|NCT03064035|567076358|FG000|Overall Study|Lost to Follow-up|1|||
157088509|NCT03064035|567076359|FG001|Overall Study|Lost to Follow-up|1|||
157088510|NCT02336178|567076362|FG000|Overall Study|Lost to Follow-up|1|||
157088511|NCT02336178|567076362|FG000|Overall Study|Protocol Violation|1|||
157088512|NCT02336178|567076362|FG000|Overall Study|Withdrawal by Subject|1|||
157088513|NCT02336178|567076362|FG000|Overall Study|Other|1|||
157088514|NCT03310268|567076363|FG000|Overall Study|(Not specified)|1|||
157088515|NCT03310268|567076364|FG001|Overall Study|(Not specified)|5|||
157088516|NCT03310268|567076365|FG002|Overall Study|(Not specified)|0|||
157088517|NCT01236365|567076366|FG000|Overall Study|Lost to Follow-up|0|||
157088518|NCT01236365|567076367|FG001|Overall Study|Lost to Follow-up|2|||
157088519|NCT01236365|567076366|FG000|Overall Study|Moved Out of State|1|||
157088520|NCT01236365|567076367|FG001|Overall Study|Moved Out of State|0|||
157088521|NCT01236365|567076366|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
157088522|NCT01236365|567076367|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
157088523|NCT00558259|567076368|FG000|Overall Study|Adverse Event|50|||
157088524|NCT00558259|567076369|FG001|Overall Study|Adverse Event|81|||
157088525|NCT00558259|567076368|FG000|Overall Study|Protocol Violation|9|||
157088526|NCT00558259|567076369|FG001|Overall Study|Protocol Violation|5|||
157088527|NCT00558259|567076368|FG000|Overall Study|Withdrawal by Subject|12|||
157088528|NCT00558259|567076369|FG001|Overall Study|Withdrawal by Subject|13|||
157088529|NCT01183234|567076372|FG000|First Intervention|Adverse Event|1|||
157088530|NCT01183234|567076373|FG001|First Intervention|Adverse Event|0|||
157088531|NCT00822172|567076378|FG000|Overall Study|Adverse Event|10|||
157088532|NCT00822172|567076379|FG001|Overall Study|Adverse Event|12|||
157088533|NCT00822172|567076378|FG000|Overall Study|Death|1|||
157088534|NCT00822172|567076379|FG001|Overall Study|Death|0|||
157088535|NCT00822172|567076378|FG000|Overall Study|Lost to Follow-up|3|||
157088536|NCT00822172|567076379|FG001|Overall Study|Lost to Follow-up|1|||
157088537|NCT00822172|567076378|FG000|Overall Study|Withdrawal by Subject|1|||
157088538|NCT00822172|567076379|FG001|Overall Study|Withdrawal by Subject|4|||
157196508|NCT01190839|567461520|FG000|Overall Study|Trial stopped by Sponsor|71|||
157196509|NCT01190839|567461521|FG001|Overall Study|Trial stopped by Sponsor|68|||
157196510|NCT01190839|567461520|FG000|Overall Study|Undefined|35|||
157196511|NCT01190839|567461521|FG001|Overall Study|Undefined|31|||
157196512|NCT01190839|567461520|FG000|Overall Study|Randomized but not treated|2|||
157196513|NCT01190839|567461521|FG001|Overall Study|Randomized but not treated|4|||
157196514|NCT03077646|567461526|FG000|Overall Study|Lost to Follow-up|29|||
157196515|NCT03077646|567461527|FG001|Overall Study|Lost to Follow-up|30|||
157196516|NCT03077646|567461528|FG002|Overall Study|Lost to Follow-up|31|||
157196517|NCT02058966|567461529|FG000|Open-Label Methamphetamine|Adverse Event|1|||
157196518|NCT02058966|567461529|FG000|First Intervention|Withdrawal by Subject|1|||
157196519|NCT02993731|567461530|FG000|Overall Study|Study Termination|101|||
157196520|NCT02993731|567461531|FG001|Overall Study|Study Termination|105|||
157196521|NCT01265511|567461532|FG000|Overall Study|Lack of Efficacy|2|||
157196522|NCT01265511|567461533|FG001|Overall Study|Lack of Efficacy|1|||
157196523|NCT01265511|567461532|FG000|Overall Study|Met stopping rules|0|||
157196524|NCT01265511|567461533|FG001|Overall Study|Met stopping rules|2|||
157196525|NCT01362062|567461534|FG000|Overall Study|Adverse Event|1|||
157196526|NCT01362062|567461535|FG001|Overall Study|Adverse Event|0|||
157196527|NCT01362062|567461534|FG000|Overall Study|Lost to Follow-up|11|||
157196528|NCT01362062|567461535|FG001|Overall Study|Lost to Follow-up|0|||
157196529|NCT01362062|567461534|FG000|Overall Study|Withdrawal by Subject|2|||
157196530|NCT01362062|567461535|FG001|Overall Study|Withdrawal by Subject|0|||
157196531|NCT01362062|567461534|FG000|Overall Study|Non-compliant participant|2|||
157196532|NCT01362062|567461535|FG001|Overall Study|Non-compliant participant|0|||
157196533|NCT01362062|567461534|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
157088539|NCT00822172|567076378|FG000|Overall Study|site closed|0|||
157088540|NCT00822172|567076379|FG001|Overall Study|site closed|1|||
157088541|NCT00822172|567076378|FG000|Overall Study|Other|0|||
157196534|NCT01362062|567461535|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
157088542|NCT00822172|567076379|FG001|Overall Study|Other|1|||
157088543|NCT04772898|567076380|FG000|Overall Study|Withdrawal by Subject|0|||
157088544|NCT04772898|567076381|FG001|Overall Study|Withdrawal by Subject|1|||
157088545|NCT00370331|567076382|FG000|Overall Study|Adverse Event|4|||
157088546|NCT00370331|567076383|FG001|Overall Study|Adverse Event|13|||
157196535|NCT01362062|567461534|FG000|Overall Study|Had significant improvement|9|||
157196536|NCT01362062|567461535|FG001|Overall Study|Had significant improvement|0|||
157196537|NCT02545504|567461537|FG000|Overall Study|Death|174|||
157196538|NCT02545504|567461538|FG001|Overall Study|Death|168|||
157196539|NCT02545504|567461537|FG000|Overall Study|Unknown reason|30|||
157088547|NCT00370331|567076382|FG000|Overall Study|Withdrawal by Subject|2|||
157088548|NCT00370331|567076383|FG001|Overall Study|Withdrawal by Subject|4|||
157088549|NCT00370331|567076382|FG000|Overall Study|Lost to Follow-up|0|||
157088550|NCT00370331|567076383|FG001|Overall Study|Lost to Follow-up|3|||
157088551|NCT00370331|567076382|FG000|Overall Study|Lack of Efficacy|0|||
157088552|NCT00370331|567076383|FG001|Overall Study|Lack of Efficacy|1|||
157088553|NCT00370331|567076382|FG000|Overall Study|Non-compliance|0|||
157088554|NCT00370331|567076383|FG001|Overall Study|Non-compliance|1|||
157088555|NCT00370331|567076382|FG000|Overall Study|Protocol Violation|1|||
157088556|NCT00370331|567076383|FG001|Overall Study|Protocol Violation|1|||
157088557|NCT02947087|567076384|FG000|Overall Study|Withdrawal by Subject|3|||
157088558|NCT02947087|567076385|FG001|Overall Study|Withdrawal by Subject|2|||
157088559|NCT00545051|567076388|FG000|Overall Study|Adverse Event|7|||
157088560|NCT00545051|567076389|FG001|Overall Study|Adverse Event|3|||
157088561|NCT00545051|567076388|FG000|Overall Study|Death|1|||
157088562|NCT00545051|567076389|FG001|Overall Study|Death|0|||
157088563|NCT00545051|567076388|FG000|Overall Study|Violation of inclusion/exclusion|0|||
157088564|NCT00545051|567076389|FG001|Overall Study|Violation of inclusion/exclusion|2|||
157088565|NCT00545051|567076388|FG000|Overall Study|Protocol Violation|1|||
157088566|NCT00545051|567076389|FG001|Overall Study|Protocol Violation|0|||
157088567|NCT00545051|567076388|FG000|Overall Study|Withdrawal by Subject|0|||
157088568|NCT00545051|567076389|FG001|Overall Study|Withdrawal by Subject|1|||
157088569|NCT00545051|567076388|FG000|Overall Study|Administrative reasons|0|||
157088570|NCT00545051|567076389|FG001|Overall Study|Administrative reasons|1|||
157088571|NCT01253304|567076390|FG000|Overall Study|Adverse Event|0|||
157088572|NCT01253304|567076391|FG001|Overall Study|Adverse Event|0|||
157088573|NCT01253304|567076392|FG002|Overall Study|Adverse Event|0|||
157088574|NCT01253304|567076393|FG003|Overall Study|Adverse Event|1|||
157088575|NCT01888900|567076397|FG000|Overall Study|failed treatment|0|||
157088576|NCT01888900|567076398|FG001|Overall Study|failed treatment|2|||
157088577|NCT01004848|567076399|FG000|Overall Study|Lost to Follow-up|55|||
157088578|NCT01004848|567076400|FG001|Overall Study|Lost to Follow-up|45|||
157088579|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
157088580|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
157088581|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
157088582|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
157088583|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
157088584|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
157088585|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
157088586|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
157088587|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
157088588|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
157088589|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
157088590|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
157088591|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
157088592|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
157088593|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
157088594|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
157088595|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
157088596|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
157088597|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
157088598|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
157088599|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
157088600|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
157088601|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
157088602|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
157088603|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
157088604|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
157088605|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
157088606|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
157088607|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
157088608|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
157088609|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
157088610|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
157088611|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
157088612|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
157088613|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
157088614|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
157088615|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
157088616|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
157088617|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
157088618|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
157088619|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
157196540|NCT02545504|567461538|FG001|Overall Study|Unknown reason|32|||
157088620|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
157088621|NCT01160289|567076401|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
157088622|NCT01160289|567076402|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
157088623|NCT01160289|567076403|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
157088624|NCT01160289|567076404|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
157088625|NCT01160289|567076405|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
157088626|NCT01160289|567076406|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
157088627|NCT01160289|567076401|FG000|Post-Randomization Period|Adverse Event|0|||
157088628|NCT01160289|567076402|FG001|Post-Randomization Period|Adverse Event|4|||
157088629|NCT01160289|567076403|FG002|Post-Randomization Period|Adverse Event|4|||
157088630|NCT01160289|567076404|FG003|Post-Randomization Period|Adverse Event|2|||
157088631|NCT01160289|567076405|FG004|Post-Randomization Period|Adverse Event|0|||
157088632|NCT01160289|567076406|FG005|Post-Randomization Period|Adverse Event|0|||
157088633|NCT01160289|567076401|FG000|Post-Randomization Period|Death|0|||
157088634|NCT01160289|567076402|FG001|Post-Randomization Period|Death|0|||
157088635|NCT01160289|567076403|FG002|Post-Randomization Period|Death|0|||
157088636|NCT01160289|567076404|FG003|Post-Randomization Period|Death|1|||
157088637|NCT01160289|567076405|FG004|Post-Randomization Period|Death|0|||
157088638|NCT01160289|567076406|FG005|Post-Randomization Period|Death|0|||
157088639|NCT01160289|567076401|FG000|Post-Randomization Period|Lack of Efficacy|0|||
157088640|NCT01160289|567076402|FG001|Post-Randomization Period|Lack of Efficacy|1|||
157088641|NCT01160289|567076403|FG002|Post-Randomization Period|Lack of Efficacy|0|||
157088642|NCT01160289|567076404|FG003|Post-Randomization Period|Lack of Efficacy|3|||
157088643|NCT01160289|567076405|FG004|Post-Randomization Period|Lack of Efficacy|0|||
157088644|NCT01160289|567076406|FG005|Post-Randomization Period|Lack of Efficacy|0|||
157088645|NCT01160289|567076401|FG000|Post-Randomization Period|Lost to Follow-up|0|||
157088646|NCT01160289|567076402|FG001|Post-Randomization Period|Lost to Follow-up|3|||
157088647|NCT01160289|567076403|FG002|Post-Randomization Period|Lost to Follow-up|2|||
157088648|NCT01160289|567076404|FG003|Post-Randomization Period|Lost to Follow-up|5|||
157088649|NCT01160289|567076405|FG004|Post-Randomization Period|Lost to Follow-up|3|||
157088650|NCT01160289|567076406|FG005|Post-Randomization Period|Lost to Follow-up|4|||
157088651|NCT01160289|567076401|FG000|Post-Randomization Period|Physician Decision|0|||
157088652|NCT01160289|567076402|FG001|Post-Randomization Period|Physician Decision|0|||
157088653|NCT01160289|567076403|FG002|Post-Randomization Period|Physician Decision|1|||
157088654|NCT01160289|567076404|FG003|Post-Randomization Period|Physician Decision|0|||
157088655|NCT01160289|567076405|FG004|Post-Randomization Period|Physician Decision|0|||
157088656|NCT01160289|567076406|FG005|Post-Randomization Period|Physician Decision|0|||
157088657|NCT01160289|567076401|FG000|Post-Randomization Period|Protocol Violation|0|||
157088658|NCT01160289|567076402|FG001|Post-Randomization Period|Protocol Violation|4|||
157088659|NCT01160289|567076403|FG002|Post-Randomization Period|Protocol Violation|2|||
157088660|NCT01160289|567076404|FG003|Post-Randomization Period|Protocol Violation|0|||
157088661|NCT01160289|567076405|FG004|Post-Randomization Period|Protocol Violation|1|||
157088662|NCT01160289|567076406|FG005|Post-Randomization Period|Protocol Violation|3|||
157088663|NCT01160289|567076401|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
157088664|NCT01160289|567076402|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
157088665|NCT01160289|567076403|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
157088666|NCT01160289|567076404|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
157088667|NCT01160289|567076405|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
157088668|NCT01160289|567076406|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
157088669|NCT01160289|567076401|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
157088670|NCT01160289|567076402|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
157088671|NCT01160289|567076403|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
157088672|NCT01160289|567076404|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
157088673|NCT01160289|567076405|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
157088674|NCT01160289|567076406|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
157088675|NCT01160289|567076401|FG000|Post-Randomization Period|Sponsor Decision|0|||
157088676|NCT01160289|567076402|FG001|Post-Randomization Period|Sponsor Decision|1|||
157088677|NCT01160289|567076403|FG002|Post-Randomization Period|Sponsor Decision|0|||
157088678|NCT01160289|567076404|FG003|Post-Randomization Period|Sponsor Decision|0|||
157088679|NCT01160289|567076405|FG004|Post-Randomization Period|Sponsor Decision|0|||
157088680|NCT01160289|567076406|FG005|Post-Randomization Period|Sponsor Decision|0|||
157196541|NCT02545504|567461537|FG000|Overall Study|Withdrew consent|9|||
157196542|NCT02545504|567461538|FG001|Overall Study|Withdrew consent|11|||
157196543|NCT02545504|567461537|FG000|Overall Study|Investigator's discretion|3|||
157196544|NCT02545504|567461538|FG001|Overall Study|Investigator's discretion|1|||
157196545|NCT02545504|567461537|FG000|Overall Study|Lost to Follow-up|2|||
157196546|NCT02545504|567461538|FG001|Overall Study|Lost to Follow-up|2|||
157196547|NCT00434876|567461541|FG000|Overall Study|Lost to Follow-up|1|||
157196548|NCT00434876|567461542|FG001|Overall Study|Lost to Follow-up|1|||
157196549|NCT00758394|567461543|FG000|2nd Intervention Order|Lost to Follow-up|0|||
157196550|NCT00758394|567461544|FG001|2nd Intervention Order|Lost to Follow-up|1|||
157236880|NCT01705574|567614341|FG000|Open-Label Extension Phase|Adverse Event|3|||
157236881|NCT01705574|567614342|FG001|Open-Label Extension Phase|Adverse Event|0|||
157236882|NCT01705574|567614343|FG002|Open-Label Extension Phase|Adverse Event|0|||
157236883|NCT01705574|567614344|FG003|Open-Label Extension Phase|Adverse Event|1|||
157236884|NCT01705574|567614341|FG000|Open-Label Extension Phase|Death|2|||
157236885|NCT01705574|567614342|FG001|Open-Label Extension Phase|Death|0|||
157236886|NCT01705574|567614343|FG002|Open-Label Extension Phase|Death|1|||
157236887|NCT01705574|567614344|FG003|Open-Label Extension Phase|Death|0|||
157236888|NCT01705574|567614341|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
157236889|NCT01705574|567614342|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
157236890|NCT01705574|567614343|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
157236891|NCT01705574|567614344|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
157236892|NCT01705574|567614341|FG000|Open-Label Extension Phase|Physician Decision|0|||
157236893|NCT01705574|567614342|FG001|Open-Label Extension Phase|Physician Decision|0|||
157236894|NCT01705574|567614343|FG002|Open-Label Extension Phase|Physician Decision|2|||
157236895|NCT01705574|567614344|FG003|Open-Label Extension Phase|Physician Decision|0|||
157236896|NCT01705574|567614341|FG000|Open-Label Extension Phase|Pregnancy|0|||
157236897|NCT01705574|567614342|FG001|Open-Label Extension Phase|Pregnancy|0|||
157236898|NCT01705574|567614343|FG002|Open-Label Extension Phase|Pregnancy|1|||
157236899|NCT01705574|567614344|FG003|Open-Label Extension Phase|Pregnancy|1|||
157236900|NCT04567186|567614349|FG000|Period 1|COVID-19 related|1|||
157236901|NCT04567186|567614350|FG001|Period 1|COVID-19 related|0|||
157236902|NCT04567186|567614349|FG000|Period 1|Protocol Violation|0|||
157236903|NCT04567186|567614350|FG001|Period 1|Protocol Violation|1|||
157236904|NCT04567186|567614349|FG000|Period 1|Adverse Event|0|||
157236905|NCT04567186|567614350|FG001|Period 1|Adverse Event|2|||
157236906|NCT04567186|567614349|FG000|Period 2|COVID-19 Related|0|||
157236907|NCT04567186|567614350|FG001|Period 2|COVID-19 Related|1|||
157236908|NCT04567186|567614349|FG000|Period 2|Protocol Violation|0|||
157236909|NCT04567186|567614350|FG001|Period 2|Protocol Violation|1|||
157236910|NCT04567186|567614349|FG000|Period 2|Lost to Follow-up|0|||
157236911|NCT04567186|567614350|FG001|Period 2|Lost to Follow-up|1|||
157236912|NCT04567186|567614349|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
157236913|NCT04567186|567614350|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
157236914|NCT02472366|567614351|FG000|Overall Study|Lost to Follow-up|1|||
157236915|NCT02472366|567614352|FG001|Overall Study|Lost to Follow-up|0|||
157236916|NCT03699020|567614355|FG000|Overall Study|Withdrawal by Subject|3|||
157236917|NCT03699020|567614356|FG001|Overall Study|Withdrawal by Subject|2|||
157236918|NCT04274686|567614359|FG000|Overall Study|Physician Decision|1|||
157236919|NCT04274686|567614360|FG001|Overall Study|Physician Decision|0|||
157236920|NCT00905840|567614361|FG000|Overall Study|Lost to Follow-up|11|||
157236921|NCT00905840|567614361|FG000|Overall Study|Death|3|||
157236922|NCT00905840|567614361|FG000|Overall Study|Withdrawal by Subject|1|||
157236923|NCT00905840|567614361|FG000|Overall Study|Adverse Event|1|||
157236924|NCT00448019|567614362|FG000|Overall Study|Withdrawal by Subject|3|||
157236925|NCT00448019|567614362|FG000|Overall Study|Disease progression|1|||
157236926|NCT00448019|567614362|FG000|Overall Study|Death|2|||
157236927|NCT00448019|567614362|FG000|Overall Study|Insurance Issues|1|||
157236928|NCT00089661|567614363|FG000|Overall Study|Adverse Event|0|||
157236929|NCT00089661|567614364|FG001|Overall Study|Adverse Event|2|||
157236930|NCT00089661|567614363|FG000|Overall Study|Death|1|||
157236931|NCT00089661|567614364|FG001|Overall Study|Death|0|||
157236932|NCT00089661|567614363|FG000|Overall Study|Lost to Follow-up|0|||
157236933|NCT00089661|567614364|FG001|Overall Study|Lost to Follow-up|3|||
157236934|NCT00089661|567614363|FG000|Overall Study|Withdrawal by Subject|11|||
157236935|NCT00089661|567614364|FG001|Overall Study|Withdrawal by Subject|9|||
157236936|NCT00089661|567614363|FG000|Overall Study|Disease progression|1|||
157236937|NCT00089661|567614364|FG001|Overall Study|Disease progression|3|||
157236938|NCT00089661|567614363|FG000|Overall Study|Ineligibility determined|4|||
157236939|NCT00089661|567614364|FG001|Overall Study|Ineligibility determined|4|||
157236940|NCT00089661|567614363|FG000|Overall Study|Noncompliance|2|||
157088681|NCT00768079|567076411|FG000|Overall Study|Lost to Follow-up|2|||
157088682|NCT00768079|567076412|FG001|Overall Study|Lost to Follow-up|0|||
157236941|NCT00089661|567614364|FG001|Overall Study|Noncompliance|4|||
157236942|NCT00089661|567614363|FG000|Overall Study|Other|2|||
157236943|NCT00089661|567614364|FG001|Overall Study|Other|1|||
157236944|NCT01827163|567614365|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
157236945|NCT01827163|567614365|FG000|Overall Study|Adverse Event|9|||
157236946|NCT03375463|567614366|FG000|Period 1|Lost to Follow-up|0|||
157236947|NCT03375463|567614367|FG001|Period 1|Lost to Follow-up|0|||
157236948|NCT03375463|567614368|FG002|Period 1|Lost to Follow-up|1|||
157088683|NCT00768079|567076413|FG002|Overall Study|Lost to Follow-up|4|||
157236949|NCT03375463|567614369|FG003|Period 1|Lost to Follow-up|0|||
157088684|NCT00768079|567076411|FG000|Overall Study|Participant incarcerated|0|||
157236950|NCT03375463|567614370|FG004|Period 1|Lost to Follow-up|0|||
157236951|NCT03375463|567614371|FG005|Period 1|Lost to Follow-up|0|||
157236952|NCT03375463|567614366|FG000|Period 1|Adverse Event|0|||
157236953|NCT03375463|567614367|FG001|Period 1|Adverse Event|0|||
157236954|NCT03375463|567614368|FG002|Period 1|Adverse Event|0|||
157236955|NCT03375463|567614369|FG003|Period 1|Adverse Event|0|||
157236956|NCT03375463|567614370|FG004|Period 1|Adverse Event|1|||
157236957|NCT03375463|567614371|FG005|Period 1|Adverse Event|0|||
157236958|NCT03375463|567614366|FG000|Period 2|Lost to Follow-up|1|||
157236959|NCT03375463|567614367|FG001|Period 2|Lost to Follow-up|1|||
157236960|NCT03375463|567614368|FG002|Period 2|Lost to Follow-up|0|||
157236961|NCT03375463|567614369|FG003|Period 2|Lost to Follow-up|0|||
157236962|NCT03375463|567614370|FG004|Period 2|Lost to Follow-up|0|||
157236963|NCT03375463|567614371|FG005|Period 2|Lost to Follow-up|0|||
157236964|NCT03620747|567614373|FG000|Overall Study|Participant decision|7|||
157236965|NCT03620747|567614373|FG000|Overall Study|Adverse Event|6|||
157236966|NCT03620747|567614373|FG000|Overall Study|Lack of Efficacy|1|||
157236967|NCT03620747|567614373|FG000|Overall Study|Poor compliance to protocol|2|||
157236968|NCT03620747|567614373|FG000|Overall Study|Other-unspecified|3|||
157236969|NCT00850174|567614381|FG000|Washout: One Week|Withdrawal by Subject|0|||
157236970|NCT00850174|567614382|FG001|Washout: One Week|Withdrawal by Subject|2|||
157236971|NCT00850174|567614381|FG000|Second Intervention|Withdrawal by Subject|1|||
157236972|NCT00850174|567614382|FG001|Second Intervention|Withdrawal by Subject|0|||
157236973|NCT01513174|567614383|FG000|Overall Study|Inclusion Error|1|||
157236974|NCT01513174|567614384|FG001|Overall Study|Inclusion Error|7|||
157236975|NCT01513174|567614383|FG000|Overall Study|Not receive study treatment|3|||
157236976|NCT01513174|567614384|FG001|Overall Study|Not receive study treatment|1|||
157236977|NCT01900626|567614385|FG000|Overall Study|study was closed due to low enrollment|1|||
157236978|NCT01900626|567614386|FG001|Overall Study|study was closed due to low enrollment|1|||
157236979|NCT00635492|567614387|FG000|Overall Study|Death|12|||
157236980|NCT00635492|567614388|FG001|Overall Study|Death|40|||
157236981|NCT00635492|567614387|FG000|Overall Study|Lost to Follow-up|151|||
157236982|NCT00635492|567614388|FG001|Overall Study|Lost to Follow-up|172|||
157236983|NCT00635492|567614387|FG000|Overall Study|Physician Decision|32|||
157236984|NCT00635492|567614388|FG001|Overall Study|Physician Decision|22|||
157236985|NCT00635492|567614387|FG000|Overall Study|Sponsor decision|2|||
157236986|NCT00635492|567614388|FG001|Overall Study|Sponsor decision|3|||
157236987|NCT00635492|567614387|FG000|Overall Study|Withdrawal by Subject|82|||
157236988|NCT00635492|567614388|FG001|Overall Study|Withdrawal by Subject|45|||
157236989|NCT01200810|567614394|FG000|Overall Study|Physician Decision|1|||
157236990|NCT01200810|567614395|FG001|Overall Study|Physician Decision|0|||
157236991|NCT01200810|567614394|FG000|Overall Study|Withdrawal by Subject|1|||
157236992|NCT01200810|567614395|FG001|Overall Study|Withdrawal by Subject|2|||
157236993|NCT01200810|567614394|FG000|Overall Study|Sponsor stopped making study drug|3|||
157236994|NCT01200810|567614395|FG001|Overall Study|Sponsor stopped making study drug|3|||
157236995|NCT03500341|567614399|FG000|Overall Study|Withdrawn prior to Completion|2|||
157236996|NCT00838630|567614402|FG000|First Intervention|Adverse Event|1|||
157236997|NCT00838630|567614403|FG001|First Intervention|Adverse Event|0|||
157236998|NCT00838630|567614402|FG000|Washout: 7 Days|Protocol Violation|1|||
157236999|NCT00838630|567614403|FG001|Washout: 7 Days|Protocol Violation|0|||
157237000|NCT02699866|567614404|FG000|Overall Study|Withdrawal by Subject|3|||
157237001|NCT02699866|567614404|FG000|Overall Study|Physician Decision|2|||
157237002|NCT02699866|567614404|FG000|Overall Study|Adverse Event|3|||
157237003|NCT04022954|567614407|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
157237004|NCT04022954|567614407|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
157237005|NCT04022954|567614407|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
157237006|NCT04400890|567614408|FG000|Overall Study|Withdrawal by Subject|3|||
157237007|NCT04400890|567614409|FG001|Overall Study|Withdrawal by Subject|2|||
157237008|NCT03925532|567614410|FG000|Overall Study|Lost to Follow-up|1|||
157237009|NCT00723710|567614415|FG000|Overall Study|Disease progression|48|||
157237010|NCT00723710|567614415|FG000|Overall Study|Adverse Event|88|||
157237011|NCT00723710|567614415|FG000|Overall Study|Withdrawal by Subject|36|||
157237012|NCT00723710|567614415|FG000|Overall Study|Physician Decision|2|||
157237013|NCT01001208|567614416|FG000|Overall Study|Adverse Event|10|||
157237014|NCT01001208|567614417|FG001|Overall Study|Adverse Event|5|||
157237015|NCT01001208|567614416|FG000|Overall Study|Lost to Follow-up|5|||
157237016|NCT01001208|567614417|FG001|Overall Study|Lost to Follow-up|9|||
157237017|NCT01001208|567614416|FG000|Overall Study|Physician Decision|1|||
157237018|NCT01001208|567614417|FG001|Overall Study|Physician Decision|0|||
157237019|NCT01001208|567614416|FG000|Overall Study|Withdrawal by Subject|4|||
157237020|NCT01001208|567614417|FG001|Overall Study|Withdrawal by Subject|5|||
157237021|NCT01001208|567614416|FG000|Overall Study|Ineligibility Determined|4|||
157237022|NCT01001208|567614417|FG001|Overall Study|Ineligibility Determined|2|||
157237023|NCT01001208|567614416|FG000|Overall Study|Noncompliance|4|||
157237024|NCT01001208|567614417|FG001|Overall Study|Noncompliance|7|||
157237025|NCT01001208|567614416|FG000|Overall Study|Disease Progression|0|||
157237026|NCT01001208|567614417|FG001|Overall Study|Disease Progression|3|||
157237027|NCT01001208|567614416|FG000|Overall Study|Other|0|||
157237028|NCT01001208|567614417|FG001|Overall Study|Other|2|||
157237029|NCT01723397|567614419|FG000|Study Period 1|Protocol Violation|0|||
157237030|NCT01723397|567614420|FG001|Study Period 1|Protocol Violation|1|||
157237031|NCT01723397|567614419|FG000|Study Period 2|Protocol Violation|0|||
157237032|NCT01723397|567614420|FG001|Study Period 2|Protocol Violation|1|||
157088685|NCT00768079|567076412|FG001|Overall Study|Participant incarcerated|1|||
157088686|NCT00768079|567076413|FG002|Overall Study|Participant incarcerated|0|||
157088687|NCT01156792|567076414|FG000|Overall Study|Adverse Event|1|||
157088688|NCT01156792|567076414|FG000|Overall Study|Lack of Efficacy|36|||
157088689|NCT01156792|567076414|FG000|Overall Study|Protocol Violation|6|||
157088690|NCT01156792|567076414|FG000|Overall Study|Lost to Follow-up|3|||
157088691|NCT01156792|567076414|FG000|Overall Study|Physician Decision|3|||
157088692|NCT01156792|567076414|FG000|Overall Study|Withdrawal by Subject|9|||
157088693|NCT01156792|567076414|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
157088694|NCT03271021|567076415|FG000|Overall Study|Adverse Event|3|||
157088695|NCT03271021|567076416|FG001|Overall Study|Adverse Event|2|||
157088696|NCT03271021|567076415|FG000|Overall Study|Withdrawal by Subject|36|||
157088697|NCT03271021|567076416|FG001|Overall Study|Withdrawal by Subject|53|||
157088698|NCT03271021|567076415|FG000|Overall Study|Lost to Follow-up|34|||
157088699|NCT03271021|567076416|FG001|Overall Study|Lost to Follow-up|39|||
157088700|NCT03271021|567076415|FG000|Overall Study|Protocol Violation|6|||
157088701|NCT03271021|567076416|FG001|Overall Study|Protocol Violation|4|||
157088702|NCT03271021|567076415|FG000|Overall Study|Abnormal Lab Results|1|||
157088703|NCT03271021|567076416|FG001|Overall Study|Abnormal Lab Results|0|||
157088704|NCT03271021|567076415|FG000|Overall Study|Miscellaneous|9|||
157088705|NCT03271021|567076416|FG001|Overall Study|Miscellaneous|8|||
157088706|NCT00635427|567076419|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
157088707|NCT00635427|567076420|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
157088708|NCT00635427|567076421|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
157088709|NCT00635427|567076422|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
157088710|NCT00635427|567076423|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
157088711|NCT00635427|567076419|FG000|Overall Study|Death|0|||
157196551|NCT00758394|567461545|FG002|2nd Intervention Order|Lost to Follow-up|0|||
157196552|NCT00758394|567461546|FG003|2nd Intervention Order|Lost to Follow-up|0|||
157196553|NCT00758394|567461543|FG000|3rd Intervention|Lost to Follow-up|1|||
157196554|NCT00758394|567461544|FG001|3rd Intervention|Lost to Follow-up|0|||
157196555|NCT00758394|567461545|FG002|3rd Intervention|Lost to Follow-up|0|||
157196556|NCT00758394|567461546|FG003|3rd Intervention|Lost to Follow-up|1|||
157196557|NCT01002573|567463730|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
157196558|NCT01002573|567463731|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
157196559|NCT00690612|567463732|FG000|Overall Study|Adverse Event|1|||
157196560|NCT00690612|567463732|FG000|Overall Study|Withdrawal by Subject|2|||
157196561|NCT02926833|567463733|FG000|Overall Study|Death|1|||
157196562|NCT02926833|567463734|FG001|Overall Study|Death|1|||
157196563|NCT02926833|567463735|FG002|Overall Study|Death|2|||
157196564|NCT02926833|567463736|FG003|Overall Study|Death|13|||
157196565|NCT02926833|567463733|FG000|Overall Study|Lost to Follow-up|1|||
157196566|NCT02926833|567463734|FG001|Overall Study|Lost to Follow-up|2|||
157196567|NCT02926833|567463735|FG002|Overall Study|Lost to Follow-up|0|||
157196568|NCT02926833|567463736|FG003|Overall Study|Lost to Follow-up|3|||
157196569|NCT02926833|567463733|FG000|Overall Study|Full Consent Withdrawal|0|||
157196570|NCT02926833|567463734|FG001|Overall Study|Full Consent Withdrawal|0|||
157196571|NCT02926833|567463735|FG002|Overall Study|Full Consent Withdrawal|0|||
157196572|NCT02926833|567463736|FG003|Overall Study|Full Consent Withdrawal|2|||
157196573|NCT02926833|567463733|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
157196574|NCT02926833|567463734|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
157196575|NCT02926833|567463735|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
157196576|NCT02926833|567463736|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
157196577|NCT02926833|567463733|FG000|Overall Study|Investigator Decision|0|||
157196578|NCT02926833|567463734|FG001|Overall Study|Investigator Decision|1|||
157196579|NCT02926833|567463735|FG002|Overall Study|Investigator Decision|0|||
157196580|NCT02926833|567463736|FG003|Overall Study|Investigator Decision|0|||
157196581|NCT02926833|567463733|FG000|Overall Study|Adverse Event|0|||
157196582|NCT02926833|567463734|FG001|Overall Study|Adverse Event|0|||
157196583|NCT02926833|567463735|FG002|Overall Study|Adverse Event|1|||
157196584|NCT02926833|567463736|FG003|Overall Study|Adverse Event|0|||
157196585|NCT02926833|567463733|FG000|Overall Study|Partial Withdrawal of Consent|0|||
157196586|NCT02926833|567463734|FG001|Overall Study|Partial Withdrawal of Consent|0|||
157196587|NCT02926833|567463735|FG002|Overall Study|Partial Withdrawal of Consent|0|||
157196588|NCT02926833|567463736|FG003|Overall Study|Partial Withdrawal of Consent|1|||
157196589|NCT01945866|567463737|FG000|Overall Study|Eyes did not complete or were dropped|2|||
157196590|NCT01945866|567463738|FG001|Overall Study|Eyes did not complete or were dropped|0|||
157196591|NCT02930889|567463741|FG000|Overall Study|Lost to Follow-up|2|||
157196592|NCT02930889|567463741|FG000|Overall Study|Withdrawal by Subject|6|||
157196593|NCT02930889|567463741|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
157196594|NCT03159455|567463743|FG000|Overall Study|Adverse Event|0|||
157196595|NCT03159455|567463744|FG001|Overall Study|Adverse Event|0|||
157196596|NCT03159455|567463745|FG002|Overall Study|Adverse Event|0|||
157196597|NCT03159455|567463746|FG003|Overall Study|Adverse Event|0|||
157196598|NCT03159455|567463747|FG004|Overall Study|Adverse Event|0|||
157196599|NCT03159455|567463748|FG005|Overall Study|Adverse Event|1|||
157196600|NCT02713490|567463751|FG000|Overall Study|Withdrawal by Subject|2|||
157196601|NCT02713490|567463752|FG001|Overall Study|Withdrawal by Subject|1|||
157196602|NCT02713490|567463751|FG000|Overall Study|Did not receive study drug|1|||
157196603|NCT02713490|567463752|FG001|Overall Study|Did not receive study drug|0|||
157196604|NCT02713490|567463751|FG000|Overall Study|Met exclusion criteria|0|||
157196605|NCT02713490|567463752|FG001|Overall Study|Met exclusion criteria|1|||
157196606|NCT01714726|567463753|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
157196607|NCT01714726|567463754|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
157196608|NCT01714726|567463755|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
157196609|NCT01714726|567463756|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
157196610|NCT01714726|567463753|FG000|Double-Blinded Induction Period|Adverse Event|0|||
157196611|NCT01714726|567463754|FG001|Double-Blinded Induction Period|Adverse Event|1|||
157196612|NCT01714726|567463755|FG002|Double-Blinded Induction Period|Adverse Event|0|||
157196613|NCT01714726|567463756|FG003|Double-Blinded Induction Period|Adverse Event|0|||
157196614|NCT01714726|567463753|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
157196615|NCT01714726|567463754|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
157196616|NCT01714726|567463755|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
157196617|NCT01714726|567463756|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
157196618|NCT01714726|567463753|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
157196619|NCT01714726|567463754|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
157196620|NCT01714726|567463755|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
157196621|NCT01714726|567463756|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
157196622|NCT01714726|567463753|FG000|Open-Label Period|Other|0|||
157196623|NCT01714726|567463754|FG001|Open-Label Period|Other|0|||
157196624|NCT01714726|567463755|FG002|Open-Label Period|Other|1|||
157196625|NCT01714726|567463756|FG003|Open-Label Period|Other|3|||
157196626|NCT01714726|567463753|FG000|Open-Label Period|Adverse Event|0|||
157196627|NCT01714726|567463754|FG001|Open-Label Period|Adverse Event|0|||
157196628|NCT01714726|567463755|FG002|Open-Label Period|Adverse Event|1|||
157196629|NCT01714726|567463756|FG003|Open-Label Period|Adverse Event|0|||
157196630|NCT01714726|567463753|FG000|Open-Label Period|Withdrawal by Subject|0|||
157196631|NCT01714726|567463754|FG001|Open-Label Period|Withdrawal by Subject|0|||
157196632|NCT01714726|567463755|FG002|Open-Label Period|Withdrawal by Subject|9|||
157196633|NCT01714726|567463756|FG003|Open-Label Period|Withdrawal by Subject|19|||
157196634|NCT01714726|567463753|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
157196635|NCT01714726|567463754|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
157196636|NCT01714726|567463755|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
157196637|NCT01714726|567463756|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
157196638|NCT01714726|567463753|FG000|Open-Label Period|Lost to Follow-up|0|||
157196639|NCT01714726|567463754|FG001|Open-Label Period|Lost to Follow-up|0|||
157196640|NCT01714726|567463755|FG002|Open-Label Period|Lost to Follow-up|3|||
157196641|NCT01714726|567463756|FG003|Open-Label Period|Lost to Follow-up|4|||
157196642|NCT00501969|567463757|FG000|Overall Study|Major Protocol Violation|4|||
157196643|NCT00501969|567463757|FG000|Overall Study|Lack of Efficacy|29|||
157196644|NCT00501969|567463757|FG000|Overall Study|Adverse Event|76|||
157196645|NCT00501969|567463757|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
157196646|NCT00501969|567463757|FG000|Overall Study|Subject withdrew consent|51|||
157196647|NCT00501969|567463757|FG000|Overall Study|Lost to Follow-up|4|||
157196648|NCT00501969|567463757|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
157196649|NCT00501969|567463757|FG000|Overall Study|Other: Sponsors Request|10|||
157196650|NCT00501969|567463757|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
157196651|NCT00501969|567463757|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
157196652|NCT00501969|567463757|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
157196653|NCT00501969|567463757|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
157196654|NCT00501969|567463757|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
157196655|NCT00501969|567463757|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
157196656|NCT00501969|567463757|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
157196657|NCT00501969|567463757|FG000|Overall Study|Other: As Required by Local EC|2|||
157196658|NCT00501969|567463757|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
157196659|NCT00501969|567463757|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
157196660|NCT00665366|567463760|FG000|Overall Study|Lack of Efficacy|11|||
157196661|NCT00665366|567463761|FG001|Overall Study|Lack of Efficacy|10|||
157196662|NCT00665366|567463760|FG000|Overall Study|Adverse Event|25|||
157196663|NCT00665366|567463761|FG001|Overall Study|Adverse Event|23|||
157196664|NCT00665366|567463760|FG000|Overall Study|Withdrawal by Subject|11|||
157196665|NCT00665366|567463761|FG001|Overall Study|Withdrawal by Subject|14|||
157196666|NCT00665366|567463760|FG000|Overall Study|Lost to Follow-up|3|||
157196667|NCT00665366|567463761|FG001|Overall Study|Lost to Follow-up|5|||
157196668|NCT00665366|567463760|FG000|Overall Study|Poor compliance/noncompliance|3|||
157196669|NCT00665366|567463761|FG001|Overall Study|Poor compliance/noncompliance|5|||
157196670|NCT00665366|567463760|FG000|Overall Study|Pregnancy|1|||
157196671|NCT00665366|567463761|FG001|Overall Study|Pregnancy|0|||
157196672|NCT00665366|567463760|FG000|Overall Study|No longer meets study criteria|0|||
157196673|NCT00665366|567463761|FG001|Overall Study|No longer meets study criteria|1|||
157196674|NCT00665366|567463760|FG000|Overall Study|Other reasons|4|||
157196675|NCT00665366|567463761|FG001|Overall Study|Other reasons|1|||
157196676|NCT03628781|567463762|FG000|Overall Study|Lost to Follow-up|16|||
157196677|NCT03628781|567463763|FG001|Overall Study|Lost to Follow-up|8|||
157196678|NCT03628781|567463762|FG000|Overall Study|Withdrawal by Subject|16|||
157196679|NCT03628781|567463763|FG001|Overall Study|Withdrawal by Subject|1|||
157196680|NCT02687815|567463767|FG000|Overall Study|Lost to Follow-up|2|||
157196681|NCT02687815|567463768|FG001|Overall Study|Lost to Follow-up|4|||
157196682|NCT02687815|567463767|FG000|Overall Study|Withdrawal by Subject|2|||
157196683|NCT02687815|567463768|FG001|Overall Study|Withdrawal by Subject|4|||
157196684|NCT00379639|567463769|FG000|Overall Study|Disease Progression|3|||
157196685|NCT00379639|567463770|FG001|Overall Study|Disease Progression|3|||
157196686|NCT00379639|567463771|FG002|Overall Study|Disease Progression|3|||
157196687|NCT00379639|567463772|FG003|Overall Study|Disease Progression|4|||
157196688|NCT00379639|567463773|FG004|Overall Study|Disease Progression|4|||
157196689|NCT00379639|567463769|FG000|Overall Study|Physician Decision|0|||
157196690|NCT00379639|567463770|FG001|Overall Study|Physician Decision|2|||
157196691|NCT00379639|567463771|FG002|Overall Study|Physician Decision|1|||
157196692|NCT00379639|567463772|FG003|Overall Study|Physician Decision|1|||
157196693|NCT00379639|567463773|FG004|Overall Study|Physician Decision|0|||
157237033|NCT02739997|567614421|FG000|Overall Study|Death|1|||
157237034|NCT02739997|567614421|FG000|Overall Study|Withdrawal by Subject|1|||
157237035|NCT00833937|567614424|FG000|Washout|Withdrawal by Subject|1|||
157237036|NCT00833937|567614425|FG001|Washout|Withdrawal by Subject|0|||
157237037|NCT01353664|567614426|FG000|Overall Study|Other|3|||
157237038|NCT01353664|567614426|FG000|Overall Study|Disease Progression|16|||
157237039|NCT02655679|567614433|FG000|Overall Study|Adverse Event|0|||
157237040|NCT02655679|567614434|FG001|Overall Study|Adverse Event|1|||
157237041|NCT02655679|567614435|FG002|Overall Study|Adverse Event|0|||
157237042|NCT02655679|567614436|FG003|Overall Study|Adverse Event|0|||
157237043|NCT02655679|567614437|FG004|Overall Study|Adverse Event|0|||
157237044|NCT02655679|567614433|FG000|Overall Study|Withdrawal by Subject|1|||
157237045|NCT02655679|567614434|FG001|Overall Study|Withdrawal by Subject|1|||
157237046|NCT02655679|567614435|FG002|Overall Study|Withdrawal by Subject|0|||
157237047|NCT02655679|567614436|FG003|Overall Study|Withdrawal by Subject|3|||
157196694|NCT00379639|567463769|FG000|Overall Study|Symptomatic Deterioration|0|||
157196695|NCT00379639|567463770|FG001|Overall Study|Symptomatic Deterioration|0|||
157196696|NCT00379639|567463771|FG002|Overall Study|Symptomatic Deterioration|1|||
157196697|NCT00379639|567463772|FG003|Overall Study|Symptomatic Deterioration|0|||
157196698|NCT00379639|567463773|FG004|Overall Study|Symptomatic Deterioration|1|||
157196699|NCT00379639|567463769|FG000|Overall Study|Adverse Event|0|||
157196700|NCT00379639|567463770|FG001|Overall Study|Adverse Event|0|||
157196701|NCT00379639|567463771|FG002|Overall Study|Adverse Event|1|||
157196702|NCT00379639|567463772|FG003|Overall Study|Adverse Event|0|||
157196703|NCT00379639|567463773|FG004|Overall Study|Adverse Event|1|||
157196704|NCT00379639|567463769|FG000|Overall Study|Lost to Follow-up|0|||
157196705|NCT00379639|567463770|FG001|Overall Study|Lost to Follow-up|0|||
157196706|NCT00379639|567463771|FG002|Overall Study|Lost to Follow-up|0|||
157196707|NCT00379639|567463772|FG003|Overall Study|Lost to Follow-up|1|||
157196708|NCT00379639|567463773|FG004|Overall Study|Lost to Follow-up|0|||
157196709|NCT00379639|567463769|FG000|Overall Study|Other|0|||
157196710|NCT00379639|567463770|FG001|Overall Study|Other|0|||
157196711|NCT00379639|567463771|FG002|Overall Study|Other|3|||
157196712|NCT00379639|567463772|FG003|Overall Study|Other|0|||
157196713|NCT00379639|567463773|FG004|Overall Study|Other|0|||
157196714|NCT01238861|567463776|FG000|Overall Study|Lost to Follow-up|4|||
157196715|NCT01238861|567463777|FG001|Overall Study|Lost to Follow-up|2|||
157196716|NCT01238861|567463778|FG002|Overall Study|Lost to Follow-up|3|||
157196717|NCT01238861|567463779|FG003|Overall Study|Lost to Follow-up|1|||
157196718|NCT01238861|567463780|FG004|Overall Study|Lost to Follow-up|1|||
157196719|NCT01238861|567463781|FG005|Overall Study|Lost to Follow-up|2|||
157196720|NCT01238861|567463776|FG000|Overall Study|Unplanned surgery|1|||
157196721|NCT01238861|567463777|FG001|Overall Study|Unplanned surgery|0|||
157196722|NCT01238861|567463778|FG002|Overall Study|Unplanned surgery|0|||
157196723|NCT01238861|567463779|FG003|Overall Study|Unplanned surgery|0|||
157196724|NCT01238861|567463780|FG004|Overall Study|Unplanned surgery|0|||
157196725|NCT01238861|567463781|FG005|Overall Study|Unplanned surgery|0|||
157196726|NCT01238861|567463776|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
157196727|NCT01238861|567463777|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
157196728|NCT01238861|567463778|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
157237048|NCT02655679|567614437|FG004|Overall Study|Withdrawal by Subject|1|||
157237049|NCT02655679|567614433|FG000|Overall Study|Inability to Comply with the Protocol|1|||
157237050|NCT02655679|567614434|FG001|Overall Study|Inability to Comply with the Protocol|0|||
157196729|NCT01238861|567463779|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
157237051|NCT02655679|567614435|FG002|Overall Study|Inability to Comply with the Protocol|0|||
157237052|NCT02655679|567614436|FG003|Overall Study|Inability to Comply with the Protocol|0|||
157237053|NCT02655679|567614437|FG004|Overall Study|Inability to Comply with the Protocol|0|||
157237054|NCT02655679|567614433|FG000|Overall Study|Lost to Follow-up|0|||
157088712|NCT00635427|567076420|FG001|Overall Study|Death|0|||
157088713|NCT00635427|567076421|FG002|Overall Study|Death|0|||
157088714|NCT00635427|567076422|FG003|Overall Study|Death|1|||
157088715|NCT00635427|567076423|FG004|Overall Study|Death|0|||
157088716|NCT00635427|567076419|FG000|Overall Study|Termination Of Study By Sponsor|12|||
157088717|NCT00635427|567076420|FG001|Overall Study|Termination Of Study By Sponsor|6|||
157088718|NCT00635427|567076421|FG002|Overall Study|Termination Of Study By Sponsor|10|||
157088719|NCT00635427|567076422|FG003|Overall Study|Termination Of Study By Sponsor|6|||
157088720|NCT00635427|567076423|FG004|Overall Study|Termination Of Study By Sponsor|6|||
157088721|NCT00635427|567076419|FG000|Overall Study|Withdrawal Of Consent|0|||
157088722|NCT00635427|567076420|FG001|Overall Study|Withdrawal Of Consent|0|||
157088723|NCT00635427|567076421|FG002|Overall Study|Withdrawal Of Consent|0|||
157088724|NCT00635427|567076422|FG003|Overall Study|Withdrawal Of Consent|2|||
157088725|NCT00635427|567076423|FG004|Overall Study|Withdrawal Of Consent|2|||
157088726|NCT00564889|567076424|FG000|Overall Study|Death|7|||
157088727|NCT00564889|567076424|FG000|Overall Study|Adverse Event|12|||
157088728|NCT00564889|567076424|FG000|Overall Study|Alternative treatment|3|||
157088729|NCT00564889|567076424|FG000|Overall Study|Disease progression|3|||
157088730|NCT00564889|567076424|FG000|Overall Study|Other, not specified|4|||
157088731|NCT01506609|567076428|FG000|Overall Study|Adverse Event Related to Progression|0|||
157088732|NCT01506609|567076429|FG001|Overall Study|Adverse Event Related to Progression|0|||
157088733|NCT01506609|567076430|FG002|Overall Study|Adverse Event Related to Progression|0|||
157088734|NCT01506609|567076431|FG003|Overall Study|Adverse Event Related to Progression|3|||
157088735|NCT01506609|567076432|FG004|Overall Study|Adverse Event Related to Progression|7|||
157088736|NCT01506609|567076433|FG005|Overall Study|Adverse Event Related to Progression|3|||
157088737|NCT01506609|567076428|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
157088738|NCT01506609|567076429|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
157088739|NCT01506609|567076430|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
157088740|NCT01506609|567076431|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
157088741|NCT01506609|567076432|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
157088742|NCT01506609|567076433|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
157088743|NCT01506609|567076428|FG000|Overall Study|Withdrawal by Subject|0|||
157088744|NCT01506609|567076429|FG001|Overall Study|Withdrawal by Subject|0|||
157088745|NCT01506609|567076430|FG002|Overall Study|Withdrawal by Subject|0|||
157088746|NCT01506609|567076431|FG003|Overall Study|Withdrawal by Subject|9|||
157088747|NCT01506609|567076432|FG004|Overall Study|Withdrawal by Subject|7|||
157088748|NCT01506609|567076433|FG005|Overall Study|Withdrawal by Subject|7|||
157088749|NCT01506609|567076428|FG000|Overall Study|Lost to Follow-up|0|||
157088750|NCT01506609|567076429|FG001|Overall Study|Lost to Follow-up|0|||
157088751|NCT01506609|567076430|FG002|Overall Study|Lost to Follow-up|0|||
157088752|NCT01506609|567076431|FG003|Overall Study|Lost to Follow-up|1|||
157088753|NCT01506609|567076432|FG004|Overall Study|Lost to Follow-up|2|||
157088754|NCT01506609|567076433|FG005|Overall Study|Lost to Follow-up|0|||
157088755|NCT01506609|567076428|FG000|Overall Study|Sponsor Discontinued Study|0|||
157088756|NCT01506609|567076429|FG001|Overall Study|Sponsor Discontinued Study|0|||
157088757|NCT01506609|567076430|FG002|Overall Study|Sponsor Discontinued Study|0|||
157088758|NCT01506609|567076431|FG003|Overall Study|Sponsor Discontinued Study|2|||
157088759|NCT01506609|567076432|FG004|Overall Study|Sponsor Discontinued Study|2|||
157088760|NCT01506609|567076433|FG005|Overall Study|Sponsor Discontinued Study|0|||
157088761|NCT01506609|567076428|FG000|Overall Study|Progressive Disease per Protocol|1|||
157088762|NCT01506609|567076429|FG001|Overall Study|Progressive Disease per Protocol|0|||
157088763|NCT01506609|567076430|FG002|Overall Study|Progressive Disease per Protocol|0|||
157088764|NCT01506609|567076431|FG003|Overall Study|Progressive Disease per Protocol|64|||
157088765|NCT01506609|567076432|FG004|Overall Study|Progressive Disease per Protocol|57|||
157088766|NCT01506609|567076433|FG005|Overall Study|Progressive Disease per Protocol|74|||
157088767|NCT01506609|567076428|FG000|Overall Study|Other, Not Specified|0|||
157088768|NCT01506609|567076429|FG001|Overall Study|Other, Not Specified|0|||
157088769|NCT01506609|567076430|FG002|Overall Study|Other, Not Specified|0|||
157088770|NCT01506609|567076431|FG003|Overall Study|Other, Not Specified|10|||
157088771|NCT01506609|567076432|FG004|Overall Study|Other, Not Specified|7|||
157088772|NCT01506609|567076433|FG005|Overall Study|Other, Not Specified|3|||
157088773|NCT01506609|567076428|FG000|Overall Study|Missing / Unknown Reason|1|||
157088774|NCT01506609|567076429|FG001|Overall Study|Missing / Unknown Reason|0|||
157088775|NCT01506609|567076430|FG002|Overall Study|Missing / Unknown Reason|1|||
157088776|NCT01506609|567076431|FG003|Overall Study|Missing / Unknown Reason|4|||
157088777|NCT01506609|567076432|FG004|Overall Study|Missing / Unknown Reason|4|||
157088778|NCT01506609|567076433|FG005|Overall Study|Missing / Unknown Reason|2|||
157088779|NCT00577473|567076438|FG000|Overall Study|Protocol Violation|1|||
157088780|NCT00577473|567076439|FG001|Overall Study|Protocol Violation|4|||
157088781|NCT00577473|567076438|FG000|Overall Study|Adverse Event|8|||
157088782|NCT00577473|567076439|FG001|Overall Study|Adverse Event|5|||
157088783|NCT00577473|567076438|FG000|Overall Study|Withdrawal by Subject|2|||
157088784|NCT00577473|567076439|FG001|Overall Study|Withdrawal by Subject|6|||
157088785|NCT00577473|567076438|FG000|Overall Study|Physician Decision|2|||
157196730|NCT01238861|567463780|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
157196731|NCT01238861|567463781|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
157196732|NCT01238861|567463776|FG000|Overall Study|Incorrect enrollment/randomization|0|||
157196733|NCT01238861|567463777|FG001|Overall Study|Incorrect enrollment/randomization|0|||
157196734|NCT01238861|567463778|FG002|Overall Study|Incorrect enrollment/randomization|1|||
157196735|NCT01238861|567463779|FG003|Overall Study|Incorrect enrollment/randomization|0|||
157196736|NCT01238861|567463780|FG004|Overall Study|Incorrect enrollment/randomization|1|||
157196737|NCT01238861|567463781|FG005|Overall Study|Incorrect enrollment/randomization|0|||
157196738|NCT01238861|567463776|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
157196739|NCT01238861|567463777|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
157196740|NCT01238861|567463778|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
157196741|NCT01238861|567463779|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
157196742|NCT01238861|567463780|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
157196743|NCT01238861|567463781|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
157196744|NCT01238861|567463776|FG000|Overall Study|Subject moved out of state/area|0|||
157196745|NCT01238861|567463777|FG001|Overall Study|Subject moved out of state/area|0|||
157196746|NCT01238861|567463778|FG002|Overall Study|Subject moved out of state/area|1|||
157196747|NCT01238861|567463779|FG003|Overall Study|Subject moved out of state/area|1|||
157196748|NCT01238861|567463780|FG004|Overall Study|Subject moved out of state/area|0|||
157196749|NCT01238861|567463781|FG005|Overall Study|Subject moved out of state/area|0|||
157196750|NCT01238861|567463776|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
157196751|NCT01238861|567463777|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
157196752|NCT01238861|567463778|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
157237055|NCT02655679|567614434|FG001|Overall Study|Lost to Follow-up|1|||
157237056|NCT02655679|567614435|FG002|Overall Study|Lost to Follow-up|1|||
157237057|NCT02655679|567614436|FG003|Overall Study|Lost to Follow-up|1|||
157237058|NCT02655679|567614437|FG004|Overall Study|Lost to Follow-up|0|||
157237059|NCT02655679|567614433|FG000|Overall Study|Other Miscellaneous Reasons|1|||
157237060|NCT02655679|567614434|FG001|Overall Study|Other Miscellaneous Reasons|0|||
157237061|NCT02655679|567614435|FG002|Overall Study|Other Miscellaneous Reasons|0|||
157237062|NCT02655679|567614436|FG003|Overall Study|Other Miscellaneous Reasons|0|||
157237063|NCT02655679|567614437|FG004|Overall Study|Other Miscellaneous Reasons|0|||
157237064|NCT04115293|567616499|FG000|Overall Study|Adverse Event|0|||
157237065|NCT04115293|567616500|FG001|Overall Study|Adverse Event|2|||
157237066|NCT04115293|567616499|FG000|Overall Study|Withdrawal by Subject|2|||
157237067|NCT04115293|567616500|FG001|Overall Study|Withdrawal by Subject|1|||
157237068|NCT04115293|567616499|FG000|Overall Study|Physician Decision|1|||
157237069|NCT04115293|567616500|FG001|Overall Study|Physician Decision|0|||
157237070|NCT04115293|567616499|FG000|Overall Study|Death|1|||
157237071|NCT04115293|567616500|FG001|Overall Study|Death|1|||
157237072|NCT02674152|567616501|FG000|Overall Study|Personal Reasons|1|||
157237073|NCT02674152|567616502|FG001|Overall Study|Personal Reasons|0|||
157237074|NCT02674152|567616503|FG002|Overall Study|Personal Reasons|0|||
157237075|NCT02674152|567616504|FG003|Overall Study|Personal Reasons|1|||
157237076|NCT02674152|567616505|FG004|Overall Study|Personal Reasons|1|||
157237077|NCT02674152|567616501|FG000|Overall Study|Other adverse event or clinical progression|0|||
157237078|NCT02674152|567616502|FG001|Overall Study|Other adverse event or clinical progression|1|||
157237079|NCT02674152|567616503|FG002|Overall Study|Other adverse event or clinical progression|0|||
157237080|NCT02674152|567616504|FG003|Overall Study|Other adverse event or clinical progression|3|||
157237081|NCT02674152|567616505|FG004|Overall Study|Other adverse event or clinical progression|0|||
157237082|NCT02674152|567616501|FG000|Overall Study|Dose-limiting toxicity|0|||
157237083|NCT02674152|567616502|FG001|Overall Study|Dose-limiting toxicity|0|||
157237084|NCT02674152|567616503|FG002|Overall Study|Dose-limiting toxicity|0|||
157237085|NCT02674152|567616504|FG003|Overall Study|Dose-limiting toxicity|0|||
157237086|NCT02674152|567616505|FG004|Overall Study|Dose-limiting toxicity|1|||
157237087|NCT02674152|567616501|FG000|Overall Study|Progressive Disease|2|||
157237088|NCT02674152|567616502|FG001|Overall Study|Progressive Disease|1|||
157237089|NCT02674152|567616503|FG002|Overall Study|Progressive Disease|1|||
157237090|NCT02674152|567616504|FG003|Overall Study|Progressive Disease|13|||
157196753|NCT01238861|567463779|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
157196754|NCT01238861|567463780|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
157196755|NCT01238861|567463781|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
157196756|NCT01238861|567463776|FG000|Overall Study|Personal problems|0|||
157196757|NCT01238861|567463777|FG001|Overall Study|Personal problems|0|||
157196758|NCT01238861|567463778|FG002|Overall Study|Personal problems|0|||
157237091|NCT02674152|567616505|FG004|Overall Study|Progressive Disease|2|||
157237092|NCT02674152|567616501|FG000|Overall Study|Adverse Event|0|||
157237093|NCT02674152|567616502|FG001|Overall Study|Adverse Event|0|||
157237094|NCT02674152|567616503|FG002|Overall Study|Adverse Event|1|||
157237095|NCT02674152|567616504|FG003|Overall Study|Adverse Event|0|||
157237096|NCT02674152|567616505|FG004|Overall Study|Adverse Event|1|||
157237097|NCT02571907|567616506|FG000|Overall Study|Death|4|||
157196759|NCT01238861|567463779|FG003|Overall Study|Personal problems|1|||
157196760|NCT01238861|567463780|FG004|Overall Study|Personal problems|0|||
157237098|NCT02571907|567616506|FG000|Overall Study|Lost to Follow-up|3|||
157237099|NCT02571907|567616506|FG000|Overall Study|Withdrawal by Subject|3|||
157237100|NCT03447353|567616510|FG000|Overall Study|Failure at Screening Visit|2|||
157237101|NCT03447353|567616510|FG000|Overall Study|Lost to Follow-up|4|||
157237102|NCT03447353|567616510|FG000|Overall Study|Scheduling Conflicts|3|||
157237103|NCT03447353|567616510|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
157237104|NCT02175095|567616511|FG000|Overall Study|Withdrawal by Subject|3|||
157237105|NCT02635750|567616512|FG000|Part 1, Period 2|Adverse Event|1|||
157237106|NCT02635750|567616513|FG001|Part 1, Period 2|Adverse Event|0|||
157237107|NCT02635750|567616514|FG002|Part 1, Period 2|Adverse Event|0|||
157237108|NCT00462345|567616515|FG000|Overall Study|Withdrawal by Subject|2|||
157237109|NCT00462345|567616515|FG000|Overall Study|Did not complete second course|1|||
157237110|NCT02642653|567616517|FG000|Overall Study|Adverse Event|2|||
157237111|NCT02642653|567616518|FG001|Overall Study|Adverse Event|0|||
157237112|NCT02875392|567616522|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
157237113|NCT02875392|567616523|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
157237114|NCT01660243|567616529|FG000|Overall Study|Adverse Event|1|||
157237115|NCT01660243|567616530|FG001|Overall Study|Adverse Event|0|||
157237116|NCT01660243|567616531|FG002|Overall Study|Adverse Event|1|||
157237117|NCT01660243|567616532|FG003|Overall Study|Adverse Event|0|||
157237118|NCT01660243|567616529|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
157237119|NCT01660243|567616530|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
157237120|NCT01660243|567616531|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
157237121|NCT01660243|567616532|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
157237122|NCT01660243|567616529|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
157237123|NCT01660243|567616530|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
157237124|NCT01660243|567616531|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
157237125|NCT01660243|567616532|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
157237126|NCT01660243|567616529|FG000|Overall Study|Randomization error|0|||
157237127|NCT01660243|567616530|FG001|Overall Study|Randomization error|0|||
157237128|NCT01660243|567616531|FG002|Overall Study|Randomization error|0|||
157237129|NCT01660243|567616532|FG003|Overall Study|Randomization error|1|||
157237130|NCT03025087|567616533|FG000|Overall Study|Physician Decision|3|||
157237131|NCT03025087|567616534|FG001|Overall Study|Physician Decision|3|||
157237132|NCT03025087|567616535|FG002|Overall Study|Physician Decision|0|||
157237133|NCT03025087|567616536|FG003|Overall Study|Physician Decision|0|||
157237134|NCT03025087|567616537|FG004|Overall Study|Physician Decision|0|||
157237135|NCT03025087|567616533|FG000|Overall Study|Withdrawal by Subject|1|||
157237136|NCT03025087|567616534|FG001|Overall Study|Withdrawal by Subject|1|||
157237137|NCT03025087|567616535|FG002|Overall Study|Withdrawal by Subject|0|||
157237138|NCT03025087|567616536|FG003|Overall Study|Withdrawal by Subject|0|||
157237139|NCT03025087|567616537|FG004|Overall Study|Withdrawal by Subject|0|||
157237140|NCT03025087|567616533|FG000|Overall Study|Unable to complete MRI|2|||
157237141|NCT03025087|567616534|FG001|Overall Study|Unable to complete MRI|2|||
157237142|NCT03025087|567616535|FG002|Overall Study|Unable to complete MRI|0|||
157237143|NCT03025087|567616536|FG003|Overall Study|Unable to complete MRI|0|||
157237144|NCT03025087|567616537|FG004|Overall Study|Unable to complete MRI|0|||
157237145|NCT00508651|567616538|FG000|Overall Study|Lost to Follow-up|3|||
157237146|NCT00508651|567616539|FG001|Overall Study|Lost to Follow-up|1|||
157237147|NCT00508651|567616538|FG000|Overall Study|Withdrawal by Subject|1|||
157237148|NCT00508651|567616539|FG001|Overall Study|Withdrawal by Subject|1|||
157237149|NCT00461786|567616540|FG000|Overall Study|Entry Criteria Not Met|2|||
157237150|NCT00461786|567616540|FG000|Overall Study|Inevaluable (Never Treated)|1|||
157237151|NCT01363765|567616545|FG000|Overall Study|non-diagnostic|2621|||
157237152|NCT01363765|567616546|FG001|Overall Study|non-diagnostic|1124|||
157237153|NCT01363765|567616545|FG000|Overall Study|duplicate records|736|||
157237154|NCT01363765|567616546|FG001|Overall Study|duplicate records|3177|||
157237155|NCT01363765|567616545|FG000|Overall Study|non-resident|156|||
157237156|NCT01363765|567616546|FG001|Overall Study|non-resident|76|||
157237157|NCT01363765|567616545|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
157237158|NCT01363765|567616546|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
157237159|NCT01363765|567616545|FG000|Overall Study|smear during intervention|2170|||
157237160|NCT01363765|567616546|FG001|Overall Study|smear during intervention|0|||
157237161|NCT02576938|567616547|FG000|Overall Study|Adverse Event|5|||
157237162|NCT02576938|567616548|FG001|Overall Study|Adverse Event|3|||
157237163|NCT02576938|567616549|FG002|Overall Study|Adverse Event|6|||
157237164|NCT02576938|567616547|FG000|Overall Study|Protocol Violation|1|||
157237165|NCT02576938|567616548|FG001|Overall Study|Protocol Violation|1|||
157237166|NCT02576938|567616549|FG002|Overall Study|Protocol Violation|1|||
157237167|NCT02576938|567616547|FG000|Overall Study|Withdrawal by Subject|3|||
157237168|NCT02576938|567616548|FG001|Overall Study|Withdrawal by Subject|2|||
157237169|NCT02576938|567616549|FG002|Overall Study|Withdrawal by Subject|4|||
157237170|NCT02576938|567616547|FG000|Overall Study|Lack of Efficacy|9|||
157237171|NCT02576938|567616548|FG001|Overall Study|Lack of Efficacy|4|||
157237172|NCT02576938|567616549|FG002|Overall Study|Lack of Efficacy|0|||
157237173|NCT02576938|567616547|FG000|Overall Study|Lost to Follow-up|2|||
157237174|NCT02576938|567616548|FG001|Overall Study|Lost to Follow-up|0|||
157088786|NCT00577473|567076439|FG001|Overall Study|Physician Decision|2|||
157088787|NCT00577473|567076438|FG000|Overall Study|Lack of Efficacy|8|||
157088788|NCT00577473|567076439|FG001|Overall Study|Lack of Efficacy|7|||
157088789|NCT01990560|567076442|FG000|Overall Study|Withdrawal by Subject|1|||
157088790|NCT01324440|567076448|FG000|Overall Study|Subject moved|0|||
157088791|NCT01324440|567076449|FG001|Overall Study|Subject moved|1|||
157088792|NCT02884908|567076450|FG000|Overall Study|Lost to Follow-up|13|||
157088793|NCT02884908|567076451|FG001|Overall Study|Lost to Follow-up|18|||
157237175|NCT02576938|567616549|FG002|Overall Study|Lost to Follow-up|1|||
157237176|NCT02576938|567616547|FG000|Overall Study|Physician Decision|0|||
157237177|NCT02576938|567616548|FG001|Overall Study|Physician Decision|1|||
157237178|NCT02576938|567616549|FG002|Overall Study|Physician Decision|0|||
157237179|NCT02576938|567616547|FG000|Overall Study|Met Exclusion Criteria|0|||
157237180|NCT02576938|567616548|FG001|Overall Study|Met Exclusion Criteria|1|||
157237181|NCT02576938|567616549|FG002|Overall Study|Met Exclusion Criteria|0|||
157237182|NCT03098394|567616553|FG000|Overall Study|Pregnancy|0|||
157237183|NCT03098394|567616554|FG001|Overall Study|Pregnancy|1|||
157237184|NCT01518972|567616557|FG000|Overall Study|Lost to Follow-up|2|||
157237185|NCT01518972|567616558|FG001|Overall Study|Lost to Follow-up|1|||
157237186|NCT01518972|567616557|FG000|Overall Study|Withdrawal by Subject|1|||
157237187|NCT01518972|567616558|FG001|Overall Study|Withdrawal by Subject|0|||
157237188|NCT01518972|567616557|FG000|Overall Study|Moved from area|1|||
157237189|NCT01518972|567616558|FG001|Overall Study|Moved from area|0|||
157237190|NCT01518972|567616557|FG000|Overall Study|Transportation problems|1|||
157237191|NCT01518972|567616558|FG001|Overall Study|Transportation problems|0|||
157237192|NCT01518972|567616557|FG000|Overall Study|Exclusionary medical condition|1|||
157237193|NCT01518972|567616558|FG001|Overall Study|Exclusionary medical condition|0|||
157237194|NCT01518972|567616557|FG000|Overall Study|Missed safety visits|0|||
157237195|NCT01518972|567616558|FG001|Overall Study|Missed safety visits|1|||
157237196|NCT01518972|567616557|FG000|Overall Study|Exclusionary medication|0|||
157237197|NCT01518972|567616558|FG001|Overall Study|Exclusionary medication|1|||
157237198|NCT01518972|567616557|FG000|Overall Study|Declined medication starting on day 12|0|||
157237199|NCT01518972|567616558|FG001|Overall Study|Declined medication starting on day 12|1|||
157237200|NCT01294917|567616561|FG000|Overall Study|Relocation|5|||
157237201|NCT01294917|567616561|FG000|Overall Study|Inconvenience|1|||
157237202|NCT02159950|567616565|FG000|Overall Study|Adverse Event|0|||
157237203|NCT02159950|567616566|FG001|Overall Study|Adverse Event|1|||
157237204|NCT02159950|567616565|FG000|Overall Study|Progression|0|||
157237205|NCT02159950|567616566|FG001|Overall Study|Progression|1|||
157237206|NCT00003659|567616567|FG000|Overall Study|Withdrawal by Subject|3|||
157237207|NCT03285594|567616574|FG000|Overall Study|At the Participant's Own Request|10|||
157237208|NCT03285594|567616575|FG001|Overall Study|At the Participant's Own Request|5|||
157237209|NCT03285594|567616576|FG002|Overall Study|At the Participant's Own Request|21|||
157237210|NCT03285594|567616574|FG000|Overall Study|Adverse Event|2|||
157237211|NCT03285594|567616575|FG001|Overall Study|Adverse Event|2|||
157237212|NCT03285594|567616576|FG002|Overall Study|Adverse Event|6|||
157237213|NCT03285594|567616574|FG000|Overall Study|Poor Compliance to Protocol|0|||
157237214|NCT03285594|567616575|FG001|Overall Study|Poor Compliance to Protocol|0|||
157237215|NCT03285594|567616576|FG002|Overall Study|Poor Compliance to Protocol|1|||
157237216|NCT03285594|567616574|FG000|Overall Study|Lost to Follow-up|0|||
157237217|NCT03285594|567616575|FG001|Overall Study|Lost to Follow-up|0|||
157237218|NCT03285594|567616576|FG002|Overall Study|Lost to Follow-up|1|||
157237219|NCT03285594|567616574|FG000|Overall Study|Reason Not Specified|3|||
157237220|NCT03285594|567616575|FG001|Overall Study|Reason Not Specified|4|||
157237221|NCT03285594|567616576|FG002|Overall Study|Reason Not Specified|8|||
157237222|NCT03733444|567616577|FG000|Overall Study|Adverse Event|8|||
157237223|NCT03733444|567616578|FG001|Overall Study|Adverse Event|10|||
157237224|NCT03733444|567616579|FG002|Overall Study|Adverse Event|5|||
157237225|NCT03733444|567616577|FG000|Overall Study|Death|20|||
157237226|NCT03733444|567616578|FG001|Overall Study|Death|19|||
157088794|NCT01801735|567076455|FG000|Overall Study|Adverse Event|79|||
157088795|NCT01801735|567076455|FG000|Overall Study|Lack of Efficacy|28|||
157088796|NCT01801735|567076455|FG000|Overall Study|Withdrawal by Subject|27|||
157088797|NCT01801735|567076455|FG000|Overall Study|Protocol Violation|25|||
157088798|NCT01801735|567076455|FG000|Overall Study|Lost to Follow-up|15|||
157237227|NCT03733444|567616579|FG002|Overall Study|Death|11|||
157237228|NCT03733444|567616577|FG000|Overall Study|Lost to Follow-up|3|||
157237229|NCT03733444|567616578|FG001|Overall Study|Lost to Follow-up|0|||
157237230|NCT03733444|567616579|FG002|Overall Study|Lost to Follow-up|1|||
157237231|NCT03733444|567616577|FG000|Overall Study|Lack of Efficacy|0|||
157237232|NCT03733444|567616578|FG001|Overall Study|Lack of Efficacy|1|||
157237233|NCT03733444|567616579|FG002|Overall Study|Lack of Efficacy|1|||
157237234|NCT03733444|567616577|FG000|Overall Study|Physician Decision|2|||
157088799|NCT01801735|567076455|FG000|Overall Study|Non-compliance with Trial Drug|13|||
157088800|NCT01801735|567076455|FG000|Overall Study|Physician Decision|3|||
157088801|NCT01801735|567076455|FG000|Overall Study|Death|1|||
157088802|NCT01801735|567076455|FG000|Overall Study|Other, including site closure|19|||
157088803|NCT01293487|567076457|FG000|Overall Study|Lost to Follow-up|0|||
157088804|NCT01293487|567076458|FG001|Overall Study|Lost to Follow-up|0|||
157088805|NCT01293487|567076459|FG002|Overall Study|Lost to Follow-up|0|||
157088806|NCT01293487|567076460|FG003|Overall Study|Lost to Follow-up|1|||
157088807|NCT01293487|567076461|FG004|Overall Study|Lost to Follow-up|0|||
157088808|NCT01293487|567076462|FG005|Overall Study|Lost to Follow-up|0|||
157088809|NCT01293487|567076463|FG006|Overall Study|Lost to Follow-up|0|||
157088810|NCT01293487|567076464|FG007|Overall Study|Lost to Follow-up|0|||
157088811|NCT01293487|567076457|FG000|Overall Study|Withdrawal by Subject|0|||
157088812|NCT01293487|567076458|FG001|Overall Study|Withdrawal by Subject|0|||
157088813|NCT01293487|567076459|FG002|Overall Study|Withdrawal by Subject|0|||
157088814|NCT01293487|567076460|FG003|Overall Study|Withdrawal by Subject|0|||
157088815|NCT01293487|567076461|FG004|Overall Study|Withdrawal by Subject|0|||
157088816|NCT01293487|567076462|FG005|Overall Study|Withdrawal by Subject|0|||
157088817|NCT01293487|567076463|FG006|Overall Study|Withdrawal by Subject|0|||
157088818|NCT01293487|567076464|FG007|Overall Study|Withdrawal by Subject|2|||
157088819|NCT02359877|567078192|FG000|Overall Study|Withdrawal by Subject|1|||
157088820|NCT02359877|567078193|FG001|Overall Study|Withdrawal by Subject|0|||
157088821|NCT02359877|567078194|FG002|Overall Study|Withdrawal by Subject|0|||
157088822|NCT02359877|567078195|FG003|Overall Study|Withdrawal by Subject|2|||
157088823|NCT02359877|567078192|FG000|Overall Study|Adverse Event|0|||
157088824|NCT02359877|567078193|FG001|Overall Study|Adverse Event|0|||
157088825|NCT02359877|567078194|FG002|Overall Study|Adverse Event|0|||
157088826|NCT02359877|567078195|FG003|Overall Study|Adverse Event|1|||
157088827|NCT00910689|567078209|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
157088828|NCT00910689|567078210|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
157088829|NCT00910689|567078211|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
157088830|NCT00910689|567078212|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
157088831|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
157088832|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
157088833|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
157088834|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
157088835|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
157088836|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
157088837|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
157088838|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
157088839|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
157088840|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
157088841|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
157196761|NCT01238861|567463781|FG005|Overall Study|Personal problems|0|||
157196762|NCT01238861|567463776|FG000|Overall Study|Unable to continue visits|0|||
157196763|NCT01238861|567463777|FG001|Overall Study|Unable to continue visits|0|||
157196764|NCT01238861|567463778|FG002|Overall Study|Unable to continue visits|0|||
157196765|NCT01238861|567463779|FG003|Overall Study|Unable to continue visits|1|||
157196766|NCT01238861|567463780|FG004|Overall Study|Unable to continue visits|0|||
157196767|NCT01238861|567463781|FG005|Overall Study|Unable to continue visits|1|||
157196768|NCT01238861|567463776|FG000|Overall Study|Serious adverse event|0|||
157196769|NCT01238861|567463777|FG001|Overall Study|Serious adverse event|0|||
157196770|NCT01238861|567463778|FG002|Overall Study|Serious adverse event|0|||
157196771|NCT01238861|567463779|FG003|Overall Study|Serious adverse event|0|||
157196772|NCT01238861|567463780|FG004|Overall Study|Serious adverse event|0|||
157196773|NCT01238861|567463781|FG005|Overall Study|Serious adverse event|1|||
157196774|NCT01238861|567463776|FG000|Overall Study|Lack of compliance|0|||
157196775|NCT01238861|567463777|FG001|Overall Study|Lack of compliance|0|||
157196776|NCT01238861|567463778|FG002|Overall Study|Lack of compliance|0|||
157196777|NCT01238861|567463779|FG003|Overall Study|Lack of compliance|0|||
157196778|NCT01238861|567463780|FG004|Overall Study|Lack of compliance|0|||
157196779|NCT01238861|567463781|FG005|Overall Study|Lack of compliance|1|||
157196780|NCT01238861|567463776|FG000|Overall Study|Adverse Event|0|||
157196781|NCT01238861|567463777|FG001|Overall Study|Adverse Event|1|||
157196782|NCT01238861|567463778|FG002|Overall Study|Adverse Event|0|||
157196783|NCT01238861|567463779|FG003|Overall Study|Adverse Event|0|||
157088842|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
157088843|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
157088844|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
157088845|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
157088846|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
157196784|NCT01238861|567463780|FG004|Overall Study|Adverse Event|0|||
157196785|NCT01238861|567463781|FG005|Overall Study|Adverse Event|0|||
157196786|NCT01238861|567463776|FG000|Overall Study|Withdrawal by Subject|6|||
157196787|NCT01238861|567463777|FG001|Overall Study|Withdrawal by Subject|5|||
157088847|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
157088848|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
157088849|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
157088850|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
157088851|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
157088852|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
157088853|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
157088854|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
157088855|NCT00910689|567078209|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
157088856|NCT00910689|567078210|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
157088857|NCT00910689|567078211|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
157088858|NCT00910689|567078212|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
157088859|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
157088860|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
157088861|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
157088862|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
157088863|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
157088864|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
157088865|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
157088866|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
157088867|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
157088868|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
157088869|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
157088870|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
157088871|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
157088872|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
157088873|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
157088874|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
157088875|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
157088876|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
157237235|NCT03733444|567616578|FG001|Overall Study|Physician Decision|1|||
157237236|NCT03733444|567616579|FG002|Overall Study|Physician Decision|0|||
157237237|NCT03733444|567616577|FG000|Overall Study|Protocol Violation|2|||
157237238|NCT03733444|567616578|FG001|Overall Study|Protocol Violation|1|||
157237239|NCT03733444|567616579|FG002|Overall Study|Protocol Violation|0|||
157237240|NCT03733444|567616577|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
157237241|NCT03733444|567616578|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
157237242|NCT03733444|567616579|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
157237243|NCT03733444|567616577|FG000|Overall Study|Study Terminated by Sponsor|203|||
157237244|NCT03733444|567616578|FG001|Overall Study|Study Terminated by Sponsor|209|||
157237245|NCT03733444|567616579|FG002|Overall Study|Study Terminated by Sponsor|221|||
157237246|NCT03733444|567616577|FG000|Overall Study|Withdrawal by Subject|19|||
157237247|NCT03733444|567616578|FG001|Overall Study|Withdrawal by Subject|18|||
157237248|NCT03733444|567616579|FG002|Overall Study|Withdrawal by Subject|16|||
157237249|NCT03733444|567616577|FG000|Overall Study|Miscellaneous|1|||
157237250|NCT03733444|567616578|FG001|Overall Study|Miscellaneous|0|||
157237251|NCT03733444|567616579|FG002|Overall Study|Miscellaneous|1|||
157237252|NCT03733444|567616577|FG000|Overall Study|Not Treated|1|||
157237253|NCT03733444|567616578|FG001|Overall Study|Not Treated|2|||
157237254|NCT03733444|567616579|FG002|Overall Study|Not Treated|1|||
157237255|NCT02258074|567616580|FG000|Overall Study|Withdrawal by Subject|1|||
157237256|NCT02258074|567616581|FG001|Overall Study|Withdrawal by Subject|0|||
157237257|NCT02258074|567616582|FG002|Overall Study|Withdrawal by Subject|0|||
157237258|NCT02258074|567616583|FG003|Overall Study|Withdrawal by Subject|0|||
157237259|NCT04405570|567616584|FG000|Overall Study|Adverse Event|0|||
157237260|NCT04405570|567616585|FG001|Overall Study|Adverse Event|1|||
157237261|NCT04405570|567616586|FG002|Overall Study|Adverse Event|1|||
157237262|NCT04405570|567616587|FG003|Overall Study|Adverse Event|1|||
157237263|NCT04405570|567616584|FG000|Overall Study|Lost to Follow-up|0|||
157237264|NCT04405570|567616585|FG001|Overall Study|Lost to Follow-up|1|||
157237265|NCT04405570|567616586|FG002|Overall Study|Lost to Follow-up|0|||
157237266|NCT04405570|567616587|FG003|Overall Study|Lost to Follow-up|0|||
157237267|NCT04405570|567616584|FG000|Overall Study|Physician Decision|0|||
157237268|NCT04405570|567616585|FG001|Overall Study|Physician Decision|0|||
157237269|NCT04405570|567616586|FG002|Overall Study|Physician Decision|1|||
157088877|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
157237270|NCT04405570|567616587|FG003|Overall Study|Physician Decision|0|||
157237271|NCT04405570|567616584|FG000|Overall Study|Withdrawal by Subject|0|||
157237272|NCT04405570|567616585|FG001|Overall Study|Withdrawal by Subject|1|||
157237273|NCT04405570|567616586|FG002|Overall Study|Withdrawal by Subject|1|||
157237274|NCT04405570|567616587|FG003|Overall Study|Withdrawal by Subject|0|||
157237275|NCT04405570|567616584|FG000|Overall Study|Randomized not dosed|0|||
157237276|NCT04405570|567616585|FG001|Overall Study|Randomized not dosed|2|||
157088878|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
157088879|NCT00910689|567078209|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
157088880|NCT00910689|567078210|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
157088881|NCT00910689|567078211|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
157088882|NCT00910689|567078212|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
157088883|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
157088884|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
157088885|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
157088886|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
157088887|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
157088888|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
157088889|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
157088890|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
157088891|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
157088892|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
157088893|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
157088894|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
157088895|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
157088896|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
157088897|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
157088898|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
157088899|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
157088900|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
157088901|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
157088902|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
157088903|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
157088904|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
157088905|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
157088906|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
157088907|NCT00910689|567078209|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
157088908|NCT00910689|567078210|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
157088909|NCT00910689|567078211|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
157088910|NCT00910689|567078212|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
157088911|NCT01290029|567078213|FG000|Overall Study|Other|2|||
157088912|NCT00189488|567078214|FG000|Overall Study|Ineligibility determined|1|||
157088913|NCT00189488|567078215|FG001|Overall Study|Ineligibility determined|0|||
157088914|NCT00189488|567078214|FG000|Overall Study|Protocol deviation|2|||
157088915|NCT00189488|567078215|FG001|Overall Study|Protocol deviation|1|||
157088916|NCT00189488|567078214|FG000|Overall Study|Adverse Event|2|||
157088917|NCT00189488|567078215|FG001|Overall Study|Adverse Event|1|||
157088918|NCT00189488|567078214|FG000|Overall Study|Withdrawal by Subject|2|||
157088919|NCT00189488|567078215|FG001|Overall Study|Withdrawal by Subject|6|||
157088920|NCT00189488|567078214|FG000|Overall Study|Disease progression|2|||
157088921|NCT00189488|567078215|FG001|Overall Study|Disease progression|4|||
157088922|NCT00189488|567078214|FG000|Overall Study|Administrative Decision|0|||
157088923|NCT00189488|567078215|FG001|Overall Study|Administrative Decision|2|||
157088924|NCT00189488|567078214|FG000|Overall Study|Death|5|||
157088925|NCT00189488|567078215|FG001|Overall Study|Death|8|||
157088926|NCT00189488|567078214|FG000|Overall Study|Other|1|||
157088927|NCT00189488|567078215|FG001|Overall Study|Other|0|||
157088928|NCT02349425|567078218|FG000|Period 1|Adverse Event|1|||
157088929|NCT02349425|567078219|FG001|Period 1|Adverse Event|1|||
157088930|NCT02349425|567078220|FG002|Period 1|Adverse Event|0|||
157088931|NCT02349425|567078221|FG003|Period 1|Adverse Event|0|||
157088932|NCT02349425|567078218|FG000|Period 2|Adverse Event|0|||
157088933|NCT02349425|567078219|FG001|Period 2|Adverse Event|1|||
157088934|NCT02349425|567078220|FG002|Period 2|Adverse Event|1|||
157088935|NCT02349425|567078221|FG003|Period 2|Adverse Event|0|||
157088936|NCT01143038|567078222|FG000|Overall Study|Withdrawal by Subject|4|||
157088937|NCT01143038|567078222|FG000|Overall Study|Requirement for alternative therapy|5|||
157088938|NCT01143038|567078222|FG000|Overall Study|Adverse Event|3|||
157088939|NCT01143038|567078222|FG000|Overall Study|Lost to Follow-up|2|||
157088940|NCT01143038|567078222|FG000|Overall Study|Protocol Deviation|1|||
157088941|NCT01143038|567078222|FG000|Overall Study|Death|1|||
157088942|NCT03215810|567078225|FG000|Overall Study|Still responding to nivolumab|1|||
157088943|NCT03215810|567078225|FG000|Overall Study|Insufficient TIL growth|1|||
157088944|NCT03215810|567078225|FG000|Overall Study|Decline in performance status|1|||
157088945|NCT03215810|567078225|FG000|Overall Study|Withdrawal by Subject|1|||
157088946|NCT02313233|567078229|FG000|Overall Study|Withdrawal by Subject|1|||
157088947|NCT02313233|567078230|FG001|Overall Study|Withdrawal by Subject|2|||
157088948|NCT02313233|567078229|FG000|Overall Study|Administrative reason|1|||
157088949|NCT02313233|567078230|FG001|Overall Study|Administrative reason|1|||
157088950|NCT02095951|567078231|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
157088951|NCT02095951|567078232|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
157088952|NCT03618823|567078233|FG000|Overall Study|Lost to Follow-up|63|||
157088953|NCT03618823|567078234|FG001|Overall Study|Lost to Follow-up|61|||
157088954|NCT05383508|567078235|FG000|Overall Study|Withdrawal by Subject|1|||
157088955|NCT05383508|567078236|FG001|Overall Study|Withdrawal by Subject|0|||
157088956|NCT05383508|567078237|FG002|Overall Study|Withdrawal by Subject|1|||
157088957|NCT05383508|567078238|FG003|Overall Study|Withdrawal by Subject|1|||
157088958|NCT05383508|567078239|FG004|Overall Study|Withdrawal by Subject|2|||
157088959|NCT05383508|567078240|FG005|Overall Study|Withdrawal by Subject|0|||
157088960|NCT01621568|567078242|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
157088961|NCT01621568|567078243|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
157088962|NCT01621568|567078242|FG000|Week 5-6 No Treatment|Death|1|||
157088963|NCT01621568|567078243|FG001|Week 5-6 No Treatment|Death|0|||
157088964|NCT01859988|567078244|FG000|Overall Study|Withdrawal by Subject|6|||
157088965|NCT01859988|567078245|FG001|Overall Study|Withdrawal by Subject|3|||
157088966|NCT01859988|567078246|FG002|Overall Study|Withdrawal by Subject|4|||
157088967|NCT01859988|567078247|FG003|Overall Study|Withdrawal by Subject|3|||
157088968|NCT01859988|567078248|FG004|Overall Study|Withdrawal by Subject|2|||
157088969|NCT01859988|567078249|FG005|Overall Study|Withdrawal by Subject|2|||
157088970|NCT01859988|567078244|FG000|Overall Study|Lack of Efficacy|1|||
157088971|NCT01859988|567078245|FG001|Overall Study|Lack of Efficacy|1|||
157088972|NCT01859988|567078246|FG002|Overall Study|Lack of Efficacy|5|||
157088973|NCT01859988|567078247|FG003|Overall Study|Lack of Efficacy|0|||
157088974|NCT01859988|567078248|FG004|Overall Study|Lack of Efficacy|7|||
157088975|NCT01859988|567078249|FG005|Overall Study|Lack of Efficacy|9|||
157088976|NCT01859988|567078244|FG000|Overall Study|Physician Decision|1|||
157088977|NCT01859988|567078245|FG001|Overall Study|Physician Decision|3|||
157088978|NCT01859988|567078246|FG002|Overall Study|Physician Decision|1|||
157088979|NCT01859988|567078247|FG003|Overall Study|Physician Decision|3|||
157088980|NCT01859988|567078248|FG004|Overall Study|Physician Decision|4|||
157088981|NCT01859988|567078249|FG005|Overall Study|Physician Decision|1|||
157088982|NCT01859988|567078244|FG000|Overall Study|Adverse Event|2|||
157088983|NCT01859988|567078245|FG001|Overall Study|Adverse Event|1|||
157088984|NCT01859988|567078246|FG002|Overall Study|Adverse Event|3|||
157088985|NCT01859988|567078247|FG003|Overall Study|Adverse Event|1|||
157088986|NCT01859988|567078248|FG004|Overall Study|Adverse Event|2|||
157088987|NCT01859988|567078249|FG005|Overall Study|Adverse Event|2|||
157088988|NCT01859988|567078244|FG000|Overall Study|Lost to Follow-up|1|||
157088989|NCT01859988|567078245|FG001|Overall Study|Lost to Follow-up|2|||
157088990|NCT01859988|567078246|FG002|Overall Study|Lost to Follow-up|3|||
157237277|NCT04405570|567616586|FG002|Overall Study|Randomized not dosed|0|||
157237278|NCT04405570|567616587|FG003|Overall Study|Randomized not dosed|0|||
157237279|NCT04499963|567616588|FG000|Overall Study|Adverse Event|3|||
157237280|NCT04499963|567616589|FG001|Overall Study|Adverse Event|0|||
157237281|NCT04499963|567616588|FG000|Overall Study|Death|3|||
157237282|NCT04499963|567616589|FG001|Overall Study|Death|0|||
157237283|NCT04499963|567616588|FG000|Overall Study|Lack of Efficacy|7|||
157237284|NCT04499963|567616589|FG001|Overall Study|Lack of Efficacy|0|||
157237285|NCT04499963|567616588|FG000|Overall Study|Lost to Follow-up|2|||
157237286|NCT04499963|567616589|FG001|Overall Study|Lost to Follow-up|0|||
157237287|NCT01208337|567616592|FG000|Overall Study|Death|3|||
157237288|NCT03663179|567616598|FG000|Overall Study|Withdrawal by Subject|2|||
157237289|NCT03663179|567616599|FG001|Overall Study|Withdrawal by Subject|0|||
157237290|NCT03663179|567616598|FG000|Overall Study|Lost to Follow-up|1|||
157237291|NCT03663179|567616599|FG001|Overall Study|Lost to Follow-up|1|||
157237292|NCT03663179|567616598|FG000|Overall Study|Revealed exclusionary condition|1|||
157237293|NCT03663179|567616599|FG001|Overall Study|Revealed exclusionary condition|0|||
157237294|NCT00984126|567616600|FG000|Overall Study|Protocol Violation|0|||
157237295|NCT00984126|567616601|FG001|Overall Study|Protocol Violation|0|||
157237296|NCT00984126|567616602|FG002|Overall Study|Protocol Violation|1|||
157237297|NCT00984126|567616603|FG003|Overall Study|Protocol Violation|2|||
157237298|NCT00984126|567616600|FG000|Overall Study|Adverse Event|0|||
157237299|NCT00984126|567616601|FG001|Overall Study|Adverse Event|0|||
157237300|NCT00984126|567616602|FG002|Overall Study|Adverse Event|0|||
157237301|NCT00984126|567616603|FG003|Overall Study|Adverse Event|2|||
157237302|NCT00984126|567616600|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
157237303|NCT00984126|567616601|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
157237304|NCT00984126|567616602|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
157237305|NCT00984126|567616603|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
157237306|NCT00984126|567616600|FG000|Overall Study|Withdrawal criteria|0|||
157237307|NCT00984126|567616601|FG001|Overall Study|Withdrawal criteria|1|||
157237308|NCT00984126|567616602|FG002|Overall Study|Withdrawal criteria|3|||
157237309|NCT00984126|567616603|FG003|Overall Study|Withdrawal criteria|9|||
157088991|NCT01859988|567078247|FG003|Overall Study|Lost to Follow-up|0|||
157088992|NCT01859988|567078248|FG004|Overall Study|Lost to Follow-up|3|||
157088993|NCT01859988|567078249|FG005|Overall Study|Lost to Follow-up|2|||
157088994|NCT01859988|567078244|FG000|Overall Study|Protocol Violation|0|||
157237310|NCT01029340|567616604|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
157088995|NCT01859988|567078245|FG001|Overall Study|Protocol Violation|0|||
157088996|NCT01859988|567078246|FG002|Overall Study|Protocol Violation|1|||
157088997|NCT01859988|567078247|FG003|Overall Study|Protocol Violation|0|||
157088998|NCT01859988|567078248|FG004|Overall Study|Protocol Violation|0|||
157088999|NCT01859988|567078249|FG005|Overall Study|Protocol Violation|0|||
157089000|NCT01859988|567078244|FG000|Overall Study|Other than specified above|0|||
157089001|NCT01859988|567078245|FG001|Overall Study|Other than specified above|2|||
157089002|NCT01859988|567078246|FG002|Overall Study|Other than specified above|11|||
157089003|NCT01859988|567078247|FG003|Overall Study|Other than specified above|3|||
157089004|NCT01859988|567078248|FG004|Overall Study|Other than specified above|5|||
157089005|NCT01859988|567078249|FG005|Overall Study|Other than specified above|3|||
157089006|NCT02930226|567078250|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
157089007|NCT02930226|567078251|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
157089008|NCT02930226|567078252|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
157089009|NCT02930226|567078253|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
157089010|NCT02930226|567078254|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
157089011|NCT02930226|567078255|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
157089012|NCT00468559|567078256|FG000|Open-label Treatment Phase|Adverse Event|5|||
157089013|NCT00468559|567078257|FG001|Open-label Treatment Phase|Adverse Event|0|||
157089014|NCT00468559|567078258|FG002|Open-label Treatment Phase|Adverse Event|0|||
157089015|NCT00468559|567078256|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
157089016|NCT00468559|567078257|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
157089017|NCT00468559|567078258|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
157089018|NCT00468559|567078256|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
157089019|NCT00468559|567078257|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
157089020|NCT00468559|567078258|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
157089021|NCT00468559|567078256|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
157089022|NCT00468559|567078257|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
157089023|NCT00468559|567078258|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
157089024|NCT00468559|567078256|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
157089025|NCT00468559|567078257|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
157089026|NCT00468559|567078258|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
157089027|NCT00862719|567078259|FG000|Overall Study|Disease Progression|5|||
157089028|NCT00862719|567078260|FG001|Overall Study|Disease Progression|0|||
157089029|NCT00862719|567078261|FG002|Overall Study|Disease Progression|1|||
157089030|NCT00862719|567078262|FG003|Overall Study|Disease Progression|0|||
157089031|NCT00862719|567078259|FG000|Overall Study|Death|5|||
157089032|NCT00862719|567078260|FG001|Overall Study|Death|6|||
157089033|NCT00862719|567078261|FG002|Overall Study|Death|1|||
157089034|NCT00862719|567078262|FG003|Overall Study|Death|1|||
157089035|NCT00862719|567078259|FG000|Overall Study|Engraftment failure|0|||
157089036|NCT00862719|567078260|FG001|Overall Study|Engraftment failure|0|||
157089037|NCT00862719|567078261|FG002|Overall Study|Engraftment failure|1|||
157237311|NCT01029340|567616605|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
157237312|NCT01029340|567616606|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
157237313|NCT01029340|567616607|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
157237314|NCT01029340|567616608|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
157237315|NCT01029340|567616609|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
157237316|NCT01029340|567616604|FG000|Part B Treatment Period|Protocol Violation|0|||
157237317|NCT01029340|567616605|FG001|Part B Treatment Period|Protocol Violation|0|||
157237318|NCT01029340|567616606|FG002|Part B Treatment Period|Protocol Violation|1|||
157237319|NCT01029340|567616607|FG003|Part B Treatment Period|Protocol Violation|0|||
157237320|NCT01029340|567616608|FG004|Part B Treatment Period|Protocol Violation|0|||
157237321|NCT01029340|567616609|FG005|Part B Treatment Period|Protocol Violation|0|||
157237322|NCT01029340|567616604|FG000|Extension Period|Adverse Event|0|||
157237323|NCT01029340|567616605|FG001|Extension Period|Adverse Event|0|||
157237324|NCT01029340|567616606|FG002|Extension Period|Adverse Event|0|||
157237325|NCT01029340|567616607|FG003|Extension Period|Adverse Event|0|||
157237326|NCT01029340|567616608|FG004|Extension Period|Adverse Event|0|||
157237327|NCT01029340|567616609|FG005|Extension Period|Adverse Event|1|||
157237328|NCT01029340|567616604|FG000|Extension Period|starting another study|0|||
157237329|NCT01029340|567616605|FG001|Extension Period|starting another study|0|||
157237330|NCT01029340|567616606|FG002|Extension Period|starting another study|0|||
157089038|NCT00862719|567078262|FG003|Overall Study|Engraftment failure|0|||
157089039|NCT00862719|567078259|FG000|Overall Study|Veno-Occlusive Disease|0|||
157089040|NCT00862719|567078260|FG001|Overall Study|Veno-Occlusive Disease|0|||
157089041|NCT00862719|567078261|FG002|Overall Study|Veno-Occlusive Disease|1|||
157089042|NCT00862719|567078262|FG003|Overall Study|Veno-Occlusive Disease|0|||
157089043|NCT02703259|567078263|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
157089044|NCT02703259|567078264|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
157237331|NCT01029340|567616607|FG003|Extension Period|starting another study|0|||
157237332|NCT01029340|567616608|FG004|Extension Period|starting another study|0|||
157237333|NCT01029340|567616609|FG005|Extension Period|starting another study|8|||
157237334|NCT01029340|567616604|FG000|Extension Period|non-compliance|0|||
157089045|NCT02703259|567078263|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
157089046|NCT02703259|567078264|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
157089047|NCT02703259|567078263|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
157089048|NCT02703259|567078264|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
157089049|NCT01153958|567078265|FG000|Overall Study|Study Terminated|36|||
157089050|NCT01153958|567078266|FG001|Overall Study|Study Terminated|32|||
157089051|NCT02624791|567078267|FG000|Overall Study|Withdrawal by Subject|2|||
157089052|NCT02624791|567078268|FG001|Overall Study|Withdrawal by Subject|0|||
157089053|NCT02624791|567078269|FG002|Overall Study|Withdrawal by Subject|0|||
157089054|NCT02624791|567078270|FG003|Overall Study|Withdrawal by Subject|0|||
157089055|NCT02624791|567078271|FG004|Overall Study|Withdrawal by Subject|0|||
157089056|NCT02624791|567078272|FG005|Overall Study|Withdrawal by Subject|0|||
157089057|NCT00287690|567078276|FG000|Overall Study|Protocol Violation|20|||
157089058|NCT00287690|567078277|FG001|Overall Study|Protocol Violation|26|||
157089059|NCT01146782|567078278|FG000|Screening Cohort|Screen Failure|187|||
157089060|NCT01146782|567078278|FG000|Screening Cohort|Lost to Follow-up|4|||
157089061|NCT01146782|567078278|FG000|Screening Cohort|Physician Decision|1|||
157089062|NCT01146782|567078278|FG000|Screening Cohort|Withdrawal by Subject|29|||
157089063|NCT01146782|567078278|FG000|Safety Cohort|Screen Failure|61|||
157089064|NCT01146782|567078278|FG000|Safety Cohort|Withdrawal by Subject|4|||
157089065|NCT01146782|567078278|FG000|Safety Cohort|Control AHI <5|4|||
157089066|NCT01146782|567078278|FG000|Safety Cohort|TST <4 hrs|14|||
157089067|NCT01146782|567078278|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
157089068|NCT01146782|567078278|FG000|Primary Endpoint Cohort|Physician Decision|1|||
157089069|NCT01605916|567078279|FG000|Overall Study|Adverse Event|1|||
157089070|NCT01605916|567078280|FG001|Overall Study|Adverse Event|0|||
157089071|NCT01605916|567078281|FG002|Overall Study|Adverse Event|0|||
157089072|NCT01605916|567078282|FG003|Overall Study|Adverse Event|1|||
157089073|NCT01605916|567078283|FG004|Overall Study|Adverse Event|0|||
157089074|NCT01605916|567078279|FG000|Overall Study|Lack of Efficacy|2|||
157089075|NCT01605916|567078280|FG001|Overall Study|Lack of Efficacy|3|||
157089076|NCT01605916|567078281|FG002|Overall Study|Lack of Efficacy|3|||
157089077|NCT01605916|567078282|FG003|Overall Study|Lack of Efficacy|5|||
157089078|NCT01605916|567078283|FG004|Overall Study|Lack of Efficacy|4|||
157089079|NCT01605916|567078279|FG000|Overall Study|Withdrawal by Subject|1|||
157089080|NCT01605916|567078280|FG001|Overall Study|Withdrawal by Subject|1|||
157089081|NCT01605916|567078281|FG002|Overall Study|Withdrawal by Subject|0|||
157089082|NCT01605916|567078282|FG003|Overall Study|Withdrawal by Subject|0|||
157089083|NCT01605916|567078283|FG004|Overall Study|Withdrawal by Subject|2|||
157089084|NCT02414932|567078284|FG000|Overall Study|Withdrawal by Subject|2|||
157089085|NCT02414932|567078285|FG001|Overall Study|Withdrawal by Subject|3|||
157089086|NCT02414932|567078284|FG000|Overall Study|Adverse Event|1|||
157089087|NCT02414932|567078285|FG001|Overall Study|Adverse Event|0|||
157089088|NCT00470366|567078286|FG000|Overall Study|Adverse Event|3|||
157089089|NCT00470366|567078286|FG000|Overall Study|Poor compliance|1|||
157089090|NCT01021215|567078293|FG000|Overall Study|Lost to Follow-up|3|||
157089091|NCT01021215|567078294|FG001|Overall Study|Lost to Follow-up|0|||
157089092|NCT02047903|567078297|FG000|Overall Study|Adverse Event|14|||
157089093|NCT02047903|567078297|FG000|Overall Study|Serious adverse event|10|||
157089094|NCT02047903|567078297|FG000|Overall Study|Withdrawal by Subject|16|||
157089095|NCT02047903|567078297|FG000|Overall Study|Lost to Follow-up|4|||
157089096|NCT02047903|567078297|FG000|Overall Study|Reason not listed|6|||
157089097|NCT02047903|567078297|FG000|Overall Study|Not Treated|9|||
157089098|NCT01014533|567078298|FG000|Overall Study|Protocol Violation|3|||
157089099|NCT01014533|567078299|FG001|Overall Study|Protocol Violation|2|||
157089100|NCT01014533|567078298|FG000|Overall Study|Withdrawal by Subject|2|||
157089101|NCT01014533|567078299|FG001|Overall Study|Withdrawal by Subject|0|||
157089102|NCT01014533|567078298|FG000|Overall Study|unable to come to appointment|0|||
157089103|NCT01014533|567078299|FG001|Overall Study|unable to come to appointment|3|||
157196788|NCT01238861|567463778|FG002|Overall Study|Withdrawal by Subject|4|||
157196789|NCT01238861|567463779|FG003|Overall Study|Withdrawal by Subject|8|||
157196790|NCT01238861|567463780|FG004|Overall Study|Withdrawal by Subject|10|||
157196791|NCT01238861|567463781|FG005|Overall Study|Withdrawal by Subject|9|||
157196792|NCT03737812|567463782|FG000|Overall Study|Withdrawal by Subject|1|||
157089104|NCT02689518|567078302|FG000|Overall Study|Withdrawal by Subject|3|||
157089105|NCT01942590|567078303|FG000|Overall Study|Withdrawal by Subject|0|||
157089106|NCT01942590|567078304|FG001|Overall Study|Withdrawal by Subject|1|||
157089107|NCT01942590|567078303|FG000|Overall Study|Adverse Event|1|||
157089108|NCT01942590|567078304|FG001|Overall Study|Adverse Event|0|||
157089109|NCT01226095|567078307|FG000|Overall Study|Poor compliance|1|||
157089110|NCT01688830|567078308|FG000|Overall Study|Lost to Follow-up|0|||
157089111|NCT01688830|567078309|FG001|Overall Study|Lost to Follow-up|0|||
157089112|NCT01688830|567078310|FG002|Overall Study|Lost to Follow-up|0|||
157089113|NCT01688830|567078311|FG003|Overall Study|Lost to Follow-up|0|||
157089114|NCT01688830|567078312|FG004|Overall Study|Lost to Follow-up|0|||
157089115|NCT01688830|567078313|FG005|Overall Study|Lost to Follow-up|0|||
157089116|NCT01688830|567078314|FG006|Overall Study|Lost to Follow-up|0|||
157089117|NCT01688830|567078315|FG007|Overall Study|Lost to Follow-up|0|||
157089118|NCT01688830|567078316|FG008|Overall Study|Lost to Follow-up|0|||
157089119|NCT01688830|567078317|FG009|Overall Study|Lost to Follow-up|0|||
157089120|NCT01688830|567078318|FG010|Overall Study|Lost to Follow-up|1|||
157089121|NCT01688830|567078319|FG011|Overall Study|Lost to Follow-up|0|||
157089122|NCT01688830|567078320|FG012|Overall Study|Lost to Follow-up|0|||
157089123|NCT01688830|567078321|FG013|Overall Study|Lost to Follow-up|0|||
157089124|NCT01688830|567078322|FG014|Overall Study|Lost to Follow-up|0|||
157089125|NCT01688830|567078323|FG015|Overall Study|Lost to Follow-up|0|||
157089126|NCT01688830|567078324|FG016|Overall Study|Lost to Follow-up|0|||
157089127|NCT01688830|567078325|FG017|Overall Study|Lost to Follow-up|0|||
157089128|NCT01688830|567078326|FG018|Overall Study|Lost to Follow-up|0|||
157089129|NCT01688830|567078327|FG019|Overall Study|Lost to Follow-up|0|||
157089130|NCT01688830|567078328|FG020|Overall Study|Lost to Follow-up|0|||
157089131|NCT04822597|567078329|FG000|Overall Study|Withdrawal by Subject|0|||
157089132|NCT04822597|567078330|FG001|Overall Study|Withdrawal by Subject|1|||
157089133|NCT04822597|567078331|FG002|Overall Study|Withdrawal by Subject|1|||
157089134|NCT04822597|567078332|FG003|Overall Study|Withdrawal by Subject|0|||
157089135|NCT04822597|567078329|FG000|Overall Study|Physician Decision|0|||
157089136|NCT04822597|567078330|FG001|Overall Study|Physician Decision|0|||
157089137|NCT04822597|567078331|FG002|Overall Study|Physician Decision|1|||
157089138|NCT04822597|567078332|FG003|Overall Study|Physician Decision|1|||
157089139|NCT04822597|567078329|FG000|Overall Study|Subject withdrawn after enrollment|0|||
157089140|NCT04822597|567078330|FG001|Overall Study|Subject withdrawn after enrollment|1|||
157089141|NCT04822597|567078331|FG002|Overall Study|Subject withdrawn after enrollment|0|||
157089142|NCT04822597|567078332|FG003|Overall Study|Subject withdrawn after enrollment|1|||
157089143|NCT04822597|567078329|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
157089144|NCT04822597|567078330|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
157089145|NCT04822597|567078331|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
157089146|NCT04822597|567078332|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
157089147|NCT00911768|567078338|FG000|Overall Study|Protocol Violation|5|||
157089148|NCT00911768|567078339|FG001|Overall Study|Protocol Violation|4|||
157089149|NCT00911768|567078338|FG000|Overall Study|Withdrawal by Subject|1|||
157089150|NCT00911768|567078339|FG001|Overall Study|Withdrawal by Subject|0|||
157089151|NCT03406078|567078341|FG000|Overall Study|Death|1|||
157089152|NCT03406078|567078342|FG001|Overall Study|Death|0|||
157089153|NCT03406078|567078341|FG000|Overall Study|Lost to Follow-up|0|||
157089154|NCT03406078|567078342|FG001|Overall Study|Lost to Follow-up|1|||
157089155|NCT03406078|567078341|FG000|Overall Study|Withdrawal by Subject|5|||
157089156|NCT03406078|567078342|FG001|Overall Study|Withdrawal by Subject|2|||
157089157|NCT03616977|567078346|FG000|Period 1|Physician Decision|0|||
157089158|NCT03616977|567078347|FG001|Period 1|Physician Decision|1|||
157089159|NCT03616977|567078346|FG000|Period 3|Adverse Event|1|||
157089160|NCT03616977|567078347|FG001|Period 3|Adverse Event|1|||
157089161|NCT00591851|567078348|FG000|Overall Study|Withdrawal by Subject|3|||
157089162|NCT00591851|567078348|FG000|Overall Study|Adverse Event|2|||
157089163|NCT00591851|567078348|FG000|Overall Study|Progressive Disease|1|||
157089164|NCT00515853|567078349|FG000|Overall Study|Lost to Follow-up|9|||
157089165|NCT00515853|567078350|FG001|Overall Study|Lost to Follow-up|13|||
157089166|NCT00515853|567078349|FG000|Overall Study|Withdrawal by Subject|6|||
157089167|NCT00515853|567078350|FG001|Overall Study|Withdrawal by Subject|4|||
157089168|NCT03965351|567078351|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
157089169|NCT03965351|567078352|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
157089170|NCT03965351|567078351|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
157089171|NCT03965351|567078352|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
157089172|NCT02859324|567078353|FG000|Overall Study|Death|4|||
157089173|NCT02859324|567078354|FG001|Overall Study|Death|6|||
157089174|NCT02859324|567078355|FG002|Overall Study|Death|5|||
157089175|NCT02859324|567078353|FG000|Overall Study|Other reasons|3|||
157089176|NCT02859324|567078354|FG001|Overall Study|Other reasons|3|||
157089177|NCT02859324|567078355|FG002|Overall Study|Other reasons|0|||
157089178|NCT05593445|567078356|FG000|12-Week DBVC Period|Adverse Event|1|||
157089179|NCT05593445|567078357|FG001|12-Week DBVC Period|Adverse Event|0|||
157089180|NCT05593445|567078358|FG002|12-Week DBVC Period|Adverse Event|0|||
157089181|NCT05593445|567078359|FG003|12-Week DBVC Period|Adverse Event|0|||
157089182|NCT05593445|567078356|FG000|12-Week DBVC Period|Physician Decision|0|||
157089183|NCT05593445|567078357|FG001|12-Week DBVC Period|Physician Decision|1|||
157089184|NCT05593445|567078358|FG002|12-Week DBVC Period|Physician Decision|0|||
157089185|NCT05593445|567078359|FG003|12-Week DBVC Period|Physician Decision|0|||
157089186|NCT05593445|567078356|FG000|12-Week DBVC Period|Protocol Violation|0|||
157089187|NCT05593445|567078357|FG001|12-Week DBVC Period|Protocol Violation|1|||
157089188|NCT05593445|567078358|FG002|12-Week DBVC Period|Protocol Violation|0|||
157089189|NCT05593445|567078359|FG003|12-Week DBVC Period|Protocol Violation|0|||
157089190|NCT05593445|567078356|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
157089191|NCT05593445|567078357|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
157089192|NCT05593445|567078358|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
157089193|NCT05593445|567078359|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
157237335|NCT01029340|567616605|FG001|Extension Period|non-compliance|0|||
157089194|NCT05593445|567078356|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
157089195|NCT05593445|567078357|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
157089196|NCT05593445|567078358|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
157089197|NCT05593445|567078359|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
157089198|NCT05593445|567078356|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
157089199|NCT05593445|567078357|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
157089200|NCT05593445|567078358|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
157089201|NCT05593445|567078359|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
157089202|NCT05593445|567078356|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
157089203|NCT05593445|567078357|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
157089204|NCT05593445|567078358|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
157089205|NCT05593445|567078359|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
157089206|NCT05593445|567078356|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
157089207|NCT05593445|567078357|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
157089208|NCT05593445|567078358|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
157089209|NCT05593445|567078359|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
157089210|NCT05559476|567078360|FG000|Overall Study|Adverse Event|2|||
157089211|NCT05559476|567078361|FG001|Overall Study|Adverse Event|0|||
157089212|NCT05559476|567078360|FG000|Overall Study|Lost to Follow-up|13|||
157089213|NCT05559476|567078361|FG001|Overall Study|Lost to Follow-up|12|||
157089214|NCT05559476|567078360|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
157089215|NCT05559476|567078361|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
157089216|NCT05559476|567078360|FG000|Overall Study|Other|0|||
157089217|NCT05559476|567078361|FG001|Overall Study|Other|2|||
157089218|NCT05110690|567078362|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
157089219|NCT05110690|567078362|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
157089220|NCT05110690|567078362|FG000|Completion of Intervention|Lost to Follow-up|1|||
157089221|NCT05110690|567078362|FG000|Completion of Intervention|Death|1|||
157089222|NCT05110690|567078362|FG000|Completion of Intervention|Withdrawal by Subject|2|||
157089223|NCT02186223|567079634|FG000|Overall Study|Not eligible for device placement|6|||
157089224|NCT02186223|567079634|FG000|Overall Study|Unable to obtain femoral access|3|||
157089225|NCT02186223|567079634|FG000|Overall Study|Death|3|||
157089226|NCT02186223|567079634|FG000|Overall Study|Device in place less than 48 hours|9|||
157089227|NCT00252733|567079635|FG000|Overall Study|Withdrawal by Subject|73|||
157089228|NCT00252733|567079636|FG001|Overall Study|Withdrawal by Subject|67|||
157089229|NCT00252733|567079635|FG000|Overall Study|Death|7|||
157089230|NCT00252733|567079636|FG001|Overall Study|Death|5|||
157089231|NCT00252733|567079635|FG000|Overall Study|Lost to Follow-up|12|||
157089232|NCT00252733|567079636|FG001|Overall Study|Lost to Follow-up|6|||
157089233|NCT00252733|567079635|FG000|Overall Study|Multiple Reasons|14|||
157089234|NCT00252733|567079636|FG001|Overall Study|Multiple Reasons|14|||
157089235|NCT00618982|567079637|FG000|Overall Study|Adverse Event|23|||
157089236|NCT00618982|567079637|FG000|Overall Study|Withdrawal by Subject|1|||
157089237|NCT00618982|567079637|FG000|Overall Study|Protocol Violation|1|||
157089238|NCT00618982|567079637|FG000|Overall Study|ongoing, still treated with study med.|25|||
157089239|NCT04101318|567079641|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
157089240|NCT04101318|567079642|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
157089241|NCT04101318|567079641|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
157089242|NCT04101318|567079642|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
157196793|NCT03737812|567463783|FG001|Overall Study|Withdrawal by Subject|2|||
157089243|NCT04101318|567079641|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
157196794|NCT03737812|567463784|FG002|Overall Study|Withdrawal by Subject|1|||
157196795|NCT03737812|567463782|FG000|Overall Study|Sponsor Discontinued the Study|4|||
157196796|NCT03737812|567463783|FG001|Overall Study|Sponsor Discontinued the Study|3|||
157196797|NCT03737812|567463784|FG002|Overall Study|Sponsor Discontinued the Study|2|||
157196798|NCT03737812|567463782|FG000|Overall Study|Adverse Event|0|||
157196799|NCT03737812|567463783|FG001|Overall Study|Adverse Event|1|||
157196800|NCT03737812|567463784|FG002|Overall Study|Adverse Event|0|||
157196801|NCT03737812|567463782|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
157196802|NCT03737812|567463783|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
157196803|NCT03737812|567463784|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
157196804|NCT02557308|567463787|FG000|Overall Study|Withdrawal by Subject|11|||
157196805|NCT02557308|567463788|FG001|Overall Study|Withdrawal by Subject|3|||
157196806|NCT02557308|567463789|FG002|Overall Study|Withdrawal by Subject|2|||
157089244|NCT04101318|567079642|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
157089245|NCT00717067|567079643|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
157089246|NCT00717067|567079644|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
157089247|NCT00717067|567079645|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
157089248|NCT00717067|567079646|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
157089249|NCT00717067|567079647|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
157196807|NCT02557308|567463790|FG003|Overall Study|Withdrawal by Subject|0|||
157196808|NCT02557308|567463791|FG004|Overall Study|Withdrawal by Subject|1|||
157237336|NCT01029340|567616606|FG002|Extension Period|non-compliance|0|||
157237337|NCT01029340|567616607|FG003|Extension Period|non-compliance|0|||
157237338|NCT01029340|567616608|FG004|Extension Period|non-compliance|0|||
157237339|NCT01029340|567616609|FG005|Extension Period|non-compliance|1|||
157237340|NCT01029340|567616604|FG000|Extension Period|Withdrawal by Subject|0|||
157237341|NCT01029340|567616605|FG001|Extension Period|Withdrawal by Subject|0|||
157237342|NCT01029340|567616606|FG002|Extension Period|Withdrawal by Subject|0|||
157237343|NCT01029340|567616607|FG003|Extension Period|Withdrawal by Subject|0|||
157237344|NCT01029340|567616608|FG004|Extension Period|Withdrawal by Subject|0|||
157237345|NCT01029340|567616609|FG005|Extension Period|Withdrawal by Subject|1|||
157237346|NCT01029340|567616604|FG000|Extension Period|Physician Decision|0|||
157237347|NCT01029340|567616605|FG001|Extension Period|Physician Decision|0|||
157237348|NCT01029340|567616606|FG002|Extension Period|Physician Decision|0|||
157237349|NCT01029340|567616607|FG003|Extension Period|Physician Decision|0|||
157237350|NCT01029340|567616608|FG004|Extension Period|Physician Decision|0|||
157237351|NCT01029340|567616609|FG005|Extension Period|Physician Decision|1|||
157237352|NCT02648347|567616613|FG000|Overall Study|Death|174|||
157237353|NCT02648347|567616614|FG001|Overall Study|Death|167|||
157237354|NCT02648347|567616613|FG000|Overall Study|Withdrawal by Subject|16|||
157237355|NCT02648347|567616614|FG001|Overall Study|Withdrawal by Subject|9|||
157237356|NCT02648347|567616613|FG000|Overall Study|Lost to Follow-up|18|||
157237357|NCT02648347|567616614|FG001|Overall Study|Lost to Follow-up|21|||
157237358|NCT02648347|567616613|FG000|Overall Study|Missing|1|||
157237359|NCT02648347|567616614|FG001|Overall Study|Missing|0|||
157237360|NCT02196675|567616618|FG000|Overall Study|Withdrawal by Subject|1|||
157237361|NCT02196675|567616619|FG001|Overall Study|Withdrawal by Subject|0|||
157237362|NCT02196675|567616620|FG002|Overall Study|Withdrawal by Subject|0|||
157237363|NCT02196675|567616618|FG000|Overall Study|Intra-operative surgical exclusion|1|||
157237364|NCT02196675|567616619|FG001|Overall Study|Intra-operative surgical exclusion|1|||
157237365|NCT02196675|567616620|FG002|Overall Study|Intra-operative surgical exclusion|0|||
157237366|NCT02196675|567616618|FG000|Overall Study|Protocol Violation|0|||
157237367|NCT02196675|567616619|FG001|Overall Study|Protocol Violation|1|||
157237368|NCT02196675|567616620|FG002|Overall Study|Protocol Violation|0|||
157237369|NCT02196675|567616618|FG000|Overall Study|Death|0|||
157237370|NCT02196675|567616619|FG001|Overall Study|Death|0|||
157237371|NCT02196675|567616620|FG002|Overall Study|Death|1|||
157237372|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
157089250|NCT00657020|567079650|FG000|PERIOD 1|Adverse Event|0|||
157089251|NCT00657020|567079651|FG001|PERIOD 1|Adverse Event|1|||
157089252|NCT02966301|567079657|FG000|Overall Study|Death|2|||
157089253|NCT02966301|567079657|FG000|Overall Study|Withdrawal by Subject|1|||
157089254|NCT02937454|567079658|FG000|Overall Study|Adverse Event|0|||
157089255|NCT02937454|567079659|FG001|Overall Study|Adverse Event|1|||
157089256|NCT02937454|567079658|FG000|Overall Study|Death|98|||
157089257|NCT02937454|567079659|FG001|Overall Study|Death|95|||
157089258|NCT02937454|567079658|FG000|Overall Study|Lost to Follow-up|1|||
157089259|NCT02937454|567079659|FG001|Overall Study|Lost to Follow-up|1|||
157089260|NCT02937454|567079658|FG000|Overall Study|Physician Decision|0|||
157089261|NCT02937454|567079659|FG001|Overall Study|Physician Decision|1|||
157089262|NCT02937454|567079658|FG000|Overall Study|Protocol Violation|6|||
157089263|NCT02937454|567079659|FG001|Overall Study|Protocol Violation|10|||
157089264|NCT02937454|567079658|FG000|Overall Study|Withdrawal by Subject|27|||
157089265|NCT02937454|567079659|FG001|Overall Study|Withdrawal by Subject|15|||
157237373|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
157237374|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
157237375|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
157089266|NCT02937454|567079658|FG000|Overall Study|Other|8|||
157237376|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
157237377|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
157237378|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
157237379|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
157089267|NCT02937454|567079659|FG001|Overall Study|Other|5|||
157237380|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
157237381|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
157237382|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
157089268|NCT01375114|567079661|FG000|Overall Study|Lost to Follow-up|1|||
157089269|NCT01375114|567079662|FG001|Overall Study|Lost to Follow-up|0|||
157089270|NCT01375114|567079663|FG002|Overall Study|Lost to Follow-up|1|||
157089271|NCT01375114|567079661|FG000|Overall Study|Disease Progression|3|||
157089272|NCT01375114|567079662|FG001|Overall Study|Disease Progression|2|||
157089273|NCT01375114|567079663|FG002|Overall Study|Disease Progression|2|||
157089274|NCT01375114|567079661|FG000|Overall Study|Patient Changed Mind|0|||
157089275|NCT01375114|567079662|FG001|Overall Study|Patient Changed Mind|0|||
157237383|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
157237384|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
157237385|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
157196809|NCT02557308|567463792|FG005|Overall Study|Withdrawal by Subject|0|||
157196810|NCT02557308|567463793|FG006|Overall Study|Withdrawal by Subject|10|||
157196811|NCT02557308|567463794|FG007|Overall Study|Withdrawal by Subject|1|||
157196812|NCT02557308|567463787|FG000|Overall Study|Disease Progression|0|||
157196813|NCT02557308|567463788|FG001|Overall Study|Disease Progression|1|||
157196814|NCT02557308|567463789|FG002|Overall Study|Disease Progression|0|||
157196815|NCT02557308|567463790|FG003|Overall Study|Disease Progression|0|||
157196816|NCT02557308|567463791|FG004|Overall Study|Disease Progression|0|||
157196817|NCT02557308|567463792|FG005|Overall Study|Disease Progression|0|||
157196818|NCT02557308|567463793|FG006|Overall Study|Disease Progression|0|||
157196819|NCT02557308|567463794|FG007|Overall Study|Disease Progression|0|||
157196820|NCT02557308|567463787|FG000|Overall Study|Lack of Efficacy|3|||
157196821|NCT02557308|567463788|FG001|Overall Study|Lack of Efficacy|0|||
157196822|NCT02557308|567463789|FG002|Overall Study|Lack of Efficacy|0|||
157196823|NCT02557308|567463790|FG003|Overall Study|Lack of Efficacy|0|||
157196824|NCT02557308|567463791|FG004|Overall Study|Lack of Efficacy|0|||
157196825|NCT02557308|567463792|FG005|Overall Study|Lack of Efficacy|0|||
157196826|NCT02557308|567463793|FG006|Overall Study|Lack of Efficacy|1|||
157196827|NCT02557308|567463794|FG007|Overall Study|Lack of Efficacy|0|||
157196828|NCT02557308|567463787|FG000|Overall Study|Adverse Event|4|||
157196829|NCT02557308|567463788|FG001|Overall Study|Adverse Event|1|||
157196830|NCT02557308|567463789|FG002|Overall Study|Adverse Event|2|||
157196831|NCT02557308|567463790|FG003|Overall Study|Adverse Event|0|||
157196832|NCT02557308|567463791|FG004|Overall Study|Adverse Event|0|||
157196833|NCT02557308|567463792|FG005|Overall Study|Adverse Event|0|||
157196834|NCT02557308|567463793|FG006|Overall Study|Adverse Event|4|||
157196835|NCT02557308|567463794|FG007|Overall Study|Adverse Event|1|||
157196836|NCT02557308|567463787|FG000|Overall Study|Lost to Follow-up|2|||
157196837|NCT02557308|567463788|FG001|Overall Study|Lost to Follow-up|0|||
157196838|NCT02557308|567463789|FG002|Overall Study|Lost to Follow-up|1|||
157196839|NCT02557308|567463790|FG003|Overall Study|Lost to Follow-up|0|||
157196840|NCT02557308|567463791|FG004|Overall Study|Lost to Follow-up|0|||
157196841|NCT02557308|567463792|FG005|Overall Study|Lost to Follow-up|0|||
157196842|NCT02557308|567463793|FG006|Overall Study|Lost to Follow-up|2|||
157196843|NCT02557308|567463794|FG007|Overall Study|Lost to Follow-up|0|||
157196844|NCT02557308|567463787|FG000|Overall Study|Death|1|||
157196845|NCT02557308|567463788|FG001|Overall Study|Death|0|||
157196846|NCT02557308|567463789|FG002|Overall Study|Death|0|||
157196847|NCT02557308|567463790|FG003|Overall Study|Death|0|||
157196848|NCT02557308|567463791|FG004|Overall Study|Death|0|||
157196849|NCT02557308|567463792|FG005|Overall Study|Death|0|||
157196850|NCT02557308|567463793|FG006|Overall Study|Death|0|||
157196851|NCT02557308|567463794|FG007|Overall Study|Death|0|||
157196852|NCT02557308|567463787|FG000|Overall Study|Study Close|98|||
157196853|NCT02557308|567463788|FG001|Overall Study|Study Close|18|||
157196854|NCT02557308|567463789|FG002|Overall Study|Study Close|5|||
157196855|NCT02557308|567463790|FG003|Overall Study|Study Close|3|||
157196856|NCT02557308|567463791|FG004|Overall Study|Study Close|1|||
157196857|NCT02557308|567463792|FG005|Overall Study|Study Close|0|||
157196858|NCT02557308|567463793|FG006|Overall Study|Study Close|123|||
157196859|NCT02557308|567463794|FG007|Overall Study|Study Close|5|||
157196860|NCT02557308|567463787|FG000|Overall Study|Except for study close|5|||
157196861|NCT02557308|567463788|FG001|Overall Study|Except for study close|0|||
157196862|NCT02557308|567463789|FG002|Overall Study|Except for study close|0|||
157196863|NCT02557308|567463790|FG003|Overall Study|Except for study close|0|||
157196864|NCT02557308|567463791|FG004|Overall Study|Except for study close|3|||
157196865|NCT02557308|567463792|FG005|Overall Study|Except for study close|0|||
157196866|NCT02557308|567463793|FG006|Overall Study|Except for study close|6|||
157196867|NCT02557308|567463794|FG007|Overall Study|Except for study close|10|||
157196868|NCT03911401|567463795|FG000|Overall Study|Adverse Event|1|||
157196869|NCT03911401|567463796|FG001|Overall Study|Adverse Event|2|||
157196870|NCT03911401|567463797|FG002|Overall Study|Adverse Event|5|||
157196871|NCT03911401|567463795|FG000|Overall Study|Lack of Efficacy|1|||
157196872|NCT03911401|567463796|FG001|Overall Study|Lack of Efficacy|1|||
157196873|NCT03911401|567463797|FG002|Overall Study|Lack of Efficacy|8|||
157196874|NCT03911401|567463795|FG000|Overall Study|Physician Decision|0|||
157196875|NCT03911401|567463796|FG001|Overall Study|Physician Decision|0|||
157196876|NCT03911401|567463797|FG002|Overall Study|Physician Decision|1|||
157196877|NCT03911401|567463795|FG000|Overall Study|Withdrawal by Subject|1|||
157196878|NCT03911401|567463796|FG001|Overall Study|Withdrawal by Subject|2|||
157196879|NCT03911401|567463797|FG002|Overall Study|Withdrawal by Subject|0|||
157196880|NCT03911401|567463795|FG000|Overall Study|Withdrawal by parent/guardian|4|||
157196881|NCT03911401|567463796|FG001|Overall Study|Withdrawal by parent/guardian|4|||
157196882|NCT03911401|567463797|FG002|Overall Study|Withdrawal by parent/guardian|11|||
157196883|NCT06104423|567463798|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
157196884|NCT06104423|567463799|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
157196885|NCT06104423|567463800|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
157196886|NCT06104423|567463798|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
157196887|NCT06104423|567463799|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
157237386|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
157237387|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
157237388|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
157237389|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
157237390|NCT02009163|567616621|FG000|Open-label Period (Non-randomized)|Other|13|||
157237391|NCT02009163|567616622|FG001|Open-label Period (Non-randomized)|Other|0|||
157237392|NCT02009163|567616623|FG002|Open-label Period (Non-randomized)|Other|0|||
157237393|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
157237394|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
157237395|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
157237396|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
157237397|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
157237398|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
157237399|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Adverse Event|0|||
157237400|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Adverse Event|0|||
157237401|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Adverse Event|6|||
157237402|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
157237403|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
157237404|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
157237405|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
157237406|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
157237407|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
157237408|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Pregnancy|0|||
157237409|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Pregnancy|0|||
157237410|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Pregnancy|2|||
157237411|NCT02009163|567616621|FG000|Randomized-withdrawal Period|Other|0|||
157237412|NCT02009163|567616622|FG001|Randomized-withdrawal Period|Other|9|||
157237413|NCT02009163|567616623|FG002|Randomized-withdrawal Period|Other|5|||
157237414|NCT00359281|567616624|FG000|Overall Study|Adverse Event|1|||
157089276|NCT01375114|567079663|FG002|Overall Study|Patient Changed Mind|2|||
157089277|NCT01375114|567079661|FG000|Overall Study|Pruritus|0|||
157237415|NCT00359281|567616625|FG001|Overall Study|Adverse Event|0|||
157237416|NCT00359281|567616626|FG002|Overall Study|Adverse Event|0|||
157237417|NCT00359281|567616627|FG003|Overall Study|Adverse Event|0|||
157237418|NCT00359281|567616628|FG004|Overall Study|Adverse Event|0|||
157237419|NCT00359281|567616629|FG005|Overall Study|Adverse Event|0|||
157237420|NCT00359281|567616630|FG006|Overall Study|Adverse Event|1|||
157237421|NCT00359281|567616631|FG007|Overall Study|Adverse Event|0|||
157237422|NCT00359281|567616632|FG008|Overall Study|Adverse Event|0|||
157237423|NCT00359281|567616624|FG000|Overall Study|Withdrawal by Subject|0|||
157237424|NCT00359281|567616625|FG001|Overall Study|Withdrawal by Subject|0|||
157089278|NCT01375114|567079662|FG001|Overall Study|Pruritus|0|||
157089279|NCT01375114|567079663|FG002|Overall Study|Pruritus|1|||
157089280|NCT01375114|567079661|FG000|Overall Study|Restlessness|0|||
157089281|NCT01375114|567079662|FG001|Overall Study|Restlessness|0|||
157089282|NCT01375114|567079663|FG002|Overall Study|Restlessness|1|||
157089283|NCT01375114|567079661|FG000|Overall Study|Diarrhea|0|||
157089284|NCT01375114|567079662|FG001|Overall Study|Diarrhea|0|||
157089285|NCT01375114|567079663|FG002|Overall Study|Diarrhea|1|||
157089286|NCT01375114|567079661|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
157089287|NCT01375114|567079662|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
157089288|NCT01375114|567079663|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
157089289|NCT01375114|567079661|FG000|Overall Study|Nausea|0|||
157089290|NCT01375114|567079662|FG001|Overall Study|Nausea|1|||
157089291|NCT01375114|567079663|FG002|Overall Study|Nausea|0|||
157089292|NCT01375114|567079661|FG000|Overall Study|Increased AST/ALT|0|||
157089293|NCT01375114|567079662|FG001|Overall Study|Increased AST/ALT|1|||
157089294|NCT01375114|567079663|FG002|Overall Study|Increased AST/ALT|0|||
157089295|NCT01375114|567079661|FG000|Overall Study|Vaginal Hemorrhage|0|||
157089296|NCT01375114|567079662|FG001|Overall Study|Vaginal Hemorrhage|1|||
157237425|NCT00359281|567616626|FG002|Overall Study|Withdrawal by Subject|0|||
157237426|NCT00359281|567616627|FG003|Overall Study|Withdrawal by Subject|0|||
157089297|NCT01375114|567079663|FG002|Overall Study|Vaginal Hemorrhage|0|||
157089298|NCT01375114|567079661|FG000|Overall Study|Family problem|0|||
157089299|NCT01375114|567079662|FG001|Overall Study|Family problem|1|||
157089300|NCT01375114|567079663|FG002|Overall Study|Family problem|0|||
157089301|NCT01375114|567079661|FG000|Overall Study|Protocol Violation|2|||
157089302|NCT01375114|567079662|FG001|Overall Study|Protocol Violation|0|||
157089303|NCT01375114|567079663|FG002|Overall Study|Protocol Violation|0|||
157089304|NCT01474434|567079668|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
157237427|NCT00359281|567616628|FG004|Overall Study|Withdrawal by Subject|0|||
157237428|NCT00359281|567616629|FG005|Overall Study|Withdrawal by Subject|0|||
157237429|NCT00359281|567616630|FG006|Overall Study|Withdrawal by Subject|1|||
157237430|NCT00359281|567616631|FG007|Overall Study|Withdrawal by Subject|0|||
157237431|NCT00359281|567616632|FG008|Overall Study|Withdrawal by Subject|0|||
157237432|NCT00838279|567616633|FG000|Washout|Protocol Violation|1|||
157089305|NCT01474434|567079669|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
157089306|NCT01474434|567079670|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
157089307|NCT01474434|567079671|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
157089308|NCT01474434|567079668|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
157089309|NCT01474434|567079669|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
157089310|NCT01474434|567079670|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
157089311|NCT01474434|567079671|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
157089312|NCT01474434|567079668|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
157089313|NCT01474434|567079669|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
157089314|NCT01474434|567079670|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
157089315|NCT01474434|567079671|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
157089316|NCT00993668|567079672|FG000|Single-Blind Period|Adverse Event|1|||
157089317|NCT00993668|567079673|FG001|Single-Blind Period|Adverse Event|1|||
157089318|NCT00993668|567079672|FG000|Single-Blind Period|Lack of Efficacy|0|||
157089319|NCT00993668|567079673|FG001|Single-Blind Period|Lack of Efficacy|1|||
157089320|NCT00993668|567079672|FG000|Single-Blind Period|Lost to Follow-up|3|||
157089321|NCT00993668|567079673|FG001|Single-Blind Period|Lost to Follow-up|1|||
157089322|NCT00993668|567079672|FG000|Open-Label Period|Adverse Event|9|||
157089323|NCT00993668|567079673|FG001|Open-Label Period|Adverse Event|8|||
157089324|NCT00993668|567079672|FG000|Open-Label Period|Lack of Efficacy|4|||
157089325|NCT00993668|567079673|FG001|Open-Label Period|Lack of Efficacy|3|||
157089326|NCT00993668|567079672|FG000|Open-Label Period|Withdrawal by Subject|4|||
157089327|NCT00993668|567079673|FG001|Open-Label Period|Withdrawal by Subject|3|||
157089328|NCT00993668|567079672|FG000|Open-Label Period|Lost to Follow-up|6|||
157089329|NCT00993668|567079673|FG001|Open-Label Period|Lost to Follow-up|1|||
157089330|NCT02207569|567079675|FG000|1-Month|Death|6|||
157089331|NCT02207569|567079675|FG000|1-Month|Withdrawal by Subject|2|||
157089332|NCT02207569|567079675|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
157089333|NCT02207569|567079675|FG000|6-Month|Death|8|||
157089334|NCT02207569|567079675|FG000|6-Month|Withdrawal by Subject|2|||
157089335|NCT02207569|567079675|FG000|12-Month|Death|14|||
157089336|NCT02207569|567079675|FG000|12-Month|Withdrawal by Subject|2|||
157089337|NCT02207569|567079675|FG000|24-Month|Death|23|||
157089338|NCT02207569|567079675|FG000|24-Month|Withdrawal by Subject|3|||
157089339|NCT02207569|567079675|FG000|36-Month|Death|23|||
157089340|NCT02207569|567079675|FG000|36-Month|Withdrawal by Subject|4|||
157089341|NCT02207569|567079675|FG000|48-Month|Death|25|||
157089342|NCT02207569|567079675|FG000|48-Month|Withdrawal by Subject|2|||
157089343|NCT02207569|567079675|FG000|48-Month|Lost to Follow-up|4|||
157089344|NCT02207569|567079675|FG000|60-Month|Death|1|||
157089345|NCT02207569|567079675|FG000|60-Month|Lost to Follow-up|1|||
157089346|NCT02207569|567079675|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
157089347|NCT02207569|567079675|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
157089348|NCT03606668|567079676|FG000|Overall Study|Screen Failure|1|||
157089349|NCT03606668|567079676|FG000|Overall Study|Lost to Follow-up|1|||
157089350|NCT01014143|567079677|FG000|Second Intervention|Lost to Follow-up|2|||
157089351|NCT01014143|567079678|FG001|Second Intervention|Lost to Follow-up|0|||
157089352|NCT01014143|567079679|FG002|Second Intervention|Lost to Follow-up|0|||
157089353|NCT02585232|567079680|FG000|Overall Study|Lost to Follow-up|8|||
157089354|NCT02585232|567079681|FG001|Overall Study|Lost to Follow-up|8|||
157089355|NCT02585232|567079680|FG000|Overall Study|Withdrawal by Subject|4|||
157089356|NCT02585232|567079681|FG001|Overall Study|Withdrawal by Subject|8|||
157089357|NCT00297232|567079687|FG000|Overall Study|Lack of Efficacy|7|||
157089358|NCT00297232|567079687|FG000|Overall Study|Lost to Follow-up|10|||
157089359|NCT00297232|567079687|FG000|Overall Study|Adverse Event|63|||
157089360|NCT00297232|567079687|FG000|Overall Study|Voluntary Withdrawal|120|||
157089361|NCT00297232|567079687|FG000|Overall Study|Subject was Noncompliant|9|||
157089362|NCT00297232|567079687|FG000|Overall Study|Death|9|||
157089363|NCT00297232|567079687|FG000|Overall Study|Anti-natalizumab Positive|8|||
157089364|NCT00297232|567079687|FG000|Overall Study|Switched to Commercial Tysabri|22|||
157089365|NCT00297232|567079687|FG000|Overall Study|Disease Progression|8|||
157089366|NCT00297232|567079687|FG000|Overall Study|Fear of PML|10|||
157089367|NCT00297232|567079687|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
157089368|NCT00297232|567079687|FG000|Overall Study|Miscellaneous|5|||
157089369|NCT00297232|567079687|FG000|Overall Study|Sponsor Decision|34|||
157089370|NCT00297232|567079687|FG000|Overall Study|Subject Relocated|7|||
157089371|NCT00297232|567079687|FG000|Overall Study|Subject Withdrew Consent|37|||
157089372|NCT00297232|567079687|FG000|Overall Study|Persistently Positive Antibodies|11|||
157089373|NCT00297232|567079687|FG000|Overall Study|Investigator Withdrew From Program|19|||
157089374|NCT00297232|567079687|FG000|Overall Study|Did Not Enroll to Week 264|34|||
157089375|NCT00297232|567079687|FG000|Overall Study|Did Not Enroll to Week 480|17|||
157089376|NCT00297232|567079687|FG000|Overall Study|No data available after Week 264|161|||
157089377|NCT00297232|567079687|FG000|Overall Study|Other|1|||
157089378|NCT01878214|567079688|FG000|Overall Study|Withdrawal by Subject|18|||
157089379|NCT01878214|567079689|FG001|Overall Study|Withdrawal by Subject|7|||
157089380|NCT01878214|567079688|FG000|Overall Study|Death|0|||
157089381|NCT01878214|567079689|FG001|Overall Study|Death|1|||
157089382|NCT01878214|567079688|FG000|Overall Study|Lost to Follow-up|35|||
157089383|NCT01878214|567079689|FG001|Overall Study|Lost to Follow-up|36|||
157089384|NCT00495586|567079690|FG000|Overall Study|Withdrawal by Subject|4|||
157089385|NCT00495586|567079691|FG001|Overall Study|Withdrawal by Subject|4|||
157089386|NCT03038438|567079692|FG000|Overall Study|Death|3|||
157089387|NCT03038438|567079692|FG000|Overall Study|Lost to Follow-up|8|||
157089388|NCT03038438|567079692|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
157089389|NCT03038438|567079692|FG000|Overall Study|Withdrawal by Subject|5|||
157089390|NCT03038438|567079692|FG000|Overall Study|No 36-Month Follow-Up|18|||
157089391|NCT02038543|567079693|FG000|Overall Study|Screen Failure|0|||
157089392|NCT02038543|567079694|FG001|Overall Study|Screen Failure|0|||
157089393|NCT02038543|567079695|FG002|Overall Study|Screen Failure|0|||
157089394|NCT02038543|567079696|FG003|Overall Study|Screen Failure|1|||
157089395|NCT02038543|567079693|FG000|Overall Study|Withdrawal by Subject|0|||
157089396|NCT02038543|567079694|FG001|Overall Study|Withdrawal by Subject|0|||
157089397|NCT02038543|567079695|FG002|Overall Study|Withdrawal by Subject|0|||
157089398|NCT02038543|567079696|FG003|Overall Study|Withdrawal by Subject|1|||
157089399|NCT03406260|567079697|FG000|Period 1|Adverse Event|0|||
157089400|NCT03406260|567079698|FG001|Period 1|Adverse Event|0|||
157089401|NCT03406260|567079699|FG002|Period 1|Adverse Event|0|||
157089402|NCT03406260|567079700|FG003|Period 1|Adverse Event|0|||
157089403|NCT03406260|567079701|FG004|Period 1|Adverse Event|1|||
157089404|NCT03406260|567079702|FG005|Period 1|Adverse Event|0|||
157089405|NCT02647866|567079703|FG000|Overall Study|Adverse Event|0|||
157089406|NCT02647866|567079704|FG001|Overall Study|Adverse Event|0|||
157089407|NCT02647866|567079705|FG002|Overall Study|Adverse Event|2|||
157089408|NCT02647866|567079706|FG003|Overall Study|Adverse Event|2|||
157089409|NCT02647866|567079707|FG004|Overall Study|Adverse Event|1|||
157089410|NCT02647866|567079703|FG000|Overall Study|Disease Worsening|3|||
157089411|NCT02647866|567079704|FG001|Overall Study|Disease Worsening|1|||
157089412|NCT02647866|567079705|FG002|Overall Study|Disease Worsening|0|||
157089413|NCT02647866|567079706|FG003|Overall Study|Disease Worsening|0|||
157089414|NCT02647866|567079707|FG004|Overall Study|Disease Worsening|1|||
157089415|NCT02647866|567079703|FG000|Overall Study|Withdrawal by Subject|1|||
157089416|NCT02647866|567079704|FG001|Overall Study|Withdrawal by Subject|1|||
157089417|NCT02647866|567079705|FG002|Overall Study|Withdrawal by Subject|2|||
157089418|NCT02647866|567079706|FG003|Overall Study|Withdrawal by Subject|4|||
157089419|NCT02647866|567079707|FG004|Overall Study|Withdrawal by Subject|4|||
157089420|NCT02647866|567079703|FG000|Overall Study|Physician Decision|0|||
157089421|NCT02647866|567079704|FG001|Overall Study|Physician Decision|1|||
157089422|NCT02647866|567079705|FG002|Overall Study|Physician Decision|1|||
157089423|NCT02647866|567079706|FG003|Overall Study|Physician Decision|0|||
157089424|NCT02647866|567079707|FG004|Overall Study|Physician Decision|2|||
157089425|NCT02647866|567079703|FG000|Overall Study|Death|0|||
157089426|NCT02647866|567079704|FG001|Overall Study|Death|1|||
157089427|NCT02647866|567079705|FG002|Overall Study|Death|0|||
157089428|NCT02647866|567079706|FG003|Overall Study|Death|0|||
157089429|NCT02647866|567079707|FG004|Overall Study|Death|0|||
157089430|NCT02647866|567079703|FG000|Overall Study|Subject moved to different country|1|||
157089431|NCT02647866|567079704|FG001|Overall Study|Subject moved to different country|0|||
157089432|NCT02647866|567079705|FG002|Overall Study|Subject moved to different country|0|||
157089433|NCT02647866|567079706|FG003|Overall Study|Subject moved to different country|0|||
157089434|NCT02647866|567079707|FG004|Overall Study|Subject moved to different country|0|||
157089435|NCT01029652|567079708|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
157089436|NCT01029652|567079709|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
157089437|NCT01029652|567079708|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
157089438|NCT01029652|567079709|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
157089439|NCT01029652|567079708|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
157089440|NCT01029652|567079709|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
157089441|NCT01029652|567079708|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
157089442|NCT01029652|567079709|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
157089443|NCT01029652|567079708|FG000|Core Study (0-12 Weeks)|Death|0|||
157089444|NCT01029652|567079709|FG001|Core Study (0-12 Weeks)|Death|1|||
157089445|NCT01029652|567079708|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
157089446|NCT01029652|567079709|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
157089447|NCT01029652|567079708|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
157089448|NCT01029652|567079709|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
157089449|NCT01029652|567079708|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
157089450|NCT01029652|567079709|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
157089451|NCT01029652|567079708|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
157089452|NCT01029652|567079709|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
157089453|NCT01029652|567079708|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
157089454|NCT01029652|567079709|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
157089455|NCT01029652|567079708|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
157089456|NCT01029652|567079709|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
157089457|NCT01029652|567079708|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
157089458|NCT01029652|567079709|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
157089459|NCT02084056|567079712|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
157089460|NCT02084056|567079713|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157089461|NCT02084056|567079714|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157089462|NCT02084056|567079715|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
157089463|NCT02084056|567079712|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
157089464|NCT02084056|567079713|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
157089465|NCT02084056|567079714|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
157089466|NCT02084056|567079715|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
157089467|NCT00938860|567079716|FG000|Overall Study|Adverse Event|2|||
157089468|NCT00938860|567079717|FG001|Overall Study|Adverse Event|1|||
157089469|NCT00938860|567079716|FG000|Overall Study|Abnormal laboratory values|2|||
157089470|NCT00938860|567079717|FG001|Overall Study|Abnormal laboratory values|2|||
157089471|NCT00938860|567079716|FG000|Overall Study|Withdrawal by Subject|11|||
157089472|NCT00938860|567079717|FG001|Overall Study|Withdrawal by Subject|8|||
157089473|NCT00938860|567079716|FG000|Overall Study|Lost to Follow-up|4|||
157089474|NCT00938860|567079717|FG001|Overall Study|Lost to Follow-up|4|||
157089475|NCT00938860|567079716|FG000|Overall Study|Administration problems|2|||
157089476|NCT00938860|567079717|FG001|Overall Study|Administration problems|0|||
157089477|NCT00938860|567079716|FG000|Overall Study|Death|1|||
157089478|NCT00938860|567079717|FG001|Overall Study|Death|1|||
157089479|NCT00938860|567079716|FG000|Overall Study|Protocol Violation|3|||
157089480|NCT00938860|567079717|FG001|Overall Study|Protocol Violation|1|||
157089481|NCT01605019|567079718|FG000|Overall Study|pt did not meet transplant endpoint|3|||
157089482|NCT01605019|567079719|FG001|Overall Study|pt did not meet transplant endpoint|0|||
157089483|NCT00324116|567079723|FG000|Overall Study|Adverse Event|5|||
157089484|NCT00324116|567079723|FG000|Overall Study|Lack of Efficacy|17|||
157089485|NCT00324116|567079723|FG000|Overall Study|Withdrawal by Subject|5|||
157089486|NCT00324116|567079723|FG000|Overall Study|Other|5|||
157089487|NCT00998790|567079725|FG000|Overall Study|Withdrawal by Subject|21|||
157089488|NCT01993927|567079726|FG000|Overall Study|Case Report Forms Uncollected|18|||
157089489|NCT01993927|567079726|FG000|Overall Study|Protocol Violation|11|||
157089490|NCT00540046|567079729|FG000|Overall Study|Lost to Follow-up|33|||
157089491|NCT00540046|567079730|FG001|Overall Study|Lost to Follow-up|23|||
157089492|NCT01103362|567079732|FG000|Overall Study|study terminated|596|||
157089493|NCT02533531|567079733|FG000|Overall Study|Device did not turn on|1|||
157089494|NCT03814187|567079734|FG000|Overall Study|Sponsor's Administrative Decision|0|||
157089495|NCT03814187|567079735|FG001|Overall Study|Sponsor's Administrative Decision|0|||
157089496|NCT03814187|567079736|FG002|Overall Study|Sponsor's Administrative Decision|272|||
157089497|NCT03814187|567079734|FG000|Overall Study|Death|80|||
157089498|NCT03814187|567079735|FG001|Overall Study|Death|81|||
157089499|NCT03814187|567079736|FG002|Overall Study|Death|4|||
157089500|NCT03814187|567079734|FG000|Overall Study|Withdrew Consent|77|||
157089501|NCT03814187|567079735|FG001|Overall Study|Withdrew Consent|78|||
157089502|NCT03814187|567079736|FG002|Overall Study|Withdrew Consent|2|||
157089503|NCT03814187|567079734|FG000|Overall Study|Lost to Follow-up|47|||
157089504|NCT03814187|567079735|FG001|Overall Study|Lost to Follow-up|52|||
157089505|NCT03814187|567079736|FG002|Overall Study|Lost to Follow-up|1|||
157089506|NCT03814187|567079734|FG000|Overall Study|Adverse Event|22|||
157089507|NCT03814187|567079735|FG001|Overall Study|Adverse Event|23|||
157089508|NCT03814187|567079736|FG002|Overall Study|Adverse Event|0|||
157089509|NCT03814187|567079734|FG000|Overall Study|Physician Decision|7|||
157089510|NCT03814187|567079735|FG001|Overall Study|Physician Decision|4|||
157089511|NCT03814187|567079736|FG002|Overall Study|Physician Decision|2|||
157089512|NCT03814187|567079734|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
157089513|NCT03814187|567079735|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
157089514|NCT03814187|567079736|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
157089515|NCT03814187|567079734|FG000|Overall Study|Other reasons|34|||
157089516|NCT03814187|567079735|FG001|Overall Study|Other reasons|40|||
157089517|NCT03814187|567079736|FG002|Overall Study|Other reasons|2|||
157196888|NCT06104423|567463800|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
157196889|NCT03814499|567463806|FG000|Overall Study|Lost to Follow-up|3|||
157089518|NCT00412061|567079737|FG000|Double Blind Phase|Disease Progression|101|||
157089519|NCT00412061|567079738|FG001|Double Blind Phase|Disease Progression|154|||
157089520|NCT00412061|567079737|FG000|Double Blind Phase|Adverse Event|61|||
157089521|NCT00412061|567079738|FG001|Double Blind Phase|Adverse Event|16|||
157089522|NCT00412061|567079737|FG000|Double Blind Phase|Final Primary Analysis|26|||
157089523|NCT00412061|567079738|FG001|Double Blind Phase|Final Primary Analysis|14|||
157089524|NCT00412061|567079737|FG000|Double Blind Phase|Withdrawal by Subject|18|||
157089525|NCT00412061|567079738|FG001|Double Blind Phase|Withdrawal by Subject|20|||
157089526|NCT00412061|567079737|FG000|Double Blind Phase|Death|6|||
157089527|NCT00412061|567079738|FG001|Double Blind Phase|Death|3|||
157089528|NCT00412061|567079737|FG000|Double Blind Phase|Protocol Violation|3|||
157089529|NCT00412061|567079738|FG001|Double Blind Phase|Protocol Violation|4|||
157089530|NCT00412061|567079737|FG000|Double Blind Phase|New Cander Therapy|1|||
157089531|NCT00412061|567079738|FG001|Double Blind Phase|New Cander Therapy|1|||
157089532|NCT00412061|567079737|FG000|Double Blind Phase|Lost to Follow-up|0|||
157089533|NCT00412061|567079738|FG001|Double Blind Phase|Lost to Follow-up|1|||
157089534|NCT00412061|567079737|FG000|Open Label Phase|Disease Progression|0|||
157089535|NCT00412061|567079738|FG001|Open Label Phase|Disease Progression|86|||
157089536|NCT00412061|567079737|FG000|Open Label Phase|Adverse Event|0|||
157089537|NCT00412061|567079738|FG001|Open Label Phase|Adverse Event|46|||
157089538|NCT00412061|567079737|FG000|Open Label Phase|Withdrawal by Subject|0|||
157089539|NCT00412061|567079738|FG001|Open Label Phase|Withdrawal by Subject|15|||
157089540|NCT00412061|567079737|FG000|Open Label Phase|Administrative Problems|0|||
157089541|NCT00412061|567079738|FG001|Open Label Phase|Administrative Problems|13|||
157089542|NCT00412061|567079737|FG000|Open Label Phase|Death|0|||
157089543|NCT00412061|567079738|FG001|Open Label Phase|Death|7|||
157089544|NCT00412061|567079737|FG000|Open Label Phase|Lost to Follow-up|0|||
157089545|NCT00412061|567079738|FG001|Open Label Phase|Lost to Follow-up|2|||
157089546|NCT00412061|567079737|FG000|Open Label Phase|New Cancer Therapy|0|||
157089547|NCT00412061|567079738|FG001|Open Label Phase|New Cancer Therapy|1|||
157089548|NCT00943111|567079743|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
157089549|NCT00943111|567079744|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
157237433|NCT00838279|567616634|FG001|Washout|Protocol Violation|0|||
157237434|NCT00838279|567616633|FG000|Washout|Withdrawal by Subject|0|||
157237435|NCT00838279|567616634|FG001|Washout|Withdrawal by Subject|1|||
157089550|NCT00943111|567079745|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
157089551|NCT00943111|567079743|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
157089552|NCT00943111|567079744|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
157089553|NCT00943111|567079745|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
157089554|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
157089555|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
157089556|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
157089557|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
157089558|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
157089559|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
157089560|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
157089561|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
157089562|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
157089563|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
157089564|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
157089565|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
157089566|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
157089567|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
157089568|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
157089569|NCT00943111|567079743|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
157089570|NCT00943111|567079744|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
157089571|NCT00943111|567079745|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
157089572|NCT02665338|567079747|FG000|Overall Study|Withdrawal by Subject|0|||
157089573|NCT02665338|567079748|FG001|Overall Study|Withdrawal by Subject|1|||
157089574|NCT00998335|567079749|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
157089575|NCT00998335|567079750|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
157089576|NCT03798691|567079751|FG000|Overall Study|Lost to Follow-up|2|||
157089577|NCT03798691|567079752|FG001|Overall Study|Lost to Follow-up|2|||
157089578|NCT02631577|567079765|FG000|Overall Study|Death|1|||
157089579|NCT02631577|567079766|FG001|Overall Study|Death|7|||
157089580|NCT02631577|567079765|FG000|Overall Study|Withdrawal by Subject|0|||
157089581|NCT02631577|567079766|FG001|Overall Study|Withdrawal by Subject|3|||
157089582|NCT00953407|567082535|FG000|Overall Study|Failed inclusion criteria|1|||
157089583|NCT00953407|567082536|FG001|Overall Study|Failed inclusion criteria|1|||
157089584|NCT00953407|567082537|FG002|Overall Study|Failed inclusion criteria|1|||
157089585|NCT00953407|567082538|FG003|Overall Study|Failed inclusion criteria|1|||
157089586|NCT00953407|567082539|FG004|Overall Study|Failed inclusion criteria|1|||
157089587|NCT00953407|567082535|FG000|Overall Study|Lost to Follow-up|0|||
157089588|NCT00953407|567082536|FG001|Overall Study|Lost to Follow-up|0|||
157089589|NCT00953407|567082537|FG002|Overall Study|Lost to Follow-up|0|||
157089590|NCT00953407|567082538|FG003|Overall Study|Lost to Follow-up|1|||
157089591|NCT00953407|567082539|FG004|Overall Study|Lost to Follow-up|0|||
157089592|NCT01111474|567082540|FG000|Overall Study|Lost to Follow-up|12|||
157089593|NCT00706433|567082541|FG000|Overall Study|Lost to Follow-up|3|||
157089594|NCT00706433|567082542|FG001|Overall Study|Lost to Follow-up|1|||
157089595|NCT00706433|567082543|FG002|Overall Study|Lost to Follow-up|6|||
157089596|NCT00706433|567082544|FG003|Overall Study|Lost to Follow-up|0|||
157089597|NCT00706433|567082541|FG000|Overall Study|Withdrawal by Subject|1|||
157089598|NCT00706433|567082542|FG001|Overall Study|Withdrawal by Subject|2|||
157089599|NCT00706433|567082543|FG002|Overall Study|Withdrawal by Subject|3|||
157089600|NCT00706433|567082544|FG003|Overall Study|Withdrawal by Subject|1|||
157089601|NCT00706433|567082541|FG000|Overall Study|Adverse Event|0|||
157089602|NCT00706433|567082542|FG001|Overall Study|Adverse Event|0|||
157089603|NCT00706433|567082543|FG002|Overall Study|Adverse Event|1|||
157089604|NCT00706433|567082544|FG003|Overall Study|Adverse Event|0|||
157089605|NCT00706433|567082541|FG000|Overall Study|Protocol Violation|1|||
157089606|NCT00706433|567082542|FG001|Overall Study|Protocol Violation|0|||
157089607|NCT00706433|567082543|FG002|Overall Study|Protocol Violation|0|||
157089608|NCT00706433|567082544|FG003|Overall Study|Protocol Violation|0|||
157089609|NCT00706433|567082541|FG000|Overall Study|new job|0|||
157089610|NCT00706433|567082542|FG001|Overall Study|new job|0|||
157089611|NCT00706433|567082543|FG002|Overall Study|new job|0|||
157089612|NCT00706433|567082544|FG003|Overall Study|new job|1|||
157089613|NCT02090959|567082546|FG000|Overall Study|Withdrawal by Subject|10|||
157089614|NCT02090959|567082546|FG000|Overall Study|Adverse Event|1|||
157089615|NCT02090959|567082546|FG000|Overall Study|Investigator decision|2|||
157089616|NCT02090959|567082546|FG000|Overall Study|Study termination|6|||
157089617|NCT02090959|567082546|FG000|Overall Study|Enrolled but not treated|1|||
157089618|NCT02090959|567082546|FG000|Overall Study|Transfer for compassionate use medicine|4|||
157089619|NCT02090959|567082546|FG000|Overall Study|Move to medical need program|3|||
157089620|NCT02090959|567082546|FG000|Overall Study|Entered in to other study|34|||
157089621|NCT02090959|567082546|FG000|Overall Study|Switched to commercial supply|88|||
157089622|NCT02090959|567082546|FG000|Overall Study|Other than specified|2|||
157089623|NCT00522873|567082547|FG000|Overall Study|Adverse Event|41|||
157089624|NCT00522873|567082548|FG001|Overall Study|Adverse Event|26|||
157089625|NCT00522873|567082547|FG000|Overall Study|Withdrawal by Subject|20|||
157089626|NCT00522873|567082548|FG001|Overall Study|Withdrawal by Subject|9|||
157089627|NCT00522873|567082547|FG000|Overall Study|Protocol Violation|14|||
157089628|NCT00522873|567082548|FG001|Overall Study|Protocol Violation|4|||
157089629|NCT00522873|567082547|FG000|Overall Study|Lost to Follow-up|11|||
157089630|NCT00522873|567082548|FG001|Overall Study|Lost to Follow-up|3|||
157089631|NCT00522873|567082547|FG000|Overall Study|Personal Reasons|8|||
157089632|NCT00522873|567082548|FG001|Overall Study|Personal Reasons|1|||
157089633|NCT00522873|567082547|FG000|Overall Study|Medication Errors|1|||
157089634|NCT00522873|567082548|FG001|Overall Study|Medication Errors|1|||
157089635|NCT00522873|567082547|FG000|Overall Study|Never Received Medication|1|||
157089636|NCT00522873|567082548|FG001|Overall Study|Never Received Medication|0|||
157089637|NCT02029846|567082549|FG000|Overall Study|n=1 each arm|1|||
157089638|NCT02029846|567082550|FG001|Overall Study|n=1 each arm|1|||
157089639|NCT02399254|567082570|FG000|Overall Study|Physician Decision|2|||
157089640|NCT00652327|567082571|FG000|Overall Study|Adverse Event|0|||
157089641|NCT00652327|567082572|FG001|Overall Study|Adverse Event|2|||
157089642|NCT00652327|567082571|FG000|Overall Study|Lost to Follow-up|0|||
157089643|NCT00652327|567082572|FG001|Overall Study|Lost to Follow-up|3|||
157089644|NCT01076647|567082573|FG000|Overall Study|Adverse Event|4|||
157089645|NCT01076647|567082574|FG001|Overall Study|Adverse Event|1|||
157089646|NCT01076647|567082573|FG000|Overall Study|Lack of Efficacy|0|||
157089647|NCT01076647|567082574|FG001|Overall Study|Lack of Efficacy|1|||
157089648|NCT01076647|567082573|FG000|Overall Study|Protocol Violation|7|||
157089649|NCT01076647|567082574|FG001|Overall Study|Protocol Violation|9|||
157089650|NCT01076647|567082573|FG000|Overall Study|Withdrawal criteria|2|||
157089651|NCT01076647|567082574|FG001|Overall Study|Withdrawal criteria|2|||
157089652|NCT01076647|567082573|FG000|Overall Study|Unclassified|12|||
157089653|NCT01076647|567082574|FG001|Overall Study|Unclassified|12|||
157089654|NCT02292927|567082582|FG000|Overall Study|Protocol Violation|13|||
157089655|NCT02292927|567082583|FG001|Overall Study|Protocol Violation|7|||
157089656|NCT01656733|567082587|FG000|Overall Study|No permission to collect birth outcomes|0|||
157089657|NCT01656733|567082588|FG001|Overall Study|No permission to collect birth outcomes|1|||
157089658|NCT01656733|567082587|FG000|Overall Study|Delivery at another hospital|0|||
157089659|NCT01656733|567082588|FG001|Overall Study|Delivery at another hospital|2|||
157089660|NCT01656733|567082587|FG000|Overall Study|Spontaneous abortion|0|||
157089661|NCT01656733|567082588|FG001|Overall Study|Spontaneous abortion|1|||
157089662|NCT02224690|567082589|FG000|Overall Study|Adverse Event|8|||
157089663|NCT02224690|567082590|FG001|Overall Study|Adverse Event|1|||
157089664|NCT02224690|567082589|FG000|Overall Study|Met Withdrawal Criteria|4|||
157089665|NCT02224690|567082590|FG001|Overall Study|Met Withdrawal Criteria|0|||
157089666|NCT02224690|567082589|FG000|Overall Study|Use of G-tube|1|||
157089667|NCT02224690|567082590|FG001|Overall Study|Use of G-tube|0|||
157089668|NCT02224690|567082589|FG000|Overall Study|Did not meet eligibility criteria|1|||
157089669|NCT02224690|567082590|FG001|Overall Study|Did not meet eligibility criteria|0|||
157089670|NCT01415531|567082591|FG000|Overall Study|Adverse Event|7|||
157089671|NCT01415531|567082592|FG001|Overall Study|Adverse Event|10|||
157089672|NCT01415531|567082591|FG000|Overall Study|Lack of Efficacy|3|||
157089673|NCT01415531|567082592|FG001|Overall Study|Lack of Efficacy|2|||
157089674|NCT01415531|567082591|FG000|Overall Study|Protocol Violation|0|||
157089675|NCT01415531|567082592|FG001|Overall Study|Protocol Violation|1|||
157089676|NCT01415531|567082591|FG000|Overall Study|Withdrawal by Subject|5|||
157089677|NCT01415531|567082592|FG001|Overall Study|Withdrawal by Subject|4|||
157089678|NCT01415531|567082591|FG000|Overall Study|Lost to Follow-up|6|||
157089679|NCT01415531|567082592|FG001|Overall Study|Lost to Follow-up|14|||
157089680|NCT01415531|567082591|FG000|Overall Study|Lack of Compliance|1|||
157089681|NCT01415531|567082592|FG001|Overall Study|Lack of Compliance|4|||
157089682|NCT01415531|567082591|FG000|Overall Study|Other Reasons|3|||
157089683|NCT01415531|567082592|FG001|Overall Study|Other Reasons|2|||
157089684|NCT05753670|567082593|FG000|Overall Study|Withdrawal by Subject|6|||
157089685|NCT05753670|567082594|FG001|Overall Study|Withdrawal by Subject|8|||
157089686|NCT05753670|567082593|FG000|Overall Study|Protocol Violation|3|||
157089687|NCT05753670|567082594|FG001|Overall Study|Protocol Violation|1|||
157089688|NCT00122460|567082595|FG000|Overall Study|investigational study phase ongoing|7|||
157089689|NCT00122460|567082596|FG001|Overall Study|investigational study phase ongoing|1|||
157089690|NCT02962960|567082597|FG000|Overall Study|Withdrawal by Subject|1|||
157089691|NCT02962960|567082598|FG001|Overall Study|Withdrawal by Subject|1|||
157089692|NCT02962960|567082599|FG002|Overall Study|Withdrawal by Subject|0|||
157089693|NCT02962960|567082597|FG000|Overall Study|Adverse Event|1|||
157089694|NCT02962960|567082598|FG001|Overall Study|Adverse Event|1|||
157089695|NCT02962960|567082599|FG002|Overall Study|Adverse Event|0|||
157089696|NCT02962960|567082597|FG000|Overall Study|Protocol Violation|1|||
157089697|NCT02962960|567082598|FG001|Overall Study|Protocol Violation|0|||
157089698|NCT02962960|567082599|FG002|Overall Study|Protocol Violation|0|||
157089699|NCT01236339|567082600|FG000|Overall Study|Termination of study by sponsor|11|||
157089700|NCT01236339|567082601|FG001|Overall Study|Termination of study by sponsor|13|||
157089701|NCT02325557|567082602|FG000|Overall Study|Progressive disease|1|||
157089702|NCT02325557|567082603|FG001|Overall Study|Progressive disease|0|||
157089703|NCT02325557|567082604|FG002|Overall Study|Progressive disease|0|||
157089704|NCT02325557|567082605|FG003|Overall Study|Progressive disease|0|||
157089705|NCT02325557|567082602|FG000|Overall Study|Withdrawal by Subject|4|||
157089706|NCT02325557|567082603|FG001|Overall Study|Withdrawal by Subject|0|||
157089707|NCT02325557|567082604|FG002|Overall Study|Withdrawal by Subject|0|||
157089708|NCT02325557|567082605|FG003|Overall Study|Withdrawal by Subject|15|||
157089709|NCT02325557|567082602|FG000|Overall Study|Death|5|||
157089710|NCT02325557|567082603|FG001|Overall Study|Death|1|||
157089711|NCT02325557|567082604|FG002|Overall Study|Death|1|||
157089712|NCT02325557|567082605|FG003|Overall Study|Death|16|||
157089713|NCT02325557|567082602|FG000|Overall Study|Lost to Follow-up|0|||
157089714|NCT02325557|567082603|FG001|Overall Study|Lost to Follow-up|0|||
157089715|NCT02325557|567082604|FG002|Overall Study|Lost to Follow-up|1|||
157089716|NCT02325557|567082605|FG003|Overall Study|Lost to Follow-up|1|||
157089717|NCT02325557|567082602|FG000|Overall Study|Other|0|||
157089718|NCT02325557|567082603|FG001|Overall Study|Other|0|||
157089719|NCT02325557|567082604|FG002|Overall Study|Other|0|||
157089720|NCT02325557|567082605|FG003|Overall Study|Other|5|||
157089721|NCT00528645|567082607|FG000|Overall Study|Adverse Event|3|||
157089722|NCT01642251|567082608|FG000|Overall Study|Progressive disease|0|||
157089723|NCT01642251|567082609|FG001|Overall Study|Progressive disease|0|||
157089724|NCT01642251|567082610|FG002|Overall Study|Progressive disease|3|||
157089725|NCT01642251|567082611|FG003|Overall Study|Progressive disease|3|||
157089726|NCT01642251|567082608|FG000|Overall Study|Adverse Event|0|||
157089727|NCT01642251|567082609|FG001|Overall Study|Adverse Event|0|||
157089728|NCT01642251|567082610|FG002|Overall Study|Adverse Event|5|||
157089729|NCT01642251|567082611|FG003|Overall Study|Adverse Event|4|||
157089730|NCT01642251|567082608|FG000|Overall Study|Death|0|||
157089731|NCT01642251|567082609|FG001|Overall Study|Death|0|||
157089732|NCT01642251|567082610|FG002|Overall Study|Death|1|||
157089733|NCT01642251|567082611|FG003|Overall Study|Death|3|||
157089734|NCT01642251|567082608|FG000|Overall Study|Withdrawal by Subject|0|||
157089735|NCT01642251|567082609|FG001|Overall Study|Withdrawal by Subject|0|||
157089736|NCT01642251|567082610|FG002|Overall Study|Withdrawal by Subject|1|||
157089737|NCT01642251|567082611|FG003|Overall Study|Withdrawal by Subject|3|||
157089738|NCT01642251|567082608|FG000|Overall Study|Alternative therapy|0|||
157089739|NCT01642251|567082609|FG001|Overall Study|Alternative therapy|0|||
157089740|NCT01642251|567082610|FG002|Overall Study|Alternative therapy|0|||
157089741|NCT01642251|567082611|FG003|Overall Study|Alternative therapy|2|||
157089742|NCT01642251|567082608|FG000|Overall Study|Other complicating disease|0|||
157196890|NCT00351611|567463807|FG000|Overall Study|Adverse Event|11|||
157196891|NCT00351611|567463808|FG001|Overall Study|Adverse Event|3|||
157196892|NCT00351611|567463807|FG000|Overall Study|Death|1|||
157196893|NCT00351611|567463808|FG001|Overall Study|Death|0|||
157196894|NCT00351611|567463807|FG000|Overall Study|Lost to Follow-up|1|||
157196895|NCT00351611|567463808|FG001|Overall Study|Lost to Follow-up|0|||
157196896|NCT00351611|567463807|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
157196897|NCT00351611|567463808|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
157196898|NCT00351611|567463807|FG000|Overall Study|Other|1|||
157196899|NCT00351611|567463808|FG001|Overall Study|Other|0|||
157196900|NCT00351611|567463807|FG000|Overall Study|Protocol Violation|0|||
157196901|NCT00351611|567463808|FG001|Overall Study|Protocol Violation|2|||
157196902|NCT03417245|567463809|FG000|Overall Study|Adverse Event|1|||
157196903|NCT03417245|567463810|FG001|Overall Study|Adverse Event|0|||
157089743|NCT01642251|567082609|FG001|Overall Study|Other complicating disease|0|||
157089744|NCT01642251|567082610|FG002|Overall Study|Other complicating disease|1|||
157089745|NCT01642251|567082611|FG003|Overall Study|Other complicating disease|0|||
157089746|NCT01642251|567082608|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
157089747|NCT01642251|567082609|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
157089748|NCT01642251|567082610|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
157089749|NCT01642251|567082611|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
157089750|NCT01154010|567082612|FG000|Overall Study|Lost to Follow-up|0|||
157089751|NCT01154010|567082613|FG001|Overall Study|Lost to Follow-up|1|||
157089752|NCT00439231|567082614|FG000|Overall Study|Lack of Efficacy|28|||
157089753|NCT00895154|567082618|FG000|Overall Study|Lost to Follow-up|1|||
157089754|NCT00895154|567082619|FG001|Overall Study|Lost to Follow-up|1|||
157089755|NCT00895154|567082618|FG000|Overall Study|Withdrawal by Subject|0|||
157089756|NCT00895154|567082619|FG001|Overall Study|Withdrawal by Subject|1|||
157089757|NCT02413333|567082622|FG000|Period 1|Adverse Event|1|||
157089758|NCT02413333|567082623|FG001|Period 1|Adverse Event|0|||
157089759|NCT02413333|567082622|FG000|Period 1|Reason Not Specified|0|||
157089760|NCT02413333|567082623|FG001|Period 1|Reason Not Specified|1|||
157089761|NCT02413333|567082622|FG000|Period 2|Protocol Deviation|1|||
157089762|NCT02413333|567082623|FG001|Period 2|Protocol Deviation|0|||
157089763|NCT01465347|567082624|FG000|Overall Study|Withdrawal by Subject|1|||
157089764|NCT01465347|567082625|FG001|Overall Study|Withdrawal by Subject|1|||
157089765|NCT01465347|567082624|FG000|Overall Study|Physician Decision|0|||
157089766|NCT01465347|567082625|FG001|Overall Study|Physician Decision|1|||
157089767|NCT01465347|567082624|FG000|Overall Study|Admitted to hospice|0|||
157089768|NCT01465347|567082625|FG001|Overall Study|Admitted to hospice|1|||
157089769|NCT02996474|567082626|FG000|Overall Study|Physician Decision|5|||
157089770|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
157089771|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
157089772|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
157089773|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
157089774|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
157089775|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
157089776|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
157089777|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
157089778|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
157089779|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
157089780|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
157089781|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
157089782|NCT04493502|567082627|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
157089783|NCT04493502|567082628|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
157089784|NCT04493502|567082627|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
157089785|NCT04493502|567082628|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
157089786|NCT04493502|567082627|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
157089787|NCT04493502|567082628|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
157089788|NCT04493502|567082627|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
157237436|NCT04608188|567616635|FG000|Overall Study|Withdrawal by Subject|4|||
157237437|NCT04608188|567616636|FG001|Overall Study|Withdrawal by Subject|8|||
157237438|NCT01415986|567616638|FG000|Overall Study|Lost to Follow-up|1|||
157237439|NCT04419311|567616639|FG000|Overall Study|Lost to Follow-up|1|||
157237440|NCT04419311|567616640|FG001|Overall Study|Lost to Follow-up|0|||
157237441|NCT03122457|567616652|FG000|Overall Study|Withdrawal by Subject|6|||
157089789|NCT04493502|567082628|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
157089790|NCT04493502|567082627|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
157089791|NCT04493502|567082628|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
157089792|NCT04493502|567082627|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
157089793|NCT04493502|567082628|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
157089794|NCT04493502|567082627|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
157089795|NCT04493502|567082628|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
157089796|NCT02891837|567082629|FG000|Overall Study|Lost to Follow-up|2|||
157089797|NCT02891837|567082630|FG001|Overall Study|Lost to Follow-up|0|||
157089798|NCT02891837|567082629|FG000|Overall Study|Withdrawal by Subject|1|||
157089799|NCT02891837|567082630|FG001|Overall Study|Withdrawal by Subject|0|||
157237442|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
157237443|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
157237444|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
157089800|NCT00709852|567082631|FG000|Period 1|Adverse Event|2|||
157089801|NCT00709852|567082632|FG001|Period 1|Adverse Event|0|||
157089802|NCT00709852|567082631|FG000|Period 1|Withdrawal by Subject|4|||
157089803|NCT00709852|567082632|FG001|Period 1|Withdrawal by Subject|2|||
157089804|NCT00709852|567082631|FG000|Period 1|Protocol Violation|1|||
157089805|NCT00709852|567082632|FG001|Period 1|Protocol Violation|0|||
157237445|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
157237446|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
157089806|NCT00709852|567082631|FG000|Period 1|Defective scanner|0|||
157089807|NCT00709852|567082632|FG001|Period 1|Defective scanner|1|||
157089808|NCT00709852|567082631|FG000|Period 1|Lost to Follow-up|1|||
157089809|NCT00709852|567082632|FG001|Period 1|Lost to Follow-up|0|||
157089810|NCT00709852|567082631|FG000|Period 2|Protocol Violation|4|||
157089811|NCT00709852|567082632|FG001|Period 2|Protocol Violation|1|||
157089812|NCT00709852|567082631|FG000|Period 2|Adverse Event|1|||
157089813|NCT00709852|567082632|FG001|Period 2|Adverse Event|1|||
157089814|NCT00709852|567082631|FG000|Period 2|Lost to Follow-up|1|||
157089815|NCT00709852|567082632|FG001|Period 2|Lost to Follow-up|0|||
157089816|NCT00709852|567082631|FG000|Period 2|No 72-hour follow-up|3|||
157089817|NCT00709852|567082632|FG001|Period 2|No 72-hour follow-up|0|||
157089818|NCT00185965|567082633|FG000|Overall Study|Adverse Event|0|||
157089819|NCT00185965|567082634|FG001|Overall Study|Adverse Event|1|||
157089820|NCT01048671|567082635|FG000|Overall Study|Protocol Violation|0|||
157089821|NCT01048671|567082636|FG001|Overall Study|Protocol Violation|1|||
157089822|NCT01048671|567082637|FG002|Overall Study|Protocol Violation|1|||
157089823|NCT00513604|567082638|FG000|Overall Study|Not treated|2|||
157089824|NCT00513604|567082639|FG001|Overall Study|Not treated|0|||
157089825|NCT00513604|567082640|FG002|Overall Study|Not treated|1|||
157089826|NCT00513604|567082641|FG003|Overall Study|Not treated|0|||
157089827|NCT00513604|567082642|FG004|Overall Study|Not treated|0|||
157089828|NCT00513604|567082638|FG000|Overall Study|Death during treatment|0|||
157089829|NCT00513604|567082639|FG001|Overall Study|Death during treatment|3|||
157089830|NCT00513604|567082640|FG002|Overall Study|Death during treatment|2|||
157089831|NCT00513604|567082641|FG003|Overall Study|Death during treatment|0|||
157089832|NCT00513604|567082642|FG004|Overall Study|Death during treatment|0|||
157089833|NCT00296400|567082646|FG000|Overall Study|Adverse Event|7|||
157089834|NCT00296400|567082647|FG001|Overall Study|Adverse Event|7|||
157089835|NCT00296400|567082648|FG002|Overall Study|Adverse Event|7|||
157089836|NCT00296400|567082646|FG000|Overall Study|Withdrawal by Subject|5|||
157089837|NCT00296400|567082647|FG001|Overall Study|Withdrawal by Subject|6|||
157089838|NCT00296400|567082648|FG002|Overall Study|Withdrawal by Subject|2|||
157089839|NCT00296400|567082646|FG000|Overall Study|Incorrect enrollment|2|||
157089840|NCT00296400|567082647|FG001|Overall Study|Incorrect enrollment|0|||
157089841|NCT00296400|567082648|FG002|Overall Study|Incorrect enrollment|0|||
157089842|NCT00296400|567082646|FG000|Overall Study|Protocol Violation|1|||
157089843|NCT00296400|567082647|FG001|Overall Study|Protocol Violation|1|||
157089844|NCT00296400|567082648|FG002|Overall Study|Protocol Violation|1|||
157089845|NCT00296400|567082646|FG000|Overall Study|Lost to Follow-up|1|||
157089846|NCT00296400|567082647|FG001|Overall Study|Lost to Follow-up|1|||
157089847|NCT00296400|567082648|FG002|Overall Study|Lost to Follow-up|2|||
157089848|NCT00296400|567082646|FG000|Overall Study|Study specific discontinuation criteria|0|||
157089849|NCT00296400|567082647|FG001|Overall Study|Study specific discontinuation criteria|0|||
157089850|NCT00296400|567082648|FG002|Overall Study|Study specific discontinuation criteria|1|||
157089851|NCT00296400|567082646|FG000|Overall Study|Visit 10 was performed earlier|0|||
157089852|NCT00296400|567082647|FG001|Overall Study|Visit 10 was performed earlier|1|||
157089853|NCT00296400|567082648|FG002|Overall Study|Visit 10 was performed earlier|0|||
157089854|NCT00296400|567082646|FG000|Overall Study|Pregnancy|1|||
157089855|NCT00296400|567082647|FG001|Overall Study|Pregnancy|2|||
157089856|NCT00296400|567082648|FG002|Overall Study|Pregnancy|0|||
157089857|NCT02433340|567082653|FG000|Overall Study|Adverse Event|0|||
157089858|NCT02433340|567082654|FG001|Overall Study|Adverse Event|0|||
157089859|NCT02433340|567082655|FG002|Overall Study|Adverse Event|1|||
157089860|NCT02433340|567082656|FG003|Overall Study|Adverse Event|0|||
157089861|NCT02433340|567082653|FG000|Overall Study|Withdrawal by Subject|1|||
157089862|NCT02433340|567082654|FG001|Overall Study|Withdrawal by Subject|0|||
157089863|NCT02433340|567082655|FG002|Overall Study|Withdrawal by Subject|1|||
157089864|NCT02433340|567082656|FG003|Overall Study|Withdrawal by Subject|2|||
157089865|NCT02433340|567082653|FG000|Overall Study|Lost to Follow-up|0|||
157089866|NCT02433340|567082654|FG001|Overall Study|Lost to Follow-up|1|||
157089867|NCT02433340|567082655|FG002|Overall Study|Lost to Follow-up|0|||
157089868|NCT02433340|567082656|FG003|Overall Study|Lost to Follow-up|0|||
157089869|NCT02433340|567082653|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
157089870|NCT02433340|567082654|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
157237447|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
157089871|NCT02433340|567082655|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
157089872|NCT02433340|567082656|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
157089873|NCT02433340|567082653|FG000|Overall Study|Other|0|||
157089874|NCT02433340|567082654|FG001|Overall Study|Other|1|||
157089875|NCT02433340|567082655|FG002|Overall Study|Other|0|||
157089876|NCT02433340|567082656|FG003|Overall Study|Other|0|||
157089877|NCT01178385|567082657|FG000|Overall Study|Withdrawal by Subject|2|||
157089878|NCT01178385|567082658|FG001|Overall Study|Withdrawal by Subject|0|||
157089879|NCT00985946|567082663|FG000|Overall Study|Lost to Follow-up|6|||
157089880|NCT00985946|567082663|FG000|Overall Study|Withdrawal by Subject|1|||
157089881|NCT02679508|567082665|FG000|Healing Phase|Protocol Violation|1|||
157089882|NCT02679508|567082666|FG001|Healing Phase|Protocol Violation|1|||
157089883|NCT02679508|567082665|FG000|Healing Phase|Lost to Follow-up|1|||
157089884|NCT02679508|567082666|FG001|Healing Phase|Lost to Follow-up|0|||
157089885|NCT02679508|567082665|FG000|Maintenance Phase|Adverse Event|12|||
157089886|NCT02679508|567082666|FG001|Maintenance Phase|Adverse Event|2|||
157089887|NCT02679508|567082665|FG000|Maintenance Phase|Lost to Follow-up|0|||
157089888|NCT02679508|567082666|FG001|Maintenance Phase|Lost to Follow-up|1|||
157089889|NCT02679508|567082665|FG000|Maintenance Phase|Withdrawal by Subject|15|||
157089890|NCT02679508|567082666|FG001|Maintenance Phase|Withdrawal by Subject|8|||
157089891|NCT02679508|567082665|FG000|Maintenance Phase|Other|5|||
157089892|NCT02679508|567082666|FG001|Maintenance Phase|Other|4|||
157089893|NCT03538301|567082667|FG000|Overall Study|Adverse Event|1|||
157089894|NCT03538301|567082668|FG001|Overall Study|Adverse Event|4|||
157089895|NCT03538301|567082669|FG002|Overall Study|Adverse Event|4|||
157089896|NCT03538301|567082667|FG000|Overall Study|Death|1|||
157089897|NCT03538301|567082668|FG001|Overall Study|Death|1|||
157089898|NCT03538301|567082669|FG002|Overall Study|Death|0|||
157089899|NCT03538301|567082667|FG000|Overall Study|Physician Decision|0|||
157237448|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
157237449|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
157237450|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
157237451|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
157237452|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
157237453|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
157089900|NCT03538301|567082668|FG001|Overall Study|Physician Decision|1|||
157089901|NCT03538301|567082669|FG002|Overall Study|Physician Decision|0|||
157089902|NCT03538301|567082667|FG000|Overall Study|Protocol Violation|0|||
157089903|NCT03538301|567082668|FG001|Overall Study|Protocol Violation|0|||
157089904|NCT03538301|567082669|FG002|Overall Study|Protocol Violation|1|||
157089905|NCT03538301|567082667|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
157089906|NCT03538301|567082668|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
157089907|NCT03538301|567082669|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
157089908|NCT05326815|567082671|FG000|Overall Study|Withdrawal by Subject|3|||
157089909|NCT05326815|567082671|FG000|Overall Study|Did not complete required labs|6|||
157089910|NCT05326815|567082671|FG000|Overall Study|Screen fail- abnormal labs|5|||
157089911|NCT01586910|567084573|FG000|Overall Study|Death|4|||
157089912|NCT01586910|567084574|FG001|Overall Study|Death|4|||
157089913|NCT01586910|567084573|FG000|Overall Study|Withdrawal by Subject|6|||
157089914|NCT01586910|567084574|FG001|Overall Study|Withdrawal by Subject|43|||
157089915|NCT01586910|567084573|FG000|Overall Study|Physician withdrew Subject|5|||
157089916|NCT01586910|567084574|FG001|Overall Study|Physician withdrew Subject|24|||
157089917|NCT02502097|567084575|FG000|Period 1|Adverse Event|0|||
157089918|NCT02502097|567084576|FG001|Period 1|Adverse Event|0|||
157237454|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
157237455|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
157237456|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
157237457|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
157237458|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
157237459|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
157237460|NCT01045161|567616654|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
157237461|NCT01045161|567616655|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
157237462|NCT01045161|567616656|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
157237463|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
157237464|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
157237465|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
157237466|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
157237467|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
157089919|NCT02502097|567084577|FG002|Period 1|Adverse Event|1|||
157089920|NCT02502097|567084578|FG003|Period 1|Adverse Event|0|||
157089921|NCT02502097|567084575|FG000|Wash Out Period|Adverse Event|0|||
157089922|NCT02502097|567084576|FG001|Wash Out Period|Adverse Event|1|||
157089923|NCT02502097|567084577|FG002|Wash Out Period|Adverse Event|1|||
157089924|NCT02502097|567084578|FG003|Wash Out Period|Adverse Event|1|||
157237468|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
157237469|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
157089925|NCT02502097|567084575|FG000|Period 2|Adverse Event|0|||
157089926|NCT02502097|567084576|FG001|Period 2|Adverse Event|0|||
157089927|NCT02502097|567084577|FG002|Period 2|Adverse Event|1|||
157089928|NCT02502097|567084578|FG003|Period 2|Adverse Event|0|||
157089929|NCT04289051|567084581|FG000|Overall Study|Lost to Follow-up|0|||
157089930|NCT04289051|567084582|FG001|Overall Study|Lost to Follow-up|0|||
157089931|NCT04289051|567084583|FG002|Overall Study|Lost to Follow-up|2|||
157089932|NCT00156819|567084586|FG000|Overall Study|Lost to Follow-up|1|||
157089933|NCT00156819|567084587|FG001|Overall Study|Lost to Follow-up|1|||
157089934|NCT00156819|567084588|FG002|Overall Study|Lost to Follow-up|3|||
157089935|NCT03718533|567084590|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
157089936|NCT03718533|567084590|FG000|Overall Study|Protocol deviation|1|||
157089937|NCT03718533|567084590|FG000|Overall Study|Disease progression|1|||
157089938|NCT03718533|567084590|FG000|Overall Study|Relapse|1|||
157089939|NCT03718533|567084590|FG000|Overall Study|Physician Decision|2|||
157089940|NCT03718533|567084590|FG000|Overall Study|Physician Decision and Adverse Event|1|||
157089941|NCT01248065|567084591|FG000|Overall Study|Lost to Follow-up|3|||
157089942|NCT01248065|567084592|FG001|Overall Study|Lost to Follow-up|5|||
157089943|NCT01248065|567084591|FG000|Overall Study|Withdrawal by Subject|14|||
157089944|NCT01248065|567084592|FG001|Overall Study|Withdrawal by Subject|11|||
157089945|NCT01248065|567084591|FG000|Overall Study|Adverse Event|3|||
157089946|NCT01248065|567084592|FG001|Overall Study|Adverse Event|0|||
157089947|NCT01248065|567084591|FG000|Overall Study|Third treatment failure event|3|||
157089948|NCT01248065|567084592|FG001|Overall Study|Third treatment failure event|1|||
157089949|NCT01248065|567084591|FG000|Overall Study|Other|3|||
157089950|NCT01248065|567084592|FG001|Overall Study|Other|5|||
157089951|NCT02781844|567084593|FG000|Treatment Period 1|Adverse Event|0|||
157089952|NCT02781844|567084594|FG001|Treatment Period 1|Adverse Event|0|||
157089953|NCT02781844|567084595|FG002|Treatment Period 1|Adverse Event|0|||
157089954|NCT02781844|567084596|FG003|Treatment Period 1|Adverse Event|0|||
157089955|NCT02781844|567084597|FG004|Treatment Period 1|Adverse Event|0|||
157089956|NCT02781844|567084598|FG005|Treatment Period 1|Adverse Event|1|||
157089957|NCT02781844|567084599|FG006|Treatment Period 1|Adverse Event|0|||
157089958|NCT02781844|567084600|FG007|Treatment Period 1|Adverse Event|0|||
157089959|NCT02518490|567084603|FG000|Overall Study|Withdrawal by Subject|1|||
157089960|NCT02518490|567084604|FG001|Overall Study|Withdrawal by Subject|1|||
157089961|NCT01383499|567084605|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
157089962|NCT01383499|567084606|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157089963|NCT01383499|567084607|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157089964|NCT01383499|567084608|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157089965|NCT01774487|567084609|FG000|Overall Study|Did not tolerate taste|4|||
157089966|NCT01774487|567084610|FG001|Overall Study|Did not tolerate taste|4|||
157089967|NCT00346632|567084611|FG000|Overall Study|Progressive Disease|2|||
157089968|NCT00346632|567084612|FG001|Overall Study|Progressive Disease|2|||
157089969|NCT00346632|567084613|FG002|Overall Study|Progressive Disease|4|||
157089970|NCT00346632|567084614|FG003|Overall Study|Progressive Disease|3|||
157089971|NCT00346632|567084615|FG004|Overall Study|Progressive Disease|3|||
157089972|NCT00346632|567084616|FG005|Overall Study|Progressive Disease|1|||
157089973|NCT00346632|567084617|FG006|Overall Study|Progressive Disease|2|||
157089974|NCT00346632|567084618|FG007|Overall Study|Progressive Disease|2|||
157089975|NCT00346632|567084619|FG008|Overall Study|Progressive Disease|2|||
157089976|NCT00346632|567084620|FG009|Overall Study|Progressive Disease|2|||
157089977|NCT00346632|567084611|FG000|Overall Study|Adverse Event|0|||
157089978|NCT00346632|567084612|FG001|Overall Study|Adverse Event|0|||
157089979|NCT00346632|567084613|FG002|Overall Study|Adverse Event|0|||
157089980|NCT00346632|567084614|FG003|Overall Study|Adverse Event|0|||
157089981|NCT00346632|567084615|FG004|Overall Study|Adverse Event|1|||
157089982|NCT00346632|567084616|FG005|Overall Study|Adverse Event|1|||
157089983|NCT00346632|567084617|FG006|Overall Study|Adverse Event|1|||
157089984|NCT00346632|567084618|FG007|Overall Study|Adverse Event|0|||
157089985|NCT00346632|567084619|FG008|Overall Study|Adverse Event|0|||
157089986|NCT00346632|567084620|FG009|Overall Study|Adverse Event|0|||
157089987|NCT00346632|567084611|FG000|Overall Study|Death|0|||
157089988|NCT00346632|567084612|FG001|Overall Study|Death|0|||
157089989|NCT00346632|567084613|FG002|Overall Study|Death|1|||
157196904|NCT03417245|567463809|FG000|Overall Study|Protocol Violation|1|||
157196905|NCT03417245|567463810|FG001|Overall Study|Protocol Violation|0|||
157196906|NCT03417245|567463809|FG000|Overall Study|Withdrawal by Subject|1|||
157196907|NCT03417245|567463810|FG001|Overall Study|Withdrawal by Subject|1|||
157196908|NCT01589185|567463811|FG000|Overall Study|Death|1|||
157196909|NCT01589185|567463812|FG001|Overall Study|Death|2|||
157196910|NCT01589185|567463813|FG002|Overall Study|Death|2|||
157196911|NCT01589185|567463814|FG003|Overall Study|Death|0|||
157196912|NCT01589185|567463815|FG004|Overall Study|Death|1|||
157196913|NCT01589185|567463811|FG000|Overall Study|Lost to Follow-up|1|||
157089990|NCT00346632|567084614|FG003|Overall Study|Death|0|||
157196914|NCT01589185|567463812|FG001|Overall Study|Lost to Follow-up|0|||
157196915|NCT01589185|567463813|FG002|Overall Study|Lost to Follow-up|2|||
157089991|NCT00346632|567084615|FG004|Overall Study|Death|0|||
157089992|NCT00346632|567084616|FG005|Overall Study|Death|0|||
157089993|NCT00346632|567084617|FG006|Overall Study|Death|0|||
157089994|NCT00346632|567084618|FG007|Overall Study|Death|0|||
157089995|NCT00346632|567084619|FG008|Overall Study|Death|0|||
157089996|NCT00346632|567084620|FG009|Overall Study|Death|0|||
157089997|NCT00346632|567084611|FG000|Overall Study|Protocol Violation|0|||
157089998|NCT00346632|567084612|FG001|Overall Study|Protocol Violation|0|||
157089999|NCT00346632|567084613|FG002|Overall Study|Protocol Violation|0|||
157090000|NCT00346632|567084614|FG003|Overall Study|Protocol Violation|0|||
157090001|NCT00346632|567084615|FG004|Overall Study|Protocol Violation|0|||
157090002|NCT00346632|567084616|FG005|Overall Study|Protocol Violation|0|||
157196916|NCT01589185|567463814|FG003|Overall Study|Lost to Follow-up|3|||
157090003|NCT00346632|567084617|FG006|Overall Study|Protocol Violation|1|||
157090004|NCT00346632|567084618|FG007|Overall Study|Protocol Violation|0|||
157090005|NCT00346632|567084619|FG008|Overall Study|Protocol Violation|0|||
157090006|NCT00346632|567084620|FG009|Overall Study|Protocol Violation|0|||
157090007|NCT00346632|567084611|FG000|Overall Study|Withdrawal by Subject|0|||
157090008|NCT00346632|567084612|FG001|Overall Study|Withdrawal by Subject|0|||
157090009|NCT00346632|567084613|FG002|Overall Study|Withdrawal by Subject|0|||
157090010|NCT00346632|567084614|FG003|Overall Study|Withdrawal by Subject|0|||
157090011|NCT00346632|567084615|FG004|Overall Study|Withdrawal by Subject|0|||
157090012|NCT00346632|567084616|FG005|Overall Study|Withdrawal by Subject|0|||
157090013|NCT00346632|567084617|FG006|Overall Study|Withdrawal by Subject|1|||
157090014|NCT00346632|567084618|FG007|Overall Study|Withdrawal by Subject|0|||
157090015|NCT00346632|567084619|FG008|Overall Study|Withdrawal by Subject|0|||
157090016|NCT00346632|567084620|FG009|Overall Study|Withdrawal by Subject|0|||
157090017|NCT00346632|567084611|FG000|Overall Study|Switched to alternative treatment|0|||
157090018|NCT00346632|567084612|FG001|Overall Study|Switched to alternative treatment|0|||
157090019|NCT00346632|567084613|FG002|Overall Study|Switched to alternative treatment|1|||
157090020|NCT00346632|567084614|FG003|Overall Study|Switched to alternative treatment|0|||
157090021|NCT00346632|567084615|FG004|Overall Study|Switched to alternative treatment|0|||
157090022|NCT00346632|567084616|FG005|Overall Study|Switched to alternative treatment|0|||
157090023|NCT00346632|567084617|FG006|Overall Study|Switched to alternative treatment|0|||
157090024|NCT00346632|567084618|FG007|Overall Study|Switched to alternative treatment|0|||
157090025|NCT00346632|567084619|FG008|Overall Study|Switched to alternative treatment|0|||
157090026|NCT00346632|567084620|FG009|Overall Study|Switched to alternative treatment|0|||
157090027|NCT00346632|567084611|FG000|Overall Study|Not Stated|1|||
157090028|NCT00346632|567084612|FG001|Overall Study|Not Stated|1|||
157090029|NCT00346632|567084613|FG002|Overall Study|Not Stated|0|||
157090030|NCT00346632|567084614|FG003|Overall Study|Not Stated|0|||
157090031|NCT00346632|567084615|FG004|Overall Study|Not Stated|0|||
157090032|NCT00346632|567084616|FG005|Overall Study|Not Stated|0|||
157090033|NCT00346632|567084617|FG006|Overall Study|Not Stated|0|||
157090034|NCT00346632|567084618|FG007|Overall Study|Not Stated|2|||
157090035|NCT00346632|567084619|FG008|Overall Study|Not Stated|2|||
157090036|NCT00346632|567084620|FG009|Overall Study|Not Stated|1|||
157090037|NCT02572882|567084624|FG000|Overall Study|Withdrawal by Subject|1|||
157090038|NCT02572882|567084624|FG000|Overall Study|Participant received kidney transplant|1|||
157090039|NCT01079663|567084627|FG000|Overall Study|Adverse Event|0|||
157090040|NCT01079663|567084628|FG001|Overall Study|Adverse Event|2|||
157090041|NCT01079663|567084627|FG000|Overall Study|Protocol Violation|0|||
157090042|NCT01079663|567084628|FG001|Overall Study|Protocol Violation|2|||
157090043|NCT02354508|567084629|FG000|Period 1: Core Phase|Adverse Event|1|||
157090044|NCT02354508|567084630|FG001|Period 1: Core Phase|Adverse Event|1|||
157090045|NCT02354508|567084631|FG002|Period 1: Core Phase|Adverse Event|2|||
157090046|NCT02354508|567084629|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
157090047|NCT02354508|567084630|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
157090048|NCT02354508|567084631|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
157090049|NCT02354508|567084629|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
157090050|NCT02354508|567084630|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
157090051|NCT02354508|567084631|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
157090052|NCT02354508|567084629|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
157090053|NCT02354508|567084630|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
157090054|NCT02354508|567084631|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
157090055|NCT02354508|567084629|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
157090056|NCT02354508|567084630|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
157090057|NCT02354508|567084631|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
157090058|NCT02354508|567084629|FG000|Period 2: Extension Phase|Physician Decision|5|||
157090059|NCT02354508|567084630|FG001|Period 2: Extension Phase|Physician Decision|0|||
157090060|NCT02354508|567084631|FG002|Period 2: Extension Phase|Physician Decision|1|||
157090061|NCT02354508|567084629|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
157090062|NCT02354508|567084630|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
157090063|NCT02354508|567084631|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
157090064|NCT02354508|567084629|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
157090065|NCT02354508|567084630|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
157090066|NCT02354508|567084631|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
157090067|NCT02354508|567084629|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
157090068|NCT02354508|567084630|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
157090069|NCT02354508|567084631|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
157090070|NCT00461032|567084633|FG000|Overall Study|Adverse Event|5|||
157090071|NCT00461032|567084634|FG001|Overall Study|Adverse Event|6|||
157090072|NCT00461032|567084633|FG000|Overall Study|Lack of Efficacy|5|||
157090073|NCT00461032|567084634|FG001|Overall Study|Lack of Efficacy|1|||
157090074|NCT00461032|567084633|FG000|Overall Study|Lost to Follow-up|7|||
157090075|NCT00461032|567084634|FG001|Overall Study|Lost to Follow-up|12|||
157090076|NCT00461032|567084633|FG000|Overall Study|Protocol Violation|4|||
157090077|NCT00461032|567084634|FG001|Overall Study|Protocol Violation|4|||
157090078|NCT00461032|567084633|FG000|Overall Study|Withdrawal by Subject|7|||
157090079|NCT00461032|567084634|FG001|Overall Study|Withdrawal by Subject|15|||
157090080|NCT00461032|567084633|FG000|Overall Study|Patient Moved or Relocated|2|||
157090081|NCT00461032|567084634|FG001|Overall Study|Patient Moved or Relocated|1|||
157090082|NCT00461032|567084633|FG000|Overall Study|Other|7|||
157090083|NCT00461032|567084634|FG001|Overall Study|Other|5|||
157090084|NCT04447846|567084635|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
157090085|NCT03536143|567084637|FG000|Overall Study|Early termination, Sponsor decision|1|||
157090086|NCT00946101|567084638|FG000|Overall Study|Lost to Follow-up|2|||
157090087|NCT00946101|567084639|FG001|Overall Study|Lost to Follow-up|1|||
157090088|NCT00946101|567084638|FG000|Overall Study|Withdrawal of consent|2|||
157090089|NCT00946101|567084639|FG001|Overall Study|Withdrawal of consent|0|||
157090090|NCT00946101|567084638|FG000|Overall Study|Physician Decision|0|||
157090091|NCT00946101|567084639|FG001|Overall Study|Physician Decision|1|||
157090092|NCT01174160|567084640|FG000|Overall Study|Adverse Event|1|||
157090093|NCT01174160|567084641|FG001|Overall Study|Adverse Event|0|||
157090094|NCT01174160|567084640|FG000|Overall Study|Lost to Follow-up|1|||
157090095|NCT01174160|567084641|FG001|Overall Study|Lost to Follow-up|0|||
157090096|NCT01174160|567084640|FG000|Overall Study|Physician Decision|1|||
157090097|NCT01174160|567084641|FG001|Overall Study|Physician Decision|0|||
157090098|NCT01174160|567084640|FG000|Overall Study|Protocol Violation|4|||
157090099|NCT01174160|567084641|FG001|Overall Study|Protocol Violation|6|||
157090100|NCT01174160|567084640|FG000|Overall Study|Withdrawal by Subject|1|||
157090101|NCT01174160|567084641|FG001|Overall Study|Withdrawal by Subject|0|||
157090102|NCT00093808|567084642|FG000|Overall Study|Cancel participation before receiving tx|1|||
157090103|NCT00093808|567084642|FG000|Overall Study|Protocol Violation|1|||
157090104|NCT00871780|567084643|FG000|Overall Study|Enrolled But Not Treated|6|||
157090105|NCT00871780|567084643|FG000|Overall Study|Withdrawal by Subject|9|||
157090106|NCT00871780|567084643|FG000|Overall Study|Adverse Event|6|||
157090107|NCT00871780|567084643|FG000|Overall Study|Voluntary Discontinuation|4|||
157090108|NCT00871780|567084643|FG000|Overall Study|Death|1|||
157090109|NCT00871780|567084643|FG000|Overall Study|Physician Decision|1|||
157090110|NCT02527343|567084644|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
157090111|NCT02527343|567084645|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
157090112|NCT02527343|567084646|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
157090113|NCT02527343|567084647|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
157090114|NCT02527343|567084648|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
157090115|NCT02527343|567084649|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
157090116|NCT02527343|567084644|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
157090117|NCT02527343|567084645|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
157090118|NCT02527343|567084646|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
157090119|NCT02527343|567084647|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
157090120|NCT02527343|567084648|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
157090121|NCT02527343|567084649|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
157090122|NCT02527343|567084644|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157090123|NCT02527343|567084645|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
157090124|NCT02527343|567084646|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157090125|NCT02527343|567084647|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157090126|NCT02527343|567084648|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157237470|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
157237471|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
157237472|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
157237473|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
157237474|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
157237475|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
157237476|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
157237477|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
157237478|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
157237479|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
157237480|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
157237481|NCT01045161|567616654|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
157237482|NCT01045161|567616655|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
157237483|NCT01045161|567616656|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
157090127|NCT02527343|567084649|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
157090128|NCT02527343|567084644|FG000|RT Period: Weeks 1 to 52|Other|4|||
157090129|NCT02527343|567084645|FG001|RT Period: Weeks 1 to 52|Other|3|||
157090130|NCT02527343|567084646|FG002|RT Period: Weeks 1 to 52|Other|0|||
157090131|NCT02527343|567084647|FG003|RT Period: Weeks 1 to 52|Other|0|||
157090132|NCT02527343|567084648|FG004|RT Period: Weeks 1 to 52|Other|0|||
157090133|NCT02527343|567084649|FG005|RT Period: Weeks 1 to 52|Other|0|||
157090134|NCT02527343|567084644|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
157090135|NCT02527343|567084645|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
157090136|NCT02527343|567084646|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
157090137|NCT02527343|567084647|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
157090138|NCT02527343|567084648|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
157090139|NCT02527343|567084649|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
157090140|NCT02527343|567084644|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
157090141|NCT02527343|567084645|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
157090142|NCT02527343|567084646|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
157090143|NCT02527343|567084647|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
157090144|NCT02527343|567084648|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
157090145|NCT02527343|567084649|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
157090146|NCT02527343|567084644|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
157090147|NCT02527343|567084645|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
157090148|NCT02527343|567084646|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
157090149|NCT02527343|567084647|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
157090150|NCT02527343|567084648|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
157090151|NCT02527343|567084649|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
157090152|NCT02527343|567084644|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
157090153|NCT02527343|567084645|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
157090154|NCT02527343|567084646|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
157090155|NCT02527343|567084647|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
157090156|NCT02527343|567084648|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
157090157|NCT02527343|567084649|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
157090158|NCT02527343|567084644|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
157090159|NCT02527343|567084645|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
157090160|NCT02527343|567084646|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
157090161|NCT02527343|567084647|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
157090162|NCT02527343|567084648|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
157090163|NCT02527343|567084649|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
157090164|NCT02527343|567084644|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
157090165|NCT02527343|567084645|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
157090166|NCT02527343|567084646|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
157090167|NCT02527343|567084647|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
157090168|NCT02527343|567084648|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
157090169|NCT02527343|567084649|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
157090170|NCT02527343|567084644|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
157090171|NCT02527343|567084645|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
157090172|NCT02527343|567084646|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
157090173|NCT02527343|567084647|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
157090174|NCT02527343|567084648|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
157090175|NCT02527343|567084649|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
157090176|NCT02527343|567084644|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
157196917|NCT01589185|567463815|FG004|Overall Study|Lost to Follow-up|0|||
157196918|NCT02708524|567463818|FG000|Overall Study|Adverse Event|0|||
157196919|NCT02708524|567463819|FG001|Overall Study|Adverse Event|1|||
157196920|NCT02708524|567463820|FG002|Overall Study|Adverse Event|0|||
157196921|NCT02708524|567463821|FG003|Overall Study|Adverse Event|0|||
157196922|NCT02708524|567463818|FG000|Overall Study|Lens Discomfort|1|||
157196923|NCT02708524|567463819|FG001|Overall Study|Lens Discomfort|0|||
157196924|NCT02708524|567463820|FG002|Overall Study|Lens Discomfort|1|||
157196925|NCT02708524|567463821|FG003|Overall Study|Lens Discomfort|0|||
157196926|NCT02708524|567463818|FG000|Overall Study|Lost to Follow-up|1|||
157196927|NCT02708524|567463819|FG001|Overall Study|Lost to Follow-up|1|||
157196928|NCT02708524|567463820|FG002|Overall Study|Lost to Follow-up|1|||
157196929|NCT02708524|567463821|FG003|Overall Study|Lost to Follow-up|0|||
157196930|NCT02708524|567463818|FG000|Overall Study|Protocol Violation|0|||
157196931|NCT02708524|567463819|FG001|Overall Study|Protocol Violation|1|||
157196932|NCT02708524|567463820|FG002|Overall Study|Protocol Violation|0|||
157196933|NCT02708524|567463821|FG003|Overall Study|Protocol Violation|0|||
157196934|NCT02708524|567463818|FG000|Overall Study|Withdrawal by Subject|1|||
157196935|NCT02708524|567463819|FG001|Overall Study|Withdrawal by Subject|1|||
157196936|NCT02708524|567463820|FG002|Overall Study|Withdrawal by Subject|0|||
157196937|NCT02708524|567463821|FG003|Overall Study|Withdrawal by Subject|0|||
157196938|NCT02708524|567463818|FG000|Overall Study|Dispensed incorrect study lens|0|||
157196939|NCT02708524|567463819|FG001|Overall Study|Dispensed incorrect study lens|1|||
157196940|NCT02708524|567463820|FG002|Overall Study|Dispensed incorrect study lens|1|||
157196941|NCT02708524|567463821|FG003|Overall Study|Dispensed incorrect study lens|0|||
157196942|NCT02708524|567463818|FG000|Overall Study|Did not wear lens at final visit|0|||
157196943|NCT02708524|567463819|FG001|Overall Study|Did not wear lens at final visit|1|||
157090177|NCT02527343|567084645|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
157090178|NCT02527343|567084646|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
157090179|NCT02527343|567084647|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
157090180|NCT02527343|567084648|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
157090181|NCT02527343|567084649|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
157090182|NCT02527343|567084644|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
157090183|NCT02527343|567084645|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
157090184|NCT02527343|567084646|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
157090185|NCT02527343|567084647|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
157090186|NCT02527343|567084648|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
157090187|NCT02527343|567084649|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
157090188|NCT05767021|567084650|FG000|Overall Study|Adverse Event|2|||
157090189|NCT05767021|567084650|FG000|Overall Study|Protocol Deviation|1|||
157090190|NCT05767021|567084650|FG000|Overall Study|Withdrawal by Subject|1|||
157090191|NCT05767021|567084650|FG000|Overall Study|Physician Decision|1|||
157090192|NCT05767021|567084650|FG000|Overall Study|Lack of Efficacy|11|||
157090193|NCT05767021|567084650|FG000|Overall Study|Assigned Treatment by Mistake|1|||
157090194|NCT00523640|567084653|FG000|Overall Study|Death|1|||
157090195|NCT06377488|567084654|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
157090196|NCT06377488|567084654|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
157090197|NCT06377488|567084654|FG000|Overall Study|Protocol Violation|1|||
157090198|NCT06377488|567084654|FG000|Overall Study|Lost to Follow-up|1|||
157090199|NCT06377488|567084654|FG000|Overall Study|Incorrect Lens Dispensed|2|||
157090200|NCT04055090|567084657|FG000|Overall Study|screen failure|1|||
157090201|NCT04055090|567084658|FG001|Overall Study|screen failure|0|||
157090202|NCT04055090|567084657|FG000|Overall Study|Withdrawal by Subject|1|||
157090203|NCT04055090|567084658|FG001|Overall Study|Withdrawal by Subject|0|||
157090204|NCT04745026|567084659|FG000|Overall Study|Physician Decision|1|||
157090205|NCT04745026|567084660|FG001|Overall Study|Physician Decision|0|||
157090206|NCT04745026|567084659|FG000|Overall Study|Adverse Event|2|||
157090207|NCT04745026|567084660|FG001|Overall Study|Adverse Event|2|||
157090208|NCT04745026|567084659|FG000|Overall Study|Protocol Violation|1|||
157090209|NCT04745026|567084660|FG001|Overall Study|Protocol Violation|3|||
157090210|NCT04745026|567084659|FG000|Overall Study|Lost to Follow-up|4|||
157090211|NCT04745026|567084660|FG001|Overall Study|Lost to Follow-up|3|||
157090212|NCT04745026|567084659|FG000|Overall Study|Withdrawal by Subject|5|||
157090213|NCT04745026|567084660|FG001|Overall Study|Withdrawal by Subject|5|||
157090214|NCT02334423|567084663|FG000|Overall Study|Protocol Violation|10|||
157090215|NCT02334423|567084664|FG001|Overall Study|Protocol Violation|3|||
157090216|NCT04426851|567084665|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
157090217|NCT04426851|567084666|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
157090218|NCT04426851|567084665|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
157090219|NCT04426851|567084666|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
157090220|NCT03625895|567084667|FG000|Overall Study|Protocol Violation|585|||
157090221|NCT02081417|567084671|FG000|Overall Study|Lost to Follow-up|26|||
157090222|NCT02081417|567084672|FG001|Overall Study|Lost to Follow-up|23|||
157090223|NCT02081417|567084671|FG000|Overall Study|Moved Away|1|||
157090224|NCT02081417|567084672|FG001|Overall Study|Moved Away|2|||
157090225|NCT02081417|567084671|FG000|Overall Study|Incarcerated|2|||
157090226|NCT02081417|567084672|FG001|Overall Study|Incarcerated|2|||
157090227|NCT02081417|567084671|FG000|Overall Study|Death|4|||
157090228|NCT02081417|567084672|FG001|Overall Study|Death|3|||
157090229|NCT02081417|567084671|FG000|Overall Study|Withdrawal by Subject|4|||
157090230|NCT02081417|567084672|FG001|Overall Study|Withdrawal by Subject|0|||
157090231|NCT02081417|567084671|FG000|Overall Study|Admitted to Residential Treatment|2|||
157090232|NCT02081417|567084672|FG001|Overall Study|Admitted to Residential Treatment|0|||
157090233|NCT02081417|567084671|FG000|Overall Study|Did not start treatment|17|||
157090234|NCT02081417|567084672|FG001|Overall Study|Did not start treatment|21|||
157090235|NCT02679573|567084673|FG000|Overall Study|Adverse Event|13|||
157237484|NCT01854047|567616657|FG000|Overall Study|Lack of Efficacy|1|||
157237485|NCT01854047|567616658|FG001|Overall Study|Lack of Efficacy|0|||
157237486|NCT01854047|567616659|FG002|Overall Study|Lack of Efficacy|0|||
157237487|NCT01854047|567616660|FG003|Overall Study|Lack of Efficacy|0|||
157237488|NCT01854047|567616661|FG004|Overall Study|Lack of Efficacy|0|||
157090236|NCT02679573|567084674|FG001|Overall Study|Adverse Event|6|||
157090237|NCT02679573|567084673|FG000|Overall Study|Lack of Efficacy|12|||
157090238|NCT02679573|567084674|FG001|Overall Study|Lack of Efficacy|15|||
157090239|NCT02679573|567084673|FG000|Overall Study|Could not complete required study visits|6|||
157090240|NCT02679573|567084674|FG001|Overall Study|Could not complete required study visits|2|||
157090241|NCT02679573|567084673|FG000|Overall Study|Withdrawal by Subject|2|||
157237489|NCT01854047|567616657|FG000|Overall Study|Poor compliance to protocol|3|||
157090242|NCT02679573|567084674|FG001|Overall Study|Withdrawal by Subject|9|||
157090243|NCT02679573|567084673|FG000|Overall Study|Death|2|||
157090244|NCT02679573|567084674|FG001|Overall Study|Death|0|||
157090245|NCT02679573|567084673|FG000|Overall Study|Physician Decision|2|||
157090246|NCT02679573|567084674|FG001|Overall Study|Physician Decision|4|||
157237490|NCT01854047|567616658|FG001|Overall Study|Poor compliance to protocol|0|||
157090247|NCT02679573|567084673|FG000|Overall Study|Lost to Follow-up|0|||
157090248|NCT02679573|567084674|FG001|Overall Study|Lost to Follow-up|3|||
157090249|NCT02128542|567084675|FG000|Overall Study|Lost to Follow-up|3|||
157090250|NCT02128542|567084676|FG001|Overall Study|Lost to Follow-up|0|||
157090251|NCT02128542|567084675|FG000|Overall Study|Withdrew Consent|1|||
157090252|NCT02128542|567084676|FG001|Overall Study|Withdrew Consent|0|||
157090253|NCT02483585|567084677|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
157090254|NCT02483585|567084678|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
157090255|NCT02483585|567084677|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
157090256|NCT02483585|567084678|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
157090257|NCT02483585|567084677|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
157090258|NCT02483585|567084678|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
157090259|NCT02483585|567084677|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
157090260|NCT02483585|567084678|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
157090261|NCT02483585|567084677|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
157090262|NCT02483585|567084678|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
157090263|NCT02483585|567084677|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
157090264|NCT02483585|567084678|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
157090265|NCT02483585|567084677|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
157090266|NCT02483585|567084678|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
157090267|NCT02054741|567084682|FG000|Overall Study|Protocol Violation|13|||
157090268|NCT02054741|567084683|FG001|Overall Study|Protocol Violation|2|||
157090269|NCT02054741|567084682|FG000|Overall Study|Withdrawal by Subject|10|||
157090270|NCT02054741|567084683|FG001|Overall Study|Withdrawal by Subject|5|||
157090271|NCT02054741|567084682|FG000|Overall Study|Death|94|||
157090272|NCT02054741|567084683|FG001|Overall Study|Death|90|||
157090273|NCT02054741|567084682|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
157090274|NCT02054741|567084683|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
157090275|NCT01502631|567084684|FG000|Overall Study|Adverse Event|5|||
157090276|NCT01502631|567084685|FG001|Overall Study|Adverse Event|8|||
157090277|NCT01502631|567084684|FG000|Overall Study|Lost to Follow-up|2|||
157090278|NCT01502631|567084685|FG001|Overall Study|Lost to Follow-up|2|||
157090279|NCT01502631|567084684|FG000|Overall Study|Participant withdrew consent|2|||
157090280|NCT01502631|567084685|FG001|Overall Study|Participant withdrew consent|4|||
157090281|NCT01502631|567084684|FG000|Overall Study|Participant non-compliant|1|||
157090282|NCT01502631|567084685|FG001|Overall Study|Participant non-compliant|0|||
157090283|NCT01502631|567084684|FG000|Overall Study|Investigator's decision|0|||
157090284|NCT01502631|567084685|FG001|Overall Study|Investigator's decision|1|||
157090285|NCT01502631|567084684|FG000|Overall Study|Other|10|||
157090286|NCT01502631|567084685|FG001|Overall Study|Other|5|||
157090287|NCT01488487|567084686|FG000|Overall Study|Adverse Event|6|||
157090288|NCT01488487|567084686|FG000|Overall Study|Death|1|||
157090289|NCT01488487|567084686|FG000|Overall Study|Withdrawal by Subject|2|||
157090290|NCT00395460|567084689|FG000|Overall Study|Withdrawal by Subject|1|||
157090291|NCT00395460|567084690|FG001|Overall Study|Withdrawal by Subject|0|||
157090292|NCT02319525|567084696|FG000|Overall Study|Withdrawal by Subject|2|||
157090293|NCT02319525|567084697|FG001|Overall Study|Withdrawal by Subject|1|||
157090294|NCT04223830|567084701|FG000|Overall Study|Lost to Follow-up|9|||
157090295|NCT04223830|567084701|FG000|Overall Study|Adverse Event|1|||
157237491|NCT01854047|567616659|FG002|Overall Study|Poor compliance to protocol|2|||
157237492|NCT01854047|567616660|FG003|Overall Study|Poor compliance to protocol|0|||
157237493|NCT01854047|567616661|FG004|Overall Study|Poor compliance to protocol|0|||
157237494|NCT01854047|567616657|FG000|Overall Study|Adverse Event|5|||
157237495|NCT01854047|567616658|FG001|Overall Study|Adverse Event|4|||
157237496|NCT01854047|567616659|FG002|Overall Study|Adverse Event|6|||
157237497|NCT01854047|567616660|FG003|Overall Study|Adverse Event|10|||
157237498|NCT01854047|567616661|FG004|Overall Study|Adverse Event|7|||
157090296|NCT01806623|567084702|FG000|Overall Study|Withdrawal by Subject|1|||
157090297|NCT01806623|567084702|FG000|Overall Study|Adverse Event|1|||
157090298|NCT01806623|567084702|FG000|Overall Study|Did not meet the inclusion criteria|56|||
157090299|NCT01737827|567084703|FG000|Overall Study|Adverse Event|3|||
157090300|NCT01737827|567084704|FG001|Overall Study|Adverse Event|6|||
157090301|NCT01737827|567084705|FG002|Overall Study|Adverse Event|0|||
157090302|NCT01737827|567084703|FG000|Overall Study|Lost to Follow-up|0|||
157090303|NCT01737827|567084704|FG001|Overall Study|Lost to Follow-up|1|||
157090304|NCT01737827|567084705|FG002|Overall Study|Lost to Follow-up|0|||
157090305|NCT01737827|567084703|FG000|Overall Study|Physician Decision|0|||
157090306|NCT01737827|567084704|FG001|Overall Study|Physician Decision|2|||
157090307|NCT01737827|567084705|FG002|Overall Study|Physician Decision|0|||
157090308|NCT01737827|567084703|FG000|Overall Study|Progressive Disease|5|||
157090309|NCT01737827|567084704|FG001|Overall Study|Progressive Disease|16|||
157090310|NCT01737827|567084705|FG002|Overall Study|Progressive Disease|2|||
157090311|NCT01737827|567084703|FG000|Overall Study|Study Terminated by Sponsor|0|||
157090312|NCT01737827|567084704|FG001|Overall Study|Study Terminated by Sponsor|1|||
157090313|NCT01737827|567084705|FG002|Overall Study|Study Terminated by Sponsor|0|||
157090314|NCT01737827|567084703|FG000|Overall Study|Subject/Guardian Decision|0|||
157090315|NCT01737827|567084704|FG001|Overall Study|Subject/Guardian Decision|2|||
157090316|NCT01737827|567084705|FG002|Overall Study|Subject/Guardian Decision|0|||
157090317|NCT01451827|567084706|FG000|Overall Study|Adverse Event|2|||
157090318|NCT01451827|567084707|FG001|Overall Study|Adverse Event|0|||
157090319|NCT01451827|567084708|FG002|Overall Study|Adverse Event|1|||
157090320|NCT01451827|567084709|FG003|Overall Study|Adverse Event|1|||
157090321|NCT01451827|567084706|FG000|Overall Study|Protocol deviation|1|||
157090322|NCT01451827|567084707|FG001|Overall Study|Protocol deviation|0|||
157090323|NCT01451827|567084708|FG002|Overall Study|Protocol deviation|0|||
157090324|NCT01451827|567084709|FG003|Overall Study|Protocol deviation|0|||
157090325|NCT01451827|567084706|FG000|Overall Study|Lost to Follow-up|0|||
157090326|NCT01451827|567084707|FG001|Overall Study|Lost to Follow-up|3|||
157090327|NCT01451827|567084708|FG002|Overall Study|Lost to Follow-up|0|||
157090328|NCT01451827|567084709|FG003|Overall Study|Lost to Follow-up|2|||
157090329|NCT01451827|567084706|FG000|Overall Study|Participant met withdrawal criteria|0|||
157090330|NCT01451827|567084707|FG001|Overall Study|Participant met withdrawal criteria|2|||
157090331|NCT01451827|567084708|FG002|Overall Study|Participant met withdrawal criteria|0|||
157090332|NCT01451827|567084709|FG003|Overall Study|Participant met withdrawal criteria|0|||
157090333|NCT01451827|567084706|FG000|Overall Study|Withdrawal by Subject|0|||
157090334|NCT01451827|567084707|FG001|Overall Study|Withdrawal by Subject|0|||
157090335|NCT01451827|567084708|FG002|Overall Study|Withdrawal by Subject|1|||
157090336|NCT01451827|567084709|FG003|Overall Study|Withdrawal by Subject|1|||
157090337|NCT01964924|567084710|FG000|Trametinib Monotherapy|Progression|19|||
157090338|NCT01964924|567084711|FG001|Trametinib Monotherapy|Progression|0|||
157090339|NCT01528345|567084712|FG000|Overall Study|Adverse Event|10|||
157090340|NCT01528345|567084713|FG001|Overall Study|Adverse Event|1|||
157090341|NCT01528345|567084712|FG000|Overall Study|Death|1|||
157090342|NCT01528345|567084713|FG001|Overall Study|Death|1|||
157090343|NCT01528345|567084712|FG000|Overall Study|Non-compliance with study treatment|1|||
157090344|NCT01528345|567084713|FG001|Overall Study|Non-compliance with study treatment|0|||
157090345|NCT01528345|567084712|FG000|Overall Study|Progressive Disease|26|||
157090346|NCT01528345|567084713|FG001|Overall Study|Progressive Disease|40|||
157090347|NCT01528345|567084712|FG000|Overall Study|Study Terminated by Sponsor|4|||
157090348|NCT01528345|567084713|FG001|Overall Study|Study Terminated by Sponsor|8|||
157090349|NCT01528345|567084712|FG000|Overall Study|Subject/Guardian Decision|5|||
157090350|NCT01528345|567084713|FG001|Overall Study|Subject/Guardian Decision|0|||
157090351|NCT01034163|567084714|FG000|Overall Study|Treatment completed as per protocol|8|||
157090352|NCT01034163|567084715|FG001|Overall Study|Treatment completed as per protocol|7|||
157090353|NCT01034163|567084714|FG000|Overall Study|Withdrawal by Subject|8|||
157090354|NCT01034163|567084715|FG001|Overall Study|Withdrawal by Subject|2|||
157090355|NCT01034163|567084714|FG000|Overall Study|Protocol deviation|1|||
157090356|NCT01034163|567084715|FG001|Overall Study|Protocol deviation|0|||
157090357|NCT01034163|567084714|FG000|Overall Study|Disease progression|3|||
157090358|NCT01034163|567084715|FG001|Overall Study|Disease progression|4|||
157090359|NCT01034163|567084714|FG000|Overall Study|Adverse Event|6|||
157090360|NCT01034163|567084715|FG001|Overall Study|Adverse Event|0|||
157090361|NCT01034163|567084714|FG000|Overall Study|Administrative problems|0|||
157090362|NCT01034163|567084715|FG001|Overall Study|Administrative problems|1|||
157090363|NCT01034163|567084714|FG000|Overall Study|Abnormal laboratory value|1|||
157090364|NCT01034163|567084715|FG001|Overall Study|Abnormal laboratory value|0|||
157090365|NCT01090427|567084720|FG000|After Controlled Period|Death|0|||
157090366|NCT01090427|567084721|FG001|After Controlled Period|Death|0|||
157090367|NCT01090427|567084722|FG002|After Controlled Period|Death|0|||
157090368|NCT01090427|567084723|FG003|After Controlled Period|Death|0|||
157237499|NCT01854047|567616657|FG000|Overall Study|Randomized but not treated|0|||
157237500|NCT01854047|567616658|FG001|Overall Study|Randomized but not treated|1|||
157237501|NCT01854047|567616659|FG002|Overall Study|Randomized but not treated|2|||
157237502|NCT01854047|567616660|FG003|Overall Study|Randomized but not treated|0|||
157237503|NCT01854047|567616661|FG004|Overall Study|Randomized but not treated|4|||
157237504|NCT01854047|567616657|FG000|Overall Study|Other than specified above|3|||
157237505|NCT01854047|567616658|FG001|Overall Study|Other than specified above|3|||
157237506|NCT01854047|567616659|FG002|Overall Study|Other than specified above|3|||
157090369|NCT01090427|567084724|FG004|After Controlled Period|Death|0|||
157090370|NCT01090427|567084725|FG005|After Controlled Period|Death|1|||
157090371|NCT01090427|567084726|FG006|After Controlled Period|Death|0|||
157090372|NCT01090427|567084720|FG000|After Controlled Period|Lack of Efficacy|0|||
157237507|NCT01854047|567616660|FG003|Overall Study|Other than specified above|5|||
157237508|NCT01854047|567616661|FG004|Overall Study|Other than specified above|8|||
157237509|NCT03686033|567616662|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
157090373|NCT01090427|567084721|FG001|After Controlled Period|Lack of Efficacy|0|||
157090374|NCT01090427|567084722|FG002|After Controlled Period|Lack of Efficacy|0|||
157090375|NCT01090427|567084723|FG003|After Controlled Period|Lack of Efficacy|0|||
157090376|NCT01090427|567084724|FG004|After Controlled Period|Lack of Efficacy|0|||
157090377|NCT01090427|567084725|FG005|After Controlled Period|Lack of Efficacy|3|||
157090378|NCT01090427|567084726|FG006|After Controlled Period|Lack of Efficacy|2|||
157090379|NCT01090427|567084720|FG000|After Controlled Period|Adverse Event|0|||
157090380|NCT01090427|567084721|FG001|After Controlled Period|Adverse Event|0|||
157090381|NCT01090427|567084722|FG002|After Controlled Period|Adverse Event|0|||
157090382|NCT01090427|567084723|FG003|After Controlled Period|Adverse Event|2|||
157090383|NCT01090427|567084724|FG004|After Controlled Period|Adverse Event|0|||
157090384|NCT01090427|567084725|FG005|After Controlled Period|Adverse Event|1|||
157090385|NCT01090427|567084726|FG006|After Controlled Period|Adverse Event|0|||
157090386|NCT00928018|567084731|FG000|Overall Study|Withdrawal by Subject|1|||
157090387|NCT00928018|567084732|FG001|Overall Study|Withdrawal by Subject|0|||
157090388|NCT02008877|567084733|FG000|Overall Study|Inevaluable|0|||
157090389|NCT02008877|567084734|FG001|Overall Study|Inevaluable|1|||
157090390|NCT02008877|567084735|FG002|Overall Study|Inevaluable|0|||
157090391|NCT00979134|567084736|FG000|Overall Study|Disease progression|18|||
157090392|NCT00979134|567084737|FG001|Overall Study|Disease progression|2|||
157090393|NCT00979134|567084738|FG002|Overall Study|Disease progression|5|||
157090394|NCT00979134|567084736|FG000|Overall Study|Adverse Event|0|||
157090395|NCT00979134|567084737|FG001|Overall Study|Adverse Event|0|||
157090396|NCT00979134|567084738|FG002|Overall Study|Adverse Event|2|||
157090397|NCT00979134|567084736|FG000|Overall Study|Withdrawal by Subject|1|||
157090398|NCT00979134|567084737|FG001|Overall Study|Withdrawal by Subject|1|||
157090399|NCT00979134|567084738|FG002|Overall Study|Withdrawal by Subject|2|||
157090400|NCT00979134|567084736|FG000|Overall Study|Lost to Follow-up|2|||
157090401|NCT00979134|567084737|FG001|Overall Study|Lost to Follow-up|2|||
157090402|NCT00979134|567084738|FG002|Overall Study|Lost to Follow-up|0|||
157090403|NCT00979134|567084736|FG000|Overall Study|Death|4|||
157090404|NCT00979134|567084737|FG001|Overall Study|Death|0|||
157090405|NCT00979134|567084738|FG002|Overall Study|Death|26|||
157090406|NCT00979134|567084736|FG000|Overall Study|Other|8|||
157090407|NCT00979134|567084737|FG001|Overall Study|Other|1|||
157090408|NCT00979134|567084738|FG002|Overall Study|Other|5|||
157090409|NCT05172050|567084739|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
157090410|NCT05172050|567084740|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
157090411|NCT05172050|567084741|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
157090412|NCT05172050|567084739|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
157090413|NCT05172050|567084740|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
157090414|NCT05172050|567084741|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
157090415|NCT05172050|567084739|FG000|Overall Study|Other|2|||
157090416|NCT05172050|567084740|FG001|Overall Study|Other|2|||
157090417|NCT05172050|567084741|FG002|Overall Study|Other|1|||
157090418|NCT04227704|567084744|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
157090419|NCT04227704|567084745|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
157090420|NCT04227704|567084746|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
157090421|NCT04227704|567084744|FG000|Overall Study|due to C/S being cancelled|1|||
157090422|NCT04227704|567084745|FG001|Overall Study|due to C/S being cancelled|0|||
157090423|NCT04227704|567084746|FG002|Overall Study|due to C/S being cancelled|0|||
157090424|NCT05917470|567084747|FG000|Overall Study|Progressive Disease|1|||
157090425|NCT05917470|567084748|FG001|Overall Study|Progressive Disease|1|||
157090426|NCT05917470|567084749|FG002|Overall Study|Progressive Disease|2|||
157090427|NCT05917470|567084750|FG003|Overall Study|Progressive Disease|3|||
157090428|NCT05917470|567084751|FG004|Overall Study|Progressive Disease|1|||
157090429|NCT05917470|567084752|FG005|Overall Study|Progressive Disease|1|||
157090430|NCT05917470|567084753|FG006|Overall Study|Progressive Disease|0|||
157090431|NCT05917470|567084754|FG007|Overall Study|Progressive Disease|0|||
157090432|NCT05917470|567084747|FG000|Overall Study|Withdrawal by Subject|0|||
157090433|NCT05917470|567084748|FG001|Overall Study|Withdrawal by Subject|0|||
157090434|NCT05917470|567084749|FG002|Overall Study|Withdrawal by Subject|1|||
157090435|NCT05917470|567084750|FG003|Overall Study|Withdrawal by Subject|0|||
157090436|NCT05917470|567084751|FG004|Overall Study|Withdrawal by Subject|0|||
157090437|NCT05917470|567084752|FG005|Overall Study|Withdrawal by Subject|0|||
157090438|NCT05917470|567084753|FG006|Overall Study|Withdrawal by Subject|0|||
157090439|NCT05917470|567084754|FG007|Overall Study|Withdrawal by Subject|0|||
157090440|NCT05917470|567084747|FG000|Overall Study|Sponsor Decision|0|||
157090441|NCT05917470|567084748|FG001|Overall Study|Sponsor Decision|0|||
157090442|NCT05917470|567084749|FG002|Overall Study|Sponsor Decision|1|||
157090443|NCT05917470|567084750|FG003|Overall Study|Sponsor Decision|0|||
157090444|NCT05917470|567084751|FG004|Overall Study|Sponsor Decision|2|||
157090445|NCT05917470|567084752|FG005|Overall Study|Sponsor Decision|1|||
157090446|NCT05917470|567084753|FG006|Overall Study|Sponsor Decision|3|||
157090447|NCT05917470|567084754|FG007|Overall Study|Sponsor Decision|3|||
157090448|NCT05917470|567084747|FG000|Overall Study|Adverse Event|0|||
157090449|NCT05917470|567084748|FG001|Overall Study|Adverse Event|0|||
157090450|NCT05917470|567084749|FG002|Overall Study|Adverse Event|0|||
157090451|NCT05917470|567084750|FG003|Overall Study|Adverse Event|0|||
157090452|NCT05917470|567084751|FG004|Overall Study|Adverse Event|0|||
157090453|NCT05917470|567084752|FG005|Overall Study|Adverse Event|1|||
157090454|NCT05917470|567084753|FG006|Overall Study|Adverse Event|0|||
157090455|NCT05917470|567084754|FG007|Overall Study|Adverse Event|0|||
157090456|NCT02317432|567084755|FG000|Overall Study|Death|4|||
157090457|NCT02317432|567084756|FG001|Overall Study|Death|1|||
157090458|NCT02317432|567084755|FG000|Overall Study|Lost to Follow-up|0|||
157090459|NCT02317432|567084756|FG001|Overall Study|Lost to Follow-up|5|||
157090460|NCT02317432|567084755|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
157090461|NCT02317432|567084756|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
157090462|NCT00729378|567086796|FG000|Baseline|Did not complete study measurements|72|||
157090463|NCT00729378|567086797|FG001|Baseline|Did not complete study measurements|33|||
157090464|NCT00729378|567086796|FG000|Baseline|Withdrawal by Subject|66|||
157090465|NCT00729378|567086797|FG001|Baseline|Withdrawal by Subject|59|||
157090466|NCT00729378|567086796|FG000|12-months|Lost to Follow-up|100|||
157090467|NCT00729378|567086797|FG001|12-months|Lost to Follow-up|65|||
157090468|NCT00729378|567086796|FG000|24-months|Lost to Follow-up|72|||
157090469|NCT00729378|567086797|FG001|24-months|Lost to Follow-up|51|||
157090470|NCT00729378|567086796|FG000|36-months|Lost to Follow-up|15|||
157090471|NCT00729378|567086797|FG001|36-months|Lost to Follow-up|6|||
157090472|NCT00690443|567086798|FG000|Overall Study|Adverse Event|1|||
157090473|NCT00690443|567086799|FG001|Overall Study|Adverse Event|2|||
157090474|NCT02874924|567086800|FG000|Overall Study|Adverse Event|2|||
157090475|NCT02874924|567086801|FG001|Overall Study|Adverse Event|0|||
157090476|NCT02874924|567086802|FG002|Overall Study|Adverse Event|0|||
157090477|NCT02874924|567086800|FG000|Overall Study|Withdrawal by Subject|1|||
157090478|NCT02874924|567086801|FG001|Overall Study|Withdrawal by Subject|0|||
157090479|NCT02874924|567086802|FG002|Overall Study|Withdrawal by Subject|0|||
157090480|NCT02808143|567086803|FG000|Maintenance Phase|Disease recurrence|1|||
157090481|NCT02808143|567086804|FG001|Maintenance Phase|Disease recurrence|3|||
157090482|NCT02808143|567086803|FG000|Maintenance Phase|Disease progression|1|||
157090483|NCT02808143|567086804|FG001|Maintenance Phase|Disease progression|2|||
157090484|NCT02808143|567086803|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
157090485|NCT02808143|567086804|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
157090486|NCT02808143|567086803|FG000|Survival Follow-Up|Disease recurrence|0|||
157090487|NCT02808143|567086804|FG001|Survival Follow-Up|Disease recurrence|2|||
157090488|NCT02808143|567086803|FG000|Survival Follow-Up|Adverse Event|0|||
157090489|NCT02808143|567086804|FG001|Survival Follow-Up|Adverse Event|1|||
157090490|NCT02808143|567086803|FG000|Survival Follow-Up|Death|1|||
157090491|NCT02808143|567086804|FG001|Survival Follow-Up|Death|0|||
157090492|NCT01689337|567086805|FG000|Overall Study|Study Discontinuation|1|||
157090493|NCT01874431|567086806|FG000|Overall Study|Physician Decision|0|||
157090494|NCT01874431|567086807|FG001|Overall Study|Physician Decision|0|||
157090495|NCT01874431|567086808|FG002|Overall Study|Physician Decision|1|||
157090496|NCT01874431|567086809|FG003|Overall Study|Physician Decision|0|||
157090497|NCT01874431|567086810|FG004|Overall Study|Physician Decision|0|||
157090498|NCT01874431|567086811|FG005|Overall Study|Physician Decision|0|||
157090499|NCT01874431|567086812|FG006|Overall Study|Physician Decision|0|||
157090500|NCT01874431|567086813|FG007|Overall Study|Physician Decision|0|||
157090501|NCT01874431|567086806|FG000|Overall Study|Adverse Event|5|||
157090502|NCT01874431|567086807|FG001|Overall Study|Adverse Event|4|||
157090503|NCT01874431|567086808|FG002|Overall Study|Adverse Event|6|||
157090504|NCT01874431|567086809|FG003|Overall Study|Adverse Event|5|||
157090505|NCT01874431|567086810|FG004|Overall Study|Adverse Event|2|||
157090506|NCT01874431|567086811|FG005|Overall Study|Adverse Event|8|||
157090507|NCT01874431|567086812|FG006|Overall Study|Adverse Event|2|||
157090508|NCT01874431|567086813|FG007|Overall Study|Adverse Event|3|||
157090509|NCT01874431|567086806|FG000|Overall Study|Protocol Violation|1|||
157090510|NCT01874431|567086807|FG001|Overall Study|Protocol Violation|1|||
157090511|NCT01874431|567086808|FG002|Overall Study|Protocol Violation|1|||
157090512|NCT01874431|567086809|FG003|Overall Study|Protocol Violation|0|||
157090513|NCT01874431|567086810|FG004|Overall Study|Protocol Violation|3|||
157090514|NCT01874431|567086811|FG005|Overall Study|Protocol Violation|2|||
157090515|NCT01874431|567086812|FG006|Overall Study|Protocol Violation|1|||
157090516|NCT01874431|567086813|FG007|Overall Study|Protocol Violation|1|||
157090517|NCT01874431|567086806|FG000|Overall Study|Non-compliance|0|||
157090518|NCT01874431|567086807|FG001|Overall Study|Non-compliance|0|||
157090519|NCT01874431|567086808|FG002|Overall Study|Non-compliance|0|||
157090520|NCT01874431|567086809|FG003|Overall Study|Non-compliance|0|||
157090521|NCT01874431|567086810|FG004|Overall Study|Non-compliance|1|||
157090522|NCT01874431|567086811|FG005|Overall Study|Non-compliance|0|||
157090523|NCT01874431|567086812|FG006|Overall Study|Non-compliance|1|||
157196944|NCT02708524|567463820|FG002|Overall Study|Did not wear lens at final visit|0|||
157196945|NCT02708524|567463821|FG003|Overall Study|Did not wear lens at final visit|0|||
157090524|NCT01874431|567086813|FG007|Overall Study|Non-compliance|0|||
157090525|NCT01874431|567086806|FG000|Overall Study|Logistical difficulties|0|||
157090526|NCT01874431|567086807|FG001|Overall Study|Logistical difficulties|0|||
157090527|NCT01874431|567086808|FG002|Overall Study|Logistical difficulties|0|||
157090528|NCT01874431|567086809|FG003|Overall Study|Logistical difficulties|0|||
157090529|NCT01874431|567086810|FG004|Overall Study|Logistical difficulties|0|||
157090530|NCT01874431|567086811|FG005|Overall Study|Logistical difficulties|0|||
157090531|NCT01874431|567086812|FG006|Overall Study|Logistical difficulties|1|||
157090532|NCT01874431|567086813|FG007|Overall Study|Logistical difficulties|0|||
157090533|NCT01874431|567086806|FG000|Overall Study|Withdrawal by Subject|0|||
157090534|NCT01874431|567086807|FG001|Overall Study|Withdrawal by Subject|0|||
157090535|NCT01874431|567086808|FG002|Overall Study|Withdrawal by Subject|1|||
157090536|NCT01874431|567086809|FG003|Overall Study|Withdrawal by Subject|2|||
157090537|NCT01874431|567086810|FG004|Overall Study|Withdrawal by Subject|1|||
157090538|NCT01874431|567086811|FG005|Overall Study|Withdrawal by Subject|1|||
157090539|NCT01874431|567086812|FG006|Overall Study|Withdrawal by Subject|3|||
157090540|NCT01874431|567086813|FG007|Overall Study|Withdrawal by Subject|0|||
157090541|NCT01874431|567086806|FG000|Overall Study|Sponsor decision|0|||
157090542|NCT01874431|567086807|FG001|Overall Study|Sponsor decision|0|||
157090543|NCT01874431|567086808|FG002|Overall Study|Sponsor decision|0|||
157090544|NCT01874431|567086809|FG003|Overall Study|Sponsor decision|0|||
157090545|NCT01874431|567086810|FG004|Overall Study|Sponsor decision|1|||
157090546|NCT01874431|567086811|FG005|Overall Study|Sponsor decision|0|||
157090547|NCT01874431|567086812|FG006|Overall Study|Sponsor decision|0|||
157090548|NCT01874431|567086813|FG007|Overall Study|Sponsor decision|0|||
157090549|NCT01874431|567086806|FG000|Overall Study|Lost to Follow-up|0|||
157090550|NCT01874431|567086807|FG001|Overall Study|Lost to Follow-up|0|||
157090551|NCT01874431|567086808|FG002|Overall Study|Lost to Follow-up|1|||
157090552|NCT01874431|567086809|FG003|Overall Study|Lost to Follow-up|0|||
157090553|NCT01874431|567086810|FG004|Overall Study|Lost to Follow-up|0|||
157090554|NCT01874431|567086811|FG005|Overall Study|Lost to Follow-up|0|||
157090555|NCT01874431|567086812|FG006|Overall Study|Lost to Follow-up|0|||
157090556|NCT01874431|567086813|FG007|Overall Study|Lost to Follow-up|0|||
157090557|NCT00642772|567086815|FG000|Overall Study|Lost to Follow-up|3|||
157090558|NCT00642772|567086815|FG000|Overall Study|Withdrawal by Subject|7|||
157090559|NCT05398237|567086822|FG000|Overall Study|Withdrawal by Subject|1|||
157090560|NCT04256629|567086823|FG000|Overall Study|Adverse Event|0|||
157090561|NCT04256629|567086824|FG001|Overall Study|Adverse Event|0|||
157090562|NCT04256629|567086825|FG002|Overall Study|Adverse Event|0|||
157090563|NCT04256629|567086826|FG003|Overall Study|Adverse Event|0|||
157090564|NCT04256629|567086827|FG004|Overall Study|Adverse Event|0|||
157090565|NCT04256629|567086828|FG005|Overall Study|Adverse Event|1|||
157090566|NCT04256629|567086823|FG000|Overall Study|Protocol Violation|0|||
157090567|NCT04256629|567086824|FG001|Overall Study|Protocol Violation|1|||
157090568|NCT04256629|567086825|FG002|Overall Study|Protocol Violation|0|||
157090569|NCT04256629|567086826|FG003|Overall Study|Protocol Violation|0|||
157090570|NCT04256629|567086827|FG004|Overall Study|Protocol Violation|0|||
157090571|NCT04256629|567086828|FG005|Overall Study|Protocol Violation|0|||
157090572|NCT00321373|567086829|FG000|Overall Study|Adverse Event|0|||
157090573|NCT00321373|567086830|FG001|Overall Study|Adverse Event|0|||
157090574|NCT00321373|567086831|FG002|Overall Study|Adverse Event|1|||
157090575|NCT00321373|567086829|FG000|Overall Study|Lost to Follow-up|1|||
157090576|NCT00321373|567086830|FG001|Overall Study|Lost to Follow-up|0|||
157090577|NCT00321373|567086831|FG002|Overall Study|Lost to Follow-up|1|||
157090578|NCT00321373|567086829|FG000|Overall Study|Withdrawal by Subject|1|||
157090579|NCT00321373|567086830|FG001|Overall Study|Withdrawal by Subject|0|||
157090580|NCT00321373|567086831|FG002|Overall Study|Withdrawal by Subject|0|||
157196946|NCT02708524|567463818|FG000|Overall Study|Subject lost study lens|1|||
157196947|NCT02708524|567463819|FG001|Overall Study|Subject lost study lens|0|||
157196948|NCT02708524|567463820|FG002|Overall Study|Subject lost study lens|0|||
157196949|NCT02708524|567463821|FG003|Overall Study|Subject lost study lens|0|||
157196950|NCT03781167|567463830|FG000|Overall Study|Adverse Event|23|||
157196951|NCT03781167|567463831|FG001|Overall Study|Adverse Event|25|||
157196952|NCT03781167|567463830|FG000|Overall Study|Withdrew consent|16|||
157196953|NCT03781167|567463831|FG001|Overall Study|Withdrew consent|12|||
157196954|NCT03781167|567463830|FG000|Overall Study|Lost to Follow-up|0|||
157196955|NCT03781167|567463831|FG001|Overall Study|Lost to Follow-up|1|||
157196956|NCT03781167|567463830|FG000|Overall Study|Lack of Efficacy|4|||
157196957|NCT03781167|567463831|FG001|Overall Study|Lack of Efficacy|5|||
157196958|NCT03781167|567463830|FG000|Overall Study|Difficulty with drug delivery system|2|||
157196959|NCT03781167|567463831|FG001|Overall Study|Difficulty with drug delivery system|3|||
157196960|NCT03781167|567463830|FG000|Overall Study|Other, not specified|2|||
157196961|NCT03781167|567463831|FG001|Overall Study|Other, not specified|2|||
157196962|NCT00462501|567463832|FG000|Overall Study|Not treated|3|||
157196963|NCT00462501|567463832|FG000|Overall Study|Adverse Event|2|||
157196964|NCT01258803|567463834|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
157196965|NCT01258803|567463835|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
157196966|NCT01258803|567463836|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
157196967|NCT01258803|567463837|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
157196968|NCT01258803|567463838|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
157090581|NCT00321373|567086829|FG000|Overall Study|Other|0|||
157090582|NCT00321373|567086830|FG001|Overall Study|Other|0|||
157090583|NCT00321373|567086831|FG002|Overall Study|Other|1|||
157090584|NCT00477334|567086832|FG000|Overall Study|Discontinued prior to taking study drug|106|||
157090585|NCT00477334|567086833|FG001|Overall Study|Discontinued prior to taking study drug|53|||
157090586|NCT00477334|567086832|FG000|Overall Study|Adverse Event|1|||
157090587|NCT00477334|567086833|FG001|Overall Study|Adverse Event|2|||
157196969|NCT01258803|567463839|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
157090588|NCT00477334|567086832|FG000|Overall Study|Withdrawal by Subject|2|||
157090589|NCT00477334|567086833|FG001|Overall Study|Withdrawal by Subject|1|||
157090590|NCT00477334|567086832|FG000|Overall Study|Lost to Follow-up|15|||
157090591|NCT00477334|567086833|FG001|Overall Study|Lost to Follow-up|4|||
157090592|NCT00477334|567086832|FG000|Overall Study|Administrative Problems|39|||
157090593|NCT00477334|567086833|FG001|Overall Study|Administrative Problems|15|||
157090594|NCT00477334|567086832|FG000|Overall Study|Protocol Violation|7|||
157090595|NCT00477334|567086833|FG001|Overall Study|Protocol Violation|1|||
157090596|NCT04275089|567086834|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
157090597|NCT03587974|567086838|FG000|Overall Study|caregiver demented, care recipient died|3|||
157090598|NCT03587974|567086839|FG001|Overall Study|caregiver demented, care recipient died|3|||
157090599|NCT03587974|567086838|FG000|Overall Study|Withdrawal by Subject|2|||
157090600|NCT03587974|567086839|FG001|Overall Study|Withdrawal by Subject|1|||
157090601|NCT03486457|567086842|FG000|Up to Month 3|Adverse Event|2|||
157090602|NCT03486457|567086843|FG001|Up to Month 3|Adverse Event|5|||
157090603|NCT03486457|567086842|FG000|Up to Month 3|Lack of Efficacy|1|||
157090604|NCT03486457|567086843|FG001|Up to Month 3|Lack of Efficacy|0|||
157090605|NCT03486457|567086842|FG000|Up to Month 3|Withdrawal by Subject|1|||
157090606|NCT03486457|567086843|FG001|Up to Month 3|Withdrawal by Subject|0|||
157090607|NCT03486457|567086842|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
157090608|NCT03486457|567086843|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
157090609|NCT03486457|567086842|FG000|Up to Month 3|Other|1|||
157090610|NCT03486457|567086843|FG001|Up to Month 3|Other|0|||
157090611|NCT03486457|567086842|FG000|Month 3 to Month 6|Adverse Event|2|||
157090612|NCT03486457|567086843|FG001|Month 3 to Month 6|Adverse Event|0|||
157090613|NCT03486457|567086842|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
157090614|NCT03486457|567086843|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
157090615|NCT03486457|567086842|FG000|Month 3 to Month 6|Pregnancy|0|||
157090616|NCT03486457|567086843|FG001|Month 3 to Month 6|Pregnancy|1|||
157090617|NCT03486457|567086842|FG000|Month 3 to Month 6|Other|1|||
157090618|NCT03486457|567086843|FG001|Month 3 to Month 6|Other|0|||
157090619|NCT02257567|567086844|FG000|Overall Study|Adverse Event|0|||
157090620|NCT02257567|567086845|FG001|Overall Study|Adverse Event|0|||
157090621|NCT02257567|567086846|FG002|Overall Study|Adverse Event|0|||
157090622|NCT02257567|567086847|FG003|Overall Study|Adverse Event|1|||
157090623|NCT02257567|567086848|FG004|Overall Study|Adverse Event|1|||
157090624|NCT02257567|567086849|FG005|Overall Study|Adverse Event|0|||
157090625|NCT02257567|567086850|FG006|Overall Study|Adverse Event|0|||
157196970|NCT01258803|567463834|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
157196971|NCT01258803|567463835|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
157196972|NCT01258803|567463836|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
157196973|NCT01258803|567463837|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
157196974|NCT01258803|567463838|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
157196975|NCT01258803|567463839|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
157196976|NCT01258803|567463834|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
157196977|NCT01258803|567463835|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
157196978|NCT01258803|567463836|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
157196979|NCT01258803|567463837|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
157196980|NCT01258803|567463838|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
157196981|NCT01258803|567463839|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
157196982|NCT00920582|567463840|FG000|Overall Study|Lost to Follow-up|5|||
157196983|NCT00920582|567463841|FG001|Overall Study|Lost to Follow-up|1|||
157196984|NCT00920582|567463842|FG002|Overall Study|Lost to Follow-up|2|||
157196985|NCT00920582|567463843|FG003|Overall Study|Lost to Follow-up|0|||
157196986|NCT00920582|567463840|FG000|Overall Study|Withdrawal by Subject|5|||
157196987|NCT00920582|567463841|FG001|Overall Study|Withdrawal by Subject|4|||
157196988|NCT00920582|567463842|FG002|Overall Study|Withdrawal by Subject|6|||
157196989|NCT00920582|567463843|FG003|Overall Study|Withdrawal by Subject|3|||
157196990|NCT00920582|567463840|FG000|Overall Study|Protocol Violation|1|||
157196991|NCT00920582|567463841|FG001|Overall Study|Protocol Violation|0|||
157196992|NCT00920582|567463842|FG002|Overall Study|Protocol Violation|0|||
157196993|NCT00920582|567463843|FG003|Overall Study|Protocol Violation|0|||
157196994|NCT00920582|567463840|FG000|Overall Study|Other|2|||
157196995|NCT00920582|567463841|FG001|Overall Study|Other|1|||
157196996|NCT00920582|567463842|FG002|Overall Study|Other|3|||
157196997|NCT00920582|567463843|FG003|Overall Study|Other|2|||
157196998|NCT01552408|567463848|FG000|Overall Study|Lost to Follow-up|2|||
157196999|NCT01552408|567463849|FG001|Overall Study|Lost to Follow-up|0|||
157197000|NCT01552408|567463848|FG000|Overall Study|Relocation|0|||
157197001|NCT01552408|567463849|FG001|Overall Study|Relocation|1|||
157197002|NCT01552408|567463848|FG000|Overall Study|Withdrawal by Subject|2|||
157197003|NCT01552408|567463849|FG001|Overall Study|Withdrawal by Subject|1|||
157197004|NCT00851721|567463852|FG000|Overall Study|planned surgery|1|||
157197005|NCT00851721|567463853|FG001|Overall Study|planned surgery|0|||
157197006|NCT00851721|567463852|FG000|Overall Study|Death|1|||
157197007|NCT00851721|567463853|FG001|Overall Study|Death|0|||
157197008|NCT00851721|567463852|FG000|Overall Study|Adverse Event|0|||
157197009|NCT00851721|567463853|FG001|Overall Study|Adverse Event|1|||
157090626|NCT02257567|567086851|FG007|Overall Study|Adverse Event|0|||
157090627|NCT02257567|567086852|FG008|Overall Study|Adverse Event|1|||
157090628|NCT02257567|567086853|FG009|Overall Study|Adverse Event|0|||
157090629|NCT02257567|567086854|FG010|Overall Study|Adverse Event|0|||
157090630|NCT02257567|567086844|FG000|Overall Study|Death|2|||
157090631|NCT02257567|567086845|FG001|Overall Study|Death|2|||
157090632|NCT02257567|567086846|FG002|Overall Study|Death|2|||
157090633|NCT02257567|567086847|FG003|Overall Study|Death|4|||
157090634|NCT02257567|567086848|FG004|Overall Study|Death|15|||
157090635|NCT02257567|567086849|FG005|Overall Study|Death|11|||
157090636|NCT02257567|567086850|FG006|Overall Study|Death|26|||
157090637|NCT02257567|567086851|FG007|Overall Study|Death|30|||
157090638|NCT02257567|567086852|FG008|Overall Study|Death|2|||
157090639|NCT02257567|567086853|FG009|Overall Study|Death|18|||
157090640|NCT02257567|567086854|FG010|Overall Study|Death|65|||
157090641|NCT02257567|567086844|FG000|Overall Study|Lost to Follow-up|0|||
157090642|NCT02257567|567086845|FG001|Overall Study|Lost to Follow-up|0|||
157090643|NCT02257567|567086846|FG002|Overall Study|Lost to Follow-up|0|||
157090644|NCT02257567|567086847|FG003|Overall Study|Lost to Follow-up|0|||
157090645|NCT02257567|567086848|FG004|Overall Study|Lost to Follow-up|2|||
157090646|NCT02257567|567086849|FG005|Overall Study|Lost to Follow-up|2|||
157090647|NCT02257567|567086850|FG006|Overall Study|Lost to Follow-up|0|||
157090648|NCT02257567|567086851|FG007|Overall Study|Lost to Follow-up|0|||
157090649|NCT02257567|567086852|FG008|Overall Study|Lost to Follow-up|0|||
157090650|NCT02257567|567086853|FG009|Overall Study|Lost to Follow-up|1|||
157090651|NCT02257567|567086854|FG010|Overall Study|Lost to Follow-up|1|||
157090652|NCT02257567|567086844|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090653|NCT02257567|567086845|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090654|NCT02257567|567086846|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157197010|NCT04533204|567463854|FG000|Overall Study|Unable to understand training instructions|1|||
157197011|NCT04533204|567463855|FG001|Overall Study|Unable to understand training instructions|1|||
157237510|NCT03686033|567616663|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
157237511|NCT03686033|567616664|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
157237512|NCT03686033|567616665|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
157237513|NCT03686033|567616666|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
157237514|NCT03686033|567616667|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
157237515|NCT01302548|567616669|FG000|Overall Study|Lost to Follow-up|2|||
157237516|NCT01302548|567616670|FG001|Overall Study|Lost to Follow-up|1|||
157237517|NCT01237054|567616671|FG000|Overall Study|imaging 10C0096|1|||
157237518|NCT02089997|567616685|FG000|Overall Study|Case report forms uncollected|99|||
157237519|NCT02089997|567616685|FG000|Overall Study|Protocol Violation|147|||
157237520|NCT00095212|567616688|FG000|Overall Study|Withdrawal by Subject|1|||
157237521|NCT00095212|567616689|FG001|Overall Study|Withdrawal by Subject|3|||
157237522|NCT02374853|567616693|FG000|Overall Study|Surgery Cancelled|5|||
157237523|NCT02374853|567616694|FG001|Overall Study|Surgery Cancelled|11|||
157237524|NCT02281084|567616695|FG000|Overall Study|Death|21|||
157237525|NCT02281084|567616696|FG001|Overall Study|Death|18|||
157237526|NCT02281084|567616697|FG002|Overall Study|Death|3|||
157237527|NCT02281084|567616698|FG003|Overall Study|Death|5|||
157237528|NCT02281084|567616695|FG000|Overall Study|Adverse Event|1|||
157237529|NCT02281084|567616696|FG001|Overall Study|Adverse Event|0|||
157197012|NCT04047472|567463856|FG000|Overall Study|Adverse Event|3|||
157197013|NCT04047472|567463857|FG001|Overall Study|Adverse Event|3|||
157197014|NCT04047472|567463856|FG000|Overall Study|Death|0|||
157197015|NCT04047472|567463857|FG001|Overall Study|Death|1|||
157197016|NCT04047472|567463856|FG000|Overall Study|Lost to Follow-up|1|||
157197017|NCT04047472|567463857|FG001|Overall Study|Lost to Follow-up|0|||
157197018|NCT04047472|567463856|FG000|Overall Study|Physician Decision|1|||
157197019|NCT04047472|567463857|FG001|Overall Study|Physician Decision|2|||
157197020|NCT04047472|567463856|FG000|Overall Study|Protocol Violation|1|||
157197021|NCT04047472|567463857|FG001|Overall Study|Protocol Violation|0|||
157197022|NCT04047472|567463856|FG000|Overall Study|Withdrawal by Subject|10|||
157237530|NCT02281084|567616697|FG002|Overall Study|Adverse Event|0|||
157237531|NCT02281084|567616698|FG003|Overall Study|Adverse Event|0|||
157237532|NCT02281084|567616695|FG000|Overall Study|Withdrawal by Subject|2|||
157090655|NCT02257567|567086847|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090656|NCT02257567|567086848|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
157090657|NCT02257567|567086849|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090658|NCT02257567|567086850|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
157197023|NCT04047472|567463857|FG001|Overall Study|Withdrawal by Subject|10|||
157237533|NCT02281084|567616696|FG001|Overall Study|Withdrawal by Subject|2|||
157197024|NCT01333501|567463861|FG000|Overall Study|Adverse Event|3|||
157197025|NCT01333501|567463862|FG001|Overall Study|Adverse Event|1|||
157237534|NCT02281084|567616697|FG002|Overall Study|Withdrawal by Subject|0|||
157237535|NCT02281084|567616698|FG003|Overall Study|Withdrawal by Subject|0|||
157090659|NCT02257567|567086851|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090660|NCT02257567|567086852|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090661|NCT02257567|567086853|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090662|NCT02257567|567086854|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
157090663|NCT02257567|567086844|FG000|Overall Study|Physician Decision|0|||
157090664|NCT02257567|567086845|FG001|Overall Study|Physician Decision|0|||
157090665|NCT02257567|567086846|FG002|Overall Study|Physician Decision|0|||
157090666|NCT02257567|567086847|FG003|Overall Study|Physician Decision|0|||
157090667|NCT02257567|567086848|FG004|Overall Study|Physician Decision|0|||
157090668|NCT02257567|567086849|FG005|Overall Study|Physician Decision|0|||
157090669|NCT02257567|567086850|FG006|Overall Study|Physician Decision|0|||
157090670|NCT02257567|567086851|FG007|Overall Study|Physician Decision|2|||
157090671|NCT02257567|567086852|FG008|Overall Study|Physician Decision|0|||
157090672|NCT02257567|567086853|FG009|Overall Study|Physician Decision|1|||
157090673|NCT02257567|567086854|FG010|Overall Study|Physician Decision|0|||
157090674|NCT02257567|567086844|FG000|Overall Study|Withdrawal by Subject|0|||
157090675|NCT02257567|567086845|FG001|Overall Study|Withdrawal by Subject|0|||
157090676|NCT02257567|567086846|FG002|Overall Study|Withdrawal by Subject|2|||
157090677|NCT02257567|567086847|FG003|Overall Study|Withdrawal by Subject|0|||
157090678|NCT02257567|567086848|FG004|Overall Study|Withdrawal by Subject|0|||
157090679|NCT02257567|567086849|FG005|Overall Study|Withdrawal by Subject|6|||
157090680|NCT02257567|567086850|FG006|Overall Study|Withdrawal by Subject|6|||
157090681|NCT02257567|567086851|FG007|Overall Study|Withdrawal by Subject|6|||
157090682|NCT02257567|567086852|FG008|Overall Study|Withdrawal by Subject|1|||
157090683|NCT02257567|567086853|FG009|Overall Study|Withdrawal by Subject|1|||
157090684|NCT02257567|567086854|FG010|Overall Study|Withdrawal by Subject|10|||
157090685|NCT01590017|567086855|FG000|Overall Study|Adverse Event|1|||
157090686|NCT01590017|567086855|FG000|Overall Study|Withdrawal by Subject|1|||
157090687|NCT01590017|567086855|FG000|Overall Study|Lack of Efficacy|1|||
157090688|NCT01590017|567086855|FG000|Overall Study|Physician Decision|1|||
157090689|NCT01382706|567086856|FG000|Overall Study|Adverse Event|1|||
157090690|NCT01382706|567086856|FG000|Overall Study|Withdrawal by Subject|1|||
157090691|NCT03256851|567086857|FG000|Overall Study|Withdrawal by Subject|1|||
157090692|NCT03256851|567086858|FG001|Overall Study|Withdrawal by Subject|0|||
157090693|NCT01065844|567086859|FG000|Overall Study|Adverse Event|5|||
157090694|NCT00552240|567086862|FG000|Overall Study|Adverse Event|9|||
157090695|NCT00552240|567086863|FG001|Overall Study|Adverse Event|9|||
157090696|NCT00552240|567086862|FG000|Overall Study|Protocol Violation|1|||
157090697|NCT00552240|567086863|FG001|Overall Study|Protocol Violation|1|||
157090698|NCT00552240|567086862|FG000|Overall Study|Lost to Follow-up|5|||
157090699|NCT00552240|567086863|FG001|Overall Study|Lost to Follow-up|6|||
157090700|NCT00552240|567086862|FG000|Overall Study|Withdrawal by Subject|2|||
157090701|NCT00552240|567086863|FG001|Overall Study|Withdrawal by Subject|2|||
157090702|NCT00552240|567086862|FG000|Overall Study|Lack of Efficacy|6|||
157090703|NCT00552240|567086863|FG001|Overall Study|Lack of Efficacy|0|||
157090704|NCT00552240|567086862|FG000|Overall Study|Other|1|||
157090705|NCT00552240|567086863|FG001|Overall Study|Other|0|||
157090706|NCT03545503|567086866|FG000|Overall Study|Protocol Violation|14|||
157090707|NCT03545503|567086867|FG001|Overall Study|Protocol Violation|16|||
157090708|NCT00825916|567086871|FG000|Overall Study|Lost to Follow-up|4|||
157090709|NCT00825916|567086872|FG001|Overall Study|Lost to Follow-up|2|||
157090710|NCT00825916|567086873|FG002|Overall Study|Lost to Follow-up|1|||
157090711|NCT01098097|567086874|FG000|Overall Study|Adverse Event|17|||
157090712|NCT01098097|567086874|FG000|Overall Study|Lost to Follow-up|18|||
157090713|NCT01098097|567086874|FG000|Overall Study|Status unknown|16|||
157090714|NCT01098097|567086874|FG000|Overall Study|No reason reported|31|||
157090715|NCT00394082|567086877|FG000|Overall Study|Unacceptable toxicity|15|||
157090716|NCT00394082|567086877|FG000|Overall Study|Adverse Event|4|||
157090717|NCT00394082|567086877|FG000|Overall Study|Physician Decision|4|||
157090718|NCT00394082|567086877|FG000|Overall Study|Withdrawal by Subject|2|||
157090719|NCT00394082|567086877|FG000|Overall Study|Other|1|||
157090720|NCT02344004|567086879|FG000|Overall Study|Adverse Event|11|||
157090721|NCT02344004|567086880|FG001|Overall Study|Adverse Event|1|||
157090722|NCT02344004|567086879|FG000|Overall Study|Death|9|||
157090723|NCT02344004|567086880|FG001|Overall Study|Death|7|||
157090724|NCT02344004|567086879|FG000|Overall Study|Physician Decision|4|||
157237536|NCT02281084|567616695|FG000|Overall Study|Site Closure by Sponsor|5|||
157090725|NCT02344004|567086880|FG001|Overall Study|Physician Decision|1|||
157090726|NCT02344004|567086879|FG000|Overall Study|Withdrawal by Subject|22|||
157090727|NCT02344004|567086880|FG001|Overall Study|Withdrawal by Subject|5|||
157090728|NCT02344004|567086879|FG000|Overall Study|Rescue Medication|2|||
157090729|NCT02344004|567086880|FG001|Overall Study|Rescue Medication|0|||
157090730|NCT02344004|567086879|FG000|Overall Study|Other Not Specified|12|||
157237537|NCT02281084|567616696|FG001|Overall Study|Site Closure by Sponsor|1|||
157090731|NCT02344004|567086880|FG001|Overall Study|Other Not Specified|0|||
157090732|NCT02344004|567086879|FG000|Overall Study|Protocol Violation|1|||
157090733|NCT02344004|567086880|FG001|Overall Study|Protocol Violation|0|||
157090734|NCT01768117|567086881|FG000|Overall Study|Lost to Follow-up|1|||
157090735|NCT01768117|567086881|FG000|Overall Study|Withdrawal by Subject|2|||
157090736|NCT01768117|567086881|FG000|Overall Study|Protocol Violation|3|||
157090737|NCT01945060|567086882|FG000|Overall Study|Lost to follow up|1|||
157090738|NCT01945060|567086883|FG001|Overall Study|Lost to follow up|0|||
157090739|NCT01945060|567086882|FG000|Overall Study|Distress related to IV access|0|||
157090740|NCT01945060|567086883|FG001|Overall Study|Distress related to IV access|1|||
157090741|NCT01000636|567086886|FG000|Overall Study|Withdrawal by Subject|1|||
157090742|NCT01000636|567086886|FG000|Overall Study|Adverse Event|1|||
157090743|NCT00138671|567086887|FG000|Overall Study|Death|0|||
157090744|NCT00138671|567086888|FG001|Overall Study|Death|3|||
157090745|NCT00138671|567086887|FG000|Overall Study|Adverse Event|6|||
157090746|NCT00138671|567086888|FG001|Overall Study|Adverse Event|3|||
157090747|NCT00138671|567086887|FG000|Overall Study|Lost to Follow-up|1|||
157090748|NCT00138671|567086888|FG001|Overall Study|Lost to Follow-up|2|||
157090749|NCT00138671|567086887|FG000|Overall Study|Withdrawal by Subject|3|||
157090750|NCT00138671|567086888|FG001|Overall Study|Withdrawal by Subject|5|||
157090751|NCT00138671|567086887|FG000|Overall Study|Other|3|||
157090752|NCT00138671|567086888|FG001|Overall Study|Other|3|||
157090753|NCT02424734|567086890|FG000|Overall Study|Treatment stopped to be discharged home|2|||
157090754|NCT02424734|567086891|FG001|Overall Study|Treatment stopped to be discharged home|2|||
157090755|NCT02424734|567086892|FG002|Overall Study|Treatment stopped to be discharged home|0|||
157090756|NCT01445301|567086893|FG000|Overall Study|Adverse Event|15|||
157090757|NCT01445301|567086894|FG001|Overall Study|Adverse Event|25|||
157090758|NCT01445301|567086895|FG002|Overall Study|Adverse Event|4|||
157237538|NCT02281084|567616697|FG002|Overall Study|Site Closure by Sponsor|2|||
157237539|NCT02281084|567616698|FG003|Overall Study|Site Closure by Sponsor|0|||
157237540|NCT02335658|567616699|FG000|Overall Study|Adverse Event|18|||
157237541|NCT02335658|567616700|FG001|Overall Study|Adverse Event|12|||
157237542|NCT02335658|567616699|FG000|Overall Study|Lack of Efficacy|4|||
157237543|NCT02335658|567616700|FG001|Overall Study|Lack of Efficacy|5|||
157237544|NCT02335658|567616699|FG000|Overall Study|Pregnancy|1|||
157237545|NCT02335658|567616700|FG001|Overall Study|Pregnancy|0|||
157237546|NCT02335658|567616699|FG000|Overall Study|Withdrawal by Subject|13|||
157237547|NCT02335658|567616700|FG001|Overall Study|Withdrawal by Subject|21|||
157237548|NCT02335658|567616699|FG000|Overall Study|non-compliance|2|||
157237549|NCT02335658|567616700|FG001|Overall Study|non-compliance|3|||
157237550|NCT02335658|567616699|FG000|Overall Study|other reason|2|||
157237551|NCT02335658|567616700|FG001|Overall Study|other reason|3|||
157237552|NCT02032888|567616701|FG000|Treatment Period|Poor compliance/noncompliance|1|||
157237553|NCT02032888|567616702|FG001|Treatment Period|Poor compliance/noncompliance|1|||
157237554|NCT02032888|567616703|FG002|Treatment Period|Poor compliance/noncompliance|0|||
157237555|NCT02032888|567616701|FG000|Treatment Period|Other|1|||
157237556|NCT02032888|567616702|FG001|Treatment Period|Other|1|||
157237557|NCT02032888|567616703|FG002|Treatment Period|Other|0|||
157237558|NCT02032888|567616701|FG000|Follow-up Period|Lost to Follow-up|1|||
157237559|NCT02032888|567616702|FG001|Follow-up Period|Lost to Follow-up|1|||
157237560|NCT02032888|567616703|FG002|Follow-up Period|Lost to Follow-up|0|||
157237561|NCT02032888|567616701|FG000|Follow-up Period|Death|1|||
157237562|NCT02032888|567616702|FG001|Follow-up Period|Death|1|||
157237563|NCT02032888|567616703|FG002|Follow-up Period|Death|0|||
157237564|NCT02032888|567616701|FG000|Follow-up Period|Other|1|||
157237565|NCT02032888|567616702|FG001|Follow-up Period|Other|0|||
157237566|NCT02032888|567616703|FG002|Follow-up Period|Other|0|||
157237567|NCT01754597|567616706|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
157237568|NCT01754597|567616707|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
157237569|NCT00819741|567616708|FG000|Overall Study|Adverse Event|5|||
157237570|NCT00819741|567616709|FG001|Overall Study|Adverse Event|2|||
157237571|NCT00819741|567616708|FG000|Overall Study|Lack of Efficacy|0|||
157237572|NCT00819741|567616709|FG001|Overall Study|Lack of Efficacy|2|||
157237573|NCT00819741|567616708|FG000|Overall Study|Lost to Follow-up|3|||
157237574|NCT00819741|567616709|FG001|Overall Study|Lost to Follow-up|1|||
157237575|NCT00819741|567616708|FG000|Overall Study|Protocol Violation|3|||
157090759|NCT01445301|567086893|FG000|Overall Study|Lack of Efficacy|0|||
157090760|NCT01445301|567086894|FG001|Overall Study|Lack of Efficacy|1|||
157237576|NCT00819741|567616709|FG001|Overall Study|Protocol Violation|4|||
157237577|NCT00819741|567616708|FG000|Overall Study|Withdrawal by Subject|2|||
157237578|NCT00819741|567616709|FG001|Overall Study|Withdrawal by Subject|2|||
157237579|NCT00819741|567616708|FG000|Overall Study|Unclassified|6|||
157237580|NCT00819741|567616709|FG001|Overall Study|Unclassified|0|||
157090761|NCT01445301|567086895|FG002|Overall Study|Lack of Efficacy|0|||
157090762|NCT01445301|567086893|FG000|Overall Study|Protocol Violation|1|||
157090763|NCT01445301|567086894|FG001|Overall Study|Protocol Violation|0|||
157090764|NCT01445301|567086895|FG002|Overall Study|Protocol Violation|0|||
157237581|NCT00819741|567616708|FG000|Overall Study|Reasons unknown|3|||
157237582|NCT00819741|567616709|FG001|Overall Study|Reasons unknown|3|||
157237583|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
157237584|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
157237585|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
157237586|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
157237587|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237588|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237589|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237590|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237591|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237592|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237593|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237594|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237595|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237596|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237597|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237598|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237599|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237600|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237601|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237602|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237603|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
157237604|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
157237605|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
157237606|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
157237607|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
157237608|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237609|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237610|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237611|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237612|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237613|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237614|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237615|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237616|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237617|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237618|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237619|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237620|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237621|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237622|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237623|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237624|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
157237625|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
157237626|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
157237627|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
157237628|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
157237629|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237630|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237631|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237632|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237633|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237634|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237635|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237636|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157090765|NCT01445301|567086893|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
157090766|NCT01445301|567086894|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
157090767|NCT01445301|567086895|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
157090768|NCT01445301|567086893|FG000|Overall Study|Physician Decision|0|||
157090769|NCT01445301|567086894|FG001|Overall Study|Physician Decision|2|||
157090770|NCT01445301|567086895|FG002|Overall Study|Physician Decision|0|||
157090771|NCT01445301|567086893|FG000|Overall Study|Withdrawal by Subject|5|||
157237637|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237638|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237639|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237640|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237641|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237642|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237643|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157090772|NCT01445301|567086894|FG001|Overall Study|Withdrawal by Subject|6|||
157237644|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237645|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
157237646|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
157237647|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
157237648|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
157237649|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237650|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237651|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237652|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237653|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237654|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237655|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237656|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237657|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237658|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237659|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237660|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237661|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237662|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237663|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237664|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237665|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237666|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
157237667|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
157237668|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237669|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237670|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
157237671|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237672|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237673|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237674|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237675|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237676|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237677|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237678|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237679|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237680|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237681|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237682|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237683|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237684|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237685|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237686|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237687|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
157237688|NCT01597245|567616710|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
157237689|NCT01597245|567616711|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
157237690|NCT01597245|567616712|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
157237691|NCT01597245|567616713|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237692|NCT01597245|567616714|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237693|NCT01597245|567616715|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237694|NCT01597245|567616716|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237695|NCT01597245|567616717|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237696|NCT01597245|567616718|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237697|NCT01597245|567616719|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237698|NCT01597245|567616720|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237699|NCT01597245|567616721|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237700|NCT01597245|567616722|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237701|NCT01597245|567616723|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237702|NCT01597245|567616724|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237703|NCT01597245|567616725|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237704|NCT01597245|567616726|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237705|NCT01597245|567616727|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237706|NCT01597245|567616728|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237707|NCT01597245|567616729|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237708|NCT01597245|567616730|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
157237709|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237710|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237711|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237712|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237713|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237714|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
157237715|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
157237716|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237717|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237718|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237719|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237720|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237721|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237722|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237723|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237724|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237725|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237726|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237727|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237728|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237729|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
157237730|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237731|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237732|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237733|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237734|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
157237735|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
157237736|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
157237737|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
157237738|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237739|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
157237740|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237741|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237742|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237743|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237744|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237745|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237746|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237747|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237748|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237749|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237750|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
157237751|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237752|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237753|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237754|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237755|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237756|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
157237757|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237758|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237759|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
157237760|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237761|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
157237762|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
157237763|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
157237764|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237765|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237766|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157090773|NCT01445301|567086895|FG002|Overall Study|Withdrawal by Subject|4|||
157090774|NCT00752557|567086896|FG000|Overall Study|Withdrawal by Subject|4|||
157090775|NCT00752557|567086897|FG001|Overall Study|Withdrawal by Subject|3|||
157090776|NCT00752557|567086898|FG002|Overall Study|Withdrawal by Subject|3|||
157090777|NCT00752557|567086896|FG000|Overall Study|Unspecified resaons|0|||
157237767|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157090778|NCT00752557|567086897|FG001|Overall Study|Unspecified resaons|2|||
157090779|NCT00752557|567086898|FG002|Overall Study|Unspecified resaons|2|||
157090780|NCT00752557|567086896|FG000|Overall Study|Lost to Follow-up|1|||
157090781|NCT00752557|567086897|FG001|Overall Study|Lost to Follow-up|0|||
157090782|NCT00752557|567086898|FG002|Overall Study|Lost to Follow-up|1|||
157090783|NCT02150343|567086899|FG000|Overall Study|Adverse Event|2|||
157090784|NCT02150343|567086900|FG001|Overall Study|Adverse Event|0|||
157090785|NCT02150343|567086901|FG002|Overall Study|Adverse Event|1|||
157090786|NCT02150343|567086902|FG003|Overall Study|Adverse Event|1|||
157090787|NCT02150343|567086899|FG000|Overall Study|Withdrawal by Subject|13|||
157197026|NCT01333501|567463861|FG000|Overall Study|Abnormal laboratory value|2|||
157197027|NCT01333501|567463862|FG001|Overall Study|Abnormal laboratory value|1|||
157197028|NCT01333501|567463861|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157197029|NCT01333501|567463862|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
157197030|NCT01333501|567463861|FG000|Overall Study|Withdrawn consent|3|||
157197031|NCT01333501|567463862|FG001|Overall Study|Withdrawn consent|12|||
157197032|NCT01016912|567463863|FG000|End of Treatment Period|Lack of Efficacy|0|||
157197033|NCT01016912|567463864|FG001|End of Treatment Period|Lack of Efficacy|1|||
157197034|NCT01016912|567463865|FG002|End of Treatment Period|Lack of Efficacy|0|||
157197035|NCT01016912|567463866|FG003|End of Treatment Period|Lack of Efficacy|4|||
157197036|NCT01016912|567463867|FG004|End of Treatment Period|Lack of Efficacy|4|||
157197037|NCT01016912|567463863|FG000|End of Treatment Period|Adverse Event|0|||
157197038|NCT01016912|567463864|FG001|End of Treatment Period|Adverse Event|1|||
157197039|NCT01016912|567463865|FG002|End of Treatment Period|Adverse Event|1|||
157197040|NCT01016912|567463866|FG003|End of Treatment Period|Adverse Event|0|||
157197041|NCT01016912|567463867|FG004|End of Treatment Period|Adverse Event|0|||
157197042|NCT01016912|567463863|FG000|End of Treatment Period|Completed double-blind period only|0|||
157197043|NCT01016912|567463864|FG001|End of Treatment Period|Completed double-blind period only|1|||
157197044|NCT01016912|567463865|FG002|End of Treatment Period|Completed double-blind period only|0|||
157197045|NCT01016912|567463866|FG003|End of Treatment Period|Completed double-blind period only|0|||
157197046|NCT01016912|567463867|FG004|End of Treatment Period|Completed double-blind period only|0|||
157197047|NCT01016912|567463863|FG000|Follow-up Period|Other reason|0|||
157197048|NCT01016912|567463864|FG001|Follow-up Period|Other reason|0|||
157197049|NCT01016912|567463865|FG002|Follow-up Period|Other reason|1|||
157197050|NCT01016912|567463866|FG003|Follow-up Period|Other reason|1|||
157197051|NCT01016912|567463867|FG004|Follow-up Period|Other reason|0|||
157197052|NCT00955682|567463868|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
157197053|NCT00955682|567463869|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
157197054|NCT04034225|567463870|FG000|Overall Study|Death|3|||
157197055|NCT04034225|567463870|FG000|Overall Study|Withdrawal by Subject|2|||
157197056|NCT04034225|567463870|FG000|Overall Study|Study termination by Sponsor|18|||
157197057|NCT04034225|567463870|FG000|Overall Study|Physician Decision|1|||
157197058|NCT04034225|567463870|FG000|Overall Study|Lack of Efficacy|1|||
157197059|NCT01348828|567463878|FG000|Overall Study|Death|20|||
157197060|NCT01348828|567463878|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
157197061|NCT01348828|567463878|FG000|Overall Study|Conversion|2|||
157197062|NCT01348828|567463878|FG000|Overall Study|missed visit|1|||
157197063|NCT04246996|567463879|FG000|Overall Study|Physician Decision|1|||
157197064|NCT04246996|567463880|FG001|Overall Study|Physician Decision|1|||
157197065|NCT04246996|567463879|FG000|Overall Study|Did not meet eligibility criteria|1|||
157197066|NCT04246996|567463880|FG001|Overall Study|Did not meet eligibility criteria|4|||
157197067|NCT02442284|567463883|FG000|Overall Study|Adverse Event|1|||
157197068|NCT02442284|567463883|FG000|Overall Study|Withdrew Consent|2|||
157197069|NCT02442284|567463883|FG000|Overall Study|Lost to Follow-up|3|||
157197070|NCT02442284|567463883|FG000|Overall Study|Other|1|||
157197071|NCT01365468|567463887|FG000|Overall Study|Physician Decision|1|||
157197072|NCT01365468|567463888|FG001|Overall Study|Physician Decision|0|||
157197073|NCT01365468|567463887|FG000|Overall Study|Disease progression|1|||
157197074|NCT01365468|567463888|FG001|Overall Study|Disease progression|0|||
157197075|NCT01365468|567463887|FG000|Overall Study|Lost to Follow-up|2|||
157197076|NCT01365468|567463888|FG001|Overall Study|Lost to Follow-up|0|||
157197077|NCT00877929|567463889|FG000|Overall Study|Adverse Event|11|||
157197078|NCT00877929|567463890|FG001|Overall Study|Adverse Event|20|||
157197079|NCT00877929|567463889|FG000|Overall Study|Protocol Violation|3|||
157197080|NCT00877929|567463890|FG001|Overall Study|Protocol Violation|3|||
157197081|NCT00877929|567463889|FG000|Overall Study|Lost to Follow-up|0|||
157197082|NCT00877929|567463890|FG001|Overall Study|Lost to Follow-up|1|||
157197083|NCT00877929|567463889|FG000|Overall Study|Withdrawal by Subject|4|||
157197084|NCT00877929|567463890|FG001|Overall Study|Withdrawal by Subject|4|||
157197085|NCT00877929|567463889|FG000|Overall Study|Lack of Efficacy|0|||
157197086|NCT00877929|567463890|FG001|Overall Study|Lack of Efficacy|1|||
157197087|NCT00877929|567463889|FG000|Overall Study|Other reason (not specified)|2|||
157197088|NCT00877929|567463890|FG001|Overall Study|Other reason (not specified)|6|||
157197089|NCT01140646|567463891|FG000|Overall Study|Adverse Event|4|||
157197090|NCT01140646|567463891|FG000|Overall Study|Refused Further Treatment|5|||
157197091|NCT00765726|567463895|FG000|Overall Study|Withdrawal by Subject|1|||
157197092|NCT00765726|567463895|FG000|Overall Study|Discontinuation of study by sponsor|8|||
157197093|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
157237768|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237769|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237770|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237771|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
157237772|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237773|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237774|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237775|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237776|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
157237777|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
157237778|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
157237779|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
157237780|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
157237781|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
157237782|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
157237783|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
157237784|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
157237785|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237786|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237787|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237788|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237789|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237790|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237791|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237792|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
157237793|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237794|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237795|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237796|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237797|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
157237798|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
157237799|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
157237800|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237801|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
157237802|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
157237803|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
157237804|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
157237805|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
157237806|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237807|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237808|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237809|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237810|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237811|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237812|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237813|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
157237814|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237815|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237816|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237817|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237818|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
157237819|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237820|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237821|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237822|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
157237823|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
157237824|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
157237825|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237826|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
157237827|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237828|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237829|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237830|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237831|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237832|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237833|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237834|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
157237835|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237836|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237837|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237838|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237839|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
157237840|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
157237841|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
157237842|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237843|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
157237844|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
157237845|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
157237846|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
157237847|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
157237848|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237849|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237850|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237851|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237852|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237853|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237854|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237855|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
157237856|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237857|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237858|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237859|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237860|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237861|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
157237862|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237863|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237864|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
157237865|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
157237866|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
157237867|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
157237868|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237869|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237870|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237871|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237872|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237873|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237874|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237875|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237876|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
157237877|NCT01597245|567616710|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237878|NCT01597245|567616711|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237879|NCT01597245|567616712|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157090788|NCT02150343|567086900|FG001|Overall Study|Withdrawal by Subject|10|||
157090789|NCT02150343|567086901|FG002|Overall Study|Withdrawal by Subject|9|||
157090790|NCT02150343|567086902|FG003|Overall Study|Withdrawal by Subject|4|||
157090791|NCT02150343|567086899|FG000|Overall Study|Lost to Follow-up|4|||
157090792|NCT02150343|567086900|FG001|Overall Study|Lost to Follow-up|4|||
157090793|NCT02150343|567086901|FG002|Overall Study|Lost to Follow-up|2|||
157090794|NCT02150343|567086902|FG003|Overall Study|Lost to Follow-up|3|||
157237880|NCT01597245|567616713|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237881|NCT01597245|567616714|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237882|NCT01597245|567616715|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237883|NCT01597245|567616716|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237884|NCT01597245|567616717|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237885|NCT01597245|567616718|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157090795|NCT02150343|567086899|FG000|Overall Study|Other|2|||
157090796|NCT02150343|567086900|FG001|Overall Study|Other|6|||
157090797|NCT02150343|567086901|FG002|Overall Study|Other|0|||
157090798|NCT02150343|567086902|FG003|Overall Study|Other|2|||
157090799|NCT02729753|567086903|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
157090800|NCT02729753|567086904|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
157090801|NCT00190749|567086905|FG000|Overall Study|Lost to Follow-up|8|||
157090802|NCT00190749|567086906|FG001|Overall Study|Lost to Follow-up|11|||
157090803|NCT00190749|567086905|FG000|Overall Study|Withdrawal by Subject|10|||
157090804|NCT00190749|567086906|FG001|Overall Study|Withdrawal by Subject|6|||
157090805|NCT00190749|567086905|FG000|Overall Study|Protocol Violation|5|||
157090806|NCT00190749|567086906|FG001|Overall Study|Protocol Violation|4|||
157090807|NCT00190749|567086905|FG000|Overall Study|Adverse Event|0|||
157090808|NCT00190749|567086906|FG001|Overall Study|Adverse Event|5|||
157090809|NCT00190749|567086905|FG000|Overall Study|Lack of Efficacy|2|||
157090810|NCT00190749|567086906|FG001|Overall Study|Lack of Efficacy|3|||
157090811|NCT00190749|567086905|FG000|Overall Study|Reason Not Specified|0|||
157090812|NCT00190749|567086906|FG001|Overall Study|Reason Not Specified|2|||
157090813|NCT00190749|567086905|FG000|Overall Study|Sponsor Decision|1|||
157090814|NCT00190749|567086906|FG001|Overall Study|Sponsor Decision|0|||
157090815|NCT00906945|567086907|FG000|Overall Study|Found to be not eligible|0|||
157090816|NCT00906945|567086908|FG001|Overall Study|Found to be not eligible|0|||
157090817|NCT00906945|567086909|FG002|Overall Study|Found to be not eligible|0|||
157090818|NCT00906945|567086910|FG003|Overall Study|Found to be not eligible|1|||
157090819|NCT00906945|567086911|FG004|Overall Study|Found to be not eligible|1|||
157090820|NCT00906945|567086912|FG005|Overall Study|Found to be not eligible|1|||
157090821|NCT00906945|567086907|FG000|Overall Study|Physician Decision|0|||
157090822|NCT00906945|567086908|FG001|Overall Study|Physician Decision|0|||
157090823|NCT00906945|567086909|FG002|Overall Study|Physician Decision|0|||
157090824|NCT00906945|567086910|FG003|Overall Study|Physician Decision|0|||
157090825|NCT00906945|567086911|FG004|Overall Study|Physician Decision|0|||
157090826|NCT00906945|567086912|FG005|Overall Study|Physician Decision|1|||
157090827|NCT01853644|567086913|FG000|Registration and Treatment Start|Did not start treatment|1|||
157090828|NCT01853644|567086913|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
157090829|NCT01853644|567086913|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
157090830|NCT01853644|567086913|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
157090831|NCT01853644|567086913|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
157090832|NCT01853644|567086913|FG000|Continued Treatment After First Response|Adverse Event|2|||
157090833|NCT01853644|567086913|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
157090834|NCT00705523|567086918|FG000|Overall Study|Lost to Follow-up|2|||
157090835|NCT00705523|567086919|FG001|Overall Study|Lost to Follow-up|3|||
157090836|NCT00589121|567086924|FG000|Overall Study|Protocol Violation|2|||
157090837|NCT00589121|567086925|FG001|Overall Study|Protocol Violation|6|||
157090838|NCT00589121|567086924|FG000|Overall Study|No protocol treatment received|0|||
157090839|NCT00589121|567086925|FG001|Overall Study|No protocol treatment received|1|||
157090840|NCT02412371|567086926|FG000|Overall Study|Withdrawal by Subject|0|||
157090841|NCT02412371|567086927|FG001|Overall Study|Withdrawal by Subject|2|||
157090842|NCT02412371|567086928|FG002|Overall Study|Withdrawal by Subject|0|||
157090843|NCT02412371|567086929|FG003|Overall Study|Withdrawal by Subject|1|||
157090844|NCT02412371|567086930|FG004|Overall Study|Withdrawal by Subject|1|||
157090845|NCT02412371|567086931|FG005|Overall Study|Withdrawal by Subject|0|||
157090846|NCT02412371|567086926|FG000|Overall Study|Sponsor Discontinued Study|1|||
157090847|NCT02412371|567086927|FG001|Overall Study|Sponsor Discontinued Study|4|||
157090848|NCT02412371|567086928|FG002|Overall Study|Sponsor Discontinued Study|6|||
157090849|NCT02412371|567086929|FG003|Overall Study|Sponsor Discontinued Study|4|||
157090850|NCT02412371|567086930|FG004|Overall Study|Sponsor Discontinued Study|5|||
157090851|NCT02412371|567086931|FG005|Overall Study|Sponsor Discontinued Study|0|||
157090852|NCT02412371|567086926|FG000|Overall Study|Death|4|||
157090853|NCT02412371|567086927|FG001|Overall Study|Death|2|||
157090854|NCT02412371|567086928|FG002|Overall Study|Death|1|||
157090855|NCT02412371|567086929|FG003|Overall Study|Death|3|||
157197094|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
157197095|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
157197096|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
157090856|NCT02412371|567086930|FG004|Overall Study|Death|5|||
157090857|NCT02412371|567086931|FG005|Overall Study|Death|2|||
157090858|NCT02412371|567086926|FG000|Overall Study|Other|2|||
157090859|NCT02412371|567086927|FG001|Overall Study|Other|1|||
157090860|NCT02412371|567086928|FG002|Overall Study|Other|0|||
157090861|NCT02412371|567086929|FG003|Overall Study|Other|0|||
157090862|NCT02412371|567086930|FG004|Overall Study|Other|1|||
157090863|NCT02412371|567086931|FG005|Overall Study|Other|3|||
157090864|NCT00847808|567086932|FG000|Overall Study|Adverse Event|7|||
157090865|NCT00847808|567086932|FG000|Overall Study|Protocol Violation|1|||
157090866|NCT00847808|567086932|FG000|Overall Study|Lost to Follow-up|1|||
157090867|NCT00847808|567086932|FG000|Overall Study|Withdrawal by Subject|4|||
157090868|NCT00847808|567086932|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
157090869|NCT00847808|567086932|FG000|Overall Study|Participant Took Excluded Medication|1|||
157090870|NCT05000931|567086941|FG000|Overall Study|Lost to Follow-up|1|||
157090871|NCT00925132|567086942|FG000|Overall Study|Withdrawal by Subject|2|||
157090872|NCT00925132|567086943|FG001|Overall Study|Withdrawal by Subject|0|||
157090873|NCT00925132|567086944|FG002|Overall Study|Withdrawal by Subject|0|||
157090874|NCT00925132|567086945|FG003|Overall Study|Withdrawal by Subject|0|||
157090875|NCT00925132|567086946|FG004|Overall Study|Withdrawal by Subject|1|||
157090876|NCT00925132|567086942|FG000|Overall Study|Removed due to disease progression|0|||
157090877|NCT00925132|567086943|FG001|Overall Study|Removed due to disease progression|0|||
157090878|NCT00925132|567086944|FG002|Overall Study|Removed due to disease progression|0|||
157197097|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
157197098|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
157197099|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
157197100|NCT00950755|567463899|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
157197101|NCT00950755|567463899|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
157197102|NCT00950755|567463899|FG000|Long-Term Follow-Up|Death|8|||
157197103|NCT00508820|567463900|FG000|Overall Study|Adverse Event|6|||
157197104|NCT00508820|567463901|FG001|Overall Study|Adverse Event|10|||
157197105|NCT00508820|567463900|FG000|Overall Study|Death|6|||
157197106|NCT00508820|567463901|FG001|Overall Study|Death|8|||
157197107|NCT00508820|567463900|FG000|Overall Study|Lost to Follow-up|1|||
157197108|NCT00508820|567463901|FG001|Overall Study|Lost to Follow-up|1|||
157197109|NCT00508820|567463900|FG000|Overall Study|Physician Decision|8|||
157197110|NCT00508820|567463901|FG001|Overall Study|Physician Decision|2|||
157197111|NCT00508820|567463900|FG000|Overall Study|Pregnancy|0|||
157197112|NCT00508820|567463901|FG001|Overall Study|Pregnancy|2|||
157197113|NCT00508820|567463900|FG000|Overall Study|Protocol Violation|2|||
157197114|NCT00508820|567463901|FG001|Overall Study|Protocol Violation|0|||
157197115|NCT00508820|567463900|FG000|Overall Study|Withdrawal by Subject|10|||
157197116|NCT00508820|567463901|FG001|Overall Study|Withdrawal by Subject|12|||
157197117|NCT00508820|567463900|FG000|Overall Study|Other|11|||
157197118|NCT00508820|567463901|FG001|Overall Study|Other|2|||
157197119|NCT00508820|567463900|FG000|Overall Study|Noncompliance|1|||
157197120|NCT00508820|567463901|FG001|Overall Study|Noncompliance|0|||
157197121|NCT00508820|567463900|FG000|Overall Study|Requirement for alternative therapy|7|||
157197122|NCT00508820|567463901|FG001|Overall Study|Requirement for alternative therapy|15|||
157197123|NCT00508820|567463900|FG000|Overall Study|Protocol-specified Criteria|3|||
157197124|NCT00508820|567463901|FG001|Overall Study|Protocol-specified Criteria|12|||
157197125|NCT04398030|567465202|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
157197126|NCT04398030|567465203|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
157197127|NCT04398030|567465202|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
157197128|NCT04398030|567465203|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
157197129|NCT03799198|567465208|FG000|Overall Study|Lost to Follow-up|4|||
157197130|NCT03799198|567465209|FG001|Overall Study|Lost to Follow-up|8|||
157197131|NCT03799198|567465208|FG000|Overall Study|Death|0|||
157197132|NCT03799198|567465209|FG001|Overall Study|Death|1|||
157197133|NCT02501642|567465211|FG000|Overall Study|Lost to Follow-up|7|||
157197134|NCT02501642|567465212|FG001|Overall Study|Lost to Follow-up|11|||
157197135|NCT00548340|567465214|FG000|Overall Study|Protocol Violation|2|||
157197136|NCT00548340|567465215|FG001|Overall Study|Protocol Violation|3|||
157197137|NCT00548340|567465216|FG002|Overall Study|Protocol Violation|3|||
157197138|NCT00548340|567465214|FG000|Overall Study|Adverse Event|2|||
157197139|NCT00548340|567465215|FG001|Overall Study|Adverse Event|2|||
157197140|NCT00548340|567465216|FG002|Overall Study|Adverse Event|2|||
157197141|NCT00548340|567465214|FG000|Overall Study|Lost to Follow-up|1|||
157197142|NCT00548340|567465215|FG001|Overall Study|Lost to Follow-up|1|||
157197143|NCT00548340|567465216|FG002|Overall Study|Lost to Follow-up|0|||
157197144|NCT00548340|567465214|FG000|Overall Study|Withdrawal by Subject|2|||
157197145|NCT00548340|567465215|FG001|Overall Study|Withdrawal by Subject|4|||
157197146|NCT00548340|567465216|FG002|Overall Study|Withdrawal by Subject|3|||
157197147|NCT00548340|567465214|FG000|Overall Study|Other|1|||
157197148|NCT00548340|567465215|FG001|Overall Study|Other|1|||
157197149|NCT00548340|567465216|FG002|Overall Study|Other|1|||
157197150|NCT03410693|567465219|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
157197151|NCT03410693|567465220|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
157197152|NCT03410693|567465219|FG000|Overall Study|Disc trt: Lost to follow up|0|||
157197153|NCT03410693|567465220|FG001|Overall Study|Disc trt: Lost to follow up|1|||
157197154|NCT03410693|567465219|FG000|Overall Study|Disc trt: radiological progression|58|||
157197155|NCT03410693|567465220|FG001|Overall Study|Disc trt: radiological progression|50|||
157197156|NCT03410693|567465219|FG000|Overall Study|Disc trt: Other|1|||
157197157|NCT03410693|567465220|FG001|Overall Study|Disc trt: Other|0|||
157197158|NCT03410693|567465219|FG000|Overall Study|Study drug never administered|1|||
157197159|NCT03410693|567465220|FG001|Overall Study|Study drug never administered|6|||
157197160|NCT03410693|567465219|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
157197161|NCT03410693|567465220|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
157197162|NCT03410693|567465219|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
157197163|NCT03410693|567465220|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
157197164|NCT03410693|567465219|FG000|Overall Study|Disc trt: Physician decision|0|||
157237886|NCT01597245|567616719|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237887|NCT01597245|567616720|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
157237888|NCT01597245|567616721|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237889|NCT01597245|567616722|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237890|NCT01597245|567616723|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237891|NCT01597245|567616724|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237892|NCT01597245|567616725|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237893|NCT01597245|567616726|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237894|NCT01597245|567616727|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237895|NCT01597245|567616728|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237896|NCT01597245|567616729|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237897|NCT01597245|567616730|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
157237898|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237899|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237900|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237901|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237902|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237903|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237904|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237905|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237906|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237907|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237908|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237909|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237910|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237911|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
157237912|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
157237913|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
157237914|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237915|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237916|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237917|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237918|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
157237919|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157090879|NCT00925132|567086945|FG003|Overall Study|Removed due to disease progression|0|||
157090880|NCT00925132|567086946|FG004|Overall Study|Removed due to disease progression|4|||
157090881|NCT02545933|567086947|FG000|Overall Study|Adverse Event|3|||
157090882|NCT02545933|567086948|FG001|Overall Study|Adverse Event|0|||
157090883|NCT02545933|567086949|FG002|Overall Study|Adverse Event|0|||
157090884|NCT02545933|567086947|FG000|Overall Study|Withdrawal by Subject|2|||
157090885|NCT02545933|567086948|FG001|Overall Study|Withdrawal by Subject|3|||
157090886|NCT02545933|567086949|FG002|Overall Study|Withdrawal by Subject|3|||
157090887|NCT02545933|567086947|FG000|Overall Study|Protocol Violation|1|||
157237920|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237921|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237922|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237923|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237924|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237925|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237926|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237927|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237928|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237929|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237930|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237931|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157090888|NCT02545933|567086948|FG001|Overall Study|Protocol Violation|0|||
157090889|NCT02545933|567086949|FG002|Overall Study|Protocol Violation|1|||
157090890|NCT03149549|567086950|FG000|Study Discontinuation--Treatment Period|Death|0|||
157090891|NCT03149549|567086951|FG001|Study Discontinuation--Treatment Period|Death|0|||
157090892|NCT03149549|567086952|FG002|Study Discontinuation--Treatment Period|Death|0|||
157090893|NCT03149549|567086953|FG003|Study Discontinuation--Treatment Period|Death|1|||
157090894|NCT03149549|567086954|FG004|Study Discontinuation--Treatment Period|Death|2|||
157090895|NCT03149549|567086955|FG005|Study Discontinuation--Treatment Period|Death|1|||
157090896|NCT03149549|567086956|FG006|Study Discontinuation--Treatment Period|Death|1|||
157090897|NCT03149549|567086957|FG007|Study Discontinuation--Treatment Period|Death|2|||
157090898|NCT03149549|567086958|FG008|Study Discontinuation--Treatment Period|Death|4|||
157090899|NCT03149549|567086959|FG009|Study Discontinuation--Treatment Period|Death|1|||
157090900|NCT03149549|567086960|FG010|Study Discontinuation--Treatment Period|Death|0|||
157090901|NCT03149549|567086961|FG011|Study Discontinuation--Treatment Period|Death|0|||
157090902|NCT03149549|567086962|FG012|Study Discontinuation--Treatment Period|Death|1|||
157090903|NCT03149549|567086950|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090904|NCT03149549|567086951|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090905|NCT03149549|567086952|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157237932|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
157237933|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
157237934|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
157237935|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237936|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237937|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237938|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237939|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
157237940|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237941|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237942|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237943|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237944|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237945|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237946|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237947|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237948|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237949|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237950|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237951|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237952|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237953|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237954|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
157237955|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
157237956|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237957|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237958|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237959|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237960|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
157237961|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237962|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237963|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237964|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237965|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237966|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237967|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237968|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237969|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237970|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237971|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237972|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237973|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237974|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237975|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
157237976|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
157237977|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157090906|NCT03149549|567086953|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090907|NCT03149549|567086954|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090908|NCT03149549|567086955|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090909|NCT03149549|567086956|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157237978|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237979|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237980|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237981|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
157237982|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237983|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157090910|NCT03149549|567086957|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
157237984|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237985|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237986|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237987|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237988|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237989|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237990|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237991|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237992|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237993|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237994|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157237995|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
157237996|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
157237997|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
157237998|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157090911|NCT03149549|567086958|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090912|NCT03149549|567086959|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090913|NCT03149549|567086960|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090914|NCT03149549|567086961|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
157090915|NCT03149549|567086962|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
157090916|NCT03149549|567086950|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090917|NCT03149549|567086951|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090918|NCT03149549|567086952|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090919|NCT03149549|567086953|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
157090920|NCT03149549|567086954|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
157090921|NCT03149549|567086955|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
157090922|NCT03149549|567086956|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
157090923|NCT03149549|567086957|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090924|NCT03149549|567086958|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
157090925|NCT03149549|567086959|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090926|NCT03149549|567086960|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090927|NCT03149549|567086961|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090928|NCT03149549|567086962|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
157090929|NCT03149549|567086950|FG000|Study Discontinuation--Treatment Period|Other|0|||
157090930|NCT03149549|567086951|FG001|Study Discontinuation--Treatment Period|Other|0|||
157090931|NCT03149549|567086952|FG002|Study Discontinuation--Treatment Period|Other|0|||
157090932|NCT03149549|567086953|FG003|Study Discontinuation--Treatment Period|Other|0|||
157090933|NCT03149549|567086954|FG004|Study Discontinuation--Treatment Period|Other|0|||
157090934|NCT03149549|567086955|FG005|Study Discontinuation--Treatment Period|Other|0|||
157090935|NCT03149549|567086956|FG006|Study Discontinuation--Treatment Period|Other|0|||
157090936|NCT03149549|567086957|FG007|Study Discontinuation--Treatment Period|Other|1|||
157090937|NCT03149549|567086958|FG008|Study Discontinuation--Treatment Period|Other|0|||
157090938|NCT03149549|567086959|FG009|Study Discontinuation--Treatment Period|Other|1|||
157090939|NCT03149549|567086960|FG010|Study Discontinuation--Treatment Period|Other|0|||
157090940|NCT03149549|567086961|FG011|Study Discontinuation--Treatment Period|Other|0|||
157090941|NCT03149549|567086962|FG012|Study Discontinuation--Treatment Period|Other|0|||
157090942|NCT03149549|567086950|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090943|NCT03149549|567086951|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090944|NCT03149549|567086952|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090945|NCT03149549|567086953|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090946|NCT03149549|567086954|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090947|NCT03149549|567086955|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
157090948|NCT03149549|567086956|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
157090949|NCT03149549|567086957|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090950|NCT03149549|567086958|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
157090951|NCT03149549|567086959|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090952|NCT03149549|567086960|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090953|NCT03149549|567086961|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090954|NCT03149549|567086962|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
157090955|NCT03149549|567086950|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090956|NCT03149549|567086951|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090957|NCT03149549|567086952|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090958|NCT03149549|567086953|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157237999|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157238000|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157238001|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157238002|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
157238003|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238004|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238005|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238006|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238007|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238008|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238009|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238010|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238011|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238012|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238013|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238014|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238015|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238016|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238017|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
157238018|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
157238019|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238020|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238021|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238022|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238023|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
157238024|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238025|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238026|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238027|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238028|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238029|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238030|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238031|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238032|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238033|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238034|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238035|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238036|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238037|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238038|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
157238039|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
157238040|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238041|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238042|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238043|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238044|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
157238045|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238046|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238047|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238048|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238049|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238050|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238051|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238052|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238053|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238054|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238055|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238056|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238057|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238058|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238059|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
157238060|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
157238061|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238062|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238063|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238064|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238065|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
157238066|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238067|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238068|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238069|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238070|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238071|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238072|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238073|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238074|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238075|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238076|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238077|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238078|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238079|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238080|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
157238081|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
157238082|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238083|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238084|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238085|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157090959|NCT03149549|567086954|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
157090960|NCT03149549|567086955|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090961|NCT03149549|567086956|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090962|NCT03149549|567086957|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
157090963|NCT03149549|567086958|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
157090964|NCT03149549|567086959|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090965|NCT03149549|567086960|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
157090966|NCT03149549|567086961|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
157090967|NCT03149549|567086962|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
157090968|NCT03149549|567086950|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090969|NCT03149549|567086951|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090970|NCT03149549|567086952|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090971|NCT03149549|567086953|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090972|NCT03149549|567086954|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
157090973|NCT03149549|567086955|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090974|NCT03149549|567086956|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157090975|NCT03149549|567086957|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
157238086|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
157238087|NCT01597245|567616710|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238088|NCT01597245|567616711|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238089|NCT01597245|567616712|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238090|NCT01597245|567616713|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238091|NCT01597245|567616714|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238092|NCT01597245|567616715|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238093|NCT01597245|567616716|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238094|NCT01597245|567616717|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238095|NCT01597245|567616718|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238096|NCT01597245|567616719|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238097|NCT01597245|567616720|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238098|NCT01597245|567616721|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238099|NCT01597245|567616722|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238100|NCT01597245|567616723|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
157238101|NCT01597245|567616724|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238102|NCT01597245|567616725|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238103|NCT01597245|567616726|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238104|NCT01597245|567616727|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238105|NCT01597245|567616728|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238106|NCT01597245|567616729|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238107|NCT01597245|567616730|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
157238108|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238109|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238110|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238111|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238112|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238113|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238114|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238115|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238116|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238117|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238118|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238119|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238120|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238121|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238122|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238123|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
157238124|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
157238125|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
157238126|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
157238127|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
157238128|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
157238129|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238130|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238131|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238132|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238133|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238134|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238135|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238136|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238137|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238138|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238139|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238140|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238141|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238142|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238143|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238144|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238145|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
157238146|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
157238147|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
157238148|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
157238149|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
157238150|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238151|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238152|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238153|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238154|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238155|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238156|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238157|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238158|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238159|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238160|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238161|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238162|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238163|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238164|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238165|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238166|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
157090976|NCT03149549|567086958|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
157090977|NCT03149549|567086959|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
157090978|NCT03149549|567086960|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
157090979|NCT03149549|567086961|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
157238167|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238168|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
157238169|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
157238170|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
157238171|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238172|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238173|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238174|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238175|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238176|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238177|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238178|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238179|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238180|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238181|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238182|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238183|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238184|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238185|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238186|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238187|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238188|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
157238189|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
157238190|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
157238191|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
157238192|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238193|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238194|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238195|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238196|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238197|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238198|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238199|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238200|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238201|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238202|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238203|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238204|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238205|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238206|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238207|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238208|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
157238209|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238210|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
157238211|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
157238212|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
157238213|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238214|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238215|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238216|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238217|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238218|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238219|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238220|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238221|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238222|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238223|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238224|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157090980|NCT03149549|567086962|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
157090981|NCT03149549|567086950|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
157238225|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238226|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238227|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238228|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238229|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
157238230|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238231|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
157238232|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
157238233|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
157238234|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238235|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238236|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238237|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238238|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238239|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238240|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238241|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238242|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238243|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238244|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238245|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238246|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238247|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238248|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238249|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238250|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
157238251|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238252|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238253|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
157238254|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
157238255|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238256|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238257|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238258|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238259|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238260|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238261|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238262|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238263|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238264|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238265|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238266|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238267|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238268|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238269|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238270|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238271|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
157238272|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238273|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238274|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
157238275|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
157238276|NCT01597245|567616710|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238277|NCT01597245|567616711|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238278|NCT01597245|567616712|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238279|NCT01597245|567616713|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238280|NCT01597245|567616714|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238281|NCT01597245|567616715|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238282|NCT01597245|567616716|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238283|NCT01597245|567616717|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238284|NCT01597245|567616718|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238285|NCT01597245|567616719|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238286|NCT01597245|567616720|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238287|NCT01597245|567616721|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238288|NCT01597245|567616722|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238289|NCT01597245|567616723|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238290|NCT01597245|567616724|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238291|NCT01597245|567616725|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157090982|NCT03149549|567086951|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
157090983|NCT03149549|567086952|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
157238292|NCT01597245|567616726|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238293|NCT01597245|567616727|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238294|NCT01597245|567616728|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238295|NCT01597245|567616729|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
157238296|NCT01597245|567616730|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
157238297|NCT04299087|567618271|FG000|Overall Study|Lost to Follow-up|2|||
157238298|NCT04299087|567618272|FG001|Overall Study|Lost to Follow-up|1|||
157238299|NCT00594035|567618273|FG000|Overall Study|Lost to Follow-up|1|||
157238300|NCT00594035|567618274|FG001|Overall Study|Lost to Follow-up|1|||
157238301|NCT00594035|567618273|FG000|Overall Study|Withdrawal by Subject|1|||
157238302|NCT00594035|567618274|FG001|Overall Study|Withdrawal by Subject|0|||
157238303|NCT00594035|567618273|FG000|Overall Study|Subject transferred to nursing home|0|||
157238304|NCT00594035|567618274|FG001|Overall Study|Subject transferred to nursing home|1|||
157238305|NCT00594035|567618273|FG000|Overall Study|Subject couldn't return due to job|0|||
157238306|NCT00594035|567618274|FG001|Overall Study|Subject couldn't return due to job|1|||
157238307|NCT00795821|567618275|FG000|Acute Treatment Phase|Adverse Event|23|||
157238308|NCT00795821|567618276|FG001|Acute Treatment Phase|Adverse Event|4|||
157238309|NCT00795821|567618275|FG000|Acute Treatment Phase|Death|1|||
157238310|NCT00795821|567618276|FG001|Acute Treatment Phase|Death|0|||
157238311|NCT00795821|567618275|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
157238312|NCT00795821|567618276|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
157238313|NCT00795821|567618275|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
157238314|NCT00795821|567618276|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
157238315|NCT00795821|567618275|FG000|Acute Treatment Phase|Physician Decision|1|||
157238316|NCT00795821|567618276|FG001|Acute Treatment Phase|Physician Decision|1|||
157238317|NCT00795821|567618275|FG000|Acute Treatment Phase|Protocol Violation|1|||
157238318|NCT00795821|567618276|FG001|Acute Treatment Phase|Protocol Violation|2|||
157238319|NCT00795821|567618275|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
157238320|NCT00795821|567618276|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
157238321|NCT00795821|567618275|FG000|Long-term Extension Phase|Adverse Event|25|||
157238322|NCT00795821|567618276|FG001|Long-term Extension Phase|Adverse Event|32|||
157238323|NCT00795821|567618275|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
157238324|NCT00795821|567618276|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
157238325|NCT00795821|567618275|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
157238326|NCT00795821|567618276|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
157238327|NCT00795821|567618275|FG000|Long-term Extension Phase|Physician Decision|1|||
157238328|NCT00795821|567618276|FG001|Long-term Extension Phase|Physician Decision|2|||
157238329|NCT00795821|567618275|FG000|Long-term Extension Phase|Protocol Violation|3|||
157238330|NCT00795821|567618276|FG001|Long-term Extension Phase|Protocol Violation|5|||
157238331|NCT00795821|567618275|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
157238332|NCT00795821|567618276|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
157238333|NCT00795821|567618275|FG000|Taper Phase|Adverse Event|2|||
157238334|NCT00795821|567618276|FG001|Taper Phase|Adverse Event|0|||
157238335|NCT00795821|567618275|FG000|Taper Phase|Lost to Follow-up|1|||
157238336|NCT00795821|567618276|FG001|Taper Phase|Lost to Follow-up|0|||
157238337|NCT00795821|567618275|FG000|Taper Phase|Physician Decision|2|||
157238338|NCT00795821|567618276|FG001|Taper Phase|Physician Decision|0|||
157238339|NCT00795821|567618275|FG000|Taper Phase|Withdrawal by Subject|4|||
157238340|NCT00795821|567618276|FG001|Taper Phase|Withdrawal by Subject|0|||
157238341|NCT00712959|567618283|FG000|Overall Study|Protocol Violation|3|||
157238342|NCT00712959|567618284|FG001|Overall Study|Protocol Violation|1|||
157238343|NCT00712959|567618283|FG000|Overall Study|Lost to Follow-up|13|||
157238344|NCT00712959|567618284|FG001|Overall Study|Lost to Follow-up|2|||
157238345|NCT00712959|567618283|FG000|Overall Study|Withdrawal by Subject|3|||
157238346|NCT00712959|567618284|FG001|Overall Study|Withdrawal by Subject|0|||
157238347|NCT00835991|567618285|FG000|First Intervention|Adverse Event|0|||
157238348|NCT00835991|567618286|FG001|First Intervention|Adverse Event|1|||
157238349|NCT00835991|567618285|FG000|Washout|Protocol Violation|0|||
157238350|NCT00835991|567618286|FG001|Washout|Protocol Violation|2|||
157238351|NCT00835991|567618285|FG000|Washout|Withdrawal by Subject|3|||
157238352|NCT00835991|567618286|FG001|Washout|Withdrawal by Subject|1|||
157238353|NCT03616535|567618287|FG000|Overall Study|Death|2|||
157238354|NCT03616535|567618288|FG001|Overall Study|Death|0|||
157238355|NCT03616535|567618289|FG002|Overall Study|Death|0|||
157238356|NCT03616535|567618290|FG003|Overall Study|Death|1|||
157238357|NCT03616535|567618287|FG000|Overall Study|Lost to Follow-up|2|||
157238358|NCT03616535|567618288|FG001|Overall Study|Lost to Follow-up|1|||
157238359|NCT03616535|567618289|FG002|Overall Study|Lost to Follow-up|0|||
157238360|NCT03616535|567618290|FG003|Overall Study|Lost to Follow-up|2|||
157238361|NCT03616535|567618287|FG000|Overall Study|Withdrawal by Subject|1|||
157238362|NCT03616535|567618288|FG001|Overall Study|Withdrawal by Subject|2|||
157238363|NCT03616535|567618289|FG002|Overall Study|Withdrawal by Subject|5|||
157238364|NCT03616535|567618290|FG003|Overall Study|Withdrawal by Subject|1|||
157238365|NCT03616535|567618287|FG000|Overall Study|Not specified or change in eligibility|2|||
157238366|NCT03616535|567618288|FG001|Overall Study|Not specified or change in eligibility|3|||
157238367|NCT03616535|567618289|FG002|Overall Study|Not specified or change in eligibility|3|||
157238368|NCT03616535|567618290|FG003|Overall Study|Not specified or change in eligibility|1|||
157238369|NCT02146105|567618291|FG000|Overall Study|Adverse Event|1|||
157238370|NCT02146105|567618291|FG000|Overall Study|Withdrawal by Subject|5|||
157238371|NCT02718326|567618294|FG000|Overall Study|Adverse Event|4|||
157238372|NCT02718326|567618295|FG001|Overall Study|Adverse Event|9|||
157238373|NCT02718326|567618296|FG002|Overall Study|Adverse Event|0|||
157238374|NCT02718326|567618294|FG000|Overall Study|Death|8|||
157238375|NCT02718326|567618295|FG001|Overall Study|Death|1|||
157238376|NCT02718326|567618296|FG002|Overall Study|Death|2|||
157238377|NCT02718326|567618294|FG000|Overall Study|Withdrawal by Subject|4|||
157238378|NCT02718326|567618295|FG001|Overall Study|Withdrawal by Subject|9|||
157238379|NCT02718326|567618296|FG002|Overall Study|Withdrawal by Subject|6|||
157238380|NCT02718326|567618294|FG000|Overall Study|Lost to Follow-up|18|||
157238381|NCT02718326|567618295|FG001|Overall Study|Lost to Follow-up|5|||
157238382|NCT02718326|567618296|FG002|Overall Study|Lost to Follow-up|14|||
157238383|NCT02718326|567618294|FG000|Overall Study|Protocol Deviation|1|||
157238384|NCT02718326|567618295|FG001|Overall Study|Protocol Deviation|0|||
157238385|NCT02718326|567618296|FG002|Overall Study|Protocol Deviation|0|||
157238386|NCT02718326|567618294|FG000|Overall Study|Pregnancy|1|||
157238387|NCT02718326|567618295|FG001|Overall Study|Pregnancy|0|||
157238388|NCT02718326|567618296|FG002|Overall Study|Pregnancy|0|||
157238389|NCT02436005|567618300|FG000|Second Intervention|Adverse Event|0|||
157238390|NCT02436005|567618301|FG001|Second Intervention|Adverse Event|1|||
157238391|NCT00583453|567618302|FG000|Overall Study|discontinued intervention|0|||
157238392|NCT00583453|567618303|FG001|Overall Study|discontinued intervention|2|||
157238393|NCT00905606|567618304|FG000|Period 1|Adverse Event|0|||
157238394|NCT00905606|567618305|FG001|Period 1|Adverse Event|1|||
157238395|NCT00905606|567618304|FG000|Washout|Withdrawal by Subject|1|||
157238396|NCT00905606|567618305|FG001|Washout|Withdrawal by Subject|0|||
157238397|NCT01558635|567618306|FG000|Overall Study|Death|1|||
157238398|NCT01558635|567618306|FG000|Overall Study|Withdrawal by Subject|2|||
157238399|NCT01558635|567618306|FG000|Overall Study|Physician Decision|1|||
157238400|NCT01558635|567618306|FG000|Overall Study|Subject received other treatment|1|||
157238401|NCT01558635|567618306|FG000|Overall Study|Reveal XT was explanted|1|||
157238402|NCT00455312|567618307|FG000|Overall Study|Death|0|||
157238403|NCT00455312|567618308|FG001|Overall Study|Death|1|||
157238404|NCT03868891|567618309|FG000|Overall Study|Adverse Event|1|||
157238405|NCT03868891|567618310|FG001|Overall Study|Adverse Event|0|||
157238406|NCT03868891|567618309|FG000|Overall Study|Lost to Follow-up|2|||
157238407|NCT03868891|567618310|FG001|Overall Study|Lost to Follow-up|1|||
157238408|NCT03868891|567618309|FG000|Overall Study|COVID-19 Restrictions|1|||
157238409|NCT03868891|567618310|FG001|Overall Study|COVID-19 Restrictions|2|||
157238410|NCT00777023|567618311|FG000|Overall Study|Adverse Event|15|||
157238411|NCT00777023|567618312|FG001|Overall Study|Adverse Event|21|||
157238412|NCT00777023|567618313|FG002|Overall Study|Adverse Event|8|||
157238413|NCT00777023|567618311|FG000|Overall Study|Lack of Efficacy|1|||
157238414|NCT00777023|567618312|FG001|Overall Study|Lack of Efficacy|0|||
157238415|NCT00777023|567618313|FG002|Overall Study|Lack of Efficacy|14|||
157238416|NCT00777023|567618311|FG000|Overall Study|Protocol Violation|2|||
157238417|NCT00777023|567618312|FG001|Overall Study|Protocol Violation|1|||
157238418|NCT00777023|567618313|FG002|Overall Study|Protocol Violation|1|||
157238419|NCT00777023|567618311|FG000|Overall Study|Lost to Follow-up|2|||
157238420|NCT00777023|567618312|FG001|Overall Study|Lost to Follow-up|3|||
157238421|NCT00777023|567618313|FG002|Overall Study|Lost to Follow-up|3|||
157238422|NCT00777023|567618311|FG000|Overall Study|Death|0|||
157238423|NCT00777023|567618312|FG001|Overall Study|Death|1|||
157238424|NCT00777023|567618313|FG002|Overall Study|Death|0|||
157238425|NCT00777023|567618311|FG000|Overall Study|Withdrawal by Subject|7|||
157238426|NCT00777023|567618312|FG001|Overall Study|Withdrawal by Subject|7|||
157238427|NCT00777023|567618313|FG002|Overall Study|Withdrawal by Subject|8|||
157238428|NCT00777023|567618311|FG000|Overall Study|Missing data|1|||
157238429|NCT00777023|567618312|FG001|Overall Study|Missing data|1|||
157238430|NCT00777023|567618313|FG002|Overall Study|Missing data|0|||
157090984|NCT03149549|567086953|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
157090985|NCT03149549|567086954|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
157090986|NCT03149549|567086955|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
157238431|NCT00777023|567618311|FG000|Overall Study|Reasons not specified|4|||
157238432|NCT00777023|567618312|FG001|Overall Study|Reasons not specified|4|||
157238433|NCT00777023|567618313|FG002|Overall Study|Reasons not specified|2|||
157238434|NCT00777023|567618311|FG000|Overall Study|Last dose date unknown|3|||
157238435|NCT00777023|567618312|FG001|Overall Study|Last dose date unknown|3|||
157238436|NCT00777023|567618313|FG002|Overall Study|Last dose date unknown|1|||
157238437|NCT02659150|567618314|FG000|Subject Enrollment|Physician Decision|3|||
157238438|NCT02659150|567618314|FG000|Subject Enrollment|Withdrawal by Subject|2|||
157238439|NCT02659150|567618314|FG000|Baseline Imaging|Withdrawal by Subject|1|||
157238440|NCT02659150|567618314|FG000|Baseline Imaging|Physician Decision|1|||
157238441|NCT02659150|567618314|FG000|Study Drug Dosing|Adverse Event|1|||
157238442|NCT02246920|567618315|FG000|Overall Study|Adverse Event|3|||
157238443|NCT02246920|567618316|FG001|Overall Study|Adverse Event|1|||
157238444|NCT02246920|567618317|FG002|Overall Study|Adverse Event|1|||
157238445|NCT02246920|567618315|FG000|Overall Study|Lost to Follow-up|2|||
157238446|NCT02246920|567618316|FG001|Overall Study|Lost to Follow-up|1|||
157238447|NCT02246920|567618317|FG002|Overall Study|Lost to Follow-up|0|||
157238448|NCT02246920|567618315|FG000|Overall Study|Protocol Violation|2|||
157238449|NCT02246920|567618316|FG001|Overall Study|Protocol Violation|5|||
157238450|NCT02246920|567618317|FG002|Overall Study|Protocol Violation|1|||
157238451|NCT02246920|567618315|FG000|Overall Study|Withdrawal by Subject|0|||
157238452|NCT02246920|567618316|FG001|Overall Study|Withdrawal by Subject|0|||
157238453|NCT02246920|567618317|FG002|Overall Study|Withdrawal by Subject|1|||
157238454|NCT02678286|567618318|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
157238455|NCT02678286|567618319|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
157238456|NCT02678286|567618318|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
157238457|NCT02678286|567618319|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
157238458|NCT02678286|567618318|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
157238459|NCT02678286|567618319|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
157238460|NCT02678286|567618318|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
157238461|NCT02678286|567618319|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
157238462|NCT02678286|567618318|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
157238463|NCT02678286|567618319|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
157238464|NCT02909907|567618327|FG000|Overall Study|Withdrawal by Subject|0|||
157238465|NCT02909907|567618328|FG001|Overall Study|Withdrawal by Subject|1|||
157238466|NCT02902211|567618329|FG000|First Three Months|Withdrawal by Subject|7|||
157238467|NCT02902211|567618330|FG001|First Three Months|Withdrawal by Subject|3|||
157238468|NCT00571064|567618335|FG000|Overall Study|Adverse Event|13|||
157238469|NCT00571064|567618335|FG000|Overall Study|Protocol Violation|4|||
157238470|NCT00571064|567618335|FG000|Overall Study|Withdrawal by Subject|2|||
157238471|NCT00571064|567618335|FG000|Overall Study|Other|2|||
157238472|NCT03637764|567618337|FG000|Overall Study|Adverse Event|2|||
157238473|NCT03637764|567618338|FG001|Overall Study|Adverse Event|0|||
157238474|NCT03637764|567618339|FG002|Overall Study|Adverse Event|0|||
157238475|NCT03637764|567618340|FG003|Overall Study|Adverse Event|1|||
157238476|NCT03637764|567618337|FG000|Overall Study|Progressive Disease|23|||
157238477|NCT03637764|567618338|FG001|Overall Study|Progressive Disease|23|||
157238478|NCT03637764|567618339|FG002|Overall Study|Progressive Disease|18|||
157238479|NCT03637764|567618340|FG003|Overall Study|Progressive Disease|31|||
157238480|NCT03637764|567618337|FG000|Overall Study|Withdrawal by Subject|1|||
157238481|NCT03637764|567618338|FG001|Overall Study|Withdrawal by Subject|3|||
157238482|NCT03637764|567618339|FG002|Overall Study|Withdrawal by Subject|0|||
157238483|NCT03637764|567618340|FG003|Overall Study|Withdrawal by Subject|1|||
157238484|NCT02648438|567618341|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157238485|NCT02648438|567618342|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
157238486|NCT02648438|567618343|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
157238487|NCT02648438|567618341|FG000|Overall Study|Protocol Violation|2|||
157238488|NCT02648438|567618342|FG001|Overall Study|Protocol Violation|0|||
157238489|NCT02648438|567618343|FG002|Overall Study|Protocol Violation|0|||
157238490|NCT02648438|567618341|FG000|Overall Study|Withdrawal by Subject|1|||
157238491|NCT02648438|567618342|FG001|Overall Study|Withdrawal by Subject|1|||
157238492|NCT02648438|567618343|FG002|Overall Study|Withdrawal by Subject|0|||
157238493|NCT03138967|567618346|FG000|Overall Study|Death|0|||
157238494|NCT03138967|567618347|FG001|Overall Study|Death|1|||
157238495|NCT03138967|567618346|FG000|Overall Study|Physician Decision|1|||
157238496|NCT03138967|567618347|FG001|Overall Study|Physician Decision|3|||
157238497|NCT04604275|567618348|FG000|Washout-1 Week|Withdrawal by Subject|1|||
157238498|NCT04604275|567618349|FG001|Washout-1 Week|Withdrawal by Subject|0|||
157238499|NCT05446870|567618350|FG000|Overall Study|Death|6|||
157238500|NCT05446870|567618351|FG001|Overall Study|Death|5|||
157238501|NCT05446870|567618350|FG000|Overall Study|Lost to Follow-up|0|||
157238502|NCT05446870|567618351|FG001|Overall Study|Lost to Follow-up|1|||
157238503|NCT05446870|567618350|FG000|Overall Study|Physician Decision|52|||
157238504|NCT05446870|567618351|FG001|Overall Study|Physician Decision|53|||
157238505|NCT05446870|567618350|FG000|Overall Study|Withdrawal by Subject|3|||
157238506|NCT05446870|567618351|FG001|Overall Study|Withdrawal by Subject|3|||
157238507|NCT04108858|567618352|FG000|Overall Study|Adverse Event|1|||
157090987|NCT03149549|567086956|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
157090988|NCT03149549|567086957|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
157090989|NCT03149549|567086958|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
157238508|NCT01615198|567618353|FG000|Overall Study|Withdrawal by Subject|5|||
157238509|NCT01615198|567618354|FG001|Overall Study|Withdrawal by Subject|5|||
157238510|NCT01615198|567618353|FG000|Overall Study|Protocol deviation|1|||
157238511|NCT01615198|567618354|FG001|Overall Study|Protocol deviation|1|||
157238512|NCT01615198|567618353|FG000|Overall Study|Physician Decision|5|||
157238513|NCT01615198|567618354|FG001|Overall Study|Physician Decision|1|||
157238514|NCT01615198|567618353|FG000|Overall Study|Lost to Follow-up|1|||
157238515|NCT01615198|567618354|FG001|Overall Study|Lost to Follow-up|1|||
157238516|NCT01615198|567618353|FG000|Overall Study|Lack of Efficacy|1|||
157238517|NCT01615198|567618354|FG001|Overall Study|Lack of Efficacy|6|||
157090990|NCT03149549|567086959|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
157238518|NCT01615198|567618353|FG000|Overall Study|Adverse Event|11|||
157238519|NCT01615198|567618354|FG001|Overall Study|Adverse Event|5|||
157238520|NCT01686438|567618355|FG000|Overall Study|Lost to Follow-up|8|||
157238521|NCT01686438|567618356|FG001|Overall Study|Lost to Follow-up|9|||
157238522|NCT01686438|567618357|FG002|Overall Study|Lost to Follow-up|10|||
157238523|NCT01686438|567618355|FG000|Overall Study|Adverse Event|0|||
157238524|NCT01686438|567618356|FG001|Overall Study|Adverse Event|0|||
157238525|NCT01686438|567618357|FG002|Overall Study|Adverse Event|1|||
157238526|NCT01686438|567618355|FG000|Overall Study|Protocol Violation|0|||
157238527|NCT01686438|567618356|FG001|Overall Study|Protocol Violation|0|||
157238528|NCT01686438|567618357|FG002|Overall Study|Protocol Violation|1|||
157238529|NCT01686438|567618355|FG000|Overall Study|Withdrawal by Subject|0|||
157238530|NCT01686438|567618356|FG001|Overall Study|Withdrawal by Subject|0|||
157238531|NCT01686438|567618357|FG002|Overall Study|Withdrawal by Subject|1|||
157238532|NCT01864174|567618360|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
157238533|NCT01864174|567618361|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
157238534|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
157238535|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
157238536|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
157238537|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
157238538|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
157238539|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
157238540|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Death|1|||
157238541|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Death|0|||
157238542|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
157238543|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
157238544|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
157238545|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
157238546|NCT01864174|567618360|FG000|Double Blind - Compliant Randomized|Other|6|||
157238547|NCT01864174|567618361|FG001|Double Blind - Compliant Randomized|Other|10|||
157238548|NCT01864174|567618360|FG000|Off Treatment Follow-Up|Other|2|||
157238549|NCT01864174|567618361|FG001|Off Treatment Follow-Up|Other|0|||
157238550|NCT01864174|567618360|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
157238551|NCT01864174|567618361|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
157238552|NCT00468286|567618362|FG000|Overall Study|Adverse Event|1|||
157238553|NCT00468286|567618363|FG001|Overall Study|Adverse Event|6|||
157238554|NCT00468286|567618362|FG000|Overall Study|Protocol Violation|2|||
157238555|NCT00468286|567618363|FG001|Overall Study|Protocol Violation|2|||
157238556|NCT00468286|567618362|FG000|Overall Study|Withdrawal by Subject|4|||
157238557|NCT00468286|567618363|FG001|Overall Study|Withdrawal by Subject|3|||
157238558|NCT00468286|567618362|FG000|Overall Study|Physician Decision|0|||
157238559|NCT00468286|567618363|FG001|Overall Study|Physician Decision|1|||
157238560|NCT02453386|567618367|FG000|Overall Study|Adverse Event|22|||
157238561|NCT02453386|567618368|FG001|Overall Study|Adverse Event|30|||
157238562|NCT02453386|567618369|FG002|Overall Study|Adverse Event|15|||
157238563|NCT02453386|567618367|FG000|Overall Study|Protocol Violation|1|||
157238564|NCT02453386|567618368|FG001|Overall Study|Protocol Violation|0|||
157238565|NCT02453386|567618369|FG002|Overall Study|Protocol Violation|1|||
157238566|NCT02453386|567618367|FG000|Overall Study|Withdrawal by Subject|10|||
157238567|NCT02453386|567618368|FG001|Overall Study|Withdrawal by Subject|9|||
157238568|NCT02453386|567618369|FG002|Overall Study|Withdrawal by Subject|9|||
157238569|NCT02453386|567618367|FG000|Overall Study|Sponsor Terminated Study|14|||
157238570|NCT02453386|567618368|FG001|Overall Study|Sponsor Terminated Study|8|||
157238571|NCT02453386|567618369|FG002|Overall Study|Sponsor Terminated Study|11|||
157238572|NCT02453386|567618367|FG000|Overall Study|Subject Terminated by Sponsor|1|||
157238573|NCT02453386|567618368|FG001|Overall Study|Subject Terminated by Sponsor|1|||
157238574|NCT02453386|567618369|FG002|Overall Study|Subject Terminated by Sponsor|1|||
157238575|NCT02453386|567618367|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
157238576|NCT02453386|567618368|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
157238577|NCT02453386|567618369|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
157238578|NCT02453386|567618367|FG000|Overall Study|Lost to Follow-up|0|||
157238579|NCT02453386|567618368|FG001|Overall Study|Lost to Follow-up|0|||
157238580|NCT02453386|567618369|FG002|Overall Study|Lost to Follow-up|1|||
157238581|NCT02453386|567618367|FG000|Overall Study|Other|1|||
157238582|NCT02453386|567618368|FG001|Overall Study|Other|0|||
157238583|NCT02453386|567618369|FG002|Overall Study|Other|1|||
157238584|NCT02601625|567618370|FG000|Overall Study|Lost to Follow-up|0|||
157238585|NCT02601625|567618371|FG001|Overall Study|Lost to Follow-up|0|||
157238586|NCT02601625|567618372|FG002|Overall Study|Lost to Follow-up|1|||
157238587|NCT02601625|567618373|FG003|Overall Study|Lost to Follow-up|1|||
157238588|NCT01289262|567618376|FG000|Overall Study|Lost to Follow-up|29|||
157238589|NCT01289262|567618377|FG001|Overall Study|Lost to Follow-up|16|||
157238590|NCT01289262|567618376|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
157238591|NCT01289262|567618377|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
157238592|NCT01474551|567618384|FG000|Overall Study|Death|1|||
157090991|NCT03149549|567086960|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
157090992|NCT03149549|567086961|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
157090993|NCT03149549|567086962|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
157090994|NCT03149549|567086950|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
157238593|NCT01921062|567618385|FG000|Overall Study|Withdrawal by Subject|0|||
157238594|NCT01921062|567618386|FG001|Overall Study|Withdrawal by Subject|7|||
157238595|NCT01921062|567618385|FG000|Overall Study|Adverse Event|5|||
157238596|NCT01921062|567618386|FG001|Overall Study|Adverse Event|6|||
157238597|NCT01921062|567618385|FG000|Overall Study|Protocol Violation|0|||
157238598|NCT01921062|567618386|FG001|Overall Study|Protocol Violation|1|||
157238599|NCT01921062|567618385|FG000|Overall Study|VMIQ score > 72|4|||
157238600|NCT01921062|567618386|FG001|Overall Study|VMIQ score > 72|1|||
157238601|NCT01921062|567618385|FG000|Overall Study|Logistic error|0|||
157238602|NCT01921062|567618386|FG001|Overall Study|Logistic error|1|||
157238603|NCT02409355|567618392|FG000|Overall Study|Withdrawal by Subject|1|||
157238604|NCT02409355|567618393|FG001|Overall Study|Withdrawal by Subject|0|||
157238605|NCT02409355|567618392|FG000|Overall Study|Death|1|||
157238606|NCT02409355|567618393|FG001|Overall Study|Death|1|||
157238607|NCT02409355|567618392|FG000|Overall Study|Study terminated by Sponsor|2|||
157238608|NCT02409355|567618393|FG001|Overall Study|Study terminated by Sponsor|3|||
157238609|NCT03290781|567618403|FG000|Overall Study|Adverse Event|5|||
157238610|NCT03290781|567618404|FG001|Overall Study|Adverse Event|7|||
157238611|NCT03290781|567618405|FG002|Overall Study|Adverse Event|4|||
157238612|NCT03290781|567618406|FG003|Overall Study|Adverse Event|1|||
157238613|NCT03290781|567618407|FG004|Overall Study|Adverse Event|0|||
157238614|NCT03290781|567618408|FG005|Overall Study|Adverse Event|0|||
157238615|NCT03290781|567618409|FG006|Overall Study|Adverse Event|0|||
157238616|NCT03290781|567618403|FG000|Overall Study|Death|0|||
157238617|NCT03290781|567618404|FG001|Overall Study|Death|0|||
157238618|NCT03290781|567618405|FG002|Overall Study|Death|1|||
157238619|NCT03290781|567618406|FG003|Overall Study|Death|0|||
157238620|NCT03290781|567618407|FG004|Overall Study|Death|1|||
157238621|NCT03290781|567618408|FG005|Overall Study|Death|0|||
157238622|NCT03290781|567618409|FG006|Overall Study|Death|0|||
157238623|NCT03290781|567618403|FG000|Overall Study|Withdrawal by Subject|6|||
157238624|NCT03290781|567618404|FG001|Overall Study|Withdrawal by Subject|5|||
157238625|NCT03290781|567618405|FG002|Overall Study|Withdrawal by Subject|9|||
157238626|NCT03290781|567618406|FG003|Overall Study|Withdrawal by Subject|10|||
157238627|NCT03290781|567618407|FG004|Overall Study|Withdrawal by Subject|1|||
157238628|NCT03290781|567618408|FG005|Overall Study|Withdrawal by Subject|2|||
157238629|NCT03290781|567618409|FG006|Overall Study|Withdrawal by Subject|0|||
157238630|NCT03290781|567618403|FG000|Overall Study|Physician Decision|0|||
157238631|NCT03290781|567618404|FG001|Overall Study|Physician Decision|1|||
157238632|NCT03290781|567618405|FG002|Overall Study|Physician Decision|0|||
157238633|NCT03290781|567618406|FG003|Overall Study|Physician Decision|0|||
157238634|NCT03290781|567618407|FG004|Overall Study|Physician Decision|0|||
157238635|NCT03290781|567618408|FG005|Overall Study|Physician Decision|0|||
157238636|NCT03290781|567618409|FG006|Overall Study|Physician Decision|0|||
157238637|NCT03290781|567618403|FG000|Overall Study|Site Terminated by Sponsor|1|||
157238638|NCT03290781|567618404|FG001|Overall Study|Site Terminated by Sponsor|0|||
157238639|NCT03290781|567618405|FG002|Overall Study|Site Terminated by Sponsor|2|||
157238640|NCT03290781|567618406|FG003|Overall Study|Site Terminated by Sponsor|1|||
157238641|NCT03290781|567618407|FG004|Overall Study|Site Terminated by Sponsor|0|||
157238642|NCT03290781|567618408|FG005|Overall Study|Site Terminated by Sponsor|0|||
157238643|NCT03290781|567618409|FG006|Overall Study|Site Terminated by Sponsor|0|||
157238644|NCT03290781|567618403|FG000|Overall Study|Lost to Follow-up|0|||
157238645|NCT03290781|567618404|FG001|Overall Study|Lost to Follow-up|0|||
157238646|NCT03290781|567618405|FG002|Overall Study|Lost to Follow-up|0|||
157238647|NCT03290781|567618406|FG003|Overall Study|Lost to Follow-up|1|||
157238648|NCT03290781|567618407|FG004|Overall Study|Lost to Follow-up|0|||
157238649|NCT03290781|567618408|FG005|Overall Study|Lost to Follow-up|0|||
157238650|NCT03290781|567618409|FG006|Overall Study|Lost to Follow-up|0|||
157238651|NCT03290781|567618403|FG000|Overall Study|Protocol Deviation|2|||
157238652|NCT03290781|567618404|FG001|Overall Study|Protocol Deviation|0|||
157238653|NCT03290781|567618405|FG002|Overall Study|Protocol Deviation|0|||
157238654|NCT03290781|567618406|FG003|Overall Study|Protocol Deviation|1|||
157238655|NCT03290781|567618407|FG004|Overall Study|Protocol Deviation|0|||
157238656|NCT03290781|567618408|FG005|Overall Study|Protocol Deviation|0|||
157238657|NCT03290781|567618409|FG006|Overall Study|Protocol Deviation|0|||
157238658|NCT03290781|567618403|FG000|Overall Study|Disease Relapse|32|||
157238659|NCT03290781|567618404|FG001|Overall Study|Disease Relapse|5|||
157238660|NCT03290781|567618405|FG002|Overall Study|Disease Relapse|38|||
157238661|NCT03290781|567618406|FG003|Overall Study|Disease Relapse|7|||
157238662|NCT03290781|567618407|FG004|Overall Study|Disease Relapse|3|||
157238663|NCT03290781|567618408|FG005|Overall Study|Disease Relapse|1|||
157238664|NCT03290781|567618409|FG006|Overall Study|Disease Relapse|4|||
157238665|NCT03290781|567618403|FG000|Overall Study|Other|3|||
157238666|NCT03290781|567618404|FG001|Overall Study|Other|0|||
157238667|NCT03290781|567618405|FG002|Overall Study|Other|2|||
157238668|NCT03290781|567618406|FG003|Overall Study|Other|2|||
157238669|NCT03290781|567618407|FG004|Overall Study|Other|0|||
157238670|NCT03290781|567618408|FG005|Overall Study|Other|0|||
157238671|NCT03290781|567618409|FG006|Overall Study|Other|0|||
157238672|NCT02957942|567618410|FG000|Overall Study|Withdrawal by Subject|0|||
157238673|NCT02957942|567618411|FG001|Overall Study|Withdrawal by Subject|1|||
157238674|NCT02957942|567618410|FG000|Overall Study|Practicing experiment protocol|0|||
157238675|NCT02957942|567618411|FG001|Overall Study|Practicing experiment protocol|6|||
157238676|NCT01802320|567618426|FG000|Overall Study|Death|1|||
157238677|NCT01802320|567618426|FG000|Overall Study|Withdrawal by Subject|1|||
157238678|NCT05265624|567619880|FG000|Overall Study|Lost to Follow-up|3|||
157238679|NCT05265624|567619881|FG001|Overall Study|Lost to Follow-up|0|||
157238680|NCT05265624|567619880|FG000|Overall Study|Withdrawal by Subject|1|||
157238681|NCT05265624|567619881|FG001|Overall Study|Withdrawal by Subject|0|||
157238682|NCT00834717|567619888|FG000|First Intervention|Adverse Event|1|||
157238683|NCT00834717|567619889|FG001|First Intervention|Adverse Event|0|||
157238684|NCT00834717|567619888|FG000|First Intervention|Withdrawal by Subject|0|||
157238685|NCT00834717|567619889|FG001|First Intervention|Withdrawal by Subject|1|||
157238686|NCT03697109|567619893|FG000|Open-label (OL) Phase|Adverse Event|24|||
157238687|NCT03697109|567619894|FG001|Open-label (OL) Phase|Adverse Event|0|||
157238688|NCT03697109|567619895|FG002|Open-label (OL) Phase|Adverse Event|0|||
157238689|NCT03697109|567619893|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
157238690|NCT03697109|567619894|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
157238691|NCT03697109|567619895|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
157238692|NCT03697109|567619893|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
157238693|NCT03697109|567619894|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
157238694|NCT03697109|567619895|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
157238695|NCT03697109|567619893|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
157238696|NCT03697109|567619894|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
157238697|NCT03697109|567619895|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
157238698|NCT03697109|567619893|FG000|Open-label (OL) Phase|Physician Decision|2|||
157238699|NCT03697109|567619894|FG001|Open-label (OL) Phase|Physician Decision|0|||
157238700|NCT03697109|567619895|FG002|Open-label (OL) Phase|Physician Decision|0|||
157238701|NCT03697109|567619893|FG000|Open-label (OL) Phase|Death|2|||
157238702|NCT03697109|567619894|FG001|Open-label (OL) Phase|Death|0|||
157238703|NCT03697109|567619895|FG002|Open-label (OL) Phase|Death|0|||
157238704|NCT03697109|567619893|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
157238705|NCT03697109|567619894|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
157238706|NCT03697109|567619895|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
157238707|NCT03697109|567619893|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
157238708|NCT03697109|567619894|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
157238709|NCT03697109|567619895|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
157238710|NCT03697109|567619893|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
157238711|NCT03697109|567619894|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
157238712|NCT03697109|567619895|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
157238713|NCT04516967|567619896|FG000|Core Phase|Adverse Event|2|||
157238714|NCT04516967|567619897|FG001|Core Phase|Adverse Event|1|||
157238715|NCT04516967|567619898|FG002|Core Phase|Adverse Event|0|||
157238716|NCT04516967|567619896|FG000|Core Phase|Physician Decision|1|||
157238717|NCT04516967|567619897|FG001|Core Phase|Physician Decision|1|||
157238718|NCT04516967|567619898|FG002|Core Phase|Physician Decision|0|||
157238719|NCT04516967|567619896|FG000|Core Phase|Lack of Efficacy|7|||
157238720|NCT04516967|567619897|FG001|Core Phase|Lack of Efficacy|18|||
157238721|NCT04516967|567619898|FG002|Core Phase|Lack of Efficacy|0|||
157238722|NCT02301975|567619901|FG000|Overall Study|Adverse Event|8|||
157238723|NCT02301975|567619902|FG001|Overall Study|Adverse Event|3|||
157238724|NCT02301975|567619903|FG002|Overall Study|Adverse Event|2|||
157238725|NCT02301975|567619901|FG000|Overall Study|Lack of Efficacy|1|||
157238726|NCT02301975|567619902|FG001|Overall Study|Lack of Efficacy|1|||
157238727|NCT02301975|567619903|FG002|Overall Study|Lack of Efficacy|1|||
157238728|NCT02301975|567619901|FG000|Overall Study|Protocol Violation|3|||
157238729|NCT02301975|567619902|FG001|Overall Study|Protocol Violation|5|||
157238730|NCT02301975|567619903|FG002|Overall Study|Protocol Violation|3|||
157238731|NCT02301975|567619901|FG000|Overall Study|Lost to Follow-up|0|||
157238732|NCT02301975|567619902|FG001|Overall Study|Lost to Follow-up|2|||
157090995|NCT03149549|567086951|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
157090996|NCT03149549|567086952|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
157238733|NCT02301975|567619903|FG002|Overall Study|Lost to Follow-up|2|||
157238734|NCT02301975|567619901|FG000|Overall Study|Physician Decision|4|||
157238735|NCT02301975|567619902|FG001|Overall Study|Physician Decision|2|||
157238736|NCT02301975|567619903|FG002|Overall Study|Physician Decision|3|||
157238737|NCT02301975|567619901|FG000|Overall Study|Withdrawal by Subject|15|||
157238738|NCT02301975|567619902|FG001|Overall Study|Withdrawal by Subject|12|||
157238739|NCT02301975|567619903|FG002|Overall Study|Withdrawal by Subject|11|||
157238740|NCT02149420|567619904|FG000|Core Study|Administrative problems|0|||
157238741|NCT02149420|567619905|FG001|Core Study|Administrative problems|1|||
157238742|NCT02149420|567619906|FG002|Core Study|Administrative problems|2|||
157238743|NCT02149420|567619904|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
157238744|NCT02149420|567619905|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
157238745|NCT02149420|567619906|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
157238746|NCT04278560|567619908|FG000|Overall Study|Adverse Event|1|||
157238747|NCT04278560|567619909|FG001|Overall Study|Adverse Event|2|||
157238748|NCT04278560|567619908|FG000|Overall Study|Withdrawal by Subject|0|||
157238749|NCT04278560|567619909|FG001|Overall Study|Withdrawal by Subject|1|||
157238750|NCT00834067|567619910|FG000|Washout of 21 Days|Protocol Violation|0|||
157238751|NCT00834067|567619911|FG001|Washout of 21 Days|Protocol Violation|1|||
157238752|NCT00440518|567619913|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
157238753|NCT00440518|567619914|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
157238754|NCT00440518|567619915|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
157238755|NCT00440518|567619913|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
157238756|NCT00440518|567619914|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
157238757|NCT00440518|567619915|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
157238758|NCT00440518|567619913|FG000|Randomized /Titration Period|Protocol Deviation|1|||
157238759|NCT00440518|567619914|FG001|Randomized /Titration Period|Protocol Deviation|0|||
157238760|NCT00440518|567619915|FG002|Randomized /Titration Period|Protocol Deviation|0|||
157238761|NCT00440518|567619913|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
157238762|NCT00440518|567619914|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
157238763|NCT00440518|567619915|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
157238764|NCT00440518|567619913|FG000|Randomized /Titration Period|Other|1|||
157238765|NCT00440518|567619914|FG001|Randomized /Titration Period|Other|0|||
157238766|NCT00440518|567619915|FG002|Randomized /Titration Period|Other|0|||
157238767|NCT00440518|567619913|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
157238768|NCT00440518|567619914|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
157238769|NCT00440518|567619915|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
157238770|NCT00440518|567619913|FG000|Randomized /Titration Period|Adverse Event|2|||
157238771|NCT00440518|567619914|FG001|Randomized /Titration Period|Adverse Event|3|||
157238772|NCT00440518|567619915|FG002|Randomized /Titration Period|Adverse Event|0|||
157238773|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
157238774|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
157238775|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
157238776|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
157238777|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
157238778|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
157238779|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
157238780|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
157238781|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
157238782|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
157238783|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
157238784|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
157238785|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
157238786|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
157238787|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
157238788|NCT00440518|567619913|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
157238789|NCT00440518|567619914|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
157238790|NCT00440518|567619915|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
157238791|NCT00561015|567619916|FG000|Overall Study|Adverse Event|0|||
157238792|NCT00561015|567619917|FG001|Overall Study|Adverse Event|0|||
157238793|NCT00561015|567619918|FG002|Overall Study|Adverse Event|0|||
157238794|NCT00561015|567619919|FG003|Overall Study|Adverse Event|0|||
157238795|NCT00561015|567619920|FG004|Overall Study|Adverse Event|1|||
157238796|NCT00561015|567619921|FG005|Overall Study|Adverse Event|0|||
157238797|NCT00561015|567619916|FG000|Overall Study|Lost to Follow-up|2|||
157238798|NCT00561015|567619917|FG001|Overall Study|Lost to Follow-up|0|||
157238799|NCT00561015|567619918|FG002|Overall Study|Lost to Follow-up|0|||
157238800|NCT00561015|567619919|FG003|Overall Study|Lost to Follow-up|1|||
157238801|NCT00561015|567619920|FG004|Overall Study|Lost to Follow-up|0|||
157238802|NCT00561015|567619921|FG005|Overall Study|Lost to Follow-up|3|||
157238803|NCT00561015|567619916|FG000|Overall Study|Participant non-compliance|2|||
157238804|NCT00561015|567619917|FG001|Overall Study|Participant non-compliance|0|||
157238805|NCT00561015|567619918|FG002|Overall Study|Participant non-compliance|0|||
157238806|NCT00561015|567619919|FG003|Overall Study|Participant non-compliance|0|||
157238807|NCT00561015|567619920|FG004|Overall Study|Participant non-compliance|0|||
157238808|NCT00561015|567619921|FG005|Overall Study|Participant non-compliance|0|||
157238809|NCT01319383|567619922|FG000|Overall Study|No ex vivo or in vivo response|4|||
157238810|NCT01319383|567619923|FG001|Overall Study|No ex vivo or in vivo response|0|||
157238811|NCT01319383|567619922|FG000|Overall Study|Physician Decision|3|||
157238812|NCT01319383|567619923|FG001|Overall Study|Physician Decision|0|||
157238813|NCT01319383|567619922|FG000|Overall Study|Lack of Efficacy|5|||
157238814|NCT01319383|567619923|FG001|Overall Study|Lack of Efficacy|9|||
157238815|NCT01319383|567619922|FG000|Overall Study|No in vivo response to interval doses|0|||
157238816|NCT01319383|567619923|FG001|Overall Study|No in vivo response to interval doses|1|||
157238817|NCT03086460|567619926|FG000|Study Participants|Lost to Follow-up|2|||
157238818|NCT03086460|567619926|FG000|Study Participants|Protocol Violation|1|||
157238819|NCT03086460|567619926|FG000|Study Participants|Withdrawal by Subject|6|||
157238820|NCT03086460|567619926|FG000|Treatment A|Lost to Follow-up|1|||
157238821|NCT03086460|567619926|FG000|Treatment A|Protocol Violation|1|||
157238822|NCT03086460|567619926|FG000|Treatment A|Withdrawal by Subject|2|||
157238823|NCT03086460|567619926|FG000|Treatment C|Withdrawal by Subject|2|||
157238824|NCT03086460|567619926|FG000|Treatment E|Lost to Follow-up|1|||
157238825|NCT03086460|567619926|FG000|Treatment E|Withdrawal by Subject|3|||
157238826|NCT03247972|567619927|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
157238827|NCT03247972|567619927|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
157238828|NCT00968812|567619928|FG000|Overall Study|Adverse Event|30|||
157238829|NCT00968812|567619929|FG001|Overall Study|Adverse Event|46|||
157238830|NCT00968812|567619930|FG002|Overall Study|Adverse Event|33|||
157238831|NCT00968812|567619928|FG000|Overall Study|Death|2|||
157238832|NCT00968812|567619929|FG001|Overall Study|Death|2|||
157238833|NCT00968812|567619930|FG002|Overall Study|Death|1|||
157238834|NCT00968812|567619928|FG000|Overall Study|Lack of Efficacy|9|||
157238835|NCT00968812|567619929|FG001|Overall Study|Lack of Efficacy|7|||
157238836|NCT00968812|567619930|FG002|Overall Study|Lack of Efficacy|16|||
157238837|NCT00968812|567619928|FG000|Overall Study|Lost to Follow-up|17|||
157238838|NCT00968812|567619929|FG001|Overall Study|Lost to Follow-up|12|||
157238839|NCT00968812|567619930|FG002|Overall Study|Lost to Follow-up|11|||
157238840|NCT00968812|567619928|FG000|Overall Study|Physician Decision|8|||
157238841|NCT00968812|567619929|FG001|Overall Study|Physician Decision|5|||
157238842|NCT00968812|567619930|FG002|Overall Study|Physician Decision|9|||
157238843|NCT00968812|567619928|FG000|Overall Study|Protocol Violation|7|||
157238844|NCT00968812|567619929|FG001|Overall Study|Protocol Violation|4|||
157238845|NCT00968812|567619930|FG002|Overall Study|Protocol Violation|3|||
157238846|NCT00968812|567619928|FG000|Overall Study|Withdrawal by Subject|17|||
157238847|NCT00968812|567619929|FG001|Overall Study|Withdrawal by Subject|23|||
157238848|NCT00968812|567619930|FG002|Overall Study|Withdrawal by Subject|25|||
157238849|NCT00968812|567619928|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
157238850|NCT00968812|567619929|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
157238851|NCT00968812|567619930|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
157238852|NCT00968812|567619928|FG000|Overall Study|Noncompliance with study drug|4|||
157238853|NCT00968812|567619929|FG001|Overall Study|Noncompliance with study drug|1|||
157238854|NCT00968812|567619930|FG002|Overall Study|Noncompliance with study drug|6|||
157238855|NCT00968812|567619928|FG000|Overall Study|Unable to take rescue therapy|12|||
157238856|NCT00968812|567619929|FG001|Overall Study|Unable to take rescue therapy|12|||
157238857|NCT00968812|567619930|FG002|Overall Study|Unable to take rescue therapy|17|||
157238858|NCT00968812|567619928|FG000|Overall Study|Other|25|||
157238859|NCT00968812|567619929|FG001|Overall Study|Other|37|||
157238860|NCT00968812|567619930|FG002|Overall Study|Other|40|||
157238861|NCT00609674|567619931|FG000|Overall Study|Adverse Event|1|||
157238862|NCT00609674|567619932|FG001|Overall Study|Adverse Event|1|||
157238863|NCT00609674|567619931|FG000|Overall Study|Protocol Violation|3|||
157238864|NCT00609674|567619932|FG001|Overall Study|Protocol Violation|5|||
157238865|NCT00609674|567619931|FG000|Overall Study|Lost to Follow-up|1|||
157238866|NCT00609674|567619932|FG001|Overall Study|Lost to Follow-up|0|||
157238867|NCT00609674|567619931|FG000|Overall Study|Withdrew consent|2|||
157238868|NCT00609674|567619932|FG001|Overall Study|Withdrew consent|1|||
157238869|NCT03872128|567619946|FG000|Overall Study|Dropped out before treatment|1|||
157238870|NCT03872128|567619947|FG001|Overall Study|Dropped out before treatment|0|||
157238871|NCT03872128|567619948|FG002|Overall Study|Dropped out before treatment|4|||
157238872|NCT03872128|567619946|FG000|Overall Study|Lost to Follow-up|2|||
157238873|NCT03872128|567619947|FG001|Overall Study|Lost to Follow-up|5|||
157238874|NCT03872128|567619948|FG002|Overall Study|Lost to Follow-up|8|||
157238875|NCT02558491|567619950|FG000|First Invention|Withdrawal by Subject|3|||
157238876|NCT02558491|567619951|FG001|First Invention|Withdrawal by Subject|1|||
157238877|NCT02558491|567619950|FG000|First Invention|Data collection issues|1|||
157238878|NCT02558491|567619951|FG001|First Invention|Data collection issues|0|||
157090997|NCT03149549|567086953|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
157090998|NCT03149549|567086954|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
157238879|NCT02558491|567619950|FG000|First Invention|Stopping criteria|0|||
157238880|NCT02558491|567619951|FG001|First Invention|Stopping criteria|1|||
157238881|NCT02558491|567619950|FG000|First Invention|Changed parameters during trial|1|||
157238882|NCT02558491|567619951|FG001|First Invention|Changed parameters during trial|0|||
157238883|NCT02558491|567619950|FG000|Second Intervention|Withdrawal by Subject|1|||
157238884|NCT02558491|567619951|FG001|Second Intervention|Withdrawal by Subject|0|||
157238885|NCT02558491|567619950|FG000|Second Intervention|Stopping Criteria|1|||
157238886|NCT02558491|567619951|FG001|Second Intervention|Stopping Criteria|0|||
157090999|NCT03149549|567086955|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
157238887|NCT00834431|567619954|FG000|First Intervention|Adverse Event|0|||
157238888|NCT00834431|567619955|FG001|First Intervention|Adverse Event|1|||
157238889|NCT00834431|567619954|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
157238890|NCT00834431|567619955|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
157238891|NCT01788423|567619958|FG000|Overall Study|See Comments in Completed (above)|0|||
157238892|NCT01788423|567619959|FG001|Overall Study|See Comments in Completed (above)|4|||
157238893|NCT01788423|567619960|FG002|Overall Study|See Comments in Completed (above)|5|||
157238894|NCT02689505|567619962|FG000|Overall Study|Progressive disease|2|||
157238895|NCT02689505|567619963|FG001|Overall Study|Progressive disease|2|||
157238896|NCT02689505|567619964|FG002|Overall Study|Progressive disease|3|||
157238897|NCT02689505|567619965|FG003|Overall Study|Progressive disease|9|||
157238898|NCT02689505|567619966|FG004|Overall Study|Progressive disease|1|||
157238899|NCT02689505|567619962|FG000|Overall Study|Dose Limiting Toxicity|0|||
157238900|NCT02689505|567619963|FG001|Overall Study|Dose Limiting Toxicity|1|||
157238901|NCT02689505|567619964|FG002|Overall Study|Dose Limiting Toxicity|0|||
157238902|NCT02689505|567619965|FG003|Overall Study|Dose Limiting Toxicity|0|||
157238903|NCT02689505|567619966|FG004|Overall Study|Dose Limiting Toxicity|2|||
157238904|NCT02689505|567619962|FG000|Overall Study|Other AE or clinical progression|0|||
157238905|NCT02689505|567619963|FG001|Overall Study|Other AE or clinical progression|2|||
157238906|NCT02689505|567619964|FG002|Overall Study|Other AE or clinical progression|0|||
157238907|NCT02689505|567619965|FG003|Overall Study|Other AE or clinical progression|2|||
157238908|NCT02689505|567619966|FG004|Overall Study|Other AE or clinical progression|0|||
157238909|NCT03792477|567619972|FG000|Overall Study|Adverse Event|0|||
157238910|NCT03792477|567619973|FG001|Overall Study|Adverse Event|0|||
157238911|NCT03792477|567619974|FG002|Overall Study|Adverse Event|0|||
157238912|NCT03792477|567619975|FG003|Overall Study|Adverse Event|1|||
157238913|NCT03792477|567619976|FG004|Overall Study|Adverse Event|0|||
157238914|NCT03792477|567619972|FG000|Overall Study|Lost to Follow-up|0|||
157238915|NCT03792477|567619973|FG001|Overall Study|Lost to Follow-up|0|||
157238916|NCT03792477|567619974|FG002|Overall Study|Lost to Follow-up|2|||
157238917|NCT03792477|567619975|FG003|Overall Study|Lost to Follow-up|0|||
157238918|NCT03792477|567619976|FG004|Overall Study|Lost to Follow-up|0|||
157238919|NCT03792477|567619972|FG000|Overall Study|Other|0|||
157238920|NCT03792477|567619973|FG001|Overall Study|Other|0|||
157238921|NCT03792477|567619974|FG002|Overall Study|Other|0|||
157238922|NCT03792477|567619975|FG003|Overall Study|Other|0|||
157238923|NCT03792477|567619976|FG004|Overall Study|Other|1|||
157238924|NCT00840411|567619978|FG000|First Intervention|Adverse Event|1|||
157238925|NCT00840411|567619979|FG001|First Intervention|Adverse Event|0|||
157238926|NCT00840411|567619978|FG000|Washout|Withdrawal by Subject|1|||
157238927|NCT00840411|567619979|FG001|Washout|Withdrawal by Subject|0|||
157238928|NCT01576042|567619982|FG000|Overall Study|Physician Decision|2|||
157238929|NCT01576042|567619983|FG001|Overall Study|Physician Decision|0|||
157238930|NCT00465270|567619984|FG000|Overall Study|Death|7|||
157238931|NCT00465270|567619985|FG001|Overall Study|Death|11|||
157238932|NCT00465270|567619984|FG000|Overall Study|Withdrawal by Subject|34|||
157238933|NCT00465270|567619985|FG001|Overall Study|Withdrawal by Subject|78|||
157238934|NCT00465270|567619984|FG000|Overall Study|Lost to Follow-up|60|||
157238935|NCT00465270|567619985|FG001|Overall Study|Lost to Follow-up|67|||
157238936|NCT00465270|567619984|FG000|Overall Study|Investigator request|3|||
157238937|NCT00465270|567619985|FG001|Overall Study|Investigator request|4|||
157238938|NCT03233724|567619986|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
157238939|NCT03233724|567619987|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
157238940|NCT03233724|567619988|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
157238941|NCT03233724|567619989|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
157238942|NCT03233724|567619990|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
157238943|NCT03233724|567619986|FG000|Phase I Dose Escalation|Best interest of participant|1|||
157238944|NCT03233724|567619987|FG001|Phase I Dose Escalation|Best interest of participant|1|||
157238945|NCT03233724|567619988|FG002|Phase I Dose Escalation|Best interest of participant|1|||
157238946|NCT03233724|567619989|FG003|Phase I Dose Escalation|Best interest of participant|0|||
157238947|NCT03233724|567619990|FG004|Phase I Dose Escalation|Best interest of participant|0|||
157238948|NCT03233724|567619986|FG000|Phase I Dose Escalation|Physician Decision|0|||
157238949|NCT03233724|567619987|FG001|Phase I Dose Escalation|Physician Decision|0|||
157238950|NCT03233724|567619988|FG002|Phase I Dose Escalation|Physician Decision|1|||
157238951|NCT03233724|567619989|FG003|Phase I Dose Escalation|Physician Decision|0|||
157091000|NCT03149549|567086956|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
157091001|NCT03149549|567086957|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
157091002|NCT03149549|567086958|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
157238952|NCT03233724|567619990|FG004|Phase I Dose Escalation|Physician Decision|0|||
157238953|NCT03233724|567619986|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
157238954|NCT03233724|567619987|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
157238955|NCT03233724|567619988|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
157238956|NCT03233724|567619989|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
157238957|NCT03233724|567619990|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
157238958|NCT00651820|567619993|FG000|Overall Study|Lost to Follow-up|2|||
157238959|NCT02388191|567619994|FG000|Overall Study|Patient did not receive IUD|1|||
157238960|NCT02388191|567619995|FG001|Overall Study|Patient did not receive IUD|0|||
157238961|NCT01911676|567619996|FG000|Period 1 of Study|Withdrawal by Subject|4|||
157238962|NCT01911676|567619997|FG001|Period 1 of Study|Withdrawal by Subject|2|||
157238963|NCT01911676|567619998|FG002|Period 1 of Study|Withdrawal by Subject|1|||
157238964|NCT01911676|567619999|FG003|Period 1 of Study|Withdrawal by Subject|2|||
157238965|NCT01911676|567619996|FG000|Period 1 of Study|Physician Decision|2|||
157238966|NCT01911676|567619997|FG001|Period 1 of Study|Physician Decision|0|||
157238967|NCT01911676|567619998|FG002|Period 1 of Study|Physician Decision|0|||
157238968|NCT01911676|567619999|FG003|Period 1 of Study|Physician Decision|1|||
157238969|NCT01911676|567619996|FG000|Period 2 of Study|Physician Decision|2|||
157238970|NCT01911676|567619997|FG001|Period 2 of Study|Physician Decision|0|||
157238971|NCT01911676|567619998|FG002|Period 2 of Study|Physician Decision|0|||
157238972|NCT01911676|567619999|FG003|Period 2 of Study|Physician Decision|1|||
157238973|NCT01911676|567619996|FG000|Period 2 of Study|Lost to Follow-up|0|||
157238974|NCT01911676|567619997|FG001|Period 2 of Study|Lost to Follow-up|0|||
157238975|NCT01911676|567619998|FG002|Period 2 of Study|Lost to Follow-up|0|||
157238976|NCT01911676|567619999|FG003|Period 2 of Study|Lost to Follow-up|1|||
157238977|NCT00773253|567620000|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
157238978|NCT00773253|567620001|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
157238979|NCT03173547|567620005|FG000|Overall Study|Adverse Event|2|||
157238980|NCT03173547|567620006|FG001|Overall Study|Adverse Event|0|||
157238981|NCT03173547|567620005|FG000|Overall Study|Withdrawal by Subject|2|||
157238982|NCT03173547|567620006|FG001|Overall Study|Withdrawal by Subject|2|||
157238983|NCT00657553|567620007|FG000|Overall Study|low accrual, no analysis run|5|||
157238984|NCT00657553|567620008|FG001|Overall Study|low accrual, no analysis run|5|||
157238985|NCT01566721|567620009|FG000|Treatment Period|Withdrawal by Subject|35|||
157238986|NCT01566721|567620010|FG001|Treatment Period|Withdrawal by Subject|9|||
157238987|NCT01566721|567620009|FG000|Treatment Period|Disease Progression/Recurrence|37|||
157238988|NCT01566721|567620010|FG001|Treatment Period|Disease Progression/Recurrence|13|||
157238989|NCT01566721|567620009|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
157238990|NCT01566721|567620010|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
157238991|NCT01566721|567620009|FG000|Treatment Period|Other|13|||
157238992|NCT01566721|567620010|FG001|Treatment Period|Other|2|||
157238993|NCT01566721|567620009|FG000|Treatment Period|Lack of Compliance|5|||
157238994|NCT01566721|567620010|FG001|Treatment Period|Lack of Compliance|1|||
157238995|NCT01566721|567620009|FG000|Treatment Period|Adverse Event|100|||
157238996|NCT01566721|567620010|FG001|Treatment Period|Adverse Event|30|||
157238997|NCT01566721|567620009|FG000|Treatment Period|Pregnancy|1|||
157238998|NCT01566721|567620010|FG001|Treatment Period|Pregnancy|0|||
157238999|NCT01566721|567620009|FG000|Safety Follow-up|Physician Decision|6|||
157239000|NCT01566721|567620010|FG001|Safety Follow-up|Physician Decision|4|||
157239001|NCT01566721|567620009|FG000|Safety Follow-up|Lost to Follow-up|101|||
157239002|NCT01566721|567620010|FG001|Safety Follow-up|Lost to Follow-up|48|||
157239003|NCT01566721|567620009|FG000|Safety Follow-up|Withdrawal by Subject|155|||
157239004|NCT01566721|567620010|FG001|Safety Follow-up|Withdrawal by Subject|49|||
157239005|NCT01566721|567620009|FG000|Safety Follow-up|Death|28|||
157239006|NCT01566721|567620010|FG001|Safety Follow-up|Death|4|||
157239007|NCT01566721|567620009|FG000|Safety Follow-up|Non-compliance|7|||
157239008|NCT01566721|567620010|FG001|Safety Follow-up|Non-compliance|3|||
157239009|NCT01566721|567620009|FG000|Safety Follow-up|Protocol Violation|7|||
157239010|NCT01566721|567620010|FG001|Safety Follow-up|Protocol Violation|0|||
157239011|NCT01566721|567620009|FG000|Safety Follow-up|Site closure|2|||
157239012|NCT01566721|567620010|FG001|Safety Follow-up|Site closure|3|||
157239013|NCT01566721|567620009|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
157239014|NCT01566721|567620010|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
157239015|NCT01566721|567620009|FG000|Safety Follow-up|Missing|7|||
157239016|NCT01566721|567620010|FG001|Safety Follow-up|Missing|2|||
157239017|NCT01566721|567620009|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
157091003|NCT03149549|567086959|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
157091004|NCT03149549|567086960|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
157239018|NCT01566721|567620010|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
157239019|NCT01566721|567620009|FG000|Safety Follow-up|Sponsor decision|1|||
157239020|NCT01566721|567620010|FG001|Safety Follow-up|Sponsor decision|0|||
157239021|NCT01566721|567620009|FG000|Safety Follow-up|Adverse Event|8|||
157239022|NCT01566721|567620010|FG001|Safety Follow-up|Adverse Event|4|||
157239023|NCT00446563|567620011|FG000|Overall Study|Adverse Event|4|||
157239024|NCT00446563|567620012|FG001|Overall Study|Adverse Event|3|||
157239025|NCT00446563|567620011|FG000|Overall Study|Abnormal laboratory value(s)|0|||
157239026|NCT00446563|567620012|FG001|Overall Study|Abnormal laboratory value(s)|1|||
157091005|NCT03149549|567086961|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
157239027|NCT00446563|567620011|FG000|Overall Study|Abnormal test procedure result(s)|1|||
157239028|NCT00446563|567620012|FG001|Overall Study|Abnormal test procedure result(s)|0|||
157239029|NCT00446563|567620011|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
157239030|NCT00446563|567620012|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
157239031|NCT00446563|567620011|FG000|Overall Study|Withdrawal by Subject|2|||
157239032|NCT00446563|567620012|FG001|Overall Study|Withdrawal by Subject|1|||
157239033|NCT00446563|567620011|FG000|Overall Study|Administrative problems|0|||
157239034|NCT00446563|567620012|FG001|Overall Study|Administrative problems|1|||
157239035|NCT03769025|567620013|FG000|Overall Study|Withdrawal by Subject|1|||
157239036|NCT03769025|567620014|FG001|Overall Study|Withdrawal by Subject|1|||
157239037|NCT03769025|567620013|FG000|Overall Study|Lost to Follow-up|4|||
157239038|NCT03769025|567620014|FG001|Overall Study|Lost to Follow-up|3|||
157239039|NCT01169558|567620015|FG000|Overall Study|Disease progression|98|||
157239040|NCT01169558|567620015|FG000|Overall Study|Adverse Event|25|||
157239041|NCT01169558|567620015|FG000|Overall Study|Withdrawal of Consent|8|||
157239042|NCT01169558|567620015|FG000|Overall Study|Medical Decision|7|||
157239043|NCT01169558|567620015|FG000|Overall Study|Stable Disease|4|||
157239044|NCT01169558|567620015|FG000|Overall Study|Lost to Follow-up|4|||
157239045|NCT01169558|567620015|FG000|Overall Study|Need for Surgery|4|||
157239046|NCT01169558|567620015|FG000|Overall Study|Non-compliance|2|||
157239047|NCT01169558|567620015|FG000|Overall Study|Protocol Violation|2|||
157239048|NCT01169558|567620015|FG000|Overall Study|Partial response|2|||
157239049|NCT02911701|567620020|FG000|Overall Study|Withdrawal by Subject|2|||
157239050|NCT02911701|567620021|FG001|Overall Study|Withdrawal by Subject|4|||
157239051|NCT02911701|567620020|FG000|Overall Study|Adverse Event|1|||
157239052|NCT02911701|567620021|FG001|Overall Study|Adverse Event|0|||
157239053|NCT03134222|567620022|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
157239054|NCT03134222|567620023|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
157239055|NCT03134222|567620024|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
157239056|NCT03134222|567620025|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
157239057|NCT03134222|567620026|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
157239058|NCT03134222|567620022|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
157239059|NCT03134222|567620023|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
157239060|NCT03134222|567620024|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
157239061|NCT03134222|567620025|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
157239062|NCT03134222|567620026|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
157239063|NCT03134222|567620022|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
157239064|NCT03134222|567620023|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
157239065|NCT03134222|567620024|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
157239066|NCT03134222|567620025|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
157239067|NCT03134222|567620026|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
157239068|NCT03134222|567620022|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
157239069|NCT03134222|567620023|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
157239070|NCT03134222|567620024|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
157239071|NCT03134222|567620025|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
157239072|NCT03134222|567620026|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
157239073|NCT03134222|567620022|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
157239074|NCT03134222|567620023|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
157239075|NCT03134222|567620024|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
157239076|NCT03134222|567620025|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
157239077|NCT03134222|567620026|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
157239078|NCT03134222|567620022|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
157239079|NCT03134222|567620023|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
157239080|NCT03134222|567620024|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
157239081|NCT03134222|567620025|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
157239082|NCT03134222|567620026|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
157239083|NCT03134222|567620022|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
157239084|NCT03134222|567620023|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
157239085|NCT03134222|567620024|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
157239086|NCT03134222|567620025|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
157239087|NCT03134222|567620026|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
157091006|NCT03149549|567086962|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
157239088|NCT03134222|567620022|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
157239089|NCT03134222|567620023|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
157239090|NCT03134222|567620024|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
157239091|NCT03134222|567620025|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
157239092|NCT03134222|567620026|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
157239093|NCT02605928|567620027|FG000|Overall Study|Model tuning phase|28|||
157239094|NCT02605928|567620027|FG000|Overall Study|Lack of Efficacy|5|||
157239095|NCT03482882|567620030|FG000|Overall Study|Adverse Event|3|||
157239096|NCT03482882|567620030|FG000|Overall Study|Lost to Follow-up|1|||
157239097|NCT03482882|567620030|FG000|Overall Study|Protocol Violation|2|||
157239098|NCT03482882|567620030|FG000|Overall Study|Not further specified|1|||
157239099|NCT04659603|567620033|FG000|Overall Study|Study terminated by sponsor|0|||
157239100|NCT04659603|567620034|FG001|Overall Study|Study terminated by sponsor|0|||
157239101|NCT04659603|567620035|FG002|Overall Study|Study terminated by sponsor|2|||
157239102|NCT04659603|567620033|FG000|Overall Study|Withdrawal by Subject|0|||
157239103|NCT04659603|567620034|FG001|Overall Study|Withdrawal by Subject|5|||
157239104|NCT04659603|567620035|FG002|Overall Study|Withdrawal by Subject|0|||
157239105|NCT04659603|567620033|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
157239106|NCT04659603|567620034|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
157239107|NCT04659603|567620035|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
157239108|NCT01110005|567620036|FG000|Overall Study|ineligible|1|||
157239109|NCT01110005|567620037|FG001|Overall Study|ineligible|2|||
157239110|NCT01110005|567620036|FG000|Overall Study|missing consent|3|||
157239111|NCT01110005|567620037|FG001|Overall Study|missing consent|2|||
157239112|NCT01110005|567620036|FG000|Overall Study|Withdrawal by Subject|0|||
157239113|NCT01110005|567620037|FG001|Overall Study|Withdrawal by Subject|1|||
157239114|NCT04646213|567620038|FG000|Overall Study|Physician Decision|3|||
157239115|NCT04646213|567620038|FG000|Overall Study|Withdrawal by Subject|2|||
157239116|NCT02441309|567620041|FG000|Overall Study|Disease progression|2|||
157239117|NCT02441309|567620042|FG001|Overall Study|Disease progression|1|||
157239118|NCT02441309|567620043|FG002|Overall Study|Disease progression|2|||
157239119|NCT02441309|567620041|FG000|Overall Study|Adverse Event|0|||
157239120|NCT02441309|567620042|FG001|Overall Study|Adverse Event|1|||
157239121|NCT02441309|567620043|FG002|Overall Study|Adverse Event|0|||
157239122|NCT02441309|567620041|FG000|Overall Study|Withdrawal by Subject|1|||
157239123|NCT02441309|567620042|FG001|Overall Study|Withdrawal by Subject|0|||
157239124|NCT02441309|567620043|FG002|Overall Study|Withdrawal by Subject|1|||
157239125|NCT04611789|567620044|FG000|Overall Study|Lost to Follow-up|1|||
157239126|NCT04611789|567620045|FG001|Overall Study|Lost to Follow-up|0|||
157239127|NCT04611789|567620046|FG002|Overall Study|Lost to Follow-up|0|||
157239128|NCT02820350|567620050|FG000|Overall Study|Withdrawal by Subject|3|||
157239129|NCT02820350|567620050|FG000|Overall Study|Death|4|||
157239130|NCT03801707|567620052|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
157239131|NCT00001703|567621498|FG000|Overall Study|progressed disease|2|||
157239132|NCT00001703|567621498|FG000|Overall Study|No evidence of disease|1|||
157239133|NCT00001703|567621498|FG000|Overall Study|recurrent disease|2|||
157239134|NCT02286739|567621499|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
157239135|NCT02286739|567621500|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
157239136|NCT02286739|567621499|FG000|Overall Study|No Verasense type documented|0|||
157239137|NCT02286739|567621500|FG001|Overall Study|No Verasense type documented|23|||
157239138|NCT02286739|567621499|FG000|Overall Study|Adverse Event|1|||
157239139|NCT02286739|567621500|FG001|Overall Study|Adverse Event|2|||
157239140|NCT02286739|567621499|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
157239141|NCT02286739|567621500|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
157239142|NCT00834795|567621501|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
157239143|NCT00834795|567621502|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
157239144|NCT00834795|567621501|FG000|Second Intervention|Adverse Event|1|||
157239145|NCT00834795|567621502|FG001|Second Intervention|Adverse Event|0|||
157239146|NCT02057835|567621507|FG000|Overall Study|Withdrawal by Subject|0|||
157239147|NCT02057835|567621508|FG001|Overall Study|Withdrawal by Subject|2|||
157239148|NCT02057835|567621509|FG002|Overall Study|Withdrawal by Subject|0|||
157239149|NCT02057835|567621510|FG003|Overall Study|Withdrawal by Subject|0|||
157239150|NCT02057835|567621511|FG004|Overall Study|Withdrawal by Subject|0|||
157239151|NCT02057835|567621512|FG005|Overall Study|Withdrawal by Subject|0|||
157239152|NCT02057835|567621513|FG006|Overall Study|Withdrawal by Subject|0|||
157091007|NCT01892540|567086963|FG000|Overall Study|Did not complete PET/MRI|0|||
157091008|NCT01892540|567086964|FG001|Overall Study|Did not complete PET/MRI|0|||
157091009|NCT01892540|567086965|FG002|Overall Study|Did not complete PET/MRI|2|||
157091010|NCT01892540|567086963|FG000|Overall Study|Did not fit in scanner|0|||
157091011|NCT01892540|567086964|FG001|Overall Study|Did not fit in scanner|0|||
157091012|NCT01892540|567086965|FG002|Overall Study|Did not fit in scanner|1|||
157091013|NCT01370590|567086966|FG000|Period 1|Adverse Event|8|||
157091014|NCT01370590|567086967|FG001|Period 1|Adverse Event|4|||
157091015|NCT01370590|567086966|FG000|Period 1|Lost to Follow-up|2|||
157091016|NCT01370590|567086967|FG001|Period 1|Lost to Follow-up|2|||
157091017|NCT01370590|567086966|FG000|Period 1|Protocol Violation|2|||
157091018|NCT01370590|567086967|FG001|Period 1|Protocol Violation|2|||
157091019|NCT01370590|567086966|FG000|Period 1|Withdrawal by Subject|4|||
157091020|NCT01370590|567086967|FG001|Period 1|Withdrawal by Subject|2|||
157091021|NCT01370590|567086966|FG000|Period 1|Could not access randomization system|0|||
157091022|NCT01370590|567086967|FG001|Period 1|Could not access randomization system|1|||
157091023|NCT01370590|567086966|FG000|Crossover Washout Period|Adverse Event|1|||
157091024|NCT01370590|567086967|FG001|Crossover Washout Period|Adverse Event|4|||
157091025|NCT01370590|567086966|FG000|Crossover Washout Period|Lost to Follow-up|2|||
157239153|NCT02057835|567621514|FG007|Overall Study|Withdrawal by Subject|0|||
157091026|NCT01370590|567086967|FG001|Crossover Washout Period|Lost to Follow-up|0|||
157239154|NCT02057835|567621515|FG008|Overall Study|Withdrawal by Subject|0|||
157239155|NCT02057835|567621516|FG009|Overall Study|Withdrawal by Subject|0|||
157239156|NCT02222818|567621517|FG000|Period 1|Eligibility criteria not met|0|||
157239157|NCT02222818|567621518|FG001|Period 1|Eligibility criteria not met|3|||
157239158|NCT01376037|567621519|FG000|Overall Study|Lost to Follow-up|0|||
157239159|NCT01376037|567621520|FG001|Overall Study|Lost to Follow-up|2|||
157239160|NCT02328040|567621521|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
157239161|NCT02328040|567621522|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
157239162|NCT06284525|567621525|FG000|Overall Study|Withdrawal by Subject|1|||
157239163|NCT03165994|567621526|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
157239164|NCT03165994|567621526|FG000|Overall Study|Death|2|||
157239165|NCT03165994|567621526|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
157239166|NCT03165994|567621526|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
157239167|NCT03165994|567621526|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
157239168|NCT03165994|567621526|FG000|Overall Study|Miscellaneous|1|||
157239169|NCT00519194|567621527|FG000|Overall Study|Withdrawal by Subject|9|||
157239170|NCT00519194|567621527|FG000|Overall Study|Death|9|||
157239171|NCT00519194|567621527|FG000|Overall Study|Lost to Follow-up|3|||
157239172|NCT00163657|567621528|FG000|Overall Study|Death|12|||
157239173|NCT00163657|567621529|FG001|Overall Study|Death|14|||
157239174|NCT00163657|567621530|FG002|Overall Study|Death|19|||
157239175|NCT00163657|567621528|FG000|Overall Study|graft loss|4|||
157239176|NCT00163657|567621529|FG001|Overall Study|graft loss|1|||
157239177|NCT00163657|567621530|FG002|Overall Study|graft loss|2|||
157239178|NCT00163657|567621528|FG000|Overall Study|Withdrawal by Subject|2|||
157239179|NCT00163657|567621529|FG001|Overall Study|Withdrawal by Subject|3|||
157239180|NCT00163657|567621530|FG002|Overall Study|Withdrawal by Subject|2|||
157239181|NCT00163657|567621528|FG000|Overall Study|Physician Decision|0|||
157239182|NCT00163657|567621529|FG001|Overall Study|Physician Decision|1|||
157239183|NCT00163657|567621530|FG002|Overall Study|Physician Decision|1|||
157239184|NCT00163657|567621528|FG000|Overall Study|Non Compliance|1|||
157239185|NCT00163657|567621529|FG001|Overall Study|Non Compliance|0|||
157239186|NCT00163657|567621530|FG002|Overall Study|Non Compliance|0|||
157239187|NCT00163657|567621528|FG000|Overall Study|Lost to Follow-up|1|||
157239188|NCT00163657|567621529|FG001|Overall Study|Lost to Follow-up|3|||
157239189|NCT00163657|567621530|FG002|Overall Study|Lost to Follow-up|10|||
157239190|NCT00163657|567621528|FG000|Overall Study|Other reason|0|||
157239191|NCT00163657|567621529|FG001|Overall Study|Other reason|1|||
157239192|NCT00163657|567621530|FG002|Overall Study|Other reason|3|||
157239193|NCT01531894|567621533|FG000|Overall Study|Physician Decision|8|||
157239194|NCT01531894|567621533|FG000|Overall Study|Death|1|||
157239195|NCT06195579|567621534|FG000|Overall Study|Withdrawal by Subject|1|||
157239196|NCT02545283|567621535|FG000|Overall Study|Lost to Follow-up|2|||
157239197|NCT02545283|567621536|FG001|Overall Study|Lost to Follow-up|4|||
157239198|NCT02545283|567621535|FG000|Overall Study|Withdrawal by Subject|5|||
157239199|NCT02545283|567621536|FG001|Overall Study|Withdrawal by Subject|9|||
157239200|NCT02545283|567621535|FG000|Overall Study|Death|109|||
157239201|NCT02545283|567621536|FG001|Overall Study|Death|211|||
157239202|NCT02545283|567621535|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
157239203|NCT02545283|567621536|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
157239204|NCT02545283|567621535|FG000|Overall Study|Study Terminated By Sponsor|33|||
157239205|NCT02545283|567621536|FG001|Overall Study|Study Terminated By Sponsor|71|||
157239206|NCT03635320|567621537|FG000|Overall Study|not implanted the device|1|||
157239207|NCT03635320|567621538|FG001|Overall Study|not implanted the device|2|||
157239208|NCT03635320|567621537|FG000|Overall Study|Withdrawal by Subject|11|||
157239209|NCT03635320|567621538|FG001|Overall Study|Withdrawal by Subject|6|||
157239210|NCT00804856|567621542|FG000|Overall Study|Progressive Disease|3|||
157239211|NCT00804856|567621543|FG001|Overall Study|Progressive Disease|2|||
157239212|NCT00804856|567621544|FG002|Overall Study|Progressive Disease|4|||
157091027|NCT01370590|567086966|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
157091028|NCT01370590|567086967|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
157091029|NCT01370590|567086966|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
157091030|NCT01370590|567086967|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
157091031|NCT01370590|567086966|FG000|Period 2|Adverse Event|0|||
157091032|NCT01370590|567086967|FG001|Period 2|Adverse Event|1|||
157091033|NCT01370590|567086966|FG000|Period 2|Withdrawal by Subject|1|||
157091034|NCT01370590|567086967|FG001|Period 2|Withdrawal by Subject|1|||
157091035|NCT04617275|567086971|FG000|Treatment Period|Adverse Event|1|||
157091036|NCT04617275|567086972|FG001|Treatment Period|Adverse Event|6|||
157239213|NCT00804856|567621545|FG003|Overall Study|Progressive Disease|6|||
157239214|NCT00804856|567621546|FG004|Overall Study|Progressive Disease|4|||
157239215|NCT00804856|567621547|FG005|Overall Study|Progressive Disease|1|||
157239216|NCT00804856|567621548|FG006|Overall Study|Progressive Disease|8|||
157239217|NCT00804856|567621549|FG007|Overall Study|Progressive Disease|2|||
157091037|NCT04617275|567086973|FG002|Treatment Period|Adverse Event|4|||
157091038|NCT04617275|567086974|FG003|Treatment Period|Adverse Event|6|||
157239218|NCT00804856|567621550|FG008|Overall Study|Progressive Disease|4|||
157091039|NCT04617275|567086975|FG004|Treatment Period|Adverse Event|7|||
157091040|NCT04617275|567086976|FG005|Treatment Period|Adverse Event|8|||
157091041|NCT04617275|567086977|FG006|Treatment Period|Adverse Event|0|||
157091042|NCT04617275|567086978|FG007|Treatment Period|Adverse Event|12|||
157091043|NCT04617275|567086971|FG000|Treatment Period|Lost to Follow-up|0|||
157091044|NCT04617275|567086972|FG001|Treatment Period|Lost to Follow-up|0|||
157091045|NCT04617275|567086973|FG002|Treatment Period|Lost to Follow-up|2|||
157091046|NCT04617275|567086974|FG003|Treatment Period|Lost to Follow-up|0|||
157091047|NCT04617275|567086975|FG004|Treatment Period|Lost to Follow-up|0|||
157091048|NCT04617275|567086976|FG005|Treatment Period|Lost to Follow-up|3|||
157091049|NCT04617275|567086977|FG006|Treatment Period|Lost to Follow-up|0|||
157091050|NCT04617275|567086978|FG007|Treatment Period|Lost to Follow-up|2|||
157091051|NCT04617275|567086971|FG000|Treatment Period|No longer meets eligibility criteria|0|||
157091052|NCT04617275|567086972|FG001|Treatment Period|No longer meets eligibility criteria|0|||
157091053|NCT04617275|567086973|FG002|Treatment Period|No longer meets eligibility criteria|0|||
157091054|NCT04617275|567086974|FG003|Treatment Period|No longer meets eligibility criteria|1|||
157091055|NCT04617275|567086975|FG004|Treatment Period|No longer meets eligibility criteria|0|||
157091056|NCT04617275|567086976|FG005|Treatment Period|No longer meets eligibility criteria|0|||
157091057|NCT04617275|567086977|FG006|Treatment Period|No longer meets eligibility criteria|0|||
157091058|NCT04617275|567086978|FG007|Treatment Period|No longer meets eligibility criteria|0|||
157091059|NCT04617275|567086971|FG000|Treatment Period|Other|0|||
157091060|NCT04617275|567086972|FG001|Treatment Period|Other|1|||
157091061|NCT04617275|567086973|FG002|Treatment Period|Other|0|||
157091062|NCT04617275|567086974|FG003|Treatment Period|Other|0|||
157091063|NCT04617275|567086975|FG004|Treatment Period|Other|0|||
157091064|NCT04617275|567086976|FG005|Treatment Period|Other|0|||
157091065|NCT04617275|567086977|FG006|Treatment Period|Other|0|||
157091066|NCT04617275|567086978|FG007|Treatment Period|Other|0|||
157091067|NCT04617275|567086971|FG000|Treatment Period|Withdrawal by Subject|2|||
157091068|NCT04617275|567086972|FG001|Treatment Period|Withdrawal by Subject|0|||
157091069|NCT04617275|567086973|FG002|Treatment Period|Withdrawal by Subject|0|||
157091070|NCT04617275|567086974|FG003|Treatment Period|Withdrawal by Subject|2|||
157091071|NCT04617275|567086975|FG004|Treatment Period|Withdrawal by Subject|2|||
157091072|NCT04617275|567086976|FG005|Treatment Period|Withdrawal by Subject|0|||
157091073|NCT04617275|567086977|FG006|Treatment Period|Withdrawal by Subject|1|||
157091074|NCT04617275|567086978|FG007|Treatment Period|Withdrawal by Subject|2|||
157091075|NCT04617275|567086971|FG000|Follow-up Period|Adverse Event|1|||
157091076|NCT04617275|567086972|FG001|Follow-up Period|Adverse Event|1|||
157091077|NCT04617275|567086973|FG002|Follow-up Period|Adverse Event|2|||
157091078|NCT04617275|567086974|FG003|Follow-up Period|Adverse Event|3|||
157091079|NCT04617275|567086975|FG004|Follow-up Period|Adverse Event|4|||
157091080|NCT04617275|567086976|FG005|Follow-up Period|Adverse Event|3|||
157091081|NCT04617275|567086977|FG006|Follow-up Period|Adverse Event|0|||
157091082|NCT04617275|567086978|FG007|Follow-up Period|Adverse Event|3|||
157091083|NCT04617275|567086971|FG000|Follow-up Period|Lost to Follow-up|0|||
157091084|NCT04617275|567086972|FG001|Follow-up Period|Lost to Follow-up|1|||
157091085|NCT04617275|567086973|FG002|Follow-up Period|Lost to Follow-up|2|||
157091086|NCT04617275|567086974|FG003|Follow-up Period|Lost to Follow-up|0|||
157091087|NCT04617275|567086975|FG004|Follow-up Period|Lost to Follow-up|0|||
157091088|NCT04617275|567086976|FG005|Follow-up Period|Lost to Follow-up|4|||
157091089|NCT04617275|567086977|FG006|Follow-up Period|Lost to Follow-up|0|||
157091090|NCT04617275|567086978|FG007|Follow-up Period|Lost to Follow-up|3|||
157091091|NCT04617275|567086971|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
157091092|NCT04617275|567086972|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
157091093|NCT04617275|567086973|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
157091094|NCT04617275|567086974|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
157091095|NCT04617275|567086975|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
157091096|NCT04617275|567086976|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
157091097|NCT04617275|567086977|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
157091098|NCT04617275|567086978|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
157091099|NCT04617275|567086971|FG000|Follow-up Period|Other|0|||
157239219|NCT00804856|567621551|FG009|Overall Study|Progressive Disease|5|||
157239220|NCT00804856|567621552|FG010|Overall Study|Progressive Disease|12|||
157239221|NCT00804856|567621553|FG011|Overall Study|Progressive Disease|2|||
157239222|NCT00804856|567621554|FG012|Overall Study|Progressive Disease|2|||
157239223|NCT00804856|567621555|FG013|Overall Study|Progressive Disease|26|||
157239224|NCT00804856|567621556|FG014|Overall Study|Progressive Disease|20|||
157239225|NCT00804856|567621542|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157091100|NCT04617275|567086972|FG001|Follow-up Period|Other|1|||
157091101|NCT04617275|567086973|FG002|Follow-up Period|Other|0|||
157091102|NCT04617275|567086974|FG003|Follow-up Period|Other|0|||
157091103|NCT04617275|567086975|FG004|Follow-up Period|Other|0|||
157091104|NCT04617275|567086976|FG005|Follow-up Period|Other|0|||
157091105|NCT04617275|567086977|FG006|Follow-up Period|Other|0|||
157091106|NCT04617275|567086978|FG007|Follow-up Period|Other|0|||
157239226|NCT00804856|567621543|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239227|NCT00804856|567621544|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239228|NCT00804856|567621545|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239229|NCT00804856|567621546|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
157239230|NCT00804856|567621547|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239231|NCT00804856|567621548|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239232|NCT00804856|567621549|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239233|NCT00804856|567621550|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239234|NCT00804856|567621551|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239235|NCT00804856|567621552|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239236|NCT00804856|567621553|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239237|NCT00804856|567621554|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239238|NCT00804856|567621555|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
157239239|NCT00804856|567621556|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
157239240|NCT00804856|567621542|FG000|Overall Study|Other Adverse Event|1|||
157239241|NCT00804856|567621543|FG001|Overall Study|Other Adverse Event|1|||
157239242|NCT00804856|567621544|FG002|Overall Study|Other Adverse Event|1|||
157239243|NCT00804856|567621545|FG003|Overall Study|Other Adverse Event|2|||
157239244|NCT00804856|567621546|FG004|Overall Study|Other Adverse Event|2|||
157239245|NCT00804856|567621547|FG005|Overall Study|Other Adverse Event|1|||
157239246|NCT00804856|567621548|FG006|Overall Study|Other Adverse Event|3|||
157239247|NCT00804856|567621549|FG007|Overall Study|Other Adverse Event|0|||
157239248|NCT00804856|567621550|FG008|Overall Study|Other Adverse Event|0|||
157239249|NCT00804856|567621551|FG009|Overall Study|Other Adverse Event|1|||
157239250|NCT00804856|567621552|FG010|Overall Study|Other Adverse Event|5|||
157239251|NCT00804856|567621553|FG011|Overall Study|Other Adverse Event|2|||
157239252|NCT00804856|567621554|FG012|Overall Study|Other Adverse Event|0|||
157239253|NCT00804856|567621555|FG013|Overall Study|Other Adverse Event|6|||
157239254|NCT00804856|567621556|FG014|Overall Study|Other Adverse Event|13|||
157239255|NCT00804856|567621542|FG000|Overall Study|Non compliance with protocol|0|||
157239256|NCT00804856|567621543|FG001|Overall Study|Non compliance with protocol|0|||
157239257|NCT00804856|567621544|FG002|Overall Study|Non compliance with protocol|0|||
157239258|NCT00804856|567621545|FG003|Overall Study|Non compliance with protocol|0|||
157239259|NCT00804856|567621546|FG004|Overall Study|Non compliance with protocol|0|||
157239260|NCT00804856|567621547|FG005|Overall Study|Non compliance with protocol|0|||
157239261|NCT00804856|567621548|FG006|Overall Study|Non compliance with protocol|0|||
157239262|NCT00804856|567621549|FG007|Overall Study|Non compliance with protocol|0|||
157239263|NCT00804856|567621550|FG008|Overall Study|Non compliance with protocol|0|||
157239264|NCT00804856|567621551|FG009|Overall Study|Non compliance with protocol|0|||
157239265|NCT00804856|567621552|FG010|Overall Study|Non compliance with protocol|0|||
157239266|NCT00804856|567621553|FG011|Overall Study|Non compliance with protocol|0|||
157239267|NCT00804856|567621554|FG012|Overall Study|Non compliance with protocol|0|||
157239268|NCT00804856|567621555|FG013|Overall Study|Non compliance with protocol|2|||
157239269|NCT00804856|567621556|FG014|Overall Study|Non compliance with protocol|0|||
157239270|NCT00804856|567621542|FG000|Overall Study|Refused to continue medication|0|||
157239271|NCT00804856|567621543|FG001|Overall Study|Refused to continue medication|0|||
157239272|NCT00804856|567621544|FG002|Overall Study|Refused to continue medication|0|||
157239273|NCT00804856|567621545|FG003|Overall Study|Refused to continue medication|1|||
157239274|NCT00804856|567621546|FG004|Overall Study|Refused to continue medication|1|||
157239275|NCT00804856|567621547|FG005|Overall Study|Refused to continue medication|0|||
157239276|NCT00804856|567621548|FG006|Overall Study|Refused to continue medication|0|||
157239277|NCT00804856|567621549|FG007|Overall Study|Refused to continue medication|0|||
157239278|NCT00804856|567621550|FG008|Overall Study|Refused to continue medication|0|||
157239279|NCT00804856|567621551|FG009|Overall Study|Refused to continue medication|0|||
157239280|NCT00804856|567621552|FG010|Overall Study|Refused to continue medication|3|||
157239281|NCT00804856|567621553|FG011|Overall Study|Refused to continue medication|0|||
157239282|NCT00804856|567621554|FG012|Overall Study|Refused to continue medication|1|||
157239283|NCT00804856|567621555|FG013|Overall Study|Refused to continue medication|1|||
157239284|NCT00804856|567621556|FG014|Overall Study|Refused to continue medication|5|||
157239285|NCT00804856|567621542|FG000|Overall Study|Other reason than listed above|0|||
157239286|NCT00804856|567621543|FG001|Overall Study|Other reason than listed above|0|||
157239287|NCT00804856|567621544|FG002|Overall Study|Other reason than listed above|0|||
157239288|NCT00804856|567621545|FG003|Overall Study|Other reason than listed above|0|||
157239289|NCT00804856|567621546|FG004|Overall Study|Other reason than listed above|0|||
157239290|NCT00804856|567621547|FG005|Overall Study|Other reason than listed above|1|||
157239291|NCT00804856|567621548|FG006|Overall Study|Other reason than listed above|0|||
157239292|NCT00804856|567621549|FG007|Overall Study|Other reason than listed above|0|||
157239293|NCT00804856|567621550|FG008|Overall Study|Other reason than listed above|1|||
157239294|NCT00804856|567621551|FG009|Overall Study|Other reason than listed above|0|||
157239295|NCT00804856|567621552|FG010|Overall Study|Other reason than listed above|3|||
157239296|NCT00804856|567621553|FG011|Overall Study|Other reason than listed above|1|||
157239297|NCT00804856|567621554|FG012|Overall Study|Other reason than listed above|1|||
157239298|NCT00804856|567621555|FG013|Overall Study|Other reason than listed above|10|||
157197165|NCT03410693|567465220|FG001|Overall Study|Disc trt: Physician decision|5|||
157197166|NCT03410693|567465219|FG000|Overall Study|Disc trt: clinical progression|1|||
157197167|NCT03410693|567465220|FG001|Overall Study|Disc trt: clinical progression|5|||
157197168|NCT03410693|567465219|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
157197169|NCT03410693|567465220|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
157197170|NCT00953576|567465221|FG000|Overall Study|Adverse Event|0|||
157197171|NCT00953576|567465222|FG001|Overall Study|Adverse Event|1|||
157197172|NCT00953576|567465221|FG000|Overall Study|Ineligible after Consent|2|||
157197173|NCT00953576|567465222|FG001|Overall Study|Ineligible after Consent|0|||
157197174|NCT03778021|567465223|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
157197175|NCT03778021|567465224|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
157197176|NCT00679042|567465225|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
157197177|NCT00679042|567465225|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
157197178|NCT00679042|567465225|FG000|5-Year Follow Up|Death|1|||
157197179|NCT00679042|567465225|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
157197180|NCT00679042|567465225|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
157197181|NCT03053102|567465228|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
157197182|NCT03053102|567465228|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
157197183|NCT01798056|567465229|FG000|Overall Study|Serious Adverse Event|13|||
157197184|NCT01798056|567465230|FG001|Overall Study|Serious Adverse Event|12|||
157197185|NCT01798056|567465229|FG000|Overall Study|Withdrawal by Subject|12|||
157197186|NCT01798056|567465230|FG001|Overall Study|Withdrawal by Subject|9|||
157197187|NCT01798056|567465229|FG000|Overall Study|Migrated/moved from study area|1|||
157197188|NCT01798056|567465230|FG001|Overall Study|Migrated/moved from study area|1|||
157197189|NCT01798056|567465229|FG000|Overall Study|Lost to Follow-up|1|||
157197190|NCT01798056|567465230|FG001|Overall Study|Lost to Follow-up|1|||
157197191|NCT01798056|567465229|FG000|Overall Study|Other|0|||
157197192|NCT01798056|567465230|FG001|Overall Study|Other|2|||
157197193|NCT01269346|567465233|FG000|Treatment Phase|Disease progression|3|||
157197194|NCT01269346|567465233|FG000|Treatment Phase|Adverse Event|3|||
157197195|NCT01269346|567465233|FG000|Treatment Phase|Withdrawal by Subject|1|||
157197196|NCT01269346|567465233|FG000|Treatment Phase|Other|2|||
157197197|NCT01269346|567465233|FG000|Extension Phase|Adverse Event|6|||
157197198|NCT01269346|567465233|FG000|Extension Phase|Withdrawal by Subject|4|||
157197199|NCT01269346|567465233|FG000|Extension Phase|Disease progression|22|||
157197200|NCT01269346|567465233|FG000|Extension Phase|Physician decision or participant choice|9|||
157197201|NCT01269346|567465233|FG000|Extension Phase|Clinical progression|1|||
157197202|NCT01269346|567465233|FG000|Extension Phase|Started a prohibited con med|1|||
157197203|NCT03472586|567465242|FG000|Overall Study|Physician Decision|6|||
157197204|NCT03472586|567465242|FG000|Overall Study|Death|6|||
157197205|NCT03472586|567465242|FG000|Overall Study|Adverse Event|1|||
157197206|NCT01342445|567465243|FG000|Overall Study|Experienced side effects|0|||
157197207|NCT01342445|567465244|FG001|Overall Study|Experienced side effects|2|||
157197208|NCT02652793|567465247|FG000|Overall Study|Adverse Event|1|||
157197209|NCT02652793|567465247|FG000|Overall Study|Lost to Follow-up|2|||
157197210|NCT02652793|567465247|FG000|Overall Study|Withdrawal by Subject|1|||
157197211|NCT04963231|567465248|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
157197212|NCT04963231|567465249|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
157197213|NCT04963231|567465250|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
157197214|NCT04963231|567465248|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
157197215|NCT04963231|567465249|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
157197216|NCT04963231|567465250|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
157197217|NCT04963231|567465248|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
157197218|NCT04963231|567465249|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
157197219|NCT04963231|567465250|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
157197220|NCT04963231|567465248|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
157197221|NCT04963231|567465249|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
157197222|NCT04963231|567465250|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
157197223|NCT04963231|567465248|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
157197224|NCT04963231|567465249|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
157197225|NCT04963231|567465250|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
157197226|NCT04963231|567465248|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
157197227|NCT04963231|567465249|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
157197228|NCT04963231|567465250|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
157197229|NCT04963231|567465248|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
157197230|NCT04963231|567465249|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
157197231|NCT04963231|567465250|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
157197232|NCT01059175|567465253|FG000|Overall Study|Death|17|||
157197233|NCT01059175|567465254|FG001|Overall Study|Death|17|||
157197234|NCT01059175|567465253|FG000|Overall Study|Adverse Event|4|||
157197235|NCT01059175|567465254|FG001|Overall Study|Adverse Event|2|||
157239299|NCT00804856|567621556|FG014|Overall Study|Other reason than listed above|3|||
157239300|NCT03343535|567621557|FG000|Overall Study|Lost to Follow-up|1|||
157239301|NCT03343535|567621557|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
157239302|NCT03343535|567621557|FG000|Overall Study|Death|12|||
157239303|NCT03049748|567621558|FG000|Overall Study|Lost to Follow-up|1|||
157239304|NCT03049748|567621559|FG001|Overall Study|Lost to Follow-up|0|||
157239305|NCT03049748|567621558|FG000|Overall Study|Death|3|||
157239306|NCT03049748|567621559|FG001|Overall Study|Death|0|||
157239307|NCT03049748|567621558|FG000|Overall Study|Withdrawal by Subject|0|||
157239308|NCT03049748|567621559|FG001|Overall Study|Withdrawal by Subject|3|||
157239309|NCT03049748|567621558|FG000|Overall Study|Protocol Violation|0|||
157239310|NCT03049748|567621559|FG001|Overall Study|Protocol Violation|2|||
157239311|NCT03049748|567621558|FG000|Overall Study|Moved out of state (relocation)|0|||
157239312|NCT03049748|567621559|FG001|Overall Study|Moved out of state (relocation)|1|||
157239313|NCT01735994|567621560|FG000|Overall Study|Withdrawal by Subject|6|||
157239314|NCT01735994|567621561|FG001|Overall Study|Withdrawal by Subject|4|||
157239315|NCT01735994|567621560|FG000|Overall Study|Injury|2|||
157239316|NCT01735994|567621561|FG001|Overall Study|Injury|0|||
157239317|NCT01735994|567621560|FG000|Overall Study|Kicked off team|5|||
157239318|NCT01735994|567621561|FG001|Overall Study|Kicked off team|0|||
157239319|NCT01735994|567621560|FG000|Overall Study|Lost to Follow-up|50|||
157239320|NCT01735994|567621561|FG001|Overall Study|Lost to Follow-up|62|||
157239321|NCT01158118|567621562|FG000|Overall Study|Screen failure|1|||
157239322|NCT01158118|567621563|FG001|Overall Study|Screen failure|0|||
157239323|NCT01158118|567621562|FG000|Overall Study|Donor match was a screen failure|0|||
157239324|NCT01158118|567621563|FG001|Overall Study|Donor match was a screen failure|1|||
157239325|NCT01158118|567621562|FG000|Overall Study|Suffered stroke prior to transplant|0|||
157239326|NCT01158118|567621563|FG001|Overall Study|Suffered stroke prior to transplant|1|||
157239327|NCT01158118|567621562|FG000|Overall Study|Death|0|||
157239328|NCT01158118|567621563|FG001|Overall Study|Death|1|||
157239329|NCT04994535|567621564|FG000|Overall Study|Lost to Follow-up|7|||
157239330|NCT04994535|567621565|FG001|Overall Study|Lost to Follow-up|7|||
157239331|NCT04994535|567621564|FG000|Overall Study|Withdrawal by Subject|10|||
157239332|NCT04994535|567621565|FG001|Overall Study|Withdrawal by Subject|7|||
157239333|NCT04994535|567621564|FG000|Overall Study|Other|1|||
157239334|NCT04994535|567621565|FG001|Overall Study|Other|1|||
157239335|NCT00960297|567621569|FG000|Overall Study|Physician Decision|1|||
157239336|NCT00960297|567621569|FG000|Overall Study|Venous port infection|1|||
157239337|NCT00960297|567621569|FG000|Overall Study|Disease progression|1|||
157239338|NCT02849457|567621577|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
157239339|NCT02849457|567621578|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
157239340|NCT02849457|567621579|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
157239341|NCT02849457|567621580|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
157239342|NCT04408794|567621584|FG000|Overall Study|Adverse Event|43|||
157239343|NCT04408794|567621584|FG000|Overall Study|Infrequent study drug usage|43|||
157239344|NCT04408794|567621584|FG000|Overall Study|Lack of Efficacy|61|||
157239345|NCT04408794|567621584|FG000|Overall Study|Lost to Follow-up|33|||
157239346|NCT04408794|567621584|FG000|Overall Study|Non-compliance|6|||
157239347|NCT04408794|567621584|FG000|Overall Study|Physician Decision|1|||
157239348|NCT04408794|567621584|FG000|Overall Study|Pregnancy|6|||
157239349|NCT04408794|567621584|FG000|Overall Study|Protocol Deviation|9|||
157239350|NCT04408794|567621584|FG000|Overall Study|Sheehan-STS Result|1|||
157239351|NCT04408794|567621584|FG000|Overall Study|Withdrawal by Subject|57|||
157239352|NCT04408794|567621584|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
157239353|NCT04408794|567621584|FG000|Overall Study|Never Treated Migraine|5|||
157239354|NCT03437265|567621587|FG000|Overall Study|Protocol Violation|6|||
157239355|NCT04238754|567621593|FG000|Washout - 1 Week|Lost to Follow-up|1|||
157239356|NCT04238754|567621594|FG001|Washout - 1 Week|Lost to Follow-up|0|||
157239357|NCT01175018|567621595|FG000|Overall Study|Adverse Event|3|||
157239358|NCT01175018|567621596|FG001|Overall Study|Adverse Event|1|||
157239359|NCT00556322|567621598|FG000|Overall Study|Insufficient therapeutic response|158|||
157239360|NCT00556322|567621599|FG001|Overall Study|Insufficient therapeutic response|168|||
157239361|NCT00556322|567621598|FG000|Overall Study|Adverse Event|7|||
157239362|NCT00556322|567621599|FG001|Overall Study|Adverse Event|4|||
157239363|NCT00556322|567621598|FG000|Overall Study|Other|4|||
157239364|NCT00556322|567621599|FG001|Overall Study|Other|1|||
157239365|NCT00556322|567621598|FG000|Overall Study|Lost to Follow-up|5|||
157239366|NCT00556322|567621599|FG001|Overall Study|Lost to Follow-up|3|||
157239367|NCT00556322|567621598|FG000|Overall Study|Withdrawal by Subject|19|||
157239368|NCT00556322|567621599|FG001|Overall Study|Withdrawal by Subject|7|||
157239369|NCT00556322|567621598|FG000|Overall Study|Protocol Violation|5|||
157239370|NCT00556322|567621599|FG001|Overall Study|Protocol Violation|1|||
157091107|NCT04617275|567086971|FG000|Follow-up Period|Withdrawal by Subject|2|||
157239371|NCT00556322|567621598|FG000|Overall Study|Ongoing at data cutoff|3|||
157239372|NCT00556322|567621599|FG001|Overall Study|Ongoing at data cutoff|5|||
157239373|NCT00556322|567621598|FG000|Overall Study|Death|20|||
157239374|NCT00556322|567621599|FG001|Overall Study|Death|14|||
157239375|NCT00835263|567621600|FG000|Second Intervention|Adverse Event|1|||
157239376|NCT00835263|567621601|FG001|Second Intervention|Adverse Event|0|||
157239377|NCT01913405|567621602|FG000|Overall Study|Withdrawal by Subject|1|||
157239378|NCT01913405|567621602|FG000|Overall Study|Adverse Event|1|||
157239379|NCT03987191|567621605|FG000|Overall Study|COVID-19 related research disruption|0|||
157239380|NCT03987191|567621606|FG001|Overall Study|COVID-19 related research disruption|2|||
157239381|NCT01020474|567621607|FG000|Overall Study|Adverse Event|4|||
157239382|NCT01020474|567621608|FG001|Overall Study|Adverse Event|4|||
157239383|NCT01020474|567621607|FG000|Overall Study|Protocol Violation|0|||
157239384|NCT01020474|567621608|FG001|Overall Study|Protocol Violation|2|||
157239385|NCT01020474|567621607|FG000|Overall Study|Withdrawal by Subject|5|||
157239386|NCT01020474|567621608|FG001|Overall Study|Withdrawal by Subject|7|||
157239387|NCT01020474|567621607|FG000|Overall Study|Other Reasons|1|||
157239388|NCT01020474|567621608|FG001|Overall Study|Other Reasons|1|||
157239389|NCT01020474|567621607|FG000|Overall Study|Insufficient Clinical Response|0|||
157239390|NCT01020474|567621608|FG001|Overall Study|Insufficient Clinical Response|3|||
157239391|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
157239392|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
157239393|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
157239394|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
157239395|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
157091108|NCT04617275|567086972|FG001|Follow-up Period|Withdrawal by Subject|0|||
157091109|NCT04617275|567086973|FG002|Follow-up Period|Withdrawal by Subject|0|||
157091110|NCT04617275|567086974|FG003|Follow-up Period|Withdrawal by Subject|2|||
157091111|NCT04617275|567086975|FG004|Follow-up Period|Withdrawal by Subject|2|||
157091112|NCT04617275|567086976|FG005|Follow-up Period|Withdrawal by Subject|0|||
157091113|NCT04617275|567086977|FG006|Follow-up Period|Withdrawal by Subject|1|||
157091114|NCT04617275|567086978|FG007|Follow-up Period|Withdrawal by Subject|2|||
157239396|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
157239397|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
157239398|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
157239399|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
157239400|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
157239401|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
157239402|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
157239403|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
157239404|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
157239405|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
157239406|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
157239407|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
157239408|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
157239409|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
157239410|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
157239411|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Death|0|||
157239412|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Death|1|||
157239413|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Death|0|||
157239414|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Death|0|||
157239415|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
157239416|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
157239417|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
157239418|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
157239419|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
157239420|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
157239421|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
157239422|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
157239423|NCT01940341|567621610|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
157239424|NCT01940341|567621611|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
157239425|NCT01940341|567621612|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
157239426|NCT01940341|567621613|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
157239427|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
157239428|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
157239429|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
157239430|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
157239431|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
157239432|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
157239433|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
157239434|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
157239435|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
157239436|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
157239437|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
157239438|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
157239439|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
157239440|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
157239441|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
157239442|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
157239443|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
157239444|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
157239445|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
157239446|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
157239447|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
157239448|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
157239449|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
157239450|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
157239451|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157239452|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157239453|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
157239454|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
157239455|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
157239456|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
157239457|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
157239458|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
157239459|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157239460|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157239461|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
157239462|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
157239463|NCT01940341|567621610|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
157239464|NCT01940341|567621611|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
157239465|NCT01940341|567621612|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
157239466|NCT01940341|567621613|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
157239467|NCT01231906|567621614|FG000|Overall Study|Lack of Efficacy|75|||
157239468|NCT01231906|567621615|FG001|Overall Study|Lack of Efficacy|68|||
157239469|NCT01231906|567621614|FG000|Overall Study|Lost to Follow-up|1|||
157239470|NCT01231906|567621615|FG001|Overall Study|Lost to Follow-up|0|||
157239471|NCT01231906|567621614|FG000|Overall Study|Physician Decision|34|||
157239472|NCT01231906|567621615|FG001|Overall Study|Physician Decision|24|||
157239473|NCT01231906|567621614|FG000|Overall Study|Withdrawal by Subject|0|||
157239474|NCT01231906|567621615|FG001|Overall Study|Withdrawal by Subject|4|||
157239475|NCT01231906|567621614|FG000|Overall Study|Ineligible|10|||
157239476|NCT01231906|567621615|FG001|Overall Study|Ineligible|3|||
157239477|NCT01231906|567621614|FG000|Overall Study|No treatment|1|||
157239478|NCT01231906|567621615|FG001|Overall Study|No treatment|2|||
157239479|NCT05341622|567621616|FG000|Overall Study|Death|0|||
157239480|NCT05341622|567621617|FG001|Overall Study|Death|0|||
157239481|NCT05341622|567621618|FG002|Overall Study|Death|0|||
157239482|NCT05341622|567621619|FG003|Overall Study|Death|0|||
157239483|NCT05341622|567621620|FG004|Overall Study|Death|1|||
157239484|NCT05341622|567621621|FG005|Overall Study|Death|0|||
157239485|NCT05341622|567621622|FG006|Overall Study|Death|0|||
157239486|NCT05341622|567621623|FG007|Overall Study|Death|1|||
157239487|NCT05341622|567621616|FG000|Overall Study|Invalid Address|0|||
157239488|NCT05341622|567621617|FG001|Overall Study|Invalid Address|1|||
157239489|NCT05341622|567621618|FG002|Overall Study|Invalid Address|0|||
157239490|NCT05341622|567621619|FG003|Overall Study|Invalid Address|0|||
157239491|NCT05341622|567621620|FG004|Overall Study|Invalid Address|0|||
157239492|NCT05341622|567621621|FG005|Overall Study|Invalid Address|0|||
157239493|NCT05341622|567621622|FG006|Overall Study|Invalid Address|0|||
157239494|NCT05341622|567621623|FG007|Overall Study|Invalid Address|0|||
157239495|NCT05341622|567621616|FG000|Overall Study|Ineligible|26|||
157091115|NCT02164383|567089010|FG000|Overall Study|Lost to Follow-up|1|||
157091116|NCT02164383|567089011|FG001|Overall Study|Lost to Follow-up|0|||
157239496|NCT05341622|567621617|FG001|Overall Study|Ineligible|21|||
157239497|NCT05341622|567621618|FG002|Overall Study|Ineligible|28|||
157239498|NCT05341622|567621619|FG003|Overall Study|Ineligible|24|||
157239499|NCT05341622|567621620|FG004|Overall Study|Ineligible|29|||
157239500|NCT05341622|567621621|FG005|Overall Study|Ineligible|31|||
157239501|NCT05341622|567621622|FG006|Overall Study|Ineligible|28|||
157239502|NCT05341622|567621623|FG007|Overall Study|Ineligible|26|||
157239503|NCT02658084|567621624|FG000|Overall Study|Withdrawal by Subject|1|||
157239504|NCT02658084|567621625|FG001|Overall Study|Withdrawal by Subject|0|||
157239505|NCT02658084|567621624|FG000|Overall Study|Study Termination|1|||
157239506|NCT02658084|567621625|FG001|Overall Study|Study Termination|0|||
157239507|NCT00811655|567621630|FG000|Overall Study|Physician Decision|1|||
157239508|NCT00119015|567621637|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
157239509|NCT00119015|567621638|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
157239510|NCT00119015|567621639|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
157239511|NCT00859430|567621643|FG000|First Intervention|Withdrawal by Subject|0|||
157239512|NCT00859430|567621644|FG001|First Intervention|Withdrawal by Subject|1|||
157239513|NCT02255149|567622943|FG000|Overall Study|Lost to Follow-up|2|||
157239514|NCT02255149|567622943|FG000|Overall Study|Withdrawal by Subject|1|||
157239515|NCT02255149|567622943|FG000|Overall Study|Withdrawal by PI|1|||
157239516|NCT02255149|567622943|FG000|Overall Study|Implant Failure|1|||
157239517|NCT05604170|567622944|FG000|Overall Study|Lack of Efficacy|5|||
157239518|NCT05604170|567622944|FG000|Overall Study|Adverse Event|6|||
157239519|NCT05604170|567622944|FG000|Overall Study|Physician Decision|6|||
157239520|NCT05604170|567622944|FG000|Overall Study|Lost to Follow-up|6|||
157239521|NCT05604170|567622944|FG000|Overall Study|Withdrawal by Subject|11|||
157239522|NCT05604170|567622944|FG000|Overall Study|Early study termination by sponsor|77|||
157239523|NCT05604170|567622944|FG000|Overall Study|Other|6|||
157239524|NCT03032172|567622947|FG000|Treatment Period|Adverse Event|0|||
157239525|NCT03032172|567622948|FG001|Treatment Period|Adverse Event|1|||
157239526|NCT03032172|567622949|FG002|Treatment Period|Adverse Event|0|||
157239527|NCT03032172|567622950|FG003|Treatment Period|Adverse Event|0|||
157239528|NCT03032172|567622951|FG004|Treatment Period|Adverse Event|0|||
157239529|NCT03032172|567622952|FG005|Treatment Period|Adverse Event|0|||
157239530|NCT03032172|567622953|FG006|Treatment Period|Adverse Event|0|||
157239531|NCT03032172|567622954|FG007|Treatment Period|Adverse Event|0|||
157239532|NCT03032172|567622947|FG000|Treatment Period|Lack of Efficacy|0|||
157239533|NCT03032172|567622948|FG001|Treatment Period|Lack of Efficacy|1|||
157239534|NCT03032172|567622949|FG002|Treatment Period|Lack of Efficacy|0|||
157239535|NCT03032172|567622950|FG003|Treatment Period|Lack of Efficacy|0|||
157239536|NCT03032172|567622951|FG004|Treatment Period|Lack of Efficacy|0|||
157239537|NCT03032172|567622952|FG005|Treatment Period|Lack of Efficacy|0|||
157239538|NCT03032172|567622953|FG006|Treatment Period|Lack of Efficacy|0|||
157239539|NCT03032172|567622954|FG007|Treatment Period|Lack of Efficacy|0|||
157239540|NCT03032172|567622947|FG000|Treatment Period|Non-compliance With Study Drug|0|||
157091117|NCT01036763|567089012|FG000|Overall Study|Adverse Event|25|||
157091118|NCT01036763|567089012|FG000|Overall Study|Lost to Follow-up|28|||
157239541|NCT03032172|567622948|FG001|Treatment Period|Non-compliance With Study Drug|1|||
157239542|NCT03032172|567622949|FG002|Treatment Period|Non-compliance With Study Drug|0|||
157239543|NCT03032172|567622950|FG003|Treatment Period|Non-compliance With Study Drug|0|||
157239544|NCT03032172|567622951|FG004|Treatment Period|Non-compliance With Study Drug|0|||
157239545|NCT03032172|567622952|FG005|Treatment Period|Non-compliance With Study Drug|0|||
157239546|NCT03032172|567622953|FG006|Treatment Period|Non-compliance With Study Drug|0|||
157239547|NCT03032172|567622954|FG007|Treatment Period|Non-compliance With Study Drug|0|||
157239548|NCT03032172|567622947|FG000|Treatment Period|Reason Not Specified|0|||
157239549|NCT03032172|567622948|FG001|Treatment Period|Reason Not Specified|4|||
157239550|NCT03032172|567622949|FG002|Treatment Period|Reason Not Specified|1|||
157239551|NCT03032172|567622950|FG003|Treatment Period|Reason Not Specified|0|||
157239552|NCT03032172|567622951|FG004|Treatment Period|Reason Not Specified|0|||
157239553|NCT03032172|567622952|FG005|Treatment Period|Reason Not Specified|0|||
157239554|NCT03032172|567622953|FG006|Treatment Period|Reason Not Specified|0|||
157239555|NCT03032172|567622954|FG007|Treatment Period|Reason Not Specified|0|||
157239556|NCT03032172|567622947|FG000|Treatment Period|Physician Decision|0|||
157239557|NCT03032172|567622948|FG001|Treatment Period|Physician Decision|2|||
157239558|NCT03032172|567622949|FG002|Treatment Period|Physician Decision|1|||
157239559|NCT03032172|567622950|FG003|Treatment Period|Physician Decision|0|||
157239560|NCT03032172|567622951|FG004|Treatment Period|Physician Decision|0|||
157239561|NCT03032172|567622952|FG005|Treatment Period|Physician Decision|0|||
157239562|NCT03032172|567622953|FG006|Treatment Period|Physician Decision|0|||
157239563|NCT03032172|567622954|FG007|Treatment Period|Physician Decision|0|||
157239564|NCT03032172|567622947|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
157239565|NCT03032172|567622948|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
157239566|NCT03032172|567622949|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
157091119|NCT01036763|567089012|FG000|Overall Study|Other reason (not specified)|40|||
157239567|NCT03032172|567622950|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
157239568|NCT03032172|567622951|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
157239569|NCT03032172|567622952|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
157239570|NCT03032172|567622953|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
157239571|NCT03032172|567622954|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
157239572|NCT03032172|567622947|FG000|Treatment Period|Withdrawal by Subject|2|||
157239573|NCT03032172|567622948|FG001|Treatment Period|Withdrawal by Subject|0|||
157239574|NCT03032172|567622949|FG002|Treatment Period|Withdrawal by Subject|3|||
157239575|NCT03032172|567622950|FG003|Treatment Period|Withdrawal by Subject|0|||
157239576|NCT03032172|567622951|FG004|Treatment Period|Withdrawal by Subject|0|||
157239577|NCT03032172|567622952|FG005|Treatment Period|Withdrawal by Subject|0|||
157239578|NCT03032172|567622953|FG006|Treatment Period|Withdrawal by Subject|0|||
157239579|NCT03032172|567622954|FG007|Treatment Period|Withdrawal by Subject|0|||
157239580|NCT03032172|567622947|FG000|Open-label Extension Period|Death|0|||
157239581|NCT03032172|567622948|FG001|Open-label Extension Period|Death|0|||
157239582|NCT03032172|567622949|FG002|Open-label Extension Period|Death|0|||
157239583|NCT03032172|567622950|FG003|Open-label Extension Period|Death|0|||
157239584|NCT03032172|567622951|FG004|Open-label Extension Period|Death|0|||
157239585|NCT03032172|567622952|FG005|Open-label Extension Period|Death|0|||
157239586|NCT03032172|567622953|FG006|Open-label Extension Period|Death|0|||
157239587|NCT03032172|567622954|FG007|Open-label Extension Period|Death|2|||
157239588|NCT03032172|567622947|FG000|Open-label Extension Period|Reason Not Specified|0|||
157239589|NCT03032172|567622948|FG001|Open-label Extension Period|Reason Not Specified|0|||
157239590|NCT03032172|567622949|FG002|Open-label Extension Period|Reason Not Specified|0|||
157239591|NCT03032172|567622950|FG003|Open-label Extension Period|Reason Not Specified|0|||
157239592|NCT03032172|567622951|FG004|Open-label Extension Period|Reason Not Specified|0|||
157239593|NCT03032172|567622952|FG005|Open-label Extension Period|Reason Not Specified|5|||
157239594|NCT03032172|567622953|FG006|Open-label Extension Period|Reason Not Specified|3|||
157239595|NCT03032172|567622954|FG007|Open-label Extension Period|Reason Not Specified|0|||
157239596|NCT03032172|567622947|FG000|Open-label Extension Period|Pregnancy|0|||
157239597|NCT03032172|567622948|FG001|Open-label Extension Period|Pregnancy|0|||
157239598|NCT03032172|567622949|FG002|Open-label Extension Period|Pregnancy|0|||
157239599|NCT03032172|567622950|FG003|Open-label Extension Period|Pregnancy|0|||
157239600|NCT03032172|567622951|FG004|Open-label Extension Period|Pregnancy|0|||
157239601|NCT03032172|567622952|FG005|Open-label Extension Period|Pregnancy|0|||
157239602|NCT03032172|567622953|FG006|Open-label Extension Period|Pregnancy|1|||
157239603|NCT03032172|567622954|FG007|Open-label Extension Period|Pregnancy|0|||
157239604|NCT03032172|567622947|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
157091120|NCT01672723|567089013|FG000|First Intervention|Adverse Event|3|||
157091121|NCT01672723|567089014|FG001|First Intervention|Adverse Event|0|||
157091122|NCT00743275|567089015|FG000|Overall Study|Protocol Violation|0|||
157239605|NCT03032172|567622948|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
157239606|NCT03032172|567622949|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
157239607|NCT03032172|567622950|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
157239608|NCT03032172|567622951|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
157239609|NCT03032172|567622952|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
157239610|NCT03032172|567622953|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
157239611|NCT03032172|567622954|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
157239612|NCT01111461|567622957|FG000|Overall Study|Adverse Event|32|||
157239613|NCT01111461|567622957|FG000|Overall Study|Participant choice|11|||
157239614|NCT01111461|567622957|FG000|Overall Study|Lost to Follow-up|1|||
157239615|NCT01111461|567622957|FG000|Overall Study|Withdrawal by Subject|1|||
157239616|NCT01111461|567622957|FG000|Overall Study|Other|6|||
157239617|NCT03600805|567622960|FG000|Overall Study|Adverse Event|2|||
157239618|NCT03600805|567622961|FG001|Overall Study|Adverse Event|1|||
157239619|NCT03600805|567622962|FG002|Overall Study|Adverse Event|1|||
157239620|NCT03600805|567622963|FG003|Overall Study|Adverse Event|7|||
157239621|NCT03600805|567622960|FG000|Overall Study|Lack of Efficacy|2|||
157239622|NCT03600805|567622961|FG001|Overall Study|Lack of Efficacy|1|||
157239623|NCT03600805|567622962|FG002|Overall Study|Lack of Efficacy|0|||
157239624|NCT03600805|567622963|FG003|Overall Study|Lack of Efficacy|0|||
157239625|NCT03600805|567622960|FG000|Overall Study|Withdrawal by Subject|1|||
157091123|NCT00743275|567089016|FG001|Overall Study|Protocol Violation|1|||
157091124|NCT00484289|567089027|FG000|Long Term Phase|Adverse Event|1|||
157091125|NCT00484289|567089028|FG001|Long Term Phase|Adverse Event|17|||
157239626|NCT03600805|567622961|FG001|Overall Study|Withdrawal by Subject|0|||
157239627|NCT03600805|567622962|FG002|Overall Study|Withdrawal by Subject|0|||
157239628|NCT03600805|567622963|FG003|Overall Study|Withdrawal by Subject|1|||
157239629|NCT03600805|567622960|FG000|Overall Study|Other unspecified|14|||
157239630|NCT03600805|567622961|FG001|Overall Study|Other unspecified|6|||
157239631|NCT03600805|567622962|FG002|Overall Study|Other unspecified|7|||
157091126|NCT00484289|567089029|FG002|Long Term Phase|Adverse Event|5|||
157239632|NCT03600805|567622963|FG003|Overall Study|Other unspecified|11|||
157239633|NCT01471353|567622968|FG000|Overall Study|remain on study|3|||
157239634|NCT03123094|567622969|FG000|Overall Study|Withdrawal by Subject|0|||
157239635|NCT03123094|567622970|FG001|Overall Study|Withdrawal by Subject|2|||
157239636|NCT03123094|567622971|FG002|Overall Study|Withdrawal by Subject|1|||
157239637|NCT03123094|567622972|FG003|Overall Study|Withdrawal by Subject|0|||
157239638|NCT03123094|567622973|FG004|Overall Study|Withdrawal by Subject|1|||
157239639|NCT00604162|567622974|FG000|Overall Study|Physician Decision|3|||
157239640|NCT00604162|567622974|FG000|Overall Study|Withdrawal by Subject|1|||
157239641|NCT00736190|567622981|FG000|Overall Study|Pregnancy|1|||
157239642|NCT00736190|567622981|FG000|Overall Study|Withdrawal by Subject|1|||
157239643|NCT00736190|567622981|FG000|Overall Study|Adverse Event|1|||
157239644|NCT05014828|567622982|FG000|Overall Study|Study Completed by Sponsor|16|||
157239645|NCT05014828|567622983|FG001|Overall Study|Study Completed by Sponsor|16|||
157239646|NCT05014828|567622984|FG002|Overall Study|Study Completed by Sponsor|3|||
157239647|NCT05014828|567622985|FG003|Overall Study|Study Completed by Sponsor|3|||
157239648|NCT05014828|567622982|FG000|Overall Study|Death|11|||
157239649|NCT05014828|567622983|FG001|Overall Study|Death|6|||
157239650|NCT05014828|567622984|FG002|Overall Study|Death|0|||
157239651|NCT05014828|567622985|FG003|Overall Study|Death|0|||
157239652|NCT05014828|567622982|FG000|Overall Study|Lost to Follow-up|0|||
157239653|NCT05014828|567622983|FG001|Overall Study|Lost to Follow-up|0|||
157239654|NCT05014828|567622984|FG002|Overall Study|Lost to Follow-up|2|||
157239655|NCT05014828|567622985|FG003|Overall Study|Lost to Follow-up|0|||
157239656|NCT05014828|567622982|FG000|Overall Study|Miscellaneous.|0|||
157239657|NCT05014828|567622983|FG001|Overall Study|Miscellaneous.|1|||
157239658|NCT05014828|567622984|FG002|Overall Study|Miscellaneous.|0|||
157239659|NCT05014828|567622985|FG003|Overall Study|Miscellaneous.|0|||
157239660|NCT02682238|567622989|FG000|Overall Study|Lost to Follow-up|0|||
157239661|NCT02682238|567622990|FG001|Overall Study|Lost to Follow-up|2|||
157239662|NCT02682238|567622989|FG000|Overall Study|Withdrawal by Subject|1|||
157239663|NCT02682238|567622990|FG001|Overall Study|Withdrawal by Subject|0|||
157239664|NCT02682238|567622989|FG000|Overall Study|Adverse Event|1|||
157239665|NCT02682238|567622990|FG001|Overall Study|Adverse Event|0|||
157239666|NCT02682238|567622989|FG000|Overall Study|Non-compliance with Study Drug|1|||
157239667|NCT02682238|567622990|FG001|Overall Study|Non-compliance with Study Drug|0|||
157239668|NCT02682238|567622989|FG000|Overall Study|Non-compliance with Protocol|0|||
157239669|NCT02682238|567622990|FG001|Overall Study|Non-compliance with Protocol|2|||
157239670|NCT01370317|567622991|FG000|Overall Study|Participant withdrew consent|1|||
157239671|NCT01370317|567622992|FG001|Overall Study|Participant withdrew consent|0|||
157239672|NCT01370317|567622991|FG000|Overall Study|Protocol deviation|0|||
157239673|NCT01370317|567622992|FG001|Overall Study|Protocol deviation|1|||
157239674|NCT00075478|567622994|FG000|Overall Study|not eligible|1|||
157239675|NCT00075478|567622995|FG001|Overall Study|not eligible|0|||
157239676|NCT00075478|567622994|FG000|Overall Study|Physician Decision|0|||
157239677|NCT00075478|567622995|FG001|Overall Study|Physician Decision|1|||
157239678|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
157239679|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
157239680|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
157239681|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
157239682|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
157239683|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
157239684|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
157239685|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
157239686|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
157239687|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
157239688|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
157239689|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
157239690|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
157239691|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
157239692|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
157239693|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
157239694|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
157239695|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
157239696|NCT01667679|567622999|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
157239697|NCT01667679|567623000|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
157239698|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
157239699|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
157239700|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
157239701|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
157239702|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
157239703|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
157239704|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
157091127|NCT00484289|567089027|FG000|Long Term Phase|Withdrawal by Subject|0|||
157091128|NCT00484289|567089028|FG001|Long Term Phase|Withdrawal by Subject|7|||
157091129|NCT00484289|567089029|FG002|Long Term Phase|Withdrawal by Subject|6|||
157091130|NCT00484289|567089027|FG000|Long Term Phase|Inadequate response|2|||
157091131|NCT00484289|567089028|FG001|Long Term Phase|Inadequate response|7|||
157091132|NCT00484289|567089029|FG002|Long Term Phase|Inadequate response|4|||
157091133|NCT00484289|567089027|FG000|Long Term Phase|Other Reason|0|||
157091134|NCT00484289|567089028|FG001|Long Term Phase|Other Reason|5|||
157239705|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
157239706|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
157239707|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
157091135|NCT00484289|567089029|FG002|Long Term Phase|Other Reason|1|||
157239708|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
157239709|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
157239710|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
157239711|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
157239712|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
157239713|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
157239714|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
157239715|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
157239716|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
157239717|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
157239718|NCT01667679|567622999|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
157239719|NCT01667679|567623000|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
157239720|NCT03249454|567623005|FG000|Overall Study|Withdrawal by Subject|0|||
157239721|NCT03249454|567623006|FG001|Overall Study|Withdrawal by Subject|0|||
157239722|NCT03249454|567623007|FG002|Overall Study|Withdrawal by Subject|0|||
157239723|NCT03249454|567623008|FG003|Overall Study|Withdrawal by Subject|0|||
157239724|NCT03249454|567623009|FG004|Overall Study|Withdrawal by Subject|0|||
157239725|NCT03249454|567623010|FG005|Overall Study|Withdrawal by Subject|0|||
157239726|NCT03249454|567623011|FG006|Overall Study|Withdrawal by Subject|0|||
157239727|NCT03249454|567623012|FG007|Overall Study|Withdrawal by Subject|0|||
157239728|NCT03249454|567623013|FG008|Overall Study|Withdrawal by Subject|0|||
157239729|NCT03249454|567623014|FG009|Overall Study|Withdrawal by Subject|1|||
157239730|NCT03249454|567623015|FG010|Overall Study|Withdrawal by Subject|1|||
157239731|NCT01103713|567623016|FG000|Overall Study|Lost to Follow-up|2|||
157239732|NCT01103713|567623016|FG000|Overall Study|Withdrawal by Subject|8|||
157239733|NCT01103713|567623016|FG000|Overall Study|Study terminated by sponsor|2|||
157239734|NCT01103713|567623016|FG000|Overall Study|Other|1|||
157239735|NCT02645409|567623017|FG000|Overall Study|Withdrawal by Subject|3|||
157239736|NCT02645409|567623018|FG001|Overall Study|Withdrawal by Subject|0|||
157239737|NCT02645409|567623017|FG000|Overall Study|Physician Decision|1|||
157239738|NCT02645409|567623018|FG001|Overall Study|Physician Decision|0|||
157239739|NCT02089685|567623019|FG000|Overall Study|Adverse Event|1|||
157239740|NCT02089685|567623020|FG001|Overall Study|Adverse Event|0|||
157239741|NCT02089685|567623021|FG002|Overall Study|Adverse Event|0|||
157239742|NCT02089685|567623022|FG003|Overall Study|Adverse Event|0|||
157239743|NCT02089685|567623023|FG004|Overall Study|Adverse Event|1|||
157239744|NCT02089685|567623024|FG005|Overall Study|Adverse Event|0|||
157239745|NCT02089685|567623019|FG000|Overall Study|Clinical Progression|4|||
157239746|NCT02089685|567623020|FG001|Overall Study|Clinical Progression|0|||
157239747|NCT02089685|567623021|FG002|Overall Study|Clinical Progression|0|||
157239748|NCT02089685|567623022|FG003|Overall Study|Clinical Progression|5|||
157091136|NCT00484289|567089027|FG000|Post Marketing Phase|Adverse Event|0|||
157091137|NCT00484289|567089028|FG001|Post Marketing Phase|Adverse Event|1|||
157091138|NCT00484289|567089029|FG002|Post Marketing Phase|Adverse Event|0|||
157091139|NCT01312857|567089033|FG000|Overall Study|Adverse Event|1|||
157091140|NCT01312857|567089034|FG001|Overall Study|Adverse Event|1|||
157091141|NCT01312857|567089033|FG000|Overall Study|Lost to Follow-up|2|||
157091142|NCT01312857|567089034|FG001|Overall Study|Lost to Follow-up|0|||
157091143|NCT01312857|567089033|FG000|Overall Study|Physician Decision|3|||
157091144|NCT01312857|567089034|FG001|Overall Study|Physician Decision|0|||
157091145|NCT01312857|567089033|FG000|Overall Study|Withdrawal by Subject|2|||
157091146|NCT01312857|567089034|FG001|Overall Study|Withdrawal by Subject|0|||
157091147|NCT00262951|567089040|FG000|Overall Study|Progressive disease/relapse|3|||
157239749|NCT02089685|567623023|FG004|Overall Study|Clinical Progression|1|||
157239750|NCT02089685|567623024|FG005|Overall Study|Clinical Progression|2|||
157239751|NCT02089685|567623019|FG000|Overall Study|Excluded Medication|1|||
157239752|NCT02089685|567623020|FG001|Overall Study|Excluded Medication|0|||
157239753|NCT02089685|567623021|FG002|Overall Study|Excluded Medication|0|||
157239754|NCT02089685|567623022|FG003|Overall Study|Excluded Medication|11|||
157239755|NCT02089685|567623023|FG004|Overall Study|Excluded Medication|2|||
157239756|NCT02089685|567623024|FG005|Overall Study|Excluded Medication|1|||
157239757|NCT02089685|567623019|FG000|Overall Study|Progressive disease|13|||
157239758|NCT02089685|567623020|FG001|Overall Study|Progressive disease|10|||
157239759|NCT02089685|567623021|FG002|Overall Study|Progressive disease|3|||
157239760|NCT02089685|567623022|FG003|Overall Study|Progressive disease|51|||
157239761|NCT02089685|567623023|FG004|Overall Study|Progressive disease|17|||
157239762|NCT02089685|567623024|FG005|Overall Study|Progressive disease|12|||
157239763|NCT02089685|567623019|FG000|Overall Study|Follow up ended by sponsor|2|||
157239764|NCT02089685|567623020|FG001|Overall Study|Follow up ended by sponsor|2|||
157239765|NCT02089685|567623021|FG002|Overall Study|Follow up ended by sponsor|0|||
157239766|NCT02089685|567623022|FG003|Overall Study|Follow up ended by sponsor|70|||
157091148|NCT00262951|567089040|FG000|Overall Study|Adverse Event|7|||
157091149|NCT00262951|567089040|FG000|Overall Study|Death|1|||
157091150|NCT00262951|567089040|FG000|Overall Study|Withdrawal by Subject|1|||
157091151|NCT00262951|567089040|FG000|Overall Study|Alternative treatment|3|||
157239767|NCT02089685|567623023|FG004|Overall Study|Follow up ended by sponsor|26|||
157239768|NCT02089685|567623024|FG005|Overall Study|Follow up ended by sponsor|26|||
157239769|NCT02089685|567623019|FG000|Overall Study|Withdrawal by Subject|0|||
157239770|NCT02089685|567623020|FG001|Overall Study|Withdrawal by Subject|2|||
157239771|NCT02089685|567623021|FG002|Overall Study|Withdrawal by Subject|0|||
157239772|NCT02089685|567623022|FG003|Overall Study|Withdrawal by Subject|8|||
157239773|NCT02089685|567623023|FG004|Overall Study|Withdrawal by Subject|1|||
157239774|NCT02089685|567623024|FG005|Overall Study|Withdrawal by Subject|1|||
157239775|NCT02089685|567623019|FG000|Overall Study|Status not recorded|1|||
157239776|NCT02089685|567623020|FG001|Overall Study|Status not recorded|0|||
157239777|NCT02089685|567623021|FG002|Overall Study|Status not recorded|0|||
157239778|NCT02089685|567623022|FG003|Overall Study|Status not recorded|0|||
157239779|NCT02089685|567623023|FG004|Overall Study|Status not recorded|1|||
157239780|NCT02089685|567623024|FG005|Overall Study|Status not recorded|0|||
157239781|NCT02089685|567623019|FG000|Overall Study|Death|0|||
157239782|NCT02089685|567623020|FG001|Overall Study|Death|0|||
157239783|NCT02089685|567623021|FG002|Overall Study|Death|0|||
157239784|NCT02089685|567623022|FG003|Overall Study|Death|7|||
157239785|NCT02089685|567623023|FG004|Overall Study|Death|2|||
157239786|NCT02089685|567623024|FG005|Overall Study|Death|5|||
157239787|NCT02089685|567623019|FG000|Overall Study|Lost to Follow-up|0|||
157239788|NCT02089685|567623020|FG001|Overall Study|Lost to Follow-up|0|||
157239789|NCT02089685|567623021|FG002|Overall Study|Lost to Follow-up|0|||
157239790|NCT02089685|567623022|FG003|Overall Study|Lost to Follow-up|1|||
157239791|NCT02089685|567623023|FG004|Overall Study|Lost to Follow-up|0|||
157239792|NCT02089685|567623024|FG005|Overall Study|Lost to Follow-up|0|||
157239793|NCT02089685|567623019|FG000|Overall Study|Physician Decision|0|||
157239794|NCT02089685|567623020|FG001|Overall Study|Physician Decision|0|||
157239795|NCT02089685|567623021|FG002|Overall Study|Physician Decision|0|||
157239796|NCT02089685|567623022|FG003|Overall Study|Physician Decision|0|||
157239797|NCT02089685|567623023|FG004|Overall Study|Physician Decision|0|||
157239798|NCT02089685|567623024|FG005|Overall Study|Physician Decision|4|||
157239799|NCT02089685|567623019|FG000|Overall Study|Screen failure|1|||
157239800|NCT02089685|567623020|FG001|Overall Study|Screen failure|0|||
157239801|NCT02089685|567623021|FG002|Overall Study|Screen failure|0|||
157239802|NCT02089685|567623022|FG003|Overall Study|Screen failure|0|||
157239803|NCT02089685|567623023|FG004|Overall Study|Screen failure|0|||
157239804|NCT02089685|567623024|FG005|Overall Study|Screen failure|0|||
157239805|NCT03552393|567623027|FG000|Core Period|Kidney Transplant|1|||
157239806|NCT03552393|567623027|FG000|Core Period|Prohibited Medication|1|||
157239807|NCT03552393|567623027|FG000|Safety Extension Period|Kidney Transplant|4|||
157239808|NCT04887415|567623030|FG000|Overall Study|Lost to Follow-up|2|||
157239809|NCT05646251|567623031|FG000|Overall Study|Physician Decision|1|||
157239810|NCT05646251|567623032|FG001|Overall Study|Physician Decision|0|||
157239811|NCT05646251|567623033|FG002|Overall Study|Physician Decision|2|||
157239812|NCT01249651|567623037|FG000|Overall Study|Withdrawal by Subject|4|||
157239813|NCT01249651|567623037|FG000|Overall Study|Adverse Event|1|||
157239814|NCT01249651|567623037|FG000|Overall Study|Protocol Violation|1|||
157239815|NCT01249651|567623037|FG000|Overall Study|Sponsor Decision|1|||
157239816|NCT00813592|567623038|FG000|Overall Study|Disease assessment was not completed per|2|||
157239817|NCT01588236|567623043|FG000|Overall Study|Adverse Event|5|||
157239818|NCT01588236|567623044|FG001|Overall Study|Adverse Event|4|||
157239819|NCT01588236|567623045|FG002|Overall Study|Adverse Event|1|||
157239820|NCT01588236|567623043|FG000|Overall Study|Lost to Follow-up|8|||
157239821|NCT01588236|567623044|FG001|Overall Study|Lost to Follow-up|13|||
157239822|NCT01588236|567623045|FG002|Overall Study|Lost to Follow-up|6|||
157239823|NCT01588236|567623043|FG000|Overall Study|Physician Decision|1|||
157239824|NCT01588236|567623044|FG001|Overall Study|Physician Decision|2|||
157239825|NCT01588236|567623045|FG002|Overall Study|Physician Decision|0|||
157239826|NCT01588236|567623043|FG000|Overall Study|Protocol Violation|0|||
157239827|NCT01588236|567623044|FG001|Overall Study|Protocol Violation|1|||
157239828|NCT01588236|567623045|FG002|Overall Study|Protocol Violation|1|||
157239829|NCT01588236|567623043|FG000|Overall Study|Withdrawal by Subject|14|||
157239830|NCT01588236|567623044|FG001|Overall Study|Withdrawal by Subject|16|||
157239831|NCT01588236|567623045|FG002|Overall Study|Withdrawal by Subject|18|||
157239832|NCT01588236|567623043|FG000|Overall Study|Exclusion Criteria met during study|2|||
157239833|NCT01588236|567623044|FG001|Overall Study|Exclusion Criteria met during study|1|||
157239834|NCT01588236|567623045|FG002|Overall Study|Exclusion Criteria met during study|0|||
157239835|NCT01588236|567623043|FG000|Overall Study|sponsor decision|1|||
157239836|NCT01588236|567623044|FG001|Overall Study|sponsor decision|6|||
157239837|NCT01588236|567623045|FG002|Overall Study|sponsor decision|2|||
157239838|NCT03873272|567623046|FG000|Overall Study|Withdrawal by Subject|2|||
157239839|NCT03873272|567623047|FG001|Overall Study|Withdrawal by Subject|0|||
157239840|NCT03873272|567623048|FG002|Overall Study|Withdrawal by Subject|1|||
157239841|NCT03873272|567623046|FG000|Overall Study|Death|0|||
157239842|NCT03873272|567623047|FG001|Overall Study|Death|2|||
157239843|NCT03873272|567623048|FG002|Overall Study|Death|1|||
157239844|NCT00787254|567623049|FG000|Overall Study|Adverse Event|24|||
157239845|NCT00787254|567623050|FG001|Overall Study|Adverse Event|23|||
157239846|NCT00787254|567623049|FG000|Overall Study|Protocol Violation|26|||
157239847|NCT00787254|567623050|FG001|Overall Study|Protocol Violation|23|||
157239848|NCT00787254|567623049|FG000|Overall Study|Withdrawal by Subject|16|||
157239849|NCT00787254|567623050|FG001|Overall Study|Withdrawal by Subject|11|||
157239850|NCT00787254|567623049|FG000|Overall Study|Lack of Efficacy|4|||
157239851|NCT00787254|567623050|FG001|Overall Study|Lack of Efficacy|15|||
157239852|NCT00787254|567623049|FG000|Overall Study|NSAIDs discontinuation|1|||
157239853|NCT00787254|567623050|FG001|Overall Study|NSAIDs discontinuation|2|||
157239854|NCT00787254|567623049|FG000|Overall Study|Institution closed|1|||
157239855|NCT00787254|567623050|FG001|Overall Study|Institution closed|0|||
157239856|NCT00787254|567623049|FG000|Overall Study|Physician Decision|4|||
157239857|NCT00787254|567623050|FG001|Overall Study|Physician Decision|8|||
157239858|NCT03761173|567623055|FG000|Overall Study|Lost to Follow-up|93|||
157239859|NCT03761173|567623055|FG000|Overall Study|Withdrawal by Subject|74|||
157239860|NCT03761173|567623055|FG000|Overall Study|Death|45|||
157239861|NCT03761173|567623055|FG000|Overall Study|Withdrawal for Other Reasons|29|||
157239862|NCT03761173|567623055|FG000|Overall Study|Protocol Violation|1|||
157239863|NCT00316186|567623056|FG000|Overall Study|Adverse Event|6|||
157239864|NCT00316186|567623056|FG000|Overall Study|Disease Progression|4|||
157239865|NCT00316186|567623056|FG000|Overall Study|Lost to Follow-up|1|||
157239866|NCT00316186|567623056|FG000|Overall Study|Other|1|||
157239867|NCT05152576|567623058|FG000|Overall Study|Lost to Follow-up|3|||
157239868|NCT05152576|567623059|FG001|Overall Study|Lost to Follow-up|0|||
157239869|NCT05152576|567623060|FG002|Overall Study|Lost to Follow-up|0|||
157239870|NCT05152576|567623061|FG003|Overall Study|Lost to Follow-up|1|||
157239871|NCT05152576|567623058|FG000|Overall Study|Withdrawal by Subject|0|||
157239872|NCT05152576|567623059|FG001|Overall Study|Withdrawal by Subject|1|||
157239873|NCT05152576|567623060|FG002|Overall Study|Withdrawal by Subject|0|||
157239874|NCT05152576|567623061|FG003|Overall Study|Withdrawal by Subject|1|||
157239875|NCT05152576|567623058|FG000|Overall Study|Other|2|||
157239876|NCT05152576|567623059|FG001|Overall Study|Other|0|||
157239877|NCT05152576|567623060|FG002|Overall Study|Other|0|||
157239878|NCT05152576|567623061|FG003|Overall Study|Other|0|||
157239879|NCT01952691|567624894|FG000|Overall Study|Lost to Follow-up|2|||
157239880|NCT00199901|567624895|FG000|Overall Study|Protocol Violation|2|||
157239881|NCT00199901|567624896|FG001|Overall Study|Protocol Violation|0|||
157239882|NCT00199901|567624895|FG000|Overall Study|Withdrawal by Subject|1|||
157239883|NCT00199901|567624896|FG001|Overall Study|Withdrawal by Subject|0|||
157239884|NCT00199901|567624895|FG000|Overall Study|Progressive Disease|24|||
157239885|NCT00199901|567624896|FG001|Overall Study|Progressive Disease|24|||
157239886|NCT05776901|567624899|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
157239887|NCT00373256|567624921|FG000|Overall Study|Adverse Event (AE)|1|||
157239888|NCT00373256|567624922|FG001|Overall Study|Adverse Event (AE)|5|||
157239889|NCT00373256|567624921|FG000|Overall Study|Lost to Follow-up|2|||
157239890|NCT00373256|567624922|FG001|Overall Study|Lost to Follow-up|1|||
157239891|NCT00373256|567624921|FG000|Overall Study|Death|9|||
157239892|NCT00373256|567624922|FG001|Overall Study|Death|8|||
157239893|NCT00373256|567624921|FG000|Overall Study|Objective Progression or Relapse|111|||
157239894|NCT00373256|567624922|FG001|Overall Study|Objective Progression or Relapse|104|||
157239895|NCT00373256|567624921|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
157239896|NCT00373256|567624922|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
157239897|NCT00373256|567624921|FG000|Overall Study|Other|73|||
157239898|NCT00373256|567624922|FG001|Overall Study|Other|107|||
157239899|NCT00373256|567624921|FG000|Overall Study|Protocol Violation|0|||
157239900|NCT00373256|567624922|FG001|Overall Study|Protocol Violation|2|||
157239901|NCT00373256|567624921|FG000|Overall Study|Study Terminated by Sponsor|41|||
157239902|NCT00373256|567624922|FG001|Overall Study|Study Terminated by Sponsor|13|||
157239903|NCT00834522|567624926|FG000|Washout|Adverse Event|1|||
157239904|NCT00834522|567624927|FG001|Washout|Adverse Event|0|||
157239905|NCT00834522|567624926|FG000|Washout|Withdrawal by Subject|2|||
157239906|NCT00834522|567624927|FG001|Washout|Withdrawal by Subject|1|||
157239907|NCT00824291|567624936|FG000|Overall Study|Adverse Event|15|||
157239908|NCT00824291|567624937|FG001|Overall Study|Adverse Event|6|||
157239909|NCT00824291|567624936|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
157239910|NCT00824291|567624937|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
157239911|NCT00824291|567624936|FG000|Overall Study|Lost to Follow-up|11|||
157239912|NCT00824291|567624937|FG001|Overall Study|Lost to Follow-up|9|||
157091152|NCT00262951|567089040|FG000|Overall Study|Off treatment for other disease|1|||
157239913|NCT00824291|567624936|FG000|Overall Study|Non-compliance|1|||
157239914|NCT00824291|567624937|FG001|Overall Study|Non-compliance|1|||
157239915|NCT00824291|567624936|FG000|Overall Study|Protocol Violation|4|||
157239916|NCT00824291|567624937|FG001|Overall Study|Protocol Violation|1|||
157239917|NCT00824291|567624936|FG000|Overall Study|Withdrawal by Subject|14|||
157239918|NCT00824291|567624937|FG001|Overall Study|Withdrawal by Subject|8|||
157239919|NCT00824291|567624936|FG000|Overall Study|Lack of Efficacy|7|||
157239920|NCT00824291|567624937|FG001|Overall Study|Lack of Efficacy|8|||
157239921|NCT00824291|567624936|FG000|Overall Study|Participant on prohibited medication|1|||
157239922|NCT00824291|567624937|FG001|Overall Study|Participant on prohibited medication|0|||
157239923|NCT00123734|567624941|FG000|Overall Study|Death|3|||
157239924|NCT00123734|567624941|FG000|Overall Study|Lost to Follow-up|3|||
157091153|NCT01778023|567089041|FG000|Overall Study|Withdrawal by Subject|0|||
157239925|NCT00123734|567624941|FG000|Overall Study|Dropout|1|||
157239926|NCT00123734|567624941|FG000|Overall Study|Withdrawal by Subject|1|||
157239927|NCT00113386|567624942|FG000|Overall Study|Withdrawal by Subject|1|||
157239928|NCT00113386|567624943|FG001|Overall Study|Withdrawal by Subject|0|||
157239929|NCT00113386|567624942|FG000|Overall Study|Physician Decision|0|||
157239930|NCT00113386|567624943|FG001|Overall Study|Physician Decision|1|||
157239931|NCT00113386|567624942|FG000|Overall Study|Toxicity|3|||
157239932|NCT00113386|567624943|FG001|Overall Study|Toxicity|0|||
157239933|NCT00113386|567624942|FG000|Overall Study|Ineligible|1|||
157239934|NCT00113386|567624943|FG001|Overall Study|Ineligible|2|||
157239935|NCT00113386|567624942|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
157239936|NCT00113386|567624943|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
157239937|NCT00834340|567624944|FG000|Washout|Adverse Event|1|||
157239938|NCT00834340|567624945|FG001|Washout|Adverse Event|0|||
157239939|NCT00834340|567624944|FG000|Washout|Withdrawal by Subject|1|||
157239940|NCT00834340|567624945|FG001|Washout|Withdrawal by Subject|0|||
157239941|NCT00395694|567624946|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
157239942|NCT00395694|567624947|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
157239943|NCT00395694|567624946|FG000|Continuation Phase|Adverse Event|1|||
157239944|NCT00395694|567624947|FG001|Continuation Phase|Adverse Event|0|||
157239945|NCT00395694|567624946|FG000|Continuation Phase|Lack of Efficacy|12|||
157091154|NCT01778023|567089042|FG001|Overall Study|Withdrawal by Subject|3|||
157091155|NCT00577577|567089046|FG000|Overall Study|Adverse Event|3|||
157091156|NCT00577577|567089047|FG001|Overall Study|Adverse Event|2|||
157091157|NCT00577577|567089046|FG000|Overall Study|Lost to Follow-up|1|||
157091158|NCT00577577|567089047|FG001|Overall Study|Lost to Follow-up|0|||
157091159|NCT00577577|567089046|FG000|Overall Study|Protocol Violation|0|||
157091160|NCT00577577|567089047|FG001|Overall Study|Protocol Violation|3|||
157091161|NCT00577577|567089046|FG000|Overall Study|Transportation|1|||
157197236|NCT01059175|567465253|FG000|Overall Study|Lost to Follow-up|0|||
157197237|NCT01059175|567465254|FG001|Overall Study|Lost to Follow-up|1|||
157197238|NCT02957149|567465255|FG000|Overall Study|Withdrawal by Subject|5|||
157197239|NCT06045026|567465256|FG000|Overall Study|Lost to Follow-up|60|||
157197240|NCT06045026|567465256|FG000|Overall Study|Adverse Event|12|||
157197241|NCT06045026|567465256|FG000|Overall Study|Withdrawal by Subject|3|||
157197242|NCT06045026|567465256|FG000|Overall Study|Enrollment closed|1|||
157197243|NCT04511533|567465257|FG000|Treatment|Other|2|||
157197244|NCT04511533|567465257|FG000|Treatment|Withdrawal by Subject|11|||
157197245|NCT04511533|567465257|FG000|Treatment|Death|5|||
157197246|NCT04511533|567465257|FG000|Treatment|Physician Decision|1|||
157197247|NCT04511533|567465257|FG000|Treatment|Progressive Disease|61|||
157197248|NCT04511533|567465257|FG000|Follow-Up|Other|7|||
157197249|NCT04511533|567465257|FG000|Follow-Up|Withdrawal by Subject|5|||
157197250|NCT04511533|567465257|FG000|Follow-Up|Lost to Follow-up|2|||
157197251|NCT04511533|567465257|FG000|Follow-Up|Death|4|||
157197252|NCT01928758|567465258|FG000|Overall Study|Lost to Follow-up|14|||
157197253|NCT01928758|567465259|FG001|Overall Study|Lost to Follow-up|9|||
157197254|NCT01928758|567465258|FG000|Overall Study|Withdrawal by Subject|5|||
157197255|NCT01928758|567465259|FG001|Overall Study|Withdrawal by Subject|2|||
157197256|NCT01928758|567465258|FG000|Overall Study|Adverse Event|3|||
157197257|NCT01928758|567465259|FG001|Overall Study|Adverse Event|5|||
157197258|NCT01928758|567465258|FG000|Overall Study|Protocol Violation|3|||
157197259|NCT01928758|567465259|FG001|Overall Study|Protocol Violation|4|||
157197260|NCT02718131|567465260|FG000|Overall Study|Withdrawal by Subject|1|||
157197261|NCT02718131|567465261|FG001|Overall Study|Withdrawal by Subject|0|||
157197262|NCT02718131|567465260|FG000|Overall Study|Adverse Event|1|||
157197263|NCT02718131|567465261|FG001|Overall Study|Adverse Event|0|||
157197264|NCT02718131|567465260|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
157197265|NCT02718131|567465261|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
157197266|NCT02452320|567465262|FG000|Overall Study|Adverse Event|0|||
157197267|NCT02452320|567465263|FG001|Overall Study|Adverse Event|1|||
157197268|NCT03198559|567465264|FG000|Overall Study|Adverse Event|2|||
157197269|NCT01474291|567465268|FG000|Overall Study|Not Evaluable for Efficacy|26|||
157197270|NCT01474291|567465268|FG000|Overall Study|Lack of Treatment Efficacy|88|||
157197271|NCT01474291|567465268|FG000|Overall Study|Adverse Event|53|||
157197272|NCT01474291|567465268|FG000|Overall Study|Lost to Follow-up|29|||
157197273|NCT01474291|567465268|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
157197274|NCT01474291|567465268|FG000|Overall Study|No Reason Reported|10|||
157197275|NCT01474291|567465268|FG000|Overall Study|Death|2|||
157197276|NCT03471507|567465269|FG000|Overall Study|Lost to Follow-up|1|||
157197277|NCT03471507|567465270|FG001|Overall Study|Lost to Follow-up|3|||
157197278|NCT03471507|567465269|FG000|Overall Study|Physician Decision|0|||
157197279|NCT03471507|567465270|FG001|Overall Study|Physician Decision|1|||
157197280|NCT03471507|567465269|FG000|Overall Study|Withdrawal by Subject|2|||
157197281|NCT03471507|567465270|FG001|Overall Study|Withdrawal by Subject|1|||
157197282|NCT02046993|567465274|FG000|Overall Study|Withdrawal by Subject|2|||
157197283|NCT02046993|567465275|FG001|Overall Study|Withdrawal by Subject|10|||
157197284|NCT02046993|567465274|FG000|Overall Study|Lost to Follow-up|1|||
157239946|NCT00395694|567624947|FG001|Continuation Phase|Lack of Efficacy|11|||
157239947|NCT00395694|567624946|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
157239948|NCT00395694|567624947|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
157239949|NCT00395694|567624946|FG000|Continuation Phase|Poor Compliance|1|||
157239950|NCT00395694|567624947|FG001|Continuation Phase|Poor Compliance|0|||
157239951|NCT00395694|567624946|FG000|Continuation Phase|Withdrawal by Subject|0|||
157239952|NCT00395694|567624947|FG001|Continuation Phase|Withdrawal by Subject|2|||
157239953|NCT00392665|567624950|FG000|Overall Study|Death|16|||
157239954|NCT00392665|567624951|FG001|Overall Study|Death|14|||
157239955|NCT00392665|567624950|FG000|Overall Study|Lost to Follow-up|1|||
157239956|NCT00392665|567624951|FG001|Overall Study|Lost to Follow-up|1|||
157239957|NCT03673670|567624952|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
157239958|NCT03673670|567624953|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
157239959|NCT03673670|567624954|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
157239960|NCT03673670|567624955|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
157239961|NCT03673670|567624956|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
157239962|NCT03673670|567624957|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
157239963|NCT03673670|567624952|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
157239964|NCT03673670|567624953|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
157239965|NCT03673670|567624954|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
157239966|NCT03673670|567624955|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
157239967|NCT03673670|567624956|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
157239968|NCT03673670|567624957|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
157239969|NCT03673670|567624952|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
157239970|NCT03673670|567624953|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
157239971|NCT03673670|567624954|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
157239972|NCT03673670|567624955|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
157239973|NCT03673670|567624956|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
157239974|NCT03673670|567624957|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
157239975|NCT03673670|567624952|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
157239976|NCT03673670|567624953|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
157239977|NCT03673670|567624954|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
157239978|NCT03673670|567624955|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
157239979|NCT03673670|567624956|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
157239980|NCT03673670|567624957|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
157239981|NCT03673670|567624952|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
157239982|NCT03673670|567624953|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
157239983|NCT03673670|567624954|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
157239984|NCT03673670|567624955|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
157239985|NCT03673670|567624956|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
157239986|NCT03673670|567624957|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
157239987|NCT03673670|567624952|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
157239988|NCT03673670|567624953|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
157239989|NCT03673670|567624954|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
157239990|NCT03673670|567624955|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
157239991|NCT03673670|567624956|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
157239992|NCT03673670|567624957|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
157239993|NCT03673670|567624952|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
157239994|NCT03673670|567624953|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
157239995|NCT03673670|567624954|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
157239996|NCT03673670|567624955|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
157239997|NCT03673670|567624956|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
157239998|NCT03673670|567624957|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
157239999|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Adverse Event|8|||
157240000|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Adverse Event|15|||
157240001|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Adverse Event|25|||
157240002|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
157240003|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
157240004|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
157240005|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
157240006|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
157240007|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
157240008|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
157240009|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
157240010|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
157240011|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
157240012|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
157240013|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
157091162|NCT00577577|567089047|FG001|Overall Study|Transportation|0|||
157240014|NCT01058668|567624958|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
157091163|NCT00232544|567089048|FG000|Overall Study|Lost to Follow-up|20|||
157091164|NCT00232544|567089049|FG001|Overall Study|Lost to Follow-up|15|||
157091165|NCT00116753|567089050|FG000|Overall Study|Adverse Event|16|||
157091166|NCT00116753|567089051|FG001|Overall Study|Adverse Event|10|||
157091167|NCT00116753|567089052|FG002|Overall Study|Adverse Event|7|||
157091168|NCT00116753|567089050|FG000|Overall Study|Withdrawal by Subject|11|||
157197285|NCT02046993|567465275|FG001|Overall Study|Lost to Follow-up|1|||
157197286|NCT00598442|567465281|FG000|Overall Study|Adverse Event|3|||
157197287|NCT00598442|567465282|FG001|Overall Study|Adverse Event|0|||
157197288|NCT00598442|567465283|FG002|Overall Study|Adverse Event|0|||
157197289|NCT00598442|567465281|FG000|Overall Study|Death|19|||
157197290|NCT00598442|567465282|FG001|Overall Study|Death|11|||
157197291|NCT00598442|567465283|FG002|Overall Study|Death|11|||
157197292|NCT00598442|567465281|FG000|Overall Study|Lost to Follow-up|4|||
157197293|NCT00598442|567465282|FG001|Overall Study|Lost to Follow-up|3|||
157197294|NCT00598442|567465283|FG002|Overall Study|Lost to Follow-up|3|||
157197295|NCT00598442|567465281|FG000|Overall Study|Physician Decision|2|||
157197296|NCT00598442|567465282|FG001|Overall Study|Physician Decision|1|||
157197297|NCT00598442|567465283|FG002|Overall Study|Physician Decision|1|||
157197298|NCT00598442|567465281|FG000|Overall Study|Withdrawal by Subject|8|||
157197299|NCT00598442|567465282|FG001|Overall Study|Withdrawal by Subject|16|||
157197300|NCT00598442|567465283|FG002|Overall Study|Withdrawal by Subject|6|||
157197301|NCT00598442|567465281|FG000|Overall Study|Noncompliance|0|||
157197302|NCT00598442|567465282|FG001|Overall Study|Noncompliance|2|||
157197303|NCT00598442|567465283|FG002|Overall Study|Noncompliance|1|||
157197304|NCT00598442|567465281|FG000|Overall Study|Relocation|1|||
157197305|NCT00598442|567465282|FG001|Overall Study|Relocation|4|||
157197306|NCT00598442|567465283|FG002|Overall Study|Relocation|0|||
157197307|NCT00598442|567465281|FG000|Overall Study|Renal transplant|0|||
157197308|NCT00598442|567465282|FG001|Overall Study|Renal transplant|0|||
157197309|NCT00598442|567465283|FG002|Overall Study|Renal transplant|1|||
157197310|NCT00598442|567465281|FG000|Overall Study|Site closed by sponsor|5|||
157197311|NCT00598442|567465282|FG001|Overall Study|Site closed by sponsor|2|||
157197312|NCT00598442|567465283|FG002|Overall Study|Site closed by sponsor|1|||
157197313|NCT00598442|567465281|FG000|Overall Study|Started dialysis|1|||
157197314|NCT00598442|567465282|FG001|Overall Study|Started dialysis|0|||
157197315|NCT00598442|567465283|FG002|Overall Study|Started dialysis|0|||
157197316|NCT01590628|567465292|FG000|Overall Study|Death|2|||
157197317|NCT01590628|567465293|FG001|Overall Study|Death|0|||
157197318|NCT00475657|567465294|FG000|Overall Study|Death|1|||
157197319|NCT00475657|567465294|FG000|Overall Study|Sponsor's Decision|3|||
157197320|NCT00761735|567465295|FG000|Overall Study|Lost to Follow-up|6|||
157197321|NCT00761735|567465295|FG000|Overall Study|Withdrawal by Subject|6|||
157197322|NCT00761735|567465295|FG000|Overall Study|Non-compliance with protocol|1|||
157197323|NCT00761735|567465295|FG000|Overall Study|Administrative|1|||
157197324|NCT00267202|567465308|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
157197325|NCT00267202|567465309|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
157197326|NCT00267202|567465308|FG000|Overall Study|Withdrawal by Subject|12|||
157197327|NCT00267202|567465309|FG001|Overall Study|Withdrawal by Subject|15|||
157197328|NCT00267202|567465308|FG000|Overall Study|Adverse Event|13|||
157197329|NCT00267202|567465309|FG001|Overall Study|Adverse Event|7|||
157197330|NCT00267202|567465308|FG000|Overall Study|Protocol Violation|2|||
157197331|NCT00267202|567465309|FG001|Overall Study|Protocol Violation|3|||
157197332|NCT00267202|567465308|FG000|Overall Study|Administrative problems|2|||
157197333|NCT00267202|567465309|FG001|Overall Study|Administrative problems|1|||
157197334|NCT00267202|567465308|FG000|Overall Study|Lost to Follow-up|3|||
157197335|NCT00267202|567465309|FG001|Overall Study|Lost to Follow-up|0|||
157197336|NCT03831282|567465310|FG000|Overall Study|Could not place sensor|1|||
157197337|NCT00334893|567465311|FG000|Overall Study|Not Treated|1|||
157197338|NCT00334893|567465312|FG001|Overall Study|Not Treated|0|||
157197339|NCT05146999|567465313|FG000|Overall Study|Withdrew consent|6|||
157197340|NCT05146999|567465314|FG001|Overall Study|Withdrew consent|1|||
157197341|NCT05146999|567465313|FG000|Overall Study|Lost to Follow-up|3|||
157197342|NCT05146999|567465314|FG001|Overall Study|Lost to Follow-up|2|||
157197343|NCT05146999|567465313|FG000|Overall Study|Other|1|||
157197344|NCT05146999|567465314|FG001|Overall Study|Other|3|||
157197345|NCT02260791|567465318|FG000|Overall Study|Lost to Follow-up|4|||
157197346|NCT02260791|567465319|FG001|Overall Study|Lost to Follow-up|4|||
157197347|NCT02260791|567465318|FG000|Overall Study|Lack of Efficacy|2|||
157197348|NCT02260791|567465319|FG001|Overall Study|Lack of Efficacy|1|||
157197349|NCT02260791|567465318|FG000|Overall Study|Adverse Event|13|||
157197350|NCT02260791|567465319|FG001|Overall Study|Adverse Event|9|||
157197351|NCT02260791|567465318|FG000|Overall Study|Death|1|||
157197352|NCT02260791|567465319|FG001|Overall Study|Death|0|||
157197353|NCT02260791|567465318|FG000|Overall Study|Withdrawal by Subject|11|||
157197354|NCT02260791|567465319|FG001|Overall Study|Withdrawal by Subject|16|||
157197355|NCT02260791|567465318|FG000|Overall Study|Screen failure|0|||
157197356|NCT02260791|567465319|FG001|Overall Study|Screen failure|1|||
157240015|NCT01058668|567624959|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
157240016|NCT01058668|567624960|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
157240017|NCT02294786|567624963|FG000|Overall Study|Withdrawal by Subject|0|||
157240018|NCT02294786|567624964|FG001|Overall Study|Withdrawal by Subject|1|||
157240019|NCT02294786|567624963|FG000|Overall Study|Physician Decision|6|||
157240020|NCT02294786|567624964|FG001|Overall Study|Physician Decision|7|||
157240021|NCT02294786|567624963|FG000|Overall Study|Lost to Follow-up|1|||
157240022|NCT02294786|567624964|FG001|Overall Study|Lost to Follow-up|2|||
157240023|NCT02294786|567624963|FG000|Overall Study|Protocol Violation|1|||
157240024|NCT02294786|567624964|FG001|Overall Study|Protocol Violation|0|||
157240025|NCT02294786|567624963|FG000|Overall Study|Adverse Event|1|||
157240026|NCT02294786|567624964|FG001|Overall Study|Adverse Event|1|||
157240027|NCT02294786|567624963|FG000|Overall Study|Death|2|||
157240028|NCT02294786|567624964|FG001|Overall Study|Death|3|||
157240029|NCT01778010|567624965|FG000|Overall Study|Withdrawal by Subject|2|||
157240030|NCT01778010|567624965|FG000|Overall Study|abnormal ECG before meds|1|||
157240031|NCT01778010|567624965|FG000|Overall Study|Arrested|1|||
157240032|NCT01778010|567624965|FG000|Overall Study|rash while on placebo|1|||
157240033|NCT02159183|567624968|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
157240034|NCT02159183|567624969|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
157240035|NCT02159183|567624968|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
157240036|NCT02159183|567624969|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
157240037|NCT02159183|567624968|FG000|Analysis After the 36 Months Follow-up|Death|0|||
157240038|NCT02159183|567624969|FG001|Analysis After the 36 Months Follow-up|Death|1|||
157240039|NCT02159183|567624968|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
157240040|NCT02159183|567624969|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
157240041|NCT02159183|567624968|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
157240042|NCT02159183|567624969|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
157240043|NCT01444378|567624975|FG000|Overall Study|Lost to Follow-up|1|||
157240044|NCT01444378|567624975|FG000|Overall Study|Withdrawal by Subject|1|||
157240045|NCT01444378|567624975|FG000|Overall Study|Death|3|||
157240046|NCT01444378|567624975|FG000|Overall Study|Administrative Closure Of The Study|2|||
157240047|NCT01444378|567624975|FG000|Overall Study|Missed Visits|10|||
157240048|NCT02911792|567624976|FG000|Overall Study|Lost to Follow-up|3|||
157240049|NCT02911792|567624977|FG001|Overall Study|Lost to Follow-up|3|||
157240050|NCT02911792|567624978|FG002|Overall Study|Lost to Follow-up|3|||
157240051|NCT02911792|567624979|FG003|Overall Study|Lost to Follow-up|3|||
157240052|NCT00840073|567624980|FG000|Second Intervention|Missed 72 hour blood draw|1|||
157240053|NCT00840073|567624981|FG001|Second Intervention|Missed 72 hour blood draw|1|||
157240054|NCT03256695|567624982|FG000|Overall Study|Adverse Event|8|||
157240055|NCT03256695|567624982|FG000|Overall Study|Death|2|||
157240056|NCT03256695|567624982|FG000|Overall Study|Withdrawal by Subject|14|||
157240057|NCT03256695|567624982|FG000|Overall Study|Non-compliance with study drug|1|||
157240058|NCT03256695|567624982|FG000|Overall Study|Lost to Follow-up|3|||
157240059|NCT03256695|567624982|FG000|Overall Study|Lack of Efficacy|3|||
157240060|NCT03256695|567624982|FG000|Overall Study|Protocol Violation|5|||
157240061|NCT03256695|567624982|FG000|Overall Study|Other than specified|3|||
157240062|NCT03406156|567624986|FG000|Overall Study|Death|9|||
157240063|NCT03406156|567624987|FG001|Overall Study|Death|3|||
157240064|NCT03406156|567624986|FG000|Overall Study|Withdrawal by Subject|1|||
157240065|NCT03406156|567624987|FG001|Overall Study|Withdrawal by Subject|2|||
157240066|NCT03406156|567624986|FG000|Overall Study|COVID-19 infection|1|||
157240067|NCT03406156|567624987|FG001|Overall Study|COVID-19 infection|0|||
157240068|NCT03406156|567624986|FG000|Overall Study|Non-compliance with study procedures|1|||
157240069|NCT03406156|567624987|FG001|Overall Study|Non-compliance with study procedures|1|||
157240070|NCT03406156|567624986|FG000|Overall Study|Lost to Follow-up|0|||
157240071|NCT03406156|567624987|FG001|Overall Study|Lost to Follow-up|2|||
157240072|NCT03406156|567624986|FG000|Overall Study|Other, not specified|72|||
157240073|NCT03406156|567624987|FG001|Overall Study|Other, not specified|28|||
157240074|NCT02838420|567624989|FG000|Overall Study|Ongoing in Study|113|||
157091169|NCT00116753|567089051|FG001|Overall Study|Withdrawal by Subject|12|||
157091170|NCT00116753|567089052|FG002|Overall Study|Withdrawal by Subject|8|||
157240075|NCT02838420|567624990|FG001|Overall Study|Ongoing in Study|45|||
157240076|NCT02838420|567624989|FG000|Overall Study|Lost to Follow-up|1|||
157240077|NCT02838420|567624990|FG001|Overall Study|Lost to Follow-up|0|||
157240078|NCT02838420|567624989|FG000|Overall Study|Withdrawal by Subject|3|||
157240079|NCT02838420|567624990|FG001|Overall Study|Withdrawal by Subject|4|||
157091171|NCT00116753|567089050|FG000|Overall Study|Lost to Follow-up|0|||
157240080|NCT02838420|567624989|FG000|Overall Study|Death|8|||
157240081|NCT02838420|567624990|FG001|Overall Study|Death|13|||
157240082|NCT02964039|567624991|FG000|Overall Study|Medical reason unrelated to study participation|1|||
157240083|NCT02964039|567624992|FG001|Overall Study|Medical reason unrelated to study participation|0|||
157240084|NCT02964039|567624993|FG002|Overall Study|Medical reason unrelated to study participation|3|||
157240085|NCT02964039|567624991|FG000|Overall Study|Research shutdown due to pandemic|2|||
157240086|NCT02964039|567624992|FG001|Overall Study|Research shutdown due to pandemic|0|||
157240087|NCT02964039|567624993|FG002|Overall Study|Research shutdown due to pandemic|1|||
157240088|NCT02964039|567624991|FG000|Overall Study|Withdrawal by Subject|0|||
157240089|NCT02964039|567624992|FG001|Overall Study|Withdrawal by Subject|1|||
157240090|NCT02964039|567624993|FG002|Overall Study|Withdrawal by Subject|0|||
157240091|NCT02964039|567624991|FG000|Overall Study|Lost to Follow-up|1|||
157240092|NCT02964039|567624992|FG001|Overall Study|Lost to Follow-up|0|||
157240093|NCT02964039|567624993|FG002|Overall Study|Lost to Follow-up|1|||
157240094|NCT05479058|567624994|FG000|Overall Study|Withdrawal by Subject|1|||
157240095|NCT05479058|567624995|FG001|Overall Study|Withdrawal by Subject|1|||
157240096|NCT05479058|567624994|FG000|Overall Study|Study terminated by sponsor|10|||
157240097|NCT05479058|567624995|FG001|Overall Study|Study terminated by sponsor|10|||
157240098|NCT05630885|567624996|FG000|Study Completion|Took prohibited medications|2|||
157240099|NCT05630885|567624997|FG001|Study Completion|Took prohibited medications|0|||
157240100|NCT05630885|567624996|FG000|Study Completion|Non-compliance with study drug|1|||
157240101|NCT05630885|567624997|FG001|Study Completion|Non-compliance with study drug|0|||
157240102|NCT05630885|567624996|FG000|Study Completion|Adverse Event|1|||
157240103|NCT05630885|567624997|FG001|Study Completion|Adverse Event|0|||
157240104|NCT05630885|567624996|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
157240105|NCT05630885|567624997|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
157240106|NCT05630885|567624996|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
157240107|NCT05630885|567624997|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
157240108|NCT03419403|567625000|FG000|Overall Study|Withdrawal by Subject|5|||
157240109|NCT03419403|567625001|FG001|Overall Study|Withdrawal by Subject|2|||
157240110|NCT03419403|567625002|FG002|Overall Study|Withdrawal by Subject|5|||
157240111|NCT03419403|567625003|FG003|Overall Study|Withdrawal by Subject|1|||
157240112|NCT03419403|567625000|FG000|Overall Study|Progressive disease (per protocol)|0|||
157240113|NCT03419403|567625001|FG001|Overall Study|Progressive disease (per protocol)|2|||
157240114|NCT03419403|567625002|FG002|Overall Study|Progressive disease (per protocol)|2|||
157240115|NCT03419403|567625003|FG003|Overall Study|Progressive disease (per protocol)|0|||
157240116|NCT03419403|567625000|FG000|Overall Study|Other, not specified|6|||
157240117|NCT03419403|567625001|FG001|Overall Study|Other, not specified|4|||
157240118|NCT03419403|567625002|FG002|Overall Study|Other, not specified|5|||
157240119|NCT03419403|567625003|FG003|Overall Study|Other, not specified|1|||
157240120|NCT03419403|567625000|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
157240121|NCT03419403|567625001|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
157240122|NCT03419403|567625002|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
157240123|NCT03419403|567625003|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
157240124|NCT00796653|567625006|FG000|Overall Study|Adverse Event|19|||
157240125|NCT00796653|567625007|FG001|Overall Study|Adverse Event|16|||
157240126|NCT00796653|567625008|FG002|Overall Study|Adverse Event|16|||
157240127|NCT00796653|567625009|FG003|Overall Study|Adverse Event|16|||
157240128|NCT00796653|567625006|FG000|Overall Study|Lost to Follow-up|2|||
157240129|NCT00796653|567625007|FG001|Overall Study|Lost to Follow-up|1|||
157240130|NCT00796653|567625008|FG002|Overall Study|Lost to Follow-up|2|||
157240131|NCT00796653|567625009|FG003|Overall Study|Lost to Follow-up|3|||
157240132|NCT00796653|567625006|FG000|Overall Study|Withdrawal by Subject|16|||
157240133|NCT00796653|567625007|FG001|Overall Study|Withdrawal by Subject|8|||
157240134|NCT00796653|567625008|FG002|Overall Study|Withdrawal by Subject|8|||
157240135|NCT00796653|567625009|FG003|Overall Study|Withdrawal by Subject|13|||
157240136|NCT00796653|567625006|FG000|Overall Study|Lack of Efficacy|8|||
157240137|NCT00796653|567625007|FG001|Overall Study|Lack of Efficacy|1|||
157240138|NCT00796653|567625008|FG002|Overall Study|Lack of Efficacy|3|||
157240139|NCT00796653|567625009|FG003|Overall Study|Lack of Efficacy|2|||
157240140|NCT00796653|567625006|FG000|Overall Study|Non compliance with protocol|2|||
157240141|NCT00796653|567625007|FG001|Overall Study|Non compliance with protocol|2|||
157240142|NCT00796653|567625008|FG002|Overall Study|Non compliance with protocol|0|||
157240143|NCT00796653|567625009|FG003|Overall Study|Non compliance with protocol|2|||
157240144|NCT00796653|567625006|FG000|Overall Study|Other reason not described above|4|||
157240145|NCT00796653|567625007|FG001|Overall Study|Other reason not described above|9|||
157240146|NCT00796653|567625008|FG002|Overall Study|Other reason not described above|7|||
157240147|NCT00796653|567625009|FG003|Overall Study|Other reason not described above|4|||
157240148|NCT02414152|567625012|FG000|Overall Study|Withdrawal by Subject|1|||
157240149|NCT02414152|567625012|FG000|Overall Study|Lack of Efficacy|1|||
157240150|NCT00841698|567625014|FG000|First Intervention|Withdrawal by Subject|1|||
157240151|NCT00841698|567625015|FG001|First Intervention|Withdrawal by Subject|0|||
157240152|NCT00191815|567625018|FG000|Overall Study|Adverse Event|2|||
157240153|NCT00191815|567625018|FG000|Overall Study|Disease progression or relapse|24|||
157240154|NCT00191815|567625018|FG000|Overall Study|Death|2|||
157240155|NCT00191815|567625018|FG000|Overall Study|Protocol Violation|3|||
157240156|NCT00191815|567625018|FG000|Overall Study|Physician Decision|2|||
157240157|NCT00191815|567625018|FG000|Overall Study|Withdrawal by Subject|7|||
157240158|NCT01218867|567625021|FG000|Overall Study|Death during treatment|0|||
157240159|NCT01218867|567625022|FG001|Overall Study|Death during treatment|0|||
157240160|NCT01218867|567625023|FG002|Overall Study|Death during treatment|0|||
157240161|NCT01218867|567625024|FG003|Overall Study|Death during treatment|0|||
157240162|NCT01218867|567625025|FG004|Overall Study|Death during treatment|0|||
157240163|NCT01218867|567625026|FG005|Overall Study|Death during treatment|0|||
157240164|NCT01218867|567625027|FG006|Overall Study|Death during treatment|1|||
157240165|NCT01218867|567625028|FG007|Overall Study|Death during treatment|0|||
157240166|NCT01218867|567625029|FG008|Overall Study|Death during treatment|0|||
157240167|NCT01218867|567625030|FG009|Overall Study|Death during treatment|0|||
157240168|NCT01218867|567625031|FG010|Overall Study|Death during treatment|0|||
157240169|NCT00251979|567625032|FG000|Overall Study|Protocol Violation|3|||
157240170|NCT00251979|567625033|FG001|Overall Study|Protocol Violation|5|||
157240171|NCT00251979|567625032|FG000|Overall Study|Adverse Event|11|||
157240172|NCT00251979|567625033|FG001|Overall Study|Adverse Event|17|||
157240173|NCT00251979|567625032|FG000|Overall Study|Withdrawal by Subject|13|||
157240174|NCT00251979|567625033|FG001|Overall Study|Withdrawal by Subject|7|||
157240175|NCT00251979|567625032|FG000|Overall Study|Lost to Follow-up|8|||
157240176|NCT00251979|567625033|FG001|Overall Study|Lost to Follow-up|6|||
157240177|NCT00251979|567625032|FG000|Overall Study|Death|3|||
157240178|NCT00251979|567625033|FG001|Overall Study|Death|5|||
157240179|NCT01348789|567625041|FG000|Overall Study|Protocol Violation|2|||
157240180|NCT01348789|567625041|FG000|Overall Study|Withdrawal by Subject|2|||
157240181|NCT01878292|567625042|FG000|Randomized|Protocol Violation|1|||
157240182|NCT01878292|567625043|FG001|Randomized|Protocol Violation|0|||
157240183|NCT01878292|567625044|FG002|Randomized|Protocol Violation|0|||
157240184|NCT01878292|567625042|FG000|Randomized|Lost to Follow-up|1|||
157240185|NCT01878292|567625043|FG001|Randomized|Lost to Follow-up|0|||
157240186|NCT01878292|567625044|FG002|Randomized|Lost to Follow-up|0|||
157240187|NCT01878292|567625042|FG000|Randomized|Adverse Event|1|||
157240188|NCT01878292|567625043|FG001|Randomized|Adverse Event|0|||
157240189|NCT01878292|567625044|FG002|Randomized|Adverse Event|0|||
157240190|NCT01878292|567625042|FG000|Double-blind Treatment Period|Other Reasons|2|||
157240191|NCT01878292|567625043|FG001|Double-blind Treatment Period|Other Reasons|0|||
157240192|NCT01878292|567625044|FG002|Double-blind Treatment Period|Other Reasons|0|||
157240193|NCT01878292|567625042|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
157240194|NCT01878292|567625043|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
157240195|NCT01878292|567625044|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
157240196|NCT01878292|567625042|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
157240197|NCT01878292|567625043|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
157240198|NCT01878292|567625044|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
157240199|NCT01878292|567625042|FG000|Double-blind Treatment Period|Protocol Violation|3|||
157240200|NCT01878292|567625043|FG001|Double-blind Treatment Period|Protocol Violation|4|||
157240201|NCT01878292|567625044|FG002|Double-blind Treatment Period|Protocol Violation|2|||
157240202|NCT01878292|567625042|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
157240203|NCT01878292|567625043|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
157240204|NCT01878292|567625044|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
157240205|NCT01878292|567625042|FG000|Double-blind Treatment Period|Adverse Event|4|||
157240206|NCT01878292|567625043|FG001|Double-blind Treatment Period|Adverse Event|9|||
157240207|NCT01878292|567625044|FG002|Double-blind Treatment Period|Adverse Event|8|||
157240208|NCT01878292|567625042|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
157240209|NCT01878292|567625043|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
157240210|NCT01878292|567625044|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
157240211|NCT00323882|567625045|FG000|Overall Study|Adverse Event|2|||
157240212|NCT00323882|567625046|FG001|Overall Study|Adverse Event|1|||
157240213|NCT00323882|567625047|FG002|Overall Study|Adverse Event|1|||
157240214|NCT00323882|567625048|FG003|Overall Study|Adverse Event|1|||
157240215|NCT00323882|567625049|FG004|Overall Study|Adverse Event|3|||
157240216|NCT00323882|567625045|FG000|Overall Study|Disease Progression|6|||
157240217|NCT00323882|567625046|FG001|Overall Study|Disease Progression|4|||
157240218|NCT00323882|567625047|FG002|Overall Study|Disease Progression|10|||
157240219|NCT00323882|567625048|FG003|Overall Study|Disease Progression|5|||
157240220|NCT00323882|567625049|FG004|Overall Study|Disease Progression|22|||
157240221|NCT00323882|567625045|FG000|Overall Study|Death|0|||
157240222|NCT00323882|567625046|FG001|Overall Study|Death|1|||
157240223|NCT00323882|567625047|FG002|Overall Study|Death|1|||
157240224|NCT00323882|567625048|FG003|Overall Study|Death|0|||
157240225|NCT00323882|567625049|FG004|Overall Study|Death|5|||
157240226|NCT00323882|567625045|FG000|Overall Study|Lost to Follow-up|0|||
157240227|NCT00323882|567625046|FG001|Overall Study|Lost to Follow-up|0|||
157240228|NCT00323882|567625047|FG002|Overall Study|Lost to Follow-up|1|||
157240229|NCT00323882|567625048|FG003|Overall Study|Lost to Follow-up|0|||
157240230|NCT00323882|567625049|FG004|Overall Study|Lost to Follow-up|1|||
157240231|NCT00323882|567625045|FG000|Overall Study|Other|0|||
157091172|NCT00116753|567089051|FG001|Overall Study|Lost to Follow-up|2|||
157240232|NCT00323882|567625046|FG001|Overall Study|Other|0|||
157240233|NCT00323882|567625047|FG002|Overall Study|Other|0|||
157240234|NCT00323882|567625048|FG003|Overall Study|Other|1|||
157240235|NCT00323882|567625049|FG004|Overall Study|Other|1|||
157240236|NCT00429416|567625050|FG000|Overall Study|Death|1|||
157091173|NCT00116753|567089052|FG002|Overall Study|Lost to Follow-up|1|||
157240237|NCT02530905|567625051|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
157240238|NCT02530905|567625052|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
157240239|NCT02530905|567625053|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
157240240|NCT00415363|567625059|FG000|Overall Study|Withdrawal by Subject|4|||
157240241|NCT00415363|567625060|FG001|Overall Study|Withdrawal by Subject|4|||
157240242|NCT00415363|567625059|FG000|Overall Study|Adverse Event|4|||
157240243|NCT00415363|567625060|FG001|Overall Study|Adverse Event|4|||
157240244|NCT00415363|567625059|FG000|Overall Study|Lost to Follow-up|2|||
157240245|NCT00415363|567625060|FG001|Overall Study|Lost to Follow-up|1|||
157240246|NCT00415363|567625059|FG000|Overall Study|Physician Decision|3|||
157240247|NCT00415363|567625060|FG001|Overall Study|Physician Decision|1|||
157240248|NCT00415363|567625059|FG000|Overall Study|Death|16|||
157240249|NCT00415363|567625060|FG001|Overall Study|Death|12|||
157240250|NCT00415363|567625059|FG000|Overall Study|Progressive disease|26|||
157240251|NCT00415363|567625060|FG001|Overall Study|Progressive disease|32|||
157240252|NCT03123471|567625063|FG000|Placebo-controlled Phase|Adverse Event|3|||
157240253|NCT03123471|567625064|FG001|Placebo-controlled Phase|Adverse Event|8|||
157240254|NCT03123471|567625063|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
157240255|NCT03123471|567625064|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
157240256|NCT03123471|567625063|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
157240257|NCT03123471|567625064|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
157240258|NCT03123471|567625063|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
157240259|NCT03123471|567625064|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
157240260|NCT03123471|567625063|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
157240261|NCT03123471|567625064|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
157240262|NCT03123471|567625063|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
157240263|NCT03123471|567625064|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
157240264|NCT03123471|567625063|FG000|Placebo-controlled Phase|Miscellaneous|0|||
157240265|NCT03123471|567625064|FG001|Placebo-controlled Phase|Miscellaneous|1|||
157240266|NCT03123471|567625063|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
157240267|NCT03123471|567625064|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
157240268|NCT03123471|567625063|FG000|Apremilast Extension Phase|Adverse Event|1|||
157240269|NCT03123471|567625064|FG001|Apremilast Extension Phase|Adverse Event|5|||
157240270|NCT03123471|567625063|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
157240271|NCT03123471|567625064|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
157240272|NCT03123471|567625063|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
157240273|NCT03123471|567625064|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
157240274|NCT01136174|567625066|FG000|Overall Study|Adverse Event|0|||
157240275|NCT01136174|567625067|FG001|Overall Study|Adverse Event|0|||
157240276|NCT01136174|567625068|FG002|Overall Study|Adverse Event|0|||
157240277|NCT01136174|567625069|FG003|Overall Study|Adverse Event|4|||
157240278|NCT01030133|567625074|FG000|Overall Study|failed to experience pain at level 7/10|2|||
157240279|NCT01030133|567625075|FG001|Overall Study|failed to experience pain at level 7/10|2|||
157240280|NCT01958294|567627064|FG000|Overall Study|Clinical Circumstances|2|||
157240281|NCT00682461|567627066|FG000|Overall Study|Adverse Event|5|||
157240282|NCT00682461|567627067|FG001|Overall Study|Adverse Event|7|||
157240283|NCT00682461|567627066|FG000|Overall Study|Lost to Follow-up|8|||
157240284|NCT00682461|567627067|FG001|Overall Study|Lost to Follow-up|5|||
157240285|NCT00682461|567627066|FG000|Overall Study|Withdrawal by Subject|12|||
157240286|NCT00682461|567627067|FG001|Overall Study|Withdrawal by Subject|19|||
157240287|NCT00665925|567627068|FG000|Overall Study|Lack of Efficacy|10|||
157240288|NCT00665925|567627069|FG001|Overall Study|Lack of Efficacy|8|||
157240289|NCT00665925|567627070|FG002|Overall Study|Lack of Efficacy|9|||
157240290|NCT00665925|567627071|FG003|Overall Study|Lack of Efficacy|8|||
157240291|NCT00665925|567627068|FG000|Overall Study|Lost to Follow-up|1|||
157240292|NCT00665925|567627069|FG001|Overall Study|Lost to Follow-up|2|||
157240293|NCT00665925|567627070|FG002|Overall Study|Lost to Follow-up|2|||
157240294|NCT00665925|567627071|FG003|Overall Study|Lost to Follow-up|2|||
157091174|NCT00116753|567089050|FG000|Overall Study|Protocol Violation|0|||
157091175|NCT00116753|567089051|FG001|Overall Study|Protocol Violation|0|||
157091176|NCT00116753|567089052|FG002|Overall Study|Protocol Violation|1|||
157091177|NCT00116753|567089050|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
157091178|NCT00116753|567089051|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
157091179|NCT00116753|567089052|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
157091180|NCT00116753|567089050|FG000|Overall Study|Disease Progression|3|||
157091181|NCT00116753|567089051|FG001|Overall Study|Disease Progression|4|||
157091182|NCT00116753|567089052|FG002|Overall Study|Disease Progression|3|||
157240295|NCT00665925|567627068|FG000|Overall Study|Withdrawal by Subject|2|||
157240296|NCT00665925|567627069|FG001|Overall Study|Withdrawal by Subject|2|||
157240297|NCT00665925|567627070|FG002|Overall Study|Withdrawal by Subject|3|||
157240298|NCT00665925|567627071|FG003|Overall Study|Withdrawal by Subject|2|||
157240299|NCT00665925|567627068|FG000|Overall Study|Physician Decision|0|||
157240300|NCT00665925|567627069|FG001|Overall Study|Physician Decision|0|||
157091183|NCT00116753|567089050|FG000|Overall Study|Abnormal Echocardiogram|0|||
157091184|NCT00116753|567089051|FG001|Overall Study|Abnormal Echocardiogram|0|||
157240301|NCT00665925|567627070|FG002|Overall Study|Physician Decision|1|||
157240302|NCT00665925|567627071|FG003|Overall Study|Physician Decision|2|||
157240303|NCT00665925|567627068|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
157240304|NCT00665925|567627069|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
157240305|NCT00665925|567627070|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
157240306|NCT00665925|567627071|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
157240307|NCT00665925|567627068|FG000|Overall Study|Adverse Event|1|||
157240308|NCT00665925|567627069|FG001|Overall Study|Adverse Event|5|||
157240309|NCT00665925|567627070|FG002|Overall Study|Adverse Event|10|||
157240310|NCT00665925|567627071|FG003|Overall Study|Adverse Event|5|||
157240311|NCT00665925|567627068|FG000|Overall Study|Enrolled by mistake|0|||
157240312|NCT00665925|567627069|FG001|Overall Study|Enrolled by mistake|0|||
157240313|NCT00665925|567627070|FG002|Overall Study|Enrolled by mistake|0|||
157240314|NCT00665925|567627071|FG003|Overall Study|Enrolled by mistake|1|||
157240315|NCT00665925|567627068|FG000|Overall Study|Due to exclusion criteria|1|||
157240316|NCT00665925|567627069|FG001|Overall Study|Due to exclusion criteria|0|||
157240317|NCT00665925|567627070|FG002|Overall Study|Due to exclusion criteria|0|||
157240318|NCT00665925|567627071|FG003|Overall Study|Due to exclusion criteria|0|||
157240319|NCT04035187|567627072|FG000|Overall Study|Withdrawal by Subject|2|||
157240320|NCT04035187|567627073|FG001|Overall Study|Withdrawal by Subject|1|||
157240321|NCT04035187|567627074|FG002|Overall Study|Withdrawal by Subject|0|||
157240322|NCT04035187|567627075|FG003|Overall Study|Withdrawal by Subject|0|||
157240323|NCT04035187|567627072|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
157240324|NCT04035187|567627073|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
157240325|NCT04035187|567627074|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
157240326|NCT04035187|567627075|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
157240327|NCT01547286|567627090|FG000|Overall Study|Did not meet all eligibility criteria|1|||
157240328|NCT01547286|567627090|FG000|Overall Study|Physician Decision|1|||
157240329|NCT03415308|567627093|FG000|Overall Study|Lost to Follow-up|0|||
157240330|NCT03415308|567627094|FG001|Overall Study|Lost to Follow-up|0|||
157240331|NCT03415308|567627095|FG002|Overall Study|Lost to Follow-up|1|||
157240332|NCT03415308|567627093|FG000|Overall Study|Scheduling Conflicts|0|||
157240333|NCT03415308|567627094|FG001|Overall Study|Scheduling Conflicts|0|||
157240334|NCT03415308|567627095|FG002|Overall Study|Scheduling Conflicts|7|||
157240335|NCT00081653|567627096|FG000|Overall Study|Adverse Event|23|||
157240336|NCT00081653|567627097|FG001|Overall Study|Adverse Event|17|||
157240337|NCT00081653|567627096|FG000|Overall Study|Lost to Follow-up|2|||
157240338|NCT00081653|567627097|FG001|Overall Study|Lost to Follow-up|4|||
157240339|NCT00081653|567627096|FG000|Overall Study|Refused Treatment|18|||
157240340|NCT00081653|567627097|FG001|Overall Study|Refused Treatment|14|||
157240341|NCT00081653|567627096|FG000|Overall Study|Low bone mineral density|1|||
157240342|NCT00081653|567627097|FG001|Overall Study|Low bone mineral density|0|||
157240343|NCT00081653|567627096|FG000|Overall Study|Bone loss|2|||
157240344|NCT00081653|567627097|FG001|Overall Study|Bone loss|0|||
157240345|NCT00081653|567627096|FG000|Overall Study|Participant leaving country|1|||
157240346|NCT00081653|567627097|FG001|Overall Study|Participant leaving country|0|||
157240347|NCT00081653|567627096|FG000|Overall Study|Loss of bone mass|0|||
157240348|NCT00081653|567627097|FG001|Overall Study|Loss of bone mass|2|||
157240349|NCT03246503|567627098|FG000|Overall Study|Lost to Follow-up|23|||
157240350|NCT03246503|567627098|FG000|Overall Study|Withdrawal by Subject|20|||
157240351|NCT03246503|567627098|FG000|Overall Study|Physician Decision|5|||
157240352|NCT03246503|567627098|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
157240353|NCT03128723|567627101|FG000|Overall Study|Withdrawal by Subject|2|||
157240354|NCT00673660|567627103|FG000|Overall Study|Lost to Follow-up|107|||
157240355|NCT00933686|567627104|FG000|Overall Study|Protocol Violation|0|||
157240356|NCT00933686|567627105|FG001|Overall Study|Protocol Violation|1|||
157240357|NCT00933686|567627104|FG000|Overall Study|Lost to Follow-up|2|||
157240358|NCT00933686|567627105|FG001|Overall Study|Lost to Follow-up|2|||
157240359|NCT00933686|567627104|FG000|Overall Study|Withdrawal by Subject|6|||
157240360|NCT00933686|567627105|FG001|Overall Study|Withdrawal by Subject|5|||
157240361|NCT00933686|567627104|FG000|Overall Study|Adverse Event|1|||
157240362|NCT00933686|567627105|FG001|Overall Study|Adverse Event|1|||
157240363|NCT00933686|567627104|FG000|Overall Study|Physician Decision|1|||
157240364|NCT00933686|567627105|FG001|Overall Study|Physician Decision|0|||
157240365|NCT00933686|567627104|FG000|Overall Study|Failure to show up at endpoint visits|0|||
157240366|NCT00933686|567627105|FG001|Overall Study|Failure to show up at endpoint visits|2|||
157240367|NCT01244620|567627106|FG000|Overall Study|Study terminated|4|||
157240368|NCT01244620|567627107|FG001|Overall Study|Study terminated|4|||
157240369|NCT01244620|567627108|FG002|Overall Study|Study terminated|4|||
157240370|NCT01244620|567627109|FG003|Overall Study|Study terminated|4|||
157240371|NCT02321098|567627110|FG000|12 Weeks Treament|Lost to Follow-up|1|||
157240372|NCT02321098|567627111|FG001|12 Weeks Treament|Lost to Follow-up|1|||
157240373|NCT02321098|567627112|FG002|12 Weeks Treament|Lost to Follow-up|0|||
157240374|NCT02321098|567627110|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
157240375|NCT02321098|567627111|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
157240376|NCT02321098|567627112|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
157240377|NCT02321098|567627110|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
157240378|NCT02321098|567627111|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
157240379|NCT02321098|567627112|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
157240380|NCT02321098|567627110|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
157240381|NCT02321098|567627111|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
157240382|NCT02321098|567627112|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
157091185|NCT00116753|567089052|FG002|Overall Study|Abnormal Echocardiogram|1|||
157091186|NCT00116753|567089050|FG000|Overall Study|Progressive Parkinson's Disease|1|||
157091187|NCT00116753|567089051|FG001|Overall Study|Progressive Parkinson's Disease|0|||
157240383|NCT01663233|567627113|FG000|Overall Study|Withdrawal by Subject|3|||
157240384|NCT01663233|567627114|FG001|Overall Study|Withdrawal by Subject|2|||
157240385|NCT01663233|567627113|FG000|Overall Study|Protocol Deviation|1|||
157240386|NCT01663233|567627114|FG001|Overall Study|Protocol Deviation|4|||
157240387|NCT01663233|567627113|FG000|Overall Study|Lost to Follow-up|0|||
157240388|NCT01663233|567627114|FG001|Overall Study|Lost to Follow-up|1|||
157240389|NCT00796328|567627117|FG000|Overall Study|experienced hypotension requiring tx|6|||
157240390|NCT03261167|567627118|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
157240391|NCT03261167|567627119|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
157240392|NCT03261167|567627118|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
157240393|NCT03261167|567627119|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
157240394|NCT03261167|567627118|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
157240395|NCT03261167|567627119|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
157240396|NCT03261167|567627118|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
157240397|NCT03261167|567627119|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
157240398|NCT03261167|567627118|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
157240399|NCT03261167|567627119|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
157240400|NCT03669861|567627122|FG000|Overall Study|Disease Flare|5|||
157240401|NCT03669861|567627122|FG000|Overall Study|Lack of Efficacy|2|||
157240402|NCT02760927|567627127|FG000|Overall Study|Tube Slippage from Device|1|||
157240403|NCT00705666|567627128|FG000|Overall Study|No post-treatment questionnaire|279|||
157240404|NCT00705666|567627128|FG000|Overall Study|Withdrawal by Subject|21|||
157240405|NCT00705666|567627128|FG000|Overall Study|Physician Decision|7|||
157240406|NCT00705666|567627128|FG000|Overall Study|Lost to Follow-up|5|||
157240407|NCT00705666|567627128|FG000|Overall Study|Death|1|||
157240408|NCT00705666|567627128|FG000|Overall Study|Adverse Event|4|||
157240409|NCT00705666|567627128|FG000|Overall Study|Other|12|||
157240410|NCT00705666|567627128|FG000|Overall Study|Other|2|||
157240411|NCT00705666|567627128|FG000|Overall Study|Lack of data|3|||
157240412|NCT00705666|567627128|FG000|Overall Study|Untreated|5|||
157240413|NCT02105272|567627130|FG000|Overall Study|Adverse Event|1|||
157240414|NCT02105272|567627131|FG001|Overall Study|Adverse Event|2|||
157240415|NCT02105272|567627130|FG000|Overall Study|Physician Decision|0|||
157240416|NCT02105272|567627131|FG001|Overall Study|Physician Decision|1|||
157240417|NCT02105272|567627130|FG000|Overall Study|Protocol Violation|2|||
157240418|NCT02105272|567627131|FG001|Overall Study|Protocol Violation|0|||
157240419|NCT02105272|567627130|FG000|Overall Study|Withdrawal by Subject|2|||
157240420|NCT02105272|567627131|FG001|Overall Study|Withdrawal by Subject|0|||
157240421|NCT04078022|567627144|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
157240422|NCT04078022|567627145|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
157240423|NCT01250912|567627146|FG000|Overall Study|Lost to Follow-up|1|||
157240424|NCT01929863|567627147|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
157240425|NCT01929863|567627148|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
157240426|NCT01929863|567627147|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
157240427|NCT01929863|567627148|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
157240428|NCT01929863|567627147|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
157240429|NCT01929863|567627148|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
157240430|NCT02152163|567627151|FG000|Overall Study|Physician Decision|12|||
157240431|NCT02152163|567627152|FG001|Overall Study|Physician Decision|13|||
157240432|NCT02358538|567627153|FG000|Through Week 26|Adverse Event|0|||
157240433|NCT02358538|567627154|FG001|Through Week 26|Adverse Event|1|||
157240434|NCT02358538|567627155|FG002|Through Week 26|Adverse Event|1|||
157240435|NCT02358538|567627156|FG003|Through Week 26|Adverse Event|2|||
157240436|NCT02358538|567627153|FG000|Through Week 26|Lack of Efficacy|1|||
157240437|NCT02358538|567627154|FG001|Through Week 26|Lack of Efficacy|1|||
157091188|NCT00116753|567089052|FG002|Overall Study|Progressive Parkinson's Disease|0|||
157240438|NCT02358538|567627155|FG002|Through Week 26|Lack of Efficacy|3|||
157240439|NCT02358538|567627156|FG003|Through Week 26|Lack of Efficacy|3|||
157240440|NCT02358538|567627153|FG000|Through Week 26|Withdrawal by Subject|1|||
157240441|NCT02358538|567627154|FG001|Through Week 26|Withdrawal by Subject|0|||
157240442|NCT02358538|567627155|FG002|Through Week 26|Withdrawal by Subject|0|||
157091189|NCT00116753|567089050|FG000|Overall Study|Dosing Error|0|||
157240443|NCT02358538|567627156|FG003|Through Week 26|Withdrawal by Subject|0|||
157240444|NCT02358538|567627153|FG000|Through Week 26|Non-Compliance|0|||
157240445|NCT02358538|567627154|FG001|Through Week 26|Non-Compliance|0|||
157240446|NCT02358538|567627155|FG002|Through Week 26|Non-Compliance|1|||
157240447|NCT02358538|567627156|FG003|Through Week 26|Non-Compliance|0|||
157240448|NCT02358538|567627153|FG000|Through Week 26|Family did not see benefit from IP|1|||
157240449|NCT02358538|567627154|FG001|Through Week 26|Family did not see benefit from IP|0|||
157240450|NCT02358538|567627155|FG002|Through Week 26|Family did not see benefit from IP|0|||
157240451|NCT02358538|567627156|FG003|Through Week 26|Family did not see benefit from IP|0|||
157240452|NCT02358538|567627153|FG000|52 Week Extension Period|Lack of Efficacy|0|||
157240453|NCT02358538|567627154|FG001|52 Week Extension Period|Lack of Efficacy|0|||
157240454|NCT02358538|567627155|FG002|52 Week Extension Period|Lack of Efficacy|2|||
157240455|NCT02358538|567627156|FG003|52 Week Extension Period|Lack of Efficacy|4|||
157240456|NCT01686477|567627157|FG000|Feeding Intervention|Death|1|||
157240457|NCT01686477|567627158|FG001|Feeding Intervention|Death|0|||
157240458|NCT01686477|567627159|FG002|Feeding Intervention|Death|1|||
157240459|NCT01686477|567627157|FG000|Feeding Intervention|Withdrawal by Subject|0|||
157240460|NCT01686477|567627158|FG001|Feeding Intervention|Withdrawal by Subject|6|||
157240461|NCT01686477|567627159|FG002|Feeding Intervention|Withdrawal by Subject|0|||
157240462|NCT01686477|567627157|FG000|Feeding Intervention|Physician Decision|1|||
157240463|NCT01686477|567627158|FG001|Feeding Intervention|Physician Decision|2|||
157240464|NCT01686477|567627159|FG002|Feeding Intervention|Physician Decision|0|||
157240465|NCT01686477|567627157|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
157240466|NCT01686477|567627158|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
157240467|NCT01686477|567627159|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
157240468|NCT01686477|567627157|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
157240469|NCT01686477|567627158|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
157240470|NCT01686477|567627159|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
157240471|NCT01686477|567627157|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
157240472|NCT01686477|567627158|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
157240473|NCT01686477|567627159|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
157240474|NCT01686477|567627157|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
157240475|NCT01686477|567627158|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
157240476|NCT01686477|567627159|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
157240477|NCT01686477|567627157|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
157240478|NCT01686477|567627158|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
157240479|NCT01686477|567627159|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
157240480|NCT01686477|567627157|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
157240481|NCT01686477|567627158|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
157240482|NCT01686477|567627159|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
157240483|NCT01686477|567627157|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
157240484|NCT01686477|567627158|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
157240485|NCT01686477|567627159|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
157240486|NCT06999265|567627160|FG000|Overall Study|Lost to Follow-up|1|||
157240487|NCT06999265|567627161|FG001|Overall Study|Lost to Follow-up|1|||
157240488|NCT00730691|567627162|FG000|Overall Study|Adverse Event|4|||
157240489|NCT00730691|567627163|FG001|Overall Study|Adverse Event|8|||
157240490|NCT00730691|567627164|FG002|Overall Study|Adverse Event|11|||
157240491|NCT00730691|567627165|FG003|Overall Study|Adverse Event|11|||
157240492|NCT00730691|567627166|FG004|Overall Study|Adverse Event|23|||
157240493|NCT00730691|567627162|FG000|Overall Study|Lack of Efficacy|4|||
157240494|NCT00730691|567627163|FG001|Overall Study|Lack of Efficacy|4|||
157240495|NCT00730691|567627164|FG002|Overall Study|Lack of Efficacy|2|||
157240496|NCT00730691|567627165|FG003|Overall Study|Lack of Efficacy|1|||
157240497|NCT00730691|567627166|FG004|Overall Study|Lack of Efficacy|1|||
157240498|NCT00730691|567627162|FG000|Overall Study|Non-compliance with Study Drug|6|||
157240499|NCT00730691|567627163|FG001|Overall Study|Non-compliance with Study Drug|1|||
157091190|NCT00116753|567089051|FG001|Overall Study|Dosing Error|1|||
157091191|NCT00116753|567089052|FG002|Overall Study|Dosing Error|0|||
157091192|NCT01200589|567089053|FG000|Overall Study|Withdrawal by Subject|13|||
157240500|NCT00730691|567627164|FG002|Overall Study|Non-compliance with Study Drug|6|||
157240501|NCT00730691|567627165|FG003|Overall Study|Non-compliance with Study Drug|3|||
157240502|NCT00730691|567627166|FG004|Overall Study|Non-compliance with Study Drug|3|||
157240503|NCT00730691|567627162|FG000|Overall Study|Protocol Deviations|3|||
157240504|NCT00730691|567627163|FG001|Overall Study|Protocol Deviations|5|||
157240505|NCT00730691|567627164|FG002|Overall Study|Protocol Deviations|3|||
157240506|NCT00730691|567627165|FG003|Overall Study|Protocol Deviations|7|||
157240507|NCT00730691|567627166|FG004|Overall Study|Protocol Deviations|5|||
157091193|NCT01200589|567089054|FG001|Overall Study|Withdrawal by Subject|11|||
157240508|NCT00730691|567627162|FG000|Overall Study|Withdrawal of Consent|7|||
157240509|NCT00730691|567627163|FG001|Overall Study|Withdrawal of Consent|9|||
157240510|NCT00730691|567627164|FG002|Overall Study|Withdrawal of Consent|3|||
157240511|NCT00730691|567627165|FG003|Overall Study|Withdrawal of Consent|6|||
157240512|NCT00730691|567627166|FG004|Overall Study|Withdrawal of Consent|3|||
157240513|NCT00730691|567627162|FG000|Overall Study|Lost to Follow-up|11|||
157240514|NCT00730691|567627163|FG001|Overall Study|Lost to Follow-up|8|||
157240515|NCT00730691|567627164|FG002|Overall Study|Lost to Follow-up|13|||
157240516|NCT00730691|567627165|FG003|Overall Study|Lost to Follow-up|15|||
157240517|NCT00730691|567627166|FG004|Overall Study|Lost to Follow-up|13|||
157240518|NCT00730691|567627162|FG000|Overall Study|Other|1|||
157240519|NCT00730691|567627163|FG001|Overall Study|Other|1|||
157240520|NCT00730691|567627164|FG002|Overall Study|Other|1|||
157240521|NCT00730691|567627165|FG003|Overall Study|Other|2|||
157240522|NCT00730691|567627166|FG004|Overall Study|Other|2|||
157240523|NCT02178787|567627167|FG000|Overall Study|Lost to Follow-up|1|||
157240524|NCT02178787|567627168|FG001|Overall Study|Lost to Follow-up|0|||
157240525|NCT02178787|567627167|FG000|Overall Study|Withdrawal by Subject|0|||
157240526|NCT02178787|567627168|FG001|Overall Study|Withdrawal by Subject|2|||
157240527|NCT02178787|567627167|FG000|Overall Study|No TCD window|3|||
157091194|NCT01200589|567089053|FG000|Overall Study|Physician Decision|2|||
157091195|NCT01200589|567089054|FG001|Overall Study|Physician Decision|2|||
157091196|NCT01200589|567089053|FG000|Overall Study|Lost to Follow-up|5|||
157091197|NCT01200589|567089054|FG001|Overall Study|Lost to Follow-up|4|||
157091198|NCT01200589|567089053|FG000|Overall Study|Study terminated|170|||
157091199|NCT01200589|567089054|FG001|Overall Study|Study terminated|172|||
157091200|NCT00986973|567089055|FG000|Overall Study|Withdrawn by study team|1|||
157091201|NCT00598273|567089056|FG000|Overall Study|Adverse Event|4|||
157091202|NCT00598273|567089057|FG001|Overall Study|Adverse Event|5|||
157091203|NCT00598273|567089058|FG002|Overall Study|Adverse Event|2|||
157091204|NCT00598273|567089056|FG000|Overall Study|Death|6|||
157091205|NCT00598273|567089057|FG001|Overall Study|Death|12|||
157091206|NCT00598273|567089058|FG002|Overall Study|Death|8|||
157091207|NCT00598273|567089056|FG000|Overall Study|Lost to Follow-up|8|||
157091208|NCT00598273|567089057|FG001|Overall Study|Lost to Follow-up|3|||
157091209|NCT00598273|567089058|FG002|Overall Study|Lost to Follow-up|5|||
157091210|NCT00598273|567089056|FG000|Overall Study|Physician Decision|0|||
157091211|NCT00598273|567089057|FG001|Overall Study|Physician Decision|0|||
157091212|NCT00598273|567089058|FG002|Overall Study|Physician Decision|1|||
157091213|NCT00598273|567089056|FG000|Overall Study|Withdrawal by Subject|12|||
157091214|NCT00598273|567089057|FG001|Overall Study|Withdrawal by Subject|10|||
157091215|NCT00598273|567089058|FG002|Overall Study|Withdrawal by Subject|10|||
157091216|NCT00598273|567089056|FG000|Overall Study|Noncompliance|3|||
157091217|NCT00598273|567089057|FG001|Overall Study|Noncompliance|2|||
157091218|NCT00598273|567089058|FG002|Overall Study|Noncompliance|3|||
157091219|NCT00598273|567089056|FG000|Overall Study|Relocation|0|||
157091220|NCT00598273|567089057|FG001|Overall Study|Relocation|2|||
157091221|NCT00598273|567089058|FG002|Overall Study|Relocation|4|||
157091222|NCT00598273|567089056|FG000|Overall Study|Renal transplant|1|||
157091223|NCT00598273|567089057|FG001|Overall Study|Renal transplant|0|||
157091224|NCT00598273|567089058|FG002|Overall Study|Renal transplant|1|||
157091225|NCT00598273|567089056|FG000|Overall Study|Site elected to close|1|||
157091226|NCT00598273|567089057|FG001|Overall Study|Site elected to close|0|||
157091227|NCT00598273|567089058|FG002|Overall Study|Site elected to close|0|||
157091228|NCT00598273|567089056|FG000|Overall Study|Started dialysis|6|||
157091229|NCT00598273|567089057|FG001|Overall Study|Started dialysis|4|||
157091230|NCT00598273|567089058|FG002|Overall Study|Started dialysis|5|||
157240528|NCT02178787|567627168|FG001|Overall Study|No TCD window|7|||
157240529|NCT02178787|567627167|FG000|Overall Study|Physician Decision|1|||
157240530|NCT02178787|567627168|FG001|Overall Study|Physician Decision|0|||
157091231|NCT01590082|567089059|FG000|Overall Study|Withdrawal by Subject|1|||
157240531|NCT02554890|567627169|FG000|Double-blind|Adverse Event|45|||
157240532|NCT02554890|567627170|FG001|Double-blind|Adverse Event|51|||
157240533|NCT02554890|567627169|FG000|Double-blind|Death|6|||
157240534|NCT02554890|567627170|FG001|Double-blind|Death|4|||
157240535|NCT02554890|567627169|FG000|Double-blind|Protocol Violation|1|||
157091232|NCT01590082|567089060|FG001|Overall Study|Withdrawal by Subject|0|||
157091233|NCT01590082|567089059|FG000|Overall Study|Ineligible|1|||
157091234|NCT01590082|567089060|FG001|Overall Study|Ineligible|0|||
157091235|NCT01210664|567089062|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
157240536|NCT02554890|567627170|FG001|Double-blind|Protocol Violation|1|||
157240537|NCT02554890|567627169|FG000|Double-blind|Physician Decision|4|||
157240538|NCT02554890|567627170|FG001|Double-blind|Physician Decision|3|||
157240539|NCT02554890|567627169|FG000|Double-blind|Subject/Guardian decision|21|||
157091236|NCT01210664|567089063|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
157240540|NCT02554890|567627170|FG001|Double-blind|Subject/Guardian decision|16|||
157240541|NCT02554890|567627169|FG000|Double-blind|Lost to Follow-up|7|||
157240542|NCT02554890|567627170|FG001|Double-blind|Lost to Follow-up|5|||
157240543|NCT02554890|567627169|FG000|Double-blind|Technical problems|1|||
157240544|NCT02554890|567627170|FG001|Double-blind|Technical problems|0|||
157091237|NCT01210664|567089064|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
157091238|NCT01210664|567089065|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
157091239|NCT01210664|567089062|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091240|NCT01210664|567089063|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091241|NCT01210664|567089064|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
157240545|NCT02554890|567627169|FG000|Double-blind|Withdrawal by Subject|5|||
157240546|NCT02554890|567627170|FG001|Double-blind|Withdrawal by Subject|6|||
157240547|NCT02554890|567627169|FG000|Double-blind|Noncompliance with study treatment|6|||
157240548|NCT02554890|567627170|FG001|Double-blind|Noncompliance with study treatment|5|||
157240549|NCT02554890|567627169|FG000|Open-label|Adverse Event|0|||
157240550|NCT02554890|567627170|FG001|Open-label|Adverse Event|30|||
157240551|NCT02554890|567627169|FG000|Open-label|Death|0|||
157240552|NCT02554890|567627170|FG001|Open-label|Death|1|||
157240553|NCT02554890|567627169|FG000|Open-label|Physician Decision|0|||
157240554|NCT02554890|567627170|FG001|Open-label|Physician Decision|1|||
157240555|NCT02554890|567627169|FG000|Open-label|Subject/Guardian decision|0|||
157240556|NCT02554890|567627170|FG001|Open-label|Subject/Guardian decision|11|||
157240557|NCT02554890|567627169|FG000|Open-label|Lost to Follow-up|0|||
157240558|NCT02554890|567627170|FG001|Open-label|Lost to Follow-up|7|||
157240559|NCT02554890|567627169|FG000|Open-label|Technical problems|0|||
157240560|NCT02554890|567627170|FG001|Open-label|Technical problems|1|||
157240561|NCT02554890|567627169|FG000|Open-label|Withdrawal by Subject|0|||
157240562|NCT02554890|567627170|FG001|Open-label|Withdrawal by Subject|1|||
157240563|NCT03649477|567627176|FG000|Overall Study|Adverse Event|2|||
157240564|NCT03649477|567627177|FG001|Overall Study|Adverse Event|0|||
157240565|NCT03649477|567627178|FG002|Overall Study|Adverse Event|0|||
157240566|NCT04544410|567627179|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
157240567|NCT04544410|567627180|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
157240568|NCT04544410|567627179|FG000|Double-blind Treatment Period|Adverse Event|1|||
157240569|NCT04544410|567627180|FG001|Double-blind Treatment Period|Adverse Event|0|||
157240570|NCT04544410|567627179|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
157240571|NCT04544410|567627180|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
157240572|NCT04544410|567627179|FG000|Double-blind Treatment Period|Protocol Violation|1|||
157240573|NCT04544410|567627180|FG001|Double-blind Treatment Period|Protocol Violation|0|||
157240574|NCT04544410|567627179|FG000|Open-Label Treatment Period|Study Terminated|15|||
157240575|NCT04544410|567627180|FG001|Open-Label Treatment Period|Study Terminated|19|||
157240576|NCT04544410|567627179|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
157240577|NCT04544410|567627180|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
157240578|NCT04544410|567627179|FG000|Open-Label Treatment Period|Adverse Event|0|||
157240579|NCT04544410|567627180|FG001|Open-Label Treatment Period|Adverse Event|1|||
157240580|NCT04544410|567627179|FG000|Open-Label Treatment Period|Physician Decision|1|||
157240581|NCT04544410|567627180|FG001|Open-Label Treatment Period|Physician Decision|0|||
157240582|NCT04544410|567627179|FG000|Open-Label Treatment Period|Other|0|||
157240583|NCT04544410|567627180|FG001|Open-Label Treatment Period|Other|1|||
157240584|NCT04493684|567627181|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
157240585|NCT04493684|567627182|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240586|NCT04493684|567627183|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
157240587|NCT04493684|567627184|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240588|NCT04493684|567627185|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240589|NCT04493684|567627186|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
157240590|NCT04493684|567627187|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240591|NCT04493684|567627188|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240592|NCT04493684|567627189|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240593|NCT04493684|567627190|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240594|NCT04493684|567627191|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240595|NCT04493684|567627192|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240596|NCT04493684|567627193|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240597|NCT04493684|567627194|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240598|NCT04493684|567627195|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240599|NCT04493684|567627196|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240600|NCT04493684|567627197|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
157240601|NCT04493684|567627181|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
157240602|NCT04493684|567627182|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240603|NCT04493684|567627183|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240604|NCT04493684|567627184|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240605|NCT04493684|567627185|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240606|NCT04493684|567627186|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240607|NCT04493684|567627187|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240608|NCT04493684|567627188|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240609|NCT04493684|567627189|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240610|NCT04493684|567627190|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240611|NCT04493684|567627191|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240612|NCT04493684|567627192|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240613|NCT04493684|567627193|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240614|NCT04493684|567627194|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240615|NCT04493684|567627195|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240616|NCT04493684|567627196|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240617|NCT04493684|567627197|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
157240618|NCT04493684|567627181|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240619|NCT04493684|567627182|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240620|NCT04493684|567627183|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240621|NCT04493684|567627184|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240622|NCT04493684|567627185|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240623|NCT04493684|567627186|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240624|NCT04493684|567627187|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
157240625|NCT04493684|567627188|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240626|NCT04493684|567627189|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240627|NCT04493684|567627190|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240628|NCT04493684|567627191|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240629|NCT04493684|567627192|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240630|NCT04493684|567627193|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240631|NCT04493684|567627194|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240632|NCT04493684|567627195|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240633|NCT04493684|567627196|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240634|NCT04493684|567627197|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
157240635|NCT04493684|567627181|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
157240636|NCT04493684|567627182|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240637|NCT04493684|567627183|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240638|NCT04493684|567627184|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240639|NCT04493684|567627185|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240640|NCT04493684|567627186|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240641|NCT04493684|567627187|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240642|NCT04493684|567627188|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240643|NCT04493684|567627189|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240644|NCT04493684|567627190|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240645|NCT04493684|567627191|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240646|NCT04493684|567627192|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240647|NCT04493684|567627193|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240648|NCT04493684|567627194|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240649|NCT04493684|567627195|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240650|NCT04493684|567627196|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240651|NCT04493684|567627197|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
157240652|NCT04493684|567627181|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240653|NCT04493684|567627182|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240654|NCT04493684|567627183|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240655|NCT04493684|567627184|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157091242|NCT01210664|567089065|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091243|NCT01210664|567089062|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091244|NCT01210664|567089063|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091245|NCT01210664|567089064|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
157091246|NCT01210664|567089065|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
157091247|NCT02891408|567089066|FG000|Overall Study|Lost to Follow-up|0|||
157091248|NCT02891408|567089067|FG001|Overall Study|Lost to Follow-up|0|||
157091249|NCT02891408|567089068|FG002|Overall Study|Lost to Follow-up|1|||
157091250|NCT02891408|567089069|FG003|Overall Study|Lost to Follow-up|0|||
157091251|NCT02891408|567089070|FG004|Overall Study|Lost to Follow-up|0|||
157091252|NCT02891408|567089071|FG005|Overall Study|Lost to Follow-up|0|||
157091253|NCT02891408|567089072|FG006|Overall Study|Lost to Follow-up|0|||
157091254|NCT02549196|567089073|FG000|Overall Study|Protocol Violation|0|||
157240656|NCT04493684|567627185|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240657|NCT04493684|567627186|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
157240658|NCT04493684|567627187|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240659|NCT04493684|567627188|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240660|NCT04493684|567627189|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240661|NCT04493684|567627190|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240662|NCT04493684|567627191|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240663|NCT04493684|567627192|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240664|NCT04493684|567627193|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240665|NCT04493684|567627194|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240666|NCT04493684|567627195|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240667|NCT04493684|567627196|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240668|NCT04493684|567627197|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
157240669|NCT04493684|567627181|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240670|NCT04493684|567627182|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240671|NCT04493684|567627183|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240672|NCT04493684|567627184|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240673|NCT04493684|567627185|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240674|NCT04493684|567627186|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240675|NCT04493684|567627187|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240676|NCT04493684|567627188|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240677|NCT04493684|567627189|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240678|NCT04493684|567627190|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240679|NCT04493684|567627191|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240680|NCT04493684|567627192|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
157240681|NCT04493684|567627193|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240682|NCT04493684|567627194|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240683|NCT04493684|567627195|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240684|NCT04493684|567627196|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157240685|NCT04493684|567627197|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
157091255|NCT02549196|567089074|FG001|Overall Study|Protocol Violation|0|||
157091256|NCT02549196|567089075|FG002|Overall Study|Protocol Violation|0|||
157091257|NCT02549196|567089076|FG003|Overall Study|Protocol Violation|1|||
157091258|NCT02549196|567089073|FG000|Overall Study|Withdrawal by Subject|1|||
157091259|NCT02549196|567089074|FG001|Overall Study|Withdrawal by Subject|0|||
157091260|NCT02549196|567089075|FG002|Overall Study|Withdrawal by Subject|1|||
157091261|NCT02549196|567089076|FG003|Overall Study|Withdrawal by Subject|0|||
157240686|NCT04493684|567627181|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240687|NCT04493684|567627182|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240688|NCT04493684|567627183|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240689|NCT04493684|567627184|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240690|NCT04493684|567627185|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240691|NCT04493684|567627186|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240692|NCT04493684|567627187|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240693|NCT04493684|567627188|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240694|NCT04493684|567627189|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240695|NCT04493684|567627190|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240696|NCT04493684|567627191|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240697|NCT04493684|567627192|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240698|NCT04493684|567627193|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240699|NCT04493684|567627194|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240700|NCT04493684|567627195|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240701|NCT04493684|567627196|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
157240702|NCT04493684|567627197|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
157240703|NCT04493684|567627181|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240704|NCT04493684|567627182|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240705|NCT04493684|567627183|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240706|NCT04493684|567627184|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240707|NCT04493684|567627185|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240708|NCT04493684|567627186|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240709|NCT04493684|567627187|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240710|NCT04493684|567627188|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240711|NCT04493684|567627189|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240712|NCT04493684|567627190|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240713|NCT04493684|567627191|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240714|NCT04493684|567627192|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240715|NCT04493684|567627193|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240716|NCT04493684|567627194|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240717|NCT04493684|567627195|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157091262|NCT01442779|567089077|FG000|Overall Study|Withdrawal by Subject|3|||
157240718|NCT04493684|567627196|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
157240719|NCT04493684|567627197|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
157240720|NCT04825275|567628302|FG000|Overall Study|Withdrawal by Subject|1|||
157240721|NCT04825275|567628303|FG001|Overall Study|Withdrawal by Subject|0|||
157240722|NCT06298396|567628306|FG000|Default MAP|Protocol Violation|1|||
157240723|NCT06137781|567628307|FG000|Baseline measurements|Lost to Follow-up|2|||
157240724|NCT06137781|567628307|FG000|Baseline measurements|Withdrawal by Subject|1|||
157240725|NCT06137781|567628307|FG000|Baseline measurements|Expedited surgery|1|||
157240726|NCT06137781|567628307|FG000|Intervention period|Lost to Follow-up|2|||
157240727|NCT06137781|567628307|FG000|Intervention period|Withdrawal by Subject|3|||
157240728|NCT06137781|567628307|FG000|Intervention period|Expedited surgery|1|||
157240729|NCT06137781|567628307|FG000|Intervention period|Adverse Event|1|||
157240730|NCT02591420|567628308|FG000|Overall Study|Lost to Follow-up|0|||
157240731|NCT02591420|567628309|FG001|Overall Study|Lost to Follow-up|1|||
157240732|NCT02591420|567628310|FG002|Overall Study|Lost to Follow-up|2|||
157240733|NCT03056755|567628311|FG000|Core Phase|Progressive disease|89|||
157240734|NCT03056755|567628312|FG001|Core Phase|Progressive disease|88|||
157240735|NCT03056755|567628313|FG002|Core Phase|Progressive disease|90|||
157240736|NCT03056755|567628311|FG000|Core Phase|Adverse Event|20|||
157240737|NCT03056755|567628312|FG001|Core Phase|Adverse Event|14|||
157240738|NCT03056755|567628313|FG002|Core Phase|Adverse Event|13|||
157240739|NCT03056755|567628311|FG000|Core Phase|Physician Decision|7|||
157240740|NCT03056755|567628312|FG001|Core Phase|Physician Decision|13|||
157240741|NCT03056755|567628313|FG002|Core Phase|Physician Decision|5|||
157240742|NCT03056755|567628311|FG000|Core Phase|Subject/guardian decision|5|||
157240743|NCT03056755|567628312|FG001|Core Phase|Subject/guardian decision|8|||
157240744|NCT03056755|567628313|FG002|Core Phase|Subject/guardian decision|4|||
157240745|NCT03056755|567628311|FG000|Core Phase|Death|3|||
157240746|NCT03056755|567628312|FG001|Core Phase|Death|2|||
157240747|NCT03056755|567628313|FG002|Core Phase|Death|4|||
157240748|NCT03056755|567628311|FG000|Core Phase|Protocol deviation|1|||
157240749|NCT03056755|567628312|FG001|Core Phase|Protocol deviation|1|||
157240750|NCT03056755|567628313|FG002|Core Phase|Protocol deviation|0|||
157240751|NCT03056755|567628311|FG000|Core Phase|Technical problems|1|||
157240752|NCT03056755|567628312|FG001|Core Phase|Technical problems|0|||
157240753|NCT03056755|567628313|FG002|Core Phase|Technical problems|0|||
157240754|NCT03056755|567628311|FG000|Extension Phase|Physician Decision|1|||
157240755|NCT03056755|567628312|FG001|Extension Phase|Physician Decision|0|||
157240756|NCT03056755|567628313|FG002|Extension Phase|Physician Decision|3|||
157240757|NCT03056755|567628311|FG000|Extension Phase|Adverse Event|0|||
157240758|NCT03056755|567628312|FG001|Extension Phase|Adverse Event|0|||
157240759|NCT03056755|567628313|FG002|Extension Phase|Adverse Event|1|||
157240760|NCT03056755|567628311|FG000|Extension Phase|Subject/guardian decision|0|||
157240761|NCT03056755|567628312|FG001|Extension Phase|Subject/guardian decision|0|||
157240762|NCT03056755|567628313|FG002|Extension Phase|Subject/guardian decision|1|||
157240763|NCT06144424|567628314|FG000|Overall Study|Withdrawal by Subject|2|||
157240764|NCT06144424|567628315|FG001|Overall Study|Withdrawal by Subject|0|||
157240765|NCT06144424|567628314|FG000|Overall Study|Incarceration|1|||
157240766|NCT06144424|567628315|FG001|Overall Study|Incarceration|0|||
157240767|NCT01528696|567628318|FG000|Overall Study|See detailed description|18|||
157240768|NCT01528696|567628319|FG001|Overall Study|See detailed description|19|||
157240769|NCT01056484|567628320|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
157240770|NCT01056484|567628321|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
157240771|NCT01056484|567628320|FG000|Randomized Controlled Trial|Physician Decision|1|||
157240772|NCT01056484|567628321|FG001|Randomized Controlled Trial|Physician Decision|0|||
157240773|NCT01056484|567628320|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
157240774|NCT01056484|567628321|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
157240775|NCT00446966|567628324|FG000|Overall Study|Lost to Follow-up|10|||
157240776|NCT00446966|567628325|FG001|Overall Study|Lost to Follow-up|7|||
157240777|NCT00835575|567628326|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
157240778|NCT00835575|567628327|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
157240779|NCT00836472|567628328|FG000|Washout|Adverse Event|1|||
157240780|NCT00836472|567628329|FG001|Washout|Adverse Event|2|||
157240781|NCT00836472|567628328|FG000|Washout|Withdrawal by Subject|1|||
157240782|NCT00836472|567628329|FG001|Washout|Withdrawal by Subject|1|||
157240783|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
157240784|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
157240785|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
157240786|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
157240787|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240788|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240789|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240790|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240791|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240792|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240793|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240794|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240795|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240796|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
157240797|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
157240798|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
157240799|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
157240800|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
157240801|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240802|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240803|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240804|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240805|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240806|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240807|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240808|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240809|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240810|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
157240811|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
157240812|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240813|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
157240814|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240815|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240816|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240817|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240818|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240819|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240820|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240821|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240822|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240823|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240824|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
157240825|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
157240826|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
157240827|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
157240828|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240829|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240830|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240831|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240832|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240833|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240834|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240835|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240836|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240837|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240838|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
157240839|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
157240840|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240841|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
157240842|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240843|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240844|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240845|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240846|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240847|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240848|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240849|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240850|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240851|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240852|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
157240853|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157240854|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240855|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
157240856|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157091263|NCT01442779|567089077|FG000|Overall Study|Death|3|||
157091264|NCT01442779|567089077|FG000|Overall Study|Non-compliance|1|||
157091265|NCT05249829|567089078|FG000|Overall Study|Participant Relocation|0|||
157091266|NCT05249829|567089079|FG001|Overall Study|Participant Relocation|1|||
157240857|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240858|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240859|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240860|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240861|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240862|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240863|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240864|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240865|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240866|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
157240867|NCT01695239|567628330|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
157240868|NCT01695239|567628331|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240869|NCT01695239|567628332|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240870|NCT01695239|567628333|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240871|NCT01695239|567628334|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240872|NCT01695239|567628335|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240873|NCT01695239|567628336|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240874|NCT01695239|567628337|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240875|NCT01695239|567628338|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240876|NCT01695239|567628339|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240877|NCT01695239|567628340|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240878|NCT01695239|567628341|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240879|NCT01695239|567628342|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240880|NCT01695239|567628343|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
157240881|NCT01695239|567628330|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240882|NCT01695239|567628331|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240883|NCT01695239|567628332|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240884|NCT01695239|567628333|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240885|NCT01695239|567628334|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240886|NCT01695239|567628335|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240887|NCT01695239|567628336|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240888|NCT01695239|567628337|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
157240889|NCT01695239|567628338|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240890|NCT01695239|567628339|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240891|NCT01695239|567628340|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240892|NCT01695239|567628341|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240893|NCT01695239|567628342|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240894|NCT01695239|567628343|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
157240895|NCT01695239|567628330|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240896|NCT01695239|567628331|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240897|NCT01695239|567628332|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240898|NCT01695239|567628333|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240899|NCT01695239|567628334|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240900|NCT01695239|567628335|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240901|NCT01695239|567628336|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240902|NCT01695239|567628337|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
157240903|NCT01695239|567628338|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240904|NCT01695239|567628339|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240905|NCT01695239|567628340|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240906|NCT01695239|567628341|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240907|NCT01695239|567628342|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240908|NCT01695239|567628343|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
157240909|NCT01695239|567628330|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240910|NCT01695239|567628331|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240911|NCT01695239|567628332|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240912|NCT01695239|567628333|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240913|NCT01695239|567628334|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240914|NCT01695239|567628335|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240915|NCT01695239|567628336|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240916|NCT01695239|567628337|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
157091267|NCT05249829|567089080|FG002|Overall Study|Participant Relocation|2|||
157091268|NCT05249829|567089081|FG003|Overall Study|Participant Relocation|2|||
157091269|NCT05249829|567089078|FG000|Overall Study|Withdrawal by Subject|9|||
157091270|NCT05249829|567089079|FG001|Overall Study|Withdrawal by Subject|17|||
157091271|NCT05249829|567089080|FG002|Overall Study|Withdrawal by Subject|40|||
157240917|NCT01695239|567628338|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240918|NCT01695239|567628339|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240919|NCT01695239|567628340|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240920|NCT01695239|567628341|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240921|NCT01695239|567628342|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240922|NCT01695239|567628343|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
157240923|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240924|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240925|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240926|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240927|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240928|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157091272|NCT05249829|567089081|FG003|Overall Study|Withdrawal by Subject|35|||
157091273|NCT05249829|567089078|FG000|Overall Study|Physician Decision|1|||
157091274|NCT05249829|567089079|FG001|Overall Study|Physician Decision|0|||
157091275|NCT05249829|567089080|FG002|Overall Study|Physician Decision|0|||
157091276|NCT05249829|567089081|FG003|Overall Study|Physician Decision|0|||
157091277|NCT05249829|567089078|FG000|Overall Study|Lost to Follow-up|16|||
157091278|NCT05249829|567089079|FG001|Overall Study|Lost to Follow-up|16|||
157091279|NCT05249829|567089080|FG002|Overall Study|Lost to Follow-up|57|||
157091280|NCT05249829|567089081|FG003|Overall Study|Lost to Follow-up|60|||
157091281|NCT05249829|567089078|FG000|Overall Study|Adverse Event|2|||
157091282|NCT05249829|567089079|FG001|Overall Study|Adverse Event|2|||
157091283|NCT05249829|567089080|FG002|Overall Study|Adverse Event|2|||
157091284|NCT05249829|567089081|FG003|Overall Study|Adverse Event|2|||
157091285|NCT05249829|567089078|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
157091286|NCT05249829|567089079|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
157091287|NCT05249829|567089080|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
157091288|NCT05249829|567089081|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
157091289|NCT05249829|567089078|FG000|Overall Study|Protocol Violation|2|||
157091290|NCT05249829|567089079|FG001|Overall Study|Protocol Violation|0|||
157091291|NCT05249829|567089080|FG002|Overall Study|Protocol Violation|5|||
157091292|NCT05249829|567089081|FG003|Overall Study|Protocol Violation|3|||
157091293|NCT05249829|567089078|FG000|Overall Study|Death|0|||
157091294|NCT05249829|567089079|FG001|Overall Study|Death|1|||
157091295|NCT05249829|567089080|FG002|Overall Study|Death|2|||
157091296|NCT05249829|567089081|FG003|Overall Study|Death|4|||
157091297|NCT00196976|567089083|FG000|Primary Study|Migrated from study area|0|||
157091298|NCT00196976|567089084|FG001|Primary Study|Migrated from study area|0|||
157091299|NCT00196976|567089085|FG002|Primary Study|Migrated from study area|0|||
157091300|NCT00196976|567089086|FG003|Primary Study|Migrated from study area|0|||
157091301|NCT00196976|567089087|FG004|Primary Study|Migrated from study area|0|||
157091302|NCT00196976|567089088|FG005|Primary Study|Migrated from study area|0|||
157091303|NCT00196976|567089089|FG006|Primary Study|Migrated from study area|0|||
157091304|NCT00196976|567089090|FG007|Primary Study|Migrated from study area|1|||
157091305|NCT00196976|567089091|FG008|Primary Study|Migrated from study area|0|||
157091306|NCT00196976|567089092|FG009|Primary Study|Migrated from study area|0|||
157091307|NCT00196976|567089093|FG010|Primary Study|Migrated from study area|0|||
157091308|NCT00196976|567089094|FG011|Primary Study|Migrated from study area|0|||
157091309|NCT00196976|567089095|FG012|Primary Study|Migrated from study area|0|||
157240929|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240930|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240931|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
157240932|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
157091310|NCT00196976|567089096|FG013|Primary Study|Migrated from study area|0|||
157091311|NCT00196976|567089083|FG000|Primary Study|Protocol Violation|0|||
157091312|NCT00196976|567089084|FG001|Primary Study|Protocol Violation|1|||
157091313|NCT00196976|567089085|FG002|Primary Study|Protocol Violation|1|||
157091314|NCT00196976|567089086|FG003|Primary Study|Protocol Violation|0|||
157091315|NCT00196976|567089087|FG004|Primary Study|Protocol Violation|0|||
157091316|NCT00196976|567089088|FG005|Primary Study|Protocol Violation|0|||
157091317|NCT00196976|567089089|FG006|Primary Study|Protocol Violation|0|||
157091318|NCT00196976|567089090|FG007|Primary Study|Protocol Violation|0|||
157091319|NCT00196976|567089091|FG008|Primary Study|Protocol Violation|0|||
157091320|NCT00196976|567089092|FG009|Primary Study|Protocol Violation|0|||
157091321|NCT00196976|567089093|FG010|Primary Study|Protocol Violation|0|||
157091322|NCT00196976|567089094|FG011|Primary Study|Protocol Violation|0|||
157091323|NCT00196976|567089095|FG012|Primary Study|Protocol Violation|0|||
157091324|NCT00196976|567089096|FG013|Primary Study|Protocol Violation|0|||
157091325|NCT00196976|567089083|FG000|Primary Study|Withdrawal by Subject|1|||
157091326|NCT00196976|567089084|FG001|Primary Study|Withdrawal by Subject|0|||
157091327|NCT00196976|567089085|FG002|Primary Study|Withdrawal by Subject|1|||
157091328|NCT00196976|567089086|FG003|Primary Study|Withdrawal by Subject|1|||
157091329|NCT00196976|567089087|FG004|Primary Study|Withdrawal by Subject|2|||
157091330|NCT00196976|567089088|FG005|Primary Study|Withdrawal by Subject|1|||
157240933|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240934|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240935|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240936|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
157240937|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
157240938|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
157240939|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
157240940|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
157240941|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
157240942|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
157240943|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
157240944|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
157240945|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
157240946|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
157240947|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
157240948|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
157240949|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
157240950|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
157240951|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240952|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240953|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240954|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240955|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240956|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240957|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240958|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240959|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
157240960|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
157240961|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240962|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240963|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240964|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
157240965|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
157240966|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
157240967|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
157240968|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
157240969|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
157240970|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
157240971|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
157240972|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
157240973|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
157240974|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
157240975|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
157240976|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
157240977|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
157091331|NCT00196976|567089089|FG006|Primary Study|Withdrawal by Subject|0|||
157091332|NCT00196976|567089090|FG007|Primary Study|Withdrawal by Subject|0|||
157091333|NCT00196976|567089091|FG008|Primary Study|Withdrawal by Subject|0|||
157091334|NCT00196976|567089092|FG009|Primary Study|Withdrawal by Subject|1|||
157091335|NCT00196976|567089093|FG010|Primary Study|Withdrawal by Subject|0|||
157091336|NCT00196976|567089094|FG011|Primary Study|Withdrawal by Subject|0|||
157091337|NCT00196976|567089095|FG012|Primary Study|Withdrawal by Subject|0|||
157091338|NCT00196976|567089096|FG013|Primary Study|Withdrawal by Subject|0|||
157091339|NCT00196976|567089083|FG000|Primary Study|Lost to Follow-up|0|||
157197357|NCT02260791|567465318|FG000|Overall Study|Protocol deviation|2|||
157197358|NCT02260791|567465319|FG001|Overall Study|Protocol deviation|3|||
157197359|NCT00736840|567465320|FG000|Overall Study|Lost to Follow-up|13|||
157197360|NCT01411917|567465321|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
157197361|NCT01411917|567465322|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
157197362|NCT03289676|567465325|FG000|Overall Study|Withdrawal by Subject|2|||
157197363|NCT03289676|567465326|FG001|Overall Study|Withdrawal by Subject|0|||
157197364|NCT03289676|567465325|FG000|Overall Study|Protocol Violation|2|||
157197365|NCT03289676|567465326|FG001|Overall Study|Protocol Violation|0|||
157197366|NCT03289676|567465325|FG000|Overall Study|Lost to Follow-up|0|||
157197367|NCT03289676|567465326|FG001|Overall Study|Lost to Follow-up|1|||
157197368|NCT02354599|567465329|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
157240978|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
157240979|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240980|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240981|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240982|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240983|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240984|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240985|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240986|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240987|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
157240988|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
157240989|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240990|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240991|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240992|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
157240993|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240994|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240995|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240996|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240997|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240998|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157240999|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241000|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241001|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
157241002|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
157241003|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241004|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241005|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241006|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
157241007|NCT01695239|567628330|FG000|Extension Long-Term Extension Periods|Death|0|||
157241008|NCT01695239|567628331|FG001|Extension Long-Term Extension Periods|Death|0|||
157241009|NCT01695239|567628332|FG002|Extension Long-Term Extension Periods|Death|0|||
157241010|NCT01695239|567628333|FG003|Extension Long-Term Extension Periods|Death|0|||
157241011|NCT01695239|567628334|FG004|Extension Long-Term Extension Periods|Death|0|||
157241012|NCT01695239|567628335|FG005|Extension Long-Term Extension Periods|Death|0|||
157241013|NCT01695239|567628336|FG006|Extension Long-Term Extension Periods|Death|0|||
157241014|NCT01695239|567628337|FG007|Extension Long-Term Extension Periods|Death|0|||
157241015|NCT01695239|567628338|FG008|Extension Long-Term Extension Periods|Death|1|||
157241016|NCT01695239|567628339|FG009|Extension Long-Term Extension Periods|Death|0|||
157241017|NCT01695239|567628340|FG010|Extension Long-Term Extension Periods|Death|0|||
157241018|NCT01695239|567628341|FG011|Extension Long-Term Extension Periods|Death|0|||
157241019|NCT01695239|567628342|FG012|Extension Long-Term Extension Periods|Death|0|||
157241020|NCT01695239|567628343|FG013|Extension Long-Term Extension Periods|Death|0|||
157241021|NCT01695239|567628330|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241022|NCT01695239|567628331|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241023|NCT01695239|567628332|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241024|NCT01695239|567628333|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241025|NCT01695239|567628334|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241026|NCT01695239|567628335|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241027|NCT01695239|567628336|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241028|NCT01695239|567628337|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241029|NCT01695239|567628338|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241030|NCT01695239|567628339|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241031|NCT01695239|567628340|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
157241032|NCT01695239|567628341|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
157241033|NCT01695239|567628342|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
157241034|NCT01695239|567628343|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
157241035|NCT01695239|567628330|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241036|NCT01695239|567628331|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241037|NCT01695239|567628332|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241038|NCT01695239|567628333|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241039|NCT01695239|567628334|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241040|NCT01695239|567628335|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241041|NCT01695239|567628336|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241042|NCT01695239|567628337|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241043|NCT01695239|567628338|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241044|NCT01695239|567628339|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157091340|NCT00196976|567089084|FG001|Primary Study|Lost to Follow-up|0|||
157241045|NCT01695239|567628340|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241046|NCT01695239|567628341|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
157241047|NCT01695239|567628342|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
157241048|NCT01695239|567628343|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
157241049|NCT01695239|567628330|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241050|NCT01695239|567628331|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241051|NCT01695239|567628332|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241052|NCT01695239|567628333|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241053|NCT01695239|567628334|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241054|NCT01695239|567628335|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241055|NCT01695239|567628336|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241056|NCT01695239|567628337|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241057|NCT01695239|567628338|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241058|NCT01695239|567628339|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241059|NCT01695239|567628340|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241060|NCT01695239|567628341|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241061|NCT01695239|567628342|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
157241062|NCT01695239|567628343|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
157241063|NCT01695239|567628330|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241064|NCT01695239|567628331|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241065|NCT01695239|567628332|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241066|NCT01695239|567628333|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241067|NCT01695239|567628334|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241068|NCT01695239|567628335|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241069|NCT01695239|567628336|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241070|NCT01695239|567628337|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241071|NCT01695239|567628338|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241072|NCT01695239|567628339|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241073|NCT01695239|567628340|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241074|NCT01695239|567628341|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241075|NCT01695239|567628342|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
157241076|NCT01695239|567628343|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
157241077|NCT03502811|567628346|FG000|Overall Study|Death|157|||
157241078|NCT03502811|567628346|FG000|Overall Study|Withdrawal by Subject|105|||
157241079|NCT03502811|567628346|FG000|Overall Study|Lost to Follow-up|26|||
157241080|NCT03502811|567628346|FG000|Overall Study|No Visits (Missed)|31|||
157241081|NCT05239195|567628347|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
157241082|NCT05239195|567628348|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
157241083|NCT02241551|567628349|FG000|Overall Study|Adverse Event|1|||
157241084|NCT02241551|567628350|FG001|Overall Study|Adverse Event|0|||
157241085|NCT01839279|567628360|FG000|Overall Study|Adverse Event|4|||
157241086|NCT01839279|567628361|FG001|Overall Study|Adverse Event|1|||
157241087|NCT01839279|567628362|FG002|Overall Study|Adverse Event|1|||
157241088|NCT01839279|567628360|FG000|Overall Study|Withdrawal by Subject|4|||
157241089|NCT01839279|567628361|FG001|Overall Study|Withdrawal by Subject|1|||
157241090|NCT01839279|567628362|FG002|Overall Study|Withdrawal by Subject|1|||
157241091|NCT01839279|567628360|FG000|Overall Study|Classified as 'Other'|5|||
157241092|NCT01839279|567628361|FG001|Overall Study|Classified as 'Other'|0|||
157241093|NCT01839279|567628362|FG002|Overall Study|Classified as 'Other'|0|||
157241094|NCT00107991|567628370|FG000|Eligibility Assessment|Disease not severe enough|7|||
157241095|NCT00107991|567628370|FG000|Eligibility Assessment|Unwilling to participate|7|||
157241096|NCT00107991|567628370|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
157241097|NCT00107991|567628370|FG000|Eligibility Assessment|Abnormal labs|2|||
157241098|NCT00107991|567628370|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
157241099|NCT00107991|567628370|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
157241100|NCT00107991|567628370|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
157241101|NCT00107991|567628370|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
157241102|NCT00107991|567628370|FG000|12 Week Treatment Period|Adverse Event|1|||
157241103|NCT00107991|567628370|FG000|12 Week Treatment Period|Protocol Violation|1|||
157241104|NCT00107991|567628370|FG000|12 Week Treatment Period|Incarcerated|1|||
157241105|NCT00107991|567628370|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
157241106|NCT03930732|567628371|FG000|Overall Study|Adverse Event|9|||
157241107|NCT03930732|567628372|FG001|Overall Study|Adverse Event|7|||
157241108|NCT03930732|567628371|FG000|Overall Study|Poor compliance to protocol|0|||
157241109|NCT03930732|567628372|FG001|Overall Study|Poor compliance to protocol|1|||
157241110|NCT03930732|567628371|FG000|Overall Study|Withdrawal by Subject|23|||
157241111|NCT03930732|567628372|FG001|Overall Study|Withdrawal by Subject|11|||
157241112|NCT03930732|567628371|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
157241113|NCT03930732|567628372|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
157197369|NCT02354599|567465330|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
157197370|NCT02354599|567465331|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
157197371|NCT02354599|567465332|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
157197372|NCT02354599|567465333|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
157197373|NCT02354599|567465334|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
157197374|NCT02354599|567465329|FG000|Overall Study|Withdrawal by Subject|1|||
157197375|NCT02354599|567465330|FG001|Overall Study|Withdrawal by Subject|1|||
157197376|NCT02354599|567465331|FG002|Overall Study|Withdrawal by Subject|0|||
157197377|NCT02354599|567465332|FG003|Overall Study|Withdrawal by Subject|0|||
157197378|NCT02354599|567465333|FG004|Overall Study|Withdrawal by Subject|0|||
157197379|NCT02354599|567465334|FG005|Overall Study|Withdrawal by Subject|0|||
157197380|NCT00660829|567465335|FG000|Overall Study|Adverse Event|3|||
157197381|NCT00660829|567465336|FG001|Overall Study|Adverse Event|4|||
157197382|NCT00660829|567465335|FG000|Overall Study|Lack of Efficacy|2|||
157197383|NCT00660829|567465336|FG001|Overall Study|Lack of Efficacy|3|||
157197384|NCT00660829|567465335|FG000|Overall Study|Non-Compliance|0|||
157197385|NCT00660829|567465336|FG001|Overall Study|Non-Compliance|4|||
157197386|NCT00660829|567465335|FG000|Overall Study|Withdrawal by Subject|1|||
157197387|NCT00660829|567465336|FG001|Overall Study|Withdrawal by Subject|2|||
157197388|NCT00660829|567465335|FG000|Overall Study|Lost to Follow-up|3|||
157197389|NCT00660829|567465336|FG001|Overall Study|Lost to Follow-up|2|||
157197390|NCT00660829|567465335|FG000|Overall Study|Other|9|||
157197391|NCT00660829|567465336|FG001|Overall Study|Other|4|||
157197392|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Death|2|||
157197393|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Death|0|||
157197394|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Adverse Event|33|||
157197395|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Adverse Event|31|||
157197396|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
157197397|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
157197398|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
157197399|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
157197400|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
157197401|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
157197402|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Other|7|||
157197403|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Other|8|||
157197404|NCT00280059|567465337|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
157197405|NCT00280059|567465338|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
157197406|NCT00495794|567465341|FG000|Overall Study|Pharmacist did not activate patient|522|||
157197407|NCT00495794|567465342|FG001|Overall Study|Pharmacist did not activate patient|0|||
157197408|NCT02127931|567465343|FG000|Overall Study|Glitch in Game|1|||
157197409|NCT01018680|567467060|FG000|Overall Study|Adverse Event|23|||
157197410|NCT01018680|567467061|FG001|Overall Study|Adverse Event|40|||
157197411|NCT01018680|567467060|FG000|Overall Study|Withdrawal by Subject|10|||
157197412|NCT01018680|567467061|FG001|Overall Study|Withdrawal by Subject|10|||
157197413|NCT01018680|567467060|FG000|Overall Study|Protocol Violation|5|||
157197414|NCT01018680|567467061|FG001|Overall Study|Protocol Violation|8|||
157197415|NCT01018680|567467060|FG000|Overall Study|Sponsor Decision|6|||
157197416|NCT01018680|567467061|FG001|Overall Study|Sponsor Decision|7|||
157197417|NCT01018680|567467060|FG000|Overall Study|Lack of Efficacy|8|||
157197418|NCT01018680|567467061|FG001|Overall Study|Lack of Efficacy|2|||
157197419|NCT01018680|567467060|FG000|Overall Study|Lost to Follow-up|5|||
157197420|NCT01018680|567467061|FG001|Overall Study|Lost to Follow-up|3|||
157197421|NCT01018680|567467060|FG000|Overall Study|Entry Criteria Not Met|1|||
157197422|NCT01018680|567467061|FG001|Overall Study|Entry Criteria Not Met|4|||
157197423|NCT01018680|567467060|FG000|Overall Study|Physician Decision|3|||
157197424|NCT01018680|567467061|FG001|Overall Study|Physician Decision|1|||
157197425|NCT05056311|567467062|FG000|Overall Study|Lost to Follow-up|14|||
157197426|NCT05056311|567467062|FG000|Overall Study|Withdrawal by Subject|1|||
157197427|NCT05056311|567467062|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
157197428|NCT00960869|567467063|FG000|Overall Study|Adverse Event|17|||
157197429|NCT00960869|567467064|FG001|Overall Study|Adverse Event|26|||
157197430|NCT00960869|567467063|FG000|Overall Study|Withdrawal by Subject|16|||
157197431|NCT00960869|567467064|FG001|Overall Study|Withdrawal by Subject|14|||
157197432|NCT00960869|567467063|FG000|Overall Study|Lost to Follow-up|1|||
157197433|NCT00960869|567467064|FG001|Overall Study|Lost to Follow-up|4|||
157197434|NCT00960869|567467063|FG000|Overall Study|Misc|19|||
157197435|NCT00960869|567467064|FG001|Overall Study|Misc|18|||
157197436|NCT01153971|567467071|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
157197437|NCT01153971|567467071|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
157197438|NCT01153971|567467071|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
157197439|NCT01153971|567467071|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
157197440|NCT01153971|567467071|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
157197441|NCT01153971|567467071|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
157197442|NCT01153971|567467071|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
157197443|NCT01789476|567467072|FG000|Overall Study|Lack of Efficacy|6|||
157197444|NCT01789476|567467073|FG001|Overall Study|Lack of Efficacy|2|||
157197445|NCT01789476|567467072|FG000|Overall Study|Adverse Event|1|||
157197446|NCT01789476|567467073|FG001|Overall Study|Adverse Event|0|||
157197447|NCT01789476|567467072|FG000|Overall Study|Unable to get IV access|1|||
157197448|NCT01789476|567467073|FG001|Overall Study|Unable to get IV access|0|||
157197449|NCT01161173|567467074|FG000|Overall Study|Protocol Violation|13|||
157197450|NCT01161173|567467074|FG000|Overall Study|Lost to Follow-up|7|||
157197451|NCT01161173|567467074|FG000|Overall Study|Progressive Disease|82|||
157197452|NCT01161173|567467074|FG000|Overall Study|Withdrawal of Consent|5|||
157197453|NCT01161173|567467074|FG000|Overall Study|Unacceptable Toxicity|21|||
157197454|NCT01161173|567467074|FG000|Overall Study|Death|194|||
157197455|NCT01161173|567467074|FG000|Overall Study|End of Study|2|||
157197456|NCT01161173|567467074|FG000|Overall Study|Reasons Not Specified|23|||
157197457|NCT01911546|567467075|FG000|Overall Study|Lost to Follow-up|1|||
157197458|NCT01911546|567467075|FG000|Overall Study|Everolimus was discontinued|5|||
157197459|NCT01319422|567467076|FG000|Overall Study|Withdrawal by Subject|1|||
157197460|NCT01319422|567467077|FG001|Overall Study|Withdrawal by Subject|0|||
157197461|NCT01399619|567467078|FG000|Overall Study|Adverse Event|10|||
157197462|NCT01399619|567467079|FG001|Overall Study|Adverse Event|0|||
157197463|NCT01399619|567467080|FG002|Overall Study|Adverse Event|4|||
157197464|NCT01399619|567467081|FG003|Overall Study|Adverse Event|10|||
157197465|NCT01399619|567467078|FG000|Overall Study|Lack of Efficacy|9|||
157197466|NCT01399619|567467079|FG001|Overall Study|Lack of Efficacy|0|||
157197467|NCT01399619|567467080|FG002|Overall Study|Lack of Efficacy|5|||
157197468|NCT01399619|567467081|FG003|Overall Study|Lack of Efficacy|0|||
157197469|NCT01399619|567467078|FG000|Overall Study|Withdrawal by Subject|6|||
157197470|NCT01399619|567467079|FG001|Overall Study|Withdrawal by Subject|0|||
157197471|NCT01399619|567467080|FG002|Overall Study|Withdrawal by Subject|3|||
157197472|NCT01399619|567467081|FG003|Overall Study|Withdrawal by Subject|4|||
157197473|NCT01399619|567467078|FG000|Overall Study|Protocol Violation|0|||
157197474|NCT01399619|567467079|FG001|Overall Study|Protocol Violation|0|||
157197475|NCT01399619|567467080|FG002|Overall Study|Protocol Violation|0|||
157197476|NCT01399619|567467081|FG003|Overall Study|Protocol Violation|1|||
157197477|NCT01399619|567467078|FG000|Overall Study|Not treated|0|||
157197478|NCT01399619|567467079|FG001|Overall Study|Not treated|0|||
157197479|NCT01399619|567467080|FG002|Overall Study|Not treated|0|||
157197480|NCT01399619|567467081|FG003|Overall Study|Not treated|2|||
157197481|NCT02918968|567467082|FG000|1st Line AAT|Progressive disease|9|||
157197482|NCT02918968|567467083|FG001|1st Line AAT|Progressive disease|4|||
157197483|NCT02918968|567467082|FG000|1st Line AAT|Adverse Event|12|||
157197484|NCT02918968|567467083|FG001|1st Line AAT|Adverse Event|3|||
157197485|NCT02918968|567467082|FG000|1st Line AAT|Physician Decision|4|||
157197486|NCT02918968|567467083|FG001|1st Line AAT|Physician Decision|2|||
157197487|NCT02918968|567467082|FG000|1st Line AAT|Withdrawal by Subject|2|||
157197488|NCT02918968|567467083|FG001|1st Line AAT|Withdrawal by Subject|1|||
157197489|NCT02918968|567467082|FG000|1st Line AAT|Lost to Follow-up|0|||
157197490|NCT02918968|567467083|FG001|1st Line AAT|Lost to Follow-up|1|||
157197491|NCT02918968|567467082|FG000|1st Line AAT|Death|1|||
157197492|NCT02918968|567467083|FG001|1st Line AAT|Death|0|||
157197493|NCT02918968|567467082|FG000|1st Line AAT|Miscellaneous|1|||
157197494|NCT02918968|567467083|FG001|1st Line AAT|Miscellaneous|0|||
157197495|NCT02918968|567467082|FG000|2nd Line AAT|Progressive disease|21|||
157197496|NCT02918968|567467083|FG001|2nd Line AAT|Progressive disease|3|||
157197497|NCT02918968|567467082|FG000|2nd Line AAT|Adverse Event|2|||
157197498|NCT02918968|567467083|FG001|2nd Line AAT|Adverse Event|5|||
157197499|NCT02918968|567467082|FG000|2nd Line AAT|Physician Decision|0|||
157197500|NCT02918968|567467083|FG001|2nd Line AAT|Physician Decision|1|||
157197501|NCT02918968|567467082|FG000|2nd Line AAT|Withdrawal by Subject|2|||
157197502|NCT02918968|567467083|FG001|2nd Line AAT|Withdrawal by Subject|2|||
157197503|NCT02918968|567467082|FG000|2nd Line AAT|Death|0|||
157197504|NCT02918968|567467083|FG001|2nd Line AAT|Death|1|||
157197505|NCT00750061|567467084|FG000|Overall Study|Adverse Event|2|||
157197506|NCT00750061|567467085|FG001|Overall Study|Adverse Event|0|||
157197507|NCT00750061|567467084|FG000|Overall Study|Withdrawal by Subject|0|||
157197508|NCT00750061|567467085|FG001|Overall Study|Withdrawal by Subject|1|||
157197509|NCT00750061|567467084|FG000|Overall Study|Physician Decision|0|||
157197510|NCT00750061|567467085|FG001|Overall Study|Physician Decision|1|||
157197511|NCT00229931|567467088|FG000|Overall Study|Death|1|||
157197512|NCT00229931|567467089|FG001|Overall Study|Death|0|||
157197513|NCT00229931|567467088|FG000|Overall Study|Lost to Follow-up|3|||
157197514|NCT00229931|567467089|FG001|Overall Study|Lost to Follow-up|2|||
157197515|NCT02992743|567467090|FG000|Overall Study|Withdrawal by Subject|1|||
157197516|NCT02992743|567467091|FG001|Overall Study|Withdrawal by Subject|1|||
157197517|NCT02992743|567467090|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
157197518|NCT02992743|567467091|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
157197519|NCT02992743|567467090|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
157197520|NCT02992743|567467091|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
157197521|NCT02992743|567467090|FG000|Overall Study|No measurable disease|1|||
157197522|NCT02992743|567467091|FG001|Overall Study|No measurable disease|0|||
157197523|NCT02992743|567467090|FG000|Overall Study|Lost to Follow-up|0|||
157197524|NCT02992743|567467091|FG001|Overall Study|Lost to Follow-up|1|||
157241114|NCT03930732|567628371|FG000|Overall Study|Other reason not related to COVID-19|5|||
157241115|NCT03930732|567628372|FG001|Overall Study|Other reason not related to COVID-19|8|||
157241116|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Adverse Event|11|||
157241117|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Adverse Event|23|||
157241118|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Adverse Event|29|||
157241119|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Adverse Event|2|||
157241120|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Adverse Event|8|||
157241121|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
157241122|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
157241123|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
157241124|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
157241125|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
157241126|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
157241127|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
157241128|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
157241129|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
157241130|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
157241131|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
157241132|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
157241133|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
157241134|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
157241135|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
157241136|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
157241137|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
157241138|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
157241139|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
157241140|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
157241141|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
157241142|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
157241143|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
157241144|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
157241145|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
157241146|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
157241147|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
157241148|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
157241149|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
157241150|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
157241151|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Move|0|||
157241152|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Move|1|||
157241153|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Move|0|||
157241154|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Move|0|||
157241155|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Move|0|||
157241156|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
157241157|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
157241158|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
157241159|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
157241160|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
157241161|NCT00318461|567628379|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
157241162|NCT00318461|567628380|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
157241163|NCT00318461|567628381|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
157241164|NCT00318461|567628382|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
157241165|NCT00318461|567628383|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
157241166|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Work commitment|0|||
157241167|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Work commitment|0|||
157241168|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Work commitment|0|||
157241169|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Work commitment|0|||
157241170|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Work commitment|1|||
157241171|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Investigator decision|0|||
157241172|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Investigator decision|0|||
157241173|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Investigator decision|0|||
157241174|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Investigator decision|0|||
157241175|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Investigator decision|1|||
157241176|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Lack of time|1|||
157241177|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Lack of time|0|||
157241178|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Lack of time|0|||
157241179|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Lack of time|0|||
157241180|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Lack of time|0|||
157241181|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
157241182|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
157241183|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
157241184|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
157241185|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
157241186|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
157241187|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
157241188|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
157241189|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
157241190|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
157241191|NCT00318461|567628379|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
157241192|NCT00318461|567628380|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
157241193|NCT00318461|567628381|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
157241194|NCT00318461|567628382|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
157241195|NCT00318461|567628383|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
157241196|NCT00318461|567628379|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
157241197|NCT00318461|567628380|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
157241198|NCT00318461|567628381|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
157241199|NCT00318461|567628382|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
157241200|NCT00318461|567628383|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
157241201|NCT00318461|567628379|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
157241202|NCT00318461|567628380|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
157241203|NCT00318461|567628381|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
157241204|NCT00318461|567628382|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
157241205|NCT00318461|567628383|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
157241206|NCT00318461|567628379|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
157241207|NCT00318461|567628380|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
157241208|NCT00318461|567628381|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
157241209|NCT00318461|567628382|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
157241210|NCT00318461|567628383|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
157241211|NCT00318461|567628379|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
157241212|NCT00318461|567628380|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
157241213|NCT00318461|567628381|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
157241214|NCT00318461|567628382|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
157241215|NCT00318461|567628383|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
157241216|NCT00318461|567628379|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
157241217|NCT00318461|567628380|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
157241218|NCT00318461|567628381|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
157241219|NCT00318461|567628382|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
157241220|NCT00318461|567628383|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
157241221|NCT03084471|567628386|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
157241222|NCT03084471|567628386|FG000|Overall Study|Condition under investigation worsened|84|||
157241223|NCT03084471|567628386|FG000|Overall Study|Lack of therapeutic response|2|||
157241224|NCT03084471|567628386|FG000|Overall Study|Protocol Violation|1|||
157241225|NCT03084471|567628386|FG000|Overall Study|Adverse Event|73|||
157241226|NCT03084471|567628386|FG000|Overall Study|Withdrawal by Subject|12|||
157241227|NCT03084471|567628386|FG000|Overall Study|Disease relapse|181|||
157241228|NCT03084471|567628386|FG000|Overall Study|Subjective disease progression|359|||
157241229|NCT03084471|567628386|FG000|Overall Study|Other (as recorded)|33|||
157241230|NCT03084471|567628386|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
157241231|NCT00505622|567628387|FG000|Overall Study|Adverse Event|5|||
157241232|NCT00505622|567628388|FG001|Overall Study|Adverse Event|6|||
157241233|NCT00505622|567628389|FG002|Overall Study|Adverse Event|4|||
157241234|NCT00505622|567628387|FG000|Overall Study|Protocol Violation|1|||
157241235|NCT00505622|567628388|FG001|Overall Study|Protocol Violation|1|||
157241236|NCT00505622|567628389|FG002|Overall Study|Protocol Violation|0|||
157241237|NCT00505622|567628387|FG000|Overall Study|Withdrawal by Subject|0|||
157241238|NCT00505622|567628388|FG001|Overall Study|Withdrawal by Subject|3|||
157241239|NCT00505622|567628389|FG002|Overall Study|Withdrawal by Subject|2|||
157241240|NCT00505622|567628387|FG000|Overall Study|Study termination by sponsor|115|||
157241241|NCT00505622|567628388|FG001|Overall Study|Study termination by sponsor|98|||
157241242|NCT00505622|567628389|FG002|Overall Study|Study termination by sponsor|90|||
157241243|NCT01757392|567628398|FG000|Overall Study|Withdrawal by Subject|1|||
157241244|NCT01757392|567628398|FG000|Overall Study|Screen Fail|3|||
157241245|NCT00207090|567628401|FG000|Overall Study|Study drug toxicity|3|||
157241246|NCT00207090|567628401|FG000|Overall Study|Chest wall mass larger|1|||
157241247|NCT00207090|567628401|FG000|Overall Study|Disease progression/relapse|2|||
157241248|NCT00207090|567628401|FG000|Overall Study|Physician Decision|1|||
157241249|NCT00835692|567628402|FG000|First Intervention|Withdrawal by Subject|1|||
157241250|NCT00835692|567628403|FG001|First Intervention|Withdrawal by Subject|0|||
157241251|NCT03644550|567628408|FG000|Overall Study|Withdrawal by Subject|3|||
157241252|NCT03644550|567628408|FG000|Overall Study|Progressive disease|15|||
157241253|NCT00830024|567628415|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
157241254|NCT00830024|567628416|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
157197525|NCT00381680|567467092|FG000|Overall Study|Adverse Event|9|||
157197526|NCT00381680|567467093|FG001|Overall Study|Adverse Event|3|||
157197527|NCT00381680|567467092|FG000|Overall Study|Death|10|||
157197528|NCT00381680|567467093|FG001|Overall Study|Death|7|||
157197529|NCT00381680|567467092|FG000|Overall Study|Lost to Follow-up|3|||
157197530|NCT00381680|567467093|FG001|Overall Study|Lost to Follow-up|2|||
157197531|NCT00381680|567467092|FG000|Overall Study|Physician Decision|25|||
157197532|NCT00381680|567467093|FG001|Overall Study|Physician Decision|6|||
157197533|NCT00381680|567467092|FG000|Overall Study|Withdrawal by Subject|3|||
157197534|NCT00381680|567467093|FG001|Overall Study|Withdrawal by Subject|1|||
157197535|NCT00381680|567467092|FG000|Overall Study|Entry onto another COG Trial|1|||
157197536|NCT00381680|567467093|FG001|Overall Study|Entry onto another COG Trial|2|||
157197537|NCT00381680|567467092|FG000|Overall Study|Alternative Therapy|11|||
157197538|NCT00381680|567467093|FG001|Overall Study|Alternative Therapy|5|||
157197539|NCT00381680|567467092|FG000|Overall Study|Secondary Malignancy|3|||
157197540|NCT00381680|567467093|FG001|Overall Study|Secondary Malignancy|0|||
157197541|NCT00381680|567467092|FG000|Overall Study|Delay initiation|1|||
157197542|NCT00381680|567467093|FG001|Overall Study|Delay initiation|0|||
157197543|NCT00381680|567467092|FG000|Overall Study|Stem Cell Transplant|26|||
157197544|NCT00381680|567467093|FG001|Overall Study|Stem Cell Transplant|10|||
157197545|NCT00381680|567467092|FG000|Overall Study|Relapse|18|||
157197546|NCT00381680|567467093|FG001|Overall Study|Relapse|9|||
157197547|NCT00381680|567467092|FG000|Overall Study|Induction Failure|4|||
157197548|NCT00381680|567467093|FG001|Overall Study|Induction Failure|1|||
157197549|NCT00381680|567467092|FG000|Overall Study|Progression|1|||
157197550|NCT00381680|567467093|FG001|Overall Study|Progression|1|||
157197551|NCT00381680|567467092|FG000|Overall Study|Other not otherwise specified|7|||
157197552|NCT00381680|567467093|FG001|Overall Study|Other not otherwise specified|2|||
157197553|NCT00381680|567467092|FG000|Overall Study|Ineligible|3|||
157197554|NCT00381680|567467093|FG001|Overall Study|Ineligible|1|||
157197555|NCT00450814|567467095|FG000|Overall Study|Failed to complete the initial therapy|0|||
157197556|NCT00450814|567467096|FG001|Overall Study|Failed to complete the initial therapy|0|||
157197557|NCT00450814|567467097|FG002|Overall Study|Failed to complete the initial therapy|0|||
157197558|NCT00450814|567467098|FG003|Overall Study|Failed to complete the initial therapy|1|||
157197559|NCT00450814|567467099|FG004|Overall Study|Failed to complete the initial therapy|1|||
157197560|NCT00450814|567467100|FG005|Overall Study|Failed to complete the initial therapy|1|||
157197561|NCT00450814|567467101|FG006|Overall Study|Failed to complete the initial therapy|0|||
157197562|NCT00450814|567467102|FG007|Overall Study|Failed to complete the initial therapy|0|||
157197563|NCT00450814|567467103|FG008|Overall Study|Failed to complete the initial therapy|0|||
157197564|NCT00450814|567467104|FG009|Overall Study|Failed to complete the initial therapy|0|||
157197565|NCT00450814|567467105|FG010|Overall Study|Failed to complete the initial therapy|0|||
157197566|NCT00450814|567467095|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
157197567|NCT00450814|567467096|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
157197568|NCT00450814|567467097|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
157197569|NCT00450814|567467098|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
157197570|NCT00450814|567467099|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
157197571|NCT00450814|567467100|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
157197572|NCT00450814|567467101|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
157197573|NCT00450814|567467102|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
157197574|NCT00450814|567467103|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
157197575|NCT00450814|567467104|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
157197576|NCT00450814|567467105|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
157197577|NCT03602976|567467110|FG000|Overall Study|Withdrawal by Subject|1|||
157197578|NCT04837807|567467111|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
157197579|NCT04837807|567467112|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
157197580|NCT04629534|567467113|FG000|Overall Study|Physician Decision|1|||
157197581|NCT04629534|567467114|FG001|Overall Study|Physician Decision|0|||
157197582|NCT04629534|567467113|FG000|Overall Study|Protocol Violation|0|||
157197583|NCT04629534|567467114|FG001|Overall Study|Protocol Violation|2|||
157197584|NCT03732534|567467115|FG000|Overall Study|Study terminated by Sponsor|6|||
157197585|NCT00612456|567467116|FG000|Overall Study|Adverse Event|1|||
157197586|NCT00612456|567467117|FG001|Overall Study|Adverse Event|0|||
157197587|NCT00612456|567467118|FG002|Overall Study|Adverse Event|0|||
157197588|NCT00612456|567467116|FG000|Overall Study|Lack of Efficacy|1|||
157197589|NCT00612456|567467117|FG001|Overall Study|Lack of Efficacy|1|||
157197590|NCT00612456|567467118|FG002|Overall Study|Lack of Efficacy|0|||
157197591|NCT00612456|567467116|FG000|Overall Study|Withdrawal by Subject|0|||
157197592|NCT00612456|567467117|FG001|Overall Study|Withdrawal by Subject|1|||
157197593|NCT00612456|567467118|FG002|Overall Study|Withdrawal by Subject|0|||
157197594|NCT03907072|567467119|FG000|Overall Study|Study Terminated by Sponsor|2|||
157197595|NCT03907072|567467120|FG001|Overall Study|Study Terminated by Sponsor|2|||
157197596|NCT03907072|567467121|FG002|Overall Study|Study Terminated by Sponsor|2|||
157197597|NCT00265109|567467124|FG000|Overall Study|Withdrawal by Subject|5|||
157197598|NCT00265109|567467124|FG000|Overall Study|Adverse Event|1|||
157091341|NCT00196976|567089085|FG002|Primary Study|Lost to Follow-up|0|||
157091342|NCT00196976|567089086|FG003|Primary Study|Lost to Follow-up|0|||
157091343|NCT00196976|567089087|FG004|Primary Study|Lost to Follow-up|1|||
157091344|NCT00196976|567089088|FG005|Primary Study|Lost to Follow-up|1|||
157091345|NCT00196976|567089089|FG006|Primary Study|Lost to Follow-up|0|||
157091346|NCT00196976|567089090|FG007|Primary Study|Lost to Follow-up|2|||
157091347|NCT00196976|567089091|FG008|Primary Study|Lost to Follow-up|0|||
157091348|NCT00196976|567089092|FG009|Primary Study|Lost to Follow-up|0|||
157091349|NCT00196976|567089093|FG010|Primary Study|Lost to Follow-up|0|||
157091350|NCT00196976|567089094|FG011|Primary Study|Lost to Follow-up|0|||
157091351|NCT00196976|567089095|FG012|Primary Study|Lost to Follow-up|0|||
157091352|NCT00196976|567089096|FG013|Primary Study|Lost to Follow-up|0|||
157091353|NCT00196976|567089083|FG000|Primary Study|Other|0|||
157091354|NCT00196976|567089084|FG001|Primary Study|Other|0|||
157091355|NCT00196976|567089085|FG002|Primary Study|Other|2|||
157091356|NCT00196976|567089086|FG003|Primary Study|Other|0|||
157091357|NCT00196976|567089087|FG004|Primary Study|Other|0|||
157091358|NCT00196976|567089088|FG005|Primary Study|Other|0|||
157091359|NCT00196976|567089089|FG006|Primary Study|Other|0|||
157091360|NCT00196976|567089090|FG007|Primary Study|Other|0|||
157091361|NCT00196976|567089091|FG008|Primary Study|Other|0|||
157091362|NCT00196976|567089092|FG009|Primary Study|Other|0|||
157091363|NCT00196976|567089093|FG010|Primary Study|Other|0|||
157091364|NCT00196976|567089094|FG011|Primary Study|Other|0|||
157091365|NCT00196976|567089095|FG012|Primary Study|Other|0|||
157091366|NCT00196976|567089096|FG013|Primary Study|Other|0|||
157091367|NCT00196976|567089083|FG000|Booster Study|Withdrawal by Subject|0|||
157091368|NCT00196976|567089084|FG001|Booster Study|Withdrawal by Subject|0|||
157091369|NCT00196976|567089085|FG002|Booster Study|Withdrawal by Subject|0|||
157091370|NCT00196976|567089086|FG003|Booster Study|Withdrawal by Subject|0|||
157091371|NCT00196976|567089087|FG004|Booster Study|Withdrawal by Subject|0|||
157091372|NCT00196976|567089088|FG005|Booster Study|Withdrawal by Subject|0|||
157091373|NCT00196976|567089089|FG006|Booster Study|Withdrawal by Subject|0|||
157091374|NCT00196976|567089090|FG007|Booster Study|Withdrawal by Subject|0|||
157091375|NCT00196976|567089091|FG008|Booster Study|Withdrawal by Subject|0|||
157091376|NCT00196976|567089092|FG009|Booster Study|Withdrawal by Subject|0|||
157091377|NCT00196976|567089093|FG010|Booster Study|Withdrawal by Subject|1|||
157091378|NCT00196976|567089094|FG011|Booster Study|Withdrawal by Subject|0|||
157091379|NCT00196976|567089095|FG012|Booster Study|Withdrawal by Subject|0|||
157091380|NCT00196976|567089096|FG013|Booster Study|Withdrawal by Subject|0|||
157091381|NCT00196976|567089083|FG000|Booster Study|Lost to Follow-up|0|||
157091382|NCT00196976|567089084|FG001|Booster Study|Lost to Follow-up|0|||
157091383|NCT00196976|567089085|FG002|Booster Study|Lost to Follow-up|0|||
157091384|NCT00196976|567089086|FG003|Booster Study|Lost to Follow-up|0|||
157091385|NCT00196976|567089087|FG004|Booster Study|Lost to Follow-up|0|||
157091386|NCT00196976|567089088|FG005|Booster Study|Lost to Follow-up|0|||
157091387|NCT00196976|567089089|FG006|Booster Study|Lost to Follow-up|0|||
157091388|NCT00196976|567089090|FG007|Booster Study|Lost to Follow-up|0|||
157091389|NCT00196976|567089091|FG008|Booster Study|Lost to Follow-up|0|||
157091390|NCT00196976|567089092|FG009|Booster Study|Lost to Follow-up|0|||
157091391|NCT00196976|567089093|FG010|Booster Study|Lost to Follow-up|1|||
157091392|NCT00196976|567089094|FG011|Booster Study|Lost to Follow-up|2|||
157091393|NCT00196976|567089095|FG012|Booster Study|Lost to Follow-up|0|||
157091394|NCT00196976|567089096|FG013|Booster Study|Lost to Follow-up|0|||
157091395|NCT01535560|567089097|FG000|Overall Study|Adverse Event|12|||
157091396|NCT01535560|567089098|FG001|Overall Study|Adverse Event|7|||
157091397|NCT01535560|567089097|FG000|Overall Study|Lost to Follow-up|1|||
157091398|NCT01535560|567089098|FG001|Overall Study|Lost to Follow-up|3|||
157091399|NCT01535560|567089097|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
157091400|NCT01535560|567089098|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
157091401|NCT01535560|567089097|FG000|Overall Study|Treatment Failure|21|||
157091402|NCT01535560|567089098|FG001|Overall Study|Treatment Failure|83|||
157091403|NCT01535560|567089097|FG000|Overall Study|Other|0|||
157091404|NCT01535560|567089098|FG001|Overall Study|Other|1|||
157091405|NCT01535560|567089097|FG000|Overall Study|Randomized in Error|0|||
157091406|NCT01535560|567089098|FG001|Overall Study|Randomized in Error|1|||
157091407|NCT02009761|567089099|FG000|Overall Study|Adverse Event|4|||
157091408|NCT02842827|567089100|FG000|Overall Study|Adverse Event|0|||
157091409|NCT02842827|567089101|FG001|Overall Study|Adverse Event|1|||
157091410|NCT02842827|567089102|FG002|Overall Study|Adverse Event|0|||
157091411|NCT02842827|567089103|FG003|Overall Study|Adverse Event|1|||
157091412|NCT02842827|567089104|FG004|Overall Study|Adverse Event|0|||
157091413|NCT02842827|567089105|FG005|Overall Study|Adverse Event|1|||
157091414|NCT02842827|567089106|FG006|Overall Study|Adverse Event|0|||
157091415|NCT02842827|567089107|FG007|Overall Study|Adverse Event|0|||
157091416|NCT02842827|567089100|FG000|Overall Study|Death|1|||
157091417|NCT02842827|567089101|FG001|Overall Study|Death|0|||
157091418|NCT02842827|567089102|FG002|Overall Study|Death|2|||
157091419|NCT02842827|567089103|FG003|Overall Study|Death|3|||
157241255|NCT02430480|567628417|FG000|Overall Study|Death|1|||
157241256|NCT02430480|567628417|FG000|Overall Study|Anesthesia concerns|1|||
157241257|NCT02430480|567628417|FG000|Overall Study|Progressed on treatment|1|||
157241258|NCT01097577|567628425|FG000|Overall Study|Adverse Event|0|||
157241259|NCT01097577|567628426|FG001|Overall Study|Adverse Event|1|||
157241260|NCT02566850|567629747|FG000|Overall Study|Protocol Violation|1|||
157241261|NCT05710718|567629748|FG000|Overall Study|Withdrawal by Subject|5|||
157241262|NCT05710718|567629749|FG001|Overall Study|Withdrawal by Subject|1|||
157241263|NCT05710718|567629748|FG000|Overall Study|Lost to Follow-up|0|||
157197599|NCT02463097|567467125|FG000|Overall Study|Withdrawal by Subject|1|||
157197600|NCT00808665|567467126|FG000|Overall Study|Withdrawal by Subject|1|||
157197601|NCT00808665|567467127|FG001|Overall Study|Withdrawal by Subject|0|||
157197602|NCT00808665|567467126|FG000|Overall Study|only required minimally invasive surgery|1|||
157197603|NCT00808665|567467127|FG001|Overall Study|only required minimally invasive surgery|0|||
157197604|NCT00808665|567467126|FG000|Overall Study|surgery cancelled|1|||
157197605|NCT00808665|567467127|FG001|Overall Study|surgery cancelled|0|||
157197606|NCT00808665|567467126|FG000|Overall Study|required an additional procedure|0|||
157197607|NCT00808665|567467127|FG001|Overall Study|required an additional procedure|1|||
157197608|NCT00808665|567467126|FG000|Overall Study|Physician Decision|3|||
157197609|NCT00808665|567467127|FG001|Overall Study|Physician Decision|1|||
157197610|NCT00808665|567467126|FG000|Overall Study|Medication stopped by resident|0|||
157197611|NCT00808665|567467127|FG001|Overall Study|Medication stopped by resident|1|||
157197612|NCT03326323|567467128|FG000|Overall Study|Unable to receive ANH protocol|3|||
157241264|NCT05710718|567629749|FG001|Overall Study|Lost to Follow-up|1|||
157241265|NCT05710718|567629748|FG000|Overall Study|Death|0|||
157241266|NCT05710718|567629749|FG001|Overall Study|Death|1|||
157241267|NCT04372238|567629750|FG000|Overall Study|Duplicate|3|||
157241268|NCT04372238|567629751|FG001|Overall Study|Duplicate|3|||
157241269|NCT04372238|567629750|FG000|Overall Study|Did not consent for data linkage|6|||
157241270|NCT04372238|567629751|FG001|Overall Study|Did not consent for data linkage|10|||
157241271|NCT04241458|567629752|FG000|Overall Study|Withdrawal by Subject|0|||
157241272|NCT04241458|567629753|FG001|Overall Study|Withdrawal by Subject|0|||
157241273|NCT04241458|567629754|FG002|Overall Study|Withdrawal by Subject|0|||
157241274|NCT04241458|567629755|FG003|Overall Study|Withdrawal by Subject|0|||
157241275|NCT04241458|567629756|FG004|Overall Study|Withdrawal by Subject|1|||
157241276|NCT05005442|567629757|FG000|Overall Study|Death|14|||
157241277|NCT05005442|567629758|FG001|Overall Study|Death|10|||
157241278|NCT05005442|567629759|FG002|Overall Study|Death|8|||
157241279|NCT05005442|567629760|FG003|Overall Study|Death|22|||
157241280|NCT05005442|567629761|FG004|Overall Study|Death|13|||
157241281|NCT05005442|567629762|FG005|Overall Study|Death|15|||
157241282|NCT05005442|567629757|FG000|Overall Study|Lost to Follow-up|0|||
157241283|NCT05005442|567629758|FG001|Overall Study|Lost to Follow-up|2|||
157241284|NCT05005442|567629759|FG002|Overall Study|Lost to Follow-up|0|||
157241285|NCT05005442|567629760|FG003|Overall Study|Lost to Follow-up|0|||
157241286|NCT05005442|567629761|FG004|Overall Study|Lost to Follow-up|1|||
157241287|NCT05005442|567629762|FG005|Overall Study|Lost to Follow-up|0|||
157241288|NCT05005442|567629757|FG000|Overall Study|Physician Decision|0|||
157241289|NCT05005442|567629758|FG001|Overall Study|Physician Decision|0|||
157241290|NCT05005442|567629759|FG002|Overall Study|Physician Decision|1|||
157241291|NCT05005442|567629760|FG003|Overall Study|Physician Decision|0|||
157241292|NCT05005442|567629761|FG004|Overall Study|Physician Decision|2|||
157241293|NCT05005442|567629762|FG005|Overall Study|Physician Decision|0|||
157241294|NCT05005442|567629757|FG000|Overall Study|Sponsor decision|26|||
157241295|NCT05005442|567629758|FG001|Overall Study|Sponsor decision|26|||
157241296|NCT05005442|567629759|FG002|Overall Study|Sponsor decision|10|||
157241297|NCT05005442|567629760|FG003|Overall Study|Sponsor decision|5|||
157241298|NCT05005442|567629761|FG004|Overall Study|Sponsor decision|9|||
157241299|NCT05005442|567629762|FG005|Overall Study|Sponsor decision|12|||
157241300|NCT05005442|567629757|FG000|Overall Study|Withdrawal by Subject|2|||
157241301|NCT05005442|567629758|FG001|Overall Study|Withdrawal by Subject|2|||
157241302|NCT05005442|567629759|FG002|Overall Study|Withdrawal by Subject|1|||
157241303|NCT05005442|567629760|FG003|Overall Study|Withdrawal by Subject|3|||
157241304|NCT05005442|567629761|FG004|Overall Study|Withdrawal by Subject|0|||
157241305|NCT05005442|567629762|FG005|Overall Study|Withdrawal by Subject|5|||
157241306|NCT05005442|567629757|FG000|Overall Study|Site terminated by sponsor|0|||
157241307|NCT05005442|567629758|FG001|Overall Study|Site terminated by sponsor|2|||
157241308|NCT05005442|567629759|FG002|Overall Study|Site terminated by sponsor|0|||
157241309|NCT05005442|567629760|FG003|Overall Study|Site terminated by sponsor|0|||
157241310|NCT05005442|567629761|FG004|Overall Study|Site terminated by sponsor|0|||
157241311|NCT05005442|567629762|FG005|Overall Study|Site terminated by sponsor|1|||
157241312|NCT03696160|567629769|FG000|Overall Study|Withdrew before IMP dosing|2|||
157241313|NCT03696160|567629770|FG001|Overall Study|Withdrew before IMP dosing|3|||
157197613|NCT01757821|567467131|FG000|Overall Study|Adverse Event|1|||
157197614|NCT03556202|567467136|FG000|Extension Treatment Period|Adverse Event|18|||
157197615|NCT03556202|567467137|FG001|Extension Treatment Period|Adverse Event|14|||
157197616|NCT03556202|567467138|FG002|Extension Treatment Period|Adverse Event|9|||
157241314|NCT00334815|567629773|FG000|Overall Study|Adverse Event|3|||
157241315|NCT00334815|567629774|FG001|Overall Study|Adverse Event|2|||
157241316|NCT00334815|567629773|FG000|Overall Study|Death|0|||
157241317|NCT00334815|567629774|FG001|Overall Study|Death|2|||
157241318|NCT00334815|567629773|FG000|Overall Study|Progression|1|||
157241319|NCT00334815|567629774|FG001|Overall Study|Progression|0|||
157241320|NCT00334815|567629773|FG000|Overall Study|ineligible|1|||
157241321|NCT00334815|567629774|FG001|Overall Study|ineligible|1|||
157241322|NCT00334815|567629773|FG000|Overall Study|patient refused treatment|0|||
157241323|NCT00334815|567629774|FG001|Overall Study|patient refused treatment|1|||
157241324|NCT00334815|567629773|FG000|Overall Study|Physician Decision|2|||
157241325|NCT00334815|567629774|FG001|Overall Study|Physician Decision|4|||
157241326|NCT04970810|567629775|FG000|Overall Study|deemed ineligible after randomization|3|||
157241327|NCT04970810|567629776|FG001|Overall Study|deemed ineligible after randomization|0|||
157241328|NCT04970810|567629777|FG002|Overall Study|deemed ineligible after randomization|4|||
157241329|NCT04742491|567629780|FG000|Overall Study|Death|2|||
157241330|NCT04742491|567629781|FG001|Overall Study|Death|0|||
157241331|NCT04742491|567629780|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
157241332|NCT04742491|567629781|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
157241333|NCT04742491|567629780|FG000|Overall Study|Lost to Follow-up|6|||
157241334|NCT04742491|567629781|FG001|Overall Study|Lost to Follow-up|8|||
157241335|NCT04742491|567629780|FG000|Overall Study|Withdrawal by Subject|4|||
157241336|NCT04742491|567629781|FG001|Overall Study|Withdrawal by Subject|2|||
157241337|NCT04742491|567629780|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
157241338|NCT04742491|567629781|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
157241339|NCT04742491|567629780|FG000|Overall Study|Participant refused further participation|2|||
157241340|NCT04742491|567629781|FG001|Overall Study|Participant refused further participation|7|||
157241341|NCT04742491|567629780|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
157241342|NCT04742491|567629781|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
157241343|NCT04742491|567629780|FG000|Overall Study|Other reasons|3|||
157241344|NCT04742491|567629781|FG001|Overall Study|Other reasons|4|||
157241345|NCT03317899|567629785|FG000|Overall Study|Death|6|||
157241346|NCT03317899|567629786|FG001|Overall Study|Death|9|||
157241347|NCT02751424|567629788|FG000|Part 2|Adverse Event|0|||
157241348|NCT02751424|567629789|FG001|Part 2|Adverse Event|0|||
157241349|NCT02751424|567629790|FG002|Part 2|Adverse Event|0|||
157241350|NCT02751424|567629791|FG003|Part 2|Adverse Event|0|||
157241351|NCT02751424|567629792|FG004|Part 2|Adverse Event|0|||
157241352|NCT02751424|567629793|FG005|Part 2|Adverse Event|0|||
157241353|NCT02751424|567629794|FG006|Part 2|Adverse Event|0|||
157241354|NCT02751424|567629795|FG007|Part 2|Adverse Event|5|||
157241355|NCT02751424|567629796|FG008|Part 2|Adverse Event|0|||
157241356|NCT02197416|567629797|FG000|Overall Study|Other reasons|0|||
157241357|NCT02197416|567629798|FG001|Overall Study|Other reasons|2|||
157241358|NCT02197416|567629799|FG002|Overall Study|Other reasons|5|||
157241359|NCT02197416|567629797|FG000|Overall Study|Withdrawal by Subject|0|||
157197617|NCT03556202|567467136|FG000|Extension Treatment Period|Death|2|||
157197618|NCT03556202|567467137|FG001|Extension Treatment Period|Death|6|||
157197619|NCT03556202|567467138|FG002|Extension Treatment Period|Death|0|||
157197620|NCT03556202|567467136|FG000|Extension Treatment Period|Lack of Efficacy|5|||
157197621|NCT03556202|567467137|FG001|Extension Treatment Period|Lack of Efficacy|12|||
157197622|NCT03556202|567467138|FG002|Extension Treatment Period|Lack of Efficacy|18|||
157197623|NCT03556202|567467136|FG000|Extension Treatment Period|Lost to Follow-up|9|||
157197624|NCT03556202|567467137|FG001|Extension Treatment Period|Lost to Follow-up|20|||
157197625|NCT03556202|567467138|FG002|Extension Treatment Period|Lost to Follow-up|2|||
157197626|NCT03556202|567467136|FG000|Extension Treatment Period|Pregnancy|2|||
157197627|NCT03556202|567467137|FG001|Extension Treatment Period|Pregnancy|4|||
157197628|NCT03556202|567467138|FG002|Extension Treatment Period|Pregnancy|3|||
157197629|NCT03556202|567467136|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
157197630|NCT03556202|567467137|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
157197631|NCT03556202|567467138|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
157197632|NCT03556202|567467136|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
157197633|NCT03556202|567467137|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
157197634|NCT03556202|567467138|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
157197635|NCT03556202|567467136|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
157197636|NCT03556202|567467137|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
157241360|NCT02197416|567629798|FG001|Overall Study|Withdrawal by Subject|2|||
157241361|NCT02197416|567629799|FG002|Overall Study|Withdrawal by Subject|1|||
157241362|NCT02197416|567629797|FG000|Overall Study|Protocol Violation|1|||
157197637|NCT03556202|567467138|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
157197638|NCT03556202|567467136|FG000|Extension Treatment Period|Physician Decision|0|||
157241363|NCT02197416|567629798|FG001|Overall Study|Protocol Violation|0|||
157241364|NCT02197416|567629799|FG002|Overall Study|Protocol Violation|1|||
157241365|NCT02197416|567629797|FG000|Overall Study|Adverse Event|0|||
157241366|NCT02197416|567629798|FG001|Overall Study|Adverse Event|0|||
157241367|NCT02197416|567629799|FG002|Overall Study|Adverse Event|1|||
157241368|NCT01492439|567629800|FG000|Overall Study|Withdrew from RTE|4|||
157241369|NCT01492439|567629801|FG001|Overall Study|Withdrew from RTE|9|||
157241370|NCT00716625|567629802|FG000|Overall Study|Safety was not Assessable|1|||
157241371|NCT02075463|567629803|FG000|Overall Study|Adverse Event|3|||
157241372|NCT02075463|567629803|FG000|Overall Study|Par. reached stopping criteria|4|||
157241373|NCT02075463|567629803|FG000|Overall Study|Withdrawal by Subject|1|||
157241374|NCT01383486|567629804|FG000|Overall Study|Lost to Follow-up|10|||
157241375|NCT01383486|567629804|FG000|Overall Study|Incomplete information for analysis|2|||
157241376|NCT01383486|567629804|FG000|Overall Study|Did not take any product|6|||
157241377|NCT00245063|567629805|FG000|Overall Study|Adverse Event|6|||
157241378|NCT00245063|567629806|FG001|Overall Study|Adverse Event|5|||
157241379|NCT00245063|567629805|FG000|Overall Study|Death|1|||
157241380|NCT00245063|567629806|FG001|Overall Study|Death|0|||
157241381|NCT03199963|567629812|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
157241382|NCT03199963|567629813|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
157241383|NCT03199963|567629812|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
157241384|NCT03199963|567629813|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
157241385|NCT03199963|567629812|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
157241386|NCT03199963|567629813|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
157241387|NCT03199963|567629812|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
157241388|NCT03199963|567629813|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
157241389|NCT03199963|567629812|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
157241390|NCT03199963|567629813|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
157241391|NCT03199963|567629812|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
157241392|NCT03199963|567629813|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
157241393|NCT00466167|567629814|FG000|Overall Study|Adverse Event|8|||
157241394|NCT00466167|567629815|FG001|Overall Study|Adverse Event|8|||
157241395|NCT00466167|567629816|FG002|Overall Study|Adverse Event|7|||
157241396|NCT00466167|567629814|FG000|Overall Study|Lack of Efficacy|2|||
157241397|NCT00466167|567629815|FG001|Overall Study|Lack of Efficacy|0|||
157241398|NCT00466167|567629816|FG002|Overall Study|Lack of Efficacy|3|||
157241399|NCT00466167|567629814|FG000|Overall Study|Protocol Violation|1|||
157241400|NCT00466167|567629815|FG001|Overall Study|Protocol Violation|1|||
157241401|NCT00466167|567629816|FG002|Overall Study|Protocol Violation|2|||
157241402|NCT00466167|567629814|FG000|Overall Study|Lost to Follow-up|3|||
157241403|NCT00466167|567629815|FG001|Overall Study|Lost to Follow-up|2|||
157241404|NCT00466167|567629816|FG002|Overall Study|Lost to Follow-up|2|||
157241405|NCT00466167|567629814|FG000|Overall Study|Withdrawal by Subject|4|||
157241406|NCT00466167|567629815|FG001|Overall Study|Withdrawal by Subject|1|||
157241407|NCT00466167|567629816|FG002|Overall Study|Withdrawal by Subject|6|||
157241408|NCT00466167|567629814|FG000|Overall Study|patient did not meet inclusion criteria|1|||
157241409|NCT00466167|567629815|FG001|Overall Study|patient did not meet inclusion criteria|0|||
157241410|NCT00466167|567629816|FG002|Overall Study|patient did not meet inclusion criteria|1|||
157241411|NCT00466167|567629814|FG000|Overall Study|Not treated|1|||
157241412|NCT00466167|567629815|FG001|Overall Study|Not treated|0|||
157241413|NCT00466167|567629816|FG002|Overall Study|Not treated|0|||
157241414|NCT04128761|567629821|FG000|Overall Study|Lost to Follow-up|5|||
157241415|NCT04128761|567629822|FG001|Overall Study|Lost to Follow-up|6|||
157241416|NCT06539676|567629823|FG000|Overall Study|Early study termination|1|||
157241417|NCT06539676|567629824|FG001|Overall Study|Early study termination|0|||
157241418|NCT06539676|567629825|FG002|Overall Study|Early study termination|6|||
157197639|NCT03556202|567467137|FG001|Extension Treatment Period|Physician Decision|8|||
157197640|NCT03556202|567467138|FG002|Extension Treatment Period|Physician Decision|2|||
157197641|NCT03556202|567467136|FG000|Extension Treatment Period|Protocol Violation|0|||
157197642|NCT03556202|567467137|FG001|Extension Treatment Period|Protocol Violation|1|||
157197643|NCT03556202|567467138|FG002|Extension Treatment Period|Protocol Violation|1|||
157197644|NCT03556202|567467136|FG000|Extension Treatment Period|Sponsor Decision|0|||
157197645|NCT03556202|567467137|FG001|Extension Treatment Period|Sponsor Decision|1|||
157197646|NCT03556202|567467138|FG002|Extension Treatment Period|Sponsor Decision|0|||
157197647|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
157197648|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
157197649|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
157197650|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Death|1|||
157241419|NCT01848938|567629833|FG000|Overall Study|Lost to Follow-up|1|||
157241420|NCT01848938|567629834|FG001|Overall Study|Lost to Follow-up|1|||
157241421|NCT00835536|567629835|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
157241422|NCT00835536|567629836|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
157241423|NCT04589650|567629839|FG000|Overall Study|Subject decision|6|||
157241424|NCT04589650|567629840|FG001|Overall Study|Subject decision|2|||
157241425|NCT04589650|567629841|FG002|Overall Study|Subject decision|2|||
157241426|NCT04589650|567629842|FG003|Overall Study|Subject decision|0|||
157241427|NCT04589650|567629843|FG004|Overall Study|Subject decision|0|||
157197651|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Death|0|||
157197652|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Death|0|||
157197653|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
157197654|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
157197655|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
157197656|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
157197657|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
157197658|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
157197659|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
157241428|NCT04589650|567629844|FG005|Overall Study|Subject decision|0|||
157241429|NCT04589650|567629839|FG000|Overall Study|Adverse Event|3|||
157241430|NCT04589650|567629840|FG001|Overall Study|Adverse Event|1|||
157241431|NCT04589650|567629841|FG002|Overall Study|Adverse Event|1|||
157241432|NCT04589650|567629842|FG003|Overall Study|Adverse Event|1|||
157241433|NCT04589650|567629843|FG004|Overall Study|Adverse Event|0|||
157241434|NCT04589650|567629844|FG005|Overall Study|Adverse Event|1|||
157241435|NCT04589650|567629839|FG000|Overall Study|Physician Decision|1|||
157241436|NCT04589650|567629840|FG001|Overall Study|Physician Decision|1|||
157241437|NCT04589650|567629841|FG002|Overall Study|Physician Decision|0|||
157241438|NCT04589650|567629842|FG003|Overall Study|Physician Decision|0|||
157241439|NCT04589650|567629843|FG004|Overall Study|Physician Decision|0|||
157241440|NCT04589650|567629844|FG005|Overall Study|Physician Decision|0|||
157241441|NCT04589650|567629839|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
157241442|NCT04589650|567629840|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
157241443|NCT04589650|567629841|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
157241444|NCT04589650|567629842|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
157241445|NCT04589650|567629843|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
157241446|NCT04589650|567629844|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
157241447|NCT04589650|567629839|FG000|Overall Study|Death|0|||
157241448|NCT04589650|567629840|FG001|Overall Study|Death|0|||
157241449|NCT04589650|567629841|FG002|Overall Study|Death|0|||
157241450|NCT04589650|567629842|FG003|Overall Study|Death|1|||
157241451|NCT04589650|567629843|FG004|Overall Study|Death|0|||
157241452|NCT04589650|567629844|FG005|Overall Study|Death|0|||
157241453|NCT04589650|567629839|FG000|Overall Study|Guardian Decision|0|||
157241454|NCT04589650|567629840|FG001|Overall Study|Guardian Decision|0|||
157241455|NCT04589650|567629841|FG002|Overall Study|Guardian Decision|0|||
157241456|NCT04589650|567629842|FG003|Overall Study|Guardian Decision|1|||
157241457|NCT04589650|567629843|FG004|Overall Study|Guardian Decision|0|||
157241458|NCT04589650|567629844|FG005|Overall Study|Guardian Decision|0|||
157241459|NCT00950989|567629845|FG000|Overall Study|Death|0|||
157241460|NCT00950989|567629846|FG001|Overall Study|Death|0|||
157241461|NCT00950989|567629847|FG002|Overall Study|Death|1|||
157241462|NCT00950989|567629848|FG003|Overall Study|Death|0|||
157241463|NCT00950989|567629845|FG000|Overall Study|Administrative Decision|0|||
157241464|NCT00950989|567629846|FG001|Overall Study|Administrative Decision|1|||
157241465|NCT00950989|567629847|FG002|Overall Study|Administrative Decision|0|||
157241466|NCT00950989|567629848|FG003|Overall Study|Administrative Decision|0|||
157241467|NCT00950989|567629845|FG000|Overall Study|Disease Progression|0|||
157241468|NCT00950989|567629846|FG001|Overall Study|Disease Progression|0|||
157241469|NCT00950989|567629847|FG002|Overall Study|Disease Progression|1|||
157241470|NCT00950989|567629848|FG003|Overall Study|Disease Progression|0|||
157241471|NCT00950989|567629845|FG000|Overall Study|Withdrawal by Subject|2|||
157241472|NCT00950989|567629846|FG001|Overall Study|Withdrawal by Subject|1|||
157241473|NCT00950989|567629847|FG002|Overall Study|Withdrawal by Subject|0|||
157241474|NCT00950989|567629848|FG003|Overall Study|Withdrawal by Subject|0|||
157241475|NCT00950989|567629845|FG000|Overall Study|Adverse Event|2|||
157241476|NCT00950989|567629846|FG001|Overall Study|Adverse Event|1|||
157241477|NCT00950989|567629847|FG002|Overall Study|Adverse Event|1|||
157241478|NCT00950989|567629848|FG003|Overall Study|Adverse Event|0|||
157241479|NCT03804983|567629849|FG000|Overall Study|Adverse Event|0|||
157241480|NCT03804983|567629850|FG001|Overall Study|Adverse Event|1|||
157241481|NCT03804983|567629849|FG000|Overall Study|Family Obligation|1|||
157241482|NCT03804983|567629850|FG001|Overall Study|Family Obligation|0|||
157241483|NCT01154231|567629851|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
157241484|NCT01154231|567629851|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
157241485|NCT01963728|567629854|FG000|Overall Study|Study terminated early|0|||
157241486|NCT01963728|567629855|FG001|Overall Study|Study terminated early|1|||
157241487|NCT01440803|567630679|FG000|Overall Study|Met study stopping rule|2|||
157241488|NCT01440803|567630680|FG001|Overall Study|Met study stopping rule|1|||
157241489|NCT01440803|567630679|FG000|Overall Study|Lost to Follow-up|0|||
157241490|NCT01440803|567630680|FG001|Overall Study|Lost to Follow-up|2|||
157241491|NCT01440803|567630679|FG000|Overall Study|Withdrawal by Subject|0|||
157241492|NCT01440803|567630680|FG001|Overall Study|Withdrawal by Subject|1|||
157241493|NCT03913377|567630682|FG000|Period 1|Test Article no longer available|0|||
157241494|NCT03913377|567630683|FG001|Period 1|Test Article no longer available|1|||
157241495|NCT03913377|567630684|FG002|Period 1|Test Article no longer available|0|||
157241496|NCT03913377|567630682|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
157197660|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
157197661|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
157197662|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
157197663|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
157197664|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
157197665|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
157197666|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
157197667|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
157197668|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
157197669|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
157197670|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
157197671|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
157197672|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
157197673|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
157197674|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
157197675|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
157197676|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
157197677|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
157197678|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
157197679|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
157197680|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
157197681|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
157197682|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
157197683|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
157197684|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
157197685|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
157197686|NCT03556202|567467136|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
157197687|NCT03556202|567467137|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
157197688|NCT03556202|567467138|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
157197689|NCT00678652|567467139|FG000|Overall Study|Protocol Violation|2|||
157197690|NCT00678652|567467140|FG001|Overall Study|Protocol Violation|0|||
157197691|NCT00678652|567467141|FG002|Overall Study|Protocol Violation|0|||
157197692|NCT00678652|567467142|FG003|Overall Study|Protocol Violation|0|||
157197693|NCT00678652|567467139|FG000|Overall Study|Pregnancy|0|||
157197694|NCT00678652|567467140|FG001|Overall Study|Pregnancy|0|||
157197695|NCT00678652|567467141|FG002|Overall Study|Pregnancy|1|||
157197696|NCT00678652|567467142|FG003|Overall Study|Pregnancy|0|||
157197697|NCT00678652|567467139|FG000|Overall Study|Relocation|1|||
157197698|NCT00678652|567467140|FG001|Overall Study|Relocation|0|||
157197699|NCT00678652|567467141|FG002|Overall Study|Relocation|0|||
157197700|NCT00678652|567467142|FG003|Overall Study|Relocation|0|||
157197701|NCT03319160|567467143|FG000|Overall Study|Data not available.|7|||
157197702|NCT03604159|567467144|FG000|Overall Study|Lost to Follow-up|6|||
157197703|NCT03604159|567467145|FG001|Overall Study|Lost to Follow-up|7|||
157197704|NCT00665002|567467146|FG000|Overall Study|Progression/relapse during treatment|11|||
157197705|NCT00665002|567467146|FG000|Overall Study|Cytogenetic resistance|1|||
157197706|NCT00383292|567467149|FG000|Overall Study|Adverse Event|4|||
157197707|NCT00383292|567467150|FG001|Overall Study|Adverse Event|1|||
157197708|NCT00383292|567467151|FG002|Overall Study|Adverse Event|2|||
157197709|NCT00383292|567467149|FG000|Overall Study|Death|3|||
157197710|NCT00383292|567467150|FG001|Overall Study|Death|3|||
157197711|NCT00383292|567467151|FG002|Overall Study|Death|3|||
157197712|NCT00383292|567467149|FG000|Overall Study|Physician Decision|4|||
157197713|NCT00383292|567467150|FG001|Overall Study|Physician Decision|0|||
157197714|NCT00383292|567467151|FG002|Overall Study|Physician Decision|1|||
157197715|NCT00383292|567467149|FG000|Overall Study|Withdrawal by Subject|3|||
157197716|NCT00383292|567467150|FG001|Overall Study|Withdrawal by Subject|2|||
157197717|NCT00383292|567467151|FG002|Overall Study|Withdrawal by Subject|2|||
157197718|NCT00383292|567467149|FG000|Overall Study|Other|1|||
157197719|NCT00383292|567467150|FG001|Overall Study|Other|0|||
157197720|NCT00383292|567467151|FG002|Overall Study|Other|0|||
157197721|NCT00697255|567467152|FG000|Stage 1a|Insufficient ovarian response|1|||
157197722|NCT00697255|567467153|FG001|Stage 1a|Insufficient ovarian response|0|||
157197723|NCT00697255|567467152|FG000|Stage 1a|Multifollicular growth|1|||
157197724|NCT00697255|567467153|FG001|Stage 1a|Multifollicular growth|0|||
157197725|NCT00697255|567467152|FG000|Stage 1a|Not growing of dominant follicle|1|||
157197726|NCT00697255|567467153|FG001|Stage 1a|Not growing of dominant follicle|0|||
157197727|NCT00697255|567467152|FG000|Stage 1b|Not growing of dominant follicle|0|||
157197728|NCT00697255|567467153|FG001|Stage 1b|Not growing of dominant follicle|1|||
157197729|NCT00697255|567467152|FG000|Stage 1b|Insufficient ovarian response|0|||
157197730|NCT00697255|567467153|FG001|Stage 1b|Insufficient ovarian response|1|||
157197731|NCT01365182|567467162|FG000|Overall Study|Withdrawal by Subject|10|||
157241497|NCT03913377|567630683|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
157241498|NCT03913377|567630684|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
157241499|NCT04349267|567630685|FG000|Overall Study|Adverse Event|0|||
157241500|NCT04349267|567630686|FG001|Overall Study|Adverse Event|0|||
157241501|NCT04349267|567630687|FG002|Overall Study|Adverse Event|0|||
157241502|NCT04349267|567630688|FG003|Overall Study|Adverse Event|0|||
157241503|NCT04349267|567630689|FG004|Overall Study|Adverse Event|0|||
157241504|NCT04349267|567630690|FG005|Overall Study|Adverse Event|1|||
157241505|NCT04349267|567630691|FG006|Overall Study|Adverse Event|0|||
157241506|NCT04349267|567630685|FG000|Overall Study|Other reason|0|||
157241507|NCT04349267|567630686|FG001|Overall Study|Other reason|1|||
157241508|NCT04349267|567630687|FG002|Overall Study|Other reason|0|||
157241509|NCT04349267|567630688|FG003|Overall Study|Other reason|0|||
157241510|NCT04349267|567630689|FG004|Overall Study|Other reason|1|||
157241511|NCT04349267|567630690|FG005|Overall Study|Other reason|1|||
157241512|NCT04349267|567630691|FG006|Overall Study|Other reason|1|||
157241513|NCT04349267|567630685|FG000|Overall Study|Disease Progression|2|||
157241514|NCT04349267|567630686|FG001|Overall Study|Disease Progression|0|||
157241515|NCT04349267|567630687|FG002|Overall Study|Disease Progression|2|||
157241516|NCT04349267|567630688|FG003|Overall Study|Disease Progression|3|||
157241517|NCT04349267|567630689|FG004|Overall Study|Disease Progression|3|||
157241518|NCT04349267|567630690|FG005|Overall Study|Disease Progression|7|||
157241519|NCT04349267|567630691|FG006|Overall Study|Disease Progression|10|||
157241520|NCT04349267|567630685|FG000|Overall Study|Participant withdrew consent|0|||
157241521|NCT04349267|567630686|FG001|Overall Study|Participant withdrew consent|1|||
157241522|NCT04349267|567630687|FG002|Overall Study|Participant withdrew consent|0|||
157241523|NCT04349267|567630688|FG003|Overall Study|Participant withdrew consent|0|||
157241524|NCT04349267|567630689|FG004|Overall Study|Participant withdrew consent|0|||
157241525|NCT04349267|567630690|FG005|Overall Study|Participant withdrew consent|0|||
157241526|NCT04349267|567630691|FG006|Overall Study|Participant withdrew consent|1|||
157241527|NCT03689400|567630692|FG000|Overall Study|Lost to Follow-up|4|||
157241528|NCT01204294|567630693|FG000|Overall Study|Adverse Event|2|||
157241529|NCT01204294|567630694|FG001|Overall Study|Adverse Event|6|||
157241530|NCT01204294|567630695|FG002|Overall Study|Adverse Event|0|||
157241531|NCT01204294|567630696|FG003|Overall Study|Adverse Event|7|||
157241532|NCT01204294|567630697|FG004|Overall Study|Adverse Event|1|||
157241533|NCT01204294|567630698|FG005|Overall Study|Adverse Event|4|||
157241534|NCT01204294|567630699|FG006|Overall Study|Adverse Event|0|||
157241535|NCT01204294|567630693|FG000|Overall Study|Protocol Violation|1|||
157241536|NCT01204294|567630694|FG001|Overall Study|Protocol Violation|0|||
157241537|NCT01204294|567630695|FG002|Overall Study|Protocol Violation|2|||
157241538|NCT01204294|567630696|FG003|Overall Study|Protocol Violation|1|||
157241539|NCT01204294|567630697|FG004|Overall Study|Protocol Violation|0|||
157241540|NCT01204294|567630698|FG005|Overall Study|Protocol Violation|0|||
157241541|NCT01204294|567630699|FG006|Overall Study|Protocol Violation|0|||
157241542|NCT01204294|567630693|FG000|Overall Study|Withdrawal by Subject|0|||
157241543|NCT01204294|567630694|FG001|Overall Study|Withdrawal by Subject|2|||
157241544|NCT01204294|567630695|FG002|Overall Study|Withdrawal by Subject|2|||
157241545|NCT01204294|567630696|FG003|Overall Study|Withdrawal by Subject|1|||
157241546|NCT01204294|567630697|FG004|Overall Study|Withdrawal by Subject|1|||
157241547|NCT01204294|567630698|FG005|Overall Study|Withdrawal by Subject|1|||
157241548|NCT01204294|567630699|FG006|Overall Study|Withdrawal by Subject|2|||
157241549|NCT01204294|567630693|FG000|Overall Study|Lack of Efficacy|0|||
157241550|NCT01204294|567630694|FG001|Overall Study|Lack of Efficacy|0|||
157241551|NCT01204294|567630695|FG002|Overall Study|Lack of Efficacy|0|||
157241552|NCT01204294|567630696|FG003|Overall Study|Lack of Efficacy|2|||
157241553|NCT01204294|567630697|FG004|Overall Study|Lack of Efficacy|0|||
157241554|NCT01204294|567630698|FG005|Overall Study|Lack of Efficacy|0|||
157241555|NCT01204294|567630699|FG006|Overall Study|Lack of Efficacy|0|||
157241556|NCT01204294|567630693|FG000|Overall Study|Other (house moving)|0|||
157241557|NCT01204294|567630694|FG001|Overall Study|Other (house moving)|0|||
157241558|NCT01204294|567630695|FG002|Overall Study|Other (house moving)|1|||
157241559|NCT01204294|567630696|FG003|Overall Study|Other (house moving)|0|||
157241560|NCT01204294|567630697|FG004|Overall Study|Other (house moving)|0|||
157241561|NCT01204294|567630698|FG005|Overall Study|Other (house moving)|0|||
157241562|NCT01204294|567630699|FG006|Overall Study|Other (house moving)|0|||
157241563|NCT04618211|567630700|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
157241564|NCT04618211|567630701|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
157241565|NCT04618211|567630702|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
157241566|NCT04618211|567630700|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
157241567|NCT04618211|567630701|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
157241568|NCT04618211|567630702|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
157241569|NCT04618211|567630700|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
157241570|NCT04618211|567630701|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
157241571|NCT04618211|567630702|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
157241572|NCT01527006|567630703|FG000|Core Study|Adverse Event|0|||
157241573|NCT01527006|567630704|FG001|Core Study|Adverse Event|2|||
157241574|NCT01527006|567630703|FG000|Core Study|Lost to Follow-up|0|||
157241575|NCT01527006|567630704|FG001|Core Study|Lost to Follow-up|1|||
157241576|NCT01527006|567630703|FG000|Core Study|Subject Choice|1|||
157241577|NCT01527006|567630704|FG001|Core Study|Subject Choice|0|||
157241578|NCT01527006|567630703|FG000|Core Study|Inadequate Therapeutic Effect|1|||
157241579|NCT01527006|567630704|FG001|Core Study|Inadequate Therapeutic Effect|0|||
157241580|NCT01527006|567630703|FG000|Core Study|Withdrawal by Subject|0|||
157241581|NCT01527006|567630704|FG001|Core Study|Withdrawal by Subject|1|||
157241582|NCT01527006|567630703|FG000|Core Study|Other|0|||
157197732|NCT01365182|567467163|FG001|Overall Study|Withdrawal by Subject|13|||
157197733|NCT01365182|567467164|FG002|Overall Study|Withdrawal by Subject|12|||
157197734|NCT02815670|567467165|FG000|Overall Study|Prematurely discontinued of the trial|1|||
157197735|NCT01815099|567467168|FG000|Overall Study|Lack of Efficacy|1|||
157197736|NCT01815099|567467168|FG000|Overall Study|unable to attend study visits|1|||
157197737|NCT01475214|567467169|FG000|Overall Study|Lost to Follow-up|1|||
157197738|NCT01475214|567467170|FG001|Overall Study|Lost to Follow-up|0|||
157241583|NCT01527006|567630704|FG001|Core Study|Other|2|||
157241584|NCT01527006|567630703|FG000|Extension Phase|Adverse Event|4|||
157241585|NCT01527006|567630704|FG001|Extension Phase|Adverse Event|2|||
157241586|NCT01527006|567630703|FG000|Extension Phase|Lost to Follow-up|0|||
157241587|NCT01527006|567630704|FG001|Extension Phase|Lost to Follow-up|1|||
157241588|NCT01527006|567630703|FG000|Extension Phase|Subject Choice|1|||
157241589|NCT01527006|567630704|FG001|Extension Phase|Subject Choice|1|||
157241590|NCT01527006|567630703|FG000|Extension Phase|Inadequate therapeutic effect|1|||
157241591|NCT01527006|567630704|FG001|Extension Phase|Inadequate therapeutic effect|1|||
157241592|NCT01527006|567630703|FG000|Extension Phase|Other|0|||
157241593|NCT01527006|567630704|FG001|Extension Phase|Other|3|||
157241594|NCT05919823|567630705|FG000|Pre-Treatment Period|Screen failure|1|||
157241595|NCT05919823|567630706|FG001|Pre-Treatment Period|Screen failure|0|||
157241596|NCT05919823|567630707|FG002|Pre-Treatment Period|Screen failure|0|||
157241597|NCT05919823|567630708|FG003|Pre-Treatment Period|Screen failure|0|||
157241598|NCT05919823|567630705|FG000|Pre-Treatment Period|Protocol Violation|0|||
157241599|NCT05919823|567630706|FG001|Pre-Treatment Period|Protocol Violation|1|||
157197739|NCT01475214|567467171|FG002|Overall Study|Lost to Follow-up|1|||
157241600|NCT05919823|567630707|FG002|Pre-Treatment Period|Protocol Violation|0|||
157241601|NCT05919823|567630708|FG003|Pre-Treatment Period|Protocol Violation|0|||
157241602|NCT05919823|567630705|FG000|Double-Blind Period|Adverse Event|8|||
157241603|NCT05919823|567630706|FG001|Double-Blind Period|Adverse Event|9|||
157241604|NCT05919823|567630707|FG002|Double-Blind Period|Adverse Event|0|||
157241605|NCT05919823|567630708|FG003|Double-Blind Period|Adverse Event|0|||
157241606|NCT05919823|567630705|FG000|Double-Blind Period|Protocol Violation|2|||
157241607|NCT05919823|567630706|FG001|Double-Blind Period|Protocol Violation|1|||
157241608|NCT05919823|567630707|FG002|Double-Blind Period|Protocol Violation|0|||
157241609|NCT05919823|567630708|FG003|Double-Blind Period|Protocol Violation|0|||
157241610|NCT05919823|567630705|FG000|Double-Blind Period|Participant withdrew consent|11|||
157241611|NCT05919823|567630706|FG001|Double-Blind Period|Participant withdrew consent|7|||
157241612|NCT05919823|567630707|FG002|Double-Blind Period|Participant withdrew consent|0|||
157241613|NCT05919823|567630708|FG003|Double-Blind Period|Participant withdrew consent|0|||
157241614|NCT05919823|567630705|FG000|Double-Blind Period|Other reasons|2|||
157241615|NCT05919823|567630706|FG001|Double-Blind Period|Other reasons|3|||
157241616|NCT05919823|567630707|FG002|Double-Blind Period|Other reasons|0|||
157241617|NCT05919823|567630708|FG003|Double-Blind Period|Other reasons|0|||
157241618|NCT05919823|567630705|FG000|Open Label Period|Adverse Event|0|||
157241619|NCT05919823|567630706|FG001|Open Label Period|Adverse Event|0|||
157241620|NCT05919823|567630707|FG002|Open Label Period|Adverse Event|2|||
157241621|NCT05919823|567630708|FG003|Open Label Period|Adverse Event|4|||
157241622|NCT05919823|567630705|FG000|Open Label Period|Lost to Follow-up|0|||
157241623|NCT05919823|567630706|FG001|Open Label Period|Lost to Follow-up|0|||
157241624|NCT05919823|567630707|FG002|Open Label Period|Lost to Follow-up|1|||
157241625|NCT05919823|567630708|FG003|Open Label Period|Lost to Follow-up|0|||
157241626|NCT05919823|567630705|FG000|Open Label Period|Protocol Violation|0|||
157241627|NCT05919823|567630706|FG001|Open Label Period|Protocol Violation|0|||
157241628|NCT05919823|567630707|FG002|Open Label Period|Protocol Violation|0|||
157241629|NCT05919823|567630708|FG003|Open Label Period|Protocol Violation|1|||
157241630|NCT05919823|567630705|FG000|Open Label Period|Participant withdrew consent|0|||
157241631|NCT05919823|567630706|FG001|Open Label Period|Participant withdrew consent|0|||
157241632|NCT05919823|567630707|FG002|Open Label Period|Participant withdrew consent|8|||
157241633|NCT05919823|567630708|FG003|Open Label Period|Participant withdrew consent|6|||
157241634|NCT05919823|567630705|FG000|Open Label Period|Death|0|||
157197740|NCT01475214|567467169|FG000|Overall Study|Physician Decision|2|||
157241635|NCT05919823|567630706|FG001|Open Label Period|Death|0|||
157241636|NCT05919823|567630707|FG002|Open Label Period|Death|0|||
157241637|NCT05919823|567630708|FG003|Open Label Period|Death|1|||
157241638|NCT05919823|567630705|FG000|Open Label Period|Other reasons|0|||
157241639|NCT05919823|567630706|FG001|Open Label Period|Other reasons|0|||
157197741|NCT01475214|567467170|FG001|Overall Study|Physician Decision|0|||
157241640|NCT05919823|567630707|FG002|Open Label Period|Other reasons|9|||
157241641|NCT05919823|567630708|FG003|Open Label Period|Other reasons|5|||
157241642|NCT01648582|567630709|FG000|Overall Study|Adverse Event|6|||
157241643|NCT01648582|567630710|FG001|Overall Study|Adverse Event|11|||
157241644|NCT01648582|567630711|FG002|Overall Study|Adverse Event|2|||
157241645|NCT01648582|567630709|FG000|Overall Study|Lost to Follow-up|9|||
157241646|NCT01648582|567630710|FG001|Overall Study|Lost to Follow-up|6|||
157241647|NCT01648582|567630711|FG002|Overall Study|Lost to Follow-up|8|||
157241648|NCT01648582|567630709|FG000|Overall Study|Protocol Violation|1|||
157241649|NCT01648582|567630710|FG001|Overall Study|Protocol Violation|2|||
157241650|NCT01648582|567630711|FG002|Overall Study|Protocol Violation|1|||
157241651|NCT01648582|567630709|FG000|Overall Study|Withdrawal by Subject|15|||
157241652|NCT01648582|567630710|FG001|Overall Study|Withdrawal by Subject|17|||
157241653|NCT01648582|567630711|FG002|Overall Study|Withdrawal by Subject|17|||
157241654|NCT01648582|567630709|FG000|Overall Study|Physician Decision|0|||
157241655|NCT01648582|567630710|FG001|Overall Study|Physician Decision|1|||
157241656|NCT01648582|567630711|FG002|Overall Study|Physician Decision|3|||
157241657|NCT01648582|567630709|FG000|Overall Study|Death|1|||
157241658|NCT01648582|567630710|FG001|Overall Study|Death|0|||
157241659|NCT01648582|567630711|FG002|Overall Study|Death|0|||
157241660|NCT01648582|567630709|FG000|Overall Study|Sponsor Decision|0|||
157241661|NCT01648582|567630710|FG001|Overall Study|Sponsor Decision|1|||
157241662|NCT01648582|567630711|FG002|Overall Study|Sponsor Decision|1|||
157241663|NCT03534193|567630720|FG000|Overall Study|Lost to Follow-up|1|||
157241664|NCT03534193|567630721|FG001|Overall Study|Lost to Follow-up|3|||
157241665|NCT04414930|567630722|FG000|Overall Study|Withdrawal by Subject|1|||
157241666|NCT04414930|567630723|FG001|Overall Study|Withdrawal by Subject|3|||
157241667|NCT05470699|567630724|FG000|Overall Study|Did not receive intervention|13|||
157241668|NCT05470699|567630724|FG000|Overall Study|Ineligible|1|||
157241669|NCT01983969|567630728|FG000|Overall Study|Disease Progression|0|||
157241670|NCT01983969|567630729|FG001|Overall Study|Disease Progression|1|||
157241671|NCT01983969|567630730|FG002|Overall Study|Disease Progression|0|||
157241672|NCT02619682|567630731|FG000|Overall Study|Withdrawal by Subject|3|||
157241673|NCT02619682|567630731|FG000|Overall Study|Lack of Efficacy|8|||
157241674|NCT02619682|567630731|FG000|Overall Study|new secondary cancer|1|||
157241675|NCT02619682|567630731|FG000|Overall Study|post surgery complications|2|||
157241676|NCT00268203|567630732|FG000|Overall Study|Lost to Follow-up|92|||
157241677|NCT00268203|567630732|FG000|Overall Study|Withdrawal by Subject|9|||
157241678|NCT00268203|567630732|FG000|Overall Study|Received Other NHL Therapy|7|||
157241679|NCT00268203|567630732|FG000|Overall Study|Progressive Disease|359|||
157241680|NCT00268203|567630732|FG000|Overall Study|Death|84|||
157241681|NCT00268203|567630732|FG000|Overall Study|Reason Not Specified|34|||
157241682|NCT00268203|567630732|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
157241683|NCT06041256|567630735|FG000|Overall Study|Withdrawal by Subject|1|||
157241684|NCT06041256|567630736|FG001|Overall Study|Withdrawal by Subject|0|||
157241685|NCT06041256|567630737|FG002|Overall Study|Withdrawal by Subject|3|||
157241686|NCT06041256|567630738|FG003|Overall Study|Withdrawal by Subject|1|||
157241687|NCT06041256|567630739|FG004|Overall Study|Withdrawal by Subject|1|||
157241688|NCT06041256|567630735|FG000|Overall Study|Rescue|17|||
157241689|NCT06041256|567630736|FG001|Overall Study|Rescue|6|||
157241690|NCT06041256|567630737|FG002|Overall Study|Rescue|9|||
157241691|NCT06041256|567630738|FG003|Overall Study|Rescue|6|||
157241692|NCT06041256|567630739|FG004|Overall Study|Rescue|2|||
157241693|NCT03114891|567630740|FG000|First Treatment Round|Lost to Follow-up|0|||
157241694|NCT03114891|567630741|FG001|First Treatment Round|Lost to Follow-up|1|||
157241695|NCT03114891|567630742|FG002|First Treatment Round|Lost to Follow-up|1|||
157241696|NCT03114891|567630743|FG003|First Treatment Round|Lost to Follow-up|0|||
157241697|NCT03114891|567630740|FG000|First Treatment Round|Withdrawal by Subject|0|||
157241698|NCT03114891|567630741|FG001|First Treatment Round|Withdrawal by Subject|2|||
157241699|NCT03114891|567630742|FG002|First Treatment Round|Withdrawal by Subject|0|||
157241700|NCT03114891|567630743|FG003|First Treatment Round|Withdrawal by Subject|1|||
157241701|NCT03114891|567630740|FG000|3 Week Break|Lost to Follow-up|1|||
157241702|NCT03114891|567630741|FG001|3 Week Break|Lost to Follow-up|0|||
157241703|NCT03114891|567630742|FG002|3 Week Break|Lost to Follow-up|0|||
157241704|NCT03114891|567630743|FG003|3 Week Break|Lost to Follow-up|1|||
157241705|NCT03114891|567630740|FG000|3 Week Break|Withdrawal by Subject|0|||
157241706|NCT03114891|567630741|FG001|3 Week Break|Withdrawal by Subject|1|||
157241707|NCT03114891|567630742|FG002|3 Week Break|Withdrawal by Subject|0|||
157241708|NCT03114891|567630743|FG003|3 Week Break|Withdrawal by Subject|0|||
157241709|NCT03114891|567630740|FG000|Second Treatment Round|Lost to Follow-up|1|||
157241710|NCT03114891|567630741|FG001|Second Treatment Round|Lost to Follow-up|0|||
157241711|NCT03114891|567630742|FG002|Second Treatment Round|Lost to Follow-up|0|||
157241712|NCT03114891|567630743|FG003|Second Treatment Round|Lost to Follow-up|0|||
157241713|NCT03114891|567630740|FG000|Second Treatment Round|Physician Decision|1|||
157241714|NCT03114891|567630741|FG001|Second Treatment Round|Physician Decision|0|||
157241715|NCT03114891|567630742|FG002|Second Treatment Round|Physician Decision|0|||
157241716|NCT03114891|567630743|FG003|Second Treatment Round|Physician Decision|0|||
157241717|NCT00772603|567631612|FG000|Overall Study|Withdrawal by Subject|11|||
157241718|NCT00772603|567631613|FG001|Overall Study|Withdrawal by Subject|10|||
157197742|NCT01475214|567467171|FG002|Overall Study|Physician Decision|0|||
157197743|NCT01475214|567467169|FG000|Overall Study|Withdrawal by Subject|2|||
157197744|NCT01475214|567467170|FG001|Overall Study|Withdrawal by Subject|4|||
157197745|NCT01475214|567467171|FG002|Overall Study|Withdrawal by Subject|1|||
157197746|NCT00643851|567467172|FG000|Overall Study|Death|0|||
157197747|NCT00643851|567467173|FG001|Overall Study|Death|1|||
157197748|NCT00643851|567467174|FG002|Overall Study|Death|0|||
157197749|NCT00643851|567467172|FG000|Overall Study|Lack of Efficacy|0|||
157197750|NCT00643851|567467173|FG001|Overall Study|Lack of Efficacy|1|||
157197751|NCT00643851|567467174|FG002|Overall Study|Lack of Efficacy|0|||
157197752|NCT00643851|567467172|FG000|Overall Study|Adverse Event|2|||
157197753|NCT00643851|567467173|FG001|Overall Study|Adverse Event|6|||
157197754|NCT00643851|567467174|FG002|Overall Study|Adverse Event|6|||
157197755|NCT00643851|567467172|FG000|Overall Study|Lost to Follow-up|4|||
157197756|NCT00643851|567467173|FG001|Overall Study|Lost to Follow-up|6|||
157197757|NCT00643851|567467174|FG002|Overall Study|Lost to Follow-up|9|||
157197758|NCT00643851|567467172|FG000|Overall Study|Withdrawal by Subject|8|||
157197759|NCT00643851|567467173|FG001|Overall Study|Withdrawal by Subject|15|||
157197760|NCT00643851|567467174|FG002|Overall Study|Withdrawal by Subject|9|||
157197761|NCT00643851|567467172|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
157197762|NCT00643851|567467173|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
157197763|NCT00643851|567467174|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
157197764|NCT04806334|567467175|FG000|Overall Study|Withdrawal by Subject|1|||
157197765|NCT01636076|567467176|FG000|Overall Study|Terminated by sponsor|1|||
157197766|NCT01636076|567467177|FG001|Overall Study|Terminated by sponsor|1|||
157197767|NCT01636076|567467176|FG000|Overall Study|Lack of Efficacy|0|||
157197768|NCT01636076|567467177|FG001|Overall Study|Lack of Efficacy|1|||
157197769|NCT01636076|567467176|FG000|Overall Study|Lost to Follow-up|1|||
157197770|NCT01636076|567467177|FG001|Overall Study|Lost to Follow-up|0|||
157197771|NCT01636076|567467176|FG000|Overall Study|Physician Decision|1|||
157197772|NCT01636076|567467177|FG001|Overall Study|Physician Decision|1|||
157197773|NCT01636076|567467176|FG000|Overall Study|Non-compliance with study treatment|1|||
157197774|NCT01636076|567467177|FG001|Overall Study|Non-compliance with study treatment|1|||
157197775|NCT01636076|567467176|FG000|Overall Study|Adverse Event|6|||
157197776|NCT01636076|567467177|FG001|Overall Study|Adverse Event|11|||
157197777|NCT01636076|567467176|FG000|Overall Study|Withdrawal by Subject|7|||
157197778|NCT01636076|567467177|FG001|Overall Study|Withdrawal by Subject|10|||
157197779|NCT01130831|567467178|FG000|Overall Study|Withdrawal by Subject|7|||
157197780|NCT01130831|567467178|FG000|Overall Study|Death|4|||
157197781|NCT01130831|567467178|FG000|Overall Study|Information was missing|3|||
157197782|NCT01159665|567467179|FG000|Overall Study|Withdrawal by Subject|0|||
157197783|NCT01159665|567467180|FG001|Overall Study|Withdrawal by Subject|1|||
157197784|NCT01159665|567467181|FG002|Overall Study|Withdrawal by Subject|0|||
157197785|NCT01159665|567467182|FG003|Overall Study|Withdrawal by Subject|0|||
157197786|NCT01159665|567467183|FG004|Overall Study|Withdrawal by Subject|0|||
157197787|NCT01159665|567467184|FG005|Overall Study|Withdrawal by Subject|0|||
157197788|NCT00951912|567467185|FG000|Overall Study|Lack of Efficacy|1|||
157197789|NCT00951912|567467186|FG001|Overall Study|Lack of Efficacy|0|||
157197790|NCT00951912|567467187|FG002|Overall Study|Lack of Efficacy|0|||
157197791|NCT00951912|567467185|FG000|Overall Study|Adverse Event|0|||
157197792|NCT00951912|567467186|FG001|Overall Study|Adverse Event|1|||
157197793|NCT00951912|567467187|FG002|Overall Study|Adverse Event|1|||
157197794|NCT00951912|567467185|FG000|Overall Study|Lost to Follow-up|2|||
157197795|NCT00951912|567467186|FG001|Overall Study|Lost to Follow-up|2|||
157197796|NCT00951912|567467187|FG002|Overall Study|Lost to Follow-up|0|||
157197797|NCT00951912|567467185|FG000|Overall Study|Physician Decision|1|||
157197798|NCT00951912|567467186|FG001|Overall Study|Physician Decision|0|||
157197799|NCT00951912|567467187|FG002|Overall Study|Physician Decision|1|||
157197800|NCT00951912|567467185|FG000|Overall Study|Withdrawal by Subject|1|||
157197801|NCT00951912|567467186|FG001|Overall Study|Withdrawal by Subject|1|||
157197802|NCT00951912|567467187|FG002|Overall Study|Withdrawal by Subject|0|||
157197803|NCT00951912|567467185|FG000|Overall Study|Other:Depression|1|||
157197804|NCT00951912|567467186|FG001|Overall Study|Other:Depression|0|||
157197805|NCT00951912|567467187|FG002|Overall Study|Other:Depression|0|||
157197806|NCT00951912|567467185|FG000|Overall Study|Other: Colon cancer|1|||
157197807|NCT00951912|567467186|FG001|Overall Study|Other: Colon cancer|0|||
157197808|NCT00951912|567467187|FG002|Overall Study|Other: Colon cancer|0|||
157197809|NCT00951912|567467185|FG000|Overall Study|Other: Stroke|0|||
157197810|NCT00951912|567467186|FG001|Overall Study|Other: Stroke|1|||
157197811|NCT00951912|567467187|FG002|Overall Study|Other: Stroke|0|||
157197812|NCT02173158|567467189|FG000|Efficacy Phase|Adverse Event|1|||
157197813|NCT01377194|567467190|FG000|Overall Study|Adverse Event|3|||
157197814|NCT01377194|567467191|FG001|Overall Study|Adverse Event|12|||
157197815|NCT01377194|567467192|FG002|Overall Study|Adverse Event|19|||
157197816|NCT01377194|567467190|FG000|Overall Study|Lack of Efficacy|3|||
157197817|NCT01377194|567467191|FG001|Overall Study|Lack of Efficacy|3|||
157197818|NCT01377194|567467192|FG002|Overall Study|Lack of Efficacy|3|||
157197819|NCT01377194|567467190|FG000|Overall Study|Protocol Violation|4|||
157197820|NCT01377194|567467191|FG001|Overall Study|Protocol Violation|10|||
157241719|NCT00772603|567631614|FG002|Overall Study|Withdrawal by Subject|6|||
157197821|NCT01377194|567467192|FG002|Overall Study|Protocol Violation|6|||
157197822|NCT01377194|567467190|FG000|Overall Study|Withdrawal by Subject|8|||
157197823|NCT01377194|567467191|FG001|Overall Study|Withdrawal by Subject|10|||
157197824|NCT01377194|567467192|FG002|Overall Study|Withdrawal by Subject|7|||
157197825|NCT01377194|567467190|FG000|Overall Study|Lost to Follow-up|14|||
157197826|NCT01377194|567467191|FG001|Overall Study|Lost to Follow-up|8|||
157197827|NCT01377194|567467192|FG002|Overall Study|Lost to Follow-up|11|||
157197828|NCT01977573|567467195|FG000|Overall Study|Adverse Event|7|||
157197829|NCT01977573|567467196|FG001|Overall Study|Adverse Event|0|||
157197830|NCT01977573|567467197|FG002|Overall Study|Adverse Event|2|||
157197831|NCT01977573|567467198|FG003|Overall Study|Adverse Event|1|||
157197832|NCT01977573|567467195|FG000|Overall Study|Lost to Follow-up|1|||
157197833|NCT01977573|567467196|FG001|Overall Study|Lost to Follow-up|0|||
157197834|NCT01977573|567467197|FG002|Overall Study|Lost to Follow-up|0|||
157197835|NCT01977573|567467198|FG003|Overall Study|Lost to Follow-up|1|||
157197836|NCT01977573|567467195|FG000|Overall Study|Physician Decision|1|||
157197837|NCT01977573|567467196|FG001|Overall Study|Physician Decision|0|||
157197838|NCT01977573|567467197|FG002|Overall Study|Physician Decision|0|||
157197839|NCT01977573|567467198|FG003|Overall Study|Physician Decision|0|||
157197840|NCT01977573|567467195|FG000|Overall Study|Protocol Violation|3|||
157197841|NCT01977573|567467196|FG001|Overall Study|Protocol Violation|1|||
157197842|NCT01977573|567467197|FG002|Overall Study|Protocol Violation|0|||
157197843|NCT01977573|567467198|FG003|Overall Study|Protocol Violation|0|||
157197844|NCT01977573|567467195|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
157197845|NCT01977573|567467196|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
157197846|NCT01977573|567467197|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
157197847|NCT01977573|567467198|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
157197848|NCT01977573|567467195|FG000|Overall Study|Withdrawal by Subject|6|||
157197849|NCT01977573|567467196|FG001|Overall Study|Withdrawal by Subject|1|||
157197850|NCT01977573|567467197|FG002|Overall Study|Withdrawal by Subject|1|||
157197851|NCT01977573|567467198|FG003|Overall Study|Withdrawal by Subject|1|||
157197852|NCT00323479|567467199|FG000|Overall Study|Adverse Event|2|||
157197853|NCT00323479|567467199|FG000|Overall Study|Withdrawal by Subject|2|||
157197854|NCT00323479|567467199|FG000|Overall Study|Protocol Violation|3|||
157197855|NCT00323479|567467199|FG000|Overall Study|house moving|1|||
157197856|NCT00967343|567467203|FG000|Overall Study|Study termination by sponsor|12|||
157197857|NCT00967343|567467203|FG000|Overall Study|Death|24|||
157197858|NCT00967343|567467203|FG000|Overall Study|Relapse|1|||
157197859|NCT00967343|567467203|FG000|Overall Study|Lost to Follow-up|1|||
157197860|NCT03044730|567467205|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
157197861|NCT03044730|567467205|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
157197862|NCT03044730|567467205|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
157197863|NCT03044730|567467205|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
157197864|NCT03044730|567467205|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
157197865|NCT03044730|567467205|FG000|Cycles 4 and Beyond|Adverse Event|1|||
157197866|NCT03044730|567467205|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
157197867|NCT03044730|567467205|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
157197868|NCT03044730|567467205|FG000|On Follow-up for 2 Years|Death|17|||
157197869|NCT00934661|567468885|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
157197870|NCT00934661|567468886|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
157197871|NCT01846442|567468888|FG000|Overall Study|Adverse Event|2|||
157197872|NCT01846442|567468889|FG001|Overall Study|Adverse Event|4|||
157197873|NCT01846442|567468890|FG002|Overall Study|Adverse Event|2|||
157197874|NCT01846442|567468891|FG003|Overall Study|Adverse Event|1|||
157197875|NCT01846442|567468888|FG000|Overall Study|Lost to Follow-up|0|||
157197876|NCT01846442|567468889|FG001|Overall Study|Lost to Follow-up|0|||
157197877|NCT01846442|567468890|FG002|Overall Study|Lost to Follow-up|1|||
157197878|NCT01846442|567468891|FG003|Overall Study|Lost to Follow-up|0|||
157197879|NCT01846442|567468888|FG000|Overall Study|Withdrawal by Subject|3|||
157197880|NCT01846442|567468889|FG001|Overall Study|Withdrawal by Subject|2|||
157197881|NCT01846442|567468890|FG002|Overall Study|Withdrawal by Subject|0|||
157197882|NCT01846442|567468891|FG003|Overall Study|Withdrawal by Subject|1|||
157197883|NCT01846442|567468888|FG000|Overall Study|Left the city/Lost medication|1|||
157197884|NCT01846442|567468889|FG001|Overall Study|Left the city/Lost medication|0|||
157197885|NCT01846442|567468890|FG002|Overall Study|Left the city/Lost medication|1|||
157197886|NCT01846442|567468891|FG003|Overall Study|Left the city/Lost medication|1|||
157197887|NCT02777554|567468898|FG000|Overall Study|Adverse Event|4|||
157197888|NCT02777554|567468899|FG001|Overall Study|Adverse Event|4|||
157197889|NCT02777554|567468900|FG002|Overall Study|Adverse Event|0|||
157197890|NCT02777554|567468901|FG003|Overall Study|Adverse Event|1|||
157197891|NCT02777554|567468902|FG004|Overall Study|Adverse Event|0|||
157197892|NCT02777554|567468903|FG005|Overall Study|Adverse Event|0|||
157197893|NCT02777554|567468898|FG000|Overall Study|Withdrawal by Subject|3|||
157197894|NCT02777554|567468899|FG001|Overall Study|Withdrawal by Subject|1|||
157197895|NCT02777554|567468900|FG002|Overall Study|Withdrawal by Subject|1|||
157197896|NCT02777554|567468901|FG003|Overall Study|Withdrawal by Subject|0|||
157241720|NCT00772603|567631612|FG000|Overall Study|Adverse Event|37|||
157241721|NCT00772603|567631613|FG001|Overall Study|Adverse Event|18|||
157241722|NCT00772603|567631614|FG002|Overall Study|Adverse Event|10|||
157241723|NCT00772603|567631612|FG000|Overall Study|Subject Non-compliance|1|||
157241724|NCT00772603|567631613|FG001|Overall Study|Subject Non-compliance|6|||
157241725|NCT00772603|567631614|FG002|Overall Study|Subject Non-compliance|4|||
157241726|NCT00772603|567631612|FG000|Overall Study|Protocol Violation|0|||
157241727|NCT00772603|567631613|FG001|Overall Study|Protocol Violation|1|||
157241728|NCT00772603|567631614|FG002|Overall Study|Protocol Violation|1|||
157241729|NCT00772603|567631612|FG000|Overall Study|Lost to Follow-up|1|||
157241730|NCT00772603|567631613|FG001|Overall Study|Lost to Follow-up|5|||
157241731|NCT00772603|567631614|FG002|Overall Study|Lost to Follow-up|2|||
157241732|NCT00772603|567631612|FG000|Overall Study|Physician Decision|0|||
157241733|NCT00772603|567631613|FG001|Overall Study|Physician Decision|0|||
157241734|NCT00772603|567631614|FG002|Overall Study|Physician Decision|1|||
157241735|NCT00772603|567631612|FG000|Overall Study|Other|2|||
157241736|NCT00772603|567631613|FG001|Overall Study|Other|0|||
157241737|NCT00772603|567631614|FG002|Overall Study|Other|2|||
157241738|NCT00859521|567631617|FG000|Washout|Withdrawal by Subject|0|||
157241739|NCT00859521|567631618|FG001|Washout|Withdrawal by Subject|1|||
157241740|NCT02125461|567631619|FG000|Overall Study|Withdrawal by Subject|30|||
157241741|NCT02125461|567631620|FG001|Overall Study|Withdrawal by Subject|16|||
157241742|NCT02125461|567631619|FG000|Overall Study|Lost to Follow-up|8|||
157241743|NCT02125461|567631620|FG001|Overall Study|Lost to Follow-up|3|||
157241744|NCT02125461|567631619|FG000|Overall Study|Death|260|||
157241745|NCT02125461|567631620|FG001|Overall Study|Death|149|||
157241746|NCT02125461|567631619|FG000|Overall Study|Missing Termination Reason|0|||
157241747|NCT02125461|567631620|FG001|Overall Study|Missing Termination Reason|1|||
157241748|NCT03552484|567631621|FG000|Overall Study|Death|6|||
157241749|NCT03552484|567631622|FG001|Overall Study|Death|4|||
157241750|NCT03552484|567631621|FG000|Overall Study|Lost to Follow-up|0|||
157241751|NCT03552484|567631622|FG001|Overall Study|Lost to Follow-up|16|||
157241752|NCT02699463|567631623|FG000|Overall Study|Lost to Follow-up|11|||
157241753|NCT02699463|567631624|FG001|Overall Study|Lost to Follow-up|8|||
157241754|NCT02699463|567631623|FG000|Overall Study|Withdrawal by Subject|4|||
157241755|NCT02699463|567631624|FG001|Overall Study|Withdrawal by Subject|1|||
157241756|NCT02488239|567631627|FG000|Overall Study|Death|3|||
157241757|NCT02488239|567631627|FG000|Overall Study|Withdrawal by Subject|3|||
157241758|NCT02488239|567631627|FG000|Overall Study|Physician Decision|2|||
157241759|NCT02488239|567631627|FG000|Overall Study|Consent ineligible|1|||
157241760|NCT02488239|567631627|FG000|Overall Study|Did not undergo implant procedure|1|||
157241761|NCT01370733|567631631|FG000|Overall Study|Withdrawal by Subject|8|||
157241762|NCT01370733|567631632|FG001|Overall Study|Withdrawal by Subject|8|||
157241763|NCT01370733|567631631|FG000|Overall Study|Lost to Follow-up|3|||
157241764|NCT01370733|567631632|FG001|Overall Study|Lost to Follow-up|0|||
157241765|NCT01370733|567631631|FG000|Overall Study|Adverse Event|2|||
157241766|NCT01370733|567631632|FG001|Overall Study|Adverse Event|4|||
157241767|NCT01370733|567631631|FG000|Overall Study|Lack of Efficacy|3|||
157241768|NCT01370733|567631632|FG001|Overall Study|Lack of Efficacy|5|||
157241769|NCT01370733|567631631|FG000|Overall Study|Physician Decision|0|||
157241770|NCT01370733|567631632|FG001|Overall Study|Physician Decision|2|||
157241771|NCT01370733|567631631|FG000|Overall Study|Protocol Violation|1|||
157241772|NCT01370733|567631632|FG001|Overall Study|Protocol Violation|3|||
157241773|NCT03325881|567631633|FG000|Overall Study|Protocol Violation|0|||
157241774|NCT03325881|567631634|FG001|Overall Study|Protocol Violation|1|||
157241775|NCT03325881|567631633|FG000|Overall Study|Withdrawal by Subject|0|||
157241776|NCT03325881|567631634|FG001|Overall Study|Withdrawal by Subject|2|||
157241777|NCT03325881|567631633|FG000|Overall Study|Lack of Efficacy|2|||
157241778|NCT03325881|567631634|FG001|Overall Study|Lack of Efficacy|0|||
157241779|NCT03325881|567631633|FG000|Overall Study|Not treated|1|||
157241780|NCT03325881|567631634|FG001|Overall Study|Not treated|0|||
157241781|NCT03676634|567631635|FG000|Overall Study|Red blood cell loss|1|||
157241782|NCT03676634|567631635|FG000|Overall Study|Out-of-limit pulse|2|||
157241783|NCT00909038|567631640|FG000|Overall Study|Protocol Violation|187|||
157241784|NCT00909038|567631640|FG000|Overall Study|Non-evaluable Subjects|230|||
157241785|NCT00909753|567631643|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
157241786|NCT00909753|567631644|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
157241787|NCT00909753|567631643|FG000|Period: Second Intervention|Protocol Violation|1|||
157241788|NCT00909753|567631644|FG001|Period: Second Intervention|Protocol Violation|0|||
157241789|NCT01895335|567631649|FG000|Overall Study|Adverse Event|106|||
157241790|NCT01895335|567631649|FG000|Overall Study|Lack of Efficacy|53|||
157241791|NCT01895335|567631649|FG000|Overall Study|Poor Compliance to Protocol|11|||
157241792|NCT01895335|567631649|FG000|Overall Study|Included But Not treated|1|||
157241793|NCT01895335|567631649|FG000|Overall Study|Other than Specified Above|44|||
157241794|NCT03480763|567631650|FG000|Overall Study|Withdrawal by Subject|18|||
157241795|NCT03480763|567631651|FG001|Overall Study|Withdrawal by Subject|10|||
157241796|NCT03480763|567631650|FG000|Overall Study|Lost to Follow-up|4|||
157241797|NCT03480763|567631651|FG001|Overall Study|Lost to Follow-up|7|||
157241798|NCT03480763|567631650|FG000|Overall Study|non-study pneumococcal vaccine|1|||
157241799|NCT03480763|567631651|FG001|Overall Study|non-study pneumococcal vaccine|0|||
157241800|NCT03480763|567631650|FG000|Overall Study|oncological treatment|0|||
157241801|NCT03480763|567631651|FG001|Overall Study|oncological treatment|2|||
157241802|NCT03480763|567631650|FG000|Overall Study|pain with vaccination|1|||
157241803|NCT03480763|567631651|FG001|Overall Study|pain with vaccination|0|||
157241804|NCT01647828|567631654|FG000|Overall Study|Death|3|||
157241805|NCT01647828|567631655|FG001|Overall Study|Death|4|||
157241806|NCT01647828|567631656|FG002|Overall Study|Death|4|||
157241807|NCT01647828|567631657|FG003|Overall Study|Death|5|||
157241808|NCT01647828|567631658|FG004|Overall Study|Death|6|||
157241809|NCT01647828|567631659|FG005|Overall Study|Death|3|||
157241810|NCT01647828|567631660|FG006|Overall Study|Death|10|||
157241811|NCT01647828|567631661|FG007|Overall Study|Death|60|||
157241812|NCT01647828|567631662|FG008|Overall Study|Death|71|||
157241813|NCT01647828|567631654|FG000|Overall Study|Withdrawal by Subject|2|||
157241814|NCT01647828|567631655|FG001|Overall Study|Withdrawal by Subject|0|||
157241815|NCT01647828|567631656|FG002|Overall Study|Withdrawal by Subject|0|||
157241816|NCT01647828|567631657|FG003|Overall Study|Withdrawal by Subject|1|||
157241817|NCT01647828|567631658|FG004|Overall Study|Withdrawal by Subject|0|||
157241818|NCT01647828|567631659|FG005|Overall Study|Withdrawal by Subject|0|||
157241819|NCT01647828|567631660|FG006|Overall Study|Withdrawal by Subject|1|||
157241820|NCT01647828|567631661|FG007|Overall Study|Withdrawal by Subject|0|||
157241821|NCT01647828|567631662|FG008|Overall Study|Withdrawal by Subject|2|||
157241822|NCT01647828|567631654|FG000|Overall Study|Study terminated by Sponsor|0|||
157241823|NCT01647828|567631655|FG001|Overall Study|Study terminated by Sponsor|0|||
157241824|NCT01647828|567631656|FG002|Overall Study|Study terminated by Sponsor|0|||
157197897|NCT02777554|567468902|FG004|Overall Study|Withdrawal by Subject|0|||
157197898|NCT02777554|567468903|FG005|Overall Study|Withdrawal by Subject|0|||
157197899|NCT02777554|567468898|FG000|Overall Study|Discharged early due to hurricane|22|||
157197900|NCT02777554|567468899|FG001|Overall Study|Discharged early due to hurricane|20|||
157197901|NCT02777554|567468900|FG002|Overall Study|Discharged early due to hurricane|0|||
157197902|NCT02777554|567468901|FG003|Overall Study|Discharged early due to hurricane|0|||
157197903|NCT02777554|567468902|FG004|Overall Study|Discharged early due to hurricane|0|||
157197904|NCT02777554|567468903|FG005|Overall Study|Discharged early due to hurricane|0|||
157197905|NCT02777554|567468898|FG000|Overall Study|Other - Miscellaneous|1|||
157197906|NCT02777554|567468899|FG001|Overall Study|Other - Miscellaneous|0|||
157197907|NCT02777554|567468900|FG002|Overall Study|Other - Miscellaneous|0|||
157197908|NCT02777554|567468901|FG003|Overall Study|Other - Miscellaneous|0|||
157197909|NCT02777554|567468902|FG004|Overall Study|Other - Miscellaneous|0|||
157197910|NCT02777554|567468903|FG005|Overall Study|Other - Miscellaneous|0|||
157197911|NCT01013207|567468904|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
157241825|NCT01647828|567631657|FG003|Overall Study|Study terminated by Sponsor|0|||
157241826|NCT01647828|567631658|FG004|Overall Study|Study terminated by Sponsor|0|||
157241827|NCT01647828|567631659|FG005|Overall Study|Study terminated by Sponsor|0|||
157241828|NCT01647828|567631660|FG006|Overall Study|Study terminated by Sponsor|1|||
157241829|NCT01647828|567631661|FG007|Overall Study|Study terminated by Sponsor|26|||
157241830|NCT01647828|567631662|FG008|Overall Study|Study terminated by Sponsor|16|||
157241831|NCT01647828|567631654|FG000|Overall Study|Lost to Follow-up|0|||
157241832|NCT01647828|567631655|FG001|Overall Study|Lost to Follow-up|0|||
157241833|NCT01647828|567631656|FG002|Overall Study|Lost to Follow-up|0|||
157241834|NCT01647828|567631657|FG003|Overall Study|Lost to Follow-up|0|||
157241835|NCT01647828|567631658|FG004|Overall Study|Lost to Follow-up|0|||
157241836|NCT01647828|567631659|FG005|Overall Study|Lost to Follow-up|0|||
157241837|NCT01647828|567631660|FG006|Overall Study|Lost to Follow-up|0|||
157241838|NCT01647828|567631661|FG007|Overall Study|Lost to Follow-up|2|||
157241839|NCT01647828|567631662|FG008|Overall Study|Lost to Follow-up|0|||
157241840|NCT00115063|567631663|FG000|Overall Study|Lost to Follow-up|98|||
157241841|NCT00115063|567631664|FG001|Overall Study|Lost to Follow-up|104|||
157241842|NCT00115063|567631663|FG000|Overall Study|Death|1|||
157241843|NCT00115063|567631664|FG001|Overall Study|Death|0|||
157241844|NCT00185458|567631667|FG000|Contraception Phase|Adverse Event|37|||
157241845|NCT00185458|567631667|FG000|Contraception Phase|Lost to Follow-up|10|||
157241846|NCT00185458|567631667|FG000|Contraception Phase|Protocol Violation|2|||
157241847|NCT00185458|567631667|FG000|Contraception Phase|Physician Decision|2|||
157197912|NCT01541644|567468905|FG000|Overall Study|Withdrawal by Subject|3|||
157241848|NCT00185458|567631667|FG000|Contraception Phase|Withdrawal by Subject|7|||
157241849|NCT00185458|567631667|FG000|HRT Phase|Adverse Event|18|||
157241850|NCT00185458|567631667|FG000|HRT Phase|Lost to Follow-up|4|||
157241851|NCT00185458|567631667|FG000|HRT Phase|Protocol Violation|2|||
157241852|NCT00185458|567631667|FG000|HRT Phase|Withdrawal by Subject|3|||
157241853|NCT03600376|567631668|FG000|Overall Study|Adverse Event|1|||
157197913|NCT01458535|567468906|FG000|Overall Study|Other|0|||
157197914|NCT01458535|567468907|FG001|Overall Study|Other|0|||
157197915|NCT01458535|567468908|FG002|Overall Study|Other|0|||
157241854|NCT03600376|567631669|FG001|Overall Study|Adverse Event|1|||
157241855|NCT03600376|567631668|FG000|Overall Study|Transferred to other facility|1|||
157241856|NCT03600376|567631669|FG001|Overall Study|Transferred to other facility|0|||
157241857|NCT03600376|567631668|FG000|Overall Study|Investigator Decision|0|||
157197916|NCT01458535|567468909|FG003|Overall Study|Other|0|||
157197917|NCT01458535|567468910|FG004|Overall Study|Other|1|||
157197918|NCT01458535|567468911|FG005|Overall Study|Other|1|||
157197919|NCT01458535|567468906|FG000|Overall Study|Withdrawal by Subject|0|||
157197920|NCT01458535|567468907|FG001|Overall Study|Withdrawal by Subject|0|||
157197921|NCT01458535|567468908|FG002|Overall Study|Withdrawal by Subject|2|||
157197922|NCT01458535|567468909|FG003|Overall Study|Withdrawal by Subject|0|||
157197923|NCT01458535|567468910|FG004|Overall Study|Withdrawal by Subject|1|||
157197924|NCT01458535|567468911|FG005|Overall Study|Withdrawal by Subject|1|||
157197925|NCT01458535|567468906|FG000|Overall Study|Lost to Follow-up|0|||
157197926|NCT01458535|567468907|FG001|Overall Study|Lost to Follow-up|2|||
157197927|NCT01458535|567468908|FG002|Overall Study|Lost to Follow-up|0|||
157197928|NCT01458535|567468909|FG003|Overall Study|Lost to Follow-up|3|||
157197929|NCT01458535|567468910|FG004|Overall Study|Lost to Follow-up|2|||
157197930|NCT01458535|567468911|FG005|Overall Study|Lost to Follow-up|2|||
157197931|NCT01458535|567468906|FG000|Overall Study|Adverse Event|0|||
157197932|NCT01458535|567468907|FG001|Overall Study|Adverse Event|0|||
157197933|NCT01458535|567468908|FG002|Overall Study|Adverse Event|0|||
157197934|NCT01458535|567468909|FG003|Overall Study|Adverse Event|1|||
157197935|NCT01458535|567468910|FG004|Overall Study|Adverse Event|0|||
157197936|NCT01458535|567468911|FG005|Overall Study|Adverse Event|0|||
157197937|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
157197938|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
157197939|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197940|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197941|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197942|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197943|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197944|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197945|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197946|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197947|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197948|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
157197949|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
157197950|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197951|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197952|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197953|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197954|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197955|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
157197956|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197957|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197958|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197959|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
157197960|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
157197961|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197962|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
157197963|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197964|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197965|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197966|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197967|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197968|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197969|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197970|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197971|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197972|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
157197973|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
157197974|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
157197975|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
157197976|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
157197977|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
157197978|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
157197979|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
157197980|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
157197981|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
157197982|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
157197983|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
157197984|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
157197985|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157241858|NCT03600376|567631669|FG001|Overall Study|Investigator Decision|4|||
157241859|NCT03600376|567631668|FG000|Overall Study|Determined to be ineligible for study|0|||
157241860|NCT03600376|567631669|FG001|Overall Study|Determined to be ineligible for study|1|||
157241861|NCT00796562|567631673|FG000|Overall Study|Death|49|||
157241862|NCT05655520|567631674|FG000|Overall Study|Adverse Event|2|||
157241863|NCT05655520|567631675|FG001|Overall Study|Adverse Event|3|||
157241864|NCT05655520|567631674|FG000|Overall Study|Physician Decision|2|||
157241865|NCT05655520|567631675|FG001|Overall Study|Physician Decision|0|||
157241866|NCT05655520|567631674|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157241867|NCT05655520|567631675|FG001|Overall Study|Non-Compliance with Study Drug|2|||
157241868|NCT05655520|567631674|FG000|Overall Study|Lost to Follow-up|1|||
157241869|NCT05655520|567631675|FG001|Overall Study|Lost to Follow-up|0|||
157241870|NCT05655520|567631674|FG000|Overall Study|Withdrawal by Subject|4|||
157241871|NCT05655520|567631675|FG001|Overall Study|Withdrawal by Subject|4|||
157241872|NCT05655520|567631674|FG000|Overall Study|Study Terminated by Sponsor|61|||
157241873|NCT05655520|567631675|FG001|Overall Study|Study Terminated by Sponsor|68|||
157241874|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
157241875|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
157241876|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
157241877|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
157241878|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
157241879|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
157241880|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
157241881|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
157241882|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
157241883|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
157241884|NCT00424047|567631676|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
157241885|NCT00424047|567631677|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
157241886|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Adverse Event|22|||
157241887|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Adverse Event|12|||
157241888|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Progression of disease|92|||
157241889|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Progression of disease|128|||
157241890|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
157241891|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
157241892|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
157241893|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
157241894|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Death|11|||
157241895|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Death|11|||
157241896|NCT00424047|567631676|FG000|On Study at Time of Unblinding|Other|5|||
157241897|NCT00424047|567631677|FG001|On Study at Time of Unblinding|Other|4|||
157241898|NCT00424047|567631676|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
157241899|NCT00424047|567631677|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
157241900|NCT00424047|567631676|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
157241901|NCT00424047|567631677|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
157241902|NCT00424047|567631676|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
157241903|NCT00424047|567631677|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
157241904|NCT00424047|567631676|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
157241905|NCT00424047|567631677|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
157241906|NCT00424047|567631676|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
157241907|NCT00424047|567631677|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
157241908|NCT01010503|567631679|FG000|Overall Study|Adverse Event|1|||
157241909|NCT01010503|567631679|FG000|Overall Study|Death|1|||
157241910|NCT06336356|567631680|FG000|Overall Study|Withdrawal by Subject|1|||
157241911|NCT06336356|567631681|FG001|Overall Study|Withdrawal by Subject|0|||
157241912|NCT06336356|567631680|FG000|Overall Study|Lost to Follow Up|1|||
157241913|NCT06336356|567631681|FG001|Overall Study|Lost to Follow Up|0|||
157241914|NCT05871151|567631684|FG000|Overall Study|Lost to Follow-up|1|||
157241915|NCT05871151|567631685|FG001|Overall Study|Lost to Follow-up|0|||
157241916|NCT05871151|567631684|FG000|Overall Study|Unrelated illness|0|||
157241917|NCT05871151|567631685|FG001|Overall Study|Unrelated illness|1|||
157241918|NCT01750294|567633039|FG000|Overall Study|Withdrawal by Subject|1|||
157241919|NCT01750294|567633039|FG000|Overall Study|Safety Endpoint|1|||
157241920|NCT01624233|567633040|FG000|Period 2 - Induction|Adverse Event|1|||
157241921|NCT01624233|567633040|FG000|Period 3 - Maintenance|Adverse Event|2|||
157241922|NCT01624233|567633040|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
157241923|NCT01624233|567633040|FG000|Period 3 - Maintenance|Physician Decision|2|||
157241924|NCT01624233|567633040|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
157241925|NCT01624233|567633040|FG000|Period 4 - Drug Free Period|Relapsed|61|||
157241926|NCT01624233|567633040|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
157241927|NCT01624233|567633040|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
157241928|NCT01624233|567633040|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
157241929|NCT01624233|567633040|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
157241930|NCT01624233|567633040|FG000|Period 6: Follow-up|Adverse Event|3|||
157241931|NCT01624233|567633040|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
157241932|NCT01624233|567633040|FG000|Period 6: Follow-up|Physician Decision|1|||
157241933|NCT01624233|567633040|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
157241934|NCT03121586|567633041|FG000|Overall Study|Study terminated by sponsor|0|||
157241935|NCT03121586|567633042|FG001|Overall Study|Study terminated by sponsor|0|||
157241936|NCT03121586|567633043|FG002|Overall Study|Study terminated by sponsor|99|||
157241937|NCT03121586|567633041|FG000|Overall Study|Withdrawal by Subject|37|||
157241938|NCT03121586|567633042|FG001|Overall Study|Withdrawal by Subject|14|||
157241939|NCT03121586|567633043|FG002|Overall Study|Withdrawal by Subject|9|||
157241940|NCT03121586|567633041|FG000|Overall Study|Not further specified|6|||
157241941|NCT03121586|567633042|FG001|Overall Study|Not further specified|11|||
157241942|NCT03121586|567633043|FG002|Overall Study|Not further specified|10|||
157241943|NCT03121586|567633041|FG000|Overall Study|Adverse Event|16|||
157241944|NCT03121586|567633042|FG001|Overall Study|Adverse Event|5|||
157241945|NCT03121586|567633043|FG002|Overall Study|Adverse Event|6|||
157241946|NCT03121586|567633041|FG000|Overall Study|Protocol Violation|0|||
157241947|NCT03121586|567633042|FG001|Overall Study|Protocol Violation|5|||
157241948|NCT03121586|567633043|FG002|Overall Study|Protocol Violation|0|||
157241949|NCT03121586|567633041|FG000|Overall Study|Lack of Efficacy|3|||
157241950|NCT03121586|567633042|FG001|Overall Study|Lack of Efficacy|3|||
157241951|NCT03121586|567633043|FG002|Overall Study|Lack of Efficacy|1|||
157241952|NCT03121586|567633041|FG000|Overall Study|Physician Decision|2|||
157241953|NCT03121586|567633042|FG001|Overall Study|Physician Decision|2|||
157241954|NCT03121586|567633043|FG002|Overall Study|Physician Decision|0|||
157241955|NCT03121586|567633041|FG000|Overall Study|Noncompliance with study drug|5|||
157241956|NCT03121586|567633042|FG001|Overall Study|Noncompliance with study drug|3|||
157241957|NCT03121586|567633043|FG002|Overall Study|Noncompliance with study drug|5|||
157241958|NCT03121586|567633041|FG000|Overall Study|Lost to Follow-up|4|||
157241959|NCT03121586|567633042|FG001|Overall Study|Lost to Follow-up|2|||
157241960|NCT03121586|567633043|FG002|Overall Study|Lost to Follow-up|0|||
157241961|NCT03121586|567633041|FG000|Overall Study|Death|2|||
157241962|NCT03121586|567633042|FG001|Overall Study|Death|0|||
157241963|NCT03121586|567633043|FG002|Overall Study|Death|0|||
157241964|NCT06381102|567633044|FG000|Washout 5 Days|Withdrawal by Subject|0|||
157241965|NCT06381102|567633045|FG001|Washout 5 Days|Withdrawal by Subject|2|||
157241966|NCT02832063|567633047|FG000|Overall Study|Adverse Event|2|||
157241967|NCT02832063|567633048|FG001|Overall Study|Adverse Event|1|||
157241968|NCT02832063|567633047|FG000|Overall Study|Physician Decision|5|||
157241969|NCT02832063|567633048|FG001|Overall Study|Physician Decision|7|||
157241970|NCT02832063|567633047|FG000|Overall Study|Lost to Follow-up|15|||
157241971|NCT02832063|567633048|FG001|Overall Study|Lost to Follow-up|8|||
157241972|NCT02832063|567633047|FG000|Overall Study|Withdrawal by Subject|10|||
157241973|NCT02832063|567633048|FG001|Overall Study|Withdrawal by Subject|21|||
157241974|NCT02832063|567633047|FG000|Overall Study|Other|2|||
157241975|NCT02832063|567633048|FG001|Overall Study|Other|1|||
157241976|NCT03733730|567633049|FG000|Overall Study|Lost to Follow-up|1|||
157241977|NCT03733730|567633050|FG001|Overall Study|Lost to Follow-up|32|||
157241978|NCT03733730|567633049|FG000|Overall Study|Other|1|||
157241979|NCT03733730|567633050|FG001|Overall Study|Other|0|||
157241980|NCT03733730|567633049|FG000|Overall Study|Adverse Event|0|||
157241981|NCT03733730|567633050|FG001|Overall Study|Adverse Event|4|||
157241982|NCT03733730|567633049|FG000|Overall Study|Death|0|||
157241983|NCT03733730|567633050|FG001|Overall Study|Death|5|||
157241984|NCT03733730|567633049|FG000|Overall Study|Withdrawal by Subject|0|||
157241985|NCT03733730|567633050|FG001|Overall Study|Withdrawal by Subject|8|||
157241986|NCT01987765|567633051|FG000|Overall Study|Protocol Violation|65|||
157241987|NCT01987765|567633051|FG000|Overall Study|Lost to Follow-up|37|||
157241988|NCT01564394|567633056|FG000|Overall Study|Withdrawal by Subject|6|||
157241989|NCT01564394|567633057|FG001|Overall Study|Withdrawal by Subject|10|||
157241990|NCT00443651|567633058|FG000|Overall Study|Death|1|||
157241991|NCT00443651|567633059|FG001|Overall Study|Death|5|||
157241992|NCT00443651|567633058|FG000|Overall Study|Adverse Event|5|||
157241993|NCT00443651|567633059|FG001|Overall Study|Adverse Event|6|||
157241994|NCT00443651|567633058|FG000|Overall Study|Lost to Follow-up|18|||
157241995|NCT00443651|567633059|FG001|Overall Study|Lost to Follow-up|12|||
157241996|NCT00443651|567633058|FG000|Overall Study|Patient's/Guardian's Decision|58|||
157241997|NCT00443651|567633059|FG001|Overall Study|Patient's/Guardian's Decision|30|||
157241998|NCT00443651|567633058|FG000|Overall Study|Physician Decision|13|||
157241999|NCT00443651|567633059|FG001|Overall Study|Physician Decision|4|||
157242000|NCT00443651|567633058|FG000|Overall Study|Pregnancy|0|||
157242001|NCT00443651|567633059|FG001|Overall Study|Pregnancy|1|||
157242002|NCT03606174|567633060|FG000|Overall Study|Death|37|||
157242003|NCT03606174|567633061|FG001|Overall Study|Death|15|||
157242004|NCT03606174|567633062|FG002|Overall Study|Death|15|||
157242005|NCT03606174|567633063|FG003|Overall Study|Death|7|||
157242006|NCT03606174|567633064|FG004|Overall Study|Death|35|||
157091420|NCT02842827|567089104|FG004|Overall Study|Death|2|||
157242007|NCT03606174|567633065|FG005|Overall Study|Death|12|||
157242008|NCT03606174|567633066|FG006|Overall Study|Death|35|||
157242009|NCT03606174|567633067|FG007|Overall Study|Death|8|||
157242010|NCT03606174|567633068|FG008|Overall Study|Death|5|||
157242011|NCT03606174|567633069|FG009|Overall Study|Death|3|||
157242012|NCT03606174|567633070|FG010|Overall Study|Death|0|||
157242013|NCT03606174|567633060|FG000|Overall Study|Lost to Follow-up|0|||
157242014|NCT03606174|567633061|FG001|Overall Study|Lost to Follow-up|0|||
157242015|NCT03606174|567633062|FG002|Overall Study|Lost to Follow-up|0|||
157242016|NCT03606174|567633063|FG003|Overall Study|Lost to Follow-up|0|||
157242017|NCT03606174|567633064|FG004|Overall Study|Lost to Follow-up|1|||
157242018|NCT03606174|567633065|FG005|Overall Study|Lost to Follow-up|1|||
157242019|NCT03606174|567633066|FG006|Overall Study|Lost to Follow-up|0|||
157242020|NCT03606174|567633067|FG007|Overall Study|Lost to Follow-up|0|||
157242021|NCT03606174|567633068|FG008|Overall Study|Lost to Follow-up|0|||
157242022|NCT03606174|567633069|FG009|Overall Study|Lost to Follow-up|0|||
157242023|NCT03606174|567633070|FG010|Overall Study|Lost to Follow-up|0|||
157242024|NCT03606174|567633060|FG000|Overall Study|Withdrawal by Subject|6|||
157242025|NCT03606174|567633061|FG001|Overall Study|Withdrawal by Subject|0|||
157242026|NCT03606174|567633062|FG002|Overall Study|Withdrawal by Subject|0|||
157242027|NCT03606174|567633063|FG003|Overall Study|Withdrawal by Subject|1|||
157242028|NCT03606174|567633064|FG004|Overall Study|Withdrawal by Subject|2|||
157242029|NCT03606174|567633065|FG005|Overall Study|Withdrawal by Subject|1|||
157242030|NCT03606174|567633066|FG006|Overall Study|Withdrawal by Subject|4|||
157242031|NCT03606174|567633067|FG007|Overall Study|Withdrawal by Subject|0|||
157242032|NCT03606174|567633068|FG008|Overall Study|Withdrawal by Subject|0|||
157242033|NCT03606174|567633069|FG009|Overall Study|Withdrawal by Subject|0|||
157242034|NCT03606174|567633070|FG010|Overall Study|Withdrawal by Subject|1|||
157242035|NCT03606174|567633060|FG000|Overall Study|Study Terminated by Sponsor|5|||
157242036|NCT03606174|567633061|FG001|Overall Study|Study Terminated by Sponsor|7|||
157242037|NCT03606174|567633062|FG002|Overall Study|Study Terminated by Sponsor|3|||
157242038|NCT03606174|567633063|FG003|Overall Study|Study Terminated by Sponsor|0|||
157242039|NCT03606174|567633064|FG004|Overall Study|Study Terminated by Sponsor|11|||
157242040|NCT03606174|567633065|FG005|Overall Study|Study Terminated by Sponsor|6|||
157242041|NCT03606174|567633066|FG006|Overall Study|Study Terminated by Sponsor|12|||
157242042|NCT03606174|567633067|FG007|Overall Study|Study Terminated by Sponsor|1|||
157242043|NCT03606174|567633068|FG008|Overall Study|Study Terminated by Sponsor|3|||
157242044|NCT03606174|567633069|FG009|Overall Study|Study Terminated by Sponsor|1|||
157242045|NCT03606174|567633070|FG010|Overall Study|Study Terminated by Sponsor|2|||
157242046|NCT03606174|567633060|FG000|Overall Study|Miscellaneous|1|||
157242047|NCT03606174|567633061|FG001|Overall Study|Miscellaneous|1|||
157242048|NCT03606174|567633062|FG002|Overall Study|Miscellaneous|0|||
157242049|NCT03606174|567633063|FG003|Overall Study|Miscellaneous|1|||
157242050|NCT03606174|567633064|FG004|Overall Study|Miscellaneous|4|||
157242051|NCT03606174|567633065|FG005|Overall Study|Miscellaneous|7|||
157242052|NCT03606174|567633066|FG006|Overall Study|Miscellaneous|5|||
157242053|NCT03606174|567633067|FG007|Overall Study|Miscellaneous|0|||
157242054|NCT03606174|567633068|FG008|Overall Study|Miscellaneous|0|||
157242055|NCT03606174|567633069|FG009|Overall Study|Miscellaneous|0|||
157242056|NCT03606174|567633070|FG010|Overall Study|Miscellaneous|1|||
157242057|NCT01609257|567633071|FG000|Overall Study|Lost to Follow-up|2|||
157242058|NCT01609257|567633072|FG001|Overall Study|Lost to Follow-up|1|||
157242059|NCT01609257|567633071|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
157242060|NCT01609257|567633072|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
157242061|NCT01609257|567633071|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
157242062|NCT01609257|567633072|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
157242063|NCT00469898|567633087|FG000|Overall Study|Adverse Event|7|||
157242064|NCT00469898|567633087|FG000|Overall Study|Withdrawal by Subject|4|||
157242065|NCT00469898|567633087|FG000|Overall Study|Death|4|||
157242066|NCT00469898|567633087|FG000|Overall Study|Disease progression|9|||
157242067|NCT00469898|567633087|FG000|Overall Study|Decreased performance status|1|||
157242068|NCT02663349|567633090|FG000|Overall Study|Withdrawal by Subject|6|||
157242069|NCT01896934|567633091|FG000|Overall Study|Adverse Event|1|||
157242070|NCT01896934|567633091|FG000|Overall Study|Withdrawal by Subject|1|||
157242071|NCT00316277|567633093|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
157242072|NCT00316277|567633094|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
157242073|NCT00316277|567633093|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
157242074|NCT00316277|567633094|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
157242075|NCT00316277|567633093|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
157242076|NCT00316277|567633094|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
157242077|NCT00316277|567633093|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
157242078|NCT00316277|567633094|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
157242079|NCT00316277|567633093|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
157242080|NCT00316277|567633094|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
157242081|NCT00927069|567633095|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
157242082|NCT00927069|567633096|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
157242083|NCT00927069|567633097|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
157242084|NCT00927069|567633098|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
157242085|NCT00927069|567633095|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
157242086|NCT00927069|567633096|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
157242087|NCT00927069|567633097|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
157242088|NCT00927069|567633098|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
157242089|NCT00927069|567633095|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
157242090|NCT00927069|567633096|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
157242091|NCT00927069|567633097|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
157242092|NCT00927069|567633098|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
157242093|NCT00927069|567633095|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
157242094|NCT00927069|567633096|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
157242095|NCT00927069|567633097|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
157242096|NCT00927069|567633098|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
157242097|NCT00927069|567633095|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
157242098|NCT00927069|567633096|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
157242099|NCT00927069|567633097|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
157242100|NCT00927069|567633098|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
157242101|NCT00848536|567633099|FG000|Overall Study|Adverse Event|2|||
157242102|NCT00848536|567633100|FG001|Overall Study|Adverse Event|2|||
157242103|NCT00848536|567633099|FG000|Overall Study|Withdrawal by Subject|0|||
157242104|NCT00848536|567633100|FG001|Overall Study|Withdrawal by Subject|1|||
157242105|NCT00848536|567633099|FG000|Overall Study|Protocol Violation|0|||
157242106|NCT00848536|567633100|FG001|Overall Study|Protocol Violation|1|||
157242107|NCT00848536|567633099|FG000|Overall Study|Noncompliance|1|||
157242108|NCT00848536|567633100|FG001|Overall Study|Noncompliance|0|||
157242109|NCT00848536|567633099|FG000|Overall Study|Inadequate Control of IOP|1|||
157242110|NCT00848536|567633100|FG001|Overall Study|Inadequate Control of IOP|1|||
157242111|NCT00848536|567633099|FG000|Overall Study|Patient Moved|0|||
157242112|NCT00848536|567633100|FG001|Overall Study|Patient Moved|2|||
157242113|NCT04089553|567633101|FG000|Overall Study|Death|1|||
157242114|NCT04089553|567633102|FG001|Overall Study|Death|1|||
157242115|NCT04089553|567633101|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
157242116|NCT04089553|567633102|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
157242117|NCT04089553|567633101|FG000|Overall Study|Withdrawal by Subject|3|||
157242118|NCT04089553|567633102|FG001|Overall Study|Withdrawal by Subject|3|||
157242119|NCT04089553|567633101|FG000|Overall Study|Physician Decision|1|||
157242120|NCT04089553|567633102|FG001|Overall Study|Physician Decision|0|||
157242121|NCT04089553|567633101|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
157242122|NCT04089553|567633102|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
157242123|NCT04089553|567633101|FG000|Overall Study|Other|1|||
157242124|NCT04089553|567633102|FG001|Overall Study|Other|0|||
157242125|NCT04089553|567633101|FG000|Overall Study|Adverse Event|1|||
157242126|NCT04089553|567633102|FG001|Overall Study|Adverse Event|1|||
157242127|NCT01175135|567633107|FG000|Overall Study|Adverse Event|2|||
157242128|NCT01175135|567633108|FG001|Overall Study|Adverse Event|5|||
157242129|NCT01175135|567633109|FG002|Overall Study|Adverse Event|3|||
157242130|NCT01175135|567633110|FG003|Overall Study|Adverse Event|4|||
157242131|NCT01175135|567633107|FG000|Overall Study|Death|1|||
157242132|NCT01175135|567633108|FG001|Overall Study|Death|0|||
157242133|NCT01175135|567633109|FG002|Overall Study|Death|0|||
157242134|NCT01175135|567633110|FG003|Overall Study|Death|0|||
157242135|NCT01175135|567633107|FG000|Overall Study|Lack of Efficacy|4|||
157242136|NCT01175135|567633108|FG001|Overall Study|Lack of Efficacy|5|||
157242137|NCT01175135|567633109|FG002|Overall Study|Lack of Efficacy|0|||
157242138|NCT01175135|567633110|FG003|Overall Study|Lack of Efficacy|5|||
157242139|NCT01175135|567633107|FG000|Overall Study|Lost to Follow-up|1|||
157242140|NCT01175135|567633108|FG001|Overall Study|Lost to Follow-up|2|||
157242141|NCT01175135|567633109|FG002|Overall Study|Lost to Follow-up|0|||
157242142|NCT01175135|567633110|FG003|Overall Study|Lost to Follow-up|0|||
157242143|NCT01175135|567633107|FG000|Overall Study|Protocol Violation|1|||
157242144|NCT01175135|567633108|FG001|Overall Study|Protocol Violation|1|||
157242145|NCT01175135|567633109|FG002|Overall Study|Protocol Violation|0|||
157242146|NCT01175135|567633110|FG003|Overall Study|Protocol Violation|0|||
157242147|NCT01175135|567633107|FG000|Overall Study|Withdrawal by Subject|4|||
157242148|NCT01175135|567633108|FG001|Overall Study|Withdrawal by Subject|8|||
157242149|NCT01175135|567633109|FG002|Overall Study|Withdrawal by Subject|5|||
157242150|NCT01175135|567633110|FG003|Overall Study|Withdrawal by Subject|5|||
157242151|NCT01175135|567633107|FG000|Overall Study|Other|3|||
157242152|NCT01175135|567633108|FG001|Overall Study|Other|1|||
157242153|NCT01175135|567633109|FG002|Overall Study|Other|3|||
157242154|NCT01175135|567633110|FG003|Overall Study|Other|0|||
157242155|NCT01175135|567633107|FG000|Overall Study|Randomized But Not Treated|0|||
157242156|NCT01175135|567633108|FG001|Overall Study|Randomized But Not Treated|0|||
157242157|NCT01175135|567633109|FG002|Overall Study|Randomized But Not Treated|1|||
157242158|NCT01175135|567633110|FG003|Overall Study|Randomized But Not Treated|0|||
157242159|NCT01572662|567633113|FG000|Overall Study|Withdrawal by Subject|1|||
157242160|NCT01572662|567633114|FG001|Overall Study|Withdrawal by Subject|0|||
157242161|NCT01572662|567633113|FG000|Overall Study|Physician Decision|0|||
157242162|NCT01572662|567633114|FG001|Overall Study|Physician Decision|1|||
157242163|NCT03364192|567633115|FG000|Overall Study|Ineligible|10|||
157242164|NCT03364192|567633115|FG000|Overall Study|Withdrawal by Subject|5|||
157242165|NCT03364192|567633115|FG000|Overall Study|Lost to Follow-up|1|||
157242166|NCT04692155|567633118|FG000|Overall Study|Death|1|||
157242167|NCT01535222|567633119|FG000|Overall Study|Inclusion/exclusion|0|||
157242168|NCT01535222|567633120|FG001|Overall Study|Inclusion/exclusion|0|||
157242169|NCT01535222|567633121|FG002|Overall Study|Inclusion/exclusion|1|||
157242170|NCT01535222|567633122|FG003|Overall Study|Inclusion/exclusion|0|||
157242171|NCT01535222|567633123|FG004|Overall Study|Inclusion/exclusion|0|||
157242172|NCT01535222|567633124|FG005|Overall Study|Inclusion/exclusion|0|||
157242173|NCT00935012|567633127|FG000|Overall Study|Death|19|||
157242174|NCT00935012|567633127|FG000|Overall Study|Withdrawal by Subject|3|||
157242175|NCT00935012|567633127|FG000|Overall Study|Other|5|||
157242176|NCT00935012|567633127|FG000|Overall Study|Adverse Event|2|||
157242177|NCT01442155|567633128|FG000|Overall Study|Complete remission|35|||
157242178|NCT01442155|567633128|FG000|Overall Study|Recurrence|26|||
157242179|NCT01442155|567633128|FG000|Overall Study|Adverse Event|2|||
157242180|NCT01442155|567633128|FG000|Overall Study|Lost to Follow-up|2|||
157242181|NCT01590563|567633135|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
157242182|NCT02294981|567633136|FG000|Overall Study|Lost to Follow-up|1|||
157242183|NCT03214588|567633139|FG000|Overall Study|Adverse Event|1|||
157242184|NCT03214588|567633140|FG001|Overall Study|Adverse Event|0|||
157242185|NCT03214588|567633141|FG002|Overall Study|Adverse Event|2|||
157242186|NCT03214588|567633139|FG000|Overall Study|Reason Not Specified|0|||
157242187|NCT03214588|567633140|FG001|Overall Study|Reason Not Specified|1|||
157242188|NCT03214588|567633141|FG002|Overall Study|Reason Not Specified|0|||
157242189|NCT02911025|567633142|FG000|Overall Study|Lost to Follow-up|3|||
157242190|NCT03719040|567633143|FG000|Overall Study|Withdrawal by Subject|177|||
157242191|NCT03719040|567633143|FG000|Overall Study|Lost to Follow-up|26|||
157242192|NCT06647173|567633148|FG000|Overall Study|Lost to Follow-up|24|||
157242193|NCT01838681|567633149|FG000|Period A|Adverse Event|39|||
157242194|NCT01838681|567633150|FG001|Period A|Adverse Event|0|||
157242195|NCT01838681|567633151|FG002|Period A|Adverse Event|0|||
157242196|NCT01838681|567633152|FG003|Period A|Adverse Event|0|||
157242197|NCT01838681|567633149|FG000|Period A|Lack of Efficacy|21|||
157242198|NCT01838681|567633150|FG001|Period A|Lack of Efficacy|0|||
157242199|NCT01838681|567633151|FG002|Period A|Lack of Efficacy|0|||
157242200|NCT01838681|567633152|FG003|Period A|Lack of Efficacy|0|||
157242201|NCT01838681|567633149|FG000|Period A|Early response|148|||
157242202|NCT01838681|567633150|FG001|Period A|Early response|0|||
157242203|NCT01838681|567633151|FG002|Period A|Early response|0|||
157242204|NCT01838681|567633152|FG003|Period A|Early response|0|||
157242205|NCT01838681|567633149|FG000|Period A|Withdrawal by Subject|70|||
157242206|NCT01838681|567633150|FG001|Period A|Withdrawal by Subject|0|||
157242207|NCT01838681|567633151|FG002|Period A|Withdrawal by Subject|0|||
157242208|NCT01838681|567633152|FG003|Period A|Withdrawal by Subject|0|||
157242209|NCT01838681|567633149|FG000|Period A|Protocol Violation|16|||
157242210|NCT01838681|567633150|FG001|Period A|Protocol Violation|0|||
157242211|NCT01838681|567633151|FG002|Period A|Protocol Violation|0|||
157242212|NCT01838681|567633152|FG003|Period A|Protocol Violation|0|||
157242213|NCT01838681|567633149|FG000|Period A|Non-compliance with IMP|6|||
157242214|NCT01838681|567633150|FG001|Period A|Non-compliance with IMP|0|||
157242215|NCT01838681|567633151|FG002|Period A|Non-compliance with IMP|0|||
157242216|NCT01838681|567633152|FG003|Period A|Non-compliance with IMP|0|||
157242217|NCT01838681|567633149|FG000|Period A|Lost to Follow-up|4|||
157242218|NCT01838681|567633150|FG001|Period A|Lost to Follow-up|0|||
157242219|NCT01838681|567633151|FG002|Period A|Lost to Follow-up|0|||
157242220|NCT01838681|567633152|FG003|Period A|Lost to Follow-up|0|||
157242221|NCT01838681|567633149|FG000|Period A|Withdrawal before treatment|4|||
157242222|NCT01838681|567633150|FG001|Period A|Withdrawal before treatment|0|||
157242223|NCT01838681|567633151|FG002|Period A|Withdrawal before treatment|0|||
157242224|NCT01838681|567633152|FG003|Period A|Withdrawal before treatment|0|||
157242225|NCT01838681|567633149|FG000|Period A|Administrative or other reasons|17|||
157242226|NCT01838681|567633150|FG001|Period A|Administrative or other reasons|0|||
157242227|NCT01838681|567633151|FG002|Period A|Administrative or other reasons|0|||
157242228|NCT01838681|567633152|FG003|Period A|Administrative or other reasons|0|||
157242229|NCT01838681|567633149|FG000|Period B/A+|Adverse Event|0|||
157242230|NCT01838681|567633150|FG001|Period B/A+|Adverse Event|13|||
157242231|NCT01838681|567633151|FG002|Period B/A+|Adverse Event|27|||
157242232|NCT01838681|567633152|FG003|Period B/A+|Adverse Event|16|||
157242233|NCT01838681|567633149|FG000|Period B/A+|Lack of Efficacy|0|||
157242234|NCT01838681|567633150|FG001|Period B/A+|Lack of Efficacy|9|||
157242235|NCT01838681|567633151|FG002|Period B/A+|Lack of Efficacy|11|||
157242236|NCT01838681|567633152|FG003|Period B/A+|Lack of Efficacy|6|||
157091421|NCT02842827|567089105|FG005|Overall Study|Death|1|||
157242237|NCT01838681|567633149|FG000|Period B/A+|Withdrawal by Subject|0|||
157242238|NCT01838681|567633150|FG001|Period B/A+|Withdrawal by Subject|28|||
157242239|NCT01838681|567633151|FG002|Period B/A+|Withdrawal by Subject|35|||
157242240|NCT01838681|567633152|FG003|Period B/A+|Withdrawal by Subject|47|||
157242241|NCT01838681|567633149|FG000|Period B/A+|Protocol Violation|0|||
157242242|NCT01838681|567633150|FG001|Period B/A+|Protocol Violation|1|||
157242243|NCT01838681|567633151|FG002|Period B/A+|Protocol Violation|4|||
157242244|NCT01838681|567633152|FG003|Period B/A+|Protocol Violation|6|||
157242245|NCT01838681|567633149|FG000|Period B/A+|Non-compliance with IMP|0|||
157242246|NCT01838681|567633150|FG001|Period B/A+|Non-compliance with IMP|2|||
157242247|NCT01838681|567633151|FG002|Period B/A+|Non-compliance with IMP|3|||
157242248|NCT01838681|567633152|FG003|Period B/A+|Non-compliance with IMP|3|||
157242249|NCT01838681|567633149|FG000|Period B/A+|Lost to Follow-up|0|||
157197986|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197987|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197988|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197989|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197990|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
157197991|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197992|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197993|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197994|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197995|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197996|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
157197997|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157197998|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157197999|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198000|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198001|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198002|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
157198003|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198004|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198005|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198006|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198007|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198008|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
157198009|NCT00151775|567468912|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198010|NCT00151775|567468913|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198011|NCT00151775|567468914|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198012|NCT00151775|567468915|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198013|NCT00151775|567468916|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198014|NCT00151775|567468917|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198015|NCT00151775|567468918|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
157198016|NCT00151775|567468919|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198017|NCT00151775|567468920|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198018|NCT00151775|567468921|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198019|NCT00151775|567468922|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198020|NCT00151775|567468923|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
157198021|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198022|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198023|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198024|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198025|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198026|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
157198027|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198028|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198029|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198030|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198031|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198032|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
157198033|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
157198034|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
157198035|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
157198036|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
157198037|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
157198038|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
157198039|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
157198040|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
157198041|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
157198042|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
157198043|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
157198044|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
157198045|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
156863409|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
157091422|NCT02842827|567089106|FG006|Overall Study|Death|0|||
157091423|NCT02842827|567089107|FG007|Overall Study|Death|4|||
157091424|NCT02842827|567089100|FG000|Overall Study|Physician Decision|1|||
157091425|NCT02842827|567089101|FG001|Overall Study|Physician Decision|3|||
157091426|NCT02842827|567089102|FG002|Overall Study|Physician Decision|0|||
157091427|NCT02842827|567089103|FG003|Overall Study|Physician Decision|0|||
157091428|NCT02842827|567089104|FG004|Overall Study|Physician Decision|1|||
157091429|NCT02842827|567089105|FG005|Overall Study|Physician Decision|4|||
157091430|NCT02842827|567089106|FG006|Overall Study|Physician Decision|2|||
157091431|NCT02842827|567089107|FG007|Overall Study|Physician Decision|1|||
157091432|NCT02842827|567089100|FG000|Overall Study|Protocol Defined Disease Progression|0|||
157091433|NCT02842827|567089101|FG001|Overall Study|Protocol Defined Disease Progression|0|||
157091434|NCT02842827|567089102|FG002|Overall Study|Protocol Defined Disease Progression|0|||
157091435|NCT02842827|567089103|FG003|Overall Study|Protocol Defined Disease Progression|0|||
157091436|NCT02842827|567089104|FG004|Overall Study|Protocol Defined Disease Progression|0|||
157091437|NCT02842827|567089105|FG005|Overall Study|Protocol Defined Disease Progression|1|||
157091438|NCT02842827|567089106|FG006|Overall Study|Protocol Defined Disease Progression|0|||
157091439|NCT02842827|567089107|FG007|Overall Study|Protocol Defined Disease Progression|0|||
157091440|NCT02842827|567089100|FG000|Overall Study|Participant Withdrawal of Consent|1|||
157091441|NCT02842827|567089101|FG001|Overall Study|Participant Withdrawal of Consent|2|||
157091442|NCT02842827|567089102|FG002|Overall Study|Participant Withdrawal of Consent|2|||
157091443|NCT02842827|567089103|FG003|Overall Study|Participant Withdrawal of Consent|2|||
157091444|NCT02842827|567089104|FG004|Overall Study|Participant Withdrawal of Consent|2|||
157091445|NCT02842827|567089105|FG005|Overall Study|Participant Withdrawal of Consent|1|||
157091446|NCT02842827|567089106|FG006|Overall Study|Participant Withdrawal of Consent|2|||
157091447|NCT02842827|567089107|FG007|Overall Study|Participant Withdrawal of Consent|1|||
157091448|NCT00825825|567089108|FG000|First Medication Period (14 Days)|Adverse Event|1|||
157091449|NCT00825825|567089109|FG001|First Medication Period (14 Days)|Adverse Event|0|||
157091450|NCT00825825|567089110|FG002|First Medication Period (14 Days)|Adverse Event|0|||
157091451|NCT00825825|567089111|FG003|First Medication Period (14 Days)|Adverse Event|0|||
157091452|NCT00825825|567089112|FG004|First Medication Period (14 Days)|Adverse Event|0|||
157091453|NCT00825825|567089113|FG005|First Medication Period (14 Days)|Adverse Event|1|||
157091454|NCT00825825|567089108|FG000|First Medication Period (14 Days)|Physician Decision|2|||
157091455|NCT00825825|567089109|FG001|First Medication Period (14 Days)|Physician Decision|0|||
157091456|NCT00825825|567089110|FG002|First Medication Period (14 Days)|Physician Decision|1|||
157091457|NCT00825825|567089111|FG003|First Medication Period (14 Days)|Physician Decision|0|||
157091458|NCT00825825|567089112|FG004|First Medication Period (14 Days)|Physician Decision|0|||
157091459|NCT00825825|567089113|FG005|First Medication Period (14 Days)|Physician Decision|1|||
157091460|NCT00825825|567089108|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
157091461|NCT00825825|567089109|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
157091462|NCT00825825|567089110|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
157091463|NCT00825825|567089111|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
157091464|NCT00825825|567089112|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
157091465|NCT00825825|567089113|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
157091466|NCT00825825|567089108|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
157091467|NCT00825825|567089109|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
157091468|NCT00825825|567089110|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
157091469|NCT00825825|567089111|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
157091470|NCT00825825|567089112|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
157091471|NCT00825825|567089113|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
157091472|NCT00825825|567089108|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
157091473|NCT00825825|567089109|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
157091474|NCT00825825|567089110|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
157091475|NCT00825825|567089111|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
157091476|NCT00825825|567089112|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
157091477|NCT00825825|567089113|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
157091478|NCT00825825|567089108|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
157091479|NCT00825825|567089109|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
157091480|NCT00825825|567089110|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
157091481|NCT00825825|567089111|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
157198046|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198047|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198048|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198049|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157091482|NCT00825825|567089112|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
157091483|NCT00825825|567089113|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
157198050|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157242250|NCT01838681|567633150|FG001|Period B/A+|Lost to Follow-up|2|||
157242251|NCT01838681|567633151|FG002|Period B/A+|Lost to Follow-up|5|||
157242252|NCT01838681|567633152|FG003|Period B/A+|Lost to Follow-up|11|||
157242253|NCT01838681|567633149|FG000|Period B/A+|Withdrawal before treatment|0|||
157242254|NCT01838681|567633150|FG001|Period B/A+|Withdrawal before treatment|1|||
157242255|NCT01838681|567633151|FG002|Period B/A+|Withdrawal before treatment|0|||
157242256|NCT01838681|567633152|FG003|Period B/A+|Withdrawal before treatment|0|||
157242257|NCT01838681|567633149|FG000|Period B/A+|Administrative or other reasons|0|||
157242258|NCT01838681|567633150|FG001|Period B/A+|Administrative or other reasons|6|||
157242259|NCT01838681|567633151|FG002|Period B/A+|Administrative or other reasons|10|||
157242260|NCT01838681|567633152|FG003|Period B/A+|Administrative or other reasons|28|||
157242261|NCT05248204|567633153|FG000|Overall Study|Lost to Follow-up|13|||
157242262|NCT05248204|567633154|FG001|Overall Study|Lost to Follow-up|13|||
157242263|NCT05248204|567633153|FG000|Overall Study|Protocol Violation|1|||
157242264|NCT05248204|567633154|FG001|Overall Study|Protocol Violation|0|||
157198051|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
157198052|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198053|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198054|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198055|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198056|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
157198057|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198058|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198059|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
157198060|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198061|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198062|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157242265|NCT03100344|567633155|FG000|Overall Study|Adverse Event|0|||
157242266|NCT03100344|567633156|FG001|Overall Study|Adverse Event|3|||
157242267|NCT03100344|567633157|FG002|Overall Study|Adverse Event|2|||
157242268|NCT03100344|567633158|FG003|Overall Study|Adverse Event|3|||
157242269|NCT03100344|567633155|FG000|Overall Study|Lack of Efficacy|2|||
157242270|NCT03100344|567633156|FG001|Overall Study|Lack of Efficacy|0|||
157242271|NCT03100344|567633157|FG002|Overall Study|Lack of Efficacy|0|||
157242272|NCT03100344|567633158|FG003|Overall Study|Lack of Efficacy|0|||
157242273|NCT03100344|567633155|FG000|Overall Study|Protocol Violation|1|||
157242274|NCT03100344|567633156|FG001|Overall Study|Protocol Violation|0|||
157242275|NCT03100344|567633157|FG002|Overall Study|Protocol Violation|0|||
157242276|NCT03100344|567633158|FG003|Overall Study|Protocol Violation|0|||
157242277|NCT03100344|567633155|FG000|Overall Study|Withdrawal by Subject|10|||
157242278|NCT03100344|567633156|FG001|Overall Study|Withdrawal by Subject|7|||
157242279|NCT03100344|567633157|FG002|Overall Study|Withdrawal by Subject|4|||
157242280|NCT03100344|567633158|FG003|Overall Study|Withdrawal by Subject|8|||
157242281|NCT03100344|567633155|FG000|Overall Study|Lost to Follow-up|1|||
157242282|NCT03100344|567633156|FG001|Overall Study|Lost to Follow-up|1|||
157242283|NCT03100344|567633157|FG002|Overall Study|Lost to Follow-up|1|||
157242284|NCT03100344|567633158|FG003|Overall Study|Lost to Follow-up|1|||
157242285|NCT00725322|567633159|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
157242286|NCT00725322|567633160|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
157242287|NCT00725322|567633159|FG000|Washout (28 Days)|Protocol Violation|0|||
157242288|NCT00725322|567633160|FG001|Washout (28 Days)|Protocol Violation|1|||
157242289|NCT04827394|567633163|FG000|Overall Study|Physician Decision|0|||
157242290|NCT04827394|567633164|FG001|Overall Study|Physician Decision|2|||
157242291|NCT03215706|567633165|FG000|Randomization|Adverse Event unrelated to study drug|1|||
157242292|NCT03215706|567633166|FG001|Randomization|Adverse Event unrelated to study drug|0|||
157242293|NCT03215706|567633165|FG000|Randomization|participant withdrew consent|1|||
157198063|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198064|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198065|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157242294|NCT03215706|567633166|FG001|Randomization|participant withdrew consent|3|||
157198066|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198067|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157198068|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
157242295|NCT03215706|567633165|FG000|Randomization|no longer meets study criteria|1|||
157242296|NCT03215706|567633166|FG001|Randomization|no longer meets study criteria|4|||
157242297|NCT03215706|567633165|FG000|Randomization|other reasons|0|||
157242298|NCT03215706|567633166|FG001|Randomization|other reasons|2|||
157242299|NCT03215706|567633165|FG000|Treatment Period|Disease Progression|184|||
157242300|NCT03215706|567633166|FG001|Treatment Period|Disease Progression|174|||
157242301|NCT03215706|567633165|FG000|Treatment Period|Study Drug Toxicity|70|||
157242302|NCT03215706|567633166|FG001|Treatment Period|Study Drug Toxicity|24|||
157242303|NCT03215706|567633165|FG000|Treatment Period|Death|7|||
157242304|NCT03215706|567633166|FG001|Treatment Period|Death|1|||
157242305|NCT03215706|567633165|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
157198069|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198070|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198071|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
157198072|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198073|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198074|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198075|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198076|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198077|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198078|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198079|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198080|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
157198081|NCT00151775|567468912|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198082|NCT00151775|567468913|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198083|NCT00151775|567468914|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198084|NCT00151775|567468915|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198085|NCT00151775|567468916|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198086|NCT00151775|567468917|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198087|NCT00151775|567468918|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198088|NCT00151775|567468919|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198089|NCT00151775|567468920|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198090|NCT00151775|567468921|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198091|NCT00151775|567468922|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
157198092|NCT00151775|567468923|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
157198093|NCT00151775|567468912|FG000|Period 4: Open Label|Increased blood pressure|0|||
157198094|NCT00151775|567468913|FG001|Period 4: Open Label|Increased blood pressure|0|||
157198095|NCT00151775|567468914|FG002|Period 4: Open Label|Increased blood pressure|0|||
157198096|NCT00151775|567468915|FG003|Period 4: Open Label|Increased blood pressure|0|||
157198097|NCT00151775|567468916|FG004|Period 4: Open Label|Increased blood pressure|1|||
157198098|NCT00151775|567468917|FG005|Period 4: Open Label|Increased blood pressure|0|||
157198099|NCT00151775|567468918|FG006|Period 4: Open Label|Increased blood pressure|0|||
157198100|NCT00151775|567468919|FG007|Period 4: Open Label|Increased blood pressure|0|||
157198101|NCT00151775|567468920|FG008|Period 4: Open Label|Increased blood pressure|0|||
157198102|NCT00151775|567468921|FG009|Period 4: Open Label|Increased blood pressure|1|||
157198103|NCT00151775|567468922|FG010|Period 4: Open Label|Increased blood pressure|0|||
157198104|NCT00151775|567468923|FG011|Period 4: Open Label|Increased blood pressure|0|||
157198105|NCT00151775|567468912|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
157198106|NCT00151775|567468913|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
157198107|NCT00151775|567468914|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
157198108|NCT00151775|567468915|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
157198109|NCT00151775|567468916|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
157198110|NCT00151775|567468917|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
157198111|NCT00151775|567468918|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
157198112|NCT00151775|567468919|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
157198113|NCT00151775|567468920|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
157198114|NCT00151775|567468921|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
157198115|NCT00151775|567468922|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
157198116|NCT00151775|567468923|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
157198117|NCT00151775|567468912|FG000|Period 4: Open Label|Adverse Event|0|||
157198118|NCT00151775|567468913|FG001|Period 4: Open Label|Adverse Event|0|||
157198119|NCT00151775|567468914|FG002|Period 4: Open Label|Adverse Event|0|||
157198120|NCT00151775|567468915|FG003|Period 4: Open Label|Adverse Event|0|||
157198121|NCT00151775|567468916|FG004|Period 4: Open Label|Adverse Event|1|||
157198122|NCT00151775|567468917|FG005|Period 4: Open Label|Adverse Event|0|||
157198123|NCT00151775|567468918|FG006|Period 4: Open Label|Adverse Event|0|||
157198124|NCT00151775|567468919|FG007|Period 4: Open Label|Adverse Event|0|||
157198125|NCT00151775|567468920|FG008|Period 4: Open Label|Adverse Event|0|||
157198126|NCT00151775|567468921|FG009|Period 4: Open Label|Adverse Event|2|||
157198127|NCT00151775|567468922|FG010|Period 4: Open Label|Adverse Event|0|||
157198128|NCT00151775|567468923|FG011|Period 4: Open Label|Adverse Event|0|||
157198129|NCT00151775|567468912|FG000|Period 4: Open Label|Lost to Follow-up|0|||
157198130|NCT00151775|567468913|FG001|Period 4: Open Label|Lost to Follow-up|0|||
157198131|NCT00151775|567468914|FG002|Period 4: Open Label|Lost to Follow-up|0|||
157198132|NCT00151775|567468915|FG003|Period 4: Open Label|Lost to Follow-up|0|||
157198133|NCT00151775|567468916|FG004|Period 4: Open Label|Lost to Follow-up|17|||
157198134|NCT00151775|567468917|FG005|Period 4: Open Label|Lost to Follow-up|0|||
157198135|NCT00151775|567468918|FG006|Period 4: Open Label|Lost to Follow-up|0|||
157198136|NCT00151775|567468919|FG007|Period 4: Open Label|Lost to Follow-up|0|||
157198137|NCT00151775|567468920|FG008|Period 4: Open Label|Lost to Follow-up|0|||
157198138|NCT00151775|567468921|FG009|Period 4: Open Label|Lost to Follow-up|7|||
157198139|NCT00151775|567468922|FG010|Period 4: Open Label|Lost to Follow-up|0|||
157198140|NCT00151775|567468923|FG011|Period 4: Open Label|Lost to Follow-up|0|||
157198141|NCT00151775|567468912|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
157198142|NCT00151775|567468913|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
157198143|NCT00151775|567468914|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
157198144|NCT00151775|567468915|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
157198145|NCT00151775|567468916|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
157198146|NCT00151775|567468917|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
157198147|NCT00151775|567468918|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
157198148|NCT00151775|567468919|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
157198149|NCT00151775|567468920|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
157198150|NCT00151775|567468921|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
157198151|NCT00151775|567468922|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
157198152|NCT00151775|567468923|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
157198153|NCT00151775|567468912|FG000|Period 4: Open Label|Other|0|||
157198154|NCT00151775|567468913|FG001|Period 4: Open Label|Other|0|||
157198155|NCT00151775|567468914|FG002|Period 4: Open Label|Other|0|||
157198156|NCT00151775|567468915|FG003|Period 4: Open Label|Other|0|||
157198157|NCT00151775|567468916|FG004|Period 4: Open Label|Other|1|||
157198158|NCT00151775|567468917|FG005|Period 4: Open Label|Other|0|||
157198159|NCT00151775|567468918|FG006|Period 4: Open Label|Other|0|||
157198160|NCT00151775|567468919|FG007|Period 4: Open Label|Other|0|||
157198161|NCT00151775|567468920|FG008|Period 4: Open Label|Other|0|||
157198162|NCT00151775|567468921|FG009|Period 4: Open Label|Other|3|||
157198163|NCT00151775|567468922|FG010|Period 4: Open Label|Other|0|||
157198164|NCT00151775|567468923|FG011|Period 4: Open Label|Other|0|||
157198165|NCT00151775|567468912|FG000|Period 4: Open Label|Physician Decision|0|||
157198166|NCT00151775|567468913|FG001|Period 4: Open Label|Physician Decision|0|||
157198167|NCT00151775|567468914|FG002|Period 4: Open Label|Physician Decision|0|||
157198168|NCT00151775|567468915|FG003|Period 4: Open Label|Physician Decision|0|||
157198169|NCT00151775|567468916|FG004|Period 4: Open Label|Physician Decision|0|||
157198170|NCT00151775|567468917|FG005|Period 4: Open Label|Physician Decision|0|||
157198171|NCT00151775|567468918|FG006|Period 4: Open Label|Physician Decision|0|||
157198172|NCT00151775|567468919|FG007|Period 4: Open Label|Physician Decision|0|||
157198173|NCT00151775|567468920|FG008|Period 4: Open Label|Physician Decision|0|||
157198174|NCT00151775|567468921|FG009|Period 4: Open Label|Physician Decision|2|||
157198175|NCT00151775|567468922|FG010|Period 4: Open Label|Physician Decision|0|||
157198176|NCT00151775|567468923|FG011|Period 4: Open Label|Physician Decision|0|||
157198177|NCT00151775|567468912|FG000|Period 4: Open Label|Protocol Violation|0|||
157198178|NCT00151775|567468913|FG001|Period 4: Open Label|Protocol Violation|0|||
157198179|NCT00151775|567468914|FG002|Period 4: Open Label|Protocol Violation|0|||
157198180|NCT00151775|567468915|FG003|Period 4: Open Label|Protocol Violation|0|||
157198181|NCT00151775|567468916|FG004|Period 4: Open Label|Protocol Violation|1|||
157198182|NCT00151775|567468917|FG005|Period 4: Open Label|Protocol Violation|0|||
157198183|NCT00151775|567468918|FG006|Period 4: Open Label|Protocol Violation|0|||
157198184|NCT00151775|567468919|FG007|Period 4: Open Label|Protocol Violation|0|||
157198185|NCT00151775|567468920|FG008|Period 4: Open Label|Protocol Violation|0|||
157198186|NCT00151775|567468921|FG009|Period 4: Open Label|Protocol Violation|0|||
157198187|NCT00151775|567468922|FG010|Period 4: Open Label|Protocol Violation|0|||
157198188|NCT00151775|567468923|FG011|Period 4: Open Label|Protocol Violation|0|||
157198189|NCT00247416|567468924|FG000|Overall Study|3 patients were found to be ineligible|1|||
157198190|NCT00247416|567468925|FG001|Overall Study|3 patients were found to be ineligible|2|||
157198191|NCT00474994|567468934|FG000|Overall Study|Patient Not treated|1|||
157198192|NCT00474994|567468934|FG000|Overall Study|Patient evaluable for toxicity only|3|||
157198193|NCT00474994|567468934|FG000|Overall Study|Patient found to be ineligible|1|||
157198194|NCT02660489|567468935|FG000|Overall Study|Lost to Follow-up|1|||
157198195|NCT02660489|567468936|FG001|Overall Study|Lost to Follow-up|1|||
157198196|NCT02660489|567468935|FG000|Overall Study|Adverse Event|1|||
157198197|NCT02660489|567468936|FG001|Overall Study|Adverse Event|3|||
157198198|NCT02660489|567468935|FG000|Overall Study|no rhinovirus infection|4|||
157198199|NCT02660489|567468936|FG001|Overall Study|no rhinovirus infection|4|||
157198200|NCT02322866|567468937|FG000|Overall Study|Adverse Event|6|||
157198201|NCT02322866|567468938|FG001|Overall Study|Adverse Event|11|||
157198202|NCT02322866|567468937|FG000|Overall Study|Withdrawal of Consent|16|||
157198203|NCT02322866|567468938|FG001|Overall Study|Withdrawal of Consent|25|||
157198204|NCT02322866|567468937|FG000|Overall Study|Lost to Follow-up|36|||
157198205|NCT02322866|567468938|FG001|Overall Study|Lost to Follow-up|39|||
157198206|NCT02322866|567468937|FG000|Overall Study|Protocol Violation|1|||
157198207|NCT02322866|567468938|FG001|Overall Study|Protocol Violation|0|||
157198208|NCT02322866|567468937|FG000|Overall Study|Noncompliance with Treatment|3|||
157198209|NCT02322866|567468938|FG001|Overall Study|Noncompliance with Treatment|4|||
157198210|NCT02322866|567468937|FG000|Overall Study|Lack of Efficacy|3|||
157198211|NCT02322866|567468938|FG001|Overall Study|Lack of Efficacy|1|||
157198212|NCT02322866|567468937|FG000|Overall Study|Other Miscellaneous Reasons|6|||
157198213|NCT02322866|567468938|FG001|Overall Study|Other Miscellaneous Reasons|6|||
157198214|NCT03735680|567468939|FG000|Overall Study|Withdrawal by Subject|0|||
157198215|NCT03735680|567468940|FG001|Overall Study|Withdrawal by Subject|1|||
157198216|NCT03735680|567468941|FG002|Overall Study|Withdrawal by Subject|0|||
157198217|NCT03735680|567468942|FG003|Overall Study|Withdrawal by Subject|0|||
157198218|NCT03735680|567468943|FG004|Overall Study|Withdrawal by Subject|0|||
157198219|NCT03735680|567468944|FG005|Overall Study|Withdrawal by Subject|1|||
157198220|NCT03735680|567468939|FG000|Overall Study|Patient unable or unwilling to continue|0|||
157198221|NCT03735680|567468940|FG001|Overall Study|Patient unable or unwilling to continue|0|||
157198222|NCT03735680|567468941|FG002|Overall Study|Patient unable or unwilling to continue|1|||
157198223|NCT03735680|567468942|FG003|Overall Study|Patient unable or unwilling to continue|0|||
157198224|NCT03735680|567468943|FG004|Overall Study|Patient unable or unwilling to continue|0|||
157198225|NCT03735680|567468944|FG005|Overall Study|Patient unable or unwilling to continue|0|||
157198226|NCT00761761|567468952|FG000|Overall Study|Lost to Follow-up|3|||
157198227|NCT00761761|567468953|FG001|Overall Study|Lost to Follow-up|1|||
157198228|NCT00761761|567468952|FG000|Overall Study|Withdrawal by Subject|3|||
157198229|NCT00761761|567468953|FG001|Overall Study|Withdrawal by Subject|0|||
157198230|NCT05064436|567468958|FG000|Overall Study|Other Reasons|1|||
157198231|NCT05064436|567468959|FG001|Overall Study|Other Reasons|0|||
157198232|NCT01711736|567468960|FG000|Overall Study|Lost to Follow-up|4|||
157198233|NCT01711736|567468961|FG001|Overall Study|Lost to Follow-up|1|||
157198234|NCT01711736|567468960|FG000|Overall Study|Withdrawal by Subject|6|||
157198235|NCT01711736|567468961|FG001|Overall Study|Withdrawal by Subject|6|||
157198236|NCT01711736|567468960|FG000|Overall Study|Migrated/moved from study area|2|||
157198237|NCT01711736|567468961|FG001|Overall Study|Migrated/moved from study area|1|||
157198238|NCT02706327|567468962|FG000|Overall Study|Lost to Follow-up|1|||
157198239|NCT02706327|567468963|FG001|Overall Study|Lost to Follow-up|1|||
157198240|NCT02706327|567468964|FG002|Overall Study|Lost to Follow-up|2|||
157198241|NCT05450198|567468965|FG000|Overall Study|Withdrawal by Subject|1|||
157198242|NCT05450198|567468966|FG001|Overall Study|Withdrawal by Subject|1|||
157198243|NCT05450198|567468967|FG002|Overall Study|Withdrawal by Subject|2|||
157198244|NCT05450198|567468968|FG003|Overall Study|Withdrawal by Subject|0|||
157198245|NCT05450198|567468965|FG000|Overall Study|Lost to Follow-up|1|||
157198246|NCT05450198|567468966|FG001|Overall Study|Lost to Follow-up|0|||
157198247|NCT05450198|567468967|FG002|Overall Study|Lost to Follow-up|2|||
157198248|NCT05450198|567468968|FG003|Overall Study|Lost to Follow-up|1|||
157198249|NCT01224171|567468974|FG000|Overall Study|Adverse Event|8|||
157198250|NCT01224171|567468975|FG001|Overall Study|Adverse Event|4|||
157198251|NCT01224171|567468974|FG000|Overall Study|Protocol Violation|0|||
157198252|NCT01224171|567468975|FG001|Overall Study|Protocol Violation|1|||
157198253|NCT01224171|567468974|FG000|Overall Study|Lack of Efficacy|5|||
157198254|NCT01224171|567468975|FG001|Overall Study|Lack of Efficacy|1|||
157198255|NCT01224171|567468974|FG000|Overall Study|Withdrawal of Consent|2|||
157198256|NCT01224171|567468975|FG001|Overall Study|Withdrawal of Consent|4|||
157198257|NCT01224171|567468974|FG000|Overall Study|Lost to Follow-up|0|||
157198258|NCT01224171|567468975|FG001|Overall Study|Lost to Follow-up|3|||
157198259|NCT01097057|567468976|FG000|Overall Study|Physician Decision|3|||
157198260|NCT01270139|567468977|FG000|Overall Study|Adverse Event|8|||
157198261|NCT01270139|567468978|FG001|Overall Study|Adverse Event|17|||
157198262|NCT01270139|567468979|FG002|Overall Study|Adverse Event|18|||
157198263|NCT01270139|567468977|FG000|Overall Study|Lost to Follow-up|10|||
157198264|NCT01270139|567468978|FG001|Overall Study|Lost to Follow-up|9|||
157198265|NCT01270139|567468979|FG002|Overall Study|Lost to Follow-up|2|||
157198266|NCT02213666|567468989|FG000|Overall Study|Withdrawal by Subject|1|||
157198267|NCT05602818|567468990|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
157198268|NCT05602818|567468991|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
157198269|NCT05602818|567468992|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
157198270|NCT05602818|567468993|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
157198271|NCT05602818|567468994|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
157198272|NCT05602818|567468995|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
157198273|NCT05602818|567468996|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
157198274|NCT05602818|567468997|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
157198275|NCT05602818|567468998|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
157198276|NCT05602818|567468999|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
157198277|NCT05602818|567469000|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
157198278|NCT05602818|567469001|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
157198279|NCT05602818|567468990|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
157198280|NCT05602818|567468991|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
157198281|NCT05602818|567468992|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198282|NCT05602818|567468993|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198283|NCT05602818|567468994|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198284|NCT05602818|567468995|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198285|NCT05602818|567468996|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198286|NCT05602818|567468997|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198287|NCT05602818|567468998|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157242306|NCT03215706|567633166|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
157242307|NCT03215706|567633165|FG000|Treatment Period|Request to D/C treatment|2|||
157242308|NCT03215706|567633166|FG001|Treatment Period|Request to D/C treatment|10|||
157242309|NCT03215706|567633165|FG000|Treatment Period|Participant withdrew consent|4|||
157242310|NCT03215706|567633166|FG001|Treatment Period|Participant withdrew consent|5|||
157242311|NCT03215706|567633165|FG000|Treatment Period|Lost to Follow-up|0|||
157242312|NCT03215706|567633166|FG001|Treatment Period|Lost to Follow-up|1|||
157242313|NCT03215706|567633165|FG000|Treatment Period|Administrative reason by sponsor|0|||
157242314|NCT03215706|567633166|FG001|Treatment Period|Administrative reason by sponsor|2|||
157242315|NCT03215706|567633165|FG000|Treatment Period|other reasons|10|||
157242316|NCT03215706|567633166|FG001|Treatment Period|other reasons|5|||
157242317|NCT03215706|567633165|FG000|Treatment Period|Not reported|1|||
157242318|NCT03215706|567633166|FG001|Treatment Period|Not reported|0|||
157242319|NCT00640341|567634618|FG000|Overall Study|Adverse Event|0|||
157242320|NCT00640341|567634619|FG001|Overall Study|Adverse Event|0|||
157242321|NCT00640341|567634620|FG002|Overall Study|Adverse Event|1|||
157242322|NCT00640341|567634618|FG000|Overall Study|Positive Slit Lamp Findings|0|||
157242323|NCT00640341|567634619|FG001|Overall Study|Positive Slit Lamp Findings|0|||
157242324|NCT00640341|567634620|FG002|Overall Study|Positive Slit Lamp Findings|1|||
157242325|NCT00640341|567634618|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
157242326|NCT00640341|567634619|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
157242327|NCT00640341|567634620|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
157242328|NCT00640341|567634618|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
157242329|NCT00640341|567634619|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
157242330|NCT00640341|567634620|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
157242331|NCT00640341|567634618|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
157242332|NCT00640341|567634619|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
157242333|NCT00640341|567634620|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
157242334|NCT00640341|567634618|FG000|Overall Study|Lost to Follow-up|2|||
157242335|NCT00640341|567634619|FG001|Overall Study|Lost to Follow-up|0|||
157242336|NCT00640341|567634620|FG002|Overall Study|Lost to Follow-up|0|||
157242337|NCT00640341|567634618|FG000|Overall Study|Withdrawal by Subject|4|||
157242338|NCT00640341|567634619|FG001|Overall Study|Withdrawal by Subject|0|||
157242339|NCT00640341|567634620|FG002|Overall Study|Withdrawal by Subject|1|||
157242340|NCT00640341|567634618|FG000|Overall Study|Unacceptable Lens Movement|1|||
157242341|NCT00640341|567634619|FG001|Overall Study|Unacceptable Lens Movement|0|||
157242342|NCT00640341|567634620|FG002|Overall Study|Unacceptable Lens Movement|0|||
157242343|NCT00640341|567634618|FG000|Overall Study|Poor fit/Uncomfortable|4|||
157242344|NCT00640341|567634619|FG001|Overall Study|Poor fit/Uncomfortable|0|||
157242345|NCT00640341|567634620|FG002|Overall Study|Poor fit/Uncomfortable|0|||
157242346|NCT00640341|567634618|FG000|Overall Study|Ineligable at Baseline|5|||
157242347|NCT00640341|567634619|FG001|Overall Study|Ineligable at Baseline|3|||
157242348|NCT00640341|567634620|FG002|Overall Study|Ineligable at Baseline|2|||
157242349|NCT00640341|567634618|FG000|Overall Study|Adverse event and positive slit lamp|1|||
157242350|NCT00640341|567634619|FG001|Overall Study|Adverse event and positive slit lamp|0|||
157242351|NCT00640341|567634620|FG002|Overall Study|Adverse event and positive slit lamp|0|||
157242352|NCT03578809|567634621|FG000|Overall Study|Death|0|||
157242353|NCT03578809|567634622|FG001|Overall Study|Death|2|||
157242354|NCT03578809|567634623|FG002|Overall Study|Death|0|||
157242355|NCT03578809|567634624|FG003|Overall Study|Death|1|||
157242356|NCT03578809|567634621|FG000|Overall Study|Lost to Follow-up|0|||
157242357|NCT03578809|567634622|FG001|Overall Study|Lost to Follow-up|1|||
157242358|NCT03578809|567634623|FG002|Overall Study|Lost to Follow-up|0|||
157242359|NCT03578809|567634624|FG003|Overall Study|Lost to Follow-up|0|||
157242360|NCT03578809|567634621|FG000|Overall Study|Withdrawal by Subject|3|||
157242361|NCT03578809|567634622|FG001|Overall Study|Withdrawal by Subject|5|||
157242362|NCT03578809|567634623|FG002|Overall Study|Withdrawal by Subject|2|||
157242363|NCT03578809|567634624|FG003|Overall Study|Withdrawal by Subject|0|||
157242364|NCT03578809|567634621|FG000|Overall Study|Other|3|||
157242365|NCT03578809|567634622|FG001|Overall Study|Other|6|||
157242366|NCT03578809|567634623|FG002|Overall Study|Other|2|||
157242367|NCT03578809|567634624|FG003|Overall Study|Other|8|||
157242368|NCT01541215|567634627|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
157242369|NCT01541215|567634628|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
157242370|NCT01541215|567634627|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
157242371|NCT01541215|567634628|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
157242372|NCT01541215|567634627|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
157242373|NCT01541215|567634628|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
157242374|NCT01541215|567634627|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
157242375|NCT01541215|567634628|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
157242376|NCT01541215|567634627|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
157242377|NCT01541215|567634628|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
157242378|NCT01541215|567634627|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
157242379|NCT01541215|567634628|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
157242380|NCT00830258|567634629|FG000|First Intervention|Adverse Event|1|||
157242381|NCT00830258|567634630|FG001|First Intervention|Adverse Event|0|||
157242382|NCT00830258|567634629|FG000|Washout: 7 Days|Protocol Violation|1|||
157242383|NCT00830258|567634630|FG001|Washout: 7 Days|Protocol Violation|0|||
157242384|NCT03599193|567634631|FG000|Overall Study|Adverse Event|0|||
157242385|NCT03599193|567634632|FG001|Overall Study|Adverse Event|2|||
157242386|NCT03599193|567634631|FG000|Overall Study|Withdrawal by Subject|1|||
157242387|NCT03599193|567634632|FG001|Overall Study|Withdrawal by Subject|0|||
157242388|NCT03599193|567634631|FG000|Overall Study|Protocol Violation|1|||
157242389|NCT03599193|567634632|FG001|Overall Study|Protocol Violation|0|||
157242390|NCT03599193|567634631|FG000|Overall Study|Lost to Follow-up|0|||
157242391|NCT03599193|567634632|FG001|Overall Study|Lost to Follow-up|1|||
157242392|NCT00798603|567634633|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
157242393|NCT00798603|567634633|FG000|Overall Study|Withdrawal by Subject|10|||
157242394|NCT00798603|567634633|FG000|Overall Study|Adverse Event|22|||
157242395|NCT00798603|567634633|FG000|Overall Study|Physician Decision|1|||
157242396|NCT00798603|567634633|FG000|Overall Study|Lack of insurance coverage|1|||
157242397|NCT00835705|567634634|FG000|First Intervention|Difficulty with vein|1|||
157242398|NCT00835705|567634635|FG001|First Intervention|Difficulty with vein|0|||
157242399|NCT00835705|567634634|FG000|Second Intervention|Difficulty with vein|1|||
157242400|NCT00835705|567634635|FG001|Second Intervention|Difficulty with vein|0|||
157242401|NCT01116739|567634638|FG000|Overall Study|Child had 2 years of HS|110|||
157242402|NCT01116739|567634639|FG001|Overall Study|Child had 2 years of HS|128|||
157242403|NCT01116739|567634638|FG000|Overall Study|Withdrawal by Subject|6|||
157242404|NCT01116739|567634639|FG001|Overall Study|Withdrawal by Subject|0|||
157242405|NCT01116739|567634638|FG000|Overall Study|child too young|2|||
157242406|NCT01116739|567634639|FG001|Overall Study|child too young|6|||
157242407|NCT01116739|567634638|FG000|Overall Study|child not enrolled in head start|10|||
157242408|NCT01116739|567634639|FG001|Overall Study|child not enrolled in head start|2|||
157242409|NCT01116739|567634638|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
157242410|NCT01116739|567634639|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
157242411|NCT05511935|567634640|FG000|Overall Study|Lost to Follow-up|9|||
157242412|NCT05511935|567634641|FG001|Overall Study|Lost to Follow-up|27|||
157242413|NCT05090839|567634642|FG000|Overall Study|Lost to Follow-up|2|||
157242414|NCT05090839|567634643|FG001|Overall Study|Lost to Follow-up|3|||
157242415|NCT05090839|567634644|FG002|Overall Study|Lost to Follow-up|1|||
157198288|NCT05602818|567468999|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198289|NCT05602818|567469000|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198290|NCT05602818|567469001|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
157198291|NCT05602818|567468990|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
157198292|NCT05602818|567468991|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198293|NCT05602818|567468992|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198294|NCT05602818|567468993|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198295|NCT05602818|567468994|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198296|NCT05602818|567468995|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198297|NCT05602818|567468996|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198298|NCT05602818|567468997|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198299|NCT05602818|567468998|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198300|NCT05602818|567468999|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198301|NCT05602818|567469000|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198302|NCT05602818|567469001|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
157198303|NCT05602818|567468990|FG000|Qualification Phase (3 Days)|Other|1|||
157198304|NCT05602818|567468991|FG001|Qualification Phase (3 Days)|Other|0|||
157198305|NCT05602818|567468992|FG002|Qualification Phase (3 Days)|Other|0|||
157198306|NCT05602818|567468993|FG003|Qualification Phase (3 Days)|Other|0|||
157198307|NCT05602818|567468994|FG004|Qualification Phase (3 Days)|Other|0|||
157198308|NCT05602818|567468995|FG005|Qualification Phase (3 Days)|Other|0|||
157198309|NCT05602818|567468996|FG006|Qualification Phase (3 Days)|Other|0|||
157198310|NCT05602818|567468997|FG007|Qualification Phase (3 Days)|Other|0|||
157198311|NCT05602818|567468998|FG008|Qualification Phase (3 Days)|Other|0|||
157198312|NCT05602818|567468999|FG009|Qualification Phase (3 Days)|Other|0|||
157198313|NCT05602818|567469000|FG010|Qualification Phase (3 Days)|Other|0|||
157198314|NCT05602818|567469001|FG011|Qualification Phase (3 Days)|Other|0|||
157198315|NCT05602818|567468990|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198316|NCT05602818|567468991|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
157198317|NCT05602818|567468992|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198318|NCT05602818|567468993|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198319|NCT05602818|567468994|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198320|NCT05602818|567468995|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198321|NCT05602818|567468996|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198322|NCT05602818|567468997|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198323|NCT05602818|567468998|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157242416|NCT05090839|567634645|FG003|Overall Study|Lost to Follow-up|1|||
157242417|NCT04406194|567634646|FG000|Period 1|Withdrawal by Subject|0|||
157242418|NCT04406194|567634647|FG001|Period 1|Withdrawal by Subject|1|||
157242419|NCT04102345|567634648|FG000|Overall Study|Withdrawal by Subject|1|||
157242420|NCT04102345|567634649|FG001|Overall Study|Withdrawal by Subject|0|||
157242421|NCT03499353|567634650|FG000|Treatment|Adverse Event|3|||
157242422|NCT03499353|567634650|FG000|Treatment|Progressive Disease|10|||
157242423|NCT03499353|567634650|FG000|Treatment|Other|1|||
157242424|NCT03499353|567634650|FG000|Treatment|Withdrawal by Subject|2|||
157242425|NCT03499353|567634650|FG000|Long-Term Follow-up|Death|2|||
157242426|NCT03499353|567634650|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
157242427|NCT03499353|567634650|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
157242428|NCT01015287|567634651|FG000|Overall Study|Death|21|||
157242429|NCT01015287|567634652|FG001|Overall Study|Death|16|||
157242430|NCT01015287|567634651|FG000|Overall Study|Adverse Event|1|||
157242431|NCT01015287|567634652|FG001|Overall Study|Adverse Event|0|||
157242432|NCT01015287|567634651|FG000|Overall Study|Sponsor Decision|3|||
157242433|NCT01015287|567634652|FG001|Overall Study|Sponsor Decision|7|||
157242434|NCT01015287|567634651|FG000|Overall Study|Physician Decision|19|||
157242435|NCT01015287|567634652|FG001|Overall Study|Physician Decision|21|||
157242436|NCT01015287|567634651|FG000|Overall Study|Withdrawal by Subject|14|||
157242437|NCT01015287|567634652|FG001|Overall Study|Withdrawal by Subject|19|||
157242438|NCT01015287|567634651|FG000|Overall Study|Entry Criteria not Met|11|||
157242439|NCT01015287|567634652|FG001|Overall Study|Entry Criteria not Met|14|||
157242440|NCT01015287|567634651|FG000|Overall Study|Lost to Follow-up|2|||
157242441|NCT01015287|567634652|FG001|Overall Study|Lost to Follow-up|1|||
157242442|NCT01015287|567634651|FG000|Overall Study|Protocol Violation|1|||
157242443|NCT01015287|567634652|FG001|Overall Study|Protocol Violation|1|||
157242444|NCT01592240|567634653|FG000|Overall Study|Adverse Event|1|||
157242445|NCT01592240|567634654|FG001|Overall Study|Adverse Event|0|||
157242446|NCT01592240|567634655|FG002|Overall Study|Adverse Event|0|||
157242447|NCT01592240|567634656|FG003|Overall Study|Adverse Event|1|||
157242448|NCT01592240|567634657|FG004|Overall Study|Adverse Event|1|||
157242449|NCT01592240|567634658|FG005|Overall Study|Adverse Event|0|||
157242450|NCT01592240|567634659|FG006|Overall Study|Adverse Event|0|||
157242451|NCT01592240|567634653|FG000|Overall Study|Death|0|||
157242452|NCT01592240|567634654|FG001|Overall Study|Death|1|||
157242453|NCT01592240|567634655|FG002|Overall Study|Death|0|||
157242454|NCT01592240|567634656|FG003|Overall Study|Death|0|||
157242455|NCT01592240|567634657|FG004|Overall Study|Death|0|||
157242456|NCT01592240|567634658|FG005|Overall Study|Death|0|||
157242457|NCT01592240|567634659|FG006|Overall Study|Death|0|||
157242458|NCT01592240|567634653|FG000|Overall Study|Lost to Follow-up|1|||
157242459|NCT01592240|567634654|FG001|Overall Study|Lost to Follow-up|3|||
157242460|NCT01592240|567634655|FG002|Overall Study|Lost to Follow-up|1|||
157242461|NCT01592240|567634656|FG003|Overall Study|Lost to Follow-up|0|||
157242462|NCT01592240|567634657|FG004|Overall Study|Lost to Follow-up|3|||
157242463|NCT01592240|567634658|FG005|Overall Study|Lost to Follow-up|2|||
157242464|NCT01592240|567634659|FG006|Overall Study|Lost to Follow-up|0|||
157242465|NCT01592240|567634653|FG000|Overall Study|Protocol Violation|0|||
157242466|NCT01592240|567634654|FG001|Overall Study|Protocol Violation|0|||
157198324|NCT05602818|567468999|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198325|NCT05602818|567469000|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198326|NCT05602818|567469001|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
157198327|NCT05602818|567468990|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
157198328|NCT05602818|567468991|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
157198329|NCT05602818|567468992|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
157198330|NCT05602818|567468993|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
157198331|NCT05602818|567468994|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
157198332|NCT05602818|567468995|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
157198333|NCT05602818|567468996|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
157198334|NCT05602818|567468997|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
157242467|NCT01592240|567634655|FG002|Overall Study|Protocol Violation|0|||
157242468|NCT01592240|567634656|FG003|Overall Study|Protocol Violation|0|||
157242469|NCT01592240|567634657|FG004|Overall Study|Protocol Violation|0|||
157242470|NCT01592240|567634658|FG005|Overall Study|Protocol Violation|1|||
157242471|NCT01592240|567634659|FG006|Overall Study|Protocol Violation|0|||
157242472|NCT01592240|567634653|FG000|Overall Study|Withdrawal by Subject|0|||
157242473|NCT01592240|567634654|FG001|Overall Study|Withdrawal by Subject|4|||
157242474|NCT01592240|567634655|FG002|Overall Study|Withdrawal by Subject|4|||
157242475|NCT01592240|567634656|FG003|Overall Study|Withdrawal by Subject|1|||
157242476|NCT01592240|567634657|FG004|Overall Study|Withdrawal by Subject|3|||
157242477|NCT01592240|567634658|FG005|Overall Study|Withdrawal by Subject|0|||
157242478|NCT01592240|567634659|FG006|Overall Study|Withdrawal by Subject|2|||
157242479|NCT01592240|567634653|FG000|Overall Study|Other|0|||
157242480|NCT01592240|567634654|FG001|Overall Study|Other|3|||
157242481|NCT01592240|567634655|FG002|Overall Study|Other|1|||
157242482|NCT01592240|567634656|FG003|Overall Study|Other|1|||
157242483|NCT01592240|567634657|FG004|Overall Study|Other|0|||
157242484|NCT01592240|567634658|FG005|Overall Study|Other|0|||
157242485|NCT01592240|567634659|FG006|Overall Study|Other|1|||
157242486|NCT01592240|567634653|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
157242487|NCT01592240|567634654|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
157242488|NCT01592240|567634655|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
157242489|NCT01592240|567634656|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
157242490|NCT01592240|567634657|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
157242491|NCT01592240|567634658|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
157242492|NCT01592240|567634659|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
157242493|NCT01205035|567634660|FG000|Overall Study|Withdrawal by Subject|1|||
157242494|NCT01205035|567634661|FG001|Overall Study|Withdrawal by Subject|0|||
157242495|NCT01205035|567634660|FG000|Overall Study|Physician Decision|1|||
157242496|NCT01205035|567634661|FG001|Overall Study|Physician Decision|0|||
157242497|NCT02451696|567634662|FG000|Overall Study|Surgery postponed|1|||
157242498|NCT02451696|567634663|FG001|Overall Study|Surgery postponed|0|||
157242499|NCT01557751|567634664|FG000|Overall Study|Physician Decision|3|||
157242500|NCT04590027|567634665|FG000|Overall Study|Lost to Follow-up|17|||
157242501|NCT04590027|567634666|FG001|Overall Study|Lost to Follow-up|14|||
157242502|NCT04590027|567634665|FG000|Overall Study|Protocol Violation|0|||
157242503|NCT04590027|567634666|FG001|Overall Study|Protocol Violation|3|||
157242504|NCT03276754|567634667|FG000|Overall Study|Withdrawal of informed consent|4|||
157242505|NCT03276754|567634667|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
157242506|NCT03276754|567634667|FG000|Overall Study|Lost to Follow-up|27|||
157242507|NCT03276754|567634667|FG000|Overall Study|No data reported at Month 24|31|||
157242508|NCT03276754|567634667|FG000|Overall Study|Death|39|||
157242509|NCT04547192|567634668|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
157242510|NCT04547192|567634669|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
157242511|NCT04547192|567634670|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
157242512|NCT04547192|567634671|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
157242513|NCT04547192|567634668|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
157242514|NCT04547192|567634669|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
157242515|NCT04547192|567634670|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
157242516|NCT04547192|567634671|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
157242517|NCT04547192|567634668|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
157242518|NCT04547192|567634669|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
157242519|NCT04547192|567634670|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
157242520|NCT04547192|567634671|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
157242521|NCT04547192|567634668|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
157242522|NCT04547192|567634669|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
157242523|NCT04547192|567634670|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
157242524|NCT04547192|567634671|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
157242525|NCT04547192|567634668|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
157242526|NCT04547192|567634669|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
157242527|NCT04547192|567634670|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
157242528|NCT04547192|567634671|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
157242529|NCT01484912|567634672|FG000|Overall Study|Withdrawal by Subject|1|||
157242530|NCT01484912|567634673|FG001|Overall Study|Withdrawal by Subject|0|||
157242531|NCT01484912|567634672|FG000|Overall Study|Physician Decision|0|||
157242532|NCT01484912|567634673|FG001|Overall Study|Physician Decision|1|||
157242533|NCT00829712|567634674|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
157242534|NCT00829712|567634675|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
157242535|NCT01188681|567634676|FG000|Overall Study|bladder cancer|0|||
157242536|NCT01188681|567634677|FG001|Overall Study|bladder cancer|0|||
157242537|NCT01188681|567634678|FG002|Overall Study|bladder cancer|1|||
157242538|NCT01188681|567634679|FG003|Overall Study|bladder cancer|0|||
157242539|NCT01188681|567634676|FG000|Overall Study|Withdrawal by Subject|0|||
157242540|NCT01188681|567634677|FG001|Overall Study|Withdrawal by Subject|0|||
157242541|NCT01188681|567634678|FG002|Overall Study|Withdrawal by Subject|0|||
157242542|NCT01188681|567634679|FG003|Overall Study|Withdrawal by Subject|1|||
157242543|NCT04345653|567634681|FG000|Overall Study|Withdrawal by Subject|2|||
157242544|NCT00418938|567634682|FG000|Overall Study|Reimbursement|1|||
157242545|NCT00418938|567634683|FG001|Overall Study|Reimbursement|0|||
157242546|NCT00418938|567634682|FG000|Overall Study|Administrative decision|3|||
157242547|NCT00418938|567634683|FG001|Overall Study|Administrative decision|3|||
157242548|NCT00418938|567634682|FG000|Overall Study|Withdrawal by Subject|16|||
157242549|NCT00418938|567634683|FG001|Overall Study|Withdrawal by Subject|15|||
157242550|NCT00418938|567634682|FG000|Overall Study|Lost to Follow-up|1|||
157242551|NCT00418938|567634683|FG001|Overall Study|Lost to Follow-up|3|||
157242552|NCT00418938|567634682|FG000|Overall Study|Adverse Event|1|||
157242553|NCT00418938|567634683|FG001|Overall Study|Adverse Event|1|||
157242554|NCT00418938|567634682|FG000|Overall Study|On-going|1|||
157242555|NCT00418938|567634683|FG001|Overall Study|On-going|1|||
157242556|NCT00418938|567634682|FG000|Overall Study|Ineligibility Determined|1|||
157242557|NCT00418938|567634683|FG001|Overall Study|Ineligibility Determined|0|||
157242558|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
157242559|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
157242560|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
157198335|NCT05602818|567468998|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
157198336|NCT05602818|567468999|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
157198337|NCT05602818|567469000|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
157198338|NCT05602818|567469001|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
157198339|NCT05602818|567468990|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198340|NCT05602818|567468991|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198341|NCT05602818|567468992|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198342|NCT05602818|567468993|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198343|NCT05602818|567468994|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198344|NCT05602818|567468995|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198345|NCT05602818|567468996|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198346|NCT05602818|567468997|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198347|NCT05602818|567468998|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198348|NCT05602818|567468999|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
157198349|NCT05602818|567469000|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
157198350|NCT05602818|567469001|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
157198351|NCT05602818|567468990|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
157198352|NCT05602818|567468991|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
157198353|NCT05602818|567468992|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
157198354|NCT05602818|567468993|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
157198355|NCT05602818|567468994|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
157198356|NCT05602818|567468995|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
157198357|NCT05602818|567468996|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
157198358|NCT05602818|567468997|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
157198359|NCT05602818|567468998|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
157198360|NCT05602818|567468999|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
157198361|NCT05602818|567469000|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
157198362|NCT05602818|567469001|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
157198363|NCT03099096|567469007|FG000|Overall Study|Adverse Event|1|||
157198364|NCT03099096|567469007|FG000|Overall Study|Physician Decision|1|||
157198365|NCT00998166|567469008|FG000|Overall Study|Early Study Termination|8|||
157198366|NCT01374516|567469010|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
157198367|NCT01374516|567469011|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
157198368|NCT01374516|567469010|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
157198369|NCT01374516|567469011|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
157198370|NCT01374516|567469010|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
157198371|NCT01374516|567469011|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
157198372|NCT01374516|567469010|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
157198373|NCT01374516|567469011|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
157198374|NCT01374516|567469010|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
157198375|NCT01374516|567469011|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
157198376|NCT01374516|567469010|FG000|Surveillance Expansion Period|Protocol Violation|386|||
157198377|NCT01374516|567469011|FG001|Surveillance Expansion Period|Protocol Violation|217|||
157198378|NCT01374516|567469010|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
157198379|NCT01374516|567469011|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
157198380|NCT01374516|567469010|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
157198381|NCT01374516|567469011|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
157198382|NCT01374516|567469010|FG000|Surveillance Expansion Period|Serious adverse event|20|||
157198383|NCT01374516|567469011|FG001|Surveillance Expansion Period|Serious adverse event|5|||
157198384|NCT02190604|567469015|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198385|NCT02190604|567469016|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198386|NCT02190604|567469017|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198387|NCT02190604|567469018|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198388|NCT02190604|567469019|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198389|NCT02190604|567469020|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198390|NCT02190604|567469021|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198391|NCT02190604|567469022|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198392|NCT02190604|567469023|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198393|NCT02190604|567469024|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198394|NCT02190604|567469025|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198395|NCT02190604|567469026|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198396|NCT02190604|567469027|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198397|NCT02190604|567469028|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198398|NCT02190604|567469029|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
157198399|NCT02190604|567469030|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198400|NCT02190604|567469031|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198401|NCT02190604|567469032|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198402|NCT02190604|567469033|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
157198403|NCT02190604|567469015|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198404|NCT02190604|567469016|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198405|NCT02190604|567469017|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198406|NCT02190604|567469018|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198407|NCT02190604|567469019|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198408|NCT02190604|567469020|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198409|NCT02190604|567469021|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198410|NCT02190604|567469022|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198411|NCT02190604|567469023|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198412|NCT02190604|567469024|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198413|NCT02190604|567469025|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198414|NCT02190604|567469026|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198415|NCT02190604|567469027|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198416|NCT02190604|567469028|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
157198417|NCT02190604|567469029|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198418|NCT02190604|567469030|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198419|NCT02190604|567469031|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198420|NCT02190604|567469032|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198421|NCT02190604|567469033|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
157198422|NCT02797951|567469034|FG000|Overall Study|Adverse Event|4|||
157198423|NCT02797951|567469034|FG000|Overall Study|Death|1|||
157198424|NCT02797951|567469034|FG000|Overall Study|Lack of Efficacy|19|||
157198425|NCT02797951|567469034|FG000|Overall Study|Lost to Follow-up|4|||
157198426|NCT02797951|567469034|FG000|Overall Study|Physician Decision|6|||
157198427|NCT02797951|567469034|FG000|Overall Study|Withdrawal by Subject|15|||
157198428|NCT00814502|567469035|FG000|Overall Study|Adverse Event|1|||
157198429|NCT00814502|567469036|FG001|Overall Study|Adverse Event|0|||
157198430|NCT00814502|567469035|FG000|Overall Study|Withdrawal by Subject|0|||
157198431|NCT00814502|567469036|FG001|Overall Study|Withdrawal by Subject|2|||
157198432|NCT01901393|567469037|FG000|Overall Study|Adverse Event|1|||
157198433|NCT01901393|567469038|FG001|Overall Study|Adverse Event|0|||
157198434|NCT03735849|567469039|FG000|Overall Study|Lost to Follow-up|1|||
157198435|NCT03735849|567469040|FG001|Overall Study|Lost to Follow-up|0|||
157198436|NCT03735849|567469041|FG002|Overall Study|Lost to Follow-up|0|||
157198437|NCT03735849|567469039|FG000|Overall Study|Participant unable to adhere to visit|1|||
157198438|NCT03735849|567469040|FG001|Overall Study|Participant unable to adhere to visit|0|||
157198439|NCT03735849|567469041|FG002|Overall Study|Participant unable to adhere to visit|0|||
157198440|NCT03735849|567469039|FG000|Overall Study|Not Randomized|0|||
157198441|NCT03735849|567469040|FG001|Overall Study|Not Randomized|0|||
157198442|NCT03735849|567469041|FG002|Overall Study|Not Randomized|4|||
157198443|NCT03125382|567469044|FG000|Randomization|screening failure|1|||
157198444|NCT03125382|567469045|FG001|Randomization|screening failure|4|||
157198445|NCT03125382|567469046|FG002|Randomization|screening failure|2|||
157198446|NCT03125382|567469047|FG003|Randomization|screening failure|0|||
157198447|NCT03125382|567469044|FG000|Follow-up|Death|1|||
157198448|NCT03125382|567469045|FG001|Follow-up|Death|2|||
157198449|NCT03125382|567469046|FG002|Follow-up|Death|1|||
157198450|NCT03125382|567469047|FG003|Follow-up|Death|2|||
157198451|NCT03125382|567469044|FG000|Follow-up|Lost to Follow-up|1|||
157198452|NCT03125382|567469045|FG001|Follow-up|Lost to Follow-up|4|||
157198453|NCT03125382|567469046|FG002|Follow-up|Lost to Follow-up|3|||
157198454|NCT03125382|567469047|FG003|Follow-up|Lost to Follow-up|1|||
157198455|NCT02243306|567469060|FG000|Overall Study|Adverse Event|0|||
157198456|NCT02243306|567469061|FG001|Overall Study|Adverse Event|1|||
157198457|NCT02243306|567469060|FG000|Overall Study|Other: Reached stopping criteria|0|||
157198458|NCT02243306|567469061|FG001|Overall Study|Other: Reached stopping criteria|1|||
157198459|NCT02243306|567469060|FG000|Overall Study|Physician Decision|0|||
157198460|NCT02243306|567469061|FG001|Overall Study|Physician Decision|1|||
157198461|NCT04768881|567469066|FG000|Overall Study|Completed Study Follow-up|0|||
157198462|NCT04768881|567469067|FG001|Overall Study|Completed Study Follow-up|2|||
157198463|NCT04768881|567469066|FG000|Overall Study|Death|3|||
157198464|NCT04768881|567469067|FG001|Overall Study|Death|2|||
157198465|NCT04768881|567469066|FG000|Overall Study|Study Terminated by Sponsor|2|||
157198466|NCT04768881|567469067|FG001|Overall Study|Study Terminated by Sponsor|2|||
157198467|NCT04768881|567469066|FG000|Overall Study|Withdrawal by Subject|2|||
157198468|NCT04768881|567469067|FG001|Overall Study|Withdrawal by Subject|0|||
157198469|NCT04768881|567469066|FG000|Overall Study|Other|2|||
157198470|NCT04768881|567469067|FG001|Overall Study|Other|0|||
156863410|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
157198471|NCT04236986|567469070|FG000|Overall Study|Withdrawal by Subject|3|||
157198472|NCT04236986|567469071|FG001|Overall Study|Withdrawal by Subject|1|||
157198473|NCT00307736|567469076|FG000|Overall Study|Adverse Event|0|||
157198474|NCT00307736|567469077|FG001|Overall Study|Adverse Event|0|||
157198475|NCT00307736|567469078|FG002|Overall Study|Adverse Event|1|||
157198476|NCT00307736|567469079|FG003|Overall Study|Adverse Event|3|||
157198477|NCT00307736|567469076|FG000|Overall Study|Withdrawal by Subject|0|||
157198478|NCT00307736|567469077|FG001|Overall Study|Withdrawal by Subject|0|||
157198479|NCT00307736|567469078|FG002|Overall Study|Withdrawal by Subject|2|||
157198480|NCT00307736|567469079|FG003|Overall Study|Withdrawal by Subject|0|||
157198481|NCT01990339|567469082|FG000|Overall Study|Data Not Available|49|||
157198482|NCT01990339|567469082|FG000|Overall Study|Voluntary Withdrawal|1402|||
157198483|NCT01990339|567469082|FG000|Overall Study|Lost to Follow-up|861|||
157198484|NCT01302366|567470624|FG000|Overall Study|patient choice or noncompliance|5|||
157198485|NCT00198107|567470627|FG000|Double-Blind Period|Adverse Event|1|||
157198486|NCT00198107|567470628|FG001|Double-Blind Period|Adverse Event|1|||
157198487|NCT00198107|567470629|FG002|Double-Blind Period|Adverse Event|0|||
157198488|NCT00198107|567470627|FG000|Double-Blind Period|Lack of Efficacy|2|||
157198489|NCT00198107|567470628|FG001|Double-Blind Period|Lack of Efficacy|0|||
157198490|NCT00198107|567470629|FG002|Double-Blind Period|Lack of Efficacy|0|||
157198491|NCT00198107|567470627|FG000|Double-Blind Period|Lost to Follow-up|2|||
157198492|NCT00198107|567470628|FG001|Double-Blind Period|Lost to Follow-up|1|||
157198493|NCT00198107|567470629|FG002|Double-Blind Period|Lost to Follow-up|0|||
157198494|NCT00198107|567470627|FG000|Double-Blind Period|Physician Decision|1|||
157198495|NCT00198107|567470628|FG001|Double-Blind Period|Physician Decision|0|||
157198496|NCT00198107|567470629|FG002|Double-Blind Period|Physician Decision|0|||
157198497|NCT00198107|567470627|FG000|Double-Blind Period|Withdrawal by Subject|0|||
157198498|NCT00198107|567470628|FG001|Double-Blind Period|Withdrawal by Subject|1|||
157198499|NCT00198107|567470629|FG002|Double-Blind Period|Withdrawal by Subject|0|||
157198500|NCT00198107|567470627|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
157198501|NCT00198107|567470628|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
157198502|NCT00198107|567470629|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
157198503|NCT02513732|567470630|FG000|Overall Study|Lost to Follow-up|11|||
157198504|NCT02513732|567470630|FG000|Overall Study|Death|9|||
157198505|NCT02513732|567470630|FG000|Overall Study|Changing hospital|2|||
157198506|NCT00467051|567470631|FG000|Overall Study|Adverse Event|2|||
157198507|NCT02147132|567470634|FG000|Overall Study|Lost to Follow-up|1|||
157198508|NCT02147132|567470635|FG001|Overall Study|Lost to Follow-up|0|||
157198509|NCT02147132|567470636|FG002|Overall Study|Lost to Follow-up|0|||
157198510|NCT02147132|567470637|FG003|Overall Study|Lost to Follow-up|0|||
157198511|NCT00278473|567470644|FG000|Overall Study|drop out|4|||
157198512|NCT00278473|567470645|FG001|Overall Study|drop out|3|||
157198513|NCT04001790|567470646|FG000|Overall Study|Withdrawal by Subject|1|||
157198514|NCT04001790|567470647|FG001|Overall Study|Withdrawal by Subject|2|||
157198515|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Adverse Event|4|||
157198516|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Adverse Event|3|||
157198517|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Adverse Event|0|||
157198518|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Adverse Event|0|||
157198519|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Death|24|||
157198520|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Death|9|||
157198521|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Death|0|||
157198522|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Death|0|||
157198523|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
157198524|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
157198525|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
157198526|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
157198527|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Physician Decision|4|||
157198528|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Physician Decision|1|||
157198529|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Physician Decision|0|||
157198530|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Physician Decision|0|||
157198531|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Progressive disease|1|||
157198532|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Progressive disease|0|||
157198533|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Progressive disease|0|||
157198534|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Progressive disease|0|||
157198535|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
157198536|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
157198537|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
157198538|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
157198539|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
157198540|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
157198541|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
157198542|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
157198543|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
157198544|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
157198545|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
157198546|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
157198547|NCT04579666|567470648|FG000|RTP (Up to Week 52)|Other|2|||
157198548|NCT04579666|567470649|FG001|RTP (Up to Week 52)|Other|0|||
157198549|NCT04579666|567470650|FG002|RTP (Up to Week 52)|Other|0|||
157198550|NCT04579666|567470651|FG003|RTP (Up to Week 52)|Other|0|||
157198551|NCT04579666|567470648|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
157198552|NCT04579666|567470649|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
157198553|NCT04579666|567470650|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
157198554|NCT04579666|567470651|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
157198555|NCT04579666|567470648|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
157198556|NCT04579666|567470649|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
157198557|NCT04579666|567470650|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
157198558|NCT04579666|567470651|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
157198559|NCT04579666|567470648|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
157198560|NCT04579666|567470649|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
157198561|NCT04579666|567470650|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
157198562|NCT04579666|567470651|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
157198563|NCT04579666|567470648|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
157198564|NCT04579666|567470649|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
157198565|NCT04579666|567470650|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
157198566|NCT04579666|567470651|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
157198567|NCT04579666|567470648|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
157198568|NCT04579666|567470649|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
157198569|NCT04579666|567470650|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
157198570|NCT04579666|567470651|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
157198571|NCT03290131|567470652|FG000|Overall Study|Adverse Event|22|||
157198572|NCT03290131|567470653|FG001|Overall Study|Adverse Event|57|||
157198573|NCT03290131|567470654|FG002|Overall Study|Adverse Event|11|||
157198574|NCT03290131|567470652|FG000|Overall Study|Withdrawal by Subject|18|||
157198575|NCT03290131|567470653|FG001|Overall Study|Withdrawal by Subject|13|||
157198576|NCT03290131|567470654|FG002|Overall Study|Withdrawal by Subject|8|||
157198577|NCT03290131|567470652|FG000|Overall Study|MS Relapse|2|||
157198578|NCT03290131|567470653|FG001|Overall Study|MS Relapse|1|||
157198579|NCT03290131|567470654|FG002|Overall Study|MS Relapse|0|||
157198580|NCT03290131|567470652|FG000|Overall Study|Unknown reason|0|||
157198581|NCT03290131|567470653|FG001|Overall Study|Unknown reason|1|||
157198582|NCT03290131|567470654|FG002|Overall Study|Unknown reason|0|||
157198583|NCT00361504|567470655|FG000|Overall Study|Withdrawal by Subject|94|||
157198584|NCT00361504|567470656|FG001|Overall Study|Withdrawal by Subject|31|||
157198585|NCT00361504|567470655|FG000|Overall Study|Lost to Follow-up|40|||
157198586|NCT00361504|567470656|FG001|Overall Study|Lost to Follow-up|7|||
157198587|NCT00361504|567470655|FG000|Overall Study|Adverse Event|203|||
157198588|NCT00361504|567470656|FG001|Overall Study|Adverse Event|82|||
157198589|NCT00361504|567470655|FG000|Overall Study|Lack of Efficacy|72|||
157198590|NCT00361504|567470656|FG001|Overall Study|Lack of Efficacy|7|||
157198591|NCT00361504|567470655|FG000|Overall Study|Resolution of Pain|2|||
157198592|NCT00361504|567470656|FG001|Overall Study|Resolution of Pain|0|||
157198593|NCT00361504|567470655|FG000|Overall Study|Study medication non compliant|42|||
157198594|NCT00361504|567470656|FG001|Overall Study|Study medication non compliant|15|||
157198595|NCT00361504|567470655|FG000|Overall Study|All other|28|||
157198596|NCT00361504|567470656|FG001|Overall Study|All other|3|||
157198597|NCT04246593|567470666|FG000|Overall Study|Withdrawal by Subject|14|||
157198598|NCT04246593|567470667|FG001|Overall Study|Withdrawal by Subject|13|||
157198599|NCT04246593|567470666|FG000|Overall Study|Lost to Follow-up|124|||
157198600|NCT04246593|567470667|FG001|Overall Study|Lost to Follow-up|71|||
157198601|NCT04246593|567470666|FG000|Overall Study|Moved out of area/became ineligible|3|||
157198602|NCT04246593|567470667|FG001|Overall Study|Moved out of area/became ineligible|1|||
157198603|NCT04246593|567470666|FG000|Overall Study|Reason unknown|4|||
157198604|NCT04246593|567470667|FG001|Overall Study|Reason unknown|2|||
157198605|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
157198606|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
157198607|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
157198608|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
157198609|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
157198610|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
157198611|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
157198612|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
157198613|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
157198614|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
157198615|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
157198616|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
157198617|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
157198618|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
157198619|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
157198620|NCT01694849|567470676|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
157198621|NCT01694849|567470677|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
157198622|NCT01694849|567470678|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
157198623|NCT01694849|567470676|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
157198624|NCT01694849|567470677|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
157198625|NCT01694849|567470678|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
157198626|NCT01694849|567470676|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
157198627|NCT01694849|567470677|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
157198628|NCT01694849|567470678|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
157198629|NCT01012765|567470679|FG000|Treatment Period 1|Adverse Event|1|||
157198630|NCT01012765|567470680|FG001|Treatment Period 1|Adverse Event|0|||
157198631|NCT01012765|567470681|FG002|Treatment Period 1|Adverse Event|1|||
157198632|NCT01012765|567470682|FG003|Treatment Period 1|Adverse Event|0|||
157198633|NCT01012765|567470683|FG004|Treatment Period 1|Adverse Event|0|||
157198634|NCT01012765|567470684|FG005|Treatment Period 1|Adverse Event|0|||
157198635|NCT01012765|567470679|FG000|Treatment Period 1|Withdrawal by Subject|2|||
157198636|NCT01012765|567470680|FG001|Treatment Period 1|Withdrawal by Subject|0|||
157198637|NCT01012765|567470681|FG002|Treatment Period 1|Withdrawal by Subject|0|||
157198638|NCT01012765|567470682|FG003|Treatment Period 1|Withdrawal by Subject|0|||
157198639|NCT01012765|567470683|FG004|Treatment Period 1|Withdrawal by Subject|0|||
157198640|NCT01012765|567470684|FG005|Treatment Period 1|Withdrawal by Subject|0|||
157198641|NCT01012765|567470679|FG000|Treatment Period 1|Administrative problems|0|||
157198642|NCT01012765|567470680|FG001|Treatment Period 1|Administrative problems|0|||
157198643|NCT01012765|567470681|FG002|Treatment Period 1|Administrative problems|1|||
157198644|NCT01012765|567470682|FG003|Treatment Period 1|Administrative problems|1|||
157198645|NCT01012765|567470683|FG004|Treatment Period 1|Administrative problems|1|||
157198646|NCT01012765|567470684|FG005|Treatment Period 1|Administrative problems|0|||
157198647|NCT01012765|567470679|FG000|Treatment Period 1|Protocol Violation|0|||
157198648|NCT01012765|567470680|FG001|Treatment Period 1|Protocol Violation|0|||
157198649|NCT01012765|567470681|FG002|Treatment Period 1|Protocol Violation|0|||
157198650|NCT01012765|567470682|FG003|Treatment Period 1|Protocol Violation|2|||
157198651|NCT01012765|567470683|FG004|Treatment Period 1|Protocol Violation|1|||
157198652|NCT01012765|567470684|FG005|Treatment Period 1|Protocol Violation|0|||
157198653|NCT01012765|567470679|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
157198654|NCT01012765|567470680|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
157198655|NCT01012765|567470681|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
157198656|NCT01012765|567470682|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
157198657|NCT01012765|567470683|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
157198658|NCT01012765|567470684|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
157198659|NCT01012765|567470679|FG000|Treatment Period 2|Withdrawal by Subject|1|||
157198660|NCT01012765|567470680|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157198661|NCT01012765|567470681|FG002|Treatment Period 2|Withdrawal by Subject|1|||
157198662|NCT01012765|567470682|FG003|Treatment Period 2|Withdrawal by Subject|0|||
157198663|NCT01012765|567470683|FG004|Treatment Period 2|Withdrawal by Subject|1|||
157198664|NCT01012765|567470684|FG005|Treatment Period 2|Withdrawal by Subject|0|||
157198665|NCT01012765|567470679|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
157198666|NCT01012765|567470680|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
157198667|NCT01012765|567470681|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
157198668|NCT01012765|567470682|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
157198669|NCT01012765|567470683|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
157198670|NCT01012765|567470684|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
157198671|NCT01012765|567470679|FG000|Treatment Period 2|Adverse Event|0|||
157198672|NCT01012765|567470680|FG001|Treatment Period 2|Adverse Event|1|||
157198673|NCT01012765|567470681|FG002|Treatment Period 2|Adverse Event|1|||
157198674|NCT01012765|567470682|FG003|Treatment Period 2|Adverse Event|0|||
157198675|NCT01012765|567470683|FG004|Treatment Period 2|Adverse Event|0|||
157198676|NCT01012765|567470684|FG005|Treatment Period 2|Adverse Event|0|||
157198677|NCT01012765|567470679|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
157198678|NCT01012765|567470680|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
157198679|NCT01012765|567470681|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
157198680|NCT01012765|567470682|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
157198681|NCT01012765|567470683|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
157198682|NCT01012765|567470684|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
157198683|NCT01326312|567470685|FG000|Overall Study|Adverse Event|11|||
157198684|NCT01326312|567470686|FG001|Overall Study|Adverse Event|11|||
157198685|NCT01326312|567470687|FG002|Overall Study|Adverse Event|1|||
157198686|NCT01326312|567470685|FG000|Overall Study|Withdrawal by Subject|1|||
157198687|NCT01326312|567470686|FG001|Overall Study|Withdrawal by Subject|2|||
157198688|NCT01326312|567470687|FG002|Overall Study|Withdrawal by Subject|1|||
157198689|NCT01326312|567470685|FG000|Overall Study|Protocol Violation|0|||
157198690|NCT01326312|567470686|FG001|Overall Study|Protocol Violation|1|||
157198691|NCT01326312|567470687|FG002|Overall Study|Protocol Violation|0|||
157198692|NCT01326312|567470685|FG000|Overall Study|Lack of Efficacy|13|||
157198693|NCT01326312|567470686|FG001|Overall Study|Lack of Efficacy|7|||
157198694|NCT01326312|567470687|FG002|Overall Study|Lack of Efficacy|1|||
157198695|NCT01326312|567470685|FG000|Overall Study|Death|1|||
157198696|NCT01326312|567470686|FG001|Overall Study|Death|0|||
157198697|NCT01326312|567470687|FG002|Overall Study|Death|1|||
157198698|NCT01326312|567470685|FG000|Overall Study|progressive disease|0|||
157198699|NCT01326312|567470686|FG001|Overall Study|progressive disease|1|||
157198700|NCT01326312|567470687|FG002|Overall Study|progressive disease|1|||
157198701|NCT01326312|567470685|FG000|Overall Study|Study terminated by Sponsor|8|||
157198702|NCT01326312|567470686|FG001|Overall Study|Study terminated by Sponsor|32|||
157198703|NCT01326312|567470687|FG002|Overall Study|Study terminated by Sponsor|46|||
157198704|NCT01326312|567470685|FG000|Overall Study|Treatment arm terminated|19|||
157198705|NCT01326312|567470686|FG001|Overall Study|Treatment arm terminated|0|||
157198706|NCT01326312|567470687|FG002|Overall Study|Treatment arm terminated|0|||
157198707|NCT01326312|567470685|FG000|Overall Study|QTc > 500|0|||
157198708|NCT01326312|567470686|FG001|Overall Study|QTc > 500|1|||
157198709|NCT01326312|567470687|FG002|Overall Study|QTc > 500|0|||
157198710|NCT00499694|567470696|FG000|Overall Study|Patient never received treatment.|1|||
157198711|NCT00976989|567470699|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
157198712|NCT00976989|567470700|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
157198713|NCT00976989|567470701|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
157198714|NCT00976989|567470699|FG000|Overall Study|Death|5|||
157198715|NCT00976989|567470700|FG001|Overall Study|Death|7|||
157198716|NCT00976989|567470701|FG002|Overall Study|Death|10|||
157198717|NCT00976989|567470699|FG000|Overall Study|Refused Treatment|4|||
157198718|NCT00976989|567470700|FG001|Overall Study|Refused Treatment|3|||
157198719|NCT00976989|567470701|FG002|Overall Study|Refused Treatment|5|||
157198720|NCT00976989|567470699|FG000|Overall Study|Failure to Return|2|||
157198721|NCT00976989|567470700|FG001|Overall Study|Failure to Return|1|||
157198722|NCT00976989|567470701|FG002|Overall Study|Failure to Return|0|||
157198723|NCT00976989|567470699|FG000|Overall Study|Recurrence of Disease|0|||
157198724|NCT00976989|567470700|FG001|Overall Study|Recurrence of Disease|1|||
157198725|NCT00976989|567470701|FG002|Overall Study|Recurrence of Disease|0|||
157198726|NCT00976989|567470699|FG000|Overall Study|Other|1|||
157198727|NCT00976989|567470700|FG001|Overall Study|Other|0|||
157198728|NCT00976989|567470701|FG002|Overall Study|Other|1|||
157198729|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
157198730|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
157198731|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
157198732|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
157198733|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
157198734|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
157198735|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
157198736|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
157198737|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
157198738|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
157198739|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
157198740|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
157198741|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
157198742|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
157198743|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
157198744|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
157198745|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
157198746|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
157198747|NCT00570492|567470702|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
157198748|NCT00570492|567470703|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
157198749|NCT00570492|567470704|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
157198750|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
157198751|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
157198752|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
157198753|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
157198754|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
157198755|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
157198756|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
157198757|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
157198758|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
157198759|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
157198760|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
157198761|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
157198762|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
157198763|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
157198764|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
157198765|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
157198766|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
157198767|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
157242561|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
157242562|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
157242563|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
157242564|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Death|9|||
157242565|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Death|7|||
157242566|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Death|14|||
157242567|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Death|7|||
157242568|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Death|0|||
157242569|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Death|0|||
157242570|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
157242571|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
157242572|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
157242573|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
157242574|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
157242575|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
157242576|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Other Event|49|||
157242577|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Other Event|52|||
157242578|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Other Event|41|||
157242579|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Other Event|58|||
157242580|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Other Event|0|||
157242581|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Other Event|0|||
157242582|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
157242583|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
157242584|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
157242585|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
157242586|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
157242587|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
157242588|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
157242589|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
157242590|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
157242591|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
157242592|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
157242593|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
157242594|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
157242595|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
157242596|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
157242597|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
157242598|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
157242599|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
157242600|NCT00205777|567634684|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
157242601|NCT00205777|567634685|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
157242602|NCT00205777|567634686|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
157242603|NCT00205777|567634687|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
157242604|NCT00205777|567634688|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
157242605|NCT00205777|567634689|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
157242606|NCT00205777|567634684|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
157242607|NCT00205777|567634685|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
157242608|NCT00205777|567634686|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
157242609|NCT00205777|567634687|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
157242610|NCT00205777|567634688|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
157242611|NCT00205777|567634689|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
157242612|NCT00205777|567634684|FG000|Completed Core Study, Entered SE I|Other Event|52|||
157242613|NCT00205777|567634685|FG001|Completed Core Study, Entered SE I|Other Event|46|||
157242614|NCT00205777|567634686|FG002|Completed Core Study, Entered SE I|Other Event|47|||
157242615|NCT00205777|567634687|FG003|Completed Core Study, Entered SE I|Other Event|50|||
157242616|NCT00205777|567634688|FG004|Completed Core Study, Entered SE I|Other Event|0|||
157242617|NCT00205777|567634689|FG005|Completed Core Study, Entered SE I|Other Event|0|||
157242618|NCT00205777|567634684|FG000|Study Extension I|Adverse Event|57|||
157242619|NCT00205777|567634685|FG001|Study Extension I|Adverse Event|0|||
157242620|NCT00205777|567634686|FG002|Study Extension I|Adverse Event|0|||
157242621|NCT00205777|567634687|FG003|Study Extension I|Adverse Event|61|||
157242622|NCT00205777|567634688|FG004|Study Extension I|Adverse Event|58|||
157242623|NCT00205777|567634689|FG005|Study Extension I|Adverse Event|0|||
157242624|NCT00205777|567634684|FG000|Study Extension I|Death|5|||
157242625|NCT00205777|567634685|FG001|Study Extension I|Death|0|||
157242626|NCT00205777|567634686|FG002|Study Extension I|Death|0|||
157242627|NCT00205777|567634687|FG003|Study Extension I|Death|1|||
157242628|NCT00205777|567634688|FG004|Study Extension I|Death|2|||
157242629|NCT00205777|567634689|FG005|Study Extension I|Death|0|||
157242630|NCT00205777|567634684|FG000|Study Extension I|Withdrawal by Subject|99|||
157242631|NCT00205777|567634685|FG001|Study Extension I|Withdrawal by Subject|0|||
157242632|NCT00205777|567634686|FG002|Study Extension I|Withdrawal by Subject|0|||
157242633|NCT00205777|567634687|FG003|Study Extension I|Withdrawal by Subject|106|||
157242634|NCT00205777|567634688|FG004|Study Extension I|Withdrawal by Subject|89|||
157242635|NCT00205777|567634689|FG005|Study Extension I|Withdrawal by Subject|0|||
157242636|NCT00205777|567634684|FG000|Study Extension I|Protocol Violation|4|||
157242637|NCT00205777|567634685|FG001|Study Extension I|Protocol Violation|0|||
157242638|NCT00205777|567634686|FG002|Study Extension I|Protocol Violation|0|||
157242639|NCT00205777|567634687|FG003|Study Extension I|Protocol Violation|8|||
157242640|NCT00205777|567634688|FG004|Study Extension I|Protocol Violation|8|||
157242641|NCT00205777|567634689|FG005|Study Extension I|Protocol Violation|0|||
157242642|NCT00205777|567634684|FG000|Study Extension I|Lack of Efficacy|0|||
157242643|NCT00205777|567634685|FG001|Study Extension I|Lack of Efficacy|0|||
157242644|NCT00205777|567634686|FG002|Study Extension I|Lack of Efficacy|0|||
157242645|NCT00205777|567634687|FG003|Study Extension I|Lack of Efficacy|1|||
157242646|NCT00205777|567634688|FG004|Study Extension I|Lack of Efficacy|2|||
157242647|NCT00205777|567634689|FG005|Study Extension I|Lack of Efficacy|0|||
157242648|NCT00205777|567634684|FG000|Study Extension I|Failed to return|15|||
157242649|NCT00205777|567634685|FG001|Study Extension I|Failed to return|0|||
157242650|NCT00205777|567634686|FG002|Study Extension I|Failed to return|0|||
157242651|NCT00205777|567634687|FG003|Study Extension I|Failed to return|17|||
157242652|NCT00205777|567634688|FG004|Study Extension I|Failed to return|13|||
157242653|NCT00205777|567634689|FG005|Study Extension I|Failed to return|0|||
157242654|NCT00205777|567634684|FG000|Study Extension I|Other Event|34|||
157242655|NCT00205777|567634685|FG001|Study Extension I|Other Event|0|||
157242656|NCT00205777|567634686|FG002|Study Extension I|Other Event|0|||
157242657|NCT00205777|567634687|FG003|Study Extension I|Other Event|34|||
157242658|NCT00205777|567634688|FG004|Study Extension I|Other Event|29|||
157242659|NCT00205777|567634689|FG005|Study Extension I|Other Event|0|||
157242660|NCT00205777|567634684|FG000|Study Extension I|Withdrawn as per protocol|0|||
157242661|NCT00205777|567634685|FG001|Study Extension I|Withdrawn as per protocol|0|||
157242662|NCT00205777|567634686|FG002|Study Extension I|Withdrawn as per protocol|1070|||
157242663|NCT00205777|567634687|FG003|Study Extension I|Withdrawn as per protocol|0|||
157242664|NCT00205777|567634688|FG004|Study Extension I|Withdrawn as per protocol|0|||
157242665|NCT00205777|567634689|FG005|Study Extension I|Withdrawn as per protocol|0|||
157242666|NCT00205777|567634684|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
157242667|NCT00205777|567634685|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
157242668|NCT00205777|567634686|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
157242669|NCT00205777|567634687|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
157242670|NCT00205777|567634688|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
157242671|NCT00205777|567634689|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
157242672|NCT00205777|567634684|FG000|Study Extension II|Adverse Event|0|||
157242673|NCT00205777|567634685|FG001|Study Extension II|Adverse Event|0|||
157242674|NCT00205777|567634686|FG002|Study Extension II|Adverse Event|0|||
157242675|NCT00205777|567634687|FG003|Study Extension II|Adverse Event|14|||
157242676|NCT00205777|567634688|FG004|Study Extension II|Adverse Event|0|||
157242677|NCT00205777|567634689|FG005|Study Extension II|Adverse Event|30|||
157242678|NCT00205777|567634684|FG000|Study Extension II|Death|0|||
157242679|NCT00205777|567634685|FG001|Study Extension II|Death|0|||
157242680|NCT00205777|567634686|FG002|Study Extension II|Death|0|||
157242681|NCT00205777|567634687|FG003|Study Extension II|Death|2|||
157242682|NCT00205777|567634688|FG004|Study Extension II|Death|0|||
157242683|NCT00205777|567634689|FG005|Study Extension II|Death|5|||
157242684|NCT00205777|567634684|FG000|Study Extension II|Withdrawal by Subject|0|||
157242685|NCT00205777|567634685|FG001|Study Extension II|Withdrawal by Subject|0|||
157242686|NCT00205777|567634686|FG002|Study Extension II|Withdrawal by Subject|0|||
157242687|NCT00205777|567634687|FG003|Study Extension II|Withdrawal by Subject|35|||
157242688|NCT00205777|567634688|FG004|Study Extension II|Withdrawal by Subject|0|||
157242689|NCT00205777|567634689|FG005|Study Extension II|Withdrawal by Subject|59|||
157242690|NCT00205777|567634684|FG000|Study Extension II|Protocol Violation|0|||
157242691|NCT00205777|567634685|FG001|Study Extension II|Protocol Violation|0|||
157242692|NCT00205777|567634686|FG002|Study Extension II|Protocol Violation|0|||
157242693|NCT00205777|567634687|FG003|Study Extension II|Protocol Violation|1|||
157242694|NCT00205777|567634688|FG004|Study Extension II|Protocol Violation|0|||
157242695|NCT00205777|567634689|FG005|Study Extension II|Protocol Violation|10|||
157242696|NCT00205777|567634684|FG000|Study Extension II|Lack of Efficacy|0|||
157242697|NCT00205777|567634685|FG001|Study Extension II|Lack of Efficacy|0|||
157242698|NCT00205777|567634686|FG002|Study Extension II|Lack of Efficacy|0|||
157242699|NCT00205777|567634687|FG003|Study Extension II|Lack of Efficacy|0|||
157242700|NCT00205777|567634688|FG004|Study Extension II|Lack of Efficacy|0|||
157242701|NCT00205777|567634689|FG005|Study Extension II|Lack of Efficacy|1|||
157242702|NCT00205777|567634684|FG000|Study Extension II|Failed to return|0|||
157242703|NCT00205777|567634685|FG001|Study Extension II|Failed to return|0|||
157242704|NCT00205777|567634686|FG002|Study Extension II|Failed to return|0|||
157242705|NCT00205777|567634687|FG003|Study Extension II|Failed to return|14|||
157242706|NCT00205777|567634688|FG004|Study Extension II|Failed to return|0|||
157242707|NCT00205777|567634689|FG005|Study Extension II|Failed to return|26|||
157242708|NCT00205777|567634684|FG000|Study Extension II|Other Event|0|||
157242709|NCT00205777|567634685|FG001|Study Extension II|Other Event|0|||
157242710|NCT00205777|567634686|FG002|Study Extension II|Other Event|0|||
157242711|NCT00205777|567634687|FG003|Study Extension II|Other Event|12|||
157242712|NCT00205777|567634688|FG004|Study Extension II|Other Event|0|||
157242713|NCT00205777|567634689|FG005|Study Extension II|Other Event|20|||
157242714|NCT00205777|567634684|FG000|Study Extension II|Enrolled but not treated|0|||
157242715|NCT00205777|567634685|FG001|Study Extension II|Enrolled but not treated|0|||
157242716|NCT00205777|567634686|FG002|Study Extension II|Enrolled but not treated|0|||
157242717|NCT00205777|567634687|FG003|Study Extension II|Enrolled but not treated|71|||
157242718|NCT00205777|567634688|FG004|Study Extension II|Enrolled but not treated|0|||
157242719|NCT00205777|567634689|FG005|Study Extension II|Enrolled but not treated|131|||
157242720|NCT03808376|567634690|FG000|Overall Study|Withdrawal by Subject|10|||
157242721|NCT00700739|567634694|FG000|Overall Study|Lost to Follow-up|4|||
157242722|NCT00700739|567634695|FG001|Overall Study|Lost to Follow-up|4|||
157242723|NCT00003470|567634699|FG000|Overall Study|Not evaluable|6|||
157242724|NCT03503318|567634703|FG000|Overall Study|Death|1|||
157242725|NCT03503318|567634704|FG001|Overall Study|Death|0|||
157242726|NCT03503318|567634705|FG002|Overall Study|Death|4|||
157242727|NCT03503318|567634703|FG000|Overall Study|Adverse Event|3|||
157242728|NCT03503318|567634704|FG001|Overall Study|Adverse Event|4|||
157242729|NCT03503318|567634705|FG002|Overall Study|Adverse Event|2|||
157242730|NCT03503318|567634703|FG000|Overall Study|Withdrawal by Subject|12|||
157242731|NCT03503318|567634704|FG001|Overall Study|Withdrawal by Subject|17|||
157242732|NCT03503318|567634705|FG002|Overall Study|Withdrawal by Subject|16|||
157242733|NCT03503318|567634703|FG000|Overall Study|Protocol Violation|5|||
157242734|NCT03503318|567634704|FG001|Overall Study|Protocol Violation|0|||
157242735|NCT03503318|567634705|FG002|Overall Study|Protocol Violation|3|||
157242736|NCT03503318|567634703|FG000|Overall Study|Lost to Follow-up|17|||
157242737|NCT03503318|567634704|FG001|Overall Study|Lost to Follow-up|15|||
157242738|NCT03503318|567634705|FG002|Overall Study|Lost to Follow-up|12|||
157242739|NCT03503318|567634703|FG000|Overall Study|Other than specified|1|||
157242740|NCT03503318|567634704|FG001|Overall Study|Other than specified|3|||
157242741|NCT03503318|567634705|FG002|Overall Study|Other than specified|3|||
157242742|NCT01794845|567634706|FG000|Overall Study|Withdrawal by Subject|1|||
157242743|NCT02139826|567634707|FG000|Overall Study|Adverse Event|1|||
157242744|NCT00867360|567634708|FG000|Overall Study|Withdrawal by Subject|1|||
157242745|NCT00867360|567634709|FG001|Overall Study|Withdrawal by Subject|0|||
157242746|NCT00867360|567634708|FG000|Overall Study|Physician Decision|0|||
157242747|NCT00867360|567634709|FG001|Overall Study|Physician Decision|1|||
157242748|NCT01004510|567634713|FG000|Overall Study|Adverse Event|1|||
157242749|NCT03218787|567634719|FG000|Overall Study|Lost to Follow-up|12|||
157242750|NCT03218787|567634719|FG000|Overall Study|Withdrawal by Subject|72|||
157242751|NCT03218787|567634719|FG000|Overall Study|Physician Decision|11|||
157242752|NCT03218787|567634719|FG000|Overall Study|Death|111|||
157198768|NCT00570492|567470702|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
157198769|NCT00570492|567470703|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
157198770|NCT00570492|567470704|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
157198771|NCT00752206|567470706|FG000|Overall Study|Disease progression|8|||
157198772|NCT00752206|567470707|FG001|Overall Study|Disease progression|11|||
157198773|NCT00752206|567470706|FG000|Overall Study|Pregnancy|1|||
157198774|NCT00752206|567470707|FG001|Overall Study|Pregnancy|0|||
157198775|NCT01484691|567470708|FG000|Overall Study|Withdrawal by Subject|1|||
157198776|NCT01484691|567470709|FG001|Overall Study|Withdrawal by Subject|1|||
157198777|NCT01484691|567470710|FG002|Overall Study|Withdrawal by Subject|1|||
157198778|NCT01484691|567470708|FG000|Overall Study|Physician Decision|0|||
157198779|NCT01484691|567470709|FG001|Overall Study|Physician Decision|2|||
157198780|NCT01484691|567470710|FG002|Overall Study|Physician Decision|1|||
157198781|NCT05437211|567470715|FG000|Overall Study|Patient's decision|1|||
157242753|NCT01248728|567634720|FG000|Overall Study|Adverse Event|1|||
157242754|NCT01248728|567634721|FG001|Overall Study|Adverse Event|1|||
157242755|NCT01248728|567634720|FG000|Overall Study|Withdrawal by Subject|2|||
157242756|NCT01248728|567634721|FG001|Overall Study|Withdrawal by Subject|1|||
157242757|NCT01248728|567634720|FG000|Overall Study|Lack of Efficacy|1|||
157242758|NCT01248728|567634721|FG001|Overall Study|Lack of Efficacy|0|||
157198782|NCT05437211|567470716|FG001|Overall Study|Patient's decision|1|||
157198783|NCT01463631|567470720|FG000|Overall Study|Withdrawal by Subject|0|||
157198784|NCT01463631|567470721|FG001|Overall Study|Withdrawal by Subject|0|||
157198785|NCT01463631|567470722|FG002|Overall Study|Withdrawal by Subject|0|||
157242759|NCT01841554|567634722|FG000|Overall Study|Death|7|||
157242760|NCT01841554|567634722|FG000|Overall Study|No Implantation|1|||
157242761|NCT01841554|567634722|FG000|Overall Study|Discontinued Follow Up|5|||
157242762|NCT01841554|567634722|FG000|Overall Study|Study exit due to secondary intervention|6|||
157242763|NCT00312897|567634723|FG000|Overall Study|Adverse Event|1|||
157242764|NCT00312897|567634724|FG001|Overall Study|Adverse Event|0|||
157242765|NCT00312897|567634723|FG000|Overall Study|Lost to Follow-up|2|||
157242766|NCT00312897|567634724|FG001|Overall Study|Lost to Follow-up|0|||
157242767|NCT00312897|567634723|FG000|Overall Study|Physician Decision|1|||
157198786|NCT01463631|567470723|FG003|Overall Study|Withdrawal by Subject|1|||
157198787|NCT01463631|567470720|FG000|Overall Study|Death|0|||
157198788|NCT01463631|567470721|FG001|Overall Study|Death|0|||
157198789|NCT01463631|567470722|FG002|Overall Study|Death|1|||
157198790|NCT01463631|567470723|FG003|Overall Study|Death|0|||
157198791|NCT01463631|567470720|FG000|Overall Study|Progressive Disease|0|||
157198792|NCT01463631|567470721|FG001|Overall Study|Progressive Disease|0|||
157198793|NCT01463631|567470722|FG002|Overall Study|Progressive Disease|0|||
157198794|NCT01463631|567470723|FG003|Overall Study|Progressive Disease|5|||
157198795|NCT01728194|567470724|FG000|Overall Study|Lost to Follow-up|4|||
157198796|NCT01728194|567470725|FG001|Overall Study|Lost to Follow-up|3|||
157198797|NCT01728194|567470724|FG000|Overall Study|Physician Decision|4|||
157198798|NCT01728194|567470725|FG001|Overall Study|Physician Decision|0|||
157242768|NCT00312897|567634724|FG001|Overall Study|Physician Decision|0|||
157242769|NCT00312897|567634723|FG000|Overall Study|Withdrawal by Subject|1|||
157242770|NCT00312897|567634724|FG001|Overall Study|Withdrawal by Subject|3|||
157242771|NCT00312897|567634723|FG000|Overall Study|Pregnancy|1|||
157242772|NCT00312897|567634724|FG001|Overall Study|Pregnancy|0|||
157242773|NCT00312897|567634723|FG000|Overall Study|discontinued prior to getting treatment|0|||
157242774|NCT00312897|567634724|FG001|Overall Study|discontinued prior to getting treatment|3|||
157242775|NCT01117623|567636717|FG000|Overall Study|Adverse Event|0|||
157242776|NCT01117623|567636718|FG001|Overall Study|Adverse Event|2|||
157242777|NCT01117623|567636719|FG002|Overall Study|Adverse Event|4|||
157242778|NCT01117623|567636720|FG003|Overall Study|Adverse Event|0|||
157242779|NCT01117623|567636721|FG004|Overall Study|Adverse Event|2|||
157242780|NCT01117623|567636722|FG005|Overall Study|Adverse Event|0|||
157242781|NCT01117623|567636723|FG006|Overall Study|Adverse Event|0|||
157242782|NCT01117623|567636724|FG007|Overall Study|Adverse Event|2|||
157242783|NCT01117623|567636717|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
157242784|NCT01117623|567636718|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
157242785|NCT01117623|567636719|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
157242786|NCT01117623|567636720|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
157242787|NCT01117623|567636721|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
157242788|NCT01117623|567636722|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
157242789|NCT01117623|567636723|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
157242790|NCT01117623|567636724|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
157242791|NCT01117623|567636717|FG000|Overall Study|Withdrawal by Subject|0|||
157242792|NCT01117623|567636718|FG001|Overall Study|Withdrawal by Subject|0|||
157242793|NCT01117623|567636719|FG002|Overall Study|Withdrawal by Subject|2|||
157242794|NCT01117623|567636720|FG003|Overall Study|Withdrawal by Subject|0|||
157242795|NCT01117623|567636721|FG004|Overall Study|Withdrawal by Subject|0|||
157242796|NCT01117623|567636722|FG005|Overall Study|Withdrawal by Subject|1|||
157242797|NCT01117623|567636723|FG006|Overall Study|Withdrawal by Subject|1|||
157242798|NCT01117623|567636724|FG007|Overall Study|Withdrawal by Subject|1|||
157242799|NCT01117623|567636717|FG000|Overall Study|Non-compliance with study medication|0|||
157242800|NCT01117623|567636718|FG001|Overall Study|Non-compliance with study medication|0|||
157242801|NCT01117623|567636719|FG002|Overall Study|Non-compliance with study medication|0|||
157242802|NCT01117623|567636720|FG003|Overall Study|Non-compliance with study medication|0|||
157242803|NCT01117623|567636721|FG004|Overall Study|Non-compliance with study medication|0|||
157242804|NCT01117623|567636722|FG005|Overall Study|Non-compliance with study medication|0|||
157242805|NCT01117623|567636723|FG006|Overall Study|Non-compliance with study medication|0|||
157242806|NCT01117623|567636724|FG007|Overall Study|Non-compliance with study medication|1|||
157242807|NCT01117623|567636717|FG000|Overall Study|Invest. text: completed all planned txs|0|||
157242808|NCT01117623|567636718|FG001|Overall Study|Invest. text: completed all planned txs|0|||
157242809|NCT01117623|567636719|FG002|Overall Study|Invest. text: completed all planned txs|0|||
157242810|NCT01117623|567636720|FG003|Overall Study|Invest. text: completed all planned txs|0|||
157242811|NCT01117623|567636721|FG004|Overall Study|Invest. text: completed all planned txs|0|||
157242812|NCT01117623|567636722|FG005|Overall Study|Invest. text: completed all planned txs|1|||
157242813|NCT01117623|567636723|FG006|Overall Study|Invest. text: completed all planned txs|0|||
157242814|NCT01117623|567636724|FG007|Overall Study|Invest. text: completed all planned txs|0|||
157242815|NCT02727192|567636730|FG000|Overall Study|Lost to Follow-up|1|||
157198799|NCT01728194|567470724|FG000|Overall Study|Withdrawal by Subject|7|||
157198800|NCT01728194|567470725|FG001|Overall Study|Withdrawal by Subject|3|||
157198801|NCT01728194|567470724|FG000|Overall Study|Perceived Medication Side Effects|4|||
157198802|NCT01728194|567470725|FG001|Overall Study|Perceived Medication Side Effects|0|||
157198803|NCT01728194|567470724|FG000|Overall Study|Family Member Request|1|||
157198804|NCT01728194|567470725|FG001|Overall Study|Family Member Request|0|||
157198805|NCT02309372|567470726|FG000|Overall Study|Lost to Follow-up|3|||
157198806|NCT02309372|567470727|FG001|Overall Study|Lost to Follow-up|2|||
157198807|NCT00242658|567470729|FG000|Overall Study|Lost to Follow-up|22|||
157242816|NCT02727192|567636731|FG001|Overall Study|Lost to Follow-up|0|||
157242817|NCT02727192|567636732|FG002|Overall Study|Lost to Follow-up|0|||
157242818|NCT00928057|567636733|FG000|Overall Study|Adverse Event|1|||
157242819|NCT00928057|567636734|FG001|Overall Study|Adverse Event|2|||
157242820|NCT00928057|567636733|FG000|Overall Study|Withdrawal by Subject|1|||
157242821|NCT00928057|567636734|FG001|Overall Study|Withdrawal by Subject|0|||
157242822|NCT00928057|567636733|FG000|Overall Study|Lost to Follow-up|0|||
157242823|NCT00928057|567636734|FG001|Overall Study|Lost to Follow-up|1|||
157242824|NCT00928057|567636733|FG000|Overall Study|Protocol Violation|0|||
157242825|NCT00928057|567636734|FG001|Overall Study|Protocol Violation|1|||
157242826|NCT03206749|567636735|FG000|Overall Study|Withdrawal of consent|5|||
157242827|NCT03206749|567636736|FG001|Overall Study|Withdrawal of consent|3|||
157242828|NCT03206749|567636737|FG002|Overall Study|Withdrawal of consent|6|||
157242829|NCT03206749|567636735|FG000|Overall Study|Lost to Follow-up|0|||
157242830|NCT03206749|567636736|FG001|Overall Study|Lost to Follow-up|0|||
157242831|NCT03206749|567636737|FG002|Overall Study|Lost to Follow-up|1|||
157242832|NCT03674892|567636738|FG000|Overall Study|Lack of Efficacy|5|||
157242833|NCT03674892|567636738|FG000|Overall Study|Lost to Follow-up|3|||
157242834|NCT03674892|567636738|FG000|Overall Study|Migraine|2|||
157242835|NCT03674892|567636738|FG000|Overall Study|Excessive Tearing|1|||
157242836|NCT03674892|567636738|FG000|Overall Study|Increased Eye Pain|1|||
157242837|NCT03674892|567636738|FG000|Overall Study|Increased Facial Pain|1|||
157242838|NCT03674892|567636738|FG000|Overall Study|Sinus Irritation|1|||
157242839|NCT03674892|567636738|FG000|Overall Study|Sinus Infection|1|||
157242840|NCT05099380|567636739|FG000|Overall Study|Subject enrolled in error|1|||
157242841|NCT05099380|567636740|FG001|Overall Study|Subject enrolled in error|0|||
157242842|NCT05099380|567636739|FG000|Overall Study|Study Procedure|1|||
157242843|NCT05099380|567636740|FG001|Overall Study|Study Procedure|0|||
157242844|NCT05099380|567636739|FG000|Overall Study|Protocol Violation|1|||
157242845|NCT05099380|567636740|FG001|Overall Study|Protocol Violation|0|||
157242846|NCT05099380|567636739|FG000|Overall Study|Adverse Event|1|||
157242847|NCT05099380|567636740|FG001|Overall Study|Adverse Event|1|||
157242848|NCT05099380|567636739|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
157242849|NCT05099380|567636740|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
157242850|NCT01959672|567636746|FG000|Overall Study|Death|1|||
157242851|NCT02392195|567636747|FG000|Overall Study|Lost to Follow-up|4|||
157242852|NCT02392195|567636747|FG000|Overall Study|Withdrawal by Subject|4|||
157242853|NCT00840216|567636748|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
157242854|NCT00840216|567636749|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
157242855|NCT00545792|567636752|FG000|Overall Study|Withdrawal by Subject|1|||
157242856|NCT05041361|567636754|FG000|Overall Study|Lost to Follow-up|1|||
157242857|NCT05041361|567636755|FG001|Overall Study|Lost to Follow-up|3|||
157242858|NCT01642277|567636756|FG000|Overall Study|Adverse Event|10|||
157242859|NCT01642277|567636757|FG001|Overall Study|Adverse Event|0|||
157242860|NCT01642277|567636756|FG000|Overall Study|Physician Decision|2|||
157242861|NCT01642277|567636757|FG001|Overall Study|Physician Decision|0|||
157242862|NCT01642277|567636756|FG000|Overall Study|Protocol Violation|1|||
157242863|NCT01642277|567636757|FG001|Overall Study|Protocol Violation|0|||
157242864|NCT01642277|567636756|FG000|Overall Study|Withdrawal by Subject|11|||
157242865|NCT01642277|567636757|FG001|Overall Study|Withdrawal by Subject|0|||
157242866|NCT03679598|567636758|FG000|Overall Study|Adverse Event|2|||
157242867|NCT03679598|567636759|FG001|Overall Study|Adverse Event|0|||
157242868|NCT03605342|567636760|FG000|Overall Study|Withdrawal by Subject|9|||
157242869|NCT03605342|567636761|FG001|Overall Study|Withdrawal by Subject|7|||
157242870|NCT03605342|567636760|FG000|Overall Study|Lost to Follow-up|1|||
157242871|NCT03605342|567636761|FG001|Overall Study|Lost to Follow-up|1|||
157242872|NCT02842853|567636764|FG000|Overall Study|Non-compliance with the protocol|3|||
157242873|NCT02842853|567636765|FG001|Overall Study|Non-compliance with the protocol|7|||
157242874|NCT02842853|567636766|FG002|Overall Study|Non-compliance with the protocol|2|||
157242875|NCT02842853|567636767|FG003|Overall Study|Non-compliance with the protocol|5|||
157242876|NCT02842853|567636764|FG000|Overall Study|Subject met exclusion criteria|0|||
157242877|NCT02842853|567636765|FG001|Overall Study|Subject met exclusion criteria|1|||
157242878|NCT02842853|567636766|FG002|Overall Study|Subject met exclusion criteria|0|||
157242879|NCT02842853|567636767|FG003|Overall Study|Subject met exclusion criteria|0|||
157242880|NCT02842853|567636764|FG000|Overall Study|Withdrawal by Subject|11|||
157242881|NCT02842853|567636765|FG001|Overall Study|Withdrawal by Subject|13|||
157242882|NCT02842853|567636766|FG002|Overall Study|Withdrawal by Subject|9|||
157242883|NCT02842853|567636767|FG003|Overall Study|Withdrawal by Subject|8|||
157242884|NCT02842853|567636764|FG000|Overall Study|Lost to Follow-up|9|||
157242885|NCT02842853|567636765|FG001|Overall Study|Lost to Follow-up|13|||
157242886|NCT02842853|567636766|FG002|Overall Study|Lost to Follow-up|10|||
157242887|NCT02842853|567636767|FG003|Overall Study|Lost to Follow-up|11|||
157242888|NCT01380782|567636768|FG000|Overall Study|Adverse Event|0|||
157242889|NCT01380782|567636769|FG001|Overall Study|Adverse Event|1|||
157242890|NCT01380782|567636770|FG002|Overall Study|Adverse Event|0|||
157242891|NCT01380782|567636771|FG003|Overall Study|Adverse Event|0|||
157242892|NCT01380782|567636768|FG000|Overall Study|Death|1|||
157242893|NCT01380782|567636769|FG001|Overall Study|Death|0|||
157242894|NCT01380782|567636770|FG002|Overall Study|Death|0|||
156863431|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
157242895|NCT01380782|567636771|FG003|Overall Study|Death|0|||
157242896|NCT01380782|567636768|FG000|Overall Study|Lack of Efficacy|10|||
157198808|NCT00242658|567470730|FG001|Overall Study|Lost to Follow-up|19|||
157198809|NCT04604015|567470731|FG000|Overall Study|Incomplete Data Collection|33|||
157198810|NCT02576652|567470734|FG000|Overall Study|Withdrawal by Subject|2|||
157198811|NCT02811640|567470735|FG000|Overall Study|Technology malfunction|2|||
157198812|NCT00553319|567470746|FG000|Overall Study|Lost to Follow-up|10|||
157198813|NCT00553319|567470747|FG001|Overall Study|Lost to Follow-up|9|||
157242897|NCT01380782|567636769|FG001|Overall Study|Lack of Efficacy|9|||
157242898|NCT01380782|567636770|FG002|Overall Study|Lack of Efficacy|10|||
157242899|NCT01380782|567636771|FG003|Overall Study|Lack of Efficacy|3|||
157242900|NCT01380782|567636768|FG000|Overall Study|Physician Decision|1|||
157242901|NCT01380782|567636769|FG001|Overall Study|Physician Decision|0|||
157242902|NCT01380782|567636770|FG002|Overall Study|Physician Decision|0|||
157242903|NCT01380782|567636771|FG003|Overall Study|Physician Decision|0|||
157242904|NCT01380782|567636768|FG000|Overall Study|Withdrawal by Subject|0|||
157242905|NCT01380782|567636769|FG001|Overall Study|Withdrawal by Subject|0|||
157242906|NCT01380782|567636770|FG002|Overall Study|Withdrawal by Subject|1|||
157242907|NCT01380782|567636771|FG003|Overall Study|Withdrawal by Subject|1|||
157242908|NCT01403194|567636775|FG000|Overall Study|Screen Failure|2|||
157242909|NCT01403194|567636775|FG000|Overall Study|Lost to Follow-up|8|||
157242910|NCT03428750|567636776|FG000|Overall Study|Withdrawal by Subject|11|||
157242911|NCT03428750|567636777|FG001|Overall Study|Withdrawal by Subject|10|||
157242912|NCT03428750|567636776|FG000|Overall Study|Lost to Follow-up|3|||
157242913|NCT03428750|567636777|FG001|Overall Study|Lost to Follow-up|9|||
157242914|NCT03428750|567636776|FG000|Overall Study|Adverse Event|9|||
157242915|NCT03428750|567636777|FG001|Overall Study|Adverse Event|1|||
157242916|NCT03428750|567636776|FG000|Overall Study|Protocol Violation|1|||
157242917|NCT03428750|567636777|FG001|Overall Study|Protocol Violation|0|||
157242918|NCT03428750|567636776|FG000|Overall Study|Administrative|0|||
157242919|NCT03428750|567636777|FG001|Overall Study|Administrative|1|||
157242920|NCT00274651|567636780|FG000|Overall Study|Adverse Event|6|||
157242921|NCT00274651|567636781|FG001|Overall Study|Adverse Event|3|||
157242922|NCT00274651|567636780|FG000|Overall Study|Lack of Efficacy|13|||
157242923|NCT00274651|567636781|FG001|Overall Study|Lack of Efficacy|6|||
157242924|NCT00274651|567636780|FG000|Overall Study|Death|1|||
157242925|NCT00274651|567636781|FG001|Overall Study|Death|3|||
157242926|NCT00274651|567636780|FG000|Overall Study|Withdrawal by Subject|0|||
157242927|NCT00274651|567636781|FG001|Overall Study|Withdrawal by Subject|1|||
157242928|NCT00274651|567636780|FG000|Overall Study|Physician Decision|8|||
157242929|NCT00274651|567636781|FG001|Overall Study|Physician Decision|7|||
157242930|NCT05133180|567636784|FG000|Overall Study|Withdrawal of consent|1|||
157242931|NCT05133180|567636785|FG001|Overall Study|Withdrawal of consent|1|||
157242932|NCT05133180|567636784|FG000|Overall Study|Lost to Follow-up|1|||
157242933|NCT05133180|567636785|FG001|Overall Study|Lost to Follow-up|1|||
157242934|NCT05133180|567636784|FG000|Overall Study|Documented disease progression|0|||
157242935|NCT05133180|567636785|FG001|Overall Study|Documented disease progression|1|||
157242936|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
157242937|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
157242938|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
157242939|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
157242940|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
157242941|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
157242942|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
157242943|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
157242944|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
157242945|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
157242946|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
157242947|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
157242948|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
157242949|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
157242950|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
157242951|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
157242952|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
157198814|NCT00553319|567470748|FG002|Overall Study|Lost to Follow-up|5|||
157198815|NCT00553319|567470746|FG000|Overall Study|wanted treatment elsewhere|2|||
157198816|NCT00553319|567470747|FG001|Overall Study|wanted treatment elsewhere|1|||
157242953|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
157242954|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
157242955|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
157242956|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
157242957|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
157242958|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
157242959|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
157198817|NCT00553319|567470748|FG002|Overall Study|wanted treatment elsewhere|1|||
157198818|NCT00553319|567470746|FG000|Overall Study|non-compliance|0|||
157198819|NCT00553319|567470747|FG001|Overall Study|non-compliance|0|||
157198820|NCT00553319|567470748|FG002|Overall Study|non-compliance|2|||
157198821|NCT00553319|567470746|FG000|Overall Study|incarceration|1|||
157198822|NCT00553319|567470747|FG001|Overall Study|incarceration|0|||
157198823|NCT00553319|567470748|FG002|Overall Study|incarceration|0|||
157198824|NCT00553319|567470746|FG000|Overall Study|moved|1|||
157198825|NCT00553319|567470747|FG001|Overall Study|moved|0|||
157198826|NCT00553319|567470748|FG002|Overall Study|moved|1|||
157198827|NCT04369742|567470754|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
157198828|NCT04369742|567470755|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
157198829|NCT04369742|567470754|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
157198830|NCT04369742|567470755|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
157198831|NCT03575975|567470756|FG000|Overall Study|Lost to Follow-up|1|||
157198832|NCT03575975|567470757|FG001|Overall Study|Lost to Follow-up|0|||
157198833|NCT03575975|567470758|FG002|Overall Study|Lost to Follow-up|0|||
157198834|NCT00465894|567470759|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
157198835|NCT00465894|567470760|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
157198836|NCT00465894|567470759|FG000|Treatment For 12 Weeks|Family Issues|1|||
157198837|NCT00465894|567470760|FG001|Treatment For 12 Weeks|Family Issues|1|||
157198838|NCT00465894|567470759|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
157198839|NCT00465894|567470760|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
157198840|NCT01383317|567470761|FG000|Overall Study|Lost to Follow-up|2|||
157198841|NCT01383317|567470762|FG001|Overall Study|Lost to Follow-up|1|||
157198842|NCT01383317|567470761|FG000|Overall Study|Death|1|||
157198843|NCT01383317|567470762|FG001|Overall Study|Death|0|||
157198844|NCT01383317|567470761|FG000|Overall Study|Adverse Event|0|||
157198845|NCT01383317|567470762|FG001|Overall Study|Adverse Event|1|||
157198846|NCT01207427|567470764|FG000|Double-blind Treatment Period|Adverse Event|0|||
157198847|NCT01207427|567470765|FG001|Double-blind Treatment Period|Adverse Event|1|||
157198848|NCT01207427|567470766|FG002|Double-blind Treatment Period|Adverse Event|0|||
157198849|NCT01207427|567470764|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
157198850|NCT01207427|567470765|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
157198851|NCT01207427|567470766|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
157198852|NCT01207427|567470764|FG000|Double-blind Treatment Period|Protocol Violation|2|||
157198853|NCT01207427|567470765|FG001|Double-blind Treatment Period|Protocol Violation|1|||
157198854|NCT01207427|567470766|FG002|Double-blind Treatment Period|Protocol Violation|1|||
157198855|NCT01207427|567470764|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
157198856|NCT01207427|567470765|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
157198857|NCT01207427|567470766|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157198858|NCT01230489|567470767|FG000|Overall Study|Death|2|||
157198859|NCT01230489|567470767|FG000|Overall Study|Adverse Event|2|||
157198860|NCT01230489|567470767|FG000|Overall Study|Treatment modality changed|1|||
157198861|NCT02451137|567470768|FG000|Overall Study|Randomized but not treated|19|||
157198862|NCT02451137|567470769|FG001|Overall Study|Randomized but not treated|27|||
157198863|NCT02451137|567470768|FG000|Overall Study|Adverse Event|43|||
157198864|NCT02451137|567470769|FG001|Overall Study|Adverse Event|42|||
157198865|NCT02451137|567470768|FG000|Overall Study|Lack of Efficacy|4|||
157198866|NCT02451137|567470769|FG001|Overall Study|Lack of Efficacy|9|||
157198867|NCT02451137|567470768|FG000|Overall Study|Participant decision:discontinue insulin|41|||
157198868|NCT02451137|567470769|FG001|Overall Study|Participant decision:discontinue insulin|43|||
157198869|NCT02451137|567470768|FG000|Overall Study|Hypoglycemia|2|||
157198870|NCT02451137|567470769|FG001|Overall Study|Hypoglycemia|1|||
157198871|NCT02451137|567470768|FG000|Overall Study|Investigator's decision|23|||
157198872|NCT02451137|567470769|FG001|Overall Study|Investigator's decision|19|||
157198873|NCT02451137|567470768|FG000|Overall Study|Lost to Follow-up|53|||
157198874|NCT02451137|567470769|FG001|Overall Study|Lost to Follow-up|61|||
157198875|NCT02451137|567470768|FG000|Overall Study|Physician Decision|6|||
157198876|NCT02451137|567470769|FG001|Overall Study|Physician Decision|5|||
157198877|NCT02451137|567470768|FG000|Overall Study|Sponsor decision|13|||
157198878|NCT02451137|567470769|FG001|Overall Study|Sponsor decision|25|||
157198879|NCT02451137|567470768|FG000|Overall Study|Withdrawal by Subject|40|||
157198880|NCT02451137|567470769|FG001|Overall Study|Withdrawal by Subject|63|||
157198881|NCT02451137|567470768|FG000|Overall Study|Other than specified above|2|||
157198882|NCT02451137|567470769|FG001|Overall Study|Other than specified above|3|||
157198883|NCT02842736|567473188|FG000|Overall Study|Lost to Follow-up|13|||
157198884|NCT02842736|567473188|FG000|Overall Study|Intervention for menstrual bleeding|17|||
157198885|NCT02842736|567473188|FG000|Overall Study|Withdrawal by Subject|4|||
157198886|NCT02842736|567473188|FG000|Overall Study|Pregnancy|3|||
157198887|NCT02842736|567473188|FG000|Overall Study|Hysterectomy for fibroids|2|||
157198888|NCT02842736|567473188|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
157198889|NCT02842736|567473188|FG000|Overall Study|IUD: Mirena|1|||
157198890|NCT03323034|567473192|FG000|Overall Study|Lack of Efficacy|5|||
157198891|NCT03323034|567473193|FG001|Overall Study|Lack of Efficacy|5|||
157198892|NCT03323034|567473194|FG002|Overall Study|Lack of Efficacy|6|||
157198893|NCT03323034|567473195|FG003|Overall Study|Lack of Efficacy|5|||
157198894|NCT03323034|567473196|FG004|Overall Study|Lack of Efficacy|5|||
157198895|NCT03323034|567473192|FG000|Overall Study|Physician Decision|0|||
157198896|NCT03323034|567473193|FG001|Overall Study|Physician Decision|0|||
157198897|NCT03323034|567473194|FG002|Overall Study|Physician Decision|0|||
157198898|NCT03323034|567473195|FG003|Overall Study|Physician Decision|0|||
157198899|NCT03323034|567473196|FG004|Overall Study|Physician Decision|1|||
157198900|NCT03323034|567473192|FG000|Overall Study|Withdrawal by Subject|1|||
157242960|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
157242961|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
157242962|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
157242963|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
157242964|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
157242965|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
157198901|NCT03323034|567473193|FG001|Overall Study|Withdrawal by Subject|1|||
157198902|NCT03323034|567473194|FG002|Overall Study|Withdrawal by Subject|0|||
157198903|NCT03323034|567473195|FG003|Overall Study|Withdrawal by Subject|1|||
157198904|NCT03323034|567473196|FG004|Overall Study|Withdrawal by Subject|0|||
157198905|NCT02646566|567473198|FG000|Overall Study|Lost to Follow-up|5|||
157198906|NCT02646566|567473199|FG001|Overall Study|Lost to Follow-up|4|||
157198907|NCT02646566|567473200|FG002|Overall Study|Lost to Follow-up|5|||
157198908|NCT02646566|567473198|FG000|Overall Study|Treatment failure|1|||
157198909|NCT02646566|567473199|FG001|Overall Study|Treatment failure|0|||
157198910|NCT02646566|567473200|FG002|Overall Study|Treatment failure|0|||
157198911|NCT00953017|567473203|FG000|Overall Study|DId not show up for colonoscopy|4|||
157198912|NCT00953017|567473204|FG001|Overall Study|DId not show up for colonoscopy|4|||
157198913|NCT00953017|567473205|FG002|Overall Study|DId not show up for colonoscopy|5|||
157198914|NCT00953017|567473206|FG003|Overall Study|DId not show up for colonoscopy|4|||
157198915|NCT00953017|567473203|FG000|Overall Study|Incomplete data|1|||
157198916|NCT00953017|567473204|FG001|Overall Study|Incomplete data|1|||
157198917|NCT00953017|567473205|FG002|Overall Study|Incomplete data|0|||
157198918|NCT00953017|567473206|FG003|Overall Study|Incomplete data|0|||
157198919|NCT00953017|567473203|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
157198920|NCT00953017|567473204|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
157198921|NCT00953017|567473205|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
157198922|NCT00953017|567473206|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
157198923|NCT00953017|567473203|FG000|Overall Study|Brown stool prior to procedure|0|||
157198924|NCT00953017|567473204|FG001|Overall Study|Brown stool prior to procedure|0|||
157198925|NCT00953017|567473205|FG002|Overall Study|Brown stool prior to procedure|1|||
157198926|NCT00953017|567473206|FG003|Overall Study|Brown stool prior to procedure|0|||
157198927|NCT00798161|567473208|FG000|Overall Study|Adverse Event|3|||
157198928|NCT00798161|567473209|FG001|Overall Study|Adverse Event|4|||
157198929|NCT00798161|567473210|FG002|Overall Study|Adverse Event|6|||
157198930|NCT00798161|567473211|FG003|Overall Study|Adverse Event|6|||
157198931|NCT00798161|567473212|FG004|Overall Study|Adverse Event|5|||
157198932|NCT00798161|567473213|FG005|Overall Study|Adverse Event|2|||
157198933|NCT00798161|567473214|FG006|Overall Study|Adverse Event|4|||
157198934|NCT00798161|567473208|FG000|Overall Study|Protocol Violation|2|||
157198935|NCT00798161|567473209|FG001|Overall Study|Protocol Violation|1|||
157198936|NCT00798161|567473210|FG002|Overall Study|Protocol Violation|3|||
157198937|NCT00798161|567473211|FG003|Overall Study|Protocol Violation|3|||
157198938|NCT00798161|567473212|FG004|Overall Study|Protocol Violation|3|||
157198939|NCT00798161|567473213|FG005|Overall Study|Protocol Violation|2|||
157198940|NCT00798161|567473214|FG006|Overall Study|Protocol Violation|0|||
157198941|NCT00798161|567473208|FG000|Overall Study|Lost to Follow-up|1|||
157198942|NCT00798161|567473209|FG001|Overall Study|Lost to Follow-up|3|||
157198943|NCT00798161|567473210|FG002|Overall Study|Lost to Follow-up|4|||
157198944|NCT00798161|567473211|FG003|Overall Study|Lost to Follow-up|3|||
157198945|NCT00798161|567473212|FG004|Overall Study|Lost to Follow-up|4|||
157198946|NCT00798161|567473213|FG005|Overall Study|Lost to Follow-up|0|||
157198947|NCT00798161|567473214|FG006|Overall Study|Lost to Follow-up|0|||
157198948|NCT00798161|567473208|FG000|Overall Study|Withdrawal by Subject|5|||
157198949|NCT00798161|567473209|FG001|Overall Study|Withdrawal by Subject|4|||
157198950|NCT00798161|567473210|FG002|Overall Study|Withdrawal by Subject|5|||
157198951|NCT00798161|567473211|FG003|Overall Study|Withdrawal by Subject|4|||
157198952|NCT00798161|567473212|FG004|Overall Study|Withdrawal by Subject|2|||
157242966|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
157198953|NCT00798161|567473213|FG005|Overall Study|Withdrawal by Subject|3|||
157198954|NCT00798161|567473214|FG006|Overall Study|Withdrawal by Subject|1|||
157198955|NCT00798161|567473208|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
157198956|NCT00798161|567473209|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
157198957|NCT00798161|567473210|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
157198958|NCT00798161|567473211|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
157198959|NCT00798161|567473212|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
157198960|NCT00798161|567473213|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
157198961|NCT00798161|567473214|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
157198962|NCT00503035|567473218|FG000|Overall Study|Lost to Follow-up|2|||
157242967|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
157242968|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
157242969|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
157242970|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
157242971|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
157242972|NCT04194801|567636786|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
157242973|NCT04194801|567636787|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
157242974|NCT04194801|567636788|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
157242975|NCT04194801|567636786|FG000|Part Ib/II End of Study|Death|2|||
157242976|NCT04194801|567636787|FG001|Part Ib/II End of Study|Death|3|||
157242977|NCT04194801|567636788|FG002|Part Ib/II End of Study|Death|3|||
157242978|NCT04194801|567636786|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
157242979|NCT04194801|567636787|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
157242980|NCT04194801|567636788|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
157242981|NCT04194801|567636786|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
157242982|NCT04194801|567636787|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
157242983|NCT04194801|567636788|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
157242984|NCT04194801|567636786|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
157242985|NCT04194801|567636787|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
157242986|NCT04194801|567636788|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
157242987|NCT04194801|567636786|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
157242988|NCT04194801|567636787|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
157242989|NCT04194801|567636788|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
157242990|NCT01604941|567636791|FG000|Overall Study|Adverse Event|1|||
157242991|NCT01604941|567636792|FG001|Overall Study|Adverse Event|2|||
157242992|NCT01604941|567636793|FG002|Overall Study|Adverse Event|0|||
157242993|NCT01604941|567636794|FG003|Overall Study|Adverse Event|0|||
157242994|NCT01604941|567636795|FG004|Overall Study|Adverse Event|1|||
157242995|NCT01604941|567636796|FG005|Overall Study|Adverse Event|5|||
157242996|NCT01604941|567636791|FG000|Overall Study|Non-compliance|1|||
157242997|NCT01604941|567636792|FG001|Overall Study|Non-compliance|0|||
157242998|NCT01604941|567636793|FG002|Overall Study|Non-compliance|0|||
157242999|NCT01604941|567636794|FG003|Overall Study|Non-compliance|0|||
157243000|NCT01604941|567636795|FG004|Overall Study|Non-compliance|0|||
157243001|NCT01604941|567636796|FG005|Overall Study|Non-compliance|0|||
157243002|NCT01604941|567636791|FG000|Overall Study|Participant Decision|0|||
157243003|NCT01604941|567636792|FG001|Overall Study|Participant Decision|0|||
157243004|NCT01604941|567636793|FG002|Overall Study|Participant Decision|0|||
157243005|NCT01604941|567636794|FG003|Overall Study|Participant Decision|0|||
157243006|NCT01604941|567636795|FG004|Overall Study|Participant Decision|0|||
157243007|NCT01604941|567636796|FG005|Overall Study|Participant Decision|2|||
157243008|NCT01604941|567636791|FG000|Overall Study|Early Study Termination|9|||
157243009|NCT01604941|567636792|FG001|Overall Study|Early Study Termination|2|||
157243010|NCT01604941|567636793|FG002|Overall Study|Early Study Termination|3|||
157243011|NCT01604941|567636794|FG003|Overall Study|Early Study Termination|3|||
157243012|NCT01604941|567636795|FG004|Overall Study|Early Study Termination|0|||
157243013|NCT01604941|567636796|FG005|Overall Study|Early Study Termination|0|||
157243014|NCT03366792|567636797|FG000|Overall Study|Withdrawal by Subject|7|||
157243015|NCT03366792|567636797|FG000|Overall Study|Lost to Follow-up|2|||
157243016|NCT03366792|567636797|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
157243017|NCT03366792|567636797|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
157243018|NCT03497130|567636798|FG000|Overall Study|Lost to Follow-up|1|||
157243019|NCT03497130|567636799|FG001|Overall Study|Lost to Follow-up|1|||
157243020|NCT02679729|567636801|FG000|Overall Study|Lost to Follow-up|0|||
157243021|NCT02679729|567636802|FG001|Overall Study|Lost to Follow-up|1|||
157243022|NCT02679729|567636803|FG002|Overall Study|Lost to Follow-up|0|||
157243023|NCT02679729|567636804|FG003|Overall Study|Lost to Follow-up|0|||
157243024|NCT02679729|567636805|FG004|Overall Study|Lost to Follow-up|1|||
157243025|NCT02679729|567636806|FG005|Overall Study|Lost to Follow-up|0|||
157243026|NCT02679729|567636807|FG006|Overall Study|Lost to Follow-up|0|||
157243027|NCT02679729|567636808|FG007|Overall Study|Lost to Follow-up|0|||
157243028|NCT02679729|567636809|FG008|Overall Study|Lost to Follow-up|0|||
157243029|NCT02679729|567636801|FG000|Overall Study|Participant decision|0|||
157243030|NCT02679729|567636802|FG001|Overall Study|Participant decision|1|||
157243031|NCT02679729|567636803|FG002|Overall Study|Participant decision|0|||
157243032|NCT02679729|567636804|FG003|Overall Study|Participant decision|0|||
157243033|NCT02679729|567636805|FG004|Overall Study|Participant decision|0|||
157243034|NCT02679729|567636806|FG005|Overall Study|Participant decision|0|||
157243035|NCT02679729|567636807|FG006|Overall Study|Participant decision|1|||
157243036|NCT02679729|567636808|FG007|Overall Study|Participant decision|0|||
157243037|NCT02679729|567636809|FG008|Overall Study|Participant decision|0|||
157243038|NCT00748566|567636810|FG000|Overall Study|Adverse Event|49|||
157243039|NCT00748566|567636810|FG000|Overall Study|Death|1|||
157243040|NCT00748566|567636810|FG000|Overall Study|Lack of Efficacy|12|||
157243041|NCT00748566|567636810|FG000|Overall Study|Lost to Follow-up|1|||
157198963|NCT00503035|567473218|FG000|Overall Study|Physician Decision|3|||
157198964|NCT00503035|567473218|FG000|Overall Study|Ineligible|15|||
157198965|NCT01982942|567473224|FG000|Overall Study|Adverse Event|10|||
157198966|NCT01982942|567473225|FG001|Overall Study|Adverse Event|5|||
157198967|NCT01982942|567473224|FG000|Overall Study|Lost to Follow-up|4|||
157198968|NCT01982942|567473225|FG001|Overall Study|Lost to Follow-up|3|||
157198969|NCT01982942|567473224|FG000|Overall Study|Multiple sclerosis progression|3|||
157198970|NCT01982942|567473225|FG001|Overall Study|Multiple sclerosis progression|2|||
157198971|NCT01982942|567473224|FG000|Overall Study|Wanted to try therapy not permitted|1|||
157198972|NCT01982942|567473225|FG001|Overall Study|Wanted to try therapy not permitted|0|||
157198973|NCT01982942|567473224|FG000|Overall Study|Subject declined future visits|0|||
157198974|NCT01982942|567473225|FG001|Overall Study|Subject declined future visits|1|||
157198975|NCT01982942|567473224|FG000|Overall Study|Left geographical area|2|||
157198976|NCT01982942|567473225|FG001|Overall Study|Left geographical area|0|||
157198977|NCT01982942|567473224|FG000|Overall Study|Too many pills|1|||
157198978|NCT01982942|567473225|FG001|Overall Study|Too many pills|0|||
157198979|NCT01982942|567473224|FG000|Overall Study|MS Relapse|0|||
157198980|NCT01982942|567473225|FG001|Overall Study|MS Relapse|1|||
157198981|NCT01982942|567473224|FG000|Overall Study|Chose to join a stem cell trial|0|||
157198982|NCT01982942|567473225|FG001|Overall Study|Chose to join a stem cell trial|1|||
157198983|NCT01982942|567473224|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
157198984|NCT01982942|567473225|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
157198985|NCT04576702|567473226|FG000|Overall Study|Death|1|||
157198986|NCT04576702|567473227|FG001|Overall Study|Death|0|||
157198987|NCT04576702|567473228|FG002|Overall Study|Death|0|||
157198988|NCT04576702|567473229|FG003|Overall Study|Death|0|||
157198989|NCT04576702|567473226|FG000|Overall Study|Withdrawal by Subject|0|||
157198990|NCT04576702|567473227|FG001|Overall Study|Withdrawal by Subject|2|||
157198991|NCT04576702|567473228|FG002|Overall Study|Withdrawal by Subject|1|||
157198992|NCT04576702|567473229|FG003|Overall Study|Withdrawal by Subject|0|||
157198993|NCT04576702|567473226|FG000|Overall Study|Lost to Follow-up|3|||
157198994|NCT04576702|567473227|FG001|Overall Study|Lost to Follow-up|3|||
157198995|NCT04576702|567473228|FG002|Overall Study|Lost to Follow-up|3|||
157198996|NCT04576702|567473229|FG003|Overall Study|Lost to Follow-up|4|||
157198997|NCT01151085|567473232|FG000|Overall Study|Lost to Follow-up|31|||
157198998|NCT01151085|567473232|FG000|Overall Study|Protocol Violation|25|||
157198999|NCT02059265|567473233|FG000|Overall Study|Ineligible|4|||
157199000|NCT00465101|567473234|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
157199001|NCT00465101|567473234|FG000|Overall Study|Change in health precluded follow up|4|||
157199002|NCT00465101|567473234|FG000|Overall Study|Did not meet study criteria|4|||
157199003|NCT00465101|567473234|FG000|Overall Study|Lost to Follow-up|5|||
157199004|NCT00465101|567473234|FG000|Overall Study|Other|6|||
157199005|NCT00465101|567473234|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
157199006|NCT00465101|567473234|FG000|Overall Study|Patient postponed procedure|1|||
157199007|NCT00465101|567473234|FG000|Overall Study|Site closed due to IRB expiration|1|||
157199008|NCT00465101|567473234|FG000|Overall Study|Unable to obtain IRB approval|1|||
157199009|NCT00465101|567473234|FG000|Overall Study|Death|3|||
157199010|NCT00465101|567473234|FG000|Overall Study|Withdrawal by Subject|25|||
157199011|NCT00465101|567473234|FG000|Overall Study|Physician Decision|1|||
157199012|NCT00465101|567473234|FG000|Overall Study|Withdrew consent prior to procedure|3|||
157199013|NCT02985996|567473240|FG000|Overall Study|Withdrawal by Subject|0|||
157199014|NCT02985996|567473241|FG001|Overall Study|Withdrawal by Subject|0|||
157199015|NCT02985996|567473242|FG002|Overall Study|Withdrawal by Subject|1|||
157199016|NCT02985996|567473243|FG003|Overall Study|Withdrawal by Subject|0|||
157199017|NCT02985996|567473244|FG004|Overall Study|Withdrawal by Subject|0|||
157199018|NCT02985996|567473240|FG000|Overall Study|Protocol Violation|0|||
157199019|NCT02985996|567473241|FG001|Overall Study|Protocol Violation|1|||
157199020|NCT02985996|567473242|FG002|Overall Study|Protocol Violation|0|||
157199021|NCT02985996|567473243|FG003|Overall Study|Protocol Violation|0|||
157199022|NCT02985996|567473244|FG004|Overall Study|Protocol Violation|0|||
157199023|NCT00401726|567473245|FG000|Overall Study|Adverse Event|34|||
157199024|NCT00401726|567473246|FG001|Overall Study|Adverse Event|45|||
157199025|NCT00401726|567473245|FG000|Overall Study|Death|0|||
157199026|NCT00401726|567473246|FG001|Overall Study|Death|3|||
157199027|NCT00401726|567473245|FG000|Overall Study|Sponsor Request|0|||
157199028|NCT00401726|567473246|FG001|Overall Study|Sponsor Request|1|||
157199029|NCT00401726|567473245|FG000|Overall Study|Physician Decision|3|||
157199030|NCT00401726|567473246|FG001|Overall Study|Physician Decision|6|||
157199031|NCT00401726|567473245|FG000|Overall Study|Lost to Follow-up|23|||
157199032|NCT00401726|567473246|FG001|Overall Study|Lost to Follow-up|20|||
157199033|NCT00401726|567473245|FG000|Overall Study|Protocol Violation|6|||
157199034|NCT00401726|567473246|FG001|Overall Study|Protocol Violation|3|||
157199035|NCT00401726|567473245|FG000|Overall Study|Withdrawal by Subject|18|||
157199036|NCT00401726|567473246|FG001|Overall Study|Withdrawal by Subject|24|||
157199037|NCT00401726|567473245|FG000|Overall Study|Lack of Efficacy|4|||
157199038|NCT00401726|567473246|FG001|Overall Study|Lack of Efficacy|6|||
157199039|NCT00401726|567473245|FG000|Overall Study|Protocol Deviation|9|||
157199040|NCT00401726|567473246|FG001|Overall Study|Protocol Deviation|4|||
157199041|NCT02067728|567473247|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
157199042|NCT02067728|567473248|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
157199043|NCT02067728|567473247|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
157199044|NCT02067728|567473248|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
157199045|NCT02067728|567473247|FG000|6 Month Measurements|Unable to attend|114|||
157199046|NCT02067728|567473248|FG001|6 Month Measurements|Unable to attend|97|||
157199047|NCT00933543|567473250|FG000|Overall Study|Adverse Event|2|||
157199048|NCT00933543|567473251|FG001|Overall Study|Adverse Event|1|||
157199049|NCT00933543|567473250|FG000|Overall Study|Lost to Follow-up|0|||
157199050|NCT00933543|567473251|FG001|Overall Study|Lost to Follow-up|1|||
157199051|NCT00933543|567473250|FG000|Overall Study|Withdrawal by Subject|0|||
157199052|NCT00933543|567473251|FG001|Overall Study|Withdrawal by Subject|1|||
157199053|NCT00933543|567473250|FG000|Overall Study|Lack of Efficacy|0|||
157199054|NCT00933543|567473251|FG001|Overall Study|Lack of Efficacy|3|||
157199055|NCT00933543|567473250|FG000|Overall Study|Other|1|||
157199056|NCT00933543|567473251|FG001|Overall Study|Other|1|||
157199057|NCT04988035|567473253|FG000|Overall Study|Death|19|||
157199058|NCT04988035|567473254|FG001|Overall Study|Death|13|||
157199059|NCT04988035|567473253|FG000|Overall Study|Lost to Follow-up|12|||
157199060|NCT04988035|567473254|FG001|Overall Study|Lost to Follow-up|6|||
157199061|NCT04988035|567473253|FG000|Overall Study|Protocol Violation|0|||
157199062|NCT04988035|567473254|FG001|Overall Study|Protocol Violation|1|||
157199063|NCT04988035|567473253|FG000|Overall Study|Withdrawal by Subject|2|||
157199064|NCT04988035|567473254|FG001|Overall Study|Withdrawal by Subject|4|||
157199065|NCT04988035|567473253|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
157199066|NCT04988035|567473254|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
157199067|NCT03532048|567473255|FG000|Overall Study|Lost to Follow-up|12|||
157199068|NCT03532048|567473256|FG001|Overall Study|Lost to Follow-up|17|||
157199069|NCT03532048|567473255|FG000|Overall Study|Withdrawal by Subject|7|||
157199070|NCT03532048|567473256|FG001|Overall Study|Withdrawal by Subject|0|||
157199071|NCT04585906|567473257|FG000|Overall Study|Lost to Follow-up|8|||
157199072|NCT04585906|567473258|FG001|Overall Study|Lost to Follow-up|5|||
157199073|NCT04626947|567473259|FG000|Overall Study|Study terminated|14|||
157199074|NCT01050998|567473264|FG000|Overall Study|Adverse Event|1|||
157199075|NCT01050998|567473265|FG001|Overall Study|Adverse Event|0|||
157199076|NCT01050998|567473266|FG002|Overall Study|Adverse Event|1|||
157199077|NCT01050998|567473267|FG003|Overall Study|Adverse Event|0|||
157199078|NCT01050998|567473268|FG004|Overall Study|Adverse Event|2|||
157199079|NCT01050998|567473264|FG000|Overall Study|Withdrawal by Subject|0|||
157199080|NCT01050998|567473265|FG001|Overall Study|Withdrawal by Subject|0|||
157199081|NCT01050998|567473266|FG002|Overall Study|Withdrawal by Subject|0|||
157199082|NCT01050998|567473267|FG003|Overall Study|Withdrawal by Subject|1|||
157199083|NCT01050998|567473268|FG004|Overall Study|Withdrawal by Subject|3|||
157199084|NCT01050998|567473264|FG000|Overall Study|Other|3|||
157199085|NCT01050998|567473265|FG001|Overall Study|Other|2|||
157199086|NCT01050998|567473266|FG002|Overall Study|Other|1|||
157199087|NCT01050998|567473267|FG003|Overall Study|Other|1|||
157199088|NCT01050998|567473268|FG004|Overall Study|Other|5|||
157199089|NCT01050998|567473264|FG000|Overall Study|Data integrity issues|0|||
157199090|NCT01050998|567473265|FG001|Overall Study|Data integrity issues|0|||
157199091|NCT01050998|567473266|FG002|Overall Study|Data integrity issues|1|||
157199092|NCT01050998|567473267|FG003|Overall Study|Data integrity issues|1|||
157199093|NCT01050998|567473268|FG004|Overall Study|Data integrity issues|4|||
157199094|NCT01428882|567473271|FG000|Overall Study|Lack of Efficacy|2|||
157199095|NCT01428882|567473272|FG001|Overall Study|Lack of Efficacy|7|||
157199096|NCT01428882|567473271|FG000|Overall Study|Protocol Violation|4|||
157199097|NCT01428882|567473272|FG001|Overall Study|Protocol Violation|3|||
157199098|NCT00903357|567473273|FG000|First Intervention|Withdrawal by Subject|5|||
157199099|NCT00903357|567473274|FG001|First Intervention|Withdrawal by Subject|3|||
157199100|NCT00903357|567473273|FG000|First Intervention|Flu|0|||
157199101|NCT00903357|567473274|FG001|First Intervention|Flu|1|||
157199102|NCT00903357|567473273|FG000|Wash Out Period of 2 Weeks|Flu|0|||
157199103|NCT00903357|567473274|FG001|Wash Out Period of 2 Weeks|Flu|1|||
157199104|NCT00903357|567473273|FG000|Second Intervention|Lost to Follow-up|1|||
157199105|NCT00903357|567473274|FG001|Second Intervention|Lost to Follow-up|0|||
157199106|NCT02221882|567473280|FG000|Overall Study|Withdrawal by Subject|0|||
157199107|NCT02221882|567473281|FG001|Overall Study|Withdrawal by Subject|0|||
157199108|NCT02221882|567473282|FG002|Overall Study|Withdrawal by Subject|4|||
157199109|NCT02221882|567473283|FG003|Overall Study|Withdrawal by Subject|2|||
157199110|NCT02221882|567473284|FG004|Overall Study|Withdrawal by Subject|2|||
157199111|NCT02221882|567473285|FG005|Overall Study|Withdrawal by Subject|2|||
157199112|NCT02221882|567473280|FG000|Overall Study|Death|0|||
157199113|NCT02221882|567473281|FG001|Overall Study|Death|1|||
157199114|NCT02221882|567473282|FG002|Overall Study|Death|0|||
157199115|NCT02221882|567473283|FG003|Overall Study|Death|0|||
157199116|NCT02221882|567473284|FG004|Overall Study|Death|0|||
157199117|NCT02221882|567473285|FG005|Overall Study|Death|0|||
157199118|NCT05664672|567473290|FG000|Overall Study|Adverse Event|0|||
157199119|NCT05664672|567473291|FG001|Overall Study|Adverse Event|0|||
157199120|NCT05664672|567473292|FG002|Overall Study|Adverse Event|0|||
157199121|NCT05664672|567473293|FG003|Overall Study|Adverse Event|0|||
157199122|NCT05664672|567473294|FG004|Overall Study|Adverse Event|0|||
157199123|NCT05664672|567473295|FG005|Overall Study|Adverse Event|1|||
157199124|NCT05664672|567473290|FG000|Overall Study|Withdrawal by Subject|0|||
157199125|NCT05664672|567473291|FG001|Overall Study|Withdrawal by Subject|1|||
157199126|NCT05664672|567473292|FG002|Overall Study|Withdrawal by Subject|3|||
157199127|NCT05664672|567473293|FG003|Overall Study|Withdrawal by Subject|0|||
157199128|NCT05664672|567473294|FG004|Overall Study|Withdrawal by Subject|5|||
157199129|NCT05664672|567473295|FG005|Overall Study|Withdrawal by Subject|6|||
157199130|NCT05664672|567473290|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
157199131|NCT05664672|567473291|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
157199132|NCT05664672|567473292|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
157199133|NCT05664672|567473293|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
157199134|NCT05664672|567473294|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
157199135|NCT05664672|567473295|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
157199136|NCT05664672|567473290|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
157199137|NCT05664672|567473291|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
157199138|NCT05664672|567473292|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
157199139|NCT05664672|567473293|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
157199140|NCT05664672|567473294|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
157199141|NCT05664672|567473295|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
157199142|NCT04095039|567473306|FG000|Overall Study|Withdrawal by Subject|2|||
157199143|NCT04095039|567473307|FG001|Overall Study|Withdrawal by Subject|16|||
157199144|NCT04095039|567473306|FG000|Overall Study|Transplanted|21|||
157199145|NCT04095039|567473307|FG001|Overall Study|Transplanted|24|||
157199146|NCT04095039|567473306|FG000|Overall Study|Transferred to Non-study Facility|47|||
157199147|NCT04095039|567473307|FG001|Overall Study|Transferred to Non-study Facility|44|||
157199148|NCT04095039|567473306|FG000|Overall Study|Withdrawal from internvention target|0|||
157199149|NCT04095039|567473307|FG001|Overall Study|Withdrawal from internvention target|2|||
157199150|NCT04095039|567473306|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
157199151|NCT04095039|567473307|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
157199152|NCT04095039|567473306|FG000|Overall Study|Cacliphylaxis|0|||
157199153|NCT04095039|567473307|FG001|Overall Study|Cacliphylaxis|1|||
157199154|NCT04095039|567473306|FG000|Overall Study|Pregnancy|1|||
157199155|NCT04095039|567473307|FG001|Overall Study|Pregnancy|0|||
157199156|NCT02370173|567473308|FG000|Overall Study|Protocol Violation|1|||
157199157|NCT02370173|567473309|FG001|Overall Study|Protocol Violation|1|||
157199158|NCT02370173|567473308|FG000|Overall Study|Withdrawal by Subject|2|||
157199159|NCT02370173|567473309|FG001|Overall Study|Withdrawal by Subject|2|||
157199160|NCT04794491|567473310|FG000|Overall Study|Adverse Event|1|||
157199161|NCT04794491|567473310|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
157199162|NCT04794491|567473310|FG000|Overall Study|Noncompliance With Study Intervention|1|||
157199163|NCT04794491|567473310|FG000|Overall Study|Withdrawal by Subject|2|||
157199164|NCT01326481|567473311|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
157199165|NCT01038609|567473316|FG000|Overall Study|Adverse Event|0|||
157199166|NCT01038609|567473317|FG001|Overall Study|Adverse Event|0|||
157199167|NCT01038609|567473318|FG002|Overall Study|Adverse Event|1|||
157199168|NCT01038609|567473319|FG003|Overall Study|Adverse Event|0|||
157199169|NCT01038609|567473320|FG004|Overall Study|Adverse Event|0|||
157199170|NCT01038609|567473316|FG000|Overall Study|Dosing Error|0|||
157199171|NCT01038609|567473317|FG001|Overall Study|Dosing Error|0|||
157199172|NCT01038609|567473318|FG002|Overall Study|Dosing Error|0|||
157199173|NCT01038609|567473319|FG003|Overall Study|Dosing Error|1|||
157199174|NCT01038609|567473320|FG004|Overall Study|Dosing Error|1|||
157199175|NCT01038609|567473316|FG000|Overall Study|Death in the Family|1|||
157199176|NCT01038609|567473317|FG001|Overall Study|Death in the Family|0|||
157199177|NCT01038609|567473318|FG002|Overall Study|Death in the Family|0|||
157199178|NCT01038609|567473319|FG003|Overall Study|Death in the Family|0|||
157199179|NCT01038609|567473320|FG004|Overall Study|Death in the Family|0|||
157199180|NCT01038609|567473316|FG000|Overall Study|Refusal of Blood Draws|0|||
157199181|NCT01038609|567473317|FG001|Overall Study|Refusal of Blood Draws|1|||
157199182|NCT01038609|567473318|FG002|Overall Study|Refusal of Blood Draws|0|||
157199183|NCT01038609|567473319|FG003|Overall Study|Refusal of Blood Draws|0|||
157199184|NCT01038609|567473320|FG004|Overall Study|Refusal of Blood Draws|0|||
157199185|NCT01314261|567473321|FG000|Overall Study|Adverse Event|1|||
157199186|NCT01314261|567473322|FG001|Overall Study|Adverse Event|0|||
157199187|NCT01314261|567473323|FG002|Overall Study|Adverse Event|0|||
157199188|NCT01314261|567473324|FG003|Overall Study|Adverse Event|0|||
157199189|NCT01314261|567473321|FG000|Overall Study|Withdrawal by Subject|0|||
157199190|NCT01314261|567473322|FG001|Overall Study|Withdrawal by Subject|3|||
157199191|NCT01314261|567473323|FG002|Overall Study|Withdrawal by Subject|1|||
157199192|NCT01314261|567473324|FG003|Overall Study|Withdrawal by Subject|0|||
157199193|NCT01314261|567473321|FG000|Overall Study|Lost to Follow-up|1|||
157199194|NCT01314261|567473322|FG001|Overall Study|Lost to Follow-up|0|||
157199195|NCT01314261|567473323|FG002|Overall Study|Lost to Follow-up|2|||
157199196|NCT01314261|567473324|FG003|Overall Study|Lost to Follow-up|2|||
157199197|NCT01314261|567473321|FG000|Overall Study|Virologic Failure|0|||
157199198|NCT01314261|567473322|FG001|Overall Study|Virologic Failure|1|||
157199199|NCT01314261|567473323|FG002|Overall Study|Virologic Failure|0|||
157199200|NCT01314261|567473324|FG003|Overall Study|Virologic Failure|1|||
157199201|NCT02129192|567473325|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
157199202|NCT02129192|567473326|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
157199203|NCT01231620|567473327|FG000|Overall Study|Physician Decision|3|||
157199204|NCT01231620|567473328|FG001|Overall Study|Physician Decision|5|||
157199205|NCT01231620|567473329|FG002|Overall Study|Physician Decision|10|||
157199206|NCT01231620|567473327|FG000|Overall Study|Death|12|||
157199207|NCT01231620|567473328|FG001|Overall Study|Death|14|||
157199208|NCT01231620|567473329|FG002|Overall Study|Death|11|||
157199209|NCT01231620|567473327|FG000|Overall Study|Adverse Event|2|||
157199210|NCT01231620|567473328|FG001|Overall Study|Adverse Event|2|||
157199211|NCT01231620|567473329|FG002|Overall Study|Adverse Event|1|||
157199212|NCT01231620|567473327|FG000|Overall Study|Withdrawal by Subject|6|||
157199213|NCT01231620|567473328|FG001|Overall Study|Withdrawal by Subject|6|||
157199214|NCT01231620|567473329|FG002|Overall Study|Withdrawal by Subject|8|||
157199215|NCT01231620|567473327|FG000|Overall Study|Lost to Follow-up|3|||
157199216|NCT01231620|567473328|FG001|Overall Study|Lost to Follow-up|4|||
157199217|NCT01231620|567473329|FG002|Overall Study|Lost to Follow-up|9|||
157199218|NCT04557189|567473339|FG000|Overall Study|Adverse Event|0|||
157199219|NCT04557189|567473340|FG001|Overall Study|Adverse Event|1|||
157199220|NCT04557189|567473339|FG000|Overall Study|Lost to Follow-up|1|||
157199221|NCT04557189|567473340|FG001|Overall Study|Lost to Follow-up|1|||
157199222|NCT04557189|567473339|FG000|Overall Study|Withdrawal by Subject|2|||
157199223|NCT04557189|567473340|FG001|Overall Study|Withdrawal by Subject|1|||
157199224|NCT04557189|567473339|FG000|Overall Study|Reason not Specified|3|||
157199225|NCT04557189|567473340|FG001|Overall Study|Reason not Specified|6|||
157199226|NCT03590613|567473349|FG000|Period 2, 4 Days|Physician Decision|0|||
157199227|NCT03590613|567473350|FG001|Period 2, 4 Days|Physician Decision|0|||
157199228|NCT03590613|567473351|FG002|Period 2, 4 Days|Physician Decision|0|||
157199229|NCT03590613|567473352|FG003|Period 2, 4 Days|Physician Decision|1|||
157199230|NCT01087944|567473353|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
157199231|NCT01087944|567473354|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
157199232|NCT01087944|567473353|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
157199233|NCT01087944|567473354|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
157199234|NCT01731600|567473355|FG000|Overall Study|Adverse Event|2|||
157199235|NCT01731600|567473356|FG001|Overall Study|Adverse Event|0|||
157199236|NCT01731600|567473355|FG000|Overall Study|Withdrawal criteria|1|||
157199237|NCT01731600|567473356|FG001|Overall Study|Withdrawal criteria|0|||
157199238|NCT01731600|567473355|FG000|Overall Study|Other reasons|3|||
157199239|NCT01731600|567473356|FG001|Overall Study|Other reasons|0|||
157199240|NCT00129220|567473357|FG000|Study Period II|Adverse Event|9|||
157199241|NCT00129220|567473358|FG001|Study Period II|Adverse Event|5|||
157199242|NCT00129220|567473359|FG002|Study Period II|Adverse Event|7|||
157199243|NCT00129220|567473357|FG000|Study Period II|Lack of Efficacy|15|||
157199244|NCT00129220|567473358|FG001|Study Period II|Lack of Efficacy|1|||
157199245|NCT00129220|567473359|FG002|Study Period II|Lack of Efficacy|28|||
157199246|NCT00129220|567473357|FG000|Study Period II|Entry Criteria Not Met|2|||
157199247|NCT00129220|567473358|FG001|Study Period II|Entry Criteria Not Met|0|||
157199248|NCT00129220|567473359|FG002|Study Period II|Entry Criteria Not Met|2|||
157199249|NCT00129220|567473357|FG000|Study Period II|Protocol Violation|4|||
157199250|NCT00129220|567473358|FG001|Study Period II|Protocol Violation|2|||
157199251|NCT00129220|567473359|FG002|Study Period II|Protocol Violation|1|||
157199252|NCT00129220|567473357|FG000|Study Period II|Physician Decision|0|||
157199253|NCT00129220|567473358|FG001|Study Period II|Physician Decision|1|||
157199254|NCT00129220|567473359|FG002|Study Period II|Physician Decision|0|||
157199255|NCT00129220|567473357|FG000|Study Period II|Withdrawal by Subject|1|||
157199256|NCT00129220|567473358|FG001|Study Period II|Withdrawal by Subject|3|||
157199257|NCT00129220|567473359|FG002|Study Period II|Withdrawal by Subject|4|||
157199258|NCT00129220|567473357|FG000|Study Period II|Reason Not Specified|2|||
157199259|NCT00129220|567473358|FG001|Study Period II|Reason Not Specified|0|||
157199260|NCT00129220|567473359|FG002|Study Period II|Reason Not Specified|5|||
157199261|NCT00129220|567473357|FG000|Study Period III|Adverse Event|1|||
157199262|NCT00129220|567473358|FG001|Study Period III|Adverse Event|0|||
157199263|NCT00129220|567473359|FG002|Study Period III|Adverse Event|3|||
157199264|NCT00129220|567473357|FG000|Study Period III|Protocol Violation|1|||
157199265|NCT00129220|567473358|FG001|Study Period III|Protocol Violation|1|||
157199266|NCT00129220|567473359|FG002|Study Period III|Protocol Violation|2|||
157199267|NCT00129220|567473357|FG000|Study Period III|Withdrawal by Subject|1|||
157199268|NCT00129220|567473358|FG001|Study Period III|Withdrawal by Subject|0|||
157199269|NCT00129220|567473359|FG002|Study Period III|Withdrawal by Subject|3|||
157199270|NCT00129220|567473357|FG000|Study Period III|Sponsor Decision|1|||
157199271|NCT00129220|567473358|FG001|Study Period III|Sponsor Decision|0|||
157199272|NCT00129220|567473359|FG002|Study Period III|Sponsor Decision|0|||
157199273|NCT00129220|567473357|FG000|Study Period III|Reason Not Specified|9|||
157199274|NCT00129220|567473358|FG001|Study Period III|Reason Not Specified|0|||
157199275|NCT00129220|567473359|FG002|Study Period III|Reason Not Specified|2|||
157199276|NCT00540228|567473361|FG000|Overall Study|Adverse Event|2|||
157199277|NCT00540228|567473362|FG001|Overall Study|Adverse Event|0|||
157199278|NCT00540228|567473363|FG002|Overall Study|Adverse Event|0|||
157199279|NCT00540228|567473364|FG003|Overall Study|Adverse Event|0|||
157199280|NCT00540228|567473365|FG004|Overall Study|Adverse Event|0|||
157199281|NCT00540228|567473361|FG000|Overall Study|Lost to Follow-up|1|||
157199282|NCT00540228|567473362|FG001|Overall Study|Lost to Follow-up|1|||
157199283|NCT00540228|567473363|FG002|Overall Study|Lost to Follow-up|0|||
157199284|NCT00540228|567473364|FG003|Overall Study|Lost to Follow-up|0|||
157199285|NCT00540228|567473365|FG004|Overall Study|Lost to Follow-up|0|||
157199286|NCT01883362|567473366|FG000|Treatment|Adverse Event|1|||
157199287|NCT01883362|567473367|FG001|Treatment|Adverse Event|8|||
157199288|NCT01883362|567473366|FG000|Treatment|Withdrawal by Subject|6|||
157199289|NCT01883362|567473367|FG001|Treatment|Withdrawal by Subject|2|||
157199290|NCT01883362|567473366|FG000|Treatment|Administrative problems|4|||
157199291|NCT01883362|567473367|FG001|Treatment|Administrative problems|1|||
157199292|NCT01883362|567473366|FG000|Treatment|Relapse|4|||
157199293|NCT01883362|567473367|FG001|Treatment|Relapse|2|||
157199294|NCT01883362|567473366|FG000|Treatment|Randomized, not treated|1|||
157199295|NCT01883362|567473367|FG001|Treatment|Randomized, not treated|1|||
157199296|NCT01883362|567473366|FG000|Post Treatment Follow-up|Protocol Violation|0|||
157199297|NCT01883362|567473367|FG001|Post Treatment Follow-up|Protocol Violation|1|||
157199298|NCT01883362|567473366|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
157199299|NCT01883362|567473367|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
157199300|NCT01883362|567473366|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
157199301|NCT01883362|567473367|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
157199302|NCT01883362|567473366|FG000|Post Treatment Follow-up|Administrative problems|2|||
157199303|NCT01883362|567473367|FG001|Post Treatment Follow-up|Administrative problems|0|||
157199304|NCT01883362|567473366|FG000|Post Treatment Follow-up|Death|8|||
157199305|NCT01883362|567473367|FG001|Post Treatment Follow-up|Death|4|||
157199306|NCT01883362|567473366|FG000|Post Treatment Follow-up|Relapse|1|||
157199307|NCT01883362|567473367|FG001|Post Treatment Follow-up|Relapse|2|||
157199308|NCT02569996|567473368|FG000|Overall Study|Adverse Event|6|||
157199309|NCT02569996|567473368|FG000|Overall Study|Physician Decision|3|||
157199310|NCT02569996|567473368|FG000|Overall Study|Progression of the disease|18|||
157199311|NCT02569996|567473368|FG000|Overall Study|New anti-lymphoma treatment|1|||
157199312|NCT02569996|567473368|FG000|Overall Study|Non-compliance|9|||
157199313|NCT02569996|567473368|FG000|Overall Study|Withdrawal by Subject|5|||
157199314|NCT02569996|567473368|FG000|Overall Study|Lost to Follow-up|5|||
157199315|NCT02569996|567473368|FG000|Overall Study|Complete remission|7|||
157199316|NCT02569996|567473368|FG000|Overall Study|Unknown reason|1|||
157199317|NCT01349816|567473371|FG000|Overall Study|Withdrawal by Subject|4|||
157199318|NCT01349816|567473371|FG000|Overall Study|Physician Decision|1|||
157199319|NCT01349816|567473371|FG000|Overall Study|Adverse Event|14|||
157199320|NCT01349816|567473371|FG000|Overall Study|Lost to Follow-up|2|||
157199321|NCT01349816|567473371|FG000|Overall Study|Protocol Violation|1|||
157199322|NCT01349816|567473371|FG000|Overall Study|Protocol-specified criteria|8|||
157199323|NCT02911285|567473372|FG000|Overall Study|Lost to Follow-up|8|||
157199324|NCT02911285|567473373|FG001|Overall Study|Lost to Follow-up|5|||
157199325|NCT02911285|567473372|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
157199326|NCT02911285|567473373|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
157199327|NCT00422227|567473374|FG000|Overall Study|Adverse Event|3|||
157199328|NCT00422227|567473375|FG001|Overall Study|Adverse Event|8|||
157199329|NCT00422227|567473374|FG000|Overall Study|Lost to Follow-up|1|||
157199330|NCT00422227|567473375|FG001|Overall Study|Lost to Follow-up|3|||
157199331|NCT00422227|567473374|FG000|Overall Study|Withdrawal by Subject|0|||
157199332|NCT00422227|567473375|FG001|Overall Study|Withdrawal by Subject|4|||
157199333|NCT00686894|567473377|FG000|Overall Study|Relapse|2|||
157199334|NCT00686894|567473377|FG000|Overall Study|Protocol Violation|4|||
157199335|NCT03996694|567475251|FG000|First Washout (7 Days)|positive urine drug screen|0|||
157199336|NCT03996694|567475252|FG001|First Washout (7 Days)|positive urine drug screen|0|||
157199337|NCT03996694|567475253|FG002|First Washout (7 Days)|positive urine drug screen|1|||
157199338|NCT03996694|567475254|FG003|First Washout (7 Days)|positive urine drug screen|0|||
157199339|NCT03996694|567475255|FG004|First Washout (7 Days)|positive urine drug screen|0|||
157199340|NCT03996694|567475256|FG005|First Washout (7 Days)|positive urine drug screen|0|||
157199341|NCT03996694|567475251|FG000|First Washout (7 Days)|Adverse Event|0|||
157199342|NCT03996694|567475252|FG001|First Washout (7 Days)|Adverse Event|1|||
157199343|NCT03996694|567475253|FG002|First Washout (7 Days)|Adverse Event|0|||
157199344|NCT03996694|567475254|FG003|First Washout (7 Days)|Adverse Event|0|||
157199345|NCT03996694|567475255|FG004|First Washout (7 Days)|Adverse Event|0|||
157199346|NCT03996694|567475256|FG005|First Washout (7 Days)|Adverse Event|0|||
157199347|NCT03996694|567475251|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
157199348|NCT03996694|567475252|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
157199349|NCT03996694|567475253|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
157199350|NCT03996694|567475254|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
157199351|NCT03996694|567475255|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
157199352|NCT03996694|567475256|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
157199353|NCT03996694|567475251|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
157199354|NCT03996694|567475252|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
157199355|NCT03996694|567475253|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
157199356|NCT03996694|567475254|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
157199357|NCT03996694|567475255|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
157199358|NCT03996694|567475256|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
157199359|NCT01241591|567475259|FG000|Overall Study|Lack of Efficacy|5|||
157199360|NCT01241591|567475260|FG001|Overall Study|Lack of Efficacy|2|||
157199361|NCT01241591|567475261|FG002|Overall Study|Lack of Efficacy|2|||
157199362|NCT01241591|567475262|FG003|Overall Study|Lack of Efficacy|3|||
157199363|NCT01241591|567475259|FG000|Overall Study|Protocol Violation|5|||
157199364|NCT01241591|567475260|FG001|Overall Study|Protocol Violation|2|||
157199365|NCT01241591|567475261|FG002|Overall Study|Protocol Violation|3|||
157199366|NCT01241591|567475262|FG003|Overall Study|Protocol Violation|0|||
157199367|NCT01241591|567475259|FG000|Overall Study|Lost to Follow-up|1|||
157199368|NCT01241591|567475260|FG001|Overall Study|Lost to Follow-up|2|||
157199369|NCT01241591|567475261|FG002|Overall Study|Lost to Follow-up|2|||
157199370|NCT01241591|567475262|FG003|Overall Study|Lost to Follow-up|2|||
157199371|NCT01241591|567475259|FG000|Overall Study|Screen Failure|3|||
157199372|NCT01241591|567475260|FG001|Overall Study|Screen Failure|2|||
157199373|NCT01241591|567475261|FG002|Overall Study|Screen Failure|1|||
157199374|NCT01241591|567475262|FG003|Overall Study|Screen Failure|0|||
157199375|NCT01241591|567475259|FG000|Overall Study|Withdrawal by Subject|6|||
157199376|NCT01241591|567475260|FG001|Overall Study|Withdrawal by Subject|4|||
157199377|NCT01241591|567475261|FG002|Overall Study|Withdrawal by Subject|2|||
157199378|NCT01241591|567475262|FG003|Overall Study|Withdrawal by Subject|2|||
157199379|NCT01241591|567475259|FG000|Overall Study|Other|0|||
157199380|NCT01241591|567475260|FG001|Overall Study|Other|1|||
157199381|NCT01241591|567475261|FG002|Overall Study|Other|0|||
157199382|NCT01241591|567475262|FG003|Overall Study|Other|1|||
157199383|NCT01241591|567475259|FG000|Overall Study|Adverse Event|3|||
157199384|NCT01241591|567475260|FG001|Overall Study|Adverse Event|11|||
157199385|NCT01241591|567475261|FG002|Overall Study|Adverse Event|12|||
157199386|NCT01241591|567475262|FG003|Overall Study|Adverse Event|4|||
157199387|NCT02389621|567475265|FG000|Treatment Period|Withdrawal by Subject|1|||
157199388|NCT02389621|567475266|FG001|Treatment Period|Withdrawal by Subject|1|||
157199389|NCT02389621|567475265|FG000|Posttreatment Period|Adverse Event|3|||
157199390|NCT02389621|567475266|FG001|Posttreatment Period|Adverse Event|1|||
157199391|NCT02389621|567475265|FG000|Posttreatment Period|Withdrawal by Subject|3|||
157199392|NCT02389621|567475266|FG001|Posttreatment Period|Withdrawal by Subject|2|||
157199393|NCT02389621|567475265|FG000|Posttreatment Period|Lost to Follow-up|1|||
157199394|NCT02389621|567475266|FG001|Posttreatment Period|Lost to Follow-up|1|||
157199395|NCT02389621|567475265|FG000|Posttreatment Period|Other - Miscellaneous|2|||
157199396|NCT02389621|567475266|FG001|Posttreatment Period|Other - Miscellaneous|0|||
157199397|NCT04887922|567475276|FG000|1st Randomization|Decided not to have surgery|0|||
157199398|NCT04887922|567475277|FG001|1st Randomization|Decided not to have surgery|1|||
157199399|NCT04887922|567475278|FG002|1st Randomization|Decided not to have surgery|0|||
157199400|NCT04887922|567475279|FG003|1st Randomization|Decided not to have surgery|0|||
157199401|NCT04887922|567475280|FG004|1st Randomization|Decided not to have surgery|0|||
157199402|NCT01300741|567475281|FG000|Overall Study|Lens deposits|1|||
157199403|NCT01300741|567475281|FG000|Overall Study|Lost to Follow-up|1|||
157199404|NCT01300741|567475281|FG000|Overall Study|Discomfort|1|||
157199405|NCT04854421|567475282|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
157199406|NCT04854421|567475283|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
157199407|NCT00718809|567475286|FG000|Overall Study|Disease progression|9|||
157199408|NCT00718809|567475287|FG001|Overall Study|Disease progression|7|||
157199409|NCT00718809|567475286|FG000|Overall Study|Adverse Event|1|||
157199410|NCT00718809|567475287|FG001|Overall Study|Adverse Event|1|||
157199411|NCT00718809|567475286|FG000|Overall Study|Withdrawal by Subject|0|||
157199412|NCT00718809|567475287|FG001|Overall Study|Withdrawal by Subject|1|||
157199413|NCT00718809|567475286|FG000|Overall Study|Lost to Follow-up|1|||
157199414|NCT00718809|567475287|FG001|Overall Study|Lost to Follow-up|0|||
157199415|NCT00718809|567475286|FG000|Overall Study|Noncompliance|1|||
157199416|NCT00718809|567475287|FG001|Overall Study|Noncompliance|0|||
157199417|NCT00463385|567475288|FG000|Overall Study|Other|4|||
157199418|NCT00463385|567475289|FG001|Overall Study|Other|3|||
157199419|NCT00463385|567475290|FG002|Overall Study|Other|6|||
157199420|NCT00463385|567475291|FG003|Overall Study|Other|4|||
157199421|NCT00463385|567475288|FG000|Overall Study|Adverse Event|5|||
157199422|NCT00463385|567475289|FG001|Overall Study|Adverse Event|8|||
157199423|NCT00463385|567475290|FG002|Overall Study|Adverse Event|4|||
157199424|NCT00463385|567475291|FG003|Overall Study|Adverse Event|2|||
157199425|NCT00463385|567475288|FG000|Overall Study|Lack of Efficacy|6|||
157199426|NCT00463385|567475289|FG001|Overall Study|Lack of Efficacy|6|||
157199427|NCT00463385|567475290|FG002|Overall Study|Lack of Efficacy|7|||
157199428|NCT00463385|567475291|FG003|Overall Study|Lack of Efficacy|9|||
157199429|NCT00463385|567475288|FG000|Overall Study|Withdrawal by Subject|3|||
157199430|NCT00463385|567475289|FG001|Overall Study|Withdrawal by Subject|3|||
157199431|NCT00463385|567475290|FG002|Overall Study|Withdrawal by Subject|3|||
157199432|NCT00463385|567475291|FG003|Overall Study|Withdrawal by Subject|4|||
157199433|NCT00463385|567475288|FG000|Overall Study|Lost to Follow-up|0|||
157199434|NCT00463385|567475289|FG001|Overall Study|Lost to Follow-up|0|||
157199435|NCT00463385|567475290|FG002|Overall Study|Lost to Follow-up|0|||
157199436|NCT00463385|567475291|FG003|Overall Study|Lost to Follow-up|1|||
157199437|NCT00463385|567475288|FG000|Overall Study|Death|2|||
157199438|NCT00463385|567475289|FG001|Overall Study|Death|1|||
157199439|NCT00463385|567475290|FG002|Overall Study|Death|2|||
157199440|NCT00463385|567475291|FG003|Overall Study|Death|0|||
157199441|NCT00463385|567475288|FG000|Overall Study|Missing|2|||
157199442|NCT00463385|567475289|FG001|Overall Study|Missing|0|||
157199443|NCT00463385|567475290|FG002|Overall Study|Missing|0|||
157199444|NCT00463385|567475291|FG003|Overall Study|Missing|2|||
157199445|NCT00463385|567475288|FG000|Overall Study|1 participant received commercial drug|0|||
157199446|NCT00463385|567475289|FG001|Overall Study|1 participant received commercial drug|1|||
157199447|NCT00463385|567475290|FG002|Overall Study|1 participant received commercial drug|0|||
157199448|NCT00463385|567475291|FG003|Overall Study|1 participant received commercial drug|0|||
157199449|NCT00726882|567475292|FG000|Overall Study|Withdrawal by Subject|5|||
157199450|NCT00726882|567475292|FG000|Overall Study|Lost to Follow-up|7|||
157199451|NCT00726882|567475292|FG000|Overall Study|Other|10|||
157199452|NCT00344968|567475293|FG000|Overall Study|Adverse Event|5|||
157199453|NCT00344968|567475294|FG001|Overall Study|Adverse Event|4|||
157199454|NCT00344968|567475295|FG002|Overall Study|Adverse Event|15|||
157199455|NCT00344968|567475293|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
157199456|NCT00344968|567475294|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
157199457|NCT00344968|567475295|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
157199458|NCT00344968|567475293|FG000|Overall Study|Protocol Violation|2|||
157199459|NCT00344968|567475294|FG001|Overall Study|Protocol Violation|2|||
157199460|NCT00344968|567475295|FG002|Overall Study|Protocol Violation|5|||
157199461|NCT00344968|567475293|FG000|Overall Study|Withdrawal by Subject|14|||
157199462|NCT00344968|567475294|FG001|Overall Study|Withdrawal by Subject|31|||
157199463|NCT00344968|567475295|FG002|Overall Study|Withdrawal by Subject|27|||
157199464|NCT00344968|567475293|FG000|Overall Study|Lost to Follow-up|24|||
157199465|NCT00344968|567475294|FG001|Overall Study|Lost to Follow-up|37|||
157199466|NCT00344968|567475295|FG002|Overall Study|Lost to Follow-up|37|||
157199467|NCT00344968|567475293|FG000|Overall Study|Death|11|||
157199468|NCT00344968|567475294|FG001|Overall Study|Death|27|||
157199469|NCT00344968|567475295|FG002|Overall Study|Death|31|||
157199470|NCT00344968|567475293|FG000|Overall Study|Other|0|||
157199471|NCT00344968|567475294|FG001|Overall Study|Other|1|||
157199472|NCT00344968|567475295|FG002|Overall Study|Other|0|||
157199473|NCT02526017|567475296|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199474|NCT02526017|567475297|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199475|NCT02526017|567475298|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199476|NCT02526017|567475299|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199477|NCT02526017|567475300|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
157199478|NCT02526017|567475301|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199479|NCT02526017|567475302|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199480|NCT02526017|567475303|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199481|NCT02526017|567475304|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
157199482|NCT01548573|567475308|FG000|Overall Study|Death|3|||
157199483|NCT01548573|567475308|FG000|Overall Study|Withdrawal by Subject|2|||
157199484|NCT00290511|567475314|FG000|Overall Study|Adverse Event|1|||
157199485|NCT00290511|567475314|FG000|Overall Study|Death|1|||
157199486|NCT00290511|567475314|FG000|Overall Study|Physician Decision|1|||
157199487|NCT00290511|567475314|FG000|Overall Study|Withdrawal by Subject|1|||
157199488|NCT00447265|567475315|FG000|Overall Study|Physician Decision|1|||
157199489|NCT00447265|567475316|FG001|Overall Study|Physician Decision|0|||
157199490|NCT05028816|567475320|FG000|Overall Study|Lost to Follow-up|5|||
157199491|NCT05028816|567475321|FG001|Overall Study|Lost to Follow-up|3|||
157199492|NCT05028816|567475320|FG000|Overall Study|Withdrawal by Subject|4|||
157199493|NCT05028816|567475321|FG001|Overall Study|Withdrawal by Subject|1|||
157199494|NCT05028816|567475320|FG000|Overall Study|Physician Decision|1|||
157199495|NCT05028816|567475321|FG001|Overall Study|Physician Decision|0|||
157199496|NCT00423137|567475324|FG000|Overall Study|Lost to Follow-up|0|||
157199497|NCT00423137|567475325|FG001|Overall Study|Lost to Follow-up|0|||
157199498|NCT00423137|567475326|FG002|Overall Study|Lost to Follow-up|1|||
157199499|NCT00423137|567475327|FG003|Overall Study|Lost to Follow-up|0|||
157199500|NCT00423137|567475324|FG000|Overall Study|Protocol Violation|0|||
157199501|NCT00423137|567475325|FG001|Overall Study|Protocol Violation|0|||
157199502|NCT00423137|567475326|FG002|Overall Study|Protocol Violation|0|||
157199503|NCT00423137|567475327|FG003|Overall Study|Protocol Violation|1|||
157199504|NCT00423137|567475324|FG000|Overall Study|Adverse Event Study disease worse|1|||
157199505|NCT00423137|567475325|FG001|Overall Study|Adverse Event Study disease worse|0|||
157199506|NCT00423137|567475326|FG002|Overall Study|Adverse Event Study disease worse|3|||
157199507|NCT00423137|567475327|FG003|Overall Study|Adverse Event Study disease worse|1|||
157199508|NCT00423137|567475324|FG000|Overall Study|Adverse Event Other|0|||
157199509|NCT00423137|567475325|FG001|Overall Study|Adverse Event Other|0|||
157199510|NCT00423137|567475326|FG002|Overall Study|Adverse Event Other|2|||
157199511|NCT00423137|567475327|FG003|Overall Study|Adverse Event Other|0|||
157199512|NCT03246152|567475328|FG000|Overall Study|Lost to Follow-up|2|||
157199513|NCT03246152|567475328|FG000|Overall Study|Protocol Violation|1|||
157199514|NCT01243762|567475330|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
157199515|NCT01243762|567475331|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
157199516|NCT01243762|567475332|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
157199517|NCT01243762|567475333|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
157199518|NCT01243762|567475334|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
157199519|NCT01243762|567475335|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
157199520|NCT01243762|567475336|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
157199521|NCT01243762|567475330|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
157199522|NCT01243762|567475331|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
157199523|NCT01243762|567475332|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
157199524|NCT01243762|567475333|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
157243042|NCT00748566|567636810|FG000|Overall Study|Protocol Violation|13|||
157243043|NCT00748566|567636810|FG000|Overall Study|Withdrawal by Subject|22|||
157199525|NCT01243762|567475334|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
157199526|NCT01243762|567475335|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
157199527|NCT01243762|567475336|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
157199528|NCT01243762|567475330|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
157199529|NCT01243762|567475331|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
157199530|NCT01243762|567475332|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
157199531|NCT01243762|567475333|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
157199532|NCT01243762|567475334|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
157199533|NCT01243762|567475335|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
157199534|NCT01243762|567475336|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
157199535|NCT01243762|567475330|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199536|NCT01243762|567475331|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
157199537|NCT01243762|567475332|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199538|NCT01243762|567475333|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199539|NCT01243762|567475334|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199540|NCT01243762|567475335|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199541|NCT01243762|567475336|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
157199542|NCT01243762|567475330|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
157199543|NCT01243762|567475331|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
157199544|NCT01243762|567475332|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
157199545|NCT01243762|567475333|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
157199546|NCT01243762|567475334|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
157199547|NCT01243762|567475335|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
157199548|NCT01243762|567475336|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
157199549|NCT01243762|567475330|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
157199550|NCT01243762|567475331|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
157199551|NCT01243762|567475332|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
157199552|NCT01243762|567475333|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
157199553|NCT01243762|567475334|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
157199554|NCT01243762|567475335|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
157199555|NCT01243762|567475336|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
157199556|NCT01243762|567475330|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
157199557|NCT01243762|567475331|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
157199558|NCT01243762|567475332|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
157199559|NCT01243762|567475333|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
157199560|NCT01243762|567475334|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
157199561|NCT01243762|567475335|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
157199562|NCT01243762|567475336|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
157199563|NCT01243762|567475330|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
157199564|NCT01243762|567475331|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
157199565|NCT01243762|567475332|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
157199566|NCT01243762|567475333|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
157199567|NCT01243762|567475334|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
157199568|NCT01243762|567475335|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
157199569|NCT01243762|567475336|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
157243044|NCT00748566|567636810|FG000|Overall Study|Study terminated by sponsor|5|||
157243045|NCT00748566|567636810|FG000|Overall Study|Other|9|||
157243046|NCT01442376|567636817|FG000|Overall Study|Adverse Event|0|||
157243047|NCT01442376|567636818|FG001|Overall Study|Adverse Event|3|||
157243048|NCT01442376|567636819|FG002|Overall Study|Adverse Event|2|||
157243049|NCT01442376|567636817|FG000|Overall Study|Death|0|||
157243050|NCT01442376|567636818|FG001|Overall Study|Death|1|||
157243051|NCT01442376|567636819|FG002|Overall Study|Death|1|||
157243052|NCT01442376|567636817|FG000|Overall Study|Withdrawal of consent|0|||
157243053|NCT01442376|567636818|FG001|Overall Study|Withdrawal of consent|0|||
157243054|NCT01442376|567636819|FG002|Overall Study|Withdrawal of consent|1|||
157243055|NCT01442376|567636817|FG000|Overall Study|Patients not treated|2|||
157243056|NCT01442376|567636818|FG001|Overall Study|Patients not treated|3|||
157243057|NCT01442376|567636819|FG002|Overall Study|Patients not treated|1|||
157243058|NCT01442376|567636817|FG000|Overall Study|Not eligible for subsequent cycles|1|||
157243059|NCT01442376|567636818|FG001|Overall Study|Not eligible for subsequent cycles|2|||
157243060|NCT01442376|567636819|FG002|Overall Study|Not eligible for subsequent cycles|0|||
157243061|NCT04404725|567636820|FG000|First Intervention|Withdrawal by Subject|0|||
157243062|NCT04404725|567636821|FG001|First Intervention|Withdrawal by Subject|2|||
157243063|NCT04404725|567636820|FG000|Second Intervention|Adverse Event|1|||
157243064|NCT04404725|567636821|FG001|Second Intervention|Adverse Event|1|||
157243065|NCT04404725|567636820|FG000|Second Intervention|Withdrawal by Subject|0|||
157243066|NCT04404725|567636821|FG001|Second Intervention|Withdrawal by Subject|1|||
157243067|NCT01075516|567636822|FG000|Overall Study|Death|5|||
157243068|NCT01075516|567636823|FG001|Overall Study|Death|9|||
157243069|NCT01075516|567636822|FG000|Overall Study|Lost to Follow-up|10|||
157243070|NCT01075516|567636823|FG001|Overall Study|Lost to Follow-up|2|||
157243071|NCT01075516|567636822|FG000|Overall Study|Withdrawal by Subject|3|||
157243072|NCT01075516|567636823|FG001|Overall Study|Withdrawal by Subject|5|||
157243073|NCT02252016|567636824|FG000|Overall Study|Lost to Follow-up|2|||
157243074|NCT02252016|567636825|FG001|Overall Study|Lost to Follow-up|1|||
157243075|NCT02252016|567636824|FG000|Overall Study|Physician Decision|1|||
157243076|NCT02252016|567636825|FG001|Overall Study|Physician Decision|0|||
157243077|NCT02252016|567636824|FG000|Overall Study|Withdrawal by Subject|0|||
157243078|NCT02252016|567636825|FG001|Overall Study|Withdrawal by Subject|2|||
157243079|NCT04631562|567636826|FG000|Overall Study|Withdrawal by Subject|0|||
157243080|NCT04631562|567636827|FG001|Overall Study|Withdrawal by Subject|0|||
157243081|NCT04631562|567636828|FG002|Overall Study|Withdrawal by Subject|0|||
157243082|NCT04631562|567636829|FG003|Overall Study|Withdrawal by Subject|0|||
157243083|NCT04631562|567636830|FG004|Overall Study|Withdrawal by Subject|0|||
157243084|NCT04631562|567636831|FG005|Overall Study|Withdrawal by Subject|0|||
157243085|NCT04631562|567636832|FG006|Overall Study|Withdrawal by Subject|0|||
157243086|NCT04631562|567636833|FG007|Overall Study|Withdrawal by Subject|1|||
157243087|NCT04631562|567636834|FG008|Overall Study|Withdrawal by Subject|0|||
157243088|NCT04631562|567636826|FG000|Overall Study|Other|0|||
157243089|NCT04631562|567636827|FG001|Overall Study|Other|0|||
157243090|NCT04631562|567636828|FG002|Overall Study|Other|0|||
157243091|NCT04631562|567636829|FG003|Overall Study|Other|0|||
157243092|NCT04631562|567636830|FG004|Overall Study|Other|0|||
157243093|NCT04631562|567636831|FG005|Overall Study|Other|0|||
157243094|NCT04631562|567636832|FG006|Overall Study|Other|0|||
157243095|NCT04631562|567636833|FG007|Overall Study|Other|0|||
157243096|NCT04631562|567636834|FG008|Overall Study|Other|1|||
157243097|NCT04631562|567636826|FG000|Overall Study|Lost to Follow-up|0|||
157243098|NCT04631562|567636827|FG001|Overall Study|Lost to Follow-up|0|||
157243099|NCT04631562|567636828|FG002|Overall Study|Lost to Follow-up|0|||
157243100|NCT04631562|567636829|FG003|Overall Study|Lost to Follow-up|1|||
157243101|NCT04631562|567636830|FG004|Overall Study|Lost to Follow-up|0|||
157243102|NCT04631562|567636831|FG005|Overall Study|Lost to Follow-up|0|||
157243103|NCT04631562|567636832|FG006|Overall Study|Lost to Follow-up|0|||
157243104|NCT04631562|567636833|FG007|Overall Study|Lost to Follow-up|0|||
157243105|NCT04631562|567636834|FG008|Overall Study|Lost to Follow-up|0|||
157243106|NCT04631562|567636826|FG000|Overall Study|Adverse Event|0|||
157243107|NCT04631562|567636827|FG001|Overall Study|Adverse Event|0|||
157243108|NCT04631562|567636828|FG002|Overall Study|Adverse Event|0|||
157243109|NCT04631562|567636829|FG003|Overall Study|Adverse Event|0|||
157243110|NCT04631562|567636830|FG004|Overall Study|Adverse Event|0|||
157243111|NCT04631562|567636831|FG005|Overall Study|Adverse Event|0|||
157243112|NCT04631562|567636832|FG006|Overall Study|Adverse Event|1|||
157243113|NCT04631562|567636833|FG007|Overall Study|Adverse Event|0|||
157243114|NCT04631562|567636834|FG008|Overall Study|Adverse Event|0|||
157243115|NCT03498560|567636837|FG000|Overall Study|Found Ineligible|2|||
157243116|NCT03498560|567636837|FG000|Overall Study|Withdrawal by Subject|14|||
157243117|NCT03498560|567636837|FG000|Overall Study|Lost to Follow-up|4|||
157243118|NCT03498560|567636837|FG000|Overall Study|Death|1|||
157243119|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
157243120|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
157243121|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
157243122|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
157199570|NCT00003526|567475337|FG000|Overall Study|Not evaluable|6|||
157199571|NCT03557775|567475338|FG000|Overall Study|Withdrawal by Subject|1|||
157199572|NCT03557775|567475339|FG001|Overall Study|Withdrawal by Subject|2|||
157199573|NCT03557775|567475340|FG002|Overall Study|Withdrawal by Subject|4|||
157199574|NCT03557775|567475338|FG000|Overall Study|Physician Decision|0|||
157199575|NCT03557775|567475339|FG001|Overall Study|Physician Decision|1|||
157199576|NCT03557775|567475340|FG002|Overall Study|Physician Decision|0|||
157199577|NCT00308555|567475341|FG000|Overall Study|Withdrawal by Subject|1|||
157199578|NCT00308555|567475342|FG001|Overall Study|Withdrawal by Subject|0|||
157199579|NCT00308555|567475341|FG000|Overall Study|Physician Decision|2|||
157199580|NCT00308555|567475342|FG001|Overall Study|Physician Decision|0|||
157199581|NCT04113746|567475350|FG000|Overall Study|Lost to Follow-up|4|||
157199582|NCT04113746|567475351|FG001|Overall Study|Lost to Follow-up|4|||
157199583|NCT00234533|567475352|FG000|Overall Study|Withdrawal by Subject|6|||
157199584|NCT00234533|567475352|FG000|Overall Study|Adverse Event|2|||
157199585|NCT00234533|567475352|FG000|Overall Study|Enrolled but not treated|3|||
157199586|NCT02967055|567475353|FG000|Overall Study|Excluded|40|||
157199587|NCT02967055|567475353|FG000|Overall Study|Screen fail|3|||
157199588|NCT02967055|567475353|FG000|Overall Study|Lost to Follow-up|2|||
157199589|NCT02967055|567475353|FG000|Overall Study|Stopped due to side effects|3|||
157199590|NCT02967055|567475353|FG000|Overall Study|Stopped due to drug cost|1|||
157199591|NCT00908375|567475354|FG000|Overall Study|Withdrawal by Subject|2|||
157199592|NCT00908375|567475355|FG001|Overall Study|Withdrawal by Subject|4|||
157199593|NCT00908375|567475354|FG000|Overall Study|Lost to Follow-up|8|||
157199594|NCT00908375|567475355|FG001|Overall Study|Lost to Follow-up|6|||
157199595|NCT02279888|567475356|FG000|Overall Study|Death|326|||
157199596|NCT02279888|567475356|FG000|Overall Study|Withdrawal by Subject|38|||
157199597|NCT02279888|567475356|FG000|Overall Study|Lost to Follow-up|21|||
157199598|NCT02279888|567475356|FG000|Overall Study|Physician Decision|62|||
157199599|NCT02279888|567475356|FG000|Overall Study|Subject Non-compliance|43|||
157199600|NCT02279888|567475356|FG000|Overall Study|Not implanted|14|||
157199601|NCT02279888|567475356|FG000|Overall Study|Visit not performed|26|||
157199602|NCT04668157|567475357|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
157199603|NCT04668157|567475358|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
157199604|NCT04668157|567475357|FG000|Treatment Period (52 Weeks)|Other|0|||
157199605|NCT04668157|567475358|FG001|Treatment Period (52 Weeks)|Other|2|||
157199606|NCT03958045|567475359|FG000|Overall Study|Withdrawal by Subject|1|||
157199607|NCT01683565|567475360|FG000|Overall Study|Lost to Follow-up|2|||
157199608|NCT01683565|567475361|FG001|Overall Study|Lost to Follow-up|0|||
157199609|NCT01683565|567475360|FG000|Overall Study|Discontinued Intervention|1|||
157199610|NCT01683565|567475361|FG001|Overall Study|Discontinued Intervention|1|||
157199611|NCT03282123|567475363|FG000|Overall Study|Withdrawal by Subject|5|||
157199612|NCT01195662|567475364|FG000|Double Blind Treatment Period|Adverse Event|4|||
157199613|NCT01195662|567475365|FG001|Double Blind Treatment Period|Adverse Event|1|||
157199614|NCT01195662|567475366|FG002|Double Blind Treatment Period|Adverse Event|2|||
157199615|NCT01195662|567475364|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
157199616|NCT01195662|567475365|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
157199617|NCT01195662|567475366|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
157199618|NCT01195662|567475364|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
157199619|NCT01195662|567475365|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
157199620|NCT01195662|567475366|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
157199621|NCT01195662|567475364|FG000|Double Blind Treatment Period|Administrative reason|2|||
157199622|NCT01195662|567475365|FG001|Double Blind Treatment Period|Administrative reason|1|||
157199623|NCT01195662|567475366|FG002|Double Blind Treatment Period|Administrative reason|1|||
157199624|NCT01195662|567475364|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
157199625|NCT01195662|567475365|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
157199626|NCT01195662|567475366|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
157199627|NCT01195662|567475364|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
157199628|NCT01195662|567475365|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
157199629|NCT01195662|567475366|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
157199630|NCT01195662|567475364|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
157199631|NCT01195662|567475365|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
157199632|NCT01195662|567475366|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
157199633|NCT01195662|567475364|FG000|Double Blind Treatment Period|Non-specified|3|||
157199634|NCT01195662|567475365|FG001|Double Blind Treatment Period|Non-specified|0|||
157199635|NCT01195662|567475366|FG002|Double Blind Treatment Period|Non-specified|0|||
157199636|NCT01195662|567475364|FG000|Double Blind Treatment Period|Missing disposition information|0|||
157199637|NCT01195662|567475365|FG001|Double Blind Treatment Period|Missing disposition information|1|||
157199638|NCT01195662|567475366|FG002|Double Blind Treatment Period|Missing disposition information|1|||
157199639|NCT01195662|567475364|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
157199640|NCT01195662|567475365|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
157243123|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
157243124|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243125|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243126|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243127|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243128|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243129|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243130|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243131|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243132|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243133|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243134|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243135|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243136|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243137|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243138|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243139|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243140|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243141|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243142|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243143|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243144|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
157243145|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243146|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
157243147|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243148|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243149|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243150|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243151|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243152|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243153|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243154|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243155|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243156|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243157|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243158|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243159|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243160|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243161|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243162|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243163|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243164|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243165|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243166|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243167|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243168|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243169|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243170|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
157243171|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243172|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
157243173|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243174|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243175|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243176|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243177|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243178|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243179|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243180|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243181|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243182|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157199641|NCT01195662|567475366|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
157199642|NCT01195662|567475364|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
157199643|NCT01195662|567475365|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
157199644|NCT01195662|567475366|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
157199645|NCT00674440|567475367|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
157199646|NCT00674440|567475367|FG000|Overall Study|did not have surgery, so unevaluable|7|||
157199647|NCT00674440|567475367|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
157243183|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243184|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243185|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243186|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243187|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243188|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243189|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243190|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157199648|NCT03457701|567475368|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
157199649|NCT03457701|567475369|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
157199650|NCT03457701|567475368|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
157199651|NCT03457701|567475369|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
157199652|NCT00796367|567475370|FG000|Overall Study|Adverse Event|6|||
157199653|NCT00796367|567475371|FG001|Overall Study|Adverse Event|4|||
157199654|NCT00796367|567475372|FG002|Overall Study|Adverse Event|7|||
157199655|NCT00796367|567475370|FG000|Overall Study|Lost to Follow-up|5|||
157199656|NCT00796367|567475371|FG001|Overall Study|Lost to Follow-up|4|||
157199657|NCT00796367|567475372|FG002|Overall Study|Lost to Follow-up|21|||
157199658|NCT00796367|567475370|FG000|Overall Study|Withdrawal by Subject|9|||
157199659|NCT00796367|567475371|FG001|Overall Study|Withdrawal by Subject|11|||
157199660|NCT00796367|567475372|FG002|Overall Study|Withdrawal by Subject|12|||
157199661|NCT00796367|567475370|FG000|Overall Study|Lack of Efficacy|2|||
157199662|NCT00796367|567475371|FG001|Overall Study|Lack of Efficacy|1|||
157199663|NCT00796367|567475372|FG002|Overall Study|Lack of Efficacy|0|||
157199664|NCT00796367|567475370|FG000|Overall Study|non compliance|3|||
157199665|NCT00796367|567475371|FG001|Overall Study|non compliance|1|||
157243191|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243192|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243193|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243194|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243195|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243196|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
157243197|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
157243198|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243199|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
157243200|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
157243201|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
157243202|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243203|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243204|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243205|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243206|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243207|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243208|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243209|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243210|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243211|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243212|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243213|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243214|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243215|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243216|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243217|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243218|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243219|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243220|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243221|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243222|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
157243223|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
157243224|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
157243225|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
157243226|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
157199666|NCT00796367|567475372|FG002|Overall Study|non compliance|1|||
157199667|NCT00796367|567475370|FG000|Overall Study|Pregnancy|1|||
157199668|NCT00796367|567475371|FG001|Overall Study|Pregnancy|0|||
157199669|NCT00796367|567475372|FG002|Overall Study|Pregnancy|1|||
157199670|NCT00796367|567475370|FG000|Overall Study|Requirement for restricted medication|2|||
157243227|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
157243228|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243229|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243230|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243231|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243232|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243233|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157199671|NCT00796367|567475371|FG001|Overall Study|Requirement for restricted medication|0|||
157199672|NCT00796367|567475372|FG002|Overall Study|Requirement for restricted medication|2|||
157199673|NCT00796367|567475370|FG000|Overall Study|other|2|||
157199674|NCT00796367|567475371|FG001|Overall Study|other|4|||
157199675|NCT00796367|567475372|FG002|Overall Study|other|3|||
157199676|NCT04409262|567475376|FG000|Overall Study|Adverse Event|0|||
157199677|NCT04409262|567475377|FG001|Overall Study|Adverse Event|2|||
157199678|NCT04409262|567475376|FG000|Overall Study|Death|55|||
157199679|NCT04409262|567475377|FG001|Overall Study|Death|97|||
157199680|NCT04409262|567475376|FG000|Overall Study|Lost to Follow-up|12|||
157199681|NCT04409262|567475377|FG001|Overall Study|Lost to Follow-up|23|||
157199682|NCT04409262|567475376|FG000|Overall Study|Lack of Staff|0|||
157199683|NCT04409262|567475377|FG001|Overall Study|Lack of Staff|1|||
157199684|NCT04409262|567475376|FG000|Overall Study|Protocol Violation|3|||
157199685|NCT04409262|567475377|FG001|Overall Study|Protocol Violation|1|||
157199686|NCT04409262|567475376|FG000|Overall Study|Withdrawal by Subject|5|||
157199687|NCT04409262|567475377|FG001|Overall Study|Withdrawal by Subject|10|||
157199688|NCT00948896|567475381|FG000|Randomization to 24 Months of Age|Death|1|||
157199689|NCT00948896|567475382|FG001|Randomization to 24 Months of Age|Death|0|||
157199690|NCT00948896|567475383|FG002|Randomization to 24 Months of Age|Death|0|||
157199691|NCT00948896|567475384|FG003|Randomization to 24 Months of Age|Death|0|||
157199692|NCT00948896|567475385|FG004|Randomization to 24 Months of Age|Death|2|||
157199693|NCT00948896|567475386|FG005|Randomization to 24 Months of Age|Death|1|||
157199694|NCT00948896|567475387|FG006|Randomization to 24 Months of Age|Death|2|||
157199695|NCT00948896|567475388|FG007|Randomization to 24 Months of Age|Death|1|||
157199696|NCT00948896|567475381|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
157199697|NCT00948896|567475382|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
157199698|NCT00948896|567475383|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
157199699|NCT00948896|567475384|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
157199700|NCT00948896|567475385|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
157199701|NCT00948896|567475386|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
157199702|NCT00948896|567475387|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
157199703|NCT00948896|567475388|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
157199704|NCT00948896|567475381|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
157199705|NCT00948896|567475382|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
157199706|NCT00948896|567475383|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
157199707|NCT00948896|567475384|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
157199708|NCT00948896|567475385|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
157199709|NCT00948896|567475386|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
157199710|NCT00948896|567475387|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
157199711|NCT00948896|567475388|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
157199712|NCT00948896|567475381|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
157199713|NCT00948896|567475382|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
157199714|NCT00948896|567475383|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
157199715|NCT00948896|567475384|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
157199716|NCT00948896|567475385|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
157199717|NCT00948896|567475386|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
157199718|NCT00948896|567475387|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
157199719|NCT00948896|567475388|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
157199720|NCT00948896|567475381|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
157199721|NCT00948896|567475382|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
157199722|NCT00948896|567475383|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
157199723|NCT00948896|567475384|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
157199724|NCT00948896|567475385|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
157199725|NCT00948896|567475386|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
157199726|NCT00948896|567475387|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
157199727|NCT00948896|567475388|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
157199728|NCT00948896|567475381|FG000|24 Months of Age to 36 Months of Age|Death|0|||
157199729|NCT00948896|567475382|FG001|24 Months of Age to 36 Months of Age|Death|2|||
157199730|NCT00948896|567475383|FG002|24 Months of Age to 36 Months of Age|Death|2|||
157199731|NCT00948896|567475384|FG003|24 Months of Age to 36 Months of Age|Death|0|||
157199732|NCT00948896|567475385|FG004|24 Months of Age to 36 Months of Age|Death|0|||
157199733|NCT00948896|567475386|FG005|24 Months of Age to 36 Months of Age|Death|1|||
157199734|NCT00948896|567475387|FG006|24 Months of Age to 36 Months of Age|Death|0|||
157199735|NCT00948896|567475388|FG007|24 Months of Age to 36 Months of Age|Death|0|||
157199736|NCT00948896|567475381|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
157199737|NCT00948896|567475382|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
157199738|NCT00948896|567475383|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
157199739|NCT00948896|567475384|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
157243234|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157199740|NCT00948896|567475385|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
157199741|NCT00948896|567475386|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
157199742|NCT00948896|567475387|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
157199743|NCT00948896|567475388|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
157199744|NCT00948896|567475381|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
157199745|NCT00948896|567475382|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
157199746|NCT00948896|567475383|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
157199747|NCT00948896|567475384|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
157199748|NCT00948896|567475385|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
157199749|NCT00948896|567475386|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
157199750|NCT00948896|567475387|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
157199751|NCT00948896|567475388|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
157199752|NCT00948896|567475381|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199753|NCT00948896|567475382|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199754|NCT00948896|567475383|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
157199755|NCT00948896|567475384|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199756|NCT00948896|567475385|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199757|NCT00948896|567475386|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
157199758|NCT00948896|567475387|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199759|NCT00948896|567475388|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
157199760|NCT00948896|567475381|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199761|NCT00948896|567475382|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199762|NCT00948896|567475383|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199763|NCT00948896|567475384|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
157199764|NCT00948896|567475385|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199765|NCT00948896|567475386|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199766|NCT00948896|567475387|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199767|NCT00948896|567475388|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
157199768|NCT00945815|567475389|FG000|Overall Study|Death|3|||
157199769|NCT00945815|567475389|FG000|Overall Study|Not protocol specified|1|||
157199770|NCT00945815|567475389|FG000|Overall Study|Ineligible|3|||
157199771|NCT00945815|567475389|FG000|Overall Study|Did not begin protocol therapy|1|||
157199772|NCT01590810|567475390|FG000|Overall Study|Physician Decision|0|||
157199773|NCT01590810|567475391|FG001|Overall Study|Physician Decision|1|||
157199774|NCT01590810|567475392|FG002|Overall Study|Physician Decision|1|||
157199775|NCT01590810|567475393|FG003|Overall Study|Physician Decision|0|||
157199776|NCT01590810|567475394|FG004|Overall Study|Physician Decision|0|||
157199777|NCT02441517|567475401|FG000|Overall Study|Lost to Follow-up|1|||
157199778|NCT02441517|567475401|FG000|Overall Study|Withdrawal by Subject|2|||
157199779|NCT02441517|567475401|FG000|Overall Study|Study Terminated by Sponsor|1|||
157199780|NCT03039699|567475402|FG000|Overall Study|Incorrect inclusion|5|||
157199781|NCT03039699|567475403|FG001|Overall Study|Incorrect inclusion|4|||
157199782|NCT03039699|567475402|FG000|Overall Study|Lack of data to assess study endpoint|5|||
157199783|NCT03039699|567475403|FG001|Overall Study|Lack of data to assess study endpoint|3|||
157199784|NCT03039699|567475402|FG000|Overall Study|Bacterial infection|12|||
157199785|NCT03039699|567475403|FG001|Overall Study|Bacterial infection|28|||
157199786|NCT01790633|567475404|FG000|Overall Study|Protocol Violation|1|||
157199787|NCT01790633|567475405|FG001|Overall Study|Protocol Violation|2|||
157199788|NCT01790633|567475404|FG000|Overall Study|Did not have serology performed|47|||
157199789|NCT01790633|567475405|FG001|Overall Study|Did not have serology performed|0|||
157199790|NCT01790633|567475404|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
157199791|NCT01790633|567475405|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
157199792|NCT01479777|567477177|FG000|Overall Study|Physician Decision|2|||
157199793|NCT00869362|567477186|FG000|Overall Study|Death|0|||
157199794|NCT00869362|567477187|FG001|Overall Study|Death|2|||
157199795|NCT00869362|567477186|FG000|Overall Study|Lost to Follow-up|1|||
157199796|NCT00869362|567477187|FG001|Overall Study|Lost to Follow-up|3|||
157199797|NCT02815540|567477191|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
157199798|NCT00594568|567477192|FG000|Initial Treatment|Adverse Event|51|||
157243235|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243236|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157199799|NCT00594568|567477193|FG001|Initial Treatment|Adverse Event|121|||
157199800|NCT00594568|567477194|FG002|Initial Treatment|Adverse Event|144|||
157199801|NCT00594568|567477192|FG000|Initial Treatment|Death|6|||
157199802|NCT00594568|567477193|FG001|Initial Treatment|Death|11|||
157199803|NCT00594568|567477194|FG002|Initial Treatment|Death|15|||
157199804|NCT00594568|567477192|FG000|Initial Treatment|Lost to Follow-up|4|||
157199805|NCT00594568|567477193|FG001|Initial Treatment|Lost to Follow-up|1|||
157199806|NCT00594568|567477194|FG002|Initial Treatment|Lost to Follow-up|4|||
157199807|NCT00594568|567477192|FG000|Initial Treatment|Physician Decision|3|||
157243237|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157199808|NCT00594568|567477193|FG001|Initial Treatment|Physician Decision|2|||
157199809|NCT00594568|567477194|FG002|Initial Treatment|Physician Decision|4|||
157199810|NCT00594568|567477192|FG000|Initial Treatment|Protocol Violation|2|||
157199811|NCT00594568|567477193|FG001|Initial Treatment|Protocol Violation|2|||
157199812|NCT00594568|567477194|FG002|Initial Treatment|Protocol Violation|5|||
157199813|NCT00594568|567477192|FG000|Initial Treatment|Withdrawal by Subject|25|||
157199814|NCT00594568|567477193|FG001|Initial Treatment|Withdrawal by Subject|31|||
157199815|NCT00594568|567477194|FG002|Initial Treatment|Withdrawal by Subject|46|||
157199816|NCT00594568|567477192|FG000|Initial Treatment|Sponsor decision|193|||
157199817|NCT00594568|567477193|FG001|Initial Treatment|Sponsor decision|142|||
157199818|NCT00594568|567477194|FG002|Initial Treatment|Sponsor decision|147|||
157199819|NCT00594568|567477192|FG000|Initial Treatment|Caregiver decision|21|||
157199820|NCT00594568|567477193|FG001|Initial Treatment|Caregiver decision|36|||
157199821|NCT00594568|567477194|FG002|Initial Treatment|Caregiver decision|36|||
157199822|NCT00594568|567477192|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
157199823|NCT00594568|567477193|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
157199824|NCT00594568|567477194|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
157199825|NCT00594568|567477192|FG000|Initial Treatment|Entry criteria exclusion|0|||
157199826|NCT00594568|567477193|FG001|Initial Treatment|Entry criteria exclusion|1|||
157199827|NCT00594568|567477194|FG002|Initial Treatment|Entry criteria exclusion|1|||
157199828|NCT00594568|567477192|FG000|Delayed Start|Death|0|||
157199829|NCT00594568|567477193|FG001|Delayed Start|Death|0|||
157199830|NCT00594568|567477194|FG002|Delayed Start|Death|1|||
157199831|NCT00594568|567477192|FG000|Delayed Start|Adverse Event|12|||
157199832|NCT00594568|567477193|FG001|Delayed Start|Adverse Event|2|||
157199833|NCT00594568|567477194|FG002|Delayed Start|Adverse Event|2|||
157199834|NCT00594568|567477192|FG000|Delayed Start|Withdrawal by Subject|4|||
157199835|NCT00594568|567477193|FG001|Delayed Start|Withdrawal by Subject|3|||
157199836|NCT00594568|567477194|FG002|Delayed Start|Withdrawal by Subject|0|||
157199837|NCT00594568|567477192|FG000|Delayed Start|Physician Decision|0|||
157199838|NCT00594568|567477193|FG001|Delayed Start|Physician Decision|0|||
157199839|NCT00594568|567477194|FG002|Delayed Start|Physician Decision|1|||
157199840|NCT00594568|567477192|FG000|Delayed Start|Lost to Follow-up|0|||
157199841|NCT00594568|567477193|FG001|Delayed Start|Lost to Follow-up|0|||
157199842|NCT00594568|567477194|FG002|Delayed Start|Lost to Follow-up|1|||
157199843|NCT00594568|567477192|FG000|Delayed Start|Caregiver Decision|5|||
157199844|NCT00594568|567477193|FG001|Delayed Start|Caregiver Decision|6|||
157199845|NCT00594568|567477194|FG002|Delayed Start|Caregiver Decision|2|||
157199846|NCT00594568|567477192|FG000|Delayed Start|Sponsor Decision|77|||
157199847|NCT00594568|567477193|FG001|Delayed Start|Sponsor Decision|66|||
157199848|NCT00594568|567477194|FG002|Delayed Start|Sponsor Decision|59|||
157199849|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
157199850|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
157199851|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
157199852|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
157199853|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
157199854|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
157199855|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
157199856|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
157199857|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
157199858|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
157199859|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
157199860|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
157199861|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
157199862|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
157199863|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
157199864|NCT00594568|567477192|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
157199865|NCT00594568|567477193|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
157199866|NCT00594568|567477194|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
157199867|NCT01976663|567477199|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
157199868|NCT01976663|567477199|FG000|Overall Study|Personal Reasons|6|||
157199869|NCT01976663|567477199|FG000|Overall Study|Withdrawal by Subject|4|||
157199870|NCT01976663|567477199|FG000|Overall Study|Screen Failure|3|||
157199871|NCT01976663|567477199|FG000|Overall Study|Adverse Event|2|||
157199872|NCT01976663|567477199|FG000|Overall Study|Lost to Follow-up|3|||
157199873|NCT04780776|567477204|FG000|Titration Week 1-5|Lost to Follow-up|2|||
157199874|NCT04780776|567477205|FG001|Titration Week 1-5|Lost to Follow-up|8|||
157199875|NCT04780776|567477204|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
157199876|NCT04780776|567477205|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
157199877|NCT04780776|567477204|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
157199878|NCT04780776|567477205|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
157199879|NCT03113760|567477207|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
157199880|NCT03113760|567477208|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
157199881|NCT03113760|567477209|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
157199882|NCT03113760|567477210|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
157199883|NCT03113760|567477207|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
157199884|NCT03113760|567477208|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
157199885|NCT03113760|567477209|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
157199886|NCT03113760|567477210|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
157199887|NCT03113760|567477207|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
157199888|NCT03113760|567477208|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
157199889|NCT03113760|567477209|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
157199890|NCT03113760|567477210|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
157199891|NCT04196023|567477214|FG000|Overall Study|Withdrawal by Subject|0|||
157199892|NCT04196023|567477215|FG001|Overall Study|Withdrawal by Subject|1|||
157199893|NCT04196023|567477214|FG000|Overall Study|Adverse Event|3|||
157199894|NCT04196023|567477215|FG001|Overall Study|Adverse Event|1|||
157199895|NCT04196023|567477214|FG000|Overall Study|Lost to Follow-up|0|||
157199896|NCT04196023|567477215|FG001|Overall Study|Lost to Follow-up|1|||
157199897|NCT04359758|567477222|FG000|Overall Study|Protocol Violation|3|||
157199898|NCT04359758|567477223|FG001|Overall Study|Protocol Violation|2|||
157199899|NCT03358407|567477227|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199900|NCT03358407|567477228|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199901|NCT03358407|567477229|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
157199902|NCT03358407|567477230|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199903|NCT03358407|567477231|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199904|NCT03358407|567477232|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199905|NCT03358407|567477233|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199906|NCT03358407|567477234|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199907|NCT03358407|567477235|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199908|NCT03358407|567477236|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
157199909|NCT03358407|567477227|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199910|NCT03358407|567477228|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199911|NCT03358407|567477229|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199912|NCT03358407|567477230|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199913|NCT03358407|567477231|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
157199914|NCT03358407|567477232|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199915|NCT03358407|567477233|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199916|NCT03358407|567477234|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199917|NCT03358407|567477235|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199918|NCT03358407|567477236|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199919|NCT03358407|567477227|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199920|NCT03358407|567477228|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199921|NCT03358407|567477229|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199922|NCT03358407|567477230|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199923|NCT03358407|567477231|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199924|NCT03358407|567477232|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
157199925|NCT03358407|567477233|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199926|NCT03358407|567477234|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
157199927|NCT03358407|567477235|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199928|NCT03358407|567477236|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
157199929|NCT03358407|567477227|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199930|NCT03358407|567477228|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199931|NCT03358407|567477229|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199932|NCT03358407|567477230|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199933|NCT03358407|567477231|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199934|NCT03358407|567477232|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
157199935|NCT03358407|567477233|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199936|NCT03358407|567477234|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
157199937|NCT03358407|567477235|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199938|NCT03358407|567477236|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
157199939|NCT03358407|567477227|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199940|NCT03358407|567477228|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199941|NCT03358407|567477229|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199942|NCT03358407|567477230|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199943|NCT03358407|567477231|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199944|NCT03358407|567477232|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
157199945|NCT03358407|567477233|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
157243238|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243239|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157199946|NCT03358407|567477234|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199947|NCT03358407|567477235|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199948|NCT03358407|567477236|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
157199949|NCT03358407|567477227|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199950|NCT03358407|567477228|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199951|NCT03358407|567477229|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199952|NCT03358407|567477230|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199953|NCT03358407|567477231|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199954|NCT03358407|567477232|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
157199955|NCT03358407|567477233|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
157199956|NCT03358407|567477234|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
157199957|NCT03358407|567477235|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199958|NCT03358407|567477236|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
157199959|NCT00483574|567477237|FG000|Overall Study|Adverse Event|6|||
157199960|NCT00483574|567477238|FG001|Overall Study|Adverse Event|0|||
157199961|NCT00483574|567477237|FG000|Overall Study|Protocol Violation|28|||
157199962|NCT00483574|567477238|FG001|Overall Study|Protocol Violation|9|||
157199963|NCT00483574|567477237|FG000|Overall Study|Lost to Follow-up|16|||
157199964|NCT00483574|567477238|FG001|Overall Study|Lost to Follow-up|4|||
157199965|NCT00483574|567477237|FG000|Overall Study|Withdrawal by Subject|52|||
157199966|NCT00483574|567477238|FG001|Overall Study|Withdrawal by Subject|0|||
157199967|NCT03605758|567477239|FG000|Overall Study|Lost to Follow-up|2|||
157199968|NCT03605758|567477240|FG001|Overall Study|Lost to Follow-up|1|||
157199969|NCT03605758|567477239|FG000|Overall Study|Illness|0|||
157199970|NCT03605758|567477240|FG001|Overall Study|Illness|1|||
157199971|NCT03605758|567477239|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
157199972|NCT03605758|567477240|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
157199973|NCT04753606|567477243|FG000|Overall Study|Adverse Event|1|||
157199974|NCT04753606|567477244|FG001|Overall Study|Adverse Event|0|||
157199975|NCT04753606|567477245|FG002|Overall Study|Adverse Event|0|||
157199976|NCT00489411|567477246|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
157199977|NCT00489411|567477247|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
157199978|NCT00489411|567477246|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
157199979|NCT00489411|567477247|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
157199980|NCT00489411|567477246|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
157199981|NCT00489411|567477247|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
157199982|NCT00489411|567477246|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
157199983|NCT00489411|567477247|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
157199984|NCT00489411|567477246|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
157199985|NCT00489411|567477247|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
157199986|NCT01748162|567477250|FG000|Overall Study|no additional croup episodes to evaluate|2|||
157199987|NCT01748162|567477251|FG001|Overall Study|no additional croup episodes to evaluate|2|||
157199988|NCT01748162|567477250|FG000|Overall Study|participant consented but did not begin|0|||
157199989|NCT01748162|567477251|FG001|Overall Study|participant consented but did not begin|1|||
157199990|NCT01748162|567477250|FG000|Overall Study|reasons not available|3|||
157199991|NCT01748162|567477251|FG001|Overall Study|reasons not available|2|||
157199992|NCT03219372|567477252|FG000|Overall Study|Withdrawal by Subject|1|||
157199993|NCT03219372|567477253|FG001|Overall Study|Withdrawal by Subject|0|||
157199994|NCT03841331|567477254|FG000|Overall Study|Withdrawal by Subject|4|||
157199995|NCT03841331|567477255|FG001|Overall Study|Withdrawal by Subject|9|||
157199996|NCT03841331|567477254|FG000|Overall Study|Lost to Follow-up|5|||
157199997|NCT03841331|567477255|FG001|Overall Study|Lost to Follow-up|1|||
157199998|NCT04145531|567477256|FG000|Part A|Adverse Event|2|||
157199999|NCT04145531|567477257|FG001|Part A|Adverse Event|12|||
157200000|NCT04145531|567477258|FG002|Part A|Adverse Event|6|||
157200001|NCT04145531|567477259|FG003|Part A|Adverse Event|0|||
157200002|NCT04145531|567477256|FG000|Part A|Death|1|||
157200003|NCT04145531|567477257|FG001|Part A|Death|2|||
157200004|NCT04145531|567477258|FG002|Part A|Death|0|||
157200005|NCT04145531|567477259|FG003|Part A|Death|0|||
157200006|NCT04145531|567477256|FG000|Part A|Physician Decision|2|||
157200007|NCT04145531|567477257|FG001|Part A|Physician Decision|5|||
157200008|NCT04145531|567477258|FG002|Part A|Physician Decision|2|||
157200009|NCT04145531|567477259|FG003|Part A|Physician Decision|0|||
157200010|NCT04145531|567477256|FG000|Part A|Progressive disease|0|||
157200011|NCT04145531|567477257|FG001|Part A|Progressive disease|2|||
157200012|NCT04145531|567477258|FG002|Part A|Progressive disease|1|||
157200013|NCT04145531|567477259|FG003|Part A|Progressive disease|0|||
157200014|NCT04145531|567477256|FG000|Part A|Protocol deviation|0|||
157200015|NCT04145531|567477257|FG001|Part A|Protocol deviation|0|||
157200016|NCT04145531|567477258|FG002|Part A|Protocol deviation|1|||
157200017|NCT04145531|567477259|FG003|Part A|Protocol deviation|0|||
157200018|NCT04145531|567477256|FG000|Part A|Withdrawal by parent or guardian|1|||
157200019|NCT04145531|567477257|FG001|Part A|Withdrawal by parent or guardian|0|||
157200020|NCT04145531|567477258|FG002|Part A|Withdrawal by parent or guardian|0|||
157200021|NCT04145531|567477259|FG003|Part A|Withdrawal by parent or guardian|0|||
157200022|NCT04145531|567477256|FG000|Part A|Withdrawal by participant|0|||
157200023|NCT04145531|567477257|FG001|Part A|Withdrawal by participant|0|||
157200024|NCT04145531|567477258|FG002|Part A|Withdrawal by participant|1|||
157200025|NCT04145531|567477259|FG003|Part A|Withdrawal by participant|0|||
157200026|NCT04145531|567477256|FG000|Part A|Other|0|||
157200027|NCT04145531|567477257|FG001|Part A|Other|0|||
157200028|NCT04145531|567477258|FG002|Part A|Other|1|||
157200029|NCT04145531|567477259|FG003|Part A|Other|0|||
157200030|NCT04145531|567477256|FG000|Part B|Adverse Event|0|||
157200031|NCT04145531|567477257|FG001|Part B|Adverse Event|0|||
157200032|NCT04145531|567477258|FG002|Part B|Adverse Event|0|||
157200033|NCT04145531|567477259|FG003|Part B|Adverse Event|21|||
157200034|NCT04145531|567477256|FG000|Part B|Physician Decision|0|||
157200035|NCT04145531|567477257|FG001|Part B|Physician Decision|0|||
157200036|NCT04145531|567477258|FG002|Part B|Physician Decision|0|||
157200037|NCT04145531|567477259|FG003|Part B|Physician Decision|7|||
157200038|NCT04145531|567477256|FG000|Part B|Progressive disease|0|||
157200039|NCT04145531|567477257|FG001|Part B|Progressive disease|0|||
157200040|NCT04145531|567477258|FG002|Part B|Progressive disease|0|||
157200041|NCT04145531|567477259|FG003|Part B|Progressive disease|1|||
157200042|NCT04145531|567477256|FG000|Part B|Recurrent disease|0|||
157200043|NCT04145531|567477257|FG001|Part B|Recurrent disease|0|||
157200044|NCT04145531|567477258|FG002|Part B|Recurrent disease|0|||
157200045|NCT04145531|567477259|FG003|Part B|Recurrent disease|1|||
157200046|NCT04145531|567477256|FG000|Part B|Withdrawal by parent or guardian|0|||
157200047|NCT04145531|567477257|FG001|Part B|Withdrawal by parent or guardian|0|||
157200048|NCT04145531|567477258|FG002|Part B|Withdrawal by parent or guardian|0|||
157200049|NCT04145531|567477259|FG003|Part B|Withdrawal by parent or guardian|3|||
157200050|NCT04145531|567477256|FG000|Part B|Withdrawal by participant|0|||
157200051|NCT04145531|567477257|FG001|Part B|Withdrawal by participant|0|||
157200052|NCT04145531|567477258|FG002|Part B|Withdrawal by participant|0|||
157200053|NCT04145531|567477259|FG003|Part B|Withdrawal by participant|1|||
157200054|NCT04145531|567477256|FG000|Part B|Other|0|||
157200055|NCT04145531|567477257|FG001|Part B|Other|0|||
157200056|NCT04145531|567477258|FG002|Part B|Other|0|||
157200057|NCT04145531|567477259|FG003|Part B|Other|1|||
157200058|NCT00779857|567477260|FG000|Overall Study|Death|1|||
157200059|NCT00779857|567477260|FG000|Overall Study|Withdrawal by Subject|3|||
157200060|NCT00779857|567477260|FG000|Overall Study|Missed Visit|2|||
157200061|NCT04640168|567477261|FG000|Overall Study|Withdrawal by Subject|8|||
157200062|NCT04640168|567477262|FG001|Overall Study|Withdrawal by Subject|7|||
157200063|NCT04640168|567477261|FG000|Overall Study|Lost to Follow-up|1|||
157200064|NCT04640168|567477262|FG001|Overall Study|Lost to Follow-up|0|||
157200065|NCT04640168|567477261|FG000|Overall Study|Enrolled but not treated|12|||
157200066|NCT04640168|567477262|FG001|Overall Study|Enrolled but not treated|12|||
157200067|NCT00442572|567477270|FG000|Overall Study|Relapse|8|||
157200068|NCT00442572|567477271|FG001|Overall Study|Relapse|1|||
157200069|NCT00442572|567477270|FG000|Overall Study|Lost to Follow-up|0|||
157200070|NCT00442572|567477271|FG001|Overall Study|Lost to Follow-up|1|||
157200071|NCT00442572|567477270|FG000|Overall Study|Withdrawal by Subject|0|||
157200072|NCT00442572|567477271|FG001|Overall Study|Withdrawal by Subject|1|||
157200073|NCT04366258|567477272|FG000|Baseline Assessments|Screen Failure|21|||
157200074|NCT04366258|567477272|FG000|Baseline Assessments|Early Termination|3|||
157200075|NCT00276458|567477274|FG000|Overall Study|Adverse Event|0|||
157200076|NCT00276458|567477275|FG001|Overall Study|Adverse Event|2|||
157200077|NCT00276458|567477274|FG000|Overall Study|Lost to Follow-up|2|||
157200078|NCT00276458|567477275|FG001|Overall Study|Lost to Follow-up|2|||
157200079|NCT00276458|567477274|FG000|Overall Study|Protocol Violation|4|||
157200080|NCT00276458|567477275|FG001|Overall Study|Protocol Violation|3|||
157200081|NCT03205046|567477279|FG000|Overall Study|Death|10|||
157200082|NCT03205046|567477280|FG001|Overall Study|Death|6|||
157200083|NCT03205046|567477279|FG000|Overall Study|Withdrawal by Subject|1|||
157200084|NCT03205046|567477280|FG001|Overall Study|Withdrawal by Subject|2|||
157200085|NCT03205046|567477279|FG000|Overall Study|Lost to Follow-up|0|||
157200086|NCT03205046|567477280|FG001|Overall Study|Lost to Follow-up|1|||
157200087|NCT03205046|567477279|FG000|Overall Study|Study terminated by sponsor|2|||
157200088|NCT03205046|567477280|FG001|Overall Study|Study terminated by sponsor|1|||
157200089|NCT01023815|567477281|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
157200090|NCT01023815|567477282|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
157200091|NCT01023815|567477283|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
157200092|NCT01023815|567477284|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
157200093|NCT01023815|567477281|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
157200094|NCT01023815|567477282|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
157200095|NCT01023815|567477283|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
157200096|NCT01023815|567477284|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
157200097|NCT01023815|567477281|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
157200098|NCT01023815|567477282|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
157200099|NCT01023815|567477283|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
157200100|NCT01023815|567477284|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
157200101|NCT01023815|567477281|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
157200102|NCT01023815|567477282|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
157200103|NCT01023815|567477283|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
157200104|NCT01023815|567477284|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
157200105|NCT01023815|567477281|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
157200106|NCT01023815|567477282|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
157200107|NCT01023815|567477283|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
157200108|NCT01023815|567477284|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
157200109|NCT01977625|567477290|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
157200110|NCT01977625|567477291|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
157200111|NCT01977625|567477290|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
157200112|NCT01977625|567477291|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
157200113|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
157200114|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
157200115|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
157200116|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
157200117|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
157200118|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Death|1|||
157200119|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Death|0|||
157200120|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Death|0|||
157200121|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Death|0|||
157200122|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Death|0|||
157200123|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
157200124|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
157200125|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
157200126|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
157200127|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
157200128|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
157200129|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
157200130|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
157200131|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
157200132|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
157200133|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
157200134|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
157200135|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
157200136|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
157200137|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
157200138|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
157200139|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
157200140|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
157200141|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
157200142|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
157200143|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
157200144|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
157200145|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
157200146|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
157200147|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
157200148|NCT00634933|567477295|FG000|Part A: Baseline to Week 24|Other|1|||
157200149|NCT00634933|567477296|FG001|Part A: Baseline to Week 24|Other|8|||
157200150|NCT00634933|567477297|FG002|Part A: Baseline to Week 24|Other|5|||
157200151|NCT00634933|567477298|FG003|Part A: Baseline to Week 24|Other|0|||
157200152|NCT00634933|567477299|FG004|Part A: Baseline to Week 24|Other|0|||
157200153|NCT00634933|567477295|FG000|Between Part A and Part B|Physician Decision|0|||
157200154|NCT00634933|567477296|FG001|Between Part A and Part B|Physician Decision|1|||
157200155|NCT00634933|567477297|FG002|Between Part A and Part B|Physician Decision|0|||
157200156|NCT00634933|567477298|FG003|Between Part A and Part B|Physician Decision|0|||
157200157|NCT00634933|567477299|FG004|Between Part A and Part B|Physician Decision|0|||
157200158|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
157200159|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
157200160|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
157243240|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157200161|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
157200162|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
157200163|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
157200164|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
157200165|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
157200166|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
157200167|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
157200168|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
157200169|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
157200170|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
157200171|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
157200172|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
157200173|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
157200174|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
157200175|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
157200176|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
157200177|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
157200178|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
157200179|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
157200180|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
157200181|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
157200182|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
157200183|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
157200184|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
157200185|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
157200186|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
157200187|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
157200188|NCT00634933|567477295|FG000|Part B: Week 24 to Week 52|Other|0|||
157200189|NCT00634933|567477296|FG001|Part B: Week 24 to Week 52|Other|0|||
157200190|NCT00634933|567477297|FG002|Part B: Week 24 to Week 52|Other|5|||
157200191|NCT00634933|567477298|FG003|Part B: Week 24 to Week 52|Other|0|||
157200192|NCT00634933|567477299|FG004|Part B: Week 24 to Week 52|Other|1|||
157200193|NCT00429026|567477300|FG000|Overall Study|Inevaluable for response.|40|||
157200194|NCT02304484|567477303|FG000|Overall Study|Death|9|||
157200195|NCT02304484|567477303|FG000|Overall Study|Withdrawal by Subject|14|||
157200196|NCT02304484|567477303|FG000|Overall Study|Lost to Follow-up|2|||
157200197|NCT04338685|567477304|FG000|Overall Study|Death|3|||
157200198|NCT04338685|567477305|FG001|Overall Study|Death|4|||
157200199|NCT04338685|567477306|FG002|Overall Study|Death|2|||
157200200|NCT04338685|567477307|FG003|Overall Study|Death|4|||
157200201|NCT04338685|567477308|FG004|Overall Study|Death|4|||
157200202|NCT04338685|567477309|FG005|Overall Study|Death|8|||
157200203|NCT04338685|567477310|FG006|Overall Study|Death|1|||
157200204|NCT04338685|567477311|FG007|Overall Study|Death|0|||
157200205|NCT04338685|567477312|FG008|Overall Study|Death|0|||
157200206|NCT04338685|567477304|FG000|Overall Study|Study terminated by Sponsor|0|||
157200207|NCT04338685|567477305|FG001|Overall Study|Study terminated by Sponsor|0|||
157200208|NCT04338685|567477306|FG002|Overall Study|Study terminated by Sponsor|1|||
157200209|NCT04338685|567477307|FG003|Overall Study|Study terminated by Sponsor|4|||
157200210|NCT04338685|567477308|FG004|Overall Study|Study terminated by Sponsor|0|||
157200211|NCT04338685|567477309|FG005|Overall Study|Study terminated by Sponsor|5|||
157200212|NCT04338685|567477310|FG006|Overall Study|Study terminated by Sponsor|2|||
157200213|NCT04338685|567477311|FG007|Overall Study|Study terminated by Sponsor|4|||
157200214|NCT04338685|567477312|FG008|Overall Study|Study terminated by Sponsor|1|||
157200215|NCT04338685|567477304|FG000|Overall Study|Withdrawal by Subject|1|||
157200216|NCT04338685|567477305|FG001|Overall Study|Withdrawal by Subject|2|||
157200217|NCT04338685|567477306|FG002|Overall Study|Withdrawal by Subject|0|||
157200218|NCT04338685|567477307|FG003|Overall Study|Withdrawal by Subject|2|||
157200219|NCT04338685|567477308|FG004|Overall Study|Withdrawal by Subject|0|||
157200220|NCT04338685|567477309|FG005|Overall Study|Withdrawal by Subject|5|||
157200221|NCT04338685|567477310|FG006|Overall Study|Withdrawal by Subject|1|||
157200222|NCT04338685|567477311|FG007|Overall Study|Withdrawal by Subject|1|||
157200223|NCT04338685|567477312|FG008|Overall Study|Withdrawal by Subject|0|||
157200224|NCT01539512|567477313|FG000|Overall Study|Adverse Event|9|||
157200225|NCT01539512|567477314|FG001|Overall Study|Adverse Event|7|||
157200226|NCT01539512|567477313|FG000|Overall Study|Physician Decision|1|||
157200227|NCT01539512|567477314|FG001|Overall Study|Physician Decision|1|||
157200228|NCT01539512|567477313|FG000|Overall Study|Withdrawal by Subject|12|||
157200229|NCT01539512|567477314|FG001|Overall Study|Withdrawal by Subject|5|||
157243241|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157200230|NCT01539512|567477313|FG000|Overall Study|Richter's Transformation|1|||
157200231|NCT01539512|567477314|FG001|Overall Study|Richter's Transformation|0|||
157200232|NCT03522506|567477315|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157200233|NCT03522506|567477316|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157200234|NCT03522506|567477317|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
157200235|NCT03522506|567477318|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
157200236|NCT03522506|567477315|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157200237|NCT03522506|567477316|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157200238|NCT03522506|567477317|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
157200239|NCT03522506|567477318|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
157200240|NCT03480243|567477319|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
157200241|NCT03480243|567477319|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
157200242|NCT04365387|567477320|FG000|Overall Study|Adverse Event|4|||
157200243|NCT04365387|567477321|FG001|Overall Study|Adverse Event|2|||
157200244|NCT04365387|567477320|FG000|Overall Study|Participants request|14|||
157200245|NCT04365387|567477321|FG001|Overall Study|Participants request|14|||
157200246|NCT04365387|567477320|FG000|Overall Study|Lost to Follow-up|8|||
157200247|NCT04365387|567477321|FG001|Overall Study|Lost to Follow-up|5|||
157200248|NCT04365387|567477320|FG000|Overall Study|Protocol deviation|3|||
157200249|NCT04365387|567477321|FG001|Overall Study|Protocol deviation|4|||
157200250|NCT04365387|567477320|FG000|Overall Study|Participant compliance with visit schedule|1|||
157200251|NCT04365387|567477321|FG001|Overall Study|Participant compliance with visit schedule|0|||
157200252|NCT04365387|567477320|FG000|Overall Study|Participant incarcerated|1|||
157200253|NCT04365387|567477321|FG001|Overall Study|Participant incarcerated|0|||
157200254|NCT04365387|567477320|FG000|Overall Study|Participant moved out of town (relocated)|0|||
157200255|NCT04365387|567477321|FG001|Overall Study|Participant moved out of town (relocated)|1|||
157200256|NCT04365387|567477320|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
157200257|NCT04365387|567477321|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
157243242|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243243|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243244|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243245|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243246|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243247|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157243248|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
157200258|NCT04365387|567477320|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
157200259|NCT04365387|567477321|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
157200260|NCT05770401|567477322|FG000|Overall Study|Lost to Follow-up|5|||
157200261|NCT05770401|567477323|FG001|Overall Study|Lost to Follow-up|4|||
157200262|NCT02283411|567477326|FG000|Overall Study|Withdrawal by Subject|3|||
157200263|NCT02283411|567477326|FG000|Overall Study|Screen Failed|28|||
157200264|NCT00764465|567477327|FG000|Overall Study|Adverse Event|2|||
157200265|NCT00764465|567477328|FG001|Overall Study|Adverse Event|0|||
157200266|NCT00764465|567477329|FG002|Overall Study|Adverse Event|0|||
157200267|NCT00764465|567477330|FG003|Overall Study|Adverse Event|1|||
157200268|NCT00764465|567477331|FG004|Overall Study|Adverse Event|1|||
157200269|NCT00764465|567477332|FG005|Overall Study|Adverse Event|1|||
157200270|NCT00764465|567477327|FG000|Overall Study|Withdrawal by Subject|0|||
157200271|NCT00764465|567477328|FG001|Overall Study|Withdrawal by Subject|1|||
157200272|NCT00764465|567477329|FG002|Overall Study|Withdrawal by Subject|1|||
157200273|NCT00764465|567477330|FG003|Overall Study|Withdrawal by Subject|0|||
157200274|NCT00764465|567477331|FG004|Overall Study|Withdrawal by Subject|0|||
157200275|NCT00764465|567477332|FG005|Overall Study|Withdrawal by Subject|0|||
157200276|NCT03329404|567477333|FG000|Overall Study|The study was suspended.|1|||
157200277|NCT03329404|567477334|FG001|Overall Study|The study was suspended.|4|||
157200278|NCT02400281|567477335|FG000|Overall Study|Adverse Event|0|||
157200279|NCT02400281|567477336|FG001|Overall Study|Adverse Event|0|||
157200280|NCT02400281|567477337|FG002|Overall Study|Adverse Event|1|||
157200281|NCT02400281|567477338|FG003|Overall Study|Adverse Event|0|||
157200282|NCT02400281|567477339|FG004|Overall Study|Adverse Event|1|||
157200283|NCT02400281|567477340|FG005|Overall Study|Adverse Event|0|||
157200284|NCT02400281|567477335|FG000|Overall Study|Physician Decision|0|||
157200285|NCT02400281|567477336|FG001|Overall Study|Physician Decision|0|||
157200286|NCT02400281|567477337|FG002|Overall Study|Physician Decision|1|||
157200287|NCT02400281|567477338|FG003|Overall Study|Physician Decision|0|||
157200288|NCT02400281|567477339|FG004|Overall Study|Physician Decision|0|||
157200289|NCT02400281|567477340|FG005|Overall Study|Physician Decision|0|||
157200290|NCT04524507|567477341|FG000|Overall Study|Lost to Follow-up|2|||
157200291|NCT04524507|567477342|FG001|Overall Study|Lost to Follow-up|4|||
157200292|NCT04524507|567477341|FG000|Overall Study|Withdrawal by Subject|2|||
157200293|NCT04524507|567477342|FG001|Overall Study|Withdrawal by Subject|9|||
157200294|NCT04524507|567477341|FG000|Overall Study|Death|2|||
157200295|NCT04524507|567477342|FG001|Overall Study|Death|10|||
157200296|NCT00761462|567478905|FG000|Treatment|Subjects never received study medication|23|||
157200297|NCT00761462|567478906|FG001|Treatment|Subjects never received study medication|12|||
157243249|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|moved|0|||
157243250|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|moved|1|||
157200298|NCT00761462|567478905|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
157200299|NCT00761462|567478906|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
157200300|NCT00761462|567478905|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
157200301|NCT00761462|567478906|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
157200302|NCT00761462|567478905|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
157200303|NCT00761462|567478906|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
157200304|NCT02985541|567478910|FG000|Overall Study|Withdrawal by Subject|33|||
157200305|NCT02985541|567478910|FG000|Overall Study|Lost to Follow-up|26|||
157200306|NCT02985541|567478910|FG000|Overall Study|Adverse Event|27|||
157200307|NCT02985541|567478910|FG000|Overall Study|Physician Decision|2|||
157200308|NCT02985541|567478910|FG000|Overall Study|Pregnancy|2|||
157200309|NCT02985541|567478910|FG000|Overall Study|Wish for pregnancy|44|||
157200310|NCT02985541|567478910|FG000|Overall Study|Other reason|5|||
157200311|NCT02985541|567478910|FG000|Overall Study|Not valid for analysis|2|||
157200312|NCT02163759|567478911|FG000|Overall Study|Withdrawal by Subject|1|||
157200313|NCT02163759|567478912|FG001|Overall Study|Withdrawal by Subject|5|||
157200314|NCT02163759|567478913|FG002|Overall Study|Withdrawal by Subject|1|||
157200315|NCT02163759|567478911|FG000|Overall Study|Adverse Event|0|||
157200316|NCT02163759|567478912|FG001|Overall Study|Adverse Event|0|||
157200317|NCT02163759|567478913|FG002|Overall Study|Adverse Event|1|||
157200318|NCT02163759|567478911|FG000|Overall Study|Death|0|||
157200319|NCT02163759|567478912|FG001|Overall Study|Death|0|||
157200320|NCT02163759|567478913|FG002|Overall Study|Death|1|||
157200321|NCT00451191|567478922|FG000|Overall Study|withdrawal or received alternate tx|15|||
157200322|NCT00451191|567478923|FG001|Overall Study|withdrawal or received alternate tx|11|||
157200323|NCT00656669|567478931|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
157200324|NCT00656669|567478931|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
157200325|NCT00656669|567478931|FG000|AC (Cycles 6-9)|Adverse Event|1|||
157200326|NCT00656669|567478931|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
157200327|NCT03575806|567478932|FG000|Overall Study|Withdrawal by Subject|0|||
157200328|NCT03575806|567478933|FG001|Overall Study|Withdrawal by Subject|2|||
157200329|NCT03575806|567478932|FG000|Overall Study|Protocol Violation|0|||
157200330|NCT03575806|567478933|FG001|Overall Study|Protocol Violation|2|||
157200331|NCT00219349|567478934|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
157200332|NCT00219349|567478934|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
157200333|NCT00219349|567478934|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
157200334|NCT00219349|567478934|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
157200335|NCT01945034|567478935|FG000|Overall Study|Medication Error|0|||
157200336|NCT01945034|567478936|FG001|Overall Study|Medication Error|1|||
157200337|NCT01945034|567478937|FG002|Overall Study|Medication Error|0|||
157200338|NCT01945034|567478935|FG000|Overall Study|Withdrawal by Subject|0|||
157200339|NCT01945034|567478936|FG001|Overall Study|Withdrawal by Subject|3|||
157200340|NCT01945034|567478937|FG002|Overall Study|Withdrawal by Subject|1|||
157200341|NCT01945034|567478935|FG000|Overall Study|Other|0|||
157200342|NCT01945034|567478936|FG001|Overall Study|Other|1|||
157200343|NCT01945034|567478937|FG002|Overall Study|Other|3|||
157200344|NCT01945034|567478935|FG000|Overall Study|Lost to Follow-up|0|||
157200345|NCT01945034|567478936|FG001|Overall Study|Lost to Follow-up|0|||
157200346|NCT01945034|567478937|FG002|Overall Study|Lost to Follow-up|2|||
157200347|NCT01945034|567478935|FG000|Overall Study|Protocol Violation|1|||
157200348|NCT01945034|567478936|FG001|Overall Study|Protocol Violation|0|||
157200349|NCT01945034|567478937|FG002|Overall Study|Protocol Violation|1|||
157200350|NCT01339273|567478944|FG000|Overall Study|Lost to Follow-up|8|||
157200351|NCT01339273|567478945|FG001|Overall Study|Lost to Follow-up|8|||
157200352|NCT00560573|567478946|FG000|Overall Study|Death|4|||
157200353|NCT00560573|567478947|FG001|Overall Study|Death|1|||
157200354|NCT00560573|567478948|FG002|Overall Study|Death|4|||
157200355|NCT00560573|567478949|FG003|Overall Study|Death|5|||
157243251|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|moved|1|||
157243252|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|moved|0|||
157243253|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|moved|0|||
157243254|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|moved|0|||
157243255|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|moved|0|||
157243256|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|moved|0|||
157243257|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|moved|0|||
157243258|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|moved|0|||
157200356|NCT00560573|567478950|FG004|Overall Study|Death|1|||
157200357|NCT00560573|567478951|FG005|Overall Study|Death|10|||
157200358|NCT00560573|567478946|FG000|Overall Study|Lost to Follow-up|0|||
157200359|NCT00560573|567478947|FG001|Overall Study|Lost to Follow-up|0|||
157243259|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|moved|0|||
157243260|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|moved|0|||
157200360|NCT00560573|567478948|FG002|Overall Study|Lost to Follow-up|0|||
157243261|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|moved|0|||
157200361|NCT00560573|567478949|FG003|Overall Study|Lost to Follow-up|1|||
157200362|NCT00560573|567478950|FG004|Overall Study|Lost to Follow-up|1|||
157243262|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|moved|0|||
157200363|NCT00560573|567478951|FG005|Overall Study|Lost to Follow-up|0|||
157200364|NCT00560573|567478946|FG000|Overall Study|Withdrawal by Subject|0|||
157243263|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|moved|0|||
157243264|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|moved|0|||
157243265|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|moved|0|||
157200365|NCT00560573|567478947|FG001|Overall Study|Withdrawal by Subject|0|||
157200366|NCT00560573|567478948|FG002|Overall Study|Withdrawal by Subject|0|||
157200367|NCT00560573|567478949|FG003|Overall Study|Withdrawal by Subject|1|||
157200368|NCT00560573|567478950|FG004|Overall Study|Withdrawal by Subject|1|||
157200369|NCT00560573|567478951|FG005|Overall Study|Withdrawal by Subject|0|||
157200370|NCT00560573|567478946|FG000|Overall Study|Other|2|||
157200371|NCT00560573|567478947|FG001|Overall Study|Other|2|||
157200372|NCT00560573|567478948|FG002|Overall Study|Other|2|||
157200373|NCT00560573|567478949|FG003|Overall Study|Other|3|||
157200374|NCT00560573|567478950|FG004|Overall Study|Other|3|||
157200375|NCT00560573|567478951|FG005|Overall Study|Other|3|||
157200376|NCT00560573|567478946|FG000|Overall Study|Enrolled, not treated|0|||
157200377|NCT00560573|567478947|FG001|Overall Study|Enrolled, not treated|0|||
157200378|NCT00560573|567478948|FG002|Overall Study|Enrolled, not treated|0|||
157200379|NCT00560573|567478949|FG003|Overall Study|Enrolled, not treated|0|||
157200380|NCT00560573|567478950|FG004|Overall Study|Enrolled, not treated|1|||
157200381|NCT00560573|567478951|FG005|Overall Study|Enrolled, not treated|0|||
157200382|NCT01422876|567478953|FG000|Week 24|Lost to Follow-up|1|||
157200383|NCT01422876|567478954|FG001|Week 24|Lost to Follow-up|1|||
157200384|NCT01422876|567478955|FG002|Week 24|Lost to Follow-up|2|||
157200385|NCT01422876|567478956|FG003|Week 24|Lost to Follow-up|4|||
157200386|NCT01422876|567478957|FG004|Week 24|Lost to Follow-up|2|||
157200387|NCT01422876|567478958|FG005|Week 24|Lost to Follow-up|0|||
157200388|NCT01422876|567478959|FG006|Week 24|Lost to Follow-up|1|||
157200389|NCT01422876|567478960|FG007|Week 24|Lost to Follow-up|3|||
157200390|NCT01422876|567478961|FG008|Week 24|Lost to Follow-up|3|||
157200391|NCT01422876|567478962|FG009|Week 24|Lost to Follow-up|4|||
157200392|NCT01422876|567478953|FG000|Week 24|Consent withdrawn|5|||
157200393|NCT01422876|567478954|FG001|Week 24|Consent withdrawn|1|||
157200394|NCT01422876|567478955|FG002|Week 24|Consent withdrawn|3|||
157200395|NCT01422876|567478956|FG003|Week 24|Consent withdrawn|4|||
157200396|NCT01422876|567478957|FG004|Week 24|Consent withdrawn|5|||
157200397|NCT01422876|567478958|FG005|Week 24|Consent withdrawn|6|||
157200398|NCT01422876|567478959|FG006|Week 24|Consent withdrawn|5|||
157200399|NCT01422876|567478960|FG007|Week 24|Consent withdrawn|4|||
157200400|NCT01422876|567478961|FG008|Week 24|Consent withdrawn|3|||
157200401|NCT01422876|567478962|FG009|Week 24|Consent withdrawn|6|||
157200402|NCT01422876|567478953|FG000|Week 24|Death|0|||
157200403|NCT01422876|567478954|FG001|Week 24|Death|1|||
157200404|NCT01422876|567478955|FG002|Week 24|Death|0|||
157200405|NCT01422876|567478956|FG003|Week 24|Death|0|||
157200406|NCT01422876|567478957|FG004|Week 24|Death|0|||
157200407|NCT01422876|567478958|FG005|Week 24|Death|0|||
157200408|NCT01422876|567478959|FG006|Week 24|Death|0|||
157200409|NCT01422876|567478960|FG007|Week 24|Death|0|||
157200410|NCT01422876|567478961|FG008|Week 24|Death|0|||
157200411|NCT01422876|567478962|FG009|Week 24|Death|0|||
157200412|NCT01422876|567478953|FG000|Week 52|Lost to Follow-up|3|||
157200413|NCT01422876|567478954|FG001|Week 52|Lost to Follow-up|5|||
157200414|NCT01422876|567478955|FG002|Week 52|Lost to Follow-up|7|||
157200415|NCT01422876|567478956|FG003|Week 52|Lost to Follow-up|5|||
157200416|NCT01422876|567478957|FG004|Week 52|Lost to Follow-up|8|||
157200417|NCT01422876|567478958|FG005|Week 52|Lost to Follow-up|5|||
157200418|NCT01422876|567478959|FG006|Week 52|Lost to Follow-up|5|||
157200419|NCT01422876|567478960|FG007|Week 52|Lost to Follow-up|8|||
157200420|NCT01422876|567478961|FG008|Week 52|Lost to Follow-up|7|||
157243266|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|moved|0|||
157243267|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|moved|0|||
157243268|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|moved|0|||
157243269|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|moved|0|||
157243270|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|moved|0|||
157243271|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|moved|0|||
157243272|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|moved|0|||
157243273|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|moved|0|||
157243274|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|moved|0|||
157243275|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200421|NCT01422876|567478962|FG009|Week 52|Lost to Follow-up|8|||
157243276|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243277|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243278|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
157243279|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243280|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200422|NCT01422876|567478953|FG000|Week 52|Consent withdrawn|9|||
157200423|NCT01422876|567478954|FG001|Week 52|Consent withdrawn|4|||
157243281|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200424|NCT01422876|567478955|FG002|Week 52|Consent withdrawn|6|||
157200425|NCT01422876|567478956|FG003|Week 52|Consent withdrawn|12|||
157200426|NCT01422876|567478957|FG004|Week 52|Consent withdrawn|7|||
157200427|NCT01422876|567478958|FG005|Week 52|Consent withdrawn|12|||
157200428|NCT01422876|567478959|FG006|Week 52|Consent withdrawn|10|||
157200429|NCT01422876|567478960|FG007|Week 52|Consent withdrawn|12|||
157200430|NCT01422876|567478961|FG008|Week 52|Consent withdrawn|13|||
157200431|NCT01422876|567478962|FG009|Week 52|Consent withdrawn|9|||
157200432|NCT01422876|567478953|FG000|Week 52|Death|0|||
157200433|NCT01422876|567478954|FG001|Week 52|Death|1|||
157200434|NCT01422876|567478955|FG002|Week 52|Death|0|||
157200435|NCT01422876|567478956|FG003|Week 52|Death|1|||
157200436|NCT01422876|567478957|FG004|Week 52|Death|0|||
157200437|NCT01422876|567478958|FG005|Week 52|Death|0|||
157200438|NCT01422876|567478959|FG006|Week 52|Death|1|||
157200439|NCT01422876|567478960|FG007|Week 52|Death|3|||
157200440|NCT01422876|567478961|FG008|Week 52|Death|1|||
157200441|NCT01422876|567478962|FG009|Week 52|Death|0|||
157200442|NCT00938392|567478964|FG000|Overall Study|Adverse Event|0|||
157200443|NCT00938392|567478965|FG001|Overall Study|Adverse Event|1|||
157200444|NCT00938392|567478964|FG000|Overall Study|Withdrawal by Subject|0|||
157200445|NCT00938392|567478965|FG001|Overall Study|Withdrawal by Subject|1|||
157200446|NCT00938392|567478964|FG000|Overall Study|Lost to Follow-up|2|||
157200447|NCT00938392|567478965|FG001|Overall Study|Lost to Follow-up|2|||
157200448|NCT01366846|567478966|FG000|Overall Study|Withdrawal by Subject|2|||
157200449|NCT01366846|567478967|FG001|Overall Study|Withdrawal by Subject|0|||
157200450|NCT01366846|567478968|FG002|Overall Study|Withdrawal by Subject|0|||
157200451|NCT01366846|567478969|FG003|Overall Study|Withdrawal by Subject|0|||
157200452|NCT01366846|567478966|FG000|Overall Study|Communication Difficulties|1|||
157200453|NCT01366846|567478967|FG001|Overall Study|Communication Difficulties|4|||
157200454|NCT01366846|567478968|FG002|Overall Study|Communication Difficulties|0|||
157200455|NCT01366846|567478969|FG003|Overall Study|Communication Difficulties|1|||
157200456|NCT01366846|567478966|FG000|Overall Study|Scheduling Conflicts|0|||
157200457|NCT01366846|567478967|FG001|Overall Study|Scheduling Conflicts|0|||
157200458|NCT01366846|567478968|FG002|Overall Study|Scheduling Conflicts|1|||
157200459|NCT01366846|567478969|FG003|Overall Study|Scheduling Conflicts|0|||
157200460|NCT00558831|567478974|FG000|Overall Study|Lost to Follow-up|1|||
157200461|NCT04341727|567478975|FG000|Overall Study|Withdrawal by Subject|0|||
157200462|NCT04341727|567478976|FG001|Overall Study|Withdrawal by Subject|0|||
157200463|NCT04341727|567478977|FG002|Overall Study|Withdrawal by Subject|1|||
157200464|NCT04341727|567478978|FG003|Overall Study|Withdrawal by Subject|0|||
157200465|NCT04341727|567478975|FG000|Overall Study|Lost to Follow-up|0|||
157200466|NCT04341727|567478976|FG001|Overall Study|Lost to Follow-up|0|||
157200467|NCT04341727|567478977|FG002|Overall Study|Lost to Follow-up|0|||
157200468|NCT04341727|567478978|FG003|Overall Study|Lost to Follow-up|1|||
157200469|NCT02204449|567478979|FG000|Overall Study|Lost to Follow-up|7|||
157200470|NCT02204449|567478980|FG001|Overall Study|Lost to Follow-up|9|||
157200471|NCT02204449|567478979|FG000|Overall Study|Death|0|||
157200472|NCT02204449|567478980|FG001|Overall Study|Death|1|||
157200473|NCT02204449|567478979|FG000|Overall Study|Withdrawal by Subject|0|||
157200474|NCT02204449|567478980|FG001|Overall Study|Withdrawal by Subject|1|||
157200475|NCT04311411|567478981|FG000|Overall Study|Adverse Event|2|||
157200476|NCT04311411|567478982|FG001|Overall Study|Adverse Event|3|||
157200477|NCT04311411|567478983|FG002|Overall Study|Adverse Event|2|||
157200478|NCT04311411|567478981|FG000|Overall Study|Withdrawal by Subject|3|||
157200479|NCT04311411|567478982|FG001|Overall Study|Withdrawal by Subject|3|||
157200480|NCT04311411|567478983|FG002|Overall Study|Withdrawal by Subject|0|||
157200481|NCT02743117|567478986|FG000|Overall Study|Lost to Follow-up|0|||
157200482|NCT02743117|567478987|FG001|Overall Study|Lost to Follow-up|1|||
157200483|NCT02743117|567478986|FG000|Overall Study|Other|1|||
157200484|NCT02743117|567478987|FG001|Overall Study|Other|0|||
157200485|NCT00978120|567478990|FG000|Overall Study|Death|0|||
157200486|NCT00978120|567478991|FG001|Overall Study|Death|0|||
157200487|NCT00978120|567478992|FG002|Overall Study|Death|0|||
157200488|NCT00978120|567478993|FG003|Overall Study|Death|1|||
157200489|NCT00978120|567478990|FG000|Overall Study|Lost to Follow-up|0|||
157200490|NCT00978120|567478991|FG001|Overall Study|Lost to Follow-up|0|||
157200491|NCT00978120|567478992|FG002|Overall Study|Lost to Follow-up|3|||
157200492|NCT00978120|567478993|FG003|Overall Study|Lost to Follow-up|0|||
157200493|NCT00978120|567478990|FG000|Overall Study|Withdrawal by Subject|2|||
157200494|NCT00978120|567478991|FG001|Overall Study|Withdrawal by Subject|0|||
157200495|NCT00978120|567478992|FG002|Overall Study|Withdrawal by Subject|0|||
157200496|NCT00978120|567478993|FG003|Overall Study|Withdrawal by Subject|0|||
157200497|NCT00978120|567478990|FG000|Overall Study|Moved out of state|0|||
157200498|NCT00978120|567478991|FG001|Overall Study|Moved out of state|0|||
157200499|NCT00978120|567478992|FG002|Overall Study|Moved out of state|0|||
157200500|NCT00978120|567478993|FG003|Overall Study|Moved out of state|1|||
157200501|NCT02940392|567478994|FG000|Overall Study|Lost to Follow-up|3|||
157200502|NCT02940392|567478994|FG000|Overall Study|Retreatment|3|||
157200503|NCT02940392|567478994|FG000|Overall Study|Death|2|||
157200504|NCT00762073|567478997|FG000|Overall Study|Lack of Efficacy|1|||
157200505|NCT00762073|567478998|FG001|Overall Study|Lack of Efficacy|1|||
157200506|NCT00762073|567478999|FG002|Overall Study|Lack of Efficacy|0|||
157200507|NCT00762073|567479000|FG003|Overall Study|Lack of Efficacy|0|||
157200508|NCT00762073|567478997|FG000|Overall Study|Adverse Event|1|||
157200509|NCT00762073|567478998|FG001|Overall Study|Adverse Event|0|||
157200510|NCT00762073|567478999|FG002|Overall Study|Adverse Event|1|||
157200511|NCT00762073|567479000|FG003|Overall Study|Adverse Event|1|||
157200512|NCT00762073|567478997|FG000|Overall Study|Significant Subject Noncompliance|0|||
157200513|NCT00762073|567478998|FG001|Overall Study|Significant Subject Noncompliance|1|||
157200514|NCT00762073|567478999|FG002|Overall Study|Significant Subject Noncompliance|0|||
157200515|NCT00762073|567479000|FG003|Overall Study|Significant Subject Noncompliance|1|||
157200516|NCT00762073|567478997|FG000|Overall Study|Withdrawal by Subject|1|||
157200517|NCT00762073|567478998|FG001|Overall Study|Withdrawal by Subject|2|||
157200518|NCT00762073|567478999|FG002|Overall Study|Withdrawal by Subject|1|||
157200519|NCT00762073|567479000|FG003|Overall Study|Withdrawal by Subject|1|||
157200520|NCT00762073|567478997|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
157200521|NCT00762073|567478998|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
157200522|NCT00762073|567478999|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
157200523|NCT00762073|567479000|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
157200524|NCT01068418|567479001|FG000|Overall Study|Physician Decision|12|||
157200525|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Adverse Event|6|||
157200526|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Adverse Event|6|||
157200527|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Death|14|||
157200528|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Death|11|||
157200529|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
157200530|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
157200531|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
157200532|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
157200533|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
157200534|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
157200535|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Disease Progression|1|||
157200536|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Disease Progression|0|||
157200537|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
157200538|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
157200539|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
157200540|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
157200541|NCT04419558|567479002|FG000|DB Period (48 Weeks)|Participant Decision|4|||
157200542|NCT04419558|567479003|FG001|DB Period (48 Weeks)|Participant Decision|3|||
157200543|NCT04419558|567479002|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
157200544|NCT04419558|567479003|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
157200545|NCT04419558|567479002|FG000|OLE Period (48 Weeks)|Death|4|||
157200546|NCT04419558|567479003|FG001|OLE Period (48 Weeks)|Death|6|||
157200547|NCT04419558|567479002|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
157200548|NCT04419558|567479003|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
157200549|NCT04419558|567479002|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
157200550|NCT04419558|567479003|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
157200551|NCT02388906|567479005|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
157200552|NCT02388906|567479006|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
157200553|NCT02388906|567479005|FG000|Treatment Period|Disease progression|121|||
157200554|NCT02388906|567479006|FG001|Treatment Period|Disease progression|100|||
157200555|NCT02388906|567479005|FG000|Treatment Period|Study drug toxicity|41|||
157200556|NCT02388906|567479006|FG001|Treatment Period|Study drug toxicity|208|||
157200557|NCT02388906|567479005|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
157200558|NCT02388906|567479006|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
157200559|NCT02388906|567479005|FG000|Treatment Period|Participant request to stop treatment|5|||
157200560|NCT02388906|567479006|FG001|Treatment Period|Participant request to stop treatment|9|||
157200561|NCT02388906|567479005|FG000|Treatment Period|Participant withdrew consent|2|||
157200562|NCT02388906|567479006|FG001|Treatment Period|Participant withdrew consent|3|||
157200563|NCT02388906|567479005|FG000|Treatment Period|Poor/non-compliance|0|||
157200564|NCT02388906|567479006|FG001|Treatment Period|Poor/non-compliance|1|||
157200565|NCT02388906|567479005|FG000|Treatment Period|Participant no longer meets study criteria|0|||
157200566|NCT02388906|567479006|FG001|Treatment Period|Participant no longer meets study criteria|1|||
157200567|NCT02388906|567479005|FG000|Treatment Period|Other reasons|3|||
157200568|NCT02388906|567479006|FG001|Treatment Period|Other reasons|3|||
157200569|NCT00402298|567479015|FG000|Overall Study|Withdrawal by Subject|1|||
157200570|NCT00402298|567479016|FG001|Overall Study|Withdrawal by Subject|0|||
157200571|NCT00480077|567479017|FG000|Overall Study|Death|19|||
157200572|NCT00480077|567479018|FG001|Overall Study|Death|15|||
157200573|NCT00480077|567479017|FG000|Overall Study|early exit|12|||
157200574|NCT00480077|567479018|FG001|Overall Study|early exit|11|||
157200575|NCT04410991|567479031|FG000|Overall Study|Poor compliance to protocol|5|||
157200576|NCT04410991|567479032|FG001|Overall Study|Poor compliance to protocol|4|||
157200577|NCT04410991|567479031|FG000|Overall Study|Withdrawal by Subject|59|||
157200578|NCT04410991|567479032|FG001|Overall Study|Withdrawal by Subject|55|||
157200579|NCT04410991|567479031|FG000|Overall Study|Other|10|||
157200580|NCT04410991|567479032|FG001|Overall Study|Other|4|||
157200581|NCT01250418|567479033|FG000|Overall Study|monitor data failure|1|||
157200582|NCT01250418|567479034|FG001|Overall Study|monitor data failure|1|||
157200583|NCT05966129|567479037|FG000|Overall Study|Death|1|||
157200584|NCT05966129|567479038|FG001|Overall Study|Death|2|||
157200585|NCT05966129|567479037|FG000|Overall Study|Lost to Follow-up|63|||
157200586|NCT05966129|567479038|FG001|Overall Study|Lost to Follow-up|66|||
157200587|NCT05966129|567479037|FG000|Overall Study|Protocol Violation|1|||
157200588|NCT05966129|567479038|FG001|Overall Study|Protocol Violation|0|||
157200589|NCT05966129|567479037|FG000|Overall Study|Withdrawal by Subject|26|||
157200590|NCT05966129|567479038|FG001|Overall Study|Withdrawal by Subject|25|||
157200591|NCT05966129|567479037|FG000|Overall Study|Surgery not completed|63|||
157200592|NCT05966129|567479038|FG001|Overall Study|Surgery not completed|69|||
157200593|NCT05966129|567479037|FG000|Overall Study|Surgery logistics issue|2|||
157200594|NCT05966129|567479038|FG001|Overall Study|Surgery logistics issue|1|||
157200595|NCT01298323|567479039|FG000|Overall Study|Adverse Event|2|||
157200596|NCT01298323|567479040|FG001|Overall Study|Adverse Event|4|||
157200597|NCT01298323|567479039|FG000|Overall Study|Death|11|||
157200598|NCT01298323|567479040|FG001|Overall Study|Death|16|||
157200599|NCT01298323|567479039|FG000|Overall Study|Lost to Follow-up|1|||
157200600|NCT01298323|567479040|FG001|Overall Study|Lost to Follow-up|0|||
157200601|NCT01298323|567479039|FG000|Overall Study|Withdrawal by Subject|6|||
157200602|NCT01298323|567479040|FG001|Overall Study|Withdrawal by Subject|3|||
157200603|NCT01298323|567479039|FG000|Overall Study|Protocol Violation|1|||
157200604|NCT01298323|567479040|FG001|Overall Study|Protocol Violation|0|||
157200605|NCT01298323|567479039|FG000|Overall Study|Other|10|||
157200606|NCT01298323|567479040|FG001|Overall Study|Other|9|||
157200607|NCT01298323|567479039|FG000|Overall Study|Ongoing|55|||
157200608|NCT01298323|567479040|FG001|Overall Study|Ongoing|55|||
157200609|NCT01298323|567479039|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
157200610|NCT01298323|567479040|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
157200611|NCT01761565|567479041|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
157200612|NCT02161380|567479042|FG000|Overall Study|Lost to Follow-up|0|||
157200613|NCT02161380|567479043|FG001|Overall Study|Lost to Follow-up|1|||
157200614|NCT02161380|567479044|FG002|Overall Study|Lost to Follow-up|0|||
157200615|NCT02161380|567479045|FG003|Overall Study|Lost to Follow-up|0|||
157200616|NCT00412360|567479047|FG000|Overall Study|Lost to Follow-up|0|||
157200617|NCT00412360|567479048|FG001|Overall Study|Lost to Follow-up|1|||
157200618|NCT00412360|567479047|FG000|Overall Study|Not Transplanted|1|||
157200619|NCT00412360|567479048|FG001|Overall Study|Not Transplanted|2|||
157200620|NCT03655951|567479049|FG000|Overall Study|Lost to Follow-up|39|||
157200621|NCT03655951|567479050|FG001|Overall Study|Lost to Follow-up|20|||
157200622|NCT03655951|567479049|FG000|Overall Study|Withdrawal by Subject|0|||
157200623|NCT03655951|567479050|FG001|Overall Study|Withdrawal by Subject|1|||
157200624|NCT01078974|567479055|FG000|Overall Study|Adverse Event|3|||
157200625|NCT01393444|567479056|FG000|Overall Study|Withdrawal by Subject|1|||
157200626|NCT01393444|567479056|FG000|Overall Study|Determined ineligible during screening.|2|||
157200627|NCT01397409|567479059|FG000|Stage 2|Adverse Event|0|||
157200628|NCT01397409|567479060|FG001|Stage 2|Adverse Event|0|||
157200629|NCT01397409|567479061|FG002|Stage 2|Adverse Event|0|||
157200630|NCT01397409|567479062|FG003|Stage 2|Adverse Event|0|||
157200631|NCT01397409|567479063|FG004|Stage 2|Adverse Event|6|||
157200632|NCT01397409|567479064|FG005|Stage 2|Adverse Event|3|||
157200633|NCT01397409|567479065|FG006|Stage 2|Adverse Event|0|||
157200634|NCT01397409|567479066|FG007|Stage 2|Adverse Event|0|||
157200635|NCT01397409|567479067|FG008|Stage 2|Adverse Event|0|||
157200636|NCT01397409|567479068|FG009|Stage 2|Adverse Event|0|||
157200637|NCT01397409|567479059|FG000|Stage 2|Personal Reasons|0|||
157200638|NCT01397409|567479060|FG001|Stage 2|Personal Reasons|0|||
157200639|NCT01397409|567479061|FG002|Stage 2|Personal Reasons|0|||
157200640|NCT01397409|567479062|FG003|Stage 2|Personal Reasons|0|||
157200641|NCT01397409|567479063|FG004|Stage 2|Personal Reasons|1|||
157200642|NCT01397409|567479064|FG005|Stage 2|Personal Reasons|0|||
157200643|NCT01397409|567479065|FG006|Stage 2|Personal Reasons|0|||
157200644|NCT01397409|567479066|FG007|Stage 2|Personal Reasons|0|||
157200645|NCT01397409|567479067|FG008|Stage 2|Personal Reasons|0|||
157200646|NCT01397409|567479068|FG009|Stage 2|Personal Reasons|0|||
157200647|NCT01397409|567479059|FG000|Stage 2|Other Miscellaneous Reasons|0|||
157200648|NCT01397409|567479060|FG001|Stage 2|Other Miscellaneous Reasons|0|||
157200649|NCT01397409|567479061|FG002|Stage 2|Other Miscellaneous Reasons|0|||
157200650|NCT01397409|567479062|FG003|Stage 2|Other Miscellaneous Reasons|0|||
157200651|NCT01397409|567479063|FG004|Stage 2|Other Miscellaneous Reasons|1|||
157200652|NCT01397409|567479064|FG005|Stage 2|Other Miscellaneous Reasons|1|||
157200653|NCT01397409|567479065|FG006|Stage 2|Other Miscellaneous Reasons|0|||
157200654|NCT01397409|567479066|FG007|Stage 2|Other Miscellaneous Reasons|0|||
157200655|NCT01397409|567479067|FG008|Stage 2|Other Miscellaneous Reasons|0|||
157200656|NCT01397409|567479068|FG009|Stage 2|Other Miscellaneous Reasons|0|||
157200657|NCT01397409|567479059|FG000|Stage 3|Adverse Event|0|||
157200658|NCT01397409|567479060|FG001|Stage 3|Adverse Event|0|||
157200659|NCT01397409|567479061|FG002|Stage 3|Adverse Event|0|||
157200660|NCT01397409|567479062|FG003|Stage 3|Adverse Event|0|||
157200661|NCT01397409|567479063|FG004|Stage 3|Adverse Event|0|||
157200662|NCT01397409|567479064|FG005|Stage 3|Adverse Event|0|||
157200663|NCT01397409|567479065|FG006|Stage 3|Adverse Event|0|||
157200664|NCT01397409|567479066|FG007|Stage 3|Adverse Event|1|||
157200665|NCT01397409|567479067|FG008|Stage 3|Adverse Event|0|||
157200666|NCT01397409|567479068|FG009|Stage 3|Adverse Event|0|||
157200667|NCT01397409|567479059|FG000|Stage 3|Other Miscellaneous Reasons|0|||
157200668|NCT01397409|567479060|FG001|Stage 3|Other Miscellaneous Reasons|0|||
157200669|NCT01397409|567479061|FG002|Stage 3|Other Miscellaneous Reasons|0|||
157200670|NCT01397409|567479062|FG003|Stage 3|Other Miscellaneous Reasons|0|||
157200671|NCT01397409|567479063|FG004|Stage 3|Other Miscellaneous Reasons|0|||
157200672|NCT01397409|567479064|FG005|Stage 3|Other Miscellaneous Reasons|0|||
157200673|NCT01397409|567479065|FG006|Stage 3|Other Miscellaneous Reasons|0|||
157200674|NCT01397409|567479066|FG007|Stage 3|Other Miscellaneous Reasons|1|||
157200675|NCT01397409|567479067|FG008|Stage 3|Other Miscellaneous Reasons|0|||
157200676|NCT01397409|567479068|FG009|Stage 3|Other Miscellaneous Reasons|0|||
157200677|NCT03418727|567479069|FG000|Overall Study|Adverse Event|1|||
157200678|NCT03418727|567479070|FG001|Overall Study|Adverse Event|2|||
157200679|NCT03418727|567479071|FG002|Overall Study|Adverse Event|0|||
157200680|NCT03418727|567479069|FG000|Overall Study|Withdrawal by Subject|0|||
157200681|NCT03418727|567479070|FG001|Overall Study|Withdrawal by Subject|0|||
157200682|NCT03418727|567479071|FG002|Overall Study|Withdrawal by Subject|2|||
157200683|NCT01791543|567479072|FG000|Overall Study|Lost to Follow-up|1|||
157200684|NCT01791543|567479072|FG000|Overall Study|Adverse Event|1|||
157200685|NCT03145207|567479073|FG000|Overall Study|volunteer started taking allergy shots|1|||
157200686|NCT03145207|567479073|FG000|Overall Study|baseline blood pressure high|1|||
157200687|NCT01396434|567479075|FG000|Overall Study|Lost to Follow-up|1|||
157200688|NCT01396434|567479076|FG001|Overall Study|Lost to Follow-up|0|||
157200689|NCT01396434|567479077|FG002|Overall Study|Lost to Follow-up|0|||
157200690|NCT01396434|567479075|FG000|Overall Study|Other|10|||
157200691|NCT01396434|567479076|FG001|Overall Study|Other|0|||
157200692|NCT01396434|567479077|FG002|Overall Study|Other|0|||
157200693|NCT04678557|567479078|FG000|Overall Study|Withdrawal by Subject|1|||
157200694|NCT04678557|567479079|FG001|Overall Study|Withdrawal by Subject|0|||
157200695|NCT04678557|567479078|FG000|Overall Study|Lack of Efficacy|0|||
157200696|NCT04678557|567479079|FG001|Overall Study|Lack of Efficacy|13|||
157200697|NCT04678557|567479078|FG000|Overall Study|Safety Evaluation|0|||
157200698|NCT04678557|567479079|FG001|Overall Study|Safety Evaluation|1|||
157200699|NCT01740297|567480996|FG000|Overall Study|Withdrawal by Subject|4|||
157200700|NCT01740297|567480997|FG001|Overall Study|Withdrawal by Subject|16|||
157200701|NCT01740297|567480998|FG002|Overall Study|Withdrawal by Subject|17|||
157200702|NCT01740297|567480996|FG000|Overall Study|Death|8|||
157200703|NCT01740297|567480997|FG001|Overall Study|Death|46|||
157200704|NCT01740297|567480998|FG002|Overall Study|Death|40|||
157200705|NCT01740297|567480996|FG000|Overall Study|Lost to Follow-up|1|||
157200706|NCT01740297|567480997|FG001|Overall Study|Lost to Follow-up|2|||
157200707|NCT01740297|567480998|FG002|Overall Study|Lost to Follow-up|4|||
157200708|NCT00563706|567481003|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
157200709|NCT00563706|567481004|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
157200710|NCT00563706|567481005|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
157200711|NCT00563706|567481006|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
157200712|NCT00563706|567481007|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
157200713|NCT00563706|567481008|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
157200714|NCT00563706|567481009|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
157200715|NCT00563706|567481010|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
157200716|NCT00563706|567481011|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
157200717|NCT00563706|567481003|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
157200718|NCT00563706|567481004|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
157200719|NCT00563706|567481005|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
157200720|NCT00563706|567481006|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
157200721|NCT00563706|567481007|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
157200722|NCT00563706|567481008|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
157200723|NCT00563706|567481009|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
157200724|NCT00563706|567481010|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
157200725|NCT00563706|567481011|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
157200726|NCT00563706|567481003|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
157200727|NCT00563706|567481004|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
157200728|NCT00563706|567481005|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
157200729|NCT00563706|567481006|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
157200730|NCT00563706|567481007|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
157200731|NCT00563706|567481008|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
157200732|NCT00563706|567481009|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
157200733|NCT00563706|567481010|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
157200734|NCT00563706|567481011|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
157200735|NCT00563706|567481003|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
157243282|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200736|NCT00563706|567481004|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200737|NCT00563706|567481005|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200738|NCT00563706|567481006|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200739|NCT00563706|567481007|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200740|NCT00563706|567481008|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200741|NCT00563706|567481009|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200742|NCT00563706|567481010|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
157200743|NCT00563706|567481011|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
157200744|NCT00563706|567481003|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200745|NCT00563706|567481004|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200746|NCT00563706|567481005|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200747|NCT00563706|567481006|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200748|NCT00563706|567481007|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200749|NCT00563706|567481008|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200750|NCT00563706|567481009|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
157200751|NCT00563706|567481010|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
157200752|NCT00563706|567481011|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
157200753|NCT03280628|567481014|FG000|Overall Study|Lost to Follow-up|8|||
157200754|NCT03280628|567481015|FG001|Overall Study|Lost to Follow-up|6|||
157200755|NCT03280628|567481016|FG002|Overall Study|Lost to Follow-up|11|||
157200756|NCT02383966|567481017|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
157200757|NCT02383966|567481018|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
157200758|NCT02383966|567481017|FG000|Overall Study|Randomized, but not treated|1|||
157200759|NCT02383966|567481018|FG001|Overall Study|Randomized, but not treated|3|||
157200760|NCT03839693|567481028|FG000|Overall Study|Lost to Follow-up|0|||
157200761|NCT03839693|567481029|FG001|Overall Study|Lost to Follow-up|2|||
157200762|NCT03839693|567481030|FG002|Overall Study|Lost to Follow-up|2|||
157200763|NCT03839693|567481028|FG000|Overall Study|Withdrawal by Subject|1|||
157200764|NCT03839693|567481029|FG001|Overall Study|Withdrawal by Subject|0|||
157200765|NCT03839693|567481030|FG002|Overall Study|Withdrawal by Subject|2|||
157200766|NCT03839693|567481028|FG000|Overall Study|subject moved out of the area|1|||
157200767|NCT03839693|567481029|FG001|Overall Study|subject moved out of the area|0|||
157200768|NCT03839693|567481030|FG002|Overall Study|subject moved out of the area|0|||
157200769|NCT00270205|567481039|FG000|Overall Study|Lost to Follow-up|1|||
157200770|NCT00270205|567481040|FG001|Overall Study|Lost to Follow-up|0|||
157243283|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243284|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243285|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243286|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243287|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243288|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243289|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243290|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243291|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243292|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200771|NCT00270205|567481041|FG002|Overall Study|Lost to Follow-up|0|||
157200772|NCT00270205|567481042|FG003|Overall Study|Lost to Follow-up|1|||
157200773|NCT00066573|567481043|FG000|Overall Study|Did not received protocol treatment|28|||
157200774|NCT00066573|567481044|FG001|Overall Study|Did not received protocol treatment|28|||
157200775|NCT00700115|567481045|FG000|Overall Study|Withdrawal by Subject|1|||
157200776|NCT00700115|567481046|FG001|Overall Study|Withdrawal by Subject|0|||
157200777|NCT00700115|567481045|FG000|Overall Study|Lost to Follow-up|0|||
157200778|NCT00700115|567481046|FG001|Overall Study|Lost to Follow-up|1|||
157200779|NCT02983305|567481047|FG000|Overall Study|incomplete data|2|||
157200780|NCT02983305|567481048|FG001|Overall Study|incomplete data|0|||
157200781|NCT00706901|567481049|FG000|Overall Study|Lost to Follow-up|2|||
157200782|NCT00706901|567481050|FG001|Overall Study|Lost to Follow-up|3|||
157200783|NCT00706901|567481051|FG002|Overall Study|Lost to Follow-up|2|||
157200784|NCT00706901|567481049|FG000|Overall Study|Withdrawal by Subject|4|||
157200785|NCT00706901|567481050|FG001|Overall Study|Withdrawal by Subject|2|||
157200786|NCT00706901|567481051|FG002|Overall Study|Withdrawal by Subject|5|||
157200787|NCT00706901|567481049|FG000|Overall Study|In Jail|1|||
157243293|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243294|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243295|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243296|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243297|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157200788|NCT00706901|567481050|FG001|Overall Study|In Jail|0|||
157200789|NCT00706901|567481051|FG002|Overall Study|In Jail|1|||
157200790|NCT00706901|567481049|FG000|Overall Study|Death|1|||
157200791|NCT00706901|567481050|FG001|Overall Study|Death|0|||
157200792|NCT00706901|567481051|FG002|Overall Study|Death|0|||
157200793|NCT00822237|567481052|FG000|Dose 1 Vaccination|Not vaccinated|3|||
157200794|NCT00822237|567481053|FG001|Dose 1 Vaccination|Not vaccinated|0|||
157200795|NCT00822237|567481052|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
157200796|NCT00822237|567481053|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
157200797|NCT00822237|567481052|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
157200798|NCT00822237|567481053|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
157200799|NCT00822237|567481052|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
157200800|NCT00822237|567481053|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
157200801|NCT00822237|567481052|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
157200802|NCT00822237|567481053|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
157200803|NCT03433482|567481054|FG000|Overall Study|Lost to Follow-up|1|||
157200804|NCT03433482|567481055|FG001|Overall Study|Lost to Follow-up|0|||
157200805|NCT03433482|567481056|FG002|Overall Study|Lost to Follow-up|1|||
157200806|NCT03433482|567481057|FG003|Overall Study|Lost to Follow-up|1|||
157200807|NCT03433482|567481054|FG000|Overall Study|Withdrawal by Subject|0|||
157200808|NCT03433482|567481055|FG001|Overall Study|Withdrawal by Subject|0|||
157200809|NCT03433482|567481056|FG002|Overall Study|Withdrawal by Subject|1|||
157200810|NCT03433482|567481057|FG003|Overall Study|Withdrawal by Subject|0|||
157200811|NCT03433482|567481054|FG000|Overall Study|Unknown reason|0|||
157200812|NCT03433482|567481055|FG001|Overall Study|Unknown reason|0|||
157200813|NCT03433482|567481056|FG002|Overall Study|Unknown reason|2|||
157200814|NCT03433482|567481057|FG003|Overall Study|Unknown reason|0|||
157200815|NCT00437294|567481058|FG000|Overall Study|Adverse Event|5|||
157200816|NCT00437294|567481059|FG001|Overall Study|Adverse Event|4|||
157200817|NCT00437294|567481058|FG000|Overall Study|Death|5|||
157200818|NCT00437294|567481059|FG001|Overall Study|Death|2|||
157200819|NCT00437294|567481058|FG000|Overall Study|Physician Decision|0|||
157200820|NCT00437294|567481059|FG001|Overall Study|Physician Decision|3|||
157200821|NCT00437294|567481058|FG000|Overall Study|Withdrawal by Subject|5|||
157200822|NCT00437294|567481059|FG001|Overall Study|Withdrawal by Subject|0|||
157200823|NCT00437294|567481058|FG000|Overall Study|Progressive Disease|19|||
157200824|NCT00437294|567481059|FG001|Overall Study|Progressive Disease|23|||
157200825|NCT00437294|567481058|FG000|Overall Study|Sponsor Decision|8|||
157200826|NCT00437294|567481059|FG001|Overall Study|Sponsor Decision|9|||
157200827|NCT00437294|567481058|FG000|Overall Study|Protocol Violation|0|||
157200828|NCT00437294|567481059|FG001|Overall Study|Protocol Violation|1|||
157200829|NCT00437294|567481058|FG000|Overall Study|Entry criteria not met|1|||
157200830|NCT00437294|567481059|FG001|Overall Study|Entry criteria not met|1|||
157200831|NCT02222246|567481066|FG000|Overall Study|No Emergency Department Visits|27|||
157200832|NCT02222246|567481067|FG001|Overall Study|No Emergency Department Visits|26|||
157200833|NCT02222246|567481066|FG000|Overall Study|Physician Decision|0|||
157200834|NCT02222246|567481067|FG001|Overall Study|Physician Decision|1|||
157200835|NCT01646268|567481068|FG000|Overall Study|Adverse Event|6|||
157200836|NCT01646268|567481069|FG001|Overall Study|Adverse Event|7|||
157200837|NCT01646268|567481068|FG000|Overall Study|Lack of Efficacy|1|||
157200838|NCT01646268|567481069|FG001|Overall Study|Lack of Efficacy|3|||
157200839|NCT01646268|567481068|FG000|Overall Study|Protocol Violation|0|||
157200840|NCT01646268|567481069|FG001|Overall Study|Protocol Violation|1|||
157200841|NCT01646268|567481068|FG000|Overall Study|Withdrawal by Subject|2|||
157200842|NCT01646268|567481069|FG001|Overall Study|Withdrawal by Subject|5|||
157200843|NCT01646268|567481068|FG000|Overall Study|Other|2|||
157200844|NCT01646268|567481069|FG001|Overall Study|Other|0|||
157200845|NCT02064231|567481076|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
157200846|NCT02064231|567481077|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
157200847|NCT02064231|567481078|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
157200848|NCT02064231|567481079|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
157200849|NCT02064231|567481076|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
157200850|NCT02064231|567481077|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
157200851|NCT02064231|567481078|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
157200852|NCT02064231|567481079|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
157200853|NCT02064231|567481076|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
157243298|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243299|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243300|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
157243301|NCT00112437|567636840|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243302|NCT00112437|567636841|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243303|NCT00112437|567636842|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243304|NCT00112437|567636843|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157200854|NCT02064231|567481077|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
157200855|NCT02064231|567481078|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
157200856|NCT02064231|567481079|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
157200857|NCT02064231|567481076|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
157200858|NCT02064231|567481077|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
157200859|NCT02064231|567481078|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
157200860|NCT02064231|567481079|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
157200861|NCT01473602|567481080|FG000|Overall Study|Adverse Event|1|||
157200862|NCT01473602|567481081|FG001|Overall Study|Adverse Event|2|||
157200863|NCT01473602|567481080|FG000|Overall Study|Death|0|||
157200864|NCT01473602|567481081|FG001|Overall Study|Death|1|||
157200865|NCT01473602|567481080|FG000|Overall Study|Lost to Follow-up|1|||
157200866|NCT01473602|567481081|FG001|Overall Study|Lost to Follow-up|1|||
157200867|NCT01473602|567481080|FG000|Overall Study|Withdrawal by Subject|5|||
157200868|NCT01473602|567481081|FG001|Overall Study|Withdrawal by Subject|4|||
157200869|NCT01473602|567481080|FG000|Overall Study|Physician Decision|1|||
157200870|NCT01473602|567481081|FG001|Overall Study|Physician Decision|0|||
157200871|NCT00449761|567481082|FG000|Overall Study|Disease progression|12|||
157200872|NCT00449761|567481082|FG000|Overall Study|Death|5|||
157200873|NCT00449761|567481082|FG000|Overall Study|New cancer therapy|1|||
157200874|NCT00536991|567481085|FG000|Overall Study|Withdrawal by Subject|10|||
157200875|NCT00536991|567481085|FG000|Overall Study|Physician Decision|1|||
157200876|NCT00536991|567481085|FG000|Overall Study|patient ineligible|2|||
157200877|NCT00518531|567481086|FG000|Treatment Period 1|Adverse Event|5|||
157200878|NCT00518531|567481087|FG001|Treatment Period 1|Adverse Event|0|||
157200879|NCT00518531|567481086|FG000|Treatment Period 1|Lost to Follow-up|5|||
157200880|NCT00518531|567481087|FG001|Treatment Period 1|Lost to Follow-up|3|||
157200881|NCT00518531|567481086|FG000|Treatment Period 1|Physician Decision|1|||
157200882|NCT00518531|567481087|FG001|Treatment Period 1|Physician Decision|0|||
157200883|NCT00518531|567481086|FG000|Treatment Period 1|Protocol Violation|2|||
157200884|NCT00518531|567481087|FG001|Treatment Period 1|Protocol Violation|0|||
157200885|NCT00518531|567481086|FG000|Treatment Period 1|Withdrawal by Subject|4|||
157200886|NCT00518531|567481087|FG001|Treatment Period 1|Withdrawal by Subject|6|||
157200887|NCT00518531|567481086|FG000|Treatment Period 1|Early crossover|1|||
157200888|NCT00518531|567481087|FG001|Treatment Period 1|Early crossover|3|||
157200889|NCT00518531|567481086|FG000|Treatment Period 2|Withdrawal by Subject|0|||
157200890|NCT00518531|567481087|FG001|Treatment Period 2|Withdrawal by Subject|8|||
157200891|NCT00518531|567481086|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
157200892|NCT00518531|567481087|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
157200893|NCT00518531|567481086|FG000|Treatment Period 2|Adverse Event|1|||
157200894|NCT00518531|567481087|FG001|Treatment Period 2|Adverse Event|7|||
157200895|NCT00518531|567481086|FG000|Treatment Period 2|Protocol-specified criteria|0|||
157200896|NCT00518531|567481087|FG001|Treatment Period 2|Protocol-specified criteria|1|||
157200897|NCT00518531|567481086|FG000|Treatment Period 2|Non-compliance|1|||
157200898|NCT00518531|567481087|FG001|Treatment Period 2|Non-compliance|2|||
157200899|NCT00054639|567481088|FG000|Overall Study|Lack of Efficacy|1|||
157200900|NCT00054639|567481088|FG000|Overall Study|Physician Decision|1|||
157200901|NCT01600755|567481089|FG000|Overall Study|Withdrawal by Subject|6|||
157200902|NCT00122954|567481094|FG000|Overall Study|Withdrawal by Subject|2|||
157243305|NCT00112437|567636844|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
157243306|NCT00112437|567636845|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243307|NCT00112437|567636846|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243308|NCT00112437|567636847|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243309|NCT00112437|567636848|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243310|NCT00112437|567636849|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243311|NCT00112437|567636850|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243312|NCT00112437|567636851|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243313|NCT00112437|567636852|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243314|NCT00112437|567636853|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243315|NCT00112437|567636854|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243316|NCT00112437|567636855|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243317|NCT00112437|567636856|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243318|NCT00112437|567636857|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243319|NCT00112437|567636858|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157200903|NCT00122954|567481095|FG001|Overall Study|Withdrawal by Subject|2|||
157200904|NCT00122954|567481094|FG000|Overall Study|Protocol Violation|0|||
157243320|NCT00112437|567636859|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243321|NCT00112437|567636860|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157200905|NCT00122954|567481095|FG001|Overall Study|Protocol Violation|1|||
157200906|NCT02856282|567481096|FG000|Overall Study|Withdrawal by Subject|1|||
157200907|NCT00057330|567481097|FG000|Overall Study|Adverse Event|9|||
157200908|NCT00057330|567481098|FG001|Overall Study|Adverse Event|12|||
157200909|NCT00057330|567481097|FG000|Overall Study|Death|1|||
157200910|NCT00057330|567481098|FG001|Overall Study|Death|0|||
157200911|NCT00057330|567481097|FG000|Overall Study|Protocol Violation|1|||
157200912|NCT00057330|567481098|FG001|Overall Study|Protocol Violation|1|||
157200913|NCT00057330|567481097|FG000|Overall Study|Withdrawal by Subject|115|||
157200914|NCT00057330|567481098|FG001|Overall Study|Withdrawal by Subject|84|||
157200915|NCT00057330|567481097|FG000|Overall Study|Lost to Follow-up|745|||
157200916|NCT00057330|567481098|FG001|Overall Study|Lost to Follow-up|617|||
157243322|NCT00112437|567636861|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243323|NCT00112437|567636862|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243324|NCT00112437|567636863|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243325|NCT00112437|567636864|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243326|NCT00112437|567636865|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
157243327|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
157243328|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
157243329|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
157243330|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
157243331|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
157243332|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
157243333|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
157243334|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
157243335|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
157243336|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
157243337|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
157243338|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
157243339|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
157243340|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
157243341|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
157243342|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
157243343|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
157243344|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
157243345|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
157243346|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
157243347|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
157243348|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
157243349|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
157200917|NCT00057330|567481097|FG000|Overall Study|Physician Decision|1|||
157200918|NCT00057330|567481098|FG001|Overall Study|Physician Decision|0|||
157200919|NCT00057330|567481097|FG000|Overall Study|Other|260|||
157200920|NCT00057330|567481098|FG001|Overall Study|Other|206|||
157200921|NCT01491737|567481102|FG000|Overall Study|Withdrawal by Subject|20|||
157200922|NCT01491737|567481103|FG001|Overall Study|Withdrawal by Subject|17|||
157200923|NCT01491737|567481102|FG000|Overall Study|Lost to Follow-up|2|||
157200924|NCT01491737|567481103|FG001|Overall Study|Lost to Follow-up|10|||
157200925|NCT01491737|567481102|FG000|Overall Study|Death|63|||
157200926|NCT01491737|567481103|FG001|Overall Study|Death|57|||
157200927|NCT01491737|567481102|FG000|Overall Study|Study Termination by Sponsor|36|||
157200928|NCT01491737|567481103|FG001|Overall Study|Study Termination by Sponsor|36|||
157200929|NCT01491737|567481102|FG000|Overall Study|Reason Not Specified|8|||
157200930|NCT01491737|567481103|FG001|Overall Study|Reason Not Specified|9|||
157200931|NCT00812968|567481104|FG000|Overall Study|Relapse after erythroid response|6|||
157200932|NCT00812968|567481104|FG000|Overall Study|Disease progression|1|||
157200933|NCT00812968|567481104|FG000|Overall Study|No further treatment required|1|||
157200934|NCT00812968|567481104|FG000|Overall Study|Study closed due to marketing approval|3|||
157200935|NCT02696382|567481105|FG000|Overall Study|Death|7|||
157200936|NCT02696382|567481106|FG001|Overall Study|Death|2|||
157200937|NCT02696382|567481105|FG000|Overall Study|Withdrawal by Subject|5|||
157200938|NCT02696382|567481106|FG001|Overall Study|Withdrawal by Subject|12|||
157200939|NCT02696382|567481105|FG000|Overall Study|Lost to Follow-up|4|||
157200940|NCT02696382|567481106|FG001|Overall Study|Lost to Follow-up|7|||
157200941|NCT00494234|567481107|FG000|Overall Study|Withdrawal by Subject|1|||
157200942|NCT00494234|567481108|FG001|Overall Study|Withdrawal by Subject|0|||
157200943|NCT00494234|567481107|FG000|Overall Study|Disease progression|11|||
157200944|NCT00494234|567481108|FG001|Overall Study|Disease progression|8|||
157200945|NCT00494234|567481107|FG000|Overall Study|Death|2|||
157200946|NCT00494234|567481108|FG001|Overall Study|Death|1|||
157200947|NCT03253809|567481116|FG000|Overall Study|Unable to obtain study related data|14|||
157200948|NCT03992456|567481117|FG000|Overall Study|Withdrawal by Subject|1|||
157200949|NCT03992456|567481118|FG001|Overall Study|Withdrawal by Subject|0|||
157200950|NCT03992456|567481117|FG000|Overall Study|Disease progression|4|||
157200951|NCT03992456|567481118|FG001|Overall Study|Disease progression|5|||
157200952|NCT03992456|567481117|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
157243350|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
157243351|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
157243352|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
157243353|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243354|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243355|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243356|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157200953|NCT03992456|567481118|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
157200954|NCT00910000|567481119|FG000|Overall Study|Adverse Event|0|||
157200955|NCT00910000|567481120|FG001|Overall Study|Adverse Event|3|||
157243357|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157200956|NCT00910000|567481121|FG002|Overall Study|Adverse Event|2|||
157200957|NCT00910000|567481122|FG003|Overall Study|Adverse Event|2|||
157200958|NCT00910000|567481123|FG004|Overall Study|Adverse Event|0|||
157200959|NCT00910000|567481124|FG005|Overall Study|Adverse Event|1|||
157200960|NCT00910000|567481119|FG000|Overall Study|Withdrawal by Subject|0|||
157200961|NCT00910000|567481120|FG001|Overall Study|Withdrawal by Subject|0|||
157200962|NCT00910000|567481121|FG002|Overall Study|Withdrawal by Subject|1|||
157200963|NCT00910000|567481122|FG003|Overall Study|Withdrawal by Subject|0|||
157200964|NCT00910000|567481123|FG004|Overall Study|Withdrawal by Subject|1|||
157200965|NCT00910000|567481124|FG005|Overall Study|Withdrawal by Subject|0|||
157200966|NCT04637815|567481125|FG000|Overall Study|Death|1|||
157200967|NCT04637815|567481126|FG001|Overall Study|Death|0|||
157200968|NCT04637815|567481125|FG000|Overall Study|Lost to Follow-up|5|||
157200969|NCT04637815|567481126|FG001|Overall Study|Lost to Follow-up|2|||
157200970|NCT02594384|567481127|FG000|Overall Study|Disease Progression|3|||
157200971|NCT02594384|567481128|FG001|Overall Study|Disease Progression|7|||
157200972|NCT02594384|567481129|FG002|Overall Study|Disease Progression|0|||
157200973|NCT02594384|567481130|FG003|Overall Study|Disease Progression|2|||
157200974|NCT02594384|567481131|FG004|Overall Study|Disease Progression|2|||
157200975|NCT02594384|567481132|FG005|Overall Study|Disease Progression|12|||
157200976|NCT02594384|567481133|FG006|Overall Study|Disease Progression|5|||
157200977|NCT02594384|567481134|FG007|Overall Study|Disease Progression|5|||
157200978|NCT02594384|567481127|FG000|Overall Study|Adverse Event|0|||
157200979|NCT02594384|567481128|FG001|Overall Study|Adverse Event|1|||
157200980|NCT02594384|567481129|FG002|Overall Study|Adverse Event|4|||
157200981|NCT02594384|567481130|FG003|Overall Study|Adverse Event|1|||
157200982|NCT02594384|567481131|FG004|Overall Study|Adverse Event|0|||
157200983|NCT02594384|567481132|FG005|Overall Study|Adverse Event|6|||
157200984|NCT02594384|567481133|FG006|Overall Study|Adverse Event|1|||
157200985|NCT02594384|567481134|FG007|Overall Study|Adverse Event|1|||
157200986|NCT02594384|567481127|FG000|Overall Study|Withdrawal by Subject|0|||
157200987|NCT02594384|567481128|FG001|Overall Study|Withdrawal by Subject|0|||
157200988|NCT02594384|567481129|FG002|Overall Study|Withdrawal by Subject|0|||
157200989|NCT02594384|567481130|FG003|Overall Study|Withdrawal by Subject|1|||
157200990|NCT02594384|567481131|FG004|Overall Study|Withdrawal by Subject|0|||
157200991|NCT02594384|567481132|FG005|Overall Study|Withdrawal by Subject|0|||
157200992|NCT02594384|567481133|FG006|Overall Study|Withdrawal by Subject|0|||
157200993|NCT02594384|567481134|FG007|Overall Study|Withdrawal by Subject|1|||
157200994|NCT02594384|567481127|FG000|Overall Study|Physician Decision|0|||
157200995|NCT02594384|567481128|FG001|Overall Study|Physician Decision|0|||
157200996|NCT02594384|567481129|FG002|Overall Study|Physician Decision|0|||
157200997|NCT02594384|567481130|FG003|Overall Study|Physician Decision|0|||
157200998|NCT02594384|567481131|FG004|Overall Study|Physician Decision|0|||
157200999|NCT02594384|567481132|FG005|Overall Study|Physician Decision|1|||
157201000|NCT02594384|567481133|FG006|Overall Study|Physician Decision|2|||
157201001|NCT02594384|567481134|FG007|Overall Study|Physician Decision|0|||
157201002|NCT02594384|567481127|FG000|Overall Study|Progressive Leukocytosis|0|||
157201003|NCT02594384|567481128|FG001|Overall Study|Progressive Leukocytosis|0|||
157201004|NCT02594384|567481129|FG002|Overall Study|Progressive Leukocytosis|1|||
157201005|NCT02594384|567481130|FG003|Overall Study|Progressive Leukocytosis|0|||
157201006|NCT02594384|567481131|FG004|Overall Study|Progressive Leukocytosis|0|||
157201007|NCT02594384|567481132|FG005|Overall Study|Progressive Leukocytosis|0|||
157201008|NCT02594384|567481133|FG006|Overall Study|Progressive Leukocytosis|0|||
157201009|NCT02594384|567481134|FG007|Overall Study|Progressive Leukocytosis|0|||
157201010|NCT02594384|567481127|FG000|Overall Study|Lack of Efficacy|0|||
157201011|NCT02594384|567481128|FG001|Overall Study|Lack of Efficacy|0|||
157201012|NCT02594384|567481129|FG002|Overall Study|Lack of Efficacy|0|||
157243358|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
157201013|NCT02594384|567481130|FG003|Overall Study|Lack of Efficacy|0|||
157201014|NCT02594384|567481131|FG004|Overall Study|Lack of Efficacy|1|||
157201015|NCT02594384|567481132|FG005|Overall Study|Lack of Efficacy|0|||
157201016|NCT02594384|567481133|FG006|Overall Study|Lack of Efficacy|0|||
157201017|NCT02594384|567481134|FG007|Overall Study|Lack of Efficacy|0|||
157201018|NCT02594384|567481127|FG000|Overall Study|Substantial noncompliance|0|||
157201019|NCT02594384|567481128|FG001|Overall Study|Substantial noncompliance|0|||
157201020|NCT02594384|567481129|FG002|Overall Study|Substantial noncompliance|0|||
157201021|NCT02594384|567481130|FG003|Overall Study|Substantial noncompliance|0|||
157243359|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
157201022|NCT02594384|567481131|FG004|Overall Study|Substantial noncompliance|0|||
157201023|NCT02594384|567481132|FG005|Overall Study|Substantial noncompliance|0|||
157201024|NCT02594384|567481133|FG006|Overall Study|Substantial noncompliance|1|||
157201025|NCT02594384|567481134|FG007|Overall Study|Substantial noncompliance|0|||
157201026|NCT01265875|567481137|FG000|Overall Study|Uncooperative/unreliable|1|||
157201027|NCT01049360|567481140|FG000|Period 1|Adverse Event|0|||
157201028|NCT01049360|567481141|FG001|Period 1|Adverse Event|1|||
157201029|NCT01049360|567481142|FG002|Period 1|Adverse Event|0|||
157201030|NCT01049360|567481143|FG003|Period 1|Adverse Event|1|||
157201031|NCT01049360|567481144|FG004|Period 1|Adverse Event|0|||
157201032|NCT01049360|567481145|FG005|Period 1|Adverse Event|0|||
157201033|NCT01049360|567481146|FG006|Period 1|Adverse Event|0|||
157201034|NCT01049360|567481147|FG007|Period 1|Adverse Event|1|||
157201035|NCT01049360|567481148|FG008|Period 1|Adverse Event|0|||
157201036|NCT01049360|567481149|FG009|Period 1|Adverse Event|0|||
157201037|NCT01049360|567481150|FG010|Period 1|Adverse Event|0|||
157201038|NCT01049360|567481151|FG011|Period 1|Adverse Event|0|||
157201039|NCT01049360|567481152|FG012|Period 1|Adverse Event|1|||
157201040|NCT01049360|567481153|FG013|Period 1|Adverse Event|1|||
157201041|NCT01049360|567481154|FG014|Period 1|Adverse Event|0|||
157201042|NCT01049360|567481155|FG015|Period 1|Adverse Event|0|||
157201043|NCT01049360|567481156|FG016|Period 1|Adverse Event|1|||
157201044|NCT01049360|567481157|FG017|Period 1|Adverse Event|0|||
157201045|NCT01049360|567481158|FG018|Period 1|Adverse Event|1|||
157201046|NCT01049360|567481159|FG019|Period 1|Adverse Event|0|||
157201047|NCT01049360|567481140|FG000|Period 1|Did not meet inc/exc criteria|0|||
157201048|NCT01049360|567481141|FG001|Period 1|Did not meet inc/exc criteria|0|||
157201049|NCT01049360|567481142|FG002|Period 1|Did not meet inc/exc criteria|0|||
157201050|NCT01049360|567481143|FG003|Period 1|Did not meet inc/exc criteria|0|||
157201051|NCT01049360|567481144|FG004|Period 1|Did not meet inc/exc criteria|0|||
157201052|NCT01049360|567481145|FG005|Period 1|Did not meet inc/exc criteria|0|||
157201053|NCT01049360|567481146|FG006|Period 1|Did not meet inc/exc criteria|0|||
157201054|NCT01049360|567481147|FG007|Period 1|Did not meet inc/exc criteria|1|||
157201055|NCT01049360|567481148|FG008|Period 1|Did not meet inc/exc criteria|1|||
157201056|NCT01049360|567481149|FG009|Period 1|Did not meet inc/exc criteria|0|||
157201057|NCT01049360|567481150|FG010|Period 1|Did not meet inc/exc criteria|0|||
157201058|NCT01049360|567481151|FG011|Period 1|Did not meet inc/exc criteria|0|||
157201059|NCT01049360|567481152|FG012|Period 1|Did not meet inc/exc criteria|0|||
157201060|NCT01049360|567481153|FG013|Period 1|Did not meet inc/exc criteria|0|||
157201061|NCT01049360|567481154|FG014|Period 1|Did not meet inc/exc criteria|0|||
157201062|NCT01049360|567481155|FG015|Period 1|Did not meet inc/exc criteria|0|||
157201063|NCT01049360|567481156|FG016|Period 1|Did not meet inc/exc criteria|0|||
157201064|NCT01049360|567481157|FG017|Period 1|Did not meet inc/exc criteria|0|||
157201065|NCT01049360|567481158|FG018|Period 1|Did not meet inc/exc criteria|0|||
157201066|NCT01049360|567481159|FG019|Period 1|Did not meet inc/exc criteria|0|||
157201067|NCT01049360|567481140|FG000|Period 1|Withdrawal by Subject|0|||
157201068|NCT01049360|567481141|FG001|Period 1|Withdrawal by Subject|0|||
157201069|NCT01049360|567481142|FG002|Period 1|Withdrawal by Subject|0|||
157201070|NCT01049360|567481143|FG003|Period 1|Withdrawal by Subject|0|||
157201071|NCT01049360|567481144|FG004|Period 1|Withdrawal by Subject|0|||
157201072|NCT01049360|567481145|FG005|Period 1|Withdrawal by Subject|0|||
157201073|NCT01049360|567481146|FG006|Period 1|Withdrawal by Subject|0|||
157201074|NCT01049360|567481147|FG007|Period 1|Withdrawal by Subject|0|||
157201075|NCT01049360|567481148|FG008|Period 1|Withdrawal by Subject|1|||
157201076|NCT01049360|567481149|FG009|Period 1|Withdrawal by Subject|0|||
157201077|NCT01049360|567481150|FG010|Period 1|Withdrawal by Subject|1|||
157201078|NCT01049360|567481151|FG011|Period 1|Withdrawal by Subject|0|||
157201079|NCT01049360|567481152|FG012|Period 1|Withdrawal by Subject|1|||
157201080|NCT01049360|567481153|FG013|Period 1|Withdrawal by Subject|0|||
157201081|NCT01049360|567481154|FG014|Period 1|Withdrawal by Subject|0|||
157201082|NCT01049360|567481155|FG015|Period 1|Withdrawal by Subject|0|||
157201083|NCT01049360|567481156|FG016|Period 1|Withdrawal by Subject|0|||
157201084|NCT01049360|567481157|FG017|Period 1|Withdrawal by Subject|0|||
157201085|NCT01049360|567481158|FG018|Period 1|Withdrawal by Subject|0|||
157201086|NCT01049360|567481159|FG019|Period 1|Withdrawal by Subject|0|||
157201087|NCT01049360|567481140|FG000|Period 2|Protocol Violation|0|||
157201088|NCT01049360|567481141|FG001|Period 2|Protocol Violation|0|||
157201089|NCT01049360|567481142|FG002|Period 2|Protocol Violation|0|||
157201090|NCT01049360|567481143|FG003|Period 2|Protocol Violation|1|||
157201091|NCT01049360|567481144|FG004|Period 2|Protocol Violation|0|||
157201092|NCT01049360|567481145|FG005|Period 2|Protocol Violation|0|||
157201093|NCT01049360|567481146|FG006|Period 2|Protocol Violation|0|||
157201094|NCT01049360|567481147|FG007|Period 2|Protocol Violation|0|||
157201095|NCT01049360|567481148|FG008|Period 2|Protocol Violation|0|||
157201096|NCT01049360|567481149|FG009|Period 2|Protocol Violation|0|||
157201097|NCT01049360|567481150|FG010|Period 2|Protocol Violation|0|||
157201098|NCT01049360|567481151|FG011|Period 2|Protocol Violation|0|||
157243360|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157201099|NCT01049360|567481152|FG012|Period 2|Protocol Violation|0|||
157201100|NCT01049360|567481153|FG013|Period 2|Protocol Violation|0|||
157201101|NCT01049360|567481154|FG014|Period 2|Protocol Violation|1|||
157201102|NCT01049360|567481155|FG015|Period 2|Protocol Violation|1|||
157201103|NCT01049360|567481156|FG016|Period 2|Protocol Violation|0|||
157201104|NCT01049360|567481157|FG017|Period 2|Protocol Violation|0|||
157201105|NCT01049360|567481158|FG018|Period 2|Protocol Violation|0|||
157201106|NCT01049360|567481159|FG019|Period 2|Protocol Violation|0|||
157201107|NCT01049360|567481140|FG000|Period 2|Adverse Event|0|||
157201108|NCT01049360|567481141|FG001|Period 2|Adverse Event|1|||
157201109|NCT01049360|567481142|FG002|Period 2|Adverse Event|0|||
157201110|NCT01049360|567481143|FG003|Period 2|Adverse Event|0|||
157201111|NCT01049360|567481144|FG004|Period 2|Adverse Event|0|||
157201112|NCT01049360|567481145|FG005|Period 2|Adverse Event|0|||
157201113|NCT01049360|567481146|FG006|Period 2|Adverse Event|0|||
157201114|NCT01049360|567481147|FG007|Period 2|Adverse Event|0|||
157201115|NCT01049360|567481148|FG008|Period 2|Adverse Event|1|||
157201116|NCT01049360|567481149|FG009|Period 2|Adverse Event|0|||
157201117|NCT01049360|567481150|FG010|Period 2|Adverse Event|0|||
157201118|NCT01049360|567481151|FG011|Period 2|Adverse Event|0|||
157201119|NCT01049360|567481152|FG012|Period 2|Adverse Event|0|||
157201120|NCT01049360|567481153|FG013|Period 2|Adverse Event|0|||
157201121|NCT01049360|567481154|FG014|Period 2|Adverse Event|0|||
157201122|NCT01049360|567481155|FG015|Period 2|Adverse Event|0|||
157201123|NCT01049360|567481156|FG016|Period 2|Adverse Event|0|||
157201124|NCT01049360|567481157|FG017|Period 2|Adverse Event|0|||
157201125|NCT01049360|567481158|FG018|Period 2|Adverse Event|0|||
157201126|NCT01049360|567481159|FG019|Period 2|Adverse Event|1|||
157201127|NCT01049360|567481140|FG000|Period 2|Withdrawal by Subject|0|||
157201128|NCT01049360|567481141|FG001|Period 2|Withdrawal by Subject|0|||
157201129|NCT01049360|567481142|FG002|Period 2|Withdrawal by Subject|0|||
157201130|NCT01049360|567481143|FG003|Period 2|Withdrawal by Subject|1|||
157201131|NCT01049360|567481144|FG004|Period 2|Withdrawal by Subject|0|||
157201132|NCT01049360|567481145|FG005|Period 2|Withdrawal by Subject|0|||
157201133|NCT01049360|567481146|FG006|Period 2|Withdrawal by Subject|0|||
157201134|NCT01049360|567481147|FG007|Period 2|Withdrawal by Subject|0|||
157201135|NCT01049360|567481148|FG008|Period 2|Withdrawal by Subject|0|||
157201136|NCT01049360|567481149|FG009|Period 2|Withdrawal by Subject|0|||
157201137|NCT01049360|567481150|FG010|Period 2|Withdrawal by Subject|0|||
157201138|NCT01049360|567481151|FG011|Period 2|Withdrawal by Subject|0|||
157201139|NCT01049360|567481152|FG012|Period 2|Withdrawal by Subject|0|||
157201140|NCT01049360|567481153|FG013|Period 2|Withdrawal by Subject|0|||
157201141|NCT01049360|567481154|FG014|Period 2|Withdrawal by Subject|1|||
157201142|NCT01049360|567481155|FG015|Period 2|Withdrawal by Subject|0|||
157201143|NCT01049360|567481156|FG016|Period 2|Withdrawal by Subject|0|||
157201144|NCT01049360|567481157|FG017|Period 2|Withdrawal by Subject|0|||
157201145|NCT01049360|567481158|FG018|Period 2|Withdrawal by Subject|0|||
157201146|NCT01049360|567481159|FG019|Period 2|Withdrawal by Subject|1|||
157201147|NCT01049360|567481140|FG000|Period 2|Lack of Efficacy|0|||
157201148|NCT01049360|567481141|FG001|Period 2|Lack of Efficacy|0|||
157201149|NCT01049360|567481142|FG002|Period 2|Lack of Efficacy|0|||
157201150|NCT01049360|567481143|FG003|Period 2|Lack of Efficacy|0|||
157201151|NCT01049360|567481144|FG004|Period 2|Lack of Efficacy|0|||
157201152|NCT01049360|567481145|FG005|Period 2|Lack of Efficacy|1|||
157201153|NCT01049360|567481146|FG006|Period 2|Lack of Efficacy|0|||
157201154|NCT01049360|567481147|FG007|Period 2|Lack of Efficacy|0|||
157201155|NCT01049360|567481148|FG008|Period 2|Lack of Efficacy|0|||
157201156|NCT01049360|567481149|FG009|Period 2|Lack of Efficacy|0|||
157201157|NCT01049360|567481150|FG010|Period 2|Lack of Efficacy|0|||
157201158|NCT01049360|567481151|FG011|Period 2|Lack of Efficacy|0|||
157201159|NCT01049360|567481152|FG012|Period 2|Lack of Efficacy|0|||
157201160|NCT01049360|567481153|FG013|Period 2|Lack of Efficacy|0|||
157201161|NCT01049360|567481154|FG014|Period 2|Lack of Efficacy|0|||
157201162|NCT01049360|567481155|FG015|Period 2|Lack of Efficacy|0|||
157201163|NCT01049360|567481156|FG016|Period 2|Lack of Efficacy|0|||
157201164|NCT01049360|567481157|FG017|Period 2|Lack of Efficacy|0|||
157201165|NCT01049360|567481158|FG018|Period 2|Lack of Efficacy|0|||
157201166|NCT01049360|567481159|FG019|Period 2|Lack of Efficacy|0|||
157201167|NCT01049360|567481140|FG000|Period 4|Protocol Violation|0|||
157201168|NCT01049360|567481141|FG001|Period 4|Protocol Violation|0|||
157201169|NCT01049360|567481142|FG002|Period 4|Protocol Violation|0|||
157201170|NCT01049360|567481143|FG003|Period 4|Protocol Violation|0|||
157201171|NCT01049360|567481144|FG004|Period 4|Protocol Violation|0|||
157201172|NCT01049360|567481145|FG005|Period 4|Protocol Violation|0|||
157201173|NCT01049360|567481146|FG006|Period 4|Protocol Violation|0|||
157201174|NCT01049360|567481147|FG007|Period 4|Protocol Violation|0|||
157201175|NCT01049360|567481148|FG008|Period 4|Protocol Violation|0|||
157243361|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243362|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
157201176|NCT01049360|567481149|FG009|Period 4|Protocol Violation|0|||
157201177|NCT01049360|567481150|FG010|Period 4|Protocol Violation|0|||
157201178|NCT01049360|567481151|FG011|Period 4|Protocol Violation|0|||
157201179|NCT01049360|567481152|FG012|Period 4|Protocol Violation|0|||
157201180|NCT01049360|567481153|FG013|Period 4|Protocol Violation|0|||
157201181|NCT01049360|567481154|FG014|Period 4|Protocol Violation|0|||
157201182|NCT01049360|567481155|FG015|Period 4|Protocol Violation|0|||
157201183|NCT01049360|567481156|FG016|Period 4|Protocol Violation|0|||
157201184|NCT01049360|567481157|FG017|Period 4|Protocol Violation|1|||
157201185|NCT01049360|567481158|FG018|Period 4|Protocol Violation|0|||
157201186|NCT01049360|567481159|FG019|Period 4|Protocol Violation|0|||
157201187|NCT01049360|567481140|FG000|Period 4|Withdrawal by Subject|0|||
157201188|NCT01049360|567481141|FG001|Period 4|Withdrawal by Subject|0|||
157201189|NCT01049360|567481142|FG002|Period 4|Withdrawal by Subject|0|||
157201190|NCT01049360|567481143|FG003|Period 4|Withdrawal by Subject|1|||
157201191|NCT01049360|567481144|FG004|Period 4|Withdrawal by Subject|0|||
157201192|NCT01049360|567481145|FG005|Period 4|Withdrawal by Subject|0|||
157201193|NCT01049360|567481146|FG006|Period 4|Withdrawal by Subject|0|||
157201194|NCT01049360|567481147|FG007|Period 4|Withdrawal by Subject|0|||
157201195|NCT01049360|567481148|FG008|Period 4|Withdrawal by Subject|0|||
157201196|NCT01049360|567481149|FG009|Period 4|Withdrawal by Subject|0|||
157201197|NCT01049360|567481150|FG010|Period 4|Withdrawal by Subject|0|||
157201198|NCT01049360|567481151|FG011|Period 4|Withdrawal by Subject|0|||
157201199|NCT01049360|567481152|FG012|Period 4|Withdrawal by Subject|0|||
157201200|NCT01049360|567481153|FG013|Period 4|Withdrawal by Subject|0|||
157201201|NCT01049360|567481154|FG014|Period 4|Withdrawal by Subject|0|||
157201202|NCT01049360|567481155|FG015|Period 4|Withdrawal by Subject|0|||
157201203|NCT01049360|567481156|FG016|Period 4|Withdrawal by Subject|0|||
157201204|NCT01049360|567481157|FG017|Period 4|Withdrawal by Subject|0|||
157201205|NCT01049360|567481158|FG018|Period 4|Withdrawal by Subject|0|||
157201206|NCT01049360|567481159|FG019|Period 4|Withdrawal by Subject|0|||
157201207|NCT05147311|567481162|FG000|Overall Study|Did not complete survey|2|||
157201208|NCT05147311|567481163|FG001|Overall Study|Did not complete survey|1|||
157201209|NCT05147311|567481162|FG000|Overall Study|Patient too sick|1|||
157201210|NCT05147311|567481163|FG001|Overall Study|Patient too sick|2|||
157201211|NCT05147311|567481162|FG000|Overall Study|Death|0|||
157201212|NCT05147311|567481163|FG001|Overall Study|Death|1|||
157201213|NCT05147311|567481162|FG000|Overall Study|Declined survey|1|||
157201214|NCT05147311|567481163|FG001|Overall Study|Declined survey|0|||
157201215|NCT00145795|567481165|FG000|Overall Study|Adverse Event|1|||
157201216|NCT00145795|567481166|FG001|Overall Study|Adverse Event|0|||
157201217|NCT03901274|567481174|FG000|Overall Study|Lost to Follow-up|120|||
157201218|NCT03901274|567481175|FG001|Overall Study|Lost to Follow-up|124|||
157201219|NCT03901274|567481174|FG000|Overall Study|Withdrawal by Subject|0|||
157201220|NCT03901274|567481175|FG001|Overall Study|Withdrawal by Subject|6|||
157201221|NCT04527380|567481176|FG000|Overall Study|Lack of Efficacy|0|||
157201222|NCT04527380|567481177|FG001|Overall Study|Lack of Efficacy|1|||
157201223|NCT04527380|567481176|FG000|Overall Study|Withdrawal by Subject|1|||
157201224|NCT04527380|567481177|FG001|Overall Study|Withdrawal by Subject|0|||
157201225|NCT05116241|567481178|FG000|Study|Withdrawal by Subject|5|||
157201226|NCT05116241|567481179|FG001|Study|Withdrawal by Subject|2|||
157201227|NCT05116241|567481180|FG002|Study|Withdrawal by Subject|1|||
157201228|NCT05116241|567481178|FG000|Study|Lost to Follow-up|0|||
157201229|NCT05116241|567481179|FG001|Study|Lost to Follow-up|2|||
157201230|NCT05116241|567481180|FG002|Study|Lost to Follow-up|2|||
157201231|NCT00938366|567481181|FG000|Overall Study|Withdrawal by Subject|1|||
157201232|NCT00938366|567481182|FG001|Overall Study|Withdrawal by Subject|0|||
157201233|NCT05182840|567481183|FG000|Run-in Period|Not treated|0|||
157201234|NCT05182840|567481184|FG001|Run-in Period|Not treated|1|||
157201235|NCT05182840|567481185|FG002|Run-in Period|Not treated|0|||
157201236|NCT05182840|567481186|FG003|Run-in Period|Not treated|0|||
157201237|NCT05182840|567481187|FG004|Run-in Period|Not treated|0|||
157201238|NCT05182840|567481188|FG005|Run-in Period|Not treated|0|||
157201239|NCT05182840|567481189|FG006|Run-in Period|Not treated|0|||
157201240|NCT05182840|567481190|FG007|Run-in Period|Not treated|0|||
157201241|NCT05182840|567481191|FG008|Run-in Period|Not treated|0|||
157201242|NCT05182840|567481192|FG009|Run-in Period|Not treated|0|||
157201243|NCT05182840|567481183|FG000|Run-in Period|Other reason but not sponsor termination|14|||
157201244|NCT05182840|567481184|FG001|Run-in Period|Other reason but not sponsor termination|18|||
157201245|NCT05182840|567481185|FG002|Run-in Period|Other reason but not sponsor termination|0|||
157201246|NCT05182840|567481186|FG003|Run-in Period|Other reason but not sponsor termination|0|||
157201247|NCT05182840|567481187|FG004|Run-in Period|Other reason but not sponsor termination|0|||
157201248|NCT05182840|567481188|FG005|Run-in Period|Other reason but not sponsor termination|0|||
157201249|NCT05182840|567481189|FG006|Run-in Period|Other reason but not sponsor termination|0|||
157201250|NCT05182840|567481190|FG007|Run-in Period|Other reason but not sponsor termination|0|||
157201251|NCT05182840|567481191|FG008|Run-in Period|Other reason but not sponsor termination|0|||
157201252|NCT05182840|567481192|FG009|Run-in Period|Other reason but not sponsor termination|0|||
157201253|NCT05182840|567481183|FG000|Run-in Period|No reason available|2|||
157201254|NCT05182840|567481184|FG001|Run-in Period|No reason available|2|||
157201255|NCT05182840|567481185|FG002|Run-in Period|No reason available|0|||
157201256|NCT05182840|567481186|FG003|Run-in Period|No reason available|0|||
157201257|NCT05182840|567481187|FG004|Run-in Period|No reason available|0|||
157201258|NCT05182840|567481188|FG005|Run-in Period|No reason available|0|||
157201259|NCT05182840|567481189|FG006|Run-in Period|No reason available|0|||
157201260|NCT05182840|567481190|FG007|Run-in Period|No reason available|0|||
157201261|NCT05182840|567481191|FG008|Run-in Period|No reason available|0|||
157201262|NCT05182840|567481192|FG009|Run-in Period|No reason available|0|||
157201263|NCT05182840|567481183|FG000|Run-in Period|Burden of study procedures|2|||
157201264|NCT05182840|567481184|FG001|Run-in Period|Burden of study procedures|2|||
157201265|NCT05182840|567481185|FG002|Run-in Period|Burden of study procedures|0|||
157201266|NCT05182840|567481186|FG003|Run-in Period|Burden of study procedures|0|||
157201267|NCT05182840|567481187|FG004|Run-in Period|Burden of study procedures|0|||
157201268|NCT05182840|567481188|FG005|Run-in Period|Burden of study procedures|0|||
157201269|NCT05182840|567481189|FG006|Run-in Period|Burden of study procedures|0|||
157201270|NCT05182840|567481190|FG007|Run-in Period|Burden of study procedures|0|||
157201271|NCT05182840|567481191|FG008|Run-in Period|Burden of study procedures|0|||
157201272|NCT05182840|567481192|FG009|Run-in Period|Burden of study procedures|0|||
157201273|NCT05182840|567481183|FG000|Run-in Period|Change of residence|1|||
157201274|NCT05182840|567481184|FG001|Run-in Period|Change of residence|0|||
157201275|NCT05182840|567481185|FG002|Run-in Period|Change of residence|0|||
157201276|NCT05182840|567481186|FG003|Run-in Period|Change of residence|0|||
157201277|NCT05182840|567481187|FG004|Run-in Period|Change of residence|0|||
157201278|NCT05182840|567481188|FG005|Run-in Period|Change of residence|0|||
157201279|NCT05182840|567481189|FG006|Run-in Period|Change of residence|0|||
157201280|NCT05182840|567481190|FG007|Run-in Period|Change of residence|0|||
157201281|NCT05182840|567481191|FG008|Run-in Period|Change of residence|0|||
157201282|NCT05182840|567481192|FG009|Run-in Period|Change of residence|0|||
157201283|NCT05182840|567481183|FG000|Run-in Period|Adverse Event|5|||
157201284|NCT05182840|567481184|FG001|Run-in Period|Adverse Event|5|||
157201285|NCT05182840|567481185|FG002|Run-in Period|Adverse Event|0|||
157201286|NCT05182840|567481186|FG003|Run-in Period|Adverse Event|0|||
157201287|NCT05182840|567481187|FG004|Run-in Period|Adverse Event|0|||
157201288|NCT05182840|567481188|FG005|Run-in Period|Adverse Event|0|||
157201289|NCT05182840|567481189|FG006|Run-in Period|Adverse Event|0|||
157201290|NCT05182840|567481190|FG007|Run-in Period|Adverse Event|0|||
157201291|NCT05182840|567481191|FG008|Run-in Period|Adverse Event|0|||
157201292|NCT05182840|567481192|FG009|Run-in Period|Adverse Event|0|||
157201293|NCT05182840|567481183|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
157201294|NCT05182840|567481184|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
157201295|NCT05182840|567481185|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201296|NCT05182840|567481186|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201297|NCT05182840|567481187|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201298|NCT05182840|567481188|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201299|NCT05182840|567481189|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201300|NCT05182840|567481190|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201301|NCT05182840|567481191|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201302|NCT05182840|567481192|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
157201303|NCT05182840|567481183|FG000|Treatment Period|Reason missing|0|||
157201304|NCT05182840|567481184|FG001|Treatment Period|Reason missing|0|||
157201305|NCT05182840|567481185|FG002|Treatment Period|Reason missing|1|||
157201306|NCT05182840|567481186|FG003|Treatment Period|Reason missing|0|||
157201307|NCT05182840|567481187|FG004|Treatment Period|Reason missing|0|||
157201308|NCT05182840|567481188|FG005|Treatment Period|Reason missing|0|||
157201309|NCT05182840|567481189|FG006|Treatment Period|Reason missing|0|||
157201310|NCT05182840|567481190|FG007|Treatment Period|Reason missing|0|||
157201311|NCT05182840|567481191|FG008|Treatment Period|Reason missing|0|||
157201312|NCT05182840|567481192|FG009|Treatment Period|Reason missing|0|||
157201313|NCT05182840|567481183|FG000|Treatment Period|Other but not sponsor termination|0|||
157201314|NCT05182840|567481184|FG001|Treatment Period|Other but not sponsor termination|0|||
157201315|NCT05182840|567481185|FG002|Treatment Period|Other but not sponsor termination|8|||
157201316|NCT05182840|567481186|FG003|Treatment Period|Other but not sponsor termination|6|||
157201317|NCT05182840|567481187|FG004|Treatment Period|Other but not sponsor termination|6|||
157201318|NCT05182840|567481188|FG005|Treatment Period|Other but not sponsor termination|7|||
157201319|NCT05182840|567481189|FG006|Treatment Period|Other but not sponsor termination|5|||
157201320|NCT05182840|567481190|FG007|Treatment Period|Other but not sponsor termination|8|||
157201321|NCT05182840|567481191|FG008|Treatment Period|Other but not sponsor termination|7|||
157201322|NCT05182840|567481192|FG009|Treatment Period|Other but not sponsor termination|2|||
157201323|NCT05182840|567481183|FG000|Treatment Period|Protocol deviation|0|||
157201324|NCT05182840|567481184|FG001|Treatment Period|Protocol deviation|0|||
157201325|NCT05182840|567481185|FG002|Treatment Period|Protocol deviation|0|||
157201326|NCT05182840|567481186|FG003|Treatment Period|Protocol deviation|0|||
157201327|NCT05182840|567481187|FG004|Treatment Period|Protocol deviation|0|||
157201328|NCT05182840|567481188|FG005|Treatment Period|Protocol deviation|0|||
157201329|NCT05182840|567481189|FG006|Treatment Period|Protocol deviation|0|||
157201330|NCT05182840|567481190|FG007|Treatment Period|Protocol deviation|0|||
157201331|NCT05182840|567481191|FG008|Treatment Period|Protocol deviation|1|||
157201332|NCT05182840|567481192|FG009|Treatment Period|Protocol deviation|0|||
157201333|NCT05182840|567481183|FG000|Treatment Period|No reason available|0|||
157201334|NCT05182840|567481184|FG001|Treatment Period|No reason available|0|||
157201335|NCT05182840|567481185|FG002|Treatment Period|No reason available|0|||
157201336|NCT05182840|567481186|FG003|Treatment Period|No reason available|1|||
157201337|NCT05182840|567481187|FG004|Treatment Period|No reason available|0|||
157201338|NCT05182840|567481188|FG005|Treatment Period|No reason available|2|||
157201339|NCT05182840|567481189|FG006|Treatment Period|No reason available|0|||
157201340|NCT05182840|567481190|FG007|Treatment Period|No reason available|1|||
157201341|NCT05182840|567481191|FG008|Treatment Period|No reason available|0|||
157201342|NCT05182840|567481192|FG009|Treatment Period|No reason available|0|||
157201343|NCT05182840|567481183|FG000|Treatment Period|Burden of study procedures|0|||
157201344|NCT05182840|567481184|FG001|Treatment Period|Burden of study procedures|0|||
157201345|NCT05182840|567481185|FG002|Treatment Period|Burden of study procedures|0|||
157201346|NCT05182840|567481186|FG003|Treatment Period|Burden of study procedures|0|||
157201347|NCT05182840|567481187|FG004|Treatment Period|Burden of study procedures|1|||
157201348|NCT05182840|567481188|FG005|Treatment Period|Burden of study procedures|0|||
157201349|NCT05182840|567481189|FG006|Treatment Period|Burden of study procedures|0|||
157201350|NCT05182840|567481190|FG007|Treatment Period|Burden of study procedures|0|||
157201351|NCT05182840|567481191|FG008|Treatment Period|Burden of study procedures|0|||
157201352|NCT05182840|567481192|FG009|Treatment Period|Burden of study procedures|0|||
157201353|NCT05182840|567481183|FG000|Treatment Period|Change of residence|0|||
157201354|NCT05182840|567481184|FG001|Treatment Period|Change of residence|0|||
157201355|NCT05182840|567481185|FG002|Treatment Period|Change of residence|0|||
157201356|NCT05182840|567481186|FG003|Treatment Period|Change of residence|0|||
157201357|NCT05182840|567481187|FG004|Treatment Period|Change of residence|0|||
157201358|NCT05182840|567481188|FG005|Treatment Period|Change of residence|1|||
157201359|NCT05182840|567481189|FG006|Treatment Period|Change of residence|0|||
157201360|NCT05182840|567481190|FG007|Treatment Period|Change of residence|0|||
157201361|NCT05182840|567481191|FG008|Treatment Period|Change of residence|0|||
157201362|NCT05182840|567481192|FG009|Treatment Period|Change of residence|0|||
157201363|NCT05182840|567481183|FG000|Treatment Period|Adverse Event|0|||
157201364|NCT05182840|567481184|FG001|Treatment Period|Adverse Event|0|||
157201365|NCT05182840|567481185|FG002|Treatment Period|Adverse Event|4|||
157201366|NCT05182840|567481186|FG003|Treatment Period|Adverse Event|16|||
157201367|NCT05182840|567481187|FG004|Treatment Period|Adverse Event|12|||
157201368|NCT05182840|567481188|FG005|Treatment Period|Adverse Event|6|||
157201369|NCT05182840|567481189|FG006|Treatment Period|Adverse Event|4|||
157201370|NCT05182840|567481190|FG007|Treatment Period|Adverse Event|8|||
157201371|NCT05182840|567481191|FG008|Treatment Period|Adverse Event|16|||
157201372|NCT05182840|567481192|FG009|Treatment Period|Adverse Event|5|||
157201373|NCT05182840|567481183|FG000|Treatment Period|Not treated with study drug|0|||
157201374|NCT05182840|567481184|FG001|Treatment Period|Not treated with study drug|0|||
157201375|NCT05182840|567481185|FG002|Treatment Period|Not treated with study drug|0|||
157201376|NCT05182840|567481186|FG003|Treatment Period|Not treated with study drug|1|||
157201377|NCT05182840|567481187|FG004|Treatment Period|Not treated with study drug|0|||
157201378|NCT05182840|567481188|FG005|Treatment Period|Not treated with study drug|0|||
157201379|NCT05182840|567481189|FG006|Treatment Period|Not treated with study drug|1|||
157201380|NCT05182840|567481190|FG007|Treatment Period|Not treated with study drug|1|||
157201381|NCT05182840|567481191|FG008|Treatment Period|Not treated with study drug|0|||
157201382|NCT05182840|567481192|FG009|Treatment Period|Not treated with study drug|0|||
157201383|NCT00509223|567483381|FG000|Overall Study|Lost to Follow-up|1|||
157201384|NCT00509223|567483382|FG001|Overall Study|Lost to Follow-up|1|||
157201385|NCT00509223|567483381|FG000|Overall Study|Adverse Event|1|||
157201386|NCT00509223|567483382|FG001|Overall Study|Adverse Event|1|||
157201387|NCT00509223|567483381|FG000|Overall Study|Withdrawal by Subject|25|||
157201388|NCT00509223|567483382|FG001|Overall Study|Withdrawal by Subject|6|||
157201389|NCT00509223|567483381|FG000|Overall Study|Including: subject change of address|5|||
157201390|NCT00509223|567483382|FG001|Overall Study|Including: subject change of address|2|||
157201391|NCT00509223|567483381|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
157201392|NCT00509223|567483382|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
157201393|NCT01361308|567483385|FG000|Overall Study|Withdrawal by Subject|9|||
157201394|NCT01361308|567483386|FG001|Overall Study|Withdrawal by Subject|13|||
157201395|NCT01361308|567483385|FG000|Overall Study|Physician Decision|3|||
157201396|NCT01361308|567483386|FG001|Overall Study|Physician Decision|3|||
157201397|NCT01361308|567483385|FG000|Overall Study|Lack of Efficacy|2|||
157201398|NCT01361308|567483386|FG001|Overall Study|Lack of Efficacy|0|||
157201399|NCT01361308|567483385|FG000|Overall Study|Protocol Violation|1|||
157201400|NCT01361308|567483386|FG001|Overall Study|Protocol Violation|0|||
157201401|NCT01361308|567483385|FG000|Overall Study|Lost to Follow-up|5|||
157201402|NCT01361308|567483386|FG001|Overall Study|Lost to Follow-up|4|||
157201403|NCT01361308|567483385|FG000|Overall Study|Adverse Event|8|||
157201404|NCT01361308|567483386|FG001|Overall Study|Adverse Event|4|||
157201405|NCT01361308|567483385|FG000|Overall Study|Eligibility Criteria Not Met|2|||
157201406|NCT01361308|567483386|FG001|Overall Study|Eligibility Criteria Not Met|3|||
157201407|NCT01361308|567483385|FG000|Overall Study|Failed C-SSRS|5|||
157201408|NCT01361308|567483386|FG001|Overall Study|Failed C-SSRS|2|||
157201409|NCT01361308|567483385|FG000|Overall Study|Other|0|||
157201410|NCT01361308|567483386|FG001|Overall Study|Other|1|||
157201411|NCT04621227|567483387|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
157201412|NCT04621227|567483387|FG000|Period 3 (29 Days)|Adverse Event|1|||
157201413|NCT04621227|567483387|FG000|Period 8 (2 Days)|Adverse Event|1|||
157201414|NCT02916056|567483388|FG000|Overall Study|Adverse Event|6|||
157201415|NCT02916056|567483388|FG000|Overall Study|Lost to Follow-up|1|||
157201416|NCT02916056|567483388|FG000|Overall Study|Other|12|||
157243363|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243364|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243365|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243366|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243367|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243368|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243369|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243370|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243371|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243372|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243373|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243374|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243375|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243376|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243377|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243378|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
157243379|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243380|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243381|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243382|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243383|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243384|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243385|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243386|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243387|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
157243388|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243389|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243390|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243391|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243392|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243393|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243394|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243395|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243396|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243397|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243398|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243399|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243400|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243401|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243402|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243403|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243404|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
157243405|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243406|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243407|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243408|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243409|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243410|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243411|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243412|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243413|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
157243414|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243415|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243416|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243417|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243418|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243419|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243420|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243421|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243422|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243423|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243424|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243425|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243426|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243427|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243428|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243429|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243430|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
157243431|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243432|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243433|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243434|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243435|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243436|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
157243437|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
157243438|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
157243439|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
157243440|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
157243441|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243442|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243443|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243444|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243445|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243446|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243447|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243448|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243449|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243450|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243451|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243452|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243453|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243454|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243455|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243456|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
157243457|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243458|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243459|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243460|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243461|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243462|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243463|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243464|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243465|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243466|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
157243467|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243468|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243469|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243470|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243471|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243472|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243473|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243474|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243475|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243476|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243477|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243478|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243479|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243480|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243481|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243482|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
157243483|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243484|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243485|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243486|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243487|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243488|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243489|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243490|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243491|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243492|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
157243493|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243494|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243495|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243496|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243497|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243498|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243499|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243500|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243501|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243502|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243503|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243504|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243505|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243506|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243507|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243508|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
157243509|NCT00112437|567636840|FG000|Year 2 (12-Month Extension)|Moved|0|||
157243510|NCT00112437|567636841|FG001|Year 2 (12-Month Extension)|Moved|0|||
157243511|NCT00112437|567636842|FG002|Year 2 (12-Month Extension)|Moved|0|||
157243512|NCT00112437|567636843|FG003|Year 2 (12-Month Extension)|Moved|0|||
157243513|NCT00112437|567636844|FG004|Year 2 (12-Month Extension)|Moved|0|||
157243514|NCT00112437|567636845|FG005|Year 2 (12-Month Extension)|Moved|0|||
157243515|NCT00112437|567636846|FG006|Year 2 (12-Month Extension)|Moved|0|||
157243516|NCT00112437|567636847|FG007|Year 2 (12-Month Extension)|Moved|0|||
157243517|NCT00112437|567636848|FG008|Year 2 (12-Month Extension)|Moved|0|||
157243518|NCT00112437|567636849|FG009|Year 2 (12-Month Extension)|Moved|1|||
157243519|NCT00112437|567636850|FG010|Year 2 (12-Month Extension)|Moved|0|||
157243520|NCT00112437|567636851|FG011|Year 2 (12-Month Extension)|Moved|0|||
157243521|NCT00112437|567636852|FG012|Year 2 (12-Month Extension)|Moved|0|||
157243522|NCT00112437|567636853|FG013|Year 2 (12-Month Extension)|Moved|0|||
157243523|NCT00112437|567636854|FG014|Year 2 (12-Month Extension)|Moved|0|||
157243524|NCT00112437|567636855|FG015|Year 2 (12-Month Extension)|Moved|0|||
157243525|NCT00112437|567636856|FG016|Year 2 (12-Month Extension)|Moved|0|||
157243526|NCT00112437|567636857|FG017|Year 2 (12-Month Extension)|Moved|0|||
157243527|NCT00112437|567636858|FG018|Year 2 (12-Month Extension)|Moved|0|||
157243528|NCT00112437|567636859|FG019|Year 2 (12-Month Extension)|Moved|0|||
157243529|NCT00112437|567636860|FG020|Year 2 (12-Month Extension)|Moved|0|||
157201417|NCT02916056|567483388|FG000|Overall Study|Protocol Violation|1|||
157201418|NCT02916056|567483388|FG000|Overall Study|Withdrawal by Subject|8|||
157201419|NCT02916056|567483388|FG000|Overall Study|Study Terminated by Sponsor|269|||
157201420|NCT00124709|567483389|FG000|Overall Study|Randomized but did not take medication|3|||
157201421|NCT00124709|567483390|FG001|Overall Study|Randomized but did not take medication|1|||
157201422|NCT00124709|567483389|FG000|Overall Study|Adverse Event|3|||
157201423|NCT00124709|567483390|FG001|Overall Study|Adverse Event|0|||
157201424|NCT00124709|567483389|FG000|Overall Study|Lack of Efficacy|5|||
157201425|NCT00124709|567483390|FG001|Overall Study|Lack of Efficacy|10|||
157201426|NCT00124709|567483389|FG000|Overall Study|Protocol Violation|3|||
157201427|NCT00124709|567483390|FG001|Overall Study|Protocol Violation|5|||
157201428|NCT00124709|567483389|FG000|Overall Study|Withdrawal by Subject|127|||
157201429|NCT00124709|567483390|FG001|Overall Study|Withdrawal by Subject|136|||
157201430|NCT00124709|567483389|FG000|Overall Study|Lost to Follow-up|114|||
157201431|NCT00124709|567483390|FG001|Overall Study|Lost to Follow-up|120|||
157201432|NCT01728376|567483391|FG000|Overall Study|Adverse Event|1|||
157201433|NCT01728376|567483392|FG001|Overall Study|Adverse Event|1|||
157201434|NCT01728376|567483393|FG002|Overall Study|Adverse Event|1|||
157201435|NCT01728376|567483394|FG003|Overall Study|Adverse Event|1|||
157201436|NCT01728376|567483395|FG004|Overall Study|Adverse Event|1|||
157201437|NCT01728376|567483396|FG005|Overall Study|Adverse Event|0|||
157201438|NCT01728376|567483391|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
157201439|NCT01728376|567483392|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
157201440|NCT01728376|567483393|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
157201441|NCT01728376|567483394|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
157201442|NCT01728376|567483395|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
157201443|NCT01728376|567483396|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
157201444|NCT01728376|567483391|FG000|Overall Study|No relevant bacteria|2|||
157201445|NCT01728376|567483392|FG001|Overall Study|No relevant bacteria|0|||
157201446|NCT01728376|567483393|FG002|Overall Study|No relevant bacteria|0|||
157201447|NCT01728376|567483394|FG003|Overall Study|No relevant bacteria|0|||
157201448|NCT01728376|567483395|FG004|Overall Study|No relevant bacteria|1|||
157201449|NCT01728376|567483396|FG005|Overall Study|No relevant bacteria|1|||
157201450|NCT01728376|567483391|FG000|Overall Study|Did not receive treatment|0|||
157201451|NCT01728376|567483392|FG001|Overall Study|Did not receive treatment|1|||
157201452|NCT01728376|567483393|FG002|Overall Study|Did not receive treatment|0|||
157201453|NCT01728376|567483394|FG003|Overall Study|Did not receive treatment|0|||
157201454|NCT01728376|567483395|FG004|Overall Study|Did not receive treatment|0|||
157243530|NCT00112437|567636861|FG021|Year 2 (12-Month Extension)|Moved|0|||
157243531|NCT00112437|567636862|FG022|Year 2 (12-Month Extension)|Moved|0|||
157243532|NCT00112437|567636863|FG023|Year 2 (12-Month Extension)|Moved|0|||
157243533|NCT00112437|567636864|FG024|Year 2 (12-Month Extension)|Moved|0|||
157243534|NCT00112437|567636865|FG025|Year 2 (12-Month Extension)|Moved|0|||
157243535|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
157243536|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
157243537|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
157243538|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
157243539|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
157243540|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
157243541|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
157243542|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
157243543|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
157243544|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
157243545|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
157243546|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
157243547|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
157243548|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
157243549|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
157243550|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
157243551|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
157243552|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
157243553|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
157243554|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
157243555|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
157243556|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
157243557|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
157243558|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
157243559|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
157243560|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
157243561|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243562|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243563|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243564|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243565|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243566|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243567|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243568|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243569|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243570|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243571|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243572|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
157243573|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243574|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
157243575|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243576|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
157243577|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243578|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243579|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
157243580|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243581|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243582|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243583|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243584|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243585|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243586|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
157243587|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243588|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243589|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243590|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243591|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243592|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243593|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243594|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243595|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243596|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243597|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243598|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243599|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243600|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243601|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243602|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
157243603|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243604|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243605|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243606|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243607|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243608|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243609|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243610|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243611|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243612|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
157243613|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243614|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243615|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243616|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243617|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243618|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243619|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243620|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243621|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243622|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243623|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243624|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243625|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243626|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243627|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243628|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
157243629|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243630|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243631|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243632|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243633|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243634|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243635|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243636|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243637|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243638|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
157243639|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243640|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243641|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243642|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243643|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243644|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243645|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243646|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243647|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243648|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243649|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243650|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
157243651|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243652|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243653|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
157243654|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243655|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243656|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243657|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243658|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243659|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243660|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243661|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243662|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243663|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243664|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
157243665|NCT00112437|567636840|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243666|NCT00112437|567636841|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243667|NCT00112437|567636842|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243668|NCT00112437|567636843|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243669|NCT00112437|567636844|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243670|NCT00112437|567636845|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243671|NCT00112437|567636846|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243672|NCT00112437|567636847|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243673|NCT00112437|567636848|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243674|NCT00112437|567636849|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243675|NCT00112437|567636850|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
157243676|NCT00112437|567636851|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
157243677|NCT00112437|567636852|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243678|NCT00112437|567636853|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243679|NCT00112437|567636854|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243680|NCT00112437|567636855|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243681|NCT00112437|567636856|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243682|NCT00112437|567636857|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243683|NCT00112437|567636858|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243684|NCT00112437|567636859|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243685|NCT00112437|567636860|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243686|NCT00112437|567636861|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243687|NCT00112437|567636862|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243688|NCT00112437|567636863|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243689|NCT00112437|567636864|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243690|NCT00112437|567636865|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
157243691|NCT00112437|567636840|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243692|NCT00112437|567636841|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243693|NCT00112437|567636842|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243694|NCT00112437|567636843|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243695|NCT00112437|567636844|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243696|NCT00112437|567636845|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243697|NCT00112437|567636846|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243698|NCT00112437|567636847|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243699|NCT00112437|567636848|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243700|NCT00112437|567636849|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243701|NCT00112437|567636850|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243702|NCT00112437|567636851|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243703|NCT00112437|567636852|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243704|NCT00112437|567636853|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243705|NCT00112437|567636854|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243706|NCT00112437|567636855|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243707|NCT00112437|567636856|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243708|NCT00112437|567636857|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243709|NCT00112437|567636858|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243710|NCT00112437|567636859|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243711|NCT00112437|567636860|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
157243712|NCT00112437|567636861|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
157243713|NCT00112437|567636862|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243714|NCT00112437|567636863|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243715|NCT00112437|567636864|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157201455|NCT01728376|567483396|FG005|Overall Study|Did not receive treatment|0|||
157201456|NCT01728376|567483391|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
157201457|NCT01728376|567483392|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
157201458|NCT01728376|567483393|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
157201459|NCT01728376|567483394|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
157201460|NCT01728376|567483395|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
157201461|NCT01728376|567483396|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
157201462|NCT05299359|567483407|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
157201463|NCT05299359|567483408|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
157201464|NCT05299359|567483407|FG000|Main Part: Day 1 up to Day 366|Other|2|||
157201465|NCT05299359|567483408|FG001|Main Part: Day 1 up to Day 366|Other|0|||
157201466|NCT05299359|567483407|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
157201467|NCT05299359|567483408|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
157201468|NCT05299359|567483407|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
157201469|NCT05299359|567483408|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
157201470|NCT05299359|567483407|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
157201471|NCT05299359|567483408|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
157201472|NCT05299359|567483407|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
157201473|NCT05299359|567483408|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
157201474|NCT05299359|567483407|FG000|Extension Part: Day 1 to Day 366|Other|0|||
157201475|NCT05299359|567483408|FG001|Extension Part: Day 1 to Day 366|Other|1|||
157201476|NCT03110107|567483409|FG000|Treatment Period|Disease Progression|3|||
157201477|NCT03110107|567483410|FG001|Treatment Period|Disease Progression|9|||
157201478|NCT03110107|567483411|FG002|Treatment Period|Disease Progression|8|||
157243716|NCT00112437|567636865|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
157243717|NCT00112437|567636840|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243718|NCT00112437|567636841|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243719|NCT00112437|567636842|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243720|NCT00112437|567636843|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243721|NCT00112437|567636844|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243722|NCT00112437|567636845|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243723|NCT00112437|567636846|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243724|NCT00112437|567636847|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243725|NCT00112437|567636848|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243726|NCT00112437|567636849|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243727|NCT00112437|567636850|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243728|NCT00112437|567636851|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243729|NCT00112437|567636852|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243730|NCT00112437|567636853|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243731|NCT00112437|567636854|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243732|NCT00112437|567636855|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243733|NCT00112437|567636856|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243734|NCT00112437|567636857|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243735|NCT00112437|567636858|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243736|NCT00112437|567636859|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243737|NCT00112437|567636860|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
157243738|NCT00112437|567636861|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243739|NCT00112437|567636862|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243740|NCT00112437|567636863|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243741|NCT00112437|567636864|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243742|NCT00112437|567636865|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
157243743|NCT00112437|567636840|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243744|NCT00112437|567636841|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243745|NCT00112437|567636842|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243746|NCT00112437|567636843|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243747|NCT00112437|567636844|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243748|NCT00112437|567636845|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243749|NCT00112437|567636846|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243750|NCT00112437|567636847|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243751|NCT00112437|567636848|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157201479|NCT03110107|567483412|FG003|Treatment Period|Disease Progression|11|||
157201480|NCT03110107|567483413|FG004|Treatment Period|Disease Progression|8|||
157201481|NCT03110107|567483414|FG005|Treatment Period|Disease Progression|4|||
157201482|NCT03110107|567483415|FG006|Treatment Period|Disease Progression|6|||
157201483|NCT03110107|567483416|FG007|Treatment Period|Disease Progression|7|||
157201484|NCT03110107|567483417|FG008|Treatment Period|Disease Progression|2|||
157201485|NCT03110107|567483418|FG009|Treatment Period|Disease Progression|10|||
157201486|NCT03110107|567483419|FG010|Treatment Period|Disease Progression|5|||
157201487|NCT03110107|567483420|FG011|Treatment Period|Disease Progression|2|||
157201488|NCT03110107|567483421|FG012|Treatment Period|Disease Progression|0|||
157201489|NCT03110107|567483422|FG013|Treatment Period|Disease Progression|5|||
157201490|NCT03110107|567483423|FG014|Treatment Period|Disease Progression|14|||
157201491|NCT03110107|567483424|FG015|Treatment Period|Disease Progression|14|||
157201492|NCT03110107|567483425|FG016|Treatment Period|Disease Progression|4|||
157201493|NCT03110107|567483426|FG017|Treatment Period|Disease Progression|3|||
157201494|NCT03110107|567483427|FG018|Treatment Period|Disease Progression|16|||
157201495|NCT03110107|567483428|FG019|Treatment Period|Disease Progression|14|||
157201496|NCT03110107|567483429|FG020|Treatment Period|Disease Progression|12|||
157201497|NCT03110107|567483430|FG021|Treatment Period|Disease Progression|16|||
157201498|NCT03110107|567483431|FG022|Treatment Period|Disease Progression|18|||
157201499|NCT03110107|567483432|FG023|Treatment Period|Disease Progression|13|||
157201500|NCT03110107|567483433|FG024|Treatment Period|Disease Progression|16|||
157201501|NCT03110107|567483434|FG025|Treatment Period|Disease Progression|31|||
157201502|NCT03110107|567483409|FG000|Treatment Period|Study drug toxicity|1|||
157201503|NCT03110107|567483410|FG001|Treatment Period|Study drug toxicity|0|||
157201504|NCT03110107|567483411|FG002|Treatment Period|Study drug toxicity|1|||
157201505|NCT03110107|567483412|FG003|Treatment Period|Study drug toxicity|2|||
157201506|NCT03110107|567483413|FG004|Treatment Period|Study drug toxicity|0|||
157201507|NCT03110107|567483414|FG005|Treatment Period|Study drug toxicity|3|||
157201508|NCT03110107|567483415|FG006|Treatment Period|Study drug toxicity|1|||
157201509|NCT03110107|567483416|FG007|Treatment Period|Study drug toxicity|1|||
157201510|NCT03110107|567483417|FG008|Treatment Period|Study drug toxicity|3|||
157201511|NCT03110107|567483418|FG009|Treatment Period|Study drug toxicity|2|||
157201512|NCT03110107|567483419|FG010|Treatment Period|Study drug toxicity|0|||
157201513|NCT03110107|567483420|FG011|Treatment Period|Study drug toxicity|2|||
157243752|NCT00112437|567636849|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157201514|NCT03110107|567483421|FG012|Treatment Period|Study drug toxicity|0|||
157201515|NCT03110107|567483422|FG013|Treatment Period|Study drug toxicity|0|||
157201516|NCT03110107|567483423|FG014|Treatment Period|Study drug toxicity|2|||
157201517|NCT03110107|567483424|FG015|Treatment Period|Study drug toxicity|3|||
157201518|NCT03110107|567483425|FG016|Treatment Period|Study drug toxicity|3|||
157201519|NCT03110107|567483426|FG017|Treatment Period|Study drug toxicity|3|||
157201520|NCT03110107|567483427|FG018|Treatment Period|Study drug toxicity|1|||
157201521|NCT03110107|567483428|FG019|Treatment Period|Study drug toxicity|2|||
157201522|NCT03110107|567483429|FG020|Treatment Period|Study drug toxicity|2|||
157201523|NCT03110107|567483430|FG021|Treatment Period|Study drug toxicity|0|||
157201524|NCT03110107|567483431|FG022|Treatment Period|Study drug toxicity|2|||
157201525|NCT03110107|567483432|FG023|Treatment Period|Study drug toxicity|6|||
157201526|NCT03110107|567483433|FG024|Treatment Period|Study drug toxicity|7|||
157201527|NCT03110107|567483434|FG025|Treatment Period|Study drug toxicity|6|||
157201528|NCT03110107|567483409|FG000|Treatment Period|Death|0|||
157201529|NCT03110107|567483410|FG001|Treatment Period|Death|0|||
157201530|NCT03110107|567483411|FG002|Treatment Period|Death|0|||
157201531|NCT03110107|567483412|FG003|Treatment Period|Death|0|||
157201532|NCT03110107|567483413|FG004|Treatment Period|Death|0|||
157201533|NCT03110107|567483414|FG005|Treatment Period|Death|0|||
157201534|NCT03110107|567483415|FG006|Treatment Period|Death|0|||
157201535|NCT03110107|567483416|FG007|Treatment Period|Death|0|||
157201536|NCT03110107|567483417|FG008|Treatment Period|Death|0|||
157201537|NCT03110107|567483418|FG009|Treatment Period|Death|0|||
157201538|NCT03110107|567483419|FG010|Treatment Period|Death|0|||
157201539|NCT03110107|567483420|FG011|Treatment Period|Death|0|||
157201540|NCT03110107|567483421|FG012|Treatment Period|Death|1|||
157201541|NCT03110107|567483422|FG013|Treatment Period|Death|0|||
157201542|NCT03110107|567483423|FG014|Treatment Period|Death|0|||
157201543|NCT03110107|567483424|FG015|Treatment Period|Death|0|||
157201544|NCT03110107|567483425|FG016|Treatment Period|Death|0|||
157201545|NCT03110107|567483426|FG017|Treatment Period|Death|0|||
157201546|NCT03110107|567483427|FG018|Treatment Period|Death|0|||
157201547|NCT03110107|567483428|FG019|Treatment Period|Death|0|||
157201548|NCT03110107|567483429|FG020|Treatment Period|Death|0|||
157201549|NCT03110107|567483430|FG021|Treatment Period|Death|0|||
157201550|NCT03110107|567483431|FG022|Treatment Period|Death|0|||
157201551|NCT03110107|567483432|FG023|Treatment Period|Death|0|||
157201552|NCT03110107|567483433|FG024|Treatment Period|Death|0|||
157201553|NCT03110107|567483434|FG025|Treatment Period|Death|0|||
157201554|NCT03110107|567483409|FG000|Treatment Period|Adverse Event|0|||
157201555|NCT03110107|567483410|FG001|Treatment Period|Adverse Event|0|||
157201556|NCT03110107|567483411|FG002|Treatment Period|Adverse Event|1|||
157201557|NCT03110107|567483412|FG003|Treatment Period|Adverse Event|0|||
157201558|NCT03110107|567483413|FG004|Treatment Period|Adverse Event|0|||
157201559|NCT03110107|567483414|FG005|Treatment Period|Adverse Event|2|||
157201560|NCT03110107|567483415|FG006|Treatment Period|Adverse Event|0|||
157201561|NCT03110107|567483416|FG007|Treatment Period|Adverse Event|2|||
157201562|NCT03110107|567483417|FG008|Treatment Period|Adverse Event|0|||
157201563|NCT03110107|567483418|FG009|Treatment Period|Adverse Event|1|||
157201564|NCT03110107|567483419|FG010|Treatment Period|Adverse Event|0|||
157201565|NCT03110107|567483420|FG011|Treatment Period|Adverse Event|0|||
157201566|NCT03110107|567483421|FG012|Treatment Period|Adverse Event|0|||
157201567|NCT03110107|567483422|FG013|Treatment Period|Adverse Event|0|||
157201568|NCT03110107|567483423|FG014|Treatment Period|Adverse Event|0|||
157201569|NCT03110107|567483424|FG015|Treatment Period|Adverse Event|2|||
157201570|NCT03110107|567483425|FG016|Treatment Period|Adverse Event|0|||
157201571|NCT03110107|567483426|FG017|Treatment Period|Adverse Event|1|||
157201572|NCT03110107|567483427|FG018|Treatment Period|Adverse Event|2|||
157201573|NCT03110107|567483428|FG019|Treatment Period|Adverse Event|1|||
157201574|NCT03110107|567483429|FG020|Treatment Period|Adverse Event|4|||
157201575|NCT03110107|567483430|FG021|Treatment Period|Adverse Event|2|||
157201576|NCT03110107|567483431|FG022|Treatment Period|Adverse Event|2|||
157201577|NCT03110107|567483432|FG023|Treatment Period|Adverse Event|2|||
157201578|NCT03110107|567483433|FG024|Treatment Period|Adverse Event|2|||
157201579|NCT03110107|567483434|FG025|Treatment Period|Adverse Event|4|||
157201580|NCT03110107|567483409|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
157201581|NCT03110107|567483410|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
157201582|NCT03110107|567483411|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
157201583|NCT03110107|567483412|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
157201584|NCT03110107|567483413|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
157201585|NCT03110107|567483414|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
157201586|NCT03110107|567483415|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
157201587|NCT03110107|567483416|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
157201588|NCT03110107|567483417|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
157201589|NCT03110107|567483418|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
157201590|NCT03110107|567483419|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
157201591|NCT03110107|567483420|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
157201592|NCT03110107|567483421|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
157201593|NCT03110107|567483422|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
157201594|NCT03110107|567483423|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
157201595|NCT03110107|567483424|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
157201596|NCT03110107|567483425|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
157201597|NCT03110107|567483426|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
157201598|NCT03110107|567483427|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
157201599|NCT03110107|567483428|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
157201600|NCT03110107|567483429|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
157201601|NCT03110107|567483430|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
157201602|NCT03110107|567483431|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
157201603|NCT03110107|567483432|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
157201604|NCT03110107|567483433|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
157201605|NCT03110107|567483434|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
157201606|NCT03110107|567483409|FG000|Treatment Period|Participant withdrew consent|0|||
157201607|NCT03110107|567483410|FG001|Treatment Period|Participant withdrew consent|0|||
157201608|NCT03110107|567483411|FG002|Treatment Period|Participant withdrew consent|1|||
157201609|NCT03110107|567483412|FG003|Treatment Period|Participant withdrew consent|0|||
157201610|NCT03110107|567483413|FG004|Treatment Period|Participant withdrew consent|4|||
157201611|NCT03110107|567483414|FG005|Treatment Period|Participant withdrew consent|3|||
157201612|NCT03110107|567483415|FG006|Treatment Period|Participant withdrew consent|0|||
157201613|NCT03110107|567483416|FG007|Treatment Period|Participant withdrew consent|0|||
157201614|NCT03110107|567483417|FG008|Treatment Period|Participant withdrew consent|0|||
157201615|NCT03110107|567483418|FG009|Treatment Period|Participant withdrew consent|1|||
157201616|NCT03110107|567483419|FG010|Treatment Period|Participant withdrew consent|0|||
157201617|NCT03110107|567483420|FG011|Treatment Period|Participant withdrew consent|0|||
157201618|NCT03110107|567483421|FG012|Treatment Period|Participant withdrew consent|0|||
157201619|NCT03110107|567483422|FG013|Treatment Period|Participant withdrew consent|0|||
157201620|NCT03110107|567483423|FG014|Treatment Period|Participant withdrew consent|0|||
157201621|NCT03110107|567483424|FG015|Treatment Period|Participant withdrew consent|0|||
157201622|NCT03110107|567483425|FG016|Treatment Period|Participant withdrew consent|0|||
157201623|NCT03110107|567483426|FG017|Treatment Period|Participant withdrew consent|0|||
157201624|NCT03110107|567483427|FG018|Treatment Period|Participant withdrew consent|0|||
157201625|NCT03110107|567483428|FG019|Treatment Period|Participant withdrew consent|1|||
157201626|NCT03110107|567483429|FG020|Treatment Period|Participant withdrew consent|0|||
157201627|NCT03110107|567483430|FG021|Treatment Period|Participant withdrew consent|2|||
157201628|NCT03110107|567483431|FG022|Treatment Period|Participant withdrew consent|0|||
157201629|NCT03110107|567483432|FG023|Treatment Period|Participant withdrew consent|0|||
157201630|NCT03110107|567483433|FG024|Treatment Period|Participant withdrew consent|0|||
157201631|NCT03110107|567483434|FG025|Treatment Period|Participant withdrew consent|2|||
157201632|NCT03110107|567483409|FG000|Treatment Period|Participants no longer meets study criteria|0|||
157201633|NCT03110107|567483410|FG001|Treatment Period|Participants no longer meets study criteria|0|||
157201634|NCT03110107|567483411|FG002|Treatment Period|Participants no longer meets study criteria|0|||
157201635|NCT03110107|567483412|FG003|Treatment Period|Participants no longer meets study criteria|0|||
157201636|NCT03110107|567483413|FG004|Treatment Period|Participants no longer meets study criteria|0|||
157201637|NCT03110107|567483414|FG005|Treatment Period|Participants no longer meets study criteria|0|||
157201638|NCT03110107|567483415|FG006|Treatment Period|Participants no longer meets study criteria|0|||
157201639|NCT03110107|567483416|FG007|Treatment Period|Participants no longer meets study criteria|0|||
157201640|NCT03110107|567483417|FG008|Treatment Period|Participants no longer meets study criteria|0|||
157201641|NCT03110107|567483418|FG009|Treatment Period|Participants no longer meets study criteria|0|||
157201642|NCT03110107|567483419|FG010|Treatment Period|Participants no longer meets study criteria|0|||
157201643|NCT03110107|567483420|FG011|Treatment Period|Participants no longer meets study criteria|0|||
157201644|NCT03110107|567483421|FG012|Treatment Period|Participants no longer meets study criteria|0|||
157201645|NCT03110107|567483422|FG013|Treatment Period|Participants no longer meets study criteria|0|||
157201646|NCT03110107|567483423|FG014|Treatment Period|Participants no longer meets study criteria|0|||
157201647|NCT03110107|567483424|FG015|Treatment Period|Participants no longer meets study criteria|0|||
157201648|NCT03110107|567483425|FG016|Treatment Period|Participants no longer meets study criteria|0|||
157201649|NCT03110107|567483426|FG017|Treatment Period|Participants no longer meets study criteria|0|||
157201650|NCT03110107|567483427|FG018|Treatment Period|Participants no longer meets study criteria|0|||
157201651|NCT03110107|567483428|FG019|Treatment Period|Participants no longer meets study criteria|0|||
157201652|NCT03110107|567483429|FG020|Treatment Period|Participants no longer meets study criteria|0|||
157201653|NCT03110107|567483430|FG021|Treatment Period|Participants no longer meets study criteria|0|||
157201654|NCT03110107|567483431|FG022|Treatment Period|Participants no longer meets study criteria|0|||
157243753|NCT00112437|567636850|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157201655|NCT03110107|567483432|FG023|Treatment Period|Participants no longer meets study criteria|1|||
157201656|NCT03110107|567483433|FG024|Treatment Period|Participants no longer meets study criteria|0|||
157201657|NCT03110107|567483434|FG025|Treatment Period|Participants no longer meets study criteria|0|||
157201658|NCT03110107|567483409|FG000|Treatment Period|Other Reasons|0|||
157201659|NCT03110107|567483410|FG001|Treatment Period|Other Reasons|0|||
157201660|NCT03110107|567483411|FG002|Treatment Period|Other Reasons|1|||
157201661|NCT03110107|567483412|FG003|Treatment Period|Other Reasons|1|||
157201662|NCT03110107|567483413|FG004|Treatment Period|Other Reasons|0|||
157201663|NCT03110107|567483414|FG005|Treatment Period|Other Reasons|1|||
157201664|NCT03110107|567483415|FG006|Treatment Period|Other Reasons|0|||
157201665|NCT03110107|567483416|FG007|Treatment Period|Other Reasons|0|||
157201666|NCT03110107|567483417|FG008|Treatment Period|Other Reasons|0|||
157201667|NCT03110107|567483418|FG009|Treatment Period|Other Reasons|0|||
157201668|NCT03110107|567483419|FG010|Treatment Period|Other Reasons|0|||
157201669|NCT03110107|567483420|FG011|Treatment Period|Other Reasons|0|||
157201670|NCT03110107|567483421|FG012|Treatment Period|Other Reasons|0|||
157201671|NCT03110107|567483422|FG013|Treatment Period|Other Reasons|0|||
157201672|NCT03110107|567483423|FG014|Treatment Period|Other Reasons|0|||
157201673|NCT03110107|567483424|FG015|Treatment Period|Other Reasons|0|||
157201674|NCT03110107|567483425|FG016|Treatment Period|Other Reasons|0|||
157201675|NCT03110107|567483426|FG017|Treatment Period|Other Reasons|0|||
157201676|NCT03110107|567483427|FG018|Treatment Period|Other Reasons|0|||
157201677|NCT03110107|567483428|FG019|Treatment Period|Other Reasons|0|||
157201678|NCT03110107|567483429|FG020|Treatment Period|Other Reasons|0|||
157201679|NCT03110107|567483430|FG021|Treatment Period|Other Reasons|0|||
157201680|NCT03110107|567483431|FG022|Treatment Period|Other Reasons|0|||
157201681|NCT03110107|567483432|FG023|Treatment Period|Other Reasons|0|||
157201682|NCT03110107|567483433|FG024|Treatment Period|Other Reasons|1|||
157201683|NCT03110107|567483434|FG025|Treatment Period|Other Reasons|0|||
157201684|NCT03927989|567483438|FG000|Overall Study|Withdrawal by Subject|0|||
157201685|NCT03927989|567483439|FG001|Overall Study|Withdrawal by Subject|1|||
157201686|NCT01308476|567483443|FG000|Overall Study|Lost to Follow-up|2|||
157201687|NCT01308476|567483444|FG001|Overall Study|Lost to Follow-up|2|||
157201688|NCT01308476|567483443|FG000|Overall Study|Other|1|||
157201689|NCT01308476|567483444|FG001|Overall Study|Other|0|||
157201690|NCT03772574|567483445|FG000|Overall Study|Protocol Violation|2|||
157201691|NCT03772574|567483446|FG001|Overall Study|Protocol Violation|0|||
157201692|NCT03772574|567483447|FG002|Overall Study|Protocol Violation|0|||
157243754|NCT00112437|567636851|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243755|NCT00112437|567636852|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243756|NCT00112437|567636853|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243757|NCT00112437|567636854|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243758|NCT00112437|567636855|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243759|NCT00112437|567636856|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243760|NCT00112437|567636857|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243761|NCT00112437|567636858|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243762|NCT00112437|567636859|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243763|NCT00112437|567636860|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243764|NCT00112437|567636861|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
157243765|NCT00112437|567636862|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243766|NCT00112437|567636863|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243767|NCT00112437|567636864|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243768|NCT00112437|567636865|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
157243769|NCT00112437|567636840|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243770|NCT00112437|567636841|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243771|NCT00112437|567636842|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243772|NCT00112437|567636843|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
157201693|NCT03772574|567483445|FG000|Overall Study|Discomfort|0|||
157201694|NCT03772574|567483446|FG001|Overall Study|Discomfort|5|||
157201695|NCT03772574|567483447|FG002|Overall Study|Discomfort|4|||
157201696|NCT00505765|567483451|FG000|Overall Study|Withdrawal by Subject|1|||
157201697|NCT00505765|567483452|FG001|Overall Study|Withdrawal by Subject|0|||
157201698|NCT00505765|567483453|FG002|Overall Study|Withdrawal by Subject|0|||
157243773|NCT00112437|567636844|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243774|NCT00112437|567636845|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
157201699|NCT00505765|567483451|FG000|Overall Study|Adverse Event|1|||
157243775|NCT00112437|567636846|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
157201700|NCT00505765|567483452|FG001|Overall Study|Adverse Event|2|||
157201701|NCT00505765|567483453|FG002|Overall Study|Adverse Event|0|||
157201702|NCT00505765|567483451|FG000|Overall Study|Noncompliance|0|||
157201703|NCT00505765|567483452|FG001|Overall Study|Noncompliance|1|||
157201704|NCT00505765|567483453|FG002|Overall Study|Noncompliance|3|||
157201705|NCT01207219|567483455|FG000|Overall Study|changed diagnosis during study period|5|||
157243776|NCT00112437|567636847|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243777|NCT00112437|567636848|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
157201706|NCT01207219|567483456|FG001|Overall Study|changed diagnosis during study period|3|||
157201707|NCT01207219|567483457|FG002|Overall Study|changed diagnosis during study period|1|||
157201708|NCT01207219|567483455|FG000|Overall Study|Lost to Follow-up|6|||
157201709|NCT01207219|567483456|FG001|Overall Study|Lost to Follow-up|8|||
157201710|NCT01207219|567483457|FG002|Overall Study|Lost to Follow-up|6|||
157201711|NCT01012609|567483458|FG000|Overall Study|Withdrawal by Subject|1|||
157201712|NCT01012609|567483459|FG001|Overall Study|Withdrawal by Subject|1|||
157201713|NCT01453296|567483460|FG000|Treatment Period 1|Adverse Event|0|||
157201714|NCT01453296|567483461|FG001|Treatment Period 1|Adverse Event|1|||
157201715|NCT01453296|567483460|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
157201716|NCT01453296|567483461|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
157201717|NCT01453296|567483460|FG000|Treatment Period 2|Adverse Event|1|||
157201718|NCT01453296|567483461|FG001|Treatment Period 2|Adverse Event|0|||
157201719|NCT01453296|567483460|FG000|Treatment Period 2|Withdrawal by Subject|1|||
157201720|NCT01453296|567483461|FG001|Treatment Period 2|Withdrawal by Subject|0|||
157201721|NCT00620776|567483462|FG000|Overall Study|Did not receive treatment|3|||
157201722|NCT00620776|567483463|FG001|Overall Study|Did not receive treatment|5|||
157201723|NCT00620776|567483462|FG000|Overall Study|Adverse Event|2|||
157201724|NCT00620776|567483463|FG001|Overall Study|Adverse Event|3|||
157201725|NCT00620776|567483462|FG000|Overall Study|Lack of Efficacy|2|||
157201726|NCT00620776|567483463|FG001|Overall Study|Lack of Efficacy|1|||
157201727|NCT00620776|567483462|FG000|Overall Study|Lost to Follow-up|2|||
157201728|NCT00620776|567483463|FG001|Overall Study|Lost to Follow-up|5|||
157201729|NCT00620776|567483462|FG000|Overall Study|Withdrawal by Subject|3|||
157201730|NCT00620776|567483463|FG001|Overall Study|Withdrawal by Subject|2|||
157201731|NCT00924820|567483464|FG000|Overall Study|Death|2|||
157201732|NCT00924820|567483464|FG000|Overall Study|Ineligible, Screen Failure|5|||
157201733|NCT04983589|567483465|FG000|Overall Study|Withdrawal by Subject|0|||
157201734|NCT04983589|567483466|FG001|Overall Study|Withdrawal by Subject|3|||
157201735|NCT04983589|567483465|FG000|Overall Study|COVID-19 Infection|1|||
157201736|NCT04983589|567483466|FG001|Overall Study|COVID-19 Infection|0|||
157201737|NCT04983589|567483465|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
157201738|NCT04983589|567483466|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
157201739|NCT00761969|567483467|FG000|Overall Study|Death|112|||
157201740|NCT00761969|567483468|FG001|Overall Study|Death|47|||
157201741|NCT00761969|567483467|FG000|Overall Study|Lost to Follow-up|88|||
157201742|NCT00761969|567483468|FG001|Overall Study|Lost to Follow-up|93|||
157201743|NCT01725217|567483469|FG000|Overall Study|Withdrawal by Subject|1|||
157201744|NCT01725217|567483470|FG001|Overall Study|Withdrawal by Subject|0|||
157201745|NCT01725217|567483471|FG002|Overall Study|Withdrawal by Subject|0|||
157201746|NCT00585468|567483472|FG000|First Intervention|Withdrawal by Subject|1|||
157201747|NCT00585468|567483473|FG001|First Intervention|Withdrawal by Subject|1|||
157201748|NCT03155269|567483476|FG000|Overall Study|Withdrawal by Subject|4|||
157201749|NCT03155269|567483477|FG001|Overall Study|Withdrawal by Subject|5|||
157201750|NCT03155269|567483476|FG000|Overall Study|Lost to Follow-up|1|||
157201751|NCT03155269|567483477|FG001|Overall Study|Lost to Follow-up|2|||
157201752|NCT03919669|567483478|FG000|Overall Study|Withdrawal by Subject|1|||
157201753|NCT03919669|567483479|FG001|Overall Study|Withdrawal by Subject|0|||
157201754|NCT03919669|567483480|FG002|Overall Study|Withdrawal by Subject|0|||
157201755|NCT02686749|567483481|FG000|Overall Study|terminated for poor enrollment|2|||
157201756|NCT02686749|567483482|FG001|Overall Study|terminated for poor enrollment|2|||
157201757|NCT02319642|567483485|FG000|Overall Study|Adverse Event|2|||
157201758|NCT02319642|567483486|FG001|Overall Study|Adverse Event|4|||
157201759|NCT02319642|567483485|FG000|Overall Study|Lack of Efficacy|1|||
157201760|NCT02319642|567483486|FG001|Overall Study|Lack of Efficacy|1|||
157201761|NCT02319642|567483485|FG000|Overall Study|Withdrawal by Subject|1|||
157201762|NCT02319642|567483486|FG001|Overall Study|Withdrawal by Subject|1|||
157201763|NCT04409509|567483487|FG000|Overall Study|Failure to meet randomization requirement|1|||
157201764|NCT04409509|567483488|FG001|Overall Study|Failure to meet randomization requirement|0|||
157201765|NCT04409509|567483487|FG000|Overall Study|Adverse Event|0|||
157201766|NCT04409509|567483488|FG001|Overall Study|Adverse Event|1|||
157201767|NCT04409509|567483487|FG000|Overall Study|Death|11|||
157201768|NCT04409509|567483488|FG001|Overall Study|Death|10|||
157201769|NCT04409509|567483487|FG000|Overall Study|Non-compliance with study drug|0|||
157201770|NCT04409509|567483488|FG001|Overall Study|Non-compliance with study drug|1|||
157201771|NCT04409509|567483487|FG000|Overall Study|Lost to Follow-up|0|||
157201772|NCT04409509|567483488|FG001|Overall Study|Lost to Follow-up|3|||
157201773|NCT04409509|567483487|FG000|Overall Study|Withdrawal by Subject|0|||
157201774|NCT04409509|567483488|FG001|Overall Study|Withdrawal by Subject|3|||
157201775|NCT04409509|567483487|FG000|Overall Study|Randomized by mistake|0|||
157201776|NCT04409509|567483488|FG001|Overall Study|Randomized by mistake|1|||
157201777|NCT04409509|567483487|FG000|Overall Study|Other|1|||
157201778|NCT04409509|567483488|FG001|Overall Study|Other|1|||
157201779|NCT00483119|567483489|FG000|Overall Study|Adverse Event|0|||
157201780|NCT00483119|567483490|FG001|Overall Study|Adverse Event|1|||
157201781|NCT00483119|567483489|FG000|Overall Study|Physician Decision|1|||
157201782|NCT00483119|567483490|FG001|Overall Study|Physician Decision|0|||
157201783|NCT04668066|567483491|FG000|Part 1: Treatment Phase|Adverse Event|0|||
157201784|NCT04668066|567483492|FG001|Part 1: Treatment Phase|Adverse Event|0|||
157201785|NCT04668066|567483493|FG002|Part 1: Treatment Phase|Adverse Event|0|||
157201786|NCT04668066|567483494|FG003|Part 1: Treatment Phase|Adverse Event|0|||
157201787|NCT04668066|567483495|FG004|Part 1: Treatment Phase|Adverse Event|0|||
157201788|NCT04668066|567483496|FG005|Part 1: Treatment Phase|Adverse Event|0|||
157201789|NCT04668066|567483497|FG006|Part 1: Treatment Phase|Adverse Event|0|||
157201790|NCT04668066|567483498|FG007|Part 1: Treatment Phase|Adverse Event|0|||
157201791|NCT04668066|567483499|FG008|Part 1: Treatment Phase|Adverse Event|0|||
157201792|NCT04668066|567483500|FG009|Part 1: Treatment Phase|Adverse Event|0|||
157201793|NCT04668066|567483501|FG010|Part 1: Treatment Phase|Adverse Event|0|||
157201794|NCT04668066|567483502|FG011|Part 1: Treatment Phase|Adverse Event|1|||
157201795|NCT04668066|567483503|FG012|Part 1: Treatment Phase|Adverse Event|1|||
157243778|NCT00112437|567636849|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243779|NCT00112437|567636850|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243780|NCT00112437|567636851|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243781|NCT00112437|567636852|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243782|NCT00112437|567636853|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243783|NCT00112437|567636854|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243784|NCT00112437|567636855|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243785|NCT00112437|567636856|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243786|NCT00112437|567636857|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243787|NCT00112437|567636858|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243788|NCT00112437|567636859|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243789|NCT00112437|567636860|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243790|NCT00112437|567636861|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
157243791|NCT00112437|567636862|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243792|NCT00112437|567636863|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243793|NCT00112437|567636864|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243794|NCT00112437|567636865|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
157243795|NCT00112437|567636840|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243796|NCT00112437|567636841|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243797|NCT00112437|567636842|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243798|NCT00112437|567636843|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243799|NCT00112437|567636844|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243800|NCT00112437|567636845|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243801|NCT00112437|567636846|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243802|NCT00112437|567636847|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243803|NCT00112437|567636848|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243804|NCT00112437|567636849|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243805|NCT00112437|567636850|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243806|NCT00112437|567636851|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243807|NCT00112437|567636852|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243808|NCT00112437|567636853|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243809|NCT00112437|567636854|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243810|NCT00112437|567636855|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243811|NCT00112437|567636856|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243812|NCT00112437|567636857|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243813|NCT00112437|567636858|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243814|NCT00112437|567636859|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243815|NCT00112437|567636860|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
157243816|NCT00112437|567636861|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
157201796|NCT04668066|567483504|FG013|Part 1: Treatment Phase|Adverse Event|0|||
157201797|NCT04668066|567483505|FG014|Part 1: Treatment Phase|Adverse Event|0|||
157201798|NCT04668066|567483506|FG015|Part 1: Treatment Phase|Adverse Event|0|||
157201799|NCT04668066|567483507|FG016|Part 1: Treatment Phase|Adverse Event|0|||
157201800|NCT04668066|567483508|FG017|Part 1: Treatment Phase|Adverse Event|0|||
157243817|NCT00112437|567636862|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243818|NCT00112437|567636863|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243819|NCT00112437|567636864|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243820|NCT00112437|567636865|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
157243821|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243822|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157201801|NCT04668066|567483509|FG018|Part 1: Treatment Phase|Adverse Event|0|||
157201802|NCT04668066|567483491|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201803|NCT04668066|567483492|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201804|NCT04668066|567483493|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
157201805|NCT04668066|567483494|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
157243823|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243824|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157201806|NCT04668066|567483495|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201807|NCT04668066|567483496|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201808|NCT04668066|567483497|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201809|NCT04668066|567483498|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201810|NCT04668066|567483499|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201811|NCT04668066|567483500|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201812|NCT04668066|567483501|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201813|NCT04668066|567483502|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201814|NCT04668066|567483503|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201815|NCT04668066|567483504|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201816|NCT04668066|567483505|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201817|NCT04668066|567483506|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201818|NCT04668066|567483507|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201819|NCT04668066|567483508|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201820|NCT04668066|567483509|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
157201821|NCT04668066|567483491|FG000|Part 1: Treatment Phase|Other|0|||
157201822|NCT04668066|567483492|FG001|Part 1: Treatment Phase|Other|0|||
157201823|NCT04668066|567483493|FG002|Part 1: Treatment Phase|Other|0|||
157201824|NCT04668066|567483494|FG003|Part 1: Treatment Phase|Other|0|||
157201825|NCT04668066|567483495|FG004|Part 1: Treatment Phase|Other|0|||
157201826|NCT04668066|567483496|FG005|Part 1: Treatment Phase|Other|0|||
157201827|NCT04668066|567483497|FG006|Part 1: Treatment Phase|Other|0|||
157201828|NCT04668066|567483498|FG007|Part 1: Treatment Phase|Other|0|||
157201829|NCT04668066|567483499|FG008|Part 1: Treatment Phase|Other|0|||
157201830|NCT04668066|567483500|FG009|Part 1: Treatment Phase|Other|0|||
157201831|NCT04668066|567483501|FG010|Part 1: Treatment Phase|Other|0|||
157201832|NCT04668066|567483502|FG011|Part 1: Treatment Phase|Other|1|||
157201833|NCT04668066|567483503|FG012|Part 1: Treatment Phase|Other|0|||
157201834|NCT04668066|567483504|FG013|Part 1: Treatment Phase|Other|0|||
157201835|NCT04668066|567483505|FG014|Part 1: Treatment Phase|Other|0|||
157201836|NCT04668066|567483506|FG015|Part 1: Treatment Phase|Other|0|||
157201837|NCT04668066|567483507|FG016|Part 1: Treatment Phase|Other|0|||
157201838|NCT04668066|567483508|FG017|Part 1: Treatment Phase|Other|0|||
157201839|NCT04668066|567483509|FG018|Part 1: Treatment Phase|Other|0|||
157201840|NCT04668066|567483491|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201841|NCT04668066|567483492|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201842|NCT04668066|567483493|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201843|NCT04668066|567483494|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201844|NCT04668066|567483495|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201845|NCT04668066|567483496|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201846|NCT04668066|567483497|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201847|NCT04668066|567483498|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201848|NCT04668066|567483499|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201849|NCT04668066|567483500|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201850|NCT04668066|567483501|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201851|NCT04668066|567483502|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201852|NCT04668066|567483503|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
157201853|NCT04668066|567483504|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201854|NCT04668066|567483505|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201855|NCT04668066|567483506|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
157201856|NCT04668066|567483507|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201857|NCT04668066|567483508|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201858|NCT04668066|567483509|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
157201859|NCT04668066|567483491|FG000|Part 1: Follow-Up|Adverse Event|0|||
157201860|NCT04668066|567483492|FG001|Part 1: Follow-Up|Adverse Event|0|||
157201861|NCT04668066|567483493|FG002|Part 1: Follow-Up|Adverse Event|0|||
157201862|NCT04668066|567483494|FG003|Part 1: Follow-Up|Adverse Event|0|||
157201863|NCT04668066|567483495|FG004|Part 1: Follow-Up|Adverse Event|0|||
157201864|NCT04668066|567483496|FG005|Part 1: Follow-Up|Adverse Event|0|||
157201865|NCT04668066|567483497|FG006|Part 1: Follow-Up|Adverse Event|0|||
157201866|NCT04668066|567483498|FG007|Part 1: Follow-Up|Adverse Event|0|||
157201867|NCT04668066|567483499|FG008|Part 1: Follow-Up|Adverse Event|0|||
157201868|NCT04668066|567483500|FG009|Part 1: Follow-Up|Adverse Event|0|||
157201869|NCT04668066|567483501|FG010|Part 1: Follow-Up|Adverse Event|0|||
157201870|NCT04668066|567483502|FG011|Part 1: Follow-Up|Adverse Event|1|||
157201871|NCT04668066|567483503|FG012|Part 1: Follow-Up|Adverse Event|0|||
157201872|NCT04668066|567483504|FG013|Part 1: Follow-Up|Adverse Event|0|||
157201873|NCT04668066|567483505|FG014|Part 1: Follow-Up|Adverse Event|0|||
157201874|NCT04668066|567483506|FG015|Part 1: Follow-Up|Adverse Event|0|||
157201875|NCT04668066|567483507|FG016|Part 1: Follow-Up|Adverse Event|0|||
157201876|NCT04668066|567483508|FG017|Part 1: Follow-Up|Adverse Event|0|||
157201877|NCT04668066|567483509|FG018|Part 1: Follow-Up|Adverse Event|0|||
157201878|NCT04668066|567483491|FG000|Part 1: Follow-Up|Other|0|||
157201879|NCT04668066|567483492|FG001|Part 1: Follow-Up|Other|0|||
157201880|NCT04668066|567483493|FG002|Part 1: Follow-Up|Other|0|||
157201881|NCT04668066|567483494|FG003|Part 1: Follow-Up|Other|0|||
157201882|NCT04668066|567483495|FG004|Part 1: Follow-Up|Other|0|||
157243825|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243826|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243827|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243828|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243829|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243830|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243831|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243832|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243833|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243834|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243835|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243836|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243837|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243838|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243839|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243840|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243841|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243842|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243843|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
157243844|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
157243845|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
157243846|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
157243847|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Death|0|||
157243848|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Death|0|||
157243849|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Death|0|||
157243850|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Death|0|||
157243851|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Death|0|||
157243852|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Death|0|||
157243853|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Death|0|||
157243854|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Death|0|||
157243855|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Death|0|||
157243856|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Death|0|||
157243857|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Death|0|||
157243858|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Death|0|||
157243859|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Death|0|||
157243860|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Death|0|||
157243861|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Death|0|||
157243862|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Death|0|||
157243863|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Death|0|||
157243864|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Death|0|||
157243865|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Death|0|||
157243866|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Death|0|||
157243867|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Death|0|||
157243868|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Death|0|||
157243869|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Death|0|||
157243870|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Death|2|||
157243871|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Death|0|||
157243872|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Death|0|||
157243873|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243874|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243875|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243876|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243877|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243878|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243879|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157201883|NCT04668066|567483496|FG005|Part 1: Follow-Up|Other|0|||
157201884|NCT04668066|567483497|FG006|Part 1: Follow-Up|Other|0|||
157201885|NCT04668066|567483498|FG007|Part 1: Follow-Up|Other|0|||
157201886|NCT04668066|567483499|FG008|Part 1: Follow-Up|Other|0|||
157201887|NCT04668066|567483500|FG009|Part 1: Follow-Up|Other|0|||
157201888|NCT04668066|567483501|FG010|Part 1: Follow-Up|Other|0|||
157201889|NCT04668066|567483502|FG011|Part 1: Follow-Up|Other|1|||
157201890|NCT04668066|567483503|FG012|Part 1: Follow-Up|Other|1|||
157243880|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243881|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243882|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243883|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243884|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243885|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157201891|NCT04668066|567483504|FG013|Part 1: Follow-Up|Other|0|||
157201892|NCT04668066|567483505|FG014|Part 1: Follow-Up|Other|0|||
157201893|NCT04668066|567483506|FG015|Part 1: Follow-Up|Other|0|||
157201894|NCT04668066|567483507|FG016|Part 1: Follow-Up|Other|0|||
157201895|NCT04668066|567483508|FG017|Part 1: Follow-Up|Other|0|||
157201896|NCT04668066|567483509|FG018|Part 1: Follow-Up|Other|0|||
157201897|NCT04668066|567483491|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201898|NCT04668066|567483492|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201899|NCT04668066|567483493|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
157243886|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243887|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243888|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243889|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243890|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243891|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243892|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243893|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243894|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243895|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243896|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243897|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
157243898|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
157243899|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Other|0|||
157243900|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Other|0|||
157243901|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Other|0|||
157243902|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Other|0|||
157243903|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Other|0|||
157243904|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Other|0|||
157243905|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Other|0|||
157243906|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Other|0|||
157243907|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Other|0|||
157243908|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Other|0|||
157243909|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Other|0|||
157243910|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Other|0|||
157201900|NCT04668066|567483494|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201901|NCT04668066|567483495|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201902|NCT04668066|567483496|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201903|NCT04668066|567483497|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201904|NCT04668066|567483498|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201905|NCT04668066|567483499|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201906|NCT04668066|567483500|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201907|NCT04668066|567483501|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201908|NCT04668066|567483502|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201909|NCT04668066|567483503|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
157201910|NCT04668066|567483504|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201911|NCT04668066|567483505|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201912|NCT04668066|567483506|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
157201913|NCT04668066|567483507|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201914|NCT04668066|567483508|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201915|NCT04668066|567483509|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
157201916|NCT04668066|567483491|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201917|NCT04668066|567483492|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201918|NCT04668066|567483493|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201919|NCT04668066|567483494|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201920|NCT04668066|567483495|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201921|NCT04668066|567483496|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201922|NCT04668066|567483497|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201923|NCT04668066|567483498|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201924|NCT04668066|567483499|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201925|NCT04668066|567483500|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201926|NCT04668066|567483501|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201927|NCT04668066|567483502|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201928|NCT04668066|567483503|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201929|NCT04668066|567483504|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201930|NCT04668066|567483505|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201931|NCT04668066|567483506|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201932|NCT04668066|567483507|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201933|NCT04668066|567483508|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
157201934|NCT04668066|567483509|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
157243911|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Other|0|||
157243912|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Other|0|||
157243913|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Other|0|||
157243914|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Other|0|||
157243915|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Other|0|||
157243916|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Other|0|||
157201935|NCT04668066|567483491|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201936|NCT04668066|567483492|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201937|NCT04668066|567483493|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
157243917|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Other|0|||
157243918|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Other|0|||
157243919|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Other|0|||
157243920|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Other|0|||
157243921|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Other|0|||
157243922|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Other|0|||
157243923|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Other|1|||
157243924|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Other|0|||
157243925|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243926|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243927|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243928|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243929|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243930|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243931|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243932|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243933|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243934|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243935|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243936|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243937|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243938|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243939|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243940|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243941|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243942|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243943|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243944|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243945|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243946|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243947|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243948|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
157243949|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243950|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
157243951|NCT00112437|567636840|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243952|NCT00112437|567636841|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243953|NCT00112437|567636842|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243954|NCT00112437|567636843|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243955|NCT00112437|567636844|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243956|NCT00112437|567636845|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243957|NCT00112437|567636846|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243958|NCT00112437|567636847|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243959|NCT00112437|567636848|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243960|NCT00112437|567636849|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243961|NCT00112437|567636850|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243962|NCT00112437|567636851|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243963|NCT00112437|567636852|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243964|NCT00112437|567636853|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243965|NCT00112437|567636854|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243966|NCT00112437|567636855|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243967|NCT00112437|567636856|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243968|NCT00112437|567636857|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243969|NCT00112437|567636858|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243970|NCT00112437|567636859|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243971|NCT00112437|567636860|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243972|NCT00112437|567636861|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243973|NCT00112437|567636862|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
157243974|NCT00112437|567636863|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
157243975|NCT00112437|567636864|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
157243976|NCT00112437|567636865|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
157243977|NCT01824576|567636868|FG000|Overall Study|Device deficiency|2|||
157243978|NCT00436163|567636869|FG000|Overall Study|Lost to Follow-up|2|||
157243979|NCT00436163|567636869|FG000|Overall Study|Adverse Event|1|||
157243980|NCT02896296|567636870|FG000|Overall Study|Adverse Event|1|||
157243981|NCT02896296|567636870|FG000|Overall Study|Lost to Follow-up|19|||
157243982|NCT02896296|567636870|FG000|Overall Study|Pregnancy|1|||
157243983|NCT02896296|567636870|FG000|Overall Study|Physician Decision|2|||
157243984|NCT02896296|567636870|FG000|Overall Study|Withdrawal by Subject|10|||
157243985|NCT02896296|567636870|FG000|Overall Study|Site closing|7|||
157243986|NCT02896296|567636870|FG000|Overall Study|Incarceration|1|||
157243987|NCT02896296|567636870|FG000|Overall Study|Relocation|1|||
157243988|NCT02597049|567636871|FG000|Overall Study|Lost to Follow-up|0|||
157243989|NCT02597049|567636872|FG001|Overall Study|Lost to Follow-up|3|||
157243990|NCT02597049|567636873|FG002|Overall Study|Lost to Follow-up|2|||
157243991|NCT02597049|567636871|FG000|Overall Study|Withdrawal by Subject|2|||
157243992|NCT02597049|567636872|FG001|Overall Study|Withdrawal by Subject|2|||
157243993|NCT02597049|567636873|FG002|Overall Study|Withdrawal by Subject|1|||
157243994|NCT02597049|567636871|FG000|Overall Study|Adverse Event|2|||
157243995|NCT02597049|567636872|FG001|Overall Study|Adverse Event|0|||
157243996|NCT02597049|567636873|FG002|Overall Study|Adverse Event|0|||
157243997|NCT02597049|567636871|FG000|Overall Study|Death|2|||
157243998|NCT02597049|567636872|FG001|Overall Study|Death|0|||
157243999|NCT02597049|567636873|FG002|Overall Study|Death|0|||
157244000|NCT02597049|567636871|FG000|Overall Study|Noncompliant with Study Visits|1|||
157244001|NCT02597049|567636872|FG001|Overall Study|Noncompliant with Study Visits|0|||
157244002|NCT02597049|567636873|FG002|Overall Study|Noncompliant with Study Visits|0|||
157244003|NCT02923349|567636877|FG000|Overall Study|Other|1|||
157244004|NCT02923349|567636878|FG001|Overall Study|Other|2|||
157244005|NCT02923349|567636879|FG002|Overall Study|Other|4|||
157244006|NCT02923349|567636880|FG003|Overall Study|Other|1|||
157244007|NCT02923349|567636881|FG004|Overall Study|Other|3|||
157244008|NCT02923349|567636882|FG005|Overall Study|Other|0|||
157244009|NCT02923349|567636883|FG006|Overall Study|Other|1|||
157244010|NCT02923349|567636877|FG000|Overall Study|Withdrawal by Subject|2|||
157244011|NCT02923349|567636878|FG001|Overall Study|Withdrawal by Subject|2|||
157244012|NCT02923349|567636879|FG002|Overall Study|Withdrawal by Subject|8|||
157244013|NCT02923349|567636880|FG003|Overall Study|Withdrawal by Subject|10|||
157244014|NCT02923349|567636881|FG004|Overall Study|Withdrawal by Subject|12|||
157201938|NCT04668066|567483494|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201939|NCT04668066|567483495|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201940|NCT04668066|567483496|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201941|NCT04668066|567483497|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201942|NCT04668066|567483498|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201943|NCT04668066|567483499|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201944|NCT04668066|567483500|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201945|NCT04668066|567483501|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201946|NCT04668066|567483502|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201947|NCT04668066|567483503|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201948|NCT04668066|567483504|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201949|NCT04668066|567483505|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201950|NCT04668066|567483506|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201951|NCT04668066|567483507|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201952|NCT04668066|567483508|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
157201953|NCT04668066|567483509|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
157201954|NCT04668066|567483491|FG000|Part 2: Treatment Phase|Other|0|||
157201955|NCT04668066|567483492|FG001|Part 2: Treatment Phase|Other|0|||
157201956|NCT04668066|567483493|FG002|Part 2: Treatment Phase|Other|0|||
157201957|NCT04668066|567483494|FG003|Part 2: Treatment Phase|Other|0|||
157201958|NCT04668066|567483495|FG004|Part 2: Treatment Phase|Other|0|||
157201959|NCT04668066|567483496|FG005|Part 2: Treatment Phase|Other|0|||
157201960|NCT04668066|567483497|FG006|Part 2: Treatment Phase|Other|0|||
157201961|NCT04668066|567483498|FG007|Part 2: Treatment Phase|Other|0|||
157201962|NCT04668066|567483499|FG008|Part 2: Treatment Phase|Other|0|||
157201963|NCT04668066|567483500|FG009|Part 2: Treatment Phase|Other|0|||
157201964|NCT04668066|567483501|FG010|Part 2: Treatment Phase|Other|0|||
157201965|NCT04668066|567483502|FG011|Part 2: Treatment Phase|Other|0|||
157201966|NCT04668066|567483503|FG012|Part 2: Treatment Phase|Other|0|||
157201967|NCT04668066|567483504|FG013|Part 2: Treatment Phase|Other|0|||
157201968|NCT04668066|567483505|FG014|Part 2: Treatment Phase|Other|0|||
157201969|NCT04668066|567483506|FG015|Part 2: Treatment Phase|Other|0|||
157201970|NCT04668066|567483507|FG016|Part 2: Treatment Phase|Other|0|||
157201971|NCT04668066|567483508|FG017|Part 2: Treatment Phase|Other|0|||
157201972|NCT04668066|567483509|FG018|Part 2: Treatment Phase|Other|1|||
157201973|NCT04668066|567483491|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201974|NCT04668066|567483492|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201975|NCT04668066|567483493|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201976|NCT04668066|567483494|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
157244015|NCT02923349|567636882|FG005|Overall Study|Withdrawal by Subject|3|||
157201977|NCT04668066|567483495|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201978|NCT04668066|567483496|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201979|NCT04668066|567483497|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201980|NCT04668066|567483498|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201981|NCT04668066|567483499|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201982|NCT04668066|567483500|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
157244016|NCT02923349|567636883|FG006|Overall Study|Withdrawal by Subject|0|||
157244017|NCT02923349|567636877|FG000|Overall Study|Physician Decision|0|||
157244018|NCT02923349|567636878|FG001|Overall Study|Physician Decision|0|||
157244019|NCT02923349|567636879|FG002|Overall Study|Physician Decision|0|||
157244020|NCT02923349|567636880|FG003|Overall Study|Physician Decision|1|||
157244021|NCT02923349|567636881|FG004|Overall Study|Physician Decision|1|||
157244022|NCT02923349|567636882|FG005|Overall Study|Physician Decision|0|||
157244023|NCT02923349|567636883|FG006|Overall Study|Physician Decision|2|||
157244024|NCT02923349|567636877|FG000|Overall Study|Lost to Follow-up|0|||
157244025|NCT02923349|567636878|FG001|Overall Study|Lost to Follow-up|0|||
157244026|NCT02923349|567636879|FG002|Overall Study|Lost to Follow-up|3|||
157244027|NCT02923349|567636880|FG003|Overall Study|Lost to Follow-up|0|||
157244028|NCT02923349|567636881|FG004|Overall Study|Lost to Follow-up|1|||
157244029|NCT02923349|567636882|FG005|Overall Study|Lost to Follow-up|1|||
157244030|NCT02923349|567636883|FG006|Overall Study|Lost to Follow-up|0|||
157244031|NCT02923349|567636877|FG000|Overall Study|Death|1|||
157244032|NCT02923349|567636878|FG001|Overall Study|Death|0|||
157244033|NCT02923349|567636879|FG002|Overall Study|Death|2|||
157244034|NCT02923349|567636880|FG003|Overall Study|Death|4|||
157244035|NCT02923349|567636881|FG004|Overall Study|Death|2|||
157244036|NCT02923349|567636882|FG005|Overall Study|Death|3|||
157244037|NCT02923349|567636883|FG006|Overall Study|Death|0|||
157244038|NCT01120028|567636886|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
157244039|NCT01120028|567636887|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
157244040|NCT01120028|567636888|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
157244041|NCT01120028|567636889|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
157244042|NCT01120028|567636886|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
157244043|NCT01120028|567636887|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
157201983|NCT04668066|567483501|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
157244044|NCT01120028|567636888|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
157244045|NCT01120028|567636889|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
157244046|NCT03250117|567636890|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
157244047|NCT03250117|567636891|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
157244048|NCT03250117|567636892|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
157244049|NCT03250117|567636893|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
157244050|NCT04063878|567636894|FG000|Overall Study|Withdrawal by Subject|2|||
157244051|NCT04063878|567636894|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
157244052|NCT02751827|567636895|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
157244053|NCT02751827|567636896|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
157244054|NCT02751827|567636897|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
157244055|NCT00147498|567636898|FG000|Overall Study|Adverse Event|1|||
157244056|NCT00147498|567636899|FG001|Overall Study|Adverse Event|6|||
157244057|NCT00147498|567636900|FG002|Overall Study|Adverse Event|7|||
157244058|NCT00147498|567636901|FG003|Overall Study|Adverse Event|3|||
157244059|NCT00147498|567636898|FG000|Overall Study|Lack of Efficacy|1|||
157244060|NCT00147498|567636899|FG001|Overall Study|Lack of Efficacy|1|||
157201984|NCT04668066|567483502|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201985|NCT04668066|567483503|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201986|NCT04668066|567483504|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201987|NCT04668066|567483505|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201988|NCT04668066|567483506|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201989|NCT04668066|567483507|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201990|NCT04668066|567483508|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
157201991|NCT04668066|567483509|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
157201992|NCT02369874|567483510|FG000|Overall Study|Lost to Follow-up|2|||
157201993|NCT02369874|567483511|FG001|Overall Study|Lost to Follow-up|2|||
157201994|NCT02369874|567483512|FG002|Overall Study|Lost to Follow-up|2|||
157201995|NCT02369874|567483510|FG000|Overall Study|Withdrawal by Subject|7|||
157201996|NCT02369874|567483511|FG001|Overall Study|Withdrawal by Subject|9|||
157201997|NCT02369874|567483512|FG002|Overall Study|Withdrawal by Subject|27|||
157244061|NCT00147498|567636900|FG002|Overall Study|Lack of Efficacy|1|||
157244062|NCT00147498|567636901|FG003|Overall Study|Lack of Efficacy|8|||
157244063|NCT00147498|567636898|FG000|Overall Study|Laboratory abnormality|0|||
157244064|NCT00147498|567636899|FG001|Overall Study|Laboratory abnormality|0|||
157244065|NCT00147498|567636900|FG002|Overall Study|Laboratory abnormality|2|||
157244066|NCT00147498|567636901|FG003|Overall Study|Laboratory abnormality|0|||
157244067|NCT00147498|567636898|FG000|Overall Study|Participant defaulted|0|||
157244068|NCT00147498|567636899|FG001|Overall Study|Participant defaulted|1|||
157244069|NCT00147498|567636900|FG002|Overall Study|Participant defaulted|4|||
157244070|NCT00147498|567636901|FG003|Overall Study|Participant defaulted|3|||
157244071|NCT00147498|567636898|FG000|Overall Study|Other|1|||
157244072|NCT00147498|567636899|FG001|Overall Study|Other|1|||
157201998|NCT02369874|567483510|FG000|Overall Study|Miscellaneous|1|||
157201999|NCT02369874|567483511|FG001|Overall Study|Miscellaneous|1|||
157202000|NCT02369874|567483512|FG002|Overall Study|Miscellaneous|0|||
157202001|NCT02369874|567483510|FG000|Overall Study|On Treatment/Off Study|34|||
157202002|NCT02369874|567483511|FG001|Overall Study|On Treatment/Off Study|45|||
157202003|NCT02369874|567483512|FG002|Overall Study|On Treatment/Off Study|32|||
157202004|NCT02058849|567483513|FG000|Overall Study|Hospitalization|1|||
157202005|NCT02058849|567483514|FG001|Overall Study|Hospitalization|1|||
157202006|NCT02058849|567483513|FG000|Overall Study|Death|1|||
157202007|NCT02058849|567483514|FG001|Overall Study|Death|0|||
157202008|NCT02058849|567483513|FG000|Overall Study|Lost to Follow-up|1|||
157202009|NCT02058849|567483514|FG001|Overall Study|Lost to Follow-up|0|||
157202010|NCT02058849|567483513|FG000|Overall Study|Withdrawal by Subject|4|||
157202011|NCT02058849|567483514|FG001|Overall Study|Withdrawal by Subject|0|||
157202012|NCT02331680|567483515|FG000|Overall Study|Adverse Event|3|||
157202013|NCT02331680|567483516|FG001|Overall Study|Adverse Event|0|||
157202014|NCT02331680|567483517|FG002|Overall Study|Adverse Event|2|||
157202015|NCT02331680|567483515|FG000|Overall Study|Physician Decision|1|||
157202016|NCT02331680|567483516|FG001|Overall Study|Physician Decision|1|||
157202017|NCT02331680|567483517|FG002|Overall Study|Physician Decision|2|||
157202018|NCT02331680|567483515|FG000|Overall Study|Withdrawal by Subject|0|||
157202019|NCT02331680|567483516|FG001|Overall Study|Withdrawal by Subject|1|||
157202020|NCT02331680|567483517|FG002|Overall Study|Withdrawal by Subject|2|||
157202021|NCT02331680|567483515|FG000|Overall Study|Met withdrawal criteria|2|||
157202022|NCT02331680|567483516|FG001|Overall Study|Met withdrawal criteria|2|||
157202023|NCT02331680|567483517|FG002|Overall Study|Met withdrawal criteria|5|||
157202024|NCT02331680|567483515|FG000|Overall Study|Non-compliance with study drug|0|||
157202025|NCT02331680|567483516|FG001|Overall Study|Non-compliance with study drug|0|||
157202026|NCT02331680|567483517|FG002|Overall Study|Non-compliance with study drug|1|||
157202027|NCT02331680|567483515|FG000|Overall Study|Protocol Violation|0|||
157202028|NCT02331680|567483516|FG001|Overall Study|Protocol Violation|0|||
157202029|NCT02331680|567483517|FG002|Overall Study|Protocol Violation|3|||
157202030|NCT02219477|567483518|FG000|Overall Study|Adverse Event|0|||
157202031|NCT02219477|567483519|FG001|Overall Study|Adverse Event|1|||
157202032|NCT02219477|567483520|FG002|Overall Study|Adverse Event|1|||
157202033|NCT02219477|567483518|FG000|Overall Study|Withdrawal by Subject|0|||
157202034|NCT02219477|567483519|FG001|Overall Study|Withdrawal by Subject|1|||
157202035|NCT02219477|567483520|FG002|Overall Study|Withdrawal by Subject|0|||
157202036|NCT00596466|567483521|FG000|Overall Study|Lack of Efficacy|5|||
157202037|NCT00596466|567483521|FG000|Overall Study|Adverse Event|4|||
157202038|NCT00596466|567483521|FG000|Overall Study|Withdrawal by Subject|2|||
157202039|NCT00596466|567483521|FG000|Overall Study|Protocol Violation|2|||
157202040|NCT00596466|567483521|FG000|Overall Study|Unpecified|2|||
157202041|NCT00596466|567483521|FG000|Overall Study|Enrolled, not treated|2|||
157202042|NCT04505592|567483522|FG000|Overall Study|Death|2|||
157202043|NCT04505592|567483523|FG001|Overall Study|Death|1|||
157202044|NCT01015118|567483524|FG000|Overall Study|Protocol Violation|5|||
157202045|NCT01015118|567483525|FG001|Overall Study|Protocol Violation|6|||
157202046|NCT01015118|567483524|FG000|Overall Study|Withdrawal by Subject|103|||
157202047|NCT01015118|567483525|FG001|Overall Study|Withdrawal by Subject|27|||
157202048|NCT01015118|567483524|FG000|Overall Study|Other Adverse Event (AE)|141|||
157202049|NCT01015118|567483525|FG001|Overall Study|Other Adverse Event (AE)|33|||
157202050|NCT01015118|567483524|FG000|Overall Study|Worsening or AE of underlying disease|5|||
157202051|NCT01015118|567483525|FG001|Overall Study|Worsening or AE of underlying disease|4|||
157202052|NCT01015118|567483524|FG000|Overall Study|Progressive disease|364|||
157202053|NCT01015118|567483525|FG001|Overall Study|Progressive disease|229|||
157202054|NCT01015118|567483524|FG000|Overall Study|Not treated|9|||
157202055|NCT01015118|567483525|FG001|Overall Study|Not treated|5|||
157202056|NCT01015118|567483524|FG000|Overall Study|Other than stated above|42|||
157202057|NCT01015118|567483525|FG001|Overall Study|Other than stated above|23|||
157202058|NCT04784455|567483530|FG000|Overall Study|Death|4|||
157202059|NCT04298229|567483533|FG000|Overall Study|Physician Decision|1|||
157202060|NCT04298229|567483534|FG001|Overall Study|Physician Decision|1|||
157202061|NCT04298229|567483533|FG000|Overall Study|Withdrawal by Subject|1|||
157202062|NCT04298229|567483534|FG001|Overall Study|Withdrawal by Subject|1|||
157202063|NCT04298229|567483533|FG000|Overall Study|Did not receive IV loop diuretics|2|||
157202064|NCT04298229|567483534|FG001|Overall Study|Did not receive IV loop diuretics|0|||
157202065|NCT00262119|567483535|FG000|Overall Study|Lost to Follow-up|38|||
157202066|NCT00262119|567483536|FG001|Overall Study|Lost to Follow-up|51|||
157202067|NCT00262119|567483537|FG002|Overall Study|Lost to Follow-up|42|||
157244073|NCT00147498|567636900|FG002|Overall Study|Other|3|||
157202068|NCT00262119|567483535|FG000|Overall Study|Death|20|||
157202069|NCT00262119|567483536|FG001|Overall Study|Death|19|||
157202070|NCT00262119|567483537|FG002|Overall Study|Death|16|||
157202071|NCT00859313|567483538|FG000|Overall Study|Lack of Efficacy|2|||
157202072|NCT00859313|567483538|FG000|Overall Study|Adverse Event|1|||
157202073|NCT00859313|567483538|FG000|Overall Study|staff error|1|||
157202074|NCT00071006|567483539|FG000|Overall Study|Lack of Efficacy|7|||
157202075|NCT00071006|567483539|FG000|Overall Study|Adverse Event|1|||
157202076|NCT00071006|567483539|FG000|Overall Study|Withdrawal by Subject|1|||
157202077|NCT00071006|567483539|FG000|Overall Study|Other|3|||
157202078|NCT05261126|567483544|FG000|Overall Study|Death|0|||
157202079|NCT05261126|567483545|FG001|Overall Study|Death|0|||
157244074|NCT00147498|567636901|FG003|Overall Study|Other|3|||
157244075|NCT01229150|567636904|FG000|Overall Study|Toxicity|2|||
157244076|NCT01229150|567636905|FG001|Overall Study|Toxicity|2|||
157244077|NCT01229150|567636906|FG002|Overall Study|Toxicity|0|||
157244078|NCT01229150|567636907|FG003|Overall Study|Toxicity|0|||
157244079|NCT01473953|567636910|FG000|Overall Study|Other|1|||
157244080|NCT01473953|567636911|FG001|Overall Study|Other|0|||
157244081|NCT01473953|567636912|FG002|Overall Study|Other|0|||
157244082|NCT01473953|567636913|FG003|Overall Study|Other|0|||
157244083|NCT01473953|567636914|FG004|Overall Study|Other|0|||
157244084|NCT04633564|567636915|FG000|Period 1|Adverse Event|28|||
157244085|NCT04633564|567636916|FG001|Period 1|Adverse Event|19|||
157244086|NCT04633564|567636915|FG000|Period 1|Death|8|||
157244087|NCT04633564|567636916|FG001|Period 1|Death|7|||
157244088|NCT04633564|567636915|FG000|Period 1|Lost to Follow-up|3|||
157244089|NCT04633564|567636916|FG001|Period 1|Lost to Follow-up|5|||
157244090|NCT04633564|567636915|FG000|Period 1|Physician Decision|4|||
157244091|NCT04633564|567636916|FG001|Period 1|Physician Decision|12|||
157244092|NCT04633564|567636915|FG000|Period 1|Protocol Violation|0|||
157244093|NCT04633564|567636916|FG001|Period 1|Protocol Violation|1|||
157244094|NCT04633564|567636915|FG000|Period 1|Withdrawal by Subject|10|||
157244095|NCT04633564|567636916|FG001|Period 1|Withdrawal by Subject|8|||
157244096|NCT04633564|567636915|FG000|Period 1|Progressive disease|47|||
157244097|NCT04633564|567636916|FG001|Period 1|Progressive disease|51|||
157244098|NCT04633564|567636915|FG000|Period 1|Terminated by Sponsor|8|||
157244099|NCT04633564|567636916|FG001|Period 1|Terminated by Sponsor|6|||
157244100|NCT04633564|567636915|FG000|Period 2|Adverse Event|3|||
157244101|NCT04633564|567636916|FG001|Period 2|Adverse Event|4|||
157244102|NCT04633564|567636915|FG000|Period 2|Death|0|||
157244103|NCT04633564|567636916|FG001|Period 2|Death|2|||
157244104|NCT04633564|567636915|FG000|Period 2|Lost to Follow-up|0|||
157244105|NCT04633564|567636916|FG001|Period 2|Lost to Follow-up|1|||
157244106|NCT04633564|567636915|FG000|Period 2|Physician Decision|2|||
157244107|NCT04633564|567636916|FG001|Period 2|Physician Decision|4|||
157244108|NCT04633564|567636915|FG000|Period 2|Withdrawal by Subject|5|||
157244109|NCT04633564|567636916|FG001|Period 2|Withdrawal by Subject|1|||
157244110|NCT04633564|567636915|FG000|Period 2|Progressive Disease|74|||
157244111|NCT04633564|567636916|FG001|Period 2|Progressive Disease|82|||
157244112|NCT04633564|567636915|FG000|Period 2|Terminated by Sponsor|9|||
157244113|NCT04633564|567636916|FG001|Period 2|Terminated by Sponsor|3|||
157244114|NCT01279486|567636917|FG000|Overall Study|Lost to Follow-up|1|||
157244115|NCT04198363|567636920|FG000|Overall Study|Adverse Event|1|||
157244116|NCT04198363|567636921|FG001|Overall Study|Adverse Event|1|||
157244117|NCT04198363|567636920|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
157244118|NCT04198363|567636921|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
157244119|NCT04198363|567636920|FG000|Overall Study|Reason not Specified|1|||
157244120|NCT04198363|567636921|FG001|Overall Study|Reason not Specified|0|||
157244121|NCT03500094|567636927|FG000|Overall Study|Withdrawal by Subject|1|||
157244122|NCT03500094|567636927|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
157244123|NCT03500094|567636927|FG000|Overall Study|Lost to Follow-up|1|||
157244124|NCT03506633|567638845|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
157244125|NCT03506633|567638846|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
157244126|NCT00258856|567638850|FG000|Overall Study|Lost to Follow-up|1|||
157244127|NCT00258856|567638851|FG001|Overall Study|Lost to Follow-up|0|||
157244128|NCT00258856|567638852|FG002|Overall Study|Lost to Follow-up|2|||
157244129|NCT00258856|567638853|FG003|Overall Study|Lost to Follow-up|0|||
157244130|NCT00258856|567638850|FG000|Overall Study|Non-compliance|2|||
157244131|NCT00258856|567638851|FG001|Overall Study|Non-compliance|0|||
157244132|NCT00258856|567638852|FG002|Overall Study|Non-compliance|0|||
157244133|NCT00258856|567638853|FG003|Overall Study|Non-compliance|1|||
157244134|NCT03247686|567638854|FG000|Overall Study|Withdrawal by Subject|1|||
157244135|NCT03247686|567638855|FG001|Overall Study|Withdrawal by Subject|2|||
157244136|NCT02488109|567638861|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
157244137|NCT02488109|567638862|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
157244138|NCT02488109|567638861|FG000|12-month Follow-Up|Lost to Follow-up|4|||
157244139|NCT02488109|567638862|FG001|12-month Follow-Up|Lost to Follow-up|7|||
157244140|NCT02302716|567638863|FG000|Overall Study|Adverse Event|1|||
157244141|NCT02302716|567638864|FG001|Overall Study|Adverse Event|1|||
157244142|NCT02302716|567638863|FG000|Overall Study|Death|0|||
157244143|NCT02302716|567638864|FG001|Overall Study|Death|1|||
157244144|NCT02302716|567638863|FG000|Overall Study|Lack of Efficacy|0|||
157244145|NCT02302716|567638864|FG001|Overall Study|Lack of Efficacy|1|||
157244146|NCT02302716|567638863|FG000|Overall Study|Lost to Follow-up|2|||
157244147|NCT02302716|567638864|FG001|Overall Study|Lost to Follow-up|4|||
157244148|NCT02302716|567638863|FG000|Overall Study|Physician Decision|3|||
157244149|NCT02302716|567638864|FG001|Overall Study|Physician Decision|4|||
157244150|NCT02302716|567638863|FG000|Overall Study|Withdrawal by Subject|13|||
157244151|NCT02302716|567638864|FG001|Overall Study|Withdrawal by Subject|7|||
157244152|NCT02302716|567638863|FG000|Overall Study|Protocol Violation|0|||
157244153|NCT02302716|567638864|FG001|Overall Study|Protocol Violation|1|||
157244154|NCT00557245|567638872|FG000|Overall Study|Lost to Follow-up|7|||
157244155|NCT00557245|567638873|FG001|Overall Study|Lost to Follow-up|8|||
157244156|NCT00557245|567638874|FG002|Overall Study|Lost to Follow-up|10|||
157244157|NCT00557245|567638872|FG000|Overall Study|Ineligible|5|||
157244158|NCT00557245|567638873|FG001|Overall Study|Ineligible|4|||
157244159|NCT00557245|567638874|FG002|Overall Study|Ineligible|2|||
157244160|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Subject request|8|||
157244161|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Subject request|11|||
157244162|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
157244163|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
157244164|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
157244165|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
157244166|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
157244167|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
157244168|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
157244169|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
157244170|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
157244171|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
157244172|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Death|1|||
157244173|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Death|0|||
157244174|NCT00521586|567638878|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
157244175|NCT00521586|567638879|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
157244176|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
157244177|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
157244178|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
157244179|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
157244180|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
157202080|NCT05261126|567483546|FG002|Overall Study|Death|1|||
157202081|NCT05261126|567483547|FG003|Overall Study|Death|0|||
157202082|NCT05261126|567483548|FG004|Overall Study|Death|0|||
157202083|NCT05261126|567483544|FG000|Overall Study|Lost to Follow-up|0|||
157202084|NCT05261126|567483545|FG001|Overall Study|Lost to Follow-up|0|||
157202085|NCT05261126|567483546|FG002|Overall Study|Lost to Follow-up|0|||
157244181|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
157244182|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
157244183|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
157244184|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
157244185|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
157244186|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
157244187|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
157244188|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
157244189|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
157244190|NCT00521586|567638878|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
157244191|NCT00521586|567638879|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
157244192|NCT00521586|567638878|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
157244193|NCT00521586|567638879|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
157244194|NCT00521586|567638878|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
157244195|NCT00521586|567638879|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
157244196|NCT00521586|567638878|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
157244197|NCT00521586|567638879|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
157244198|NCT00828321|567638880|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
157244199|NCT00828321|567638881|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
157244200|NCT00828321|567638880|FG000|Second Intervention|Protocol Violation|0|||
157244201|NCT00828321|567638881|FG001|Second Intervention|Protocol Violation|1|||
157244202|NCT02997176|567638882|FG000|Overall Study|Adverse Event|0|||
157244203|NCT02997176|567638883|FG001|Overall Study|Adverse Event|0|||
157244204|NCT02997176|567638884|FG002|Overall Study|Adverse Event|0|||
157244205|NCT02997176|567638885|FG003|Overall Study|Adverse Event|8|||
157244206|NCT02997176|567638882|FG000|Overall Study|Progressive Disease|1|||
157244207|NCT02997176|567638883|FG001|Overall Study|Progressive Disease|0|||
157244208|NCT02997176|567638884|FG002|Overall Study|Progressive Disease|1|||
157202086|NCT05261126|567483547|FG003|Overall Study|Lost to Follow-up|0|||
157202087|NCT05261126|567483548|FG004|Overall Study|Lost to Follow-up|1|||
157202088|NCT05261126|567483544|FG000|Overall Study|Physician Decision|1|||
157202089|NCT05261126|567483545|FG001|Overall Study|Physician Decision|0|||
157202090|NCT05261126|567483546|FG002|Overall Study|Physician Decision|0|||
157244209|NCT02997176|567638885|FG003|Overall Study|Progressive Disease|1|||
157244210|NCT02997176|567638882|FG000|Overall Study|Death|0|||
157244211|NCT02997176|567638883|FG001|Overall Study|Death|0|||
157244212|NCT02997176|567638884|FG002|Overall Study|Death|1|||
157244213|NCT02997176|567638885|FG003|Overall Study|Death|1|||
157244214|NCT02997176|567638882|FG000|Overall Study|Withdrawal by Subject|0|||
157202091|NCT05261126|567483547|FG003|Overall Study|Physician Decision|0|||
157202092|NCT05261126|567483548|FG004|Overall Study|Physician Decision|0|||
157202093|NCT05261126|567483544|FG000|Overall Study|Screen Failure|0|||
157202094|NCT05261126|567483545|FG001|Overall Study|Screen Failure|0|||
157202095|NCT05261126|567483546|FG002|Overall Study|Screen Failure|0|||
157202096|NCT05261126|567483547|FG003|Overall Study|Screen Failure|0|||
157244215|NCT02997176|567638883|FG001|Overall Study|Withdrawal by Subject|2|||
157244216|NCT02997176|567638884|FG002|Overall Study|Withdrawal by Subject|0|||
157244217|NCT02997176|567638885|FG003|Overall Study|Withdrawal by Subject|1|||
157244218|NCT00691704|567638888|FG000|Induction Therapy|Disease Progression|1|||
157244219|NCT00691704|567638888|FG000|Induction Therapy|Active Hepatitis|1|||
157244220|NCT00691704|567638888|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
157244221|NCT00691704|567638888|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
157244222|NCT00691704|567638888|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
157244223|NCT02888756|567638890|FG000|Analytical Treatment Interruption|Physician Decision|10|||
157244224|NCT02888756|567638891|FG001|Analytical Treatment Interruption|Physician Decision|6|||
157244225|NCT02888756|567638892|FG002|Analytical Treatment Interruption|Physician Decision|5|||
157244226|NCT05497557|567638898|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
157244227|NCT05497557|567638899|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
157244228|NCT05497557|567638900|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
157244229|NCT00198133|567638902|FG000|Overall Study|Disease progression|2|||
157244230|NCT00198133|567638903|FG001|Overall Study|Disease progression|5|||
157244231|NCT00198133|567638902|FG000|Overall Study|Adverse Event|1|||
157244232|NCT00198133|567638903|FG001|Overall Study|Adverse Event|3|||
157244233|NCT00198133|567638902|FG000|Overall Study|Withdrawal by Subject|1|||
157244234|NCT00198133|567638903|FG001|Overall Study|Withdrawal by Subject|0|||
157244235|NCT00198133|567638902|FG000|Overall Study|Physician Decision|1|||
157244236|NCT00198133|567638903|FG001|Overall Study|Physician Decision|0|||
157244237|NCT02752074|567638904|FG000|Overall Study|Lost to Follow-up|1|||
157244238|NCT02752074|567638905|FG001|Overall Study|Lost to Follow-up|4|||
157244239|NCT02752074|567638904|FG000|Overall Study|Death|146|||
157244240|NCT02752074|567638905|FG001|Overall Study|Death|129|||
157244241|NCT02752074|567638904|FG000|Overall Study|Withdrawal by Subject|9|||
157244242|NCT02752074|567638905|FG001|Overall Study|Withdrawal by Subject|10|||
157244243|NCT00488774|567638906|FG000|Overall Study|Withdrawal of consent|2|||
157244244|NCT00488774|567638907|FG001|Overall Study|Withdrawal of consent|2|||
157244245|NCT00488774|567638908|FG002|Overall Study|Withdrawal of consent|2|||
157244246|NCT00488774|567638909|FG003|Overall Study|Withdrawal of consent|0|||
157244247|NCT00488774|567638906|FG000|Overall Study|Other|6|||
157202097|NCT05261126|567483548|FG004|Overall Study|Screen Failure|1|||
157202098|NCT05261126|567483544|FG000|Overall Study|Withdrawal by Subject|1|||
157202099|NCT05261126|567483545|FG001|Overall Study|Withdrawal by Subject|0|||
157202100|NCT05261126|567483546|FG002|Overall Study|Withdrawal by Subject|1|||
157202101|NCT05261126|567483547|FG003|Overall Study|Withdrawal by Subject|1|||
157202102|NCT05261126|567483548|FG004|Overall Study|Withdrawal by Subject|0|||
157202103|NCT05261126|567483544|FG000|Overall Study|Not Recorded|0|||
157202104|NCT05261126|567483545|FG001|Overall Study|Not Recorded|0|||
157202105|NCT05261126|567483546|FG002|Overall Study|Not Recorded|0|||
157202106|NCT05261126|567483547|FG003|Overall Study|Not Recorded|1|||
157202107|NCT05261126|567483548|FG004|Overall Study|Not Recorded|0|||
157202108|NCT05939388|567483549|FG000|Overall Study|Lost to Follow-up|1|||
157202109|NCT05570604|567483550|FG000|Overall Study|Lost to Follow-up|1|||
157202110|NCT05570604|567483551|FG001|Overall Study|Lost to Follow-up|5|||
157202111|NCT05570604|567483550|FG000|Overall Study|Illness|2|||
157202112|NCT05570604|567483551|FG001|Overall Study|Illness|2|||
157202113|NCT04479358|567483554|FG000|Overall Study|Withdrawal by Subject|0|||
157202114|NCT04479358|567483555|FG001|Overall Study|Withdrawal by Subject|0|||
157202115|NCT04479358|567483556|FG002|Overall Study|Withdrawal by Subject|1|||
157202116|NCT04479358|567483557|FG003|Overall Study|Withdrawal by Subject|0|||
157202117|NCT04479358|567483558|FG004|Overall Study|Withdrawal by Subject|0|||
157202118|NCT04479358|567483559|FG005|Overall Study|Withdrawal by Subject|1|||
157202119|NCT02396849|567483574|FG000|Overall Study|Lost to Follow-up|1|||
157202120|NCT02396849|567483575|FG001|Overall Study|Lost to Follow-up|1|||
157202121|NCT02396849|567483574|FG000|Overall Study|Did not tolerate intervention|1|||
157244248|NCT00488774|567638907|FG001|Overall Study|Other|3|||
157244249|NCT00488774|567638908|FG002|Overall Study|Other|2|||
157244250|NCT00488774|567638909|FG003|Overall Study|Other|2|||
157244251|NCT00488774|567638906|FG000|Overall Study|Lost to Follow-up|0|||
157244252|NCT00488774|567638907|FG001|Overall Study|Lost to Follow-up|0|||
157244253|NCT00488774|567638908|FG002|Overall Study|Lost to Follow-up|1|||
157244254|NCT00488774|567638909|FG003|Overall Study|Lost to Follow-up|1|||
157244255|NCT05523895|567638910|FG000|Overall Study|Adverse Event|2|||
157244256|NCT05523895|567638911|FG001|Overall Study|Adverse Event|1|||
157244257|NCT05523895|567638912|FG002|Overall Study|Adverse Event|1|||
157244258|NCT05523895|567638910|FG000|Overall Study|Lost to Follow-up|0|||
157244259|NCT05523895|567638911|FG001|Overall Study|Lost to Follow-up|1|||
157202122|NCT02396849|567483575|FG001|Overall Study|Did not tolerate intervention|1|||
157202123|NCT00157157|567483581|FG000|Overall Study|Withdrawal by Subject|6|||
157202124|NCT00157157|567483581|FG000|Overall Study|Physician Decision|1|||
157244260|NCT05523895|567638912|FG002|Overall Study|Lost to Follow-up|2|||
157244261|NCT05523895|567638910|FG000|Overall Study|Noncompliance with study drug|1|||
157244262|NCT05523895|567638911|FG001|Overall Study|Noncompliance with study drug|1|||
157244263|NCT05523895|567638912|FG002|Overall Study|Noncompliance with study drug|1|||
157244264|NCT05523895|567638910|FG000|Overall Study|Protocol Violation|0|||
157244265|NCT05523895|567638911|FG001|Overall Study|Protocol Violation|2|||
157244266|NCT05523895|567638912|FG002|Overall Study|Protocol Violation|0|||
157244267|NCT05523895|567638910|FG000|Overall Study|Withdrawal by Subject|1|||
157244268|NCT05523895|567638911|FG001|Overall Study|Withdrawal by Subject|3|||
157244269|NCT05523895|567638912|FG002|Overall Study|Withdrawal by Subject|1|||
157244270|NCT05523895|567638910|FG000|Overall Study|Not further specified|0|||
157244271|NCT05523895|567638911|FG001|Overall Study|Not further specified|3|||
157244272|NCT05523895|567638912|FG002|Overall Study|Not further specified|1|||
157244273|NCT02213263|567638913|FG000|Overall Study|Insufficient clinical response|4|||
157244274|NCT02213263|567638914|FG001|Overall Study|Insufficient clinical response|3|||
157244275|NCT02213263|567638913|FG000|Overall Study|Lost to Follow-up|0|||
157244276|NCT02213263|567638914|FG001|Overall Study|Lost to Follow-up|1|||
157244277|NCT02213263|567638913|FG000|Overall Study|No longer willing to participate|3|||
157244278|NCT02213263|567638914|FG001|Overall Study|No longer willing to participate|4|||
157244279|NCT02213263|567638913|FG000|Overall Study|Progressive disease|20|||
157244280|NCT02213263|567638914|FG001|Overall Study|Progressive disease|14|||
157244281|NCT02213263|567638913|FG000|Overall Study|Protocol Violation|0|||
157244282|NCT02213263|567638914|FG001|Overall Study|Protocol Violation|1|||
157244283|NCT02213263|567638913|FG000|Overall Study|Adverse Event|1|||
157244284|NCT02213263|567638914|FG001|Overall Study|Adverse Event|3|||
157244285|NCT05752721|567638915|FG000|Overall Study|Lost to Follow-up|22|||
157244286|NCT05752721|567638916|FG001|Overall Study|Lost to Follow-up|20|||
157244287|NCT05752721|567638915|FG000|Overall Study|Withdrawal by Subject|15|||
157244288|NCT05752721|567638916|FG001|Overall Study|Withdrawal by Subject|12|||
157244289|NCT00263588|567638917|FG000|Overall Study|Death|54|||
157244290|NCT00263588|567638918|FG001|Overall Study|Death|90|||
157244291|NCT00263588|567638917|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
157244292|NCT00263588|567638918|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
157244293|NCT00263588|567638917|FG000|Overall Study|Lost to Follow-up|7|||
157244294|NCT00263588|567638918|FG001|Overall Study|Lost to Follow-up|10|||
157244295|NCT00263588|567638917|FG000|Overall Study|Withdrawal by Subject|3|||
157244296|NCT00263588|567638918|FG001|Overall Study|Withdrawal by Subject|4|||
157202125|NCT00157157|567483581|FG000|Overall Study|Lost to Follow-up|1|||
157202126|NCT00157157|567483581|FG000|Overall Study|Enrolled in another study|1|||
157202127|NCT00157157|567483581|FG000|Overall Study|Met exclusion criteria|1|||
157202128|NCT00157157|567483581|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
157202129|NCT02260804|567483582|FG000|Induction Study Period|Protocol Violation|2|||
157202130|NCT02260804|567483583|FG001|Induction Study Period|Protocol Violation|0|||
157202131|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
157202132|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
157202133|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
157202134|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
157202135|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
157202136|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
157202137|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
157202138|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
157202139|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
157202140|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
157202141|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
157244297|NCT00263588|567638917|FG000|Overall Study|Protocol Violation|0|||
157244298|NCT00263588|567638918|FG001|Overall Study|Protocol Violation|1|||
157244299|NCT00263588|567638917|FG000|Overall Study|Investigator decision|7|||
157244300|NCT00263588|567638918|FG001|Overall Study|Investigator decision|15|||
157244301|NCT00263588|567638917|FG000|Overall Study|Sponsor terminated study|0|||
157244302|NCT00263588|567638918|FG001|Overall Study|Sponsor terminated study|1|||
157244303|NCT00216736|567638925|FG000|Overall Study|Lost to Follow-up|1|||
157244304|NCT00216736|567638926|FG001|Overall Study|Lost to Follow-up|1|||
157244305|NCT00807495|567638928|FG000|Overall Study|Adverse Event|6|||
157244306|NCT00807495|567638929|FG001|Overall Study|Adverse Event|3|||
157244307|NCT00807495|567638930|FG002|Overall Study|Adverse Event|1|||
157244308|NCT00807495|567638931|FG003|Overall Study|Adverse Event|1|||
157244309|NCT00807495|567638932|FG004|Overall Study|Adverse Event|2|||
157244310|NCT00807495|567638928|FG000|Overall Study|Withdrawal by Patient|2|||
157244311|NCT00807495|567638929|FG001|Overall Study|Withdrawal by Patient|0|||
157244312|NCT00807495|567638930|FG002|Overall Study|Withdrawal by Patient|1|||
157244313|NCT00807495|567638931|FG003|Overall Study|Withdrawal by Patient|0|||
157244314|NCT00807495|567638932|FG004|Overall Study|Withdrawal by Patient|0|||
157244315|NCT00807495|567638928|FG000|Overall Study|Reason Not Specified|0|||
157244316|NCT00807495|567638929|FG001|Overall Study|Reason Not Specified|3|||
157244317|NCT00807495|567638930|FG002|Overall Study|Reason Not Specified|2|||
157244318|NCT00807495|567638931|FG003|Overall Study|Reason Not Specified|0|||
157244319|NCT00807495|567638932|FG004|Overall Study|Reason Not Specified|3|||
157244320|NCT00841542|567638933|FG000|Period 1|Adverse Event|1|||
157244321|NCT00841542|567638934|FG001|Period 1|Adverse Event|0|||
157244322|NCT01906372|567638935|FG000|Overall Study|Withdrawal by Subject|2|||
157244323|NCT03629054|567638936|FG000|Period 2 (4 Days)|Not treated|0|||
157244324|NCT03629054|567638937|FG001|Period 2 (4 Days)|Not treated|1|||
157244325|NCT00924638|567638941|FG000|Overall Study|Death|3|||
157244326|NCT00924638|567638942|FG001|Overall Study|Death|2|||
157244327|NCT00924638|567638941|FG000|Overall Study|Lost to Follow-up|1|||
157244328|NCT00924638|567638942|FG001|Overall Study|Lost to Follow-up|1|||
157244329|NCT00924638|567638941|FG000|Overall Study|Withdrawal by Subject|5|||
157244330|NCT00924638|567638942|FG001|Overall Study|Withdrawal by Subject|7|||
157244331|NCT00924638|567638941|FG000|Overall Study|Physician Decision|3|||
157244332|NCT00924638|567638942|FG001|Overall Study|Physician Decision|3|||
157244333|NCT01316055|567638943|FG000|Overall Study|Lost to Follow-up|1|||
157244334|NCT01316055|567638944|FG001|Overall Study|Lost to Follow-up|0|||
157244335|NCT01316055|567638945|FG002|Overall Study|Lost to Follow-up|0|||
157244336|NCT00624286|567638947|FG000|Overall Study|Protocol Deviation|7|||
157244337|NCT00624286|567638948|FG001|Overall Study|Protocol Deviation|9|||
157244338|NCT00624286|567638947|FG000|Overall Study|Adverse Event|6|||
157244339|NCT00624286|567638948|FG001|Overall Study|Adverse Event|3|||
157244340|NCT00624286|567638947|FG000|Overall Study|Withdrawal by Subject|5|||
157244341|NCT00624286|567638948|FG001|Overall Study|Withdrawal by Subject|4|||
157244342|NCT00624286|567638947|FG000|Overall Study|Lost to Follow-up|3|||
157244343|NCT00624286|567638948|FG001|Overall Study|Lost to Follow-up|2|||
157244344|NCT00624286|567638947|FG000|Overall Study|Administrative problems|3|||
157244345|NCT00624286|567638948|FG001|Overall Study|Administrative problems|0|||
157244346|NCT00624286|567638947|FG000|Overall Study|Lack of Efficacy|1|||
157244347|NCT00624286|567638948|FG001|Overall Study|Lack of Efficacy|6|||
157244348|NCT00624286|567638947|FG000|Overall Study|Not stated|0|||
157244349|NCT00624286|567638948|FG001|Overall Study|Not stated|1|||
157244350|NCT00624286|567638947|FG000|Overall Study|Abnormal test procedure result(s)|0|||
157244351|NCT00624286|567638948|FG001|Overall Study|Abnormal test procedure result(s)|1|||
157244352|NCT00624286|567638947|FG000|Overall Study|Death|0|||
157244353|NCT00624286|567638948|FG001|Overall Study|Death|1|||
157244354|NCT03488108|567638952|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
157244355|NCT03488108|567638953|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
157244356|NCT03488108|567638952|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
157244357|NCT03488108|567638953|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
157244358|NCT00674128|567638956|FG000|Overall Study|Withdrawal by Subject|25|||
157244359|NCT00674128|567638957|FG001|Overall Study|Withdrawal by Subject|23|||
157244360|NCT01825798|567638966|FG000|Overall Study|Adverse Event|1|||
157244361|NCT01825798|567638967|FG001|Overall Study|Adverse Event|5|||
157244362|NCT01825798|567638966|FG000|Overall Study|Lost to Follow-up|1|||
157244363|NCT01825798|567638967|FG001|Overall Study|Lost to Follow-up|0|||
157244364|NCT02471807|567638977|FG000|Overall Study|Death|14|||
157244365|NCT02471807|567638977|FG000|Overall Study|Withdrawal by Subject|2|||
157244366|NCT02471807|567638977|FG000|Overall Study|Explant|5|||
157244367|NCT02471807|567638977|FG000|Overall Study|Lost to Follow-up|1|||
157244368|NCT00834873|567638978|FG000|First Intervention|Adverse Event|0|||
157244369|NCT00834873|567638979|FG001|First Intervention|Adverse Event|1|||
157244370|NCT02055547|567638980|FG000|Overall Study|Protocol Violation|0|||
157244371|NCT02055547|567638981|FG001|Overall Study|Protocol Violation|0|||
157244372|NCT02055547|567638982|FG002|Overall Study|Protocol Violation|1|||
157244373|NCT02055547|567638983|FG003|Overall Study|Protocol Violation|0|||
157244374|NCT02055547|567638984|FG004|Overall Study|Protocol Violation|0|||
157244375|NCT02055547|567638985|FG005|Overall Study|Protocol Violation|0|||
157244376|NCT02055547|567638986|FG006|Overall Study|Protocol Violation|1|||
157244377|NCT02055547|567638987|FG007|Overall Study|Protocol Violation|0|||
157244378|NCT02055547|567638988|FG008|Overall Study|Protocol Violation|0|||
157244379|NCT02055547|567638989|FG009|Overall Study|Protocol Violation|0|||
157244380|NCT02055547|567638990|FG010|Overall Study|Protocol Violation|0|||
157244381|NCT02055547|567638991|FG011|Overall Study|Protocol Violation|0|||
157244382|NCT02055547|567638992|FG012|Overall Study|Protocol Violation|0|||
157244383|NCT02055547|567638993|FG013|Overall Study|Protocol Violation|0|||
157244384|NCT02055547|567638994|FG014|Overall Study|Protocol Violation|0|||
157244385|NCT02055547|567638995|FG015|Overall Study|Protocol Violation|0|||
157244386|NCT02055547|567638996|FG016|Overall Study|Protocol Violation|0|||
157244387|NCT02055547|567638997|FG017|Overall Study|Protocol Violation|0|||
157244388|NCT02055547|567638998|FG018|Overall Study|Protocol Violation|0|||
157244389|NCT02055547|567638980|FG000|Overall Study|Physician Decision|0|||
157244390|NCT02055547|567638981|FG001|Overall Study|Physician Decision|1|||
157244391|NCT02055547|567638982|FG002|Overall Study|Physician Decision|1|||
157244392|NCT02055547|567638983|FG003|Overall Study|Physician Decision|0|||
157244393|NCT02055547|567638984|FG004|Overall Study|Physician Decision|1|||
157244394|NCT02055547|567638985|FG005|Overall Study|Physician Decision|0|||
157244395|NCT02055547|567638986|FG006|Overall Study|Physician Decision|0|||
157244396|NCT02055547|567638987|FG007|Overall Study|Physician Decision|0|||
157244397|NCT02055547|567638988|FG008|Overall Study|Physician Decision|0|||
157202142|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
157202143|NCT02260804|567483582|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
157202144|NCT02260804|567483583|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
157202145|NCT02260804|567483582|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
157202146|NCT02260804|567483583|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
157202147|NCT02260804|567483582|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
157202148|NCT02260804|567483583|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
157202149|NCT02260804|567483582|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
157202150|NCT02260804|567483583|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
157202151|NCT02503215|567485215|FG000|Overall Study|Unable to wear compression stockings|1|||
157202152|NCT02503215|567485215|FG000|Overall Study|Unable to use positive airway pressure|2|||
157202153|NCT04478994|567485216|FG000|Overall Study|Withdrawal by Subject|1|||
157202154|NCT04478994|567485217|FG001|Overall Study|Withdrawal by Subject|1|||
157202155|NCT00457249|567485218|FG000|Overall Study|Lost to Follow-up|3|||
157202156|NCT00457249|567485219|FG001|Overall Study|Lost to Follow-up|0|||
157202157|NCT00457249|567485218|FG000|Overall Study|Protocol Violation|4|||
157202158|NCT00457249|567485219|FG001|Overall Study|Protocol Violation|1|||
157202159|NCT00457249|567485218|FG000|Overall Study|Withdrawal by Subject|3|||
157202160|NCT00457249|567485219|FG001|Overall Study|Withdrawal by Subject|1|||
157202161|NCT00457249|567485218|FG000|Overall Study|Serious Adverse Events|2|||
157202162|NCT00457249|567485219|FG001|Overall Study|Serious Adverse Events|0|||
157202163|NCT02094573|567485222|FG000|Overall Study|Adverse Event|4|||
157202164|NCT02094573|567485223|FG001|Overall Study|Adverse Event|14|||
157202165|NCT02094573|567485222|FG000|Overall Study|Clinical Progressive Disease|9|||
157202166|NCT02094573|567485223|FG001|Overall Study|Clinical Progressive Disease|13|||
157202167|NCT02094573|567485222|FG000|Overall Study|Death|11|||
157202168|NCT02094573|567485223|FG001|Overall Study|Death|3|||
157202169|NCT02094573|567485222|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
157202170|NCT02094573|567485223|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
157202171|NCT02094573|567485222|FG000|Overall Study|Non-compliance with Study Drug|1|||
157202172|NCT02094573|567485223|FG001|Overall Study|Non-compliance with Study Drug|1|||
157202173|NCT02094573|567485222|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
157202174|NCT02094573|567485223|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
157202175|NCT02094573|567485222|FG000|Overall Study|Physician Decision|4|||
157202176|NCT02094573|567485223|FG001|Overall Study|Physician Decision|4|||
157202177|NCT02094573|567485222|FG000|Overall Study|Site Terminated by Sponsor|10|||
157202178|NCT02094573|567485223|FG001|Overall Study|Site Terminated by Sponsor|17|||
157202179|NCT02094573|567485222|FG000|Overall Study|Withdrawal by Subject|6|||
157202180|NCT02094573|567485223|FG001|Overall Study|Withdrawal by Subject|8|||
157202181|NCT02094573|567485222|FG000|Overall Study|Randomized but not Treated|3|||
157202182|NCT02094573|567485223|FG001|Overall Study|Randomized but not Treated|0|||
157202183|NCT02875340|567485224|FG000|Overall Study|Death|2|||
157202184|NCT02875340|567485224|FG000|Overall Study|Withdrawal by Subject|2|||
157202185|NCT02875340|567485224|FG000|Overall Study|Physician Decision|3|||
157202186|NCT02875340|567485224|FG000|Overall Study|Adverse Event|1|||
157202187|NCT01160770|567485227|FG000|Overall Study|Adverse Event|10|||
157202188|NCT01160770|567485227|FG000|Overall Study|Protocol Violation|2|||
157202189|NCT01160770|567485227|FG000|Overall Study|Subject/parent/caregiver request|33|||
157202190|NCT01160770|567485227|FG000|Overall Study|Physician Decision|1|||
157202191|NCT01160770|567485227|FG000|Overall Study|Lost to Follow-up|7|||
157202192|NCT01160770|567485227|FG000|Overall Study|Study termination or sponsor request|1|||
157202193|NCT01160770|567485227|FG000|Overall Study|Death|9|||
157202194|NCT01160770|567485227|FG000|Overall Study|Lack of Efficacy|15|||
157202195|NCT01160770|567485227|FG000|Overall Study|Other Reasons|1|||
157202196|NCT02411110|567485228|FG000|Treatment Period 1|Adverse Event|4|||
157202197|NCT02411110|567485229|FG001|Treatment Period 1|Adverse Event|2|||
157202198|NCT02411110|567485228|FG000|Treatment Period 1|Lost to Follow-up|1|||
157202199|NCT02411110|567485229|FG001|Treatment Period 1|Lost to Follow-up|0|||
157202200|NCT02411110|567485228|FG000|Treatment Period 1|Personal Reasons|2|||
157202201|NCT02411110|567485229|FG001|Treatment Period 1|Personal Reasons|5|||
157202202|NCT02411110|567485228|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
157202203|NCT02411110|567485229|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
157202204|NCT02411110|567485228|FG000|Treatment Period 2|Adverse Event|1|||
157202205|NCT02411110|567485229|FG001|Treatment Period 2|Adverse Event|0|||
157202206|NCT02411110|567485228|FG000|Treatment Period 2|Lost to Follow-up|0|||
157202207|NCT02411110|567485229|FG001|Treatment Period 2|Lost to Follow-up|2|||
157202208|NCT02411110|567485228|FG000|Treatment Period 2|Personal Reasons|0|||
157202209|NCT02411110|567485229|FG001|Treatment Period 2|Personal Reasons|2|||
157202210|NCT04888377|567485230|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
157202211|NCT04888377|567485231|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
157202212|NCT04888377|567485230|FG000|Overall Study|Physician Decision|6|||
157202213|NCT04888377|567485231|FG001|Overall Study|Physician Decision|6|||
157202214|NCT04888377|567485230|FG000|Overall Study|Withdrawal by Subject|7|||
157202215|NCT04888377|567485231|FG001|Overall Study|Withdrawal by Subject|3|||
157244398|NCT02055547|567638989|FG009|Overall Study|Physician Decision|1|||
157244399|NCT02055547|567638990|FG010|Overall Study|Physician Decision|1|||
157244400|NCT02055547|567638991|FG011|Overall Study|Physician Decision|0|||
157244401|NCT02055547|567638992|FG012|Overall Study|Physician Decision|0|||
157244402|NCT02055547|567638993|FG013|Overall Study|Physician Decision|0|||
157244403|NCT02055547|567638994|FG014|Overall Study|Physician Decision|0|||
157244404|NCT02055547|567638995|FG015|Overall Study|Physician Decision|0|||
157244405|NCT02055547|567638996|FG016|Overall Study|Physician Decision|0|||
157244406|NCT02055547|567638997|FG017|Overall Study|Physician Decision|0|||
157244407|NCT02055547|567638998|FG018|Overall Study|Physician Decision|0|||
157244408|NCT02055547|567638980|FG000|Overall Study|Adverse Event|0|||
157244409|NCT02055547|567638981|FG001|Overall Study|Adverse Event|0|||
157244410|NCT02055547|567638982|FG002|Overall Study|Adverse Event|0|||
157244411|NCT02055547|567638983|FG003|Overall Study|Adverse Event|0|||
157244412|NCT02055547|567638984|FG004|Overall Study|Adverse Event|0|||
157244413|NCT02055547|567638985|FG005|Overall Study|Adverse Event|0|||
157244414|NCT02055547|567638986|FG006|Overall Study|Adverse Event|1|||
157244415|NCT02055547|567638987|FG007|Overall Study|Adverse Event|0|||
157244416|NCT02055547|567638988|FG008|Overall Study|Adverse Event|1|||
157244417|NCT02055547|567638989|FG009|Overall Study|Adverse Event|0|||
157244418|NCT02055547|567638990|FG010|Overall Study|Adverse Event|0|||
157244419|NCT02055547|567638991|FG011|Overall Study|Adverse Event|0|||
157244420|NCT02055547|567638992|FG012|Overall Study|Adverse Event|0|||
157244421|NCT02055547|567638993|FG013|Overall Study|Adverse Event|0|||
157244422|NCT02055547|567638994|FG014|Overall Study|Adverse Event|0|||
157244423|NCT02055547|567638995|FG015|Overall Study|Adverse Event|0|||
157244424|NCT02055547|567638996|FG016|Overall Study|Adverse Event|0|||
157244425|NCT02055547|567638997|FG017|Overall Study|Adverse Event|0|||
157244426|NCT02055547|567638998|FG018|Overall Study|Adverse Event|0|||
157244427|NCT02055547|567638980|FG000|Overall Study|Withdrawal by Subject|0|||
157244428|NCT02055547|567638981|FG001|Overall Study|Withdrawal by Subject|0|||
157244429|NCT02055547|567638982|FG002|Overall Study|Withdrawal by Subject|0|||
157244430|NCT02055547|567638983|FG003|Overall Study|Withdrawal by Subject|0|||
157244431|NCT02055547|567638984|FG004|Overall Study|Withdrawal by Subject|0|||
157244432|NCT02055547|567638985|FG005|Overall Study|Withdrawal by Subject|1|||
157244433|NCT02055547|567638986|FG006|Overall Study|Withdrawal by Subject|0|||
157244434|NCT02055547|567638987|FG007|Overall Study|Withdrawal by Subject|0|||
157244435|NCT02055547|567638988|FG008|Overall Study|Withdrawal by Subject|1|||
157244436|NCT02055547|567638989|FG009|Overall Study|Withdrawal by Subject|0|||
157244437|NCT02055547|567638990|FG010|Overall Study|Withdrawal by Subject|0|||
157244438|NCT02055547|567638991|FG011|Overall Study|Withdrawal by Subject|0|||
157244439|NCT02055547|567638992|FG012|Overall Study|Withdrawal by Subject|0|||
157244440|NCT02055547|567638993|FG013|Overall Study|Withdrawal by Subject|1|||
157244441|NCT02055547|567638994|FG014|Overall Study|Withdrawal by Subject|0|||
157244442|NCT02055547|567638995|FG015|Overall Study|Withdrawal by Subject|1|||
157244443|NCT02055547|567638996|FG016|Overall Study|Withdrawal by Subject|0|||
157244444|NCT02055547|567638997|FG017|Overall Study|Withdrawal by Subject|0|||
157244445|NCT02055547|567638998|FG018|Overall Study|Withdrawal by Subject|0|||
157244446|NCT02055547|567638980|FG000|Overall Study|Lost to Follow-up|0|||
157244447|NCT02055547|567638981|FG001|Overall Study|Lost to Follow-up|0|||
157244448|NCT02055547|567638982|FG002|Overall Study|Lost to Follow-up|1|||
157244449|NCT02055547|567638983|FG003|Overall Study|Lost to Follow-up|0|||
157244450|NCT02055547|567638984|FG004|Overall Study|Lost to Follow-up|0|||
157244451|NCT02055547|567638985|FG005|Overall Study|Lost to Follow-up|0|||
157244452|NCT02055547|567638986|FG006|Overall Study|Lost to Follow-up|0|||
157244453|NCT02055547|567638987|FG007|Overall Study|Lost to Follow-up|0|||
157202216|NCT00526162|567485232|FG000|Overall Study|Device not implanted|3|||
157202217|NCT05279807|567485233|FG000|Overall Study|Withdrawal by Subject|1|||
157202218|NCT05279807|567485234|FG001|Overall Study|Withdrawal by Subject|0|||
157202219|NCT05279807|567485233|FG000|Overall Study|Adverse Event|0|||
157202220|NCT05279807|567485234|FG001|Overall Study|Adverse Event|1|||
157202221|NCT05279807|567485233|FG000|Overall Study|Laboratory Abnormal Results|1|||
157202222|NCT05279807|567485234|FG001|Overall Study|Laboratory Abnormal Results|0|||
157202223|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
157202224|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
157202225|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
157202226|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202227|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157244454|NCT02055547|567638988|FG008|Overall Study|Lost to Follow-up|0|||
157244455|NCT02055547|567638989|FG009|Overall Study|Lost to Follow-up|0|||
157244456|NCT02055547|567638990|FG010|Overall Study|Lost to Follow-up|0|||
157244457|NCT02055547|567638991|FG011|Overall Study|Lost to Follow-up|0|||
157244458|NCT02055547|567638992|FG012|Overall Study|Lost to Follow-up|0|||
157244459|NCT02055547|567638993|FG013|Overall Study|Lost to Follow-up|0|||
157244460|NCT02055547|567638994|FG014|Overall Study|Lost to Follow-up|0|||
157244461|NCT02055547|567638995|FG015|Overall Study|Lost to Follow-up|0|||
157244462|NCT02055547|567638996|FG016|Overall Study|Lost to Follow-up|0|||
157244463|NCT02055547|567638997|FG017|Overall Study|Lost to Follow-up|0|||
157202228|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202229|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202230|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202231|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
157202232|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
157202233|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202234|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202235|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202236|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202237|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
157202238|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
157202239|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
157202240|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202241|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202242|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202243|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202244|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
157202245|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
157202246|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
157202247|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202248|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202249|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202250|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202251|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
157202252|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202253|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202254|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202255|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202256|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202257|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
157202258|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202259|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202260|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
157202261|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202262|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202263|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202264|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
157202265|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202266|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202267|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
157202268|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202269|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202270|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202271|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
157202272|NCT04242446|567485239|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202273|NCT04242446|567485240|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
157202274|NCT04242446|567485241|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
157202275|NCT04242446|567485242|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202276|NCT04242446|567485243|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202277|NCT04242446|567485244|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202278|NCT04242446|567485245|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202279|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202280|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202281|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202282|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
157202283|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
157202284|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
157202285|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
157202286|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202287|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202288|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202289|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
157202290|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
157202291|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
157202292|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
157202293|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202294|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202295|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202296|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
157202297|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
157202298|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
157202299|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
157202300|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157202301|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157202302|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157202303|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
157202304|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
157202305|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
157202306|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
157202307|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202308|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202309|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202310|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
157202311|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
157202312|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
157202313|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
157202314|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202315|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202316|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202317|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
157202318|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202319|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202320|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
157202321|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202322|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202323|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202324|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202325|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
157202326|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202327|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
157202328|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202329|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202330|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202331|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202332|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
157202333|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202334|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
157202335|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202336|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202337|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202338|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202339|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
157202340|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202341|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
157202342|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157244464|NCT02055547|567638998|FG018|Overall Study|Lost to Follow-up|0|||
157244465|NCT01456221|567638999|FG000|Overall Study|Withdrawal by Subject|56|||
157244466|NCT01456221|567639000|FG001|Overall Study|Withdrawal by Subject|49|||
157244467|NCT01456221|567638999|FG000|Overall Study|Lost to Follow-up|1|||
157244468|NCT01456221|567639000|FG001|Overall Study|Lost to Follow-up|4|||
157244469|NCT01456221|567638999|FG000|Overall Study|Received medication|3|||
157244470|NCT01456221|567639000|FG001|Overall Study|Received medication|2|||
157244471|NCT01456221|567638999|FG000|Overall Study|Incomplete data|4|||
157244472|NCT01456221|567639000|FG001|Overall Study|Incomplete data|2|||
157244473|NCT02272803|567639001|FG000|Overall Study|Disease progression|16|||
157244474|NCT02272803|567639002|FG001|Overall Study|Disease progression|8|||
157244475|NCT02272803|567639001|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
157244476|NCT02272803|567639002|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
157244477|NCT02272803|567639001|FG000|Overall Study|Study drug toxicity|4|||
157244478|NCT02272803|567639002|FG001|Overall Study|Study drug toxicity|9|||
157244479|NCT02272803|567639001|FG000|Overall Study|Participant request to discontinue study treatment|3|||
157244480|NCT02272803|567639002|FG001|Overall Study|Participant request to discontinue study treatment|7|||
157244481|NCT02272803|567639001|FG000|Overall Study|Maximum clinical benefit|4|||
157244482|NCT02272803|567639002|FG001|Overall Study|Maximum clinical benefit|2|||
157244483|NCT02272803|567639001|FG000|Overall Study|Poor/non-compliance|2|||
157244484|NCT02272803|567639002|FG001|Overall Study|Poor/non-compliance|2|||
157244485|NCT02272803|567639001|FG000|Overall Study|Withdrawal by Subject|2|||
157244486|NCT02272803|567639002|FG001|Overall Study|Withdrawal by Subject|1|||
157244487|NCT02272803|567639001|FG000|Overall Study|Death|0|||
157244488|NCT02272803|567639002|FG001|Overall Study|Death|1|||
157244489|NCT02272803|567639001|FG000|Overall Study|Other reasons|1|||
157244490|NCT02272803|567639002|FG001|Overall Study|Other reasons|3|||
157244491|NCT02272803|567639001|FG000|Overall Study|Administrative reason by sponsor|5|||
157244492|NCT02272803|567639002|FG001|Overall Study|Administrative reason by sponsor|4|||
157244493|NCT02611323|567639003|FG000|Overall Study|Death|3|||
157244494|NCT02611323|567639004|FG001|Overall Study|Death|1|||
157244495|NCT02611323|567639005|FG002|Overall Study|Death|0|||
157244496|NCT02611323|567639006|FG003|Overall Study|Death|0|||
157244497|NCT02611323|567639007|FG004|Overall Study|Death|1|||
157244498|NCT02611323|567639008|FG005|Overall Study|Death|1|||
157244499|NCT02611323|567639009|FG006|Overall Study|Death|8|||
157244500|NCT02611323|567639010|FG007|Overall Study|Death|0|||
157244501|NCT02611323|567639011|FG008|Overall Study|Death|4|||
157244502|NCT02611323|567639012|FG009|Overall Study|Death|6|||
157244503|NCT02611323|567639013|FG010|Overall Study|Death|26|||
157244504|NCT02611323|567639003|FG000|Overall Study|Lost to Follow-up|1|||
157244505|NCT02611323|567639004|FG001|Overall Study|Lost to Follow-up|0|||
157244506|NCT02611323|567639005|FG002|Overall Study|Lost to Follow-up|0|||
157244507|NCT02611323|567639006|FG003|Overall Study|Lost to Follow-up|0|||
157244508|NCT02611323|567639007|FG004|Overall Study|Lost to Follow-up|0|||
157244509|NCT02611323|567639008|FG005|Overall Study|Lost to Follow-up|0|||
157244510|NCT02611323|567639009|FG006|Overall Study|Lost to Follow-up|3|||
157244511|NCT02611323|567639010|FG007|Overall Study|Lost to Follow-up|0|||
157244512|NCT02611323|567639011|FG008|Overall Study|Lost to Follow-up|0|||
157244513|NCT02611323|567639012|FG009|Overall Study|Lost to Follow-up|0|||
157244514|NCT02611323|567639013|FG010|Overall Study|Lost to Follow-up|2|||
157244515|NCT02611323|567639003|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244516|NCT02611323|567639004|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244517|NCT02611323|567639005|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244518|NCT02611323|567639006|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244519|NCT02611323|567639007|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244520|NCT02611323|567639008|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244521|NCT02611323|567639009|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244522|NCT02611323|567639010|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244523|NCT02611323|567639011|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244524|NCT02611323|567639012|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
157244525|NCT02611323|567639013|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
157244526|NCT02611323|567639003|FG000|Overall Study|Progressive Disease|0|||
157244527|NCT02611323|567639004|FG001|Overall Study|Progressive Disease|0|||
157244528|NCT02611323|567639005|FG002|Overall Study|Progressive Disease|0|||
157244529|NCT02611323|567639006|FG003|Overall Study|Progressive Disease|0|||
157244530|NCT02611323|567639007|FG004|Overall Study|Progressive Disease|0|||
157244531|NCT02611323|567639008|FG005|Overall Study|Progressive Disease|0|||
157244532|NCT02611323|567639009|FG006|Overall Study|Progressive Disease|0|||
157244533|NCT02611323|567639010|FG007|Overall Study|Progressive Disease|0|||
157244534|NCT02611323|567639011|FG008|Overall Study|Progressive Disease|0|||
157244535|NCT02611323|567639012|FG009|Overall Study|Progressive Disease|0|||
157244536|NCT02611323|567639013|FG010|Overall Study|Progressive Disease|1|||
157244537|NCT02611323|567639003|FG000|Overall Study|Withdrawal by Subject|1|||
157244538|NCT02611323|567639004|FG001|Overall Study|Withdrawal by Subject|0|||
157244539|NCT02611323|567639005|FG002|Overall Study|Withdrawal by Subject|0|||
157244540|NCT02611323|567639006|FG003|Overall Study|Withdrawal by Subject|0|||
157202343|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157202344|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157202345|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157202346|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
157202347|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157202348|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
157202349|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202350|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202351|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202352|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202353|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
157202354|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202355|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
157202356|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202357|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202358|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202359|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202360|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202361|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
157202362|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
157202363|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202364|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202365|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202366|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202367|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202368|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
157202369|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
157202370|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202371|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202372|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202373|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202374|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202375|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
157202376|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
157202377|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202378|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202379|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202380|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202381|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202382|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
157202383|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
157202384|NCT04242446|567485239|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202385|NCT04242446|567485240|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202386|NCT04242446|567485241|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202387|NCT04242446|567485242|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202388|NCT04242446|567485243|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202389|NCT04242446|567485244|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
157202390|NCT04242446|567485245|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
157202391|NCT03587116|567485246|FG000|Overall Study|Lost to Follow-up|0|||
157202392|NCT03587116|567485247|FG001|Overall Study|Lost to Follow-up|1|||
157202393|NCT03587116|567485246|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
157202394|NCT03587116|567485247|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
157202395|NCT03587116|567485246|FG000|Overall Study|Withdrawal by Subject|4|||
157202396|NCT03587116|567485247|FG001|Overall Study|Withdrawal by Subject|0|||
157202397|NCT05993299|567485251|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
157202398|NCT05993299|567485251|FG000|Overall Study|Ongoing|4|||
157202399|NCT05644756|567485252|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
157202400|NCT05644756|567485252|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
157202401|NCT03985982|567485253|FG000|Double-Blind Phase|Lost to Follow-up|4|||
157202402|NCT03985982|567485254|FG001|Double-Blind Phase|Lost to Follow-up|3|||
157202403|NCT03985982|567485255|FG002|Double-Blind Phase|Lost to Follow-up|0|||
157202404|NCT03985982|567485253|FG000|Double-Blind Phase|Physician Decision|1|||
157202405|NCT03985982|567485254|FG001|Double-Blind Phase|Physician Decision|0|||
157202406|NCT03985982|567485255|FG002|Double-Blind Phase|Physician Decision|0|||
157202407|NCT03985982|567485253|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
157202408|NCT03985982|567485254|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
157202409|NCT03985982|567485255|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
157202410|NCT03985982|567485253|FG000|Double-Blind Phase|COVID-19|1|||
157202411|NCT03985982|567485254|FG001|Double-Blind Phase|COVID-19|0|||
157202412|NCT03985982|567485255|FG002|Double-Blind Phase|COVID-19|0|||
157202413|NCT03985982|567485253|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
157202414|NCT03985982|567485254|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
157202415|NCT03985982|567485255|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
157202416|NCT03985982|567485253|FG000|Open-Label Phase|Lost to Follow-up|0|||
157202417|NCT03985982|567485254|FG001|Open-Label Phase|Lost to Follow-up|0|||
157202418|NCT03985982|567485255|FG002|Open-Label Phase|Lost to Follow-up|13|||
157202419|NCT03985982|567485253|FG000|Open-Label Phase|Physician Decision|0|||
157202420|NCT03985982|567485254|FG001|Open-Label Phase|Physician Decision|0|||
157202421|NCT03985982|567485255|FG002|Open-Label Phase|Physician Decision|2|||
157202422|NCT03985982|567485253|FG000|Open-Label Phase|Withdrawal by Subject|0|||
157202423|NCT03985982|567485254|FG001|Open-Label Phase|Withdrawal by Subject|0|||
157202424|NCT03985982|567485255|FG002|Open-Label Phase|Withdrawal by Subject|11|||
157202425|NCT03526549|567485257|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
157202426|NCT03526549|567485258|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
157202427|NCT03526549|567485257|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
157202428|NCT03526549|567485258|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
157202429|NCT03526549|567485257|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
157202430|NCT03526549|567485258|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
157202431|NCT03526549|567485257|FG000|Open-label Phase|Adverse Event|4|||
157202432|NCT03526549|567485258|FG001|Open-label Phase|Adverse Event|0|||
157202433|NCT03526549|567485257|FG000|Open-label Phase|Withdrawal by Subject|54|||
157202434|NCT03526549|567485258|FG001|Open-label Phase|Withdrawal by Subject|0|||
157202435|NCT03526549|567485257|FG000|Open-label Phase|Lost to Follow-up|35|||
157202436|NCT03526549|567485258|FG001|Open-label Phase|Lost to Follow-up|0|||
157202437|NCT03526549|567485257|FG000|Open-label Phase|Other than Specified|5|||
157202438|NCT03526549|567485258|FG001|Open-label Phase|Other than Specified|0|||
157202439|NCT05981365|567485259|FG000|Period 1|Adverse Event|1|||
157202440|NCT05981365|567485260|FG001|Period 1|Adverse Event|0|||
157202441|NCT02593175|567485263|FG000|Overall Study|Adverse Event|5|||
157202442|NCT02593175|567485263|FG000|Overall Study|Disease progression|4|||
157202443|NCT00478933|567485264|FG000|Overall Study|Protocol Violation|22|||
157202444|NCT00478933|567485264|FG000|Overall Study|Informed consent not verified|3|||
157202445|NCT00478933|567485264|FG000|Overall Study|Inadequate data available|53|||
157202446|NCT00643006|567485266|FG000|Overall Study|Lost to Follow-up|5|||
157202447|NCT00643006|567485267|FG001|Overall Study|Lost to Follow-up|4|||
157202448|NCT02506101|567485268|FG000|Overall Study|Transportation issues|1|||
157202449|NCT02506101|567485269|FG001|Overall Study|Transportation issues|0|||
157202450|NCT02506101|567485268|FG000|Overall Study|No enrollment and staff unavailability|1|||
157202451|NCT02506101|567485269|FG001|Overall Study|No enrollment and staff unavailability|0|||
157202452|NCT03586427|567485273|FG000|Overall Study|Lost to Follow-up|0|||
157202453|NCT03586427|567485274|FG001|Overall Study|Lost to Follow-up|3|||
157202454|NCT03586427|567485275|FG002|Overall Study|Lost to Follow-up|1|||
157202455|NCT03586427|567485276|FG003|Overall Study|Lost to Follow-up|3|||
157202456|NCT03586427|567485277|FG004|Overall Study|Lost to Follow-up|3|||
157202457|NCT03586427|567485273|FG000|Overall Study|Withdrawal by Subject|0|||
157202458|NCT03586427|567485274|FG001|Overall Study|Withdrawal by Subject|1|||
157202459|NCT03586427|567485275|FG002|Overall Study|Withdrawal by Subject|2|||
157202460|NCT03586427|567485276|FG003|Overall Study|Withdrawal by Subject|1|||
157202461|NCT03586427|567485277|FG004|Overall Study|Withdrawal by Subject|1|||
157202462|NCT03586427|567485273|FG000|Overall Study|Adverse Event|0|||
157202463|NCT03586427|567485274|FG001|Overall Study|Adverse Event|0|||
157202464|NCT03586427|567485275|FG002|Overall Study|Adverse Event|1|||
157202465|NCT03586427|567485276|FG003|Overall Study|Adverse Event|0|||
157202466|NCT03586427|567485277|FG004|Overall Study|Adverse Event|0|||
157202467|NCT03586427|567485273|FG000|Overall Study|Protocol Violation|0|||
157202468|NCT03586427|567485274|FG001|Overall Study|Protocol Violation|0|||
157202469|NCT03586427|567485275|FG002|Overall Study|Protocol Violation|1|||
157202470|NCT03586427|567485276|FG003|Overall Study|Protocol Violation|0|||
157202471|NCT03586427|567485277|FG004|Overall Study|Protocol Violation|1|||
157202472|NCT03586427|567485273|FG000|Overall Study|Noncompliance with study drug|0|||
157202473|NCT03586427|567485274|FG001|Overall Study|Noncompliance with study drug|0|||
157202474|NCT03586427|567485275|FG002|Overall Study|Noncompliance with study drug|1|||
157202475|NCT03586427|567485276|FG003|Overall Study|Noncompliance with study drug|0|||
157202476|NCT03586427|567485277|FG004|Overall Study|Noncompliance with study drug|0|||
157202477|NCT03193996|567485280|FG000|Overall Study|Withdrawal by Subject|4|||
157202478|NCT03193996|567485280|FG000|Overall Study|Lost to Follow-up|4|||
157202479|NCT03193996|567485280|FG000|Overall Study|Physician Decision|2|||
157202480|NCT03193996|567485280|FG000|Overall Study|Pregnancy|1|||
157202481|NCT03193996|567485280|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
157202482|NCT03193996|567485280|FG000|Overall Study|Complicating disease|1|||
157202483|NCT00593385|567485283|FG000|Overall Study|Death|14|||
157202484|NCT00593385|567485283|FG000|Overall Study|Lost to Follow-up|17|||
157202485|NCT00593385|567485283|FG000|Overall Study|Withdrawal by Subject|9|||
157202486|NCT01471197|567485284|FG000|Overall Study|Disease Progression|4|||
157202487|NCT01471197|567485285|FG001|Overall Study|Disease Progression|2|||
157202488|NCT01471197|567485284|FG000|Overall Study|Death|1|||
157202489|NCT01471197|567485285|FG001|Overall Study|Death|0|||
157202490|NCT01471197|567485284|FG000|Overall Study|Study Drug Toxicity|1|||
157202491|NCT01471197|567485285|FG001|Overall Study|Study Drug Toxicity|0|||
157202492|NCT00455923|567485292|FG000|Overall Study|Pregnancy|0|||
157202493|NCT00455923|567485293|FG001|Overall Study|Pregnancy|2|||
157202494|NCT00455923|567485292|FG000|Overall Study|Other|3|||
157202495|NCT00455923|567485293|FG001|Overall Study|Other|1|||
157202496|NCT01891669|567485294|FG000|Overall Study|Death|0|||
157202497|NCT01891669|567485295|FG001|Overall Study|Death|0|||
157202498|NCT01891669|567485296|FG002|Overall Study|Death|0|||
157202499|NCT01891669|567485297|FG003|Overall Study|Death|0|||
157202500|NCT01891669|567485298|FG004|Overall Study|Death|0|||
157202501|NCT01891669|567485299|FG005|Overall Study|Death|0|||
157202502|NCT01891669|567485300|FG006|Overall Study|Death|0|||
157202503|NCT01891669|567485301|FG007|Overall Study|Death|1|||
157202504|NCT01891669|567485302|FG008|Overall Study|Death|0|||
157202505|NCT01891669|567485303|FG009|Overall Study|Death|1|||
157202506|NCT01891669|567485294|FG000|Overall Study|Withdrawal by Subject|1|||
157202507|NCT01891669|567485295|FG001|Overall Study|Withdrawal by Subject|1|||
157202508|NCT01891669|567485296|FG002|Overall Study|Withdrawal by Subject|0|||
157202509|NCT01891669|567485297|FG003|Overall Study|Withdrawal by Subject|0|||
157202510|NCT01891669|567485298|FG004|Overall Study|Withdrawal by Subject|0|||
157202511|NCT01891669|567485299|FG005|Overall Study|Withdrawal by Subject|0|||
157202512|NCT01891669|567485300|FG006|Overall Study|Withdrawal by Subject|1|||
157202513|NCT01891669|567485301|FG007|Overall Study|Withdrawal by Subject|2|||
157202514|NCT01891669|567485302|FG008|Overall Study|Withdrawal by Subject|1|||
157202515|NCT01891669|567485303|FG009|Overall Study|Withdrawal by Subject|1|||
157202516|NCT01891669|567485294|FG000|Overall Study|Other|1|||
157202517|NCT01891669|567485295|FG001|Overall Study|Other|0|||
157202518|NCT01891669|567485296|FG002|Overall Study|Other|0|||
157202519|NCT01891669|567485297|FG003|Overall Study|Other|0|||
157202520|NCT01891669|567485298|FG004|Overall Study|Other|0|||
157202521|NCT01891669|567485299|FG005|Overall Study|Other|0|||
157202522|NCT01891669|567485300|FG006|Overall Study|Other|0|||
157202523|NCT01891669|567485301|FG007|Overall Study|Other|1|||
157202524|NCT01891669|567485302|FG008|Overall Study|Other|0|||
157202525|NCT01891669|567485303|FG009|Overall Study|Other|0|||
157202526|NCT05643573|567485306|FG000|Overall Study|Adverse Event|117|||
157202527|NCT05643573|567485307|FG001|Overall Study|Adverse Event|90|||
157202528|NCT05643573|567485306|FG000|Overall Study|Death|53|||
157202529|NCT05643573|567485307|FG001|Overall Study|Death|57|||
157202530|NCT05643573|567485306|FG000|Overall Study|Lost to Follow-up|6|||
157202531|NCT05643573|567485307|FG001|Overall Study|Lost to Follow-up|3|||
157202532|NCT05643573|567485306|FG000|Overall Study|Other|18|||
157202533|NCT05643573|567485307|FG001|Overall Study|Other|15|||
157202534|NCT05643573|567485306|FG000|Overall Study|Outcome event|64|||
157202535|NCT05643573|567485307|FG001|Overall Study|Outcome event|36|||
157202536|NCT05643573|567485306|FG000|Overall Study|Physician Decision|33|||
157202537|NCT05643573|567485307|FG001|Overall Study|Physician Decision|19|||
157202538|NCT05643573|567485306|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
157202539|NCT05643573|567485307|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
157202540|NCT05643573|567485306|FG000|Overall Study|Site terminated by sponsor|10|||
157202541|NCT05643573|567485307|FG001|Overall Study|Site terminated by sponsor|10|||
157202542|NCT05643573|567485306|FG000|Overall Study|Study terminated by sponsor|1|||
157202543|NCT05643573|567485307|FG001|Overall Study|Study terminated by sponsor|0|||
157202544|NCT05643573|567485306|FG000|Overall Study|Withdrawal by Subject|178|||
157202545|NCT05643573|567485307|FG001|Overall Study|Withdrawal by Subject|130|||
157202546|NCT03328325|567485310|FG000|Overall Study|Lost to Follow-up|4|||
157202547|NCT03328325|567485310|FG000|Overall Study|Physician Decision|1|||
157202548|NCT03328325|567485310|FG000|Overall Study|Withdrawal by Subject|3|||
157202549|NCT03328325|567485310|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
157202550|NCT00931515|567485311|FG000|Overall Study|Lost to Follow-up|2|||
157202551|NCT00931515|567485312|FG001|Overall Study|Lost to Follow-up|5|||
157202552|NCT01054443|567485313|FG000|Overall Study|Withdrawal by Subject|0|||
157202553|NCT01054443|567485314|FG001|Overall Study|Withdrawal by Subject|0|||
157202554|NCT01054443|567485315|FG002|Overall Study|Withdrawal by Subject|0|||
157202555|NCT01054443|567485316|FG003|Overall Study|Withdrawal by Subject|1|||
157202556|NCT00985114|567485317|FG000|Overall Study|Adverse Event|1|||
157202557|NCT00985114|567485318|FG001|Overall Study|Adverse Event|0|||
157202558|NCT00985114|567485317|FG000|Overall Study|Withdrawal by Subject|0|||
157202559|NCT00985114|567485318|FG001|Overall Study|Withdrawal by Subject|2|||
157202560|NCT02950831|567485319|FG000|Overall Study|Lost to Follow-up|1|||
157202561|NCT02950831|567485319|FG000|Overall Study|Withdrawal by Subject|3|||
157202562|NCT02950831|567485319|FG000|Overall Study|stimulation trail failure|5|||
157202563|NCT01869959|567485323|FG000|Randomization Period|Physician Decision|0|||
157202564|NCT01869959|567485324|FG001|Randomization Period|Physician Decision|0|||
157202565|NCT01869959|567485325|FG002|Randomization Period|Physician Decision|0|||
157202566|NCT01869959|567485326|FG003|Randomization Period|Physician Decision|0|||
157202567|NCT01869959|567485327|FG004|Randomization Period|Physician Decision|1|||
157202568|NCT01869959|567485323|FG000|Treatment Period|Adverse Event|1|||
157202569|NCT01869959|567485324|FG001|Treatment Period|Adverse Event|0|||
157202570|NCT01869959|567485325|FG002|Treatment Period|Adverse Event|3|||
157202571|NCT01869959|567485326|FG003|Treatment Period|Adverse Event|1|||
157202572|NCT01869959|567485327|FG004|Treatment Period|Adverse Event|0|||
157202573|NCT01869959|567485323|FG000|Treatment Period|Sponsor decision|0|||
157202574|NCT01869959|567485324|FG001|Treatment Period|Sponsor decision|1|||
157202575|NCT01869959|567485325|FG002|Treatment Period|Sponsor decision|0|||
157202576|NCT01869959|567485326|FG003|Treatment Period|Sponsor decision|1|||
157202577|NCT01869959|567485327|FG004|Treatment Period|Sponsor decision|0|||
157202578|NCT01869959|567485323|FG000|Treatment Period|Withdrawal by Subject|0|||
157202579|NCT01869959|567485324|FG001|Treatment Period|Withdrawal by Subject|1|||
157202580|NCT01869959|567485325|FG002|Treatment Period|Withdrawal by Subject|0|||
157202581|NCT01869959|567485326|FG003|Treatment Period|Withdrawal by Subject|0|||
157202582|NCT01869959|567485327|FG004|Treatment Period|Withdrawal by Subject|0|||
157202583|NCT01965600|567485328|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
157202584|NCT01965600|567485329|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
157202585|NCT01965600|567485330|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
157202586|NCT01965600|567485331|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
157202587|NCT01965600|567485328|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
157202588|NCT01965600|567485329|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
157202589|NCT01965600|567485330|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
157202590|NCT01965600|567485331|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
157202591|NCT01965600|567485328|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
157202592|NCT01965600|567485329|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
157202593|NCT01965600|567485330|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
157202594|NCT01965600|567485331|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
157202595|NCT01965600|567485328|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
157202596|NCT01965600|567485329|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
157202597|NCT01965600|567485330|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
157202598|NCT01965600|567485331|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
157202599|NCT01965600|567485328|FG000|Second Intervention|Study terminated by Sponsor|0|||
157202600|NCT01965600|567485329|FG001|Second Intervention|Study terminated by Sponsor|0|||
157202601|NCT01965600|567485330|FG002|Second Intervention|Study terminated by Sponsor|2|||
157202602|NCT01965600|567485331|FG003|Second Intervention|Study terminated by Sponsor|2|||
157202603|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
157202604|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
157202605|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
157202606|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
157202607|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
157202608|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
157202609|NCT00828009|567485332|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
157202610|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
157202611|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
157202612|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Death|1|||
157202613|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
157202614|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
157202615|NCT00828009|567485332|FG000|Step 2 - Maintenance Therapy|Other|1|||
157202616|NCT00924313|567486595|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
157202617|NCT01298362|567486599|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
157202618|NCT01298362|567486600|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
157202619|NCT01283009|567486603|FG000|Overall Study|Death|83|||
157244541|NCT02611323|567639007|FG004|Overall Study|Withdrawal by Subject|0|||
157202620|NCT01283009|567486604|FG001|Overall Study|Death|78|||
157202621|NCT01283009|567486603|FG000|Overall Study|Study ended early|23|||
157202622|NCT01283009|567486604|FG001|Overall Study|Study ended early|26|||
157202623|NCT01283009|567486603|FG000|Overall Study|Withdrawal by Subject|10|||
157202624|NCT01283009|567486604|FG001|Overall Study|Withdrawal by Subject|8|||
157202625|NCT01283009|567486603|FG000|Overall Study|Physician Decision|1|||
157202626|NCT01283009|567486604|FG001|Overall Study|Physician Decision|1|||
157202627|NCT01283009|567486603|FG000|Overall Study|Lost to Follow-up|1|||
157202628|NCT01283009|567486604|FG001|Overall Study|Lost to Follow-up|0|||
157202629|NCT01283009|567486603|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
157202630|NCT01283009|567486604|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
157202631|NCT00183170|567486608|FG000|First Intervention|Did not complete study|1|||
157202632|NCT00183170|567486609|FG001|First Intervention|Did not complete study|0|||
157202633|NCT00183170|567486608|FG000|First Intervention|Did not meet targeted BrAC|1|||
157202634|NCT00183170|567486609|FG001|First Intervention|Did not meet targeted BrAC|0|||
157202635|NCT00183170|567486608|FG000|Washout 1 Week|Did not complete study|6|||
157202636|NCT00183170|567486609|FG001|Washout 1 Week|Did not complete study|8|||
157202637|NCT00183170|567486608|FG000|Second Intervention|Did not complete study|1|||
157202638|NCT00183170|567486609|FG001|Second Intervention|Did not complete study|0|||
157202639|NCT00183170|567486608|FG000|Second Intervention|Did not meet targeted BrAC|0|||
157202640|NCT00183170|567486609|FG001|Second Intervention|Did not meet targeted BrAC|2|||
157202641|NCT05102162|567486610|FG000|Overall Study|Withdrawal by Subject|3|||
157202642|NCT05102162|567486611|FG001|Overall Study|Withdrawal by Subject|0|||
157202643|NCT05102162|567486610|FG000|Overall Study|Baseline cultures negative|4|||
157202644|NCT05102162|567486611|FG001|Overall Study|Baseline cultures negative|2|||
157202645|NCT05102162|567486610|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
157202646|NCT05102162|567486611|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
157202647|NCT05102162|567486610|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
157202648|NCT05102162|567486611|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
157202649|NCT01353586|567486612|FG000|Overall Study|Procedure terminated prior to ablation|3|||
157202650|NCT01353586|567486613|FG001|Overall Study|Procedure terminated prior to ablation|0|||
157202651|NCT01353586|567486612|FG000|Overall Study|Never had insertion of study catheter|4|||
157202652|NCT01353586|567486613|FG001|Overall Study|Never had insertion of study catheter|1|||
157202653|NCT01353586|567486612|FG000|Overall Study|Neurological exam not done|0|||
157202654|NCT01353586|567486613|FG001|Overall Study|Neurological exam not done|1|||
157202655|NCT05027958|567486614|FG000|Overall Study|Lost to Follow-up|1|||
157202656|NCT05027958|567486615|FG001|Overall Study|Lost to Follow-up|1|||
157202657|NCT05027958|567486614|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
157202658|NCT05027958|567486615|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
157202659|NCT05027958|567486614|FG000|Overall Study|Physician Decision|1|||
157202660|NCT05027958|567486615|FG001|Overall Study|Physician Decision|4|||
157202661|NCT05027958|567486614|FG000|Overall Study|Adverse Event|0|||
157202662|NCT05027958|567486615|FG001|Overall Study|Adverse Event|1|||
157202663|NCT02871921|567486616|FG000|Overall Study|Withdrawal by Subject|34|||
157202664|NCT02871921|567486617|FG001|Overall Study|Withdrawal by Subject|27|||
157202665|NCT02871921|567486618|FG002|Overall Study|Withdrawal by Subject|27|||
157202666|NCT02871921|567486619|FG003|Overall Study|Withdrawal by Subject|30|||
157202667|NCT00326625|567486623|FG000|Overall Study|Adverse Event|20|||
157202668|NCT00326625|567486624|FG001|Overall Study|Adverse Event|9|||
157202669|NCT00326625|567486623|FG000|Overall Study|Withdrawal by Subject|15|||
157202670|NCT00326625|567486624|FG001|Overall Study|Withdrawal by Subject|12|||
157202671|NCT00326625|567486623|FG000|Overall Study|Death|18|||
157202672|NCT00326625|567486624|FG001|Overall Study|Death|16|||
157202673|NCT00326625|567486623|FG000|Overall Study|Lost to Follow-up|1|||
157202674|NCT00326625|567486624|FG001|Overall Study|Lost to Follow-up|0|||
157202675|NCT00326625|567486623|FG000|Overall Study|prescheduled medical intervention|0|||
157202676|NCT00326625|567486624|FG001|Overall Study|prescheduled medical intervention|1|||
157202677|NCT00625846|567486625|FG000|Overall Study|Withdrawal by Subject|2|||
157202678|NCT00625846|567486626|FG001|Overall Study|Withdrawal by Subject|0|||
157202679|NCT00625846|567486627|FG002|Overall Study|Withdrawal by Subject|1|||
157202680|NCT00625846|567486628|FG003|Overall Study|Withdrawal by Subject|2|||
157202681|NCT00890409|567486633|FG000|Overall Study|Lost to Follow-up|20|||
157202682|NCT00890409|567486634|FG001|Overall Study|Lost to Follow-up|21|||
157202683|NCT02353572|567486635|FG000|Overall Study|Withdrawal by Subject|1|||
157202684|NCT02353572|567486635|FG000|Overall Study|Study terminated|2|||
157202685|NCT03707145|567486646|FG000|Overall Study|Lost to Follow-up|0|||
157202686|NCT03707145|567486647|FG001|Overall Study|Lost to Follow-up|1|||
157202687|NCT03707145|567486648|FG002|Overall Study|Lost to Follow-up|1|||
157202688|NCT03707145|567486649|FG003|Overall Study|Lost to Follow-up|0|||
157202689|NCT04221477|567486650|FG000|Overall Study|Adverse Event|1|||
157202690|NCT04221477|567486651|FG001|Overall Study|Adverse Event|1|||
157202691|NCT04221477|567486650|FG000|Overall Study|Death|5|||
157202692|NCT04221477|567486651|FG001|Overall Study|Death|4|||
157202693|NCT04221477|567486650|FG000|Overall Study|Lack of Efficacy|1|||
157202694|NCT04221477|567486651|FG001|Overall Study|Lack of Efficacy|2|||
157202695|NCT04221477|567486650|FG000|Overall Study|Lost to Follow-up|1|||
157202696|NCT04221477|567486651|FG001|Overall Study|Lost to Follow-up|2|||
157202697|NCT04221477|567486650|FG000|Overall Study|Non-compliance with Study Drug|1|||
157202698|NCT04221477|567486651|FG001|Overall Study|Non-compliance with Study Drug|0|||
157244542|NCT02611323|567639008|FG005|Overall Study|Withdrawal by Subject|0|||
157244543|NCT02611323|567639009|FG006|Overall Study|Withdrawal by Subject|0|||
157244544|NCT02611323|567639010|FG007|Overall Study|Withdrawal by Subject|1|||
157244545|NCT02611323|567639011|FG008|Overall Study|Withdrawal by Subject|0|||
157244546|NCT02611323|567639012|FG009|Overall Study|Withdrawal by Subject|1|||
157244547|NCT02611323|567639013|FG010|Overall Study|Withdrawal by Subject|0|||
157244548|NCT01899053|567639016|FG000|Overall Study|Progressive Disease|4|||
157244549|NCT01899053|567639017|FG001|Overall Study|Progressive Disease|0|||
157244550|NCT01899053|567639018|FG002|Overall Study|Progressive Disease|3|||
157244551|NCT01899053|567639019|FG003|Overall Study|Progressive Disease|0|||
157244552|NCT01899053|567639020|FG004|Overall Study|Progressive Disease|3|||
157244553|NCT01899053|567639021|FG005|Overall Study|Progressive Disease|1|||
157244554|NCT01899053|567639022|FG006|Overall Study|Progressive Disease|1|||
157244555|NCT01899053|567639023|FG007|Overall Study|Progressive Disease|1|||
157244556|NCT01899053|567639024|FG008|Overall Study|Progressive Disease|4|||
157244557|NCT01899053|567639025|FG009|Overall Study|Progressive Disease|3|||
157244558|NCT01899053|567639026|FG010|Overall Study|Progressive Disease|12|||
157244559|NCT01899053|567639027|FG011|Overall Study|Progressive Disease|5|||
157244560|NCT01899053|567639028|FG012|Overall Study|Progressive Disease|8|||
157244561|NCT01899053|567639029|FG013|Overall Study|Progressive Disease|17|||
157244562|NCT01899053|567639016|FG000|Overall Study|Adverse Event|1|||
157244563|NCT01899053|567639017|FG001|Overall Study|Adverse Event|1|||
157244564|NCT01899053|567639018|FG002|Overall Study|Adverse Event|1|||
157244565|NCT01899053|567639019|FG003|Overall Study|Adverse Event|3|||
157244566|NCT01899053|567639020|FG004|Overall Study|Adverse Event|1|||
157244567|NCT01899053|567639021|FG005|Overall Study|Adverse Event|1|||
157244568|NCT01899053|567639022|FG006|Overall Study|Adverse Event|1|||
157244569|NCT01899053|567639023|FG007|Overall Study|Adverse Event|0|||
157244570|NCT01899053|567639024|FG008|Overall Study|Adverse Event|2|||
157244571|NCT01899053|567639025|FG009|Overall Study|Adverse Event|0|||
157244572|NCT01899053|567639026|FG010|Overall Study|Adverse Event|3|||
157244573|NCT01899053|567639027|FG011|Overall Study|Adverse Event|1|||
157244574|NCT01899053|567639028|FG012|Overall Study|Adverse Event|2|||
157244575|NCT01899053|567639029|FG013|Overall Study|Adverse Event|2|||
157244576|NCT01899053|567639016|FG000|Overall Study|Reason Not Specified|0|||
157244577|NCT01899053|567639017|FG001|Overall Study|Reason Not Specified|0|||
157244578|NCT01899053|567639018|FG002|Overall Study|Reason Not Specified|0|||
157244579|NCT01899053|567639019|FG003|Overall Study|Reason Not Specified|0|||
157244580|NCT01899053|567639020|FG004|Overall Study|Reason Not Specified|0|||
157244581|NCT01899053|567639021|FG005|Overall Study|Reason Not Specified|0|||
157244582|NCT01899053|567639022|FG006|Overall Study|Reason Not Specified|1|||
157244583|NCT01899053|567639023|FG007|Overall Study|Reason Not Specified|0|||
157244584|NCT01899053|567639024|FG008|Overall Study|Reason Not Specified|0|||
157244585|NCT01899053|567639025|FG009|Overall Study|Reason Not Specified|0|||
157244586|NCT01899053|567639026|FG010|Overall Study|Reason Not Specified|0|||
157244587|NCT01899053|567639027|FG011|Overall Study|Reason Not Specified|0|||
157244588|NCT01899053|567639028|FG012|Overall Study|Reason Not Specified|1|||
157244589|NCT01899053|567639029|FG013|Overall Study|Reason Not Specified|0|||
157244590|NCT01899053|567639016|FG000|Overall Study|Withdrawal by Subject|1|||
157244591|NCT01899053|567639017|FG001|Overall Study|Withdrawal by Subject|1|||
157244592|NCT01899053|567639018|FG002|Overall Study|Withdrawal by Subject|2|||
157244593|NCT01899053|567639019|FG003|Overall Study|Withdrawal by Subject|0|||
157202699|NCT04221477|567486650|FG000|Overall Study|Reason not Specified|0|||
157202700|NCT04221477|567486651|FG001|Overall Study|Reason not Specified|5|||
157202701|NCT04221477|567486650|FG000|Overall Study|Physician Decision|0|||
157202702|NCT04221477|567486651|FG001|Overall Study|Physician Decision|6|||
157202703|NCT04221477|567486650|FG000|Overall Study|Withdrawal by Subject|10|||
157202704|NCT04221477|567486651|FG001|Overall Study|Withdrawal by Subject|14|||
157202705|NCT04221477|567486650|FG000|Overall Study|Ongoing in the Study|116|||
157202706|NCT04221477|567486651|FG001|Overall Study|Ongoing in the Study|102|||
157244594|NCT01899053|567639020|FG004|Overall Study|Withdrawal by Subject|2|||
157244595|NCT01899053|567639021|FG005|Overall Study|Withdrawal by Subject|0|||
157244596|NCT01899053|567639022|FG006|Overall Study|Withdrawal by Subject|0|||
157244597|NCT01899053|567639023|FG007|Overall Study|Withdrawal by Subject|1|||
157244598|NCT01899053|567639024|FG008|Overall Study|Withdrawal by Subject|0|||
157244599|NCT01899053|567639025|FG009|Overall Study|Withdrawal by Subject|0|||
157244600|NCT01899053|567639026|FG010|Overall Study|Withdrawal by Subject|0|||
157244601|NCT01899053|567639027|FG011|Overall Study|Withdrawal by Subject|0|||
157244602|NCT01899053|567639028|FG012|Overall Study|Withdrawal by Subject|1|||
157244603|NCT01899053|567639029|FG013|Overall Study|Withdrawal by Subject|1|||
157244604|NCT01899053|567639016|FG000|Overall Study|Protocol Violation|0|||
157244605|NCT01899053|567639017|FG001|Overall Study|Protocol Violation|0|||
157244606|NCT01899053|567639018|FG002|Overall Study|Protocol Violation|1|||
157244607|NCT01899053|567639019|FG003|Overall Study|Protocol Violation|0|||
157244608|NCT01899053|567639020|FG004|Overall Study|Protocol Violation|0|||
157202707|NCT02242942|567486652|FG000|Overall Study|Death|17|||
157244609|NCT01899053|567639021|FG005|Overall Study|Protocol Violation|0|||
157244610|NCT01899053|567639022|FG006|Overall Study|Protocol Violation|0|||
157244611|NCT01899053|567639023|FG007|Overall Study|Protocol Violation|0|||
157244612|NCT01899053|567639024|FG008|Overall Study|Protocol Violation|0|||
157244613|NCT01899053|567639025|FG009|Overall Study|Protocol Violation|0|||
157244614|NCT01899053|567639026|FG010|Overall Study|Protocol Violation|0|||
157244615|NCT01899053|567639027|FG011|Overall Study|Protocol Violation|0|||
157244616|NCT01899053|567639028|FG012|Overall Study|Protocol Violation|0|||
157244617|NCT01899053|567639029|FG013|Overall Study|Protocol Violation|0|||
157244618|NCT01899053|567639016|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
157244619|NCT01899053|567639017|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
157244620|NCT01899053|567639018|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244621|NCT01899053|567639019|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244622|NCT01899053|567639020|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244623|NCT01899053|567639021|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244624|NCT01899053|567639022|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244625|NCT01899053|567639023|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244626|NCT01899053|567639024|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244627|NCT01899053|567639025|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244628|NCT01899053|567639026|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
157244629|NCT01899053|567639027|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244630|NCT01899053|567639028|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244631|NCT01899053|567639029|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
157244632|NCT01899053|567639016|FG000|Overall Study|Symptomatic Deterioration|0|||
157244633|NCT01899053|567639017|FG001|Overall Study|Symptomatic Deterioration|0|||
157244634|NCT01899053|567639018|FG002|Overall Study|Symptomatic Deterioration|0|||
157244635|NCT01899053|567639019|FG003|Overall Study|Symptomatic Deterioration|0|||
157244636|NCT01899053|567639020|FG004|Overall Study|Symptomatic Deterioration|0|||
157244637|NCT01899053|567639021|FG005|Overall Study|Symptomatic Deterioration|1|||
157244638|NCT01899053|567639022|FG006|Overall Study|Symptomatic Deterioration|0|||
157244639|NCT01899053|567639023|FG007|Overall Study|Symptomatic Deterioration|1|||
157244640|NCT01899053|567639024|FG008|Overall Study|Symptomatic Deterioration|0|||
157244641|NCT01899053|567639025|FG009|Overall Study|Symptomatic Deterioration|0|||
157244642|NCT01899053|567639026|FG010|Overall Study|Symptomatic Deterioration|0|||
157244643|NCT01899053|567639027|FG011|Overall Study|Symptomatic Deterioration|1|||
157244644|NCT01899053|567639028|FG012|Overall Study|Symptomatic Deterioration|2|||
157244645|NCT01899053|567639029|FG013|Overall Study|Symptomatic Deterioration|0|||
157244646|NCT00227370|567639031|FG000|Overall Study|Withdrawal by Subject|1|||
157244647|NCT00227370|567639032|FG001|Overall Study|Withdrawal by Subject|2|||
157244648|NCT00227370|567639031|FG000|Overall Study|Death|3|||
157244649|NCT00227370|567639032|FG001|Overall Study|Death|4|||
157244650|NCT00227370|567639031|FG000|Overall Study|Adverse Event|6|||
157244651|NCT00227370|567639032|FG001|Overall Study|Adverse Event|11|||
157244652|NCT00227370|567639031|FG000|Overall Study|Physician Decision|9|||
157244653|NCT00227370|567639032|FG001|Overall Study|Physician Decision|6|||
157244654|NCT00227370|567639031|FG000|Overall Study|Other reasons|2|||
157244655|NCT00227370|567639032|FG001|Overall Study|Other reasons|1|||
157244656|NCT02011945|567639036|FG000|Overall Study|Participant requested to Discontinue|0|||
157244657|NCT02011945|567639037|FG001|Overall Study|Participant requested to Discontinue|1|||
157244658|NCT02011945|567639038|FG002|Overall Study|Participant requested to Discontinue|1|||
157244659|NCT02011945|567639036|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
157244660|NCT02011945|567639037|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
157244661|NCT02011945|567639038|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
157244662|NCT02011945|567639036|FG000|Overall Study|Study Drug Toxicity|0|||
157244663|NCT02011945|567639037|FG001|Overall Study|Study Drug Toxicity|0|||
157244664|NCT02011945|567639038|FG002|Overall Study|Study Drug Toxicity|1|||
157244665|NCT02011945|567639036|FG000|Overall Study|Treatment Failure|0|||
157244666|NCT02011945|567639037|FG001|Overall Study|Treatment Failure|7|||
157244667|NCT02011945|567639038|FG002|Overall Study|Treatment Failure|6|||
157244668|NCT02011945|567639036|FG000|Overall Study|No Longer Meets Study Criteria|1|||
157244669|NCT02011945|567639037|FG001|Overall Study|No Longer Meets Study Criteria|0|||
157244670|NCT02011945|567639038|FG002|Overall Study|No Longer Meets Study Criteria|0|||
157244671|NCT02011945|567639036|FG000|Overall Study|Proceeded to stem cell transplant|0|||
157244672|NCT02011945|567639037|FG001|Overall Study|Proceeded to stem cell transplant|0|||
157244673|NCT02011945|567639038|FG002|Overall Study|Proceeded to stem cell transplant|1|||
157244674|NCT02011945|567639036|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
157244675|NCT02011945|567639037|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
157244676|NCT02011945|567639038|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
157244677|NCT00902538|567639039|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
157244678|NCT00902538|567639040|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
157244679|NCT00902538|567639041|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
157244680|NCT00902538|567639042|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
157244681|NCT00902538|567639043|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
157244682|NCT00902538|567639044|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
157244683|NCT00902538|567639039|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
157244684|NCT00902538|567639040|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
157244685|NCT00902538|567639041|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
157244686|NCT00902538|567639042|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
157244687|NCT00902538|567639043|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
157244688|NCT00902538|567639044|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
157244689|NCT00902538|567639039|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
157244690|NCT00902538|567639040|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
157244691|NCT00902538|567639041|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
157244692|NCT00902538|567639042|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
157244693|NCT00902538|567639043|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
157244694|NCT00902538|567639044|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
157244695|NCT00902538|567639039|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
157244696|NCT00902538|567639040|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
157244697|NCT00902538|567639041|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
157244698|NCT00902538|567639042|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
157244699|NCT00902538|567639043|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
157244700|NCT00902538|567639044|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
157244701|NCT00902538|567639039|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
157244702|NCT00902538|567639040|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
157244703|NCT00902538|567639041|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
157244704|NCT00902538|567639042|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
157244705|NCT00902538|567639043|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
157244706|NCT00902538|567639044|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
157244707|NCT00902538|567639039|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
157244708|NCT00902538|567639040|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
157244709|NCT00902538|567639041|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
157244710|NCT00902538|567639042|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
157244711|NCT00902538|567639043|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
157244712|NCT00902538|567639044|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
157244713|NCT00902538|567639039|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
157244714|NCT00902538|567639040|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
157244715|NCT00902538|567639041|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
157244716|NCT00902538|567639042|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
157244717|NCT00902538|567639043|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
157244718|NCT00902538|567639044|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
157244719|NCT00902538|567639039|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
157244720|NCT00902538|567639040|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
157244721|NCT00902538|567639041|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
157244722|NCT00902538|567639042|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
157244723|NCT00902538|567639043|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
157244724|NCT00902538|567639044|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
157244725|NCT00902538|567639039|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
157244726|NCT00902538|567639040|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
157244727|NCT00902538|567639041|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
157244728|NCT00902538|567639042|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
157244729|NCT00902538|567639043|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
157244730|NCT00902538|567639044|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
157244731|NCT00902538|567639039|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
157244732|NCT00902538|567639040|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
157244733|NCT00902538|567639041|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
157244734|NCT00902538|567639042|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
157244735|NCT00902538|567639043|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
157244736|NCT00902538|567639044|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
157244737|NCT00902538|567639039|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
157244738|NCT00902538|567639040|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
157244739|NCT00902538|567639041|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
157244740|NCT00902538|567639042|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
157244741|NCT00902538|567639043|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
157244742|NCT00902538|567639044|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
157244743|NCT00902538|567639039|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
157244744|NCT00902538|567639040|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
157244745|NCT00902538|567639041|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
157244746|NCT00902538|567639042|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
157244747|NCT00902538|567639043|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
157244748|NCT00902538|567639044|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
157202708|NCT02242942|567486653|FG001|Overall Study|Death|20|||
157202709|NCT02242942|567486654|FG002|Overall Study|Death|2|||
157202710|NCT02242942|567486652|FG000|Overall Study|Physician Decision|1|||
157202711|NCT02242942|567486653|FG001|Overall Study|Physician Decision|0|||
157202712|NCT02242942|567486654|FG002|Overall Study|Physician Decision|0|||
157202713|NCT02242942|567486652|FG000|Overall Study|Withdrawal by Subject|8|||
157202714|NCT02242942|567486653|FG001|Overall Study|Withdrawal by Subject|10|||
157202715|NCT02242942|567486654|FG002|Overall Study|Withdrawal by Subject|0|||
157202716|NCT02242942|567486652|FG000|Overall Study|On-going in Study|190|||
157202717|NCT02242942|567486653|FG001|Overall Study|On-going in Study|186|||
157202718|NCT02242942|567486654|FG002|Overall Study|On-going in Study|11|||
157202719|NCT01215968|567486658|FG000|Overall Study|Adverse Event|0|||
157202720|NCT01215968|567486659|FG001|Overall Study|Adverse Event|2|||
157202721|NCT01215968|567486658|FG000|Overall Study|Protocol Violation|2|||
157202722|NCT01215968|567486659|FG001|Overall Study|Protocol Violation|4|||
157202723|NCT01215968|567486658|FG000|Overall Study|Not received study drug|0|||
157202724|NCT01215968|567486659|FG001|Overall Study|Not received study drug|1|||
157202725|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
157202726|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
157202727|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
157202728|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202729|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202730|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202731|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
157202732|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202733|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202734|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
157202735|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202736|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202737|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202738|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
157202739|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
157202740|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202741|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
157202742|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202743|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202744|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202745|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
157202746|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
157202747|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202748|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
157202749|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202750|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202751|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202752|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
157202753|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
157202754|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
157202755|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
157202756|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202757|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202758|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202759|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
157202760|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202761|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202762|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
157202763|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202764|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202765|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202766|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
157202767|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157202768|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157202769|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
157202770|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157202771|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157202772|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157244749|NCT00902538|567639039|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
157244750|NCT00902538|567639040|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
157244751|NCT00902538|567639041|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
157244752|NCT00902538|567639042|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
157244753|NCT00902538|567639043|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
157244754|NCT00902538|567639044|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
157244755|NCT00902538|567639039|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
157244756|NCT00902538|567639040|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
157244757|NCT00902538|567639041|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
157244758|NCT00902538|567639042|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
157244759|NCT00902538|567639043|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
157244760|NCT00902538|567639044|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
157244761|NCT00902538|567639039|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
157244762|NCT00902538|567639040|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
157244763|NCT00902538|567639041|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
157244764|NCT00902538|567639042|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
157244765|NCT00902538|567639043|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
157244766|NCT00902538|567639044|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
157244767|NCT00902538|567639039|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
157244768|NCT00902538|567639040|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
157244769|NCT00902538|567639041|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
157244770|NCT00902538|567639042|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
157244771|NCT00902538|567639043|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
157244772|NCT00902538|567639044|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
157244773|NCT00902538|567639039|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
157244774|NCT00902538|567639040|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
157244775|NCT00902538|567639041|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
157244776|NCT00902538|567639042|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
157244777|NCT00902538|567639043|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
157244778|NCT00902538|567639044|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
157244779|NCT03531827|567639045|FG000|Overall Study|Adverse Event|2|||
157244780|NCT03531827|567639046|FG001|Overall Study|Adverse Event|0|||
157202773|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
157202774|NCT04242498|567486664|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202775|NCT04242498|567486665|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
157202776|NCT04242498|567486666|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
157202777|NCT04242498|567486667|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202778|NCT04242498|567486668|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202779|NCT04242498|567486669|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202780|NCT04242498|567486670|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
157202781|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202782|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202783|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202784|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
157202785|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
157202786|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
157202787|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
157202788|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202789|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202790|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202791|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
157202792|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
157202793|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
157202794|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
157202795|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202796|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202797|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202798|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202799|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
157202800|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
157202801|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
157202802|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157202803|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157202804|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
157244781|NCT03531827|567639045|FG000|Overall Study|Progressive disease|1|||
157244782|NCT03531827|567639046|FG001|Overall Study|Progressive disease|0|||
157244783|NCT03067987|567639047|FG000|Overall Study|Lost to Follow-up|7|||
157244784|NCT03067987|567639048|FG001|Overall Study|Lost to Follow-up|10|||
157244785|NCT03067987|567639047|FG000|Overall Study|Protocol Violation|1|||
157244786|NCT03067987|567639048|FG001|Overall Study|Protocol Violation|2|||
157244787|NCT03067987|567639047|FG000|Overall Study|Withdrawal by Subject|2|||
157244788|NCT03067987|567639048|FG001|Overall Study|Withdrawal by Subject|1|||
157244789|NCT02316223|567640922|FG000|Overall Study|Lack of Efficacy|0|||
157244790|NCT02316223|567640923|FG001|Overall Study|Lack of Efficacy|1|||
157244791|NCT02316223|567640924|FG002|Overall Study|Lack of Efficacy|1|||
157244792|NCT02316223|567640922|FG000|Overall Study|Lost to Follow-up|27|||
157244793|NCT02316223|567640923|FG001|Overall Study|Lost to Follow-up|34|||
157244794|NCT02316223|567640924|FG002|Overall Study|Lost to Follow-up|36|||
157244795|NCT02316223|567640922|FG000|Overall Study|COPD Diagnosis|3|||
157244796|NCT02316223|567640923|FG001|Overall Study|COPD Diagnosis|2|||
157244797|NCT02316223|567640924|FG002|Overall Study|COPD Diagnosis|3|||
157244798|NCT02316223|567640922|FG000|Overall Study|Reside outside study area|1|||
157244799|NCT02316223|567640923|FG001|Overall Study|Reside outside study area|1|||
157244800|NCT02316223|567640924|FG002|Overall Study|Reside outside study area|1|||
157244801|NCT02316223|567640922|FG000|Overall Study|No asthma|2|||
157244802|NCT02316223|567640923|FG001|Overall Study|No asthma|0|||
157244803|NCT02316223|567640924|FG002|Overall Study|No asthma|0|||
157244804|NCT02316223|567640922|FG000|Overall Study|Discontinued by PI|11|||
157244805|NCT02316223|567640923|FG001|Overall Study|Discontinued by PI|19|||
157244806|NCT02316223|567640924|FG002|Overall Study|Discontinued by PI|3|||
157244807|NCT00529763|567640925|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
157244808|NCT00529763|567640926|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
157244809|NCT00529763|567640927|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
157244810|NCT00529763|567640925|FG000|Overall Study|Death|1|||
157244811|NCT00529763|567640926|FG001|Overall Study|Death|1|||
157244812|NCT00529763|567640927|FG002|Overall Study|Death|1|||
157244813|NCT00529763|567640925|FG000|Overall Study|Disease Progression|10|||
157244814|NCT00529763|567640926|FG001|Overall Study|Disease Progression|16|||
157244815|NCT00529763|567640927|FG002|Overall Study|Disease Progression|11|||
157244816|NCT00529763|567640925|FG000|Overall Study|Lost to Follow-up|1|||
157244817|NCT00529763|567640926|FG001|Overall Study|Lost to Follow-up|2|||
157244818|NCT00529763|567640927|FG002|Overall Study|Lost to Follow-up|3|||
157244819|NCT00529763|567640925|FG000|Overall Study|Stem Cell Transplant|0|||
157244820|NCT00529763|567640926|FG001|Overall Study|Stem Cell Transplant|3|||
157244821|NCT00529763|567640927|FG002|Overall Study|Stem Cell Transplant|1|||
157244822|NCT00529763|567640925|FG000|Overall Study|Study Drug Toxicity|3|||
157244823|NCT00529763|567640926|FG001|Overall Study|Study Drug Toxicity|6|||
157244824|NCT00529763|567640927|FG002|Overall Study|Study Drug Toxicity|4|||
157244825|NCT00529763|567640925|FG000|Overall Study|Participant Withdrew Consent|2|||
157244826|NCT00529763|567640926|FG001|Overall Study|Participant Withdrew Consent|3|||
157244827|NCT00529763|567640927|FG002|Overall Study|Participant Withdrew Consent|4|||
157244828|NCT00529763|567640925|FG000|Overall Study|Other reasons|2|||
157244829|NCT00529763|567640926|FG001|Overall Study|Other reasons|0|||
157244830|NCT00529763|567640927|FG002|Overall Study|Other reasons|2|||
157244831|NCT00529763|567640925|FG000|Overall Study|Participant request to discontinue treatment|1|||
157244832|NCT00529763|567640926|FG001|Overall Study|Participant request to discontinue treatment|1|||
157244833|NCT00529763|567640927|FG002|Overall Study|Participant request to discontinue treatment|3|||
157244834|NCT03669250|567640928|FG000|Overall Study|Adverse Event|0|||
157244835|NCT03669250|567640929|FG001|Overall Study|Adverse Event|0|||
157244836|NCT03669250|567640930|FG002|Overall Study|Adverse Event|0|||
157244837|NCT03669250|567640931|FG003|Overall Study|Adverse Event|0|||
157244838|NCT03669250|567640932|FG004|Overall Study|Adverse Event|1|||
157244839|NCT03669250|567640933|FG005|Overall Study|Adverse Event|0|||
157244840|NCT03669250|567640928|FG000|Overall Study|Withdrawal by Subject|0|||
157244841|NCT03669250|567640929|FG001|Overall Study|Withdrawal by Subject|1|||
157244842|NCT03669250|567640930|FG002|Overall Study|Withdrawal by Subject|0|||
157244843|NCT03669250|567640931|FG003|Overall Study|Withdrawal by Subject|1|||
157244844|NCT03669250|567640932|FG004|Overall Study|Withdrawal by Subject|0|||
157244845|NCT03669250|567640933|FG005|Overall Study|Withdrawal by Subject|0|||
157244846|NCT03234907|567640934|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
157244847|NCT03234907|567640935|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
157244848|NCT03234907|567640936|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
157244849|NCT03234907|567640937|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
157244850|NCT03234907|567640938|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
157244851|NCT03234907|567640939|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
157244852|NCT03234907|567640934|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
157244853|NCT03234907|567640935|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
157244854|NCT03234907|567640936|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
157244855|NCT03234907|567640937|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
157244856|NCT03234907|567640938|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
157244857|NCT03234907|567640939|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
157244858|NCT03234907|567640934|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
157244859|NCT03234907|567640935|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
157244860|NCT03234907|567640936|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
157244861|NCT03234907|567640937|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
157244862|NCT03234907|567640938|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
157244863|NCT03234907|567640939|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
157244864|NCT03234907|567640934|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
157244865|NCT03234907|567640935|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
157244866|NCT03234907|567640936|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
157244867|NCT03234907|567640937|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
157244868|NCT03234907|567640938|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
157244869|NCT03234907|567640939|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
157244870|NCT03234907|567640934|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
157244871|NCT03234907|567640935|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
157244872|NCT03234907|567640936|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
157244873|NCT03234907|567640937|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
157244874|NCT03234907|567640938|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
157244875|NCT03234907|567640939|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
157244876|NCT03234907|567640934|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
157244877|NCT03234907|567640935|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
157244878|NCT03234907|567640936|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
157244879|NCT03234907|567640937|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
157244880|NCT03234907|567640938|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
157244881|NCT03234907|567640939|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
157244882|NCT03234907|567640934|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
157244883|NCT03234907|567640935|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
157244884|NCT03234907|567640936|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
157244885|NCT03234907|567640937|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
157244886|NCT03234907|567640938|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
157244887|NCT03234907|567640939|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
157244888|NCT02986139|567640942|FG000|Overall Study|Sponsor Decision|1|||
157244889|NCT02986139|567640943|FG001|Overall Study|Sponsor Decision|2|||
157244890|NCT02986139|567640942|FG000|Overall Study|Withdrawal by Subject|0|||
157244891|NCT02986139|567640943|FG001|Overall Study|Withdrawal by Subject|1|||
157244892|NCT02986139|567640942|FG000|Overall Study|Lost to Follow-up|0|||
157244893|NCT02986139|567640943|FG001|Overall Study|Lost to Follow-up|1|||
157244894|NCT00414726|567640944|FG000|Overall Study|Withdrawal by Subject|0|||
157244895|NCT00414726|567640945|FG001|Overall Study|Withdrawal by Subject|1|||
157244896|NCT02107196|567640946|FG000|12-week Treatment Period|Adverse Event|6|||
157244897|NCT02107196|567640947|FG001|12-week Treatment Period|Adverse Event|3|||
157244898|NCT02107196|567640946|FG000|12-week Treatment Period|Lack of Efficacy|2|||
157244899|NCT02107196|567640947|FG001|12-week Treatment Period|Lack of Efficacy|1|||
157244900|NCT02107196|567640946|FG000|12-week Treatment Period|Lost to Follow-up|3|||
157244901|NCT02107196|567640947|FG001|12-week Treatment Period|Lost to Follow-up|6|||
157244902|NCT02107196|567640946|FG000|12-week Treatment Period|Physician Decision|0|||
157244903|NCT02107196|567640947|FG001|12-week Treatment Period|Physician Decision|1|||
157244904|NCT02107196|567640946|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
157244905|NCT02107196|567640947|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
157244906|NCT02107196|567640946|FG000|12-week Treatment Period|Protocol Violation|7|||
157244907|NCT02107196|567640947|FG001|12-week Treatment Period|Protocol Violation|8|||
157244908|NCT02107196|567640946|FG000|12-week Treatment Period|Reason Missing|11|||
157244909|NCT02107196|567640947|FG001|12-week Treatment Period|Reason Missing|8|||
157244910|NCT02107196|567640946|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
157244911|NCT02107196|567640947|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
157244912|NCT02107196|567640946|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
157244913|NCT02107196|567640947|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
157244914|NCT02107196|567640946|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
157244915|NCT02107196|567640947|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
157244916|NCT02107196|567640946|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
157244917|NCT02107196|567640947|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
157244918|NCT00660660|567640950|FG000|Overall Study|Adverse Event|1|||
157244919|NCT00660660|567640951|FG001|Overall Study|Adverse Event|0|||
157244920|NCT00660660|567640950|FG000|Overall Study|Lost to Follow-up|0|||
157244921|NCT00660660|567640951|FG001|Overall Study|Lost to Follow-up|6|||
157244922|NCT00660660|567640950|FG000|Overall Study|Lack of Efficacy|0|||
157244923|NCT00660660|567640951|FG001|Overall Study|Lack of Efficacy|2|||
157244924|NCT00660660|567640950|FG000|Overall Study|Withdrawal by Subject|3|||
157202805|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
157202806|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
157202807|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
157202808|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
157202809|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202810|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202811|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
157202812|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
157202813|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
157202814|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
157202815|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
157202816|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202817|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202818|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202819|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202820|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
157202821|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202822|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
157202823|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202824|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202825|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202826|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202827|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202828|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
157202829|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
157202830|NCT04242498|567486664|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
157202831|NCT04242498|567486665|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
157202832|NCT04242498|567486666|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
157202833|NCT04242498|567486667|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
157202834|NCT04242498|567486668|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
157202835|NCT04242498|567486669|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
157202836|NCT04242498|567486670|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
157202837|NCT02500732|567486673|FG000|Overall Study|Physician Decision|0|||
157202838|NCT02500732|567486674|FG001|Overall Study|Physician Decision|1|||
157202839|NCT01958619|567486675|FG000|Overall Study|Protocol Violation|2|||
157202840|NCT01958619|567486676|FG001|Overall Study|Protocol Violation|0|||
157202841|NCT01958619|567486677|FG002|Overall Study|Protocol Violation|1|||
157202842|NCT01958619|567486678|FG003|Overall Study|Protocol Violation|0|||
157202843|NCT03205605|567486679|FG000|Overall Study|Withdrawal by Subject|1|||
157202844|NCT03795233|567486680|FG000|Overall Study|Withdrawal by Subject|2|||
157202845|NCT03795233|567486681|FG001|Overall Study|Withdrawal by Subject|1|||
157202846|NCT03795233|567486680|FG000|Overall Study|Lost to Follow-up|1|||
157202847|NCT03795233|567486681|FG001|Overall Study|Lost to Follow-up|0|||
157202848|NCT03795233|567486680|FG000|Overall Study|Death|1|||
157202849|NCT03795233|567486681|FG001|Overall Study|Death|0|||
157202850|NCT02756182|567486682|FG000|Overall Study|StudyTechnical Difficulties|4|||
157202851|NCT01003691|567486684|FG000|Overall Study|Adverse Event|0|||
157202852|NCT01003691|567486685|FG001|Overall Study|Adverse Event|0|||
157202853|NCT01003691|567486686|FG002|Overall Study|Adverse Event|0|||
157202854|NCT01003691|567486687|FG003|Overall Study|Adverse Event|1|||
157202855|NCT01676818|567486697|FG000|Overall Study|Physician Decision|1|||
157202856|NCT01676818|567486697|FG000|Overall Study|Withdrawal by Subject|1|||
157202857|NCT00347776|567488042|FG000|1.5 Month Follow-up|Death|2|||
157202858|NCT00347776|567488043|FG001|1.5 Month Follow-up|Death|0|||
157202859|NCT00347776|567488044|FG002|1.5 Month Follow-up|Death|0|||
157202860|NCT00347776|567488042|FG000|1.5 Month Follow-up|reached the endpoint|12|||
157202861|NCT00347776|567488043|FG001|1.5 Month Follow-up|reached the endpoint|8|||
157202862|NCT00347776|567488044|FG002|1.5 Month Follow-up|reached the endpoint|12|||
157202863|NCT00347776|567488042|FG000|6 Month Follow-up|Death|2|||
157202864|NCT00347776|567488043|FG001|6 Month Follow-up|Death|1|||
157202865|NCT00347776|567488044|FG002|6 Month Follow-up|Death|3|||
157202866|NCT00347776|567488042|FG000|6 Month Follow-up|reached endpont|20|||
157202867|NCT00347776|567488043|FG001|6 Month Follow-up|reached endpont|12|||
157202868|NCT00347776|567488044|FG002|6 Month Follow-up|reached endpont|15|||
157202869|NCT00347776|567488042|FG000|12 Month Follow-up|Lost to Follow-up|7|||
157202870|NCT00347776|567488043|FG001|12 Month Follow-up|Lost to Follow-up|6|||
157202871|NCT00347776|567488044|FG002|12 Month Follow-up|Lost to Follow-up|6|||
157202872|NCT00347776|567488042|FG000|12 Month Follow-up|Death|3|||
157202873|NCT00347776|567488043|FG001|12 Month Follow-up|Death|4|||
157202874|NCT00347776|567488044|FG002|12 Month Follow-up|Death|4|||
157202875|NCT00347776|567488042|FG000|12 Month Follow-up|Reached endpoint|13|||
157202876|NCT00347776|567488043|FG001|12 Month Follow-up|Reached endpoint|6|||
157202877|NCT00347776|567488044|FG002|12 Month Follow-up|Reached endpoint|9|||
157202878|NCT01100073|567488045|FG000|Overall Study|Lack of Efficacy|4|||
157202879|NCT01100073|567488045|FG000|Overall Study|Insufficient Tolerability|21|||
157202880|NCT01100073|567488045|FG000|Overall Study|Withdrawal by Subject|13|||
157202881|NCT01100073|567488045|FG000|Overall Study|Lost to Follow-up|39|||
157202882|NCT01100073|567488045|FG000|Overall Study|Lack of effect + patient's wish|2|||
157202883|NCT01100073|567488045|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
157202884|NCT01100073|567488045|FG000|Overall Study|Other|8|||
157202885|NCT01100073|567488045|FG000|Overall Study|Missing|5|||
157202886|NCT03099265|567488046|FG000|Overall Study|Adverse Event|1|||
157202887|NCT00968539|567488054|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
157202888|NCT00968539|567488055|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
157202889|NCT00396318|567488056|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
157202890|NCT00326118|567488057|FG000|Active Phase|Withdrawal by Subject|4|||
157202891|NCT00326118|567488058|FG001|Active Phase|Withdrawal by Subject|1|||
157202892|NCT00602927|567488059|FG000|Period 1: 13 Days|Protocol Violation|2|||
157202893|NCT00602927|567488060|FG001|Period 1: 13 Days|Protocol Violation|4|||
157202894|NCT00602927|567488059|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
157202895|NCT00602927|567488060|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
157202896|NCT00602927|567488059|FG000|Period 1: 13 Days|Time|1|||
157202897|NCT00602927|567488060|FG001|Period 1: 13 Days|Time|0|||
157202898|NCT00602927|567488059|FG000|Period 1: 13 Days|Claustrophobia|0|||
157202899|NCT00602927|567488060|FG001|Period 1: 13 Days|Claustrophobia|1|||
157202900|NCT00602927|567488059|FG000|Period 2: 14 Days|Protocol Violation|0|||
157202901|NCT00602927|567488060|FG001|Period 2: 14 Days|Protocol Violation|2|||
157202902|NCT00602927|567488059|FG000|Period 3: 13 Days|Protocol Violation|0|||
157202903|NCT00602927|567488060|FG001|Period 3: 13 Days|Protocol Violation|1|||
157202904|NCT00602927|567488059|FG000|Period 3: 13 Days|MRI data quality|2|||
157202905|NCT00602927|567488060|FG001|Period 3: 13 Days|MRI data quality|2|||
157202906|NCT01741259|567488069|FG000|Overall Study|Protocol Violation|6|||
157202907|NCT01741259|567488070|FG001|Overall Study|Protocol Violation|4|||
157202908|NCT01741259|567488069|FG000|Overall Study|Withdrawal by Subject|0|||
157202909|NCT01741259|567488070|FG001|Overall Study|Withdrawal by Subject|2|||
157202910|NCT05604521|567488075|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
157202911|NCT05604521|567488076|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
157202912|NCT05604521|567488075|FG000|Overall Study|Adverse Event|1|||
157202913|NCT05604521|567488076|FG001|Overall Study|Adverse Event|0|||
157202914|NCT02074982|567488077|FG000|Overall Study|Adverse Event|15|||
157202915|NCT02074982|567488078|FG001|Overall Study|Adverse Event|7|||
157202916|NCT02074982|567488077|FG000|Overall Study|Lack of Efficacy|6|||
157202917|NCT02074982|567488078|FG001|Overall Study|Lack of Efficacy|1|||
157202918|NCT02074982|567488077|FG000|Overall Study|Lost to Follow-up|9|||
157202919|NCT02074982|567488078|FG001|Overall Study|Lost to Follow-up|10|||
157202920|NCT02074982|567488077|FG000|Overall Study|Non-compliance with study treatment|0|||
157202921|NCT02074982|567488078|FG001|Overall Study|Non-compliance with study treatment|2|||
157202922|NCT02074982|567488077|FG000|Overall Study|Physician Decision|1|||
157202923|NCT02074982|567488078|FG001|Overall Study|Physician Decision|1|||
157202924|NCT02074982|567488077|FG000|Overall Study|Pregnancy|1|||
157202925|NCT02074982|567488078|FG001|Overall Study|Pregnancy|2|||
157202926|NCT02074982|567488077|FG000|Overall Study|Protocol deviation|4|||
157202927|NCT02074982|567488078|FG001|Overall Study|Protocol deviation|3|||
157202928|NCT02074982|567488077|FG000|Overall Study|Technical problems|0|||
157202929|NCT02074982|567488078|FG001|Overall Study|Technical problems|2|||
157202930|NCT02074982|567488077|FG000|Overall Study|Subject/guardian decision|15|||
157202931|NCT02074982|567488078|FG001|Overall Study|Subject/guardian decision|24|||
157202932|NCT02074982|567488077|FG000|Overall Study|Death|0|||
157202933|NCT02074982|567488078|FG001|Overall Study|Death|2|||
157202934|NCT02525627|567488083|FG000|Overall Study|Revision|1|||
157202935|NCT02525627|567488084|FG001|Overall Study|Revision|1|||
157202936|NCT02525627|567488083|FG000|Overall Study|Withdrawal by Subject|1|||
157202937|NCT02525627|567488084|FG001|Overall Study|Withdrawal by Subject|2|||
157202938|NCT02525627|567488083|FG000|Overall Study|Death|1|||
157202939|NCT02525627|567488084|FG001|Overall Study|Death|0|||
157202940|NCT02525627|567488083|FG000|Overall Study|Site terminated|11|||
157202941|NCT02525627|567488084|FG001|Overall Study|Site terminated|10|||
157202942|NCT00242567|567488085|FG000|Overall Study|Adverse Event|70|||
157202943|NCT00242567|567488086|FG001|Overall Study|Adverse Event|43|||
157202944|NCT00242567|567488085|FG000|Overall Study|Disease Progression|17|||
157202945|NCT00242567|567488086|FG001|Overall Study|Disease Progression|22|||
157202946|NCT00242567|567488085|FG000|Overall Study|Symptomatic deterioration|9|||
157244925|NCT00660660|567640951|FG001|Overall Study|Withdrawal by Subject|0|||
157244926|NCT00660660|567640950|FG000|Overall Study|Incorrect enrollment and other|0|||
157244927|NCT00660660|567640951|FG001|Overall Study|Incorrect enrollment and other|1|||
157244928|NCT00660660|567640950|FG000|Overall Study|New medication after randomization|1|||
157244929|NCT00660660|567640951|FG001|Overall Study|New medication after randomization|0|||
157244930|NCT01630616|567640952|FG000|Overall Study|Adverse Event|0|||
157244931|NCT01630616|567640953|FG001|Overall Study|Adverse Event|0|||
157244932|NCT01630616|567640954|FG002|Overall Study|Adverse Event|0|||
157244933|NCT01630616|567640955|FG003|Overall Study|Adverse Event|1|||
157244934|NCT01630616|567640956|FG004|Overall Study|Adverse Event|0|||
157244935|NCT01630616|567640957|FG005|Overall Study|Adverse Event|0|||
157244936|NCT01630616|567640952|FG000|Overall Study|Withdrawal by Subject|0|||
157244937|NCT01630616|567640953|FG001|Overall Study|Withdrawal by Subject|0|||
157244938|NCT01630616|567640954|FG002|Overall Study|Withdrawal by Subject|0|||
157244939|NCT01630616|567640955|FG003|Overall Study|Withdrawal by Subject|2|||
157244940|NCT01630616|567640956|FG004|Overall Study|Withdrawal by Subject|0|||
157244941|NCT01630616|567640957|FG005|Overall Study|Withdrawal by Subject|0|||
157244942|NCT01993186|567640958|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
157244943|NCT01993186|567640959|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
157244944|NCT01993186|567640958|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
157244945|NCT01993186|567640959|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
157244946|NCT01993186|567640958|FG000|Open-Label Extension Period|Other, Not Specified|0|||
157244947|NCT01993186|567640959|FG001|Open-Label Extension Period|Other, Not Specified|1|||
157244948|NCT01993186|567640958|FG000|Open-Label Extension Period|Adverse Event|1|||
157244949|NCT01993186|567640959|FG001|Open-Label Extension Period|Adverse Event|0|||
157244950|NCT01993186|567640958|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
157244951|NCT01993186|567640959|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
157244952|NCT01993186|567640958|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
157244953|NCT01993186|567640959|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
157244954|NCT01993186|567640958|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
157244955|NCT01993186|567640959|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
157244956|NCT04523480|567640960|FG000|Overall Study|Lost to Follow-up|30|||
157244957|NCT04523480|567640961|FG001|Overall Study|Lost to Follow-up|35|||
157244958|NCT04523480|567640962|FG002|Overall Study|Lost to Follow-up|0|||
157244959|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
157244960|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
157244961|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
157244962|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
157244963|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
157244964|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
157244965|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
157244966|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
157244967|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
157244968|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
157244969|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
157244970|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
157244971|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
157244972|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
157244973|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
157244974|NCT00385736|567640964|FG000|Efficacy Analysis Set - Induction|Other|0|||
157244975|NCT00385736|567640965|FG001|Efficacy Analysis Set - Induction|Other|0|||
157244976|NCT00385736|567640966|FG002|Efficacy Analysis Set - Induction|Other|1|||
157244977|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
157244978|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
157244979|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
157244980|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
157244981|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
157244982|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
157244983|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
157244984|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
157244985|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
157244986|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
157244987|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
157244988|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
157244989|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
157244990|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
157244991|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
157244992|NCT00385736|567640964|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
157244993|NCT00385736|567640965|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
157244994|NCT00385736|567640966|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
157202947|NCT00242567|567488086|FG001|Overall Study|Symptomatic deterioration|3|||
157202948|NCT00242567|567488085|FG000|Overall Study|Lack of Efficacy|2|||
157202949|NCT00242567|567488086|FG001|Overall Study|Lack of Efficacy|2|||
157202950|NCT00242567|567488085|FG000|Overall Study|Lost to Follow-up|9|||
157202951|NCT00242567|567488086|FG001|Overall Study|Lost to Follow-up|19|||
157202952|NCT00242567|567488085|FG000|Overall Study|Withdrawal by Subject|33|||
157202953|NCT00242567|567488086|FG001|Overall Study|Withdrawal by Subject|28|||
157202954|NCT00242567|567488085|FG000|Overall Study|Protocol Violation|12|||
157202955|NCT00242567|567488086|FG001|Overall Study|Protocol Violation|12|||
157202956|NCT00242567|567488085|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
157202957|NCT00242567|567488086|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
157202958|NCT00242567|567488085|FG000|Overall Study|Other|14|||
157202959|NCT00242567|567488086|FG001|Overall Study|Other|9|||
157202960|NCT00630994|567488087|FG000|Overall Study|Adverse Event|1|||
157202961|NCT00630994|567488087|FG000|Overall Study|Disease Progression|1|||
157202962|NCT00630994|567488087|FG000|Overall Study|Lack of Efficacy|1|||
157202963|NCT00630994|567488087|FG000|Overall Study|Other|1|||
157202964|NCT05553600|567488088|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
157202965|NCT05553600|567488089|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
157202966|NCT05553600|567488090|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
157202967|NCT05553600|567488091|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
157202968|NCT05553600|567488088|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
157202969|NCT05553600|567488089|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
157202970|NCT05553600|567488090|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
157202971|NCT05553600|567488091|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
157202972|NCT05553600|567488088|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
157202973|NCT05553600|567488089|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
157202974|NCT05553600|567488090|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
157202975|NCT05553600|567488091|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
157202976|NCT05553600|567488088|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
157202977|NCT05553600|567488089|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
157202978|NCT05553600|567488090|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
157202979|NCT05553600|567488091|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
157202980|NCT05553600|567488088|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
157202981|NCT05553600|567488089|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
157202982|NCT05553600|567488090|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
157202983|NCT05553600|567488091|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
157202984|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
157202985|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
157202986|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
157202987|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
157202988|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
157202989|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
157202990|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
157202991|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
157202992|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
157202993|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
157202994|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
157202995|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
157202996|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
157202997|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
157202998|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
157202999|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
157203000|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
157203001|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
157203002|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
157203003|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
157203004|NCT05553600|567488088|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
157203005|NCT05553600|567488089|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
157203006|NCT05553600|567488090|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
157203007|NCT05553600|567488091|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
157203008|NCT05553600|567488088|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
157203009|NCT05553600|567488089|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
157203010|NCT05553600|567488090|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
157203011|NCT05553600|567488091|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
157203012|NCT03710824|567488099|FG000|Overall Study|Withdrawal by Subject|1|||
157203013|NCT03710824|567488099|FG000|Overall Study|Lost to Follow-up|3|||
157203014|NCT03710824|567488099|FG000|Overall Study|Adverse Event|25|||
157203015|NCT03710824|567488099|FG000|Overall Study|Treatment discontinuation|2|||
157203016|NCT01605370|567488100|FG000|Overall Study|Adverse Event|1|||
157203017|NCT01605370|567488101|FG001|Overall Study|Adverse Event|0|||
157203018|NCT01870921|567488108|FG000|Overall Study|Subject decision|80|||
157203019|NCT01870921|567488108|FG000|Overall Study|Severe non-compliance to protocol|7|||
157203020|NCT01870921|567488108|FG000|Overall Study|Subject Lost to Follow up|2|||
157203021|NCT01870921|567488108|FG000|Overall Study|Other|1|||
157203022|NCT02060188|567488112|FG000|Overall Study|Disease Progression|36|||
157203023|NCT02060188|567488113|FG001|Overall Study|Disease Progression|42|||
157203024|NCT02060188|567488114|FG002|Overall Study|Disease Progression|8|||
157203025|NCT02060188|567488115|FG003|Overall Study|Disease Progression|5|||
157203026|NCT02060188|567488116|FG004|Overall Study|Disease Progression|6|||
157203027|NCT02060188|567488117|FG005|Overall Study|Disease Progression|3|||
157203028|NCT02060188|567488118|FG006|Overall Study|Disease Progression|23|||
157203029|NCT02060188|567488119|FG007|Overall Study|Disease Progression|20|||
157203030|NCT02060188|567488120|FG008|Overall Study|Disease Progression|43|||
157203031|NCT02060188|567488112|FG000|Overall Study|Study Drug Toxicity|10|||
157203032|NCT02060188|567488113|FG001|Overall Study|Study Drug Toxicity|18|||
157203033|NCT02060188|567488114|FG002|Overall Study|Study Drug Toxicity|7|||
157203034|NCT02060188|567488115|FG003|Overall Study|Study Drug Toxicity|4|||
157203035|NCT02060188|567488116|FG004|Overall Study|Study Drug Toxicity|3|||
157203036|NCT02060188|567488117|FG005|Overall Study|Study Drug Toxicity|0|||
157203037|NCT02060188|567488118|FG006|Overall Study|Study Drug Toxicity|2|||
157203038|NCT02060188|567488119|FG007|Overall Study|Study Drug Toxicity|5|||
157203039|NCT02060188|567488120|FG008|Overall Study|Study Drug Toxicity|0|||
157203040|NCT02060188|567488112|FG000|Overall Study|Adverse event unrelated to study drug|2|||
157203041|NCT02060188|567488113|FG001|Overall Study|Adverse event unrelated to study drug|5|||
157203042|NCT02060188|567488114|FG002|Overall Study|Adverse event unrelated to study drug|6|||
157203043|NCT02060188|567488115|FG003|Overall Study|Adverse event unrelated to study drug|0|||
157203044|NCT02060188|567488116|FG004|Overall Study|Adverse event unrelated to study drug|1|||
157203045|NCT02060188|567488117|FG005|Overall Study|Adverse event unrelated to study drug|0|||
157203046|NCT02060188|567488118|FG006|Overall Study|Adverse event unrelated to study drug|4|||
157203047|NCT02060188|567488119|FG007|Overall Study|Adverse event unrelated to study drug|4|||
157203048|NCT02060188|567488120|FG008|Overall Study|Adverse event unrelated to study drug|1|||
157203049|NCT02060188|567488112|FG000|Overall Study|Participant request to discontinue study treatment|7|||
157203050|NCT02060188|567488113|FG001|Overall Study|Participant request to discontinue study treatment|7|||
157203051|NCT02060188|567488114|FG002|Overall Study|Participant request to discontinue study treatment|4|||
157203052|NCT02060188|567488115|FG003|Overall Study|Participant request to discontinue study treatment|0|||
157203053|NCT02060188|567488116|FG004|Overall Study|Participant request to discontinue study treatment|0|||
157203054|NCT02060188|567488117|FG005|Overall Study|Participant request to discontinue study treatment|0|||
157203055|NCT02060188|567488118|FG006|Overall Study|Participant request to discontinue study treatment|1|||
157203056|NCT02060188|567488119|FG007|Overall Study|Participant request to discontinue study treatment|1|||
157203057|NCT02060188|567488120|FG008|Overall Study|Participant request to discontinue study treatment|0|||
157203058|NCT02060188|567488112|FG000|Overall Study|Participant withdrew consent|3|||
157203059|NCT02060188|567488113|FG001|Overall Study|Participant withdrew consent|0|||
157203060|NCT02060188|567488114|FG002|Overall Study|Participant withdrew consent|0|||
157203061|NCT02060188|567488115|FG003|Overall Study|Participant withdrew consent|0|||
157203062|NCT02060188|567488116|FG004|Overall Study|Participant withdrew consent|0|||
157203063|NCT02060188|567488117|FG005|Overall Study|Participant withdrew consent|0|||
157203064|NCT02060188|567488118|FG006|Overall Study|Participant withdrew consent|0|||
157203065|NCT02060188|567488119|FG007|Overall Study|Participant withdrew consent|0|||
157203066|NCT02060188|567488120|FG008|Overall Study|Participant withdrew consent|0|||
157203067|NCT02060188|567488112|FG000|Overall Study|Maximum clinical benefit|13|||
157203068|NCT02060188|567488113|FG001|Overall Study|Maximum clinical benefit|38|||
157203069|NCT02060188|567488114|FG002|Overall Study|Maximum clinical benefit|19|||
157203070|NCT02060188|567488115|FG003|Overall Study|Maximum clinical benefit|0|||
157203071|NCT02060188|567488116|FG004|Overall Study|Maximum clinical benefit|0|||
157203072|NCT02060188|567488117|FG005|Overall Study|Maximum clinical benefit|0|||
157203073|NCT02060188|567488118|FG006|Overall Study|Maximum clinical benefit|0|||
157203074|NCT02060188|567488119|FG007|Overall Study|Maximum clinical benefit|10|||
157203075|NCT02060188|567488120|FG008|Overall Study|Maximum clinical benefit|0|||
157203076|NCT02060188|567488112|FG000|Overall Study|Other reason|3|||
157203077|NCT02060188|567488113|FG001|Overall Study|Other reason|7|||
157203078|NCT02060188|567488114|FG002|Overall Study|Other reason|0|||
157203079|NCT02060188|567488115|FG003|Overall Study|Other reason|1|||
157203080|NCT02060188|567488116|FG004|Overall Study|Other reason|0|||
157203081|NCT02060188|567488117|FG005|Overall Study|Other reason|0|||
157203082|NCT02060188|567488118|FG006|Overall Study|Other reason|0|||
157203083|NCT02060188|567488119|FG007|Overall Study|Other reason|9|||
157203084|NCT02060188|567488120|FG008|Overall Study|Other reason|0|||
157203085|NCT02060188|567488112|FG000|Overall Study|Death|0|||
157203086|NCT02060188|567488113|FG001|Overall Study|Death|1|||
157244995|NCT00385736|567640964|FG000|Safety Analysis Set|Adverse Event|23|||
157203087|NCT02060188|567488114|FG002|Overall Study|Death|0|||
157203088|NCT02060188|567488115|FG003|Overall Study|Death|0|||
157203089|NCT02060188|567488116|FG004|Overall Study|Death|0|||
157203090|NCT02060188|567488117|FG005|Overall Study|Death|0|||
157203091|NCT02060188|567488118|FG006|Overall Study|Death|0|||
157203092|NCT02060188|567488119|FG007|Overall Study|Death|1|||
157203093|NCT02060188|567488120|FG008|Overall Study|Death|0|||
157203094|NCT02060188|567488112|FG000|Overall Study|Administrative reasons by sponsor|0|||
157203095|NCT02060188|567488113|FG001|Overall Study|Administrative reasons by sponsor|1|||
157203096|NCT02060188|567488114|FG002|Overall Study|Administrative reasons by sponsor|0|||
157203097|NCT02060188|567488115|FG003|Overall Study|Administrative reasons by sponsor|0|||
157203098|NCT02060188|567488116|FG004|Overall Study|Administrative reasons by sponsor|0|||
157203099|NCT02060188|567488117|FG005|Overall Study|Administrative reasons by sponsor|0|||
157203100|NCT02060188|567488118|FG006|Overall Study|Administrative reasons by sponsor|0|||
157203101|NCT02060188|567488119|FG007|Overall Study|Administrative reasons by sponsor|0|||
157203102|NCT02060188|567488120|FG008|Overall Study|Administrative reasons by sponsor|0|||
157203103|NCT02060188|567488112|FG000|Overall Study|Lost to Follow-up|0|||
157203104|NCT02060188|567488113|FG001|Overall Study|Lost to Follow-up|0|||
157203105|NCT02060188|567488114|FG002|Overall Study|Lost to Follow-up|1|||
157203106|NCT02060188|567488115|FG003|Overall Study|Lost to Follow-up|0|||
157203107|NCT02060188|567488116|FG004|Overall Study|Lost to Follow-up|0|||
157203108|NCT02060188|567488117|FG005|Overall Study|Lost to Follow-up|0|||
157203109|NCT02060188|567488118|FG006|Overall Study|Lost to Follow-up|0|||
157203110|NCT02060188|567488119|FG007|Overall Study|Lost to Follow-up|0|||
157203111|NCT02060188|567488120|FG008|Overall Study|Lost to Follow-up|0|||
157203112|NCT04456998|567488123|FG000|Overall Study|Adverse Event|0|||
157203113|NCT04456998|567488124|FG001|Overall Study|Adverse Event|4|||
157203114|NCT04456998|567488123|FG000|Overall Study|Protocol Deviation|0|||
157203115|NCT04456998|567488124|FG001|Overall Study|Protocol Deviation|1|||
157203116|NCT04456998|567488123|FG000|Overall Study|Withdrawal by Subject|0|||
157203117|NCT04456998|567488124|FG001|Overall Study|Withdrawal by Subject|1|||
157203118|NCT04882085|567488128|FG000|Overall Study|Death|6|||
157203119|NCT04882085|567488129|FG001|Overall Study|Death|9|||
157203120|NCT04882085|567488128|FG000|Overall Study|Withdrawal by Subject|0|||
157203121|NCT04882085|567488129|FG001|Overall Study|Withdrawal by Subject|3|||
157203122|NCT04882085|567488128|FG000|Overall Study|Randomized not treated|1|||
157203123|NCT04882085|567488129|FG001|Overall Study|Randomized not treated|0|||
157203124|NCT04455620|567488133|FG000|Overall Study|Withdrawal by Subject|0|||
157203125|NCT04455620|567488134|FG001|Overall Study|Withdrawal by Subject|0|||
157203126|NCT04455620|567488135|FG002|Overall Study|Withdrawal by Subject|2|||
157203127|NCT04455620|567488136|FG003|Overall Study|Withdrawal by Subject|0|||
157203128|NCT04455620|567488137|FG004|Overall Study|Withdrawal by Subject|1|||
157203129|NCT04455620|567488133|FG000|Overall Study|Lost to Follow-up|0|||
157203130|NCT04455620|567488134|FG001|Overall Study|Lost to Follow-up|0|||
157203131|NCT04455620|567488135|FG002|Overall Study|Lost to Follow-up|1|||
157203132|NCT04455620|567488136|FG003|Overall Study|Lost to Follow-up|1|||
157203133|NCT04455620|567488137|FG004|Overall Study|Lost to Follow-up|0|||
157203134|NCT04455620|567488133|FG000|Overall Study|Death|1|||
157203135|NCT04455620|567488134|FG001|Overall Study|Death|6|||
157203136|NCT04455620|567488135|FG002|Overall Study|Death|20|||
157203137|NCT04455620|567488136|FG003|Overall Study|Death|1|||
157203138|NCT04455620|567488137|FG004|Overall Study|Death|7|||
157203139|NCT04455620|567488133|FG000|Overall Study|Study Termination|0|||
157203140|NCT04455620|567488134|FG001|Overall Study|Study Termination|2|||
157203141|NCT04455620|567488135|FG002|Overall Study|Study Termination|1|||
157203142|NCT04455620|567488136|FG003|Overall Study|Study Termination|0|||
157203143|NCT04455620|567488137|FG004|Overall Study|Study Termination|6|||
157203144|NCT03792633|567488138|FG000|Overall Study|Alternative Treatment|17|||
157203145|NCT03792633|567488139|FG001|Overall Study|Alternative Treatment|19|||
157203146|NCT03792633|567488138|FG000|Overall Study|Death|2|||
157203147|NCT03792633|567488139|FG001|Overall Study|Death|0|||
157244996|NCT00385736|567640965|FG001|Safety Analysis Set|Adverse Event|15|||
157203148|NCT03792633|567488138|FG000|Overall Study|Disease progression|8|||
157203149|NCT03792633|567488139|FG001|Overall Study|Disease progression|9|||
157203150|NCT03792633|567488138|FG000|Overall Study|Lost to Follow-up|1|||
157203151|NCT03792633|567488139|FG001|Overall Study|Lost to Follow-up|1|||
157203152|NCT03792633|567488138|FG000|Overall Study|Screen fail|1|||
157203153|NCT03792633|567488139|FG001|Overall Study|Screen fail|0|||
157203154|NCT03792633|567488138|FG000|Overall Study|Second malignancy|0|||
157203155|NCT03792633|567488139|FG001|Overall Study|Second malignancy|1|||
157203156|NCT00145119|567488140|FG000|Overall Study|Death|45|||
157203157|NCT05681715|567488141|FG000|Training Period (6-weeks)|Adverse Event|3|||
157203158|NCT05681715|567488142|FG001|Training Period (6-weeks)|Adverse Event|0|||
157203159|NCT05681715|567488143|FG002|Training Period (6-weeks)|Adverse Event|0|||
157203160|NCT05681715|567488141|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
157203161|NCT05681715|567488142|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
157203162|NCT05681715|567488143|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
157203163|NCT05681715|567488141|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
157244997|NCT00385736|567640966|FG002|Safety Analysis Set|Adverse Event|23|||
157244998|NCT00385736|567640964|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
157244999|NCT00385736|567640965|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
157245000|NCT00385736|567640966|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
157245001|NCT00385736|567640964|FG000|Safety Analysis Set|Lost to Follow-up|0|||
157245002|NCT00385736|567640965|FG001|Safety Analysis Set|Lost to Follow-up|2|||
157245003|NCT00385736|567640966|FG002|Safety Analysis Set|Lost to Follow-up|2|||
157245004|NCT00385736|567640964|FG000|Safety Analysis Set|Lack of Efficacy|38|||
157245005|NCT00385736|567640965|FG001|Safety Analysis Set|Lack of Efficacy|16|||
157245006|NCT00385736|567640966|FG002|Safety Analysis Set|Lack of Efficacy|31|||
157245007|NCT00385736|567640964|FG000|Safety Analysis Set|Protocol Violation|2|||
157245008|NCT00385736|567640965|FG001|Safety Analysis Set|Protocol Violation|1|||
157245009|NCT00385736|567640966|FG002|Safety Analysis Set|Protocol Violation|6|||
157245010|NCT00385736|567640964|FG000|Safety Analysis Set|Other|1|||
157245011|NCT00385736|567640965|FG001|Safety Analysis Set|Other|4|||
157245012|NCT00385736|567640966|FG002|Safety Analysis Set|Other|4|||
157245013|NCT01701063|567640969|FG000|Overall Study|Lost to Follow-up|0|||
157245014|NCT01701063|567640970|FG001|Overall Study|Lost to Follow-up|1|||
157245015|NCT01701063|567640971|FG002|Overall Study|Lost to Follow-up|0|||
157245016|NCT01701063|567640969|FG000|Overall Study|Withdrawal by Subject|0|||
157245017|NCT01701063|567640970|FG001|Overall Study|Withdrawal by Subject|0|||
157245018|NCT01701063|567640971|FG002|Overall Study|Withdrawal by Subject|1|||
157245019|NCT01701063|567640969|FG000|Overall Study|Other|0|||
157245020|NCT01701063|567640970|FG001|Overall Study|Other|0|||
157245021|NCT01701063|567640971|FG002|Overall Study|Other|1|||
157245022|NCT01919112|567640972|FG000|Secondary Analysis-day 30|Death|1|||
157245023|NCT01919112|567640973|FG001|Secondary Analysis-day 30|Death|1|||
157245024|NCT01919112|567640974|FG002|Secondary Analysis-day 30|Death|1|||
157245025|NCT01919112|567640972|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
157203164|NCT05681715|567488142|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
157203165|NCT05681715|567488143|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
157245026|NCT01919112|567640973|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
157245027|NCT01919112|567640974|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
157245028|NCT02043132|567640975|FG000|Overall Study|Lost to Follow-up|1|||
157245029|NCT02043132|567640976|FG001|Overall Study|Lost to Follow-up|1|||
157245030|NCT02043132|567640975|FG000|Overall Study|screen failures|4|||
157245031|NCT02043132|567640976|FG001|Overall Study|screen failures|8|||
157245032|NCT04474405|567640977|FG000|Overall Study|Withdrawal by Subject|0|||
157245033|NCT04474405|567640978|FG001|Overall Study|Withdrawal by Subject|0|||
157245034|NCT04474405|567640979|FG002|Overall Study|Withdrawal by Subject|1|||
157245035|NCT04474405|567640980|FG003|Overall Study|Withdrawal by Subject|0|||
157245036|NCT04474405|567640981|FG004|Overall Study|Withdrawal by Subject|1|||
157245037|NCT04474405|567640982|FG005|Overall Study|Withdrawal by Subject|0|||
157245038|NCT04474405|567640977|FG000|Overall Study|Other|0|||
157245039|NCT04474405|567640978|FG001|Overall Study|Other|0|||
157245040|NCT04474405|567640979|FG002|Overall Study|Other|0|||
157245041|NCT04474405|567640980|FG003|Overall Study|Other|0|||
157245042|NCT04474405|567640981|FG004|Overall Study|Other|3|||
157245043|NCT04474405|567640982|FG005|Overall Study|Other|0|||
157245044|NCT00918645|567640983|FG000|Overall Study|Withdrawal by Subject|1|||
157245045|NCT03446768|567640984|FG000|Overall Study|Withdrawal by Subject|0|||
157245046|NCT03446768|567640985|FG001|Overall Study|Withdrawal by Subject|1|||
157245047|NCT00635648|567640986|FG000|Overall Study|Adverse Event|12|||
157245048|NCT00635648|567640986|FG000|Overall Study|Withdrawal by Subject|9|||
157245049|NCT00635648|567640986|FG000|Overall Study|Physician Decision|4|||
157245050|NCT00635648|567640986|FG000|Overall Study|Rapid progression of baseline disease|4|||
157203166|NCT05681715|567488141|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
157203167|NCT05681715|567488142|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
157203168|NCT05681715|567488143|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
157245051|NCT00635648|567640986|FG000|Overall Study|Use of other antifungal agent needed|1|||
157245052|NCT00635648|567640986|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
157245053|NCT00635648|567640986|FG000|Overall Study|Noncompliance with protocol|1|||
157203169|NCT05681715|567488141|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
157245054|NCT00635648|567640986|FG000|Overall Study|Other reason|2|||
157245055|NCT03827395|567640990|FG000|Overall Study|Lost to Follow-up|1|||
157245056|NCT03827395|567640991|FG001|Overall Study|Lost to Follow-up|0|||
157203170|NCT05681715|567488142|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
157203171|NCT05681715|567488143|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
157203172|NCT05681715|567488141|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
157203173|NCT05681715|567488142|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
157203174|NCT05681715|567488143|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
157245057|NCT03827395|567640990|FG000|Overall Study|Protocol Violation|1|||
157245058|NCT03827395|567640991|FG001|Overall Study|Protocol Violation|0|||
157245059|NCT03827395|567640990|FG000|Overall Study|Became ineligible after enrollment|1|||
157203175|NCT05681715|567488141|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
157203176|NCT05681715|567488142|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
157203177|NCT05681715|567488143|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
157203178|NCT05681715|567488141|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
157203179|NCT05681715|567488142|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
157203180|NCT05681715|567488143|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
157203181|NCT05455684|567488144|FG000|Overall Study|Withdrawal by Subject|7|||
157203182|NCT05455684|567488145|FG001|Overall Study|Withdrawal by Subject|4|||
157203183|NCT05455684|567488144|FG000|Overall Study|Lost to Follow-up|3|||
157203184|NCT05455684|567488145|FG001|Overall Study|Lost to Follow-up|3|||
157203185|NCT05455684|567488144|FG000|Overall Study|Adverse Event|2|||
157203186|NCT05455684|567488145|FG001|Overall Study|Adverse Event|3|||
157203187|NCT05455684|567488144|FG000|Overall Study|Protocol Violation|1|||
157203188|NCT05455684|567488145|FG001|Overall Study|Protocol Violation|1|||
157203189|NCT05455684|567488144|FG000|Overall Study|Non-Compliant with study drug|0|||
157203190|NCT05455684|567488145|FG001|Overall Study|Non-Compliant with study drug|1|||
157203191|NCT05455684|567488144|FG000|Overall Study|Other|1|||
157203192|NCT05455684|567488145|FG001|Overall Study|Other|2|||
157203193|NCT05455684|567488144|FG000|Overall Study|Randomized but not treated|1|||
157203194|NCT05455684|567488145|FG001|Overall Study|Randomized but not treated|0|||
157203195|NCT05204563|567488146|FG000|Overall Study|Other than Specified|2|||
157203196|NCT05204563|567488147|FG001|Overall Study|Other than Specified|1|||
157203197|NCT05204563|567488146|FG000|Overall Study|Death|18|||
157203198|NCT05204563|567488147|FG001|Overall Study|Death|4|||
157203199|NCT05204563|567488146|FG000|Overall Study|Lost to Follow-up|6|||
157203200|NCT05204563|567488147|FG001|Overall Study|Lost to Follow-up|3|||
157245060|NCT03827395|567640991|FG001|Overall Study|Became ineligible after enrollment|2|||
157245061|NCT04723693|567640992|FG000|Overall Study|Withdrawal by Subject|2|||
157245062|NCT00294047|567640993|FG000|Month 48|Adverse Event|28|||
157245063|NCT00294047|567640994|FG001|Month 48|Adverse Event|13|||
157245064|NCT00294047|567640993|FG000|Month 48|Protocol Violation|4|||
157245065|NCT00294047|567640994|FG001|Month 48|Protocol Violation|4|||
157245066|NCT00294047|567640993|FG000|Month 48|Withdrawal by Subject|111|||
157245067|NCT00294047|567640994|FG001|Month 48|Withdrawal by Subject|115|||
157245068|NCT00294047|567640993|FG000|Month 48|Lost to Follow-up|272|||
157245069|NCT00294047|567640994|FG001|Month 48|Lost to Follow-up|287|||
157245070|NCT00294047|567640993|FG000|Month 48|Other|10|||
157245071|NCT00294047|567640994|FG001|Month 48|Other|14|||
157203201|NCT05204563|567488146|FG000|Overall Study|Withdrawal by Subject|12|||
157203202|NCT05204563|567488147|FG001|Overall Study|Withdrawal by Subject|3|||
157203203|NCT05204563|567488146|FG000|Overall Study|Enrolled, Not Treated|1|||
157203204|NCT05204563|567488147|FG001|Overall Study|Enrolled, Not Treated|0|||
157203205|NCT04411641|567488148|FG000|DB Period|Other|7|||
157203206|NCT04411641|567488149|FG001|DB Period|Other|27|||
157203207|NCT04411641|567488150|FG002|DB Period|Other|0|||
157203208|NCT04411641|567488151|FG003|DB Period|Other|0|||
157203209|NCT04411641|567488148|FG000|DB Period|Withdrawal by Subject|67|||
157203210|NCT04411641|567488149|FG001|DB Period|Withdrawal by Subject|122|||
157203211|NCT04411641|567488150|FG002|DB Period|Withdrawal by Subject|0|||
157203212|NCT04411641|567488151|FG003|DB Period|Withdrawal by Subject|0|||
157203213|NCT04411641|567488148|FG000|DB Period|Progressive disease|76|||
157203214|NCT04411641|567488149|FG001|DB Period|Progressive disease|116|||
157203215|NCT04411641|567488150|FG002|DB Period|Progressive disease|0|||
157203216|NCT04411641|567488151|FG003|DB Period|Progressive disease|0|||
157203217|NCT04411641|567488148|FG000|DB Period|Poor compliance to protocol|1|||
157203218|NCT04411641|567488149|FG001|DB Period|Poor compliance to protocol|5|||
157203219|NCT04411641|567488150|FG002|DB Period|Poor compliance to protocol|0|||
157203220|NCT04411641|567488151|FG003|DB Period|Poor compliance to protocol|0|||
157203221|NCT04411641|567488148|FG000|DB Period|Lack of Efficacy|19|||
157203222|NCT04411641|567488149|FG001|DB Period|Lack of Efficacy|19|||
157203223|NCT04411641|567488150|FG002|DB Period|Lack of Efficacy|0|||
157203224|NCT04411641|567488151|FG003|DB Period|Lack of Efficacy|0|||
157203225|NCT04411641|567488148|FG000|DB Period|Adverse Event|13|||
157203226|NCT04411641|567488149|FG001|DB Period|Adverse Event|29|||
157203227|NCT04411641|567488150|FG002|DB Period|Adverse Event|0|||
157203228|NCT04411641|567488151|FG003|DB Period|Adverse Event|0|||
157203229|NCT04411641|567488148|FG000|DB Period|Randomized and not treated|2|||
157203230|NCT04411641|567488149|FG001|DB Period|Randomized and not treated|2|||
157203231|NCT04411641|567488150|FG002|DB Period|Randomized and not treated|0|||
157203232|NCT04411641|567488151|FG003|DB Period|Randomized and not treated|0|||
157203233|NCT04411641|567488148|FG000|OL|Withdrawal by Subject|0|||
157203234|NCT04411641|567488149|FG001|OL|Withdrawal by Subject|0|||
157245072|NCT00294047|567640993|FG000|Month 84|Adverse Event|4|||
157203235|NCT04411641|567488150|FG002|OL|Withdrawal by Subject|6|||
157203236|NCT04411641|567488151|FG003|OL|Withdrawal by Subject|17|||
157203237|NCT04411641|567488148|FG000|OL|Progressive disease|0|||
157203238|NCT04411641|567488149|FG001|OL|Progressive disease|0|||
157245073|NCT00294047|567640994|FG001|Month 84|Adverse Event|2|||
157203239|NCT04411641|567488150|FG002|OL|Progressive disease|1|||
157203240|NCT04411641|567488151|FG003|OL|Progressive disease|2|||
157203241|NCT04411641|567488148|FG000|OL|Poor compliance to protocol|0|||
157203242|NCT04411641|567488149|FG001|OL|Poor compliance to protocol|0|||
157203243|NCT04411641|567488150|FG002|OL|Poor compliance to protocol|1|||
157203244|NCT04411641|567488151|FG003|OL|Poor compliance to protocol|0|||
157203245|NCT04411641|567488148|FG000|OL|Adverse Event|0|||
157203246|NCT04411641|567488149|FG001|OL|Adverse Event|0|||
157203247|NCT04411641|567488150|FG002|OL|Adverse Event|1|||
157203248|NCT04411641|567488151|FG003|OL|Adverse Event|0|||
157203249|NCT04411641|567488148|FG000|OL|Other|0|||
157203250|NCT04411641|567488149|FG001|OL|Other|0|||
157203251|NCT04411641|567488150|FG002|OL|Other|0|||
157203252|NCT04411641|567488151|FG003|OL|Other|6|||
157203253|NCT02268214|567488155|FG000|Overall Study|Subject no longer meets study criteria|0|||
157203254|NCT02268214|567488156|FG001|Overall Study|Subject no longer meets study criteria|2|||
157203255|NCT02268214|567488157|FG002|Overall Study|Subject no longer meets study criteria|0|||
157203256|NCT02268214|567488155|FG000|Overall Study|Pregnancy|2|||
157203257|NCT02268214|567488156|FG001|Overall Study|Pregnancy|2|||
157203258|NCT02268214|567488157|FG002|Overall Study|Pregnancy|1|||
157203259|NCT02268214|567488155|FG000|Overall Study|Lost to Follow-up|3|||
157203260|NCT02268214|567488156|FG001|Overall Study|Lost to Follow-up|3|||
157203261|NCT02268214|567488157|FG002|Overall Study|Lost to Follow-up|4|||
157203262|NCT02268214|567488155|FG000|Overall Study|Lack of Efficacy|1|||
157203263|NCT02268214|567488156|FG001|Overall Study|Lack of Efficacy|0|||
157203264|NCT02268214|567488157|FG002|Overall Study|Lack of Efficacy|2|||
157203265|NCT02268214|567488155|FG000|Overall Study|Adverse Event|11|||
157203266|NCT02268214|567488156|FG001|Overall Study|Adverse Event|14|||
157203267|NCT02268214|567488157|FG002|Overall Study|Adverse Event|9|||
157203268|NCT02268214|567488155|FG000|Overall Study|Withdrawal by Subject|4|||
157203269|NCT02268214|567488156|FG001|Overall Study|Withdrawal by Subject|5|||
157203270|NCT02268214|567488157|FG002|Overall Study|Withdrawal by Subject|10|||
157203271|NCT02268214|567488155|FG000|Overall Study|Subject request to discontinue treatment|10|||
157203272|NCT02268214|567488156|FG001|Overall Study|Subject request to discontinue treatment|8|||
157203273|NCT02268214|567488157|FG002|Overall Study|Subject request to discontinue treatment|6|||
157203274|NCT02268214|567488155|FG000|Overall Study|Poor/non-compliance|2|||
157203275|NCT02268214|567488156|FG001|Overall Study|Poor/non-compliance|1|||
157203276|NCT02268214|567488157|FG002|Overall Study|Poor/non-compliance|2|||
157203277|NCT02268214|567488155|FG000|Overall Study|Other reasons|7|||
157203278|NCT02268214|567488156|FG001|Overall Study|Other reasons|3|||
157203279|NCT02268214|567488157|FG002|Overall Study|Other reasons|3|||
157203280|NCT02268214|567488155|FG000|Overall Study|Not entering long-term period|2|||
157203281|NCT02268214|567488156|FG001|Overall Study|Not entering long-term period|3|||
157203282|NCT02268214|567488157|FG002|Overall Study|Not entering long-term period|5|||
157203283|NCT04342390|567488159|FG000|Overall Study|Lost to Follow-up|3|||
157203284|NCT04342390|567488160|FG001|Overall Study|Lost to Follow-up|0|||
157203285|NCT02951130|567488161|FG000|Overall Study|Protocol Violation|1|||
157203286|NCT02951130|567488162|FG001|Overall Study|Protocol Violation|1|||
157203287|NCT04584294|567488163|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
157203288|NCT04584294|567488164|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
157203289|NCT04584294|567488163|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
157203290|NCT04584294|567488164|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
157203291|NCT04584294|567488163|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
157203292|NCT04584294|567488164|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
157203293|NCT04584294|567488163|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
157203294|NCT04584294|567488164|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
157203295|NCT04584294|567488163|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
157203296|NCT04584294|567488164|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
157203297|NCT04584294|567488163|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
157203298|NCT04584294|567488164|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
157203299|NCT03759340|567488179|FG000|Overall Study|Adverse Event|2|||
157203300|NCT03759340|567488179|FG000|Overall Study|Lost to Follow-up|1|||
157203301|NCT03759340|567488179|FG000|Overall Study|Withdrawal by Subject|15|||
157203302|NCT03759340|567488179|FG000|Overall Study|Study Terminated by Sponsor|38|||
157203303|NCT01119118|567488180|FG000|Overall Study|Adverse Event|1|||
157203304|NCT02711306|567488181|FG000|Overall Study|Withdrawal by Subject|2|||
157203305|NCT02711306|567488182|FG001|Overall Study|Withdrawal by Subject|2|||
157203306|NCT00157820|567488187|FG000|Randomized|Physician Decision|4|||
157203307|NCT00157820|567488188|FG001|Randomized|Physician Decision|2|||
157203308|NCT00157820|567488189|FG002|Randomized|Physician Decision|3|||
157203309|NCT00157820|567488187|FG000|Randomized|Withdrawal by Subject|1|||
157203310|NCT00157820|567488188|FG001|Randomized|Withdrawal by Subject|2|||
157203311|NCT00157820|567488189|FG002|Randomized|Withdrawal by Subject|3|||
157203312|NCT00157820|567488187|FG000|Randomized|Protocol Violation|2|||
157203313|NCT00157820|567488188|FG001|Randomized|Protocol Violation|1|||
157203314|NCT00157820|567488189|FG002|Randomized|Protocol Violation|2|||
157203315|NCT00157820|567488187|FG000|1st 8 Month|Death|7|||
157203316|NCT00157820|567488188|FG001|1st 8 Month|Death|8|||
157203317|NCT00157820|567488189|FG002|1st 8 Month|Death|3|||
157203318|NCT00157820|567488187|FG000|1st 8 Month|Lost to Follow-up|1|||
157203319|NCT00157820|567488188|FG001|1st 8 Month|Lost to Follow-up|2|||
157203320|NCT00157820|567488189|FG002|1st 8 Month|Lost to Follow-up|1|||
157203321|NCT00157820|567488187|FG000|1st 8 Month|Premature cross-over|0|||
157203322|NCT00157820|567488188|FG001|1st 8 Month|Premature cross-over|2|||
157203323|NCT00157820|567488189|FG002|1st 8 Month|Premature cross-over|2|||
157203324|NCT00157820|567488187|FG000|2nd 8 Months|Death|3|||
157203325|NCT00157820|567488188|FG001|2nd 8 Months|Death|1|||
157203326|NCT00157820|567488189|FG002|2nd 8 Months|Death|3|||
157203327|NCT00157820|567488187|FG000|2nd 8 Months|Lost to Follow-up|1|||
157203328|NCT00157820|567488188|FG001|2nd 8 Months|Lost to Follow-up|5|||
157203329|NCT00157820|567488189|FG002|2nd 8 Months|Lost to Follow-up|2|||
157203330|NCT00157820|567488187|FG000|2nd 8 Months|Premature cross-over|1|||
157203331|NCT00157820|567488188|FG001|2nd 8 Months|Premature cross-over|7|||
157203332|NCT00157820|567488189|FG002|2nd 8 Months|Premature cross-over|9|||
157203333|NCT02207413|567488190|FG000|Overall Study|Withdrawal by Subject|1|||
157203334|NCT02207413|567488191|FG001|Overall Study|Withdrawal by Subject|0|||
157203335|NCT02207413|567488192|FG002|Overall Study|Withdrawal by Subject|0|||
157203336|NCT02207413|567488193|FG003|Overall Study|Withdrawal by Subject|0|||
157203337|NCT02207413|567488194|FG004|Overall Study|Withdrawal by Subject|3|||
157203338|NCT02207413|567488195|FG005|Overall Study|Withdrawal by Subject|7|||
157203339|NCT02207413|567488190|FG000|Overall Study|Lost to Follow-up|0|||
157203340|NCT02207413|567488191|FG001|Overall Study|Lost to Follow-up|0|||
157203341|NCT02207413|567488192|FG002|Overall Study|Lost to Follow-up|0|||
157203342|NCT02207413|567488193|FG003|Overall Study|Lost to Follow-up|1|||
157203343|NCT02207413|567488194|FG004|Overall Study|Lost to Follow-up|1|||
157203344|NCT02207413|567488195|FG005|Overall Study|Lost to Follow-up|5|||
157203345|NCT02207413|567488190|FG000|Overall Study|Adverse Event|0|||
157203346|NCT02207413|567488191|FG001|Overall Study|Adverse Event|0|||
157203347|NCT02207413|567488192|FG002|Overall Study|Adverse Event|0|||
157203348|NCT02207413|567488193|FG003|Overall Study|Adverse Event|0|||
157203349|NCT02207413|567488194|FG004|Overall Study|Adverse Event|2|||
157203350|NCT02207413|567488195|FG005|Overall Study|Adverse Event|1|||
157203351|NCT02207413|567488190|FG000|Overall Study|Migrated/moved from study area|0|||
157203352|NCT02207413|567488191|FG001|Overall Study|Migrated/moved from study area|0|||
157203353|NCT02207413|567488192|FG002|Overall Study|Migrated/moved from study area|0|||
157203354|NCT02207413|567488193|FG003|Overall Study|Migrated/moved from study area|0|||
157203355|NCT02207413|567488194|FG004|Overall Study|Migrated/moved from study area|1|||
157203356|NCT02207413|567488195|FG005|Overall Study|Migrated/moved from study area|0|||
157203357|NCT04075656|567488196|FG000|Overall Study|Withdrawal by Subject|5|||
157203358|NCT04075656|567488197|FG001|Overall Study|Withdrawal by Subject|5|||
157203359|NCT01519635|567489712|FG000|Overall Study|Withdrawal by Subject|0|||
157203360|NCT01519635|567489713|FG001|Overall Study|Withdrawal by Subject|1|||
157203361|NCT01519635|567489712|FG000|Overall Study|No possibility to put a catheter|1|||
157203362|NCT01519635|567489713|FG001|Overall Study|No possibility to put a catheter|2|||
157203363|NCT00299546|567489714|FG000|Overall Study|Death|3|||
157245074|NCT00294047|567640993|FG000|Month 84|Protocol Violation|1|||
157245075|NCT00294047|567640994|FG001|Month 84|Protocol Violation|1|||
157245076|NCT00294047|567640993|FG000|Month 84|Withdrawal by Subject|33|||
157245077|NCT00294047|567640994|FG001|Month 84|Withdrawal by Subject|31|||
157245078|NCT00294047|567640993|FG000|Month 84|Lost to Follow-up|187|||
157245079|NCT00294047|567640994|FG001|Month 84|Lost to Follow-up|190|||
157245080|NCT00294047|567640993|FG000|Month 84|Absent Cervix|2|||
157245081|NCT00294047|567640994|FG001|Month 84|Absent Cervix|0|||
157245082|NCT00294047|567640993|FG000|Month 84|Work related reasons|4|||
157245083|NCT00294047|567640994|FG001|Month 84|Work related reasons|2|||
157245084|NCT00294047|567640993|FG000|Month 84|Center closed, subject did not transfer|1|||
157245085|NCT00294047|567640994|FG001|Month 84|Center closed, subject did not transfer|0|||
157245086|NCT00294047|567640993|FG000|Month 84|Family problems|2|||
157245087|NCT00294047|567640994|FG001|Month 84|Family problems|2|||
157245088|NCT00294047|567640993|FG000|Month 84|Lack of time|3|||
157245089|NCT00294047|567640994|FG001|Month 84|Lack of time|1|||
157245090|NCT00294047|567640993|FG000|Month 84|Personal reason|2|||
157245091|NCT00294047|567640994|FG001|Month 84|Personal reason|4|||
157203364|NCT00299546|567489715|FG001|Overall Study|Death|2|||
157203365|NCT00299546|567489716|FG002|Overall Study|Death|0|||
157203366|NCT00299546|567489714|FG000|Overall Study|Lost to Follow-up|2|||
157203367|NCT00299546|567489715|FG001|Overall Study|Lost to Follow-up|2|||
157245092|NCT00294047|567640993|FG000|Month 84|Subject does not want male physician|1|||
157245093|NCT00294047|567640994|FG001|Month 84|Subject does not want male physician|0|||
157245094|NCT00294047|567640993|FG000|Month 84|Transport reimbursement delayed|0|||
157245095|NCT00294047|567640994|FG001|Month 84|Transport reimbursement delayed|1|||
157245096|NCT00294047|567640993|FG000|Month 84|Unable to reach study site|1|||
157203368|NCT00299546|567489716|FG002|Overall Study|Lost to Follow-up|5|||
157203369|NCT00299546|567489714|FG000|Overall Study|Adverse Event|37|||
157203370|NCT00299546|567489715|FG001|Overall Study|Adverse Event|22|||
157203371|NCT00299546|567489716|FG002|Overall Study|Adverse Event|27|||
157245097|NCT00294047|567640994|FG001|Month 84|Unable to reach study site|0|||
157203372|NCT00299546|567489714|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
157203373|NCT00299546|567489715|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
157203374|NCT00299546|567489716|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
157203375|NCT00299546|567489714|FG000|Overall Study|Other|24|||
157203376|NCT00299546|567489715|FG001|Overall Study|Other|26|||
157203377|NCT00299546|567489716|FG002|Overall Study|Other|19|||
157203378|NCT00299546|567489714|FG000|Overall Study|Not treated|0|||
157203379|NCT00299546|567489715|FG001|Overall Study|Not treated|1|||
157203380|NCT00299546|567489716|FG002|Overall Study|Not treated|1|||
157203381|NCT01656850|567489717|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
157203382|NCT01656850|567489718|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
157203383|NCT01317199|567489719|FG000|Dose-escalation Phase 1|Physician Decision|5|||
157203384|NCT01317199|567489720|FG001|Dose-escalation Phase 1|Physician Decision|0|||
157203385|NCT01317199|567489721|FG002|Dose-escalation Phase 1|Physician Decision|0|||
157203386|NCT01317199|567489722|FG003|Dose-escalation Phase 1|Physician Decision|0|||
157203387|NCT01317199|567489719|FG000|Dose-escalation Phase 1|Disease progression|1|||
157203388|NCT01317199|567489720|FG001|Dose-escalation Phase 1|Disease progression|0|||
157203389|NCT01317199|567489721|FG002|Dose-escalation Phase 1|Disease progression|0|||
157203390|NCT01317199|567489722|FG003|Dose-escalation Phase 1|Disease progression|0|||
157203391|NCT01317199|567489719|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
157203392|NCT01317199|567489720|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
157203393|NCT01317199|567489721|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
157203394|NCT01317199|567489722|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
157203395|NCT01317199|567489719|FG000|Randomized Phase 2|Disease progression|0|||
157203396|NCT01317199|567489720|FG001|Randomized Phase 2|Disease progression|3|||
157203397|NCT01317199|567489721|FG002|Randomized Phase 2|Disease progression|7|||
157203398|NCT01317199|567489722|FG003|Randomized Phase 2|Disease progression|5|||
157203399|NCT01317199|567489719|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
157203400|NCT01317199|567489720|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
157203401|NCT01317199|567489721|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
157203402|NCT01317199|567489722|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
157203403|NCT01317199|567489719|FG000|Randomized Phase 2|Adverse Event|0|||
157203404|NCT01317199|567489720|FG001|Randomized Phase 2|Adverse Event|0|||
157203405|NCT01317199|567489721|FG002|Randomized Phase 2|Adverse Event|0|||
157203406|NCT01317199|567489722|FG003|Randomized Phase 2|Adverse Event|1|||
157203407|NCT01317199|567489719|FG000|Randomized Phase 2|Comorbidities|0|||
157203408|NCT01317199|567489720|FG001|Randomized Phase 2|Comorbidities|2|||
157203409|NCT01317199|567489721|FG002|Randomized Phase 2|Comorbidities|2|||
157203410|NCT01317199|567489722|FG003|Randomized Phase 2|Comorbidities|2|||
157203411|NCT01317199|567489719|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
157203412|NCT01317199|567489720|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
157203413|NCT01317199|567489721|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
157203414|NCT01317199|567489722|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
157203415|NCT01317199|567489719|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
157203416|NCT01317199|567489720|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
157203417|NCT01317199|567489721|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
157203418|NCT01317199|567489722|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
157203419|NCT01317199|567489719|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
157203420|NCT01317199|567489720|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
157203421|NCT01317199|567489721|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
157203422|NCT01317199|567489722|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
157203423|NCT01317199|567489719|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
157203424|NCT01317199|567489720|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
157203425|NCT01317199|567489721|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
157203426|NCT01317199|567489722|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
157203427|NCT01353209|567489723|FG000|Overall Study|Adverse Event|1|||
157203428|NCT01353209|567489724|FG001|Overall Study|Adverse Event|1|||
157203429|NCT01301625|567489725|FG000|Overall Study|Death|5|||
157203430|NCT01301625|567489725|FG000|Overall Study|Not Due|21|||
157203431|NCT01301625|567489725|FG000|Overall Study|Expected|8|||
157203432|NCT01301625|567489725|FG000|Overall Study|Lost to Follow-up|1|||
157203433|NCT02684370|567489729|FG000|Part A|Adverse Event|2|||
157203434|NCT02684370|567489730|FG001|Part A|Adverse Event|0|||
157203435|NCT02684370|567489731|FG002|Part A|Adverse Event|1|||
157203436|NCT02684370|567489732|FG003|Part A|Adverse Event|0|||
157203437|NCT02684370|567489733|FG004|Part A|Adverse Event|0|||
157203438|NCT02684370|567489734|FG005|Part A|Adverse Event|0|||
157203439|NCT02684370|567489729|FG000|Part A|Lost to Follow-up|1|||
157203440|NCT02684370|567489730|FG001|Part A|Lost to Follow-up|1|||
157203441|NCT02684370|567489731|FG002|Part A|Lost to Follow-up|0|||
157203442|NCT02684370|567489732|FG003|Part A|Lost to Follow-up|0|||
157203443|NCT02684370|567489733|FG004|Part A|Lost to Follow-up|0|||
157203444|NCT02684370|567489734|FG005|Part A|Lost to Follow-up|0|||
157203445|NCT02684370|567489729|FG000|Part A|Subject Withdrawal|1|||
157203446|NCT02684370|567489730|FG001|Part A|Subject Withdrawal|0|||
157203447|NCT02684370|567489731|FG002|Part A|Subject Withdrawal|3|||
157203448|NCT02684370|567489732|FG003|Part A|Subject Withdrawal|0|||
157203449|NCT02684370|567489733|FG004|Part A|Subject Withdrawal|0|||
157203450|NCT02684370|567489734|FG005|Part A|Subject Withdrawal|0|||
157203451|NCT02684370|567489729|FG000|Part A|Other|0|||
157203452|NCT02684370|567489730|FG001|Part A|Other|0|||
157203453|NCT02684370|567489731|FG002|Part A|Other|1|||
157203454|NCT02684370|567489732|FG003|Part A|Other|0|||
157203455|NCT02684370|567489733|FG004|Part A|Other|0|||
157203456|NCT02684370|567489734|FG005|Part A|Other|0|||
157203457|NCT02684370|567489729|FG000|Part B|Adverse Event|0|||
157203458|NCT02684370|567489730|FG001|Part B|Adverse Event|0|||
157203459|NCT02684370|567489731|FG002|Part B|Adverse Event|0|||
157203460|NCT02684370|567489732|FG003|Part B|Adverse Event|0|||
157203461|NCT02684370|567489733|FG004|Part B|Adverse Event|2|||
157203462|NCT02684370|567489734|FG005|Part B|Adverse Event|1|||
157203463|NCT02684370|567489729|FG000|Part B|Lost to Follow-up|0|||
157203464|NCT02684370|567489730|FG001|Part B|Lost to Follow-up|0|||
157203465|NCT02684370|567489731|FG002|Part B|Lost to Follow-up|0|||
157203466|NCT02684370|567489732|FG003|Part B|Lost to Follow-up|1|||
157203467|NCT02684370|567489733|FG004|Part B|Lost to Follow-up|2|||
157203468|NCT02684370|567489734|FG005|Part B|Lost to Follow-up|5|||
157203469|NCT02684370|567489729|FG000|Part B|Subject Withdrawal|0|||
157203470|NCT02684370|567489730|FG001|Part B|Subject Withdrawal|0|||
157203471|NCT02684370|567489731|FG002|Part B|Subject Withdrawal|0|||
157203472|NCT02684370|567489732|FG003|Part B|Subject Withdrawal|1|||
157203473|NCT02684370|567489733|FG004|Part B|Subject Withdrawal|1|||
157203474|NCT02684370|567489734|FG005|Part B|Subject Withdrawal|2|||
157203475|NCT02181673|567489737|FG000|Up to Week 24|Adverse Event|2|||
157203476|NCT02181673|567489738|FG001|Up to Week 24|Adverse Event|0|||
157203477|NCT02181673|567489739|FG002|Up to Week 24|Adverse Event|3|||
157203478|NCT02181673|567489737|FG000|Up to Week 24|Death|1|||
157203479|NCT02181673|567489738|FG001|Up to Week 24|Death|0|||
157203480|NCT02181673|567489739|FG002|Up to Week 24|Death|0|||
157203481|NCT02181673|567489737|FG000|Up to Week 24|Lack of Efficacy|1|||
157203482|NCT02181673|567489738|FG001|Up to Week 24|Lack of Efficacy|0|||
157203483|NCT02181673|567489739|FG002|Up to Week 24|Lack of Efficacy|0|||
157203484|NCT02181673|567489737|FG000|Up to Week 24|Lost to Follow-up|1|||
157203485|NCT02181673|567489738|FG001|Up to Week 24|Lost to Follow-up|0|||
157203486|NCT02181673|567489739|FG002|Up to Week 24|Lost to Follow-up|0|||
157203487|NCT02181673|567489737|FG000|Up to Week 24|Physician Decision|0|||
157203488|NCT02181673|567489738|FG001|Up to Week 24|Physician Decision|0|||
157203489|NCT02181673|567489739|FG002|Up to Week 24|Physician Decision|3|||
157203490|NCT02181673|567489737|FG000|Up to Week 24|Withdrawal by Subject|10|||
157203491|NCT02181673|567489738|FG001|Up to Week 24|Withdrawal by Subject|0|||
157203492|NCT02181673|567489739|FG002|Up to Week 24|Withdrawal by Subject|1|||
157203493|NCT02181673|567489737|FG000|Up to Week 24|Other|2|||
157203494|NCT02181673|567489738|FG001|Up to Week 24|Other|0|||
157203495|NCT02181673|567489739|FG002|Up to Week 24|Other|3|||
157203496|NCT02181673|567489737|FG000|Up to Week 24|Randomized not Treated|0|||
157203497|NCT02181673|567489738|FG001|Up to Week 24|Randomized not Treated|0|||
157203498|NCT02181673|567489739|FG002|Up to Week 24|Randomized not Treated|1|||
157203499|NCT02181673|567489737|FG000|Week 24-Week 60|Adverse Event|0|||
157203500|NCT02181673|567489738|FG001|Week 24-Week 60|Adverse Event|4|||
157203501|NCT02181673|567489739|FG002|Week 24-Week 60|Adverse Event|10|||
157203502|NCT02181673|567489737|FG000|Week 24-Week 60|Other|0|||
157203503|NCT02181673|567489738|FG001|Week 24-Week 60|Other|2|||
157203504|NCT02181673|567489739|FG002|Week 24-Week 60|Other|1|||
157203505|NCT02181673|567489737|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
157203506|NCT02181673|567489738|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
157203507|NCT02181673|567489739|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
157203508|NCT02181673|567489737|FG000|Week 24-Week 60|Pregnancy|0|||
157203509|NCT02181673|567489738|FG001|Week 24-Week 60|Pregnancy|0|||
157203510|NCT02181673|567489739|FG002|Week 24-Week 60|Pregnancy|1|||
157203511|NCT02181673|567489737|FG000|Week 24-Week 60|Lack of Efficacy|0|||
157203512|NCT02181673|567489738|FG001|Week 24-Week 60|Lack of Efficacy|0|||
157203513|NCT02181673|567489739|FG002|Week 24-Week 60|Lack of Efficacy|1|||
157203514|NCT02181673|567489737|FG000|Week 24-Week 60|Lost to Follow-up|0|||
157203515|NCT02181673|567489738|FG001|Week 24-Week 60|Lost to Follow-up|0|||
157203516|NCT02181673|567489739|FG002|Week 24-Week 60|Lost to Follow-up|1|||
157203517|NCT02181673|567489737|FG000|Week 24-Week 60|Physician Decision|0|||
157203518|NCT02181673|567489738|FG001|Week 24-Week 60|Physician Decision|0|||
157203519|NCT02181673|567489739|FG002|Week 24-Week 60|Physician Decision|1|||
157203520|NCT00320801|567489742|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
157203521|NCT00320801|567489743|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
157203522|NCT00320801|567489744|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
157203523|NCT00320801|567489745|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
157203524|NCT00320801|567489742|FG000|Open-label Run-in Period|Adverse Event|33|||
157203525|NCT00320801|567489743|FG001|Open-label Run-in Period|Adverse Event|0|||
157203526|NCT00320801|567489744|FG002|Open-label Run-in Period|Adverse Event|0|||
157203527|NCT00320801|567489745|FG003|Open-label Run-in Period|Adverse Event|0|||
157203528|NCT00320801|567489742|FG000|Open-label Run-in Period|Administrative|10|||
157203529|NCT00320801|567489743|FG001|Open-label Run-in Period|Administrative|0|||
157203530|NCT00320801|567489744|FG002|Open-label Run-in Period|Administrative|0|||
157245098|NCT00294047|567640993|FG000|Month 84|Under investigation locally|1|||
157245099|NCT00294047|567640994|FG001|Month 84|Under investigation locally|0|||
157245100|NCT00294047|567640993|FG000|Month 84|Visit missed|0|||
157245101|NCT00294047|567640994|FG001|Month 84|Visit missed|1|||
157245102|NCT00294047|567640993|FG000|Month 84|No consent for Month 84 Follow-up|731|||
157245103|NCT00294047|567640994|FG001|Month 84|No consent for Month 84 Follow-up|754|||
157245104|NCT02157974|567640995|FG000|Overall Study|Withdrawal by Subject|0|||
157245105|NCT02157974|567640996|FG001|Overall Study|Withdrawal by Subject|1|||
157245106|NCT02157974|567640997|FG002|Overall Study|Withdrawal by Subject|0|||
157245107|NCT02157974|567640998|FG003|Overall Study|Withdrawal by Subject|0|||
157245108|NCT02157974|567640999|FG004|Overall Study|Withdrawal by Subject|0|||
157245109|NCT02157974|567640995|FG000|Overall Study|Screen Failure|0|||
157245110|NCT02157974|567640996|FG001|Overall Study|Screen Failure|1|||
157245111|NCT02157974|567640997|FG002|Overall Study|Screen Failure|0|||
157245112|NCT02157974|567640998|FG003|Overall Study|Screen Failure|0|||
157245113|NCT02157974|567640999|FG004|Overall Study|Screen Failure|0|||
157245114|NCT02157974|567640995|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
157245115|NCT02157974|567640996|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
157245116|NCT02157974|567640997|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
157245117|NCT02157974|567640998|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
157245118|NCT02157974|567640999|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
157245119|NCT00506831|567641002|FG000|Overall Study|Death|1|||
157245120|NCT00506831|567641002|FG000|Overall Study|Withdrawal by Subject|1|||
157245121|NCT01410227|567641006|FG000|Overall Study|Adverse Event|1|||
157245122|NCT01410227|567641007|FG001|Overall Study|Adverse Event|0|||
157245123|NCT01410227|567641008|FG002|Overall Study|Adverse Event|0|||
157245124|NCT01410227|567641009|FG003|Overall Study|Adverse Event|0|||
157245125|NCT01410227|567641006|FG000|Overall Study|Withdrawal by Subject|3|||
157245126|NCT01410227|567641007|FG001|Overall Study|Withdrawal by Subject|0|||
157245127|NCT01410227|567641008|FG002|Overall Study|Withdrawal by Subject|1|||
157245128|NCT01410227|567641009|FG003|Overall Study|Withdrawal by Subject|0|||
157245129|NCT01410227|567641006|FG000|Overall Study|Pregnancy|0|||
157245130|NCT01410227|567641007|FG001|Overall Study|Pregnancy|0|||
157245131|NCT01410227|567641008|FG002|Overall Study|Pregnancy|0|||
157245132|NCT01410227|567641009|FG003|Overall Study|Pregnancy|1|||
157245133|NCT01410227|567641006|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
157245134|NCT01410227|567641007|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
157245135|NCT01410227|567641008|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
157245136|NCT01410227|567641009|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
157245137|NCT01808651|567641010|FG000|Study Period 1|Lost to Follow-up|1|||
157245138|NCT01808651|567641011|FG001|Study Period 1|Lost to Follow-up|3|||
157203531|NCT00320801|567489745|FG003|Open-label Run-in Period|Administrative|0|||
157203532|NCT00320801|567489742|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
157203533|NCT00320801|567489743|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
157203534|NCT00320801|567489744|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
157203535|NCT00320801|567489745|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
157203536|NCT00320801|567489742|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
157203537|NCT00320801|567489743|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
157203538|NCT00320801|567489744|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
157203539|NCT00320801|567489745|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
157203540|NCT00320801|567489742|FG000|Open-label Run-in Period|Did not qualify|1|||
157203541|NCT00320801|567489743|FG001|Open-label Run-in Period|Did not qualify|0|||
157203542|NCT00320801|567489744|FG002|Open-label Run-in Period|Did not qualify|0|||
157203543|NCT00320801|567489745|FG003|Open-label Run-in Period|Did not qualify|0|||
157203544|NCT00320801|567489742|FG000|Double-blind Phase|Withdrawal by Subject|0|||
157203545|NCT00320801|567489743|FG001|Double-blind Phase|Withdrawal by Subject|0|||
157203546|NCT00320801|567489744|FG002|Double-blind Phase|Withdrawal by Subject|1|||
157203547|NCT00320801|567489745|FG003|Double-blind Phase|Withdrawal by Subject|0|||
157203548|NCT00320801|567489742|FG000|Double-blind Phase|Adverse Event|0|||
157203549|NCT00320801|567489743|FG001|Double-blind Phase|Adverse Event|2|||
157203550|NCT00320801|567489744|FG002|Double-blind Phase|Adverse Event|8|||
157203551|NCT00320801|567489745|FG003|Double-blind Phase|Adverse Event|0|||
157245139|NCT01808651|567641012|FG002|Study Period 1|Lost to Follow-up|0|||
157245140|NCT01808651|567641010|FG000|Study Period 1|Protocol Violation|1|||
157245141|NCT01808651|567641011|FG001|Study Period 1|Protocol Violation|0|||
157245142|NCT01808651|567641012|FG002|Study Period 1|Protocol Violation|1|||
157203552|NCT00320801|567489742|FG000|Double-blind Phase|Administrative|0|||
157245143|NCT01808651|567641010|FG000|Study Period 1|Physician Decision|3|||
157245144|NCT01808651|567641011|FG001|Study Period 1|Physician Decision|2|||
157245145|NCT01808651|567641012|FG002|Study Period 1|Physician Decision|0|||
157245146|NCT01808651|567641010|FG000|Study Period 1|Lack of Efficacy|2|||
157203553|NCT00320801|567489743|FG001|Double-blind Phase|Administrative|0|||
157203554|NCT00320801|567489744|FG002|Double-blind Phase|Administrative|4|||
157203555|NCT00320801|567489745|FG003|Double-blind Phase|Administrative|0|||
157203556|NCT00320801|567489742|FG000|Double-blind Phase|Lack of Efficacy|0|||
157203557|NCT00320801|567489743|FG001|Double-blind Phase|Lack of Efficacy|9|||
157203558|NCT00320801|567489744|FG002|Double-blind Phase|Lack of Efficacy|1|||
157203559|NCT00320801|567489745|FG003|Double-blind Phase|Lack of Efficacy|0|||
157203560|NCT00320801|567489742|FG000|Extension Phase|Withdrawal by Subject|0|||
157203561|NCT00320801|567489743|FG001|Extension Phase|Withdrawal by Subject|0|||
157203562|NCT00320801|567489744|FG002|Extension Phase|Withdrawal by Subject|0|||
157245147|NCT01808651|567641011|FG001|Study Period 1|Lack of Efficacy|1|||
157245148|NCT01808651|567641012|FG002|Study Period 1|Lack of Efficacy|0|||
157203563|NCT00320801|567489745|FG003|Extension Phase|Withdrawal by Subject|6|||
157203564|NCT00320801|567489742|FG000|Extension Phase|Adverse Event|0|||
157203565|NCT00320801|567489743|FG001|Extension Phase|Adverse Event|0|||
157203566|NCT00320801|567489744|FG002|Extension Phase|Adverse Event|0|||
157203567|NCT00320801|567489745|FG003|Extension Phase|Adverse Event|8|||
157203568|NCT00320801|567489742|FG000|Extension Phase|Administrative|0|||
157203569|NCT00320801|567489743|FG001|Extension Phase|Administrative|0|||
157203570|NCT00320801|567489744|FG002|Extension Phase|Administrative|0|||
157203571|NCT00320801|567489745|FG003|Extension Phase|Administrative|29|||
157203572|NCT00320801|567489742|FG000|Extension Phase|Lack of Efficacy|0|||
157203573|NCT00320801|567489743|FG001|Extension Phase|Lack of Efficacy|0|||
157203574|NCT00320801|567489744|FG002|Extension Phase|Lack of Efficacy|0|||
157203575|NCT00320801|567489745|FG003|Extension Phase|Lack of Efficacy|2|||
157203576|NCT00320801|567489742|FG000|Extension Phase|Lost to Follow-up|0|||
157203577|NCT00320801|567489743|FG001|Extension Phase|Lost to Follow-up|0|||
157203578|NCT00320801|567489744|FG002|Extension Phase|Lost to Follow-up|0|||
157203579|NCT00320801|567489745|FG003|Extension Phase|Lost to Follow-up|3|||
157203580|NCT00337727|567489746|FG000|Overall Study|Adverse Event|5|||
157203581|NCT00337727|567489747|FG001|Overall Study|Adverse Event|3|||
157203582|NCT00337727|567489746|FG000|Overall Study|Lost to Follow-up|5|||
157203583|NCT00337727|567489747|FG001|Overall Study|Lost to Follow-up|4|||
157203584|NCT00337727|567489746|FG000|Overall Study|Physician Decision|1|||
157203585|NCT00337727|567489747|FG001|Overall Study|Physician Decision|0|||
157203586|NCT00337727|567489746|FG000|Overall Study|Protocol Violation|4|||
157203587|NCT00337727|567489747|FG001|Overall Study|Protocol Violation|0|||
157203588|NCT00337727|567489746|FG000|Overall Study|Withdrawal by Subject|3|||
157203589|NCT00337727|567489747|FG001|Overall Study|Withdrawal by Subject|5|||
157203590|NCT00491322|567489749|FG000|Overall Study|Protocol Violation|1|||
157203591|NCT00491322|567489750|FG001|Overall Study|Protocol Violation|0|||
157203592|NCT00491322|567489749|FG000|Overall Study|Pregnancy|0|||
157203593|NCT00491322|567489750|FG001|Overall Study|Pregnancy|1|||
157203594|NCT06067191|567489754|FG000|Overall Study|Withdrawal by Subject|0|||
157203595|NCT06067191|567489755|FG001|Overall Study|Withdrawal by Subject|1|||
157203596|NCT00807040|567489758|FG000|Overall Study|Death|24|||
157203597|NCT00807040|567489759|FG001|Overall Study|Death|29|||
157203598|NCT00807040|567489758|FG000|Overall Study|Withdrawal by Subject|8|||
157203599|NCT00807040|567489759|FG001|Overall Study|Withdrawal by Subject|6|||
157203600|NCT00807040|567489758|FG000|Overall Study|Lost to Follow-up|4|||
157203601|NCT00807040|567489759|FG001|Overall Study|Lost to Follow-up|6|||
157203602|NCT00806416|567489761|FG000|Period 1 - Part I|Adverse Event|0|||
157203603|NCT00806416|567489762|FG001|Period 1 - Part I|Adverse Event|1|||
157203604|NCT00806416|567489763|FG002|Period 1 - Part I|Adverse Event|0|||
157203605|NCT00806416|567489764|FG003|Period 1 - Part I|Adverse Event|0|||
157203606|NCT00806416|567489761|FG000|Period 1 - Part I|Lost to Follow-up|0|||
157245149|NCT01808651|567641010|FG000|Study Period 1|Adverse Event|10|||
157245150|NCT01808651|567641011|FG001|Study Period 1|Adverse Event|4|||
157245151|NCT01808651|567641012|FG002|Study Period 1|Adverse Event|1|||
157245152|NCT01808651|567641010|FG000|Study Period 1|Participant Decision|9|||
157203607|NCT00806416|567489762|FG001|Period 1 - Part I|Lost to Follow-up|2|||
157203608|NCT00806416|567489763|FG002|Period 1 - Part I|Lost to Follow-up|0|||
157203609|NCT00806416|567489764|FG003|Period 1 - Part I|Lost to Follow-up|0|||
157203610|NCT00806416|567489761|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
157203611|NCT00806416|567489762|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
157203612|NCT00806416|567489763|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
157203613|NCT00806416|567489764|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
157203614|NCT00806416|567489761|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
157245153|NCT01808651|567641011|FG001|Study Period 1|Participant Decision|7|||
157245154|NCT01808651|567641012|FG002|Study Period 1|Participant Decision|3|||
157203615|NCT00806416|567489762|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
157203616|NCT00806416|567489763|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
157203617|NCT00806416|567489764|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
157203618|NCT01244516|567489768|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
157245155|NCT00585286|567641014|FG000|Overall Study|Lost to Follow-up|1|||
157245156|NCT00608322|567641018|FG000|Overall Study|Death|2|||
157203619|NCT01244516|567489769|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
157203620|NCT01244516|567489770|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
157203621|NCT01244516|567489768|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
157245157|NCT00608322|567641019|FG001|Overall Study|Death|1|||
157245158|NCT04002648|567641020|FG000|Overall Study|Lost to Follow-up|2|||
157245159|NCT04002648|567641021|FG001|Overall Study|Lost to Follow-up|0|||
157245160|NCT00606281|567641026|FG000|Overall Study|Adverse Event|11|||
157245161|NCT00606281|567641027|FG001|Overall Study|Adverse Event|12|||
157245162|NCT00606281|567641026|FG000|Overall Study|Death|1|||
157245163|NCT00606281|567641027|FG001|Overall Study|Death|0|||
157245164|NCT00606281|567641026|FG000|Overall Study|Lack of Efficacy|28|||
157245165|NCT00606281|567641027|FG001|Overall Study|Lack of Efficacy|35|||
157245166|NCT00606281|567641026|FG000|Overall Study|Physician Decision|0|||
157245167|NCT00606281|567641027|FG001|Overall Study|Physician Decision|1|||
157245168|NCT00606281|567641026|FG000|Overall Study|Protocol Violation|3|||
157245169|NCT00606281|567641027|FG001|Overall Study|Protocol Violation|3|||
157245170|NCT00606281|567641026|FG000|Overall Study|Withdrawal by Subject|11|||
157245171|NCT00606281|567641027|FG001|Overall Study|Withdrawal by Subject|13|||
157245172|NCT00606281|567641026|FG000|Overall Study|Progression to depressive phase|1|||
157245173|NCT00606281|567641027|FG001|Overall Study|Progression to depressive phase|1|||
157245174|NCT00606281|567641026|FG000|Overall Study|Change of residence or other commitments|1|||
157245175|NCT00606281|567641027|FG001|Overall Study|Change of residence or other commitments|1|||
157245176|NCT00540423|567641029|FG000|Double-Blind Treatment Period|Adverse Event|0|||
157245177|NCT00540423|567641030|FG001|Double-Blind Treatment Period|Adverse Event|1|||
157245178|NCT00540423|567641031|FG002|Double-Blind Treatment Period|Adverse Event|0|||
157245179|NCT00540423|567641029|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
157245180|NCT00540423|567641030|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
157245181|NCT00540423|567641031|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
157245182|NCT03131895|567641032|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
157245183|NCT03131895|567641033|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
157245184|NCT03131895|567641034|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
157245185|NCT03131895|567641035|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
157245186|NCT03131895|567641032|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
157245187|NCT03131895|567641033|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
157245188|NCT03131895|567641034|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
157245189|NCT03131895|567641035|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
157245190|NCT03131895|567641032|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157245191|NCT03131895|567641033|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
157245192|NCT03131895|567641034|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
157245193|NCT03131895|567641035|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
157245194|NCT03131895|567641032|FG000|Washout Period (at Least 5 Days)|Other|0|||
157245195|NCT03131895|567641033|FG001|Washout Period (at Least 5 Days)|Other|0|||
157245196|NCT03131895|567641034|FG002|Washout Period (at Least 5 Days)|Other|2|||
157245197|NCT03131895|567641035|FG003|Washout Period (at Least 5 Days)|Other|0|||
157245198|NCT03131895|567641032|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
157245199|NCT03131895|567641033|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
157245200|NCT03131895|567641034|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
157203622|NCT01244516|567489769|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
157203623|NCT01244516|567489770|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
157203624|NCT01244516|567489768|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
157203625|NCT01244516|567489769|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
157203626|NCT01244516|567489770|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
157203627|NCT01244516|567489768|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
157203628|NCT01244516|567489769|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
157203629|NCT01244516|567489770|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
157203630|NCT01244516|567489768|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
157203631|NCT01244516|567489769|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
157203632|NCT01244516|567489770|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
157203633|NCT01244516|567489768|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
157203634|NCT01244516|567489769|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
157203635|NCT01244516|567489770|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
157203636|NCT01244516|567489768|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
157203637|NCT01244516|567489769|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
157203638|NCT01244516|567489770|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
157203639|NCT01102972|567489773|FG000|Overall Study|Adverse Event|8|||
157203640|NCT01102972|567489774|FG001|Overall Study|Adverse Event|2|||
157203641|NCT01102972|567489773|FG000|Overall Study|Lack of Efficacy|2|||
157203642|NCT01102972|567489774|FG001|Overall Study|Lack of Efficacy|1|||
157203643|NCT01102972|567489773|FG000|Overall Study|Protocol Violation|1|||
157203644|NCT01102972|567489774|FG001|Overall Study|Protocol Violation|0|||
157203645|NCT01102972|567489773|FG000|Overall Study|Lost to Follow-up|10|||
157203646|NCT01102972|567489774|FG001|Overall Study|Lost to Follow-up|5|||
157203647|NCT01102972|567489773|FG000|Overall Study|Investigator Discretion|2|||
157203648|NCT01102972|567489774|FG001|Overall Study|Investigator Discretion|0|||
157245201|NCT03131895|567641035|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
157245202|NCT03131895|567641032|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
157245203|NCT03131895|567641033|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
157245204|NCT03131895|567641034|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
157245205|NCT03131895|567641035|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
157203649|NCT01102972|567489773|FG000|Overall Study|Withdrawal by Subject|6|||
157203650|NCT01102972|567489774|FG001|Overall Study|Withdrawal by Subject|6|||
157203651|NCT03664024|567489778|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
157203652|NCT03664024|567489778|FG000|Overall Study|Lost to Follow-up|2|||
157203653|NCT03664024|567489778|FG000|Overall Study|Withdrawal by Subject|2|||
157203654|NCT03664024|567489778|FG000|Overall Study|Death|80|||
157203655|NCT01157065|567489779|FG000|Overall Study|Death|0|||
157203656|NCT01157065|567489780|FG001|Overall Study|Death|1|||
157203657|NCT05275673|567489783|FG000|Overall Study|Study Termination by Sponsor|2|||
157203658|NCT05275673|567489784|FG001|Overall Study|Study Termination by Sponsor|3|||
157203659|NCT05275673|567489783|FG000|Overall Study|Death|1|||
157203660|NCT05275673|567489784|FG001|Overall Study|Death|0|||
157203661|NCT05275673|567489783|FG000|Overall Study|Withdrawal by Subject|1|||
157203662|NCT05275673|567489784|FG001|Overall Study|Withdrawal by Subject|0|||
157203663|NCT02325739|567489785|FG000|Phase I Part|Adverse Event|1|||
157203664|NCT02325739|567489786|FG001|Phase I Part|Adverse Event|0|||
157203665|NCT02325739|567489787|FG002|Phase I Part|Adverse Event|1|||
157203666|NCT02325739|567489788|FG003|Phase I Part|Adverse Event|2|||
157203667|NCT02325739|567489789|FG004|Phase I Part|Adverse Event|3|||
157203668|NCT02325739|567489790|FG005|Phase I Part|Adverse Event|1|||
157203669|NCT02325739|567489791|FG006|Phase I Part|Adverse Event|0|||
157203670|NCT02325739|567489792|FG007|Phase I Part|Adverse Event|2|||
157203671|NCT02325739|567489793|FG008|Phase I Part|Adverse Event|0|||
157203672|NCT02325739|567489794|FG009|Phase I Part|Adverse Event|0|||
157203673|NCT02325739|567489795|FG010|Phase I Part|Adverse Event|0|||
157203674|NCT02325739|567489785|FG000|Phase I Part|Progressive disease|9|||
157203675|NCT02325739|567489786|FG001|Phase I Part|Progressive disease|6|||
157203676|NCT02325739|567489787|FG002|Phase I Part|Progressive disease|3|||
157203677|NCT02325739|567489788|FG003|Phase I Part|Progressive disease|23|||
157203678|NCT02325739|567489789|FG004|Phase I Part|Progressive disease|14|||
157203679|NCT02325739|567489790|FG005|Phase I Part|Progressive disease|6|||
157203680|NCT02325739|567489791|FG006|Phase I Part|Progressive disease|6|||
157203681|NCT02325739|567489792|FG007|Phase I Part|Progressive disease|3|||
157203682|NCT02325739|567489793|FG008|Phase I Part|Progressive disease|0|||
157203683|NCT02325739|567489794|FG009|Phase I Part|Progressive disease|0|||
157203684|NCT02325739|567489795|FG010|Phase I Part|Progressive disease|0|||
157203685|NCT02325739|567489785|FG000|Phase I Part|Subject/guardian decision|1|||
157203686|NCT02325739|567489786|FG001|Phase I Part|Subject/guardian decision|0|||
157203687|NCT02325739|567489787|FG002|Phase I Part|Subject/guardian decision|1|||
157203688|NCT02325739|567489788|FG003|Phase I Part|Subject/guardian decision|1|||
157245206|NCT00918684|567641040|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
157245207|NCT00918684|567641040|FG000|Treatment Phase|Lack of Efficacy|6|||
157245208|NCT00918684|567641040|FG000|Treatment Phase|Lost to Follow-up|2|||
157245209|NCT00918684|567641040|FG000|Treatment Phase|Physician Decision|8|||
157245210|NCT00918684|567641040|FG000|Treatment Phase|Protocol Violation|1|||
157245211|NCT00918684|567641040|FG000|Treatment Phase|Withdrawal by Subject|8|||
157245212|NCT00463684|567641046|FG000|Overall Study|Withdrawal by Subject|1|||
157245213|NCT00463684|567641046|FG000|Overall Study|Lost to Follow-up|3|||
157245214|NCT02462837|567641047|FG000|Overall Study|pt developed hives|1|||
157245215|NCT02462837|567641048|FG001|Overall Study|pt developed hives|0|||
157245216|NCT02462837|567641047|FG000|Overall Study|Withdrawal by Subject|1|||
157245217|NCT02462837|567641048|FG001|Overall Study|Withdrawal by Subject|0|||
157245218|NCT00906399|567641049|FG000|Year 1|Randomized But Not Treated|0|||
157245219|NCT00906399|567641050|FG001|Year 1|Randomized But Not Treated|1|||
157245220|NCT00906399|567641051|FG002|Year 1|Randomized But Not Treated|3|||
157245221|NCT00906399|567641052|FG003|Year 1|Randomized But Not Treated|0|||
157245222|NCT00906399|567641053|FG004|Year 1|Randomized But Not Treated|0|||
157245223|NCT00906399|567641054|FG005|Year 1|Randomized But Not Treated|0|||
157245224|NCT00906399|567641055|FG006|Year 1|Randomized But Not Treated|0|||
157245225|NCT00906399|567641049|FG000|Year 1|Adverse Event|4|||
157245226|NCT00906399|567641050|FG001|Year 1|Adverse Event|22|||
157245227|NCT00906399|567641051|FG002|Year 1|Adverse Event|24|||
157245228|NCT00906399|567641052|FG003|Year 1|Adverse Event|0|||
157245229|NCT00906399|567641053|FG004|Year 1|Adverse Event|0|||
157245230|NCT00906399|567641054|FG005|Year 1|Adverse Event|0|||
157245231|NCT00906399|567641055|FG006|Year 1|Adverse Event|0|||
157203689|NCT02325739|567489789|FG004|Phase I Part|Subject/guardian decision|0|||
157203690|NCT02325739|567489790|FG005|Phase I Part|Subject/guardian decision|0|||
157203691|NCT02325739|567489791|FG006|Phase I Part|Subject/guardian decision|0|||
157203692|NCT02325739|567489792|FG007|Phase I Part|Subject/guardian decision|1|||
157203693|NCT02325739|567489793|FG008|Phase I Part|Subject/guardian decision|0|||
157203694|NCT02325739|567489794|FG009|Phase I Part|Subject/guardian decision|0|||
157245232|NCT00906399|567641049|FG000|Year 1|Lost to Follow-up|4|||
157245233|NCT00906399|567641050|FG001|Year 1|Lost to Follow-up|4|||
157245234|NCT00906399|567641051|FG002|Year 1|Lost to Follow-up|2|||
157245235|NCT00906399|567641052|FG003|Year 1|Lost to Follow-up|0|||
157245236|NCT00906399|567641053|FG004|Year 1|Lost to Follow-up|0|||
157245237|NCT00906399|567641054|FG005|Year 1|Lost to Follow-up|0|||
157245238|NCT00906399|567641055|FG006|Year 1|Lost to Follow-up|0|||
157245239|NCT00906399|567641049|FG000|Year 1|Withdrawal by Subject|30|||
157203695|NCT02325739|567489795|FG010|Phase I Part|Subject/guardian decision|0|||
157203696|NCT02325739|567489785|FG000|Phase I Part|Death|0|||
157203697|NCT02325739|567489786|FG001|Phase I Part|Death|0|||
157203698|NCT02325739|567489787|FG002|Phase I Part|Death|0|||
157203699|NCT02325739|567489788|FG003|Phase I Part|Death|0|||
157203700|NCT02325739|567489789|FG004|Phase I Part|Death|2|||
157203701|NCT02325739|567489790|FG005|Phase I Part|Death|0|||
157203702|NCT02325739|567489791|FG006|Phase I Part|Death|0|||
157203703|NCT02325739|567489792|FG007|Phase I Part|Death|0|||
157203704|NCT02325739|567489793|FG008|Phase I Part|Death|0|||
157203705|NCT02325739|567489794|FG009|Phase I Part|Death|0|||
157203706|NCT02325739|567489795|FG010|Phase I Part|Death|0|||
157203707|NCT02325739|567489785|FG000|Phase II Part|Adverse Event|0|||
157203708|NCT02325739|567489786|FG001|Phase II Part|Adverse Event|0|||
157203709|NCT02325739|567489787|FG002|Phase II Part|Adverse Event|0|||
157203710|NCT02325739|567489788|FG003|Phase II Part|Adverse Event|0|||
157203711|NCT02325739|567489789|FG004|Phase II Part|Adverse Event|0|||
157203712|NCT02325739|567489790|FG005|Phase II Part|Adverse Event|0|||
157203713|NCT02325739|567489791|FG006|Phase II Part|Adverse Event|0|||
157203714|NCT02325739|567489792|FG007|Phase II Part|Adverse Event|0|||
157203715|NCT02325739|567489793|FG008|Phase II Part|Adverse Event|4|||
157203716|NCT02325739|567489794|FG009|Phase II Part|Adverse Event|5|||
157203717|NCT02325739|567489795|FG010|Phase II Part|Adverse Event|1|||
157203718|NCT02325739|567489785|FG000|Phase II Part|Physician Decision|0|||
157203719|NCT02325739|567489786|FG001|Phase II Part|Physician Decision|0|||
157203720|NCT02325739|567489787|FG002|Phase II Part|Physician Decision|0|||
157203721|NCT02325739|567489788|FG003|Phase II Part|Physician Decision|0|||
157203722|NCT02325739|567489789|FG004|Phase II Part|Physician Decision|0|||
157203723|NCT02325739|567489790|FG005|Phase II Part|Physician Decision|0|||
157203724|NCT02325739|567489791|FG006|Phase II Part|Physician Decision|0|||
157203725|NCT02325739|567489792|FG007|Phase II Part|Physician Decision|0|||
157203726|NCT02325739|567489793|FG008|Phase II Part|Physician Decision|0|||
157203727|NCT02325739|567489794|FG009|Phase II Part|Physician Decision|1|||
157203728|NCT02325739|567489795|FG010|Phase II Part|Physician Decision|0|||
157203729|NCT02325739|567489785|FG000|Phase II Part|Progressive disease|0|||
157203730|NCT02325739|567489786|FG001|Phase II Part|Progressive disease|0|||
157203731|NCT02325739|567489787|FG002|Phase II Part|Progressive disease|0|||
157203732|NCT02325739|567489788|FG003|Phase II Part|Progressive disease|0|||
157203733|NCT02325739|567489789|FG004|Phase II Part|Progressive disease|0|||
157203734|NCT02325739|567489790|FG005|Phase II Part|Progressive disease|0|||
157203735|NCT02325739|567489791|FG006|Phase II Part|Progressive disease|0|||
157203736|NCT02325739|567489792|FG007|Phase II Part|Progressive disease|0|||
157203737|NCT02325739|567489793|FG008|Phase II Part|Progressive disease|22|||
157203738|NCT02325739|567489794|FG009|Phase II Part|Progressive disease|29|||
157203739|NCT02325739|567489795|FG010|Phase II Part|Progressive disease|18|||
157203740|NCT02325739|567489785|FG000|Phase II Part|Subject/guardian decision|0|||
157203741|NCT02325739|567489786|FG001|Phase II Part|Subject/guardian decision|0|||
157203742|NCT02325739|567489787|FG002|Phase II Part|Subject/guardian decision|0|||
157203743|NCT02325739|567489788|FG003|Phase II Part|Subject/guardian decision|0|||
157203744|NCT02325739|567489789|FG004|Phase II Part|Subject/guardian decision|0|||
157203745|NCT02325739|567489790|FG005|Phase II Part|Subject/guardian decision|0|||
157203746|NCT02325739|567489791|FG006|Phase II Part|Subject/guardian decision|0|||
157203747|NCT02325739|567489792|FG007|Phase II Part|Subject/guardian decision|0|||
157203748|NCT02325739|567489793|FG008|Phase II Part|Subject/guardian decision|4|||
157203749|NCT02325739|567489794|FG009|Phase II Part|Subject/guardian decision|1|||
157203750|NCT02325739|567489795|FG010|Phase II Part|Subject/guardian decision|1|||
157203751|NCT03075826|567489797|FG000|Overall Study|Withdrawal by Subject|1|||
157245240|NCT00906399|567641050|FG001|Year 1|Withdrawal by Subject|32|||
157245241|NCT00906399|567641051|FG002|Year 1|Withdrawal by Subject|36|||
157245242|NCT00906399|567641052|FG003|Year 1|Withdrawal by Subject|0|||
157245243|NCT00906399|567641053|FG004|Year 1|Withdrawal by Subject|0|||
157245244|NCT00906399|567641054|FG005|Year 1|Withdrawal by Subject|0|||
157245245|NCT00906399|567641055|FG006|Year 1|Withdrawal by Subject|0|||
157245246|NCT00906399|567641049|FG000|Year 1|Physician Decision|0|||
157245247|NCT00906399|567641050|FG001|Year 1|Physician Decision|1|||
157203752|NCT03075826|567489797|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
157203753|NCT04228107|567489798|FG000|Overall Study|Protocol Violation|1|||
157203754|NCT04228107|567489799|FG001|Overall Study|Protocol Violation|0|||
157203755|NCT04228107|567489798|FG000|Overall Study|Withdrawal by Subject|6|||
157203756|NCT04228107|567489799|FG001|Overall Study|Withdrawal by Subject|0|||
157203757|NCT04228107|567489798|FG000|Overall Study|Lost to Follow-up|18|||
157203758|NCT04228107|567489799|FG001|Overall Study|Lost to Follow-up|0|||
157203759|NCT04228107|567489798|FG000|Overall Study|No controller use data|1|||
157203760|NCT04228107|567489799|FG001|Overall Study|No controller use data|0|||
157203761|NCT04228107|567489798|FG000|Overall Study|No medication data collected|1|||
157203762|NCT04228107|567489799|FG001|Overall Study|No medication data collected|0|||
157203763|NCT00965562|567489800|FG000|Overall Study|Lost to Follow-up|1|||
157203764|NCT00965562|567489801|FG001|Overall Study|Lost to Follow-up|2|||
157245248|NCT00906399|567641051|FG002|Year 1|Physician Decision|3|||
157245249|NCT00906399|567641052|FG003|Year 1|Physician Decision|0|||
157245250|NCT00906399|567641053|FG004|Year 1|Physician Decision|0|||
157203765|NCT00965562|567489802|FG002|Overall Study|Lost to Follow-up|3|||
157203766|NCT00965562|567489800|FG000|Overall Study|Withdrawal by Subject|2|||
157203767|NCT00965562|567489801|FG001|Overall Study|Withdrawal by Subject|2|||
157203768|NCT00965562|567489802|FG002|Overall Study|Withdrawal by Subject|0|||
157203769|NCT04755283|567489803|FG000|Overall Study|Withdrawal by Subject|14|||
157203770|NCT04755283|567489804|FG001|Overall Study|Withdrawal by Subject|3|||
157203771|NCT04755283|567489805|FG002|Overall Study|Withdrawal by Subject|6|||
157203772|NCT04755283|567489803|FG000|Overall Study|Lost to Follow-up|0|||
157203773|NCT04755283|567489804|FG001|Overall Study|Lost to Follow-up|0|||
157203774|NCT04755283|567489805|FG002|Overall Study|Lost to Follow-up|1|||
157203775|NCT04755283|567489803|FG000|Overall Study|Death|31|||
157203776|NCT04755283|567489804|FG001|Overall Study|Death|36|||
157203777|NCT04755283|567489805|FG002|Overall Study|Death|34|||
157203778|NCT03179462|567489808|FG000|Overall Study|screening failure|1|||
157203779|NCT03179462|567489809|FG001|Overall Study|screening failure|2|||
157203780|NCT03179462|567489810|FG002|Overall Study|screening failure|0|||
157203781|NCT05153629|567489814|FG000|Overall Study|Withdrawal by Subject|0|||
157203782|NCT05153629|567489815|FG001|Overall Study|Withdrawal by Subject|2|||
157203783|NCT01233284|567489823|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
157203784|NCT01233284|567489824|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157203785|NCT01233284|567489825|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157203786|NCT01233284|567489826|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157203787|NCT01233284|567489827|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
157203788|NCT01233284|567489823|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157203789|NCT01233284|567489824|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
157203790|NCT01233284|567489825|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157203791|NCT01233284|567489826|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157203792|NCT01233284|567489827|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
157203793|NCT01233284|567489823|FG000|Period 1 (4 Weeks)|Other|0|||
157203794|NCT01233284|567489824|FG001|Period 1 (4 Weeks)|Other|0|||
157203795|NCT01233284|567489825|FG002|Period 1 (4 Weeks)|Other|1|||
157203796|NCT01233284|567489826|FG003|Period 1 (4 Weeks)|Other|0|||
157203797|NCT01233284|567489827|FG004|Period 1 (4 Weeks)|Other|0|||
157203798|NCT01233284|567489823|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157203799|NCT01233284|567489824|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157203800|NCT01233284|567489825|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
157203801|NCT01233284|567489826|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157203802|NCT01233284|567489827|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
157203803|NCT01233284|567489823|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
157203804|NCT01233284|567489824|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
157203805|NCT01233284|567489825|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
157203806|NCT01233284|567489826|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
157203807|NCT01233284|567489827|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
157203808|NCT01233284|567489823|FG000|Period 3 (4 Weeks)|Other|0|||
157203809|NCT01233284|567489824|FG001|Period 3 (4 Weeks)|Other|0|||
157203810|NCT01233284|567489825|FG002|Period 3 (4 Weeks)|Other|0|||
157203811|NCT01233284|567489826|FG003|Period 3 (4 Weeks)|Other|1|||
157203812|NCT01233284|567489827|FG004|Period 3 (4 Weeks)|Other|0|||
157203813|NCT01233284|567489823|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
157203814|NCT01233284|567489824|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
157203815|NCT01233284|567489825|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
157203816|NCT01233284|567489826|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
157203817|NCT01233284|567489827|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
157203818|NCT01233284|567489823|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
157203819|NCT01233284|567489824|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
157203820|NCT01233284|567489825|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
157203821|NCT01233284|567489826|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
157203822|NCT01233284|567489827|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
157203823|NCT05403502|567489829|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
157203824|NCT05403502|567489829|FG000|Humalog Lead-In Period|Physician Decision|2|||
157203825|NCT05403502|567489829|FG000|Humalog Lead-In Period|Protocol Violation|1|||
157203826|NCT05403502|567489829|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
157203827|NCT05403502|567489829|FG000|Lyumjev Treatment Period|Physician Decision|2|||
157203828|NCT01058707|567489830|FG000|Overall Study|Disease Progression|15|||
157203829|NCT01058707|567489831|FG001|Overall Study|Disease Progression|20|||
157203830|NCT01058707|567489832|FG002|Overall Study|Disease Progression|20|||
157203831|NCT01058707|567489833|FG003|Overall Study|Disease Progression|15|||
157203832|NCT01058707|567489834|FG004|Overall Study|Disease Progression|23|||
157203833|NCT01058707|567489835|FG005|Overall Study|Disease Progression|10|||
157203834|NCT01058707|567489836|FG006|Overall Study|Disease Progression|12|||
157203835|NCT01058707|567489830|FG000|Overall Study|Adverse Event|11|||
157203836|NCT01058707|567489831|FG001|Overall Study|Adverse Event|4|||
157203837|NCT01058707|567489832|FG002|Overall Study|Adverse Event|7|||
157203838|NCT01058707|567489833|FG003|Overall Study|Adverse Event|6|||
157203839|NCT01058707|567489834|FG004|Overall Study|Adverse Event|7|||
157203840|NCT01058707|567489835|FG005|Overall Study|Adverse Event|3|||
157203841|NCT01058707|567489836|FG006|Overall Study|Adverse Event|1|||
157203842|NCT01058707|567489830|FG000|Overall Study|Subject Decision|5|||
157203843|NCT01058707|567489831|FG001|Overall Study|Subject Decision|3|||
157203844|NCT01058707|567489832|FG002|Overall Study|Subject Decision|3|||
157203845|NCT01058707|567489833|FG003|Overall Study|Subject Decision|1|||
157203846|NCT01058707|567489834|FG004|Overall Study|Subject Decision|2|||
157203847|NCT01058707|567489835|FG005|Overall Study|Subject Decision|3|||
157203848|NCT01058707|567489836|FG006|Overall Study|Subject Decision|6|||
157203849|NCT01058707|567489830|FG000|Overall Study|Lost to Follow-up|0|||
157203850|NCT01058707|567489831|FG001|Overall Study|Lost to Follow-up|0|||
157203851|NCT01058707|567489832|FG002|Overall Study|Lost to Follow-up|1|||
157203852|NCT01058707|567489833|FG003|Overall Study|Lost to Follow-up|0|||
157203853|NCT01058707|567489834|FG004|Overall Study|Lost to Follow-up|0|||
157203854|NCT01058707|567489835|FG005|Overall Study|Lost to Follow-up|0|||
157203855|NCT01058707|567489836|FG006|Overall Study|Lost to Follow-up|0|||
157203856|NCT01058707|567489830|FG000|Overall Study|Reason Not Specified|0|||
157203857|NCT01058707|567489831|FG001|Overall Study|Reason Not Specified|3|||
157203858|NCT01058707|567489832|FG002|Overall Study|Reason Not Specified|2|||
157203859|NCT01058707|567489833|FG003|Overall Study|Reason Not Specified|0|||
157203860|NCT01058707|567489834|FG004|Overall Study|Reason Not Specified|7|||
157203861|NCT01058707|567489835|FG005|Overall Study|Reason Not Specified|1|||
157203862|NCT01058707|567489836|FG006|Overall Study|Reason Not Specified|7|||
157203863|NCT00167414|567489839|FG000|Overall Study|Death|10|||
157203864|NCT01593761|567489840|FG000|Overall Study|Lost to Follow-up|1|||
157203865|NCT01593761|567489840|FG000|Overall Study|culture negative for MRSA at baseline|5|||
157203866|NCT01593761|567489840|FG000|Overall Study|positive for hepatitis C virus|1|||
157203867|NCT01593761|567489840|FG000|Overall Study|secondary cellulitis|1|||
157203868|NCT00795886|567489845|FG000|Overall Study|Death|10|||
157203869|NCT05554471|567489846|FG000|Overall Study|Physician Decision|2|||
157203870|NCT05554471|567489847|FG001|Overall Study|Physician Decision|1|||
157203871|NCT05554471|567489846|FG000|Overall Study|Lost to Follow-up|2|||
157203872|NCT05554471|567489847|FG001|Overall Study|Lost to Follow-up|1|||
157203873|NCT05554471|567489846|FG000|Overall Study|Death|0|||
157203874|NCT05554471|567489847|FG001|Overall Study|Death|1|||
157203875|NCT04814654|567489848|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
157203876|NCT04814654|567489849|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
157203877|NCT04814654|567489850|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
157203878|NCT04292171|567491826|FG000|Overall Study|Pharmacy error|2|||
157203879|NCT04292171|567491827|FG001|Overall Study|Pharmacy error|0|||
157203880|NCT04292171|567491826|FG000|Overall Study|Delivered prior to procedure|0|||
157203881|NCT04292171|567491827|FG001|Overall Study|Delivered prior to procedure|1|||
157245251|NCT00906399|567641054|FG005|Year 1|Physician Decision|0|||
157245252|NCT00906399|567641055|FG006|Year 1|Physician Decision|0|||
157245253|NCT00906399|567641049|FG000|Year 1|Death|2|||
157245254|NCT00906399|567641050|FG001|Year 1|Death|1|||
157245255|NCT00906399|567641051|FG002|Year 1|Death|1|||
157245256|NCT00906399|567641052|FG003|Year 1|Death|0|||
157245257|NCT00906399|567641053|FG004|Year 1|Death|0|||
157245258|NCT00906399|567641054|FG005|Year 1|Death|0|||
157245259|NCT00906399|567641055|FG006|Year 1|Death|0|||
157245260|NCT00906399|567641049|FG000|Year 1|Other|4|||
157245261|NCT00906399|567641050|FG001|Year 1|Other|2|||
157245262|NCT00906399|567641051|FG002|Year 1|Other|7|||
157245263|NCT00906399|567641052|FG003|Year 1|Other|0|||
157245264|NCT00906399|567641053|FG004|Year 1|Other|0|||
157245265|NCT00906399|567641054|FG005|Year 1|Other|0|||
157245266|NCT00906399|567641055|FG006|Year 1|Other|0|||
157245267|NCT00906399|567641049|FG000|Year 2|Adverse Event|0|||
157245268|NCT00906399|567641050|FG001|Year 2|Adverse Event|0|||
157245269|NCT00906399|567641051|FG002|Year 2|Adverse Event|0|||
157245270|NCT00906399|567641052|FG003|Year 2|Adverse Event|9|||
157245271|NCT00906399|567641053|FG004|Year 2|Adverse Event|8|||
157245272|NCT00906399|567641054|FG005|Year 2|Adverse Event|11|||
157203882|NCT04633434|567491828|FG000|Overall Study|Lost to Follow-up|32|||
157203883|NCT04633434|567491829|FG001|Overall Study|Lost to Follow-up|32|||
157203884|NCT02116309|567491831|FG000|Overall Study|Lost to Follow-up|0|||
157203885|NCT02116309|567491832|FG001|Overall Study|Lost to Follow-up|1|||
157245273|NCT00906399|567641055|FG006|Year 2|Adverse Event|6|||
157245274|NCT00906399|567641049|FG000|Year 2|Lost to Follow-up|0|||
157245275|NCT00906399|567641050|FG001|Year 2|Lost to Follow-up|0|||
157203886|NCT03292731|567491833|FG000|Overall Study|Protocol Violation|4|||
157203887|NCT03292731|567491834|FG001|Overall Study|Protocol Violation|11|||
157203888|NCT03292731|567491835|FG002|Overall Study|Protocol Violation|1|||
157203889|NCT00471237|567491836|FG000|Overall Study|Adverse Event|6|||
157203890|NCT00471237|567491837|FG001|Overall Study|Adverse Event|5|||
157203891|NCT00471237|567491838|FG002|Overall Study|Adverse Event|4|||
157245276|NCT00906399|567641051|FG002|Year 2|Lost to Follow-up|0|||
157245277|NCT00906399|567641052|FG003|Year 2|Lost to Follow-up|1|||
157245278|NCT00906399|567641053|FG004|Year 2|Lost to Follow-up|4|||
157245279|NCT00906399|567641054|FG005|Year 2|Lost to Follow-up|2|||
157245280|NCT00906399|567641055|FG006|Year 2|Lost to Follow-up|4|||
157245281|NCT00906399|567641049|FG000|Year 2|Withdrawal by Subject|0|||
157245282|NCT00906399|567641050|FG001|Year 2|Withdrawal by Subject|0|||
157245283|NCT00906399|567641051|FG002|Year 2|Withdrawal by Subject|0|||
157203892|NCT00471237|567491839|FG003|Overall Study|Adverse Event|8|||
157203893|NCT00471237|567491840|FG004|Overall Study|Adverse Event|7|||
157203894|NCT00471237|567491841|FG005|Overall Study|Adverse Event|5|||
157203895|NCT00471237|567491842|FG006|Overall Study|Adverse Event|0|||
157203896|NCT00471237|567491836|FG000|Overall Study|Lost to Follow-up|1|||
157203897|NCT00471237|567491837|FG001|Overall Study|Lost to Follow-up|1|||
157203898|NCT00471237|567491838|FG002|Overall Study|Lost to Follow-up|0|||
157203899|NCT00471237|567491839|FG003|Overall Study|Lost to Follow-up|2|||
157203900|NCT00471237|567491840|FG004|Overall Study|Lost to Follow-up|3|||
157203901|NCT00471237|567491841|FG005|Overall Study|Lost to Follow-up|0|||
157203902|NCT00471237|567491842|FG006|Overall Study|Lost to Follow-up|0|||
157203903|NCT00471237|567491836|FG000|Overall Study|Protocol Violation|3|||
157203904|NCT00471237|567491837|FG001|Overall Study|Protocol Violation|6|||
157203905|NCT00471237|567491838|FG002|Overall Study|Protocol Violation|3|||
157203906|NCT00471237|567491839|FG003|Overall Study|Protocol Violation|2|||
157203907|NCT00471237|567491840|FG004|Overall Study|Protocol Violation|2|||
157203908|NCT00471237|567491841|FG005|Overall Study|Protocol Violation|4|||
157203909|NCT00471237|567491842|FG006|Overall Study|Protocol Violation|1|||
157203910|NCT00471237|567491836|FG000|Overall Study|Withdrawal by Subject|8|||
157203911|NCT00471237|567491837|FG001|Overall Study|Withdrawal by Subject|6|||
157203912|NCT00471237|567491838|FG002|Overall Study|Withdrawal by Subject|5|||
157203913|NCT00471237|567491839|FG003|Overall Study|Withdrawal by Subject|8|||
157203914|NCT00471237|567491840|FG004|Overall Study|Withdrawal by Subject|7|||
157203915|NCT00471237|567491841|FG005|Overall Study|Withdrawal by Subject|4|||
157203916|NCT00471237|567491842|FG006|Overall Study|Withdrawal by Subject|2|||
157203917|NCT00471237|567491836|FG000|Overall Study|Sponsor terminated study|20|||
157203918|NCT00471237|567491837|FG001|Overall Study|Sponsor terminated study|23|||
157203919|NCT00471237|567491838|FG002|Overall Study|Sponsor terminated study|19|||
157203920|NCT00471237|567491839|FG003|Overall Study|Sponsor terminated study|22|||
157203921|NCT00471237|567491840|FG004|Overall Study|Sponsor terminated study|18|||
157203922|NCT00471237|567491841|FG005|Overall Study|Sponsor terminated study|24|||
157203923|NCT00471237|567491842|FG006|Overall Study|Sponsor terminated study|0|||
157203924|NCT00471237|567491836|FG000|Overall Study|Non-compliance|0|||
157203925|NCT00471237|567491837|FG001|Overall Study|Non-compliance|1|||
157203926|NCT00471237|567491838|FG002|Overall Study|Non-compliance|0|||
157203927|NCT00471237|567491839|FG003|Overall Study|Non-compliance|1|||
157203928|NCT00471237|567491840|FG004|Overall Study|Non-compliance|0|||
157203929|NCT00471237|567491841|FG005|Overall Study|Non-compliance|0|||
157203930|NCT00471237|567491842|FG006|Overall Study|Non-compliance|0|||
157203931|NCT00471237|567491836|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
157203932|NCT00471237|567491837|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
157203933|NCT00471237|567491838|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
157203934|NCT00471237|567491839|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
157203935|NCT00471237|567491840|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
157203936|NCT00471237|567491841|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
157203937|NCT00471237|567491842|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
157203938|NCT00471237|567491836|FG000|Overall Study|Early stopping due to non-efficacy|1|||
157203939|NCT00471237|567491837|FG001|Overall Study|Early stopping due to non-efficacy|0|||
157203940|NCT00471237|567491838|FG002|Overall Study|Early stopping due to non-efficacy|0|||
157203941|NCT00471237|567491839|FG003|Overall Study|Early stopping due to non-efficacy|0|||
157203942|NCT00471237|567491840|FG004|Overall Study|Early stopping due to non-efficacy|1|||
157203943|NCT00471237|567491841|FG005|Overall Study|Early stopping due to non-efficacy|0|||
157203944|NCT00471237|567491842|FG006|Overall Study|Early stopping due to non-efficacy|0|||
157203945|NCT00471237|567491836|FG000|Overall Study|Participant planned to travel to abraod|1|||
157203946|NCT00471237|567491837|FG001|Overall Study|Participant planned to travel to abraod|0|||
157203947|NCT00471237|567491838|FG002|Overall Study|Participant planned to travel to abraod|0|||
157203948|NCT00471237|567491839|FG003|Overall Study|Participant planned to travel to abraod|0|||
157203949|NCT00471237|567491840|FG004|Overall Study|Participant planned to travel to abraod|0|||
157203950|NCT00471237|567491841|FG005|Overall Study|Participant planned to travel to abraod|1|||
157203951|NCT00471237|567491842|FG006|Overall Study|Participant planned to travel to abraod|0|||
157203952|NCT00471237|567491836|FG000|Overall Study|High parathyroid hormone|0|||
157203953|NCT00471237|567491837|FG001|Overall Study|High parathyroid hormone|0|||
157203954|NCT00471237|567491838|FG002|Overall Study|High parathyroid hormone|1|||
157203955|NCT00471237|567491839|FG003|Overall Study|High parathyroid hormone|0|||
157203956|NCT00471237|567491840|FG004|Overall Study|High parathyroid hormone|0|||
157203957|NCT00471237|567491841|FG005|Overall Study|High parathyroid hormone|0|||
157203958|NCT00471237|567491842|FG006|Overall Study|High parathyroid hormone|0|||
157203959|NCT00471237|567491836|FG000|Overall Study|Participant lost medication|0|||
157203960|NCT00471237|567491837|FG001|Overall Study|Participant lost medication|0|||
157203961|NCT00471237|567491838|FG002|Overall Study|Participant lost medication|0|||
157203962|NCT00471237|567491839|FG003|Overall Study|Participant lost medication|0|||
157203963|NCT00471237|567491840|FG004|Overall Study|Participant lost medication|1|||
157203964|NCT00471237|567491841|FG005|Overall Study|Participant lost medication|0|||
157203965|NCT00471237|567491842|FG006|Overall Study|Participant lost medication|0|||
157203966|NCT00471237|567491836|FG000|Overall Study|Administration of prohibited medicine|0|||
157203967|NCT00471237|567491837|FG001|Overall Study|Administration of prohibited medicine|0|||
157203968|NCT00471237|567491838|FG002|Overall Study|Administration of prohibited medicine|0|||
157203969|NCT00471237|567491839|FG003|Overall Study|Administration of prohibited medicine|0|||
157203970|NCT00471237|567491840|FG004|Overall Study|Administration of prohibited medicine|1|||
157203971|NCT00471237|567491841|FG005|Overall Study|Administration of prohibited medicine|0|||
157203972|NCT00471237|567491842|FG006|Overall Study|Administration of prohibited medicine|0|||
157203973|NCT00471237|567491836|FG000|Overall Study|Participant shifted residence|0|||
157203974|NCT00471237|567491837|FG001|Overall Study|Participant shifted residence|0|||
157203975|NCT00471237|567491838|FG002|Overall Study|Participant shifted residence|0|||
157203976|NCT00471237|567491839|FG003|Overall Study|Participant shifted residence|0|||
157203977|NCT00471237|567491840|FG004|Overall Study|Participant shifted residence|1|||
157203978|NCT00471237|567491841|FG005|Overall Study|Participant shifted residence|0|||
157203979|NCT00471237|567491842|FG006|Overall Study|Participant shifted residence|0|||
157203980|NCT00471237|567491836|FG000|Overall Study|Participant's decision|0|||
157203981|NCT00471237|567491837|FG001|Overall Study|Participant's decision|0|||
157203982|NCT00471237|567491838|FG002|Overall Study|Participant's decision|0|||
157203983|NCT00471237|567491839|FG003|Overall Study|Participant's decision|0|||
157203984|NCT00471237|567491840|FG004|Overall Study|Participant's decision|0|||
157203985|NCT00471237|567491841|FG005|Overall Study|Participant's decision|1|||
157203986|NCT00471237|567491842|FG006|Overall Study|Participant's decision|0|||
157203987|NCT00848965|567491843|FG000|Overall Study|Adverse Event|1|||
157203988|NCT00848965|567491843|FG000|Overall Study|Withdrawal by Subject|1|||
157203989|NCT00348348|567491844|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
157203990|NCT00348348|567491845|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
157203991|NCT00348348|567491844|FG000|Overall Study|Lack of Efficacy|1|||
157203992|NCT00348348|567491845|FG001|Overall Study|Lack of Efficacy|1|||
157203993|NCT00348348|567491844|FG000|Overall Study|Lost to Follow-up|8|||
157203994|NCT00348348|567491845|FG001|Overall Study|Lost to Follow-up|10|||
157203995|NCT00348348|567491844|FG000|Overall Study|Withdrawal by Subject|4|||
157203996|NCT00348348|567491845|FG001|Overall Study|Withdrawal by Subject|1|||
157203997|NCT00348348|567491844|FG000|Overall Study|Other|7|||
157203998|NCT00348348|567491845|FG001|Overall Study|Other|4|||
157203999|NCT00348348|567491844|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
157204000|NCT00348348|567491845|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
157204001|NCT00348348|567491844|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
157204002|NCT00348348|567491845|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
157204003|NCT00348348|567491844|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
157204004|NCT00348348|567491845|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
157204005|NCT00348348|567491844|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
157204006|NCT00348348|567491845|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
157204007|NCT00348348|567491844|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
157204008|NCT00348348|567491845|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
157204009|NCT00348348|567491844|FG000|Overall Study|Adverse event probably related to study|1|||
157204010|NCT00348348|567491845|FG001|Overall Study|Adverse event probably related to study|0|||
157204011|NCT02329834|567491846|FG000|Overall Study|Physician Decision|1|||
157204012|NCT02329834|567491847|FG001|Overall Study|Physician Decision|0|||
157204013|NCT00578448|567491850|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
157204014|NCT00578448|567491850|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
157204015|NCT00578448|567491850|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
157204016|NCT00578448|567491850|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
157204017|NCT01976104|567491851|FG000|Overall Study|Adverse Event|0|||
157204018|NCT01976104|567491852|FG001|Overall Study|Adverse Event|0|||
157204019|NCT01976104|567491853|FG002|Overall Study|Adverse Event|1|||
157204020|NCT01976104|567491854|FG003|Overall Study|Adverse Event|0|||
157204021|NCT01976104|567491851|FG000|Overall Study|Lost to Follow-up|3|||
157204022|NCT01976104|567491852|FG001|Overall Study|Lost to Follow-up|0|||
157204023|NCT01976104|567491853|FG002|Overall Study|Lost to Follow-up|1|||
157204024|NCT01976104|567491854|FG003|Overall Study|Lost to Follow-up|1|||
157204025|NCT01976104|567491851|FG000|Overall Study|Subject Choice|0|||
157204026|NCT01976104|567491852|FG001|Overall Study|Subject Choice|1|||
157204027|NCT01976104|567491853|FG002|Overall Study|Subject Choice|0|||
157204028|NCT01976104|567491854|FG003|Overall Study|Subject Choice|1|||
157204029|NCT01976104|567491851|FG000|Overall Study|Withdrawal by Subject|3|||
157204030|NCT01976104|567491852|FG001|Overall Study|Withdrawal by Subject|0|||
157204031|NCT01976104|567491853|FG002|Overall Study|Withdrawal by Subject|0|||
157204032|NCT01976104|567491854|FG003|Overall Study|Withdrawal by Subject|1|||
157204033|NCT01976104|567491851|FG000|Overall Study|Other|0|||
157204034|NCT01976104|567491852|FG001|Overall Study|Other|1|||
157204035|NCT01976104|567491853|FG002|Overall Study|Other|0|||
157204036|NCT01976104|567491854|FG003|Overall Study|Other|0|||
157204037|NCT03237325|567491861|FG000|Overall Study|Lost to Follow-up|3|||
157204038|NCT03237325|567491862|FG001|Overall Study|Lost to Follow-up|5|||
157204039|NCT03237325|567491861|FG000|Overall Study|Physician Decision|2|||
157245284|NCT00906399|567641052|FG003|Year 2|Withdrawal by Subject|17|||
157245285|NCT00906399|567641053|FG004|Year 2|Withdrawal by Subject|18|||
157245286|NCT00906399|567641054|FG005|Year 2|Withdrawal by Subject|27|||
157245287|NCT00906399|567641055|FG006|Year 2|Withdrawal by Subject|13|||
157204040|NCT03237325|567491862|FG001|Overall Study|Physician Decision|4|||
157204041|NCT03237325|567491861|FG000|Overall Study|Withdrawal by Subject|9|||
157204042|NCT03237325|567491862|FG001|Overall Study|Withdrawal by Subject|12|||
157204043|NCT03237325|567491861|FG000|Overall Study|Noncompliance with Study Procedures|1|||
157204044|NCT03237325|567491862|FG001|Overall Study|Noncompliance with Study Procedures|1|||
157204045|NCT03237325|567491861|FG000|Overall Study|Termination by Sponsor|0|||
157204046|NCT03237325|567491862|FG001|Overall Study|Termination by Sponsor|1|||
157204047|NCT03237325|567491861|FG000|Overall Study|Reason other than described|0|||
157204048|NCT03237325|567491862|FG001|Overall Study|Reason other than described|2|||
157204049|NCT00433771|567491865|FG000|Overall Study|screen fail|14|||
157204050|NCT00433771|567491865|FG000|Overall Study|Treated and later found to be ineligible|2|||
157204051|NCT00433771|567491865|FG000|Overall Study|Death|2|||
157204052|NCT00433771|567491865|FG000|Overall Study|Failure to deploy stent|1|||
157204053|NCT00138658|567491866|FG000|Overall Study|Adverse Event|23|||
157204054|NCT00138658|567491866|FG000|Overall Study|Death|1|||
157204055|NCT00138658|567491866|FG000|Overall Study|Disease Progression|21|||
157204056|NCT00138658|567491866|FG000|Overall Study|Physician Decision|11|||
157204057|NCT00138658|567491866|FG000|Overall Study|Withdrawal by Subject|5|||
157204058|NCT03426995|567491869|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204059|NCT03426995|567491870|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204060|NCT03426995|567491871|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
157204061|NCT03426995|567491872|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204062|NCT03426995|567491873|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204063|NCT03426995|567491874|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204064|NCT03426995|567491875|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204065|NCT03426995|567491876|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204066|NCT03426995|567491877|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204067|NCT03426995|567491878|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204068|NCT03426995|567491879|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204069|NCT03426995|567491880|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204070|NCT03426995|567491881|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204071|NCT03426995|567491882|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204072|NCT03426995|567491883|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204073|NCT03426995|567491884|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204074|NCT03426995|567491885|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204075|NCT03426995|567491886|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204076|NCT03426995|567491887|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
157204077|NCT03426995|567491869|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204078|NCT03426995|567491870|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204079|NCT03426995|567491871|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204080|NCT03426995|567491872|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204081|NCT03426995|567491873|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204082|NCT03426995|567491874|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
157204083|NCT03426995|567491875|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204084|NCT03426995|567491876|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204085|NCT03426995|567491877|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204086|NCT03426995|567491878|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204087|NCT03426995|567491879|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204088|NCT03426995|567491880|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204089|NCT03426995|567491881|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204090|NCT03426995|567491882|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204091|NCT03426995|567491883|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204092|NCT03426995|567491884|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204093|NCT03426995|567491885|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204094|NCT03426995|567491886|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204095|NCT03426995|567491887|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
157204096|NCT03426995|567491869|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204097|NCT03426995|567491870|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204098|NCT03426995|567491871|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157245288|NCT00906399|567641049|FG000|Year 2|Physician Decision|0|||
157204099|NCT03426995|567491872|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157245289|NCT00906399|567641050|FG001|Year 2|Physician Decision|0|||
157245290|NCT00906399|567641051|FG002|Year 2|Physician Decision|0|||
157245291|NCT00906399|567641052|FG003|Year 2|Physician Decision|0|||
157245292|NCT00906399|567641053|FG004|Year 2|Physician Decision|2|||
157245293|NCT00906399|567641054|FG005|Year 2|Physician Decision|6|||
157245294|NCT00906399|567641055|FG006|Year 2|Physician Decision|3|||
157245295|NCT00906399|567641049|FG000|Year 2|Death|0|||
157245296|NCT00906399|567641050|FG001|Year 2|Death|0|||
157245297|NCT00906399|567641051|FG002|Year 2|Death|0|||
157245298|NCT00906399|567641052|FG003|Year 2|Death|1|||
157245299|NCT00906399|567641053|FG004|Year 2|Death|0|||
157245300|NCT00906399|567641054|FG005|Year 2|Death|0|||
157245301|NCT00906399|567641055|FG006|Year 2|Death|3|||
157245302|NCT00906399|567641049|FG000|Year 2|Other|0|||
157245303|NCT00906399|567641050|FG001|Year 2|Other|0|||
157245304|NCT00906399|567641051|FG002|Year 2|Other|0|||
157245305|NCT00906399|567641052|FG003|Year 2|Other|2|||
157245306|NCT00906399|567641053|FG004|Year 2|Other|3|||
157245307|NCT00906399|567641054|FG005|Year 2|Other|1|||
157245308|NCT00906399|567641055|FG006|Year 2|Other|0|||
157245309|NCT02845336|567641056|FG000|Overall Study|Lost to Follow-up|3|||
157245310|NCT02845336|567641057|FG001|Overall Study|Lost to Follow-up|1|||
157245311|NCT02845336|567641056|FG000|Overall Study|Inability to get medication|2|||
157245312|NCT02845336|567641057|FG001|Overall Study|Inability to get medication|0|||
157245313|NCT01559363|567641059|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
157245314|NCT01559363|567641060|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
157245315|NCT01559363|567641061|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
157245316|NCT01559363|567641062|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
157245317|NCT01559363|567641063|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
157245318|NCT01559363|567641064|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
157245319|NCT01559363|567641059|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
157245320|NCT01559363|567641060|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
157245321|NCT01559363|567641061|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
157245322|NCT01559363|567641062|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
157245323|NCT01559363|567641063|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
157245324|NCT01559363|567641064|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
157245325|NCT01559363|567641059|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
157245326|NCT01559363|567641060|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
157245327|NCT01559363|567641061|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
157245328|NCT01559363|567641062|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
157245329|NCT01559363|567641063|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
157245330|NCT01559363|567641064|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
157245331|NCT01559363|567641059|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
157245332|NCT01559363|567641060|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
157245333|NCT01559363|567641061|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
157245334|NCT01559363|567641062|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
157245335|NCT01559363|567641063|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
157245336|NCT01559363|567641064|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
157245337|NCT01559363|567641059|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
157245338|NCT01559363|567641060|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
157245339|NCT01559363|567641061|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
157245340|NCT01559363|567641062|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
157245341|NCT01559363|567641063|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
157245342|NCT01559363|567641064|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
157245343|NCT01559363|567641059|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
157245344|NCT01559363|567641060|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
157245345|NCT01559363|567641061|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
157245346|NCT01559363|567641062|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
157245347|NCT01559363|567641063|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
157245348|NCT01559363|567641064|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
157245349|NCT01559363|567641059|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
157245350|NCT01559363|567641060|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
157245351|NCT01559363|567641061|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
157245352|NCT01559363|567641062|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
157245353|NCT01559363|567641063|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
157245354|NCT01559363|567641064|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
157245355|NCT05098743|567641069|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
157245356|NCT05098743|567641070|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
157245357|NCT05098743|567641069|FG000|Overall Study|Lost to Follow-up|1|||
157245358|NCT05098743|567641070|FG001|Overall Study|Lost to Follow-up|2|||
157245359|NCT02452463|567641071|FG000|Overall Study|Death|1|||
157245360|NCT02452463|567641072|FG001|Overall Study|Death|0|||
157245361|NCT02452463|567641073|FG002|Overall Study|Death|0|||
157245362|NCT02452463|567641071|FG000|Overall Study|Study Suspended|1|||
157245363|NCT02452463|567641072|FG001|Overall Study|Study Suspended|0|||
157245364|NCT02452463|567641073|FG002|Overall Study|Study Suspended|0|||
157245365|NCT02452463|567641071|FG000|Overall Study|Recommended by DSMB|0|||
157245366|NCT02452463|567641072|FG001|Overall Study|Recommended by DSMB|1|||
157245367|NCT02452463|567641073|FG002|Overall Study|Recommended by DSMB|0|||
157245368|NCT02452463|567641071|FG000|Overall Study|Withdrawal by Subject|0|||
157245369|NCT02452463|567641072|FG001|Overall Study|Withdrawal by Subject|1|||
157245370|NCT02452463|567641073|FG002|Overall Study|Withdrawal by Subject|0|||
157245371|NCT01073631|567641074|FG000|Overall Study|Death|82|||
157245372|NCT01073631|567641074|FG000|Overall Study|Adverse Event|24|||
157245373|NCT01073631|567641074|FG000|Overall Study|Other|63|||
157245374|NCT00849797|567641077|FG000|First Intervention|bad veins|1|||
157245375|NCT00849797|567641078|FG001|First Intervention|bad veins|0|||
157245376|NCT00849797|567641077|FG000|First Intervention|Adverse Event|0|||
157245377|NCT00849797|567641078|FG001|First Intervention|Adverse Event|1|||
157245378|NCT00849797|567641077|FG000|Washout: One Week|Withdrawal by Subject|0|||
157204100|NCT03426995|567491873|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
157204101|NCT03426995|567491874|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
157204102|NCT03426995|567491875|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204103|NCT03426995|567491876|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204104|NCT03426995|567491877|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204105|NCT03426995|567491878|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204106|NCT03426995|567491879|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204107|NCT03426995|567491880|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204108|NCT03426995|567491881|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204109|NCT03426995|567491882|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204110|NCT03426995|567491883|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204111|NCT03426995|567491884|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204112|NCT03426995|567491885|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204113|NCT03426995|567491886|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204114|NCT03426995|567491887|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
157204115|NCT03426995|567491869|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204116|NCT03426995|567491870|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204117|NCT03426995|567491871|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204118|NCT03426995|567491872|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204119|NCT03426995|567491873|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204120|NCT03426995|567491874|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204121|NCT03426995|567491875|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204122|NCT03426995|567491876|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204123|NCT03426995|567491877|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204124|NCT03426995|567491878|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204125|NCT03426995|567491879|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
157204126|NCT03426995|567491880|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204127|NCT03426995|567491881|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204128|NCT03426995|567491882|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204129|NCT03426995|567491883|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204130|NCT03426995|567491884|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204131|NCT03426995|567491885|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204132|NCT03426995|567491886|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204133|NCT03426995|567491887|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
157204134|NCT03426995|567491869|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204135|NCT03426995|567491870|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204136|NCT03426995|567491871|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204137|NCT03426995|567491872|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204138|NCT03426995|567491873|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204139|NCT03426995|567491874|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204140|NCT03426995|567491875|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204141|NCT03426995|567491876|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
157204142|NCT03426995|567491877|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204143|NCT03426995|567491878|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204144|NCT03426995|567491879|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204145|NCT03426995|567491880|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204146|NCT03426995|567491881|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204147|NCT03426995|567491882|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204148|NCT03426995|567491883|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204149|NCT03426995|567491884|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204150|NCT03426995|567491885|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204151|NCT03426995|567491886|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204152|NCT03426995|567491887|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
157204153|NCT03426995|567491869|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157245379|NCT00849797|567641078|FG001|Washout: One Week|Withdrawal by Subject|2|||
157245380|NCT01494532|567641079|FG000|Overall Study|Adverse Event|4|||
157245381|NCT01494532|567641080|FG001|Overall Study|Adverse Event|1|||
157245382|NCT01494532|567641081|FG002|Overall Study|Adverse Event|8|||
157245383|NCT01494532|567641082|FG003|Overall Study|Adverse Event|6|||
157245384|NCT01494532|567641083|FG004|Overall Study|Adverse Event|5|||
157245385|NCT01494532|567641084|FG005|Overall Study|Adverse Event|0|||
157245386|NCT01494532|567641079|FG000|Overall Study|Lack of Efficacy|0|||
157245387|NCT01494532|567641080|FG001|Overall Study|Lack of Efficacy|0|||
157245388|NCT01494532|567641081|FG002|Overall Study|Lack of Efficacy|0|||
157245389|NCT01494532|567641082|FG003|Overall Study|Lack of Efficacy|0|||
157245390|NCT01494532|567641083|FG004|Overall Study|Lack of Efficacy|2|||
157245391|NCT01494532|567641084|FG005|Overall Study|Lack of Efficacy|0|||
157245392|NCT01494532|567641079|FG000|Overall Study|Protocol deviation|2|||
157245393|NCT01494532|567641080|FG001|Overall Study|Protocol deviation|1|||
157245394|NCT01494532|567641081|FG002|Overall Study|Protocol deviation|3|||
157245395|NCT01494532|567641082|FG003|Overall Study|Protocol deviation|2|||
157245396|NCT01494532|567641083|FG004|Overall Study|Protocol deviation|3|||
157245397|NCT01494532|567641084|FG005|Overall Study|Protocol deviation|0|||
157245398|NCT01494532|567641079|FG000|Overall Study|Protocol-defined stopping criteria|0|||
157245399|NCT01494532|567641080|FG001|Overall Study|Protocol-defined stopping criteria|0|||
157245400|NCT01494532|567641081|FG002|Overall Study|Protocol-defined stopping criteria|1|||
157245401|NCT01494532|567641082|FG003|Overall Study|Protocol-defined stopping criteria|0|||
157245402|NCT01494532|567641083|FG004|Overall Study|Protocol-defined stopping criteria|0|||
157245403|NCT01494532|567641084|FG005|Overall Study|Protocol-defined stopping criteria|0|||
157245404|NCT01494532|567641079|FG000|Overall Study|Lost to Follow-up|1|||
157245405|NCT01494532|567641080|FG001|Overall Study|Lost to Follow-up|0|||
157245406|NCT01494532|567641081|FG002|Overall Study|Lost to Follow-up|0|||
157245407|NCT01494532|567641082|FG003|Overall Study|Lost to Follow-up|2|||
157245408|NCT01494532|567641083|FG004|Overall Study|Lost to Follow-up|0|||
157245409|NCT01494532|567641084|FG005|Overall Study|Lost to Follow-up|0|||
157245410|NCT01494532|567641079|FG000|Overall Study|Physician Decision|0|||
157245411|NCT01494532|567641080|FG001|Overall Study|Physician Decision|1|||
157245412|NCT01494532|567641081|FG002|Overall Study|Physician Decision|1|||
157245413|NCT01494532|567641082|FG003|Overall Study|Physician Decision|2|||
157245414|NCT01494532|567641083|FG004|Overall Study|Physician Decision|0|||
157245415|NCT01494532|567641084|FG005|Overall Study|Physician Decision|0|||
157245416|NCT01494532|567641079|FG000|Overall Study|Withdrawal by Subject|3|||
157245417|NCT01494532|567641080|FG001|Overall Study|Withdrawal by Subject|1|||
157245418|NCT01494532|567641081|FG002|Overall Study|Withdrawal by Subject|4|||
157245419|NCT01494532|567641082|FG003|Overall Study|Withdrawal by Subject|3|||
157245420|NCT01494532|567641083|FG004|Overall Study|Withdrawal by Subject|2|||
157245421|NCT01494532|567641084|FG005|Overall Study|Withdrawal by Subject|0|||
157245422|NCT00679081|567641085|FG000|Overall Study|Lost to Follow-up|1|||
157245423|NCT01891357|567641089|FG000|Overall Study|Protocol Violation|3|||
157245424|NCT03733145|567641090|FG000|Overall Study|screenfail|3|||
157245425|NCT03733145|567641091|FG001|Overall Study|screenfail|3|||
157245426|NCT03733145|567641092|FG002|Overall Study|screenfail|2|||
157245427|NCT01404988|567641095|FG000|Overall Study|Death|2|||
157245428|NCT01404988|567641096|FG001|Overall Study|Death|0|||
157245429|NCT01404988|567641097|FG002|Overall Study|Death|2|||
157245430|NCT01404988|567641095|FG000|Overall Study|Adverse Event|1|||
157245431|NCT01404988|567641096|FG001|Overall Study|Adverse Event|0|||
157245432|NCT01404988|567641097|FG002|Overall Study|Adverse Event|0|||
157245433|NCT01404988|567641095|FG000|Overall Study|Withdrawal by Subject|2|||
157245434|NCT01404988|567641096|FG001|Overall Study|Withdrawal by Subject|2|||
157245435|NCT01404988|567641097|FG002|Overall Study|Withdrawal by Subject|0|||
157245436|NCT01404988|567641095|FG000|Overall Study|Lost to Follow-up|1|||
157245437|NCT01404988|567641096|FG001|Overall Study|Lost to Follow-up|2|||
157245438|NCT01404988|567641097|FG002|Overall Study|Lost to Follow-up|1|||
157245439|NCT00829764|567641098|FG000|First Intervention|Adverse Event|1|||
157245440|NCT00829764|567641099|FG001|First Intervention|Adverse Event|0|||
157245441|NCT00829764|567641098|FG000|First Intervention|Withdrawal by Subject|1|||
157245442|NCT00829764|567641099|FG001|First Intervention|Withdrawal by Subject|1|||
157245443|NCT00477594|567641100|FG000|Year 1 and Year 2|Adverse Event|4|||
157245444|NCT00477594|567641101|FG001|Year 1 and Year 2|Adverse Event|2|||
157245445|NCT00477594|567641100|FG000|Year 1 and Year 2|Physician Decision|2|||
157245446|NCT00477594|567641101|FG001|Year 1 and Year 2|Physician Decision|1|||
157245447|NCT00477594|567641100|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
157245448|NCT00477594|567641101|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
157245449|NCT00477594|567641100|FG000|Year 1 and Year 2|Other|1|||
157245450|NCT00477594|567641101|FG001|Year 1 and Year 2|Other|0|||
157245451|NCT00477594|567641100|FG000|Year 3|Adverse Event|1|||
157245452|NCT00477594|567641101|FG001|Year 3|Adverse Event|0|||
157245453|NCT00477594|567641100|FG000|Year 3|Withdrawal by Subject|1|||
157245454|NCT00477594|567641101|FG001|Year 3|Withdrawal by Subject|0|||
157245455|NCT00477594|567641100|FG000|Follow-up Period|Withdrawal by Subject|2|||
157245456|NCT00477594|567641101|FG001|Follow-up Period|Withdrawal by Subject|1|||
157245457|NCT00477594|567641100|FG000|Follow-up Period|Other|1|||
157245458|NCT00477594|567641101|FG001|Follow-up Period|Other|0|||
157245459|NCT01109849|567642782|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
157245460|NCT01109849|567642783|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
157245461|NCT01109849|567642784|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
157245462|NCT01109849|567642785|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
157245463|NCT01109849|567642786|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
157245464|NCT01109849|567642782|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
157245465|NCT01109849|567642783|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
157245466|NCT01109849|567642784|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
157245467|NCT01109849|567642785|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
157245468|NCT01109849|567642786|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
157245469|NCT01109849|567642782|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
157245470|NCT01109849|567642783|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
157245471|NCT01109849|567642784|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
157245472|NCT01109849|567642785|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
157245473|NCT01109849|567642786|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
157245474|NCT01109849|567642782|FG000|Initial Randomization: ADHD Treatment|move away|2|||
157245475|NCT01109849|567642783|FG001|Initial Randomization: ADHD Treatment|move away|7|||
157245476|NCT01109849|567642784|FG002|Initial Randomization: ADHD Treatment|move away|0|||
157245477|NCT01109849|567642785|FG003|Initial Randomization: ADHD Treatment|move away|0|||
157204154|NCT03426995|567491870|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204155|NCT03426995|567491871|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204156|NCT03426995|567491872|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204157|NCT03426995|567491873|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204158|NCT03426995|567491874|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204159|NCT03426995|567491875|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204160|NCT03426995|567491876|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204161|NCT03426995|567491877|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204162|NCT03426995|567491878|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204163|NCT03426995|567491879|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204164|NCT03426995|567491880|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204165|NCT03426995|567491881|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204166|NCT03426995|567491882|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204167|NCT03426995|567491883|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
157204168|NCT03426995|567491884|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
157204169|NCT03426995|567491885|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204170|NCT03426995|567491886|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204171|NCT03426995|567491887|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
157204172|NCT03426995|567491869|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204173|NCT03426995|567491870|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204174|NCT03426995|567491871|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204175|NCT03426995|567491872|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204176|NCT03426995|567491873|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204177|NCT03426995|567491874|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204178|NCT03426995|567491875|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204179|NCT03426995|567491876|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204180|NCT03426995|567491877|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204181|NCT03426995|567491878|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204182|NCT03426995|567491879|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204183|NCT03426995|567491880|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204184|NCT03426995|567491881|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204185|NCT03426995|567491882|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204186|NCT03426995|567491883|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
157204187|NCT03426995|567491884|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
157204188|NCT03426995|567491885|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204189|NCT03426995|567491886|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204190|NCT03426995|567491887|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
157204191|NCT00227591|567491888|FG000|Overall Study|Withdrawal by Subject|1|||
157204192|NCT02335411|567491889|FG000|Overall Study|Death|223|||
157204193|NCT02335411|567491890|FG001|Overall Study|Death|22|||
157204194|NCT02335411|567491891|FG002|Overall Study|Death|26|||
157204195|NCT02335411|567491889|FG000|Overall Study|Physician Decision|3|||
157204196|NCT02335411|567491890|FG001|Overall Study|Physician Decision|0|||
157204197|NCT02335411|567491891|FG002|Overall Study|Physician Decision|0|||
157204198|NCT02335411|567491889|FG000|Overall Study|Protocol Violation|1|||
157204199|NCT02335411|567491890|FG001|Overall Study|Protocol Violation|0|||
157204200|NCT02335411|567491891|FG002|Overall Study|Protocol Violation|0|||
157204201|NCT02335411|567491889|FG000|Overall Study|Withdrawal by Subject|11|||
157204202|NCT02335411|567491890|FG001|Overall Study|Withdrawal by Subject|0|||
157204203|NCT02335411|567491891|FG002|Overall Study|Withdrawal by Subject|3|||
157204204|NCT02335411|567491889|FG000|Overall Study|Sponsor Decision|12|||
157204205|NCT02335411|567491890|FG001|Overall Study|Sponsor Decision|3|||
157204206|NCT02335411|567491891|FG002|Overall Study|Sponsor Decision|2|||
157204207|NCT02335411|567491889|FG000|Overall Study|Adverse Event|9|||
157204208|NCT02335411|567491890|FG001|Overall Study|Adverse Event|0|||
157245478|NCT01109849|567642786|FG004|Initial Randomization: ADHD Treatment|move away|0|||
157245479|NCT01109849|567642782|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
157245480|NCT01109849|567642783|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
157245481|NCT01109849|567642784|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
157245482|NCT01109849|567642785|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
157245483|NCT01109849|567642786|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
157245484|NCT01109849|567642782|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
157245485|NCT01109849|567642783|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
157245486|NCT01109849|567642784|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
157245487|NCT01109849|567642785|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
157245488|NCT01109849|567642786|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
157245489|NCT03969641|567642789|FG000|Overall Study|Lost to Follow-up|5|||
157245490|NCT03969641|567642790|FG001|Overall Study|Lost to Follow-up|3|||
157245491|NCT03969641|567642789|FG000|Overall Study|Withdrawal by Subject|1|||
157245492|NCT03969641|567642790|FG001|Overall Study|Withdrawal by Subject|2|||
157245493|NCT03969641|567642789|FG000|Overall Study|Found to be ineligible|1|||
157245494|NCT03969641|567642790|FG001|Overall Study|Found to be ineligible|1|||
157245495|NCT03969641|567642789|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
157245496|NCT03969641|567642790|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
157245497|NCT03969641|567642789|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
157245498|NCT03969641|567642790|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
157245499|NCT03969641|567642789|FG000|Overall Study|Elective termination|0|||
157245500|NCT03969641|567642790|FG001|Overall Study|Elective termination|1|||
157245501|NCT00754052|567642799|FG000|Overall Study|Study terminated by Sponsor|5|||
157245502|NCT00754052|567642800|FG001|Overall Study|Study terminated by Sponsor|3|||
157245503|NCT02658019|567642804|FG000|Overall Study|Adverse Event|1|||
157245504|NCT02485158|567642808|FG000|Overall Study|Withdrawal by Subject|3|||
157245505|NCT02485158|567642808|FG000|Overall Study|expected drug side effect|1|||
157245506|NCT01098851|567642809|FG000|Overall Study|Equipment failure|1|||
157245507|NCT01098851|567642810|FG001|Overall Study|Equipment failure|0|||
157204209|NCT02335411|567491891|FG002|Overall Study|Adverse Event|0|||
157204210|NCT01886105|567491892|FG000|Overall Study|Lack of Efficacy|3|||
157204211|NCT01360021|567491895|FG000|Overall Study|Eligibility criteria + other|2|||
157204212|NCT01360021|567491896|FG001|Overall Study|Eligibility criteria + other|1|||
157204213|NCT01360021|567491897|FG002|Overall Study|Eligibility criteria + other|1|||
157204214|NCT01360021|567491895|FG000|Overall Study|Protocol Violation|0|||
157204215|NCT01360021|567491896|FG001|Overall Study|Protocol Violation|0|||
157204216|NCT01360021|567491897|FG002|Overall Study|Protocol Violation|1|||
157204217|NCT01360021|567491895|FG000|Overall Study|Withdrawal by Subject|4|||
157204218|NCT01360021|567491896|FG001|Overall Study|Withdrawal by Subject|0|||
157204219|NCT01360021|567491897|FG002|Overall Study|Withdrawal by Subject|2|||
157204220|NCT01360021|567491895|FG000|Overall Study|Adverse Event|2|||
157204221|NCT01360021|567491896|FG001|Overall Study|Adverse Event|3|||
157204222|NCT01360021|567491897|FG002|Overall Study|Adverse Event|3|||
157204223|NCT00530621|567491901|FG000|Overall Study|Adverse Event|11|||
157204224|NCT00530621|567491902|FG001|Overall Study|Adverse Event|8|||
157204225|NCT00530621|567491901|FG000|Overall Study|Physician Decision|2|||
157204226|NCT00530621|567491902|FG001|Overall Study|Physician Decision|4|||
157204227|NCT00530621|567491901|FG000|Overall Study|Progressive Disease (PD)|47|||
157204228|NCT00530621|567491902|FG001|Overall Study|Progressive Disease (PD)|40|||
157204229|NCT00530621|567491901|FG000|Overall Study|Sponsor Decision|12|||
157204230|NCT00530621|567491902|FG001|Overall Study|Sponsor Decision|15|||
157204231|NCT00530621|567491901|FG000|Overall Study|Subject Decision|4|||
157204232|NCT00530621|567491902|FG001|Overall Study|Subject Decision|7|||
157204233|NCT00530621|567491901|FG000|Overall Study|Death|3|||
157204234|NCT00530621|567491902|FG001|Overall Study|Death|6|||
157204235|NCT00530621|567491901|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
157204236|NCT00530621|567491902|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
157204237|NCT02596009|567491903|FG000|Overall Study|Administrative problems|0|||
157204238|NCT02596009|567491904|FG001|Overall Study|Administrative problems|1|||
157204239|NCT02596009|567491905|FG002|Overall Study|Administrative problems|0|||
157204240|NCT02596009|567491906|FG003|Overall Study|Administrative problems|0|||
157204241|NCT02596009|567491907|FG004|Overall Study|Administrative problems|0|||
157204242|NCT02596009|567491908|FG005|Overall Study|Administrative problems|0|||
157204243|NCT04611152|567491909|FG000|Overall Study|Adverse Event|9|||
157204244|NCT04611152|567491910|FG001|Overall Study|Adverse Event|8|||
157204245|NCT04611152|567491909|FG000|Overall Study|Non-compliance with study schedule|1|||
157245508|NCT03087786|567642811|FG000|Overall Study|Withdrawal by Subject|2|||
157245509|NCT03087786|567642812|FG001|Overall Study|Withdrawal by Subject|0|||
157245510|NCT02583048|567642814|FG000|Overall Study|Withdrawal by Subject|0|||
157245511|NCT02583048|567642815|FG001|Overall Study|Withdrawal by Subject|1|||
157245512|NCT02583048|567642816|FG002|Overall Study|Withdrawal by Subject|0|||
157245513|NCT02583048|567642814|FG000|Overall Study|Failed to meet eligibility criterion|0|||
157245514|NCT02583048|567642815|FG001|Overall Study|Failed to meet eligibility criterion|0|||
157245515|NCT02583048|567642816|FG002|Overall Study|Failed to meet eligibility criterion|1|||
157245516|NCT00516295|567642820|FG000|Overall Study|Lack of Efficacy|2|||
157245517|NCT00516295|567642821|FG001|Overall Study|Lack of Efficacy|0|||
157245518|NCT00516295|567642822|FG002|Overall Study|Lack of Efficacy|0|||
157245519|NCT00516295|567642820|FG000|Overall Study|Ineligible|1|||
157245520|NCT00516295|567642821|FG001|Overall Study|Ineligible|0|||
157245521|NCT00516295|567642822|FG002|Overall Study|Ineligible|0|||
157245522|NCT02313558|567642828|FG000|Overall Study|Withdrawal by Subject|2|||
157245523|NCT02313558|567642829|FG001|Overall Study|Withdrawal by Subject|0|||
157245524|NCT02313558|567642828|FG000|Overall Study|Lost to Follow-up|4|||
157245525|NCT02313558|567642829|FG001|Overall Study|Lost to Follow-up|4|||
157245526|NCT04158687|567642830|FG000|Overall Study|Adverse Event|2|||
157245527|NCT04158687|567642831|FG001|Overall Study|Adverse Event|3|||
157245528|NCT04158687|567642832|FG002|Overall Study|Adverse Event|0|||
157245529|NCT04158687|567642833|FG003|Overall Study|Adverse Event|3|||
157245530|NCT04158687|567642830|FG000|Overall Study|Lost to Follow-up|5|||
157245531|NCT04158687|567642831|FG001|Overall Study|Lost to Follow-up|12|||
157245532|NCT04158687|567642832|FG002|Overall Study|Lost to Follow-up|4|||
157245533|NCT04158687|567642833|FG003|Overall Study|Lost to Follow-up|5|||
157245534|NCT04158687|567642830|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
157245535|NCT04158687|567642831|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
157245536|NCT04158687|567642832|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
157245537|NCT04158687|567642833|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
157245538|NCT04158687|567642830|FG000|Overall Study|Non-Compliance with Study Medication|2|||
157245539|NCT04158687|567642831|FG001|Overall Study|Non-Compliance with Study Medication|2|||
157245540|NCT04158687|567642832|FG002|Overall Study|Non-Compliance with Study Medication|3|||
157245541|NCT04158687|567642833|FG003|Overall Study|Non-Compliance with Study Medication|0|||
157245542|NCT04158687|567642830|FG000|Overall Study|Investigator Decision|0|||
157245543|NCT04158687|567642831|FG001|Overall Study|Investigator Decision|0|||
157245544|NCT04158687|567642832|FG002|Overall Study|Investigator Decision|2|||
157245545|NCT04158687|567642833|FG003|Overall Study|Investigator Decision|0|||
157245546|NCT04158687|567642830|FG000|Overall Study|Protocol Violation|0|||
157245547|NCT04158687|567642831|FG001|Overall Study|Protocol Violation|2|||
157245548|NCT04158687|567642832|FG002|Overall Study|Protocol Violation|1|||
157245549|NCT04158687|567642833|FG003|Overall Study|Protocol Violation|0|||
157245550|NCT04158687|567642830|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
157245551|NCT04158687|567642831|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
157245552|NCT04158687|567642832|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
157245553|NCT04158687|567642833|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
157245554|NCT04158687|567642830|FG000|Overall Study|Reason not Specified|3|||
157245555|NCT04158687|567642831|FG001|Overall Study|Reason not Specified|2|||
157245556|NCT04158687|567642832|FG002|Overall Study|Reason not Specified|4|||
157245557|NCT04158687|567642833|FG003|Overall Study|Reason not Specified|4|||
157245558|NCT00640393|567642834|FG000|Part 1|Lost to Follow-up|2|||
157245559|NCT00640393|567642835|FG001|Part 1|Lost to Follow-up|0|||
157245560|NCT00640393|567642836|FG002|Part 1|Lost to Follow-up|0|||
157245561|NCT00640393|567642834|FG000|Part 1|Withdrawal by Subject|3|||
157245562|NCT00640393|567642835|FG001|Part 1|Withdrawal by Subject|0|||
157245563|NCT00640393|567642836|FG002|Part 1|Withdrawal by Subject|0|||
157245564|NCT00640393|567642834|FG000|Randomization|Withdrawn per protocol|17|||
157245565|NCT00640393|567642835|FG001|Randomization|Withdrawn per protocol|0|||
157245566|NCT00640393|567642836|FG002|Randomization|Withdrawn per protocol|0|||
157245567|NCT00640393|567642834|FG000|Randomization|Never randomized by site|2|||
157245568|NCT00640393|567642835|FG001|Randomization|Never randomized by site|0|||
157245569|NCT00640393|567642836|FG002|Randomization|Never randomized by site|0|||
157245570|NCT00640393|567642834|FG000|Part 2|Lost to Follow-up|0|||
157245571|NCT00640393|567642835|FG001|Part 2|Lost to Follow-up|2|||
157245572|NCT00640393|567642836|FG002|Part 2|Lost to Follow-up|2|||
157245573|NCT00640393|567642834|FG000|Part 2|Withdrawal by Subject|0|||
157245574|NCT00640393|567642835|FG001|Part 2|Withdrawal by Subject|6|||
157245575|NCT00640393|567642836|FG002|Part 2|Withdrawal by Subject|1|||
157245576|NCT00640393|567642834|FG000|Part 2|Non-adherence|0|||
157245577|NCT00640393|567642835|FG001|Part 2|Non-adherence|1|||
157245578|NCT00640393|567642836|FG002|Part 2|Non-adherence|0|||
157245579|NCT00640393|567642834|FG000|Part 2|Adverse Event|0|||
157245580|NCT00640393|567642835|FG001|Part 2|Adverse Event|1|||
157245581|NCT00640393|567642836|FG002|Part 2|Adverse Event|0|||
157245582|NCT02554877|567642841|FG000|Overall Study|Adverse Event|2|||
157245583|NCT02554877|567642842|FG001|Overall Study|Adverse Event|0|||
157245584|NCT02554877|567642843|FG002|Overall Study|Adverse Event|0|||
157245585|NCT02554877|567642844|FG003|Overall Study|Adverse Event|1|||
157245586|NCT02554877|567642841|FG000|Overall Study|Lost to Follow-up|1|||
157245587|NCT02554877|567642842|FG001|Overall Study|Lost to Follow-up|1|||
157245588|NCT02554877|567642843|FG002|Overall Study|Lost to Follow-up|1|||
157245589|NCT02554877|567642844|FG003|Overall Study|Lost to Follow-up|2|||
157245590|NCT02554877|567642841|FG000|Overall Study|Did not meet entrance criteria|0|||
157245591|NCT02554877|567642842|FG001|Overall Study|Did not meet entrance criteria|0|||
157245592|NCT02554877|567642843|FG002|Overall Study|Did not meet entrance criteria|1|||
157245593|NCT02554877|567642844|FG003|Overall Study|Did not meet entrance criteria|0|||
157245594|NCT02554877|567642841|FG000|Overall Study|No longer met eligibility criteria|1|||
157245595|NCT02554877|567642842|FG001|Overall Study|No longer met eligibility criteria|0|||
157245596|NCT02554877|567642843|FG002|Overall Study|No longer met eligibility criteria|1|||
157245597|NCT02554877|567642844|FG003|Overall Study|No longer met eligibility criteria|1|||
157245598|NCT02554877|567642841|FG000|Overall Study|Protocol Violation|3|||
157245599|NCT02554877|567642842|FG001|Overall Study|Protocol Violation|1|||
157245600|NCT02554877|567642843|FG002|Overall Study|Protocol Violation|1|||
157245601|NCT02554877|567642844|FG003|Overall Study|Protocol Violation|0|||
157245602|NCT02554877|567642841|FG000|Overall Study|Other|1|||
157245603|NCT02554877|567642842|FG001|Overall Study|Other|3|||
157245604|NCT02554877|567642843|FG002|Overall Study|Other|0|||
157245605|NCT02554877|567642844|FG003|Overall Study|Other|3|||
157245606|NCT02554877|567642841|FG000|Overall Study|Insufficient clinical response|4|||
157245607|NCT02554877|567642842|FG001|Overall Study|Insufficient clinical response|0|||
157245608|NCT02554877|567642843|FG002|Overall Study|Insufficient clinical response|0|||
157245609|NCT02554877|567642844|FG003|Overall Study|Insufficient clinical response|0|||
157245610|NCT02554877|567642841|FG000|Overall Study|No longer willing to participate|0|||
157245611|NCT02554877|567642842|FG001|Overall Study|No longer willing to participate|2|||
157245612|NCT02554877|567642843|FG002|Overall Study|No longer willing to participate|2|||
157245613|NCT02554877|567642844|FG003|Overall Study|No longer willing to participate|0|||
157245614|NCT00835666|567642845|FG000|Washout|Protocol Violation|1|||
157245615|NCT00835666|567642846|FG001|Washout|Protocol Violation|0|||
157245616|NCT00835666|567642845|FG000|Washout|Withdrawal by Subject|1|||
157245617|NCT00835666|567642846|FG001|Washout|Withdrawal by Subject|0|||
157245618|NCT01537887|567642847|FG000|Period 1|Physician Decision|0|||
157245619|NCT01537887|567642848|FG001|Period 1|Physician Decision|0|||
157245620|NCT01537887|567642849|FG002|Period 1|Physician Decision|0|||
157245621|NCT01537887|567642850|FG003|Period 1|Physician Decision|0|||
157245622|NCT01537887|567642851|FG004|Period 1|Physician Decision|1|||
157245623|NCT01537887|567642852|FG005|Period 1|Physician Decision|1|||
157245624|NCT01537887|567642847|FG000|Period 1|Did not receive treatment|0|||
157245625|NCT01537887|567642848|FG001|Period 1|Did not receive treatment|0|||
157245626|NCT01537887|567642849|FG002|Period 1|Did not receive treatment|1|||
157245627|NCT01537887|567642850|FG003|Period 1|Did not receive treatment|0|||
157245628|NCT01537887|567642851|FG004|Period 1|Did not receive treatment|0|||
157245629|NCT01537887|567642852|FG005|Period 1|Did not receive treatment|0|||
157245630|NCT01537887|567642847|FG000|Period 2|Withdrawal by Subject|0|||
157245631|NCT01537887|567642848|FG001|Period 2|Withdrawal by Subject|1|||
157245632|NCT01537887|567642849|FG002|Period 2|Withdrawal by Subject|0|||
157245633|NCT01537887|567642850|FG003|Period 2|Withdrawal by Subject|0|||
157245634|NCT01537887|567642851|FG004|Period 2|Withdrawal by Subject|0|||
157245635|NCT01537887|567642852|FG005|Period 2|Withdrawal by Subject|0|||
157245636|NCT01537887|567642847|FG000|Period 3|Adverse Event|0|||
157245637|NCT01537887|567642848|FG001|Period 3|Adverse Event|0|||
157245638|NCT01537887|567642849|FG002|Period 3|Adverse Event|1|||
157245639|NCT01537887|567642850|FG003|Period 3|Adverse Event|0|||
157245640|NCT01537887|567642851|FG004|Period 3|Adverse Event|0|||
157245641|NCT01537887|567642852|FG005|Period 3|Adverse Event|0|||
157245642|NCT01537887|567642847|FG000|Period 3|Withdrawal by Subject|0|||
157245643|NCT01537887|567642848|FG001|Period 3|Withdrawal by Subject|1|||
157245644|NCT01537887|567642849|FG002|Period 3|Withdrawal by Subject|0|||
157245645|NCT01537887|567642850|FG003|Period 3|Withdrawal by Subject|0|||
157245646|NCT01537887|567642851|FG004|Period 3|Withdrawal by Subject|0|||
157245647|NCT01537887|567642852|FG005|Period 3|Withdrawal by Subject|0|||
157245648|NCT03236311|567642853|FG000|Overall Study|Study terminated by sponsor|0|||
157245649|NCT03236311|567642854|FG001|Overall Study|Study terminated by sponsor|2|||
157245650|NCT03236311|567642853|FG000|Overall Study|Adverse Event|0|||
157245651|NCT03236311|567642854|FG001|Overall Study|Adverse Event|1|||
157245652|NCT00669162|567642855|FG000|Overall Study|Withdrawal by Subject|1|||
157245653|NCT01174186|567642856|FG000|Overall Study|Lost to Follow-up|0|||
157245654|NCT01174186|567642857|FG001|Overall Study|Lost to Follow-up|1|||
157245655|NCT01174186|567642856|FG000|Overall Study|Withdrawal by Subject|0|||
157245656|NCT01174186|567642857|FG001|Overall Study|Withdrawal by Subject|2|||
157245657|NCT05274763|567642858|FG000|Overall Study|Lost to Follow-up|1|||
157245658|NCT01051349|567642859|FG000|Overall Study|Adverse Event|88|||
157245659|NCT01051349|567642859|FG000|Overall Study|Consent Withdrawn|54|||
157245660|NCT01051349|567642859|FG000|Overall Study|Investigator Decision|6|||
157245661|NCT01051349|567642859|FG000|Overall Study|Lost to Follow-up|6|||
157245662|NCT01051349|567642859|FG000|Overall Study|Subject non-compliance|7|||
157245663|NCT01051349|567642859|FG000|Overall Study|Reason not Specified|12|||
157245664|NCT00484679|567642860|FG000|Overall Study|Withdrawal by Subject|3|||
157245665|NCT00402103|567642861|FG000|Overall Study|Adverse Event|60|||
157245666|NCT00402103|567642862|FG001|Overall Study|Adverse Event|7|||
157245667|NCT00402103|567642861|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
157245668|NCT00402103|567642862|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
157245669|NCT00402103|567642861|FG000|Overall Study|Condition no longer requires study drug|2|||
157245670|NCT00402103|567642862|FG001|Overall Study|Condition no longer requires study drug|0|||
157245671|NCT00402103|567642861|FG000|Overall Study|Protocol Deviation|8|||
157245672|NCT00402103|567642862|FG001|Overall Study|Protocol Deviation|0|||
157245673|NCT00402103|567642861|FG000|Overall Study|Patient withdrew consent|12|||
157245674|NCT00402103|567642862|FG001|Overall Study|Patient withdrew consent|1|||
157245675|NCT00402103|567642861|FG000|Overall Study|Lost to Follow-up|6|||
157245676|NCT00402103|567642862|FG001|Overall Study|Lost to Follow-up|3|||
157245677|NCT00402103|567642861|FG000|Overall Study|Administrative problems|2|||
157245678|NCT00402103|567642862|FG001|Overall Study|Administrative problems|0|||
157245679|NCT00418145|567642865|FG000|Overall Study|study terminated|6|||
157245680|NCT00425308|567642866|FG000|Overall Study|Adverse Event|2|||
157245681|NCT00425308|567642867|FG001|Overall Study|Adverse Event|1|||
157245682|NCT00425308|567642866|FG000|Overall Study|Withdrawal by Subject|1|||
157245683|NCT00425308|567642867|FG001|Overall Study|Withdrawal by Subject|0|||
157245684|NCT00425308|567642866|FG000|Overall Study|Death|1|||
157245685|NCT00425308|567642867|FG001|Overall Study|Death|0|||
157245686|NCT01075282|567642869|FG000|Overall Study|Withdrawal by Subject|11|||
157245687|NCT01075282|567642870|FG001|Overall Study|Withdrawal by Subject|7|||
157245688|NCT01075282|567642871|FG002|Overall Study|Withdrawal by Subject|11|||
157245689|NCT01075282|567642869|FG000|Overall Study|Adverse Event|9|||
157245690|NCT01075282|567642870|FG001|Overall Study|Adverse Event|8|||
157245691|NCT01075282|567642871|FG002|Overall Study|Adverse Event|5|||
157245692|NCT01075282|567642869|FG000|Overall Study|Entry Criteria Not Met|3|||
157245693|NCT01075282|567642870|FG001|Overall Study|Entry Criteria Not Met|2|||
157245694|NCT01075282|567642871|FG002|Overall Study|Entry Criteria Not Met|0|||
157245695|NCT01075282|567642869|FG000|Overall Study|Lost to Follow-up|3|||
157245696|NCT01075282|567642870|FG001|Overall Study|Lost to Follow-up|3|||
157245697|NCT01075282|567642871|FG002|Overall Study|Lost to Follow-up|3|||
157245698|NCT01075282|567642869|FG000|Overall Study|Physician Decision|3|||
157245699|NCT01075282|567642870|FG001|Overall Study|Physician Decision|3|||
157245700|NCT01075282|567642871|FG002|Overall Study|Physician Decision|3|||
157245701|NCT01075282|567642869|FG000|Overall Study|Lack of Efficacy|1|||
157245702|NCT01075282|567642870|FG001|Overall Study|Lack of Efficacy|1|||
157245703|NCT01075282|567642871|FG002|Overall Study|Lack of Efficacy|0|||
157245704|NCT01075282|567642869|FG000|Overall Study|Treatment Non-compliance|1|||
157245705|NCT01075282|567642870|FG001|Overall Study|Treatment Non-compliance|2|||
157245706|NCT01075282|567642871|FG002|Overall Study|Treatment Non-compliance|2|||
157245707|NCT01075282|567642869|FG000|Overall Study|Protocol Violation|0|||
157245708|NCT01075282|567642870|FG001|Overall Study|Protocol Violation|2|||
157245709|NCT01075282|567642871|FG002|Overall Study|Protocol Violation|1|||
157245710|NCT01075282|567642869|FG000|Overall Study|Death|0|||
157245711|NCT01075282|567642870|FG001|Overall Study|Death|1|||
157245712|NCT01075282|567642871|FG002|Overall Study|Death|2|||
157245713|NCT00367133|567642872|FG000|2 Years|Death|20|||
157245714|NCT00367133|567642873|FG001|2 Years|Death|12|||
157245715|NCT00367133|567642874|FG002|2 Years|Death|12|||
157245716|NCT00367133|567642872|FG000|2 Years|Dropped|34|||
157245717|NCT00367133|567642873|FG001|2 Years|Dropped|19|||
157245718|NCT00367133|567642874|FG002|2 Years|Dropped|33|||
157245719|NCT00367133|567642872|FG000|2 Years|Missed visit|4|||
157245720|NCT00367133|567642873|FG001|2 Years|Missed visit|5|||
157245721|NCT00367133|567642874|FG002|2 Years|Missed visit|4|||
157245722|NCT00847535|567642875|FG000|Overall Study|Withdrawal by Subject|2|||
157245723|NCT00847535|567642876|FG001|Overall Study|Withdrawal by Subject|1|||
157245724|NCT00847535|567642877|FG002|Overall Study|Withdrawal by Subject|1|||
157245725|NCT00847535|567642875|FG000|Overall Study|Lost to Follow-up|0|||
157245726|NCT00847535|567642876|FG001|Overall Study|Lost to Follow-up|1|||
157245727|NCT00847535|567642877|FG002|Overall Study|Lost to Follow-up|0|||
157245728|NCT01252953|567642878|FG000|Overall Study|Withdrawal by Subject|16|||
157245729|NCT01252953|567642879|FG001|Overall Study|Withdrawal by Subject|17|||
157245730|NCT01252953|567642878|FG000|Overall Study|Lost to Follow-up|22|||
157245731|NCT01252953|567642879|FG001|Overall Study|Lost to Follow-up|21|||
157245732|NCT00840203|567642880|FG000|First Intervention|Protocol Violation|1|||
157245733|NCT00840203|567642881|FG001|First Intervention|Protocol Violation|1|||
157245734|NCT00840203|567642880|FG000|Washout|Protocol Violation|1|||
157245735|NCT00840203|567642881|FG001|Washout|Protocol Violation|0|||
157245736|NCT00989950|567642886|FG000|Randomized Phase|Protocol Violation|1|||
157245737|NCT00989950|567642887|FG001|Randomized Phase|Protocol Violation|0|||
157245738|NCT00989950|567642888|FG002|Randomized Phase|Protocol Violation|0|||
157245739|NCT00989950|567642889|FG003|Randomized Phase|Protocol Violation|0|||
157245740|NCT00989950|567642886|FG000|Randomized Phase|Adverse Event|0|||
157245741|NCT00989950|567642887|FG001|Randomized Phase|Adverse Event|1|||
157245742|NCT00989950|567642888|FG002|Randomized Phase|Adverse Event|0|||
157245743|NCT00989950|567642889|FG003|Randomized Phase|Adverse Event|0|||
157245744|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Refused|1|||
157245745|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Refused|3|||
157245746|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Medical|0|||
157245747|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Medical|1|||
157245748|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
157245749|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
157245750|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
157245751|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
157245752|NCT02054715|567642892|FG000|Baseline/Follow-up 1|No Reason|0|||
157245753|NCT02054715|567642893|FG001|Baseline/Follow-up 1|No Reason|1|||
157245754|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
157245755|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
157245756|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Ineligible|3|||
157245757|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Ineligible|0|||
157245758|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Hospitalization|1|||
157245759|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Hospitalization|0|||
157245760|NCT02054715|567642892|FG000|Baseline/Follow-up 1|Changed Mind|1|||
157245761|NCT02054715|567642893|FG001|Baseline/Follow-up 1|Changed Mind|0|||
157245762|NCT02054715|567642892|FG000|Follow-up 2|Lost to Followup|3|||
157245763|NCT02054715|567642893|FG001|Follow-up 2|Lost to Followup|1|||
157245764|NCT02054715|567642892|FG000|Follow-up 2|Refused|3|||
157245765|NCT02054715|567642893|FG001|Follow-up 2|Refused|2|||
157245766|NCT02054715|567642892|FG000|Follow-up 2|Followup Not Completed|3|||
157245767|NCT02054715|567642893|FG001|Follow-up 2|Followup Not Completed|4|||
157245768|NCT02054715|567642892|FG000|Follow-up 2|Ineligible|4|||
157245769|NCT02054715|567642893|FG001|Follow-up 2|Ineligible|5|||
157245770|NCT02054715|567642892|FG000|Follow-up 2|Death|3|||
157245771|NCT02054715|567642893|FG001|Follow-up 2|Death|3|||
157245772|NCT02054715|567642892|FG000|Follow-up 2|Hospitalization|0|||
157245773|NCT02054715|567642893|FG001|Follow-up 2|Hospitalization|2|||
157245774|NCT02054715|567642892|FG000|Follow-up 2|Changed MD/Facility|0|||
157245775|NCT02054715|567642893|FG001|Follow-up 2|Changed MD/Facility|1|||
157245776|NCT02054715|567642892|FG000|Follow-up 2|Changed Mind|0|||
157245777|NCT02054715|567642893|FG001|Follow-up 2|Changed Mind|1|||
157245778|NCT02054715|567642892|FG000|Follow-up 2|No Reason|2|||
157245779|NCT02054715|567642893|FG001|Follow-up 2|No Reason|0|||
157245780|NCT02054715|567642892|FG000|Follow-up 2|Treatment Change or Delay|1|||
157245781|NCT02054715|567642893|FG001|Follow-up 2|Treatment Change or Delay|0|||
157245782|NCT00863330|567642894|FG000|Overall Study|study terminated early due to administra|6|||
157245783|NCT02615249|567642897|FG000|Overall Study|Withdrawal by Subject|1|||
157245784|NCT04025021|567642898|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
157245785|NCT04025021|567642899|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
157245786|NCT03966911|567642900|FG000|Overall Study|Adverse Event|1|||
157245787|NCT03966911|567642901|FG001|Overall Study|Adverse Event|1|||
157245788|NCT03966911|567642900|FG000|Overall Study|Withdrawal by Subject|8|||
157245789|NCT03966911|567642901|FG001|Overall Study|Withdrawal by Subject|2|||
157245790|NCT03966911|567642900|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
157245791|NCT03966911|567642901|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
157245792|NCT00985751|567642903|FG000|Overall Study|Adverse Event|0|||
157245793|NCT00985751|567642904|FG001|Overall Study|Adverse Event|0|||
157245794|NCT00985751|567642905|FG002|Overall Study|Adverse Event|0|||
157245795|NCT00985751|567642906|FG003|Overall Study|Adverse Event|0|||
157245796|NCT00985751|567642907|FG004|Overall Study|Adverse Event|1|||
157245797|NCT01986647|567642909|FG000|Overall Study|Lost to Follow-up|4|||
157245798|NCT01986647|567642910|FG001|Overall Study|Lost to Follow-up|1|||
157245799|NCT01986647|567642911|FG002|Overall Study|Lost to Follow-up|4|||
157245800|NCT01986647|567642912|FG003|Overall Study|Lost to Follow-up|4|||
157245801|NCT01986647|567642909|FG000|Overall Study|Withdrawal by Subject|1|||
157245802|NCT01986647|567642910|FG001|Overall Study|Withdrawal by Subject|3|||
157245803|NCT01986647|567642911|FG002|Overall Study|Withdrawal by Subject|2|||
157245804|NCT01986647|567642912|FG003|Overall Study|Withdrawal by Subject|3|||
157245805|NCT01986647|567642909|FG000|Overall Study|Health|5|||
157245806|NCT01986647|567642910|FG001|Overall Study|Health|3|||
157245807|NCT01986647|567642911|FG002|Overall Study|Health|6|||
157245808|NCT01986647|567642912|FG003|Overall Study|Health|4|||
157245809|NCT00868998|567642913|FG000|Overall Study|Screen Failure|1|||
157245810|NCT00868998|567642913|FG000|Overall Study|Withdrawal by Subject|1|||
157245811|NCT00868998|567642913|FG000|Overall Study|Progression of disease|2|||
157245812|NCT00868998|567642913|FG000|Overall Study|Death|1|||
157245813|NCT01483820|567642914|FG000|Overall Study|Lack of Efficacy|6|||
157245814|NCT01483820|567642914|FG000|Overall Study|Adverse Event|1|||
157245815|NCT01483820|567642914|FG000|Overall Study|Death|1|||
157245816|NCT00474188|567642917|FG000|Overall Study|Withdrawal by Subject|1|||
157245817|NCT00474188|567642917|FG000|Overall Study|Study discontinued by sponsor|5|||
157245818|NCT03541252|567642918|FG000|Overall Study|Withdrawal by Subject|1|||
157245819|NCT01960296|567642925|FG000|Overall Study|Postponed surgery|1|||
157245820|NCT01960296|567642926|FG001|Overall Study|Postponed surgery|0|||
157245821|NCT01960296|567642925|FG000|Overall Study|Received different procedure|1|||
157245822|NCT01960296|567642926|FG001|Overall Study|Received different procedure|3|||
157245823|NCT02003391|567642927|FG000|Overall Study|Withdrawal by Subject|2|||
157245824|NCT02003391|567642928|FG001|Overall Study|Withdrawal by Subject|1|||
157245825|NCT02003391|567642927|FG000|Overall Study|Protocol Violation|0|||
157204246|NCT04611152|567491910|FG001|Overall Study|Non-compliance with study schedule|3|||
157204247|NCT04611152|567491909|FG000|Overall Study|Withdrawal by Subject|5|||
157204248|NCT04611152|567491910|FG001|Overall Study|Withdrawal by Subject|6|||
157204249|NCT04611152|567491909|FG000|Overall Study|Lost to Follow-up|11|||
157204250|NCT04611152|567491910|FG001|Overall Study|Lost to Follow-up|2|||
157204251|NCT03917654|567491922|FG000|Year 1|Withdrawal by Subject|1|||
157204252|NCT03917654|567491923|FG001|Year 1|Withdrawal by Subject|0|||
157204253|NCT03917654|567491924|FG002|Year 1|Withdrawal by Subject|0|||
157204254|NCT03917654|567491925|FG003|Year 1|Withdrawal by Subject|0|||
157204255|NCT03917654|567491926|FG004|Year 1|Withdrawal by Subject|0|||
157204256|NCT03917654|567491927|FG005|Year 1|Withdrawal by Subject|1|||
157204257|NCT03917654|567491928|FG006|Year 1|Withdrawal by Subject|6|||
157204258|NCT03917654|567491929|FG007|Year 1|Withdrawal by Subject|2|||
157204259|NCT03917654|567491930|FG008|Year 1|Withdrawal by Subject|5|||
157204260|NCT03917654|567491931|FG009|Year 1|Withdrawal by Subject|3|||
157204261|NCT03917654|567491932|FG010|Year 1|Withdrawal by Subject|1|||
157204262|NCT03917654|567491933|FG011|Year 1|Withdrawal by Subject|0|||
157204263|NCT03917654|567491922|FG000|Year 1|Travel|0|||
157204264|NCT03917654|567491923|FG001|Year 1|Travel|1|||
157204265|NCT03917654|567491924|FG002|Year 1|Travel|1|||
157204266|NCT03917654|567491925|FG003|Year 1|Travel|0|||
157204267|NCT03917654|567491926|FG004|Year 1|Travel|4|||
157204268|NCT03917654|567491927|FG005|Year 1|Travel|4|||
157204269|NCT03917654|567491928|FG006|Year 1|Travel|10|||
157204270|NCT03917654|567491929|FG007|Year 1|Travel|8|||
157204271|NCT03917654|567491930|FG008|Year 1|Travel|2|||
157204272|NCT03917654|567491931|FG009|Year 1|Travel|5|||
157204273|NCT03917654|567491932|FG010|Year 1|Travel|3|||
157204274|NCT03917654|567491933|FG011|Year 1|Travel|3|||
157204275|NCT03917654|567491922|FG000|Year 1|Subject moved away from site|0|||
157204276|NCT03917654|567491923|FG001|Year 1|Subject moved away from site|1|||
157204277|NCT03917654|567491924|FG002|Year 1|Subject moved away from site|0|||
157204278|NCT03917654|567491925|FG003|Year 1|Subject moved away from site|0|||
157204279|NCT03917654|567491926|FG004|Year 1|Subject moved away from site|0|||
157204280|NCT03917654|567491927|FG005|Year 1|Subject moved away from site|0|||
157204281|NCT03917654|567491928|FG006|Year 1|Subject moved away from site|1|||
157204282|NCT03917654|567491929|FG007|Year 1|Subject moved away from site|2|||
157204283|NCT03917654|567491930|FG008|Year 1|Subject moved away from site|1|||
157204284|NCT03917654|567491931|FG009|Year 1|Subject moved away from site|0|||
157204285|NCT03917654|567491932|FG010|Year 1|Subject moved away from site|0|||
157204286|NCT03917654|567491933|FG011|Year 1|Subject moved away from site|3|||
157204287|NCT03917654|567491922|FG000|Year 1|Spouse/Family member request|0|||
157204288|NCT03917654|567491923|FG001|Year 1|Spouse/Family member request|0|||
157204289|NCT03917654|567491924|FG002|Year 1|Spouse/Family member request|1|||
157204290|NCT03917654|567491925|FG003|Year 1|Spouse/Family member request|0|||
157204291|NCT03917654|567491926|FG004|Year 1|Spouse/Family member request|1|||
157204292|NCT03917654|567491927|FG005|Year 1|Spouse/Family member request|0|||
157204293|NCT03917654|567491928|FG006|Year 1|Spouse/Family member request|0|||
157204294|NCT03917654|567491929|FG007|Year 1|Spouse/Family member request|2|||
157204295|NCT03917654|567491930|FG008|Year 1|Spouse/Family member request|0|||
157204296|NCT03917654|567491931|FG009|Year 1|Spouse/Family member request|0|||
157204297|NCT03917654|567491932|FG010|Year 1|Spouse/Family member request|0|||
157204298|NCT03917654|567491933|FG011|Year 1|Spouse/Family member request|1|||
157204299|NCT03917654|567491922|FG000|Year 1|Death|0|||
157204300|NCT03917654|567491923|FG001|Year 1|Death|0|||
157204301|NCT03917654|567491924|FG002|Year 1|Death|0|||
157204302|NCT03917654|567491925|FG003|Year 1|Death|0|||
157204303|NCT03917654|567491926|FG004|Year 1|Death|0|||
157204304|NCT03917654|567491927|FG005|Year 1|Death|0|||
157204305|NCT03917654|567491928|FG006|Year 1|Death|0|||
157204306|NCT03917654|567491929|FG007|Year 1|Death|0|||
157204307|NCT03917654|567491930|FG008|Year 1|Death|1|||
157204308|NCT03917654|567491931|FG009|Year 1|Death|1|||
157204309|NCT03917654|567491932|FG010|Year 1|Death|0|||
157204310|NCT03917654|567491933|FG011|Year 1|Death|0|||
157204311|NCT03917654|567491922|FG000|Year 1|Lost to Follow-up|0|||
157204312|NCT03917654|567491923|FG001|Year 1|Lost to Follow-up|0|||
157204313|NCT03917654|567491924|FG002|Year 1|Lost to Follow-up|0|||
157204314|NCT03917654|567491925|FG003|Year 1|Lost to Follow-up|0|||
157204315|NCT03917654|567491926|FG004|Year 1|Lost to Follow-up|0|||
157204316|NCT03917654|567491927|FG005|Year 1|Lost to Follow-up|0|||
157204317|NCT03917654|567491928|FG006|Year 1|Lost to Follow-up|2|||
157204318|NCT03917654|567491929|FG007|Year 1|Lost to Follow-up|0|||
157204319|NCT03917654|567491930|FG008|Year 1|Lost to Follow-up|0|||
157204320|NCT03917654|567491931|FG009|Year 1|Lost to Follow-up|0|||
157204321|NCT03917654|567491932|FG010|Year 1|Lost to Follow-up|0|||
157204322|NCT03917654|567491933|FG011|Year 1|Lost to Follow-up|0|||
157204323|NCT03917654|567491922|FG000|Year 1|Missed visits|0|||
157204324|NCT03917654|567491923|FG001|Year 1|Missed visits|0|||
157204325|NCT03917654|567491924|FG002|Year 1|Missed visits|0|||
157204326|NCT03917654|567491925|FG003|Year 1|Missed visits|0|||
157204327|NCT03917654|567491926|FG004|Year 1|Missed visits|0|||
157204328|NCT03917654|567491927|FG005|Year 1|Missed visits|0|||
157204329|NCT03917654|567491928|FG006|Year 1|Missed visits|0|||
157204330|NCT03917654|567491929|FG007|Year 1|Missed visits|0|||
157204331|NCT03917654|567491930|FG008|Year 1|Missed visits|0|||
157204332|NCT03917654|567491931|FG009|Year 1|Missed visits|0|||
157204333|NCT03917654|567491932|FG010|Year 1|Missed visits|1|||
157204334|NCT03917654|567491933|FG011|Year 1|Missed visits|1|||
157204335|NCT03917654|567491922|FG000|Year 1|Pregnancy|0|||
157204336|NCT03917654|567491923|FG001|Year 1|Pregnancy|0|||
157204337|NCT03917654|567491924|FG002|Year 1|Pregnancy|0|||
157204338|NCT03917654|567491925|FG003|Year 1|Pregnancy|0|||
157204339|NCT03917654|567491926|FG004|Year 1|Pregnancy|0|||
157204340|NCT03917654|567491927|FG005|Year 1|Pregnancy|0|||
157204341|NCT03917654|567491928|FG006|Year 1|Pregnancy|0|||
157204342|NCT03917654|567491929|FG007|Year 1|Pregnancy|1|||
157204343|NCT03917654|567491930|FG008|Year 1|Pregnancy|0|||
157204344|NCT03917654|567491931|FG009|Year 1|Pregnancy|1|||
157204345|NCT03917654|567491932|FG010|Year 1|Pregnancy|0|||
157204346|NCT03917654|567491933|FG011|Year 1|Pregnancy|0|||
157204347|NCT03917654|567491922|FG000|Year 2|Travel|1|||
157204348|NCT03917654|567491923|FG001|Year 2|Travel|0|||
157204349|NCT03917654|567491924|FG002|Year 2|Travel|0|||
157204350|NCT03917654|567491925|FG003|Year 2|Travel|0|||
157204351|NCT03917654|567491926|FG004|Year 2|Travel|1|||
157204352|NCT03917654|567491927|FG005|Year 2|Travel|1|||
157204353|NCT03917654|567491928|FG006|Year 2|Travel|2|||
157204354|NCT03917654|567491929|FG007|Year 2|Travel|1|||
157204355|NCT03917654|567491930|FG008|Year 2|Travel|0|||
157204356|NCT03917654|567491931|FG009|Year 2|Travel|1|||
157204357|NCT03917654|567491932|FG010|Year 2|Travel|0|||
157204358|NCT03917654|567491933|FG011|Year 2|Travel|1|||
157204359|NCT03917654|567491922|FG000|Year 2|Married|1|||
157204360|NCT03917654|567491923|FG001|Year 2|Married|0|||
157204361|NCT03917654|567491924|FG002|Year 2|Married|0|||
157204362|NCT03917654|567491925|FG003|Year 2|Married|0|||
157204363|NCT03917654|567491926|FG004|Year 2|Married|0|||
157204364|NCT03917654|567491927|FG005|Year 2|Married|0|||
157204365|NCT03917654|567491928|FG006|Year 2|Married|1|||
157204366|NCT03917654|567491929|FG007|Year 2|Married|1|||
157204367|NCT03917654|567491930|FG008|Year 2|Married|0|||
157204368|NCT03917654|567491931|FG009|Year 2|Married|0|||
157204369|NCT03917654|567491932|FG010|Year 2|Married|0|||
157204370|NCT03917654|567491933|FG011|Year 2|Married|0|||
157204371|NCT03917654|567491922|FG000|Year 2|Subject moved away from site|1|||
157204372|NCT03917654|567491923|FG001|Year 2|Subject moved away from site|0|||
157204373|NCT03917654|567491924|FG002|Year 2|Subject moved away from site|0|||
157204374|NCT03917654|567491925|FG003|Year 2|Subject moved away from site|0|||
157204375|NCT03917654|567491926|FG004|Year 2|Subject moved away from site|1|||
157204376|NCT03917654|567491927|FG005|Year 2|Subject moved away from site|0|||
157204377|NCT03917654|567491928|FG006|Year 2|Subject moved away from site|2|||
157204378|NCT03917654|567491929|FG007|Year 2|Subject moved away from site|3|||
157204379|NCT03917654|567491930|FG008|Year 2|Subject moved away from site|0|||
157204380|NCT03917654|567491931|FG009|Year 2|Subject moved away from site|2|||
157204381|NCT03917654|567491932|FG010|Year 2|Subject moved away from site|0|||
157204382|NCT03917654|567491933|FG011|Year 2|Subject moved away from site|1|||
157204383|NCT03917654|567491922|FG000|Year 2|Year 2 Screening failure|0|||
157204384|NCT03917654|567491923|FG001|Year 2|Year 2 Screening failure|1|||
157204385|NCT03917654|567491924|FG002|Year 2|Year 2 Screening failure|0|||
157204386|NCT03917654|567491925|FG003|Year 2|Year 2 Screening failure|0|||
157204387|NCT03917654|567491926|FG004|Year 2|Year 2 Screening failure|2|||
157204388|NCT03917654|567491927|FG005|Year 2|Year 2 Screening failure|0|||
157204389|NCT03917654|567491928|FG006|Year 2|Year 2 Screening failure|4|||
157204390|NCT03917654|567491929|FG007|Year 2|Year 2 Screening failure|3|||
157204391|NCT03917654|567491930|FG008|Year 2|Year 2 Screening failure|10|||
157204392|NCT03917654|567491931|FG009|Year 2|Year 2 Screening failure|2|||
157204393|NCT03917654|567491932|FG010|Year 2|Year 2 Screening failure|1|||
157204394|NCT03917654|567491933|FG011|Year 2|Year 2 Screening failure|1|||
157204395|NCT03917654|567491922|FG000|Year 2|Death|0|||
157204396|NCT03917654|567491923|FG001|Year 2|Death|0|||
157204397|NCT03917654|567491924|FG002|Year 2|Death|0|||
157204398|NCT03917654|567491925|FG003|Year 2|Death|0|||
157204399|NCT03917654|567491926|FG004|Year 2|Death|0|||
157204400|NCT03917654|567491927|FG005|Year 2|Death|1|||
157204401|NCT03917654|567491928|FG006|Year 2|Death|0|||
157204402|NCT03917654|567491929|FG007|Year 2|Death|0|||
157204403|NCT03917654|567491930|FG008|Year 2|Death|1|||
157204404|NCT03917654|567491931|FG009|Year 2|Death|1|||
157204405|NCT03917654|567491932|FG010|Year 2|Death|0|||
157204406|NCT03917654|567491933|FG011|Year 2|Death|0|||
157204407|NCT03917654|567491922|FG000|Year 2|Withdrawal by Subject|0|||
157204408|NCT03917654|567491923|FG001|Year 2|Withdrawal by Subject|0|||
157204409|NCT03917654|567491924|FG002|Year 2|Withdrawal by Subject|0|||
157204410|NCT03917654|567491925|FG003|Year 2|Withdrawal by Subject|0|||
157204411|NCT03917654|567491926|FG004|Year 2|Withdrawal by Subject|0|||
157204412|NCT03917654|567491927|FG005|Year 2|Withdrawal by Subject|0|||
157204413|NCT03917654|567491928|FG006|Year 2|Withdrawal by Subject|3|||
157204414|NCT03917654|567491929|FG007|Year 2|Withdrawal by Subject|0|||
157204415|NCT03917654|567491930|FG008|Year 2|Withdrawal by Subject|2|||
157204416|NCT03917654|567491931|FG009|Year 2|Withdrawal by Subject|5|||
157204417|NCT03917654|567491932|FG010|Year 2|Withdrawal by Subject|0|||
157245826|NCT02003391|567642928|FG001|Overall Study|Protocol Violation|1|||
157245827|NCT02003391|567642927|FG000|Overall Study|Adverse Event|1|||
157245828|NCT02003391|567642928|FG001|Overall Study|Adverse Event|0|||
157245829|NCT00243347|567642929|FG000|Overall Study|Lack of Efficacy|4|||
157245830|NCT00243347|567642929|FG000|Overall Study|Adverse Event|2|||
157245831|NCT00243347|567642929|FG000|Overall Study|Death|1|||
157245832|NCT00243347|567642929|FG000|Overall Study|Withdrawal by Subject|5|||
157245833|NCT00243347|567642929|FG000|Overall Study|Condition worsened|7|||
157245834|NCT03846193|567642932|FG000|Overall Study|Physician Decision|0|||
157245835|NCT03846193|567642933|FG001|Overall Study|Physician Decision|0|||
157204418|NCT03917654|567491933|FG011|Year 2|Withdrawal by Subject|0|||
157204419|NCT03917654|567491922|FG000|Year 2|Spouse/family member request|0|||
157204420|NCT03917654|567491923|FG001|Year 2|Spouse/family member request|0|||
157204421|NCT03917654|567491924|FG002|Year 2|Spouse/family member request|0|||
157204422|NCT03917654|567491925|FG003|Year 2|Spouse/family member request|0|||
157204423|NCT03917654|567491926|FG004|Year 2|Spouse/family member request|0|||
157204424|NCT03917654|567491927|FG005|Year 2|Spouse/family member request|0|||
157204425|NCT03917654|567491928|FG006|Year 2|Spouse/family member request|1|||
157204426|NCT03917654|567491929|FG007|Year 2|Spouse/family member request|0|||
157204427|NCT03917654|567491930|FG008|Year 2|Spouse/family member request|0|||
157204428|NCT03917654|567491931|FG009|Year 2|Spouse/family member request|0|||
157204429|NCT03917654|567491932|FG010|Year 2|Spouse/family member request|0|||
157204430|NCT03917654|567491933|FG011|Year 2|Spouse/family member request|0|||
157204431|NCT03917654|567491922|FG000|Year 2|Lost to Follow-up|0|||
157204432|NCT03917654|567491923|FG001|Year 2|Lost to Follow-up|0|||
157204433|NCT03917654|567491924|FG002|Year 2|Lost to Follow-up|0|||
157204434|NCT03917654|567491925|FG003|Year 2|Lost to Follow-up|0|||
157204435|NCT03917654|567491926|FG004|Year 2|Lost to Follow-up|0|||
157204436|NCT03917654|567491927|FG005|Year 2|Lost to Follow-up|0|||
157204437|NCT03917654|567491928|FG006|Year 2|Lost to Follow-up|1|||
157204438|NCT03917654|567491929|FG007|Year 2|Lost to Follow-up|0|||
157204439|NCT03917654|567491930|FG008|Year 2|Lost to Follow-up|1|||
157204440|NCT03917654|567491931|FG009|Year 2|Lost to Follow-up|0|||
157204441|NCT03917654|567491932|FG010|Year 2|Lost to Follow-up|0|||
157204442|NCT03917654|567491933|FG011|Year 2|Lost to Follow-up|1|||
157204443|NCT03917654|567491922|FG000|Year 2|Adverse Event|0|||
157204444|NCT03917654|567491923|FG001|Year 2|Adverse Event|0|||
157204445|NCT03917654|567491924|FG002|Year 2|Adverse Event|0|||
157204446|NCT03917654|567491925|FG003|Year 2|Adverse Event|0|||
157204447|NCT03917654|567491926|FG004|Year 2|Adverse Event|0|||
157204448|NCT03917654|567491927|FG005|Year 2|Adverse Event|0|||
157204449|NCT03917654|567491928|FG006|Year 2|Adverse Event|0|||
157204450|NCT03917654|567491929|FG007|Year 2|Adverse Event|0|||
157204451|NCT03917654|567491930|FG008|Year 2|Adverse Event|0|||
157204452|NCT03917654|567491931|FG009|Year 2|Adverse Event|1|||
157204453|NCT03917654|567491932|FG010|Year 2|Adverse Event|0|||
157204454|NCT03917654|567491933|FG011|Year 2|Adverse Event|0|||
157204455|NCT05012943|567491934|FG000|Overall Study|Adverse Event|2|||
157204456|NCT05012943|567491935|FG001|Overall Study|Adverse Event|1|||
157204457|NCT05012943|567491936|FG002|Overall Study|Adverse Event|0|||
157204458|NCT05012943|567491934|FG000|Overall Study|Withdrawal by Subject|1052|||
157204459|NCT05012943|567491935|FG001|Overall Study|Withdrawal by Subject|1006|||
157204460|NCT05012943|567491936|FG002|Overall Study|Withdrawal by Subject|20|||
157204461|NCT05012943|567491934|FG000|Overall Study|Death|25|||
157204462|NCT05012943|567491935|FG001|Overall Study|Death|17|||
157204463|NCT05012943|567491936|FG002|Overall Study|Death|4|||
157204464|NCT05012943|567491934|FG000|Overall Study|Lost to Follow-up|11|||
157204465|NCT05012943|567491935|FG001|Overall Study|Lost to Follow-up|24|||
157204466|NCT05012943|567491936|FG002|Overall Study|Lost to Follow-up|3|||
157204467|NCT05012943|567491934|FG000|Overall Study|Physician Decision|1|||
157204468|NCT05012943|567491935|FG001|Overall Study|Physician Decision|1|||
157204469|NCT05012943|567491936|FG002|Overall Study|Physician Decision|0|||
157204470|NCT05012943|567491934|FG000|Overall Study|Other than Specified|2|||
157204471|NCT05012943|567491935|FG001|Overall Study|Other than Specified|1|||
157204472|NCT05012943|567491936|FG002|Overall Study|Other than Specified|0|||
157204473|NCT00400985|567491938|FG000|Overall Study|Withdrawal by Subject|5|||
157204474|NCT00400985|567491938|FG000|Overall Study|system modification|8|||
157204475|NCT00400985|567491938|FG000|Overall Study|Death|30|||
157204476|NCT00400985|567491938|FG000|Overall Study|Lost to Follow-up|9|||
157204477|NCT05048875|567491940|FG000|Overall Study|Withdrawal by Subject|1|||
157204478|NCT05048875|567491941|FG001|Overall Study|Withdrawal by Subject|0|||
157245836|NCT03846193|567642934|FG002|Overall Study|Physician Decision|1|||
157204479|NCT05048875|567491942|FG002|Overall Study|Withdrawal by Subject|0|||
157204480|NCT05048875|567491943|FG003|Overall Study|Withdrawal by Subject|0|||
157204481|NCT05048875|567491944|FG004|Overall Study|Withdrawal by Subject|0|||
157204482|NCT05048875|567491945|FG005|Overall Study|Withdrawal by Subject|0|||
157204483|NCT05048875|567491946|FG006|Overall Study|Withdrawal by Subject|0|||
157204484|NCT05048875|567491947|FG007|Overall Study|Withdrawal by Subject|0|||
157204485|NCT05048875|567491940|FG000|Overall Study|Adverse Event|0|||
157245837|NCT03846193|567642935|FG003|Overall Study|Physician Decision|0|||
157245838|NCT03846193|567642936|FG004|Overall Study|Physician Decision|0|||
157245839|NCT03846193|567642932|FG000|Overall Study|Lost to Follow-up|0|||
157245840|NCT03846193|567642933|FG001|Overall Study|Lost to Follow-up|0|||
157245841|NCT03846193|567642934|FG002|Overall Study|Lost to Follow-up|0|||
157245842|NCT03846193|567642935|FG003|Overall Study|Lost to Follow-up|0|||
157245843|NCT03846193|567642936|FG004|Overall Study|Lost to Follow-up|1|||
157245844|NCT03846193|567642932|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
157245845|NCT03846193|567642933|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
157245846|NCT03846193|567642934|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
157245847|NCT03846193|567642935|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
157245848|NCT03846193|567642936|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
157245849|NCT04594252|567642944|FG000|Overall Study|Adverse Event|0|||
157245850|NCT04594252|567642945|FG001|Overall Study|Adverse Event|2|||
157245851|NCT04661202|567644892|FG000|Overall Study|Withdrawal by Subject|1|||
157245852|NCT04661202|567644893|FG001|Overall Study|Withdrawal by Subject|1|||
157245853|NCT04661202|567644892|FG000|Overall Study|Lack of Efficacy|2|||
157245854|NCT04661202|567644893|FG001|Overall Study|Lack of Efficacy|0|||
157245855|NCT02725515|567644894|FG000|Overall Study|Refused infusion (no study treatment)|1|||
157245856|NCT02725515|567644895|FG001|Overall Study|Refused infusion (no study treatment)|0|||
157245857|NCT02725515|567644894|FG000|Overall Study|Loss of Improvement per Protocol|14|||
157245858|NCT02725515|567644895|FG001|Overall Study|Loss of Improvement per Protocol|25|||
157245859|NCT02725515|567644894|FG000|Overall Study|Withdrawal by Subject|2|||
157245860|NCT02725515|567644895|FG001|Overall Study|Withdrawal by Subject|1|||
157245861|NCT02725515|567644894|FG000|Overall Study|Non-Compliance With Study Drug|0|||
157245862|NCT02725515|567644895|FG001|Overall Study|Non-Compliance With Study Drug|3|||
157245863|NCT02725515|567644894|FG000|Overall Study|Lost to Follow-up|1|||
157245864|NCT02725515|567644895|FG001|Overall Study|Lost to Follow-up|1|||
157245865|NCT02725515|567644894|FG000|Overall Study|Adverse Event|7|||
157204486|NCT05048875|567491941|FG001|Overall Study|Adverse Event|0|||
157204487|NCT05048875|567491942|FG002|Overall Study|Adverse Event|0|||
157204488|NCT05048875|567491943|FG003|Overall Study|Adverse Event|1|||
157204489|NCT05048875|567491944|FG004|Overall Study|Adverse Event|0|||
157204490|NCT05048875|567491945|FG005|Overall Study|Adverse Event|0|||
157204491|NCT05048875|567491946|FG006|Overall Study|Adverse Event|0|||
157245866|NCT02725515|567644895|FG001|Overall Study|Adverse Event|2|||
157245867|NCT02725515|567644894|FG000|Overall Study|No Documented Disease Improvement|0|||
157245868|NCT02725515|567644895|FG001|Overall Study|No Documented Disease Improvement|1|||
157245869|NCT02725515|567644894|FG000|Overall Study|Completed Study Under Original Protocol|0|||
157245870|NCT02725515|567644895|FG001|Overall Study|Completed Study Under Original Protocol|1|||
157245871|NCT02725515|567644894|FG000|Overall Study|Lack of Response|0|||
157245872|NCT02725515|567644895|FG001|Overall Study|Lack of Response|1|||
157245873|NCT00183196|567644900|FG000|Overall Study|Withdrawal by Subject|18|||
157245874|NCT00183196|567644901|FG001|Overall Study|Withdrawal by Subject|11|||
157245875|NCT00183196|567644902|FG002|Overall Study|Withdrawal by Subject|13|||
157245876|NCT00183196|567644900|FG000|Overall Study|Adverse Event|1|||
157245877|NCT00183196|567644901|FG001|Overall Study|Adverse Event|2|||
157245878|NCT00183196|567644902|FG002|Overall Study|Adverse Event|2|||
157245879|NCT00183196|567644900|FG000|Overall Study|Legal event|1|||
157245880|NCT00183196|567644901|FG001|Overall Study|Legal event|1|||
157245881|NCT00183196|567644902|FG002|Overall Study|Legal event|1|||
157204492|NCT05048875|567491947|FG007|Overall Study|Adverse Event|0|||
157204493|NCT04410978|567491954|FG000|Overall Study|Poor compliance to protocol|2|||
157204494|NCT04410978|567491955|FG001|Overall Study|Poor compliance to protocol|4|||
157204495|NCT04410978|567491954|FG000|Overall Study|Withdrawal by Subject|64|||
157204496|NCT04410978|567491955|FG001|Overall Study|Withdrawal by Subject|66|||
157204497|NCT04410978|567491954|FG000|Overall Study|Other|6|||
157204498|NCT04410978|567491955|FG001|Overall Study|Other|7|||
157204499|NCT04410978|567491954|FG000|Overall Study|Missing study status|1|||
157204500|NCT04410978|567491955|FG001|Overall Study|Missing study status|0|||
157204501|NCT02684162|567491956|FG000|Overall Study|Physician Decision|0|||
157204502|NCT02684162|567491957|FG001|Overall Study|Physician Decision|1|||
157204503|NCT02684162|567491958|FG002|Overall Study|Physician Decision|0|||
157204504|NCT04089566|567491961|FG000|Overall Study|Death|0|||
157204505|NCT04089566|567491962|FG001|Overall Study|Death|6|||
157204506|NCT04089566|567491963|FG002|Overall Study|Death|10|||
157204507|NCT04089566|567491964|FG003|Overall Study|Death|0|||
157204508|NCT04089566|567491965|FG004|Overall Study|Death|0|||
157204509|NCT04089566|567491966|FG005|Overall Study|Death|0|||
157204510|NCT04089566|567491961|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
157204511|NCT04089566|567491962|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
157245882|NCT00183196|567644900|FG000|Overall Study|Required more intensive care|0|||
157245883|NCT00183196|567644901|FG001|Overall Study|Required more intensive care|1|||
157245884|NCT00183196|567644902|FG002|Overall Study|Required more intensive care|2|||
157245885|NCT01911429|567644903|FG000|Overall Study|Adverse Event|5|||
157245886|NCT01911429|567644904|FG001|Overall Study|Adverse Event|3|||
157245887|NCT01911429|567644905|FG002|Overall Study|Adverse Event|9|||
157245888|NCT01911429|567644903|FG000|Overall Study|Lack of Efficacy|1|||
157245889|NCT01911429|567644904|FG001|Overall Study|Lack of Efficacy|2|||
157245890|NCT01911429|567644905|FG002|Overall Study|Lack of Efficacy|4|||
157245891|NCT01911429|567644903|FG000|Overall Study|Lost to Follow-up|0|||
157245892|NCT01911429|567644904|FG001|Overall Study|Lost to Follow-up|0|||
157245893|NCT01911429|567644905|FG002|Overall Study|Lost to Follow-up|1|||
157245894|NCT01911429|567644903|FG000|Overall Study|Protocol Violation|0|||
157245895|NCT01911429|567644904|FG001|Overall Study|Protocol Violation|0|||
157245896|NCT01911429|567644905|FG002|Overall Study|Protocol Violation|1|||
157245897|NCT01911429|567644903|FG000|Overall Study|Withdrawal by Subject|5|||
157245898|NCT01911429|567644904|FG001|Overall Study|Withdrawal by Subject|5|||
157245899|NCT01911429|567644905|FG002|Overall Study|Withdrawal by Subject|4|||
157245900|NCT01911429|567644903|FG000|Overall Study|Accidental randomization|0|||
157245901|NCT01911429|567644904|FG001|Overall Study|Accidental randomization|0|||
157245902|NCT01911429|567644905|FG002|Overall Study|Accidental randomization|1|||
157245903|NCT01911429|567644903|FG000|Overall Study|subject left study|1|||
157245904|NCT01911429|567644904|FG001|Overall Study|subject left study|0|||
157245905|NCT01911429|567644905|FG002|Overall Study|subject left study|0|||
157245906|NCT03540160|567644908|FG000|Overall Study|Protocol Violation|1|||
157245907|NCT03540160|567644908|FG000|Overall Study|Physician Decision|8|||
157245908|NCT03540160|567644908|FG000|Overall Study|Lack of Efficacy|60|||
157245909|NCT03540160|567644908|FG000|Overall Study|Pregnancy|1|||
157245910|NCT03540160|567644908|FG000|Overall Study|Adverse Event|20|||
157245911|NCT03540160|567644908|FG000|Overall Study|Withdrawal by Subject|68|||
157245912|NCT03540160|567644908|FG000|Overall Study|COVID-19|2|||
157245913|NCT03540160|567644908|FG000|Overall Study|Study Closure|10|||
157245914|NCT03540160|567644908|FG000|Overall Study|Lost to Follow-up|18|||
157245915|NCT03540160|567644908|FG000|Overall Study|Sponsor decision|191|||
157245916|NCT01944722|567644909|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
157245917|NCT01944722|567644909|FG000|Overall Study|Specimen Shipping Issues|34|||
157245918|NCT01944722|567644909|FG000|Overall Study|Improper Storage/Transport|5|||
157245919|NCT01944722|567644909|FG000|Overall Study|Insufficient Volume for Test|1|||
157245920|NCT01944722|567644909|FG000|Overall Study|Missing Specimens|3|||
157245921|NCT01944722|567644909|FG000|Overall Study|Specimens Mislabeled|2|||
157245922|NCT01944722|567644909|FG000|Overall Study|Withdrawal by Subject|8|||
157245923|NCT01944722|567644909|FG000|Overall Study|NILM Subjects <30 years old|8106|||
157245924|NCT01944722|567644909|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
157245925|NCT01944722|567644909|FG000|Overall Study|>ASCUS Cytology|1122|||
157245926|NCT02906917|567644913|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
157245927|NCT02906917|567644914|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
157245928|NCT02906917|567644913|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
157245929|NCT02906917|567644914|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
157245930|NCT02906917|567644913|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
157245931|NCT02906917|567644914|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
157245932|NCT02906917|567644913|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
157245933|NCT02906917|567644914|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
157245934|NCT02906917|567644913|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
157245935|NCT02906917|567644914|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
157245936|NCT02906917|567644913|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
157245937|NCT02906917|567644914|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
157245938|NCT02906917|567644913|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
157245939|NCT02906917|567644914|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
157245940|NCT02906917|567644913|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
157245941|NCT02906917|567644914|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
157245942|NCT01370083|567644915|FG000|Overall Study|Lost to Follow-up|2|||
157245943|NCT01370083|567644916|FG001|Overall Study|Lost to Follow-up|0|||
157245944|NCT01370083|567644915|FG000|Overall Study|Adverse Event|0|||
157245945|NCT01370083|567644916|FG001|Overall Study|Adverse Event|1|||
157245946|NCT02450539|567644917|FG000|Overall Study|Withdrawal by Subject|12|||
157245947|NCT02450539|567644918|FG001|Overall Study|Withdrawal by Subject|6|||
157245948|NCT02450539|567644917|FG000|Overall Study|Lost to Follow-up|4|||
157245949|NCT02450539|567644918|FG001|Overall Study|Lost to Follow-up|1|||
157245950|NCT03358147|567644922|FG000|Overall Study|Withdrawal by Subject|13|||
157245951|NCT03358147|567644923|FG001|Overall Study|Withdrawal by Subject|19|||
157245952|NCT03358147|567644924|FG002|Overall Study|Withdrawal by Subject|16|||
157245953|NCT03358147|567644925|FG003|Overall Study|Withdrawal by Subject|10|||
157245954|NCT03358147|567644926|FG004|Overall Study|Withdrawal by Subject|5|||
157245955|NCT03358147|567644922|FG000|Overall Study|Adverse Event|3|||
157245956|NCT03358147|567644923|FG001|Overall Study|Adverse Event|9|||
157245957|NCT03358147|567644924|FG002|Overall Study|Adverse Event|7|||
157245958|NCT03358147|567644925|FG003|Overall Study|Adverse Event|5|||
157245959|NCT03358147|567644926|FG004|Overall Study|Adverse Event|2|||
157245960|NCT03358147|567644922|FG000|Overall Study|Lost to Follow-up|4|||
157245961|NCT03358147|567644923|FG001|Overall Study|Lost to Follow-up|3|||
157245962|NCT03358147|567644924|FG002|Overall Study|Lost to Follow-up|7|||
157245963|NCT03358147|567644925|FG003|Overall Study|Lost to Follow-up|6|||
157245964|NCT03358147|567644926|FG004|Overall Study|Lost to Follow-up|4|||
157245965|NCT03358147|567644922|FG000|Overall Study|Major Protocol Deviation|11|||
157245966|NCT03358147|567644923|FG001|Overall Study|Major Protocol Deviation|3|||
157245967|NCT03358147|567644924|FG002|Overall Study|Major Protocol Deviation|2|||
157245968|NCT03358147|567644925|FG003|Overall Study|Major Protocol Deviation|3|||
157245969|NCT03358147|567644926|FG004|Overall Study|Major Protocol Deviation|1|||
157245970|NCT03358147|567644922|FG000|Overall Study|Protocol specified criteria|2|||
157245971|NCT03358147|567644923|FG001|Overall Study|Protocol specified criteria|3|||
157245972|NCT03358147|567644924|FG002|Overall Study|Protocol specified criteria|0|||
157245973|NCT03358147|567644925|FG003|Overall Study|Protocol specified criteria|3|||
157245974|NCT03358147|567644926|FG004|Overall Study|Protocol specified criteria|1|||
157245975|NCT03358147|567644922|FG000|Overall Study|Physician Decision|1|||
157245976|NCT03358147|567644923|FG001|Overall Study|Physician Decision|0|||
157245977|NCT03358147|567644924|FG002|Overall Study|Physician Decision|1|||
157245978|NCT03358147|567644925|FG003|Overall Study|Physician Decision|6|||
157245979|NCT03358147|567644926|FG004|Overall Study|Physician Decision|1|||
157245980|NCT03358147|567644922|FG000|Overall Study|Administrative reasons|0|||
157245981|NCT03358147|567644923|FG001|Overall Study|Administrative reasons|1|||
157245982|NCT03358147|567644924|FG002|Overall Study|Administrative reasons|0|||
157245983|NCT03358147|567644925|FG003|Overall Study|Administrative reasons|3|||
157245984|NCT03358147|567644926|FG004|Overall Study|Administrative reasons|0|||
157245985|NCT03358147|567644922|FG000|Overall Study|Lack of Efficacy|0|||
157245986|NCT03358147|567644923|FG001|Overall Study|Lack of Efficacy|1|||
157245987|NCT03358147|567644924|FG002|Overall Study|Lack of Efficacy|1|||
157245988|NCT03358147|567644925|FG003|Overall Study|Lack of Efficacy|0|||
157245989|NCT03358147|567644926|FG004|Overall Study|Lack of Efficacy|0|||
157245990|NCT00731939|567644934|FG000|Overall Study|Adverse Event|6|||
157245991|NCT00731939|567644934|FG000|Overall Study|Lost to Follow-up|15|||
157245992|NCT00731939|567644934|FG000|Overall Study|Not implanted with study device|9|||
157245993|NCT00731939|567644934|FG000|Overall Study|Withdrawal by Subject|2|||
157245994|NCT00731939|567644934|FG000|Overall Study|Did not meet enrollment criteria|2|||
157245995|NCT02280863|567644935|FG000|Integrated Platform|Met stopping criteria|0|||
157245996|NCT02280863|567644936|FG001|Integrated Platform|Met stopping criteria|1|||
157245997|NCT02890992|567644939|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157245998|NCT02890992|567644940|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
157245999|NCT02890992|567644941|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246000|NCT02890992|567644942|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246001|NCT02890992|567644943|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246002|NCT02890992|567644944|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246003|NCT02890992|567644945|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246004|NCT02890992|567644946|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
157246005|NCT02890992|567644939|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246006|NCT02890992|567644940|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246007|NCT02890992|567644941|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246008|NCT02890992|567644942|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246009|NCT02890992|567644943|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246010|NCT02890992|567644944|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
157246011|NCT02890992|567644945|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
157246012|NCT02890992|567644946|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
157246013|NCT02890992|567644939|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246014|NCT02890992|567644940|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
157246015|NCT02890992|567644941|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246016|NCT02890992|567644942|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246017|NCT02890992|567644943|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246018|NCT02890992|567644944|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246019|NCT02890992|567644945|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246020|NCT02890992|567644946|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
157246021|NCT02622386|567644947|FG000|First Assignment|Withdrawal by Subject|3|||
157246022|NCT02622386|567644948|FG001|First Assignment|Withdrawal by Subject|2|||
157246023|NCT02622386|567644947|FG000|Washout|Withdrawal by Subject|4|||
157246024|NCT02622386|567644948|FG001|Washout|Withdrawal by Subject|4|||
157246025|NCT02622386|567644947|FG000|Second Assignment|Withdrawal by Subject|0|||
157246026|NCT02622386|567644948|FG001|Second Assignment|Withdrawal by Subject|2|||
157246027|NCT02704091|567644949|FG000|Overall Study|Adverse Event|4|||
157246028|NCT02704091|567644950|FG001|Overall Study|Adverse Event|3|||
157246029|NCT02704091|567644949|FG000|Overall Study|Protocol Violation|5|||
157246030|NCT02704091|567644950|FG001|Overall Study|Protocol Violation|3|||
157246031|NCT02704091|567644949|FG000|Overall Study|Consent withdrawn|4|||
157246032|NCT02704091|567644950|FG001|Overall Study|Consent withdrawn|4|||
157246033|NCT02704091|567644949|FG000|Overall Study|Lost to Follow-up|13|||
157246034|NCT02704091|567644950|FG001|Overall Study|Lost to Follow-up|5|||
157246035|NCT02704091|567644949|FG000|Overall Study|Other|2|||
157246036|NCT02704091|567644950|FG001|Overall Study|Other|8|||
157204512|NCT04089566|567491963|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
157204513|NCT04089566|567491964|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
157204514|NCT04089566|567491965|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
157204515|NCT04089566|567491966|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
157204516|NCT04089566|567491961|FG000|Overall Study|Reason not Specified|0|||
157204517|NCT04089566|567491962|FG001|Overall Study|Reason not Specified|4|||
157204518|NCT04089566|567491963|FG002|Overall Study|Reason not Specified|4|||
157204519|NCT04089566|567491964|FG003|Overall Study|Reason not Specified|1|||
157204520|NCT04089566|567491965|FG004|Overall Study|Reason not Specified|0|||
157204521|NCT04089566|567491966|FG005|Overall Study|Reason not Specified|0|||
157204522|NCT01083121|567491967|FG000|Overall Study|Use of Humira outside the approved label|81|||
157204523|NCT03743571|567491971|FG000|Overall Study|Withdrawal by Subject|1|||
157204524|NCT03743571|567491972|FG001|Overall Study|Withdrawal by Subject|1|||
157204525|NCT03743571|567491971|FG000|Overall Study|Lost to Follow-up|1|||
157204526|NCT03743571|567491972|FG001|Overall Study|Lost to Follow-up|2|||
157204527|NCT04115488|567491973|FG000|Overall Study|Adverse Event|8|||
157204528|NCT04115488|567491974|FG001|Overall Study|Adverse Event|4|||
157204529|NCT04115488|567491973|FG000|Overall Study|Withdrawal by Subject|3|||
157204530|NCT04115488|567491974|FG001|Overall Study|Withdrawal by Subject|6|||
157204531|NCT04115488|567491973|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
157204532|NCT04115488|567491974|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
157204533|NCT04115488|567491973|FG000|Overall Study|Patient 's location change|1|||
157204534|NCT04115488|567491974|FG001|Overall Study|Patient 's location change|0|||
157204535|NCT04115488|567491973|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
157204536|NCT04115488|567491974|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
157204537|NCT00885677|567491975|FG000|Overall Study|Death|40|||
157204538|NCT00885677|567491976|FG001|Overall Study|Death|34|||
157204539|NCT00885677|567491975|FG000|Overall Study|Lost to Follow-up|15|||
157204540|NCT00885677|567491976|FG001|Overall Study|Lost to Follow-up|13|||
157204541|NCT00885677|567491975|FG000|Overall Study|Protocol Violation|54|||
157204542|NCT00885677|567491976|FG001|Overall Study|Protocol Violation|54|||
157204543|NCT00885677|567491975|FG000|Overall Study|premature study closure|41|||
157204544|NCT00885677|567491976|FG001|Overall Study|premature study closure|44|||
157204545|NCT00885677|567491975|FG000|Overall Study|device/lead revision or replacement|7|||
157204546|NCT00885677|567491976|FG001|Overall Study|device/lead revision or replacement|6|||
157204547|NCT00885677|567491975|FG000|Overall Study|Heart transplantation|1|||
157204548|NCT00885677|567491976|FG001|Overall Study|Heart transplantation|0|||
157204549|NCT00885677|567491975|FG000|Overall Study|Inclusion/exclusion not met|25|||
157204550|NCT00885677|567491976|FG001|Overall Study|Inclusion/exclusion not met|27|||
157204551|NCT01875731|567491988|FG000|Overall Study|Fail to obtain lab sample|1|||
157204552|NCT01875731|567491989|FG001|Overall Study|Fail to obtain lab sample|0|||
157204553|NCT02576951|567491990|FG000|Overall Study|Lost to Follow-up|0|||
157204554|NCT02576951|567491991|FG001|Overall Study|Lost to Follow-up|0|||
157204555|NCT02576951|567491992|FG002|Overall Study|Lost to Follow-up|2|||
157204556|NCT02576951|567491993|FG003|Overall Study|Lost to Follow-up|2|||
157204557|NCT02576951|567491990|FG000|Overall Study|Withdrawal by Subject|1|||
157204558|NCT02576951|567491991|FG001|Overall Study|Withdrawal by Subject|0|||
157204559|NCT02576951|567491992|FG002|Overall Study|Withdrawal by Subject|0|||
157204560|NCT02576951|567491993|FG003|Overall Study|Withdrawal by Subject|2|||
157204561|NCT02576951|567491990|FG000|Overall Study|Protocol Violation|0|||
157204562|NCT02576951|567491991|FG001|Overall Study|Protocol Violation|0|||
157204563|NCT02576951|567491992|FG002|Overall Study|Protocol Violation|0|||
157204564|NCT02576951|567491993|FG003|Overall Study|Protocol Violation|1|||
157204565|NCT03417102|567491994|FG000|Overall Study|Adverse Event|0|||
157204566|NCT03417102|567491995|FG001|Overall Study|Adverse Event|1|||
157204567|NCT03417102|567491994|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
157204568|NCT03417102|567491995|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
157204569|NCT03417102|567491994|FG000|Overall Study|Other|0|||
157204570|NCT03417102|567491995|FG001|Overall Study|Other|1|||
157204571|NCT02062385|567491999|FG000|Overall Study|Adverse Event|19|||
157204572|NCT02062385|567492000|FG001|Overall Study|Adverse Event|13|||
157204573|NCT02062385|567492001|FG002|Overall Study|Adverse Event|1|||
157204574|NCT02062385|567492002|FG003|Overall Study|Adverse Event|0|||
157204575|NCT02062385|567491999|FG000|Overall Study|Protocol Violation|1|||
157204576|NCT02062385|567492000|FG001|Overall Study|Protocol Violation|0|||
157204577|NCT02062385|567492001|FG002|Overall Study|Protocol Violation|0|||
157204578|NCT02062385|567492002|FG003|Overall Study|Protocol Violation|0|||
157204579|NCT02062385|567491999|FG000|Overall Study|Incomplete EPI by database lock|2|||
157204580|NCT02062385|567492000|FG001|Overall Study|Incomplete EPI by database lock|0|||
157204581|NCT02062385|567492001|FG002|Overall Study|Incomplete EPI by database lock|0|||
157204582|NCT02062385|567492002|FG003|Overall Study|Incomplete EPI by database lock|0|||
157204583|NCT02062385|567491999|FG000|Overall Study|Moved|10|||
157204584|NCT02062385|567492000|FG001|Overall Study|Moved|11|||
157204585|NCT02062385|567492001|FG002|Overall Study|Moved|1|||
157204586|NCT02062385|567492002|FG003|Overall Study|Moved|0|||
157204587|NCT02062385|567491999|FG000|Overall Study|Withdrawn by parent/guardian|46|||
157204588|NCT02062385|567492000|FG001|Overall Study|Withdrawn by parent/guardian|41|||
157204589|NCT02062385|567492001|FG002|Overall Study|Withdrawn by parent/guardian|9|||
157204590|NCT02062385|567492002|FG003|Overall Study|Withdrawn by parent/guardian|8|||
157204591|NCT02062385|567491999|FG000|Overall Study|Death|0|||
157204592|NCT02062385|567492000|FG001|Overall Study|Death|0|||
157204593|NCT02062385|567492001|FG002|Overall Study|Death|0|||
157204594|NCT02062385|567492002|FG003|Overall Study|Death|1|||
157204595|NCT02062385|567491999|FG000|Overall Study|Lost to Follow-up|0|||
157204596|NCT02062385|567492000|FG001|Overall Study|Lost to Follow-up|0|||
157204597|NCT02062385|567492001|FG002|Overall Study|Lost to Follow-up|1|||
157204598|NCT02062385|567492002|FG003|Overall Study|Lost to Follow-up|0|||
157204599|NCT03188991|567492003|FG000|Overall Study|Withdrawal by Subject|0|||
157204600|NCT03188991|567492004|FG001|Overall Study|Withdrawal by Subject|0|||
157204601|NCT03188991|567492005|FG002|Overall Study|Withdrawal by Subject|0|||
157204602|NCT03188991|567492006|FG003|Overall Study|Withdrawal by Subject|1|||
157204603|NCT00223990|567492007|FG000|Overall Study|Moved from area|2|||
157204604|NCT00223990|567492008|FG001|Overall Study|Moved from area|1|||
157204605|NCT00223990|567492007|FG000|Overall Study|Withdrawal by Subject|4|||
157204606|NCT00223990|567492008|FG001|Overall Study|Withdrawal by Subject|8|||
157204607|NCT00223990|567492007|FG000|Overall Study|Lost to Follow-up|1|||
157204608|NCT00223990|567492008|FG001|Overall Study|Lost to Follow-up|0|||
157204609|NCT03505606|567493742|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
157204610|NCT03505606|567493743|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
157204611|NCT03505606|567493744|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
157204612|NCT03505606|567493742|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
157204613|NCT03505606|567493743|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
157204614|NCT03505606|567493744|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
157204615|NCT03505606|567493742|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
157204616|NCT03505606|567493743|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
157204617|NCT03505606|567493744|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
157204618|NCT03505606|567493742|FG000|Overall Study|Poor compliance with refractive correction|0|||
157204619|NCT03505606|567493743|FG001|Overall Study|Poor compliance with refractive correction|0|||
157204620|NCT03505606|567493744|FG002|Overall Study|Poor compliance with refractive correction|1|||
157204621|NCT03505606|567493742|FG000|Overall Study|Insufficient anisometropia|0|||
157204622|NCT03505606|567493743|FG001|Overall Study|Insufficient anisometropia|0|||
157204623|NCT03505606|567493744|FG002|Overall Study|Insufficient anisometropia|2|||
157204624|NCT03505606|567493742|FG000|Overall Study|Ectopia Lentis|0|||
157204625|NCT03505606|567493743|FG001|Overall Study|Ectopia Lentis|0|||
157204626|NCT03505606|567493744|FG002|Overall Study|Ectopia Lentis|1|||
157204627|NCT03505606|567493742|FG000|Overall Study|alternation of amblyopic eye|0|||
157204628|NCT03505606|567493743|FG001|Overall Study|alternation of amblyopic eye|1|||
157204629|NCT03505606|567493744|FG002|Overall Study|alternation of amblyopic eye|0|||
157204630|NCT02087865|567493747|FG000|Overall Study|Withdrawal by Subject|6|||
157204631|NCT02087865|567493748|FG001|Overall Study|Withdrawal by Subject|0|||
157204632|NCT02087865|567493749|FG002|Overall Study|Withdrawal by Subject|1|||
157204633|NCT02087865|567493747|FG000|Overall Study|Lost to Follow-up|0|||
157204634|NCT02087865|567493748|FG001|Overall Study|Lost to Follow-up|0|||
157204635|NCT02087865|567493749|FG002|Overall Study|Lost to Follow-up|1|||
157204636|NCT02087865|567493747|FG000|Overall Study|Drug Non-compliance|0|||
157204637|NCT02087865|567493748|FG001|Overall Study|Drug Non-compliance|2|||
157204638|NCT02087865|567493749|FG002|Overall Study|Drug Non-compliance|0|||
157204639|NCT02087865|567493747|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
157204640|NCT02087865|567493748|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
157204641|NCT02087865|567493749|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
157204642|NCT01319994|567493750|FG000|Overall Study|Protocol Violation|7|||
157204643|NCT01319994|567493751|FG001|Overall Study|Protocol Violation|6|||
157204644|NCT01340794|567493752|FG000|Overall Study|Withdrawal by Subject|0|||
157204645|NCT01340794|567493753|FG001|Overall Study|Withdrawal by Subject|1|||
157204646|NCT01392469|567493757|FG000|Overall Study|Adverse Event|2|||
157204647|NCT01392469|567493757|FG000|Overall Study|Withdrawal by Subject|1|||
157204648|NCT01392469|567493757|FG000|Overall Study|Protocol Violation|1|||
157204649|NCT02674568|567493763|FG000|Overall Study|Withdrawal by Subject|5|||
157204650|NCT02674568|567493763|FG000|Overall Study|Death|303|||
157204651|NCT02674568|567493763|FG000|Overall Study|Physician Decision|2|||
157204652|NCT02674568|567493763|FG000|Overall Study|Lost to Follow-up|9|||
157204653|NCT02674568|567493763|FG000|Overall Study|Other, Not Specified|20|||
157204654|NCT01808508|567493766|FG000|Overall Study|Lost to Follow-up|1|||
157204655|NCT01808508|567493767|FG001|Overall Study|Lost to Follow-up|0|||
157204656|NCT01808508|567493768|FG002|Overall Study|Lost to Follow-up|0|||
157204657|NCT01118949|567493769|FG000|Overall Study|Adverse Event|5|||
157204658|NCT01118949|567493769|FG000|Overall Study|Withdrawal by Subject|4|||
157204659|NCT01017731|567493773|FG000|Overall Study|Lost to Follow-up|2|||
157204660|NCT01017731|567493773|FG000|Overall Study|Withdrawal by Subject|3|||
157204661|NCT01017731|567493773|FG000|Overall Study|Physician Decision|2|||
157204662|NCT01017731|567493773|FG000|Overall Study|Adverse Event|1|||
157204663|NCT00648739|567493774|FG000|Overall Study|Adverse Event|1|||
157204664|NCT00648739|567493775|FG001|Overall Study|Adverse Event|0|||
157204665|NCT00648739|567493776|FG002|Overall Study|Adverse Event|1|||
157204666|NCT00648739|567493777|FG003|Overall Study|Adverse Event|2|||
157204667|NCT00648739|567493778|FG004|Overall Study|Adverse Event|1|||
157204668|NCT00648739|567493779|FG005|Overall Study|Adverse Event|0|||
157204669|NCT00648739|567493780|FG006|Overall Study|Adverse Event|0|||
157204670|NCT00648739|567493774|FG000|Overall Study|Withdrawal by Subject|1|||
157204671|NCT00648739|567493775|FG001|Overall Study|Withdrawal by Subject|0|||
157204672|NCT00648739|567493776|FG002|Overall Study|Withdrawal by Subject|1|||
157204673|NCT00648739|567493777|FG003|Overall Study|Withdrawal by Subject|0|||
157204674|NCT00648739|567493778|FG004|Overall Study|Withdrawal by Subject|0|||
157204675|NCT00648739|567493779|FG005|Overall Study|Withdrawal by Subject|2|||
157204676|NCT00648739|567493780|FG006|Overall Study|Withdrawal by Subject|0|||
157204677|NCT00648739|567493774|FG000|Overall Study|Lack of Efficacy|0|||
157204678|NCT00648739|567493775|FG001|Overall Study|Lack of Efficacy|0|||
157204679|NCT00648739|567493776|FG002|Overall Study|Lack of Efficacy|0|||
157204680|NCT00648739|567493777|FG003|Overall Study|Lack of Efficacy|0|||
157204681|NCT00648739|567493778|FG004|Overall Study|Lack of Efficacy|1|||
157204682|NCT00648739|567493779|FG005|Overall Study|Lack of Efficacy|2|||
157204683|NCT00648739|567493780|FG006|Overall Study|Lack of Efficacy|0|||
157204684|NCT00648739|567493774|FG000|Overall Study|Investigator Considered it Advisable|0|||
157204685|NCT00648739|567493775|FG001|Overall Study|Investigator Considered it Advisable|0|||
157204686|NCT00648739|567493776|FG002|Overall Study|Investigator Considered it Advisable|0|||
157204687|NCT00648739|567493777|FG003|Overall Study|Investigator Considered it Advisable|0|||
157204688|NCT00648739|567493778|FG004|Overall Study|Investigator Considered it Advisable|0|||
157204689|NCT00648739|567493779|FG005|Overall Study|Investigator Considered it Advisable|1|||
157204690|NCT00648739|567493780|FG006|Overall Study|Investigator Considered it Advisable|1|||
157204691|NCT00648739|567493774|FG000|Overall Study|Death|0|||
157204692|NCT00648739|567493775|FG001|Overall Study|Death|1|||
157204693|NCT00648739|567493776|FG002|Overall Study|Death|0|||
157204694|NCT00648739|567493777|FG003|Overall Study|Death|0|||
157204695|NCT00648739|567493778|FG004|Overall Study|Death|0|||
157204696|NCT00648739|567493779|FG005|Overall Study|Death|0|||
157204697|NCT00648739|567493780|FG006|Overall Study|Death|0|||
157204698|NCT00648739|567493774|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
157204699|NCT00648739|567493775|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
157204700|NCT00648739|567493776|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
157204701|NCT00648739|567493777|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
157204702|NCT00648739|567493778|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
157204703|NCT00648739|567493779|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
157204704|NCT00648739|567493780|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
157204705|NCT00648739|567493774|FG000|Overall Study|Follow-up Visits Not Completed|0|||
157204706|NCT00648739|567493775|FG001|Overall Study|Follow-up Visits Not Completed|1|||
157204707|NCT00648739|567493776|FG002|Overall Study|Follow-up Visits Not Completed|0|||
157204708|NCT00648739|567493777|FG003|Overall Study|Follow-up Visits Not Completed|0|||
157204709|NCT00648739|567493778|FG004|Overall Study|Follow-up Visits Not Completed|0|||
157204710|NCT00648739|567493779|FG005|Overall Study|Follow-up Visits Not Completed|0|||
157204711|NCT00648739|567493780|FG006|Overall Study|Follow-up Visits Not Completed|0|||
157204712|NCT00685763|567493781|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
157204713|NCT00685763|567493781|FG000|Overall Study|Protocol Violation|1|||
157204714|NCT00698009|567493789|FG000|Overall Study|Withdrawal by Subject|1|||
157204715|NCT03862807|567493790|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
157204716|NCT04362761|567493791|FG000|Part A (48 Weeks)|Adverse Event|2|||
157204717|NCT04362761|567493791|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
157204718|NCT04362761|567493791|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
157204719|NCT04362761|567493791|FG000|Part A (48 Weeks)|Other|5|||
157204720|NCT04362761|567493791|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
157204721|NCT04362761|567493791|FG000|Part B (86 Weeks)|Other|4|||
157204722|NCT00929201|567493799|FG000|Period 1|Withdrawal by Subject|0|||
157204723|NCT00929201|567493800|FG001|Period 1|Withdrawal by Subject|1|||
157204724|NCT03606109|567493801|FG000|Overall Study|Lost to Follow-up|2|||
157204725|NCT03606109|567493802|FG001|Overall Study|Lost to Follow-up|1|||
157204726|NCT03286426|567493807|FG000|Overall Study|Physician Decision|3|||
157204727|NCT01817764|567493808|FG000|Overall Study|Adverse Event|7|||
157204728|NCT01817764|567493809|FG001|Overall Study|Adverse Event|10|||
157204729|NCT01817764|567493808|FG000|Overall Study|Lack of Efficacy|9|||
157204730|NCT01817764|567493809|FG001|Overall Study|Lack of Efficacy|7|||
157204731|NCT01817764|567493808|FG000|Overall Study|Protocol Violation|7|||
157204732|NCT01817764|567493809|FG001|Overall Study|Protocol Violation|5|||
157204733|NCT01817764|567493808|FG000|Overall Study|Lost to Follow-up|1|||
157204734|NCT01817764|567493809|FG001|Overall Study|Lost to Follow-up|4|||
157204735|NCT01817764|567493808|FG000|Overall Study|Withdrawal by Subject|10|||
157204736|NCT01817764|567493809|FG001|Overall Study|Withdrawal by Subject|12|||
157204737|NCT04930536|567493810|FG000|Overall Study|Adverse Event|1|||
157246037|NCT02412852|567644951|FG000|Overall Study|Withdrawal by Subject|0|||
157246038|NCT02412852|567644952|FG001|Overall Study|Withdrawal by Subject|1|||
157246039|NCT02412852|567644953|FG002|Overall Study|Withdrawal by Subject|0|||
157246040|NCT02412852|567644954|FG003|Overall Study|Withdrawal by Subject|0|||
157246041|NCT02412852|567644951|FG000|Overall Study|Physician Decision|0|||
157246042|NCT02412852|567644952|FG001|Overall Study|Physician Decision|0|||
157246043|NCT02412852|567644953|FG002|Overall Study|Physician Decision|0|||
157246044|NCT02412852|567644954|FG003|Overall Study|Physician Decision|1|||
157246045|NCT00985439|567644955|FG000|Overall Study|Adverse Event|0|||
157246046|NCT00985439|567644956|FG001|Overall Study|Adverse Event|0|||
157246047|NCT00985439|567644957|FG002|Overall Study|Adverse Event|1|||
157246048|NCT00985439|567644958|FG003|Overall Study|Adverse Event|0|||
157246049|NCT00472212|567644959|FG000|Overall Study|Lost to Follow-up|6|||
157246050|NCT00472212|567644960|FG001|Overall Study|Lost to Follow-up|4|||
157246051|NCT05604014|567644963|FG000|Overall Study|Lost to Follow-up|13|||
157246052|NCT00101439|567644983|FG000|Period 2|Withdrawal by Subject|0|||
157246053|NCT00101439|567644984|FG001|Period 2|Withdrawal by Subject|2|||
157246054|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
157246055|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
157246056|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
157246057|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
157246058|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
157246059|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
157246060|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
157246061|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
157246062|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
157246063|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
157246064|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
157246065|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
157246066|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
157246067|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
157246068|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
157246069|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
157246070|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
157246071|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
157246072|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
157246073|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
157246074|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
157246075|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
157246076|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
157246077|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
157246078|NCT00073307|567644989|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
157246079|NCT00073307|567644990|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
157246080|NCT00073307|567644991|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
157246081|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
157246082|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
157246083|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
157246084|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
157246085|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
157246086|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
157246087|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
157246088|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
157246089|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
157246090|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
157246091|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
157246092|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
157246093|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
157246094|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
157246095|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
157246096|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
157246097|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
157246098|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
157246099|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
157246100|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
157246101|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
157246102|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
157246103|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
157246104|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
157246105|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
157246106|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
157246107|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
157246108|NCT00073307|567644989|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
157246109|NCT00073307|567644990|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
157246110|NCT00073307|567644991|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
157246111|NCT00858780|567644992|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
157246112|NCT00858780|567644993|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
157246113|NCT00858780|567644994|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
157246114|NCT00858780|567644995|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
157246115|NCT00858780|567644996|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
157246116|NCT00858780|567644992|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
157246117|NCT00858780|567644993|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
157246118|NCT00858780|567644994|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
157246119|NCT00858780|567644995|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
157246120|NCT00858780|567644996|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
157246121|NCT00858780|567644992|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
157246122|NCT00858780|567644993|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
157246123|NCT00858780|567644994|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
157246124|NCT00858780|567644995|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
157246125|NCT00858780|567644996|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
157246126|NCT00858780|567644992|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
157246127|NCT00858780|567644993|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
157246128|NCT00858780|567644994|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
157246129|NCT00858780|567644995|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
157246130|NCT00858780|567644996|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
157246131|NCT00858780|567644992|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
157246132|NCT00858780|567644993|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
157246133|NCT00858780|567644994|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
157246134|NCT00858780|567644995|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
157246135|NCT00858780|567644996|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
157246136|NCT00858780|567644992|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
157246137|NCT00858780|567644993|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
157246138|NCT00858780|567644994|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
157246139|NCT00858780|567644995|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
157246140|NCT00858780|567644996|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
157246141|NCT01149057|567644997|FG000|Overall Study|Lack of Efficacy|16|||
157246142|NCT01149057|567644997|FG000|Overall Study|Adverse Event|13|||
157246143|NCT01149057|567644997|FG000|Overall Study|Withdrawal by Subject|9|||
157246144|NCT01149057|567644997|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
157246145|NCT01149057|567644997|FG000|Overall Study|B Cell Depletion|4|||
157246146|NCT01149057|567644997|FG000|Overall Study|Participant Non-Compliance|2|||
157246147|NCT01149057|567644997|FG000|Overall Study|Lost to Follow-up|1|||
157246148|NCT01149057|567644997|FG000|Overall Study|High Parathyroid Hormone Value|1|||
157246149|NCT01149057|567644997|FG000|Overall Study|Other|6|||
157246150|NCT03499873|567644998|FG000|Overall Study|Withdrawal by Subject|4|||
157246151|NCT03499873|567644999|FG001|Overall Study|Withdrawal by Subject|6|||
157246152|NCT03499873|567645000|FG002|Overall Study|Withdrawal by Subject|1|||
157246153|NCT03499873|567644998|FG000|Overall Study|Subjects condition worsened|0|||
157246154|NCT03499873|567644999|FG001|Overall Study|Subjects condition worsened|3|||
157246155|NCT03499873|567645000|FG002|Overall Study|Subjects condition worsened|11|||
157246156|NCT03499873|567644998|FG000|Overall Study|Adverse Event|8|||
157246157|NCT03499873|567644999|FG001|Overall Study|Adverse Event|3|||
157246158|NCT03499873|567645000|FG002|Overall Study|Adverse Event|6|||
157246159|NCT03499873|567644998|FG000|Overall Study|Physician Decision|1|||
157246160|NCT03499873|567644999|FG001|Overall Study|Physician Decision|0|||
157246161|NCT03499873|567645000|FG002|Overall Study|Physician Decision|0|||
157246162|NCT03499873|567644998|FG000|Overall Study|Administrative reasons|0|||
157246163|NCT03499873|567644999|FG001|Overall Study|Administrative reasons|1|||
157246164|NCT03499873|567645000|FG002|Overall Study|Administrative reasons|0|||
157246165|NCT03499873|567644998|FG000|Overall Study|Concomitant therapy|5|||
157246166|NCT03499873|567644999|FG001|Overall Study|Concomitant therapy|4|||
157246167|NCT03499873|567645000|FG002|Overall Study|Concomitant therapy|7|||
157246168|NCT03499873|567644998|FG000|Overall Study|Miscellaneous|1|||
157246169|NCT03499873|567644999|FG001|Overall Study|Miscellaneous|2|||
157246170|NCT03499873|567645000|FG002|Overall Study|Miscellaneous|2|||
157204738|NCT04930536|567493811|FG001|Overall Study|Adverse Event|0|||
157204739|NCT04930536|567493810|FG000|Overall Study|Disease Progression|2|||
157204740|NCT04930536|567493811|FG001|Overall Study|Disease Progression|0|||
157204741|NCT04930536|567493810|FG000|Overall Study|Patient Decision|4|||
157204742|NCT04930536|567493811|FG001|Overall Study|Patient Decision|2|||
157204743|NCT04930536|567493810|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
157204744|NCT04930536|567493811|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
157204745|NCT00267020|567493812|FG000|Overall Study|Adverse Event|22|||
157204746|NCT00267020|567493813|FG001|Overall Study|Adverse Event|5|||
157204747|NCT00267020|567493812|FG000|Overall Study|Death|2|||
157204748|NCT00267020|567493813|FG001|Overall Study|Death|1|||
157204749|NCT00267020|567493812|FG000|Overall Study|Withdrawal by Subject|17|||
157204750|NCT00267020|567493813|FG001|Overall Study|Withdrawal by Subject|7|||
157204751|NCT00267020|567493812|FG000|Overall Study|Physician Decision|3|||
157204752|NCT00267020|567493813|FG001|Overall Study|Physician Decision|2|||
157204753|NCT00267020|567493812|FG000|Overall Study|Disease Progression|39|||
157204754|NCT00267020|567493813|FG001|Overall Study|Disease Progression|25|||
157204755|NCT00267020|567493812|FG000|Overall Study|Unrelated Complication|1|||
157204756|NCT00267020|567493813|FG001|Overall Study|Unrelated Complication|1|||
157204757|NCT00267020|567493812|FG000|Overall Study|Sponsor Request|1|||
157204758|NCT00267020|567493813|FG001|Overall Study|Sponsor Request|0|||
157204759|NCT00267020|567493812|FG000|Overall Study|Other|1|||
157204760|NCT00267020|567493813|FG001|Overall Study|Other|2|||
157204761|NCT02209454|567493814|FG000|Second Period|Adverse Event|1|||
157204762|NCT02209454|567493815|FG001|Second Period|Adverse Event|0|||
157204763|NCT03079869|567493820|FG000|Overall Study|Adverse Event|6|||
157204764|NCT03079869|567493821|FG001|Overall Study|Adverse Event|8|||
157204765|NCT03079869|567493820|FG000|Overall Study|Withdrawal by Subject|4|||
157204766|NCT03079869|567493821|FG001|Overall Study|Withdrawal by Subject|1|||
157204767|NCT03079869|567493820|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
157204768|NCT03079869|567493821|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
157204769|NCT01325701|567493822|FG000|Overall Study|Adverse Event|12|||
157204770|NCT01325701|567493823|FG001|Overall Study|Adverse Event|0|||
157204771|NCT01325701|567493822|FG000|Overall Study|Protocol Violation|1|||
157204772|NCT01325701|567493823|FG001|Overall Study|Protocol Violation|0|||
157204773|NCT01325701|567493822|FG000|Overall Study|Physician Decision|2|||
157204774|NCT01325701|567493823|FG001|Overall Study|Physician Decision|2|||
157204775|NCT01325701|567493822|FG000|Overall Study|Withdrawal by Subject|2|||
157204776|NCT01325701|567493823|FG001|Overall Study|Withdrawal by Subject|1|||
157204777|NCT01325701|567493822|FG000|Overall Study|Rollerover Extension Study|4|||
157204778|NCT01325701|567493823|FG001|Overall Study|Rollerover Extension Study|0|||
157204779|NCT00297882|567493841|FG000|Day 14|Lack of Efficacy|12|||
157204780|NCT00297882|567493842|FG001|Day 14|Lack of Efficacy|49|||
157204781|NCT00297882|567493841|FG000|Day 28|Lost to Follow-up|13|||
157204782|NCT00297882|567493842|FG001|Day 28|Lost to Follow-up|23|||
157204783|NCT00297882|567493841|FG000|Day 28|Lack of Efficacy|3|||
157204784|NCT00297882|567493842|FG001|Day 28|Lack of Efficacy|0|||
157204785|NCT04242264|567493843|FG000|Overall Study|Lost to Follow-up|2|||
157204786|NCT04242264|567493844|FG001|Overall Study|Lost to Follow-up|2|||
157204787|NCT04242264|567493845|FG002|Overall Study|Lost to Follow-up|1|||
157204788|NCT04242264|567493846|FG003|Overall Study|Lost to Follow-up|1|||
157204789|NCT04242264|567493843|FG000|Overall Study|Withdrawal by Subject|1|||
157204790|NCT04242264|567493844|FG001|Overall Study|Withdrawal by Subject|0|||
157204791|NCT04242264|567493845|FG002|Overall Study|Withdrawal by Subject|0|||
157204792|NCT04242264|567493846|FG003|Overall Study|Withdrawal by Subject|0|||
157204793|NCT04221373|567493849|FG000|Overall Study|Physician Decision|4|||
157204794|NCT04221373|567493850|FG001|Overall Study|Physician Decision|0|||
157204795|NCT00627094|567493854|FG000|Overall Study|Adverse Event|8|||
157204796|NCT00627094|567493855|FG001|Overall Study|Adverse Event|7|||
157204797|NCT00627094|567493854|FG000|Overall Study|Lost to Follow-up|1|||
157204798|NCT00627094|567493855|FG001|Overall Study|Lost to Follow-up|0|||
157204799|NCT00627094|567493854|FG000|Overall Study|Withdrawal by Subject|1|||
157204800|NCT00627094|567493855|FG001|Overall Study|Withdrawal by Subject|1|||
157204801|NCT00627094|567493854|FG000|Overall Study|ulcer healed|1|||
157204802|NCT00627094|567493855|FG001|Overall Study|ulcer healed|7|||
157204803|NCT00627094|567493854|FG000|Overall Study|Other reason|1|||
157204804|NCT00627094|567493855|FG001|Overall Study|Other reason|0|||
157204805|NCT01165424|567493862|FG000|Overall Study|Clinical adverse experiences|1|||
157204806|NCT01165424|567493862|FG000|Overall Study|Laboratory adverse experiences|1|||
157204807|NCT01165424|567493862|FG000|Overall Study|Did not meet entry criteria|1|||
157204808|NCT01165424|567493862|FG000|Overall Study|Participant moved (relocated)|1|||
157204809|NCT04139642|567493863|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
157204810|NCT04139642|567493864|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
157204811|NCT01067339|567493872|FG000|Overall Study|Withdrawal by Subject|6|||
157204812|NCT01067339|567493873|FG001|Overall Study|Withdrawal by Subject|5|||
157204813|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
157204814|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
157204815|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
157246171|NCT03499873|567644998|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
157246172|NCT03499873|567644999|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
157246173|NCT03499873|567645000|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
157246174|NCT03602339|567645001|FG000|Overall Study|Withdrawal by Subject|9|||
157246175|NCT03602339|567645001|FG000|Overall Study|Physician Decision|2|||
157246176|NCT03602339|567645001|FG000|Overall Study|Other reason|4|||
157246177|NCT01297504|567645002|FG000|Overall Study|Invalid Consent|1|||
157246178|NCT01297504|567645002|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
157246179|NCT01297504|567645002|FG000|Overall Study|No Study Visits|4|||
157246180|NCT01297504|567645002|FG000|Overall Study|Death|3|||
157246181|NCT01297504|567645002|FG000|Overall Study|Lost to Follow-up|43|||
157246182|NCT01297504|567645002|FG000|Overall Study|Withdrawal by Subject|9|||
157246183|NCT01297504|567645002|FG000|Overall Study|Site Closure|3|||
157246184|NCT01297504|567645002|FG000|Overall Study|Protocol Violation|3|||
157246185|NCT01190865|567645009|FG000|Overall Study|Withdrawal by Subject|1|||
157246186|NCT01190865|567645009|FG000|Overall Study|Non-compliance|2|||
157246187|NCT00574847|567645012|FG000|Overall Study|Adverse Event|2|||
157246188|NCT00574847|567645013|FG001|Overall Study|Adverse Event|0|||
157246189|NCT00574847|567645012|FG000|Overall Study|Death|1|||
157246190|NCT00574847|567645013|FG001|Overall Study|Death|0|||
157246191|NCT00574847|567645012|FG000|Overall Study|Withdrawal by Subject|2|||
157246192|NCT00574847|567645013|FG001|Overall Study|Withdrawal by Subject|2|||
157246193|NCT00574847|567645012|FG000|Overall Study|Physician Decision|1|||
157246194|NCT00574847|567645013|FG001|Overall Study|Physician Decision|0|||
157246195|NCT00574847|567645012|FG000|Overall Study|Did not receive medication (declined)|2|||
157246196|NCT00574847|567645013|FG001|Overall Study|Did not receive medication (declined)|5|||
157246197|NCT00957021|567645014|FG000|Overall Study|Death|5|||
157246198|NCT00957021|567645014|FG000|Overall Study|Lost to Follow-up|8|||
157246199|NCT00957021|567645014|FG000|Overall Study|Withdrawal by Subject|34|||
157246200|NCT00957021|567645014|FG000|Overall Study|No 2 yr ROM data|35|||
157246201|NCT00957021|567645014|FG000|Overall Study|Revised study component by 2 yr visit|8|||
157246202|NCT00957021|567645014|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
157246203|NCT00957021|567645014|FG000|Overall Study|Surgery Cancelled|9|||
157246204|NCT00957021|567645014|FG000|Overall Study|Termination due to language issue|2|||
157246205|NCT01087502|567645015|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
157246206|NCT01087502|567645016|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
157246207|NCT01087502|567645015|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
157246208|NCT01087502|567645016|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
157246209|NCT01087502|567645015|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
157204816|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
157204817|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
157204818|NCT01179191|567493874|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
157204819|NCT01179191|567493874|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
157204820|NCT01179191|567493874|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
157204821|NCT01179191|567493874|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
157204822|NCT01179191|567493874|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
157204823|NCT01179191|567493874|FG000|Maintenance Phase (8 Weeks)|Other|66|||
157204824|NCT01833897|567493886|FG000|Overall Study|Lack of Efficacy|1|||
157204825|NCT00669110|567493887|FG000|Overall Study|Adverse Event|4|||
157204826|NCT00669110|567493888|FG001|Overall Study|Adverse Event|3|||
157204827|NCT00669110|567493887|FG000|Overall Study|Caregiver request|3|||
157204828|NCT00669110|567493888|FG001|Overall Study|Caregiver request|2|||
157204829|NCT00669110|567493887|FG000|Overall Study|Physician Decision|0|||
157204830|NCT00669110|567493888|FG001|Overall Study|Physician Decision|1|||
157204831|NCT00669110|567493887|FG000|Overall Study|Lost to Follow-up|1|||
157204832|NCT00669110|567493888|FG001|Overall Study|Lost to Follow-up|0|||
157204833|NCT00669110|567493887|FG000|Overall Study|Protocol Violation|0|||
157204834|NCT00669110|567493888|FG001|Overall Study|Protocol Violation|5|||
157204835|NCT00669110|567493887|FG000|Overall Study|Withdrawal by Subject|0|||
157204836|NCT00669110|567493888|FG001|Overall Study|Withdrawal by Subject|2|||
157204837|NCT03843775|567493891|FG000|Overall Study|Adverse Event|1|||
157204838|NCT03843775|567493892|FG001|Overall Study|Adverse Event|1|||
157204839|NCT03843775|567493891|FG000|Overall Study|Lack of Efficacy|2|||
157204840|NCT03843775|567493892|FG001|Overall Study|Lack of Efficacy|6|||
157204841|NCT03843775|567493891|FG000|Overall Study|Withdrawal by Subject|0|||
157204842|NCT03843775|567493892|FG001|Overall Study|Withdrawal by Subject|1|||
157204843|NCT00650806|567493894|FG000|Overall Study|Adverse Event|0|||
157204844|NCT00650806|567493895|FG001|Overall Study|Adverse Event|5|||
157204845|NCT00650806|567493896|FG002|Overall Study|Adverse Event|3|||
157246210|NCT01087502|567645016|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
157204846|NCT00650806|567493897|FG003|Overall Study|Adverse Event|4|||
157204847|NCT00650806|567493894|FG000|Overall Study|Lost to Follow-up|7|||
157204848|NCT00650806|567493895|FG001|Overall Study|Lost to Follow-up|6|||
157204849|NCT00650806|567493896|FG002|Overall Study|Lost to Follow-up|11|||
157204850|NCT00650806|567493897|FG003|Overall Study|Lost to Follow-up|10|||
157204851|NCT00650806|567493894|FG000|Overall Study|Protocol Violation|0|||
157204852|NCT00650806|567493895|FG001|Overall Study|Protocol Violation|0|||
157204853|NCT00650806|567493896|FG002|Overall Study|Protocol Violation|0|||
157204854|NCT00650806|567493897|FG003|Overall Study|Protocol Violation|1|||
157204855|NCT00650806|567493894|FG000|Overall Study|Pregnancy|0|||
157204856|NCT00650806|567493895|FG001|Overall Study|Pregnancy|0|||
157204857|NCT00650806|567493896|FG002|Overall Study|Pregnancy|0|||
157204858|NCT00650806|567493897|FG003|Overall Study|Pregnancy|1|||
157204859|NCT00650806|567493894|FG000|Overall Study|Withdrawal by Subject|7|||
157204860|NCT00650806|567493895|FG001|Overall Study|Withdrawal by Subject|5|||
157204861|NCT00650806|567493896|FG002|Overall Study|Withdrawal by Subject|8|||
157204862|NCT00650806|567493897|FG003|Overall Study|Withdrawal by Subject|6|||
157204863|NCT00650806|567493894|FG000|Overall Study|Noncompliance with study drug regimen|1|||
157204864|NCT00650806|567493895|FG001|Overall Study|Noncompliance with study drug regimen|1|||
157204865|NCT00650806|567493896|FG002|Overall Study|Noncompliance with study drug regimen|0|||
157204866|NCT00650806|567493897|FG003|Overall Study|Noncompliance with study drug regimen|0|||
157204867|NCT00650806|567493894|FG000|Overall Study|Study terminated by sponsor|2|||
157204868|NCT00650806|567493895|FG001|Overall Study|Study terminated by sponsor|3|||
157204869|NCT00650806|567493896|FG002|Overall Study|Study terminated by sponsor|5|||
157204870|NCT00650806|567493897|FG003|Overall Study|Study terminated by sponsor|4|||
157204871|NCT00650806|567493894|FG000|Overall Study|Other|1|||
157204872|NCT00650806|567493895|FG001|Overall Study|Other|1|||
157204873|NCT00650806|567493896|FG002|Overall Study|Other|2|||
157204874|NCT00650806|567493897|FG003|Overall Study|Other|0|||
157204875|NCT00605839|567493900|FG000|Overall Study|Protocol Violation|1|||
157204876|NCT00605839|567493901|FG001|Overall Study|Protocol Violation|0|||
157204877|NCT00605839|567493902|FG002|Overall Study|Protocol Violation|0|||
157204878|NCT02255422|567493903|FG000|Overall Study|Withdrawal by Subject|0|||
157204879|NCT02255422|567493904|FG001|Overall Study|Withdrawal by Subject|0|||
157204880|NCT02255422|567493905|FG002|Overall Study|Withdrawal by Subject|0|||
157204881|NCT02255422|567493906|FG003|Overall Study|Withdrawal by Subject|0|||
157204882|NCT02255422|567493907|FG004|Overall Study|Withdrawal by Subject|0|||
157204883|NCT02255422|567493908|FG005|Overall Study|Withdrawal by Subject|0|||
157204884|NCT02255422|567493909|FG006|Overall Study|Withdrawal by Subject|2|||
157204885|NCT02255422|567493903|FG000|Overall Study|Lost to Follow-up|0|||
157204886|NCT02255422|567493904|FG001|Overall Study|Lost to Follow-up|0|||
157204887|NCT02255422|567493905|FG002|Overall Study|Lost to Follow-up|1|||
157204888|NCT02255422|567493906|FG003|Overall Study|Lost to Follow-up|0|||
157204889|NCT02255422|567493907|FG004|Overall Study|Lost to Follow-up|0|||
157204890|NCT02255422|567493908|FG005|Overall Study|Lost to Follow-up|0|||
157204891|NCT02255422|567493909|FG006|Overall Study|Lost to Follow-up|0|||
157204892|NCT00602667|567493910|FG000|Overall Study|Still on Therapy|0|||
157204893|NCT00602667|567493911|FG001|Overall Study|Still on Therapy|2|||
157204894|NCT00602667|567493912|FG002|Overall Study|Still on Therapy|2|||
157204895|NCT00602667|567493910|FG000|Overall Study|Death|0|||
157204896|NCT00602667|567493911|FG001|Overall Study|Death|1|||
157204897|NCT00602667|567493912|FG002|Overall Study|Death|1|||
157204898|NCT00602667|567493910|FG000|Overall Study|Family request|3|||
157204899|NCT00602667|567493911|FG001|Overall Study|Family request|25|||
157204900|NCT00602667|567493912|FG002|Overall Study|Family request|6|||
157204901|NCT00602667|567493910|FG000|Overall Study|Excessive toxicity|1|||
157204902|NCT00602667|567493911|FG001|Overall Study|Excessive toxicity|1|||
157204903|NCT00602667|567493912|FG002|Overall Study|Excessive toxicity|0|||
157204904|NCT00602667|567493910|FG000|Overall Study|Second malignancy|0|||
157204905|NCT00602667|567493911|FG001|Overall Study|Second malignancy|1|||
157204906|NCT00602667|567493912|FG002|Overall Study|Second malignancy|0|||
157204907|NCT00602667|567493910|FG000|Overall Study|Physician Decision|2|||
157204908|NCT00602667|567493911|FG001|Overall Study|Physician Decision|3|||
157204909|NCT00602667|567493912|FG002|Overall Study|Physician Decision|8|||
157204910|NCT00602667|567493910|FG000|Overall Study|Progressive disease|13|||
157204911|NCT00602667|567493911|FG001|Overall Study|Progressive disease|48|||
157204912|NCT00602667|567493912|FG002|Overall Study|Progressive disease|45|||
157204913|NCT00602667|567493910|FG000|Overall Study|Progressive disease prior to therapy|0|||
157204914|NCT00602667|567493911|FG001|Overall Study|Progressive disease prior to therapy|0|||
157204915|NCT00602667|567493912|FG002|Overall Study|Progressive disease prior to therapy|1|||
157204916|NCT01489865|567493920|FG000|Overall Study|Progression of Disease|4|||
157204917|NCT01489865|567493921|FG001|Overall Study|Progression of Disease|2|||
157204918|NCT01489865|567493922|FG002|Overall Study|Progression of Disease|2|||
157204919|NCT01489865|567493923|FG003|Overall Study|Progression of Disease|3|||
157204920|NCT01489865|567493924|FG004|Overall Study|Progression of Disease|1|||
157204921|NCT01489865|567493925|FG005|Overall Study|Progression of Disease|6|||
157204922|NCT01489865|567493926|FG006|Overall Study|Progression of Disease|3|||
157204923|NCT01489865|567493927|FG007|Overall Study|Progression of Disease|0|||
157204924|NCT01489865|567493928|FG008|Overall Study|Progression of Disease|23|||
157204925|NCT01489865|567493920|FG000|Overall Study|Adverse Event|2|||
157204926|NCT01489865|567493921|FG001|Overall Study|Adverse Event|0|||
157204927|NCT01489865|567493922|FG002|Overall Study|Adverse Event|0|||
157204928|NCT01489865|567493923|FG003|Overall Study|Adverse Event|0|||
157204929|NCT01489865|567493924|FG004|Overall Study|Adverse Event|1|||
157204930|NCT01489865|567493925|FG005|Overall Study|Adverse Event|0|||
157204931|NCT01489865|567493926|FG006|Overall Study|Adverse Event|2|||
157204932|NCT01489865|567493927|FG007|Overall Study|Adverse Event|0|||
157204933|NCT01489865|567493928|FG008|Overall Study|Adverse Event|5|||
157204934|NCT01489865|567493920|FG000|Overall Study|Death|0|||
157204935|NCT01489865|567493921|FG001|Overall Study|Death|1|||
157204936|NCT01489865|567493922|FG002|Overall Study|Death|0|||
157204937|NCT01489865|567493923|FG003|Overall Study|Death|0|||
157204938|NCT01489865|567493924|FG004|Overall Study|Death|1|||
157204939|NCT01489865|567493925|FG005|Overall Study|Death|0|||
157204940|NCT01489865|567493926|FG006|Overall Study|Death|0|||
157204941|NCT01489865|567493927|FG007|Overall Study|Death|0|||
157204942|NCT01489865|567493928|FG008|Overall Study|Death|2|||
157204943|NCT01489865|567493920|FG000|Overall Study|Withdrawal by Subject|0|||
157204944|NCT01489865|567493921|FG001|Overall Study|Withdrawal by Subject|0|||
157204945|NCT01489865|567493922|FG002|Overall Study|Withdrawal by Subject|0|||
157204946|NCT01489865|567493923|FG003|Overall Study|Withdrawal by Subject|0|||
157204947|NCT01489865|567493924|FG004|Overall Study|Withdrawal by Subject|0|||
157204948|NCT01489865|567493925|FG005|Overall Study|Withdrawal by Subject|1|||
157204949|NCT01489865|567493926|FG006|Overall Study|Withdrawal by Subject|1|||
157204950|NCT01489865|567493927|FG007|Overall Study|Withdrawal by Subject|0|||
157204951|NCT01489865|567493928|FG008|Overall Study|Withdrawal by Subject|2|||
157204952|NCT01489865|567493920|FG000|Overall Study|Shifted|0|||
157204953|NCT01489865|567493921|FG001|Overall Study|Shifted|0|||
157204954|NCT01489865|567493922|FG002|Overall Study|Shifted|1|||
157204955|NCT01489865|567493923|FG003|Overall Study|Shifted|0|||
157204956|NCT01489865|567493924|FG004|Overall Study|Shifted|0|||
157204957|NCT01489865|567493925|FG005|Overall Study|Shifted|0|||
157204958|NCT01489865|567493926|FG006|Overall Study|Shifted|0|||
157204959|NCT01489865|567493927|FG007|Overall Study|Shifted|0|||
157204960|NCT01489865|567493928|FG008|Overall Study|Shifted|0|||
157204961|NCT00972309|567493929|FG000|Overall Study|Switched to alternative treatment|0|||
157204962|NCT00972309|567493930|FG001|Overall Study|Switched to alternative treatment|2|||
157204963|NCT00972309|567493929|FG000|Overall Study|Refused further treatment|0|||
157204964|NCT00972309|567493930|FG001|Overall Study|Refused further treatment|1|||
157204965|NCT00972309|567493929|FG000|Overall Study|Late determination of ineligibility|0|||
157204966|NCT00972309|567493930|FG001|Overall Study|Late determination of ineligibility|1|||
157204967|NCT00972309|567493929|FG000|Overall Study|Second malignancy|1|||
157204968|NCT00972309|567493930|FG001|Overall Study|Second malignancy|1|||
157204969|NCT00972309|567493929|FG000|Overall Study|Visa issues|0|||
157204970|NCT00972309|567493930|FG001|Overall Study|Visa issues|1|||
157204971|NCT00972309|567493929|FG000|Overall Study|Secondary cancer (SCC)|0|||
157204972|NCT00972309|567493930|FG001|Overall Study|Secondary cancer (SCC)|1|||
157204973|NCT00972309|567493929|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
157204974|NCT00972309|567493930|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
157204975|NCT00972309|567493929|FG000|Overall Study|Lost to Follow-up|1|||
157204976|NCT00972309|567493930|FG001|Overall Study|Lost to Follow-up|1|||
157204977|NCT00972309|567493929|FG000|Overall Study|Disease progression on study|10|||
157204978|NCT00972309|567493930|FG001|Overall Study|Disease progression on study|4|||
157204979|NCT03255226|567496016|FG000|Overall Study|Adverse Event|2|||
157204980|NCT03255226|567496016|FG000|Overall Study|Physician Decision|3|||
157204981|NCT03255226|567496016|FG000|Overall Study|Withdrawal by Subject|1|||
157204982|NCT03255226|567496016|FG000|Overall Study|Serum or blood sodium increased|4|||
157204983|NCT03255226|567496016|FG000|Overall Study|Serum or blood potassium increased|4|||
157204984|NCT01035229|567496017|FG000|Overall Study|Adverse Event|61|||
157204985|NCT01035229|567496018|FG001|Overall Study|Adverse Event|14|||
157204986|NCT01035229|567496017|FG000|Overall Study|Withdrawal by Subject|20|||
157204987|NCT01035229|567496018|FG001|Overall Study|Withdrawal by Subject|7|||
157204988|NCT01035229|567496017|FG000|Overall Study|Lost to Follow-up|1|||
157204989|NCT01035229|567496018|FG001|Overall Study|Lost to Follow-up|0|||
157204990|NCT01035229|567496017|FG000|Overall Study|Administrative problems|1|||
157204991|NCT01035229|567496018|FG001|Overall Study|Administrative problems|1|||
157204992|NCT01035229|567496017|FG000|Overall Study|Death|13|||
157204993|NCT01035229|567496018|FG001|Overall Study|Death|5|||
157204994|NCT01035229|567496017|FG000|Overall Study|New cancer therapy|2|||
157204995|NCT01035229|567496018|FG001|Overall Study|New cancer therapy|0|||
157204996|NCT01035229|567496017|FG000|Overall Study|Protocol Violation|0|||
157204997|NCT01035229|567496018|FG001|Overall Study|Protocol Violation|2|||
157204998|NCT01035229|567496017|FG000|Overall Study|Sponsor's decision to end study|3|||
157204999|NCT01035229|567496018|FG001|Overall Study|Sponsor's decision to end study|3|||
157205000|NCT01035229|567496017|FG000|Overall Study|Disease Progression|261|||
157205001|NCT01035229|567496018|FG001|Overall Study|Disease Progression|152|||
157205002|NCT00564486|567496023|FG000|Overall Study|Adverse Event|0|||
157205003|NCT00564486|567496024|FG001|Overall Study|Adverse Event|1|||
157205004|NCT00564486|567496025|FG002|Overall Study|Adverse Event|0|||
157205005|NCT00564486|567496026|FG003|Overall Study|Adverse Event|0|||
157205006|NCT00564486|567496023|FG000|Overall Study|Withdrawal by Subject|4|||
157246211|NCT01087502|567645015|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
157246212|NCT01087502|567645016|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
157246213|NCT01087502|567645015|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
157246214|NCT01087502|567645016|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
157246215|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
157246216|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
157246217|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
157246218|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
157246219|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
157246220|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
157246221|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
157246222|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
157246223|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
157246224|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
157246225|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
157246226|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
157246227|NCT01087502|567645015|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
157246228|NCT01087502|567645016|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
157246229|NCT01653704|567645017|FG000|Overall Study|Technical failure during recording|1|||
157246230|NCT01653704|567645018|FG001|Overall Study|Technical failure during recording|1|||
157246231|NCT01653704|567645017|FG000|Overall Study|Performance not reflective of training|1|||
157246232|NCT01653704|567645018|FG001|Overall Study|Performance not reflective of training|0|||
157246233|NCT02705716|567645019|FG000|Overall Study|Adverse Event|0|||
157246234|NCT02705716|567645020|FG001|Overall Study|Adverse Event|1|||
157246235|NCT02705716|567645019|FG000|Overall Study|Protocol Violation|3|||
157246236|NCT02705716|567645020|FG001|Overall Study|Protocol Violation|0|||
157246237|NCT02705716|567645019|FG000|Overall Study|Withdrawal of Consent|1|||
157246238|NCT02705716|567645020|FG001|Overall Study|Withdrawal of Consent|1|||
157246239|NCT01151618|567645021|FG000|Overall Study|Adverse Event|2|||
157246240|NCT01151618|567645021|FG000|Overall Study|Withdrawal by Subject|7|||
157246241|NCT00562718|567645022|FG000|Overall Study|Death|1|||
157246242|NCT00562718|567645022|FG000|Overall Study|Withdrawal by Subject|3|||
157246243|NCT00562718|567645022|FG000|Overall Study|Adverse Event|4|||
157246244|NCT00562718|567645022|FG000|Overall Study|Lack of Efficacy|2|||
157246245|NCT00562718|567645022|FG000|Overall Study|not stated|1|||
157246246|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
157246247|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
157246248|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
157246249|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
157246250|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
157246251|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
157246252|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
157246253|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
157246254|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
157246255|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
157246256|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
157246257|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
157246258|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
157246259|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
157246260|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
157246261|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
157246262|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
157246263|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
157246264|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
157246265|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
157246266|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
157246267|NCT02227238|567645023|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
157246268|NCT02227238|567645024|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
157246269|NCT02227238|567645025|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
157246270|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
157246271|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
157246272|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
157246273|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
157246274|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
157246275|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
157246276|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
157246277|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
157246278|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
157246279|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
157246280|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
157246281|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
157246282|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
157246283|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
157246284|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
157246285|NCT02227238|567645023|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
157246286|NCT02227238|567645024|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
157246287|NCT02227238|567645025|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
157246288|NCT01507662|567645030|FG000|Overall Study|Death|26|||
157246289|NCT01507662|567645031|FG001|Overall Study|Death|18|||
157246290|NCT01507662|567645030|FG000|Overall Study|Withdrawal by Subject|290|||
157246291|NCT01507662|567645031|FG001|Overall Study|Withdrawal by Subject|287|||
157246292|NCT01507662|567645030|FG000|Overall Study|Lost to Follow-up|498|||
157246293|NCT01507662|567645031|FG001|Overall Study|Lost to Follow-up|523|||
157246294|NCT01507662|567645030|FG000|Overall Study|Proxy interview done|2|||
157246295|NCT01507662|567645031|FG001|Overall Study|Proxy interview done|3|||
157246296|NCT01663896|567645036|FG000|Overall Study|Various reasons|43|||
157246297|NCT05412121|567645041|FG000|Overall Study|Withdrawal by Subject|4|||
157246298|NCT05412121|567645041|FG000|Overall Study|Physician Decision|1|||
157246299|NCT05412121|567645041|FG000|Overall Study|Lost to Follow-up|5|||
157246300|NCT01962298|567645042|FG000|Overall Study|Protocol Violation|1|||
157246301|NCT01962298|567645043|FG001|Overall Study|Protocol Violation|0|||
157246302|NCT01962298|567645044|FG002|Overall Study|Protocol Violation|1|||
157246303|NCT01962298|567645045|FG003|Overall Study|Protocol Violation|1|||
157246304|NCT01962298|567645046|FG004|Overall Study|Protocol Violation|0|||
157246305|NCT01962298|567645042|FG000|Overall Study|Data quality insufficient|2|||
157246306|NCT01962298|567645043|FG001|Overall Study|Data quality insufficient|0|||
157246307|NCT01962298|567645044|FG002|Overall Study|Data quality insufficient|3|||
157246308|NCT01962298|567645045|FG003|Overall Study|Data quality insufficient|1|||
157246309|NCT01962298|567645046|FG004|Overall Study|Data quality insufficient|4|||
157246310|NCT01962298|567645042|FG000|Overall Study|Insufficient data|0|||
157246311|NCT01962298|567645043|FG001|Overall Study|Insufficient data|2|||
157246312|NCT01962298|567645044|FG002|Overall Study|Insufficient data|1|||
157246313|NCT01962298|567645045|FG003|Overall Study|Insufficient data|0|||
157246314|NCT01962298|567645046|FG004|Overall Study|Insufficient data|1|||
157246315|NCT01962298|567645042|FG000|Overall Study|Incorrect data recorded|0|||
157246316|NCT01962298|567645043|FG001|Overall Study|Incorrect data recorded|1|||
157246317|NCT01962298|567645044|FG002|Overall Study|Incorrect data recorded|0|||
157246318|NCT01962298|567645045|FG003|Overall Study|Incorrect data recorded|0|||
157246319|NCT01962298|567645046|FG004|Overall Study|Incorrect data recorded|0|||
157246320|NCT01962298|567645042|FG000|Overall Study|Physician Decision|0|||
157205007|NCT00564486|567496024|FG001|Overall Study|Withdrawal by Subject|0|||
157205008|NCT00564486|567496025|FG002|Overall Study|Withdrawal by Subject|0|||
157205009|NCT00564486|567496026|FG003|Overall Study|Withdrawal by Subject|5|||
157205010|NCT00564486|567496023|FG000|Overall Study|Subject refused to have blood drawn|0|||
157205011|NCT00564486|567496024|FG001|Overall Study|Subject refused to have blood drawn|0|||
157205012|NCT00564486|567496025|FG002|Overall Study|Subject refused to have blood drawn|1|||
157205013|NCT00564486|567496026|FG003|Overall Study|Subject refused to have blood drawn|0|||
157205014|NCT00564486|567496023|FG000|Overall Study|Lost to Follow-up|3|||
157205015|NCT00564486|567496024|FG001|Overall Study|Lost to Follow-up|0|||
157205016|NCT00564486|567496025|FG002|Overall Study|Lost to Follow-up|2|||
157205017|NCT00564486|567496026|FG003|Overall Study|Lost to Follow-up|2|||
157205018|NCT03387423|567496027|FG000|Overall Study|Lost to Follow-up|16|||
157205019|NCT03387423|567496028|FG001|Overall Study|Lost to Follow-up|12|||
157205020|NCT03387423|567496029|FG002|Overall Study|Lost to Follow-up|1|||
157205021|NCT03387423|567496030|FG003|Overall Study|Lost to Follow-up|0|||
157205022|NCT03387423|567496027|FG000|Overall Study|Other|0|||
157205023|NCT03387423|567496028|FG001|Overall Study|Other|3|||
157205024|NCT03387423|567496029|FG002|Overall Study|Other|0|||
157205025|NCT03387423|567496030|FG003|Overall Study|Other|0|||
157205026|NCT03387423|567496027|FG000|Overall Study|Administrative Reason|166|||
157205027|NCT03387423|567496028|FG001|Overall Study|Administrative Reason|89|||
157205028|NCT03387423|567496029|FG002|Overall Study|Administrative Reason|17|||
157205029|NCT03387423|567496030|FG003|Overall Study|Administrative Reason|19|||
157205030|NCT03387423|567496027|FG000|Overall Study|Revocation Consent|76|||
157246321|NCT01962298|567645043|FG001|Overall Study|Physician Decision|1|||
157246322|NCT01962298|567645044|FG002|Overall Study|Physician Decision|0|||
157246323|NCT01962298|567645045|FG003|Overall Study|Physician Decision|0|||
157246324|NCT01962298|567645046|FG004|Overall Study|Physician Decision|1|||
157246325|NCT04476277|567645047|FG000|Overall Study|Withdrawal by Subject|0|||
157246326|NCT04476277|567645048|FG001|Overall Study|Withdrawal by Subject|0|||
157246327|NCT04476277|567645049|FG002|Overall Study|Withdrawal by Subject|1|||
157246328|NCT04476277|567645050|FG003|Overall Study|Withdrawal by Subject|0|||
157205031|NCT03387423|567496028|FG001|Overall Study|Revocation Consent|32|||
157205032|NCT03387423|567496029|FG002|Overall Study|Revocation Consent|3|||
157205033|NCT03387423|567496030|FG003|Overall Study|Revocation Consent|5|||
157205034|NCT00798707|567496039|FG000|Overall Study|Adverse Event|6|||
157205035|NCT00798707|567496040|FG001|Overall Study|Adverse Event|8|||
157205036|NCT00798707|567496041|FG002|Overall Study|Adverse Event|8|||
157205037|NCT00798707|567496039|FG000|Overall Study|Failed to return|2|||
157205038|NCT00798707|567496040|FG001|Overall Study|Failed to return|2|||
157205039|NCT00798707|567496041|FG002|Overall Study|Failed to return|0|||
157205040|NCT00798707|567496039|FG000|Overall Study|Investigator|0|||
157205041|NCT00798707|567496040|FG001|Overall Study|Investigator|1|||
157205042|NCT00798707|567496041|FG002|Overall Study|Investigator|2|||
157205043|NCT00798707|567496039|FG000|Overall Study|Lack of Efficacy|2|||
157205044|NCT00798707|567496040|FG001|Overall Study|Lack of Efficacy|2|||
157205045|NCT00798707|567496041|FG002|Overall Study|Lack of Efficacy|1|||
157205046|NCT00798707|567496039|FG000|Overall Study|Lost to Follow-up|5|||
157205047|NCT00798707|567496040|FG001|Overall Study|Lost to Follow-up|6|||
157205048|NCT00798707|567496041|FG002|Overall Study|Lost to Follow-up|6|||
157205049|NCT00798707|567496039|FG000|Overall Study|Other|0|||
157205050|NCT00798707|567496040|FG001|Overall Study|Other|1|||
157205051|NCT00798707|567496041|FG002|Overall Study|Other|0|||
157205052|NCT00798707|567496039|FG000|Overall Study|Protocol Violation|4|||
157205053|NCT00798707|567496040|FG001|Overall Study|Protocol Violation|0|||
157205054|NCT00798707|567496041|FG002|Overall Study|Protocol Violation|2|||
157205055|NCT00798707|567496039|FG000|Overall Study|Withdrawal by Subject|3|||
157205056|NCT00798707|567496040|FG001|Overall Study|Withdrawal by Subject|8|||
157205057|NCT00798707|567496041|FG002|Overall Study|Withdrawal by Subject|2|||
157205058|NCT00798707|567496039|FG000|Overall Study|Randomized not treated|4|||
157205059|NCT00798707|567496040|FG001|Overall Study|Randomized not treated|5|||
157205060|NCT00798707|567496041|FG002|Overall Study|Randomized not treated|1|||
157205061|NCT01473589|567496042|FG000|Overall Study|Adverse Event|1|||
157205062|NCT01473589|567496043|FG001|Overall Study|Adverse Event|1|||
157205063|NCT01473589|567496042|FG000|Overall Study|Death|2|||
157205064|NCT01473589|567496043|FG001|Overall Study|Death|0|||
157205065|NCT01473589|567496042|FG000|Overall Study|Lost to Follow-up|2|||
157205066|NCT01473589|567496043|FG001|Overall Study|Lost to Follow-up|2|||
157205067|NCT01473589|567496042|FG000|Overall Study|Protocol Violation|1|||
157205068|NCT01473589|567496043|FG001|Overall Study|Protocol Violation|0|||
157205069|NCT01473589|567496042|FG000|Overall Study|Withdrawal by Subject|5|||
157205070|NCT01473589|567496043|FG001|Overall Study|Withdrawal by Subject|11|||
157205071|NCT01473589|567496042|FG000|Overall Study|Physician Decision|0|||
157205072|NCT01473589|567496043|FG001|Overall Study|Physician Decision|1|||
157205073|NCT01473589|567496042|FG000|Overall Study|Entry criteria not met|0|||
157205074|NCT01473589|567496043|FG001|Overall Study|Entry criteria not met|1|||
157205075|NCT03457727|567496045|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
157205076|NCT03457727|567496046|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
157205077|NCT03457727|567496047|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
157205078|NCT03457727|567496048|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
157205079|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
157205080|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
157205081|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
157205082|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
157205083|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
157205084|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
157205085|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
157205086|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
157205087|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
157205088|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
157205089|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
157205090|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
157205091|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
157205092|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
157205093|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
157205094|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
157205095|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
157205096|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
157205097|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
157205098|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
157205099|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
157205100|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
157205101|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
157205102|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
157205103|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
157205104|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
157205105|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
157205106|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
157205107|NCT01299272|567496051|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
157205108|NCT01299272|567496052|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
157205109|NCT01299272|567496053|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
157205110|NCT01299272|567496054|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
157205111|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
157205112|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
157205113|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
157205114|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
157205115|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
157205116|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
157205117|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
157205118|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
157205119|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
157205120|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
157205121|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
157205122|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
157205123|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
157205124|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
157205125|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
157205126|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
157205127|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
157205128|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
157205129|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
157205130|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
157205131|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
157205132|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
157205133|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
157205134|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
157205135|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
157205136|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
157205137|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
157205138|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
157205139|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
157205140|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
157205141|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
157205142|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
157205143|NCT01299272|567496051|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
157205144|NCT01299272|567496052|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
157205145|NCT01299272|567496053|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
157205146|NCT01299272|567496054|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
157205147|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
157205148|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
157205149|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
157205150|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
157205151|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
157205152|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
157205153|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
157205154|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
157205155|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
157205156|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
157205157|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
157205158|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
157205159|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
157205160|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
157205161|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
157205162|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
157205163|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
157205164|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
157205165|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
157205166|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
157205167|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
157205168|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
157205169|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
157205170|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
157205171|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
157246329|NCT01576705|567645051|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
157246330|NCT01576705|567645052|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
157246331|NCT01576705|567645053|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
157246332|NCT01576705|567645054|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
157246333|NCT01576705|567645051|FG000|Overall Study|invalid ICF|0|||
157246334|NCT01576705|567645052|FG001|Overall Study|invalid ICF|1|||
157246335|NCT01576705|567645053|FG002|Overall Study|invalid ICF|0|||
157246336|NCT01576705|567645054|FG003|Overall Study|invalid ICF|0|||
157246337|NCT03727139|567645055|FG000|Overall Study|Protocol Violation|60|||
157246338|NCT00566722|567645056|FG000|Overall Study|Adverse Event|0|||
157246339|NCT00566722|567645057|FG001|Overall Study|Adverse Event|1|||
157246340|NCT00566722|567645058|FG002|Overall Study|Adverse Event|0|||
157246341|NCT00566722|567645056|FG000|Overall Study|Withdrawal by Subject|0|||
157246342|NCT00566722|567645057|FG001|Overall Study|Withdrawal by Subject|0|||
157246343|NCT00566722|567645058|FG002|Overall Study|Withdrawal by Subject|1|||
157246344|NCT00566722|567645056|FG000|Overall Study|Lost to Follow-up|1|||
157246345|NCT00566722|567645057|FG001|Overall Study|Lost to Follow-up|1|||
157246346|NCT00566722|567645058|FG002|Overall Study|Lost to Follow-up|1|||
157246347|NCT00566722|567645056|FG000|Overall Study|Lack of Efficacy|1|||
157246348|NCT00566722|567645057|FG001|Overall Study|Lack of Efficacy|2|||
157246349|NCT00566722|567645058|FG002|Overall Study|Lack of Efficacy|4|||
157246350|NCT00566722|567645056|FG000|Overall Study|Did not meet exclusion criteria|0|||
157246351|NCT00566722|567645057|FG001|Overall Study|Did not meet exclusion criteria|0|||
157246352|NCT00566722|567645058|FG002|Overall Study|Did not meet exclusion criteria|2|||
157246353|NCT00566722|567645056|FG000|Overall Study|Serious adverse event|0|||
157246354|NCT00566722|567645057|FG001|Overall Study|Serious adverse event|1|||
157246355|NCT00566722|567645058|FG002|Overall Study|Serious adverse event|0|||
157246356|NCT00566722|567645056|FG000|Overall Study|Noncompliant with drug administration|0|||
157246357|NCT00566722|567645057|FG001|Overall Study|Noncompliant with drug administration|0|||
157246358|NCT00566722|567645058|FG002|Overall Study|Noncompliant with drug administration|1|||
157246359|NCT00858403|567645059|FG000|Overall Study|Withdrawal by Subject|1|||
157205172|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
157205173|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
157205174|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
157205175|NCT01299272|567496051|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
157205176|NCT01299272|567496052|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
157205177|NCT01299272|567496053|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
157205178|NCT01299272|567496054|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
157205179|NCT00464308|567496055|FG000|Overall Study|Adverse Event|22|||
157205180|NCT00464308|567496056|FG001|Overall Study|Adverse Event|27|||
157205181|NCT00464308|567496057|FG002|Overall Study|Adverse Event|16|||
157205182|NCT00464308|567496055|FG000|Overall Study|Lost to Follow-up|29|||
157205183|NCT00464308|567496056|FG001|Overall Study|Lost to Follow-up|19|||
157205184|NCT00464308|567496057|FG002|Overall Study|Lost to Follow-up|20|||
157205185|NCT00464308|567496055|FG000|Overall Study|Patient discontinued and other reasons|17|||
157246360|NCT00858403|567645059|FG000|Overall Study|Death|3|||
157246361|NCT00858403|567645059|FG000|Overall Study|Disease Progression|1|||
157246362|NCT02264977|567645060|FG000|Overall Study|Death|3|||
157246363|NCT02264977|567645060|FG000|Overall Study|Physician Decision|1|||
157246364|NCT02264977|567645060|FG000|Overall Study|Refuse to return|1|||
157246365|NCT03573544|567645061|FG000|Overall Study|Adverse Event|0|||
157246366|NCT03573544|567645062|FG001|Overall Study|Adverse Event|0|||
157246367|NCT03573544|567645063|FG002|Overall Study|Adverse Event|0|||
157246368|NCT03573544|567645064|FG003|Overall Study|Adverse Event|3|||
157246369|NCT03573544|567645065|FG004|Overall Study|Adverse Event|1|||
157246370|NCT03573544|567645066|FG005|Overall Study|Adverse Event|0|||
157246371|NCT03573544|567645067|FG006|Overall Study|Adverse Event|2|||
157246372|NCT03573544|567645068|FG007|Overall Study|Adverse Event|0|||
157246373|NCT03573544|567645061|FG000|Overall Study|Physician Decision|0|||
157246374|NCT03573544|567645062|FG001|Overall Study|Physician Decision|0|||
157246375|NCT03573544|567645063|FG002|Overall Study|Physician Decision|0|||
157246376|NCT03573544|567645064|FG003|Overall Study|Physician Decision|0|||
157246377|NCT03573544|567645065|FG004|Overall Study|Physician Decision|0|||
157246378|NCT03573544|567645066|FG005|Overall Study|Physician Decision|0|||
157246379|NCT03573544|567645067|FG006|Overall Study|Physician Decision|1|||
157246380|NCT03573544|567645068|FG007|Overall Study|Physician Decision|0|||
157246381|NCT03573544|567645061|FG000|Overall Study|Withdrawal by Subject|2|||
157246382|NCT03573544|567645062|FG001|Overall Study|Withdrawal by Subject|0|||
157246383|NCT03573544|567645063|FG002|Overall Study|Withdrawal by Subject|0|||
157246384|NCT03573544|567645064|FG003|Overall Study|Withdrawal by Subject|1|||
157246385|NCT03573544|567645065|FG004|Overall Study|Withdrawal by Subject|1|||
157246386|NCT03573544|567645066|FG005|Overall Study|Withdrawal by Subject|1|||
157246387|NCT03573544|567645067|FG006|Overall Study|Withdrawal by Subject|0|||
157246388|NCT03573544|567645068|FG007|Overall Study|Withdrawal by Subject|1|||
157246389|NCT03573544|567645061|FG000|Overall Study|Disease progression|3|||
157246390|NCT03573544|567645062|FG001|Overall Study|Disease progression|3|||
157246391|NCT03573544|567645063|FG002|Overall Study|Disease progression|6|||
157246392|NCT03573544|567645064|FG003|Overall Study|Disease progression|4|||
157246393|NCT03573544|567645065|FG004|Overall Study|Disease progression|5|||
157246394|NCT03573544|567645066|FG005|Overall Study|Disease progression|7|||
157246395|NCT03573544|567645067|FG006|Overall Study|Disease progression|6|||
157246396|NCT03573544|567645068|FG007|Overall Study|Disease progression|7|||
157246397|NCT03961204|567645069|FG000|Overall Study|Withdrawal by Subject|2|||
157246398|NCT03961204|567645069|FG000|Overall Study|Lost to Follow-up|3|||
157246399|NCT03961204|567645069|FG000|Overall Study|Other|1|||
157246400|NCT03961204|567645069|FG000|Overall Study|Missing|1|||
157246401|NCT01401062|567645076|FG000|Overall Study|Death|9|||
157246402|NCT01401062|567645077|FG001|Overall Study|Death|7|||
157246403|NCT01401062|567645076|FG000|Overall Study|Physician Decision|1|||
157246404|NCT01401062|567645077|FG001|Overall Study|Physician Decision|0|||
157246405|NCT01401062|567645076|FG000|Overall Study|Withdrawal by Subject|1|||
157246406|NCT01401062|567645077|FG001|Overall Study|Withdrawal by Subject|1|||
157246407|NCT01131260|567645078|FG000|Overall Study|Randomization error|5|||
157246408|NCT01131260|567645079|FG001|Overall Study|Randomization error|1|||
157246409|NCT01131260|567645078|FG000|Overall Study|Declined to continue participation|8|||
157246410|NCT01131260|567645079|FG001|Overall Study|Declined to continue participation|13|||
157246411|NCT01131260|567645078|FG000|Overall Study|Physician Decision|22|||
157246412|NCT01131260|567645079|FG001|Overall Study|Physician Decision|24|||
157246413|NCT01131260|567645078|FG000|Overall Study|Technical problems|7|||
157246414|NCT01131260|567645079|FG001|Overall Study|Technical problems|6|||
157246415|NCT01131260|567645078|FG000|Overall Study|Staff error|2|||
157246416|NCT01131260|567645079|FG001|Overall Study|Staff error|1|||
157246417|NCT01131260|567645078|FG000|Overall Study|Ineligible|0|||
157246418|NCT01131260|567645079|FG001|Overall Study|Ineligible|2|||
157246419|NCT01018862|567645082|FG000|Overall Study|Adverse Event|2|||
157246420|NCT01018862|567645083|FG001|Overall Study|Adverse Event|0|||
157246421|NCT01018862|567645084|FG002|Overall Study|Adverse Event|6|||
157246422|NCT01018862|567645082|FG000|Overall Study|Lack of Efficacy|1|||
157246423|NCT01018862|567645083|FG001|Overall Study|Lack of Efficacy|0|||
157246424|NCT01018862|567645084|FG002|Overall Study|Lack of Efficacy|2|||
157246425|NCT01018862|567645082|FG000|Overall Study|Lost to Follow-up|3|||
157246426|NCT01018862|567645083|FG001|Overall Study|Lost to Follow-up|1|||
157246427|NCT01018862|567645084|FG002|Overall Study|Lost to Follow-up|0|||
157246428|NCT01018862|567645082|FG000|Overall Study|Protocol Violation|1|||
157246429|NCT01018862|567645083|FG001|Overall Study|Protocol Violation|3|||
157246430|NCT01018862|567645084|FG002|Overall Study|Protocol Violation|3|||
157246431|NCT01018862|567645082|FG000|Overall Study|Withdrawal by Subject|1|||
157246432|NCT01018862|567645083|FG001|Overall Study|Withdrawal by Subject|2|||
157246433|NCT01018862|567645084|FG002|Overall Study|Withdrawal by Subject|1|||
157246434|NCT01018862|567645082|FG000|Overall Study|administrative problems|5|||
157246435|NCT01018862|567645083|FG001|Overall Study|administrative problems|4|||
157246436|NCT01018862|567645084|FG002|Overall Study|administrative problems|4|||
157246437|NCT01968031|567645088|FG000|Overall Study|Adverse Event|13|||
157246438|NCT01968031|567645089|FG001|Overall Study|Adverse Event|10|||
157246439|NCT01968031|567645090|FG002|Overall Study|Adverse Event|22|||
157246440|NCT01968031|567645088|FG000|Overall Study|Withdrawal by Subject|3|||
157246441|NCT01968031|567645089|FG001|Overall Study|Withdrawal by Subject|7|||
157246442|NCT01968031|567645090|FG002|Overall Study|Withdrawal by Subject|3|||
157246443|NCT01968031|567645088|FG000|Overall Study|Did not meet entry criteria|1|||
157246444|NCT01968031|567645089|FG001|Overall Study|Did not meet entry criteria|1|||
157246445|NCT01968031|567645090|FG002|Overall Study|Did not meet entry criteria|1|||
157246446|NCT01968031|567645088|FG000|Overall Study|Noncompliance|0|||
157246447|NCT01968031|567645089|FG001|Overall Study|Noncompliance|0|||
157246448|NCT01968031|567645090|FG002|Overall Study|Noncompliance|2|||
157246449|NCT01968031|567645088|FG000|Overall Study|Failed inclusion criteria|0|||
157246450|NCT01968031|567645089|FG001|Overall Study|Failed inclusion criteria|2|||
157246451|NCT01968031|567645090|FG002|Overall Study|Failed inclusion criteria|0|||
157246452|NCT01968031|567645088|FG000|Overall Study|Death|0|||
157246453|NCT01968031|567645089|FG001|Overall Study|Death|0|||
157246454|NCT01968031|567645090|FG002|Overall Study|Death|1|||
157246455|NCT01968031|567645088|FG000|Overall Study|Prohibited concomitant medication|1|||
157246456|NCT01968031|567645089|FG001|Overall Study|Prohibited concomitant medication|0|||
157246457|NCT01968031|567645090|FG002|Overall Study|Prohibited concomitant medication|0|||
157246458|NCT00840879|567645091|FG000|Second Intervention|Withdrawal by Subject|1|||
157246459|NCT00840879|567645092|FG001|Second Intervention|Withdrawal by Subject|0|||
157246460|NCT04573309|567646696|FG000|Overall Study|Protocol Violation|1|||
157246461|NCT04573309|567646697|FG001|Overall Study|Protocol Violation|0|||
157246462|NCT01691430|567646698|FG000|Overall Study|Death|17|||
157246463|NCT01691430|567646699|FG001|Overall Study|Death|16|||
157246464|NCT01691430|567646698|FG000|Overall Study|Withdrawal by Subject|5|||
157246465|NCT01691430|567646699|FG001|Overall Study|Withdrawal by Subject|1|||
157246466|NCT01691430|567646698|FG000|Overall Study|Lost to Follow-up|0|||
157246467|NCT01691430|567646699|FG001|Overall Study|Lost to Follow-up|3|||
157246468|NCT01894230|567646700|FG000|Overall Study|Lost to Follow-up|2|||
157246469|NCT01894230|567646701|FG001|Overall Study|Lost to Follow-up|2|||
157246470|NCT01894230|567646700|FG000|Overall Study|Withdrawal by Subject|4|||
157246471|NCT01894230|567646701|FG001|Overall Study|Withdrawal by Subject|4|||
157246472|NCT01894230|567646700|FG000|Overall Study|Non-adherent|0|||
157246473|NCT01894230|567646701|FG001|Overall Study|Non-adherent|1|||
157246474|NCT01894230|567646700|FG000|Overall Study|Death|1|||
157246475|NCT01894230|567646701|FG001|Overall Study|Death|0|||
157246476|NCT00642993|567646702|FG000|Overall Study|Adverse Event|85|||
157246477|NCT00642993|567646703|FG001|Overall Study|Adverse Event|4|||
157246478|NCT00642993|567646702|FG000|Overall Study|Lost to Follow-up|8|||
157246479|NCT00642993|567646703|FG001|Overall Study|Lost to Follow-up|4|||
157246480|NCT00642993|567646702|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
157246481|NCT00642993|567646703|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
157246482|NCT00642993|567646702|FG000|Overall Study|Protocol Violation|1|||
157246483|NCT00642993|567646703|FG001|Overall Study|Protocol Violation|4|||
157246484|NCT00642993|567646702|FG000|Overall Study|Did not meet protocol eligibility|0|||
157246485|NCT00642993|567646703|FG001|Overall Study|Did not meet protocol eligibility|1|||
157246486|NCT00642993|567646702|FG000|Overall Study|Administrative|1|||
157246487|NCT00642993|567646703|FG001|Overall Study|Administrative|0|||
157246488|NCT00757705|567646704|FG000|Overall Study|Adverse Event|19|||
157246489|NCT00757705|567646704|FG000|Overall Study|Lost to Follow-up|16|||
157246490|NCT00757705|567646704|FG000|Overall Study|Withdrawal by Subject|25|||
157246491|NCT00757705|567646704|FG000|Overall Study|Insufficient Response|26|||
157246492|NCT00757705|567646704|FG000|Overall Study|Ineligible to continue|8|||
157246493|NCT00757705|567646704|FG000|Overall Study|Non-compliant|9|||
157246494|NCT00757705|567646704|FG000|Overall Study|Other|18|||
157246495|NCT02651987|567646705|FG000|Overall Study|Adverse Event|2|||
157246496|NCT02651987|567646706|FG001|Overall Study|Adverse Event|2|||
157246497|NCT02651987|567646705|FG000|Overall Study|Consent Withdrawn|2|||
157246498|NCT02651987|567646706|FG001|Overall Study|Consent Withdrawn|0|||
157246499|NCT02651987|567646705|FG000|Overall Study|Local PD|0|||
157246500|NCT02651987|567646706|FG001|Overall Study|Local PD|2|||
157246501|NCT02651987|567646705|FG000|Overall Study|Investigator Decision|1|||
157246502|NCT02651987|567646706|FG001|Overall Study|Investigator Decision|1|||
157246503|NCT00856349|567646707|FG000|Overall Study|Death|418|||
157246504|NCT00856349|567646707|FG000|Overall Study|Withdrawal by Subject|116|||
157246505|NCT00856349|567646707|FG000|Overall Study|Lost to Follow-up|91|||
157246506|NCT00856349|567646707|FG000|Overall Study|Protocol Violation|38|||
157246507|NCT00856349|567646707|FG000|Overall Study|Physician Decision|13|||
157246508|NCT00856349|567646707|FG000|Overall Study|Subject relocation|104|||
157246509|NCT00856349|567646707|FG000|Overall Study|Device explant|33|||
157246510|NCT00856349|567646707|FG000|Overall Study|Site closure|78|||
157246511|NCT00856349|567646707|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
157246512|NCT00687739|567646708|FG000|Overall Study|Lost to Follow-up|2|||
157246513|NCT00687739|567646709|FG001|Overall Study|Lost to Follow-up|2|||
157246514|NCT00687739|567646710|FG002|Overall Study|Lost to Follow-up|1|||
157246515|NCT00687739|567646711|FG003|Overall Study|Lost to Follow-up|2|||
157246516|NCT00687739|567646708|FG000|Overall Study|Adverse Event|0|||
157246517|NCT00687739|567646709|FG001|Overall Study|Adverse Event|1|||
157246518|NCT00687739|567646710|FG002|Overall Study|Adverse Event|1|||
157246519|NCT00687739|567646711|FG003|Overall Study|Adverse Event|0|||
157246520|NCT03599362|567646716|FG000|Overall Study|Screen Failure|3|||
157246521|NCT01923740|567646717|FG000|Overall Study|Lost to Follow-up|4|||
157246522|NCT01923740|567646718|FG001|Overall Study|Lost to Follow-up|9|||
157246523|NCT01923740|567646717|FG000|Overall Study|Withdrawal by Subject|2|||
157246524|NCT01923740|567646718|FG001|Overall Study|Withdrawal by Subject|0|||
157246525|NCT03707587|567646719|FG000|Overall Study|Death|0|||
157246526|NCT03707587|567646720|FG001|Overall Study|Death|1|||
157246527|NCT00834444|567646721|FG000|First Intervention|Adverse Event|1|||
157246528|NCT00834444|567646722|FG001|First Intervention|Adverse Event|0|||
157246529|NCT00834444|567646721|FG000|First Intervention|Intolerance to Venopuncture|0|||
157246530|NCT00834444|567646722|FG001|First Intervention|Intolerance to Venopuncture|1|||
157246531|NCT00834444|567646721|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
157246532|NCT00834444|567646722|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
157246533|NCT00834444|567646721|FG000|Second Intervention|Adverse Event|1|||
157246534|NCT00834444|567646722|FG001|Second Intervention|Adverse Event|0|||
157246535|NCT02072096|567646725|FG000|Overall Study|Lack of Efficacy|18|||
157246536|NCT02072096|567646726|FG001|Overall Study|Lack of Efficacy|29|||
157246537|NCT02072096|567646725|FG000|Overall Study|Protocol Violation|7|||
157246538|NCT02072096|567646726|FG001|Overall Study|Protocol Violation|7|||
157246539|NCT02072096|567646725|FG000|Overall Study|Withdrawal by Subject|5|||
157246540|NCT02072096|567646726|FG001|Overall Study|Withdrawal by Subject|7|||
157246541|NCT02072096|567646725|FG000|Overall Study|Adverse Event|5|||
157246542|NCT02072096|567646726|FG001|Overall Study|Adverse Event|2|||
157246543|NCT02072096|567646725|FG000|Overall Study|No Reason Provided|4|||
157246544|NCT02072096|567646726|FG001|Overall Study|No Reason Provided|2|||
157246545|NCT02072096|567646725|FG000|Overall Study|Death|2|||
157246546|NCT02072096|567646726|FG001|Overall Study|Death|0|||
157246547|NCT02072096|567646725|FG000|Overall Study|Physician Decision|0|||
157246548|NCT02072096|567646726|FG001|Overall Study|Physician Decision|1|||
157246549|NCT02072096|567646725|FG000|Overall Study|Study Terminated by Sponsor|43|||
157246550|NCT02072096|567646726|FG001|Overall Study|Study Terminated by Sponsor|30|||
157246551|NCT02072096|567646725|FG000|Overall Study|Lost to Follow-up|1|||
157246552|NCT02072096|567646726|FG001|Overall Study|Lost to Follow-up|0|||
157246553|NCT03158727|567646727|FG000|Overall Study|Withdrawal by Subject|2|||
157246554|NCT03158727|567646728|FG001|Overall Study|Withdrawal by Subject|6|||
157246555|NCT03158727|567646727|FG000|Overall Study|Death|11|||
157246556|NCT03158727|567646728|FG001|Overall Study|Death|12|||
157246557|NCT03158727|567646727|FG000|Overall Study|Lost to Follow-up|1|||
157246558|NCT03158727|567646728|FG001|Overall Study|Lost to Follow-up|0|||
157246559|NCT03158727|567646727|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
157246560|NCT03158727|567646728|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
157246561|NCT03158727|567646727|FG000|Overall Study|Visit 11 not done by mistake|0|||
157246562|NCT03158727|567646728|FG001|Overall Study|Visit 11 not done by mistake|1|||
157246563|NCT03158727|567646727|FG000|Overall Study|Enrolled, not treated|1|||
157246564|NCT03158727|567646728|FG001|Overall Study|Enrolled, not treated|0|||
157246565|NCT01634139|567646729|FG000|Overall Study|Non compliant with protocol|1|||
157246566|NCT01634139|567646730|FG001|Overall Study|Non compliant with protocol|0|||
157246567|NCT01634139|567646731|FG002|Overall Study|Non compliant with protocol|0|||
157246568|NCT01634139|567646729|FG000|Overall Study|Consent withdrawn not due to AE|4|||
157246569|NCT01634139|567646730|FG001|Overall Study|Consent withdrawn not due to AE|3|||
157246570|NCT01634139|567646731|FG002|Overall Study|Consent withdrawn not due to AE|2|||
157246571|NCT01634139|567646729|FG000|Overall Study|Other|4|||
157246572|NCT01634139|567646730|FG001|Overall Study|Other|0|||
157246573|NCT01634139|567646731|FG002|Overall Study|Other|3|||
157246574|NCT01634139|567646729|FG000|Overall Study|Lost to Follow-up|0|||
157246575|NCT01634139|567646730|FG001|Overall Study|Lost to Follow-up|2|||
157246576|NCT01634139|567646731|FG002|Overall Study|Lost to Follow-up|0|||
157246577|NCT01634139|567646729|FG000|Overall Study|Not treated|1|||
157246578|NCT01634139|567646730|FG001|Overall Study|Not treated|1|||
157246579|NCT01634139|567646731|FG002|Overall Study|Not treated|0|||
157246580|NCT02336074|567646747|FG000|Overall Study|Adverse Event|0|||
157246581|NCT02336074|567646748|FG001|Overall Study|Adverse Event|2|||
157246582|NCT00958724|567646749|FG000|Overall Study|Disease Progression|6|||
157246583|NCT02121184|567646751|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
157246584|NCT02121184|567646752|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
157246585|NCT02121184|567646751|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
157246586|NCT02121184|567646752|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
157246587|NCT02121184|567646751|FG000|Overall Study|Emergency cesarean section required|0|||
157246588|NCT02121184|567646752|FG001|Overall Study|Emergency cesarean section required|2|||
157246589|NCT02121184|567646751|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
157246590|NCT02121184|567646752|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
157246591|NCT04567329|567646758|FG000|Overall Study|Withdrawal by Subject|5|||
157246592|NCT04567329|567646759|FG001|Overall Study|Withdrawal by Subject|6|||
157246593|NCT04567329|567646758|FG000|Overall Study|Protocol Violation|2|||
157246594|NCT04567329|567646759|FG001|Overall Study|Protocol Violation|3|||
157246595|NCT04567329|567646758|FG000|Overall Study|Discontinued|2|||
157246596|NCT04567329|567646759|FG001|Overall Study|Discontinued|2|||
157246597|NCT04567329|567646758|FG000|Overall Study|Lost to Follow-up|0|||
157246598|NCT04567329|567646759|FG001|Overall Study|Lost to Follow-up|1|||
157246599|NCT04567329|567646758|FG000|Overall Study|Lack of Efficacy|0|||
157246600|NCT04567329|567646759|FG001|Overall Study|Lack of Efficacy|1|||
157246601|NCT02933060|567646760|FG000|Overall Study|Withdrawal by Subject|0|||
157246602|NCT02933060|567646761|FG001|Overall Study|Withdrawal by Subject|1|||
157246603|NCT01945580|567646762|FG000|Overall Study|Withdrawal by Subject|13|||
157246604|NCT01945580|567646763|FG001|Overall Study|Withdrawal by Subject|35|||
157246605|NCT01945580|567646762|FG000|Overall Study|Physician Decision|3|||
157246606|NCT01945580|567646763|FG001|Overall Study|Physician Decision|2|||
157246607|NCT01945580|567646762|FG000|Overall Study|Lost to Follow-up|26|||
157246608|NCT01945580|567646763|FG001|Overall Study|Lost to Follow-up|39|||
157246609|NCT01945580|567646762|FG000|Overall Study|Death|7|||
157246610|NCT01945580|567646763|FG001|Overall Study|Death|2|||
157246611|NCT01945580|567646762|FG000|Overall Study|Patient moved out of state|0|||
157246612|NCT01945580|567646763|FG001|Overall Study|Patient moved out of state|1|||
157246613|NCT01945580|567646762|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
157246614|NCT01945580|567646763|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
157246615|NCT01945580|567646762|FG000|Overall Study|Family illness - unable to return|0|||
157246616|NCT01945580|567646763|FG001|Overall Study|Family illness - unable to return|1|||
157246617|NCT01945580|567646762|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
157246618|NCT01945580|567646763|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
157246619|NCT01945580|567646762|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
157246620|NCT01945580|567646763|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
157246621|NCT01945580|567646762|FG000|Overall Study|Noncompliance with 36 month visit|1|||
157246622|NCT01945580|567646763|FG001|Overall Study|Noncompliance with 36 month visit|0|||
157246623|NCT01945580|567646762|FG000|Overall Study|The patient moved.|1|||
157246624|NCT01945580|567646763|FG001|Overall Study|The patient moved.|0|||
157246625|NCT01945580|567646762|FG000|Overall Study|No data available|0|||
157246626|NCT01945580|567646763|FG001|Overall Study|No data available|2|||
157246627|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
157246628|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
157246629|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
157246630|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
157246631|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
157246632|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
157246633|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
157246634|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
157246635|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
157246636|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
157246637|NCT01438060|567646766|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
157246638|NCT01438060|567646767|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
157246639|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
157246640|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
157246641|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
157246642|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
157246643|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
157246644|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
157246645|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
157246646|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
157246647|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
157246648|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
157246649|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
157246650|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
157246651|NCT01438060|567646766|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
157246652|NCT01438060|567646767|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
157246653|NCT01438060|567646766|FG000|On Study Beyond Week 140|Adverse Event|0|||
157246654|NCT01438060|567646767|FG001|On Study Beyond Week 140|Adverse Event|2|||
157246655|NCT01438060|567646766|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
157246656|NCT01438060|567646767|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
157246657|NCT01438060|567646766|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
157246658|NCT01438060|567646767|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
157246659|NCT01438060|567646766|FG000|On Study Beyond Week 140|Death|0|||
157246660|NCT01438060|567646767|FG001|On Study Beyond Week 140|Death|1|||
157246661|NCT01438060|567646766|FG000|On Study Beyond Week 140|Other Reason|0|||
157246662|NCT01438060|567646767|FG001|On Study Beyond Week 140|Other Reason|3|||
157246663|NCT01964950|567646768|FG000|Overall Study|Protocol Violation|25|||
157246664|NCT03306277|567646769|FG000|Overall Study|Death|1|||
157246665|NCT03306277|567646769|FG000|Overall Study|Adverse Event|1|||
157246666|NCT03306277|567646769|FG000|Overall Study|Withdrawal by Subject|1|||
157246667|NCT00829452|567646773|FG000|First Intervention|Withdrawal by Subject|0|||
157246668|NCT00829452|567646774|FG001|First Intervention|Withdrawal by Subject|1|||
157246669|NCT00829452|567646773|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
157246670|NCT00829452|567646774|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
157246671|NCT00829452|567646773|FG000|Second Intervention|Physician Decision|0|||
157246672|NCT00829452|567646774|FG001|Second Intervention|Physician Decision|1|||
157246673|NCT01370863|567646781|FG000|Overall Study|Adverse Event|1|||
157246674|NCT01370863|567646782|FG001|Overall Study|Adverse Event|1|||
157246675|NCT01370863|567646781|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
157246676|NCT01370863|567646782|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
157246677|NCT01370863|567646781|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
157246678|NCT01370863|567646782|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
157246679|NCT00881751|567646785|FG000|Overall Study|Physician Decision|0|||
157246680|NCT00881751|567646786|FG001|Overall Study|Physician Decision|1|||
157246681|NCT00881751|567646785|FG000|Overall Study|Adverse Event|0|||
157246682|NCT00881751|567646786|FG001|Overall Study|Adverse Event|2|||
157246683|NCT00881751|567646785|FG000|Overall Study|Withdrawal by Subject|0|||
157246684|NCT00881751|567646786|FG001|Overall Study|Withdrawal by Subject|2|||
157246685|NCT03885934|567646793|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
157246686|NCT03885934|567646794|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
157246687|NCT03885934|567646795|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
157246688|NCT03885934|567646796|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
157246689|NCT03885934|567646797|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
157246690|NCT03885934|567646798|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
157246691|NCT04060251|567646799|FG000|Overall Study|Study terminated due to low enrollment.|7|||
157246692|NCT04060251|567646800|FG001|Overall Study|Study terminated due to low enrollment.|5|||
157246693|NCT04060251|567646801|FG002|Overall Study|Study terminated due to low enrollment.|7|||
157246694|NCT04060251|567646799|FG000|Overall Study|Adverse Event|1|||
157246695|NCT04060251|567646800|FG001|Overall Study|Adverse Event|1|||
157246696|NCT04060251|567646801|FG002|Overall Study|Adverse Event|0|||
157246697|NCT00999687|567646808|FG000|First Intervention|Withdrawal by Subject|1|||
157246698|NCT00999687|567646808|FG000|Second Intervention|Withdrawal by Subject|2|||
157246699|NCT00999687|567646808|FG000|Second Intervention|Lack of Efficacy|1|||
157246700|NCT00842309|567646811|FG000|Overall Study|Withdrawal by Subject|3|||
157246701|NCT00842309|567646812|FG001|Overall Study|Withdrawal by Subject|1|||
157246702|NCT03105297|567646813|FG000|Baseline Phase (Day 1)|Other|21|||
157246703|NCT03105297|567646813|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
157246704|NCT03105297|567646813|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
157246705|NCT01390948|567646814|FG000|Overall Study|End of Study|1|||
157246706|NCT01390948|567646815|FG001|Overall Study|End of Study|0|||
157246707|NCT01390948|567646816|FG002|Overall Study|End of Study|0|||
157246708|NCT01390948|567646814|FG000|Overall Study|Withdrew consent|2|||
157246709|NCT01390948|567646815|FG001|Overall Study|Withdrew consent|2|||
157246710|NCT01390948|567646816|FG002|Overall Study|Withdrew consent|0|||
157246711|NCT01390948|567646814|FG000|Overall Study|Progressive Disease|2|||
157246712|NCT01390948|567646815|FG001|Overall Study|Progressive Disease|5|||
157246713|NCT01390948|567646816|FG002|Overall Study|Progressive Disease|0|||
157246714|NCT01390948|567646814|FG000|Overall Study|Death during follow-up|10|||
157246715|NCT01390948|567646815|FG001|Overall Study|Death during follow-up|11|||
157246716|NCT01390948|567646816|FG002|Overall Study|Death during follow-up|1|||
157246717|NCT02218216|567646821|FG000|Overall Study|Study terminated before completed|6|||
157246718|NCT02218216|567646822|FG001|Overall Study|Study terminated before completed|0|||
157246719|NCT02218216|567646823|FG002|Overall Study|Study terminated before completed|0|||
157246720|NCT05740098|567646826|FG000|Overall Study|Lost to Follow-up|26|||
157246721|NCT05740098|567646827|FG001|Overall Study|Lost to Follow-up|17|||
157246722|NCT05740098|567646828|FG002|Overall Study|Lost to Follow-up|21|||
157246723|NCT03867760|567646829|FG000|Overall Study|Lost to Follow-up|2|||
157246724|NCT03867760|567646830|FG001|Overall Study|Lost to Follow-up|3|||
157246725|NCT03867760|567646829|FG000|Overall Study|Withdrawal by Subject|1|||
157246726|NCT03867760|567646830|FG001|Overall Study|Withdrawal by Subject|2|||
157246727|NCT03867760|567646829|FG000|Overall Study|subject could not meet study logistics|3|||
157246728|NCT03867760|567646830|FG001|Overall Study|subject could not meet study logistics|3|||
157246729|NCT03684928|567646834|FG000|First Intervention|Lost to Follow-up|0|||
157246730|NCT03684928|567646835|FG001|First Intervention|Lost to Follow-up|1|||
157246731|NCT03684928|567646834|FG000|First Intervention|Withdrawal by Subject|0|||
157246732|NCT03684928|567646835|FG001|First Intervention|Withdrawal by Subject|2|||
157246733|NCT03684928|567646834|FG000|Second Intervention|Soft Tissue Injury|1|||
157246734|NCT03684928|567646835|FG001|Second Intervention|Soft Tissue Injury|0|||
157246735|NCT02300987|567648252|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
157246736|NCT02300987|567648253|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
157246737|NCT02300987|567648252|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
157246738|NCT02300987|567648253|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
157246739|NCT02300987|567648252|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
157246740|NCT02300987|567648253|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
157246741|NCT02300987|567648252|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
157246742|NCT02300987|567648253|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
157246743|NCT02300987|567648252|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
157246744|NCT02300987|567648253|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
157246745|NCT02219009|567648254|FG000|Overall Study|Withdrawal by Subject|5|||
157246746|NCT02219009|567648255|FG001|Overall Study|Withdrawal by Subject|1|||
157246747|NCT02219009|567648254|FG000|Overall Study|Adverse Event|2|||
157246748|NCT02219009|567648255|FG001|Overall Study|Adverse Event|4|||
157246749|NCT02219009|567648254|FG000|Overall Study|Lost to Follow-up|2|||
157246750|NCT02219009|567648255|FG001|Overall Study|Lost to Follow-up|2|||
157246751|NCT02219009|567648254|FG000|Overall Study|Protocol deviation|1|||
157246752|NCT02219009|567648255|FG001|Overall Study|Protocol deviation|0|||
157246753|NCT02219009|567648254|FG000|Overall Study|Physician Decision|0|||
157246754|NCT02219009|567648255|FG001|Overall Study|Physician Decision|1|||
157246755|NCT02259348|567648256|FG000|Overall Study|Donors|6|||
157246756|NCT02259348|567648256|FG000|Overall Study|Death|4|||
157246757|NCT01622660|567648257|FG000|Overall Study|Adverse Event|1|||
157246758|NCT04211766|567648258|FG000|Overall Study|Withdrawal by Subject|5|||
157246759|NCT04211766|567648259|FG001|Overall Study|Withdrawal by Subject|1|||
157246760|NCT00960154|567648260|FG000|Overall Study|Study termination|25|||
157246761|NCT00960154|567648261|FG001|Overall Study|Study termination|25|||
157246762|NCT04408924|567648265|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
157246763|NCT04408924|567648265|FG000|Overall Study|Lost to Follow-up|3|||
157246764|NCT04408924|567648265|FG000|Overall Study|Withdrawal by Subject|5|||
157246765|NCT04408924|567648265|FG000|Overall Study|Sponsor Decision|2|||
157246766|NCT00486434|567648266|FG000|Overall Study|Withdrawal by Subject|34|||
157246767|NCT00486434|567648267|FG001|Overall Study|Withdrawal by Subject|39|||
157246768|NCT00486434|567648266|FG000|Overall Study|Adverse Event|118|||
157246769|NCT00486434|567648267|FG001|Overall Study|Adverse Event|44|||
157246770|NCT00486434|567648266|FG000|Overall Study|Protocol Violation|22|||
157246771|NCT00486434|567648267|FG001|Overall Study|Protocol Violation|21|||
157246772|NCT00486434|567648266|FG000|Overall Study|Lack of Efficacy|12|||
157246773|NCT00486434|567648267|FG001|Overall Study|Lack of Efficacy|19|||
157246774|NCT00486434|567648266|FG000|Overall Study|Lost to Follow-up|2|||
157246775|NCT00486434|567648267|FG001|Overall Study|Lost to Follow-up|3|||
157246776|NCT00486434|567648266|FG000|Overall Study|Death|1|||
157246777|NCT00486434|567648267|FG001|Overall Study|Death|2|||
157246778|NCT00486434|567648266|FG000|Overall Study|Personal reasons|5|||
157246779|NCT00486434|567648267|FG001|Overall Study|Personal reasons|6|||
157246780|NCT02218541|567648268|FG000|Overall Study|Lost to Follow-up|2|||
157246781|NCT02218541|567648269|FG001|Overall Study|Lost to Follow-up|1|||
157246782|NCT02218541|567648268|FG000|Overall Study|Implant Failure|4|||
157246783|NCT02218541|567648269|FG001|Overall Study|Implant Failure|1|||
157246784|NCT02578641|567648270|FG000|Overall Study|Adverse Event|5|||
157246785|NCT02578641|567648271|FG001|Overall Study|Adverse Event|15|||
157246786|NCT02578641|567648270|FG000|Overall Study|Death|16|||
157246787|NCT02578641|567648271|FG001|Overall Study|Death|8|||
157246788|NCT02578641|567648270|FG000|Overall Study|Lost to Follow-up|0|||
157246789|NCT02578641|567648271|FG001|Overall Study|Lost to Follow-up|1|||
157246790|NCT02578641|567648270|FG000|Overall Study|Withdrawal by Subject|14|||
157246791|NCT02578641|567648271|FG001|Overall Study|Withdrawal by Subject|7|||
157246792|NCT02578641|567648270|FG000|Overall Study|Progressive Disease|69|||
157246793|NCT02578641|567648271|FG001|Overall Study|Progressive Disease|21|||
157246794|NCT02578641|567648270|FG000|Overall Study|No Study Drug|2|||
157246795|NCT02578641|567648271|FG001|Overall Study|No Study Drug|0|||
157246796|NCT02578641|567648270|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
157246797|NCT02578641|567648271|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
157246798|NCT02578641|567648270|FG000|Overall Study|Non-compliance with Study Schedule|1|||
157246799|NCT02578641|567648271|FG001|Overall Study|Non-compliance with Study Schedule|0|||
157246800|NCT02578641|567648270|FG000|Overall Study|Other|1|||
157246801|NCT02578641|567648271|FG001|Overall Study|Other|10|||
157246802|NCT02578641|567648270|FG000|Overall Study|Not treated|1|||
157246803|NCT02578641|567648271|FG001|Overall Study|Not treated|4|||
157246804|NCT02694536|567648273|FG000|Overall Study|Progressive Disease|40|||
157246805|NCT02694536|567648273|FG000|Overall Study|Lost to Follow-up|1|||
157246806|NCT02694536|567648273|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
157246807|NCT02694536|567648273|FG000|Overall Study|Withdrawal by Subject|8|||
157246808|NCT02694536|567648273|FG000|Overall Study|Death|8|||
157246809|NCT02694536|567648273|FG000|Overall Study|Other|22|||
157246810|NCT01266902|567648279|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
157246811|NCT01266902|567648280|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
157246812|NCT01266902|567648281|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
157246813|NCT01266902|567648279|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
157246814|NCT01266902|567648280|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
157246815|NCT01266902|567648281|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
157246816|NCT01266902|567648279|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
157246817|NCT01266902|567648280|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
157246818|NCT01266902|567648281|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
157246819|NCT01266902|567648279|FG000|Period 1 (Main Study)|Adverse Event|3|||
157246820|NCT01266902|567648280|FG001|Period 1 (Main Study)|Adverse Event|11|||
157246821|NCT01266902|567648281|FG002|Period 1 (Main Study)|Adverse Event|0|||
157246822|NCT01266902|567648279|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
157246823|NCT01266902|567648280|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
157246824|NCT01266902|567648281|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
157246825|NCT01266902|567648279|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
157246826|NCT01266902|567648280|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
157246827|NCT01266902|567648281|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
157246828|NCT01266902|567648279|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
157246829|NCT01266902|567648280|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
157246830|NCT01266902|567648281|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
157246831|NCT01266902|567648279|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
157246832|NCT01266902|567648280|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
157246833|NCT01266902|567648281|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
157246834|NCT01266902|567648279|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
157246835|NCT01266902|567648280|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
157246836|NCT01266902|567648281|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
157246837|NCT01266902|567648279|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
157246838|NCT01266902|567648280|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
157246839|NCT01266902|567648281|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
157246840|NCT05562011|567648282|FG000|Overall Study|Withdrawal by Subject|3|||
157246841|NCT05562011|567648282|FG000|Overall Study|Lost to Follow-up|1|||
157248011|NCT02531126|567651775|FG002|Overall Study|Switched to commercial drug|4|||
157246842|NCT05562011|567648282|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
157246843|NCT05562011|567648282|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
157246844|NCT05562011|567648282|FG000|Overall Study|Device malfunction|13|||
157246845|NCT04411680|567648283|FG000|Treatment Period|Adverse Event|3|||
157246846|NCT04411680|567648284|FG001|Treatment Period|Adverse Event|0|||
157246847|NCT04411680|567648283|FG000|Treatment Period|Discharged from hospital|18|||
157246848|NCT04411680|567648284|FG001|Treatment Period|Discharged from hospital|7|||
157246849|NCT04411680|567648283|FG000|Treatment Period|Missed 1 or more doses|8|||
157246850|NCT04411680|567648284|FG001|Treatment Period|Missed 1 or more doses|0|||
157246851|NCT04411680|567648283|FG000|Treatment Period|Transferred to another hospital|0|||
157246852|NCT04411680|567648284|FG001|Treatment Period|Transferred to another hospital|1|||
157246853|NCT04411680|567648283|FG000|Follow up Period|Withdrawal by Subject|2|||
157246854|NCT04411680|567648284|FG001|Follow up Period|Withdrawal by Subject|0|||
157246855|NCT04411680|567648283|FG000|Follow up Period|Lost to Follow-up|5|||
157246856|NCT04411680|567648284|FG001|Follow up Period|Lost to Follow-up|6|||
157246857|NCT04411680|567648283|FG000|Follow up Period|Death|11|||
157246858|NCT04411680|567648284|FG001|Follow up Period|Death|8|||
157246859|NCT05034874|567648285|FG000|Overall Study|Withdrawal by Subject|6|||
157246860|NCT05034874|567648286|FG001|Overall Study|Withdrawal by Subject|6|||
157246861|NCT05034874|567648285|FG000|Overall Study|Lost to Follow-up|18|||
157246862|NCT05034874|567648286|FG001|Overall Study|Lost to Follow-up|8|||
157246863|NCT05034874|567648285|FG000|Overall Study|Physician Decision|0|||
157246864|NCT05034874|567648286|FG001|Overall Study|Physician Decision|1|||
157246865|NCT05034874|567648285|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
157246866|NCT05034874|567648286|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
157246867|NCT03101358|567648287|FG000|Overall Study|Non-compliance with study schedule|1|||
157246868|NCT03101358|567648288|FG001|Overall Study|Non-compliance with study schedule|0|||
157246869|NCT03101358|567648289|FG002|Overall Study|Non-compliance with study schedule|0|||
157246870|NCT03101358|567648290|FG003|Overall Study|Non-compliance with study schedule|1|||
157246871|NCT03101358|567648287|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
157246872|NCT03101358|567648288|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
157246873|NCT03101358|567648289|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
157246874|NCT03101358|567648290|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
157246875|NCT03101358|567648287|FG000|Overall Study|Physician Decision|1|||
157246876|NCT03101358|567648288|FG001|Overall Study|Physician Decision|0|||
157246877|NCT03101358|567648289|FG002|Overall Study|Physician Decision|0|||
157246878|NCT03101358|567648290|FG003|Overall Study|Physician Decision|3|||
157246879|NCT03101358|567648287|FG000|Overall Study|Adverse Event|0|||
157246880|NCT03101358|567648288|FG001|Overall Study|Adverse Event|0|||
157246881|NCT03101358|567648289|FG002|Overall Study|Adverse Event|1|||
157246882|NCT03101358|567648290|FG003|Overall Study|Adverse Event|0|||
157246883|NCT03101358|567648287|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
157246884|NCT03101358|567648288|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
157246885|NCT03101358|567648289|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
157246886|NCT03101358|567648290|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
157246887|NCT03101358|567648287|FG000|Overall Study|Lost to Follow-up|1|||
157246888|NCT03101358|567648288|FG001|Overall Study|Lost to Follow-up|0|||
157246889|NCT03101358|567648289|FG002|Overall Study|Lost to Follow-up|0|||
157246890|NCT03101358|567648290|FG003|Overall Study|Lost to Follow-up|1|||
157246891|NCT00474058|567648291|FG000|Overall Study|Adverse Event|11|||
157246892|NCT00474058|567648292|FG001|Overall Study|Adverse Event|6|||
157246893|NCT00474058|567648291|FG000|Overall Study|Lack of Efficacy|0|||
157246894|NCT00474058|567648292|FG001|Overall Study|Lack of Efficacy|4|||
157246895|NCT00474058|567648291|FG000|Overall Study|Withdrawal by Subject|11|||
157246896|NCT00474058|567648292|FG001|Overall Study|Withdrawal by Subject|7|||
157246897|NCT00474058|567648291|FG000|Overall Study|Other|2|||
157246898|NCT00474058|567648292|FG001|Overall Study|Other|0|||
157246899|NCT02640235|567648293|FG000|Overall Study|Withdrawal by Subject|7|||
157246900|NCT02640235|567648294|FG001|Overall Study|Withdrawal by Subject|6|||
157246901|NCT02640235|567648293|FG000|Overall Study|Lost to Follow-up|4|||
157246902|NCT02640235|567648294|FG001|Overall Study|Lost to Follow-up|3|||
157246903|NCT02640235|567648293|FG000|Overall Study|Death|2|||
157246904|NCT02640235|567648294|FG001|Overall Study|Death|3|||
157246905|NCT02640235|567648293|FG000|Overall Study|Other|1|||
157246906|NCT02640235|567648294|FG001|Overall Study|Other|2|||
157246907|NCT02426918|567648295|FG000|Overall Study|Adverse Event|2|||
157246908|NCT02426918|567648296|FG001|Overall Study|Adverse Event|2|||
157246909|NCT02426918|567648297|FG002|Overall Study|Adverse Event|0|||
157246910|NCT02426918|567648295|FG000|Overall Study|Physician Decision|1|||
157246911|NCT02426918|567648296|FG001|Overall Study|Physician Decision|1|||
157246912|NCT02426918|567648297|FG002|Overall Study|Physician Decision|1|||
157246913|NCT02426918|567648295|FG000|Overall Study|Withdrawal by Subject|5|||
157246914|NCT02426918|567648296|FG001|Overall Study|Withdrawal by Subject|5|||
157246915|NCT02426918|567648297|FG002|Overall Study|Withdrawal by Subject|4|||
157246916|NCT02426918|567648295|FG000|Overall Study|Other|9|||
157246917|NCT02426918|567648296|FG001|Overall Study|Other|11|||
157246918|NCT02426918|567648297|FG002|Overall Study|Other|9|||
157246919|NCT01496118|567648298|FG000|Overall Study|Disease progression|3|||
157246920|NCT01496118|567648299|FG001|Overall Study|Disease progression|2|||
157246921|NCT01496118|567648300|FG002|Overall Study|Disease progression|3|||
157246922|NCT01496118|567648301|FG003|Overall Study|Disease progression|1|||
157246923|NCT01496118|567648302|FG004|Overall Study|Disease progression|2|||
157246924|NCT01496118|567648303|FG005|Overall Study|Disease progression|2|||
157246925|NCT01496118|567648304|FG006|Overall Study|Disease progression|14|||
157246926|NCT01496118|567648305|FG007|Overall Study|Disease progression|10|||
157246927|NCT01496118|567648298|FG000|Overall Study|Physician Decision|0|||
157246928|NCT01496118|567648299|FG001|Overall Study|Physician Decision|0|||
157246929|NCT01496118|567648300|FG002|Overall Study|Physician Decision|0|||
157246930|NCT01496118|567648301|FG003|Overall Study|Physician Decision|0|||
157246931|NCT01496118|567648302|FG004|Overall Study|Physician Decision|1|||
157246932|NCT01496118|567648303|FG005|Overall Study|Physician Decision|0|||
157246933|NCT01496118|567648304|FG006|Overall Study|Physician Decision|3|||
157246934|NCT01496118|567648305|FG007|Overall Study|Physician Decision|6|||
157246935|NCT01496118|567648298|FG000|Overall Study|Adverse Event|1|||
157246936|NCT01496118|567648299|FG001|Overall Study|Adverse Event|1|||
157246937|NCT01496118|567648300|FG002|Overall Study|Adverse Event|0|||
157246938|NCT01496118|567648301|FG003|Overall Study|Adverse Event|0|||
157246939|NCT01496118|567648302|FG004|Overall Study|Adverse Event|0|||
157246940|NCT01496118|567648303|FG005|Overall Study|Adverse Event|0|||
157246941|NCT01496118|567648304|FG006|Overall Study|Adverse Event|6|||
157246942|NCT01496118|567648305|FG007|Overall Study|Adverse Event|10|||
157246943|NCT01496118|567648298|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246944|NCT01496118|567648299|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246945|NCT01496118|567648300|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246946|NCT01496118|567648301|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246947|NCT01496118|567648302|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246948|NCT01496118|567648303|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246949|NCT01496118|567648304|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
157246950|NCT01496118|567648305|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
157246951|NCT01496118|567648298|FG000|Overall Study|Death|0|||
157246952|NCT01496118|567648299|FG001|Overall Study|Death|0|||
157246953|NCT01496118|567648300|FG002|Overall Study|Death|0|||
157246954|NCT01496118|567648301|FG003|Overall Study|Death|0|||
157246955|NCT01496118|567648302|FG004|Overall Study|Death|0|||
157246956|NCT01496118|567648303|FG005|Overall Study|Death|0|||
157246957|NCT01496118|567648304|FG006|Overall Study|Death|1|||
157246958|NCT01496118|567648305|FG007|Overall Study|Death|1|||
157246959|NCT01496118|567648298|FG000|Overall Study|Withdrawal by Subject|0|||
157246960|NCT01496118|567648299|FG001|Overall Study|Withdrawal by Subject|0|||
157246961|NCT01496118|567648300|FG002|Overall Study|Withdrawal by Subject|0|||
157246962|NCT01496118|567648301|FG003|Overall Study|Withdrawal by Subject|2|||
157246963|NCT01496118|567648302|FG004|Overall Study|Withdrawal by Subject|0|||
157246964|NCT01496118|567648303|FG005|Overall Study|Withdrawal by Subject|1|||
157246965|NCT01496118|567648304|FG006|Overall Study|Withdrawal by Subject|6|||
157246966|NCT01496118|567648305|FG007|Overall Study|Withdrawal by Subject|3|||
157246967|NCT00841659|567648306|FG000|Washout: 2 Weeks|Protocol Violation|1|||
157246968|NCT00841659|567648307|FG001|Washout: 2 Weeks|Protocol Violation|0|||
157246969|NCT04608448|567648315|FG000|Overall Study|Withdrawal by Subject|1|||
157246970|NCT04608448|567648315|FG000|Overall Study|Adverse Event|1|||
157246971|NCT00654186|567648316|FG000|Overall Study|Withdrawal by Subject|5|||
157246972|NCT05616728|567648317|FG000|Overall Study|Lost to Follow-up|0|||
157246973|NCT05616728|567648318|FG001|Overall Study|Lost to Follow-up|0|||
157246974|NCT05616728|567648319|FG002|Overall Study|Lost to Follow-up|1|||
157246975|NCT05616728|567648317|FG000|Overall Study|Withdrawal by Subject|1|||
157246976|NCT05616728|567648318|FG001|Overall Study|Withdrawal by Subject|1|||
157246977|NCT05616728|567648319|FG002|Overall Study|Withdrawal by Subject|0|||
157246978|NCT05616728|567648317|FG000|Overall Study|Physician Decision|1|||
157246979|NCT05616728|567648318|FG001|Overall Study|Physician Decision|1|||
157246980|NCT05616728|567648319|FG002|Overall Study|Physician Decision|1|||
157246981|NCT05616728|567648317|FG000|Overall Study|Other|0|||
157246982|NCT05616728|567648318|FG001|Overall Study|Other|2|||
157246983|NCT05616728|567648319|FG002|Overall Study|Other|0|||
157246984|NCT00577655|567648322|FG000|Overall Study|Patient Request|0|||
157246985|NCT00577655|567648323|FG001|Overall Study|Patient Request|2|||
157246986|NCT00577655|567648322|FG000|Overall Study|Protocol Violation|0|||
157246987|NCT00577655|567648323|FG001|Overall Study|Protocol Violation|1|||
157246988|NCT00577655|567648322|FG000|Overall Study|Lost to Follow-up|1|||
157246989|NCT00577655|567648323|FG001|Overall Study|Lost to Follow-up|1|||
157246990|NCT01024855|567648324|FG000|Overall Study|Inclusion/exclusion criteria|1|||
157246991|NCT00875524|567648329|FG000|Overall Study|Serious adverse event|0|||
157246992|NCT00875524|567648330|FG001|Overall Study|Serious adverse event|1|||
157246993|NCT00875524|567648329|FG000|Overall Study|Protocol Violation|4|||
157246994|NCT00875524|567648330|FG001|Overall Study|Protocol Violation|0|||
157246995|NCT00875524|567648329|FG000|Overall Study|Lost to Follow-up|1|||
157246996|NCT00875524|567648330|FG001|Overall Study|Lost to Follow-up|0|||
157246997|NCT00875524|567648329|FG000|Overall Study|Withdrawal by Subject|3|||
157246998|NCT00875524|567648330|FG001|Overall Study|Withdrawal by Subject|5|||
157246999|NCT02436200|567648333|FG000|Overall Study|Significant outlier|1|||
157247000|NCT01926119|567648342|FG000|Overall Study|Withdrawal by Subject|1|||
157247001|NCT02654145|567648348|FG000|Overall Study|Lack of Efficacy|1|||
157247002|NCT02654145|567648348|FG000|Overall Study|Protocol Violation|1|||
157247003|NCT02654145|567648348|FG000|Overall Study|Withdrawal by Subject|5|||
157247004|NCT01968551|567648349|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
157247005|NCT01968551|567648350|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
157247006|NCT01968551|567648351|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
157247007|NCT01968551|567648349|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
157247008|NCT01968551|567648350|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
157247009|NCT01968551|567648351|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
157247010|NCT01968551|567648349|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
157247011|NCT01968551|567648350|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
157247012|NCT01968551|567648351|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
157247013|NCT01968551|567648349|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
157247014|NCT01968551|567648350|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
157247015|NCT01968551|567648351|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
157247016|NCT01968551|567648349|FG000|Extension Phase|Adverse Event|0|||
157247017|NCT01968551|567648350|FG001|Extension Phase|Adverse Event|0|||
157247018|NCT01968551|567648351|FG002|Extension Phase|Adverse Event|2|||
157247019|NCT01968551|567648349|FG000|Extension Phase|Death|0|||
157247020|NCT01968551|567648350|FG001|Extension Phase|Death|1|||
157247021|NCT01968551|567648351|FG002|Extension Phase|Death|0|||
157247022|NCT01968551|567648349|FG000|Extension Phase|Withdrew Consent|0|||
157247023|NCT01968551|567648350|FG001|Extension Phase|Withdrew Consent|0|||
157247024|NCT01968551|567648351|FG002|Extension Phase|Withdrew Consent|1|||
157247025|NCT01968551|567648349|FG000|Extension Phase|Lost to Follow-up|1|||
157247026|NCT01968551|567648350|FG001|Extension Phase|Lost to Follow-up|0|||
157247027|NCT01968551|567648351|FG002|Extension Phase|Lost to Follow-up|1|||
157247028|NCT00645853|567648352|FG000|Overall Study|Adverse Event|18|||
157247029|NCT00645853|567648353|FG001|Overall Study|Adverse Event|7|||
157247030|NCT00645853|567648352|FG000|Overall Study|AZ study closure in Hungary|60|||
157247031|NCT00645853|567648353|FG001|Overall Study|AZ study closure in Hungary|40|||
157247032|NCT00645853|567648352|FG000|Overall Study|Withdrawal by Subject|5|||
157247033|NCT00645853|567648353|FG001|Overall Study|Withdrawal by Subject|2|||
157247034|NCT00645853|567648352|FG000|Overall Study|Protocol Violation|0|||
157247035|NCT00645853|567648353|FG001|Overall Study|Protocol Violation|2|||
157247036|NCT00645853|567648352|FG000|Overall Study|Discontinuation criteria|2|||
157247037|NCT00645853|567648353|FG001|Overall Study|Discontinuation criteria|2|||
157247038|NCT00645853|567648352|FG000|Overall Study|recall of ICF, planned operation, death|7|||
157247039|NCT00645853|567648353|FG001|Overall Study|recall of ICF, planned operation, death|4|||
157247040|NCT00819169|567648354|FG000|Overall Study|Withdrawal by Subject|2|||
157247041|NCT00819169|567648355|FG001|Overall Study|Withdrawal by Subject|0|||
157247042|NCT00819169|567648356|FG002|Overall Study|Withdrawal by Subject|0|||
157247043|NCT00819169|567648357|FG003|Overall Study|Withdrawal by Subject|1|||
157247044|NCT00819169|567648358|FG004|Overall Study|Withdrawal by Subject|1|||
157247045|NCT00819169|567648359|FG005|Overall Study|Withdrawal by Subject|1|||
157247046|NCT00819169|567648360|FG006|Overall Study|Withdrawal by Subject|5|||
157247047|NCT00819169|567648361|FG007|Overall Study|Withdrawal by Subject|1|||
157247048|NCT00819169|567648362|FG008|Overall Study|Withdrawal by Subject|4|||
157247049|NCT00819169|567648354|FG000|Overall Study|Lost to Follow-up|0|||
157247050|NCT00819169|567648355|FG001|Overall Study|Lost to Follow-up|2|||
157247051|NCT00819169|567648356|FG002|Overall Study|Lost to Follow-up|0|||
157247052|NCT00819169|567648357|FG003|Overall Study|Lost to Follow-up|1|||
157247053|NCT00819169|567648358|FG004|Overall Study|Lost to Follow-up|0|||
157247054|NCT00819169|567648359|FG005|Overall Study|Lost to Follow-up|6|||
157247055|NCT00819169|567648360|FG006|Overall Study|Lost to Follow-up|2|||
157247056|NCT00819169|567648361|FG007|Overall Study|Lost to Follow-up|2|||
157247057|NCT00819169|567648362|FG008|Overall Study|Lost to Follow-up|1|||
157247058|NCT00819169|567648354|FG000|Overall Study|Death|1|||
157247059|NCT00819169|567648355|FG001|Overall Study|Death|1|||
157247060|NCT00819169|567648356|FG002|Overall Study|Death|3|||
157247061|NCT00819169|567648357|FG003|Overall Study|Death|8|||
157247062|NCT00819169|567648358|FG004|Overall Study|Death|5|||
157247063|NCT00819169|567648359|FG005|Overall Study|Death|7|||
157247064|NCT00819169|567648360|FG006|Overall Study|Death|9|||
157247065|NCT00819169|567648361|FG007|Overall Study|Death|4|||
157247066|NCT00819169|567648362|FG008|Overall Study|Death|7|||
157247067|NCT00819169|567648354|FG000|Overall Study|Ineligibility determined|0|||
157247068|NCT00819169|567648355|FG001|Overall Study|Ineligibility determined|0|||
157247069|NCT00819169|567648356|FG002|Overall Study|Ineligibility determined|0|||
157247070|NCT00819169|567648357|FG003|Overall Study|Ineligibility determined|2|||
157247071|NCT00819169|567648358|FG004|Overall Study|Ineligibility determined|0|||
157247072|NCT00819169|567648359|FG005|Overall Study|Ineligibility determined|0|||
157247073|NCT00819169|567648360|FG006|Overall Study|Ineligibility determined|0|||
157247074|NCT00819169|567648361|FG007|Overall Study|Ineligibility determined|0|||
157247075|NCT00819169|567648362|FG008|Overall Study|Ineligibility determined|1|||
157247076|NCT00819169|567648354|FG000|Overall Study|Adverse Event|0|||
157247077|NCT00819169|567648355|FG001|Overall Study|Adverse Event|0|||
157247078|NCT00819169|567648356|FG002|Overall Study|Adverse Event|0|||
157247079|NCT00819169|567648357|FG003|Overall Study|Adverse Event|0|||
157247080|NCT00819169|567648358|FG004|Overall Study|Adverse Event|1|||
157247081|NCT00819169|567648359|FG005|Overall Study|Adverse Event|0|||
157247082|NCT00819169|567648360|FG006|Overall Study|Adverse Event|0|||
157247083|NCT00819169|567648361|FG007|Overall Study|Adverse Event|0|||
157247084|NCT00819169|567648362|FG008|Overall Study|Adverse Event|0|||
157247085|NCT00819169|567648354|FG000|Overall Study|Administrative Decision|0|||
157247086|NCT00819169|567648355|FG001|Overall Study|Administrative Decision|0|||
157247087|NCT00819169|567648356|FG002|Overall Study|Administrative Decision|0|||
157247088|NCT00819169|567648357|FG003|Overall Study|Administrative Decision|0|||
157247089|NCT00819169|567648358|FG004|Overall Study|Administrative Decision|1|||
157247090|NCT00819169|567648359|FG005|Overall Study|Administrative Decision|2|||
157247091|NCT00819169|567648360|FG006|Overall Study|Administrative Decision|0|||
157247092|NCT00819169|567648361|FG007|Overall Study|Administrative Decision|2|||
157247093|NCT00819169|567648362|FG008|Overall Study|Administrative Decision|0|||
157247094|NCT02637141|567648364|FG000|Overall Study|Adverse Event|1|||
157247095|NCT02637141|567648365|FG001|Overall Study|Adverse Event|1|||
157247096|NCT02637141|567648366|FG002|Overall Study|Adverse Event|0|||
157247097|NCT02637141|567648364|FG000|Overall Study|Withdrawal by Subject|1|||
157247098|NCT02637141|567648365|FG001|Overall Study|Withdrawal by Subject|1|||
157247099|NCT02637141|567648366|FG002|Overall Study|Withdrawal by Subject|1|||
157247100|NCT00406393|567648370|FG000|Overall Study|Did not undergo transplantation|2|||
157247101|NCT00406393|567648371|FG001|Overall Study|Did not undergo transplantation|1|||
157247102|NCT00487435|567648372|FG000|Overall Study|Adverse Event|146|||
157247103|NCT00487435|567648372|FG000|Overall Study|Death|2|||
157247104|NCT00487435|567648372|FG000|Overall Study|Lack of Efficacy|33|||
157247105|NCT00487435|567648372|FG000|Overall Study|Lost to Follow-up|54|||
157247106|NCT00487435|567648372|FG000|Overall Study|Pregnancy|2|||
157247107|NCT00487435|567648372|FG000|Overall Study|Withdrawal by Subject|132|||
157247108|NCT00487435|567648372|FG000|Overall Study|Resolution Of Pain|1|||
157247109|NCT00487435|567648372|FG000|Overall Study|Study Medication Non-Compliant|32|||
157247110|NCT00487435|567648372|FG000|Overall Study|Other|83|||
157247111|NCT01155531|567648373|FG000|Overall Study|Adverse Event|0|||
157247112|NCT01155531|567648374|FG001|Overall Study|Adverse Event|0|||
157247113|NCT01155531|567648375|FG002|Overall Study|Adverse Event|1|||
157247114|NCT01155531|567648376|FG003|Overall Study|Adverse Event|0|||
157247115|NCT01155531|567648373|FG000|Overall Study|Lost to Follow-up|0|||
157247116|NCT01155531|567648374|FG001|Overall Study|Lost to Follow-up|0|||
157247117|NCT01155531|567648375|FG002|Overall Study|Lost to Follow-up|0|||
157247118|NCT01155531|567648376|FG003|Overall Study|Lost to Follow-up|1|||
157247119|NCT01155531|567648373|FG000|Overall Study|Withdrawal by Subject|1|||
157247120|NCT01155531|567648374|FG001|Overall Study|Withdrawal by Subject|0|||
157247121|NCT01155531|567648375|FG002|Overall Study|Withdrawal by Subject|1|||
157247122|NCT01155531|567648376|FG003|Overall Study|Withdrawal by Subject|0|||
157247123|NCT00380588|567648377|FG000|Overall Study|Unequivocal Disease Progression|25|||
157247124|NCT00380588|567648378|FG001|Overall Study|Unequivocal Disease Progression|34|||
157247125|NCT00380588|567648377|FG000|Overall Study|Next Cycle Not Started|4|||
157247126|NCT00380588|567648378|FG001|Overall Study|Next Cycle Not Started|0|||
157247127|NCT00380588|567648377|FG000|Overall Study|Adverse Event|7|||
157247128|NCT00380588|567648378|FG001|Overall Study|Adverse Event|3|||
157247129|NCT00380588|567648377|FG000|Overall Study|Withdrawal by Subject|1|||
157247130|NCT00380588|567648378|FG001|Overall Study|Withdrawal by Subject|3|||
157247131|NCT00380588|567648377|FG000|Overall Study|Physician Decision|2|||
157247132|NCT00380588|567648378|FG001|Overall Study|Physician Decision|0|||
157247133|NCT02096705|567648379|FG000|Treatment|Adverse Event|6|||
157247134|NCT02096705|567648380|FG001|Treatment|Adverse Event|3|||
157247135|NCT02096705|567648379|FG000|Treatment|Subject request to discontinue treatment|1|||
157247136|NCT02096705|567648380|FG001|Treatment|Subject request to discontinue treatment|1|||
157247137|NCT02096705|567648379|FG000|Treatment|Withdrawal by Subject|1|||
157247138|NCT02096705|567648380|FG001|Treatment|Withdrawal by Subject|0|||
157247139|NCT02096705|567648379|FG000|Treatment|Other|1|||
157247140|NCT02096705|567648380|FG001|Treatment|Other|1|||
157247141|NCT02096705|567648379|FG000|Follow-up|Withdrawal by Subject|1|||
157247142|NCT02096705|567648380|FG001|Follow-up|Withdrawal by Subject|0|||
157247143|NCT02096705|567648379|FG000|Follow-up|Adverse Event|2|||
157247144|NCT02096705|567648380|FG001|Follow-up|Adverse Event|2|||
157247145|NCT02096705|567648379|FG000|Follow-up|Subjects not reporting status|1|||
157247146|NCT02096705|567648380|FG001|Follow-up|Subjects not reporting status|2|||
157247147|NCT02905435|567648381|FG000|Overall Study|Death|2|||
157247148|NCT02905435|567648381|FG000|Overall Study|Physician Decision|1|||
157247149|NCT02905435|567648381|FG000|Overall Study|Lost to Follow-up|4|||
157247150|NCT02377349|567648385|FG000|Overall Study|Serious Adverse Event|1|||
157247151|NCT02377349|567648386|FG001|Overall Study|Serious Adverse Event|0|||
157247152|NCT02377349|567648385|FG000|Overall Study|Protocol Violation|3|||
157247153|NCT02377349|567648386|FG001|Overall Study|Protocol Violation|2|||
157247154|NCT02377349|567648385|FG000|Overall Study|Withdrawal by Subject|5|||
157247155|NCT02377349|567648386|FG001|Overall Study|Withdrawal by Subject|3|||
157247156|NCT02377349|567648385|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
157247157|NCT02377349|567648386|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
157247158|NCT02377349|567648385|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
157247159|NCT02377349|567648386|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
157247160|NCT02377349|567648385|FG000|Overall Study|Other|0|||
157247161|NCT02377349|567648386|FG001|Overall Study|Other|1|||
157247162|NCT03614728|567648395|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
157247163|NCT03614728|567648396|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
157247164|NCT03614728|567648397|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
157247165|NCT03614728|567648398|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
157247166|NCT03614728|567648395|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
157247167|NCT03614728|567648396|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
157247168|NCT03614728|567648397|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
157247169|NCT03614728|567648398|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
157247170|NCT01958476|567648399|FG000|Overall Study|Parent requested exclusion from analysis|1|||
157247171|NCT01958476|567648400|FG001|Overall Study|Parent requested exclusion from analysis|0|||
157247172|NCT02670551|567648401|FG000|Overall Study|Adverse Event|4|||
157247173|NCT02670551|567648402|FG001|Overall Study|Adverse Event|7|||
157247174|NCT02670551|567648403|FG002|Overall Study|Adverse Event|9|||
157247175|NCT02670551|567648401|FG000|Overall Study|Lack of Efficacy|2|||
157247176|NCT02670551|567648402|FG001|Overall Study|Lack of Efficacy|0|||
157247177|NCT02670551|567648403|FG002|Overall Study|Lack of Efficacy|3|||
157247178|NCT02670551|567648401|FG000|Overall Study|Withdrawal of Consent|6|||
157247179|NCT02670551|567648402|FG001|Overall Study|Withdrawal of Consent|3|||
157247180|NCT02670551|567648403|FG002|Overall Study|Withdrawal of Consent|8|||
157247181|NCT02670551|567648401|FG000|Overall Study|Lost to Follow-up|5|||
157247182|NCT02670551|567648402|FG001|Overall Study|Lost to Follow-up|7|||
157247183|NCT02670551|567648403|FG002|Overall Study|Lost to Follow-up|6|||
157247184|NCT02670551|567648401|FG000|Overall Study|Protocol Violation|1|||
157247185|NCT02670551|567648402|FG001|Overall Study|Protocol Violation|0|||
157247186|NCT02670551|567648403|FG002|Overall Study|Protocol Violation|0|||
157247187|NCT02670551|567648401|FG000|Overall Study|Noncompliance with study drug|3|||
157247188|NCT02670551|567648402|FG001|Overall Study|Noncompliance with study drug|3|||
157247189|NCT02670551|567648403|FG002|Overall Study|Noncompliance with study drug|2|||
157247190|NCT02670551|567648401|FG000|Overall Study|Other Miscellaneous Reasons|2|||
157247191|NCT02670551|567648402|FG001|Overall Study|Other Miscellaneous Reasons|3|||
157247192|NCT02670551|567648403|FG002|Overall Study|Other Miscellaneous Reasons|3|||
157247193|NCT02670551|567648401|FG000|Overall Study|Did Not Receive Treatment|5|||
157247194|NCT02670551|567648402|FG001|Overall Study|Did Not Receive Treatment|3|||
157247195|NCT02670551|567648403|FG002|Overall Study|Did Not Receive Treatment|0|||
157247196|NCT00714051|567648404|FG000|Overall Study|Withdrawal by Subject|1|||
157247197|NCT00714051|567648405|FG001|Overall Study|Withdrawal by Subject|0|||
157247198|NCT00714051|567648404|FG000|Overall Study|Death|0|||
157247199|NCT00714051|567648405|FG001|Overall Study|Death|1|||
157247200|NCT03868631|567648406|FG000|Baseline to Week 6|Adverse Event|0|||
157247201|NCT03868631|567648407|FG001|Baseline to Week 6|Adverse Event|3|||
157247202|NCT03868631|567648406|FG000|Baseline to Week 6|Protocol Violation|1|||
157247203|NCT03868631|567648407|FG001|Baseline to Week 6|Protocol Violation|1|||
157247204|NCT03868631|567648406|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
157247205|NCT03868631|567648407|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
157247206|NCT03868631|567648406|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
157247207|NCT03868631|567648407|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
157247208|NCT03868631|567648406|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
157247209|NCT03868631|567648407|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
157247210|NCT03868631|567648406|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
157247211|NCT03868631|567648407|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
157247212|NCT00835081|567648408|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
157247213|NCT00835081|567648409|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
157247214|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
157247215|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
157247216|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
157247217|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
157247218|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
157247219|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
157247220|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
157247221|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
157247222|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
157247223|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
157247224|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
157247225|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
157247226|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
157247227|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
157247228|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
157247229|NCT01139762|567648410|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
157247230|NCT01139762|567648411|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
157247231|NCT01139762|567648412|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
157247232|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
157247233|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
157247234|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
157247235|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Death|0|||
157247236|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Death|1|||
157247237|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Death|1|||
157247238|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
157247239|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
157247240|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
157247241|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
157247242|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
157247243|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
157247244|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
157247245|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
157247246|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
157247247|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
157247248|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
157247249|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
157247250|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
157247251|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
157247252|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
157247253|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
157247254|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
157247255|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
157247256|NCT01139762|567648410|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
157247257|NCT01139762|567648411|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
157247258|NCT01139762|567648412|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
157247259|NCT01675596|567648413|FG000|Overall Study|Death|6|||
157247260|NCT01675596|567648413|FG000|Overall Study|Exit with other reason|1|||
157247261|NCT01675596|567648413|FG000|Overall Study|Missed Visit|1|||
157247262|NCT00874276|567648414|FG000|Overall Study|Withdrawal by Subject|1|||
157247263|NCT00874276|567648415|FG001|Overall Study|Withdrawal by Subject|1|||
157247264|NCT04236596|567648416|FG000|Overall Study|Withdrawal by Subject|1|||
157247265|NCT04236596|567648416|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
157247266|NCT04236596|567648416|FG000|Overall Study|Participants did not receive implant at all|4|||
157247267|NCT02588339|567648418|FG000|Overall Study|Withdrawal by Subject|1|||
157247268|NCT02588339|567648418|FG000|Overall Study|GVHD Progression prior to treatment|2|||
157247269|NCT01520987|567649656|FG000|Overall Study|Withdrawal by Subject|1|||
157247270|NCT01520987|567649657|FG001|Overall Study|Withdrawal by Subject|0|||
157247271|NCT01520987|567649658|FG002|Overall Study|Withdrawal by Subject|0|||
157247272|NCT01520987|567649659|FG003|Overall Study|Withdrawal by Subject|0|||
157247273|NCT01520987|567649660|FG004|Overall Study|Withdrawal by Subject|0|||
157247274|NCT01520987|567649661|FG005|Overall Study|Withdrawal by Subject|1|||
157247275|NCT01520987|567649662|FG006|Overall Study|Withdrawal by Subject|0|||
157247276|NCT01520987|567649663|FG007|Overall Study|Withdrawal by Subject|0|||
157247277|NCT02005562|567649664|FG000|Overall Study|Death|2|||
157247278|NCT02005562|567649665|FG001|Overall Study|Death|2|||
157247279|NCT02005562|567649664|FG000|Overall Study|Graft loss|7|||
157247280|NCT02005562|567649665|FG001|Overall Study|Graft loss|6|||
157247281|NCT02005562|567649664|FG000|Overall Study|Withdrawal by Subject|2|||
157247282|NCT02005562|567649665|FG001|Overall Study|Withdrawal by Subject|2|||
157247283|NCT02005562|567649664|FG000|Overall Study|No transplant|1|||
157247284|NCT02005562|567649665|FG001|Overall Study|No transplant|4|||
157247285|NCT02005562|567649664|FG000|Overall Study|Physician Decision|0|||
157247286|NCT02005562|567649665|FG001|Overall Study|Physician Decision|1|||
157247287|NCT00660387|567649666|FG000|Overall Study|Adverse Event|1|||
157247288|NCT00660387|567649667|FG001|Overall Study|Adverse Event|2|||
157247289|NCT00660387|567649666|FG000|Overall Study|Lack of Efficacy|0|||
157247290|NCT00660387|567649667|FG001|Overall Study|Lack of Efficacy|1|||
157247291|NCT00660387|567649666|FG000|Overall Study|Protocol Violation|1|||
157247292|NCT00660387|567649667|FG001|Overall Study|Protocol Violation|0|||
157247293|NCT03086135|567649668|FG000|Overall Study|Adverse Event|1|||
157247294|NCT03086135|567649668|FG000|Overall Study|Lost to Follow-up|2|||
157247295|NCT01023061|567649669|FG000|Overall Study|Withdrawal prior to treatment|2|||
157247296|NCT02966340|567649670|FG000|Overall Study|Adverse Event|0|||
157247297|NCT02966340|567649671|FG001|Overall Study|Adverse Event|1|||
157247298|NCT02966340|567649670|FG000|Overall Study|Lost to Follow-up|0|||
157247299|NCT02966340|567649671|FG001|Overall Study|Lost to Follow-up|1|||
157247300|NCT02966340|567649670|FG000|Overall Study|Withdrawal by Subject|1|||
157247301|NCT02966340|567649671|FG001|Overall Study|Withdrawal by Subject|0|||
157247302|NCT02966340|567649670|FG000|Overall Study|data acquisition error|1|||
157247303|NCT02966340|567649671|FG001|Overall Study|data acquisition error|0|||
157247304|NCT02966340|567649670|FG000|Overall Study|startle non-responder|1|||
157247305|NCT02966340|567649671|FG001|Overall Study|startle non-responder|1|||
157247306|NCT02664415|567649672|FG000|Overall Study|Adverse Event|1|||
157247307|NCT02664415|567649673|FG001|Overall Study|Adverse Event|0|||
157247308|NCT02034513|567649677|FG000|Overall Study|Adverse Event|11|||
157247309|NCT02034513|567649678|FG001|Overall Study|Adverse Event|10|||
157247310|NCT02034513|567649677|FG000|Overall Study|Lack of Efficacy|0|||
157247311|NCT02034513|567649678|FG001|Overall Study|Lack of Efficacy|1|||
157247312|NCT02034513|567649677|FG000|Overall Study|Lost to Follow-up|6|||
157247313|NCT02034513|567649678|FG001|Overall Study|Lost to Follow-up|7|||
157247314|NCT02034513|567649677|FG000|Overall Study|Pregnancy|0|||
157247315|NCT02034513|567649678|FG001|Overall Study|Pregnancy|3|||
157247316|NCT02034513|567649677|FG000|Overall Study|Protocol Violation|7|||
157247317|NCT02034513|567649678|FG001|Overall Study|Protocol Violation|10|||
157247318|NCT02034513|567649677|FG000|Overall Study|Withdrawal by Subject|25|||
157247319|NCT02034513|567649678|FG001|Overall Study|Withdrawal by Subject|25|||
157247320|NCT02034513|567649677|FG000|Overall Study|Unclassified|0|||
157247321|NCT02034513|567649678|FG001|Overall Study|Unclassified|1|||
157247322|NCT02308241|567649679|FG000|Overall Study|Withdrawal by Subject|3|||
157247323|NCT00659815|567649680|FG000|Overall Study|Study related symptoms and complaints|2|||
157247324|NCT00659815|567649681|FG001|Overall Study|Study related symptoms and complaints|1|||
157247325|NCT00659815|567649680|FG000|Overall Study|Inability to maintain wearing schedule|1|||
157247326|NCT00659815|567649681|FG001|Overall Study|Inability to maintain wearing schedule|2|||
157247327|NCT00659815|567649680|FG000|Overall Study|Withdrawal by Subject|1|||
157247328|NCT00659815|567649681|FG001|Overall Study|Withdrawal by Subject|1|||
157247329|NCT02998541|567649682|FG000|Overall Study|Adverse Event|4|||
157247330|NCT02998541|567649683|FG001|Overall Study|Adverse Event|5|||
157247331|NCT02998541|567649684|FG002|Overall Study|Adverse Event|1|||
157247332|NCT02998541|567649682|FG000|Overall Study|Protocol Violation|1|||
157247333|NCT02998541|567649683|FG001|Overall Study|Protocol Violation|0|||
157247334|NCT02998541|567649684|FG002|Overall Study|Protocol Violation|0|||
157247335|NCT02998541|567649682|FG000|Overall Study|Withdrawal by Subject|3|||
157247336|NCT02998541|567649683|FG001|Overall Study|Withdrawal by Subject|1|||
157247337|NCT02998541|567649684|FG002|Overall Study|Withdrawal by Subject|0|||
157247338|NCT02998541|567649682|FG000|Overall Study|Lost to Follow-up|0|||
157247339|NCT02998541|567649683|FG001|Overall Study|Lost to Follow-up|3|||
157247340|NCT02998541|567649684|FG002|Overall Study|Lost to Follow-up|1|||
157247341|NCT02998541|567649682|FG000|Overall Study|Physician Decision|0|||
157247342|NCT02998541|567649683|FG001|Overall Study|Physician Decision|0|||
157247343|NCT02998541|567649684|FG002|Overall Study|Physician Decision|3|||
157247344|NCT02998541|567649682|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157247345|NCT02998541|567649683|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
157247346|NCT02998541|567649684|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
157247347|NCT01513239|567649685|FG000|Period 1: Main Phase|Adverse Event|1|||
157247348|NCT01513239|567649686|FG001|Period 1: Main Phase|Adverse Event|1|||
157247349|NCT01513239|567649687|FG002|Period 1: Main Phase|Adverse Event|2|||
157247350|NCT01513239|567649688|FG003|Period 1: Main Phase|Adverse Event|0|||
157247351|NCT01513239|567649689|FG004|Period 1: Main Phase|Adverse Event|0|||
157247352|NCT01513239|567649690|FG005|Period 1: Main Phase|Adverse Event|0|||
157247353|NCT01513239|567649685|FG000|Period 1: Main Phase|Death|29|||
157247354|NCT01513239|567649686|FG001|Period 1: Main Phase|Death|22|||
157247355|NCT01513239|567649687|FG002|Period 1: Main Phase|Death|32|||
157247356|NCT01513239|567649688|FG003|Period 1: Main Phase|Death|0|||
157247357|NCT01513239|567649689|FG004|Period 1: Main Phase|Death|0|||
157247358|NCT01513239|567649690|FG005|Period 1: Main Phase|Death|0|||
157247359|NCT01513239|567649685|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
157247360|NCT01513239|567649686|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
157247361|NCT01513239|567649687|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
157247362|NCT01513239|567649688|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
157247363|NCT01513239|567649689|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
157247364|NCT01513239|567649690|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
157247365|NCT01513239|567649685|FG000|Period 1: Main Phase|Physician Decision|4|||
157247366|NCT01513239|567649686|FG001|Period 1: Main Phase|Physician Decision|4|||
157247367|NCT01513239|567649687|FG002|Period 1: Main Phase|Physician Decision|4|||
157247368|NCT01513239|567649688|FG003|Period 1: Main Phase|Physician Decision|0|||
157247369|NCT01513239|567649689|FG004|Period 1: Main Phase|Physician Decision|0|||
157247370|NCT01513239|567649690|FG005|Period 1: Main Phase|Physician Decision|0|||
157247371|NCT01513239|567649685|FG000|Period 1: Main Phase|Protocol Violation|2|||
157247372|NCT01513239|567649686|FG001|Period 1: Main Phase|Protocol Violation|2|||
157247373|NCT01513239|567649687|FG002|Period 1: Main Phase|Protocol Violation|2|||
157247374|NCT01513239|567649688|FG003|Period 1: Main Phase|Protocol Violation|0|||
157247375|NCT01513239|567649689|FG004|Period 1: Main Phase|Protocol Violation|0|||
157247376|NCT01513239|567649690|FG005|Period 1: Main Phase|Protocol Violation|0|||
157247377|NCT01513239|567649685|FG000|Period 1: Main Phase|Technical Problems|1|||
157247378|NCT01513239|567649686|FG001|Period 1: Main Phase|Technical Problems|2|||
157247379|NCT01513239|567649687|FG002|Period 1: Main Phase|Technical Problems|0|||
157247380|NCT01513239|567649688|FG003|Period 1: Main Phase|Technical Problems|0|||
157247381|NCT01513239|567649689|FG004|Period 1: Main Phase|Technical Problems|0|||
157247382|NCT01513239|567649690|FG005|Period 1: Main Phase|Technical Problems|0|||
157247383|NCT01513239|567649685|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
157247384|NCT01513239|567649686|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
157247385|NCT01513239|567649687|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
157247386|NCT01513239|567649688|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
157247387|NCT01513239|567649689|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
157247388|NCT01513239|567649690|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
157247389|NCT01513239|567649685|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
157247390|NCT01513239|567649686|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
157247391|NCT01513239|567649687|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
157247392|NCT01513239|567649688|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
157247393|NCT01513239|567649689|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
157247394|NCT01513239|567649690|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
157247395|NCT01513239|567649685|FG000|Period 2: 9 Month Extension Phase|Death|0|||
157247396|NCT01513239|567649686|FG001|Period 2: 9 Month Extension Phase|Death|0|||
157247397|NCT01513239|567649687|FG002|Period 2: 9 Month Extension Phase|Death|0|||
157247398|NCT01513239|567649688|FG003|Period 2: 9 Month Extension Phase|Death|2|||
157247399|NCT01513239|567649689|FG004|Period 2: 9 Month Extension Phase|Death|5|||
157247400|NCT01513239|567649690|FG005|Period 2: 9 Month Extension Phase|Death|2|||
157247401|NCT01513239|567649685|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
157247402|NCT01513239|567649686|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
157247403|NCT01513239|567649687|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
157247404|NCT01513239|567649688|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
157247405|NCT01513239|567649689|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
157247406|NCT01513239|567649690|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
157247407|NCT01513239|567649685|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
157247408|NCT01513239|567649686|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
157247409|NCT01513239|567649687|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
157247410|NCT01513239|567649688|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
157247411|NCT01513239|567649689|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
157247412|NCT01513239|567649690|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
157247413|NCT01513239|567649685|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
157247414|NCT01513239|567649686|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
157247415|NCT01513239|567649687|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
157247416|NCT01513239|567649688|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
156977423|NCT02130284|566670712|FG000|Overall Study|Subject Withdrew Consent|1|||
156977424|NCT02130284|566670712|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
156977425|NCT02130284|566670712|FG000|Overall Study|Subject was screened as backup for study|3|||
156977426|NCT02130284|566670712|FG000|Overall Study|Screen Failure|1|||
156977427|NCT04534114|566670717|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156977428|NCT04534114|566670718|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
156977429|NCT04534114|566670719|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156977430|NCT04534114|566670720|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
156977431|NCT04534114|566670717|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
156977432|NCT04534114|566670718|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
156977433|NCT04534114|566670719|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
156977434|NCT04534114|566670720|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
157247417|NCT01513239|567649689|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
157247418|NCT01513239|567649690|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
157247419|NCT00396162|567649691|FG000|Overall Study|Withdrawal by Subject|2|||
157247420|NCT00396162|567649692|FG001|Overall Study|Withdrawal by Subject|3|||
157247421|NCT01664039|567649696|FG000|Overall Study|Adverse Event|3|||
157247422|NCT01664039|567649697|FG001|Overall Study|Adverse Event|4|||
157247423|NCT01664039|567649696|FG000|Overall Study|Lost to Follow-up|1|||
157247424|NCT01664039|567649697|FG001|Overall Study|Lost to Follow-up|1|||
157247425|NCT01664039|567649696|FG000|Overall Study|Withdrawal by Subject|1|||
157247426|NCT01664039|567649697|FG001|Overall Study|Withdrawal by Subject|3|||
157247427|NCT01664039|567649696|FG000|Overall Study|Noncompliance|1|||
157247428|NCT01664039|567649697|FG001|Overall Study|Noncompliance|1|||
157247429|NCT01853176|567649698|FG000|Overall Study|Study terminated|4|||
157247430|NCT01853176|567649699|FG001|Overall Study|Study terminated|0|||
157247431|NCT00874822|567649700|FG000|Overall Study|excluded by criteria|8|||
157247432|NCT01168856|567649704|FG000|Overall Study|Lost to Follow-up|4|||
157247433|NCT01168856|567649705|FG001|Overall Study|Lost to Follow-up|34|||
157247434|NCT01168856|567649704|FG000|Overall Study|Withdrawal by Subject|6|||
157247435|NCT01168856|567649705|FG001|Overall Study|Withdrawal by Subject|8|||
157247436|NCT01168856|567649704|FG000|Overall Study|Physician Decision|2|||
157247437|NCT01168856|567649705|FG001|Overall Study|Physician Decision|1|||
157247438|NCT01168856|567649704|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
157247439|NCT01168856|567649705|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
157247440|NCT01168856|567649704|FG000|Overall Study|Participant received anti-HCV treatment|1|||
157247441|NCT01168856|567649705|FG001|Overall Study|Participant received anti-HCV treatment|0|||
157247442|NCT01168856|567649704|FG000|Overall Study|Death|0|||
157247443|NCT01168856|567649705|FG001|Overall Study|Death|2|||
157247444|NCT01168856|567649704|FG000|Overall Study|Other|1|||
157247445|NCT01168856|567649705|FG001|Overall Study|Other|291|||
157247446|NCT01168856|567649704|FG000|Overall Study|Protocol Violation|4|||
157247447|NCT01168856|567649705|FG001|Overall Study|Protocol Violation|6|||
157247448|NCT04442503|567649706|FG000|Overall Study|Adverse Event|1|||
157247449|NCT04442503|567649707|FG001|Overall Study|Adverse Event|1|||
157247450|NCT04442503|567649706|FG000|Overall Study|Lost to Follow-up|8|||
157247451|NCT04442503|567649707|FG001|Overall Study|Lost to Follow-up|6|||
157247452|NCT04442503|567649706|FG000|Overall Study|Physician Decision|0|||
157247453|NCT04442503|567649707|FG001|Overall Study|Physician Decision|2|||
157247454|NCT04442503|567649706|FG000|Overall Study|Withdrawal by Subject|3|||
157247455|NCT04442503|567649707|FG001|Overall Study|Withdrawal by Subject|4|||
157247456|NCT04442503|567649706|FG000|Overall Study|Reason not Specified|0|||
157247457|NCT04442503|567649707|FG001|Overall Study|Reason not Specified|1|||
157247458|NCT04442503|567649706|FG000|Overall Study|Randomized but not Treated|3|||
157247459|NCT04442503|567649707|FG001|Overall Study|Randomized but not Treated|1|||
157247460|NCT00387153|567649714|FG000|Overall Study|Adverse Event|1|||
157247461|NCT00387153|567649714|FG000|Overall Study|Disease Progression|3|||
157247462|NCT00387153|567649714|FG000|Overall Study|Lack of Response|4|||
157247463|NCT01867658|567649719|FG000|Overall Study|Withdrawal by Subject|6|||
157247464|NCT01867658|567649719|FG000|Overall Study|Death|2|||
157247465|NCT01867658|567649719|FG000|Overall Study|Subject could not be contacted|1|||
157247466|NCT02420353|567649720|FG000|Overall Study|Withdrawal by Subject|0|||
157247467|NCT02420353|567649721|FG001|Overall Study|Withdrawal by Subject|1|||
157247468|NCT00503867|567649722|FG000|Overall Study|Lost to Follow-up|1|||
157247469|NCT00503867|567649722|FG000|Overall Study|Adverse Event|1|||
157247470|NCT05004649|567649729|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
157247471|NCT05004649|567649729|FG000|Overall Study|Lost to Follow-up|1|||
157247472|NCT05004649|567649729|FG000|Overall Study|Withdrawal by Subject|2|||
157247473|NCT05004649|567649729|FG000|Overall Study|COVID-19|1|||
157247474|NCT00301964|567649730|FG000|Overall Study|Second primary|2|||
157247475|NCT00301964|567649730|FG000|Overall Study|Wrong primary|1|||
157247476|NCT00301964|567649730|FG000|Overall Study|Inadequate pathology|1|||
157247477|NCT02385708|567649732|FG000|Overall Study|Withdrawal by Subject|0|||
157247478|NCT02385708|567649733|FG001|Overall Study|Withdrawal by Subject|2|||
157247479|NCT02385708|567649732|FG000|Overall Study|Withdrawn - surgery canceled|2|||
157247480|NCT02385708|567649733|FG001|Overall Study|Withdrawn - surgery canceled|5|||
157247481|NCT02385708|567649732|FG000|Overall Study|Investigator decision|5|||
157247482|NCT02385708|567649733|FG001|Overall Study|Investigator decision|7|||
157247483|NCT02385708|567649732|FG000|Overall Study|Protocol Violation|1|||
157247484|NCT02385708|567649733|FG001|Overall Study|Protocol Violation|1|||
157247485|NCT02761915|567649734|FG000|Overall Study|Death|3|||
157247486|NCT02761915|567649735|FG001|Overall Study|Death|1|||
157247487|NCT02761915|567649736|FG002|Overall Study|Death|1|||
157247488|NCT02761915|567649737|FG003|Overall Study|Death|1|||
157247489|NCT02761915|567649738|FG004|Overall Study|Death|0|||
157247490|NCT02761915|567649739|FG005|Overall Study|Death|1|||
157247491|NCT02761915|567649734|FG000|Overall Study|Withdrawal by Subject|1|||
157247492|NCT02761915|567649735|FG001|Overall Study|Withdrawal by Subject|0|||
157247493|NCT02761915|567649736|FG002|Overall Study|Withdrawal by Subject|0|||
157247494|NCT02761915|567649737|FG003|Overall Study|Withdrawal by Subject|0|||
157247495|NCT02761915|567649738|FG004|Overall Study|Withdrawal by Subject|1|||
157247496|NCT02761915|567649739|FG005|Overall Study|Withdrawal by Subject|2|||
157247497|NCT02761915|567649734|FG000|Overall Study|Disease Progression|0|||
157247498|NCT02761915|567649735|FG001|Overall Study|Disease Progression|0|||
157247499|NCT02761915|567649736|FG002|Overall Study|Disease Progression|0|||
157247500|NCT02761915|567649737|FG003|Overall Study|Disease Progression|2|||
157247501|NCT02761915|567649738|FG004|Overall Study|Disease Progression|2|||
157247502|NCT02761915|567649739|FG005|Overall Study|Disease Progression|2|||
157247503|NCT00354835|567649740|FG000|Overall Study|Death|1|||
157247504|NCT00354835|567649741|FG001|Overall Study|Death|1|||
157247505|NCT00354835|567649740|FG000|Overall Study|Physician Decision|8|||
157247506|NCT00354835|567649741|FG001|Overall Study|Physician Decision|13|||
157247507|NCT00354835|567649740|FG000|Overall Study|Withdrawal by Subject|2|||
157247508|NCT00354835|567649741|FG001|Overall Study|Withdrawal by Subject|1|||
157247509|NCT00354835|567649740|FG000|Overall Study|Ineligible|17|||
157247510|NCT00354835|567649741|FG001|Overall Study|Ineligible|16|||
157247511|NCT00354835|567649740|FG000|Overall Study|Disease progression or relapse|15|||
157247512|NCT00354835|567649741|FG001|Overall Study|Disease progression or relapse|22|||
157247513|NCT00354835|567649740|FG000|Overall Study|Adverse Event|6|||
157247514|NCT00354835|567649741|FG001|Overall Study|Adverse Event|0|||
157247515|NCT00354835|567649740|FG000|Overall Study|Refusal of further therapy|3|||
157247516|NCT00354835|567649741|FG001|Overall Study|Refusal of further therapy|8|||
157247517|NCT01395017|567649744|FG000|Overall Study|Lost to Follow-up|1|||
157247518|NCT01395017|567649745|FG001|Overall Study|Lost to Follow-up|0|||
157247519|NCT01395017|567649744|FG000|Overall Study|Adverse Event|26|||
157247520|NCT01395017|567649745|FG001|Overall Study|Adverse Event|12|||
157247521|NCT01395017|567649744|FG000|Overall Study|Physician Decision|11|||
157247522|NCT01395017|567649745|FG001|Overall Study|Physician Decision|15|||
157247523|NCT01395017|567649744|FG000|Overall Study|Withdrawal by Subject|14|||
157247524|NCT01395017|567649745|FG001|Overall Study|Withdrawal by Subject|8|||
157247525|NCT01395017|567649744|FG000|Overall Study|Protocol deviation|1|||
157247526|NCT01395017|567649745|FG001|Overall Study|Protocol deviation|2|||
157247527|NCT01395017|567649744|FG000|Overall Study|Death|4|||
157247528|NCT01395017|567649745|FG001|Overall Study|Death|3|||
157247529|NCT01395017|567649744|FG000|Overall Study|Disease progression|42|||
157247530|NCT01395017|567649745|FG001|Overall Study|Disease progression|58|||
157247531|NCT01395017|567649744|FG000|Overall Study|Sponsor discontinued study|1|||
157247532|NCT01395017|567649745|FG001|Overall Study|Sponsor discontinued study|4|||
157247533|NCT03366428|567649746|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
157247534|NCT03366428|567649746|FG000|Overall Study|Adverse Event|12|||
157247535|NCT03366428|567649746|FG000|Overall Study|Clinical progression|2|||
157247536|NCT03366428|567649746|FG000|Overall Study|Withdrawal by Subject|4|||
157247537|NCT01046084|567649750|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
157247538|NCT01046084|567649751|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
157247539|NCT02166606|567649752|FG000|Overall Study|Adverse Event|3|||
157247540|NCT02166606|567649752|FG000|Overall Study|Death|31|||
157247541|NCT02166606|567649752|FG000|Overall Study|Protocol Violation|7|||
157247542|NCT02166606|567649752|FG000|Overall Study|Lost to Follow-up|30|||
157247543|NCT02166606|567649752|FG000|Overall Study|Withdrawal by Subject|1|||
157247544|NCT02166606|567649752|FG000|Overall Study|Physician Decision|1|||
157247545|NCT02166606|567649752|FG000|Overall Study|Device upgrade|1|||
157247546|NCT02166606|567649752|FG000|Overall Study|Enrolled after End of Enrollment|4|||
157247547|NCT01971645|567649755|FG000|Overall Study|Adverse Event|1|||
157247548|NCT01971645|567649756|FG001|Overall Study|Adverse Event|0|||
157247549|NCT01971645|567649757|FG002|Overall Study|Adverse Event|0|||
157247550|NCT01971645|567649755|FG000|Overall Study|Lost to Follow-up|1|||
157247551|NCT01971645|567649756|FG001|Overall Study|Lost to Follow-up|0|||
157247552|NCT01971645|567649757|FG002|Overall Study|Lost to Follow-up|1|||
157247553|NCT01971645|567649755|FG000|Overall Study|Protocol Violation|0|||
157247554|NCT01971645|567649756|FG001|Overall Study|Protocol Violation|0|||
157247555|NCT01971645|567649757|FG002|Overall Study|Protocol Violation|1|||
157247556|NCT02943096|567649760|FG000|Overall Study|Lack of Efficacy|0|||
157247557|NCT02943096|567649761|FG001|Overall Study|Lack of Efficacy|1|||
157247558|NCT04203823|567649762|FG000|Overall Study|Withdrawal by Subject|2|||
157247559|NCT04203823|567649763|FG001|Overall Study|Withdrawal by Subject|2|||
157247560|NCT04203823|567649762|FG000|Overall Study|Adverse Event|1|||
157247561|NCT04203823|567649763|FG001|Overall Study|Adverse Event|1|||
157247562|NCT04203823|567649762|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
157247563|NCT04203823|567649763|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
157247564|NCT03193021|567649764|FG000|Overall Study|Lost to Follow-up|1|||
157247565|NCT03193021|567649765|FG001|Overall Study|Lost to Follow-up|1|||
157247566|NCT02286466|567649766|FG000|Overall Study|Death|1|||
157247567|NCT02286466|567649767|FG001|Overall Study|Death|3|||
157247568|NCT02286466|567649766|FG000|Overall Study|Withdrawal by Subject|5|||
157247569|NCT02286466|567649767|FG001|Overall Study|Withdrawal by Subject|2|||
157247570|NCT02286466|567649766|FG000|Overall Study|Lost to Follow-up|1|||
157247571|NCT02286466|567649767|FG001|Overall Study|Lost to Follow-up|4|||
157247572|NCT02286466|567649766|FG000|Overall Study|Declined Clinician Assessment|0|||
157247573|NCT02286466|567649767|FG001|Overall Study|Declined Clinician Assessment|1|||
157247574|NCT02957331|567649770|FG000|Overall Study|Protocol Violation|1|||
157247575|NCT02957331|567649771|FG001|Overall Study|Protocol Violation|0|||
157247576|NCT05568615|567651680|FG000|Overall Study|Death|1|||
157247577|NCT05568615|567651680|FG000|Overall Study|Physician Decision|1|||
157247578|NCT05440097|567651682|FG000|Overall Study|Withdrawal by Subject|154|||
157247579|NCT05440097|567651682|FG000|Overall Study|Death|2|||
157247580|NCT05440097|567651682|FG000|Overall Study|Physician Decision|2|||
157247581|NCT05440097|567651682|FG000|Overall Study|Lost to Follow-up|56|||
157247582|NCT05440097|567651682|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
157247583|NCT00565851|567651683|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
157247584|NCT00565851|567651684|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
157247585|NCT00565851|567651685|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
157247586|NCT00565851|567651686|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
157247587|NCT00565851|567651687|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
157247588|NCT00565851|567651688|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
157247589|NCT00565851|567651689|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
157247590|NCT00565851|567651690|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
157247591|NCT00565851|567651683|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
157247592|NCT00565851|567651684|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
157247593|NCT00565851|567651685|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
157247594|NCT00565851|567651686|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
157247595|NCT00565851|567651687|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
157247596|NCT00565851|567651688|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
157247597|NCT00565851|567651689|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
157247598|NCT00565851|567651690|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
157247599|NCT03291067|567651691|FG000|Overall Study|Adverse Event|0|||
157247600|NCT03291067|567651692|FG001|Overall Study|Adverse Event|2|||
157247601|NCT03291067|567651693|FG002|Overall Study|Adverse Event|17|||
157247602|NCT03291067|567651694|FG003|Overall Study|Adverse Event|3|||
157247603|NCT03291067|567651691|FG000|Overall Study|Lost to Follow-up|2|||
157247604|NCT03291067|567651692|FG001|Overall Study|Lost to Follow-up|1|||
157247605|NCT03291067|567651693|FG002|Overall Study|Lost to Follow-up|0|||
157247606|NCT03291067|567651694|FG003|Overall Study|Lost to Follow-up|1|||
157247607|NCT03291067|567651691|FG000|Overall Study|Physician Decision|0|||
157247608|NCT03291067|567651692|FG001|Overall Study|Physician Decision|0|||
157247609|NCT03291067|567651693|FG002|Overall Study|Physician Decision|1|||
157247610|NCT03291067|567651694|FG003|Overall Study|Physician Decision|0|||
157247611|NCT03291067|567651691|FG000|Overall Study|Protocol Violation|5|||
157247612|NCT03291067|567651692|FG001|Overall Study|Protocol Violation|3|||
157247613|NCT03291067|567651693|FG002|Overall Study|Protocol Violation|4|||
157247614|NCT03291067|567651694|FG003|Overall Study|Protocol Violation|2|||
157247615|NCT03291067|567651691|FG000|Overall Study|Withdrawal by Subject|3|||
157247616|NCT03291067|567651692|FG001|Overall Study|Withdrawal by Subject|4|||
157247617|NCT03291067|567651693|FG002|Overall Study|Withdrawal by Subject|7|||
157247618|NCT03291067|567651694|FG003|Overall Study|Withdrawal by Subject|5|||
157247619|NCT03291067|567651691|FG000|Overall Study|Other|0|||
157247620|NCT03291067|567651692|FG001|Overall Study|Other|4|||
157247621|NCT03291067|567651693|FG002|Overall Study|Other|4|||
157247622|NCT03291067|567651694|FG003|Overall Study|Other|6|||
157247623|NCT02255435|567651696|FG000|Overall Study|Patient's Limited Time Availability|0|||
157247624|NCT02255435|567651697|FG001|Overall Study|Patient's Limited Time Availability|0|||
157247625|NCT02255435|567651698|FG002|Overall Study|Patient's Limited Time Availability|0|||
157247626|NCT02255435|567651699|FG003|Overall Study|Patient's Limited Time Availability|0|||
157247627|NCT02255435|567651700|FG004|Overall Study|Patient's Limited Time Availability|0|||
157247628|NCT02255435|567651701|FG005|Overall Study|Patient's Limited Time Availability|0|||
157247629|NCT02255435|567651702|FG006|Overall Study|Patient's Limited Time Availability|0|||
157247630|NCT02255435|567651703|FG007|Overall Study|Patient's Limited Time Availability|1|||
157247631|NCT02255435|567651704|FG008|Overall Study|Patient's Limited Time Availability|0|||
157247632|NCT02255435|567651705|FG009|Overall Study|Patient's Limited Time Availability|0|||
157247633|NCT02255435|567651696|FG000|Overall Study|Withdrawal by Subject|0|||
157247634|NCT02255435|567651697|FG001|Overall Study|Withdrawal by Subject|0|||
157247635|NCT02255435|567651698|FG002|Overall Study|Withdrawal by Subject|0|||
157247636|NCT02255435|567651699|FG003|Overall Study|Withdrawal by Subject|0|||
157247637|NCT02255435|567651700|FG004|Overall Study|Withdrawal by Subject|0|||
157247638|NCT02255435|567651701|FG005|Overall Study|Withdrawal by Subject|0|||
157247639|NCT02255435|567651702|FG006|Overall Study|Withdrawal by Subject|0|||
157247640|NCT02255435|567651703|FG007|Overall Study|Withdrawal by Subject|0|||
157247641|NCT02255435|567651704|FG008|Overall Study|Withdrawal by Subject|1|||
157247642|NCT02255435|567651705|FG009|Overall Study|Withdrawal by Subject|4|||
157247643|NCT02255435|567651696|FG000|Overall Study|Administrative reasons|0|||
157247644|NCT02255435|567651697|FG001|Overall Study|Administrative reasons|0|||
157247645|NCT02255435|567651698|FG002|Overall Study|Administrative reasons|0|||
157247646|NCT02255435|567651699|FG003|Overall Study|Administrative reasons|0|||
157247647|NCT02255435|567651700|FG004|Overall Study|Administrative reasons|0|||
157247648|NCT02255435|567651701|FG005|Overall Study|Administrative reasons|0|||
157247649|NCT02255435|567651702|FG006|Overall Study|Administrative reasons|0|||
157247650|NCT02255435|567651703|FG007|Overall Study|Administrative reasons|0|||
157247651|NCT02255435|567651704|FG008|Overall Study|Administrative reasons|0|||
157247652|NCT02255435|567651705|FG009|Overall Study|Administrative reasons|2|||
157247653|NCT03596905|567651710|FG000|Overall Study|Protocol Violation|0|||
157247654|NCT03596905|567651711|FG001|Overall Study|Protocol Violation|0|||
157247655|NCT03596905|567651712|FG002|Overall Study|Protocol Violation|0|||
157247656|NCT03596905|567651713|FG003|Overall Study|Protocol Violation|0|||
157247657|NCT03596905|567651714|FG004|Overall Study|Protocol Violation|1|||
157247658|NCT03596905|567651715|FG005|Overall Study|Protocol Violation|0|||
157247659|NCT03596905|567651716|FG006|Overall Study|Protocol Violation|0|||
157247660|NCT03596905|567651710|FG000|Overall Study|Withdrawal by Subject|0|||
157247661|NCT03596905|567651711|FG001|Overall Study|Withdrawal by Subject|2|||
157247662|NCT03596905|567651712|FG002|Overall Study|Withdrawal by Subject|1|||
157247663|NCT03596905|567651713|FG003|Overall Study|Withdrawal by Subject|0|||
157247664|NCT03596905|567651714|FG004|Overall Study|Withdrawal by Subject|2|||
157247665|NCT03596905|567651715|FG005|Overall Study|Withdrawal by Subject|0|||
157247666|NCT03596905|567651716|FG006|Overall Study|Withdrawal by Subject|0|||
157247667|NCT03596905|567651710|FG000|Overall Study|Participant moved and was unable to complete study|0|||
157247668|NCT03596905|567651711|FG001|Overall Study|Participant moved and was unable to complete study|1|||
157247669|NCT03596905|567651712|FG002|Overall Study|Participant moved and was unable to complete study|0|||
157247670|NCT03596905|567651713|FG003|Overall Study|Participant moved and was unable to complete study|0|||
157247671|NCT03596905|567651714|FG004|Overall Study|Participant moved and was unable to complete study|0|||
157247672|NCT03596905|567651715|FG005|Overall Study|Participant moved and was unable to complete study|0|||
157247673|NCT03596905|567651716|FG006|Overall Study|Participant moved and was unable to complete study|0|||
157247674|NCT03596905|567651710|FG000|Overall Study|Adverse Event|0|||
157247675|NCT03596905|567651711|FG001|Overall Study|Adverse Event|0|||
157247676|NCT03596905|567651712|FG002|Overall Study|Adverse Event|0|||
157247677|NCT03596905|567651713|FG003|Overall Study|Adverse Event|0|||
157247678|NCT03596905|567651714|FG004|Overall Study|Adverse Event|0|||
157247679|NCT03596905|567651715|FG005|Overall Study|Adverse Event|0|||
157247680|NCT03596905|567651716|FG006|Overall Study|Adverse Event|1|||
157247681|NCT03596905|567651710|FG000|Overall Study|Non-Compliance with eDiary|1|||
157247682|NCT03596905|567651711|FG001|Overall Study|Non-Compliance with eDiary|0|||
157247683|NCT03596905|567651712|FG002|Overall Study|Non-Compliance with eDiary|0|||
157247684|NCT03596905|567651713|FG003|Overall Study|Non-Compliance with eDiary|0|||
157247685|NCT03596905|567651714|FG004|Overall Study|Non-Compliance with eDiary|1|||
157247686|NCT03596905|567651715|FG005|Overall Study|Non-Compliance with eDiary|0|||
157247687|NCT03596905|567651716|FG006|Overall Study|Non-Compliance with eDiary|2|||
157247688|NCT03596905|567651710|FG000|Overall Study|Non-Compliance with Study Drug|0|||
157247689|NCT03596905|567651711|FG001|Overall Study|Non-Compliance with Study Drug|0|||
157247690|NCT03596905|567651712|FG002|Overall Study|Non-Compliance with Study Drug|0|||
157247691|NCT03596905|567651713|FG003|Overall Study|Non-Compliance with Study Drug|0|||
157247692|NCT03596905|567651714|FG004|Overall Study|Non-Compliance with Study Drug|1|||
157247693|NCT03596905|567651715|FG005|Overall Study|Non-Compliance with Study Drug|0|||
157247694|NCT03596905|567651716|FG006|Overall Study|Non-Compliance with Study Drug|0|||
157247695|NCT03596905|567651710|FG000|Overall Study|Lost to Follow-up|0|||
157247696|NCT03596905|567651711|FG001|Overall Study|Lost to Follow-up|0|||
157247697|NCT03596905|567651712|FG002|Overall Study|Lost to Follow-up|0|||
157247698|NCT03596905|567651713|FG003|Overall Study|Lost to Follow-up|0|||
157247699|NCT03596905|567651714|FG004|Overall Study|Lost to Follow-up|0|||
157247700|NCT03596905|567651715|FG005|Overall Study|Lost to Follow-up|1|||
157247701|NCT03596905|567651716|FG006|Overall Study|Lost to Follow-up|0|||
157247702|NCT02081599|567651717|FG000|Period 1：Double-blind Period|Adverse Event|3|||
157247703|NCT02081599|567651718|FG001|Period 1：Double-blind Period|Adverse Event|0|||
157247704|NCT02081599|567651717|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
157247705|NCT02081599|567651718|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
157247706|NCT02081599|567651717|FG000|Period 1：Double-blind Period|Physician Decision|1|||
157247707|NCT02081599|567651718|FG001|Period 1：Double-blind Period|Physician Decision|0|||
157247708|NCT02081599|567651717|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
157247709|NCT02081599|567651718|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
157247710|NCT02081599|567651717|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
157247711|NCT02081599|567651718|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
157247712|NCT02081599|567651717|FG000|Period 1：Double-blind Period|stopping criteria|1|||
157247713|NCT02081599|567651718|FG001|Period 1：Double-blind Period|stopping criteria|0|||
157247714|NCT02081599|567651717|FG000|Period 2：Open-label Period|Adverse Event|1|||
157247715|NCT02081599|567651718|FG001|Period 2：Open-label Period|Adverse Event|0|||
157247716|NCT02081599|567651717|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
157247717|NCT02081599|567651718|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
157247718|NCT02081599|567651717|FG000|Period 2：Open-label Period|Physician Decision|1|||
157247719|NCT02081599|567651718|FG001|Period 2：Open-label Period|Physician Decision|0|||
157247720|NCT02081599|567651717|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
157247721|NCT02081599|567651718|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
157247722|NCT04307134|567651719|FG000|Overall Study|Lost to Follow-up|2|||
157247723|NCT04307134|567651719|FG000|Overall Study|Withdrawal by Subject|3|||
157247724|NCT04307134|567651719|FG000|Overall Study|Other|3|||
157247725|NCT04307134|567651719|FG000|Overall Study|Death|21|||
157247726|NCT04307134|567651719|FG000|Overall Study|Enrolled but not Treated|1|||
157247727|NCT00255346|567651732|FG000|Overall Study|Adverse Event|1|||
157247728|NCT00255346|567651733|FG001|Overall Study|Adverse Event|0|||
157247729|NCT00255346|567651734|FG002|Overall Study|Adverse Event|0|||
157247730|NCT00255346|567651735|FG003|Overall Study|Adverse Event|0|||
157247731|NCT00255346|567651736|FG004|Overall Study|Adverse Event|0|||
157247732|NCT04402489|567651738|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
157247733|NCT04402489|567651739|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
157247734|NCT04402489|567651740|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
157247735|NCT04402489|567651741|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
157247736|NCT04402489|567651742|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
157247737|NCT04402489|567651738|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
157247738|NCT04402489|567651739|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
157247739|NCT04402489|567651740|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
157247740|NCT04402489|567651741|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
157247741|NCT04402489|567651742|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
157247742|NCT04402489|567651738|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
157247743|NCT04402489|567651739|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
157247744|NCT04402489|567651740|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
157247745|NCT04402489|567651741|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
157247746|NCT04402489|567651742|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
157247747|NCT04402489|567651738|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
157247748|NCT04402489|567651739|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
157247749|NCT04402489|567651740|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
157247750|NCT04402489|567651741|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
157247751|NCT04402489|567651742|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
157247752|NCT04402489|567651738|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
157247753|NCT04402489|567651739|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
157247754|NCT04402489|567651740|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
157247755|NCT04402489|567651741|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
157247756|NCT04402489|567651742|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
157247757|NCT04402489|567651738|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
157247758|NCT04402489|567651739|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
157247759|NCT04402489|567651740|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
157247760|NCT04402489|567651741|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
157247761|NCT04402489|567651742|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
157247762|NCT03192891|567651743|FG000|Overall Study|Lost to Follow-up|55|||
157247763|NCT05223868|567651744|FG000|Overall Study|Lost to Follow-up|1|||
157247764|NCT05223868|567651745|FG001|Overall Study|Lost to Follow-up|3|||
157247765|NCT05223868|567651746|FG002|Overall Study|Lost to Follow-up|0|||
157247766|NCT05223868|567651747|FG003|Overall Study|Lost to Follow-up|0|||
157247767|NCT05223868|567651748|FG004|Overall Study|Lost to Follow-up|0|||
157247768|NCT05223868|567651749|FG005|Overall Study|Lost to Follow-up|1|||
157247769|NCT05223868|567651744|FG000|Overall Study|Withdrawal by Subject|6|||
157247770|NCT05223868|567651745|FG001|Overall Study|Withdrawal by Subject|2|||
157247771|NCT05223868|567651746|FG002|Overall Study|Withdrawal by Subject|3|||
157247772|NCT05223868|567651747|FG003|Overall Study|Withdrawal by Subject|1|||
157247773|NCT05223868|567651748|FG004|Overall Study|Withdrawal by Subject|1|||
157247774|NCT05223868|567651749|FG005|Overall Study|Withdrawal by Subject|2|||
157247775|NCT05223868|567651744|FG000|Overall Study|Other|0|||
157247776|NCT05223868|567651745|FG001|Overall Study|Other|2|||
157247777|NCT05223868|567651746|FG002|Overall Study|Other|0|||
157247778|NCT05223868|567651747|FG003|Overall Study|Other|0|||
157247779|NCT05223868|567651748|FG004|Overall Study|Other|1|||
157247780|NCT05223868|567651749|FG005|Overall Study|Other|1|||
157247781|NCT05590585|567651750|FG000|Overall Study|Lost to Follow-up|3|||
157247782|NCT05590585|567651750|FG000|Overall Study|Withdrawal by Subject|1|||
157247783|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
157247784|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
157247785|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
157247786|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
157247787|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
157247788|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
157247789|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
157247790|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
157247791|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
157247792|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
157247793|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
157247794|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
157247795|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
157247796|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
157247797|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
157247798|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
157247799|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
157247800|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
157247801|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
157247802|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
157247803|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
157247804|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
157247805|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
157247806|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
157247807|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
157247808|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
157247809|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
157247810|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
157247811|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
157247812|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
157247813|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
157247814|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
157247815|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
157247816|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
157247817|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
157247818|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
157247819|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
157247820|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
157247821|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
157247822|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
157247823|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
157247824|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
157247825|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
157247826|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
157247827|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
157247828|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
157247829|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
157247830|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
157247831|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
157247832|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
157247833|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
157247834|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
157247835|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
157247836|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
157247837|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
157247838|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
157247839|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
157247840|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
157247841|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
157247842|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
157247843|NCT03395197|567651751|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
157247844|NCT03395197|567651752|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
157247845|NCT03395197|567651753|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
157247846|NCT03395197|567651754|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
157247847|NCT03395197|567651755|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
157247848|NCT03395197|567651756|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
157247849|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Death|0|||
157247850|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Death|0|||
157247851|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Death|0|||
157247852|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Death|0|||
157247853|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Death|1|||
157247854|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Death|4|||
157247855|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
157247856|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
157247857|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
157247858|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
157247859|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
157247860|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
157247861|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
157247862|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
157247863|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
157247864|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
157247865|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
157247866|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
157247867|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
157247868|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
157247869|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
157247870|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
157247871|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
157247872|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
157247873|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
157247874|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
157247875|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
157247876|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
157247877|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
157247878|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
157247879|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
157247880|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
157247881|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
157247882|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
157247883|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
157247884|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
157247885|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
157247886|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
157247887|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
157247888|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
157247889|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
157247890|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
157247891|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Other|0|||
157247892|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Other|0|||
157247893|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Other|0|||
157247894|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Other|0|||
157247895|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Other|3|||
157247896|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Other|3|||
157247897|NCT03395197|567651751|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
157247898|NCT03395197|567651752|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
157247899|NCT03395197|567651753|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
157247900|NCT03395197|567651754|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
157247901|NCT03395197|567651755|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
157247902|NCT03395197|567651756|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
157247903|NCT03609944|567651757|FG000|Overall Study|Lost to Follow-up|1|||
157247904|NCT03609944|567651758|FG001|Overall Study|Lost to Follow-up|5|||
157247905|NCT03609944|567651757|FG000|Overall Study|Withdrawal by Subject|1|||
157247906|NCT03609944|567651758|FG001|Overall Study|Withdrawal by Subject|1|||
157247907|NCT06041646|567651761|FG000|Overall Study|Withdrawal by Subject|1|||
157247908|NCT05330975|567651762|FG000|Primary|Lost to Follow-up|12|||
157247909|NCT05330975|567651763|FG001|Primary|Lost to Follow-up|21|||
157247910|NCT05330975|567651764|FG002|Primary|Lost to Follow-up|38|||
157247911|NCT05330975|567651765|FG003|Primary|Lost to Follow-up|30|||
157247912|NCT05330975|567651766|FG004|Primary|Lost to Follow-up|25|||
157247913|NCT05330975|567651767|FG005|Primary|Lost to Follow-up|28|||
157247914|NCT05330975|567651768|FG006|Primary|Lost to Follow-up|0|||
157247915|NCT05330975|567651762|FG000|Primary|Withdrawal by Subject|4|||
157247916|NCT05330975|567651763|FG001|Primary|Withdrawal by Subject|11|||
157247917|NCT05330975|567651764|FG002|Primary|Withdrawal by Subject|8|||
157247918|NCT05330975|567651765|FG003|Primary|Withdrawal by Subject|23|||
157247919|NCT05330975|567651766|FG004|Primary|Withdrawal by Subject|20|||
157247920|NCT05330975|567651767|FG005|Primary|Withdrawal by Subject|19|||
157247921|NCT05330975|567651768|FG006|Primary|Withdrawal by Subject|0|||
157247922|NCT05330975|567651762|FG000|Primary|Protocol Violation|0|||
157247923|NCT05330975|567651763|FG001|Primary|Protocol Violation|2|||
157247924|NCT05330975|567651764|FG002|Primary|Protocol Violation|0|||
157247925|NCT05330975|567651765|FG003|Primary|Protocol Violation|4|||
157247926|NCT05330975|567651766|FG004|Primary|Protocol Violation|0|||
157247927|NCT05330975|567651767|FG005|Primary|Protocol Violation|3|||
157247928|NCT05330975|567651768|FG006|Primary|Protocol Violation|0|||
157247929|NCT05330975|567651762|FG000|Primary|Death|0|||
157247930|NCT05330975|567651763|FG001|Primary|Death|3|||
157247931|NCT05330975|567651764|FG002|Primary|Death|1|||
157247932|NCT05330975|567651765|FG003|Primary|Death|1|||
157247933|NCT05330975|567651766|FG004|Primary|Death|0|||
157247934|NCT05330975|567651767|FG005|Primary|Death|0|||
157247935|NCT05330975|567651768|FG006|Primary|Death|0|||
157247936|NCT05330975|567651762|FG000|Primary|Other Than Specified|0|||
157247937|NCT05330975|567651763|FG001|Primary|Other Than Specified|1|||
157247938|NCT05330975|567651764|FG002|Primary|Other Than Specified|2|||
157247939|NCT05330975|567651765|FG003|Primary|Other Than Specified|1|||
157247940|NCT05330975|567651766|FG004|Primary|Other Than Specified|2|||
157247941|NCT05330975|567651767|FG005|Primary|Other Than Specified|2|||
157247942|NCT05330975|567651768|FG006|Primary|Other Than Specified|0|||
157247943|NCT05330975|567651762|FG000|Primary|Adverse Event|0|||
157247944|NCT05330975|567651763|FG001|Primary|Adverse Event|0|||
157247945|NCT05330975|567651764|FG002|Primary|Adverse Event|0|||
157247946|NCT05330975|567651765|FG003|Primary|Adverse Event|1|||
157247947|NCT05330975|567651766|FG004|Primary|Adverse Event|0|||
157247948|NCT05330975|567651767|FG005|Primary|Adverse Event|0|||
157247949|NCT05330975|567651768|FG006|Primary|Adverse Event|0|||
157247950|NCT05330975|567651762|FG000|Primary|Physician Decision|0|||
157247951|NCT05330975|567651763|FG001|Primary|Physician Decision|0|||
157247952|NCT05330975|567651764|FG002|Primary|Physician Decision|0|||
157247953|NCT05330975|567651765|FG003|Primary|Physician Decision|0|||
157247954|NCT05330975|567651766|FG004|Primary|Physician Decision|1|||
157247955|NCT05330975|567651767|FG005|Primary|Physician Decision|0|||
157247956|NCT05330975|567651768|FG006|Primary|Physician Decision|0|||
157247957|NCT05330975|567651762|FG000|Revaccination|Adverse Event|0|||
157247958|NCT05330975|567651763|FG001|Revaccination|Adverse Event|0|||
157247959|NCT05330975|567651764|FG002|Revaccination|Adverse Event|0|||
157247960|NCT05330975|567651765|FG003|Revaccination|Adverse Event|0|||
157247961|NCT05330975|567651766|FG004|Revaccination|Adverse Event|0|||
157247962|NCT05330975|567651767|FG005|Revaccination|Adverse Event|0|||
157247963|NCT05330975|567651768|FG006|Revaccination|Adverse Event|3|||
157247964|NCT05330975|567651762|FG000|Revaccination|Lost to Follow-up|0|||
157247965|NCT05330975|567651763|FG001|Revaccination|Lost to Follow-up|0|||
157247966|NCT05330975|567651764|FG002|Revaccination|Lost to Follow-up|0|||
157247967|NCT05330975|567651765|FG003|Revaccination|Lost to Follow-up|0|||
157247968|NCT05330975|567651766|FG004|Revaccination|Lost to Follow-up|0|||
157247969|NCT05330975|567651767|FG005|Revaccination|Lost to Follow-up|0|||
157247970|NCT05330975|567651768|FG006|Revaccination|Lost to Follow-up|10|||
157247971|NCT05330975|567651762|FG000|Revaccination|Withdrawal by Subject|0|||
157247972|NCT05330975|567651763|FG001|Revaccination|Withdrawal by Subject|0|||
157247973|NCT05330975|567651764|FG002|Revaccination|Withdrawal by Subject|0|||
157247974|NCT05330975|567651765|FG003|Revaccination|Withdrawal by Subject|0|||
157247975|NCT05330975|567651766|FG004|Revaccination|Withdrawal by Subject|0|||
157247976|NCT05330975|567651767|FG005|Revaccination|Withdrawal by Subject|0|||
157247977|NCT05330975|567651768|FG006|Revaccination|Withdrawal by Subject|2|||
157247978|NCT05330975|567651762|FG000|Revaccination|Death|0|||
157247979|NCT05330975|567651763|FG001|Revaccination|Death|0|||
157247980|NCT05330975|567651764|FG002|Revaccination|Death|0|||
157247981|NCT05330975|567651765|FG003|Revaccination|Death|0|||
157247982|NCT05330975|567651766|FG004|Revaccination|Death|0|||
157247983|NCT05330975|567651767|FG005|Revaccination|Death|0|||
157247984|NCT05330975|567651768|FG006|Revaccination|Death|3|||
157247985|NCT04903288|567651769|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
157247986|NCT04903288|567651769|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
157247987|NCT04903288|567651769|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
157247988|NCT04903288|567651769|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
157247989|NCT02531126|567651773|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
157247990|NCT02531126|567651774|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
157247991|NCT02531126|567651775|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
157247992|NCT02531126|567651776|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
157247993|NCT02531126|567651773|FG000|Overall Study|Adverse Event|16|||
157247994|NCT02531126|567651774|FG001|Overall Study|Adverse Event|13|||
157247995|NCT02531126|567651775|FG002|Overall Study|Adverse Event|27|||
157247996|NCT02531126|567651776|FG003|Overall Study|Adverse Event|4|||
157247997|NCT02531126|567651773|FG000|Overall Study|Lack of Efficacy|50|||
157247998|NCT02531126|567651774|FG001|Overall Study|Lack of Efficacy|32|||
157247999|NCT02531126|567651775|FG002|Overall Study|Lack of Efficacy|121|||
157248000|NCT02531126|567651776|FG003|Overall Study|Lack of Efficacy|0|||
157248001|NCT02531126|567651773|FG000|Overall Study|Withdrawal by Subject|38|||
157248002|NCT02531126|567651774|FG001|Overall Study|Withdrawal by Subject|31|||
157248003|NCT02531126|567651775|FG002|Overall Study|Withdrawal by Subject|96|||
157248004|NCT02531126|567651776|FG003|Overall Study|Withdrawal by Subject|6|||
157248005|NCT02531126|567651773|FG000|Overall Study|Pregnancy|2|||
157248006|NCT02531126|567651774|FG001|Overall Study|Pregnancy|3|||
157248007|NCT02531126|567651775|FG002|Overall Study|Pregnancy|2|||
157248008|NCT02531126|567651776|FG003|Overall Study|Pregnancy|0|||
157248009|NCT02531126|567651773|FG000|Overall Study|Switched to commercial drug|2|||
157248012|NCT02531126|567651776|FG003|Overall Study|Switched to commercial drug|0|||
157248013|NCT02531126|567651773|FG000|Overall Study|Other reasons|23|||
157248014|NCT02531126|567651774|FG001|Overall Study|Other reasons|29|||
157248015|NCT02531126|567651775|FG002|Overall Study|Other reasons|27|||
157248016|NCT02531126|567651776|FG003|Overall Study|Other reasons|15|||
157248017|NCT02531126|567651773|FG000|Overall Study|Physician Decision|6|||
157248018|NCT02531126|567651774|FG001|Overall Study|Physician Decision|6|||
157248019|NCT02531126|567651775|FG002|Overall Study|Physician Decision|28|||
157248020|NCT02531126|567651776|FG003|Overall Study|Physician Decision|0|||
157248021|NCT02531126|567651773|FG000|Overall Study|Non-compliance with investigational drug|1|||
157248022|NCT02531126|567651774|FG001|Overall Study|Non-compliance with investigational drug|0|||
157248023|NCT02531126|567651775|FG002|Overall Study|Non-compliance with investigational drug|0|||
157248024|NCT02531126|567651776|FG003|Overall Study|Non-compliance with investigational drug|0|||
157248025|NCT01809691|567651777|FG000|Overall Study|Currently on Treatment|192|||
157248026|NCT01809691|567651778|FG001|Overall Study|Currently on Treatment|100|||
157248027|NCT01809691|567651777|FG000|Overall Study|No Protocol Treatment|10|||
157248028|NCT01809691|567651778|FG001|Overall Study|No Protocol Treatment|11|||
157248029|NCT01809691|567651777|FG000|Overall Study|Adverse Event|80|||
157248030|NCT01809691|567651778|FG001|Overall Study|Adverse Event|21|||
157248031|NCT01809691|567651777|FG000|Overall Study|Disease Progression|226|||
157248032|NCT01809691|567651778|FG001|Overall Study|Disease Progression|372|||
157248033|NCT01809691|567651777|FG000|Overall Study|Death|26|||
157248034|NCT01809691|567651778|FG001|Overall Study|Death|13|||
157248035|NCT01809691|567651777|FG000|Overall Study|Participant Refusal|70|||
157248036|NCT01809691|567651778|FG001|Overall Study|Participant Refusal|72|||
157248037|NCT01809691|567651777|FG000|Overall Study|Other, Not Specified|34|||
157248038|NCT01809691|567651778|FG001|Overall Study|Other, Not Specified|52|||
157248039|NCT05267106|567651779|FG000|Overall Study|Death|50|||
157248040|NCT05267106|567651780|FG001|Overall Study|Death|2|||
157248041|NCT05267106|567651779|FG000|Overall Study|Study terminated by Sponsor|24|||
157248042|NCT05267106|567651780|FG001|Overall Study|Study terminated by Sponsor|6|||
157248043|NCT05267106|567651779|FG000|Overall Study|Withdrawal by Subject|0|||
157248044|NCT05267106|567651780|FG001|Overall Study|Withdrawal by Subject|1|||
157248045|NCT04165824|567651781|FG000|Overall Study|Adverse Event|23|||
157248046|NCT04165824|567651781|FG000|Overall Study|Physician Decision|1|||
157248047|NCT04165824|567651781|FG000|Overall Study|Withdrawal by Subject|17|||
157248048|NCT04165824|567651781|FG000|Overall Study|Other|5|||
157248049|NCT03085433|567651782|FG000|Overall Study|Withdrawal by Subject|2|||
157248050|NCT03085433|567651783|FG001|Overall Study|Withdrawal by Subject|4|||
157248051|NCT03085433|567651782|FG000|Overall Study|Physician Decision|33|||
157248052|NCT03085433|567651783|FG001|Overall Study|Physician Decision|50|||
157248053|NCT03809039|567651786|FG000|Part 1|Withdrawal by Subject|1|||
157248054|NCT03809039|567651787|FG001|Part 1|Withdrawal by Subject|0|||
157248055|NCT03809039|567651788|FG002|Part 1|Withdrawal by Subject|0|||
157248056|NCT03809039|567651789|FG003|Part 1|Withdrawal by Subject|1|||
157248057|NCT03809039|567651790|FG004|Part 1|Withdrawal by Subject|0|||
157248058|NCT03809039|567651791|FG005|Part 1|Withdrawal by Subject|0|||
157248059|NCT03809039|567651792|FG006|Part 1|Withdrawal by Subject|0|||
157248060|NCT03809039|567651793|FG007|Part 1|Withdrawal by Subject|0|||
157248061|NCT03809039|567651794|FG008|Part 1|Withdrawal by Subject|0|||
157248062|NCT03809039|567651786|FG000|Part 3|Withdrawn by study termination|0|||
157248063|NCT03809039|567651787|FG001|Part 3|Withdrawn by study termination|0|||
157248064|NCT03809039|567651788|FG002|Part 3|Withdrawn by study termination|0|||
157248065|NCT03809039|567651789|FG003|Part 3|Withdrawn by study termination|0|||
157248066|NCT03809039|567651790|FG004|Part 3|Withdrawn by study termination|0|||
157248067|NCT03809039|567651791|FG005|Part 3|Withdrawn by study termination|0|||
157248068|NCT03809039|567651792|FG006|Part 3|Withdrawn by study termination|0|||
157248069|NCT03809039|567651793|FG007|Part 3|Withdrawn by study termination|2|||
157248070|NCT03809039|567651794|FG008|Part 3|Withdrawn by study termination|6|||
157248071|NCT03036930|567651795|FG000|Overall Study|Lost to Follow-up|7|||
157248072|NCT03036930|567651795|FG000|Overall Study|Withdrawal by Subject|3|||
157248073|NCT03036930|567651795|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
157248074|NCT05271552|567651796|FG000|Overall Study|Adverse Event|4|||
157248075|NCT05271552|567651797|FG001|Overall Study|Adverse Event|6|||
157248076|NCT05271552|567651798|FG002|Overall Study|Adverse Event|3|||
157248077|NCT05271552|567651796|FG000|Overall Study|Death|1|||
157248078|NCT05271552|567651797|FG001|Overall Study|Death|1|||
157248079|NCT05271552|567651798|FG002|Overall Study|Death|1|||
157248080|NCT05271552|567651796|FG000|Overall Study|Lost to Follow-up|1|||
157248081|NCT05271552|567651797|FG001|Overall Study|Lost to Follow-up|5|||
157248082|NCT05271552|567651798|FG002|Overall Study|Lost to Follow-up|4|||
157248083|NCT05271552|567651796|FG000|Overall Study|Withdrawal by Subject|0|||
157248084|NCT05271552|567651797|FG001|Overall Study|Withdrawal by Subject|4|||
157248085|NCT05271552|567651798|FG002|Overall Study|Withdrawal by Subject|7|||
157248086|NCT05271552|567651796|FG000|Overall Study|Other medical reason.|1|||
157248087|NCT05271552|567651797|FG001|Overall Study|Other medical reason.|2|||
157248088|NCT05271552|567651798|FG002|Overall Study|Other medical reason.|0|||
157248089|NCT05271552|567651796|FG000|Overall Study|Other|3|||
157248090|NCT05271552|567651797|FG001|Overall Study|Other|3|||
157248091|NCT05271552|567651798|FG002|Overall Study|Other|6|||
157248092|NCT04227899|567651807|FG000|Overall Study|Withdrawal by Subject|6|||
157248093|NCT04227899|567651808|FG001|Overall Study|Withdrawal by Subject|3|||
157248094|NCT04227899|567651807|FG000|Overall Study|Death|12|||
157248095|NCT04227899|567651808|FG001|Overall Study|Death|6|||
157248096|NCT04227899|567651807|FG000|Overall Study|Lost to Follow-up|2|||
157248097|NCT04227899|567651808|FG001|Overall Study|Lost to Follow-up|1|||
157248098|NCT05151471|567651809|FG000|Overall Study|Adverse Event|21|||
157248099|NCT05151471|567651810|FG001|Overall Study|Adverse Event|16|||
157248100|NCT05151471|567651809|FG000|Overall Study|Death|1|||
157248101|NCT05151471|567651810|FG001|Overall Study|Death|0|||
157248102|NCT05151471|567651809|FG000|Overall Study|Lost to Follow-up|0|||
157248103|NCT05151471|567651810|FG001|Overall Study|Lost to Follow-up|1|||
157248104|NCT05151471|567651809|FG000|Overall Study|Withdrawal by Subject|7|||
157248105|NCT05151471|567651810|FG001|Overall Study|Withdrawal by Subject|9|||
157248106|NCT05151471|567651809|FG000|Overall Study|Study terminated by sponsor|49|||
157248107|NCT05151471|567651810|FG001|Overall Study|Study terminated by sponsor|47|||
157248108|NCT05151471|567651809|FG000|Overall Study|Other|2|||
157248109|NCT05151471|567651810|FG001|Overall Study|Other|1|||
157248110|NCT03988608|567651811|FG000|Overall Study|Adverse Event|1|||
157248111|NCT03988608|567651811|FG000|Overall Study|Lost to Follow-up|1|||
157248112|NCT03988608|567651811|FG000|Overall Study|Withdrawal by Subject|3|||
157248113|NCT03988608|567651811|FG000|Overall Study|Death|1|||
157248114|NCT03840993|567651813|FG000|Overall Study|Adverse Event|1|||
157248115|NCT03840993|567651814|FG001|Overall Study|Adverse Event|0|||
157248116|NCT03840993|567651813|FG000|Overall Study|Lost to Follow-up|4|||
157248117|NCT03840993|567651814|FG001|Overall Study|Lost to Follow-up|0|||
157248118|NCT03840993|567651813|FG000|Overall Study|Physician Decision|0|||
157248119|NCT03840993|567651814|FG001|Overall Study|Physician Decision|1|||
157248120|NCT03840993|567651813|FG000|Overall Study|Pregnancy|0|||
157248121|NCT03840993|567651814|FG001|Overall Study|Pregnancy|1|||
157248122|NCT03840993|567651813|FG000|Overall Study|Withdrawal by Subject|1|||
157248123|NCT03840993|567651814|FG001|Overall Study|Withdrawal by Subject|3|||
157248124|NCT03840993|567651813|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
157248125|NCT03840993|567651814|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
157248126|NCT00998881|567651823|FG000|Overall Study|Adverse Event|2|||
157248127|NCT00998881|567651824|FG001|Overall Study|Adverse Event|2|||
157248128|NCT00998881|567651823|FG000|Overall Study|Lack of Efficacy|1|||
157248129|NCT00998881|567651824|FG001|Overall Study|Lack of Efficacy|0|||
157248130|NCT00998881|567651823|FG000|Overall Study|Physician Decision|3|||
157248131|NCT00998881|567651824|FG001|Overall Study|Physician Decision|0|||
157248132|NCT00998881|567651823|FG000|Overall Study|Withdrawal by Subject|1|||
157248133|NCT00998881|567651824|FG001|Overall Study|Withdrawal by Subject|0|||
157248134|NCT00998881|567651823|FG000|Overall Study|Personal matter|1|||
157248135|NCT00998881|567651824|FG001|Overall Study|Personal matter|0|||
157248136|NCT03292458|567651825|FG000|Period 1|Adverse Event|2|||
157248137|NCT03292458|567651826|FG001|Period 1|Adverse Event|0|||
157248138|NCT04281485|567651827|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
157248139|NCT04281485|567651828|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
157248140|NCT04281485|567651827|FG000|Overall Study|Ongoing (Safety data collection)|10|||
157248141|NCT04281485|567651828|FG001|Overall Study|Ongoing (Safety data collection)|5|||
157248142|NCT04203160|567651829|FG000|Overall Study|Alternative Therapy|3|||
157248143|NCT04203160|567651830|FG001|Overall Study|Alternative Therapy|0|||
157248144|NCT04203160|567651831|FG002|Overall Study|Alternative Therapy|1|||
157248145|NCT04203160|567651832|FG003|Overall Study|Alternative Therapy|0|||
157248146|NCT04203160|567651833|FG004|Overall Study|Alternative Therapy|0|||
157248147|NCT04203160|567651834|FG005|Overall Study|Alternative Therapy|2|||
157248148|NCT04203160|567651829|FG000|Overall Study|Withdrawal by Subject|4|||
157248149|NCT04203160|567651830|FG001|Overall Study|Withdrawal by Subject|5|||
157248150|NCT04203160|567651831|FG002|Overall Study|Withdrawal by Subject|0|||
157248151|NCT04203160|567651832|FG003|Overall Study|Withdrawal by Subject|0|||
157248152|NCT04203160|567651833|FG004|Overall Study|Withdrawal by Subject|0|||
157248153|NCT04203160|567651834|FG005|Overall Study|Withdrawal by Subject|4|||
157248154|NCT04203160|567651829|FG000|Overall Study|Adverse Event|7|||
157248155|NCT04203160|567651830|FG001|Overall Study|Adverse Event|5|||
157248156|NCT04203160|567651831|FG002|Overall Study|Adverse Event|0|||
157248157|NCT04203160|567651832|FG003|Overall Study|Adverse Event|0|||
157248158|NCT04203160|567651833|FG004|Overall Study|Adverse Event|0|||
157248159|NCT04203160|567651834|FG005|Overall Study|Adverse Event|0|||
157248160|NCT04203160|567651829|FG000|Overall Study|Sponsor Termination|1|||
157248161|NCT04203160|567651830|FG001|Overall Study|Sponsor Termination|0|||
157248162|NCT04203160|567651831|FG002|Overall Study|Sponsor Termination|0|||
157248163|NCT04203160|567651832|FG003|Overall Study|Sponsor Termination|0|||
157248164|NCT04203160|567651833|FG004|Overall Study|Sponsor Termination|0|||
157248165|NCT04203160|567651834|FG005|Overall Study|Sponsor Termination|0|||
157248166|NCT04203160|567651829|FG000|Overall Study|Physician Decision|3|||
157248167|NCT04203160|567651830|FG001|Overall Study|Physician Decision|2|||
157248168|NCT04203160|567651831|FG002|Overall Study|Physician Decision|0|||
157248169|NCT04203160|567651832|FG003|Overall Study|Physician Decision|0|||
157248170|NCT04203160|567651833|FG004|Overall Study|Physician Decision|0|||
157248171|NCT04203160|567651834|FG005|Overall Study|Physician Decision|0|||
157248172|NCT04317599|567651835|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
157248173|NCT04317599|567651835|FG000|Overall Study|treatment outside standard of care|4|||
157248174|NCT02276885|567651836|FG000|Overall Study|Withdrawal by Subject|2|||
157248175|NCT02276885|567651837|FG001|Overall Study|Withdrawal by Subject|0|||
157248176|NCT02276885|567651836|FG000|Overall Study|Lost to Follow-up|5|||
157248177|NCT02276885|567651837|FG001|Overall Study|Lost to Follow-up|2|||
157248178|NCT04569032|567651841|FG000|Overall Study|Death|10|||
157248179|NCT04569032|567651842|FG001|Overall Study|Death|13|||
157248180|NCT04569032|567651841|FG000|Overall Study|Withdrawal by Subject|2|||
157248181|NCT04569032|567651842|FG001|Overall Study|Withdrawal by Subject|0|||
157248182|NCT04569032|567651841|FG000|Overall Study|Lost to Follow-up|0|||
157248183|NCT04569032|567651842|FG001|Overall Study|Lost to Follow-up|1|||
157248184|NCT04569032|567651841|FG000|Overall Study|In long term follow up|22|||
157248185|NCT04569032|567651842|FG001|Overall Study|In long term follow up|34|||
157248186|NCT03541200|567651843|FG000|Overall Study|Adverse Event|19|||
157248187|NCT03541200|567651843|FG000|Overall Study|Death|1|||
157248188|NCT03541200|567651843|FG000|Overall Study|Lost to Follow-up|10|||
157248189|NCT03541200|567651843|FG000|Overall Study|Physician Decision|1|||
157248190|NCT03541200|567651843|FG000|Overall Study|Protocol Violation|51|||
157248191|NCT03541200|567651843|FG000|Overall Study|Withdrawal by Subject|23|||
157248192|NCT03541200|567651843|FG000|Overall Study|other|8|||
157248193|NCT05714345|567651844|FG000|Overall Study|Death|1|||
157248194|NCT05714345|567651845|FG001|Overall Study|Death|1|||
157248195|NCT03837626|567651851|FG000|Overall Study|Adverse Event|3|||
157248196|NCT03837626|567651852|FG001|Overall Study|Adverse Event|3|||
157248197|NCT03837626|567651851|FG000|Overall Study|Withdrawal by Subject|2|||
157248198|NCT03837626|567651852|FG001|Overall Study|Withdrawal by Subject|4|||
157248199|NCT03837626|567651851|FG000|Overall Study|Physician Decision|2|||
157248200|NCT03837626|567651852|FG001|Overall Study|Physician Decision|3|||
157248201|NCT03837626|567651851|FG000|Overall Study|Lost to Follow-up|3|||
157248202|NCT03837626|567651852|FG001|Overall Study|Lost to Follow-up|1|||
157248203|NCT04601857|567651853|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
157248204|NCT04601857|567651854|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
157248205|NCT04601857|567651853|FG000|Overall Study|Disease Progression|2|||
157248206|NCT04601857|567651854|FG001|Overall Study|Disease Progression|4|||
157248207|NCT04601857|567651853|FG000|Overall Study|Clinical Disease Progression|2|||
157248208|NCT04601857|567651854|FG001|Overall Study|Clinical Disease Progression|1|||
157248209|NCT04601857|567651853|FG000|Overall Study|Radiological Progression|4|||
157248210|NCT04601857|567651854|FG001|Overall Study|Radiological Progression|11|||
157248211|NCT04601857|567651853|FG000|Overall Study|Death|1|||
157248212|NCT04601857|567651854|FG001|Overall Study|Death|0|||
157248213|NCT04601857|567651853|FG000|Overall Study|Reason Not Specified|0|||
157248214|NCT04601857|567651854|FG001|Overall Study|Reason Not Specified|1|||
157248215|NCT04601857|567651853|FG000|Overall Study|At the Participant's Request|0|||
157248216|NCT04601857|567651854|FG001|Overall Study|At the Participant's Request|1|||
157248217|NCT03933202|567651855|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
157248218|NCT03933202|567651856|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
157248219|NCT03933202|567651855|FG000|Overall Study|Participant transferred care|1|||
157248220|NCT03933202|567651856|FG001|Overall Study|Participant transferred care|0|||
157248221|NCT03933202|567651855|FG000|Overall Study|Site research department closing|1|||
157248222|NCT03933202|567651856|FG001|Overall Study|Site research department closing|0|||
157248223|NCT03933202|567651855|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
157248224|NCT03933202|567651856|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
157248225|NCT03933202|567651855|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
157248226|NCT03933202|567651856|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
157248227|NCT03933202|567651855|FG000|Overall Study|Participant changed primary neurology provider|1|||
157248228|NCT03933202|567651856|FG001|Overall Study|Participant changed primary neurology provider|0|||
157248229|NCT03933202|567651855|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
157248230|NCT03933202|567651856|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
157248231|NCT03933202|567651855|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
157248232|NCT03933202|567651856|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
157248233|NCT03933202|567651855|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
157248234|NCT03933202|567651856|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
157248235|NCT03933202|567651855|FG000|Overall Study|Missed visit|0|||
157248236|NCT03933202|567651856|FG001|Overall Study|Missed visit|1|||
157248237|NCT03933202|567651855|FG000|Overall Study|Investigator decision|4|||
157248238|NCT03933202|567651856|FG001|Overall Study|Investigator decision|0|||
157248239|NCT03933202|567651855|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
157248240|NCT03933202|567651856|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
157248241|NCT03933202|567651855|FG000|Overall Study|Withdrawal by Subject|10|||
157248242|NCT03933202|567651856|FG001|Overall Study|Withdrawal by Subject|8|||
157248243|NCT03933202|567651855|FG000|Overall Study|Death|2|||
157248244|NCT03933202|567651856|FG001|Overall Study|Death|0|||
157248245|NCT03933202|567651855|FG000|Overall Study|Progressive disease|0|||
157248246|NCT03933202|567651856|FG001|Overall Study|Progressive disease|3|||
157248247|NCT03933202|567651855|FG000|Overall Study|Protocol non-compliance|6|||
157248248|NCT03933202|567651856|FG001|Overall Study|Protocol non-compliance|3|||
157248249|NCT03933202|567651855|FG000|Overall Study|Lost to Follow-up|16|||
157248250|NCT03933202|567651856|FG001|Overall Study|Lost to Follow-up|8|||
157248251|NCT03933202|567651855|FG000|Overall Study|Adverse Event|3|||
157248252|NCT03933202|567651856|FG001|Overall Study|Adverse Event|0|||
157248253|NCT00980954|567651857|FG000|Overall Study|Protocol Violation|9|||
157248254|NCT00980954|567651858|FG001|Overall Study|Protocol Violation|15|||
157248255|NCT04115319|567651861|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
157248256|NCT04115319|567651862|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
157248257|NCT04115319|567651861|FG000|Overall Study|Withdrawal by participant|17|||
157248258|NCT04115319|567651862|FG001|Overall Study|Withdrawal by participant|9|||
157248259|NCT04115319|567651861|FG000|Overall Study|Geopolitical Conflict Related|2|||
157248260|NCT04115319|567651862|FG001|Overall Study|Geopolitical Conflict Related|1|||
157248261|NCT04115319|567651861|FG000|Overall Study|COVID-19 Related|1|||
157248262|NCT04115319|567651862|FG001|Overall Study|COVID-19 Related|0|||
157248263|NCT04115319|567651861|FG000|Overall Study|Adverse Event|48|||
157248264|NCT04115319|567651862|FG001|Overall Study|Adverse Event|21|||
157248265|NCT04115319|567651861|FG000|Overall Study|Noncompliance with Study Drug|5|||
157248266|NCT04115319|567651862|FG001|Overall Study|Noncompliance with Study Drug|1|||
157248267|NCT04115319|567651861|FG000|Overall Study|Lack of Efficacy|6|||
157248268|NCT04115319|567651862|FG001|Overall Study|Lack of Efficacy|2|||
157248269|NCT04115319|567651861|FG000|Overall Study|Lost to Follow-up|6|||
157248270|NCT04115319|567651862|FG001|Overall Study|Lost to Follow-up|7|||
157248271|NCT04115319|567651861|FG000|Overall Study|Protocol Deviation|5|||
157248272|NCT04115319|567651862|FG001|Overall Study|Protocol Deviation|1|||
157248273|NCT04115319|567651861|FG000|Overall Study|Participant relocated|5|||
157248274|NCT04115319|567651862|FG001|Overall Study|Participant relocated|2|||
157248275|NCT04115319|567651861|FG000|Overall Study|Personal Reasons|0|||
157248276|NCT04115319|567651862|FG001|Overall Study|Personal Reasons|1|||
157248277|NCT04115319|567651861|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
157248278|NCT04115319|567651862|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
157248279|NCT05658523|567651863|FG000|Baseline|No blood draw|1|||
157248280|NCT05658523|567651864|FG001|Baseline|No blood draw|0|||
157248281|NCT05658523|567651865|FG002|Baseline|No blood draw|0|||
157248282|NCT05658523|567651863|FG000|28 Days|Lost to Follow-up|1|||
157248283|NCT05658523|567651864|FG001|28 Days|Lost to Follow-up|0|||
157248284|NCT05658523|567651865|FG002|28 Days|Lost to Follow-up|0|||
157248285|NCT05658523|567651863|FG000|28 Days|Withdrawal by Subject|1|||
157248286|NCT05658523|567651864|FG001|28 Days|Withdrawal by Subject|1|||
157248287|NCT05658523|567651865|FG002|28 Days|Withdrawal by Subject|0|||
157248288|NCT05658523|567651863|FG000|28 Days|Visit missed|0|||
157248289|NCT05658523|567651864|FG001|28 Days|Visit missed|4|||
157248290|NCT05658523|567651865|FG002|28 Days|Visit missed|0|||
157248291|NCT05658523|567651863|FG000|6 Months|Lost to Follow-up|1|||
157248292|NCT05658523|567651864|FG001|6 Months|Lost to Follow-up|7|||
157248293|NCT05658523|567651865|FG002|6 Months|Lost to Follow-up|2|||
157248294|NCT05658523|567651863|FG000|6 Months|Withdrawal by Subject|1|||
157248295|NCT05658523|567651864|FG001|6 Months|Withdrawal by Subject|3|||
157248296|NCT05658523|567651865|FG002|6 Months|Withdrawal by Subject|4|||
157248297|NCT05658523|567651863|FG000|6 Months|Visit missed|5|||
157248298|NCT05658523|567651864|FG001|6 Months|Visit missed|7|||
157248299|NCT05658523|567651865|FG002|6 Months|Visit missed|0|||
157248300|NCT05658523|567651863|FG000|6 Months|No blood draw|0|||
157248301|NCT05658523|567651864|FG001|6 Months|No blood draw|0|||
157248302|NCT05658523|567651865|FG002|6 Months|No blood draw|1|||
157248303|NCT05658523|567651863|FG000|12 Months|Lost to Follow-up|2|||
157248304|NCT05658523|567651864|FG001|12 Months|Lost to Follow-up|6|||
157248305|NCT05658523|567651865|FG002|12 Months|Lost to Follow-up|3|||
157248306|NCT05658523|567651863|FG000|12 Months|Withdrawal by Subject|4|||
157248307|NCT05658523|567651864|FG001|12 Months|Withdrawal by Subject|4|||
157248308|NCT05658523|567651865|FG002|12 Months|Withdrawal by Subject|2|||
157248309|NCT05658523|567651863|FG000|12 Months|Visit missed|4|||
157248310|NCT05658523|567651864|FG001|12 Months|Visit missed|8|||
157248311|NCT05658523|567651865|FG002|12 Months|Visit missed|8|||
157248312|NCT05658523|567651863|FG000|18 Months|Lost to Follow-up|5|||
157248313|NCT05658523|567651864|FG001|18 Months|Lost to Follow-up|8|||
157248314|NCT05658523|567651865|FG002|18 Months|Lost to Follow-up|2|||
157248315|NCT05658523|567651863|FG000|18 Months|Withdrawal by Subject|17|||
157248316|NCT05658523|567651864|FG001|18 Months|Withdrawal by Subject|9|||
157248317|NCT05658523|567651865|FG002|18 Months|Withdrawal by Subject|16|||
157248318|NCT05658523|567651863|FG000|18 Months|Visit missed|12|||
157248319|NCT05658523|567651864|FG001|18 Months|Visit missed|14|||
157248320|NCT05658523|567651865|FG002|18 Months|Visit missed|6|||
157248321|NCT03212170|567651866|FG000|Overall Study|Withdrawal by Subject|1|||
157248322|NCT05029687|567651878|FG000|Overall Study|Withdrawal by Subject|4|||
157248323|NCT05029687|567651879|FG001|Overall Study|Withdrawal by Subject|0|||
157248324|NCT05029687|567651880|FG002|Overall Study|Withdrawal by Subject|2|||
157248325|NCT05029687|567651878|FG000|Overall Study|Lost to Follow-up|4|||
157248326|NCT05029687|567651879|FG001|Overall Study|Lost to Follow-up|0|||
157248327|NCT05029687|567651880|FG002|Overall Study|Lost to Follow-up|2|||
157248328|NCT04803214|567651881|FG000|Overall Study|Adverse Event|1|||
157248329|NCT04803214|567651882|FG001|Overall Study|Adverse Event|0|||
157248330|NCT04803214|567651881|FG000|Overall Study|Withdrawal by Subject|1|||
157248331|NCT04803214|567651882|FG001|Overall Study|Withdrawal by Subject|2|||
157248332|NCT04803214|567651881|FG000|Overall Study|Lost to Follow-up|2|||
157248333|NCT04803214|567651882|FG001|Overall Study|Lost to Follow-up|4|||
157248334|NCT04803214|567651881|FG000|Overall Study|Physician Decision|1|||
157248335|NCT04803214|567651882|FG001|Overall Study|Physician Decision|1|||
157248336|NCT04803214|567651881|FG000|Overall Study|Missed 12 month visit|0|||
157248337|NCT04803214|567651882|FG001|Overall Study|Missed 12 month visit|3|||
157248338|NCT03345420|567651883|FG000|Overall Study|Withdrawal by Subject|1|||
157248339|NCT00628212|567651889|FG000|Overall Study|Adverse Event|2|||
157248340|NCT00628212|567651890|FG001|Overall Study|Adverse Event|0|||
157248341|NCT00628212|567651891|FG002|Overall Study|Adverse Event|1|||
157248342|NCT00628212|567651892|FG003|Overall Study|Adverse Event|2|||
157248343|NCT00628212|567651889|FG000|Overall Study|Physician Decision|1|||
157248344|NCT00628212|567651890|FG001|Overall Study|Physician Decision|1|||
157248345|NCT00628212|567651891|FG002|Overall Study|Physician Decision|2|||
157248346|NCT00628212|567651892|FG003|Overall Study|Physician Decision|3|||
157248347|NCT05740371|567651896|FG000|Overall Study|Death|1|||
157248348|NCT04930445|567651897|FG000|Overall Study|Adverse Event|7|||
157248349|NCT04930445|567651897|FG000|Overall Study|Lost to Follow-up|1|||
157248350|NCT04930445|567651897|FG000|Overall Study|Physician Decision|1|||
157248351|NCT04930445|567651897|FG000|Overall Study|Lack of Efficacy|1|||
157248352|NCT04930445|567651897|FG000|Overall Study|Study Terminated by Sponsor|245|||
157248353|NCT04930445|567651897|FG000|Overall Study|Screen Failure|8|||
157248354|NCT04930445|567651897|FG000|Overall Study|Other|2|||
157248355|NCT03211416|567651898|FG000|Overall Study|Adverse Event|7|||
157248356|NCT03211416|567651898|FG000|Overall Study|Lack of Efficacy|2|||
157248357|NCT03211416|567651898|FG000|Overall Study|Physician Decision|1|||
157248358|NCT03199274|567651902|FG000|Overall Study|Withdrawal by Subject|4|||
157248359|NCT03199274|567651903|FG001|Overall Study|Withdrawal by Subject|0|||
157248360|NCT03199274|567651902|FG000|Overall Study|Lost to Follow-up|0|||
157248361|NCT03199274|567651903|FG001|Overall Study|Lost to Follow-up|1|||
157248362|NCT03199274|567651902|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
157248363|NCT03199274|567651903|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
157248364|NCT05550532|567652565|FG000|Overall Study|Withdrawal by Subject|8|||
157248365|NCT05550532|567652566|FG001|Overall Study|Withdrawal by Subject|3|||
157248366|NCT05550532|567652565|FG000|Overall Study|Adverse Event|2|||
157248367|NCT05550532|567652566|FG001|Overall Study|Adverse Event|3|||
157248368|NCT05550532|567652565|FG000|Overall Study|Lost to Follow-up|4|||
157248369|NCT05550532|567652566|FG001|Overall Study|Lost to Follow-up|0|||
157248370|NCT05550532|567652565|FG000|Overall Study|Other|0|||
157248371|NCT05550532|567652566|FG001|Overall Study|Other|4|||
157248372|NCT06475729|567652567|FG000|Overall Study|Withdrawal by Subject|2|||
157248373|NCT06475729|567652568|FG001|Overall Study|Withdrawal by Subject|1|||
157248374|NCT06475729|567652567|FG000|Overall Study|Randomized but did not receive any dose|3|||
157248375|NCT06475729|567652568|FG001|Overall Study|Randomized but did not receive any dose|2|||
157248376|NCT06475729|567652567|FG000|Overall Study|Lost to Follow-up|1|||
157248377|NCT06475729|567652568|FG001|Overall Study|Lost to Follow-up|2|||
157248378|NCT06475729|567652567|FG000|Overall Study|Physician Decision|5|||
157248379|NCT06475729|567652568|FG001|Overall Study|Physician Decision|2|||
157248380|NCT06475729|567652567|FG000|Overall Study|Adverse Event|1|||
157248381|NCT06475729|567652568|FG001|Overall Study|Adverse Event|1|||
157248382|NCT03520036|567652569|FG000|Overall Study|Adverse Event|1|||
157248383|NCT03520036|567652570|FG001|Overall Study|Adverse Event|2|||
157248384|NCT03520036|567652571|FG002|Overall Study|Adverse Event|0|||
157248385|NCT03520036|567652569|FG000|Overall Study|Protocol Violation|1|||
157248386|NCT03520036|567652570|FG001|Overall Study|Protocol Violation|0|||
157248387|NCT03520036|567652571|FG002|Overall Study|Protocol Violation|0|||
157248388|NCT03520036|567652569|FG000|Overall Study|Withdrawal by Subject|0|||
157248389|NCT03520036|567652570|FG001|Overall Study|Withdrawal by Subject|1|||
157248390|NCT03520036|567652571|FG002|Overall Study|Withdrawal by Subject|4|||
157248391|NCT03520036|567652569|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
157248392|NCT03520036|567652570|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
157248393|NCT03520036|567652571|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
157248394|NCT00006436|567652572|FG000|Overall Study|Refused further treatment|2|||
157248395|NCT00006436|567652572|FG000|Overall Study|Declined to participate (before treatment started)|1|||
157248396|NCT03926117|567652575|FG000|Overall Study|Unclassified|1|||
157248397|NCT03926117|567652576|FG001|Overall Study|Unclassified|4|||
157248398|NCT03926117|567652577|FG002|Overall Study|Unclassified|1|||
157248399|NCT03926117|567652578|FG003|Overall Study|Unclassified|4|||
157248400|NCT03926117|567652575|FG000|Overall Study|Withdrawal by Subject|3|||
157248401|NCT03926117|567652576|FG001|Overall Study|Withdrawal by Subject|0|||
157248402|NCT03926117|567652577|FG002|Overall Study|Withdrawal by Subject|1|||
157248403|NCT03926117|567652578|FG003|Overall Study|Withdrawal by Subject|1|||
157248404|NCT03926117|567652575|FG000|Overall Study|Lost to Follow-up|0|||
157248405|NCT03926117|567652576|FG001|Overall Study|Lost to Follow-up|2|||
157248406|NCT03926117|567652577|FG002|Overall Study|Lost to Follow-up|1|||
157248407|NCT03926117|567652578|FG003|Overall Study|Lost to Follow-up|0|||
157248408|NCT03926117|567652575|FG000|Overall Study|Adverse Event|1|||
157248409|NCT03926117|567652576|FG001|Overall Study|Adverse Event|2|||
157248410|NCT03926117|567652577|FG002|Overall Study|Adverse Event|3|||
157248411|NCT03926117|567652578|FG003|Overall Study|Adverse Event|1|||
157248412|NCT03926117|567652575|FG000|Overall Study|Randomized but not treated|1|||
157248413|NCT03926117|567652576|FG001|Overall Study|Randomized but not treated|1|||
157248414|NCT03926117|567652577|FG002|Overall Study|Randomized but not treated|0|||
157248415|NCT03926117|567652578|FG003|Overall Study|Randomized but not treated|1|||
157248416|NCT04071769|567652581|FG000|Overall Study|Lost to Follow-up|3|||
157248417|NCT04071769|567652581|FG000|Overall Study|Physician Decision|2|||
157248418|NCT04071769|567652581|FG000|Overall Study|Withdrawal by Subject|8|||
157248419|NCT02938520|567652582|FG000|Overall Study|On-going at the time of analysis|258|||
157248420|NCT02938520|567652583|FG001|Overall Study|On-going at the time of analysis|261|||
157248421|NCT02938520|567652582|FG000|Overall Study|Physician Decision|2|||
157248422|NCT02938520|567652583|FG001|Overall Study|Physician Decision|5|||
157248423|NCT02938520|567652582|FG000|Overall Study|Lost to Follow-up|2|||
157248424|NCT02938520|567652583|FG001|Overall Study|Lost to Follow-up|2|||
157248425|NCT02938520|567652582|FG000|Overall Study|Withdrawal by Subject|7|||
157248426|NCT02938520|567652583|FG001|Overall Study|Withdrawal by Subject|7|||
157248427|NCT02938520|567652582|FG000|Overall Study|Protocol Violation|0|||
157248428|NCT02938520|567652583|FG001|Overall Study|Protocol Violation|1|||
157248429|NCT02938520|567652582|FG000|Overall Study|Lack of Efficacy|5|||
157248430|NCT02938520|567652583|FG001|Overall Study|Lack of Efficacy|3|||
157248431|NCT02938520|567652582|FG000|Overall Study|Adverse Event|9|||
157248432|NCT02938520|567652583|FG001|Overall Study|Adverse Event|4|||
157248433|NCT05379023|567652586|FG000|Overall Study|Lost to Follow-up|1|||
157248434|NCT05379023|567652587|FG001|Overall Study|Lost to Follow-up|0|||
157248435|NCT05379023|567652588|FG002|Overall Study|Lost to Follow-up|0|||
157248436|NCT05379023|567652586|FG000|Overall Study|Withdrawal by Subject|2|||
157248437|NCT05379023|567652587|FG001|Overall Study|Withdrawal by Subject|0|||
157248438|NCT05379023|567652588|FG002|Overall Study|Withdrawal by Subject|0|||
157248439|NCT04569084|567653049|FG000|Overall Study|Adverse Event|10|||
157248440|NCT04569084|567653050|FG001|Overall Study|Adverse Event|14|||
157248441|NCT04569084|567653049|FG000|Overall Study|Death|2|||
157248442|NCT04569084|567653050|FG001|Overall Study|Death|3|||
157248443|NCT04569084|567653049|FG000|Overall Study|Lost to Follow-up|1|||
157248444|NCT04569084|567653050|FG001|Overall Study|Lost to Follow-up|1|||
157248445|NCT04569084|567653049|FG000|Overall Study|Physician Decision|3|||
157248446|NCT04569084|567653050|FG001|Overall Study|Physician Decision|3|||
157248447|NCT04569084|567653049|FG000|Overall Study|Protocol Violation|2|||
157248448|NCT04569084|567653050|FG001|Overall Study|Protocol Violation|1|||
157248449|NCT04569084|567653049|FG000|Overall Study|Withdrawal by Subject|20|||
157248450|NCT04569084|567653050|FG001|Overall Study|Withdrawal by Subject|21|||
157248451|NCT04569084|567653049|FG000|Overall Study|Study terminated by sponsor|26|||
157248452|NCT04569084|567653050|FG001|Overall Study|Study terminated by sponsor|23|||
157248453|NCT04569084|567653049|FG000|Overall Study|Other|3|||
157248454|NCT04569084|567653050|FG001|Overall Study|Other|5|||
157248455|NCT05147662|567653051|FG000|Overall Study|Withdrawal by parent/guardian|3|||
157248456|NCT05147662|567653051|FG000|Overall Study|Assigned to treatment but never treated|1|||
157248457|NCT02951052|567653053|FG000|Overall Study|Adverse Event|13|||
157248458|NCT02951052|567653054|FG001|Overall Study|Adverse Event|5|||
157248459|NCT02951052|567653053|FG000|Overall Study|Withdrawal by Subject|1|||
157248460|NCT02951052|567653054|FG001|Overall Study|Withdrawal by Subject|5|||
157248461|NCT02951052|567653053|FG000|Overall Study|Physician Decision|2|||
157248462|NCT02951052|567653054|FG001|Overall Study|Physician Decision|0|||
157248463|NCT02951052|567653053|FG000|Overall Study|Lost to Follow-up|1|||
157248464|NCT02951052|567653054|FG001|Overall Study|Lost to Follow-up|1|||
157248465|NCT02951052|567653053|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
157248466|NCT02951052|567653054|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
157248467|NCT02951052|567653053|FG000|Overall Study|Protocol Violation|5|||
157248468|NCT02951052|567653054|FG001|Overall Study|Protocol Violation|3|||
157248469|NCT02951052|567653053|FG000|Overall Study|Lack of Efficacy|3|||
157248470|NCT02951052|567653054|FG001|Overall Study|Lack of Efficacy|4|||
157248471|NCT02951052|567653053|FG000|Overall Study|Ongoing|1|||
157248472|NCT02951052|567653054|FG001|Overall Study|Ongoing|0|||
157248473|NCT04577404|567653055|FG000|Overall Study|Adverse Event|31|||
157248474|NCT04577404|567653055|FG000|Overall Study|Death|1|||
157248475|NCT04577404|567653055|FG000|Overall Study|Lack of Efficacy|3|||
157248476|NCT04577404|567653055|FG000|Overall Study|Physician Decision|7|||
157248477|NCT04577404|567653055|FG000|Overall Study|Withdrawal by Subject|21|||
157248478|NCT04577404|567653055|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
157248479|NCT05468320|567653056|FG000|Overall Study|Other|1|||
157248480|NCT05468320|567653056|FG000|Overall Study|Adverse Event|1|||
157248481|NCT03921554|567653057|FG000|Overall Study|Adverse Event|2|||
157248482|NCT03921554|567653057|FG000|Overall Study|Withdrawal by Subject|1|||
157248483|NCT03921554|567653057|FG000|Overall Study|Death|3|||
157248484|NCT04440592|567653058|FG000|Overall Study|Adverse Event|8|||
157248485|NCT04440592|567653059|FG001|Overall Study|Adverse Event|0|||
157248486|NCT04440592|567653058|FG000|Overall Study|Lost to Follow-up|1|||
157248487|NCT04440592|567653059|FG001|Overall Study|Lost to Follow-up|0|||
157248488|NCT04440592|567653058|FG000|Overall Study|Withdrawal by Subject|1|||
157248489|NCT04440592|567653059|FG001|Overall Study|Withdrawal by Subject|1|||
157248490|NCT04440592|567653058|FG000|Overall Study|Other therapy needed|0|||
157248491|NCT04440592|567653059|FG001|Overall Study|Other therapy needed|1|||
157248492|NCT03820947|567653060|FG000|Overall Study|Physician Decision|0|||
157248493|NCT03820947|567653061|FG001|Overall Study|Physician Decision|1|||
157248494|NCT03820947|567653062|FG002|Overall Study|Physician Decision|1|||
157248495|NCT03820947|567653063|FG003|Overall Study|Physician Decision|0|||
157248496|NCT03820947|567653064|FG004|Overall Study|Physician Decision|3|||
157248497|NCT03820947|567653060|FG000|Overall Study|Withdrawal by Subject|6|||
157248498|NCT03820947|567653061|FG001|Overall Study|Withdrawal by Subject|10|||
157248499|NCT03820947|567653062|FG002|Overall Study|Withdrawal by Subject|3|||
157248500|NCT03820947|567653063|FG003|Overall Study|Withdrawal by Subject|8|||
157248501|NCT03820947|567653064|FG004|Overall Study|Withdrawal by Subject|5|||
157248502|NCT03820947|567653060|FG000|Overall Study|Procedure Not Attempted|0|||
157248503|NCT03820947|567653061|FG001|Overall Study|Procedure Not Attempted|2|||
157248504|NCT03820947|567653062|FG002|Overall Study|Procedure Not Attempted|1|||
157248505|NCT03820947|567653063|FG003|Overall Study|Procedure Not Attempted|0|||
157248506|NCT03820947|567653064|FG004|Overall Study|Procedure Not Attempted|0|||
157248507|NCT03820947|567653060|FG000|Overall Study|Other Exit|1|||
157248508|NCT03820947|567653061|FG001|Overall Study|Other Exit|3|||
157248509|NCT03820947|567653062|FG002|Overall Study|Other Exit|3|||
157248510|NCT03820947|567653063|FG003|Overall Study|Other Exit|3|||
157248511|NCT03820947|567653064|FG004|Overall Study|Other Exit|0|||
157248512|NCT03820947|567653060|FG000|Overall Study|Follow-up Not Done|10|||
157248513|NCT03820947|567653061|FG001|Overall Study|Follow-up Not Done|13|||
157248514|NCT03820947|567653062|FG002|Overall Study|Follow-up Not Done|2|||
157248515|NCT03820947|567653063|FG003|Overall Study|Follow-up Not Done|3|||
157248516|NCT03820947|567653064|FG004|Overall Study|Follow-up Not Done|12|||
157248517|NCT03820947|567653060|FG000|Overall Study|Death|0|||
157248518|NCT03820947|567653061|FG001|Overall Study|Death|0|||
157248519|NCT03820947|567653062|FG002|Overall Study|Death|0|||
157248520|NCT03820947|567653063|FG003|Overall Study|Death|0|||
157248521|NCT03820947|567653064|FG004|Overall Study|Death|9|||
157248522|NCT03820947|567653060|FG000|Overall Study|Lost to Follow-up|4|||
157248523|NCT03820947|567653061|FG001|Overall Study|Lost to Follow-up|6|||
157248524|NCT03820947|567653062|FG002|Overall Study|Lost to Follow-up|0|||
157248525|NCT03820947|567653063|FG003|Overall Study|Lost to Follow-up|0|||
157248526|NCT03820947|567653064|FG004|Overall Study|Lost to Follow-up|9|||
157248527|NCT03626857|567653067|FG000|Overall Study|Adverse Event|9|||
157248528|NCT03626857|567653068|FG001|Overall Study|Adverse Event|7|||
157248529|NCT03626857|567653067|FG000|Overall Study|Lost to Follow-up|8|||
157248530|NCT03626857|567653068|FG001|Overall Study|Lost to Follow-up|8|||
157248531|NCT03626857|567653067|FG000|Overall Study|Withdrawal by Subject|2|||
157248532|NCT03626857|567653068|FG001|Overall Study|Withdrawal by Subject|2|||
157248533|NCT03626857|567653067|FG000|Overall Study|Protocol Violation|1|||
157248534|NCT03626857|567653068|FG001|Overall Study|Protocol Violation|3|||
157248535|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
157248536|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
157248537|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
157248538|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
157248539|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
157248540|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
157248541|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
157248542|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
157248543|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
157248544|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
157248545|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
157248546|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
157248547|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
157248548|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
157248549|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
157248550|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
157248551|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
157248552|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
157248553|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
157248554|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
157248555|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
157248556|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
157248557|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
157248558|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
157248559|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
157248560|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
157248561|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
157248562|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
157248563|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
157248564|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
157248565|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
157248566|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
157248567|NCT03602859|567653069|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
157248568|NCT03602859|567653070|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
157248569|NCT03602859|567653071|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
157248570|NCT03602859|567653072|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
157248571|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
157248572|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
157248573|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
157248574|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
157248575|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
157248576|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
157248577|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
157248578|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
157248579|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
157248580|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
157248581|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
157248582|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
157248583|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
157248584|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
157248585|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
157248586|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
157248587|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
157248588|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
157248589|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
157248590|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
157248591|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
157248592|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
157248593|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
157248594|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
157248595|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
157248596|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
157248597|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
157248598|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
157248599|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
157248600|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
157248601|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
157248602|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
157248603|NCT03602859|567653069|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
157248604|NCT03602859|567653070|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
157248605|NCT03602859|567653071|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
157248606|NCT03602859|567653072|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
157248607|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
157248608|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
157248609|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
157248610|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
157248611|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
157248612|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
157248613|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
157248614|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
157248615|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
157248616|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
157248617|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
157248618|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
157248619|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
157248620|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
157248621|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
157248622|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
157248623|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
157248624|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
157248625|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
157248626|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
157248627|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
157248628|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
157248629|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
157248630|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
157248631|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
157248632|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
157248633|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
157248634|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
157248635|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
157248636|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
157248637|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
157248638|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
157248639|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
157248640|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
157248641|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
157248642|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
157248643|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
157248644|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
157248645|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
157248646|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
157248647|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
157248648|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
157248649|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
157248650|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
157248651|NCT03602859|567653069|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
157248652|NCT03602859|567653070|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
157248653|NCT03602859|567653071|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
157248654|NCT03602859|567653072|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
157248655|NCT01301833|567653073|FG000|Overall Study|Adverse Event|7|||
157248656|NCT01301833|567653074|FG001|Overall Study|Adverse Event|5|||
157248657|NCT01301833|567653075|FG002|Overall Study|Adverse Event|5|||
157248658|NCT01301833|567653076|FG003|Overall Study|Adverse Event|5|||
157248659|NCT01301833|567653073|FG000|Overall Study|Lack of Efficacy|1|||
157248660|NCT01301833|567653074|FG001|Overall Study|Lack of Efficacy|1|||
157248661|NCT01301833|567653075|FG002|Overall Study|Lack of Efficacy|0|||
157248662|NCT01301833|567653076|FG003|Overall Study|Lack of Efficacy|0|||
157248663|NCT01301833|567653073|FG000|Overall Study|Physician Decision|3|||
157248664|NCT01301833|567653074|FG001|Overall Study|Physician Decision|1|||
157248665|NCT01301833|567653075|FG002|Overall Study|Physician Decision|1|||
157248666|NCT01301833|567653076|FG003|Overall Study|Physician Decision|0|||
157248667|NCT01301833|567653073|FG000|Overall Study|Withdrawal by Subject|3|||
157248668|NCT01301833|567653074|FG001|Overall Study|Withdrawal by Subject|1|||
157248669|NCT01301833|567653075|FG002|Overall Study|Withdrawal by Subject|1|||
157248670|NCT01301833|567653076|FG003|Overall Study|Withdrawal by Subject|2|||
157248671|NCT01301833|567653073|FG000|Overall Study|Personal matter|1|||
157248672|NCT01301833|567653074|FG001|Overall Study|Personal matter|0|||
157248673|NCT01301833|567653075|FG002|Overall Study|Personal matter|0|||
157248674|NCT01301833|567653076|FG003|Overall Study|Personal matter|0|||
157205273|NCT03993288|567496083|FG000|Overall Study|did not follow the treatment regimen|1|||
157205274|NCT03993288|567496084|FG001|Overall Study|did not follow the treatment regimen|0|||
157205275|NCT03993288|567496083|FG000|Overall Study|Adverse Event|1|||
157205276|NCT03993288|567496084|FG001|Overall Study|Adverse Event|0|||
157205277|NCT03993288|567496083|FG000|Overall Study|Withdrawal by Subject|1|||
157205278|NCT03993288|567496084|FG001|Overall Study|Withdrawal by Subject|1|||
157205279|NCT02729545|567496085|FG000|Overall Study|Pregnancy|1|||
157205280|NCT02729545|567496086|FG001|Overall Study|Pregnancy|1|||
157205281|NCT02729545|567496085|FG000|Overall Study|Lost to Follow-up|0|||
157205282|NCT02729545|567496086|FG001|Overall Study|Lost to Follow-up|1|||
157205283|NCT02729545|567496085|FG000|Overall Study|Withdrawal by Subject|2|||
157205284|NCT02729545|567496086|FG001|Overall Study|Withdrawal by Subject|3|||
157205285|NCT03533608|567496087|FG000|Overall Study|Withdrawal by Subject|3|||
157205286|NCT03533608|567496087|FG000|Overall Study|Physician Decision|2|||
156863436|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
157205287|NCT00915473|567496088|FG000|Screening|Withdrawal by Subject|1|||
157205288|NCT00915473|567496089|FG001|Screening|Withdrawal by Subject|0|||
157205289|NCT00915473|567496088|FG000|4-week Follow Up|Lost to Follow-up|1|||
157205290|NCT00915473|567496089|FG001|4-week Follow Up|Lost to Follow-up|5|||
157205291|NCT01389024|567496090|FG000|Overall Study|Withdrawal by Subject|0|||
157205292|NCT01389024|567496091|FG001|Overall Study|Withdrawal by Subject|1|||
157205293|NCT01389024|567496090|FG000|Overall Study|Lost to Follow-up|1|||
157205294|NCT01389024|567496091|FG001|Overall Study|Lost to Follow-up|0|||
157205295|NCT03443973|567496093|FG000|Double-blind Treatment Period|Adverse Event|5|||
157205296|NCT03443973|567496094|FG001|Double-blind Treatment Period|Adverse Event|19|||
157205297|NCT03443973|567496095|FG002|Double-blind Treatment Period|Adverse Event|0|||
157205298|NCT03443973|567496096|FG003|Double-blind Treatment Period|Adverse Event|0|||
157205299|NCT03443973|567496093|FG000|Double-blind Treatment Period|Death|5|||
157205300|NCT03443973|567496094|FG001|Double-blind Treatment Period|Death|7|||
157205301|NCT03443973|567496095|FG002|Double-blind Treatment Period|Death|0|||
157205302|NCT03443973|567496096|FG003|Double-blind Treatment Period|Death|0|||
157205303|NCT03443973|567496093|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
157205304|NCT03443973|567496094|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
157205305|NCT03443973|567496095|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
157205306|NCT03443973|567496096|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
157205307|NCT03443973|567496093|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
157205308|NCT03443973|567496094|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
157205309|NCT03443973|567496095|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
157205310|NCT03443973|567496096|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
157205311|NCT03443973|567496093|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
157205312|NCT03443973|567496094|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
157205313|NCT03443973|567496095|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
157205314|NCT03443973|567496096|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
157205315|NCT03443973|567496093|FG000|Double-blind Treatment Period|Physician Decision|5|||
157205316|NCT03443973|567496094|FG001|Double-blind Treatment Period|Physician Decision|6|||
157205317|NCT03443973|567496095|FG002|Double-blind Treatment Period|Physician Decision|0|||
157205318|NCT03443973|567496096|FG003|Double-blind Treatment Period|Physician Decision|0|||
157205319|NCT03443973|567496093|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
157205320|NCT03443973|567496094|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
157205321|NCT03443973|567496095|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
157205322|NCT03443973|567496096|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
157205323|NCT03443973|567496093|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
157205324|NCT03443973|567496094|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
157205325|NCT03443973|567496095|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
157205326|NCT03443973|567496096|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
157205327|NCT03443973|567496093|FG000|Open-label Extension Period|Reason Not Specified|0|||
157205328|NCT03443973|567496094|FG001|Open-label Extension Period|Reason Not Specified|0|||
157205329|NCT03443973|567496095|FG002|Open-label Extension Period|Reason Not Specified|3|||
157205330|NCT03443973|567496096|FG003|Open-label Extension Period|Reason Not Specified|0|||
157205331|NCT03443973|567496093|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
157205332|NCT03443973|567496094|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
157205333|NCT03443973|567496095|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
157205334|NCT03443973|567496096|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
157205335|NCT01956123|567496097|FG000|COS Cycle 2|Protocol Violation|8|||
157205336|NCT01956123|567496098|FG001|COS Cycle 2|Protocol Violation|3|||
157205337|NCT01956123|567496099|FG002|COS Cycle 2|Protocol Violation|0|||
157205338|NCT01956123|567496100|FG003|COS Cycle 2|Protocol Violation|0|||
157205339|NCT01956123|567496097|FG000|COS Cycle 2|Adverse Event|3|||
157205340|NCT01956123|567496098|FG001|COS Cycle 2|Adverse Event|4|||
157205341|NCT01956123|567496099|FG002|COS Cycle 2|Adverse Event|0|||
157205342|NCT01956123|567496100|FG003|COS Cycle 2|Adverse Event|0|||
157205343|NCT01956123|567496097|FG000|COS Cycle 2|Personal Reasons|2|||
157205344|NCT01956123|567496098|FG001|COS Cycle 2|Personal Reasons|0|||
157205345|NCT01956123|567496099|FG002|COS Cycle 2|Personal Reasons|0|||
157205346|NCT01956123|567496100|FG003|COS Cycle 2|Personal Reasons|0|||
157205347|NCT01956123|567496097|FG000|COS Cycle 2|Withdrawal by Subject|1|||
157205348|NCT01956123|567496098|FG001|COS Cycle 2|Withdrawal by Subject|0|||
157205349|NCT01956123|567496099|FG002|COS Cycle 2|Withdrawal by Subject|0|||
157205350|NCT01956123|567496100|FG003|COS Cycle 2|Withdrawal by Subject|0|||
157205351|NCT01956123|567496097|FG000|COS Cycle 3|Protocol Violation|0|||
157205352|NCT01956123|567496098|FG001|COS Cycle 3|Protocol Violation|0|||
157205353|NCT01956123|567496099|FG002|COS Cycle 3|Protocol Violation|2|||
157205354|NCT01956123|567496100|FG003|COS Cycle 3|Protocol Violation|1|||
157205355|NCT01956123|567496097|FG000|COS Cycle 3|Adverse Event|0|||
157205356|NCT01956123|567496098|FG001|COS Cycle 3|Adverse Event|0|||
157205357|NCT01956123|567496099|FG002|COS Cycle 3|Adverse Event|3|||
157205358|NCT01956123|567496100|FG003|COS Cycle 3|Adverse Event|0|||
157205359|NCT01956123|567496097|FG000|COS Cycle 3|Personal Reasons|0|||
157205360|NCT01956123|567496098|FG001|COS Cycle 3|Personal Reasons|0|||
157205361|NCT01956123|567496099|FG002|COS Cycle 3|Personal Reasons|1|||
157205362|NCT01956123|567496100|FG003|COS Cycle 3|Personal Reasons|0|||
157205363|NCT01956123|567496097|FG000|COS Cycle 3|Withdrawal by Subject|0|||
157205364|NCT01956123|567496098|FG001|COS Cycle 3|Withdrawal by Subject|0|||
157205365|NCT01956123|567496099|FG002|COS Cycle 3|Withdrawal by Subject|0|||
157205366|NCT01956123|567496100|FG003|COS Cycle 3|Withdrawal by Subject|1|||
157205367|NCT01432600|567496101|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
157205368|NCT01432600|567496102|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
157205369|NCT01432600|567496103|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
157205370|NCT00398632|567496104|FG000|Overall Study|Withdrawal by Subject|1|||
157205371|NCT00398632|567496104|FG000|Overall Study|Lack of Efficacy|1|||
157205372|NCT00640614|567496108|FG000|Overall Study|Lost to Follow-up|1|||
157205373|NCT00640614|567496109|FG001|Overall Study|Lost to Follow-up|0|||
157205374|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
157205375|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
157205376|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
157205377|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Death|1|||
157205378|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
157205379|NCT00529802|567496110|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
157205380|NCT00529802|567496110|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
157205381|NCT00366678|567496116|FG000|Infant Series|Withdrawal by Subject|8|||
157205382|NCT00366678|567496117|FG001|Infant Series|Withdrawal by Subject|6|||
157205383|NCT00366678|567496118|FG002|Infant Series|Withdrawal by Subject|0|||
157205384|NCT00366678|567496116|FG000|Infant Series|Protocol Violation|4|||
157205385|NCT00366678|567496117|FG001|Infant Series|Protocol Violation|3|||
157205386|NCT00366678|567496118|FG002|Infant Series|Protocol Violation|0|||
157205387|NCT00366678|567496116|FG000|Infant Series|Failed to return|1|||
157205388|NCT00366678|567496117|FG001|Infant Series|Failed to return|1|||
157205389|NCT00366678|567496118|FG002|Infant Series|Failed to return|0|||
157205390|NCT00366678|567496116|FG000|Infant Series|Adverse Event|1|||
157205391|NCT00366678|567496117|FG001|Infant Series|Adverse Event|0|||
157205392|NCT00366678|567496118|FG002|Infant Series|Adverse Event|0|||
157205393|NCT00366678|567496116|FG000|After Infant|Withdrawal by Subject|8|||
157205394|NCT00366678|567496117|FG001|After Infant|Withdrawal by Subject|4|||
157205395|NCT00366678|567496118|FG002|After Infant|Withdrawal by Subject|0|||
157205396|NCT00366678|567496116|FG000|After Infant|Lost to Follow-up|2|||
157205397|NCT00366678|567496117|FG001|After Infant|Lost to Follow-up|1|||
157205398|NCT00366678|567496118|FG002|After Infant|Lost to Follow-up|0|||
157205399|NCT00366678|567496116|FG000|After Infant|Failed to return|5|||
157205400|NCT00366678|567496117|FG001|After Infant|Failed to return|5|||
157205401|NCT00366678|567496118|FG002|After Infant|Failed to return|0|||
157205402|NCT00366678|567496116|FG000|After Infant|Adverse Event|1|||
157205403|NCT00366678|567496117|FG001|After Infant|Adverse Event|0|||
157205404|NCT00366678|567496118|FG002|After Infant|Adverse Event|0|||
157205405|NCT00366678|567496116|FG000|After Infant|Protocol Violation|1|||
157205406|NCT00366678|567496117|FG001|After Infant|Protocol Violation|0|||
157205407|NCT00366678|567496118|FG002|After Infant|Protocol Violation|0|||
157205408|NCT00366678|567496116|FG000|Toddler Dose|Protocol Violation|2|||
157205409|NCT00366678|567496117|FG001|Toddler Dose|Protocol Violation|1|||
157205410|NCT00366678|567496118|FG002|Toddler Dose|Protocol Violation|0|||
157205411|NCT00366678|567496116|FG000|Toddler Dose|Failed to return|1|||
157205412|NCT00366678|567496117|FG001|Toddler Dose|Failed to return|0|||
157205413|NCT00366678|567496118|FG002|Toddler Dose|Failed to return|0|||
157205414|NCT00366678|567496116|FG000|Toddler Dose|Withdrawal by Subject|1|||
157205415|NCT00366678|567496117|FG001|Toddler Dose|Withdrawal by Subject|0|||
157205416|NCT00366678|567496118|FG002|Toddler Dose|Withdrawal by Subject|0|||
157205417|NCT00366678|567496116|FG000|Toddler Dose|protocol deviation|1|||
157205418|NCT00366678|567496117|FG001|Toddler Dose|protocol deviation|0|||
157205419|NCT00366678|567496118|FG002|Toddler Dose|protocol deviation|0|||
157205420|NCT04465916|567496128|FG000|Overall Study|Withdrawal by Subject|0|||
157205421|NCT04465916|567496129|FG001|Overall Study|Withdrawal by Subject|1|||
157205422|NCT00826176|567496136|FG000|Overall Study|Lost to Follow-up|1|||
157205423|NCT00826176|567496137|FG001|Overall Study|Lost to Follow-up|0|||
157205424|NCT00826176|567496136|FG000|Overall Study|Subject Withdrew Consent|3|||
157205425|NCT00826176|567496137|FG001|Overall Study|Subject Withdrew Consent|0|||
157205426|NCT00826176|567496136|FG000|Overall Study|Administrative|9|||
157205427|NCT00826176|567496137|FG001|Overall Study|Administrative|0|||
157205428|NCT00740480|567496138|FG000|Overall Study|Adverse Event|1|||
157205429|NCT00740480|567496138|FG000|Overall Study|Physician Decision|1|||
157205430|NCT01005680|567496140|FG000|Overall Study|Lost to Follow-up|4|||
157205431|NCT01005680|567496141|FG001|Overall Study|Lost to Follow-up|6|||
157205432|NCT01005680|567496140|FG000|Overall Study|Withdrawal by Subject|1|||
157205433|NCT01005680|567496141|FG001|Overall Study|Withdrawal by Subject|4|||
157205434|NCT01005680|567496140|FG000|Overall Study|Physician Decision|1|||
157205435|NCT01005680|567496141|FG001|Overall Study|Physician Decision|1|||
157205436|NCT04484805|567496146|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
157205437|NCT04484805|567496147|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
157205438|NCT04484805|567496146|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
157205439|NCT04484805|567496147|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
157205440|NCT00539006|567496154|FG000|Pre-treatment|Other|0|||
157205441|NCT00539006|567496155|FG001|Pre-treatment|Other|1|||
157205442|NCT00539006|567496156|FG002|Pre-treatment|Other|0|||
157205443|NCT00539006|567496157|FG003|Pre-treatment|Other|0|||
157205444|NCT00539006|567496154|FG000|Treatment Period 1|Lost to Follow-up|0|||
157205445|NCT00539006|567496155|FG001|Treatment Period 1|Lost to Follow-up|0|||
157205446|NCT00539006|567496156|FG002|Treatment Period 1|Lost to Follow-up|1|||
157205447|NCT00539006|567496157|FG003|Treatment Period 1|Lost to Follow-up|0|||
157205448|NCT00539006|567496154|FG000|Treatment Period 1|Protocol Violation|0|||
157205449|NCT00539006|567496155|FG001|Treatment Period 1|Protocol Violation|0|||
157205450|NCT00539006|567496156|FG002|Treatment Period 1|Protocol Violation|1|||
157205451|NCT00539006|567496157|FG003|Treatment Period 1|Protocol Violation|0|||
157205452|NCT00539006|567496154|FG000|Treatment Period 1|Lack of Efficacy|0|||
157205453|NCT00539006|567496155|FG001|Treatment Period 1|Lack of Efficacy|0|||
157205454|NCT00539006|567496156|FG002|Treatment Period 1|Lack of Efficacy|0|||
156863437|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156863438|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156863439|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
156863440|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
156863441|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
156863442|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
156863443|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
156863444|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863445|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
156863446|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
156863447|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863448|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
156863449|NCT01054885|566258632|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
156863450|NCT01054885|566258633|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
156863451|NCT01054885|566258634|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156863452|NCT01054885|566258635|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
156863453|NCT01054885|566258636|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
156863454|NCT01054885|566258637|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
156863455|NCT01054885|566258638|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
156863456|NCT03137381|566258642|FG000|Overall Study|Adverse Event|3|||
156863457|NCT03137381|566258643|FG001|Overall Study|Adverse Event|0|||
156863458|NCT03137381|566258644|FG002|Overall Study|Adverse Event|2|||
156863459|NCT03137381|566258645|FG003|Overall Study|Adverse Event|0|||
156863460|NCT03137381|566258642|FG000|Overall Study|Lost to Follow-up|2|||
156863461|NCT03137381|566258643|FG001|Overall Study|Lost to Follow-up|1|||
156863462|NCT03137381|566258644|FG002|Overall Study|Lost to Follow-up|1|||
156863463|NCT03137381|566258645|FG003|Overall Study|Lost to Follow-up|0|||
156863464|NCT03137381|566258642|FG000|Overall Study|Protocol deviation|1|||
156863465|NCT03137381|566258643|FG001|Overall Study|Protocol deviation|1|||
156863466|NCT03137381|566258644|FG002|Overall Study|Protocol deviation|0|||
156863467|NCT03137381|566258645|FG003|Overall Study|Protocol deviation|1|||
156863468|NCT03137381|566258642|FG000|Overall Study|Withdrawal by Investigator|0|||
156863469|NCT03137381|566258643|FG001|Overall Study|Withdrawal by Investigator|1|||
156863470|NCT03137381|566258644|FG002|Overall Study|Withdrawal by Investigator|1|||
156863471|NCT03137381|566258645|FG003|Overall Study|Withdrawal by Investigator|0|||
156863472|NCT03137381|566258642|FG000|Overall Study|Withdrawal by Subject|3|||
156863473|NCT03137381|566258643|FG001|Overall Study|Withdrawal by Subject|4|||
156863474|NCT03137381|566258644|FG002|Overall Study|Withdrawal by Subject|3|||
156863475|NCT03137381|566258645|FG003|Overall Study|Withdrawal by Subject|0|||
156863476|NCT03137381|566258642|FG000|Overall Study|Pregnancy|0|||
156863477|NCT03137381|566258643|FG001|Overall Study|Pregnancy|0|||
156863478|NCT03137381|566258644|FG002|Overall Study|Pregnancy|1|||
156863479|NCT03137381|566258645|FG003|Overall Study|Pregnancy|0|||
156863480|NCT01980017|566258646|FG000|Overall Study|Lost to Follow-up|30|||
156863481|NCT01980017|566258647|FG001|Overall Study|Lost to Follow-up|21|||
156863482|NCT01980017|566258646|FG000|Overall Study|Death|0|||
156863483|NCT01980017|566258647|FG001|Overall Study|Death|1|||
156863484|NCT03044106|566258648|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
156863485|NCT03044106|566258649|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
156863486|NCT02057250|566258651|FG000|AID Assessment Phase|Adverse Event|3|||
156863487|NCT02057250|566258652|FG001|AID Assessment Phase|Adverse Event|2|||
156863488|NCT02057250|566258653|FG002|AID Assessment Phase|Adverse Event|6|||
156863489|NCT02057250|566258654|FG003|AID Assessment Phase|Adverse Event|1|||
156863490|NCT02057250|566258655|FG004|AID Assessment Phase|Adverse Event|0|||
156863491|NCT02057250|566258651|FG000|AID Assessment Phase|Other than specified above|1|||
156863492|NCT02057250|566258652|FG001|AID Assessment Phase|Other than specified above|1|||
156863493|NCT02057250|566258653|FG002|AID Assessment Phase|Other than specified above|1|||
156863494|NCT02057250|566258654|FG003|AID Assessment Phase|Other than specified above|1|||
156863495|NCT02057250|566258655|FG004|AID Assessment Phase|Other than specified above|0|||
156863496|NCT02057250|566258651|FG000|Extension Phase|Adverse Event|0|||
156863497|NCT02057250|566258652|FG001|Extension Phase|Adverse Event|0|||
156863498|NCT02057250|566258653|FG002|Extension Phase|Adverse Event|0|||
156863499|NCT02057250|566258654|FG003|Extension Phase|Adverse Event|0|||
156863500|NCT02057250|566258655|FG004|Extension Phase|Adverse Event|15|||
156863501|NCT02057250|566258651|FG000|Extension Phase|Lack of Efficacy|0|||
156863502|NCT02057250|566258652|FG001|Extension Phase|Lack of Efficacy|0|||
156863503|NCT02057250|566258653|FG002|Extension Phase|Lack of Efficacy|0|||
156863504|NCT02057250|566258654|FG003|Extension Phase|Lack of Efficacy|0|||
156863505|NCT02057250|566258655|FG004|Extension Phase|Lack of Efficacy|10|||
156863506|NCT02057250|566258651|FG000|Extension Phase|Entered in this period but not treated|0|||
156863507|NCT02057250|566258652|FG001|Extension Phase|Entered in this period but not treated|0|||
156863508|NCT02057250|566258653|FG002|Extension Phase|Entered in this period but not treated|0|||
156863509|NCT02057250|566258654|FG003|Extension Phase|Entered in this period but not treated|0|||
156863510|NCT02057250|566258655|FG004|Extension Phase|Entered in this period but not treated|4|||
156863511|NCT02057250|566258651|FG000|Extension Phase|Other than specified above|0|||
156863512|NCT02057250|566258652|FG001|Extension Phase|Other than specified above|0|||
156863513|NCT02057250|566258653|FG002|Extension Phase|Other than specified above|0|||
156863514|NCT02057250|566258654|FG003|Extension Phase|Other than specified above|0|||
156863515|NCT02057250|566258655|FG004|Extension Phase|Other than specified above|7|||
156863516|NCT03379818|566258656|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
156863517|NCT03379818|566258657|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
156863518|NCT03379818|566258656|FG000|Overall Study|Withdrawal by Subject|2|||
156863519|NCT03379818|566258657|FG001|Overall Study|Withdrawal by Subject|3|||
156863520|NCT03379818|566258656|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
156863521|NCT03379818|566258657|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
156863522|NCT03367793|566258658|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863523|NCT03367793|566258659|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863524|NCT03367793|566258660|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
156863525|NCT03367793|566258661|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863526|NCT03367793|566258662|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863527|NCT03367793|566258663|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
156863528|NCT00260533|566258664|FG000|Overall Study|Other|3|||
156863529|NCT00260533|566258665|FG001|Overall Study|Other|3|||
156863530|NCT01310777|566258666|FG000|Overall Study|Adverse Event|23|||
156863531|NCT01310777|566258667|FG001|Overall Study|Adverse Event|1|||
156863532|NCT01310777|566258668|FG002|Overall Study|Adverse Event|15|||
156863533|NCT01310777|566258666|FG000|Overall Study|Lost to Follow-up|0|||
156863534|NCT01310777|566258667|FG001|Overall Study|Lost to Follow-up|4|||
156863535|NCT01310777|566258668|FG002|Overall Study|Lost to Follow-up|1|||
156863536|NCT01310777|566258666|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
156863537|NCT01310777|566258667|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
156863538|NCT01310777|566258668|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
156863539|NCT01310777|566258666|FG000|Overall Study|Inadequate Control of IOP|5|||
156863540|NCT01310777|566258667|FG001|Overall Study|Inadequate Control of IOP|7|||
156863541|NCT01310777|566258668|FG002|Overall Study|Inadequate Control of IOP|10|||
156863542|NCT01310777|566258666|FG000|Overall Study|Other|4|||
156863543|NCT01310777|566258667|FG001|Overall Study|Other|1|||
156863544|NCT01310777|566258668|FG002|Overall Study|Other|2|||
156863545|NCT04218240|566258670|FG000|Overall Study|Withdrawal by Subject|6|||
156863546|NCT04218240|566258671|FG001|Overall Study|Withdrawal by Subject|0|||
156863547|NCT04218240|566258670|FG000|Overall Study|Lack of Efficacy|24|||
156863548|NCT04218240|566258671|FG001|Overall Study|Lack of Efficacy|19|||
156863549|NCT04218240|566258670|FG000|Overall Study|Physician Decision|0|||
156863550|NCT04218240|566258671|FG001|Overall Study|Physician Decision|1|||
156863551|NCT04218240|566258670|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
156863552|NCT04218240|566258671|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
156863553|NCT02738801|566258696|FG000|Overall Study|Adverse Event|1|||
156863554|NCT02738801|566258697|FG001|Overall Study|Adverse Event|1|||
156863555|NCT02738801|566258696|FG000|Overall Study|Withdrawal by Subject|0|||
156863556|NCT02738801|566258697|FG001|Overall Study|Withdrawal by Subject|1|||
156863557|NCT03279081|566258698|FG000|Overall Study|Withdrawal by Subject|12|||
156863558|NCT03279081|566258699|FG001|Overall Study|Withdrawal by Subject|20|||
156863559|NCT03279081|566258698|FG000|Overall Study|Physician Decision|4|||
156863560|NCT03279081|566258699|FG001|Overall Study|Physician Decision|1|||
156863561|NCT03279081|566258698|FG000|Overall Study|Lost to Follow-up|8|||
156863562|NCT03279081|566258699|FG001|Overall Study|Lost to Follow-up|8|||
156863563|NCT03279081|566258698|FG000|Overall Study|Death|0|||
156863564|NCT03279081|566258699|FG001|Overall Study|Death|1|||
156863565|NCT03279081|566258698|FG000|Overall Study|Adverse Event|1|||
156863566|NCT03279081|566258699|FG001|Overall Study|Adverse Event|0|||
156863567|NCT03279081|566258698|FG000|Overall Study|Reason not Specified|14|||
156863568|NCT03279081|566258699|FG001|Overall Study|Reason not Specified|4|||
156863569|NCT00771914|566258702|FG000|Overall Study|Physician Decision|0|||
156863570|NCT00771914|566258703|FG001|Overall Study|Physician Decision|0|||
156863571|NCT00771914|566258704|FG002|Overall Study|Physician Decision|0|||
156863572|NCT00771914|566258705|FG003|Overall Study|Physician Decision|1|||
156863573|NCT00771914|566258702|FG000|Overall Study|Lost to Follow-up|0|||
156863574|NCT00771914|566258703|FG001|Overall Study|Lost to Follow-up|0|||
156863575|NCT00771914|566258704|FG002|Overall Study|Lost to Follow-up|0|||
156863576|NCT00771914|566258705|FG003|Overall Study|Lost to Follow-up|1|||
156863577|NCT04842747|566258706|FG000|Overall Study|Withdrawal by Subject|6|||
156863578|NCT04842747|566258707|FG001|Overall Study|Withdrawal by Subject|2|||
156863579|NCT04842747|566258706|FG000|Overall Study|Lost to Follow-up|1|||
156863580|NCT04842747|566258707|FG001|Overall Study|Lost to Follow-up|2|||
156863581|NCT04842747|566258706|FG000|Overall Study|Physician Decision|1|||
156863582|NCT04842747|566258707|FG001|Overall Study|Physician Decision|0|||
156863583|NCT04842747|566258706|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
156863584|NCT04842747|566258707|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
156863585|NCT01743469|566258708|FG000|Active Treatment Phase|Adverse Event|10|||
156863586|NCT01743469|566258709|FG001|Active Treatment Phase|Adverse Event|5|||
156863587|NCT01743469|566258710|FG002|Active Treatment Phase|Adverse Event|8|||
156863588|NCT01743469|566258711|FG003|Active Treatment Phase|Adverse Event|1|||
156863589|NCT01743469|566258708|FG000|Active Treatment Phase|Disease Progression|40|||
156863590|NCT01743469|566258709|FG001|Active Treatment Phase|Disease Progression|47|||
156863591|NCT01743469|566258710|FG002|Active Treatment Phase|Disease Progression|30|||
156863592|NCT01743469|566258711|FG003|Active Treatment Phase|Disease Progression|20|||
156863593|NCT01743469|566258708|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
156863594|NCT01743469|566258709|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
157205455|NCT00539006|567496157|FG003|Treatment Period 1|Lack of Efficacy|1|||
157205456|NCT00539006|567496154|FG000|Washout|Adverse Event|2|||
157205457|NCT00539006|567496155|FG001|Washout|Adverse Event|1|||
157205458|NCT00539006|567496156|FG002|Washout|Adverse Event|0|||
157205459|NCT00539006|567496157|FG003|Washout|Adverse Event|0|||
157205460|NCT00539006|567496154|FG000|Washout|Protocol Violation|1|||
157205461|NCT00539006|567496155|FG001|Washout|Protocol Violation|1|||
157205462|NCT00539006|567496156|FG002|Washout|Protocol Violation|0|||
157205463|NCT00539006|567496157|FG003|Washout|Protocol Violation|0|||
157205464|NCT00539006|567496154|FG000|Washout|Withdrawal by Subject|0|||
157205465|NCT00539006|567496155|FG001|Washout|Withdrawal by Subject|2|||
157205466|NCT00539006|567496156|FG002|Washout|Withdrawal by Subject|0|||
157205467|NCT00539006|567496157|FG003|Washout|Withdrawal by Subject|0|||
157205468|NCT00539006|567496154|FG000|Washout|Failed to meet continuation criteria|16|||
156863595|NCT01743469|566258710|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
156863596|NCT01743469|566258711|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
156863597|NCT01743469|566258708|FG000|Active Treatment Phase|Missing|1|||
156863598|NCT01743469|566258709|FG001|Active Treatment Phase|Missing|0|||
156863599|NCT01743469|566258710|FG002|Active Treatment Phase|Missing|0|||
156863600|NCT01743469|566258711|FG003|Active Treatment Phase|Missing|0|||
156863601|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
156863602|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
156863603|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
156863604|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
156863605|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Death|43|||
156863606|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Death|47|||
156863607|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Death|22|||
156863608|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Death|16|||
156863609|NCT01743469|566258708|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
156863610|NCT01743469|566258709|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
156863611|NCT01743469|566258710|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
156863612|NCT01743469|566258711|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
156863613|NCT00317473|566258712|FG000|Overall Study|Withdrawal by Subject|2|||
156863614|NCT00317473|566258713|FG001|Overall Study|Withdrawal by Subject|1|||
156863615|NCT00317473|566258714|FG002|Overall Study|Withdrawal by Subject|2|||
156863616|NCT00317473|566258715|FG003|Overall Study|Withdrawal by Subject|1|||
156863617|NCT00317473|566258716|FG004|Overall Study|Withdrawal by Subject|3|||
156863618|NCT00317473|566258717|FG005|Overall Study|Withdrawal by Subject|1|||
156863619|NCT00317473|566258712|FG000|Overall Study|Relocation|1|||
156863620|NCT00317473|566258713|FG001|Overall Study|Relocation|0|||
156863621|NCT00317473|566258714|FG002|Overall Study|Relocation|1|||
156863622|NCT00317473|566258715|FG003|Overall Study|Relocation|1|||
156863623|NCT00317473|566258716|FG004|Overall Study|Relocation|5|||
156863624|NCT00317473|566258717|FG005|Overall Study|Relocation|2|||
156863625|NCT00317473|566258712|FG000|Overall Study|Death|1|||
156863626|NCT00317473|566258713|FG001|Overall Study|Death|0|||
156863627|NCT00317473|566258714|FG002|Overall Study|Death|0|||
156863628|NCT00317473|566258715|FG003|Overall Study|Death|0|||
156863629|NCT00317473|566258716|FG004|Overall Study|Death|0|||
156863630|NCT00317473|566258717|FG005|Overall Study|Death|0|||
156863631|NCT00317473|566258712|FG000|Overall Study|Other|0|||
156863632|NCT00317473|566258713|FG001|Overall Study|Other|2|||
156863633|NCT00317473|566258714|FG002|Overall Study|Other|0|||
156863634|NCT00317473|566258715|FG003|Overall Study|Other|0|||
156863635|NCT00317473|566258716|FG004|Overall Study|Other|0|||
156863636|NCT00317473|566258717|FG005|Overall Study|Other|0|||
156863637|NCT02285855|566258718|FG000|Overall Study|Withdrawal by Subject|2|||
156863638|NCT02285855|566258719|FG001|Overall Study|Withdrawal by Subject|1|||
156863639|NCT00627393|566258730|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
156863640|NCT00627393|566258731|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
157205469|NCT00539006|567496155|FG001|Washout|Failed to meet continuation criteria|5|||
157205470|NCT00539006|567496156|FG002|Washout|Failed to meet continuation criteria|14|||
157205471|NCT00539006|567496157|FG003|Washout|Failed to meet continuation criteria|6|||
157205472|NCT00539006|567496154|FG000|Washout|Other|1|||
157205473|NCT00539006|567496155|FG001|Washout|Other|1|||
157205474|NCT00539006|567496156|FG002|Washout|Other|2|||
157205475|NCT00539006|567496157|FG003|Washout|Other|3|||
157205476|NCT00539006|567496154|FG000|Treatment Period 2|Protocol Violation|1|||
157205477|NCT00539006|567496155|FG001|Treatment Period 2|Protocol Violation|0|||
157205478|NCT00539006|567496156|FG002|Treatment Period 2|Protocol Violation|0|||
157205479|NCT00539006|567496157|FG003|Treatment Period 2|Protocol Violation|0|||
157205480|NCT00539006|567496154|FG000|Treatment Period 2|Other|0|||
157205481|NCT00539006|567496155|FG001|Treatment Period 2|Other|1|||
157205482|NCT00539006|567496156|FG002|Treatment Period 2|Other|0|||
157205483|NCT00539006|567496157|FG003|Treatment Period 2|Other|0|||
157205484|NCT03733301|567496158|FG000|Overall Study|Screen Fail|1|||
157205485|NCT03733301|567496159|FG001|Overall Study|Screen Fail|0|||
157205486|NCT03733301|567496160|FG002|Overall Study|Screen Fail|0|||
157205487|NCT03733301|567496158|FG000|Overall Study|Non-compliance|1|||
157205488|NCT03733301|567496159|FG001|Overall Study|Non-compliance|0|||
157205489|NCT03733301|567496160|FG002|Overall Study|Non-compliance|0|||
157205490|NCT03733301|567496158|FG000|Overall Study|Lack of Efficacy|2|||
157205491|NCT03733301|567496159|FG001|Overall Study|Lack of Efficacy|3|||
157205492|NCT03733301|567496160|FG002|Overall Study|Lack of Efficacy|0|||
157205493|NCT03733301|567496158|FG000|Overall Study|Adverse Event|0|||
157205494|NCT03733301|567496159|FG001|Overall Study|Adverse Event|1|||
157205495|NCT03733301|567496160|FG002|Overall Study|Adverse Event|3|||
157205496|NCT03733301|567496158|FG000|Overall Study|Withdrawal by Subject|3|||
157205497|NCT03733301|567496159|FG001|Overall Study|Withdrawal by Subject|5|||
157205498|NCT03733301|567496160|FG002|Overall Study|Withdrawal by Subject|1|||
157205499|NCT01965431|567496163|FG000|Overall Study|Adverse Event|0|||
157205500|NCT01965431|567496164|FG001|Overall Study|Adverse Event|1|||
157205501|NCT01965431|567496165|FG002|Overall Study|Adverse Event|0|||
157205502|NCT01965431|567496166|FG003|Overall Study|Adverse Event|0|||
157205503|NCT01965431|567496167|FG004|Overall Study|Adverse Event|0|||
157205504|NCT01965431|567496168|FG005|Overall Study|Adverse Event|0|||
157205505|NCT01965431|567496163|FG000|Overall Study|Other than stated above|6|||
157205506|NCT01965431|567496164|FG001|Overall Study|Other than stated above|5|||
157205507|NCT01965431|567496165|FG002|Overall Study|Other than stated above|6|||
157205508|NCT01965431|567496166|FG003|Overall Study|Other than stated above|6|||
157205509|NCT01965431|567496167|FG004|Overall Study|Other than stated above|6|||
157205510|NCT01965431|567496168|FG005|Overall Study|Other than stated above|6|||
157205511|NCT04635631|567496169|FG000|Overall Study|Adverse Event|1|||
157205512|NCT04635631|567496169|FG000|Overall Study|Progressive disease|13|||
157205513|NCT04635631|567496169|FG000|Overall Study|Withdrawal by Subject|1|||
157205514|NCT00577031|567496170|FG000|Overall Study|Adverse Event|52|||
157205515|NCT00577031|567496170|FG000|Overall Study|Progression of disease|93|||
157205516|NCT00577031|567496170|FG000|Overall Study|Protocol Violation|5|||
157205517|NCT00577031|567496170|FG000|Overall Study|Participant withdrew consent|13|||
157205518|NCT00577031|567496170|FG000|Overall Study|Participant non-compliance|5|||
157205519|NCT00577031|567496170|FG000|Overall Study|Need for surgery|17|||
157205520|NCT00577031|567496170|FG000|Overall Study|Medical decision|14|||
157205521|NCT00577031|567496170|FG000|Overall Study|Death|6|||
157205522|NCT00943826|567496171|FG000|Concurrent Phase|Adverse Event|50|||
157205523|NCT00943826|567496172|FG001|Concurrent Phase|Adverse Event|27|||
157205524|NCT00943826|567496171|FG000|Concurrent Phase|Withdrew consent|3|||
157205525|NCT00943826|567496172|FG001|Concurrent Phase|Withdrew consent|7|||
157205526|NCT00943826|567496171|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
157205527|NCT00943826|567496172|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
157205528|NCT00943826|567496171|FG000|Concurrent Phase|Administrative reasons|2|||
157205529|NCT00943826|567496172|FG001|Concurrent Phase|Administrative reasons|1|||
157205530|NCT00943826|567496171|FG000|Concurrent Phase|Protocol Violation|1|||
157205531|NCT00943826|567496172|FG001|Concurrent Phase|Protocol Violation|0|||
157205532|NCT00943826|567496171|FG000|Maintenance Phase|Adverse Event|31|||
157205533|NCT00943826|567496172|FG001|Maintenance Phase|Adverse Event|30|||
157205534|NCT00943826|567496171|FG000|Maintenance Phase|Withdrew consent|2|||
157205535|NCT00943826|567496172|FG001|Maintenance Phase|Withdrew consent|4|||
157205536|NCT00943826|567496171|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
157205537|NCT00943826|567496172|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
157205538|NCT00943826|567496171|FG000|Maintenance Phase|Administrative reasons|4|||
157205539|NCT00943826|567496172|FG001|Maintenance Phase|Administrative reasons|1|||
157205540|NCT00943826|567496171|FG000|Maintenance Phase|Failure to return|0|||
157205541|NCT00943826|567496172|FG001|Maintenance Phase|Failure to return|1|||
157205542|NCT00943826|567496171|FG000|Monotherapy Phase|Adverse Event|42|||
157205543|NCT00943826|567496172|FG001|Monotherapy Phase|Adverse Event|5|||
157205544|NCT00943826|567496171|FG000|Monotherapy Phase|Administrative reasons|11|||
157205545|NCT00943826|567496172|FG001|Monotherapy Phase|Administrative reasons|5|||
157205546|NCT00943826|567496171|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
157205547|NCT00943826|567496172|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
157205548|NCT00943826|567496171|FG000|Monotherapy Phase|Withdrew Consent|2|||
157205549|NCT00943826|567496172|FG001|Monotherapy Phase|Withdrew Consent|3|||
157205550|NCT00943826|567496171|FG000|Monotherapy Phase|Failure to return|2|||
157205551|NCT00943826|567496172|FG001|Monotherapy Phase|Failure to return|1|||
157205552|NCT00943826|567496171|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
157205553|NCT00943826|567496172|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
157205554|NCT00943826|567496171|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
157205555|NCT00943826|567496172|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
157205556|NCT00943826|567496171|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
157205557|NCT00943826|567496172|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
157205558|NCT00943826|567496171|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
157205559|NCT00943826|567496172|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
157205560|NCT02050373|567496173|FG000|Overall Study|Adverse Event|4|||
157205561|NCT02050373|567496174|FG001|Overall Study|Adverse Event|7|||
157205562|NCT02050373|567496173|FG000|Overall Study|Death|3|||
157205563|NCT02050373|567496174|FG001|Overall Study|Death|3|||
157205564|NCT04764669|567496176|FG000|Overall Study|Adverse Event|1|||
157205565|NCT04764669|567496177|FG001|Overall Study|Adverse Event|0|||
157205566|NCT04764669|567496178|FG002|Overall Study|Adverse Event|1|||
157205567|NCT04764669|567496179|FG003|Overall Study|Adverse Event|0|||
157205568|NCT04764669|567496176|FG000|Overall Study|Subject Choice|0|||
157205569|NCT04764669|567496177|FG001|Overall Study|Subject Choice|0|||
157205570|NCT04764669|567496178|FG002|Overall Study|Subject Choice|1|||
157205571|NCT04764669|567496179|FG003|Overall Study|Subject Choice|0|||
157205572|NCT04764669|567496176|FG000|Overall Study|Withdrawal by Subject|2|||
157205573|NCT04764669|567496177|FG001|Overall Study|Withdrawal by Subject|0|||
157205574|NCT04764669|567496178|FG002|Overall Study|Withdrawal by Subject|0|||
157205575|NCT04764669|567496179|FG003|Overall Study|Withdrawal by Subject|0|||
157205576|NCT00572910|567496180|FG000|Overall Study|Adverse Event|1|||
157205577|NCT00572910|567496181|FG001|Overall Study|Adverse Event|2|||
157205578|NCT00572910|567496182|FG002|Overall Study|Adverse Event|0|||
157205579|NCT00572910|567496183|FG003|Overall Study|Adverse Event|2|||
157205580|NCT00572910|567496184|FG004|Overall Study|Adverse Event|0|||
157205581|NCT00572910|567496185|FG005|Overall Study|Adverse Event|0|||
157205582|NCT00572910|567496186|FG006|Overall Study|Adverse Event|4|||
157205583|NCT00572910|567496187|FG007|Overall Study|Adverse Event|2|||
157205584|NCT00572910|567496188|FG008|Overall Study|Adverse Event|1|||
157205585|NCT00572910|567496189|FG009|Overall Study|Adverse Event|3|||
157205586|NCT00572910|567496190|FG010|Overall Study|Adverse Event|2|||
157205587|NCT00572910|567496180|FG000|Overall Study|Lost to Follow-up|0|||
157205588|NCT00572910|567496181|FG001|Overall Study|Lost to Follow-up|1|||
157205589|NCT00572910|567496182|FG002|Overall Study|Lost to Follow-up|1|||
157205590|NCT00572910|567496183|FG003|Overall Study|Lost to Follow-up|2|||
157205591|NCT00572910|567496184|FG004|Overall Study|Lost to Follow-up|1|||
157205592|NCT00572910|567496185|FG005|Overall Study|Lost to Follow-up|0|||
157205593|NCT00572910|567496186|FG006|Overall Study|Lost to Follow-up|0|||
157205594|NCT00572910|567496187|FG007|Overall Study|Lost to Follow-up|0|||
157205595|NCT00572910|567496188|FG008|Overall Study|Lost to Follow-up|0|||
157205596|NCT00572910|567496189|FG009|Overall Study|Lost to Follow-up|1|||
157205597|NCT00572910|567496190|FG010|Overall Study|Lost to Follow-up|0|||
157205598|NCT00572910|567496180|FG000|Overall Study|Withdrawal by Subject|3|||
157205599|NCT00572910|567496181|FG001|Overall Study|Withdrawal by Subject|0|||
157205600|NCT00572910|567496182|FG002|Overall Study|Withdrawal by Subject|1|||
157205601|NCT00572910|567496183|FG003|Overall Study|Withdrawal by Subject|0|||
157205602|NCT00572910|567496184|FG004|Overall Study|Withdrawal by Subject|1|||
157205603|NCT00572910|567496185|FG005|Overall Study|Withdrawal by Subject|3|||
157205604|NCT00572910|567496186|FG006|Overall Study|Withdrawal by Subject|0|||
157205605|NCT00572910|567496187|FG007|Overall Study|Withdrawal by Subject|2|||
157205606|NCT00572910|567496188|FG008|Overall Study|Withdrawal by Subject|2|||
157205607|NCT00572910|567496189|FG009|Overall Study|Withdrawal by Subject|2|||
157205608|NCT00572910|567496190|FG010|Overall Study|Withdrawal by Subject|1|||
157205609|NCT01803464|567496192|FG000|Overall Study|Incomplete data|0|||
157205610|NCT01803464|567496193|FG001|Overall Study|Incomplete data|0|||
157205611|NCT01803464|567496194|FG002|Overall Study|Incomplete data|4|||
157205612|NCT01803464|567496195|FG003|Overall Study|Incomplete data|0|||
157205613|NCT01803464|567496192|FG000|Overall Study|Withdrawal by Subject|1|||
157205614|NCT01803464|567496193|FG001|Overall Study|Withdrawal by Subject|0|||
157205615|NCT01803464|567496194|FG002|Overall Study|Withdrawal by Subject|0|||
157205616|NCT01803464|567496195|FG003|Overall Study|Withdrawal by Subject|0|||
157205617|NCT02851069|567496196|FG000|Overall Study|Failure to Return|3|||
157205618|NCT02851069|567496196|FG000|Overall Study|Other|3|||
156863641|NCT00627393|566258730|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
156863642|NCT00627393|566258731|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
156863643|NCT00627393|566258730|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
156863644|NCT00627393|566258731|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
156863645|NCT00627393|566258730|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
156863646|NCT00627393|566258731|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
156863647|NCT00888134|566258735|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
156863648|NCT00888134|566258735|FG000|Follow-up|being followed for long-term survival|1|||
156863649|NCT03043313|566258736|FG000|Overall Study|Withdrawal by Subject|5|||
156863650|NCT03043313|566258737|FG001|Overall Study|Withdrawal by Subject|1|||
156863651|NCT03043313|566258738|FG002|Overall Study|Withdrawal by Subject|1|||
156863652|NCT03043313|566258736|FG000|Overall Study|Lost to Follow-up|1|||
156863653|NCT03043313|566258737|FG001|Overall Study|Lost to Follow-up|1|||
156863654|NCT03043313|566258738|FG002|Overall Study|Lost to Follow-up|0|||
156863655|NCT03043313|566258736|FG000|Overall Study|Death|28|||
156863656|NCT03043313|566258737|FG001|Overall Study|Death|26|||
156863657|NCT03043313|566258738|FG002|Overall Study|Death|17|||
156863658|NCT03043313|566258736|FG000|Overall Study|Participation terminated by sponsor|11|||
156863659|NCT03043313|566258737|FG001|Overall Study|Participation terminated by sponsor|13|||
156863660|NCT03043313|566258738|FG002|Overall Study|Participation terminated by sponsor|13|||
156863661|NCT00795535|566258739|FG000|Overall Study|incomplete data and technical problems|20|||
156863662|NCT00374140|566258742|FG000|Overall Study|Lost to Follow-up|1|||
156863663|NCT00374140|566258742|FG000|Overall Study|Protocol Violation|1|||
156863664|NCT02651675|566258743|FG000|Overall Study|Death|0|||
156863665|NCT02651675|566258744|FG001|Overall Study|Death|0|||
156863666|NCT02651675|566258745|FG002|Overall Study|Death|1|||
156863667|NCT02246530|566258746|FG000|Overall Study|Lost to Follow-up|4|||
156863668|NCT02246530|566258747|FG001|Overall Study|Lost to Follow-up|0|||
156863669|NCT01506596|566258748|FG000|Overall Study|ineligible pathology|1|||
156863670|NCT04366349|566258750|FG000|Overall Study|Withdrawal by Subject|1|||
156863671|NCT04366349|566258751|FG001|Overall Study|Withdrawal by Subject|0|||
156863672|NCT04366349|566258752|FG002|Overall Study|Withdrawal by Subject|0|||
156863673|NCT04366349|566258753|FG003|Overall Study|Withdrawal by Subject|0|||
156863674|NCT04366349|566258754|FG004|Overall Study|Withdrawal by Subject|0|||
156863675|NCT04366349|566258755|FG005|Overall Study|Withdrawal by Subject|0|||
156863676|NCT05194124|566258760|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863677|NCT05194124|566258761|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863678|NCT05194124|566258762|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863679|NCT05194124|566258763|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
156863680|NCT05194124|566258764|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863681|NCT05194124|566258765|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
156863682|NCT05194124|566258766|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863683|NCT05194124|566258767|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863684|NCT05194124|566258768|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863685|NCT05194124|566258769|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
156863686|NCT05194124|566258760|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863687|NCT05194124|566258761|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863688|NCT05194124|566258762|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863689|NCT05194124|566258763|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863690|NCT05194124|566258764|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863691|NCT05194124|566258765|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863692|NCT05194124|566258766|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863693|NCT05194124|566258767|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863694|NCT05194124|566258768|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
156863695|NCT05194124|566258769|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
156863696|NCT03642873|566258772|FG000|Third Intervention (1 Day)|Screen failure|0|||
156863697|NCT03642873|566258773|FG001|Third Intervention (1 Day)|Screen failure|0|||
156863698|NCT03642873|566258774|FG002|Third Intervention (1 Day)|Screen failure|0|||
156863699|NCT03642873|566258775|FG003|Third Intervention (1 Day)|Screen failure|0|||
156863700|NCT03642873|566258776|FG004|Third Intervention (1 Day)|Screen failure|1|||
156863701|NCT03642873|566258777|FG005|Third Intervention (1 Day)|Screen failure|0|||
156863702|NCT03694353|566258785|FG000|Overall Study|Withdrawal by Subject|1|||
156863703|NCT03694353|566258785|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
156863704|NCT03804528|566258786|FG000|Overall Study|Time Commitment|18|||
156863705|NCT03804528|566258786|FG000|Overall Study|Health Reasons|5|||
156863706|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
156863707|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863708|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863709|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863710|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863711|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863712|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863713|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863714|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863715|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863716|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863717|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863718|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863719|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863720|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863721|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
156863722|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863723|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
156863724|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863725|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863726|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863727|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863728|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863729|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863730|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
156863731|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863732|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863733|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863734|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863735|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863736|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863737|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
156863738|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863739|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
156863740|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863741|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863742|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
156863743|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863744|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863745|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863746|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863747|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863748|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863749|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863750|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863751|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863752|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863753|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
156863754|NCT05138653|566258789|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863755|NCT05138653|566258790|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863756|NCT05138653|566258791|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863757|NCT05138653|566258792|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863758|NCT05138653|566258793|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863759|NCT05138653|566258794|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863760|NCT05138653|566258795|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
156863761|NCT05138653|566258796|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863762|NCT05138653|566258797|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863763|NCT05138653|566258798|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863764|NCT05138653|566258799|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863765|NCT05138653|566258800|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863766|NCT05138653|566258801|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863767|NCT05138653|566258802|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863768|NCT05138653|566258803|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863769|NCT05138653|566258804|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
156863770|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863771|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863772|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863773|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863774|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863775|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863776|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863777|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863778|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863779|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863780|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863781|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863782|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863783|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863784|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
156863785|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
156863786|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863787|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863788|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863789|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863790|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863791|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863792|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863793|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863794|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863795|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863796|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863797|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863798|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863799|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863800|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
156863801|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
156863802|NCT05138653|566258789|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863803|NCT05138653|566258790|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863804|NCT05138653|566258791|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863805|NCT05138653|566258792|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863806|NCT05138653|566258793|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863807|NCT05138653|566258794|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863808|NCT05138653|566258795|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863809|NCT05138653|566258796|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863810|NCT05138653|566258797|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863811|NCT05138653|566258798|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863812|NCT05138653|566258799|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863813|NCT05138653|566258800|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863814|NCT05138653|566258801|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863815|NCT05138653|566258802|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
156863816|NCT05138653|566258803|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863817|NCT05138653|566258804|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
156863818|NCT04607005|566258805|FG000|Overall Study|Adverse Event|0|||
156863819|NCT04607005|566258806|FG001|Overall Study|Adverse Event|1|||
156863820|NCT04607005|566258805|FG000|Overall Study|Lack of Efficacy|1|||
156863821|NCT04607005|566258806|FG001|Overall Study|Lack of Efficacy|6|||
156863822|NCT04607005|566258805|FG000|Overall Study|Withdrawal by Subject|4|||
156863823|NCT04607005|566258806|FG001|Overall Study|Withdrawal by Subject|9|||
156863824|NCT04607005|566258805|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
156863825|NCT04607005|566258806|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
156863826|NCT02331134|566258807|FG000|Overall Study|Withdrawal by Subject|1|||
156863827|NCT04825574|566258808|FG000|Overall Study|Commercial treatment became available|1|||
156863828|NCT04825574|566258808|FG000|Overall Study|Disease progression|1|||
156863829|NCT04272242|566258809|FG000|Overall Study|Withdrawal by Subject|3|||
156863830|NCT04272242|566258809|FG000|Overall Study|Lost to Follow-up|1|||
156863831|NCT04272242|566258809|FG000|Overall Study|Adverse Event|1|||
156863832|NCT03204188|566258811|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
156863833|NCT03204188|566258811|FG000|Immunotherapy Phase (1 Year)|Death|1|||
156863834|NCT03204188|566258811|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
156863835|NCT03204188|566258811|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
